Citrus Sinensis ID: 017594

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------37
Protein Sequence
MMFDLDLNLKADNVIIELPANNKQAKRSKKKEVDQFPLFSFSSVSTATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNEAATLLPPKQPAFSYVRNTVTSTSSTGKTEDCSINQVTISLLEAR
Secondary Structure (PSIPRED)
ccccccccccccHHHHcccccHHHHHHcccccccccccEEHHHHHHHHccccccccccccccccccEEEcccccEEEEEEccccccccHHHHHHHHHHHHHccccccccEEcccccccEEEEEEEEcccccccEEcccccccccccHHHHHHHHHHHHHHHHHHcccccccEEccccccccccccccccccccccccccccccccccccccEEEEEcccccHHHHcccccccccccccHHHEEEEEEcccccccccccccccHHHHHHHHcccccccccccccccccccccccHHHHHHHHHHcccccccccccHHHHHHHHccccccccccccccEEEEccccccccccccccccccccEEEEEcccc
Secondary Structure Prediction (SSPRO)
cEEEEccccccccHEEEcccccccccccccccccccccEcHHHHHHHHHcccHHccccccccccEEccccccccEEEEEEccccccccHHHHHHHHHHHHHHHHHHHHHHHHcccccccEEEEEEEcccccccEEEccHHHcccccHHHHHHHHHHHHHHHHHHHHccHcccccccccHHHEEEcccccEEEcccccccEcccccEEccccEEEEEccHccHHHHHHccccHHHHHHHHHHHHHHHHHccccccccccccccHHHHHHHHHHcccccEHccHHHccccccHHHHHHHHHHHHHEEcccHcccccHHHEEEEccccccccccccccEEEEEccccccccccccccccccccEEEEEEccc
Coil and Loop (DISEMBL)
mmfdldlnlkadnviielpannkqakrskkkevdqfplfsfssvstatnkfsdanklgeggfgpvykgvlkkgdEIAVKRlsgrsgqglrEMKNEASVIAKVQHKNLVRLLGccidrdekiliyeympnksldfflfdptkrmlLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASnilldkdmnpkisdfgmaricggnelqantsrivgtygymspeyaLEGIFSIKSDVFSFGVLLLEIVSgkkntglyrtdslNLLGYAWdlwtsnrtlelidpiledeYSSKQMLLRYANIALLCVqesaddrptmNDVVSMLTNEaatllppkqpafsyvrntvtstsstgktedcsiNQVTISLLEAR
Flexible Loop (DISEMBL)
MMFDLDLNLKADNVIielpannkqakrskkkevdqfplfsfssvstatnkfsdanklgeggfgpVYKGVLKKGDEIAVkrlsgrsgqglreMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVsgkkntglyRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNEAAtllppkqpafsyVRNTVtstsstgktedcsinqvtisllear
Low Complexity Region (SEG)
MMFDLDLNLKADNVIIELPANNKQAKRSKKKEVDQFPLFSFSSVSTATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNEAATLLPPKQPAFSYVRNTVTSTSSTGKTEDCSINQVTISLLEAR
Disordered region (IsUnstruct)
*******NLKADNVIIE***************************************LGEGGFGPVYKGVLKKGDEIAV******************SVIAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYSSKQMLLRYANIALLCVQE**************************************************************
Disordered Region (DISOPRED)
MMFD********************************PLFSFSSVSTATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNEAATLLPPKQPAFS**********************VTISLLEAR
Disordered Region (DISEMBL)
MMFDLDLNLKADNVIIELPAN***********VDQFPLFSFSSVSTATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNEAATLLPPKQPAFSYVRN***********EDCSINQVTISLLEAR
Disordered Region (DISPRO)
MMFDLDLNLKADNVIIELPA************VDQFPLFSFSSVSTATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNEAATLLPPKQPAFSYVRN*************CSINQVTISLLEA*
Transmembrane Helix (TMHMM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (MEMSAT_SVM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooohhhhhhhhhhhhhhhhiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MMFDLDLNLKADNVIIELPANNKQAKRSKKKEVDQFPLFSFSSVSTATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNEAATLLPPKQPAFSYVRNTVTSTSSTGKTEDCSINQVTISLLEAR
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	369	2.2.26 [Sep-21-2011]
O81906	849	G-type lectin S-receptor-	yes	no	0.845	0.367	0.632	1e-116
Q9LW83	850	G-type lectin S-receptor-	no	no	0.910	0.395	0.592	1e-115
Q9ZR08	852	G-type lectin S-receptor-	no	no	0.899	0.389	0.613	1e-112
O64793	818	G-type lectin S-receptor-	no	no	0.932	0.420	0.571	1e-111
Q9SXB8	842	G-type lectin S-receptor-	no	no	0.945	0.414	0.555	1e-111
Q9S972	847	Receptor-like serine/thre	no	no	0.989	0.430	0.561	1e-110
Q39086	843	Receptor-like serine/thre	no	no	0.880	0.385	0.604	1e-110
Q9ZT07	833	G-type lectin S-receptor-	no	no	0.905	0.400	0.559	1e-109
Q9SY89	842	Putative G-type lectin S-	no	no	0.899	0.394	0.573	1e-108
O81905	850	Receptor-like serine/thre	no	no	0.989	0.429	0.549	1e-108

>sp|O81906|B120_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase B120 OS=Arabidopsis thaliana GN=B120 PE=1 SV=1

 Score =  417 bits (1071), Expect = e-116,   Method: Compositional matrix adjust.
 Identities = 198/313 (63%), Positives = 249/313 (79%), Gaps = 1/313 (0%)

Query: 29  KKKEVDQFPLFSFSSVSTATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQG 88
           K     + P+FS ++++ ATN F   N+LG GGFGPVYKGVL+ G EIAVKRLSG+SGQG
Sbjct: 507 KAVNTSELPVFSLNAIAIATNDFCKENELGRGGFGPVYKGVLEDGREIAVKRLSGKSGQG 566

Query: 89  LREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWV 148
           + E KNE  +IAK+QH+NLVRLLGCC + +EK+L+YEYMPNKSLDFFLFD TK+ L+DW 
Sbjct: 567 VDEFKNEIILIAKLQHRNLVRLLGCCFEGEEKMLVYEYMPNKSLDFFLFDETKQALIDWK 626

Query: 149 TRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQA 208
            R  IIEGIA+GLLYLH+ SR+RIIHRDLK SN+LLD +MNPKISDFGMARI GGN+ +A
Sbjct: 627 LRFSIIEGIARGLLYLHRDSRLRIIHRDLKVSNVLLDAEMNPKISDFGMARIFGGNQNEA 686

Query: 209 NTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAW 268
           NT R+VGTYGYMSPEYA+EG+FS+KSDV+SFGVLLLEIVSGK+NT L  ++  +L+GYAW
Sbjct: 687 NTVRVVGTYGYMSPEYAMEGLFSVKSDVYSFGVLLLEIVSGKRNTSLRSSEHGSLIGYAW 746

Query: 269 DLWTSNRTLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNEAAT 328
            L+T  R+ EL+DP +     SK+  LR  ++A+LCVQ+SA +RP M  V+ ML ++ AT
Sbjct: 747 YLYTHGRSEELVDPKIRVT-CSKREALRCIHVAMLCVQDSAAERPNMASVLLMLESDTAT 805

Query: 329 LLPPKQPAFSYVR 341
           L  P+QP F+  R
Sbjct: 806 LAAPRQPTFTSTR 818

Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|Q9LW83|CE101_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase CES101 OS=Arabidopsis thaliana GN=CES101 PE=2 SV=2

 Score =  414 bits (1064), Expect = e-115,   Method: Compositional matrix adjust.
 Identities = 202/341 (59%), Positives = 259/341 (75%), Gaps = 5/341 (1%)

Query: 34  DQFPLFSFSSVSTATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMK 93
           ++  +FSF SV+ AT+ FSDANKLGEGGFGPVYKG L  G+E+A+KRLS  SGQGL E K
Sbjct: 510 NELQIFSFESVAFATDYFSDANKLGEGGFGPVYKGRLIDGEEVAIKRLSLASGQGLVEFK 569

Query: 94  NEASVIAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQI 153
           NEA +IAK+QH NLV+LLGCC+++DEK+LIYEYMPNKSLD+FLFDP ++++LDW  R +I
Sbjct: 570 NEAMLIAKLQHTNLVKLLGCCVEKDEKMLIYEYMPNKSLDYFLFDPLRKIVLDWKLRFRI 629

Query: 154 IEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRI 213
           +EGI QGLLYLH+YSR+++IHRD+KA NILLD+DMNPKISDFGMARI G  E +ANT R+
Sbjct: 630 MEGIIQGLLYLHKYSRLKVIHRDIKAGNILLDEDMNPKISDFGMARIFGAQESKANTKRV 689

Query: 214 VGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDS--LNLLGYAWDLW 271
            GT+GYMSPEY  EG+FS KSDVFSFGVL+LEI+ G+KN   +      LNL+ + W+L+
Sbjct: 690 AGTFGYMSPEYFREGLFSAKSDVFSFGVLMLEIICGRKNNSFHHDSEGPLNLIVHVWNLF 749

Query: 272 TSNRTLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNEAATLLP 331
             NR  E+IDP L D       +LR   +ALLCVQ++ADDRP+M DVVSM+  +    L 
Sbjct: 750 KENRVREVIDPSLGDSAVENPQVLRCVQVALLCVQQNADDRPSMLDVVSMIYGDGNNALS 809

Query: 332 -PKQPAF--SYVRNTVTSTSSTGKTEDCSINQVTISLLEAR 369
            PK+PAF     R++        + E+ S N+VTI+++EAR
Sbjct: 810 LPKEPAFYDGPPRSSPEMEVEPPEMENVSANRVTITVMEAR 850

Promotes the expression of genes involved in photosynthesis at least in dedifferentiated calli.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9ZR08|Y4230_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At4g03230 OS=Arabidopsis thaliana GN=At4g03230 PE=3 SV=3

 Score =  405 bits (1040), Expect = e-112,   Method: Compositional matrix adjust.
 Identities = 206/336 (61%), Positives = 258/336 (76%), Gaps = 4/336 (1%)

Query: 37  PLFSFSSVSTATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEA 96
           P F   ++  AT+ FS+ANKLG+GGFGPVYKG+     EIAVKRLS  SGQGL E KNE 
Sbjct: 518 PSFELETILYATSNFSNANKLGQGGFGPVYKGMFPGDQEIAVKRLSRCSGQGLEEFKNEV 577

Query: 97  SVIAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEG 156
            +IAK+QH+NLVRLLG C+  +EK+L+YEYMP+KSLDFF+FD      LDW  R  II G
Sbjct: 578 VLIAKLQHRNLVRLLGYCVAGEEKLLLYEYMPHKSLDFFIFDRKLCQRLDWKMRCNIILG 637

Query: 157 IAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 216
           IA+GLLYLHQ SR+RIIHRDLK SNILLD++MNPKISDFG+ARI GG+E  ANT+R+VGT
Sbjct: 638 IARGLLYLHQDSRLRIIHRDLKTSNILLDEEMNPKISDFGLARIFGGSETSANTNRVVGT 697

Query: 217 YGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTD-SLNLLGYAWDLWTSNR 275
           YGYMSPEYALEG+FS KSDVFSFGV+++E +SGK+NTG +  + SL+LLG+AWDLW + R
Sbjct: 698 YGYMSPEYALEGLFSFKSDVFSFGVVVIETISGKRNTGFHEPEKSLSLLGHAWDLWKAER 757

Query: 276 TLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSML-TNEAATLLPPKQ 334
            +EL+D  L+ E    +  L+  N+ LLCVQE  +DRPTM++VV ML ++EAATL  PKQ
Sbjct: 758 GIELLDQALQ-ESCETEGFLKCLNVGLLCVQEDPNDRPTMSNVVFMLGSSEAATLPTPKQ 816

Query: 335 PAFSYVR-NTVTSTSSTGKTEDCSINQVTISLLEAR 369
           PAF   R  + +  SS+ K E CS N++TI+L + R
Sbjct: 817 PAFVLRRCPSSSKASSSTKPETCSENELTITLEDGR 852

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O64793|Y1675_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g67520 OS=Arabidopsis thaliana GN=At1g67520 PE=2 SV=3

 Score =  402 bits (1033), Expect = e-111,   Method: Compositional matrix adjust.
 Identities = 199/348 (57%), Positives = 257/348 (73%), Gaps = 4/348 (1%)

Query: 26  KRSKKKEVDQFPLFSFSSVSTATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRS 85
           KR+++K  ++  +FSF SV +AT+ FSD NKLGEGGFGPVYKG L  G+E+A+KRLS  S
Sbjct: 471 KRNERKSNNELQIFSFESVVSATDDFSDENKLGEGGFGPVYKGKLLNGEEVAIKRLSLAS 530

Query: 86  GQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLL 145
           GQGL E KNEA +IAK+QH NLV++LGCCI++DEK+LIYEYM NKSLD+FLFDP ++ +L
Sbjct: 531 GQGLVEFKNEAILIAKLQHTNLVQVLGCCIEKDEKMLIYEYMQNKSLDYFLFDPLRKNVL 590

Query: 146 DWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE 205
           DW  R +I+EGI QGLLYLH+YSR+++IHRD+KASNILLD+DMNPKISDFG+ARI G  E
Sbjct: 591 DWTLRFRIMEGIIQGLLYLHKYSRLKVIHRDIKASNILLDEDMNPKISDFGLARIFGAEE 650

Query: 206 LQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYR--TDSLNL 263
            +ANT R+ GT+GYMSPEY  EG+FS KSDVFSFGVL+LEI+ G+KN   +      LNL
Sbjct: 651 TRANTKRVAGTFGYMSPEYFREGLFSAKSDVFSFGVLMLEIICGRKNNSFHHDLEGPLNL 710

Query: 264 LGYAWDLWTSNRTLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLT 323
           + + W+L+  N+  E+ID  L D       +LR   +ALLCVQE+A+DRP+M DVVSM+ 
Sbjct: 711 IVHVWNLFKENKIREVIDLSLRDSALDYPQVLRCVQVALLCVQENAEDRPSMLDVVSMIY 770

Query: 324 NEAATLLP-PKQPAF-SYVRNTVTSTSSTGKTEDCSINQVTISLLEAR 369
            E    L  PK+PAF    R +        +  +     +TI++LEAR
Sbjct: 771 GEGNNALSLPKEPAFYDGPRRSFPEMKVEPQEPENVSASITITVLEAR 818

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9SXB8|Y1133_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g11330 OS=Arabidopsis thaliana GN=At1g11330 PE=1 SV=3

 Score =  400 bits (1029), Expect = e-111,   Method: Compositional matrix adjust.
 Identities = 196/353 (55%), Positives = 263/353 (74%), Gaps = 4/353 (1%)

Query: 18  LPANNKQAKRSKKKEVDQFPLFSFSSVSTATNKFSDANKLGEGGFGPVYKGVLKKGDEIA 77
           L ++N+ A  S + ++ + PLF F  ++T+T+ FS  NKLG+GGFGPVYKG L +G EIA
Sbjct: 493 LTSDNESA--SNQIKLKELPLFEFQVLATSTDSFSLRNKLGQGGFGPVYKGKLPEGQEIA 550

Query: 78  VKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLF 137
           VKRLS +SGQGL E+ NE  VI+K+QH+NLV+LLGCCI+ +E++L+YEYMP KSLD +LF
Sbjct: 551 VKRLSRKSGQGLEELMNEVVVISKLQHRNLVKLLGCCIEGEERMLVYEYMPKKSLDAYLF 610

Query: 138 DPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGM 197
           DP K+ +LDW TR  I+EGI +GLLYLH+ SR++IIHRDLKASNILLD+++NPKISDFG+
Sbjct: 611 DPMKQKILDWKTRFNIMEGICRGLLYLHRDSRLKIIHRDLKASNILLDENLNPKISDFGL 670

Query: 198 ARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYR 257
           ARI   NE +ANT R+VGTYGYMSPEYA+EG FS KSDVFS GV+ LEI+SG++N+  ++
Sbjct: 671 ARIFRANEDEANTRRVVGTYGYMSPEYAMEGFFSEKSDVFSLGVIFLEIISGRRNSSSHK 730

Query: 258 TD-SLNLLGYAWDLWTSNRTLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMN 316
            + +LNLL YAW LW       L DP + D+   K+ + +  +I LLCVQE A+DRP ++
Sbjct: 731 EENNLNLLAYAWKLWNDGEAASLADPAVFDKCFEKE-IEKCVHIGLLCVQEVANDRPNVS 789

Query: 317 DVVSMLTNEAATLLPPKQPAFSYVRNTVTSTSSTGKTEDCSINQVTISLLEAR 369
           +V+ MLT E  +L  PKQPAF   R    + SS   ++  SIN V+++ +  R
Sbjct: 790 NVIWMLTTENMSLADPKQPAFIVRRGASEAESSDQSSQKVSINDVSLTAVTGR 842

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9S972|SD16_ARATH Receptor-like serine/threonine-protein kinase SD1-6 OS=Arabidopsis thaliana GN=SD16 PE=1 SV=2

 Score =  399 bits (1026), Expect = e-110,   Method: Compositional matrix adjust.
 Identities = 209/372 (56%), Positives = 265/372 (71%), Gaps = 7/372 (1%)

Query: 5   LDLNLKADNVIIEL-PANNKQAKRSKKKEVDQFPLFSFSSVSTATNKFSDANKLGEGGFG 63
           +DL    D+++ EL  A+     +  K +  + PL  + +++ ATN FS  NKLG+GGFG
Sbjct: 476 VDLVRSQDSLMNELVKASRSYTSKENKTDYLELPLMEWKALAMATNNFSTDNKLGQGGFG 535

Query: 64  PVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILI 123
            VYKG+L  G EIAVKRLS  S QG  E  NE  +IAK+QH NLVRLLGCC+D+ EK+LI
Sbjct: 536 IVYKGMLLDGKEIAVKRLSKMSSQGTDEFMNEVRLIAKLQHINLVRLLGCCVDKGEKMLI 595

Query: 124 YEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNIL 183
           YEY+ N SLD  LFD T+   L+W  R  II GIA+GLLYLHQ SR RIIHRDLKASN+L
Sbjct: 596 YEYLENLSLDSHLFDQTRSSNLNWQKRFDIINGIARGLLYLHQDSRCRIIHRDLKASNVL 655

Query: 184 LDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLL 243
           LDK+M PKISDFGMARI G  E +ANT R+VGTYGYMSPEYA++GIFS+KSDVFSFGVLL
Sbjct: 656 LDKNMTPKISDFGMARIFGREETEANTRRVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLL 715

Query: 244 LEIVSGKKNTGLYRTD-SLNLLGYAWDLWTSNRTLELIDPILEDEYSSK---QMLLRYAN 299
           LEI+SGK+N G Y ++  LNLLG+ W  W   + LE++DPI  D  SS+     +LR   
Sbjct: 716 LEIISGKRNKGFYNSNRDLNLLGFVWRHWKEGKELEIVDPINIDALSSEFPTHEILRCIQ 775

Query: 300 IALLCVQESADDRPTMNDVVSMLTNEAATLLPPKQPAFSYVR--NTVTSTSSTGKTEDCS 357
           I LLCVQE A+DRP M+ V+ ML +E   +  PK+P F   R    V S+SST + ++C+
Sbjct: 776 IGLLCVQERAEDRPVMSSVMVMLGSETTAIPQPKRPGFCVGRSSLEVDSSSSTQRDDECT 835

Query: 358 INQVTISLLEAR 369
           +NQVT+S+++AR
Sbjct: 836 VNQVTLSVIDAR 847

Involved in the regulation of cellular expansion and differentiation.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q39086|SD17_ARATH Receptor-like serine/threonine-protein kinase SD1-7 OS=Arabidopsis thaliana GN=SD17 PE=1 SV=1

 Score =  398 bits (1022), Expect = e-110,   Method: Compositional matrix adjust.
 Identities = 200/331 (60%), Positives = 246/331 (74%), Gaps = 6/331 (1%)

Query: 45  STATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQH 104
           +TATN FS+ NKLG+GGFG VYKG L  G EIAVKRLS  S QG  E  NE  +IAK+QH
Sbjct: 513 ATATNNFSNDNKLGQGGFGIVYKGRLLDGKEIAVKRLSKMSSQGTDEFMNEVRLIAKLQH 572

Query: 105 KNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYL 164
            NLVRLLGCC+D+ EK+LIYEY+ N SLD  LFD T+   L+W  R  II GIA+GLLYL
Sbjct: 573 INLVRLLGCCVDKGEKMLIYEYLENLSLDSHLFDQTRSSNLNWQKRFDIINGIARGLLYL 632

Query: 165 HQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY 224
           HQ SR RIIHRDLKASN+LLDK+M PKISDFGMARI G  E +ANT R+VGTYGYMSPEY
Sbjct: 633 HQDSRCRIIHRDLKASNVLLDKNMTPKISDFGMARIFGREETEANTRRVVGTYGYMSPEY 692

Query: 225 ALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTD-SLNLLGYAWDLWTSNRTLELIDPI 283
           A++GIFS+KSDVFSFGVLLLEI+SGK+N G Y ++  LNLLG+ W  W     LE++DPI
Sbjct: 693 AMDGIFSMKSDVFSFGVLLLEIISGKRNKGFYNSNRDLNLLGFVWRHWKEGNELEIVDPI 752

Query: 284 LEDEYSSK---QMLLRYANIALLCVQESADDRPTMNDVVSMLTNEAATLLPPKQPAFSYV 340
             D  SSK     +LR   I LLCVQE A+DRP M+ V+ ML +E   +  PK+P F   
Sbjct: 753 NIDSLSSKFPTHEILRCIQIGLLCVQERAEDRPVMSSVMVMLGSETTAIPQPKRPGFCIG 812

Query: 341 RNTVT--STSSTGKTEDCSINQVTISLLEAR 369
           R+ +   S+SST + ++C++NQ+T+S+++AR
Sbjct: 813 RSPLEADSSSSTQRDDECTVNQITLSVIDAR 843

Involved in the regulation of cellular expansion and differentiation. Mediates subcellular relocalization of PUB9 from nucleus to plasma membrane in a protein-phosphorylation-dependent manner. May be involved in the abscisic acid-mediated signaling pathway, at least during germination.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9ZT07|RKS1_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase RKS1 OS=Arabidopsis thaliana GN=RKS1 PE=2 SV=3

 Score =  394 bits (1013), Expect = e-109,   Method: Compositional matrix adjust.
 Identities = 188/336 (55%), Positives = 250/336 (74%), Gaps = 2/336 (0%)

Query: 35  QFPLFSFSSVSTATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKN 94
           + PLF  +++  ATN FS  NKLG GGFGPVYKGVL+   EIAVKRLS  SGQG+ E KN
Sbjct: 499 ELPLFDLNTIVAATNNFSSQNKLGAGGFGPVYKGVLQNRMEIAVKRLSRNSGQGMEEFKN 558

Query: 95  EASVIAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQII 154
           E  +I+K+QH+NLVR+LGCC++ +EK+L+YEY+PNKSLD+F+F   +R  LDW  R++I+
Sbjct: 559 EVKLISKLQHRNLVRILGCCVELEEKMLVYEYLPNKSLDYFIFHEEQRAELDWPKRMEIV 618

Query: 155 EGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIV 214
            GIA+G+LYLHQ SR+RIIHRDLKASNILLD +M PKISDFGMARI GGN+++  TSR+V
Sbjct: 619 RGIARGILYLHQDSRLRIIHRDLKASNILLDSEMIPKISDFGMARIFGGNQMEGCTSRVV 678

Query: 215 GTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSN 274
           GT+GYM+PEYA+EG FSIKSDV+SFGVL+LEI++GKKN+  +  +S NL+G+ WDLW + 
Sbjct: 679 GTFGYMAPEYAMEGQFSIKSDVYSFGVLMLEIITGKKNSAFHE-ESSNLVGHIWDLWENG 737

Query: 275 RTLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNEAATLLPPKQ 334
              E+ID +++ E   ++ +++   I LLCVQE+A DR  M+ VV ML + A  L  PK 
Sbjct: 738 EATEIIDNLMDQETYDEREVMKCIQIGLLCVQENASDRVDMSSVVIMLGHNATNLPNPKH 797

Query: 335 PAFSYVRNTVTSTSSTGKTE-DCSINQVTISLLEAR 369
           PAF+  R       +  K +   S+N VT S ++ R
Sbjct: 798 PAFTSARRRGGENGACLKGQTGISVNDVTFSDIQGR 833

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9SY89|Y1661_ARATH Putative G-type lectin S-receptor-like serine/threonine-protein kinase At1g61610 OS=Arabidopsis thaliana GN=At1g61610 PE=2 SV=1

 Score =  391 bits (1004), Expect = e-108,   Method: Compositional matrix adjust.
 Identities = 191/333 (57%), Positives = 246/333 (73%), Gaps = 1/333 (0%)

Query: 37  PLFSFSSVSTATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEA 96
           P+FSF SV++AT  F++ NKLG+GGFG VYKG   +G EIAVKRLSG+S QGL E KNE 
Sbjct: 511 PIFSFDSVASATGDFAEENKLGQGGFGTVYKGNFSEGREIAVKRLSGKSKQGLEEFKNEI 570

Query: 97  SVIAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEG 156
            +IAK+QH+NLVRLLGCCI+ +EK+L+YEYMPNKSLD FLFD +K+  LDW  R ++I G
Sbjct: 571 LLIAKLQHRNLVRLLGCCIEDNEKMLLYEYMPNKSLDRFLFDESKQGSLDWRKRWEVIGG 630

Query: 157 IAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 216
           IA+GLLYLH+ SR++IIHRDLKASNILLD +MNPKISDFGMARI    +  ANT R+VGT
Sbjct: 631 IARGLLYLHRDSRLKIIHRDLKASNILLDTEMNPKISDFGMARIFNYRQDHANTIRVVGT 690

Query: 217 YGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRT 276
           YGYM+PEYA+EGIFS KSDV+SFGVL+LEIVSG+KN     TD  +L+GYAW LW+  +T
Sbjct: 691 YGYMAPEYAMEGIFSEKSDVYSFGVLILEIVSGRKNVSFRGTDHGSLIGYAWHLWSQGKT 750

Query: 277 LELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNEAATLLPPKQPA 336
            E+IDPI++D     +  +R  ++ +LC Q+S   RP M  V+ ML ++ + L PP+QP 
Sbjct: 751 KEMIDPIVKDTRDVTEA-MRCIHVGMLCTQDSVIHRPNMGSVLLMLESQTSQLPPPRQPT 809

Query: 337 FSYVRNTVTSTSSTGKTEDCSINQVTISLLEAR 369
           F    N+     +    +  S+N VT + +  R
Sbjct: 810 FHSFLNSGDIELNFDGHDVASVNDVTFTTIVGR 842

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O81905|SD18_ARATH Receptor-like serine/threonine-protein kinase SD1-8 OS=Arabidopsis thaliana GN=SD18 PE=1 SV=1

 Score =  390 bits (1002), Expect = e-108,   Method: Compositional matrix adjust.
 Identities = 205/373 (54%), Positives = 264/373 (70%), Gaps = 8/373 (2%)

Query: 5   LDLNLKADNVIIELPANNKQAKRSKKKEVD--QFPLFSFSSVSTATNKFSDANKLGEGGF 62
           +D  L++ ++++     + +   S++   D  + PL  F  V+ ATN FS+ANKLG+GGF
Sbjct: 478 VDHQLRSRDLLMNEVVISSRRHISRENNTDDLELPLMEFEEVAMATNNFSNANKLGQGGF 537

Query: 63  GPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKIL 122
           G VYKG L  G E+AVKRLS  S QG  E KNE  +IA++QH NLVRLL CC+D  EK+L
Sbjct: 538 GIVYKGKLLDGQEMAVKRLSKTSVQGTDEFKNEVKLIARLQHINLVRLLACCVDAGEKML 597

Query: 123 IYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNI 182
           IYEY+ N SLD  LFD ++   L+W  R  II GIA+GLLYLHQ SR RIIHRDLKASNI
Sbjct: 598 IYEYLENLSLDSHLFDKSRNSKLNWQMRFDIINGIARGLLYLHQDSRFRIIHRDLKASNI 657

Query: 183 LLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVL 242
           LLDK M PKISDFGMARI G +E +ANT ++VGTYGYMSPEYA++GIFS+KSDVFSFGVL
Sbjct: 658 LLDKYMTPKISDFGMARIFGRDETEANTRKVVGTYGYMSPEYAMDGIFSMKSDVFSFGVL 717

Query: 243 LLEIVSGKKNTGLYRTD-SLNLLGYAWDLWTSNRTLELIDPILEDEYSS--KQMLLRYAN 299
           LLEI+S K+N G Y +D  LNLLG  W  W   + LE+IDPI+ D  S+  +  +LR   
Sbjct: 718 LLEIISSKRNKGFYNSDRDLNLLGCVWRNWKEGKGLEIIDPIITDSSSTFRQHEILRCIQ 777

Query: 300 IALLCVQESADDRPTMNDVVSMLTNEAATLLPPKQPAFSYVRNTVTSTSSTGKTED---C 356
           I LLCVQE A+DRPTM+ V+ ML +E+ T+  PK P +   R+ + + SS+ K  D    
Sbjct: 778 IGLLCVQERAEDRPTMSLVILMLGSESTTIPQPKAPGYCLERSLLDTDSSSSKQRDDESW 837

Query: 357 SINQVTISLLEAR 369
           ++NQ+T+S+L+AR
Sbjct: 838 TVNQITVSVLDAR 850

Involved in the regulation of cellular expansion and differentiation.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	369
359484155	865	PREDICTED: receptor-like serine/threonin	0.915	0.390	0.736	1e-141
297742753	637	unnamed protein product [Vitis vinifera]	0.915	0.530	0.736	1e-141
356514857	834	PREDICTED: G-type lectin S-receptor-like	0.989	0.437	0.680	1e-140
359493705	830	PREDICTED: receptor-like serine/threonin	0.978	0.434	0.690	1e-139
302143120	674	unnamed protein product [Vitis vinifera]	0.978	0.535	0.690	1e-138
296090091	674	unnamed protein product [Vitis vinifera]	0.986	0.540	0.685	1e-137
302143128	692	unnamed protein product [Vitis vinifera]	0.940	0.501	0.690	1e-135
302143125	585	unnamed protein product [Vitis vinifera]	0.983	0.620	0.677	1e-135
302143119	547	unnamed protein product [Vitis vinifera]	0.924	0.623	0.696	1e-134
224106535	333	predicted protein [Populus trichocarpa]	0.899	0.996	0.707	1e-133

>gi|359484155|ref|XP_002272509.2| PREDICTED: receptor-like serine/threonine-protein kinase SD1-8-like [Vitis vinifera]

 Score =  506 bits (1304), Expect = e-141,   Method: Compositional matrix adjust.
 Identities = 251/341 (73%), Positives = 287/341 (84%), Gaps = 3/341 (0%)

Query: 29  KKKEVDQFPLFSFSSVSTATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQG 88
           +KKEVD  P+FSF+SVS ATN FS  NKLGEGGFGPVYKG  +KG E+AVKRLS RSGQG
Sbjct: 528 EKKEVD-LPMFSFASVSAATNNFSIENKLGEGGFGPVYKGKSQKGYEVAVKRLSKRSGQG 586

Query: 89  LREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWV 148
             E+KNE  +IAK+QHKNLV+L G CI++DEKILIYEYMPNKSLDFFLFDPTK  +L+W 
Sbjct: 587 WEELKNEVMLIAKLQHKNLVKLFGYCIEKDEKILIYEYMPNKSLDFFLFDPTKHGILNWK 646

Query: 149 TRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQA 208
           TRV II+G+AQGLLYLHQYSR+RIIHRDLKASNILLDKDMNP+ISDFGMARI GGNE +A
Sbjct: 647 TRVHIIKGVAQGLLYLHQYSRLRIIHRDLKASNILLDKDMNPQISDFGMARIFGGNESKA 706

Query: 209 NTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAW 268
            T+ IVGTYGYMSPEYALEG+FS KSDVFSFGVLLLEI+SGKKNTG Y+TDSLNLLGYAW
Sbjct: 707 -TNHIVGTYGYMSPEYALEGLFSTKSDVFSFGVLLLEILSGKKNTGFYQTDSLNLLGYAW 765

Query: 269 DLWTSNRTLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNEAAT 328
           DLW  +R  EL+DP LE+   +  +LLRY NI LLCVQESADDRPTM+DVVSML NE+  
Sbjct: 766 DLWKDSRGQELMDPGLEETLPT-HILLRYINIGLLCVQESADDRPTMSDVVSMLGNESVR 824

Query: 329 LLPPKQPAFSYVRNTVTSTSSTGKTEDCSINQVTISLLEAR 369
           L  PKQPAFS +R+ V    S  K + CS+N VT+S++EAR
Sbjct: 825 LPSPKQPAFSNLRSGVEPHISQNKPKICSLNGVTLSVMEAR 865

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|297742753|emb|CBI35387.3| unnamed protein product [Vitis vinifera]

 Score =  506 bits (1302), Expect = e-141,   Method: Compositional matrix adjust.
 Identities = 251/341 (73%), Positives = 287/341 (84%), Gaps = 3/341 (0%)

Query: 29  KKKEVDQFPLFSFSSVSTATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQG 88
           +KKEVD  P+FSF+SVS ATN FS  NKLGEGGFGPVYKG  +KG E+AVKRLS RSGQG
Sbjct: 300 EKKEVD-LPMFSFASVSAATNNFSIENKLGEGGFGPVYKGKSQKGYEVAVKRLSKRSGQG 358

Query: 89  LREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWV 148
             E+KNE  +IAK+QHKNLV+L G CI++DEKILIYEYMPNKSLDFFLFDPTK  +L+W 
Sbjct: 359 WEELKNEVMLIAKLQHKNLVKLFGYCIEKDEKILIYEYMPNKSLDFFLFDPTKHGILNWK 418

Query: 149 TRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQA 208
           TRV II+G+AQGLLYLHQYSR+RIIHRDLKASNILLDKDMNP+ISDFGMARI GGNE +A
Sbjct: 419 TRVHIIKGVAQGLLYLHQYSRLRIIHRDLKASNILLDKDMNPQISDFGMARIFGGNESKA 478

Query: 209 NTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAW 268
            T+ IVGTYGYMSPEYALEG+FS KSDVFSFGVLLLEI+SGKKNTG Y+TDSLNLLGYAW
Sbjct: 479 -TNHIVGTYGYMSPEYALEGLFSTKSDVFSFGVLLLEILSGKKNTGFYQTDSLNLLGYAW 537

Query: 269 DLWTSNRTLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNEAAT 328
           DLW  +R  EL+DP LE+   +  +LLRY NI LLCVQESADDRPTM+DVVSML NE+  
Sbjct: 538 DLWKDSRGQELMDPGLEETLPT-HILLRYINIGLLCVQESADDRPTMSDVVSMLGNESVR 596

Query: 329 LLPPKQPAFSYVRNTVTSTSSTGKTEDCSINQVTISLLEAR 369
           L  PKQPAFS +R+ V    S  K + CS+N VT+S++EAR
Sbjct: 597 LPSPKQPAFSNLRSGVEPHISQNKPKICSLNGVTLSVMEAR 637

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356514857|ref|XP_003526119.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase At1g11300-like [Glycine max]

 Score =  505 bits (1301), Expect = e-140,   Method: Compositional matrix adjust.
 Identities = 253/372 (68%), Positives = 296/372 (79%), Gaps = 7/372 (1%)

Query: 1   MMFDLDLNLKADNVIIELPANNKQAKRSKKKEVDQFPLFSFSSVSTATNKFSDANKLGEG 60
           + F + +++K ++   EL   ++ AK  KKKEV + PLFSF SV+ ATN FSDANKLGEG
Sbjct: 467 LRFHVSMSMKVEDS--ELAEAHRGAK-VKKKEV-KLPLFSFVSVAAATNNFSDANKLGEG 522

Query: 61  GFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEK 120
           GFGPVYKG+L  GDE+AVKRLS RSGQG  E++NEA +IAK+QH NLVRLLGCCIDRDEK
Sbjct: 523 GFGPVYKGILLNGDEVAVKRLSRRSGQGWEELRNEALLIAKLQHNNLVRLLGCCIDRDEK 582

Query: 121 ILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKAS 180
           +LIYE MPNKSLD FLFD TKR +LDW TRV+II+GIAQG+LYLHQYSR RIIHRDLKAS
Sbjct: 583 MLIYELMPNKSLDVFLFDATKRRMLDWGTRVRIIDGIAQGILYLHQYSRFRIIHRDLKAS 642

Query: 181 NILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFG 240
           NILLD +MNPKISDFGMARI G NELQANT+RIVGTYGYMSPEYA+EG+FSIKSDVFSFG
Sbjct: 643 NILLDTNMNPKISDFGMARIFGDNELQANTNRIVGTYGYMSPEYAMEGLFSIKSDVFSFG 702

Query: 241 VLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDE---YSSKQMLLRY 297
           VLLLEI+SGKKNTG Y+T+S NLLGYAWDLWT+N  ++L+DP L+D     SS   + RY
Sbjct: 703 VLLLEILSGKKNTGFYQTNSFNLLGYAWDLWTNNSGMDLMDPALDDSDTTSSSMHTVPRY 762

Query: 298 ANIALLCVQESADDRPTMNDVVSMLTNEAATLLPPKQPAFSYVRNTVTSTSSTGKTEDCS 357
            NI LLCVQES  DRPTM+DVVSM+ N+   L  PK PAF  VR    S       E  S
Sbjct: 763 VNIGLLCVQESPADRPTMSDVVSMIGNDTVALPSPKPPAFLNVRGNQNSILPASMPESFS 822

Query: 358 INQVTISLLEAR 369
           +N +T +++EAR
Sbjct: 823 LNLITDTMVEAR 834

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359493705|ref|XP_003634654.1| PREDICTED: receptor-like serine/threonine-protein kinase SD1-8-like [Vitis vinifera]

 Score =  499 bits (1286), Expect = e-139,   Method: Compositional matrix adjust.
 Identities = 252/365 (69%), Positives = 294/365 (80%), Gaps = 4/365 (1%)

Query: 5   LDLNLKADNVIIELPANNKQAKRSKKKEVDQFPLFSFSSVSTATNKFSDANKLGEGGFGP 64
            D    +++   EL   N+   R +K+EVD  P+FSF+SVS +TN FS  NKLGEGGFG 
Sbjct: 470 FDFGNSSEDTSYELDETNR-LWRGEKREVD-LPMFSFASVSASTNNFSIENKLGEGGFGS 527

Query: 65  VYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIY 124
           VYKG  ++  E+AVKRLS RS QG  E+KNEA +IAK+QHKNLV++LG CI+RDEKILIY
Sbjct: 528 VYKGKSQRRYEVAVKRLSKRSKQGWEELKNEAMLIAKLQHKNLVKVLGYCIERDEKILIY 587

Query: 125 EYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILL 184
           EYM NKSLDFFLFDPTK  +L+W TRV IIEG+AQGLLYLHQYSR+RIIHRDLKASNILL
Sbjct: 588 EYMSNKSLDFFLFDPTKHGILNWKTRVHIIEGVAQGLLYLHQYSRLRIIHRDLKASNILL 647

Query: 185 DKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLL 244
           DKDMNPKISDFGMARI GGNE +  T+ IVGTYGYMSPEYALEG+FS KSDVFSFGVLLL
Sbjct: 648 DKDMNPKISDFGMARIFGGNESKV-TNHIVGTYGYMSPEYALEGLFSTKSDVFSFGVLLL 706

Query: 245 EIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYSSKQMLLRYANIALLC 304
           EI+SGKKNTG Y+TDSLNLLGYAWDLW  +R LEL+DP LE+   +  +LLRY N+ LLC
Sbjct: 707 EILSGKKNTGFYQTDSLNLLGYAWDLWKDSRGLELMDPGLEETLPT-HILLRYINVGLLC 765

Query: 305 VQESADDRPTMNDVVSMLTNEAATLLPPKQPAFSYVRNTVTSTSSTGKTEDCSINQVTIS 364
           VQESADDRPTM+DVVSML NE+  L  PKQPAFS +R+ V    S  + E CS+N VT+S
Sbjct: 766 VQESADDRPTMSDVVSMLGNESVRLPSPKQPAFSNLRSGVEPHISQNRPEVCSLNGVTLS 825

Query: 365 LLEAR 369
           ++EAR
Sbjct: 826 VMEAR 830

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|302143120|emb|CBI20415.3| unnamed protein product [Vitis vinifera]

 Score =  498 bits (1282), Expect = e-138,   Method: Compositional matrix adjust.
 Identities = 252/365 (69%), Positives = 294/365 (80%), Gaps = 4/365 (1%)

Query: 5   LDLNLKADNVIIELPANNKQAKRSKKKEVDQFPLFSFSSVSTATNKFSDANKLGEGGFGP 64
            D    +++   EL   N+   R +K+EVD  P+FSF+SVS +TN FS  NKLGEGGFG 
Sbjct: 314 FDFGNSSEDTSYELDETNR-LWRGEKREVD-LPMFSFASVSASTNNFSIENKLGEGGFGS 371

Query: 65  VYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIY 124
           VYKG  ++  E+AVKRLS RS QG  E+KNEA +IAK+QHKNLV++LG CI+RDEKILIY
Sbjct: 372 VYKGKSQRRYEVAVKRLSKRSKQGWEELKNEAMLIAKLQHKNLVKVLGYCIERDEKILIY 431

Query: 125 EYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILL 184
           EYM NKSLDFFLFDPTK  +L+W TRV IIEG+AQGLLYLHQYSR+RIIHRDLKASNILL
Sbjct: 432 EYMSNKSLDFFLFDPTKHGILNWKTRVHIIEGVAQGLLYLHQYSRLRIIHRDLKASNILL 491

Query: 185 DKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLL 244
           DKDMNPKISDFGMARI GGNE +  T+ IVGTYGYMSPEYALEG+FS KSDVFSFGVLLL
Sbjct: 492 DKDMNPKISDFGMARIFGGNESKV-TNHIVGTYGYMSPEYALEGLFSTKSDVFSFGVLLL 550

Query: 245 EIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYSSKQMLLRYANIALLC 304
           EI+SGKKNTG Y+TDSLNLLGYAWDLW  +R LEL+DP LE+   +  +LLRY N+ LLC
Sbjct: 551 EILSGKKNTGFYQTDSLNLLGYAWDLWKDSRGLELMDPGLEETLPT-HILLRYINVGLLC 609

Query: 305 VQESADDRPTMNDVVSMLTNEAATLLPPKQPAFSYVRNTVTSTSSTGKTEDCSINQVTIS 364
           VQESADDRPTM+DVVSML NE+  L  PKQPAFS +R+ V    S  + E CS+N VT+S
Sbjct: 610 VQESADDRPTMSDVVSMLGNESVRLPSPKQPAFSNLRSGVEPHISQNRPEVCSLNGVTLS 669

Query: 365 LLEAR 369
           ++EAR
Sbjct: 670 VMEAR 674

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|296090091|emb|CBI39910.3| unnamed protein product [Vitis vinifera]

 Score =  493 bits (1269), Expect = e-137,   Method: Compositional matrix adjust.
 Identities = 253/369 (68%), Positives = 293/369 (79%), Gaps = 5/369 (1%)

Query: 1   MMFDLDLNLKADNVIIELPANNKQAKRSKKKEVDQFPLFSFSSVSTATNKFSDANKLGEG 60
           ++FD   N   D    EL   N+   R +KKEVD  P+FSF+SVS +TN F + NKLGEG
Sbjct: 311 LLFDFG-NSSEDTSCYELGETNR-LWRGEKKEVD-LPMFSFASVSASTNNFCNENKLGEG 367

Query: 61  GFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEK 120
           GFG VYKG  ++  E+AVKRLS RS QG  E+KNEA +IAK+QHKNLV++LG CI+RDEK
Sbjct: 368 GFGSVYKGKSQRRYEVAVKRLSKRSKQGWEELKNEAMLIAKLQHKNLVKVLGYCIERDEK 427

Query: 121 ILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKAS 180
           ILIYEYM NKSLDFFLFDPTK  +L+W T V IIEG+AQGLLYLHQYSR+RIIHRDLKAS
Sbjct: 428 ILIYEYMSNKSLDFFLFDPTKHGILNWKTWVHIIEGVAQGLLYLHQYSRMRIIHRDLKAS 487

Query: 181 NILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFG 240
           NILLDKDMNPKISDFGMARI GGNE +A T+ IVGTYGYMSPEYALEG+FS KSDVFSFG
Sbjct: 488 NILLDKDMNPKISDFGMARIFGGNEPKA-TNHIVGTYGYMSPEYALEGLFSTKSDVFSFG 546

Query: 241 VLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYSSKQMLLRYANI 300
           VLL+EI+SGKKNTG Y+TDSLNLLGYAWDLW  +R  EL+DP LE E S   +LLRY N+
Sbjct: 547 VLLMEILSGKKNTGFYQTDSLNLLGYAWDLWKDSRGQELMDPGLE-ETSPTHILLRYINV 605

Query: 301 ALLCVQESADDRPTMNDVVSMLTNEAATLLPPKQPAFSYVRNTVTSTSSTGKTEDCSINQ 360
            LLCVQESADDRPTM+DVVSML NE+  L  PKQPAFS +R+ V    S  +    S+N 
Sbjct: 606 GLLCVQESADDRPTMSDVVSMLGNESVRLPSPKQPAFSNLRSGVEPHISQNRPGIYSLNG 665

Query: 361 VTISLLEAR 369
           VT+S++EAR
Sbjct: 666 VTLSVMEAR 674

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|302143128|emb|CBI20423.3| unnamed protein product [Vitis vinifera]

 Score =  489 bits (1258), Expect = e-135,   Method: Compositional matrix adjust.
 Identities = 241/349 (69%), Positives = 282/349 (80%), Gaps = 2/349 (0%)

Query: 22  NKQAKRSKKKEVDQF-PLFSFSSVSTATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKR 80
           N+  +  K K  D + PLFSF+SVS AT  FS  NKLG+GGFGPVYKG L  G EIAVKR
Sbjct: 345 NEGNRVGKDKNKDAWLPLFSFASVSAATEHFSTENKLGQGGFGPVYKGELFNGQEIAVKR 404

Query: 81  LSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPT 140
           LS  SGQGL E+KNE  ++A++QH+NLVRLLGCCI++ EKILIYEYMPNKSLD FLFDP 
Sbjct: 405 LSRSSGQGLEELKNETVLLAELQHRNLVRLLGCCIEQGEKILIYEYMPNKSLDSFLFDPN 464

Query: 141 KRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARI 200
           KR  LDW  RV IIEGIAQGLLYLH+YSR+RIIHRDLKASNILLD DMNPKISDFGMAR+
Sbjct: 465 KRGQLDWAKRVSIIEGIAQGLLYLHEYSRLRIIHRDLKASNILLDNDMNPKISDFGMARM 524

Query: 201 CGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDS 260
            GGNE  ANT+RIVGTYGYMSPEYALEG+FS KSDVFSFGVL+LEI+SGKKNTG Y +D+
Sbjct: 525 FGGNESYANTNRIVGTYGYMSPEYALEGLFSTKSDVFSFGVLMLEILSGKKNTGFYNSDT 584

Query: 261 LNLLGYAWDLWTSNRTLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVS 320
           LNL+GYAW+LW S+  + L+DP+LE + SS+ MLLRY N+ LLCV+E A DRPT+++VVS
Sbjct: 585 LNLIGYAWELWKSDMAINLMDPMLEGQ-SSQYMLLRYINVGLLCVEEIAADRPTLSEVVS 643

Query: 321 MLTNEAATLLPPKQPAFSYVRNTVTSTSSTGKTEDCSINQVTISLLEAR 369
           MLTNE A L  PK PAFS VR+     SS  + E  S N ++IS++EAR
Sbjct: 644 MLTNELAVLPSPKHPAFSTVRSMENPRSSMSRPEIYSANGLSISVMEAR 692

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|302143125|emb|CBI20420.3| unnamed protein product [Vitis vinifera]

 Score =  487 bits (1253), Expect = e-135,   Method: Compositional matrix adjust.
 Identities = 250/369 (67%), Positives = 290/369 (78%), Gaps = 6/369 (1%)

Query: 1   MMFDLDLNLKADNVIIELPANNKQAKRSKKKEVDQFPLFSFSSVSTATNKFSDANKLGEG 60
           ++FD   N   D    EL   N+   R +KKEVD  P+FSF SVS +TN F   NKLGEG
Sbjct: 223 LVFDFG-NSSEDTSCYELGETNR-LWRGEKKEVD-LPMFSFVSVSASTNNFCIENKLGEG 279

Query: 61  GFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEK 120
           GFG VYKG  ++G E+AVKRLS RS QG  E+KNEA +IAK+QHKNLV++LG CI+RDEK
Sbjct: 280 GFGSVYKGKSQRGYEVAVKRLSKRSKQGWEELKNEAMLIAKLQHKNLVKVLGYCIERDEK 339

Query: 121 ILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKAS 180
           ILIYEYM NKSLDFFLFDP KR +L+W TRV+IIEG+AQGLLYLHQYSR+R+IHRDLKAS
Sbjct: 340 ILIYEYMSNKSLDFFLFDPAKRGILNWETRVRIIEGVAQGLLYLHQYSRLRVIHRDLKAS 399

Query: 181 NILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFG 240
           NILLDKDMNPKISDFGMARI GGNE +A T  IVGTYGYMSPEY L G+FS KSDVFSFG
Sbjct: 400 NILLDKDMNPKISDFGMARIFGGNESKA-TKHIVGTYGYMSPEYVLRGLFSTKSDVFSFG 458

Query: 241 VLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYSSKQMLLRYANI 300
           VLLLEI+SGKK T  Y +DSLNLLGYAWDLW +NR  ELIDP+  +E SS+ +LLRY N+
Sbjct: 459 VLLLEILSGKKITEFYHSDSLNLLGYAWDLWKNNRGQELIDPV-PNEISSRHILLRYINV 517

Query: 301 ALLCVQESADDRPTMNDVVSMLTNEAATLLPPKQPAFSYVRNTVTSTSSTGKTEDCSINQ 360
           ALLCVQE+ADDRPTM+DVVSML  E   L  P +PAFSY+R  V   +S  + E CS+N 
Sbjct: 518 ALLCVQENADDRPTMSDVVSMLGRENVLLSSPNEPAFSYLRG-VKPHASQERPEICSLND 576

Query: 361 VTISLLEAR 369
           VT+S + AR
Sbjct: 577 VTLSSMGAR 585

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|302143119|emb|CBI20414.3| unnamed protein product [Vitis vinifera]

 Score =  483 bits (1244), Expect = e-134,   Method: Compositional matrix adjust.
 Identities = 241/346 (69%), Positives = 282/346 (81%), Gaps = 5/346 (1%)

Query: 27  RSKKKEVDQFPLFSFSSVSTATN-KFSDANKL--GEGGFGPVYKGVLKKGDEIAVKRLSG 83
           R  +++ +   LF FS+ S  TN + S+ANKL  GEGGFGPVYKG  +KG E+AVKRLS 
Sbjct: 204 RKIRRKGENLLLFDFSNSSEDTNYELSEANKLWRGEGGFGPVYKGKSQKGYEVAVKRLSK 263

Query: 84  RSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRM 143
           RSGQG  E+KNEA +IAK+QHKNLV+L GCCI++DEKILIYEYMPNKSLDFFLFD     
Sbjct: 264 RSGQGWEELKNEAMLIAKLQHKNLVKLFGCCIEQDEKILIYEYMPNKSLDFFLFDSANHG 323

Query: 144 LLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGG 203
           +L+W TRV IIEG+AQGLLYLHQYSR+RIIHRDLKASNILLDKD+NPKISDFGMARI G 
Sbjct: 324 ILNWETRVHIIEGVAQGLLYLHQYSRLRIIHRDLKASNILLDKDLNPKISDFGMARIFGS 383

Query: 204 NELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNL 263
           NE +A T+ IVGTYGYMSPEYALEG+FS KSDVFSFGVLLLEI+SGKKNTG Y++DSLNL
Sbjct: 384 NESKA-TNHIVGTYGYMSPEYALEGLFSTKSDVFSFGVLLLEILSGKKNTGFYQSDSLNL 442

Query: 264 LGYAWDLWTSNRTLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLT 323
           LGYAWDLW  +R  EL+DP+LE E   + +LL+Y NI LLCVQESADDRPTM+DVVSML 
Sbjct: 443 LGYAWDLWKDSRGQELMDPVLE-EALPRHILLKYINIGLLCVQESADDRPTMSDVVSMLG 501

Query: 324 NEAATLLPPKQPAFSYVRNTVTSTSSTGKTEDCSINQVTISLLEAR 369
           NE+  L  PKQPAFS +R+ V       + E CS+N VT+S++EAR
Sbjct: 502 NESLHLPSPKQPAFSNLRSGVEPHIFQNRPEMCSLNSVTLSIMEAR 547

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224106535|ref|XP_002333668.1| predicted protein [Populus trichocarpa] gi|222837959|gb|EEE76324.1| predicted protein [Populus trichocarpa]

 Score =  482 bits (1241), Expect = e-133,   Method: Compositional matrix adjust.
 Identities = 237/335 (70%), Positives = 270/335 (80%), Gaps = 3/335 (0%)

Query: 35  QFPLFSFSSVSTATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKN 94
           + PLFS+ SVS AT +FSD  KLGEGGFGPVYKG L KG EIAVKRLS RSGQGL E +N
Sbjct: 2   ELPLFSYESVSVATEQFSD--KLGEGGFGPVYKGKLPKGLEIAVKRLSERSGQGLEEFRN 59

Query: 95  EASVIAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQII 154
           E  +IAK+QH+NLVRLLG CI+RDEK+LIYEYMPNKSLDFFLFD  +  +LDW TR++II
Sbjct: 60  ETILIAKLQHRNLVRLLGSCIERDEKMLIYEYMPNKSLDFFLFDANRGQILDWGTRIRII 119

Query: 155 EGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIV 214
           EGIAQGLLYLH+YSR+RIIHRDLK SNILLD +MNPKISDFGMARI GGNE QANT+RIV
Sbjct: 120 EGIAQGLLYLHRYSRLRIIHRDLKPSNILLDSEMNPKISDFGMARIFGGNETQANTNRIV 179

Query: 215 GTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSN 274
           GTYGYMSPEYA+EG+FSIKSDVFSFGVL+LEIVSGKKNT  Y + SLNLLG+AW LW SN
Sbjct: 180 GTYGYMSPEYAMEGLFSIKSDVFSFGVLVLEIVSGKKNTSFYHSGSLNLLGHAWKLWNSN 239

Query: 275 RTLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNEAATLLPPKQ 334
           + L+L+DPIL D  S+   LLRY NI LLCVQES  DRPTM+DV+SM+ NE   L  PKQ
Sbjct: 240 KALDLMDPILGDPPSTAT-LLRYINIGLLCVQESPADRPTMSDVISMIVNEHVALPEPKQ 298

Query: 335 PAFSYVRNTVTSTSSTGKTEDCSINQVTISLLEAR 369
           PAF   RN     S        S+N VTI+ ++AR
Sbjct: 299 PAFVAGRNVAEPRSLMSFAGVPSVNNVTITTIDAR 333

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	369
TAIR|locus:2093397	850	CES101 "CALLUS EXPRESSION OF R	0.964	0.418	0.571	7.2e-107
TAIR|locus:2141176	849	B120 [Arabidopsis thaliana (ta	0.921	0.400	0.590	1.4e-105
TAIR|locus:2018506	847	RK2 "receptor kinase 2" [Arabi	0.989	0.430	0.561	4.1e-104
TAIR|locus:2018546	843	RK1 "receptor kinase 1" [Arabi	0.970	0.424	0.567	6.7e-104
UNIPROTKB|O49974	848	KIK1 "Serine/threonine-protein	0.905	0.393	0.583	2.9e-103
TAIR|locus:2141181	850	RK3 "receptor kinase 3" [Arabi	0.989	0.429	0.549	6.2e-101
TAIR|locus:2200908	842	AT1G61610 [Arabidopsis thalian	0.910	0.399	0.566	2.2e-98
TAIR|locus:2131684	783	AT4G27290 [Arabidopsis thalian	0.986	0.464	0.532	6.6e-97
TAIR|locus:2077147	676	CRK4 "cysteine-rich RLK (RECEP	0.859	0.468	0.577	1.4e-96
TAIR|locus:2123111	669	CRK34 "cysteine-rich RLK (RECE	0.880	0.485	0.570	1.8e-96

TAIR|locus:2093397 CES101 "CALLUS EXPRESSION OF RBCS 101" [Arabidopsis thaliana (taxid:3702)]

 Score = 1057 (377.1 bits), Expect = 7.2e-107, P = 7.2e-107
 Identities = 207/362 (57%), Positives = 270/362 (74%)

Query:    14 VIIELPANNKQ-AKRSKKKEVDQFPLFSFSSVSTATNKFSDANKLGEGGFGPVYKGVLKK 72
             +++EL    ++  KRS +   ++  +FSF SV+ AT+ FSDANKLGEGGFGPVYKG L  
Sbjct:   489 LLLELGIERRRRGKRSARNNNNELQIFSFESVAFATDYFSDANKLGEGGFGPVYKGRLID 548

Query:    73 GDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSL 132
             G+E+A+KRLS  SGQGL E KNEA +IAK+QH NLV+LLGCC+++DEK+LIYEYMPNKSL
Sbjct:   549 GEEVAIKRLSLASGQGLVEFKNEAMLIAKLQHTNLVKLLGCCVEKDEKMLIYEYMPNKSL 608

Query:   133 DFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKI 192
             D+FLFDP ++++LDW  R +I+EGI QGLLYLH+YSR+++IHRD+KA NILLD+DMNPKI
Sbjct:   609 DYFLFDPLRKIVLDWKLRFRIMEGIIQGLLYLHKYSRLKVIHRDIKAGNILLDEDMNPKI 668

Query:   193 SDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKN 252
             SDFGMARI G  E +ANT R+ GT+GYMSPEY  EG+FS KSDVFSFGVL+LEI+ G+KN
Sbjct:   669 SDFGMARIFGAQESKANTKRVAGTFGYMSPEYFREGLFSAKSDVFSFGVLMLEIICGRKN 728

Query:   253 TGLYRTDS--LNLLGYAWDLWTSNRTLELIDPILEDEYSSKQMLLRYANIALLCVQESAD 310
                +      LNL+ + W+L+  NR  E+IDP L D       +LR   +ALLCVQ++AD
Sbjct:   729 NSFHHDSEGPLNLIVHVWNLFKENRVREVIDPSLGDSAVENPQVLRCVQVALLCVQQNAD 788

Query:   311 DRPTMNDVVSMLTNEAATLLP-PKQPAF--SYVRNTVTSTSSTGKTEDCSINQVTISLLE 367
             DRP+M DVVSM+  +    L  PK+PAF     R++        + E+ S N+VTI+++E
Sbjct:   789 DRPSMLDVVSMIYGDGNNALSLPKEPAFYDGPPRSSPEMEVEPPEMENVSANRVTITVME 848

Query:   368 AR 369
             AR
Sbjct:   849 AR 850

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA;ISS

TAIR|locus:2141176 B120 [Arabidopsis thaliana (taxid:3702)]

 Score = 1045 (372.9 bits), Expect = 1.4e-105, P = 1.4e-105
 Identities = 203/344 (59%), Positives = 264/344 (76%)

Query:    29 KKKEVDQFPLFSFSSVSTATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQG 88
             K     + P+FS ++++ ATN F   N+LG GGFGPVYKGVL+ G EIAVKRLSG+SGQG
Sbjct:   507 KAVNTSELPVFSLNAIAIATNDFCKENELGRGGFGPVYKGVLEDGREIAVKRLSGKSGQG 566

Query:    89 LREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWV 148
             + E KNE  +IAK+QH+NLVRLLGCC + +EK+L+YEYMPNKSLDFFLFD TK+ L+DW 
Sbjct:   567 VDEFKNEIILIAKLQHRNLVRLLGCCFEGEEKMLVYEYMPNKSLDFFLFDETKQALIDWK 626

Query:   149 TRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQA 208
              R  IIEGIA+GLLYLH+ SR+RIIHRDLK SN+LLD +MNPKISDFGMARI GGN+ +A
Sbjct:   627 LRFSIIEGIARGLLYLHRDSRLRIIHRDLKVSNVLLDAEMNPKISDFGMARIFGGNQNEA 686

Query:   209 NTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAW 268
             NT R+VGTYGYMSPEYA+EG+FS+KSDV+SFGVLLLEIVSGK+NT L  ++  +L+GYAW
Sbjct:   687 NTVRVVGTYGYMSPEYAMEGLFSVKSDVYSFGVLLLEIVSGKRNTSLRSSEHGSLIGYAW 746

Query:   269 DLWTSNRTLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNEAAT 328
              L+T  R+ EL+DP +     SK+  LR  ++A+LCVQ+SA +RP M  V+ ML ++ AT
Sbjct:   747 YLYTHGRSEELVDPKIRVT-CSKREALRCIHVAMLCVQDSAAERPNMASVLLMLESDTAT 805

Query:   329 LLPPKQPAFSYVR-NTVTSTSSTGKTED--CSINQVTISLLEAR 369
             L  P+QP F+  R N++    +   ++    S N++T +++  R
Sbjct:   806 LAAPRQPTFTSTRRNSIDVNFALDSSQQYIVSSNEITSTVVLGR 849

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA;ISS

GO:0048544 "recognition of pollen" evidence=IEA

GO:0002679 "respiratory burst involved in defense response" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0006944 "cellular membrane fusion" evidence=RCA

GO:0006979 "response to oxidative stress" evidence=RCA

GO:0009611 "response to wounding" evidence=RCA

GO:0009863 "salicylic acid mediated signaling pathway" evidence=RCA

GO:0010200 "response to chitin" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0043069 "negative regulation of programmed cell death" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

TAIR|locus:2018506 RK2 "receptor kinase 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 1031 (368.0 bits), Expect = 4.1e-104, P = 4.1e-104
 Identities = 209/372 (56%), Positives = 267/372 (71%)

Query:     5 LDLNLKADNVIIEL-PANNKQAKRSKKKEVDQFPLFSFSSVSTATNKFSDANKLGEGGFG 63
             +DL    D+++ EL  A+     +  K +  + PL  + +++ ATN FS  NKLG+GGFG
Sbjct:   476 VDLVRSQDSLMNELVKASRSYTSKENKTDYLELPLMEWKALAMATNNFSTDNKLGQGGFG 535

Query:    64 PVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILI 123
              VYKG+L  G EIAVKRLS  S QG  E  NE  +IAK+QH NLVRLLGCC+D+ EK+LI
Sbjct:   536 IVYKGMLLDGKEIAVKRLSKMSSQGTDEFMNEVRLIAKLQHINLVRLLGCCVDKGEKMLI 595

Query:   124 YEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNIL 183
             YEY+ N SLD  LFD T+   L+W  R  II GIA+GLLYLHQ SR RIIHRDLKASN+L
Sbjct:   596 YEYLENLSLDSHLFDQTRSSNLNWQKRFDIINGIARGLLYLHQDSRCRIIHRDLKASNVL 655

Query:   184 LDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLL 243
             LDK+M PKISDFGMARI G  E +ANT R+VGTYGYMSPEYA++GIFS+KSDVFSFGVLL
Sbjct:   656 LDKNMTPKISDFGMARIFGREETEANTRRVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLL 715

Query:   244 LEIVSGKKNTGLYRTD-SLNLLGYAWDLWTSNRTLELIDPILEDEYSSK---QMLLRYAN 299
             LEI+SGK+N G Y ++  LNLLG+ W  W   + LE++DPI  D  SS+     +LR   
Sbjct:   716 LEIISGKRNKGFYNSNRDLNLLGFVWRHWKEGKELEIVDPINIDALSSEFPTHEILRCIQ 775

Query:   300 IALLCVQESADDRPTMNDVVSMLTNEAATLLPPKQPAFSYVRNT--VTSTSSTGKTEDCS 357
             I LLCVQE A+DRP M+ V+ ML +E   +  PK+P F   R++  V S+SST + ++C+
Sbjct:   776 IGLLCVQERAEDRPVMSSVMVMLGSETTAIPQPKRPGFCVGRSSLEVDSSSSTQRDDECT 835

Query:   358 INQVTISLLEAR 369
             +NQVT+S+++AR
Sbjct:   836 VNQVTLSVIDAR 847

GO:0004672 "protein kinase activity" evidence=IEA;IDA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;IDA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA

GO:0048544 "recognition of pollen" evidence=IEA

GO:0005829 "cytosol" evidence=IDA

GO:0031625 "ubiquitin protein ligase binding" evidence=IPI

GO:0034613 "cellular protein localization" evidence=IGI

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0004675 "transmembrane receptor protein serine/threonine kinase activity" evidence=ISS

TAIR|locus:2018546 RK1 "receptor kinase 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 1029 (367.3 bits), Expect = 6.7e-104, P = 6.7e-104
 Identities = 207/365 (56%), Positives = 263/365 (72%)

Query:    12 DNVIIELPANNK-QAKRSKKKEVDQFPLFSFSSVSTATNKFSDANKLGEGGFGPVYKGVL 70
             D++I ++  + +    + KK E  + PL    +++TATN FS+ NKLG+GGFG VYKG L
Sbjct:   479 DSLINDVVVSRRGYTSKEKKSEYLELPLLELEALATATNNFSNDNKLGQGGFGIVYKGRL 538

Query:    71 KKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIYEYMPNK 130
               G EIAVKRLS  S QG  E  NE  +IAK+QH NLVRLLGCC+D+ EK+LIYEY+ N 
Sbjct:   539 LDGKEIAVKRLSKMSSQGTDEFMNEVRLIAKLQHINLVRLLGCCVDKGEKMLIYEYLENL 598

Query:   131 SLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNP 190
             SLD  LFD T+   L+W  R  II GIA+GLLYLHQ SR RIIHRDLKASN+LLDK+M P
Sbjct:   599 SLDSHLFDQTRSSNLNWQKRFDIINGIARGLLYLHQDSRCRIIHRDLKASNVLLDKNMTP 658

Query:   191 KISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 250
             KISDFGMARI G  E +ANT R+VGTYGYMSPEYA++GIFS+KSDVFSFGVLLLEI+SGK
Sbjct:   659 KISDFGMARIFGREETEANTRRVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISGK 718

Query:   251 KNTGLYRTD-SLNLLGYAWDLWTSNRTLELIDPILEDEYSSK---QMLLRYANIALLCVQ 306
             +N G Y ++  LNLLG+ W  W     LE++DPI  D  SSK     +LR   I LLCVQ
Sbjct:   719 RNKGFYNSNRDLNLLGFVWRHWKEGNELEIVDPINIDSLSSKFPTHEILRCIQIGLLCVQ 778

Query:   307 ESADDRPTMNDVVSMLTNEAATLLPPKQPAFSYVRNTVT--STSSTGKTEDCSINQVTIS 364
             E A+DRP M+ V+ ML +E   +  PK+P F   R+ +   S+SST + ++C++NQ+T+S
Sbjct:   779 ERAEDRPVMSSVMVMLGSETTAIPQPKRPGFCIGRSPLEADSSSSTQRDDECTVNQITLS 838

Query:   365 LLEAR 369
             +++AR
Sbjct:   839 VIDAR 843

GO:0004672 "protein kinase activity" evidence=IEA;IDA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;IDA

GO:0009875 "pollen-pistil interaction" evidence=TAS

GO:0016020 "membrane" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0019199 "transmembrane receptor protein kinase activity" evidence=ISS

GO:0030246 "carbohydrate binding" evidence=IEA

GO:0048544 "recognition of pollen" evidence=IEA

GO:0005634 "nucleus" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=IDA

UNIPROTKB|O49974 KIK1 "Serine/threonine-protein kinase" [Zea mays (taxid:4577)]

 Score = 1023 (365.2 bits), Expect = 2.9e-103, P = 2.9e-103
 Identities = 196/336 (58%), Positives = 252/336 (75%)

Query:    35 QFPLFSFSSVSTATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKN 94
             +  ++S   + TAT+ FSD+NKLGEGGFGPVY G L  G+E+AVKRL   SGQGL E KN
Sbjct:   514 ELKVYSLDRIRTATSNFSDSNKLGEGGFGPVYMGTLPGGEEVAVKRLCRNSGQGLEEFKN 573

Query:    95 EASVIAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQII 154
             E  +IAK+QH+NLVRLLGCCI R+EKIL+YEYMPNKSLD FLF+P K+ LLDW  R  II
Sbjct:   574 EVILIAKLQHRNLVRLLGCCIPREEKILVYEYMPNKSLDAFLFNPEKQRLLDWKKRFDII 633

Query:   155 EGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIV 214
             EGIA+GLLYLH+ SR+R++HRDLKASNILLD DM PKISDFGMAR+ GG++ Q NT+R+V
Sbjct:   634 EGIARGLLYLHRDSRLRVVHRDLKASNILLDADMKPKISDFGMARMFGGDQNQFNTNRVV 693

Query:   215 GTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLY-RTDSLNLLGYAWDLWTS 273
             GT+GYMSPEYA+EGIFS+KSDV+ FGVL+LEI++GK+    +   DSLN+ GYAW  W  
Sbjct:   694 GTFGYMSPEYAMEGIFSVKSDVYGFGVLILEIITGKRAVSFHCHEDSLNIAGYAWRQWNE 753

Query:   274 NRTLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNEAATLLPPK 333
             +   ELIDP++    S +Q+L R  +IALLCVQ+ AD+RP +  V+ ML+N++++L  P+
Sbjct:   754 DNAAELIDPVIRASCSVRQVL-RCIHIALLCVQDHADERPDIPTVILMLSNDSSSLPNPR 812

Query:   334 QPAFSYVRNTVTSTSSTGKTEDCSINQVTISLLEAR 369
              P        + S+ S+ K    SI  VT++ L  R
Sbjct:   813 PPTLMLRGREIESSKSSEKDRSHSIGTVTMTQLHGR 848

GO:0005515 "protein binding" evidence=IPI

TAIR|locus:2141181 RK3 "receptor kinase 3" [Arabidopsis thaliana (taxid:3702)]

 Score = 1001 (357.4 bits), Expect = 6.2e-101, P = 6.2e-101
 Identities = 205/373 (54%), Positives = 264/373 (70%)

Query:     5 LDLNLKADNVIIELPANNKQAKRSKKKEVD--QFPLFSFSSVSTATNKFSDANKLGEGGF 62
             +D  L++ ++++     + +   S++   D  + PL  F  V+ ATN FS+ANKLG+GGF
Sbjct:   478 VDHQLRSRDLLMNEVVISSRRHISRENNTDDLELPLMEFEEVAMATNNFSNANKLGQGGF 537

Query:    63 GPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKIL 122
             G VYKG L  G E+AVKRLS  S QG  E KNE  +IA++QH NLVRLL CC+D  EK+L
Sbjct:   538 GIVYKGKLLDGQEMAVKRLSKTSVQGTDEFKNEVKLIARLQHINLVRLLACCVDAGEKML 597

Query:   123 IYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNI 182
             IYEY+ N SLD  LFD ++   L+W  R  II GIA+GLLYLHQ SR RIIHRDLKASNI
Sbjct:   598 IYEYLENLSLDSHLFDKSRNSKLNWQMRFDIINGIARGLLYLHQDSRFRIIHRDLKASNI 657

Query:   183 LLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVL 242
             LLDK M PKISDFGMARI G +E +ANT ++VGTYGYMSPEYA++GIFS+KSDVFSFGVL
Sbjct:   658 LLDKYMTPKISDFGMARIFGRDETEANTRKVVGTYGYMSPEYAMDGIFSMKSDVFSFGVL 717

Query:   243 LLEIVSGKKNTGLYRTD-SLNLLGYAWDLWTSNRTLELIDPILEDEYSS--KQMLLRYAN 299
             LLEI+S K+N G Y +D  LNLLG  W  W   + LE+IDPI+ D  S+  +  +LR   
Sbjct:   718 LLEIISSKRNKGFYNSDRDLNLLGCVWRNWKEGKGLEIIDPIITDSSSTFRQHEILRCIQ 777

Query:   300 IALLCVQESADDRPTMNDVVSMLTNEAATLLPPKQPAFSYVRNTVTSTSSTGKTED---C 356
             I LLCVQE A+DRPTM+ V+ ML +E+ T+  PK P +   R+ + + SS+ K  D    
Sbjct:   778 IGLLCVQERAEDRPTMSLVILMLGSESTTIPQPKAPGYCLERSLLDTDSSSSKQRDDESW 837

Query:   357 SINQVTISLLEAR 369
             ++NQ+T+S+L+AR
Sbjct:   838 TVNQITVSVLDAR 850

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA

GO:0048544 "recognition of pollen" evidence=IEA

GO:0004675 "transmembrane receptor protein serine/threonine kinase activity" evidence=ISS

GO:0005773 "vacuole" evidence=IDA

GO:0031625 "ubiquitin protein ligase binding" evidence=IPI

GO:0009506 "plasmodesma" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=RCA

TAIR|locus:2200908 AT1G61610 [Arabidopsis thaliana (taxid:3702)]

 Score = 977 (349.0 bits), Expect = 2.2e-98, P = 2.2e-98
 Identities = 192/339 (56%), Positives = 250/339 (73%)

Query:    32 EVDQFPLFSFSSVSTATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLRE 91
             +    P+FSF SV++AT  F++ NKLG+GGFG VYKG   +G EIAVKRLSG+S QGL E
Sbjct:   506 DTPDLPIFSFDSVASATGDFAEENKLGQGGFGTVYKGNFSEGREIAVKRLSGKSKQGLEE 565

Query:    92 MKNEASVIAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRV 151
              KNE  +IAK+QH+NLVRLLGCCI+ +EK+L+YEYMPNKSLD FLFD +K+  LDW  R 
Sbjct:   566 FKNEILLIAKLQHRNLVRLLGCCIEDNEKMLLYEYMPNKSLDRFLFDESKQGSLDWRKRW 625

Query:   152 QIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTS 211
             ++I GIA+GLLYLH+ SR++IIHRDLKASNILLD +MNPKISDFGMARI    +  ANT 
Sbjct:   626 EVIGGIARGLLYLHRDSRLKIIHRDLKASNILLDTEMNPKISDFGMARIFNYRQDHANTI 685

Query:   212 RIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLW 271
             R+VGTYGYM+PEYA+EGIFS KSDV+SFGVL+LEIVSG+KN     TD  +L+GYAW LW
Sbjct:   686 RVVGTYGYMAPEYAMEGIFSEKSDVYSFGVLILEIVSGRKNVSFRGTDHGSLIGYAWHLW 745

Query:   272 TSNRTLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNEAATLLP 331
             +  +T E+IDPI++D     + + R  ++ +LC Q+S   RP M  V+ ML ++ + L P
Sbjct:   746 SQGKTKEMIDPIVKDTRDVTEAM-RCIHVGMLCTQDSVIHRPNMGSVLLMLESQTSQLPP 804

Query:   332 PKQPAF-SYVRNTVTSTSSTGKTEDCSINQVTISLLEAR 369
             P+QP F S++ +     +  G  +  S+N VT + +  R
Sbjct:   805 PRQPTFHSFLNSGDIELNFDGH-DVASVNDVTFTTIVGR 842

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA;ISS

GO:0048544 "recognition of pollen" evidence=IEA

GO:0009693 "ethylene biosynthetic process" evidence=RCA

TAIR|locus:2131684 AT4G27290 [Arabidopsis thaliana (taxid:3702)]

 Score = 963 (344.1 bits), Expect = 6.6e-97, P = 6.6e-97
 Identities = 196/368 (53%), Positives = 260/368 (70%)

Query:     4 DLDLNLKADNVIIELPANNKQAKRSKKKEVD-QFPLFSFSSVSTATNKFSDANKLGEGGF 62
             DL + L A + I  L   + +    K++E D + P     +VS AT+ FS  NKLG+GGF
Sbjct:   418 DLYVRL-ASSEIETLQRESSRVSSRKQEEEDLELPFLDLDTVSEATSGFSAGNKLGQGGF 476

Query:    63 GPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKIL 122
             GPVYKG L  G E+AVKRLS  S QG+ E KNE  +IAK+QH+NLV++LG C+D +E++L
Sbjct:   477 GPVYKGTLACGQEVAVKRLSRTSRQGVEEFKNEIKLIAKLQHRNLVKILGYCVDEEERML 536

Query:   123 IYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNI 182
             IYEY PNKSLD F+FD  +R  LDW  RV+II+GIA+G+LYLH+ SR+RIIHRDLKASN+
Sbjct:   537 IYEYQPNKSLDSFIFDKERRRELDWPKRVEIIKGIARGMLYLHEDSRLRIIHRDLKASNV 596

Query:   183 LLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVL 242
             LLD DMN KISDFG+AR  GG+E +ANT+R+VGTYGYMSPEY ++G FS+KSDVFSFGVL
Sbjct:   597 LLDSDMNAKISDFGLARTLGGDETEANTTRVVGTYGYMSPEYQIDGYFSLKSDVFSFGVL 656

Query:   243 LLEIVSGKKNTGLYRTD-SLNLLGYAWDLWTSNRTLELIDPILEDEYSSKQMLLRYANIA 301
             +LEIVSG++N G    +  LNLLG+AW  +  ++  E+ID  + +  +    +LR  +I 
Sbjct:   657 VLEIVSGRRNRGFRNEEHKLNLLGHAWRQFLEDKAYEIIDEAVNESCTDISEVLRVIHIG 716

Query:   302 LLCVQESADDRPTMNDVVSMLTNEAATLLPPKQPAFSYVRNTVTSTSSTGKTEDCSINQV 361
             LLCVQ+   DRP M+ VV ML++E   LL P+QP F   RN + S + +   E  S N  
Sbjct:   717 LLCVQQDPKDRPNMSVVVLMLSSEML-LLDPRQPGFFNERNLLFSDTVSINLEIPSNNFQ 775

Query:   362 TISLLEAR 369
             T+S+++ R
Sbjct:   776 TMSVIDPR 783

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA

GO:0048544 "recognition of pollen" evidence=IEA

GO:0048765 "root hair cell differentiation" evidence=RCA

TAIR|locus:2077147 CRK4 "cysteine-rich RLK (RECEPTOR-like protein kinase) 4" [Arabidopsis thaliana (taxid:3702)]

 Score = 960 (343.0 bits), Expect = 1.4e-96, P = 1.4e-96
 Identities = 187/324 (57%), Positives = 239/324 (73%)

Query:    39 FSFSSVSTATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASV 98
             F F ++  ATNKF + NKLG+GGFG VYKG+   G ++AVKRLS  SGQG RE  NE  V
Sbjct:   339 FDFKAIEAATNKFCETNKLGQGGFGEVYKGIFPSGVQVAVKRLSKTSGQGEREFANEVIV 398

Query:    99 IAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIA 158
             +AK+QH+NLVRLLG C++RDE+IL+YE++PNKSLD+F+FD T + LLDW  R +II GIA
Sbjct:   399 VAKLQHRNLVRLLGFCLERDERILVYEFVPNKSLDYFIFDSTMQSLLDWTRRYKIIGGIA 458

Query:   159 QGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG 218
             +G+LYLHQ SR+ IIHRDLKA NILL  DMN KI+DFGMARI G ++ +ANT RIVGTYG
Sbjct:   459 RGILYLHQDSRLTIIHRDLKAGNILLGDDMNAKIADFGMARIFGMDQTEANTRRIVGTYG 518

Query:   219 YMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSL---NLLGYAWDLWTSNR 275
             YMSPEYA+ G FS+KSDV+SFGVL+LEI+SGKKN+ +Y+ D     NL+ Y W LW++  
Sbjct:   519 YMSPEYAMYGQFSMKSDVYSFGVLVLEIISGKKNSNVYQMDGTSAGNLVTYTWRLWSNGS 578

Query:   276 TLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNEAATLLPPKQP 335
              LEL+DP   D Y   ++  R  +IALLCVQE A+DRPTM+ +V MLT  +  L  P++P
Sbjct:   579 PLELVDPSFRDNYRINEVS-RCIHIALLCVQEEAEDRPTMSAIVQMLTTSSIALAVPQRP 637

Query:   336 AFSYVRNTVTSTSSTGKTEDCSIN 359
              F + R++       G  +  SIN
Sbjct:   638 GF-FFRSS--KHEQVGLVDRLSIN 658

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0006952 "defense response" evidence=TAS

GO:0009751 "response to salicylic acid stimulus" evidence=IEP

GO:0012501 "programmed cell death" evidence=IMP

GO:0042742 "defense response to bacterium" evidence=IEP

TAIR|locus:2123111 CRK34 "cysteine-rich RLK (RECEPTOR-like protein kinase) 34" [Arabidopsis thaliana (taxid:3702)]

 Score = 959 (342.6 bits), Expect = 1.8e-96, P = 1.8e-96
 Identities = 190/333 (57%), Positives = 241/333 (72%)

Query:    39 FSFSSVSTATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASV 98
             FSF ++  AT+KFSD+N +G GGFG VY+G L  G E+AVKRLS  SGQG  E KNEA +
Sbjct:   333 FSFKTIEAATDKFSDSNMIGRGGFGEVYRGKLSSGPEVAVKRLSKTSGQGAEEFKNEAVL 392

Query:    99 IAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIA 158
             ++K+QHKNLVRLLG C++ +EKIL+YE++PNKSLD+FLFDP K+  LDW  R  II GIA
Sbjct:   393 VSKLQHKNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLFDPAKQGELDWTRRYNIIGGIA 452

Query:   159 QGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG 218
             +G+LYLHQ SR+ IIHRDLKASNILLD DMNPKI+DFGMARI G ++ QANT RI GT+G
Sbjct:   453 RGILYLHQDSRLTIIHRDLKASNILLDADMNPKIADFGMARIFGVDQSQANTRRIAGTFG 512

Query:   219 YMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSL--NLLGYAWDLWTSNRT 276
             YMSPEYA+ G FS+KSDV+SFGVL+LEI+SGKKN+  Y  D    NL+ +AW LW +   
Sbjct:   513 YMSPEYAMRGHFSMKSDVYSFGVLVLEIISGKKNSSFYNIDDSGSNLVTHAWRLWRNGSP 572

Query:   277 LELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNEAATLLPPKQPA 336
             LEL+DP + + Y S +   R  +IALLCVQE   DRP +  ++ MLT+   TL  P+ P 
Sbjct:   573 LELVDPTIGESYQSSEAT-RCIHIALLCVQEDPADRPLLPAIIMMLTSSTTTLHVPRAPG 631

Query:   337 F-----SYVRNTVTSTSSTGKTEDCSINQVTIS 364
             F        ++ V  T ST ++   SIN  +I+
Sbjct:   632 FCLSGRDLEQDGVEYTESTSRSIPGSINDASIT 664

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	0.824
3rd Layer	2.7.11	0.766

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Fail to connect to STRING server

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	369
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	2e-58
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	7e-57
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	6e-56
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	5e-55
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	2e-52
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	1e-48
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	3e-48
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	1e-42
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	3e-36
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	3e-36
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	8e-35
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	5e-34
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	8e-34
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	3e-32
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	3e-32
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	1e-31
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	1e-31
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	2e-31
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	2e-31
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	3e-31
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	8e-31
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	1e-30
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	2e-30
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	2e-30
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	2e-30
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	2e-30
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	1e-29
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	9e-29
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	1e-28
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	2e-28
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	2e-28
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	4e-28
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	7e-28
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	9e-28
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	1e-27
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	1e-27
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	1e-27
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	2e-27
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	3e-27
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	7e-27
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	1e-26
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	1e-26
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	1e-26
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	2e-26
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	1e-25
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	1e-25
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	2e-25
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	4e-25
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	6e-25
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	6e-25
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	7e-25
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	2e-24
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	2e-24
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	2e-24
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	3e-24
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	3e-24
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	5e-24
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	5e-24
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	7e-24
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	1e-23
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	3e-23
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	3e-23
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	4e-23
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	5e-23
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	6e-23
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	1e-22
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	1e-22
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	1e-22
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	1e-22
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	1e-22
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	2e-22
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	2e-22
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	2e-22
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	4e-22
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	6e-22
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	7e-22
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	7e-22
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	7e-22
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	8e-22
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	2e-21
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	2e-21
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	4e-21
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	4e-21
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	5e-21
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	1e-20
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	1e-20
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	1e-20
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	1e-20
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	2e-20
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	2e-20
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	2e-20
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	2e-20
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	2e-20
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	3e-20
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	3e-20
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	4e-20
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	4e-20
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	4e-20
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	4e-20
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	6e-20
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	6e-20
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	1e-19
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	1e-19
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	1e-19
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	2e-19
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	2e-19
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	2e-19
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	3e-19
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	3e-19
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	4e-19
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	4e-19
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	5e-19
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	7e-19
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	7e-19
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	8e-19
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	8e-19
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	9e-19
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	9e-19
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	1e-18
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	1e-18
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	1e-18
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	1e-18
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	1e-18
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	2e-18
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	2e-18
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	2e-18
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	3e-18
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	3e-18
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	3e-18
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	4e-18
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	4e-18
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	5e-18
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	5e-18
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	6e-18
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	7e-18
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	8e-18
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	8e-18
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	1e-17
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	1e-17
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	1e-17
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	3e-17
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	4e-17
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	5e-17
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	6e-17
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	8e-17
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	8e-17
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	9e-17
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	1e-16
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	2e-16
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	2e-16
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	2e-16
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	2e-16
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	2e-16
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	2e-16
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	3e-16
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	3e-16
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	3e-16
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	3e-16
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	4e-16
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	5e-16
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	8e-16
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	8e-16
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	1e-15
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	2e-15
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	2e-15
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	3e-15
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	5e-15
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	6e-15
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	1e-14
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	1e-14
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	1e-14
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	1e-14
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	1e-14
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	1e-14
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	1e-14
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	2e-14
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	2e-14
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	2e-14
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	3e-14
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	4e-14
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	5e-14
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	6e-14
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	6e-14
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	6e-14
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	6e-14
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	9e-14
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	1e-13
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	1e-13
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	2e-13
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	2e-13
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	3e-13
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	3e-13
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	3e-13
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	3e-13
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	4e-13
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	4e-13
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	5e-13
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	5e-13
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	5e-13
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	6e-13
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	7e-13
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	8e-13
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	8e-13
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	9e-13
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	1e-12
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	1e-12
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	1e-12
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	2e-12
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	2e-12
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	2e-12
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	2e-12
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	4e-12
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	4e-12
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	4e-12
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	6e-12
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	6e-12
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	6e-12
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	7e-12
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	7e-12
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	7e-12
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	2e-11
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	2e-11
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	2e-11
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	3e-11
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	3e-11
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	3e-11
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	4e-11
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	4e-11
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	5e-11
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	5e-11
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	6e-11
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	7e-11
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	8e-11
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	1e-10
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	1e-10
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	1e-10
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	2e-10
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	2e-10
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	2e-10
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	2e-10
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	3e-10
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	3e-10
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	3e-10
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	3e-10
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	4e-10
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	4e-10
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	4e-10
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	4e-10
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	4e-10
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	4e-10
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	4e-10
PTZ00284	467	PTZ00284, PTZ00284, protein kinase; Provisional	6e-10
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	1e-09
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	1e-09
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	2e-09
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	2e-09
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	3e-09
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	6e-09
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	6e-09
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	6e-09
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	7e-09
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	1e-08
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	1e-08
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	1e-08
cd05120	155	cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot	1e-08
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	1e-08
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	2e-08
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	2e-08
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	2e-08
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	2e-08
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	2e-08
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	2e-08
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	3e-08
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	3e-08
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	4e-08
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	5e-08
pfam11883	48	pfam11883, DUF3403, Domain of unknown function (DU	5e-08
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	5e-08
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	8e-08
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	1e-07
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	1e-07
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	2e-07
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	2e-07
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	3e-07
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	4e-07
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	5e-07
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	6e-07
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	7e-07
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	1e-06
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	2e-06
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	2e-06
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	2e-06
cd05076	274	cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do	2e-06
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	3e-06
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	4e-06
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	4e-06
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	6e-06
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	1e-05
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	1e-05
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	1e-05
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	2e-05
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	2e-05
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	5e-05
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	5e-05
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	2e-04
PLN03225	566	PLN03225, PLN03225, Serine/threonine-protein kinas	3e-04
COG3642	204	COG3642, COG3642, Mn2+-dependent serine/threonine	0.001
PLN03224	507	PLN03224, PLN03224, probable serine/threonine prot	0.001
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	0.001

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  189 bits (483), Expect = 2e-58
 Identities = 97/292 (33%), Positives = 137/292 (46%), Gaps = 53/292 (18%)

Query: 55  NKLGEGGFGPVYKGVLKKGD----EIAVKRLSGR-SGQGLREMKNEASVIAKVQHKNLVR 109
            KLGEG FG VYKG LK  D    E+AVK L    S +  ++   EA V+ K+ H N+VR
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60

Query: 110 LLGCCIDRDEKILIYEYMPNKSLDFFL------FDPTKRMLLDWVTRVQIIEGIAQGLLY 163
           LLG C + +   L+ EYM    L  +L      F   ++  L     +     IA+G+ Y
Sbjct: 61  LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120

Query: 164 LHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG----- 218
           L      + +HRDL A N L+ +D+  KISDFG++R     ++  +      T G     
Sbjct: 121 LAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSR-----DVYDDDYYRKKTGGKLPIR 172

Query: 219 YMSPEYALEGIFSIKSDVFSFGVLLLEIVS-------GKKNTGLYRTDSLNLLGYAWDLW 271
           +M+PE   +GIF+ KSDV+SFGVLL EI +       G  N  +     L  L       
Sbjct: 173 WMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEV-----LEYL------- 220

Query: 272 TSNRTLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLT 323
                L    P    EY   ++      + L C Q   +DRPT +++V  L 
Sbjct: 221 RKGYRLP--KP----EYCPDEL----YELMLSCWQLDPEDRPTFSELVERLE 262

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  185 bits (473), Expect = 7e-57
 Identities = 92/277 (33%), Positives = 133/277 (48%), Gaps = 35/277 (12%)

Query: 56  KLGEGGFGPVYKGVLKKGD-----EIAVKRL-SGRSGQGLREMKNEASVIAKVQHKNLVR 109
           KLGEG FG VYKG LK        E+AVK L    S Q + E   EA ++ K+ H N+V+
Sbjct: 6   KLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVK 65

Query: 110 LLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSR 169
           LLG C + +   ++ EYM    L  +L     R  L     +     IA+G+ YL     
Sbjct: 66  LLGVCTEEEPLYIVMEYMEGGDLLSYL--RKNRPKLSLSDLLSFALQIARGMEYLE---S 120

Query: 170 VRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGI 229
              IHRDL A N L+ +++  KISDFG++R    ++        +    +M+PE   EG 
Sbjct: 121 KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKL-PIRWMAPESLKEGK 179

Query: 230 FSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYA-WDLWTSNRTLELIDPILEDEY 288
           F+ KSDV+SFGVLL EI +               LG   +   ++   LE     L++ Y
Sbjct: 180 FTSKSDVWSFGVLLWEIFT---------------LGEQPYPGMSNEEVLEY----LKNGY 220

Query: 289 SSKQMLL---RYANIALLCVQESADDRPTMNDVVSML 322
              Q         ++ L C  E  +DRPT +++V +L
Sbjct: 221 RLPQPPNCPPELYDLMLQCWAEDPEDRPTFSELVEIL 257

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  183 bits (467), Expect = 6e-56
 Identities = 91/277 (32%), Positives = 133/277 (48%), Gaps = 34/277 (12%)

Query: 56  KLGEGGFGPVYKGVLKKGD-----EIAVKRL-SGRSGQGLREMKNEASVIAKVQHKNLVR 109
           KLGEG FG VYKG LK        E+AVK L    S Q + E   EA ++ K+ H N+V+
Sbjct: 6   KLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVK 65

Query: 110 LLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSR 169
           LLG C + +  +++ EYMP   L  +L    +   L     +     IA+G+ YL     
Sbjct: 66  LLGVCTEEEPLMIVMEYMPGGDLLDYLRK-NRPKELSLSDLLSFALQIARGMEYLE---S 121

Query: 170 VRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGI 229
              IHRDL A N L+ +++  KISDFG++R    ++        +    +M+PE   EG 
Sbjct: 122 KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKL-PIRWMAPESLKEGK 180

Query: 230 FSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYA-WDLWTSNRTLELIDPILEDEY 288
           F+ KSDV+SFGVLL EI +               LG   +   ++   LE     L+  Y
Sbjct: 181 FTSKSDVWSFGVLLWEIFT---------------LGEEPYPGMSNAEVLEY----LKKGY 221

Query: 289 SSKQMLL---RYANIALLCVQESADDRPTMNDVVSML 322
              +          + L C  E  +DRPT +++V +L
Sbjct: 222 RLPKPPNCPPELYKLMLQCWAEDPEDRPTFSELVEIL 258

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  181 bits (461), Expect = 5e-55
 Identities = 94/282 (33%), Positives = 135/282 (47%), Gaps = 44/282 (15%)

Query: 56  KLGEGGFGPVYKGVLKKGDE-----IAVKRL-SGRSGQGLREMKNEASVIAKVQHKNLVR 109
           KLGEG FG VYKG LK   E     +AVK L  G S +   E   EAS++ K+ H N+VR
Sbjct: 6   KLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVR 65

Query: 110 LLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSR 169
           LLG C   +   ++ EYMP   L  FL        L     +Q+   IA+G+ YL     
Sbjct: 66  LLGVCTQGEPLYIVTEYMPGGDLLDFL--RKHGEKLTLKDLLQMALQIAKGMEYLE---S 120

Query: 170 VRIIHRDLKASNILLDKDMNPKISDFGMAR-ICGGNELQANTSRIVGTYGYMSPEYALEG 228
              +HRDL A N L+ +++  KISDFG++R I   +  +      +    +M+PE   +G
Sbjct: 121 KNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKL-PIKWMAPESLKDG 179

Query: 229 IFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYA-WDLWTSNRTLELID------ 281
            F+ KSDV+SFGVLL EI +               LG   +   ++   LEL++      
Sbjct: 180 KFTSKSDVWSFGVLLWEIFT---------------LGEQPYPGMSNEEVLELLEDGYRLP 224

Query: 282 -PILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSML 322
            P    E    ++      + L C     +DRPT +++V  L
Sbjct: 225 RP----ENCPDEL----YELMLQCWAYDPEDRPTFSELVEDL 258

Length = 258

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  173 bits (440), Expect = 2e-52
 Identities = 75/194 (38%), Positives = 107/194 (55%), Gaps = 11/194 (5%)

Query: 57  LGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLREM-KNEASVIAKVQHKNLVRLLGCC 114
           LGEGGFG VY    KK G ++A+K +       L E    E  ++ K+ H N+V+L G  
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60

Query: 115 IDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 174
            D +   L+ EY    SL   L +   +  L     ++I+  I +GL YLH      IIH
Sbjct: 61  EDENHLYLVMEYCEGGSLKDLLKENEGK--LSEDEILRILLQILEGLEYLHS---NGIIH 115

Query: 175 RDLKASNILLDKD-MNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAL-EGIFSI 232
           RDLK  NILLD D    K++DFG++++   ++    T  IVGT  YM+PE  L +G +S 
Sbjct: 116 RDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKT--IVGTPAYMAPEVLLGKGYYSE 173

Query: 233 KSDVFSFGVLLLEI 246
           KSD++S GV+L E+
Sbjct: 174 KSDIWSLGVILYEL 187

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  164 bits (417), Expect = 1e-48
 Identities = 73/199 (36%), Positives = 104/199 (52%), Gaps = 12/199 (6%)

Query: 56  KLGEGGFGPVYKGVLKK-GDEIAVKRL--SGRSGQGLREMKNEASVIAKVQHKNLVRLLG 112
           KLG G FG VYK   K  G  +AVK L       +  +  + E  ++ ++ H N+VRL+ 
Sbjct: 6   KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLID 65

Query: 113 CCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRI 172
              D+D   L+ EY     L  +L        L      +I   I +GL YLH      I
Sbjct: 66  AFEDKDHLYLVMEYCEGGDLFDYLSRGGP---LSEDEAKKIALQILRGLEYLHSN---GI 119

Query: 173 IHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGI-FS 231
           IHRDLK  NILLD++   KI+DFG+A+    +   ++ +  VGT  YM+PE  L G  + 
Sbjct: 120 IHRDLKPENILLDENGVVKIADFGLAKKLLKS--SSSLTTFVGTPWYMAPEVLLGGNGYG 177

Query: 232 IKSDVFSFGVLLLEIVSGK 250
            K DV+S GV+L E+++GK
Sbjct: 178 PKVDVWSLGVILYELLTGK 196

Length = 260

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  163 bits (415), Expect = 3e-48
 Identities = 73/204 (35%), Positives = 105/204 (51%), Gaps = 15/204 (7%)

Query: 51  FSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLRE-MKNEASVIAKVQHKNLV 108
           +    KLGEG FG VY    KK G  +A+K +  +  +  RE +  E  ++ K++H N+V
Sbjct: 1   YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60

Query: 109 RLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRV--QIIEGIAQGLLYLHQ 166
           RL     D D+  L+ EY     L F L     R+  D       QI+  +     YLH 
Sbjct: 61  RLYDVFEDEDKLYLVMEYCEGGDL-FDLLKKRGRLSEDEARFYLRQILSALE----YLHS 115

Query: 167 YSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAL 226
                I+HRDLK  NILLD+D + K++DFG+AR     E     +  VGT  YM+PE  L
Sbjct: 116 K---GIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEK---LTTFVGTPEYMAPEVLL 169

Query: 227 EGIFSIKSDVFSFGVLLLEIVSGK 250
              +    D++S GV+L E+++GK
Sbjct: 170 GKGYGKAVDIWSLGVILYELLTGK 193

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  148 bits (377), Expect = 1e-42
 Identities = 71/203 (34%), Positives = 109/203 (53%), Gaps = 15/203 (7%)

Query: 55  NKLGEGGFGPVYKGVLKK-GDEIAVK--RLSGRSGQGLREMKNEASVIAKVQHKNLVRLL 111
             LG G FG VY  + K  G+ +AVK   LSG S + L  ++ E  +++ +QH N+VR  
Sbjct: 6   ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65

Query: 112 GCCIDRDEK-ILIY-EYMPNKSLDFFL--FDPTKRMLLDWVTRVQIIEGIAQGLLYLHQY 167
           G   D ++  + I+ EY+   SL   L  F      ++   TR QI+EG+A    YLH  
Sbjct: 66  GSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTR-QILEGLA----YLH-- 118

Query: 168 SRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALE 227
               I+HRD+K +NIL+D D   K++DFG A+  G  E    T  + GT  +M+PE    
Sbjct: 119 -SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRG 177

Query: 228 GIFSIKSDVFSFGVLLLEIVSGK 250
             +   +D++S G  ++E+ +GK
Sbjct: 178 EEYGRAADIWSLGCTVIEMATGK 200

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score =  132 bits (333), Expect = 3e-36
 Identities = 74/201 (36%), Positives = 104/201 (51%), Gaps = 22/201 (10%)

Query: 56  KLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMK-----NEASVIAKVQHKNLVRL 110
           KLG G FG V+ G      ++AVK L  + G     M       EA ++ K++H  LV+L
Sbjct: 13  KLGAGQFGEVWMGTWNGTTKVAVKTL--KPGT----MSPEAFLQEAQIMKKLRHDKLVQL 66

Query: 111 LGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRV 170
              C + +   ++ EYM   SL  FL     + L      V +   IA+G+ YL      
Sbjct: 67  YAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLR-LPQLVDMAAQIAEGMAYLE---SR 122

Query: 171 RIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR---IVGTYGYMSPEYALE 227
             IHRDL A NIL+ +++  KI+DFG+AR+   +E  A       I  T    +PE A  
Sbjct: 123 NYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWT----APEAANY 178

Query: 228 GIFSIKSDVFSFGVLLLEIVS 248
           G F+IKSDV+SFG+LL EIV+
Sbjct: 179 GRFTIKSDVWSFGILLTEIVT 199

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  131 bits (332), Expect = 3e-36
 Identities = 69/205 (33%), Positives = 108/205 (52%), Gaps = 15/205 (7%)

Query: 50  KFSDANKLGEGGFGPVYKG-VLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLV 108
            F    K+G+GGFG VYK    + G E+A+K +   S +   ++ NE  ++ K +H N+V
Sbjct: 1   LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIV 60

Query: 109 RLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQI---IEGIAQGLLYLH 165
           +  G  + +DE  ++ E+    SL   L   T + L    T  QI    + + +GL YLH
Sbjct: 61  KYYGSYLKKDELWIVMEFCSGGSLKD-LLKSTNQTL----TESQIAYVCKELLKGLEYLH 115

Query: 166 QYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYA 225
                 IIHRD+KA+NILL  D   K+ DFG++     +    NT  +VGT  +M+PE  
Sbjct: 116 SN---GIIHRDIKAANILLTSDGEVKLIDFGLS-AQLSDTKARNT--MVGTPYWMAPEVI 169

Query: 226 LEGIFSIKSDVFSFGVLLLEIVSGK 250
               +  K+D++S G+  +E+  GK
Sbjct: 170 NGKPYDYKADIWSLGITAIELAEGK 194

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score =  129 bits (325), Expect = 8e-35
 Identities = 78/289 (26%), Positives = 126/289 (43%), Gaps = 31/289 (10%)

Query: 55  NKLGEGGFGPVYKGVL-----KKGDEIAVKRLSGRSG-QGLREMKNEASVIAKVQHKNLV 108
            +LGEG FG V            G+++AVK L+     Q   + + E  ++  + H+N+V
Sbjct: 10  KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69

Query: 109 RLLGCCIDRDEKI--LIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQ 166
           +  G C     +   LI EY+P+ SL  +L     R  ++    +     I +G+ YL  
Sbjct: 70  KYKGVCEKPGGRSLRLIMEYLPSGSLRDYL--QRHRDQINLKRLLLFSSQICKGMDYLGS 127

Query: 167 YSRVRIIHRDLKASNILLDKDMNPKISDFGMARI--CGGNELQANTSRIVGTYGYMSPEY 224
               R IHRDL A NIL++ +   KISDFG+A++     +            + Y +PE 
Sbjct: 128 Q---RYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWY-APEC 183

Query: 225 ALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPIL 284
                FS  SDV+SFGV L E+ +    +     + L ++G A       R LEL+    
Sbjct: 184 LRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKE-- 241

Query: 285 EDEYSSKQMLLRYAN-------IALLCVQESADDRPTMNDVVSMLTNEA 326
                  + L R  +       +  LC +    DRP+  D++ ++    
Sbjct: 242 ------GERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRLR 284

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  126 bits (318), Expect = 5e-34
 Identities = 74/268 (27%), Positives = 120/268 (44%), Gaps = 35/268 (13%)

Query: 56  KLGEGGFGPVYKGVLKK-GDEIAVKRL-SGRSGQGLREMKNEASVIAKVQHKNLVRLLGC 113
            LG+G  G VYK   K  G   A+K++      +  +++  E   +   +   +V+  G 
Sbjct: 8   VLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGA 67

Query: 114 CIDRDEKILIYEYMPNKSLDFFLFDPTKRM---LLDWVTRVQIIEGIAQGLLYLHQYSRV 170
                E  ++ EYM   SL   L     ++   +L ++ R QI+    +GL YLH     
Sbjct: 68  FYKEGEISIVLEYMDGGSLADLL-KKVGKIPEPVLAYIAR-QIL----KGLDYLHTKRH- 120

Query: 171 RIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIF 230
            IIHRD+K SN+L++     KI+DFG++++      Q NT   VGT  YMSPE      +
Sbjct: 121 -IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTF--VGTVTYMSPERIQGESY 177

Query: 231 SIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELI----DPILED 286
           S  +D++S G+ LLE   GK     +         + ++L      ++ I     P L  
Sbjct: 178 SYAADIWSLGLTLLECALGK-----FPFLPPGQPSF-FEL------MQAICDGPPPSLPA 225

Query: 287 EYSSKQMLLRYANIALLCVQESADDRPT 314
           E  S +      +    C+Q+    RP+
Sbjct: 226 EEFSPEF----RDFISACLQKDPKKRPS 249

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score =  125 bits (316), Expect = 8e-34
 Identities = 68/203 (33%), Positives = 109/203 (53%), Gaps = 16/203 (7%)

Query: 51  FSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRL 110
           F+   KLG G FG V++G+ K    +A+K L        ++ + E   + +++HK+L+ L
Sbjct: 8   FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL 67

Query: 111 LGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRM-----LLDWVTRVQIIEGIAQGLLYLH 165
              C   +   +I E M   SL  FL  P  ++     L+D   +V      A+G+ YL 
Sbjct: 68  FAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQV------AEGMAYLE 121

Query: 166 QYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYA 225
           +      IHRDL A NIL+ +D+  K++DFG+AR+   +   ++  +I   Y + +PE A
Sbjct: 122 EQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKI--PYKWTAPEAA 176

Query: 226 LEGIFSIKSDVFSFGVLLLEIVS 248
             G FS KSDV+SFG+LL E+ +
Sbjct: 177 SHGTFSTKSDVWSFGILLYEMFT 199

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score =  121 bits (305), Expect = 3e-32
 Identities = 65/194 (33%), Positives = 103/194 (53%), Gaps = 15/194 (7%)

Query: 57  LGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCID 116
           +G+G FG V  G  + G ++AVK L        +    EASV+  ++H NLV+LLG  + 
Sbjct: 14  IGKGEFGDVMLGDYR-GQKVAVKCLK-DDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQ 71

Query: 117 RDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRD 176
            +   ++ EYM   SL  +L     R ++    ++     + +G+ YL +      +HRD
Sbjct: 72  GNPLYIVTEYMAKGSLVDYL-RSRGRAVITLAQQLGFALDVCEGMEYLEEK---NFVHRD 127

Query: 177 LKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTY--GYMSPEYALEGIFSIKS 234
           L A N+L+ +D+  K+SDFG+A+       +A+  +  G     + +PE   E  FS KS
Sbjct: 128 LAARNVLVSEDLVAKVSDFGLAK-------EASQGQDSGKLPVKWTAPEALREKKFSTKS 180

Query: 235 DVFSFGVLLLEIVS 248
           DV+SFG+LL EI S
Sbjct: 181 DVWSFGILLWEIYS 194

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  121 bits (305), Expect = 3e-32
 Identities = 66/206 (32%), Positives = 107/206 (51%), Gaps = 15/206 (7%)

Query: 50  KFSDANKLGEGGFGPVYKGV-LKKGDEIAVKRLS--GRSGQGLREMKNEASVIAKVQHKN 106
            +   + +G G FG VYKG+ L+ GD +A+K++S      + L+ +  E  ++  ++H N
Sbjct: 1   NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60

Query: 107 LVRLLGCCIDRDEKILIYEYMPNKSLDFFL--FDPTKRMLLDWVTRVQIIEGIAQGLLYL 164
           +V+ +G     D   +I EY  N SL   +  F P    L   V     +  + QGL YL
Sbjct: 61  IVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESL---VAV--YVYQVLQGLAYL 115

Query: 165 HQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY 224
           H+     +IHRD+KA+NIL  KD   K++DFG+A           +  +VGT  +M+PE 
Sbjct: 116 HEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDAS--VVGTPYWMAPEV 170

Query: 225 ALEGIFSIKSDVFSFGVLLLEIVSGK 250
                 S  SD++S G  ++E+++G 
Sbjct: 171 IEMSGASTASDIWSLGCTVIELLTGN 196

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score =  119 bits (301), Expect = 1e-31
 Identities = 68/195 (34%), Positives = 107/195 (54%), Gaps = 7/195 (3%)

Query: 55  NKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGC 113
           +KLG G +G VY+GV KK    +AVK L       + E   EA+V+ +++H NLV+LLG 
Sbjct: 12  HKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 70

Query: 114 CIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRII 173
           C       +I E+M   +L  +L +   R  ++ V  + +   I+  + YL + +    I
Sbjct: 71  CTREPPFYIITEFMTYGNLLDYLRE-CNRQEVNAVVLLYMATQISSAMEYLEKKN---FI 126

Query: 174 HRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIK 233
           HRDL A N L+ ++   K++DFG++R+  G+   A+         + +PE      FSIK
Sbjct: 127 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF-PIKWTAPESLAYNKFSIK 185

Query: 234 SDVFSFGVLLLEIVS 248
           SDV++FGVLL EI +
Sbjct: 186 SDVWAFGVLLWEIAT 200

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score =  120 bits (302), Expect = 1e-31
 Identities = 72/218 (33%), Positives = 110/218 (50%), Gaps = 30/218 (13%)

Query: 57  LGEGGFGPVYKG---VLKKGDE---IAVKRLSGRSGQGLRE-MKNEASVIAKVQHKNLVR 109
           LGEG FG V+ G    L+  ++   +AVK L   +    R+  + EA ++   QH+N+V+
Sbjct: 13  LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72

Query: 110 LLGCCIDRDEKILIYEYMPNKSLDFFL--FDPTKRML---------LDWVTRVQIIEGIA 158
             G C + D  I+++EYM +  L+ FL    P    L         L     +QI   IA
Sbjct: 73  FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132

Query: 159 QGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT-- 216
            G++YL   +    +HRDL   N L+  D+  KI DFGM+R    +    +  R+ G   
Sbjct: 133 SGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSR----DVYTTDYYRVGGHTM 185

Query: 217 --YGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKK 251
               +M PE  +   F+ +SDV+SFGV+L EI + GK+
Sbjct: 186 LPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQ 223

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score =  119 bits (301), Expect = 2e-31
 Identities = 72/212 (33%), Positives = 106/212 (50%), Gaps = 23/212 (10%)

Query: 57  LGEGGFGPVYKGVL------KKGDEIAVKRLSGRSGQGLR-EMKNEASVIAKVQHKNLVR 109
           LGEG FG VYKG L           +A+K L   +   ++ E + EA +++ +QH N+V 
Sbjct: 13  LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72

Query: 110 LLGCCIDRDEKILIYEYMPNKSLDFFLF-------------DPTKRMLLDWVTRVQIIEG 156
           LLG C       +++EY+ +  L  FL              D T +  LD    + I   
Sbjct: 73  LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQ 132

Query: 157 IAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 216
           IA G+ YL   S    +HRDL A N L+ + +  KISDFG++R     +     S+ +  
Sbjct: 133 IAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLP 189

Query: 217 YGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 248
             +M PE  L G F+ +SD++SFGV+L EI S
Sbjct: 190 VRWMPPEAILYGKFTTESDIWSFGVVLWEIFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score =  119 bits (300), Expect = 2e-31
 Identities = 69/206 (33%), Positives = 115/206 (55%), Gaps = 21/206 (10%)

Query: 57  LGEGGFGPVYKGVLK-KGD----EIAVKRLSGRSG-QGLREMKNEASVIAKVQHKNLVRL 110
           LG G FG VYKGV   +G+     +A+K L   +  +  +E+ +EA V+A V H ++VRL
Sbjct: 15  LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74

Query: 111 LGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRM----LLDWVTRVQIIEGIAQGLLYLHQ 166
           LG C+   +  LI + MP   L  ++ +    +    LL+W  +      IA+G+ YL +
Sbjct: 75  LGICLS-SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQ------IAKGMSYLEE 127

Query: 167 YSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAL 226
               R++HRDL A N+L+    + KI+DFG+A++   +E + +         +M+ E  L
Sbjct: 128 ---KRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESIL 184

Query: 227 EGIFSIKSDVFSFGVLLLEIVS-GKK 251
             I++ KSDV+S+GV + E+++ G K
Sbjct: 185 HRIYTHKSDVWSYGVTVWELMTFGAK 210

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  118 bits (298), Expect = 3e-31
 Identities = 60/208 (28%), Positives = 101/208 (48%), Gaps = 23/208 (11%)

Query: 55  NKLGEGGFGPVYKGVLKKGDEI-AVKR--LSGRSGQGLREMKNEASVIAKVQHKNLVRLL 111
            ++G+G FG VY    K   ++  +K   LS  S +   +  NE  ++ K+ H N+++  
Sbjct: 6   KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYY 65

Query: 112 GCCIDRDEKILIYEYMPNKSLDFFLFDPTKR-------MLLDWVTRVQIIEGIAQGLLYL 164
               ++ +  ++ EY     L   +    K         +LDW   VQ+       L YL
Sbjct: 66  ESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWF--VQL----CLALKYL 119

Query: 165 HQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY 224
           H  SR +I+HRD+K  NI L  +   K+ DFG++++       A T  +VGT  Y+SPE 
Sbjct: 120 H--SR-KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKT--VVGTPYYLSPE- 173

Query: 225 ALEGI-FSIKSDVFSFGVLLLEIVSGKK 251
             +   ++ KSD++S G +L E+ + K 
Sbjct: 174 LCQNKPYNYKSDIWSLGCVLYELCTLKH 201

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  118 bits (297), Expect = 8e-31
 Identities = 66/211 (31%), Positives = 104/211 (49%), Gaps = 25/211 (11%)

Query: 48  TNKFSDANKLGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKN 106
              + +  K+GEG  G VYK      G E+A+K++  R  Q    + NE  ++   +H N
Sbjct: 18  RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRK-QNKELIINEILIMKDCKHPN 76

Query: 107 LVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEG-IA------- 158
           +V      +  DE  ++ EYM   SL       T   ++     V++ E  IA       
Sbjct: 77  IVDYYDSYLVGDELWVVMEYMDGGSL-------TD--IITQ-NFVRMNEPQIAYVCREVL 126

Query: 159 QGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG 218
           QGL YLH      +IHRD+K+ NILL KD + K++DFG A      + + N+  +VGT  
Sbjct: 127 QGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNS--VVGTPY 181

Query: 219 YMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 249
           +M+PE      +  K D++S G++ +E+  G
Sbjct: 182 WMAPEVIKRKDYGPKVDIWSLGIMCIEMAEG 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score =  117 bits (294), Expect = 1e-30
 Identities = 65/196 (33%), Positives = 102/196 (52%), Gaps = 12/196 (6%)

Query: 56  KLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCI 115
           KLG G FG V++G+      +AVK L   +    ++   EA ++ K++H  L++L   C 
Sbjct: 13  KLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMD-PKDFLAEAQIMKKLRHPKLIQLYAVCT 71

Query: 116 DRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHR 175
             +   ++ E M   SL  +L     R L      + +   +A G+ YL   +    IHR
Sbjct: 72  LEEPIYIVTELMKYGSLLEYLQGGAGRAL-KLPQLIDMAAQVASGMAYLEAQN---YIHR 127

Query: 176 DLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT---YGYMSPEYALEGIFSI 232
           DL A N+L+ ++   K++DFG+AR+   +  +A      G      + +PE AL   FSI
Sbjct: 128 DLAARNVLVGENNICKVADFGLARVIKEDIYEARE----GAKFPIKWTAPEAALYNRFSI 183

Query: 233 KSDVFSFGVLLLEIVS 248
           KSDV+SFG+LL EIV+
Sbjct: 184 KSDVWSFGILLTEIVT 199

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score =  117 bits (294), Expect = 2e-30
 Identities = 87/280 (31%), Positives = 140/280 (50%), Gaps = 43/280 (15%)

Query: 57  LGEGGFGPVYKGVLKKGDE----IAVKRL-SGRSGQGLREMKNEASVIAKVQHKNLVRLL 111
           +G G FG V +G LK   +    +A+K L +G S +   +   EAS++ +  H N++RL 
Sbjct: 12  IGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLE 71

Query: 112 GCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVR 171
           G        ++I EYM N SLD FL +            V ++ GIA G+ YL   S + 
Sbjct: 72  GVVTKSRPVMIITEYMENGSLDKFLRE--NDGKFTVGQLVGMLRGIASGMKYL---SEMN 126

Query: 172 IIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTS--RIVGTYGYMSPEYALEGI 229
            +HRDL A NIL++ ++  K+SDFG++R    +E    T   +I     + +PE      
Sbjct: 127 YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKI--PIRWTAPEAIAYRK 184

Query: 230 FSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEY 288
           F+  SDV+SFG+++ E++S G++    Y           WD+  SN+  ++I  + ED Y
Sbjct: 185 FTSASDVWSFGIVMWEVMSYGERP---Y-----------WDM--SNQ--DVIKAV-EDGY 225

Query: 289 ------SSKQMLLRYANIALLCVQESADDRPTMNDVVSML 322
                      L +   + L C Q+  ++RPT + +VS L
Sbjct: 226 RLPPPMDCPSALYQ---LMLDCWQKDRNERPTFSQIVSTL 262

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score =  116 bits (292), Expect = 2e-30
 Identities = 79/276 (28%), Positives = 125/276 (45%), Gaps = 35/276 (12%)

Query: 56  KLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLRE-MKNEASVIAKVQHKNLVRLLGCC 114
           K+G+G FG VYKGVLK   E+AVK         L+     EA ++ +  H N+V+L+G C
Sbjct: 2   KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61

Query: 115 IDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 174
           + +    ++ E +P  SL  FL     R+ +     +Q+    A G+ YL   +    IH
Sbjct: 62  VQKQPIYIVMELVPGGSLLTFLRKKKNRLTVK--KLLQMSLDAAAGMEYLESKN---CIH 116

Query: 175 RDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKS 234
           RDL A N L+ ++   KISDFGM+R   G     +         + +PE    G ++ +S
Sbjct: 117 RDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSES 176

Query: 235 DVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELID-------PILEDE 287
           DV+S+G+LL E  S       Y               ++ +T E I+       P L  E
Sbjct: 177 DVWSYGILLWETFSL--GDTPYPG------------MSNQQTRERIESGYRMPAPQLCPE 222

Query: 288 YSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLT 323
              + M        L C     ++RP+ +++ + L 
Sbjct: 223 EIYRLM--------LQCWAYDPENRPSFSEIYNELQ 250

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score =  116 bits (293), Expect = 2e-30
 Identities = 73/206 (35%), Positives = 111/206 (53%), Gaps = 15/206 (7%)

Query: 51  FSDANKLGEGGFGPVYKGVLK-KGDEIAVKR--LSGRSGQGLREMKNEASVIAKVQHKNL 107
           F   NK+G+G FG V+K V K      A+K+  LS  + +   E  +EA V+AK+    +
Sbjct: 2   FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYI 61

Query: 108 VRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLD---WVTRVQIIEGIAQGLLYL 164
           +R     +D+ +  ++ EY  N  L   L     R L +   W   +QI+ G+A    +L
Sbjct: 62  IRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLA----HL 117

Query: 165 HQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY 224
           H     +I+HRD+K+ N+ LD   N KI D G+A++   N   ANT  IVGT  Y+SPE 
Sbjct: 118 HSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANT--IVGTPYYLSPEL 172

Query: 225 ALEGIFSIKSDVFSFGVLLLEIVSGK 250
             +  ++ KSDV++ GV+L E  +GK
Sbjct: 173 CEDKPYNEKSDVWALGVVLYECCTGK 198

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score =  116 bits (293), Expect = 2e-30
 Identities = 89/284 (31%), Positives = 128/284 (45%), Gaps = 44/284 (15%)

Query: 55  NKLGEGGFGPVYKGV--LKKGDEI--AVKRLS-GRSGQGLREMKNEASVIAKVQHKNLVR 109
            +LG G FG V KGV  +K G E+  AVK L       G +E   EASV+A++ H  +VR
Sbjct: 1   KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVR 60

Query: 110 LLGCCIDRDEKILIYEYMPNKSLDFFLFDP---TKRMLLDWVTRVQIIEGIAQGLLYLHQ 166
           L+G C   +  +L+ E  P   L  +L          L +   +V      A G+ YL  
Sbjct: 61  LIGVCKG-EPLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQV------AMGMAYLES 113

Query: 167 YSRVRIIHRDLKASNILLDKDMNPKISDFGMARI--CGGNELQANTSRIVGTY--GYMSP 222
                 +HRDL A N+LL      KISDFGM+R    G +  +A T+   G +   + +P
Sbjct: 114 ---KHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTA---GRWPLKWYAP 167

Query: 223 EYALEGIFSIKSDVFSFGVLLLEIVS--GKKNTGLYRTDSLNLLGYAWDLWTSNRTLELI 280
           E    G FS KSDV+S+GV L E  S   K    +   + + +L        S   L   
Sbjct: 168 ECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAML-------ESGERLPRP 220

Query: 281 DPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTN 324
           +   ++ YS          I L C +   +DRPT +++ S    
Sbjct: 221 EECPQEIYS----------IMLSCWKYRPEDRPTFSELESTFRR 254

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score =  114 bits (288), Expect = 1e-29
 Identities = 73/211 (34%), Positives = 104/211 (49%), Gaps = 23/211 (10%)

Query: 55  NKLGEGGFGPVYKGVL--KKGD----EIAVKRL-SGRSGQGLREMKNEASVIAKVQHKNL 107
             LG G FG VY+G+   + GD    ++AVK L    S Q   +   EA +++K  H+N+
Sbjct: 12  RALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNI 71

Query: 108 VRLLGCCIDRDEKILIYEYMPNKSLDFFLFD-------PTKRMLLDWVTRVQIIEGIAQG 160
           VRL+G   +R  + ++ E M    L  FL +       P+   + D +        +A+G
Sbjct: 72  VRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLL---FCARDVAKG 128

Query: 161 LLYLHQYSRVRIIHRDLKASNILLD---KDMNPKISDFGMARICGGNELQANTSRIVGTY 217
             YL +      IHRD+ A N LL         KI+DFGMAR            R +   
Sbjct: 129 CKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPI 185

Query: 218 GYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 248
            +M PE  L+GIF+ K+DV+SFGVLL EI S
Sbjct: 186 KWMPPEAFLDGIFTSKTDVWSFGVLLWEIFS 216

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =  112 bits (283), Expect = 9e-29
 Identities = 67/219 (30%), Positives = 98/219 (44%), Gaps = 33/219 (15%)

Query: 57  LGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLREMK-----NEASVIAKV-QHKNLVR 109
           +GEG F  V     K+   E A+K L  R  Q ++E K      E  V+ ++  H  +++
Sbjct: 9   IGEGSFSTVVLAKEKETNKEYAIKILDKR--QLIKEKKVKYVKIEKEVLTRLNGHPGIIK 66

Query: 110 LLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSR 169
           L     D +    + EY PN  L  ++    K   LD          I   L YLH    
Sbjct: 67  LYYTFQDEENLYFVLEYAPNGELLQYI---RKYGSLDEKCTRFYAAEILLALEYLHS--- 120

Query: 170 VRIIHRDLKASNILLDKDMNPKISDFGMARICGGNEL------------------QANTS 211
             IIHRDLK  NILLDKDM+ KI+DFG A++   N                    +   +
Sbjct: 121 KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFA 180

Query: 212 RIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 250
             VGT  Y+SPE   E      SD+++ G ++ ++++GK
Sbjct: 181 SFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  111 bits (280), Expect = 1e-28
 Identities = 65/200 (32%), Positives = 98/200 (49%), Gaps = 16/200 (8%)

Query: 57  LGEGGFGPVYKGVLKKGDE--IAVKRLSGRS---GQGLREMKNEASVIAKVQHKNLVRLL 111
           LG+G FG V   V KK      A+K L  +     + +     E ++++++ H  +V+L 
Sbjct: 1   LGKGSFGKVLL-VRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLH 59

Query: 112 GCCIDRDEKI-LIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRV 170
                 +EK+ L+ EY P   L   L    +    +   R    E I   L YLH    +
Sbjct: 60  -YAFQTEEKLYLVLEYAPGGELFSHLSK--EGRFSEERARFYAAE-IVLALEYLH---SL 112

Query: 171 RIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIF 230
            II+RDLK  NILLD D + K++DFG+A+       + NT    GT  Y++PE  L   +
Sbjct: 113 GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNT--FCGTPEYLAPEVLLGKGY 170

Query: 231 SIKSDVFSFGVLLLEIVSGK 250
               D +S GVLL E+++GK
Sbjct: 171 GKAVDWWSLGVLLYEMLTGK 190

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score =  111 bits (280), Expect = 2e-28
 Identities = 71/209 (33%), Positives = 104/209 (49%), Gaps = 20/209 (9%)

Query: 57  LGEGGFGPVYKGVLKKGD-------EIAVKRL-SGRSGQGLREMKNEASVIAKVQHKNLV 108
           LG G FG VY+G              +AVK L  G + Q  +E   EA +++   H N+V
Sbjct: 3   LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62

Query: 109 RLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRM----LLDWVTRVQIIEGIAQGLLYL 164
           +LLG C+  + + +I E M    L  +L D         LL     + I   +A+G +YL
Sbjct: 63  KLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYL 122

Query: 165 HQYSRVRIIHRDLKASNILL-----DKDMNPKISDFGMARICGGNELQANTSRIVGTYGY 219
            Q   +  IHRDL A N L+     D D   KI DFG+AR    ++        +    +
Sbjct: 123 EQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRW 179

Query: 220 MSPEYALEGIFSIKSDVFSFGVLLLEIVS 248
           M+PE  L+G F+ +SDV+SFGVL+ EI++
Sbjct: 180 MAPESLLDGKFTTQSDVWSFGVLMWEILT 208

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score =  111 bits (279), Expect = 2e-28
 Identities = 70/197 (35%), Positives = 108/197 (54%), Gaps = 15/197 (7%)

Query: 56  KLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMK---NEASVIAKVQHKNLVRLLG 112
           KLG G FG V+ G      ++A+K L     QG    +    EA+++ ++QH  LVRL  
Sbjct: 13  KLGAGQFGEVWMGYYNGHTKVAIKSLK----QGSMSPEAFLAEANLMKQLQHPRLVRLYA 68

Query: 113 CCIDRDEKILIYEYMPNKSL-DFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVR 171
             + ++   +I EYM N SL DF       ++ ++    + +   IA+G+ ++    R  
Sbjct: 69  V-VTQEPIYIITEYMENGSLVDFLKTPEGIKLTIN--KLIDMAAQIAEGMAFIE---RKN 122

Query: 172 IIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFS 231
            IHRDL+A+NIL+ + +  KI+DFG+AR+   NE  A          + +PE    G F+
Sbjct: 123 YIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKF-PIKWTAPEAINYGTFT 181

Query: 232 IKSDVFSFGVLLLEIVS 248
           IKSDV+SFG+LL EIV+
Sbjct: 182 IKSDVWSFGILLTEIVT 198

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score =  110 bits (275), Expect = 4e-28
 Identities = 67/209 (32%), Positives = 108/209 (51%), Gaps = 15/209 (7%)

Query: 56  KLGEGGFGPVYKGVLKKGDEIAVKRLSGRSG-QGLREMKNEASVIAKVQHKNLVRLLGCC 114
           ++G G FG V+ G   +  ++A+K +  R G     +   EA V+ K+ H  LV+L G C
Sbjct: 11  EIGSGQFGLVWLGYWLEKRKVAIKTI--REGAMSEEDFIEEAQVMMKLSHPKLVQLYGVC 68

Query: 115 IDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 174
            +R    L++E+M +  L  +L    +R      T + +   + +G+ YL   +   +IH
Sbjct: 69  TERSPICLVFEFMEHGCLSDYL--RAQRGKFSQETLLGMCLDVCEGMAYLESSN---VIH 123

Query: 175 RDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT---YGYMSPEYALEGIFS 231
           RDL A N L+ ++   K+SDFGM R    ++  ++T    GT     + SPE      +S
Sbjct: 124 RDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSST----GTKFPVKWSSPEVFSFSKYS 179

Query: 232 IKSDVFSFGVLLLEIVSGKKNTGLYRTDS 260
            KSDV+SFGVL+ E+ S  K     R++S
Sbjct: 180 SKSDVWSFGVLMWEVFSEGKTPYENRSNS 208

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score =  109 bits (275), Expect = 7e-28
 Identities = 61/200 (30%), Positives = 105/200 (52%), Gaps = 18/200 (9%)

Query: 56  KLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCC 114
           KLGEG +G VYK + K+ G  +A+K +     + L+E+  E S++ +     +V+  G  
Sbjct: 10  KLGEGSYGSVYKAIHKETGQVVAIKVVP--VEEDLQEIIKEISILKQCDSPYIVKYYGSY 67

Query: 115 IDRDEKILIYEYMPNKS-LDFFLFDPTKRMLLDWVTRVQI---IEGIAQGLLYLHQYSRV 170
               +  ++ EY    S  D  +   T + L    T  +I   +    +GL YLH     
Sbjct: 68  FKNTDLWIVMEYCGAGSVSD--IMKITNKTL----TEEEIAAILYQTLKGLEYLHS---N 118

Query: 171 RIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIF 230
           + IHRD+KA NILL+++   K++DFG++        + NT  ++GT  +M+PE   E  +
Sbjct: 119 KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNT--VIGTPFWMAPEVIQEIGY 176

Query: 231 SIKSDVFSFGVLLLEIVSGK 250
           + K+D++S G+  +E+  GK
Sbjct: 177 NNKADIWSLGITAIEMAEGK 196

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score =  109 bits (275), Expect = 9e-28
 Identities = 65/212 (30%), Positives = 103/212 (48%), Gaps = 29/212 (13%)

Query: 57  LGEGGFGPVYKGVLK---KGD---EIAVKRLSGRSGQGLR-EMKNEASVIAKVQHKNLVR 109
           LG+G FG VY+G+ K   KG+    +A+K ++  +    R E  NEASV+ +    ++VR
Sbjct: 14  LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73

Query: 110 LLGCCIDRDEKILIYEYM-------------PNKSLDFFLFDPTKRMLLDWVTRVQIIEG 156
           LLG        +++ E M             P    +  L  PT +  +           
Sbjct: 74  LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAE------ 127

Query: 157 IAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 216
           IA G+ YL      + +HRDL A N ++ +D+  KI DFGM R     +      + +  
Sbjct: 128 IADGMAYLAA---KKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLP 184

Query: 217 YGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 248
             +M+PE   +G+F+ KSDV+SFGV+L E+ +
Sbjct: 185 VRWMAPESLKDGVFTTKSDVWSFGVVLWEMAT 216

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  112 bits (279), Expect = 1e-27
 Identities = 77/324 (23%), Positives = 129/324 (39%), Gaps = 21/324 (6%)

Query: 56  KLGEGGFGPVYKGVLKKGDEIAVKRLSGR---SGQGLREMKNEASVIAKVQH-KNLVRLL 111
           KLGEG FG VY    +K   +A+K L+ +     + +     E  ++A + H  N+V+L 
Sbjct: 7   KLGEGSFGEVYLARDRK--LVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLY 64

Query: 112 GCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVR 171
               D     L+ EY+   SL+  L    ++  L     + I+  I   L YLH      
Sbjct: 65  DFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH---SKG 121

Query: 172 IIHRDLKASNILLDKDMN-PKISDFGMARICGGN----ELQANTSRIVGTYGYMSPEYAL 226
           IIHRD+K  NILLD+D    K+ DFG+A++         + A  S  VGT GYM+PE  L
Sbjct: 122 IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLL 181

Query: 227 ---EGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPI 283
                  S  SD++S G+ L E+++G          + +       +     T  L  P+
Sbjct: 182 GLSLAYASSSSDIWSLGITLYELLTGL--PPFEGEKNSSATSQTLKIILELPTPSLASPL 239

Query: 284 LEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNEAATLLPPKQPAFSYVRNT 343
                          ++    + +   +R + +  +S        L            ++
Sbjct: 240 SPSNPELISKAAS--DLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLKESDLSDLLKPDDS 297

Query: 344 VTSTSSTGKTEDCSINQVTISLLE 367
                S   + +  I+ +    + 
Sbjct: 298 APLRLSLPPSLEALISSLNSLAIS 321

Length = 384

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score =  109 bits (273), Expect = 1e-27
 Identities = 88/271 (32%), Positives = 133/271 (49%), Gaps = 29/271 (10%)

Query: 56  KLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCI 115
           KLG G FG V+ G      ++AVK L   +   ++    EA+++  +QH  LVRL     
Sbjct: 13  KLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVT 71

Query: 116 DRDEKILIYEYMPNKSL-DFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 174
             +   +I EYM   SL DF   D   ++LL     +     IA+G+ Y+    R   IH
Sbjct: 72  KEEPIYIITEYMAKGSLLDFLKSDEGGKVLLP--KLIDFSAQIAEGMAYIE---RKNYIH 126

Query: 175 RDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKS 234
           RDL+A+N+L+ + +  KI+DFG+AR+   NE  A          + +PE    G F+IKS
Sbjct: 127 RDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKF-PIKWTAPEAINFGSFTIKS 185

Query: 235 DVFSFGVLLLEIVSGKK--NTGLYRTDSLNLLGYAWDL-WTSNRTLELIDPILEDEYSSK 291
           DV+SFG+LL EIV+  K    G+  +D ++ L   + +    N   EL D          
Sbjct: 186 DVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPRMENCPDELYD---------- 235

Query: 292 QMLLRYANIALLCVQESADDRPTMNDVVSML 322
                   I   C +E A++RPT + + S+L
Sbjct: 236 --------IMKTCWKEKAEERPTFDYLQSVL 258

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score =  109 bits (273), Expect = 1e-27
 Identities = 82/268 (30%), Positives = 138/268 (51%), Gaps = 37/268 (13%)

Query: 57  LGEGGFGPVYKGV-LKKGDEIAVKRLS----GRSGQG-LREMKNEASVIAKVQHKNLVRL 110
           LG G FG VY+G+ L  GD  AVK +S    G++GQ  +++++ E ++++K+QH N+V+ 
Sbjct: 8   LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67

Query: 111 LGCCIDRDEKILIY-EYMPNKSLDFFL--FDPTKRMLLDWVTRVQIIEGIAQGLLYLHQY 167
           LG   + ++ + I+ E +P  SL   L  +      ++   TR QI+ G+     YLH  
Sbjct: 68  LGTERE-EDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTR-QILLGLE----YLH-- 119

Query: 168 SRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAL- 226
            R   +HRD+K +NIL+D +   K++DFGMA+        +      G+  +M+PE    
Sbjct: 120 DR-NTVHRDIKGANILVDTNGVVKLADFGMAKQV---VEFSFAKSFKGSPYWMAPEVIAQ 175

Query: 227 EGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILED 286
           +G + + +D++S G  +LE+ +GK            L G A  ++   R+ EL  P + D
Sbjct: 176 QGGYGLAADIWSLGCTVLEMATGKPPWS-------QLEGVAA-VFKIGRSKEL--PPIPD 225

Query: 287 EYSSKQMLLRYANIALLCVQESADDRPT 314
             S +       +  L C+Q     RPT
Sbjct: 226 HLSDEA-----KDFILKCLQRDPSLRPT 248

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score =  109 bits (273), Expect = 2e-27
 Identities = 82/283 (28%), Positives = 124/283 (43%), Gaps = 35/283 (12%)

Query: 57  LGEGGFGPVYKGVLKKGDE------IAVKRLSGRSGQG-LREMKNEASVIAKVQHKNLVR 109
           LG G FG V+    K  +E      + VK L     +    E + E  +  K+ HKN+VR
Sbjct: 13  LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVR 72

Query: 110 LLGCCIDRDEKILIYEYMPNKSLDFFL------FDPTKRMLLDWVTRVQIIEGIAQGLLY 163
           LLG C + +   +I EY     L  FL       +  K   L    +V +   IA G+ +
Sbjct: 73  LLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDH 132

Query: 164 LHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE 223
           L   S  R +HRDL A N L+      K+S   +++    +E     + ++    +++PE
Sbjct: 133 L---SNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALI-PLRWLAPE 188

Query: 224 YALEGIFSIKSDVFSFGVLLLEIVSGKK--NTGLYRTDSLNLLGYAWDLWTSNRTLELID 281
              E  FS KSDV+SFGVL+ E+ +  +    GL   + LN L            LEL  
Sbjct: 189 AVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQ--------AGKLEL-- 238

Query: 282 PILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTN 324
           P+ E   S    L+        C   +  DRP+ +++VS L  
Sbjct: 239 PVPEGCPSRLYKLM------TRCWAVNPKDRPSFSELVSALGE 275

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score =  108 bits (273), Expect = 3e-27
 Identities = 64/210 (30%), Positives = 108/210 (51%), Gaps = 29/210 (13%)

Query: 55  NKLGEGGFGPVYKGVLKK-GDEIAVKRL---SGRSG---QGLREMKNEASVIAKVQHKNL 107
            ++GEG +G VYK   KK G+ +A+K++   + + G     +RE+K    ++ K++H N+
Sbjct: 5   AQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIK----LLQKLRHPNI 60

Query: 108 VRLLGCCIDRDEK--ILIYEYMPNKSLDF--FLFDPTKRMLLDWVTRV--QIIEGIAQGL 161
           VRL      + +    +++EYM +   D    L  P  +     +     Q++EG+    
Sbjct: 61  VRLKEIVTSKGKGSIYMVFEYMDH---DLTGLLDSPEVKFTESQIKCYMKQLLEGLQ--- 114

Query: 162 LYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMS 221
            YLH      I+HRD+K SNIL++ D   K++DFG+AR          T+R++ T  Y  
Sbjct: 115 -YLHS---NGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI-TLWYRP 169

Query: 222 PEYAL-EGIFSIKSDVFSFGVLLLEIVSGK 250
           PE  L    +  + D++S G +L E+  GK
Sbjct: 170 PELLLGATRYGPEVDMWSVGCILAELFLGK 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score =  107 bits (270), Expect = 7e-27
 Identities = 71/215 (33%), Positives = 113/215 (52%), Gaps = 27/215 (12%)

Query: 56  KLGEGGFGPVYKGVLKKGDEI-AVKRL------SGRSGQGLREMKNEASVIAKVQHKNLV 108
           KLGEG +G VYK   KK  EI A+K++       G     LRE+    S++ +++H N+V
Sbjct: 6   KLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREI----SLLKELKHPNIV 61

Query: 109 RLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRV--QIIEGIAQGLLYLHQ 166
           +LL       +  L++EY  +  L  +L      +  + +  +  Q++ G+A    Y H 
Sbjct: 62  KLLDVIHTERKLYLVFEYC-DMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLA----YCHS 116

Query: 167 YSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAL 226
               RI+HRDLK  NIL+++D   K++DFG+AR   G  L+  T  +V T  Y +PE  L
Sbjct: 117 ---HRILHRDLKPQNILINRDGVLKLADFGLARAF-GIPLRTYTHEVV-TLWYRAPEILL 171

Query: 227 -EGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDS 260
               +S   D++S G +  E+++GK    L+  DS
Sbjct: 172 GSKHYSTAVDIWSVGCIFAEMITGK---PLFPGDS 203

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score =  106 bits (266), Expect = 1e-26
 Identities = 80/275 (29%), Positives = 122/275 (44%), Gaps = 38/275 (13%)

Query: 57  LGEGGFGPVYKGVLKKGDEIAVKRLSGRSG-QGLREMKNEASVIAKVQHKNLVRLLGCCI 115
           LG G FG V+ G  +   ++A+K +  R G     +   EA V+ K+ H NLV+L G C 
Sbjct: 12  LGSGQFGVVHLGKWRGKIDVAIKMI--REGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCT 69

Query: 116 DRDEKILIYEYMPNKSLDFFLFDPTKR----MLLDWVTRVQIIEGIAQGLLYLHQYSRVR 171
            +    ++ EYM N  L  +L +   +     LLD  + V       + + YL       
Sbjct: 70  KQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDV------CEAMEYLESNG--- 120

Query: 172 IIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT---YGYMSPEYALEG 228
            IHRDL A N L+ +D   K+SDFG+AR    ++  ++     GT     +  PE     
Sbjct: 121 FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQ----GTKFPVKWAPPEVFDYS 176

Query: 229 IFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEY 288
            FS KSDV+SFGVL+ E+ S  K                ++ ++++  +E +       Y
Sbjct: 177 RFSSKSDVWSFGVLMWEVFSEGK--------------MPYERFSNSEVVESVSAGYR-LY 221

Query: 289 SSKQMLLRYANIALLCVQESADDRPTMNDVVSMLT 323
             K        I   C  E  +DRP    ++S LT
Sbjct: 222 RPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQLT 256

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score =  106 bits (267), Expect = 1e-26
 Identities = 66/205 (32%), Positives = 102/205 (49%), Gaps = 24/205 (11%)

Query: 55  NKLGEGGFGPVYKGVLKKGDEI-AVK--RLSGRSG---QGLREMKNEASVIAKVQHKNLV 108
            +LG G  G V K + +   +I AVK  RL        Q LRE+     ++ K     +V
Sbjct: 7   GELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELD----ILHKCNSPYIV 62

Query: 109 RLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYS 168
              G   +  +  +  EYM   SLD  L +   R+    + +  I   + +GL YLH   
Sbjct: 63  GFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGK--IAVAVLKGLTYLH--E 118

Query: 169 RVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNEL---QANTSRIVGTYGYMSPEYA 225
           + +IIHRD+K SNIL++     K+ DFG++      +L    A T   VGT  YM+PE  
Sbjct: 119 KHKIIHRDVKPSNILVNSRGQIKLCDFGVSG-----QLVNSLAKTF--VGTSSYMAPERI 171

Query: 226 LEGIFSIKSDVFSFGVLLLEIVSGK 250
               +S+KSD++S G+ L+E+ +G+
Sbjct: 172 QGNDYSVKSDIWSLGLSLIELATGR 196

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  106 bits (267), Expect = 1e-26
 Identities = 70/213 (32%), Positives = 112/213 (52%), Gaps = 30/213 (14%)

Query: 55  NKLGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQG--LREMKNEASVIAKVQHKNLVRLL 111
           NK+G G FG VY  V L  G+ +AVK +  +      ++E+ +E  V+  ++H NLV+  
Sbjct: 6   NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65

Query: 112 GCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRV---QIIEGIAQGLLYLHQYS 168
           G  + R++  +  EY    +L+  L     R+L + V RV   Q++EG+A    YLH + 
Sbjct: 66  GVEVHREKVYIFMEYCSGGTLEELL--EHGRILDEHVIRVYTLQLLEGLA----YLHSH- 118

Query: 169 RVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRI-------VGTYGYMS 221
              I+HRD+K +NI LD +   K+ DFG A       L+ NT+ +        GT  YM+
Sbjct: 119 --GIVHRDIKPANIFLDHNGVIKLGDFGCAVK-----LKNNTTTMGEEVQSLAGTPAYMA 171

Query: 222 PEYALEGIFSIK---SDVFSFGVLLLEIVSGKK 251
           PE    G        +D++S G ++LE+ +GK+
Sbjct: 172 PEVITGGKGKGHGRAADIWSLGCVVLEMATGKR 204

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score =  105 bits (263), Expect = 2e-26
 Identities = 72/194 (37%), Positives = 105/194 (54%), Gaps = 9/194 (4%)

Query: 56  KLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLRE-MKNEASVIAKVQHKNLVRLLGCC 114
           KLG G FG V+ G      ++AVK L  + G    E    EA ++ K++H  LV+L    
Sbjct: 13  KLGNGQFGEVWMGTWNGNTKVAVKTL--KPGTMSPESFLEEAQIMKKLRHDKLVQLYAV- 69

Query: 115 IDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 174
           +  +   ++ EYM   SL  FL D   R L      V +   +A G+ Y+    R+  IH
Sbjct: 70  VSEEPIYIVTEYMSKGSLLDFLKDGEGRAL-KLPNLVDMAAQVAAGMAYIE---RMNYIH 125

Query: 175 RDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKS 234
           RDL+++NIL+   +  KI+DFG+AR+   NE  A          + +PE AL G F+IKS
Sbjct: 126 RDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKS 184

Query: 235 DVFSFGVLLLEIVS 248
           DV+SFG+LL E+V+
Sbjct: 185 DVWSFGILLTELVT 198

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score =  103 bits (259), Expect = 1e-25
 Identities = 69/194 (35%), Positives = 106/194 (54%), Gaps = 9/194 (4%)

Query: 56  KLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLRE-MKNEASVIAKVQHKNLVRLLGCC 114
           KLG+G FG V+ G       +A+K L  + G    E    EA V+ K++H+ LV+L    
Sbjct: 13  KLGQGCFGEVWMGTWNGTTRVAIKTL--KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV- 69

Query: 115 IDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 174
           +  +   ++ EYM   SL  FL     + L      V +   IA G+ Y+    R+  +H
Sbjct: 70  VSEEPIYIVTEYMSKGSLLDFLKGEMGKYL-RLPQLVDMAAQIASGMAYVE---RMNYVH 125

Query: 175 RDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKS 234
           RDL+A+NIL+ +++  K++DFG+AR+   NE  A          + +PE AL G F+IKS
Sbjct: 126 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKS 184

Query: 235 DVFSFGVLLLEIVS 248
           DV+SFG+LL E+ +
Sbjct: 185 DVWSFGILLTELTT 198

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score =  103 bits (259), Expect = 1e-25
 Identities = 81/280 (28%), Positives = 118/280 (42%), Gaps = 39/280 (13%)

Query: 56  KLGEGGFGPVYKGVLKK--GDEI--AVKRL-SGRSGQGLREMKNEASVIAKVQHKNLVRL 110
           KLG+G FG V +G      G  I  AVK L S +    + +   EA+++  + H+NL+RL
Sbjct: 2   KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61

Query: 111 LGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRV-QIIEGIAQGLLYLHQYSR 169
            G  +      ++ E  P  SL   L        L  ++ +      IA G+ YL     
Sbjct: 62  YGVVLTHPLM-MVTELAPLGSLLDRLRKDALGHFL--ISTLCDYAVQIANGMRYLESK-- 116

Query: 170 VRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE----LQANTSRIVGTYGYMSPEYA 225
            R IHRDL A NILL  D   KI DFG+ R    NE    ++ +    V  + + +PE  
Sbjct: 117 -RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEH--LKV-PFAWCAPESL 172

Query: 226 LEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLW---TSNRTLELIDP 282
               FS  SDV+ FGV L E+ +                 Y  + W   + ++ L+ ID 
Sbjct: 173 RTRTFSHASDVWMFGVTLWEMFT-----------------YGEEPWAGLSGSQILKKIDK 215

Query: 283 ILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSML 322
             E     +       N+ L C   +  DRPT   +   L
Sbjct: 216 EGERLERPEACPQDIYNVMLQCWAHNPADRPTFAALREFL 255

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score =  102 bits (256), Expect = 2e-25
 Identities = 70/194 (36%), Positives = 106/194 (54%), Gaps = 15/194 (7%)

Query: 56  KLGEGGFGPVYKGVLKKGDEIAVKRLS-GRSGQGLREMKNEASVIAKVQHKNLVRLLGCC 114
            +GEG FG V +G    G ++AVK +    + Q   E   E +V+ K+ HKNLVRLLG  
Sbjct: 13  IIGEGEFGAVLQGEYT-GQKVAVKNIKCDVTAQAFLE---ETAVMTKLHHKNLVRLLGVI 68

Query: 115 IDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 174
           +     I++ E M   +L  FL     R L+  +  +Q    +A+G+ YL      +++H
Sbjct: 69  LHNGLYIVM-ELMSKGNLVNFL-RTRGRALVSVIQLLQFSLDVAEGMEYLESK---KLVH 123

Query: 175 RDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKS 234
           RDL A NIL+ +D   K+SDFG+AR+     +  + S++     + +PE      FS KS
Sbjct: 124 RDLAARNILVSEDGVAKVSDFGLARV---GSMGVDNSKL--PVKWTAPEALKHKKFSSKS 178

Query: 235 DVFSFGVLLLEIVS 248
           DV+S+GVLL E+ S
Sbjct: 179 DVWSYGVLLWEVFS 192

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score =  102 bits (255), Expect = 4e-25
 Identities = 80/273 (29%), Positives = 131/273 (47%), Gaps = 30/273 (10%)

Query: 56  KLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCI 115
           KLG G FG V+     K  ++AVK +   S   +     EA+V+  +QH  LV+L    +
Sbjct: 13  KLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKL-HAVV 70

Query: 116 DRDEKILIYEYMPNKSL-DFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 174
            ++   +I E+M   SL DF   D   +  L  +  +     IA+G+ ++ Q +    IH
Sbjct: 71  TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKL--IDFSAQIAEGMAFIEQRN---YIH 125

Query: 175 RDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKS 234
           RDL+A+NIL+   +  KI+DFG+AR+   NE  A          + +PE    G F+IKS
Sbjct: 126 RDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKF-PIKWTAPEAINFGSFTIKS 184

Query: 235 DVFSFGVLLLEIVSGKKN--TGLYRTDSLNLLGYAWDLW-TSNRTLELIDPILEDEYSSK 291
           DV+SFG+LL+EIV+  +    G+   + +  L   + +    N   EL + ++       
Sbjct: 185 DVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELYNIMMR------ 238

Query: 292 QMLLRYANIALLCVQESADDRPTMNDVVSMLTN 324
                       C +   ++RPT   + S+L +
Sbjct: 239 ------------CWKNRPEERPTFEYIQSVLDD 259

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score =  102 bits (255), Expect = 6e-25
 Identities = 67/215 (31%), Positives = 111/215 (51%), Gaps = 22/215 (10%)

Query: 56  KLGEGGFGPVY----KGVLKKGDE--IAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVR 109
           +LGEG FG V+      +L + D+  +AVK L   S    ++ + EA ++  +QH+++VR
Sbjct: 12  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVR 71

Query: 110 LLGCCIDRDEKILIYEYMPNKSLDFFL--FDPTKRML----------LDWVTRVQIIEGI 157
             G C +    ++++EYM +  L+ FL    P  ++L          L     + I   I
Sbjct: 72  FYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQI 131

Query: 158 AQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTY 217
           A G++YL   + +  +HRDL   N L+ + +  KI DFGM+R     +      R +   
Sbjct: 132 ASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 188

Query: 218 GYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKK 251
            +M PE  L   F+ +SD++SFGV+L EI + GK+
Sbjct: 189 RWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQ 223

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score =  102 bits (255), Expect = 6e-25
 Identities = 68/216 (31%), Positives = 101/216 (46%), Gaps = 30/216 (13%)

Query: 49  NKFSDANKLGEGGFGPVYKGVLKKGDEI-AVKRLSGRSG-----QGLREMKNEASVIAKV 102
            K  + ++LGEG  G V K  LK    I A+K ++         Q LRE++    +    
Sbjct: 1   EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELE----INKSC 56

Query: 103 QHKNLVRLLGCCID-RDEKILI-YEYMPNKSLDFFLFDPTKRMLLDWVTRV------QII 154
           +   +V+  G  +D     I I  EY    SLD       K++      R+      +I 
Sbjct: 57  KSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIY----KKVK-KRGGRIGEKVLGKIA 111

Query: 155 EGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIV 214
           E + +GL YLH     +IIHRD+K SNILL +    K+ DFG++    G  + +      
Sbjct: 112 ESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVS----GELVNSLAGTFT 164

Query: 215 GTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 250
           GT  YM+PE      +SI SDV+S G+ LLE+   +
Sbjct: 165 GTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNR 200

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score =  101 bits (254), Expect = 7e-25
 Identities = 85/288 (29%), Positives = 127/288 (44%), Gaps = 43/288 (14%)

Query: 57  LGEGGFG--------PVYKGVLKKGDEIAVKRLSGRSGQGLRE-MKNEASVIAKVQHKNL 107
           LGEG FG        P   G    G+ +AVK L    GQ      K E +++  + H+N+
Sbjct: 12  LGEGHFGKVSLYCYDPANDGT---GEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENI 68

Query: 108 VRLLGCCIDRDEKI--LIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQII---EGIAQGLL 162
           V+  GCC ++  K   LI EY+P  SL  +L  P  ++ L      Q++   + I +G+ 
Sbjct: 69  VKYKGCCSEQGGKGLQLIMEYVPLGSLRDYL--PKHKLNL-----AQLLLFAQQICEGMA 121

Query: 163 YLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMAR-ICGGNELQANTSRIVGTYGYMS 221
           YLH       IHRDL A N+LLD D   KI DFG+A+ +  G+E             + +
Sbjct: 122 YLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYA 178

Query: 222 PEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELID 281
            E   E  FS  SDV+SFGV L E+++   +          ++G      T  R +EL++
Sbjct: 179 VECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLE 238

Query: 282 PILEDEYSSKQMLLRYAN-------IALLCVQESADDRPTMNDVVSML 322
                       L    N       +   C +  A  RPT   ++ +L
Sbjct: 239 --------RGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPIL 278

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score =  100 bits (251), Expect = 2e-24
 Identities = 68/208 (32%), Positives = 105/208 (50%), Gaps = 27/208 (12%)

Query: 57  LGEGGFGPVYKGV-LKKGDEIAVKRLS-GRSGQGLRE----MKNEASVIAKVQHKNLVRL 110
           LG+G FG VY    +  G E+AVK++         ++    ++ E  ++  +QH+ +V+ 
Sbjct: 10  LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQY 69

Query: 111 LGCCIDRDEKILIY-EYMPNKSLDFFLFDPTKRMLLDWVTR---VQIIEGIAQGLLYLHQ 166
            GC  D DE + I+ EYMP  S+   L       L + VTR    QI+EG+     YLH 
Sbjct: 70  YGCLRD-DETLSIFMEYMPGGSVKDQL--KAYGALTETVTRKYTRQILEGVE----YLH- 121

Query: 167 YSRVRIIHRDLKASNILLDKDMNPKISDFGMAR----ICGGNELQANTSRIVGTYGYMSP 222
                I+HRD+K +NIL D   N K+ DFG ++    IC           + GT  +MSP
Sbjct: 122 --SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSS---GTGMKSVTGTPYWMSP 176

Query: 223 EYALEGIFSIKSDVFSFGVLLLEIVSGK 250
           E      +  K+DV+S G  ++E+++ K
Sbjct: 177 EVISGEGYGRKADVWSVGCTVVEMLTEK 204

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score =  100 bits (250), Expect = 2e-24
 Identities = 83/280 (29%), Positives = 138/280 (49%), Gaps = 42/280 (15%)

Query: 57  LGEGGFGPVYKGVLK----KGDEIAVKRL-SGRSGQGLREMKNEASVIAKVQHKNLVRLL 111
           +G G FG V++G+LK    K   +A+K L  G + +  ++  +EAS++ +  H N++RL 
Sbjct: 13  IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLE 72

Query: 112 GCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVR 171
           G        ++I EYM N +LD +L D            V ++ GIA G+ YL   S + 
Sbjct: 73  GVVTKFKPAMIITEYMENGALDKYLRDHDGE--FSSYQLVGMLRGIAAGMKYL---SDMN 127

Query: 172 IIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG------YMSPEYA 225
            +HRDL A NIL++ ++  K+SDFG++R+     L+ +      T G      + +PE  
Sbjct: 128 YVHRDLAARNILVNSNLECKVSDFGLSRV-----LEDDPEGTYTTSGGKIPIRWTAPEAI 182

Query: 226 LEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPIL 284
               F+  SDV+SFG+++ E++S G++                WD+  SN   E++  I 
Sbjct: 183 AYRKFTSASDVWSFGIVMWEVMSFGERPY--------------WDM--SNH--EVMKAIN 224

Query: 285 EDEYSSKQMLLRYA--NIALLCVQESADDRPTMNDVVSML 322
           +       M    A   + L C Q+    RP   D+V++L
Sbjct: 225 DGFRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLL 264

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score =  101 bits (252), Expect = 2e-24
 Identities = 65/224 (29%), Positives = 105/224 (46%), Gaps = 41/224 (18%)

Query: 57  LGEGGFGPVYK----GVLKKGDE--IAVKRL-SGRSGQGLREMKNEASVIAKVQHKNLVR 109
           +G+G FG V++    G+L       +AVK L    S     + + EA+++A+  H N+V+
Sbjct: 13  IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72

Query: 110 LLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRML-------------------LDWVTR 150
           LLG C       L++EYM    L+ FL   + R                     L    +
Sbjct: 73  LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132

Query: 151 VQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMAR------ICGGN 204
           + I + +A G+ YL   S  + +HRDL   N L+ ++M  KI+DFG++R          +
Sbjct: 133 LCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKAS 189

Query: 205 ELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 248
           E  A   R      +M PE      ++ +SDV+++GV+L EI S
Sbjct: 190 ENDAIPIR------WMPPESIFYNRYTTESDVWAYGVVLWEIFS 227

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score =   99 bits (249), Expect = 3e-24
 Identities = 85/285 (29%), Positives = 140/285 (49%), Gaps = 50/285 (17%)

Query: 57  LGEGGFGPVYKGVLK----KGDEIAVKRL-SGRSGQGLREMKNEASVIAKVQHKNLVRLL 111
           +G G FG V +G LK    +   +A+K L SG + +  R+  +EAS++ +  H N++ L 
Sbjct: 12  IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71

Query: 112 GCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQII---EGIAQGLLYLHQYS 168
           G        ++I E+M N +LD FL     R      T +Q++    GIA G+ YL + +
Sbjct: 72  GVVTKSRPVMIITEFMENGALDSFL-----RQNDGQFTVIQLVGMLRGIAAGMKYLSEMN 126

Query: 169 RVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG--------YM 220
            V   HRDL A NIL++ ++  K+SDFG++R      L+ +TS    T          + 
Sbjct: 127 YV---HRDLAARNILVNSNLVCKVSDFGLSRF-----LEDDTSDPTYTSSLGGKIPIRWT 178

Query: 221 SPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDLWTSNRTLEL 279
           +PE      F+  SDV+S+G+++ E++S G++                WD+  SN+  ++
Sbjct: 179 APEAIAYRKFTSASDVWSYGIVMWEVMSYGERPY--------------WDM--SNQ--DV 220

Query: 280 IDPILEDEYSSKQMLLRYA--NIALLCVQESADDRPTMNDVVSML 322
           I+ I +D      M    A   + L C Q+  + RP    +VS L
Sbjct: 221 INAIEQDYRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTL 265

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score =   99 bits (249), Expect = 3e-24
 Identities = 82/280 (29%), Positives = 138/280 (49%), Gaps = 42/280 (15%)

Query: 57  LGEGGFGPVYKGVLK----KGDEIAVKRL-SGRSGQGLREMKNEASVIAKVQHKNLVRLL 111
           +G G FG V  G LK    +   +A+K L +G + +  R+  +EAS++ +  H N++ L 
Sbjct: 12  IGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71

Query: 112 GCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVR 171
           G        +++ EYM N SLD FL     +  +  +  V ++ GIA G+ YL     V 
Sbjct: 72  GVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTV--IQLVGMLRGIASGMKYLSDMGYV- 128

Query: 172 IIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG------YMSPEYA 225
             HRDL A NIL++ ++  K+SDFG++R+   +   A T+R     G      + +PE  
Sbjct: 129 --HRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTR-----GGKIPIRWTAPEAI 181

Query: 226 LEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPIL 284
               F+  SDV+S+G+++ E++S G++                W++  SN+  ++I  I 
Sbjct: 182 AYRKFTSASDVWSYGIVMWEVMSYGERPY--------------WEM--SNQ--DVIKAIE 223

Query: 285 EDEYSSKQMLLRYA--NIALLCVQESADDRPTMNDVVSML 322
           E       M    A   + L C Q+  ++RP    +VS+L
Sbjct: 224 EGYRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSIL 263

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 99.2 bits (247), Expect = 5e-24
 Identities = 63/208 (30%), Positives = 111/208 (53%), Gaps = 20/208 (9%)

Query: 55  NKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGL------REMKNEASVIAKVQHKNLV 108
             LG+G +G VY G+  +G  IAVK++   +   L       +++ E  ++  ++H N+V
Sbjct: 6   EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65

Query: 109 RLLGCCIDRDEKILIYEYMPNKSLDFFL--FDPTKRMLLDWVTRVQIIEGIAQGLLYLHQ 166
           + LG C+D +   +  E++P  S+   L  F P    +    T+ QI++G+A    YLH 
Sbjct: 66  QYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTK-QILDGVA----YLHN 120

Query: 167 YSRVRIIHRDLKASNILLDKDMNPKISDFGMA-RIC--GGNELQANTSRIV-GTYGYMSP 222
                ++HRD+K +N++L  +   K+ DFG A R+   G +   +N  + + GT  +M+P
Sbjct: 121 NC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAP 177

Query: 223 EYALEGIFSIKSDVFSFGVLLLEIVSGK 250
           E   E  +  KSD++S G  + E+ +GK
Sbjct: 178 EVINESGYGRKSDIWSIGCTVFEMATGK 205

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 99.4 bits (247), Expect = 5e-24
 Identities = 71/195 (36%), Positives = 108/195 (55%), Gaps = 11/195 (5%)

Query: 56  KLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLRE-MKNEASVIAKVQHKNLVRLLGCC 114
           KLG+G FG V+ G      ++A+K L  + G  + E    EA ++ K++H  LV L    
Sbjct: 13  KLGQGCFGEVWMGTWNGTTKVAIKTL--KPGTMMPEAFLQEAQIMKKLRHDKLVPLYAV- 69

Query: 115 IDRDEKILIYEYMPNKSL-DFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRII 173
           +  +   ++ E+M   SL DF      K + L  +  V +   IA G+ Y+    R+  I
Sbjct: 70  VSEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQL--VDMAAQIADGMAYIE---RMNYI 124

Query: 174 HRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIK 233
           HRDL+A+NIL+  ++  KI+DFG+AR+   NE  A          + +PE AL G F+IK
Sbjct: 125 HRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIK 183

Query: 234 SDVFSFGVLLLEIVS 248
           SDV+SFG+LL E+V+
Sbjct: 184 SDVWSFGILLTELVT 198

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 99.3 bits (247), Expect = 7e-24
 Identities = 72/229 (31%), Positives = 117/229 (51%), Gaps = 33/229 (14%)

Query: 44  VSTATNKFSDANKLGEGGFGPVYKGVL------KKGDEIAVKRLSGRSGQGLRE-MKNEA 96
           ++ +T +F +  +LGE  FG VYKG L      ++   +A+K L  ++   LRE  K+EA
Sbjct: 2   INLSTVRFME--ELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEA 59

Query: 97  SVIAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLF-------------DPTKRM 143
            + +++QH N+V LLG         +I+ Y  +  L  FL              D T + 
Sbjct: 60  MMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKS 119

Query: 144 LLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGG 203
            L+    V I+  IA G+ +L  +    ++H+DL   N+L+   +N KISD G+ R    
Sbjct: 120 TLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKLNVKISDLGLFR---- 172

Query: 204 NELQANTSRIVGT----YGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 248
               A+  +++G       +MSPE  + G FSI SD++S+GV+L E+ S
Sbjct: 173 EVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 98.4 bits (245), Expect = 1e-23
 Identities = 82/274 (29%), Positives = 128/274 (46%), Gaps = 40/274 (14%)

Query: 56  KLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCI 115
           +LG G FG V  G  +   ++A+K +   S     E   EA V+ K+ H+ LV+L G C 
Sbjct: 11  ELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCT 69

Query: 116 DRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIE---GIAQGLLYL--HQYSRV 170
            +    ++ EYM N  L  +L +  KR         Q++E    + +G+ YL   Q+   
Sbjct: 70  KQRPIYIVTEYMSNGCLLNYLREHGKRF-----QPSQLLEMCKDVCEGMAYLESKQF--- 121

Query: 171 RIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT---YGYMSPEYALE 227
             IHRDL A N L+D     K+SDFG++R    +E  ++    VG+     +  PE  L 
Sbjct: 122 --IHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSS----VGSKFPVRWSPPEVLLY 175

Query: 228 GIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILED 286
             FS KSDV++FGVL+ E+ S GK                 ++ + ++ T+E +   L  
Sbjct: 176 SKFSSKSDVWAFGVLMWEVYSLGKM---------------PYERFNNSETVEKVSQGLR- 219

Query: 287 EYSSKQMLLRYANIALLCVQESADDRPTMNDVVS 320
            Y       +   I   C  E A++RPT   ++S
Sbjct: 220 LYRPHLASEKVYAIMYSCWHEKAEERPTFQQLLS 253

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 97.1 bits (242), Expect = 3e-23
 Identities = 72/275 (26%), Positives = 128/275 (46%), Gaps = 37/275 (13%)

Query: 57  LGEGGFGP--VYKGVLKKGD-------EIAVKRLSGRSGQGLREMKNEASVIAKVQHKNL 107
           LG+G FG   +Y+   +  D       E+ + RLS +     R+  NE  +++ +QH N+
Sbjct: 8   LGKGAFGEATLYR---RTEDDSLVVWKEVNLTRLSEK---ERRDALNEIVILSLLQHPNI 61

Query: 108 VRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQY 167
           +      +D +  ++  EY    +L +      K  L +    +  +  I   + Y+H+ 
Sbjct: 62  IAYYNHFMDDNTLLIEMEYANGGTL-YDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKA 120

Query: 168 SRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALE 227
               I+HRD+K  NI L K    K+ DFG+++I G     A T  +VGT  YMSPE    
Sbjct: 121 G---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET--VVGTPYYMSPELCQG 175

Query: 228 GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDE 287
             ++ KSD+++ G +L E+++ K+       D+ N L     +   N T  +        
Sbjct: 176 VKYNFKSDIWALGCVLYELLTLKRT-----FDATNPLNLVVKIVQGNYTPVV------SV 224

Query: 288 YSSKQMLLRYANIALLCVQESADDRPTMNDVVSML 322
           YSS+ + L ++      +Q+  + RPT ++V+   
Sbjct: 225 YSSELISLVHS-----LLQQDPEKRPTADEVLDQP 254

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 96.9 bits (242), Expect = 3e-23
 Identities = 62/207 (29%), Positives = 100/207 (48%), Gaps = 16/207 (7%)

Query: 55  NKLGEGGFGPVYKGVLKKGD--EIAVKRLS-GRSGQGLREM-KNEASVIAKVQHKNLVRL 110
             +G+G FG V K V +K D   +  K +  G   +  ++   +E +++ +++H N+VR 
Sbjct: 6   ETIGKGSFGTVRK-VRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRY 64

Query: 111 LGCCIDRD-EKILIY-EYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLH--- 165
               IDR  + + I  EY     L   +     +    ++    I   + Q LL L+   
Sbjct: 65  YDRIIDRSNQTLYIVMEYCEGGDLAQLI--QKCKKERKYIEEEFIWRILTQLLLALYECH 122

Query: 166 --QYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE 223
                   ++HRDLK +NI LD + N K+ DFG+A+I G +   A T   VGT  YMSPE
Sbjct: 123 NRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKT--YVGTPYYMSPE 180

Query: 224 YALEGIFSIKSDVFSFGVLLLEIVSGK 250
                 +  KSD++S G L+ E+ +  
Sbjct: 181 QLNHMSYDEKSDIWSLGCLIYELCALS 207

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 97.1 bits (242), Expect = 4e-23
 Identities = 64/204 (31%), Positives = 101/204 (49%), Gaps = 21/204 (10%)

Query: 57  LGEGGFGPVYKGVL-----KKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLL 111
           LG+G FG V            G+ +AVK+L   + + LR+ + E  ++  +QH N+V+  
Sbjct: 12  LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYK 71

Query: 112 GCCID--RDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSR 169
           G C    R    L+ EY+P  SL  +L    +R  LD    +     I +G+ YL     
Sbjct: 72  GVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRER--LDHRKLLLYASQICKGMEYL---GS 126

Query: 170 VRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE-----LQANTSRIVGTYGYMSPEY 224
            R +HRDL   NIL++ +   KI DFG+ ++   ++      +   S I     + +PE 
Sbjct: 127 KRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIF----WYAPES 182

Query: 225 ALEGIFSIKSDVFSFGVLLLEIVS 248
             E  FS+ SDV+SFGV+L E+ +
Sbjct: 183 LTESKFSVASDVWSFGVVLYELFT 206

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 97.4 bits (242), Expect = 5e-23
 Identities = 71/220 (32%), Positives = 124/220 (56%), Gaps = 22/220 (10%)

Query: 57  LGEGGFGPVYKGV-LKKGDEI----AVKRLSGRSG-QGLREMKNEASVIAKVQHKNLVRL 110
           LG G FG VYKG+ + +G+ +    A+K L+  +G +   E  +EA ++A + H +LVRL
Sbjct: 15  LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 74

Query: 111 LGCCIDRDEKILIYEYMPNKSLDFFLFDPT----KRMLLDWVTRVQIIEGIAQGLLYLHQ 166
           LG C+    + L+ + MP+  L  ++ +       ++LL+W  +      IA+G++YL +
Sbjct: 75  LGVCLSPTIQ-LVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQ------IAKGMMYLEE 127

Query: 167 YSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAL 226
               R++HRDL A N+L+    + KI+DFG+AR+  G+E + N         +M+ E   
Sbjct: 128 R---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIH 184

Query: 227 EGIFSIKSDVFSFGVLLLEIVS--GKKNTGLYRTDSLNLL 264
              F+ +SDV+S+GV + E+++  GK   G+   +  +LL
Sbjct: 185 YRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLL 224

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 96.4 bits (240), Expect = 6e-23
 Identities = 73/281 (25%), Positives = 129/281 (45%), Gaps = 38/281 (13%)

Query: 57  LGEGGFGPVYKGV-LKKGDEIAVK------RLSGRSGQGLREM----KNEASVIAKVQHK 105
           +G+G +G VY  + +  G+ +AVK       ++GR     ++M    ++E   +  + H 
Sbjct: 9   IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68

Query: 106 NLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTK--RMLLDWVTRVQIIEGIAQGLLY 163
           N+V+ LG     +   +  EY+P  S+   L    +    L+ + T  Q++EG+A    Y
Sbjct: 69  NIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTE-QVLEGLA----Y 123

Query: 164 LHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE 223
           LH      I+HRDLKA N+L+D D   KISDFG+++             + G+  +M+PE
Sbjct: 124 LHSKG---ILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPE 180

Query: 224 --YALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELID 281
             ++    +S K D++S G ++LE+ +G++            +   + L           
Sbjct: 181 VIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWS-----DEEAIAAMFKLGNKRSA----P 231

Query: 282 PILEDEYSSKQMLLRYANIALL--CVQESADDRPTMNDVVS 320
           PI  D      M L    +  L  C   + D+RPT  +++ 
Sbjct: 232 PIPPD----VSMNLSPVALDFLNACFTINPDNRPTARELLQ 268

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 96.2 bits (239), Expect = 1e-22
 Identities = 67/216 (31%), Positives = 109/216 (50%), Gaps = 23/216 (10%)

Query: 56  KLGEGGFGPVY----KGVLKKGDE--IAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVR 109
           +LGEG FG V+      +    D+  +AVK L   +    ++ + EA ++  +QH+++V+
Sbjct: 12  ELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVK 71

Query: 110 LLGCCIDRDEKILIYEYMPNKSLDFFL--FDPTKRMLLDWVTR-----------VQIIEG 156
             G C D D  I+++EYM +  L+ FL    P   +L+D   R           + I   
Sbjct: 72  FYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQ 131

Query: 157 IAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 216
           IA G++YL   +    +HRDL   N L+  ++  KI DFGM+R     +        +  
Sbjct: 132 IASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLP 188

Query: 217 YGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKK 251
             +M PE  +   F+ +SDV+SFGV+L EI + GK+
Sbjct: 189 IRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQ 224

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 96.2 bits (239), Expect = 1e-22
 Identities = 68/213 (31%), Positives = 103/213 (48%), Gaps = 23/213 (10%)

Query: 56  KLGEGGFGPVYKGVL-----KKGDEIAVKRLSG-RSGQGLREMKNEASVIAKVQHKNLVR 109
           +LGE  FG +YKG L          +A+K L    + Q   E + EAS++A++ H N+V 
Sbjct: 12  ELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVC 71

Query: 110 LLGCCIDRDEKILIYEYMPNKSLDFFLF--------------DPTKRMLLDWVTRVQIIE 155
           LLG         +++EY+    L  FL               D T +  LD    + I  
Sbjct: 72  LLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAI 131

Query: 156 GIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVG 215
            IA G+ YL  +     +H+DL A NIL+ + ++ KISD G++R     +      + + 
Sbjct: 132 QIAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLL 188

Query: 216 TYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 248
              +M PE  + G FS  SD++SFGV+L EI S
Sbjct: 189 PIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 95.7 bits (238), Expect = 1e-22
 Identities = 61/209 (29%), Positives = 108/209 (51%), Gaps = 22/209 (10%)

Query: 57  LGEGGFGPVYKGVLKKGD----EIAVK--RLSGRSGQGLREMKNEASVIAKVQHKNLVRL 110
           LGEG FG V +G L + D    ++AVK  +L   +   + E  +EA+ +    H N+++L
Sbjct: 7   LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKL 66

Query: 111 LGCCIDRDEK------ILIYEYMPNKSLDFFLFDPTKRMLLDWV---TRVQIIEGIAQGL 161
           +G C +          ++I  +M +  L  FL       L + +   T ++ +  IA G+
Sbjct: 67  IGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGM 126

Query: 162 LYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMAR-ICGGNEL-QANTSRIVGTYGY 219
            YL   S    IHRDL A N +L +DM   ++DFG+++ I  G+   Q   +++     +
Sbjct: 127 EYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKM--PVKW 181

Query: 220 MSPEYALEGIFSIKSDVFSFGVLLLEIVS 248
           ++ E   + +++ KSDV++FGV + EI +
Sbjct: 182 IAIESLADRVYTSKSDVWAFGVTMWEIAT 210

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 95.8 bits (238), Expect = 1e-22
 Identities = 87/304 (28%), Positives = 136/304 (44%), Gaps = 66/304 (21%)

Query: 57  LGEGGFGPVYKGVLK--KG----DEIAVKRL-SGRSGQGLREMKNEASVIAKVQHKNLVR 109
           LGEG FG V K      KG      +AVK L    S   LR++ +E +++ +V H ++++
Sbjct: 8   LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67

Query: 110 LLGCCIDRDEKILIYEYMPNKSLDFFL----------------------FDPTKR----- 142
           L G C      +LI EY    SL  FL                       +P +R     
Sbjct: 68  LYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMG 127

Query: 143 MLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICG 202
            L+ +  +      I++G+ YL   + ++++HRDL A N+L+ +    KISDFG++R   
Sbjct: 128 DLISFAWQ------ISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVY 178

Query: 203 GNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS--GKKNTGLYRTDS 260
             +     S+      +M+ E   + I++ +SDV+SFGVLL EIV+  G    G+     
Sbjct: 179 EEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERL 238

Query: 261 LNLL--GYAWDLWTSNRTLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDV 318
            NLL  GY  +                 E  S++M     N+ L C ++  D RPT  D+
Sbjct: 239 FNLLKTGYRME---------------RPENCSEEMY----NLMLTCWKQEPDKRPTFADI 279

Query: 319 VSML 322
              L
Sbjct: 280 SKEL 283

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 96.0 bits (239), Expect = 1e-22
 Identities = 67/207 (32%), Positives = 106/207 (51%), Gaps = 19/207 (9%)

Query: 51  FSDANKLGEGGFGPVYKGVLKKGDEI-AVKRL--SGRSGQ-GLREMKNEASVIAKVQHKN 106
           F+D  ++G G FG VY     + +E+ A+K++  SG+      +++  E   + +++H N
Sbjct: 17  FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPN 76

Query: 107 LVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQ 166
            +   GC +      L+ EY    + D  + +  K+ L + V    I  G  QGL YLH 
Sbjct: 77  TIEYKGCYLREHTAWLVMEYCLGSASD--ILEVHKKPLQE-VEIAAICHGALQGLAYLHS 133

Query: 167 YSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAL 226
           + R   IHRD+KA NILL +    K++DFG A +       AN+   VGT  +M+PE  L
Sbjct: 134 HER---IHRDIKAGNILLTEPGTVKLADFGSASLVS----PANS--FVGTPYWMAPEVIL 184

Query: 227 ---EGIFSIKSDVFSFGVLLLEIVSGK 250
              EG +  K DV+S G+  +E+   K
Sbjct: 185 AMDEGQYDGKVDVWSLGITCIELAERK 211

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 95.6 bits (238), Expect = 2e-22
 Identities = 64/214 (29%), Positives = 106/214 (49%), Gaps = 26/214 (12%)

Query: 57  LGEGGFGPVYKGVLKKGDE------IAVKRLSG-RSGQGLREMKNEASVIAKV-QHKNLV 108
           LGEG FG V K      D       +AVK L    + + L ++ +E  ++  + +HKN++
Sbjct: 20  LGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNII 79

Query: 109 RLLGCCIDRDEKILIYEYMPNKSLDFFL-----------FDPTKRMLLDWVTRVQIIE-- 155
            LLG C       ++ EY  + +L  FL            D   R   + +T+  ++   
Sbjct: 80  NLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDP-RPPEETLTQKDLVSFA 138

Query: 156 -GIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIV 214
             +A+G+ +L      + IHRDL A N+L+ +D   KI+DFG+AR     +    T+   
Sbjct: 139 YQVARGMEFLASK---KCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGR 195

Query: 215 GTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 248
               +M+PE   + +++ +SDV+SFGVLL EI +
Sbjct: 196 LPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 94.9 bits (236), Expect = 2e-22
 Identities = 67/208 (32%), Positives = 111/208 (53%), Gaps = 20/208 (9%)

Query: 57  LGEGGFGPVYKGV-LKKGDEIAVKR--LSGRSGQG-------LREMKNEASVIAKVQHKN 106
           +G G FG VY G+    G+ +AVK+  L   S          L  +  E +++ ++QH+N
Sbjct: 8   IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67

Query: 107 LVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQ 166
           +V+ LG  +D D   +  EY+P  S+   L         +       +  I +GL YLH 
Sbjct: 68  IVQYLGSSLDADHLNIFLEYVPGGSVAALL---NNYGAFEETLVRNFVRQILKGLNYLH- 123

Query: 167 YSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQA--NTSR--IVGTYGYMSP 222
            +R  IIHRD+K +NIL+D     KISDFG+++    N L    N +R  + G+  +M+P
Sbjct: 124 -NR-GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAP 181

Query: 223 EYALEGIFSIKSDVFSFGVLLLEIVSGK 250
           E   +  ++ K+D++S G L++E+++GK
Sbjct: 182 EVVKQTSYTRKADIWSLGCLVVEMLTGK 209

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 95.5 bits (237), Expect = 2e-22
 Identities = 80/271 (29%), Positives = 133/271 (49%), Gaps = 34/271 (12%)

Query: 51  FSDANKLGEGGFGPVYKGVLKKGDEI-AVKRLS---GRSGQGLREMKNEASVIAKVQHKN 106
           FSD  ++G G FG VY     +  E+ A+K++S    +S +  +++  E   + K++H N
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76

Query: 107 LVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQ 166
            ++  GC +      L+ EY    + D  L +  K+ L + V    +  G  QGL YLH 
Sbjct: 77  TIQYRGCYLREHTAWLVMEYCLGSASD--LLEVHKKPLQE-VEIAAVTHGALQGLAYLHS 133

Query: 167 YSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAL 226
           ++   +IHRD+KA NILL +    K+ DFG A I       A  +  VGT  +M+PE  L
Sbjct: 134 HN---MIHRDVKAGNILLSEPGLVKLGDFGSASIM------APANXFVGTPYWMAPEVIL 184

Query: 227 ---EGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPI 283
              EG +  K DV+S G+  +E+   ++   L+  ++++ L +       N +     P 
Sbjct: 185 AMDEGQYDGKVDVWSLGITCIEL--AERKPPLFNMNAMSALYHI----AQNES-----PA 233

Query: 284 LEDEYSSKQMLLRYANIALLCVQESADDRPT 314
           L+  + S+     + N    C+Q+   DRPT
Sbjct: 234 LQSGHWSEY----FRNFVDSCLQKIPQDRPT 260

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 94.4 bits (234), Expect = 4e-22
 Identities = 65/213 (30%), Positives = 109/213 (51%), Gaps = 20/213 (9%)

Query: 56  KLGEGGFGPVY----KGVLKKGDEI--AVKRLSGRSGQGLREMKNEASVIAKVQHKNLVR 109
           +LGEG FG V+      +  + D+I  AVK L   S    ++   EA ++  +QH+++V+
Sbjct: 12  ELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVK 71

Query: 110 LLGCCIDRDEKILIYEYMPNKSLDFFL--FDPTKRML--------LDWVTRVQIIEGIAQ 159
             G C++ D  I+++EYM +  L+ FL    P   ++        L     + I + IA 
Sbjct: 72  FYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAA 131

Query: 160 GLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGY 219
           G++YL   +    +HRDL   N L+ +++  KI DFGM+R     +        +    +
Sbjct: 132 GMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRW 188

Query: 220 MSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKK 251
           M PE  +   F+ +SDV+S GV+L EI + GK+
Sbjct: 189 MPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQ 221

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 93.8 bits (234), Expect = 6e-22
 Identities = 55/207 (26%), Positives = 103/207 (49%), Gaps = 17/207 (8%)

Query: 49  NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQG-LREMKNEASVIAKVQHKN 106
             F+    +G+G FG VYK + K+    +A+K +     +  + +++ E   +++ +   
Sbjct: 1   ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPY 60

Query: 107 LVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQ 166
           + +  G  +   +  +I EY    S      D  K   LD      I+  +  GL YLH+
Sbjct: 61  ITKYYGSFLKGSKLWIIMEYCGGGSC----LDLLKPGKLDETYIAFILREVLLGLEYLHE 116

Query: 167 YSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR---IVGTYGYMSPE 223
                 IHRD+KA+NILL ++ + K++DFG++      +L +  S+    VGT  +M+PE
Sbjct: 117 E---GKIHRDIKAANILLSEEGDVKLADFGVS-----GQLTSTMSKRNTFVGTPFWMAPE 168

Query: 224 YALEGIFSIKSDVFSFGVLLLEIVSGK 250
              +  +  K+D++S G+  +E+  G+
Sbjct: 169 VIKQSGYDEKADIWSLGITAIELAKGE 195

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 94.3 bits (234), Expect = 7e-22
 Identities = 67/211 (31%), Positives = 118/211 (55%), Gaps = 24/211 (11%)

Query: 50  KFSDANKLGEGGFGPVYKGV-LKKGDEI----AVKRL-SGRSGQGLREMKNEASVIAKVQ 103
           +F     LG G FG VYKG+ + +G+++    A+K L    S +  +E+ +EA V+A V 
Sbjct: 8   EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 67

Query: 104 HKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRM----LLDWVTRVQIIEGIAQ 159
           + ++ RLLG C+    + LI + MP   L  ++ +    +    LL+W  +      IA+
Sbjct: 68  NPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAK 120

Query: 160 GLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE--LQANTSRIVGTY 217
           G+ YL +    R++HRDL A N+L+    + KI+DFG+A++ G +E    A   ++    
Sbjct: 121 GMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKV--PI 175

Query: 218 GYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 248
            +M+ E  L  I++ +SDV+S+GV + E+++
Sbjct: 176 KWMALESILHRIYTHQSDVWSYGVTVWELMT 206

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 93.1 bits (231), Expect = 7e-22
 Identities = 65/193 (33%), Positives = 99/193 (51%), Gaps = 7/193 (3%)

Query: 57  LGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLR-EMKNEASVIAKVQHKNLVRLLGCCI 115
           LG+G FG V+KG LK    +AVK       Q L+ +  +EA ++ +  H N+V+L+G C 
Sbjct: 3   LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCT 62

Query: 116 DRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHR 175
            R    ++ E +P    DF  F   K+  L     V+     A G+ YL   +    IHR
Sbjct: 63  QRQPIYIVMELVPGG--DFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKN---CIHR 117

Query: 176 DLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSD 235
           DL A N L+ ++   KISDFGM+R        ++  + +    + +PE    G +S +SD
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQI-PIKWTAPEALNYGRYSSESD 176

Query: 236 VFSFGVLLLEIVS 248
           V+S+G+LL E  S
Sbjct: 177 VWSYGILLWETFS 189

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 94.4 bits (234), Expect = 7e-22
 Identities = 81/277 (29%), Positives = 139/277 (50%), Gaps = 36/277 (12%)

Query: 51  FSDANKLGEGGFGPVYKGVLKKGDEI-AVKRLS---GRSGQGLREMKNEASVIAKVQHKN 106
           F+D  ++G G FG VY     + +E+ A+K++S    +S +  +++  E   + +++H N
Sbjct: 27  FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86

Query: 107 LVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQ 166
            +   GC +      L+ EY    + D  L +  K+ L + V    I  G  QGL YLH 
Sbjct: 87  SIEYKGCYLREHTAWLVMEYCLGSASD--LLEVHKKPLQE-VEIAAITHGALQGLAYLHS 143

Query: 167 YSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAL 226
           ++   +IHRD+KA NILL +    K++DFG A I       AN+   VGT  +M+PE  L
Sbjct: 144 HN---MIHRDIKAGNILLTEPGQVKLADFGSASIAS----PANS--FVGTPYWMAPEVIL 194

Query: 227 ---EGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPI 283
              EG +  K DV+S G+  +E+   ++   L+  ++++ L +       N +     P 
Sbjct: 195 AMDEGQYDGKVDVWSLGITCIEL--AERKPPLFNMNAMSALYHI----AQNES-----PT 243

Query: 284 LE-DEYSSKQMLLRYANIALLCVQESADDRPTMNDVV 319
           L+ +E+S       + N    C+Q+   DRPT  +++
Sbjct: 244 LQSNEWSD-----YFRNFVDSCLQKIPQDRPTSEELL 275

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 93.8 bits (233), Expect = 8e-22
 Identities = 87/308 (28%), Positives = 135/308 (43%), Gaps = 64/308 (20%)

Query: 56  KLGEGGFGPVY----KGVLKKGDE-------------IAVKRLSGRSGQGLR-EMKNEAS 97
           KLGEG FG V+    +G+ K  D+             +AVK L   + +  R +   E  
Sbjct: 12  KLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIK 71

Query: 98  VIAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFL--------FDPTKRMLLDWVT 149
           ++++++  N++RLL  CI  D   +I EYM N  L+ FL         +    + + + T
Sbjct: 72  IMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYST 131

Query: 150 RVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQAN 209
            + +   IA G+ YL   S +  +HRDL   N L+ K+   KI+DFGM+R     +    
Sbjct: 132 LIFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRI 188

Query: 210 TSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKK--------------NTGL 255
             R V    +MS E  L G F+  SDV++FGV L EI++  K              NTG 
Sbjct: 189 QGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQVIENTGE 248

Query: 256 YRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTM 315
           +  D               R + L  P L  +   K M        L C + +A +RP+ 
Sbjct: 249 FFRD-------------QGRQVYLPKPALCPDSLYKLM--------LSCWRRNAKERPSF 287

Query: 316 NDVVSMLT 323
            ++ + L 
Sbjct: 288 QEIHATLL 295

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 92.8 bits (231), Expect = 2e-21
 Identities = 66/223 (29%), Positives = 100/223 (44%), Gaps = 37/223 (16%)

Query: 56  KLGEGGFGPVY----KGVLKKGDEI-------------AVKRL-SGRSGQGLREMKNEAS 97
           KLGEG FG V+     G+    ++              AVK L    S     +   E  
Sbjct: 12  KLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVK 71

Query: 98  VIAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFL-----FDPTKRMLLDWVTR-- 150
           +++++   N+ RLLG C       +I EYM N  L+ FL                ++   
Sbjct: 72  ILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFST 131

Query: 151 -VQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQAN 209
            + +   IA G+ YL     +  +HRDL   N L+ K+   KI+DFGM+R    N   ++
Sbjct: 132 LLYMATQIASGMRYL---ESLNFVHRDLATRNCLVGKNYTIKIADFGMSR----NLYSSD 184

Query: 210 TSRIVGT----YGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 248
             R+ G       +M+ E  L G F+ KSDV++FGV L EI++
Sbjct: 185 YYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILT 227

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 92.7 bits (230), Expect = 2e-21
 Identities = 65/207 (31%), Positives = 102/207 (49%), Gaps = 17/207 (8%)

Query: 56  KLGEGGFGPVYKGVLK---KGD---EIAVKRLSGRSGQGLR-EMKNEASVIAKVQHKNLV 108
           +LG+G FG VY+G  +   KG+    +AVK ++  +    R E  NEASV+      ++V
Sbjct: 13  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 72

Query: 109 RLLGCCIDRDEKILIYEYMPNKSLDFFLF-------DPTKRMLLDWVTRVQIIEGIAQGL 161
           RLLG        +++ E M +  L  +L        +   R        +Q+   IA G+
Sbjct: 73  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 132

Query: 162 LYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMS 221
            YL+     + +HRDL A N ++  D   KI DFGM R     +      + +    +M+
Sbjct: 133 AYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMA 189

Query: 222 PEYALEGIFSIKSDVFSFGVLLLEIVS 248
           PE   +G+F+  SD++SFGV+L EI S
Sbjct: 190 PESLKDGVFTTSSDMWSFGVVLWEITS 216

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 91.5 bits (227), Expect = 4e-21
 Identities = 56/209 (26%), Positives = 104/209 (49%), Gaps = 26/209 (12%)

Query: 57  LGEGGFGPVYKGV-LKKGDEIAVKRLS------GRSGQGLREMKNEASVIAKVQHKNLVR 109
           LG G F   Y+   +K G  +AVK+++          + +  ++ E  ++A++ H +++R
Sbjct: 8   LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67

Query: 110 LLGCCIDRDEKILIYEYMPNKSLDFFL--FDPTKRMLLDWVTRVQIIEGIAQGLLYLHQY 167
           +LG   +     L  E+M   S+   L  +   K  ++     +   E + +GL YLH+ 
Sbjct: 68  MLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVI-----INYTEQLLRGLSYLHEN 122

Query: 168 SRVRIIHRDLKASNILLDKD-MNPKISDFGMA-----RICGGNELQANTSRIVGTYGYMS 221
              +IIHRD+K +N+L+D      +I+DFG A     +  G  E Q    +++GT  +M+
Sbjct: 123 ---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQG---QLLGTIAFMA 176

Query: 222 PEYALEGIFSIKSDVFSFGVLLLEIVSGK 250
           PE      +    DV+S G +++E+ + K
Sbjct: 177 PEVLRGEQYGRSCDVWSVGCVIIEMATAK 205

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 91.2 bits (226), Expect = 4e-21
 Identities = 70/223 (31%), Positives = 108/223 (48%), Gaps = 31/223 (13%)

Query: 47  ATNKFSDANKLGEGGFGPVYKGVLKK--GDE----IAVKRLSGRSGQGLR-EMKNEASVI 99
           A  K + + +LG+G FG VY+G+ K    DE    +A+K ++  +    R E  NEASV+
Sbjct: 4   AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 63

Query: 100 AKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFD--------------PTKRMLL 145
            +    ++VRLLG        ++I E M    L  +L                  K+M  
Sbjct: 64  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKM-- 121

Query: 146 DWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE 205
                +Q+   IA G+ YL+     + +HRDL A N ++ +D   KI DFGM R     +
Sbjct: 122 -----IQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD 173

Query: 206 LQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 248
                 + +    +MSPE   +G+F+  SDV+SFGV+L EI +
Sbjct: 174 YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 216

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 90.8 bits (226), Expect = 5e-21
 Identities = 57/206 (27%), Positives = 103/206 (50%), Gaps = 23/206 (11%)

Query: 55  NKLGEGGFGPVYKGVLKKGDEI-AVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGC 113
            ++G G +G VYK       E+ A+K +    G     ++ E S++ + +H N+V   G 
Sbjct: 9   QRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGS 68

Query: 114 CIDRDEKILIYEYMPNKSLD---FFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRV 170
            + RD+  ++ EY    SL         P   + + +V R  +     +GL YLH+  + 
Sbjct: 69  YLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETL-----KGLAYLHETGK- 122

Query: 171 RIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR---IVGTYGYMSPEYALE 227
             IHRD+K +NILL +D + K++DFG++      +L A  ++    +GT  +M+PE A  
Sbjct: 123 --IHRDIKGANILLTEDGDVKLADFGVS-----AQLTATIAKRKSFIGTPYWMAPEVAAV 175

Query: 228 ---GIFSIKSDVFSFGVLLLEIVSGK 250
              G +  K D+++ G+  +E+   +
Sbjct: 176 ERKGGYDGKCDIWALGITAIELAELQ 201

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 91.8 bits (228), Expect = 1e-20
 Identities = 76/241 (31%), Positives = 110/241 (45%), Gaps = 52/241 (21%)

Query: 42  SSVSTATNKFSD---ANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSGQGLR-EMKNEA 96
            S  +A    S+    N++G G  G VYK + +  G   A+K + G     +R ++  E 
Sbjct: 64  GSAPSAAKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREI 123

Query: 97  SVIAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSLD-------FFLFDPTKRMLLDWVT 149
            ++  V H N+V+         E  ++ E+M   SL+        FL D         V 
Sbjct: 124 EILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLAD---------VA 174

Query: 150 RVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQAN 209
           R QI+ GIA    YLH   R  I+HRD+K SN+L++   N KI+DFG++RI        N
Sbjct: 175 R-QILSGIA----YLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCN 226

Query: 210 TSRIVGTYGYMSPE-------------YALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLY 256
           +S  VGT  YMSPE             YA         D++S GV +LE   G+   G+ 
Sbjct: 227 SS--VGTIAYMSPERINTDLNHGAYDGYA--------GDIWSLGVSILEFYLGRFPFGVG 276

Query: 257 R 257
           R
Sbjct: 277 R 277

Length = 353

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 90.1 bits (224), Expect = 1e-20
 Identities = 58/201 (28%), Positives = 103/201 (51%), Gaps = 8/201 (3%)

Query: 55  NKLGEGGFGPVYKGV-LKKGDEIAVKRLS-GRSGQGLREMKNEASVIAKVQHKNLVRLLG 112
             +G G    VY  + L   +++A+KR+   +    + E++ E   +++  H N+V+   
Sbjct: 7   EVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYT 66

Query: 113 CCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRI 172
             +  DE  L+  Y+   SL   +     R  LD      +++ + +GL YLH   +   
Sbjct: 67  SFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQ--- 123

Query: 173 IHRDLKASNILLDKDMNPKISDFGM-ARICGGNELQANTSR-IVGTYGYMSPEYALEGI- 229
           IHRD+KA NILL +D + KI+DFG+ A +  G +      +  VGT  +M+PE   +   
Sbjct: 124 IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHG 183

Query: 230 FSIKSDVFSFGVLLLEIVSGK 250
           +  K+D++SFG+  +E+ +G 
Sbjct: 184 YDFKADIWSFGITAIELATGA 204

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 89.9 bits (223), Expect = 1e-20
 Identities = 59/199 (29%), Positives = 101/199 (50%), Gaps = 11/199 (5%)

Query: 57  LGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCI 115
           LG+G +G VY    L     IA+K +  R  + ++ +  E ++ + ++H+N+V+ LG   
Sbjct: 16  LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDS 75

Query: 116 DRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHR 175
           +     +  E +P  SL   L      +  +  T +   + I +GL YLH     +I+HR
Sbjct: 76  ENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHD---NQIVHR 132

Query: 176 DLKASNILLDKDMNP-KISDFGMA-RICGGNELQANTSRIVGTYGYMSPEYALEGI--FS 231
           D+K  N+L++      KISDFG + R+ G N     T    GT  YM+PE   +G   + 
Sbjct: 133 DIKGDNVLVNTYSGVVKISDFGTSKRLAGINPC---TETFTGTLQYMAPEVIDKGPRGYG 189

Query: 232 IKSDVFSFGVLLLEIVSGK 250
             +D++S G  ++E+ +GK
Sbjct: 190 APADIWSLGCTIVEMATGK 208

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 89.9 bits (223), Expect = 1e-20
 Identities = 59/200 (29%), Positives = 94/200 (47%), Gaps = 15/200 (7%)

Query: 57  LGEGGFGPVY------KGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRL 110
           LG+GGFG V        G +    ++  KRL  R G+ +    NE  ++ KV  + +V L
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQM--ALNEKKILEKVSSRFIVSL 58

Query: 111 LGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRV 170
                 +D+  L+   M    L + +++  +    +        + I  GL +LHQ    
Sbjct: 59  AYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQ-IICGLEHLHQ---R 114

Query: 171 RIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIF 230
           RI++RDLK  N+LLD   N +ISD G+A        +    R  GT GYM+PE     ++
Sbjct: 115 RIVYRDLKPENVLLDDHGNVRISDLGLA--VELKGGKKIKGR-AGTPGYMAPEVLQGEVY 171

Query: 231 SIKSDVFSFGVLLLEIVSGK 250
               D F+ G  L E+++G+
Sbjct: 172 DFSVDWFALGCTLYEMIAGR 191

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 90.1 bits (223), Expect = 2e-20
 Identities = 59/203 (29%), Positives = 108/203 (53%), Gaps = 13/203 (6%)

Query: 51  FSDANKLGEGGFGPVYKGVLKKGDEI-AVKRLSGRSGQG-LREMKNEASVIAKVQHKNLV 108
           F+   ++G+G FG VYKG+  +  E+ A+K +     +  + +++ E +V+++     + 
Sbjct: 6   FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65

Query: 109 RLLGCCIDRDEKILIYEYMPNKS-LDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQY 167
           R  G  +   +  +I EY+   S LD     P +   +       I+  I +GL YLH  
Sbjct: 66  RYYGSYLKGTKLWIIMEYLGGGSALDLLKPGPLEETYI-----ATILREILKGLDYLHSE 120

Query: 168 SRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALE 227
              R IHRD+KA+N+LL +  + K++DFG+A      +++ NT   VGT  +M+PE   +
Sbjct: 121 ---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVIKQ 175

Query: 228 GIFSIKSDVFSFGVLLLEIVSGK 250
             +  K+D++S G+  +E+  G+
Sbjct: 176 SAYDFKADIWSLGITAIELAKGE 198

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 90.0 bits (224), Expect = 2e-20
 Identities = 54/187 (28%), Positives = 92/187 (49%), Gaps = 42/187 (22%)

Query: 56  KLGEGGFGPVYK-GVLKKGDEIAVKRLSGRSGQG------LREMKNEASVIAKVQHKNLV 108
           ++GEG  G V+K    + G+ +A+K+++ R  +G      LRE+K     +   QH  +V
Sbjct: 7   RIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIK----ALQACQHPYVV 62

Query: 109 RLL-----GCCIDRDEKILIYEYMPN------KSLDFFLFDP-TKRMLLDWVTRVQIIEG 156
           +LL     G        +L+ EYMP+      +  +  L +   K  +        +++G
Sbjct: 63  KLLDVFPHGSGF-----VLVMEYMPSDLSEVLRDEERPLPEAQVKSYMR------MLLKG 111

Query: 157 IAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 216
           +A    Y+H      I+HRDLK +N+L+  D   KI+DFG+AR+    E +  + + V T
Sbjct: 112 VA----YMHA---NGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQ-VAT 163

Query: 217 YGYMSPE 223
             Y +PE
Sbjct: 164 RWYRAPE 170

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 89.6 bits (222), Expect = 2e-20
 Identities = 67/204 (32%), Positives = 110/204 (53%), Gaps = 24/204 (11%)

Query: 57  LGEGGFGPVYKGV-LKKGDEI----AVKRLSGRSG-QGLREMKNEASVIAKVQHKNLVRL 110
           LG G FG V+KG+ + +GD I    A+K +  RSG Q  +E+ +    +  + H  +VRL
Sbjct: 15  LGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRL 74

Query: 111 LGCCIDRDEKILIYEYMPNKSLDFFL------FDPTKRMLLDWVTRVQIIEGIAQGLLYL 164
           LG C     + L+ +  P  SL   +       DP  + LL+W  +      IA+G+ YL
Sbjct: 75  LGICPGASLQ-LVTQLSPLGSLLDHVRQHRDSLDP--QRLLNWCVQ------IAKGMYYL 125

Query: 165 HQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY 224
            ++   R++HR+L A NILL  D   +I+DFG+A +   ++ +   S       +M+ E 
Sbjct: 126 EEH---RMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALES 182

Query: 225 ALEGIFSIKSDVFSFGVLLLEIVS 248
            L G ++ +SDV+S+GV + E++S
Sbjct: 183 ILFGRYTHQSDVWSYGVTVWEMMS 206

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 90.0 bits (223), Expect = 2e-20
 Identities = 66/221 (29%), Positives = 104/221 (47%), Gaps = 34/221 (15%)

Query: 56  KLGEGGFGPVY----KGVLK-----------KGDEIAVKRLSGRSGQGLR-EMKNEASVI 99
           KLGEG FG V+    +G+ +           +   +AVK L     +  R +   E  ++
Sbjct: 12  KLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIM 71

Query: 100 AKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEG--- 156
           +++++ N++RLLG C+  D   +I EYM N  L+ FL   ++R +    T    I     
Sbjct: 72  SRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFL---SQREIESTFTHANNIPSVSI 128

Query: 157 ---------IAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQ 207
                    IA G+ YL   + +  +HRDL   N L+      KI+DFGM+R     +  
Sbjct: 129 ANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYY 185

Query: 208 ANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 248
               R V    +M+ E  L G F+  SDV++FGV L E+ +
Sbjct: 186 RIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 89.3 bits (221), Expect = 2e-20
 Identities = 66/202 (32%), Positives = 109/202 (53%), Gaps = 20/202 (9%)

Query: 57  LGEGGFGPVYKGVLKKGDE-----IAVKRL-SGRSGQGLREMKNEASVIAKVQHKNLVRL 110
           LG G FG VYKG+     E     +A+K L    S +  +E+ +EA V+A V    + RL
Sbjct: 15  LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRL 74

Query: 111 LGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRM----LLDWVTRVQIIEGIAQGLLYLHQ 166
           LG C+    + L+ + MP   L  ++ +   R+    LL+W  +      IA+G+ YL +
Sbjct: 75  LGICLTSTVQ-LVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQ------IAKGMSYLEE 127

Query: 167 YSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAL 226
              VR++HRDL A N+L+    + KI+DFG+AR+   +E + +         +M+ E  L
Sbjct: 128 ---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESIL 184

Query: 227 EGIFSIKSDVFSFGVLLLEIVS 248
              F+ +SDV+S+GV + E+++
Sbjct: 185 HRRFTHQSDVWSYGVTVWELMT 206

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 88.8 bits (220), Expect = 3e-20
 Identities = 75/275 (27%), Positives = 119/275 (43%), Gaps = 36/275 (13%)

Query: 56  KLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLRE-MKNEASVIAKVQHKNLVRLLGCC 114
           +LG G FG V+ G  +   ++A+K +    G    E    EA V+ K+ H  LV+L G C
Sbjct: 11  ELGSGQFGVVHLGKWRAQIKVAIKAI--NEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVC 68

Query: 115 IDRDEKILIYEYMPNKSLDFFLFDP----TKRMLLDWVTRVQIIEGIAQGLLYLHQYSRV 170
             +    ++ E+M N  L  +L       +K MLL       + + + +G+ YL + S  
Sbjct: 69  TQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLL------SMCQDVCEGMEYLERNS-- 120

Query: 171 RIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIF 230
             IHRDL A N L+      K+SDFGM R    +E   ++S       +  PE      +
Sbjct: 121 -FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEY-TSSSGAKFPVKWSPPEVFNFSKY 178

Query: 231 SIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDE--Y 288
           S KSDV+SFGVL+ E+ +  K                   +      E+++ I      Y
Sbjct: 179 SSKSDVWSFGVLMWEVFTEGKMP-----------------FEKKSNYEVVEMISRGFRLY 221

Query: 289 SSKQMLLRYANIALLCVQESADDRPTMNDVVSMLT 323
             K   +    +   C  E  + RPT  +++  +T
Sbjct: 222 RPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAIT 256

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 89.7 bits (222), Expect = 3e-20
 Identities = 73/231 (31%), Positives = 114/231 (49%), Gaps = 31/231 (13%)

Query: 36  FPLFSFSSVSTATNKFSDANKLGEGGFGPVYKGVLKKGD---EIAVKRLSGRSGQG-LRE 91
           +P+  ++ +     KF D   +GEG FG V K  +KK     + A+KR+   + +   R+
Sbjct: 1   YPVLEWNDI-----KFQDV--IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRD 53

Query: 92  MKNEASVIAKV-QHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFL-------FDP---- 139
              E  V+ K+  H N++ LLG C  R    L  EY P+ +L  FL        DP    
Sbjct: 54  FAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAI 113

Query: 140 --TKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGM 197
             +    L     +     +A+G+ YL   S+ + IHRDL A NIL+ ++   KI+DFG+
Sbjct: 114 ANSTASTLSSQQLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGL 170

Query: 198 ARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 248
           +R   G E+    +       +M+ E     +++  SDV+S+GVLL EIVS
Sbjct: 171 SR---GQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 89.3 bits (221), Expect = 4e-20
 Identities = 75/223 (33%), Positives = 113/223 (50%), Gaps = 38/223 (17%)

Query: 50  KFSDANKLGEGGFGPVYKGVLKK-GDEI--AVKRLSGRSGQG-LREMKNEASVIAKV-QH 104
           KF D   +GEG FG V + ++KK G ++  A+K L   + +   R+   E  V+ K+  H
Sbjct: 5   KFEDV--IGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHH 62

Query: 105 KNLVRLLGCCIDRDEKILIYEYMPNKSLDFFL-------FDP------------TKRMLL 145
            N++ LLG C +R    +  EY P  +L  FL        DP            T + LL
Sbjct: 63  PNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLL 122

Query: 146 DWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE 205
            + + V      A G+ YL   S  + IHRDL A N+L+ +++  KI+DFG++R   G E
Sbjct: 123 QFASDV------ATGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGLSR---GEE 170

Query: 206 LQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 248
           +    +       +M+ E     +++ KSDV+SFGVLL EIVS
Sbjct: 171 VYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 88.8 bits (221), Expect = 4e-20
 Identities = 71/216 (32%), Positives = 111/216 (51%), Gaps = 42/216 (19%)

Query: 55  NKLGEGGFGPVYKGVLKKGDEI-AVKRL---SGRSG---QGLREMKNEASVIAKVQHKNL 107
           N++ EG +G VY+   KK  EI A+K+L     + G     LRE+    +++ K+QH N+
Sbjct: 11  NRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREI----NILLKLQHPNI 66

Query: 108 VRL----LGCCIDRDEKI-LIYEYMPN--KSL-----DFFLFDPTKRMLLDWVTRVQIIE 155
           V +    +G      +KI ++ EY+ +  KSL       FL    K ++L      Q++ 
Sbjct: 67  VTVKEVVVG---SNLDKIYMVMEYVEHDLKSLMETMKQPFLQSEVKCLML------QLLS 117

Query: 156 GIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVG 215
           G+A    +LH      I+HRDLK SN+LL+     KI DFG+AR  G   L+  T  +V 
Sbjct: 118 GVA----HLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGSP-LKPYTQLVV- 168

Query: 216 TYGYMSPEYAL-EGIFSIKSDVFSFGVLLLEIVSGK 250
           T  Y +PE  L    +S   D++S G +  E+++ K
Sbjct: 169 TLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKK 204

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 88.1 bits (218), Expect = 4e-20
 Identities = 63/193 (32%), Positives = 104/193 (53%), Gaps = 13/193 (6%)

Query: 57  LGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCID 116
           +G+G FG V  G  + G+++AVK +  ++    +    EASV+ +++H NLV+LLG  ++
Sbjct: 14  IGKGEFGDVMLGDYR-GNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 70

Query: 117 RDEKILIY-EYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHR 175
               + I  EYM   SL  +L     R +L     ++    + + + YL   +    +HR
Sbjct: 71  EKGGLYIVTEYMAKGSLVDYL-RSRGRSVLGGDCLLKFSLDVCEAMEYLEANN---FVHR 126

Query: 176 DLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSD 235
           DL A N+L+ +D   K+SDFG+ +     +   +T ++     + +PE   E  FS KSD
Sbjct: 127 DLAARNVLVSEDNVAKVSDFGLTKEASSTQ---DTGKL--PVKWTAPEALREKKFSTKSD 181

Query: 236 VFSFGVLLLEIVS 248
           V+SFG+LL EI S
Sbjct: 182 VWSFGILLWEIYS 194

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 88.8 bits (220), Expect = 4e-20
 Identities = 69/224 (30%), Positives = 113/224 (50%), Gaps = 30/224 (13%)

Query: 38  LFSFSSVSTATNKFSDANKLGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMK-NE 95
           L +  SV     K++   K+G+G  G VY  + +  G E+A+K+++    Q  +E+  NE
Sbjct: 8   LRTIVSVGDPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMN-LQQQPKKELIINE 66

Query: 96  ASVIAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIE 155
             V+ + +H N+V  L   +  DE  ++ EY+   SL             D VT   + E
Sbjct: 67  ILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLT------------DVVTETCMDE 114

Query: 156 GIA--------QGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGM-ARICGGNEL 206
           G          Q L +LH     ++IHRD+K+ NILL  D + K++DFG  A+I      
Sbjct: 115 GQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQI---TPE 168

Query: 207 QANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 250
           Q+  S +VGT  +M+PE      +  K D++S G++ +E+V G+
Sbjct: 169 QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGE 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 88.1 bits (218), Expect = 6e-20
 Identities = 66/200 (33%), Positives = 98/200 (49%), Gaps = 17/200 (8%)

Query: 56  KLGEGGFGPVYKGVLKKGD---------EIAVKRLSGRSGQGLREMKNEASVIAKVQHKN 106
           +LG+G FG VY    KK           EI V  L+        +   EA +++K+ H  
Sbjct: 7   RLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNE---TVQANQEAQLLSKLDHPA 63

Query: 107 LVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQ 166
           +V+     ++RD   +I EY   + LD  L +         ++  Q+ E   Q LL +H 
Sbjct: 64  IVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTG--KTLSENQVCEWFIQLLLGVHY 121

Query: 167 YSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAL 226
             + RI+HRDLKA NI L  ++  KI DFG++R+  G+   A T    GT  YMSPE   
Sbjct: 122 MHQRRILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCDLATT--FTGTPYYMSPEALK 178

Query: 227 EGIFSIKSDVFSFGVLLLEI 246
              +  KSD++S G +L E+
Sbjct: 179 HQGYDSKSDIWSLGCILYEM 198

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 88.2 bits (219), Expect = 6e-20
 Identities = 58/203 (28%), Positives = 101/203 (49%), Gaps = 20/203 (9%)

Query: 56  KLGEGGFGPVYKGVLKKGDEI-AVKRLS------GRSGQGLREMKNEASVIAKVQHKNLV 108
           K+GEG +G VYK   K   EI A+K++       G     LRE+K    ++ ++ H N++
Sbjct: 6   KIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIK----LLKELNHPNII 61

Query: 109 RLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYS 168
           +LL     + +  L++E+M     D +     ++  L        +  + QGL + H + 
Sbjct: 62  KLLDVFRHKGDLYLVFEFM---DTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSH- 117

Query: 169 RVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAL-E 227
              I+HRDLK  N+L++ +   K++DFG+AR  G        +  V T  Y +PE  L +
Sbjct: 118 --GILHRDLKPENLLINTEGVLKLADFGLARSFGSP--VRPYTHYVVTRWYRAPELLLGD 173

Query: 228 GIFSIKSDVFSFGVLLLEIVSGK 250
             +S   D++S G +  E++S +
Sbjct: 174 KGYSTPVDIWSVGCIFAELLSRR 196

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 87.3 bits (217), Expect = 1e-19
 Identities = 60/203 (29%), Positives = 90/203 (44%), Gaps = 22/203 (10%)

Query: 60  GGFGPVYKGVLKK--GDEIAVKRLSGRSGQG---LREMKNEASVIAKVQHKNLVRLLGCC 114
           G +G V+    KK  GD  A+K +          + ++  E  ++++ Q   +V+L    
Sbjct: 4   GAYGRVFL-AKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSF 62

Query: 115 IDRDEKILIYEYMPNKSLDFFLFDPTKRML--LDWVTRVQIIEGIAQGLLYLHQYSRVRI 172
             +    L+ EY+P   L   L       +  LD       I  I   L YLH      I
Sbjct: 63  QGKKNLYLVMEYLPGGDLASLL-----ENVGSLDEDVARIYIAEIVLALEYLHSNG---I 114

Query: 173 IHRDLKASNILLDKDMNPKISDFG------MARICGGNELQANTSRIVGTYGYMSPEYAL 226
           IHRDLK  NIL+D + + K++DFG      + R    N+ +    RIVGT  Y++PE  L
Sbjct: 115 IHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVIL 174

Query: 227 EGIFSIKSDVFSFGVLLLEIVSG 249
               S   D +S G +L E + G
Sbjct: 175 GQGHSKTVDWWSLGCILYEFLVG 197

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 87.4 bits (217), Expect = 1e-19
 Identities = 63/206 (30%), Positives = 107/206 (51%), Gaps = 25/206 (12%)

Query: 56  KLGEGGFGPVYKGVLKKGDEI-AVKRL------SGRSGQGLREMKNEASVIAKVQHKNLV 108
           K+GEG +G VYK   K   EI A+K++       G     +RE+    S++ ++ H N+V
Sbjct: 6   KIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREI----SLLKELNHPNIV 61

Query: 109 RLLGCCIDRDEKILIYEYMP---NKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLH 165
           RLL      ++  L++E++     K +D          L+      Q+++GIA    Y H
Sbjct: 62  RLLDVVHSENKLYLVFEFLDLDLKKYMDSSPLTGLDPPLIKSYLY-QLLQGIA----YCH 116

Query: 166 QYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYA 225
            +   R++HRDLK  N+L+D++   K++DFG+AR   G  ++  T  +V T  Y +PE  
Sbjct: 117 SH---RVLHRDLKPQNLLIDREGALKLADFGLARAF-GVPVRTYTHEVV-TLWYRAPEIL 171

Query: 226 LEG-IFSIKSDVFSFGVLLLEIVSGK 250
           L    +S   D++S G +  E+V+ +
Sbjct: 172 LGSRQYSTPVDIWSIGCIFAEMVNRR 197

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 87.7 bits (217), Expect = 1e-19
 Identities = 69/230 (30%), Positives = 108/230 (46%), Gaps = 43/230 (18%)

Query: 56  KLGEGGFGPV---------------YKGVLKKGDE--IAVKRLSGRSGQGLR-EMKNEAS 97
           KLGEG FG V               +   ++KG    +AVK L   + +  R +   E  
Sbjct: 12  KLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVK 71

Query: 98  VIAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLD----------- 146
           ++++++  N++RLLG C+D D   +I EYM N  L+ FL   +   L D           
Sbjct: 72  ILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFL---SSHHLDDKEENGNDAVPP 128

Query: 147 --------WVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMA 198
                   + + + +   IA G+ YL   S +  +HRDL   N L+ +++  KI+DFGM+
Sbjct: 129 AHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADFGMS 185

Query: 199 RICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 248
           R     +      R V    +M+ E  L G F+  SDV++FGV L EI+ 
Sbjct: 186 RNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILM 235

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 87.8 bits (217), Expect = 2e-19
 Identities = 69/208 (33%), Positives = 104/208 (50%), Gaps = 21/208 (10%)

Query: 51  FSDANKLGEGGFGPVYKGVLKKGDEI-AVKRLSGRSGQGLRE----MKNEASVIAKVQHK 105
           F   +++G G FG VY       +E+ AVK++S  SG+   E    +  E   + +++H 
Sbjct: 23  FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMS-YSGKQTNEKWQDIIKEVKFLQQLKHP 81

Query: 106 NLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLH 165
           N +   GC +      L+ EY    + D  L +  K+ L + V    I  G  QGL YLH
Sbjct: 82  NTIEYKGCYLKEHTAWLVMEYCLGSASD--LLEVHKKPLQE-VEIAAITHGALQGLAYLH 138

Query: 166 QYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYA 225
            ++   +IHRD+KA NILL +    K++DFG A         AN+   VGT  +M+PE  
Sbjct: 139 SHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSS----PANS--FVGTPYWMAPEVI 189

Query: 226 L---EGIFSIKSDVFSFGVLLLEIVSGK 250
           L   EG +  K DV+S G+  +E+   K
Sbjct: 190 LAMDEGQYDGKVDVWSLGITCIELAERK 217

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 87.1 bits (216), Expect = 2e-19
 Identities = 57/196 (29%), Positives = 100/196 (51%), Gaps = 13/196 (6%)

Query: 57  LGEGGFGPVYKGVLKKGDEI-AVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCI 115
           LG+G FG VYK   K+     A K +   S + L +   E  ++++ +H N+V L     
Sbjct: 13  LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72

Query: 116 DRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHR 175
             ++  ++ E+    +LD  +    +R L +   R  +   + + L +LH +   ++IHR
Sbjct: 73  YENKLWILIEFCDGGALDS-IMLELERGLTEPQIRY-VCRQMLEALNFLHSH---KVIHR 127

Query: 176 DLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFS---- 231
           DLKA NILL  D + K++DFG++     + LQ   +  +GT  +M+PE      F     
Sbjct: 128 DLKAGNILLTLDGDVKLADFGVSAK-NKSTLQKRDT-FIGTPYWMAPEVVACETFKDNPY 185

Query: 232 -IKSDVFSFGVLLLEI 246
             K+D++S G+ L+E+
Sbjct: 186 DYKADIWSLGITLIEL 201

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 87.4 bits (217), Expect = 2e-19
 Identities = 69/227 (30%), Positives = 109/227 (48%), Gaps = 49/227 (21%)

Query: 56  KLGEGGFGPVYKGV-LKKGDEIAVKRL---SGRSG---QGLREMKNEASVIAKVQHKNLV 108
           KLGEG FG VYK   +K G  +A+K++   + + G     LRE+K    ++ K++H N+V
Sbjct: 15  KLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIK----ILKKLKHPNVV 70

Query: 109 RLLGCCIDRDEKIL-----IYEYMPNKSLDF--FLFDPT--------KRMLLDWVTRVQI 153
            L+   ++R +K       +Y   P    D    L +P+        K  +L      Q+
Sbjct: 71  PLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYML------QL 124

Query: 154 IEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARI---------CGGN 204
           +EGI     YLH+     I+HRD+KA+NIL+D     KI+DFG+AR           GG 
Sbjct: 125 LEGIN----YLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGG 177

Query: 205 ELQANTSRIVGTYGYMSPEYAL-EGIFSIKSDVFSFGVLLLEIVSGK 250
                 + +V T  Y  PE  L E  ++   D++  G +  E+ + +
Sbjct: 178 GGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRR 224

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 86.3 bits (214), Expect = 3e-19
 Identities = 60/213 (28%), Positives = 101/213 (47%), Gaps = 32/213 (15%)

Query: 50  KFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLV 108
              +  K+GEG  G V     K  G ++AVK++  R  Q    + NE  ++   QH N+V
Sbjct: 20  YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIV 79

Query: 109 RLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIE-GIA-------QG 160
            +    +  DE  ++ E++   +L             D VT  ++ E  IA       + 
Sbjct: 80  EMYSSYLVGDELWVVMEFLEGGALT------------DIVTHTRMNEEQIATVCLAVLKA 127

Query: 161 LLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR---IVGTY 217
           L +LH      +IHRD+K+ +ILL  D   K+SDFG    C   ++     R   +VGT 
Sbjct: 128 LSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGF---CA--QVSKEVPRRKSLVGTP 179

Query: 218 GYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 250
            +M+PE      +  + D++S G++++E+V G+
Sbjct: 180 YWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGE 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 85.8 bits (213), Expect = 3e-19
 Identities = 62/219 (28%), Positives = 100/219 (45%), Gaps = 22/219 (10%)

Query: 47  ATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKV-QHK 105
            T  F     +GEG +G VYK   KK  ++   ++         E+K E +++ K   H 
Sbjct: 4   PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHP 63

Query: 106 NLVRLLGCCIDRDEKI------LIYEYMPNKS---LDFFLFDPTKRMLLDWVTRVQIIEG 156
           N+    G  I ++         L+ E     S   L   L    KR+  +W+    I+  
Sbjct: 64  NIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIA--YILRE 121

Query: 157 IAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 216
             +GL YLH+    ++IHRD+K  NILL K+   K+ DFG++        + NT   +GT
Sbjct: 122 TLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTF--IGT 176

Query: 217 YGYMSPE-----YALEGIFSIKSDVFSFGVLLLEIVSGK 250
             +M+PE        +  +  +SDV+S G+  +E+  GK
Sbjct: 177 PYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGK 215

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 85.8 bits (212), Expect = 4e-19
 Identities = 63/203 (31%), Positives = 109/203 (53%), Gaps = 14/203 (6%)

Query: 56  KLGEGGFGPVYKGVLK---KGDEIAVKRLSGRSGQGLR-EMKNEASVIAKVQHKNLVRLL 111
           +LG G FG V KGV K   K  ++A+K L   + + +R EM  EA ++ ++ +  +VR++
Sbjct: 2   ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMI 61

Query: 112 GCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVR 171
           G C + +  +L+ E      L+ FL    K+  +     V+++  ++ G+ YL   +   
Sbjct: 62  GVC-EAEALMLVMEMASGGPLNKFL--SGKKDEITVSNVVELMHQVSMGMKYLEGKN--- 115

Query: 172 IIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTY--GYMSPEYALEGI 229
            +HRDL A N+LL      KISDFG+++  G ++     +R  G +   + +PE      
Sbjct: 116 FVHRDLAARNVLLVNQHYAKISDFGLSKALGADD-SYYKARSAGKWPLKWYAPECINFRK 174

Query: 230 FSIKSDVFSFGVLLLEIVS-GKK 251
           FS +SDV+S+G+ + E  S G+K
Sbjct: 175 FSSRSDVWSYGITMWEAFSYGQK 197

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 86.3 bits (213), Expect = 4e-19
 Identities = 64/215 (29%), Positives = 109/215 (50%), Gaps = 12/215 (5%)

Query: 38  LFSFSSVSTATNKFSDANKLGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKNEA 96
           L S  SV     K++   K+G+G  G VY  + +  G E+A+K+++ +       + NE 
Sbjct: 8   LRSIVSVGDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEI 67

Query: 97  SVIAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEG 156
            V+ + ++ N+V  L   +  DE  ++ EY+   SL     D      +D      +   
Sbjct: 68  LVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRE 123

Query: 157 IAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGM-ARICGGNELQANTSRIVG 215
             Q L +LH     ++IHRD+K+ NILL  D + K++DFG  A+I      Q+  S +VG
Sbjct: 124 CLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQI---TPEQSKRSTMVG 177

Query: 216 TYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 250
           T  +M+PE      +  K D++S G++ +E+V G+
Sbjct: 178 TPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGE 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 85.6 bits (212), Expect = 5e-19
 Identities = 65/208 (31%), Positives = 113/208 (54%), Gaps = 19/208 (9%)

Query: 51  FSDANKLGEGGFGPVYKGVLKKGDEI-AVKRLSGRSGQG-----LREMKNEASVIAKVQH 104
           F    KLGEG +  VYKG  +   EI A+K +   + +G     +RE+    S++ +++H
Sbjct: 2   FKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREI----SLMKELKH 57

Query: 105 KNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYL 164
           +N+VRL       ++ +L++EYM +K L  ++     R  LD  T       + +G+ + 
Sbjct: 58  ENIVRLHDVIHTENKLMLVFEYM-DKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFC 116

Query: 165 HQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANT-SRIVGTYGYMSPE 223
           H+    R++HRDLK  N+L++K    K++DFG+AR  G   +  NT S  V T  Y +P+
Sbjct: 117 HEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFG---IPVNTFSNEVVTLWYRAPD 170

Query: 224 YALEG-IFSIKSDVFSFGVLLLEIVSGK 250
             L    +S   D++S G ++ E+++G+
Sbjct: 171 VLLGSRTYSTSIDIWSVGCIMAEMITGR 198

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 85.1 bits (210), Expect = 7e-19
 Identities = 71/216 (32%), Positives = 107/216 (49%), Gaps = 36/216 (16%)

Query: 57  LGEGGFGPVYKGVLKKGD---EIAVKRLSGRSGQG-LREMKNEASVIAKV-QHKNLVRLL 111
           +GEG FG V K  +KK     + A+KR+   + +   R+   E  V+ K+  H N++ LL
Sbjct: 3   IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62

Query: 112 GCCIDRDEKILIYEYMPNKSLDFFL-------FDP------------TKRMLLDWVTRVQ 152
           G C  R    L  EY P+ +L  FL        DP            + + LL +   V 
Sbjct: 63  GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV- 121

Query: 153 IIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR 212
                A+G+ YL   S+ + IHRDL A NIL+ ++   KI+DFG++R   G E+    + 
Sbjct: 122 -----ARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTM 170

Query: 213 IVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 248
                 +M+ E     +++  SDV+S+GVLL EIVS
Sbjct: 171 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 85.3 bits (212), Expect = 7e-19
 Identities = 64/221 (28%), Positives = 103/221 (46%), Gaps = 51/221 (23%)

Query: 55  NKLGEGGFGPVYKGVLKK-GDEIAVK--RLSGRSGQG-------LREMKNEASVIAKVQH 104
            KLGEG +  VYK   K+ G  +A+K  +L  R           LRE+K    ++ +++H
Sbjct: 6   KKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIK----LLQELKH 61

Query: 105 KNLVRLLGCCIDRDEKILIYEYMP--------NKSLDFFLFDPTK---RMLLDWVTRVQI 153
            N++ LL     +    L++E+M         +KS+     D  K    M L        
Sbjct: 62  PNIIGLLDVFGHKSNINLVFEFMETDLEKVIKDKSIVLTPAD-IKSYMLMTL-------- 112

Query: 154 IEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICG--GNELQANTS 211
                +GL YLH      I+HRDLK +N+L+  D   K++DFG+AR  G    ++   T 
Sbjct: 113 -----RGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKM---TH 161

Query: 212 RIVGTYGYMSPEYALEG--IFSIKSDVFSFGVLLLEIVSGK 250
           ++V T  Y +PE  L G   + +  D++S G +  E++   
Sbjct: 162 QVV-TRWYRAPEL-LFGARHYGVGVDMWSVGCIFAELLLRV 200

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 84.6 bits (210), Expect = 8e-19
 Identities = 61/200 (30%), Positives = 92/200 (46%), Gaps = 17/200 (8%)

Query: 57  LGEGGFGPVYKGVLKKGDEI-AVKRLSGRS--GQGLREM-KNEASVIAKVQHKNLVRLLG 112
           LG GGFG V    +K  +   A+K +  R     G +E   +E  ++ +  H  +V+L  
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLY- 59

Query: 113 CCIDRDEKIL--IYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRV 170
               +D+K +  + EY     L   L D   R L D  T    I  +     YLH     
Sbjct: 60  -RTFKDKKYIYMLMEYCLGGELWTILRD---RGLFDEYTARFYIACVVLAFEYLHNRG-- 113

Query: 171 RIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIF 230
            II+RDLK  N+LLD +   K+ DFG A+     +    T    GT  Y++PE  L   +
Sbjct: 114 -IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWTFCGTPEYVAPEIILNKGY 169

Query: 231 SIKSDVFSFGVLLLEIVSGK 250
               D +S G+LL E+++G+
Sbjct: 170 DFSVDYWSLGILLYELLTGR 189

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 85.1 bits (210), Expect = 8e-19
 Identities = 67/230 (29%), Positives = 118/230 (51%), Gaps = 42/230 (18%)

Query: 57  LGEGGFGPVYKGVLKKGDEI---AVK--RLSGRSGQGLREMKNEASVIAKVQHKNLVRLL 111
           LGEG FG V +G L + D I   AVK  +++  +   + +  +EA  + +  H N++RL+
Sbjct: 7   LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66

Query: 112 GCCIDRDEK------ILIYEYMPNKSLDFFL----------FDPTKRMLLDWVTRVQIIE 155
           G C+   E       ++I  +M +  L  FL          + PT+ +       V+ + 
Sbjct: 67  GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQML-------VKFMT 119

Query: 156 GIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMA-RICGGNEL-QANTSRI 213
            IA G+ YL   S    IHRDL A N +L+++MN  ++DFG++ +I  G+   Q   +++
Sbjct: 120 DIASGMEYL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKM 176

Query: 214 VGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-------GKKNTGLY 256
                +++ E   + +++ KSDV+SFGV + EI +       G +N+ +Y
Sbjct: 177 --PVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIY 224

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 84.5 bits (209), Expect = 9e-19
 Identities = 64/211 (30%), Positives = 103/211 (48%), Gaps = 21/211 (9%)

Query: 50  KFSDANKLGEGGFGPVY--------KGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAK 101
           K+     +G G FG V+        K V+ K  +I V++++          +NE  V+  
Sbjct: 1   KYEKIRVVGRGAFGIVHLCRRKADQKLVIIK--QIPVEQMTKDERLA---AQNECQVLKL 55

Query: 102 VQHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGL 161
           + H N++      ++    +++ EY P  +L  ++       LLD  T   I+    Q L
Sbjct: 56  LSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQK-RCNSLLDEDT---ILHFFVQIL 111

Query: 162 LYLHQYSRVRIIHRDLKASNILLDK-DMNPKISDFGMARICGGNELQANTSRIVGTYGYM 220
           L LH      I+HRDLK  NILLDK  M  KI DFG+++I      ++    +VGT  Y+
Sbjct: 112 LALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSS---KSKAYTVVGTPCYI 168

Query: 221 SPEYALEGIFSIKSDVFSFGVLLLEIVSGKK 251
           SPE      ++ KSD+++ G +L E+ S K+
Sbjct: 169 SPELCEGKPYNQKSDIWALGCVLYELASLKR 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 85.2 bits (211), Expect = 9e-19
 Identities = 68/221 (30%), Positives = 111/221 (50%), Gaps = 25/221 (11%)

Query: 50  KFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRL------SGRSGQGLREMKNEASVIAKV 102
            ++   K+GEG +G VYKG  KK G  +A+K++       G     +RE+    S++ ++
Sbjct: 1   DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREI----SLLKEL 56

Query: 103 QHKNLVRLLGCCIDRDEKILIYEYMPNKSLDF--FLFDPTKRMLLDWVTRVQIIEGIAQG 160
           QH N+V L    +      LI+E++   S+D   +L    K   +D       +  I QG
Sbjct: 57  QHPNIVCLQDVLMQESRLYLIFEFL---SMDLKKYLDSLPKGQYMDAELVKSYLYQILQG 113

Query: 161 LLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYM 220
           +L+ H     R++HRDLK  N+L+D     K++DFG+AR   G  ++  T  +V T  Y 
Sbjct: 114 ILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLAR-AFGIPVRVYTHEVV-TLWYR 168

Query: 221 SPEYALEGI-FSIKSDVFSFGVLLLEIVSGKKNTGLYRTDS 260
           +PE  L    +S   D++S G +  E+ + K    L+  DS
Sbjct: 169 APEVLLGSPRYSTPVDIWSIGTIFAEMATKKP---LFHGDS 206

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 84.7 bits (209), Expect = 1e-18
 Identities = 69/209 (33%), Positives = 109/209 (52%), Gaps = 27/209 (12%)

Query: 57  LGEGGFGPVYKGV-LKKGDEIAVKRL-----SGRSGQGLREMKNEASVIAKVQHKNLVRL 110
           LG+G FG VY    +  G E+A K++     S  + + +  ++ E  ++  +QH+ +V+ 
Sbjct: 10  LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69

Query: 111 LGCCIDRDEKIL--IYEYMPNKSLDFFLFDPTKR--MLLDWVTRVQIIEGIAQGLLYLHQ 166
            GC  DR EK L    EYMP  S+     D  K    L + VTR +    I +G+ YLH 
Sbjct: 70  YGCLRDRAEKTLTIFMEYMPGGSVK----DQLKAYGALTESVTR-KYTRQILEGMSYLHS 124

Query: 167 YSRVRIIHRDLKASNILLDKDMNPKISDFGMAR----IC-GGNELQANTSRIVGTYGYMS 221
                I+HRD+K +NIL D   N K+ DFG ++    IC  G  +++    + GT  +MS
Sbjct: 125 N---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRS----VTGTPYWMS 177

Query: 222 PEYALEGIFSIKSDVFSFGVLLLEIVSGK 250
           PE      +  K+DV+S G  ++E+++ K
Sbjct: 178 PEVISGEGYGRKADVWSLGCTVVEMLTEK 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 85.4 bits (211), Expect = 1e-18
 Identities = 71/215 (33%), Positives = 109/215 (50%), Gaps = 26/215 (12%)

Query: 57  LGEGGFGPVYK----GVLKKGDE----IAVKRLSGR-SGQGLREMKNEASVIAKV-QHKN 106
           LGEG FG V +    G+ K   +    +AVK L    + + L ++ +E  ++  + +HKN
Sbjct: 20  LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79

Query: 107 LVRLLGCCIDRDEKILIYEYMPNKSLDFFL-----------FDPTK--RMLLDWVTRVQI 153
           ++ LLG C       +I EY    +L  FL           FD TK     L +   V  
Sbjct: 80  IINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSC 139

Query: 154 IEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRI 213
              +A+G+ YL   SR R IHRDL A N+L+ +D   KI+DFG+AR     +    TS  
Sbjct: 140 AYQVARGMEYLE--SR-RCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNG 196

Query: 214 VGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 248
                +M+PE   + +++ +SDV+SFG+L+ EI +
Sbjct: 197 RLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 85.2 bits (210), Expect = 1e-18
 Identities = 62/215 (28%), Positives = 109/215 (50%), Gaps = 12/215 (5%)

Query: 38  LFSFSSVSTATNKFSDANKLGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKNEA 96
           L S  SV     K++   K+G+G  G VY  + +  G E+A+++++ +       + NE 
Sbjct: 9   LRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEI 68

Query: 97  SVIAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEG 156
            V+ + ++ N+V  L   +  DE  ++ EY+   SL     D      +D      +   
Sbjct: 69  LVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRE 124

Query: 157 IAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGM-ARICGGNELQANTSRIVG 215
             Q L +LH     ++IHRD+K+ NILL  D + K++DFG  A+I      Q+  S +VG
Sbjct: 125 CLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQI---TPEQSKRSTMVG 178

Query: 216 TYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 250
           T  +M+PE      +  K D++S G++ +E++ G+
Sbjct: 179 TPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 84.4 bits (209), Expect = 1e-18
 Identities = 64/213 (30%), Positives = 102/213 (47%), Gaps = 39/213 (18%)

Query: 56  KLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMK-------------NEASVIAKV 102
           KLG+G +G VYK          VKRLS      L+E+              NE  ++A V
Sbjct: 7   KLGKGSYGSVYK----------VKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASV 56

Query: 103 QHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFL--FDPTKRML---LDWVTRVQIIEGI 157
            H N++      +D ++  ++ EY P   L   +      ++++     W   +Q++ G 
Sbjct: 57  NHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRG- 115

Query: 158 AQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTY 217
              L  LH+    +I+HRDLK++NILL  +   KI D G++++   N   A T   +GT 
Sbjct: 116 ---LQALHE---QKILHRDLKSANILLVANDLVKIGDLGISKVLKKN--MAKTQ--IGTP 165

Query: 218 GYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 250
            YM+PE      +S KSD++S G LL E+ +  
Sbjct: 166 HYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFA 198

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 84.4 bits (209), Expect = 1e-18
 Identities = 69/278 (24%), Positives = 126/278 (45%), Gaps = 44/278 (15%)

Query: 57  LGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQG-LREMKNEASVIAKVQH---KNLVRLL 111
           +G G +G VY+G  +  G  +A+K ++  +    + +++ E +++++++     N+ +  
Sbjct: 9   IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYY 68

Query: 112 GCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVR 171
           G  +      +I EY    S+   +    K   +       II  +   L Y+H   +V 
Sbjct: 69  GSYLKGPRLWIIMEYAEGGSVRTLM----KAGPIAEKYISVIIREVLVALKYIH---KVG 121

Query: 172 IIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR---IVGTYGYMSPEYALEG 228
           +IHRD+KA+NIL+    N K+ DFG+A       L  N+S+    VGT  +M+PE   EG
Sbjct: 122 VIHRDIKAANILVTNTGNVKLCDFGVAA-----LLNQNSSKRSTFVGTPYWMAPEVITEG 176

Query: 229 I-FSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELI----DPI 283
             +  K+D++S G+ + E+ +G  N      D+              R + LI     P 
Sbjct: 177 KYYDTKADIWSLGITIYEMATG--NPPYSDVDAF-------------RAMMLIPKSKPPR 221

Query: 284 LEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSM 321
           LED   SK +          C+ E   +R +  +++  
Sbjct: 222 LEDNGYSKLL----REFVAACLDEEPKERLSAEELLKS 255

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 86.8 bits (215), Expect = 2e-18
 Identities = 68/272 (25%), Positives = 118/272 (43%), Gaps = 19/272 (6%)

Query: 53  DANKLGEGGFGPVYKGVLKKGD-EIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLL 111
           + N +  G  G  YKG   K   +  VK +       +     E + + K+QH N+V+L+
Sbjct: 694 EENVISRGKKGASYKGKSIKNGMQFVVKEI--NDVNSIPSS--EIADMGKLQHPNIVKLI 749

Query: 112 GCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVR 171
           G C       LI+EY+  K+L   L +      L W  R +I  GIA+ L +LH      
Sbjct: 750 GLCRSEKGAYLIHEYIEGKNLSEVLRN------LSWERRRKIAIGIAKALRFLHCRCSPA 803

Query: 172 IIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFS 231
           ++  +L    I++D    P +             L    ++   +  Y++PE       +
Sbjct: 804 VVVGNLSPEKIIIDGKDEPHL-------RLSLPGLLCTDTKCFISSAYVAPETRETKDIT 856

Query: 232 IKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYSSK 291
            KSD++ FG++L+E+++GK           +++ +A   ++       IDP +  + S  
Sbjct: 857 EKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVN 916

Query: 292 Q-MLLRYANIALLCVQESADDRPTMNDVVSML 322
           Q  ++   N+AL C       RP  NDV+  L
Sbjct: 917 QNEIVEVMNLALHCTATDPTARPCANDVLKTL 948

Length = 968

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 84.7 bits (210), Expect = 2e-18
 Identities = 67/203 (33%), Positives = 97/203 (47%), Gaps = 21/203 (10%)

Query: 57  LGEGGFGPVYKGVLKKGDEI-AVKRLSGRSGQGLRE-----MKNEASVIAKV-QHKNLVR 109
           LG+G FG V    LK  DE+ AVK L  +    L++        E  V+A   +H  L +
Sbjct: 3   LGKGSFGKVLLAELKGTDELYAVKVL--KKDVILQDDDVECTMTEKRVLALAGKHPFLTQ 60

Query: 110 LLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSR 169
           L  C   +D    + EY+    L F +         +   R    E I  GL +LH+   
Sbjct: 61  LHSCFQTKDRLFFVMEYVNGGDLMFHI--QRSGRFDEPRARFYAAE-IVLGLQFLHERG- 116

Query: 170 VRIIHRDLKASNILLDKDMNPKISDFGMAR--ICGGNELQANTSRIVGTYGYMSPEYALE 227
             II+RDLK  N+LLD + + KI+DFGM +  I GG      TS   GT  Y++PE    
Sbjct: 117 --IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV----TTSTFCGTPDYIAPEILSY 170

Query: 228 GIFSIKSDVFSFGVLLLEIVSGK 250
             +    D ++ GVLL E+++G+
Sbjct: 171 QPYGPAVDWWALGVLLYEMLAGQ 193

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 84.0 bits (207), Expect = 2e-18
 Identities = 60/215 (27%), Positives = 110/215 (51%), Gaps = 12/215 (5%)

Query: 38  LFSFSSVSTATNKFSDANKLGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKNEA 96
           L +  S+     K++   K+G+G  G V+  + +  G E+A+K+++ +       + NE 
Sbjct: 8   LRTIVSIGDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEI 67

Query: 97  SVIAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEG 156
            V+ ++++ N+V  L   +  DE  ++ EY+   SL     D      +D      +   
Sbjct: 68  LVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLT----DVVTETCMDEAQIAAVCRE 123

Query: 157 IAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGM-ARICGGNELQANTSRIVG 215
             Q L +LH     ++IHRD+K+ N+LL  D + K++DFG  A+I      Q+  S +VG
Sbjct: 124 CLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQI---TPEQSKRSTMVG 177

Query: 216 TYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 250
           T  +M+PE      +  K D++S G++ +E+V G+
Sbjct: 178 TPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGE 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 84.0 bits (208), Expect = 3e-18
 Identities = 59/205 (28%), Positives = 94/205 (45%), Gaps = 15/205 (7%)

Query: 49  NKFSDANKLGEGGFGPVYKGVLKKGDEI-AVKRLSGRSGQGL---REMKNEASVIAKVQH 104
             F    ++G+GG+G V+    K   EI A+KR+       L   R +  E  ++   + 
Sbjct: 1   KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKS 60

Query: 105 KNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYL 164
           + LV+LL    D +   L  EY+P    DF        +L +   R  + E     +  L
Sbjct: 61  EWLVKLLYAFQDDEYLYLAMEYVPGG--DFRTLLNNLGVLSEDHARFYMAEMFE-AVDAL 117

Query: 165 HQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY 224
           H+      IHRDLK  N L+D   + K++DFG+++  G     AN+  +VG+  YM+PE 
Sbjct: 118 HELG---YIHRDLKPENFLIDASGHIKLTDFGLSK--GIVTY-ANS--VVGSPDYMAPEV 169

Query: 225 ALEGIFSIKSDVFSFGVLLLEIVSG 249
                +    D +S G +L E + G
Sbjct: 170 LRGKGYDFTVDYWSLGCMLYEFLCG 194

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 83.5 bits (207), Expect = 3e-18
 Identities = 63/211 (29%), Positives = 111/211 (52%), Gaps = 27/211 (12%)

Query: 51  FSDANKLGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQG------LREMKNEASVIAKVQ 103
           + +  ++GEG +G VYK   L  G  +A+K++     +       LRE+    +++ +++
Sbjct: 1   YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREI----ALLKQLE 56

Query: 104 ---HKNLVRLLGCC--IDRDEKI---LIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIE 155
              H N+VRLL  C     D ++   L++E++ ++ L  +L    K  L     +  ++ 
Sbjct: 57  SFEHPNIVRLLDVCHGPRTDRELKLTLVFEHV-DQDLATYLSKCPKPGLPPETIK-DLMR 114

Query: 156 GIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVG 215
            + +G+ +LH +   RI+HRDLK  NIL+  D   KI+DFG+ARI       A TS +V 
Sbjct: 115 QLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLARIYSFE--MALTS-VVV 168

Query: 216 TYGYMSPEYALEGIFSIKSDVFSFGVLLLEI 246
           T  Y +PE  L+  ++   D++S G +  E+
Sbjct: 169 TLWYRAPEVLLQSSYATPVDMWSVGCIFAEL 199

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 83.3 bits (206), Expect = 3e-18
 Identities = 60/202 (29%), Positives = 97/202 (48%), Gaps = 23/202 (11%)

Query: 57  LGEGGFGPVYK------GVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRL 110
           LG G  G V K      G +     + +   S    Q LRE++    ++ + +   +V  
Sbjct: 13  LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQ----IMHECRSPYIVSF 68

Query: 111 LGCCIDRDEKILIYEYMPNKSLDFFL--FDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYS 168
            G  ++ +   +  E+M   SLD       P    +L      +I   + +GL YL  Y+
Sbjct: 69  YGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILG-----KIAVAVVEGLTYL--YN 121

Query: 169 RVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEG 228
             RI+HRD+K SNIL++     K+ DFG++    G  + +     VGT  YMSPE    G
Sbjct: 122 VHRIMHRDIKPSNILVNSRGQIKLCDFGVS----GELINSIADTFVGTSTYMSPERIQGG 177

Query: 229 IFSIKSDVFSFGVLLLEIVSGK 250
            +++KSDV+S G+ ++E+  GK
Sbjct: 178 KYTVKSDVWSLGISIIELALGK 199

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 83.3 bits (206), Expect = 4e-18
 Identities = 64/202 (31%), Positives = 100/202 (49%), Gaps = 16/202 (7%)

Query: 57  LGEGGFGPVYKGV---LKKGD---EIAVKRLSGRSGQGLRE-MKNEASVIAKV-QHKNLV 108
           LG G FG V +     L K D   ++AVK L   +    RE + +E  +++ +  H+N+V
Sbjct: 43  LGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIV 102

Query: 109 RLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYS 168
            LLG C      ++I EY     L  FL    +   L     +     +A+G+ +L   +
Sbjct: 103 NLLGACTIGGPILVITEYCCYGDLLNFL-RRKRESFLTLEDLLSFSYQVAKGMAFLASKN 161

Query: 169 RVRIIHRDLKASNILLDKDMNPKISDFGMAR--ICGGNELQANTSRIVGTYGYMSPEYAL 226
               IHRDL A N+LL      KI DFG+AR  +   N +    +R+     +M+PE   
Sbjct: 162 ---CIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARL--PVKWMAPESIF 216

Query: 227 EGIFSIKSDVFSFGVLLLEIVS 248
             +++ +SDV+S+G+LL EI S
Sbjct: 217 NCVYTFESDVWSYGILLWEIFS 238

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 82.9 bits (205), Expect = 4e-18
 Identities = 74/287 (25%), Positives = 131/287 (45%), Gaps = 41/287 (14%)

Query: 48  TNKFSDANKLGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKN---------EAS 97
              F    K+G+G F  VYK + L  G  +A+K++       + EM +         E  
Sbjct: 1   LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQ------IFEMMDAKARQDCLKEID 54

Query: 98  VIAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFL--FDPTKRMLLDWVTRVQIIE 155
           ++ ++ H N+++ L   I+ +E  ++ E      L   +  F   KR L+   T  +   
Sbjct: 55  LLKQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKR-LIPERTIWKYFV 113

Query: 156 GIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVG 215
            +   L ++H     RI+HRD+K +N+ +      K+ D G+ R        A++  +VG
Sbjct: 114 QLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVG 168

Query: 216 TYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNR 275
           T  YMSPE   E  ++ KSD++S G LL E+ + +     +  D +NL    + L    +
Sbjct: 169 TPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP---FYGDKMNL----YSLC---K 218

Query: 276 TLELID--PILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVS 320
            +E  D  P+  D YS +   LR  ++   C+    + RP ++ V+ 
Sbjct: 219 KIEKCDYPPLPADHYSEE---LR--DLVSRCINPDPEKRPDISYVLQ 260

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 82.8 bits (205), Expect = 5e-18
 Identities = 58/215 (26%), Positives = 104/215 (48%), Gaps = 41/215 (19%)

Query: 59  EGGFGPVYKGVLKKGD-----EIAVKRLS-GRSGQGLREMKNEASVIAKVQHKNLVRLLG 112
           EG FG ++ G+L         E+ VK +    S   +  +  E+ ++  + H+N++ +L 
Sbjct: 16  EGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILH 75

Query: 113 CCI-DRDEKILIYEYMPNKSLDFFLFDP-----------TKRMLLDWVTRVQIIEGIAQG 160
            CI D +   ++Y YM   +L  FL              + + L+    +      IA G
Sbjct: 76  VCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQ------IACG 129

Query: 161 LLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARI-------CGGNELQANTSRI 213
           + YLH+     +IH+D+ A N ++D+++  KI+D  ++R        C G+    N +R 
Sbjct: 130 MSYLHKR---GVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGD----NENRP 182

Query: 214 VGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 248
           V    +M+ E  +   +S  SDV+SFGVLL E+++
Sbjct: 183 VK---WMALESLVNKEYSSASDVWSFGVLLWELMT 214

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 82.8 bits (205), Expect = 5e-18
 Identities = 69/215 (32%), Positives = 103/215 (47%), Gaps = 32/215 (14%)

Query: 53  DANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLREMKN---EASVIAKVQH-KNL 107
           D  ++G G FG V K + K  G  +AVKR+  RS    +E K    +  V+ +      +
Sbjct: 8   DLGEIGRGAFGTVNKMLHKPSGTIMAVKRI--RSTVDEKEQKRLLMDLDVVMRSSDCPYI 65

Query: 108 VRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGI--------AQ 159
           V+  G      +  +  E M + SLD F         +  V +  I E I         +
Sbjct: 66  VKFYGALFREGDCWICMELM-DISLDKFY------KYVYEVLKSVIPEEILGKIAVATVK 118

Query: 160 GLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGY 219
            L YL +   ++IIHRD+K SNILLD++ N K+ DFG   I G        +R  G   Y
Sbjct: 119 ALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFG---ISGQLVDSIAKTRDAGCRPY 173

Query: 220 MSPE----YALEGIFSIKSDVFSFGVLLLEIVSGK 250
           M+PE     A +G + ++SDV+S G+ L E+ +GK
Sbjct: 174 MAPERIDPSARDG-YDVRSDVWSLGITLYEVATGK 207

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 82.4 bits (203), Expect = 6e-18
 Identities = 55/203 (27%), Positives = 108/203 (53%), Gaps = 13/203 (6%)

Query: 51  FSDANKLGEGGFGPVYKGVLKKGDEI-AVKRLSGRSGQG-LREMKNEASVIAKVQHKNLV 108
           F+   ++G+G FG V+KG+  +  ++ A+K +     +  + +++ E +V+++     + 
Sbjct: 6   FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65

Query: 109 RLLGCCIDRDEKILIYEYMPNKS-LDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQY 167
           +  G  +   +  +I EY+   S LD     P      D      +++ I +GL YLH  
Sbjct: 66  KYYGSYLKGTKLWIIMEYLGGGSALDLLRAGP-----FDEFQIATMLKEILKGLDYLHSE 120

Query: 168 SRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALE 227
            +   IHRD+KA+N+LL +  + K++DFG+A      +++ NT   VGT  +M+PE   +
Sbjct: 121 KK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVIQQ 175

Query: 228 GIFSIKSDVFSFGVLLLEIVSGK 250
             +  K+D++S G+  +E+  G+
Sbjct: 176 SAYDSKADIWSLGITAIELAKGE 198

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 82.4 bits (203), Expect = 7e-18
 Identities = 69/228 (30%), Positives = 119/228 (52%), Gaps = 24/228 (10%)

Query: 56  KLGEGGFGPVYKGV-LKKGDE-IAVKRL---SGRSGQGLREMKNEASV--IAKVQHKNLV 108
           ++GEG +G V+K   LK G   +A+KR+   +G  G  L  ++  A +  +   +H N+V
Sbjct: 8   EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 67

Query: 109 RLLGCCI----DRDEKI-LIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLY 163
           RL   C     DR+ K+ L++E++ ++ L  +L D      +   T   ++  + +GL +
Sbjct: 68  RLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYL-DKVPEPGVPTETIKDMMFQLLRGLDF 125

Query: 164 LHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE 223
           LH +   R++HRDLK  NIL+      K++DFG+ARI      Q   + +V T  Y +PE
Sbjct: 126 LHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARI---YSFQMALTSVVVTLWYRAPE 179

Query: 224 YALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDS-LNLLGYAWDL 270
             L+  ++   D++S G +  E+   K    L+R  S ++ LG   D+
Sbjct: 180 VLLQSSYATPVDLWSVGCIFAEMFRRKP---LFRGSSDVDQLGKILDV 224

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 82.1 bits (203), Expect = 8e-18
 Identities = 57/203 (28%), Positives = 98/203 (48%), Gaps = 15/203 (7%)

Query: 56  KLGEGGFGPVYKGV--LKKGDEI--AVKRLSGRSGQGLRE-MKNEASVIAKVQHKNLVRL 110
            +GEG FG VY+GV    + ++I  AVK     +   +RE    EA ++ +  H ++V+L
Sbjct: 13  CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKL 72

Query: 111 LGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRV 170
           +G   + +   ++ E  P   L  +L     +  LD  + +     ++  L YL      
Sbjct: 73  IGVITE-NPVWIVMELAPLGELRSYL--QVNKYSLDLASLILYSYQLSTALAYLES---K 126

Query: 171 RIIHRDLKASNILLDKDMNPKISDFGMARICGGNEL-QANTSRIVGTYGYMSPEYALEGI 229
           R +HRD+ A N+L+      K+ DFG++R        +A+  ++     +M+PE      
Sbjct: 127 RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKL--PIKWMAPESINFRR 184

Query: 230 FSIKSDVFSFGVLLLEIVS-GKK 251
           F+  SDV+ FGV + EI+  G K
Sbjct: 185 FTSASDVWMFGVCMWEILMLGVK 207

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 82.0 bits (202), Expect = 8e-18
 Identities = 57/203 (28%), Positives = 106/203 (52%), Gaps = 13/203 (6%)

Query: 51  FSDANKLGEGGFGPVYKGVLKKGDEI-AVKRLSGRSGQG-LREMKNEASVIAKVQHKNLV 108
           F+   K+G+G FG V+KG+  +  ++ A+K +     +  + +++ E +V+++     + 
Sbjct: 6   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65

Query: 109 RLLGCCIDRDEKILIYEYMPNKS-LDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQY 167
           +  G  +   +  +I EY+   S LD     P     LD      I+  I +GL YLH  
Sbjct: 66  KYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP-----LDETQIATILREILKGLDYLHSE 120

Query: 168 SRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALE 227
            +   IHRD+KA+N+LL +    K++DFG+A      +++ N    VGT  +M+PE   +
Sbjct: 121 KK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRN--TFVGTPFWMAPEVIKQ 175

Query: 228 GIFSIKSDVFSFGVLLLEIVSGK 250
             +  K+D++S G+  +E+  G+
Sbjct: 176 SAYDSKADIWSLGITAIELAKGE 198

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 81.2 bits (200), Expect = 1e-17
 Identities = 62/195 (31%), Positives = 95/195 (48%), Gaps = 7/195 (3%)

Query: 56  KLGEGGFGPVYKGVLKKGDE-IAVKRLSGRSGQGLR-EMKNEASVIAKVQHKNLVRLLGC 113
           ++G G FG V+ G L+  +  +AVK         L+ +   EA ++ +  H N+VRL+G 
Sbjct: 2   RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 61

Query: 114 CIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRII 173
           C  +    ++ E +  +  DF  F  T+   L     +Q++E  A G+ YL        I
Sbjct: 62  CTQKQPIYIVMELV--QGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKH---CI 116

Query: 174 HRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIK 233
           HRDL A N L+ +    KISDFGM+R        +          + +PE    G +S +
Sbjct: 117 HRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSE 176

Query: 234 SDVFSFGVLLLEIVS 248
           SDV+SFG+LL E  S
Sbjct: 177 SDVWSFGILLWEAFS 191

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 82.0 bits (202), Expect = 1e-17
 Identities = 62/197 (31%), Positives = 105/197 (53%), Gaps = 13/197 (6%)

Query: 56  KLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCC 114
           +LG+G FG VYK   K+ G   A K +  +S + L +   E  ++A   H  +V+LLG  
Sbjct: 19  ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAF 78

Query: 115 IDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 174
               +  ++ E+ P  ++D  + +   R L +   +V I   + + L YLH    ++IIH
Sbjct: 79  YWDGKLWIMIEFCPGGAVDAIMLE-LDRGLTEPQIQV-ICRQMLEALQYLHS---MKIIH 133

Query: 175 RDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAL-----EGI 229
           RDLKA N+LL  D + K++DFG++       LQ   S  +GT  +M+PE  +     +  
Sbjct: 134 RDLKAGNVLLTLDGDIKLADFGVSAK-NVKTLQRRDS-FIGTPYWMAPEVVMCETMKDTP 191

Query: 230 FSIKSDVFSFGVLLLEI 246
           +  K+D++S G+ L+E+
Sbjct: 192 YDYKADIWSLGITLIEM 208

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 81.4 bits (202), Expect = 1e-17
 Identities = 63/209 (30%), Positives = 103/209 (49%), Gaps = 32/209 (15%)

Query: 56  KLGEGGFGPVYKGVLKKGDEI-AVKRLSGRSGQ-----GLREMKNEASVIAKVQHKNLVR 109
           +LG+G FG VY    K+  E+ A+K++  +         LRE+K   S+    +H N+V+
Sbjct: 6   QLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVK---SLRKLNEHPNIVK 62

Query: 110 LLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQ--Y 167
           L     + DE   ++EYM   +L   + D   +   + V R  II  I QGL ++H+  +
Sbjct: 63  LKEVFRENDELYFVFEYM-EGNLYQLMKDRKGKPFSESVIR-SIIYQILQGLAHIHKHGF 120

Query: 168 SRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR-----IVGTYGYMSP 222
                 HRDLK  N+L+      KI+DFG+AR     E++   SR      V T  Y +P
Sbjct: 121 -----FHRDLKPENLLVSGPEVVKIADFGLAR-----EIR---SRPPYTDYVSTRWYRAP 167

Query: 223 EYALE-GIFSIKSDVFSFGVLLLEIVSGK 250
           E  L    +S   D+++ G ++ E+ + +
Sbjct: 168 EILLRSTSYSSPVDIWALGCIMAELYTLR 196

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 80.7 bits (200), Expect = 3e-17
 Identities = 62/203 (30%), Positives = 93/203 (45%), Gaps = 27/203 (13%)

Query: 57  LGEGGFGPVYKGVLKKGDEI-AVKRLSG----RSGQGLREMKNEASVIAKVQHKNLVRLL 111
           LG G FG V     K   +  A+K LS     +  Q +  + NE  ++  ++H  LV L 
Sbjct: 9   LGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQ-VEHVLNEKRILQSIRHPFLVNLY 67

Query: 112 GCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVR 171
           G   D     L+ EY+P   L F     + R     V R    + +   L YLH      
Sbjct: 68  GSFQDDSNLYLVMEYVPGGEL-FSHLRKSGRFPEP-VARFYAAQ-VVLALEYLHSLD--- 121

Query: 172 IIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFS 231
           I++RDLK  N+LLD D   KI+DFG A+      ++  T  + GT  Y++PE     I  
Sbjct: 122 IVYRDLKPENLLLDSDGYIKITDFGFAK-----RVKGRTYTLCGTPEYLAPE-----IIL 171

Query: 232 IK-----SDVFSFGVLLLEIVSG 249
            K      D ++ G+L+ E+++G
Sbjct: 172 SKGYGKAVDWWALGILIYEMLAG 194

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 80.8 bits (199), Expect = 4e-17
 Identities = 67/215 (31%), Positives = 108/215 (50%), Gaps = 26/215 (12%)

Query: 57  LGEGGFGPVY--------KGVLKKGDEIAVKRL-SGRSGQGLREMKNEASVIAKV-QHKN 106
           LGEG FG V         K    +  ++AVK L S  + + L ++ +E  ++  + +HKN
Sbjct: 26  LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85

Query: 107 LVRLLGCCIDRDEKILIYEYMPNKSLDFFL-----------FDPTK--RMLLDWVTRVQI 153
           ++ LLG C       +I EY    +L  +L           ++PT+     L +   V  
Sbjct: 86  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSC 145

Query: 154 IEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRI 213
              +A+G+ YL   +  + IHRDL A N+L+ +D   KI+DFG+AR     +    T+  
Sbjct: 146 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 202

Query: 214 VGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 248
                +M+PE   + I++ +SDV+SFGVLL EI +
Sbjct: 203 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 80.0 bits (197), Expect = 5e-17
 Identities = 64/204 (31%), Positives = 105/204 (51%), Gaps = 20/204 (9%)

Query: 57  LGEGGFGPVY------KGVLKKGDEIAVKRLS-GRSGQGLREMKNEASVIAKVQHKNLVR 109
           LGEG FG V       +G    G+++AVK L     G  + ++K E  ++  + H+N+V+
Sbjct: 12  LGEGHFGKVELCRYDPEGD-NTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVK 70

Query: 110 LLGCCI-DRDEKI-LIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYL--H 165
             G C  D    I LI E++P+ SL  +L  P  +  ++   +++    I +G+ YL   
Sbjct: 71  YKGICTEDGGNGIKLIMEFLPSGSLKEYL--PRNKNKINLKQQLKYAVQICKGMDYLGSR 128

Query: 166 QYSRVRIIHRDLKASNILLDKDMNPKISDFGMAR-ICGGNELQANTSRIVGTYGYMSPEY 224
           QY     +HRDL A N+L++ +   KI DFG+ + I    E       +     + +PE 
Sbjct: 129 QY-----VHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPEC 183

Query: 225 ALEGIFSIKSDVFSFGVLLLEIVS 248
            ++  F I SDV+SFGV L E+++
Sbjct: 184 LIQSKFYIASDVWSFGVTLYELLT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 79.7 bits (196), Expect = 6e-17
 Identities = 65/209 (31%), Positives = 107/209 (51%), Gaps = 27/209 (12%)

Query: 57  LGEGGFGPVYKGV-LKKGDEIAVKRL-----SGRSGQGLREMKNEASVIAKVQHKNLVRL 110
           LG+G FG VY       G E+AVK++     S  + + +  ++ E  ++  + H+ +V+ 
Sbjct: 10  LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQY 69

Query: 111 LGCCIDRDEKIL--IYEYMPNKSLDFFLFDPTKR--MLLDWVTRVQIIEGIAQGLLYLHQ 166
            GC  D  E+ L    E+MP  S+     D  K    L + VTR +    I +G+ YLH 
Sbjct: 70  YGCLRDPMERTLSIFMEHMPGGSIK----DQLKSYGALTENVTR-KYTRQILEGVSYLHS 124

Query: 167 YSRVRIIHRDLKASNILLDKDMNPKISDFGMAR----IC-GGNELQANTSRIVGTYGYMS 221
                I+HRD+K +NIL D   N K+ DFG ++    IC  G  +++    + GT  +MS
Sbjct: 125 N---MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKS----VTGTPYWMS 177

Query: 222 PEYALEGIFSIKSDVFSFGVLLLEIVSGK 250
           PE      +  K+D++S G  ++E+++ K
Sbjct: 178 PEVISGEGYGRKADIWSVGCTVVEMLTEK 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 79.3 bits (195), Expect = 8e-17
 Identities = 68/209 (32%), Positives = 106/209 (50%), Gaps = 27/209 (12%)

Query: 57  LGEGGFGPVYKGV-LKKGDEIAVKRL-----SGRSGQGLREMKNEASVIAKVQHKNLVRL 110
           LG G FG VY       G E+AVK++     S  + + +  ++ E  ++  ++H  +V+ 
Sbjct: 10  LGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQY 69

Query: 111 LGCCIDRDEKIL--IYEYMPNKSLDFFLFDPTKR--MLLDWVTRVQIIEGIAQGLLYLHQ 166
            GC  D +EK L    EYMP  S+     D  K    L + VTR +    I QG+ YLH 
Sbjct: 70  YGCLRDPEEKKLSIFVEYMPGGSIK----DQLKAYGALTENVTR-RYTRQILQGVSYLHS 124

Query: 167 YSRVRIIHRDLKASNILLDKDMNPKISDFGMAR----IC-GGNELQANTSRIVGTYGYMS 221
                I+HRD+K +NIL D   N K+ DFG ++    IC  G  +++    + GT  +MS
Sbjct: 125 N---MIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKS----VTGTPYWMS 177

Query: 222 PEYALEGIFSIKSDVFSFGVLLLEIVSGK 250
           PE      +  K+DV+S    ++E+++ K
Sbjct: 178 PEVISGEGYGRKADVWSVACTVVEMLTEK 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 79.5 bits (196), Expect = 8e-17
 Identities = 67/216 (31%), Positives = 117/216 (54%), Gaps = 30/216 (13%)

Query: 49  NKFSDANKLGEGGFGPVYKGVLKKGDE-IAVKRL------SGRSGQGLREMKNEASVIAK 101
           +++    K+GEG +G VYK   +  +E IA+K++       G     +RE+    S++ +
Sbjct: 2   DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREI----SLLKE 57

Query: 102 VQHKNLVRLLGCCIDRDEKI-LIYEYMP---NKSLDFF-LFDPTKRMLLDWVTRVQIIEG 156
           +QH N+VRL    +  ++++ L++EY+     K +D    F    R++  ++   QI+ G
Sbjct: 58  MQHGNIVRLQDV-VHSEKRLYLVFEYLDLDLKKHMDSSPDFAKNPRLIKTYL--YQILRG 114

Query: 157 IAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNP-KISDFGMARICGGNELQANTSRIVG 215
           IA    Y H +   R++HRDLK  N+L+D+  N  K++DFG+AR   G  ++  T  +V 
Sbjct: 115 IA----YCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLAR-AFGIPVRTFTHEVV- 165

Query: 216 TYGYMSPEYALEG-IFSIKSDVFSFGVLLLEIVSGK 250
           T  Y +PE  L    +S   D++S G +  E+V+ K
Sbjct: 166 TLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQK 201

Length = 294

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 79.1 bits (195), Expect = 9e-17
 Identities = 69/219 (31%), Positives = 99/219 (45%), Gaps = 37/219 (16%)

Query: 57  LGEGGFGPVY------KGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRL 110
           LG+GGFG V        G L    ++  KRL  R  +G      E  ++AKV  + +V L
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKR--KGYEGAMVEKRILAKVHSRFIVSL 58

Query: 111 LGCCIDRDEKILIYEYMPNKSLDFFLFD--------PTKRMLLDWVTRVQIIEGIAQGLL 162
                 + +  L+   M    L + +++        P  R         QII     GL 
Sbjct: 59  AYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACF---YTAQII----SGLE 111

Query: 163 YLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNEL---QANTSRIVGTYGY 219
           +LHQ    RII+RDLK  N+LLD D N +ISD G+A      EL   Q+ T    GT G+
Sbjct: 112 HLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAV-----ELKDGQSKTKGYAGTPGF 163

Query: 220 MSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRT 258
           M+PE      +    D F+ GV L E+++ +   G +R 
Sbjct: 164 MAPELLQGEEYDFSVDYFALGVTLYEMIAAR---GPFRA 199

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 79.2 bits (196), Expect = 1e-16
 Identities = 50/194 (25%), Positives = 90/194 (46%), Gaps = 29/194 (14%)

Query: 50  KFSDANKLGEGGFGPVYKGVLKKGD---EIAVKRLSGRSGQG-------LREMKNEASVI 99
           K+     +G G +G VYK   K G    E A+K+  G   Q         RE+    +++
Sbjct: 1   KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREI----ALL 56

Query: 100 AKVQHKNLVRLLGCCIDRDEKI--LIYEYMPNKSLDFFLF--DPTKRMLLDWVTRVQIIE 155
            +++H+N+V L+   ++  +K   L+++Y  +       F     +  +   + +  ++ 
Sbjct: 57  RELKHENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVK-SLLW 115

Query: 156 GIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNP----KISDFGMARICGGNELQ--AN 209
            I  G+ YLH      ++HRDLK +NIL+  +       KI D G+AR+     L+  A+
Sbjct: 116 QILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDLGLARLF-NAPLKPLAD 171

Query: 210 TSRIVGTYGYMSPE 223
              +V T  Y +PE
Sbjct: 172 LDPVVVTIWYRAPE 185

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 78.4 bits (193), Expect = 2e-16
 Identities = 63/218 (28%), Positives = 109/218 (50%), Gaps = 28/218 (12%)

Query: 51  FSDANKLGEGGFGPVYKGVLKKGD----EIAVKRLSGR--SGQGLREMKNEASVIAKVQH 104
           F+    LG+G FG V +  LK  D    ++AVK L     S   + E   EA+ + +  H
Sbjct: 1   FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60

Query: 105 KNLVRLLGCCIDRDEK------ILIYEYMPNKSLDFFLF------DPTKRMLLDWVTRVQ 152
            N+++L+G  +    K      ++I  +M +  L  FL       +P     L   T V+
Sbjct: 61  PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEP---FTLPLQTLVR 117

Query: 153 IIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMAR-ICGGNEL-QANT 210
            +  IA G+ YL   S    IHRDL A N +L+++M   ++DFG+++ I  G+   Q   
Sbjct: 118 FMIDIASGMEYL---SSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCA 174

Query: 211 SRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 248
           S++     +++ E   + +++  SDV++FGV + EI++
Sbjct: 175 SKL--PVKWLALESLADNVYTTHSDVWAFGVTMWEIMT 210

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 79.0 bits (195), Expect = 2e-16
 Identities = 60/196 (30%), Positives = 102/196 (52%), Gaps = 29/196 (14%)

Query: 49  NKFSDANKLGEGGFGPVYKGVLKKGDEI-AVKR-LSGRSGQG-----LREMKNEASVIAK 101
           +K+    K+G+G FG V+K   KK  +I A+K+ L     +G     LRE+K    ++  
Sbjct: 12  SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIK----ILQL 67

Query: 102 VQHKNLVRLLGCCI--------DRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQI 153
           ++H+N+V L+  C          +    L++E+  +  L   L +   +  L  + +V  
Sbjct: 68  LKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKV-- 124

Query: 154 IEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQAN---T 210
           ++ +  GL Y+H   R +I+HRD+KA+NIL+ KD   K++DFG+AR    ++       T
Sbjct: 125 MKMLLNGLYYIH---RNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYT 181

Query: 211 SRIVGTYGYMSPEYAL 226
           +R+V T  Y  PE  L
Sbjct: 182 NRVV-TLWYRPPELLL 196

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 78.1 bits (193), Expect = 2e-16
 Identities = 59/198 (29%), Positives = 93/198 (46%), Gaps = 13/198 (6%)

Query: 58  GEGGFGPVYKGVLKKGDEI-AVKRLSGR---SGQGLREMKNEASVIAKVQHKNLVRLLGC 113
           G+G FG V     +   ++ A+K ++ +       +R + NE  ++ ++ H  LV L   
Sbjct: 9   GKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYS 68

Query: 114 CIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRII 173
             D +   L+ + +    L + L    K    +   +  I E I   L YLH      II
Sbjct: 69  FQDEENMYLVVDLLLGGDLRYHL--SQKVKFSEEQVKFWICE-IVLALEYLHSK---GII 122

Query: 174 HRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIK 233
           HRD+K  NILLD+  +  I+DF +A     + L  +TS   GT GYM+PE      +S+ 
Sbjct: 123 HRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTSTS---GTPGYMAPEVLCRQGYSVA 179

Query: 234 SDVFSFGVLLLEIVSGKK 251
            D +S GV   E + GK+
Sbjct: 180 VDWWSLGVTAYECLRGKR 197

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 78.5 bits (193), Expect = 2e-16
 Identities = 58/197 (29%), Positives = 100/197 (50%), Gaps = 12/197 (6%)

Query: 56  KLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCC 114
           K+GEG  G V     K  G ++AVK +  R  Q    + NE  ++   QH+N+V +    
Sbjct: 28  KIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSY 87

Query: 115 IDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 174
           +  +E  ++ E++   +L     D   +  L+      + E + Q L YLH      +IH
Sbjct: 88  LVGEELWVLMEFLQGGALT----DIVSQTRLNEEQIATVCESVLQALCYLHSQG---VIH 140

Query: 175 RDLKASNILLDKDMNPKISDFGM-ARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIK 233
           RD+K+ +ILL  D   K+SDFG  A+I   ++       +VGT  +M+PE      +  +
Sbjct: 141 RDIKSDSILLTLDGRVKLSDFGFCAQI---SKDVPKRKSLVGTPYWMAPEVISRTPYGTE 197

Query: 234 SDVFSFGVLLLEIVSGK 250
            D++S G++++E+V G+
Sbjct: 198 VDIWSLGIMVIEMVDGE 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 78.3 bits (193), Expect = 2e-16
 Identities = 62/218 (28%), Positives = 113/218 (51%), Gaps = 22/218 (10%)

Query: 51  FSDANKLGEGGFGPVYKGVLKK-GDEIAVKRL------SGRSGQGLREMKNEASVIAKVQ 103
           F    K+GEG +G VYK   K  G+ +A+K++       G     +RE+    S++ ++ 
Sbjct: 2   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREI----SLLKELN 57

Query: 104 HKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLY 163
           H N+V+LL      ++  L++E++ ++ L  F+ D +    +        +  + QGL +
Sbjct: 58  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASPLSGIPLPLIKSYLFQLLQGLAF 115

Query: 164 LHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE 223
            H +   R++HRDLK  N+L++ +   K++DFG+AR   G  ++  T  +V T  Y +PE
Sbjct: 116 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYTHEVV-TLWYRAPE 170

Query: 224 YAL-EGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDS 260
             L    +S   D++S G +  E+V+ +    L+  DS
Sbjct: 171 ILLGCKYYSTAVDIWSLGCIFAEMVTRR---ALFPGDS 205

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 77.7 bits (191), Expect = 2e-16
 Identities = 68/206 (33%), Positives = 111/206 (53%), Gaps = 20/206 (9%)

Query: 56  KLGEGGFGPVYKGVL--KKGDE-IAVKRLSGRSG-QGLR-EMKNEASVIAKVQHKNLVRL 110
           +LG G FG V KG+   KK ++ +AVK L   +    L+ E+  EA+V+ ++ +  +VR+
Sbjct: 2   ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRM 61

Query: 111 LGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRV 170
           +G C + +  +L+ E      L+ FL    K +    +T  +++  ++ G+ YL + +  
Sbjct: 62  IGIC-EAESWMLVMELAELGPLNKFL-QKNKHVTEKNIT--ELVHQVSMGMKYLEETN-- 115

Query: 171 RIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGI- 229
             +HRDL A N+LL      KISDFG+++  G +E   N  +      +    YA E + 
Sbjct: 116 -FVHRDLAARNVLLVTQHYAKISDFGLSKALGADE---NYYKAKTHGKWPVKWYAPECMN 171

Query: 230 ---FSIKSDVFSFGVLLLEIVS-GKK 251
              FS KSDV+SFGVL+ E  S G+K
Sbjct: 172 YYKFSSKSDVWSFGVLMWEAFSYGQK 197

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 77.8 bits (191), Expect = 3e-16
 Identities = 70/282 (24%), Positives = 128/282 (45%), Gaps = 35/282 (12%)

Query: 51  FSDANKLGEGGFGPVYKGV-LKKGDEIAVKRLS---GRSGQGLREMKNEASVIAKVQHKN 106
           F    K+G G F  VY+   L  G  +A+K++        +   +   E  ++ ++ H N
Sbjct: 4   FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 63

Query: 107 LVRLLGCCIDRDEKILIYEYMPNKSLDFFL--FDPTKRMLLD---WVTRVQIIEGIAQGL 161
           +++     I+ +E  ++ E      L   +  F   KR++ +   W   VQ+   +    
Sbjct: 64  VIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALE--- 120

Query: 162 LYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMS 221
              H +SR R++HRD+K +N+ +      K+ D G+ R        A++  +VGT  YMS
Sbjct: 121 ---HMHSR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYMS 174

Query: 222 PEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELID 281
           PE   E  ++ KSD++S G LL E+ + +     +  D +N       L++  + +E  D
Sbjct: 175 PERIHENGYNFKSDIWSLGCLLYEMAALQSP---FYGDKMN-------LYSLCKKIEQCD 224

Query: 282 --PILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSM 321
             P+  D YS  + L +  N   +C+    + RP +  V  +
Sbjct: 225 YPPLPSDHYS--EELRQLVN---MCINPDPEKRPDITYVYDV 261

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 77.7 bits (192), Expect = 3e-16
 Identities = 60/209 (28%), Positives = 93/209 (44%), Gaps = 19/209 (9%)

Query: 49  NKFSDANKLGEGGFGPVYKGVLKKGDEI-AVKRLSGRSGQ------GLREMKNEASVIAK 101
           NK+     +GEG +G V K   K   EI A+K+              LRE+K    V+ +
Sbjct: 1   NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVK----VLRQ 56

Query: 102 VQHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGL 161
           ++H+N+V L      +    L++EY+    L+  L + +   L     R   I  + Q +
Sbjct: 57  LRHENIVNLKEAFRRKGRLYLVFEYVERTLLE--LLEASPGGLPPDAVR-SYIWQLLQAI 113

Query: 162 LYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMS 221
            Y H      IIHRD+K  NIL+ +    K+ DFG AR          T   V T  Y +
Sbjct: 114 AYCH---SHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTD-YVATRWYRA 169

Query: 222 PEYALEGIFSIKS-DVFSFGVLLLEIVSG 249
           PE  +      K  DV++ G ++ E++ G
Sbjct: 170 PELLVGDTNYGKPVDVWAIGCIMAELLDG 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 77.4 bits (190), Expect = 3e-16
 Identities = 69/279 (24%), Positives = 124/279 (44%), Gaps = 35/279 (12%)

Query: 51  FSDANKLGEGGFGPVYKGV-LKKGDEIAVKRLS---GRSGQGLREMKNEASVIAKVQHKN 106
           F    K+G G F  VY+   L     +A+K++        +  ++   E  ++ ++ H N
Sbjct: 4   FQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPN 63

Query: 107 LVRLLGCCIDRDEKILIYEYMPNKSLDFFL--FDPTKRMLLD---WVTRVQIIEGIAQGL 161
           +++ L   I+ +E  ++ E      L   +  F   KR++ +   W   VQ+   +    
Sbjct: 64  VIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVE--- 120

Query: 162 LYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMS 221
              H +SR R++HRD+K +N+ +      K+ D G+ R        A++  +VGT  YMS
Sbjct: 121 ---HMHSR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYMS 174

Query: 222 PEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELID 281
           PE   E  ++ KSD++S G LL E+ + +     +  D +NL           + +E  D
Sbjct: 175 PERIHENGYNFKSDIWSLGCLLYEMAALQSP---FYGDKMNLFSLC-------QKIEQCD 224

Query: 282 --PILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDV 318
             P+  + YS K        +  +C+    D RP +  V
Sbjct: 225 YPPLPTEHYSEK-----LRELVSMCIYPDPDQRPDIGYV 258

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 77.8 bits (191), Expect = 3e-16
 Identities = 60/197 (30%), Positives = 104/197 (52%), Gaps = 13/197 (6%)

Query: 56  KLGEGGFGPVYKGVLKKGDEIAV-KRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCC 114
           +LG+G FG VYK   K+   +A  K +  +S + L +   E  ++A   H N+V+LL   
Sbjct: 12  ELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 71

Query: 115 IDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 174
              +   ++ E+    ++D  + +  +R L +   RV + +   + L YLH+    +IIH
Sbjct: 72  YYENNLWILIEFCAGGAVDAVMLE-LERPLTEPQIRV-VCKQTLEALNYLHEN---KIIH 126

Query: 175 RDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAL-----EGI 229
           RDLKA NIL   D + K++DFG++       +Q   S  +GT  +M+PE  +     +  
Sbjct: 127 RDLKAGNILFTLDGDIKLADFGVSAK-NTRTIQRRDS-FIGTPYWMAPEVVMCETSKDRP 184

Query: 230 FSIKSDVFSFGVLLLEI 246
           +  K+DV+S G+ L+E+
Sbjct: 185 YDYKADVWSLGITLIEM 201

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 77.8 bits (191), Expect = 4e-16
 Identities = 67/240 (27%), Positives = 115/240 (47%), Gaps = 31/240 (12%)

Query: 32  EVDQFPLFSFSSVSTATNKFSDANKLGEGGFGPVY--------KGVLKKGDEIAVKRLSG 83
           E+ + P + FS      +K +    LGEG FG V         K   K+   +AVK L  
Sbjct: 3   ELPEDPRWEFSR-----DKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKD 57

Query: 84  RSGQ-GLREMKNEASVIAKV-QHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFL----- 136
            + +  L ++ +E  ++  + +HKN++ LLG C       +I EY    +L  +L     
Sbjct: 58  DATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRP 117

Query: 137 ------FDPTK--RMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDM 188
                 +D  +     + +   V     +A+G+ YL   +  + IHRDL A N+L+ ++ 
Sbjct: 118 PGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYL---ASQKCIHRDLAARNVLVTENN 174

Query: 189 NPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 248
             KI+DFG+AR     +    T+       +M+PE   + +++ +SDV+SFGVL+ EI +
Sbjct: 175 VMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 77.8 bits (191), Expect = 5e-16
 Identities = 66/215 (30%), Positives = 104/215 (48%), Gaps = 26/215 (12%)

Query: 57  LGEGGFGPVY--------KGVLKKGDEIAVKRLSGR-SGQGLREMKNEASVIAKV-QHKN 106
           LGEG FG V         K    K   +AVK L    + + L ++ +E  ++  + +HKN
Sbjct: 20  LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79

Query: 107 LVRLLGCCIDRDEKILIYEYMPNKSLDFFL-----------FDPTK--RMLLDWVTRVQI 153
           ++ LLG C       ++ EY    +L  +L           FD  K     L +   V  
Sbjct: 80  IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139

Query: 154 IEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRI 213
              +A+G+ YL   +  + IHRDL A N+L+ +D   KI+DFG+AR     +    T+  
Sbjct: 140 AYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNG 196

Query: 214 VGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 248
                +M+PE   + +++ +SDV+SFGVLL EI +
Sbjct: 197 RLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 76.7 bits (189), Expect = 8e-16
 Identities = 63/226 (27%), Positives = 111/226 (49%), Gaps = 33/226 (14%)

Query: 45  STATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRL------SGRSGQGLREMKNEAS 97
               +KF    ++GEG +G VYK   K  G+ +A+K++       G     +RE+K    
Sbjct: 3   KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIK---- 58

Query: 98  VIAKVQHKNLVRLLGCCIDRDEKI----------LIYEYMPNKSLDFFLFDPTKRMLLDW 147
           ++ ++ H+N+V L     D+ + +          L++EYM     D  L    +  L+ +
Sbjct: 59  ILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYM-----DHDLMGLLESGLVHF 113

Query: 148 VTR--VQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE 205
                   ++ + +GL Y H+ +    +HRD+K SNILL+     K++DFG+AR+    E
Sbjct: 114 SEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKLADFGLARLYNSEE 170

Query: 206 LQANTSRIVGTYGYMSPEYAL-EGIFSIKSDVFSFGVLLLEIVSGK 250
            +  T++++ T  Y  PE  L E  +    DV+S G +L E+ + K
Sbjct: 171 SRPYTNKVI-TLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKK 215

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 76.0 bits (187), Expect = 8e-16
 Identities = 58/210 (27%), Positives = 101/210 (48%), Gaps = 21/210 (10%)

Query: 50  KFSDANKLGEGGFGPVYKGVLKKG---------DEIAVKRLSGRSGQGLREMKNEASVIA 100
           K+    K+GEG FG   K +L K           EI + ++S +  +   E + E +V++
Sbjct: 1   KYVKVKKIGEGSFG---KAILVKSKEDGKQYVIKEINISKMSPKERE---ESRKEVAVLS 54

Query: 101 KVQHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQG 160
            ++H N+V+      +     ++ +Y     L +   +  + +L       QI++   Q 
Sbjct: 55  NMKHPNIVQYQESFEENGNLYIVMDYCEGGDL-YKKINAQRGVLF---PEDQILDWFVQI 110

Query: 161 LLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYM 220
            L L      +I+HRD+K+ NI L KD   K+ DFG+AR+       A T   +GT  Y+
Sbjct: 111 CLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTC--IGTPYYL 168

Query: 221 SPEYALEGIFSIKSDVFSFGVLLLEIVSGK 250
           SPE      ++ KSD+++ G +L E+ + K
Sbjct: 169 SPEICENRPYNNKSDIWALGCVLYEMCTLK 198

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 75.8 bits (186), Expect = 1e-15
 Identities = 62/213 (29%), Positives = 95/213 (44%), Gaps = 29/213 (13%)

Query: 51  FSDANKLGEGGFGPV------YKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQH 104
           F     LG+GGFG V        G +    ++  KR+  R G+ +    NE  ++ KV  
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESM--ALNEKQILEKVNS 59

Query: 105 KNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFD------PTKRMLLDWVTRVQIIEGIA 158
           + +V L      +D   L+   M    L F ++          R +            I 
Sbjct: 60  RFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVF-------YAAEIC 112

Query: 159 QGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMA-RICGGNELQANTSRIVGTY 217
            GL  LHQ    RI++RDLK  NILLD   + +ISD G+A  +  G  ++      VGT 
Sbjct: 113 CGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGR----VGTV 165

Query: 218 GYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 250
           GYM+PE      ++   D ++ G LL E+++G+
Sbjct: 166 GYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQ 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 75.5 bits (185), Expect = 2e-15
 Identities = 57/206 (27%), Positives = 102/206 (49%), Gaps = 20/206 (9%)

Query: 57  LGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKV-QHKNLVRLLGCCI 115
           +G G +G VYKG   K  ++A  ++   +G    E+K E +++ K   H+N+    G  I
Sbjct: 14  VGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFI 73

Query: 116 DR------DEKILIYEYMPNKSLDFFLFDPTKRMLLD-WVTRVQIIEGIAQGLLYLHQYS 168
            +      D+  L+ E+    S+   + +     L + W+    I   I +GL +LHQ+ 
Sbjct: 74  KKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIA--YICREILRGLSHLHQH- 130

Query: 169 RVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAL-- 226
             ++IHRD+K  N+LL ++   K+ DFG++        + NT   +GT  +M+PE     
Sbjct: 131 --KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT--FIGTPYWMAPEVIACD 186

Query: 227 ---EGIFSIKSDVFSFGVLLLEIVSG 249
              +  +  KSD++S G+  +E+  G
Sbjct: 187 ENPDATYDFKSDLWSLGITAIEMAEG 212

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 75.8 bits (186), Expect = 2e-15
 Identities = 58/197 (29%), Positives = 102/197 (51%), Gaps = 12/197 (6%)

Query: 56  KLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCC 114
           K+GEG  G V    +K  G  +AVK++  R  Q    + NE  ++   QH+N+V +    
Sbjct: 27  KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 86

Query: 115 IDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 174
           +  DE  ++ E++   +L   +     RM  + +  V +   + + L  LH      +IH
Sbjct: 87  LVGDELWVVMEFLEGGALTDIV--THTRMNEEQIAAVCL--AVLKALSVLHAQG---VIH 139

Query: 175 RDLKASNILLDKDMNPKISDFGM-ARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIK 233
           RD+K+ +ILL  D   K+SDFG  A++    E+    S +VGT  +M+PE      +  +
Sbjct: 140 RDIKSDSILLTHDGRVKLSDFGFCAQV--SKEVPRRKS-LVGTPYWMAPELISRLPYGPE 196

Query: 234 SDVFSFGVLLLEIVSGK 250
            D++S G++++E+V G+
Sbjct: 197 VDIWSLGIMVIEMVDGE 213

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 74.8 bits (184), Expect = 3e-15
 Identities = 62/204 (30%), Positives = 102/204 (50%), Gaps = 21/204 (10%)

Query: 57  LGEGGFGPVYKGVLKKGDEI----AVKRLSGRSG-QGLREMKNEASVIAKVQHKNLVRLL 111
           +G+G FG VY G L   D      AVK L+  +  + + +   E  ++    H N++ LL
Sbjct: 3   IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62

Query: 112 GCCIDRD-EKILIYEYMPNKSLDFFLFD----PTKRMLLDWVTRVQIIEGIAQGLLYLHQ 166
           G C+  +   +++  YM +  L  F+      PT + L+ +  +V      A+G+ YL  
Sbjct: 63  GICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQV------AKGMEYLAS 116

Query: 167 YSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQA--NTSRIVGTYGYMSPEY 224
               + +HRDL A N +LD+    K++DFG+AR     E  +  N +       +M+ E 
Sbjct: 117 K---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALES 173

Query: 225 ALEGIFSIKSDVFSFGVLLLEIVS 248
                F+ KSDV+SFGVLL E+++
Sbjct: 174 LQTQKFTTKSDVWSFGVLLWELMT 197

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 74.2 bits (182), Expect = 5e-15
 Identities = 57/201 (28%), Positives = 98/201 (48%), Gaps = 17/201 (8%)

Query: 57  LGEGGFGPV------YKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRL 110
           LG+GGFG V        G +    ++  KRL  +SG+ +  ++ E  ++ KV    +V L
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKE--ILEKVNSPFIVNL 58

Query: 111 LGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRV 170
                 +    L+   M    L + +++  +R L +    +     I  G+L+LH    +
Sbjct: 59  AYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGL-EMERVIHYSAQITCGILHLHS---M 114

Query: 171 RIIHRDLKASNILLDKDMNPKISDFGMA-RICGGNELQANTSRIVGTYGYMSPEYALEGI 229
            I++RD+K  N+LLD   N ++SD G+A  +  G       ++  GT GYM+PE   E  
Sbjct: 115 DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK----TITQRAGTNGYMAPEILKEEP 170

Query: 230 FSIKSDVFSFGVLLLEIVSGK 250
           +S   D F+ G  + E+V+G+
Sbjct: 171 YSYPVDWFAMGCSIYEMVAGR 191

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 73.7 bits (181), Expect = 6e-15
 Identities = 75/288 (26%), Positives = 135/288 (46%), Gaps = 46/288 (15%)

Query: 57  LGEGGFGPVYKGVLKK---GDEIAVKRLSGRS---GQGLRE-------MKNEASVIAK-V 102
           LG G FG VYK V KK    + +A+K ++  +   G+  RE       + +E ++I + +
Sbjct: 8   LGSGAFGCVYK-VRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQL 66

Query: 103 QHKNLVRLLGCCIDRDEKILIYEYMPNKSL-DFFLFDPTKRMLLD----WVTRVQIIEGI 157
           +H N+VR     ++ D   ++ + +    L + F     K+        W   VQ++   
Sbjct: 67  RHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMV--- 123

Query: 158 AQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTY 217
              L YLH+  R  I+HRDL  +NI+L +D    I+DFG+A+           + +VGT 
Sbjct: 124 -LALRYLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPES---KLTSVVGTI 177

Query: 218 GYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTL 277
            Y  PE      +  K+DV++FG +L ++ +       Y T+ L+L         + + +
Sbjct: 178 LYSCPEIVKNEPYGEKADVWAFGCILYQMCT--LQPPFYSTNMLSL---------ATKIV 226

Query: 278 E-LIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTN 324
           E + +P+ E  YS     +  +     C+   A+ RP +  V +M+++
Sbjct: 227 EAVYEPLPEGMYSEDVTDVITS-----CLTPDAEARPDIIQVSAMISD 269

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 73.0 bits (179), Expect = 1e-14
 Identities = 61/204 (29%), Positives = 101/204 (49%), Gaps = 25/204 (12%)

Query: 57  LGEGGFGPVYKGVLKKGDE----IAVKRL-SGRSGQGLREMKNEASVIAKVQHKNLVRLL 111
           LG G FG + +G LK   +    +A+  L +G S +  R    EA  + +  H N+VRL 
Sbjct: 13  LGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLE 72

Query: 112 GCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVR 171
           G     +  +++ EYM N +LD FL     +++   +  + ++ G+A G+ YL   S + 
Sbjct: 73  GVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQL--MGMLPGLASGMKYL---SEMG 127

Query: 172 IIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR-IVGTYG------YMSPEY 224
            +H+ L A  +L++ D+  KIS F          LQ + S  I  T        + +PE 
Sbjct: 128 YVHKGLAAHKVLVNSDLVCKISGFR--------RLQEDKSEAIYTTMSGKSPVLWAAPEA 179

Query: 225 ALEGIFSIKSDVFSFGVLLLEIVS 248
                FS  SDV+SFG+++ E++S
Sbjct: 180 IQYHHFSSASDVWSFGIVMWEVMS 203

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 72.9 bits (179), Expect = 1e-14
 Identities = 62/207 (29%), Positives = 94/207 (45%), Gaps = 29/207 (14%)

Query: 57  LGEGGFGPV------YKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRL 110
           LG+GGFG V        G +    ++  KR+  R G+ +    NE  ++ KV  + +V L
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAM--ALNEKQILEKVNSRFVVSL 65

Query: 111 LGCCIDRDEKILIYEYMPNKSLDFFLFD------PTKRMLLDWVTRVQIIEGIAQGLLYL 164
                 +D   L+   M    L F +++        +R +            I  GL  L
Sbjct: 66  AYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVF-------YAAEITCGLEDL 118

Query: 165 HQYSRVRIIHRDLKASNILLDKDMNPKISDFGMA-RICGGNELQANTSRIVGTYGYMSPE 223
           H   R RI++RDLK  NILLD   + +ISD G+A  I  G  ++      VGT GYM+PE
Sbjct: 119 H---RERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGR----VGTVGYMAPE 171

Query: 224 YALEGIFSIKSDVFSFGVLLLEIVSGK 250
                 ++   D +  G L+ E++ GK
Sbjct: 172 VVKNERYTFSPDWWGLGCLIYEMIEGK 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 73.2 bits (180), Expect = 1e-14
 Identities = 58/207 (28%), Positives = 98/207 (47%), Gaps = 33/207 (15%)

Query: 57  LGEGGFGPVYKGVLKKGDE-IAVKRLSGRSGQGLRE---MKNEASVIAKVQHKNLVRLLG 112
           +G G FG V+    +  +   A+K ++      L++   + NE  V+ +V H  ++RL  
Sbjct: 9   VGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLF- 67

Query: 113 CCIDRDEKIL--IYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRV 170
              + D++ L  + EY+P   L  F +        +        E I   L YLH     
Sbjct: 68  -WTEHDQRFLYMLMEYVPGGEL--FSYLRNSGRFSNSTGLFYASE-IVCALEYLHSKE-- 121

Query: 171 RIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIF 230
            I++RDLK  NILLDK+ + K++DFG A+     +L+  T  + GT  Y++PE       
Sbjct: 122 -IVYRDLKPENILLDKEGHIKLTDFGFAK-----KLRDRTWTLCGTPEYLAPE------- 168

Query: 231 SIKS-------DVFSFGVLLLEIVSGK 250
            I+S       D ++ G+L+ E++ G 
Sbjct: 169 VIQSKGHNKAVDWWALGILIYEMLVGY 195

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 73.2 bits (180), Expect = 1e-14
 Identities = 60/202 (29%), Positives = 104/202 (51%), Gaps = 23/202 (11%)

Query: 57  LGEGGFGPVYKGVLKKGDEIAVKRL-------SGRSGQGLREMKNEASVIAKVQHKNLVR 109
           LG G  G V K + +    I  ++L       + R+ Q +RE+K    V+ +     +V 
Sbjct: 9   LGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRN-QIIRELK----VLHECNSPYIVG 63

Query: 110 LLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSR 169
             G      E  +  E+M   SLD  L     R+  + + ++ I   + +GL YL +  +
Sbjct: 64  FYGAFYSDGEISICMEHMDGGSLDQVL-KKAGRIPENILGKISI--AVLRGLTYLRE--K 118

Query: 170 VRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGI 229
            +I+HRD+K SNIL++     K+ DFG++    G  + +  +  VGT  YMSPE  L+G 
Sbjct: 119 HKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRSYMSPE-RLQGT 173

Query: 230 -FSIKSDVFSFGVLLLEIVSGK 250
            ++++SD++S G+ L+E+  G+
Sbjct: 174 HYTVQSDIWSLGLSLVEMAIGR 195

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 72.3 bits (177), Expect = 1e-14
 Identities = 61/212 (28%), Positives = 99/212 (46%), Gaps = 24/212 (11%)

Query: 50  KFSDANKLGEGGFGPVYKGVLKKGDEIAVKR---LSGRSGQGLREMKNEASVIAKVQHKN 106
           ++    K+GEG FG +Y    K   E  V +   L+    +     K E  ++AK++H N
Sbjct: 1   RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPN 60

Query: 107 LVRLLGCCIDRDEKILIYEYMPNKSL-------DFFLFDPTKRMLLDWVTRVQIIEGIAQ 159
           +V       +     ++ EY     L          LF   +  +L W  +      I+ 
Sbjct: 61  IVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQ--ILSWFVQ------ISL 112

Query: 160 GLLYLHQYSRVRIIHRDLKASNILLDKD-MNPKISDFGMARICGGNELQANTSRIVGTYG 218
           GL ++H     +I+HRD+K+ NI L K+ M  K+ DFG+AR    +   A T   VGT  
Sbjct: 113 GLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTC--VGTPY 167

Query: 219 YMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 250
           Y+SPE      ++ K+D++S G +L E+ + K
Sbjct: 168 YLSPEICQNRPYNNKTDIWSLGCVLYELCTLK 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 73.1 bits (179), Expect = 1e-14
 Identities = 57/197 (28%), Positives = 102/197 (51%), Gaps = 12/197 (6%)

Query: 56  KLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCC 114
           K+GEG  G V     K  G ++AVK++  R  Q    + NE  ++    H+N+V +    
Sbjct: 29  KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSY 88

Query: 115 IDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 174
           +  DE  ++ E++   +L   +     RM  + +  V +   + + L YLH      +IH
Sbjct: 89  LVGDELWVVMEFLEGGALTDIV--THTRMNEEQIATVCL--SVLRALSYLHNQG---VIH 141

Query: 175 RDLKASNILLDKDMNPKISDFGM-ARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIK 233
           RD+K+ +ILL  D   K+SDFG  A++    E+    S +VGT  +M+PE      +  +
Sbjct: 142 RDIKSDSILLTSDGRIKLSDFGFCAQV--SKEVPKRKS-LVGTPYWMAPEVISRLPYGTE 198

Query: 234 SDVFSFGVLLLEIVSGK 250
            D++S G++++E++ G+
Sbjct: 199 VDIWSLGIMVIEMIDGE 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 72.8 bits (178), Expect = 1e-14
 Identities = 55/203 (27%), Positives = 101/203 (49%), Gaps = 18/203 (8%)

Query: 51  FSDANKLGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVR 109
           F    ++G G +G VYK   +  G+  A+K +    G+    ++ E  ++   +H N+V 
Sbjct: 11  FELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVA 70

Query: 110 LLGCCIDRDEKILIYEYMPNKSLD--FFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQY 167
             G  + RD+  +  E+    SL   + +  P     + +V+R  +     QGL YLH  
Sbjct: 71  YFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETL-----QGLYYLHSK 125

Query: 168 SRVRIIHRDLKASNILLDKDMNPKISDFGM-ARICGGNELQANTSRIVGTYGYMSPEYAL 226
            +   +HRD+K +NILL  + + K++DFG+ A+I       A     +GT  +M+PE A 
Sbjct: 126 GK---MHRDIKGANILLTDNGHVKLADFGVSAQI---TATIAKRKSFIGTPYWMAPEVAA 179

Query: 227 ---EGIFSIKSDVFSFGVLLLEI 246
              +G ++   D+++ G+  +E+
Sbjct: 180 VERKGGYNQLCDIWAVGITAIEL 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 72.7 bits (178), Expect = 2e-14
 Identities = 59/207 (28%), Positives = 94/207 (45%), Gaps = 17/207 (8%)

Query: 51  FSDANKLGEGGFGPV------YKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQH 104
           F     LG+GGFG V        G +     +  KR+  R G+ +    NE  ++ KV  
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESM--ALNEKQILEKVNS 59

Query: 105 KNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYL 164
           + +V L      +D   L+   M    L F +++       +        E I  GL  L
Sbjct: 60  QFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAE-ILCGLEDL 118

Query: 165 HQYSRVRIIHRDLKASNILLDKDMNPKISDFGMA-RICGGNELQANTSRIVGTYGYMSPE 223
           H+ +    ++RDLK  NILLD   + +ISD G+A +I  G  ++      VGT GYM+PE
Sbjct: 119 HREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGR----VGTVGYMAPE 171

Query: 224 YALEGIFSIKSDVFSFGVLLLEIVSGK 250
                 +++  D +  G L+ E++ G+
Sbjct: 172 VLNNQRYTLSPDYWGLGCLIYEMIEGQ 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 72.4 bits (177), Expect = 2e-14
 Identities = 55/197 (27%), Positives = 97/197 (49%), Gaps = 16/197 (8%)

Query: 56  KLGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCC 114
           ++G G +G VYK   L  G+  AVK +    G     ++ E  ++ + +H N+V   G  
Sbjct: 16  RVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSY 75

Query: 115 IDRDEKILIYEYMPNKSLD--FFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRI 172
           + R++  +  EY    SL   + +  P   + + +V R  +     QGL YLH   +   
Sbjct: 76  LSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETL-----QGLAYLHSKGK--- 127

Query: 173 IHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAL---EGI 229
           +HRD+K +NILL  + + K++DFG+A         A     +GT  +M+PE A     G 
Sbjct: 128 MHRDIKGANILLTDNGDVKLADFGVAAKITAT--IAKRKSFIGTPYWMAPEVAAVEKNGG 185

Query: 230 FSIKSDVFSFGVLLLEI 246
           ++   D+++ G+  +E+
Sbjct: 186 YNQLCDIWAVGITAIEL 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 72.8 bits (179), Expect = 2e-14
 Identities = 65/221 (29%), Positives = 103/221 (46%), Gaps = 44/221 (19%)

Query: 51  FSDANKLGEGGFGPVYKGVLKKGDEI-AVKRL------SGRSGQGLREMKNEASVIAKVQ 103
           F   N++GEG +G VY+       EI A+K++       G     LRE+    +++  ++
Sbjct: 9   FEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREI----TLLLNLR 64

Query: 104 HKNLVRLLGCCIDR--DEKILIYEY-----------MPNKSLDFFLFDPTKRMLLDWVTR 150
           H N+V L    + +  D   L+ EY           MP      F     K ++L     
Sbjct: 65  HPNIVELKEVVVGKHLDSIFLVMEYCEQDLASLLDNMPTP----FSESQVKCLML----- 115

Query: 151 VQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANT 210
            Q++ G+     YLH+     IIHRDLK SN+LL      KI+DFG+AR   G   +  T
Sbjct: 116 -QLLRGLQ----YLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTY-GLPAKPMT 166

Query: 211 SRIVGTYGYMSPEYALEGIFSIKS-DVFSFGVLLLEIVSGK 250
            ++V T  Y +PE  L       + D+++ G +L E+++ K
Sbjct: 167 PKVV-TLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHK 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 71.9 bits (176), Expect = 3e-14
 Identities = 56/207 (27%), Positives = 102/207 (49%), Gaps = 21/207 (10%)

Query: 56  KLGEGGFGPVYKGV-LKKGDEIAVKRL---SGRSGQGLREMKNEASVIAKVQ---HKNLV 108
           ++G G +G VYK      G  +A+K +   +   G  L  ++ E +++ +++   H N+V
Sbjct: 7   EIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVR-EVALLKRLEAFDHPNIV 65

Query: 109 RLLGCC----IDRDEKI-LIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLY 163
           RL+  C     DR+ K+ L++E++      +    P   +  + +    ++    +GL +
Sbjct: 66  RLMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIK--DLMRQFLRGLDF 123

Query: 164 LHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE 223
           LH      I+HRDLK  NIL+      K++DFG+ARI      Q   + +V T  Y +PE
Sbjct: 124 LHAN---CIVHRDLKPENILVTSGGQVKLADFGLARI---YSCQMALTPVVVTLWYRAPE 177

Query: 224 YALEGIFSIKSDVFSFGVLLLEIVSGK 250
             L+  ++   D++S G +  E+   K
Sbjct: 178 VLLQSTYATPVDMWSVGCIFAEMFRRK 204

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 71.7 bits (176), Expect = 4e-14
 Identities = 59/209 (28%), Positives = 102/209 (48%), Gaps = 28/209 (13%)

Query: 57  LGEGGFGPVYKGVLKKGDEI-AVKRLSGRSGQGLREMK---NEASVIAKVQH-KNLVRLL 111
           LG G +G V K        I AVKR+  R+    +E K    +  +  +       V   
Sbjct: 9   LGRGAYGVVDKMRHVPTGTIMAVKRI--RATVNSQEQKRLLMDLDISMRSVDCPYTVTFY 66

Query: 112 GCCIDRDEKILIYEYMPNKSLDFF---LFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYS 168
           G      +  +  E M + SLD F   ++D    +  D + ++ +   I + L YLH  S
Sbjct: 67  GALFREGDVWICMEVM-DTSLDKFYKKVYDKGLTIPEDILGKIAV--SIVKALEYLH--S 121

Query: 169 RVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIV--GTYGYMSPE--- 223
           ++ +IHRD+K SN+L++++   K+ DFG   I G   L  + ++ +  G   YM+PE   
Sbjct: 122 KLSVIHRDVKPSNVLINRNGQVKLCDFG---ISG--YLVDSVAKTIDAGCKPYMAPERIN 176

Query: 224 --YALEGIFSIKSDVFSFGVLLLEIVSGK 250
                +G + +KSDV+S G+ ++E+ +G+
Sbjct: 177 PELNQKG-YDVKSDVWSLGITMIELATGR 204

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 71.5 bits (175), Expect = 5e-14
 Identities = 63/207 (30%), Positives = 94/207 (45%), Gaps = 31/207 (14%)

Query: 57  LGEGGFGPVYKGVLKKGDEI-AVKRLSGRSGQGLREMKNEASVIAK------VQHKNLVR 109
           LG+G FG V    LK+   + AVK L  +    L++   E ++  K        H  L +
Sbjct: 3   LGKGSFGKVMLARLKESGRLYAVKVL--KKDVILQDDDVECTMTEKRILSLARNHPFLTQ 60

Query: 110 LLGCCIDRDEKILIYEYMPNKSLDFFL-----FDPTKRMLLDWVTRVQIIEGIAQGLLYL 164
           L  C    D    + E++    L F +     FD  +        R    E I   L++L
Sbjct: 61  LYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEAR-------ARFYAAE-ITSALMFL 112

Query: 165 HQYSRVRIIHRDLKASNILLDKDMNPKISDFGMAR--ICGGNELQANTSRIVGTYGYMSP 222
           H      II+RDLK  N+LLD + + K++DFGM +  I  G      TS   GT  Y++P
Sbjct: 113 HDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG----KTTSTFCGTPDYIAP 165

Query: 223 EYALEGIFSIKSDVFSFGVLLLEIVSG 249
           E   E ++    D ++ GVLL E++ G
Sbjct: 166 EILQEMLYGPSVDWWAMGVLLYEMLCG 192

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 71.4 bits (175), Expect = 6e-14
 Identities = 63/222 (28%), Positives = 103/222 (46%), Gaps = 32/222 (14%)

Query: 41  FSSVSTATNKFSDANKLGEGGFGPVYKGV-LKKGDEIAVKRL------SGRSGQGLREMK 93
           F +V   TN++ D   +G G FG V        G  +A+K++         + +  RE+K
Sbjct: 2   FGTVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELK 61

Query: 94  NEASVIAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQI 153
               ++  ++H+N++ L    I   E I     +    L   L   T R L       Q 
Sbjct: 62  ----LLKHLRHENIISLSDIFISPLEDIYFVTELLGTDLHRLL---TSRPLEK-----QF 109

Query: 154 IE----GIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQAN 209
           I+     I +GL Y+H      ++HRDLK SNIL++++ + KI DFG+ARI         
Sbjct: 110 IQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARI-----QDPQ 161

Query: 210 TSRIVGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGK 250
            +  V T  Y +PE  L    + ++ D++S G +  E++ GK
Sbjct: 162 MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 71.2 bits (174), Expect = 6e-14
 Identities = 58/207 (28%), Positives = 105/207 (50%), Gaps = 11/207 (5%)

Query: 47  ATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSGQGLR-EMKNEASVIAKVQH 104
           A   + +  KLGEG +  VYKG+ +  G  +A+K +S ++ +G+      EAS++  ++H
Sbjct: 3   AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKH 62

Query: 105 KNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYL 164
            N+V L      ++    ++EYM      + +  P    L  +  R+ + + + +GL Y+
Sbjct: 63  ANIVLLHDIIHTKETLTFVFEYMHTDLAQYMIQHPGG--LHPYNVRLFMFQ-LLRGLAYI 119

Query: 165 HQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY 224
           H      I+HRDLK  N+L+      K++DFG+AR       Q  +S +V T  Y  P+ 
Sbjct: 120 H---GQHILHRDLKPQNLLISYLGELKLADFGLAR-AKSIPSQTYSSEVV-TLWYRPPDV 174

Query: 225 ALEGI-FSIKSDVFSFGVLLLEIVSGK 250
            L    +S   D++  G + +E++ G+
Sbjct: 175 LLGATDYSSALDIWGAGCIFIEMLQGQ 201

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 71.6 bits (176), Expect = 6e-14
 Identities = 59/224 (26%), Positives = 102/224 (45%), Gaps = 47/224 (20%)

Query: 49  NKFSDANKLGEGGFGPVYKGVLKKGDE-IAVKRLSGRSGQGL-------REMKNEASVIA 100
           +++ + + +G G +G V      K    +A+K+LS R  Q         RE++    ++ 
Sbjct: 15  DRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLS-RPFQSAIHAKRTYRELR----LLK 69

Query: 101 KVQHKNLVRLLGCCIDRDEKILIYEYMPNKSL----DFFLFDPTKRMLLDWVTRVQ---- 152
            + H+N++ LL              + P  SL    D +L        L+ + + Q    
Sbjct: 70  HMDHENVIGLLDV------------FTPASSLEDFQDVYLVTHLMGADLNNIVKCQKLSD 117

Query: 153 -----IIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQ 207
                ++  I +GL Y+H      IIHRDLK SNI +++D   KI DFG+AR        
Sbjct: 118 DHIQFLVYQILRGLKYIHS---AGIIHRDLKPSNIAVNEDCELKILDFGLARHT-----D 169

Query: 208 ANTSRIVGTYGYMSPEYALEGIFSIKS-DVFSFGVLLLEIVSGK 250
              +  V T  Y +PE  L  +   ++ D++S G ++ E+++GK
Sbjct: 170 DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 70.9 bits (174), Expect = 6e-14
 Identities = 57/208 (27%), Positives = 107/208 (51%), Gaps = 20/208 (9%)

Query: 50  KFSDANKLGEGGFGPVYKGVLKKGDEI-AVKRLS------GRSGQGLREMKNEASVIAKV 102
           K+    K+GEG +G V+K   ++  EI A+KR+       G     LRE+     ++ ++
Sbjct: 1   KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREI----CLLKEL 56

Query: 103 QHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLL 162
           +HKN+VRL        +  L++EY  ++ L  + FD +    +D       +  + +GL 
Sbjct: 57  KHKNIVRLYDVLHSDKKLTLVFEYC-DQDLKKY-FD-SCNGDIDPEIVKSFMFQLLKGLA 113

Query: 163 YLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSP 222
           + H +    ++HRDLK  N+L++K+   K++DFG+AR   G  ++  ++ +V T  Y  P
Sbjct: 114 FCHSH---NVLHRDLKPQNLLINKNGELKLADFGLAR-AFGIPVRCYSAEVV-TLWYRPP 168

Query: 223 EYALEG-IFSIKSDVFSFGVLLLEIVSG 249
           +      ++S   D++S G +  E+ + 
Sbjct: 169 DVLFGAKLYSTSIDMWSAGCIFAELANA 196

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 71.2 bits (174), Expect = 9e-14
 Identities = 65/202 (32%), Positives = 94/202 (46%), Gaps = 19/202 (9%)

Query: 57  LGEGGFGPVYKGVLKKGDE-IAVKRLSGRSGQGLREMKNEASVIAKV------QHKNLVR 109
           LG+G FG V+   LK  ++  A+K L  +    L +   E +++ K       +H  L  
Sbjct: 3   LGKGSFGKVFLAELKGTNQFFAIKAL--KKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 60

Query: 110 LLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSR 169
           L      ++    + EY+    L F +    K    D          I  GL +LH    
Sbjct: 61  LYCTFQTKENLFFVMEYLNGGDLMFHIQSCHK---FDLPRATFYAAEIICGLQFLHSKG- 116

Query: 170 VRIIHRDLKASNILLDKDMNPKISDFGMARICGGNEL-QANTSRIVGTYGYMSPEYALEG 228
             I++RDLK  NILLD D + KI+DFGM   C  N L  A T    GT  Y++PE  L  
Sbjct: 117 --IVYRDLKLDNILLDTDGHIKIADFGM---CKENMLGDAKTCTFCGTPDYIAPEILLGQ 171

Query: 229 IFSIKSDVFSFGVLLLEIVSGK 250
            ++   D +SFGVLL E++ G+
Sbjct: 172 KYNTSVDWWSFGVLLYEMLIGQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 70.0 bits (171), Expect = 1e-13
 Identities = 59/201 (29%), Positives = 93/201 (46%), Gaps = 17/201 (8%)

Query: 57  LGEGGFGPV------YKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRL 110
           LG+GGFG V        G +    ++  KR+  R G+ +    NE  ++ KV  + +V L
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAM--ALNEKRILEKVNSRFVVSL 65

Query: 111 LGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRV 170
                 +D   L+   M    L F +++       D    +     +  GL  L    R 
Sbjct: 66  AYAYETKDALCLVLTIMNGGDLKFHIYN-MGNPGFDEQRAIFYAAELCCGLEDLQ---RE 121

Query: 171 RIIHRDLKASNILLDKDMNPKISDFGMA-RICGGNELQANTSRIVGTYGYMSPEYALEGI 229
           RI++RDLK  NILLD   + +ISD G+A +I  G  ++      VGT GYM+PE      
Sbjct: 122 RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGR----VGTVGYMAPEVINNEK 177

Query: 230 FSIKSDVFSFGVLLLEIVSGK 250
           ++   D +  G L+ E++ G+
Sbjct: 178 YTFSPDWWGLGCLIYEMIQGQ 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 70.5 bits (172), Expect = 1e-13
 Identities = 61/206 (29%), Positives = 102/206 (49%), Gaps = 19/206 (9%)

Query: 51  FSDANKLGEGGFGPVYKGVLKKGDEIAVKRL------SGRSGQGLREMKNEASVIAKVQH 104
           F   ++LG G  G V K   K    I  ++L           Q +RE++    V+ +   
Sbjct: 7   FERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQ----VLHECNS 62

Query: 105 KNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYL 164
             +V   G      E  +  E+M   SLD  L +  KR+  + + +V I   + +GL YL
Sbjct: 63  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKE-AKRIPEEILGKVSI--AVLRGLAYL 119

Query: 165 HQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY 224
            +  + +I+HRD+K SNIL++     K+ DFG++    G  + +  +  VGT  YMSPE 
Sbjct: 120 RE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRSYMSPER 173

Query: 225 ALEGIFSIKSDVFSFGVLLLEIVSGK 250
                +S++SD++S G+ L+E+  G+
Sbjct: 174 LQGTHYSVQSDIWSMGLSLVELAIGR 199

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 69.5 bits (170), Expect = 2e-13
 Identities = 66/282 (23%), Positives = 113/282 (40%), Gaps = 27/282 (9%)

Query: 55  NKLGEGGFGPVYKGVLKKGDEIA---VKRLSGRSG-QGLREMKNEASVIAKVQHKNLVRL 110
           +++G G FG V  G   +G   A   VK L   +          E     ++ H N+++ 
Sbjct: 1   DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQC 60

Query: 111 LGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQ--IIEGIAQGLLYLHQYS 168
           LG CI+    +L+ E+ P   L  +L      +       V   +   +A GLL+LHQ  
Sbjct: 61  LGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ-- 118

Query: 169 RVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEG 228
               IH DL   N  L  D++ KI D+G+A      +             +++PE     
Sbjct: 119 -ADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIR 177

Query: 229 IFSI-------KSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELID 281
              +       KS+++S GV + E+ +         +D   +L          + ++L  
Sbjct: 178 GQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSD-EQVLKQV----VREQDIKLPK 232

Query: 282 PILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLT 323
           P L+ +YS      R+  +   C  +  + RPT  +V  +LT
Sbjct: 233 PQLDLKYSD-----RWYEVMQFCWLDP-ETRPTAEEVHELLT 268

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 70.2 bits (172), Expect = 2e-13
 Identities = 56/234 (23%), Positives = 104/234 (44%), Gaps = 55/234 (23%)

Query: 55  NKLGEGGFGPVYKGV-LKKGDEIAVKRL------SGRSGQG------------LREMKNE 95
             LGEG +G V K      G  +A+K++      +  +               LRE+K  
Sbjct: 15  AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELK-- 72

Query: 96  ASVIAKVQHKNLVRLLGCCIDRDEKILIYEYMPN---KSLD--FFLFDPTKRMLLDWVTR 150
             ++ +++H+N++ L+   ++ D   L+ + M +   K +D    L +   + +L     
Sbjct: 73  --IMNEIKHENIMGLVDVYVEGDFINLVMDIMASDLKKVVDRKIRLTESQVKCIL----- 125

Query: 151 VQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQAN- 209
           +QI+ G+      LH++     +HRDL  +NI ++     KI+DFG+AR  G        
Sbjct: 126 LQILNGLNV----LHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTL 178

Query: 210 ------------TSRIVGTYGYMSPEYAL-EGIFSIKSDVFSFGVLLLEIVSGK 250
                       TS++V T  Y +PE  +    +    D++S G +  E+++GK
Sbjct: 179 SKDETMQRREEMTSKVV-TLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231

Length = 335

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 69.8 bits (171), Expect = 3e-13
 Identities = 38/95 (40%), Positives = 55/95 (57%), Gaps = 7/95 (7%)

Query: 157 IAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR-IVG 215
           IA GL +LH      II+RDLK  N++LD + + KI+DFGM   C  N     T+R   G
Sbjct: 110 IAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGM---CKENIFGGKTTRTFCG 163

Query: 216 TYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 250
           T  Y++PE      +    D ++FGVLL E+++G+
Sbjct: 164 TPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 198

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 69.1 bits (169), Expect = 3e-13
 Identities = 52/196 (26%), Positives = 93/196 (47%), Gaps = 16/196 (8%)

Query: 57  LGEGGFGPVYKG-VLKKGDEIAVKRLSGRSGQGL-REMKNEASVIAKVQHKNLVRLLGCC 114
           LG G  G VYK   L     +AVK +       L +++ +E  ++ K     ++   G  
Sbjct: 9   LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAF 68

Query: 115 IDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 174
              +   +  E+M   SLD +     +++    + R+ +   + +GL YL     ++I+H
Sbjct: 69  FVENRISICTEFMDGGSLDVY-----RKIPEHVLGRIAV--AVVKGLTYLWS---LKILH 118

Query: 175 RDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKS 234
           RD+K SN+L++     K+ DFG++       + +     VGT  YM+PE      + I S
Sbjct: 119 RDVKPSNMLVNTRGQVKLCDFGVST----QLVNSIAKTYVGTNAYMAPERISGEQYGIHS 174

Query: 235 DVFSFGVLLLEIVSGK 250
           DV+S G+  +E+  G+
Sbjct: 175 DVWSLGISFMELALGR 190

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 69.4 bits (170), Expect = 3e-13
 Identities = 40/94 (42%), Positives = 57/94 (60%), Gaps = 5/94 (5%)

Query: 157 IAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 216
           I  GL +LH+     II+RDLK  N+LLDKD + KI+DFGM +     E +A+T    GT
Sbjct: 105 IICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKAST--FCGT 159

Query: 217 YGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 250
             Y++PE      ++   D +SFGVLL E++ G+
Sbjct: 160 PDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 69.7 bits (171), Expect = 3e-13
 Identities = 67/226 (29%), Positives = 101/226 (44%), Gaps = 39/226 (17%)

Query: 43  SVSTATNKFSDANKLGEGGFGPV---YKGVLKKGDEIAVKRLSGRSGQGLREMKN---EA 96
           S  T   ++ +   +G G  G V   Y  V   G  +A+K+LS R  Q +   K    E 
Sbjct: 10  STFTVLKRYQNLKPIGSGAQGIVCAAYDTVT--GQNVAIKKLS-RPFQNVTHAKRAYREL 66

Query: 97  SVIAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFF--------LFDPTK----RML 144
            ++  V HKN++ LL              + P KSL+ F        L D       +M 
Sbjct: 67  VLMKLVNHKNIIGLLNV------------FTPQKSLEEFQDVYLVMELMDANLCQVIQMD 114

Query: 145 LDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGN 204
           LD      ++  +  G+ +LH      IIHRDLK SNI++  D   KI DFG+AR  G +
Sbjct: 115 LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 171

Query: 205 ELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 250
            +   T  +V  Y Y +PE  L   +    D++S G ++ E++ G 
Sbjct: 172 FMM--TPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMIRGT 214

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 69.3 bits (169), Expect = 4e-13
 Identities = 60/208 (28%), Positives = 101/208 (48%), Gaps = 19/208 (9%)

Query: 49  NKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRL------SGRSGQGLREMKNEASVIAKV 102
           + F   ++LG G  G V+K   K    I  ++L           Q +RE++    V+ + 
Sbjct: 5   DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQ----VLHEC 60

Query: 103 QHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLL 162
               +V   G      E  +  E+M   SLD  L     R+    + +V I   + +GL 
Sbjct: 61  NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL-KKAGRIPEQILGKVSI--AVIKGLT 117

Query: 163 YLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSP 222
           YL +  + +I+HRD+K SNIL++     K+ DFG++    G  + +  +  VGT  YMSP
Sbjct: 118 YLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRSYMSP 171

Query: 223 EYALEGIFSIKSDVFSFGVLLLEIVSGK 250
           E      +S++SD++S G+ L+E+  G+
Sbjct: 172 ERLQGTHYSVQSDIWSMGLSLVEMAIGR 199

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 68.9 bits (169), Expect = 4e-13
 Identities = 63/211 (29%), Positives = 88/211 (41%), Gaps = 38/211 (18%)

Query: 57  LGEGGFGPV----YKG--------VLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQH 104
           LG G FG V    YK          LKKGD IA   +     + L   K         +H
Sbjct: 7   LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEV-----ESLMCEKRIFETANSERH 61

Query: 105 KNLVRLLGCCIDRDEKILIYEYMPNKSL------DFFLFDPTKRMLLDWVTRVQIIEGIA 158
             LV L  C    D    + EY     L      D F      R +  +   V +     
Sbjct: 62  PFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHTDVF---SEPRAVF-YAACVVL----- 112

Query: 159 QGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG 218
            GL YLH+    +I++RDLK  N+LLD +   KI+DFG+ +   G      TS   GT  
Sbjct: 113 -GLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCK--EGMGFGDRTSTFCGTPE 166

Query: 219 YMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 249
           +++PE   E  ++   D +  GVL+ E++ G
Sbjct: 167 FLAPEVLTETSYTRAVDWWGLGVLIYEMLVG 197

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 68.7 bits (168), Expect = 5e-13
 Identities = 61/208 (29%), Positives = 100/208 (48%), Gaps = 31/208 (14%)

Query: 57  LGEGGFGPVYKGVLKKGDEI-AVKRLSGRSGQGLREMKNEASVIAK------VQHKNLVR 109
           LG+G FG V    LK  DE+ A+K L  +    L++   + ++  K       +H  L  
Sbjct: 3   LGKGSFGKVMLAELKGTDEVYAIKVL--KKDVILQDDDVDCTMTEKRILALAAKHPFLTA 60

Query: 110 LLGCCIDRDEKILIYEYMPNKSLDFFL-----FDPTKRMLLDWVTRVQIIEGIAQGLLYL 164
           L  C   +D    + EY+    L F +     FD  +       +R    E +   L++L
Sbjct: 61  LHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPR-------SRFYAAE-VTLALMFL 112

Query: 165 HQYSRVRIIHRDLKASNILLDKDMNPKISDFGMAR--ICGGNELQANTSRIVGTYGYMSP 222
           H++    +I+RDLK  NILLD + + K++DFGM +  I  G      T+   GT  Y++P
Sbjct: 113 HRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV----TTTTFCGTPDYIAP 165

Query: 223 EYALEGIFSIKSDVFSFGVLLLEIVSGK 250
           E   E  +    D ++ GVL+ E+++G+
Sbjct: 166 EILQELEYGPSVDWWALGVLMYEMMAGQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 68.9 bits (169), Expect = 5e-13
 Identities = 59/226 (26%), Positives = 103/226 (45%), Gaps = 51/226 (22%)

Query: 51  FSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSGQ-----GLREMKNEASVIAKVQH 104
           + + + +GEG +G V     K  G ++A+K++S    Q      LRE+K    ++ + +H
Sbjct: 7   YQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIK----ILRRFKH 62

Query: 105 KNLVRLLGCCIDRD-----EKILIYEYMP-------------NKSLDFFLFDPTKRMLLD 146
           +N++ +L            +  ++ E M              N  + +FL+         
Sbjct: 63  ENIIGILDIIRPPSFESFNDVYIVQELMETDLYKLIKTQHLSNDHIQYFLY--------- 113

Query: 147 WVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNEL 206
                QI+    +GL Y+H      ++HRDLK SN+LL+ + + KI DFG+ARI      
Sbjct: 114 -----QIL----RGLKYIHS---ANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHD 161

Query: 207 QANT-SRIVGTYGYMSPEYALEGIFSIKS-DVFSFGVLLLEIVSGK 250
                +  V T  Y +PE  L      K+ D++S G +L E++S +
Sbjct: 162 HTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 68.2 bits (167), Expect = 5e-13
 Identities = 54/206 (26%), Positives = 104/206 (50%), Gaps = 14/206 (6%)

Query: 49  NKFSDANKLGEGGFGPVYKGVLKKGDEI-AVKR-LSGRSGQGLREMK-NEASVIAKVQHK 105
            K+ +   +GEG +G V K   K+  +I A+K+ L     + ++++   E  ++ +++H+
Sbjct: 1   EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHE 60

Query: 106 NLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLH 165
           NLV L+     +    L++E++ +  LD     P     LD     + +  I +G+ + H
Sbjct: 61  NLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYP---NGLDESRVRKYLFQILRGIEFCH 117

Query: 166 QYSRVRIIHRDLKASNILLDKDMNPKISDFGMAR-ICGGNELQANTSRIVGTYGYMSPEY 224
            ++   IIHRD+K  NIL+ +    K+ DFG AR +    E+  +    V T  Y +PE 
Sbjct: 118 SHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTD---YVATRWYRAPEL 171

Query: 225 ALEGI-FSIKSDVFSFGVLLLEIVSG 249
            +    +    D+++ G L+ E+++G
Sbjct: 172 LVGDTKYGRAVDIWAVGCLVTEMLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 68.1 bits (166), Expect = 6e-13
 Identities = 60/210 (28%), Positives = 97/210 (46%), Gaps = 20/210 (9%)

Query: 49  NKFSDANKLGEGGFGPVYKGVLKKGDEI-AVKRLSGRSGQ------GLREMKNEASVIAK 101
           NKF     +GEG +G V K   K+  EI A+K+              LRE+K    ++  
Sbjct: 1   NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELK----MLRT 56

Query: 102 VQHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGL 161
           ++ +N+V L      R +  L++EY+    L+     P        V   ++   I Q +
Sbjct: 57  LKQENIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNG------VPPEKVRSYIYQLI 110

Query: 162 LYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMAR-ICGGNELQANTSRIVGTYGYM 220
             +H   +  I+HRD+K  N+L+  +   K+ DFG AR +  G+   AN +  V T  Y 
Sbjct: 111 KAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSN--ANYTEYVATRWYR 168

Query: 221 SPEYALEGIFSIKSDVFSFGVLLLEIVSGK 250
           SPE  L   +    D++S G +L E+  G+
Sbjct: 169 SPELLLGAPYGKAVDMWSVGCILGELSDGQ 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 67.5 bits (165), Expect = 7e-13
 Identities = 57/202 (28%), Positives = 93/202 (46%), Gaps = 31/202 (15%)

Query: 60  GGFGPVYKGVLKK---GDEIAVKRLSGRSGQGLREMKN----EASVIAKVQHKNLVRLLG 112
           G FG VY  + KK   GD  A+K L         ++ N     A ++ + +   + +L  
Sbjct: 7   GAFGSVY--LAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYY 64

Query: 113 CCIDRDEKILIYEYMPNKSLDFFLFDPTKRML----LDWVTRVQIIEGIAQGLLYLHQYS 168
               +D   L+ EY+        +     + L     DW    Q I  +  G+  LHQ  
Sbjct: 65  SFQSKDYLYLVMEYLNGGDCASLI-----KTLGGLPEDWAK--QYIAEVVLGVEDLHQRG 117

Query: 169 RVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEG 228
              IIHRD+K  N+L+D+  + K++DFG++R    N+      + VGT  Y++PE  + G
Sbjct: 118 ---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENK------KFVGTPDYLAPE-TILG 167

Query: 229 IFSIK-SDVFSFGVLLLEIVSG 249
           +   K SD +S G ++ E + G
Sbjct: 168 VGDDKMSDWWSLGCVIFEFLFG 189

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 68.1 bits (166), Expect = 8e-13
 Identities = 60/201 (29%), Positives = 101/201 (50%), Gaps = 15/201 (7%)

Query: 55  NKLGEGGFGPVYKGVLKKGDE-IAVK--RLSGRSGQGLREMKNEASVIAKVQHKNLVRLL 111
           +KLGEG +  VYKG  K  D  +A+K  RL    G     ++ E S++  ++H N+V L 
Sbjct: 12  DKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIR-EVSLLKDLKHANIVTLH 70

Query: 112 GCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVR 171
                     L++EY+ +K L  +L D    + +  V     +  + +GL Y H   R +
Sbjct: 71  DIIHTEKSLTLVFEYL-DKDLKQYLDDCGNSINMHNVK--LFLFQLLRGLNYCH---RRK 124

Query: 172 IIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANT-SRIVGTYGYMSPEYALEGI- 229
           ++HRDLK  N+L+++    K++DFG+AR      +   T S  V T  Y  P+  L    
Sbjct: 125 VLHRDLKPQNLLINERGELKLADFGLAR---AKSIPTKTYSNEVVTLWYRPPDILLGSTD 181

Query: 230 FSIKSDVFSFGVLLLEIVSGK 250
           +S + D++  G +  E+ +G+
Sbjct: 182 YSTQIDMWGVGCIFYEMSTGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 67.8 bits (166), Expect = 8e-13
 Identities = 59/210 (28%), Positives = 103/210 (49%), Gaps = 24/210 (11%)

Query: 50  KFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQ------GLREMKNEASVIAKV 102
           K+   +K+GEG +G V+K   ++ G  +A+K+              LRE++    ++ ++
Sbjct: 2   KYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIR----MLKQL 57

Query: 103 QHKNLVRLLGCCIDRDEKI-LIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGL 161
           +H NLV L+     R  K+ L++EY  +  L+    +P     +      +II    Q +
Sbjct: 58  KHPNLVNLIEV-FRRKRKLHLVFEYCDHTVLNELEKNPRG---VPEHLIKKIIWQTLQAV 113

Query: 162 LYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMS 221
            + H+++    IHRD+K  NIL+ K    K+ DFG ARI  G     + +  V T  Y +
Sbjct: 114 NFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGPG--DDYTDYVATRWYRA 168

Query: 222 PEYALEG--IFSIKSDVFSFGVLLLEIVSG 249
           PE  L G   +    DV++ G +  E+++G
Sbjct: 169 PEL-LVGDTQYGPPVDVWAIGCVFAELLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 68.0 bits (166), Expect = 9e-13
 Identities = 58/214 (27%), Positives = 106/214 (49%), Gaps = 30/214 (14%)

Query: 50  KFSDANKLGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQG---LREMKNEASVIAKVQHK 105
           +++   ++G G +G V   +  + G+++A+K+LS R  Q     +    E +++  +QH+
Sbjct: 16  RYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLS-RPFQSEIFAKRAYRELTLLKHMQHE 74

Query: 106 NLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVT-------RVQ-IIEGI 157
           N++ LL    D     +  +       DF+L  P  +  L  +        +VQ ++  +
Sbjct: 75  NVIGLL----DVFTSAVSGDEFQ----DFYLVMPYMQTDLQKIMGHPLSEDKVQYLVYQM 126

Query: 158 AQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTY 217
             GL Y+H      IIHRDLK  N+ +++D   KI DFG+AR        A  +  V T 
Sbjct: 127 LCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLAR-----HADAEMTGYVVTR 178

Query: 218 GYMSPEYALEGIFSIKS-DVFSFGVLLLEIVSGK 250
            Y +PE  L  +   ++ D++S G ++ E+++GK
Sbjct: 179 WYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGK 212

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 67.3 bits (164), Expect = 1e-12
 Identities = 58/207 (28%), Positives = 101/207 (48%), Gaps = 22/207 (10%)

Query: 57  LGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKV-QHKNLVRLLGCCI 115
           +G G +G VYKG   K  ++A  ++   +     E+K E +++ K   H+N+    G  I
Sbjct: 24  VGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFI 83

Query: 116 DR------DEKILIYEYMPNKSLDFFLFDPTKRMLL--DWVTRVQIIEGIAQGLLYLHQY 167
            +      D+  L+ E+    S+   L   TK   L  DW+    I   I +GL +LH +
Sbjct: 84  KKSPPGHDDQLWLVMEFCGAGSVTD-LVKNTKGNALKEDWIA--YICREILRGLAHLHAH 140

Query: 168 SRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAL- 226
              ++IHRD+K  N+LL ++   K+ DFG++        + NT   +GT  +M+PE    
Sbjct: 141 ---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT--FIGTPYWMAPEVIAC 195

Query: 227 ----EGIFSIKSDVFSFGVLLLEIVSG 249
               +  +  +SD++S G+  +E+  G
Sbjct: 196 DENPDATYDYRSDIWSLGITAIEMAEG 222

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 67.5 bits (165), Expect = 1e-12
 Identities = 60/225 (26%), Positives = 108/225 (48%), Gaps = 35/225 (15%)

Query: 57  LGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMK----------------NEASVIA 100
           LG+G FG V+           V++++G     L  MK                 E  ++A
Sbjct: 4   LGQGSFGKVF----------LVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILA 53

Query: 101 KVQHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQG 160
           +V H  +V+L        +  LI +++  +  D F     + M  +   +  + E +A  
Sbjct: 54  EVNHPFIVKLHYAFQTEGKLYLILDFL--RGGDLFTRLSKEVMFTEEDVKFYLAE-LALA 110

Query: 161 LLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYM 220
           L +LH    + II+RDLK  NILLD++ + K++DFG+++    +E +A +    GT  YM
Sbjct: 111 LDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCGTVEYM 165

Query: 221 SPEYALEGIFSIKSDVFSFGVLLLEIVSGK-KNTGLYRTDSLNLL 264
           +PE       +  +D +SFGVL+ E+++G     G  R +++ ++
Sbjct: 166 APEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMI 210

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 67.3 bits (164), Expect = 1e-12
 Identities = 60/201 (29%), Positives = 100/201 (49%), Gaps = 15/201 (7%)

Query: 55  NKLGEGGFGPVYKGVLKKGDE-IAVK--RLSGRSGQGLREMKNEASVIAKVQHKNLVRLL 111
            KLGEG +  V+KG  K  +  +A+K  RL    G     ++ E S++  ++H N+V L 
Sbjct: 12  EKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIR-EVSLLKDLKHANIVTLH 70

Query: 112 GCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVR 171
                     L++EY+ +K L  ++ D    M +  V     +  I +GL Y H   R +
Sbjct: 71  DIVHTDKSLTLVFEYL-DKDLKQYMDDCGNIMSMHNVK--IFLYQILRGLAYCH---RRK 124

Query: 172 IIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANT-SRIVGTYGYMSPEYAL-EGI 229
           ++HRDLK  N+L+++    K++DFG+AR      +   T S  V T  Y  P+  L    
Sbjct: 125 VLHRDLKPQNLLINERGELKLADFGLAR---AKSVPTKTYSNEVVTLWYRPPDVLLGSSE 181

Query: 230 FSIKSDVFSFGVLLLEIVSGK 250
           +S + D++  G +  E+ SG+
Sbjct: 182 YSTQIDMWGVGCIFFEMASGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 67.4 bits (164), Expect = 2e-12
 Identities = 68/239 (28%), Positives = 110/239 (46%), Gaps = 34/239 (14%)

Query: 28  SKKKEVDQFPLFSF-SSVSTATNKFSDANKLGEGGFGPV---YKGVLKKGDEIAVKRLSG 83
           S+ K  + F       S  T   ++ +   +G G  G V   Y  +L++   +A+K+LS 
Sbjct: 2   SRSKRDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILER--NVAIKKLS- 58

Query: 84  RSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFF-------- 135
                 R  +N+    AK  ++ LV L+ C   ++   L+  + P KSL+ F        
Sbjct: 59  ------RPFQNQTH--AKRAYRELV-LMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVME 109

Query: 136 LFDPTK----RMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPK 191
           L D       +M LD      ++  +  G+ +LH      IIHRDLK SNI++  D   K
Sbjct: 110 LMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLK 166

Query: 192 ISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 250
           I DFG+AR  G + +   T  +V  Y Y +PE  L   +    D++S G ++ E++ G 
Sbjct: 167 ILDFGLARTAGTSFMM--TPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 222

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 67.2 bits (165), Expect = 2e-12
 Identities = 63/236 (26%), Positives = 107/236 (45%), Gaps = 67/236 (28%)

Query: 50  KFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLS--------GRSGQGLREMKNEASVIA 100
           ++     +G G +G V   V K+ G ++A+K++S         +  + LRE+K    ++ 
Sbjct: 1   RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAK--RILREIK----LLR 54

Query: 101 KVQHKNLVRLLGCCIDRDEKI-------LIYEYMP---------NKSLD-----FFLFDP 139
            ++H+N++ LL   I R           ++ E M           + L      +FL+  
Sbjct: 55  HLRHENIIGLLD--ILRPPSPEDFNDVYIVTELMETDLHKVIKSPQPLTDDHIQYFLY-- 110

Query: 140 TKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMAR 199
                       QI+    +GL YLH      +IHRDLK SNIL++ + + KI DFG+AR
Sbjct: 111 ------------QIL----RGLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLAR 151

Query: 200 ICGGNELQAN--TSRIVGTYGYMSPEYALEGI---FSIKSDVFSFGVLLLEIVSGK 250
               +E +    T  +V T  Y +PE  L       +I  D++S G +  E+++ K
Sbjct: 152 GVDPDEDEKGFLTEYVV-TRWYRAPELLLSSSRYTKAI--DIWSVGCIFAELLTRK 204

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 67.0 bits (164), Expect = 2e-12
 Identities = 65/209 (31%), Positives = 100/209 (47%), Gaps = 31/209 (14%)

Query: 57  LGEGGFGPVYKG-VLKKGDEIAVKRLSGRSGQGLREMKN---EASVIAKVQH-KNLVRLL 111
           +G G  G VYK    K G  +AVK++  R+G    E K    +  V+ K      +V+  
Sbjct: 23  IGSGTCGQVYKMRFKKTGHVMAVKQMR-RTGNK-EENKRILMDLDVVLKSHDCPYIVKCY 80

Query: 112 GCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRV--QIIEGIAQGLLYL---HQ 166
           G  I  D  + I   + +  LD  L    KR+       +  ++   I + L YL   H 
Sbjct: 81  GYFI-TDSDVFICMELMSTCLDKLL----KRIQGPIPEDILGKMTVAIVKALHYLKEKHG 135

Query: 167 YSRVRIIHRDLKASNILLDKDMNPKISDFGMA-RICGGNELQANTSRIVGTYGYMSPEY- 224
                +IHRD+K SNILLD   N K+ DFG++ R+    + +A T R  G   YM+PE  
Sbjct: 136 -----VIHRDVKPSNILLDASGNVKLCDFGISGRLV---DSKAKT-RSAGCAAYMAPERI 186

Query: 225 ---ALEGIFSIKSDVFSFGVLLLEIVSGK 250
                   + I++DV+S G+ L+E+ +G+
Sbjct: 187 DPPDPNPKYDIRADVWSLGISLVELATGQ 215

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 66.9 bits (163), Expect = 2e-12
 Identities = 63/202 (31%), Positives = 94/202 (46%), Gaps = 19/202 (9%)

Query: 57  LGEGGFGPVYKGVLK-KGDEIAVKRLSGRSGQGLREMKNEASVIAK------VQHKNLVR 109
           LG+G FG V    LK KG+  AVK L  +    L +   E +++ K       ++  L  
Sbjct: 3   LGKGSFGKVLLAELKGKGEYFAVKAL--KKDVVLIDDDVECTMVEKRVLALAWENPFLTH 60

Query: 110 LLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSR 169
           L      ++    + E++    L F + D  +    D          I  GL +LH    
Sbjct: 61  LYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGR---FDLYRATFYAAEIVCGLQFLHSKG- 116

Query: 170 VRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQAN-TSRIVGTYGYMSPEYALEG 228
             II+RDLK  N++LD+D + KI+DFGM   C  N    N  S   GT  Y++PE     
Sbjct: 117 --IIYRDLKLDNVMLDRDGHIKIADFGM---CKENVFGDNRASTFCGTPDYIAPEILQGL 171

Query: 229 IFSIKSDVFSFGVLLLEIVSGK 250
            ++   D +SFGVLL E++ G+
Sbjct: 172 KYTFSVDWWSFGVLLYEMLIGQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 65.8 bits (160), Expect = 4e-12
 Identities = 65/225 (28%), Positives = 103/225 (45%), Gaps = 19/225 (8%)

Query: 38  LFSFSSVSTATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLREMKNEA 96
           +    S+   T+ +     +G+G +G VYK   KK G   AVK L   S     E++ E 
Sbjct: 11  MLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVD-EEIEAEY 69

Query: 97  SVIAKV-QHKNLVRLLGCCIDRDEKI-----LIYEYMPNKSLDFFLFDPTKR-MLLDWVT 149
           +++  +  H N+V+  G     D+ +     L+ E     S+   +         LD   
Sbjct: 70  NILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAM 129

Query: 150 RVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQAN 209
              I+ G   GL +LH     RIIHRD+K +NILL  +   K+ DFG++       L+ N
Sbjct: 130 ISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRN 186

Query: 210 TSRIVGTYGYMSPEY-----ALEGIFSIKSDVFSFGVLLLEIVSG 249
           TS  VGT  +M+PE        +  +  + DV+S G+  +E+  G
Sbjct: 187 TS--VGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDG 229

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 65.6 bits (160), Expect = 4e-12
 Identities = 63/214 (29%), Positives = 104/214 (48%), Gaps = 31/214 (14%)

Query: 57  LGEGGFGPVYKGVLK---------KGDEIAVKR-LSGRSGQGLREMKNEASVIAKVQHKN 106
           LG+G F  +YKGVL+          G E++V   + G   +        AS+++++ HK+
Sbjct: 3   LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62

Query: 107 LVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQ 166
           LV+L G C+ RDE I++ EY+    LD FL      + L W  ++ + + +A  L YL  
Sbjct: 63  LVKLYGVCV-RDENIMVEEYVKFGPLDVFLHREKNNVSLHW--KLDVAKQLASALHYLED 119

Query: 167 YSRVRIIHRDLKASNILLDK-DMNP------KISDFGMARICGGNELQANTSRIVGTYGY 219
               +++H ++   NIL+ +  +N       K+SD G+       E +    RI     +
Sbjct: 120 ---KKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREER--VERI----PW 170

Query: 220 MSPEYALEGIFSIKS--DVFSFGVLLLEIVSGKK 251
           ++PE    G  S+    D +SFG  LLEI S  +
Sbjct: 171 IAPECIRNGQASLTIAADKWSFGTTLLEICSNGE 204

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 66.1 bits (162), Expect = 4e-12
 Identities = 80/310 (25%), Positives = 134/310 (43%), Gaps = 92/310 (29%)

Query: 55  NKLGEGGFGPVYKGVLKKGDEI-AVKRLSG------------RSGQGLREMKNEASVIAK 101
            KLG+G +G V+K + ++  E+ A+K++              R    L+E+ +       
Sbjct: 13  QKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGD------- 65

Query: 102 VQHKNLVRLLGCC-IDRDEKI-LIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQ 159
             H N+V+LL     + D+ I L++EYM     +  L    +  +L+ V +  I+  + +
Sbjct: 66  --HPNIVKLLNVIKAENDKDIYLVFEYM-----ETDLHAVIRANILEDVHKRYIMYQLLK 118

Query: 160 GLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMAR-ICGGNELQANT--SRIVGT 216
            L Y+H  S   +IHRDLK SNILL+ D   K++DFG+AR +    E   N   +  V T
Sbjct: 119 ALKYIH--SG-NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVAT 175

Query: 217 YGYMSPEYAL------EGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDL 270
             Y +PE  L      +G+     D++S G +L E++ GK                   L
Sbjct: 176 RWYRAPEILLGSTRYTKGV-----DMWSVGCILGEMLLGKP------------------L 212

Query: 271 WTSNRTLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNEAATLL 330
           +    TL  ++ I+E                           P+  D+ S+ +  AAT+L
Sbjct: 213 FPGTSTLNQLEKIIE-----------------------VIGPPSAEDIESIKSPFAATML 249

Query: 331 -----PPKQP 335
                 P++P
Sbjct: 250 DSLPSRPRKP 259

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 65.6 bits (160), Expect = 6e-12
 Identities = 38/94 (40%), Positives = 59/94 (62%), Gaps = 7/94 (7%)

Query: 157 IAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE--LQANTSRIV 214
           +A+G+ +L   SR + IHRDL A NILL ++   KI DFG+AR    +   ++   +R+ 
Sbjct: 182 VARGMEFLA--SR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL- 237

Query: 215 GTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 248
               +M+PE   + +++ +SDV+SFGVLL EI S
Sbjct: 238 -PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 270

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 65.5 bits (159), Expect = 6e-12
 Identities = 60/212 (28%), Positives = 99/212 (46%), Gaps = 27/212 (12%)

Query: 49  NKFSDANKLGEGGFGPVYKGVLK-KGDEIAVK--RLSGRSGQGLREMKNEASVIAKVQHK 105
           + +    KLGEG +  VYKG  K  G  +A+K  RL    G     ++ EAS++  ++H 
Sbjct: 5   DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIR-EASLLKGLKHA 63

Query: 106 NLVRLLGCCIDRDEKILIYEYMPNKSLDFF------LFDPTKRMLLDWVTRVQIIEGIAQ 159
           N+V L      ++   L++EY+      +       L     ++ L  + R         
Sbjct: 64  NIVLLHDIIHTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLR--------- 114

Query: 160 GLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANT-SRIVGTYG 218
           GL Y+HQ     I+HRDLK  N+L+      K++DFG+AR      + ++T S  V T  
Sbjct: 115 GLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLAR---AKSVPSHTYSNEVVTLW 168

Query: 219 YMSPEYALEGI-FSIKSDVFSFGVLLLEIVSG 249
           Y  P+  L    +S   D++  G + +E++ G
Sbjct: 169 YRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQG 200

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 64.6 bits (157), Expect = 6e-12
 Identities = 54/211 (25%), Positives = 99/211 (46%), Gaps = 36/211 (17%)

Query: 57  LGEGGFGPVYKGVLKK-GDEIAVKRLSGR--SGQGLREMKNEASVIAKVQHKNLVR---- 109
           +G+G +G V     +  G +  +K+L+ R  S +  +  + EA ++++++H N+V     
Sbjct: 8   VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRES 67

Query: 110 ----------LLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQ 159
                     ++G C   D    +Y  +  +          +  +++W  +      IA 
Sbjct: 68  WEGEDGLLYIVMGFCEGGD----LYHKLKEQKGKLLP----ENQVVEWFVQ------IAM 113

Query: 160 GLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGY 219
            L YLH+     I+HRDLK  N+ L +    K+ D G+AR+       A+T  ++GT  Y
Sbjct: 114 ALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMAST--LIGTPYY 168

Query: 220 MSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 250
           MSPE      ++ KSDV++ G  + E+ + K
Sbjct: 169 MSPELFSNKPYNYKSDVWALGCCVYEMATLK 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 65.4 bits (159), Expect = 7e-12
 Identities = 64/233 (27%), Positives = 109/233 (46%), Gaps = 41/233 (17%)

Query: 50  KFSDANKLGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKN---EASVIAKVQHK 105
           ++ + + +G G +G V      K G  +AVK+LS R  Q +   K    E  ++  ++H+
Sbjct: 18  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMKHE 76

Query: 106 NLVRLLGCCIDRDEKILIYEYMPNKSL----DFFLFDPTKRMLLDWVTRVQ--------- 152
           N++ LL              + P +SL    D +L        L+ + + Q         
Sbjct: 77  NVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 124

Query: 153 IIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR 212
           +I  I +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR           + 
Sbjct: 125 LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTG 176

Query: 213 IVGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLL 264
            V T  Y +PE  L  + ++   D++S G ++ E+++G+  T    TD ++ L
Sbjct: 177 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR--TLFPGTDHIDQL 227

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 65.4 bits (159), Expect = 7e-12
 Identities = 69/225 (30%), Positives = 98/225 (43%), Gaps = 39/225 (17%)

Query: 43  SVSTATNKFSDANKLGEGGFGPV---YKGVLKKGDEIAVKRLSGRSGQGLREMKN---EA 96
           S  T   ++     +G G  G V   +  VL  G  +AVK+LS R  Q     K    E 
Sbjct: 15  STFTVLKRYQQLKPIGSGAQGIVCAAFDTVL--GINVAVKKLS-RPFQNQTHAKRAYREL 71

Query: 97  SVIAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFF--------LFDPTK----RML 144
            ++  V HKN++ LL              + P KSL+ F        L D        M 
Sbjct: 72  VLLKCVNHKNIISLLNV------------FTPQKSLEEFQDVYLVMELMDANLCQVIHME 119

Query: 145 LDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGN 204
           LD      ++  +  G+ +LH      IIHRDLK SNI++  D   KI DFG+AR    N
Sbjct: 120 LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTACTN 176

Query: 205 ELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 249
            +   T  +V  Y Y +PE  L   +    D++S G ++ E+V G
Sbjct: 177 FMM--TPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGELVKG 218

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 64.5 bits (157), Expect = 7e-12
 Identities = 59/210 (28%), Positives = 100/210 (47%), Gaps = 28/210 (13%)

Query: 57  LGEGGFGPVYKGVLKK-GD-------EIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLV 108
           LG+G F  ++KG+ ++ GD       E+ +K L              AS+++++ HK+LV
Sbjct: 3   LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62

Query: 109 RLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYS 168
              G C+  DE I++ EY+   SLD +L      + + W  ++++ + +A  L +L    
Sbjct: 63  LNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISW--KLEVAKQLAWALHFLEDKG 120

Query: 169 RVRIIHRDLKASNILL-----DKDMNP---KISDFGMARICGGNELQANTSRIVGTYGYM 220
              + H ++ A N+LL      K  NP   K+SD G++      E+     RI     ++
Sbjct: 121 ---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEIL--LERI----PWV 171

Query: 221 SPEYALEG-IFSIKSDVFSFGVLLLEIVSG 249
            PE        S+ +D +SFG  L EI SG
Sbjct: 172 PPECIENPQNLSLAADKWSFGTTLWEIFSG 201

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 65.2 bits (159), Expect = 2e-11
 Identities = 59/231 (25%), Positives = 94/231 (40%), Gaps = 51/231 (22%)

Query: 56  KLGEGGFGPVYKGVLKK-GDEIAVKR----LSGRSGQGLREMKNEASVIAKVQHKNLVRL 110
            +G+GG G VY          +A+K+    LS       R ++ EA + A + H  +V +
Sbjct: 9   LIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLR-EAKIAADLIHPGIVPV 67

Query: 111 LGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWV-----------------TRVQI 153
              C D D    +Y  MP      ++   T + LL  V                   + I
Sbjct: 68  YSICSDGD---PVYYTMP------YIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSI 118

Query: 154 IEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE-----LQA 208
              I   + Y+H  S+  ++HRDLK  NILL       I D+G A      E     +  
Sbjct: 119 FHKICATIEYVH--SK-GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDV 175

Query: 209 NTS-----------RIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 248
           +             +IVGT  YM+PE  L    S  +D+++ GV+L ++++
Sbjct: 176 DERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLT 226

Length = 932

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 64.1 bits (156), Expect = 2e-11
 Identities = 39/154 (25%), Positives = 73/154 (47%), Gaps = 9/154 (5%)

Query: 95  EASVIAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQII 154
           EA ++  V H +++R+    +      ++   +P+ S D + +   +   L     + I 
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMV---LPHYSSDLYTYLTKRSRPLPIDQALIIE 163

Query: 155 EGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIV 214
           + I +GL YLH     RIIHRD+K  NI ++      I D G A+      +      + 
Sbjct: 164 KQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQF---PVVAPAFLGLA 217

Query: 215 GTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 248
           GT    +PE      ++ K+D++S G++L E+++
Sbjct: 218 GTVETNAPEVLARDKYNSKADIWSAGIVLFEMLA 251

Length = 357

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 63.1 bits (153), Expect = 2e-11
 Identities = 53/201 (26%), Positives = 93/201 (46%), Gaps = 18/201 (8%)

Query: 57  LGEGGFGPVYKGVLKKGDEI-AVKRLS-GRSGQGLREMKNEASVIAKVQHKNLVRLLGCC 114
           +GEG FG          D+  A+K +   +S   + + + EA ++AK++H N+V      
Sbjct: 8   VGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESF 67

Query: 115 IDRDEKILIYEYMPNKSLDFFLFDP-----TKRMLLDWVTRVQIIEGIAQGLLYLHQYSR 169
                  ++ EY     L   +         +  +L W  +      +  G+ ++H+   
Sbjct: 68  EADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQ------MCLGVQHIHEK-- 119

Query: 170 VRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGI 229
            R++HRD+K+ NI L ++   K+ DFG AR+       A T   VGT  Y+ PE      
Sbjct: 120 -RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACT--YVGTPYYVPPEIWENMP 176

Query: 230 FSIKSDVFSFGVLLLEIVSGK 250
           ++ KSD++S G +L E+ + K
Sbjct: 177 YNNKSDIWSLGCILYELCTLK 197

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 64.0 bits (155), Expect = 3e-11
 Identities = 67/223 (30%), Positives = 104/223 (46%), Gaps = 33/223 (14%)

Query: 43  SVSTATNKFSDANKLGEGGFGPV---YKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVI 99
           S  T   ++ +   +G G  G V   Y  VL +   +A+K+LS       R  +N+    
Sbjct: 11  STFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDR--NVAIKKLS-------RPFQNQTH-- 59

Query: 100 AKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFF--------LFDPTK----RMLLDW 147
           AK  ++ LV L+ C   ++   L+  + P KSL+ F        L D       +M LD 
Sbjct: 60  AKRAYRELV-LMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMELDH 118

Query: 148 VTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQ 207
                ++  +  G+ +LH      IIHRDLK SNI++  D   KI DFG+AR  G + + 
Sbjct: 119 ERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM 175

Query: 208 ANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 250
             T  +V  Y Y +PE  L   +    D++S G ++ E+V  K
Sbjct: 176 --TPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 63.6 bits (155), Expect = 3e-11
 Identities = 53/227 (23%), Positives = 99/227 (43%), Gaps = 42/227 (18%)

Query: 50  KFSDANKLGEGGFGPVYKGVLKKGDE-IAVKRLSGRSGQGLREMKNEASVIAKVQHKNLV 108
           ++ D   LG G  G V+  V    D+ +AVK++     Q ++    E  +I ++ H N+V
Sbjct: 6   RYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIV 65

Query: 109 RLLGCCIDRDEKILIYEYMPNKS--LDFFLFDPTK-------RMLLDWVTRVQIIEG--- 156
           +             +YE +      L   +   T+       +  ++      + +G   
Sbjct: 66  K-------------VYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLS 112

Query: 157 ----------IAQGLLYLHQYSRVRIIHRDLKASNILLD-KDMNPKISDFGMARICGGN- 204
                     + +GL Y+H      ++HRDLK +N+ ++ +D+  KI DFG+ARI   + 
Sbjct: 113 EEHARLFMYQLLRGLKYIHS---ANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHY 169

Query: 205 ELQANTSRIVGTYGYMSPEYALEGIFSIKS-DVFSFGVLLLEIVSGK 250
             +   S  + T  Y SP   L      K+ D+++ G +  E+++GK
Sbjct: 170 SHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 63.0 bits (153), Expect = 3e-11
 Identities = 38/126 (30%), Positives = 68/126 (53%), Gaps = 15/126 (11%)

Query: 165 HQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY 224
           H ++R  +++RDLK +NILLD+  + +ISD G+A  C  ++ + + S  VGT+GYM+PE 
Sbjct: 112 HMHNRF-VVYRDLKPANILLDEHGHVRISDLGLA--CDFSKKKPHAS--VGTHGYMAPEV 166

Query: 225 ALEGI-FSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPI 283
             +G+ +   +D FS G +L +++ G      ++T   +           +R    +   
Sbjct: 167 LQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH---------EIDRMTLTMAVE 217

Query: 284 LEDEYS 289
           L D +S
Sbjct: 218 LPDSFS 223

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 63.2 bits (153), Expect = 4e-11
 Identities = 57/199 (28%), Positives = 91/199 (45%), Gaps = 13/199 (6%)

Query: 57  LGEGGFGPVYKGVLKKGDEI----AVKRLSGRSGQGLREMKNEASVIAKV-QHKNLVRLL 111
           +G G +  V    LKK + I     VK+      + +  ++ E  V  +   H  LV L 
Sbjct: 3   IGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 62

Query: 112 GCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVR 171
            C         + EY+    L F +    +R L +   R    E I+  L YLH+     
Sbjct: 63  SCFQTESRLFFVIEYVNGGDLMFHM--QRQRKLPEEHARFYSAE-ISLALNYLHERG--- 116

Query: 172 IIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFS 231
           II+RDLK  N+LLD + + K++D+GM +   G      TS   GT  Y++PE      + 
Sbjct: 117 IIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSTFCGTPNYIAPEILRGEDYG 174

Query: 232 IKSDVFSFGVLLLEIVSGK 250
              D ++ GVL+ E+++G+
Sbjct: 175 FSVDWWALGVLMFEMMAGR 193

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 62.7 bits (153), Expect = 4e-11
 Identities = 59/209 (28%), Positives = 94/209 (44%), Gaps = 34/209 (16%)

Query: 55  NKLGEGGFGPVYKG-VLKKGDEIAVKRLSGRSGQGLREMKNEASVIA--KVQ-HKNLVRL 110
            K+GEG F  V K    K G   A+K +     + L ++ N   + A  ++  H N++RL
Sbjct: 5   GKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHF-KSLEQVNNLREIQALRRLSPHPNILRL 63

Query: 111 LGCCIDRDEKIL----------IYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQG 160
           +    DR    L          +YE +  +        P KR+   ++   Q++    + 
Sbjct: 64  IEVLFDRKTGRLALVFELMDMNLYELIKGRKRPL----PEKRVKS-YMY--QLL----KS 112

Query: 161 LLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYM 220
           L ++H   R  I HRD+K  NIL+  D   K++DFG  R  G       T  I  T  Y 
Sbjct: 113 LDHMH---RNGIFHRDIKPENILIKDD-ILKLADFGSCR--GIYSKPPYTEYI-STRWYR 165

Query: 221 SPEYAL-EGIFSIKSDVFSFGVLLLEIVS 248
           +PE  L +G +  K D+++ G +  EI+S
Sbjct: 166 APECLLTDGYYGPKMDIWAVGCVFFEILS 194

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 63.1 bits (153), Expect = 5e-11
 Identities = 64/252 (25%), Positives = 105/252 (41%), Gaps = 39/252 (15%)

Query: 4   DLDLNLKADNVIIELPANNKQAKRSKKKEVDQFPLFSFSSVSTATNKFSDANKLGEGGFG 63
           +L L+ K D+       + K+ KR  K + + F                    LG G FG
Sbjct: 6   NLQLHKKKDS------DSTKEPKRKNKMKYEDFNFI---------------RTLGTGSFG 44

Query: 64  PVYKGVLKKGD--EIAVKRLSG----RSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDR 117
            V     K  D   +A+KR       +  Q +  + +E  ++  + H   V L G   D 
Sbjct: 45  RVILATYKNEDFPPVAIKRFEKSKIIKQKQ-VDHVFSERKILNYINHPFCVNLYGSFKDE 103

Query: 118 DEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDL 177
               L+ E++     +FF F    +   + V         AQ +L       + I++RDL
Sbjct: 104 SYLYLVLEFVIGG--EFFTFLRRNKRFPNDVGCFYA----AQIVLIFEYLQSLNIVYRDL 157

Query: 178 KASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVF 237
           K  N+LLDKD   K++DFG A++     +   T  + GT  Y++PE  L       +D +
Sbjct: 158 KPENLLLDKDGFIKMTDFGFAKV-----VDTRTYTLCGTPEYIAPEILLNVGHGKAADWW 212

Query: 238 SFGVLLLEIVSG 249
           + G+ + EI+ G
Sbjct: 213 TLGIFIYEILVG 224

Length = 340

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 62.9 bits (153), Expect = 5e-11
 Identities = 62/198 (31%), Positives = 93/198 (46%), Gaps = 13/198 (6%)

Query: 57  LGEGGFGPVYKGVLKKGDEI-AVKRLSGRSGQGLREMKN---EASVIAK-VQHKNLVRLL 111
           +G+G FG V     K   +  AVK L  ++    +E K+   E +V+ K V+H  LV L 
Sbjct: 3   IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62

Query: 112 GCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVR 171
                 D+   + +Y+    L F L    +R   +   R    E IA  L YLH    + 
Sbjct: 63  YSFQTADKLYFVLDYVNGGELFFHL--QRERSFPEPRARFYAAE-IASALGYLHS---LN 116

Query: 172 IIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFS 231
           II+RDLK  NILLD   +  ++DFG+ +   G E    TS   GT  Y++PE   +  + 
Sbjct: 117 IIYRDLKPENILLDSQGHVVLTDFGLCK--EGIEHSKTTSTFCGTPEYLAPEVLRKQPYD 174

Query: 232 IKSDVFSFGVLLLEIVSG 249
              D +  G +L E++ G
Sbjct: 175 RTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 62.7 bits (152), Expect = 6e-11
 Identities = 36/95 (37%), Positives = 57/95 (60%), Gaps = 7/95 (7%)

Query: 157 IAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR-IVG 215
           I+ GL +LH   R  II+RDLK  N++LD + + KI+DFGM   C  + +   T+R   G
Sbjct: 110 ISVGLFFLH---RRGIIYRDLKLDNVMLDSEGHIKIADFGM---CKEHMVDGVTTRTFCG 163

Query: 216 TYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 250
           T  Y++PE      +    D +++GVLL E+++G+
Sbjct: 164 TPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQ 198

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 62.4 bits (151), Expect = 7e-11
 Identities = 56/199 (28%), Positives = 92/199 (46%), Gaps = 13/199 (6%)

Query: 57  LGEGGFGPVYKGVLKKGDEI----AVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLG 112
           +G G +  V    LKK D+I     VK+      + +  ++ E  V  +      +  L 
Sbjct: 3   IGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLH 62

Query: 113 CCIDRDEKI-LIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVR 171
            C     ++ L+ EY+    L F +    +R L +   R    E I   L +LH+     
Sbjct: 63  SCFQTTSRLFLVIEYVNGGDLMFHM--QRQRKLPEEHARFYAAE-ICIALNFLHERG--- 116

Query: 172 IIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFS 231
           II+RDLK  N+LLD D + K++D+GM +   G      TS   GT  Y++PE      + 
Sbjct: 117 IIYRDLKLDNVLLDADGHIKLTDYGMCK--EGLGPGDTTSTFCGTPNYIAPEILRGEEYG 174

Query: 232 IKSDVFSFGVLLLEIVSGK 250
              D ++ GVL+ E+++G+
Sbjct: 175 FSVDWWALGVLMFEMMAGR 193

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 62.4 bits (151), Expect = 8e-11
 Identities = 39/94 (41%), Positives = 60/94 (63%), Gaps = 7/94 (7%)

Query: 157 IAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARIC--GGNELQANTSRIV 214
           +A+G+ +L   SR + IHRDL A NILL ++   KI DFG+AR      + ++   +R+ 
Sbjct: 188 VAKGMEFLA--SR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL- 243

Query: 215 GTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 248
               +M+PE   + +++I+SDV+SFGVLL EI S
Sbjct: 244 -PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 276

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 61.9 bits (150), Expect = 1e-10
 Identities = 37/95 (38%), Positives = 55/95 (57%), Gaps = 7/95 (7%)

Query: 157 IAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR-IVG 215
           IA GL +LH      II+RDLK  N++LD + + KI+DFGM   C  N     T++   G
Sbjct: 110 IAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGM---CKENMWDGVTTKTFCG 163

Query: 216 TYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 250
           T  Y++PE      +    D ++FGVLL E+++G+
Sbjct: 164 TPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 198

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 61.6 bits (149), Expect = 1e-10
 Identities = 38/94 (40%), Positives = 60/94 (63%), Gaps = 7/94 (7%)

Query: 157 IAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARIC--GGNELQANTSRIV 214
           +A+G+ +L   SR + IHRDL A NILL ++   KI DFG+AR      + ++  ++R+ 
Sbjct: 183 VARGMEFLA--SR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARL- 238

Query: 215 GTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 248
               +M+PE   + +++ +SDV+SFGVLL EI S
Sbjct: 239 -PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 271

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 61.2 bits (148), Expect = 1e-10
 Identities = 58/201 (28%), Positives = 103/201 (51%), Gaps = 15/201 (7%)

Query: 55  NKLGEGGFGPVYKGVLK-KGDEIAVK--RLSGRSGQGLREMKNEASVIAKVQHKNLVRLL 111
           +KLGEG +  V+KG  K   + +A+K  RL    G     ++ E S++  ++H N+V L 
Sbjct: 11  DKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIR-EVSLLKNLKHANIVTLH 69

Query: 112 GCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVR 171
                     L++EY+ +  L  +L +    M +  V ++ + + + +GL Y H   + +
Sbjct: 70  DIIHTERCLTLVFEYLDS-DLKQYLDNCGNLMSMHNV-KIFMFQ-LLRGLSYCH---KRK 123

Query: 172 IIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANT-SRIVGTYGYMSPEYALEGI- 229
           I+HRDLK  N+L+++    K++DFG+AR      +   T S  V T  Y  P+  L    
Sbjct: 124 ILHRDLKPQNLLINEKGELKLADFGLAR---AKSVPTKTYSNEVVTLWYRPPDVLLGSTE 180

Query: 230 FSIKSDVFSFGVLLLEIVSGK 250
           +S   D++  G +L E+ +G+
Sbjct: 181 YSTPIDMWGVGCILYEMATGR 201

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 60.7 bits (147), Expect = 2e-10
 Identities = 48/149 (32%), Positives = 73/149 (48%), Gaps = 9/149 (6%)

Query: 56  KLGEGGFGPVYKGVLKKG---DEIAVKRLSGRSG-QGLREMKNEASVIAKVQHKNLVRLL 111
           ++G G FG V  G +  G    ++ VK L   +  Q   +   EA     +QH NL++ L
Sbjct: 2   EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCL 61

Query: 112 GCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLL--DWVTRVQIIEGIAQGLLYLHQYSR 169
           G C +    +L+ E+ P   L  +L    K  L+  D  T  ++   IA GLL+LH+ + 
Sbjct: 62  GQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN- 120

Query: 170 VRIIHRDLKASNILLDKDMNPKISDFGMA 198
              IH DL   N LL  D+  KI D+G++
Sbjct: 121 --FIHSDLALRNCLLTADLTVKIGDYGLS 147

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 61.1 bits (148), Expect = 2e-10
 Identities = 60/225 (26%), Positives = 112/225 (49%), Gaps = 51/225 (22%)

Query: 50  KFSDANKLGEGGFGPVYKGV-LKKGDEIAVKRL---------SGRSGQGLREMKNEASVI 99
           ++ D  ++G G +G V   +  + G ++A+K+L         + R+ + LR +K+     
Sbjct: 16  RYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKH----- 70

Query: 100 AKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSLD----FFLFDP------TKRMLLDWVT 149
             ++H+N++ LL              + P+ SLD    F+L  P       K M  + ++
Sbjct: 71  --MKHENVIGLLDV------------FTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLS 116

Query: 150 --RVQ-IIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNEL 206
             R+Q ++  + +GL Y+H      IIHRDLK  N+ +++D   KI DFG+AR     + 
Sbjct: 117 EDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLAR-----QT 168

Query: 207 QANTSRIVGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 250
            +  +  V T  Y +PE  L  + ++   D++S G ++ E+++GK
Sbjct: 169 DSEMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 60.6 bits (147), Expect = 2e-10
 Identities = 60/214 (28%), Positives = 101/214 (47%), Gaps = 33/214 (15%)

Query: 56  KLGEGGFGPVYKGV-LKKGDEIAVK--RLS----GRSGQGLREMKNEASVIAKVQHKN-L 107
           K+GEG +G VYK      G  +A+K  RL     G     LRE+    S++  +     +
Sbjct: 8   KIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREI----SLLQMLSESIYI 63

Query: 108 VRLLGC--CIDRDEKILIY---EYMPN---KSLDFFLFDPTKRMLLDWVTRV--QIIEGI 157
           VRLL      +++ K  +Y   EY+ +   K +D     P + +    +     Q+++G+
Sbjct: 64  VRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGV 123

Query: 158 AQGLLYLHQYSRVRIIHRDLKASNILLDKDMNP-KISDFGMARICGGNELQANTSRIVGT 216
           A    + H++    ++HRDLK  N+L+DK     KI+D G+ R      +++ T  IV T
Sbjct: 124 A----HCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLGLGR-AFSIPVKSYTHEIV-T 174

Query: 217 YGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSG 249
             Y +PE  L    +S   D++S G +  E+   
Sbjct: 175 LWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRK 208

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 60.9 bits (148), Expect = 2e-10
 Identities = 52/180 (28%), Positives = 84/180 (46%), Gaps = 29/180 (16%)

Query: 157 IAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 216
           I +GL YLH      I+HRD+K  N+L++ +   KI DFG+AR+   +E +  T  +V  
Sbjct: 112 ILRGLKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQ 168

Query: 217 YGYMSPEYALEGI--FSIKSDVFSFGVLLLEIVSGKKNTGLYRTDS----LNLLGYAWDL 270
           Y Y +PE  L G   ++   D++S G +  E++  +    L++  S    L+L+    DL
Sbjct: 169 Y-YRAPEI-LMGSRHYTSAVDIWSVGCIFAELLGRRI---LFQAQSPIQQLDLI---TDL 220

Query: 271 WTSNRTLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNEAATLL 330
                   L  P LE   S+ +    +    +L         P +  + S  T+EA  LL
Sbjct: 221 --------LGTPSLEAMRSACEGARAH----ILRGPHKPPSLPVLYTLSSQATHEAVHLL 268

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 61.0 bits (148), Expect = 3e-10
 Identities = 35/98 (35%), Positives = 58/98 (59%), Gaps = 7/98 (7%)

Query: 157 IAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMAR--ICGGNELQANTSRIV 214
           +AQG+ +L   +    IHRD+ A N+LL      KI DFG+AR  +   N +    +R+ 
Sbjct: 221 VAQGMDFL---ASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARL- 276

Query: 215 GTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKN 252
               +M+PE   + +++++SDV+S+G+LL EI S  K+
Sbjct: 277 -PVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKS 313

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 60.0 bits (145), Expect = 3e-10
 Identities = 64/226 (28%), Positives = 104/226 (46%), Gaps = 27/226 (11%)

Query: 41  FSSVSTATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLREMKNEASVI 99
           F S    ++ +     +G+G +G V+K + KK G + AVK L         E++ E +++
Sbjct: 10  FDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDID-EEIEAEYNIL 68

Query: 100 -AKVQHKNLVRLLGCCIDRDEKI-----LIYEYMPNKSLDFFLFDPTKRML-----LDWV 148
            A   H N+V+  G    +D K      L+ E     S+     D  K  L     ++  
Sbjct: 69  KALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVT----DLVKGFLKRGERMEEP 124

Query: 149 TRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQA 208
               I+     GL +LH     + IHRD+K +NILL  +   K+ DFG++       L+ 
Sbjct: 125 IIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRR 181

Query: 209 NTSRIVGTYGYMSPEY-----ALEGIFSIKSDVFSFGVLLLEIVSG 249
           NTS  VGT  +M+PE       L+  +  + DV+S G+  +E+  G
Sbjct: 182 NTS--VGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDG 225

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 60.0 bits (145), Expect = 3e-10
 Identities = 33/86 (38%), Positives = 56/86 (65%), Gaps = 6/86 (6%)

Query: 165 HQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY 224
           H ++R  +++RDLK +NILLD+  + +ISD G+A  C  ++ + + S  VGT+GYM+PE 
Sbjct: 112 HMHNRF-VVYRDLKPANILLDEHGHVRISDLGLA--CDFSKKKPHAS--VGTHGYMAPEV 166

Query: 225 ALEGI-FSIKSDVFSFGVLLLEIVSG 249
             +G  +   +D FS G +L +++ G
Sbjct: 167 LQKGTAYDSSADWFSLGCMLFKLLRG 192

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 60.4 bits (146), Expect = 3e-10
 Identities = 59/198 (29%), Positives = 94/198 (47%), Gaps = 13/198 (6%)

Query: 57  LGEGGFGPVYKGVLK-KGDEIAVKRLSGRSGQGLREMKN---EASVIAK-VQHKNLVRLL 111
           +G+G FG V     K  G   AVK L  ++    +E  +   E +V+ K ++H  LV L 
Sbjct: 3   IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLH 62

Query: 112 GCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVR 171
                 ++   + +Y+    L F L    +R  L+   R    E +A  + YLH    + 
Sbjct: 63  YSFQTAEKLYFVLDYVNGGELFFHL--QRERCFLEPRARFYAAE-VASAIGYLHS---LN 116

Query: 172 IIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFS 231
           II+RDLK  NILLD   +  ++DFG+ +   G E +  TS   GT  Y++PE   +  + 
Sbjct: 117 IIYRDLKPENILLDSQGHVVLTDFGLCK--EGVEPEETTSTFCGTPEYLAPEVLRKEPYD 174

Query: 232 IKSDVFSFGVLLLEIVSG 249
              D +  G +L E++ G
Sbjct: 175 RTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 59.9 bits (145), Expect = 4e-10
 Identities = 58/207 (28%), Positives = 101/207 (48%), Gaps = 20/207 (9%)

Query: 55  NKLGEGGFGPVYKGVLKK--GDEIAVK--RLSGRSGQGLREMKNEASVIAKVQHKNLVRL 110
           ++LG+G +G VYK VL +  G  +A+K  RL     +   ++  E  ++ K     +V  
Sbjct: 7   DELGKGNYGSVYK-VLHRPTGVTMAMKEIRLELDESK-FNQIIMELDILHKAVSPYIVDF 64

Query: 111 LGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRV 170
            G         +  EYM   SLD           +      +I   + +GL +L +    
Sbjct: 65  YGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKE--EH 122

Query: 171 RIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRI-VGTYGYMSPEYALEG- 228
            IIHRD+K +N+L++ +   K+ DFG++    GN L A+ ++  +G   YM+PE    G 
Sbjct: 123 NIIHRDVKPTNVLVNGNGQVKLCDFGVS----GN-LVASLAKTNIGCQSYMAPERIKSGG 177

Query: 229 -----IFSIKSDVFSFGVLLLEIVSGK 250
                 ++++SDV+S G+ +LE+  G+
Sbjct: 178 PNQNPTYTVQSDVWSLGLSILEMALGR 204

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 59.8 bits (145), Expect = 4e-10
 Identities = 38/102 (37%), Positives = 55/102 (53%), Gaps = 7/102 (6%)

Query: 150 RVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQAN 209
           RV I E I   L +LHQ   + II+RD+K  NILLD + +  ++DFG+++     E +  
Sbjct: 108 RVYIAE-IVLALDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERA 163

Query: 210 TSRIVGTYGYMSPEYALEGI--FSIKSDVFSFGVLLLEIVSG 249
            S   GT  YM+PE    G        D +S GVL  E+++G
Sbjct: 164 YS-FCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTG 204

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 61.4 bits (149), Expect = 4e-10
 Identities = 48/198 (24%), Positives = 94/198 (47%), Gaps = 34/198 (17%)

Query: 73  GDEIAVKRLSGRSGQGLREMKN---EASVIAKVQHKNLVRLL--GCCIDRDEKILIYEYM 127
           G E+A+K L   + +   +      E ++ A++ H N+V LL  G          ++EY+
Sbjct: 3   GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPP-GLLFAVFEYV 61

Query: 128 PNKSLDFFLFD-------PTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKAS 180
           P ++L   L          T R++L      Q+++ +A        +++  I+HRDLK  
Sbjct: 62  PGRTLREVLAADGALPAGETGRLML------QVLDALA------CAHNQ-GIVHRDLKPQ 108

Query: 181 NILL---DKDMNPKISDFGMARICGG----NELQAN-TSRIVGTYGYMSPEYALEGIFSI 232
           NI++       + K+ DFG+  +  G    +      T+ ++GT  Y +PE       + 
Sbjct: 109 NIMVSQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTP 168

Query: 233 KSDVFSFGVLLLEIVSGK 250
            SD++++G++ LE ++G+
Sbjct: 169 NSDLYAWGLIFLECLTGQ 186

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 59.7 bits (145), Expect = 4e-10
 Identities = 62/202 (30%), Positives = 102/202 (50%), Gaps = 21/202 (10%)

Query: 56  KLGEGGFGPVYKGVLK-KGDEIAVK--RLSGRSGQGLREMKNEASVIAKVQHKNLVRLLG 112
           KLGEG +  VYKG  K  G  +A+K  RL    G     ++ EAS++  ++H N+V  L 
Sbjct: 12  KLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIR-EASLLKDLKHANIV-TLH 69

Query: 113 CCIDRDEKI-LIYEYMPNKSLDFFLFDPTKRMLLDWVT--RVQIIEGIAQGLLYLHQYSR 169
             I   + + L++EY+ +  L  ++ D    + +  V     Q++ G+A    Y HQ   
Sbjct: 70  DIIHTKKTLTLVFEYL-DTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLA----YCHQR-- 122

Query: 170 VRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANT-SRIVGTYGYMSPEYALEG 228
            R++HRDLK  N+L+ +    K++DFG+AR      + + T S  V T  Y  P+  L  
Sbjct: 123 -RVLHRDLKPQNLLISERGELKLADFGLAR---AKSVPSKTYSNEVVTLWYRPPDVLLGS 178

Query: 229 I-FSIKSDVFSFGVLLLEIVSG 249
             +S   D++  G +  E+ +G
Sbjct: 179 TEYSTSLDMWGVGCIFYEMATG 200

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 59.8 bits (145), Expect = 4e-10
 Identities = 60/216 (27%), Positives = 99/216 (45%), Gaps = 18/216 (8%)

Query: 41  FSSVSTATNKFSD---ANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSGQGLREMKN-- 94
           F+   T++ K SD      LG G FG V     K  G+  A+K L  R    ++++++  
Sbjct: 7   FTKPDTSSWKLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVA 66

Query: 95  -EASVIAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQI 153
            E S++ ++ H  +V ++    D +    + E++    L F       R   D V +   
Sbjct: 67  QEKSILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGEL-FTHLRKAGRFPND-VAKFYH 124

Query: 154 IEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRI 213
            E +     YLH      II+RDLK  N+LLD   + K++DFG A+     ++   T  +
Sbjct: 125 AE-LVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAK-----KVPDRTFTL 175

Query: 214 VGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 249
            GT  Y++PE           D ++ GVLL E ++G
Sbjct: 176 CGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAG 211

Length = 329

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 60.1 bits (145), Expect = 4e-10
 Identities = 58/219 (26%), Positives = 102/219 (46%), Gaps = 39/219 (17%)

Query: 50  KFSDANKLGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGL---REMKNEASVIAKVQHK 105
           ++ +   +G G +G V      +   ++AVK+LS R  Q L   R    E  ++  ++H+
Sbjct: 16  RYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLS-RPFQSLIHARRTYRELRLLKHMKHE 74

Query: 106 NLVRLLGCCIDRDEKILIYEYMPNKSLDFF--LFDPTKRMLLDWVTRVQ----------- 152
           N++ LL              + P  S++ F  ++  T  M  D    V+           
Sbjct: 75  NVIGLLDV------------FTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQF 122

Query: 153 IIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR 212
           +I  + +GL Y+H      IIHRDLK SN+ +++D   +I DFG+AR     +     + 
Sbjct: 123 LIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLAR-----QADDEMTG 174

Query: 213 IVGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 250
            V T  Y +PE  L  + ++   D++S G ++ E++ GK
Sbjct: 175 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 60.3 bits (146), Expect = 4e-10
 Identities = 34/97 (35%), Positives = 56/97 (57%), Gaps = 13/97 (13%)

Query: 157 IAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 216
           +A+G+ +L   +    IHRDL A NILL      KI DFG+AR     +++ +++ +V  
Sbjct: 223 VAKGMSFL---ASKNCIHRDLAARNILLTHGRITKICDFGLAR-----DIRNDSNYVVKG 274

Query: 217 YG-----YMSPEYALEGIFSIKSDVFSFGVLLLEIVS 248
                  +M+PE     +++ +SDV+S+G+LL EI S
Sbjct: 275 NARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFS 311

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional

 Score = 60.0 bits (145), Expect = 6e-10
 Identities = 63/229 (27%), Positives = 101/229 (44%), Gaps = 32/229 (13%)

Query: 44  VSTATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQ 103
           +  +T +F   + LGEG FG V +   +K  E    ++     +  R+ K E   + KV+
Sbjct: 124 IDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVR 183

Query: 104 HKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPT-KRMLLDWVTR---------VQI 153
             +         DR   + I  Y  N++    +  P     LLDW+ +          QI
Sbjct: 184 QADPA-------DRFPLMKIQRYFQNETGHMCIVMPKYGPCLLDWIMKHGPFSHRHLAQI 236

Query: 154 IEGIAQGLLYLHQYSRVRIIHRDLKASNILL---DKDMNPKIS-----DFGMARIC--GG 203
           I      L Y H  + + ++H DLK  NIL+   D  ++P  +     D    RIC  GG
Sbjct: 237 IFQTGVALDYFH--TELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGG 294

Query: 204 --NELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 250
             +E  + T+ IV T  Y SPE  L   +   +D++S G ++ E+ +GK
Sbjct: 295 CCDERHSRTA-IVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGK 342

Length = 467

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 58.5 bits (141), Expect = 1e-09
 Identities = 47/156 (30%), Positives = 75/156 (48%), Gaps = 8/156 (5%)

Query: 95  EASVIAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQII 154
           E+ V+   +H  L  L      +D    + EY+    L F L    +R+  +  TR    
Sbjct: 45  ESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGGELFFHL--SRERVFSEDRTRFYGA 102

Query: 155 EGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIV 214
           E I   L YLH     +I++RDLK  N++LDKD + KI+DFG+ +   G    A      
Sbjct: 103 E-IVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCK--EGITDAATMKTFC 156

Query: 215 GTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 250
           GT  Y++PE   +  +    D +  GV++ E++ G+
Sbjct: 157 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 58.7 bits (142), Expect = 1e-09
 Identities = 60/204 (29%), Positives = 97/204 (47%), Gaps = 22/204 (10%)

Query: 57  LGEGGFGPVYKGVLK-----KGDEIAVKRLSG----RSGQGLREMKNEASVIAKVQHKNL 107
           LG+GG+G V++ V K      G   A+K L      R+ +     K E +++  V+H  +
Sbjct: 4   LGKGGYGKVFQ-VRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFI 62

Query: 108 VRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQY 167
           V L+       +  LI EY+    L  F+    + + ++      + E I+  L +LHQ 
Sbjct: 63  VDLIYAFQTGGKLYLILEYLSGGEL--FMHLEREGIFMEDTACFYLSE-ISLALEHLHQQ 119

Query: 168 SRVRIIHRDLKASNILLDKDMNPKISDFGMAR--ICGGNELQANTSRIVGTYGYMSPEYA 225
               II+RDLK  NILLD   + K++DFG+ +  I  G      T    GT  YM+PE  
Sbjct: 120 G---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG----TVTHTFCGTIEYMAPEIL 172

Query: 226 LEGIFSIKSDVFSFGVLLLEIVSG 249
           +        D +S G L+ ++++G
Sbjct: 173 MRSGHGKAVDWWSLGALMYDMLTG 196

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 58.1 bits (140), Expect = 2e-09
 Identities = 63/200 (31%), Positives = 95/200 (47%), Gaps = 17/200 (8%)

Query: 57  LGEGGFGPVYKGVLKKGDEI--AVKRLSGRSGQGLREMK---NEASVIAK-VQHKNLVRL 110
           +G+G FG V      K +E   AVK L  ++    +E K   +E +V+ K V+H  LV L
Sbjct: 3   IGKGSFGKVLLA-RHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 61

Query: 111 LGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRV 170
                  D+   + +Y+    L + L    +R  L+   R    E IA  L YLH    +
Sbjct: 62  HFSFQTADKLYFVLDYINGGELFYHL--QRERCFLEPRARFYAAE-IASALGYLHS---L 115

Query: 171 RIIHRDLKASNILLDKDMNPKISDFGMARICGGN-ELQANTSRIVGTYGYMSPEYALEGI 229
            I++RDLK  NILLD   +  ++DFG+   C  N E    TS   GT  Y++PE   +  
Sbjct: 116 NIVYRDLKPENILLDSQGHIVLTDFGL---CKENIEHNGTTSTFCGTPEYLAPEVLHKQP 172

Query: 230 FSIKSDVFSFGVLLLEIVSG 249
           +    D +  G +L E++ G
Sbjct: 173 YDRTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 58.7 bits (142), Expect = 2e-09
 Identities = 34/94 (36%), Positives = 55/94 (58%), Gaps = 2/94 (2%)

Query: 159 QGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR-IVGTY 217
           Q LL +H      +IHRD+K++NILL  +   K+ DFG +++     +  +  R   GT 
Sbjct: 151 QVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMY-AATVSDDVGRTFCGTP 209

Query: 218 GYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKK 251
            Y++PE      +S K+D+FS GVLL E+++ K+
Sbjct: 210 YYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKR 243

Length = 496

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 57.5 bits (139), Expect = 3e-09
 Identities = 59/208 (28%), Positives = 94/208 (45%), Gaps = 31/208 (14%)

Query: 57  LGEGGFGPVYKGVLKKGDEI-AVKRLSGRSGQGLREMKNEASVIAKVQ-----------H 104
           +G G +  V    LKK   I A+K +        +E+ N+   I  VQ           H
Sbjct: 3   IGRGSYAKVLLVELKKTRRIYAMKVIK-------KELVNDDEDIDWVQTEKHVFETASNH 55

Query: 105 KNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYL 164
             LV L  C         + E++    L F +    +R L +   R    E I+  L +L
Sbjct: 56  PFLVGLHSCFQTESRLFFVIEFVSGGDLMFHM--QRQRKLPEEHARFYSAE-ISLALNFL 112

Query: 165 HQYSRVRIIHRDLKASNILLDKDMNPKISDFGMAR--ICGGNELQANTSRIVGTYGYMSP 222
           H+     II+RDLK  N+LLD + + K++D+GM +  I  G+     TS   GT  Y++P
Sbjct: 113 HERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGD----TTSTFCGTPNYIAP 165

Query: 223 EYALEGIFSIKSDVFSFGVLLLEIVSGK 250
           E      +    D ++ GVL+ E+++G+
Sbjct: 166 EILRGEDYGFSVDWWALGVLMFEMMAGR 193

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 56.6 bits (137), Expect = 6e-09
 Identities = 31/94 (32%), Positives = 50/94 (53%), Gaps = 6/94 (6%)

Query: 157 IAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMAR-ICGGNELQAN-TSRIV 214
           + +GL Y+H      +IHRDLK SN+L+++D   +I DFGMAR +           +  V
Sbjct: 116 LLRGLKYIHS---ANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYV 172

Query: 215 GTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIV 247
            T  Y +PE  L    ++   D++S G +  E++
Sbjct: 173 ATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEML 206

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 56.8 bits (137), Expect = 6e-09
 Identities = 51/194 (26%), Positives = 87/194 (44%), Gaps = 17/194 (8%)

Query: 57  LGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCID 116
           L  G  G V+  V  K  +   K++  ++  G +    E  ++  + H+ ++ L+     
Sbjct: 100 LTPGSEGEVF--VCTKHGDEQRKKVIVKAVTGGKTPGREIDILKTISHRAIINLIHA--- 154

Query: 117 RDEKILIYEYMPNKSLDFFLF-DPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHR 175
              K  +   MP    D F + D +  + L+    +Q    + + L YLH      IIHR
Sbjct: 155 YRWKSTVCMVMPKYKCDLFTYVDRSGPLPLEQAITIQ--RRLLEALAYLHGRG---IIHR 209

Query: 176 DLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYM---SPEYALEGIFSI 232
           D+K  NI LD+  N  + DFG A  C  +    +T +  G  G +   SPE      +  
Sbjct: 210 DVKTENIFLDEPENAVLGDFGAA--CKLDA-HPDTPQCYGWSGTLETNSPELLALDPYCA 266

Query: 233 KSDVFSFGVLLLEI 246
           K+D++S G++L E+
Sbjct: 267 KTDIWSAGLVLFEM 280

Length = 392

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 56.2 bits (135), Expect = 6e-09
 Identities = 78/313 (24%), Positives = 140/313 (44%), Gaps = 49/313 (15%)

Query: 56  KLGEGGFGPVYKGVLKKGD---EIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLG 112
           K+G G +G VYK   K G    E A+K++ G +G  +   + E +++ +++H N++ L  
Sbjct: 8   KVGRGTYGHVYKAKRKDGKDEKEYALKQIEG-TGISMSACR-EIALLRELKHPNVIALQK 65

Query: 113 CCIDR-DEKI-LIYEYMPNKSLDFFLFDPT-----KRMLLDWVTRVQIIEGIAQGLLYLH 165
             +   D K+ L+++Y  +       F        K M L       ++  I  G+ YLH
Sbjct: 66  VFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLH 125

Query: 166 QYSRVRIIHRDLKASNILL----DKDMNPKISDFGMARICGGN-ELQANTSRIVGTYGYM 220
                 ++HRDLK +NIL+     +    KI+D G AR+     +  A+   +V T+ Y 
Sbjct: 126 AN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYR 182

Query: 221 SPEYALEGIFSIKS-DVFSFGVLLLEIVSGK----------KNTGLYRTDSLN----LLG 265
           +PE  L      K+ D+++ G +  E+++ +          K +  +  D L+    ++G
Sbjct: 183 APELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMG 242

Query: 266 YAWDL-WTSNRTLELIDPILEDEYSSKQMLLR---YANIALLCVQESADDRPTMNDVVSM 321
           +  D  W   R +         EY + Q   R   YAN +L+   E    +P  +  V +
Sbjct: 243 FPADKDWEDIRKMP--------EYPTLQKDFRRTTYANSSLIKYMEKHKVKP--DSKVFL 292

Query: 322 LTNEAATLLPPKQ 334
           L  +  T+ P K+
Sbjct: 293 LLQKLLTMDPTKR 305

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 56.2 bits (135), Expect = 7e-09
 Identities = 58/198 (29%), Positives = 91/198 (45%), Gaps = 13/198 (6%)

Query: 57  LGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLREMKN---EASVIAK-VQHKNLVRLL 111
           +G+G FG V     K  G   AVK L  +     +E K+   E +V+ K V+H  LV L 
Sbjct: 3   IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLH 62

Query: 112 GCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVR 171
                 ++   + +++    L F L    +R   +   R    E IA  L YLH    + 
Sbjct: 63  YSFQTTEKLYFVLDFVNGGELFFHL--QRERSFPEPRARFYAAE-IASALGYLHS---IN 116

Query: 172 IIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFS 231
           I++RDLK  NILLD   +  ++DFG+ +   G      T+   GT  Y++PE   +  + 
Sbjct: 117 IVYRDLKPENILLDSQGHVVLTDFGLCK--EGIAQSDTTTTFCGTPEYLAPEVIRKQPYD 174

Query: 232 IKSDVFSFGVLLLEIVSG 249
              D +  G +L E++ G
Sbjct: 175 NTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 55.4 bits (133), Expect = 1e-08
 Identities = 44/156 (28%), Positives = 71/156 (45%), Gaps = 8/156 (5%)

Query: 95  EASVIAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQII 154
           E+ V+   +H  L  L       D    + EY     L F L    +R+  +   R    
Sbjct: 45  ESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHL--SRERVFTEERARFYGA 102

Query: 155 EGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIV 214
           E I   L YLH      +++RD+K  N++LDKD + KI+DFG+ +   G    A      
Sbjct: 103 E-IVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFC 156

Query: 215 GTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 250
           GT  Y++PE   +  +    D +  GV++ E++ G+
Sbjct: 157 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 56.7 bits (136), Expect = 1e-08
 Identities = 66/239 (27%), Positives = 113/239 (47%), Gaps = 48/239 (20%)

Query: 49  NKFSDANKLGEGGFGPVYKGVLKKGDEIAV-KRLSGRSGQGLREMKN-----EASVIAKV 102
           N++    K+G G FG V+    K+  E    K +S R   GL+E +      E +V+ ++
Sbjct: 13  NEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYR---GLKEREKSQLVIEVNVMREL 69

Query: 103 QHKNLVRLLGCCIDR-DEKILI-YEYMPNKSLD------FFLFDPTKRMLLDWVTRVQII 154
           +HKN+VR +   +++ ++K+ I  E+     L       + +F   +   +  +TR Q++
Sbjct: 70  KHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITR-QLL 128

Query: 155 EGIAQGLLYLHQY----SRVRIIHRDLKASNILLD-------------KDMN----PKIS 193
             +A    Y H      +  R++HRDLK  NI L               ++N     KI 
Sbjct: 129 HALA----YCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIG 184

Query: 194 DFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSI--KSDVFSFGVLLLEIVSGK 250
           DFG+++  G   +++     VGT  Y SPE  L    S   KSD+++ G ++ E+ SGK
Sbjct: 185 DFGLSKNIG---IESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGK 240

Length = 1021

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 55.5 bits (134), Expect = 1e-08
 Identities = 36/97 (37%), Positives = 50/97 (51%), Gaps = 6/97 (6%)

Query: 157 IAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGN--ELQANTSRIV 214
           I  GL Y+H      ++HRDLK  N+L++ D   KI DFG+AR    N  E     +  V
Sbjct: 114 ILCGLKYIHS---ANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYV 170

Query: 215 GTYGYMSPEYALEGIFSIKS-DVFSFGVLLLEIVSGK 250
            T  Y +PE  L      K+ DV+S G +L E++  K
Sbjct: 171 ATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRK 207

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

 Score = 53.2 bits (128), Expect = 1e-08
 Identities = 36/151 (23%), Positives = 56/151 (37%), Gaps = 15/151 (9%)

Query: 52  SDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLV--R 109
           S    L  G    VY    K  D   +K    R     RE   E +++  +  K L   +
Sbjct: 1   SSIKLLKGGLTNRVYLLGTKDED-YVLKINPSREKGADRE--REVAILQLLARKGLPVPK 57

Query: 110 LLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSR 169
           +L          L+ E++  ++LD           +    +  I E +A+ L  LHQ   
Sbjct: 58  VLASGESDGWSYLLMEWIEGETLDE----------VSEEEKEDIAEQLAELLAKLHQLPL 107

Query: 170 VRIIHRDLKASNILLDKDMNPKISDFGMARI 200
           + + H DL   NIL+D      I D+  A  
Sbjct: 108 LVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 55.2 bits (133), Expect = 1e-08
 Identities = 31/94 (32%), Positives = 50/94 (53%), Gaps = 5/94 (5%)

Query: 157 IAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 216
           I   L YLH      +++RDLK  N++LDKD + KI+DFG+ +   G    A      GT
Sbjct: 104 IVSALGYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGT 158

Query: 217 YGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 250
             Y++PE   +  +    D +  GV++ E++ G+
Sbjct: 159 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 55.1 bits (132), Expect = 2e-08
 Identities = 61/244 (25%), Positives = 114/244 (46%), Gaps = 35/244 (14%)

Query: 56  KLGEGGFGPVYKGVLKKGDE---IAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLG 112
           K+G G +G VYK   K G +    A+K++ G +G  +   + E +++ +++H N++ L  
Sbjct: 8   KVGRGTYGHVYKAKRKDGKDDRDYALKQIEG-TGISMSACR-EIALLRELKHPNVISLQK 65

Query: 113 CCIDR-DEKI-LIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLY-----LH 165
             +   D K+ L+++Y  +       F    +        VQ+  G+ + LLY     +H
Sbjct: 66  VFLSHADRKVWLLFDYAEHDLWHIIKFHRASKAN---KKPVQLPRGMVKSLLYQILDGIH 122

Query: 166 QYSRVRIIHRDLKASNILL----DKDMNPKISDFGMARICGGN-ELQANTSRIVGTYGYM 220
                 ++HRDLK +NIL+     +    KI+D G AR+     +  A+   +V T+ Y 
Sbjct: 123 YLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYR 182

Query: 221 SPEYALEGIFSIKS-DVFSFGVLLLEIVSGK----------KNTGLYRTDSL----NLLG 265
           +PE  L      K+ D+++ G +  E+++ +          K +  Y  D L    N++G
Sbjct: 183 APELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMG 242

Query: 266 YAWD 269
           +  D
Sbjct: 243 FPAD 246

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 55.4 bits (133), Expect = 2e-08
 Identities = 44/169 (26%), Positives = 78/169 (46%), Gaps = 12/169 (7%)

Query: 95  EASVIAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQII 154
           EA ++  + H ++++L G         LI   +P    D + +   KR +      + I 
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLI---LPRYKTDLYCYLAAKRNI-AICDILAIE 188

Query: 155 EGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR-I 213
             + + + YLH+    RIIHRD+KA NI ++   +  + DFG A  C   ++ AN     
Sbjct: 189 RSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAA--CFPVDINANKYYGW 243

Query: 214 VGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLN 262
            GT    +PE      +    D++S G++L E+ +   +  L+  D L+
Sbjct: 244 AGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDS--LFEKDGLD 290

Length = 391

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 55.4 bits (134), Expect = 2e-08
 Identities = 56/234 (23%), Positives = 90/234 (38%), Gaps = 57/234 (24%)

Query: 57  LGEGGFGPVYKGVLKKGDEI--AVKRLSGRSGQGLREMKNEASVIA----KVQHKN--LV 108
           +G G FG V+  V  K      A+K L       + +    A V A         +  +V
Sbjct: 9   IGRGAFGEVWL-VRDKDTGQVYAMKVLRKSD---MIKRNQIAHVRAERDILADADSPWIV 64

Query: 109 RLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEG------IAQGLL 162
           +L     D +   L+ EYMP   L            ++ + R  +         IA+ +L
Sbjct: 65  KLYYSFQDEEHLYLVMEYMPGGDL------------MNLLIRKDVFPEETARFYIAELVL 112

Query: 163 YLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMA------------------RICGGN 204
            L    ++  IHRD+K  NIL+D D + K++DFG+                    +   N
Sbjct: 113 ALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDN 172

Query: 205 ELQANTSR---------IVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 249
            L                VGT  Y++PE      + ++ D +S GV+L E++ G
Sbjct: 173 VLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYG 226

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 54.9 bits (132), Expect = 2e-08
 Identities = 31/93 (33%), Positives = 52/93 (55%), Gaps = 2/93 (2%)

Query: 157 IAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 216
            A+ L  L    +  +I+RDLK  NILLD   +  + DFG+ ++   ++ + NT    GT
Sbjct: 99  TAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNT--FCGT 156

Query: 217 YGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 249
             Y++PE  L   ++   D ++ GVLL E+++G
Sbjct: 157 PEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTG 189

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 54.9 bits (132), Expect = 2e-08
 Identities = 34/96 (35%), Positives = 52/96 (54%), Gaps = 7/96 (7%)

Query: 157 IAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQAN--TSRIV 214
           IA+ +L L    +  I++RDLK  NILLD   +  + DFG+++      L  N  T+   
Sbjct: 102 IAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSK----ANLTDNKTTNTFC 157

Query: 215 GTYGYMSPEYAL-EGIFSIKSDVFSFGVLLLEIVSG 249
           GT  Y++PE  L E  ++   D +S GVL+ E+  G
Sbjct: 158 GTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCG 193

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 55.5 bits (133), Expect = 2e-08
 Identities = 53/184 (28%), Positives = 90/184 (48%), Gaps = 28/184 (15%)

Query: 79  KRLSGRSGQGLR---EMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIYE---YMPNKSL 132
           + ++ R   G R   +++NE   + ++ H+N++++        E+IL  E   YM  +  
Sbjct: 194 RLIAKRVKAGSRAAIQLENEILALGRLNHENILKI--------EEILRSEANTYMITQKY 245

Query: 133 DFFL--------FDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILL 184
           DF L        FD   R LL   TR  I++ +   + Y+H     ++IHRD+K  NI L
Sbjct: 246 DFDLYSFMYDEAFDWKDRPLL-KQTR-AIMKQLLCAVEYIHDK---KLIHRDIKLENIFL 300

Query: 185 DKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLL 244
           + D    + DFG A +    E +A     VGT    SPE      +   +D++S G++LL
Sbjct: 301 NCDGKIVLGDFGTA-MPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILL 359

Query: 245 EIVS 248
           +++S
Sbjct: 360 DMLS 363

Length = 501

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 54.6 bits (131), Expect = 3e-08
 Identities = 33/93 (35%), Positives = 54/93 (58%), Gaps = 5/93 (5%)

Query: 157 IAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMAR-ICGGNELQANTSRIVG 215
           +A+G+ +L   +    +HRDL A N+LL +    KI DFG+AR I   +   +  S  + 
Sbjct: 246 VARGMEFL---ASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLP 302

Query: 216 TYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 248
              +M+PE   + +++  SDV+S+G+LL EI S
Sbjct: 303 V-KWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 54.3 bits (130), Expect = 3e-08
 Identities = 32/94 (34%), Positives = 52/94 (55%), Gaps = 4/94 (4%)

Query: 157 IAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 216
           I   L YLH  S   +++RDLK  N++LDKD + KI+DFG+ +   G +  A      GT
Sbjct: 104 IVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKTFCGT 159

Query: 217 YGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 250
             Y++PE   +  +    D +  GV++ E++ G+
Sbjct: 160 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 193

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 53.6 bits (129), Expect = 4e-08
 Identities = 46/171 (26%), Positives = 79/171 (46%), Gaps = 22/171 (12%)

Query: 89  LREMKNEASVIAKVQHKNLVRLLGCCIDRDEK----ILIYEYMPNKSLDFFLFDPTKRML 144
           +   +NE   + ++   N++++ G  ID  +      LI EY     L   L    K   
Sbjct: 62  IDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVL---DKEKD 118

Query: 145 LDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGN 204
           L + T++ +     +GL  L++Y+     +++L + + L+ ++   KI       IC G 
Sbjct: 119 LSFKTKLDMAIDCCKGLYNLYKYTNKP--YKNLTSVSFLVTENYKLKI-------ICHGL 169

Query: 205 E--LQANTSRIVGTYGYMSPEYALEGIFS---IKSDVFSFGVLLLEIVSGK 250
           E  L +   + V    Y S +  L  IFS   IK D++S GV+L EI +GK
Sbjct: 170 EKILSSPPFKNVNFMVYFSYKM-LNDIFSEYTIKDDIYSLGVVLWEIFTGK 219

Length = 283

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 53.9 bits (130), Expect = 5e-08
 Identities = 35/97 (36%), Positives = 53/97 (54%), Gaps = 10/97 (10%)

Query: 157 IAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 216
           + +GL Y+H      ++HRDLK SN+LL+ + + KI DFG+AR    +E     +  V T
Sbjct: 117 LLRGLKYIHS---ANVLHRDLKPSNLLLNANCDLKICDFGLART--TSEKGDFMTEYVVT 171

Query: 217 YGYMSPEYAL---EGIFSIKSDVFSFGVLLLEIVSGK 250
             Y +PE  L   E   +I  DV+S G +  E++  K
Sbjct: 172 RWYRAPELLLNCSEYTTAI--DVWSVGCIFAELLGRK 206

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|221289 pfam11883, DUF3403, Domain of unknown function (DUF3403)

 Score = 48.5 bits (116), Expect = 5e-08
 Identities = 19/48 (39%), Positives = 30/48 (62%), Gaps = 2/48 (4%)

Query: 324 NEAATLLPPKQPAFSYVRNTV--TSTSSTGKTEDCSINQVTISLLEAR 369
           +E   +  PKQP F   R+     S+SST + E  ++NQVT+S+++AR
Sbjct: 1   SETTEIPQPKQPGFCVGRSPYETDSSSSTQRDESWTVNQVTVSVIDAR 48

This domain is functionally uncharacterized. This domain is found in eukaryotes. This presumed domain is about 50 amino acids in length. This domain is found associated with pfam00069, pfam08276, pfam00954, pfam01453. Length = 48

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 53.6 bits (129), Expect = 5e-08
 Identities = 33/100 (33%), Positives = 60/100 (60%), Gaps = 8/100 (8%)

Query: 157 IAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMA-RICGGNELQANTSRIVG 215
           +A+ +L +    ++  +HRD+K  N+LLDK+ + +++DFG   R+     +Q+N +  VG
Sbjct: 108 LAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVA--VG 165

Query: 216 TYGYMSPEY--ALE---GIFSIKSDVFSFGVLLLEIVSGK 250
           T  Y+SPE   A+E   G +  + D +S GV + E++ G+
Sbjct: 166 TPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGE 205

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 53.2 bits (128), Expect = 8e-08
 Identities = 61/208 (29%), Positives = 90/208 (43%), Gaps = 30/208 (14%)

Query: 57  LGEGGFGPVYKGVLKKGDEI-AVKRLSG-----RSGQGLREMKNEASVIAKVQHKNLVRL 110
           +G G FG V     K   ++ A+K LS      RS         E  ++A    + +V+L
Sbjct: 51  IGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAF--FWEERDIMAHANSEWIVQL 108

Query: 111 LGCCIDRDEKIL--IYEYMPNKSLDFFLFD---PTKRMLLDWVTRVQIIEGIAQGLLYLH 165
                 +D+K L  + EYMP   L   + +   P K     W  R    E +   L  +H
Sbjct: 109 --HYAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPEK-----W-ARFYTAE-VVLALDAIH 159

Query: 166 QYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYA 225
                  IHRD+K  N+LLDK  + K++DFG       N +       VGT  Y+SPE  
Sbjct: 160 SMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGM-VRCDTAVGTPDYISPEVL 215

Query: 226 L----EGIFSIKSDVFSFGVLLLEIVSG 249
                +G +  + D +S GV L E++ G
Sbjct: 216 KSQGGDGYYGRECDWWSVGVFLYEMLVG 243

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 52.3 bits (125), Expect = 1e-07
 Identities = 57/218 (26%), Positives = 98/218 (44%), Gaps = 46/218 (21%)

Query: 57  LGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMK--NEASVIAK---VQHKNLVRLL 111
           LG G +G V+           V+++SG     L  MK   +A+++ K    +H    R +
Sbjct: 8   LGTGAYGKVF----------LVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQV 57

Query: 112 GCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVT-----------------RVQII 154
              I +   ++   Y        F  D    ++LD++                   VQI 
Sbjct: 58  LEHIRQSPFLVTLHYA-------FQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIY 110

Query: 155 EG-IAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRI 213
            G I   L +LH   ++ II+RD+K  NILLD + +  ++DFG+++    +E++   S  
Sbjct: 111 SGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYS-F 166

Query: 214 VGTYGYMSPEYAL--EGIFSIKSDVFSFGVLLLEIVSG 249
            GT  YM+P+     +G      D +S GVL+ E+++G
Sbjct: 167 CGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTG 204

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 52.4 bits (126), Expect = 1e-07
 Identities = 61/235 (25%), Positives = 97/235 (41%), Gaps = 50/235 (21%)

Query: 57  LGEGGFGPVYKGVLKK--GDEIAVKRLSG----RSGQGLREMKNEASVIAKVQHKNLVRL 110
           +G G FG V + V KK  G   A+K+L         Q +  ++ E  ++A+  +  +V+L
Sbjct: 9   IGRGAFGEV-RLVQKKDTGHIYAMKKLRKSEMLEKEQ-VAHVRAERDILAEADNPWVVKL 66

Query: 111 LGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRV 170
                D +   LI EY+P   +   L    K    +  TR  I E I    L +    ++
Sbjct: 67  YYSFQDENYLYLIMEYLPGGDMMTLLM--KKDTFTEEETRFYIAETI----LAIDSIHKL 120

Query: 171 RIIHRDLKASNILLDKDMNPKISDFGM------------ARICGGNELQANTSRI----- 213
             IHRD+K  N+LLD   + K+SDFG+             RI            I     
Sbjct: 121 GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMS 180

Query: 214 -------------------VGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 249
                              VGT  Y++PE  L+  ++ + D +S GV++ E++ G
Sbjct: 181 SKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVG 235

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 52.1 bits (125), Expect = 2e-07
 Identities = 54/216 (25%), Positives = 97/216 (44%), Gaps = 24/216 (11%)

Query: 49  NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLRE----MKNEASVIAKVQ 103
             F   + +G G FG V     K  GD  A+K +  +S    +E     + E  +++   
Sbjct: 1   KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMK-KSVLLAQETVSFFEEERDILSISN 59

Query: 104 HKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFL---FDPTKRMLLDWVTRVQIIEGIAQG 160
              + +L     D+D   L+ EY P   L   L    D     +  +         +A+ 
Sbjct: 60  SPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFY--------LAEL 111

Query: 161 LLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYM 220
           +L +H   ++  +HRD+K  N+L+D+  + K++DFG A     N+   N+   VGT  Y+
Sbjct: 112 VLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANK-MVNSKLPVGTPDYI 170

Query: 221 SPEY------ALEGIFSIKSDVFSFGVLLLEIVSGK 250
           +PE         +G + ++ D +S GV+  E++ G+
Sbjct: 171 APEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGR 206

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 51.1 bits (122), Expect = 2e-07
 Identities = 55/216 (25%), Positives = 93/216 (43%), Gaps = 42/216 (19%)

Query: 57  LGEGGFGPVYKGVLKK---------GDEIAVKRLSGRSGQGLREMK----NEASVIAKVQ 103
           LG G    +Y G+L             E  +K +        R++       AS++ +V 
Sbjct: 3   LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVS 62

Query: 104 HKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLY 163
           HK++V L G C+   E I++ E++    LD F+   +  +   W  + ++ + +A  L Y
Sbjct: 63  HKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPW--KFKVAKQLASALSY 120

Query: 164 LHQYSRVRIIHRDLKASNILL-----DKDMNP--KISDFG-----MARICGGNELQANTS 211
           L       ++H ++   NILL     D +  P  K+SD G     ++R       Q    
Sbjct: 121 LEDK---DLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSR-------QECVE 170

Query: 212 RIVGTYGYMSPEYALEG-IFSIKSDVFSFGVLLLEI 246
           RI     +++PE   +    SI +D +SFG  L EI
Sbjct: 171 RI----PWIAPECVEDSKNLSIAADKWSFGTTLWEI 202

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 51.2 bits (122), Expect = 3e-07
 Identities = 32/100 (32%), Positives = 60/100 (60%), Gaps = 8/100 (8%)

Query: 157 IAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMA-RICGGNELQANTSRIVG 215
           IA+ +L +H   ++  +HRD+K  N+LLD + + +++DFG   ++     +Q++ +  VG
Sbjct: 108 IAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVA--VG 165

Query: 216 TYGYMSPEY--ALE---GIFSIKSDVFSFGVLLLEIVSGK 250
           T  Y+SPE   A+E   G +  + D +S GV + E++ G+
Sbjct: 166 TPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGE 205

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 50.6 bits (121), Expect = 4e-07
 Identities = 63/289 (21%), Positives = 120/289 (41%), Gaps = 44/289 (15%)

Query: 56  KLGEGGFGPVYKGVLKKGDEIA---VKRLSGRSGQGLREMKN---EASVIAKVQHKNLVR 109
           ++G G FG V    +     +A   VK L  ++    +E      +      +QH N+++
Sbjct: 2   EIGNGWFGKVLLSEIYTDTGVARVVVKEL--KANASSKEQNEFLQQGDPYRILQHPNILQ 59

Query: 110 LLGCCIDRDEKILIYEYMPNKSLDFFL------FDPTKRMLLDWVTRVQIIEGIAQGLLY 163
            LG C++    +L++EY     L  +L         ++ +LL      ++   IA G+ +
Sbjct: 60  CLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQ-----RMACEIAAGVTH 114

Query: 164 LHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE 223
           +H+++    +H DL   N  L  D+  K+ D+G+       +             +++PE
Sbjct: 115 MHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPE 171

Query: 224 YALE---GIFSIK----SDVFSFGVLLLEIVSGKKN--TGLYRTDSLNLLGYAWDLWTSN 274
              E   G+ + +    S+V++ GV L E+        + L   + LN +         +
Sbjct: 172 LVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHV-------IKD 224

Query: 275 RTLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLT 323
           + ++L  P LE  YS      R+  +   C   S + R T  +V  +LT
Sbjct: 225 QQVKLFKPQLELPYSE-----RWYEVLQFC-WLSPEKRATAEEVHRLLT 267

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 50.6 bits (121), Expect = 5e-07
 Identities = 58/252 (23%), Positives = 101/252 (40%), Gaps = 65/252 (25%)

Query: 51  FSDANKLGEGGFGPVYKGVLKKGDE---IAVKRLSGRSGQGLRE-----MKNEASVIAKV 102
           F     +G G FG V   +++K D     A+K L  R    L       +K E  ++A+ 
Sbjct: 3   FVKIKTIGIGAFGEVC--LVRKVDTNALYAMKTL--RKADVLMRNQAAHVKAERDILAEA 58

Query: 103 QHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLL 162
            ++ +V+L     D+D    + +Y+P   +   L      +  + + R  I E +   + 
Sbjct: 59  DNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLI--RLGIFEEDLARFYIAE-LTCAIE 115

Query: 163 YLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGG------------------- 203
            +H   ++  IHRD+K  NIL+D+D + K++DFG+   C G                   
Sbjct: 116 SVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGL---CTGFRWTHDSKYYQKGDHHRQD 169

Query: 204 -----NELQANTSR--------------------IVGTYGYMSPEYALEGIFSIKSDVFS 238
                 E                           +VGT  Y++PE  L   ++   D +S
Sbjct: 170 SMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWS 229

Query: 239 FGVLLLEIVSGK 250
            GV+L E++ G+
Sbjct: 230 VGVILYEMLVGQ 241

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 50.4 bits (120), Expect = 6e-07
 Identities = 66/221 (29%), Positives = 102/221 (46%), Gaps = 35/221 (15%)

Query: 57  LGEGGFGPVYKGVLKKGDEI-AVKRLSG-----RSGQGLREMKNEASVIAKVQHKNLVRL 110
           +G G FG V     K   ++ A+K LS      RS         E  ++A      +V+L
Sbjct: 51  IGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAF--FWEERDIMAFANSPWVVQL 108

Query: 111 LGCCIDRDEKIL--IYEYMPNKSLDFFLFD---PTKRMLLDWVTRVQIIEGIAQGLLYLH 165
              C  +D+K L  + EYMP   L   + +   P K     W          A+ +L L 
Sbjct: 109 F--CAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEK-----WAKFYT-----AEVVLALD 156

Query: 166 QYSRVRIIHRDLKASNILLDKDMNPKISDFGMA-RICGGNELQANTSRIVGTYGYMSPEY 224
               + +IHRD+K  N+LLDK  + K++DFG   ++     ++ +T+  VGT  Y+SPE 
Sbjct: 157 AIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTA--VGTPDYISPEV 214

Query: 225 ----ALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSL 261
                 +G +  + D +S GV L E++ G  +T  Y  DSL
Sbjct: 215 LKSQGGDGYYGRECDWWSVGVFLFEMLVG--DTPFY-ADSL 252

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 50.4 bits (120), Expect = 7e-07
 Identities = 30/92 (32%), Positives = 49/92 (53%), Gaps = 3/92 (3%)

Query: 157 IAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 216
           +A G+ +L   +    +HRDL A N+L+ +    KI DFG+AR    +    +       
Sbjct: 248 VANGMEFL---ASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLP 304

Query: 217 YGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 248
             +M+PE     +++  SDV+SFG+LL EI +
Sbjct: 305 LKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 49.3 bits (118), Expect = 1e-06
 Identities = 47/203 (23%), Positives = 83/203 (40%), Gaps = 16/203 (7%)

Query: 57  LGEGGFGPVYKGVLKKGDEIAVKR--LSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCC 114
             +     + K        +AVK+  L   S + L+ ++ E     ++QH N++  +   
Sbjct: 10  FEDLMIVHLAKHK-PTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSF 68

Query: 115 IDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 174
           I   E  ++   M   S +  L       L +      I++ +   L Y+H       IH
Sbjct: 69  IVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIA-FILKDVLNALDYIHSKG---FIH 124

Query: 175 RDLKASNILLDKDMNPKISDFGMAR--ICGGNELQA---NTSRIVGTYGYMSPEY---AL 226
           R +KAS+ILL  D    +S    +   I  G   +         V    ++SPE     L
Sbjct: 125 RSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNL 184

Query: 227 EGIFSIKSDVFSFGVLLLEIVSG 249
           +G ++ KSD++S G+   E+ +G
Sbjct: 185 QG-YNEKSDIYSVGITACELANG 206

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 49.2 bits (117), Expect = 2e-06
 Identities = 30/95 (31%), Positives = 51/95 (53%), Gaps = 12/95 (12%)

Query: 161 LLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYM 220
           +L L    ++ I++RD+K  NILLD + +  ++DFG+++     E +  T    GT  YM
Sbjct: 115 ILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEE-KERTYSFCGTIEYM 173

Query: 221 SPEYALEGIFSIKS------DVFSFGVLLLEIVSG 249
           +PE     I   K       D +S G+L+ E+++G
Sbjct: 174 APE-----IIRGKGGHGKAVDWWSLGILIFELLTG 203

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 49.1 bits (117), Expect = 2e-06
 Identities = 48/162 (29%), Positives = 73/162 (45%), Gaps = 26/162 (16%)

Query: 49  NKFSDANKLGEGGFGPVYKGVLKK--GDEIAVKRLSG----RSGQGLREMKNEASVIAKV 102
             F     +G+G FG V + V KK  G   A+K L      +  Q L  +K E  V+A+ 
Sbjct: 1   EDFHTVKVIGKGAFGEV-RLVQKKDTGKIYAMKTLLKSEMFKKDQ-LAHVKAERDVLAES 58

Query: 103 QHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDW------VTRVQIIEG 156
               +V L     D     LI E++P   L          ML+ +      VTR  + E 
Sbjct: 59  DSPWVVSLYYSFQDAQYLYLIMEFLPGGDL--------MTMLIKYDTFSEDVTRFYMAEC 110

Query: 157 IAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMA 198
           +    L +    ++  IHRD+K  NIL+D+  + K+SDFG++
Sbjct: 111 V----LAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLS 148

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 49.0 bits (117), Expect = 2e-06
 Identities = 35/97 (36%), Positives = 51/97 (52%), Gaps = 10/97 (10%)

Query: 159 QGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANT-SRIVGTY 217
           + L Y+H  +   + HRDLK  NIL + D   KI DFG+AR+   +   A   +  V T 
Sbjct: 114 RALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATR 170

Query: 218 GYMSPEYALEGIFSIKS----DVFSFGVLLLEIVSGK 250
            Y +PE  L G F  K     D++S G +  E+++GK
Sbjct: 171 WYRAPE--LCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 48.4 bits (115), Expect = 2e-06
 Identities = 45/160 (28%), Positives = 80/160 (50%), Gaps = 21/160 (13%)

Query: 96  ASVIAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIE 155
           AS++++V H +L  + G C+   E I++ E++ +  LD  L     R+ + W  ++ + +
Sbjct: 67  ASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAW--KITVAQ 124

Query: 156 GIAQGLLYLHQYSRVRIIHRDLKASNILLDK-----DMNP--KISDFGMARICGGNELQA 208
            +A  L YL   +   ++H ++ A NILL +       +P  K+SD G++      E   
Sbjct: 125 QLASALSYLEDKN---LVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSRE--E 179

Query: 209 NTSRIVGTYGYMSPEYALEGI--FSIKSDVFSFGVLLLEI 246
              RI     +++PE  + G    S  +D +SFG  LLEI
Sbjct: 180 RVERI----PWIAPE-CVPGGNSLSTAADKWSFGTTLLEI 214

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 48.1 bits (114), Expect = 3e-06
 Identities = 61/254 (24%), Positives = 103/254 (40%), Gaps = 65/254 (25%)

Query: 51  FSDANKLGEGGFGPVYKGVLKKGDE---IAVKRLSGRS---GQGLREMKNEASVIAKVQH 104
           F     LG G FG V   + +K D     A+K L  +       +  +K E  ++A+  +
Sbjct: 3   FVKIKTLGIGAFGEVC--LARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADN 60

Query: 105 KNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYL 164
           + +VRL     D+D    + +Y+P   +   L     RM +      +    IA+    +
Sbjct: 61  EWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLI----RMGIFPEDLARFY--IAELTCAV 114

Query: 165 HQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGG--------------------- 203
               ++  IHRD+K  NIL+D+D + K++DFG+   C G                     
Sbjct: 115 ESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGL---CTGFRWTHDSKYYQSGDHVRQDSM 171

Query: 204 ---NE---------------LQANTSR---------IVGTYGYMSPEYALEGIFSIKSDV 236
              NE               L+   +R         +VGT  Y++PE  L   ++   D 
Sbjct: 172 DFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDW 231

Query: 237 FSFGVLLLEIVSGK 250
           +S GV+L E++ G+
Sbjct: 232 WSVGVILYEMLVGQ 245

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 48.1 bits (114), Expect = 4e-06
 Identities = 29/90 (32%), Positives = 50/90 (55%)

Query: 159 QGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG 218
           Q +L L +    +++HRDLK++NI L      K+ DFG ++    +      S   GT  
Sbjct: 177 QIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPY 236

Query: 219 YMSPEYALEGIFSIKSDVFSFGVLLLEIVS 248
           Y++PE      +S K+D++S GV+L E+++
Sbjct: 237 YLAPELWERKRYSKKADMWSLGVILYELLT 266

Length = 478

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 48.1 bits (114), Expect = 4e-06
 Identities = 57/246 (23%), Positives = 112/246 (45%), Gaps = 39/246 (15%)

Query: 21  NNKQAKRSKKKEVDQFPLFSFSSVSTATNK-FSDANKLGEGGFGPVYKGV-LKKGDEIAV 78
           NN      ++K +D       + ++ + NK +   N +G G FG VY+ + +   +++A+
Sbjct: 44  NNAGEDEDEEKMID-------NDINRSPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAI 96

Query: 79  KRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGC----CIDRDEKIL----IYEYMPNK 130
           K++     Q  +    E  ++  + H N++ L       C  ++EK +    + E++P  
Sbjct: 97  KKVL----QDPQYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQT 152

Query: 131 SLDFFLF----DPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDK 186
              +       +    + L  +   Q+   +A    Y+H      I HRDLK  N+L+D 
Sbjct: 153 VHKYMKHYARNNHALPLFLVKLYSYQLCRALA----YIHSKF---ICHRDLKPQNLLIDP 205

Query: 187 DMNP-KISDFGMAR-ICGGNELQANTSRIVGTYGYMSPEYALEGI-FSIKSDVFSFGVLL 243
           + +  K+ DFG A+ +  G   Q + S I   + Y +PE  L    ++   D++S G ++
Sbjct: 206 NTHTLKLCDFGSAKNLLAG---QRSVSYICSRF-YRAPELMLGATNYTTHIDLWSLGCII 261

Query: 244 LEIVSG 249
            E++ G
Sbjct: 262 AEMILG 267

Length = 440

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 47.4 bits (112), Expect = 6e-06
 Identities = 49/204 (24%), Positives = 95/204 (46%), Gaps = 17/204 (8%)

Query: 57  LGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLRE----MKNEASVIAKVQHKNLVRLLG 112
           +G G FG V    LK  D++   ++  +     R      + E  V+    ++ +  L  
Sbjct: 9   IGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHY 68

Query: 113 CCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRI 172
              D +   L+ +Y     L   L     R+  D + R  +    A+ ++ +    ++  
Sbjct: 69  AFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPED-MARFYL----AEMVIAIDSVHQLHY 123

Query: 173 IHRDLKASNILLDKDMNPKISDFGMA-RICGGNELQANTSRIVGTYGYMSPEY--ALE-- 227
           +HRD+K  NIL+D + + +++DFG   ++     +Q++ +  VGT  Y+SPE   A+E  
Sbjct: 124 VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVA--VGTPDYISPEILQAMEDG 181

Query: 228 -GIFSIKSDVFSFGVLLLEIVSGK 250
            G +  + D +S GV + E++ G+
Sbjct: 182 KGKYGPECDWWSLGVCMYEMLYGE 205

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 46.9 bits (111), Expect = 1e-05
 Identities = 38/109 (34%), Positives = 60/109 (55%), Gaps = 10/109 (9%)

Query: 158 AQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMA-RICGGNELQANTSRIVGT 216
           A+ +L L     +  IHRD+K  N+LLDK  + K++DFG   ++     ++ +T+  VGT
Sbjct: 149 AEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTA--VGT 206

Query: 217 YGYMSPEY----ALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSL 261
             Y+SPE       +G +  + D +S GV L E++ G  +T  Y  DSL
Sbjct: 207 PDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG--DTPFY-ADSL 252

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 46.3 bits (110), Expect = 1e-05
 Identities = 32/103 (31%), Positives = 51/103 (49%), Gaps = 18/103 (17%)

Query: 161 LLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANT---------- 210
           L YLH Y    I+HRDLK  N+L+    + K++DFG+++I G   L  N           
Sbjct: 114 LEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKI-GLMSLTTNLYEGHIEKDTR 169

Query: 211 ----SRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 249
                ++ GT  Y++PE  L   +    D ++ G++L E + G
Sbjct: 170 EFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVG 212

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 46.2 bits (109), Expect = 1e-05
 Identities = 57/254 (22%), Positives = 99/254 (38%), Gaps = 65/254 (25%)

Query: 51  FSDANKLGEGGFGPVYKGV-LKKGDEIAVKRLSGR---SGQGLREMKNEASVIAKVQHKN 106
           F     LG G FG V     +      A+K L  +   +   +  +K E  ++A+  ++ 
Sbjct: 3   FVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEW 62

Query: 107 LVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLL--DWVTRVQIIEGIAQGLLYL 164
           +V+L     D+D    + +Y+P   +   L     RM +  + + R  I    A+  L +
Sbjct: 63  VVKLYYSFQDKDNLYFVMDYIPGGDMMSLLI----RMEVFPEVLARFYI----AELTLAI 114

Query: 165 HQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTS------------- 211
               ++  IHRD+K  NIL+D D + K++DFG+   C G     N+              
Sbjct: 115 ESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGL---CTGFRWTHNSKYYQKGSHIRQDSM 171

Query: 212 -----------------------------------RIVGTYGYMSPEYALEGIFSIKSDV 236
                                               +VGT  Y++PE  L   ++   D 
Sbjct: 172 EPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDW 231

Query: 237 FSFGVLLLEIVSGK 250
           +S GV+L E++ G+
Sbjct: 232 WSVGVILFEMLVGQ 245

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 45.8 bits (108), Expect = 2e-05
 Identities = 59/242 (24%), Positives = 102/242 (42%), Gaps = 55/242 (22%)

Query: 51  FSDANKLGEGGFGPVYKGVLKK--GDEIAVKRLSGRSGQGLRE-----MKNEASVIAKVQ 103
           F     +G G FG V + V KK  G   A+K L  R    L +     ++ E  ++ +  
Sbjct: 3   FESLKVIGRGAFGEV-RLVQKKDTGHVYAMKIL--RKADMLEKEQVGHIRAERDILVEAD 59

Query: 104 HKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLY 163
              +V++     D+    LI E++P   +   L      M  D +T  +    IA+ +L 
Sbjct: 60  SLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLL------MKKDTLTEEETQFYIAETVLA 113

Query: 164 LHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGG-------------------- 203
           +    ++  IHRD+K  N+LLD   + K+SDFG+   C G                    
Sbjct: 114 IDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGL---CTGLKKAHRTEFYRNLNHSLPSD 170

Query: 204 -------NELQANTSR---------IVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIV 247
                  ++ +A T +          VGT  Y++PE  ++  ++   D +S GV++ E++
Sbjct: 171 FTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEML 230

Query: 248 SG 249
            G
Sbjct: 231 IG 232

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 46.0 bits (109), Expect = 2e-05
 Identities = 20/52 (38%), Positives = 34/52 (65%), Gaps = 3/52 (5%)

Query: 149 TRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARI 200
             V+ I  +A  L YLH++    IIHRDLK  N+L+  + + K++DFG++++
Sbjct: 105 MAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSKV 153

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 44.1 bits (105), Expect = 5e-05
 Identities = 59/222 (26%), Positives = 85/222 (38%), Gaps = 68/222 (30%)

Query: 56  KLGEGGFGPVYKGVLKK------------------GDEIAVKRLSGRSGQGLREMKNEAS 97
           KL +G FG V   VLK                     E  V +L          MK+   
Sbjct: 23  KLIDGKFGKVS--VLKHKPTQKLFVQKIIKAKNFNAIEPMVHQL----------MKD--- 67

Query: 98  VIAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKR-MLLDWVTRVQIIEG 156
                 + N ++L          +LI +Y+     D  LFD  K+   L      +II  
Sbjct: 68  ------NPNFIKLYYSVTTLKGHVLIMDYIK----DGDLFDLLKKEGKLSEAEVKKIIRQ 117

Query: 157 IAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNP-KISDFGMARICGGNELQANTSRIVG 215
           + + L  LH++    IIH D+K  N+L D+  +   + D+G+ +I G        S   G
Sbjct: 118 LVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIG------TPSCYDG 168

Query: 216 TYGYMSPEYALEGIFSIKSDV--FSF-----GVLLLEIVSGK 250
           T  Y SPE        IK      SF     GVL  E+++GK
Sbjct: 169 TLDYFSPE-------KIKGHNYDVSFDWWAVGVLTYELLTGK 203

Length = 267

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 44.2 bits (104), Expect = 5e-05
 Identities = 56/242 (23%), Positives = 101/242 (41%), Gaps = 51/242 (21%)

Query: 49  NKFSDANKLGEGGFGPVYKGVLKK--GDEIAVKRLSGR---SGQGLREMKNEASVIAKVQ 103
           + F     +G G FG V + V KK  G   A+K L        + +  ++ E  ++ +  
Sbjct: 1   DDFESLKVIGRGAFGEV-RLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEAD 59

Query: 104 HKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLY 163
              +V++     D+    LI E++P   +   L      M  D ++       IA+ +L 
Sbjct: 60  GAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLL------MKKDTLSEEATQFYIAETVLA 113

Query: 164 LHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGG-------------------- 203
           +    ++  IHRD+K  N+LLD   + K+SDFG+   C G                    
Sbjct: 114 IDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGL---CTGLKKAHRTEFYRNLTHNPPSD 170

Query: 204 -------NELQANTSR---------IVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIV 247
                  ++ +A T +          VGT  Y++PE  ++  ++   D +S GV++ E++
Sbjct: 171 FSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEML 230

Query: 248 SG 249
            G
Sbjct: 231 IG 232

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 42.6 bits (100), Expect = 2e-04
 Identities = 33/113 (29%), Positives = 56/113 (49%), Gaps = 26/113 (23%)

Query: 153 IIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQA---N 209
           I+ G  +GL YLHQ      IHR++KAS+IL        IS  G+  + G + L +   N
Sbjct: 106 ILFGALRGLNYLHQNG---YIHRNIKASHIL--------ISGDGLVSLSGLSHLYSLVRN 154

Query: 210 TSRIVGTYGY----------MSPEYALEGI--FSIKSDVFSFGVLLLEIVSGK 250
             +    Y +          +SPE   + +  +++KSD++S G+   E+ +G+
Sbjct: 155 GQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGR 207

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional

 Score = 42.5 bits (100), Expect = 3e-04
 Identities = 43/172 (25%), Positives = 66/172 (38%), Gaps = 26/172 (15%)

Query: 51  FSDANKLGEGGFGPVYKGVL-----KKGDEIAVKRLSGRSGQGL----REMKNEASVIAK 101
           F    KLGEG FG VYK  L     KK  +  +K+ +      +    R  +   +  A 
Sbjct: 134 FVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVEIWMNERVRRACPNSCAD 193

Query: 102 VQHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDP-----TKRMLLDWVT------- 149
             +  L  +       DE  L++ Y    +L   +         +  LL  V        
Sbjct: 194 FVYGFLEPVSS--KKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLE 251

Query: 150 -RVQIIEGIAQGLLY-LHQYSRVRIIHRDLKASNILLDKDMNP-KISDFGMA 198
              +II+ I + +L+ L       I+HRD+K  NI+  +     KI D G A
Sbjct: 252 RENKIIQTIMRQILFALDGLHSTGIVHRDVKPQNIIFSEGSGSFKIIDLGAA 303

Length = 566

>gnl|CDD|226168 COG3642, COG3642, Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

 Score = 39.6 bits (93), Expect = 0.001
 Identities = 28/117 (23%), Positives = 44/117 (37%), Gaps = 26/117 (22%)

Query: 90  REMKNEASVIAKVQHKNLVRLLGCC------IDRDEKILIYEYMPNKSLDFFLFDPTKRM 143
              + EA ++AK       R  G        +D D  +++ EY+  + L   L +     
Sbjct: 44  ERTRREARILAKA------REAGVPVPIVYDVDPDNGLIVMEYIEGELLKDALEEA---- 93

Query: 144 LLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARI 200
             D +  V    G   G L+     +  I+H DL  SNI+L         DFG+   
Sbjct: 94  RPDLLREV----GRLVGKLH-----KAGIVHGDLTTSNIILSGG-RIYFIDFGLGEF 140

Length = 204

>gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional

 Score = 40.8 bits (95), Expect = 0.001
 Identities = 26/77 (33%), Positives = 39/77 (50%), Gaps = 9/77 (11%)

Query: 151 VQIIEGIA-QGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMA-RICGGNELQA 208
           + +I+G+  Q L  L +  R+ I+HRD+K  N+L+  D   KI DFG A  +C G     
Sbjct: 308 INVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNP 367

Query: 209 NTSRIVGTYGYMSPEYA 225
                   YG + P Y+
Sbjct: 368 -------LYGMLDPRYS 377

Length = 507

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 40.0 bits (94), Expect = 0.001
 Identities = 55/233 (23%), Positives = 92/233 (39%), Gaps = 51/233 (21%)

Query: 56  KLGEGGFGPVYKGVLKKGDEI-AVKRLSGRSGQGLREMKN---EASVIAKVQHKNLVRLL 111
            LG+G  G V+   LK   ++ A+K L  +      ++K    E  ++A + H  L  L 
Sbjct: 8   LLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLY 67

Query: 112 GCCIDRDEKI-LIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRV 170
                 +  + L+ +Y P   L   L     + L + V R    E +   L YLH     
Sbjct: 68  -ASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLL-ALEYLHLLG-- 123

Query: 171 RIIHRDLKASNILLDKDMNPKISDFG-----------MARICGGNELQANTSRI------ 213
            I++RDLK  NILL +  +  +SDF            +++       +++ + I      
Sbjct: 124 -IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFS 182

Query: 214 ----------VGTYGYMSPEYALEGIFSIKS-------DVFSFGVLLLEIVSG 249
                     VGT  Y++PE        I         D ++ G+LL E++ G
Sbjct: 183 EEPSFRSNSFVGTEEYIAPEV-------ISGDGHGSAVDWWTLGILLYEMLYG 228

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	369
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	99.98
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	99.98
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.98
KOG0696	683	consensus Serine/threonine protein kinase [Signal	99.98
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.97
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.97
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.97
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	99.97
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	99.97
KOG0695	593	consensus Serine/threonine protein kinase [Signal	99.97
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.97
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.97
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.97
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	99.97
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.97
KOG1152	772	consensus Signal transduction serine/threonine kin	99.96
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.96
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.96
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.96
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.95
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.95
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.95
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.95
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.93
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.93
PLN00181	793	protein SPA1-RELATED; Provisional	99.92
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.92
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.91
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.91
PRK09188	365	serine/threonine protein kinase; Provisional	99.9
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.89
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.88
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.88
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.86
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.86
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.85
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.83
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.83
PRK12274	218	serine/threonine protein kinase; Provisional	99.8
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.8
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.79
PRK14879	211	serine/threonine protein kinase; Provisional	99.76
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.75
smart00090	237	RIO RIO-like kinase.	99.75
PRK10345	210	hypothetical protein; Provisional	99.74
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.73
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.71
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.71
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.7
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.67
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.63
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.63
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.62
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.57
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.52
KOG1243	690	consensus Protein kinase [General function predict	99.51
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.46
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.43
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.4
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.37
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.32
COG4248	637	Uncharacterized protein with protein kinase and he	99.31
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	99.27
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.27
KOG3087	229	consensus Serine/threonine protein kinase [General	99.25
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.18
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.14
COG0478	304	RIO-like serine/threonine protein kinase fused to	99.13
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	99.06
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	98.98
KOG0606	1205	consensus Microtubule-associated serine/threonine	98.97
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.88
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.8
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.71
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.69
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.66
PRK09902	216	hypothetical protein; Provisional	98.66
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.6
PF01636	239	APH: Phosphotransferase enzyme family This family	98.48
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.46
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	98.34
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.23
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	98.22
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	98.21
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	98.18
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	98.16
PLN02876	822	acyl-CoA dehydrogenase	98.15
PRK10593	297	hypothetical protein; Provisional	98.09
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	98.08
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	98.07
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.06
PRK05231	319	homoserine kinase; Provisional	98.04
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	98.03
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	97.95
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.91
KOG2268	465	consensus Serine/threonine protein kinase [Signal	97.79
KOG2270	520	consensus Serine/threonine protein kinase involved	97.76
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.69
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	97.6
PLN02236	344	choline kinase	97.58
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	97.56
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	97.44
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	97.38
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	97.23
PLN02756	418	S-methyl-5-thioribose kinase	97.0
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	96.89
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	96.86
PRK12396	409	5-methylribose kinase; Reviewed	96.85
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	96.79
COG3001	286	Uncharacterized protein conserved in bacteria [Fun	96.77
COG2334	331	Putative homoserine kinase type II (protein kinase	96.73
PF11883	48	DUF3403: Domain of unknown function (DUF3403); Int	96.69
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	96.57
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	96.53
PRK11768	325	serine/threonine protein kinase; Provisional	96.39
PTZ00384	383	choline kinase; Provisional	96.01
PRK06148	1013	hypothetical protein; Provisional	95.94
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	95.94
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	95.62
PTZ00296	442	choline kinase; Provisional	95.61

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4e-48  Score=359.03  Aligned_cols=246  Identities=25%  Similarity=0.425  Sum_probs=213.2

Q ss_pred             cCCccCccccccCCccEEEEEE-cCCCEEEEEEecCC---CchhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEEE
Q 017594           49 NKFSDANKLGEGGFGPVYKGVL-KKGDEIAVKRLSGR---SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIY  124 (369)
Q Consensus        49 ~~y~i~~~lg~G~~~~v~~~~~-~~~~~valK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  124 (369)
                      .+|...+.||+|+|+.+|.+++ .+|+.||+|++.+.   .....+.+.+|+++.+.|+||||++++++|++.+..|+|.
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL   97 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL   97 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence            6799999999999999999997 67999999999753   3345678889999999999999999999999999999999


Q ss_pred             EecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCCC
Q 017594          125 EYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGN  204 (369)
Q Consensus       125 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~~  204 (369)
                      |.|..++|..++.   +++.+.+.+++.++.||+.||.|||+++   |+|||||..|+|++++-+|||+|||++..+...
T Consensus        98 ELC~~~sL~el~K---rrk~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~  171 (592)
T KOG0575|consen   98 ELCHRGSLMELLK---RRKPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD  171 (592)
T ss_pred             EecCCccHHHHHH---hcCCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceeeeecCc
Confidence            9999999999984   5677999999999999999999999999   999999999999999999999999999987643


Q ss_pred             CcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCccccccCccc
Q 017594          205 ELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPIL  284 (369)
Q Consensus       205 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (369)
                      .  ......+|||.|.|||++.....+..+||||+||++|.|+.|++||+...                  +.+.+..+.
T Consensus       172 ~--Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~------------------vkety~~Ik  231 (592)
T KOG0575|consen  172 G--ERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKT------------------VKETYNKIK  231 (592)
T ss_pred             c--cccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccch------------------HHHHHHHHH
Confidence            2  34556799999999999999999999999999999999999999997432                  122222222


Q ss_pred             cccc-cHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 017594          285 EDEY-SSKQMLLRYANIALLCVQESADDRPTMNDVVS  320 (369)
Q Consensus       285 ~~~~-~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~  320 (369)
                      ..++ .+...+.+..+||.++|+.||.+|||+++|+.
T Consensus       232 ~~~Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~  268 (592)
T KOG0575|consen  232 LNEYSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLD  268 (592)
T ss_pred             hcCcccccccCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            2211 12234778999999999999999999999994

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.2e-47  Score=340.09  Aligned_cols=250  Identities=26%  Similarity=0.398  Sum_probs=205.9

Q ss_pred             HHhcCCccCccccccCCccEEEEEEc-CCCEEEEEEecCCCch-------hHHHHHHHHHHHhcCCCCceeeeeeeEEeC
Q 017594           46 TATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSGQ-------GLREMKNEASVIAKVQHKNLVRLLGCCIDR  117 (369)
Q Consensus        46 ~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~~~~-------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~  117 (369)
                      ...+.|.+.+.||+|+||.|-+|..+ +|+.||||++......       ......+|+++|++|+||||+++.++|...
T Consensus       169 s~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~  248 (475)
T KOG0615|consen  169 SFNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVP  248 (475)
T ss_pred             hhcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecC
Confidence            36788999999999999999999954 5999999999754211       123456899999999999999999999999


Q ss_pred             CccEEEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCC---CceEEee
Q 017594          118 DEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKD---MNPKISD  194 (369)
Q Consensus       118 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~---~~~~L~D  194 (369)
                      +..|+|+||++||.|.+.+-.   ++.+.+.....+++||+.|+.|||++|   |+||||||+|||++.+   -.+||+|
T Consensus       249 ds~YmVlE~v~GGeLfd~vv~---nk~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKItD  322 (475)
T KOG0615|consen  249 DSSYMVLEYVEGGELFDKVVA---NKYLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKITD  322 (475)
T ss_pred             CceEEEEEEecCccHHHHHHh---ccccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEecc
Confidence            999999999999999998844   444888888999999999999999999   9999999999999766   6789999


Q ss_pred             cCCceecCCCCcccccccccccccccCchhhccCC---CCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhh
Q 017594          195 FGMARICGGNELQANTSRIVGTYGYMSPEYALEGI---FSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLW  271 (369)
Q Consensus       195 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~---~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~  271 (369)
                      ||++...+..   ......+||+.|.|||++.+..   +..+.|+|||||+||-+++|.+||.....+..          
T Consensus       323 FGlAK~~g~~---sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~s----------  389 (475)
T KOG0615|consen  323 FGLAKVSGEG---SFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPS----------  389 (475)
T ss_pred             cchhhccccc---eehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCcc----------
Confidence            9999876533   3455679999999999998655   34578999999999999999999974432221          


Q ss_pred             hcCccccccCcccccc-----ccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 017594          272 TSNRTLELIDPILEDE-----YSSKQMLLRYANIALLCVQESADDRPTMNDVVSM  321 (369)
Q Consensus       272 ~~~~~~~~~~~~~~~~-----~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~  321 (369)
                             +.+.+..+.     .....++.+..+||.+||..||++|||+.|+|+.
T Consensus       390 -------l~eQI~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~h  437 (475)
T KOG0615|consen  390 -------LKEQILKGRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALNH  437 (475)
T ss_pred             -------HHHHHhcCcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcC
Confidence                   111111111     2244568899999999999999999999999964

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-46  Score=330.79  Aligned_cols=253  Identities=27%  Similarity=0.389  Sum_probs=211.4

Q ss_pred             HHhcCCccCccccccCCccEEEEEEcC-CCEEEEEEecCC-CchhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCc-cEE
Q 017594           46 TATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGR-SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDE-KIL  122 (369)
Q Consensus        46 ~~~~~y~i~~~lg~G~~~~v~~~~~~~-~~~valK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-~~l  122 (369)
                      ....+.+.++.||+|..|+||+|+++. +.-+|+|++... +....+++.+|+++++..+||+|+.+++.|..... ..+
T Consensus        76 i~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI  155 (364)
T KOG0581|consen   76 ISLSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISI  155 (364)
T ss_pred             cCHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEe
Confidence            334578889999999999999999765 788999998533 45567889999999999999999999999999885 999


Q ss_pred             EEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhc-CCCCCcccCCCCCCCEEEeCCCceEEeecCCceec
Q 017594          123 IYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQ-YSRVRIIHRDLKASNILLDKDMNPKISDFGMARIC  201 (369)
Q Consensus       123 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~-~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~  201 (369)
                      +|||+++|+|+.++...   ..+++..+.+++.++++||.|||. .+   |+||||||.||||+..|.|||+|||.+..+
T Consensus       156 ~mEYMDgGSLd~~~k~~---g~i~E~~L~~ia~~VL~GL~YLh~~~~---IIHRDIKPsNlLvNskGeVKicDFGVS~~l  229 (364)
T KOG0581|consen  156 CMEYMDGGSLDDILKRV---GRIPEPVLGKIARAVLRGLSYLHEERK---IIHRDIKPSNLLVNSKGEVKICDFGVSGIL  229 (364)
T ss_pred             ehhhcCCCCHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhhccC---eeeccCCHHHeeeccCCCEEeccccccHHh
Confidence            99999999999999654   338999999999999999999996 66   999999999999999999999999998876


Q ss_pred             CCCCcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCccccccC
Q 017594          202 GGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELID  281 (369)
Q Consensus       202 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (369)
                      .+.    ......||..|+|||.+.+..|+.++||||||++++|+++|+.||......             ...+.+++.
T Consensus       230 vnS----~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~-------------~~~~~~Ll~  292 (364)
T KOG0581|consen  230 VNS----IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPP-------------YLDIFELLC  292 (364)
T ss_pred             hhh----hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCC-------------CCCHHHHHH
Confidence            544    334468999999999999999999999999999999999999998754211             122233333


Q ss_pred             cccccccc--HH-HHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 017594          282 PILEDEYS--SK-QMLLRYANIALLCVQESADDRPTMNDVVSM  321 (369)
Q Consensus       282 ~~~~~~~~--~~-~~~~~l~~li~~~L~~dP~~Rps~~ell~~  321 (369)
                      .+..+..+  +. .++++++++|..||+.||.+||++.++++.
T Consensus       293 ~Iv~~ppP~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H  335 (364)
T KOG0581|consen  293 AIVDEPPPRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQH  335 (364)
T ss_pred             HHhcCCCCCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence            33322111  22 358889999999999999999999999963

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=7.1e-46  Score=328.99  Aligned_cols=200  Identities=32%  Similarity=0.523  Sum_probs=180.6

Q ss_pred             HhcCCccCccccccCCccEEEEEEcC-CCEEEEEEecCC--CchhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEE
Q 017594           47 ATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILI  123 (369)
Q Consensus        47 ~~~~y~i~~~lg~G~~~~v~~~~~~~-~~~valK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv  123 (369)
                      ...+|.+.+.||+|+||+||+|+.+. +..||||.+...  .....+.+..|+.+|+.++||||+.++++....+..|+|
T Consensus         8 ~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lV   87 (429)
T KOG0595|consen    8 VVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLV   87 (429)
T ss_pred             ccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEE
Confidence            34789999999999999999999654 899999999866  455667788999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCC------CceEEeecCC
Q 017594          124 YEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKD------MNPKISDFGM  197 (369)
Q Consensus       124 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~------~~~~L~Dfg~  197 (369)
                      ||||+||+|.++++...   .+++..+..++.||+.||++||.++   |+||||||+|||++..      ..+||+|||+
T Consensus        88 MEyC~gGDLs~yi~~~~---~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGf  161 (429)
T KOG0595|consen   88 MEYCNGGDLSDYIRRRG---RLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADFGF  161 (429)
T ss_pred             EEeCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEecccch
Confidence            99999999999996544   4999999999999999999999999   9999999999999765      4589999999


Q ss_pred             ceecCCCCcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCC
Q 017594          198 ARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGL  255 (369)
Q Consensus       198 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~  255 (369)
                      ++.+....   .....+|++.|+|||++....|+.|+|+||+|+|+|+|++|+.||..
T Consensus       162 AR~L~~~~---~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a  216 (429)
T KOG0595|consen  162 ARFLQPGS---MAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDA  216 (429)
T ss_pred             hhhCCchh---HHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccc
Confidence            99887443   34556899999999999999999999999999999999999999874

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-44  Score=334.55  Aligned_cols=291  Identities=45%  Similarity=0.787  Sum_probs=249.3

Q ss_pred             CccccchhhHHHHhcCCccCccccccCCccEEEEEEcCCCEEEEEEecCCCchhHHHHHHHHHHHhcCCCCceeeeeeeE
Q 017594           35 QFPLFSFSSVSTATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCC  114 (369)
Q Consensus        35 ~~~~~~~~~~~~~~~~y~i~~~lg~G~~~~v~~~~~~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~  114 (369)
                      ....|++.++..+.+.|.-.+.||+|+||.||+|...+|..||||++.........++..|+.++.+++|||+++++++|
T Consensus        61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC  140 (361)
T KOG1187|consen   61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC  140 (361)
T ss_pred             CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence            67789999999999999999999999999999999998899999988755432145699999999999999999999999


Q ss_pred             EeCC-ccEEEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEe
Q 017594          115 IDRD-EKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKIS  193 (369)
Q Consensus       115 ~~~~-~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~  193 (369)
                      .+.+ +.++|+||+.+|+|.+.+...... +++|..+.+|+.++|+||+|||....++++|||||+.|||+|.+...||+
T Consensus       141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKls  219 (361)
T KOG1187|consen  141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLS  219 (361)
T ss_pred             ecCCceEEEEEEccCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEcc
Confidence            9988 499999999999999999765543 78999999999999999999999887789999999999999999999999


Q ss_pred             ecCCceecCCCCcccccccc-cccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCc-ccccccchhhhhhh
Q 017594          194 DFGMARICGGNELQANTSRI-VGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYR-TDSLNLLGYAWDLW  271 (369)
Q Consensus       194 Dfg~~~~~~~~~~~~~~~~~-~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~-~~~~~~~~~~~~~~  271 (369)
                      |||++......  ....... .|+.+|+|||+...+..+.++||||+|+++.||++|+.+..... ........|.+..+
T Consensus       220 DFGLa~~~~~~--~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~  297 (361)
T KOG1187|consen  220 DFGLAKLGPEG--DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLL  297 (361)
T ss_pred             CccCcccCCcc--ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHH
Confidence            99999654321  1111112 78999999999999999999999999999999999998877544 33334677888888


Q ss_pred             hcCccccccCcccc-ccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHhhhhc
Q 017594          272 TSNRTLELIDPILE-DEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNEAAT  328 (369)
Q Consensus       272 ~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L~~~~~~  328 (369)
                      ......+.+++.+. +..........+..+...|++.+|.+||++.++++.|+.+...
T Consensus       298 ~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~~  355 (361)
T KOG1187|consen  298 EEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILSL  355 (361)
T ss_pred             HCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhccc
Confidence            88889999999987 4444324466799999999999999999999999999665543

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=8.1e-47  Score=319.62  Aligned_cols=258  Identities=24%  Similarity=0.386  Sum_probs=209.1

Q ss_pred             HhcCCccCccccccCCccEEEEE-EcCCCEEEEEEecCC--CchhHHHHHHHHHHHhcCCCCceeeeee-eEEeCCc-cE
Q 017594           47 ATNKFSDANKLGEGGFGPVYKGV-LKKGDEIAVKRLSGR--SGQGLREMKNEASVIAKVQHKNLVRLLG-CCIDRDE-KI  121 (369)
Q Consensus        47 ~~~~y~i~~~lg~G~~~~v~~~~-~~~~~~valK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~-~~~~~~~-~~  121 (369)
                      ....|+|++.||+|.||.||+++ ..+|..+|.|.+.-.  +....+.+..|+.+|++|+||||+++++ .|.+++. ++
T Consensus        17 ~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evln   96 (375)
T KOG0591|consen   17 TLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLN   96 (375)
T ss_pred             cHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhH
Confidence            34579999999999999999999 456999999988633  3445567888999999999999999998 5555555 89


Q ss_pred             EEEEecCCCChhhhhcC-CCccccCChHHHHHHHHHHHHHHHHHhcCC-CCCcccCCCCCCCEEEeCCCceEEeecCCce
Q 017594          122 LIYEYMPNKSLDFFLFD-PTKRMLLDWVTRVQIIEGIAQGLLYLHQYS-RVRIIHRDLKASNILLDKDMNPKISDFGMAR  199 (369)
Q Consensus       122 lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~i~~qi~~al~~LH~~~-~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~  199 (369)
                      +|||+|.+|.|...+.. ...+..+++..+|+++.|++.||.++|++- ...+.||||||.|||++.+|.+||+|||+++
T Consensus        97 ivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r  176 (375)
T KOG0591|consen   97 IVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGR  176 (375)
T ss_pred             HHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHh
Confidence            99999999999988864 233566999999999999999999999832 1249999999999999999999999999999


Q ss_pred             ecCCCCcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCccccc
Q 017594          200 ICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLEL  279 (369)
Q Consensus       200 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (369)
                      .+.+..  .......|||.|++||++.+.+|+.++||||+||++|||+.-++||....                  ..++
T Consensus       177 ~l~s~~--tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n------------------~~~L  236 (375)
T KOG0591|consen  177 FLSSKT--TFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDN------------------LLSL  236 (375)
T ss_pred             Hhcchh--HHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCccccc------------------HHHH
Confidence            876443  22334689999999999999999999999999999999999999986431                  1111


Q ss_pred             cCccccccc---cHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHh
Q 017594          280 IDPILEDEY---SSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTN  324 (369)
Q Consensus       280 ~~~~~~~~~---~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L~~  324 (369)
                      -.++-.+++   +...++.++..+|..|+..||+.||+.-.++..+..
T Consensus       237 ~~KI~qgd~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~  284 (375)
T KOG0591|consen  237 CKKIEQGDYPPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS  284 (375)
T ss_pred             HHHHHcCCCCCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence            112222222   235568899999999999999999997666665554

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=1.9e-45  Score=314.20  Aligned_cols=264  Identities=21%  Similarity=0.313  Sum_probs=206.8

Q ss_pred             cCCccCccccccCCccEEEEEEcC-CCEEEEEEecCCCc--hhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEEEE
Q 017594           49 NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSG--QGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIYE  125 (369)
Q Consensus        49 ~~y~i~~~lg~G~~~~v~~~~~~~-~~~valK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  125 (369)
                      ++|+.+.++|+|+||.||++++++ |+-||||+|..++.  ...+-..+|+.+|++++|+|++.++++|......++|+|
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE   81 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE   81 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence            479999999999999999999776 99999999976543  334557789999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCCCC
Q 017594          126 YMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE  205 (369)
Q Consensus       126 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~~~  205 (369)
                      ||+..-|.++-....+   ++...+.+++.|++.|+.|+|+++   ++||||||+||+++.+|.+||+|||+++.+....
T Consensus        82 ~~dhTvL~eLe~~p~G---~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pg  155 (396)
T KOG0593|consen   82 YCDHTVLHELERYPNG---VPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLSAPG  155 (396)
T ss_pred             ecchHHHHHHHhccCC---CCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhhcCCc
Confidence            9998877766543333   888999999999999999999999   9999999999999999999999999999876432


Q ss_pred             cccccccccccccccCchhhcc-CCCCcccchHhHHHHHHHHHhCCCCCCCCccccccc---------chhhhhhhhcCc
Q 017594          206 LQANTSRIVGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNL---------LGYAWDLWTSNR  275 (369)
Q Consensus       206 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~---------~~~~~~~~~~~~  275 (369)
                      .  .-.....|.+|+|||.+.+ ..|+...||||+||++.||++|.+.|...++.++..         ..-....+....
T Consensus       156 d--~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~  233 (396)
T KOG0593|consen  156 D--NYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNP  233 (396)
T ss_pred             c--hhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCC
Confidence            2  2233467899999999987 679999999999999999999999998766433211         111112222221


Q ss_pred             cccccC-ccc-ccccc---HHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 017594          276 TLELID-PIL-EDEYS---SKQMLLRYANIALLCVQESADDRPTMNDVVS  320 (369)
Q Consensus       276 ~~~~~~-~~~-~~~~~---~~~~~~~l~~li~~~L~~dP~~Rps~~ell~  320 (369)
                      ...-+. +.. ..+..   ....+.-+.++++.||+.||.+|++-++++.
T Consensus       234 ~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~  283 (396)
T KOG0593|consen  234 FFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH  283 (396)
T ss_pred             ceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence            111110 000 00100   1122557899999999999999999999984

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=7.9e-44  Score=327.17  Aligned_cols=266  Identities=30%  Similarity=0.494  Sum_probs=214.9

Q ss_pred             HhcCCccCccccccCCccEEEEEEcCCCEEEEEEecCCCchh--HHHHHHHHHHHhcCCCCceeeeeeeEEeCC-ccEEE
Q 017594           47 ATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQG--LREMKNEASVIAKVQHKNLVRLLGCCIDRD-EKILI  123 (369)
Q Consensus        47 ~~~~y~i~~~lg~G~~~~v~~~~~~~~~~valK~~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~lv  123 (369)
                      ......+.+.||.|+||+||++.++....||+|++.......  .+.+.+|+.+|..++||||+++++++.... .+++|
T Consensus        39 ~~~~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iV  118 (362)
T KOG0192|consen   39 DPDELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIV  118 (362)
T ss_pred             ChHHhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEE
Confidence            344556666799999999999999954449999998654222  458999999999999999999999998877 79999


Q ss_pred             EEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCC-ceEEeecCCceecC
Q 017594          124 YEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDM-NPKISDFGMARICG  202 (369)
Q Consensus       124 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~-~~~L~Dfg~~~~~~  202 (369)
                      |||+.+|+|..++... .+..++...+..++.+|+.|+.|||+.+  +|+||||||+|||++.++ .+||+|||+++...
T Consensus       119 tEy~~~GsL~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH~~~--~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~  195 (362)
T KOG0192|consen  119 TEYMPGGSLSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLHSEG--PIIHRDLKSDNILVDLKGKTLKIADFGLSREKV  195 (362)
T ss_pred             EEeCCCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcCC--CeeecccChhhEEEcCCCCEEEECCCccceeec
Confidence            9999999999999764 3556999999999999999999999986  289999999999999998 99999999998765


Q ss_pred             CCCcccccccccccccccCchhhc--cCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCcccccc
Q 017594          203 GNELQANTSRIVGTYGYMSPEYAL--EGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELI  280 (369)
Q Consensus       203 ~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (369)
                      ...  .......||..|+|||++.  +..|+.++||||+|+++|+|+||+.||..... .    ......     .....
T Consensus       196 ~~~--~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~-~----~~~~~v-----~~~~~  263 (362)
T KOG0192|consen  196 ISK--TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP-V----QVASAV-----VVGGL  263 (362)
T ss_pred             ccc--ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH-H----HHHHHH-----HhcCC
Confidence            432  2223357899999999999  66999999999999999999999999975442 1    111111     11111


Q ss_pred             CccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHhhhhccCCC
Q 017594          281 DPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNEAATLLPP  332 (369)
Q Consensus       281 ~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L~~~~~~~~~~  332 (369)
                      .+.+...     ++..+..++..||..||+.||++.+++..|+.+.......
T Consensus       264 Rp~~p~~-----~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~~~  310 (362)
T KOG0192|consen  264 RPPIPKE-----CPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHISSA  310 (362)
T ss_pred             CCCCCcc-----CCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhccc
Confidence            1111111     3667999999999999999999999999999998865543

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=3.5e-45  Score=321.68  Aligned_cols=248  Identities=25%  Similarity=0.372  Sum_probs=205.2

Q ss_pred             HHhcCCccCccccccCCccEEEEEEcC-CCEEEEEEecCC---CchhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccE
Q 017594           46 TATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGR---SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKI  121 (369)
Q Consensus        46 ~~~~~y~i~~~lg~G~~~~v~~~~~~~-~~~valK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  121 (369)
                      ...++|++++.||+|+||+||.++.++ ++-+|+|++.+.   .....+....|..+|..++||.|++++..|.+.+++|
T Consensus        22 ~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLy  101 (357)
T KOG0598|consen   22 VGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLY  101 (357)
T ss_pred             CChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEE
Confidence            446889999999999999999999655 889999998754   2345677889999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceec
Q 017594          122 LIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARIC  201 (369)
Q Consensus       122 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~  201 (369)
                      +|++|+.||.|...+.+...   +++..++-++..|+.||.|||++|   |+||||||+|||++.+|+++|+|||++...
T Consensus       102 lVld~~~GGeLf~hL~~eg~---F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~~  175 (357)
T KOG0598|consen  102 LVLDYLNGGELFYHLQREGR---FSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKED  175 (357)
T ss_pred             EEEeccCCccHHHHHHhcCC---cchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchhc
Confidence            99999999999999865444   999999999999999999999999   999999999999999999999999999854


Q ss_pred             CCCCcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCccccccC
Q 017594          202 GGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELID  281 (369)
Q Consensus       202 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (369)
                      -...  ......+||+.|+|||++.+..|+.++|.||||+++|+|++|.+||....                  ..+.++
T Consensus       176 ~~~~--~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~------------------~~~~~~  235 (357)
T KOG0598|consen  176 LKDG--DATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAED------------------VKKMYD  235 (357)
T ss_pred             ccCC--CccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCcc------------------HHHHHH
Confidence            3222  22334799999999999999999999999999999999999999986432                  111111


Q ss_pred             cccccc-c-cHHHHHHHHHHHHHHhhcCCCCCCC----CHHHHH
Q 017594          282 PILEDE-Y-SSKQMLLRYANIALLCVQESADDRP----TMNDVV  319 (369)
Q Consensus       282 ~~~~~~-~-~~~~~~~~l~~li~~~L~~dP~~Rp----s~~ell  319 (369)
                      .++.+. . .+...+.+.++++.++|+.||++|.    ++.+|-
T Consensus       236 ~I~~~k~~~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik  279 (357)
T KOG0598|consen  236 KILKGKLPLPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIK  279 (357)
T ss_pred             HHhcCcCCCCCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhh
Confidence            222111 1 1111367799999999999999996    455543

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-43  Score=323.17  Aligned_cols=253  Identities=27%  Similarity=0.363  Sum_probs=207.5

Q ss_pred             HHhcCCccCccccccCCccEEEEEEcC-CCEEEEEEecCC---CchhHHHHHHHHHHHhcC-CCCceeeeeeeEEeCCcc
Q 017594           46 TATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGR---SGQGLREMKNEASVIAKV-QHKNLVRLLGCCIDRDEK  120 (369)
Q Consensus        46 ~~~~~y~i~~~lg~G~~~~v~~~~~~~-~~~valK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~  120 (369)
                      ....+|.+.+.||.|+|++|++|+.+. ++.||||++.+.   .....+.+..|-.+|.+| .||.|++++..|.++..+
T Consensus        70 k~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sL  149 (604)
T KOG0592|consen   70 KTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESL  149 (604)
T ss_pred             CChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccce
Confidence            345789999999999999999999654 999999998643   223346677889999999 799999999999999999


Q ss_pred             EEEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCcee
Q 017594          121 ILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARI  200 (369)
Q Consensus       121 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~  200 (369)
                      |+|+||+++|.|.+++...   ..+++.-.+.++.+|+.||+|||+.|   |+||||||+|||++.+++++|+|||.+..
T Consensus       150 YFvLe~A~nGdll~~i~K~---Gsfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGsAK~  223 (604)
T KOG0592|consen  150 YFVLEYAPNGDLLDLIKKY---GSFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGSAKI  223 (604)
T ss_pred             EEEEEecCCCcHHHHHHHh---CcchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeecccccc
Confidence            9999999999999999554   44999999999999999999999999   99999999999999999999999999988


Q ss_pred             cCCCCcc---------ccc--ccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhh
Q 017594          201 CGGNELQ---------ANT--SRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWD  269 (369)
Q Consensus       201 ~~~~~~~---------~~~--~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~  269 (369)
                      +......         ...  ....||..|.+||++.....+..+|+|+||||+|+|+.|.+||......-         
T Consensus       224 l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Neyl---------  294 (604)
T KOG0592|consen  224 LSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYL---------  294 (604)
T ss_pred             CChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHH---------
Confidence            7532211         111  34679999999999999999999999999999999999999996332111         


Q ss_pred             hhhcCccccccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 017594          270 LWTSNRTLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSM  321 (369)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~  321 (369)
                        .-+++. .++..+..     .+++...+||.++|-.||++|+++++|-++
T Consensus       295 --iFqkI~-~l~y~fp~-----~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~H  338 (604)
T KOG0592|consen  295 --IFQKIQ-ALDYEFPE-----GFPEDARDLIKKLLVRDPSDRLTSQQIKAH  338 (604)
T ss_pred             --HHHHHH-HhcccCCC-----CCCHHHHHHHHHHHccCccccccHHHHhhC
Confidence              001111 11111222     225678999999999999999999999865

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-44  Score=325.50  Aligned_cols=266  Identities=24%  Similarity=0.336  Sum_probs=207.8

Q ss_pred             HHhcCCccCccccccCCccEEEEEEc-CCCEEEEEEecCCCchhHHH--HHHHHHHHhcCC-CCceeeeeeeEEeCC-cc
Q 017594           46 TATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSGQGLRE--MKNEASVIAKVQ-HKNLVRLLGCCIDRD-EK  120 (369)
Q Consensus        46 ~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~~~~~~~~--~~~e~~~l~~l~-h~~i~~~~~~~~~~~-~~  120 (369)
                      .+-+||.++++||.|+||.||+|+.+ +|..||||+++..-.. +++  -.+|++.|++|+ ||||+++.+++.+.+ .+
T Consensus         7 ~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s-~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L   85 (538)
T KOG0661|consen    7 IFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRIL   85 (538)
T ss_pred             hHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhcc-HHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceE
Confidence            45689999999999999999999955 4899999998765433 233  346999999998 999999999999887 89


Q ss_pred             EEEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCcee
Q 017594          121 ILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARI  200 (369)
Q Consensus       121 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~  200 (369)
                      ++||||++ .+|.+++...  +..+++..+..|+.||++||+|+|.+|   +.|||+||+|||+.....+||+|||+++.
T Consensus        86 ~fVfE~Md-~NLYqLmK~R--~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLARe  159 (538)
T KOG0661|consen   86 YFVFEFMD-CNLYQLMKDR--NRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLARE  159 (538)
T ss_pred             eeeHHhhh-hhHHHHHhhc--CCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEecccccccc
Confidence            99999985 5788888654  677999999999999999999999999   99999999999999999999999999998


Q ss_pred             cCCCCcccccccccccccccCchhhc-cCCCCcccchHhHHHHHHHHHhCCCCCCCCcccc-cccc-----hhhhhhhhc
Q 017594          201 CGGNELQANTSRIVGTYGYMSPEYAL-EGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDS-LNLL-----GYAWDLWTS  273 (369)
Q Consensus       201 ~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~-~~~~-----~~~~~~~~~  273 (369)
                      ......   -.....|.+|+|||++. .+.|+.+.|+||+|||++|+.+-++.|......+ ....     ...++.+..
T Consensus       160 v~SkpP---YTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~e  236 (538)
T KOG0661|consen  160 VRSKPP---YTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPE  236 (538)
T ss_pred             cccCCC---cchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchh
Confidence            765432   33457899999999875 6779999999999999999999999997654211 1100     001111111


Q ss_pred             -CccccccCccccc-------cccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHH
Q 017594          274 -NRTLELIDPILED-------EYSSKQMLLRYANIALLCVQESADDRPTMNDVVSML  322 (369)
Q Consensus       274 -~~~~~~~~~~~~~-------~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L  322 (369)
                       ......+...+..       ...+. .+.++.++|.+||++||.+||||.++++.-
T Consensus       237 g~~La~~mnf~~P~~~~~~l~~L~p~-~s~~~~~li~~ll~WDP~kRpTA~~al~~p  292 (538)
T KOG0661|consen  237 GYNLASAMNFRFPQVKPSPLKDLLPN-ASSEAASLIERLLAWDPDKRPTASQALQHP  292 (538)
T ss_pred             HHHHHHHhccCCCcCCCCChHHhCcc-cCHHHHHHHHHHhcCCCccCccHHHHhcCc
Confidence             1111112221111       11111 478899999999999999999999999753

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-43  Score=325.34  Aligned_cols=253  Identities=26%  Similarity=0.390  Sum_probs=211.9

Q ss_pred             HHHhcCCccCccccccCCccEEEEEEc-CCCEEEEEEecCCCchhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEE
Q 017594           45 STATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILI  123 (369)
Q Consensus        45 ~~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv  123 (369)
                      ..-..+|....+||+|+.|.||.|+.. +++.||+|++....-...+.+.+|+.+|+..+|+||+.+++.|...+.+|+|
T Consensus       269 ~dP~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVV  348 (550)
T KOG0578|consen  269 GDPRSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVV  348 (550)
T ss_pred             CChhhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEE
Confidence            334567999999999999999999954 5889999999877656667889999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCC
Q 017594          124 YEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGG  203 (369)
Q Consensus       124 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~  203 (369)
                      |||++||+|.+.+..    ..+++..+..+++.+++||+|||.+|   |+|+|||.+||+++.+|.+||+|||++..+..
T Consensus       349 MEym~ggsLTDvVt~----~~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~  421 (550)
T KOG0578|consen  349 MEYMEGGSLTDVVTK----TRMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQISE  421 (550)
T ss_pred             EeecCCCchhhhhhc----ccccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeecccc
Confidence            999999999999843    33899999999999999999999999   99999999999999999999999999988765


Q ss_pred             CCcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCccccccCcc
Q 017594          204 NELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPI  283 (369)
Q Consensus       204 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (369)
                      ...  ......||+.|+|||+.....|+++.||||||++++||+.|.+||-....     +.-.+-........      
T Consensus       422 ~~~--KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~P-----lrAlyLIa~ng~P~------  488 (550)
T KOG0578|consen  422 EQS--KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENP-----LRALYLIATNGTPK------  488 (550)
T ss_pred             ccC--ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCCh-----HHHHHHHhhcCCCC------
Confidence            442  44556899999999999999999999999999999999999999853210     00011111111111      


Q ss_pred             ccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 017594          284 LEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVS  320 (369)
Q Consensus       284 ~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~  320 (369)
                         -..+...+..+.+|+.+||+.|+++|++|.|||+
T Consensus       489 ---lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~  522 (550)
T KOG0578|consen  489 ---LKNPEKLSPELKDFLDRCLVVDVEQRASAKELLE  522 (550)
T ss_pred             ---cCCccccCHHHHHHHHHHhhcchhcCCCHHHHhc
Confidence               1113334788999999999999999999999996

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-42  Score=310.15  Aligned_cols=266  Identities=23%  Similarity=0.354  Sum_probs=211.1

Q ss_pred             HHHHhcCCccCccccccCCccEEEEE-EcCCCEEEEEEecCC-CchhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccE
Q 017594           44 VSTATNKFSDANKLGEGGFGPVYKGV-LKKGDEIAVKRLSGR-SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKI  121 (369)
Q Consensus        44 ~~~~~~~y~i~~~lg~G~~~~v~~~~-~~~~~~valK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  121 (369)
                      .....+.|++...||.|..+.||+|+ ...+..||||++... .......+.+|+..+..+.||||+.++..|..+..+|
T Consensus        21 ~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LW  100 (516)
T KOG0582|consen   21 FPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELW  100 (516)
T ss_pred             CCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeE
Confidence            34556889999999999999999999 455899999999744 3344688999999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceec
Q 017594          122 LIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARIC  201 (369)
Q Consensus       122 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~  201 (369)
                      +||+|+.+|++.+++..... ..+++..+..|++++++||.|||++|   .+|||||+.|||++.+|.|+|+|||.+..+
T Consensus       101 vVmpfMa~GS~ldIik~~~~-~Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa~l  176 (516)
T KOG0582|consen  101 VVMPFMAGGSLLDIIKTYYP-DGLEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSASL  176 (516)
T ss_pred             EeehhhcCCcHHHHHHHHcc-ccccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeeeee
Confidence            99999999999999876443 33899999999999999999999999   999999999999999999999999986655


Q ss_pred             CCCCccc--ccccccccccccCchhhcc--CCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCccc
Q 017594          202 GGNELQA--NTSRIVGTYGYMSPEYALE--GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTL  277 (369)
Q Consensus       202 ~~~~~~~--~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  277 (369)
                      .......  .+....|+++|+|||++..  ..|+.|+||||+|++++||.+|..||..+..-....     ...... +.
T Consensus       177 ~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl-----~tLqn~-pp  250 (516)
T KOG0582|consen  177 FDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLL-----LTLQND-PP  250 (516)
T ss_pred             cccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHH-----HHhcCC-CC
Confidence            4322221  1245679999999999553  469999999999999999999999998654221110     000000 00


Q ss_pred             cccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 017594          278 ELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVS  320 (369)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~  320 (369)
                      ......+ ..-....++..+.++|..||+.||.+|||+.++++
T Consensus       251 ~~~t~~~-~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk  292 (516)
T KOG0582|consen  251 TLLTSGL-DKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK  292 (516)
T ss_pred             CcccccC-ChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence            0000011 11123334668999999999999999999999985

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=9.3e-43  Score=311.01  Aligned_cols=258  Identities=26%  Similarity=0.396  Sum_probs=205.2

Q ss_pred             hcCCccCccccccCCccEEEEEEcC-CCEEEEEEecCCCchhHHHHHHHHHHHhcCCCCceeeeeeeEEeCC--ccEEEE
Q 017594           48 TNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDRD--EKILIY  124 (369)
Q Consensus        48 ~~~y~i~~~lg~G~~~~v~~~~~~~-~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~lv~  124 (369)
                      ..+|...+.||+|+||.||++...+ |..+|+|.+...+....+.+..|+.+|.+++||||+++++......  .++++|
T Consensus        16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~m   95 (313)
T KOG0198|consen   16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFM   95 (313)
T ss_pred             cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeee
Confidence            5679999999999999999999765 8999999987654444677999999999999999999999754444  589999


Q ss_pred             EecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeC-CCceEEeecCCceecCC
Q 017594          125 EYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDK-DMNPKISDFGMARICGG  203 (369)
Q Consensus       125 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~-~~~~~L~Dfg~~~~~~~  203 (369)
                      ||+.+|+|.+++.....  .+++..+..+..||+.||+|||++|   ++||||||.||+++. ++.++|+|||++.....
T Consensus        96 Ey~~~GsL~~~~~~~g~--~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~  170 (313)
T KOG0198|consen   96 EYAPGGSLSDLIKRYGG--KLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKKLES  170 (313)
T ss_pred             eccCCCcHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCcccccccc
Confidence            99999999999976543  5899999999999999999999999   999999999999999 79999999999887653


Q ss_pred             -CCcccccccccccccccCchhhccC-CCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCccccccC
Q 017594          204 -NELQANTSRIVGTYGYMSPEYALEG-IFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELID  281 (369)
Q Consensus       204 -~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (369)
                       ...........|++.|+|||++.++ ....++|||||||++.+|+||.+||....    ................ .+ 
T Consensus       171 ~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~----~~~~~~~~ig~~~~~P-~i-  244 (313)
T KOG0198|consen  171 KGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFF----EEAEALLLIGREDSLP-EI-  244 (313)
T ss_pred             ccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhc----chHHHHHHHhccCCCC-CC-
Confidence             1112223346799999999999853 33459999999999999999999987530    0001111111111111 11 


Q ss_pred             ccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHh
Q 017594          282 PILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTN  324 (369)
Q Consensus       282 ~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L~~  324 (369)
                              +...+.+..+++.+|++.+|+.||||.++|+..-.
T Consensus       245 --------p~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~  279 (313)
T KOG0198|consen  245 --------PDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFL  279 (313)
T ss_pred             --------CcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhh
Confidence                    12237789999999999999999999999985433

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-42  Score=321.97  Aligned_cols=250  Identities=24%  Similarity=0.368  Sum_probs=206.4

Q ss_pred             HHHHhcCCccCccccccCCccEEEEEEc-CCCEEEEEEecCC----Cc-hhHHHHHHHHHHHhcCC-CCceeeeeeeEEe
Q 017594           44 VSTATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGR----SG-QGLREMKNEASVIAKVQ-HKNLVRLLGCCID  116 (369)
Q Consensus        44 ~~~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~----~~-~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~  116 (369)
                      .....++|.+.+.||.|.||+|+.|... +|..||+|++...    .. ...+.+.+|+.+++.+. ||||+++++++..
T Consensus        12 ~~~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t   91 (370)
T KOG0583|consen   12 LQLSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFAT   91 (370)
T ss_pred             cccccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEec
Confidence            3456789999999999999999999854 5899999977653    11 23456778999999998 9999999999999


Q ss_pred             CCccEEEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCC-CceEEeec
Q 017594          117 RDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKD-MNPKISDF  195 (369)
Q Consensus       117 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~-~~~~L~Df  195 (369)
                      ..+.++||||+.||.|.+++..   ...+.+.....+++||+.|++|||++|   ++||||||+||+++.+ +++||+||
T Consensus        92 ~~~~~ivmEy~~gGdL~~~i~~---~g~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DF  165 (370)
T KOG0583|consen   92 PTKIYIVMEYCSGGDLFDYIVN---KGRLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDF  165 (370)
T ss_pred             CCeEEEEEEecCCccHHHHHHH---cCCCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEecc
Confidence            9999999999999999999965   344888999999999999999999999   9999999999999999 99999999


Q ss_pred             CCceecCCCCcccccccccccccccCchhhccCC-CC-cccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhc
Q 017594          196 GMARICGGNELQANTSRIVGTYGYMSPEYALEGI-FS-IKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTS  273 (369)
Q Consensus       196 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~-~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~  273 (369)
                      |++....  .........+|++.|+|||++.+.. |+ .++||||+|++||.|++|..||....                
T Consensus       166 G~s~~~~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~----------------  227 (370)
T KOG0583|consen  166 GLSAISP--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSN----------------  227 (370)
T ss_pred             ccccccC--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCcc----------------
Confidence            9998774  1122344568999999999999877 75 78999999999999999999997422                


Q ss_pred             CccccccCcccccccc-HHHH-HHHHHHHHHHhhcCCCCCCCCHHHHH
Q 017594          274 NRTLELIDPILEDEYS-SKQM-LLRYANIALLCVQESADDRPTMNDVV  319 (369)
Q Consensus       274 ~~~~~~~~~~~~~~~~-~~~~-~~~l~~li~~~L~~dP~~Rps~~ell  319 (369)
                        .......+..+.+. +... +.++..|+.+||..||.+|+++.+|+
T Consensus       228 --~~~l~~ki~~~~~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~  273 (370)
T KOG0583|consen  228 --VPNLYRKIRKGEFKIPSYLLSPEARSLIEKMLVPDPSTRITLLEIL  273 (370)
T ss_pred             --HHHHHHHHhcCCccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHh
Confidence              11111112222221 1122 66799999999999999999999999

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.2e-43  Score=328.06  Aligned_cols=247  Identities=24%  Similarity=0.357  Sum_probs=211.0

Q ss_pred             cCCccCccccccCCccEEEEEE-cCCCEEEEEEecCCC---chhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEEE
Q 017594           49 NKFSDANKLGEGGFGPVYKGVL-KKGDEIAVKRLSGRS---GQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIY  124 (369)
Q Consensus        49 ~~y~i~~~lg~G~~~~v~~~~~-~~~~~valK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  124 (369)
                      +-|++.+.||.|+.|.|-+|++ .+|+..|||++....   ......+.+|+-+|+.+.|||++++++++++.+++|+|.
T Consensus        12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl   91 (786)
T KOG0588|consen   12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL   91 (786)
T ss_pred             cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence            5699999999999999999995 459999999997652   223466889999999999999999999999999999999


Q ss_pred             EecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCCC
Q 017594          125 EYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGN  204 (369)
Q Consensus       125 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~~  204 (369)
                      ||+.+|-|.+++.   .+.++.+.+..+++.||+.|+.|+|..+   |||||+||+|++++..+++||+|||++..-..+
T Consensus        92 Eyv~gGELFdylv---~kG~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe~~g  165 (786)
T KOG0588|consen   92 EYVPGGELFDYLV---RKGPLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASLEVPG  165 (786)
T ss_pred             EecCCchhHHHHH---hhCCCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeecccCC
Confidence            9999999999984   4555899999999999999999999999   999999999999999999999999998764433


Q ss_pred             CcccccccccccccccCchhhccCCC-CcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCccccccCcc
Q 017594          205 ELQANTSRIVGTYGYMSPEYALEGIF-SIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPI  283 (369)
Q Consensus       205 ~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (369)
                      .   ....-+|.+.|.|||++.+.+| +.++||||+|+|||.|++|+.||+.                  .++..++.+.
T Consensus       166 k---lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdD------------------dNir~LLlKV  224 (786)
T KOG0588|consen  166 K---LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDD------------------DNIRVLLLKV  224 (786)
T ss_pred             c---cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCC------------------ccHHHHHHHH
Confidence            2   3344589999999999999998 5789999999999999999999862                  2233334444


Q ss_pred             ccccc-cHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHH
Q 017594          284 LEDEY-SSKQMLLRYANIALLCVQESADDRPTMNDVVSML  322 (369)
Q Consensus       284 ~~~~~-~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L  322 (369)
                      ..+.+ .+..++.+.++||.+||..||++|.|+++|++.-
T Consensus       225 ~~G~f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP  264 (786)
T KOG0588|consen  225 QRGVFEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHP  264 (786)
T ss_pred             HcCcccCCCcCCHHHHHHHHHHhccCccccccHHHHhhCc
Confidence            44433 2344578899999999999999999999999853

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=7.7e-43  Score=290.60  Aligned_cols=269  Identities=22%  Similarity=0.241  Sum_probs=212.2

Q ss_pred             HHHHhcCCccCccccccCCccEEEEE-EcCCCEEEEEEecCCCchhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCc---
Q 017594           44 VSTATNKFSDANKLGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDE---  119 (369)
Q Consensus        44 ~~~~~~~y~i~~~lg~G~~~~v~~~~-~~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~---  119 (369)
                      +-..++||++.+.||.|+|+-||+++ ..+++.||+|++.....++.+...+|+...++++|||+++++++...+..   
T Consensus        16 v~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~   95 (302)
T KOG2345|consen   16 VIINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGK   95 (302)
T ss_pred             EEEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCc
Confidence            34567899999999999999999999 45588999999998887888999999999999999999999988765444   


Q ss_pred             --cEEEEEecCCCChhhhhcCCC-ccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecC
Q 017594          120 --KILIYEYMPNKSLDFFLFDPT-KRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFG  196 (369)
Q Consensus       120 --~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg  196 (369)
                        .|++++|+..|+|.+.+.... ++..+++..+.+|+.+|++||++||... +++.|+||||.||+++..+..+|.|||
T Consensus        96 ~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~G  174 (302)
T KOG2345|consen   96 HEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLG  174 (302)
T ss_pred             eeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEecc
Confidence              899999999999988876533 3457999999999999999999999885 469999999999999999999999999


Q ss_pred             CceecCCCCccc----cc---ccccccccccCchhhc---cCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchh
Q 017594          197 MARICGGNELQA----NT---SRIVGTYGYMSPEYAL---EGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGY  266 (369)
Q Consensus       197 ~~~~~~~~~~~~----~~---~~~~~~~~y~aPE~~~---~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~  266 (369)
                      .+....-.....    ..   .....+..|.|||.+.   +...+.++|||||||+||.|+.|..||+..-..       
T Consensus       175 S~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~-------  247 (302)
T KOG2345|consen  175 SATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQ-------  247 (302)
T ss_pred             CccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhc-------
Confidence            987653211110    00   1134678899999986   445789999999999999999999999743211       


Q ss_pred             hhhhhhcCccccccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHhhh
Q 017594          267 AWDLWTSNRTLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNEA  326 (369)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L~~~~  326 (369)
                            ...+.-.+....-.-+....++..+.++|++||+.||.+||++.+++..+..+.
T Consensus       248 ------GgSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li  301 (302)
T KOG2345|consen  248 ------GGSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI  301 (302)
T ss_pred             ------CCeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence                  111111111100000011114888999999999999999999999999987764

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3e-42  Score=316.47  Aligned_cols=265  Identities=31%  Similarity=0.461  Sum_probs=215.4

Q ss_pred             hhhHHHHhcCCccCccccccCCccEEEEEEcCCCEEEEEEecCCCchhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCcc
Q 017594           41 FSSVSTATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEK  120 (369)
Q Consensus        41 ~~~~~~~~~~y~i~~~lg~G~~~~v~~~~~~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~  120 (369)
                      ....+...+.++.++.||+|.||.||.|.++....|++|.+.... ...+.+.+|+++|++|+|++|+++++++..+...
T Consensus       198 ~d~wei~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~-m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~pi  276 (468)
T KOG0197|consen  198 RDPWEIPREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGS-MSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPI  276 (468)
T ss_pred             cCCeeecHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEeccc-cChhHHHHHHHHHHhCcccCeEEEEEEEecCCce
Confidence            444455556678899999999999999999987899999997643 3346778999999999999999999999998899


Q ss_pred             EEEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCcee
Q 017594          121 ILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARI  200 (369)
Q Consensus       121 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~  200 (369)
                      +|||||+..|+|.+++.. ..+..++......++.||+.|++||++++   +|||||.+.||||+.+..+||+|||+++.
T Consensus       277 yIVtE~m~~GsLl~yLr~-~~~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLAr~  352 (468)
T KOG0197|consen  277 YIVTEYMPKGSLLDYLRT-REGGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLARL  352 (468)
T ss_pred             EEEEEecccCcHHHHhhh-cCCCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEcccccccc
Confidence            999999999999999976 33455888899999999999999999999   99999999999999999999999999995


Q ss_pred             cCCCCcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHh-CCCCCCCCcccccccchhhhhhhhcCccccc
Q 017594          201 CGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDLWTSNRTLEL  279 (369)
Q Consensus       201 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (369)
                      ...... ..........-|.|||.+..+.++.++||||+|++||||+| |+.|++.....               ++.+.
T Consensus       353 ~~d~~Y-~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~---------------ev~~~  416 (468)
T KOG0197|consen  353 IGDDEY-TASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNE---------------EVLEL  416 (468)
T ss_pred             cCCCce-eecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHH---------------HHHHH
Confidence            543332 22222334567999999999999999999999999999998 77776543311               11111


Q ss_pred             cCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHhhhh
Q 017594          280 IDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNEAA  327 (369)
Q Consensus       280 ~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L~~~~~  327 (369)
                      ++..-. -..+..+|+.+.+++..||+.+|++|||++.+...|+.+-.
T Consensus       417 le~GyR-lp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~  463 (468)
T KOG0197|consen  417 LERGYR-LPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFT  463 (468)
T ss_pred             HhccCc-CCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhh
Confidence            111100 01133358889999999999999999999999999987755

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-42  Score=296.33  Aligned_cols=237  Identities=28%  Similarity=0.380  Sum_probs=203.6

Q ss_pred             HhcCCccCccccccCCccEEEEEEcC-CCEEEEEEecCCCc---hhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEE
Q 017594           47 ATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSG---QGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKIL  122 (369)
Q Consensus        47 ~~~~y~i~~~lg~G~~~~v~~~~~~~-~~~valK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l  122 (369)
                      ..++|++++.||.|+||.|.+++.+. |..+|+|++....-   ...+...+|..+|+.+.||.++++++.+.+.+.+++
T Consensus        42 ~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lym  121 (355)
T KOG0616|consen   42 SLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYM  121 (355)
T ss_pred             chhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEE
Confidence            44689999999999999999999765 88999999976543   334556679999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecC
Q 017594          123 IYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICG  202 (369)
Q Consensus       123 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~  202 (369)
                      ||||++||-|..+++...   .+++..++-++.||+.||+|||+.+   |++|||||+|||++.+|.++|+|||++....
T Consensus       122 vmeyv~GGElFS~Lrk~~---rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~v~  195 (355)
T KOG0616|consen  122 VMEYVPGGELFSYLRKSG---RFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKRVS  195 (355)
T ss_pred             EEeccCCccHHHHHHhcC---CCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEEec
Confidence            999999999999996544   4999999999999999999999999   9999999999999999999999999998764


Q ss_pred             CCCcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCccccccCc
Q 017594          203 GNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDP  282 (369)
Q Consensus       203 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (369)
                      ..     .-..+||+.|+|||++...+|+.++|.||||+++|||+.|.+||....                  ..+...+
T Consensus       196 ~r-----T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~------------------~~~iY~K  252 (355)
T KOG0616|consen  196 GR-----TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDN------------------PIQIYEK  252 (355)
T ss_pred             Cc-----EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCC------------------hHHHHHH
Confidence            32     445789999999999999999999999999999999999999986332                  1233333


Q ss_pred             cccccc-cHHHHHHHHHHHHHHhhcCCCCCC
Q 017594          283 ILEDEY-SSKQMLLRYANIALLCVQESADDR  312 (369)
Q Consensus       283 ~~~~~~-~~~~~~~~l~~li~~~L~~dP~~R  312 (369)
                      ++.+.. .+..++.++.+||..+|+.|-++|
T Consensus       253 I~~~~v~fP~~fs~~~kdLl~~LL~vD~t~R  283 (355)
T KOG0616|consen  253 ILEGKVKFPSYFSSDAKDLLKKLLQVDLTKR  283 (355)
T ss_pred             HHhCcccCCcccCHHHHHHHHHHHhhhhHhh
Confidence            443332 244447789999999999999999

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=1.2e-42  Score=318.61  Aligned_cols=262  Identities=28%  Similarity=0.410  Sum_probs=218.6

Q ss_pred             cCCccCccccccCCccEEEEEEc-CCCEEEEEEecCC--CchhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEEEE
Q 017594           49 NKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIYE  125 (369)
Q Consensus        49 ~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  125 (369)
                      ++|.+.+.||+|.||.||+|+.+ +.+.||+|.+.+.  ...+.+.+.+|+++++.++||||+.+++.|+...++|+|.|
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte   81 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE   81 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence            57999999999999999999965 4889999998754  34567789999999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCCCC
Q 017594          126 YMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE  205 (369)
Q Consensus       126 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~~~  205 (369)
                      |+.| .|..++.+...   ++++.+..++.++++||.|||+++   |+|+|+||.||++...|.+|++|||+++.+..+.
T Consensus        82 ~a~g-~L~~il~~d~~---lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t  154 (808)
T KOG0597|consen   82 YAVG-DLFTILEQDGK---LPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNT  154 (808)
T ss_pred             hhhh-hHHHHHHhccC---CCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhhcccCc
Confidence            9987 88888855444   999999999999999999999999   9999999999999999999999999998776432


Q ss_pred             cccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCccccccCcccc
Q 017594          206 LQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILE  285 (369)
Q Consensus       206 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (369)
                        .......||+.|+|||+..+.+|+..+|+||||||+||++.|++||-                  ...+.+++..++.
T Consensus       155 --~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~------------------a~si~~Lv~~I~~  214 (808)
T KOG0597|consen  155 --SVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFY------------------ARSITQLVKSILK  214 (808)
T ss_pred             --eeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCch------------------HHHHHHHHHHHhc
Confidence              34455789999999999999999999999999999999999999974                  2223334444433


Q ss_pred             ccc-cHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH--HHHhhhhccCCCCCCCc
Q 017594          286 DEY-SSKQMLLRYANIALLCVQESADDRPTMNDVVS--MLTNEAATLLPPKQPAF  337 (369)
Q Consensus       286 ~~~-~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~--~L~~~~~~~~~~~~~~~  337 (369)
                      ... .+...+..+.+++..+|..||..|.+..+++.  +++........+..++.
T Consensus       215 d~v~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~HpF~k~~~~~~~~~~~~a~  269 (808)
T KOG0597|consen  215 DPVKPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGHPFWKGKINIAELPAQVAF  269 (808)
T ss_pred             CCCCCcccccHHHHHHHHHHhhcChhhcccHHHHhcChHHhhhhhhhcccccccc
Confidence            322 23344788999999999999999999999994  44544444444444443

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=6e-42  Score=310.91  Aligned_cols=265  Identities=23%  Similarity=0.319  Sum_probs=203.0

Q ss_pred             HhcCCccCccccccCCccEEEEEE-cCCCEEEEEEecCCC--chhHHHHHHHHHHHhcCCCCceeeeeeeEEeC--CccE
Q 017594           47 ATNKFSDANKLGEGGFGPVYKGVL-KKGDEIAVKRLSGRS--GQGLREMKNEASVIAKVQHKNLVRLLGCCIDR--DEKI  121 (369)
Q Consensus        47 ~~~~y~i~~~lg~G~~~~v~~~~~-~~~~~valK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~  121 (369)
                      ....|+.+++||+|+||.||+|++ .+|+-||+|++....  +.......+|+.+|++|.||||+++.+.....  ..+|
T Consensus       115 ~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siY  194 (560)
T KOG0600|consen  115 RADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIY  194 (560)
T ss_pred             chHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEE
Confidence            345588999999999999999995 459999999987554  45566778999999999999999999998876  5789


Q ss_pred             EEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceec
Q 017594          122 LIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARIC  201 (369)
Q Consensus       122 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~  201 (369)
                      +|+||++.. |.-++..  ....+++..+..++.||+.||+|||..|   ++|||||..|||++.+|.+||+|||+++.+
T Consensus       195 lVFeYMdhD-L~GLl~~--p~vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr~y  268 (560)
T KOG0600|consen  195 LVFEYMDHD-LSGLLSS--PGVKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLARFY  268 (560)
T ss_pred             EEEecccch-hhhhhcC--CCcccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccceeec
Confidence            999999774 4444433  2344899999999999999999999999   999999999999999999999999999977


Q ss_pred             CCCCcccccccccccccccCchhhccC-CCCcccchHhHHHHHHHHHhCCCCCCCCcccccc---------cchhhhhhh
Q 017594          202 GGNELQANTSRIVGTYGYMSPEYALEG-IFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLN---------LLGYAWDLW  271 (369)
Q Consensus       202 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~---------~~~~~~~~~  271 (369)
                      ....... .....-|.+|.|||++.+. .|+.+.|+||.||||.||+.|++.|+......+.         ..+..|...
T Consensus       269 ~~~~~~~-~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~  347 (560)
T KOG0600|consen  269 TPSGSAP-YTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVS  347 (560)
T ss_pred             cCCCCcc-cccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccc
Confidence            6544333 2334569999999998765 6999999999999999999999988754311110         001112210


Q ss_pred             hcC-----ccccccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 017594          272 TSN-----RTLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVS  320 (369)
Q Consensus       272 ~~~-----~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~  320 (369)
                      .-.     .........+.+.  -..++....+|+..||..||.+|.||.++|+
T Consensus       348 kLP~~~~~kp~~~y~r~l~E~--~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~  399 (560)
T KOG0600|consen  348 KLPHATIFKPQQPYKRRLRET--FKDFPASALDLLEKLLSLDPDKRGTASSALQ  399 (560)
T ss_pred             cCCcccccCCCCcccchHHHH--hccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence            000     0111111111111  2233677899999999999999999999884

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=8.2e-42  Score=287.14  Aligned_cols=261  Identities=23%  Similarity=0.349  Sum_probs=204.2

Q ss_pred             cCCccCccccccCCccEEEEEE-cCCCEEEEEEecCCCc--hhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEEEE
Q 017594           49 NKFSDANKLGEGGFGPVYKGVL-KKGDEIAVKRLSGRSG--QGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIYE  125 (369)
Q Consensus        49 ~~y~i~~~lg~G~~~~v~~~~~-~~~~~valK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  125 (369)
                      .+|...+.||+|.||.||+|++ ++|+.||||++...+.  .......+|++.|+.++|+||+.++++|.+.+...+|+|
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE   81 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE   81 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence            5899999999999999999995 4599999999975532  224567789999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCCCC
Q 017594          126 YMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE  205 (369)
Q Consensus       126 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~~~  205 (369)
                      |++ .+|+..+.+  +...++...+.+++.++++|++|||.++   |+||||||.|++++.+|.+||+|||+++.+....
T Consensus        82 fm~-tdLe~vIkd--~~i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~  155 (318)
T KOG0659|consen   82 FMP-TDLEVVIKD--KNIILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFGSPN  155 (318)
T ss_pred             ecc-ccHHHHhcc--cccccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccCCCC
Confidence            985 577777754  3456889999999999999999999999   9999999999999999999999999999887654


Q ss_pred             cccccccccccccccCchhhcc-CCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhc-----------
Q 017594          206 LQANTSRIVGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTS-----------  273 (369)
Q Consensus       206 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~-----------  273 (369)
                      .....  ...|.+|.|||++.| ..|+...|+||.|||+.||+-+.+-|...++-.+  +......+..           
T Consensus       156 ~~~~~--~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQ--L~~If~~LGTP~~~~WP~~~~  231 (318)
T KOG0659|consen  156 RIQTH--QVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQ--LSKIFRALGTPTPDQWPEMTS  231 (318)
T ss_pred             ccccc--ceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHH--HHHHHHHcCCCCcccCccccc
Confidence            33332  367889999999875 5699999999999999999999877664432211  1111111111           


Q ss_pred             ----CccccccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 017594          274 ----NRTLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSM  321 (369)
Q Consensus       274 ----~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~  321 (369)
                          .+......+.+.. .-+ ..+.+..+|+..||..||.+|+++.++++.
T Consensus       232 lpdY~~~~~~P~~~~~~-lf~-aas~d~ldLl~~m~~ynP~~Rita~qaL~~  281 (318)
T KOG0659|consen  232 LPDYVKIQQFPKPPLNN-LFP-AASSDALDLLSKMLTYNPKKRITASQALKH  281 (318)
T ss_pred             cccHHHHhcCCCCcccc-ccc-cccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence                0111111111111 111 125677999999999999999999999963

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=3.4e-41  Score=313.27  Aligned_cols=263  Identities=26%  Similarity=0.386  Sum_probs=203.0

Q ss_pred             HhcCCccCccccccCCccEEEEEEc------CCCEEEEEEecCCC-chhHHHHHHHHHHHhcC-CCCceeeeeeeEEeCC
Q 017594           47 ATNKFSDANKLGEGGFGPVYKGVLK------KGDEIAVKRLSGRS-GQGLREMKNEASVIAKV-QHKNLVRLLGCCIDRD  118 (369)
Q Consensus        47 ~~~~y~i~~~lg~G~~~~v~~~~~~------~~~~valK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~  118 (369)
                      ..++|++.+.||.|+||.||+|.+.      ++..||+|++.... ......+..|+.++..+ +||||+++++++...+
T Consensus         5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~   84 (338)
T cd05102           5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPN   84 (338)
T ss_pred             chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC
Confidence            3578999999999999999999742      25679999987442 23345688899999999 8999999999887544


Q ss_pred             -ccEEEEEecCCCChhhhhcCCCc--------------------------------------------------------
Q 017594          119 -EKILIYEYMPNKSLDFFLFDPTK--------------------------------------------------------  141 (369)
Q Consensus       119 -~~~lv~e~~~~~~L~~~l~~~~~--------------------------------------------------------  141 (369)
                       ..+++|||+++++|.+++.....                                                        
T Consensus        85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (338)
T cd05102          85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD  164 (338)
T ss_pred             CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence             57899999999999888754211                                                        


Q ss_pred             ---cccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCCCCccccccccccccc
Q 017594          142 ---RMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG  218 (369)
Q Consensus       142 ---~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~  218 (369)
                         ...+++..+..++.||+.||+|||+.+   ++||||||+||+++.++.++|+|||++................++..
T Consensus       165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~  241 (338)
T cd05102         165 DLWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLK  241 (338)
T ss_pred             ccccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcc
Confidence               134777888899999999999999998   99999999999999999999999999876533222122222345678


Q ss_pred             ccCchhhccCCCCcccchHhHHHHHHHHHh-CCCCCCCCcccccccchhhhhhhhcCccccccCccccccccHHHHHHHH
Q 017594          219 YMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYSSKQMLLRY  297 (369)
Q Consensus       219 y~aPE~~~~~~~~~~~DiwslG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  297 (369)
                      |+|||++.+..++.++|||||||++|+|++ |..||........     ............     .     +...+..+
T Consensus       242 y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~-----~~~~~~~~~~~~-----~-----~~~~~~~l  306 (338)
T cd05102         242 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEE-----FCQRLKDGTRMR-----A-----PENATPEI  306 (338)
T ss_pred             ccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHH-----HHHHHhcCCCCC-----C-----CCCCCHHH
Confidence            999999998899999999999999999997 9999864332110     001111110000     0     11225679


Q ss_pred             HHHHHHhhcCCCCCCCCHHHHHHHHHhhhh
Q 017594          298 ANIALLCVQESADDRPTMNDVVSMLTNEAA  327 (369)
Q Consensus       298 ~~li~~~L~~dP~~Rps~~ell~~L~~~~~  327 (369)
                      .+++.+||+.||.+|||+.+|++.|+.+..
T Consensus       307 ~~li~~cl~~dp~~RPs~~el~~~l~~~~~  336 (338)
T cd05102         307 YRIMLACWQGDPKERPTFSALVEILGDLLQ  336 (338)
T ss_pred             HHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            999999999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2e-42  Score=316.52  Aligned_cols=249  Identities=23%  Similarity=0.338  Sum_probs=213.0

Q ss_pred             cCCccCccccccCCccEEEEEEcC-CCEEEEEEecCCC--chhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCc-cEEEE
Q 017594           49 NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRS--GQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDE-KILIY  124 (369)
Q Consensus        49 ~~y~i~~~lg~G~~~~v~~~~~~~-~~~valK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-~~lv~  124 (369)
                      +.|.+++.+|+|+||.+++++.+. +..+++|.+....  ........+|+.++.+++||||+.+.+.|..++. +++||
T Consensus         4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm   83 (426)
T KOG0589|consen    4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM   83 (426)
T ss_pred             chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence            579999999999999999999664 7789999886442  2233467889999999999999999999999888 89999


Q ss_pred             EecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCCC
Q 017594          125 EYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGN  204 (369)
Q Consensus       125 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~~  204 (369)
                      +||+||++.+.+.... +..++++.++.|+.||+.|+.|||+..   ++|||||+.|||++.++.|+|+|||++...+..
T Consensus        84 ~Y~eGg~l~~~i~~~k-~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~  159 (426)
T KOG0589|consen   84 EYCEGGDLAQLIKEQK-GVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE  159 (426)
T ss_pred             eecCCCCHHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhhhhcCCc
Confidence            9999999999997654 567999999999999999999999888   999999999999999999999999999987654


Q ss_pred             CcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCccccccCccc
Q 017594          205 ELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPIL  284 (369)
Q Consensus       205 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (369)
                      .  .......||+.|++||++.+.+|+.|+|||||||++|+|++-+++|...+                  ...++.++.
T Consensus       160 ~--~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~------------------m~~Li~ki~  219 (426)
T KOG0589|consen  160 D--SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASN------------------MSELILKIN  219 (426)
T ss_pred             h--hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccc------------------hHHHHHHHh
Confidence            3  23344689999999999999999999999999999999999999986333                  333333333


Q ss_pred             ccc--ccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 017594          285 EDE--YSSKQMLLRYANIALLCVQESADDRPTMNDVVSM  321 (369)
Q Consensus       285 ~~~--~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~  321 (369)
                      ...  ..+..++.++..+|..||+.+|+.||++.+||..
T Consensus       220 ~~~~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~  258 (426)
T KOG0589|consen  220 RGLYSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR  258 (426)
T ss_pred             hccCCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence            332  2344558889999999999999999999999976

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-42  Score=309.73  Aligned_cols=250  Identities=24%  Similarity=0.406  Sum_probs=209.1

Q ss_pred             HhcCCccCccccccCCccEEEEEEc-CCCEEEEEEecCCC-chhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEEE
Q 017594           47 ATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIY  124 (369)
Q Consensus        47 ~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  124 (369)
                      ....|+..+.||+|.||.||+|.++ +++.||+|++.... ....+.+.+|+.+|.+++++||.++++.+..+..++++|
T Consensus        11 ~~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiM   90 (467)
T KOG0201|consen   11 PELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIM   90 (467)
T ss_pred             cccccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHH
Confidence            3467888999999999999999965 48899999997553 345688999999999999999999999999999999999


Q ss_pred             EecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCCC
Q 017594          125 EYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGN  204 (369)
Q Consensus       125 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~~  204 (369)
                      |||.||++.+.+.   .+..+++..+..++++++.|+.|||.++   .+|+|||+.||++..+|.++|+|||++......
T Consensus        91 ey~~gGsv~~lL~---~~~~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~  164 (467)
T KOG0201|consen   91 EYCGGGSVLDLLK---SGNILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTNT  164 (467)
T ss_pred             HHhcCcchhhhhc---cCCCCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeech
Confidence            9999999999884   3344578888889999999999999999   999999999999999999999999998877654


Q ss_pred             CcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCccccccCccc
Q 017594          205 ELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPIL  284 (369)
Q Consensus       205 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (369)
                      ...  .....||+.|+|||++.+..|+.++||||||+++++|++|.+|+.....               ..+.-+|.+..
T Consensus       165 ~~r--r~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hP---------------mrvlflIpk~~  227 (467)
T KOG0201|consen  165 VKR--RKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHP---------------MRVLFLIPKSA  227 (467)
T ss_pred             hhc--cccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCc---------------ceEEEeccCCC
Confidence            432  2557899999999999988999999999999999999999999764321               11222222222


Q ss_pred             cccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 017594          285 EDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVS  320 (369)
Q Consensus       285 ~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~  320 (369)
                      ...... .++..+++|+..||+.||+.||+|.++++
T Consensus       228 PP~L~~-~~S~~~kEFV~~CL~k~P~~RpsA~~LLK  262 (467)
T KOG0201|consen  228 PPRLDG-DFSPPFKEFVEACLDKNPEFRPSAKELLK  262 (467)
T ss_pred             CCcccc-ccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence            221111 33677999999999999999999999985

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-41  Score=327.13  Aligned_cols=263  Identities=26%  Similarity=0.332  Sum_probs=213.2

Q ss_pred             hhHHHHhcCCccCccccccCCccEEEEEEcCC-CEEEEEEecCCCchhHHHHHHHHHHHhcCC-CCceeeeeee-EEeC-
Q 017594           42 SSVSTATNKFSDANKLGEGGFGPVYKGVLKKG-DEIAVKRLSGRSGQGLREMKNEASVIAKVQ-HKNLVRLLGC-CIDR-  117 (369)
Q Consensus        42 ~~~~~~~~~y~i~~~lg~G~~~~v~~~~~~~~-~~valK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~-~~~~-  117 (369)
                      ..+.+...+++|.+.|.+|||+.||+|++..+ ..||+|++...+....+.+.+|+.++++|+ |+|||.+++. .... 
T Consensus        30 ~~~~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~  109 (738)
T KOG1989|consen   30 QTFTVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRS  109 (738)
T ss_pred             eEEEECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEecccccccc
Confidence            34456678899999999999999999997765 999999998888889999999999999997 9999999993 3221 


Q ss_pred             -----CccEEEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEE
Q 017594          118 -----DEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKI  192 (369)
Q Consensus       118 -----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L  192 (369)
                           -.+.++||||.|+.|-+++....... +.+.++++|+++++.|+++||... ++|+|||||.+|||++.+|..||
T Consensus       110 ~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~-lte~eVLkIf~dv~~AVa~mH~~~-pPiIHRDLKiENvLls~~g~~KL  187 (738)
T KOG1989|consen  110 SNNGVWEVLLLMEYCKGGSLVDFMNTRLQTR-LTEDEVLKIFYDVCEAVAAMHYLK-PPIIHRDLKIENVLLSADGNYKL  187 (738)
T ss_pred             CCCceeEEEeehhhccCCcHHHHHHHHHhcc-CChHHHHHHHHHHHHHHHHHhcCC-CccchhhhhhhheEEcCCCCEEe
Confidence                 24679999999999989886544433 999999999999999999999995 66999999999999999999999


Q ss_pred             eecCCceecCCCCcc-ccc------ccccccccccCchhhc---cCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccc
Q 017594          193 SDFGMARICGGNELQ-ANT------SRIVGTYGYMSPEYAL---EGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLN  262 (369)
Q Consensus       193 ~Dfg~~~~~~~~~~~-~~~------~~~~~~~~y~aPE~~~---~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~  262 (369)
                      ||||.+.-....... ...      -...-|+.|+|||++.   +.+++.|+|||+|||+||-||+...||+....-.  
T Consensus       188 CDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~la--  265 (738)
T KOG1989|consen  188 CDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLA--  265 (738)
T ss_pred             CcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCccee--
Confidence            999988643322210 000      0124689999999875   7789999999999999999999999997542111  


Q ss_pred             cchhhhhhhhcCccccccCccccccc---cHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHhhhhc
Q 017594          263 LLGYAWDLWTSNRTLELIDPILEDEY---SSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNEAAT  328 (369)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L~~~~~~  328 (369)
                                          ++.+.+   ....++..+.+||+.||+.||.+||++-+++..+..+...
T Consensus       266 --------------------Ilng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~  314 (738)
T KOG1989|consen  266 --------------------ILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANK  314 (738)
T ss_pred             --------------------EEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcC
Confidence                                111111   1134488899999999999999999999999999777664

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=2e-40  Score=303.62  Aligned_cols=265  Identities=27%  Similarity=0.430  Sum_probs=201.1

Q ss_pred             hcCCccCccccccCCccEEEEEEcC-----------------CCEEEEEEecCCC-chhHHHHHHHHHHHhcCCCCceee
Q 017594           48 TNKFSDANKLGEGGFGPVYKGVLKK-----------------GDEIAVKRLSGRS-GQGLREMKNEASVIAKVQHKNLVR  109 (369)
Q Consensus        48 ~~~y~i~~~lg~G~~~~v~~~~~~~-----------------~~~valK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~  109 (369)
                      .++|++.+.||+|+||.||+|.+++                 +..||+|.+.... ......+.+|+.++..++||||++
T Consensus         4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~   83 (304)
T cd05096           4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR   83 (304)
T ss_pred             hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence            4689999999999999999998532                 3369999987543 233456888999999999999999


Q ss_pred             eeeeEEeCCccEEEEEecCCCChhhhhcCCC----------------ccccCChHHHHHHHHHHHHHHHHHhcCCCCCcc
Q 017594          110 LLGCCIDRDEKILIYEYMPNKSLDFFLFDPT----------------KRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRII  173 (369)
Q Consensus       110 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----------------~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~  173 (369)
                      +++++...+..+++|||+.+++|.+++....                ....+++..++.++.||+.||.|||+.+   ++
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---iv  160 (304)
T cd05096          84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FV  160 (304)
T ss_pred             EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---cc
Confidence            9999999999999999999999988874321                1134677788999999999999999999   99


Q ss_pred             cCCCCCCCEEEeCCCceEEeecCCceecCCCCcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHh--CCC
Q 017594          174 HRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS--GKK  251 (369)
Q Consensus       174 H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~t--g~~  251 (369)
                      |+||||+||+++.++.++|+|||++................++..|+|||++.+..++.++||||||+++|+|++  +..
T Consensus       161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~  240 (304)
T cd05096         161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQ  240 (304)
T ss_pred             ccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCC
Confidence            999999999999999999999999876543332222233345778999999988889999999999999999987  455


Q ss_pred             CCCCCcccccccchhhhhhhhcCccccccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHh
Q 017594          252 NTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTN  324 (369)
Q Consensus       252 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L~~  324 (369)
                      ||.......  ...............  ....     .+..++..+.+++.+||+.||++|||+.+|.+.|++
T Consensus       241 p~~~~~~~~--~~~~~~~~~~~~~~~--~~~~-----~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~  304 (304)
T cd05096         241 PYGELTDEQ--VIENAGEFFRDQGRQ--VYLF-----RPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE  304 (304)
T ss_pred             CCCcCCHHH--HHHHHHHHhhhcccc--cccc-----CCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence            665432111  111111111110000  0000     011125679999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3.8e-42  Score=304.32  Aligned_cols=251  Identities=24%  Similarity=0.402  Sum_probs=214.3

Q ss_pred             HHHhcCCccCccccccCCccEEEEEE-cCCCEEEEEEecCC---CchhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCcc
Q 017594           45 STATNKFSDANKLGEGGFGPVYKGVL-KKGDEIAVKRLSGR---SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEK  120 (369)
Q Consensus        45 ~~~~~~y~i~~~lg~G~~~~v~~~~~-~~~~~valK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~  120 (369)
                      -....||++.+.||+|.||.|-+|.. ..|+.||||.+.++   +..+.-.+++|++++..|+||||+.++++|++.+..
T Consensus        49 hnlkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKI  128 (668)
T KOG0611|consen   49 HNLKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKI  128 (668)
T ss_pred             cchhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceE
Confidence            34567999999999999999999995 66999999988754   445566788999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCcee
Q 017594          121 ILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARI  200 (369)
Q Consensus       121 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~  200 (369)
                      ++||||..+|.|.+++..   +..+++.+...+++||.+|+.|+|.++   ++|||||.+||+++.+++++|+|||++..
T Consensus       129 vivMEYaS~GeLYDYiSe---r~~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSNl  202 (668)
T KOG0611|consen  129 VIVMEYASGGELYDYISE---RGSLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSNL  202 (668)
T ss_pred             EEEEEecCCccHHHHHHH---hccccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhhh
Confidence            999999999999999954   344999999999999999999999999   99999999999999999999999999987


Q ss_pred             cCCCCcccccccccccccccCchhhccCCC-CcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCccccc
Q 017594          201 CGGNELQANTSRIVGTYGYMSPEYALEGIF-SIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLEL  279 (369)
Q Consensus       201 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (369)
                      +.....   ....+|++.|.+||++++.+| ++..|-||||++||.|..|..||...+                  ...+
T Consensus       203 y~~~kf---LqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~D------------------hk~l  261 (668)
T KOG0611|consen  203 YADKKF---LQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRD------------------HKRL  261 (668)
T ss_pred             hccccH---HHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCch------------------HHHH
Confidence            764432   345689999999999999998 578999999999999999999987443                  1122


Q ss_pred             cCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHH
Q 017594          280 IDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSML  322 (369)
Q Consensus       280 ~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L  322 (369)
                      +..+-.+.+.....+.+..-||++||..+|++|-|+.+|...+
T Consensus       262 vrQIs~GaYrEP~~PSdA~gLIRwmLmVNP~RRATieDiAsHW  304 (668)
T KOG0611|consen  262 VRQISRGAYREPETPSDASGLIRWMLMVNPERRATIEDIASHW  304 (668)
T ss_pred             HHHhhcccccCCCCCchHHHHHHHHHhcCcccchhHHHHhhhh
Confidence            2222233333333366688899999999999999999999876

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=1.2e-40  Score=308.22  Aligned_cols=246  Identities=23%  Similarity=0.284  Sum_probs=199.4

Q ss_pred             hcCCccCccccccCCccEEEEEEc-CCCEEEEEEecCCC---chhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEE
Q 017594           48 TNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS---GQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILI  123 (369)
Q Consensus        48 ~~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv  123 (369)
                      ..+|++.+.||+|+||.||+|+++ +|+.||+|++....   ......+..|+.+++.++||||+++++++..++..+++
T Consensus        17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv   96 (329)
T PTZ00263         17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFL   96 (329)
T ss_pred             chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEE
Confidence            367999999999999999999976 48899999986432   22345678899999999999999999999999999999


Q ss_pred             EEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCC
Q 017594          124 YEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGG  203 (369)
Q Consensus       124 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~  203 (369)
                      |||+.+++|.+++...   ..+++..+..++.||+.||+|||+++   ++||||||+||+++.++.++|+|||++.....
T Consensus        97 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~  170 (329)
T PTZ00263         97 LEFVVGGELFTHLRKA---GRFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD  170 (329)
T ss_pred             EcCCCCChHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEcCC
Confidence            9999999998888543   34788889999999999999999999   99999999999999999999999999876543


Q ss_pred             CCcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCccccccCcc
Q 017594          204 NELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPI  283 (369)
Q Consensus       204 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (369)
                      ..     ....|++.|+|||++.+..++.++|||||||++|+|++|..||.......     ...... .... .     
T Consensus       171 ~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~-----~~~~i~-~~~~-~-----  233 (329)
T PTZ00263        171 RT-----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFR-----IYEKIL-AGRL-K-----  233 (329)
T ss_pred             Cc-----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHH-----HHHHHh-cCCc-C-----
Confidence            21     22468899999999999889999999999999999999999986432110     001110 1100 0     


Q ss_pred             ccccccHHHHHHHHHHHHHHhhcCCCCCCCC-----HHHHHHH
Q 017594          284 LEDEYSSKQMLLRYANIALLCVQESADDRPT-----MNDVVSM  321 (369)
Q Consensus       284 ~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps-----~~ell~~  321 (369)
                      +     +..++..+.++|.+||+.||.+||+     +.++++.
T Consensus       234 ~-----p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h  271 (329)
T PTZ00263        234 F-----PNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH  271 (329)
T ss_pred             C-----CCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence            0     0112556899999999999999997     6888744

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=9e-41  Score=309.11  Aligned_cols=281  Identities=27%  Similarity=0.427  Sum_probs=220.7

Q ss_pred             chhhHHHHhcCCccCccccccCCccEEEEEEcCCCEEEEEEecCC--CchhHHHHHHHHHHHhcCCCCceeeeeeeEEeC
Q 017594           40 SFSSVSTATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDR  117 (369)
Q Consensus        40 ~~~~~~~~~~~y~i~~~lg~G~~~~v~~~~~~~~~~valK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~  117 (369)
                      +....+...++..+...||+|.||+||+|+|..  .||||++...  ..+..+.|+.|+.++++-+|.||+-+++++...
T Consensus       383 s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p  460 (678)
T KOG0193|consen  383 SLEEWEIPPEEVLLGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNP  460 (678)
T ss_pred             cccccccCHHHhhccceeccccccceeeccccc--ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCC
Confidence            335566667788899999999999999999873  7899998755  345678899999999999999999999999877


Q ss_pred             CccEEEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCC
Q 017594          118 DEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGM  197 (369)
Q Consensus       118 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~  197 (369)
                      .. .+|+-+|+|.+|..++....  ..++....+.|+.||++|+.|||.++   |+|+|||..|||+.++++|+|+|||+
T Consensus       461 ~~-AIiTqwCeGsSLY~hlHv~e--tkfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIgDFGL  534 (678)
T KOG0193|consen  461 PL-AIITQWCEGSSLYTHLHVQE--TKFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIGDFGL  534 (678)
T ss_pred             ce-eeeehhccCchhhhhccchh--hhhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEecccc
Confidence            66 99999999999999987544  34888999999999999999999999   99999999999999999999999999


Q ss_pred             ceecCCCCcccccccccccccccCchhhc---cCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcC
Q 017594          198 ARICGGNELQANTSRIVGTYGYMSPEYAL---EGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSN  274 (369)
Q Consensus       198 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~  274 (369)
                      +..-..-.-........+...|+|||++.   ..+|+..+||||+|+++|||++|..||.....+.     +.|.+....
T Consensus       535 atvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dq-----IifmVGrG~  609 (678)
T KOG0193|consen  535 ATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQ-----IIFMVGRGY  609 (678)
T ss_pred             eeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhh-----eEEEecccc
Confidence            87543221111222345677899999986   4679999999999999999999999987322222     112221111


Q ss_pred             ccccccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHhhhhccCCCCCCCcccc
Q 017594          275 RTLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNEAATLLPPKQPAFSYV  340 (369)
Q Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L~~~~~~~~~~~~~~~~~~  340 (369)
                      -....       ......++.++.+|+..||..++++||.+.+|+..|+.+..+++--.+.++++.
T Consensus       610 l~pd~-------s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~~pki~RS~S~P~  668 (678)
T KOG0193|consen  610 LMPDL-------SKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPSLPKINRSASEPV  668 (678)
T ss_pred             cCccc-------hhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhcccccccCcCccc
Confidence            00000       011223367899999999999999999999999999999887654444444443

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.3e-41  Score=304.21  Aligned_cols=245  Identities=23%  Similarity=0.275  Sum_probs=199.0

Q ss_pred             cCCccCccccccCCccEEEEEEc-CCCEEEEEEecCCC---chhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEEE
Q 017594           49 NKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS---GQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIY  124 (369)
Q Consensus        49 ~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  124 (369)
                      ++|++.+.||+|+||.||+|+.+ +|+.||+|++....   ....+.+.+|+.+++.++||||+++++++.+....++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   80 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM   80 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence            47999999999999999999976 58899999986432   223456788999999999999999999999999999999


Q ss_pred             EecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCCC
Q 017594          125 EYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGN  204 (369)
Q Consensus       125 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~~  204 (369)
                      ||+.+++|.+++...   ..+++..+..++.||+.||+|||++|   ++||||+|+||+++.++.++|+|||++......
T Consensus        81 e~~~~~~L~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~  154 (291)
T cd05612          81 EYVPGGELFSYLRNS---GRFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR  154 (291)
T ss_pred             eCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhccCC
Confidence            999999999888543   34888899999999999999999999   999999999999999999999999998765322


Q ss_pred             CcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCccccccCccc
Q 017594          205 ELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPIL  284 (369)
Q Consensus       205 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (369)
                           .....|++.|+|||++.+..++.++|||||||++|+|++|..||.......     ....... ...      .+
T Consensus       155 -----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~-----~~~~i~~-~~~------~~  217 (291)
T cd05612         155 -----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFG-----IYEKILA-GKL------EF  217 (291)
T ss_pred             -----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-----HHHHHHh-CCc------CC
Confidence                 123468899999999998889999999999999999999999986432111     0011100 000      00


Q ss_pred             cccccHHHHHHHHHHHHHHhhcCCCCCCCC-----HHHHHHH
Q 017594          285 EDEYSSKQMLLRYANIALLCVQESADDRPT-----MNDVVSM  321 (369)
Q Consensus       285 ~~~~~~~~~~~~l~~li~~~L~~dP~~Rps-----~~ell~~  321 (369)
                           +...+..+.++|.+||+.||.+||+     +.++++.
T Consensus       218 -----~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h  254 (291)
T cd05612         218 -----PRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH  254 (291)
T ss_pred             -----CccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence                 1112556899999999999999995     8888854

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=6.6e-40  Score=303.65  Aligned_cols=265  Identities=23%  Similarity=0.330  Sum_probs=203.4

Q ss_pred             HhcCCccCccccccCCccEEEEEEc-CCCEEEEEEecCCC-chhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEEE
Q 017594           47 ATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIY  124 (369)
Q Consensus        47 ~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  124 (369)
                      ..++|++.+.||+|+||.||+|+++ +|..+++|.+.... ......+.+|++++++++||||+++++++...+..++||
T Consensus         3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   82 (331)
T cd06649           3 KDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM   82 (331)
T ss_pred             CcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEe
Confidence            3578999999999999999999976 48889999887542 233467889999999999999999999999999999999


Q ss_pred             EecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCCC
Q 017594          125 EYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGN  204 (369)
Q Consensus       125 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~~  204 (369)
                      ||+.+++|.+++...   ..+++..+..++.|++.||.|||+.+  +++|+||||+||+++.++.++|+|||++......
T Consensus        83 e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  157 (331)
T cd06649          83 EHMDGGSLDQVLKEA---KRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS  157 (331)
T ss_pred             ecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCccccccccc
Confidence            999999999988543   34888999999999999999999853  3999999999999999999999999998755322


Q ss_pred             CcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhc-C---------
Q 017594          205 ELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTS-N---------  274 (369)
Q Consensus       205 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~-~---------  274 (369)
                          ......++..|+|||++.+..++.++|||||||++|+|++|+.||........... ........ .         
T Consensus       158 ----~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~  232 (331)
T cd06649         158 ----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAI-FGRPVVDGEEGEPHSISPR  232 (331)
T ss_pred             ----ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-hcccccccccCCccccCcc
Confidence                12234688999999999988999999999999999999999999964331110000 00000000 0         


Q ss_pred             -------------------ccccccCcccc---ccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 017594          275 -------------------RTLELIDPILE---DEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSM  321 (369)
Q Consensus       275 -------------------~~~~~~~~~~~---~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~  321 (369)
                                         ......+....   .......++.++.+||.+||+.||++|||+.+|++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h  301 (331)
T cd06649         233 PRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNH  301 (331)
T ss_pred             cccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence                               00000000000   000111236779999999999999999999999974

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=1.6e-40  Score=304.03  Aligned_cols=257  Identities=21%  Similarity=0.297  Sum_probs=203.4

Q ss_pred             hHHHHhcCCccCccccccCCccEEEEEEcC-CCEEEEEEecCCC---chhHHHHHHHHHHHhcCCCCceeeeeeeEEeCC
Q 017594           43 SVSTATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRS---GQGLREMKNEASVIAKVQHKNLVRLLGCCIDRD  118 (369)
Q Consensus        43 ~~~~~~~~y~i~~~lg~G~~~~v~~~~~~~-~~~valK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~  118 (369)
                      +.....++|+++..||+|+||.||+|+.++ |..+|+|++.++.   ....+.+..|-.+|....+|.|++++..|.+.+
T Consensus       135 R~r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~  214 (550)
T KOG0605|consen  135 RTRLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKE  214 (550)
T ss_pred             cccCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCC
Confidence            334467889999999999999999999655 9999999998764   344566778999999999999999999999999


Q ss_pred             ccEEEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCc
Q 017594          119 EKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMA  198 (369)
Q Consensus       119 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~  198 (369)
                      .+|+||||++||.+..++.   +...+++..++.++.+++-|++.||+.|   ++||||||+|+||+..|+++|+|||++
T Consensus       215 ~LYLiMEylPGGD~mTLL~---~~~~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs  288 (550)
T KOG0605|consen  215 YLYLIMEYLPGGDMMTLLM---RKDTLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLS  288 (550)
T ss_pred             eeEEEEEecCCccHHHHHH---hcCcCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeecccccc
Confidence            9999999999999999984   4556999999999999999999999999   999999999999999999999999998


Q ss_pred             eecCCC---------------------Cccc-----cc-------------------ccccccccccCchhhccCCCCcc
Q 017594          199 RICGGN---------------------ELQA-----NT-------------------SRIVGTYGYMSPEYALEGIFSIK  233 (369)
Q Consensus       199 ~~~~~~---------------------~~~~-----~~-------------------~~~~~~~~y~aPE~~~~~~~~~~  233 (369)
                      ..+...                     ....     ..                   ....|||.|+|||++.+..|+..
T Consensus       289 ~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~  368 (550)
T KOG0605|consen  289 TGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKE  368 (550)
T ss_pred             chhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCcc
Confidence            544210                     0000     00                   01359999999999999999999


Q ss_pred             cchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCccccccCccccccccHHHHHHHHHHHHHHhhcCCCCCCC
Q 017594          234 SDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRP  313 (369)
Q Consensus       234 ~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp  313 (369)
                      +|.||||||+|||+.|.+||-........     ......+........        ..++.+..+||.+||+ ||++|.
T Consensus       369 cDwWSLG~ImyEmLvGyPPF~s~tp~~T~-----rkI~nwr~~l~fP~~--------~~~s~eA~DLI~rll~-d~~~RL  434 (550)
T KOG0605|consen  369 CDWWSLGCIMYEMLVGYPPFCSETPQETY-----RKIVNWRETLKFPEE--------VDLSDEAKDLITRLLC-DPENRL  434 (550)
T ss_pred             ccHHHHHHHHHHHHhCCCCCCCCCHHHHH-----HHHHHHhhhccCCCc--------CcccHHHHHHHHHHhc-CHHHhc
Confidence            99999999999999999999644322111     111111111111111        1115779999999999 999998


Q ss_pred             C---HHHHH
Q 017594          314 T---MNDVV  319 (369)
Q Consensus       314 s---~~ell  319 (369)
                      -   ++||-
T Consensus       435 G~~G~~EIK  443 (550)
T KOG0605|consen  435 GSKGAEEIK  443 (550)
T ss_pred             CcccHHHHh
Confidence            6   55554

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2e-40  Score=307.43  Aligned_cols=253  Identities=22%  Similarity=0.326  Sum_probs=202.3

Q ss_pred             cCCccCccccccCCccEEEEEEcC-CCEEEEEEecCCC---chhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEEE
Q 017594           49 NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRS---GQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIY  124 (369)
Q Consensus        49 ~~y~i~~~lg~G~~~~v~~~~~~~-~~~valK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  124 (369)
                      ++|++.+.||+|+||.||+|++.. ++.||+|++....   ......+..|+.++..++||||+++++++...+..++||
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~   80 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM   80 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence            479999999999999999999764 8899999986432   233456778999999999999999999999999999999


Q ss_pred             EecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCCC
Q 017594          125 EYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGN  204 (369)
Q Consensus       125 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~~  204 (369)
                      ||+.+++|.+++...   ..+++..+..++.||+.||.|||+.+   ++||||||+||+++.++.++|+|||++..... 
T Consensus        81 e~~~g~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~-  153 (333)
T cd05600          81 EYVPGGDFRTLLNNL---GVLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT-  153 (333)
T ss_pred             eCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCccccc-
Confidence            999999999998532   34788999999999999999999999   99999999999999999999999999875543 


Q ss_pred             CcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCccccccCccc
Q 017594          205 ELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPIL  284 (369)
Q Consensus       205 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (369)
                          ......|++.|+|||++.+..++.++|||||||++|+|++|..||........     .............  +..
T Consensus       154 ----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~-----~~~i~~~~~~~~~--~~~  222 (333)
T cd05600         154 ----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNET-----WENLKYWKETLQR--PVY  222 (333)
T ss_pred             ----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHH-----HHHHHhccccccC--CCC
Confidence                22334689999999999988999999999999999999999999864331110     0000000000000  000


Q ss_pred             cccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 017594          285 EDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSM  321 (369)
Q Consensus       285 ~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~  321 (369)
                      .  ......+.++.++|.+||+.+|.+||++.++++.
T Consensus       223 ~--~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h  257 (333)
T cd05600         223 D--DPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH  257 (333)
T ss_pred             C--ccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence            0  0001236779999999999999999999999965

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=1e-39  Score=296.34  Aligned_cols=265  Identities=22%  Similarity=0.271  Sum_probs=200.8

Q ss_pred             cCCccCccccccCCccEEEEEEcC-CCEEEEEEecCCC--chhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEEEE
Q 017594           49 NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRS--GQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIYE  125 (369)
Q Consensus        49 ~~y~i~~~lg~G~~~~v~~~~~~~-~~~valK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  125 (369)
                      ++|++.+.||+|+||.||+|+++. ++.|++|++....  ......+.+|+.+++.++|+||+++++++...+..++|||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE   80 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence            479999999999999999999764 8889999986442  2334567789999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCCCC
Q 017594          126 YMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE  205 (369)
Q Consensus       126 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~~~  205 (369)
                      |+.++.+..+...   ...+++..+..++.||+.||.|||+.+   ++|+||||+||+++.++.++|+|||++.......
T Consensus        81 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  154 (287)
T cd07848          81 YVEKNMLELLEEM---PNGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGS  154 (287)
T ss_pred             cCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCcccccccc
Confidence            9999877655432   234888999999999999999999999   9999999999999999999999999987654322


Q ss_pred             cccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCccccccc-chh--------hhhhhhcC-c
Q 017594          206 LQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNL-LGY--------AWDLWTSN-R  275 (369)
Q Consensus       206 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~-~~~--------~~~~~~~~-~  275 (369)
                      . .......++..|+|||++.+..++.++|+|||||++|+|++|++||.......... ...        ....+... .
T Consensus       155 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (287)
T cd07848         155 N-ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPR  233 (287)
T ss_pred             c-ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccch
Confidence            1 11223467889999999998889999999999999999999999997543111000 000        00000000 0


Q ss_pred             cccccCcccccc-----ccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 017594          276 TLELIDPILEDE-----YSSKQMLLRYANIALLCVQESADDRPTMNDVVS  320 (369)
Q Consensus       276 ~~~~~~~~~~~~-----~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~  320 (369)
                      ......+.....     ......+.++.++|.+||+.||++|||++++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~  283 (287)
T cd07848         234 FHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN  283 (287)
T ss_pred             hcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            000000000000     001123667999999999999999999999986

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=1.2e-39  Score=306.65  Aligned_cols=260  Identities=27%  Similarity=0.383  Sum_probs=202.3

Q ss_pred             hcCCccCccccccCCccEEEEEE------cCCCEEEEEEecCCC-chhHHHHHHHHHHHhcC-CCCceeeeeeeEEeCCc
Q 017594           48 TNKFSDANKLGEGGFGPVYKGVL------KKGDEIAVKRLSGRS-GQGLREMKNEASVIAKV-QHKNLVRLLGCCIDRDE  119 (369)
Q Consensus        48 ~~~y~i~~~lg~G~~~~v~~~~~------~~~~~valK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~  119 (369)
                      .++|++.+.||+|+||.||+|++      .++..||+|++.... ....+.+.+|+.++..+ +||||+++++++.....
T Consensus        34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~  113 (375)
T cd05104          34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP  113 (375)
T ss_pred             hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence            45799999999999999999973      235679999986442 23345678899999999 89999999999999999


Q ss_pred             cEEEEEecCCCChhhhhcCCCc----------------------------------------------------------
Q 017594          120 KILIYEYMPNKSLDFFLFDPTK----------------------------------------------------------  141 (369)
Q Consensus       120 ~~lv~e~~~~~~L~~~l~~~~~----------------------------------------------------------  141 (369)
                      .++||||+.+++|.+++.....                                                          
T Consensus       114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (375)
T cd05104         114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS  193 (375)
T ss_pred             ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence            9999999999999888754211                                                          


Q ss_pred             --------------cccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCCCCcc
Q 017594          142 --------------RMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQ  207 (369)
Q Consensus       142 --------------~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~~~~~  207 (369)
                                    ...+++..+..++.||+.||.|||+.+   ++||||||+||+++.++.++|+|||++.........
T Consensus       194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~  270 (375)
T cd05104         194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY  270 (375)
T ss_pred             ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence                          124678888999999999999999998   999999999999999999999999998866443222


Q ss_pred             cccccccccccccCchhhccCCCCcccchHhHHHHHHHHHh-CCCCCCCCcccccccchhhhhhhhcCccccccCccccc
Q 017594          208 ANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILED  286 (369)
Q Consensus       208 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  286 (369)
                      .......++..|+|||++.+..++.++|||||||++|+|++ |..||........     ......... ..    ..  
T Consensus       271 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~-----~~~~~~~~~-~~----~~--  338 (375)
T cd05104         271 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSK-----FYKMIKEGY-RM----LS--  338 (375)
T ss_pred             cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHH-----HHHHHHhCc-cC----CC--
Confidence            22222334567999999999999999999999999999998 8888864321110     111111110 00    00  


Q ss_pred             cccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHhh
Q 017594          287 EYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNE  325 (369)
Q Consensus       287 ~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L~~~  325 (369)
                         +...+.++.+++.+||+.||++||++.+|++.|++.
T Consensus       339 ---~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~  374 (375)
T cd05104         339 ---PECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ  374 (375)
T ss_pred             ---CCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence               011155799999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=5.8e-40  Score=303.03  Aligned_cols=241  Identities=22%  Similarity=0.301  Sum_probs=193.4

Q ss_pred             ccccccCCccEEEEEEc-CCCEEEEEEecCCC---chhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEEEEecCCC
Q 017594           55 NKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS---GQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIYEYMPNK  130 (369)
Q Consensus        55 ~~lg~G~~~~v~~~~~~-~~~~valK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~  130 (369)
                      +.||+|+||.||+|+.+ +|+.||+|++....   ......+..|+.+++.++||||+++++++...+..++||||+.++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   80 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence            46899999999999965 58899999986431   233456678999999999999999999999999999999999999


Q ss_pred             ChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCCCCccccc
Q 017594          131 SLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANT  210 (369)
Q Consensus       131 ~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~~~~~~~~  210 (369)
                      +|..++..   ...+++..+..++.||+.||+|||+.|   ++||||||+||+++.++.++|+|||++.......  ...
T Consensus        81 ~L~~~l~~---~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~--~~~  152 (323)
T cd05571          81 ELFFHLSR---ERVFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG--ATM  152 (323)
T ss_pred             cHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC--Ccc
Confidence            99888853   345889999999999999999999999   9999999999999999999999999986432211  112


Q ss_pred             ccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCccccccCccccccccH
Q 017594          211 SRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYSS  290 (369)
Q Consensus       211 ~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  290 (369)
                      ....|++.|+|||++.+..++.++|||||||++|+|++|..||.......      ..........      .+     +
T Consensus       153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~------~~~~~~~~~~------~~-----p  215 (323)
T cd05571         153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK------LFELILMEEI------RF-----P  215 (323)
T ss_pred             cceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHH------HHHHHHcCCC------CC-----C
Confidence            33468999999999999999999999999999999999999986432111      0000000100      00     1


Q ss_pred             HHHHHHHHHHHHHhhcCCCCCCC-----CHHHHHH
Q 017594          291 KQMLLRYANIALLCVQESADDRP-----TMNDVVS  320 (369)
Q Consensus       291 ~~~~~~l~~li~~~L~~dP~~Rp-----s~~ell~  320 (369)
                      ...+.++.++|.+||+.||++||     ++.++++
T Consensus       216 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~  250 (323)
T cd05571         216 RTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME  250 (323)
T ss_pred             CCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence            12266799999999999999999     7999985

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=1e-39  Score=295.82  Aligned_cols=251  Identities=21%  Similarity=0.302  Sum_probs=198.3

Q ss_pred             CCccCccccccCCccEEEEEEcCCCEEEEEEecCCCchh---HHHHHHHHHHHhcCCCCceeeeeeeEEe----CCccEE
Q 017594           50 KFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQG---LREMKNEASVIAKVQHKNLVRLLGCCID----RDEKIL  122 (369)
Q Consensus        50 ~y~i~~~lg~G~~~~v~~~~~~~~~~valK~~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~~l  122 (369)
                      +..-...||.|+++.||+|..+ |+.||+|.+.......   .+.+.+|+.++.+++||||+++++++.+    ....++
T Consensus        21 ~~~~~~~i~~g~~~~v~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~l   99 (283)
T PHA02988         21 DKYTSVLIKENDQNSIYKGIFN-NKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSL   99 (283)
T ss_pred             CCCCCeEEeeCCceEEEEEEEC-CEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEE
Confidence            3333467899999999999984 8899999987543322   4667799999999999999999999876    346789


Q ss_pred             EEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcC-CCCCcccCCCCCCCEEEeCCCceEEeecCCceec
Q 017594          123 IYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQY-SRVRIIHRDLKASNILLDKDMNPKISDFGMARIC  201 (369)
Q Consensus       123 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~-~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~  201 (369)
                      +|||+.+++|.+++...   ..+++.....++.+++.|+.+||+. +   ++||||+|.||+++.++.++|+|||++...
T Consensus       100 v~Ey~~~g~L~~~l~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~---~~Hrdlkp~nill~~~~~~kl~dfg~~~~~  173 (283)
T PHA02988        100 ILEYCTRGYLREVLDKE---KDLSFKTKLDMAIDCCKGLYNLYKYTN---KPYKNLTSVSFLVTENYKLKIICHGLEKIL  173 (283)
T ss_pred             EEEeCCCCcHHHHHhhC---CCCChhHHHHHHHHHHHHHHHHHhcCC---CCCCcCChhhEEECCCCcEEEcccchHhhh
Confidence            99999999999998543   3478889999999999999999985 6   889999999999999999999999998754


Q ss_pred             CCCCcccccccccccccccCchhhcc--CCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCccccc
Q 017594          202 GGNELQANTSRIVGTYGYMSPEYALE--GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLEL  279 (369)
Q Consensus       202 ~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (369)
                      ....     ....++..|+|||++.+  ..++.++|||||||++|+|++|..||.......     .. .........  
T Consensus       174 ~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~-----~~-~~i~~~~~~--  240 (283)
T PHA02988        174 SSPP-----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKE-----IY-DLIINKNNS--  240 (283)
T ss_pred             cccc-----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHH-----HH-HHHHhcCCC--
Confidence            3221     12356789999999876  678999999999999999999999997432111     00 111001000  


Q ss_pred             cCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHhhhh
Q 017594          280 IDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNEAA  327 (369)
Q Consensus       280 ~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L~~~~~  327 (369)
                        ..+     +..++..+.+++.+||+.||++|||+.++++.|+..+.
T Consensus       241 --~~~-----~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~~  281 (283)
T PHA02988        241 --LKL-----PLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYKF  281 (283)
T ss_pred             --CCC-----CCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHh
Confidence              001     11126679999999999999999999999999998763

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=7.7e-40  Score=299.57  Aligned_cols=265  Identities=24%  Similarity=0.322  Sum_probs=194.9

Q ss_pred             hcCCccCccccccCCccEEEEEEc-CCCEEEEEEecCCCc-hhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEEEE
Q 017594           48 TNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSG-QGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIYE  125 (369)
Q Consensus        48 ~~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  125 (369)
                      .++|++.+.||.|+||.||+|+.+ +++.||+|++..... .....+.+|+.+++.++||||+++++++......++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e   83 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE   83 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence            478999999999999999999976 588999999864432 223456789999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCCCC
Q 017594          126 YMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE  205 (369)
Q Consensus       126 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~~~  205 (369)
                      |+.+ ++.+++...  ...+++..+..++.||+.||.|||+.+   ++|+||||+||+++.++.++|+|||++.......
T Consensus        84 ~~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  157 (303)
T cd07869          84 YVHT-DLCQYMDKH--PGGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVPS  157 (303)
T ss_pred             CCCc-CHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceeccCCC
Confidence            9965 555555332  234788899999999999999999999   9999999999999999999999999987543221


Q ss_pred             cccccccccccccccCchhhcc-CCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhh-------hhhhc----
Q 017594          206 LQANTSRIVGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAW-------DLWTS----  273 (369)
Q Consensus       206 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~-------~~~~~----  273 (369)
                        .......++..|+|||++.+ ..++.++|+|||||++|+|++|..||...............       ..+..    
T Consensus       158 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (303)
T cd07869         158 --HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSL  235 (303)
T ss_pred             --ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhc
Confidence              11223457889999998865 45888999999999999999999999753221100000000       00000    


Q ss_pred             -----CccccccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 017594          274 -----NRTLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVS  320 (369)
Q Consensus       274 -----~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~  320 (369)
                           ..........+.........+..+.+|+.+||+.||++|||+.++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~  287 (303)
T cd07869         236 PHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS  287 (303)
T ss_pred             cccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence                 00000000000000001112356889999999999999999999986

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-40  Score=298.36  Aligned_cols=255  Identities=26%  Similarity=0.386  Sum_probs=202.0

Q ss_pred             HHHHhcCCccCccccccCCccEEEEEEc-CCCEEEEEEecCCC--------------chhHHHHHHHHHHHhcCCCCcee
Q 017594           44 VSTATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS--------------GQGLREMKNEASVIAKVQHKNLV  108 (369)
Q Consensus        44 ~~~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~~--------------~~~~~~~~~e~~~l~~l~h~~i~  108 (369)
                      --...++|++.+.||+|.||.|-+|++. +++.||||++.+..              ....+...+|+.+|+++.||||+
T Consensus        92 ~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV  171 (576)
T KOG0585|consen   92 DRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVV  171 (576)
T ss_pred             cceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCee
Confidence            3455689999999999999999999954 58999999986431              12346788999999999999999


Q ss_pred             eeeeeEEeC--CccEEEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeC
Q 017594          109 RLLGCCIDR--DEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDK  186 (369)
Q Consensus       109 ~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~  186 (369)
                      +++++..+.  +.+|+|+|||..|.+.+   ....+..+++..+++++.+++.||+|||.+|   |+||||||.|+|++.
T Consensus       172 ~LiEvLDDP~s~~~YlVley~s~G~v~w---~p~d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLLl~~  245 (576)
T KOG0585|consen  172 KLIEVLDDPESDKLYLVLEYCSKGEVKW---CPPDKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLLLSS  245 (576)
T ss_pred             EEEEeecCcccCceEEEEEeccCCcccc---CCCCcccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEEcC
Confidence            999998754  67899999999887633   3233333899999999999999999999999   999999999999999


Q ss_pred             CCceEEeecCCceecCCCCcc---cccccccccccccCchhhccCC----CCcccchHhHHHHHHHHHhCCCCCCCCccc
Q 017594          187 DMNPKISDFGMARICGGNELQ---ANTSRIVGTYGYMSPEYALEGI----FSIKSDVFSFGVLLLEIVSGKKNTGLYRTD  259 (369)
Q Consensus       187 ~~~~~L~Dfg~~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~----~~~~~DiwslG~il~~l~tg~~p~~~~~~~  259 (369)
                      +|.+||+|||.+..+......   .......||+.|+|||...++.    .+.+.||||+|++||.|+.|+.||-.    
T Consensus       246 ~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~----  321 (576)
T KOG0585|consen  246 DGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFD----  321 (576)
T ss_pred             CCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCccc----
Confidence            999999999999877433111   1123367999999999987632    36789999999999999999999852    


Q ss_pred             ccccchhhhhhhhcCccccccCcccccccc---HHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHH
Q 017594          260 SLNLLGYAWDLWTSNRTLELIDPILEDEYS---SKQMLLRYANIALLCVQESADDRPTMNDVVSML  322 (369)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L  322 (369)
                                    ....++.+++......   ..+....+.+||.+||+.||+.|.+..+|....
T Consensus       322 --------------~~~~~l~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hp  373 (576)
T KOG0585|consen  322 --------------DFELELFDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHP  373 (576)
T ss_pred             --------------chHHHHHHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecc
Confidence                          2222222222222111   112367799999999999999999999997655

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=2e-39  Score=294.73  Aligned_cols=265  Identities=22%  Similarity=0.293  Sum_probs=196.9

Q ss_pred             hcCCccCccccccCCccEEEEEEc-CCCEEEEEEecCCC-chhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEEEE
Q 017594           48 TNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIYE  125 (369)
Q Consensus        48 ~~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  125 (369)
                      .++|++.+.||.|+||.||+|+.+ ++..||+|.+.... ......+.+|+.+++.++||||+++++++..+...++|+|
T Consensus         4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e   83 (288)
T cd07871           4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFE   83 (288)
T ss_pred             cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEe
Confidence            367999999999999999999965 58899999986432 2233467789999999999999999999998888999999


Q ss_pred             ecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCCCC
Q 017594          126 YMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE  205 (369)
Q Consensus       126 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~~~  205 (369)
                      |+.+ +|..++...  ...++...+..++.||+.||+|||+++   ++||||||+||+++.++.++|+|||++.......
T Consensus        84 ~~~~-~l~~~l~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~  157 (288)
T cd07871          84 YLDS-DLKQYLDNC--GNLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSVPT  157 (288)
T ss_pred             CCCc-CHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeeccCCC
Confidence            9976 777766432  234788899999999999999999999   9999999999999999999999999987543222


Q ss_pred             cccccccccccccccCchhhcc-CCCCcccchHhHHHHHHHHHhCCCCCCCCccccccc---------chhhhhhhhc-C
Q 017594          206 LQANTSRIVGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNL---------LGYAWDLWTS-N  274 (369)
Q Consensus       206 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~---------~~~~~~~~~~-~  274 (369)
                      .  ......++..|+|||++.+ ..++.++||||+||++|+|++|+.||..........         ....|..... .
T Consensus       158 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (288)
T cd07871         158 K--TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNE  235 (288)
T ss_pred             c--cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccch
Confidence            1  1223457889999998865 568999999999999999999999996543111000         0000000000 0


Q ss_pred             ccccccCccccccc---cHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 017594          275 RTLELIDPILEDEY---SSKQMLLRYANIALLCVQESADDRPTMNDVVS  320 (369)
Q Consensus       275 ~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~  320 (369)
                      .......+......   .....+.++.+||.+||+.||.+|||+.++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~  284 (288)
T cd07871         236 EFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR  284 (288)
T ss_pred             hhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence            00111100000000   00112467899999999999999999999985

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=3.1e-39  Score=288.96  Aligned_cols=257  Identities=30%  Similarity=0.467  Sum_probs=208.9

Q ss_pred             HhcCCccCccccccCCccEEEEEEcCCCEEEEEEecCCCchhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEEEEe
Q 017594           47 ATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIYEY  126 (369)
Q Consensus        47 ~~~~y~i~~~lg~G~~~~v~~~~~~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  126 (369)
                      ...+|++.+.||.|++|.||+|.+.++..+++|.+..........+..|+.+++.++|+|++++++++......+++|||
T Consensus         4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   83 (261)
T cd05148           4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITEL   83 (261)
T ss_pred             cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEee
Confidence            45679999999999999999999888899999999876655567888999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCCCCc
Q 017594          127 MPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNEL  206 (369)
Q Consensus       127 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~~~~  206 (369)
                      +.+++|.+++.... ...+++..++.++.||+.|+.|||+.+   ++|+||+|+||+++.++.++|+|||.+........
T Consensus        84 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~  159 (261)
T cd05148          84 MEKGSLLAFLRSPE-GQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY  159 (261)
T ss_pred             cccCCHHHHHhcCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhcCCccc
Confidence            99999999986543 345788899999999999999999998   99999999999999999999999999876543221


Q ss_pred             ccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHh-CCCCCCCCcccccccchhhhhhhhcCccccccCcccc
Q 017594          207 QANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILE  285 (369)
Q Consensus       207 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (369)
                      .  .....++..|+|||...+..++.++|+||||+++|+|++ |..||.......      ........ .    ..   
T Consensus       160 ~--~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~------~~~~~~~~-~----~~---  223 (261)
T cd05148         160 L--SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHE------VYDQITAG-Y----RM---  223 (261)
T ss_pred             c--ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHH------HHHHHHhC-C----cC---
Confidence            1  112234667999999988889999999999999999998 888986432110      00000100 0    00   


Q ss_pred             ccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHhh
Q 017594          286 DEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNE  325 (369)
Q Consensus       286 ~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L~~~  325 (369)
                        ..+..++..+.+++.+||+.+|.+|||+.+|++.|+.+
T Consensus       224 --~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~  261 (261)
T cd05148         224 --PCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI  261 (261)
T ss_pred             --CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence              00112256789999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=2.1e-39  Score=299.83  Aligned_cols=242  Identities=22%  Similarity=0.274  Sum_probs=193.7

Q ss_pred             ccccccCCccEEEEEEc-CCCEEEEEEecCC---CchhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEEEEecCCC
Q 017594           55 NKLGEGGFGPVYKGVLK-KGDEIAVKRLSGR---SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIYEYMPNK  130 (369)
Q Consensus        55 ~~lg~G~~~~v~~~~~~-~~~~valK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~  130 (369)
                      +.||+|+||.||+|+.+ +|+.||+|++...   .......+..|+.+++.+.||||+++.+.+...+..++||||+.++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g   80 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG   80 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence            46899999999999965 4899999998643   2233456778999999999999999999999999999999999999


Q ss_pred             ChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCCCCccccc
Q 017594          131 SLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANT  210 (369)
Q Consensus       131 ~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~~~~~~~~  210 (369)
                      +|...+...   ..+++..+..++.||+.||.|||+++   ++||||||+||+++.++.++|+|||++.......  ...
T Consensus        81 ~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~--~~~  152 (328)
T cd05593          81 ELFFHLSRE---RVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA--ATM  152 (328)
T ss_pred             CHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCCCcc--ccc
Confidence            998887432   34889999999999999999999999   9999999999999999999999999986532211  122


Q ss_pred             ccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCccccccCccccccccH
Q 017594          211 SRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYSS  290 (369)
Q Consensus       211 ~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  290 (369)
                      ....|++.|+|||++.+..++.++|||||||++|+|++|..||.......     ..... ....      ..+     +
T Consensus       153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~-----~~~~~-~~~~------~~~-----p  215 (328)
T cd05593         153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK-----LFELI-LMED------IKF-----P  215 (328)
T ss_pred             ccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHH-----HHHHh-ccCC------ccC-----C
Confidence            33468999999999998899999999999999999999999986432111     00000 0000      001     1


Q ss_pred             HHHHHHHHHHHHHhhcCCCCCCC-----CHHHHHHH
Q 017594          291 KQMLLRYANIALLCVQESADDRP-----TMNDVVSM  321 (369)
Q Consensus       291 ~~~~~~l~~li~~~L~~dP~~Rp-----s~~ell~~  321 (369)
                      ..++.++.++|.+||+.||++|+     ++.++++.
T Consensus       216 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h  251 (328)
T cd05593         216 RTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH  251 (328)
T ss_pred             CCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence            12256789999999999999997     89999864

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=2.5e-39  Score=304.28  Aligned_cols=263  Identities=26%  Similarity=0.377  Sum_probs=203.5

Q ss_pred             HHhcCCccCccccccCCccEEEEEEc------CCCEEEEEEecCCC-chhHHHHHHHHHHHhcC-CCCceeeeeeeEEeC
Q 017594           46 TATNKFSDANKLGEGGFGPVYKGVLK------KGDEIAVKRLSGRS-GQGLREMKNEASVIAKV-QHKNLVRLLGCCIDR  117 (369)
Q Consensus        46 ~~~~~y~i~~~lg~G~~~~v~~~~~~------~~~~valK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~  117 (369)
                      ...++|++.+.||+|+||.||+|++.      ++..||+|.+.... ......+..|+.+++.+ .|+||+++++.+...
T Consensus        35 ~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~  114 (374)
T cd05106          35 FPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHG  114 (374)
T ss_pred             ccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCC
Confidence            33458999999999999999999843      23579999987543 33345678899999999 899999999999999


Q ss_pred             CccEEEEEecCCCChhhhhcCCC---------------------------------------------------------
Q 017594          118 DEKILIYEYMPNKSLDFFLFDPT---------------------------------------------------------  140 (369)
Q Consensus       118 ~~~~lv~e~~~~~~L~~~l~~~~---------------------------------------------------------  140 (369)
                      ...++||||+.+++|.+++....                                                         
T Consensus       115 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  194 (374)
T cd05106         115 GPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQS  194 (374)
T ss_pred             CCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccc
Confidence            99999999999999988874321                                                         


Q ss_pred             ----------ccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCCCCccccc
Q 017594          141 ----------KRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANT  210 (369)
Q Consensus       141 ----------~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~~~~~~~~  210 (369)
                                ....+++..+++++.||+.||.|||+.+   ++||||||+||+++.++.++|+|||++............
T Consensus       195 ~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~  271 (374)
T cd05106         195 SDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVK  271 (374)
T ss_pred             ccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeec
Confidence                      1124678889999999999999999998   999999999999999999999999998765433221112


Q ss_pred             ccccccccccCchhhccCCCCcccchHhHHHHHHHHHh-CCCCCCCCcccccccchhhhhhhhcCccccccCcccccccc
Q 017594          211 SRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYS  289 (369)
Q Consensus       211 ~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  289 (369)
                      ....++..|+|||++.+..++.++|||||||++|+|++ |..||.......     ..........     ....     
T Consensus       272 ~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~-----~~~~~~~~~~-----~~~~-----  336 (374)
T cd05106         272 GNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS-----KFYKMVKRGY-----QMSR-----  336 (374)
T ss_pred             cCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH-----HHHHHHHccc-----CccC-----
Confidence            22234567999999988899999999999999999997 999986432111     0111111100     0000     


Q ss_pred             HHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHhhh
Q 017594          290 SKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNEA  326 (369)
Q Consensus       290 ~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L~~~~  326 (369)
                      +...+.++.+++.+||+.||.+||++.++++.|+++.
T Consensus       337 ~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~  373 (374)
T cd05106         337 PDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL  373 (374)
T ss_pred             CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence            0012567999999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=2e-39  Score=299.57  Aligned_cols=245  Identities=24%  Similarity=0.345  Sum_probs=192.0

Q ss_pred             CccCccccccCCccEEEEEEc-CCCEEEEEEecCCC---chhHHHHHHHHHHH---hcCCCCceeeeeeeEEeCCccEEE
Q 017594           51 FSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS---GQGLREMKNEASVI---AKVQHKNLVRLLGCCIDRDEKILI  123 (369)
Q Consensus        51 y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~~---~~~~~~~~~e~~~l---~~l~h~~i~~~~~~~~~~~~~~lv  123 (369)
                      |++.+.||+|++|.||+|.++ +|+.||+|++....   ....+.+..|..++   +.++||||+++++++...+..|+|
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv   80 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV   80 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence            788999999999999999965 48999999986432   22234555565544   566899999999999999999999


Q ss_pred             EEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCC
Q 017594          124 YEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGG  203 (369)
Q Consensus       124 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~  203 (369)
                      |||+.+++|...+..    ..+++..++.++.||+.||.|||+++   ++||||||+||+++.++.++|+|||++.....
T Consensus        81 ~E~~~~~~L~~~~~~----~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~  153 (324)
T cd05589          81 MEYAAGGDLMMHIHT----DVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMG  153 (324)
T ss_pred             EcCCCCCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCccCCC
Confidence            999999999877732    34899999999999999999999999   99999999999999999999999998764322


Q ss_pred             CCcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCccccccCcc
Q 017594          204 NELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPI  283 (369)
Q Consensus       204 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (369)
                      ..  .......|++.|+|||++.+..++.++|+|||||++|+|++|..||.......     ...... ....      .
T Consensus       154 ~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~-----~~~~i~-~~~~------~  219 (324)
T cd05589         154 FG--DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEE-----VFDSIV-NDEV------R  219 (324)
T ss_pred             CC--CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHH-----HHHHHH-hCCC------C
Confidence            11  12233568899999999998899999999999999999999999986432111     000000 0000      0


Q ss_pred             ccccccHHHHHHHHHHHHHHhhcCCCCCCC-----CHHHHHHH
Q 017594          284 LEDEYSSKQMLLRYANIALLCVQESADDRP-----TMNDVVSM  321 (369)
Q Consensus       284 ~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp-----s~~ell~~  321 (369)
                      .     +..++..+.++|.+||+.||.+||     ++.++++.
T Consensus       220 ~-----p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~  257 (324)
T cd05589         220 Y-----PRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQ  257 (324)
T ss_pred             C-----CCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhC
Confidence            0     111256689999999999999999     57777764

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=5.4e-39  Score=291.79  Aligned_cols=262  Identities=28%  Similarity=0.439  Sum_probs=207.8

Q ss_pred             hcCCccCccccccCCccEEEEEEc------CCCEEEEEEecCCCchhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccE
Q 017594           48 TNKFSDANKLGEGGFGPVYKGVLK------KGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKI  121 (369)
Q Consensus        48 ~~~y~i~~~lg~G~~~~v~~~~~~------~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  121 (369)
                      ...|.+.+.||.|+||.||++...      ++..+++|.+..........+..|+.+++.++|+|++++++++......+
T Consensus         4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   83 (288)
T cd05093           4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI   83 (288)
T ss_pred             hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence            467899999999999999999842      24568999887665555677889999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhcCCC----------ccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceE
Q 017594          122 LIYEYMPNKSLDFFLFDPT----------KRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPK  191 (369)
Q Consensus       122 lv~e~~~~~~L~~~l~~~~----------~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~  191 (369)
                      +++||+.+++|.+++....          ....+++..+..++.|++.||+|||+.+   ++||||+|+||+++.++.++
T Consensus        84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~~k  160 (288)
T cd05093          84 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVK  160 (288)
T ss_pred             EEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEE
Confidence            9999999999988885322          2234889999999999999999999998   99999999999999999999


Q ss_pred             EeecCCceecCCCCcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHh-CCCCCCCCcccccccchhhhhh
Q 017594          192 ISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDL  270 (369)
Q Consensus       192 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~  270 (369)
                      |+|||++................++..|+|||.+.+..++.++|+|||||++|+|++ |..||.......     .. ..
T Consensus       161 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~-----~~-~~  234 (288)
T cd05093         161 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE-----VI-EC  234 (288)
T ss_pred             eccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-----HH-HH
Confidence            999999876543322222222334678999999988889999999999999999998 888875332111     00 11


Q ss_pred             hhcCccccccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHhhhhc
Q 017594          271 WTSNRTLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNEAAT  328 (369)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L~~~~~~  328 (369)
                      ........     ...     .++.++.+++.+||+.+|.+|||+.++++.|+.+...
T Consensus       235 i~~~~~~~-----~~~-----~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~  282 (288)
T cd05093         235 ITQGRVLQ-----RPR-----TCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA  282 (288)
T ss_pred             HHcCCcCC-----CCC-----CCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence            11111100     001     1255699999999999999999999999999988764

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=4.1e-39  Score=291.13  Aligned_cols=257  Identities=29%  Similarity=0.456  Sum_probs=204.0

Q ss_pred             hcCCccCccccccCCccEEEEEEcC------CCEEEEEEecCCCch-hHHHHHHHHHHHhcCCCCceeeeeeeEEeCCcc
Q 017594           48 TNKFSDANKLGEGGFGPVYKGVLKK------GDEIAVKRLSGRSGQ-GLREMKNEASVIAKVQHKNLVRLLGCCIDRDEK  120 (369)
Q Consensus        48 ~~~y~i~~~lg~G~~~~v~~~~~~~------~~~valK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~  120 (369)
                      .++|.+.+.||+|++|.||+|+..+      +..|++|.+...... ....+.+|+++++.+.|+|++++++++......
T Consensus         4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   83 (280)
T cd05049           4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP   83 (280)
T ss_pred             hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence            4679999999999999999998643      467999998755433 456788999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhcCCC-----------ccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCc
Q 017594          121 ILIYEYMPNKSLDFFLFDPT-----------KRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMN  189 (369)
Q Consensus       121 ~lv~e~~~~~~L~~~l~~~~-----------~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~  189 (369)
                      +++|||+.+++|.+++....           ....+++..+..++.|++.|+.+||+++   ++|+||+|+||+++.++.
T Consensus        84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~  160 (280)
T cd05049          84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLV  160 (280)
T ss_pred             EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCe
Confidence            99999999999999885432           2344778889999999999999999999   999999999999999999


Q ss_pred             eEEeecCCceecCCCCcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHh-CCCCCCCCcccccccchhhh
Q 017594          190 PKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAW  268 (369)
Q Consensus       190 ~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~t-g~~p~~~~~~~~~~~~~~~~  268 (369)
                      ++|+|||++................++..|+|||++.+..++.++||||||+++|+|++ |..||.......     .. 
T Consensus       161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~-----~~-  234 (280)
T cd05049         161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEE-----VI-  234 (280)
T ss_pred             EEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHH-----HH-
Confidence            99999999875533222112222345678999999999999999999999999999998 999985332111     00 


Q ss_pred             hhhhcCccccccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 017594          269 DLWTSNRTLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLT  323 (369)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L~  323 (369)
                      ..........          .+...+..+.+++.+||+.||++||++.|+++.|+
T Consensus       235 ~~~~~~~~~~----------~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~  279 (280)
T cd05049         235 ECITQGRLLQ----------RPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ  279 (280)
T ss_pred             HHHHcCCcCC----------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence            0001110000          01122567999999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.1e-40  Score=287.59  Aligned_cols=272  Identities=22%  Similarity=0.292  Sum_probs=207.0

Q ss_pred             hHHHHhcCCccCccccccCCccEEEEEEc-CCCEEEEEEec--CCCchhHHHHHHHHHHHhcCCCCceeeeeeeEEe---
Q 017594           43 SVSTATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLS--GRSGQGLREMKNEASVIAKVQHKNLVRLLGCCID---  116 (369)
Q Consensus        43 ~~~~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~--~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---  116 (369)
                      ....+..+|..++.||.|+||.|+.|.++ +|..||+|++.  .......++..+|+..|+.++|+||+.+.+++.-   
T Consensus        16 ~~~~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~   95 (359)
T KOG0660|consen   16 ELFEIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSR   95 (359)
T ss_pred             eEEeccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccc
Confidence            44556678888999999999999999965 49999999987  4455567788899999999999999999999865   


Q ss_pred             --CCccEEEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEee
Q 017594          117 --RDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISD  194 (369)
Q Consensus       117 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~D  194 (369)
                        -+..|+|+|++ +..|...+..   ...++...+..+++||+.||.|+|+.+   ++||||||.|++++.+..+|++|
T Consensus        96 ~~f~DvYiV~elM-etDL~~iik~---~~~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~D  168 (359)
T KOG0660|consen   96 DKFNDVYLVFELM-ETDLHQIIKS---QQDLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICD  168 (359)
T ss_pred             cccceeEEehhHH-hhHHHHHHHc---CccccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEecc
Confidence              24579999998 5677777743   333899999999999999999999999   99999999999999999999999


Q ss_pred             cCCceecCCCCcccccccccccccccCchhhc-cCCCCcccchHhHHHHHHHHHhCCCCCCCCccccc-cc--------c
Q 017594          195 FGMARICGGNELQANTSRIVGTYGYMSPEYAL-EGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSL-NL--------L  264 (369)
Q Consensus       195 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~-~~--------~  264 (369)
                      ||+++...........+....|.+|.|||++. ...|+.+.||||+|||+.||++|++.|...+...+ ..        .
T Consensus       169 FGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~  248 (359)
T KOG0660|consen  169 FGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPS  248 (359)
T ss_pred             ccceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCC
Confidence            99999876442223335567799999999875 56799999999999999999999999876541111 10        0


Q ss_pred             hhhhhhhhcCccccccCccc---ccccc--HHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 017594          265 GYAWDLWTSNRTLELIDPIL---EDEYS--SKQMLLRYANIALLCVQESADDRPTMNDVVSM  321 (369)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~---~~~~~--~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~  321 (369)
                      ........+......+....   ...+.  -...++...+|+.+||..||.+|+|++|+|+.
T Consensus       249 ~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~h  310 (359)
T KOG0660|consen  249 EEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAH  310 (359)
T ss_pred             HHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence            01111111111111111110   00000  01225678999999999999999999999963

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=6.2e-39  Score=290.51  Aligned_cols=257  Identities=31%  Similarity=0.497  Sum_probs=203.9

Q ss_pred             cCCccCccccccCCccEEEEEEcC-C-----CEEEEEEecCCC-chhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccE
Q 017594           49 NKFSDANKLGEGGFGPVYKGVLKK-G-----DEIAVKRLSGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKI  121 (369)
Q Consensus        49 ~~y~i~~~lg~G~~~~v~~~~~~~-~-----~~valK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  121 (369)
                      ++|++.+.||.|++|.||+|.... +     ..|++|.+.... ......+.+|+..+..++|||++++++++......+
T Consensus         5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T cd05048           5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC   84 (283)
T ss_pred             HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence            579999999999999999998543 2     568999886443 233456788999999999999999999999888999


Q ss_pred             EEEEecCCCChhhhhcCCCc-------------cccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCC
Q 017594          122 LIYEYMPNKSLDFFLFDPTK-------------RMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDM  188 (369)
Q Consensus       122 lv~e~~~~~~L~~~l~~~~~-------------~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~  188 (369)
                      +++||+.+++|.+++.....             ...+++..+..++.|++.||.|||..+   ++|+||+|+||+++.++
T Consensus        85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~~  161 (283)
T cd05048          85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGL  161 (283)
T ss_pred             EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCCC
Confidence            99999999999888854321             145788889999999999999999998   99999999999999999


Q ss_pred             ceEEeecCCceecCCCCcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHh-CCCCCCCCcccccccchhh
Q 017594          189 NPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYA  267 (369)
Q Consensus       189 ~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~t-g~~p~~~~~~~~~~~~~~~  267 (369)
                      .++|+|||++................++..|+|||.+.+..++.++|+|||||++|+|++ |..||.......      .
T Consensus       162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~------~  235 (283)
T cd05048         162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQE------V  235 (283)
T ss_pred             cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHH------H
Confidence            999999999876543322222233345778999999988889999999999999999998 998885432111      1


Q ss_pred             hhhhhcCccccccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHh
Q 017594          268 WDLWTSNRTLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTN  324 (369)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L~~  324 (369)
                      ...........          .+..++.++.+++.+||+.||.+||++.+|++.|++
T Consensus       236 ~~~i~~~~~~~----------~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05048         236 IEMIRSRQLLP----------CPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS  282 (283)
T ss_pred             HHHHHcCCcCC----------CcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence            11111111110          112236779999999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=7e-39  Score=291.49  Aligned_cols=262  Identities=28%  Similarity=0.426  Sum_probs=208.7

Q ss_pred             hcCCccCccccccCCccEEEEEEc------CCCEEEEEEecCCCchhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccE
Q 017594           48 TNKFSDANKLGEGGFGPVYKGVLK------KGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKI  121 (369)
Q Consensus        48 ~~~y~i~~~lg~G~~~~v~~~~~~------~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  121 (369)
                      .++|.+.+.||.|++|.||+|+..      ++..+++|.+..........+.+|+..++.++|+|++++++++......+
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   83 (291)
T cd05094           4 RRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLI   83 (291)
T ss_pred             hHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceE
Confidence            356889999999999999999843      24568899887665555567889999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhcCCC-------------ccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCC
Q 017594          122 LIYEYMPNKSLDFFLFDPT-------------KRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDM  188 (369)
Q Consensus       122 lv~e~~~~~~L~~~l~~~~-------------~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~  188 (369)
                      +||||+.+++|.+++....             ....+++..++.++.||+.|++|||+.+   ++|+||+|.||+++.++
T Consensus        84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~~  160 (291)
T cd05094          84 MVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANL  160 (291)
T ss_pred             EEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCC
Confidence            9999999999999985432             1234788899999999999999999999   99999999999999999


Q ss_pred             ceEEeecCCceecCCCCcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHh-CCCCCCCCcccccccchhh
Q 017594          189 NPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYA  267 (369)
Q Consensus       189 ~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~t-g~~p~~~~~~~~~~~~~~~  267 (369)
                      .++|+|||++................++..|+|||.+.+..++.++||||||+++|+|++ |..||.......      .
T Consensus       161 ~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~------~  234 (291)
T cd05094         161 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE------V  234 (291)
T ss_pred             cEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH------H
Confidence            999999999876543322222223345678999999988889999999999999999998 999975432111      1


Q ss_pred             hhhhhcCccccccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHhhhhc
Q 017594          268 WDLWTSNRTLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNEAAT  328 (369)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L~~~~~~  328 (369)
                      ............          ...++..+.+++.+||+.+|++||++.++++.|+.+...
T Consensus       235 ~~~~~~~~~~~~----------~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~  285 (291)
T cd05094         235 IECITQGRVLER----------PRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA  285 (291)
T ss_pred             HHHHhCCCCCCC----------CccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence            111111111110          011256799999999999999999999999999999763

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=3.6e-39  Score=292.59  Aligned_cols=251  Identities=24%  Similarity=0.315  Sum_probs=198.0

Q ss_pred             CccCccccccCCccEEEEEEc-CCCEEEEEEecCCC---chhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEEEEe
Q 017594           51 FSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS---GQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIYEY  126 (369)
Q Consensus        51 y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  126 (369)
                      |++.+.||+|+||.||+|... +|+.||+|.+....   ......+.+|+.++..+.|++++++.+++...+..++++||
T Consensus         2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~   81 (285)
T cd05631           2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence            788899999999999999964 58999999886432   12234567899999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCCCCc
Q 017594          127 MPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNEL  206 (369)
Q Consensus       127 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~~~~  206 (369)
                      +.+++|...+.... ...+++..+..++.|++.||+|||+.+   ++||||||+||+++.++.++|+|||++........
T Consensus        82 ~~~g~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~  157 (285)
T cd05631          82 MNGGDLKFHIYNMG-NPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET  157 (285)
T ss_pred             cCCCcHHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCe
Confidence            99999987775322 234788899999999999999999999   99999999999999999999999999876543221


Q ss_pred             ccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCccccccCccccc
Q 017594          207 QANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILED  286 (369)
Q Consensus       207 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  286 (369)
                         .....|+..|+|||++.+..++.++|||||||++|+|++|+.||........  ......... ....         
T Consensus       158 ---~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~--~~~~~~~~~-~~~~---------  222 (285)
T cd05631         158 ---VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVK--REEVDRRVK-EDQE---------  222 (285)
T ss_pred             ---ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchh--HHHHHHHhh-cccc---------
Confidence               1234678999999999999999999999999999999999999974332110  000000000 0000         


Q ss_pred             cccHHHHHHHHHHHHHHhhcCCCCCCCC-----HHHHHHH
Q 017594          287 EYSSKQMLLRYANIALLCVQESADDRPT-----MNDVVSM  321 (369)
Q Consensus       287 ~~~~~~~~~~l~~li~~~L~~dP~~Rps-----~~ell~~  321 (369)
                       ..+..++.++.+||.+||+.||.+||+     +.++++.
T Consensus       223 -~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h  261 (285)
T cd05631         223 -EYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQH  261 (285)
T ss_pred             -cCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence             001123667999999999999999997     7888863

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=4.7e-39  Score=296.03  Aligned_cols=241  Identities=27%  Similarity=0.359  Sum_probs=188.0

Q ss_pred             ccccccCCccEEEEEEcC-CCEEEEEEecCCC---chhHHHHHHHHHHHhcC-CCCceeeeeeeEEeCCccEEEEEecCC
Q 017594           55 NKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRS---GQGLREMKNEASVIAKV-QHKNLVRLLGCCIDRDEKILIYEYMPN  129 (369)
Q Consensus        55 ~~lg~G~~~~v~~~~~~~-~~~valK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~  129 (369)
                      +.||+|+||.||+|+.+. ++.||+|.+....   .........|..++..+ .||||+++++++......++||||+.+
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g   80 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            468999999999999654 8889999986431   22234445566666644 899999999999999999999999999


Q ss_pred             CChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCCCCcccc
Q 017594          130 KSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQAN  209 (369)
Q Consensus       130 ~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~~~~~~~  209 (369)
                      ++|..++...   ..+++..+..++.||+.||.|||+.+   ++||||||+||+++.++.++|+|||++.......  ..
T Consensus        81 g~L~~~~~~~---~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~--~~  152 (316)
T cd05592          81 GDLMFHIQSS---GRFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE--GK  152 (316)
T ss_pred             CcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC--Cc
Confidence            9998888543   34889999999999999999999998   9999999999999999999999999987643222  22


Q ss_pred             cccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCccccccCcccccccc
Q 017594          210 TSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYS  289 (369)
Q Consensus       210 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  289 (369)
                      .....|++.|+|||++.+..++.++|||||||++|+|++|..||.......     ....... .  .    +.+     
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~-----~~~~i~~-~--~----~~~-----  215 (316)
T cd05592         153 ASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDE-----LFDSILN-D--R----PHF-----  215 (316)
T ss_pred             cccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHH-----HHHHHHc-C--C----CCC-----
Confidence            233568999999999998899999999999999999999999986433111     0111100 0  0    000     


Q ss_pred             HHHHHHHHHHHHHHhhcCCCCCCCCHH-HHHH
Q 017594          290 SKQMLLRYANIALLCVQESADDRPTMN-DVVS  320 (369)
Q Consensus       290 ~~~~~~~l~~li~~~L~~dP~~Rps~~-ell~  320 (369)
                      +..++.++.+++.+||+.+|++||++. ++++
T Consensus       216 ~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~  247 (316)
T cd05592         216 PRWISKEAKDCLSKLFERDPTKRLGVDGDIRQ  247 (316)
T ss_pred             CCCCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence            111256689999999999999999875 5544

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=1.3e-39  Score=315.53  Aligned_cols=254  Identities=18%  Similarity=0.202  Sum_probs=204.3

Q ss_pred             hcCCccCccccccCCccEEEEEEcC--CCEEEEEEecCCCchhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEEEE
Q 017594           48 TNKFSDANKLGEGGFGPVYKGVLKK--GDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIYE  125 (369)
Q Consensus        48 ~~~y~i~~~lg~G~~~~v~~~~~~~--~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  125 (369)
                      ...|.+.+.||+|++|.||+|....  +..|++|.+..........+..|+..+..++||||+++++++..++..++|||
T Consensus        66 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E  145 (478)
T PTZ00267         66 EHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIME  145 (478)
T ss_pred             ceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEE
Confidence            4459999999999999999998543  67788998765555555677889999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCC-CccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCCC
Q 017594          126 YMPNKSLDFFLFDP-TKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGN  204 (369)
Q Consensus       126 ~~~~~~L~~~l~~~-~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~~  204 (369)
                      |+.+++|.+++... ....++++..+..++.||+.||.|||+.+   ++||||||+||+++.++.++|+|||++..+...
T Consensus       146 ~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~  222 (478)
T PTZ00267        146 YGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDS  222 (478)
T ss_pred             CCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceecCCc
Confidence            99999998877542 23456889999999999999999999998   999999999999999999999999999876543


Q ss_pred             CcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCccccccCccc
Q 017594          205 ELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPIL  284 (369)
Q Consensus       205 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (369)
                      ..........|++.|+|||++.+..++.++|||||||++|+|++|..||......     ........ ....    +  
T Consensus       223 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~-----~~~~~~~~-~~~~----~--  290 (478)
T PTZ00267        223 VSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQR-----EIMQQVLY-GKYD----P--  290 (478)
T ss_pred             cccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHHHh-CCCC----C--
Confidence            3222233456899999999999889999999999999999999999998633211     01111111 0000    0  


Q ss_pred             cccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 017594          285 EDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVS  320 (369)
Q Consensus       285 ~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~  320 (369)
                          .+..++.++.++|.+||+.+|++||++.+++.
T Consensus       291 ----~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~  322 (478)
T PTZ00267        291 ----FPCPVSSGMKALLDPLLSKNPALRPTTQQLLH  322 (478)
T ss_pred             ----CCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence                01122567999999999999999999999874

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=4.9e-39  Score=288.64  Aligned_cols=260  Identities=20%  Similarity=0.331  Sum_probs=206.2

Q ss_pred             cCCccCccccccCCccEEEEEEc-CCCEEEEEEecCC---CchhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEEE
Q 017594           49 NKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGR---SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIY  124 (369)
Q Consensus        49 ~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  124 (369)
                      ++|++.+.||.|+||.||+|+.+ ++..|++|.+...   .......+..|+.+++.++|||++++++++...+..++++
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL   81 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence            57999999999999999999965 5889999987542   2233456778999999999999999999999989999999


Q ss_pred             EecCCCChhhhhcCCC-ccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCC
Q 017594          125 EYMPNKSLDFFLFDPT-KRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGG  203 (369)
Q Consensus       125 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~  203 (369)
                      ||+.+++|..++.... ....+++..+..++.||+.||.|||+.+   ++|+||+|+||+++.++.++|+|||.+.....
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~  158 (267)
T cd08228          82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence            9999999988775322 2345788899999999999999999998   99999999999999999999999999876543


Q ss_pred             CCcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCccccccCcc
Q 017594          204 NELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPI  283 (369)
Q Consensus       204 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (369)
                      ...  ......++..|+|||.+.+..++.++|+||+|+++|+|++|..||........   ...... ..         .
T Consensus       159 ~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~---~~~~~~-~~---------~  223 (267)
T cd08228         159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLF---SLCQKI-EQ---------C  223 (267)
T ss_pred             hhH--HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHH---HHHHHH-hc---------C
Confidence            221  11223577889999999888899999999999999999999999853321110   011110 00         0


Q ss_pred             ccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHhhh
Q 017594          284 LEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNEA  326 (369)
Q Consensus       284 ~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L~~~~  326 (369)
                      ..........+..+.+++.+||+.+|++||++.++++.|+++.
T Consensus       224 ~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~  266 (267)
T cd08228         224 DYPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH  266 (267)
T ss_pred             CCCCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence            0011112233577999999999999999999999999998864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=3.6e-39  Score=297.67  Aligned_cols=242  Identities=22%  Similarity=0.300  Sum_probs=193.0

Q ss_pred             ccccccCCccEEEEEEc-CCCEEEEEEecCC---CchhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEEEEecCCC
Q 017594           55 NKLGEGGFGPVYKGVLK-KGDEIAVKRLSGR---SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIYEYMPNK  130 (369)
Q Consensus        55 ~~lg~G~~~~v~~~~~~-~~~~valK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~  130 (369)
                      +.||+|+||.||+++.+ +|..||+|++...   .......+..|+.+++.++||||+++++.+...+..++||||+.++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence            46899999999999965 4899999998643   2233455677999999999999999999999999999999999999


Q ss_pred             ChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCCCCccccc
Q 017594          131 SLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANT  210 (369)
Q Consensus       131 ~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~~~~~~~~  210 (369)
                      +|..++..   ...+++..++.++.||+.||.|||+++   ++||||||+||+++.++.++|+|||++.......  ...
T Consensus        81 ~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~--~~~  152 (323)
T cd05595          81 ELFFHLSR---ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--ATM  152 (323)
T ss_pred             cHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccccCCC--Ccc
Confidence            99887743   334889999999999999999999999   9999999999999999999999999876432211  112


Q ss_pred             ccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCccccccCccccccccH
Q 017594          211 SRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYSS  290 (369)
Q Consensus       211 ~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  290 (369)
                      ....|++.|+|||++.+..++.++|||||||++|+|++|..||.......      ..........      .+     +
T Consensus       153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~------~~~~~~~~~~------~~-----p  215 (323)
T cd05595         153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER------LFELILMEEI------RF-----P  215 (323)
T ss_pred             ccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHH------HHHHHhcCCC------CC-----C
Confidence            23468899999999998899999999999999999999999986432111      0000000000      00     1


Q ss_pred             HHHHHHHHHHHHHhhcCCCCCCC-----CHHHHHHH
Q 017594          291 KQMLLRYANIALLCVQESADDRP-----TMNDVVSM  321 (369)
Q Consensus       291 ~~~~~~l~~li~~~L~~dP~~Rp-----s~~ell~~  321 (369)
                      ..++.++.++|.+||+.||.+||     ++.++++.
T Consensus       216 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h  251 (323)
T cd05595         216 RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH  251 (323)
T ss_pred             CCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence            12256789999999999999998     88888763

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=5.4e-39  Score=297.70  Aligned_cols=264  Identities=25%  Similarity=0.345  Sum_probs=200.6

Q ss_pred             HhcCCccCccccccCCccEEEEEEc-CCCEEEEEEecCC-CchhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEEE
Q 017594           47 ATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGR-SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIY  124 (369)
Q Consensus        47 ~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  124 (369)
                      ..++|++.+.||.|+||.||+|.+. ++..+++|.+... .......+..|+++++.++|+||+++++++...+..++||
T Consensus         3 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   82 (333)
T cd06650           3 KDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM   82 (333)
T ss_pred             chhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEE
Confidence            4578999999999999999999976 4888999987654 2233467889999999999999999999999999999999


Q ss_pred             EecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcC-CCCCcccCCCCCCCEEEeCCCceEEeecCCceecCC
Q 017594          125 EYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQY-SRVRIIHRDLKASNILLDKDMNPKISDFGMARICGG  203 (369)
Q Consensus       125 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~-~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~  203 (369)
                      ||+.+++|.+++...   ..+++..+..++.|++.||.|||+. +   ++|+||||+||+++.++.++|+|||++.....
T Consensus        83 e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~  156 (333)
T cd06650          83 EHMDGGSLDQVLKKA---GRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID  156 (333)
T ss_pred             ecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChhhEEEcCCCCEEEeeCCcchhhhh
Confidence            999999999988542   3478889999999999999999975 5   99999999999999999999999999865432


Q ss_pred             CCcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccc-h------hhhhhh--hcC
Q 017594          204 NELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLL-G------YAWDLW--TSN  274 (369)
Q Consensus       204 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~-~------~~~~~~--~~~  274 (369)
                      .    ......++..|+|||.+.+..++.++|+|||||++|+|++|+.||........... .      ......  ...
T Consensus       157 ~----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (333)
T cd06650         157 S----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPR  232 (333)
T ss_pred             h----ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccC
Confidence            2    12234678899999999888899999999999999999999999874331110000 0      000000  000


Q ss_pred             -----------------ccccccCccccc---cccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 017594          275 -----------------RTLELIDPILED---EYSSKQMLLRYANIALLCVQESADDRPTMNDVVS  320 (369)
Q Consensus       275 -----------------~~~~~~~~~~~~---~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~  320 (369)
                                       ............   ......++.++.+|+.+||+.||++|||+.++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~  298 (333)
T cd06650         233 PPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMV  298 (333)
T ss_pred             CccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhh
Confidence                             000000000000   0000112567899999999999999999999974

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.1e-39  Score=302.30  Aligned_cols=253  Identities=23%  Similarity=0.314  Sum_probs=199.1

Q ss_pred             cCCccCccccccCCccEEEEEEc-CCCEEEEEEecCCC---chhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEEE
Q 017594           49 NKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS---GQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIY  124 (369)
Q Consensus        49 ~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  124 (369)
                      ++|++.+.||.|+||.||+|+.. +|+.||+|++....   ......+..|+.++..++||||+++++++...+..++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM   80 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence            47999999999999999999975 48899999986431   233456778999999999999999999999999999999


Q ss_pred             EecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCCC
Q 017594          125 EYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGN  204 (369)
Q Consensus       125 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~~  204 (369)
                      ||+.+++|.+++...   ..+++..+..++.||+.||+|||+.+   ++||||||+||+++.++.++|+|||++..+...
T Consensus        81 E~~~~g~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~  154 (364)
T cd05599          81 EYLPGGDMMTLLMKK---DTFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKS  154 (364)
T ss_pred             CCCCCcHHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceecccc
Confidence            999999999988543   34899999999999999999999999   999999999999999999999999998754321


Q ss_pred             Cccc------------------------------------ccccccccccccCchhhccCCCCcccchHhHHHHHHHHHh
Q 017594          205 ELQA------------------------------------NTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS  248 (369)
Q Consensus       205 ~~~~------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~t  248 (369)
                      ....                                    ......|++.|+|||++.+..++.++|||||||++|+|++
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~  234 (364)
T cd05599         155 HRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLV  234 (364)
T ss_pred             ccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhc
Confidence            1000                                    0011358999999999998899999999999999999999


Q ss_pred             CCCCCCCCcccccccchhhhhhhhcCccccccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCC---HHHHHHH
Q 017594          249 GKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPT---MNDVVSM  321 (369)
Q Consensus       249 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps---~~ell~~  321 (369)
                      |..||.......     ................     .   ...+.++.++|.+||. +|.+|++   +.++++.
T Consensus       235 G~~Pf~~~~~~~-----~~~~i~~~~~~~~~~~-----~---~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h  296 (364)
T cd05599         235 GYPPFCSDNPQE-----TYRKIINWKETLQFPD-----E---VPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSH  296 (364)
T ss_pred             CCCCCCCCCHHH-----HHHHHHcCCCccCCCC-----C---CCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcC
Confidence            999996433111     1111111111101000     0   0125678999999997 9999998   9998873

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=8.6e-39  Score=296.38  Aligned_cols=252  Identities=22%  Similarity=0.282  Sum_probs=196.1

Q ss_pred             CCccCccccccCCccEEEEEEc----CCCEEEEEEecCC----CchhHHHHHHHHHHHhcC-CCCceeeeeeeEEeCCcc
Q 017594           50 KFSDANKLGEGGFGPVYKGVLK----KGDEIAVKRLSGR----SGQGLREMKNEASVIAKV-QHKNLVRLLGCCIDRDEK  120 (369)
Q Consensus        50 ~y~i~~~lg~G~~~~v~~~~~~----~~~~valK~~~~~----~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~  120 (369)
                      +|++.+.||+|+||.||+|+..    ++..||+|++...    .....+.+..|+.++..+ .|++|+++++++...+..
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL   80 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence            4889999999999999999852    4788999998632    223345677899999999 489999999999999999


Q ss_pred             EEEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCcee
Q 017594          121 ILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARI  200 (369)
Q Consensus       121 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~  200 (369)
                      ++||||+.+++|..++..   +..+++..+..++.||+.||.|||+.+   ++||||||+||+++.++.++|+|||++..
T Consensus        81 ~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~~~~  154 (332)
T cd05614          81 HLILDYVSGGEMFTHLYQ---RDNFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKE  154 (332)
T ss_pred             EEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcCCcc
Confidence            999999999999888854   334889999999999999999999999   99999999999999999999999999876


Q ss_pred             cCCCCcccccccccccccccCchhhccC-CCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCccccc
Q 017594          201 CGGNELQANTSRIVGTYGYMSPEYALEG-IFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLEL  279 (369)
Q Consensus       201 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (369)
                      +...... ......|+..|+|||++.+. .++.++|||||||++|+|++|..||......... .........       
T Consensus       155 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~-~~~~~~~~~-------  225 (332)
T cd05614         155 FLSEEKE-RTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQ-SEVSRRILK-------  225 (332)
T ss_pred             ccccCCC-ccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCH-HHHHHHHhc-------
Confidence            5332211 12234689999999998765 4788999999999999999999999643211110 000000000       


Q ss_pred             cCccccccccHHHHHHHHHHHHHHhhcCCCCCCC-----CHHHHHHH
Q 017594          280 IDPILEDEYSSKQMLLRYANIALLCVQESADDRP-----TMNDVVSM  321 (369)
Q Consensus       280 ~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp-----s~~ell~~  321 (369)
                      ..+.+.     ..++..+.+++.+||+.||++||     +++++++.
T Consensus       226 ~~~~~~-----~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h  267 (332)
T cd05614         226 CDPPFP-----SFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH  267 (332)
T ss_pred             CCCCCC-----CCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence            001111     11256689999999999999999     77788753

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.5e-38  Score=284.70  Aligned_cols=257  Identities=29%  Similarity=0.425  Sum_probs=205.1

Q ss_pred             HhcCCccCccccccCCccEEEEEEcCCCEEEEEEecCCCchhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEEEEe
Q 017594           47 ATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIYEY  126 (369)
Q Consensus        47 ~~~~y~i~~~lg~G~~~~v~~~~~~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  126 (369)
                      ..++|++.+.||.|++|.||+|.++++..|++|.+.... ...+.+..|+..+++++|+|++++++++...+..++++|+
T Consensus         4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   82 (261)
T cd05068           4 DRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTEL   82 (261)
T ss_pred             chhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeec
Confidence            456799999999999999999998778889999987543 3346788899999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCCCCc
Q 017594          127 MPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNEL  206 (369)
Q Consensus       127 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~~~~  206 (369)
                      +.+++|.+++.... ...+++..+..++.|++.|+.+||+.+   ++|+||+|+||+++.++.++|+|||++........
T Consensus        83 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~  158 (261)
T cd05068          83 MKYGSLLEYLQGGA-GRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKEDIY  158 (261)
T ss_pred             ccCCcHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEccCCcc
Confidence            99999999986533 335789999999999999999999998   99999999999999999999999999887653221


Q ss_pred             ccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHh-CCCCCCCCcccccccchhhhhhhhcCccccccCcccc
Q 017594          207 QANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILE  285 (369)
Q Consensus       207 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (369)
                      . ..........|+|||.+.+..++.++|+||||+++|+|++ |+.||.......      ...........    +   
T Consensus       159 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~------~~~~~~~~~~~----~---  224 (261)
T cd05068         159 E-AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAE------VLQQVDQGYRM----P---  224 (261)
T ss_pred             c-ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHH------HHHHHHcCCCC----C---
Confidence            1 1111122457999999988889999999999999999999 998885332110      00110000000    0   


Q ss_pred             ccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHhh
Q 017594          286 DEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNE  325 (369)
Q Consensus       286 ~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L~~~  325 (369)
                         .+...+..+.+++.+||+.+|.+||++.+|++.|+.+
T Consensus       225 ---~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~  261 (261)
T cd05068         225 ---CPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF  261 (261)
T ss_pred             ---CCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence               0111256799999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=1.6e-39  Score=301.79  Aligned_cols=247  Identities=22%  Similarity=0.271  Sum_probs=199.7

Q ss_pred             HhcCCccCccccccCCccEEEEEEcC--CCEEEEEEecCC---CchhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccE
Q 017594           47 ATNKFSDANKLGEGGFGPVYKGVLKK--GDEIAVKRLSGR---SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKI  121 (369)
Q Consensus        47 ~~~~y~i~~~lg~G~~~~v~~~~~~~--~~~valK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  121 (369)
                      ..++|++.+.||.|+||.||+|.++.  +..||+|.+...   .......+..|+.+++.++||||+++++++..+...+
T Consensus        28 ~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~  107 (340)
T PTZ00426         28 KYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLY  107 (340)
T ss_pred             ChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEE
Confidence            45689999999999999999998554  368999988533   2233456778999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceec
Q 017594          122 LIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARIC  201 (369)
Q Consensus       122 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~  201 (369)
                      +||||+.+++|.+++...   ..+++..+..++.||+.||.|||+.+   ++||||||+||+++.++.++|+|||++...
T Consensus       108 lv~Ey~~~g~L~~~i~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~~  181 (340)
T PTZ00426        108 LVLEFVIGGEFFTFLRRN---KRFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVV  181 (340)
T ss_pred             EEEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCeec
Confidence            999999999999888543   34889999999999999999999999   999999999999999999999999998765


Q ss_pred             CCCCcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCccccccC
Q 017594          202 GGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELID  281 (369)
Q Consensus       202 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (369)
                      ...     .....|++.|+|||++.+..++.++|+|||||++|+|++|..||.......     ...... ... .. + 
T Consensus       182 ~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~-----~~~~i~-~~~-~~-~-  247 (340)
T PTZ00426        182 DTR-----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLL-----IYQKIL-EGI-IY-F-  247 (340)
T ss_pred             CCC-----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHH-----HHHHHh-cCC-CC-C-
Confidence            422     223468899999999998889999999999999999999999986432110     001111 100 00 0 


Q ss_pred             ccccccccHHHHHHHHHHHHHHhhcCCCCCCC-----CHHHHHHH
Q 017594          282 PILEDEYSSKQMLLRYANIALLCVQESADDRP-----TMNDVVSM  321 (369)
Q Consensus       282 ~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp-----s~~ell~~  321 (369)
                              +...+..+.++|.+||+.||++|+     +++++++.
T Consensus       248 --------p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h  284 (340)
T PTZ00426        248 --------PKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH  284 (340)
T ss_pred             --------CCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence                    111255689999999999999995     89998864

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=7.8e-39  Score=286.43  Aligned_cols=257  Identities=31%  Similarity=0.444  Sum_probs=205.2

Q ss_pred             HhcCCccCccccccCCccEEEEEEcCCCEEEEEEecCCCchhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEEEEe
Q 017594           47 ATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIYEY  126 (369)
Q Consensus        47 ~~~~y~i~~~lg~G~~~~v~~~~~~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  126 (369)
                      ..++|++.++||.|++|.||+|...++..|++|.+.... ...+.+..|+.+++.++|+|++++++.+...+..++++||
T Consensus         4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   82 (261)
T cd05072           4 PRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEY   82 (261)
T ss_pred             chHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEec
Confidence            357899999999999999999998888889999876543 3356788899999999999999999999988899999999


Q ss_pred             cCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCCCCc
Q 017594          127 MPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNEL  206 (369)
Q Consensus       127 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~~~~  206 (369)
                      +.+++|.+++.... ...++...+..++.|++.||+|||+.+   ++|+||+|+||+++.++.++|+|||.+........
T Consensus        83 ~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~  158 (261)
T cd05072          83 MAKGSLLDFLKSDE-GGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY  158 (261)
T ss_pred             CCCCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecCCCce
Confidence            99999998885432 234778888999999999999999998   99999999999999999999999999987643321


Q ss_pred             ccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHh-CCCCCCCCcccccccchhhhhhhhcCccccccCcccc
Q 017594          207 QANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILE  285 (369)
Q Consensus       207 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (369)
                      . ......++..|+|||.+.+..++.++|+||||+++|+|++ |..||.......     ..... .....    .+.. 
T Consensus       159 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~-----~~~~~-~~~~~----~~~~-  226 (261)
T cd05072         159 T-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSD-----VMSAL-QRGYR----MPRM-  226 (261)
T ss_pred             e-ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHH-----HHHHH-HcCCC----CCCC-
Confidence            1 1122234567999999988889999999999999999998 899986432111     00000 00000    0000 


Q ss_pred             ccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHhh
Q 017594          286 DEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNE  325 (369)
Q Consensus       286 ~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L~~~  325 (369)
                           ..++.++.+++.+||..+|++||+++++++.|+.+
T Consensus       227 -----~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  261 (261)
T cd05072         227 -----ENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF  261 (261)
T ss_pred             -----CCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence                 11256689999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=2.3e-39  Score=300.84  Aligned_cols=265  Identities=18%  Similarity=0.256  Sum_probs=193.8

Q ss_pred             CCccCccccccCCccEEEEEEc-CCCEEEEEEecCC--CchhHHHHHHHHHHHhcCCCCceeeeeeeEEeCC-----ccE
Q 017594           50 KFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDRD-----EKI  121 (369)
Q Consensus        50 ~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~  121 (369)
                      +|++.+.||.|+||.||+|+++ +|..||+|++...  .......+.+|+.+++.++||||+++++++....     ..|
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   80 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY   80 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence            6899999999999999999965 5899999998642  2233456788999999999999999999876432     479


Q ss_pred             EEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceec
Q 017594          122 LIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARIC  201 (369)
Q Consensus       122 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~  201 (369)
                      +||||+. ++|..++..   ...+++..+..++.||+.||.|||+++   ++||||||+||+++.++.++|+|||++...
T Consensus        81 lv~e~~~-~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~  153 (338)
T cd07859          81 VVFELME-SDLHQVIKA---NDDLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVA  153 (338)
T ss_pred             EEEecCC-CCHHHHHHh---cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCcccccc
Confidence            9999996 577777743   234889999999999999999999999   999999999999999999999999998754


Q ss_pred             CCCCcc-cccccccccccccCchhhcc--CCCCcccchHhHHHHHHHHHhCCCCCCCCccccccc---------chhhhh
Q 017594          202 GGNELQ-ANTSRIVGTYGYMSPEYALE--GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNL---------LGYAWD  269 (369)
Q Consensus       202 ~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~---------~~~~~~  269 (369)
                      ...... .......++..|+|||++.+  ..++.++|||||||++|+|++|++||..........         ......
T Consensus       154 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  233 (338)
T cd07859         154 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETIS  233 (338)
T ss_pred             ccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence            322211 11223468899999999875  678999999999999999999999996543111000         000000


Q ss_pred             hhhcCccccc---cCcccccccc--HHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 017594          270 LWTSNRTLEL---IDPILEDEYS--SKQMLLRYANIALLCVQESADDRPTMNDVVSM  321 (369)
Q Consensus       270 ~~~~~~~~~~---~~~~~~~~~~--~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~  321 (369)
                      ..........   +.........  ....+..+.+++.+||+.||++||++.++++.
T Consensus       234 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h  290 (338)
T cd07859         234 RVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD  290 (338)
T ss_pred             HhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence            0000000000   0000000000  00124568899999999999999999999963

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=8e-39  Score=302.09  Aligned_cols=261  Identities=17%  Similarity=0.201  Sum_probs=194.5

Q ss_pred             HHhcCCccCccccccCCccEEEEEEc-CCCEEEEEEecCCCchhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEEE
Q 017594           46 TATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIY  124 (369)
Q Consensus        46 ~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  124 (369)
                      ....+|++++.||.|+||.||+|.+. +++.||+|....      ..+.+|+.+++.++||||+++++++......++++
T Consensus        89 ~~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~  162 (391)
T PHA03212         89 IEKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLIL  162 (391)
T ss_pred             cccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEE
Confidence            34468999999999999999999965 488999997532      34678999999999999999999999999999999


Q ss_pred             EecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCCC
Q 017594          125 EYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGN  204 (369)
Q Consensus       125 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~~  204 (369)
                      |++. +.|..++...   ..+++..+..++.||+.||.|||+++   ++||||||+||+++.++.++|+|||++......
T Consensus       163 e~~~-~~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~  235 (391)
T PHA03212        163 PRYK-TDLYCYLAAK---RNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDI  235 (391)
T ss_pred             ecCC-CCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCcccccccc
Confidence            9986 5666666432   34788899999999999999999999   999999999999999999999999998643221


Q ss_pred             CcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCccccc-----ccchhhhhhh-------h
Q 017594          205 ELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSL-----NLLGYAWDLW-------T  272 (369)
Q Consensus       205 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~-----~~~~~~~~~~-------~  272 (369)
                      . ........|++.|+|||++.+..++.++|||||||++|+|++|..||-.......     ..........       .
T Consensus       236 ~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~  314 (391)
T PHA03212        236 N-ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFP  314 (391)
T ss_pred             c-ccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcC
Confidence            1 1122335689999999999988999999999999999999999987643221000     0000000000       0


Q ss_pred             c---Ccccccc---------Cccccc-cccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 017594          273 S---NRTLELI---------DPILED-EYSSKQMLLRYANIALLCVQESADDRPTMNDVVS  320 (369)
Q Consensus       273 ~---~~~~~~~---------~~~~~~-~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~  320 (369)
                      .   .......         .+.... .......+.++.+||.+||+.||++|||+.++++
T Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~  375 (391)
T PHA03212        315 IDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD  375 (391)
T ss_pred             cchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence            0   0000000         000000 0011234668999999999999999999999995

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=8.1e-39  Score=295.55  Aligned_cols=246  Identities=25%  Similarity=0.307  Sum_probs=194.0

Q ss_pred             CCccCccccccCCccEEEEEEcC-CCEEEEEEecCC---CchhHHHHHHHHHHHhcCCCC-ceeeeeeeEEeCCccEEEE
Q 017594           50 KFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGR---SGQGLREMKNEASVIAKVQHK-NLVRLLGCCIDRDEKILIY  124 (369)
Q Consensus        50 ~y~i~~~lg~G~~~~v~~~~~~~-~~~valK~~~~~---~~~~~~~~~~e~~~l~~l~h~-~i~~~~~~~~~~~~~~lv~  124 (369)
                      +|++.+.||+|+||.||+|+.+. ++.||+|++...   .....+.+..|..++..+.|+ +++++++++...+..|+||
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM   80 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence            58999999999999999999664 788999998643   223445677888999999765 5888999998889999999


Q ss_pred             EecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCCC
Q 017594          125 EYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGN  204 (369)
Q Consensus       125 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~~  204 (369)
                      ||+.+++|..++...   ..+++..+..++.||+.||.|||+.+   ++||||||+||+++.++.++|+|||++......
T Consensus        81 E~~~~g~L~~~~~~~---~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~  154 (324)
T cd05587          81 EYVNGGDLMYHIQQV---GKFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG  154 (324)
T ss_pred             cCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceecCCC
Confidence            999999998888543   34788899999999999999999999   999999999999999999999999998643221


Q ss_pred             CcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCccccccCccc
Q 017594          205 ELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPIL  284 (369)
Q Consensus       205 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (369)
                      .  .......|+..|+|||++.+..++.++|+||+||++|+|++|+.||.......     ....... ..      ...
T Consensus       155 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~-----~~~~i~~-~~------~~~  220 (324)
T cd05587         155 G--KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE-----LFQSIME-HN------VSY  220 (324)
T ss_pred             C--CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH-----HHHHHHc-CC------CCC
Confidence            1  12233468999999999999999999999999999999999999986432111     0011100 00      000


Q ss_pred             cccccHHHHHHHHHHHHHHhhcCCCCCCCCH-----HHHHH
Q 017594          285 EDEYSSKQMLLRYANIALLCVQESADDRPTM-----NDVVS  320 (369)
Q Consensus       285 ~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~-----~ell~  320 (369)
                           +...+.++.+++.+||+.||.+|++.     .++++
T Consensus       221 -----~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~  256 (324)
T cd05587         221 -----PKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIRE  256 (324)
T ss_pred             -----CCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence                 11125668999999999999999976     56664

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=7.8e-39  Score=289.97  Aligned_cols=270  Identities=29%  Similarity=0.405  Sum_probs=200.9

Q ss_pred             cCC-ccCccccccCCccEEEEEE-----cCCCEEEEEEecCCCc-hhHHHHHHHHHHHhcCCCCceeeeeeeEEeC--Cc
Q 017594           49 NKF-SDANKLGEGGFGPVYKGVL-----KKGDEIAVKRLSGRSG-QGLREMKNEASVIAKVQHKNLVRLLGCCIDR--DE  119 (369)
Q Consensus        49 ~~y-~i~~~lg~G~~~~v~~~~~-----~~~~~valK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~  119 (369)
                      +|| ++.+.||.|+||.||++..     .++..|++|.+..... .....+.+|+..++.++|||++++++++...  ..
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   82 (283)
T cd05080           3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKG   82 (283)
T ss_pred             hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCce
Confidence            455 9999999999999988652     3477899999875432 2346677899999999999999999987654  35


Q ss_pred             cEEEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCce
Q 017594          120 KILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMAR  199 (369)
Q Consensus       120 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~  199 (369)
                      .+++|||+.+++|.+++..    ..+++..++.++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||++.
T Consensus        83 ~~lv~e~~~~~~l~~~~~~----~~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~  155 (283)
T cd05080          83 LQLIMEYVPLGSLRDYLPK----HKLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAK  155 (283)
T ss_pred             EEEEecCCCCCCHHHHHHH----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeeccccc
Confidence            7899999999999988843    23889999999999999999999998   9999999999999999999999999987


Q ss_pred             ecCCCCcccc-cccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCcccc
Q 017594          200 ICGGNELQAN-TSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLE  278 (369)
Q Consensus       200 ~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (369)
                      .......... .....++..|+|||...+..++.++||||||+++|+|++|..||........................+
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (283)
T cd05080         156 AVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIE  235 (283)
T ss_pred             ccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhh
Confidence            6653322111 112234566999999988889999999999999999999999976432111000000000000000001


Q ss_pred             ccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHhhh
Q 017594          279 LIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNEA  326 (369)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L~~~~  326 (369)
                      .+....... .+..++..+.+++.+||+.+|++|||++++++.|+.+.
T Consensus       236 ~~~~~~~~~-~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~  282 (283)
T cd05080         236 LLERGMRLP-CPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH  282 (283)
T ss_pred             hhhcCCCCC-CCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence            111100000 01123567999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.1e-39  Score=302.62  Aligned_cols=253  Identities=23%  Similarity=0.334  Sum_probs=202.5

Q ss_pred             cCCccCccccccCCccEEEEEEc-CCCEEEEEEecCCC---chhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEEE
Q 017594           49 NKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS---GQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIY  124 (369)
Q Consensus        49 ~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  124 (369)
                      ++|++.+.||+|+||.||+|+.. +|+.||+|++....   ......+..|+.++..++|+||+++++++.+++..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM   80 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence            47999999999999999999976 58999999986432   234466788999999999999999999999999999999


Q ss_pred             EecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCCC
Q 017594          125 EYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGN  204 (369)
Q Consensus       125 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~~  204 (369)
                      ||+.+++|.+++...   ..+++..++.++.||+.||+|||+.|   ++||||||+||+++.++.++|+|||++......
T Consensus        81 e~~~~~~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~  154 (350)
T cd05573          81 EYMPGGDLMNLLIRK---DVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNKA  154 (350)
T ss_pred             cCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccCccc
Confidence            999999999988543   45889999999999999999999998   999999999999999999999999998765433


Q ss_pred             C---------------------------cccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCc
Q 017594          205 E---------------------------LQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYR  257 (369)
Q Consensus       205 ~---------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~  257 (369)
                      .                           .........|++.|+|||++.+..++.++|||||||++|+|++|..||....
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~  234 (350)
T cd05573         155 KDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDT  234 (350)
T ss_pred             CcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCC
Confidence            2                           0011223468899999999999999999999999999999999999987543


Q ss_pred             ccccccchhhhhhhhcCccccccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCC-HHHHHHH
Q 017594          258 TDSLNLLGYAWDLWTSNRTLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPT-MNDVVSM  321 (369)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps-~~ell~~  321 (369)
                      ...     ..............     ...   ..++.++.++|..||+ +|.+||+ +.++++.
T Consensus       235 ~~~-----~~~~i~~~~~~~~~-----p~~---~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h  285 (350)
T cd05573         235 LQE-----TYNKIINWKESLRF-----PPD---PPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH  285 (350)
T ss_pred             HHH-----HHHHHhccCCcccC-----CCC---CCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence            111     00111110000000     000   0036779999999998 9999999 9999974

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=8.7e-39  Score=285.35  Aligned_cols=252  Identities=28%  Similarity=0.395  Sum_probs=200.3

Q ss_pred             cCCccCccccccCCccEEEEEEcCCCEEEEEEecCCCchhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEEEEecC
Q 017594           49 NKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIYEYMP  128 (369)
Q Consensus        49 ~~y~i~~~lg~G~~~~v~~~~~~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~  128 (369)
                      ++|++.+.||+|+||.||++.++++..+++|.+.... .....+..|+.+++.++||||+++++++......+++|||+.
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~   82 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME   82 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence            5789999999999999999998888889999876433 234678889999999999999999999999999999999999


Q ss_pred             CCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCCCCccc
Q 017594          129 NKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQA  208 (369)
Q Consensus       129 ~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~~~~~~  208 (369)
                      +++|.+++....  ..+++..+..++.|++.||.|||+++   ++|+||+|+||+++.++.++|+|||.+..........
T Consensus        83 ~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~  157 (256)
T cd05114          83 NGCLLNYLRQRQ--GKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTS  157 (256)
T ss_pred             CCcHHHHHHhCc--cCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccCCCceec
Confidence            999998885432  24788899999999999999999999   9999999999999999999999999887653322111


Q ss_pred             ccccccccccccCchhhccCCCCcccchHhHHHHHHHHHh-CCCCCCCCcccccccchhhhhhhhcCccccccCcccccc
Q 017594          209 NTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDE  287 (369)
Q Consensus       209 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  287 (369)
                       .....++..|+|||.+.+..++.++|+||+|+++|+|++ |+.||.......     ..........   ...      
T Consensus       158 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~-----~~~~i~~~~~---~~~------  222 (256)
T cd05114         158 -SSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYE-----VVEMISRGFR---LYR------  222 (256)
T ss_pred             -cCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHH-----HHHHHHCCCC---CCC------
Confidence             112234567999999988889999999999999999999 888885432110     1111100000   000      


Q ss_pred             ccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 017594          288 YSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLT  323 (369)
Q Consensus       288 ~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L~  323 (369)
                        +...+..+.+++.+||+.+|.+||++.++++.|+
T Consensus       223 --~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~  256 (256)
T cd05114         223 --PKLASMTVYEVMYSCWHEKPEGRPTFAELLRAIT  256 (256)
T ss_pred             --CCCCCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence              0111456899999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.6e-39  Score=297.31  Aligned_cols=239  Identities=21%  Similarity=0.282  Sum_probs=190.5

Q ss_pred             ccccCCccEEEEEEcC-CCEEEEEEecCC---CchhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEEEEecCCCCh
Q 017594           57 LGEGGFGPVYKGVLKK-GDEIAVKRLSGR---SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSL  132 (369)
Q Consensus        57 lg~G~~~~v~~~~~~~-~~~valK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L  132 (369)
                      ||+|+||.||+|++.. ++.||+|++...   .......+..|+.++..++||||+++++++...+..++||||+.+++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            6999999999999764 888999998642   223345677899999999999999999999999999999999999999


Q ss_pred             hhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCCCCccccccc
Q 017594          133 DFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR  212 (369)
Q Consensus       133 ~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~~~~~~~~~~  212 (369)
                      .+++...   ..+++..+..++.||+.||.|||+.+   ++||||||+||+++.++.++|+|||++.......  .....
T Consensus        81 ~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~~~~  152 (312)
T cd05585          81 FHHLQRE---GRFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD--DKTNT  152 (312)
T ss_pred             HHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCccCC--Ccccc
Confidence            8888543   34889999999999999999999999   9999999999999999999999999987532221  12233


Q ss_pred             ccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCccccccCccccccccHHH
Q 017594          213 IVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYSSKQ  292 (369)
Q Consensus       213 ~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  292 (369)
                      ..|++.|+|||++.+..++.++|||||||++|+|++|..||.......     ....... . ..     .+     +..
T Consensus       153 ~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~-----~~~~~~~-~-~~-----~~-----~~~  215 (312)
T cd05585         153 FCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNE-----MYRKILQ-E-PL-----RF-----PDG  215 (312)
T ss_pred             ccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHH-----HHHHHHc-C-CC-----CC-----CCc
Confidence            468999999999999999999999999999999999999986432110     0011100 0 00     00     112


Q ss_pred             HHHHHHHHHHHhhcCCCCCCCC---HHHHHH
Q 017594          293 MLLRYANIALLCVQESADDRPT---MNDVVS  320 (369)
Q Consensus       293 ~~~~l~~li~~~L~~dP~~Rps---~~ell~  320 (369)
                      ++..+.++|.+||+.||.+||+   +.+++.
T Consensus       216 ~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~  246 (312)
T cd05585         216 FDRDAKDLLIGLLSRDPTRRLGYNGAQEIKN  246 (312)
T ss_pred             CCHHHHHHHHHHcCCCHHHcCCCCCHHHHHc
Confidence            3567899999999999999985   566664

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=1.9e-38  Score=299.85  Aligned_cols=267  Identities=24%  Similarity=0.338  Sum_probs=206.5

Q ss_pred             hHHHHhcCCccCccccccCCccEEEEEEcC------CCEEEEEEecCCC-chhHHHHHHHHHHHhcCC-CCceeeeeeeE
Q 017594           43 SVSTATNKFSDANKLGEGGFGPVYKGVLKK------GDEIAVKRLSGRS-GQGLREMKNEASVIAKVQ-HKNLVRLLGCC  114 (369)
Q Consensus        43 ~~~~~~~~y~i~~~lg~G~~~~v~~~~~~~------~~~valK~~~~~~-~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~  114 (369)
                      ..+...++|++.+.||.|+||.||+|++..      +..||+|++.... ....+.+..|++++..+. ||||+++++++
T Consensus        31 ~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~  110 (400)
T cd05105          31 RWEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGAC  110 (400)
T ss_pred             ceeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEE
Confidence            344456789999999999999999998532      3469999986543 233456888999999996 99999999999


Q ss_pred             EeCCccEEEEEecCCCChhhhhcCCCc-----------------------------------------------------
Q 017594          115 IDRDEKILIYEYMPNKSLDFFLFDPTK-----------------------------------------------------  141 (369)
Q Consensus       115 ~~~~~~~lv~e~~~~~~L~~~l~~~~~-----------------------------------------------------  141 (369)
                      ......++||||+.+++|.+++.....                                                     
T Consensus       111 ~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  190 (400)
T cd05105         111 TKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVP  190 (400)
T ss_pred             ccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccch
Confidence            998999999999999999887753210                                                     


Q ss_pred             ----------------------------------------cccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCC
Q 017594          142 ----------------------------------------RMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASN  181 (369)
Q Consensus       142 ----------------------------------------~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~N  181 (369)
                                                              ...+++..+..++.||+.||.|||..+   ++|+||||+|
T Consensus       191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~N  267 (400)
T cd05105         191 MLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARN  267 (400)
T ss_pred             hhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHh
Confidence                                                    123677788899999999999999998   9999999999


Q ss_pred             EEEeCCCceEEeecCCceecCCCCcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHh-CCCCCCCCcccc
Q 017594          182 ILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDS  260 (369)
Q Consensus       182 Ilv~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~t-g~~p~~~~~~~~  260 (369)
                      |+++.++.++|+|||++................++..|+|||.+.+..++.++||||||+++|+|++ |..||.....+.
T Consensus       268 ill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~  347 (400)
T cd05105         268 VLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDS  347 (400)
T ss_pred             EEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhH
Confidence            9999999999999999876543322222223345678999999988889999999999999999997 888886432111


Q ss_pred             cccchhhhhhhhcCccccccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHhhhh
Q 017594          261 LNLLGYAWDLWTSNRTLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNEAA  327 (369)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L~~~~~  327 (369)
                      .     .........     ....     +..++..+.+++.+||+.+|++||++.+|.+.|+++..
T Consensus       348 ~-----~~~~~~~~~-----~~~~-----~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~  399 (400)
T cd05105         348 T-----FYNKIKSGY-----RMAK-----PDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP  399 (400)
T ss_pred             H-----HHHHHhcCC-----CCCC-----CccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence            0     001111110     0000     11235679999999999999999999999999998654

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=1.3e-38  Score=285.93  Aligned_cols=257  Identities=25%  Similarity=0.354  Sum_probs=201.4

Q ss_pred             HhcCCccCccccccCCccEEEEEEc----CCCEEEEEEecCCC-chhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccE
Q 017594           47 ATNKFSDANKLGEGGFGPVYKGVLK----KGDEIAVKRLSGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKI  121 (369)
Q Consensus        47 ~~~~y~i~~~lg~G~~~~v~~~~~~----~~~~valK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  121 (369)
                      ..++|++.+.||+|+||.||+|.++    .+..|++|.+.... ......+..|+..+++++|||++++++++...+..+
T Consensus         3 ~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   82 (266)
T cd05064           3 DNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMM   82 (266)
T ss_pred             chHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcE
Confidence            3567999999999999999999853    35689999987543 233456788999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceec
Q 017594          122 LIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARIC  201 (369)
Q Consensus       122 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~  201 (369)
                      +||||+.+++|.+++....  ..+++..++.++.||+.||+|||+.+   ++|+||+|+||+++.++.++++|||.+...
T Consensus        83 lv~e~~~~~~L~~~l~~~~--~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~~~  157 (266)
T cd05064          83 IVTEYMSNGALDSFLRKHE--GQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQED  157 (266)
T ss_pred             EEEEeCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCcccccc
Confidence            9999999999998885432  34789999999999999999999999   999999999999999999999999976543


Q ss_pred             CCCCcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHh-CCCCCCCCcccccccchhhhhhhhcCcccccc
Q 017594          202 GGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDLWTSNRTLELI  280 (369)
Q Consensus       202 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (369)
                      ..... .......++..|+|||.+.+..++.++||||+||++|++++ |..||.......     ..... ....     
T Consensus       158 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~-----~~~~~-~~~~-----  225 (266)
T cd05064         158 KSEAI-YTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQD-----VIKAV-EDGF-----  225 (266)
T ss_pred             cccch-hcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH-----HHHHH-HCCC-----
Confidence            22111 11111234567999999999999999999999999999775 999986432111     00110 0000     


Q ss_pred             CccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHhh
Q 017594          281 DPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNE  325 (369)
Q Consensus       281 ~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L~~~  325 (369)
                      ...     .+..++..+.+++.+||+.+|++||++.+|++.|++.
T Consensus       226 ~~~-----~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~  265 (266)
T cd05064         226 RLP-----APRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM  265 (266)
T ss_pred             CCC-----CCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence            000     0112356799999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=4.4e-39  Score=296.32  Aligned_cols=260  Identities=27%  Similarity=0.431  Sum_probs=202.9

Q ss_pred             hcCCccCccccccCCccEEEEEEcC-CC----EEEEEEecCCC-chhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccE
Q 017594           48 TNKFSDANKLGEGGFGPVYKGVLKK-GD----EIAVKRLSGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKI  121 (369)
Q Consensus        48 ~~~y~i~~~lg~G~~~~v~~~~~~~-~~----~valK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  121 (369)
                      ..+|++.+.||+|+||.||+|++.. |.    .|++|.+.... ......+..|+.+++.++||||+++++++.. ...+
T Consensus         6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~-~~~~   84 (316)
T cd05108           6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT-STVQ   84 (316)
T ss_pred             hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcC-CCce
Confidence            4679999999999999999998643 33    38999986443 3345678889999999999999999999875 4678


Q ss_pred             EEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceec
Q 017594          122 LIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARIC  201 (369)
Q Consensus       122 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~  201 (369)
                      ++++|+.+++|.+++....  ..++...++.++.||+.||+|||+.+   ++||||||+||+++.++.++|+|||++..+
T Consensus        85 ~v~e~~~~g~l~~~l~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~~~  159 (316)
T cd05108          85 LITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL  159 (316)
T ss_pred             eeeecCCCCCHHHHHHhcc--ccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEccccccccc
Confidence            9999999999998886432  24778889999999999999999999   999999999999999999999999999876


Q ss_pred             CCCCcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHh-CCCCCCCCcccccccchhhhhhhhcCcccccc
Q 017594          202 GGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDLWTSNRTLELI  280 (369)
Q Consensus       202 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (369)
                      .............++..|+|||.+.+..++.++||||||+++|+|++ |..||.......      ............  
T Consensus       160 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~------~~~~~~~~~~~~--  231 (316)
T cd05108         160 GADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE------ISSILEKGERLP--  231 (316)
T ss_pred             cCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH------HHHHHhCCCCCC--
Confidence            54332222222234567999999999999999999999999999997 999986432111      011111110000  


Q ss_pred             CccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHhhhhcc
Q 017594          281 DPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNEAATL  329 (369)
Q Consensus       281 ~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L~~~~~~~  329 (369)
                         .     +..++.++.+++.+||+.+|++||++.+++..|..+....
T Consensus       232 ---~-----~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~  272 (316)
T cd05108         232 ---Q-----PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP  272 (316)
T ss_pred             ---C-----CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCC
Confidence               0     0112456899999999999999999999999998887643

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=3.9e-39  Score=302.24  Aligned_cols=211  Identities=25%  Similarity=0.344  Sum_probs=179.6

Q ss_pred             ccccchhhHHHHhcCCccCccccccCCccEEEEEEc-CCCEEEEEEecCCCchhHHHHHHHHHHHhcCC-C-----Ccee
Q 017594           36 FPLFSFSSVSTATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSGQGLREMKNEASVIAKVQ-H-----KNLV  108 (369)
Q Consensus        36 ~~~~~~~~~~~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~-h-----~~i~  108 (369)
                      -..|.+..-+.+.-+|+|.+.||+|+||.|.+|.+. +++.||||+++.. ..-..+...|+.+|..|+ |     -|++
T Consensus       173 ~~dY~~v~~d~i~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~-k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~V  251 (586)
T KOG0667|consen  173 DGDYQLVVNDHIAYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK-KRFLRQAQIEIRILELLNKHDPDDKYNIV  251 (586)
T ss_pred             CCceeEEecceeEEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccC-hHHHHHHHHHHHHHHHHhccCCCCCeeEE
Confidence            345777777888889999999999999999999965 4999999999744 344566778999999996 3     3799


Q ss_pred             eeeeeEEeCCccEEEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCC-
Q 017594          109 RLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKD-  187 (369)
Q Consensus       109 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~-  187 (369)
                      +++++|...++.|+|+|.+ ..+|.+++.... -..++...++.++.||+.||.+||..+   |+|+||||+|||+..- 
T Consensus       252 rm~d~F~fr~HlciVfELL-~~NLYellK~n~-f~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~  326 (586)
T KOG0667|consen  252 RMLDYFYFRNHLCIVFELL-STNLYELLKNNK-FRGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPK  326 (586)
T ss_pred             Eeeeccccccceeeeehhh-hhhHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCC
Confidence            9999999999999999988 568888887643 344899999999999999999999999   9999999999999644 


Q ss_pred             -CceEEeecCCceecCCCCcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCc
Q 017594          188 -MNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYR  257 (369)
Q Consensus       188 -~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~  257 (369)
                       ..+||+|||.++.......     ....+..|+|||++-+.+|+.+.||||||||+.||++|.+.|....
T Consensus       327 r~~vKVIDFGSSc~~~q~vy-----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~n  392 (586)
T KOG0667|consen  327 RSRIKVIDFGSSCFESQRVY-----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDN  392 (586)
T ss_pred             cCceeEEecccccccCCcce-----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCC
Confidence             3699999999987654332     3355778999999999999999999999999999999998887544

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=1.2e-38  Score=297.77  Aligned_cols=250  Identities=26%  Similarity=0.391  Sum_probs=194.1

Q ss_pred             HhcCCccCccccccCCccEEEEEEc-CCCEEEEEEecCCC-chhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEEE
Q 017594           47 ATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIY  124 (369)
Q Consensus        47 ~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  124 (369)
                      ...+|+.++.||.|+||.||+|++. +|+.|++|++.... ......+.+|+++++.++|+||+++++++...+..++|+
T Consensus        72 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  151 (353)
T PLN00034         72 SLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLL  151 (353)
T ss_pred             CHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEE
Confidence            3567889999999999999999965 58999999986543 233466889999999999999999999999999999999


Q ss_pred             EecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCCC
Q 017594          125 EYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGN  204 (369)
Q Consensus       125 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~~  204 (369)
                      ||+.+++|....       ..++..+..++.||+.||.|||+++   ++||||||+||+++.++.++|+|||++..+...
T Consensus       152 e~~~~~~L~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~  221 (353)
T PLN00034        152 EFMDGGSLEGTH-------IADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQT  221 (353)
T ss_pred             ecCCCCcccccc-------cCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceecccc
Confidence            999999885432       2456778899999999999999999   999999999999999999999999998765432


Q ss_pred             CcccccccccccccccCchhhcc-----CCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCccccc
Q 017594          205 ELQANTSRIVGTYGYMSPEYALE-----GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLEL  279 (369)
Q Consensus       205 ~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (369)
                      ..  ......|+..|+|||++..     ...+.++|||||||++|+|++|+.||..........  ..... .....   
T Consensus       222 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~--~~~~~-~~~~~---  293 (353)
T PLN00034        222 MD--PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWAS--LMCAI-CMSQP---  293 (353)
T ss_pred             cc--cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHH--HHHHH-hccCC---
Confidence            21  1123468899999998743     234568999999999999999999997332111100  00000 00000   


Q ss_pred             cCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 017594          280 IDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSM  321 (369)
Q Consensus       280 ~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~  321 (369)
                        ..     ....++.++.+||.+||+.||++||++.++++.
T Consensus       294 --~~-----~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h  328 (353)
T PLN00034        294 --PE-----APATASREFRHFISCCLQREPAKRWSAMQLLQH  328 (353)
T ss_pred             --CC-----CCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence              00     011225679999999999999999999999974

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=3.1e-39  Score=313.20  Aligned_cols=261  Identities=21%  Similarity=0.280  Sum_probs=204.9

Q ss_pred             hhHHHHhcCCccCccccccCCccEEEEEEc-CCCEEEEEEecCC--CchhHHHHHHHHHHHhcCCCCceeeeeeeEEeCC
Q 017594           42 SSVSTATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDRD  118 (369)
Q Consensus        42 ~~~~~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~  118 (369)
                      .......++|++.+.||+|+||.||+|+.. +|+.||+|++...  .......+..|+..+..++|++++++.+.+....
T Consensus        25 ~~~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~  104 (496)
T PTZ00283         25 ATAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKD  104 (496)
T ss_pred             ccccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceeccc
Confidence            334455689999999999999999999954 5899999998644  2344566778999999999999999888765432


Q ss_pred             --------ccEEEEEecCCCChhhhhcCCC-ccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCc
Q 017594          119 --------EKILIYEYMPNKSLDFFLFDPT-KRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMN  189 (369)
Q Consensus       119 --------~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~  189 (369)
                              ..++||||+.+++|.+++.... ....+++..++.++.|++.||.|||+.+   ++||||||+||+++.++.
T Consensus       105 ~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~~  181 (496)
T PTZ00283        105 PRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNGL  181 (496)
T ss_pred             ccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCCC
Confidence                    2579999999999998885432 2346889999999999999999999998   999999999999999999


Q ss_pred             eEEeecCCceecCCCCcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhh
Q 017594          190 PKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWD  269 (369)
Q Consensus       190 ~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~  269 (369)
                      ++|+|||++..+.............|++.|+|||++.+..++.++|||||||++|+|++|+.||.......     ....
T Consensus       182 vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~-----~~~~  256 (496)
T PTZ00283        182 VKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEE-----VMHK  256 (496)
T ss_pred             EEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH-----HHHH
Confidence            99999999876654322222334568999999999999999999999999999999999999986432110     1111


Q ss_pred             hhhcCccccccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 017594          270 LWTSNRTLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSM  321 (369)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~  321 (369)
                      ... ...    .+ +     +..++.++.+++.+||+.||.+||++.++++.
T Consensus       257 ~~~-~~~----~~-~-----~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~  297 (496)
T PTZ00283        257 TLA-GRY----DP-L-----PPSISPEMQEIVTALLSSDPKRRPSSSKLLNM  297 (496)
T ss_pred             Hhc-CCC----CC-C-----CCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence            100 000    00 0     11225679999999999999999999999863

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=2.4e-38  Score=283.94  Aligned_cols=260  Identities=21%  Similarity=0.340  Sum_probs=207.4

Q ss_pred             cCCccCccccccCCccEEEEEEc-CCCEEEEEEecCC---CchhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEEE
Q 017594           49 NKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGR---SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIY  124 (369)
Q Consensus        49 ~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  124 (369)
                      ++|++.+.||.|++|.||+|... +|+.|++|.+...   .......+.+|+.++++++|++++++++.+...+..++++
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~   81 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL   81 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence            57999999999999999999976 6899999988532   2233567889999999999999999999999999999999


Q ss_pred             EecCCCChhhhhcCC-CccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCC
Q 017594          125 EYMPNKSLDFFLFDP-TKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGG  203 (369)
Q Consensus       125 e~~~~~~L~~~l~~~-~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~  203 (369)
                      ||+.+++|..++... .....++...++.++.+++.|+.+||+.|   ++|+||+|+||+++.++.++|+|||++.....
T Consensus        82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~  158 (267)
T cd08224          82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence            999999998887542 22345788999999999999999999999   99999999999999999999999999876543


Q ss_pred             CCcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCccccccCcc
Q 017594          204 NELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPI  283 (369)
Q Consensus       204 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (369)
                      ...  ......++..|.|||.+.+..++.++|+||||+++|+|++|..||.........   . ........        
T Consensus       159 ~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~---~-~~~~~~~~--------  224 (267)
T cd08224         159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYS---L-CKKIEKCD--------  224 (267)
T ss_pred             CCc--ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHH---H-HhhhhcCC--------
Confidence            221  112235778899999998888999999999999999999999998533211100   0 00000000        


Q ss_pred             ccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHhhh
Q 017594          284 LEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNEA  326 (369)
Q Consensus       284 ~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L~~~~  326 (369)
                       ........++..+.++|.+||..+|++||++.+|++.|+++.
T Consensus       225 -~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~  266 (267)
T cd08224         225 -YPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH  266 (267)
T ss_pred             -CCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence             001111233667999999999999999999999999998764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=1.3e-38  Score=286.03  Aligned_cols=255  Identities=23%  Similarity=0.364  Sum_probs=200.6

Q ss_pred             hcCCccCccccccCCccEEEEEEc-CCCEEEEEEecCCCchhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEEEEe
Q 017594           48 TNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIYEY  126 (369)
Q Consensus        48 ~~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  126 (369)
                      ..+|++.+.||+|+||.||+|+.. +++.|++|++..........+..|+.+++.++|||++++++++......++|+||
T Consensus         8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~   87 (267)
T cd06646           8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY   87 (267)
T ss_pred             hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence            467999999999999999999964 5888999998765545556788899999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCCCCc
Q 017594          127 MPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNEL  206 (369)
Q Consensus       127 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~~~~  206 (369)
                      +.+++|.+++...   ..+++..+..++.|++.|+.|||+.+   ++|+||+|+||+++.++.++|+|||++........
T Consensus        88 ~~~~~L~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~  161 (267)
T cd06646          88 CGGGSLQDIYHVT---GPLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKITATIA  161 (267)
T ss_pred             CCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeeccccc
Confidence            9999999888532   34788999999999999999999998   99999999999999999999999999876542211


Q ss_pred             ccccccccccccccCchhhc---cCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCccccccCcc
Q 017594          207 QANTSRIVGTYGYMSPEYAL---EGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPI  283 (369)
Q Consensus       207 ~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (369)
                        ......++..|+|||.+.   ...++.++|+||+||++|+|++|..||..........     .. ....   ...+.
T Consensus       162 --~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~-----~~-~~~~---~~~~~  230 (267)
T cd06646         162 --KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF-----LM-SKSN---FQPPK  230 (267)
T ss_pred             --ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhhe-----ee-ecCC---CCCCC
Confidence              122235778899999874   3457889999999999999999999975322110000     00 0000   00000


Q ss_pred             ccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHH
Q 017594          284 LEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSML  322 (369)
Q Consensus       284 ~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L  322 (369)
                      ..   ....++..+.++|.+||+.+|++||++++|++.|
T Consensus       231 ~~---~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l  266 (267)
T cd06646         231 LK---DKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL  266 (267)
T ss_pred             Cc---cccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence            00   0112356799999999999999999999998753

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=2.3e-38  Score=283.77  Aligned_cols=257  Identities=29%  Similarity=0.434  Sum_probs=204.5

Q ss_pred             HhcCCccCccccccCCccEEEEEEcC-CCEEEEEEecCCCchhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEEEE
Q 017594           47 ATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIYE  125 (369)
Q Consensus        47 ~~~~y~i~~~lg~G~~~~v~~~~~~~-~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  125 (369)
                      ...+|.+.+.||.|++|.||+|.++. +..|++|.+.... .....+..|+..++.++|+|++++++++..+...++++|
T Consensus         4 ~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (263)
T cd05052           4 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE   82 (263)
T ss_pred             chHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc-hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEE
Confidence            34568999999999999999999654 8889999987443 345678889999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCCCC
Q 017594          126 YMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE  205 (369)
Q Consensus       126 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~~~  205 (369)
                      |+.+++|.+++.... ...+++..+..++.|++.||++||+.+   ++|+||+|+||+++.++.++|+|||.+.......
T Consensus        83 ~~~~~~L~~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~  158 (263)
T cd05052          83 FMTYGNLLDYLRECN-RQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT  158 (263)
T ss_pred             eCCCCcHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCccccccccce
Confidence            999999999885432 345788899999999999999999998   9999999999999999999999999987654332


Q ss_pred             cccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHh-CCCCCCCCcccccccchhhhhhhhcCccccccCccc
Q 017594          206 LQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPIL  284 (369)
Q Consensus       206 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (369)
                      .. .......+..|+|||.+.+..++.++|||||||++|+|++ |..||.......      .+......     .....
T Consensus       159 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~------~~~~~~~~-----~~~~~  226 (263)
T cd05052         159 YT-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ------VYELLEKG-----YRMER  226 (263)
T ss_pred             ee-ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH------HHHHHHCC-----CCCCC
Confidence            11 1111223567999999988899999999999999999998 888876432111      11111110     00011


Q ss_pred             cccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHhh
Q 017594          285 EDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNE  325 (369)
Q Consensus       285 ~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L~~~  325 (369)
                           +...+.++.++|.+||+.+|++||++.++++.|+++
T Consensus       227 -----~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~  262 (263)
T cd05052         227 -----PEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM  262 (263)
T ss_pred             -----CCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence                 111256799999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-39  Score=304.25  Aligned_cols=245  Identities=25%  Similarity=0.368  Sum_probs=205.3

Q ss_pred             HHHHhcCCccCccccccCCccEEEEEEcC-CCEEEEEEecCCC---chhHHHHHHHHHHHhcC-CCCceeeeeeeEEeCC
Q 017594           44 VSTATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRS---GQGLREMKNEASVIAKV-QHKNLVRLLGCCIDRD  118 (369)
Q Consensus        44 ~~~~~~~y~i~~~lg~G~~~~v~~~~~~~-~~~valK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~  118 (369)
                      ......+|+++++||+|.||+|++|..+. ++.+|||.+++..   .++.+....|..++... +||.++.++..|...+
T Consensus       363 ~~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~  442 (694)
T KOG0694|consen  363 GPLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKE  442 (694)
T ss_pred             CcccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCC
Confidence            34556789999999999999999999765 8899999998653   45677888888888887 4999999999999999


Q ss_pred             ccEEEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCc
Q 017594          119 EKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMA  198 (369)
Q Consensus       119 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~  198 (369)
                      ++|+||||+.||++..+.    +...+++..+.-++..++.||.|||.+|   |++||||.+||+++.+|.++|+|||++
T Consensus       443 ~l~fvmey~~Ggdm~~~~----~~~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGlc  515 (694)
T KOG0694|consen  443 HLFFVMEYVAGGDLMHHI----HTDVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGLC  515 (694)
T ss_pred             eEEEEEEecCCCcEEEEE----ecccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEecccccc
Confidence            999999999999843333    3345999999999999999999999999   999999999999999999999999998


Q ss_pred             eecCCCCcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCcccc
Q 017594          199 RICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLE  278 (369)
Q Consensus       199 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (369)
                      ..--..  ....+..+||+.|+|||++.+..|+.+.|.||||++||+|+.|..||...+                  ..+
T Consensus       516 Ke~m~~--g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gdd------------------Eee  575 (694)
T KOG0694|consen  516 KEGMGQ--GDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDD------------------EEE  575 (694)
T ss_pred             cccCCC--CCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCC------------------HHH
Confidence            754322  234566899999999999999999999999999999999999999986433                  233


Q ss_pred             ccCccccccc-cHHHHHHHHHHHHHHhhcCCCCCCCCH
Q 017594          279 LIDPILEDEY-SSKQMLLRYANIALLCVQESADDRPTM  315 (369)
Q Consensus       279 ~~~~~~~~~~-~~~~~~~~l~~li~~~L~~dP~~Rps~  315 (369)
                      ..+.++..+. .+..++.+..++++++|..+|++|.-+
T Consensus       576 ~FdsI~~d~~~yP~~ls~ea~~il~~ll~k~p~kRLG~  613 (694)
T KOG0694|consen  576 VFDSIVNDEVRYPRFLSKEAIAIMRRLLRKNPEKRLGS  613 (694)
T ss_pred             HHHHHhcCCCCCCCcccHHHHHHHHHHhccCcccccCC
Confidence            3333333332 244447889999999999999999865

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=1.2e-38  Score=283.80  Aligned_cols=248  Identities=26%  Similarity=0.368  Sum_probs=194.1

Q ss_pred             ccccccCCccEEEEEEc-CCCEEEEEEecCCC-chhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEEEEecCCCCh
Q 017594           55 NKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSL  132 (369)
Q Consensus        55 ~~lg~G~~~~v~~~~~~-~~~~valK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L  132 (369)
                      +.||+|+||.||+|+++ +++.+++|.+.... ......+.+|+++++.+.||||+++++++......++|+||+.+++|
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF   80 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence            47899999999999975 58889999876443 33456788899999999999999999999999999999999999999


Q ss_pred             hhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCCCCccccccc
Q 017594          133 DFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR  212 (369)
Q Consensus       133 ~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~~~~~~~~~~  212 (369)
                      .+++...  ...+++..++.++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++..............
T Consensus        81 ~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~  155 (252)
T cd05084          81 LTFLRTE--GPRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGM  155 (252)
T ss_pred             HHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCcccccccccccCCC
Confidence            9888542  234788899999999999999999999   99999999999999999999999999875433221111111


Q ss_pred             ccccccccCchhhccCCCCcccchHhHHHHHHHHHh-CCCCCCCCcccccccchhhhhhhhcCccccccCccccccccHH
Q 017594          213 IVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYSSK  291 (369)
Q Consensus       213 ~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  291 (369)
                      ...+..|+|||.+.+..++.++|+||||+++|+|++ |..||.......      ........     .....     +.
T Consensus       156 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~------~~~~~~~~-----~~~~~-----~~  219 (252)
T cd05084         156 KQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQ------TREAIEQG-----VRLPC-----PE  219 (252)
T ss_pred             CCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHH------HHHHHHcC-----CCCCC-----cc
Confidence            123456999999988889999999999999999997 888875332110      00000000     00000     11


Q ss_pred             HHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 017594          292 QMLLRYANIALLCVQESADDRPTMNDVVSMLT  323 (369)
Q Consensus       292 ~~~~~l~~li~~~L~~dP~~Rps~~ell~~L~  323 (369)
                      ..+..+.+++.+||+.+|++|||+.++++.|.
T Consensus       220 ~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  251 (252)
T cd05084         220 LCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ  251 (252)
T ss_pred             cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence            22567899999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=4.3e-39  Score=287.97  Aligned_cols=250  Identities=34%  Similarity=0.532  Sum_probs=192.2

Q ss_pred             cCccccccCCccEEEEEEc-----CCCEEEEEEecCCC-chhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEEEEe
Q 017594           53 DANKLGEGGFGPVYKGVLK-----KGDEIAVKRLSGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIYEY  126 (369)
Q Consensus        53 i~~~lg~G~~~~v~~~~~~-----~~~~valK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  126 (369)
                      +.+.||.|.||.||+|.++     .+..|++|.+.... ......+.+|++.+++++||||+++++++...+..++|+||
T Consensus         3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~   82 (259)
T PF07714_consen    3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY   82 (259)
T ss_dssp             EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred             EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence            5678999999999999977     25679999996543 33467889999999999999999999999988889999999


Q ss_pred             cCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCCCCc
Q 017594          127 MPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNEL  206 (369)
Q Consensus       127 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~~~~  206 (369)
                      +.+++|.+++... ....+++..++.++.||+.||.|||+.+   ++|++|++.||+++.++.++|+|||+.........
T Consensus        83 ~~~g~L~~~L~~~-~~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~  158 (259)
T PF07714_consen   83 CPGGSLDDYLKSK-NKEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSK  158 (259)
T ss_dssp             -TTEBHHHHHHHT-CTTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEETTTSSS
T ss_pred             ccccccccccccc-cccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccc
Confidence            9999999998654 2345889999999999999999999998   99999999999999999999999999987643332


Q ss_pred             ccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHh-CCCCCCCCcccccccchhhhhhhhcCccccccCcccc
Q 017594          207 QANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILE  285 (369)
Q Consensus       207 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (369)
                      ............|+|||.+.+..++.++||||||+++|+|++ |..||.......     ..... ........      
T Consensus       159 ~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~-----~~~~~-~~~~~~~~------  226 (259)
T PF07714_consen  159 YKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEE-----IIEKL-KQGQRLPI------  226 (259)
T ss_dssp             EEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHH-----HHHHH-HTTEETTS------
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccccccc-----ccccc-ccccccee------
Confidence            222333446678999999998889999999999999999999 678875432111     11111 11111000      


Q ss_pred             ccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHH
Q 017594          286 DEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSML  322 (369)
Q Consensus       286 ~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L  322 (369)
                          +..++..+.++|..||+.+|++||++.+|++.|
T Consensus       227 ----~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  227 ----PDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             ----BTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred             ----ccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence                111256689999999999999999999999876

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=5.5e-39  Score=297.44  Aligned_cols=252  Identities=21%  Similarity=0.310  Sum_probs=199.1

Q ss_pred             cCCccCccccccCCccEEEEEEc-CCCEEEEEEecCCC---chhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEEE
Q 017594           49 NKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS---GQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIY  124 (369)
Q Consensus        49 ~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  124 (369)
                      ++|++.+.||+|+||.||+|+.+ +|+.||+|++....   ......+..|+.+++.+.|++|+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM   80 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence            47999999999999999999965 48899999987432   234456788999999999999999999999999999999


Q ss_pred             EecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCCC
Q 017594          125 EYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGN  204 (369)
Q Consensus       125 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~~  204 (369)
                      ||+++++|.+++...  ...+++..+..++.||+.||.|||+.+   ++||||||+||+++.++.++|+|||++......
T Consensus        81 e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~  155 (330)
T cd05601          81 EYQPGGDLLSLLNRY--EDQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLTAN  155 (330)
T ss_pred             CCCCCCCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeECCCC
Confidence            999999999988543  234889999999999999999999999   999999999999999999999999998866433


Q ss_pred             CcccccccccccccccCchhhc------cCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCcccc
Q 017594          205 ELQANTSRIVGTYGYMSPEYAL------EGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLE  278 (369)
Q Consensus       205 ~~~~~~~~~~~~~~y~aPE~~~------~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (369)
                      ... ......+++.|+|||++.      +..++.++|||||||++|+|++|..||.......     .............
T Consensus       156 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~-----~~~~i~~~~~~~~  229 (330)
T cd05601         156 KMV-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAK-----TYNNIMNFQRFLK  229 (330)
T ss_pred             Cce-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHH-----HHHHHHcCCCccC
Confidence            221 222346789999999986      4567899999999999999999999986432111     0111111111000


Q ss_pred             ccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 017594          279 LIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVS  320 (369)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~  320 (369)
                      ..     .   ....+.++.+||..||+ +|.+||++.++++
T Consensus       230 ~~-----~---~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~  262 (330)
T cd05601         230 FP-----E---DPKVSSDFLDLIQSLLC-GQKERLGYEGLCC  262 (330)
T ss_pred             CC-----C---CCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence            00     0   01125668999999998 9999999999985

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=2.6e-38  Score=283.91  Aligned_cols=257  Identities=30%  Similarity=0.434  Sum_probs=203.3

Q ss_pred             hcCCccCccccccCCccEEEEEEcC----CCEEEEEEecCCC-chhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEE
Q 017594           48 TNKFSDANKLGEGGFGPVYKGVLKK----GDEIAVKRLSGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKIL  122 (369)
Q Consensus        48 ~~~y~i~~~lg~G~~~~v~~~~~~~----~~~valK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l  122 (369)
                      .++|++.+.||+|+||.||+|.++.    ...|++|.+.... ......+..|+..++.++|+|++++++++......++
T Consensus         3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i   82 (266)
T cd05033           3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI   82 (266)
T ss_pred             hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence            4679999999999999999999643    4578999886543 2334567789999999999999999999999899999


Q ss_pred             EEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecC
Q 017594          123 IYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICG  202 (369)
Q Consensus       123 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~  202 (369)
                      ++||+.+++|.+++....  ..+++..++.++.|++.|+.|||+.+   ++|+||+|.||+++.++.++|+|||++....
T Consensus        83 v~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~  157 (266)
T cd05033          83 ITEYMENGSLDKFLREND--GKFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLE  157 (266)
T ss_pred             EEEcCCCCCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhhccc
Confidence            999999999999985433  25789999999999999999999998   9999999999999999999999999988765


Q ss_pred             CCCcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHh-CCCCCCCCcccccccchhhhhhhhcCccccccC
Q 017594          203 GNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDLWTSNRTLELID  281 (369)
Q Consensus       203 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (369)
                      ............++..|+|||.+.+..++.++|+||||+++|+|++ |..||.......      ...........    
T Consensus       158 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~------~~~~~~~~~~~----  227 (266)
T cd05033         158 DSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQD------VIKAVEDGYRL----  227 (266)
T ss_pred             ccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHH------HHHHHHcCCCC----
Confidence            2222222222234568999999998889999999999999999997 988885432111      00000000000    


Q ss_pred             ccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHhh
Q 017594          282 PILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNE  325 (369)
Q Consensus       282 ~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L~~~  325 (369)
                      +.      +..++..+.+++.+||+.+|++||++.++++.|+.+
T Consensus       228 ~~------~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~  265 (266)
T cd05033         228 PP------PMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM  265 (266)
T ss_pred             CC------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            00      011256789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=2.3e-38  Score=286.00  Aligned_cols=259  Identities=27%  Similarity=0.423  Sum_probs=200.2

Q ss_pred             HHhcCCccCccccccCCccEEEEEEc------CCCEEEEEEecCCC-chhHHHHHHHHHHHhcCCCCceeeeeeeEEeCC
Q 017594           46 TATNKFSDANKLGEGGFGPVYKGVLK------KGDEIAVKRLSGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCCIDRD  118 (369)
Q Consensus        46 ~~~~~y~i~~~lg~G~~~~v~~~~~~------~~~~valK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~  118 (369)
                      ...++|++.+.||+|++|.||.|.++      .+..|++|.+.... ......+.+|+.+++.++|+||+++++++....
T Consensus         3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~   82 (277)
T cd05062           3 VAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ   82 (277)
T ss_pred             ccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence            35678999999999999999999853      24679999886432 223445778999999999999999999998888


Q ss_pred             ccEEEEEecCCCChhhhhcCCCc-------cccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceE
Q 017594          119 EKILIYEYMPNKSLDFFLFDPTK-------RMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPK  191 (369)
Q Consensus       119 ~~~lv~e~~~~~~L~~~l~~~~~-------~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~  191 (369)
                      ..++|+||+.+++|.+++.....       ...++...+..++.|++.||.|||+.+   ++|+||||+||+++.++.++
T Consensus        83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~  159 (277)
T cd05062          83 PTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVK  159 (277)
T ss_pred             CeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEE
Confidence            99999999999999988854221       123567788899999999999999998   99999999999999999999


Q ss_pred             EeecCCceecCCCCcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHh-CCCCCCCCcccccccchhhhhh
Q 017594          192 ISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDL  270 (369)
Q Consensus       192 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~  270 (369)
                      |+|||++................++..|+|||.+.+..++.++|+||||+++|+|++ |..||.......      ....
T Consensus       160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~------~~~~  233 (277)
T cd05062         160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQ------VLRF  233 (277)
T ss_pred             ECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH------HHHH
Confidence            999999876543322222222344678999999988889999999999999999999 688875332110      0011


Q ss_pred             hhcCccccccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 017594          271 WTSNRTLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLT  323 (369)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L~  323 (369)
                      .........          +...+..+.+++.+||+.+|++|||+.++++.|+
T Consensus       234 ~~~~~~~~~----------~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~  276 (277)
T cd05062         234 VMEGGLLDK----------PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK  276 (277)
T ss_pred             HHcCCcCCC----------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence            111111000          0112556899999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=4.9e-39  Score=287.20  Aligned_cols=251  Identities=30%  Similarity=0.459  Sum_probs=198.6

Q ss_pred             CccCccccccCCccEEEEEEcC-CCEEEEEEecCCCchhHH--HHHHHHHHHhcCCCCceeeeeeeEEeCCccEEEEEec
Q 017594           51 FSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLR--EMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIYEYM  127 (369)
Q Consensus        51 y~i~~~lg~G~~~~v~~~~~~~-~~~valK~~~~~~~~~~~--~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~  127 (369)
                      |++++.||+|+||+||+++... ++.||+|++.........  ....|+..++.++|+||+++++++......+++||++
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~   80 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC   80 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence            7889999999999999999776 668999999877544322  2345999999999999999999999999999999999


Q ss_pred             CCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCCCCcc
Q 017594          128 PNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQ  207 (369)
Q Consensus       128 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~~~~~  207 (369)
                      .+++|.+++.   ....++...++.++.||+.||.+||+.+   ++|+||+|+||+++.++.++|+|||.+....  ...
T Consensus        81 ~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~--~~~  152 (260)
T PF00069_consen   81 PGGSLQDYLQ---KNKPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKLS--ENN  152 (260)
T ss_dssp             TTEBHHHHHH---HHSSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEEST--STT
T ss_pred             cccccccccc---cccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccc--ccc
Confidence            9999998885   4455899999999999999999999999   9999999999999999999999999987641  112


Q ss_pred             cccccccccccccCchhhc-cCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCccccccCccccc
Q 017594          208 ANTSRIVGTYGYMSPEYAL-EGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILED  286 (369)
Q Consensus       208 ~~~~~~~~~~~y~aPE~~~-~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  286 (369)
                      .......++..|.|||++. +..++.++|+||||+++++|++|..||........  .......         .......
T Consensus       153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~--~~~~~~~---------~~~~~~~  221 (260)
T PF00069_consen  153 ENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQ--LEIIEKI---------LKRPLPS  221 (260)
T ss_dssp             SEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHH--HHHHHHH---------HHTHHHH
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccchhh--hhhhhhc---------ccccccc
Confidence            2333456788999999998 78899999999999999999999999875410000  0000000         0000000


Q ss_pred             cc-cHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 017594          287 EY-SSKQMLLRYANIALLCVQESADDRPTMNDVVS  320 (369)
Q Consensus       287 ~~-~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~  320 (369)
                      .. ........+.++|.+||+.||++||++.++++
T Consensus       222 ~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~  256 (260)
T PF00069_consen  222 SSQQSREKSEELRDLIKKMLSKDPEQRPSAEELLK  256 (260)
T ss_dssp             HTTSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred             cccccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            00 00000367999999999999999999999986

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=2e-38  Score=289.08  Aligned_cols=265  Identities=26%  Similarity=0.397  Sum_probs=199.3

Q ss_pred             hcCCccCccccccCCccEEEEEEcC---------------CCEEEEEEecCCC-chhHHHHHHHHHHHhcCCCCceeeee
Q 017594           48 TNKFSDANKLGEGGFGPVYKGVLKK---------------GDEIAVKRLSGRS-GQGLREMKNEASVIAKVQHKNLVRLL  111 (369)
Q Consensus        48 ~~~y~i~~~lg~G~~~~v~~~~~~~---------------~~~valK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~  111 (369)
                      .++|++.+.||+|+||.||+|+...               ...|++|.+.... ......+.+|++.+..++|+|+++++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~   83 (295)
T cd05097           4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL   83 (295)
T ss_pred             hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence            4689999999999999999988542               2248999987542 23345688899999999999999999


Q ss_pred             eeEEeCCccEEEEEecCCCChhhhhcCCC---------ccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCE
Q 017594          112 GCCIDRDEKILIYEYMPNKSLDFFLFDPT---------KRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNI  182 (369)
Q Consensus       112 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---------~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NI  182 (369)
                      +++...+..++||||+.+++|.+++....         ....+++..+..++.|++.||+|||+.+   ++|+||+|+||
T Consensus        84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Ni  160 (295)
T cd05097          84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNC  160 (295)
T ss_pred             EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhhE
Confidence            99999999999999999999998875422         1123677888999999999999999999   99999999999


Q ss_pred             EEeCCCceEEeecCCceecCCCCcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHh--CCCCCCCCcccc
Q 017594          183 LLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS--GKKNTGLYRTDS  260 (369)
Q Consensus       183 lv~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~t--g~~p~~~~~~~~  260 (369)
                      +++.++.++|+|||++................++..|+|||...+..++.++|+||||+++|+|++  +..||.......
T Consensus       161 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~  240 (295)
T cd05097         161 LVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ  240 (295)
T ss_pred             EEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHH
Confidence            999999999999999876543222222222334668999999988889999999999999999998  555665332111


Q ss_pred             cccchhhhhhhhcCccccccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHh
Q 017594          261 LNLLGYAWDLWTSNRTLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTN  324 (369)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L~~  324 (369)
                      .  .................  ..     +...+..+.+++.+||+.+|++||++.+|++.|++
T Consensus       241 ~--~~~~~~~~~~~~~~~~~--~~-----~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~  295 (295)
T cd05097         241 V--IENTGEFFRNQGRQIYL--SQ-----TPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE  295 (295)
T ss_pred             H--HHHHHHhhhhccccccC--CC-----CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence            0  00000111100000000  00     01125679999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-38  Score=300.50  Aligned_cols=253  Identities=23%  Similarity=0.294  Sum_probs=196.0

Q ss_pred             cCCccCccccccCCccEEEEEEc-CCCEEEEEEecCCC---chhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEEE
Q 017594           49 NKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS---GQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIY  124 (369)
Q Consensus        49 ~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  124 (369)
                      ++|++++.||.|+||.||+|+.+ +|+.||+|++....   ......+..|+.+++.+.||||+++++++.+....|+||
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~   80 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM   80 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence            47999999999999999999965 58899999986432   233456788999999999999999999999999999999


Q ss_pred             EecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCCC
Q 017594          125 EYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGN  204 (369)
Q Consensus       125 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~~  204 (369)
                      ||+.+++|.+++...   ..+++..+..++.|++.||+|||+.|   ++||||||+||+++.++.++|+|||++..+...
T Consensus        81 E~~~gg~L~~~l~~~---~~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~  154 (377)
T cd05629          81 EFLPGGDLMTMLIKY---DTFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQ  154 (377)
T ss_pred             eCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeecccccccccc
Confidence            999999999888543   34888899999999999999999999   999999999999999999999999998643211


Q ss_pred             Ccc------------c---------------------------------ccccccccccccCchhhccCCCCcccchHhH
Q 017594          205 ELQ------------A---------------------------------NTSRIVGTYGYMSPEYALEGIFSIKSDVFSF  239 (369)
Q Consensus       205 ~~~------------~---------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  239 (369)
                      ...            .                                 ......|++.|+|||++.+..++.++|||||
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl  234 (377)
T cd05629         155 HDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSL  234 (377)
T ss_pred             cccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEec
Confidence            000            0                                 0001358899999999998899999999999


Q ss_pred             HHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCccccccCccccccccHHHHHHHHHHHHHHhhcCCCCCC---CCHH
Q 017594          240 GVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYSSKQMLLRYANIALLCVQESADDR---PTMN  316 (369)
Q Consensus       240 G~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R---ps~~  316 (369)
                      ||++|+|++|..||.......     ..............     ..   ....+.++.++|.+||+ +|.+|   +++.
T Consensus       235 Gvil~elltG~~Pf~~~~~~~-----~~~~i~~~~~~~~~-----p~---~~~~s~~~~dli~~lL~-~~~~r~~r~~~~  300 (377)
T cd05629         235 GAIMFECLIGWPPFCSENSHE-----TYRKIINWRETLYF-----PD---DIHLSVEAEDLIRRLIT-NAENRLGRGGAH  300 (377)
T ss_pred             chhhhhhhcCCCCCCCCCHHH-----HHHHHHccCCccCC-----CC---CCCCCHHHHHHHHHHhc-CHhhcCCCCCHH
Confidence            999999999999986433111     00111111110000     00   01125668999999998 67765   5999


Q ss_pred             HHHHH
Q 017594          317 DVVSM  321 (369)
Q Consensus       317 ell~~  321 (369)
                      ++++.
T Consensus       301 ~~l~h  305 (377)
T cd05629         301 EIKSH  305 (377)
T ss_pred             HHhcC
Confidence            98875

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=2.8e-38  Score=293.29  Aligned_cols=263  Identities=27%  Similarity=0.385  Sum_probs=202.8

Q ss_pred             HhcCCccCccccccCCccEEEEEEc------CCCEEEEEEecCCC-chhHHHHHHHHHHHhcC-CCCceeeeeeeEEeC-
Q 017594           47 ATNKFSDANKLGEGGFGPVYKGVLK------KGDEIAVKRLSGRS-GQGLREMKNEASVIAKV-QHKNLVRLLGCCIDR-  117 (369)
Q Consensus        47 ~~~~y~i~~~lg~G~~~~v~~~~~~------~~~~valK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~-  117 (369)
                      ..++|++.+.||.|+||.||+|...      +++.|++|++.... ......+..|+.++.++ .|+||+++++++... 
T Consensus         5 ~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~   84 (337)
T cd05054           5 PRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPG   84 (337)
T ss_pred             CHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCC
Confidence            4568999999999999999999732      24689999987443 23345677899999999 799999999987644 


Q ss_pred             CccEEEEEecCCCChhhhhcCCCc--------------------------------------------------------
Q 017594          118 DEKILIYEYMPNKSLDFFLFDPTK--------------------------------------------------------  141 (369)
Q Consensus       118 ~~~~lv~e~~~~~~L~~~l~~~~~--------------------------------------------------------  141 (369)
                      ...++++||+.+++|..++.....                                                        
T Consensus        85 ~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (337)
T cd05054          85 GPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDE  164 (337)
T ss_pred             CCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhH
Confidence            567899999999999888753211                                                        


Q ss_pred             --cccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCCCCcccccccccccccc
Q 017594          142 --RMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGY  219 (369)
Q Consensus       142 --~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y  219 (369)
                        ...+++..+..++.||+.||+|||+.+   ++||||||.||+++.++.++|+|||++..+.............++..|
T Consensus       165 ~~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y  241 (337)
T cd05054         165 LYKEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKW  241 (337)
T ss_pred             HhhcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccc
Confidence              125788899999999999999999998   999999999999999999999999998765433222222233456789


Q ss_pred             cCchhhccCCCCcccchHhHHHHHHHHHh-CCCCCCCCcccccccchhhhhhhhcCccccccCccccccccHHHHHHHHH
Q 017594          220 MSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYSSKQMLLRYA  298 (369)
Q Consensus       220 ~aPE~~~~~~~~~~~DiwslG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  298 (369)
                      +|||++.+..++.++|||||||++|+|++ |..||.......     ......... ...    ..     +...+.++.
T Consensus       242 ~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~-----~~~~~~~~~-~~~----~~-----~~~~~~~~~  306 (337)
T cd05054         242 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE-----EFCRRLKEG-TRM----RA-----PEYATPEIY  306 (337)
T ss_pred             cCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH-----HHHHHHhcc-CCC----CC-----CccCCHHHH
Confidence            99999999999999999999999999998 999985322110     000111110 000    00     112256789


Q ss_pred             HHHHHhhcCCCCCCCCHHHHHHHHHhhhh
Q 017594          299 NIALLCVQESADDRPTMNDVVSMLTNEAA  327 (369)
Q Consensus       299 ~li~~~L~~dP~~Rps~~ell~~L~~~~~  327 (369)
                      +++.+||+.+|++||++.++++.|+.+..
T Consensus       307 ~l~~~cl~~~p~~RPs~~ell~~l~~~~~  335 (337)
T cd05054         307 SIMLDCWHNNPEDRPTFSELVEILGDLLQ  335 (337)
T ss_pred             HHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            99999999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=2.9e-38  Score=287.57  Aligned_cols=263  Identities=27%  Similarity=0.414  Sum_probs=205.4

Q ss_pred             HHHhcCCccCccccccCCccEEEEEEcC------CCEEEEEEecCCC-chhHHHHHHHHHHHhcC-CCCceeeeeeeEEe
Q 017594           45 STATNKFSDANKLGEGGFGPVYKGVLKK------GDEIAVKRLSGRS-GQGLREMKNEASVIAKV-QHKNLVRLLGCCID  116 (369)
Q Consensus        45 ~~~~~~y~i~~~lg~G~~~~v~~~~~~~------~~~valK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~  116 (369)
                      ....++|++.+.||+|++|.||++....      ...+++|.+.... ......+..|+.++..+ +|+||+++++++..
T Consensus         8 ~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~   87 (293)
T cd05053           8 ELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQ   87 (293)
T ss_pred             ccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcC
Confidence            3445789999999999999999998642      3578999887532 23445678899999999 79999999999998


Q ss_pred             CCccEEEEEecCCCChhhhhcCC-------------CccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEE
Q 017594          117 RDEKILIYEYMPNKSLDFFLFDP-------------TKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNIL  183 (369)
Q Consensus       117 ~~~~~lv~e~~~~~~L~~~l~~~-------------~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIl  183 (369)
                      ....+++|||+.+++|..++...             .....+++..+..++.|++.||.|||+.+   ++|+||+|.||+
T Consensus        88 ~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Nil  164 (293)
T cd05053          88 EGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNVL  164 (293)
T ss_pred             CCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeEE
Confidence            88999999999999999888532             12345888899999999999999999998   999999999999


Q ss_pred             EeCCCceEEeecCCceecCCCCcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHh-CCCCCCCCcccccc
Q 017594          184 LDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLN  262 (369)
Q Consensus       184 v~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~t-g~~p~~~~~~~~~~  262 (369)
                      ++.++.++|+|||.+................++..|+|||...+..++.++|||||||++|+|++ |..||.......  
T Consensus       165 ~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~--  242 (293)
T cd05053         165 VTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE--  242 (293)
T ss_pred             EcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHH--
Confidence            99999999999999886544322222222234567999999988889999999999999999997 888875432111  


Q ss_pred             cchhhhhhhhcCccccccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHhhh
Q 017594          263 LLGYAWDLWTSNRTLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNEA  326 (369)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L~~~~  326 (369)
                          ............          .+...+..+.+++.+||+.+|++|||+.++++.|+.+.
T Consensus       243 ----~~~~~~~~~~~~----------~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~  292 (293)
T cd05053         243 ----LFKLLKEGYRME----------KPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML  292 (293)
T ss_pred             ----HHHHHHcCCcCC----------CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence                111111110000          01112566899999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=2.3e-38  Score=282.70  Aligned_cols=253  Identities=28%  Similarity=0.419  Sum_probs=200.9

Q ss_pred             hcCCccCccccccCCccEEEEEEcCCCEEEEEEecCCCchhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEEEEec
Q 017594           48 TNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIYEYM  127 (369)
Q Consensus        48 ~~~y~i~~~lg~G~~~~v~~~~~~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~  127 (369)
                      .++|++.+.||+|++|.||.|+++++..+++|.+.... .....+.+|+..++.++||||+++++++......+++|||+
T Consensus         3 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   81 (256)
T cd05113           3 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYM   81 (256)
T ss_pred             hHHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcC
Confidence            46799999999999999999998777779999887443 23467888999999999999999999998888899999999


Q ss_pred             CCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCCCCcc
Q 017594          128 PNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQ  207 (369)
Q Consensus       128 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~~~~~  207 (369)
                      .+++|.+++.....  .+++..++.++.||+.||.|||+.+   ++|+||+|.||+++.++.++|+|||.+.........
T Consensus        82 ~~~~l~~~i~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~  156 (256)
T cd05113          82 SNGCLLNYLREHGK--RFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYT  156 (256)
T ss_pred             CCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCCCcee
Confidence            99999998854322  5889999999999999999999998   999999999999999999999999998765432211


Q ss_pred             cccccccccccccCchhhccCCCCcccchHhHHHHHHHHHh-CCCCCCCCcccccccchhhhhhhhcCccccccCccccc
Q 017594          208 ANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILED  286 (369)
Q Consensus       208 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  286 (369)
                       ......++..|.|||...+..++.++|+||||+++|+|++ |..||.......     ..... .... .    .....
T Consensus       157 -~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~-----~~~~~-~~~~-~----~~~~~  224 (256)
T cd05113         157 -SSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSE-----TVEKV-SQGL-R----LYRPH  224 (256)
T ss_pred             -ecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH-----HHHHH-hcCC-C----CCCCC
Confidence             1111234567999999988889999999999999999998 898886433111     00001 0000 0    00000


Q ss_pred             cccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 017594          287 EYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLT  323 (369)
Q Consensus       287 ~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L~  323 (369)
                           ..+..+.+++.+||+.+|.+||++.+|++.|+
T Consensus       225 -----~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~  256 (256)
T cd05113         225 -----LASEKVYAIMYSCWHEKAEERPTFQQLLSSIE  256 (256)
T ss_pred             -----CCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence                 11567899999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=4.4e-38  Score=285.03  Aligned_cols=257  Identities=30%  Similarity=0.449  Sum_probs=201.0

Q ss_pred             cCCccCccccccCCccEEEEEEc-----CCCEEEEEEecCCC-chhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEE
Q 017594           49 NKFSDANKLGEGGFGPVYKGVLK-----KGDEIAVKRLSGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKIL  122 (369)
Q Consensus        49 ~~y~i~~~lg~G~~~~v~~~~~~-----~~~~valK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l  122 (369)
                      .+|++.+.||+|+||.||+|.+.     .+..+++|.+.... ......+.+|+..++.++|||++++++++......++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l   84 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM   84 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence            56889999999999999999842     35789999987433 3334678889999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhcCCC--------------ccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCC
Q 017594          123 IYEYMPNKSLDFFLFDPT--------------KRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDM  188 (369)
Q Consensus       123 v~e~~~~~~L~~~l~~~~--------------~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~  188 (369)
                      +|||+.+++|.+++....              ....+++.....++.|++.||.|||+++   ++|+||+|+||+++.++
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~~  161 (283)
T cd05090          85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQL  161 (283)
T ss_pred             EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCCC
Confidence            999999999988874221              1234778888999999999999999999   99999999999999999


Q ss_pred             ceEEeecCCceecCCCCcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHh-CCCCCCCCcccccccchhh
Q 017594          189 NPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYA  267 (369)
Q Consensus       189 ~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~t-g~~p~~~~~~~~~~~~~~~  267 (369)
                      .++|+|||++................++..|+|||.+.+..++.++|+||||+++|+|++ |..||.......      .
T Consensus       162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~------~  235 (283)
T cd05090         162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQE------V  235 (283)
T ss_pred             cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH------H
Confidence            999999999876543322222233345667999999988889999999999999999998 888875322110      0


Q ss_pred             hhhhhcCccccccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHh
Q 017594          268 WDLWTSNRTLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTN  324 (369)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L~~  324 (369)
                      ...........     ..     ..++..+.+++.+||+.+|++||++.+|++.|..
T Consensus       236 ~~~~~~~~~~~-----~~-----~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05090         236 IEMVRKRQLLP-----CS-----EDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS  282 (283)
T ss_pred             HHHHHcCCcCC-----CC-----CCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence            11111111110     00     1125668999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=1.7e-38  Score=288.70  Aligned_cols=263  Identities=22%  Similarity=0.277  Sum_probs=191.2

Q ss_pred             cCCccCccccccCCccEEEEEEc--CCCEEEEEEecCCC--chhHHHHHHHHHHHhcC---CCCceeeeeeeEEe-----
Q 017594           49 NKFSDANKLGEGGFGPVYKGVLK--KGDEIAVKRLSGRS--GQGLREMKNEASVIAKV---QHKNLVRLLGCCID-----  116 (369)
Q Consensus        49 ~~y~i~~~lg~G~~~~v~~~~~~--~~~~valK~~~~~~--~~~~~~~~~e~~~l~~l---~h~~i~~~~~~~~~-----  116 (369)
                      ++|++.+.||+|+||.||+|++.  +|..||+|.+....  ........+|+.+++.+   .||||+++++++..     
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~   80 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   80 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence            47999999999999999999963  36789999886432  22223455667666665   69999999998752     


Q ss_pred             CCccEEEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecC
Q 017594          117 RDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFG  196 (369)
Q Consensus       117 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg  196 (369)
                      ....++|+|++. ++|..++.... ...+++..++.++.||+.||.|||+.+   ++|+||||+||+++.++.++|+|||
T Consensus        81 ~~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~Dfg  155 (290)
T cd07862          81 ETKLTLVFEHVD-QDLTTYLDKVP-EPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFG  155 (290)
T ss_pred             CCcEEEEEccCC-CCHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEcccc
Confidence            345899999997 47777764422 234788999999999999999999999   9999999999999999999999999


Q ss_pred             CceecCCCCcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhh--hhcC
Q 017594          197 MARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDL--WTSN  274 (369)
Q Consensus       197 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~--~~~~  274 (369)
                      ++......   .......++..|+|||.+.+..++.++|||||||++|+|++|.+||.......... ......  ....
T Consensus       156 ~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~-~i~~~~~~~~~~  231 (290)
T cd07862         156 LARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLG-KILDVIGLPGEE  231 (290)
T ss_pred             ceEeccCC---cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHH-HHHHHhCCCChh
Confidence            98765433   12233467899999999988889999999999999999999999997543211000 000000  0000


Q ss_pred             cc-------ccccCccccccc--cHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 017594          275 RT-------LELIDPILEDEY--SSKQMLLRYANIALLCVQESADDRPTMNDVVS  320 (369)
Q Consensus       275 ~~-------~~~~~~~~~~~~--~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~  320 (369)
                      ..       ............  .....+..+.+++.+||+.||++|||+.++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  286 (290)
T cd07862         232 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  286 (290)
T ss_pred             hchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence            00       000000000000  01123567889999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.8e-39  Score=269.27  Aligned_cols=249  Identities=26%  Similarity=0.332  Sum_probs=206.3

Q ss_pred             hcCCccCccccccCCccEEEEEEc-CCCEEEEEEecCCC---chhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEE
Q 017594           48 TNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS---GQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILI  123 (369)
Q Consensus        48 ~~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv  123 (369)
                      .++|++.+.||+|.||.||+|+.+ ++--||+|++.+++   ....+++.+|+++-..|+||||++++++|.+....|++
T Consensus        21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi  100 (281)
T KOG0580|consen   21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI  100 (281)
T ss_pred             hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence            468999999999999999999955 47779999986553   33457788999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCC
Q 017594          124 YEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGG  203 (369)
Q Consensus       124 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~  203 (369)
                      +||..+|.+...++.. +...+++...+.+..|++.|+.|+|..+   ++||||||+|++++..|.++++|||.+.... 
T Consensus       101 lEya~~gel~k~L~~~-~~~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p-  175 (281)
T KOG0580|consen  101 LEYAPRGELYKDLQEG-RMKRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP-  175 (281)
T ss_pred             EEecCCchHHHHHHhc-ccccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCCCceeecC-
Confidence            9999999998888643 3445889999999999999999999998   9999999999999999999999999987644 


Q ss_pred             CCcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCccccccCcc
Q 017594          204 NELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPI  283 (369)
Q Consensus       204 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (369)
                         .......+||..|++||...+..++...|+|++|++.|+++.|.+||....... .          ...+.+ .+-.
T Consensus       176 ---~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~e-t----------YkrI~k-~~~~  240 (281)
T KOG0580|consen  176 ---SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSE-T----------YKRIRK-VDLK  240 (281)
T ss_pred             ---CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHH-H----------HHHHHH-cccc
Confidence               223455789999999999999999999999999999999999999997433110 0          000000 0000


Q ss_pred             ccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 017594          284 LEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSM  321 (369)
Q Consensus       284 ~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~  321 (369)
                           .+...+....++|.+||..+|.+|.+..+++..
T Consensus       241 -----~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h  273 (281)
T KOG0580|consen  241 -----FPSTISGGAADLISRLLVKNPIERLALTEVMDH  273 (281)
T ss_pred             -----CCcccChhHHHHHHHHhccCccccccHHHHhhh
Confidence                 112236779999999999999999999999864

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=4.3e-39  Score=297.52  Aligned_cols=242  Identities=23%  Similarity=0.300  Sum_probs=192.4

Q ss_pred             ccccccCCccEEEEEEc-CCCEEEEEEecCC---CchhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEEEEecCCC
Q 017594           55 NKLGEGGFGPVYKGVLK-KGDEIAVKRLSGR---SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIYEYMPNK  130 (369)
Q Consensus        55 ~~lg~G~~~~v~~~~~~-~~~~valK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~  130 (369)
                      +.||+|+||.||+|+.+ +|..||+|++...   .......+..|+.++..+.||||+++.+.+...+..++||||+.++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            46899999999999965 5889999998643   2233456677899999999999999999999999999999999999


Q ss_pred             ChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhc-CCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCCCCcccc
Q 017594          131 SLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQ-YSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQAN  209 (369)
Q Consensus       131 ~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~-~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~~~~~~~  209 (369)
                      +|..++..   ...+++..++.++.||+.||.|||+ .+   ++||||||+||+++.++.++|+|||++.......  ..
T Consensus        81 ~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~--~~  152 (325)
T cd05594          81 ELFFHLSR---ERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG--AT  152 (325)
T ss_pred             cHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecCCCC--cc
Confidence            99888743   3348899999999999999999997 67   9999999999999999999999999987533211  11


Q ss_pred             cccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCccccccCcccccccc
Q 017594          210 TSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYS  289 (369)
Q Consensus       210 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  289 (369)
                      .....|+..|+|||++.+..++.++|||||||++|+|++|..||........      .........      .+     
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~------~~~i~~~~~------~~-----  215 (325)
T cd05594         153 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL------FELILMEEI------RF-----  215 (325)
T ss_pred             cccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHH------HHHHhcCCC------CC-----
Confidence            2234689999999999988999999999999999999999999864321110      000000000      00     


Q ss_pred             HHHHHHHHHHHHHHhhcCCCCCCC-----CHHHHHHH
Q 017594          290 SKQMLLRYANIALLCVQESADDRP-----TMNDVVSM  321 (369)
Q Consensus       290 ~~~~~~~l~~li~~~L~~dP~~Rp-----s~~ell~~  321 (369)
                      +..++.++.++|.+||+.||.+|+     ++.++++.
T Consensus       216 p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h  252 (325)
T cd05594         216 PRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH  252 (325)
T ss_pred             CCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence            111256789999999999999997     89999864

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-39  Score=297.28  Aligned_cols=245  Identities=28%  Similarity=0.420  Sum_probs=203.3

Q ss_pred             CccccccCCccEEEEEEcCCCEEEEEEecCCCchhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEEEEecCCCChh
Q 017594           54 ANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSLD  133 (369)
Q Consensus        54 ~~~lg~G~~~~v~~~~~~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~  133 (369)
                      ++.||.|+.|.||+|+.+ ++.||||++..       .-..+++.|++|+|+||+.+.++|...-.+|||||||..|.|.
T Consensus       129 LeWlGSGaQGAVF~Grl~-netVAVKKV~e-------lkETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~  200 (904)
T KOG4721|consen  129 LEWLGSGAQGAVFLGRLH-NETVAVKKVRE-------LKETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLY  200 (904)
T ss_pred             hhhhccCcccceeeeecc-CceehhHHHhh-------hhhhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHH
Confidence            568999999999999987 78999998862       2345788999999999999999999999999999999999999


Q ss_pred             hhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCCCCcccccccc
Q 017594          134 FFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRI  213 (369)
Q Consensus       134 ~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~  213 (369)
                      ..+..   +..+.......|..+|+.++.|||.+.   |+|||||.-||||+.+..|||+|||-++.....   ...-..
T Consensus       201 ~VLka---~~~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~---STkMSF  271 (904)
T KOG4721|consen  201 EVLKA---GRPITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGTSKELSDK---STKMSF  271 (904)
T ss_pred             HHHhc---cCccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccchHhhhhh---hhhhhh
Confidence            99954   344788899999999999999999998   999999999999999999999999988765433   223335


Q ss_pred             cccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCccccccCccccccccHHHH
Q 017594          214 VGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYSSKQM  293 (369)
Q Consensus       214 ~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  293 (369)
                      .||..|+|||++.+.+++.|+||||+|++||+|+||..||..-+.     ..++|.+..+.  ..+.        .+..+
T Consensus       272 aGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVds-----sAIIwGVGsNs--L~Lp--------vPstc  336 (904)
T KOG4721|consen  272 AGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDS-----SAIIWGVGSNS--LHLP--------VPSTC  336 (904)
T ss_pred             hhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccch-----heeEEeccCCc--cccc--------CcccC
Confidence            799999999999999999999999999999999999999863221     12233332211  1111        12233


Q ss_pred             HHHHHHHHHHhhcCCCCCCCCHHHHHHHHHhhhhccC
Q 017594          294 LLRYANIALLCVQESADDRPTMNDVVSMLTNEAATLL  330 (369)
Q Consensus       294 ~~~l~~li~~~L~~dP~~Rps~~ell~~L~~~~~~~~  330 (369)
                      +.-+.-|+++||+..|..||++.+|+..|.-+.+.+.
T Consensus       337 P~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~pell  373 (904)
T KOG4721|consen  337 PDGFKLLLKQCWNSKPRNRPSFRQILLHLDIASPELL  373 (904)
T ss_pred             chHHHHHHHHHHhcCCCCCccHHHHHHHHhhcCHHHh
Confidence            6678999999999999999999999999988777654

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=3.3e-38  Score=285.35  Aligned_cols=264  Identities=24%  Similarity=0.375  Sum_probs=207.1

Q ss_pred             HHhcCCccCccccccCCccEEEEEEcC-----CCEEEEEEecCC-CchhHHHHHHHHHHHhcCCCCceeeeeeeEEe-CC
Q 017594           46 TATNKFSDANKLGEGGFGPVYKGVLKK-----GDEIAVKRLSGR-SGQGLREMKNEASVIAKVQHKNLVRLLGCCID-RD  118 (369)
Q Consensus        46 ~~~~~y~i~~~lg~G~~~~v~~~~~~~-----~~~valK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~  118 (369)
                      ...++|++.+.||+|+||.||+|.+..     +..|++|++... .......+..|+..++.+.|+|++++++++.. ..
T Consensus         3 ~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~   82 (280)
T cd05043           3 ISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGE   82 (280)
T ss_pred             cchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC
Confidence            456789999999999999999999765     678999988644 23345667889999999999999999998766 46


Q ss_pred             ccEEEEEecCCCChhhhhcCCCcc-----ccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEe
Q 017594          119 EKILIYEYMPNKSLDFFLFDPTKR-----MLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKIS  193 (369)
Q Consensus       119 ~~~lv~e~~~~~~L~~~l~~~~~~-----~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~  193 (369)
                      ..+++++|+.+++|..++......     ..+++..++.++.|++.||+|||+.+   ++|+||+|.||+++.++.++|+
T Consensus        83 ~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~  159 (280)
T cd05043          83 PPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKIT  159 (280)
T ss_pred             CCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEEC
Confidence            789999999999999888543222     45889999999999999999999998   9999999999999999999999


Q ss_pred             ecCCceecCCCCcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHh-CCCCCCCCcccccccchhhhhhhh
Q 017594          194 DFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDLWT  272 (369)
Q Consensus       194 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~  272 (369)
                      |||++..+.............++..|+|||.+.+..++.++||||||+++|++++ |+.||.......     +. ....
T Consensus       160 d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-----~~-~~~~  233 (280)
T cd05043         160 DNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFE-----MA-AYLK  233 (280)
T ss_pred             CCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHH-----HH-HHHH
Confidence            9999876543322222222345667999999988889999999999999999998 999985432110     00 1111


Q ss_pred             cCccccccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHhhhhc
Q 017594          273 SNRTLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNEAAT  328 (369)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L~~~~~~  328 (369)
                      ....       ...   ...++..+.+++.+||..+|++|||+.++++.|+.+...
T Consensus       234 ~~~~-------~~~---~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~  279 (280)
T cd05043         234 DGYR-------LAQ---PINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHAQ  279 (280)
T ss_pred             cCCC-------CCC---CCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhc
Confidence            1100       000   011256689999999999999999999999999988764

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1.2e-38  Score=294.24  Aligned_cols=242  Identities=24%  Similarity=0.316  Sum_probs=192.1

Q ss_pred             CccccccCCccEEEEEEc----CCCEEEEEEecCC----CchhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEEEE
Q 017594           54 ANKLGEGGFGPVYKGVLK----KGDEIAVKRLSGR----SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIYE  125 (369)
Q Consensus        54 ~~~lg~G~~~~v~~~~~~----~~~~valK~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  125 (369)
                      ++.||+|+||.||+|+..    .++.||+|++...    .......+..|+.+++.++||||+++++.+..++..++|||
T Consensus         1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e   80 (323)
T cd05584           1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILE   80 (323)
T ss_pred             CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEe
Confidence            468999999999999852    4788999998642    12233456789999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCCCC
Q 017594          126 YMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE  205 (369)
Q Consensus       126 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~~~  205 (369)
                      |+.+++|.+++..   ...+.+..+..++.||+.||.|||+++   ++||||||+||+++.++.++|+|||++.......
T Consensus        81 ~~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  154 (323)
T cd05584          81 YLSGGELFMHLER---EGIFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG  154 (323)
T ss_pred             CCCCchHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeecccCC
Confidence            9999999888843   334778888899999999999999999   9999999999999999999999999987543221


Q ss_pred             cccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCccccccCcccc
Q 017594          206 LQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILE  285 (369)
Q Consensus       206 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (369)
                        .......|++.|+|||++.+..++.++||||||+++|+|++|..||.......     .........  . .+     
T Consensus       155 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~-----~~~~~~~~~--~-~~-----  219 (323)
T cd05584         155 --TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKK-----TIDKILKGK--L-NL-----  219 (323)
T ss_pred             --CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHH-----HHHHHHcCC--C-CC-----
Confidence              11223468999999999998889999999999999999999999986432110     011111100  0 00     


Q ss_pred             ccccHHHHHHHHHHHHHHhhcCCCCCCC-----CHHHHHH
Q 017594          286 DEYSSKQMLLRYANIALLCVQESADDRP-----TMNDVVS  320 (369)
Q Consensus       286 ~~~~~~~~~~~l~~li~~~L~~dP~~Rp-----s~~ell~  320 (369)
                          +...+..+.++|.+||+.+|++||     ++.++++
T Consensus       220 ----~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~  255 (323)
T cd05584         220 ----PPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS  255 (323)
T ss_pred             ----CCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence                111256689999999999999999     7888876

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=2.7e-38  Score=298.38  Aligned_cols=253  Identities=22%  Similarity=0.316  Sum_probs=195.3

Q ss_pred             CCccCccccccCCccEEEEEEc-CCCEEEEEEecCCC---chhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEEEE
Q 017594           50 KFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS---GQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIYE  125 (369)
Q Consensus        50 ~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  125 (369)
                      .|++++.||+|+||.||+|+.+ +++.||+|++....   ......+..|+.+++.++|+||+++++++.+.+..++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E   81 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence            6899999999999999999965 48899999986432   2334567889999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCCCC
Q 017594          126 YMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE  205 (369)
Q Consensus       126 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~~~  205 (369)
                      |+.+++|.+++...   ..+++..+..++.||+.||.|||+.+   ++||||||+||+++.++.++|+|||++..+....
T Consensus        82 ~~~gg~L~~~l~~~---~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~  155 (381)
T cd05626          82 YIPGGDMMSLLIRM---EVFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTH  155 (381)
T ss_pred             cCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCccccccc
Confidence            99999999888543   34888899999999999999999999   9999999999999999999999999875431100


Q ss_pred             c---------------------------------------------ccccccccccccccCchhhccCCCCcccchHhHH
Q 017594          206 L---------------------------------------------QANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFG  240 (369)
Q Consensus       206 ~---------------------------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG  240 (369)
                      .                                             ........|+..|+|||++.+..++.++||||||
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG  235 (381)
T cd05626         156 NSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVG  235 (381)
T ss_pred             ccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehh
Confidence            0                                             0001123688999999999988899999999999


Q ss_pred             HHHHHHHhCCCCCCCCcccccccchhhhhhhhcCccccccCccccccccHHHHHHHHHHHHHHhh--cCCCCCCCCHHHH
Q 017594          241 VLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYSSKQMLLRYANIALLCV--QESADDRPTMNDV  318 (369)
Q Consensus       241 ~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L--~~dP~~Rps~~el  318 (369)
                      |++|+|++|..||........     .............     ..   ...++.++.++|.+|+  ..++..||++.++
T Consensus       236 ~il~elltG~~Pf~~~~~~~~-----~~~i~~~~~~~~~-----~~---~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~  302 (381)
T cd05626         236 VILFEMLVGQPPFLAPTPTET-----QLKVINWENTLHI-----PP---QVKLSPEAVDLITKLCCSAEERLGRNGADDI  302 (381)
T ss_pred             hHHHHHHhCCCCCcCCCHHHH-----HHHHHccccccCC-----CC---CCCCCHHHHHHHHHHccCcccccCCCCHHHH
Confidence            999999999999964331110     0000000000000     00   0112567889999855  4555569999999


Q ss_pred             HHH
Q 017594          319 VSM  321 (369)
Q Consensus       319 l~~  321 (369)
                      ++.
T Consensus       303 l~h  305 (381)
T cd05626         303 KAH  305 (381)
T ss_pred             hcC
Confidence            874

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=2.5e-38  Score=284.05  Aligned_cols=260  Identities=20%  Similarity=0.335  Sum_probs=205.8

Q ss_pred             cCCccCccccccCCccEEEEEEc-CCCEEEEEEecCCC---chhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEEE
Q 017594           49 NKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS---GQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIY  124 (369)
Q Consensus        49 ~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  124 (369)
                      .+|++.+.||.|++|.||+|+.+ ++..+++|.+....   ......+.+|+.+++.+.|+|++++++++......++++
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL   81 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence            57899999999999999999964 68899999876432   233456778999999999999999999999999999999


Q ss_pred             EecCCCChhhhhcCC-CccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCC
Q 017594          125 EYMPNKSLDFFLFDP-TKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGG  203 (369)
Q Consensus       125 e~~~~~~L~~~l~~~-~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~  203 (369)
                      ||+.+++|.+++... .....+++..++.++.||+.||.|||+.+   ++|+||+|+||+++.++.++|+|||++.....
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~  158 (267)
T cd08229          82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence            999999998887532 22345788999999999999999999999   99999999999999999999999998876543


Q ss_pred             CCcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCccccccCcc
Q 017594          204 NELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPI  283 (369)
Q Consensus       204 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (369)
                      ...  ......++..|+|||.+.+..++.++|+||||+++|+|++|..||..........   .      ........  
T Consensus       159 ~~~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~---~------~~~~~~~~--  225 (267)
T cd08229         159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSL---C------KKIEQCDY--  225 (267)
T ss_pred             CCc--ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHH---h------hhhhcCCC--
Confidence            221  1122357888999999988889999999999999999999999985322111000   0      00000000  


Q ss_pred             ccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHhhh
Q 017594          284 LEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNEA  326 (369)
Q Consensus       284 ~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L~~~~  326 (369)
                        ........+..+.+++.+||+.+|++|||+.+|++.++++.
T Consensus       226 --~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~  266 (267)
T cd08229         226 --PPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH  266 (267)
T ss_pred             --CCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence              01111223667999999999999999999999999998764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.2e-38  Score=281.75  Aligned_cols=253  Identities=28%  Similarity=0.404  Sum_probs=200.4

Q ss_pred             hcCCccCccccccCCccEEEEEEcCCCEEEEEEecCCCchhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEEEEec
Q 017594           48 TNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIYEYM  127 (369)
Q Consensus        48 ~~~y~i~~~lg~G~~~~v~~~~~~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~  127 (369)
                      ..+|++.+.||.|++|.||++.++++..+++|.+..... ....+.+|+.+++.++|+|++++++++......++++||+
T Consensus         3 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   81 (256)
T cd05059           3 PSELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM-SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYM   81 (256)
T ss_pred             hHHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecC
Confidence            356899999999999999999988777899999864432 2356778999999999999999999999888999999999


Q ss_pred             CCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCCCCcc
Q 017594          128 PNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQ  207 (369)
Q Consensus       128 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~~~~~  207 (369)
                      ++++|.+++....  ..+++..++.++.||+.|++|||+.+   ++|+||+|+||+++.++.++|+|||++.........
T Consensus        82 ~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~  156 (256)
T cd05059          82 ANGCLLNYLRERK--GKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYT  156 (256)
T ss_pred             CCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceeccccccc
Confidence            9999999885432  25788999999999999999999999   999999999999999999999999998765432211


Q ss_pred             cccccccccccccCchhhccCCCCcccchHhHHHHHHHHHh-CCCCCCCCcccccccchhhhhhhhcCccccccCccccc
Q 017594          208 ANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILED  286 (369)
Q Consensus       208 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  286 (369)
                      . .....++..|+|||.+.+..++.++|+||||+++|+|++ |..||.......     ..... ...     .....  
T Consensus       157 ~-~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~-----~~~~~-~~~-----~~~~~--  222 (256)
T cd05059         157 S-SQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSE-----VVESV-SAG-----YRLYR--  222 (256)
T ss_pred             c-cCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHH-----HHHHH-HcC-----CcCCC--
Confidence            1 111123457999999998899999999999999999998 788886432111     11111 000     00000  


Q ss_pred             cccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 017594          287 EYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLT  323 (369)
Q Consensus       287 ~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L~  323 (369)
                         +..++..+.+++.+||+.+|++|||+.++++.|.
T Consensus       223 ---~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l~  256 (256)
T cd05059         223 ---PKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQLT  256 (256)
T ss_pred             ---CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHhC
Confidence               0112667999999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=1.3e-38  Score=275.64  Aligned_cols=265  Identities=25%  Similarity=0.308  Sum_probs=199.5

Q ss_pred             hcCCccCccccccCCccEEEEEEcC-CCEEEEEEecCCCc--hhHHHHHHHHHHHhcCCCCceeeeeeeEEeC--CccEE
Q 017594           48 TNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSG--QGLREMKNEASVIAKVQHKNLVRLLGCCIDR--DEKIL  122 (369)
Q Consensus        48 ~~~y~i~~~lg~G~~~~v~~~~~~~-~~~valK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~l  122 (369)
                      .+.|+.+..|+.|+||.||+|+++. ++-||+|+++....  .-.-...+|+.+|.+++||||+.+-++..-.  +..|+
T Consensus        75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~  154 (419)
T KOG0663|consen   75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYI  154 (419)
T ss_pred             HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeee
Confidence            3568999999999999999999654 88899999974432  1123456799999999999999999988643  46899


Q ss_pred             EEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecC
Q 017594          123 IYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICG  202 (369)
Q Consensus       123 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~  202 (369)
                      |||||+. .|..++....  .++...++..+..|+++|++|||.++   |+|||||++|++++..|.++++|||+++.++
T Consensus       155 VMe~~Eh-DLksl~d~m~--q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR~yg  228 (419)
T KOG0663|consen  155 VMEYVEH-DLKSLMETMK--QPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLAREYG  228 (419)
T ss_pred             eHHHHHh-hHHHHHHhcc--CCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhhhhc
Confidence            9999976 4555554322  46889999999999999999999999   9999999999999999999999999999887


Q ss_pred             CCCcccccccccccccccCchhhccC-CCCcccchHhHHHHHHHHHhCCCCCCCCcccc-ccc----ch----hhhhhhh
Q 017594          203 GNELQANTSRIVGTYGYMSPEYALEG-IFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDS-LNL----LG----YAWDLWT  272 (369)
Q Consensus       203 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~-~~~----~~----~~~~~~~  272 (369)
                      .....  .....-|.+|+|||++.+. .|+.+.|+||+|||+.+|+++++.|...+... ...    ++    -.|.-+.
T Consensus       229 sp~k~--~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~  306 (419)
T KOG0663|consen  229 SPLKP--YTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYS  306 (419)
T ss_pred             CCccc--CcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCcc
Confidence            65332  2335679999999998765 59999999999999999999999887654211 110    00    0111111


Q ss_pred             cCc------cccccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 017594          273 SNR------TLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVS  320 (369)
Q Consensus       273 ~~~------~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~  320 (369)
                      .-.      ..+.....+...+.....++.-.+|+..+|..||.+|.||.+.|+
T Consensus       307 ~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~  360 (419)
T KOG0663|consen  307 ELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLK  360 (419)
T ss_pred             ccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhc
Confidence            100      001111111112211113577889999999999999999999986

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=9.8e-38  Score=278.70  Aligned_cols=250  Identities=34%  Similarity=0.513  Sum_probs=201.4

Q ss_pred             ccccccCCccEEEEEEcC----CCEEEEEEecCCCchh-HHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEEEEecCC
Q 017594           55 NKLGEGGFGPVYKGVLKK----GDEIAVKRLSGRSGQG-LREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIYEYMPN  129 (369)
Q Consensus        55 ~~lg~G~~~~v~~~~~~~----~~~valK~~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~  129 (369)
                      +.||.|+||.||+|.+..    +..|++|.+....... ...+..|+..+..+.|+|++++++++......++++||+.+
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG   80 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence            478999999999999654    7889999987654332 67888999999999999999999999998899999999999


Q ss_pred             CChhhhhcCCCc------cccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCC
Q 017594          130 KSLDFFLFDPTK------RMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGG  203 (369)
Q Consensus       130 ~~L~~~l~~~~~------~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~  203 (369)
                      ++|.+++.....      ...+++..++.++.|++.||++||+++   ++|+||+|+||+++.++.++|+|||.+.....
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~  157 (262)
T cd00192          81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVYD  157 (262)
T ss_pred             CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEccccccccccc
Confidence            999999865421      256899999999999999999999998   99999999999999999999999999987654


Q ss_pred             CCcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHh-CCCCCCCCcccccccchhhhhhhhcCccccccCc
Q 017594          204 NELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDP  282 (369)
Q Consensus       204 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (369)
                      ...........++..|+|||.+.+..++.++|+||||+++|+|++ |..||.......      ...........     
T Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~------~~~~~~~~~~~-----  226 (262)
T cd00192         158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEE------VLEYLRKGYRL-----  226 (262)
T ss_pred             ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHH------HHHHHHcCCCC-----
Confidence            432222333456788999999988889999999999999999999 588886542111      01111110000     


Q ss_pred             cccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 017594          283 ILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLT  323 (369)
Q Consensus       283 ~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L~  323 (369)
                           ..+..++.++.+++.+||+.+|.+|||+.++++.|+
T Consensus       227 -----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~  262 (262)
T cd00192         227 -----PKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE  262 (262)
T ss_pred             -----CCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence                 001122567999999999999999999999999874

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=4.8e-39  Score=303.14  Aligned_cols=253  Identities=22%  Similarity=0.316  Sum_probs=196.5

Q ss_pred             cCCccCccccccCCccEEEEEEc-CCCEEEEEEecCCC---chhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEEE
Q 017594           49 NKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS---GQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIY  124 (369)
Q Consensus        49 ~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  124 (369)
                      .+|++++.||+|+||.||+|+.+ +++.||+|++....   ......+..|+.+++.+.|+||+++++.+..++..++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM   80 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence            47999999999999999999965 48899999986432   223456778999999999999999999999999999999


Q ss_pred             EecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCCC
Q 017594          125 EYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGN  204 (369)
Q Consensus       125 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~~  204 (369)
                      ||+.+++|.+++...   ..+++..+..++.||+.||+|||+++   ++||||||+||+++.++.++|+|||++..+...
T Consensus        81 E~~~~g~L~~~i~~~---~~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~  154 (376)
T cd05598          81 DYIPGGDMMSLLIRL---GIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT  154 (376)
T ss_pred             eCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCcccccc
Confidence            999999999998543   34788889999999999999999999   999999999999999999999999987533110


Q ss_pred             Cc-----------------------------------------ccccccccccccccCchhhccCCCCcccchHhHHHHH
Q 017594          205 EL-----------------------------------------QANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLL  243 (369)
Q Consensus       205 ~~-----------------------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il  243 (369)
                      ..                                         ........|++.|+|||++.+..++.++|||||||++
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil  234 (376)
T cd05598         155 HDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL  234 (376)
T ss_pred             ccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeecccee
Confidence            00                                         0001123689999999999999999999999999999


Q ss_pred             HHHHhCCCCCCCCcccccccchhhhhhhhcCccccccCccccccccHHHHHHHHHHHHHHhhcCCCCCCC---CHHHHHH
Q 017594          244 LEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRP---TMNDVVS  320 (369)
Q Consensus       244 ~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp---s~~ell~  320 (369)
                      |+|++|+.||........     .............     ..   ....+.++.++|.+|+ .+|.+|+   ++.++++
T Consensus       235 yell~G~~Pf~~~~~~~~-----~~~i~~~~~~~~~-----~~---~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~  300 (376)
T cd05598         235 YEMLVGQPPFLADTPAET-----QLKVINWETTLHI-----PS---QAKLSREASDLILRLC-CGAEDRLGKNGADEIKA  300 (376)
T ss_pred             eehhhCCCCCCCCCHHHH-----HHHHhccCccccC-----CC---CCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhC
Confidence            999999999965431110     0001000000000     00   0112566888999876 5999999   8999986


Q ss_pred             H
Q 017594          321 M  321 (369)
Q Consensus       321 ~  321 (369)
                      .
T Consensus       301 h  301 (376)
T cd05598         301 H  301 (376)
T ss_pred             C
Confidence            5

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=9.2e-38  Score=284.67  Aligned_cols=265  Identities=27%  Similarity=0.404  Sum_probs=202.9

Q ss_pred             hcCCccCccccccCCccEEEEEEcC-----------------CCEEEEEEecCCC-chhHHHHHHHHHHHhcCCCCceee
Q 017594           48 TNKFSDANKLGEGGFGPVYKGVLKK-----------------GDEIAVKRLSGRS-GQGLREMKNEASVIAKVQHKNLVR  109 (369)
Q Consensus        48 ~~~y~i~~~lg~G~~~~v~~~~~~~-----------------~~~valK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~  109 (369)
                      .++|++++.||+|+||.||+|....                 +..|++|.+.... ......+..|+.+++.++|||+++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~   83 (296)
T cd05051           4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR   83 (296)
T ss_pred             hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence            4689999999999999999998543                 2457999887543 234567888999999999999999


Q ss_pred             eeeeEEeCCccEEEEEecCCCChhhhhcCCC--------ccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCC
Q 017594          110 LLGCCIDRDEKILIYEYMPNKSLDFFLFDPT--------KRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASN  181 (369)
Q Consensus       110 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--------~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~N  181 (369)
                      +++++..+...++++|++.+++|..++....        ....+++..++.++.|++.||.|||+.+   ++|+||||+|
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~N  160 (296)
T cd05051          84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRN  160 (296)
T ss_pred             EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhc
Confidence            9999999899999999999999998885433        1235889999999999999999999998   9999999999


Q ss_pred             EEEeCCCceEEeecCCceecCCCCcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHh--CCCCCCCCccc
Q 017594          182 ILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS--GKKNTGLYRTD  259 (369)
Q Consensus       182 Ilv~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~t--g~~p~~~~~~~  259 (369)
                      |+++.++.++|+|||++................++..|+|||.+.+..++.++|||||||++|+|++  +..||......
T Consensus       161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~  240 (296)
T cd05051         161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQ  240 (296)
T ss_pred             eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChH
Confidence            9999999999999999876543332222233345678999999988889999999999999999998  56676533211


Q ss_pred             ccccchhhhhhhhcCccccccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHh
Q 017594          260 SLNLLGYAWDLWTSNRTLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTN  324 (369)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L~~  324 (369)
                      .  ........+..........       .+..++.++.+++.+||+.||++|||+.+|++.|++
T Consensus       241 ~--~~~~~~~~~~~~~~~~~~~-------~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~  296 (296)
T cd05051         241 Q--VIENAGHFFRDDGRQIYLP-------RPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR  296 (296)
T ss_pred             H--HHHHHHhccccccccccCC-------CccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence            1  0000111100000000000       011225679999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=4.3e-39  Score=296.61  Aligned_cols=239  Identities=24%  Similarity=0.299  Sum_probs=189.6

Q ss_pred             CccccccCCccEEEEEE----cCCCEEEEEEecCCCc--hhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEEEEec
Q 017594           54 ANKLGEGGFGPVYKGVL----KKGDEIAVKRLSGRSG--QGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIYEYM  127 (369)
Q Consensus        54 ~~~lg~G~~~~v~~~~~----~~~~~valK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~  127 (369)
                      ++.||+|+||.||+++.    .+|+.||+|++.....  .....+..|++++++++||||+++++++......|+||||+
T Consensus         1 l~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~   80 (318)
T cd05582           1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFL   80 (318)
T ss_pred             CceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCC
Confidence            36799999999999984    2478999999874321  22345677999999999999999999999999999999999


Q ss_pred             CCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCCCCcc
Q 017594          128 PNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQ  207 (369)
Q Consensus       128 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~~~~~  207 (369)
                      .+++|..++..   ...+++..++.++.||+.||.|||+.+   ++||||||+||+++.++.++|+|||++.......  
T Consensus        81 ~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~--  152 (318)
T cd05582          81 RGGDLFTRLSK---EVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE--  152 (318)
T ss_pred             CCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCCC--
Confidence            99999888843   334889999999999999999999999   9999999999999999999999999987543321  


Q ss_pred             cccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCccccccCcccccc
Q 017594          208 ANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDE  287 (369)
Q Consensus       208 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  287 (369)
                      .......|+..|+|||.+.+..++.++|||||||++|+|++|+.||.......     .........  ..     +   
T Consensus       153 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~-----~~~~i~~~~--~~-----~---  217 (318)
T cd05582         153 KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKE-----TMTMILKAK--LG-----M---  217 (318)
T ss_pred             CceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHH-----HHHHHHcCC--CC-----C---
Confidence            11223468899999999998889999999999999999999999986432111     011110000  00     0   


Q ss_pred             ccHHHHHHHHHHHHHHhhcCCCCCCCCHHH
Q 017594          288 YSSKQMLLRYANIALLCVQESADDRPTMND  317 (369)
Q Consensus       288 ~~~~~~~~~l~~li~~~L~~dP~~Rps~~e  317 (369)
                        +...+..+.++|.+||+.||++||++.+
T Consensus       218 --p~~~~~~~~~li~~~l~~~P~~R~~a~~  245 (318)
T cd05582         218 --PQFLSPEAQSLLRALFKRNPANRLGAGP  245 (318)
T ss_pred             --CCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence              1112567899999999999999999544

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=3.3e-38  Score=285.52  Aligned_cols=257  Identities=29%  Similarity=0.417  Sum_probs=202.4

Q ss_pred             hcCCccCccccccCCccEEEEEEc------CCCEEEEEEecCCCchhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccE
Q 017594           48 TNKFSDANKLGEGGFGPVYKGVLK------KGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKI  121 (369)
Q Consensus        48 ~~~y~i~~~lg~G~~~~v~~~~~~------~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  121 (369)
                      ..+|.+.+.||+|+||.||++...      ++..+++|.+..........+..|++.++.++|+||+++++++......+
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   83 (280)
T cd05092           4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLL   83 (280)
T ss_pred             hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceE
Confidence            467889999999999999999732      25578899887666566678899999999999999999999999888999


Q ss_pred             EEEEecCCCChhhhhcCCCc------------cccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCc
Q 017594          122 LIYEYMPNKSLDFFLFDPTK------------RMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMN  189 (369)
Q Consensus       122 lv~e~~~~~~L~~~l~~~~~------------~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~  189 (369)
                      +++||+.+++|.+++.....            ...+++..+..++.||+.|++|||+.+   ++|+||+|+||+++.++.
T Consensus        84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~~  160 (280)
T cd05092          84 MVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLV  160 (280)
T ss_pred             EEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCCC
Confidence            99999999999988854321            134788899999999999999999999   999999999999999999


Q ss_pred             eEEeecCCceecCCCCcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHh-CCCCCCCCcccccccchhhh
Q 017594          190 PKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAW  268 (369)
Q Consensus       190 ~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~t-g~~p~~~~~~~~~~~~~~~~  268 (369)
                      ++|+|||++................++..|+|||.+.+..++.++|+|||||++|+|++ |.+||.......     ...
T Consensus       161 ~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~-----~~~  235 (280)
T cd05092         161 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTE-----AIE  235 (280)
T ss_pred             EEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHH-----HHH
Confidence            99999999875543221111222234578999999998889999999999999999998 888875322110     000


Q ss_pred             hhhhcCccccccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 017594          269 DLWTSNRTLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLT  323 (369)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L~  323 (369)
                      .. ........          +..++..+.+++.+||+.||.+||++.+|++.|+
T Consensus       236 ~~-~~~~~~~~----------~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~  279 (280)
T cd05092         236 CI-TQGRELER----------PRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ  279 (280)
T ss_pred             HH-HcCccCCC----------CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence            00 00000000          0112566899999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=1.4e-38  Score=293.66  Aligned_cols=242  Identities=24%  Similarity=0.334  Sum_probs=191.6

Q ss_pred             ccccccCCccEEEEEEcC-CCEEEEEEecCC---CchhHHHHHHHHHHHhcC-CCCceeeeeeeEEeCCccEEEEEecCC
Q 017594           55 NKLGEGGFGPVYKGVLKK-GDEIAVKRLSGR---SGQGLREMKNEASVIAKV-QHKNLVRLLGCCIDRDEKILIYEYMPN  129 (369)
Q Consensus        55 ~~lg~G~~~~v~~~~~~~-~~~valK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~  129 (369)
                      +.||+|+||.||+|+.+. ++.||+|++...   .......+..|..++..+ +||+|+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   80 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG   80 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence            469999999999999764 789999998643   223345566788888766 799999999999999999999999999


Q ss_pred             CChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCCCCcccc
Q 017594          130 KSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQAN  209 (369)
Q Consensus       130 ~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~~~~~~~  209 (369)
                      ++|...+...   ..+++..+..++.||+.||.|||+++   ++||||||+||+++.++.++|+|||++.......  ..
T Consensus        81 ~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~--~~  152 (321)
T cd05591          81 GDLMFQIQRS---RKFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG--VT  152 (321)
T ss_pred             CcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceecccCC--cc
Confidence            9998887543   34788899999999999999999999   9999999999999999999999999987543221  11


Q ss_pred             cccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCccccccCcccccccc
Q 017594          210 TSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYS  289 (369)
Q Consensus       210 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  289 (369)
                      .....|+..|+|||++.+..++.++|||||||++|+|++|+.||.......     ....... ...      .     .
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~-----~~~~i~~-~~~------~-----~  215 (321)
T cd05591         153 TTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDD-----LFESILH-DDV------L-----Y  215 (321)
T ss_pred             ccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHH-----HHHHHHc-CCC------C-----C
Confidence            223468899999999998899999999999999999999999996433111     0111110 000      0     0


Q ss_pred             HHHHHHHHHHHHHHhhcCCCCCCC-------CHHHHHHH
Q 017594          290 SKQMLLRYANIALLCVQESADDRP-------TMNDVVSM  321 (369)
Q Consensus       290 ~~~~~~~l~~li~~~L~~dP~~Rp-------s~~ell~~  321 (369)
                      +...+.++.++|.+||+.||++||       ++.++++.
T Consensus       216 p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h  254 (321)
T cd05591         216 PVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH  254 (321)
T ss_pred             CCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence            111256789999999999999999       88888754

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=1.1e-38  Score=280.47  Aligned_cols=266  Identities=22%  Similarity=0.282  Sum_probs=199.9

Q ss_pred             hcCCccCccccccCCccEEEEEEc-CCCEEEEEEecCCCc--hhHHHHHHHHHHHhcCCCCc-eeeeeeeEEeCC-----
Q 017594           48 TNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSG--QGLREMKNEASVIAKVQHKN-LVRLLGCCIDRD-----  118 (369)
Q Consensus        48 ~~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~~~--~~~~~~~~e~~~l~~l~h~~-i~~~~~~~~~~~-----  118 (369)
                      ...|..+++||.|+||+||+|+.+ +|+.||+|.+.....  .......+|+.+|+.++|+| |+.+++++...+     
T Consensus        10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~   89 (323)
T KOG0594|consen   10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI   89 (323)
T ss_pred             HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence            456888899999999999999955 589999999875533  35567889999999999999 999999998777     


Q ss_pred             -ccEEEEEecCCCChhhhhcCCCcc-ccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecC
Q 017594          119 -EKILIYEYMPNKSLDFFLFDPTKR-MLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFG  196 (369)
Q Consensus       119 -~~~lv~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg  196 (369)
                       ..++|+||++. .|..++...... ..++...+..++.||+.||+|||+++   |+||||||+||+|+.+|.+||+|||
T Consensus        90 ~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFG  165 (323)
T KOG0594|consen   90 GKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFG  165 (323)
T ss_pred             ceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccc
Confidence             78999999854 666666543321 34677889999999999999999999   9999999999999999999999999


Q ss_pred             CceecCCCCcccccccccccccccCchhhccC-CCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhh-------
Q 017594          197 MARICGGNELQANTSRIVGTYGYMSPEYALEG-IFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAW-------  268 (369)
Q Consensus       197 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~-------  268 (369)
                      +++.+.-....  .....+|.+|+|||++.+. .|+...||||+|||+.+|++++..|...+.....  .-.+       
T Consensus       166 lAra~~ip~~~--yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql--~~If~~lGtP~  241 (323)
T KOG0594|consen  166 LARAFSIPMRT--YTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQL--FRIFRLLGTPN  241 (323)
T ss_pred             hHHHhcCCccc--ccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHH--HHHHHHcCCCC
Confidence            99865433222  2334678899999998866 6999999999999999999999988765432111  0011       


Q ss_pred             -hhhhcCccccccCccccc----cccHHHH---HHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 017594          269 -DLWTSNRTLELIDPILED----EYSSKQM---LLRYANIALLCVQESADDRPTMNDVVSM  321 (369)
Q Consensus       269 -~~~~~~~~~~~~~~~~~~----~~~~~~~---~~~l~~li~~~L~~dP~~Rps~~ell~~  321 (369)
                       +.|.........+.....    .......   ..+..+++.+||+.+|.+|.|++.+++.
T Consensus       242 e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h  302 (323)
T KOG0594|consen  242 EKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH  302 (323)
T ss_pred             ccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence             111111100001101100    0001111   2478999999999999999999999985

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=1.2e-38  Score=293.86  Aligned_cols=236  Identities=26%  Similarity=0.357  Sum_probs=187.6

Q ss_pred             ccccccCCccEEEEEEcC-CCEEEEEEecCC---CchhHHHHHHHHHHHhcC-CCCceeeeeeeEEeCCccEEEEEecCC
Q 017594           55 NKLGEGGFGPVYKGVLKK-GDEIAVKRLSGR---SGQGLREMKNEASVIAKV-QHKNLVRLLGCCIDRDEKILIYEYMPN  129 (369)
Q Consensus        55 ~~lg~G~~~~v~~~~~~~-~~~valK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~  129 (369)
                      +.||+|+||.||+|+.+. ++.||+|++...   .......+..|..++..+ .||||+++++++...+..++||||+.+
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~   80 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG   80 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence            468999999999999764 889999998643   223345566788888776 699999999999999999999999999


Q ss_pred             CChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCCCCcccc
Q 017594          130 KSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQAN  209 (369)
Q Consensus       130 ~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~~~~~~~  209 (369)
                      ++|..++...   ..+++..++.++.||+.||.|||+.+   ++||||||+||+++.++.++|+|||++.......  ..
T Consensus        81 g~L~~~i~~~---~~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~--~~  152 (320)
T cd05590          81 GDLMFHIQKS---RRFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG--KT  152 (320)
T ss_pred             chHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC--Cc
Confidence            9998887543   34889999999999999999999999   9999999999999999999999999987543221  12


Q ss_pred             cccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCccccccCcccccccc
Q 017594          210 TSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYS  289 (369)
Q Consensus       210 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  289 (369)
                      .....|++.|+|||++.+..++.++|+|||||++|+|++|+.||.......     ...... ....      .     .
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~-----~~~~i~-~~~~------~-----~  215 (320)
T cd05590         153 TSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDD-----LFEAIL-NDEV------V-----Y  215 (320)
T ss_pred             ccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHH-----HHHHHh-cCCC------C-----C
Confidence            233468999999999998899999999999999999999999996433111     011110 0000      0     0


Q ss_pred             HHHHHHHHHHHHHHhhcCCCCCCCCH
Q 017594          290 SKQMLLRYANIALLCVQESADDRPTM  315 (369)
Q Consensus       290 ~~~~~~~l~~li~~~L~~dP~~Rps~  315 (369)
                      +...+.++.++|.+||+.||.+||++
T Consensus       216 ~~~~~~~~~~li~~~L~~dP~~R~~~  241 (320)
T cd05590         216 PTWLSQDAVDILKAFMTKNPTMRLGS  241 (320)
T ss_pred             CCCCCHHHHHHHHHHcccCHHHCCCC
Confidence            11125678999999999999999998

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=3.1e-38  Score=287.96  Aligned_cols=254  Identities=23%  Similarity=0.380  Sum_probs=204.3

Q ss_pred             HHHHhcCCccCccccccCCccEEEEEEc-CCCEEEEEEecCCCchhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEE
Q 017594           44 VSTATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKIL  122 (369)
Q Consensus        44 ~~~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l  122 (369)
                      +.....+|++.+.||.|++|.||+|++. +++.|++|.+..........+.+|+.+++.+.|+|++++++.+......++
T Consensus        15 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~l   94 (296)
T cd06654          15 VGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWV   94 (296)
T ss_pred             cCCcccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEE
Confidence            4445679999999999999999999964 488999999876655556778899999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecC
Q 017594          123 IYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICG  202 (369)
Q Consensus       123 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~  202 (369)
                      |+||+.+++|.+++..    ..++...+..++.|++.||+|||+.+   ++|+||+|+||+++.++.++|+|||++....
T Consensus        95 v~e~~~~~~L~~~~~~----~~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~  167 (296)
T cd06654          95 VMEYLAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQIT  167 (296)
T ss_pred             eecccCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhcc
Confidence            9999999999998843    23788899999999999999999999   9999999999999999999999999877543


Q ss_pred             CCCcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCccccccCc
Q 017594          203 GNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDP  282 (369)
Q Consensus       203 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (369)
                      ...  .......++..|+|||.+.+..++.++|+||+||++|+|++|..||.........     .........      
T Consensus       168 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~-----~~~~~~~~~------  234 (296)
T cd06654         168 PEQ--SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRAL-----YLIATNGTP------  234 (296)
T ss_pred             ccc--cccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhH-----HHHhcCCCC------
Confidence            221  1112235788999999998888899999999999999999999998643211100     000000000      


Q ss_pred             cccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 017594          283 ILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVS  320 (369)
Q Consensus       283 ~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~  320 (369)
                      ..   ..+...+..+.+++.+||..+|++||++.++++
T Consensus       235 ~~---~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~  269 (296)
T cd06654         235 EL---QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ  269 (296)
T ss_pred             CC---CCccccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence            00   001223566899999999999999999999997

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=7.3e-38  Score=280.05  Aligned_cols=257  Identities=30%  Similarity=0.442  Sum_probs=205.3

Q ss_pred             HHhcCCccCccccccCCccEEEEEEcCCCEEEEEEecCCCchhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEEEE
Q 017594           46 TATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIYE  125 (369)
Q Consensus        46 ~~~~~y~i~~~lg~G~~~~v~~~~~~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  125 (369)
                      ...++|++.+.||.|++|.||+|..+++..+++|.+.... ...+.+..|+..++.++|+|++++++++......++++|
T Consensus         3 ~~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   81 (261)
T cd05034           3 IPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTE   81 (261)
T ss_pred             cchhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEe
Confidence            3467899999999999999999998878889999987543 334678899999999999999999999988889999999


Q ss_pred             ecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCCCC
Q 017594          126 YMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE  205 (369)
Q Consensus       126 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~~~  205 (369)
                      ++.+++|.+++.... ...+++..+..++.+++.|+.|||+++   ++|+||+|+||+++.++.++|+|||.+..+....
T Consensus        82 ~~~~~~L~~~i~~~~-~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~  157 (261)
T cd05034          82 YMSKGSLLDFLKSGE-GKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIEDDE  157 (261)
T ss_pred             ccCCCCHHHHHhccc-cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceeccchh
Confidence            999999999886533 234788999999999999999999998   9999999999999999999999999987665322


Q ss_pred             cccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHh-CCCCCCCCcccccccchhhhhhhhcCccccccCccc
Q 017594          206 LQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPIL  284 (369)
Q Consensus       206 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (369)
                      .. .......+..|+|||.+.+..++.++|+||||+++|+|++ |+.||.......     ..... ...     .....
T Consensus       158 ~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~-----~~~~~-~~~-----~~~~~  225 (261)
T cd05034         158 YT-AREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNRE-----VLEQV-ERG-----YRMPR  225 (261)
T ss_pred             hh-hhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH-----HHHHH-HcC-----CCCCC
Confidence            11 1112234567999999998889999999999999999998 899985322110     00000 000     00000


Q ss_pred             cccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHh
Q 017594          285 EDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTN  324 (369)
Q Consensus       285 ~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L~~  324 (369)
                           +...+.++.+++.+||+.+|.+||+++++++.|+.
T Consensus       226 -----~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~  260 (261)
T cd05034         226 -----PPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED  260 (261)
T ss_pred             -----CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence                 01115568999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=3.1e-38  Score=296.16  Aligned_cols=253  Identities=21%  Similarity=0.287  Sum_probs=195.4

Q ss_pred             cCCccCccccccCCccEEEEEEc-CCCEEEEEEecCCC---chhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEEE
Q 017594           49 NKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS---GQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIY  124 (369)
Q Consensus        49 ~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  124 (369)
                      ++|++.+.||+|+||.||+|+.+ +++.||+|++....   ......+..|+.++..++|++|+++++.+.+....++||
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~   80 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM   80 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence            47999999999999999999965 48899999986432   223456778999999999999999999999999999999


Q ss_pred             EecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCCC
Q 017594          125 EYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGN  204 (369)
Q Consensus       125 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~~  204 (369)
                      ||+.+++|.+++...   ..+++..+..++.|++.||.|||++|   ++||||||+||+++.++.++|+|||++..+...
T Consensus        81 E~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~~~~  154 (363)
T cd05628          81 EFLPGGDMMTLLMKK---DTLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKA  154 (363)
T ss_pred             cCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCccccccc
Confidence            999999999988543   34889999999999999999999999   999999999999999999999999998754321


Q ss_pred             Ccc---------------------------------cccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCC
Q 017594          205 ELQ---------------------------------ANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKK  251 (369)
Q Consensus       205 ~~~---------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~  251 (369)
                      ...                                 .......|++.|+|||++.+..++.++|||||||++|+|++|..
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~  234 (363)
T cd05628         155 HRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP  234 (363)
T ss_pred             ccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCC
Confidence            100                                 00112468999999999999999999999999999999999999


Q ss_pred             CCCCCcccccccchhhhhhhhcCccccccCccccccccHHHHHHHHHHHHHHhhcCCCC---CCCCHHHHHHH
Q 017594          252 NTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYSSKQMLLRYANIALLCVQESAD---DRPTMNDVVSM  321 (369)
Q Consensus       252 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~---~Rps~~ell~~  321 (369)
                      ||.......     .............     +...   ...+.++.++|.+|+. +|.   .||++.+|++.
T Consensus       235 Pf~~~~~~~-----~~~~i~~~~~~~~-----~p~~---~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~h  293 (363)
T cd05628         235 PFCSETPQE-----TYKKVMNWKETLI-----FPPE---VPISEKAKDLILRFCC-EWEHRIGAPGVEEIKTN  293 (363)
T ss_pred             CCCCCCHHH-----HHHHHHcCcCccc-----CCCc---CCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhCC
Confidence            996432110     0011111000000     0000   0125668888888765 444   46899999976

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=1e-37  Score=279.14  Aligned_cols=255  Identities=29%  Similarity=0.455  Sum_probs=201.6

Q ss_pred             HhcCCccCccccccCCccEEEEEEcCCCEEEEEEecCCCchhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEEEEe
Q 017594           47 ATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIYEY  126 (369)
Q Consensus        47 ~~~~y~i~~~lg~G~~~~v~~~~~~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  126 (369)
                      ..++|++.+.||+|++|.||+|..+++..+++|.+..... ....+.+|+.+++.++|++++++++++. ....+++|||
T Consensus         4 ~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~   81 (260)
T cd05070           4 PRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEY   81 (260)
T ss_pred             chHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEe
Confidence            4568999999999999999999988888899999875433 3467889999999999999999998874 5668999999


Q ss_pred             cCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCCCCc
Q 017594          127 MPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNEL  206 (369)
Q Consensus       127 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~~~~  206 (369)
                      +.+++|.+++.... ...+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||.+........
T Consensus        82 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~  157 (260)
T cd05070          82 MSKGSLLDFLKDGE-GRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEY  157 (260)
T ss_pred             cCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeeccCccc
Confidence            99999999886432 234788899999999999999999999   99999999999999999999999999876543221


Q ss_pred             ccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHh-CCCCCCCCcccccccchhhhhhhhcCccccccCcccc
Q 017594          207 QANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILE  285 (369)
Q Consensus       207 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (369)
                      . ......++..|+|||.+.+..++.++|+||||+++|+|++ |..||......     ...... ...     ..... 
T Consensus       158 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~-----~~~~~~-~~~-----~~~~~-  224 (260)
T cd05070         158 T-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNR-----EVLEQV-ERG-----YRMPC-  224 (260)
T ss_pred             c-cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHH-----HHHHHH-HcC-----CCCCC-
Confidence            1 1111234567999999988889999999999999999999 88888532211     001111 000     00000 


Q ss_pred             ccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHh
Q 017594          286 DEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTN  324 (369)
Q Consensus       286 ~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L~~  324 (369)
                          +...+..+.+++.+||+.+|.+|||+.++.++|++
T Consensus       225 ----~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  259 (260)
T cd05070         225 ----PQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED  259 (260)
T ss_pred             ----CCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence                11225679999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=1.5e-37  Score=282.52  Aligned_cols=259  Identities=29%  Similarity=0.428  Sum_probs=202.4

Q ss_pred             CCccCccccccCCccEEEEEEcC------CCEEEEEEecCCC-chhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEE
Q 017594           50 KFSDANKLGEGGFGPVYKGVLKK------GDEIAVKRLSGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKIL  122 (369)
Q Consensus        50 ~y~i~~~lg~G~~~~v~~~~~~~------~~~valK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l  122 (369)
                      +|++.+.||+|+||.||+|....      ...+++|.+.... ......+..|+..++.+.||||+++++.+......++
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   80 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL   80 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence            58899999999999999998532      3468888876443 2335678889999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhcCCC---------------------ccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCC
Q 017594          123 IYEYMPNKSLDFFLFDPT---------------------KRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASN  181 (369)
Q Consensus       123 v~e~~~~~~L~~~l~~~~---------------------~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~N  181 (369)
                      ++||+.+++|.+++....                     ....+++..++.++.|++.||.|||+.+   ++||||+|.|
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~n  157 (290)
T cd05045          81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARN  157 (290)
T ss_pred             EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhhe
Confidence            999999999988874321                     1234788899999999999999999998   9999999999


Q ss_pred             EEEeCCCceEEeecCCceecCCCCcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHh-CCCCCCCCcccc
Q 017594          182 ILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDS  260 (369)
Q Consensus       182 Ilv~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~t-g~~p~~~~~~~~  260 (369)
                      |+++.++.++|+|||++................++..|+|||.+.+..++.++||||||+++|+|++ |..||...... 
T Consensus       158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-  236 (290)
T cd05045         158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPE-  236 (290)
T ss_pred             EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHH-
Confidence            9999999999999999876543322112222345668999999988889999999999999999998 98888533211 


Q ss_pred             cccchhhhhhhhcCccccccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHhhhh
Q 017594          261 LNLLGYAWDLWTSNRTLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNEAA  327 (369)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L~~~~~  327 (369)
                           ..+.......     ....     +..++.++.+++.+||+.+|++||++.++++.|+++..
T Consensus       237 -----~~~~~~~~~~-----~~~~-----~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~  288 (290)
T cd05045         237 -----RLFNLLKTGY-----RMER-----PENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV  288 (290)
T ss_pred             -----HHHHHHhCCC-----CCCC-----CCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence                 1111111100     0000     11125679999999999999999999999999998765

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.6e-38  Score=283.25  Aligned_cols=258  Identities=28%  Similarity=0.430  Sum_probs=202.6

Q ss_pred             HhcCCccCccccccCCccEEEEEEcC------CCEEEEEEecCCC-chhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCc
Q 017594           47 ATNKFSDANKLGEGGFGPVYKGVLKK------GDEIAVKRLSGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDE  119 (369)
Q Consensus        47 ~~~~y~i~~~lg~G~~~~v~~~~~~~------~~~valK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~  119 (369)
                      ..++|++.+.||.|+||.||+|..+.      +..|++|.+.... ......+..|+.++..+.|+|++++++++.....
T Consensus         4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~   83 (277)
T cd05032           4 PREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQP   83 (277)
T ss_pred             chHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCC
Confidence            45789999999999999999999653      3679999986443 2334567789999999999999999999999999


Q ss_pred             cEEEEEecCCCChhhhhcCCCc-------cccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEE
Q 017594          120 KILIYEYMPNKSLDFFLFDPTK-------RMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKI  192 (369)
Q Consensus       120 ~~lv~e~~~~~~L~~~l~~~~~-------~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L  192 (369)
                      .++++||+.+++|.+++.....       ...+++..++.++.||+.||.|||+.+   ++|+||+|+||+++.++.++|
T Consensus        84 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~kl  160 (277)
T cd05032          84 TLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKI  160 (277)
T ss_pred             cEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEEE
Confidence            9999999999999988854321       223677888999999999999999998   999999999999999999999


Q ss_pred             eecCCceecCCCCcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHh-CCCCCCCCcccccccchhhhhhh
Q 017594          193 SDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDLW  271 (369)
Q Consensus       193 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~  271 (369)
                      +|||++................++..|+|||.+.+..++.++|||||||++|+|++ |..||.......      .....
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~------~~~~~  234 (277)
T cd05032         161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEE------VLKFV  234 (277)
T ss_pred             CCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHH------HHHHH
Confidence            99999876543322122222345678999999988889999999999999999998 888885332111      11111


Q ss_pred             hcCccccccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 017594          272 TSNRTLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLT  323 (369)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L~  323 (369)
                      ........     .     ..++..+.+++.+||+.+|++|||+.++++.|+
T Consensus       235 ~~~~~~~~-----~-----~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~  276 (277)
T cd05032         235 IDGGHLDL-----P-----ENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK  276 (277)
T ss_pred             hcCCCCCC-----C-----CCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence            11111111     1     111567899999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=7e-38  Score=287.15  Aligned_cols=265  Identities=27%  Similarity=0.389  Sum_probs=205.4

Q ss_pred             HHHhcCCccCccccccCCccEEEEEEcC--------CCEEEEEEecCCC-chhHHHHHHHHHHHhcC-CCCceeeeeeeE
Q 017594           45 STATNKFSDANKLGEGGFGPVYKGVLKK--------GDEIAVKRLSGRS-GQGLREMKNEASVIAKV-QHKNLVRLLGCC  114 (369)
Q Consensus        45 ~~~~~~y~i~~~lg~G~~~~v~~~~~~~--------~~~valK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~  114 (369)
                      ....++|.+.+.||+|+||.||+|++..        +..+++|.+.... ......+..|+.+++.+ +|+|++++++++
T Consensus        14 ~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~   93 (307)
T cd05098          14 EVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC   93 (307)
T ss_pred             eeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEE
Confidence            3445789999999999999999998532        3469999987542 33456678899999999 799999999999


Q ss_pred             EeCCccEEEEEecCCCChhhhhcCCCc-------------cccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCC
Q 017594          115 IDRDEKILIYEYMPNKSLDFFLFDPTK-------------RMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASN  181 (369)
Q Consensus       115 ~~~~~~~lv~e~~~~~~L~~~l~~~~~-------------~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~N  181 (369)
                      ......++|+||+.+++|.+++.....             ...++...+..++.|++.||+|||+.+   ++|+||+|+|
T Consensus        94 ~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~N  170 (307)
T cd05098          94 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARN  170 (307)
T ss_pred             ecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHh
Confidence            999999999999999999999864321             134788889999999999999999998   9999999999


Q ss_pred             EEEeCCCceEEeecCCceecCCCCcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHh-CCCCCCCCcccc
Q 017594          182 ILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDS  260 (369)
Q Consensus       182 Ilv~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~t-g~~p~~~~~~~~  260 (369)
                      |+++.++.++|+|||.+................++..|+|||.+.+..++.++|+||||+++|+|++ |..||...... 
T Consensus       171 ill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~-  249 (307)
T cd05098         171 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE-  249 (307)
T ss_pred             eEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHH-
Confidence            9999999999999999876543221111111223467999999988889999999999999999998 88887532211 


Q ss_pred             cccchhhhhhhhcCccccccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHhhhhc
Q 017594          261 LNLLGYAWDLWTSNRTLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNEAAT  328 (369)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L~~~~~~  328 (369)
                           ..............          +...+.++.+++.+||..+|.+||++.++++.|..+.+.
T Consensus       250 -----~~~~~~~~~~~~~~----------~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~  302 (307)
T cd05098         250 -----ELFKLLKEGHRMDK----------PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILAL  302 (307)
T ss_pred             -----HHHHHHHcCCCCCC----------CCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHH
Confidence                 01111111110000          112256789999999999999999999999999988764

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.8e-38  Score=299.26  Aligned_cols=265  Identities=20%  Similarity=0.249  Sum_probs=199.2

Q ss_pred             HHHhcCCccCccccccCCccEEEEEEc---CCCEEEEEEecCCCchhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccE
Q 017594           45 STATNKFSDANKLGEGGFGPVYKGVLK---KGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKI  121 (369)
Q Consensus        45 ~~~~~~y~i~~~lg~G~~~~v~~~~~~---~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  121 (369)
                      .....+|++++.||.|+||.||+|...   .+..|++|.+...     ....+|+.+++.++||||+++++++......+
T Consensus        88 ~~~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~  162 (392)
T PHA03207         88 SVVRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVC  162 (392)
T ss_pred             hhccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEE
Confidence            345568999999999999999999853   3577999988643     24467999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceec
Q 017594          122 LIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARIC  201 (369)
Q Consensus       122 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~  201 (369)
                      ++||++.+ .|..++.   ....+++..+..++.||+.||.|||++|   ++||||||+||+++.++.++|+|||++...
T Consensus       163 lv~e~~~~-~l~~~l~---~~~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~~  235 (392)
T PHA03207        163 MVMPKYKC-DLFTYVD---RSGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKL  235 (392)
T ss_pred             EEehhcCC-CHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCcccccc
Confidence            99999864 5666662   3345899999999999999999999999   999999999999999999999999998766


Q ss_pred             CCCCcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCccccc-ccchhhhhhhh-------c
Q 017594          202 GGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSL-NLLGYAWDLWT-------S  273 (369)
Q Consensus       202 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~-~~~~~~~~~~~-------~  273 (369)
                      .............|+..|+|||++.+..++.++|||||||++|+|++|+.||........ ...........       .
T Consensus       236 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~  315 (392)
T PHA03207        236 DAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQ  315 (392)
T ss_pred             CcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCC
Confidence            544333333345689999999999988999999999999999999999999865432210 00000000000       0


Q ss_pred             Cccc------cccCc------cccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 017594          274 NRTL------ELIDP------ILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSM  321 (369)
Q Consensus       274 ~~~~------~~~~~------~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~  321 (369)
                      ....      .....      ..........++.++.++|.+||+.||++||++.+++..
T Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~  375 (392)
T PHA03207        316 NGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL  375 (392)
T ss_pred             ccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence            0000      00000      000000011224578899999999999999999999974

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=5.3e-38  Score=284.47  Aligned_cols=258  Identities=29%  Similarity=0.435  Sum_probs=201.0

Q ss_pred             hcCCccCccccccCCccEEEEEEcC------CCEEEEEEecCCCch-hHHHHHHHHHHHhcCCCCceeeeeeeEEeCCcc
Q 017594           48 TNKFSDANKLGEGGFGPVYKGVLKK------GDEIAVKRLSGRSGQ-GLREMKNEASVIAKVQHKNLVRLLGCCIDRDEK  120 (369)
Q Consensus        48 ~~~y~i~~~lg~G~~~~v~~~~~~~------~~~valK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~  120 (369)
                      ..+|++.+.||.|+||.||+|...+      +..|++|++...... ....+..|+.++..++||||+++++++......
T Consensus         4 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~   83 (283)
T cd05091           4 LSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPL   83 (283)
T ss_pred             HHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCce
Confidence            3568899999999999999998532      467999998754332 235677899999999999999999999988999


Q ss_pred             EEEEEecCCCChhhhhcCC-------------CccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCC
Q 017594          121 ILIYEYMPNKSLDFFLFDP-------------TKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKD  187 (369)
Q Consensus       121 ~lv~e~~~~~~L~~~l~~~-------------~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~  187 (369)
                      +++++|+.+++|..++...             .....+++..+..++.|++.||.|||+.+   ++||||||.||+++.+
T Consensus        84 ~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~  160 (283)
T cd05091          84 SMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDK  160 (283)
T ss_pred             EEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCC
Confidence            9999999999998887421             11234778888999999999999999998   9999999999999999


Q ss_pred             CceEEeecCCceecCCCCcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHh-CCCCCCCCcccccccchh
Q 017594          188 MNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGY  266 (369)
Q Consensus       188 ~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~t-g~~p~~~~~~~~~~~~~~  266 (369)
                      +.++|+|||++................+++.|+|||.+.+..++.++|||||||++|+|++ |..||.......     .
T Consensus       161 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~-----~  235 (283)
T cd05091         161 LNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD-----V  235 (283)
T ss_pred             CceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHH-----H
Confidence            9999999999876543322222223345678999999988889999999999999999998 777875432110     0


Q ss_pred             hhhhhhcCccccccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHh
Q 017594          267 AWDLWTSNRTLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTN  324 (369)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L~~  324 (369)
                       ...........          .+..++..+.+++.+||+.+|.+||++++|++.|+.
T Consensus       236 -~~~i~~~~~~~----------~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~  282 (283)
T cd05091         236 -IEMIRNRQVLP----------CPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT  282 (283)
T ss_pred             -HHHHHcCCcCC----------CCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence             11111111100          011236678999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=4.8e-38  Score=289.28  Aligned_cols=240  Identities=26%  Similarity=0.359  Sum_probs=188.0

Q ss_pred             ccccccCCccEEEEEEcC-CCEEEEEEecCCC---chhHHHHHHHHHHHhcC-CCCceeeeeeeEEeCCccEEEEEecCC
Q 017594           55 NKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRS---GQGLREMKNEASVIAKV-QHKNLVRLLGCCIDRDEKILIYEYMPN  129 (369)
Q Consensus        55 ~~lg~G~~~~v~~~~~~~-~~~valK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~  129 (369)
                      +.||+|+||.||+|+++. |..||+|.+....   .........|..++..+ .||+|+++++++...+..++||||+.+
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            469999999999999764 8899999986431   22344556677777654 899999999999999999999999999


Q ss_pred             CChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCCCCcccc
Q 017594          130 KSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQAN  209 (369)
Q Consensus       130 ~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~~~~~~~  209 (369)
                      ++|..++...   ..+++..+..++.||+.||+|||++|   ++||||||+||+++.++.++|+|||++.......  ..
T Consensus        81 g~L~~~i~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~  152 (316)
T cd05620          81 GDLMFHIQDK---GRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD--NR  152 (316)
T ss_pred             CcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeecccCC--Cc
Confidence            9998887542   34788899999999999999999999   9999999999999999999999999876432111  11


Q ss_pred             cccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCccccccCcccccccc
Q 017594          210 TSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYS  289 (369)
Q Consensus       210 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  289 (369)
                      .....|+..|+|||++.+..++.++|||||||++|+|++|..||.......      ........      .+...    
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~------~~~~~~~~------~~~~~----  216 (316)
T cd05620         153 ASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDE------LFESIRVD------TPHYP----  216 (316)
T ss_pred             eeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH------HHHHHHhC------CCCCC----
Confidence            233468999999999999999999999999999999999999986432111      00110000      00011    


Q ss_pred             HHHHHHHHHHHHHHhhcCCCCCCCCHH-HHH
Q 017594          290 SKQMLLRYANIALLCVQESADDRPTMN-DVV  319 (369)
Q Consensus       290 ~~~~~~~l~~li~~~L~~dP~~Rps~~-ell  319 (369)
                       ...+.++.++|.+||+.||++||++. +++
T Consensus       217 -~~~~~~~~~li~~~l~~dP~~R~~~~~~~~  246 (316)
T cd05620         217 -RWITKESKDILEKLFERDPTRRLGVVGNIR  246 (316)
T ss_pred             -CCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence             11256789999999999999999985 565

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=6.2e-39  Score=308.57  Aligned_cols=261  Identities=30%  Similarity=0.446  Sum_probs=216.8

Q ss_pred             cCCccCccccccCCccEEEEEEc------CCCEEEEEEecCCCch-hHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccE
Q 017594           49 NKFSDANKLGEGGFGPVYKGVLK------KGDEIAVKRLSGRSGQ-GLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKI  121 (369)
Q Consensus        49 ~~y~i~~~lg~G~~~~v~~~~~~------~~~~valK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  121 (369)
                      ..-...+.||+|+||.||+|+..      +..-||||.++..... ...+|++|++++..++|||||++++++.+++..+
T Consensus       486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~  565 (774)
T KOG1026|consen  486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLC  565 (774)
T ss_pred             hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeE
Confidence            34456789999999999999933      2456999999876555 6788999999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhcCCCc-----------cccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCce
Q 017594          122 LIYEYMPNKSLDFFLFDPTK-----------RMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNP  190 (369)
Q Consensus       122 lv~e~~~~~~L~~~l~~~~~-----------~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~  190 (369)
                      +|+||+..|.|.+++.....           ..+++..+...|+.||+.|+.||-++.   ++||||-..|++|+++-.|
T Consensus       566 MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVge~l~V  642 (774)
T KOG1026|consen  566 MVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVGENLVV  642 (774)
T ss_pred             EEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceeccceEE
Confidence            99999999999999864221           233888899999999999999999999   9999999999999999999


Q ss_pred             EEeecCCceecCCCCcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHh-CCCCCCCCcccccccchhhhh
Q 017594          191 KISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWD  269 (369)
Q Consensus       191 ~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~  269 (369)
                      ||+|||+++.....+.........-..+|+|||-+..+.|+.++||||+|++|||+++ |.-||.....+      .+.+
T Consensus       643 KIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~------EVIe  716 (774)
T KOG1026|consen  643 KISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQ------EVIE  716 (774)
T ss_pred             EecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchH------HHHH
Confidence            9999999998776655554444445678999999999999999999999999999997 77787644422      2223


Q ss_pred             hhhcCccccccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHhhhhc
Q 017594          270 LWTSNRTLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNEAAT  328 (369)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L~~~~~~  328 (369)
                      ....+++....          ..++.++.+|+..||+.+|.+||+++||-..|+.....
T Consensus       717 ~i~~g~lL~~P----------e~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~  765 (774)
T KOG1026|consen  717 CIRAGQLLSCP----------ENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQA  765 (774)
T ss_pred             HHHcCCcccCC----------CCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhc
Confidence            33334443332          33478899999999999999999999999999887663

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=3.5e-38  Score=285.79  Aligned_cols=272  Identities=25%  Similarity=0.382  Sum_probs=200.8

Q ss_pred             hcCCccCccccccCCccEEEEEE-----cCCCEEEEEEecCCCchhHHHHHHHHHHHhcCCCCceeeeeeeEEeC--Ccc
Q 017594           48 TNKFSDANKLGEGGFGPVYKGVL-----KKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDR--DEK  120 (369)
Q Consensus        48 ~~~y~i~~~lg~G~~~~v~~~~~-----~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~  120 (369)
                      ..+|++.+.||+|+||.||.+..     .++..|++|.+..........+..|+++++.++|||++++.+++...  ...
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   82 (284)
T cd05081           3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL   82 (284)
T ss_pred             cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCce
Confidence            35799999999999999999974     24788999998876666667888999999999999999999887543  457


Q ss_pred             EEEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCcee
Q 017594          121 ILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARI  200 (369)
Q Consensus       121 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~  200 (369)
                      ++|+||+.+++|.+++...  ...+++..++.++.|++.||+|||..|   ++|+||||+||+++.++.++|+|||++..
T Consensus        83 ~lv~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~  157 (284)
T cd05081          83 RLVMEYLPYGSLRDYLQKH--RERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTKV  157 (284)
T ss_pred             EEEEEecCCCCHHHHHHhc--CcCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCccccc
Confidence            9999999999999988543  234788899999999999999999998   99999999999999999999999999886


Q ss_pred             cCCCCcccc-cccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhh-hhhcCcccc
Q 017594          201 CGGNELQAN-TSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWD-LWTSNRTLE  278 (369)
Q Consensus       201 ~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~  278 (369)
                      ......... .....+...|+|||...+..++.++|+||||+++|+|++|..++................ ........+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (284)
T cd05081         158 LPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIE  237 (284)
T ss_pred             ccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHH
Confidence            643221111 111123445999999988889999999999999999999877653221110000000000 000000000


Q ss_pred             ccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHhh
Q 017594          279 LIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNE  325 (369)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L~~~  325 (369)
                      .+.... .......++.++.+++.+||+.+|++|||+.+|++.|+.+
T Consensus       238 ~~~~~~-~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~  283 (284)
T cd05081         238 LLKNNG-RLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI  283 (284)
T ss_pred             HHhcCC-cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence            000000 0000112256799999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=1e-37  Score=284.60  Aligned_cols=265  Identities=27%  Similarity=0.416  Sum_probs=200.1

Q ss_pred             hcCCccCccccccCCccEEEEEEcC-----------------CCEEEEEEecCCC-chhHHHHHHHHHHHhcCCCCceee
Q 017594           48 TNKFSDANKLGEGGFGPVYKGVLKK-----------------GDEIAVKRLSGRS-GQGLREMKNEASVIAKVQHKNLVR  109 (369)
Q Consensus        48 ~~~y~i~~~lg~G~~~~v~~~~~~~-----------------~~~valK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~  109 (369)
                      .++|++.+.||.|+||.||++...+                 +..+++|.+.... ......+..|+..++.++|+|+++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~   83 (296)
T cd05095           4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR   83 (296)
T ss_pred             hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence            4679999999999999999986431                 3468999887543 233467889999999999999999


Q ss_pred             eeeeEEeCCccEEEEEecCCCChhhhhcCCCc--------cccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCC
Q 017594          110 LLGCCIDRDEKILIYEYMPNKSLDFFLFDPTK--------RMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASN  181 (369)
Q Consensus       110 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--------~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~N  181 (369)
                      +++++......++++||+.+++|..++.....        ...+++..++.++.||+.||+|||+.+   ++|+||||+|
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~N  160 (296)
T cd05095          84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRN  160 (296)
T ss_pred             EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhe
Confidence            99999999999999999999999988854321        123667789999999999999999999   9999999999


Q ss_pred             EEEeCCCceEEeecCCceecCCCCcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHh--CCCCCCCCccc
Q 017594          182 ILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS--GKKNTGLYRTD  259 (369)
Q Consensus       182 Ilv~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~t--g~~p~~~~~~~  259 (369)
                      |+++.++.++|+|||++..+..............+..|+|||...+..++.++|+|||||++|+|++  |..||......
T Consensus       161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~  240 (296)
T cd05095         161 CLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDE  240 (296)
T ss_pred             EEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChH
Confidence            9999999999999999876543322111222234567999999888889999999999999999998  66777543211


Q ss_pred             ccccchhhhhhhhcCccccccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHh
Q 017594          260 SLNLLGYAWDLWTSNRTLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTN  324 (369)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L~~  324 (369)
                      ..  ................ .+.      +..++..+.+++.+||+.||.+||++.+|++.|++
T Consensus       241 ~~--~~~~~~~~~~~~~~~~-~~~------~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  296 (296)
T cd05095         241 QV--IENTGEFFRDQGRQVY-LPK------PALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE  296 (296)
T ss_pred             HH--HHHHHHHHhhcccccc-CCC------CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence            10  0001111111000000 000      11124668999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=5.1e-38  Score=290.76  Aligned_cols=247  Identities=22%  Similarity=0.345  Sum_probs=192.4

Q ss_pred             ccccccCCccEEEEEEc-CCCEEEEEEecCC---CchhHHHHHHHHHHHhcC-CCCceeeeeeeEEeCCccEEEEEecCC
Q 017594           55 NKLGEGGFGPVYKGVLK-KGDEIAVKRLSGR---SGQGLREMKNEASVIAKV-QHKNLVRLLGCCIDRDEKILIYEYMPN  129 (369)
Q Consensus        55 ~~lg~G~~~~v~~~~~~-~~~~valK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~  129 (369)
                      +.||+|+||.||+|+++ +++.||+|++...   .......+..|..++..+ .||||+++++++...+..++||||+.+
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            46899999999999965 4889999998743   223345677899999888 699999999999999999999999999


Q ss_pred             CChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCCCCcccc
Q 017594          130 KSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQAN  209 (369)
Q Consensus       130 ~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~~~~~~~  209 (369)
                      ++|..++...   ..+++..+..++.||+.||.|||+++   ++||||||+||+++.++.++|+|||++.......  ..
T Consensus        81 g~L~~~~~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~--~~  152 (329)
T cd05588          81 GDLMFHMQRQ---RKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG--DT  152 (329)
T ss_pred             CCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCccccccccCC--Cc
Confidence            9998877433   34899999999999999999999999   9999999999999999999999999886422111  12


Q ss_pred             cccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccc---cccchhhhhhhhcCccccccCccccc
Q 017594          210 TSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDS---LNLLGYAWDLWTSNRTLELIDPILED  286 (369)
Q Consensus       210 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~  286 (369)
                      .....|+..|+|||++.+..++.++|+|||||++|+|++|..||.......   ................ .     +  
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~-~-----~--  224 (329)
T cd05588         153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQI-R-----I--  224 (329)
T ss_pred             cccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCC-C-----C--
Confidence            233568999999999999999999999999999999999999996432111   0001111111111110 0     1  


Q ss_pred             cccHHHHHHHHHHHHHHhhcCCCCCCCC------HHHHHH
Q 017594          287 EYSSKQMLLRYANIALLCVQESADDRPT------MNDVVS  320 (369)
Q Consensus       287 ~~~~~~~~~~l~~li~~~L~~dP~~Rps------~~ell~  320 (369)
                         +..++..+.++|.+||+.||.+|++      +.++++
T Consensus       225 ---p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~  261 (329)
T cd05588         225 ---PRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS  261 (329)
T ss_pred             ---CCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence               1112566899999999999999997      667764

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=3.8e-38  Score=290.93  Aligned_cols=237  Identities=25%  Similarity=0.311  Sum_probs=184.6

Q ss_pred             ccccccCCccEEEEEEc-CCCEEEEEEecCCC---chhHHHHHHHHH-HHhcCCCCceeeeeeeEEeCCccEEEEEecCC
Q 017594           55 NKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS---GQGLREMKNEAS-VIAKVQHKNLVRLLGCCIDRDEKILIYEYMPN  129 (369)
Q Consensus        55 ~~lg~G~~~~v~~~~~~-~~~~valK~~~~~~---~~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~  129 (369)
                      +.||+|+||.||+|+++ +|+.||+|++....   ......+..|.. +++.++||||+++++.+...+..++||||+.+
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence            46899999999999975 58999999986432   112233344444 56778999999999999999999999999999


Q ss_pred             CChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCCCCcccc
Q 017594          130 KSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQAN  209 (369)
Q Consensus       130 ~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~~~~~~~  209 (369)
                      ++|..++..   ...+++..+..++.||+.||.|||++|   ++||||||+||+++.++.++|+|||++.......  ..
T Consensus        81 g~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~--~~  152 (323)
T cd05575          81 GELFFHLQR---ERSFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS--KT  152 (323)
T ss_pred             CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCcccccCC--Cc
Confidence            999888854   334888999999999999999999999   9999999999999999999999999886432211  12


Q ss_pred             cccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCccccccCcccccccc
Q 017594          210 TSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYS  289 (369)
Q Consensus       210 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  289 (369)
                      .....|++.|+|||++.+..++.++|||||||++|+|++|..||.......     ...... ... ..     +.    
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~-----~~~~i~-~~~-~~-----~~----  216 (323)
T cd05575         153 TSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAE-----MYDNIL-NKP-LR-----LK----  216 (323)
T ss_pred             cccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHH-----HHHHHH-cCC-CC-----CC----
Confidence            233468999999999999899999999999999999999999986432110     000100 000 00     00    


Q ss_pred             HHHHHHHHHHHHHHhhcCCCCCCCCHH
Q 017594          290 SKQMLLRYANIALLCVQESADDRPTMN  316 (369)
Q Consensus       290 ~~~~~~~l~~li~~~L~~dP~~Rps~~  316 (369)
                       ...+..+.++|.+||+.||.+||++.
T Consensus       217 -~~~~~~~~~li~~~l~~~p~~R~~~~  242 (323)
T cd05575         217 -PNISVSARHLLEGLLQKDRTKRLGAK  242 (323)
T ss_pred             -CCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence             11256689999999999999999984

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=9.9e-38  Score=285.71  Aligned_cols=266  Identities=26%  Similarity=0.389  Sum_probs=207.9

Q ss_pred             HHHHhcCCccCccccccCCccEEEEEEc--------CCCEEEEEEecCCC-chhHHHHHHHHHHHhcC-CCCceeeeeee
Q 017594           44 VSTATNKFSDANKLGEGGFGPVYKGVLK--------KGDEIAVKRLSGRS-GQGLREMKNEASVIAKV-QHKNLVRLLGC  113 (369)
Q Consensus        44 ~~~~~~~y~i~~~lg~G~~~~v~~~~~~--------~~~~valK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~  113 (369)
                      ......+|++.+.||.|+||.||.|+..        ++..+++|.+.... ......+..|+..++.+ .||||++++++
T Consensus        10 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~   89 (304)
T cd05101          10 WEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGA   89 (304)
T ss_pred             ccccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEE
Confidence            3456788999999999999999999731        24478999886432 33456788999999999 79999999999


Q ss_pred             EEeCCccEEEEEecCCCChhhhhcCCCc-------------cccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCC
Q 017594          114 CIDRDEKILIYEYMPNKSLDFFLFDPTK-------------RMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKAS  180 (369)
Q Consensus       114 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~-------------~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~  180 (369)
                      +......+++|||+.+++|.+++.....             ...++...+..++.||+.||.|||++|   ++|+||||+
T Consensus        90 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~  166 (304)
T cd05101          90 CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAAR  166 (304)
T ss_pred             EecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccc
Confidence            9999999999999999999988864321             234677888999999999999999998   999999999


Q ss_pred             CEEEeCCCceEEeecCCceecCCCCcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHh-CCCCCCCCccc
Q 017594          181 NILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTD  259 (369)
Q Consensus       181 NIlv~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~t-g~~p~~~~~~~  259 (369)
                      ||+++.++.++|+|||.+................++..|+|||++.+..++.++||||||+++|+|++ |..||......
T Consensus       167 Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~  246 (304)
T cd05101         167 NVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE  246 (304)
T ss_pred             eEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH
Confidence            99999999999999999887654332222222344567999999988889999999999999999998 77777533211


Q ss_pred             ccccchhhhhhhhcCccccccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHhhhhc
Q 017594          260 SLNLLGYAWDLWTSNRTLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNEAAT  328 (369)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L~~~~~~  328 (369)
                      .      ............          .+..++..+.+++.+||+.+|.+||++.++++.|+++...
T Consensus       247 ~------~~~~~~~~~~~~----------~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~  299 (304)
T cd05101         247 E------LFKLLKEGHRMD----------KPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTL  299 (304)
T ss_pred             H------HHHHHHcCCcCC----------CCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHh
Confidence            1      111111111000          0112256799999999999999999999999999988764

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=1.6e-37  Score=288.05  Aligned_cols=267  Identities=26%  Similarity=0.389  Sum_probs=206.2

Q ss_pred             HHHHhcCCccCccccccCCccEEEEEEcC--------CCEEEEEEecCCC-chhHHHHHHHHHHHhcC-CCCceeeeeee
Q 017594           44 VSTATNKFSDANKLGEGGFGPVYKGVLKK--------GDEIAVKRLSGRS-GQGLREMKNEASVIAKV-QHKNLVRLLGC  113 (369)
Q Consensus        44 ~~~~~~~y~i~~~lg~G~~~~v~~~~~~~--------~~~valK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~  113 (369)
                      .+....+|++.+.||+|+||.||+|++..        +..|++|.+.... ......+..|+.+++++ .|+||++++++
T Consensus         7 ~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~   86 (334)
T cd05100           7 WELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGA   86 (334)
T ss_pred             cccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEE
Confidence            34455789999999999999999998421        2368999887432 33456788899999999 79999999999


Q ss_pred             EEeCCccEEEEEecCCCChhhhhcCCC-------------ccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCC
Q 017594          114 CIDRDEKILIYEYMPNKSLDFFLFDPT-------------KRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKAS  180 (369)
Q Consensus       114 ~~~~~~~~lv~e~~~~~~L~~~l~~~~-------------~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~  180 (369)
                      +......++++||+.+++|.+++....             ....++...+..++.|++.||+|||.++   ++|+||+|+
T Consensus        87 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~  163 (334)
T cd05100          87 CTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAAR  163 (334)
T ss_pred             EccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccc
Confidence            998889999999999999999885422             1234677788899999999999999998   999999999


Q ss_pred             CEEEeCCCceEEeecCCceecCCCCcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHh-CCCCCCCCccc
Q 017594          181 NILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTD  259 (369)
Q Consensus       181 NIlv~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~t-g~~p~~~~~~~  259 (369)
                      ||+++.++.++|+|||++................++..|+|||++.+..++.++||||||+++|+|++ |..||......
T Consensus       164 Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~  243 (334)
T cd05100         164 NVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE  243 (334)
T ss_pred             eEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHH
Confidence            99999999999999999876543322111222233467999999999899999999999999999998 78887533211


Q ss_pred             ccccchhhhhhhhcCccccccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHhhhhcc
Q 017594          260 SLNLLGYAWDLWTSNRTLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNEAATL  329 (369)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L~~~~~~~  329 (369)
                      .      .............          +..++..+.+++.+||+.+|++||++.++++.|+.+....
T Consensus       244 ~------~~~~~~~~~~~~~----------~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~  297 (334)
T cd05100         244 E------LFKLLKEGHRMDK----------PANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVT  297 (334)
T ss_pred             H------HHHHHHcCCCCCC----------CCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhc
Confidence            1      1111111110000          1112556899999999999999999999999999888644

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=1.5e-37  Score=278.09  Aligned_cols=256  Identities=31%  Similarity=0.462  Sum_probs=203.3

Q ss_pred             HHhcCCccCccccccCCccEEEEEEcCCCEEEEEEecCCCchhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEEEE
Q 017594           46 TATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIYE  125 (369)
Q Consensus        46 ~~~~~y~i~~~lg~G~~~~v~~~~~~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  125 (369)
                      ...++|+++++||+|+||.||+|..++++.|++|.+..... ....+..|+.+++.++|+|++++++++. .+..++++|
T Consensus         3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e   80 (260)
T cd05067           3 VPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITE   80 (260)
T ss_pred             cchHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEE
Confidence            34678999999999999999999988889999999875443 3467888999999999999999998864 567899999


Q ss_pred             ecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCCCC
Q 017594          126 YMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE  205 (369)
Q Consensus       126 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~~~  205 (369)
                      ++.+++|.+++.... ...++...+..++.|++.||+|||+.+   ++|+||+|+||+++.++.++|+|||.+.......
T Consensus        81 ~~~~~~L~~~~~~~~-~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~  156 (260)
T cd05067          81 YMENGSLVDFLKTPE-GIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIEDNE  156 (260)
T ss_pred             cCCCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecCCCC
Confidence            999999988875433 345788899999999999999999998   9999999999999999999999999987654222


Q ss_pred             cccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHh-CCCCCCCCcccccccchhhhhhhhcCccccccCccc
Q 017594          206 LQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPIL  284 (369)
Q Consensus       206 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (369)
                      .. ......++..|+|||.+.+..++.++|+||||+++|+|++ |..||.......     ..... .......     .
T Consensus       157 ~~-~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-----~~~~~-~~~~~~~-----~  224 (260)
T cd05067         157 YT-AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPE-----VIQNL-ERGYRMP-----R  224 (260)
T ss_pred             cc-cccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHH-----HHHHH-HcCCCCC-----C
Confidence            11 1112234668999999988889999999999999999998 999986332110     00000 0000000     0


Q ss_pred             cccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHh
Q 017594          285 EDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTN  324 (369)
Q Consensus       285 ~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L~~  324 (369)
                           +...+.++.+++.+||+.+|++||+++++++.|+.
T Consensus       225 -----~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  259 (260)
T cd05067         225 -----PDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED  259 (260)
T ss_pred             -----CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence                 01125679999999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=7.3e-38  Score=280.48  Aligned_cols=255  Identities=28%  Similarity=0.420  Sum_probs=201.2

Q ss_pred             hcCCccCccccccCCccEEEEEEcCCCEEEEEEecCCCchhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEEEEec
Q 017594           48 TNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIYEYM  127 (369)
Q Consensus        48 ~~~y~i~~~lg~G~~~~v~~~~~~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~  127 (369)
                      .++|++.+.||.|++|.||+|+++++..|++|.+..... ..+.+..|+..++.++|+|++++++.+. ....+++|||+
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~   82 (262)
T cd05071           5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYM   82 (262)
T ss_pred             hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcC
Confidence            467999999999999999999987777899999875332 3457888999999999999999998874 46689999999


Q ss_pred             CCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCCCCcc
Q 017594          128 PNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQ  207 (369)
Q Consensus       128 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~~~~~  207 (369)
                      .+++|.+++.... ...+++..+..++.|++.||++||+.+   ++|+||+|.||+++.++.++|+|||.+.........
T Consensus        83 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~  158 (262)
T cd05071          83 SKGSLLDFLKGEM-GKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT  158 (262)
T ss_pred             CCCcHHHHHhhcc-ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeeccccccc
Confidence            9999999986432 234688899999999999999999998   999999999999999999999999998766433221


Q ss_pred             cccccccccccccCchhhccCCCCcccchHhHHHHHHHHHh-CCCCCCCCcccccccchhhhhhhhcCccccccCccccc
Q 017594          208 ANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILED  286 (369)
Q Consensus       208 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  286 (369)
                       ......++..|+|||...+..++.++|+||||+++|+|++ |..||.......     ..... ....     ..    
T Consensus       159 -~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~-----~~~~~-~~~~-----~~----  222 (262)
T cd05071         159 -ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE-----VLDQV-ERGY-----RM----  222 (262)
T ss_pred             -cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHH-----HHHHH-hcCC-----CC----
Confidence             1122335567999999988889999999999999999999 787875332110     00000 0000     00    


Q ss_pred             cccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHhh
Q 017594          287 EYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNE  325 (369)
Q Consensus       287 ~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L~~~  325 (369)
                       ......+..+.+++.+||+.+|++||++.++++.|+..
T Consensus       223 -~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~  260 (262)
T cd05071         223 -PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY  260 (262)
T ss_pred             -CCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence             00122366789999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=2.5e-38  Score=297.23  Aligned_cols=255  Identities=22%  Similarity=0.268  Sum_probs=199.7

Q ss_pred             HHhcCCccCccccccCCccEEEEEEc-CCCEEEEEEecCC---CchhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccE
Q 017594           46 TATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGR---SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKI  121 (369)
Q Consensus        46 ~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  121 (369)
                      ...++|++.+.||.|+||.||+|+.+ ++..||+|++...   .......+..|+.+++.++||||+++++++.+++..+
T Consensus        40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~  119 (370)
T cd05596          40 MKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLY  119 (370)
T ss_pred             CCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence            44578999999999999999999965 4889999998632   1223345678999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceec
Q 017594          122 LIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARIC  201 (369)
Q Consensus       122 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~  201 (369)
                      +||||+.+++|..++..    ..+++..+..++.||+.||+|||+++   ++||||||+||+++.++.++|+|||++...
T Consensus       120 lv~Ey~~gg~L~~~l~~----~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~~~~  192 (370)
T cd05596         120 MVMEYMPGGDLVNLMSN----YDIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKM  192 (370)
T ss_pred             EEEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccceeec
Confidence            99999999999988843    23788888999999999999999999   999999999999999999999999998765


Q ss_pred             CCCCcccccccccccccccCchhhccC----CCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCccc
Q 017594          202 GGNELQANTSRIVGTYGYMSPEYALEG----IFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTL  277 (369)
Q Consensus       202 ~~~~~~~~~~~~~~~~~y~aPE~~~~~----~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  277 (369)
                      ..... .......|++.|+|||++.+.    .++.++|+|||||++|+|++|..||.......     ............
T Consensus       193 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~-----~~~~i~~~~~~~  266 (370)
T cd05596         193 DANGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG-----TYSKIMDHKNSL  266 (370)
T ss_pred             cCCCc-ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHH-----HHHHHHcCCCcC
Confidence            43221 112234689999999998643    47899999999999999999999986433111     001111110000


Q ss_pred             cccCccccccccHHHHHHHHHHHHHHhhcCCCCC--CCCHHHHHHH
Q 017594          278 ELIDPILEDEYSSKQMLLRYANIALLCVQESADD--RPTMNDVVSM  321 (369)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~--Rps~~ell~~  321 (369)
                      ..     ..   ...++.++.++|.+||+.+|.+  |+++.++++.
T Consensus       267 ~~-----~~---~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h  304 (370)
T cd05596         267 TF-----PD---DIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH  304 (370)
T ss_pred             CC-----CC---cCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence            00     00   0112667899999999999988  9999999864

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-38  Score=292.05  Aligned_cols=255  Identities=24%  Similarity=0.313  Sum_probs=211.9

Q ss_pred             HHHHhcCCccCccccccCCccEEEEEEcC-CCEEEEEEecCCCc---hhHHHHHHHHHHHhcCC-CCceeeeeeeEEeCC
Q 017594           44 VSTATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSG---QGLREMKNEASVIAKVQ-HKNLVRLLGCCIDRD  118 (369)
Q Consensus        44 ~~~~~~~y~i~~~lg~G~~~~v~~~~~~~-~~~valK~~~~~~~---~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~  118 (369)
                      .......|++.+.||+|.||.||.++.+. |+.+|+|.+.....   .....+.+|+.+|+++. ||||+.+.+.|+...
T Consensus        30 ~~~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~  109 (382)
T KOG0032|consen   30 SEDIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPD  109 (382)
T ss_pred             cccccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCC
Confidence            35566789999999999999999999776 99999999976543   24568999999999998 999999999999999


Q ss_pred             ccEEEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCC----CceEEee
Q 017594          119 EKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKD----MNPKISD  194 (369)
Q Consensus       119 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~----~~~~L~D  194 (369)
                      ..++|||++.||.|.+.+...    .+++..+..++.|++.++.|||+.|   ++|+||||+|+++...    +.++++|
T Consensus       110 ~~~lvmEL~~GGeLfd~i~~~----~~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~D  182 (382)
T KOG0032|consen  110 SVYLVMELCEGGELFDRIVKK----HYSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLID  182 (382)
T ss_pred             eEEEEEEecCCchHHHHHHHc----cCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEee
Confidence            999999999999998888654    2999999999999999999999999   9999999999999533    4799999


Q ss_pred             cCCceecCCCCcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcC
Q 017594          195 FGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSN  274 (369)
Q Consensus       195 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~  274 (369)
                      ||++.....   .......+|++.|+|||++....|+..+|+||+|+++|.|++|.+||..........     .. ...
T Consensus       183 FGla~~~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~-----~i-~~~  253 (382)
T KOG0032|consen  183 FGLAKFIKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL-----AI-LRG  253 (382)
T ss_pred             CCCceEccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH-----HH-HcC
Confidence            999988764   345566799999999999999999999999999999999999999997554222111     00 000


Q ss_pred             ccccccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 017594          275 RTLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSM  321 (369)
Q Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~  321 (369)
                      +.     ....+  ....++..+.++|+.||..||.+|+|+.++|+.
T Consensus       254 ~~-----~f~~~--~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H  293 (382)
T KOG0032|consen  254 DF-----DFTSE--PWDDISESAKDFIRKLLEFDPRKRLTAAQALQH  293 (382)
T ss_pred             CC-----CCCCC--CccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence            00     00111  122237789999999999999999999999993

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=1.6e-37  Score=279.47  Aligned_cols=256  Identities=26%  Similarity=0.428  Sum_probs=196.4

Q ss_pred             CccCccccccCCccEEEEEEcC-CC--EEEEEEecCC--CchhHHHHHHHHHHHhcCCCCceeeeeeeEEeC------Cc
Q 017594           51 FSDANKLGEGGFGPVYKGVLKK-GD--EIAVKRLSGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDR------DE  119 (369)
Q Consensus        51 y~i~~~lg~G~~~~v~~~~~~~-~~--~valK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~~  119 (369)
                      |.+.+.||.|+||.||+|++.. +.  .+++|.+...  .....+.+..|+..++.++|+||+++++++...      ..
T Consensus         1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   80 (272)
T cd05075           1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS   80 (272)
T ss_pred             CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence            4578899999999999999765 33  5899987643  234456788899999999999999999876532      24


Q ss_pred             cEEEEEecCCCChhhhhcCC---CccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecC
Q 017594          120 KILIYEYMPNKSLDFFLFDP---TKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFG  196 (369)
Q Consensus       120 ~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg  196 (369)
                      .++++||+.+++|..++...   .....+++..+..++.||+.||.|||+.+   ++|+||||+||+++.++.++|+|||
T Consensus        81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg  157 (272)
T cd05075          81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFG  157 (272)
T ss_pred             cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCC
Confidence            68999999999998776321   12344788999999999999999999998   9999999999999999999999999


Q ss_pred             CceecCCCCcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHh-CCCCCCCCcccccccchhhhhhhhcCc
Q 017594          197 MARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDLWTSNR  275 (369)
Q Consensus       197 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~  275 (369)
                      ++................++..|+|||...+..++.++|+||||+++|+|++ |..||......      ..........
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~------~~~~~~~~~~  231 (272)
T cd05075         158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENS------EIYDYLRQGN  231 (272)
T ss_pred             cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHH------HHHHHHHcCC
Confidence            9886643322112222345678999999998889999999999999999999 78888642211      0111111111


Q ss_pred             cccccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHhh
Q 017594          276 TLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNE  325 (369)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L~~~  325 (369)
                      ....          ...++..+.++|.+||+.+|++|||+.+|++.|+++
T Consensus       232 ~~~~----------~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~  271 (272)
T cd05075         232 RLKQ----------PPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA  271 (272)
T ss_pred             CCCC----------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            1000          011256689999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=6.1e-38  Score=286.17  Aligned_cols=255  Identities=25%  Similarity=0.392  Sum_probs=205.5

Q ss_pred             hHHHHhcCCccCccccccCCccEEEEEEc-CCCEEEEEEecCCCchhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccE
Q 017594           43 SVSTATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKI  121 (369)
Q Consensus        43 ~~~~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  121 (369)
                      .+.....+|++++.||.|++|.||+|... +++.|++|.+........+.+..|+.+++.++|+|++++++++......+
T Consensus        13 ~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~   92 (297)
T cd06656          13 SVGDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELW   92 (297)
T ss_pred             ccCChhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEE
Confidence            34556689999999999999999999964 58999999997655555567888999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceec
Q 017594          122 LIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARIC  201 (369)
Q Consensus       122 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~  201 (369)
                      +|+||+++++|.+++..    ..+++..+..++.|++.+|.+||+.+   ++|+||+|+||+++.++.++|+|||.+...
T Consensus        93 lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~  165 (297)
T cd06656          93 VVMEYLAGGSLTDVVTE----TCMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQI  165 (297)
T ss_pred             EeecccCCCCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEc
Confidence            99999999999988843    34788899999999999999999998   999999999999999999999999988765


Q ss_pred             CCCCcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCccccccC
Q 017594          202 GGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELID  281 (369)
Q Consensus       202 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (369)
                      ....  .......+++.|+|||...+..++.++|+||+|+++|+|++|..||...........     .....      .
T Consensus       166 ~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~-----~~~~~------~  232 (297)
T cd06656         166 TPEQ--SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL-----IATNG------T  232 (297)
T ss_pred             cCCc--cCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheee-----eccCC------C
Confidence            3322  112234578889999999988899999999999999999999999864321110000     00000      0


Q ss_pred             ccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 017594          282 PILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVS  320 (369)
Q Consensus       282 ~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~  320 (369)
                      +.   ...+...+..+.+++.+||+.+|++||++.++++
T Consensus       233 ~~---~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  268 (297)
T cd06656         233 PE---LQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ  268 (297)
T ss_pred             CC---CCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            00   0011223566899999999999999999999998

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=7.6e-38  Score=293.12  Aligned_cols=264  Identities=24%  Similarity=0.280  Sum_probs=194.8

Q ss_pred             HHhcCCccCccccccCCccEEEEEEc-CCCEEEEEEecCC--CchhHHHHHHHHHHHhcCCCCceeeeeeeEEeCC----
Q 017594           46 TATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDRD----  118 (369)
Q Consensus        46 ~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----  118 (369)
                      ...++|++.+.||+|+||.||+|++. +|..||+|++...  .......+.+|+.+++.++||||+++++++....    
T Consensus        18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~   97 (359)
T cd07876          18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEE   97 (359)
T ss_pred             hhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccc
Confidence            45789999999999999999999965 4889999998643  2334566778999999999999999999986443    


Q ss_pred             --ccEEEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecC
Q 017594          119 --EKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFG  196 (369)
Q Consensus       119 --~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg  196 (369)
                        ..++||||+.++ +...+.     ..++...+..++.||+.||.|||+.|   ++||||||+||+++.++.++|+|||
T Consensus        98 ~~~~~lv~e~~~~~-l~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Dfg  168 (359)
T cd07876          98 FQDVYLVMELMDAN-LCQVIH-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG  168 (359)
T ss_pred             cceeEEEEeCCCcC-HHHHHh-----ccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecCC
Confidence              469999999765 434432     12678889999999999999999999   9999999999999999999999999


Q ss_pred             CceecCCCCcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCccccccc----------chh
Q 017594          197 MARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNL----------LGY  266 (369)
Q Consensus       197 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~----------~~~  266 (369)
                      ++.......   ......++..|+|||++.+..++.++|||||||++|+|++|..||..........          ..+
T Consensus       169 ~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~  245 (359)
T cd07876         169 LARTACTNF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEF  245 (359)
T ss_pred             CccccccCc---cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHH
Confidence            987543221   1223467889999999999999999999999999999999999997543111000          000


Q ss_pred             -------hhhhhhcCc------cccccCccc-cc-cccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 017594          267 -------AWDLWTSNR------TLELIDPIL-ED-EYSSKQMLLRYANIALLCVQESADDRPTMNDVVSM  321 (369)
Q Consensus       267 -------~~~~~~~~~------~~~~~~~~~-~~-~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~  321 (369)
                             .........      ..+...... .. .......+..+.+||.+||+.||++|||+.|+++.
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  315 (359)
T cd07876         246 MNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH  315 (359)
T ss_pred             HHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence                   000000000      000000000 00 00011124568999999999999999999999974

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-37  Score=278.63  Aligned_cols=252  Identities=26%  Similarity=0.385  Sum_probs=199.6

Q ss_pred             cCCccCccccccCCccEEEEEEc-CCCEEEEEEecCCCc-----hhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEE
Q 017594           49 NKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSG-----QGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKIL  122 (369)
Q Consensus        49 ~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l  122 (369)
                      +.|.+.+.||.|++|.||.|... +++.|++|.+.....     .....+.+|+.+++.++||||+++++++......++
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   81 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI   81 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence            46999999999999999999965 489999998864321     123567889999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecC
Q 017594          123 IYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICG  202 (369)
Q Consensus       123 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~  202 (369)
                      ++|++.+++|.+++...   ..+++..+..++.|++.||.+||..+   ++|+||+|+||+++.++.++|+|||.+....
T Consensus        82 v~e~~~~~~l~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~  155 (263)
T cd06625          82 FMEYMPGGSVKDQLKAY---GALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQ  155 (263)
T ss_pred             EEEECCCCcHHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecc
Confidence            99999999998888542   34788899999999999999999999   9999999999999999999999999987654


Q ss_pred             CCCcccc-cccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCccccccC
Q 017594          203 GNELQAN-TSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELID  281 (369)
Q Consensus       203 ~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (369)
                      ....... .....++..|+|||.+.+..++.++||||||+++|+|++|+.||.......     ...........     
T Consensus       156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-----~~~~~~~~~~~-----  225 (263)
T cd06625         156 TICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMA-----AIFKIATQPTN-----  225 (263)
T ss_pred             ccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHH-----HHHHHhccCCC-----
Confidence            3221111 122356788999999998889999999999999999999999986432110     01111111100     


Q ss_pred             ccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 017594          282 PILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSM  321 (369)
Q Consensus       282 ~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~  321 (369)
                      ..+     +..++..+.++|.+||..+|.+||++.++++.
T Consensus       226 ~~~-----~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  260 (263)
T cd06625         226 PQL-----PSHVSPDARNFLRRTFVENAKKRPSAEELLRH  260 (263)
T ss_pred             CCC-----CccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence            001     11225678999999999999999999999874

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.1e-37  Score=278.70  Aligned_cols=256  Identities=26%  Similarity=0.416  Sum_probs=198.5

Q ss_pred             CccCccccccCCccEEEEEEcC----CCEEEEEEecCCC--chhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCc-----
Q 017594           51 FSDANKLGEGGFGPVYKGVLKK----GDEIAVKRLSGRS--GQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDE-----  119 (369)
Q Consensus        51 y~i~~~lg~G~~~~v~~~~~~~----~~~valK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-----  119 (369)
                      |++.+.||+|+||.||.|....    +..||+|++....  ......+..|+..++.++|+|++++++++.....     
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   80 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP   80 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence            6789999999999999998542    3679999987432  2334678889999999999999999998866544     


Q ss_pred             -cEEEEEecCCCChhhhhcCCC---ccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeec
Q 017594          120 -KILIYEYMPNKSLDFFLFDPT---KRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDF  195 (369)
Q Consensus       120 -~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Df  195 (369)
                       .++++||+.+++|..++....   ....+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+||
T Consensus        81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~df  157 (273)
T cd05035          81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADF  157 (273)
T ss_pred             ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECCc
Confidence             799999999999988874321   2345888899999999999999999998   999999999999999999999999


Q ss_pred             CCceecCCCCcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHh-CCCCCCCCcccccccchhhhhhhhcC
Q 017594          196 GMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDLWTSN  274 (369)
Q Consensus       196 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~  274 (369)
                      |++.................+..|+|||.+.+..++.++|||||||++|+|++ |..||.......     .. ......
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~-----~~-~~~~~~  231 (273)
T cd05035         158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHE-----IY-DYLRHG  231 (273)
T ss_pred             cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHH-----HH-HHHHcC
Confidence            99886643322211222234567999999988889999999999999999999 888875332111     00 011111


Q ss_pred             ccccccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHhh
Q 017594          275 RTLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNE  325 (369)
Q Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L~~~  325 (369)
                      .....          +..++..+.+++.+||+.||.+||++.++++.|+++
T Consensus       232 ~~~~~----------~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~  272 (273)
T cd05035         232 NRLKQ----------PEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI  272 (273)
T ss_pred             CCCCC----------CcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            11000          112256799999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=2.2e-38  Score=303.62  Aligned_cols=261  Identities=18%  Similarity=0.252  Sum_probs=189.1

Q ss_pred             HhcCCccCccccccCCccEEEEEEc-CCCEEEEEEecCCCchhHHHHHHHHHHHhcCCCCceeeeeeeEEeC--------
Q 017594           47 ATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDR--------  117 (369)
Q Consensus        47 ~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--------  117 (369)
                      ...+|++.+.||+|+||.||+|... +++.||+|++....    ....+|+.+++.++||||+++.+++...        
T Consensus        64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~  139 (440)
T PTZ00036         64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN  139 (440)
T ss_pred             cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence            4568999999999999999999975 48899999886432    2345799999999999999998876432        


Q ss_pred             CccEEEEEecCCCChhhhhcC-CCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCC-ceEEeec
Q 017594          118 DEKILIYEYMPNKSLDFFLFD-PTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDM-NPKISDF  195 (369)
Q Consensus       118 ~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~-~~~L~Df  195 (369)
                      ..+++||||+.+ ++..++.. ......+++..++.++.||+.||.|||+.+   ++||||||+||+++.++ .++|+||
T Consensus       140 ~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~DF  215 (440)
T PTZ00036        140 IFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDF  215 (440)
T ss_pred             eEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeeecc
Confidence            135789999976 45444432 223445889999999999999999999999   99999999999998665 6999999


Q ss_pred             CCceecCCCCcccccccccccccccCchhhcc-CCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhc-
Q 017594          196 GMARICGGNELQANTSRIVGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTS-  273 (369)
Q Consensus       196 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~-  273 (369)
                      |++..+.....   .....+++.|+|||++.+ ..++.++|||||||++|+|++|.+||.........  ......... 
T Consensus       216 Gla~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~--~~i~~~~~~p  290 (440)
T PTZ00036        216 GSAKNLLAGQR---SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQL--VRIIQVLGTP  290 (440)
T ss_pred             ccchhccCCCC---cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHH--HHHHHHhCCC
Confidence            99976543221   122457889999998865 46899999999999999999999999654311100  000000000 


Q ss_pred             ---------CccccccCcccc-c---cccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 017594          274 ---------NRTLELIDPILE-D---EYSSKQMLLRYANIALLCVQESADDRPTMNDVVS  320 (369)
Q Consensus       274 ---------~~~~~~~~~~~~-~---~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~  320 (369)
                               ........+... .   ...+...+.++.+||.+||+.||.+|||+.++++
T Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~  350 (440)
T PTZ00036        291 TEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALA  350 (440)
T ss_pred             CHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhC
Confidence                     000000000000 0   0001122567999999999999999999999994

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=1.5e-37  Score=281.03  Aligned_cols=250  Identities=23%  Similarity=0.370  Sum_probs=196.9

Q ss_pred             cCCccCccccccCCccEEEEEEc-CCCEEEEEEecCCC-chhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEEEEe
Q 017594           49 NKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIYEY  126 (369)
Q Consensus        49 ~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  126 (369)
                      ++|++.+.||+|++|.||+|++. +++.|++|.+.... ......+..|+.++.++.|||++++++.+...+..++++||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   80 (279)
T cd06619           1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF   80 (279)
T ss_pred             CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence            46889999999999999999964 58899999986442 23345688899999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCCCCc
Q 017594          127 MPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNEL  206 (369)
Q Consensus       127 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~~~~  206 (369)
                      +.++++..+.       .+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++......  
T Consensus        81 ~~~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~--  148 (279)
T cd06619          81 MDGGSLDVYR-------KIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS--  148 (279)
T ss_pred             CCCCChHHhh-------cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceecccc--
Confidence            9999986542       2677888999999999999999999   999999999999999999999999998765422  


Q ss_pred             ccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhh-hhhhhcCccccccCcccc
Q 017594          207 QANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYA-WDLWTSNRTLELIDPILE  285 (369)
Q Consensus       207 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~  285 (369)
                        ......++..|+|||.+.+..++.++|+||||+++|+|++|..||.............. ........     .+.+ 
T Consensus       149 --~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-----~~~~-  220 (279)
T cd06619         149 --IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDED-----PPVL-  220 (279)
T ss_pred             --cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccC-----CCCC-
Confidence              12334678899999999988899999999999999999999999865331111100000 00000000     0000 


Q ss_pred             ccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 017594          286 DEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSM  321 (369)
Q Consensus       286 ~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~  321 (369)
                         .....+.++.+++.+||+.+|.+||+++++++.
T Consensus       221 ---~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~  253 (279)
T cd06619         221 ---PVGQFSEKFVHFITQCMRKQPKERPAPENLMDH  253 (279)
T ss_pred             ---CCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence               011125568999999999999999999999874

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=1.6e-37  Score=287.47  Aligned_cols=248  Identities=23%  Similarity=0.351  Sum_probs=191.6

Q ss_pred             ccccccCCccEEEEEEcC-CCEEEEEEecCC---CchhHHHHHHHHHHHhcC-CCCceeeeeeeEEeCCccEEEEEecCC
Q 017594           55 NKLGEGGFGPVYKGVLKK-GDEIAVKRLSGR---SGQGLREMKNEASVIAKV-QHKNLVRLLGCCIDRDEKILIYEYMPN  129 (369)
Q Consensus        55 ~~lg~G~~~~v~~~~~~~-~~~valK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~  129 (369)
                      +.||+|+||.||+|+.+. ++.||+|++...   .......+..|..++.++ +||||+++++++...+..++||||+.+
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            479999999999999654 789999998743   223345677788888776 799999999999999999999999999


Q ss_pred             CChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCCCCcccc
Q 017594          130 KSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQAN  209 (369)
Q Consensus       130 ~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~~~~~~~  209 (369)
                      ++|..++...   ..+++..+..++.||+.||.|||+.+   ++||||||+||+++.++.++|+|||++.......  ..
T Consensus        81 ~~L~~~~~~~---~~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~--~~  152 (329)
T cd05618          81 GDLMFHMQRQ---RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG--DT  152 (329)
T ss_pred             CCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccccCCC--Cc
Confidence            9998877433   34889999999999999999999999   9999999999999999999999999986432211  11


Q ss_pred             cccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccc---cccchhhhhhhhcCccccccCccccc
Q 017594          210 TSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDS---LNLLGYAWDLWTSNRTLELIDPILED  286 (369)
Q Consensus       210 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~  286 (369)
                      .....|+..|+|||++.+..++.++|+|||||++|+|++|..||.......   .....+..........      .+  
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~------~~--  224 (329)
T cd05618         153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI------RI--  224 (329)
T ss_pred             cccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCC------CC--
Confidence            233468999999999999999999999999999999999999996422111   1111111111111110      01  


Q ss_pred             cccHHHHHHHHHHHHHHhhcCCCCCCCCH------HHHHHH
Q 017594          287 EYSSKQMLLRYANIALLCVQESADDRPTM------NDVVSM  321 (369)
Q Consensus       287 ~~~~~~~~~~l~~li~~~L~~dP~~Rps~------~ell~~  321 (369)
                         +...+..+.++|.+||+.||.+||++      .++++.
T Consensus       225 ---p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~h  262 (329)
T cd05618         225 ---PRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH  262 (329)
T ss_pred             ---CCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcC
Confidence               11125668999999999999999984      566543

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=5.6e-38  Score=285.69  Aligned_cols=252  Identities=25%  Similarity=0.402  Sum_probs=200.5

Q ss_pred             hcCCccCccccccCCccEEEEEEcC-CCEEEEEEecCCCchhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEEEEe
Q 017594           48 TNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIYEY  126 (369)
Q Consensus        48 ~~~y~i~~~lg~G~~~~v~~~~~~~-~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  126 (369)
                      .+.|++++.||.|++|.||+|+... +..+++|.+..........+..|+.+++.++|+|++++++.+..+...++||||
T Consensus        11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   90 (292)
T cd06644          11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEF   90 (292)
T ss_pred             chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEec
Confidence            4679999999999999999999765 889999999877666677788899999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCCCCc
Q 017594          127 MPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNEL  206 (369)
Q Consensus       127 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~~~~  206 (369)
                      +.++++..++....  ..+++..+..++.|++.++.+||..+   ++|+||+|+||+++.++.++|+|||++....... 
T Consensus        91 ~~~~~l~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~-  164 (292)
T cd06644          91 CPGGAVDAIMLELD--RGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL-  164 (292)
T ss_pred             CCCCcHHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceeccccc-
Confidence            99999987764422  34788999999999999999999998   9999999999999999999999999876543221 


Q ss_pred             ccccccccccccccCchhhc-----cCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCccccccC
Q 017594          207 QANTSRIVGTYGYMSPEYAL-----EGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELID  281 (369)
Q Consensus       207 ~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (369)
                       .......++..|+|||.+.     ...++.++|+|||||++|+|++|..||.......     .........      .
T Consensus       165 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~-----~~~~~~~~~------~  232 (292)
T cd06644         165 -QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR-----VLLKIAKSE------P  232 (292)
T ss_pred             -cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHH-----HHHHHhcCC------C
Confidence             1122345778899999874     3457889999999999999999999986432110     000000000      0


Q ss_pred             ccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 017594          282 PILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVS  320 (369)
Q Consensus       282 ~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~  320 (369)
                      +..   ..+..++.++.++|.+||+.+|++||++.++++
T Consensus       233 ~~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  268 (292)
T cd06644         233 PTL---SQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE  268 (292)
T ss_pred             ccC---CCCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            000   011122566899999999999999999999986

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=8.8e-38  Score=282.29  Aligned_cols=245  Identities=24%  Similarity=0.342  Sum_probs=190.5

Q ss_pred             ccccCCccEEEEEEc-CCCEEEEEEecCCC---chhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEEEEecCCCCh
Q 017594           57 LGEGGFGPVYKGVLK-KGDEIAVKRLSGRS---GQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSL  132 (369)
Q Consensus        57 lg~G~~~~v~~~~~~-~~~~valK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L  132 (369)
                      ||+|+||.||+++.+ +|+.|++|.+....   ......+..|+++++.++||||+++.+.+..+...++||||+.+++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            699999999999965 48999999986422   11233456699999999999999999999999999999999999999


Q ss_pred             hhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCCCCccccccc
Q 017594          133 DFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR  212 (369)
Q Consensus       133 ~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~~~~~~~~~~  212 (369)
                      ..++.... ...+++..+..++.||+.||+|||+.+   ++|+||+|+||+++.++.++|+|||++........   ...
T Consensus        81 ~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~---~~~  153 (277)
T cd05607          81 KYHIYNVG-ERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT---ITQ  153 (277)
T ss_pred             HHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCCce---eec
Confidence            87775432 234788888999999999999999998   99999999999999999999999999876543321   123


Q ss_pred             ccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCccccccCccccccccHHH
Q 017594          213 IVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYSSKQ  292 (369)
Q Consensus       213 ~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  292 (369)
                      ..++..|+|||++.+..++.++|+|||||++|+|++|..||........ ........     ....+..      ....
T Consensus       154 ~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~-~~~~~~~~-----~~~~~~~------~~~~  221 (277)
T cd05607         154 RAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVA-KEELKRRT-----LEDEVKF------EHQN  221 (277)
T ss_pred             cCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhh-HHHHHHHh-----hcccccc------cccc
Confidence            4578899999999988899999999999999999999999864321110 00000000     0000000      0112


Q ss_pred             HHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 017594          293 MLLRYANIALLCVQESADDRPTMNDVVS  320 (369)
Q Consensus       293 ~~~~l~~li~~~L~~dP~~Rps~~ell~  320 (369)
                      ++.++.+++.+||+.||++||++.++++
T Consensus       222 ~~~~~~~li~~~L~~~P~~R~~~~~~~~  249 (277)
T cd05607         222 FTEESKDICRLFLAKKPEDRLGSREKND  249 (277)
T ss_pred             CCHHHHHHHHHHhccCHhhCCCCccchh
Confidence            3667899999999999999999977654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=2e-38  Score=299.54  Aligned_cols=251  Identities=22%  Similarity=0.322  Sum_probs=194.4

Q ss_pred             CCccCccccccCCccEEEEEEc-CCCEEEEEEecCCC---chhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEEEE
Q 017594           50 KFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS---GQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIYE  125 (369)
Q Consensus        50 ~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  125 (369)
                      +|++++.||+|+||.||+|+.. +++.||+|++....   ......+..|+.+++++.|+||+++++.+.+....++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E   81 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD   81 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence            6899999999999999999965 48889999986432   2334567889999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCCCC
Q 017594          126 YMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE  205 (369)
Q Consensus       126 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~~~  205 (369)
                      |+.+++|..++...   ..+++..+..++.||+.||+|||+++   ++||||||+||+++.++.++|+|||++..+....
T Consensus        82 ~~~gg~L~~~l~~~---~~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~  155 (382)
T cd05625          82 YIPGGDMMSLLIRM---GIFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH  155 (382)
T ss_pred             CCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCccccccc
Confidence            99999998888543   34788899999999999999999999   9999999999999999999999999875332100


Q ss_pred             c---------------------------------------------ccccccccccccccCchhhccCCCCcccchHhHH
Q 017594          206 L---------------------------------------------QANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFG  240 (369)
Q Consensus       206 ~---------------------------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG  240 (369)
                      .                                             ........|++.|+|||++.+..++.++||||||
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG  235 (382)
T cd05625         156 DSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVG  235 (382)
T ss_pred             cccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEech
Confidence            0                                             0001123588999999999998999999999999


Q ss_pred             HHHHHHHhCCCCCCCCcccccccchhhhhhhhcCccccccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCC---HHH
Q 017594          241 VLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPT---MND  317 (369)
Q Consensus       241 ~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps---~~e  317 (369)
                      |++|+|++|..||.......     ..............     .   .....+.++.++|.+|+ .+|++|++   +.+
T Consensus       236 vil~elltG~~Pf~~~~~~~-----~~~~i~~~~~~~~~-----p---~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~e  301 (382)
T cd05625         236 VILYEMLVGQPPFLAQTPLE-----TQMKVINWQTSLHI-----P---PQAKLSPEASDLIIKLC-RGPEDRLGKNGADE  301 (382)
T ss_pred             HHHHHHHhCCCCCCCCCHHH-----HHHHHHccCCCcCC-----C---CcccCCHHHHHHHHHHc-cCHhHcCCCCCHHH
Confidence            99999999999996432110     00111110000000     0   01112566888998876 59999997   888


Q ss_pred             HHH
Q 017594          318 VVS  320 (369)
Q Consensus       318 ll~  320 (369)
                      +++
T Consensus       302 i~~  304 (382)
T cd05625         302 IKA  304 (382)
T ss_pred             Hhc
Confidence            775

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=2.7e-38  Score=291.24  Aligned_cols=242  Identities=26%  Similarity=0.348  Sum_probs=192.0

Q ss_pred             ccccccCCccEEEEEEcC-CCEEEEEEecCC---CchhHHHHHHHHHHHhcC-CCCceeeeeeeEEeCCccEEEEEecCC
Q 017594           55 NKLGEGGFGPVYKGVLKK-GDEIAVKRLSGR---SGQGLREMKNEASVIAKV-QHKNLVRLLGCCIDRDEKILIYEYMPN  129 (369)
Q Consensus        55 ~~lg~G~~~~v~~~~~~~-~~~valK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~  129 (369)
                      +.||.|+||.||+|+++. ++.||+|++...   .......+..|..++..+ .||||+++++++...+..++||||+.+
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            469999999999999764 789999998743   223345667788888877 699999999999999999999999999


Q ss_pred             CChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCCCCcccc
Q 017594          130 KSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQAN  209 (369)
Q Consensus       130 ~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~~~~~~~  209 (369)
                      ++|...+...   ..+++..+..++.||+.||.|||+.+   ++|+||+|+||+++.++.++|+|||++.......  ..
T Consensus        81 ~~L~~~~~~~---~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--~~  152 (318)
T cd05570          81 GDLMFHIQRS---GRFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG--VT  152 (318)
T ss_pred             CCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeecCcCC--Cc
Confidence            9998887543   34889999999999999999999999   9999999999999999999999999886432211  11


Q ss_pred             cccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCccccccCcccccccc
Q 017594          210 TSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYS  289 (369)
Q Consensus       210 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  289 (369)
                      .....++..|+|||++.+..++.++|+|||||++|+|++|..||.......      ..........      ..     
T Consensus       153 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~------~~~~i~~~~~------~~-----  215 (318)
T cd05570         153 TSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDE------LFQSILEDEV------RY-----  215 (318)
T ss_pred             ccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHH------HHHHHHcCCC------CC-----
Confidence            223458899999999999999999999999999999999999986433111      0000011100      00     


Q ss_pred             HHHHHHHHHHHHHHhhcCCCCCCCCH-----HHHHHH
Q 017594          290 SKQMLLRYANIALLCVQESADDRPTM-----NDVVSM  321 (369)
Q Consensus       290 ~~~~~~~l~~li~~~L~~dP~~Rps~-----~ell~~  321 (369)
                      +...+..+.++|.+||+.||.+||++     .++++.
T Consensus       216 ~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~  252 (318)
T cd05570         216 PRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH  252 (318)
T ss_pred             CCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence            11125678999999999999999999     888753

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=3e-38  Score=291.60  Aligned_cols=246  Identities=26%  Similarity=0.315  Sum_probs=193.3

Q ss_pred             CCccCccccccCCccEEEEEEcC-CCEEEEEEecCCC---chhHHHHHHHHHHHhcC-CCCceeeeeeeEEeCCccEEEE
Q 017594           50 KFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRS---GQGLREMKNEASVIAKV-QHKNLVRLLGCCIDRDEKILIY  124 (369)
Q Consensus        50 ~y~i~~~lg~G~~~~v~~~~~~~-~~~valK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~  124 (369)
                      +|++.+.||+|+||.||+|+.+. ++.||+|++....   .........|..++..+ .|++++++.+++...+..++||
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM   80 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence            58899999999999999999764 7899999987432   22334556677777777 5789999999999999999999


Q ss_pred             EecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCCC
Q 017594          125 EYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGN  204 (369)
Q Consensus       125 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~~  204 (369)
                      ||+.+++|...+...   ..+++..+..++.||+.||.|||+++   ++||||||+||+++.++.++|+|||++......
T Consensus        81 E~~~~g~L~~~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~  154 (323)
T cd05616          81 EYVNGGDLMYQIQQV---GRFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD  154 (323)
T ss_pred             cCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceecCCC
Confidence            999999998887543   34888999999999999999999999   999999999999999999999999998754321


Q ss_pred             CcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCccccccCccc
Q 017594          205 ELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPIL  284 (369)
Q Consensus       205 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (369)
                      .  .......|++.|+|||++.+..++.++|+|||||++|+|++|..||.......     ...... ....      ..
T Consensus       155 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~-----~~~~i~-~~~~------~~  220 (323)
T cd05616         155 G--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE-----LFQSIM-EHNV------AY  220 (323)
T ss_pred             C--CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHH-----HHHHHH-hCCC------CC
Confidence            1  12233468999999999999999999999999999999999999986433211     001110 0000      00


Q ss_pred             cccccHHHHHHHHHHHHHHhhcCCCCCCCCH-----HHHHH
Q 017594          285 EDEYSSKQMLLRYANIALLCVQESADDRPTM-----NDVVS  320 (369)
Q Consensus       285 ~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~-----~ell~  320 (369)
                           +...+.++.+++.+||+.+|++|++.     .++++
T Consensus       221 -----p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~  256 (323)
T cd05616         221 -----PKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE  256 (323)
T ss_pred             -----CCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhc
Confidence                 11125678999999999999999985     56653

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=8.7e-38  Score=282.61  Aligned_cols=259  Identities=29%  Similarity=0.417  Sum_probs=200.4

Q ss_pred             hcCCccCccccccCCccEEEEEEcC-CC----EEEEEEecCCCc-hhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccE
Q 017594           48 TNKFSDANKLGEGGFGPVYKGVLKK-GD----EIAVKRLSGRSG-QGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKI  121 (369)
Q Consensus        48 ~~~y~i~~~lg~G~~~~v~~~~~~~-~~----~valK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  121 (369)
                      ..+|++.+.||.|+||.||+|.+.. |+    .+++|.+..... .....+..|+..+..+.||||+++++++. +...+
T Consensus         6 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~   84 (279)
T cd05111           6 ETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQ   84 (279)
T ss_pred             HhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccE
Confidence            3688999999999999999999643 44    478888754322 23456777888899999999999999875 45678


Q ss_pred             EEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceec
Q 017594          122 LIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARIC  201 (369)
Q Consensus       122 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~  201 (369)
                      +++||+.+++|.+++...  ...+++..+..++.||+.||.|||+.+   ++|+||||+||+++.++.++|+|||.+...
T Consensus        85 ~i~e~~~~gsL~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~~~  159 (279)
T cd05111          85 LVTQLSPLGSLLDHVRQH--RDSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLL  159 (279)
T ss_pred             EEEEeCCCCcHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCccceec
Confidence            999999999999998543  234888999999999999999999998   999999999999999999999999998765


Q ss_pred             CCCCcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHh-CCCCCCCCcccccccchhhhhhhhcCcccccc
Q 017594          202 GGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDLWTSNRTLELI  280 (369)
Q Consensus       202 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (369)
                      .............++..|+|||.+.+..++.++||||||+++|+|++ |..||.......      ............  
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~------~~~~~~~~~~~~--  231 (279)
T cd05111         160 YPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHE------VPDLLEKGERLA--  231 (279)
T ss_pred             cCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH------HHHHHHCCCcCC--
Confidence            43322222233446678999999988899999999999999999998 998885432111      011111111100  


Q ss_pred             CccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHhhhhc
Q 017594          281 DPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNEAAT  328 (369)
Q Consensus       281 ~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L~~~~~~  328 (369)
                      .+        ..++.++.+++.+||..+|++|||+.++++.|..+...
T Consensus       232 ~~--------~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~  271 (279)
T cd05111         232 QP--------QICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARD  271 (279)
T ss_pred             CC--------CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhC
Confidence            00        01145678899999999999999999999999887764

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=1.8e-37  Score=281.69  Aligned_cols=258  Identities=26%  Similarity=0.433  Sum_probs=201.1

Q ss_pred             hcCCccCccccccCCccEEEEEEc------CCCEEEEEEecCCC-chhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCcc
Q 017594           48 TNKFSDANKLGEGGFGPVYKGVLK------KGDEIAVKRLSGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEK  120 (369)
Q Consensus        48 ~~~y~i~~~lg~G~~~~v~~~~~~------~~~~valK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~  120 (369)
                      .++|++.+.||.|+||.||+|..+      ++..+++|.+.... ......+..|+..++.+.|||++++++++.++...
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~   83 (288)
T cd05050           4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM   83 (288)
T ss_pred             hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence            467999999999999999999864      36789999887543 23345688899999999999999999999998999


Q ss_pred             EEEEEecCCCChhhhhcCCC-------------------ccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCC
Q 017594          121 ILIYEYMPNKSLDFFLFDPT-------------------KRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASN  181 (369)
Q Consensus       121 ~lv~e~~~~~~L~~~l~~~~-------------------~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~N  181 (369)
                      ++++||+.+++|.+++....                   ....+++..++.++.||+.||++||..+   ++|+||+|.|
T Consensus        84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~n  160 (288)
T cd05050          84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATRN  160 (288)
T ss_pred             EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHhh
Confidence            99999999999988885321                   1234677888999999999999999998   9999999999


Q ss_pred             EEEeCCCceEEeecCCceecCCCCcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHh-CCCCCCCCcccc
Q 017594          182 ILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDS  260 (369)
Q Consensus       182 Ilv~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~t-g~~p~~~~~~~~  260 (369)
                      |+++.++.++|+|||++.................+..|+|||.+.+..++.++|+|||||++|+|++ |..||...... 
T Consensus       161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~-  239 (288)
T cd05050         161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHE-  239 (288)
T ss_pred             eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH-
Confidence            9999999999999999876543322122222234567999999988899999999999999999997 77777422111 


Q ss_pred             cccchhhhhhhhcCccccccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHh
Q 017594          261 LNLLGYAWDLWTSNRTLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTN  324 (369)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L~~  324 (369)
                          ... ...........          +...+.++.+++.+||+.+|++|||+.|+++.|++
T Consensus       240 ----~~~-~~~~~~~~~~~----------~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~  288 (288)
T cd05050         240 ----EVI-YYVRDGNVLSC----------PDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR  288 (288)
T ss_pred             ----HHH-HHHhcCCCCCC----------CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence                000 11111111000          01125679999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-40  Score=275.63  Aligned_cols=247  Identities=25%  Similarity=0.373  Sum_probs=201.1

Q ss_pred             HhcCCccCccccccCCccEEEEEEc-CCCEEEEEEecCC--CchhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEE
Q 017594           47 ATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILI  123 (369)
Q Consensus        47 ~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv  123 (369)
                      +.++|.+.+.||+|.|+.|+++... +|+.+++|+++..  ...+.+.+.+|+.+-+.|+||||+++.+.+..+...|+|
T Consensus         9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylv   88 (355)
T KOG0033|consen    9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV   88 (355)
T ss_pred             cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEE
Confidence            4578999999999999999999854 5999998887522  334678899999999999999999999999988999999


Q ss_pred             EEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCC---CceEEeecCCcee
Q 017594          124 YEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKD---MNPKISDFGMARI  200 (369)
Q Consensus       124 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~---~~~~L~Dfg~~~~  200 (369)
                      +|++.|+.|..-+-   .+..+++..+...+.||+.||.|+|.++   |+|||+||+|+++...   .-+||+|||++..
T Consensus        89 Fe~m~G~dl~~eIV---~R~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~  162 (355)
T KOG0033|consen   89 FDLVTGGELFEDIV---AREFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLAIE  162 (355)
T ss_pred             EecccchHHHHHHH---HHHHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccceEEE
Confidence            99999998854442   3355888899999999999999999999   9999999999999543   4589999999998


Q ss_pred             cCCCCcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCcccccc
Q 017594          201 CGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELI  280 (369)
Q Consensus       201 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (369)
                      ...+....   ...|+|.|+|||++...+|+..+|||+.|+|||-|+.|.+||-..+...                  +.
T Consensus       163 l~~g~~~~---G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~r------------------ly  221 (355)
T KOG0033|consen  163 VNDGEAWH---GFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR------------------LY  221 (355)
T ss_pred             eCCccccc---cccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHH------------------HH
Confidence            87444333   3479999999999999999999999999999999999999985422111                  11


Q ss_pred             Cccccccc-----cHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 017594          281 DPILEDEY-----SSKQMLLRYANIALLCVQESADDRPTMNDVVS  320 (369)
Q Consensus       281 ~~~~~~~~-----~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~  320 (369)
                      +.+..+.+     .....+++..+||++||..||.+|.|+.|.|+
T Consensus       222 e~I~~g~yd~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~  266 (355)
T KOG0033|consen  222 EQIKAGAYDYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALK  266 (355)
T ss_pred             HHHhccccCCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence            11111111     11122677999999999999999999998874

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=1.8e-37  Score=280.23  Aligned_cols=257  Identities=31%  Similarity=0.442  Sum_probs=199.2

Q ss_pred             hcCCccCccccccCCccEEEEEEcC------CCEEEEEEecCCC-chhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCcc
Q 017594           48 TNKFSDANKLGEGGFGPVYKGVLKK------GDEIAVKRLSGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEK  120 (369)
Q Consensus        48 ~~~y~i~~~lg~G~~~~v~~~~~~~------~~~valK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~  120 (369)
                      .++|.+.+.||+|++|.||+|.+..      +..|++|.+.... ......+..|+..++.++|+||+++++++......
T Consensus         5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   84 (277)
T cd05036           5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR   84 (277)
T ss_pred             HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence            4679999999999999999999653      5678999886443 22335678899999999999999999999888899


Q ss_pred             EEEEEecCCCChhhhhcCCCc----cccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCC---ceEEe
Q 017594          121 ILIYEYMPNKSLDFFLFDPTK----RMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDM---NPKIS  193 (369)
Q Consensus       121 ~lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~---~~~L~  193 (369)
                      ++++||+.+++|.+++.....    ...+++..+..++.||+.||+|||+.+   ++|+||+|+||+++.++   .++|+
T Consensus        85 ~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~kl~  161 (277)
T cd05036          85 FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKIA  161 (277)
T ss_pred             EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceEec
Confidence            999999999999998854321    234788899999999999999999998   99999999999998765   58999


Q ss_pred             ecCCceecCCCCcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHh-CCCCCCCCcccccccchhhhhhhh
Q 017594          194 DFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDLWT  272 (369)
Q Consensus       194 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~  272 (369)
                      |||++.................+..|+|||++.+..++.++|||||||++|+|++ |..||.......     . .....
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~-----~-~~~~~  235 (277)
T cd05036         162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQE-----V-MEFVT  235 (277)
T ss_pred             cCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH-----H-HHHHH
Confidence            9999876533222111112233467999999998899999999999999999997 888886432111     0 01111


Q ss_pred             cCccccccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 017594          273 SNRTLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLT  323 (369)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L~  323 (369)
                      ......          .+..++..+.+++.+||+.+|++||++.++++.|.
T Consensus       236 ~~~~~~----------~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~  276 (277)
T cd05036         236 GGGRLD----------PPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ  276 (277)
T ss_pred             cCCcCC----------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence            100000          01112567899999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=2.7e-37  Score=275.41  Aligned_cols=250  Identities=28%  Similarity=0.389  Sum_probs=201.5

Q ss_pred             CCccCccccccCCccEEEEEEc-CCCEEEEEEecCC--CchhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEEEEe
Q 017594           50 KFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIYEY  126 (369)
Q Consensus        50 ~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  126 (369)
                      +|.+.+.||.|++|.||+|..+ ++..|++|.+...  .......+..|+.+++.++|||++++++++...+..++++||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY   80 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence            4788899999999999999975 4889999988643  234456778899999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCCCCc
Q 017594          127 MPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNEL  206 (369)
Q Consensus       127 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~~~~  206 (369)
                      +.+++|.+++.... ...++...++.++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++........
T Consensus        81 ~~~~~L~~~l~~~~-~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~  156 (256)
T cd08529          81 AENGDLHKLLKMQR-GRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN  156 (256)
T ss_pred             CCCCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccCccc
Confidence            99999999886532 345888899999999999999999998   99999999999999999999999999876653321


Q ss_pred             ccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCccccccCccccc
Q 017594          207 QANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILED  286 (369)
Q Consensus       207 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  286 (369)
                        ......++..|+|||+..+..++.++|+||||+++++|++|..||.......     ..... .....     +.+  
T Consensus       157 --~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-----~~~~~-~~~~~-----~~~--  221 (256)
T cd08529         157 --FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGA-----LILKI-IRGVF-----PPV--  221 (256)
T ss_pred             --hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH-----HHHHH-HcCCC-----CCC--
Confidence              1223457888999999998889999999999999999999999986433110     00110 00000     001  


Q ss_pred             cccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 017594          287 EYSSKQMLLRYANIALLCVQESADDRPTMNDVVSM  321 (369)
Q Consensus       287 ~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~  321 (369)
                         ...++..+.+++.+||+.+|++||++.++++.
T Consensus       222 ---~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~  253 (256)
T cd08529         222 ---SQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN  253 (256)
T ss_pred             ---ccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence               11235679999999999999999999999863

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=1.7e-37  Score=282.03  Aligned_cols=262  Identities=27%  Similarity=0.425  Sum_probs=201.2

Q ss_pred             HHhcCCccCccccccCCccEEEEEEc------CCCEEEEEEecCCC-chhHHHHHHHHHHHhcCCCCceeeeeeeEEeCC
Q 017594           46 TATNKFSDANKLGEGGFGPVYKGVLK------KGDEIAVKRLSGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCCIDRD  118 (369)
Q Consensus        46 ~~~~~y~i~~~lg~G~~~~v~~~~~~------~~~~valK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~  118 (369)
                      ....+|++.+.||+|+||.||+|..+      .+..|++|.+.... ......+.+|+..++.+.|+|++++++++....
T Consensus         3 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   82 (288)
T cd05061           3 VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQ   82 (288)
T ss_pred             ccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence            45689999999999999999999743      24579999876443 222345678999999999999999999999888


Q ss_pred             ccEEEEEecCCCChhhhhcCCCc-------cccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceE
Q 017594          119 EKILIYEYMPNKSLDFFLFDPTK-------RMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPK  191 (369)
Q Consensus       119 ~~~lv~e~~~~~~L~~~l~~~~~-------~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~  191 (369)
                      ..+++|||+.+++|.+++.....       ........+..++.|++.||.|||+++   ++|+||||+||+++.++.++
T Consensus        83 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~~  159 (288)
T cd05061          83 PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVK  159 (288)
T ss_pred             CcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcEE
Confidence            99999999999999999854221       233456678899999999999999999   99999999999999999999


Q ss_pred             EeecCCceecCCCCcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHh-CCCCCCCCcccccccchhhhhh
Q 017594          192 ISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDL  270 (369)
Q Consensus       192 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~  270 (369)
                      |+|||++................++..|+|||.+.+..++.++|+|||||++|+|++ |..||.......     .. ..
T Consensus       160 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~-----~~-~~  233 (288)
T cd05061         160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQ-----VL-KF  233 (288)
T ss_pred             ECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHH-----HH-HH
Confidence            999999875543222222222234667999999988889999999999999999998 777875322111     00 00


Q ss_pred             hhcCccccccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHhhh
Q 017594          271 WTSNRTLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNEA  326 (369)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L~~~~  326 (369)
                      .........          +...+..+.+++.+||+.+|.+|||+.++++.|....
T Consensus       234 ~~~~~~~~~----------~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~  279 (288)
T cd05061         234 VMDGGYLDQ----------PDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL  279 (288)
T ss_pred             HHcCCCCCC----------CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence            000100000          0112467999999999999999999999999988763

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=1.2e-37  Score=277.59  Aligned_cols=250  Identities=24%  Similarity=0.397  Sum_probs=202.5

Q ss_pred             hcCCccCccccccCCccEEEEEEcC-CCEEEEEEecCCCchhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEEEEe
Q 017594           48 TNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIYEY  126 (369)
Q Consensus        48 ~~~y~i~~~lg~G~~~~v~~~~~~~-~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  126 (369)
                      .++|++.+.||.|++|.||+|++.. ++.+++|.+.....  ...+.+|+.+++.++|+|++++++.+......++++|+
T Consensus         2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~   79 (256)
T cd06612           2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEY   79 (256)
T ss_pred             cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEec
Confidence            3689999999999999999999765 78999999875432  57889999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCCCCc
Q 017594          127 MPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNEL  206 (369)
Q Consensus       127 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~~~~  206 (369)
                      +.+++|.+++...  ...+++..+..++.|++.|+.|||+.+   ++|+||+|.||+++.++.++|+|||++........
T Consensus        80 ~~~~~L~~~l~~~--~~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~  154 (256)
T cd06612          80 CGAGSVSDIMKIT--NKTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA  154 (256)
T ss_pred             CCCCcHHHHHHhC--ccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhcccCcc
Confidence            9999999988542  245889999999999999999999998   99999999999999999999999999876543321


Q ss_pred             ccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCccccccCccccc
Q 017594          207 QANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILED  286 (369)
Q Consensus       207 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  286 (369)
                        ......++..|+|||.+.+..++.++||||+|+++|+|++|..||.........        ..   ........   
T Consensus       155 --~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~--------~~---~~~~~~~~---  218 (256)
T cd06612         155 --KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAI--------FM---IPNKPPPT---  218 (256)
T ss_pred             --ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhh--------hh---hccCCCCC---
Confidence              122234678899999998888999999999999999999999998643211100        00   00000000   


Q ss_pred             cccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 017594          287 EYSSKQMLLRYANIALLCVQESADDRPTMNDVVS  320 (369)
Q Consensus       287 ~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~  320 (369)
                      ...+..++..+.++|.+||+.+|++|||+.++++
T Consensus       219 ~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~  252 (256)
T cd06612         219 LSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ  252 (256)
T ss_pred             CCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence            0012223567999999999999999999999986

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=1.5e-37  Score=281.23  Aligned_cols=247  Identities=24%  Similarity=0.333  Sum_probs=193.3

Q ss_pred             ccccCCccEEEEEEc-CCCEEEEEEecCCCc---hhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEEEEecCCCCh
Q 017594           57 LGEGGFGPVYKGVLK-KGDEIAVKRLSGRSG---QGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSL  132 (369)
Q Consensus        57 lg~G~~~~v~~~~~~-~~~~valK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L  132 (369)
                      ||+|+||.||++.++ +|+.||+|.+.....   ...+.+..|+.+++.++|++++++.+++......++||||+++++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            699999999999965 588999999864322   2335567799999999999999999999988899999999999999


Q ss_pred             hhhhcCC-CccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCCCCcccccc
Q 017594          133 DFFLFDP-TKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTS  211 (369)
Q Consensus       133 ~~~l~~~-~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~~~~~~~~~  211 (369)
                      ...+... .....+++..++.++.||+.||.|||+.+   ++|+||+|+||+++.++.++|+|||++........  ...
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~--~~~  155 (280)
T cd05608          81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS--KTK  155 (280)
T ss_pred             HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCCCc--ccc
Confidence            8776432 23345889999999999999999999999   99999999999999999999999999876543322  122


Q ss_pred             cccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCccccccCccccccccHH
Q 017594          212 RIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYSSK  291 (369)
Q Consensus       212 ~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  291 (369)
                      ...++..|+|||.+.+..++.++|+||+|+++|+|++|+.||.......... ......         .....   ..+.
T Consensus       156 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~-~~~~~~---------~~~~~---~~~~  222 (280)
T cd05608         156 GYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENK-ELKQRI---------LNDSV---TYPD  222 (280)
T ss_pred             ccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHH-HHHHhh---------cccCC---CCcc
Confidence            3467889999999999999999999999999999999999986433111000 000000         00000   0011


Q ss_pred             HHHHHHHHHHHHhhcCCCCCCC-----CHHHHHHH
Q 017594          292 QMLLRYANIALLCVQESADDRP-----TMNDVVSM  321 (369)
Q Consensus       292 ~~~~~l~~li~~~L~~dP~~Rp-----s~~ell~~  321 (369)
                      .++..+.+++.+||+.||++||     +++++++.
T Consensus       223 ~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h  257 (280)
T cd05608         223 KFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTH  257 (280)
T ss_pred             cCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence            2366799999999999999999     77888863

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=1e-37  Score=282.12  Aligned_cols=260  Identities=27%  Similarity=0.407  Sum_probs=202.1

Q ss_pred             hcCCccCccccccCCccEEEEEEc-CCC----EEEEEEecCCC-chhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccE
Q 017594           48 TNKFSDANKLGEGGFGPVYKGVLK-KGD----EIAVKRLSGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKI  121 (369)
Q Consensus        48 ~~~y~i~~~lg~G~~~~v~~~~~~-~~~----~valK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  121 (369)
                      ..+|++.+.||.|+||.||+|++. +|.    .||+|.+.... ......+..|+..+..+.|+|++++++++.. ...+
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~   84 (279)
T cd05109           6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQ   84 (279)
T ss_pred             hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcE
Confidence            468999999999999999999854 344    48999886443 2335567789999999999999999998864 4578


Q ss_pred             EEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceec
Q 017594          122 LIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARIC  201 (369)
Q Consensus       122 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~  201 (369)
                      ++++++++++|.+++...  ...+++..+..++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||++..+
T Consensus        85 l~~~~~~~g~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~  159 (279)
T cd05109          85 LVTQLMPYGCLLDYVREN--KDRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARLL  159 (279)
T ss_pred             EEEEcCCCCCHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCceeec
Confidence            999999999999888543  234788899999999999999999999   999999999999999999999999998876


Q ss_pred             CCCCcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHh-CCCCCCCCcccccccchhhhhhhhcCcccccc
Q 017594          202 GGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDLWTSNRTLELI  280 (369)
Q Consensus       202 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (369)
                      .............++..|+|||...+..++.++|||||||++|+|++ |..||.......      ............. 
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~------~~~~~~~~~~~~~-  232 (279)
T cd05109         160 DIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPARE------IPDLLEKGERLPQ-  232 (279)
T ss_pred             ccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH------HHHHHHCCCcCCC-
Confidence            53322211222234567999999988889999999999999999998 888886432111      0011111100000 


Q ss_pred             CccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHhhhhcc
Q 017594          281 DPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNEAATL  329 (369)
Q Consensus       281 ~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L~~~~~~~  329 (369)
                               +..++.++.+++.+||+.||++||++.++++.|+.+....
T Consensus       233 ---------~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~  272 (279)
T cd05109         233 ---------PPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDP  272 (279)
T ss_pred             ---------CccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCC
Confidence                     0112566899999999999999999999999998886644

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=7.1e-38  Score=285.60  Aligned_cols=253  Identities=23%  Similarity=0.403  Sum_probs=203.4

Q ss_pred             HHHhcCCccCccccccCCccEEEEEEc-CCCEEEEEEecCCCchhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEE
Q 017594           45 STATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILI  123 (369)
Q Consensus        45 ~~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv  123 (369)
                      .....+|++.+.||.|++|.||+|.+. +|+.|++|.+........+.+.+|+..++.++|+|++++++++..+...++|
T Consensus        15 ~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   94 (296)
T cd06655          15 GDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVV   94 (296)
T ss_pred             CCCcceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEE
Confidence            334467999999999999999999964 5899999998766555567788899999999999999999999999999999


Q ss_pred             EEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCC
Q 017594          124 YEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGG  203 (369)
Q Consensus       124 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~  203 (369)
                      +||+.+++|..++..    ..+++..+..++.|++.|+++||+.+   ++|+||+|+||+++.++.++|+|||++.....
T Consensus        95 ~e~~~~~~L~~~~~~----~~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~  167 (296)
T cd06655          95 MEYLAGGSLTDVVTE----TCMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITP  167 (296)
T ss_pred             EEecCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhccc
Confidence            999999999988743    24789999999999999999999999   99999999999999999999999998775433


Q ss_pred             CCcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCccccccCcc
Q 017594          204 NELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPI  283 (369)
Q Consensus       204 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (369)
                      ...  ......++..|+|||.+.+..++.++|+|||||++|+|++|..||........     .........      +.
T Consensus       168 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~-----~~~~~~~~~------~~  234 (296)
T cd06655         168 EQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA-----LYLIATNGT------PE  234 (296)
T ss_pred             ccc--cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-----HHHHHhcCC------cc
Confidence            221  12234578899999999888899999999999999999999999864332110     000000000      00


Q ss_pred             ccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 017594          284 LEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVS  320 (369)
Q Consensus       284 ~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~  320 (369)
                      +.   .+..++..+.++|.+||..+|++||++.+++.
T Consensus       235 ~~---~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~  268 (296)
T cd06655         235 LQ---NPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ  268 (296)
T ss_pred             cC---CcccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence            00   11122566899999999999999999999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=1.6e-37  Score=285.70  Aligned_cols=241  Identities=27%  Similarity=0.377  Sum_probs=188.5

Q ss_pred             ccccccCCccEEEEEEcC-CCEEEEEEecCCC---chhHHHHHHHHHHHhc-CCCCceeeeeeeEEeCCccEEEEEecCC
Q 017594           55 NKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRS---GQGLREMKNEASVIAK-VQHKNLVRLLGCCIDRDEKILIYEYMPN  129 (369)
Q Consensus        55 ~~lg~G~~~~v~~~~~~~-~~~valK~~~~~~---~~~~~~~~~e~~~l~~-l~h~~i~~~~~~~~~~~~~~lv~e~~~~  129 (369)
                      +.||+|+||.||+|+++. ++.||+|++....   .........|..++.. +.||||+++++++...+..++||||+.+
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            468999999999999764 7899999986431   1223455567777775 4899999999999999999999999999


Q ss_pred             CChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCCCCcccc
Q 017594          130 KSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQAN  209 (369)
Q Consensus       130 ~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~~~~~~~  209 (369)
                      ++|..++...   ..+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.++|+|||++.......  ..
T Consensus        81 g~L~~~l~~~---~~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~  152 (316)
T cd05619          81 GDLMFHIQSC---HKFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD--AK  152 (316)
T ss_pred             CcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceECCCCC--Cc
Confidence            9998888532   34788899999999999999999999   9999999999999999999999999987532211  11


Q ss_pred             cccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCccccccCcccccccc
Q 017594          210 TSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYS  289 (369)
Q Consensus       210 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  289 (369)
                      .....|+..|+|||++.+..++.++|+||+||++|+|++|..||.......     . .......      .+..     
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~-----~-~~~i~~~------~~~~-----  215 (316)
T cd05619         153 TCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEE-----L-FQSIRMD------NPCY-----  215 (316)
T ss_pred             eeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHH-----H-HHHHHhC------CCCC-----
Confidence            223468899999999998899999999999999999999999986432110     0 0000000      0001     


Q ss_pred             HHHHHHHHHHHHHHhhcCCCCCCCCHH-HHHH
Q 017594          290 SKQMLLRYANIALLCVQESADDRPTMN-DVVS  320 (369)
Q Consensus       290 ~~~~~~~l~~li~~~L~~dP~~Rps~~-ell~  320 (369)
                      +...+.++.++|.+||+.||.+||++. ++++
T Consensus       216 ~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~  247 (316)
T cd05619         216 PRWLTREAKDILVKLFVREPERRLGVKGDIRQ  247 (316)
T ss_pred             CccCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence            111256689999999999999999997 6654

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=1.6e-37  Score=310.63  Aligned_cols=263  Identities=22%  Similarity=0.303  Sum_probs=202.9

Q ss_pred             cCCccCccccccCCccEEEEEEcC-CCEEEEEEecCCC---chhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEEE
Q 017594           49 NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRS---GQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIY  124 (369)
Q Consensus        49 ~~y~i~~~lg~G~~~~v~~~~~~~-~~~valK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  124 (369)
                      ++|++.+.||+|+||.||+|++.. |+.||+|++....   ....+.+.+|+.+++.++|||++++++++.+.+..+++|
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM   81 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM   81 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence            689999999999999999999754 8999999986432   223456788999999999999999999999999999999


Q ss_pred             EecCCCChhhhhcCCCc--------cccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecC
Q 017594          125 EYMPNKSLDFFLFDPTK--------RMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFG  196 (369)
Q Consensus       125 e~~~~~~L~~~l~~~~~--------~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg  196 (369)
                      ||++|++|.+++.....        ....+...+..++.||+.||+|||++|   ++||||||+||+++.++.++|+|||
T Consensus        82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFG  158 (932)
T PRK13184         82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWG  158 (932)
T ss_pred             EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecC
Confidence            99999999888753211        123456677899999999999999999   9999999999999999999999999


Q ss_pred             CceecCCCCc----------------ccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccc
Q 017594          197 MARICGGNEL----------------QANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDS  260 (369)
Q Consensus       197 ~~~~~~~~~~----------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~  260 (369)
                      ++........                ........|++.|+|||.+.+..++.++|||||||++|+|++|..||.......
T Consensus       159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k  238 (932)
T PRK13184        159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK  238 (932)
T ss_pred             cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence            9886621110                001122468999999999999999999999999999999999999986432111


Q ss_pred             cccchhhhhhhhcCccccccCccccccccHHHHHHHHHHHHHHhhcCCCCCCC-CHHHHHHHHHhhhhc
Q 017594          261 LNLLGYAWDLWTSNRTLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRP-TMNDVVSMLTNEAAT  328 (369)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp-s~~ell~~L~~~~~~  328 (369)
                      ..     ..    ...   ..+. . ......++..+.+++.+||+.||++|| +++++++.|+.....
T Consensus       239 i~-----~~----~~i---~~P~-~-~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~  293 (932)
T PRK13184        239 IS-----YR----DVI---LSPI-E-VAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQG  293 (932)
T ss_pred             hh-----hh----hhc---cChh-h-ccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence            00     00    000   0000 0 000112356789999999999999996 667777888776553

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-37  Score=280.88  Aligned_cols=248  Identities=24%  Similarity=0.405  Sum_probs=201.5

Q ss_pred             cCCccCccccccCCccEEEEEEc-CCCEEEEEEecCCC-chhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEEEEe
Q 017594           49 NKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIYEY  126 (369)
Q Consensus        49 ~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  126 (369)
                      ++|++.+.||.|++|.||+|++. +++.|++|.+.... ......+..|+.+++.++|+|++++.+++..+...++++||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY   80 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence            47999999999999999999966 48899999987543 33446678899999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCCCCc
Q 017594          127 MPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNEL  206 (369)
Q Consensus       127 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~~~~  206 (369)
                      +.+++|.+++...    .+++..++.++.|++.|+.+||+.+   ++|+||+|+||+++.++.++|+|||++....... 
T Consensus        81 ~~~~~L~~~~~~~----~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-  152 (274)
T cd06609          81 CGGGSCLDLLKPG----KLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM-  152 (274)
T ss_pred             eCCCcHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeecccc-
Confidence            9999999888542    5889999999999999999999998   9999999999999999999999999987765332 


Q ss_pred             ccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCccccccCccccc
Q 017594          207 QANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILED  286 (369)
Q Consensus       207 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  286 (369)
                       .......++..|+|||.+.+..++.++|+||||+++|+|++|..||.......     .....      .....+.+..
T Consensus       153 -~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~-----~~~~~------~~~~~~~~~~  220 (274)
T cd06609         153 -SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMR-----VLFLI------PKNNPPSLEG  220 (274)
T ss_pred             -cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHH-----HHHHh------hhcCCCCCcc
Confidence             12223457788999999998889999999999999999999999986432110     00000      0000111111


Q ss_pred             cccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 017594          287 EYSSKQMLLRYANIALLCVQESADDRPTMNDVVS  320 (369)
Q Consensus       287 ~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~  320 (369)
                          ..++.++.+++.+||..+|++||+++++++
T Consensus       221 ----~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~  250 (274)
T cd06609         221 ----NKFSKPFKDFVSLCLNKDPKERPSAKELLK  250 (274)
T ss_pred             ----cccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence                113567999999999999999999999986

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.3e-37  Score=275.12  Aligned_cols=251  Identities=28%  Similarity=0.417  Sum_probs=203.7

Q ss_pred             hcCCccCccccccCCccEEEEEEcCCCEEEEEEecCCCchhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEEEEec
Q 017594           48 TNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIYEYM  127 (369)
Q Consensus        48 ~~~y~i~~~lg~G~~~~v~~~~~~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~  127 (369)
                      .++|++.+.||.|++|.||+|... |+.|++|.+..... ....+..|+.+++.++|+|++++++++......++|+||+
T Consensus         5 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   82 (256)
T cd05039           5 SKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYM   82 (256)
T ss_pred             hhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEec
Confidence            568999999999999999999876 78999999976543 4567888999999999999999999999888999999999


Q ss_pred             CCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCCCCcc
Q 017594          128 PNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQ  207 (369)
Q Consensus       128 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~~~~~  207 (369)
                      .+++|.+++..... ..+++..++.++.|++.||.|||..+   ++|+||+|+||+++.++.++|+|||.+........ 
T Consensus        83 ~~~~L~~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~-  157 (256)
T cd05039          83 AKGSLVDYLRSRGR-AVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD-  157 (256)
T ss_pred             CCCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEcccccccccccccc-
Confidence            99999998854332 25889999999999999999999999   99999999999999999999999999876532211 


Q ss_pred             cccccccccccccCchhhccCCCCcccchHhHHHHHHHHHh-CCCCCCCCcccccccchhhhhhhhcCccccccCccccc
Q 017594          208 ANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILED  286 (369)
Q Consensus       208 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  286 (369)
                          ....+..|.|||.+.+..++.++|+||||+++++|++ |..||.......      ............        
T Consensus       158 ----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~------~~~~~~~~~~~~--------  219 (256)
T cd05039         158 ----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD------VVPHVEKGYRME--------  219 (256)
T ss_pred             ----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHH------HHHHHhcCCCCC--------
Confidence                2234567999999988889999999999999999997 998886432111      000000000000        


Q ss_pred             cccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHhh
Q 017594          287 EYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNE  325 (369)
Q Consensus       287 ~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L~~~  325 (369)
                        .+..++..+.++|.+||..+|++||++.++++.|+++
T Consensus       220 --~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~  256 (256)
T cd05039         220 --APEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI  256 (256)
T ss_pred             --CccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence              0112256799999999999999999999999999763

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=2e-37  Score=278.20  Aligned_cols=249  Identities=28%  Similarity=0.453  Sum_probs=198.5

Q ss_pred             CCccCccccccCCccEEEEEEc-CCCEEEEEEecCCCch---------hHHHHHHHHHHHhcCCCCceeeeeeeEEeCCc
Q 017594           50 KFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSGQ---------GLREMKNEASVIAKVQHKNLVRLLGCCIDRDE  119 (369)
Q Consensus        50 ~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~~~~---------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~  119 (369)
                      +|.+.+.||.|++|.||+|... +++.+++|.+......         ..+.+..|+.++++++|||++++++++.....
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH   80 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence            5899999999999999999965 4788999988644321         23567789999999999999999999999999


Q ss_pred             cEEEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCce
Q 017594          120 KILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMAR  199 (369)
Q Consensus       120 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~  199 (369)
                      .++++||+.+++|..++...   ..+++..+..++.|++.||.+||+.+   ++|+||+|+||+++.++.++|+|||.+.
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg~~~  154 (267)
T cd06628          81 LNIFLEYVPGGSVAALLNNY---GAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISK  154 (267)
T ss_pred             cEEEEEecCCCCHHHHHHhc---cCccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccCCCc
Confidence            99999999999999988543   34788889999999999999999998   9999999999999999999999999987


Q ss_pred             ecCCCCccc----ccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCc
Q 017594          200 ICGGNELQA----NTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNR  275 (369)
Q Consensus       200 ~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  275 (369)
                      .........    ......++..|+|||.+.+..++.++|+||||+++|+|++|..||.......     ......    
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-----~~~~~~----  225 (267)
T cd06628         155 KLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQ-----AIFKIG----  225 (267)
T ss_pred             ccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHH-----HHHHHh----
Confidence            665321111    1122346788999999988889999999999999999999999986432110     000000    


Q ss_pred             cccccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 017594          276 TLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVS  320 (369)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~  320 (369)
                        ....+.+.     ...+..+.++|.+||+.+|.+||++.++++
T Consensus       226 --~~~~~~~~-----~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  263 (267)
T cd06628         226 --ENASPEIP-----SNISSEAIDFLEKTFEIDHNKRPTAAELLK  263 (267)
T ss_pred             --ccCCCcCC-----cccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence              00111111     122567899999999999999999999986

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=5.7e-38  Score=289.52  Aligned_cols=237  Identities=23%  Similarity=0.294  Sum_probs=183.4

Q ss_pred             ccccccCCccEEEEEEcC-CCEEEEEEecCCC---chhHHHHHHHH-HHHhcCCCCceeeeeeeEEeCCccEEEEEecCC
Q 017594           55 NKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRS---GQGLREMKNEA-SVIAKVQHKNLVRLLGCCIDRDEKILIYEYMPN  129 (369)
Q Consensus        55 ~~lg~G~~~~v~~~~~~~-~~~valK~~~~~~---~~~~~~~~~e~-~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~  129 (369)
                      +.||.|+||.||+|++.. |+.||+|++....   ......+..|. .+++.++||||+++++.+...+..++||||+++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG   80 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            468999999999999754 8899999986432   11223344444 467889999999999999999999999999999


Q ss_pred             CChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCCCCcccc
Q 017594          130 KSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQAN  209 (369)
Q Consensus       130 ~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~~~~~~~  209 (369)
                      ++|...+..   ...+++..+..++.||+.||.|||+.+   ++||||||+||+++.++.++|+|||++.......  ..
T Consensus        81 ~~L~~~l~~---~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~--~~  152 (321)
T cd05603          81 GELFFHLQR---ERCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE--ET  152 (321)
T ss_pred             CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccCCCCC--Cc
Confidence            999877743   334788899999999999999999998   9999999999999999999999999876432211  12


Q ss_pred             cccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCccccccCcccccccc
Q 017594          210 TSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYS  289 (369)
Q Consensus       210 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  289 (369)
                      .....|++.|+|||++.+..++.++|||||||++|+|++|..||.......     ....... . ...     +     
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-----~~~~i~~-~-~~~-----~-----  215 (321)
T cd05603         153 TSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQ-----MYDNILH-K-PLQ-----L-----  215 (321)
T ss_pred             cccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHH-----HHHHHhc-C-CCC-----C-----
Confidence            233468899999999998889999999999999999999999986432110     0001100 0 000     0     


Q ss_pred             HHHHHHHHHHHHHHhhcCCCCCCCCHH
Q 017594          290 SKQMLLRYANIALLCVQESADDRPTMN  316 (369)
Q Consensus       290 ~~~~~~~l~~li~~~L~~dP~~Rps~~  316 (369)
                      +...+..+.++|.+||+.||.+||++.
T Consensus       216 ~~~~~~~~~~li~~~l~~~p~~R~~~~  242 (321)
T cd05603         216 PGGKTVAACDLLVGLLHKDQRRRLGAK  242 (321)
T ss_pred             CCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence            011255689999999999999999764

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=1.1e-37  Score=286.01  Aligned_cols=264  Identities=22%  Similarity=0.333  Sum_probs=195.6

Q ss_pred             cCCccCccccccCCccEEEEEEc-CCCEEEEEEecCCC-chhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEEEEe
Q 017594           49 NKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIYEY  126 (369)
Q Consensus        49 ~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  126 (369)
                      ++|++.+.||.|+||.||+|+.+ +++.||+|.+.... ......+.+|+.+++.++|+|++++++++..++..++||||
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   85 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY   85 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence            67999999999999999999965 47889999886442 22234567899999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCCCCc
Q 017594          127 MPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNEL  206 (369)
Q Consensus       127 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~~~~  206 (369)
                      +.+ ++..++...  ...++...+..++.||+.||.|||+.+   ++||||+|+||+++.++.++|+|||++........
T Consensus        86 ~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  159 (309)
T cd07872          86 LDK-DLKQYMDDC--GNIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSVPTK  159 (309)
T ss_pred             CCC-CHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceecCCCcc
Confidence            976 666655432  234788889999999999999999999   99999999999999999999999999875433221


Q ss_pred             ccccccccccccccCchhhcc-CCCCcccchHhHHHHHHHHHhCCCCCCCCccccccc---------chhhhhhhhcCcc
Q 017594          207 QANTSRIVGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNL---------LGYAWDLWTSNRT  276 (369)
Q Consensus       207 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~---------~~~~~~~~~~~~~  276 (369)
                        ......++..|+|||++.+ ..++.++|||||||++|+|++|+.||..........         ....|........
T Consensus       160 --~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (309)
T cd07872         160 --TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDE  237 (309)
T ss_pred             --ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhh
Confidence              1222356889999998764 468899999999999999999999996543211000         0000111000000


Q ss_pred             ccccC-cccccc---ccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 017594          277 LELID-PILEDE---YSSKQMLLRYANIALLCVQESADDRPTMNDVVS  320 (369)
Q Consensus       277 ~~~~~-~~~~~~---~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~  320 (369)
                      ..... +.....   ......+.++.++|.+||+.||.+|||+.++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~  285 (309)
T cd07872         238 FKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK  285 (309)
T ss_pred             hhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence            00000 000000   001123567899999999999999999999996

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1e-37  Score=282.95  Aligned_cols=252  Identities=26%  Similarity=0.319  Sum_probs=198.5

Q ss_pred             CCccCccccccCCccEEEEEEc-CCCEEEEEEecCCCc---hhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEEEE
Q 017594           50 KFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSG---QGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIYE  125 (369)
Q Consensus        50 ~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  125 (369)
                      .|++.+.||+|+||.||++.+. ++..||+|.+.....   .....+.+|+.+++.++|+||+++++.+..++..++|||
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence            4889999999999999999965 588999999864321   223446679999999999999999999998899999999


Q ss_pred             ecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCCCC
Q 017594          126 YMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE  205 (369)
Q Consensus       126 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~~~  205 (369)
                      |+.+++|..++... ....+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++.......
T Consensus        81 ~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~  156 (285)
T cd05605          81 LMNGGDLKFHIYNM-GNPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE  156 (285)
T ss_pred             ccCCCcHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecCCCC
Confidence            99999998877542 2234889999999999999999999999   9999999999999999999999999987654322


Q ss_pred             cccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCccccccCcccc
Q 017594          206 LQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILE  285 (369)
Q Consensus       206 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (369)
                      .   .....++..|+|||++.+..++.++|+||+|+++|+|++|..||........  .....         ..+.... 
T Consensus       157 ~---~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~--~~~~~---------~~~~~~~-  221 (285)
T cd05605         157 T---IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVK--REEVE---------RRVKEDQ-  221 (285)
T ss_pred             c---cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhH--HHHHH---------HHhhhcc-
Confidence            1   1223678899999999888899999999999999999999999964321110  00000         0000000 


Q ss_pred             ccccHHHHHHHHHHHHHHhhcCCCCCCC-----CHHHHHHH
Q 017594          286 DEYSSKQMLLRYANIALLCVQESADDRP-----TMNDVVSM  321 (369)
Q Consensus       286 ~~~~~~~~~~~l~~li~~~L~~dP~~Rp-----s~~ell~~  321 (369)
                       ...+..++..+.++|.+||+.||.+||     +++++++.
T Consensus       222 -~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~  261 (285)
T cd05605         222 -EEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH  261 (285)
T ss_pred             -cccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence             001122366789999999999999999     88899764

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=1.1e-37  Score=279.90  Aligned_cols=253  Identities=23%  Similarity=0.360  Sum_probs=200.1

Q ss_pred             hcCCccCccccccCCccEEEEEEc-CCCEEEEEEecCCCchhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEEEEe
Q 017594           48 TNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIYEY  126 (369)
Q Consensus        48 ~~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  126 (369)
                      .++|++.+.||.|++|.||+|++. +++.|++|.+..........+.+|+.+++.++|||++++++.+...+..++++||
T Consensus         8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~   87 (267)
T cd06645           8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEF   87 (267)
T ss_pred             HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEec
Confidence            458999999999999999999965 4889999998766555556778899999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCCCCc
Q 017594          127 MPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNEL  206 (369)
Q Consensus       127 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~~~~  206 (369)
                      +.+++|.+++...   ..+++..+..++.|++.|+.|||+.|   ++|+||+|+||+++.++.++|+|||++....... 
T Consensus        88 ~~~~~L~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~-  160 (267)
T cd06645          88 CGGGSLQDIYHVT---GPLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQITATI-  160 (267)
T ss_pred             cCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEccCcc-
Confidence            9999999988543   34889999999999999999999999   9999999999999999999999999987654221 


Q ss_pred             ccccccccccccccCchhhc---cCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCccccccCcc
Q 017594          207 QANTSRIVGTYGYMSPEYAL---EGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPI  283 (369)
Q Consensus       207 ~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (369)
                       .......++..|+|||.+.   ...++.++|+|||||++|+|++|..||.......     ........ ..   ..+.
T Consensus       161 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~-----~~~~~~~~-~~---~~~~  230 (267)
T cd06645         161 -AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMR-----ALFLMTKS-NF---QPPK  230 (267)
T ss_pred             -cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchh-----hHHhhhcc-CC---CCCc
Confidence             1223346788999999874   4568899999999999999999999975322110     00000000 00   0000


Q ss_pred             ccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 017594          284 LEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVS  320 (369)
Q Consensus       284 ~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~  320 (369)
                      ...   ...++..+.++|.+||+.+|++||++.+|++
T Consensus       231 ~~~---~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~  264 (267)
T cd06645         231 LKD---KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ  264 (267)
T ss_pred             ccc---cCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence            000   0112456899999999999999999999886

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=2.6e-37  Score=282.65  Aligned_cols=262  Identities=26%  Similarity=0.374  Sum_probs=204.1

Q ss_pred             HHHhcCCccCccccccCCccEEEEEEc------CCCEEEEEEecCCC-chhHHHHHHHHHHHhcC-CCCceeeeeeeEEe
Q 017594           45 STATNKFSDANKLGEGGFGPVYKGVLK------KGDEIAVKRLSGRS-GQGLREMKNEASVIAKV-QHKNLVRLLGCCID  116 (369)
Q Consensus        45 ~~~~~~y~i~~~lg~G~~~~v~~~~~~------~~~~valK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~  116 (369)
                      ....++|.+.+.||+|+||.||+|...      .+..+++|.+.... ....+.+.+|+.+++++ +|+||+++++++..
T Consensus        31 ~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~  110 (302)
T cd05055          31 EFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTI  110 (302)
T ss_pred             cccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEec
Confidence            344568999999999999999999742      24579999887543 33345688899999999 79999999999999


Q ss_pred             CCccEEEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecC
Q 017594          117 RDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFG  196 (369)
Q Consensus       117 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg  196 (369)
                      ....++++||+.+++|..++.... ...+++..+..++.|++.||.|||+++   ++|+||+|+||+++.++.++|+|||
T Consensus       111 ~~~~~lv~e~~~~~~L~~~i~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg  186 (302)
T cd05055         111 GGPILVITEYCCYGDLLNFLRRKR-ESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFG  186 (302)
T ss_pred             CCceEEEEEcCCCCcHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCc
Confidence            999999999999999998885432 233789999999999999999999998   9999999999999999999999999


Q ss_pred             CceecCCCCcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHh-CCCCCCCCcccccccchhhhhhhhcCc
Q 017594          197 MARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDLWTSNR  275 (369)
Q Consensus       197 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~  275 (369)
                      ++................++..|+|||.+.+..++.++||||+|+++|+|++ |..||........     ........ 
T Consensus       187 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~-----~~~~~~~~-  260 (302)
T cd05055         187 LARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSK-----FYKLIKEG-  260 (302)
T ss_pred             ccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHH-----HHHHHHcC-
Confidence            9876543322111222345678999999988889999999999999999998 8988754321110     00000000 


Q ss_pred             cccccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHhh
Q 017594          276 TLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNE  325 (369)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L~~~  325 (369)
                      .    ....     +...+..+.+++.+||..+|++||++.++++.|+++
T Consensus       261 ~----~~~~-----~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~  301 (302)
T cd05055         261 Y----RMAQ-----PEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ  301 (302)
T ss_pred             C----cCCC-----CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence            0    0000     011145699999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.7e-37  Score=276.09  Aligned_cols=248  Identities=29%  Similarity=0.434  Sum_probs=196.3

Q ss_pred             ccccccCCccEEEEEEcCCCEEEEEEecCCCch-hHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEEEEecCCCChh
Q 017594           55 NKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQ-GLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSLD  133 (369)
Q Consensus        55 ~~lg~G~~~~v~~~~~~~~~~valK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~  133 (369)
                      +.||.|++|.||+|.+++++.|++|.+...... ....+..|+.+++++.|+||+++++++......++++||+.+++|.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~   80 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL   80 (251)
T ss_pred             CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence            478999999999999877999999988755433 4567888999999999999999999999999999999999999998


Q ss_pred             hhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCCCCcccccccc
Q 017594          134 FFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRI  213 (369)
Q Consensus       134 ~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~  213 (369)
                      +++....  ..++...+..++.+++.++.+||+++   ++|+||+|+||+++.++.++|+|||.+...............
T Consensus        81 ~~l~~~~--~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~  155 (251)
T cd05041          81 TFLRKKK--NRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLK  155 (251)
T ss_pred             HHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccC
Confidence            8885432  24788889999999999999999998   999999999999999999999999998765432221111122


Q ss_pred             cccccccCchhhccCCCCcccchHhHHHHHHHHHh-CCCCCCCCcccccccchhhhhhhhcCccccccCccccccccHHH
Q 017594          214 VGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYSSKQ  292 (369)
Q Consensus       214 ~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  292 (369)
                      ..+..|+|||.+.+..++.++|+||||+++|+|++ |..||.......      ........ . ..        ..+..
T Consensus       156 ~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~------~~~~~~~~-~-~~--------~~~~~  219 (251)
T cd05041         156 QIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQ------TRERIESG-Y-RM--------PAPQL  219 (251)
T ss_pred             cceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHH------HHHHHhcC-C-CC--------CCCcc
Confidence            33567999999988889999999999999999999 788875432111      00000000 0 00        01112


Q ss_pred             HHHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 017594          293 MLLRYANIALLCVQESADDRPTMNDVVSMLT  323 (369)
Q Consensus       293 ~~~~l~~li~~~L~~dP~~Rps~~ell~~L~  323 (369)
                      .+..+.+++.+||..+|.+||++.++++.|.
T Consensus       220 ~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~  250 (251)
T cd05041         220 CPEEIYRLMLQCWAYDPENRPSFSEIYNELQ  250 (251)
T ss_pred             CCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence            2567999999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-38  Score=287.07  Aligned_cols=249  Identities=22%  Similarity=0.335  Sum_probs=207.7

Q ss_pred             HHhcCCccCccccccCCccEEEEE-EcCCCEEEEEEecCCCc--hhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEE
Q 017594           46 TATNKFSDANKLGEGGFGPVYKGV-LKKGDEIAVKRLSGRSG--QGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKIL  122 (369)
Q Consensus        46 ~~~~~y~i~~~lg~G~~~~v~~~~-~~~~~~valK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l  122 (369)
                      .+.+=|.+.+.||+|.|+.|-+|+ .-+|.+||||++.+...  -....+.+|+.-++.++||||++++++......+|+
T Consensus        15 kIAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyL   94 (864)
T KOG4717|consen   15 KIAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYL   94 (864)
T ss_pred             ceeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEE
Confidence            345668999999999999999999 45699999999986533  334568889999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEE-eCCCceEEeecCCceec
Q 017594          123 IYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILL-DKDMNPKISDFGMARIC  201 (369)
Q Consensus       123 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv-~~~~~~~L~Dfg~~~~~  201 (369)
                      |+|.-++|.|.+++..+..+  +++....+++.||+.|+.|+|+.+   ++||||||+|+++ ..-|-|||.|||++..+
T Consensus        95 iLELGD~GDl~DyImKHe~G--l~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf  169 (864)
T KOG4717|consen   95 ILELGDGGDLFDYIMKHEEG--LNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKF  169 (864)
T ss_pred             EEEecCCchHHHHHHhhhcc--ccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccC
Confidence            99999999999999765544  899999999999999999999999   9999999999887 56689999999999877


Q ss_pred             CCCCcccccccccccccccCchhhccCCCC-cccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCcccccc
Q 017594          202 GGNELQANTSRIVGTYGYMSPEYALEGIFS-IKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELI  280 (369)
Q Consensus       202 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (369)
                      ..+..   ....+|...|.|||++.+..|+ ++.||||||+|||.|.+|++||+...+.                  +.+
T Consensus       170 ~PG~k---L~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDS------------------ETL  228 (864)
T KOG4717|consen  170 QPGKK---LTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDS------------------ETL  228 (864)
T ss_pred             CCcch---hhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccch------------------hhh
Confidence            64433   3345889999999999999986 6799999999999999999999744321                  111


Q ss_pred             Cccccccc-cHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 017594          281 DPILEDEY-SSKQMLLRYANIALLCVQESADDRPTMNDVVS  320 (369)
Q Consensus       281 ~~~~~~~~-~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~  320 (369)
                      ..++.=.+ .+...+.++.+||..||..||.+|.+.++|..
T Consensus       229 TmImDCKYtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s  269 (864)
T KOG4717|consen  229 TMIMDCKYTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVS  269 (864)
T ss_pred             hhhhcccccCchhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence            11221111 24445888999999999999999999999986

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=1.8e-37  Score=281.09  Aligned_cols=265  Identities=25%  Similarity=0.311  Sum_probs=196.7

Q ss_pred             CCccCccccccCCccEEEEEEc-CCCEEEEEEecCCC--chhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEEEEe
Q 017594           50 KFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS--GQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIYEY  126 (369)
Q Consensus        50 ~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  126 (369)
                      +|++.+.||.|++|.||+|+.+ ++..|++|.+....  ......+..|+.+++.+.|||++++++++..+...++|+||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF   80 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence            5889999999999999999965 58899999886432  22346678899999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCCCCc
Q 017594          127 MPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNEL  206 (369)
Q Consensus       127 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~~~~  206 (369)
                      +. +++..++........+++..++.++.||+.||.|||+.+   ++|+||+|+||+++.++.++|+|||++....... 
T Consensus        81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-  155 (285)
T cd07861          81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV-  155 (285)
T ss_pred             CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecCCCc-
Confidence            97 477777655444456899999999999999999999998   9999999999999999999999999987654221 


Q ss_pred             ccccccccccccccCchhhcc-CCCCcccchHhHHHHHHHHHhCCCCCCCCccccccc---------chhhhhhhhc-Cc
Q 017594          207 QANTSRIVGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNL---------LGYAWDLWTS-NR  275 (369)
Q Consensus       207 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~---------~~~~~~~~~~-~~  275 (369)
                       .......++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||..........         ....|..... ..
T Consensus       156 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (285)
T cd07861         156 -RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPD  234 (285)
T ss_pred             -ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHH
Confidence             11122346788999998765 457889999999999999999999986432111000         0000000000 00


Q ss_pred             cccccCccccccc--cHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 017594          276 TLELIDPILEDEY--SSKQMLLRYANIALLCVQESADDRPTMNDVVS  320 (369)
Q Consensus       276 ~~~~~~~~~~~~~--~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~  320 (369)
                      ..........+..  ....++.++.++|.+||+.||.+|||+.+|++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~  281 (285)
T cd07861         235 YKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN  281 (285)
T ss_pred             HHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence            0000000000000  01113567899999999999999999999986

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=9.4e-38  Score=278.44  Aligned_cols=250  Identities=22%  Similarity=0.309  Sum_probs=200.1

Q ss_pred             CCccCccccccCCccEEEEEEc-CCCEEEEEEecCC-CchhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEEEEec
Q 017594           50 KFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGR-SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIYEYM  127 (369)
Q Consensus        50 ~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~  127 (369)
                      +|++.+.||.|++|.||++++. +++.+++|.+... .....+.+..|+.+++.++|+|++++.+.+......++++||+
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC   80 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence            5889999999999999999965 4889999988543 2334567788999999999999999999999999999999999


Q ss_pred             CCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCCCCcc
Q 017594          128 PNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQ  207 (369)
Q Consensus       128 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~~~~~  207 (369)
                      .++++.+++... ....+++..+..++.||+.||.+||+++   ++|+||+|+||+++.++.++|+|||.+........ 
T Consensus        81 ~~~~l~~~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~-  155 (255)
T cd08219          81 DGGDLMQKIKLQ-RGKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA-  155 (255)
T ss_pred             CCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeeccccc-
Confidence            999998877542 2344788899999999999999999999   99999999999999999999999999876543221 


Q ss_pred             cccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCccccccCcccccc
Q 017594          208 ANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDE  287 (369)
Q Consensus       208 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  287 (369)
                       ......++..|+|||++.+..++.++|+||+|+++|+|++|..||.......     ...... .....    + +   
T Consensus       156 -~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~-----~~~~~~-~~~~~----~-~---  220 (255)
T cd08219         156 -YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKN-----LILKVC-QGSYK----P-L---  220 (255)
T ss_pred             -ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHH-----HHHHHh-cCCCC----C-C---
Confidence             1223457888999999998889999999999999999999999986432110     011110 01000    0 0   


Q ss_pred             ccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 017594          288 YSSKQMLLRYANIALLCVQESADDRPTMNDVVSM  321 (369)
Q Consensus       288 ~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~  321 (369)
                        +..++..+.++|.+||+.||++||++.+++..
T Consensus       221 --~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         221 --PSHYSYELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             --CcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence              11125568999999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1e-38  Score=298.67  Aligned_cols=246  Identities=26%  Similarity=0.414  Sum_probs=202.3

Q ss_pred             cccccCCccEEEEEEcC-CCEEEEEEecCCCchhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEEEEecCCCChhh
Q 017594           56 KLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSLDF  134 (369)
Q Consensus        56 ~lg~G~~~~v~~~~~~~-~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~  134 (369)
                      +||+|.||+||.|++.+ ...+|||.+...+....+-+.+|+..-++|+|.||+++++.+..+...-++||-++||+|..
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs  661 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS  661 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence            68999999999999765 66799999987777777889999999999999999999999988888889999999999999


Q ss_pred             hhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEe-CCCceEEeecCCceecCCCCcccccccc
Q 017594          135 FLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLD-KDMNPKISDFGMARICGGNELQANTSRI  213 (369)
Q Consensus       135 ~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~-~~~~~~L~Dfg~~~~~~~~~~~~~~~~~  213 (369)
                      ++...-+...=++..+-.+.+||+.||.|||.+.   |+|||||-+|++|+ -.|.+||.|||-+..+..  ..+.....
T Consensus       662 LLrskWGPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAg--inP~TETF  736 (1226)
T KOG4279|consen  662 LLRSKWGPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAG--INPCTETF  736 (1226)
T ss_pred             HHHhccCCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhcc--CCcccccc
Confidence            9976444333377888899999999999999998   99999999999995 578899999998887643  33455667


Q ss_pred             cccccccCchhhccC--CCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCccccccCccccccccHH
Q 017594          214 VGTYGYMSPEYALEG--IFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYSSK  291 (369)
Q Consensus       214 ~~~~~y~aPE~~~~~--~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  291 (369)
                      .||..|+|||++..+  .|+.++|||||||++.+|.||++||-......       ...+.-+       ..-.....+.
T Consensus       737 TGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgspq-------AAMFkVG-------myKvHP~iPe  802 (1226)
T KOG4279|consen  737 TGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQ-------AAMFKVG-------MYKVHPPIPE  802 (1226)
T ss_pred             ccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChh-------Hhhhhhc-------ceecCCCCcH
Confidence            899999999999865  48999999999999999999999985332111       0001111       0001122355


Q ss_pred             HHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 017594          292 QMLLRYANIALLCVQESADDRPTMNDVVS  320 (369)
Q Consensus       292 ~~~~~l~~li~~~L~~dP~~Rps~~ell~  320 (369)
                      +.+.+.+.+|.+|+.+||-+||+|.++|.
T Consensus       803 elsaeak~FilrcFepd~~~R~sA~~LL~  831 (1226)
T KOG4279|consen  803 ELSAEAKNFILRCFEPDPCDRPSAKDLLQ  831 (1226)
T ss_pred             HHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence            56889999999999999999999999995

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=6.1e-39  Score=281.82  Aligned_cols=259  Identities=23%  Similarity=0.304  Sum_probs=193.4

Q ss_pred             cCCccCccccccCCccEEEEEEcC-CCEEEEEEecCCCchhHHHHHHHHHHHhcCCCCceeeeeeeEEeC--C---ccEE
Q 017594           49 NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDR--D---EKIL  122 (369)
Q Consensus        49 ~~y~i~~~lg~G~~~~v~~~~~~~-~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~---~~~l  122 (369)
                      -.|+..+.+|+|+||.||.|+... ++.||||++..+.    +.-..|+++|+.+.||||+++..+|...  +   ...+
T Consensus        24 i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~----r~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnl   99 (364)
T KOG0658|consen   24 ISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDK----RYKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNL   99 (364)
T ss_pred             EEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCC----CcCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHH
Confidence            457888999999999999999544 7999999987554    2445789999999999999999888643  2   3468


Q ss_pred             EEEecCCCChhhhhcCC-CccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCC-CceEEeecCCcee
Q 017594          123 IYEYMPNKSLDFFLFDP-TKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKD-MNPKISDFGMARI  200 (369)
Q Consensus       123 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~-~~~~L~Dfg~~~~  200 (369)
                      ||||++. +|.+.+... ..+..++...+.-+..||++||+|||..|   ||||||||.|++|+.+ |.+||+|||.+..
T Consensus       100 VleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFGSAK~  175 (364)
T KOG0658|consen  100 VLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFGSAKV  175 (364)
T ss_pred             HHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCCccee
Confidence            9999965 666666431 22345788888999999999999999998   9999999999999876 8999999999988


Q ss_pred             cCCCCcccccccccccccccCchhhccC-CCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcC-----
Q 017594          201 CGGNELQANTSRIVGTYGYMSPEYALEG-IFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSN-----  274 (369)
Q Consensus       201 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~-----  274 (369)
                      ...+...   .....+..|+|||.+.+. .|+.+.||||.||++.||+-|++.|...+...  .+....+.+...     
T Consensus       176 L~~~epn---iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~d--QL~eIik~lG~Pt~e~I  250 (364)
T KOG0658|consen  176 LVKGEPN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVD--QLVEIIKVLGTPTREDI  250 (364)
T ss_pred             eccCCCc---eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHH--HHHHHHHHhCCCCHHHH
Confidence            7644432   223457789999998865 69999999999999999999999998644222  111111111110     


Q ss_pred             ---------ccccccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 017594          275 ---------RTLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVS  320 (369)
Q Consensus       275 ---------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~  320 (369)
                               .....+.............++++.+|+.++|+.+|.+|.++.+++.
T Consensus       251 ~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~  305 (364)
T KOG0658|consen  251 KSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA  305 (364)
T ss_pred             hhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence                     0001111111111123334678999999999999999999999983

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=5.5e-38  Score=290.13  Aligned_cols=238  Identities=22%  Similarity=0.284  Sum_probs=184.9

Q ss_pred             ccccccCCccEEEEEEc-CCCEEEEEEecCCC---chhHHHHHHHHH-HHhcCCCCceeeeeeeEEeCCccEEEEEecCC
Q 017594           55 NKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS---GQGLREMKNEAS-VIAKVQHKNLVRLLGCCIDRDEKILIYEYMPN  129 (369)
Q Consensus        55 ~~lg~G~~~~v~~~~~~-~~~~valK~~~~~~---~~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~  129 (369)
                      +.||+|+||.||+|+.+ +|+.||+|++....   ......+..|.. +++.++||||+++++.+...+..++||||+.+
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG   80 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence            46899999999999965 48899999986431   122233444444 56778999999999999999999999999999


Q ss_pred             CChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCCCCcccc
Q 017594          130 KSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQAN  209 (369)
Q Consensus       130 ~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~~~~~~~  209 (369)
                      ++|...+..   ...+++..+..++.||+.||.|||+.|   ++||||||+||+++.++.++|+|||++.......  ..
T Consensus        81 ~~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~--~~  152 (325)
T cd05604          81 GELFFHLQR---ERSFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS--DT  152 (325)
T ss_pred             CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccCCCCC--CC
Confidence            999887743   345889999999999999999999999   9999999999999999999999999986432211  12


Q ss_pred             cccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCccccccCcccccccc
Q 017594          210 TSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYS  289 (369)
Q Consensus       210 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  289 (369)
                      .....|+..|+|||++.+..++.++|||||||++|+|++|..||.......     ....... ...  .+.        
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~-----~~~~~~~-~~~--~~~--------  216 (325)
T cd05604         153 TTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAE-----MYDNILH-KPL--VLR--------  216 (325)
T ss_pred             cccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHH-----HHHHHHc-CCc--cCC--------
Confidence            233468999999999999999999999999999999999999986432110     0111110 000  000        


Q ss_pred             HHHHHHHHHHHHHHhhcCCCCCCCCHHH
Q 017594          290 SKQMLLRYANIALLCVQESADDRPTMND  317 (369)
Q Consensus       290 ~~~~~~~l~~li~~~L~~dP~~Rps~~e  317 (369)
                       ...+..+.++|.+||+.+|.+||++.+
T Consensus       217 -~~~~~~~~~ll~~ll~~~p~~R~~~~~  243 (325)
T cd05604         217 -PGASLTAWSILEELLEKDRQRRLGAKE  243 (325)
T ss_pred             -CCCCHHHHHHHHHHhccCHHhcCCCCC
Confidence             012566889999999999999998863

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=1.7e-37  Score=286.97  Aligned_cols=242  Identities=23%  Similarity=0.352  Sum_probs=189.0

Q ss_pred             ccccccCCccEEEEEEcC-CCEEEEEEecCCC---chhHHHHHHHHHHHhcC-CCCceeeeeeeEEeCCccEEEEEecCC
Q 017594           55 NKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRS---GQGLREMKNEASVIAKV-QHKNLVRLLGCCIDRDEKILIYEYMPN  129 (369)
Q Consensus        55 ~~lg~G~~~~v~~~~~~~-~~~valK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~  129 (369)
                      +.||+|+||.||+|+... ++.||+|++....   ....+.+..|..++.++ .||+|+.+++++...+..++||||+.+
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            479999999999999654 7889999987432   23345677888988888 699999999999999999999999999


Q ss_pred             CChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCCCCcccc
Q 017594          130 KSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQAN  209 (369)
Q Consensus       130 ~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~~~~~~~  209 (369)
                      ++|..++...   ..+++..+..++.||+.||+|||+++   ++||||||+||+++.++.++|+|||++.......  ..
T Consensus        81 ~~L~~~~~~~---~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~  152 (327)
T cd05617          81 GDLMFHMQRQ---RKLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG--DT  152 (327)
T ss_pred             CcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceeccCCC--Cc
Confidence            9998877432   34899999999999999999999999   9999999999999999999999999886432211  11


Q ss_pred             cccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCccccc-ccchhhhhhhhcCccccccCccccccc
Q 017594          210 TSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSL-NLLGYAWDLWTSNRTLELIDPILEDEY  288 (369)
Q Consensus       210 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~  288 (369)
                      .....|++.|+|||++.+..++.++|+|||||++|+|++|..||........ .............. ..     +    
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-~~-----~----  222 (327)
T cd05617         153 TSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKP-IR-----I----  222 (327)
T ss_pred             eecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCC-CC-----C----
Confidence            2334689999999999999999999999999999999999999964332111 11111111111110 00     0    


Q ss_pred             cHHHHHHHHHHHHHHhhcCCCCCCCCH
Q 017594          289 SSKQMLLRYANIALLCVQESADDRPTM  315 (369)
Q Consensus       289 ~~~~~~~~l~~li~~~L~~dP~~Rps~  315 (369)
                       +...+..+.++|.+||+.||.+|+++
T Consensus       223 -p~~~~~~~~~li~~~L~~dP~~R~~~  248 (327)
T cd05617         223 -PRFLSVKASHVLKGFLNKDPKERLGC  248 (327)
T ss_pred             -CCCCCHHHHHHHHHHhccCHHHcCCC
Confidence             11125668999999999999999985

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=8e-38  Score=293.57  Aligned_cols=259  Identities=20%  Similarity=0.257  Sum_probs=200.2

Q ss_pred             hhHHHHhcCCccCccccccCCccEEEEEEcC-CCEEEEEEecCC---CchhHHHHHHHHHHHhcCCCCceeeeeeeEEeC
Q 017594           42 SSVSTATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGR---SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDR  117 (369)
Q Consensus        42 ~~~~~~~~~y~i~~~lg~G~~~~v~~~~~~~-~~~valK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~  117 (369)
                      .......++|++.+.||+|+||.||+|+.+. ++.+|+|++...   .......+.+|+.+++.+.||||+++++++..+
T Consensus        36 ~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~  115 (370)
T cd05621          36 RKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDD  115 (370)
T ss_pred             HhcCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcC
Confidence            3344556889999999999999999999764 888999998532   122345577899999999999999999999999


Q ss_pred             CccEEEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCC
Q 017594          118 DEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGM  197 (369)
Q Consensus       118 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~  197 (369)
                      +..++||||+.+++|.+++..    ..+++..+..++.||+.||+|||+.+   ++||||||+||+++.++.++|+|||+
T Consensus       116 ~~~~lv~Ey~~gg~L~~~l~~----~~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~  188 (370)
T cd05621         116 KYLYMVMEYMPGGDLVNLMSN----YDVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGT  188 (370)
T ss_pred             CEEEEEEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEeccc
Confidence            999999999999999998843    23788889999999999999999999   99999999999999999999999999


Q ss_pred             ceecCCCCcccccccccccccccCchhhccC----CCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhc
Q 017594          198 ARICGGNELQANTSRIVGTYGYMSPEYALEG----IFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTS  273 (369)
Q Consensus       198 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~----~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~  273 (369)
                      +........ .......|++.|+|||++.+.    .++.++|+|||||++|+|++|..||.......     ........
T Consensus       189 a~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~-----~~~~i~~~  262 (370)
T cd05621         189 CMKMDETGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVG-----TYSKIMDH  262 (370)
T ss_pred             ceecccCCc-eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHH-----HHHHHHhC
Confidence            886543221 112345689999999998753    37889999999999999999999996432110     01111110


Q ss_pred             CccccccCccccccccHHHHHHHHHHHHHHhhcCCCCC--CCCHHHHHHH
Q 017594          274 NRTLELIDPILEDEYSSKQMLLRYANIALLCVQESADD--RPTMNDVVSM  321 (369)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~--Rps~~ell~~  321 (369)
                      ......     ..   ....+..+.+++..||+.++.+  |+++.++++.
T Consensus       263 ~~~~~~-----p~---~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h  304 (370)
T cd05621         263 KNSLNF-----PE---DVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH  304 (370)
T ss_pred             CcccCC-----CC---cccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence            000000     00   1122566889999999865544  8999999975

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=3.7e-38  Score=291.23  Aligned_cols=240  Identities=23%  Similarity=0.283  Sum_probs=185.1

Q ss_pred             ccccccCCccEEEEEEcC-CCEEEEEEecCCC---chhHHHHHHH-HHHHhcCCCCceeeeeeeEEeCCccEEEEEecCC
Q 017594           55 NKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRS---GQGLREMKNE-ASVIAKVQHKNLVRLLGCCIDRDEKILIYEYMPN  129 (369)
Q Consensus        55 ~~lg~G~~~~v~~~~~~~-~~~valK~~~~~~---~~~~~~~~~e-~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~  129 (369)
                      +.||+|+||.||+|+++. ++.||+|++....   ......+..| ..+++.+.|+||+++++++...+..++||||+.+
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING   80 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence            469999999999999764 7789999986432   1112233333 3456788999999999999999999999999999


Q ss_pred             CChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCCCCcccc
Q 017594          130 KSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQAN  209 (369)
Q Consensus       130 ~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~~~~~~~  209 (369)
                      ++|..++...   ..+.+..+..++.||+.||.|||+.|   ++||||||+||+++.++.++|+|||++.......  ..
T Consensus        81 ~~L~~~~~~~---~~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~--~~  152 (325)
T cd05602          81 GELFYHLQRE---RCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN--GT  152 (325)
T ss_pred             CcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCcccccCC--CC
Confidence            9998888542   34778888899999999999999999   9999999999999999999999999986532211  12


Q ss_pred             cccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCccccccCcccccccc
Q 017594          210 TSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYS  289 (369)
Q Consensus       210 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  289 (369)
                      .....|++.|+|||++.+..++.++|||||||++|+|++|..||.......     ...... ... .. +.        
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-----~~~~i~-~~~-~~-~~--------  216 (325)
T cd05602         153 TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE-----MYDNIL-NKP-LQ-LK--------  216 (325)
T ss_pred             cccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHH-----HHHHHH-hCC-cC-CC--------
Confidence            233468999999999999999999999999999999999999986432111     000100 000 00 00        


Q ss_pred             HHHHHHHHHHHHHHhhcCCCCCCCCHHHHH
Q 017594          290 SKQMLLRYANIALLCVQESADDRPTMNDVV  319 (369)
Q Consensus       290 ~~~~~~~l~~li~~~L~~dP~~Rps~~ell  319 (369)
                       ...+..+.++|.+||+.+|.+||++.+.+
T Consensus       217 -~~~~~~~~~li~~~l~~~p~~R~~~~~~~  245 (325)
T cd05602         217 -PNITNSARHLLEGLLQKDRTKRLGAKDDF  245 (325)
T ss_pred             -CCCCHHHHHHHHHHcccCHHHCCCCCCCH
Confidence             11256689999999999999999987433

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=3.8e-37  Score=280.93  Aligned_cols=262  Identities=27%  Similarity=0.381  Sum_probs=202.2

Q ss_pred             cCCccCccccccCCccEEEEEEcC-CC--EEEEEEecCC-CchhHHHHHHHHHHHhcC-CCCceeeeeeeEEeCCccEEE
Q 017594           49 NKFSDANKLGEGGFGPVYKGVLKK-GD--EIAVKRLSGR-SGQGLREMKNEASVIAKV-QHKNLVRLLGCCIDRDEKILI  123 (369)
Q Consensus        49 ~~y~i~~~lg~G~~~~v~~~~~~~-~~--~valK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv  123 (369)
                      ++|++.+.||.|+||.||+|..++ +.  .+++|.+... .....+.+..|+.++.++ .|||++++++++......+++
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv   81 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA   81 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence            579999999999999999999654 33  4688887642 333456788899999999 799999999999988889999


Q ss_pred             EEecCCCChhhhhcCCC-------------ccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCce
Q 017594          124 YEYMPNKSLDFFLFDPT-------------KRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNP  190 (369)
Q Consensus       124 ~e~~~~~~L~~~l~~~~-------------~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~  190 (369)
                      +||+.+++|.+++....             ....+++..++.++.||+.||+|||+.+   ++|+||||+||+++.++.+
T Consensus        82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~  158 (297)
T cd05089          82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLAS  158 (297)
T ss_pred             EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCeE
Confidence            99999999998885422             1134788899999999999999999998   9999999999999999999


Q ss_pred             EEeecCCceecCCCCcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHh-CCCCCCCCcccccccchhhhh
Q 017594          191 KISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWD  269 (369)
Q Consensus       191 ~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~  269 (369)
                      +|+|||++......   ........+..|+|||...+..++.++|||||||++|+|++ |..||.......      ...
T Consensus       159 kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~------~~~  229 (297)
T cd05089         159 KIADFGLSRGEEVY---VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAE------LYE  229 (297)
T ss_pred             EECCcCCCccccce---eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH------HHH
Confidence            99999987532211   01111122456999999988889999999999999999997 999985432111      001


Q ss_pred             hhhcCccccccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHhhhhccCCC
Q 017594          270 LWTSNRTLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNEAATLLPP  332 (369)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L~~~~~~~~~~  332 (369)
                      .....     .....     +..++..+.+++.+||+.+|.+||++.++++.|+.+.......
T Consensus       230 ~~~~~-----~~~~~-----~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~~~~  282 (297)
T cd05089         230 KLPQG-----YRMEK-----PRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARKAY  282 (297)
T ss_pred             HHhcC-----CCCCC-----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhccc
Confidence            11000     00000     1112567899999999999999999999999999888765433

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=2.1e-37  Score=277.76  Aligned_cols=251  Identities=25%  Similarity=0.415  Sum_probs=199.0

Q ss_pred             CCccCccccccCCccEEEEEEcCCCEEEEEEecCCC------chhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEE
Q 017594           50 KFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRS------GQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILI  123 (369)
Q Consensus        50 ~y~i~~~lg~G~~~~v~~~~~~~~~~valK~~~~~~------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv  123 (369)
                      +|++.+.||.|+||.||+|...+|+.+++|.+....      ......+.+|++.++.++|+|++++.+++......+++
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   80 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF   80 (265)
T ss_pred             CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence            689999999999999999998789999999886432      12235678899999999999999999999999999999


Q ss_pred             EEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCC
Q 017594          124 YEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGG  203 (369)
Q Consensus       124 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~  203 (369)
                      +||+.+++|.+++...   ..+++..++.++.|++.||++||+.+   ++|+||+|+||+++.++.++|+|||++.....
T Consensus        81 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~  154 (265)
T cd06631          81 MEFVPGGSISSILNRF---GPLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAW  154 (265)
T ss_pred             EecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHhhhh
Confidence            9999999999998543   34788899999999999999999998   99999999999999999999999998875432


Q ss_pred             CCc----ccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCccccc
Q 017594          204 NEL----QANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLEL  279 (369)
Q Consensus       204 ~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (369)
                      ...    ........++..|+|||.+.+..++.++|+||||+++|+|++|..||........     ..........   
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~-----~~~~~~~~~~---  226 (265)
T cd06631         155 VGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAA-----MFYIGAHRGL---  226 (265)
T ss_pred             ccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHH-----HHHhhhccCC---
Confidence            111    1111234578889999999988899999999999999999999999864321110     0000000000   


Q ss_pred             cCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 017594          280 IDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVS  320 (369)
Q Consensus       280 ~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~  320 (369)
                       .+.+.     ..++.++.++|.+||+.+|++||++.++++
T Consensus       227 -~~~~~-----~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~  261 (265)
T cd06631         227 -MPRLP-----DSFSAAAIDFVTSCLTRDQHERPSALQLLR  261 (265)
T ss_pred             -CCCCC-----CCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence             01111     112567899999999999999999999985

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=1.1e-37  Score=282.66  Aligned_cols=271  Identities=24%  Similarity=0.374  Sum_probs=199.3

Q ss_pred             cCCccCccccccCCccEEEEEE-----cCCCEEEEEEecCCC-chhHHHHHHHHHHHhcCCCCceeeeeeeEEeC--Ccc
Q 017594           49 NKFSDANKLGEGGFGPVYKGVL-----KKGDEIAVKRLSGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCCIDR--DEK  120 (369)
Q Consensus        49 ~~y~i~~~lg~G~~~~v~~~~~-----~~~~~valK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~  120 (369)
                      +-|++++.||+|+||.||.|+.     .++..|++|.+.... ......+.+|+.+++.+.|+|++++.+++...  ...
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (284)
T cd05079           4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI   83 (284)
T ss_pred             hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence            4479999999999999999983     247889999986443 33446788999999999999999999988765  567


Q ss_pred             EEEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCcee
Q 017594          121 ILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARI  200 (369)
Q Consensus       121 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~  200 (369)
                      ++++||+++++|..++....  ..+++..++.++.||+.||+|||+.|   ++|+||+|+||+++.++.++|+|||++..
T Consensus        84 ~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~~~  158 (284)
T cd05079          84 KLIMEFLPSGSLKEYLPRNK--NKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKA  158 (284)
T ss_pred             EEEEEccCCCCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCccccc
Confidence            99999999999999885432  34788999999999999999999999   99999999999999999999999999876


Q ss_pred             cCCCCccc-ccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCccccc
Q 017594          201 CGGNELQA-NTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLEL  279 (369)
Q Consensus       201 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (369)
                      ........ ......++..|+|||.+.+..++.++||||||+++|+|+++..|+..........................
T Consensus       159 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (284)
T cd05079         159 IETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRV  238 (284)
T ss_pred             cccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHH
Confidence            64332211 11223456679999999888899999999999999999998765422110000000000000000000000


Q ss_pred             cCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHhh
Q 017594          280 IDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNE  325 (369)
Q Consensus       280 ~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L~~~  325 (369)
                      +.... .......++..+.+++.+||+.+|.+||++.++++.|+.+
T Consensus       239 ~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~  283 (284)
T cd05079         239 LEEGK-RLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI  283 (284)
T ss_pred             HHcCc-cCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence            00000 0000112356799999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3.3e-38  Score=280.41  Aligned_cols=261  Identities=21%  Similarity=0.258  Sum_probs=208.2

Q ss_pred             hhhHHHHhcCCccCccccccCCccEEEEEEcC-CCEEEEEEecCCC---chhHHHHHHHHHHHhcCCCCceeeeeeeEEe
Q 017594           41 FSSVSTATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRS---GQGLREMKNEASVIAKVQHKNLVRLLGCCID  116 (369)
Q Consensus        41 ~~~~~~~~~~y~i~~~lg~G~~~~v~~~~~~~-~~~valK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~  116 (369)
                      .+.+....+.|++++.||+|..|+||+|+.++ +..+|+|++.+..   .....++..|.++|..+.||.++.++..|+.
T Consensus        69 ~~~~~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet  148 (459)
T KOG0610|consen   69 SKDGSLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFET  148 (459)
T ss_pred             cCCCccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeec
Confidence            34456667789999999999999999999765 6889999997553   3445677789999999999999999999999


Q ss_pred             CCccEEEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecC
Q 017594          117 RDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFG  196 (369)
Q Consensus       117 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg  196 (369)
                      +...|++||||.||.|..+.+.+ ....+++..++-++..++-||+|||.+|   |+.|||||+||||-++|++.|.||.
T Consensus       149 ~~~~cl~meyCpGGdL~~LrqkQ-p~~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFD  224 (459)
T KOG0610|consen  149 DKYSCLVMEYCPGGDLHSLRQKQ-PGKRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFD  224 (459)
T ss_pred             cceeEEEEecCCCccHHHHHhhC-CCCccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeecc
Confidence            99999999999999998887654 4456899999999999999999999999   9999999999999999999999999


Q ss_pred             CceecCCCC---------------------------------cc---------------------cccccccccccccCc
Q 017594          197 MARICGGNE---------------------------------LQ---------------------ANTSRIVGTYGYMSP  222 (369)
Q Consensus       197 ~~~~~~~~~---------------------------------~~---------------------~~~~~~~~~~~y~aP  222 (369)
                      ++..+....                                 ..                     .......||-+|+||
T Consensus       225 LS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAP  304 (459)
T KOG0610|consen  225 LSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAP  304 (459)
T ss_pred             ccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccc
Confidence            876552100                                 00                     000113588899999


Q ss_pred             hhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCccccccCccccccccHHHHHHHHHHHHH
Q 017594          223 EYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYSSKQMLLRYANIAL  302 (369)
Q Consensus       223 E~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  302 (369)
                      |++.+...+.++|.|+||+.+|||+.|..||........              ....+...+.-.- ....+..+.+||+
T Consensus       305 EvI~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~T--------------l~NIv~~~l~Fp~-~~~vs~~akDLIr  369 (459)
T KOG0610|consen  305 EVIRGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKET--------------LRNIVGQPLKFPE-EPEVSSAAKDLIR  369 (459)
T ss_pred             eeeecCCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhh--------------HHHHhcCCCcCCC-CCcchhHHHHHHH
Confidence            999999999999999999999999999999975442221              1111110000000 0023677999999


Q ss_pred             HhhcCCCCCCCC----HHHHHH
Q 017594          303 LCVQESADDRPT----MNDVVS  320 (369)
Q Consensus       303 ~~L~~dP~~Rps----~~ell~  320 (369)
                      ++|-.||++|..    |.||-+
T Consensus       370 ~LLvKdP~kRlg~~rGA~eIK~  391 (459)
T KOG0610|consen  370 KLLVKDPSKRLGSKRGAAEIKR  391 (459)
T ss_pred             HHhccChhhhhccccchHHhhc
Confidence            999999999998    778764

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-37  Score=277.41  Aligned_cols=253  Identities=24%  Similarity=0.392  Sum_probs=203.1

Q ss_pred             cCCccCccccccCCccEEEEEEc-CCCEEEEEEecCCCchhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEEEEec
Q 017594           49 NKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIYEYM  127 (369)
Q Consensus        49 ~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~  127 (369)
                      ++|++.+.||.|++|.||+|... ++..+++|.+..........+..|+.+++.++|||++++++++......+++|||+
T Consensus         3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~   82 (262)
T cd06613           3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC   82 (262)
T ss_pred             cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence            68999999999999999999965 47889999998766556788899999999999999999999999999999999999


Q ss_pred             CCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCCCCcc
Q 017594          128 PNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQ  207 (369)
Q Consensus       128 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~~~~~  207 (369)
                      .+++|.+++...  ...+++..++.++.|++.||.|||+++   ++|+||+|+||+++.++.++|+|||.+.......  
T Consensus        83 ~~~~l~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~--  155 (262)
T cd06613          83 GGGSLQDIYQVT--RGPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLTATI--  155 (262)
T ss_pred             CCCcHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhhhhh--
Confidence            999999887543  234889999999999999999999998   9999999999999999999999999987654321  


Q ss_pred             cccccccccccccCchhhccC---CCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCccccccCccc
Q 017594          208 ANTSRIVGTYGYMSPEYALEG---IFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPIL  284 (369)
Q Consensus       208 ~~~~~~~~~~~y~aPE~~~~~---~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (369)
                      .......++..|+|||.+.+.   .++.++|+||||+++|+|++|..||........     .... ....   .....+
T Consensus       156 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~-----~~~~-~~~~---~~~~~~  226 (262)
T cd06613         156 AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRA-----LFLI-SKSN---FPPPKL  226 (262)
T ss_pred             hccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH-----HHHH-Hhcc---CCCccc
Confidence            111223567789999998766   789999999999999999999999864321110     0000 0000   000000


Q ss_pred             cccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 017594          285 EDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVS  320 (369)
Q Consensus       285 ~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~  320 (369)
                         ......+.++.+++.+||+.+|.+||++.+++.
T Consensus       227 ---~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  259 (262)
T cd06613         227 ---KDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ  259 (262)
T ss_pred             ---cchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence               012234677999999999999999999999985

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=5.1e-37  Score=282.34  Aligned_cols=262  Identities=27%  Similarity=0.417  Sum_probs=203.0

Q ss_pred             hcCCccCccccccCCccEEEEEEc--------CCCEEEEEEecCCC-chhHHHHHHHHHHHhcC-CCCceeeeeeeEEeC
Q 017594           48 TNKFSDANKLGEGGFGPVYKGVLK--------KGDEIAVKRLSGRS-GQGLREMKNEASVIAKV-QHKNLVRLLGCCIDR  117 (369)
Q Consensus        48 ~~~y~i~~~lg~G~~~~v~~~~~~--------~~~~valK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~  117 (369)
                      ..+|.+.+.||+|++|.||+|+..        .+..+++|.+.... ......+..|+..++.+ .||||+++++++...
T Consensus        11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~   90 (314)
T cd05099          11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQE   90 (314)
T ss_pred             HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence            468999999999999999999742        24568999887442 33456678899999999 699999999999988


Q ss_pred             CccEEEEEecCCCChhhhhcCCC-------------ccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEE
Q 017594          118 DEKILIYEYMPNKSLDFFLFDPT-------------KRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILL  184 (369)
Q Consensus       118 ~~~~lv~e~~~~~~L~~~l~~~~-------------~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv  184 (369)
                      ...++++||+.+++|.+++....             ....+++..+..++.||+.||.|||+.|   ++|+||+|+||++
T Consensus        91 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill  167 (314)
T cd05099          91 GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNVLV  167 (314)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeEEE
Confidence            88999999999999998885432             1234788889999999999999999998   9999999999999


Q ss_pred             eCCCceEEeecCCceecCCCCcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHh-CCCCCCCCccccccc
Q 017594          185 DKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNL  263 (369)
Q Consensus       185 ~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~t-g~~p~~~~~~~~~~~  263 (369)
                      +.++.++|+|||.+................++..|+|||.+.+..++.++|+||||+++|+|++ |..||.......   
T Consensus       168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~---  244 (314)
T cd05099         168 TEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEE---  244 (314)
T ss_pred             cCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHH---
Confidence            9999999999999876543221111111223457999999988889999999999999999999 888875332110   


Q ss_pred             chhhhhhhhcCccccccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHhhhhc
Q 017594          264 LGYAWDLWTSNRTLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNEAAT  328 (369)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L~~~~~~  328 (369)
                         .............          +..++.++.+++.+||..+|++||++.++++.|..+...
T Consensus       245 ---~~~~~~~~~~~~~----------~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~  296 (314)
T cd05099         245 ---LFKLLREGHRMDK----------PSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAA  296 (314)
T ss_pred             ---HHHHHHcCCCCCC----------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHH
Confidence               1111111110000          111245688999999999999999999999999988764

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=1.1e-37  Score=282.90  Aligned_cols=261  Identities=23%  Similarity=0.327  Sum_probs=189.4

Q ss_pred             CCccCccccccCCccEEEEEEc-CCCEEEEEEecCCC--chhHHHHHHHHHHHhcC---CCCceeeeeeeEEeC-----C
Q 017594           50 KFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS--GQGLREMKNEASVIAKV---QHKNLVRLLGCCIDR-----D  118 (369)
Q Consensus        50 ~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~~--~~~~~~~~~e~~~l~~l---~h~~i~~~~~~~~~~-----~  118 (369)
                      +|++.+.||+|++|.||+|+++ +|+.||+|.+....  .........|+..++.+   .||||+++++++...     .
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            6899999999999999999976 48899999886432  11223445566666555   799999999987642     3


Q ss_pred             ccEEEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCc
Q 017594          119 EKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMA  198 (369)
Q Consensus       119 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~  198 (369)
                      ..++++|++.+ ++..++.... ...+++..+..++.||+.||.|||+.|   ++|+||||+||+++.++.++|+|||++
T Consensus        81 ~~~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg~~  155 (288)
T cd07863          81 KVTLVFEHVDQ-DLRTYLDKVP-PPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLA  155 (288)
T ss_pred             eEEEEEccccc-CHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccCcc
Confidence            47999999975 6766664322 234789999999999999999999999   999999999999999999999999998


Q ss_pred             eecCCCCcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhh---cCc
Q 017594          199 RICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWT---SNR  275 (369)
Q Consensus       199 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~---~~~  275 (369)
                      .......   ......++..|+|||++.+..++.++||||+||++|+|++|.+||.........  ........   ...
T Consensus       156 ~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~--~~~~~~~~~~~~~~  230 (288)
T cd07863         156 RIYSCQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQL--GKIFDLIGLPPEDD  230 (288)
T ss_pred             ccccCcc---cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHH--HHHHHHhCCCChhh
Confidence            7654322   122245788999999998889999999999999999999999998643311100  00000000   000


Q ss_pred             c---c----cccCcccccc--ccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 017594          276 T---L----ELIDPILEDE--YSSKQMLLRYANIALLCVQESADDRPTMNDVVS  320 (369)
Q Consensus       276 ~---~----~~~~~~~~~~--~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~  320 (369)
                      .   .    ....+.....  .....++..+.++|.+||+.||++|||+.+++.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~  284 (288)
T cd07863         231 WPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ  284 (288)
T ss_pred             CcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence            0   0    0000000000  001123567899999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=1.4e-37  Score=277.67  Aligned_cols=249  Identities=30%  Similarity=0.399  Sum_probs=197.0

Q ss_pred             ccccccCCccEEEEEEcC--CC--EEEEEEecCCCc-hhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEEEEecCC
Q 017594           55 NKLGEGGFGPVYKGVLKK--GD--EIAVKRLSGRSG-QGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIYEYMPN  129 (369)
Q Consensus        55 ~~lg~G~~~~v~~~~~~~--~~--~valK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~  129 (369)
                      +.||.|++|.||+|.+.+  +.  .|++|.+..... ...+.+..|+..+++++|+|++++++.+.. ...++++||+++
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~   79 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL   79 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence            468999999999999643  32  589999876655 556788899999999999999999999887 889999999999


Q ss_pred             CChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCCCCcccc
Q 017594          130 KSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQAN  209 (369)
Q Consensus       130 ~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~~~~~~~  209 (369)
                      ++|..++..... ..+++..++.++.|++.||.+||+.+   ++|+||+|+||+++.++.++|+|||++..+........
T Consensus        80 ~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~  155 (257)
T cd05040          80 GSLLDRLRKDAL-GHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYV  155 (257)
T ss_pred             CcHHHHHHhccc-ccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEecccccccccccccccee
Confidence            999998865432 45889999999999999999999998   99999999999999999999999999887654222111


Q ss_pred             -cccccccccccCchhhccCCCCcccchHhHHHHHHHHHh-CCCCCCCCcccccccchhhhhhhhcCccccccCcccccc
Q 017594          210 -TSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDE  287 (369)
Q Consensus       210 -~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  287 (369)
                       .....++..|+|||.+.+..++.++|+|||||++|+|++ |..||.......     .............         
T Consensus       156 ~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~-----~~~~~~~~~~~~~---------  221 (257)
T cd05040         156 MEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQ-----ILKKIDKEGERLE---------  221 (257)
T ss_pred             cccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH-----HHHHHHhcCCcCC---------
Confidence             112345678999999988889999999999999999998 999985332111     0111100000000         


Q ss_pred             ccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 017594          288 YSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLT  323 (369)
Q Consensus       288 ~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L~  323 (369)
                       .+...+..+.+++.+||+.+|++||++.++++.|.
T Consensus       222 -~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  256 (257)
T cd05040         222 -RPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP  256 (257)
T ss_pred             -CCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence             01122567999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=1.2e-37  Score=281.99  Aligned_cols=251  Identities=25%  Similarity=0.383  Sum_probs=198.5

Q ss_pred             cCCccCccccccCCccEEEEEEcC-CCEEEEEEecCCCchhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEEEEec
Q 017594           49 NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIYEYM  127 (369)
Q Consensus        49 ~~y~i~~~lg~G~~~~v~~~~~~~-~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~  127 (369)
                      +.|++.+.||.|++|.||+|.+.. +..+++|.+........+.+..|+++++.+.|+|++++++++..+...++|+||+
T Consensus         5 ~~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~   84 (282)
T cd06643           5 EFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC   84 (282)
T ss_pred             HHHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEec
Confidence            347899999999999999999765 7788999887666556677888999999999999999999999999999999999


Q ss_pred             CCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCCCCcc
Q 017594          128 PNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQ  207 (369)
Q Consensus       128 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~~~~~  207 (369)
                      .+++|..++...  ...+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++.......  
T Consensus        85 ~~~~l~~~~~~~--~~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~--  157 (282)
T cd06643          85 AGGAVDAVMLEL--ERPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI--  157 (282)
T ss_pred             CCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEccccccccccccc--
Confidence            999998877432  235889999999999999999999998   9999999999999999999999999987543221  


Q ss_pred             cccccccccccccCchhhc-----cCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCccccccCc
Q 017594          208 ANTSRIVGTYGYMSPEYAL-----EGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDP  282 (369)
Q Consensus       208 ~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (369)
                      .......++..|+|||++.     +..++.++|+||+||++|+|++|.+||.......     ...........      
T Consensus       158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~-----~~~~~~~~~~~------  226 (282)
T cd06643         158 QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMR-----VLLKIAKSEPP------  226 (282)
T ss_pred             cccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHH-----HHHHHhhcCCC------
Confidence            1122345788999999874     3457889999999999999999999986432110     00011000000      


Q ss_pred             cccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 017594          283 ILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVS  320 (369)
Q Consensus       283 ~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~  320 (369)
                      ...   .+..++.++.++|.+||+.+|.+||++.++++
T Consensus       227 ~~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  261 (282)
T cd06643         227 TLA---QPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQ  261 (282)
T ss_pred             CCC---CccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            000   01123567999999999999999999999876

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=2.4e-37  Score=277.32  Aligned_cols=258  Identities=26%  Similarity=0.408  Sum_probs=204.3

Q ss_pred             cCCccCccccccCCccEEEEEEc-CCCEEEEEEecCCC-chhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEEEEe
Q 017594           49 NKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIYEY  126 (369)
Q Consensus        49 ~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  126 (369)
                      ++|++.+.||.|++|.||+|... ++..+++|++.... ......+.+|+..++.++|+|++++++.+...+..++++|+
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   80 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY   80 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence            47999999999999999999965 47889999986443 23567788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCCCCc
Q 017594          127 MPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNEL  206 (369)
Q Consensus       127 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~~~~  206 (369)
                      +.+++|.+++........+++..++.++.|++.|+++||+.+   ++|+||+|+||+++.++.++|+|||++........
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~  157 (267)
T cd06610          81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD  157 (267)
T ss_pred             cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence            999999999865433345889999999999999999999998   99999999999999999999999999876654332


Q ss_pred             cc--ccccccccccccCchhhccC-CCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCccccccCcc
Q 017594          207 QA--NTSRIVGTYGYMSPEYALEG-IFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPI  283 (369)
Q Consensus       207 ~~--~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (369)
                      ..  ......++..|+|||.+... .++.++|+||||+++++|++|+.||.......     ........      ..+.
T Consensus       158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~-----~~~~~~~~------~~~~  226 (267)
T cd06610         158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK-----VLMLTLQN------DPPS  226 (267)
T ss_pred             ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh-----hHHHHhcC------CCCC
Confidence            21  22334578899999998776 78999999999999999999999986432111     01111110      0011


Q ss_pred             ccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 017594          284 LEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVS  320 (369)
Q Consensus       284 ~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~  320 (369)
                      .........++..+.+++.+||+.||++||++.+|++
T Consensus       227 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~  263 (267)
T cd06610         227 LETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK  263 (267)
T ss_pred             cCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence            1111111233677899999999999999999999986

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=1.1e-37  Score=282.22  Aligned_cols=272  Identities=26%  Similarity=0.375  Sum_probs=204.0

Q ss_pred             hcCCccCccccccCCccEEEEEEc-----CCCEEEEEEecCCCch-hHHHHHHHHHHHhcCCCCceeeeeeeEEe--CCc
Q 017594           48 TNKFSDANKLGEGGFGPVYKGVLK-----KGDEIAVKRLSGRSGQ-GLREMKNEASVIAKVQHKNLVRLLGCCID--RDE  119 (369)
Q Consensus        48 ~~~y~i~~~lg~G~~~~v~~~~~~-----~~~~valK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~  119 (369)
                      .+.|++.+.||+|+||.||+|+..     ++..+++|.+...... ....+..|++.++.+.|+|++++++++..  ...
T Consensus         3 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~   82 (284)
T cd05038           3 KRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRS   82 (284)
T ss_pred             hhhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCc
Confidence            367889999999999999999853     3678999998755442 46788999999999999999999999877  557


Q ss_pred             cEEEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCce
Q 017594          120 KILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMAR  199 (369)
Q Consensus       120 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~  199 (369)
                      .++++||+.+++|.+++.....  .+++..+..++.|++.||++||+.+   ++|+||+|.||+++.++.++|+|||.+.
T Consensus        83 ~~lv~e~~~~~~l~~~l~~~~~--~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~  157 (284)
T cd05038          83 LRLIMEYLPSGSLRDYLQRHRD--QINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAK  157 (284)
T ss_pred             eEEEEecCCCCCHHHHHHhCcc--ccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEccccccc
Confidence            8999999999999999864332  4888899999999999999999998   9999999999999999999999999988


Q ss_pred             ecCCCCccc-ccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCcccc
Q 017594          200 ICGGNELQA-NTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLE  278 (369)
Q Consensus       200 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (369)
                      ......... ......+...|+|||...+..++.++|+||||+++++|++|..|+.........................
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (284)
T cd05038         158 VLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLE  237 (284)
T ss_pred             ccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHH
Confidence            765322111 1112234556999999988889999999999999999999998875432211110000000000000000


Q ss_pred             ccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHhh
Q 017594          279 LIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNE  325 (369)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L~~~  325 (369)
                      .+...... ..+..++.++.+++.+||+.+|.+||++.+|++.|+.+
T Consensus       238 ~~~~~~~~-~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i  283 (284)
T cd05038         238 LLKEGERL-PRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL  283 (284)
T ss_pred             HHHcCCcC-CCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence            00000000 00112256799999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=4.6e-37  Score=274.94  Aligned_cols=254  Identities=30%  Similarity=0.437  Sum_probs=200.1

Q ss_pred             hcCCccCccccccCCccEEEEEEcCCCEEEEEEecCCCchhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEEEEec
Q 017594           48 TNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIYEYM  127 (369)
Q Consensus        48 ~~~y~i~~~lg~G~~~~v~~~~~~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~  127 (369)
                      .++|++.+.||.|++|.||+|.++.+..+++|.+.... ...+.+..|+.+++.+.|++++++++++. ....+++|||+
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~   82 (260)
T cd05069           5 RESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFM   82 (260)
T ss_pred             hHHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcC
Confidence            46799999999999999999998877789999876443 23456788999999999999999998874 56689999999


Q ss_pred             CCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCCCCcc
Q 017594          128 PNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQ  207 (369)
Q Consensus       128 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~~~~~  207 (369)
                      .+++|.+++.... ...+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||.+.........
T Consensus        83 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~  158 (260)
T cd05069          83 GKGSLLDFLKEGD-GKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT  158 (260)
T ss_pred             CCCCHHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccCCccc
Confidence            9999998886432 234788889999999999999999998   999999999999999999999999998765432211


Q ss_pred             cccccccccccccCchhhccCCCCcccchHhHHHHHHHHHh-CCCCCCCCcccccccchhhhhhhhcCccccccCccccc
Q 017594          208 ANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILED  286 (369)
Q Consensus       208 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  286 (369)
                       ......++..|+|||...+..++.++|+||||+++|+|++ |..||.......      ........ .    ....  
T Consensus       159 -~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~------~~~~~~~~-~----~~~~--  224 (260)
T cd05069         159 -ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNRE------VLEQVERG-Y----RMPC--  224 (260)
T ss_pred             -ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH------HHHHHHcC-C----CCCC--
Confidence             1112234567999999988889999999999999999999 888886322110      00111000 0    0000  


Q ss_pred             cccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHh
Q 017594          287 EYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTN  324 (369)
Q Consensus       287 ~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L~~  324 (369)
                         +...+..+.+++.+||+.+|++||++++++++|+.
T Consensus       225 ---~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  259 (260)
T cd05069         225 ---PQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED  259 (260)
T ss_pred             ---CcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence               11225679999999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=4.6e-37  Score=285.99  Aligned_cols=263  Identities=27%  Similarity=0.378  Sum_probs=200.4

Q ss_pred             HhcCCccCccccccCCccEEEEEE------cCCCEEEEEEecCCC-chhHHHHHHHHHHHhcC-CCCceeeeeeeEEeC-
Q 017594           47 ATNKFSDANKLGEGGFGPVYKGVL------KKGDEIAVKRLSGRS-GQGLREMKNEASVIAKV-QHKNLVRLLGCCIDR-  117 (369)
Q Consensus        47 ~~~~y~i~~~lg~G~~~~v~~~~~------~~~~~valK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~-  117 (369)
                      ..++|++.+.||.|+||.||+|++      .+++.||+|++.... ......+..|+.++.++ +|+|++++++++... 
T Consensus         5 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~   84 (343)
T cd05103           5 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG   84 (343)
T ss_pred             chhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCC
Confidence            356899999999999999999974      236789999987543 23345678899999999 689999999987654 


Q ss_pred             CccEEEEEecCCCChhhhhcCCCc--------------------------------------------------------
Q 017594          118 DEKILIYEYMPNKSLDFFLFDPTK--------------------------------------------------------  141 (369)
Q Consensus       118 ~~~~lv~e~~~~~~L~~~l~~~~~--------------------------------------------------------  141 (369)
                      ...++++||+++++|.+++.....                                                        
T Consensus        85 ~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (343)
T cd05103          85 GPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE  164 (343)
T ss_pred             CceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhh
Confidence            457899999999999888753210                                                        


Q ss_pred             --------cccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCCCCcccccccc
Q 017594          142 --------RMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRI  213 (369)
Q Consensus       142 --------~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~  213 (369)
                              ...+++..+..++.||+.||+|||+.+   ++|+||||.||+++.++.++|+|||++...............
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~  241 (343)
T cd05103         165 EAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDA  241 (343)
T ss_pred             hhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCC
Confidence                    123677788899999999999999998   999999999999999999999999998765332221122223


Q ss_pred             cccccccCchhhccCCCCcccchHhHHHHHHHHHh-CCCCCCCCcccccccchhhhhhhhcCccccccCccccccccHHH
Q 017594          214 VGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYSSKQ  292 (369)
Q Consensus       214 ~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  292 (369)
                      .++..|+|||.+.+..++.++|+||||+++|+|++ |..||........     ............     .     +..
T Consensus       242 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~-----~~~~~~~~~~~~-----~-----~~~  306 (343)
T cd05103         242 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE-----FCRRLKEGTRMR-----A-----PDY  306 (343)
T ss_pred             CCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHH-----HHHHHhccCCCC-----C-----CCC
Confidence            34567999999988889999999999999999997 8888754321110     001111110000     0     001


Q ss_pred             HHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHhhhh
Q 017594          293 MLLRYANIALLCVQESADDRPTMNDVVSMLTNEAA  327 (369)
Q Consensus       293 ~~~~l~~li~~~L~~dP~~Rps~~ell~~L~~~~~  327 (369)
                      .+.++.+++..||+.+|++||++.+|++.|+.+..
T Consensus       307 ~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~  341 (343)
T cd05103         307 TTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ  341 (343)
T ss_pred             CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            24568999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=5.8e-37  Score=289.65  Aligned_cols=264  Identities=23%  Similarity=0.352  Sum_probs=203.4

Q ss_pred             HHHhcCCccCccccccCCccEEEEEEc------CCCEEEEEEecCCC-chhHHHHHHHHHHHhcCC-CCceeeeeeeEEe
Q 017594           45 STATNKFSDANKLGEGGFGPVYKGVLK------KGDEIAVKRLSGRS-GQGLREMKNEASVIAKVQ-HKNLVRLLGCCID  116 (369)
Q Consensus        45 ~~~~~~y~i~~~lg~G~~~~v~~~~~~------~~~~valK~~~~~~-~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~  116 (369)
                      ....++|.+.+.||+|+||.||+|++.      .+..||+|++.... ......+..|+.++..+. ||||+++++++..
T Consensus        33 ~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~  112 (401)
T cd05107          33 EMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTK  112 (401)
T ss_pred             eecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEcc
Confidence            344567889999999999999999864      24579999997543 223456788999999997 9999999999998


Q ss_pred             CCccEEEEEecCCCChhhhhcCCCc-------------------------------------------------------
Q 017594          117 RDEKILIYEYMPNKSLDFFLFDPTK-------------------------------------------------------  141 (369)
Q Consensus       117 ~~~~~lv~e~~~~~~L~~~l~~~~~-------------------------------------------------------  141 (369)
                      ....++|+||+.+++|.+++.....                                                       
T Consensus       113 ~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  192 (401)
T cd05107         113 GGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPM  192 (401)
T ss_pred             CCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccch
Confidence            8899999999999999888854211                                                       


Q ss_pred             ----------------------------------------cccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCC
Q 017594          142 ----------------------------------------RMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASN  181 (369)
Q Consensus       142 ----------------------------------------~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~N  181 (369)
                                                              ...+++..+..++.||+.||+|||+.+   ++|+||||.|
T Consensus       193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp~N  269 (401)
T cd05107         193 QDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAARN  269 (401)
T ss_pred             hcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCcce
Confidence                                                    123566778889999999999999998   9999999999


Q ss_pred             EEEeCCCceEEeecCCceecCCCCcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHh-CCCCCCCCcccc
Q 017594          182 ILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDS  260 (369)
Q Consensus       182 Ilv~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~t-g~~p~~~~~~~~  260 (369)
                      |+++.++.++|+|||++................++..|+|||.+.+..++.++|+||||+++|+|++ |..||.......
T Consensus       270 iLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~  349 (401)
T cd05107         270 VLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNE  349 (401)
T ss_pred             EEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchH
Confidence            9999999999999999876533222111222345678999999988889999999999999999998 888875432111


Q ss_pred             cccchhhhhhhhcCccccccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHhhh
Q 017594          261 LNLLGYAWDLWTSNRTLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNEA  326 (369)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L~~~~  326 (369)
                           ...........     ...     +..++.++.+++.+||..+|.+||++++|++.|+.+.
T Consensus       350 -----~~~~~~~~~~~-----~~~-----p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~  400 (401)
T cd05107         350 -----QFYNAIKRGYR-----MAK-----PAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL  400 (401)
T ss_pred             -----HHHHHHHcCCC-----CCC-----CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence                 00111111100     000     1112567999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-37  Score=282.02  Aligned_cols=253  Identities=25%  Similarity=0.400  Sum_probs=201.8

Q ss_pred             hcCCccCccccccCCccEEEEEEc-CCCEEEEEEecCCCchhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEEEEe
Q 017594           48 TNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIYEY  126 (369)
Q Consensus        48 ~~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  126 (369)
                      .++|++.+.||.|++|.||+|.+. ++..+++|.+..........+..|+++++.++|+|++++++.+......++||||
T Consensus         4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (280)
T cd06611           4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF   83 (280)
T ss_pred             hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence            357999999999999999999965 5889999998766666667788899999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCCCCc
Q 017594          127 MPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNEL  206 (369)
Q Consensus       127 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~~~~  206 (369)
                      +++++|..++...  ...+++..++.++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||.+....... 
T Consensus        84 ~~~~~L~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~-  157 (280)
T cd06611          84 CDGGALDSIMLEL--ERGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL-  157 (280)
T ss_pred             cCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhhcccc-
Confidence            9999999888543  235889999999999999999999999   9999999999999999999999999876543221 


Q ss_pred             ccccccccccccccCchhhc-----cCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCccccccC
Q 017594          207 QANTSRIVGTYGYMSPEYAL-----EGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELID  281 (369)
Q Consensus       207 ~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (369)
                       .......++..|+|||.+.     ...++.++|+||||+++|+|++|..||.......     .........      .
T Consensus       158 -~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~-----~~~~~~~~~------~  225 (280)
T cd06611         158 -QKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMR-----VLLKILKSE------P  225 (280)
T ss_pred             -cccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHH-----HHHHHhcCC------C
Confidence             1122345788899999874     3457889999999999999999999986432111     000000000      0


Q ss_pred             ccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 017594          282 PILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSM  321 (369)
Q Consensus       282 ~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~  321 (369)
                      +.+.   .+..++.++.++|.+||+.+|.+||++.++++.
T Consensus       226 ~~~~---~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  262 (280)
T cd06611         226 PTLD---QPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH  262 (280)
T ss_pred             CCcC---CcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence            0000   011235678999999999999999999999863

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=7.5e-38  Score=292.75  Aligned_cols=264  Identities=23%  Similarity=0.270  Sum_probs=194.8

Q ss_pred             HHhcCCccCccccccCCccEEEEEEc-CCCEEEEEEecCC--CchhHHHHHHHHHHHhcCCCCceeeeeeeEEeC-----
Q 017594           46 TATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDR-----  117 (369)
Q Consensus        46 ~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----  117 (369)
                      ...++|++.+.||+|+||.||+|.+. .++.||+|++...  .......+.+|+.+++.++||||+++++++...     
T Consensus        14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~   93 (355)
T cd07874          14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE   93 (355)
T ss_pred             hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence            46689999999999999999999965 4889999998643  223345677899999999999999999988643     


Q ss_pred             -CccEEEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecC
Q 017594          118 -DEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFG  196 (369)
Q Consensus       118 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg  196 (369)
                       ...+++|||++++ +...+.     ..++...++.++.|++.||.|||+.|   ++||||||+||+++.++.++|+|||
T Consensus        94 ~~~~~lv~e~~~~~-l~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~Dfg  164 (355)
T cd07874          94 FQDVYLVMELMDAN-LCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG  164 (355)
T ss_pred             cceeEEEhhhhccc-HHHHHh-----hcCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEeeCc
Confidence             2469999999764 444442     13778889999999999999999999   9999999999999999999999999


Q ss_pred             CceecCCCCcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCccccccc----------ch-
Q 017594          197 MARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNL----------LG-  265 (369)
Q Consensus       197 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~----------~~-  265 (369)
                      ++.......   ......++..|+|||++.+..++.++|||||||++|+|++|+.||..........          .. 
T Consensus       165 ~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  241 (355)
T cd07874         165 LARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEF  241 (355)
T ss_pred             ccccCCCcc---ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence            987643321   1223467899999999998899999999999999999999999996433110000          00 


Q ss_pred             ------hhhhhhhcC-ccc-----ccc-Cccccc-cccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 017594          266 ------YAWDLWTSN-RTL-----ELI-DPILED-EYSSKQMLLRYANIALLCVQESADDRPTMNDVVSM  321 (369)
Q Consensus       266 ------~~~~~~~~~-~~~-----~~~-~~~~~~-~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~  321 (369)
                            ......... ...     ... +..... .......+..+.++|.+||+.||++|||+.++++.
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h  311 (355)
T cd07874         242 MKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH  311 (355)
T ss_pred             HHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence                  000000000 000     000 000000 00011124568999999999999999999999974

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=2.4e-37  Score=278.06  Aligned_cols=256  Identities=27%  Similarity=0.436  Sum_probs=200.1

Q ss_pred             cCCccCccccccCCccEEEEEEcC-C---CEEEEEEecCC-CchhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEE
Q 017594           49 NKFSDANKLGEGGFGPVYKGVLKK-G---DEIAVKRLSGR-SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILI  123 (369)
Q Consensus        49 ~~y~i~~~lg~G~~~~v~~~~~~~-~---~~valK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv  123 (369)
                      ..|++.+.||+|+||.||+|..+. +   ..|++|.+... .......+..|+..++.+.|||++++.+++..+...+++
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv   83 (269)
T cd05065           4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII   83 (269)
T ss_pred             HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence            568999999999999999999653 3   35999998754 334456788999999999999999999999988899999


Q ss_pred             EEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCC
Q 017594          124 YEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGG  203 (369)
Q Consensus       124 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~  203 (369)
                      +||+.+++|.+++....  ..+++..++.++.|++.||.+||+++   ++|+||+|.||+++.++.++|+|||++.....
T Consensus        84 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~  158 (269)
T cd05065          84 TEFMENGALDSFLRQND--GQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLED  158 (269)
T ss_pred             EecCCCCcHHHHHhhCC--CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCcccccccc
Confidence            99999999998885432  34788899999999999999999998   99999999999999999999999998876543


Q ss_pred             CCccccccccc---ccccccCchhhccCCCCcccchHhHHHHHHHHHh-CCCCCCCCcccccccchhhhhhhhcCccccc
Q 017594          204 NELQANTSRIV---GTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDLWTSNRTLEL  279 (369)
Q Consensus       204 ~~~~~~~~~~~---~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (369)
                      ...........   .+..|+|||.+.+..++.++||||+||++|++++ |..||.......     ..... . .. ...
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~-----~~~~i-~-~~-~~~  230 (269)
T cd05065         159 DTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD-----VINAI-E-QD-YRL  230 (269)
T ss_pred             CccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHH-----HHHHH-H-cC-CcC
Confidence            22211111111   1346999999998899999999999999999886 999885332110     00000 0 00 000


Q ss_pred             cCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHhh
Q 017594          280 IDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNE  325 (369)
Q Consensus       280 ~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L~~~  325 (369)
                              ..+..++..+.+++.+||+.+|.+||++.+|++.|+++
T Consensus       231 --------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  268 (269)
T cd05065         231 --------PPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM  268 (269)
T ss_pred             --------CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence                    00112256689999999999999999999999998865

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=1.8e-37  Score=290.65  Aligned_cols=253  Identities=22%  Similarity=0.307  Sum_probs=195.5

Q ss_pred             cCCccCccccccCCccEEEEEEc-CCCEEEEEEecCC---CchhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEEE
Q 017594           49 NKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGR---SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIY  124 (369)
Q Consensus        49 ~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  124 (369)
                      ++|++.+.||+|+||.||+|+.+ +++.||+|++...   .......+..|+.++..++|++++++++.+...+..++||
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~   80 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM   80 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            46899999999999999999965 4889999998632   2233456778999999999999999999999999999999


Q ss_pred             EecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCCC
Q 017594          125 EYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGN  204 (369)
Q Consensus       125 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~~  204 (369)
                      ||+.+++|.+++...   ..+++..+..++.|++.||.|||+.|   ++||||||+||+++.++.++|+|||++......
T Consensus        81 E~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~  154 (360)
T cd05627          81 EFLPGGDMMTLLMKK---DTLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKA  154 (360)
T ss_pred             eCCCCccHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCcccccc
Confidence            999999999988543   34889999999999999999999999   999999999999999999999999998654321


Q ss_pred             Ccc---------------------------------cccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCC
Q 017594          205 ELQ---------------------------------ANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKK  251 (369)
Q Consensus       205 ~~~---------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~  251 (369)
                      ...                                 .......|++.|+|||++.+..++.++|+|||||++|+|++|..
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~  234 (360)
T cd05627         155 HRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP  234 (360)
T ss_pred             cccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCC
Confidence            100                                 00112358899999999999999999999999999999999999


Q ss_pred             CCCCCcccccccchhhhhhhhcCccccccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCC---HHHHHHH
Q 017594          252 NTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPT---MNDVVSM  321 (369)
Q Consensus       252 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps---~~ell~~  321 (369)
                      ||.......     .............     +...   ...+.++.++|.+|+. +|.+|++   +.++++.
T Consensus       235 Pf~~~~~~~-----~~~~i~~~~~~~~-----~p~~---~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~h  293 (360)
T cd05627         235 PFCSETPQE-----TYRKVMNWKETLV-----FPPE---VPISEKAKDLILRFCT-DSENRIGSNGVEEIKSH  293 (360)
T ss_pred             CCCCCCHHH-----HHHHHHcCCCcee-----cCCC---CCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhcC
Confidence            986432111     0011111000000     0000   0125678899999774 9999995   5666654

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=7.3e-37  Score=273.62  Aligned_cols=256  Identities=29%  Similarity=0.432  Sum_probs=202.6

Q ss_pred             HHhcCCccCccccccCCccEEEEEEcCCCEEEEEEecCCCchhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEEEE
Q 017594           46 TATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIYE  125 (369)
Q Consensus        46 ~~~~~y~i~~~lg~G~~~~v~~~~~~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  125 (369)
                      ...++|++.+.||+|++|.||+|..+++..+++|.+.... .....+.+|+.+++.++|+|++++.+++.. ...++++|
T Consensus         3 ~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e   80 (260)
T cd05073           3 IPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITE   80 (260)
T ss_pred             ccccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEE
Confidence            4467899999999999999999998778889999886442 334678889999999999999999999877 77899999


Q ss_pred             ecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCCCC
Q 017594          126 YMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE  205 (369)
Q Consensus       126 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~~~  205 (369)
                      |+.+++|.+++.... ...++...+..++.|++.||.+||+.+   ++|+||+|+||+++.++.++|+|||.+.......
T Consensus        81 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~  156 (260)
T cd05073          81 FMAKGSLLDFLKSDE-GSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNE  156 (260)
T ss_pred             eCCCCcHHHHHHhCC-ccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeeccCCC
Confidence            999999998886532 334778888999999999999999998   9999999999999999999999999987654322


Q ss_pred             cccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHh-CCCCCCCCcccccccchhhhhhhhcCccccccCccc
Q 017594          206 LQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPIL  284 (369)
Q Consensus       206 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (369)
                      .. ......++..|+|||++.+..++.++|+||||+++|++++ |..||.......      ............      
T Consensus       157 ~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~------~~~~~~~~~~~~------  223 (260)
T cd05073         157 YT-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE------VIRALERGYRMP------  223 (260)
T ss_pred             cc-cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHH------HHHHHhCCCCCC------
Confidence            11 1112234567999999988889999999999999999998 888886432111      000000110000      


Q ss_pred             cccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHh
Q 017594          285 EDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTN  324 (369)
Q Consensus       285 ~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L~~  324 (369)
                          .....+.++.+++.+||+.+|++||++.++++.|+.
T Consensus       224 ----~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~  259 (260)
T cd05073         224 ----RPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD  259 (260)
T ss_pred             ----CcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence                011225679999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=1.4e-37  Score=312.24  Aligned_cols=261  Identities=25%  Similarity=0.339  Sum_probs=199.7

Q ss_pred             hhhHHHHhcCCccCccccccCCccEEEEEEcC-CCEEEEEEecCC--CchhHHHHHHHHHHHhcCCCCceeeeeeeEEeC
Q 017594           41 FSSVSTATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDR  117 (369)
Q Consensus        41 ~~~~~~~~~~y~i~~~lg~G~~~~v~~~~~~~-~~~valK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~  117 (369)
                      +...+....+|++++.||.|+||.||+|++.. +..+++|.+...  .......+..|+.++..++||||++++++|...
T Consensus         5 ~~~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de   84 (1021)
T PTZ00266          5 YDDGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNK   84 (1021)
T ss_pred             ccCCccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEec
Confidence            34456667899999999999999999999765 778899988643  223456788899999999999999999988654


Q ss_pred             --CccEEEEEecCCCChhhhhcCCC-ccccCChHHHHHHHHHHHHHHHHHhcCCC----CCcccCCCCCCCEEEeCC---
Q 017594          118 --DEKILIYEYMPNKSLDFFLFDPT-KRMLLDWVTRVQIIEGIAQGLLYLHQYSR----VRIIHRDLKASNILLDKD---  187 (369)
Q Consensus       118 --~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~al~~LH~~~~----~~i~H~dl~p~NIlv~~~---  187 (369)
                        ..+|+||||+.+++|..++.... ....+++..++.|+.||+.||.|||..+.    .+|+|+||||+|||++.+   
T Consensus        85 ~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~  164 (1021)
T PTZ00266         85 ANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRH  164 (1021)
T ss_pred             CCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccc
Confidence              45899999999999998885422 23458999999999999999999998531    239999999999999642   


Q ss_pred             --------------CceEEeecCCceecCCCCcccccccccccccccCchhhcc--CCCCcccchHhHHHHHHHHHhCCC
Q 017594          188 --------------MNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALE--GIFSIKSDVFSFGVLLLEIVSGKK  251 (369)
Q Consensus       188 --------------~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslG~il~~l~tg~~  251 (369)
                                    +.++|+|||++.......   ......+++.|+|||++.+  ..++.++||||||||||+|++|..
T Consensus       165 lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s---~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~  241 (1021)
T PTZ00266        165 IGKITAQANNLNGRPIAKIGDFGLSKNIGIES---MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKT  241 (1021)
T ss_pred             cccccccccccCCCCceEEccCCccccccccc---cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCC
Confidence                          348999999987654322   1223468999999999854  458899999999999999999999


Q ss_pred             CCCCCcccccccchhhhhhhhcCccccccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 017594          252 NTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVS  320 (369)
Q Consensus       252 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~  320 (369)
                      ||.......    ..... ....       +.+    .....+.++.+||..||+.+|.+||++.+++.
T Consensus       242 PF~~~~~~~----qli~~-lk~~-------p~l----pi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~  294 (1021)
T PTZ00266        242 PFHKANNFS----QLISE-LKRG-------PDL----PIKGKSKELNILIKNLLNLSAKERPSALQCLG  294 (1021)
T ss_pred             CCCcCCcHH----HHHHH-HhcC-------CCC----CcCCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence            996432111    00111 0000       000    00112567999999999999999999999994

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.5e-37  Score=283.19  Aligned_cols=255  Identities=20%  Similarity=0.248  Sum_probs=195.8

Q ss_pred             cCCccCccccccCCccEEEEEEc-CCCEEEEEEecCC---CchhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEEE
Q 017594           49 NKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGR---SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIY  124 (369)
Q Consensus        49 ~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  124 (369)
                      ++|++.+.||+|+||.||+++.. +++.||+|++...   .......+..|..++..++|++|+++++++..++..++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM   80 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence            47999999999999999999965 4889999998632   2223456788999999999999999999999999999999


Q ss_pred             EecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCCC
Q 017594          125 EYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGN  204 (369)
Q Consensus       125 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~~  204 (369)
                      ||+.+++|..++...  ...+++..+..++.||+.||+|||+++   ++||||||+||+++.++.++|+|||++......
T Consensus        81 e~~~g~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  155 (331)
T cd05597          81 DYYVGGDLLTLLSKF--EDRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLAD  155 (331)
T ss_pred             ecCCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeecCCC
Confidence            999999999888542  234788899999999999999999999   999999999999999999999999998765432


Q ss_pred             CcccccccccccccccCchhhcc-----CCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCccccc
Q 017594          205 ELQANTSRIVGTYGYMSPEYALE-----GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLEL  279 (369)
Q Consensus       205 ~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (369)
                      .. .......|++.|+|||++.+     ..++.++||||+||++|+|++|..||.......     ..............
T Consensus       156 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~-----~~~~i~~~~~~~~~  229 (331)
T cd05597         156 GT-VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVE-----TYGKIMNHKEHFQF  229 (331)
T ss_pred             CC-ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHH-----HHHHHHcCCCcccC
Confidence            21 11222458999999999863     457889999999999999999999986432110     00111111100000


Q ss_pred             cCccccccccHHHHHHHHHHHHHHhhcCCCCC--CCCHHHHHHH
Q 017594          280 IDPILEDEYSSKQMLLRYANIALLCVQESADD--RPTMNDVVSM  321 (369)
Q Consensus       280 ~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~--Rps~~ell~~  321 (369)
                           ...  ....+..+.++|.+||..++++  |+++.++++.
T Consensus       230 -----~~~--~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h  266 (331)
T cd05597         230 -----PPD--VTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH  266 (331)
T ss_pred             -----CCc--cCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence                 000  0113667899999988764444  7899999976

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=5.2e-37  Score=281.47  Aligned_cols=263  Identities=24%  Similarity=0.333  Sum_probs=199.1

Q ss_pred             cCCccCccccccCCccEEEEEEc-CCCEEEEEEecCCC-chhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEEEEe
Q 017594           49 NKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIYEY  126 (369)
Q Consensus        49 ~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  126 (369)
                      ++|++.+.||.|+||.||++.+. ++..+++|.+.... ......+..|++++++++||||+++++++..++..++++||
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey   80 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH   80 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence            36999999999999999999965 47888999886442 23345678899999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhc-CCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCCCC
Q 017594          127 MPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQ-YSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE  205 (369)
Q Consensus       127 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~-~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~~~  205 (369)
                      +++++|.+++...   ..+++..+..++.|++.||.|||+ .+   ++|+||+|+||+++.++.++|+|||++...... 
T Consensus        81 ~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-  153 (308)
T cd06615          81 MDGGSLDQVLKKA---GRIPENILGKISIAVLRGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-  153 (308)
T ss_pred             cCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhhCC---EEECCCChHHEEEecCCcEEEccCCCccccccc-
Confidence            9999999998543   447888999999999999999997 46   999999999999999999999999987654322 


Q ss_pred             cccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCccccccc-chhhhhhhhcCc---------
Q 017594          206 LQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNL-LGYAWDLWTSNR---------  275 (369)
Q Consensus       206 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~-~~~~~~~~~~~~---------  275 (369)
                         ......++..|+|||.+.+..++.++|+||||+++|+|++|..||.......... ............         
T Consensus       154 ---~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (308)
T cd06615         154 ---MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHP  230 (308)
T ss_pred             ---ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCC
Confidence               1223467889999999888889999999999999999999999985332111000 000000000000         


Q ss_pred             --------cccccCcccc---ccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 017594          276 --------TLELIDPILE---DEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSM  321 (369)
Q Consensus       276 --------~~~~~~~~~~---~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~  321 (369)
                              ..+..+....   .......++.++.+++.+||+.+|++||++.++++.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  287 (308)
T cd06615         231 PDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH  287 (308)
T ss_pred             CCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                    0000000000   000011135679999999999999999999999975

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.6e-38  Score=310.82  Aligned_cols=266  Identities=30%  Similarity=0.456  Sum_probs=215.0

Q ss_pred             hcCCccCccccccCCccEEEEEEcC--CC----EEEEEEecCC-CchhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCcc
Q 017594           48 TNKFSDANKLGEGGFGPVYKGVLKK--GD----EIAVKRLSGR-SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEK  120 (369)
Q Consensus        48 ~~~y~i~~~lg~G~~~~v~~~~~~~--~~----~valK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~  120 (369)
                      ...-+..+.||+|+||.||.|...+  |.    .|++|.+... +.+....+..|+.++..+.||||+++++++.+....
T Consensus       691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~  770 (1025)
T KOG1095|consen  691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPP  770 (1025)
T ss_pred             hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCc
Confidence            4556778899999999999999543  43    3899988754 455677899999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhcCCCc----cccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecC
Q 017594          121 ILIYEYMPNKSLDFFLFDPTK----RMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFG  196 (369)
Q Consensus       121 ~lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg  196 (369)
                      ++++||+.+|.|..++++...    ...+....+..++.+|++|+.||++++   ++||||...|+|++....+|++|||
T Consensus       771 ~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaDFG  847 (1025)
T KOG1095|consen  771 LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIADFG  847 (1025)
T ss_pred             EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEcccc
Confidence            999999999999999976421    345888899999999999999999999   9999999999999999999999999


Q ss_pred             CceecCCCCcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHh-CCCCCCCCcccccccchhhhhhhhcCc
Q 017594          197 MARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDLWTSNR  275 (369)
Q Consensus       197 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~  275 (369)
                      +++.+.............-...|+|||.+..+.++.|+||||||+++||++| |..||+...+...     ........ 
T Consensus       848 lArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v-----~~~~~~gg-  921 (1025)
T KOG1095|consen  848 LARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEV-----LLDVLEGG-  921 (1025)
T ss_pred             hhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHH-----HHHHHhCC-
Confidence            9996654444333333334568999999999999999999999999999998 8888864432110     00011111 


Q ss_pred             cccccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHhhhhccCCC
Q 017594          276 TLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNEAATLLPP  332 (369)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L~~~~~~~~~~  332 (369)
                                .-..+..++..+.+++.+||+.+|++||++..|++.+..+.....+.
T Consensus       922 ----------RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~~~  968 (1025)
T KOG1095|consen  922 ----------RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAALGT  968 (1025)
T ss_pred             ----------ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhccC
Confidence                      01124445778999999999999999999999999998877754443

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=4.7e-37  Score=281.15  Aligned_cols=261  Identities=28%  Similarity=0.384  Sum_probs=200.5

Q ss_pred             hcCCccCccccccCCccEEEEEEcC-CC--EEEEEEecCCC-chhHHHHHHHHHHHhcC-CCCceeeeeeeEEeCCccEE
Q 017594           48 TNKFSDANKLGEGGFGPVYKGVLKK-GD--EIAVKRLSGRS-GQGLREMKNEASVIAKV-QHKNLVRLLGCCIDRDEKIL  122 (369)
Q Consensus        48 ~~~y~i~~~lg~G~~~~v~~~~~~~-~~--~valK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~l  122 (369)
                      .++|++.+.||+|+||.||+|.++. +.  .+++|.+.... ......+.+|+.++.++ +|+|++++++++...+..++
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l   85 (303)
T cd05088           6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL   85 (303)
T ss_pred             hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence            3578999999999999999999653 44  45777765432 23445678899999999 89999999999999999999


Q ss_pred             EEEecCCCChhhhhcCCC-------------ccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCc
Q 017594          123 IYEYMPNKSLDFFLFDPT-------------KRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMN  189 (369)
Q Consensus       123 v~e~~~~~~L~~~l~~~~-------------~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~  189 (369)
                      ++||+.+++|.+++....             ....+++..++.++.||+.|++|||+.|   ++||||+|+||+++.++.
T Consensus        86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~  162 (303)
T cd05088          86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYV  162 (303)
T ss_pred             EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCc
Confidence            999999999998885432             1235788899999999999999999998   999999999999999999


Q ss_pred             eEEeecCCceecCCCCcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHh-CCCCCCCCcccccccchhhh
Q 017594          190 PKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAW  268 (369)
Q Consensus       190 ~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~t-g~~p~~~~~~~~~~~~~~~~  268 (369)
                      ++|+|||++......   ........+..|+|||.+.+..++.++||||||+++|+|++ |..||.......     . .
T Consensus       163 ~kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~-----~-~  233 (303)
T cd05088         163 AKIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE-----L-Y  233 (303)
T ss_pred             EEeCccccCcccchh---hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHH-----H-H
Confidence            999999987532111   01111123567999999988889999999999999999998 999985332111     0 0


Q ss_pred             hhhhcCccccccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHhhhhccC
Q 017594          269 DLWTSNRTLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNEAATLL  330 (369)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L~~~~~~~~  330 (369)
                      ......     .....     +...+..+.+++.+||+.+|++||++.+++..|..+.....
T Consensus       234 ~~~~~~-----~~~~~-----~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~~  285 (303)
T cd05088         234 EKLPQG-----YRLEK-----PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK  285 (303)
T ss_pred             HHHhcC-----CcCCC-----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhh
Confidence            000000     00000     01125568999999999999999999999999988766543

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.4e-38  Score=292.69  Aligned_cols=265  Identities=31%  Similarity=0.429  Sum_probs=209.4

Q ss_pred             HHHhcCCccCccccccCCccEEEEEEcC--C--CE-EEEEEecCC---CchhHHHHHHHHHHHhcCCCCceeeeeeeEEe
Q 017594           45 STATNKFSDANKLGEGGFGPVYKGVLKK--G--DE-IAVKRLSGR---SGQGLREMKNEASVIAKVQHKNLVRLLGCCID  116 (369)
Q Consensus        45 ~~~~~~y~i~~~lg~G~~~~v~~~~~~~--~--~~-valK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~  116 (369)
                      +....+-.+.++||+|+||.||+|+.+.  +  .. ||+|.....   .......+.+|++++++++||||++++++...
T Consensus       153 el~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~  232 (474)
T KOG0194|consen  153 ELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVL  232 (474)
T ss_pred             EEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcC
Confidence            3344455667899999999999999543  2  23 899988752   35667788999999999999999999999999


Q ss_pred             CCccEEEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecC
Q 017594          117 RDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFG  196 (369)
Q Consensus       117 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg  196 (369)
                      .+.+++|||+|.||+|.+++.....  .++......++.+.+.||+|||+++   ++||||-..|+|++.++.+||+|||
T Consensus       233 ~~Pl~ivmEl~~gGsL~~~L~k~~~--~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vKISDFG  307 (474)
T KOG0194|consen  233 EEPLMLVMELCNGGSLDDYLKKNKK--SLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVKISDFG  307 (474)
T ss_pred             CCccEEEEEecCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEEeCccc
Confidence            9999999999999999999965443  4889999999999999999999999   9999999999999999999999999


Q ss_pred             CceecCCCCcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHh-CCCCCCCCcccccccchhhhhhhhcCc
Q 017594          197 MARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDLWTSNR  275 (369)
Q Consensus       197 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~  275 (369)
                      ++.....-.  .......-...|+|||.+..+.|+.++||||+|+++||+++ |..||.......     ......... 
T Consensus       308 Ls~~~~~~~--~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~-----v~~kI~~~~-  379 (474)
T KOG0194|consen  308 LSRAGSQYV--MKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYE-----VKAKIVKNG-  379 (474)
T ss_pred             cccCCccee--eccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHH-----HHHHHHhcC-
Confidence            977543111  11111134578999999999999999999999999999998 777876443211     011110111 


Q ss_pred             cccccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHhhhhccCC
Q 017594          276 TLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNEAATLLP  331 (369)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L~~~~~~~~~  331 (369)
                      .....         +...+.++..++.+||..+|++||++.++.+.|+.+......
T Consensus       380 ~r~~~---------~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~  426 (474)
T KOG0194|consen  380 YRMPI---------PSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEA  426 (474)
T ss_pred             ccCCC---------CCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcccc
Confidence            11111         112267799999999999999999999999999999886654

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=9.5e-37  Score=272.19  Aligned_cols=250  Identities=27%  Similarity=0.380  Sum_probs=197.7

Q ss_pred             hcCCccCccccccCCccEEEEEEcCCCEEEEEEecCCCchhHHHHHHHHHHHhcCCCCceeeeeeeEE-eCCccEEEEEe
Q 017594           48 TNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCI-DRDEKILIYEY  126 (369)
Q Consensus        48 ~~~y~i~~~lg~G~~~~v~~~~~~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~~lv~e~  126 (369)
                      -.+|++.+.||+|++|.||++..+ |..+++|.+....  ....+..|+.+++.++|++++++++++. ..+..++++||
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~   81 (256)
T cd05082           5 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY   81 (256)
T ss_pred             HHhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEEC
Confidence            358999999999999999999876 7789999886443  3467888999999999999999998765 44678999999


Q ss_pred             cCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCCCCc
Q 017594          127 MPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNEL  206 (369)
Q Consensus       127 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~~~~  206 (369)
                      +.+++|.+++.... ...+++..+..++.|++.||++||+++   ++|+||+|+||+++.++.++|+|||++....... 
T Consensus        82 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-  156 (256)
T cd05082          82 MAKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-  156 (256)
T ss_pred             CCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceeccccC-
Confidence            99999998885432 234788899999999999999999998   9999999999999999999999999887543221 


Q ss_pred             ccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHh-CCCCCCCCcccccccchhhhhhhhcCccccccCcccc
Q 017594          207 QANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILE  285 (369)
Q Consensus       207 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (369)
                          .....+..|+|||++.+..++.++|||||||++|+|++ |+.||.......     .... .....     .... 
T Consensus       157 ----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~-----~~~~-~~~~~-----~~~~-  220 (256)
T cd05082         157 ----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD-----VVPR-VEKGY-----KMDA-  220 (256)
T ss_pred             ----CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH-----HHHH-HhcCC-----CCCC-
Confidence                12233567999999988889999999999999999997 888886332111     0000 00000     0000 


Q ss_pred             ccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHhh
Q 017594          286 DEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNE  325 (369)
Q Consensus       286 ~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L~~~  325 (369)
                          ...++..+.+++.+||+.+|++|||+.++++.|+.+
T Consensus       221 ----~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~  256 (256)
T cd05082         221 ----PDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI  256 (256)
T ss_pred             ----CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence                112256789999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=2.1e-37  Score=290.95  Aligned_cols=261  Identities=20%  Similarity=0.243  Sum_probs=200.9

Q ss_pred             chhhHHHHhcCCccCccccccCCccEEEEEEcC-CCEEEEEEecCC---CchhHHHHHHHHHHHhcCCCCceeeeeeeEE
Q 017594           40 SFSSVSTATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGR---SGQGLREMKNEASVIAKVQHKNLVRLLGCCI  115 (369)
Q Consensus        40 ~~~~~~~~~~~y~i~~~lg~G~~~~v~~~~~~~-~~~valK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~  115 (369)
                      .+.......++|++.+.||+|+||.||+|+.+. ++.+|+|++...   .......+.+|+.+++.++||||+++++.+.
T Consensus        34 ~~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~  113 (371)
T cd05622          34 KIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQ  113 (371)
T ss_pred             HHhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence            344556667899999999999999999999764 888999998632   1223455678999999999999999999999


Q ss_pred             eCCccEEEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeec
Q 017594          116 DRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDF  195 (369)
Q Consensus       116 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Df  195 (369)
                      .+...++||||+.+++|..++..    ..+++..+..++.||+.||.|||+.+   ++||||||+||+++.++.++|+||
T Consensus       114 ~~~~~~lv~Ey~~gg~L~~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~Df  186 (371)
T cd05622         114 DDRYLYMVMEYMPGGDLVNLMSN----YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADF  186 (371)
T ss_pred             cCCEEEEEEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEeC
Confidence            99999999999999999988843    23788888999999999999999999   999999999999999999999999


Q ss_pred             CCceecCCCCcccccccccccccccCchhhccC----CCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhh
Q 017594          196 GMARICGGNELQANTSRIVGTYGYMSPEYALEG----IFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLW  271 (369)
Q Consensus       196 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~----~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~  271 (369)
                      |++........ .......|++.|+|||++.+.    .++.++|||||||++|+|++|..||.......     ......
T Consensus       187 G~a~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~-----~~~~i~  260 (371)
T cd05622         187 GTCMKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG-----TYSKIM  260 (371)
T ss_pred             CceeEcCcCCc-ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHH-----HHHHHH
Confidence            99886643221 112234689999999998653    37899999999999999999999996432110     011111


Q ss_pred             hcCccccccCccccccccHHHHHHHHHHHHHHhhcCCCCC--CCCHHHHHHH
Q 017594          272 TSNRTLELIDPILEDEYSSKQMLLRYANIALLCVQESADD--RPTMNDVVSM  321 (369)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~--Rps~~ell~~  321 (369)
                      .........        ....++..+.++|.+||..++.+  |+++.++++.
T Consensus       261 ~~~~~~~~~--------~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h  304 (371)
T cd05622         261 NHKNSLTFP--------DDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH  304 (371)
T ss_pred             cCCCcccCC--------CcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcC
Confidence            111111100        01123667899999999844433  7899999875

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=4.6e-37  Score=276.02  Aligned_cols=257  Identities=28%  Similarity=0.446  Sum_probs=201.3

Q ss_pred             hcCCccCccccccCCccEEEEEEcC----CCEEEEEEecCCC-chhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEE
Q 017594           48 TNKFSDANKLGEGGFGPVYKGVLKK----GDEIAVKRLSGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKIL  122 (369)
Q Consensus        48 ~~~y~i~~~lg~G~~~~v~~~~~~~----~~~valK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l  122 (369)
                      ..+|++.+.||.|+||.||+|++..    +..+++|.+.... ......+..|+.+++.++||||+++++++...+..++
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   82 (267)
T cd05066           3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMI   82 (267)
T ss_pred             HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence            4689999999999999999998642    3368999886443 2334678889999999999999999999998899999


Q ss_pred             EEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecC
Q 017594          123 IYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICG  202 (369)
Q Consensus       123 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~  202 (369)
                      +|||+++++|.+++....  ..+++..+..++.|++.|+.+||+++   ++|+||+|+||+++.++.++|+|||++....
T Consensus        83 v~e~~~~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~~~  157 (267)
T cd05066          83 VTEYMENGSLDAFLRKHD--GQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVLE  157 (267)
T ss_pred             EEEcCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCcccccc
Confidence            999999999999986432  34788899999999999999999999   9999999999999999999999999987664


Q ss_pred             CCCcccc-cccccccccccCchhhccCCCCcccchHhHHHHHHHHHh-CCCCCCCCcccccccchhhhhhhhcCcccccc
Q 017594          203 GNELQAN-TSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDLWTSNRTLELI  280 (369)
Q Consensus       203 ~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (369)
                      ....... .....++..|+|||.+.+..++.++|+||||+++|++++ |..||.......     ..... ...  ... 
T Consensus       158 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~-----~~~~~-~~~--~~~-  228 (267)
T cd05066         158 DDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQD-----VIKAI-EEG--YRL-  228 (267)
T ss_pred             cccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHH-----HHHHH-hCC--CcC-
Confidence            3321111 111223457999999998889999999999999999886 999986432111     00000 000  000 


Q ss_pred             CccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHhh
Q 017594          281 DPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNE  325 (369)
Q Consensus       281 ~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L~~~  325 (369)
                       +      .+...+..+.+++.+||+.+|.+||++.++++.|..+
T Consensus       229 -~------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  266 (267)
T cd05066         229 -P------APMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL  266 (267)
T ss_pred             -C------CCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence             0      0111256789999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=8.8e-37  Score=272.26  Aligned_cols=252  Identities=27%  Similarity=0.433  Sum_probs=200.1

Q ss_pred             hcCCccCccccccCCccEEEEEEcCCCEEEEEEecCCCchhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEEEEec
Q 017594           48 TNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIYEYM  127 (369)
Q Consensus        48 ~~~y~i~~~lg~G~~~~v~~~~~~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~  127 (369)
                      ..+|++.+.||.|++|.||+|.+.++..+++|.+..... ....+..|+++++++.||+++++++++......++++||+
T Consensus         3 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   81 (256)
T cd05112           3 PSELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAM-SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFM   81 (256)
T ss_pred             hhHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCC-CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcC
Confidence            357899999999999999999987788999998864432 2356888999999999999999999999889999999999


Q ss_pred             CCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCCCCcc
Q 017594          128 PNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQ  207 (369)
Q Consensus       128 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~~~~~  207 (369)
                      .+++|.+++....  ..+++..++.++.|++.++++||+.+   ++|+||+|.||+++.++.++|+|||.+.........
T Consensus        82 ~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~  156 (256)
T cd05112          82 EHGCLSDYLRAQR--GKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYT  156 (256)
T ss_pred             CCCcHHHHHHhCc--cCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeecccCccc
Confidence            9999998885432  34788899999999999999999998   999999999999999999999999998765432211


Q ss_pred             cccccccccccccCchhhccCCCCcccchHhHHHHHHHHHh-CCCCCCCCcccccccchhhhhhhhcCccccccCccccc
Q 017594          208 ANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILED  286 (369)
Q Consensus       208 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  286 (369)
                      . .....++..|+|||.+.+..++.++|+||||+++|+|++ |..||.......     ..... ...  .....+.   
T Consensus       157 ~-~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~-----~~~~~-~~~--~~~~~~~---  224 (256)
T cd05112         157 S-STGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSE-----VVETI-NAG--FRLYKPR---  224 (256)
T ss_pred             c-cCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHH-----HHHHH-hCC--CCCCCCC---
Confidence            1 111224567999999988889999999999999999998 888886432110     01110 000  0000111   


Q ss_pred             cccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHH
Q 017594          287 EYSSKQMLLRYANIALLCVQESADDRPTMNDVVSML  322 (369)
Q Consensus       287 ~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L  322 (369)
                           ..+..+.+++.+||+.+|++||++.++++.|
T Consensus       225 -----~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l  255 (256)
T cd05112         225 -----LASQSVYELMQHCWKERPEDRPSFSLLLHQL  255 (256)
T ss_pred             -----CCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence                 1156699999999999999999999999987

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=4.9e-37  Score=288.98  Aligned_cols=262  Identities=22%  Similarity=0.286  Sum_probs=193.8

Q ss_pred             CCccCccccccCCccEEEEEEc-CCCEEEEEEecCC--CchhHHHHHHHHHHHhcCCCCceeeeeeeEEeCC-----ccE
Q 017594           50 KFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDRD-----EKI  121 (369)
Q Consensus        50 ~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~  121 (369)
                      +|++.+.||.|+||.||+|.+. +|+.||+|++...  .......+.+|+.+++.++|+||+++++++....     ..+
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   80 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY   80 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence            4789999999999999999964 5899999998643  2234567888999999999999999999998766     789


Q ss_pred             EEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceec
Q 017594          122 LIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARIC  201 (369)
Q Consensus       122 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~  201 (369)
                      +|+||+.+ .|...+..   ...+++..+..++.||+.||.|||+.+   ++||||||+||+++.++.++|+|||++...
T Consensus        81 lv~e~~~~-~l~~~~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~  153 (372)
T cd07853          81 VVTELMQS-DLHKIIVS---PQPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVE  153 (372)
T ss_pred             EEeecccc-CHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccceeec
Confidence            99999975 56555533   334889999999999999999999999   999999999999999999999999998765


Q ss_pred             CCCCcccccccccccccccCchhhccC-CCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCc-----
Q 017594          202 GGNELQANTSRIVGTYGYMSPEYALEG-IFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNR-----  275 (369)
Q Consensus       202 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~-----  275 (369)
                      ..... .......++..|+|||++.+. .++.++||||+||++|+|++|+.||........  ............     
T Consensus       154 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~i~~~~g~~~~~~~~  230 (372)
T cd07853         154 EPDES-KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQ--LDLITDLLGTPSLEAMR  230 (372)
T ss_pred             ccCcc-ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHH--HHHHHHHcCCCCHHHHH
Confidence            43221 112223568889999998764 478999999999999999999999964431110  000000000000     


Q ss_pred             -----ccccc------Ccccccc-ccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 017594          276 -----TLELI------DPILEDE-YSSKQMLLRYANIALLCVQESADDRPTMNDVVSM  321 (369)
Q Consensus       276 -----~~~~~------~~~~~~~-~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~  321 (369)
                           ....+      .+..... ......+.++.+||.+||+.||++|||+.++++.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  288 (372)
T cd07853         231 SACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH  288 (372)
T ss_pred             HhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence                 00000      0000000 0001125678999999999999999999999863

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=1.6e-37  Score=286.63  Aligned_cols=241  Identities=24%  Similarity=0.320  Sum_probs=189.9

Q ss_pred             CCccCccccccCCccEEEEEEc-CCCEEEEEEecCC---CchhHHHHHHHHHHHhcCC-CCceeeeeeeEEeCCccEEEE
Q 017594           50 KFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGR---SGQGLREMKNEASVIAKVQ-HKNLVRLLGCCIDRDEKILIY  124 (369)
Q Consensus        50 ~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~---~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~  124 (369)
                      +|++.+.||+|+||.||+|+.+ +|+.||+|++...   .....+.+..|..++..+. |++++++.+++...+..++||
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM   80 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence            4788899999999999999965 4889999998643   1233455677888888875 567888999998888999999


Q ss_pred             EecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCCC
Q 017594          125 EYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGN  204 (369)
Q Consensus       125 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~~  204 (369)
                      ||+.+++|..++...   ..+++..+..++.||+.||.|||+.|   ++||||||+||+++.++.++|+|||++......
T Consensus        81 Ey~~~g~L~~~i~~~---~~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~  154 (323)
T cd05615          81 EYVNGGDLMYHIQQV---GKFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD  154 (323)
T ss_pred             cCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccccccCCC
Confidence            999999998888543   34889999999999999999999999   999999999999999999999999998753221


Q ss_pred             CcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCccccccCccc
Q 017594          205 ELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPIL  284 (369)
Q Consensus       205 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (369)
                      .  .......|+..|+|||++.+..++.++|+||+||++|+|++|..||.......     ....... ... .     .
T Consensus       155 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~-----~~~~i~~-~~~-~-----~  220 (323)
T cd05615         155 G--VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDE-----LFQSIME-HNV-S-----Y  220 (323)
T ss_pred             C--ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHH-----HHHHHHh-CCC-C-----C
Confidence            1  11223458899999999998899999999999999999999999986433111     0011100 000 0     0


Q ss_pred             cccccHHHHHHHHHHHHHHhhcCCCCCCCCH
Q 017594          285 EDEYSSKQMLLRYANIALLCVQESADDRPTM  315 (369)
Q Consensus       285 ~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~  315 (369)
                           +...+.++.+++.+||+.+|.+|++.
T Consensus       221 -----p~~~~~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05615         221 -----PKSLSKEAVSICKGLMTKHPSKRLGC  246 (323)
T ss_pred             -----CccCCHHHHHHHHHHcccCHhhCCCC
Confidence                 11125668999999999999999985

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=2.4e-37  Score=280.50  Aligned_cols=264  Identities=23%  Similarity=0.363  Sum_probs=202.8

Q ss_pred             ccchhhHHHHhcCCccCccccccCCccEEEEEEcC-CCEEEEEEecCCCchhHHHHHHHHHHHhcC-CCCceeeeeeeEE
Q 017594           38 LFSFSSVSTATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLREMKNEASVIAKV-QHKNLVRLLGCCI  115 (369)
Q Consensus        38 ~~~~~~~~~~~~~y~i~~~lg~G~~~~v~~~~~~~-~~~valK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~  115 (369)
                      .+.+.......++|++.+.||+|++|.||+|+.+. ++.+++|++.... .....+..|+.+++.+ +|+|++++++++.
T Consensus         7 ~~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~   85 (286)
T cd06638           7 TIIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYY   85 (286)
T ss_pred             eEEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeee
Confidence            35667777888999999999999999999999654 8889999876432 2235677899999999 6999999999874


Q ss_pred             -----eCCccEEEEEecCCCChhhhhcCC-CccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCc
Q 017594          116 -----DRDEKILIYEYMPNKSLDFFLFDP-TKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMN  189 (369)
Q Consensus       116 -----~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~  189 (369)
                           .+...+++|||+++++|.+++... .....+++..++.++.|++.||.|||+.+   ++|+||+|+||+++.++.
T Consensus        86 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~  162 (286)
T cd06638          86 KKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGG  162 (286)
T ss_pred             ecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCC
Confidence                 335689999999999998876532 22345788889999999999999999998   999999999999999999


Q ss_pred             eEEeecCCceecCCCCcccccccccccccccCchhhc-----cCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccc
Q 017594          190 PKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAL-----EGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLL  264 (369)
Q Consensus       190 ~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~  264 (369)
                      ++|+|||++........  ......++..|+|||++.     +..++.++|+||+||++|+|++|..||........   
T Consensus       163 ~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~---  237 (286)
T cd06638         163 VKLVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRA---  237 (286)
T ss_pred             EEEccCCceeecccCCC--ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHH---
Confidence            99999999876543221  122345788999999875     34578899999999999999999999864321110   


Q ss_pred             hhhhhhhhcCccccccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 017594          265 GYAWDLWTSNRTLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSM  321 (369)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~  321 (369)
                        .......      ..+..   ..+..++..+.+++.+||+.+|++|||+.++++.
T Consensus       238 --~~~~~~~------~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~  283 (286)
T cd06638         238 --LFKIPRN------PPPTL---HQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH  283 (286)
T ss_pred             --Hhhcccc------CCCcc---cCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence              0000000      00000   0111124568999999999999999999999874

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-39  Score=276.92  Aligned_cols=249  Identities=25%  Similarity=0.425  Sum_probs=207.5

Q ss_pred             cCCccCccccccCCccEEEEEEcC-CCEEEEEEecCCCchhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEEEEec
Q 017594           49 NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIYEYM  127 (369)
Q Consensus        49 ~~y~i~~~lg~G~~~~v~~~~~~~-~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~  127 (369)
                      +-|.++++||.|.||.||+|.++. |+.+|+|.+...  .+.+.+..|+.+++++.+++++++++.+.....+|+|||||
T Consensus        33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYC  110 (502)
T KOG0574|consen   33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYC  110 (502)
T ss_pred             HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhc
Confidence            447788999999999999999664 999999999754  45688999999999999999999999999999999999999


Q ss_pred             CCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCCCCcc
Q 017594          128 PNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQ  207 (369)
Q Consensus       128 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~~~~~  207 (369)
                      ..|+..++++.  +++++.+.++..++..-+++|+|||...   -+|||||..||+++.+|..+|+|||.+-.+....  
T Consensus       111 GAGSiSDI~R~--R~K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTM--  183 (502)
T KOG0574|consen  111 GAGSISDIMRA--RRKPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTM--  183 (502)
T ss_pred             CCCcHHHHHHH--hcCCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchhhhhH--
Confidence            99999999964  5677999999999999999999999998   8999999999999999999999999987654221  


Q ss_pred             cccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCccccccCcccccc
Q 017594          208 ANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDE  287 (369)
Q Consensus       208 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  287 (369)
                      .......||+.|+|||++..-.|+.++||||||++..+|..|++||..--.               -...-.+.-.....
T Consensus       184 AKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHP---------------MRAIFMIPT~PPPT  248 (502)
T KOG0574|consen  184 AKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHP---------------MRAIFMIPTKPPPT  248 (502)
T ss_pred             HhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccc---------------cceeEeccCCCCCC
Confidence            223346799999999999999999999999999999999999999752110               00000000001111


Q ss_pred             c-cHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 017594          288 Y-SSKQMLLRYANIALLCVQESADDRPTMNDVVSM  321 (369)
Q Consensus       288 ~-~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~  321 (369)
                      + .+..++.++.++|++||-..|++|-|+.++++.
T Consensus       249 F~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H  283 (502)
T KOG0574|consen  249 FKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH  283 (502)
T ss_pred             CCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence            1 255668899999999999999999999988764

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=5.8e-37  Score=283.95  Aligned_cols=255  Identities=19%  Similarity=0.221  Sum_probs=195.3

Q ss_pred             cCCccCccccccCCccEEEEEEc-CCCEEEEEEecCC---CchhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEEE
Q 017594           49 NKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGR---SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIY  124 (369)
Q Consensus        49 ~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  124 (369)
                      ++|++.+.||+|+||.||+++.+ +++.||+|++...   .......+..|..++..+.|++|+.+++++...+..|+||
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~   80 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM   80 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            47999999999999999999965 4788999998642   1223445778899999999999999999999999999999


Q ss_pred             EecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCCC
Q 017594          125 EYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGN  204 (369)
Q Consensus       125 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~~  204 (369)
                      ||+.+++|..++...  ...+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.++|+|||++......
T Consensus        81 Ey~~gg~L~~~l~~~--~~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  155 (331)
T cd05624          81 DYYVGGDLLTLLSKF--EDRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD  155 (331)
T ss_pred             eCCCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeeccCC
Confidence            999999999988542  234788899999999999999999999   999999999999999999999999998765432


Q ss_pred             CcccccccccccccccCchhhcc-----CCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCccccc
Q 017594          205 ELQANTSRIVGTYGYMSPEYALE-----GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLEL  279 (369)
Q Consensus       205 ~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (369)
                      .. .......|++.|+|||++.+     ..++.++|+||+|+++|+|++|+.||.......     ............. 
T Consensus       156 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~-----~~~~i~~~~~~~~-  228 (331)
T cd05624         156 GT-VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVE-----TYGKIMNHEERFQ-  228 (331)
T ss_pred             Cc-eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHH-----HHHHHHcCCCccc-
Confidence            21 11223468999999998875     467889999999999999999999986432110     0001110000000 


Q ss_pred             cCccccccccHHHHHHHHHHHHHHhhcCCCCC--CCCHHHHHHH
Q 017594          280 IDPILEDEYSSKQMLLRYANIALLCVQESADD--RPTMNDVVSM  321 (369)
Q Consensus       280 ~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~--Rps~~ell~~  321 (369)
                      +...      ....+.++.++|.+||+.++.+  |++++++++.
T Consensus       229 ~p~~------~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h  266 (331)
T cd05624         229 FPSH------ITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH  266 (331)
T ss_pred             CCCc------cccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence            0000      0112567899999999876654  4688888764

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=1e-37  Score=292.79  Aligned_cols=264  Identities=23%  Similarity=0.265  Sum_probs=194.5

Q ss_pred             HHhcCCccCccccccCCccEEEEEEc-CCCEEEEEEecCC--CchhHHHHHHHHHHHhcCCCCceeeeeeeEEeC-----
Q 017594           46 TATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDR-----  117 (369)
Q Consensus        46 ~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----  117 (369)
                      ...++|++.+.||+|+||.||+|.+. .++.||+|++...  .......+.+|+.+++.++||||+++++++...     
T Consensus        21 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~  100 (364)
T cd07875          21 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEE  100 (364)
T ss_pred             chhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccc
Confidence            45689999999999999999999965 4888999998643  233445677899999999999999999887543     


Q ss_pred             -CccEEEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecC
Q 017594          118 -DEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFG  196 (369)
Q Consensus       118 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg  196 (369)
                       ...++||||+.+ ++...+.     ..++...++.++.|++.||.|||+++   ++||||||+||+++.++.++|+|||
T Consensus       101 ~~~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG  171 (364)
T cd07875         101 FQDVYIVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG  171 (364)
T ss_pred             cCeEEEEEeCCCC-CHHHHHH-----hcCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeCC
Confidence             346999999976 4555542     12678888999999999999999999   9999999999999999999999999


Q ss_pred             CceecCCCCcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCccccccc----------chh
Q 017594          197 MARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNL----------LGY  266 (369)
Q Consensus       197 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~----------~~~  266 (369)
                      ++.......   ......++..|+|||++.+..++.++|||||||++|+|++|+.||..........          ...
T Consensus       172 ~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  248 (364)
T cd07875         172 LARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEF  248 (364)
T ss_pred             CccccCCCC---cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence            987653321   1223467889999999999999999999999999999999999996543111000          000


Q ss_pred             h-------hhhhhcCc-c-----ccccCccccc--cccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 017594          267 A-------WDLWTSNR-T-----LELIDPILED--EYSSKQMLLRYANIALLCVQESADDRPTMNDVVSM  321 (369)
Q Consensus       267 ~-------~~~~~~~~-~-----~~~~~~~~~~--~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~  321 (369)
                      .       ........ .     ..........  .......+..+.++|.+||+.||.+|||+.++++.
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h  318 (364)
T cd07875         249 MKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH  318 (364)
T ss_pred             HHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence            0       00000000 0     0000000000  00011124568999999999999999999999874

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=3.2e-37  Score=277.02  Aligned_cols=257  Identities=28%  Similarity=0.459  Sum_probs=200.9

Q ss_pred             hcCCccCccccccCCccEEEEEEcC-CC---EEEEEEecCCC-chhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEE
Q 017594           48 TNKFSDANKLGEGGFGPVYKGVLKK-GD---EIAVKRLSGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKIL  122 (369)
Q Consensus        48 ~~~y~i~~~lg~G~~~~v~~~~~~~-~~---~valK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l  122 (369)
                      ..+|+..+.||+|++|.||+|+.+. +.   .+++|.+.... ....+.+..|+.+++.++|+|++++.+++...+..++
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   83 (268)
T cd05063           4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI   83 (268)
T ss_pred             hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence            4578899999999999999999653 33   68999886542 3335668889999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecC
Q 017594          123 IYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICG  202 (369)
Q Consensus       123 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~  202 (369)
                      +|||+.+++|..++....  ..+++..+..++.|++.|++|||+.+   ++|+||+|.||+++.++.++|+|||++....
T Consensus        84 v~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~  158 (268)
T cd05063          84 ITEYMENGALDKYLRDHD--GEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRVLE  158 (268)
T ss_pred             EEEcCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCccceecc
Confidence            999999999998885432  34788899999999999999999998   9999999999999999999999999987654


Q ss_pred             CCCccccc-ccccccccccCchhhccCCCCcccchHhHHHHHHHHHh-CCCCCCCCcccccccchhhhhhhhcCcccccc
Q 017594          203 GNELQANT-SRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDLWTSNRTLELI  280 (369)
Q Consensus       203 ~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (369)
                      ........ .....+..|+|||.+.+..++.++|+||||+++|+|++ |..||.......     ..... ....    .
T Consensus       159 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~-----~~~~i-~~~~----~  228 (268)
T cd05063         159 DDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHE-----VMKAI-NDGF----R  228 (268)
T ss_pred             cccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHH-----HHHHH-hcCC----C
Confidence            32211111 11122457999999988889999999999999999997 999985332110     01111 1000    0


Q ss_pred             CccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHhh
Q 017594          281 DPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNE  325 (369)
Q Consensus       281 ~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L~~~  325 (369)
                      .+      .....+..+.+++.+||+.+|++||++.++++.|+++
T Consensus       229 ~~------~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~  267 (268)
T cd05063         229 LP------APMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL  267 (268)
T ss_pred             CC------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            00      0111256689999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=1.2e-36  Score=271.84  Aligned_cols=247  Identities=29%  Similarity=0.417  Sum_probs=192.6

Q ss_pred             cccccCCccEEEEEEc---CCCEEEEEEecCCC--chhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEEEEecCCC
Q 017594           56 KLGEGGFGPVYKGVLK---KGDEIAVKRLSGRS--GQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIYEYMPNK  130 (369)
Q Consensus        56 ~lg~G~~~~v~~~~~~---~~~~valK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~  130 (369)
                      .||+|+||.||+|.++   ++..+++|++....  ....+.+..|+.+++.+.|+||+++++++. .+..++++||+.++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~   80 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG   80 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence            6899999999999743   47889999886442  223466788999999999999999999874 55779999999999


Q ss_pred             ChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCCCCcccc-
Q 017594          131 SLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQAN-  209 (369)
Q Consensus       131 ~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~~~~~~~-  209 (369)
                      +|.+++...   ..+++..+..++.|++.||.+||+++   ++|+||+|.||+++.++.++|+|||++........... 
T Consensus        81 ~L~~~l~~~---~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  154 (257)
T cd05116          81 PLNKFLQKN---KHVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKA  154 (257)
T ss_pred             cHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCCCCeeee
Confidence            999888533   34889999999999999999999999   99999999999999999999999999876643322111 


Q ss_pred             cccccccccccCchhhccCCCCcccchHhHHHHHHHHHh-CCCCCCCCcccccccchhhhhhhhcCccccccCccccccc
Q 017594          210 TSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEY  288 (369)
Q Consensus       210 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  288 (369)
                      .....++..|+|||.+.+..++.++|+|||||++|+|++ |..||.......     ... .........     .    
T Consensus       155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~-----~~~-~i~~~~~~~-----~----  219 (257)
T cd05116         155 KTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNE-----VTQ-MIESGERME-----C----  219 (257)
T ss_pred             cCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH-----HHH-HHHCCCCCC-----C----
Confidence            111233568999999988889999999999999999998 999986432111     111 111111000     1    


Q ss_pred             cHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHhh
Q 017594          289 SSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNE  325 (369)
Q Consensus       289 ~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L~~~  325 (369)
                       +..++.++.++|.+||+.||++||++.+|.+.|++.
T Consensus       220 -~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~  255 (257)
T cd05116         220 -PQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY  255 (257)
T ss_pred             -CCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence             111256799999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.1e-37  Score=290.34  Aligned_cols=265  Identities=22%  Similarity=0.288  Sum_probs=193.8

Q ss_pred             HHHHhcCCccCccccccCCccEEEEEEc-CCCEEEEEEecCCC--chhHHHHHHHHHHHhcCCCCceeeeeeeEEeC---
Q 017594           44 VSTATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS--GQGLREMKNEASVIAKVQHKNLVRLLGCCIDR---  117 (369)
Q Consensus        44 ~~~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---  117 (369)
                      +....++|++.+.||.|+||.||+|.+. +++.||+|.+....  ......+.+|+.+++.++|+||+++++++...   
T Consensus        10 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   89 (343)
T cd07878          10 VWEVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSI   89 (343)
T ss_pred             HhhhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccc
Confidence            3345689999999999999999999965 58899999986432  12335567899999999999999999887543   


Q ss_pred             ---CccEEEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEee
Q 017594          118 ---DEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISD  194 (369)
Q Consensus       118 ---~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~D  194 (369)
                         ...+++++++ +++|..++..    ..+++..+..++.||+.||.|||+++   ++||||||+||+++.++.++|+|
T Consensus        90 ~~~~~~~~~~~~~-~~~l~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~D  161 (343)
T cd07878          90 ENFNEVYLVTNLM-GADLNNIVKC----QKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILD  161 (343)
T ss_pred             cccCcEEEEeecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEcC
Confidence               3468999987 6778777632    34889999999999999999999999   99999999999999999999999


Q ss_pred             cCCceecCCCCcccccccccccccccCchhhcc-CCCCcccchHhHHHHHHHHHhCCCCCCCCccccccc-c--------
Q 017594          195 FGMARICGGNELQANTSRIVGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNL-L--------  264 (369)
Q Consensus       195 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~-~--------  264 (369)
                      ||++......     .....++..|+|||++.+ ..++.++|||||||++|+|++|..||.......... .        
T Consensus       162 fg~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~  236 (343)
T cd07878         162 FGLARQADDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPS  236 (343)
T ss_pred             CccceecCCC-----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence            9998765432     223467889999999876 568999999999999999999999986432110000 0        


Q ss_pred             hhhhhhhhcCccccccC---ccccccc--cHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 017594          265 GYAWDLWTSNRTLELID---PILEDEY--SSKQMLLRYANIALLCVQESADDRPTMNDVVSM  321 (369)
Q Consensus       265 ~~~~~~~~~~~~~~~~~---~~~~~~~--~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~  321 (369)
                      ...............+.   .......  .....+..+.+||.+||+.||.+|||+.++++.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h  298 (343)
T cd07878         237 PEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH  298 (343)
T ss_pred             HHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            00000000000000000   0000000  000113457899999999999999999999963

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.6e-36  Score=270.97  Aligned_cols=249  Identities=33%  Similarity=0.471  Sum_probs=194.5

Q ss_pred             ccccccCCccEEEEEEcC----CCEEEEEEecCCCc-hhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEEEEecCC
Q 017594           55 NKLGEGGFGPVYKGVLKK----GDEIAVKRLSGRSG-QGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIYEYMPN  129 (369)
Q Consensus        55 ~~lg~G~~~~v~~~~~~~----~~~valK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~  129 (369)
                      +.||+|+||.||+|++..    +..+++|.+..... .....+..|+.+++.+.|+|++++++++. .+..++++||+.+
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~   79 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL   79 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence            479999999999998432    36899999875543 24467888999999999999999999875 5678999999999


Q ss_pred             CChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCCCCcccc
Q 017594          130 KSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQAN  209 (369)
Q Consensus       130 ~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~~~~~~~  209 (369)
                      ++|.+++....   .+++..+..++.|++.|+++||..+   ++|+||+|+||+++.++.++|+|||.+...........
T Consensus        80 ~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~  153 (257)
T cd05060          80 GPLLKYLKKRR---EIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYR  153 (257)
T ss_pred             CcHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecCCcccc
Confidence            99999985433   5889999999999999999999998   99999999999999999999999999886643322111


Q ss_pred             -cccccccccccCchhhccCCCCcccchHhHHHHHHHHHh-CCCCCCCCcccccccchhhhhhhhcCccccccCcccccc
Q 017594          210 -TSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDE  287 (369)
Q Consensus       210 -~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  287 (369)
                       .....++..|+|||.+.+..++.++|+||||+++|+|++ |..||.......  .    ...........         
T Consensus       154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~--~----~~~~~~~~~~~---------  218 (257)
T cd05060         154 ATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAE--V----IAMLESGERLP---------  218 (257)
T ss_pred             cccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHH--H----HHHHHcCCcCC---------
Confidence             111123457999999988889999999999999999998 999986432111  0    01111110000         


Q ss_pred             ccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHhhh
Q 017594          288 YSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNEA  326 (369)
Q Consensus       288 ~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L~~~~  326 (369)
                       .+..++..+.++|.+||+.+|++||++.++++.|+...
T Consensus       219 -~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~  256 (257)
T cd05060         219 -RPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP  256 (257)
T ss_pred             -CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence             01112567899999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=5.5e-37  Score=293.49  Aligned_cols=263  Identities=17%  Similarity=0.198  Sum_probs=194.0

Q ss_pred             HhcCCccCccccccCCccEEEEEEcC-CCEEEEEEecCCCchhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEEEE
Q 017594           47 ATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIYE  125 (369)
Q Consensus        47 ~~~~y~i~~~lg~G~~~~v~~~~~~~-~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  125 (369)
                      ....|.+.+.||.|+||.||+|.+.. ++.|++|....      ....+|+.++++++|+||+++++++......+++++
T Consensus       167 ~~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e  240 (461)
T PHA03211        167 AGLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLP  240 (461)
T ss_pred             ccCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEE
Confidence            35579999999999999999999765 78899996432      345679999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCCCC
Q 017594          126 YMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE  205 (369)
Q Consensus       126 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~~~  205 (369)
                      ++. ++|..++...  ...+++..++.++.||+.||.|||+.|   ++||||||+||+++.++.++|+|||++.......
T Consensus       241 ~~~-~~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~  314 (461)
T PHA03211        241 KYR-SDLYTYLGAR--LRPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSW  314 (461)
T ss_pred             ccC-CCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceeccccc
Confidence            996 5666665432  235899999999999999999999999   9999999999999999999999999987664332


Q ss_pred             cccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCccc-c-cccchhhhhhhhcC-----cccc
Q 017594          206 LQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTD-S-LNLLGYAWDLWTSN-----RTLE  278 (369)
Q Consensus       206 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~-~-~~~~~~~~~~~~~~-----~~~~  278 (369)
                      .........|+..|+|||++.+..++.++|||||||++|+|++|..++-..... . ..............     ....
T Consensus       315 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~  394 (461)
T PHA03211        315 STPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQ  394 (461)
T ss_pred             ccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCC
Confidence            222223356899999999999999999999999999999999987654222111 0 00000000000000     0000


Q ss_pred             cc----------------Cccccc-ccc-HHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 017594          279 LI----------------DPILED-EYS-SKQMLLRYANIALLCVQESADDRPTMNDVVSM  321 (369)
Q Consensus       279 ~~----------------~~~~~~-~~~-~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~  321 (369)
                      ..                .+.... ... ....+.++.+||.+||+.||.+|||+.|+|+.
T Consensus       395 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h  455 (461)
T PHA03211        395 HAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL  455 (461)
T ss_pred             CcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence            00                000000 000 00124578899999999999999999999974

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=4.4e-37  Score=274.24  Aligned_cols=250  Identities=22%  Similarity=0.329  Sum_probs=201.8

Q ss_pred             CCccCccccccCCccEEEEEEc-CCCEEEEEEecCC--CchhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEEEEe
Q 017594           50 KFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIYEY  126 (369)
Q Consensus        50 ~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  126 (369)
                      +|++++.||.|++|.||.++.. +++.+++|.+...  .......+.+|+.++++++|+|++++++++.+....++++||
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~   80 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY   80 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence            5899999999999999999954 4889999987644  234456778899999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCCCCc
Q 017594          127 MPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNEL  206 (369)
Q Consensus       127 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~~~~  206 (369)
                      +.+++|.+++.... ...+++..+..++.|++.++.+||+.+   ++|+||+|+||+++.++.++|+|||.+........
T Consensus        81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~  156 (256)
T cd08221          81 ANGGTLYDKIVRQK-GQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS  156 (256)
T ss_pred             cCCCcHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEcccccc
Confidence            99999999886432 345788999999999999999999998   99999999999999999999999999876643331


Q ss_pred             ccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCccccccCccccc
Q 017594          207 QANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILED  286 (369)
Q Consensus       207 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  286 (369)
                        ......++..|.|||...+..++.++|+||||+++++|++|..||......     ....... .......       
T Consensus       157 --~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~-----~~~~~~~-~~~~~~~-------  221 (256)
T cd08221         157 --MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPL-----NLVVKIV-QGNYTPV-------  221 (256)
T ss_pred             --cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHH-----HHHHHHH-cCCCCCC-------
Confidence              223345788999999998888899999999999999999999998532210     0111111 1111000       


Q ss_pred             cccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 017594          287 EYSSKQMLLRYANIALLCVQESADDRPTMNDVVSM  321 (369)
Q Consensus       287 ~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~  321 (369)
                         ...++.++.+++.+||+.+|.+||++.++++.
T Consensus       222 ---~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~  253 (256)
T cd08221         222 ---VSVYSSELISLVHSLLQQDPEKRPTADEVLDQ  253 (256)
T ss_pred             ---ccccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence               12225679999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=5.6e-38  Score=264.99  Aligned_cols=268  Identities=24%  Similarity=0.321  Sum_probs=209.0

Q ss_pred             HHhcCCccCccccccCCccEEEEEEc-CCCEEEEEEecCCC-----c---hhHHHHHHHHHHHhcC-CCCceeeeeeeEE
Q 017594           46 TATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS-----G---QGLREMKNEASVIAKV-QHKNLVRLLGCCI  115 (369)
Q Consensus        46 ~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~~-----~---~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~  115 (369)
                      ..-..|.-.+.||.|..+.|-.+..+ +|+.+++|++....     +   ...+.-..|+.+|+++ -||+|+.+.++++
T Consensus        14 ~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~ye   93 (411)
T KOG0599|consen   14 GFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYE   93 (411)
T ss_pred             hHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeecc
Confidence            44567888999999999999998854 58889999875321     1   1233445699999998 5999999999999


Q ss_pred             eCCccEEEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeec
Q 017594          116 DRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDF  195 (369)
Q Consensus       116 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Df  195 (369)
                      ...-.++|+|.+..|-|.+++..   .-.+++....+|+.|++.+++|||..+   |+||||||+||+++++-+++|+||
T Consensus        94 s~sF~FlVFdl~prGELFDyLts---~VtlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~isDF  167 (411)
T KOG0599|consen   94 SDAFVFLVFDLMPRGELFDYLTS---KVTLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIKISDF  167 (411)
T ss_pred             CcchhhhhhhhcccchHHHHhhh---heeecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceEEecc
Confidence            99999999999999999999944   455999999999999999999999999   999999999999999999999999


Q ss_pred             CCceecCCCCcccccccccccccccCchhhcc------CCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhh
Q 017594          196 GMARICGGNELQANTSRIVGTYGYMSPEYALE------GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWD  269 (369)
Q Consensus       196 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~  269 (369)
                      |+++.+..+.   .....+||++|+|||.+.+      ..|+...|+|++|+|+|.|+.|.+||=...           .
T Consensus       168 GFa~~l~~Ge---kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRk-----------Q  233 (411)
T KOG0599|consen  168 GFACQLEPGE---KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRK-----------Q  233 (411)
T ss_pred             ceeeccCCch---hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHH-----------H
Confidence            9998876443   3345689999999999863      458889999999999999999999983211           0


Q ss_pred             hhhcCccccccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH--HHHhhhhccCCCCCC
Q 017594          270 LWTSNRTLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVS--MLTNEAATLLPPKQP  335 (369)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~--~L~~~~~~~~~~~~~  335 (369)
                      ....+.+.+-.-...  ......++....+||.+||+.||++|.|++|+|.  ++.++.....+..+|
T Consensus       234 mlMLR~ImeGkyqF~--speWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~~~~~~r~msP  299 (411)
T KOG0599|consen  234 MLMLRMIMEGKYQFR--SPEWADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQIAQQQARQMSP  299 (411)
T ss_pred             HHHHHHHHhcccccC--CcchhhccccHHHHHHHHHeeCchhcccHHHHhcChHHHHHHHhcccccCC
Confidence            011111111100111  1123344788999999999999999999999995  455555544444444

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=1.1e-36  Score=271.56  Aligned_cols=247  Identities=28%  Similarity=0.431  Sum_probs=199.1

Q ss_pred             CCccCccccccCCccEEEEEEc-CCCEEEEEEecCCC-----chhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEE
Q 017594           50 KFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS-----GQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILI  123 (369)
Q Consensus        50 ~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~~-----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv  123 (369)
                      +|+..+.||+|++|.||+|..+ ++..|++|.+....     ......+..|+.+++.++|+|++++++++......+++
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF   80 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence            6889999999999999999976 68999999886443     22456788899999999999999999999998999999


Q ss_pred             EEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCC
Q 017594          124 YEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGG  203 (369)
Q Consensus       124 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~  203 (369)
                      +||+.+++|.+++...   ..+++..++.++.||+.|+.+||+.+   ++|+||+|+||+++.++.++|+|||.+.....
T Consensus        81 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~  154 (258)
T cd06632          81 LELVPGGSLAKLLKKY---GSFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVVE  154 (258)
T ss_pred             EEecCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence            9999999999888543   34788899999999999999999999   99999999999999999999999999876543


Q ss_pred             CCcccccccccccccccCchhhccCC-CCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCccccccCc
Q 017594          204 NELQANTSRIVGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDP  282 (369)
Q Consensus       204 ~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (369)
                      ..   ......++..|+|||.+.... ++.++|+||||+++|+|++|..||......     .......... ....+  
T Consensus       155 ~~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~-----~~~~~~~~~~-~~~~~--  223 (258)
T cd06632         155 FS---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGV-----AAVFKIGRSK-ELPPI--  223 (258)
T ss_pred             cc---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHH-----HHHHHHHhcc-cCCCc--
Confidence            32   123345788899999987666 899999999999999999999998654310     0111111000 00011  


Q ss_pred             cccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 017594          283 ILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVS  320 (369)
Q Consensus       283 ~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~  320 (369)
                             +...+..+.+++.+||+.+|.+||++.++++
T Consensus       224 -------~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  254 (258)
T cd06632         224 -------PDHLSDEAKDFILKCLQRDPSLRPTAAELLE  254 (258)
T ss_pred             -------CCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence                   1112567899999999999999999999986

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=7e-37  Score=281.73  Aligned_cols=198  Identities=25%  Similarity=0.402  Sum_probs=158.3

Q ss_pred             CccccccCCccEEEEEEc---CCCEEEEEEecCCCchhHHHHHHHHHHHhcCCCCceeeeeeeEEe--CCccEEEEEecC
Q 017594           54 ANKLGEGGFGPVYKGVLK---KGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCID--RDEKILIYEYMP  128 (369)
Q Consensus        54 ~~~lg~G~~~~v~~~~~~---~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~  128 (369)
                      .++||+|+||.||+|+.+   +++.||+|.+.....  ...+.+|+.+++.++||||+++++++..  ....++++||+.
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~   83 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE   83 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC--cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence            468999999999999964   467899999865432  2457789999999999999999998864  345789999986


Q ss_pred             CCChhhhhcCC------CccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEE----eCCCceEEeecCCc
Q 017594          129 NKSLDFFLFDP------TKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILL----DKDMNPKISDFGMA  198 (369)
Q Consensus       129 ~~~L~~~l~~~------~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv----~~~~~~~L~Dfg~~  198 (369)
                      + ++..++...      .....+++..++.++.||+.||.|||+++   ++||||||+||++    +.++.++|+|||++
T Consensus        84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a  159 (317)
T cd07868          84 H-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA  159 (317)
T ss_pred             C-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence            5 565555321      12235888899999999999999999999   9999999999999    45678999999999


Q ss_pred             eecCCCCcc-cccccccccccccCchhhcc-CCCCcccchHhHHHHHHHHHhCCCCCCCCc
Q 017594          199 RICGGNELQ-ANTSRIVGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYR  257 (369)
Q Consensus       199 ~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~tg~~p~~~~~  257 (369)
                      ......... .......+++.|+|||++.+ ..++.++|+||+||++|+|++|.+||....
T Consensus       160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~  220 (317)
T cd07868         160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ  220 (317)
T ss_pred             eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCc
Confidence            866433211 12233467889999999876 458999999999999999999999996443

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=3.9e-37  Score=275.87  Aligned_cols=253  Identities=25%  Similarity=0.380  Sum_probs=201.2

Q ss_pred             cCCccCccccccCCccEEEEEEc-CCCEEEEEEecCCC-chhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEEEEe
Q 017594           49 NKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIYEY  126 (369)
Q Consensus        49 ~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  126 (369)
                      ++|++.+.||.|++|.||+|.++ +++.+++|.+.... ......+.+|++.++.+.|||++++++.+......++++||
T Consensus         1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (265)
T cd06605           1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY   80 (265)
T ss_pred             CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence            46889999999999999999976 48899999887553 23446678899999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhc-CCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCCCC
Q 017594          127 MPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQ-YSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE  205 (369)
Q Consensus       127 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~-~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~~~  205 (369)
                      +.+++|.+++....  ..+++..+..++.|++.|+++||+ .+   ++|+||+|+||+++.++.++|+|||.+.......
T Consensus        81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~  155 (265)
T cd06605          81 MDGGSLDKILKEVQ--GRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL  155 (265)
T ss_pred             cCCCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchhhHHHH
Confidence            99999999885432  458889999999999999999999 88   9999999999999999999999999876543221


Q ss_pred             cccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCccccccCcccc
Q 017594          206 LQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILE  285 (369)
Q Consensus       206 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (369)
                          .....++..|+|||.+.+..++.++|+||||+++|+|++|..||................... .     ..+.+ 
T Consensus       156 ----~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-~-----~~~~~-  224 (265)
T cd06605         156 ----AKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVN-E-----PPPRL-  224 (265)
T ss_pred             ----hhcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhc-C-----CCCCC-
Confidence                111467888999999998899999999999999999999999986443211111111111100 0     00011 


Q ss_pred             ccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 017594          286 DEYSSKQMLLRYANIALLCVQESADDRPTMNDVVS  320 (369)
Q Consensus       286 ~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~  320 (369)
                         ....++..+.++|.+||..+|++||++.+++.
T Consensus       225 ---~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~  256 (265)
T cd06605         225 ---PSGKFSPDFQDFVNLCLIKDPRERPSYKELLE  256 (265)
T ss_pred             ---ChhhcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence               11114677999999999999999999999985

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.6e-37  Score=277.24  Aligned_cols=255  Identities=25%  Similarity=0.379  Sum_probs=199.1

Q ss_pred             HHhcCCccCccccccCCccEEEEEEc-CCCEEEEEEecCCCchhHHHHHHHHHHHhcC-CCCceeeeeeeEEeCC-----
Q 017594           46 TATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSGQGLREMKNEASVIAKV-QHKNLVRLLGCCIDRD-----  118 (369)
Q Consensus        46 ~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~-----  118 (369)
                      ...++|++.+.||.|++|.||+|..+ +++.+++|++..... ....+..|+.+++.+ .|+|++++++++....     
T Consensus         3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~   81 (275)
T cd06608           3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND   81 (275)
T ss_pred             CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence            35689999999999999999999975 478899999875543 346788999999999 6999999999997644     


Q ss_pred             -ccEEEEEecCCCChhhhhcCCC-ccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecC
Q 017594          119 -EKILIYEYMPNKSLDFFLFDPT-KRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFG  196 (369)
Q Consensus       119 -~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg  196 (369)
                       ..++++||+.+++|.+++.... ....+++..++.++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||
T Consensus        82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~~  158 (275)
T cd06608          82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFG  158 (275)
T ss_pred             eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECCCc
Confidence             3799999999999988875422 2345889999999999999999999998   9999999999999999999999999


Q ss_pred             CceecCCCCcccccccccccccccCchhhcc-----CCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhh
Q 017594          197 MARICGGNELQANTSRIVGTYGYMSPEYALE-----GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLW  271 (369)
Q Consensus       197 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~  271 (369)
                      ++.......  .......++..|+|||.+..     ..++.++||||||+++|+|++|..||.......     ......
T Consensus       159 ~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-----~~~~~~  231 (275)
T cd06608         159 VSAQLDSTL--GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMR-----ALFKIP  231 (275)
T ss_pred             cceecccch--hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHH-----HHHHhh
Confidence            987654322  11223457888999998753     346789999999999999999999986322110     000000


Q ss_pred             hcCccccccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 017594          272 TSNRTLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVS  320 (369)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~  320 (369)
                      .      ...   ..-..+..++..+.++|.+||..||++|||+.++++
T Consensus       232 ~------~~~---~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~  271 (275)
T cd06608         232 R------NPP---PTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLE  271 (275)
T ss_pred             c------cCC---CCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence            0      000   001112234677999999999999999999999986

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=1.2e-36  Score=274.36  Aligned_cols=256  Identities=27%  Similarity=0.372  Sum_probs=200.3

Q ss_pred             cCCccCccccccCCccEEEEEEc------CCCEEEEEEecCCCch-hHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccE
Q 017594           49 NKFSDANKLGEGGFGPVYKGVLK------KGDEIAVKRLSGRSGQ-GLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKI  121 (369)
Q Consensus        49 ~~y~i~~~lg~G~~~~v~~~~~~------~~~~valK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  121 (369)
                      ++|++.+.||.|+||.||+|+.+      +.+.+++|.+...... ....+..|+.++++++|+|++++++++.+....+
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   84 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY   84 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence            67999999999999999999954      2456899988654333 4567888999999999999999999998888999


Q ss_pred             EEEEecCCCChhhhhcCCCcc------ccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeec
Q 017594          122 LIYEYMPNKSLDFFLFDPTKR------MLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDF  195 (369)
Q Consensus       122 lv~e~~~~~~L~~~l~~~~~~------~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Df  195 (369)
                      +|+||+.+++|.+++......      ..+++..+..++.||+.||.|||+.+   ++|+||+|+||+++.++.++++||
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~~~  161 (275)
T cd05046          85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLL  161 (275)
T ss_pred             EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEccc
Confidence            999999999999998654322      25899999999999999999999998   999999999999999999999999


Q ss_pred             CCceecCCCCcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHh-CCCCCCCCcccccccchhhhhhhhcC
Q 017594          196 GMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDLWTSN  274 (369)
Q Consensus       196 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~  274 (369)
                      |++....... ........++..|+|||.+.+..++.++||||||+++|+|++ |..||.......     .... ....
T Consensus       162 ~~~~~~~~~~-~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~-----~~~~-~~~~  234 (275)
T cd05046         162 SLSKDVYNSE-YYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEE-----VLNR-LQAG  234 (275)
T ss_pred             ccccccCccc-ccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHH-----HHHH-HHcC
Confidence            9876432221 111222345667999999888888999999999999999998 777875322111     0000 0101


Q ss_pred             ccccccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 017594          275 RTLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLT  323 (369)
Q Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L~  323 (369)
                      .....    .     ...++..+.+++.+||+.+|++||++.++++.|+
T Consensus       235 ~~~~~----~-----~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~  274 (275)
T cd05046         235 KLELP----V-----PEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG  274 (275)
T ss_pred             CcCCC----C-----CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence            10000    0     0112567999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=4.8e-37  Score=278.58  Aligned_cols=252  Identities=22%  Similarity=0.372  Sum_probs=198.3

Q ss_pred             cCCccCccccccCCccEEEEEEc-CCCEEEEEEecCC-CchhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEEEEe
Q 017594           49 NKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGR-SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIYEY  126 (369)
Q Consensus        49 ~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  126 (369)
                      ++|++++.||.|++|.||+|+++ +|..|++|.+... .......+.+|+.++++++|+|++++++.+......++|+||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY   80 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence            47999999999999999999976 5899999988643 333456788899999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhc-CCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCCCC
Q 017594          127 MPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQ-YSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE  205 (369)
Q Consensus       127 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~-~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~~~  205 (369)
                      +.+++|..++........+++..+..++.||+.||.|||. .+   ++|+||+|+||+++.++.++|+|||++.......
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~  157 (286)
T cd06622          81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN---IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL  157 (286)
T ss_pred             cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCC---EeeCCCCHHHEEECCCCCEEEeecCCcccccCCc
Confidence            9999998888653333468999999999999999999996 47   9999999999999999999999999886543221


Q ss_pred             cccccccccccccccCchhhccC------CCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCccccc
Q 017594          206 LQANTSRIVGTYGYMSPEYALEG------IFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLEL  279 (369)
Q Consensus       206 ~~~~~~~~~~~~~y~aPE~~~~~------~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (369)
                          .....++..|+|||.+.+.      .++.++|+|||||++|+|++|..||........  ....... ....    
T Consensus       158 ----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~--~~~~~~~-~~~~----  226 (286)
T cd06622         158 ----AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANI--FAQLSAI-VDGD----  226 (286)
T ss_pred             ----cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhH--HHHHHHH-hhcC----
Confidence                2223567789999988543      357899999999999999999999864321110  0000000 0000    


Q ss_pred             cCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 017594          280 IDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVS  320 (369)
Q Consensus       280 ~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~  320 (369)
                       .+.+     +..++.++.++|.+||+.+|.+||++.+++.
T Consensus       227 -~~~~-----~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  261 (286)
T cd06622         227 -PPTL-----PSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE  261 (286)
T ss_pred             -CCCC-----CcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence             0001     1123677899999999999999999999997

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=1.6e-36  Score=269.61  Aligned_cols=247  Identities=27%  Similarity=0.362  Sum_probs=194.3

Q ss_pred             ccccccCCccEEEEEEcCCCEEEEEEecCCCc-hhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEEEEecCCCChh
Q 017594           55 NKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSG-QGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSLD  133 (369)
Q Consensus        55 ~~lg~G~~~~v~~~~~~~~~~valK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~  133 (369)
                      +.||.|++|.||+|...++..+++|.+..... .....+.+|+..++.+.|||++++++++......++||||+.+++|.
T Consensus         1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   80 (250)
T cd05085           1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL   80 (250)
T ss_pred             CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence            46899999999999987888999999875432 22346778999999999999999999999999999999999999999


Q ss_pred             hhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCCCCcccccccc
Q 017594          134 FFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRI  213 (369)
Q Consensus       134 ~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~  213 (369)
                      +++....  ..+++..+..++.+++.+|.+||+.+   ++|+||+|+||+++.++.++|+|||++......... .....
T Consensus        81 ~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~-~~~~~  154 (250)
T cd05085          81 SFLRKKK--DELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYS-SSGLK  154 (250)
T ss_pred             HHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceeccccccc-cCCCC
Confidence            8875432  34788899999999999999999998   999999999999999999999999998754322211 11112


Q ss_pred             cccccccCchhhccCCCCcccchHhHHHHHHHHHh-CCCCCCCCcccccccchhhhhhhhcCccccccCccccccccHHH
Q 017594          214 VGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYSSKQ  292 (369)
Q Consensus       214 ~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  292 (369)
                      .++..|+|||++.+..++.++|+||||+++|++++ |..||.......     ..... ... ....    .     +..
T Consensus       155 ~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~-----~~~~~-~~~-~~~~----~-----~~~  218 (250)
T cd05085         155 QIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQ-----AREQV-EKG-YRMS----C-----PQK  218 (250)
T ss_pred             CCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHH-----HHHHH-HcC-CCCC----C-----CCC
Confidence            33567999999988889999999999999999998 888986332111     00000 000 0000    0     011


Q ss_pred             HHHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 017594          293 MLLRYANIALLCVQESADDRPTMNDVVSMLT  323 (369)
Q Consensus       293 ~~~~l~~li~~~L~~dP~~Rps~~ell~~L~  323 (369)
                      .+..+.+++.+||+.+|++||++.++++.|.
T Consensus       219 ~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~  249 (250)
T cd05085         219 CPDDVYKVMQRCWDYKPENRPKFSELQKELA  249 (250)
T ss_pred             CCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence            2567999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.8e-39  Score=296.21  Aligned_cols=252  Identities=23%  Similarity=0.390  Sum_probs=204.5

Q ss_pred             hcCCccCccccccCCccEEEEEEcC-CCEEEEEEecCCCchhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEEEEe
Q 017594           48 TNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIYEY  126 (369)
Q Consensus        48 ~~~y~i~~~lg~G~~~~v~~~~~~~-~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  126 (369)
                      .+-|+|+..||-|+||.||+|..+. +--.|.|++.....+..+.+.-|+++|..+.||+|+++++.|..++.++++.||
T Consensus        31 ~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEF  110 (1187)
T KOG0579|consen   31 RDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEF  110 (1187)
T ss_pred             HHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEee
Confidence            3568999999999999999999775 444577888777777888999999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCCCCc
Q 017594          127 MPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNEL  206 (369)
Q Consensus       127 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~~~~  206 (369)
                      |.||-.+.++....+  .+.+..+..+++|++.||.|||+++   |+|||||..||+++.+|.++|+|||.+....  ..
T Consensus       111 C~GGAVDaimlEL~r--~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAKn~--~t  183 (1187)
T KOG0579|consen  111 CGGGAVDAIMLELGR--VLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAKNK--ST  183 (1187)
T ss_pred             cCCchHhHHHHHhcc--ccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccccccch--hH
Confidence            999999888765443  4889999999999999999999999   9999999999999999999999999876432  12


Q ss_pred             ccccccccccccccCchhhc-----cCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCccccccC
Q 017594          207 QANTSRIVGTYGYMSPEYAL-----EGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELID  281 (369)
Q Consensus       207 ~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (369)
                      ........||+.|+|||+..     ..+|+.++||||||++|.+|..+.+|-....         +..+  .-.+...-.
T Consensus       184 ~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHheln---------pMRV--llKiaKSeP  252 (1187)
T KOG0579|consen  184 RQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELN---------PMRV--LLKIAKSEP  252 (1187)
T ss_pred             HhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccc---------hHHH--HHHHhhcCC
Confidence            22334567999999999976     4679999999999999999999999843211         0000  000111111


Q ss_pred             ccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 017594          282 PILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVS  320 (369)
Q Consensus       282 ~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~  320 (369)
                      +.+   ..+..++..+.+++..||..||..||++.+|++
T Consensus       253 PTL---lqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~  288 (1187)
T KOG0579|consen  253 PTL---LQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK  288 (1187)
T ss_pred             Ccc---cCcchhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence            111   124455788999999999999999999999885

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=1.4e-36  Score=274.33  Aligned_cols=249  Identities=23%  Similarity=0.400  Sum_probs=200.9

Q ss_pred             hcCCccCccccccCCccEEEEEEc-CCCEEEEEEecCCC-chhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEEEE
Q 017594           48 TNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIYE  125 (369)
Q Consensus        48 ~~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  125 (369)
                      ...|+..+.||.|++|.||.|.++ ++..|++|.+.... ......+..|+.+++.+.|+|++++++++......++|+|
T Consensus         3 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (277)
T cd06640           3 EELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIME   82 (277)
T ss_pred             HHhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEe
Confidence            457889999999999999999975 48889999887443 3445678889999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCCCC
Q 017594          126 YMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE  205 (369)
Q Consensus       126 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~~~  205 (369)
                      |+.+++|.+++..    ..+++..+..++.|++.|+.+||+.+   ++|+||+|+||+++.++.++|+|||++.......
T Consensus        83 ~~~~~~L~~~i~~----~~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~  155 (277)
T cd06640          83 YLGGGSALDLLRA----GPFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ  155 (277)
T ss_pred             cCCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceeccCCc
Confidence            9999999988843    24788889999999999999999998   9999999999999999999999999987654332


Q ss_pred             cccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCccccccCcccc
Q 017594          206 LQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILE  285 (369)
Q Consensus       206 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (369)
                      .  ......++..|.|||.+.+..++.++|+||||+++|+|++|..||........     .          ..+.....
T Consensus       156 ~--~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~-----~----------~~~~~~~~  218 (277)
T cd06640         156 I--KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRV-----L----------FLIPKNNP  218 (277)
T ss_pred             c--ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhH-----h----------hhhhcCCC
Confidence            1  11223567789999999888899999999999999999999999864321110     0          00000000


Q ss_pred             ccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 017594          286 DEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSM  321 (369)
Q Consensus       286 ~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~  321 (369)
                       ......++..+.+++.+||+.+|++||++.++++.
T Consensus       219 -~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06640         219 -PTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH  253 (277)
T ss_pred             -CCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence             01122346779999999999999999999999865

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=2.1e-36  Score=269.78  Aligned_cols=251  Identities=33%  Similarity=0.517  Sum_probs=198.9

Q ss_pred             CccCccccccCCccEEEEEEcC-----CCEEEEEEecCCCch-hHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEEE
Q 017594           51 FSDANKLGEGGFGPVYKGVLKK-----GDEIAVKRLSGRSGQ-GLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIY  124 (369)
Q Consensus        51 y~i~~~lg~G~~~~v~~~~~~~-----~~~valK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  124 (369)
                      +++.+.||.|+||.||++++..     +..|++|.+...... ....+..|+..+..+.|+|++++++++...+..+++|
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~   80 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM   80 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence            4678999999999999999764     378999998755432 5678889999999999999999999999989999999


Q ss_pred             EecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCCC
Q 017594          125 EYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGN  204 (369)
Q Consensus       125 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~~  204 (369)
                      |++.+++|.+++..... ..+++..++.++.|++.||++||+.+   ++|+||+|+||+++.++.++|+|||++......
T Consensus        81 e~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~  156 (258)
T smart00219       81 EYMEGGDLLDYLRKNRP-KELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDD  156 (258)
T ss_pred             eccCCCCHHHHHHhhhh-ccCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceecccc
Confidence            99999999988854322 12789999999999999999999999   999999999999999999999999998876544


Q ss_pred             CcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHh-CCCCCCCCcccccccchhhhhhhhcCccccccCcc
Q 017594          205 ELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPI  283 (369)
Q Consensus       205 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (369)
                      ...... ...++..|+|||.+.+..++.++|+||||+++++|++ |..||.......      ............     
T Consensus       157 ~~~~~~-~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~------~~~~~~~~~~~~-----  224 (258)
T smart00219      157 DYYKKK-GGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEE------VLEYLKKGYRLP-----  224 (258)
T ss_pred             cccccc-cCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHH------HHHHHhcCCCCC-----
Confidence            221111 2235678999999988889999999999999999998 778875422110      001111111000     


Q ss_pred             ccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHH
Q 017594          284 LEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSML  322 (369)
Q Consensus       284 ~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L  322 (369)
                      .     +...+.++.+++.+||..+|++|||+.++++.|
T Consensus       225 ~-----~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l  258 (258)
T smart00219      225 K-----PENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL  258 (258)
T ss_pred             C-----CCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence            0     011366799999999999999999999999864

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=5.9e-37  Score=280.18  Aligned_cols=265  Identities=22%  Similarity=0.311  Sum_probs=196.2

Q ss_pred             hcCCccCccccccCCccEEEEEEc-CCCEEEEEEecCCC-chhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEEEE
Q 017594           48 TNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIYE  125 (369)
Q Consensus        48 ~~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  125 (369)
                      .++|++.+.||.|++|.||+|+.+ ++..|++|.+.... ......+..|+..++.++|+||+++++++......++|+|
T Consensus         5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e   84 (301)
T cd07873           5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE   84 (301)
T ss_pred             ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEe
Confidence            467999999999999999999965 48899999986432 2233466789999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCCCC
Q 017594          126 YMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE  205 (369)
Q Consensus       126 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~~~  205 (369)
                      |+.+ +|..++...  ...+++..+..++.||+.||.|||+.+   ++|+||+|+||+++.++.++|+|||++.......
T Consensus        85 ~~~~-~l~~~l~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~  158 (301)
T cd07873          85 YLDK-DLKQYLDDC--GNSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPT  158 (301)
T ss_pred             cccc-CHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccCCCC
Confidence            9975 776666432  234788899999999999999999998   9999999999999999999999999987543221


Q ss_pred             cccccccccccccccCchhhcc-CCCCcccchHhHHHHHHHHHhCCCCCCCCcccccc---------cchhhhhhhhcCc
Q 017594          206 LQANTSRIVGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLN---------LLGYAWDLWTSNR  275 (369)
Q Consensus       206 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~---------~~~~~~~~~~~~~  275 (369)
                      .  ......++..|+|||++.+ ..++.++||||||+++|+|++|++||.........         .....|.......
T Consensus       159 ~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (301)
T cd07873         159 K--TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNE  236 (301)
T ss_pred             C--cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccc
Confidence            1  1122346788999998765 45788999999999999999999999754321100         0000011100000


Q ss_pred             ccccc-Cccccccc---cHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 017594          276 TLELI-DPILEDEY---SSKQMLLRYANIALLCVQESADDRPTMNDVVS  320 (369)
Q Consensus       276 ~~~~~-~~~~~~~~---~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~  320 (369)
                      ..... .+......   .....+..+.+||.+||+.||.+|||+.++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~  285 (301)
T cd07873         237 EFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK  285 (301)
T ss_pred             cccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            00000 00000000   01122567899999999999999999999996

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=4.3e-37  Score=276.58  Aligned_cols=258  Identities=22%  Similarity=0.328  Sum_probs=202.0

Q ss_pred             HhcCCccCccccccCCccEEEEEEcC----CCEEEEEEecCCC-chhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccE
Q 017594           47 ATNKFSDANKLGEGGFGPVYKGVLKK----GDEIAVKRLSGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKI  121 (369)
Q Consensus        47 ~~~~y~i~~~lg~G~~~~v~~~~~~~----~~~valK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  121 (369)
                      ...+|.+.+.||.|++|.||+|.+.+    ...|++|...... ....+.+.+|+..++.+.|+|++++++++.+ ...+
T Consensus         4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~   82 (270)
T cd05056           4 QREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVW   82 (270)
T ss_pred             chhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcE
Confidence            45679999999999999999998543    2468999887554 3445678889999999999999999998864 5678


Q ss_pred             EEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceec
Q 017594          122 LIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARIC  201 (369)
Q Consensus       122 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~  201 (369)
                      +++||+.+++|.+++....  ..+++..++.++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++...
T Consensus        83 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~  157 (270)
T cd05056          83 IVMELAPLGELRSYLQVNK--YSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYL  157 (270)
T ss_pred             EEEEcCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeeec
Confidence            9999999999999985432  24788999999999999999999998   999999999999999999999999998765


Q ss_pred             CCCCcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHh-CCCCCCCCcccccccchhhhhhhhcCcccccc
Q 017594          202 GGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDLWTSNRTLELI  280 (369)
Q Consensus       202 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (369)
                      ...... ......+...|+|||.+....++.++|+||||+++|+|++ |..||.......     ...........    
T Consensus       158 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~-----~~~~~~~~~~~----  227 (270)
T cd05056         158 EDESYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNND-----VIGRIENGERL----  227 (270)
T ss_pred             ccccce-ecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHH-----HHHHHHcCCcC----
Confidence            433211 1112233467999999888889999999999999999986 999986433111     11111000000    


Q ss_pred             CccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHhhhh
Q 017594          281 DPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNEAA  327 (369)
Q Consensus       281 ~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L~~~~~  327 (369)
                        ..     +..++..+.+++.+||..+|.+|||+.++++.|+.+..
T Consensus       228 --~~-----~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~  267 (270)
T cd05056         228 --PM-----PPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQ  267 (270)
T ss_pred             --CC-----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence              00     11225679999999999999999999999999988754

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=6.8e-37  Score=283.07  Aligned_cols=265  Identities=18%  Similarity=0.239  Sum_probs=192.2

Q ss_pred             ccCcccccc--CCccEEEEEEc-CCCEEEEEEecCCC--chhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEEEEe
Q 017594           52 SDANKLGEG--GFGPVYKGVLK-KGDEIAVKRLSGRS--GQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIYEY  126 (369)
Q Consensus        52 ~i~~~lg~G--~~~~v~~~~~~-~~~~valK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  126 (369)
                      ++++.||+|  ++++||+++.+ +|+.||+|++....  ......+..|+.+++.++||||+++++++..++..++|+||
T Consensus         1 ~~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~   80 (327)
T cd08227           1 ELLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSF   80 (327)
T ss_pred             ChhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEec
Confidence            356789999  67899999965 58999999987542  23345677899999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCCCCc
Q 017594          127 MPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNEL  206 (369)
Q Consensus       127 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~~~~  206 (369)
                      +.+++|.+++.... ...+++..++.++.|++.||.|||+.+   ++|+||||+||+++.++.+++.||+..........
T Consensus        81 ~~~~~l~~~~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~  156 (327)
T cd08227          81 MAYGSAKDLICTHF-MDGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQ  156 (327)
T ss_pred             cCCCcHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhccccccc
Confidence            99999999885432 234788899999999999999999999   99999999999999999999999986543321110


Q ss_pred             cc-----ccccccccccccCchhhcc--CCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchh-------------
Q 017594          207 QA-----NTSRIVGTYGYMSPEYALE--GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGY-------------  266 (369)
Q Consensus       207 ~~-----~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~-------------  266 (369)
                      ..     ......++..|+|||++.+  ..++.++|||||||++|+|++|..||.............             
T Consensus       157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (327)
T cd08227         157 RLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTI  236 (327)
T ss_pred             cccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccch
Confidence            00     0112245667999999875  458999999999999999999999996432111000000             


Q ss_pred             hhhhhhcCcccc----------c---cCcccc---ccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 017594          267 AWDLWTSNRTLE----------L---IDPILE---DEYSSKQMLLRYANIALLCVQESADDRPTMNDVVS  320 (369)
Q Consensus       267 ~~~~~~~~~~~~----------~---~~~~~~---~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~  320 (369)
                      ............          .   ..+...   .......++..+.+++.+||+.||++|||+.++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~  306 (327)
T cd08227         237 PAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN  306 (327)
T ss_pred             hhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence            000000000000          0   000000   00011233567999999999999999999999986

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=5.8e-37  Score=286.76  Aligned_cols=193  Identities=23%  Similarity=0.305  Sum_probs=161.5

Q ss_pred             HHhcCCccCccccccCCccEEEEEEcC-CCEEEEEEecCCCchhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEEE
Q 017594           46 TATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIY  124 (369)
Q Consensus        46 ~~~~~y~i~~~lg~G~~~~v~~~~~~~-~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  124 (369)
                      .....|++++.||.|+||.||+|+... +..||+|+....      ....|+.+++.++|+||+++++++......++|+
T Consensus        63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  136 (357)
T PHA03209         63 VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVL  136 (357)
T ss_pred             hhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEE
Confidence            344579999999999999999999764 778999975432      2346899999999999999999999999999999


Q ss_pred             EecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCCC
Q 017594          125 EYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGN  204 (369)
Q Consensus       125 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~~  204 (369)
                      |++.+ +|..++..  ....+++..+..++.||+.||.|||..+   ++||||||+||+++.++.++|+|||.+......
T Consensus       137 e~~~~-~l~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  210 (357)
T PHA03209        137 PHYSS-DLYTYLTK--RSRPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA  210 (357)
T ss_pred             EccCC-cHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCccccccccC
Confidence            99965 56565543  2345889999999999999999999999   999999999999999999999999998643221


Q ss_pred             CcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCC
Q 017594          205 ELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNT  253 (369)
Q Consensus       205 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~  253 (369)
                         .......|+..|+|||++.+..++.++|||||||++|+|+++..++
T Consensus       211 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~  256 (357)
T PHA03209        211 ---PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI  256 (357)
T ss_pred             ---cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence               1122345889999999999889999999999999999999865543

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=7.8e-37  Score=277.02  Aligned_cols=264  Identities=22%  Similarity=0.331  Sum_probs=198.1

Q ss_pred             cCCccCccccccCCccEEEEEEc-CCCEEEEEEecCCC--chhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEEEE
Q 017594           49 NKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS--GQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIYE  125 (369)
Q Consensus        49 ~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  125 (369)
                      ++|++.+.||.|++|.||+|+++ +|+.|++|++....  ....+.+..|+.+++.++|+|++++++++......++++|
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e   80 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE   80 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence            47999999999999999999976 48899999886432  2223557789999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCCCC
Q 017594          126 YMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE  205 (369)
Q Consensus       126 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~~~  205 (369)
                      |++++++..+....   ..+++..+..++.||+.+|+|||+++   ++|+||+|.||+++.++.++|+|||++.......
T Consensus        81 ~~~~~~l~~~~~~~---~~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~  154 (286)
T cd07847          81 YCDHTVLNELEKNP---RGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGPG  154 (286)
T ss_pred             ccCccHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecCCCc
Confidence            99999888776432   34889999999999999999999998   9999999999999999999999999988764432


Q ss_pred             cccccccccccccccCchhhcc-CCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccc------hhh---hhhhhcCc
Q 017594          206 LQANTSRIVGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLL------GYA---WDLWTSNR  275 (369)
Q Consensus       206 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~------~~~---~~~~~~~~  275 (369)
                      .  ......++..|+|||.+.+ ..++.++|+||+|+++|+|++|..||...........      ...   ...+....
T Consensus       155 ~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (286)
T cd07847         155 D--DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQ  232 (286)
T ss_pred             c--cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccccc
Confidence            1  1122346788999998865 5578999999999999999999999975432110000      000   00000000


Q ss_pred             cc---cccCcccccc--ccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 017594          276 TL---ELIDPILEDE--YSSKQMLLRYANIALLCVQESADDRPTMNDVVS  320 (369)
Q Consensus       276 ~~---~~~~~~~~~~--~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~  320 (369)
                      ..   ....+.....  ......+..+.+++.+||+.+|++||++.+++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  282 (286)
T cd07847         233 FFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE  282 (286)
T ss_pred             ccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence            00   0000000000  001122567899999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=1e-36  Score=274.01  Aligned_cols=254  Identities=26%  Similarity=0.396  Sum_probs=188.8

Q ss_pred             ccccccCCccEEEEEEcC---CCEEEEEEecCCCc-hhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEEEEecCCC
Q 017594           55 NKLGEGGFGPVYKGVLKK---GDEIAVKRLSGRSG-QGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIYEYMPNK  130 (369)
Q Consensus        55 ~~lg~G~~~~v~~~~~~~---~~~valK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~  130 (369)
                      +.||+|+||.||+|.+.+   +..+++|.+..... .....+.+|+..++.++|||++++++++......++||||+.++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG   80 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence            468999999999998643   45789998865432 23346778999999999999999999998888899999999999


Q ss_pred             ChhhhhcCCCc--cccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCCCCccc
Q 017594          131 SLDFFLFDPTK--RMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQA  208 (369)
Q Consensus       131 ~L~~~l~~~~~--~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~~~~~~  208 (369)
                      +|.+++.....  ....+...+..++.|++.|+.|||+.+   ++|+||||+||+++.++.++|+|||.+..........
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~  157 (269)
T cd05087          81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV  157 (269)
T ss_pred             cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence            99988854321  233566677889999999999999998   9999999999999999999999999986543322222


Q ss_pred             ccccccccccccCchhhccC-------CCCcccchHhHHHHHHHHHh-CCCCCCCCcccccccchhhhhhhhcCcccccc
Q 017594          209 NTSRIVGTYGYMSPEYALEG-------IFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDLWTSNRTLELI  280 (369)
Q Consensus       209 ~~~~~~~~~~y~aPE~~~~~-------~~~~~~DiwslG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (369)
                      ......++..|+|||++.+.       .++.++|+||||+++|+|++ |..||.........    ...  .........
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~----~~~--~~~~~~~~~  231 (269)
T cd05087         158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVL----TYT--VREQQLKLP  231 (269)
T ss_pred             cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHH----HHH--hhcccCCCC
Confidence            22234467789999988642       35789999999999999996 99998644321100    000  001111111


Q ss_pred             CccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 017594          281 DPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLT  323 (369)
Q Consensus       281 ~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L~  323 (369)
                      .+.+..     ..+..+.+++..|+ .+|++|||+++|+..|+
T Consensus       232 ~~~~~~-----~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~  268 (269)
T cd05087         232 KPRLKL-----PLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS  268 (269)
T ss_pred             CCccCC-----CCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence            111111     11455888999998 68999999999998875

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.9e-36  Score=272.51  Aligned_cols=259  Identities=29%  Similarity=0.438  Sum_probs=203.1

Q ss_pred             hcCCccCccccccCCccEEEEEEcC-CC----EEEEEEecCCC-chhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccE
Q 017594           48 TNKFSDANKLGEGGFGPVYKGVLKK-GD----EIAVKRLSGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKI  121 (369)
Q Consensus        48 ~~~y~i~~~lg~G~~~~v~~~~~~~-~~----~valK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  121 (369)
                      ..+|++.+.||+|+||.||+|.++. |.    .+++|...... ......+..|+..+..+.|+|++++++++.. ...+
T Consensus         6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~   84 (279)
T cd05057           6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQ   84 (279)
T ss_pred             HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceE
Confidence            4789999999999999999999643 33    58899876543 2344677889999999999999999999876 7889


Q ss_pred             EEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceec
Q 017594          122 LIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARIC  201 (369)
Q Consensus       122 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~  201 (369)
                      +++||+.+++|.+++....  ..+++..+..++.||+.||+|||+.+   ++|+||+|+||+++.++.++|+|||.+...
T Consensus        85 ~v~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~~~  159 (279)
T cd05057          85 LITQLMPLGCLLDYVRNHK--DNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL  159 (279)
T ss_pred             EEEecCCCCcHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCcccccc
Confidence            9999999999999886432  23889999999999999999999998   999999999999999999999999998866


Q ss_pred             CCCCcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHh-CCCCCCCCcccccccchhhhhhhhcCcccccc
Q 017594          202 GGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDLWTSNRTLELI  280 (369)
Q Consensus       202 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (369)
                      .............++..|+|||.+....++.++|+||||+++|++++ |..||.......     .. .........   
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-----~~-~~~~~~~~~---  230 (279)
T cd05057         160 DVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVE-----IP-DLLEKGERL---  230 (279)
T ss_pred             cCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHH-----HH-HHHhCCCCC---
Confidence            53322222222223567999999988889999999999999999998 999986432111     11 111111000   


Q ss_pred             CccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHhhhhc
Q 017594          281 DPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNEAAT  328 (369)
Q Consensus       281 ~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L~~~~~~  328 (369)
                        ..     +..++..+.+++.+||..+|.+||++.++++.|.++...
T Consensus       231 --~~-----~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~  271 (279)
T cd05057         231 --PQ-----PPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARD  271 (279)
T ss_pred             --CC-----CCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhC
Confidence              00     001145688999999999999999999999999998664

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=1.1e-36  Score=276.33  Aligned_cols=251  Identities=25%  Similarity=0.349  Sum_probs=197.1

Q ss_pred             CCccCccccccCCccEEEEEEc-CCCEEEEEEecCCC---chhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEEEE
Q 017594           50 KFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS---GQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIYE  125 (369)
Q Consensus        50 ~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  125 (369)
                      .|++.+.||+|+||.||++.+. +++.||+|.+....   ......+..|+.+++.++|++++.+++.+...+..+++||
T Consensus         1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e   80 (285)
T cd05630           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence            4788899999999999999965 48899999886432   1223456679999999999999999999999899999999


Q ss_pred             ecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCCCC
Q 017594          126 YMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE  205 (369)
Q Consensus       126 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~~~  205 (369)
                      |+.+++|.+++.... ...+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++.......
T Consensus        81 ~~~g~~L~~~l~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~  156 (285)
T cd05630          81 LMNGGDLKFHIYHMG-EAGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ  156 (285)
T ss_pred             ecCCCcHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeecCCCc
Confidence            999999988875422 234888899999999999999999998   9999999999999999999999999987543222


Q ss_pred             cccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCccccccCcccc
Q 017594          206 LQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILE  285 (369)
Q Consensus       206 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (369)
                      .   .....++..|+|||.+.+..++.++|+||+|+++|+|++|..||.........  ........      ...... 
T Consensus       157 ~---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~--~~~~~~~~------~~~~~~-  224 (285)
T cd05630         157 T---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKR--EEVERLVK------EVQEEY-  224 (285)
T ss_pred             c---ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchH--HHHHhhhh------hhhhhc-
Confidence            1   12236788999999999888999999999999999999999999643211100  00000000      000001 


Q ss_pred             ccccHHHHHHHHHHHHHHhhcCCCCCCCC-----HHHHHH
Q 017594          286 DEYSSKQMLLRYANIALLCVQESADDRPT-----MNDVVS  320 (369)
Q Consensus       286 ~~~~~~~~~~~l~~li~~~L~~dP~~Rps-----~~ell~  320 (369)
                          +..++.++.+++.+||+.||++|||     +.++++
T Consensus       225 ----~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~  260 (285)
T cd05630         225 ----SEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE  260 (285)
T ss_pred             ----CccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence                1112566899999999999999999     888886

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=3.4e-37  Score=279.20  Aligned_cols=262  Identities=20%  Similarity=0.274  Sum_probs=192.7

Q ss_pred             CCccCccccccCCccEEEEEEc-CCCEEEEEEecCCC--chhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEEEEe
Q 017594           50 KFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS--GQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIYEY  126 (369)
Q Consensus        50 ~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  126 (369)
                      +|++.+.||.|++|.||+|+++ +|..|++|.+....  ......+..|+.+++.++|+|++++++++.+....++++||
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY   80 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence            5899999999999999999975 48899999986432  12234567899999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCCCCc
Q 017594          127 MPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNEL  206 (369)
Q Consensus       127 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~~~~  206 (369)
                      +.+ ++..++...  ...+++..++.++.||+.||.|||+.+   ++|+||+|+||+++.++.++|+|||++........
T Consensus        81 ~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~  154 (284)
T cd07839          81 CDQ-DLKKYFDSC--NGDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR  154 (284)
T ss_pred             CCC-CHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccCCCCC
Confidence            975 565555332  234889999999999999999999999   99999999999999999999999999876543221


Q ss_pred             ccccccccccccccCchhhccC-CCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhh-----------hhhc-
Q 017594          207 QANTSRIVGTYGYMSPEYALEG-IFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWD-----------LWTS-  273 (369)
Q Consensus       207 ~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~-----------~~~~-  273 (369)
                        ......++..|+|||.+.+. .++.++|||||||++|+|++|..|+....... ........           .... 
T Consensus       155 --~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~  231 (284)
T cd07839         155 --CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD-DQLKRIFRLLGTPTEESWPGVSKL  231 (284)
T ss_pred             --CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHH-HHHHHHHHHhCCCChHHhHHhhhc
Confidence              11223467889999988664 47899999999999999999998864322111 00000000           0000 


Q ss_pred             Cc--cccccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 017594          274 NR--TLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVS  320 (369)
Q Consensus       274 ~~--~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~  320 (369)
                      ..  ..........-.......+.++.++|.+||+.||.+|||+.++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~  280 (284)
T cd07839         232 PDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ  280 (284)
T ss_pred             ccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence            00  000000000000001123567899999999999999999999986

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=5.1e-37  Score=276.26  Aligned_cols=253  Identities=25%  Similarity=0.402  Sum_probs=196.9

Q ss_pred             HHhcCCccCccccccCCccEEEEEEcC-CCEEEEEEecCCCchhHHHHHHHHHHHhcC-CCCceeeeeeeEEeC------
Q 017594           46 TATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLREMKNEASVIAKV-QHKNLVRLLGCCIDR------  117 (369)
Q Consensus        46 ~~~~~y~i~~~lg~G~~~~v~~~~~~~-~~~valK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~------  117 (369)
                      ...++|++.+.||.|+||.||+|.... ++.+++|.+.... .....+..|+.++..+ .|+|++++.+++...      
T Consensus         3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~   81 (272)
T cd06637           3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD   81 (272)
T ss_pred             ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence            456789999999999999999999654 8889999987543 3345778899999998 699999999998753      


Q ss_pred             CccEEEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCC
Q 017594          118 DEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGM  197 (369)
Q Consensus       118 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~  197 (369)
                      ...++++||+.+++|..++... ....+++..+..++.|++.|++|||+.+   ++|+||+|.||+++.++.++|+|||+
T Consensus        82 ~~~~iv~e~~~~~~L~~~l~~~-~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Dfg~  157 (272)
T cd06637          82 DQLWLVMEFCGAGSVTDLIKNT-KGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGV  157 (272)
T ss_pred             cEEEEEEEcCCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccCCC
Confidence            3578999999999999988643 2345788899999999999999999998   99999999999999999999999999


Q ss_pred             ceecCCCCcccccccccccccccCchhhc-----cCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhh
Q 017594          198 ARICGGNELQANTSRIVGTYGYMSPEYAL-----EGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWT  272 (369)
Q Consensus       198 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~  272 (369)
                      +.......  .......++..|+|||++.     +..++.++|+||+||++|+|++|..||........     ..... 
T Consensus       158 ~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~-----~~~~~-  229 (272)
T cd06637         158 SAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRA-----LFLIP-  229 (272)
T ss_pred             ceeccccc--ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHH-----HHHHh-
Confidence            87653221  1122345788999999885     34578899999999999999999999853321100     00000 


Q ss_pred             cCccccccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 017594          273 SNRTLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVS  320 (369)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~  320 (369)
                      ......    .     ....++.++.+++.+||..+|.+|||+.++++
T Consensus       230 ~~~~~~----~-----~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  268 (272)
T cd06637         230 RNPAPR----L-----KSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK  268 (272)
T ss_pred             cCCCCC----C-----CCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence            000000    0     01112566899999999999999999999986

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=2.2e-36  Score=269.78  Aligned_cols=249  Identities=23%  Similarity=0.366  Sum_probs=197.8

Q ss_pred             CCccCccccccCCccEEEEEEcC-CCEEEEEEecCCC--chhHHHHHHHHHHHhcCCCCceeeeeeeEEeC-CccEEEEE
Q 017594           50 KFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRS--GQGLREMKNEASVIAKVQHKNLVRLLGCCIDR-DEKILIYE  125 (369)
Q Consensus        50 ~y~i~~~lg~G~~~~v~~~~~~~-~~~valK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e  125 (369)
                      .|++.+.||.|++|.||.++++. ++.|++|.+....  ......+..|+++++.++|+|++++.+.+... ...++++|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e   80 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG   80 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence            58999999999999999999654 7889999986432  23445678899999999999999999887643 45789999


Q ss_pred             ecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCCCC
Q 017594          126 YMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE  205 (369)
Q Consensus       126 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~~~  205 (369)
                      |+.+++|.+++... ....+++..++.++.+++.|+++||+.+   ++|+||+|+||+++.++.++|+|||++.......
T Consensus        81 ~~~~~~l~~~l~~~-~~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~  156 (257)
T cd08223          81 FCEGGDLYHKLKEQ-KGKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC  156 (257)
T ss_pred             ccCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEecccC
Confidence            99999998888643 2345789999999999999999999999   9999999999999999999999999987664322


Q ss_pred             cccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCccccccCcccc
Q 017594          206 LQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILE  285 (369)
Q Consensus       206 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (369)
                      .  ......+++.|+|||+..+..++.++|+||||+++++|++|+.||.......     ...... ....     +.. 
T Consensus       157 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~-----~~~~~~-~~~~-----~~~-  222 (257)
T cd08223         157 D--MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNS-----LVYRII-EGKL-----PPM-  222 (257)
T ss_pred             C--ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHH-----HHHHHH-hcCC-----CCC-
Confidence            1  2233457889999999998889999999999999999999999986332111     001110 0000     001 


Q ss_pred             ccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 017594          286 DEYSSKQMLLRYANIALLCVQESADDRPTMNDVVS  320 (369)
Q Consensus       286 ~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~  320 (369)
                          +...+..+.+++.+||+.+|++||++.++++
T Consensus       223 ----~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  253 (257)
T cd08223         223 ----PKDYSPELGELIATMLSKRPEKRPSVKSILR  253 (257)
T ss_pred             ----ccccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence                1123667999999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=8.4e-37  Score=283.01  Aligned_cols=255  Identities=19%  Similarity=0.228  Sum_probs=194.9

Q ss_pred             cCCccCccccccCCccEEEEEEcC-CCEEEEEEecCC---CchhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEEE
Q 017594           49 NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGR---SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIY  124 (369)
Q Consensus        49 ~~y~i~~~lg~G~~~~v~~~~~~~-~~~valK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  124 (369)
                      ++|++.+.||+|+||.||+++.+. ++.+|+|++...   .......+..|+.++..+.|++|+++++.+......++||
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM   80 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence            479999999999999999999765 778999998532   1222345778899999999999999999999999999999


Q ss_pred             EecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCCC
Q 017594          125 EYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGN  204 (369)
Q Consensus       125 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~~  204 (369)
                      ||+.+++|.+++...  ...+++..+..++.||+.||.|||+.+   ++||||||+||+++.++.++|+|||++......
T Consensus        81 ey~~~g~L~~~l~~~--~~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~  155 (332)
T cd05623          81 DYYVGGDLLTLLSKF--EDRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMED  155 (332)
T ss_pred             eccCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheecccC
Confidence            999999999998542  234788899999999999999999999   999999999999999999999999998754322


Q ss_pred             CcccccccccccccccCchhhc-----cCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCccccc
Q 017594          205 ELQANTSRIVGTYGYMSPEYAL-----EGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLEL  279 (369)
Q Consensus       205 ~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (369)
                      .. .......|++.|+|||++.     ...++.++|||||||++|+|++|+.||.......     ............. 
T Consensus       156 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~-----~~~~i~~~~~~~~-  228 (332)
T cd05623         156 GT-VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVE-----TYGKIMNHKERFQ-  228 (332)
T ss_pred             Cc-ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHH-----HHHHHhCCCcccc-
Confidence            11 1122346899999999986     3457899999999999999999999986432111     0111111000000 


Q ss_pred             cCccccccccHHHHHHHHHHHHHHhhcCCCCC--CCCHHHHHHH
Q 017594          280 IDPILEDEYSSKQMLLRYANIALLCVQESADD--RPTMNDVVSM  321 (369)
Q Consensus       280 ~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~--Rps~~ell~~  321 (369)
                          ...  .....+.++.+++.+||..++.+  |+++.++++.
T Consensus       229 ----~p~--~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h  266 (332)
T cd05623         229 ----FPA--QVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH  266 (332)
T ss_pred             ----CCC--ccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence                000  01122667899999999765554  6899999876

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1.1e-36  Score=274.20  Aligned_cols=255  Identities=25%  Similarity=0.387  Sum_probs=197.4

Q ss_pred             CCccCccccccCCccEEEEEEc-CCCEEEEEEecCCCc----------hhHHHHHHHHHHHhcCCCCceeeeeeeEEeCC
Q 017594           50 KFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSG----------QGLREMKNEASVIAKVQHKNLVRLLGCCIDRD  118 (369)
Q Consensus        50 ~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~~~----------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~  118 (369)
                      +|.+.+.||.|++|.||+|... +|+.+++|.+.....          ...+.+..|+..++.+.|+|++++++++...+
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   81 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE   81 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence            6889999999999999999965 488999998753211          11345778999999999999999999999889


Q ss_pred             ccEEEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCc
Q 017594          119 EKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMA  198 (369)
Q Consensus       119 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~  198 (369)
                      ..++|+||+.+++|.+++...   ..+++..+..++.||+.||.+||+++   ++|+||+|+||+++.++.++|+|||++
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~~~~  155 (272)
T cd06629          82 YLSIFLEYVPGGSIGSCLRTY---GRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGIS  155 (272)
T ss_pred             ceEEEEecCCCCcHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeecccc
Confidence            999999999999999988543   34788889999999999999999998   999999999999999999999999998


Q ss_pred             eecCCCCcccccccccccccccCchhhccCC--CCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCcc
Q 017594          199 RICGGNELQANTSRIVGTYGYMSPEYALEGI--FSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRT  276 (369)
Q Consensus       199 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  276 (369)
                      ................++..|+|||.+.+..  ++.++|+||||++++++++|..||......     .......... .
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~-----~~~~~~~~~~-~  229 (272)
T cd06629         156 KKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAI-----AAMFKLGNKR-S  229 (272)
T ss_pred             ccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchH-----HHHHHhhccc-c
Confidence            7654322222222345778899999987654  789999999999999999999998532210     0011111000 0


Q ss_pred             ccccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 017594          277 LELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSM  321 (369)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~  321 (369)
                      ...+....     ...++..+.++|.+||+.+|.+||++.++++.
T Consensus       230 ~~~~~~~~-----~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  269 (272)
T cd06629         230 APPIPPDV-----SMNLSPVALDFLNACFTINPDNRPTARELLQH  269 (272)
T ss_pred             CCcCCccc-----cccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence            00111111     11235679999999999999999999999863

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=1.1e-36  Score=272.55  Aligned_cols=253  Identities=26%  Similarity=0.389  Sum_probs=204.3

Q ss_pred             cCCccCccccccCCccEEEEEEcC-CCEEEEEEecCCCc-hhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEEEEe
Q 017594           49 NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSG-QGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIYEY  126 (369)
Q Consensus        49 ~~y~i~~~lg~G~~~~v~~~~~~~-~~~valK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  126 (369)
                      ++|++.+.||.|++|.||+|+... ++.|++|++..... .....+..|+..+..++|+|++++++++......++++||
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY   80 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence            368899999999999999999765 89999999876543 3457788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhc-CCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCCCC
Q 017594          127 MPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQ-YSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE  205 (369)
Q Consensus       127 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~-~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~~~  205 (369)
                      +.+++|.+++...   ..+++..++.++.|++.|+.+||+ .+   ++|+||+|+||+++.++.++|+|||.+.......
T Consensus        81 ~~~~~L~~~l~~~---~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~  154 (264)
T cd06623          81 MDGGSLADLLKKV---GKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLENTL  154 (264)
T ss_pred             cCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceecccCC
Confidence            9999999998543   458999999999999999999999 88   9999999999999999999999999988664332


Q ss_pred             cccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCccccccCcccc
Q 017594          206 LQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILE  285 (369)
Q Consensus       206 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (369)
                      ...  ....++..|+|||.+.+..++.++|+||||+++|+|++|..||.......  ........ .....     ... 
T Consensus       155 ~~~--~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~--~~~~~~~~-~~~~~-----~~~-  223 (264)
T cd06623         155 DQC--NTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPS--FFELMQAI-CDGPP-----PSL-  223 (264)
T ss_pred             Ccc--cceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccC--HHHHHHHH-hcCCC-----CCC-
Confidence            221  23457888999999988889999999999999999999999986543200  00000000 00000     001 


Q ss_pred             ccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 017594          286 DEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSM  321 (369)
Q Consensus       286 ~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~  321 (369)
                         ....++..+.++|.+||..+|++||++.++++.
T Consensus       224 ---~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~  256 (264)
T cd06623         224 ---PAEEFSPEFRDFISACLQKDPKKRPSAAELLQH  256 (264)
T ss_pred             ---CcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence               111136679999999999999999999999973

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.3e-37  Score=285.13  Aligned_cols=256  Identities=23%  Similarity=0.302  Sum_probs=199.2

Q ss_pred             HHHhcCCccCccccccCCccEEEEEEcCCCEEEEEEec--CCCchhHHHHHHHHHHHhcCC-CCceeeeeeeEEeCCccE
Q 017594           45 STATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLS--GRSGQGLREMKNEASVIAKVQ-HKNLVRLLGCCIDRDEKI  121 (369)
Q Consensus        45 ~~~~~~y~i~~~lg~G~~~~v~~~~~~~~~~valK~~~--~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~  121 (369)
                      .+.++.|+++++||+||.+.||++...+.+-+|+|++.  ..+.....-+.+|+..|.+|+ |.+|+.++++=..++.+|
T Consensus       357 ~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lY  436 (677)
T KOG0596|consen  357 KVKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLY  436 (677)
T ss_pred             EECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEE
Confidence            34567899999999999999999998777777777654  335566788999999999996 889999999988889999


Q ss_pred             EEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceec
Q 017594          122 LIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARIC  201 (369)
Q Consensus       122 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~  201 (369)
                      +|||+ ....|..++......  .+.-.+..++.||+.|+.++|..|   |+|.||||.|+++- .|.+||+|||++..+
T Consensus       437 mvmE~-Gd~DL~kiL~k~~~~--~~~~~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlV-kG~LKLIDFGIA~aI  509 (677)
T KOG0596|consen  437 MVMEC-GDIDLNKILKKKKSI--DPDWFLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLV-KGRLKLIDFGIANAI  509 (677)
T ss_pred             EEeec-ccccHHHHHHhccCC--CchHHHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEE-eeeEEeeeechhccc
Confidence            99996 456788888654332  232378889999999999999999   99999999999885 469999999999888


Q ss_pred             CCCCcccccccccccccccCchhhccC-----------CCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhh
Q 017594          202 GGNELQANTSRIVGTYGYMSPEYALEG-----------IFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDL  270 (369)
Q Consensus       202 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-----------~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~  270 (369)
                      .............||..|++||.+...           ..++++||||||||||+|+.|+.||+.......         
T Consensus       510 ~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~a---------  580 (677)
T KOG0596|consen  510 QPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIA---------  580 (677)
T ss_pred             CccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHH---------
Confidence            766665666677899999999988632           256889999999999999999999974431111         


Q ss_pred             hhcCccccccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 017594          271 WTSNRTLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVS  320 (369)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~  320 (369)
                          ++....++.-.=++....-..++.++++.||+.||.+||+..+||+
T Consensus       581 ----Kl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLq  626 (677)
T KOG0596|consen  581 ----KLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQ  626 (677)
T ss_pred             ----HHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhc
Confidence                1111111111000100000223899999999999999999999996

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=2.4e-36  Score=273.82  Aligned_cols=265  Identities=23%  Similarity=0.281  Sum_probs=199.0

Q ss_pred             CCccCccccccCCccEEEEEEc-CCCEEEEEEecCCC--chhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEEEEe
Q 017594           50 KFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS--GQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIYEY  126 (369)
Q Consensus        50 ~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  126 (369)
                      +|++.+.||.|++|.||+|.+. +|..|++|++....  ......+..|+.+++.++|+|++++++++..+...++|+||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~   80 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY   80 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence            6899999999999999999975 58899999987543  23356788899999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCCCCc
Q 017594          127 MPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNEL  206 (369)
Q Consensus       127 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~~~~  206 (369)
                      + +++|..++....  ..+++..++.++.||+.||+|||+.+   ++|+||+|+||+++.++.++|+|||.+........
T Consensus        81 ~-~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~  154 (286)
T cd07832          81 M-PSDLSEVLRDEE--RPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEEEP  154 (286)
T ss_pred             c-CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC
Confidence            9 999988875433  45889999999999999999999998   99999999999999999999999999876653321


Q ss_pred             ccccccccccccccCchhhccC-CCCcccchHhHHHHHHHHHhCCCCCCCCccccccc---------chhhhhhhhcCcc
Q 017594          207 QANTSRIVGTYGYMSPEYALEG-IFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNL---------LGYAWDLWTSNRT  276 (369)
Q Consensus       207 ~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~---------~~~~~~~~~~~~~  276 (369)
                       .......++..|+|||.+.+. .++.++||||+|+++++|++|.++|..........         ....+.....-..
T Consensus       155 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (286)
T cd07832         155 -RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPD  233 (286)
T ss_pred             -CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcch
Confidence             112234578899999987654 46899999999999999999988775432111000         0000000000000


Q ss_pred             ccccCccccccc----cHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 017594          277 LELIDPILEDEY----SSKQMLLRYANIALLCVQESADDRPTMNDVVSM  321 (369)
Q Consensus       277 ~~~~~~~~~~~~----~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~  321 (369)
                      ...+........    .....+..+.++|.+||+.+|++||+++++++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h  282 (286)
T cd07832         234 YNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH  282 (286)
T ss_pred             hhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence            000000000000    001225779999999999999999999999863

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=7.3e-37  Score=274.81  Aligned_cols=251  Identities=31%  Similarity=0.476  Sum_probs=194.9

Q ss_pred             ccccccCCccEEEEEEcC-------CCEEEEEEecCCC-chhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEEEEe
Q 017594           55 NKLGEGGFGPVYKGVLKK-------GDEIAVKRLSGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIYEY  126 (369)
Q Consensus        55 ~~lg~G~~~~v~~~~~~~-------~~~valK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  126 (369)
                      +.||.|++|.||+|+.++       +..+++|.+.... ......+.+|+..++.++||||+++++++......++++||
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL   80 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence            468999999999999643       2578999876442 23456788899999999999999999999988899999999


Q ss_pred             cCCCChhhhhcCCC----ccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCC-----ceEEeecCC
Q 017594          127 MPNKSLDFFLFDPT----KRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDM-----NPKISDFGM  197 (369)
Q Consensus       127 ~~~~~L~~~l~~~~----~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~-----~~~L~Dfg~  197 (369)
                      +.+++|.+++....    ....+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++     .++|+|||+
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~  157 (269)
T cd05044          81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGL  157 (269)
T ss_pred             cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCccc
Confidence            99999998885422    2234778889999999999999999998   99999999999999887     899999999


Q ss_pred             ceecCCCCcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHh-CCCCCCCCcccccccchhhhhhhhcCcc
Q 017594          198 ARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDLWTSNRT  276 (369)
Q Consensus       198 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  276 (369)
                      +................++..|+|||.+.+..++.++||||||+++|+|++ |..||.......     .. ........
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~-----~~-~~~~~~~~  231 (269)
T cd05044         158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQE-----VL-QHVTAGGR  231 (269)
T ss_pred             ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHH-----HH-HHHhcCCc
Confidence            876543322222222345678999999998999999999999999999998 999986332110     00 00000000


Q ss_pred             ccccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHh
Q 017594          277 LELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTN  324 (369)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L~~  324 (369)
                      .          ..+...+..+.++|.+||+.+|.+||++.++++.|+.
T Consensus       232 ~----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  269 (269)
T cd05044         232 L----------QKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN  269 (269)
T ss_pred             c----------CCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence            0          0111236678999999999999999999999998863

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=1.3e-36  Score=273.41  Aligned_cols=254  Identities=23%  Similarity=0.354  Sum_probs=186.6

Q ss_pred             ccccccCCccEEEEEEcC---CCEEEEEEecCCC-chhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEEEEecCCC
Q 017594           55 NKLGEGGFGPVYKGVLKK---GDEIAVKRLSGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIYEYMPNK  130 (369)
Q Consensus        55 ~~lg~G~~~~v~~~~~~~---~~~valK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~  130 (369)
                      +.||+|+||.||+|....   ...+++|.+.... ......+.+|+..++.++|+||+++++.+......++||||+.++
T Consensus         1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05042           1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG   80 (269)
T ss_pred             CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence            368999999999998543   3568888776443 233456778999999999999999999999889999999999999


Q ss_pred             ChhhhhcCCCc--cccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCCCCccc
Q 017594          131 SLDFFLFDPTK--RMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQA  208 (369)
Q Consensus       131 ~L~~~l~~~~~--~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~~~~~~  208 (369)
                      +|.+++.....  ....++.....++.||+.||+|||+++   ++|+||||.||+++.++.++|+|||++..........
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~  157 (269)
T cd05042          81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI  157 (269)
T ss_pred             cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccccccchhee
Confidence            99998865332  223456778899999999999999999   9999999999999999999999999876433221111


Q ss_pred             ccccccccccccCchhhcc-------CCCCcccchHhHHHHHHHHHh-CCCCCCCCcccccccchhhhhhhhcCcccccc
Q 017594          209 NTSRIVGTYGYMSPEYALE-------GIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDLWTSNRTLELI  280 (369)
Q Consensus       209 ~~~~~~~~~~y~aPE~~~~-------~~~~~~~DiwslG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (369)
                      ......++..|+|||+...       ..++.++|||||||++|+|++ |..||.......     ....... .......
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~-----~~~~~~~-~~~~~~~  231 (269)
T cd05042         158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQ-----VLKQVVR-EQDIKLP  231 (269)
T ss_pred             ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHH-----HHHHHhh-ccCccCC
Confidence            1222334667999998742       356889999999999999999 777875432111     0111111 1111111


Q ss_pred             CccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 017594          281 DPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLT  323 (369)
Q Consensus       281 ~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L~  323 (369)
                      .+...     ..++..+.+++..|+ .||++||++++|++.|.
T Consensus       232 ~~~~~-----~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~  268 (269)
T cd05042         232 KPQLD-----LKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT  268 (269)
T ss_pred             CCccc-----ccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence            11111     122556788888888 59999999999999873

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2e-36  Score=278.62  Aligned_cols=253  Identities=21%  Similarity=0.277  Sum_probs=200.4

Q ss_pred             cCCccCccccccCCccEEEEEEcC-CCEEEEEEecCCCc---hhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEEE
Q 017594           49 NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSG---QGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIY  124 (369)
Q Consensus        49 ~~y~i~~~lg~G~~~~v~~~~~~~-~~~valK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  124 (369)
                      ++|++.+.||.|++|.||+|...+ ++.+++|.+.....   .....+..|++.++.+.|+||+++++.+......++++
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   80 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM   80 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence            479999999999999999999765 89999999875432   24456788999999999999999999999999999999


Q ss_pred             EecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCCC
Q 017594          125 EYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGN  204 (369)
Q Consensus       125 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~~  204 (369)
                      ||+.+++|.+++... ....+++..++.++.|++.||+|||+.+   ++|+||||+||+++.++.++|+|||++......
T Consensus        81 e~~~~~~L~~~~~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~  156 (316)
T cd05574          81 DYCPGGELFRLLQRQ-PGKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVE  156 (316)
T ss_pred             EecCCCCHHHHHHhC-CCCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhccccc
Confidence            999999999988543 2345889999999999999999999998   999999999999999999999999987755322


Q ss_pred             Cccc---------------------------ccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCc
Q 017594          205 ELQA---------------------------NTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYR  257 (369)
Q Consensus       205 ~~~~---------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~  257 (369)
                      ....                           ......|+..|+|||++.+..++.++||||||+++|+|++|..||....
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~  236 (316)
T cd05574         157 PPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSN  236 (316)
T ss_pred             ccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCc
Confidence            1100                           1112356788999999998889999999999999999999999986433


Q ss_pred             ccccccchhhhhhhhcCccccccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCC----HHHHHH
Q 017594          258 TDSLNLLGYAWDLWTSNRTLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPT----MNDVVS  320 (369)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps----~~ell~  320 (369)
                      ....     ..... .... .     ...   ....+..+.++|.+||+.+|++||+    +.+++.
T Consensus       237 ~~~~-----~~~~~-~~~~-~-----~~~---~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~  288 (316)
T cd05574         237 RDET-----FSNIL-KKEV-T-----FPG---SPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ  288 (316)
T ss_pred             hHHH-----HHHHh-cCCc-c-----CCC---ccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence            2110     00000 0000 0     000   0113677999999999999999999    777776

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=1.3e-36  Score=272.33  Aligned_cols=239  Identities=23%  Similarity=0.351  Sum_probs=185.7

Q ss_pred             ccccccCCccEEEEEEcC-------------CCEEEEEEecCCCchhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccE
Q 017594           55 NKLGEGGFGPVYKGVLKK-------------GDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKI  121 (369)
Q Consensus        55 ~~lg~G~~~~v~~~~~~~-------------~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  121 (369)
                      +.||+|++|.||+|+...             ...+++|.+..........+..|+.+++.++||||+++++++......+
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~   80 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI   80 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence            468999999999998432             2358899877655555567788999999999999999999999888999


Q ss_pred             EEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCc-------eEEee
Q 017594          122 LIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMN-------PKISD  194 (369)
Q Consensus       122 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~-------~~L~D  194 (369)
                      +++||+++++|..++...  ...+++..++.++.||+.||+|||+.+   ++|+||+|+||+++.++.       ++++|
T Consensus        81 lv~e~~~~~~l~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~l~d  155 (262)
T cd05077          81 MVEEFVEFGPLDLFMHRK--SDVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKLSD  155 (262)
T ss_pred             EEEecccCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeEeCC
Confidence            999999999998887532  234788899999999999999999998   999999999999987664       89999


Q ss_pred             cCCceecCCCCcccccccccccccccCchhhc-cCCCCcccchHhHHHHHHHHH-hCCCCCCCCcccccccchhhhhhhh
Q 017594          195 FGMARICGGNELQANTSRIVGTYGYMSPEYAL-EGIFSIKSDVFSFGVLLLEIV-SGKKNTGLYRTDSLNLLGYAWDLWT  272 (369)
Q Consensus       195 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~DiwslG~il~~l~-tg~~p~~~~~~~~~~~~~~~~~~~~  272 (369)
                      ||++......      ....++..|+|||.+. +..++.++|||||||++|+|+ +|..||.......      .... .
T Consensus       156 ~g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~------~~~~-~  222 (262)
T cd05077         156 PGIPITVLSR------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAE------KERF-Y  222 (262)
T ss_pred             CCCCccccCc------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhH------HHHH-H
Confidence            9987654321      2234677899999886 567899999999999999998 5777765322110      0000 0


Q ss_pred             cCccccccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHH
Q 017594          273 SNRTLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSML  322 (369)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L  322 (369)
                      .. ......          ..+.++.+++.+||+.||.+||++.+|++.|
T Consensus       223 ~~-~~~~~~----------~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~  261 (262)
T cd05077         223 EG-QCMLVT----------PSCKELADLMTHCMNYDPNQRPFFRAIMRDI  261 (262)
T ss_pred             hc-CccCCC----------CChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence            00 000000          1145689999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=9.7e-37  Score=277.28  Aligned_cols=244  Identities=26%  Similarity=0.336  Sum_probs=198.2

Q ss_pred             cCCccCccccccCCccEEEEEEc-CCCEEEEEEecCCC---chhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEEE
Q 017594           49 NKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS---GQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIY  124 (369)
Q Consensus        49 ~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  124 (369)
                      ++|++.+.||.|++|.||++.+. +++.+++|.+....   ......+.+|+++++.+.||||+++++++..+...++++
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   80 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM   80 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence            47999999999999999999965 48899999886432   233456788999999999999999999999999999999


Q ss_pred             EecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCCC
Q 017594          125 EYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGN  204 (369)
Q Consensus       125 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~~  204 (369)
                      ||+.+++|.+++...   ..+++..+..++.||+.||.+||+.+   ++|+||+|.||+++.++.++|+|||++......
T Consensus        81 e~~~~~~L~~~~~~~---~~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~  154 (290)
T cd05580          81 EYVPGGELFSHLRKS---GRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR  154 (290)
T ss_pred             ecCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCccccCCC
Confidence            999999998888543   45889999999999999999999998   999999999999999999999999998765433


Q ss_pred             CcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCccccccCccc
Q 017594          205 ELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPIL  284 (369)
Q Consensus       205 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (369)
                           .....+++.|+|||.+.+..++.++|+||||+++|+|++|..||.......      .........      ..+
T Consensus       155 -----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------~~~~~~~~~------~~~  217 (290)
T cd05580         155 -----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQ------IYEKILEGK------VRF  217 (290)
T ss_pred             -----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHhcCC------ccC
Confidence                 223457889999999988888999999999999999999999986433110      000000000      001


Q ss_pred             cccccHHHHHHHHHHHHHHhhcCCCCCCC-----CHHHHHH
Q 017594          285 EDEYSSKQMLLRYANIALLCVQESADDRP-----TMNDVVS  320 (369)
Q Consensus       285 ~~~~~~~~~~~~l~~li~~~L~~dP~~Rp-----s~~ell~  320 (369)
                           +...+..+.++|.+||+.+|.+|+     +++++++
T Consensus       218 -----~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~  253 (290)
T cd05580         218 -----PSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN  253 (290)
T ss_pred             -----CccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence                 111256689999999999999999     7777774

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=2.1e-36  Score=275.97  Aligned_cols=261  Identities=22%  Similarity=0.296  Sum_probs=196.6

Q ss_pred             CCccCccccccCCccEEEEEEc-CCCEEEEEEecCCCch-----hHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEE
Q 017594           50 KFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSGQ-----GLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILI  123 (369)
Q Consensus        50 ~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv  123 (369)
                      +|++.+.||.|++|.||+|.++ +|+.|++|.+......     ....+..|+..++.++|+|++++++++...+..++|
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV   80 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence            5889999999999999999965 5889999998754322     334567899999999999999999999998899999


Q ss_pred             EEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCC
Q 017594          124 YEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGG  203 (369)
Q Consensus       124 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~  203 (369)
                      |||+ +++|..++....  ..+++..+..++.||+.||.|||+++   ++|+||+|+||+++.++.++|+|||++.....
T Consensus        81 ~e~~-~~~L~~~i~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~  154 (298)
T cd07841          81 FEFM-ETDLEKVIKDKS--IVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGS  154 (298)
T ss_pred             Eccc-CCCHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeeeccC
Confidence            9999 889988885433  25889999999999999999999999   99999999999999999999999999887654


Q ss_pred             CCcccccccccccccccCchhhcc-CCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhh--------hc-
Q 017594          204 NELQANTSRIVGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLW--------TS-  273 (369)
Q Consensus       204 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~--------~~-  273 (369)
                      ...  ......++..|+|||.+.+ ..++.++|+|||||++|+|++|.++|.......  .........        .. 
T Consensus       155 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~  230 (298)
T cd07841         155 PNR--KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDID--QLGKIFEALGTPTEENWPGV  230 (298)
T ss_pred             CCc--cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHH--HHHHHHHHcCCCchhhhhhc
Confidence            321  1122345778999998854 467899999999999999999987775332111  000000000        00 


Q ss_pred             CccccccCccccccc----cHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 017594          274 NRTLELIDPILEDEY----SSKQMLLRYANIALLCVQESADDRPTMNDVVS  320 (369)
Q Consensus       274 ~~~~~~~~~~~~~~~----~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~  320 (369)
                      ...............    .....+..+.++|.+||+.+|.+|||+.++++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~  281 (298)
T cd07841         231 TSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALE  281 (298)
T ss_pred             ccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence            000000000000000    01122567899999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-38  Score=290.26  Aligned_cols=247  Identities=30%  Similarity=0.447  Sum_probs=201.4

Q ss_pred             hcCCccCccccccCCccEEEEEEc-CCCEEEEEEecCC---CchhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEE
Q 017594           48 TNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGR---SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILI  123 (369)
Q Consensus        48 ~~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv  123 (369)
                      .+.|..++.||.|+||.||-|++. +.+.||||++.-+   ..+.++.+..|+..|+++.|||++.+-++|..+...|+|
T Consensus        25 Eklf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLV  104 (948)
T KOG0577|consen   25 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLV  104 (948)
T ss_pred             HHHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHH
Confidence            356888999999999999999954 5788999998644   345678899999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCC
Q 017594          124 YEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGG  203 (369)
Q Consensus       124 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~  203 (369)
                      ||||-| +-.+++.  ..++++.+.++..|+.+.+.||+|||+++   .+|||||..||++++.|.|+|+|||.+.... 
T Consensus       105 MEYClG-SAsDlle--VhkKplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi~~-  177 (948)
T KOG0577|consen  105 MEYCLG-SASDLLE--VHKKPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASIMA-  177 (948)
T ss_pred             HHHHhc-cHHHHHH--HHhccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhhcC-
Confidence            999965 5666663  34667999999999999999999999999   9999999999999999999999999986542 


Q ss_pred             CCcccccccccccccccCchhhc---cCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCcccccc
Q 017594          204 NELQANTSRIVGTYGYMSPEYAL---EGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELI  280 (369)
Q Consensus       204 ~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (369)
                           ......|||.|+|||++.   .+.|+-++||||||++..+|...++|.....           .......+.+--
T Consensus       178 -----PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMN-----------AMSALYHIAQNe  241 (948)
T KOG0577|consen  178 -----PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN-----------AMSALYHIAQNE  241 (948)
T ss_pred             -----chhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCch-----------HHHHHHHHHhcC
Confidence                 234468999999999985   5789999999999999999999999854221           000111111111


Q ss_pred             CccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 017594          281 DPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSM  321 (369)
Q Consensus       281 ~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~  321 (369)
                      .+.+    ...+++..+.+++..||+.-|.+|||..++++.
T Consensus       242 sPtL----qs~eWS~~F~~Fvd~CLqKipqeRptse~ll~H  278 (948)
T KOG0577|consen  242 SPTL----QSNEWSDYFRNFVDSCLQKIPQERPTSEELLKH  278 (948)
T ss_pred             CCCC----CCchhHHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence            1222    133458889999999999999999999988753

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=5.9e-36  Score=267.35  Aligned_cols=248  Identities=26%  Similarity=0.390  Sum_probs=191.3

Q ss_pred             cccccCCccEEEEEEc---CCCEEEEEEecCCCc-hhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEEEEecCCCC
Q 017594           56 KLGEGGFGPVYKGVLK---KGDEIAVKRLSGRSG-QGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKS  131 (369)
Q Consensus        56 ~lg~G~~~~v~~~~~~---~~~~valK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~  131 (369)
                      .||.|+||.||+|.+.   .+..|++|++..... ...+.+..|+.+++.++|+||+++++++. ....++|+||+.+++
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~   80 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP   80 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence            4899999999999854   355699998875532 23456888999999999999999999875 457899999999999


Q ss_pred             hhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCCCCcccc-c
Q 017594          132 LDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQAN-T  210 (369)
Q Consensus       132 L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~~~~~~~-~  210 (369)
                      |.+++...  ...+++..++.++.||+.||.|||+.+   ++|+||+|+||+++.++.++|+|||++........... .
T Consensus        81 L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~  155 (257)
T cd05115          81 LNKFLSGK--KDEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKAR  155 (257)
T ss_pred             HHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCCccceecc
Confidence            99888532  335889999999999999999999998   99999999999999999999999999875543221111 1


Q ss_pred             ccccccccccCchhhccCCCCcccchHhHHHHHHHHHh-CCCCCCCCcccccccchhhhhhhhcCccccccCcccccccc
Q 017594          211 SRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYS  289 (369)
Q Consensus       211 ~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  289 (369)
                      ....++..|+|||.+.+..++.++|+||||+++|+|++ |..||.......      ..........     ....    
T Consensus       156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~------~~~~~~~~~~-----~~~~----  220 (257)
T cd05115         156 SAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPE------VMSFIEQGKR-----LDCP----  220 (257)
T ss_pred             CCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHH------HHHHHHCCCC-----CCCC----
Confidence            11223567999999888889999999999999999996 999986432111      0011111100     0000    


Q ss_pred             HHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHhh
Q 017594          290 SKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNE  325 (369)
Q Consensus       290 ~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L~~~  325 (369)
                       ...+.++.+++.+||..+|++||++.+|.+.|+..
T Consensus       221 -~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~  255 (257)
T cd05115         221 -AECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY  255 (257)
T ss_pred             -CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence             11256789999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=9.3e-37  Score=276.55  Aligned_cols=255  Identities=24%  Similarity=0.346  Sum_probs=201.9

Q ss_pred             hcCCccCccccccCCccEEEEEEc-CCCEEEEEEecCCC-chhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEEEE
Q 017594           48 TNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIYE  125 (369)
Q Consensus        48 ~~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  125 (369)
                      ..+|++.+.||+|++|.||++... +|..|++|++.... ......+..|+++++.++|||++++++.+......++|+|
T Consensus         4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   83 (284)
T cd06620           4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCME   83 (284)
T ss_pred             HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEe
Confidence            478999999999999999999965 48889999876443 3345678889999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhc-CCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCCC
Q 017594          126 YMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQ-YSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGN  204 (369)
Q Consensus       126 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~-~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~~  204 (369)
                      |+.+++|..++..   ...+++..+..++.+++.+|.|||+ .+   ++|+||+|+||+++.++.++|+|||++......
T Consensus        84 ~~~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~  157 (284)
T cd06620          84 FMDCGSLDRIYKK---GGPIPVEILGKIAVAVVEGLTYLYNVHR---IMHRDIKPSNILVNSRGQIKLCDFGVSGELINS  157 (284)
T ss_pred             cCCCCCHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHHhcC---eeccCCCHHHEEECCCCcEEEccCCcccchhhh
Confidence            9999999888744   2348899999999999999999997 46   999999999999999999999999987654221


Q ss_pred             CcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccc------cchhhhhhhhcCcccc
Q 017594          205 ELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLN------LLGYAWDLWTSNRTLE  278 (369)
Q Consensus       205 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~------~~~~~~~~~~~~~~~~  278 (369)
                      .    .....++..|+|||.+.+..++.++|+||+||++|+|++|..||.........      .......... ..   
T Consensus       158 ~----~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-~~---  229 (284)
T cd06620         158 I----ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQ-EP---  229 (284)
T ss_pred             c----cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhh-cc---
Confidence            1    22346788999999998888999999999999999999999998754321100      0000000000 00   


Q ss_pred             ccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHH
Q 017594          279 LIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSML  322 (369)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L  322 (369)
                        .    .......++.++.+++.+||+.||.+||++.++++..
T Consensus       230 --~----~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~  267 (284)
T cd06620         230 --P----PRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP  267 (284)
T ss_pred             --C----CCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence              0    0111112356799999999999999999999999853

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=5.9e-36  Score=271.74  Aligned_cols=260  Identities=25%  Similarity=0.327  Sum_probs=198.9

Q ss_pred             cCCccCccccccCCccEEEEEEc-CCCEEEEEEecCCCc-hhHHHHHHHHHHHhcCCCCceeeeeeeEEeC--CccEEEE
Q 017594           49 NKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSG-QGLREMKNEASVIAKVQHKNLVRLLGCCIDR--DEKILIY  124 (369)
Q Consensus        49 ~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~  124 (369)
                      ++|++.+.||.|++|.||+|... +++.+++|.+..... .....+.+|++.++.++||||+++++++...  ...++||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   80 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM   80 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence            46889999999999999999975 488899999875432 3456788899999999999999999988654  3689999


Q ss_pred             EecCCCChhhhhcCC-CccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCC
Q 017594          125 EYMPNKSLDFFLFDP-TKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGG  203 (369)
Q Consensus       125 e~~~~~~L~~~l~~~-~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~  203 (369)
                      ||+++++|.+++... .....++...+..++.||+.||.|||+.+   ++|+||+|+||+++.++.++|+|||++.....
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~  157 (287)
T cd06621          81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELVN  157 (287)
T ss_pred             EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence            999999998876431 22345788899999999999999999999   99999999999999999999999999765432


Q ss_pred             CCcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCccccccCcc
Q 017594          204 NELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPI  283 (369)
Q Consensus       204 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (369)
                      ..    .....++..|+|||.+.+..++.++|+||||+++|+|++|..||................ ....... .+...
T Consensus       158 ~~----~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~-~~~~~  231 (287)
T cd06621         158 SL----AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSY-IVNMPNP-ELKDE  231 (287)
T ss_pred             cc----cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHH-HhcCCch-hhccC
Confidence            21    122356778999999998899999999999999999999999987553211111111100 0000000 00000


Q ss_pred             ccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 017594          284 LEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVS  320 (369)
Q Consensus       284 ~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~  320 (369)
                      ...   ...++..+.+++.+||+.+|++|||+.++++
T Consensus       232 ~~~---~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~  265 (287)
T cd06621         232 PGN---GIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE  265 (287)
T ss_pred             CCC---CCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence            000   0123567999999999999999999999997

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=6.8e-37  Score=277.50  Aligned_cols=264  Identities=23%  Similarity=0.329  Sum_probs=197.0

Q ss_pred             cCCccCccccccCCccEEEEEEcC-CCEEEEEEecCCCc--hhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEEEE
Q 017594           49 NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSG--QGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIYE  125 (369)
Q Consensus        49 ~~y~i~~~lg~G~~~~v~~~~~~~-~~~valK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  125 (369)
                      ++|++.+.||.|++|.||+|.+++ ++.|++|++.....  ...+.+.+|+++++.++|||++++++++..+...++|+|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE   80 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence            478999999999999999999764 88999998764322  234567789999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCCCC
Q 017594          126 YMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE  205 (369)
Q Consensus       126 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~~~  205 (369)
                      |++++++..+....   ..+++..+..++.||+.||.|||+.+   ++|+||+|+||+++.++.++|+|||++.......
T Consensus        81 ~~~~~~l~~~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~  154 (286)
T cd07846          81 FVDHTVLDDLEKYP---NGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG  154 (286)
T ss_pred             cCCccHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc
Confidence            99999988776432   23789999999999999999999998   9999999999999999999999999987654332


Q ss_pred             cccccccccccccccCchhhcc-CCCCcccchHhHHHHHHHHHhCCCCCCCCcccccc-cchh--------hhhhhhcCc
Q 017594          206 LQANTSRIVGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLN-LLGY--------AWDLWTSNR  275 (369)
Q Consensus       206 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~-~~~~--------~~~~~~~~~  275 (369)
                      .  ......++..|+|||++.+ ..++.++||||||+++|+|++|.+||......... ....        .........
T Consensus       155 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (286)
T cd07846         155 E--VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNP  232 (286)
T ss_pred             c--ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccch
Confidence            1  1222356788999998875 44788999999999999999999988643311000 0000        000000000


Q ss_pred             -----cccccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 017594          276 -----TLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVS  320 (369)
Q Consensus       276 -----~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~  320 (369)
                           .................++..+.+++.+||+.+|++||++.++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  282 (286)
T cd07846         233 LFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH  282 (286)
T ss_pred             HhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence                 000000000000001123677999999999999999999999986

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=5.3e-36  Score=269.60  Aligned_cols=250  Identities=30%  Similarity=0.426  Sum_probs=192.3

Q ss_pred             ccccccCCccEEEEEEcC-CC--EEEEEEecCC-CchhHHHHHHHHHHHhcC-CCCceeeeeeeEEeCCccEEEEEecCC
Q 017594           55 NKLGEGGFGPVYKGVLKK-GD--EIAVKRLSGR-SGQGLREMKNEASVIAKV-QHKNLVRLLGCCIDRDEKILIYEYMPN  129 (369)
Q Consensus        55 ~~lg~G~~~~v~~~~~~~-~~--~valK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~  129 (369)
                      +.||+|+||.||+|+.++ +.  .+++|.+... .......+..|++++.++ .|||++++++++...+..+++|||+.+
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH   80 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence            468999999999999754 43  4688887643 234456788899999999 799999999999998899999999999


Q ss_pred             CChhhhhcCCC-------------ccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecC
Q 017594          130 KSLDFFLFDPT-------------KRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFG  196 (369)
Q Consensus       130 ~~L~~~l~~~~-------------~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg  196 (369)
                      ++|.+++....             ....+++..+..++.|++.|++|||+.+   ++|+||+|+||+++.++.++|+|||
T Consensus        81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~dfg  157 (270)
T cd05047          81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFG  157 (270)
T ss_pred             CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCCC
Confidence            99998885422             1234788899999999999999999998   9999999999999999999999999


Q ss_pred             CceecCCCCcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHh-CCCCCCCCcccccccchhhhhhhhcCc
Q 017594          197 MARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDLWTSNR  275 (369)
Q Consensus       197 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~  275 (369)
                      ++......   ........+..|+|||.+.+..++.++|+||||+++|+|++ |..||.......      .........
T Consensus       158 l~~~~~~~---~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~------~~~~~~~~~  228 (270)
T cd05047         158 LSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE------LYEKLPQGY  228 (270)
T ss_pred             Cccccchh---hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHH------HHHHHhCCC
Confidence            87532211   11111123456999999988889999999999999999997 999985322110      011111110


Q ss_pred             cccccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHhhh
Q 017594          276 TLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNEA  326 (369)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L~~~~  326 (369)
                      ...     .     +...+.++.+++.+||+.+|.+|||+.+++..|+++.
T Consensus       229 ~~~-----~-----~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~  269 (270)
T cd05047         229 RLE-----K-----PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML  269 (270)
T ss_pred             CCC-----C-----CCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence            000     0     0112456899999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=1e-36  Score=271.87  Aligned_cols=249  Identities=23%  Similarity=0.349  Sum_probs=199.4

Q ss_pred             CCccCccccccCCccEEEEEEc-CCCEEEEEEecCC--CchhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEEEEe
Q 017594           50 KFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIYEY  126 (369)
Q Consensus        50 ~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  126 (369)
                      +|++.+.||.|++|.+|.++.. +|+.|++|.+...  .......+.+|+.+++.++|+|++++.+++...+..++|+||
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY   80 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence            6899999999999999999965 4889999998643  223345788899999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCCCCc
Q 017594          127 MPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNEL  206 (369)
Q Consensus       127 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~~~~  206 (369)
                      +.+++|.+.+.... ...+++..+..++.|++.|+.+||+.+   ++|+||+|+||+++.++.++|+|||.+........
T Consensus        81 ~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~  156 (256)
T cd08218          81 CEGGDLYKKINAQR-GVLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE  156 (256)
T ss_pred             CCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCcchh
Confidence            99999988875422 234788889999999999999999998   99999999999999999999999999876543221


Q ss_pred             ccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCccccccCccccc
Q 017594          207 QANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILED  286 (369)
Q Consensus       207 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  286 (369)
                        ......++..|+|||...+..++.++|+||||+++++|++|..||.......     ....... ....     .   
T Consensus       157 --~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~-----~~~~~~~-~~~~-----~---  220 (256)
T cd08218         157 --LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKN-----LVLKIIR-GSYP-----P---  220 (256)
T ss_pred             --hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHH-----HHHHHhc-CCCC-----C---
Confidence              1122346788999999988889999999999999999999999986432110     1111100 0000     0   


Q ss_pred             cccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 017594          287 EYSSKQMLLRYANIALLCVQESADDRPTMNDVVS  320 (369)
Q Consensus       287 ~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~  320 (369)
                        .+...+.++.++|.+||+.+|.+||++.++++
T Consensus       221 --~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~  252 (256)
T cd08218         221 --VSSHYSYDLRNLVSQLFKRNPRDRPSVNSILE  252 (256)
T ss_pred             --CcccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence              01122567999999999999999999999987

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=5.2e-36  Score=266.90  Aligned_cols=251  Identities=27%  Similarity=0.436  Sum_probs=203.8

Q ss_pred             CCccCccccccCCccEEEEEEc-CCCEEEEEEecCCCc--hhHHHHHHHHHHHhcCCCCceeeeeeeEEeC--CccEEEE
Q 017594           50 KFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSG--QGLREMKNEASVIAKVQHKNLVRLLGCCIDR--DEKILIY  124 (369)
Q Consensus        50 ~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~  124 (369)
                      +|.+.+.||+|++|.||+|... ++..|++|.+.....  ...+.+..|+..+++++|+|++++++.+...  ...++++
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   80 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL   80 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence            5888999999999999999976 588999999875542  4467788999999999999999999999888  7899999


Q ss_pred             EecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCCC
Q 017594          125 EYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGN  204 (369)
Q Consensus       125 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~~  204 (369)
                      |++.+++|.+++....   .+++..++.++.|++.|++|||+.+   ++|+||+|+||+++.++.++|+|||.+......
T Consensus        81 e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~  154 (260)
T cd06606          81 EYVSGGSLSSLLKKFG---KLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDI  154 (260)
T ss_pred             EecCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEecccc
Confidence            9999999999885433   5899999999999999999999998   999999999999999999999999998877654


Q ss_pred             CcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCccccccCccc
Q 017594          205 ELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPIL  284 (369)
Q Consensus       205 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (369)
                      ..........++..|+|||...+...+.++|+||||+++++|++|..||......    ....+..........      
T Consensus       155 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----~~~~~~~~~~~~~~~------  224 (260)
T cd06606         155 ETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNP----MAALYKIGSSGEPPE------  224 (260)
T ss_pred             cccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCch----HHHHHhccccCCCcC------
Confidence            3211123346788999999998888999999999999999999999998754411    111111111001100      


Q ss_pred             cccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 017594          285 EDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVS  320 (369)
Q Consensus       285 ~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~  320 (369)
                          .+...+..+.++|.+||+.+|.+||++.+++.
T Consensus       225 ----~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~  256 (260)
T cd06606         225 ----IPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ  256 (260)
T ss_pred             ----CCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence                11122567999999999999999999999986

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=3.2e-36  Score=270.43  Aligned_cols=253  Identities=24%  Similarity=0.438  Sum_probs=198.8

Q ss_pred             CCccCccccccCCccEEEEEE-cCCCEEEEEEecCCC------chhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEE
Q 017594           50 KFSDANKLGEGGFGPVYKGVL-KKGDEIAVKRLSGRS------GQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKIL  122 (369)
Q Consensus        50 ~y~i~~~lg~G~~~~v~~~~~-~~~~~valK~~~~~~------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l  122 (369)
                      +|+..+.||+|++|.||+|.. .+++.+++|.+....      ......+..|+..++.++|+|++++++++.+.+..++
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   80 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL   80 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence            488999999999999999996 458899999986432      1235678889999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCC-ceEEeecCCceec
Q 017594          123 IYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDM-NPKISDFGMARIC  201 (369)
Q Consensus       123 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~-~~~L~Dfg~~~~~  201 (369)
                      |+||+.+++|.+++...   ..+++..++.++.||+.||.+||+.+   ++|+||+|.||+++.++ .++|+|||.+...
T Consensus        81 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~  154 (268)
T cd06630          81 FVEWMAGGSVSHLLSKY---GAFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARL  154 (268)
T ss_pred             EEeccCCCcHHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccccccccc
Confidence            99999999999988542   35788999999999999999999998   99999999999998776 5899999998766


Q ss_pred             CCCCccc--ccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCccccc
Q 017594          202 GGNELQA--NTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLEL  279 (369)
Q Consensus       202 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (369)
                      .......  ......++..|+|||.+.+..++.++|+||||+++++|++|..||........  ..........     .
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~--~~~~~~~~~~-----~  227 (268)
T cd06630         155 AAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNH--LALIFKIASA-----T  227 (268)
T ss_pred             ccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcch--HHHHHHHhcc-----C
Confidence            4331111  11223567889999999888899999999999999999999999864321110  0000000000     0


Q ss_pred             cCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 017594          280 IDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVS  320 (369)
Q Consensus       280 ~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~  320 (369)
                      ..+     ..+...+.++.+++.+||+.+|.+||++.++++
T Consensus       228 ~~~-----~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~  263 (268)
T cd06630         228 TAP-----SIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK  263 (268)
T ss_pred             CCC-----CCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence            000     111223677999999999999999999999985

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=2.1e-36  Score=274.40  Aligned_cols=252  Identities=26%  Similarity=0.347  Sum_probs=197.1

Q ss_pred             CCccCccccccCCccEEEEEEc-CCCEEEEEEecCCC---chhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEEEE
Q 017594           50 KFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS---GQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIYE  125 (369)
Q Consensus        50 ~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  125 (369)
                      .|++.+.||.|+||.||+|.+. +++.+|+|.+....   ......+..|+.+++.++|++++.+.+.+..++..++++|
T Consensus         1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e   80 (285)
T cd05632           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence            4778899999999999999965 58899999986432   2223456779999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCCCC
Q 017594          126 YMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE  205 (369)
Q Consensus       126 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~~~  205 (369)
                      |+.+++|..++.... ...+++..+..++.|++.||.|||+.+   ++|+||+|.||+++.++.++|+|||++.......
T Consensus        81 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~  156 (285)
T cd05632          81 IMNGGDLKFHIYNMG-NPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE  156 (285)
T ss_pred             eccCccHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecCCCC
Confidence            999999988775432 235899999999999999999999999   9999999999999999999999999886543221


Q ss_pred             cccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCccccccCcccc
Q 017594          206 LQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILE  285 (369)
Q Consensus       206 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (369)
                         ......++..|+|||.+.+..++.++|+||+|+++|+|++|..||.........  ....     ....... ... 
T Consensus       157 ---~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~--~~~~-----~~~~~~~-~~~-  224 (285)
T cd05632         157 ---SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKR--EEVD-----RRVLETE-EVY-  224 (285)
T ss_pred             ---cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHH--HHHH-----Hhhhccc-ccc-
Confidence               112236789999999998888999999999999999999999998643211100  0000     0000000 000 


Q ss_pred             ccccHHHHHHHHHHHHHHhhcCCCCCCCC-----HHHHHHH
Q 017594          286 DEYSSKQMLLRYANIALLCVQESADDRPT-----MNDVVSM  321 (369)
Q Consensus       286 ~~~~~~~~~~~l~~li~~~L~~dP~~Rps-----~~ell~~  321 (369)
                          ...++..+.+++..||+.||++||+     +.+++..
T Consensus       225 ----~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~  261 (285)
T cd05632         225 ----SAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH  261 (285)
T ss_pred             ----CccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence                1122566899999999999999999     7788764

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=1.7e-36  Score=273.74  Aligned_cols=249  Identities=25%  Similarity=0.441  Sum_probs=198.6

Q ss_pred             hcCCccCccccccCCccEEEEEEc-CCCEEEEEEecCCC-chhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEEEE
Q 017594           48 TNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIYE  125 (369)
Q Consensus        48 ~~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  125 (369)
                      ...|++.+.||.|++|.||+|.+. ++..|++|.+.... ....+.+..|+..++.+.|+|++++++.+......++|+|
T Consensus         3 ~~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (277)
T cd06642           3 EELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIME   82 (277)
T ss_pred             HHHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEE
Confidence            356788899999999999999965 47889999886443 3345678899999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCCCC
Q 017594          126 YMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE  205 (369)
Q Consensus       126 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~~~  205 (369)
                      |+.+++|.+++..    ..+++..+..++.|++.|+.|||+.+   ++|+||+|+||+++.++.++|+|||++.......
T Consensus        83 ~~~~~~L~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~  155 (277)
T cd06642          83 YLGGGSALDLLKP----GPLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ  155 (277)
T ss_pred             ccCCCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccCcc
Confidence            9999999888742    34788899999999999999999998   9999999999999999999999999987654321


Q ss_pred             cccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCccccccCcccc
Q 017594          206 LQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILE  285 (369)
Q Consensus       206 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (369)
                      .  ......++..|+|||.+.+..++.++|+||||+++|+|++|..||........     ....  ...    ..+.+.
T Consensus       156 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~-----~~~~--~~~----~~~~~~  222 (277)
T cd06642         156 I--KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRV-----LFLI--PKN----SPPTLE  222 (277)
T ss_pred             h--hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhH-----Hhhh--hcC----CCCCCC
Confidence            1  11223567889999999988899999999999999999999999753221110     0000  000    001111


Q ss_pred             ccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 017594          286 DEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSM  321 (369)
Q Consensus       286 ~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~  321 (369)
                           ...+..+.++|.+||+.+|++||++.++++.
T Consensus       223 -----~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06642         223 -----GQYSKPFKEFVEACLNKDPRFRPTAKELLKH  253 (277)
T ss_pred             -----cccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence                 1125668999999999999999999999973

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=1.1e-36  Score=278.60  Aligned_cols=259  Identities=29%  Similarity=0.457  Sum_probs=199.9

Q ss_pred             hcCCccCccccccCCccEEEEEEcC-CC----EEEEEEecCCCc-hhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccE
Q 017594           48 TNKFSDANKLGEGGFGPVYKGVLKK-GD----EIAVKRLSGRSG-QGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKI  121 (369)
Q Consensus        48 ~~~y~i~~~lg~G~~~~v~~~~~~~-~~----~valK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  121 (369)
                      ..+|++.+.||+|++|.||+|.+.. |.    .+++|.+..... .....+..|+.+++.+.||||+++++++.. ...+
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~-~~~~   84 (303)
T cd05110           6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLS-PTIQ   84 (303)
T ss_pred             hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcC-CCce
Confidence            4678999999999999999999643 44    478888765432 223467789999999999999999998864 4577


Q ss_pred             EEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceec
Q 017594          122 LIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARIC  201 (369)
Q Consensus       122 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~  201 (369)
                      ++++|+.+++|.+++...  ...+++..++.++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++...
T Consensus        85 ~v~e~~~~g~l~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~~~  159 (303)
T cd05110          85 LVTQLMPHGCLLDYVHEH--KDNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLL  159 (303)
T ss_pred             eeehhcCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEccccccccc
Confidence            999999999998888543  234788889999999999999999998   999999999999999999999999999866


Q ss_pred             CCCCcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHh-CCCCCCCCcccccccchhhhhhhhcCcccccc
Q 017594          202 GGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDLWTSNRTLELI  280 (369)
Q Consensus       202 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (369)
                      .............++..|+|||.+.+..++.++||||||+++|+|++ |..||.......      ............  
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~------~~~~~~~~~~~~--  231 (303)
T cd05110         160 EGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTRE------IPDLLEKGERLP--  231 (303)
T ss_pred             cCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH------HHHHHHCCCCCC--
Confidence            53332222222345678999999988889999999999999999997 888885332110      011111110000  


Q ss_pred             CccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHhhhhc
Q 017594          281 DPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNEAAT  328 (369)
Q Consensus       281 ~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L~~~~~~  328 (369)
                         .     +..++.++.+++.+||..+|++||++.++++.|+.+...
T Consensus       232 ---~-----~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~  271 (303)
T cd05110         232 ---Q-----PPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARD  271 (303)
T ss_pred             ---C-----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence               0     011245689999999999999999999999999987653

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=1.5e-36  Score=274.87  Aligned_cols=259  Identities=23%  Similarity=0.368  Sum_probs=199.7

Q ss_pred             chhhHHHHhcCCccCccccccCCccEEEEEEc-CCCEEEEEEecCCCchhHHHHHHHHHHHhcC-CCCceeeeeeeEEe-
Q 017594           40 SFSSVSTATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSGQGLREMKNEASVIAKV-QHKNLVRLLGCCID-  116 (369)
Q Consensus        40 ~~~~~~~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~-  116 (369)
                      +........+.|++.+.||.|+||.||+|++. +++.+++|++.... .....+..|+.+++.+ .|+|++++++++.. 
T Consensus         7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~   85 (282)
T cd06636           7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKK   85 (282)
T ss_pred             hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcc
Confidence            44555566789999999999999999999965 48899999986543 2345677889999988 69999999999853 


Q ss_pred             -----CCccEEEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceE
Q 017594          117 -----RDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPK  191 (369)
Q Consensus       117 -----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~  191 (369)
                           ....+++|||+.+++|..++.... ...+++..++.++.||+.|+.|||+.+   ++|+||+|+||+++.++.++
T Consensus        86 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~~~  161 (282)
T cd06636          86 SPPGHDDQLWLVMEFCGAGSVTDLVKNTK-GNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEVK  161 (282)
T ss_pred             cccCCCCEEEEEEEeCCCCcHHHHHHHcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEE
Confidence                 356799999999999988885432 334778888999999999999999999   99999999999999999999


Q ss_pred             EeecCCceecCCCCcccccccccccccccCchhhc-----cCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchh
Q 017594          192 ISDFGMARICGGNELQANTSRIVGTYGYMSPEYAL-----EGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGY  266 (369)
Q Consensus       192 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~  266 (369)
                      |+|||++.......  .......++..|+|||.+.     +..++.++|+||||+++|+|++|..||.......      
T Consensus       162 l~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~------  233 (282)
T cd06636         162 LVDFGVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMR------  233 (282)
T ss_pred             EeeCcchhhhhccc--cCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHh------
Confidence            99999877543211  1122345788899999875     3457889999999999999999999985332110      


Q ss_pred             hhhhhhcCccccccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 017594          267 AWDLWTSNRTLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVS  320 (369)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~  320 (369)
                        ....   ...    ..........++.++.++|.+||+.||.+||++.+|++
T Consensus       234 --~~~~---~~~----~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~  278 (282)
T cd06636         234 --ALFL---IPR----NPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK  278 (282)
T ss_pred             --hhhh---Hhh----CCCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence              0000   000    00001111123567999999999999999999999975

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=6.8e-36  Score=267.58  Aligned_cols=252  Identities=28%  Similarity=0.465  Sum_probs=200.6

Q ss_pred             CCccCccccccCCccEEEEEEc-CCCEEEEEEecCCCc--hhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEEEEe
Q 017594           50 KFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSG--QGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIYEY  126 (369)
Q Consensus        50 ~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  126 (369)
                      ||.+.+.||.|++|.||+|... +++.|++|.+.....  .....+..|+.+++.++|+||+++++.+...+..++++||
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY   80 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence            6999999999999999999965 588999999875544  3567888999999999999999999999888999999999


Q ss_pred             cCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCCCCc
Q 017594          127 MPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNEL  206 (369)
Q Consensus       127 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~~~~  206 (369)
                      +.+++|.+++...   ..+++..+..++.+++.|+.+||+.+   ++|+||+|+||+++.++.++|+|||.+........
T Consensus        81 ~~~~~L~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~  154 (264)
T cd06626          81 CSGGTLEELLEHG---RILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTT  154 (264)
T ss_pred             CCCCcHHHHHhhc---CCCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCCCCC
Confidence            9999999988542   34788899999999999999999999   99999999999999999999999999877654322


Q ss_pred             ccc--cccccccccccCchhhccCC---CCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCccccccC
Q 017594          207 QAN--TSRIVGTYGYMSPEYALEGI---FSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELID  281 (369)
Q Consensus       207 ~~~--~~~~~~~~~y~aPE~~~~~~---~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (369)
                      ...  .....++..|+|||.+.+..   ++.++|+||+|++++++++|..||.......    ........  ..    .
T Consensus       155 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~----~~~~~~~~--~~----~  224 (264)
T cd06626         155 TMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEF----QIMFHVGA--GH----K  224 (264)
T ss_pred             cccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchH----HHHHHHhc--CC----C
Confidence            111  11245678999999988766   8899999999999999999999986432111    00000000  00    0


Q ss_pred             ccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 017594          282 PILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVS  320 (369)
Q Consensus       282 ~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~  320 (369)
                      +.+..   ....+..+.++|.+||+.+|.+||++.+++.
T Consensus       225 ~~~~~---~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~  260 (264)
T cd06626         225 PPIPD---SLQLSPEGKDFLDRCLESDPKKRPTASELLQ  260 (264)
T ss_pred             CCCCc---ccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            00110   1112556889999999999999999999875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=9.5e-37  Score=277.63  Aligned_cols=251  Identities=23%  Similarity=0.346  Sum_probs=199.6

Q ss_pred             hcCCccCccccccCCccEEEEEEc-CCCEEEEEEecCCCchhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEEEEe
Q 017594           48 TNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIYEY  126 (369)
Q Consensus        48 ~~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  126 (369)
                      .+.|.....||.|++|.||++... ++..|++|.+........+.+..|+..++.++|+|++++++.+...+..++++||
T Consensus        21 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~  100 (292)
T cd06658          21 REYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEF  100 (292)
T ss_pred             HHHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeC
Confidence            345666778999999999999965 4889999998765555566788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCCCCc
Q 017594          127 MPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNEL  206 (369)
Q Consensus       127 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~~~~  206 (369)
                      +.+++|.+++..    ..+++..++.++.||+.||.|||+.+   ++|+||+|.||+++.++.++|+|||++....... 
T Consensus       101 ~~~~~L~~~~~~----~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~-  172 (292)
T cd06658         101 LEGGALTDIVTH----TRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV-  172 (292)
T ss_pred             CCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhccccc-
Confidence            999999888732    23788899999999999999999998   9999999999999999999999999886543222 


Q ss_pred             ccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCccccccCccccc
Q 017594          207 QANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILED  286 (369)
Q Consensus       207 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  286 (369)
                       .......++..|+|||.+.+..++.++|+||+|+++|+|++|..||.......     .....      ...+...+..
T Consensus       173 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~-----~~~~~------~~~~~~~~~~  240 (292)
T cd06658         173 -PKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQ-----AMRRI------RDNLPPRVKD  240 (292)
T ss_pred             -ccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-----HHHHH------HhcCCCcccc
Confidence             11223457889999999988889999999999999999999999986432110     00000      0001111111


Q ss_pred             cccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 017594          287 EYSSKQMLLRYANIALLCVQESADDRPTMNDVVSM  321 (369)
Q Consensus       287 ~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~  321 (369)
                         ....+..+.+++.+||..+|++|||+.++++.
T Consensus       241 ---~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~  272 (292)
T cd06658         241 ---SHKVSSVLRGFLDLMLVREPSQRATAQELLQH  272 (292)
T ss_pred             ---ccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence               11125668999999999999999999999973

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=1.4e-36  Score=277.24  Aligned_cols=249  Identities=24%  Similarity=0.341  Sum_probs=197.8

Q ss_pred             CCccCccccccCCccEEEEEEc-CCCEEEEEEecCCCchhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEEEEecC
Q 017594           50 KFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIYEYMP  128 (369)
Q Consensus        50 ~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~  128 (369)
                      .|.....||.|+||.||+|..+ +++.|++|.+........+.+.+|+..+..+.|||++++++++..++..++++||++
T Consensus        22 ~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~  101 (297)
T cd06659          22 LLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQ  101 (297)
T ss_pred             hHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCC
Confidence            3455668999999999999965 588999999875544445678889999999999999999999999999999999999


Q ss_pred             CCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCCCCccc
Q 017594          129 NKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQA  208 (369)
Q Consensus       129 ~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~~~~~~  208 (369)
                      +++|..++..    ..+++..++.++.|++.||.+||+++   ++|+||+|.||+++.++.++|+|||++........  
T Consensus       102 ~~~L~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~--  172 (297)
T cd06659         102 GGALTDIVSQ----TRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP--  172 (297)
T ss_pred             CCCHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhcccccc--
Confidence            9999887632    34788999999999999999999998   99999999999999999999999998865432221  


Q ss_pred             ccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCccccccCccccccc
Q 017594          209 NTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEY  288 (369)
Q Consensus       209 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  288 (369)
                      ......++..|+|||.+.+..++.++|+||+||++|+|++|..||........     .... ... ....    ..   
T Consensus       173 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~-----~~~~-~~~-~~~~----~~---  238 (297)
T cd06659         173 KRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQA-----MKRL-RDS-PPPK----LK---  238 (297)
T ss_pred             cccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-----HHHH-hcc-CCCC----cc---
Confidence            12234578899999999888899999999999999999999999864321110     0000 000 0000    00   


Q ss_pred             cHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 017594          289 SSKQMLLRYANIALLCVQESADDRPTMNDVVSM  321 (369)
Q Consensus       289 ~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~  321 (369)
                      .....+..+.++|.+||+.+|.+||++.++++.
T Consensus       239 ~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~  271 (297)
T cd06659         239 NAHKISPVLRDFLERMLTREPQERATAQELLDH  271 (297)
T ss_pred             ccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence            011125568999999999999999999999984

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=2.4e-36  Score=275.10  Aligned_cols=254  Identities=24%  Similarity=0.385  Sum_probs=203.1

Q ss_pred             HHHhcCCccCccccccCCccEEEEEEc-CCCEEEEEEecCCCchhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEE
Q 017594           45 STATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILI  123 (369)
Q Consensus        45 ~~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv  123 (369)
                      .....+|.+.+.||.|++|.||++... +++.|++|.+........+.+..|+.+++.++|||++++++.+...+..++|
T Consensus        15 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv   94 (293)
T cd06647          15 GDPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVV   94 (293)
T ss_pred             cCchhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEE
Confidence            344589999999999999999999964 5788999998755545556788899999999999999999999999999999


Q ss_pred             EEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCC
Q 017594          124 YEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGG  203 (369)
Q Consensus       124 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~  203 (369)
                      +||+.+++|.+++..    ..+++..+..++.|++.|+.+||+++   ++|+||+|+||+++.++.++|+|||++.....
T Consensus        95 ~e~~~~~~L~~~~~~----~~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~  167 (293)
T cd06647          95 MEYLAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITP  167 (293)
T ss_pred             EecCCCCcHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceecccc
Confidence            999999999988843    23678889999999999999999999   99999999999999999999999998765543


Q ss_pred             CCcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCccccccCcc
Q 017594          204 NELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPI  283 (369)
Q Consensus       204 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (369)
                      ...  ......++..|+|||.+.+..++.++|+||+|+++|++++|..||..........     .......      +.
T Consensus       168 ~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~-----~~~~~~~------~~  234 (293)
T cd06647         168 EQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY-----LIATNGT------PE  234 (293)
T ss_pred             ccc--ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhee-----ehhcCCC------CC
Confidence            221  1223357788999999988889999999999999999999999986432211000     0000000      00


Q ss_pred             ccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 017594          284 LEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSM  321 (369)
Q Consensus       284 ~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~  321 (369)
                      .   ..+...+..+.++|.+||+.+|++||++.+++..
T Consensus       235 ~---~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h  269 (293)
T cd06647         235 L---QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH  269 (293)
T ss_pred             C---CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            0   0111235668999999999999999999999964

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=4.8e-36  Score=269.47  Aligned_cols=253  Identities=25%  Similarity=0.396  Sum_probs=195.6

Q ss_pred             cCCccCccccccCCccEEEEEEc-CCCEEEEEEecCCCchhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEEEEec
Q 017594           49 NKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIYEYM  127 (369)
Q Consensus        49 ~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~  127 (369)
                      ........||+|+||.||+|++. ++..|++|.+........+.+.+|+.+++.++|+||+++++++..++..++++||+
T Consensus         8 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   87 (268)
T cd06624           8 DENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQV   87 (268)
T ss_pred             ccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecC
Confidence            34445568999999999999965 47789999988766666778899999999999999999999999999999999999


Q ss_pred             CCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeC-CCceEEeecCCceecCCCCc
Q 017594          128 PNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDK-DMNPKISDFGMARICGGNEL  206 (369)
Q Consensus       128 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~-~~~~~L~Dfg~~~~~~~~~~  206 (369)
                      .+++|..++.........+...+..++.||+.|++|||+.+   ++|+||+|.||+++. ++.++|+|||.+........
T Consensus        88 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~  164 (268)
T cd06624          88 PGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINP  164 (268)
T ss_pred             CCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchhheecccCCC
Confidence            99999998864322211267788889999999999999998   999999999999976 67899999999876543221


Q ss_pred             ccccccccccccccCchhhccCC--CCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCccccccCccc
Q 017594          207 QANTSRIVGTYGYMSPEYALEGI--FSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPIL  284 (369)
Q Consensus       207 ~~~~~~~~~~~~y~aPE~~~~~~--~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (369)
                        ......++..|+|||.+.+..  ++.++|+||+|+++|+|++|..||.........    .+......     ..+.+
T Consensus       165 --~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~----~~~~~~~~-----~~~~~  233 (268)
T cd06624         165 --CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAA----MFKVGMFK-----IHPEI  233 (268)
T ss_pred             --ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhh----Hhhhhhhc-----cCCCC
Confidence              122235788999999986543  788999999999999999999998543211100    00000000     00001


Q ss_pred             cccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 017594          285 EDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVS  320 (369)
Q Consensus       285 ~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~  320 (369)
                           +...+.++.+++.+||+.+|.+|||+.++++
T Consensus       234 -----~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~  264 (268)
T cd06624         234 -----PESLSAEAKNFILRCFEPDPDKRASAHDLLQ  264 (268)
T ss_pred             -----CcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence                 1123567899999999999999999999986

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-36  Score=276.04  Aligned_cols=265  Identities=23%  Similarity=0.318  Sum_probs=199.5

Q ss_pred             cCCccCccccccCCccEEEEEEc-CCCEEEEEEecCCC--chhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEEEE
Q 017594           49 NKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS--GQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIYE  125 (369)
Q Consensus        49 ~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  125 (369)
                      ++|++.+.||.|++|.||+|.++ +++.|++|.+....  ......+..|+++++.++|+|++++++++...+..++++|
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   80 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE   80 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence            47999999999999999999976 48899999886432  2334678899999999999999999999999899999999


Q ss_pred             ecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCCCC
Q 017594          126 YMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE  205 (369)
Q Consensus       126 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~~~  205 (369)
                      |+.++.+..+...   ...+++..++.++.||+.|+.|||..+   ++|+||+|+||+++.++.++|+|||.+.......
T Consensus        81 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~  154 (288)
T cd07833          81 YVERTLLELLEAS---PGGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRARP  154 (288)
T ss_pred             cCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccCCCc
Confidence            9998777666533   234789999999999999999999998   9999999999999999999999999987665433


Q ss_pred             cccccccccccccccCchhhccC-CCCcccchHhHHHHHHHHHhCCCCCCCCcccccc-cchhh--------hhhhhcCc
Q 017594          206 LQANTSRIVGTYGYMSPEYALEG-IFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLN-LLGYA--------WDLWTSNR  275 (369)
Q Consensus       206 ~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~-~~~~~--------~~~~~~~~  275 (369)
                      .. ......++..|+|||++.+. .++.++|+||||+++|+|++|..||......... .....        ...+....
T Consensus       155 ~~-~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (288)
T cd07833         155 AS-PLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNP  233 (288)
T ss_pred             cc-cccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCc
Confidence            21 12234567889999999877 7899999999999999999999998644311100 00000        00000000


Q ss_pred             ------cccccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 017594          276 ------TLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVS  320 (369)
Q Consensus       276 ------~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~  320 (369)
                            ..............+..++.++.++|.+||..+|++||+++++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  284 (288)
T cd07833         234 RFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ  284 (288)
T ss_pred             cccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence                  000000000000011123677999999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=3.8e-36  Score=276.74  Aligned_cols=197  Identities=26%  Similarity=0.412  Sum_probs=157.2

Q ss_pred             ccccccCCccEEEEEEcC---CCEEEEEEecCCCchhHHHHHHHHHHHhcCCCCceeeeeeeEEe--CCccEEEEEecCC
Q 017594           55 NKLGEGGFGPVYKGVLKK---GDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCID--RDEKILIYEYMPN  129 (369)
Q Consensus        55 ~~lg~G~~~~v~~~~~~~---~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~  129 (369)
                      .+||+|+||.||+|+.++   +..||+|.+.....  ...+.+|+.+++.++|||++++++++..  ....++++||+.+
T Consensus         7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~   84 (317)
T cd07867           7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI--SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH   84 (317)
T ss_pred             eEeccCCCeeEEEEEecCCCccceEEEEEecCCCC--cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC
Confidence            579999999999999653   57899998865432  2467789999999999999999998854  4567899999876


Q ss_pred             CChhhhhcC------CCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEE----eCCCceEEeecCCce
Q 017594          130 KSLDFFLFD------PTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILL----DKDMNPKISDFGMAR  199 (369)
Q Consensus       130 ~~L~~~l~~------~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv----~~~~~~~L~Dfg~~~  199 (369)
                       ++.+++..      ......+++..++.++.||+.||.|||+.+   ++|+||||+||++    +.++.++|+|||++.
T Consensus        85 -~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~  160 (317)
T cd07867          85 -DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFAR  160 (317)
T ss_pred             -cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence             55444421      112235788899999999999999999999   9999999999999    456789999999998


Q ss_pred             ecCCCCcc-cccccccccccccCchhhcc-CCCCcccchHhHHHHHHHHHhCCCCCCCCc
Q 017594          200 ICGGNELQ-ANTSRIVGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYR  257 (369)
Q Consensus       200 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~tg~~p~~~~~  257 (369)
                      ........ .......++..|+|||++.+ ..++.++|||||||++|+|++|.+||....
T Consensus       161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~  220 (317)
T cd07867         161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ  220 (317)
T ss_pred             ccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccccc
Confidence            76543221 11223457889999999876 457999999999999999999999997543

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=1e-36  Score=272.16  Aligned_cols=248  Identities=23%  Similarity=0.281  Sum_probs=199.9

Q ss_pred             CCccCccccccCCccEEEEEEc-CCCEEEEEEecCCC---chhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEEEE
Q 017594           50 KFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS---GQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIYE  125 (369)
Q Consensus        50 ~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  125 (369)
                      +|++.+.||.|++|.||+|+++ ++..|++|.+....   ....+.+.+|++.+++++|||++++++.+......++|+|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD   80 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence            5889999999999999999976 48899999986432   2345678889999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCCCC
Q 017594          126 YMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE  205 (369)
Q Consensus       126 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~~~  205 (369)
                      |+.+++|..++...   ..+++..+..++.||+.||.|||.++   ++|+||+|.||+++.++.++|+|||.+.......
T Consensus        81 ~~~~~~L~~~l~~~---~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~  154 (258)
T cd05578          81 LLLGGDLRYHLSQK---VKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT  154 (258)
T ss_pred             CCCCCCHHHHHHhc---CCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccCCCc
Confidence            99999999888543   45889999999999999999999998   9999999999999999999999999987654332


Q ss_pred             cccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCccccccCcccc
Q 017594          206 LQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILE  285 (369)
Q Consensus       206 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (369)
                         ......++..|+|||.+.+..++.++|+||||+++|+|++|..||.........   ........  ..        
T Consensus       155 ---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~---~~~~~~~~--~~--------  218 (258)
T cd05578         155 ---LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRD---QIRAKQET--AD--------  218 (258)
T ss_pred             ---cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHH---HHHHHhcc--cc--------
Confidence               122345778899999998888999999999999999999999998754321100   00000000  00        


Q ss_pred             ccccHHHHHHHHHHHHHHhhcCCCCCCCCH--HHHHH
Q 017594          286 DEYSSKQMLLRYANIALLCVQESADDRPTM--NDVVS  320 (369)
Q Consensus       286 ~~~~~~~~~~~l~~li~~~L~~dP~~Rps~--~ell~  320 (369)
                       ...+...+..+.++|.+||+.||.+||++  +++++
T Consensus       219 -~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~  254 (258)
T cd05578         219 -VLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKN  254 (258)
T ss_pred             -ccCcccCcHHHHHHHHHHccCChhHcCCccHHHHhc
Confidence             01111235779999999999999999999  66653

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=1.4e-36  Score=294.02  Aligned_cols=264  Identities=20%  Similarity=0.245  Sum_probs=187.6

Q ss_pred             HHHHhcCCccCccccccCCccEEEEEEc-CCCEEEEEEecCCCchhHHHHHHHHHHHhcCCC------CceeeeeeeEEe
Q 017594           44 VSTATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSGQGLREMKNEASVIAKVQH------KNLVRLLGCCID  116 (369)
Q Consensus        44 ~~~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h------~~i~~~~~~~~~  116 (369)
                      +....++|++.+.||+|+||.||+|.+. .++.||||++.... ........|+.++..++|      .+++++++++..
T Consensus       124 ~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~  202 (467)
T PTZ00284        124 IDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQN  202 (467)
T ss_pred             cccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEc
Confidence            3445689999999999999999999965 47889999986432 222345567777766654      458888888875


Q ss_pred             C-CccEEEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhc-CCCCCcccCCCCCCCEEEeCCC------
Q 017594          117 R-DEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQ-YSRVRIIHRDLKASNILLDKDM------  188 (369)
Q Consensus       117 ~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~-~~~~~i~H~dl~p~NIlv~~~~------  188 (369)
                      + .+.++|++++ +++|.+++...   ..+++..+..++.||+.||.|||+ .|   |+||||||+||+++.++      
T Consensus       203 ~~~~~~iv~~~~-g~~l~~~l~~~---~~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~~~~~~~~~  275 (467)
T PTZ00284        203 ETGHMCIVMPKY-GPCLLDWIMKH---GPFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMETSDTVVDPV  275 (467)
T ss_pred             CCceEEEEEecc-CCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEecCCcccccc
Confidence            5 4688999987 56676666432   348899999999999999999997 48   99999999999998765      


Q ss_pred             ----------ceEEeecCCceecCCCCcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcc
Q 017594          189 ----------NPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRT  258 (369)
Q Consensus       189 ----------~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~  258 (369)
                                .++|+|||.+....     .......|+..|+|||++.+..++.++|||||||++|+|++|+.||.....
T Consensus       276 ~~~~~~~~~~~vkl~DfG~~~~~~-----~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~  350 (467)
T PTZ00284        276 TNRALPPDPCRVRICDLGGCCDER-----HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDN  350 (467)
T ss_pred             cccccCCCCceEEECCCCccccCc-----cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh
Confidence                      49999999875322     122345789999999999999999999999999999999999999975432


Q ss_pred             ccccc-c----hhhhhhhhc----Cc---ccc---ccCccccc---------c-ccHHHHHHHHHHHHHHhhcCCCCCCC
Q 017594          259 DSLNL-L----GYAWDLWTS----NR---TLE---LIDPILED---------E-YSSKQMLLRYANIALLCVQESADDRP  313 (369)
Q Consensus       259 ~~~~~-~----~~~~~~~~~----~~---~~~---~~~~~~~~---------~-~~~~~~~~~l~~li~~~L~~dP~~Rp  313 (369)
                      ..... .    ......+..    ..   ...   .+.+....         . .........+.+||.+||+.||++||
T Consensus       351 ~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~  430 (467)
T PTZ00284        351 LEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRL  430 (467)
T ss_pred             HHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCC
Confidence            11000 0    000000000    00   000   00000000         0 00001135678999999999999999


Q ss_pred             CHHHHHH
Q 017594          314 TMNDVVS  320 (369)
Q Consensus       314 s~~ell~  320 (369)
                      |+.|+++
T Consensus       431 ta~e~L~  437 (467)
T PTZ00284        431 NARQMTT  437 (467)
T ss_pred             CHHHHhc
Confidence            9999997

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=3.8e-36  Score=275.41  Aligned_cols=256  Identities=18%  Similarity=0.254  Sum_probs=197.2

Q ss_pred             cCCccCccccccCCccEEEEEEcC-CCEEEEEEecCCC---chhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEEE
Q 017594           49 NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRS---GQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIY  124 (369)
Q Consensus        49 ~~y~i~~~lg~G~~~~v~~~~~~~-~~~valK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  124 (369)
                      +.|++.+.||.|++|.||++.... ++.|++|.+....   ......+..|+.+++.++||||+++++.+...+..++++
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM   80 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence            368999999999999999999764 7889999886543   123456778999999999999999999999888999999


Q ss_pred             EecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCCC
Q 017594          125 EYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGN  204 (369)
Q Consensus       125 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~~  204 (369)
                      ||+.+++|..++...   ..+++..+..++.|++.|+.|||+.+   ++|+||+|.||+++.++.++|+|||++......
T Consensus        81 e~~~g~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~  154 (305)
T cd05609          81 EYVEGGDCATLLKNI---GALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMS  154 (305)
T ss_pred             ecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCccccCcC
Confidence            999999999998543   34788899999999999999999998   999999999999999999999999987632111


Q ss_pred             Ccc-------------cccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhh
Q 017594          205 ELQ-------------ANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLW  271 (369)
Q Consensus       205 ~~~-------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~  271 (369)
                      ...             .......++..|+|||.+.+..++.++|+||||+++|+|++|..||.......     ......
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~-----~~~~~~  229 (305)
T cd05609         155 LTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE-----LFGQVI  229 (305)
T ss_pred             ccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-----HHHHHH
Confidence            000             01112346778999999988889999999999999999999999985322110     011100


Q ss_pred             hcCccccccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHh
Q 017594          272 TSNRTLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTN  324 (369)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L~~  324 (369)
                      ... .   ..+..     ...++.++.++|.+||+.+|++||+..++.+.|+.
T Consensus       230 ~~~-~---~~~~~-----~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~  273 (305)
T cd05609         230 SDD-I---EWPEG-----DEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH  273 (305)
T ss_pred             hcc-c---CCCCc-----cccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence            000 0   00000     01226678999999999999999997666665544

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=5.6e-36  Score=265.62  Aligned_cols=249  Identities=29%  Similarity=0.474  Sum_probs=202.4

Q ss_pred             CCccCccccccCCccEEEEEEc-CCCEEEEEEecCCCchhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEEEEecC
Q 017594           50 KFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIYEYMP  128 (369)
Q Consensus        50 ~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~  128 (369)
                      +|++.+.||.|++|.||++.++ ++..+++|++..........+..|+..++.++|++++++.+.+......++++||++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~   80 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS   80 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence            4889999999999999999976 588999999976654456788899999999999999999999999999999999999


Q ss_pred             CCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCCCCccc
Q 017594          129 NKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQA  208 (369)
Q Consensus       129 ~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~~~~~~  208 (369)
                      +++|.+++....  ..+++..++.++.|++.|+.+||..+   ++||||+|+||+++.++.++|+|||.+........  
T Consensus        81 ~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--  153 (253)
T cd05122          81 GGSLKDLLKSTN--QTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA--  153 (253)
T ss_pred             CCcHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeecccccccccccc--
Confidence            999998885432  35889999999999999999999988   99999999999999999999999999876553321  


Q ss_pred             ccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCccccccCccccccc
Q 017594          209 NTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEY  288 (369)
Q Consensus       209 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  288 (369)
                       .....++..|+|||.+.+..++.++|+||||+++|+|++|..||........     .... ........        .
T Consensus       154 -~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-----~~~~-~~~~~~~~--------~  218 (253)
T cd05122         154 -RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKA-----LFKI-ATNGPPGL--------R  218 (253)
T ss_pred             -ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHH-----HHHH-HhcCCCCc--------C
Confidence             2334678889999999888899999999999999999999999864421110     0000 00000000        0


Q ss_pred             cHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 017594          289 SSKQMLLRYANIALLCVQESADDRPTMNDVVS  320 (369)
Q Consensus       289 ~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~  320 (369)
                      ....++..+.++|.+||+.||++|||+.++++
T Consensus       219 ~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~  250 (253)
T cd05122         219 NPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLK  250 (253)
T ss_pred             cccccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            11112566999999999999999999999986

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.6e-36  Score=270.83  Aligned_cols=247  Identities=23%  Similarity=0.393  Sum_probs=196.8

Q ss_pred             CCccCccccccCCccEEEEEEc-CCCEEEEEEecCC-CchhHHHHHHHHHHHhcCC---CCceeeeeeeEEeCCccEEEE
Q 017594           50 KFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGR-SGQGLREMKNEASVIAKVQ---HKNLVRLLGCCIDRDEKILIY  124 (369)
Q Consensus        50 ~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~-~~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~~~~~lv~  124 (369)
                      .|++.+.||.|++|.||+|.+. ++..+++|.+... .......+..|+.+++.+.   |||++++++++..+...++++
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~   81 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM   81 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence            5888999999999999999964 5889999988644 2344566788999999986   999999999999989999999


Q ss_pred             EecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCCC
Q 017594          125 EYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGN  204 (369)
Q Consensus       125 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~~  204 (369)
                      ||+.+++|.+++..    ..+++..++.++.|++.+|.+||+.+   ++|+||+|+||+++.++.++|+|||.+......
T Consensus        82 e~~~~~~L~~~~~~----~~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~  154 (277)
T cd06917          82 EYAEGGSVRTLMKA----GPIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQN  154 (277)
T ss_pred             ecCCCCcHHHHHHc----cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeecCCC
Confidence            99999999988743    25889999999999999999999999   999999999999999999999999998876543


Q ss_pred             CcccccccccccccccCchhhcc-CCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCccccccCcc
Q 017594          205 ELQANTSRIVGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPI  283 (369)
Q Consensus       205 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (369)
                      ..  ......++..|+|||.+.+ ..++.++|+||||+++|+|++|..||.........     .      .......+.
T Consensus       155 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~-----~------~~~~~~~~~  221 (277)
T cd06917         155 SS--KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAM-----M------LIPKSKPPR  221 (277)
T ss_pred             cc--ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhh-----h------ccccCCCCC
Confidence            31  1222357888999998865 45789999999999999999999998643211100     0      000000011


Q ss_pred             ccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 017594          284 LEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVS  320 (369)
Q Consensus       284 ~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~  320 (369)
                      +.    ...++.++.+++.+||+.||.+||++.++++
T Consensus       222 ~~----~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~  254 (277)
T cd06917         222 LE----DNGYSKLLREFVAACLDEEPKERLSAEELLK  254 (277)
T ss_pred             CC----cccCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence            11    1113567999999999999999999999986

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=6.1e-36  Score=266.66  Aligned_cols=248  Identities=25%  Similarity=0.384  Sum_probs=198.8

Q ss_pred             CCccCccccccCCccEEEEEEc-CCCEEEEEEecCC--CchhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEEEEe
Q 017594           50 KFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIYEY  126 (369)
Q Consensus        50 ~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  126 (369)
                      +|++.+.||.|++|.||+|... +++.+++|.+...  .......+..|+.+++.++|||++++++.+..+...++|+||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY   80 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence            6899999999999999999965 4888999998654  233456788899999999999999999999988999999999


Q ss_pred             cCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCC-ceEEeecCCceecCCCC
Q 017594          127 MPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDM-NPKISDFGMARICGGNE  205 (369)
Q Consensus       127 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~-~~~L~Dfg~~~~~~~~~  205 (369)
                      +.+++|.+++.... ...+++..+..++.+++.++.+||+++   ++|+||+|+||+++.++ .++|+|||.+.......
T Consensus        81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~  156 (256)
T cd08220          81 APGGTLAEYIQKRC-NSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS  156 (256)
T ss_pred             CCCCCHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc
Confidence            99999999885432 344788899999999999999999998   99999999999998654 57999999988664332


Q ss_pred             cccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCccccccCcccc
Q 017594          206 LQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILE  285 (369)
Q Consensus       206 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (369)
                      .   .....++..|+|||.+.+..++.++|+||+|+++|+|++|+.||.......     ....... ......      
T Consensus       157 ~---~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~-----~~~~~~~-~~~~~~------  221 (256)
T cd08220         157 K---AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPA-----LVLKIMS-GTFAPI------  221 (256)
T ss_pred             c---ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHH-----HHHHHHh-cCCCCC------
Confidence            1   222457889999999988889999999999999999999999986432111     0001000 000000      


Q ss_pred             ccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 017594          286 DEYSSKQMLLRYANIALLCVQESADDRPTMNDVVS  320 (369)
Q Consensus       286 ~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~  320 (369)
                          +..++..+.+++.+||+.+|.+|||+.++++
T Consensus       222 ----~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~  252 (256)
T cd08220         222 ----SDRYSPDLRQLILSMLNLDPSKRPQLSQIMA  252 (256)
T ss_pred             ----CCCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence                1112567999999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=6.2e-37  Score=273.81  Aligned_cols=240  Identities=25%  Similarity=0.419  Sum_probs=186.2

Q ss_pred             ccccccCCccEEEEEEcC-C-------CEEEEEEecCCCchhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEEEEe
Q 017594           55 NKLGEGGFGPVYKGVLKK-G-------DEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIYEY  126 (369)
Q Consensus        55 ~~lg~G~~~~v~~~~~~~-~-------~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  126 (369)
                      +.||.|+||.||+|..+. +       ..+++|.+........+.+..|+.+++.+.|||++++++++..+...++||||
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~   80 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY   80 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence            469999999999998643 2       24788887655445556788899999999999999999999998999999999


Q ss_pred             cCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCc--------eEEeecCCc
Q 017594          127 MPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMN--------PKISDFGMA  198 (369)
Q Consensus       127 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~--------~~L~Dfg~~  198 (369)
                      +.+++|..++....  ..+++..+..++.||+.||+|||+.+   ++|+||||.||+++.++.        ++++|||.+
T Consensus        81 ~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~  155 (258)
T cd05078          81 VKFGSLDTYLKKNK--NLINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS  155 (258)
T ss_pred             CCCCcHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEecccccc
Confidence            99999999986432  24788889999999999999999998   999999999999987765        689999987


Q ss_pred             eecCCCCcccccccccccccccCchhhcc-CCCCcccchHhHHHHHHHHHhCC-CCCCCCcccccccchhhhhhhhcCcc
Q 017594          199 RICGGNELQANTSRIVGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGK-KNTGLYRTDSLNLLGYAWDLWTSNRT  276 (369)
Q Consensus       199 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~tg~-~p~~~~~~~~~~~~~~~~~~~~~~~~  276 (369)
                      .....      .....++..|+|||.+.+ ..++.++|+||||+++|+|++|. .||........      .......  
T Consensus       156 ~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~------~~~~~~~--  221 (258)
T cd05078         156 ITVLP------KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKK------LQFYEDR--  221 (258)
T ss_pred             cccCC------chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHH------HHHHHcc--
Confidence            54332      122356778999999876 45789999999999999999985 55442221100      0000000  


Q ss_pred             ccccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 017594          277 LELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLT  323 (369)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L~  323 (369)
                      ..     +.     ...+.++.+++.+||+.+|++|||+++|++.|.
T Consensus       222 ~~-----~~-----~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~  258 (258)
T cd05078         222 HQ-----LP-----APKWTELANLINQCMDYEPDFRPSFRAIIRDLN  258 (258)
T ss_pred             cc-----CC-----CCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence            00     00     011456899999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=2.4e-36  Score=274.77  Aligned_cols=262  Identities=24%  Similarity=0.339  Sum_probs=200.1

Q ss_pred             chhhHHHHhcCCccCccccccCCccEEEEEEc-CCCEEEEEEecCCCchhHHHHHHHHHHHhcC-CCCceeeeeeeEEeC
Q 017594           40 SFSSVSTATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSGQGLREMKNEASVIAKV-QHKNLVRLLGCCIDR  117 (369)
Q Consensus        40 ~~~~~~~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~  117 (369)
                      .+..+....++|++.+.||.|++|.||+|..+ +++.+++|.+.... .....+..|+.+++.+ +|||++++++++...
T Consensus        13 ~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~   91 (291)
T cd06639          13 GLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKA   91 (291)
T ss_pred             hcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEec
Confidence            34555566789999999999999999999975 48889999986443 2235677889999998 799999999998753


Q ss_pred             -----CccEEEEEecCCCChhhhhcCC-CccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceE
Q 017594          118 -----DEKILIYEYMPNKSLDFFLFDP-TKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPK  191 (369)
Q Consensus       118 -----~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~  191 (369)
                           ...++|+||+++++|.+++... .....+++..++.++.|++.||.+||+.+   ++|+||+|+||+++.++.++
T Consensus        92 ~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~~~k  168 (291)
T cd06639          92 DKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGGVK  168 (291)
T ss_pred             cccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEE
Confidence                 3579999999999998887532 22345788999999999999999999998   99999999999999999999


Q ss_pred             EeecCCceecCCCCcccccccccccccccCchhhccC-----CCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchh
Q 017594          192 ISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEG-----IFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGY  266 (369)
Q Consensus       192 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~  266 (369)
                      |+|||.+........  ......++..|+|||.+...     .++.++|+|||||++|+|++|+.||.......     .
T Consensus       169 l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~-----~  241 (291)
T cd06639         169 LVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVK-----T  241 (291)
T ss_pred             Eeecccchhcccccc--cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHH-----H
Confidence            999999876543221  11223578889999987543     36889999999999999999999986432110     0


Q ss_pred             hhhhhhcCccccccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 017594          267 AWDLWTSNRTLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSM  321 (369)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~  321 (369)
                      ........ ...     +   ..+...+..+.++|.+||+.+|++||++.++++.
T Consensus       242 ~~~~~~~~-~~~-----~---~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~  287 (291)
T cd06639         242 LFKIPRNP-PPT-----L---LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH  287 (291)
T ss_pred             HHHHhcCC-CCC-----C---CcccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence            01110000 000     0   0111224569999999999999999999999863

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=6.5e-36  Score=266.47  Aligned_cols=247  Identities=29%  Similarity=0.445  Sum_probs=196.2

Q ss_pred             cCCccCccccccCCccEEEEEEcCCCEEEEEEecCCCchhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEEEEecC
Q 017594           49 NKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIYEYMP  128 (369)
Q Consensus        49 ~~y~i~~~lg~G~~~~v~~~~~~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~  128 (369)
                      ++|++.+.||+|+||.||++.. .++.+++|.+....  ....+.+|+..++.++|||++++++++.. +..++++||+.
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~~v~e~~~   81 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILH-NGLYIVMELMS   81 (254)
T ss_pred             HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcC-CCcEEEEECCC
Confidence            6799999999999999999875 47789999986543  23577889999999999999999999865 45799999999


Q ss_pred             CCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCCCCccc
Q 017594          129 NKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQA  208 (369)
Q Consensus       129 ~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~~~~~~  208 (369)
                      +++|..++.... ...+++..++.++.|++.|+.+||+.+   ++||||+|+||+++.++.++|+|||++......    
T Consensus        82 ~~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~----  153 (254)
T cd05083          82 KGNLVNFLRTRG-RALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGSMG----  153 (254)
T ss_pred             CCCHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceecccc----
Confidence            999999886533 234788889999999999999999998   999999999999999999999999998754321    


Q ss_pred             ccccccccccccCchhhccCCCCcccchHhHHHHHHHHHh-CCCCCCCCcccccccchhhhhhhhcCccccccCcccccc
Q 017594          209 NTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDE  287 (369)
Q Consensus       209 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  287 (369)
                       .........|+|||.+.+..++.++|+||||+++|+|++ |..||.......      ........ ..  ..      
T Consensus       154 -~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~------~~~~~~~~-~~--~~------  217 (254)
T cd05083         154 -VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKE------VKECVEKG-YR--ME------  217 (254)
T ss_pred             -CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHH------HHHHHhCC-CC--CC------
Confidence             111233567999999988889999999999999999997 898886432111      00111100 00  00      


Q ss_pred             ccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHh
Q 017594          288 YSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTN  324 (369)
Q Consensus       288 ~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L~~  324 (369)
                       ....++..+.+++.+||+.+|..||++.++++.|+.
T Consensus       218 -~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  253 (254)
T cd05083         218 -PPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK  253 (254)
T ss_pred             -CCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence             011225678999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=8e-36  Score=267.01  Aligned_cols=251  Identities=27%  Similarity=0.374  Sum_probs=188.9

Q ss_pred             ccccccCCccEEEEEEcC----CCEEEEEEecCC-CchhHHHHHHHHHHHhcCCCCceeeeeeeEE-eCCccEEEEEecC
Q 017594           55 NKLGEGGFGPVYKGVLKK----GDEIAVKRLSGR-SGQGLREMKNEASVIAKVQHKNLVRLLGCCI-DRDEKILIYEYMP  128 (369)
Q Consensus        55 ~~lg~G~~~~v~~~~~~~----~~~valK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~~lv~e~~~  128 (369)
                      +.||+|+||.||+|.+.+    +..+++|.+... .......+..|+.+++.++|||++++++++. .+...++++||+.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~   80 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK   80 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence            468999999999998532    356899988543 2334567788999999999999999999765 4556899999999


Q ss_pred             CCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCCCCccc
Q 017594          129 NKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQA  208 (369)
Q Consensus       129 ~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~~~~~~  208 (369)
                      +++|..++....  ...+...+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++..........
T Consensus        81 ~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~  155 (262)
T cd05058          81 HGDLRNFIRSET--HNPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYS  155 (262)
T ss_pred             CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccccccccCCccee
Confidence            999999985432  22566777889999999999999998   9999999999999999999999999987553321111


Q ss_pred             --ccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhC-CCCCCCCcccccccchhhhhhhhcCccccccCcccc
Q 017594          209 --NTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG-KKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILE  285 (369)
Q Consensus       209 --~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (369)
                        ......++..|+|||...+..++.++||||||+++|+|++| .+||......     ........ ...     ... 
T Consensus       156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~-----~~~~~~~~-~~~-----~~~-  223 (262)
T cd05058         156 VHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSF-----DITVYLLQ-GRR-----LLQ-  223 (262)
T ss_pred             ecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHH-----HHHHHHhc-CCC-----CCC-
Confidence              11122346689999999888899999999999999999995 5555422110     01111100 000     000 


Q ss_pred             ccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHhhh
Q 017594          286 DEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNEA  326 (369)
Q Consensus       286 ~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L~~~~  326 (369)
                          +...+..+.+++.+||+.+|++||++.++++.|+++.
T Consensus       224 ----~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~  260 (262)
T cd05058         224 ----PEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF  260 (262)
T ss_pred             ----CCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence                0112456899999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=2.4e-36  Score=277.83  Aligned_cols=267  Identities=21%  Similarity=0.277  Sum_probs=195.0

Q ss_pred             CCccCccccccCCccEEEEEEcC---CCEEEEEEecCCC---chhHHHHHHHHHHHhcCCCCceeeeeeeEEeC--CccE
Q 017594           50 KFSDANKLGEGGFGPVYKGVLKK---GDEIAVKRLSGRS---GQGLREMKNEASVIAKVQHKNLVRLLGCCIDR--DEKI  121 (369)
Q Consensus        50 ~y~i~~~lg~G~~~~v~~~~~~~---~~~valK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~  121 (369)
                      +|++.+.||+|++|.||+|..+.   +..||+|.+....   ......+..|+.++..++|||++++++++...  ...+
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY   80 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence            58899999999999999999653   7899999987632   33346678899999999999999999999887  7799


Q ss_pred             EEEEecCCCChhhhhcCC-C-ccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeC----CCceEEeec
Q 017594          122 LIYEYMPNKSLDFFLFDP-T-KRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDK----DMNPKISDF  195 (369)
Q Consensus       122 lv~e~~~~~~L~~~l~~~-~-~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~----~~~~~L~Df  195 (369)
                      +|+||+++. +..++... . ....+++..++.++.||+.||.|||+.+   ++|+||+|+||+++.    ++.++|+||
T Consensus        81 lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Df  156 (316)
T cd07842          81 LLFDYAEHD-LWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDL  156 (316)
T ss_pred             EEEeCCCcC-HHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECCC
Confidence            999999764 44444321 1 1236889999999999999999999999   999999999999999    899999999


Q ss_pred             CCceecCCCCc-ccccccccccccccCchhhcc-CCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchh-------
Q 017594          196 GMARICGGNEL-QANTSRIVGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGY-------  266 (369)
Q Consensus       196 g~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~-------  266 (369)
                      |++........ ........++..|+|||.+.+ ..++.++|+||||+++++|++|.+||.............       
T Consensus       157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (316)
T cd07842         157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER  236 (316)
T ss_pred             ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence            99886643322 111223456788999998765 457899999999999999999999997544322000000       


Q ss_pred             hhhhhh------------cCcccc---c-cCcccccccc----HH--HHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 017594          267 AWDLWT------------SNRTLE---L-IDPILEDEYS----SK--QMLLRYANIALLCVQESADDRPTMNDVVS  320 (369)
Q Consensus       267 ~~~~~~------------~~~~~~---~-~~~~~~~~~~----~~--~~~~~l~~li~~~L~~dP~~Rps~~ell~  320 (369)
                      ......            ......   . ..........    ..  ..+..+.+++.+||+.||++|||+.++++
T Consensus       237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~  312 (316)
T cd07842         237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE  312 (316)
T ss_pred             HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            000000            000000   0 0000000000    00  22457899999999999999999999986

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=1.2e-35  Score=267.36  Aligned_cols=256  Identities=24%  Similarity=0.406  Sum_probs=195.4

Q ss_pred             CccCccccccCCccEEEEEEc----CCCEEEEEEecCC--CchhHHHHHHHHHHHhcCCCCceeeeeeeEEeCC------
Q 017594           51 FSDANKLGEGGFGPVYKGVLK----KGDEIAVKRLSGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDRD------  118 (369)
Q Consensus        51 y~i~~~lg~G~~~~v~~~~~~----~~~~valK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------  118 (369)
                      |++.+.||+|++|.||+|.+.    ++..|++|++...  .....+.+.+|+..++.++|||++++++++....      
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   80 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP   80 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence            678899999999999999853    3678999988654  2334566788999999999999999999886542      


Q ss_pred             ccEEEEEecCCCChhhhhcCC---CccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeec
Q 017594          119 EKILIYEYMPNKSLDFFLFDP---TKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDF  195 (369)
Q Consensus       119 ~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Df  195 (369)
                      ..+++++|+.+++|..++...   .....++...++.++.||+.|++|||+.+   ++|+||+|+||+++.++.++|+||
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~df  157 (273)
T cd05074          81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADF  157 (273)
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECcc
Confidence            236889999999998776421   12234788889999999999999999998   999999999999999999999999


Q ss_pred             CCceecCCCCcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHh-CCCCCCCCcccccccchhhhhhhhcC
Q 017594          196 GMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDLWTSN  274 (369)
Q Consensus       196 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~  274 (369)
                      |.+................++..|++||...+..++.++|||||||++|+|++ |.+||.......     . .......
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~-----~-~~~~~~~  231 (273)
T cd05074         158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSE-----I-YNYLIKG  231 (273)
T ss_pred             cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHH-----H-HHHHHcC
Confidence            99876543222111222234567999999988889999999999999999999 888875332110     0 0000000


Q ss_pred             ccccccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHhh
Q 017594          275 RTLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNE  325 (369)
Q Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L~~~  325 (369)
                      .....          ....+..+.+++.+||+.+|++||++.++++.|+++
T Consensus       232 ~~~~~----------~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~  272 (273)
T cd05074         232 NRLKQ----------PPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI  272 (273)
T ss_pred             CcCCC----------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            00000          011256799999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=3e-36  Score=270.90  Aligned_cols=253  Identities=24%  Similarity=0.399  Sum_probs=198.0

Q ss_pred             CCccCccccccCCccEEEEEEcC--CCEEEEEEecCCC----------chhHHHHHHHHHHHhc-CCCCceeeeeeeEEe
Q 017594           50 KFSDANKLGEGGFGPVYKGVLKK--GDEIAVKRLSGRS----------GQGLREMKNEASVIAK-VQHKNLVRLLGCCID  116 (369)
Q Consensus        50 ~y~i~~~lg~G~~~~v~~~~~~~--~~~valK~~~~~~----------~~~~~~~~~e~~~l~~-l~h~~i~~~~~~~~~  116 (369)
                      .|++.+.||.|++|.||+|.++.  ++.+++|.+....          ......+..|+.++.. +.|+|++++++++..
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            48899999999999999999764  6789999875321          2234456678887765 689999999999999


Q ss_pred             CCccEEEEEecCCCChhhhhcCC-CccccCChHHHHHHHHHHHHHHHHHhc-CCCCCcccCCCCCCCEEEeCCCceEEee
Q 017594          117 RDEKILIYEYMPNKSLDFFLFDP-TKRMLLDWVTRVQIIEGIAQGLLYLHQ-YSRVRIIHRDLKASNILLDKDMNPKISD  194 (369)
Q Consensus       117 ~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~i~~qi~~al~~LH~-~~~~~i~H~dl~p~NIlv~~~~~~~L~D  194 (369)
                      ....++++||+.+++|.+++... .....+++..++.++.|++.+|.+||. .+   ++|+||+|.||+++.++.++|+|
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~---i~H~dl~~~nil~~~~~~~~l~d  157 (269)
T cd08528          81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR---IVHRDLTPNNIMLGEDDKVTITD  157 (269)
T ss_pred             CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc---eeecCCCHHHEEECCCCcEEEec
Confidence            99999999999999998876431 223458889999999999999999996 56   99999999999999999999999


Q ss_pred             cCCceecCCCCcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcC
Q 017594          195 FGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSN  274 (369)
Q Consensus       195 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~  274 (369)
                      ||.+.......   ......++..|.|||.+.+..++.++|+||||+++|+|++|..||.......     ..... ...
T Consensus       158 fg~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~-----~~~~~-~~~  228 (269)
T cd08528         158 FGLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLS-----LATKI-VEA  228 (269)
T ss_pred             ccceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHH-----HHHHH-hhc
Confidence            99987654432   2233467888999999998889999999999999999999999985332110     00000 001


Q ss_pred             ccccccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 017594          275 RTLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLT  323 (369)
Q Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L~  323 (369)
                      ..    .+...     ..++..+.++|.+||+.||++||++.++.+.++
T Consensus       229 ~~----~~~~~-----~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~  268 (269)
T cd08528         229 VY----EPLPE-----GMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS  268 (269)
T ss_pred             cC----CcCCc-----ccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence            00    01100     112567999999999999999999999998875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=4.8e-36  Score=269.20  Aligned_cols=250  Identities=26%  Similarity=0.409  Sum_probs=192.9

Q ss_pred             cCCccCccccccCCccEEEEEEc-CCCEEEEEEecCCC-----chhHHHHHHHHHHHhcCCCCceeeeeeeEEeC--Ccc
Q 017594           49 NKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS-----GQGLREMKNEASVIAKVQHKNLVRLLGCCIDR--DEK  120 (369)
Q Consensus        49 ~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~~-----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~  120 (369)
                      ..|++.+.||+|++|.||+|... ++..|++|.+....     ......+..|+.+++.++|||++++++++...  ...
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL   81 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence            46899999999999999999965 48899999875332     12345678899999999999999999988753  557


Q ss_pred             EEEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCcee
Q 017594          121 ILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARI  200 (369)
Q Consensus       121 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~  200 (369)
                      ++++||+.+++|.+++...   ..+++...+.++.|++.||.+||+.+   ++|+||+|+||+++.++.++|+|||++..
T Consensus        82 ~l~~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~~~  155 (266)
T cd06651          82 TIFMEYMPGGSVKDQLKAY---GALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR  155 (266)
T ss_pred             EEEEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCccc
Confidence            8999999999999888542   34788889999999999999999998   99999999999999999999999999875


Q ss_pred             cCCCCcc-cccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCccccc
Q 017594          201 CGGNELQ-ANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLEL  279 (369)
Q Consensus       201 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (369)
                      ....... .......++..|+|||.+.+..++.++|+||+||++|+|++|+.||.......     .........     
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~-----~~~~~~~~~-----  225 (266)
T cd06651         156 LQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMA-----AIFKIATQP-----  225 (266)
T ss_pred             cccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHH-----HHHHHhcCC-----
Confidence            5321111 11122357788999999988889999999999999999999999986432110     000000000     


Q ss_pred             cCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 017594          280 IDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVS  320 (369)
Q Consensus       280 ~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~  320 (369)
                      ..+.+     +...+..+.+++ .||..+|++||++++|++
T Consensus       226 ~~~~~-----~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~  260 (266)
T cd06651         226 TNPQL-----PSHISEHARDFL-GCIFVEARHRPSAEELLR  260 (266)
T ss_pred             CCCCC-----chhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence            01111     122255677888 688899999999999986

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=2.9e-36  Score=269.19  Aligned_cols=238  Identities=26%  Similarity=0.444  Sum_probs=186.3

Q ss_pred             ccccccCCccEEEEEEcCCC-----------EEEEEEecCCCchhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEE
Q 017594           55 NKLGEGGFGPVYKGVLKKGD-----------EIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILI  123 (369)
Q Consensus        55 ~~lg~G~~~~v~~~~~~~~~-----------~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv  123 (369)
                      +.||+|+||.||+|.+....           .+++|.+...... ...+.+|+.+++.++|||++++++++.. ...++|
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv   78 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV   78 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence            46899999999999976432           4788877654433 5778889999999999999999999887 778999


Q ss_pred             EEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCC-------ceEEeecC
Q 017594          124 YEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDM-------NPKISDFG  196 (369)
Q Consensus       124 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~-------~~~L~Dfg  196 (369)
                      +||+.+++|.+++.....  .++...+..++.||+.||.|||+.+   ++|+||||+||+++.++       .++|+|||
T Consensus        79 ~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg  153 (259)
T cd05037          79 EEYVKFGPLDVFLHREKN--NVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDPG  153 (259)
T ss_pred             EEcCCCCcHHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCCCC
Confidence            999999999998864332  5788889999999999999999998   99999999999999887       79999999


Q ss_pred             CceecCCCCcccccccccccccccCchhhccC--CCCcccchHhHHHHHHHHHh-CCCCCCCCcccccccchhhhhhhhc
Q 017594          197 MARICGGNELQANTSRIVGTYGYMSPEYALEG--IFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDLWTS  273 (369)
Q Consensus       197 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DiwslG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~  273 (369)
                      ++.....      .....+...|+|||.+.+.  .++.++|+||||+++|+|++ |..||........      ......
T Consensus       154 ~a~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~------~~~~~~  221 (259)
T cd05037         154 IPITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEK------ERFYQD  221 (259)
T ss_pred             ccccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhH------HHHHhc
Confidence            9876433      1223456679999998766  78999999999999999999 4666653321100      000000


Q ss_pred             CccccccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 017594          274 NRTLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLT  323 (369)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L~  323 (369)
                      ...       .... .    ...+.+++.+||+.+|.+||++.++++.|+
T Consensus       222 ~~~-------~~~~-~----~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  259 (259)
T cd05037         222 QHR-------LPMP-D----CAELANLINQCWTYDPTKRPSFRAILRDLN  259 (259)
T ss_pred             CCC-------CCCC-C----chHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence            000       0000 0    256899999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=4.8e-36  Score=271.49  Aligned_cols=251  Identities=24%  Similarity=0.377  Sum_probs=190.4

Q ss_pred             cCCccCccccccCCccEEEEEEc-CCCEEEEEEecCCC-chhHHHHHHHHHH-HhcCCCCceeeeeeeEEeCCccEEEEE
Q 017594           49 NKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS-GQGLREMKNEASV-IAKVQHKNLVRLLGCCIDRDEKILIYE  125 (369)
Q Consensus        49 ~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~~-~~~~~~~~~e~~~-l~~l~h~~i~~~~~~~~~~~~~~lv~e  125 (369)
                      ++|++.+.||.|+||.||+|+++ +|..||+|++.... ......+..|+.. ++.+.|||++++++++......++++|
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e   80 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME   80 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence            47899999999999999999976 48999999987542 2223344445554 566789999999999999999999999


Q ss_pred             ecCCCChhhhhcC-CCccccCChHHHHHHHHHHHHHHHHHhcC-CCCCcccCCCCCCCEEEeCCCceEEeecCCceecCC
Q 017594          126 YMPNKSLDFFLFD-PTKRMLLDWVTRVQIIEGIAQGLLYLHQY-SRVRIIHRDLKASNILLDKDMNPKISDFGMARICGG  203 (369)
Q Consensus       126 ~~~~~~L~~~l~~-~~~~~~~~~~~~~~i~~qi~~al~~LH~~-~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~  203 (369)
                      |++ ++|..++.. ......+++..++.++.||+.||.|||++ +   ++|+||+|+||+++.++.++|+|||++.....
T Consensus        81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~---i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~  156 (283)
T cd06617          81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS---VIHRDVKPSNVLINRNGQVKLCDFGISGYLVD  156 (283)
T ss_pred             hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence            997 566666543 22335689999999999999999999987 7   99999999999999999999999999876532


Q ss_pred             CCcccccccccccccccCchhhcc----CCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCccccc
Q 017594          204 NELQANTSRIVGTYGYMSPEYALE----GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLEL  279 (369)
Q Consensus       204 ~~~~~~~~~~~~~~~y~aPE~~~~----~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (369)
                      ..   ......++..|+|||.+.+    ..++.++|+||+||++|+|++|..||.......    .........      
T Consensus       157 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~----~~~~~~~~~------  223 (283)
T cd06617         157 SV---AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPF----QQLKQVVEE------  223 (283)
T ss_pred             cc---ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCH----HHHHHHHhc------
Confidence            21   1122356788999998764    456889999999999999999999986322110    000000000      


Q ss_pred             cCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 017594          280 IDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVS  320 (369)
Q Consensus       280 ~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~  320 (369)
                      ..+    ......++.++.++|.+||..+|.+||++.++++
T Consensus       224 ~~~----~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~  260 (283)
T cd06617         224 PSP----QLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQ  260 (283)
T ss_pred             CCC----CCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            000    0011123677999999999999999999999986

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=4.6e-36  Score=272.21  Aligned_cols=253  Identities=25%  Similarity=0.405  Sum_probs=203.5

Q ss_pred             HHhcCCccCccccccCCccEEEEEEc-CCCEEEEEEecCCCchhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEEE
Q 017594           46 TATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIY  124 (369)
Q Consensus        46 ~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  124 (369)
                      ...+.|++.+.||.|++|.||+|.++ ++..+++|.+..... ....+..|+..++.++|+|++++++.+......++++
T Consensus        16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   94 (286)
T cd06614          16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVM   94 (286)
T ss_pred             CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEE
Confidence            45667999999999999999999976 588999999876543 4567888999999999999999999999999999999


Q ss_pred             EecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCCC
Q 017594          125 EYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGN  204 (369)
Q Consensus       125 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~~  204 (369)
                      ||+++++|.+++....  ..++...++.++.|++.||.+||+.|   ++|+||+|.||+++.++.++|+|||.+......
T Consensus        95 e~~~~~~L~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~  169 (286)
T cd06614          95 EYMDGGSLTDIITQNF--VRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKE  169 (286)
T ss_pred             eccCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhhhccc
Confidence            9999999999986533  35889999999999999999999998   999999999999999999999999987654322


Q ss_pred             CcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCccccccCccc
Q 017594          205 ELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPIL  284 (369)
Q Consensus       205 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (369)
                      ..  ......++..|+|||.+.+..++.++|+||||+++|+|++|..||........     .... .....        
T Consensus       170 ~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~-----~~~~-~~~~~--------  233 (286)
T cd06614         170 KS--KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRA-----LFLI-TTKGI--------  233 (286)
T ss_pred             hh--hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHH-----HHHH-HhcCC--------
Confidence            11  11223467889999999888899999999999999999999999864321110     0000 00000        


Q ss_pred             cccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 017594          285 EDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVS  320 (369)
Q Consensus       285 ~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~  320 (369)
                      ........++..+.++|.+||+.+|.+||++.++++
T Consensus       234 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~  269 (286)
T cd06614         234 PPLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ  269 (286)
T ss_pred             CCCcchhhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence            000011123567999999999999999999999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=6.8e-36  Score=268.04  Aligned_cols=250  Identities=24%  Similarity=0.354  Sum_probs=194.4

Q ss_pred             cCCccCccccccCCccEEEEEEcC-CCEEEEEEecCCC-----chhHHHHHHHHHHHhcCCCCceeeeeeeEEeC--Ccc
Q 017594           49 NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRS-----GQGLREMKNEASVIAKVQHKNLVRLLGCCIDR--DEK  120 (369)
Q Consensus        49 ~~y~i~~~lg~G~~~~v~~~~~~~-~~~valK~~~~~~-----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~  120 (369)
                      ..|++.+.||+|++|.||.|.+++ |..|++|.+....     ....+.+..|+.+++.+.|||++++++++.+.  ...
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL   81 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence            579999999999999999999754 8899999875321     12345778899999999999999999988763  457


Q ss_pred             EEEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCcee
Q 017594          121 ILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARI  200 (369)
Q Consensus       121 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~  200 (369)
                      ++++||+.+++|.+++...   ..+++.....++.|++.||.+||+.+   ++|+||+|.||+++.++.++|+|||.+..
T Consensus        82 ~~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~~~  155 (265)
T cd06652          82 SIFMEHMPGGSIKDQLKSY---GALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKR  155 (265)
T ss_pred             EEEEEecCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCccccc
Confidence            8999999999999888533   33788888999999999999999999   99999999999999999999999998875


Q ss_pred             cCCCCcc-cccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCccccc
Q 017594          201 CGGNELQ-ANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLEL  279 (369)
Q Consensus       201 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (369)
                      ....... .......++..|+|||.+.+..++.++|+||||+++|+|++|+.||.......     ....... .    .
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~-----~~~~~~~-~----~  225 (265)
T cd06652         156 LQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMA-----AIFKIAT-Q----P  225 (265)
T ss_pred             cccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHH-----HHHHHhc-C----C
Confidence            5322111 11222357788999999988889999999999999999999999986332110     0000000 0    0


Q ss_pred             cCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 017594          280 IDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVS  320 (369)
Q Consensus       280 ~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~  320 (369)
                      ..+.     .+...+..+.++|.+||. +|.+||+++++++
T Consensus       226 ~~~~-----~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~  260 (265)
T cd06652         226 TNPV-----LPPHVSDHCRDFLKRIFV-EAKLRPSADELLR  260 (265)
T ss_pred             CCCC-----CchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence            0011     122335678899999995 9999999999985

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=4.2e-36  Score=273.10  Aligned_cols=264  Identities=23%  Similarity=0.323  Sum_probs=193.5

Q ss_pred             hcCCccCccccccCCccEEEEEEc-CCCEEEEEEecCCCc-hhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEEEE
Q 017594           48 TNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSG-QGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIYE  125 (369)
Q Consensus        48 ~~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  125 (369)
                      .++|++.+.||.|++|.||+|..+ +++.|++|.+..... .....+.+|+++++.++|+||+++++++...+..++|+|
T Consensus         4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   83 (291)
T cd07844           4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFE   83 (291)
T ss_pred             ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEe
Confidence            368999999999999999999976 488999999864422 122446679999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCCCC
Q 017594          126 YMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE  205 (369)
Q Consensus       126 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~~~  205 (369)
                      |+.+ +|..++....  ..+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++.......
T Consensus        84 ~~~~-~L~~~~~~~~--~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~  157 (291)
T cd07844          84 YLDT-DLKQYMDDCG--GGLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSVPS  157 (291)
T ss_pred             cCCC-CHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECccccccccCCCC
Confidence            9985 7877765432  25788999999999999999999998   9999999999999999999999999876543211


Q ss_pred             cccccccccccccccCchhhcc-CCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhc--Ccc------
Q 017594          206 LQANTSRIVGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTS--NRT------  276 (369)
Q Consensus       206 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~--~~~------  276 (369)
                      .  ......++..|+|||.+.+ ..++.++||||+|+++|+|++|..||....... ......+.....  ...      
T Consensus       158 ~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  234 (291)
T cd07844         158 K--TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVE-DQLHKIFRVLGTPTEETWPGVSS  234 (291)
T ss_pred             c--cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHH-HHHHHHHHhcCCCChhhhhhhhh
Confidence            1  1112245778999998865 458899999999999999999999986433100 000000000000  000      


Q ss_pred             ----ccc----c-CccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 017594          277 ----LEL----I-DPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVS  320 (369)
Q Consensus       277 ----~~~----~-~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~  320 (369)
                          ...    . ...+...........++.+++.+||+.+|++|||+.++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~  287 (291)
T cd07844         235 NPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK  287 (291)
T ss_pred             ccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence                000    0 0000000000001256889999999999999999999885

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=1.3e-35  Score=265.64  Aligned_cols=251  Identities=23%  Similarity=0.350  Sum_probs=198.6

Q ss_pred             CCccCccccccCCccEEEEEEc-CCCEEEEEEecCCC--chhHHHHHHHHHHHhcCCCCceeeeeeeEEe--CCccEEEE
Q 017594           50 KFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS--GQGLREMKNEASVIAKVQHKNLVRLLGCCID--RDEKILIY  124 (369)
Q Consensus        50 ~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~  124 (369)
                      +|++.+.||.|++|.||+|.+. +|..+++|.+....  ....+.+..|+..++.++|+|++++++++..  +...++++
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM   80 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence            5889999999999999999964 58889999886432  3334567889999999999999999998764  34579999


Q ss_pred             EecCCCChhhhhcCC-CccccCChHHHHHHHHHHHHHHHHHh-----cCCCCCcccCCCCCCCEEEeCCCceEEeecCCc
Q 017594          125 EYMPNKSLDFFLFDP-TKRMLLDWVTRVQIIEGIAQGLLYLH-----QYSRVRIIHRDLKASNILLDKDMNPKISDFGMA  198 (369)
Q Consensus       125 e~~~~~~L~~~l~~~-~~~~~~~~~~~~~i~~qi~~al~~LH-----~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~  198 (369)
                      ||+.+++|..++... .....+++..++.++.||+.||.+||     +.+   ++|+||+|+||+++.++.++|+|||++
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~---i~h~dl~p~nili~~~~~~kl~d~g~~  157 (265)
T cd08217          81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNT---VLHRDLKPANIFLDANNNVKLGDFGLA  157 (265)
T ss_pred             hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCc---ceecCCCHHHEEEecCCCEEEeccccc
Confidence            999999998888542 22345888999999999999999999     666   999999999999999999999999998


Q ss_pred             eecCCCCcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCcccc
Q 017594          199 RICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLE  278 (369)
Q Consensus       199 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (369)
                      .........  .....++..|+|||.+.+..++.++|+||||+++++|++|..||.......      ..........  
T Consensus       158 ~~~~~~~~~--~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~------~~~~~~~~~~--  227 (265)
T cd08217         158 KILGHDSSF--AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQ------LASKIKEGKF--  227 (265)
T ss_pred             ccccCCccc--ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHH------HHHHHhcCCC--
Confidence            876543321  222457889999999988889999999999999999999999987443110      0011111110  


Q ss_pred             ccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 017594          279 LIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSM  321 (369)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~  321 (369)
                         +.+     +..++..+.+++.+||+.+|.+||++.+|++.
T Consensus       228 ---~~~-----~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~  262 (265)
T cd08217         228 ---RRI-----PYRYSSELNEVIKSMLNVDPDKRPSTEELLQL  262 (265)
T ss_pred             ---CCC-----ccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence               011     11235679999999999999999999999873

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=2.6e-35  Score=264.82  Aligned_cols=254  Identities=22%  Similarity=0.345  Sum_probs=186.4

Q ss_pred             ccccccCCccEEEEEEcCC---CEEEEEEecCCC-chhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEEEEecCCC
Q 017594           55 NKLGEGGFGPVYKGVLKKG---DEIAVKRLSGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIYEYMPNK  130 (369)
Q Consensus        55 ~~lg~G~~~~v~~~~~~~~---~~valK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~  130 (369)
                      +.||+|+||.||+++..++   ..+++|.+.... ......+.+|+..++.++|||++++++.+......++||||+.++
T Consensus         1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~   80 (268)
T cd05086           1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG   80 (268)
T ss_pred             CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence            3689999999999985433   346677765433 234467888999999999999999999999888999999999999


Q ss_pred             ChhhhhcCCCc-cccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCCCCcccc
Q 017594          131 SLDFFLFDPTK-RMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQAN  209 (369)
Q Consensus       131 ~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~~~~~~~  209 (369)
                      +|..++..... ....+...+..++.||+.||+|||+.+   ++|+||||+||+++.++.++|+|||++...........
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~  157 (268)
T cd05086          81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET  157 (268)
T ss_pred             cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence            99988865322 234566677899999999999999998   99999999999999999999999998754322211112


Q ss_pred             cccccccccccCchhhcc-------CCCCcccchHhHHHHHHHHHh-CCCCCCCCcccccccchhhhhhhhcCccccccC
Q 017594          210 TSRIVGTYGYMSPEYALE-------GIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDLWTSNRTLELID  281 (369)
Q Consensus       210 ~~~~~~~~~y~aPE~~~~-------~~~~~~~DiwslG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (369)
                      .....++..|+|||+..+       ..++.++||||||+++|+|++ |..||......     ....... .+......+
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~-----~~~~~~~-~~~~~~~~~  231 (268)
T cd05086         158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDR-----EVLNHVI-KDQQVKLFK  231 (268)
T ss_pred             ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHH-----HHHHHHH-hhcccccCC
Confidence            223456788999998743       245789999999999999997 46676432211     0111111 111122222


Q ss_pred             ccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 017594          282 PILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLT  323 (369)
Q Consensus       282 ~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L~  323 (369)
                      +.+...     ++..+.+++..|| .+|.+||++++|++.|+
T Consensus       232 ~~~~~~-----~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~  267 (268)
T cd05086         232 PQLELP-----YSERWYEVLQFCW-LSPEKRATAEEVHRLLT  267 (268)
T ss_pred             CccCCC-----CcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence            222211     2556888999999 67999999999999885

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=4.6e-36  Score=272.89  Aligned_cols=264  Identities=23%  Similarity=0.323  Sum_probs=191.9

Q ss_pred             hcCCccCccccccCCccEEEEEEc-CCCEEEEEEecCCCc-hhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEEEE
Q 017594           48 TNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSG-QGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIYE  125 (369)
Q Consensus        48 ~~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  125 (369)
                      .++|++.+.||.|++|.||+|... +|..|++|.+..... .....+.+|+..++.++|+|++++.+++..+...++|+|
T Consensus         4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e   83 (291)
T cd07870           4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFE   83 (291)
T ss_pred             cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEe
Confidence            478999999999999999999965 488999999864432 223456789999999999999999999998889999999


Q ss_pred             ecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCCCC
Q 017594          126 YMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE  205 (369)
Q Consensus       126 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~~~  205 (369)
                      |+. +++...+...  ...+.+..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++.......
T Consensus        84 ~~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~  157 (291)
T cd07870          84 YMH-TDLAQYMIQH--PGGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKSIPS  157 (291)
T ss_pred             ccc-CCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEeccccccccCCCC
Confidence            996 4555554332  233677788899999999999999998   9999999999999999999999999886543221


Q ss_pred             cccccccccccccccCchhhccC-CCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhh------------
Q 017594          206 LQANTSRIVGTYGYMSPEYALEG-IFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWT------------  272 (369)
Q Consensus       206 ~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~------------  272 (369)
                      .  ......++..|+|||.+.+. .++.++|+||||+++|+|++|..||........ .....+....            
T Consensus       158 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~  234 (291)
T cd07870         158 Q--TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFE-QLEKIWTVLGVPTEDTWPGVSK  234 (291)
T ss_pred             C--CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHH-HHHHHHHHcCCCChhhhhhhhh
Confidence            1  11223467889999988653 578899999999999999999999864432110 0000000000            


Q ss_pred             cCcc-ccccCcccccc----ccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 017594          273 SNRT-LELIDPILEDE----YSSKQMLLRYANIALLCVQESADDRPTMNDVVS  320 (369)
Q Consensus       273 ~~~~-~~~~~~~~~~~----~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~  320 (369)
                      .... ...........    ......+..+.+++.+||+.||++|||+.+++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~  287 (291)
T cd07870         235 LPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL  287 (291)
T ss_pred             cccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence            0000 00000000000    000001456889999999999999999999875

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=1e-35  Score=269.85  Aligned_cols=249  Identities=23%  Similarity=0.349  Sum_probs=198.5

Q ss_pred             cCCccCccccccCCccEEEEEEc-CCCEEEEEEecCCCchhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEEEEec
Q 017594           49 NKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIYEYM  127 (369)
Q Consensus        49 ~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~  127 (369)
                      ..|...+.||.|++|.||++... +++.+++|.+........+.+.+|+.+++.+.|+|++++++++...+..++++||+
T Consensus        19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~   98 (285)
T cd06648          19 SYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFL   98 (285)
T ss_pred             HhhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEecc
Confidence            45667789999999999999964 58899999887555444566888999999999999999999999999999999999


Q ss_pred             CCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCCCCcc
Q 017594          128 PNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQ  207 (369)
Q Consensus       128 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~~~~~  207 (369)
                      .+++|.+++..    ..++...+..++.|++.|+++||+++   ++||||+|.||+++.++.++|+|||.+.......  
T Consensus        99 ~~~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~--  169 (285)
T cd06648          99 EGGALTDIVTH----TRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEV--  169 (285)
T ss_pred             CCCCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhccCC--
Confidence            99999988854    34788899999999999999999999   9999999999999999999999999876543221  


Q ss_pred             cccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCccccccCcccccc
Q 017594          208 ANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDE  287 (369)
Q Consensus       208 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  287 (369)
                      .......++..|+|||...+..++.++|+||+|+++|+|++|..||.......     ..... ...     ..+.... 
T Consensus       170 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~-----~~~~~-~~~-----~~~~~~~-  237 (285)
T cd06648         170 PRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQ-----AMKRI-RDN-----LPPKLKN-  237 (285)
T ss_pred             cccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHH-----HHHHH-Hhc-----CCCCCcc-
Confidence            11222457889999999988889999999999999999999999985322100     00000 000     0001100 


Q ss_pred             ccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 017594          288 YSSKQMLLRYANIALLCVQESADDRPTMNDVVS  320 (369)
Q Consensus       288 ~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~  320 (369)
                        ...++..+.+++.+||+.+|++||++.++++
T Consensus       238 --~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~  268 (285)
T cd06648         238 --LHKVSPRLRSFLDRMLVRDPAQRATAAELLN  268 (285)
T ss_pred             --cccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence              1112567999999999999999999999996

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=4.8e-36  Score=270.54  Aligned_cols=239  Identities=23%  Similarity=0.338  Sum_probs=183.6

Q ss_pred             cccccCCccEEEEEEcC-------------------------CCEEEEEEecCCCchhHHHHHHHHHHHhcCCCCceeee
Q 017594           56 KLGEGGFGPVYKGVLKK-------------------------GDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRL  110 (369)
Q Consensus        56 ~lg~G~~~~v~~~~~~~-------------------------~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~  110 (369)
                      .||+|+||.||+|....                         ...|++|.+..........+.+|+..++.++||||+++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~   81 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV   81 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence            68999999999987421                         13488898865544445567788999999999999999


Q ss_pred             eeeEEeCCccEEEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCC--
Q 017594          111 LGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDM--  188 (369)
Q Consensus       111 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~--  188 (369)
                      ++++......++||||+++++|..++...  ...+++..+..++.||+.||+|||+.+   ++|+||||.||+++..+  
T Consensus        82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~~~  156 (274)
T cd05076          82 HGVCVRGSENIMVEEFVEHGPLDVCLRKE--KGRVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGLA  156 (274)
T ss_pred             EEEEEeCCceEEEEecCCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEeccCcc
Confidence            99999999999999999999998888542  234788889999999999999999998   99999999999997643  


Q ss_pred             -----ceEEeecCCceecCCCCcccccccccccccccCchhhcc-CCCCcccchHhHHHHHHHHH-hCCCCCCCCccccc
Q 017594          189 -----NPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIV-SGKKNTGLYRTDSL  261 (369)
Q Consensus       189 -----~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~-tg~~p~~~~~~~~~  261 (369)
                           .++++|||.+......      ....++..|+|||.+.+ ..++.++|+||||+++|+|+ +|..||........
T Consensus       157 ~~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~  230 (274)
T cd05076         157 EGTSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEK  230 (274)
T ss_pred             cCccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHH
Confidence                 3799999987543211      12245678999998865 56899999999999999985 68888764321110


Q ss_pred             ccchhhhhhhhcCccccccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 017594          262 NLLGYAWDLWTSNRTLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLT  323 (369)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L~  323 (369)
                            .......       .....     .....+.++|.+||+.+|++||++.++++.|+
T Consensus       231 ------~~~~~~~-------~~~~~-----~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~  274 (274)
T cd05076         231 ------ERFYEKK-------HRLPE-----PSCKELATLISQCLTYEPTQRPSFRTILRDLT  274 (274)
T ss_pred             ------HHHHHhc-------cCCCC-----CCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence                  0000000       00000     01345899999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=6e-36  Score=272.42  Aligned_cols=264  Identities=22%  Similarity=0.286  Sum_probs=196.0

Q ss_pred             cCCccCccccccCCccEEEEEEc-CCCEEEEEEecCCCc--hhHHHHHHHHHHHhcCCCCceeeeeeeEEeC--CccEEE
Q 017594           49 NKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSG--QGLREMKNEASVIAKVQHKNLVRLLGCCIDR--DEKILI  123 (369)
Q Consensus        49 ~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv  123 (369)
                      ++|++.+.||.|++|.||+|.++ ++..+++|.+.....  .....+.+|+..++.++|||++++.+++...  ...+++
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv   84 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV   84 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence            57999999999999999999976 488899999864432  2223556799999999999999999998877  789999


Q ss_pred             EEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCC
Q 017594          124 YEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGG  203 (369)
Q Consensus       124 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~  203 (369)
                      +||+.+ +|..++....  ..+++..+..++.||+.||.|||+.+   ++|+||+|+||+++.++.++|+|||++..+..
T Consensus        85 ~e~~~~-~L~~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~  158 (293)
T cd07843          85 MEYVEH-DLKSLMETMK--QPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGS  158 (293)
T ss_pred             ehhcCc-CHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceeeccC
Confidence            999975 7777764422  35899999999999999999999999   99999999999999999999999999887654


Q ss_pred             CCcccccccccccccccCchhhccC-CCCcccchHhHHHHHHHHHhCCCCCCCCccccccc---------chhhhhhhhc
Q 017594          204 NELQANTSRIVGTYGYMSPEYALEG-IFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNL---------LGYAWDLWTS  273 (369)
Q Consensus       204 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~---------~~~~~~~~~~  273 (369)
                      ...  ......++..|+|||.+.+. .++.++|+||||+++|+|++|..||..........         ....|..+..
T Consensus       159 ~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (293)
T cd07843         159 PLK--PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSE  236 (293)
T ss_pred             Ccc--ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhc
Confidence            321  12223567889999988654 46899999999999999999999987543211000         0000000000


Q ss_pred             ------CccccccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 017594          274 ------NRTLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVS  320 (369)
Q Consensus       274 ------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~  320 (369)
                            ..........+.........+..+.++|.+||+.+|++|||+.|+++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~  289 (293)
T cd07843         237 LPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK  289 (293)
T ss_pred             cchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence                  00000000000111111112566899999999999999999999986

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.4e-37  Score=284.69  Aligned_cols=240  Identities=22%  Similarity=0.296  Sum_probs=182.9

Q ss_pred             ccccCCccEEEEEEcC-CCEEEEEEecCCC---chhHHHHHHHHHHHhcC---CCCceeeeeeeEEeCCccEEEEEecCC
Q 017594           57 LGEGGFGPVYKGVLKK-GDEIAVKRLSGRS---GQGLREMKNEASVIAKV---QHKNLVRLLGCCIDRDEKILIYEYMPN  129 (369)
Q Consensus        57 lg~G~~~~v~~~~~~~-~~~valK~~~~~~---~~~~~~~~~e~~~l~~l---~h~~i~~~~~~~~~~~~~~lv~e~~~~  129 (369)
                      ||+|+||.||+|+++. |+.||+|++....   .........|..++..+   .||+|+++++.+......++||||+.+
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            6999999999999654 8999999986432   11222334455666554   699999999999999999999999999


Q ss_pred             CChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCCCCcccc
Q 017594          130 KSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQAN  209 (369)
Q Consensus       130 ~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~~~~~~~  209 (369)
                      ++|..++..   ...+++..+..++.||+.||+|||+++   ++||||||+||+++.++.++|+|||++.......  ..
T Consensus        81 g~L~~~l~~---~~~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~--~~  152 (330)
T cd05586          81 GELFWHLQK---EGRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTDN--KT  152 (330)
T ss_pred             ChHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC--CC
Confidence            999888754   334889999999999999999999999   9999999999999999999999999986532221  11


Q ss_pred             cccccccccccCchhhccC-CCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCccccccCccccccc
Q 017594          210 TSRIVGTYGYMSPEYALEG-IFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEY  288 (369)
Q Consensus       210 ~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  288 (369)
                      .....|+..|+|||++.+. .++.++|||||||++|+|++|..||.......      .......... ..     .   
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~------~~~~i~~~~~-~~-----~---  217 (330)
T cd05586         153 TNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQ------MYRNIAFGKV-RF-----P---  217 (330)
T ss_pred             ccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHH------HHHHHHcCCC-CC-----C---
Confidence            2334689999999998754 48999999999999999999999986432110      0011110100 00     0   


Q ss_pred             cHHHHHHHHHHHHHHhhcCCCCCCC----CHHHHHH
Q 017594          289 SSKQMLLRYANIALLCVQESADDRP----TMNDVVS  320 (369)
Q Consensus       289 ~~~~~~~~l~~li~~~L~~dP~~Rp----s~~ell~  320 (369)
                       ....+.++.++|.+||+.||.+||    ++.++++
T Consensus       218 -~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~  252 (330)
T cd05586         218 -KNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE  252 (330)
T ss_pred             -CccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence             011256689999999999999998    5667665

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=9.9e-36  Score=278.20  Aligned_cols=264  Identities=25%  Similarity=0.300  Sum_probs=196.0

Q ss_pred             HHhcCCccCccccccCCccEEEEEEc-CCCEEEEEEecCC--CchhHHHHHHHHHHHhcCCCCceeeeeeeEEeC-----
Q 017594           46 TATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDR-----  117 (369)
Q Consensus        46 ~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----  117 (369)
                      ...++|++.+.||+|++|.||+|++. +|+.|++|.+...  .......+..|+.+++.++|+|++++++++...     
T Consensus        13 ~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   92 (353)
T cd07850          13 TVLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEE   92 (353)
T ss_pred             hhhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccc
Confidence            46789999999999999999999965 5899999998643  233445677899999999999999999987643     


Q ss_pred             -CccEEEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecC
Q 017594          118 -DEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFG  196 (369)
Q Consensus       118 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg  196 (369)
                       ...++|+||+.+ +|.+.+..     .++...+..++.|++.||++||+.|   ++|+||||+||+++.++.++|+|||
T Consensus        93 ~~~~~lv~e~~~~-~l~~~~~~-----~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Dfg  163 (353)
T cd07850          93 FQDVYLVMELMDA-NLCQVIQM-----DLDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG  163 (353)
T ss_pred             cCcEEEEEeccCC-CHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCc
Confidence             346999999965 66666532     1788889999999999999999999   9999999999999999999999999


Q ss_pred             CceecCCCCcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCccccccc----------chh
Q 017594          197 MARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNL----------LGY  266 (369)
Q Consensus       197 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~----------~~~  266 (369)
                      ++........   .....++..|+|||.+.+..++.++|||||||++|+|++|+.||...+......          ..+
T Consensus       164 ~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  240 (353)
T cd07850         164 LARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEF  240 (353)
T ss_pred             cceeCCCCCC---CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence            9886543221   222356788999999999999999999999999999999999986443110000          000


Q ss_pred             ------hhhhhhcCc-------cccccCccccc---cccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 017594          267 ------AWDLWTSNR-------TLELIDPILED---EYSSKQMLLRYANIALLCVQESADDRPTMNDVVSM  321 (369)
Q Consensus       267 ------~~~~~~~~~-------~~~~~~~~~~~---~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~  321 (369)
                            .........       ..+........   .......+..+.++|.+||+.||++|||+.+++..
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~  311 (353)
T cd07850         241 MSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH  311 (353)
T ss_pred             HHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence                  000000000       00000000000   00011235678999999999999999999999963

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=2.5e-35  Score=266.16  Aligned_cols=248  Identities=25%  Similarity=0.427  Sum_probs=198.1

Q ss_pred             cCCccCccccccCCccEEEEEEc-CCCEEEEEEecCCC-chhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEEEEe
Q 017594           49 NKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIYEY  126 (369)
Q Consensus        49 ~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  126 (369)
                      +-|++.+.||.|+||.||+|.++ ++..+++|.+.... ......+.+|+..+..+.|||++++++++..+...++|+||
T Consensus         4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   83 (277)
T cd06641           4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY   83 (277)
T ss_pred             HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEe
Confidence            45788999999999999999965 58899999876443 23345678899999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCCCCc
Q 017594          127 MPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNEL  206 (369)
Q Consensus       127 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~~~~  206 (369)
                      +.+++|..++..    ..++...+..++.|++.++.+||+.+   ++|+||+|.||+++.++.++|+|||++........
T Consensus        84 ~~~~~l~~~i~~----~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~  156 (277)
T cd06641          84 LGGGSALDLLEP----GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI  156 (277)
T ss_pred             CCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceecccchh
Confidence            999999888742    34788999999999999999999998   99999999999999999999999998876543221


Q ss_pred             ccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCccccccCccccc
Q 017594          207 QANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILED  286 (369)
Q Consensus       207 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  286 (369)
                        ......++..|+|||.+.+..++.++|+||+||++|+|++|..||.......     ..... ....     .+.+. 
T Consensus       157 --~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~-----~~~~~-~~~~-----~~~~~-  222 (277)
T cd06641         157 --KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMK-----VLFLI-PKNN-----PPTLE-  222 (277)
T ss_pred             --hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHH-----HHHHH-hcCC-----CCCCC-
Confidence              1122356788999999988888999999999999999999999985322110     00000 0000     01111 


Q ss_pred             cccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 017594          287 EYSSKQMLLRYANIALLCVQESADDRPTMNDVVSM  321 (369)
Q Consensus       287 ~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~  321 (369)
                          ..++.++.+++.+||+.+|.+||++.++++.
T Consensus       223 ----~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~  253 (277)
T cd06641         223 ----GNYSKPLKEFVEACLNKEPSFRPTAKELLKH  253 (277)
T ss_pred             ----cccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence                1125668999999999999999999999984

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-36  Score=277.62  Aligned_cols=276  Identities=26%  Similarity=0.389  Sum_probs=222.0

Q ss_pred             ccchhhHHHHhcCCccCccccccCCccEEEEEEcCCCEEEEEEecCCC-chhHHHHHHHHHHHhcCCCCceeeeeeeEEe
Q 017594           38 LFSFSSVSTATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCCID  116 (369)
Q Consensus        38 ~~~~~~~~~~~~~y~i~~~lg~G~~~~v~~~~~~~~~~valK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~  116 (369)
                      .+..+..+....+..+.++||+|.||.|.++....+..||+|.+.... .+..+.+..|+++|.+|+||||+.++++|..
T Consensus       527 ~k~~al~EfPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~  606 (807)
T KOG1094|consen  527 GKGPALVEFPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQ  606 (807)
T ss_pred             ccCcchhhcchhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeec
Confidence            345556667778899999999999999999998878999999998654 3445889999999999999999999999999


Q ss_pred             CCccEEEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecC
Q 017594          117 RDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFG  196 (369)
Q Consensus       117 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg  196 (369)
                      ++.+++++||+++|.|..++..+.... .......+++.||++|++||.+.+   ++||||.+.|++++.++++||+|||
T Consensus       607 DePicmI~EYmEnGDLnqFl~aheapt-~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfg  682 (807)
T KOG1094|consen  607 DDPLCMITEYMENGDLNQFLSAHELPT-AETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFG  682 (807)
T ss_pred             CCchHHHHHHHhcCcHHHHHHhccCcc-cccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCcc
Confidence            999999999999999999997654322 455667789999999999999999   9999999999999999999999999


Q ss_pred             CceecCCCCcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHh--CCCCCCCCcccccccchhhhhhhhcC
Q 017594          197 MARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS--GKKNTGLYRTDSLNLLGYAWDLWTSN  274 (369)
Q Consensus       197 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~t--g~~p~~~~~~~~~~~~~~~~~~~~~~  274 (369)
                      +++-+...+......+..-..+|+|+|-+.-++++.++|+|++|+++||+++  ...||+...++.  ..+.....+..+
T Consensus       683 msR~lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~--vven~~~~~~~~  760 (807)
T KOG1094|consen  683 MSRNLYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQ--VVENAGEFFRDQ  760 (807)
T ss_pred             cccccccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHH--HHHhhhhhcCCC
Confidence            9987666655555555566789999999999999999999999999999876  566765433222  111111221111


Q ss_pred             ccccccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHhhh
Q 017594          275 RTLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNEA  326 (369)
Q Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L~~~~  326 (369)
                      .... +.      ..+..++..+.+++..||..|-++||+.+++...|.+..
T Consensus       761 ~~~~-~l------~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~~  805 (807)
T KOG1094|consen  761 GRQV-VL------SRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQEDA  805 (807)
T ss_pred             Ccce-ec------cCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHhc
Confidence            1111 00      113344777999999999999999999999999998754

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=1e-35  Score=269.47  Aligned_cols=265  Identities=24%  Similarity=0.333  Sum_probs=197.6

Q ss_pred             CCccCccccccCCccEEEEEEc-CCCEEEEEEecCCCc-hhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEEEEec
Q 017594           50 KFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSG-QGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIYEYM  127 (369)
Q Consensus        50 ~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~  127 (369)
                      +|++.+.||.|++|.||+|+++ +|..|++|.+..... .....+..|+.+++.++|+|++++++++...+..++|+||+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM   80 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence            5889999999999999999976 488999999875432 23456678999999999999999999999999999999999


Q ss_pred             CCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCCCCcc
Q 017594          128 PNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQ  207 (369)
Q Consensus       128 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~~~~~  207 (369)
                      .+ ++.+++........+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++........ 
T Consensus        81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~-  155 (284)
T cd07836          81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN-  155 (284)
T ss_pred             Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc-
Confidence            86 77777655444456899999999999999999999998   99999999999999999999999998865432211 


Q ss_pred             cccccccccccccCchhhcc-CCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccc---------hhhhhhhhc-Ccc
Q 017594          208 ANTSRIVGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLL---------GYAWDLWTS-NRT  276 (369)
Q Consensus       208 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~---------~~~~~~~~~-~~~  276 (369)
                       ......++..|++||.+.+ ..++.++|+||||+++|+|++|..||...........         ...+..... ...
T Consensus       156 -~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (284)
T cd07836         156 -TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEY  234 (284)
T ss_pred             -ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchh
Confidence             1122345778999998765 4578899999999999999999999875432111000         000000000 000


Q ss_pred             ccccCccccc--cccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 017594          277 LELIDPILED--EYSSKQMLLRYANIALLCVQESADDRPTMNDVVS  320 (369)
Q Consensus       277 ~~~~~~~~~~--~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~  320 (369)
                      ..........  .......+..+.+++.+||+.||.+||++.++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  280 (284)
T cd07836         235 KPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ  280 (284)
T ss_pred             cccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            0000000000  0001123567899999999999999999999985

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=3.6e-35  Score=262.81  Aligned_cols=242  Identities=27%  Similarity=0.375  Sum_probs=193.2

Q ss_pred             ccccCCccEEEEEEcC-CCEEEEEEecCCC---chhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEEEEecCCCCh
Q 017594           57 LGEGGFGPVYKGVLKK-GDEIAVKRLSGRS---GQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSL  132 (369)
Q Consensus        57 lg~G~~~~v~~~~~~~-~~~valK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L  132 (369)
                      ||.|++|.||+|+.+. +..+++|.+....   ....+.+..|+.+++.+.|||++++++.+.++...++++||+.+++|
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            6899999999999764 8899999986432   23346788899999999999999999999999999999999999999


Q ss_pred             hhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCCCCccccccc
Q 017594          133 DFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR  212 (369)
Q Consensus       133 ~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~~~~~~~~~~  212 (369)
                      .+++...   ..++...+..++.||+.||.|||+.+   ++|+||+|+||+++.++.++|+|||.+.......   ....
T Consensus        81 ~~~l~~~---~~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~~  151 (262)
T cd05572          81 WTILRDR---GLFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWT  151 (262)
T ss_pred             HHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---cccc
Confidence            9988543   34788899999999999999999998   9999999999999999999999999987664432   1222


Q ss_pred             ccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCccccccCccccccccHHH
Q 017594          213 IVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYSSKQ  292 (369)
Q Consensus       213 ~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  292 (369)
                      ..++..|+|||.+.+..++.++|+||+|+++|+|++|..||.....+...   ............         . .+..
T Consensus       152 ~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~---~~~~~~~~~~~~---------~-~~~~  218 (262)
T cd05572         152 FCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPME---IYNDILKGNGKL---------E-FPNY  218 (262)
T ss_pred             ccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHH---HHHHHhccCCCC---------C-CCcc
Confidence            35788899999988888999999999999999999999998754321100   001100000000         0 0111


Q ss_pred             HHHHHHHHHHHhhcCCCCCCCC-----HHHHHH
Q 017594          293 MLLRYANIALLCVQESADDRPT-----MNDVVS  320 (369)
Q Consensus       293 ~~~~l~~li~~~L~~dP~~Rps-----~~ell~  320 (369)
                      .+.++.++|.+||+.+|++||+     +.++++
T Consensus       219 ~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~  251 (262)
T cd05572         219 IDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK  251 (262)
T ss_pred             cCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence            1567999999999999999999     788876

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=4e-35  Score=261.23  Aligned_cols=250  Identities=22%  Similarity=0.366  Sum_probs=202.9

Q ss_pred             CCccCccccccCCccEEEEEEc-CCCEEEEEEecCCCc--hhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEEEEe
Q 017594           50 KFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSG--QGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIYEY  126 (369)
Q Consensus        50 ~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  126 (369)
                      +|.+.+.||.|++|.||++.+. ++..+++|++.....  .....+..|++.++.++|+|++++.+.+......++++|+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~   80 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY   80 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence            5889999999999999999965 588999999875532  4556788899999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCC-ccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCCCC
Q 017594          127 MPNKSLDFFLFDPT-KRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE  205 (369)
Q Consensus       127 ~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~~~  205 (369)
                      +++++|.+.+.... ....+++..++.++.+++.||.+||+.+   ++|+||+|+||+++.++.++|+|||.+.......
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~  157 (258)
T cd08215          81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV  157 (258)
T ss_pred             cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence            99999988886532 2356899999999999999999999998   9999999999999999999999999987665432


Q ss_pred             cccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCccccccCcccc
Q 017594          206 LQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILE  285 (369)
Q Consensus       206 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (369)
                        .......+++.|+|||...+..++.++|+||+|+++++|++|..||.......     ..... ......    + +.
T Consensus       158 --~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~-----~~~~~-~~~~~~----~-~~  224 (258)
T cd08215         158 --DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLE-----LALKI-LKGQYP----P-IP  224 (258)
T ss_pred             --ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHH-----HHHHH-hcCCCC----C-CC
Confidence              12233467888999999988889999999999999999999999986433110     01111 011000    0 11


Q ss_pred             ccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 017594          286 DEYSSKQMLLRYANIALLCVQESADDRPTMNDVVS  320 (369)
Q Consensus       286 ~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~  320 (369)
                           ..++..+.+++.+||..+|++||++.++++
T Consensus       225 -----~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~  254 (258)
T cd08215         225 -----SQYSSELRNLVSSLLQKDPEERPSIAQILQ  254 (258)
T ss_pred             -----CCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence                 122567999999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=4.8e-36  Score=291.70  Aligned_cols=274  Identities=19%  Similarity=0.252  Sum_probs=188.1

Q ss_pred             hhHHHHhcCCccCccccccCCccEEEEEEcC--CCEEEEE------------------EecCCCchhHHHHHHHHHHHhc
Q 017594           42 SSVSTATNKFSDANKLGEGGFGPVYKGVLKK--GDEIAVK------------------RLSGRSGQGLREMKNEASVIAK  101 (369)
Q Consensus        42 ~~~~~~~~~y~i~~~lg~G~~~~v~~~~~~~--~~~valK------------------~~~~~~~~~~~~~~~e~~~l~~  101 (369)
                      ........+|++++.||+|+||.||+|..+.  +...+.|                  .+. ........+.+|+.+++.
T Consensus       141 ~~~~~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~-~~~~~~~~~~~Ei~il~~  219 (501)
T PHA03210        141 KHDDEFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVK-AGSRAAIQLENEILALGR  219 (501)
T ss_pred             ccchhhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhh-cchHHHHHHHHHHHHHHh
Confidence            3345567899999999999999999987532  2222222                  111 112234567889999999


Q ss_pred             CCCCceeeeeeeEEeCCccEEEEEecCCCChhhhhcCCCc--cccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCC
Q 017594          102 VQHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTK--RMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKA  179 (369)
Q Consensus       102 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p  179 (369)
                      ++|+||+++++++...+..+++++++.+. +..++.....  ........+..++.||+.||.|||+++   ++||||||
T Consensus       220 l~HpnIv~l~~~~~~~~~~~lv~e~~~~~-l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP  295 (501)
T PHA03210        220 LNHENILKIEEILRSEANTYMITQKYDFD-LYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKL  295 (501)
T ss_pred             CCCCCcCcEeEEEEECCeeEEEEeccccC-HHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCH
Confidence            99999999999999999999999998654 4444432111  112335567789999999999999999   99999999


Q ss_pred             CCEEEeCCCceEEeecCCceecCCCCcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCC-CCCCCcc
Q 017594          180 SNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKK-NTGLYRT  258 (369)
Q Consensus       180 ~NIlv~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~-p~~~~~~  258 (369)
                      +|||++.++.++|+|||++..+..... .......|+..|+|||++.+..++.++|||||||++|+|++|.. |+.....
T Consensus       296 ~NILl~~~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~  374 (501)
T PHA03210        296 ENIFLNCDGKIVLGDFGTAMPFEKERE-AFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGG  374 (501)
T ss_pred             HHEEECCCCCEEEEeCCCceecCcccc-cccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCC
Confidence            999999999999999999987653322 11223568999999999999999999999999999999999875 4432221


Q ss_pred             ccccc-chhhhhh------hhcC--ccccccC--------ccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 017594          259 DSLNL-LGYAWDL------WTSN--RTLELID--------PILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSM  321 (369)
Q Consensus       259 ~~~~~-~~~~~~~------~~~~--~~~~~~~--------~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~  321 (369)
                      ..... .......      +...  .....+.        ..+.........+.++.++|.+||+.||.+|||+.|+++.
T Consensus       375 ~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h  454 (501)
T PHA03210        375 KPGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL  454 (501)
T ss_pred             CHHHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence            11000 0000000      0000  0000000        0000000111124567889999999999999999999863

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.1e-35  Score=260.18  Aligned_cols=247  Identities=28%  Similarity=0.419  Sum_probs=201.3

Q ss_pred             CCccCccccccCCccEEEEEEc-CCCEEEEEEecCCCc--hhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEEEEe
Q 017594           50 KFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSG--QGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIYEY  126 (369)
Q Consensus        50 ~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  126 (369)
                      +|++.+.||.|++|.||+++++ +++.|++|.+.....  .....+..|++++.++.|+|++++++++...+..++++|+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY   80 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence            5889999999999999999966 478999999876543  4556788999999999999999999999998999999999


Q ss_pred             cCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCCCCc
Q 017594          127 MPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNEL  206 (369)
Q Consensus       127 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~~~~  206 (369)
                      +.+++|.+++...   ..+++..++.++.|++.++.+||+.|   ++|+||+|+||+++.++.++|+|||.+........
T Consensus        81 ~~~~~L~~~~~~~---~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~  154 (254)
T cd06627          81 AENGSLRQIIKKF---GPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK  154 (254)
T ss_pred             CCCCcHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCCCcc
Confidence            9999999888543   45899999999999999999999998   99999999999999999999999999887654332


Q ss_pred             ccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCccccccCccccc
Q 017594          207 QANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILED  286 (369)
Q Consensus       207 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  286 (369)
                      .  .....++..|+|||...+..++.++|+||+|+++++|++|..||......     ...+....  ...    +.+  
T Consensus       155 ~--~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~-----~~~~~~~~--~~~----~~~--  219 (254)
T cd06627         155 D--DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPM-----AALFRIVQ--DDH----PPL--  219 (254)
T ss_pred             c--ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHH-----HHHHHHhc--cCC----CCC--
Confidence            1  22345788899999988877899999999999999999999998643211     11111110  000    011  


Q ss_pred             cccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 017594          287 EYSSKQMLLRYANIALLCVQESADDRPTMNDVVS  320 (369)
Q Consensus       287 ~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~  320 (369)
                         +...+..+.+++.+||..+|++||++.+++.
T Consensus       220 ---~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  250 (254)
T cd06627         220 ---PEGISPELKDFLMQCFQKDPNLRPTAKQLLK  250 (254)
T ss_pred             ---CCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence               1112567899999999999999999999985

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=4.4e-35  Score=263.22  Aligned_cols=251  Identities=23%  Similarity=0.285  Sum_probs=194.0

Q ss_pred             chhhHHHHhcCCccCccc--cccCCccEEEEEEc-CCCEEEEEEecCCCchhHHHHHHHHHHHhcC-CCCceeeeeeeEE
Q 017594           40 SFSSVSTATNKFSDANKL--GEGGFGPVYKGVLK-KGDEIAVKRLSGRSGQGLREMKNEASVIAKV-QHKNLVRLLGCCI  115 (369)
Q Consensus        40 ~~~~~~~~~~~y~i~~~l--g~G~~~~v~~~~~~-~~~~valK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~  115 (369)
                      ++.......++|++.+.+  |.|+||.||+++.+ ++..+++|.+.......     .|+.....+ .|+|++++++.+.
T Consensus         5 ~~~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-----~e~~~~~~~~~h~~iv~~~~~~~   79 (267)
T PHA03390          5 SLSELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-----IEPMVHQLMKDNPNFIKLYYSVT   79 (267)
T ss_pred             HHHHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-----hhHHHHHHhhcCCCEEEEEEEEe
Confidence            455566677888998888  99999999999965 47889999886442211     122222222 6999999999999


Q ss_pred             eCCccEEEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCC-ceEEee
Q 017594          116 DRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDM-NPKISD  194 (369)
Q Consensus       116 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~-~~~L~D  194 (369)
                      ..+..++||||+.+++|.+++...   ..+++..++.++.||+.||.+||+.+   ++|+||+|+||+++.++ .++|+|
T Consensus        80 ~~~~~~iv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~d  153 (267)
T PHA03390         80 TLKGHVLIMDYIKDGDLFDLLKKE---GKLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCD  153 (267)
T ss_pred             cCCeeEEEEEcCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEec
Confidence            999999999999999999988543   25899999999999999999999999   99999999999999998 999999


Q ss_pred             cCCceecCCCCcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcC
Q 017594          195 FGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSN  274 (369)
Q Consensus       195 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~  274 (369)
                      ||.+......      ....++..|+|||++.+..++.++|+||+|+++|+|++|..||............+....   .
T Consensus       154 fg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~---~  224 (267)
T PHA03390        154 YGLCKIIGTP------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ---Q  224 (267)
T ss_pred             CccceecCCC------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhh---c
Confidence            9988755322      123578899999999988899999999999999999999999974332211110000000   0


Q ss_pred             ccccccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCC-HHHHHH
Q 017594          275 RTLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPT-MNDVVS  320 (369)
Q Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps-~~ell~  320 (369)
                      ....          .....+..+.++|.+||+.+|.+||+ ++++++
T Consensus       225 ~~~~----------~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~  261 (267)
T PHA03390        225 KKLP----------FIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK  261 (267)
T ss_pred             ccCC----------cccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence            0000          01123677999999999999999996 588885

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=1.3e-35  Score=268.89  Aligned_cols=264  Identities=22%  Similarity=0.305  Sum_probs=193.8

Q ss_pred             CCccCccccccCCccEEEEEEc-CCCEEEEEEecCCC--chhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEEEEe
Q 017594           50 KFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS--GQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIYEY  126 (369)
Q Consensus        50 ~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  126 (369)
                      .|++++.||.|++|.||+|+++ +|+.|++|.+....  ......+..|+++++.++|||++++++++......++++||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF   80 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence            4889999999999999999975 48899999886432  22335678899999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCCCCc
Q 017594          127 MPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNEL  206 (369)
Q Consensus       127 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~~~~  206 (369)
                      +. ++|..++.... ...+++..+..++.|++.||+|||..+   ++|+||+|+||+++.++.++|+|||++........
T Consensus        81 ~~-~~l~~~~~~~~-~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~  155 (284)
T cd07860          81 LH-QDLKKFMDASP-LSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR  155 (284)
T ss_pred             cc-cCHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhcccCcc
Confidence            96 56777664422 345788999999999999999999998   99999999999999999999999998875532221


Q ss_pred             ccccccccccccccCchhhccCC-CCcccchHhHHHHHHHHHhCCCCCCCCcccccccch---------hhhhhhh-cCc
Q 017594          207 QANTSRIVGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLG---------YAWDLWT-SNR  275 (369)
Q Consensus       207 ~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~---------~~~~~~~-~~~  275 (369)
                        ......++..|+|||.+.+.. ++.++|+||||+++|+|+||+.||............         ..+.... ...
T Consensus       156 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (284)
T cd07860         156 --TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPD  233 (284)
T ss_pred             --ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHH
Confidence              112234577899999876544 688999999999999999999998644321100000         0000000 000


Q ss_pred             cccccCccccccc--cHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 017594          276 TLELIDPILEDEY--SSKQMLLRYANIALLCVQESADDRPTMNDVVS  320 (369)
Q Consensus       276 ~~~~~~~~~~~~~--~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~  320 (369)
                      .............  .....+.++.++|.+||+.||.+||+++++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~  280 (284)
T cd07860         234 YKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA  280 (284)
T ss_pred             HHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence            0000000000000  01112566889999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=2.2e-35  Score=270.64  Aligned_cols=248  Identities=29%  Similarity=0.439  Sum_probs=193.8

Q ss_pred             HhcCCccCccccccCCccEEEEEEc-CCCEEEEEEecCCC---chhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEE
Q 017594           47 ATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS---GQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKIL  122 (369)
Q Consensus        47 ~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l  122 (369)
                      ..++|.+.+.||.|++|.||+|+.. +|+.|++|.+....   ......+..|+.+++.++|||++++.+++......++
T Consensus        13 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~l   92 (307)
T cd06607          13 PEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWL   92 (307)
T ss_pred             cchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEE
Confidence            3467999999999999999999965 48899999886432   2334567889999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecC
Q 017594          123 IYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICG  202 (369)
Q Consensus       123 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~  202 (369)
                      |+||+.+ ++.+++...  ...+++..+..++.|++.||.|||+.+   ++|+||+|.||+++.++.++|+|||++....
T Consensus        93 v~e~~~g-~l~~~~~~~--~~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~  166 (307)
T cd06607          93 VMEYCLG-SASDILEVH--KKPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVS  166 (307)
T ss_pred             EHHhhCC-CHHHHHHHc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceecC
Confidence            9999975 554554322  234889999999999999999999998   9999999999999999999999999886543


Q ss_pred             CCCcccccccccccccccCchhhc---cCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCccccc
Q 017594          203 GNELQANTSRIVGTYGYMSPEYAL---EGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLEL  279 (369)
Q Consensus       203 ~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (369)
                      ..      ....++..|+|||++.   ...++.++||||+|+++|+|++|..||.......     ...... ....   
T Consensus       167 ~~------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~-----~~~~~~-~~~~---  231 (307)
T cd06607         167 PA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-----ALYHIA-QNDS---  231 (307)
T ss_pred             CC------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHH-----HHHHHh-cCCC---
Confidence            21      2235677899999874   4568899999999999999999999985332110     000000 0000   


Q ss_pred             cCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 017594          280 IDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSM  321 (369)
Q Consensus       280 ~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~  321 (369)
                            .......++..+.++|.+||+.+|++||++.+++..
T Consensus       232 ------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  267 (307)
T cd06607         232 ------PTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH  267 (307)
T ss_pred             ------CCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence                  011122246679999999999999999999999874

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=1.3e-35  Score=272.36  Aligned_cols=265  Identities=23%  Similarity=0.308  Sum_probs=192.8

Q ss_pred             hcCCccCccccccCCccEEEEEEc-CCCEEEEEEecCCCc--hhHHHHHHHHHHHhcCCCCceeeeeeeEEeC--CccEE
Q 017594           48 TNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSG--QGLREMKNEASVIAKVQHKNLVRLLGCCIDR--DEKIL  122 (369)
Q Consensus        48 ~~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~l  122 (369)
                      ..+|++.+.||.|++|.||+|.++ +|+.||+|.+.....  .......+|+.++++++|+|++++++++...  +..++
T Consensus         6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (309)
T cd07845           6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL   85 (309)
T ss_pred             ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence            468999999999999999999975 489999999864322  1223456799999999999999999998755  45799


Q ss_pred             EEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecC
Q 017594          123 IYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICG  202 (369)
Q Consensus       123 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~  202 (369)
                      |+||+.+ +|..++...  ...+++..++.++.||+.||.|||+.+   ++|+||+|+||+++.++.++|+|||.+....
T Consensus        86 v~e~~~~-~l~~~l~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~  159 (309)
T cd07845          86 VMEYCEQ-DLASLLDNM--PTPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYG  159 (309)
T ss_pred             EEecCCC-CHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeeecC
Confidence            9999975 676666432  245889999999999999999999999   9999999999999999999999999988765


Q ss_pred             CCCcccccccccccccccCchhhcc-CCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccc---------hhhhhhhh
Q 017594          203 GNELQANTSRIVGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLL---------GYAWDLWT  272 (369)
Q Consensus       203 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~---------~~~~~~~~  272 (369)
                      ....  ......++..|+|||.+.+ ..++.++|+||||+++|+|++|..||...........         ...+....
T Consensus       160 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (309)
T cd07845         160 LPAK--PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFS  237 (309)
T ss_pred             CccC--CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhh
Confidence            3321  1112234678999998865 4578999999999999999999999864331110000         00000000


Q ss_pred             cCcc---ccccCccccc-cccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 017594          273 SNRT---LELIDPILED-EYSSKQMLLRYANIALLCVQESADDRPTMNDVVS  320 (369)
Q Consensus       273 ~~~~---~~~~~~~~~~-~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~  320 (369)
                      ....   .......... .......+.++.++|.+||+.||++|||+.++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~  289 (309)
T cd07845         238 DLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE  289 (309)
T ss_pred             cccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence            0000   0000000000 0000112567889999999999999999999996

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-35  Score=267.89  Aligned_cols=262  Identities=23%  Similarity=0.318  Sum_probs=196.7

Q ss_pred             CccCccccccCCccEEEEEEc-CCCEEEEEEecCCCc--hhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEEEEec
Q 017594           51 FSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSG--QGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIYEYM  127 (369)
Q Consensus        51 y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~  127 (369)
                      |++.+.||.|++|.||+|..+ +|+.+++|.+.....  .....+..|+.+++.++|++++++++++..+...++++||+
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   80 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM   80 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence            678899999999999999965 588899999875432  23467778999999999999999999999999999999999


Q ss_pred             CCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCCCCcc
Q 017594          128 PNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQ  207 (369)
Q Consensus       128 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~~~~~  207 (369)
                      .+ ++..++....  ..+++..+..++.|++.||.+||+++   ++|+||+|+||+++.++.++|+|||.+.......  
T Consensus        81 ~~-~l~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~--  152 (283)
T cd05118          81 DT-DLYKLIKDRQ--RGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPV--  152 (283)
T ss_pred             CC-CHHHHHHhhc--ccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc--
Confidence            76 6666664322  35889999999999999999999999   9999999999999999999999999987665432  


Q ss_pred             cccccccccccccCchhhccC-CCCcccchHhHHHHHHHHHhCCCCCCCCcccccccc---------hhhhhhhhc---C
Q 017594          208 ANTSRIVGTYGYMSPEYALEG-IFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLL---------GYAWDLWTS---N  274 (369)
Q Consensus       208 ~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~---------~~~~~~~~~---~  274 (369)
                      .......++..|.|||.+.+. .++.++|+||||+++|+|++|+.||...........         ...+.....   .
T Consensus       153 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (283)
T cd05118         153 RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARN  232 (283)
T ss_pred             ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhh
Confidence            111223467789999998776 789999999999999999999999864332110000         000000000   0


Q ss_pred             ccccccCc-cccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 017594          275 RTLELIDP-ILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVS  320 (369)
Q Consensus       275 ~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~  320 (369)
                      ........ ...........+.++.++|.+||+.||.+||++.+++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~  279 (283)
T cd05118         233 YKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA  279 (283)
T ss_pred             hhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence            00000000 00000112234678999999999999999999999986

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.2e-36  Score=283.27  Aligned_cols=253  Identities=23%  Similarity=0.365  Sum_probs=198.1

Q ss_pred             HHHHhcCCccCccccccCCccEEEEEEcC-CCEEE---EEEecC-CCchhHHHHHHHHHHHhcCCCCceeeeeeeEEeCC
Q 017594           44 VSTATNKFSDANKLGEGGFGPVYKGVLKK-GDEIA---VKRLSG-RSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDRD  118 (369)
Q Consensus        44 ~~~~~~~y~i~~~lg~G~~~~v~~~~~~~-~~~va---lK~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~  118 (369)
                      .....+-.+....||+|+|-+||+|.+.. |-.||   +|.-.. ......+++..|+++|+.|+|+||+++++++.+..
T Consensus        35 ~~p~gRy~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~  114 (632)
T KOG0584|consen   35 KDPTGRYLKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTD  114 (632)
T ss_pred             cCCCCceeehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCC
Confidence            33444445677899999999999999754 66665   332111 23455688999999999999999999999998776


Q ss_pred             c--cEEEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCC-CceEEeec
Q 017594          119 E--KILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKD-MNPKISDF  195 (369)
Q Consensus       119 ~--~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~-~~~~L~Df  195 (369)
                      .  ..+|+|.+..|+|..+.....+   ++...+.+|++||++||.|||++ +++|+|||||-+||||+.+ |.|||+|+
T Consensus       115 n~~in~iTEL~TSGtLr~Y~kk~~~---vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDL  190 (632)
T KOG0584|consen  115 NKTINFITELFTSGTLREYRKKHRR---VNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDL  190 (632)
T ss_pred             CceeeeeeecccCCcHHHHHHHhcc---CCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecch
Confidence            5  7899999999999999965444   88889999999999999999999 5789999999999999765 89999999


Q ss_pred             CCceecCCCCcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCc
Q 017594          196 GMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNR  275 (369)
Q Consensus       196 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  275 (369)
                      |++.......    .....|||.|+|||+.. -.|+...|||||||.++||.|+..||..+.....     +.+....+.
T Consensus       191 GLAtl~r~s~----aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQ-----IYKKV~SGi  260 (632)
T KOG0584|consen  191 GLATLLRKSH----AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQ-----IYKKVTSGI  260 (632)
T ss_pred             hHHHHhhccc----cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHH-----HHHHHHcCC
Confidence            9998765332    22358999999999765 7899999999999999999999999875542221     111112221


Q ss_pred             cccccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 017594          276 TLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVS  320 (369)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~  320 (369)
                      ....+.+.-         .++++++|.+||.. .++|||+.|||.
T Consensus       261 KP~sl~kV~---------dPevr~fIekCl~~-~~~R~sa~eLL~  295 (632)
T KOG0584|consen  261 KPAALSKVK---------DPEVREFIEKCLAT-KSERLSAKELLK  295 (632)
T ss_pred             CHHHhhccC---------CHHHHHHHHHHhcC-chhccCHHHHhh
Confidence            111111111         46799999999999 999999999995

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=1.3e-35  Score=275.39  Aligned_cols=267  Identities=19%  Similarity=0.281  Sum_probs=196.3

Q ss_pred             HhcCCccCccccccCCccEEEEEEc-CCCEEEEEEecCCC--chhHHHHHHHHHHHhcCCCCceeeeeeeEEe----CCc
Q 017594           47 ATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS--GQGLREMKNEASVIAKVQHKNLVRLLGCCID----RDE  119 (369)
Q Consensus        47 ~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~  119 (369)
                      ...+|++.+.||.|++|.||+|+.+ +|..|++|++....  ......+..|+.+++.++||||+++.+++..    ...
T Consensus         3 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   82 (334)
T cd07855           3 VGSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKD   82 (334)
T ss_pred             hhhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCce
Confidence            3478999999999999999999965 48999999987542  2334567789999999999999999988763    345


Q ss_pred             cEEEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCce
Q 017594          120 KILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMAR  199 (369)
Q Consensus       120 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~  199 (369)
                      .++|+||+. ++|..++..   ...+++..++.++.||+.||.|||+.+   ++|+||+|+||+++.++.++|+|||++.
T Consensus        83 ~~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~~  155 (334)
T cd07855          83 VYVVMDLME-SDLHHIIHS---DQPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMAR  155 (334)
T ss_pred             EEEEEehhh-hhHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEecccccce
Confidence            799999996 578777743   234899999999999999999999998   9999999999999999999999999987


Q ss_pred             ecCCCCcc--cccccccccccccCchhhcc-CCCCcccchHhHHHHHHHHHhCCCCCCCCccccccc---------chhh
Q 017594          200 ICGGNELQ--ANTSRIVGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNL---------LGYA  267 (369)
Q Consensus       200 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~---------~~~~  267 (369)
                      ........  .......++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||..........         ....
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~  235 (334)
T cd07855         156 GLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEV  235 (334)
T ss_pred             eecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHh
Confidence            65432211  11123467889999998765 458899999999999999999999996432110000         0000


Q ss_pred             hhhhhcCccccccCccccc-ccc----HHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 017594          268 WDLWTSNRTLELIDPILED-EYS----SKQMLLRYANIALLCVQESADDRPTMNDVVS  320 (369)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~-~~~----~~~~~~~l~~li~~~L~~dP~~Rps~~ell~  320 (369)
                      ................... ...    ....+.++.++|.+||+.+|.+||++.+++.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~  293 (334)
T cd07855         236 LNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQ  293 (334)
T ss_pred             hhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence            0000000000000000000 000    1123677999999999999999999999986

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=3.2e-35  Score=267.59  Aligned_cols=247  Identities=23%  Similarity=0.339  Sum_probs=195.8

Q ss_pred             CccCccccccCCccEEEEEEc-CCCEEEEEEecCCCchhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEEEEecCC
Q 017594           51 FSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIYEYMPN  129 (369)
Q Consensus        51 y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~  129 (369)
                      |.....||.|++|.||++..+ +|+.|++|.+..........+.+|+.+++.+.|+|++++++.+...+..++++||+.+
T Consensus        22 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~  101 (292)
T cd06657          22 LDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEG  101 (292)
T ss_pred             hhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCC
Confidence            444578999999999999965 5889999998655545556788899999999999999999999999999999999999


Q ss_pred             CChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCCCCcccc
Q 017594          130 KSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQAN  209 (369)
Q Consensus       130 ~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~~~~~~~  209 (369)
                      ++|.+++..    ..+++..+..++.|++.|++|||+.|   ++|+||+|.||+++.++.++|+|||++.......  ..
T Consensus       102 ~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~--~~  172 (292)
T cd06657         102 GALTDIVTH----TRMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV--PR  172 (292)
T ss_pred             CcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceeccccc--cc
Confidence            999887732    23788899999999999999999998   9999999999999999999999999876554322  11


Q ss_pred             cccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCccccccCcccccccc
Q 017594          210 TSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYS  289 (369)
Q Consensus       210 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  289 (369)
                      .....++..|+|||.+.+..++.++|+||+|+++|+|++|..||........  .    .....     .....+..   
T Consensus       173 ~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~--~----~~~~~-----~~~~~~~~---  238 (292)
T cd06657         173 RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKA--M----KMIRD-----NLPPKLKN---  238 (292)
T ss_pred             ccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--H----HHHHh-----hCCcccCC---
Confidence            2224577889999999888889999999999999999999999864321110  0    00000     00000000   


Q ss_pred             HHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 017594          290 SKQMLLRYANIALLCVQESADDRPTMNDVVS  320 (369)
Q Consensus       290 ~~~~~~~l~~li~~~L~~dP~~Rps~~ell~  320 (369)
                      ....+..+.+++.+||+.+|.+||++.++++
T Consensus       239 ~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~  269 (292)
T cd06657         239 LHKVSPSLKGFLDRLLVRDPAQRATAAELLK  269 (292)
T ss_pred             cccCCHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence            0112556889999999999999999999997

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=4.9e-35  Score=264.30  Aligned_cols=244  Identities=27%  Similarity=0.397  Sum_probs=189.9

Q ss_pred             ccccCCccEEEEEEc-CCCEEEEEEecCCC---chhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEEEEecCCCCh
Q 017594           57 LGEGGFGPVYKGVLK-KGDEIAVKRLSGRS---GQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSL  132 (369)
Q Consensus        57 lg~G~~~~v~~~~~~-~~~~valK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L  132 (369)
                      ||.|+||+||+|..+ +|+.|++|.+....   ......+..|+.+++.++|||++++.+.+...+..++|+||+++++|
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            689999999999965 48899999886432   22234556799999999999999999999998999999999999999


Q ss_pred             hhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCCCCccccccc
Q 017594          133 DFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR  212 (369)
Q Consensus       133 ~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~~~~~~~~~~  212 (369)
                      .+++..... ..+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||.+.......   ....
T Consensus        81 ~~~l~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~---~~~~  153 (277)
T cd05577          81 KYHIYNVGE-PGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK---KIKG  153 (277)
T ss_pred             HHHHHHcCc-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhccCC---cccc
Confidence            988854332 35889999999999999999999999   9999999999999999999999999887543211   1222


Q ss_pred             ccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCccccccCccccccccHHH
Q 017594          213 IVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYSSKQ  292 (369)
Q Consensus       213 ~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  292 (369)
                      ..++..|+|||.+.+..++.++|+||||+++|+|++|+.||.........      .... ...... ..     ..+..
T Consensus       154 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~------~~~~-~~~~~~-~~-----~~~~~  220 (277)
T cd05577         154 RAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEK------EELK-RRTLEM-AV-----EYPDK  220 (277)
T ss_pred             ccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccH------HHHH-hccccc-cc-----cCCcc
Confidence            35677899999998888999999999999999999999998643321100      0000 000000 00     01112


Q ss_pred             HHHHHHHHHHHhhcCCCCCCC-----CHHHHHH
Q 017594          293 MLLRYANIALLCVQESADDRP-----TMNDVVS  320 (369)
Q Consensus       293 ~~~~l~~li~~~L~~dP~~Rp-----s~~ell~  320 (369)
                      ++..+.++|.+||+.+|++||     ++.+++.
T Consensus       221 ~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~  253 (277)
T cd05577         221 FSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE  253 (277)
T ss_pred             CCHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence            266789999999999999999     7777765

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=3.5e-35  Score=265.93  Aligned_cols=263  Identities=23%  Similarity=0.303  Sum_probs=193.7

Q ss_pred             CccCccccccCCccEEEEEEc-CCCEEEEEEecCCC--chhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEEEEec
Q 017594           51 FSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS--GQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIYEYM  127 (369)
Q Consensus        51 y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~  127 (369)
                      |++.+.||.|++|.||+|.++ +|..|++|++....  ......+.+|+..++.++|+|++++++++......++++||+
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~   80 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL   80 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence            788999999999999999965 58999999986442  222356778999999999999999999999999999999999


Q ss_pred             CCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCCCCcc
Q 017594          128 PNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQ  207 (369)
Q Consensus       128 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~~~~~  207 (369)
                      . ++|..++..... ..+++..+..++.|++.||+|||+++   ++|+||+|.||+++.++.++|+|||.+.........
T Consensus        81 ~-~~l~~~~~~~~~-~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~  155 (283)
T cd07835          81 D-LDLKKYMDSSPL-TGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRT  155 (283)
T ss_pred             C-cCHHHHHhhCCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccCCCccc
Confidence            5 578777754331 35889999999999999999999998   999999999999999999999999998755322111


Q ss_pred             cccccccccccccCchhhccC-CCCcccchHhHHHHHHHHHhCCCCCCCCcccccccc---------hhhhhhhhc-Ccc
Q 017594          208 ANTSRIVGTYGYMSPEYALEG-IFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLL---------GYAWDLWTS-NRT  276 (369)
Q Consensus       208 ~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~---------~~~~~~~~~-~~~  276 (369)
                        .....++..|+|||++.+. .++.++|+||||+++|+|++|..||...........         ...+..... ...
T Consensus       156 --~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (283)
T cd07835         156 --YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDY  233 (283)
T ss_pred             --cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhh
Confidence              1222457789999987654 578899999999999999999999864432110000         000000000 000


Q ss_pred             ccccCccccc--cccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 017594          277 LELIDPILED--EYSSKQMLLRYANIALLCVQESADDRPTMNDVVS  320 (369)
Q Consensus       277 ~~~~~~~~~~--~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~  320 (369)
                      ..........  ......++..+.++|.+||+.+|.+||+++++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~  279 (283)
T cd07835         234 KPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ  279 (283)
T ss_pred             hhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence            0000000000  0001112467899999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=4.4e-35  Score=266.96  Aligned_cols=263  Identities=16%  Similarity=0.182  Sum_probs=183.7

Q ss_pred             HHHhcCCccCccccccCCccEEEEEEcCC----CEEEEEEecCCCchhH-----------HHHHHHHHHHhcCCCCceee
Q 017594           45 STATNKFSDANKLGEGGFGPVYKGVLKKG----DEIAVKRLSGRSGQGL-----------REMKNEASVIAKVQHKNLVR  109 (369)
Q Consensus        45 ~~~~~~y~i~~~lg~G~~~~v~~~~~~~~----~~valK~~~~~~~~~~-----------~~~~~e~~~l~~l~h~~i~~  109 (369)
                      ....++|++.+.||+|+||.||+|...++    ..+++|..........           .....+...+..+.|+++++
T Consensus         8 ~i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~   87 (294)
T PHA02882          8 DITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPK   87 (294)
T ss_pred             ccCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCc
Confidence            35568999999999999999999996543    4566665432221110           01122334556678999999


Q ss_pred             eeeeEEeCC----ccEEEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEe
Q 017594          110 LLGCCIDRD----EKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLD  185 (369)
Q Consensus       110 ~~~~~~~~~----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~  185 (369)
                      +++++....    ..+++++++.. ++.+.+..   ....++..+..++.|++.||+|||+.+   ++||||||+||+++
T Consensus        88 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill~  160 (294)
T PHA02882         88 YYGCGSFKRCRMYYRFILLEKLVE-NTKEIFKR---IKCKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVD  160 (294)
T ss_pred             EEEeeeEecCCceEEEEEEehhcc-CHHHHHHh---hccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEc
Confidence            998766543    23677776643 44444422   122567788899999999999999998   99999999999999


Q ss_pred             CCCceEEeecCCceecCCCCcc-----cccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccc
Q 017594          186 KDMNPKISDFGMARICGGNELQ-----ANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDS  260 (369)
Q Consensus       186 ~~~~~~L~Dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~  260 (369)
                      .++.++|+|||++..+......     .......|++.|+|||+..+..++.++|||||||++|+|++|..||.......
T Consensus       161 ~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~  240 (294)
T PHA02882        161 GNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNG  240 (294)
T ss_pred             CCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccch
Confidence            9999999999998876422111     11122468999999999999999999999999999999999999997553211


Q ss_pred             cccchhhhhhhhcCccccccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 017594          261 LNLLGYAWDLWTSNRTLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLT  323 (369)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L~  323 (369)
                      ........+         .+.....+.......+..+.+++..|++.+|++||++.+|++.|+
T Consensus       241 ~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~  294 (294)
T PHA02882        241 NLIHAAKCD---------FIKRLHEGKIKIKNANKFIYDFIECVTKLSYEEKPDYDALIKIFD  294 (294)
T ss_pred             HHHHHhHHH---------HHHHhhhhhhccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence            110000000         001111111111122566999999999999999999999998763

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=2e-35  Score=263.28  Aligned_cols=249  Identities=26%  Similarity=0.356  Sum_probs=200.5

Q ss_pred             CCccCccccccCCccEEEEEEc-CCCEEEEEEecCCC--chhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEEEEe
Q 017594           50 KFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS--GQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIYEY  126 (369)
Q Consensus        50 ~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  126 (369)
                      +|++.+.||.|++|.||+++.+ +++.+++|.+....  ......+..|+..++.++|+|++++.+++......++++||
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY   80 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence            5889999999999999999865 57899999986432  23345667899999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCC-CccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCCCC
Q 017594          127 MPNKSLDFFLFDP-TKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE  205 (369)
Q Consensus       127 ~~~~~L~~~l~~~-~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~~~  205 (369)
                      +++++|..++... .....+++..++.++.|++.||.+||+.|   ++|+||+|.||+++.++.++|+|||++...... 
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~-  156 (256)
T cd08530          81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKKN-  156 (256)
T ss_pred             cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence            9999998887542 12355788899999999999999999998   999999999999999999999999998766543 


Q ss_pred             cccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCccccccCcccc
Q 017594          206 LQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILE  285 (369)
Q Consensus       206 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (369)
                         ......++..|+|||...+..++.++|+||||+++++|++|+.||.......     ..... .....         
T Consensus       157 ---~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~-----~~~~~-~~~~~---------  218 (256)
T cd08530         157 ---MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQD-----LRYKV-QRGKY---------  218 (256)
T ss_pred             ---CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-----HHHHH-hcCCC---------
Confidence               1222357889999999998889999999999999999999999986433110     00000 00000         


Q ss_pred             ccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 017594          286 DEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSM  321 (369)
Q Consensus       286 ~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~  321 (369)
                      .. .+..++.++.+++.+||+.+|++||++.++++.
T Consensus       219 ~~-~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  253 (256)
T cd08530         219 PP-IPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS  253 (256)
T ss_pred             CC-CchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence            00 112346779999999999999999999999863

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=7.3e-35  Score=263.54  Aligned_cols=260  Identities=21%  Similarity=0.241  Sum_probs=188.8

Q ss_pred             CccCccccccCCccEEEEEEc-CCCEEEEEEecCCC-chhHHHHHHHHHHHhcCC-CCceeeeeeeEEeC--CccEEEEE
Q 017594           51 FSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS-GQGLREMKNEASVIAKVQ-HKNLVRLLGCCIDR--DEKILIYE  125 (369)
Q Consensus        51 y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~~-~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~--~~~~lv~e  125 (369)
                      |++.+.||.|++|.||+|... ++..|++|++.... .........|+..+.++. |+|++++++++.+.  +..++|+|
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e   80 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE   80 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence            788999999999999999965 48899999886532 112223446888888885 99999999999887  78999999


Q ss_pred             ecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCCCC
Q 017594          126 YMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE  205 (369)
Q Consensus       126 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~~~  205 (369)
                      |+.+ ++.+.+...  ...+++..++.++.|++.||.|||+.+   ++|+||+|+||+++. +.++|+|||++.......
T Consensus        81 ~~~~-~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~  153 (282)
T cd07831          81 LMDM-NLYELIKGR--KRPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYSKP  153 (282)
T ss_pred             cCCc-cHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEecccccccccCC
Confidence            9975 565555432  245889999999999999999999998   999999999999999 999999999987654322


Q ss_pred             cccccccccccccccCchhhc-cCCCCcccchHhHHHHHHHHHhCCCCCCCCccccc-cc--------chhhhhhhhcCc
Q 017594          206 LQANTSRIVGTYGYMSPEYAL-EGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSL-NL--------LGYAWDLWTSNR  275 (369)
Q Consensus       206 ~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~-~~--------~~~~~~~~~~~~  275 (369)
                      .   .....++..|+|||... +..++.++|+|||||++|+|++|..||........ ..        ............
T Consensus       154 ~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (282)
T cd07831         154 P---YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSR  230 (282)
T ss_pred             C---cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccc
Confidence            1   12235678899999764 45578899999999999999999999964331110 00        000000000000


Q ss_pred             cccccCccccc-c--ccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 017594          276 TLELIDPILED-E--YSSKQMLLRYANIALLCVQESADDRPTMNDVVS  320 (369)
Q Consensus       276 ~~~~~~~~~~~-~--~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~  320 (369)
                      ......+.... .  ......+..+.++|.+||+.+|++||++.++++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~  278 (282)
T cd07831         231 HMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR  278 (282)
T ss_pred             cccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence            00000000000 0  001133678999999999999999999999986

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=3.3e-35  Score=269.42  Aligned_cols=266  Identities=21%  Similarity=0.303  Sum_probs=191.1

Q ss_pred             HhcCCccCccccccCCccEEEEEEc-CCCEEEEEEecCCCc--hhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCc----
Q 017594           47 ATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSG--QGLREMKNEASVIAKVQHKNLVRLLGCCIDRDE----  119 (369)
Q Consensus        47 ~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~----  119 (369)
                      ..++|++.+.||.|++|.||+|+.+ +++.|++|.+.....  .....+.+|+.+++.++|||++++++++.....    
T Consensus        10 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   89 (310)
T cd07865          10 EVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNR   89 (310)
T ss_pred             hhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccC
Confidence            4467999999999999999999975 488999998864321  223345679999999999999999998875543    


Q ss_pred             ----cEEEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeec
Q 017594          120 ----KILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDF  195 (369)
Q Consensus       120 ----~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Df  195 (369)
                          .++|+||+.+ ++...+...  ...+++..++.++.||+.||.|||+++   ++|+||+|+||+++.++.++|+||
T Consensus        90 ~~~~~~lv~e~~~~-~l~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~df  163 (310)
T cd07865          90 YKGSFYLVFEFCEH-DLAGLLSNK--NVKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADF  163 (310)
T ss_pred             CCceEEEEEcCCCc-CHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEECcC
Confidence                4999999975 566655332  234889999999999999999999998   999999999999999999999999


Q ss_pred             CCceecCCCCcc--cccccccccccccCchhhccC-CCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhh--
Q 017594          196 GMARICGGNELQ--ANTSRIVGTYGYMSPEYALEG-IFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDL--  270 (369)
Q Consensus       196 g~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~--  270 (369)
                      |++.........  .......++..|+|||.+.+. .++.++|+||+|+++|+|++|..||........  .......  
T Consensus       164 g~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~--~~~~~~~~~  241 (310)
T cd07865         164 GLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQ--LTLISQLCG  241 (310)
T ss_pred             CCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHHhC
Confidence            998766432211  111223467789999987654 478899999999999999999999864432110  0000000  


Q ss_pred             ------hhcC---cccc------ccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 017594          271 ------WTSN---RTLE------LIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVS  320 (369)
Q Consensus       271 ------~~~~---~~~~------~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~  320 (369)
                            +...   ....      ...............+..+.++|.+||+.||.+|||++++++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~  306 (310)
T cd07865         242 SITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN  306 (310)
T ss_pred             CCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence                  0000   0000      000000000000001345789999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=2e-35  Score=263.42  Aligned_cols=249  Identities=24%  Similarity=0.368  Sum_probs=197.3

Q ss_pred             CCccCccccccCCccEEEEEEcC-CCEEEEEEecCCC--chhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEEEEe
Q 017594           50 KFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRS--GQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIYEY  126 (369)
Q Consensus        50 ~y~i~~~lg~G~~~~v~~~~~~~-~~~valK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  126 (369)
                      +|++.+.||.|++|.||+|..+. |..+++|.+....  ....+.+.+|+.+++.++|+|++++++.+......++++||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   80 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY   80 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence            58899999999999999999764 8889999986432  22345678899999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCc-eEEeecCCceecCCCC
Q 017594          127 MPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMN-PKISDFGMARICGGNE  205 (369)
Q Consensus       127 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~-~~L~Dfg~~~~~~~~~  205 (369)
                      +.+++|.+++.... ...+++..+..++.|++.|+.|||+.+   ++|+||+|.||+++.++. ++|+|||.+.......
T Consensus        81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~  156 (257)
T cd08225          81 CDGGDLMKRINRQR-GVLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM  156 (257)
T ss_pred             CCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhccCCc
Confidence            99999988885432 234788899999999999999999998   999999999999988864 6999999887654322


Q ss_pred             cccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCccccccCcccc
Q 017594          206 LQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILE  285 (369)
Q Consensus       206 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (369)
                      .  ......++..|+|||...+..++.++|+||+|+++++|++|..||......     ........ ..    ..+.  
T Consensus       157 ~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-----~~~~~~~~-~~----~~~~--  222 (257)
T cd08225         157 E--LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLH-----QLVLKICQ-GY----FAPI--  222 (257)
T ss_pred             c--cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHH-----HHHHHHhc-cc----CCCC--
Confidence            1  112235788899999998888999999999999999999999998633211     01111110 00    0000  


Q ss_pred             ccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 017594          286 DEYSSKQMLLRYANIALLCVQESADDRPTMNDVVS  320 (369)
Q Consensus       286 ~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~  320 (369)
                          ....+.++.++|.+||+.+|++|||+.++++
T Consensus       223 ----~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~  253 (257)
T cd08225         223 ----SPNFSRDLRSLISQLFKVSPRDRPSITSILK  253 (257)
T ss_pred             ----CCCCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence                1112567999999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=2.7e-35  Score=268.23  Aligned_cols=264  Identities=20%  Similarity=0.246  Sum_probs=192.4

Q ss_pred             cCCccCccccccCCccEEEEEEc-CCCEEEEEEecCCC--chhHHHHHHHHHHHhcCC-CCceeeeeeeEEeCCc-----
Q 017594           49 NKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS--GQGLREMKNEASVIAKVQ-HKNLVRLLGCCIDRDE-----  119 (369)
Q Consensus        49 ~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~~--~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~-----  119 (369)
                      ++|++.+.||.|++|.||+|.+. +|+.|++|.+....  ......+.+|+.+++.+. |+|++++++++.....     
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~   80 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS   80 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence            47999999999999999999965 48899999876432  223356778999999995 6999999999887665     


Q ss_pred             cEEEEEecCCCChhhhhcCCCc--cccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeC-CCceEEeecC
Q 017594          120 KILIYEYMPNKSLDFFLFDPTK--RMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDK-DMNPKISDFG  196 (369)
Q Consensus       120 ~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~-~~~~~L~Dfg  196 (369)
                      .++++||+.+ ++..++.....  ...+++..++.++.||+.||.|||+.+   ++|+||+|+||+++. ++.++|+|||
T Consensus        81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg  156 (295)
T cd07837          81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLG  156 (295)
T ss_pred             EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeecc
Confidence            7999999986 67666643222  345899999999999999999999998   999999999999998 8899999999


Q ss_pred             CceecCCCCcccccccccccccccCchhhcc-CCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhc--
Q 017594          197 MARICGGNELQANTSRIVGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTS--  273 (369)
Q Consensus       197 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~--  273 (369)
                      ++..+......  .....+++.|.|||++.+ ..++.++|+||||+++|+|++|..||.......... .. ......  
T Consensus       157 ~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~-~~-~~~~~~~~  232 (295)
T cd07837         157 LGRAFSIPVKS--YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLL-HI-FKLLGTPT  232 (295)
T ss_pred             cceecCCCccc--cCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHH-HH-HHHhCCCC
Confidence            98765332111  112245778999998765 457899999999999999999999986432111000 00 000000  


Q ss_pred             Cccccc---------cCccccc--cccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 017594          274 NRTLEL---------IDPILED--EYSSKQMLLRYANIALLCVQESADDRPTMNDVVS  320 (369)
Q Consensus       274 ~~~~~~---------~~~~~~~--~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~  320 (369)
                      ......         .......  .......+..+.++|.+||..||.+||++.+++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~  290 (295)
T cd07837         233 EQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT  290 (295)
T ss_pred             hhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence            000000         0000000  0001123677999999999999999999999985

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=1e-36  Score=261.62  Aligned_cols=270  Identities=21%  Similarity=0.291  Sum_probs=198.3

Q ss_pred             cCCccCccccccCCccEEEEEEc-C----CCEEEEEEecCCC--chhHHHHHHHHHHHhcCCCCceeeeeeeEEe-CCcc
Q 017594           49 NKFSDANKLGEGGFGPVYKGVLK-K----GDEIAVKRLSGRS--GQGLREMKNEASVIAKVQHKNLVRLLGCCID-RDEK  120 (369)
Q Consensus        49 ~~y~i~~~lg~G~~~~v~~~~~~-~----~~~valK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~  120 (369)
                      .+|+++..||+|+||.||+|..+ +    ...+|+|.+....  +..-....+|+..++.++|||++.+..+|.. +..+
T Consensus        24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v  103 (438)
T KOG0666|consen   24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKV  103 (438)
T ss_pred             HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence            57999999999999999999732 2    2368999987542  2233567789999999999999999999987 7789


Q ss_pred             EEEEEecCCCChhhhhcC--CCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCC----CceEEee
Q 017594          121 ILIYEYMPNKSLDFFLFD--PTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKD----MNPKISD  194 (369)
Q Consensus       121 ~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~----~~~~L~D  194 (369)
                      ++++||.+...+ .++.-  ......++...+.+|+.||+.|+.|||++.   ++||||||.||+|..+    |+|||+|
T Consensus       104 ~l~fdYAEhDL~-~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VKIaD  179 (438)
T KOG0666|consen  104 WLLFDYAEHDLW-HIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVKIAD  179 (438)
T ss_pred             EEEehhhhhhHH-HHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeEeec
Confidence            999999987544 44432  223356889999999999999999999999   9999999999999888    9999999


Q ss_pred             cCCceecCCCCccc-ccccccccccccCchhhccC-CCCcccchHhHHHHHHHHHhCCCCCCCCcccccc----cchh--
Q 017594          195 FGMARICGGNELQA-NTSRIVGTYGYMSPEYALEG-IFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLN----LLGY--  266 (369)
Q Consensus       195 fg~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~----~~~~--  266 (369)
                      +|+++.+.+.-... .......|.+|.|||++.+. .|+.+.|+|++|||+.||++-.+.|.........    ..+.  
T Consensus       180 lGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~  259 (438)
T KOG0666|consen  180 LGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLD  259 (438)
T ss_pred             ccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHH
Confidence            99999887654333 34456679999999998765 5999999999999999999999888654311111    0111  


Q ss_pred             -hhhhh-----------hc-CccccccCccccccccH---H------H-HHHHHHHHHHHhhcCCCCCCCCHHHHHHHH
Q 017594          267 -AWDLW-----------TS-NRTLELIDPILEDEYSS---K------Q-MLLRYANIALLCVQESADDRPTMNDVVSML  322 (369)
Q Consensus       267 -~~~~~-----------~~-~~~~~~~~~~~~~~~~~---~------~-~~~~l~~li~~~L~~dP~~Rps~~ell~~L  322 (369)
                       .....           .. .+....+.........+   .      . -++...+|+.+||+.||-+|.|+.+.++..
T Consensus       260 rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~  338 (438)
T KOG0666|consen  260 RIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHP  338 (438)
T ss_pred             HHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhccc
Confidence             11110           00 00000111111000000   0      0 023478999999999999999999999753

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-35  Score=275.65  Aligned_cols=269  Identities=22%  Similarity=0.292  Sum_probs=195.6

Q ss_pred             HhcCCccCccccccCCccEEEEEEc-CCCEEEEEEecCCC-chhHHHHHHHHHHHhcCCCCceeeeeeeEEeC-----Cc
Q 017594           47 ATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCCIDR-----DE  119 (369)
Q Consensus        47 ~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~  119 (369)
                      +.++|++.+.||.|++|.||+|++. +|+.|++|.+.... ......+..|+.+++.++|+|++++++++...     ..
T Consensus         3 ~~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~   82 (336)
T cd07849           3 VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFND   82 (336)
T ss_pred             cccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccce
Confidence            3578999999999999999999965 58999999986432 23345677899999999999999999887643     34


Q ss_pred             cEEEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCce
Q 017594          120 KILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMAR  199 (369)
Q Consensus       120 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~  199 (369)
                      .++++|++.+ ++...+.    ...+++..++.++.|++.||.+||+.+   ++|+||+|+||+++.++.++|+|||++.
T Consensus        83 ~~lv~e~~~~-~l~~~~~----~~~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~  154 (336)
T cd07849          83 VYIVQELMET-DLYKLIK----TQHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLAR  154 (336)
T ss_pred             EEEEehhccc-CHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECccccee
Confidence            7999999975 6655553    234889999999999999999999999   9999999999999999999999999987


Q ss_pred             ecCCCCccc-ccccccccccccCchhhcc-CCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhh-----
Q 017594          200 ICGGNELQA-NTSRIVGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWT-----  272 (369)
Q Consensus       200 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~-----  272 (369)
                      ......... ......++..|+|||.+.+ ..++.++||||+|+++|+|++|+.||.......  ..........     
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~--~~~~~~~~~~~~~~~  232 (336)
T cd07849         155 IADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLH--QLNLILGVLGTPSQE  232 (336)
T ss_pred             eccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHcCCCCHH
Confidence            654322111 1123457888999998654 568899999999999999999999986432110  0000000000     


Q ss_pred             ------cCccccccCc-----cccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH--HHhh
Q 017594          273 ------SNRTLELIDP-----ILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSM--LTNE  325 (369)
Q Consensus       273 ------~~~~~~~~~~-----~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~--L~~~  325 (369)
                            .......+..     ...........+.++.+++.+||+.+|++||++.++++.  |+..
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~  298 (336)
T cd07849         233 DLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQY  298 (336)
T ss_pred             HHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCcccccc
Confidence                  0000000000     000000011225678999999999999999999999985  5444

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=2.6e-35  Score=267.46  Aligned_cols=255  Identities=26%  Similarity=0.398  Sum_probs=191.4

Q ss_pred             cCCccCccccccCCccEEEEEEcC-CCEEEEEEecCCC-chhHHHHHHHHHHHhcCC-CCceeeeeeeEEeCCccEEEEE
Q 017594           49 NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRS-GQGLREMKNEASVIAKVQ-HKNLVRLLGCCIDRDEKILIYE  125 (369)
Q Consensus        49 ~~y~i~~~lg~G~~~~v~~~~~~~-~~~valK~~~~~~-~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e  125 (369)
                      .+|+..+.||.|+||.||++.+.. |+.+++|.+.... ......+..|+..+.++. |+||+++++++..+...++++|
T Consensus         4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e   83 (288)
T cd06616           4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICME   83 (288)
T ss_pred             HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEe
Confidence            356778899999999999999654 8899999986443 234456778999999996 9999999999998889999999


Q ss_pred             ecCCCChhhhhcC--CCccccCChHHHHHHHHHHHHHHHHHhcC-CCCCcccCCCCCCCEEEeCCCceEEeecCCceecC
Q 017594          126 YMPNKSLDFFLFD--PTKRMLLDWVTRVQIIEGIAQGLLYLHQY-SRVRIIHRDLKASNILLDKDMNPKISDFGMARICG  202 (369)
Q Consensus       126 ~~~~~~L~~~l~~--~~~~~~~~~~~~~~i~~qi~~al~~LH~~-~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~  202 (369)
                      ++.. ++..+...  ......+++..+..++.|++.||+|||+. +   ++||||+|+||+++.++.++|+|||++....
T Consensus        84 ~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~  159 (288)
T cd06616          84 LMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK---IIHRDVKPSNILLDRNGNIKLCDFGISGQLV  159 (288)
T ss_pred             cccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC---eeccCCCHHHEEEccCCcEEEeecchhHHhc
Confidence            9864 44333211  11224588899999999999999999975 7   9999999999999999999999999987553


Q ss_pred             CCCcccccccccccccccCchhhccC---CCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCccccc
Q 017594          203 GNELQANTSRIVGTYGYMSPEYALEG---IFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLEL  279 (369)
Q Consensus       203 ~~~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (369)
                      ....   .....++..|+|||.+.+.   .++.++|+||+|+++|+|++|+.||.....    ..........      .
T Consensus       160 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~----~~~~~~~~~~------~  226 (288)
T cd06616         160 DSIA---KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS----VFDQLTQVVK------G  226 (288)
T ss_pred             cCCc---cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch----HHHHHhhhcC------C
Confidence            3221   1223567889999998765   689999999999999999999999864431    0000000000      0


Q ss_pred             cCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 017594          280 IDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSM  321 (369)
Q Consensus       280 ~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~  321 (369)
                      ..+.+.... ...++.++.+|+.+||+.+|++|||+.+|++.
T Consensus       227 ~~~~~~~~~-~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~  267 (288)
T cd06616         227 DPPILSNSE-EREFSPSFVNFINLCLIKDESKRPKYKELLEH  267 (288)
T ss_pred             CCCcCCCcC-CCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            001111110 12236679999999999999999999999863

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=2e-35  Score=274.43  Aligned_cols=268  Identities=19%  Similarity=0.283  Sum_probs=197.1

Q ss_pred             HhcCCccCccccccCCccEEEEEEc-CCCEEEEEEecCC--CchhHHHHHHHHHHHhcCCCCceeeeeeeEEeC-----C
Q 017594           47 ATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDR-----D  118 (369)
Q Consensus        47 ~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~  118 (369)
                      +.++|.+.+.||.|++|.||+|++. ++..|++|.+...  .......+..|+.+++.++|+|++++++++...     .
T Consensus         3 ~~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~   82 (337)
T cd07858           3 VDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFN   82 (337)
T ss_pred             cccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccC
Confidence            3568999999999999999999965 4899999988643  223345677899999999999999999987644     3


Q ss_pred             ccEEEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCc
Q 017594          119 EKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMA  198 (369)
Q Consensus       119 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~  198 (369)
                      ..++++||+. ++|..++...   ..+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++
T Consensus        83 ~~~lv~e~~~-~~L~~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~  155 (337)
T cd07858          83 DVYIVYELMD-TDLHQIIRSS---QTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLA  155 (337)
T ss_pred             cEEEEEeCCC-CCHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCccc
Confidence            4799999996 5777776432   34889999999999999999999998   999999999999999999999999998


Q ss_pred             eecCCCCcccccccccccccccCchhhcc-CCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhh-------
Q 017594          199 RICGGNELQANTSRIVGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDL-------  270 (369)
Q Consensus       199 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~-------  270 (369)
                      .......  .......++..|+|||.+.+ ..++.++|+||||+++|+|++|..||.......  ........       
T Consensus       156 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~  231 (337)
T cd07858         156 RTTSEKG--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVH--QLKLITELLGSPSEE  231 (337)
T ss_pred             cccCCCc--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHH--HHHHHHHHhCCCChH
Confidence            7654321  11122356788999998764 468899999999999999999999986432110  00000000       


Q ss_pred             ----hhcCccccc---cCccccc--cccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH--HHhh
Q 017594          271 ----WTSNRTLEL---IDPILED--EYSSKQMLLRYANIALLCVQESADDRPTMNDVVSM--LTNE  325 (369)
Q Consensus       271 ----~~~~~~~~~---~~~~~~~--~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~--L~~~  325 (369)
                          .........   +......  ......++.++.++|.+||+.+|++|||+.++++.  ++..
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~  297 (337)
T cd07858         232 DLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL  297 (337)
T ss_pred             HhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhh
Confidence                000000000   0000000  00011236778999999999999999999999976  5543

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=1.7e-35  Score=267.12  Aligned_cols=249  Identities=27%  Similarity=0.357  Sum_probs=199.8

Q ss_pred             cCCccCccccccCCccEEEEEEc-CCCEEEEEEecCC---CchhHHHHHHHHHHHhcCC-CCceeeeeeeEEeCCccEEE
Q 017594           49 NKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGR---SGQGLREMKNEASVIAKVQ-HKNLVRLLGCCIDRDEKILI  123 (369)
Q Consensus        49 ~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~---~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv  123 (369)
                      ++|.+.+.||.|++|.||+|+.. +|+.|++|++...   .......+..|+.+++.+. |+||+++++++...+..+++
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv   80 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV   80 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence            47999999999999999999975 5899999998643   2233466788999999998 99999999999999999999


Q ss_pred             EEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCC
Q 017594          124 YEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGG  203 (369)
Q Consensus       124 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~  203 (369)
                      ||++.+++|.+++...   ..+++..++.++.|++.||.+||+.+   ++|+||+|+||+++.++.++|+|||++.....
T Consensus        81 ~e~~~~~~L~~~l~~~---~~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~  154 (280)
T cd05581          81 LEYAPNGELLQYIRKY---GSLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDP  154 (280)
T ss_pred             EcCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCccccccCC
Confidence            9999999999888543   35899999999999999999999998   99999999999999999999999999876654


Q ss_pred             CCcc------------------cccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccch
Q 017594          204 NELQ------------------ANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLG  265 (369)
Q Consensus       204 ~~~~------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~  265 (369)
                      ....                  .......++..|+|||...+..++.++|+||||++++++++|..||.......     
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-----  229 (280)
T cd05581         155 NSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYL-----  229 (280)
T ss_pred             ccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHH-----
Confidence            3221                  11222346788999999888889999999999999999999999987443110     


Q ss_pred             hhhhhhhcCccccccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCH----HHHHH
Q 017594          266 YAWDLWTSNRTLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTM----NDVVS  320 (369)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~----~ell~  320 (369)
                      ......   ..    ...     .+..++..+.++|.+||+.+|++||++    .++++
T Consensus       230 ~~~~~~---~~----~~~-----~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~  276 (280)
T cd05581         230 TFQKIL---KL----EYS-----FPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA  276 (280)
T ss_pred             HHHHHH---hc----CCC-----CCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence            000000   00    000     011125668999999999999999999    77775

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=9.3e-35  Score=267.64  Aligned_cols=252  Identities=29%  Similarity=0.449  Sum_probs=195.4

Q ss_pred             cCCccCccccccCCccEEEEEEc-CCCEEEEEEecCCC---chhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEEE
Q 017594           49 NKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS---GQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIY  124 (369)
Q Consensus        49 ~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  124 (369)
                      +.|...+.||+|+||.||+|++. ++..+++|.+....   ......+..|+..++.++|+|++++++++..+...++|+
T Consensus        25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  104 (317)
T cd06635          25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVM  104 (317)
T ss_pred             hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEE
Confidence            44889999999999999999965 48899999986432   233456788999999999999999999999999999999


Q ss_pred             EecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCCC
Q 017594          125 EYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGN  204 (369)
Q Consensus       125 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~~  204 (369)
                      ||+.+ ++.+.+...  ...+++..+..++.|++.|+.|||+.+   ++|+||+|+||+++.++.++|+|||++..... 
T Consensus       105 e~~~g-~l~~~~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~-  177 (317)
T cd06635         105 EYCLG-SASDLLEVH--KKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASP-  177 (317)
T ss_pred             eCCCC-CHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccCC-
Confidence            99976 555555322  334888999999999999999999998   99999999999999999999999998764332 


Q ss_pred             CcccccccccccccccCchhhc---cCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCccccccC
Q 017594          205 ELQANTSRIVGTYGYMSPEYAL---EGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELID  281 (369)
Q Consensus       205 ~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (369)
                           .....++..|+|||.+.   ...++.++|+||+|+++|+|++|..||.......     ......... .     
T Consensus       178 -----~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~-----~~~~~~~~~-~-----  241 (317)
T cd06635         178 -----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-----ALYHIAQNE-S-----  241 (317)
T ss_pred             -----cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHH-----HHHHHHhcc-C-----
Confidence                 12235778899999874   4568899999999999999999999975322110     000000000 0     


Q ss_pred             ccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHhhhh
Q 017594          282 PILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNEAA  327 (369)
Q Consensus       282 ~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L~~~~~  327 (369)
                      +    ......++..+.+++.+||+.+|.+||++.++++.+-....
T Consensus       242 ~----~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~  283 (317)
T cd06635         242 P----TLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRE  283 (317)
T ss_pred             C----CCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhcc
Confidence            0    00111235668999999999999999999999987655444

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2e-35  Score=273.62  Aligned_cols=271  Identities=23%  Similarity=0.292  Sum_probs=201.7

Q ss_pred             CCccCccccccCCccEEEEEEcC-CCEEEEEEecCCC--chhHHHHHHHHHHHhcCCCCceeeeeeeEEeCC-----ccE
Q 017594           50 KFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRS--GQGLREMKNEASVIAKVQHKNLVRLLGCCIDRD-----EKI  121 (369)
Q Consensus        50 ~y~i~~~lg~G~~~~v~~~~~~~-~~~valK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~  121 (369)
                      +|++.+.||.|++|.||+|+... |+.|++|.+....  ....+.+..|+..++.++|+|++++.+++....     ..+
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY   80 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence            68999999999999999999764 8999999887543  334567888999999999999999999988765     789


Q ss_pred             EEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceec
Q 017594          122 LIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARIC  201 (369)
Q Consensus       122 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~  201 (369)
                      ++++|+.+ +|..++...   ..+++..++.++.||+.||.+||+.|   ++|+||+|.||+++.++.++|+|||.+...
T Consensus        81 lv~e~~~~-~l~~~l~~~---~~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~~~  153 (330)
T cd07834          81 IVTELMET-DLHKVIKSP---QPLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGV  153 (330)
T ss_pred             EEecchhh-hHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceEee
Confidence            99999974 677777432   25899999999999999999999999   999999999999999999999999998876


Q ss_pred             CCCCcc-cccccccccccccCchhhccC-CCCcccchHhHHHHHHHHHhCCCCCCCCcccccccc---------hhhhhh
Q 017594          202 GGNELQ-ANTSRIVGTYGYMSPEYALEG-IFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLL---------GYAWDL  270 (369)
Q Consensus       202 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~---------~~~~~~  270 (369)
                      ...... .......++..|+|||.+.+. .++.++|+||||+++|+|++|..||...........         ...+..
T Consensus       154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  233 (330)
T cd07834         154 DPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKF  233 (330)
T ss_pred             cccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhh
Confidence            543210 112233568889999999877 789999999999999999999999864432110000         000000


Q ss_pred             hhcCccccccCccccccc-----cHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH--HHhhhh
Q 017594          271 WTSNRTLELIDPILEDEY-----SSKQMLLRYANIALLCVQESADDRPTMNDVVSM--LTNEAA  327 (369)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~-----~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~--L~~~~~  327 (369)
                      .........+........     .....+..+.++|.+||+.+|++||++.+++..  +++...
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~  297 (330)
T cd07834         234 ITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHD  297 (330)
T ss_pred             ccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcc
Confidence            000000000000000000     011135678999999999999999999999974  555444

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=5.9e-35  Score=264.59  Aligned_cols=260  Identities=24%  Similarity=0.335  Sum_probs=194.7

Q ss_pred             CccCccccccCCccEEEEEEcC-CCEEEEEEecCCC--chhHHHHHHHHHHHhcCCCCceeeeeeeEEeC--CccEEEEE
Q 017594           51 FSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRS--GQGLREMKNEASVIAKVQHKNLVRLLGCCIDR--DEKILIYE  125 (369)
Q Consensus        51 y~i~~~lg~G~~~~v~~~~~~~-~~~valK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e  125 (369)
                      |++.+.||.|++|.||+|+..+ |+.+++|.+....  ......+..|+.+++.+.|+|++++++++...  ...++|+|
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e   80 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE   80 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence            7889999999999999999764 8899999997653  33345677899999999999999999999887  78999999


Q ss_pred             ecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCCCC
Q 017594          126 YMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE  205 (369)
Q Consensus       126 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~~~  205 (369)
                      |+.+ +|..++....  ..+++..++.++.||+.||++||+.+   ++|+||+|.||+++.++.++|+|||++.......
T Consensus        81 ~~~~-~l~~~~~~~~--~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~  154 (287)
T cd07840          81 YMDH-DLTGLLDSPE--VKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRN  154 (287)
T ss_pred             cccc-cHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccCCC
Confidence            9975 7777664332  35889999999999999999999998   9999999999999999999999999988665432


Q ss_pred             cccccccccccccccCchhhcc-CCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhh---cCc---c--
Q 017594          206 LQANTSRIVGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWT---SNR---T--  276 (369)
Q Consensus       206 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~---~~~---~--  276 (369)
                      . .......++..|+|||.+.+ ..++.++||||||+++|+|++|..||.........  ........   ...   .  
T Consensus       155 ~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~  231 (287)
T cd07840         155 S-ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQL--EKIFELCGSPTDENWPGVSK  231 (287)
T ss_pred             c-ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHH--HHHHHHhCCCchhhcccccc
Confidence            1 11222345778999997664 45789999999999999999999998644321100  00000000   000   0  


Q ss_pred             ---c------cccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 017594          277 ---L------ELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVS  320 (369)
Q Consensus       277 ---~------~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~  320 (369)
                         .      ......+... ....++..+.+++.+||+.+|.+||++.++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  283 (287)
T cd07840         232 LPWFENLKPKKPYKRRLREF-FKHLIDPSALDLLDKLLTLDPKKRISADQALQ  283 (287)
T ss_pred             chhhhhccccccchhHHHHH-hcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence               0      0000000000 00012567899999999999999999999986

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=1.4e-34  Score=261.63  Aligned_cols=242  Identities=24%  Similarity=0.285  Sum_probs=183.6

Q ss_pred             cccccCCccEEEEEEc-CCCEEEEEEecCCCc---hhHHHHHHHHHHH---hcCCCCceeeeeeeEEeCCccEEEEEecC
Q 017594           56 KLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSG---QGLREMKNEASVI---AKVQHKNLVRLLGCCIDRDEKILIYEYMP  128 (369)
Q Consensus        56 ~lg~G~~~~v~~~~~~-~~~~valK~~~~~~~---~~~~~~~~e~~~l---~~l~h~~i~~~~~~~~~~~~~~lv~e~~~  128 (369)
                      .||+|+||.||++... +++.+|+|.+.....   ........+..++   ....||+++.+.+.+..++..++||||+.
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            4899999999999975 488999998864321   1112233343333   33479999999999998899999999999


Q ss_pred             CCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCCCCccc
Q 017594          129 NKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQA  208 (369)
Q Consensus       129 ~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~~~~~~  208 (369)
                      +++|..++...   ..+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++.......   
T Consensus        81 ~~~L~~~i~~~---~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~---  151 (279)
T cd05633          81 GGDLHYHLSQH---GVFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---  151 (279)
T ss_pred             CCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceeccccC---
Confidence            99998887533   34899999999999999999999999   9999999999999999999999999987553221   


Q ss_pred             ccccccccccccCchhhc-cCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCccccccCcccccc
Q 017594          209 NTSRIVGTYGYMSPEYAL-EGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDE  287 (369)
Q Consensus       209 ~~~~~~~~~~y~aPE~~~-~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  287 (369)
                       .....++..|+|||.+. +..++.++|+||+||++|+|++|..||.........   ......      ......+   
T Consensus       152 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~---~~~~~~------~~~~~~~---  218 (279)
T cd05633         152 -PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH---EIDRMT------LTVNVEL---  218 (279)
T ss_pred             -ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHH---HHHHHh------hcCCcCC---
Confidence             12235788999999886 456889999999999999999999998643221110   000000      0000011   


Q ss_pred             ccHHHHHHHHHHHHHHhhcCCCCCCC-----CHHHHHHH
Q 017594          288 YSSKQMLLRYANIALLCVQESADDRP-----TMNDVVSM  321 (369)
Q Consensus       288 ~~~~~~~~~l~~li~~~L~~dP~~Rp-----s~~ell~~  321 (369)
                        +..++.++.++|.+||+.||.+||     +++++++.
T Consensus       219 --~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h  255 (279)
T cd05633         219 --PDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH  255 (279)
T ss_pred             --ccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence              122366799999999999999999     69999874

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=4.8e-36  Score=253.37  Aligned_cols=253  Identities=25%  Similarity=0.384  Sum_probs=198.4

Q ss_pred             hcCCccCccccccCCccEEEEEEcC-CCEEEEEEecCC-CchhHHHHHHHHHHHhcCC-CCceeeeeeeEEeCCccEEEE
Q 017594           48 TNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGR-SGQGLREMKNEASVIAKVQ-HKNLVRLLGCCIDRDEKILIY  124 (369)
Q Consensus        48 ~~~y~i~~~lg~G~~~~v~~~~~~~-~~~valK~~~~~-~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~  124 (369)
                      .++.+++..||.|..|.||+++.++ |.-.|||.+... +.+..+++...+.++.... +|+|++.+++|..+..+++.|
T Consensus        91 indl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcM  170 (391)
T KOG0983|consen   91 INDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICM  170 (391)
T ss_pred             hHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHH
Confidence            3456678899999999999999765 888999998755 3445566777777766664 899999999999999999999


Q ss_pred             EecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCCC
Q 017594          125 EYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGN  204 (369)
Q Consensus       125 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~~  204 (369)
                      |.+ ..+++.++..  -..++++..+-++...+++||.||..++  +++|||+||.||++++.|++||+|||++-.+...
T Consensus       171 elM-s~C~ekLlkr--ik~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdS  245 (391)
T KOG0983|consen  171 ELM-STCAEKLLKR--IKGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDS  245 (391)
T ss_pred             HHH-HHHHHHHHHH--hcCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeecc
Confidence            976 4556666543  2345888888899999999999998877  6999999999999999999999999998766433


Q ss_pred             CcccccccccccccccCchhhc---cCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCccccccC
Q 017594          205 ELQANTSRIVGTYGYMSPEYAL---EGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELID  281 (369)
Q Consensus       205 ~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (369)
                      .   ......|-+.|+|||.+.   ...|+..+||||||+++++|.||+.||.....+....    ....+      -..
T Consensus       246 k---AhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~l----tkvln------~eP  312 (391)
T KOG0983|consen  246 K---AHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVL----TKVLN------EEP  312 (391)
T ss_pred             c---ccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHH----HHHHh------cCC
Confidence            2   233446888999999886   4568999999999999999999999998765443211    11111      111


Q ss_pred             ccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 017594          282 PILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSM  321 (369)
Q Consensus       282 ~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~  321 (369)
                      +.+.+..   .+++++++++..||+.|+.+||.+.++++.
T Consensus       313 P~L~~~~---gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h  349 (391)
T KOG0983|consen  313 PLLPGHM---GFSPDFQSFVKDCLTKDHRKRPKYNKLLEH  349 (391)
T ss_pred             CCCCccc---CcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence            2222221   147889999999999999999999999863

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=2.6e-35  Score=263.62  Aligned_cols=245  Identities=24%  Similarity=0.347  Sum_probs=192.1

Q ss_pred             ccccCCccEEEEEEcC-CCEEEEEEecCCCc---hhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEEEEecCCCCh
Q 017594           57 LGEGGFGPVYKGVLKK-GDEIAVKRLSGRSG---QGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSL  132 (369)
Q Consensus        57 lg~G~~~~v~~~~~~~-~~~valK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L  132 (369)
                      ||.|++|.||+++... |+.+++|.+.....   .....+..|+..++.++|+|++++++.+......++++|++.+++|
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            6899999999999765 89999999865432   3456788899999999999999999999988999999999999999


Q ss_pred             hhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCCCCc------
Q 017594          133 DFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNEL------  206 (369)
Q Consensus       133 ~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~~~~------  206 (369)
                      ..++....   .+++..++.++.||+.||.+||..+   ++|+||+|+||+++.++.++|+|||++........      
T Consensus        81 ~~~l~~~~---~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~  154 (265)
T cd05579          81 ASLLENVG---SLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDD  154 (265)
T ss_pred             HHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccc
Confidence            98885432   5889999999999999999999999   99999999999999999999999998775433211      


Q ss_pred             ccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCccccccCccccc
Q 017594          207 QANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILED  286 (369)
Q Consensus       207 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  286 (369)
                      ........++..|+|||...+..++.++|+||||+++|+|++|..||.......     ..... ..... .     ...
T Consensus       155 ~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~-----~~~~~-~~~~~-~-----~~~  222 (265)
T cd05579         155 EKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEE-----IFQNI-LNGKI-E-----WPE  222 (265)
T ss_pred             cccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH-----HHHHH-hcCCc-C-----CCc
Confidence            112233456788999999988889999999999999999999999986443111     00000 00000 0     000


Q ss_pred             cccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHH
Q 017594          287 EYSSKQMLLRYANIALLCVQESADDRPTMNDVVSML  322 (369)
Q Consensus       287 ~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L  322 (369)
                         ....+..+.+++.+||+.+|.+||++..+.+.|
T Consensus       223 ---~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l  255 (265)
T cd05579         223 ---DVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIK  255 (265)
T ss_pred             ---cccCCHHHHHHHHHHhcCCHhhcCCCccHHHHh
Confidence               000256789999999999999999995444443

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=1.7e-34  Score=302.87  Aligned_cols=266  Identities=24%  Similarity=0.427  Sum_probs=202.4

Q ss_pred             HHHhcCCccCccccccCCccEEEEEEc-CCCEEEEEEecCCCchhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEE
Q 017594           45 STATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILI  123 (369)
Q Consensus        45 ~~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv  123 (369)
                      ......|...+.||+|+||.||+|+.. +|..||+|++.....    ....|++.+++++||||+++++++......++|
T Consensus       686 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv  761 (968)
T PLN00113        686 NDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS----IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLI  761 (968)
T ss_pred             HHHHhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc----ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEE
Confidence            334467888899999999999999974 588999999864432    123458889999999999999999999999999


Q ss_pred             EEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCC
Q 017594          124 YEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGG  203 (369)
Q Consensus       124 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~  203 (369)
                      |||+++++|.+++..      +++..+.+++.|++.|++|||....++++||||||+||+++.++..++. ++...... 
T Consensus       762 ~Ey~~~g~L~~~l~~------l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~-  833 (968)
T PLN00113        762 HEYIEGKNLSEVLRN------LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLC-  833 (968)
T ss_pred             EeCCCCCcHHHHHhc------CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccc-
Confidence            999999999999842      7888999999999999999995533449999999999999988877765 44432211 


Q ss_pred             CCcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCccccccCcc
Q 017594          204 NELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPI  283 (369)
Q Consensus       204 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (369)
                           ......++..|+|||++.+..++.++||||+|+++|||++|+.||............+.............+++.
T Consensus       834 -----~~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  908 (968)
T PLN00113        834 -----TDTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPS  908 (968)
T ss_pred             -----cCCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCcc
Confidence                 111225678999999999999999999999999999999999998543322222222222222222223333444


Q ss_pred             ccccc-cHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHhhhh
Q 017594          284 LEDEY-SSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNEAA  327 (369)
Q Consensus       284 ~~~~~-~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L~~~~~  327 (369)
                      +.... .......++.+++.+||+.+|++||++.++++.|+.+..
T Consensus       909 ~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~  953 (968)
T PLN00113        909 IRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR  953 (968)
T ss_pred             ccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence            33221 122335678899999999999999999999999998766

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=7.9e-35  Score=270.41  Aligned_cols=268  Identities=24%  Similarity=0.316  Sum_probs=196.1

Q ss_pred             HHhcCCccCccccccCCccEEEEEEc-CCCEEEEEEecCC--CchhHHHHHHHHHHHhcC-CCCceeeeeeeEEeC--Cc
Q 017594           46 TATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGR--SGQGLREMKNEASVIAKV-QHKNLVRLLGCCIDR--DE  119 (369)
Q Consensus        46 ~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~--~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~--~~  119 (369)
                      .+.++|++.+.||.|++|.||+|.+. +|..+++|.+...  .......+..|+.+++++ +|+||+++++++...  ..
T Consensus         4 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~   83 (337)
T cd07852           4 HILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKD   83 (337)
T ss_pred             hhhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCce
Confidence            45688999999999999999999976 4888999988542  223345677899999999 999999999988654  35


Q ss_pred             cEEEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCce
Q 017594          120 KILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMAR  199 (369)
Q Consensus       120 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~  199 (369)
                      .++|+||+.+ +|..++...    .+++...+.++.||+.||.|||+.|   ++|+||+|+||+++.++.++|+|||++.
T Consensus        84 ~~lv~e~~~~-~L~~~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~~  155 (337)
T cd07852          84 IYLVFEYMET-DLHAVIRAN----ILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLAR  155 (337)
T ss_pred             EEEEeccccc-CHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccchh
Confidence            7999999975 777776432    5788888999999999999999998   9999999999999999999999999987


Q ss_pred             ecCCCCcc---cccccccccccccCchhhcc-CCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccc---------hh
Q 017594          200 ICGGNELQ---ANTSRIVGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLL---------GY  266 (369)
Q Consensus       200 ~~~~~~~~---~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~---------~~  266 (369)
                      ........   .......++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||...........         ..
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~  235 (337)
T cd07852         156 SLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAE  235 (337)
T ss_pred             ccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence            66433221   12223457888999998754 4578899999999999999999999864332110000         00


Q ss_pred             hhhhhhcCccccccCccccccc-----cHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 017594          267 AWDLWTSNRTLELIDPILEDEY-----SSKQMLLRYANIALLCVQESADDRPTMNDVVSM  321 (369)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~  321 (369)
                      .+...........+........     ....++.++.++|.+||+.+|++|||+.++++.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~  295 (337)
T cd07852         236 DIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH  295 (337)
T ss_pred             HHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence            0000000000000000000000     001135679999999999999999999999974

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=1.6e-34  Score=263.12  Aligned_cols=265  Identities=23%  Similarity=0.285  Sum_probs=192.1

Q ss_pred             cCCccCccccccCCccEEEEEEc-CCCEEEEEEecCCC--chhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEEEE
Q 017594           49 NKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS--GQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIYE  125 (369)
Q Consensus        49 ~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  125 (369)
                      ++|++.+.||.|++|.||+|.++ +|+.|++|.+....  ......+..|+.+++.++|+|++++++++......++|+|
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   81 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE   81 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence            57999999999999999999976 58899999886432  2233567789999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeC-CCceEEeecCCceecCCC
Q 017594          126 YMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDK-DMNPKISDFGMARICGGN  204 (369)
Q Consensus       126 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~-~~~~~L~Dfg~~~~~~~~  204 (369)
                      |+.+ ++...+.... ...+++..++.++.||+.||+|||+++   ++|+||+|+||+++. ++.++|+|||++......
T Consensus        82 ~~~~-~l~~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~  156 (294)
T PLN00009         82 YLDL-DLKKHMDSSP-DFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP  156 (294)
T ss_pred             cccc-cHHHHHHhCC-CCCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccccccCCC
Confidence            9965 5655553322 233577888899999999999999998   999999999999985 557899999998755332


Q ss_pred             CcccccccccccccccCchhhcc-CCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccc---------hhhhhhhhc-
Q 017594          205 ELQANTSRIVGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLL---------GYAWDLWTS-  273 (369)
Q Consensus       205 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~---------~~~~~~~~~-  273 (369)
                      ..  ......++..|+|||.+.+ ..++.++|+||+|+++|+|++|..||...........         ...|..... 
T Consensus       157 ~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (294)
T PLN00009        157 VR--TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSL  234 (294)
T ss_pred             cc--ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccc
Confidence            11  1122346788999998765 4578999999999999999999999864321110000         000000000 


Q ss_pred             CccccccCccccc--cccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 017594          274 NRTLELIDPILED--EYSSKQMLLRYANIALLCVQESADDRPTMNDVVS  320 (369)
Q Consensus       274 ~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~  320 (369)
                      .+...........  .......+..+.+++.+||+.+|++||++.++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~  283 (294)
T PLN00009        235 PDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE  283 (294)
T ss_pred             hhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence            0000000000000  0001122566899999999999999999999986

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=7.8e-37  Score=303.26  Aligned_cols=257  Identities=26%  Similarity=0.396  Sum_probs=206.3

Q ss_pred             HHHHhcCCccCccccccCCccEEEEEEcC-CCEEEEEEecCC--CchhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCcc
Q 017594           44 VSTATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEK  120 (369)
Q Consensus        44 ~~~~~~~y~i~~~lg~G~~~~v~~~~~~~-~~~valK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~  120 (369)
                      .....-+|.-..+||.|.||.||.|.+.+ |.-.|+|.+...  .......+.+|..++..++|||+++++++=.+.+..
T Consensus      1230 lsnV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv 1309 (1509)
T KOG4645|consen 1230 LSNVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKV 1309 (1509)
T ss_pred             hccceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHH
Confidence            34556789999999999999999999654 888899977533  234456678899999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCcee
Q 017594          121 ILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARI  200 (369)
Q Consensus       121 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~  200 (369)
                      ++.||||.+|+|.+++..   ....++.....+..|++.|++|||++|   |+||||||.||+++.+|.+|++|||.+..
T Consensus      1310 ~IFMEyC~~GsLa~ll~~---gri~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~k 1383 (1509)
T KOG4645|consen 1310 YIFMEYCEGGSLASLLEH---GRIEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAVK 1383 (1509)
T ss_pred             HHHHHHhccCcHHHHHHh---cchhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccceeE
Confidence            999999999999999843   333677777888999999999999999   99999999999999999999999999998


Q ss_pred             cCCCC--cccccccccccccccCchhhccC---CCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCc
Q 017594          201 CGGNE--LQANTSRIVGTYGYMSPEYALEG---IFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNR  275 (369)
Q Consensus       201 ~~~~~--~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  275 (369)
                      ..+..  .........||+.|+|||++.+.   ....++|||||||++.||+||+.||...+.+-.    +...+. .++
T Consensus      1384 i~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~a----IMy~V~-~gh 1458 (1509)
T KOG4645|consen 1384 IKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWA----IMYHVA-AGH 1458 (1509)
T ss_pred             ecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhH----HHhHHh-ccC
Confidence            87653  11222346799999999999753   457899999999999999999999976553221    111111 111


Q ss_pred             cccccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 017594          276 TLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSM  321 (369)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~  321 (369)
                      ..+.          +...+.+-.++|..||..||.+|+++.+|++.
T Consensus      1459 ~Pq~----------P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1459 KPQI----------PERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred             CCCC----------chhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence            1111          22247788999999999999999999988863

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.9e-34  Score=257.41  Aligned_cols=250  Identities=25%  Similarity=0.355  Sum_probs=194.9

Q ss_pred             cCCccCccccccCCccEEEEEEc-CCCEEEEEEecCC-----CchhHHHHHHHHHHHhcCCCCceeeeeeeEEeC--Ccc
Q 017594           49 NKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGR-----SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDR--DEK  120 (369)
Q Consensus        49 ~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~-----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~  120 (369)
                      ..|++.+.||+|++|.||+|.+. ++..|++|.+...     .......+.+|+++++.++|+|++++++++.+.  ...
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL   81 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence            47999999999999999999965 4889999987532     123446788899999999999999999998764  457


Q ss_pred             EEEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCcee
Q 017594          121 ILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARI  200 (369)
Q Consensus       121 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~  200 (369)
                      ++++||+.+++|.+.+...   ..+++.....++.|++.||.+||+.+   ++|+||+|+||+++.++.++|+|||++..
T Consensus        82 ~~v~e~~~~~~L~~~~~~~---~~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~  155 (264)
T cd06653          82 SIFVEYMPGGSIKDQLKAY---GALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR  155 (264)
T ss_pred             EEEEEeCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECccccccc
Confidence            8999999999998888532   33788889999999999999999999   99999999999999999999999999876


Q ss_pred             cCCCCcc-cccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCccccc
Q 017594          201 CGGNELQ-ANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLEL  279 (369)
Q Consensus       201 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (369)
                      ....... .......++..|+|||.+.+..++.++|+|||||++|+|++|+.||.......     .........     
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-----~~~~~~~~~-----  225 (264)
T cd06653         156 IQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMA-----AIFKIATQP-----  225 (264)
T ss_pred             cccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHH-----HHHHHHcCC-----
Confidence            5322111 11123457888999999988888999999999999999999999986332100     000100000     


Q ss_pred             cCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 017594          280 IDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVS  320 (369)
Q Consensus       280 ~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~  320 (369)
                      ..+.     .+...+..+.+++.+||+ +|..||++.+++.
T Consensus       226 ~~~~-----~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~  260 (264)
T cd06653         226 TKPM-----LPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR  260 (264)
T ss_pred             CCCC-----CCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence            0011     122236779999999999 5799999999876

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=6.8e-35  Score=271.40  Aligned_cols=272  Identities=20%  Similarity=0.283  Sum_probs=198.4

Q ss_pred             hHHHHhcCCccCccccccCCccEEEEEEc-CCCEEEEEEecCCC--chhHHHHHHHHHHHhcCCCCceeeeeeeEEeCC-
Q 017594           43 SVSTATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS--GQGLREMKNEASVIAKVQHKNLVRLLGCCIDRD-  118 (369)
Q Consensus        43 ~~~~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-  118 (369)
                      .+..+.++|++++.||.|++|.||+|... +|..||+|++....  ......+..|+.+++.++|+||+++.+++.... 
T Consensus         9 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   88 (343)
T cd07880           9 TIWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLS   88 (343)
T ss_pred             hhhccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcc
Confidence            34456789999999999999999999955 58899999985432  223456778999999999999999999887543 


Q ss_pred             -----ccEEEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEe
Q 017594          119 -----EKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKIS  193 (369)
Q Consensus       119 -----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~  193 (369)
                           ..++|++++ +++|..++..    ..+++..+..++.||+.||.|||+.|   ++|+||+|.||+++.++.++|+
T Consensus        89 ~~~~~~~~lv~e~~-~~~l~~~~~~----~~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~  160 (343)
T cd07880          89 LDRFHDFYLVMPFM-GTDLGKLMKH----EKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKIL  160 (343)
T ss_pred             ccccceEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEe
Confidence                 348999998 6688777632    34889999999999999999999999   9999999999999999999999


Q ss_pred             ecCCceecCCCCcccccccccccccccCchhhcc-CCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccc--------
Q 017594          194 DFGMARICGGNELQANTSRIVGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLL--------  264 (369)
Q Consensus       194 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~--------  264 (369)
                      |||++......     .....++..|+|||.+.+ ..++.++|+||||+++|+|++|..||...........        
T Consensus       161 dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  235 (343)
T cd07880         161 DFGLARQTDSE-----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTP  235 (343)
T ss_pred             ecccccccccC-----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence            99998754322     122356788999998875 4578999999999999999999999874331100000        


Q ss_pred             -hhhhhhhhcCccccc---cCccccccc--cHHHHHHHHHHHHHHhhcCCCCCCCCHHHHH--HHHHhhhh
Q 017594          265 -GYAWDLWTSNRTLEL---IDPILEDEY--SSKQMLLRYANIALLCVQESADDRPTMNDVV--SMLTNEAA  327 (369)
Q Consensus       265 -~~~~~~~~~~~~~~~---~~~~~~~~~--~~~~~~~~l~~li~~~L~~dP~~Rps~~ell--~~L~~~~~  327 (369)
                       ...............   +........  .....+..+.++|.+||+.||++|||+.+++  ..++....
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~~  306 (343)
T cd07880         236 SKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHD  306 (343)
T ss_pred             CHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhcC
Confidence             000000000000000   000000000  0112255689999999999999999999999  45555444

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.4e-36  Score=264.42  Aligned_cols=279  Identities=20%  Similarity=0.238  Sum_probs=208.6

Q ss_pred             ccCCCccccchhhHHHHhcCCccCccccccCCccEEEEEEcC-CCEEEEEEecCCCchhHHHHHHHHHHHhcCC--CC--
Q 017594           31 KEVDQFPLFSFSSVSTATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLREMKNEASVIAKVQ--HK--  105 (369)
Q Consensus        31 ~~~~~~~~~~~~~~~~~~~~y~i~~~lg~G~~~~v~~~~~~~-~~~valK~~~~~~~~~~~~~~~e~~~l~~l~--h~--  105 (369)
                      ..++....|.+.....+.+||+++..+|+|+||.|-.+.++. +..||+|++..-. .-.+...-|+++|.++.  .|  
T Consensus        71 ~~dD~dGH~v~~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~-kYreAa~iEi~vLqki~~~DP~g  149 (415)
T KOG0671|consen   71 RPDDKDGHYVYQVGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD-KYREAALIEIEVLQKINESDPNG  149 (415)
T ss_pred             CCCCCCceEEEEeccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH-HHhhHHHHHHHHHHHHHhcCCCC
Confidence            335666679999999999999999999999999999999655 7889999986332 22345566899999993  23  


Q ss_pred             --ceeeeeeeEEeCCccEEEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEE
Q 017594          106 --NLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNIL  183 (369)
Q Consensus       106 --~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIl  183 (369)
                        -++.+.++|...++.|+|+|.+ |.++.+++..+ +-.+++...+..+..|++.++++||+.+   ++|.||||+||+
T Consensus       150 ~~rcv~m~~wFdyrghiCivfell-G~S~~dFlk~N-~y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENIL  224 (415)
T KOG0671|consen  150 KFRCVQMRDWFDYRGHICIVFELL-GLSTFDFLKEN-NYIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENIL  224 (415)
T ss_pred             ceEEEeeehhhhccCceEEEEecc-ChhHHHHhccC-CccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEE
Confidence              2677778899999999999987 66788888653 3456889999999999999999999998   999999999999


Q ss_pred             EeC--------------------CCceEEeecCCceecCCCCcccccccccccccccCchhhccCCCCcccchHhHHHHH
Q 017594          184 LDK--------------------DMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLL  243 (369)
Q Consensus       184 v~~--------------------~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il  243 (369)
                      +..                    +..++|+|||.+..-...     .+....|..|.|||++.+.+|+.++||||+||||
T Consensus       225 fvss~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~-----hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL  299 (415)
T KOG0671|consen  225 FVSSEYFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEH-----HSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCIL  299 (415)
T ss_pred             EeccceEEEeccCCccceeccCCCcceEEEecCCcceeccC-----cceeeeccccCCchheeccCcCCccCceeeeeEE
Confidence            932                    234899999998764332     3556789999999999999999999999999999


Q ss_pred             HHHHhCCCCCCCCccccccc-----c-----hhhhhh-----hhcC--------------ccccccCccccccccHHHHH
Q 017594          244 LEIVSGKKNTGLYRTDSLNL-----L-----GYAWDL-----WTSN--------------RTLELIDPILEDEYSSKQML  294 (369)
Q Consensus       244 ~~l~tg~~p~~~~~~~~~~~-----~-----~~~~~~-----~~~~--------------~~~~~~~~~~~~~~~~~~~~  294 (369)
                      +||++|...|+..++-....     +     ......     +..+              ...+...+.-.-........
T Consensus       300 ~ElytG~~LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~  379 (415)
T KOG0671|consen  300 VELYTGETLFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEH  379 (415)
T ss_pred             EEeeccceecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHH
Confidence            99999999888655211000     0     000000     0000              00000000000001122224


Q ss_pred             HHHHHHHHHhhcCCCCCCCCHHHHHH
Q 017594          295 LRYANIALLCVQESADDRPTMNDVVS  320 (369)
Q Consensus       295 ~~l~~li~~~L~~dP~~Rps~~ell~  320 (369)
                      .+|.+|++.||..||.+|+|+.|++.
T Consensus       380 ~~LfDLl~~mL~fDP~~RiTl~EAL~  405 (415)
T KOG0671|consen  380 VQLFDLLRRMLEFDPARRITLREALS  405 (415)
T ss_pred             hHHHHHHHHHHccCccccccHHHHhc
Confidence            67999999999999999999999985

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=1.7e-34  Score=265.50  Aligned_cols=264  Identities=19%  Similarity=0.193  Sum_probs=189.7

Q ss_pred             ccCccccccCCccEEEEEEc-CCCEEEEEEecCC--CchhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEEEEecC
Q 017594           52 SDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIYEYMP  128 (369)
Q Consensus        52 ~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~  128 (369)
                      .+.+.+|.|  +.||.++.. +++.||+|++...  .......+..|+..++.++|+||+++++++...+..++++||+.
T Consensus         5 ~i~~~~~~~--~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~   82 (314)
T cd08216           5 LIGKCFEDL--MIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMA   82 (314)
T ss_pred             hhhHhhcCC--ceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccC
Confidence            344444444  445555533 4899999998754  34456788999999999999999999999999999999999999


Q ss_pred             CCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCCCCcc-
Q 017594          129 NKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQ-  207 (369)
Q Consensus       129 ~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~~~~~-  207 (369)
                      ++++.+++.... ...+++..+..++.|++.||.|||+++   ++|+||+|+||+++.++.++|+|||.+......... 
T Consensus        83 ~~~l~~~l~~~~-~~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~  158 (314)
T cd08216          83 YGSCEDLLKTHF-PEGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQ  158 (314)
T ss_pred             CCCHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeeccccccc
Confidence            999999886432 234788899999999999999999999   999999999999999999999999988755322111 


Q ss_pred             ----cccccccccccccCchhhcc--CCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchh---hhhhhh------
Q 017594          208 ----ANTSRIVGTYGYMSPEYALE--GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGY---AWDLWT------  272 (369)
Q Consensus       208 ----~~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~---~~~~~~------  272 (369)
                          .......++..|+|||++.+  ..++.++|+||+||++|+|++|..||.............   ......      
T Consensus       159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (314)
T cd08216         159 RVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPL  238 (314)
T ss_pred             cccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhh
Confidence                11122345678999999865  358899999999999999999999997432111000000   000000      


Q ss_pred             -cCcccc----ccC---ccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 017594          273 -SNRTLE----LID---PILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSM  321 (369)
Q Consensus       273 -~~~~~~----~~~---~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~  321 (369)
                       ......    ...   ...........++.++.+++.+||+.||++|||+.++++.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  295 (314)
T cd08216         239 YEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH  295 (314)
T ss_pred             hcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence             000000    000   0001111233446789999999999999999999999963

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=2.7e-35  Score=273.99  Aligned_cols=264  Identities=22%  Similarity=0.268  Sum_probs=191.8

Q ss_pred             hcCCccCccccccCCccEEEEEEc-CCCEEEEEEecCCCchhHHHHHHHHHHHhcCCCCceeeeeeeEEeC---------
Q 017594           48 TNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDR---------  117 (369)
Q Consensus        48 ~~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---------  117 (369)
                      ..+|++.+.||.|++|.||+|... +|..|++|.+........+.+.+|+.+++.++|||++++++++...         
T Consensus         4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   83 (342)
T cd07854           4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG   83 (342)
T ss_pred             CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence            589999999999999999999965 4889999998766655667788999999999999999999776543         


Q ss_pred             -----CccEEEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeC-CCceE
Q 017594          118 -----DEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDK-DMNPK  191 (369)
Q Consensus       118 -----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~-~~~~~  191 (369)
                           ...++++||+.+ +|..++..    ..+++..++.++.||+.||.|||+.|   ++|+||+|+||+++. ++.++
T Consensus        84 ~~~~~~~~~lv~e~~~~-~L~~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~~k  155 (342)
T cd07854          84 SLTELNSVYIVQEYMET-DLANVLEQ----GPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLK  155 (342)
T ss_pred             cccccceEEEEeecccc-cHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCceEE
Confidence                 346899999974 77766632    24788999999999999999999999   999999999999974 55789


Q ss_pred             EeecCCceecCCCCcccc-cccccccccccCchhhcc-CCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhh
Q 017594          192 ISDFGMARICGGNELQAN-TSRIVGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWD  269 (369)
Q Consensus       192 L~Dfg~~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~  269 (369)
                      |+|||.+........... .....++..|.|||.+.+ ..++.++|+|||||++|+|++|..||.......... .....
T Consensus       156 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~-~~~~~  234 (342)
T cd07854         156 IGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQ-LILES  234 (342)
T ss_pred             ECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH-HHHHh
Confidence            999999876543211111 122346778999998654 567889999999999999999999996432110000 00000


Q ss_pred             hh-----hcCccc----cccC-cccccccc----HHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 017594          270 LW-----TSNRTL----ELID-PILEDEYS----SKQMLLRYANIALLCVQESADDRPTMNDVVS  320 (369)
Q Consensus       270 ~~-----~~~~~~----~~~~-~~~~~~~~----~~~~~~~l~~li~~~L~~dP~~Rps~~ell~  320 (369)
                      ..     ......    .... ........    ....+.++.++|.+||+.||.+||++.++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  299 (342)
T cd07854         235 VPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM  299 (342)
T ss_pred             cCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence            00     000000    0000 00000000    0112567889999999999999999999995

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=1.2e-34  Score=265.91  Aligned_cols=248  Identities=31%  Similarity=0.449  Sum_probs=192.6

Q ss_pred             hcCCccCccccccCCccEEEEEEc-CCCEEEEEEecCC---CchhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEE
Q 017594           48 TNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGR---SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILI  123 (369)
Q Consensus        48 ~~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv  123 (369)
                      ..+|...+.||.|++|.||+|+.. ++..+++|.+...   .......+..|+.+++.++|+|++++.+++......++|
T Consensus        14 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   93 (308)
T cd06634          14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV   93 (308)
T ss_pred             HHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEE
Confidence            455888999999999999999965 4788999988632   223345677899999999999999999999999999999


Q ss_pred             EEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCC
Q 017594          124 YEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGG  203 (369)
Q Consensus       124 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~  203 (369)
                      +||+.+ ++.+.+...  ...+++..+..++.|++.|+.|||+.+   ++|+||+|.||+++.++.++|+|||++.....
T Consensus        94 ~e~~~~-~l~~~~~~~--~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~  167 (308)
T cd06634          94 MEYCLG-SASDLLEVH--KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP  167 (308)
T ss_pred             EEccCC-CHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceeecC
Confidence            999975 665555332  234788999999999999999999998   99999999999999999999999998875432


Q ss_pred             CCcccccccccccccccCchhhc---cCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCcccccc
Q 017594          204 NELQANTSRIVGTYGYMSPEYAL---EGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELI  280 (369)
Q Consensus       204 ~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (369)
                      .      ....++..|+|||.+.   ...++.++|||||||++|+|++|..||.......     ....... ...    
T Consensus       168 ~------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-----~~~~~~~-~~~----  231 (308)
T cd06634         168 A------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-----ALYHIAQ-NES----  231 (308)
T ss_pred             c------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHH-----HHHHHhh-cCC----
Confidence            1      2235678899999874   3457889999999999999999999975432110     0000000 000    


Q ss_pred             CccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHH
Q 017594          281 DPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSML  322 (369)
Q Consensus       281 ~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L  322 (369)
                       +    ......++..+.++|.+||+.+|++||++.++++..
T Consensus       232 -~----~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~  268 (308)
T cd06634         232 -P----ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR  268 (308)
T ss_pred             -C----CcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCc
Confidence             0    001112356789999999999999999999999753

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.9e-35  Score=273.73  Aligned_cols=248  Identities=23%  Similarity=0.341  Sum_probs=207.9

Q ss_pred             HHhcCCccCccccccCCccEEEEEEc-CCCEEEEEEecCCCch--hHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEE
Q 017594           46 TATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSGQ--GLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKIL  122 (369)
Q Consensus        46 ~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l  122 (369)
                      ....-|.+.+.||+|.|+.|.+|+.. ++..||+|.+.+...+  ....+.+|+++++.++||||++++.+.+....+|+
T Consensus        53 ~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lyl  132 (596)
T KOG0586|consen   53 NSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYL  132 (596)
T ss_pred             ccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEE
Confidence            34467999999999999999999954 5999999999866432  33557889999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecC
Q 017594          123 IYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICG  202 (369)
Q Consensus       123 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~  202 (369)
                      ||||+.++.+.+++....+   ..+..+..++.|+.+|++|||+++   |+|||||++||+++.+-+++|+|||++..+.
T Consensus       133 V~eya~~ge~~~yl~~~gr---~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~~~~  206 (596)
T KOG0586|consen  133 VMEYASGGELFDYLVKHGR---MKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFSTFFD  206 (596)
T ss_pred             EEEeccCchhHHHHHhccc---chhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccceeec
Confidence            9999999999999965544   666888999999999999999999   9999999999999999999999999999886


Q ss_pred             CCCcccccccccccccccCchhhccCCC-CcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCccccccC
Q 017594          203 GNELQANTSRIVGTYGYMSPEYALEGIF-SIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELID  281 (369)
Q Consensus       203 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (369)
                      ..   .....++|++.|.|||++.+..| ++.+|+||+|+++|.|+.|..||...                  .+..+-.
T Consensus       207 ~~---~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~------------------~lk~Lr~  265 (596)
T KOG0586|consen  207 YG---LMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQ------------------NLKELRP  265 (596)
T ss_pred             cc---ccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCc------------------ccccccc
Confidence            43   33455789999999999998876 68899999999999999999998632                  2222222


Q ss_pred             cccccccc-HHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 017594          282 PILEDEYS-SKQMLLRYANIALLCVQESADDRPTMNDVVS  320 (369)
Q Consensus       282 ~~~~~~~~-~~~~~~~l~~li~~~L~~dP~~Rps~~ell~  320 (369)
                      +.+.+.+. +...+.++.++|+++|-.+|.+|++.+++.+
T Consensus       266 rvl~gk~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~  305 (596)
T KOG0586|consen  266 RVLRGKYRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMK  305 (596)
T ss_pred             hheeeeecccceeechhHHHHHHhhccCccccCCHHHhhh
Confidence            23333221 2223667999999999999999999999875

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-34  Score=259.00  Aligned_cols=242  Identities=24%  Similarity=0.275  Sum_probs=184.3

Q ss_pred             ccccccCCccEEEEEEc-CCCEEEEEEecCCCc---hhHHHHHHHHHH-HhcCCCCceeeeeeeEEeCCccEEEEEecCC
Q 017594           55 NKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSG---QGLREMKNEASV-IAKVQHKNLVRLLGCCIDRDEKILIYEYMPN  129 (369)
Q Consensus        55 ~~lg~G~~~~v~~~~~~-~~~~valK~~~~~~~---~~~~~~~~e~~~-l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~  129 (369)
                      +.||.|++|.||+|... +|+.|++|.+.....   .....+..|... .....|+|++++++++...+..++++||+.+
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            57899999999999965 488999999864432   112223344443 3445899999999999998999999999999


Q ss_pred             CChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCCCCcccc
Q 017594          130 KSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQAN  209 (369)
Q Consensus       130 ~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~~~~~~~  209 (369)
                      ++|..++...   ..+++..+..++.|++.||.|||+.+   ++|+||+|.||+++.++.++|+|||++.....      
T Consensus        82 ~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------  149 (260)
T cd05611          82 GDCASLIKTL---GGLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------  149 (260)
T ss_pred             CCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceeccc------
Confidence            9999988543   34788999999999999999999998   99999999999999999999999998765432      


Q ss_pred             cccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCccccccCcccccccc
Q 017594          210 TSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYS  289 (369)
Q Consensus       210 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  289 (369)
                      .....++..|+|||.+.+..++.++|+||+|+++|+|++|..||.......      ...........  ...     ..
T Consensus       150 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~------~~~~~~~~~~~--~~~-----~~  216 (260)
T cd05611         150 NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDA------VFDNILSRRIN--WPE-----EV  216 (260)
T ss_pred             cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHH------HHHHHHhcccC--CCC-----cc
Confidence            223357788999999988888999999999999999999999986432111      01111110000  000     00


Q ss_pred             HHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 017594          290 SKQMLLRYANIALLCVQESADDRPTMNDVVSM  321 (369)
Q Consensus       290 ~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~  321 (369)
                      ...++..+.++|.+||+.+|++||++.++.+.
T Consensus       217 ~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~  248 (260)
T cd05611         217 KEFCSPEAVDLINRLLCMDPAKRLGANGYQEI  248 (260)
T ss_pred             cccCCHHHHHHHHHHccCCHHHccCCCcHHHH
Confidence            11236679999999999999999977655443

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=9.1e-35  Score=265.66  Aligned_cols=265  Identities=25%  Similarity=0.322  Sum_probs=194.6

Q ss_pred             HHHhcCCccCccccccCCccEEEEEEcC-CCEEEEEEecCCC--chhHHHHHHHHHHHhcCCCCceeeeeeeEEeCC---
Q 017594           45 STATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRS--GQGLREMKNEASVIAKVQHKNLVRLLGCCIDRD---  118 (369)
Q Consensus        45 ~~~~~~y~i~~~lg~G~~~~v~~~~~~~-~~~valK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~---  118 (369)
                      +...++|++.+.||.|++|.||+|..+. |+.|++|++....  ......+.+|+.+++.++|||++++++++....   
T Consensus         3 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~   82 (302)
T cd07864           3 KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDAL   82 (302)
T ss_pred             hhhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhh
Confidence            4567889999999999999999999764 8899999986442  223356678999999999999999999887654   


Q ss_pred             -------ccEEEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceE
Q 017594          119 -------EKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPK  191 (369)
Q Consensus       119 -------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~  191 (369)
                             ..++++||+++ .+...+...  ...+++..++.++.||+.||+|||+.+   ++|+||+|.||+++.++.++
T Consensus        83 ~~~~~~~~~~lv~e~~~~-~l~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~k  156 (302)
T cd07864          83 DFKKDKGAFYLVFEYMDH-DLMGLLESG--LVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIK  156 (302)
T ss_pred             hccccCCcEEEEEcccCc-cHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCcEE
Confidence                   68999999987 454555332  234889999999999999999999998   99999999999999999999


Q ss_pred             EeecCCceecCCCCcccccccccccccccCchhhcc-CCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhh
Q 017594          192 ISDFGMARICGGNELQANTSRIVGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDL  270 (369)
Q Consensus       192 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~  270 (369)
                      |+|||.+......... ......++..|+|||.+.+ ..++.++|||||||++++|++|++||.......  ........
T Consensus       157 l~dfg~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~--~~~~~~~~  233 (302)
T cd07864         157 LADFGLARLYNSEESR-PYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELA--QLELISRL  233 (302)
T ss_pred             eCcccccccccCCccc-ccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHH--HHHHHHHH
Confidence            9999998765433211 1112235678999998764 457899999999999999999999986432111  00000110


Q ss_pred             hhcC------cc-----c------cccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 017594          271 WTSN------RT-----L------ELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVS  320 (369)
Q Consensus       271 ~~~~------~~-----~------~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~  320 (369)
                      ....      ..     .      ..........  ....+..+.+++..||+.+|.+||++.++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  298 (302)
T cd07864         234 CGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREE--FSFIPTPALDLLDHMLTLDPSKRCTAEEALN  298 (302)
T ss_pred             hCCCChhhcccccccccccccccccccccchhhh--cCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            0000      00     0      0000000000  0112567999999999999999999999986

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=2.4e-34  Score=266.20  Aligned_cols=269  Identities=21%  Similarity=0.249  Sum_probs=192.1

Q ss_pred             cccccc--CCccEEEEEEc-CCCEEEEEEecCCC--chhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEEEEecCC
Q 017594           55 NKLGEG--GFGPVYKGVLK-KGDEIAVKRLSGRS--GQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIYEYMPN  129 (369)
Q Consensus        55 ~~lg~G--~~~~v~~~~~~-~~~~valK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~  129 (369)
                      ..||.|  ++++||.|++. +|+.||+|++....  ....+.+.+|+.+++.++||||+++++++..+...++++||+.+
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~   83 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY   83 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence            456666  89999999975 58999999987432  23456788899999999999999999999999999999999999


Q ss_pred             CChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCCCCccc-
Q 017594          130 KSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQA-  208 (369)
Q Consensus       130 ~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~~~~~~-  208 (369)
                      +++.+++.... ...+++..+..++.||+.||+|||+.+   ++|+||||+||+++.++.++++||+.+.......... 
T Consensus        84 ~~l~~~l~~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~  159 (328)
T cd08226          84 GSANSLLKTYF-PEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAK  159 (328)
T ss_pred             CCHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccc
Confidence            99988886532 234788888999999999999999998   9999999999999999999999997543322111000 


Q ss_pred             ----ccccccccccccCchhhccC--CCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhh-------------
Q 017594          209 ----NTSRIVGTYGYMSPEYALEG--IFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWD-------------  269 (369)
Q Consensus       209 ----~~~~~~~~~~y~aPE~~~~~--~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~-------------  269 (369)
                          ......++..|+|||++.+.  .++.++|+||+||++|+|++|..||................             
T Consensus       160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (328)
T cd08226         160 VVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCE  239 (328)
T ss_pred             ccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchh
Confidence                01112245569999998763  47899999999999999999999997543111000000000             


Q ss_pred             --hhhcC------cccc---------ccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH--HHHhhhh
Q 017594          270 --LWTSN------RTLE---------LIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVS--MLTNEAA  327 (369)
Q Consensus       270 --~~~~~------~~~~---------~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~--~L~~~~~  327 (369)
                        .....      ...+         ..............++..+.+|+.+||+.||++|||+.++++  .+.+...
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~~  316 (328)
T cd08226         240 ESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVKE  316 (328)
T ss_pred             hhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHHH
Confidence              00000      0000         000000011113345778999999999999999999999984  4444444

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.4e-36  Score=257.82  Aligned_cols=240  Identities=25%  Similarity=0.321  Sum_probs=194.7

Q ss_pred             hcCCccCccccccCCccEEEEEEcC-CCEEEEEEecCCC---chhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEE
Q 017594           48 TNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRS---GQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILI  123 (369)
Q Consensus        48 ~~~y~i~~~lg~G~~~~v~~~~~~~-~~~valK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv  123 (369)
                      -++|..++.||+|.||+|.+++.+. |+.+|+|++.+.-   .+....-..|-.+|+..+||.+..+...|...+.+|+|
T Consensus       167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV  246 (516)
T KOG0690|consen  167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV  246 (516)
T ss_pred             cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence            3568899999999999999999664 8999999987542   22334445688899999999999999899889999999


Q ss_pred             EEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCC
Q 017594          124 YEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGG  203 (369)
Q Consensus       124 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~  203 (369)
                      |||.+||.|...+.   +...+++....-+-..|+.||.|||+.+   |+.||||.+|.+++.+|+++|+|||++..-. 
T Consensus       247 MeyanGGeLf~HLs---rer~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCKE~I-  319 (516)
T KOG0690|consen  247 MEYANGGELFFHLS---RERVFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCKEEI-  319 (516)
T ss_pred             EEEccCceEeeehh---hhhcccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccchhcc-
Confidence            99999999987774   3445889889999999999999999998   9999999999999999999999999987432 


Q ss_pred             CCcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCccccccCcc
Q 017594          204 NELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPI  283 (369)
Q Consensus       204 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (369)
                       .........+||+.|+|||++....|+.+.|.|.+|+++|+|++|+.||-..+-+..               .++   +
T Consensus       320 -~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kL---------------FeL---I  380 (516)
T KOG0690|consen  320 -KYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKL---------------FEL---I  380 (516)
T ss_pred             -cccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHH---------------HHH---H
Confidence             122334567999999999999999999999999999999999999999853332111               111   1


Q ss_pred             ccccc-cHHHHHHHHHHHHHHhhcCCCCCCC
Q 017594          284 LEDEY-SSKQMLLRYANIALLCVQESADDRP  313 (369)
Q Consensus       284 ~~~~~-~~~~~~~~l~~li~~~L~~dP~~Rp  313 (369)
                      +..+. .+...+++...|+..+|..||.+|.
T Consensus       381 l~ed~kFPr~ls~eAktLLsGLL~kdP~kRL  411 (516)
T KOG0690|consen  381 LMEDLKFPRTLSPEAKTLLSGLLKKDPKKRL  411 (516)
T ss_pred             HhhhccCCccCCHHHHHHHHHHhhcChHhhc
Confidence            11110 1222267789999999999999997

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=4e-34  Score=259.25  Aligned_cols=260  Identities=22%  Similarity=0.309  Sum_probs=191.3

Q ss_pred             CccCccccccCCccEEEEEEcC-CCEEEEEEecCCCc--hhHHHHHHHHHHHhcC---CCCceeeeeeeEEeCCc-----
Q 017594           51 FSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSG--QGLREMKNEASVIAKV---QHKNLVRLLGCCIDRDE-----  119 (369)
Q Consensus        51 y~i~~~lg~G~~~~v~~~~~~~-~~~valK~~~~~~~--~~~~~~~~e~~~l~~l---~h~~i~~~~~~~~~~~~-----  119 (369)
                      |++.+.||.|++|.||+|+++. +..+++|.+.....  .....+..|+.+++++   .|+|++++++++.....     
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            6788999999999999999765 89999999874322  2223455677666655   69999999999987766     


Q ss_pred             cEEEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCce
Q 017594          120 KILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMAR  199 (369)
Q Consensus       120 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~  199 (369)
                      .++++|++.+ ++..++.... ...+++..++.++.|++.||.+||+.+   ++|+||+|+||+++.++.++|+|||.+.
T Consensus        81 ~~l~~e~~~~-~l~~~l~~~~-~~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~~~  155 (287)
T cd07838          81 LTLVFEHVDQ-DLATYLSKCP-KPGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLAR  155 (287)
T ss_pred             eEEEehhccc-CHHHHHHHcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCcce
Confidence            8999999975 6777664322 234889999999999999999999998   9999999999999999999999999987


Q ss_pred             ecCCCCcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhh--------
Q 017594          200 ICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLW--------  271 (369)
Q Consensus       200 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~--------  271 (369)
                      .......   .....++..|+|||.+.+..++.++|+||+||++|+|++|.+||.........  ....+..        
T Consensus       156 ~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~  230 (287)
T cd07838         156 IYSFEMA---LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQL--DKIFDVIGLPSEEEW  230 (287)
T ss_pred             eccCCcc---cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHH--HHHHHHcCCCChHhc
Confidence            7643321   12224677899999999888999999999999999999999998643321100  0000000        


Q ss_pred             hcCc--cccccCcccccc--ccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 017594          272 TSNR--TLELIDPILEDE--YSSKQMLLRYANIALLCVQESADDRPTMNDVVS  320 (369)
Q Consensus       272 ~~~~--~~~~~~~~~~~~--~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~  320 (369)
                      ....  ............  ......+..+.++|.+||+.||.+||++.+++.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~  283 (287)
T cd07838         231 PRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ  283 (287)
T ss_pred             CCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence            0000  000000000000  011233577899999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=5.4e-34  Score=257.70  Aligned_cols=241  Identities=24%  Similarity=0.306  Sum_probs=183.5

Q ss_pred             cccccCCccEEEEEEc-CCCEEEEEEecCCCch---hHHHHHHHH---HHHhcCCCCceeeeeeeEEeCCccEEEEEecC
Q 017594           56 KLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSGQ---GLREMKNEA---SVIAKVQHKNLVRLLGCCIDRDEKILIYEYMP  128 (369)
Q Consensus        56 ~lg~G~~~~v~~~~~~-~~~~valK~~~~~~~~---~~~~~~~e~---~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~  128 (369)
                      .||.|+||.||+|... +++.||+|.+......   .......|.   ..++...||+++.+.+.+...+..++|+||+.
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            4799999999999965 4889999988654211   111223333   34444579999999999999999999999999


Q ss_pred             CCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCCCCccc
Q 017594          129 NKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQA  208 (369)
Q Consensus       129 ~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~~~~~~  208 (369)
                      +++|..++..   ...+++..+..++.|++.|+.|||+.+   ++|+||+|+||+++.++.++|+|||++..+....   
T Consensus        81 g~~L~~~l~~---~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~---  151 (278)
T cd05606          81 GGDLHYHLSQ---HGVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---  151 (278)
T ss_pred             CCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccCccC---
Confidence            9999888743   335899999999999999999999998   9999999999999999999999999987543221   


Q ss_pred             ccccccccccccCchhhccC-CCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCccccccCcccccc
Q 017594          209 NTSRIVGTYGYMSPEYALEG-IFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDE  287 (369)
Q Consensus       209 ~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  287 (369)
                       .....++..|+|||.+.++ .++.++|+||+|+++|+|++|..||..........   ......      .....+.  
T Consensus       152 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~---~~~~~~------~~~~~~~--  219 (278)
T cd05606         152 -PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE---IDRMTL------TMAVELP--  219 (278)
T ss_pred             -CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHH---HHHHhh------ccCCCCC--
Confidence             1223678899999998754 68999999999999999999999986442111100   000000      0001111  


Q ss_pred             ccHHHHHHHHHHHHHHhhcCCCCCCC-----CHHHHHH
Q 017594          288 YSSKQMLLRYANIALLCVQESADDRP-----TMNDVVS  320 (369)
Q Consensus       288 ~~~~~~~~~l~~li~~~L~~dP~~Rp-----s~~ell~  320 (369)
                         ...+.++.+++.+||..+|.+||     ++.++++
T Consensus       220 ---~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~  254 (278)
T cd05606         220 ---DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  254 (278)
T ss_pred             ---CcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence               11256799999999999999999     9999985

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=1e-34  Score=266.36  Aligned_cols=265  Identities=24%  Similarity=0.337  Sum_probs=190.6

Q ss_pred             hcCCccCccccccCCccEEEEEEc-CCCEEEEEEecCCCc--hhHHHHHHHHHHHhcCCCCceeeeeeeEEeCC------
Q 017594           48 TNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSG--QGLREMKNEASVIAKVQHKNLVRLLGCCIDRD------  118 (369)
Q Consensus        48 ~~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------  118 (369)
                      .++|++.+.||.|++|.||+|+++ +++.+++|.+.....  .......+|++.++.++|+||+++++++....      
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   86 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK   86 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence            579999999999999999999966 488999998864322  12245678999999999999999998875443      


Q ss_pred             --ccEEEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecC
Q 017594          119 --EKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFG  196 (369)
Q Consensus       119 --~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg  196 (369)
                        ..+++++|+.+ ++...+..  ....+++..+..++.||+.||.|||+++   ++|+||+|+||+++.++.++|+|||
T Consensus        87 ~~~~~lv~~~~~~-~l~~~~~~--~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg  160 (311)
T cd07866          87 RGSVYMVTPYMDH-DLSGLLEN--PSVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFG  160 (311)
T ss_pred             CceEEEEEecCCc-CHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcCc
Confidence              35999999876 45444432  2335899999999999999999999999   9999999999999999999999999


Q ss_pred             CceecCCCCcccc---------cccccccccccCchhhcc-CCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccc--
Q 017594          197 MARICGGNELQAN---------TSRIVGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLL--  264 (369)
Q Consensus       197 ~~~~~~~~~~~~~---------~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~--  264 (369)
                      ++...........         .....++..|+|||.+.+ ..++.++||||+|+++|+|++|++||...........  
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~  240 (311)
T cd07866         161 LARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIF  240 (311)
T ss_pred             cchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            9876543221111         112245778999998765 4578999999999999999999999864332110000  


Q ss_pred             -------hhhhhhhh---cC---ccccccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 017594          265 -------GYAWDLWT---SN---RTLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVS  320 (369)
Q Consensus       265 -------~~~~~~~~---~~---~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~  320 (369)
                             ...+..+.   ..   .......+.+...  .......+.++|.+||+.+|++|||+.+++.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~  307 (311)
T cd07866         241 KLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEER--FGKLGPEGLDLLSKLLSLDPYKRLTASDALE  307 (311)
T ss_pred             HHhCCCChhhchhhhhcccccccccCCCCCccHHHH--cccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence                   00000000   00   0000000011000  0112356889999999999999999999885

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=6.7e-34  Score=261.45  Aligned_cols=247  Identities=28%  Similarity=0.441  Sum_probs=191.0

Q ss_pred             hcCCccCccccccCCccEEEEEEc-CCCEEEEEEecCCC---chhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEE
Q 017594           48 TNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS---GQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILI  123 (369)
Q Consensus        48 ~~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv  123 (369)
                      .+.|...+.||.|++|.||+|+.. +|..|++|.+....   ......+..|+..++.++|+|++++.+++......+++
T Consensus        20 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   99 (313)
T cd06633          20 EEIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLV   99 (313)
T ss_pred             HHHhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEE
Confidence            344788889999999999999965 48899999986432   23345677899999999999999999999999999999


Q ss_pred             EEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCC
Q 017594          124 YEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGG  203 (369)
Q Consensus       124 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~  203 (369)
                      +||+.+ ++.+++..  ....+++..+..++.||+.|+.|||+.|   ++|+||+|+||+++.++.++|+|||++.... 
T Consensus       100 ~e~~~~-~l~~~l~~--~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~~-  172 (313)
T cd06633         100 MEYCLG-SASDLLEV--HKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSS-  172 (313)
T ss_pred             EecCCC-CHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCcccC-
Confidence            999965 55555533  2234888999999999999999999998   9999999999999999999999999875322 


Q ss_pred             CCcccccccccccccccCchhhc---cCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCcccccc
Q 017594          204 NELQANTSRIVGTYGYMSPEYAL---EGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELI  280 (369)
Q Consensus       204 ~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (369)
                           ......++..|+|||.+.   ...++.++|+||||+++|+|++|..||.......     ........ ..... 
T Consensus       173 -----~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~-----~~~~~~~~-~~~~~-  240 (313)
T cd06633         173 -----PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-----ALYHIAQN-DSPTL-  240 (313)
T ss_pred             -----CCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHH-----HHHHHHhc-CCCCC-
Confidence                 122345788899999874   4568889999999999999999999975432111     00000000 00000 


Q ss_pred             CccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 017594          281 DPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSM  321 (369)
Q Consensus       281 ~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~  321 (369)
                              ....++..+.+++.+||+.+|.+||++.+++..
T Consensus       241 --------~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~  273 (313)
T cd06633         241 --------QSNEWTDSFRGFVDYCLQKIPQERPASAELLRH  273 (313)
T ss_pred             --------CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                    011124568999999999999999999999964

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=2.3e-35  Score=291.52  Aligned_cols=255  Identities=26%  Similarity=0.364  Sum_probs=188.6

Q ss_pred             HHhcCCccCccccccCCccEEEEEEc-CCCEEEEEEecCC-CchhHHHHHHHHHHHhcCCCCceeeeeeeEEeC------
Q 017594           46 TATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGR-SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDR------  117 (369)
Q Consensus        46 ~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------  117 (369)
                      .-..+|+.++.||+|+||.||+++++ +|+.||||++... .......+.+|+..|.+|+|||+++++..+.+.      
T Consensus       476 RY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~  555 (1351)
T KOG1035|consen  476 RYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTV  555 (1351)
T ss_pred             hHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccc
Confidence            34567899999999999999999976 6999999998755 344566788999999999999999987654110      


Q ss_pred             --------------------------------------------------------------------------------
Q 017594          118 --------------------------------------------------------------------------------  117 (369)
Q Consensus       118 --------------------------------------------------------------------------------  117 (369)
                                                                                                      
T Consensus       556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~  635 (1351)
T KOG1035|consen  556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD  635 (1351)
T ss_pred             ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence                                                                                            


Q ss_pred             ---------------------------------CccEEEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHH
Q 017594          118 ---------------------------------DEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYL  164 (369)
Q Consensus       118 ---------------------------------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~L  164 (369)
                                                       ..+||-||||+..++.+++..+....  .....|+++++|+.||.|+
T Consensus       636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~--~~d~~wrLFreIlEGLaYI  713 (1351)
T KOG1035|consen  636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS--QRDEAWRLFREILEGLAYI  713 (1351)
T ss_pred             cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch--hhHHHHHHHHHHHHHHHHH
Confidence                                             01367789999888888885433211  4678999999999999999


Q ss_pred             hcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecC------C----------CCcccccccccccccccCchhhccC
Q 017594          165 HQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICG------G----------NELQANTSRIVGTYGYMSPEYALEG  228 (369)
Q Consensus       165 H~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~------~----------~~~~~~~~~~~~~~~y~aPE~~~~~  228 (369)
                      |++|   ++||||||.|||++.++.|||+|||++....      .          ...........||..|.|||++.+.
T Consensus       714 H~~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~  790 (1351)
T KOG1035|consen  714 HDQG---IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDT  790 (1351)
T ss_pred             HhCc---eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccc
Confidence            9999   9999999999999999999999999998721      0          0011122345799999999998754


Q ss_pred             ---CCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCccccccCccccccccHHHHHHHHHHHHHHhh
Q 017594          229 ---IFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYSSKQMLLRYANIALLCV  305 (369)
Q Consensus       229 ---~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L  305 (369)
                         .|+.|+|+||||+|++||+.   ||+........     -.......+..-  ..+....     -+.-.++|++||
T Consensus       791 ~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~i-----L~~LR~g~iP~~--~~f~~~~-----~~~e~slI~~Ll  855 (1351)
T KOG1035|consen  791 SSNKYNSKIDMYSLGIVLFEMLY---PFGTSMERASI-----LTNLRKGSIPEP--ADFFDPE-----HPEEASLIRWLL  855 (1351)
T ss_pred             ccccccchhhhHHHHHHHHHHhc---cCCchHHHHHH-----HHhcccCCCCCC--ccccccc-----chHHHHHHHHHh
Confidence               49999999999999999996   45543211100     000011111000  0111111     234578999999


Q ss_pred             cCCCCCCCCHHHHHH
Q 017594          306 QESADDRPTMNDVVS  320 (369)
Q Consensus       306 ~~dP~~Rps~~ell~  320 (369)
                      +.||++||||.|+|.
T Consensus       856 ~hdP~kRPtA~eLL~  870 (1351)
T KOG1035|consen  856 SHDPSKRPTATELLN  870 (1351)
T ss_pred             cCCCccCCCHHHHhh
Confidence            999999999999997

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.6e-34  Score=268.90  Aligned_cols=265  Identities=22%  Similarity=0.322  Sum_probs=193.3

Q ss_pred             HhcCCccCccccccCCccEEEEEEc-CCCEEEEEEecCCC--chhHHHHHHHHHHHhcCCCCceeeeeeeEEeCC-----
Q 017594           47 ATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS--GQGLREMKNEASVIAKVQHKNLVRLLGCCIDRD-----  118 (369)
Q Consensus        47 ~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----  118 (369)
                      ...+|.+.+.||.|++|.||+|++. +|+.||+|.+....  ......+..|+.+++.+.|+||+++++++....     
T Consensus        13 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~   92 (342)
T cd07879          13 LPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEF   92 (342)
T ss_pred             cccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCC
Confidence            3579999999999999999999965 58999999986432  222355778999999999999999999986543     


Q ss_pred             -ccEEEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCC
Q 017594          119 -EKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGM  197 (369)
Q Consensus       119 -~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~  197 (369)
                       ..++++||+.. ++..+.     ...+++..+..++.|++.||+|||+.+   ++||||+|+||+++.++.++|+|||+
T Consensus        93 ~~~~lv~e~~~~-~l~~~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg~  163 (342)
T cd07879          93 QDFYLVMPYMQT-DLQKIM-----GHPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGL  163 (342)
T ss_pred             ceEEEEeccccc-CHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCCC
Confidence             35899999864 555443     124788899999999999999999999   99999999999999999999999999


Q ss_pred             ceecCCCCcccccccccccccccCchhhcc-CCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhh-------
Q 017594          198 ARICGGNELQANTSRIVGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWD-------  269 (369)
Q Consensus       198 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~-------  269 (369)
                      +......     .....++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||........  ......       
T Consensus       164 ~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~--~~~~~~~~~~~~~  236 (342)
T cd07879         164 ARHADAE-----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQ--LTQILKVTGVPGP  236 (342)
T ss_pred             CcCCCCC-----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHhcCCCCH
Confidence            8654321     122356788999998875 4688999999999999999999999974321110  000000       


Q ss_pred             ----hhhcCccccc---cCcccccccc--HHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH--HHhhhh
Q 017594          270 ----LWTSNRTLEL---IDPILEDEYS--SKQMLLRYANIALLCVQESADDRPTMNDVVSM--LTNEAA  327 (369)
Q Consensus       270 ----~~~~~~~~~~---~~~~~~~~~~--~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~--L~~~~~  327 (369)
                          ..........   ..........  ....+..+.++|.+||+.||++||++.+++..  ++....
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~  305 (342)
T cd07879         237 EFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRD  305 (342)
T ss_pred             HHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccc
Confidence                0000000000   0000000000  01124568899999999999999999999943  666544

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=1e-34  Score=269.18  Aligned_cols=258  Identities=26%  Similarity=0.387  Sum_probs=204.9

Q ss_pred             HhcCCccCccccccCCccEEEEEEc---CCC--EEEEEEecCC-CchhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCcc
Q 017594           47 ATNKFSDANKLGEGGFGPVYKGVLK---KGD--EIAVKRLSGR-SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEK  120 (369)
Q Consensus        47 ~~~~y~i~~~lg~G~~~~v~~~~~~---~~~--~valK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~  120 (369)
                      ....-+..+.||.|.||.||.|...   .|.  .||||.-+.+ .....+.+..|+.+++++.||||+++++++. ++..
T Consensus       387 ~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~-e~P~  465 (974)
T KOG4257|consen  387 RRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCV-EQPM  465 (974)
T ss_pred             ehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeee-ccce
Confidence            3344556788999999999999943   244  4788877653 3455788999999999999999999999986 5689


Q ss_pred             EEEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCcee
Q 017594          121 ILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARI  200 (369)
Q Consensus       121 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~  200 (369)
                      |+|||.+..|-|..++...  +..++......++.||+.||+|||+..   ++||||...||+|.....|||+|||+++.
T Consensus       466 WivmEL~~~GELr~yLq~n--k~sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLaDFGLSR~  540 (974)
T KOG4257|consen  466 WIVMELAPLGELREYLQQN--KDSLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLADFGLSRY  540 (974)
T ss_pred             eEEEecccchhHHHHHHhc--cccchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeecccchhhh
Confidence            9999999999999999653  445888899999999999999999998   99999999999999999999999999998


Q ss_pred             cCCCCcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHh-CCCCCCCCcccccccchhhhhhhhcCccccc
Q 017594          201 CGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDLWTSNRTLEL  279 (369)
Q Consensus       201 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (369)
                      +........ +...-..-|+|||-++-..++.++|||.||+.+||++. |..||..-.+.+               +.-.
T Consensus       541 ~ed~~yYka-S~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsD---------------VI~~  604 (974)
T KOG4257|consen  541 LEDDAYYKA-SRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSD---------------VIGH  604 (974)
T ss_pred             ccccchhhc-cccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccc---------------eEEE
Confidence            765443222 23334567999999998999999999999999999985 889987433211               1111


Q ss_pred             cCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHhhhh
Q 017594          280 IDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNEAA  327 (369)
Q Consensus       280 ~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L~~~~~  327 (369)
                      ++.. ..-.-++.+++.+..|+.+||+++|.+||...+|...|+....
T Consensus       605 iEnG-eRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q  651 (974)
T KOG4257|consen  605 IENG-ERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ  651 (974)
T ss_pred             ecCC-CCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence            1110 0111233447779999999999999999999999988866554

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.4e-34  Score=269.62  Aligned_cols=267  Identities=22%  Similarity=0.288  Sum_probs=194.3

Q ss_pred             hhHHHHhcCCccCccccccCCccEEEEEEc-CCCEEEEEEecCCC--chhHHHHHHHHHHHhcCCCCceeeeeeeEEeC-
Q 017594           42 SSVSTATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS--GQGLREMKNEASVIAKVQHKNLVRLLGCCIDR-  117 (369)
Q Consensus        42 ~~~~~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-  117 (369)
                      ..+-...++|++.+.||+|+||.||+|... +|+.||+|++....  ....+.+.+|+.+++.++|+||+++.+++... 
T Consensus        10 ~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~   89 (345)
T cd07877          10 KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPAR   89 (345)
T ss_pred             HHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecc
Confidence            445567799999999999999999999954 58899999986432  22345677899999999999999999988643 


Q ss_pred             -----CccEEEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEE
Q 017594          118 -----DEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKI  192 (369)
Q Consensus       118 -----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L  192 (369)
                           ...+++++++ +++|..++..    ..+++..++.++.|++.||.|||+.+   ++|+||+|+||+++.++.++|
T Consensus        90 ~~~~~~~~~lv~~~~-~~~L~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl  161 (345)
T cd07877          90 SLEEFNDVYLVTHLM-GADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKI  161 (345)
T ss_pred             cccccccEEEEehhc-ccCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCCCCEEE
Confidence                 2357777776 6788777642    23888999999999999999999999   999999999999999999999


Q ss_pred             eecCCceecCCCCcccccccccccccccCchhhcc-CCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccc-------
Q 017594          193 SDFGMARICGGNELQANTSRIVGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLL-------  264 (369)
Q Consensus       193 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~-------  264 (369)
                      +|||++.....     ......++..|+|||.+.+ ..++.++|+|||||++|+|++|..||...........       
T Consensus       162 ~dfg~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~  236 (345)
T cd07877         162 LDFGLARHTDD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT  236 (345)
T ss_pred             ecccccccccc-----cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence            99999875432     1223456888999998765 5688999999999999999999999854321110000       


Q ss_pred             --hhhhhhhhcC---ccccccCcccccccc--HHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 017594          265 --GYAWDLWTSN---RTLELIDPILEDEYS--SKQMLLRYANIALLCVQESADDRPTMNDVVSM  321 (369)
Q Consensus       265 --~~~~~~~~~~---~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~  321 (369)
                        ..........   .....+.........  ....+..+.++|.+||+.||.+||++.++++.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h  300 (345)
T cd07877         237 PGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  300 (345)
T ss_pred             CCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence              0000000000   000000000000000  00125568999999999999999999999964

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=2.9e-34  Score=260.66  Aligned_cols=255  Identities=24%  Similarity=0.296  Sum_probs=195.4

Q ss_pred             CCccCccccccCCccEEEEEEc----CCCEEEEEEecCCC----chhHHHHHHHHHHHhcC-CCCceeeeeeeEEeCCcc
Q 017594           50 KFSDANKLGEGGFGPVYKGVLK----KGDEIAVKRLSGRS----GQGLREMKNEASVIAKV-QHKNLVRLLGCCIDRDEK  120 (369)
Q Consensus        50 ~y~i~~~lg~G~~~~v~~~~~~----~~~~valK~~~~~~----~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~  120 (369)
                      +|++.+.||.|++|.||+++..    ++..|++|.+....    ......+..|+.++..+ .|++++++.+.+......
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~   80 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL   80 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence            4888999999999999999843    46789999886432    22345677899999999 599999999999988899


Q ss_pred             EEEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCcee
Q 017594          121 ILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARI  200 (369)
Q Consensus       121 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~  200 (369)
                      ++|+||+.+++|..++..   ...+++..+..++.|++.+|.+||+.+   ++|+||+|.||+++.++.++|+|||++..
T Consensus        81 ~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~~~~  154 (288)
T cd05583          81 HLILDYVNGGELFTHLYQ---REHFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKE  154 (288)
T ss_pred             EEEEecCCCCcHHHHHhh---cCCcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECccccc
Confidence            999999999999888743   234788899999999999999999998   99999999999999999999999998876


Q ss_pred             cCCCCcccccccccccccccCchhhccCC--CCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCcccc
Q 017594          201 CGGNELQANTSRIVGTYGYMSPEYALEGI--FSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLE  278 (369)
Q Consensus       201 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (369)
                      ....... ......++..|+|||...+..  .+.++|+||||+++|+|++|..||....... ............     
T Consensus       155 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~-~~~~~~~~~~~~-----  227 (288)
T cd05583         155 FLAEEEE-RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQN-SQSEISRRILKS-----  227 (288)
T ss_pred             ccccccc-ccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccc-hHHHHHHHHHcc-----
Confidence            5432211 112235788999999987654  7889999999999999999999986432111 000011111000     


Q ss_pred             ccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHh
Q 017594          279 LIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTN  324 (369)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L~~  324 (369)
                        ...     .+..++..+.+++.+||+.+|++|||+.++.+.|.-
T Consensus       228 --~~~-----~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~  266 (288)
T cd05583         228 --KPP-----FPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH  266 (288)
T ss_pred             --CCC-----CCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence              000     011125668999999999999999998888776544

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.8e-35  Score=251.69  Aligned_cols=256  Identities=25%  Similarity=0.337  Sum_probs=201.4

Q ss_pred             CccccccCCccEEEEE-EcCCCEEEEEEecCCCchhHHHHHHHHHHHhcCC-CCceeeeeeeEEeCCccEEEEEecCCCC
Q 017594           54 ANKLGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQ-HKNLVRLLGCCIDRDEKILIYEYMPNKS  131 (369)
Q Consensus        54 ~~~lg~G~~~~v~~~~-~~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~  131 (369)
                      .+.||.|+|+.|--++ ..+|..||||++.+.......++.+|++++.+.+ |+||+.++++|+++...|+|||-+.||+
T Consensus        83 ~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGp  162 (463)
T KOG0607|consen   83 SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGP  162 (463)
T ss_pred             HHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCch
Confidence            3578999999999999 6779999999999887788889999999999996 9999999999999999999999999999


Q ss_pred             hhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCc---eEEeecCCceecCCCCcc-
Q 017594          132 LDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMN---PKISDFGMARICGGNELQ-  207 (369)
Q Consensus       132 L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~---~~L~Dfg~~~~~~~~~~~-  207 (369)
                      |...+.   .+..+++.++.++..+|+.||.+||.+|   |.|||+||+||+....+.   +||+||.+..-...+... 
T Consensus       163 lLshI~---~~~~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~s  236 (463)
T KOG0607|consen  163 LLSHIQ---KRKHFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCS  236 (463)
T ss_pred             HHHHHH---HhhhccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeeeccccccccccCCCCC
Confidence            988884   4455999999999999999999999999   999999999999976655   799999876544322211 


Q ss_pred             ----cccccccccccccCchhhc-----cCCCCcccchHhHHHHHHHHHhCCCCCCCCcccc--cccchhhhhhhhcCcc
Q 017594          208 ----ANTSRIVGTYGYMSPEYAL-----EGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDS--LNLLGYAWDLWTSNRT  276 (369)
Q Consensus       208 ----~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~--~~~~~~~~~~~~~~~~  276 (369)
                          +......|+..|+|||+..     ...|+.+.|.||||+|+|-|+.|.+||......+  +.. +.+-....    
T Consensus       237 pastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdr-Ge~Cr~CQ----  311 (463)
T KOG0607|consen  237 PASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDR-GEVCRVCQ----  311 (463)
T ss_pred             CCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccC-CCccHHHH----
Confidence                1122356888999999874     3458999999999999999999999997654221  111 00000000    


Q ss_pred             ccccCccccccc-----cHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 017594          277 LELIDPILEDEY-----SSKQMLLRYANIALLCVQESADDRPTMNDVVS  320 (369)
Q Consensus       277 ~~~~~~~~~~~~-----~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~  320 (369)
                      ..+...+..+.+     ....++.+..++|..+|-.|+.+|.++..++.
T Consensus       312 ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln  360 (463)
T KOG0607|consen  312 NKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN  360 (463)
T ss_pred             HHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence            011122222221     24455788999999999999999999999886

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=3.4e-34  Score=265.97  Aligned_cols=265  Identities=21%  Similarity=0.292  Sum_probs=193.5

Q ss_pred             HhcCCcc-CccccccCCccEEEEEEc-CCCEEEEEEecCCCchh--------------HHHHHHHHHHHhcCCCCceeee
Q 017594           47 ATNKFSD-ANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSGQG--------------LREMKNEASVIAKVQHKNLVRL  110 (369)
Q Consensus        47 ~~~~y~i-~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~~~~~--------------~~~~~~e~~~l~~l~h~~i~~~  110 (369)
                      ..++|.. .+.||.|++|.||+|.++ +++.||+|.+.......              ...+.+|+.+++.++|+|++++
T Consensus         6 ~~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~   85 (335)
T PTZ00024          6 ISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGL   85 (335)
T ss_pred             cccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeee
Confidence            3467765 577999999999999965 58999999886432211              1246789999999999999999


Q ss_pred             eeeEEeCCccEEEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCce
Q 017594          111 LGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNP  190 (369)
Q Consensus       111 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~  190 (369)
                      ++++..+...++++||+. ++|..++..   ...+++.....++.|++.||.+||+.+   ++|+||+|+||+++.++.+
T Consensus        86 ~~~~~~~~~~~lv~e~~~-~~l~~~l~~---~~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~~  158 (335)
T PTZ00024         86 VDVYVEGDFINLVMDIMA-SDLKKVVDR---KIRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGIC  158 (335)
T ss_pred             eEEEecCCcEEEEEeccc-cCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCCE
Confidence            999999999999999997 477777743   334889999999999999999999999   9999999999999999999


Q ss_pred             EEeecCCceecCCCCc------------ccccccccccccccCchhhccC-CCCcccchHhHHHHHHHHHhCCCCCCCCc
Q 017594          191 KISDFGMARICGGNEL------------QANTSRIVGTYGYMSPEYALEG-IFSIKSDVFSFGVLLLEIVSGKKNTGLYR  257 (369)
Q Consensus       191 ~L~Dfg~~~~~~~~~~------------~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~tg~~p~~~~~  257 (369)
                      +|+|||++........            ........++..|+|||.+.+. .++.++|+|||||++|+|++|..||....
T Consensus       159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~  238 (335)
T PTZ00024        159 KIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGEN  238 (335)
T ss_pred             EECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            9999999876652110            0111123457789999988754 46899999999999999999999987543


Q ss_pred             ccccccchhhhhhhhcCc---ccc--------ccCccccccc--cHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 017594          258 TDSLNLLGYAWDLWTSNR---TLE--------LIDPILEDEY--SSKQMLLRYANIALLCVQESADDRPTMNDVVS  320 (369)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~---~~~--------~~~~~~~~~~--~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~  320 (369)
                      ....  ............   ...        ..........  .....+..+.++|.+||+.+|++||++.+++.
T Consensus       239 ~~~~--~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  312 (335)
T PTZ00024        239 EIDQ--LGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK  312 (335)
T ss_pred             HHHH--HHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence            2110  000000000000   000        0000000000  00112567899999999999999999999996

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=1.6e-34  Score=263.53  Aligned_cols=253  Identities=25%  Similarity=0.378  Sum_probs=190.4

Q ss_pred             HhcCCccCccccccCCccEEEEEEcC-CCEEEEEEecCCC-chhHHHHHHHHHHHhcCC-CCceeeeeeeEEeCCccEEE
Q 017594           47 ATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRS-GQGLREMKNEASVIAKVQ-HKNLVRLLGCCIDRDEKILI  123 (369)
Q Consensus        47 ~~~~y~i~~~lg~G~~~~v~~~~~~~-~~~valK~~~~~~-~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv  123 (369)
                      ..++|++.+.||.|++|.||+|.++. ++.|++|.+.... ......+..|+..+..+. |+||+++++++......+++
T Consensus        13 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v   92 (296)
T cd06618          13 DLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFIC   92 (296)
T ss_pred             CcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEE
Confidence            34678999999999999999999775 8899999987543 223344556776666664 99999999999999999999


Q ss_pred             EEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhc-CCCCCcccCCCCCCCEEEeCCCceEEeecCCceecC
Q 017594          124 YEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQ-YSRVRIIHRDLKASNILLDKDMNPKISDFGMARICG  202 (369)
Q Consensus       124 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~-~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~  202 (369)
                      +||+.+ ++..+.....  ..+++..+..++.||+.|++|||+ .+   ++|+||+|+||+++.++.++|+|||++....
T Consensus        93 ~e~~~~-~l~~l~~~~~--~~l~~~~~~~i~~~i~~~l~~lH~~~~---i~H~dl~p~nill~~~~~~kL~dfg~~~~~~  166 (296)
T cd06618          93 MELMST-CLDKLLKRIQ--GPIPEDILGKMTVAIVKALHYLKEKHG---VIHRDVKPSNILLDASGNVKLCDFGISGRLV  166 (296)
T ss_pred             eeccCc-CHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhhCC---EecCCCcHHHEEEcCCCCEEECccccchhcc
Confidence            999854 6655553322  358888899999999999999997 47   9999999999999999999999999987654


Q ss_pred             CCCcccccccccccccccCchhhccCC----CCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCcccc
Q 017594          203 GNELQANTSRIVGTYGYMSPEYALEGI----FSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLE  278 (369)
Q Consensus       203 ~~~~~~~~~~~~~~~~y~aPE~~~~~~----~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (369)
                      ....   .....++..|+|||.+.+..    ++.++|+||||+++|+|++|+.||.......    ..........  ..
T Consensus       167 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~----~~~~~~~~~~--~~  237 (296)
T cd06618         167 DSKA---KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEF----EVLTKILQEE--PP  237 (296)
T ss_pred             CCCc---ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHH----HHHHHHhcCC--CC
Confidence            3221   12234677899999987543    7889999999999999999999986432111    0011111110  00


Q ss_pred             ccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 017594          279 LIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSM  321 (369)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~  321 (369)
                      ...    .   ...++.++.+++.+||+.||.+||++.++++.
T Consensus       238 ~~~----~---~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~  273 (296)
T cd06618         238 SLP----P---NEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH  273 (296)
T ss_pred             CCC----C---CCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            000    0   00125668999999999999999999999864

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=4.3e-34  Score=264.35  Aligned_cols=263  Identities=23%  Similarity=0.325  Sum_probs=193.8

Q ss_pred             HHhcCCccCccccccCCccEEEEEEc-CCCEEEEEEecCC--CchhHHHHHHHHHHHhcCCCCceeeeeeeEEe-CCccE
Q 017594           46 TATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCID-RDEKI  121 (369)
Q Consensus        46 ~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~  121 (369)
                      .+.++|++.+.||.|++|.||+|..+ +|..|++|++...  .......+..|+.+++.++|||++++.+++.. ....+
T Consensus         7 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~   86 (328)
T cd07856           7 EITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIY   86 (328)
T ss_pred             ccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEE
Confidence            46789999999999999999999965 5889999987532  22234667789999999999999999999865 45789


Q ss_pred             EEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceec
Q 017594          122 LIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARIC  201 (369)
Q Consensus       122 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~  201 (369)
                      +++||+ +++|..++..    ..++......++.||+.||.+||+.+   ++|+||+|.||+++.++.++|+|||.+...
T Consensus        87 lv~e~~-~~~L~~~~~~----~~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg~~~~~  158 (328)
T cd07856          87 FVTELL-GTDLHRLLTS----RPLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARIQ  158 (328)
T ss_pred             EEeehh-ccCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCcccccccc
Confidence            999998 4578777632    24778888899999999999999999   999999999999999999999999988754


Q ss_pred             CCCCcccccccccccccccCchhhcc-CCCCcccchHhHHHHHHHHHhCCCCCCCCccccccc---------chhhhhhh
Q 017594          202 GGNELQANTSRIVGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNL---------LGYAWDLW  271 (369)
Q Consensus       202 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~---------~~~~~~~~  271 (369)
                      ...     .....++..|+|||.+.+ ..++.++|+||||+++|+|++|..||..........         ........
T Consensus       159 ~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (328)
T cd07856         159 DPQ-----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTI  233 (328)
T ss_pred             CCC-----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhc
Confidence            321     122356778999998765 568999999999999999999999986432110000         00000000


Q ss_pred             hcCccccccCccccccc-c----HHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 017594          272 TSNRTLELIDPILEDEY-S----SKQMLLRYANIALLCVQESADDRPTMNDVVSM  321 (369)
Q Consensus       272 ~~~~~~~~~~~~~~~~~-~----~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~  321 (369)
                      ......+.+........ .    ....+..+.++|.+||+.+|++||++.+++..
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~  288 (328)
T cd07856         234 CSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH  288 (328)
T ss_pred             cchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            00000011000000000 0    01125679999999999999999999999864

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=4.9e-34  Score=258.34  Aligned_cols=261  Identities=22%  Similarity=0.276  Sum_probs=192.3

Q ss_pred             CccCccccccCCccEEEEEEcC-CCEEEEEEecCCCc-hhHHHHHHHHHHHhcCC-CCceeeeeeeEEeCCccEEEEEec
Q 017594           51 FSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSG-QGLREMKNEASVIAKVQ-HKNLVRLLGCCIDRDEKILIYEYM  127 (369)
Q Consensus        51 y~i~~~lg~G~~~~v~~~~~~~-~~~valK~~~~~~~-~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~  127 (369)
                      |++.+.||.|++|.||+|+..+ ++.|++|.+..... .......+|+..++.+. |+|++++++++..++..++||||+
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~   80 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM   80 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence            7889999999999999999764 78899998864422 22234456889999998 999999999999999999999999


Q ss_pred             CCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCCCCcc
Q 017594          128 PNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQ  207 (369)
Q Consensus       128 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~~~~~  207 (369)
                       ++++.+.+.... ...+++..+..++.|++.+|.|||+++   ++|+||+|+||+++.++.++|+|||.+........ 
T Consensus        81 -~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~-  154 (283)
T cd07830          81 -EGNLYQLMKDRK-GKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP-  154 (283)
T ss_pred             -CCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccCCCC-
Confidence             677777764432 235789999999999999999999998   99999999999999999999999999876543221 


Q ss_pred             cccccccccccccCchhhc-cCCCCcccchHhHHHHHHHHHhCCCCCCCCccccccc-----------chhhhhhhhcCc
Q 017594          208 ANTSRIVGTYGYMSPEYAL-EGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNL-----------LGYAWDLWTSNR  275 (369)
Q Consensus       208 ~~~~~~~~~~~y~aPE~~~-~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~-----------~~~~~~~~~~~~  275 (369)
                        .....++..|+|||++. +..++.++|+||||+++++|++|++||..........           ..+.........
T Consensus       155 --~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (283)
T cd07830         155 --YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASK  232 (283)
T ss_pred             --cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcc
Confidence              12235678899999875 4557899999999999999999999986443211000           000000000000


Q ss_pred             cccccCcccc---ccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 017594          276 TLELIDPILE---DEYSSKQMLLRYANIALLCVQESADDRPTMNDVVS  320 (369)
Q Consensus       276 ~~~~~~~~~~---~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~  320 (369)
                      ....+.....   ....+ ..+..+.++|.+||+.+|++||++.+++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~-~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  279 (283)
T cd07830         233 LGFRFPQFAPTSLHQLIP-NASPEAIDLIKDMLRWDPKKRPTASQALQ  279 (283)
T ss_pred             ccccccccccccHHHHcc-cCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence            0000000000   00001 11467999999999999999999999976

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=3.8e-34  Score=258.73  Aligned_cols=262  Identities=25%  Similarity=0.319  Sum_probs=196.0

Q ss_pred             CccCccccccCCccEEEEEEcC-CCEEEEEEecCCC--chhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEEEEec
Q 017594           51 FSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRS--GQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIYEYM  127 (369)
Q Consensus        51 y~i~~~lg~G~~~~v~~~~~~~-~~~valK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~  127 (369)
                      |++.+.||.|.+|.||+|+... ++.+++|.+....  ......+..|+..++.++|++++++.+++......++|+|++
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~   80 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC   80 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence            6778899999999999999764 8999999987542  333456778999999999999999999999989999999999


Q ss_pred             CCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCCCCcc
Q 017594          128 PNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQ  207 (369)
Q Consensus       128 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~~~~~  207 (369)
                      .+ +|.+++....  ..+++..+..++.|++.||.+||..+   ++||||+|+||+++.++.++|+|||.+........ 
T Consensus        81 ~~-~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-  153 (282)
T cd07829          81 DM-DLKKYLDKRP--GPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR-  153 (282)
T ss_pred             Cc-CHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCCCcc-
Confidence            74 7888885432  35889999999999999999999999   99999999999999999999999999876543221 


Q ss_pred             cccccccccccccCchhhccC-CCCcccchHhHHHHHHHHHhCCCCCCCCccccccc---------chhhhhhhhcCc-c
Q 017594          208 ANTSRIVGTYGYMSPEYALEG-IFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNL---------LGYAWDLWTSNR-T  276 (369)
Q Consensus       208 ~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~---------~~~~~~~~~~~~-~  276 (369)
                       ......++..|+|||.+.+. .++.++|+||||+++++|++|..||..........         ....|.....-. .
T Consensus       154 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (282)
T cd07829         154 -TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDY  232 (282)
T ss_pred             -ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccc
Confidence             11223456789999998766 78999999999999999999999986543111000         000000000000 0


Q ss_pred             ccccCccccccc--cHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 017594          277 LELIDPILEDEY--SSKQMLLRYANIALLCVQESADDRPTMNDVVS  320 (369)
Q Consensus       277 ~~~~~~~~~~~~--~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~  320 (369)
                      ............  .....+..+.++|.+||+.+|++||++.+++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  278 (282)
T cd07829         233 KPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK  278 (282)
T ss_pred             cccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence            000000000000  00112567999999999999999999999986

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=6.2e-35  Score=271.71  Aligned_cols=260  Identities=23%  Similarity=0.329  Sum_probs=194.7

Q ss_pred             HHhcCCccCccccccCCccEEEEEEc-CCCEEEEEEecCC--CchhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCc---
Q 017594           46 TATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDE---  119 (369)
Q Consensus        46 ~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~---  119 (369)
                      .+.++|++.+.||.|++|.||+|++. +++.|++|++...  .......+..|+.+++.+.|+|++++.+++...+.   
T Consensus        12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   91 (343)
T cd07851          12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLED   91 (343)
T ss_pred             cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccc
Confidence            45688999999999999999999976 4889999988643  22334567789999999999999999988765544   


Q ss_pred             ---cEEEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecC
Q 017594          120 ---KILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFG  196 (369)
Q Consensus       120 ---~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg  196 (369)
                         .++|+|++ +++|.+++..    ..+++..++.++.|++.||.+||+.|   ++|+||+|+||+++.++.++|+|||
T Consensus        92 ~~~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~dfg  163 (343)
T cd07851          92 FQDVYLVTHLM-GADLNNIVKC----QKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFG  163 (343)
T ss_pred             cccEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEcccc
Confidence               89999998 5688887743    34889999999999999999999998   9999999999999999999999999


Q ss_pred             CceecCCCCcccccccccccccccCchhhcc-CCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhh-----
Q 017594          197 MARICGGNELQANTSRIVGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDL-----  270 (369)
Q Consensus       197 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~-----  270 (369)
                      ++......     .....++..|+|||.+.+ ..++.++||||||+++|+|++|..||........  .......     
T Consensus       164 ~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~--~~~i~~~~~~~~  236 (343)
T cd07851         164 LARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQ--LKRIMNLVGTPD  236 (343)
T ss_pred             cccccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHH--HHHHHHhcCCCC
Confidence            98765432     222356778999998765 4678999999999999999999999864332110  0000000     


Q ss_pred             ------hhcCccc---cccCcccccccc--HHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 017594          271 ------WTSNRTL---ELIDPILEDEYS--SKQMLLRYANIALLCVQESADDRPTMNDVVS  320 (369)
Q Consensus       271 ------~~~~~~~---~~~~~~~~~~~~--~~~~~~~l~~li~~~L~~dP~~Rps~~ell~  320 (369)
                            .......   ..+.........  ....+..+.++|.+||+.+|++|||+.+|++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~  297 (343)
T cd07851         237 EELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA  297 (343)
T ss_pred             HHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence                  0000000   000000000000  0112667999999999999999999999986

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.4e-35  Score=275.44  Aligned_cols=254  Identities=30%  Similarity=0.388  Sum_probs=209.3

Q ss_pred             hcCCccCccccccCCccEEEEEEcC--CCE--EEEEEecCCCch-hHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEE
Q 017594           48 TNKFSDANKLGEGGFGPVYKGVLKK--GDE--IAVKRLSGRSGQ-GLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKIL  122 (369)
Q Consensus        48 ~~~y~i~~~lg~G~~~~v~~~~~~~--~~~--valK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l  122 (369)
                      +++.+..+.||.|.||.|+.|.|+.  |+.  ||||.+...... ....|.+|+.+|.+|+|+|+++++++..+ ....+
T Consensus       109 ee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mM  187 (1039)
T KOG0199|consen  109 EEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMM  187 (1039)
T ss_pred             HHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhH
Confidence            3456778899999999999999764  443  799998765443 67889999999999999999999999876 78999


Q ss_pred             EEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecC
Q 017594          123 IYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICG  202 (369)
Q Consensus       123 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~  202 (369)
                      |+|.+.+|+|.+.+.. ..+..+-...++.++.||+.|+.||..++   ++||||-..|+++-....|||+|||+.+.++
T Consensus       188 V~ELaplGSLldrLrk-a~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRaLg  263 (1039)
T KOG0199|consen  188 VFELAPLGSLLDRLRK-AKKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRALG  263 (1039)
T ss_pred             HhhhcccchHHHHHhh-ccccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceeccC
Confidence            9999999999999877 55667888899999999999999999999   9999999999999999999999999999887


Q ss_pred             CCCccccccc-ccccccccCchhhccCCCCcccchHhHHHHHHHHHh-CCCCCCCCcccccccchhhhhhhhcCcccccc
Q 017594          203 GNELQANTSR-IVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDLWTSNRTLELI  280 (369)
Q Consensus       203 ~~~~~~~~~~-~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (369)
                      .+...+.... ..-...|||||.+....++-++|+|++|+++|||++ |..||....               ...+.+.+
T Consensus       264 ~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~---------------g~qIL~~i  328 (1039)
T KOG0199|consen  264 ENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCR---------------GIQILKNI  328 (1039)
T ss_pred             CCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCC---------------HHHHHHhc
Confidence            7665554432 334567999999999999999999999999999998 666765332               22233333


Q ss_pred             CccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHH
Q 017594          281 DPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSML  322 (369)
Q Consensus       281 ~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L  322 (369)
                      + .-..-..+..+++++++++..||+.+|.+||++..|.+.+
T Consensus       329 D-~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~  369 (1039)
T KOG0199|consen  329 D-AGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDL  369 (1039)
T ss_pred             c-ccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence            3 1122223455689999999999999999999999998433

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=3e-34  Score=256.61  Aligned_cols=249  Identities=27%  Similarity=0.360  Sum_probs=191.8

Q ss_pred             CCccCccccccCCccEEEEEEcC-CCEEEEEEecCC-----CchhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEE
Q 017594           50 KFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGR-----SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILI  123 (369)
Q Consensus        50 ~y~i~~~lg~G~~~~v~~~~~~~-~~~valK~~~~~-----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv  123 (369)
                      ||.+.+.||.|++|.||++++.. +..+++|.+...     .......+..|+.+++.++|||++++++++......+++
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII   80 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence            68999999999999999999654 444555554321     122234566789999999999999999999988899999


Q ss_pred             EEecCCCChhhhhcCC-CccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecC
Q 017594          124 YEYMPNKSLDFFLFDP-TKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICG  202 (369)
Q Consensus       124 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~  202 (369)
                      +||+.+++|..++... .....+++..++.++.|++.|+.+||+.+   ++|+||+|+||+++. +.++|+|||.+....
T Consensus        81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~~~~~  156 (260)
T cd08222          81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM  156 (260)
T ss_pred             EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCceeecC
Confidence            9999999998877532 22345889999999999999999999998   999999999999975 579999999987654


Q ss_pred             CCCcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCccccccCc
Q 017594          203 GNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDP  282 (369)
Q Consensus       203 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (369)
                      ....  ......++..|+|||...+..++.++|+||+|+++|+|++|..||.....     ......... .     ..+
T Consensus       157 ~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~-----~~~~~~~~~-~-----~~~  223 (260)
T cd08222         157 GSCD--LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNF-----LSVVLRIVE-G-----PTP  223 (260)
T ss_pred             CCcc--cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccH-----HHHHHHHHc-C-----CCC
Confidence            3221  12234567889999998888889999999999999999999999853221     001111100 0     011


Q ss_pred             cccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 017594          283 ILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVS  320 (369)
Q Consensus       283 ~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~  320 (369)
                      .+     +..++.++.++|.+||+.+|++||++.++++
T Consensus       224 ~~-----~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  256 (260)
T cd08222         224 SL-----PETYSRQLNSIMQSMLNKDPSLRPSAAEILR  256 (260)
T ss_pred             CC-----cchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence            11     1233667999999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=1.2e-33  Score=256.96  Aligned_cols=251  Identities=23%  Similarity=0.293  Sum_probs=192.9

Q ss_pred             CCccCccccccCCccEEEEEEc----CCCEEEEEEecCCC----chhHHHHHHHHHHHhcC-CCCceeeeeeeEEeCCcc
Q 017594           50 KFSDANKLGEGGFGPVYKGVLK----KGDEIAVKRLSGRS----GQGLREMKNEASVIAKV-QHKNLVRLLGCCIDRDEK  120 (369)
Q Consensus        50 ~y~i~~~lg~G~~~~v~~~~~~----~~~~valK~~~~~~----~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~  120 (369)
                      .|++.+.||.|++|.||.|...    +|..|++|++....    ......+..|+.++..+ .|++|+++.+.+..+...
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL   80 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence            4889999999999999999963    58899999986432    12335677899999999 589999999999988889


Q ss_pred             EEEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCcee
Q 017594          121 ILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARI  200 (369)
Q Consensus       121 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~  200 (369)
                      ++|+||+.+++|.+++...   ..+++..+..++.|++.||.+||+.+   ++|+||+|+||+++.++.++|+|||++..
T Consensus        81 ~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~  154 (290)
T cd05613          81 HLILDYINGGELFTHLSQR---ERFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKE  154 (290)
T ss_pred             EEEEecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCcccee
Confidence            9999999999999888543   34788899999999999999999998   99999999999999999999999999876


Q ss_pred             cCCCCcccccccccccccccCchhhccC--CCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCcccc
Q 017594          201 CGGNELQANTSRIVGTYGYMSPEYALEG--IFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLE  278 (369)
Q Consensus       201 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (369)
                      ....... ......++..|+|||.+.+.  .++.++|+||||+++|+|++|..||....... .............    
T Consensus       155 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~-~~~~~~~~~~~~~----  228 (290)
T cd05613         155 FHEDEVE-RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKN-SQAEISRRILKSE----  228 (290)
T ss_pred             ccccccc-ccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccc-cHHHHHHHhhccC----
Confidence            5432211 11224578889999988653  46789999999999999999999986322110 0111111110000    


Q ss_pred             ccCccccccccHHHHHHHHHHHHHHhhcCCCCCCC-----CHHHHHH
Q 017594          279 LIDPILEDEYSSKQMLLRYANIALLCVQESADDRP-----TMNDVVS  320 (369)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp-----s~~ell~  320 (369)
                         +     ..+..++..+.+++.+||+.+|++||     ++.+++.
T Consensus       229 ---~-----~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~  267 (290)
T cd05613         229 ---P-----PYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK  267 (290)
T ss_pred             ---C-----CCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence               0     00112356689999999999999997     6777765

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=8e-34  Score=252.08  Aligned_cols=236  Identities=26%  Similarity=0.323  Sum_probs=189.0

Q ss_pred             ccccCCccEEEEEEcC-CCEEEEEEecCCCc---hhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEEEEecCCCCh
Q 017594           57 LGEGGFGPVYKGVLKK-GDEIAVKRLSGRSG---QGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSL  132 (369)
Q Consensus        57 lg~G~~~~v~~~~~~~-~~~valK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L  132 (369)
                      ||.|++|.||.+.... ++.+++|.+.....   .....+..|+.+++.+.|+|++++++.+..+...+++||++.+++|
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            6899999999999764 88999999865432   2455788899999999999999999999999999999999999999


Q ss_pred             hhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCCCCccccccc
Q 017594          133 DFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR  212 (369)
Q Consensus       133 ~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~~~~~~~~~~  212 (369)
                      .+++...   ..+++..++.++.|++.|+.+||..+   ++|+||+|+||+++.++.++|+|||.+.......  .....
T Consensus        81 ~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~  152 (250)
T cd05123          81 FSHLSKE---GRFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEG--SRTNT  152 (250)
T ss_pred             HHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccCC--CcccC
Confidence            8888543   24889999999999999999999998   9999999999999999999999999987654332  11233


Q ss_pred             ccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCccccccCccccccccHHH
Q 017594          213 IVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYSSKQ  292 (369)
Q Consensus       213 ~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  292 (369)
                      ..++..|.|||...+..++.++|+||||+++|+|++|..||...+...     ....... .      ...+     +..
T Consensus       153 ~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~-----~~~~~~~-~------~~~~-----~~~  215 (250)
T cd05123         153 FCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKE-----IYEKILK-D------PLRF-----PEF  215 (250)
T ss_pred             CcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH-----HHHHHhc-C------CCCC-----CCC
Confidence            457888999999988888999999999999999999999986433210     0011100 0      0001     111


Q ss_pred             HHHHHHHHHHHhhcCCCCCCCCHHH
Q 017594          293 MLLRYANIALLCVQESADDRPTMND  317 (369)
Q Consensus       293 ~~~~l~~li~~~L~~dP~~Rps~~e  317 (369)
                      .+..+.+++.+||..||++||++.+
T Consensus       216 ~~~~l~~~i~~~l~~~p~~R~~~~~  240 (250)
T cd05123         216 LSPEARDLISGLLQKDPTKRLGSGG  240 (250)
T ss_pred             CCHHHHHHHHHHhcCCHhhCCCccc
Confidence            1566899999999999999999943

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-34  Score=256.85  Aligned_cols=271  Identities=25%  Similarity=0.349  Sum_probs=211.6

Q ss_pred             HHHHhcCCccCccccccCCccEEEEEEcCCCEEEEEEecCCCchhHHHHHHHHHHHhcC--CCCceeeeeeeEEeC----
Q 017594           44 VSTATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKV--QHKNLVRLLGCCIDR----  117 (369)
Q Consensus        44 ~~~~~~~y~i~~~lg~G~~~~v~~~~~~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l--~h~~i~~~~~~~~~~----  117 (369)
                      -.++.++-++.+.||+|.||.||+|+|+ |+.||||+|...++   ....+|.++++..  +|+||+.+++.-..+    
T Consensus       206 QRTiarqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~srdE---~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~  281 (513)
T KOG2052|consen  206 QRTIARQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSRDE---RSWFRETEIYQTVMLRHENILGFIAADNKDNGSW  281 (513)
T ss_pred             HHhhhheeEEEEEecCccccceeecccc-CCceEEEEecccch---hhhhhHHHHHHHHHhccchhhhhhhccccCCCce
Confidence            3567788999999999999999999999 89999999986654   4666777877764  999999999876543    


Q ss_pred             CccEEEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhc-----CCCCCcccCCCCCCCEEEeCCCceEE
Q 017594          118 DEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQ-----YSRVRIIHRDLKASNILLDKDMNPKI  192 (369)
Q Consensus       118 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~-----~~~~~i~H~dl~p~NIlv~~~~~~~L  192 (369)
                      .++++|++|.+.|+|.+++..    ..++.....+++..++.||++||.     +|.+.|.|||||..||+|..++...|
T Consensus       282 TQLwLvTdYHe~GSL~DyL~r----~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~I  357 (513)
T KOG2052|consen  282 TQLWLVTDYHEHGSLYDYLNR----NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCI  357 (513)
T ss_pred             EEEEEeeecccCCcHHHHHhh----ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEE
Confidence            357999999999999999943    458899999999999999999995     35678999999999999999999999


Q ss_pred             eecCCceecCCCC--cccccccccccccccCchhhccCC----C--CcccchHhHHHHHHHHHhCC----------CCCC
Q 017594          193 SDFGMARICGGNE--LQANTSRIVGTYGYMSPEYALEGI----F--SIKSDVFSFGVLLLEIVSGK----------KNTG  254 (369)
Q Consensus       193 ~Dfg~~~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~----~--~~~~DiwslG~il~~l~tg~----------~p~~  254 (369)
                      +|+|++.......  .........||.+|+|||++...-    +  -..+||||+|.++||++-..          .||-
T Consensus       358 ADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyy  437 (513)
T KOG2052|consen  358 ADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYY  437 (513)
T ss_pred             eeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcc
Confidence            9999998876542  222334568999999999986422    1  24589999999999998632          3332


Q ss_pred             CCcccccccchhhhhhhhcCccccccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHhhhh
Q 017594          255 LYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNEAA  327 (369)
Q Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L~~~~~  327 (369)
                      ..-..+.+     .+....---.+.+.+.+++.....+....+.++++.||..+|.-|.|+--|-+.|.++..
T Consensus       438 d~Vp~DPs-----~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~  505 (513)
T KOG2052|consen  438 DVVPSDPS-----FEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN  505 (513)
T ss_pred             cCCCCCCC-----HHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence            11111100     111111112345566666666677778889999999999999999999999999988874

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.2e-35  Score=262.41  Aligned_cols=248  Identities=27%  Similarity=0.349  Sum_probs=202.6

Q ss_pred             HHhcCCccCccccccCCccEEEEEEc-CCCEEEEEEecCCC---chhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccE
Q 017594           46 TATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS---GQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKI  121 (369)
Q Consensus        46 ~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  121 (369)
                      ...+.|+.-++||+|+||.||-++.+ +|+.+|.|.+.+..   .........|-.+|.+++.+.|+.+-..|+..+.+|
T Consensus       182 vt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LC  261 (591)
T KOG0986|consen  182 VTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALC  261 (591)
T ss_pred             ccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceE
Confidence            34466888999999999999999955 49999999875432   233455678999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceec
Q 017594          122 LIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARIC  201 (369)
Q Consensus       122 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~  201 (369)
                      +|+..++||.|...+.+... ..+++..+.-++.+|+-||++||+.+   |+.||+||+||++|+.|++.|.|+|++..+
T Consensus       262 lVLtlMNGGDLkfHiyn~g~-~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGLAvei  337 (591)
T KOG0986|consen  262 LVLTLMNGGDLKFHIYNHGN-PGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGLAVEI  337 (591)
T ss_pred             EEEEeecCCceeEEeeccCC-CCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccceEEec
Confidence            99999999999888877554 56999999999999999999999999   999999999999999999999999999988


Q ss_pred             CCCCcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCccccccC
Q 017594          202 GGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELID  281 (369)
Q Consensus       202 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (369)
                      ..+..-   ....||.+|+|||++.+..|+...|.|||||++|+|+.|+.||.....               ..-.+-++
T Consensus       338 ~~g~~~---~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~Ke---------------Kvk~eEvd  399 (591)
T KOG0986|consen  338 PEGKPI---RGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKE---------------KVKREEVD  399 (591)
T ss_pred             CCCCcc---ccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhh---------------hhhHHHHH
Confidence            655432   223799999999999999999999999999999999999999864321               00111111


Q ss_pred             cccc--ccccHHHHHHHHHHHHHHhhcCCCCCCCCH
Q 017594          282 PILE--DEYSSKQMLLRYANIALLCVQESADDRPTM  315 (369)
Q Consensus       282 ~~~~--~~~~~~~~~~~l~~li~~~L~~dP~~Rps~  315 (369)
                      ....  ..-.+..++++..++++.+|+.||++|.--
T Consensus       400 rr~~~~~~ey~~kFS~eakslc~~LL~Kdp~~RLGc  435 (591)
T KOG0986|consen  400 RRTLEDPEEYSDKFSEEAKSLCEGLLTKDPEKRLGC  435 (591)
T ss_pred             HHHhcchhhcccccCHHHHHHHHHHHccCHHHhccC
Confidence            1111  111234558889999999999999999743

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-34  Score=270.90  Aligned_cols=267  Identities=25%  Similarity=0.354  Sum_probs=202.0

Q ss_pred             cCCccCccccccCCccEEEEEEc-CCCEEEEEEecCC-CchhHHHHHHHHHHHhcCCCCceeeeeeeEEeCC------cc
Q 017594           49 NKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGR-SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDRD------EK  120 (369)
Q Consensus        49 ~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------~~  120 (369)
                      .-|...+.||+|+||.||+++++ +|+.||+|.+... .....+....|+++|++++|+|||+++++=+...      ..
T Consensus        13 y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~   92 (732)
T KOG4250|consen   13 YLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLP   92 (732)
T ss_pred             cceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccc
Confidence            55788899999999999999955 5999999998753 2233567788999999999999999998854333      45


Q ss_pred             EEEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEE--eCCCc--eEEeecC
Q 017594          121 ILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILL--DKDMN--PKISDFG  196 (369)
Q Consensus       121 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv--~~~~~--~~L~Dfg  196 (369)
                      +++||||.||+|...+....+...+++.+...++.++..||.|||.+|   |+||||||.||++  ..+|+  .||+|||
T Consensus        93 vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtDfG  169 (732)
T KOG4250|consen   93 VLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTDFG  169 (732)
T ss_pred             eEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeeccc
Confidence            899999999999999998888888999999999999999999999998   9999999999999  34344  6999999


Q ss_pred             CceecCCCCcccccccccccccccCchhhc-cCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCc
Q 017594          197 MARICGGNELQANTSRIVGTYGYMSPEYAL-EGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNR  275 (369)
Q Consensus       197 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  275 (369)
                      .++....+.   ......||..|++||+.. ++.|+..+|.||+||++|+++||..||.......... ...|.....+.
T Consensus       170 ~Arel~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~-~~~~~~~tkkp  245 (732)
T KOG4250|consen  170 AARELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNK-EIMWHIITKKP  245 (732)
T ss_pred             ccccCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccc-hhhhhhhccCC
Confidence            999877655   344568999999999998 5889999999999999999999999998765443211 01111111100


Q ss_pred             --ccccc----------Cccccc-cccHHHHHHHHHHHHHHhhcCCCCCCC--CHHHHHHHH
Q 017594          276 --TLELI----------DPILED-EYSSKQMLLRYANIALLCVQESADDRP--TMNDVVSML  322 (369)
Q Consensus       276 --~~~~~----------~~~~~~-~~~~~~~~~~l~~li~~~L~~dP~~Rp--s~~ell~~L  322 (369)
                        ..-..          ...++. ..-....-..+-..+..+|..+|.+|.  ...+....+
T Consensus       246 ~~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~  307 (732)
T KOG4250|consen  246 SGVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEV  307 (732)
T ss_pred             CceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHH
Confidence              00000          000111 111223345566788889999999999  444444333

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=7e-34  Score=256.56  Aligned_cols=284  Identities=26%  Similarity=0.346  Sum_probs=212.5

Q ss_pred             CCCccccchhhHHHHhcCCccCccccccCCccEEEEEEcCCCEEEEEEecCCCchhHHHHHHHHHHHhc--CCCCceeee
Q 017594           33 VDQFPLFSFSSVSTATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAK--VQHKNLVRL  110 (369)
Q Consensus        33 ~~~~~~~~~~~~~~~~~~y~i~~~lg~G~~~~v~~~~~~~~~~valK~~~~~~~~~~~~~~~e~~~l~~--l~h~~i~~~  110 (369)
                      .++.+.++...++  ....+..+.||+|.||.||+|+.+ ++.||||++...+   .+.+..|-+++..  ++|+||+.+
T Consensus       196 ~d~~~~~sspl~~--l~pl~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~~~---kqs~~~Ek~Iy~lp~m~h~nIl~F  269 (534)
T KOG3653|consen  196 EDSGPAPSSPLLE--LDPLQLLELIGRGRFGCVWKAQLD-NRLVAVKIFPEQE---KQSFQNEKNIYSLPGMKHENILQF  269 (534)
T ss_pred             CCCCCCCCccccc--CCchhhHHHhhcCccceeehhhcc-CceeEEEecCHHH---HHHHHhHHHHHhccCccchhHHHh
Confidence            3444455555555  556778899999999999999987 5899999997443   3566666666655  589999999


Q ss_pred             eeeEEeCC----ccEEEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCC------CCCcccCCCCCC
Q 017594          111 LGCCIDRD----EKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYS------RVRIIHRDLKAS  180 (369)
Q Consensus       111 ~~~~~~~~----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~------~~~i~H~dl~p~  180 (369)
                      ++.-....    .+++|++|.+.|+|.+++..+    .+++....+++..+++||+|||.--      .+.|+|||||..
T Consensus       270 i~~ekr~t~~~~eywLVt~fh~kGsL~dyL~~n----tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSk  345 (534)
T KOG3653|consen  270 IGAEKRGTADRMEYWLVTEFHPKGSLCDYLKAN----TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSK  345 (534)
T ss_pred             hchhccCCccccceeEEeeeccCCcHHHHHHhc----cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCcccccccccc
Confidence            98876555    789999999999999999543    4899999999999999999999753      468999999999


Q ss_pred             CEEEeCCCceEEeecCCceecCCCCcccccccccccccccCchhhccCCC-C-----cccchHhHHHHHHHHHhCCCCCC
Q 017594          181 NILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIF-S-----IKSDVFSFGVLLLEIVSGKKNTG  254 (369)
Q Consensus       181 NIlv~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~-----~~~DiwslG~il~~l~tg~~p~~  254 (369)
                      ||||..|+...|+|||++..+.-.......-...||.+|+|||++.+... .     .+.||||+|.++|||++...-+.
T Consensus       346 NVLvK~DlTccIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~  425 (534)
T KOG3653|consen  346 NVLVKNDLTCCIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDAD  425 (534)
T ss_pred             ceEEccCCcEEeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhccccc
Confidence            99999999999999999998875554444445789999999999976532 2     36899999999999998765432


Q ss_pred             CCc--ccc---------cccchhhhhhhhcCccccccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 017594          255 LYR--TDS---------LNLLGYAWDLWTSNRTLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLT  323 (369)
Q Consensus       255 ~~~--~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L~  323 (369)
                      ...  ...         ....+..+.....++.    .+.+...........-+.+.+..||+.|++.|.|+.=+-+.+.
T Consensus       426 ~~~vp~Yqlpfe~evG~hPt~e~mq~~VV~kK~----RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~  501 (534)
T KOG3653|consen  426 PGPVPEYQLPFEAEVGNHPTLEEMQELVVRKKQ----RPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMA  501 (534)
T ss_pred             CCCCCcccCchhHHhcCCCCHHHHHHHHHhhcc----CCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHH
Confidence            111  000         1111222222222222    2333222222233566999999999999999999999999998


Q ss_pred             hhhhccC
Q 017594          324 NEAATLL  330 (369)
Q Consensus       324 ~~~~~~~  330 (369)
                      ++.....
T Consensus       502 ~l~~~~~  508 (534)
T KOG3653|consen  502 ELMMLWE  508 (534)
T ss_pred             HHhccCC
Confidence            8877443

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.2e-34  Score=265.04  Aligned_cols=257  Identities=29%  Similarity=0.427  Sum_probs=207.2

Q ss_pred             hcCCccCccccccCCccEEEEEEcC-CCEEEEEEecCCCchhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEEEEe
Q 017594           48 TNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIYEY  126 (369)
Q Consensus        48 ~~~y~i~~~lg~G~~~~v~~~~~~~-~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  126 (369)
                      ..+-+..++||-|.||.||.+.|+. .-.||||.++.+ .-..+.+..|+.+++.++|||+++++++|..+-.+|||+||
T Consensus       266 RtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED-tMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEf  344 (1157)
T KOG4278|consen  266 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEF  344 (1157)
T ss_pred             chheeeeeccCCCcccceeeeeeeccceeeehhhhhhc-chhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEec
Confidence            3444567899999999999999986 667999998754 45678899999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCCCCc
Q 017594          127 MPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNEL  206 (369)
Q Consensus       127 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~~~~  206 (369)
                      +..|+|.++++.. .+..++...+..++.||.+|++||...+   ++||||...|+||.++..|+++|||+++.+.....
T Consensus       345 M~yGNLLdYLRec-nr~ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTY  420 (1157)
T KOG4278|consen  345 MCYGNLLDYLREC-NRSEVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTY  420 (1157)
T ss_pred             ccCccHHHHHHHh-chhhcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccchhhhhcCCce
Confidence            9999999999764 3455788888999999999999999999   99999999999999999999999999998765432


Q ss_pred             ccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHh-CCCCCCCCcccccccchhhhhhhhcCccccccCcccc
Q 017594          207 QANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILE  285 (369)
Q Consensus       207 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (369)
                      . .........-|.|||-+....++.++|||+||++||++.| |-.||..-+.               .++..++++...
T Consensus       421 T-AHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidl---------------SqVY~LLEkgyR  484 (1157)
T KOG4278|consen  421 T-AHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDL---------------SQVYGLLEKGYR  484 (1157)
T ss_pred             e-cccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccH---------------HHHHHHHhcccc
Confidence            2 2222234567999999999999999999999999999998 5556543221               011111111111


Q ss_pred             ccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHhhh
Q 017594          286 DEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNEA  326 (369)
Q Consensus       286 ~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L~~~~  326 (369)
                      .+ .+..+++.+.+|+++||++.|.+||++.|+-+.|+..-
T Consensus       485 M~-~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf  524 (1157)
T KOG4278|consen  485 MD-GPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMF  524 (1157)
T ss_pred             cc-CCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHh
Confidence            10 13344778999999999999999999999998886553

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-34  Score=247.30  Aligned_cols=254  Identities=20%  Similarity=0.233  Sum_probs=193.8

Q ss_pred             HhcCCccC-ccccccCCccEEEEEEc-CCCEEEEEEecCCCchhHHHHHHHHHHHhcC-CCCceeeeeeeEEeC----Cc
Q 017594           47 ATNKFSDA-NKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSGQGLREMKNEASVIAKV-QHKNLVRLLGCCIDR----DE  119 (369)
Q Consensus        47 ~~~~y~i~-~~lg~G~~~~v~~~~~~-~~~~valK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~----~~  119 (369)
                      +.++|.+. ++||-|-.|.|-.+..+ +|+++|+|++...     ...++|++.--.. .||||+.++++|.+.    ..
T Consensus        59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc  133 (400)
T KOG0604|consen   59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKC  133 (400)
T ss_pred             chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence            34566654 57899999999999965 5999999998644     4566677654444 699999999998743    45


Q ss_pred             cEEEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeC---CCceEEeecC
Q 017594          120 KILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDK---DMNPKISDFG  196 (369)
Q Consensus       120 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~---~~~~~L~Dfg  196 (369)
                      +.+|||.++||.|...+.+. +...+.+.++..|++||+.|+.|||+.+   |.||||||+|+|.+.   +..+||+|||
T Consensus       134 LLiVmE~meGGeLfsriq~~-g~~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~lKLtDfG  209 (400)
T KOG0604|consen  134 LLIVMECMEGGELFSRIQDR-GDQAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPLKLTDFG  209 (400)
T ss_pred             eEeeeecccchHHHHHHHHc-ccccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcceEecccc
Confidence            68999999999998888654 4466999999999999999999999999   999999999999964   4568999999


Q ss_pred             CceecCCCCcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCcc
Q 017594          197 MARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRT  276 (369)
Q Consensus       197 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  276 (369)
                      ++......   ......+.|+.|.|||++....|+...|+||+|+++|-|++|.+||-  +........-........  
T Consensus       210 FAK~t~~~---~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFY--S~hg~aispgMk~rI~~g--  282 (400)
T KOG0604|consen  210 FAKETQEP---GDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFY--SNHGLAISPGMKRRIRTG--  282 (400)
T ss_pred             cccccCCC---ccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCccc--ccCCccCChhHHhHhhcc--
Confidence            99865432   23344577999999999998899999999999999999999999983  222211111111111110  


Q ss_pred             ccccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 017594          277 LELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSM  321 (369)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~  321 (369)
                         .-..-..  .....+....++|+.+|..+|++|.|+.+++..
T Consensus       283 ---qy~FP~p--EWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~h  322 (400)
T KOG0604|consen  283 ---QYEFPEP--EWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDH  322 (400)
T ss_pred             ---CccCCCh--hHhHHHHHHHHHHHHHhcCCchhheeHHHhhcC
Confidence               0001111  133447889999999999999999999999863

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2e-34  Score=258.08  Aligned_cols=265  Identities=27%  Similarity=0.381  Sum_probs=202.9

Q ss_pred             hhhHHHHhcCCccCccccccCCccEEEEEEc-CCCEEEEEEecCCCc-------hhHHHHHHHHHHHhcCCCCceeeeee
Q 017594           41 FSSVSTATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSG-------QGLREMKNEASVIAKVQHKNLVRLLG  112 (369)
Q Consensus        41 ~~~~~~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~~~-------~~~~~~~~e~~~l~~l~h~~i~~~~~  112 (369)
                      |+.-..+.+||-+++.||+|+|+.||+|.+- ..++||+|+......       .-.+...+|..+-+.|.||.|+++++
T Consensus       455 FkDHptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYD  534 (775)
T KOG1151|consen  455 FKDHPTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYD  534 (775)
T ss_pred             hccCcchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeee
Confidence            4455678899999999999999999999954 478899998653321       11234567999999999999999999


Q ss_pred             eEEeC-CccEEEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEe---CCC
Q 017594          113 CCIDR-DEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLD---KDM  188 (369)
Q Consensus       113 ~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~---~~~  188 (369)
                      +|..+ +.+|-|+|||+|..|+.++.+   .+.+++.++..|+.||+.||.||.... ++|+|.||||.||++.   .-|
T Consensus       535 yfslDtdsFCTVLEYceGNDLDFYLKQ---hklmSEKEARSIiMQiVnAL~YLNEik-pPIIHYDLKPgNILLv~GtacG  610 (775)
T KOG1151|consen  535 YFSLDTDSFCTVLEYCEGNDLDFYLKQ---HKLMSEKEARSIIMQIVNALKYLNEIK-PPIIHYDLKPGNILLVNGTACG  610 (775)
T ss_pred             eeeeccccceeeeeecCCCchhHHHHh---hhhhhHHHHHHHHHHHHHHHHHHhccC-CCeeeeccCCccEEEecCcccc
Confidence            99754 568999999999999999954   455999999999999999999999884 5699999999999994   457


Q ss_pred             ceEEeecCCceecCCCCcccc-----cccccccccccCchhhccC----CCCcccchHhHHHHHHHHHhCCCCCCCCccc
Q 017594          189 NPKISDFGMARICGGNELQAN-----TSRIVGTYGYMSPEYALEG----IFSIKSDVFSFGVLLLEIVSGKKNTGLYRTD  259 (369)
Q Consensus       189 ~~~L~Dfg~~~~~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~----~~~~~~DiwslG~il~~l~tg~~p~~~~~~~  259 (369)
                      .++|+|||++..+........     .+...||.+|++||.+.-+    ..+.++||||+|+|+|.++.|+.||+.....
T Consensus       611 eIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQ  690 (775)
T KOG1151|consen  611 EIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQ  690 (775)
T ss_pred             eeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhH
Confidence            899999999998876544322     2335689999999987633    4688999999999999999999999854321


Q ss_pred             ccccchhhhhhhhcCccccccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 017594          260 SLNLLGYAWDLWTSNRTLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVS  320 (369)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~  320 (369)
                      .        +.+....+...-+--++.   .+..+.+...+|++||++--++|....++..
T Consensus       691 Q--------dILqeNTIlkAtEVqFP~---KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~  740 (775)
T KOG1151|consen  691 Q--------DILQENTILKATEVQFPP---KPVVSSEAKAFIRRCLAYRKEDRIDVQQLAC  740 (775)
T ss_pred             H--------HHHhhhchhcceeccCCC---CCccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence            1        111111111111101111   1112567899999999999999998877653

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-34  Score=284.20  Aligned_cols=259  Identities=22%  Similarity=0.256  Sum_probs=205.0

Q ss_pred             hhhHHHHhcCCccCccccccCCccEEEEEEcC-CCEEEEEEecCC---CchhHHHHHHHHHHHhcCCCCceeeeeeeEEe
Q 017594           41 FSSVSTATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGR---SGQGLREMKNEASVIAKVQHKNLVRLLGCCID  116 (369)
Q Consensus        41 ~~~~~~~~~~y~i~~~lg~G~~~~v~~~~~~~-~~~valK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~  116 (369)
                      +........+|+|++.||+|+||.|..++.+. ++.||+|++.+.   .......|..|-.+|..-.++=|+.++..|.+
T Consensus        67 v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD  146 (1317)
T KOG0612|consen   67 VKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQD  146 (1317)
T ss_pred             HHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcC
Confidence            34445567889999999999999999999654 888999998752   22345678889999998889999999999999


Q ss_pred             CCccEEEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecC
Q 017594          117 RDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFG  196 (369)
Q Consensus       117 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg  196 (369)
                      +.++|+||||+.||.|-.++....   .+++..+.-++..|.-||..||+.|   +|||||||+|||++..|+++|+|||
T Consensus       147 ~~~LYlVMdY~pGGDlltLlSk~~---~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLADFG  220 (1317)
T KOG0612|consen  147 ERYLYLVMDYMPGGDLLTLLSKFD---RLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLADFG  220 (1317)
T ss_pred             ccceEEEEecccCchHHHHHhhcC---CChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeeccch
Confidence            999999999999999988885544   4899999999999999999999999   9999999999999999999999999


Q ss_pred             CceecCCCCcccccccccccccccCchhhc----c-CCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhh
Q 017594          197 MARICGGNELQANTSRIVGTYGYMSPEYAL----E-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLW  271 (369)
Q Consensus       197 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~----~-~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~  271 (369)
                      .+..+..... .......|||-|.+||++.    + +.|+..+|.||+|+++|+|+.|..||-..+.     ++......
T Consensus       221 sClkm~~dG~-V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadsl-----veTY~KIm  294 (1317)
T KOG0612|consen  221 SCLKMDADGT-VRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSL-----VETYGKIM  294 (1317)
T ss_pred             hHHhcCCCCc-EEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHH-----HHHHHHHh
Confidence            9988764332 2334568999999999985    3 5699999999999999999999999842220     00001111


Q ss_pred             hcCccccccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCC---HHHHHH
Q 017594          272 TSNRTLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPT---MNDVVS  320 (369)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps---~~ell~  320 (369)
                      .-.....+.     .   ....+.+..+||.+.+.. |+.|..   ++++..
T Consensus       295 ~hk~~l~FP-----~---~~~VSeeakdLI~~ll~~-~e~RLgrngiedik~  337 (1317)
T KOG0612|consen  295 NHKESLSFP-----D---ETDVSEEAKDLIEALLCD-REVRLGRNGIEDIKN  337 (1317)
T ss_pred             chhhhcCCC-----c---ccccCHHHHHHHHHHhcC-hhhhcccccHHHHHh
Confidence            111111111     0   111377899999998875 889988   888764

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=3.9e-33  Score=258.54  Aligned_cols=264  Identities=22%  Similarity=0.242  Sum_probs=188.6

Q ss_pred             CCccCccccccCCccEEEEEEc-C--CCEEEEEEecCC--CchhHHHHHHHHHHHhcC-CCCceeeeeeeEEeC----Cc
Q 017594           50 KFSDANKLGEGGFGPVYKGVLK-K--GDEIAVKRLSGR--SGQGLREMKNEASVIAKV-QHKNLVRLLGCCIDR----DE  119 (369)
Q Consensus        50 ~y~i~~~lg~G~~~~v~~~~~~-~--~~~valK~~~~~--~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~----~~  119 (369)
                      +|++.+.||.|+||.||+++.. .  +..||+|.+...  .......+..|+.+++.+ .||||+++++.+...    ..
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~   80 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE   80 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence            5889999999999999999965 3  678999988642  222345677899999999 599999999875432    34


Q ss_pred             cEEEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCce
Q 017594          120 KILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMAR  199 (369)
Q Consensus       120 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~  199 (369)
                      .+++++++. ++|..++..   ...+++..+..++.||+.||.|||++|   ++|+||+|+||+++.++.++|+|||.+.
T Consensus        81 ~~~~~e~~~-~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~a~  153 (332)
T cd07857          81 LYLYEELME-ADLHQIIRS---GQPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLAR  153 (332)
T ss_pred             EEEEEeccc-CCHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCCce
Confidence            678888876 577777743   334889999999999999999999999   9999999999999999999999999988


Q ss_pred             ecCCCCcc--cccccccccccccCchhhcc-CCCCcccchHhHHHHHHHHHhCCCCCCCCccccccc---------chhh
Q 017594          200 ICGGNELQ--ANTSRIVGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNL---------LGYA  267 (369)
Q Consensus       200 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~---------~~~~  267 (369)
                      .+......  .......++..|+|||.+.+ ..++.++|+||+|+++|+|++|.+||..........         ....
T Consensus       154 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  233 (332)
T cd07857         154 GFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEET  233 (332)
T ss_pred             ecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence            65432211  11223467889999998765 468999999999999999999999987543111000         0000


Q ss_pred             hhhhhcCccccc---cCccccccc--cHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 017594          268 WDLWTSNRTLEL---IDPILEDEY--SSKQMLLRYANIALLCVQESADDRPTMNDVVS  320 (369)
Q Consensus       268 ~~~~~~~~~~~~---~~~~~~~~~--~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~  320 (369)
                      ............   .........  .....+..+.+++.+||+.||.+|||+.+++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~  291 (332)
T cd07857         234 LSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE  291 (332)
T ss_pred             HHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            000000000000   000000000  00011467899999999999999999999984

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-34  Score=273.68  Aligned_cols=260  Identities=28%  Similarity=0.419  Sum_probs=211.6

Q ss_pred             hcCCccCccccccCCccEEEEEEcC----CCEEEEEEecCCC-chhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEE
Q 017594           48 TNKFSDANKLGEGGFGPVYKGVLKK----GDEIAVKRLSGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKIL  122 (369)
Q Consensus        48 ~~~y~i~~~lg~G~~~~v~~~~~~~----~~~valK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l  122 (369)
                      ...-.|.++||.|.||.|++|+.+.    ...||||.++... +.....|..|+.+|-++.||||+++.++........+
T Consensus       628 ~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMI  707 (996)
T KOG0196|consen  628 PSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMI  707 (996)
T ss_pred             hhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEE
Confidence            3445788999999999999999653    3469999998553 4456678899999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecC
Q 017594          123 IYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICG  202 (369)
Q Consensus       123 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~  202 (369)
                      |+||+++|+|+.+++.+...  +....+..+++.|+.|+.||-..+   ++||||...||||+.+-.+|+.|||+++...
T Consensus       708 iTEyMENGsLDsFLR~~DGq--ftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsDFGLSRvle  782 (996)
T KOG0196|consen  708 ITEYMENGSLDSFLRQNDGQ--FTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLE  782 (996)
T ss_pred             EhhhhhCCcHHHHHhhcCCc--eEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEeccccceeecc
Confidence            99999999999999876543  888899999999999999999999   9999999999999999999999999999775


Q ss_pred             CCCcc-cccccccccccccCchhhccCCCCcccchHhHHHHHHHHHh-CCCCCCCCcccccccchhhhhhhhcCcccccc
Q 017594          203 GNELQ-ANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDLWTSNRTLELI  280 (369)
Q Consensus       203 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (369)
                      +.... +....-.-..+|.|||.+...+++.++||||+|+++||.++ |.+||-..+               ++++.+.+
T Consensus       783 dd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmS---------------NQdVIkaI  847 (996)
T KOG0196|consen  783 DDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMS---------------NQDVIKAI  847 (996)
T ss_pred             cCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccc---------------hHHHHHHH
Confidence            44311 11111122568999999999999999999999999999875 888874322               11222222


Q ss_pred             CccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHhhhhc
Q 017594          281 DPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNEAAT  328 (369)
Q Consensus       281 ~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L~~~~~~  328 (369)
                      +.... -..+..++..|.+|+..||+.|-++||.+.+|+..|.++...
T Consensus       848 e~gyR-LPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrn  894 (996)
T KOG0196|consen  848 EQGYR-LPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRN  894 (996)
T ss_pred             HhccC-CCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcC
Confidence            11110 122445588899999999999999999999999999998874

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=5.4e-33  Score=278.49  Aligned_cols=146  Identities=27%  Similarity=0.405  Sum_probs=129.9

Q ss_pred             hcCCccCccccccCCccEEEEEEc-CCCEEEEEEecCCC---chhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEE
Q 017594           48 TNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS---GQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILI  123 (369)
Q Consensus        48 ~~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv  123 (369)
                      .++|++++.||.|+||.||+|.+. +++.||+|++....   ......+..|+..+..++|+||++++..+......|+|
T Consensus         3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV   82 (669)
T cd05610           3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV   82 (669)
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence            468999999999999999999976 58899999986432   23346778899999999999999999999999999999


Q ss_pred             EEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCce
Q 017594          124 YEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMAR  199 (369)
Q Consensus       124 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~  199 (369)
                      |||+.+++|..++...   ..+++..++.++.||+.||.|||..+   |+|+||||+|||++.++.++|+|||+++
T Consensus        83 mEy~~g~~L~~li~~~---~~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          83 MEYLIGGDVKSLLHIY---GYFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             EeCCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            9999999999888543   34788889999999999999999998   9999999999999999999999999875

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-33  Score=269.46  Aligned_cols=260  Identities=23%  Similarity=0.371  Sum_probs=207.7

Q ss_pred             chhhHHHHhcCCccCccccccCCccEEEEEE-cCCCEEEEEEecCCCchhHHHHHHHHHHHhcC-CCCceeeeeeeEEe-
Q 017594           40 SFSSVSTATNKFSDANKLGEGGFGPVYKGVL-KKGDEIAVKRLSGRSGQGLREMKNEASVIAKV-QHKNLVRLLGCCID-  116 (369)
Q Consensus        40 ~~~~~~~~~~~y~i~~~lg~G~~~~v~~~~~-~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~-  116 (369)
                      .+.....-...|++.+.||.|.+|.||+++. ++|+-.|+|+.....+ ..+.++.|+++|+.+ .|||++.++++|.. 
T Consensus        10 ~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d-~deEiE~eynil~~~~~hpnv~~fyg~~~k~   88 (953)
T KOG0587|consen   10 DLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTED-EEEEIELEYNMLKKYSHHPNVATFYGAFIKK   88 (953)
T ss_pred             chhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcc-ccHHHHHHHHHHHhccCCCCcceEEEEEEEe
Confidence            3444555667899999999999999999995 4588889998875543 336788899999988 59999999999874 


Q ss_pred             ----CCccEEEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEE
Q 017594          117 ----RDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKI  192 (369)
Q Consensus       117 ----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L  192 (369)
                          ++.+|||||||.+|+..+++..-. +..+.+..+..|++.++.|+.+||.+.   ++|||||-.||+++.++.|||
T Consensus        89 ~~~~~DqLWLVMEfC~gGSVTDLVKn~~-g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~VKL  164 (953)
T KOG0587|consen   89 DPGNGDQLWLVMEFCGGGSVTDLVKNTK-GNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEVKL  164 (953)
T ss_pred             cCCCCCeEEEEeeccCCccHHHHHhhhc-ccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcEEE
Confidence                467899999999999999997654 566899999999999999999999998   999999999999999999999


Q ss_pred             eecCCceecCCCCcccccccccccccccCchhhccC-----CCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhh
Q 017594          193 SDFGMARICGGNELQANTSRIVGTYGYMSPEYALEG-----IFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYA  267 (369)
Q Consensus       193 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~  267 (369)
                      +|||.+.......  .......|++.|+|||++.+.     .|+..+|+||||++..+|.-|.+|+-..-          
T Consensus       165 vDFGvSaQldsT~--grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmH----------  232 (953)
T KOG0587|consen  165 VDFGVSAQLDSTV--GRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMH----------  232 (953)
T ss_pred             eeeeeeeeeeccc--ccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcc----------
Confidence            9999988765332  233345799999999999754     37889999999999999999999964211          


Q ss_pred             hhhhhcCccccccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 017594          268 WDLWTSNRTLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVS  320 (369)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~  320 (369)
                          ..+-+..........-..+..++.++.++|..||..|.++||+..++++
T Consensus       233 ----PmraLF~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~  281 (953)
T KOG0587|consen  233 ----PMRALFLIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK  281 (953)
T ss_pred             ----hhhhhccCCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence                0011111111111111125566899999999999999999999999885

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.1e-34  Score=266.26  Aligned_cols=253  Identities=23%  Similarity=0.275  Sum_probs=197.7

Q ss_pred             CCccccchhhHHHH--------hcCCccCccccccCCccEEEEEEc-CCCEEEEEEecCCCchhHHHHHHHHHHHhcC-C
Q 017594           34 DQFPLFSFSSVSTA--------TNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSGQGLREMKNEASVIAKV-Q  103 (369)
Q Consensus        34 ~~~~~~~~~~~~~~--------~~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~~~~~~~~~~~e~~~l~~l-~  103 (369)
                      ..+..|++......        ...|++...+|.|+|+.|-.+... +++..++|++....    ....+|..++... .
T Consensus       299 ~if~g~sfva~~il~~~~~~~~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~  374 (612)
T KOG0603|consen  299 TIFSGPSFVAPGVLEDAVTAPFTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRD  374 (612)
T ss_pred             chhcCCCccChHHhhccccCCcchhhccccccCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcC
Confidence            34445666555444        457999999999999999999954 48889999997652    2334556555544 7


Q ss_pred             CCceeeeeeeEEeCCccEEEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEE
Q 017594          104 HKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNIL  183 (369)
Q Consensus       104 h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIl  183 (369)
                      |||++++.+.+.+..+.|+|||.+.++-+.+.+.....   .. ..+..|+.+|+.|+.|||.+|   ++||||||+||+
T Consensus       375 h~niv~~~~v~~~~~~~~~v~e~l~g~ell~ri~~~~~---~~-~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL  447 (612)
T KOG0603|consen  375 HPNIVKSHDVYEDGKEIYLVMELLDGGELLRRIRSKPE---FC-SEASQWAAELVSAVDYLHEQG---VVHRDLKPGNIL  447 (612)
T ss_pred             CCcceeecceecCCceeeeeehhccccHHHHHHHhcch---hH-HHHHHHHHHHHHHHHHHHhcC---eeecCCChhhee
Confidence            99999999999999999999999999987666643222   33 567789999999999999999   999999999999


Q ss_pred             E-eCCCceEEeecCCceecCCCCcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccc
Q 017594          184 L-DKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLN  262 (369)
Q Consensus       184 v-~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~  262 (369)
                      + +..++++|+|||.+......     ....+-|..|+|||+.....|+.++|+||||++||+|++|+.||.....+   
T Consensus       448 ~~~~~g~lrltyFG~a~~~~~~-----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~---  519 (612)
T KOG0603|consen  448 LDGSAGHLRLTYFGFWSELERS-----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG---  519 (612)
T ss_pred             ecCCCCcEEEEEechhhhCchh-----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch---
Confidence            9 68899999999998765433     22235688899999999999999999999999999999999998755433   


Q ss_pred             cchhhhhhhhcCccccccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 017594          263 LLGYAWDLWTSNRTLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVS  320 (369)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~  320 (369)
                                    .+....+..+... ...+...++||.+||+.||.+||++.++..
T Consensus       520 --------------~ei~~~i~~~~~s-~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~  562 (612)
T KOG0603|consen  520 --------------IEIHTRIQMPKFS-ECVSDEAKDLLQQLLQVDPALRLGADEIGA  562 (612)
T ss_pred             --------------HHHHHhhcCCccc-cccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence                          1111111111111 333778999999999999999999999985

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=5.3e-33  Score=245.30  Aligned_cols=219  Identities=18%  Similarity=0.120  Sum_probs=173.0

Q ss_pred             cCCccEEEEEEc-CCCEEEEEEecCCCchhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEEEEecCCCChhhhhcC
Q 017594           60 GGFGPVYKGVLK-KGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFD  138 (369)
Q Consensus        60 G~~~~v~~~~~~-~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~  138 (369)
                      |.++.||+|+++ +++.|++|.+....     ....|...+....|||++++++++...+..+++|||+.+++|.+++..
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~   78 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK   78 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence            899999999965 48899999987543     223344455556799999999999999999999999999999888854


Q ss_pred             CCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCCCCccccccccccccc
Q 017594          139 PTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG  218 (369)
Q Consensus       139 ~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~  218 (369)
                      .   ..+++..+..++.|++.||.|||+.+   ++|+||||+||+++.++.++++|||.+.......     ....++..
T Consensus        79 ~---~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~-----~~~~~~~~  147 (237)
T cd05576          79 F---LNIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC-----DGEAVENM  147 (237)
T ss_pred             h---cCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhcccccc-----ccCCcCcc
Confidence            3   34889999999999999999999998   9999999999999999999999999876543321     12234667


Q ss_pred             ccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCccccccCccccccccHHHHHHHHH
Q 017594          219 YMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYSSKQMLLRYA  298 (369)
Q Consensus       219 y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  298 (369)
                      |+|||...+..++.++|+||+|+++|+|++|..|+........           ..     ....+     +..++..+.
T Consensus       148 y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~~-----------~~-----~~~~~-----~~~~~~~~~  206 (237)
T cd05576         148 YCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGIN-----------TH-----TTLNI-----PEWVSEEAR  206 (237)
T ss_pred             ccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhcc-----------cc-----cccCC-----cccCCHHHH
Confidence            9999998888889999999999999999999987643211000           00     00000     111256689


Q ss_pred             HHHHHhhcCCCCCCCCH
Q 017594          299 NIALLCVQESADDRPTM  315 (369)
Q Consensus       299 ~li~~~L~~dP~~Rps~  315 (369)
                      ++|.+||+.||++||++
T Consensus       207 ~li~~~l~~dp~~R~~~  223 (237)
T cd05576         207 SLLQQLLQFNPTERLGA  223 (237)
T ss_pred             HHHHHHccCCHHHhcCC
Confidence            99999999999999997

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-34  Score=261.49  Aligned_cols=248  Identities=23%  Similarity=0.334  Sum_probs=200.4

Q ss_pred             cCCcc--CccccccCCccEEEEEE-cCCCEEEEEEecCC--CchhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEE
Q 017594           49 NKFSD--ANKLGEGGFGPVYKGVL-KKGDEIAVKRLSGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILI  123 (369)
Q Consensus        49 ~~y~i--~~~lg~G~~~~v~~~~~-~~~~~valK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv  123 (369)
                      .-|+|  .+.||+|.||+||-|+. ++|+.||+|++.+.  ......++++|+.+|+++.||.|+.+...|+..+..++|
T Consensus       562 tvYQif~devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVV  641 (888)
T KOG4236|consen  562 TVYQIFADEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVV  641 (888)
T ss_pred             HHHHhhhHhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEE
Confidence            33554  47899999999999995 46999999998644  234457899999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeC---CCceEEeecCCcee
Q 017594          124 YEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDK---DMNPKISDFGMARI  200 (369)
Q Consensus       124 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~---~~~~~L~Dfg~~~~  200 (369)
                      ||-+.|.-|+-++.....  .+++....-++.||+.||.|||.++   |+|+||||+||++..   ..++||+|||+++.
T Consensus       642 MEKl~GDMLEMILSsEkg--RL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfARi  716 (888)
T KOG4236|consen  642 MEKLHGDMLEMILSSEKG--RLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFARI  716 (888)
T ss_pred             ehhhcchHHHHHHHhhcc--cchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccceee
Confidence            999988877766654333  3888888999999999999999999   999999999999954   45799999999999


Q ss_pred             cCCCCcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCcccccc
Q 017594          201 CGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELI  280 (369)
Q Consensus       201 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (369)
                      ++....   .....||+.|+|||++.++.|+..-|+||.|+|+|--++|..||....+......       +.       
T Consensus       717 IgEksF---RrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQIQ-------NA-------  779 (888)
T KOG4236|consen  717 IGEKSF---RRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQIQ-------NA-------  779 (888)
T ss_pred             cchhhh---hhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhHHhh-------cc-------
Confidence            876543   2335899999999999999999999999999999999999999975432111000       00       


Q ss_pred             CccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHH
Q 017594          281 DPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVV  319 (369)
Q Consensus       281 ~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell  319 (369)
                       ..+-...+..+++....+||..+|+..-.+|.|.+..+
T Consensus       780 -aFMyPp~PW~eis~~AidlIn~LLqVkm~kRysvdk~l  817 (888)
T KOG4236|consen  780 -AFMYPPNPWSEISPEAIDLINNLLQVKMRKRYSVDKSL  817 (888)
T ss_pred             -ccccCCCchhhcCHHHHHHHHHHHHHHHHHhcchHhhc
Confidence             00011122345577899999999999999999988544

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-33  Score=222.67  Aligned_cols=263  Identities=22%  Similarity=0.276  Sum_probs=194.4

Q ss_pred             CCccCccccccCCccEEEEEEc-CCCEEEEEEecCC--CchhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEEEEe
Q 017594           50 KFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIYEY  126 (369)
Q Consensus        50 ~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  126 (369)
                      +|.-.++||+|.||+||+|++. +++-||+|++...  ++.......+|+-+|+.++|.||++++++...++.+-+|+||
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~   82 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF   82 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence            5677889999999999999955 4888999988644  344466788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCCCCc
Q 017594          127 MPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNEL  206 (369)
Q Consensus       127 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~~~~  206 (369)
                      |.. .|..+....  ...++...+.+++.|++.+|.++|+++   +.|||+||.|.+++.+|.++|+|||+++.++-...
T Consensus        83 cdq-dlkkyfdsl--ng~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglarafgipvr  156 (292)
T KOG0662|consen   83 CDQ-DLKKYFDSL--NGDLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAFGIPVR  156 (292)
T ss_pred             hhH-HHHHHHHhc--CCcCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhcCCceE
Confidence            965 344443221  234888999999999999999999999   99999999999999999999999999988764443


Q ss_pred             ccccccccccccccCchhhccCC-CCcccchHhHHHHHHHHHh-CCCCCCCCcccccc-cchhhhhhhhc---Ccccccc
Q 017594          207 QANTSRIVGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLN-LLGYAWDLWTS---NRTLELI  280 (369)
Q Consensus       207 ~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~il~~l~t-g~~p~~~~~~~~~~-~~~~~~~~~~~---~~~~~~~  280 (369)
                      +...  ...|.+|.+|.++.+.. |+...|+||.|||+.++.. |.+.|...+.+.+. ..-..-.....   ....++.
T Consensus       157 cysa--evvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lp  234 (292)
T KOG0662|consen  157 CYSA--EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLP  234 (292)
T ss_pred             eeec--eeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCC
Confidence            3322  35688999999988765 8899999999999999997 55556544432211 11000000001   1111111


Q ss_pred             Cccccccc----c----HHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 017594          281 DPILEDEY----S----SKQMLLRYANIALLCVQESADDRPTMNDVVS  320 (369)
Q Consensus       281 ~~~~~~~~----~----~~~~~~~l~~li~~~L~~dP~~Rps~~ell~  320 (369)
                      +...-..+    .    .+.....-.+++.++|..+|..|.+++..++
T Consensus       235 dyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq  282 (292)
T KOG0662|consen  235 DYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ  282 (292)
T ss_pred             CCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence            11111111    1    1122334578999999999999999998876

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.7e-34  Score=257.56  Aligned_cols=251  Identities=23%  Similarity=0.298  Sum_probs=205.5

Q ss_pred             HhcCCccCccccccCCccEEEEEEcCCCE-EEEEEecCC---CchhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEE
Q 017594           47 ATNKFSDANKLGEGGFGPVYKGVLKKGDE-IAVKRLSGR---SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKIL  122 (369)
Q Consensus        47 ~~~~y~i~~~lg~G~~~~v~~~~~~~~~~-valK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l  122 (369)
                      ...+++++..||-|+||.|=++..++... +|+|++++.   +....+.+..|-++|..+.+|.|++++..|.+....|+
T Consensus       418 ~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYm  497 (732)
T KOG0614|consen  418 KLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYM  497 (732)
T ss_pred             chhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhh
Confidence            44567888999999999999999775443 788877543   34445667789999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecC
Q 017594          123 IYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICG  202 (369)
Q Consensus       123 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~  202 (369)
                      +||-|-||.+...++.   +..++.....-++..++.|++|||++|   |+.|||||+|.+++.+|-+||.|||++..+.
T Consensus       498 LmEaClGGElWTiLrd---Rg~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKki~  571 (732)
T KOG0614|consen  498 LMEACLGGELWTILRD---RGSFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKKIG  571 (732)
T ss_pred             hHHhhcCchhhhhhhh---cCCcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHHHhc
Confidence            9999999999999854   445899999999999999999999999   9999999999999999999999999999887


Q ss_pred             CCCcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCccccccCc
Q 017594          203 GNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDP  282 (369)
Q Consensus       203 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (369)
                      .+.....   .+||++|.|||++.+...+.++|.||||+++|||++|.+||...+.-.               ...++.+
T Consensus       572 ~g~KTwT---FcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmk---------------tYn~ILk  633 (732)
T KOG0614|consen  572 SGRKTWT---FCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMK---------------TYNLILK  633 (732)
T ss_pred             cCCceee---ecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHH---------------HHHHHHh
Confidence            6654333   489999999999999999999999999999999999999997443111               1112222


Q ss_pred             cccccccHHHHHHHHHHHHHHhhcCCCCCCCC-----HHHHHHH
Q 017594          283 ILEDEYSSKQMLLRYANIALLCVQESADDRPT-----MNDVVSM  321 (369)
Q Consensus       283 ~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps-----~~ell~~  321 (369)
                      .+..-..+..++....+||++++..+|.+|.-     +.+|-+.
T Consensus       634 Gid~i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH  677 (732)
T KOG0614|consen  634 GIDKIEFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKH  677 (732)
T ss_pred             hhhhhhcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhh
Confidence            22222223444667889999999999999986     5566654

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=1.4e-31  Score=235.74  Aligned_cols=238  Identities=29%  Similarity=0.350  Sum_probs=190.4

Q ss_pred             CCccEEEEEEcC-CCEEEEEEecCCCchh-HHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEEEEecCCCChhhhhcC
Q 017594           61 GFGPVYKGVLKK-GDEIAVKRLSGRSGQG-LREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFD  138 (369)
Q Consensus        61 ~~~~v~~~~~~~-~~~valK~~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~  138 (369)
                      ++|.||+|+... |+.+++|++....... ...+..|+..++.++|++++++++.+......++++|++.+++|..++..
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~   80 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK   80 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence            579999999765 8999999997665443 67889999999999999999999999988999999999999999988854


Q ss_pred             CCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCCCCccccccccccccc
Q 017594          139 PTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG  218 (369)
Q Consensus       139 ~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~  218 (369)
                      ...   ++...++.++.+++.++.+||+.+   ++|+||+|.||+++.++.++|+|||.+.......   ......++..
T Consensus        81 ~~~---~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~  151 (244)
T smart00220       81 RGR---LSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTPE  151 (244)
T ss_pred             ccC---CCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCcC
Confidence            322   788999999999999999999998   9999999999999999999999999988765432   2233457788


Q ss_pred             ccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCccccccCccccccccHHHHHHHHH
Q 017594          219 YMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYSSKQMLLRYA  298 (369)
Q Consensus       219 y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  298 (369)
                      |++||...+..++.++|+||+|+++++|++|..||.......     .............        ......++.++.
T Consensus       152 ~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~-----~~~~~~~~~~~~~--------~~~~~~~~~~~~  218 (244)
T smart00220      152 YMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLL-----ELFKKIGKPKPPF--------PPPEWKISPEAK  218 (244)
T ss_pred             CCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHH-----HHHHHHhccCCCC--------ccccccCCHHHH
Confidence            999999988888999999999999999999999986421110     0011111000000        000000256799


Q ss_pred             HHHHHhhcCCCCCCCCHHHHHH
Q 017594          299 NIALLCVQESADDRPTMNDVVS  320 (369)
Q Consensus       299 ~li~~~L~~dP~~Rps~~ell~  320 (369)
                      +++.+||..+|++||++.++++
T Consensus       219 ~~i~~~l~~~p~~Rp~~~~~~~  240 (244)
T smart00220      219 DLIRKLLVKDPEKRLTAEEALQ  240 (244)
T ss_pred             HHHHHHccCCchhccCHHHHhh
Confidence            9999999999999999999986

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.98  E-value=4.2e-34  Score=239.05  Aligned_cols=268  Identities=21%  Similarity=0.345  Sum_probs=194.0

Q ss_pred             hcCCccCccccccCCccEEEEEEc-CCCEEEEEEecCCC--chhHHHHHHHHHHHhcCCCCceeeeeeeEEe--------
Q 017594           48 TNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS--GQGLREMKNEASVIAKVQHKNLVRLLGCCID--------  116 (369)
Q Consensus        48 ~~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--------  116 (369)
                      ...|+-..+||+|.||.||+|+.+ +|+.|++|++.-.+  ..-.....+|+.+|..|+|+|++.++++|..        
T Consensus        16 ~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~   95 (376)
T KOG0669|consen   16 VSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRD   95 (376)
T ss_pred             chHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccc
Confidence            456788889999999999999955 48888988765322  1223456789999999999999999888753        


Q ss_pred             CCccEEEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecC
Q 017594          117 RDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFG  196 (369)
Q Consensus       117 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg  196 (369)
                      ...+|+||++|+.. |.-++.+.  ...++...+.+++.+++.||.|+|...   |+|||+||.|++++.+|.++|+|||
T Consensus        96 r~t~ylVf~~cehD-LaGlLsn~--~vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilklADFG  169 (376)
T KOG0669|consen   96 RATFYLVFDFCEHD-LAGLLSNR--KVRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILKLADFG  169 (376)
T ss_pred             cceeeeeHHHhhhh-HHHHhcCc--cccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEEeeccc
Confidence            23479999999764 44555432  244888999999999999999999998   9999999999999999999999999


Q ss_pred             CceecCCCCc--ccccccccccccccCchhhcc-CCCCcccchHhHHHHHHHHHhCCCCCCCCccccc---------ccc
Q 017594          197 MARICGGNEL--QANTSRIVGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSL---------NLL  264 (369)
Q Consensus       197 ~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~---------~~~  264 (369)
                      +++.+.....  .........|.+|++||.+.+ ..|+++.|+|+.|||+.+|+++.+.++.......         +.-
T Consensus       170 lar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~t  249 (376)
T KOG0669|consen  170 LARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSIT  249 (376)
T ss_pred             cccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCC
Confidence            9977643322  122233456899999998875 5699999999999999999999988764321110         011


Q ss_pred             hhhhhhhhcCcccccc--Ccccccccc-------HHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 017594          265 GYAWDLWTSNRTLELI--DPILEDEYS-------SKQMLLRYANIALLCVQESADDRPTMNDVVSM  321 (369)
Q Consensus       265 ~~~~~~~~~~~~~~~~--~~~~~~~~~-------~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~  321 (369)
                      ..+|+....-...+.+  .+...+...       +..-.++..+|+.++|..||.+|+++++++..
T Consensus       250 kevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh  315 (376)
T KOG0669|consen  250 KEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNH  315 (376)
T ss_pred             cccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhch
Confidence            1122222222222222  211111111       11113468899999999999999999988853

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=99.98  E-value=3.6e-34  Score=241.07  Aligned_cols=257  Identities=25%  Similarity=0.357  Sum_probs=192.8

Q ss_pred             cCCccCccccccCCccEEEEEEc-CCCEEEEEEecCCCc-hhHHHHHHHHHHHhcC-CCCceeeeeeeEEeCCccEEEEE
Q 017594           49 NKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSG-QGLREMKNEASVIAKV-QHKNLVRLLGCCIDRDEKILIYE  125 (369)
Q Consensus        49 ~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~~~-~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e  125 (369)
                      ...+-+..||.|+||+|++-..+ +|+..|+|++...+. ....++..|.+...+- ++|||+++++....+...|+.||
T Consensus        64 ~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCME  143 (361)
T KOG1006|consen   64 DNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICME  143 (361)
T ss_pred             chHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHH
Confidence            34556788999999999999865 499999999976643 4456677777765554 69999999999999999999999


Q ss_pred             ecCCCChhhhhcC--CCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCC
Q 017594          126 YMPNKSLDFFLFD--PTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGG  203 (369)
Q Consensus       126 ~~~~~~L~~~l~~--~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~  203 (369)
                      .++ .+++.+...  ......+++..+-.|......||.||...-  .++|||+||+||+++..|.+||+|||++-.+.+
T Consensus       144 LMd-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~  220 (361)
T KOG1006|consen  144 LMD-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLVD  220 (361)
T ss_pred             HHh-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHHH
Confidence            874 466544321  122344788888888888999999998754  599999999999999999999999999866543


Q ss_pred             CCcccccccccccccccCchhhc--cCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCccccccC
Q 017594          204 NELQANTSRIVGTYGYMSPEYAL--EGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELID  281 (369)
Q Consensus       204 ~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (369)
                      ..   ......|-..|+|||.+.  +..|+.++|+||||++|||+.||..|+..+....     ..-.....++     .
T Consensus       221 Si---AkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svf-----eql~~Vv~gd-----p  287 (361)
T KOG1006|consen  221 SI---AKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVF-----EQLCQVVIGD-----P  287 (361)
T ss_pred             HH---HhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHH-----HHHHHHHcCC-----C
Confidence            22   223345677899999986  3459999999999999999999999987554211     0001111122     2


Q ss_pred             ccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 017594          282 PILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSM  321 (369)
Q Consensus       282 ~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~  321 (369)
                      +.+........++..+..+|.-||..|-+.||.+.+++++
T Consensus       288 p~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~  327 (361)
T KOG1006|consen  288 PILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF  327 (361)
T ss_pred             CeecCcccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence            2222222233447779999999999999999999999863

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.98  E-value=4e-33  Score=253.90  Aligned_cols=216  Identities=20%  Similarity=0.258  Sum_probs=184.5

Q ss_pred             CCCccccchhhHHHHhcCCccCccccccCCccEEEEEEcC-CCEEEEEEecCCCchhHHHHHHHHHHHhcCCC------C
Q 017594           33 VDQFPLFSFSSVSTATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLREMKNEASVIAKVQH------K  105 (369)
Q Consensus        33 ~~~~~~~~~~~~~~~~~~y~i~~~lg~G~~~~v~~~~~~~-~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h------~  105 (369)
                      .+-+.-|.+.-.+.+..+|.+....|+|-|++|..|.+.. |+.||||++.... -..+.=..|+++|++|..      -
T Consensus       416 dDaEGYYrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE-~M~KtGl~EleiLkKL~~AD~Edk~  494 (752)
T KOG0670|consen  416 DDAEGYYRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNE-VMHKTGLKELEILKKLNDADPEDKF  494 (752)
T ss_pred             ccccceEEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecch-HHhhhhhHHHHHHHHhhccCchhhh
Confidence            3445567888899999999999999999999999999765 8899999997543 334555679999999952      3


Q ss_pred             ceeeeeeeEEeCCccEEEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEe
Q 017594          106 NLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLD  185 (369)
Q Consensus       106 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~  185 (369)
                      |.++++..|.+.+++|+|||.+ .-+|.+++...+....+...++..++.|++.||..|...|   ++|+||||+||||+
T Consensus       495 Hclrl~r~F~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVN  570 (752)
T KOG0670|consen  495 HCLRLFRHFKHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVN  570 (752)
T ss_pred             HHHHHHHHhhhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEec
Confidence            7899999999999999999987 5688999988777777889999999999999999999999   99999999999998


Q ss_pred             CC-CceEEeecCCceecCCCCcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCc
Q 017594          186 KD-MNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYR  257 (369)
Q Consensus       186 ~~-~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~  257 (369)
                      +. ..++|||||.+.....+...+    ...+-.|.|||++.+.+|+...|+||.||+||+|.||+..|....
T Consensus       571 E~k~iLKLCDfGSA~~~~eneitP----YLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~T  639 (752)
T KOG0670|consen  571 ESKNILKLCDFGSASFASENEITP----YLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRT  639 (752)
T ss_pred             cCcceeeeccCccccccccccccH----HHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCC
Confidence            65 457999999998776554322    223556999999999999999999999999999999999887544

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.98  E-value=6.5e-33  Score=246.38  Aligned_cols=245  Identities=27%  Similarity=0.336  Sum_probs=196.0

Q ss_pred             HHHhcCCccCccccccCCccEEEEEEcC-CCEEEEEEecCC---CchhHHHHHHHHHHHhcC-CCCceeeeeeeEEeCCc
Q 017594           45 STATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGR---SGQGLREMKNEASVIAKV-QHKNLVRLLGCCIDRDE  119 (369)
Q Consensus        45 ~~~~~~y~i~~~lg~G~~~~v~~~~~~~-~~~valK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~  119 (369)
                      .....+|..+.+||+|+||.|.+|..+. .+-+|||++.++   +..+.+.-..|-.+|... +-|.++.+..+|..-+.
T Consensus       345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDR  424 (683)
T KOG0696|consen  345 RIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDR  424 (683)
T ss_pred             ceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhh
Confidence            4556789999999999999999999664 677999988754   233444445566666655 45788889999988899


Q ss_pred             cEEEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCce
Q 017594          120 KILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMAR  199 (369)
Q Consensus       120 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~  199 (369)
                      +|+||||++||.|-..+++..+   +.+..+.-++..|+-||-+||++|   |+.||||.+||+++.+|+++|+|||++.
T Consensus       425 LyFVMEyvnGGDLMyhiQQ~Gk---FKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmcK  498 (683)
T KOG0696|consen  425 LYFVMEYVNGGDLMYHIQQVGK---FKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCK  498 (683)
T ss_pred             eeeEEEEecCchhhhHHHHhcc---cCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeeccccc
Confidence            9999999999999888766554   778888889999999999999999   9999999999999999999999999986


Q ss_pred             ecCCCCcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCccccc
Q 017594          200 ICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLEL  279 (369)
Q Consensus       200 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (369)
                      .--.  ........+||+.|+|||++...+|+.++|.||+|++||+|+.|++||...+.+.                  +
T Consensus       499 Eni~--~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~e------------------l  558 (683)
T KOG0696|consen  499 ENIF--DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE------------------L  558 (683)
T ss_pred             cccc--CCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHH------------------H
Confidence            4321  2233455789999999999999999999999999999999999999997554222                  1


Q ss_pred             cCcccccc-ccHHHHHHHHHHHHHHhhcCCCCCCCCH
Q 017594          280 IDPILEDE-YSSKQMLLRYANIALLCVQESADDRPTM  315 (369)
Q Consensus       280 ~~~~~~~~-~~~~~~~~~l~~li~~~L~~dP~~Rps~  315 (369)
                      ...+.... ..+...+.+...+++..|..+|.+|...
T Consensus       559 F~aI~ehnvsyPKslSkEAv~ickg~ltK~P~kRLGc  595 (683)
T KOG0696|consen  559 FQAIMEHNVSYPKSLSKEAVAICKGLLTKHPGKRLGC  595 (683)
T ss_pred             HHHHHHccCcCcccccHHHHHHHHHHhhcCCccccCC
Confidence            11111111 1244447789999999999999999743

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.97  E-value=3.2e-32  Score=224.81  Aligned_cols=258  Identities=20%  Similarity=0.324  Sum_probs=195.3

Q ss_pred             HhcCCccCccccccCCccEEEEE-EcCCCEEEEEEecCCCchhHHHHHHHHHHHhcCC-CCceeeeeeeEEeC--CccEE
Q 017594           47 ATNKFSDANKLGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQ-HKNLVRLLGCCIDR--DEKIL  122 (369)
Q Consensus        47 ~~~~y~i~~~lg~G~~~~v~~~~-~~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~--~~~~l  122 (369)
                      ..++|++++++|+|.++.||.|. ..+++++++|+++.-.   .+.+.+|+.+|+.|. +|||++++++..+.  ....+
T Consensus        36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk---kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaL  112 (338)
T KOG0668|consen   36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK---KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSL  112 (338)
T ss_pred             ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH---HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchh
Confidence            45789999999999999999999 4568899999997443   478999999999997 99999999998765  45689


Q ss_pred             EEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCC-CceEEeecCCceec
Q 017594          123 IYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKD-MNPKISDFGMARIC  201 (369)
Q Consensus       123 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~-~~~~L~Dfg~~~~~  201 (369)
                      ++||+++..+..+..      .++...+...+.++++||.|+|++|   |.|||+||.|++++.. ..++|+|||++..+
T Consensus       113 iFE~v~n~Dfk~ly~------tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFY  183 (338)
T KOG0668|consen  113 IFEYVNNTDFKQLYP------TLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFY  183 (338)
T ss_pred             HhhhhccccHHHHhh------hhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecchHhhc
Confidence            999999887766552      2667788999999999999999999   9999999999999865 46999999999876


Q ss_pred             CCCCcccccccccccccccCchhhccC-CCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCcccc--
Q 017594          202 GGNELQANTSRIVGTYGYMSPEYALEG-IFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLE--  278 (369)
Q Consensus       202 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--  278 (369)
                      ..+..-   .....+..|--||++... .|+..-|+|||||++..|+..+.||-...+.....+.++.-.... +...  
T Consensus       184 Hp~~eY---nVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~-el~~Yl  259 (338)
T KOG0668|consen  184 HPGKEY---NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTD-ELYAYL  259 (338)
T ss_pred             CCCcee---eeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChH-HHHHHH
Confidence            533221   112345567789988754 588999999999999999999999977665544333332211111 0000  


Q ss_pred             -----ccCccccc---cc------------cHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 017594          279 -----LIDPILED---EY------------SSKQMLLRYANIALLCVQESADDRPTMNDVVS  320 (369)
Q Consensus       279 -----~~~~~~~~---~~------------~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~  320 (369)
                           .+++...+   ..            .....+++..+|+.++|..|..+|+|++|.+.
T Consensus       260 ~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~  321 (338)
T KOG0668|consen  260 NKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA  321 (338)
T ss_pred             HHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence                 01111110   00            00111467899999999999999999999885

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.97  E-value=2.4e-31  Score=260.64  Aligned_cols=262  Identities=18%  Similarity=0.201  Sum_probs=165.6

Q ss_pred             HhcCCccCccccccCCccEEEEEEcC-----CCEEEEEEecCCCchhHHHHHHHHHHHhcCCCCceeeeeee------EE
Q 017594           47 ATNKFSDANKLGEGGFGPVYKGVLKK-----GDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGC------CI  115 (369)
Q Consensus        47 ~~~~y~i~~~lg~G~~~~v~~~~~~~-----~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~------~~  115 (369)
                      ..++|.+.+.||+|+||.||+|++.+     +..||+|++......  +....  +.+....+.++..+...      ..
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~--e~l~~~~~~~~~~~~~~~~~~~~~~  205 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMN--ERVRRACPNSCADFVYGFLEPVSSK  205 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHH--HHHHhhchhhHHHHHHhhhcccccc
Confidence            55789999999999999999999653     688999987643221  11111  11222222222222111      23


Q ss_pred             eCCccEEEEEecCCCChhhhhcCCCcc-----------------ccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCC
Q 017594          116 DRDEKILIYEYMPNKSLDFFLFDPTKR-----------------MLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLK  178 (369)
Q Consensus       116 ~~~~~~lv~e~~~~~~L~~~l~~~~~~-----------------~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~  178 (369)
                      .+...++|++|+.+++|.+++......                 .......+..++.||+.||.|||+.+   |+|||||
T Consensus       206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDLK  282 (566)
T PLN03225        206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVK  282 (566)
T ss_pred             cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcCC
Confidence            456789999999999998887542210                 11123346689999999999999998   9999999


Q ss_pred             CCCEEEeC-CCceEEeecCCceecCCCCcccccccccccccccCchhhccC----------------------CCCcccc
Q 017594          179 ASNILLDK-DMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEG----------------------IFSIKSD  235 (369)
Q Consensus       179 p~NIlv~~-~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~----------------------~~~~~~D  235 (369)
                      |+|||++. ++.++|+|||++..+..... .......+++.|+|||.+...                      .++.++|
T Consensus       283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~-~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D  361 (566)
T PLN03225        283 PQNIIFSEGSGSFKIIDLGAAADLRVGIN-YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD  361 (566)
T ss_pred             HHHEEEeCCCCcEEEEeCCCccccccccc-cCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence            99999986 57899999999975533221 222345678999999965321                      2345679


Q ss_pred             hHhHHHHHHHHHhCCCCCCCCccccc---ccchhhhhhhhcCccccccCcccccc----cc-HHHHHHHHHHHHHHhhcC
Q 017594          236 VFSFGVLLLEIVSGKKNTGLYRTDSL---NLLGYAWDLWTSNRTLELIDPILEDE----YS-SKQMLLRYANIALLCVQE  307 (369)
Q Consensus       236 iwslG~il~~l~tg~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~----~~-~~~~~~~l~~li~~~L~~  307 (369)
                      ||||||++|+|+++..++........   .........+     ...+.+.....    +. .........+||.+||+.
T Consensus       362 VwSlGviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~  436 (566)
T PLN03225        362 IYSAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAW-----RKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRF  436 (566)
T ss_pred             cHHHHHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHH-----HHhhccccchhhhhhhhhccccchHHHHHHHHHccC
Confidence            99999999999997665431100000   0000000000     00000000000    00 000023456899999999


Q ss_pred             CCCCCCCHHHHHHH
Q 017594          308 SADDRPTMNDVVSM  321 (369)
Q Consensus       308 dP~~Rps~~ell~~  321 (369)
                      ||++|||+.++++.
T Consensus       437 dP~kR~ta~e~L~H  450 (566)
T PLN03225        437 KGRQRISAKAALAH  450 (566)
T ss_pred             CcccCCCHHHHhCC
Confidence            99999999999973

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.4e-31  Score=226.07  Aligned_cols=284  Identities=18%  Similarity=0.304  Sum_probs=211.0

Q ss_pred             HHhcCCccCccccccCCccEEEEEEcC-CCEEEEEEecCCCchhHHHHHHHHHHHhcC-CCCceeeeeeeE-EeCCccEE
Q 017594           46 TATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLREMKNEASVIAKV-QHKNLVRLLGCC-IDRDEKIL  122 (369)
Q Consensus        46 ~~~~~y~i~~~lg~G~~~~v~~~~~~~-~~~valK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~-~~~~~~~l  122 (369)
                      .+.+.|.|.+.||.|.||.+-+|+++. ...+++|.+.... .....+.+|...--.| .|.||+.-+++. ...+.+++
T Consensus        21 ~l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~-tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF   99 (378)
T KOG1345|consen   21 DLEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ-TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVF   99 (378)
T ss_pred             chhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch-hhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEE
Confidence            345789999999999999999999765 7889999987554 3356777888776667 488998877764 44556789


Q ss_pred             EEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEE--eCCCceEEeecCCcee
Q 017594          123 IYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILL--DKDMNPKISDFGMARI  200 (369)
Q Consensus       123 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv--~~~~~~~L~Dfg~~~~  200 (369)
                      ++||++.|+|...+..    ..+-+....+++.|+++|+.|+|+.+   ++|||||.+||+|  ....+++|+|||....
T Consensus       100 ~qE~aP~gdL~snv~~----~GigE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDFG~t~k  172 (378)
T KOG1345|consen  100 VQEFAPRGDLRSNVEA----AGIGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDFGLTRK  172 (378)
T ss_pred             eeccCccchhhhhcCc----ccccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeecccccc
Confidence            9999999999877743    33778889999999999999999999   9999999999999  3445899999999876


Q ss_pred             cCCCCcccccccccccccccCchhhcc-----CCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCc
Q 017594          201 CGGNELQANTSRIVGTYGYMSPEYALE-----GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNR  275 (369)
Q Consensus       201 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  275 (369)
                      .+..     .........|++||+...     ....+.+|+|+||++++.++||..||+.....+...  +-|..+..+.
T Consensus       173 ~g~t-----V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y--~~~~~w~~rk  245 (378)
T KOG1345|consen  173 VGTT-----VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPY--WEWEQWLKRK  245 (378)
T ss_pred             cCce-----ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchH--HHHHHHhccc
Confidence            5422     222334667999998652     235788999999999999999999999655443332  2233333333


Q ss_pred             cccccCccccccccHHHHHHHHHHHHHHhhcCCCCCC---CCHHHHHHHHHhhhhccCCCCCCCcccccccccccCCCCC
Q 017594          276 TLELIDPILEDEYSSKQMLLRYANIALLCVQESADDR---PTMNDVVSMLTNEAATLLPPKQPAFSYVRNTVTSTSSTGK  352 (369)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R---ps~~ell~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  352 (369)
                      ..     .++..+.+  +++.+..+.++-|..++++|   .++......+-.. ..+...+.|.+.+..+..+.|++-.+
T Consensus       246 ~~-----~~P~~F~~--fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~E-~~i~t~k~~ee~~~tn~d~~S~iysr  317 (378)
T KOG1345|consen  246 NP-----ALPKKFNP--FSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWKE-KLIKTVKRPEEDYYTNIDTASKIYSR  317 (378)
T ss_pred             Cc-----cCchhhcc--cCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHHH-hhhccccChhhccccccCCcchhhhc
Confidence            22     22222221  26678999999999999999   4444444444333 23666788889999999888884333

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=99.97  E-value=1.6e-31  Score=254.70  Aligned_cols=259  Identities=27%  Similarity=0.407  Sum_probs=207.9

Q ss_pred             cCCccCccccccCCccEEEEEEc-CCC----EEEEEEecCCC-chhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEE
Q 017594           49 NKFSDANKLGEGGFGPVYKGVLK-KGD----EIAVKRLSGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKIL  122 (369)
Q Consensus        49 ~~y~i~~~lg~G~~~~v~~~~~~-~~~----~valK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l  122 (369)
                      .+.+..++||+|+||+||+|.|- .|+    +|++|++.... .+....+.+|+-.|..+.|||++++++++.... .-+
T Consensus       696 telkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~ql  774 (1177)
T KOG1025|consen  696 TELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQL  774 (1177)
T ss_pred             hhhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHH
Confidence            34566789999999999999953 343    58999886443 334577889999999999999999999997654 889


Q ss_pred             EEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecC
Q 017594          123 IYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICG  202 (369)
Q Consensus       123 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~  202 (369)
                      |++++++|+|.++++.+  +..+.......|+.||++|+.|||.+.   ++||||-..|+||..-+.+++.|||++....
T Consensus       775 vtq~mP~G~LlDyvr~h--r~~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~ll~  849 (1177)
T KOG1025|consen  775 VTQLMPLGCLLDYVREH--RDNIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAKLLA  849 (1177)
T ss_pred             HHHhcccchHHHHHHHh--hccccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhhccC
Confidence            99999999999999763  445778889999999999999999999   9999999999999999999999999998876


Q ss_pred             CCCcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHh-CCCCCCCCcccccccchhhhhhhhcCccccccC
Q 017594          203 GNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDLWTSNRTLELID  281 (369)
Q Consensus       203 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (369)
                      ............-.+-|+|=|.+....|+.++||||+|+++|||+| |..|+.....+.      +.+.+...      +
T Consensus       850 ~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~e------I~dlle~g------e  917 (1177)
T KOG1025|consen  850 PDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEE------IPDLLEKG------E  917 (1177)
T ss_pred             cccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHH------hhHHHhcc------c
Confidence            6555555544445667999999999999999999999999999997 888876443221      11111111      1


Q ss_pred             ccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHhhhhcc
Q 017594          282 PILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNEAATL  329 (369)
Q Consensus       282 ~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L~~~~~~~  329 (369)
                      . +   ..+.-++.++..++.+||..|+..||+++++...+++.+...
T Consensus       918 R-L---sqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ardp  961 (1177)
T KOG1025|consen  918 R-L---SQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARDP  961 (1177)
T ss_pred             c-C---CCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcCc
Confidence            1 1   112233778999999999999999999999999998887753

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.97  E-value=3.6e-30  Score=254.61  Aligned_cols=266  Identities=27%  Similarity=0.395  Sum_probs=205.9

Q ss_pred             HHHHhcCCccCccccccCCccEEEEEEcC--------CCEEEEEEecCCC-chhHHHHHHHHHHHhcC-CCCceeeeeee
Q 017594           44 VSTATNKFSDANKLGEGGFGPVYKGVLKK--------GDEIAVKRLSGRS-GQGLREMKNEASVIAKV-QHKNLVRLLGC  113 (369)
Q Consensus        44 ~~~~~~~y~i~~~lg~G~~~~v~~~~~~~--------~~~valK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~  113 (369)
                      .+...+...+.+.||.|+||.|++|..+.        ...||+|.+.... ....+.+..|+++++.+ +|+|++.+.+.
T Consensus       291 ~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~  370 (609)
T KOG0200|consen  291 WEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGA  370 (609)
T ss_pred             eeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheee
Confidence            34444555677799999999999998331        3458999987543 34567889999999999 69999999999


Q ss_pred             EEeCCccEEEEEecCCCChhhhhcCCC-----cc--------ccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCC
Q 017594          114 CIDRDEKILIYEYMPNKSLDFFLFDPT-----KR--------MLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKAS  180 (369)
Q Consensus       114 ~~~~~~~~lv~e~~~~~~L~~~l~~~~-----~~--------~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~  180 (369)
                      +......++|.||+..|.|..+++...     ..        ..+.....+.++.||+.|++||++..   ++||||-..
T Consensus       371 ~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLAaR  447 (609)
T KOG0200|consen  371 CTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLAAR  447 (609)
T ss_pred             eccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhhhh
Confidence            999889999999999999999997644     00        24888899999999999999999998   999999999


Q ss_pred             CEEEeCCCceEEeecCCceecCCCCccccc-ccccccccccCchhhccCCCCcccchHhHHHHHHHHHh-CCCCCCCCcc
Q 017594          181 NILLDKDMNPKISDFGMARICGGNELQANT-SRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRT  258 (369)
Q Consensus       181 NIlv~~~~~~~L~Dfg~~~~~~~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~t-g~~p~~~~~~  258 (369)
                      ||+++.+..++++|||+++........... +...-...|+|||.+....|+.++||||+|++||||++ |..||..-..
T Consensus       448 NVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~  527 (609)
T KOG0200|consen  448 NVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPP  527 (609)
T ss_pred             hEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCc
Confidence            999999999999999999865443322211 11112446999999999999999999999999999998 7788753110


Q ss_pred             cccccchhhhhhhhcCccccccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHhhhh
Q 017594          259 DSLNLLGYAWDLWTSNRTLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNEAA  327 (369)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L~~~~~  327 (369)
                          .. ...+....+.-.+          .+..++.++.++++.||+.+|++||+..++.+.|+....
T Consensus       528 ----~~-~l~~~l~~G~r~~----------~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l~  581 (609)
T KOG0200|consen  528 ----TE-ELLEFLKEGNRME----------QPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHLQ  581 (609)
T ss_pred             ----HH-HHHHHHhcCCCCC----------CCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHHH
Confidence                00 0111111111111          122336778999999999999999999999999999543

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=4.3e-31  Score=229.36  Aligned_cols=252  Identities=22%  Similarity=0.345  Sum_probs=201.0

Q ss_pred             HHHHhcCCccCccccccCCccEEEEEEc-CCCEEEEEEecCC---CchhHHHHHHHHHHHhcC-CCCceeeeeeeEEeCC
Q 017594           44 VSTATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGR---SGQGLREMKNEASVIAKV-QHKNLVRLLGCCIDRD  118 (369)
Q Consensus        44 ~~~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~  118 (369)
                      .....++|.+++.||+|+|++|.+++.+ +.+-+|+|++++.   +.++......|-.+..+. +||.++.+..+|..+.
T Consensus       245 ~~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtes  324 (593)
T KOG0695|consen  245 QGLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTES  324 (593)
T ss_pred             cccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccc
Confidence            3445678999999999999999999955 4788999988643   445566677777777776 6999999999999999


Q ss_pred             ccEEEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCc
Q 017594          119 EKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMA  198 (369)
Q Consensus       119 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~  198 (369)
                      .+++|.||++||.|-..++++.+   ++++.+.-+...|+-||.|||+.|   |+.||||.+|++++.+|+++|+|||++
T Consensus       325 rlffvieyv~ggdlmfhmqrqrk---lpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmc  398 (593)
T KOG0695|consen  325 RLFFVIEYVNGGDLMFHMQRQRK---LPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMC  398 (593)
T ss_pred             eEEEEEEEecCcceeeehhhhhc---CcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchh
Confidence            99999999999998666654433   899999999999999999999999   999999999999999999999999998


Q ss_pred             eecCCCCcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccc--cccchhhhhhhhcCcc
Q 017594          199 RICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDS--LNLLGYAWDLWTSNRT  276 (369)
Q Consensus       199 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~--~~~~~~~~~~~~~~~~  276 (369)
                      ..-..  .....+..+||+.|.|||++.+..|+...|.|+||+++++|+.|+.||..-..+.  ....++.+.....+++
T Consensus       399 ke~l~--~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqi  476 (593)
T KOG0695|consen  399 KEGLG--PGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQI  476 (593)
T ss_pred             hcCCC--CCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcc
Confidence            75322  2233456799999999999999999999999999999999999999998654332  2223344443333322


Q ss_pred             ccccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCC
Q 017594          277 LELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPT  314 (369)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps  314 (369)
                      +           .+...+-....+++.-|..||.+|..
T Consensus       477 r-----------iprslsvkas~vlkgflnkdp~erlg  503 (593)
T KOG0695|consen  477 R-----------IPRSLSVKASHVLKGFLNKDPKERLG  503 (593)
T ss_pred             c-----------ccceeehhhHHHHHHhhcCCcHHhcC
Confidence            1           11112445677899999999999863

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.97  E-value=1.5e-31  Score=255.92  Aligned_cols=246  Identities=29%  Similarity=0.416  Sum_probs=187.2

Q ss_pred             CccCccccccCCcc-EEEEEEcCCCEEEEEEecCCCchhHHHHHHHHHHHhcC-CCCceeeeeeeEEeCCccEEEEEecC
Q 017594           51 FSDANKLGEGGFGP-VYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKV-QHKNLVRLLGCCIDRDEKILIYEYMP  128 (369)
Q Consensus        51 y~i~~~lg~G~~~~-v~~~~~~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~  128 (369)
                      |.-.+.+|.|+.|+ ||+|... |+.||||++....   ...+.+|+..|+.- .||||+++++.=.+.+..|+..|.|.
T Consensus       511 ~~~~eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~e~---~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~  586 (903)
T KOG1027|consen  511 FSPKEILGYGSNGTVVFRGVYE-GREVAVKRLLEEF---FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA  586 (903)
T ss_pred             eccHHHcccCCCCcEEEEEeeC-CceehHHHHhhHh---HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh
Confidence            33456788999887 7888876 7899999986443   35778899999998 69999999998888888999999995


Q ss_pred             CCChhhhhcCCCc-cccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeC---C--CceEEeecCCceecC
Q 017594          129 NKSLDFFLFDPTK-RMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDK---D--MNPKISDFGMARICG  202 (369)
Q Consensus       129 ~~~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~---~--~~~~L~Dfg~~~~~~  202 (369)
                       .+|++++..... .........+.++.|+++||++||+.+   |+||||||.||+|+.   +  .+++|.|||++..+.
T Consensus       587 -~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~  662 (903)
T KOG1027|consen  587 -CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA  662 (903)
T ss_pred             -hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence             588888865311 111222566889999999999999999   999999999999976   3  468999999999887


Q ss_pred             CCCccc-ccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhC-CCCCCCCcccccccchhhhhhhhcCcccccc
Q 017594          203 GNELQA-NTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG-KKNTGLYRTDSLNLLGYAWDLWTSNRTLELI  280 (369)
Q Consensus       203 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (369)
                      .+.... ......|+.+|.|||++....-+.++|||||||++|+.++| .+||+.......+.       .........+
T Consensus       663 ~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NI-------l~~~~~L~~L  735 (903)
T KOG1027|consen  663 GGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANI-------LTGNYTLVHL  735 (903)
T ss_pred             CCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhhh-------hcCccceeee
Confidence            554322 23456789999999999988888899999999999999986 89998533111110       1111111111


Q ss_pred             CccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 017594          281 DPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVS  320 (369)
Q Consensus       281 ~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~  320 (369)
                      .+..         ..+..+||.+|+.++|..||+|.+++.
T Consensus       736 ~~~~---------d~eA~dLI~~ml~~dP~~RPsa~~VL~  766 (903)
T KOG1027|consen  736 EPLP---------DCEAKDLISRMLNPDPQLRPSATDVLN  766 (903)
T ss_pred             ccCc---------hHHHHHHHHHhcCCCcccCCCHHHHhC
Confidence            1111         115889999999999999999999974

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=5.1e-30  Score=232.28  Aligned_cols=136  Identities=24%  Similarity=0.304  Sum_probs=110.1

Q ss_pred             HHHh-cCCccCccccccCCccEEEEEEcC-CCEEEEEEecCCCchhHHHHHHHHHHHhcCC-----C---CceeeeeeeE
Q 017594           45 STAT-NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLREMKNEASVIAKVQ-----H---KNLVRLLGCC  114 (369)
Q Consensus        45 ~~~~-~~y~i~~~lg~G~~~~v~~~~~~~-~~~valK~~~~~~~~~~~~~~~e~~~l~~l~-----h---~~i~~~~~~~  114 (369)
                      ..+. .||.+.++||-|.|++||+|.+.. .+.||+|+++.- ..-.+....|+.+|++++     |   .+|+++++.|
T Consensus        73 D~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA-qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~F  151 (590)
T KOG1290|consen   73 DVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA-QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHF  151 (590)
T ss_pred             ccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh-hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccc
Confidence            4455 899999999999999999999654 678999998633 344567788999999984     3   3699999999


Q ss_pred             E----eCCccEEEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEe
Q 017594          115 I----DRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLD  185 (369)
Q Consensus       115 ~----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~  185 (369)
                      .    ++.++|+|+|++.. +|..++.... ...++...+..|++||+.||.|||...  +|+|.||||+|||+.
T Consensus       152 khsGpNG~HVCMVfEvLGd-nLLklI~~s~-YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~  222 (590)
T KOG1290|consen  152 KHSGPNGQHVCMVFEVLGD-NLLKLIKYSN-YRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLC  222 (590)
T ss_pred             eecCCCCcEEEEEehhhhh-HHHHHHHHhC-CCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeee
Confidence            7    46789999999955 4444443322 233788899999999999999999987  799999999999993

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.97  E-value=1.4e-29  Score=242.65  Aligned_cols=261  Identities=21%  Similarity=0.271  Sum_probs=175.7

Q ss_pred             hcCCccCccccccCCccEEEEEE-----------------cCCCEEEEEEecCCCchhHHH--------------HHHHH
Q 017594           48 TNKFSDANKLGEGGFGPVYKGVL-----------------KKGDEIAVKRLSGRSGQGLRE--------------MKNEA   96 (369)
Q Consensus        48 ~~~y~i~~~lg~G~~~~v~~~~~-----------------~~~~~valK~~~~~~~~~~~~--------------~~~e~   96 (369)
                      .++|.+.++||+|+||.||+|..                 ..++.||||++........+.              ...|+
T Consensus       144 ~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~  223 (507)
T PLN03224        144 SDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEA  223 (507)
T ss_pred             ccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHH
Confidence            56899999999999999999863                 235679999986543222222              23366


Q ss_pred             HHHhcCCCCce-----eeeeeeEEe--------CCccEEEEEecCCCChhhhhcCCCc---------------------c
Q 017594           97 SVIAKVQHKNL-----VRLLGCCID--------RDEKILIYEYMPNKSLDFFLFDPTK---------------------R  142 (369)
Q Consensus        97 ~~l~~l~h~~i-----~~~~~~~~~--------~~~~~lv~e~~~~~~L~~~l~~~~~---------------------~  142 (369)
                      .++.+++|.++     +++++++..        ....++|+||+.+++|.+++.....                     .
T Consensus       224 ~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~  303 (507)
T PLN03224        224 YMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQ  303 (507)
T ss_pred             HHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccc
Confidence            66777766543     556666542        3467999999999999888753211                     1


Q ss_pred             ccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCCCCcccccccccccccccCc
Q 017594          143 MLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSP  222 (369)
Q Consensus       143 ~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aP  222 (369)
                      ..+++..+..++.|++.+|.|||+.+   ++|+||||.||+++.++.++|+|||++........ .......+++.|+||
T Consensus       304 ~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~-~~~~~g~~tp~Y~aP  379 (507)
T PLN03224        304 DKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGIN-FNPLYGMLDPRYSPP  379 (507)
T ss_pred             ccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCc-cCccccCCCcceeCh
Confidence            12456678889999999999999998   99999999999999999999999999865432211 111112347899999


Q ss_pred             hhhccCC--------------------C--CcccchHhHHHHHHHHHhCCC-CCCCCcccccccc--h---hhhhhhhcC
Q 017594          223 EYALEGI--------------------F--SIKSDVFSFGVLLLEIVSGKK-NTGLYRTDSLNLL--G---YAWDLWTSN  274 (369)
Q Consensus       223 E~~~~~~--------------------~--~~~~DiwslG~il~~l~tg~~-p~~~~~~~~~~~~--~---~~~~~~~~~  274 (369)
                      |.+....                    +  ..+.|+||+||++|+|+++.. ||...........  .   ..|......
T Consensus       380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~  459 (507)
T PLN03224        380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQ  459 (507)
T ss_pred             hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhccc
Confidence            9875322                    1  124799999999999999875 6542211110000  0   011111111


Q ss_pred             ccccccCccccccccHHHHHHHHHHHHHHhhcCCC---CCCCCHHHHHHH
Q 017594          275 RTLELIDPILEDEYSSKQMLLRYANIALLCVQESA---DDRPTMNDVVSM  321 (369)
Q Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP---~~Rps~~ell~~  321 (369)
                      .    .+...     ....+....+|+.+||..+|   .+|+|+.++|+.
T Consensus       460 ~----~~~~~-----~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H  500 (507)
T PLN03224        460 K----YDFSL-----LDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH  500 (507)
T ss_pred             C----CCccc-----ccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence            0    01000     11125678999999999766   689999999863

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.97  E-value=1.9e-30  Score=241.39  Aligned_cols=202  Identities=24%  Similarity=0.364  Sum_probs=169.7

Q ss_pred             cCCccCccccccCCccEEEEEEcC-CCEEEEEEecCCCc---hhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEEE
Q 017594           49 NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSG---QGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIY  124 (369)
Q Consensus        49 ~~y~i~~~lg~G~~~~v~~~~~~~-~~~valK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  124 (369)
                      .-|..++.||-|+||.|.+++..+ ...||+|.+.+.+.   ......+.|-.+|.....+-|++++..|.+.+.+|+||
T Consensus       629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVM  708 (1034)
T KOG0608|consen  629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM  708 (1034)
T ss_pred             cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEE
Confidence            347789999999999999999443 66789998875532   33445677889999999999999999999999999999


Q ss_pred             EecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCC-
Q 017594          125 EYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGG-  203 (369)
Q Consensus       125 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~-  203 (369)
                      +|+.||.+-.++..   ...+.+..++.++..+..|+++.|..|   ++||||||+||||+.+|++||+|||++.-+.. 
T Consensus       709 dYIPGGDmMSLLIr---mgIFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWT  782 (1034)
T KOG0608|consen  709 DYIPGGDMMSLLIR---MGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT  782 (1034)
T ss_pred             eccCCccHHHHHHH---hccCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeeccccccceec
Confidence            99999999888743   445899999999999999999999999   99999999999999999999999999875521 


Q ss_pred             --------CCcccc-------------------------------cccccccccccCchhhccCCCCcccchHhHHHHHH
Q 017594          204 --------NELQAN-------------------------------TSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLL  244 (369)
Q Consensus       204 --------~~~~~~-------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~  244 (369)
                              +.....                               .-...||+.|+|||++....|+..+|.||.|+|||
T Consensus       783 HdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~  862 (1034)
T KOG0608|consen  783 HDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILY  862 (1034)
T ss_pred             cccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHH
Confidence                    000000                               00135899999999999999999999999999999


Q ss_pred             HHHhCCCCCCCC
Q 017594          245 EIVSGKKNTGLY  256 (369)
Q Consensus       245 ~l~tg~~p~~~~  256 (369)
                      +|+.|++||-..
T Consensus       863 em~~g~~pf~~~  874 (1034)
T KOG0608|consen  863 EMLVGQPPFLAD  874 (1034)
T ss_pred             HHhhCCCCccCC
Confidence            999999998643

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.97  E-value=8.2e-29  Score=212.88  Aligned_cols=210  Identities=36%  Similarity=0.573  Sum_probs=181.4

Q ss_pred             ccccCCccEEEEEEcC-CCEEEEEEecCCCch-hHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEEEEecCCCChhh
Q 017594           57 LGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQ-GLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSLDF  134 (369)
Q Consensus        57 lg~G~~~~v~~~~~~~-~~~valK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~  134 (369)
                      ||.|.+|.||++.... ++.+++|++...... ....+.+|+..++.++|++++++++++......++++|++.+++|..
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~   80 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD   80 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence            6899999999999765 899999999765432 34678899999999999999999999998889999999999999999


Q ss_pred             hhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeC-CCceEEeecCCceecCCCCcccccccc
Q 017594          135 FLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDK-DMNPKISDFGMARICGGNELQANTSRI  213 (369)
Q Consensus       135 ~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~-~~~~~L~Dfg~~~~~~~~~~~~~~~~~  213 (369)
                      ++....  ..++...++.++.+++.++.+||+.+   ++|+||+|.||+++. ++.++|+|||.+........  .....
T Consensus        81 ~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~  153 (215)
T cd00180          81 LLKENE--GKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTI  153 (215)
T ss_pred             HHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhcc
Confidence            885432  34788999999999999999999998   999999999999999 89999999999876643321  12224


Q ss_pred             cccccccCchhhccC-CCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCccccccCccccccccHHH
Q 017594          214 VGTYGYMSPEYALEG-IFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYSSKQ  292 (369)
Q Consensus       214 ~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  292 (369)
                      .+...|.+||..... .++.++|+|++|+++++|                                              
T Consensus       154 ~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l----------------------------------------------  187 (215)
T cd00180         154 VGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL----------------------------------------------  187 (215)
T ss_pred             cCCCCccChhHhcccCCCCchhhhHHHHHHHHHH----------------------------------------------
Confidence            567889999998877 788999999999999999                                              


Q ss_pred             HHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 017594          293 MLLRYANIALLCVQESADDRPTMNDVVSM  321 (369)
Q Consensus       293 ~~~~l~~li~~~L~~dP~~Rps~~ell~~  321 (369)
                        ..+.+++..|++.+|++||++.++++.
T Consensus       188 --~~~~~~l~~~l~~~p~~R~~~~~l~~~  214 (215)
T cd00180         188 --PELKDLIRKMLQKDPEKRPSAKEILEH  214 (215)
T ss_pred             --HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence              348899999999999999999999875

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.96  E-value=4.3e-30  Score=236.86  Aligned_cols=199  Identities=26%  Similarity=0.368  Sum_probs=167.2

Q ss_pred             HHHhcCCccCccccccCCccEEEEEEcC-CCEEEEEEecCCCc--------hhHHHHHHHHHHHhcCC---CCceeeeee
Q 017594           45 STATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSG--------QGLREMKNEASVIAKVQ---HKNLVRLLG  112 (369)
Q Consensus        45 ~~~~~~y~i~~~lg~G~~~~v~~~~~~~-~~~valK~~~~~~~--------~~~~~~~~e~~~l~~l~---h~~i~~~~~  112 (369)
                      -.....|+.++.+|.|+||.|++|.++. ...|++|.+.+..-        ...-.+-.|+++|..++   |+||+++++
T Consensus       557 ~~k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLd  636 (772)
T KOG1152|consen  557 YKKFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLD  636 (772)
T ss_pred             ecccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhh
Confidence            3445669999999999999999999776 56688998764421        11223446999999997   999999999


Q ss_pred             eEEeCCccEEEEEecC-CCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceE
Q 017594          113 CCIDRDEKILIYEYMP-NKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPK  191 (369)
Q Consensus       113 ~~~~~~~~~lv~e~~~-~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~  191 (369)
                      +|++++.+|+++|.-. +-.|.+++.   .+..+++.+...|+.|++.|+++||++|   |+|||||-+|+.++.+|-++
T Consensus       637 fFEddd~yyl~te~hg~gIDLFd~IE---~kp~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~k  710 (772)
T KOG1152|consen  637 FFEDDDYYYLETEVHGEGIDLFDFIE---FKPRMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVK  710 (772)
T ss_pred             eeecCCeeEEEecCCCCCcchhhhhh---ccCccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEE
Confidence            9999999999999754 335677773   4455899999999999999999999999   99999999999999999999


Q ss_pred             EeecCCceecCCCCcccccccccccccccCchhhccCCC-CcccchHhHHHHHHHHHhCCCCC
Q 017594          192 ISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIF-SIKSDVFSFGVLLLEIVSGKKNT  253 (369)
Q Consensus       192 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~il~~l~tg~~p~  253 (369)
                      |+|||.+....++.    +....||..|.|||++.+.+| +..-|||+||++||.+.....||
T Consensus       711 lidfgsaa~~ksgp----fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpy  769 (772)
T KOG1152|consen  711 LIDFGSAAYTKSGP----FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPY  769 (772)
T ss_pred             EeeccchhhhcCCC----cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCC
Confidence            99999988766543    455689999999999998887 56789999999999999888776

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.96  E-value=3.7e-29  Score=221.18  Aligned_cols=272  Identities=22%  Similarity=0.314  Sum_probs=212.2

Q ss_pred             cchhhHHHHhcCCccCccccccCCccEEEEEEcC------CCEEEEEEecCCC-chhHHHHHHHHHHHhcCCCCceeeee
Q 017594           39 FSFSSVSTATNKFSDANKLGEGGFGPVYKGVLKK------GDEIAVKRLSGRS-GQGLREMKNEASVIAKVQHKNLVRLL  111 (369)
Q Consensus        39 ~~~~~~~~~~~~y~i~~~lg~G~~~~v~~~~~~~------~~~valK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~  111 (369)
                      --++.+.....|++....+-+|.||.||.|.|.+      .+.|.+|.+.... .-....+..|.-.+..+.|||++.+.
T Consensus       274 ~r~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~  353 (563)
T KOG1024|consen  274 RRLQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVL  353 (563)
T ss_pred             hhHHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCcccee
Confidence            3456667777889999999999999999997653      3446677765432 23456677888899999999999999


Q ss_pred             eeEEeC-CccEEEEEecCCCChhhhhc-----CCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEe
Q 017594          112 GCCIDR-DEKILIYEYMPNKSLDFFLF-----DPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLD  185 (369)
Q Consensus       112 ~~~~~~-~~~~lv~e~~~~~~L~~~l~-----~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~  185 (369)
                      ++..++ ...+.++++.+-++|..++.     +......+.......++.|++.|++|||+.+   ++|.||...|.+++
T Consensus       354 ~V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvId  430 (563)
T KOG1024|consen  354 GVSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVID  430 (563)
T ss_pred             EEEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceeh
Confidence            988754 56799999999999999987     3333445667788899999999999999999   99999999999999


Q ss_pred             CCCceEEeecCCceecCCCCcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHh-CCCCCCCCcccccccc
Q 017594          186 KDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLL  264 (369)
Q Consensus       186 ~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~t-g~~p~~~~~~~~~~~~  264 (369)
                      +.-+++|+|=.+++..-..+..+-.........|++||.+.+..|+.++|+||||+++|||+| |+.|+..-+...  -.
T Consensus       431 d~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfE--m~  508 (563)
T KOG1024|consen  431 DQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFE--ME  508 (563)
T ss_pred             hheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHH--HH
Confidence            999999999999887655555555555556778999999999999999999999999999998 777865322100  00


Q ss_pred             hhhhhhhhcCccccccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHhhhhcc
Q 017594          265 GYAWDLWTSNRTLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNEAATL  329 (369)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L~~~~~~~  329 (369)
                      .+..+-           ..+   ..+..+++++..++.-||+..|++||+.+++...|+..-..+
T Consensus       509 ~ylkdG-----------yRl---aQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~ql  559 (563)
T KOG1024|consen  509 HYLKDG-----------YRL---AQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHTQL  559 (563)
T ss_pred             HHHhcc-----------cee---cCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHHH
Confidence            000000           011   112234888999999999999999999999999998876544

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.96  E-value=1.2e-29  Score=206.45  Aligned_cols=209  Identities=26%  Similarity=0.360  Sum_probs=167.9

Q ss_pred             HHHHhcCCccCccccccCCccEEEEEE-cCCCEEEEEEecCC-CchhHHHHHHHHHHHhcC-CCCceeeeeeeEEeCCcc
Q 017594           44 VSTATNKFSDANKLGEGGFGPVYKGVL-KKGDEIAVKRLSGR-SGQGLREMKNEASVIAKV-QHKNLVRLLGCCIDRDEK  120 (369)
Q Consensus        44 ~~~~~~~y~i~~~lg~G~~~~v~~~~~-~~~~~valK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~  120 (369)
                      .+...+....+..||+|++|.|-+.++ .+|.-.|+|.+... +....+++..|+.+..+. .+|.++.+++.+..+...
T Consensus        41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdv  120 (282)
T KOG0984|consen   41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDV  120 (282)
T ss_pred             cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccE
Confidence            455566777788999999999988884 45889999998754 233445566677766655 699999999999999999


Q ss_pred             EEEEEecCCCChhhhhcC-CCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCce
Q 017594          121 ILIYEYMPNKSLDFFLFD-PTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMAR  199 (369)
Q Consensus       121 ~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~  199 (369)
                      ++.||.+. .+|+.+..+ ..++..+++..+-+|+..++.||.|||++=  .++|||+||.||+++.+|++|++|||++-
T Consensus       121 wIcME~M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGIsG  197 (282)
T KOG0984|consen  121 WICMELMD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGISG  197 (282)
T ss_pred             EEeHHHhh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcccccce
Confidence            99999874 566555433 234556889999999999999999999975  59999999999999999999999999987


Q ss_pred             ecCCCCcccccccccccccccCchhhc----cCCCCcccchHhHHHHHHHHHhCCCCCCCCcc
Q 017594          200 ICGGNELQANTSRIVGTYGYMSPEYAL----EGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRT  258 (369)
Q Consensus       200 ~~~~~~~~~~~~~~~~~~~y~aPE~~~----~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~  258 (369)
                      .+.+...   .+...|-..|+|||.+.    +..|+.++||||||+++.||.+++.||..+..
T Consensus       198 ~L~dSiA---kt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~t  257 (282)
T KOG0984|consen  198 YLVDSIA---KTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGT  257 (282)
T ss_pred             eehhhhH---HHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCC
Confidence            7654322   12235677899999875    34699999999999999999999999876543

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.96  E-value=8.7e-30  Score=238.34  Aligned_cols=253  Identities=24%  Similarity=0.369  Sum_probs=202.7

Q ss_pred             hcCCccCccccccCCccEEEEEEc-CCCEEEEEEecCCCchhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEEEEe
Q 017594           48 TNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIYEY  126 (369)
Q Consensus        48 ~~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  126 (369)
                      ..+|+.+..+|.|.||.||+|+++ +++..|+|+++.....+..-+.+|+-+++..+||||+.+++.+...+.++++|||
T Consensus        14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEy   93 (829)
T KOG0576|consen   14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEY   93 (829)
T ss_pred             ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEe
Confidence            367999999999999999999965 5888999999887777888899999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCCCCc
Q 017594          127 MPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNEL  206 (369)
Q Consensus       127 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~~~~  206 (369)
                      |.+|+|++..+   ...++++..+...++..+++++|||++|   -+|||||-.||+++..|.+++.|||.+-.+.... 
T Consensus        94 cgggslQdiy~---~TgplselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqitati-  166 (829)
T KOG0576|consen   94 CGGGSLQDIYH---VTGPLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQITATI-  166 (829)
T ss_pred             cCCCcccceee---ecccchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhhhhhh-
Confidence            99999988874   3456999999999999999999999999   8999999999999999999999999876554221 


Q ss_pred             ccccccccccccccCchhhc---cCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCccccccCcc
Q 017594          207 QANTSRIVGTYGYMSPEYAL---EGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPI  283 (369)
Q Consensus       207 ~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (369)
                       .......|++.|+|||+..   .+.|...+|+|++|+...++-.-++|....-       ....-........+  .+.
T Consensus       167 -~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlh-------pmr~l~LmTkS~~q--pp~  236 (829)
T KOG0576|consen  167 -AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLH-------PMRALFLMTKSGFQ--PPT  236 (829)
T ss_pred             -hhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccc-------hHHHHHHhhccCCC--CCc
Confidence             1223357999999999875   5679999999999999999988776632110       00001111111110  111


Q ss_pred             ccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 017594          284 LEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVS  320 (369)
Q Consensus       284 ~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~  320 (369)
                      +.   +...+++.+.+|++.+|..+|.+||+++.+|.
T Consensus       237 lk---Dk~kws~~fh~fvK~altknpKkRptaeklL~  270 (829)
T KOG0576|consen  237 LK---DKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ  270 (829)
T ss_pred             cc---CCccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence            11   11223677999999999999999999997764

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.95  E-value=1.3e-28  Score=220.10  Aligned_cols=270  Identities=24%  Similarity=0.380  Sum_probs=203.7

Q ss_pred             hhhHHHHhcCCccCccccccCCccEEEEEEc----CCCEEEEEEecCCCchhHHHHHHHHHHHhcCC-CCceeeeeeeEE
Q 017594           41 FSSVSTATNKFSDANKLGEGGFGPVYKGVLK----KGDEIAVKRLSGRSGQGLREMKNEASVIAKVQ-HKNLVRLLGCCI  115 (369)
Q Consensus        41 ~~~~~~~~~~y~i~~~lg~G~~~~v~~~~~~----~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~  115 (369)
                      .+.+....+.|.++++||.|.|++||++.+.    .++.||+|.+....  ....+..|+++|..+. +.||+++.+++.
T Consensus        28 ~q~~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts--~p~ri~~El~~L~~~gG~~ni~~~~~~~r  105 (418)
T KOG1167|consen   28 RQDIPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS--SPSRILNELEMLYRLGGSDNIIKLNGCFR  105 (418)
T ss_pred             HhhhhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc--CchHHHHHHHHHHHhccchhhhcchhhhc
Confidence            3446677888999999999999999999943    47789999987553  3478999999999995 889999999999


Q ss_pred             eCCccEEEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeC-CCceEEee
Q 017594          116 DRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDK-DMNPKISD  194 (369)
Q Consensus       116 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~-~~~~~L~D  194 (369)
                      .++...+|+||++.....++...      ++...+..+++.++.||.++|.+|   |+||||||.|++.+. .++-.|+|
T Consensus       106 nnd~v~ivlp~~~H~~f~~l~~~------l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvD  176 (418)
T KOG1167|consen  106 NNDQVAIVLPYFEHDRFRDLYRS------LSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVD  176 (418)
T ss_pred             cCCeeEEEecccCccCHHHHHhc------CCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEe
Confidence            99999999999999999888843      667788999999999999999999   999999999999974 57789999


Q ss_pred             cCCceecCCCC-------------cc-----------------c------------ccccccccccccCchhhcc-CCCC
Q 017594          195 FGMARICGGNE-------------LQ-----------------A------------NTSRIVGTYGYMSPEYALE-GIFS  231 (369)
Q Consensus       195 fg~~~~~~~~~-------------~~-----------------~------------~~~~~~~~~~y~aPE~~~~-~~~~  231 (369)
                      ||++.......             ..                 .            ......||++|.|||++.. ...+
T Consensus       177 FgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qt  256 (418)
T KOG1167|consen  177 FGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQT  256 (418)
T ss_pred             chhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcC
Confidence            99988321000             00                 0            0011348999999999875 4568


Q ss_pred             cccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhh-----------------hhcC---------cccccc--Ccc
Q 017594          232 IKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDL-----------------WTSN---------RTLELI--DPI  283 (369)
Q Consensus       232 ~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~-----------------~~~~---------~~~~~~--~~~  283 (369)
                      .+.||||.|+|+..++++..||-...++.....+++...                 +...         ...+.+  ...
T Consensus       257 taiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~  336 (418)
T KOG1167|consen  257 TAIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESI  336 (418)
T ss_pred             CccceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhc
Confidence            999999999999999999999987665553332222100                 0000         000000  000


Q ss_pred             c-------cccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 017594          284 L-------EDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSM  321 (369)
Q Consensus       284 ~-------~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~  321 (369)
                      .       .........+..+.+|+.+||..||.+|.|+++.|+.
T Consensus       337 ~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkH  381 (418)
T KOG1167|consen  337 YKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKH  381 (418)
T ss_pred             ccccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcC
Confidence            0       1111122335578999999999999999999999863

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.95  E-value=2.7e-27  Score=206.32  Aligned_cols=198  Identities=32%  Similarity=0.455  Sum_probs=170.8

Q ss_pred             CccCccccccCCccEEEEEEcC-CCEEEEEEecCCCch-hHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEEEEecC
Q 017594           51 FSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQ-GLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIYEYMP  128 (369)
Q Consensus        51 y~i~~~lg~G~~~~v~~~~~~~-~~~valK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~  128 (369)
                      |.+.+.||.|++|.||++.... ++.+++|.+...... ..+.+..|+..++.++|+|++++++++......++++|++.
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE   80 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence            6778999999999999999765 889999999866544 56788899999999999999999999998899999999999


Q ss_pred             CCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCCCCccc
Q 017594          129 NKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQA  208 (369)
Q Consensus       129 ~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~~~~~~  208 (369)
                      +++|..++......  +++..++.++.+++.++.+||+.+   ++|+|++|.||+++.++.++|+|||.+......... 
T Consensus        81 ~~~L~~~~~~~~~~--~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~-  154 (225)
T smart00221       81 GGDLFDYLRKKGGK--LSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA-  154 (225)
T ss_pred             CCCHHHHHHhcccC--CCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc-
Confidence            99998888543221  678899999999999999999998   999999999999999999999999998876543211 


Q ss_pred             ccccccccccccCchhh-ccCCCCcccchHhHHHHHHHHHhCCCCCC
Q 017594          209 NTSRIVGTYGYMSPEYA-LEGIFSIKSDVFSFGVLLLEIVSGKKNTG  254 (369)
Q Consensus       209 ~~~~~~~~~~y~aPE~~-~~~~~~~~~DiwslG~il~~l~tg~~p~~  254 (369)
                      ......+...|++||.. ....++.++|+|+||+++++|++|+.||.
T Consensus       155 ~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~  201 (225)
T smart00221      155 LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFS  201 (225)
T ss_pred             cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCcc
Confidence            22334567789999998 66678889999999999999999999985

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.95  E-value=1.5e-28  Score=212.36  Aligned_cols=265  Identities=26%  Similarity=0.302  Sum_probs=193.0

Q ss_pred             HHHHhcCCccCccccccCCccEEEEEEc-CCCEEEEEEecCC--CchhHHHHHHHHHHHhcCCCCceeeeeeeEEeC---
Q 017594           44 VSTATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDR---  117 (369)
Q Consensus        44 ~~~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---  117 (369)
                      ..+...||.-+..+|.|+- .|..|-+. .++.|++|.+...  +...+++..+|+..+..++|+|+++++.+|.-.   
T Consensus        12 ~ftv~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l   90 (369)
T KOG0665|consen   12 TFTVPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTL   90 (369)
T ss_pred             ceeeeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccH
Confidence            3456689999999999998 66666543 4889999987543  234467788899999999999999999998643   


Q ss_pred             ---CccEEEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEee
Q 017594          118 ---DEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISD  194 (369)
Q Consensus       118 ---~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~D  194 (369)
                         ...|+|||++. .+|...+.     ..++-..+.+++.|++.|+.|||+.|   |+||||||+||++..+..+|+.|
T Consensus        91 ~~~~e~y~v~e~m~-~nl~~vi~-----~elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~d  161 (369)
T KOG0665|consen   91 EEFQEVYLVMELMD-ANLCQVIL-----MELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILD  161 (369)
T ss_pred             HHHHhHHHHHHhhh-hHHHHHHH-----HhcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeecc
Confidence               35699999985 46666553     22566788999999999999999999   99999999999999999999999


Q ss_pred             cCCceecCCCCcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCc-cccccc----chh---
Q 017594          195 FGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYR-TDSLNL----LGY---  266 (369)
Q Consensus       195 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~-~~~~~~----~~~---  266 (369)
                      ||++...+..   ...+....+..|.|||++-+..|...+||||+||++.+|++|+..|...+ .+....    ++.   
T Consensus       162 fg~ar~e~~~---~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~  238 (369)
T KOG0665|consen  162 FGLARTEDTD---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDP  238 (369)
T ss_pred             chhhcccCcc---cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCH
Confidence            9998754322   23344567888999999998889999999999999999999998887432 111000    000   


Q ss_pred             ---------hhhhhhc------Ccccc-ccCcccccccc-HHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 017594          267 ---------AWDLWTS------NRTLE-LIDPILEDEYS-SKQMLLRYANIALLCVQESADDRPTMNDVVSM  321 (369)
Q Consensus       267 ---------~~~~~~~------~~~~~-~~~~~~~~~~~-~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~  321 (369)
                               ..-....      ....+ ..+..+..... +......+.+++.+||-.+|++|.|++++|+.
T Consensus       239 ~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H  310 (369)
T KOG0665|consen  239 SFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH  310 (369)
T ss_pred             HHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence                     0000000      00000 01111111110 11224568899999999999999999999974

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=1.4e-28  Score=208.27  Aligned_cols=196  Identities=24%  Similarity=0.372  Sum_probs=155.1

Q ss_pred             CccCccccccCCccEEEEEEc-CCCEEEEEEecCC--CchhHHHHHHHHHHHhcCCCCceeeeeeeEEeC-----CccEE
Q 017594           51 FSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDR-----DEKIL  122 (369)
Q Consensus        51 y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~l  122 (369)
                      -+-.+.||.|+||.||.+.+. +|+.|++|++...  +.-..+.+.+|+++|.-++|.|++..+++..-.     +..|+
T Consensus        55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV  134 (449)
T KOG0664|consen   55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYV  134 (449)
T ss_pred             CCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHH
Confidence            345689999999999999964 5999999988633  223456788899999999999999988876432     23466


Q ss_pred             EEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecC
Q 017594          123 IYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICG  202 (369)
Q Consensus       123 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~  202 (369)
                      ++|.+.. .|..++   .....++...+.-+++||+.||.|||+.+   |.||||||.|.+|+.+-.+||+|||+++...
T Consensus       135 ~TELmQS-DLHKII---VSPQ~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARvee  207 (449)
T KOG0664|consen  135 LTELMQS-DLHKII---VSPQALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLARTWD  207 (449)
T ss_pred             HHHHHHh-hhhhee---ccCCCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEecccccccccc
Confidence            6776643 444444   23445788888889999999999999998   9999999999999999999999999998755


Q ss_pred             CCCcccccccccccccccCchhhccC-CCCcccchHhHHHHHHHHHhCCCCCC
Q 017594          203 GNELQANTSRIVGTYGYMSPEYALEG-IFSIKSDVFSFGVLLLEIVSGKKNTG  254 (369)
Q Consensus       203 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~tg~~p~~  254 (369)
                      ...... .....-|..|.|||++.+. .|+.+.||||.|||+.||+..+..|+
T Consensus       208 ~d~~~h-MTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQ  259 (449)
T KOG0664|consen  208 QRDRLN-MTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQ  259 (449)
T ss_pred             hhhhhh-hHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhh
Confidence            433222 2233467889999999865 69999999999999999998876654

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.93  E-value=3.5e-25  Score=186.16  Aligned_cols=169  Identities=20%  Similarity=0.097  Sum_probs=124.4

Q ss_pred             CChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCCCCcccc
Q 017594          130 KSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQAN  209 (369)
Q Consensus       130 ~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~~~~~~~  209 (369)
                      |+|.+++...  +..+++..++.++.||+.||.|||+.+         ||+||+++.++.+++  ||++.......    
T Consensus         1 GsL~~~l~~~--~~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~~----   63 (176)
T smart00750        1 VSLADILEVR--GRPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPEQ----   63 (176)
T ss_pred             CcHHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeecccc----
Confidence            5677777532  345899999999999999999999875         999999999999999  99887654321    


Q ss_pred             cccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCccccccCcccccccc
Q 017594          210 TSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYS  289 (369)
Q Consensus       210 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  289 (369)
                         ..+++.|+|||++.+..++.++|||||||++|+|++|..||.........    ........  ....   ......
T Consensus        64 ---~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~----~~~~~~~~--~~~~---~~~~~~  131 (176)
T smart00750       64 ---SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAI----LEILLNGM--PADD---PRDRSN  131 (176)
T ss_pred             ---CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHH----HHHHHHHh--ccCC---cccccc
Confidence               25789999999999999999999999999999999999998543211110    00110000  0000   000011


Q ss_pred             HHHHHH--HHHHHHHHhhcCCCCCCCCHHHHHHHHHhhhh
Q 017594          290 SKQMLL--RYANIALLCVQESADDRPTMNDVVSMLTNEAA  327 (369)
Q Consensus       290 ~~~~~~--~l~~li~~~L~~dP~~Rps~~ell~~L~~~~~  327 (369)
                      ....+.  .+.+++.+||+.+|.+||++.++++.+.....
T Consensus       132 ~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~  171 (176)
T smart00750      132 LESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALFA  171 (176)
T ss_pred             HHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHH
Confidence            222233  69999999999999999999999998876654

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.93  E-value=2.8e-24  Score=197.87  Aligned_cols=274  Identities=22%  Similarity=0.243  Sum_probs=202.0

Q ss_pred             CCccCccccccCCccEEEEEEcCC--CEEEEEEecCCCchhHHHHHHHHHHHhcCC----CCceeeeeeeE-EeCCccEE
Q 017594           50 KFSDANKLGEGGFGPVYKGVLKKG--DEIAVKRLSGRSGQGLREMKNEASVIAKVQ----HKNLVRLLGCC-IDRDEKIL  122 (369)
Q Consensus        50 ~y~i~~~lg~G~~~~v~~~~~~~~--~~valK~~~~~~~~~~~~~~~e~~~l~~l~----h~~i~~~~~~~-~~~~~~~l  122 (369)
                      +|.+.+.||.|+||.||.|.....  ..+|+|............+..|..++..+.    ..++..+++.. ......++
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i   98 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI   98 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence            899999999999999999997653  478888876543332236778888888886    35888999888 46677899


Q ss_pred             EEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCC-----CceEEeecCC
Q 017594          123 IYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKD-----MNPKISDFGM  197 (369)
Q Consensus       123 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~-----~~~~L~Dfg~  197 (369)
                      ||+.+ |.+|.++..... ...++...+..++.|++.+|.+||+.|   ++||||||.|+++...     ..+.|.|||+
T Consensus        99 VM~l~-G~sL~dl~~~~~-~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDfGl  173 (322)
T KOG1164|consen   99 VMSLL-GPSLEDLRKRNP-PGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDFGL  173 (322)
T ss_pred             EEecc-CccHHHHHHhCC-CCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEecCC
Confidence            99976 788988875544 456899999999999999999999999   9999999999999765     3589999999


Q ss_pred             ceecC--CCCc----ccc--cccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhh
Q 017594          198 ARICG--GNEL----QAN--TSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWD  269 (369)
Q Consensus       198 ~~~~~--~~~~----~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~  269 (369)
                      ++.+.  ....    ...  .....||..|+++....+...+.+.|+||+++++.+++.|..||.........     ..
T Consensus       174 ar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~-----~~  248 (322)
T KOG1164|consen  174 ARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLK-----SK  248 (322)
T ss_pred             CccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchH-----HH
Confidence            98332  1111    111  22345999999999999999999999999999999999999998544321110     00


Q ss_pred             hhhcCccccccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHhhhhccCCCCCCCcccc
Q 017594          270 LWTSNRTLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNEAATLLPPKQPAFSYV  340 (369)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L~~~~~~~~~~~~~~~~~~  340 (369)
                      ..... .......      .....+..+.++...+-..+...+|.+..+...|+............++++.
T Consensus       249 ~~~~~-~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~~~~~~~~~dw~  312 (322)
T KOG1164|consen  249 FEKDP-RKLLTDR------FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSEGSKEDSPFDWE  312 (322)
T ss_pred             HHHHh-hhhcccc------ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhcCCCCCCCCccc
Confidence            00000 0000000      0011145577777777779999999999999999888876644444444443

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.92  E-value=1.1e-25  Score=230.93  Aligned_cols=196  Identities=18%  Similarity=0.215  Sum_probs=133.8

Q ss_pred             cCCC-CceeeeeeeE-------EeCCccEEEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCc
Q 017594          101 KVQH-KNLVRLLGCC-------IDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRI  172 (369)
Q Consensus       101 ~l~h-~~i~~~~~~~-------~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i  172 (369)
                      .++| +||+++++.|       ......++++|++ +++|.+++...  ...+++..+..++.||+.||.|||++|   |
T Consensus        28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~g---I  101 (793)
T PLN00181         28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP--DRSVDAFECFHVFRQIVEIVNAAHSQG---I  101 (793)
T ss_pred             hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc--cccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence            4455 4677777766       2234567778876 66898888542  344899999999999999999999999   9


Q ss_pred             ccCCCCCCCEEEeCCCceEEe-------------------ecCCceecCCCCc--------------ccccccccccccc
Q 017594          173 IHRDLKASNILLDKDMNPKIS-------------------DFGMARICGGNEL--------------QANTSRIVGTYGY  219 (369)
Q Consensus       173 ~H~dl~p~NIlv~~~~~~~L~-------------------Dfg~~~~~~~~~~--------------~~~~~~~~~~~~y  219 (369)
                      +||||||+|||++..+.++++                   |||+++.......              ........+++.|
T Consensus       102 vHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y  181 (793)
T PLN00181        102 VVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWY  181 (793)
T ss_pred             eeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcce
Confidence            999999999999765555554                   5554432110000              0000113467889


Q ss_pred             cCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCccccccCccccccccHHHHHHHHHH
Q 017594          220 MSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYSSKQMLLRYAN  299 (369)
Q Consensus       220 ~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  299 (369)
                      +|||++.+..++.++|||||||+||+|++|.+|+.....       .. ......    ...+    .. . .......+
T Consensus       182 ~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~-------~~-~~~~~~----~~~~----~~-~-~~~~~~~~  243 (793)
T PLN00181        182 TSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR-------TM-SSLRHR----VLPP----QI-L-LNWPKEAS  243 (793)
T ss_pred             EChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH-------HH-HHHHHh----hcCh----hh-h-hcCHHHHH
Confidence            999999999999999999999999999998887542110       00 000000    0000    00 0 01334678


Q ss_pred             HHHHhhcCCCCCCCCHHHHHH
Q 017594          300 IALLCVQESADDRPTMNDVVS  320 (369)
Q Consensus       300 li~~~L~~dP~~Rps~~ell~  320 (369)
                      ++.+||+.+|.+||++.++++
T Consensus       244 ~~~~~L~~~P~~Rps~~eil~  264 (793)
T PLN00181        244 FCLWLLHPEPSCRPSMSELLQ  264 (793)
T ss_pred             HHHHhCCCChhhCcChHHHhh
Confidence            899999999999999999975

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.92  E-value=3.2e-24  Score=178.85  Aligned_cols=278  Identities=19%  Similarity=0.274  Sum_probs=209.2

Q ss_pred             HHhcCCccCccccccCCccEEEEE-EcCCCEEEEEEecCCCchhHHHHHHHHHHHhcCCC-CceeeeeeeEEeCCccEEE
Q 017594           46 TATNKFSDANKLGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQH-KNLVRLLGCCIDRDEKILI  123 (369)
Q Consensus        46 ~~~~~y~i~~~lg~G~~~~v~~~~-~~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv  123 (369)
                      ...++|.++++||.|+||.+|.|. ..+|..||||.-.....  ..++..|..+.+.|++ ..|..+..++.+....++|
T Consensus        12 iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~--hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlV   89 (341)
T KOG1163|consen   12 IVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK--HPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLV   89 (341)
T ss_pred             eeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC--CcchhHHHHHHHHhccCCCCchhhhhccccccceee
Confidence            346899999999999999999999 56699999998754433  2567788999999975 5788888888888899999


Q ss_pred             EEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeC---CCceEEeecCCcee
Q 017594          124 YEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDK---DMNPKISDFGMARI  200 (369)
Q Consensus       124 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~---~~~~~L~Dfg~~~~  200 (369)
                      |+.+ |.+|+++..-..++  ++..++.-++.|++.-++|+|..+   ++||||||+|++-.-   ..++.|+|||++..
T Consensus        90 MdLL-GPsLEdLfnfC~R~--ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKk  163 (341)
T KOG1163|consen   90 MDLL-GPSLEDLFNFCSRR--FTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKK  163 (341)
T ss_pred             eecc-CccHHHHHHHHhhh--hhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccchhh
Confidence            9987 78888887543333  788899999999999999999999   999999999999954   35799999999998


Q ss_pred             cCCCCccc-----ccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCc
Q 017594          201 CGGNELQA-----NTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNR  275 (369)
Q Consensus       201 ~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  275 (369)
                      +.......     ....+.||..|.+-....+...+...|+-|+|.+|.++.-|..||+..........   .+...+.+
T Consensus       164 y~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QK---yEkI~EkK  240 (341)
T KOG1163|consen  164 YRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQK---YEKISEKK  240 (341)
T ss_pred             hccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHH---HHHHHHhh
Confidence            76433221     22346789999887666677778899999999999999999999986543221110   01111111


Q ss_pred             cccccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHhhhhccCCCCCCCcccc
Q 017594          276 TLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNEAATLLPPKQPAFSYV  340 (369)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L~~~~~~~~~~~~~~~~~~  340 (369)
                      ....+.      ..-..+|.++.-.+..|-..--++-|....|.+.+.-+-..+....--.++|.
T Consensus       241 ~s~~ie------~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr~ln~~~d~iyDW~  299 (341)
T KOG1163|consen  241 MSTPIE------VLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFRTLNHQYDYIYDWT  299 (341)
T ss_pred             cCCCHH------HHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHhhccccCCeEeeHH
Confidence            111111      11222367789999999999999999999999988877776655544444443

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.91  E-value=1.9e-25  Score=219.70  Aligned_cols=250  Identities=20%  Similarity=0.242  Sum_probs=182.0

Q ss_pred             CCccCccccccCCccEEEEEEcCCCEEEEEEecCCC-chhHHHHHHHHHH--HhcCCCCceeeeeeeEEeCCccEEEEEe
Q 017594           50 KFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRS-GQGLREMKNEASV--IAKVQHKNLVRLLGCCIDRDEKILIYEY  126 (369)
Q Consensus        50 ~y~i~~~lg~G~~~~v~~~~~~~~~~valK~~~~~~-~~~~~~~~~e~~~--l~~l~h~~i~~~~~~~~~~~~~~lv~e~  126 (369)
                      +|...+.||.+.|-+|.+|++..|. |++|++-... .-....+.+.++.  ...+++||.+++..........|+|.+|
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy  102 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY  102 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence            7889999999999999999998776 8899886543 2233334333332  4556899999998887777778999999


Q ss_pred             cCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCCCCc
Q 017594          127 MPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNEL  206 (369)
Q Consensus       127 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~~~~  206 (369)
                      +.. +|.+.+   ..+..+...+...|+.||+.||..+|..|   ++|||||.+||||+.-+-+.|+||.......-...
T Consensus       103 vkh-nLyDRl---STRPFL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeD  175 (1431)
T KOG1240|consen  103 VKH-NLYDRL---STRPFLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFKPTYLPED  175 (1431)
T ss_pred             Hhh-hhhhhh---ccchHHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccCCccCCCC
Confidence            865 555555   35667888899999999999999999999   99999999999999999999999987665532222


Q ss_pred             c-cccc----cccccccccCchhhccC----------C-CCcccchHhHHHHHHHHHh-CCCCCCCCcccccccchhhhh
Q 017594          207 Q-ANTS----RIVGTYGYMSPEYALEG----------I-FSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWD  269 (369)
Q Consensus       207 ~-~~~~----~~~~~~~y~aPE~~~~~----------~-~~~~~DiwslG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~  269 (369)
                      . ..+.    .-..-.+|.|||.+...          . .+++.||||+||++.||++ |.+||....-     ..|...
T Consensus       176 NPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL-----~aYr~~  250 (1431)
T KOG1240|consen  176 NPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQL-----LAYRSG  250 (1431)
T ss_pred             CcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHH-----HhHhcc
Confidence            1 1122    22334589999988531          1 6789999999999999998 5777763220     000000


Q ss_pred             hhhcCccccccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 017594          270 LWTSNRTLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLT  323 (369)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L~  323 (369)
                        ........++.+-         ...++++|..|++.||++|.++++.|+..+
T Consensus       251 --~~~~~e~~Le~Ie---------d~~~Rnlil~Mi~rdPs~RlSAedyL~~yr  293 (1431)
T KOG1240|consen  251 --NADDPEQLLEKIE---------DVSLRNLILSMIQRDPSKRLSAEDYLQKYR  293 (1431)
T ss_pred             --CccCHHHHHHhCc---------CccHHHHHHHHHccCchhccCHHHHHHhhh
Confidence              0001111111111         235899999999999999999999998743

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.91  E-value=3.6e-23  Score=180.00  Aligned_cols=275  Identities=17%  Similarity=0.222  Sum_probs=210.3

Q ss_pred             HHhcCCccCccccccCCccEEEEE-EcCCCEEEEEEecCCCchhHHHHHHHHHHHhcCC-CCceeeeeeeEEeCCccEEE
Q 017594           46 TATNKFSDANKLGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQ-HKNLVRLLGCCIDRDEKILI  123 (369)
Q Consensus        46 ~~~~~y~i~~~lg~G~~~~v~~~~-~~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv  123 (369)
                      ..+-.|+|.++||+|.||.++.|+ .-+++.||||.-....  ...+++.|+...+.|. .++|...+.+...+.+..+|
T Consensus        25 ~VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS--~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLV  102 (449)
T KOG1165|consen   25 MVGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS--EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILV  102 (449)
T ss_pred             EecccceeccccccCcceeeecccccccCceEEEEeccccC--CcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhh
Confidence            345679999999999999999999 4458999999765443  3468889999999985 68999988888888889999


Q ss_pred             EEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCC-----CceEEeecCCc
Q 017594          124 YEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKD-----MNPKISDFGMA  198 (369)
Q Consensus       124 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~-----~~~~L~Dfg~~  198 (369)
                      +|.+ |.+|+++..-..+  .++...+.-++.|++.-++++|.+.   ++.|||||+|+||..-     ..+.++|||++
T Consensus       103 idLL-GPSLEDLFD~CgR--~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmA  176 (449)
T KOG1165|consen  103 IDLL-GPSLEDLFDLCGR--RFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMA  176 (449)
T ss_pred             hhhh-CcCHHHHHHHhcC--cccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccch
Confidence            9987 7788887743333  3899999999999999999999999   9999999999999643     45899999999


Q ss_pred             eecCCCCccc-----ccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhc
Q 017594          199 RICGGNELQA-----NTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTS  273 (369)
Q Consensus       199 ~~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~  273 (369)
                      ..+.......     ......||..|++-....+..-+...|+-|||-++++.+-|..||+....+.....   .+....
T Consensus       177 K~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~k---YeKIGe  253 (449)
T KOG1165|consen  177 KEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEK---YEKIGE  253 (449)
T ss_pred             hhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHH---HHHhcc
Confidence            9876543222     22345689999998888889999999999999999999999999987664432210   000000


Q ss_pred             CccccccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHhhhhccCCCCCCCc
Q 017594          274 NRTLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNEAATLLPPKQPAF  337 (369)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L~~~~~~~~~~~~~~~  337 (369)
                      . .+...-..     ....++.++...+...-..+-.+-|.++.+...+......+...--..+
T Consensus       254 ~-Kr~T~i~~-----Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr~g~t~Dg~y  311 (449)
T KOG1165|consen  254 T-KRSTPIEV-----LCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDRLGETDDGEY  311 (449)
T ss_pred             c-cccCCHHH-----HHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHhcCCcccccc
Confidence            0 00000000     1222377888999999999999999999999999888776554433333

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.90  E-value=4.9e-23  Score=189.68  Aligned_cols=169  Identities=18%  Similarity=0.214  Sum_probs=130.0

Q ss_pred             hhHHHHhcCCccCccccccCCccEEEEEEc--CCCEEEEEEecCC-----CchhHHHHHHHHHHHhcCCCCceeeeeeeE
Q 017594           42 SSVSTATNKFSDANKLGEGGFGPVYKGVLK--KGDEIAVKRLSGR-----SGQGLREMKNEASVIAKVQHKNLVRLLGCC  114 (369)
Q Consensus        42 ~~~~~~~~~y~i~~~lg~G~~~~v~~~~~~--~~~~valK~~~~~-----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~  114 (369)
                      .....+..+|.+.+.||+|+||.||+|+++  +++.+|+|++...     .......+.+|+++|+.++|++++..+.. 
T Consensus        11 ~~~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~-   89 (365)
T PRK09188         11 DQIPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA-   89 (365)
T ss_pred             cccccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE-
Confidence            344567789999999999999999999865  4777899986532     12234568899999999999998853322 


Q ss_pred             EeCCccEEEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCC-CCCCEEEeCCCceEEe
Q 017594          115 IDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDL-KASNILLDKDMNPKIS  193 (369)
Q Consensus       115 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl-~p~NIlv~~~~~~~L~  193 (369)
                        ....++||||+.|++|....    .   ..   ...++.+++.+|.+||+.|   ++|||| ||+||+++.++.++|+
T Consensus        90 --~~~~~LVmE~~~G~~L~~~~----~---~~---~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikLi  154 (365)
T PRK09188         90 --TGKDGLVRGWTEGVPLHLAR----P---HG---DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAVI  154 (365)
T ss_pred             --cCCcEEEEEccCCCCHHHhC----c---cc---hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEEE
Confidence              24689999999999886321    1   11   1467889999999999999   999999 9999999999999999


Q ss_pred             ecCCceecCCCCcccc------cccccccccccCchhhc
Q 017594          194 DFGMARICGGNELQAN------TSRIVGTYGYMSPEYAL  226 (369)
Q Consensus       194 Dfg~~~~~~~~~~~~~------~~~~~~~~~y~aPE~~~  226 (369)
                      |||++..+........      -....+++.|.|||.+.
T Consensus       155 DFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~  193 (365)
T PRK09188        155 DFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALT  193 (365)
T ss_pred             ECccceecccCcchhhhhhhhhhhhhhccCccCCcccCC
Confidence            9999997754321111      12345778899999876

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.89  E-value=9.8e-24  Score=206.60  Aligned_cols=257  Identities=21%  Similarity=0.271  Sum_probs=186.8

Q ss_pred             cCC-ccCccccccCCccEEEEEEcC-CCEEEEEEec-----CCCchhHHH-HHHHHHHHhcCCCCceeeeeeeEEeCCcc
Q 017594           49 NKF-SDANKLGEGGFGPVYKGVLKK-GDEIAVKRLS-----GRSGQGLRE-MKNEASVIAKVQHKNLVRLLGCCIDRDEK  120 (369)
Q Consensus        49 ~~y-~i~~~lg~G~~~~v~~~~~~~-~~~valK~~~-----~~~~~~~~~-~~~e~~~l~~l~h~~i~~~~~~~~~~~~~  120 (369)
                      +.| .-.+.+|.|++|.++.+.... ...+..|.+.     ......... +..|+.+=..+.|+|++..+..+.+....
T Consensus       317 ~~y~~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~  396 (601)
T KOG0590|consen  317 EKYGKPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGI  396 (601)
T ss_pred             cccCCccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccc
Confidence            445 567889999999888777432 3333333322     111111111 44566667778999998877777666555


Q ss_pred             EEEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCcee
Q 017594          121 ILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARI  200 (369)
Q Consensus       121 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~  200 (369)
                      ...||||.+ .|..++...   ..+....+..++.|++.|+.|+|..|   +.|+|+|++|++++.+|.++++|||.+..
T Consensus       397 ~~~mE~~~~-Dlf~~~~~~---~~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~v  469 (601)
T KOG0590|consen  397 LQSMEYCPY-DLFSLVMSN---GKLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAASV  469 (601)
T ss_pred             hhhhhcccH-HHHHHHhcc---cccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCccee
Confidence            555999999 887777443   34788889999999999999999999   99999999999999999999999999888


Q ss_pred             cCCCCcc--cccccccccccccCchhhccCCCCc-ccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCccc
Q 017594          201 CGGNELQ--ANTSRIVGTYGYMSPEYALEGIFSI-KSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTL  277 (369)
Q Consensus       201 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~-~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  277 (369)
                      +......  .......|...|.|||++.+..|++ ..||||.|++++.|.+|+.||...........       ... ..
T Consensus       470 f~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~-------~~~-~~  541 (601)
T KOG0590|consen  470 FRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFK-------TNN-YS  541 (601)
T ss_pred             eccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchh-------hhc-cc
Confidence            7655544  4455678999999999999999865 58999999999999999999976553332210       000 00


Q ss_pred             cccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 017594          278 ELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVS  320 (369)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~  320 (369)
                      ....-...........+...+.+|..||+++|.+|.|+++|++
T Consensus       542 ~~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~  584 (601)
T KOG0590|consen  542 DQRNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN  584 (601)
T ss_pred             cccccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence            0000001111123344677899999999999999999999985

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.88  E-value=6.8e-21  Score=174.65  Aligned_cols=262  Identities=27%  Similarity=0.367  Sum_probs=195.8

Q ss_pred             CccCccccccCCccEEEEEEcCCCEEEEEEecCCCch---hHHHHHHHHHHHhcCCCC-ceeeeeeeEEeCCccEEEEEe
Q 017594           51 FSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQ---GLREMKNEASVIAKVQHK-NLVRLLGCCIDRDEKILIYEY  126 (369)
Q Consensus        51 y~i~~~lg~G~~~~v~~~~~~~~~~valK~~~~~~~~---~~~~~~~e~~~l~~l~h~-~i~~~~~~~~~~~~~~lv~e~  126 (369)
                      |++.+.||.|+|+.||.+...  ..+++|.+......   ....+.+|+..+..+.|+ +++++.+.+......++++++
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~   79 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY   79 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence            788899999999999999977  78899988754332   356788899999999988 799999999766668999999


Q ss_pred             cCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCC-ceEEeecCCceecCCCC
Q 017594          127 MPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDM-NPKISDFGMARICGGNE  205 (369)
Q Consensus       127 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~-~~~L~Dfg~~~~~~~~~  205 (369)
                      +.++++..++........+.......++.|++.++.++|..+   ++|+|+||+||+++..+ .++++|||.+.......
T Consensus        80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~  156 (384)
T COG0515          80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG  156 (384)
T ss_pred             CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence            999999866643221125888899999999999999999999   99999999999999998 79999999988655433


Q ss_pred             ccc----ccccccccccccCchhhcc---CCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCcccc
Q 017594          206 LQA----NTSRIVGTYGYMSPEYALE---GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLE  278 (369)
Q Consensus       206 ~~~----~~~~~~~~~~y~aPE~~~~---~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (369)
                      ...    ......++..|.|||.+.+   .......|+|++|++++++++|..||......  ................ 
T Consensus       157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~--~~~~~~~~~~~~~~~~-  233 (384)
T COG0515         157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNS--SATSQTLKIILELPTP-  233 (384)
T ss_pred             ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCcc--ccHHHHHHHHHhcCCc-
Confidence            221    2345678999999999987   57889999999999999999999996544321  0000001111110000 


Q ss_pred             ccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 017594          279 LIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSM  321 (369)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~  321 (369)
                      ........... ......+.+++..|+..+|..|.+..+....
T Consensus       234 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~  275 (384)
T COG0515         234 SLASPLSPSNP-ELISKAASDLLKKLLAKDPKNRLSSSSDLSH  275 (384)
T ss_pred             ccccccCcccc-chhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence            00000000000 1113568899999999999999999887764

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.88  E-value=1.7e-22  Score=173.48  Aligned_cols=174  Identities=16%  Similarity=0.146  Sum_probs=134.0

Q ss_pred             HHHhcCCccCccccccCCccEEEEEEcCCCEEEEEEecCCCchhHHH---------HHHHHHHHhcCCCCceeeeeeeEE
Q 017594           45 STATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLRE---------MKNEASVIAKVQHKNLVRLLGCCI  115 (369)
Q Consensus        45 ~~~~~~y~i~~~lg~G~~~~v~~~~~~~~~~valK~~~~~~~~~~~~---------~~~e~~~l~~l~h~~i~~~~~~~~  115 (369)
                      ..+.++|++++.||.|+||.||++.. ++..+++|.+..........         +.+|+..+.++.|+++..+.+++.
T Consensus        27 ~~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~  105 (232)
T PRK10359         27 DFLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYL  105 (232)
T ss_pred             HHhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeee
Confidence            45689999999999999999999766 47789999997443222222         578999999999999999988866


Q ss_pred             eC--------CccEEEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCC
Q 017594          116 DR--------DEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKD  187 (369)
Q Consensus       116 ~~--------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~  187 (369)
                      ..        ...+++|||++|.+|.++..       +++    ....+++.++..+|..|   ++|||++|.||+++.+
T Consensus       106 ~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~-------~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~~  171 (232)
T PRK10359        106 LAERKTLRYAHTYIMLIEYIEGVELNDMPE-------ISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIVSKN  171 (232)
T ss_pred             ecccccccccCCeEEEEEEECCccHHHhhh-------ccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEEeCC
Confidence            43        35789999999999977631       222    24568999999999999   9999999999999998


Q ss_pred             CceEEeecCCceecCCCCcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHh
Q 017594          188 MNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS  248 (369)
Q Consensus       188 ~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~t  248 (369)
                      | ++|+|||..........              ...+.....++.++|+|+||+++..+..
T Consensus       172 g-i~liDfg~~~~~~e~~a--------------~d~~vler~y~~~~di~~lg~~~~~~~~  217 (232)
T PRK10359        172 G-LRIIDLSGKRCTAQRKA--------------KDRIDLERHYGIKNEIKDLGYYLLIYKK  217 (232)
T ss_pred             C-EEEEECCCcccccchhh--------------HHHHHHHhHhcccccccceeEeehHHHH
Confidence            8 99999998754321110              0112334556689999999999877653

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.86  E-value=6e-22  Score=175.12  Aligned_cols=235  Identities=19%  Similarity=0.246  Sum_probs=149.8

Q ss_pred             hcCCccCccccccCCccEEEEEEcC-CCEEEEEEecCCC---chhHHHHHHHHHHHhcCCC----------Cceeeeeee
Q 017594           48 TNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRS---GQGLREMKNEASVIAKVQH----------KNLVRLLGC  113 (369)
Q Consensus        48 ~~~y~i~~~lg~G~~~~v~~~~~~~-~~~valK~~~~~~---~~~~~~~~~e~~~l~~l~h----------~~i~~~~~~  113 (369)
                      ...+...+.||.|+++.||.+++.. |+.+++|++....   ...++.+++|.-....+.+          -.++..++.
T Consensus        11 ~r~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~   90 (288)
T PF14531_consen   11 PRTLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDL   90 (288)
T ss_dssp             EEEEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEE
T ss_pred             ceEEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEE
Confidence            3456778899999999999999775 8999999886433   2345666666655555322          233333443


Q ss_pred             EEeC------------C-----ccEEEEEecCCCChhhhhcC----CCccccCChHHHHHHHHHHHHHHHHHhcCCCCCc
Q 017594          114 CIDR------------D-----EKILIYEYMPNKSLDFFLFD----PTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRI  172 (369)
Q Consensus       114 ~~~~------------~-----~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i  172 (369)
                      ....            +     ..+++|+-+ .++|..++..    ......+.......+..|+++.+++||..|   +
T Consensus        91 ~~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---l  166 (288)
T PF14531_consen   91 LRIPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---L  166 (288)
T ss_dssp             EEETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred             EEEcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---e
Confidence            3211            1     225677766 4566555421    111223444455677799999999999999   9


Q ss_pred             ccCCCCCCCEEEeCCCceEEeecCCceecCCCCcccccccccccccccCchhhcc--------CCCCcccchHhHHHHHH
Q 017594          173 IHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALE--------GIFSIKSDVFSFGVLLL  244 (369)
Q Consensus       173 ~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~DiwslG~il~  244 (369)
                      +|+||+|+|++++.+|.+.|+||+.....+.....     ...+..|.+||....        ..++.+.|.|+||+++|
T Consensus       167 VHgdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~-----~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly  241 (288)
T PF14531_consen  167 VHGDIKPENFLLDQDGGVFLGDFSSLVRAGTRYRC-----SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLY  241 (288)
T ss_dssp             EEST-SGGGEEE-TTS-EEE--GGGEEETTEEEEG-----GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHH
T ss_pred             EecccceeeEEEcCCCCEEEcChHHHeecCceeec-----cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHH
Confidence            99999999999999999999999887765432211     233467899997653        24788999999999999


Q ss_pred             HHHhCCCCCCCCcccccccchhhhhhhhcCccccccCccccccccHHHHHHHHHHHHHHhhcCCCCCC
Q 017594          245 EIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYSSKQMLLRYANIALLCVQESADDR  312 (369)
Q Consensus       245 ~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R  312 (369)
                      .|+++..||+..........                  .+....   ..++.++.||..+|+.+|++|
T Consensus       242 ~lWC~~lPf~~~~~~~~~~~------------------~f~~C~---~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  242 SLWCGRLPFGLSSPEADPEW------------------DFSRCR---DMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             HHHHSS-STCCCGGGSTSGG------------------GGTTSS------HHHHHHHHHHT-SSGGGS
T ss_pred             HHHHccCCCCCCCccccccc------------------cchhcC---CcCHHHHHHHHHHccCCcccC
Confidence            99999999985542221110                  111111   237889999999999999988

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.86  E-value=5.4e-22  Score=198.44  Aligned_cols=253  Identities=17%  Similarity=0.192  Sum_probs=188.4

Q ss_pred             HHHHhcCCccCccccccCCccEEEEEEcCCCEEEEEEecCCCchhHHHHHHHHHHHhcCC---CCceeeeeeeEEeCCcc
Q 017594           44 VSTATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQ---HKNLVRLLGCCIDRDEK  120 (369)
Q Consensus        44 ~~~~~~~y~i~~~lg~G~~~~v~~~~~~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~~~~  120 (369)
                      .+.-+..|.|.+.||.|+||+||.|...+|+.||+|+-...+...   +.--.+++.+|+   -+.|..+...+...+..
T Consensus       693 ~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WE---fYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S  769 (974)
T KOG1166|consen  693 FEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWE---FYICLQVMERLKPQMLPSIMHISSAHVFQNAS  769 (974)
T ss_pred             eeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCcee---eeehHHHHHhhchhhhcchHHHHHHHccCCcc
Confidence            355677899999999999999999997779999999877655432   111233444444   34566677777778889


Q ss_pred             EEEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEe-------CCCceEEe
Q 017594          121 ILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLD-------KDMNPKIS  193 (369)
Q Consensus       121 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~-------~~~~~~L~  193 (369)
                      ++|++|.+.|+|.+++.   ..+.+++..+..+..|++..+++||..+   |+||||||+|+++.       ....++|+
T Consensus       770 ~lv~ey~~~Gtlld~~N---~~~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~l~lI  843 (974)
T KOG1166|consen  770 VLVSEYSPYGTLLDLIN---TNKVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKGLYLI  843 (974)
T ss_pred             eeeeeccccccHHHhhc---cCCCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccceEEE
Confidence            99999999999999995   4455899999999999999999999999   99999999999994       23458999


Q ss_pred             ecCCceecCCCCcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhc
Q 017594          194 DFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTS  273 (369)
Q Consensus       194 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~  273 (369)
                      |||.+..+.--.....+....++..+-++|+..|.+|+..+|.|.|..+++.|+.|+..-                .+..
T Consensus       844 DfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~q----------------~~~g  907 (974)
T KOG1166|consen  844 DFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYME----------------VKNG  907 (974)
T ss_pred             ecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHHH----------------hcCC
Confidence            999988765544455566677899999999999999999999999999999999998541                1111


Q ss_pred             CccccccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHhhhh
Q 017594          274 NRTLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNEAA  327 (369)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L~~~~~  327 (369)
                      . .+.. ...+.+-..    ..-..+++..+|..|-..=|...+|...|+....
T Consensus       908 ~-~~~~-~~~~~Ry~~----~~~W~~~F~~lLN~~~~~~p~l~~lr~~~~~~~~  955 (974)
T KOG1166|consen  908 S-SWMV-KTNFPRYWK----RDMWNKFFDLLLNPDCDTLPNLQELRTELEEVLA  955 (974)
T ss_pred             c-ceec-cccchhhhh----HHHHHHHHHHHhCcCcccchhHHHHHHHHHHHHH
Confidence            1 1111 110111110    1224567777787555555777777777765543

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.85  E-value=9.7e-21  Score=160.54  Aligned_cols=141  Identities=15%  Similarity=0.119  Sum_probs=108.3

Q ss_pred             cCccccccCCccEEEEEEcCCCEEEEEEecCCCch--h------------------------HHHHHHHHHHHhcCCCCc
Q 017594           53 DANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQ--G------------------------LREMKNEASVIAKVQHKN  106 (369)
Q Consensus        53 i~~~lg~G~~~~v~~~~~~~~~~valK~~~~~~~~--~------------------------~~~~~~e~~~l~~l~h~~  106 (369)
                      +.+.||+|++|.||+|...+|+.||+|++......  .                        ......|+..+..+.+++
T Consensus         1 ~~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   80 (190)
T cd05147           1 INGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG   80 (190)
T ss_pred             CCCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence            35789999999999999878999999998644211  0                        012234889999998777


Q ss_pred             eeeeeeeEEeCCccEEEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHH-hcCCCCCcccCCCCCCCEEEe
Q 017594          107 LVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYL-HQYSRVRIIHRDLKASNILLD  185 (369)
Q Consensus       107 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~L-H~~~~~~i~H~dl~p~NIlv~  185 (369)
                      +.....+.  ....++||||++++++......   ...++......++.|++.+|.++ |..|   ++||||||.||+++
T Consensus        81 v~~p~~~~--~~~~~iVmE~i~g~~l~~~~~~---~~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIli~  152 (190)
T cd05147          81 IPCPEPIL--LKSHVLVMEFIGDDGWAAPRLK---DAPLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLLYH  152 (190)
T ss_pred             CCCCcEEE--ecCCEEEEEEeCCCCCcchhhh---cCCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEE
Confidence            64433322  2234899999998776544322   23478889999999999999999 7888   99999999999998


Q ss_pred             CCCceEEeecCCceecC
Q 017594          186 KDMNPKISDFGMARICG  202 (369)
Q Consensus       186 ~~~~~~L~Dfg~~~~~~  202 (369)
                       ++.++|+|||++....
T Consensus       153 -~~~v~LiDFG~a~~~~  168 (190)
T cd05147         153 -DGKLYIIDVSQSVEHD  168 (190)
T ss_pred             -CCcEEEEEccccccCC
Confidence             5789999999987543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.83  E-value=7.7e-20  Score=155.48  Aligned_cols=141  Identities=18%  Similarity=0.189  Sum_probs=109.8

Q ss_pred             cCccccccCCccEEEEEEcCCCEEEEEEecCCCchh--------------------------HHHHHHHHHHHhcCCCCc
Q 017594           53 DANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQG--------------------------LREMKNEASVIAKVQHKN  106 (369)
Q Consensus        53 i~~~lg~G~~~~v~~~~~~~~~~valK~~~~~~~~~--------------------------~~~~~~e~~~l~~l~h~~  106 (369)
                      +.+.||+|++|.||+|...+|+.||+|++.......                          ......|...+.++.+++
T Consensus         1 ~~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   80 (190)
T cd05145           1 INGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG   80 (190)
T ss_pred             CCceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence            467899999999999997789999999987542110                          122356888999998888


Q ss_pred             eeeeeeeEEeCCccEEEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhc-CCCCCcccCCCCCCCEEEe
Q 017594          107 LVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQ-YSRVRIIHRDLKASNILLD  185 (369)
Q Consensus       107 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~-~~~~~i~H~dl~p~NIlv~  185 (369)
                      +.....+...  ..++||||++++++......   ...++......++.|++.++.++|. .|   ++|+||||+||+++
T Consensus        81 i~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~---~~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIll~  152 (190)
T cd05145          81 VPVPEPILLK--KNVLVMEFIGDDGSPAPRLK---DVPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNILYH  152 (190)
T ss_pred             CCCceEEEec--CCEEEEEEecCCCchhhhhh---hccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEEEE
Confidence            7544443322  35899999998855333211   2336778889999999999999999 88   99999999999999


Q ss_pred             CCCceEEeecCCceecC
Q 017594          186 KDMNPKISDFGMARICG  202 (369)
Q Consensus       186 ~~~~~~L~Dfg~~~~~~  202 (369)
                       ++.++|+|||++....
T Consensus       153 -~~~~~liDFG~a~~~~  168 (190)
T cd05145         153 -DGKPYIIDVSQAVELD  168 (190)
T ss_pred             -CCCEEEEEcccceecC
Confidence             8899999999987654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.83  E-value=1.3e-20  Score=160.13  Aligned_cols=247  Identities=23%  Similarity=0.344  Sum_probs=185.2

Q ss_pred             CccCccccccCCccEEEEEEcCCCEEEEEEecCCC--chhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEEEEecC
Q 017594           51 FSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRS--GQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIYEYMP  128 (369)
Q Consensus        51 y~i~~~lg~G~~~~v~~~~~~~~~~valK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~  128 (369)
                      ..+..+|.....|..|+++|+ |..+++|++...+  .-.-..+..|.-.|+-+.||||+.+++.+...-.+.++..|++
T Consensus       192 lnl~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp  270 (448)
T KOG0195|consen  192 LNLITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMP  270 (448)
T ss_pred             hhhhhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeecc
Confidence            445568889999999999998 5566778775432  2223567888889999999999999999988889999999999


Q ss_pred             CCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEE--eecCCceecCCCCc
Q 017594          129 NKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKI--SDFGMARICGGNEL  206 (369)
Q Consensus       129 ~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L--~Dfg~~~~~~~~~~  206 (369)
                      .++|...+..... -..+.....+++.+++.+++|||+.. +.+.---|....++++++-..+|  +|--++...     
T Consensus       271 ~gslynvlhe~t~-vvvd~sqav~faldiargmaflhsle-p~ipr~~lns~hvmidedltarismad~kfsfqe-----  343 (448)
T KOG0195|consen  271 FGSLYNVLHEQTS-VVVDHSQAVRFALDIARGMAFLHSLE-PMIPRFYLNSKHVMIDEDLTARISMADTKFSFQE-----  343 (448)
T ss_pred             chHHHHHHhcCcc-EEEecchHHHHHHHHHhhHHHHhhcc-hhhhhhhcccceEEecchhhhheecccceeeeec-----
Confidence            9999999876443 34566788899999999999999995 33555568899999998866544  343332211     


Q ss_pred             ccccccccccccccCchhhccCCC---CcccchHhHHHHHHHHHhCCCCCCCCcc-cccccchhhhhhhhcCccccccCc
Q 017594          207 QANTSRIVGTYGYMSPEYALEGIF---SIKSDVFSFGVLLLEIVSGKKNTGLYRT-DSLNLLGYAWDLWTSNRTLELIDP  282 (369)
Q Consensus       207 ~~~~~~~~~~~~y~aPE~~~~~~~---~~~~DiwslG~il~~l~tg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~  282 (369)
                          ......+.|++||.++..+-   -.++|+||+.+++|+|.|...||...+. +..       -....+..+..+.+
T Consensus       344 ----~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecg-------mkialeglrv~ipp  412 (448)
T KOG0195|consen  344 ----VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECG-------MKIALEGLRVHIPP  412 (448)
T ss_pred             ----cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhh-------hhhhhccccccCCC
Confidence                11234788999999987653   4679999999999999999999975542 111       00111222222222


Q ss_pred             cccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHhh
Q 017594          283 ILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNE  325 (369)
Q Consensus       283 ~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L~~~  325 (369)
                               .++..+.+|+.-|+..||.+||.++.|+-.|++.
T Consensus       413 ---------gis~hm~klm~icmnedpgkrpkfdmivpilekm  446 (448)
T KOG0195|consen  413 ---------GISRHMNKLMNICMNEDPGKRPKFDMIVPILEKM  446 (448)
T ss_pred             ---------CccHHHHHHHHHHhcCCCCcCCCcceehhhHHHh
Confidence                     2367799999999999999999999999888864

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.80  E-value=7.6e-19  Score=147.88  Aligned_cols=184  Identities=18%  Similarity=0.142  Sum_probs=137.0

Q ss_pred             ccCccccccCCccEEEEEEcCCCEEEEEEecCCCchh----HHHHHHHHHHHhcCC-CCceeeeeeeEEeCCccEEEEEe
Q 017594           52 SDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQG----LREMKNEASVIAKVQ-HKNLVRLLGCCIDRDEKILIYEY  126 (369)
Q Consensus        52 ~i~~~lg~G~~~~v~~~~~~~~~~valK~~~~~~~~~----~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~  126 (369)
                      -+...|++|+||+|+.+.. .+.+++.+.+.......    ...+.+|+++|++|. ++++++++++    +..+++|+|
T Consensus         5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey   79 (218)
T PRK12274          5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY   79 (218)
T ss_pred             ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence            4667899999999997766 58888888776543211    125788999999995 4778888875    457999999


Q ss_pred             cCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCC-CCCCEEEeCCCceEEeecCCceecCCCC
Q 017594          127 MPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDL-KASNILLDKDMNPKISDFGMARICGGNE  205 (369)
Q Consensus       127 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl-~p~NIlv~~~~~~~L~Dfg~~~~~~~~~  205 (369)
                      +.|.+|.....   .       ....++.|++.+|.++|.+|   ++|+|| +|.||+++.++.++|+|||++.......
T Consensus        80 I~G~~L~~~~~---~-------~~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~  146 (218)
T PRK12274         80 LAGAAMYQRPP---R-------GDLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRA  146 (218)
T ss_pred             ecCccHHhhhh---h-------hhHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecCCcc
Confidence            99998854321   0       11347789999999999999   999999 7999999999999999999998654332


Q ss_pred             cc----cc-------cccccccccccCchhhcc--CCCCcccchHhHHHHHHHHHhCCCCC
Q 017594          206 LQ----AN-------TSRIVGTYGYMSPEYALE--GIFSIKSDVFSFGVLLLEIVSGKKNT  253 (369)
Q Consensus       206 ~~----~~-------~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslG~il~~l~tg~~p~  253 (369)
                      ..    ..       ......++.+++|+...-  ..--...+.++.|+-+|.++|+..++
T Consensus       147 ~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~  207 (218)
T PRK12274        147 RWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLH  207 (218)
T ss_pred             hHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCc
Confidence            10    00       001225677888876432  22235678999999999999998764

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.80  E-value=3e-20  Score=174.77  Aligned_cols=231  Identities=24%  Similarity=0.305  Sum_probs=178.9

Q ss_pred             cccccCCccEEEEEE----cCCCEEEEEEecCCCch--hHHHHHHHHHHHhcCC-CCceeeeeeeEEeCCccEEEEEecC
Q 017594           56 KLGEGGFGPVYKGVL----KKGDEIAVKRLSGRSGQ--GLREMKNEASVIAKVQ-HKNLVRLLGCCIDRDEKILIYEYMP  128 (369)
Q Consensus        56 ~lg~G~~~~v~~~~~----~~~~~valK~~~~~~~~--~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~  128 (369)
                      .+|.|++|.|++++.    ..|.-+++|++......  .......|..++...+ ||.++++...+..+...+++.++..
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r   80 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR   80 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence            378999999999872    23667888877543211  1114456777888886 9999999999999999999999999


Q ss_pred             CCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCCCCccc
Q 017594          129 NKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQA  208 (369)
Q Consensus       129 ~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~~~~~~  208 (369)
                      ++.+...+..   ...+.+.........++-+++++|+.+   ++|+|+|++||+++.+|++++.|||.++..-...   
T Consensus        81 gg~lft~l~~---~~~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~~---  151 (612)
T KOG0603|consen   81 GGDLFTRLSK---EVMFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEK---  151 (612)
T ss_pred             cchhhhcccc---CCchHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhhh---
Confidence            9888666643   333677777888888999999999999   9999999999999999999999999987543222   


Q ss_pred             ccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCccccccCcccc-cc
Q 017594          209 NTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILE-DE  287 (369)
Q Consensus       209 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~  287 (369)
                         ..+|+..|+|||++.  ....++|.||+|+++++|++|..||+.                      +....++. .-
T Consensus       152 ---~~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~----------------------~~~~~Il~~~~  204 (612)
T KOG0603|consen  152 ---IACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG----------------------DTMKRILKAEL  204 (612)
T ss_pred             ---hcccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch----------------------HHHHHHhhhcc
Confidence               228899999999988  567889999999999999999999874                      11111111 11


Q ss_pred             ccHHHHHHHHHHHHHHhhcCCCCCCCCH--HHHHHHH
Q 017594          288 YSSKQMLLRYANIALLCVQESADDRPTM--NDVVSML  322 (369)
Q Consensus       288 ~~~~~~~~~l~~li~~~L~~dP~~Rps~--~ell~~L  322 (369)
                      ..+...+....+++..++..+|..|.-.  ..+.+..
T Consensus       205 ~~p~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik  241 (612)
T KOG0603|consen  205 EMPRELSAEARSLFRQLFKRNPENRLGAGPDGVDEIK  241 (612)
T ss_pred             CCchhhhHHHHHHHHHHHhhCHHHHhccCcchhHHHh
Confidence            2244557889999999999999999866  3444444

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.79  E-value=8.1e-19  Score=164.89  Aligned_cols=219  Identities=24%  Similarity=0.348  Sum_probs=163.5

Q ss_pred             HhcCCCCceeeeeeeEEeCCccEEEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCC
Q 017594           99 IAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLK  178 (369)
Q Consensus        99 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~  178 (369)
                      |+.+.|.|+.++++.+.++...+.|.+||..|+|.+.+..  ....+++.....+.++|+.+++|||...  -.+||.++
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~--~~~~~d~~F~~s~~rdi~~Gl~ylh~s~--i~~hg~l~   76 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN--EDIKLDYFFILSFIRDISKGLAYLHNSP--IGYHGALK   76 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc--cccCccHHHHHHHHHHHHHHHHHHhcCc--ceeeeeec
Confidence            4578899999999999999999999999999999999976  3344888889999999999999999986  23999999


Q ss_pred             CCCEEEeCCCceEEeecCCceecCCCCcccccccccccccccCchhhccCC-------CCcccchHhHHHHHHHHHhCCC
Q 017594          179 ASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGI-------FSIKSDVFSFGVLLLEIVSGKK  251 (369)
Q Consensus       179 p~NIlv~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-------~~~~~DiwslG~il~~l~tg~~  251 (369)
                      ..|.+++....++|.|||+.................-...|.|||.+....       .+.++|+||+|++++++++...
T Consensus        77 s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~  156 (484)
T KOG1023|consen   77 SSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSG  156 (484)
T ss_pred             cccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccC
Confidence            999999999999999999976653211111111122355699999987531       4677999999999999999999


Q ss_pred             CCCCCcccccccchhhhhhhhcCccccccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHhhhh
Q 017594          252 NTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNEAA  327 (369)
Q Consensus       252 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L~~~~~  327 (369)
                      ||......... .+.......  .....+.+.+....   +..+++..++..||..+|+.||+++.+...++....
T Consensus       157 ~~~~~~~~~~~-~eii~~~~~--~~~~~~rP~i~~~~---e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~  226 (484)
T KOG1023|consen  157 PFDLRNLVEDP-DEIILRVKK--GGSNPFRPSIELLN---ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINK  226 (484)
T ss_pred             ccccccccCCh-HHHHHHHHh--cCCCCcCcchhhhh---hcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcc
Confidence            99865422221 111222111  11222222222111   334579999999999999999999999998877665

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.76  E-value=3e-17  Score=142.01  Aligned_cols=134  Identities=20%  Similarity=0.308  Sum_probs=110.7

Q ss_pred             CccccccCCccEEEEEEcCCCEEEEEEecCCCch--------hHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEEEE
Q 017594           54 ANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQ--------GLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIYE  125 (369)
Q Consensus        54 ~~~lg~G~~~~v~~~~~~~~~~valK~~~~~~~~--------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  125 (369)
                      ++.||+|++|.||+|.. .|..+++|+.......        ....+..|+..+..+.|+++.....++......+++||
T Consensus         1 ~~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e   79 (211)
T PRK14879          1 MKLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVME   79 (211)
T ss_pred             CcccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEE
Confidence            36799999999999988 5778899976533211        12346678999999999988777777777788999999


Q ss_pred             ecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCce
Q 017594          126 YMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMAR  199 (369)
Q Consensus       126 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~  199 (369)
                      |++|.+|.+++...      .. ....++.+++.+|.++|+.+   ++|+|++|.||+++ ++.++|+|||.+.
T Consensus        80 ~~~G~~L~~~~~~~------~~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~  142 (211)
T PRK14879         80 YIEGEPLKDLINSN------GM-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAE  142 (211)
T ss_pred             EeCCcCHHHHHHhc------cH-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCccc
Confidence            99999998887431      12 77889999999999999999   99999999999999 7899999999865

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.75  E-value=1.2e-17  Score=149.03  Aligned_cols=198  Identities=23%  Similarity=0.270  Sum_probs=137.8

Q ss_pred             CCCceeeeeeeEEe---------------------------CCccEEEEEecCCCChhhhhcCCCccccCChHHHHHHHH
Q 017594          103 QHKNLVRLLGCCID---------------------------RDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIE  155 (369)
Q Consensus       103 ~h~~i~~~~~~~~~---------------------------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~  155 (369)
                      +||||+++...|.+                           ...+|+||.-+ ..+|..++....    .+.....-++.
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY-~~tLr~yl~~~~----~s~r~~~~~la  348 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRY-RQTLREYLWTRH----RSYRTGRVILA  348 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcc-hhhHHHHHhcCC----CchHHHHHHHH
Confidence            59999999888743                           22458888876 457888876533    45556677899


Q ss_pred             HHHHHHHHHhcCCCCCcccCCCCCCCEEEe--CC--CceEEeecCCceecCCCCcc--cc--cccccccccccCchhhcc
Q 017594          156 GIAQGLLYLHQYSRVRIIHRDLKASNILLD--KD--MNPKISDFGMARICGGNELQ--AN--TSRIVGTYGYMSPEYALE  227 (369)
Q Consensus       156 qi~~al~~LH~~~~~~i~H~dl~p~NIlv~--~~--~~~~L~Dfg~~~~~~~~~~~--~~--~~~~~~~~~y~aPE~~~~  227 (369)
                      |++.|+.|||++|   +.|||+|.+||++.  .|  ..+.+.|||.+--.......  ..  .-...|+..-+|||+...
T Consensus       349 QlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta  425 (598)
T KOG4158|consen  349 QLLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATA  425 (598)
T ss_pred             HHHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhc
Confidence            9999999999999   99999999999994  33  34789999987544321111  11  112347788999999874


Q ss_pred             CC------CCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCccccccCccccccccHHHHHHHHHHHH
Q 017594          228 GI------FSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYSSKQMLLRYANIA  301 (369)
Q Consensus       228 ~~------~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  301 (369)
                      .+      .-.++|.|+.|.+.||+++...||-......          .......+.-.+.+..     .++..+++++
T Consensus       426 ~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~----------L~~r~Yqe~qLPalp~-----~vpp~~rqlV  490 (598)
T KOG4158|consen  426 VPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEML----------LDTRTYQESQLPALPS-----RVPPVARQLV  490 (598)
T ss_pred             CCCCceeeccchhhhhhhhhhHHHHhccCCcccccchhe----------echhhhhhhhCCCCcc-----cCChHHHHHH
Confidence            32      2358999999999999999999985321111          1111122222222222     2256689999


Q ss_pred             HHhhcCCCCCCCCHHHHHHHHH
Q 017594          302 LLCVQESADDRPTMNDVVSMLT  323 (369)
Q Consensus       302 ~~~L~~dP~~Rps~~ell~~L~  323 (369)
                      ...|+.||++|+++.=....|.
T Consensus       491 ~~lL~r~pskRvsp~iAANvl~  512 (598)
T KOG4158|consen  491 FDLLKRDPSKRVSPNIAANVLN  512 (598)
T ss_pred             HHHhcCCccccCCccHHHhHHH
Confidence            9999999999999876665553

>smart00090 RIO RIO-like kinase

Probab=99.75  E-value=1.4e-17  Score=146.03  Aligned_cols=146  Identities=16%  Similarity=0.141  Sum_probs=110.9

Q ss_pred             HHhcCCccCccccccCCccEEEEE--EcCCCEEEEEEecCCCch------------------------hHHHHHHHHHHH
Q 017594           46 TATNKFSDANKLGEGGFGPVYKGV--LKKGDEIAVKRLSGRSGQ------------------------GLREMKNEASVI   99 (369)
Q Consensus        46 ~~~~~y~i~~~lg~G~~~~v~~~~--~~~~~~valK~~~~~~~~------------------------~~~~~~~e~~~l   99 (369)
                      ....-|.+.+.||.|++|.||+|.  ..+|+.||+|++......                        ....+..|+..+
T Consensus        25 ~~~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L  104 (237)
T smart00090       25 NRGILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNL  104 (237)
T ss_pred             hcCchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHH
Confidence            333459999999999999999998  457999999998744210                        012346799999


Q ss_pred             hcCCCC--ceeeeeeeEEeCCccEEEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCC
Q 017594          100 AKVQHK--NLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDL  177 (369)
Q Consensus       100 ~~l~h~--~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl  177 (369)
                      .++.+.  .+.++++.    ...++||||+.+.++......   ...........++.||+.++.+||..|  .++|+||
T Consensus       105 ~~L~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~g--~iiH~Di  175 (237)
T smart00090      105 QRLYEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLK---DVEPEEEEEFELYDDILEEMRKLYKEG--ELVHGDL  175 (237)
T ss_pred             HHHHhcCCCCCeeeEe----cCceEEEEEecCCcccccccc---cCCcchHHHHHHHHHHHHHHHHHHhcC--CEEeCCC
Confidence            999653  23344432    345899999999887655422   223555667889999999999999876  5999999


Q ss_pred             CCCCEEEeCCCceEEeecCCceec
Q 017594          178 KASNILLDKDMNPKISDFGMARIC  201 (369)
Q Consensus       178 ~p~NIlv~~~~~~~L~Dfg~~~~~  201 (369)
                      +|+||+++ ++.++|+|||.+...
T Consensus       176 kp~NIli~-~~~i~LiDFg~a~~~  198 (237)
T smart00090      176 SEYNILVH-DGKVVIIDVSQSVEL  198 (237)
T ss_pred             ChhhEEEE-CCCEEEEEChhhhcc
Confidence            99999999 889999999987644

>PRK10345 hypothetical protein; Provisional

Probab=99.74  E-value=2e-17  Score=141.69  Aligned_cols=136  Identities=21%  Similarity=0.280  Sum_probs=104.2

Q ss_pred             CccCccccccCCccEEEEEEcCCCEEEEEEecCCCchhHHHHHHHHHHHhcC-----CCCceeeeeeeEEeCC---c-cE
Q 017594           51 FSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKV-----QHKNLVRLLGCCIDRD---E-KI  121 (369)
Q Consensus        51 y~i~~~lg~G~~~~v~~~~~~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~~---~-~~  121 (369)
                      +.-.+.||+|+++.||. .-.++.. +||++........+.+.+|+.+++.+     .||||+++++++..+.   . +.
T Consensus         4 L~~~~~LG~G~~~~Vy~-hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~   81 (210)
T PRK10345          4 LSEQSPLGTGRHRKCYA-HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYD   81 (210)
T ss_pred             cCCcceecCCCceEEEE-CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEE
Confidence            34567899999999995 2223444 68988765444557789999999999     5799999999998764   2 23


Q ss_pred             EEEEe--cCCCChhhhhcCCCccccCChHHHHHHHHHHHHHH-HHHhcCCCCCcccCCCCCCCEEEeC----CCceEEee
Q 017594          122 LIYEY--MPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGL-LYLHQYSRVRIIHRDLKASNILLDK----DMNPKISD  194 (369)
Q Consensus       122 lv~e~--~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al-~~LH~~~~~~i~H~dl~p~NIlv~~----~~~~~L~D  194 (369)
                      +|+||  +.+++|.+++.+.    .+++.  ..++.+++.++ +|||+++   |+|+||||+||+++.    ++.++|+|
T Consensus        82 ~I~e~~G~~~~tL~~~l~~~----~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~LiD  152 (210)
T PRK10345         82 VIADFDGKPSITLTEFAEQC----RYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVCD  152 (210)
T ss_pred             EEecCCCCcchhHHHHHHcc----cccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEEE
Confidence            78999  4578999999542    24444  35677788777 9999999   999999999999974    34799999


Q ss_pred             cCC
Q 017594          195 FGM  197 (369)
Q Consensus       195 fg~  197 (369)
                      ++.
T Consensus       153 g~G  155 (210)
T PRK10345        153 NIG  155 (210)
T ss_pred             CCC
Confidence            543

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.73  E-value=1.6e-18  Score=160.19  Aligned_cols=170  Identities=25%  Similarity=0.336  Sum_probs=129.4

Q ss_pred             ccEEEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCc
Q 017594          119 EKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMA  198 (369)
Q Consensus       119 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~  198 (369)
                      .+++.|++|...+|.+++.........+......++.|++.++.|   ++   .+|+|++|.||++..+..++|+|||+.
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDFgl~  403 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDFGLV  403 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhhhhe
Confidence            578999999999999999765555667778889999999999999   76   999999999999999999999999998


Q ss_pred             eecCCCC----cccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhC-CCCCCCCcccccccchhhhhhhhc
Q 017594          199 RICGGNE----LQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG-KKNTGLYRTDSLNLLGYAWDLWTS  273 (369)
Q Consensus       199 ~~~~~~~----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg-~~p~~~~~~~~~~~~~~~~~~~~~  273 (369)
                      .......    .........|+.+|++||.+.+..|+.++||||||++|++|+.. ...+..              ....
T Consensus       404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er--------------~~t~  469 (516)
T KOG1033|consen  404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFER--------------IATL  469 (516)
T ss_pred             eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHH--------------HHhh
Confidence            8765444    22344567899999999999999999999999999999999982 212110              0011


Q ss_pred             Ccccccc-CccccccccHHHHHHHHHHHHHHhhcCCCCCCCC
Q 017594          274 NRTLELI-DPILEDEYSSKQMLLRYANIALLCVQESADDRPT  314 (369)
Q Consensus       274 ~~~~~~~-~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps  314 (369)
                      .++...+ .+.....      .+.-..|+.+|+...|.+||+
T Consensus       470 ~d~r~g~ip~~~~~d------~p~e~~ll~~lls~~p~~RP~  505 (516)
T KOG1033|consen  470 TDIRDGIIPPEFLQD------YPEEYTLLQQLLSPSPEERPS  505 (516)
T ss_pred             hhhhcCCCChHHhhc------CcHHHHHHHHhcCCCcccCch
Confidence            1111111 1011111      233468999999999999993

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.71  E-value=1.5e-17  Score=164.26  Aligned_cols=218  Identities=20%  Similarity=0.260  Sum_probs=144.9

Q ss_pred             hHHHHhcCCccCccccccCCccEEEEEEcC-CCEEEEEEecCCCchhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccE
Q 017594           43 SVSTATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKI  121 (369)
Q Consensus        43 ~~~~~~~~y~i~~~lg~G~~~~v~~~~~~~-~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  121 (369)
                      .-.....+|..++.|..|+||.||.++++. .+++|+| +++.+.     +.+-  ++.....|.++             
T Consensus        77 ~~~p~e~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~l-----ilRn--ilt~a~npfvv-------------  135 (1205)
T KOG0606|consen   77 RRAPSESDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNL-----ILRN--ILTFAGNPFVV-------------  135 (1205)
T ss_pred             ccCCCccccceeEeeccCCCCceeeeeccccccchhhc-ccccch-----hhhc--cccccCCccee-------------
Confidence            445667889999999999999999999765 7888884 332221     1000  12222223222             


Q ss_pred             EEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceec
Q 017594          122 LIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARIC  201 (369)
Q Consensus       122 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~  201 (369)
                           -+..+   .+..   ..+++..        ++.+++|||+.|   ++|+|+||+|.+|+.-|+++++|||+....
T Consensus       136 -----gDc~t---llk~---~g~lPvd--------mvla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~G  193 (1205)
T KOG0606|consen  136 -----GDCAT---LLKN---IGPLPVD--------MVLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKG  193 (1205)
T ss_pred             -----chhhh---hccc---CCCCcch--------hhHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhh
Confidence                 11112   2211   1123322        378899999999   999999999999999999999999987654


Q ss_pred             CCCCcc-------------cccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhh
Q 017594          202 GGNELQ-------------ANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAW  268 (369)
Q Consensus       202 ~~~~~~-------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~  268 (369)
                      ......             ......+||+.|.|||++....|+..+|.|++|+|+|+.+-|..||.....+...      
T Consensus       194 Lms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelf------  267 (1205)
T KOG0606|consen  194 LMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELF------  267 (1205)
T ss_pred             hhhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHH------
Confidence            211100             1113357999999999999999999999999999999999999998754222111      


Q ss_pred             hhhhcCc--cccccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHH
Q 017594          269 DLWTSNR--TLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVV  319 (369)
Q Consensus       269 ~~~~~~~--~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell  319 (369)
                      ..+....  +.+. +         ...+.+.+++|.++|+.+|..|.-....+
T Consensus       268 g~visd~i~wpE~-d---------ea~p~Ea~dli~~LL~qnp~~Rlgt~ga~  310 (1205)
T KOG0606|consen  268 GQVISDDIEWPEE-D---------EALPPEAQDLIEQLLRQNPLCRLGTGGAL  310 (1205)
T ss_pred             hhhhhhhcccccc-C---------cCCCHHHHHHHHHHHHhChHhhcccchhh
Confidence            1111000  0000 1         11156799999999999999997444333

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.71  E-value=1.7e-16  Score=135.92  Aligned_cols=143  Identities=18%  Similarity=0.202  Sum_probs=109.9

Q ss_pred             HHHHhcCCccCccccccCCccEEEEEEcCCCEEEEEEecCCCch----------------------hHHHHHHHHHHHhc
Q 017594           44 VSTATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQ----------------------GLREMKNEASVIAK  101 (369)
Q Consensus        44 ~~~~~~~y~i~~~lg~G~~~~v~~~~~~~~~~valK~~~~~~~~----------------------~~~~~~~e~~~l~~  101 (369)
                      +......|.+.+.||.|++|.||++...+|+.|++|++......                      .......|+..+..
T Consensus        10 ~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~   89 (198)
T cd05144          10 LVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKA   89 (198)
T ss_pred             HHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHH
Confidence            33444458999999999999999999888999999987543210                      01135668888888


Q ss_pred             CCCCc--eeeeeeeEEeCCccEEEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCC
Q 017594          102 VQHKN--LVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKA  179 (369)
Q Consensus       102 l~h~~--i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p  179 (369)
                      +.+++  +...++    ....+++|||++++++.....         ......++.+++.++.++|..+   ++|+||+|
T Consensus        90 l~~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~---------~~~~~~~~~~i~~~l~~lh~~g---i~H~Dl~p  153 (198)
T cd05144          90 LYEEGFPVPKPID----WNRHAVVMEYIDGVELYRVRV---------LEDPEEVLDEILEEIVKAYKHG---IIHGDLSE  153 (198)
T ss_pred             HHHcCCCCCceee----cCCceEEEEEeCCcchhhccc---------cccHHHHHHHHHHHHHHHHHCC---CCcCCCCc
Confidence            87764  333332    345689999999998865542         0245578899999999999998   99999999


Q ss_pred             CCEEEeCCCceEEeecCCceecC
Q 017594          180 SNILLDKDMNPKISDFGMARICG  202 (369)
Q Consensus       180 ~NIlv~~~~~~~L~Dfg~~~~~~  202 (369)
                      .||+++.++.++|+|||++....
T Consensus       154 ~Nill~~~~~~~liDfg~~~~~~  176 (198)
T cd05144         154 FNILVDDDEKIYIIDWPQMVSTD  176 (198)
T ss_pred             ccEEEcCCCcEEEEECCccccCC
Confidence            99999999999999999986543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.70  E-value=1.8e-16  Score=135.87  Aligned_cols=130  Identities=23%  Similarity=0.367  Sum_probs=104.3

Q ss_pred             cccccCCccEEEEEEcCCCEEEEEEecCCCc--------hhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEEEEec
Q 017594           56 KLGEGGFGPVYKGVLKKGDEIAVKRLSGRSG--------QGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIYEYM  127 (369)
Q Consensus        56 ~lg~G~~~~v~~~~~~~~~~valK~~~~~~~--------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~  127 (369)
                      .||+|++|.||++.+. |..+++|.......        .....+..|+.++..+.++++....-++......+++|||+
T Consensus         1 ~ig~G~~~~vy~~~~~-~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~   79 (199)
T TIGR03724         1 LIAKGAEAIIYLGDFL-GLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI   79 (199)
T ss_pred             CCCCCceEEEEEeecC-CccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence            4799999999999964 67899998653321        11245668999999998877655555555677789999999


Q ss_pred             CCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCcee
Q 017594          128 PNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARI  200 (369)
Q Consensus       128 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~  200 (369)
                      +|++|.+++....        .  .++.+++.+|.+||+.+   ++|+|++|.||+++ ++.++++|||.+..
T Consensus        80 ~g~~l~~~~~~~~--------~--~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~  138 (199)
T TIGR03724        80 EGKPLKDVIEEGN--------D--ELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKY  138 (199)
T ss_pred             CCccHHHHHhhcH--------H--HHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence            9999988763211        0  78999999999999999   99999999999999 88999999998653

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.67  E-value=5.6e-16  Score=152.30  Aligned_cols=138  Identities=20%  Similarity=0.330  Sum_probs=110.6

Q ss_pred             HhcCCccCccccccCCccEEEEEEcCCCEEEEEEecCC--C------chhHHHHHHHHHHHhcCCCCceeeeeeeEEeCC
Q 017594           47 ATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGR--S------GQGLREMKNEASVIAKVQHKNLVRLLGCCIDRD  118 (369)
Q Consensus        47 ~~~~y~i~~~lg~G~~~~v~~~~~~~~~~valK~~~~~--~------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~  118 (369)
                      ....|...+.||+|+||.||++.+..+. +++|+....  .      ....+.+..|+.++..++|++++....+.....
T Consensus       331 ~~~~~~~~~~iG~G~~g~Vy~~~~~~~~-~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~  409 (535)
T PRK09605        331 VKRRKIPDHLIGKGAEADIKKGEYLGRD-AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPE  409 (535)
T ss_pred             cccccCccceeccCCcEEEEEEeecCcc-ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCC
Confidence            3455677899999999999999876443 444432211  1      112345778999999999999888777777777


Q ss_pred             ccEEEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCc
Q 017594          119 EKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMA  198 (369)
Q Consensus       119 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~  198 (369)
                      ..++||||+++++|.+++.           ....++.+++.+|.+||+.+   ++||||||.||++ .++.++|+|||++
T Consensus       410 ~~~lv~E~~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~liDFGla  474 (535)
T PRK09605        410 EKTIVMEYIGGKDLKDVLE-----------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYLIDFGLG  474 (535)
T ss_pred             CCEEEEEecCCCcHHHHHH-----------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEEEeCccc
Confidence            8899999999999988773           34678999999999999999   9999999999999 6789999999987


Q ss_pred             ee
Q 017594          199 RI  200 (369)
Q Consensus       199 ~~  200 (369)
                      ..
T Consensus       475 ~~  476 (535)
T PRK09605        475 KY  476 (535)
T ss_pred             cc
Confidence            64

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.63  E-value=5.3e-17  Score=159.38  Aligned_cols=257  Identities=19%  Similarity=0.260  Sum_probs=191.7

Q ss_pred             hcCCccCccccccCCccEEEEEEcC--CCEEEEEEecCCC--chhHHHHHHHHHHHhcCC-CCceeeeeeeEEeCCccEE
Q 017594           48 TNKFSDANKLGEGGFGPVYKGVLKK--GDEIAVKRLSGRS--GQGLREMKNEASVIAKVQ-HKNLVRLLGCCIDRDEKIL  122 (369)
Q Consensus        48 ~~~y~i~~~lg~G~~~~v~~~~~~~--~~~valK~~~~~~--~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~l  122 (369)
                      ...|.+.+.||+|+++.+-.+....  ...++.|.+....  .........|..+-..+. |.|++.+++...+.+..++
T Consensus        19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~   98 (601)
T KOG0590|consen   19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL   98 (601)
T ss_pred             cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence            5678999999999999999888543  4456666665432  222334445666666676 9999999999999999999


Q ss_pred             EEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHh-cCCCCCcccCCCCCCCEEEeCCC-ceEEeecCCcee
Q 017594          123 IYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLH-QYSRVRIIHRDLKASNILLDKDM-NPKISDFGMARI  200 (369)
Q Consensus       123 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH-~~~~~~i~H~dl~p~NIlv~~~~-~~~L~Dfg~~~~  200 (369)
                      ++++..++.+...+.. ......+.......+.|+..++.|+| ..+   +.|+|++|+|.+++..+ .+++.|||++..
T Consensus        99 ~~~~s~g~~~f~~i~~-~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~~At~  174 (601)
T KOG0590|consen   99 SLSYSDGGSLFSKISH-PDSTGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFGLATA  174 (601)
T ss_pred             ccCccccccccccccc-CCccCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCchhhcc
Confidence            9999999998777731 12223566677889999999999999 888   99999999999999999 999999999998


Q ss_pred             cCC-CCcccccccccc-cccccCchhhccC-CCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCccc
Q 017594          201 CGG-NELQANTSRIVG-TYGYMSPEYALEG-IFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTL  277 (369)
Q Consensus       201 ~~~-~~~~~~~~~~~~-~~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  277 (369)
                      +.. +..........| ++.|.|||...+. ...+..|+||+|+++..+++|..|+............+.     .....
T Consensus       175 ~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~-----~~~~~  249 (601)
T KOG0590|consen  175 YRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWK-----SNKGR  249 (601)
T ss_pred             ccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeec-----ccccc
Confidence            876 454555555677 9999999998875 446789999999999999999999876553332111111     01000


Q ss_pred             cccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 017594          278 ELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVS  320 (369)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~  320 (369)
                             ..............+++.+++..+|+.|.+.+++-.
T Consensus       250 -------~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~  285 (601)
T KOG0590|consen  250 -------FTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKL  285 (601)
T ss_pred             -------cccCccccCChhhhhcccccccCCchhccccccccc
Confidence                   000111112455788999999999999999988753

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.63  E-value=3.5e-15  Score=126.52  Aligned_cols=138  Identities=18%  Similarity=0.234  Sum_probs=96.9

Q ss_pred             cCccccccCCccEEEEEEcCCCEEEEEEecCCCch--hHHH----------------------HHHHHHHHhcCCCCc--
Q 017594           53 DANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQ--GLRE----------------------MKNEASVIAKVQHKN--  106 (369)
Q Consensus        53 i~~~lg~G~~~~v~~~~~~~~~~valK~~~~~~~~--~~~~----------------------~~~e~~~l~~l~h~~--  106 (369)
                      +.+.||+|++|.||+|...+|+.||+|++......  ....                      ...|...+..+.+..  
T Consensus         1 ~~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~   80 (187)
T cd05119           1 VGGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP   80 (187)
T ss_pred             CCcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence            35789999999999999878999999988643211  0011                      124555555553332  


Q ss_pred             eeeeeeeEEeCCccEEEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhc-CCCCCcccCCCCCCCEEEe
Q 017594          107 LVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQ-YSRVRIIHRDLKASNILLD  185 (369)
Q Consensus       107 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~-~~~~~i~H~dl~p~NIlv~  185 (369)
                      +.+++..    ...+++|||+.++.+.........   .. .....++.+++.++.++|. .+   ++|+||+|+||+++
T Consensus        81 ~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~---~~-~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Nili~  149 (187)
T cd05119          81 VPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR---LL-EDPEELYDQILELMRKLYREAG---LVHGDLSEYNILVD  149 (187)
T ss_pred             CCceEec----CCCEEEEEEeCCCCccChhhhhhh---hc-ccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhEEEE
Confidence            3333332    346999999998543211111000   11 5677899999999999999 88   99999999999999


Q ss_pred             CCCceEEeecCCceecC
Q 017594          186 KDMNPKISDFGMARICG  202 (369)
Q Consensus       186 ~~~~~~L~Dfg~~~~~~  202 (369)
                       ++.++|+|||.+....
T Consensus       150 -~~~~~liDfg~a~~~~  165 (187)
T cd05119         150 -DGKVYIIDVPQAVEID  165 (187)
T ss_pred             -CCcEEEEECccccccc
Confidence             8999999999986543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.62  E-value=7.5e-15  Score=119.46  Aligned_cols=135  Identities=22%  Similarity=0.238  Sum_probs=111.3

Q ss_pred             cCccccccCCccEEEEEEcCCCEEEEEEecCCCchhHHHHHHHHHHHhcCCC--CceeeeeeeEEeCCccEEEEEecCCC
Q 017594           53 DANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQH--KNLVRLLGCCIDRDEKILIYEYMPNK  130 (369)
Q Consensus        53 i~~~lg~G~~~~v~~~~~~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h--~~i~~~~~~~~~~~~~~lv~e~~~~~  130 (369)
                      +++.||.|.++.||++...+ ..+++|.......  ...+..|+..+..+++  .++++++.+....+..++++||+.+.
T Consensus         2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~   78 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE   78 (155)
T ss_pred             cceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence            56789999999999999864 7889998865433  4577889999999976  58888888887777899999999887


Q ss_pred             ChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCcee
Q 017594          131 SLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARI  200 (369)
Q Consensus       131 ~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~  200 (369)
                      .+..+          +......++.+++.+++.+|.....+++|+|++|.||+++..+.++++|||.+..
T Consensus        79 ~~~~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          79 TLDEV----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             ecccC----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence            66433          4456677889999999999986434499999999999999989999999998753

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.57  E-value=4.3e-14  Score=124.18  Aligned_cols=135  Identities=22%  Similarity=0.256  Sum_probs=101.7

Q ss_pred             Ccccc-ccCCccEEEEEEcCCCEEEEEEecCCC-------------chhHHHHHHHHHHHhcCCCCce--eeeeeeEEeC
Q 017594           54 ANKLG-EGGFGPVYKGVLKKGDEIAVKRLSGRS-------------GQGLREMKNEASVIAKVQHKNL--VRLLGCCIDR  117 (369)
Q Consensus        54 ~~~lg-~G~~~~v~~~~~~~~~~valK~~~~~~-------------~~~~~~~~~e~~~l~~l~h~~i--~~~~~~~~~~  117 (369)
                      ...|| .|+.|+||.+... +..+++|.+....             ......+.+|+.++..+.|+++  +..+++....
T Consensus        36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~  114 (239)
T PRK01723         36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR  114 (239)
T ss_pred             CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence            34577 8899999999876 6788999875311             1223457789999999988774  6666654433


Q ss_pred             Cc----cEEEEEecCC-CChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEE
Q 017594          118 DE----KILIYEYMPN-KSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKI  192 (369)
Q Consensus       118 ~~----~~lv~e~~~~-~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L  192 (369)
                      ..    .++|+|++++ .+|.+++..    ..++..    .+.+|+.++.+||..|   ++|+||+|.||+++.++.++|
T Consensus       115 ~~~~~~~~lV~e~l~G~~~L~~~l~~----~~l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v~L  183 (239)
T PRK01723        115 HGLFYRADILIERIEGARDLVALLQE----APLSEE----QWQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKFWL  183 (239)
T ss_pred             cCcceeeeEEEEecCCCCCHHHHHhc----CCCCHH----HHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCEEE
Confidence            22    2599999997 688777643    123433    3678999999999999   999999999999999999999


Q ss_pred             eecCCcee
Q 017594          193 SDFGMARI  200 (369)
Q Consensus       193 ~Dfg~~~~  200 (369)
                      +|||.+..
T Consensus       184 IDfg~~~~  191 (239)
T PRK01723        184 IDFDRGEL  191 (239)
T ss_pred             EECCCccc
Confidence            99998764

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.52  E-value=1.7e-14  Score=126.23  Aligned_cols=207  Identities=21%  Similarity=0.215  Sum_probs=141.9

Q ss_pred             HHHHHhcCCCCceeeeeeeEEeCC-----ccEEEEEecCCCChhhhhcCCC-ccccCChHHHHHHHHHHHHHHHHHhcCC
Q 017594           95 EASVIAKVQHKNLVRLLGCCIDRD-----EKILIYEYMPNKSLDFFLFDPT-KRMLLDWVTRVQIIEGIAQGLLYLHQYS  168 (369)
Q Consensus        95 e~~~l~~l~h~~i~~~~~~~~~~~-----~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~al~~LH~~~  168 (369)
                      -+.-|.++-|.|++++..++.+.+     ...++.||+..+++..+++... ....+......+|+-||+.||.|||+. 
T Consensus       117 vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~-  195 (458)
T KOG1266|consen  117 VFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC-  195 (458)
T ss_pred             HHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc-
Confidence            344566677999999999987543     3589999999999999986522 245577788889999999999999998 


Q ss_pred             CCCcccCCCCCCCEEEeCCCceEEeecC--CceecCCCCcccccccccccccccCchhhccCCCCcccchHhHHHHHHHH
Q 017594          169 RVRIIHRDLKASNILLDKDMNPKISDFG--MARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEI  246 (369)
Q Consensus       169 ~~~i~H~dl~p~NIlv~~~~~~~L~Dfg--~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l  246 (369)
                      .++++|+++..+.|++..+|-++++--.  ..+..-............+.++|.+||.-.....+.++|||++|+...+|
T Consensus       196 ~PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlem  275 (458)
T KOG1266|consen  196 DPPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEM  275 (458)
T ss_pred             CCccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHH
Confidence            4679999999999999998888876321  11111111111122334678899999976666678899999999999999


Q ss_pred             HhCCCCCCCCcccccccchhhhhhhhcCccccccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 017594          247 VSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSM  321 (369)
Q Consensus       247 ~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~  321 (369)
                      .-+..--....    .      ...    ..+.+.....+..     ...-..+|.+|++..|..||++++++..
T Consensus       276 ailEiq~tnse----S------~~~----~ee~ia~~i~~le-----n~lqr~~i~kcl~~eP~~rp~ar~llfH  331 (458)
T KOG1266|consen  276 AILEIQSTNSE----S------KVE----VEENIANVIIGLE-----NGLQRGSITKCLEGEPNGRPDARLLLFH  331 (458)
T ss_pred             HHheeccCCCc----c------eee----hhhhhhhheeecc-----CccccCcCcccccCCCCCCcchhhhhcC
Confidence            88764211110    0      000    0011111110000     1113468999999999999999988753

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.51  E-value=5.4e-13  Score=127.30  Aligned_cols=167  Identities=15%  Similarity=0.210  Sum_probs=129.5

Q ss_pred             EcCCCEEEEEEecCCCchhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEEEEecCCCChhhhhcCCCccccCChHH
Q 017594           70 LKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVT  149 (369)
Q Consensus        70 ~~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~  149 (369)
                      ..++.+|.++.....+........+-++.|+.++||+|+++++.++.+.+.|+|+|-+.  .|..++.+      +....
T Consensus        34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~------l~~~~  105 (690)
T KOG1243|consen   34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE------LGKEE  105 (690)
T ss_pred             eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH------hHHHH
Confidence            34588899998887666555667888899999999999999999999999999999874  45555533      33667


Q ss_pred             HHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCCCCcccccccccccccccCchhhccCC
Q 017594          150 RVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGI  229 (369)
Q Consensus       150 ~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~  229 (369)
                      +...+.||+.||.+||..+  +++|+||+...|+|+..|..+|++|..+........  ..........|..|+.+....
T Consensus       106 v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~~s~  181 (690)
T KOG1243|consen  106 VCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEIDPSE  181 (690)
T ss_pred             HHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhcCccc
Confidence            7888999999999998655  599999999999999999999999998765443221  112222344567777554333


Q ss_pred             CCcccchHhHHHHHHHHHhCC
Q 017594          230 FSIKSDVFSFGVLLLEIVSGK  250 (369)
Q Consensus       230 ~~~~~DiwslG~il~~l~tg~  250 (369)
                        -..|.|.|||++++++.|.
T Consensus       182 --~s~D~~~Lg~li~el~ng~  200 (690)
T KOG1243|consen  182 --WSIDSWGLGCLIEELFNGS  200 (690)
T ss_pred             --cchhhhhHHHHHHHHhCcc
Confidence              3469999999999999993

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.46  E-value=5.2e-13  Score=127.30  Aligned_cols=141  Identities=22%  Similarity=0.258  Sum_probs=96.9

Q ss_pred             CccccccCCccEEEEEEcCCCEEEEEEecCCCchhHH----------------------------------------HHH
Q 017594           54 ANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLR----------------------------------------EMK   93 (369)
Q Consensus        54 ~~~lg~G~~~~v~~~~~~~~~~valK~~~~~~~~~~~----------------------------------------~~~   93 (369)
                      .+.||.|++|.||+|+.++|+.||||+....-.....                                        .+.
T Consensus       122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~  201 (437)
T TIGR01982       122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR  201 (437)
T ss_pred             CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence            4679999999999999999999999998643211000                                        122


Q ss_pred             HHHHHHhcC----CCCceeeeeeeE-EeCCccEEEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHH-HHHHHhcC
Q 017594           94 NEASVIAKV----QHKNLVRLLGCC-IDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQ-GLLYLHQY  167 (369)
Q Consensus        94 ~e~~~l~~l----~h~~i~~~~~~~-~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~-al~~LH~~  167 (369)
                      .|+..+.++    ++.+-+.+-.++ ...+..++||||++|.++.++.......  .   ....++..++. .+..+|..
T Consensus       202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~--~---~~~~ia~~~~~~~l~ql~~~  276 (437)
T TIGR01982       202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAG--L---DRKALAENLARSFLNQVLRD  276 (437)
T ss_pred             HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcC--C---CHHHHHHHHHHHHHHHHHhC
Confidence            344444443    222222222222 2345679999999999998775321111  1   23345556655 46788988


Q ss_pred             CCCCcccCCCCCCCEEEeCCCceEEeecCCceecC
Q 017594          168 SRVRIIHRDLKASNILLDKDMNPKISDFGMARICG  202 (369)
Q Consensus       168 ~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~  202 (369)
                      |   ++|+|++|.||+++.++.++++|||++..+.
T Consensus       277 g---~~H~D~hPgNilv~~~g~i~liDfG~~~~l~  308 (437)
T TIGR01982       277 G---FFHADLHPGNIFVLKDGKIIALDFGIVGRLS  308 (437)
T ss_pred             C---ceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence            8   9999999999999999999999999987654

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.43  E-value=2.6e-13  Score=128.06  Aligned_cols=253  Identities=22%  Similarity=0.242  Sum_probs=182.3

Q ss_pred             HHHhcCCccCccccc--cCCccEEEEEE--c-CCCEEEEEEecCCC--chhHHHHHHHHHHHhcC-CCCceeeeeeeEEe
Q 017594           45 STATNKFSDANKLGE--GGFGPVYKGVL--K-KGDEIAVKRLSGRS--GQGLREMKNEASVIAKV-QHKNLVRLLGCCID  116 (369)
Q Consensus        45 ~~~~~~y~i~~~lg~--G~~~~v~~~~~--~-~~~~valK~~~~~~--~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~  116 (369)
                      ......+.+...+|.  |.+|.+|.+..  . ++..+++|.-....  ...-..-.+|+...+.+ .|++.++....+..
T Consensus       110 s~~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~  189 (524)
T KOG0601|consen  110 SFFDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEG  189 (524)
T ss_pred             chhhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCccccc
Confidence            345567888999999  99999999985  3 47788888743222  12222223455555555 48899998888888


Q ss_pred             CCccEEEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHH----HHHHHhcCCCCCcccCCCCCCCEEEeCC-CceE
Q 017594          117 RDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQ----GLLYLHQYSRVRIIHRDLKASNILLDKD-MNPK  191 (369)
Q Consensus       117 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~----al~~LH~~~~~~i~H~dl~p~NIlv~~~-~~~~  191 (369)
                      .+..++-+|.+. .++..+..  .....++...+|..+.+...    |+.++|..+   ++|-|++|.||+...+ ...+
T Consensus       190 ~~~lfiqtE~~~-~sl~~~~~--~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s~~  263 (524)
T KOG0601|consen  190 SGILFIQTELCG-ESLQSYCH--TPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTSCK  263 (524)
T ss_pred             CCcceeeecccc-chhHHhhh--cccccCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccceee
Confidence            899999999986 55555543  34455788899999999999    999999999   9999999999999999 8899


Q ss_pred             EeecCCceecCCCCcccccc---cccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhh
Q 017594          192 ISDFGMARICGGNELQANTS---RIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAW  268 (369)
Q Consensus       192 L~Dfg~~~~~~~~~~~~~~~---~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~  268 (369)
                      ++|||+...+..........   ...+...|++||.. ++-++.+.|+|+||.++.+-.++.+.........       |
T Consensus       264 ~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~-~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~-------W  335 (524)
T KOG0601|consen  264 LTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELL-NGLATFASDIFSLGEVILEAILGSHLPSVGKNSS-------W  335 (524)
T ss_pred             cCCcceeEEccCCccccceeeeecCCCCceEeChhhh-ccccchHhhhcchhhhhHhhHhhcccccCCCCCC-------c
Confidence            99999998887655333222   23678889999955 5667889999999999999998876543322111       1


Q ss_pred             hhhhcCccccccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 017594          269 DLWTSNRTLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVS  320 (369)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~  320 (369)
                      .......   ..+....+      .+.++...+..|++.+|-.|++++.+..
T Consensus       336 ~~~r~~~---ip~e~~~~------~s~~l~~~~~~~~d~~~~~~~~~q~~~~  378 (524)
T KOG0601|consen  336 SQLRQGY---IPLEFCEG------GSSSLRSVTSQMLDEDPRLRLTAQILTA  378 (524)
T ss_pred             ccccccc---CchhhhcC------cchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence            1111111   11111111      1455666999999999999999987764

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.40  E-value=2.4e-12  Score=107.23  Aligned_cols=130  Identities=23%  Similarity=0.207  Sum_probs=95.6

Q ss_pred             CccccccCCccEEEEEEcCCCEEEEEEecCCCchhHHHHHHHHHHHhcCCCCce-eeeeeeEEeCCccEEEEEecCCCCh
Q 017594           54 ANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNL-VRLLGCCIDRDEKILIYEYMPNKSL  132 (369)
Q Consensus        54 ~~~lg~G~~~~v~~~~~~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~lv~e~~~~~~L  132 (369)
                      ++.|+.|.++.||.+... +..|++|....... ....+..|+..++.+.+.++ .+++..  .....++|||+++|.++
T Consensus         3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~--~~~~~~lv~e~i~G~~l   78 (170)
T cd05151           3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYF--DPETGVLITEFIEGSEL   78 (170)
T ss_pred             eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEE--eCCCCeEEEEecCCCcc
Confidence            457889999999999876 77899998764432 12345778888888865443 344433  33456899999999877


Q ss_pred             hhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCC--CCCcccCCCCCCCEEEeCCCceEEeecCCce
Q 017594          133 DFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYS--RVRIIHRDLKASNILLDKDMNPKISDFGMAR  199 (369)
Q Consensus       133 ~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~--~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~  199 (369)
                      ....        .   ....++.+++.+++.||..+  ...++|||++|.||+++ ++.++++||+.+.
T Consensus        79 ~~~~--------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~  135 (170)
T cd05151          79 LTED--------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG  135 (170)
T ss_pred             cccc--------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence            5320        1   11345678999999999987  12249999999999999 6789999999865

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.37  E-value=1.8e-11  Score=103.08  Aligned_cols=138  Identities=13%  Similarity=0.077  Sum_probs=98.7

Q ss_pred             cCccccccCCccEEEEEEcC-------CCEEEEEEecCCC----------------------chhHHHH----HHHHHHH
Q 017594           53 DANKLGEGGFGPVYKGVLKK-------GDEIAVKRLSGRS----------------------GQGLREM----KNEASVI   99 (369)
Q Consensus        53 i~~~lg~G~~~~v~~~~~~~-------~~~valK~~~~~~----------------------~~~~~~~----~~e~~~l   99 (369)
                      +...||.|.-+.||.|...+       +..+|+|++....                      ......+    ..|+..|
T Consensus         1 ~~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L   80 (197)
T cd05146           1 INGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNL   80 (197)
T ss_pred             CCCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHH
Confidence            35679999999999998543       4789999873210                      0112222    3788899


Q ss_pred             hcCCC--CceeeeeeeEEeCCccEEEEEecCCCChhh-hhcCCCccccCChHHHHHHHHHHHHHHHHH-hcCCCCCcccC
Q 017594          100 AKVQH--KNLVRLLGCCIDRDEKILIYEYMPNKSLDF-FLFDPTKRMLLDWVTRVQIIEGIAQGLLYL-HQYSRVRIIHR  175 (369)
Q Consensus       100 ~~l~h--~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~-~l~~~~~~~~~~~~~~~~i~~qi~~al~~L-H~~~~~~i~H~  175 (369)
                      .++..  -+++.++.+    ...++||||+.+..+.. .+.    ...++......+..+++.++..| |..|   ++||
T Consensus        81 ~rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lk----d~~~~~~~~~~i~~~i~~~l~~l~H~~g---lVHG  149 (197)
T cd05146          81 KRMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLK----DAKLNDEEMKNAYYQVLSMMKQLYKECN---LVHA  149 (197)
T ss_pred             HHHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhh----ccccCHHHHHHHHHHHHHHHHHHHHhCC---eecC
Confidence            88853  355556643    57899999998753321 121    12244455667889999999988 8888   9999


Q ss_pred             CCCCCCEEEeCCCceEEeecCCceecC
Q 017594          176 DLKASNILLDKDMNPKISDFGMARICG  202 (369)
Q Consensus       176 dl~p~NIlv~~~~~~~L~Dfg~~~~~~  202 (369)
                      ||++.||++. ++.+.|+|||.+....
T Consensus       150 DLs~~NIL~~-~~~v~iIDF~qav~~~  175 (197)
T cd05146         150 DLSEYNMLWH-DGKVWFIDVSQSVEPT  175 (197)
T ss_pred             CCCHHHEEEE-CCcEEEEECCCceeCC
Confidence            9999999997 4689999999887543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.32  E-value=9.8e-12  Score=120.17  Aligned_cols=146  Identities=17%  Similarity=0.162  Sum_probs=94.6

Q ss_pred             HHhcCCccCccccccCCccEEEEEEcC-CCEEEEEEecCCCchh----------------------------------HH
Q 017594           46 TATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQG----------------------------------LR   90 (369)
Q Consensus        46 ~~~~~y~i~~~lg~G~~~~v~~~~~~~-~~~valK~~~~~~~~~----------------------------------~~   90 (369)
                      .....|.. +.||+|++|.||.|+.++ |+.||||+....-...                                  .+
T Consensus       117 ~~F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~  195 (537)
T PRK04750        117 EWFDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEK  195 (537)
T ss_pred             HHHHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHH
Confidence            33455776 899999999999999887 9999999986432100                                  11


Q ss_pred             H------HHHHHHHHhcC----CCCceeeeeeeEE-eCCccEEEEEecCCCChhhhhc--CCC-ccccCChHHHHHHHHH
Q 017594           91 E------MKNEASVIAKV----QHKNLVRLLGCCI-DRDEKILIYEYMPNKSLDFFLF--DPT-KRMLLDWVTRVQIIEG  156 (369)
Q Consensus        91 ~------~~~e~~~l~~l----~h~~i~~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~--~~~-~~~~~~~~~~~~i~~q  156 (369)
                      .      +..|+..+.++    .+...+.+-.++. .....++||||++|+.+.++..  ... ....+....+..++.|
T Consensus       196 ~l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Q  275 (537)
T PRK04750        196 TLHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQ  275 (537)
T ss_pred             HHHHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHH
Confidence            1      22333333333    2333333333333 2567899999999999976431  111 1112223333333333


Q ss_pred             HHHHHHHHhcCCCCCcccCCCCCCCEEEeCCC----ceEEeecCCceecC
Q 017594          157 IAQGLLYLHQYSRVRIIHRDLKASNILLDKDM----NPKISDFGMARICG  202 (369)
Q Consensus       157 i~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~----~~~L~Dfg~~~~~~  202 (369)
                             +...|   ++|+|++|.||+++.+|    +++++|||+...+.
T Consensus       276 -------if~~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~  315 (537)
T PRK04750        276 -------VFRDG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN  315 (537)
T ss_pred             -------HHhCC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence                   34567   99999999999999888    99999999988764

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=99.31  E-value=4.1e-10  Score=102.40  Aligned_cols=276  Identities=15%  Similarity=0.113  Sum_probs=170.9

Q ss_pred             ccCccccccCCccEEEEEEcCCCEEEEEEecCCCchhHHHHHHHHHHHhcC-CCCcee----eeeeeEE--eCCc-cEEE
Q 017594           52 SDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKV-QHKNLV----RLLGCCI--DRDE-KILI  123 (369)
Q Consensus        52 ~i~~~lg~G~~~~v~~~~~~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~----~~~~~~~--~~~~-~~lv  123 (369)
                      ...+.||+|+.+.+|..-.-  ...+.|++......   ...+....|... .||-+-    .......  +++. ..++
T Consensus        14 ~~gr~LgqGgea~ly~l~e~--~d~VAKIYh~Pppa---~~aqk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGfl   88 (637)
T COG4248          14 PPGRPLGQGGEADLYTLGEV--RDQVAKIYHAPPPA---AQAQKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFL   88 (637)
T ss_pred             CCCccccCCccceeeecchh--hchhheeecCCCch---HHHHHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEe
Confidence            35678999999999965422  23467888765432   222233344444 455322    2221111  2222 5788


Q ss_pred             EEecCCCCh-hhhhcC---CCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCce
Q 017594          124 YEYMPNKSL-DFFLFD---PTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMAR  199 (369)
Q Consensus       124 ~e~~~~~~L-~~~l~~---~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~  199 (369)
                      |+.+.+.-- ..++.-   ...-...++....+.++.|+.+.+.||..|   .+-||++++|++|++++.|.|.|=....
T Consensus        89 mP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVdsDsfq  165 (637)
T COG4248          89 MPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVDSDSFQ  165 (637)
T ss_pred             cccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEccccee
Confidence            887766532 222221   122344677888999999999999999999   9999999999999999999999866544


Q ss_pred             ecCCCCcccccccccccccccCchhhc-----cCCCCcccchHhHHHHHHHHHhC-CCCCCCCcc--cccccc--hhhhh
Q 017594          200 ICGGNELQANTSRIVGTYGYMSPEYAL-----EGIFSIKSDVFSFGVLLLEIVSG-KKNTGLYRT--DSLNLL--GYAWD  269 (369)
Q Consensus       200 ~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DiwslG~il~~l~tg-~~p~~~~~~--~~~~~~--~~~~~  269 (369)
                      ...+.   .......|.++|.+||...     +..-+...|.|.||+++++|+.| ++||..-..  +.....  .+...
T Consensus       166 i~~ng---~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g  242 (637)
T COG4248         166 INANG---TLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHG  242 (637)
T ss_pred             eccCC---ceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcc
Confidence            43222   2233456889999999765     33456789999999999999986 899864321  111100  11111


Q ss_pred             hhhcCccccccCccccccccHHHHHHHHHHHHHHhhcCC--CCCCCCHHHHHHHHHhhhhccCCCCCCCcc
Q 017594          270 LWTSNRTLELIDPILEDEYSSKQMLLRYANIALLCVQES--ADDRPTMNDVVSMLTNEAATLLPPKQPAFS  338 (369)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~d--P~~Rps~~ell~~L~~~~~~~~~~~~~~~~  338 (369)
                      .+........-...-.........+++++-+..+|+..-  +.-|||++-.+..|..+.+++..=...+.+
T Consensus       243 ~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L~~C~v~a~H  313 (637)
T COG4248         243 RFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQLKKCTVSAMH  313 (637)
T ss_pred             eeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhhhhhhhcccc
Confidence            111111111111111223333344678899999998754  568999999998888887776544444433

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=99.27  E-value=2e-10  Score=106.89  Aligned_cols=217  Identities=18%  Similarity=0.267  Sum_probs=150.4

Q ss_pred             CCccEEEEEE-cCCCEEEEEEecCCCchhHHHHHHHHHHHhcCCCCceeeeeeeEE----eCCccEEEEEecCCC-Chhh
Q 017594           61 GFGPVYKGVL-KKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCI----DRDEKILIYEYMPNK-SLDF  134 (369)
Q Consensus        61 ~~~~v~~~~~-~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~----~~~~~~lv~e~~~~~-~L~~  134 (369)
                      ...+.|++.. .+|..|++|+++............-+++++++.|+|++++.++|.    .+..+++|++|+++. +|.+
T Consensus       288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d  367 (655)
T KOG3741|consen  288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYD  367 (655)
T ss_pred             ccceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHH
Confidence            4467888884 469999999996555444445566788999999999999999886    345679999998765 4544


Q ss_pred             hhcCC------------CccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecC
Q 017594          135 FLFDP------------TKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICG  202 (369)
Q Consensus       135 ~l~~~------------~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~  202 (369)
                      +....            ..+...++..+|.++.|++.||.++|+.|   +.-.-|.+.+|+++++-+++|..+|+.....
T Consensus       368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~  444 (655)
T KOG3741|consen  368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQ  444 (655)
T ss_pred             HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeec
Confidence            43221            12234677899999999999999999999   8889999999999999999999888765543


Q ss_pred             CCCcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCccccccCc
Q 017594          203 GNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDP  282 (369)
Q Consensus       203 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (369)
                      ...              .+|  +.+   -.+-|.=.||.++..|.||...--..                 ....+.   
T Consensus       445 ~d~--------------~~~--le~---~Qq~D~~~lG~ll~aLAt~~~ns~~~-----------------d~~~~s---  485 (655)
T KOG3741|consen  445 EDP--------------TEP--LES---QQQNDLRDLGLLLLALATGTENSNRT-----------------DSTQSS---  485 (655)
T ss_pred             CCC--------------Ccc--hhH---HhhhhHHHHHHHHHHHhhcccccccc-----------------cchHHH---
Confidence            322              111  111   23458889999999999996421000                 000000   


Q ss_pred             cccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHH
Q 017594          283 ILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSML  322 (369)
Q Consensus       283 ~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L  322 (369)
                        .-......++.++.++|......++++ -++.+++..+
T Consensus       486 --~~~~I~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~~  522 (655)
T KOG3741|consen  486 --HLTRITTTYSTDLRNVVEYLESLNFRE-KSIQDLLPMI  522 (655)
T ss_pred             --HHHHhhhhhhHHHHHHHHHHHhcCccc-ccHHHHHHHH
Confidence              000112233667788888888877776 6677666443

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.27  E-value=7.2e-11  Score=96.35  Aligned_cols=130  Identities=22%  Similarity=0.326  Sum_probs=101.0

Q ss_pred             ccccccCCccEEEEEEcCCCEEEEEEecCCC---ch-----hHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEEEEe
Q 017594           55 NKLGEGGFGPVYKGVLKKGDEIAVKRLSGRS---GQ-----GLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIYEY  126 (369)
Q Consensus        55 ~~lg~G~~~~v~~~~~~~~~~valK~~~~~~---~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  126 (369)
                      ..+++|+-+.++.+.+. |..+++|.-....   +.     ....-..|+.++.+++--.+.-..-+..+.....++|||
T Consensus         2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~   80 (204)
T COG3642           2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY   80 (204)
T ss_pred             chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence            46789999999999775 4457777543321   11     123345689999998766666666666778889999999


Q ss_pred             cCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCce
Q 017594          127 MPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMAR  199 (369)
Q Consensus       127 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~  199 (369)
                      ++|..|.+.+...          ...++..+-..+.-||..|   ++||||.++||+++.++ +.++|||++.
T Consensus        81 I~G~~lkd~l~~~----------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~  139 (204)
T COG3642          81 IEGELLKDALEEA----------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGE  139 (204)
T ss_pred             eCChhHHHHHHhc----------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCccc
Confidence            9999998888543          2457778888899999999   99999999999998875 9999999975

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.25  E-value=7.9e-11  Score=95.73  Aligned_cols=143  Identities=23%  Similarity=0.317  Sum_probs=108.3

Q ss_pred             cCccccccCCccEEEEEEcCCCEEEEEEecCCC-c-------hhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEEE
Q 017594           53 DANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRS-G-------QGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIY  124 (369)
Q Consensus        53 i~~~lg~G~~~~v~~~~~~~~~~valK~~~~~~-~-------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  124 (369)
                      .+..+-+|+-+.|+.+.+. |+.++||.-.... .       -...+..+|+..|.++.--.|.-..-++.+.....++|
T Consensus        11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M   89 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM   89 (229)
T ss_pred             cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence            5678889999999999887 7777777533221 1       12345667999999987667777777788888899999


Q ss_pred             EecCC-CChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCc---eEEeecCCcee
Q 017594          125 EYMPN-KSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMN---PKISDFGMARI  200 (369)
Q Consensus       125 e~~~~-~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~---~~L~Dfg~~~~  200 (369)
                      ||++| .++.++++....... .......++.+|-..+.-||..+   ++||||..+||++..++.   +.++|||++..
T Consensus        90 E~~~g~~~vk~~i~~~~~~~~-~d~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lIdfgls~~  165 (229)
T KOG3087|consen   90 EFIDGASTVKDFILSTMEDES-EDEGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILIDFGLSSV  165 (229)
T ss_pred             EeccchhHHHHHHHHHccCcc-cchhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEeecchhc
Confidence            99987 467777765444332 22333678899999999999999   999999999999966543   48999999754

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.18  E-value=3.2e-10  Score=98.53  Aligned_cols=142  Identities=18%  Similarity=0.252  Sum_probs=106.7

Q ss_pred             CccccccCCccEEEEEEcCCCEEEEEEecCCCc-hhHHHHHHHHHHHhcCCCC--ceeeeeeeEEeC---CccEEEEEec
Q 017594           54 ANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSG-QGLREMKNEASVIAKVQHK--NLVRLLGCCIDR---DEKILIYEYM  127 (369)
Q Consensus        54 ~~~lg~G~~~~v~~~~~~~~~~valK~~~~~~~-~~~~~~~~e~~~l~~l~h~--~i~~~~~~~~~~---~~~~lv~e~~  127 (369)
                      .+.|+.|..+.+|++...+|..+++|....... .....+..|++++..+.+.  .+.+++.+....   ...+++||++
T Consensus         3 ~~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i   82 (223)
T cd05154           3 VRQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERV   82 (223)
T ss_pred             ceecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEe
Confidence            357899999999999977678899998764332 1346788899999999753  456666665543   2568999999


Q ss_pred             CCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCC---------------------------------------
Q 017594          128 PNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYS---------------------------------------  168 (369)
Q Consensus       128 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---------------------------------------  168 (369)
                      +|.++...+..    ..++......++.+++.+|..||+..                                       
T Consensus        83 ~G~~l~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (223)
T cd05154          83 DGRVLRDRLLR----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAME  158 (223)
T ss_pred             CCEecCCCCCC----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHH
Confidence            99888665421    23566677778888888888888532                                       


Q ss_pred             --------------CCCcccCCCCCCCEEEeC--CCceEEeecCCce
Q 017594          169 --------------RVRIIHRDLKASNILLDK--DMNPKISDFGMAR  199 (369)
Q Consensus       169 --------------~~~i~H~dl~p~NIlv~~--~~~~~L~Dfg~~~  199 (369)
                                    ...++|||+.|.||+++.  ++.+.|+||+.+.
T Consensus       159 ~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~  205 (223)
T cd05154         159 RLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELAT  205 (223)
T ss_pred             HHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccc
Confidence                          135799999999999998  5668999998765

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.14  E-value=3.9e-11  Score=113.54  Aligned_cols=250  Identities=19%  Similarity=0.167  Sum_probs=173.1

Q ss_pred             HHHHhcCCccCccccccCCccEEEEEEc--CCCEEEEEEecCCCchhHHHH--HHHHHHHhcC-CCCceeeeeeeEEeCC
Q 017594           44 VSTATNKFSDANKLGEGGFGPVYKGVLK--KGDEIAVKRLSGRSGQGLREM--KNEASVIAKV-QHKNLVRLLGCCIDRD  118 (369)
Q Consensus        44 ~~~~~~~y~i~~~lg~G~~~~v~~~~~~--~~~~valK~~~~~~~~~~~~~--~~e~~~l~~l-~h~~i~~~~~~~~~~~  118 (369)
                      ......+|..+..||.|.|+.++.+..+  ++..|++|.+...-.....++  ..|+.+...+ .|.+++.....+..-.
T Consensus       260 ~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r  339 (524)
T KOG0601|consen  260 TSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLR  339 (524)
T ss_pred             ceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccc
Confidence            4445678899999999999999998844  477788887764433222222  2345555555 4788888888887777


Q ss_pred             ccEEEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCC-CceEEeecCC
Q 017594          119 EKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKD-MNPKISDFGM  197 (369)
Q Consensus       119 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~-~~~~L~Dfg~  197 (369)
                      +.++--|||++++.....   .-..-+++...+++..|++.++.++|+..   ++|+|++|.||++..+ +..+++|||.
T Consensus       340 ~~~ip~e~~~~~s~~l~~---~~~~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~~~~~~~~  413 (524)
T KOG0601|consen  340 QGYIPLEFCEGGSSSLRS---VTSQMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFSKLGDFGC  413 (524)
T ss_pred             cccCchhhhcCcchhhhh---HHHHhcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchhhhhcccccc
Confidence            888999999999876555   22333777888999999999999999998   9999999999999886 6778999988


Q ss_pred             ceecCCCCccccccccccccccc--CchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCc
Q 017594          198 ARICGGNELQANTSRIVGTYGYM--SPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNR  275 (369)
Q Consensus       198 ~~~~~~~~~~~~~~~~~~~~~y~--aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  275 (369)
                      ...+...     ........++.  ++.......+..++|++|||..+.+..++...-..              ......
T Consensus       414 ~t~~~~~-----~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~--------------~~~~~~  474 (524)
T KOG0601|consen  414 WTRLAFS-----SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSES--------------GVQSLT  474 (524)
T ss_pred             cccccee-----cccccccccccccchhhccccccccccccccccccccccccCcccCcc--------------ccccee
Confidence            7532111     11112233333  45555567788999999999999999998753110              000111


Q ss_pred             cccccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHh
Q 017594          276 TLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTN  324 (369)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L~~  324 (369)
                      ...-..+...      .....++.+.+.++..++..||.+.++....+-
T Consensus       475 i~~~~~p~~~------~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~  517 (524)
T KOG0601|consen  475 IRSGDTPNLP------GLKLQLQVLLKVMINPDRKRRPSAVELSLHSEF  517 (524)
T ss_pred             eecccccCCC------chHHhhhhhhhhhcCCccccchhhhhhcccchh
Confidence            1111111111      113568889999999999999999988765443

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=99.13  E-value=6.6e-10  Score=96.11  Aligned_cols=136  Identities=21%  Similarity=0.229  Sum_probs=103.1

Q ss_pred             CCccCccccccCCccEEEEEEcCCCEEEEEEecCCCc----------------------hhHHHHHHHHHHHhcCCCC--
Q 017594           50 KFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSG----------------------QGLREMKNEASVIAKVQHK--  105 (369)
Q Consensus        50 ~y~i~~~lg~G~~~~v~~~~~~~~~~valK~~~~~~~----------------------~~~~~~~~e~~~l~~l~h~--  105 (369)
                      =+.+...||-|.-|.||.|...+|.++++|.-....+                      -.....++|.++|..|...  
T Consensus        92 ve~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~  171 (304)
T COG0478          92 VEAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV  171 (304)
T ss_pred             HHhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence            3667889999999999999999999999997532110                      0123456799999999654  


Q ss_pred             ceeeeeeeEEeCCccEEEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEe
Q 017594          106 NLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLD  185 (369)
Q Consensus       106 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~  185 (369)
                      .+++.++.    +...+|||+++|..|...-        ++......++..|+.-+..+-..|   ++|||+++-||+|+
T Consensus       172 ~VP~P~~~----nRHaVvMe~ieG~eL~~~r--------~~~en~~~il~~il~~~~~~~~~G---iVHGDlSefNIlV~  236 (304)
T COG0478         172 KVPKPIAW----NRHAVVMEYIEGVELYRLR--------LDVENPDEILDKILEEVRKAYRRG---IVHGDLSEFNILVT  236 (304)
T ss_pred             CCCCcccc----ccceeeeehcccceeeccc--------CcccCHHHHHHHHHHHHHHHHHcC---ccccCCchheEEEe
Confidence            66666644    5678999999987663332        234455556777777777777777   99999999999999


Q ss_pred             CCCceEEeecCCcee
Q 017594          186 KDMNPKISDFGMARI  200 (369)
Q Consensus       186 ~~~~~~L~Dfg~~~~  200 (369)
                      .+|.+.++||-.+..
T Consensus       237 ~dg~~~vIDwPQ~v~  251 (304)
T COG0478         237 EDGDIVVIDWPQAVP  251 (304)
T ss_pred             cCCCEEEEeCccccc
Confidence            999999999976654

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.06  E-value=2.5e-09  Score=89.82  Aligned_cols=126  Identities=24%  Similarity=0.300  Sum_probs=83.1

Q ss_pred             cEEEEEEcCCCEEEEEEecCCCc--------------------------hhHHHHHHHHHHHhcCCCC--ceeeeeeeEE
Q 017594           64 PVYKGVLKKGDEIAVKRLSGRSG--------------------------QGLREMKNEASVIAKVQHK--NLVRLLGCCI  115 (369)
Q Consensus        64 ~v~~~~~~~~~~valK~~~~~~~--------------------------~~~~~~~~e~~~l~~l~h~--~i~~~~~~~~  115 (369)
                      .||.|...+|..+|+|+......                          ........|+..|..+..-  ++++++++  
T Consensus         1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~--   78 (188)
T PF01163_consen    1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY--   78 (188)
T ss_dssp             EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE--
T ss_pred             CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE--
Confidence            38999988899999998742210                          0122456799999999755  45666644  


Q ss_pred             eCCccEEEEEecC--CCChhhhhcCCCccccCChHHHHHHHHHHHHHHHH-HhcCCCCCcccCCCCCCCEEEeCCCceEE
Q 017594          116 DRDEKILIYEYMP--NKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLY-LHQYSRVRIIHRDLKASNILLDKDMNPKI  192 (369)
Q Consensus       116 ~~~~~~lv~e~~~--~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~-LH~~~~~~i~H~dl~p~NIlv~~~~~~~L  192 (369)
                        ...++||||++  |..+..+....     ++......++.+++..+.. +|..|   ++|||+++.||+++.+ .+.+
T Consensus        79 --~~~~ivME~I~~~G~~~~~l~~~~-----~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~~-~~~i  147 (188)
T PF01163_consen   79 --NRNVIVMEYIGEDGVPLPRLKDVD-----LSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDDG-KVYI  147 (188)
T ss_dssp             --ETTEEEEE--EETTEEGGCHHHCG-----GGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEETT-CEEE
T ss_pred             --eCCEEEEEecCCCccchhhHHhcc-----ccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeecc-eEEE
Confidence              35689999998  65554433211     1134556677888885554 67888   9999999999999988 9999


Q ss_pred             eecCCceecC
Q 017594          193 SDFGMARICG  202 (369)
Q Consensus       193 ~Dfg~~~~~~  202 (369)
                      +|||.+....
T Consensus       148 IDf~qav~~~  157 (188)
T PF01163_consen  148 IDFGQAVDSS  157 (188)
T ss_dssp             --GTTEEETT
T ss_pred             EecCcceecC
Confidence            9999876543

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=98.98  E-value=1.1e-08  Score=91.06  Aligned_cols=138  Identities=18%  Similarity=0.119  Sum_probs=95.2

Q ss_pred             ccccCCccEEEEEEcCCCEEEEEEecCCCch-----------hHHHHHHHHHHHhcCCCCc--eeeeeeeEEe-----CC
Q 017594           57 LGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQ-----------GLREMKNEASVIAKVQHKN--LVRLLGCCID-----RD  118 (369)
Q Consensus        57 lg~G~~~~v~~~~~~~~~~valK~~~~~~~~-----------~~~~~~~e~~~l~~l~h~~--i~~~~~~~~~-----~~  118 (369)
                      +.......|+.+.. +|+.|++|........           ....+..|+..+..|...+  .+.++.+...     ..
T Consensus        30 v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~  108 (268)
T PRK15123         30 FRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATR  108 (268)
T ss_pred             EecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccc
Confidence            33333344666655 4778999987543311           1113667888888874322  3334444432     23


Q ss_pred             ccEEEEEecCCC-ChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeC-------CCce
Q 017594          119 EKILIYEYMPNK-SLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDK-------DMNP  190 (369)
Q Consensus       119 ~~~lv~e~~~~~-~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~-------~~~~  190 (369)
                      ..++|+|++++. +|.+++.... ....+......++.+++..+..||..|   ++|+|+++.||+++.       ++.+
T Consensus       109 ~s~LVte~l~~~~sL~~~~~~~~-~~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~~~~~  184 (268)
T PRK15123        109 TSFIITEDLAPTISLEDYCADWA-TNPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREEDLKL  184 (268)
T ss_pred             eeEEEEeeCCCCccHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCCCceE
Confidence            468999999886 7888874322 123455677789999999999999999   999999999999975       4679


Q ss_pred             EEeecCCce
Q 017594          191 KISDFGMAR  199 (369)
Q Consensus       191 ~L~Dfg~~~  199 (369)
                      .|+||+.+.
T Consensus       185 ~LIDl~r~~  193 (268)
T PRK15123        185 SVIDLHRAQ  193 (268)
T ss_pred             EEEECCccc
Confidence            999999764

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=98.97  E-value=1.7e-10  Score=115.21  Aligned_cols=247  Identities=19%  Similarity=0.226  Sum_probs=168.5

Q ss_pred             HHhcCCccCccccccCCccEEEEEEc-CCCEEEEEEecCC---CchhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccE
Q 017594           46 TATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGR---SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKI  121 (369)
Q Consensus        46 ~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  121 (369)
                      .....+.+.+.+-+|.++.++.+.-. .|.-.+.|.....   ....++....+-..+-...+|.++.....+......+
T Consensus       801 sS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~  880 (1205)
T KOG0606|consen  801 SSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLP  880 (1205)
T ss_pred             CCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcc
Confidence            35567778888999999999988833 2533344433211   1111222222222233334566666555555667789


Q ss_pred             EEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceec
Q 017594          122 LIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARIC  201 (369)
Q Consensus       122 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~  201 (369)
                      ++++|++++.|...++...   ..+.+........+..++++||...   +.|+|++|.|.+...++...+.||+.....
T Consensus       881 L~~~~~~~~~~~Skl~~~~---~~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh~~l~~~~t~~~v  954 (1205)
T KOG0606|consen  881 LVGHYLNGGDLPSKLHNSG---CLSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGHRPLTDFGTLSKV  954 (1205)
T ss_pred             hhhHHhccCCchhhhhcCC---CcccccccchhHHHHhhhhccccch---hhcccccccchhhcccCCcccCcccccccc
Confidence            9999999998888876544   3566666667777889999999987   899999999999999999999999743322


Q ss_pred             CCC-------------------------Ccc----cccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCC
Q 017594          202 GGN-------------------------ELQ----ANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKN  252 (369)
Q Consensus       202 ~~~-------------------------~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p  252 (369)
                      ...                         ...    .......+++.|.+||...+......+|.|+.|+++++.++|.+|
T Consensus       955 g~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp 1034 (1205)
T KOG0606|consen  955 GLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPP 1034 (1205)
T ss_pred             ccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCC
Confidence            110                         000    001124578999999999999999999999999999999999999


Q ss_pred             CCCCcccccccchhhhhhhhcCccccccCccccccc----cHHHHHHHHHHHHHHhhcCCCCCCCCHH
Q 017594          253 TGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEY----SSKQMLLRYANIALLCVQESADDRPTMN  316 (369)
Q Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~l~~li~~~L~~dP~~Rps~~  316 (369)
                      |....                  ..+.++.++.+..    .+...+...++++...+..+|.+|..+.
T Consensus      1035 ~na~t------------------pq~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1035 FNAET------------------PQQIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred             CCCcc------------------hhhhhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence            86322                  1111122222211    1223366789999999999999998877

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.88  E-value=5.1e-10  Score=107.68  Aligned_cols=149  Identities=21%  Similarity=0.334  Sum_probs=101.5

Q ss_pred             HHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCCCCcccc-------cccccccccccCchhhccCC
Q 017594          157 IAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQAN-------TSRIVGTYGYMSPEYALEGI  229 (369)
Q Consensus       157 i~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~~~~~~~-------~~~~~~~~~y~aPE~~~~~~  229 (369)
                      .+.|+.++|...  +++|++|.|++|+++.++.+||+.|+++.....+.....       .........|.|||++.+..
T Consensus       108 v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~~  185 (700)
T KOG2137|consen  108 VADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGTT  185 (700)
T ss_pred             ccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcccc
Confidence            448999999865  799999999999999999999999998776544221111       11123456799999999888


Q ss_pred             CCcccchHhHHHHHHHHHhC-CCCCCCCcccccccchhhhhhhhcCccccccCccccccccHHHHHHHHHHHHHHhhcCC
Q 017594          230 FSIKSDVFSFGVLLLEIVSG-KKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYSSKQMLLRYANIALLCVQES  308 (369)
Q Consensus       230 ~~~~~DiwslG~il~~l~tg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~d  308 (369)
                      .+.++|+||+|+++|.+..| +..+........    +....       ...+ . .....+...+.++.+=+.+++..+
T Consensus       186 ~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~----~~~~~-------~~~~-~-~~~~~s~~~p~el~~~l~k~l~~~  252 (700)
T KOG2137|consen  186 NTPASDVFSLGVLIYTIYNGGKSIIAANGGLLS----YSFSR-------NLLN-A-GAFGYSNNLPSELRESLKKLLNGD  252 (700)
T ss_pred             ccccccceeeeeEEEEEecCCcchhhccCCcch----hhhhh-------cccc-c-ccccccccCcHHHHHHHHHHhcCC
Confidence            89999999999999999954 443322110000    00000       0000 0 000011233778999999999999


Q ss_pred             CCCCCCHHHHHH
Q 017594          309 ADDRPTMNDVVS  320 (369)
Q Consensus       309 P~~Rps~~ell~  320 (369)
                      +.-||++..+..
T Consensus       253 ~~~rp~~~~l~~  264 (700)
T KOG2137|consen  253 SAVRPTLDLLLS  264 (700)
T ss_pred             cccCcchhhhhc
Confidence            999998776654

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.80  E-value=4.7e-08  Score=94.24  Aligned_cols=140  Identities=19%  Similarity=0.221  Sum_probs=92.3

Q ss_pred             ccccccCCccEEEEEEcCCCEEEEEEecCCCchh------------------------------H----H------HHHH
Q 017594           55 NKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQG------------------------------L----R------EMKN   94 (369)
Q Consensus        55 ~~lg~G~~~~v~~~~~~~~~~valK~~~~~~~~~------------------------------~----~------~~~~   94 (369)
                      ..|+.++-|.||.|+.++|+.||||+....-...                              .    +      .+..
T Consensus       131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~  210 (517)
T COG0661         131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR  210 (517)
T ss_pred             CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence            6889999999999999999999999974331110                              0    0      1233


Q ss_pred             HHHHHhcCC-----CCceeeeeeeEEeCCccEEEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHH-HHHHhcCC
Q 017594           95 EASVIAKVQ-----HKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQG-LLYLHQYS  168 (369)
Q Consensus        95 e~~~l~~l~-----h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~a-l~~LH~~~  168 (369)
                      |+..+.++.     .+.+.-..=+++..+..+++|||++|-.+.++.....  ...+...+   +..++.+ +..+-..|
T Consensus       211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~--~g~d~k~i---a~~~~~~f~~q~~~dg  285 (517)
T COG0661         211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS--AGIDRKEL---AELLVRAFLRQLLRDG  285 (517)
T ss_pred             HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh--cCCCHHHH---HHHHHHHHHHHHHhcC
Confidence            444444442     3333322223334677899999999999887742212  12342232   2223322 33333456


Q ss_pred             CCCcccCCCCCCCEEEeCCCceEEeecCCceecC
Q 017594          169 RVRIIHRDLKASNILLDKDMNPKISDFGMARICG  202 (369)
Q Consensus       169 ~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~  202 (369)
                         ++|+|.+|.||+++.+|++.+.|||+.....
T Consensus       286 ---ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~  316 (517)
T COG0661         286 ---FFHADPHPGNILVRSDGRIVLLDFGIVGRLD  316 (517)
T ss_pred             ---ccccCCCccceEEecCCcEEEEcCcceecCC
Confidence               9999999999999999999999999987664

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.71  E-value=3.2e-07  Score=78.85  Aligned_cols=159  Identities=18%  Similarity=0.216  Sum_probs=108.2

Q ss_pred             CCCccccchhhHHHHhcCCccCcccc---ccCCccEEEEEEcCCCEEEEEEecCCCch-------------------h--
Q 017594           33 VDQFPLFSFSSVSTATNKFSDANKLG---EGGFGPVYKGVLKKGDEIAVKRLSGRSGQ-------------------G--   88 (369)
Q Consensus        33 ~~~~~~~~~~~~~~~~~~y~i~~~lg---~G~~~~v~~~~~~~~~~valK~~~~~~~~-------------------~--   88 (369)
                      ..-++......+-.+..+..+....|   +|..+.||+|...++..+|+|++......                   .  
T Consensus        29 ~~v~D~~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr  108 (268)
T COG1718          29 DEVFDKRTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRR  108 (268)
T ss_pred             hhhhhhHHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHH
Confidence            33455677777788888887766555   67778899999888999999998532110                   0  


Q ss_pred             ---HHHHHHHHHHHhcCC--CCceeeeeeeEEeCCccEEEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHH
Q 017594           89 ---LREMKNEASVIAKVQ--HKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLY  163 (369)
Q Consensus        89 ---~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~  163 (369)
                         ......|+..|.++.  +-.+++.+.+.    ...+||||+.....--   -..+...+.......+..++++.+.-
T Consensus       109 ~lv~~W~~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pA---P~LkDv~~e~~e~~~~~~~~v~~~~~  181 (268)
T COG1718         109 KLVFAWARKEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPA---PRLKDVPLELEEAEGLYEDVVEYMRR  181 (268)
T ss_pred             HHHHHHHHHHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCC---CCcccCCcCchhHHHHHHHHHHHHHH
Confidence               111335777777763  34455555443    5689999986652100   00111223333566778888888888


Q ss_pred             Hhc-CCCCCcccCCCCCCCEEEeCCCceEEeecCCceecC
Q 017594          164 LHQ-YSRVRIIHRDLKASNILLDKDMNPKISDFGMARICG  202 (369)
Q Consensus       164 LH~-~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~  202 (369)
                      |-. .+   ++||||+.-||++. ++.+.++||+.+....
T Consensus       182 l~~~a~---LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~  217 (268)
T COG1718         182 LYKEAG---LVHGDLSEYNILVH-DGEPYIIDVSQAVTID  217 (268)
T ss_pred             HHHhcC---cccccchhhheEEE-CCeEEEEECccccccC
Confidence            877 55   99999999999999 8899999999887544

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.69  E-value=2.1e-07  Score=80.06  Aligned_cols=105  Identities=26%  Similarity=0.292  Sum_probs=80.0

Q ss_pred             HHHHHHHHHHhcCCC--CceeeeeeeEEeCC----ccEEEEEecCCC-ChhhhhcCCCccccCChHHHHHHHHHHHHHHH
Q 017594           90 REMKNEASVIAKVQH--KNLVRLLGCCIDRD----EKILIYEYMPNK-SLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLL  162 (369)
Q Consensus        90 ~~~~~e~~~l~~l~h--~~i~~~~~~~~~~~----~~~lv~e~~~~~-~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~  162 (369)
                      .....|...+..|..  -.++.++.+.....    ..++|+|++++. +|.+++.....   .+......++.+++..+.
T Consensus        56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~---~~~~~~~~ll~~l~~~i~  132 (206)
T PF06293_consen   56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ---LDPSQRRELLRALARLIA  132 (206)
T ss_pred             hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc---cchhhHHHHHHHHHHHHH
Confidence            456678887777743  23445555554422    348999999875 78888754222   556677889999999999


Q ss_pred             HHhcCCCCCcccCCCCCCCEEEeCCC---ceEEeecCCcee
Q 017594          163 YLHQYSRVRIIHRDLKASNILLDKDM---NPKISDFGMARI  200 (369)
Q Consensus       163 ~LH~~~~~~i~H~dl~p~NIlv~~~~---~~~L~Dfg~~~~  200 (369)
                      -||..|   ++|+|+++.|||++.++   .+.|+||+-+..
T Consensus       133 ~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~  170 (206)
T PF06293_consen  133 KLHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF  170 (206)
T ss_pred             HHHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence            999999   99999999999999887   899999987654

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.66  E-value=4.5e-07  Score=79.03  Aligned_cols=132  Identities=20%  Similarity=0.165  Sum_probs=85.4

Q ss_pred             ccccccCCccEEEEEEcCCCEEEEEEecCCCchhHHHHHHHHHHHhcCCCC--ceeeeeeeEEeCCccEEEEEecCCCC-
Q 017594           55 NKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHK--NLVRLLGCCIDRDEKILIYEYMPNKS-  131 (369)
Q Consensus        55 ~~lg~G~~~~v~~~~~~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~--~i~~~~~~~~~~~~~~lv~e~~~~~~-  131 (369)
                      ..||.|..+.||+.   .|..+++|......  ......+|++.++.+..-  .+.+++.+....+...++|++++|.. 
T Consensus         7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~   81 (226)
T TIGR02172         7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS   81 (226)
T ss_pred             eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence            57899999999984   25577889876432  335678899999888533  25667777777777889999999963 


Q ss_pred             hhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcC----------------------------------------CCCC
Q 017594          132 LDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQY----------------------------------------SRVR  171 (369)
Q Consensus       132 L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~----------------------------------------~~~~  171 (369)
                      +...+.       .+......++.+++..+.-||+.                                        ....
T Consensus        82 ~~~~~~-------~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~  154 (226)
T TIGR02172        82 FSRIIS-------DNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTST  154 (226)
T ss_pred             hhhhhc-------CCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCc
Confidence            211110       00111111222222222222211                                        1235


Q ss_pred             cccCCCCCCCEEEeCCCceEEeecCCce
Q 017594          172 IIHRDLKASNILLDKDMNPKISDFGMAR  199 (369)
Q Consensus       172 i~H~dl~p~NIlv~~~~~~~L~Dfg~~~  199 (369)
                      ++|||+.|.||+++.++ +.++||+.+.
T Consensus       155 ~~HgD~~~~Nii~~~~~-~~iIDwe~a~  181 (226)
T TIGR02172       155 CLHGDFQIGNLITSGKG-TYWIDLGDFG  181 (226)
T ss_pred             eEecCCCCCcEEEcCCC-cEEEechhcC
Confidence            79999999999999888 9999998764

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>PRK09902 hypothetical protein; Provisional

Probab=98.66  E-value=4e-07  Score=77.13  Aligned_cols=141  Identities=15%  Similarity=0.146  Sum_probs=101.3

Q ss_pred             CccccccCCccEEEEEEcCCCEEEEEEecCCC------chhHHHHHHHHHHHhcCCCC--ceeeeeeeEE-eC----Ccc
Q 017594           54 ANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRS------GQGLREMKNEASVIAKVQHK--NLVRLLGCCI-DR----DEK  120 (369)
Q Consensus        54 ~~~lg~G~~~~v~~~~~~~~~~valK~~~~~~------~~~~~~~~~e~~~l~~l~h~--~i~~~~~~~~-~~----~~~  120 (369)
                      .---|+|+-|.|+..... |+.+.+|.....-      +.....+..|+..|..|...  .++++. ++. ..    -..
T Consensus        23 ~pN~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA  100 (216)
T PRK09902         23 EPNYRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRA  100 (216)
T ss_pred             CCCcCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEE
Confidence            333467999999998765 4578889764110      33567889999999998532  244444 322 11    235


Q ss_pred             EEEEEecCC-CChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCc--eEEeecCC
Q 017594          121 ILIYEYMPN-KSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMN--PKISDFGM  197 (369)
Q Consensus       121 ~lv~e~~~~-~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~--~~L~Dfg~  197 (369)
                      +||+|-+.+ .+|.+++.+.. ....+......++.+++.++.-||..|   +.|+|+.+.||+++.++.  +.++||.-
T Consensus       101 ~LVTe~L~g~~~L~~~l~~~~-~~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lIDlEk  176 (216)
T PRK09902        101 LLVTEDMAGFISIADWYAQHA-VSPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLDLEK  176 (216)
T ss_pred             EEEEEeCCCCccHHHHHhcCC-cCCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEEhhc
Confidence            899997654 46777764422 223566777889999999999999999   999999999999986677  99999986


Q ss_pred             cee
Q 017594          198 ARI  200 (369)
Q Consensus       198 ~~~  200 (369)
                      ++.
T Consensus       177 ~r~  179 (216)
T PRK09902        177 SRR  179 (216)
T ss_pred             cch
Confidence            653

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.60  E-value=6.2e-07  Score=76.29  Aligned_cols=139  Identities=16%  Similarity=0.152  Sum_probs=90.5

Q ss_pred             HHHhcCCccCccccccCCccEEEEEEcCCCEEEEEEecCCCchhHHHH---------HHHHHHHhcCC---CCceeeeee
Q 017594           45 STATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREM---------KNEASVIAKVQ---HKNLVRLLG  112 (369)
Q Consensus        45 ~~~~~~y~i~~~lg~G~~~~v~~~~~~~~~~valK~~~~~~~~~~~~~---------~~e~~~l~~l~---h~~i~~~~~  112 (369)
                      .....+|.+.+.+.......|.+...+ |..+++|.......-..+.+         .+.+..+..+.   ......++.
T Consensus        27 ~i~~~~~~~~kv~k~~~r~~ValIei~-~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl  105 (229)
T PF06176_consen   27 KILDNNYKIIKVFKNTKRNYVALIEID-GKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYL  105 (229)
T ss_pred             HHHhCCceEEEeecCCCccEEEEEEEC-CcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCcccccccee
Confidence            345678888899988887778777665 78899998764432222221         22333333332   222222222


Q ss_pred             eE-----EeCCccEEEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCC
Q 017594          113 CC-----IDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKD  187 (369)
Q Consensus       113 ~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~  187 (369)
                      +.     ......+++|||++|..|.+...       +++    .+...+..++..||..|   ++|||.+|.|++++.+
T Consensus       106 ~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~-------i~e----~~~~ki~~~ikqlH~~G---~~HGD~hpgNFlv~~~  171 (229)
T PF06176_consen  106 AAEKKIFRYTSSYVLLMEYIEGVELNDIED-------IDE----DLAEKIVEAIKQLHKHG---FYHGDPHPGNFLVSNN  171 (229)
T ss_pred             eeeeeeccceeEEEEEEEEecCeecccchh-------cCH----HHHHHHHHHHHHHHHcC---CccCCCCcCcEEEECC
Confidence            22     22344578999999988755431       222    24456778899999999   9999999999999855


Q ss_pred             CceEEeecCCce
Q 017594          188 MNPKISDFGMAR  199 (369)
Q Consensus       188 ~~~~L~Dfg~~~  199 (369)
                       .++++||+.-.
T Consensus       172 -~i~iID~~~k~  182 (229)
T PF06176_consen  172 -GIRIIDTQGKR  182 (229)
T ss_pred             -cEEEEECcccc
Confidence             59999997643

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.48  E-value=1.7e-06  Score=75.65  Aligned_cols=78  Identities=21%  Similarity=0.303  Sum_probs=55.7

Q ss_pred             CccccccCCccEEEEEEcCCCEEEEEEecCCCchhHHHHHHHHHHHhcCCCC--ceeeeeeeEEe---CCccEEEEEecC
Q 017594           54 ANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHK--NLVRLLGCCID---RDEKILIYEYMP  128 (369)
Q Consensus        54 ~~~lg~G~~~~v~~~~~~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~--~i~~~~~~~~~---~~~~~lv~e~~~  128 (369)
                      ++.|+.|..+.||.+...+ ..+++|.....  .....+..|..+++.+...  .+.+++.....   ....+++|++++
T Consensus         2 i~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~   78 (239)
T PF01636_consen    2 IRPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIP   78 (239)
T ss_dssp             EEEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEES
T ss_pred             CccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEec
Confidence            4678999999999999886 68999987644  4456777888888888532  34555553322   233689999999


Q ss_pred             CCChhh
Q 017594          129 NKSLDF  134 (369)
Q Consensus       129 ~~~L~~  134 (369)
                      |..+..
T Consensus        79 g~~~~~   84 (239)
T PF01636_consen   79 GRPLDD   84 (239)
T ss_dssp             SEEHHH
T ss_pred             cccccc
Confidence            988876

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.46  E-value=2.9e-06  Score=75.00  Aligned_cols=76  Identities=16%  Similarity=0.163  Sum_probs=53.8

Q ss_pred             cccccCC-ccEEEEEEcCCCEEEEEEecCCCchhHHHHHHHHHHHhcCC-CCceeeeeeeEEeCCccEEEEEecCCCChh
Q 017594           56 KLGEGGF-GPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQ-HKNLVRLLGCCIDRDEKILIYEYMPNKSLD  133 (369)
Q Consensus        56 ~lg~G~~-~~v~~~~~~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~  133 (369)
                      .|..|.. +.||++... +..+++|+.....   ...+..|+.+++.+. +.-+.+++.+.......++||++++|.++.
T Consensus         5 ~~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~   80 (244)
T cd05150           5 RVTEGQSGATVYRLDGK-NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAA   80 (244)
T ss_pred             ecCCCCCcCeEEEEcCC-CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHh
Confidence            3445555 788988765 4788889876443   345677888888884 344666777766666789999999998875


Q ss_pred             hh
Q 017594          134 FF  135 (369)
Q Consensus       134 ~~  135 (369)
                      ..
T Consensus        81 ~~   82 (244)
T cd05150          81 AL   82 (244)
T ss_pred             Hh
Confidence            43

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=98.34  E-value=4.6e-06  Score=68.00  Aligned_cols=133  Identities=21%  Similarity=0.280  Sum_probs=94.2

Q ss_pred             HhcCCccCccccccCCccEEEEEEcCCCEEEEEEecCCCchhHHHHHHHHHHHhcCCCCceee-eeeeEEeCCccEEEEE
Q 017594           47 ATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVR-LLGCCIDRDEKILIYE  125 (369)
Q Consensus        47 ~~~~y~i~~~lg~G~~~~v~~~~~~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~-~~~~~~~~~~~~lv~e  125 (369)
                      ....-++.+.|++|..|.||++.+. |..+++|+-..+.  ....+..|+++|..++-.++-+ ++.+.    .-++.||
T Consensus        20 ~~~~~~v~~~L~KG~~s~Vyl~~~~-~~~~a~Kvrr~ds--~r~~l~kEakiLeil~g~~~~p~vy~yg----~~~i~me   92 (201)
T COG2112          20 GKYELRVEKELAKGTTSVVYLGEWR-GGEVALKVRRRDS--PRRNLEKEAKILEILAGEGVTPEVYFYG----EDFIRME   92 (201)
T ss_pred             cchhhhhhhhhhcccccEEEEeecc-CceEEEEEecCCc--chhhHHHHHHHHHHhhhcCCCceEEEec----hhhhhhh
Confidence            3344567889999999999999998 5588888765443  3478889999999988655443 33332    2345599


Q ss_pred             ecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCC-CCCEEEeCCCceEEeecCCce
Q 017594          126 YMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLK-ASNILLDKDMNPKISDFGMAR  199 (369)
Q Consensus       126 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~-p~NIlv~~~~~~~L~Dfg~~~  199 (369)
                      |+.|..|..+....      +    .+.+..++.+---|...|   |-|+.|+ |...++..++.+.|+||..+.
T Consensus        93 ~i~G~~L~~~~~~~------~----rk~l~~vlE~a~~LD~~G---I~H~El~~~~k~vlv~~~~~~iIDFd~At  154 (201)
T COG2112          93 YIDGRPLGKLEIGG------D----RKHLLRVLEKAYKLDRLG---IEHGELSRPWKNVLVNDRDVYIIDFDSAT  154 (201)
T ss_pred             hhcCcchhhhhhcc------c----HHHHHHHHHHHHHHHHhc---cchhhhcCCceeEEecCCcEEEEEccchh
Confidence            99998886655211      1    122334555556677777   9999987 666666666799999999876

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.23  E-value=1.3e-05  Score=77.37  Aligned_cols=141  Identities=16%  Similarity=0.207  Sum_probs=86.7

Q ss_pred             CccccccCCccEEEEEEcCCCEEEEEEecCCCch----h---------------------------HHH------HHHHH
Q 017594           54 ANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQ----G---------------------------LRE------MKNEA   96 (369)
Q Consensus        54 ~~~lg~G~~~~v~~~~~~~~~~valK~~~~~~~~----~---------------------------~~~------~~~e~   96 (369)
                      .+.||....|.||+|+.++|+.||+|+.+..-..    +                           .+.      +..|+
T Consensus       166 ~~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA  245 (538)
T KOG1235|consen  166 EEPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA  245 (538)
T ss_pred             cchhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence            4688999999999999999999999986533110    0                           001      12233


Q ss_pred             HHHhc----CCCCc---eeeeeeeEE-eCCccEEEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHH-HHhcC
Q 017594           97 SVIAK----VQHKN---LVRLLGCCI-DRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLL-YLHQY  167 (369)
Q Consensus        97 ~~l~~----l~h~~---i~~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~-~LH~~  167 (369)
                      +-..+    ++|-+   -+.+-.++. .....+++|||++|..+.+.-.-..  ..++...+   +..+.++.. .+=..
T Consensus       246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~~--~gi~~~~i---~~~l~~~~~~qIf~~  320 (538)
T KOG1235|consen  246 KNAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAIDK--RGISPHDI---LNKLVEAYLEQIFKT  320 (538)
T ss_pred             HhHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHHH--cCCCHHHH---HHHHHHHHHHHHHhc
Confidence            32222    23333   112222222 2457899999999998876643211  22444443   333333322 22234


Q ss_pred             CCCCcccCCCCCCCEEEeC----CCceEEeecCCceecC
Q 017594          168 SRVRIIHRDLKASNILLDK----DMNPKISDFGMARICG  202 (369)
Q Consensus       168 ~~~~i~H~dl~p~NIlv~~----~~~~~L~Dfg~~~~~~  202 (369)
                      |   ++|+|=+|.||+++.    ++.+.+.|||+.....
T Consensus       321 G---ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is  356 (538)
T KOG1235|consen  321 G---FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS  356 (538)
T ss_pred             C---CccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence            4   999999999999984    6789999999976543

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=98.22  E-value=5.8e-05  Score=63.69  Aligned_cols=104  Identities=20%  Similarity=0.219  Sum_probs=79.0

Q ss_pred             HHHHHHhcCCC-CceeeeeeeEEeCCccEEEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCc
Q 017594           94 NEASVIAKVQH-KNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRI  172 (369)
Q Consensus        94 ~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i  172 (369)
                      .|.-+++.+++ ++++++++++    ..+++.|+...+++.........-...++..+.+++.+++..+.+|+......+
T Consensus         8 ~E~lll~~l~~~~~~pk~lG~C----G~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~~   83 (188)
T PF12260_consen    8 NEPLLLQLLQGSEPFPKLLGSC----GRFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGFF   83 (188)
T ss_pred             cHHHHHHHcCCCCCCCCeeeEC----CCEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCcE
Confidence            47778888875 5899999998    457888998866543211000111226788999999999999999998654458


Q ss_pred             ccCCCCCCCEEEeCCCceEEeecCCceec
Q 017594          173 IHRDLKASNILLDKDMNPKISDFGMARIC  201 (369)
Q Consensus       173 ~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~  201 (369)
                      .-+|++++|+-++.+++++++|.+.+...
T Consensus        84 ~lcDv~~~nfgv~~~~~lk~iDld~v~~~  112 (188)
T PF12260_consen   84 YLCDVSPDNFGVNDDGRLKLIDLDDVFVE  112 (188)
T ss_pred             EEeecchHHeEEeCCCcEEEEechhcchh
Confidence            99999999999999999999999865543

Proteins in this uncharacterised family are described as transmembrane proteins.

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=98.21  E-value=2.1e-05  Score=69.15  Aligned_cols=74  Identities=14%  Similarity=0.264  Sum_probs=46.0

Q ss_pred             CccccccCCc-cEEEEEEcCCCEEEEEEecCCCchhHHHHHHHHHHHhcCCCC---ceeeeeeeEEeCC---ccEEEEEe
Q 017594           54 ANKLGEGGFG-PVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHK---NLVRLLGCCIDRD---EKILIYEY  126 (369)
Q Consensus        54 ~~~lg~G~~~-~v~~~~~~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~---~i~~~~~~~~~~~---~~~lv~e~  126 (369)
                      ++.|+.|+.. .||..    +..+++|......  ....+..|++.+..+...   .+..++......+   ..+++|++
T Consensus         2 ~~~~~~gG~~n~vy~~----~~~~VlR~~~~~~--~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~   75 (235)
T cd05155           2 IEPVDSGGTDNATFRL----GDDMSVRLPSAAG--YAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRW   75 (235)
T ss_pred             ceeccCCCcccceEEc----CCceEEEcCCccc--hHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEe
Confidence            3567766666 58876    3457788755322  235788899999887531   2344443332221   34889999


Q ss_pred             cCCCChh
Q 017594          127 MPNKSLD  133 (369)
Q Consensus       127 ~~~~~L~  133 (369)
                      ++|.++.
T Consensus        76 i~G~~l~   82 (235)
T cd05155          76 LEGETAT   82 (235)
T ss_pred             ecCCCCC
Confidence            9998774

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>TIGR02721 ycfN_thiK thiamine kinase

Probab=98.18  E-value=2.1e-05  Score=70.05  Aligned_cols=138  Identities=14%  Similarity=0.082  Sum_probs=77.0

Q ss_pred             cccccCCccEEEEEEcCCCEEEEEEecCCCchhHHHHHHHHHHHhcCCCCce-eeeeeeEEeCCccEEEEEecCCCChhh
Q 017594           56 KLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNL-VRLLGCCIDRDEKILIYEYMPNKSLDF  134 (369)
Q Consensus        56 ~lg~G~~~~v~~~~~~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~lv~e~~~~~~L~~  134 (369)
                      .+..|-.+.+|+... ++..+++|..........-....|..+++.+....+ .+++...    ..++|++|++|..+..
T Consensus         3 ~~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~----~~~~v~e~i~G~~~~~   77 (256)
T TIGR02721         3 TLSGGLTNRSWRIEH-PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVN----EHWLLVEWLEGEVITL   77 (256)
T ss_pred             cCCCcCcCCeEEEEe-CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEe----CCEEEEEeccCccccc
Confidence            456788889998874 467888887653322110134678888888854333 3333332    2479999999877642


Q ss_pred             h-----------------hcCCC-ccccCChH-HHHHHHHHH---------HHHHHHHhcC-----CCCCcccCCCCCCC
Q 017594          135 F-----------------LFDPT-KRMLLDWV-TRVQIIEGI---------AQGLLYLHQY-----SRVRIIHRDLKASN  181 (369)
Q Consensus       135 ~-----------------l~~~~-~~~~~~~~-~~~~i~~qi---------~~al~~LH~~-----~~~~i~H~dl~p~N  181 (369)
                      .                 ++... ....++.. ....+..++         ...+..+-..     ....++|+|+.|.|
T Consensus        78 ~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~N  157 (256)
T TIGR02721        78 DQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYN  157 (256)
T ss_pred             ccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCc
Confidence            1                 01100 01111111 111111111         1112222111     02248999999999


Q ss_pred             EEEeCCCceEEeecCCce
Q 017594          182 ILLDKDMNPKISDFGMAR  199 (369)
Q Consensus       182 Ilv~~~~~~~L~Dfg~~~  199 (369)
                      |+++.++ +.|+||+.+.
T Consensus       158 il~~~~~-~~lIDwE~a~  174 (256)
T TIGR02721       158 LVVTPQG-LKLIDWEYAS  174 (256)
T ss_pred             EEEeCCC-CEEEeccccC
Confidence            9999876 7899998765

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=98.16  E-value=1.3e-05  Score=82.07  Aligned_cols=199  Identities=20%  Similarity=0.197  Sum_probs=135.8

Q ss_pred             HHHHHHHHHHHhcCCCCceeeeeeeEEeCCcc----EEEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHH
Q 017594           89 LREMKNEASVIAKVQHKNLVRLLGCCIDRDEK----ILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYL  164 (369)
Q Consensus        89 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~----~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~L  164 (369)
                      ......|+..+....|+|+..++.+.......    .+..+++...++...+..   ....+....+.+..++..++.++
T Consensus       226 i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~---v~~i~~~~~r~~~~~~~~GL~~~  302 (1351)
T KOG1035|consen  226 IQTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQS---VGSIPLETLRILHQKLLEGLAYL  302 (1351)
T ss_pred             HHHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhh---ccccCHHHHHHHHHHHhhhHHHH
Confidence            34455678888889999999999887755433    344677877777777743   33478888889999999999999


Q ss_pred             hcCCCCCcccCCCCCC---CEEEeCCCceEEe--ecCCceecCCCCcccccccccccccccCchhhccCCCC--cccchH
Q 017594          165 HQYSRVRIIHRDLKAS---NILLDKDMNPKIS--DFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFS--IKSDVF  237 (369)
Q Consensus       165 H~~~~~~i~H~dl~p~---NIlv~~~~~~~L~--Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~--~~~Diw  237 (369)
                      |...   +.|.-+...   +--++.++.+..+  ||+.+...........   ......+.++|........  ...|+|
T Consensus       303 h~~~---l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~---~~~~~~~~~~e~~~~~~~~~~r~~dL~  376 (1351)
T KOG1035|consen  303 HSLS---LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFS---DLLAEIRNADEDLKENTAKKSRLTDLW  376 (1351)
T ss_pred             HHhc---cceeEEecccccccccCccceeecchhhhcccccCCCcccchh---hcCccccccccccccccchhhhhhHHH
Confidence            9986   666665555   4444566666666  8888776543322111   1334567778876655544  347999


Q ss_pred             hHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCccccccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHH
Q 017594          238 SFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMND  317 (369)
Q Consensus       238 slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e  317 (369)
                      ++|..+..+..|..+-..                     .......+....     ...+.+...+|+.-++++|+++.+
T Consensus       377 ~lgll~~~~~~~~~i~~~---------------------~~~~~~~l~~~~-----~~~~~d~~~~~~~~~~~~Rl~~~~  430 (1351)
T KOG1035|consen  377 CLGLLLLQLSQGEDISEK---------------------SAVPVSLLDVLS-----TSELLDALPKCLDEDSEERLSALE  430 (1351)
T ss_pred             HHHHHHhhhhhcCccccc---------------------ccchhhhhcccc-----chhhhhhhhhhcchhhhhccchhh
Confidence            999999999988764221                     111111111111     114778999999999999999999


Q ss_pred             HHHHH
Q 017594          318 VVSML  322 (369)
Q Consensus       318 ll~~L  322 (369)
                      ++...
T Consensus       431 ll~~~  435 (1351)
T KOG1035|consen  431 LLTHP  435 (1351)
T ss_pred             hhhch
Confidence            98643

>PLN02876 acyl-CoA dehydrogenase

Probab=98.15  E-value=4.4e-05  Score=79.22  Aligned_cols=79  Identities=16%  Similarity=0.360  Sum_probs=56.7

Q ss_pred             CccccccCCccEEEEEEcCC---CEEEEEEecCCC-chhHHHHHHHHHHHhcCC-CCce--eeeeeeEEeC---CccEEE
Q 017594           54 ANKLGEGGFGPVYKGVLKKG---DEIAVKRLSGRS-GQGLREMKNEASVIAKVQ-HKNL--VRLLGCCIDR---DEKILI  123 (369)
Q Consensus        54 ~~~lg~G~~~~v~~~~~~~~---~~valK~~~~~~-~~~~~~~~~e~~~l~~l~-h~~i--~~~~~~~~~~---~~~~lv  123 (369)
                      ++.++.|.+..+|+....++   ..+++|+..... ......+.+|+.+++.+. |.++  .+++.++.+.   ...|+|
T Consensus        43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV  122 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI  122 (822)
T ss_pred             EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence            67788999999999886553   467888765322 123457889999999985 5554  6666666543   357899


Q ss_pred             EEecCCCCh
Q 017594          124 YEYMPNKSL  132 (369)
Q Consensus       124 ~e~~~~~~L  132 (369)
                      ||+++|..+
T Consensus       123 ME~v~G~~~  131 (822)
T PLN02876        123 MEYLEGRIF  131 (822)
T ss_pred             EEecCCccc
Confidence            999998754

>PRK10593 hypothetical protein; Provisional

Probab=98.09  E-value=6.7e-05  Score=68.25  Aligned_cols=80  Identities=13%  Similarity=0.135  Sum_probs=57.6

Q ss_pred             CCccCccccccCCccEEEEEEcCCCEEEEEEecCCCchhHHHHHHHHHHHhcCCC---CceeeeeeeEEeC---CccEEE
Q 017594           50 KFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQH---KNLVRLLGCCIDR---DEKILI  123 (369)
Q Consensus        50 ~y~i~~~lg~G~~~~v~~~~~~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h---~~i~~~~~~~~~~---~~~~lv  123 (369)
                      +-.-.+.||.|..+.||.....++ .+++|.....  .....+..|+..|+.|.-   ..++++++++..+   +..++|
T Consensus        15 ~~~~~~~i~~G~~~~vy~~~~~~~-~~~~k~~~~~--~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LV   91 (297)
T PRK10593         15 KLSRVECISEQPYAALWALYDSQG-NPMPLMARSF--STPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLL   91 (297)
T ss_pred             hhheeeecCCccceeEEEEEcCCC-CEEEEEeccc--ccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEE
Confidence            444567899999999999976655 5677775431  123578889999988853   3577777766543   568999


Q ss_pred             EEecCCCCh
Q 017594          124 YEYMPNKSL  132 (369)
Q Consensus       124 ~e~~~~~~L  132 (369)
                      ||++++.++
T Consensus        92 mE~i~G~~~  100 (297)
T PRK10593         92 LERLRGVSV  100 (297)
T ss_pred             EeccCCEec
Confidence            999998764

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=98.08  E-value=5e-05  Score=66.62  Aligned_cols=74  Identities=18%  Similarity=0.268  Sum_probs=48.5

Q ss_pred             CccccccCCccEEEEEEcC--CCEEEEEEecCCCchhHHHHHHHHHHHhcCCCCc-eeeeeeeEEeCCccEEEEEecCCC
Q 017594           54 ANKLGEGGFGPVYKGVLKK--GDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKN-LVRLLGCCIDRDEKILIYEYMPNK  130 (369)
Q Consensus        54 ~~~lg~G~~~~v~~~~~~~--~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~-i~~~~~~~~~~~~~~lv~e~~~~~  130 (369)
                      ++.|..|-...+|++...+  +..|++|+...... ..-....|+.+++.+...+ .++++..+.    ..+++||++|.
T Consensus         3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~-~~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~   77 (235)
T cd05157           3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE-LIIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGR   77 (235)
T ss_pred             EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCcc-ceecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCC
Confidence            3567788889999998664  67889997754322 1123346888888885333 344443322    24899999998


Q ss_pred             Ch
Q 017594          131 SL  132 (369)
Q Consensus       131 ~L  132 (369)
                      ++
T Consensus        78 ~l   79 (235)
T cd05157          78 TL   79 (235)
T ss_pred             cC
Confidence            76

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=98.07  E-value=7.5e-05  Score=67.98  Aligned_cols=142  Identities=15%  Similarity=0.141  Sum_probs=82.3

Q ss_pred             CccccccCCccEEEEEEcCCCEEEEEEecCCCchhHHHHHHHHHHHhcCCCCc--eeeeeee------EEeCCccEEEEE
Q 017594           54 ANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKN--LVRLLGC------CIDRDEKILIYE  125 (369)
Q Consensus        54 ~~~lg~G~~~~v~~~~~~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~--i~~~~~~------~~~~~~~~lv~e  125 (369)
                      ++.+..|....+|++...+ ..+++|+....   ....+..|+.++..+...+  +.+++..      ....+..+++++
T Consensus        19 i~~i~~G~~n~~y~v~~~~-~~~vLr~~~~~---~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~   94 (296)
T cd05153          19 FEGISAGIENTNYFVTTDS-GRYVLTLFEKV---SAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVE   94 (296)
T ss_pred             eecccCccccceEEEEeCC-CcEEEEEcCCC---ChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEE
Confidence            5667788889999987654 47888987642   2345667777777774322  3333321      123445689999


Q ss_pred             ecCCCChhhh----h----------cCC----Ccc----ccCChHHH----------HHHHHHHHHHHHHHhcC----CC
Q 017594          126 YMPNKSLDFF----L----------FDP----TKR----MLLDWVTR----------VQIIEGIAQGLLYLHQY----SR  169 (369)
Q Consensus       126 ~~~~~~L~~~----l----------~~~----~~~----~~~~~~~~----------~~i~~qi~~al~~LH~~----~~  169 (369)
                      +++|..+...    .          +..    ...    ....+...          ......+..++.++...    -.
T Consensus        95 ~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~  174 (296)
T cd05153          95 FLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLP  174 (296)
T ss_pred             eCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCC
Confidence            9998775320    0          000    000    00000000          00111123334444431    12


Q ss_pred             CCcccCCCCCCCEEEeCCCceEEeecCCce
Q 017594          170 VRIIHRDLKASNILLDKDMNPKISDFGMAR  199 (369)
Q Consensus       170 ~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~  199 (369)
                      ..++|||+.|.||+++.++.+.|+||+.+.
T Consensus       175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~  204 (296)
T cd05153         175 RGVIHADLFRDNVLFDGDELSGVIDFYFAC  204 (296)
T ss_pred             CcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence            349999999999999998777899998764

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.06  E-value=1e-06  Score=84.67  Aligned_cols=192  Identities=18%  Similarity=0.122  Sum_probs=136.5

Q ss_pred             hHHHHhcCCccCccccccCCccEEEEEEcCCCEEEEEEecCCCchhHHHHHHHHHHHhcCCCCc-eeeeeeeEEeCCccE
Q 017594           43 SVSTATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKN-LVRLLGCCIDRDEKI  121 (369)
Q Consensus        43 ~~~~~~~~y~i~~~lg~G~~~~v~~~~~~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~-i~~~~~~~~~~~~~~  121 (369)
                      ......+-|...+-+++|+++++++.+....+....+.+...     ....-++++|.+++||| .+..++.+..+...+
T Consensus       236 ~lkDk~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~  310 (829)
T KOG0576|consen  236 TLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLW  310 (829)
T ss_pred             cccCCccchHHHHHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccc
Confidence            344455667788889999999999998554444555655433     34566889999999999 666666666677889


Q ss_pred             EEEEecCCC-ChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCcee
Q 017594          122 LIYEYMPNK-SLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARI  200 (369)
Q Consensus       122 lv~e~~~~~-~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~  200 (369)
                      +.++++.++ +-.....  .....+.......+++.-+.+++++|+..   -+|+|    ||+.++ +..+++||+....
T Consensus       311 i~~~i~s~~rs~~~~~~--~se~~~~~~~~~~~~r~et~~l~~l~~~~---~~~~d----~~l~s~-~~~~~~~~~v~~~  380 (829)
T KOG0576|consen  311 IPMRICSTGRSSALEMT--VSEIALEQYQFAYPLRKETRPLAELHSSY---KVHRD----NILGSE-EEVKLLDFAVPPQ  380 (829)
T ss_pred             hhhhhhcCCccccccCC--hhhHhhhhhhhhhhhhhhccccccccccc---ccCcc----cccccc-cccccccccCCcc
Confidence            999999876 2211110  01111233344455666677899999875   58888    665554 6889999998776


Q ss_pred             cCCCCcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCC
Q 017594          201 CGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKN  252 (369)
Q Consensus       201 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p  252 (369)
                      +....   ......+++.++|||+.....+....|.|++|.-..++.-|.+|
T Consensus       381 L~~~~---~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pP  429 (829)
T KOG0576|consen  381 LTRTM---KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPP  429 (829)
T ss_pred             cCccc---ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCC
Confidence            55433   23335689999999999999999999999999888888877766

>PRK05231 homoserine kinase; Provisional

Probab=98.04  E-value=0.00014  Score=66.93  Aligned_cols=155  Identities=14%  Similarity=0.121  Sum_probs=81.4

Q ss_pred             hhhHHHHhcCCcc-----CccccccCCccEEEEEEcCCCEEEEEEecCCCchhHHHHHHHHHHHhcCCCC--ceeeeee-
Q 017594           41 FSSVSTATNKFSD-----ANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHK--NLVRLLG-  112 (369)
Q Consensus        41 ~~~~~~~~~~y~i-----~~~lg~G~~~~v~~~~~~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~--~i~~~~~-  112 (369)
                      ...+......|.+     .+.++.|....+|.+...+| .+++|++....   ...+..++..+..|...  .+.+++. 
T Consensus         9 ~~~l~~~l~~y~~~~~~~~~~l~~G~~n~~y~v~t~~g-~~vLK~~~~~~---~~~l~~~~~~l~~L~~~glpvP~~i~~   84 (319)
T PRK05231          9 DDELAAFLAPYDLGELLSLKGIAEGIENSNFFLTTTQG-EYVLTLFERLT---AEDLPFFLGLMQHLAARGVPVPAPVAR   84 (319)
T ss_pred             HHHHHHHHHhcCCchhhccchhccccccceEEEEeCCC-cEEEEEeccCC---hHHhHHHHHHHHHHHHCCCCCCcceeC
Confidence            3344444455654     45566788889999987655 68889876222   23444455555555311  1223332 


Q ss_pred             -----eEEeCCccEEEEEecCCCChhh-----h------h---cCCCcc------ccCCh---HHH------------HH
Q 017594          113 -----CCIDRDEKILIYEYMPNKSLDF-----F------L---FDPTKR------MLLDW---VTR------------VQ  152 (369)
Q Consensus       113 -----~~~~~~~~~lv~e~~~~~~L~~-----~------l---~~~~~~------~~~~~---~~~------------~~  152 (369)
                           +....+..++++++++|..+..     .      +   +.....      .....   ...            ..
T Consensus        85 ~~G~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (319)
T PRK05231         85 RDGAALGELAGKPAAIVTFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAA  164 (319)
T ss_pred             CCCCEeeeeCCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHH
Confidence                 1123455789999999875421     1      0   000000      00000   000            00


Q ss_pred             HHHH-HHHHHHHHhcC----CCCCcccCCCCCCCEEEeCCCceEEeecCCce
Q 017594          153 IIEG-IAQGLLYLHQY----SRVRIIHRDLKASNILLDKDMNPKISDFGMAR  199 (369)
Q Consensus       153 i~~q-i~~al~~LH~~----~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~  199 (369)
                      .+.+ +...+..+...    -..++||||+.|.||+++.+....++||+.+.
T Consensus       165 ~l~~~~~~~~~~~~~~~~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~  216 (319)
T PRK05231        165 LLEAELAAQLAFLASAAWPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC  216 (319)
T ss_pred             HHHHHHHHHHHhhhccccccCCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence            1111 11122333211    12359999999999999976556899999764

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=98.03  E-value=0.00014  Score=61.78  Aligned_cols=132  Identities=18%  Similarity=0.250  Sum_probs=90.4

Q ss_pred             cCccccccCCccEEEEEEcCCCEEEEEEecCCC----------------chhHHHHHHHHHHHhcCC------CCceeee
Q 017594           53 DANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRS----------------GQGLREMKNEASVIAKVQ------HKNLVRL  110 (369)
Q Consensus        53 i~~~lg~G~~~~v~~~~~~~~~~valK~~~~~~----------------~~~~~~~~~e~~~l~~l~------h~~i~~~  110 (369)
                      -...||+|+.-.||.  +.++...+||+.....                .........|+.....+.      +.+|.++
T Consensus         5 ~~~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~   82 (199)
T PF10707_consen    5 ESDLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF   82 (199)
T ss_pred             CCcccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence            346789999999984  4455667899887554                122455566666666555      7789999


Q ss_pred             eeeEEeCCccEEEEEecCCC------ChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEE
Q 017594          111 LGCCIDRDEKILIYEYMPNK------SLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILL  184 (369)
Q Consensus       111 ~~~~~~~~~~~lv~e~~~~~------~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv  184 (369)
                      +++.+......+|+|.+.+.      +|.+++..    ..++. .....   +-....+|-..+   |+.+|++|.||++
T Consensus        83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~----~~~~~-~~~~~---L~~f~~~l~~~~---Iv~~dl~~~NIv~  151 (199)
T PF10707_consen   83 YGFVETNLGLGLVVELIRDADGNISPTLEDYLKE----GGLTE-ELRQA---LDEFKRYLLDHH---IVIRDLNPHNIVV  151 (199)
T ss_pred             eEEEecCCceEEEEEEEECCCCCcCccHHHHHHc----CCccH-HHHHH---HHHHHHHHHHcC---CeecCCCcccEEE
Confidence            99999988999999876432      56666632    22444 33333   444556777777   9999999999999


Q ss_pred             eCCC----ceEEee-cCC
Q 017594          185 DKDM----NPKISD-FGM  197 (369)
Q Consensus       185 ~~~~----~~~L~D-fg~  197 (369)
                      ....    .+.|+| ||.
T Consensus       152 ~~~~~~~~~lvlIDG~G~  169 (199)
T PF10707_consen  152 QRRDSGEFRLVLIDGLGE  169 (199)
T ss_pred             EecCCCceEEEEEeCCCC
Confidence            5432    577777 443

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=97.95  E-value=0.00016  Score=66.20  Aligned_cols=155  Identities=15%  Similarity=0.145  Sum_probs=84.8

Q ss_pred             hhHHHHhcCCcc-----CccccccCCccEEEEEEcCCCEEEEEEecCCCchhHHHHHHHHHHHhcCCCCc--eeeeeee-
Q 017594           42 SSVSTATNKFSD-----ANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKN--LVRLLGC-  113 (369)
Q Consensus        42 ~~~~~~~~~y~i-----~~~lg~G~~~~v~~~~~~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~--i~~~~~~-  113 (369)
                      ..+....++|.+     ++.++.|....+|.+...+| .+++|+......  ...+..+.+++..|...+  +.+++.. 
T Consensus        10 ~~l~~~l~~y~~~~~~~i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~~--~~~i~~e~~~l~~L~~~g~pvp~~i~t~   86 (307)
T TIGR00938        10 EEMSSFLDGYDLGELLSLKGIAEGVENSNYLLTTDVG-RYILTLYEKRVK--AEELPFFLALTTHLAARGLPVPKPVKSR   86 (307)
T ss_pred             HHHHHHHHhcCCCCceeccccCCccccceEEEEeCCC-cEEEEEecCCCC--HHHHHHHHHHHHHHHHCCCCCCccccCC
Confidence            334444445544     55677888889999886545 677898754321  244556677776664222  3333321 


Q ss_pred             -----EEeCCccEEEEEecCCCChhhh--------------hcCCCccccCC-----hHHHH----------------HH
Q 017594          114 -----CIDRDEKILIYEYMPNKSLDFF--------------LFDPTKRMLLD-----WVTRV----------------QI  153 (369)
Q Consensus       114 -----~~~~~~~~lv~e~~~~~~L~~~--------------l~~~~~~~~~~-----~~~~~----------------~i  153 (369)
                           ....+..++++++++|..+...              ++........+     ....|                ..
T Consensus        87 ~g~~~~~~~g~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~  166 (307)
T TIGR00938        87 DGRQLSTLAGKPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHM  166 (307)
T ss_pred             CCCeehhcCCeEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHH
Confidence                 1123456899999988654211              00000000000     00000                00


Q ss_pred             HHHHHHHHHHHhc----CCCCCcccCCCCCCCEEEeCCCceEEeecCCce
Q 017594          154 IEGIAQGLLYLHQ----YSRVRIIHRDLKASNILLDKDMNPKISDFGMAR  199 (369)
Q Consensus       154 ~~qi~~al~~LH~----~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~  199 (369)
                      ...+...++++..    .-..+++|||+.+.|++++.++.+.|+||+.+.
T Consensus       167 ~~~l~~~~~~l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~  216 (307)
T TIGR00938       167 GAELDKELDYLDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC  216 (307)
T ss_pred             HHHHHHHHHHHHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence            1112334444432    112359999999999999998777899999764

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.91  E-value=0.00018  Score=67.56  Aligned_cols=76  Identities=16%  Similarity=0.254  Sum_probs=54.1

Q ss_pred             CccccccCCccEEEEEEcCC-CEEEEEEecCC-----C--chhHHHHHHHHHHHhcCC---CCceeeeeeeEEeCCccEE
Q 017594           54 ANKLGEGGFGPVYKGVLKKG-DEIAVKRLSGR-----S--GQGLREMKNEASVIAKVQ---HKNLVRLLGCCIDRDEKIL  122 (369)
Q Consensus        54 ~~~lg~G~~~~v~~~~~~~~-~~valK~~~~~-----~--~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~~~~~l  122 (369)
                      .+.||.|....||++...+| +.++||.-...     .  .-..+....|.+.|+.+.   ..++++++.+  +.+..++
T Consensus        31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~l  108 (401)
T PRK09550         31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVT  108 (401)
T ss_pred             eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEE
Confidence            46789999999999998776 48999984311     1  124566777888888863   2346666655  4566899


Q ss_pred             EEEecCCCC
Q 017594          123 IYEYMPNKS  131 (369)
Q Consensus       123 v~e~~~~~~  131 (369)
                      |||++++..
T Consensus       109 VME~L~~~~  117 (401)
T PRK09550        109 VMEDLSDHK  117 (401)
T ss_pred             EEecCCCcc
Confidence            999987643

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=97.79  E-value=2.9e-05  Score=69.40  Aligned_cols=135  Identities=14%  Similarity=0.170  Sum_probs=96.2

Q ss_pred             CCccCccccccCCccEEEEEEcCCCEEEEEEecCCCc-----------------hhHH-----HHHHHHHHHhcCCCC--
Q 017594           50 KFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSG-----------------QGLR-----EMKNEASVIAKVQHK--  105 (369)
Q Consensus        50 ~y~i~~~lg~G~~~~v~~~~~~~~~~valK~~~~~~~-----------------~~~~-----~~~~e~~~l~~l~h~--  105 (369)
                      -+.+.+.||-|.-+.+|.+-+..|...++|.......                 ..|-     ....|+..|+.|...  
T Consensus        93 v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf  172 (465)
T KOG2268|consen   93 VESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF  172 (465)
T ss_pred             hhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence            4788999999999999999999999999996421110                 0011     233577777777432  


Q ss_pred             ceeeeeeeEEeCCccEEEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEe
Q 017594          106 NLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLD  185 (369)
Q Consensus       106 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~  185 (369)
                      -+++.+++    +..++||+++.+..|...-.      ..   ....+...++..+--|-.+|   ++|||+.--||+++
T Consensus       173 pVPkpiD~----~RH~Vvmelv~g~Pl~~v~~------v~---d~~~ly~~lm~~Iv~la~~G---lIHgDFNEFNimv~  236 (465)
T KOG2268|consen  173 PVPKPIDH----NRHCVVMELVDGYPLRQVRH------VE---DPPTLYDDLMGLIVRLANHG---LIHGDFNEFNIMVK  236 (465)
T ss_pred             CCCCcccc----cceeeHHHhhcccceeeeee------cC---ChHHHHHHHHHHHHHHHHcC---ceecccchheeEEe
Confidence            24455543    46689999999887743321      12   23345566667777888888   99999999999999


Q ss_pred             CCCceEEeecCCcee
Q 017594          186 KDMNPKISDFGMARI  200 (369)
Q Consensus       186 ~~~~~~L~Dfg~~~~  200 (369)
                      .++.++++||-.+..
T Consensus       237 dd~~i~vIDFPQmvS  251 (465)
T KOG2268|consen  237 DDDKIVVIDFPQMVS  251 (465)
T ss_pred             cCCCEEEeechHhhc
Confidence            999999999975443

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=97.76  E-value=0.00032  Score=63.97  Aligned_cols=143  Identities=16%  Similarity=0.163  Sum_probs=95.3

Q ss_pred             CccCccccccCCccEEEEEEcCCCEEEEEEecCC-----Cc-----------------hh----HHHHHHHHHHHhcCCC
Q 017594           51 FSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGR-----SG-----------------QG----LREMKNEASVIAKVQH  104 (369)
Q Consensus        51 y~i~~~lg~G~~~~v~~~~~~~~~~valK~~~~~-----~~-----------------~~----~~~~~~e~~~l~~l~h  104 (369)
                      -.+...|..|.-+.||.|...+|..+|||++.-+     +.                 ..    .-....|+.-|.+|..
T Consensus       146 ~~inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~  225 (520)
T KOG2270|consen  146 VEINGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNN  225 (520)
T ss_pred             eecccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHh
Confidence            4567788899999999999989999999987321     00                 00    1123457777777755


Q ss_pred             CceeeeeeeEEeCCccEEEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEE
Q 017594          105 KNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILL  184 (369)
Q Consensus       105 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv  184 (369)
                      ..|.-.--+..  ...++||+|+.....   ..-..+...++...+..+-.+++.-+.-|.+..  .++|.||+--|+++
T Consensus       226 aGIP~PePIlL--k~hVLVM~FlGrdgw---~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLSEfN~Ly  298 (520)
T KOG2270|consen  226 AGIPCPEPILL--KNHVLVMEFLGRDGW---AAPKLKDASLSTSKARELYQQCVRIMRRLYQKC--RLVHADLSEFNLLY  298 (520)
T ss_pred             cCCCCCCceee--ecceEeeeeccCCCC---cCcccccccCChHHHHHHHHHHHHHHHHHHHHh--ceeccchhhhhheE
Confidence            44332221211  346899999864432   111223344666666667777777777777765  59999999999988


Q ss_pred             eCCCceEEeecCCceec
Q 017594          185 DKDMNPKISDFGMARIC  201 (369)
Q Consensus       185 ~~~~~~~L~Dfg~~~~~  201 (369)
                       .+|.+.++|.+.+...
T Consensus       299 -hdG~lyiIDVSQSVE~  314 (520)
T KOG2270|consen  299 -HDGKLYIIDVSQSVEH  314 (520)
T ss_pred             -ECCEEEEEEccccccC
Confidence             5568999998876543

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.69  E-value=0.00027  Score=64.52  Aligned_cols=74  Identities=23%  Similarity=0.318  Sum_probs=48.1

Q ss_pred             ccccccCCccEEEEEEcC-------CCEEEEEEecCCCchhHHHHHHHHHHHhcCCCCc-eeeeeeeEEeCCccEEEEEe
Q 017594           55 NKLGEGGFGPVYKGVLKK-------GDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKN-LVRLLGCCIDRDEKILIYEY  126 (369)
Q Consensus        55 ~~lg~G~~~~v~~~~~~~-------~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~-i~~~~~~~~~~~~~~lv~e~  126 (369)
                      +.|..|-...+|++...+       ++.+++|+..... ........|+.++..+...+ ..+++..+.    ...|++|
T Consensus         4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~----~~~v~e~   78 (302)
T cd05156           4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFP----NGRIEEF   78 (302)
T ss_pred             EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeC----CCchhhe
Confidence            456677778999988654       5789999876433 22345667888888875333 334444442    2468899


Q ss_pred             cCCCChh
Q 017594          127 MPNKSLD  133 (369)
Q Consensus       127 ~~~~~L~  133 (369)
                      ++|..+.
T Consensus        79 i~G~~l~   85 (302)
T cd05156          79 IPSRTLT   85 (302)
T ss_pred             eCCCcCC
Confidence            8887764

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=97.60  E-value=0.00097  Score=59.99  Aligned_cols=29  Identities=31%  Similarity=0.591  Sum_probs=24.7

Q ss_pred             CcccCCCCCCCEEEeCCCc-eEEeecCCce
Q 017594          171 RIIHRDLKASNILLDKDMN-PKISDFGMAR  199 (369)
Q Consensus       171 ~i~H~dl~p~NIlv~~~~~-~~L~Dfg~~~  199 (369)
                      .++|||++|.||+++.+++ .-|+||+.+.
T Consensus       186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~  215 (276)
T cd05152         186 VLVHGDLHPGHILIDEDARVTGLIDWTEAK  215 (276)
T ss_pred             eeEeCCCCCCcEEEeCCCCEEEEECcHhcc
Confidence            4899999999999997565 4699999765

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>PLN02236 choline kinase

Probab=97.58  E-value=0.00084  Score=62.43  Aligned_cols=141  Identities=16%  Similarity=0.181  Sum_probs=78.9

Q ss_pred             CccccccCCccEEEEEEcC-----CCEEEEEEecCCCchhHHHHHHHHHHHhcCCCCc-eeeeeeeEEeCCccEEEEEec
Q 017594           54 ANKLGEGGFGPVYKGVLKK-----GDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKN-LVRLLGCCIDRDEKILIYEYM  127 (369)
Q Consensus        54 ~~~lg~G~~~~v~~~~~~~-----~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~-i~~~~~~~~~~~~~~lv~e~~  127 (369)
                      +..|..|-...+|++...+     ++.|++|+......... ....|..+++.+...+ -.++++.+..+    .|.+|+
T Consensus        41 i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~i-dR~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi  115 (344)
T PLN02236         41 VIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFF-DRDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFI  115 (344)
T ss_pred             EEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeee-chHHHHHHHHHHHHcCCCCceEEEECCc----eEEEee
Confidence            3455568888999987532     36789998865433222 2366888888885333 33445554322    578999


Q ss_pred             CCCChhhhh-----------------cCCC--ccc-cCChHHHHHHHHHH-----------------HHHHHHH----hc
Q 017594          128 PNKSLDFFL-----------------FDPT--KRM-LLDWVTRVQIIEGI-----------------AQGLLYL----HQ  166 (369)
Q Consensus       128 ~~~~L~~~l-----------------~~~~--~~~-~~~~~~~~~i~~qi-----------------~~al~~L----H~  166 (369)
                      ++.++...-                 +...  ... ......+.++..++                 ...+..|    ..
T Consensus       116 ~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~  195 (344)
T PLN02236        116 HARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSG  195 (344)
T ss_pred             CCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcc
Confidence            887764210                 0100  000 11111222222111                 1111111    11


Q ss_pred             -CCCCCcccCCCCCCCEEEeC-CCceEEeecCCce
Q 017594          167 -YSRVRIIHRDLKASNILLDK-DMNPKISDFGMAR  199 (369)
Q Consensus       167 -~~~~~i~H~dl~p~NIlv~~-~~~~~L~Dfg~~~  199 (369)
                       .....++|+|+++.||+++. ++.+.++||..+.
T Consensus       196 ~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~  230 (344)
T PLN02236        196 DDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYAS  230 (344)
T ss_pred             cCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence             11235899999999999986 4689999998765

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=97.56  E-value=0.0014  Score=59.62  Aligned_cols=141  Identities=17%  Similarity=0.226  Sum_probs=92.4

Q ss_pred             CCccCccccccCCccEEEEEEcCCCEEEEEEec--CCCchhHHHHHHHHHHHhcCCC--CceeeeeeeEEeCC--ccEEE
Q 017594           50 KFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLS--GRSGQGLREMKNEASVIAKVQH--KNLVRLLGCCIDRD--EKILI  123 (369)
Q Consensus        50 ~y~i~~~lg~G~~~~v~~~~~~~~~~valK~~~--~~~~~~~~~~~~e~~~l~~l~h--~~i~~~~~~~~~~~--~~~lv  123 (369)
                      ...+++.+..|....+|..... ++++++. ..  ...........+|+..++.+..  .-+...+.++..+.  ..|+|
T Consensus        26 ~~~~v~~~~~G~sn~t~~~~~~-~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v  103 (321)
T COG3173          26 GLLIVEEISGGWSNDTFRLGDT-GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYV  103 (321)
T ss_pred             CCceeeeccCCcccceEEEecC-CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEE
Confidence            3455566656666677777665 7788888 33  2233455667778888888743  23444555555555  56999


Q ss_pred             EEecCCCChhhhhcCCCccccCChHHHHHHH-HHHHHHHHHHhcCC----------------------------------
Q 017594          124 YEYMPNKSLDFFLFDPTKRMLLDWVTRVQII-EGIAQGLLYLHQYS----------------------------------  168 (369)
Q Consensus       124 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~-~qi~~al~~LH~~~----------------------------------  168 (369)
                      |++++|.........        .....+.+ ..++..|..||+-.                                  
T Consensus       104 ~~~veGe~~~~~~~~--------~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~  175 (321)
T COG3173         104 MEWVEGEVVWSALPP--------ESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGG  175 (321)
T ss_pred             EEEecceeccCcCCc--------ccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccC
Confidence            999998644222211        11111222 36677777777654                                  


Q ss_pred             ---------------------CCCcccCCCCCCCEEEeCCCceEEeecCCcee
Q 017594          169 ---------------------RVRIIHRDLKASNILLDKDMNPKISDFGMARI  200 (369)
Q Consensus       169 ---------------------~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~  200 (369)
                                           ...++|||+.+.|++++.++-+-++||+++..
T Consensus       176 ~~p~~~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~l  228 (321)
T COG3173         176 RIPLADRLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATL  228 (321)
T ss_pred             CCchHHHHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEecccccc
Confidence                                 12789999999999999998899999998764

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=97.44  E-value=0.0012  Score=59.46  Aligned_cols=75  Identities=16%  Similarity=0.232  Sum_probs=47.7

Q ss_pred             ccCccccccCCccEEEEEEcCCCEEEEEEecCCCchhHHHHHHHHHHHhcCC---CCceeeeeeeEEeCCccEEEEEecC
Q 017594           52 SDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQ---HKNLVRLLGCCIDRDEKILIYEYMP  128 (369)
Q Consensus        52 ~i~~~lg~G~~~~v~~~~~~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~~~~~lv~e~~~  128 (369)
                      +-.+.++.|....+|... .+++.+.+|+-..   .....+..|+.-|+.|.   .-.+++++.+....+..++++||++
T Consensus        20 ~~~~~v~GG~i~~a~~~~-~~~~~~FvK~~~~---~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~   95 (288)
T PF03881_consen   20 TSIEPVSGGDINEAYRLD-TDGGSYFVKVNSE---SGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLE   95 (288)
T ss_dssp             -EEEEE--SSSSEEEEEE-TTS-EEEEEEEEG---GGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE---
T ss_pred             eeeEecCCCChhheEEEE-CCCccEEEEecCh---hhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeec
Confidence            345678889999999887 5578899998762   22356777888888773   3467788888877778899999987


Q ss_pred             CC
Q 017594          129 NK  130 (369)
Q Consensus       129 ~~  130 (369)
                      .+
T Consensus        96 ~~   97 (288)
T PF03881_consen   96 MG   97 (288)
T ss_dssp             --
T ss_pred             CC
Confidence            66

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=97.38  E-value=0.0036  Score=52.94  Aligned_cols=137  Identities=20%  Similarity=0.328  Sum_probs=89.4

Q ss_pred             cCCCccccchhhHHHHhcCCccCccccccCC-ccEEEEEEcCCCEEEEEEecC---CCc------------------hhH
Q 017594           32 EVDQFPLFSFSSVSTATNKFSDANKLGEGGF-GPVYKGVLKKGDEIAVKRLSG---RSG------------------QGL   89 (369)
Q Consensus        32 ~~~~~~~~~~~~~~~~~~~y~i~~~lg~G~~-~~v~~~~~~~~~~valK~~~~---~~~------------------~~~   89 (369)
                      +-.++..|..     -...++.++.||.|.- |.||+++.. |+.+|+|++..   ...                  .-.
T Consensus        25 ~gPKL~~F~~-----h~~~I~flefLg~g~~~~~V~kv~I~-g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~   98 (207)
T PF13095_consen   25 PGPKLEPFTH-----HGDDIEFLEFLGHGSHDGYVFKVEID-GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYA   98 (207)
T ss_pred             CCCCcCCcCC-----CCCcEeeeeecCCCCceeEEEEEEEC-CeEEEEEEeeccccCCCccccccccccccccchhhhhc
Confidence            3444445555     2278999999999999 999999987 77999999321   110                  011


Q ss_pred             HHHHHHHHHHhcC---CCCce--eeeeeeEEeCC------------------ccEEEEEecCCCChhhhhcCCCccccCC
Q 017594           90 REMKNEASVIAKV---QHKNL--VRLLGCCIDRD------------------EKILIYEYMPNKSLDFFLFDPTKRMLLD  146 (369)
Q Consensus        90 ~~~~~e~~~l~~l---~h~~i--~~~~~~~~~~~------------------~~~lv~e~~~~~~L~~~l~~~~~~~~~~  146 (369)
                      .-+..|-.+..+|   .+.++  ++++++..-..                  ...||.||+....            .+.
T Consensus        99 ~PF~~ECRAfgRLke~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~------------~~~  166 (207)
T PF13095_consen   99 DPFNCECRAFGRLKEAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP------------PLQ  166 (207)
T ss_pred             ChHHHHHHhhHHHHhccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc------------ccc
Confidence            1244555555555   44555  88888874321                  1246666654432            112


Q ss_pred             hHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCc
Q 017594          147 WVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMA  198 (369)
Q Consensus       147 ~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~  198 (369)
                          ..-+.+|.+-+..+|..|   |+-+|+++.|..     .-+|+|||.+
T Consensus       167 ----~~~~~~~~~dl~~~~k~g---I~~~Dv~~~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  167 ----IRDIPQMLRDLKILHKLG---IVPRDVKPRNYR-----GGKLVDFSSS  206 (207)
T ss_pred             ----hhHHHHHHHHHHHHHHCC---eeeccCcccccc-----CCEEEecccC
Confidence                233556777888999999   999999999985     3478888853

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=97.23  E-value=0.0055  Score=56.16  Aligned_cols=29  Identities=24%  Similarity=0.346  Sum_probs=26.7

Q ss_pred             CcccCCCCCCCEEEeCCCceEEeecCCce
Q 017594          171 RIIHRDLKASNILLDKDMNPKISDFGMAR  199 (369)
Q Consensus       171 ~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~  199 (369)
                      ++||||+.++|++++.++.+.++||..++
T Consensus       197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~  225 (309)
T TIGR02904       197 VLVHGKLSLSHFLYDETRGGYFINFEKAS  225 (309)
T ss_pred             eeeCCCCcHHhEEEcCCCCEEEEEhhhcc
Confidence            59999999999999999999999998765

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>PLN02756 S-methyl-5-thioribose kinase

Probab=97.00  E-value=0.0052  Score=57.80  Aligned_cols=74  Identities=12%  Similarity=0.135  Sum_probs=51.4

Q ss_pred             cCccccccCCccEEEEEEcCCCEEEEEEecC-----CC--chhHHHHHHHHHHHhcCC--C-CceeeeeeeEEeCCccEE
Q 017594           53 DANKLGEGGFGPVYKGVLKKGDEIAVKRLSG-----RS--GQGLREMKNEASVIAKVQ--H-KNLVRLLGCCIDRDEKIL  122 (369)
Q Consensus        53 i~~~lg~G~~~~v~~~~~~~~~~valK~~~~-----~~--~~~~~~~~~e~~~l~~l~--h-~~i~~~~~~~~~~~~~~l  122 (369)
                      ..+.||.|....||++... ++.++||.-..     ..  +....+...|+..|+.+.  . ..+++++.++.  +..++
T Consensus        36 ~~~eiggGn~N~VyrV~~~-~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vl  112 (418)
T PLN02756         36 KIKEVGDGNLNFVYIVVSS-SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALI  112 (418)
T ss_pred             eEEEcCCCceeeEEEEEcC-CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEE
Confidence            3668899999999998875 55789997541     11  123455566677777664  2 36777776654  56788


Q ss_pred             EEEecCC
Q 017594          123 IYEYMPN  129 (369)
Q Consensus       123 v~e~~~~  129 (369)
                      +||++++
T Consensus       113 vME~L~~  119 (418)
T PLN02756        113 GMRYLEP  119 (418)
T ss_pred             EEeecCC
Confidence            9999977

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=96.89  E-value=0.0074  Score=55.82  Aligned_cols=73  Identities=15%  Similarity=0.259  Sum_probs=45.1

Q ss_pred             ccccccCCccEEEEEEcC----CCEEEEEEecCCCchhHHHHHHHHHHHhcCCCCce-eeeeeeEEeCCccEEEEEecCC
Q 017594           55 NKLGEGGFGPVYKGVLKK----GDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNL-VRLLGCCIDRDEKILIYEYMPN  129 (369)
Q Consensus        55 ~~lg~G~~~~v~~~~~~~----~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~lv~e~~~~  129 (369)
                      +.|..|-...+|++...+    +..|++|+...... ..-....|..+++.+...++ .+++.++.  +.  +|.+|+++
T Consensus        20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~-~~IdR~~E~~il~~l~~~gl~P~~l~~~~--~G--~i~~fi~g   94 (330)
T PLN02421         20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTD-YVIDRERELQAIKYLSAAGFGAKLLGVFG--NG--MIQSFINA   94 (330)
T ss_pred             EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcC-eEechHHHHHHHHHHHhcCCCCceeEEeC--Cc--EeehhhcC
Confidence            455567788899887543    23788998764432 22234568888888854433 34454442  22  58888887


Q ss_pred             CCh
Q 017594          130 KSL  132 (369)
Q Consensus       130 ~~L  132 (369)
                      .++
T Consensus        95 ~~l   97 (330)
T PLN02421         95 RTL   97 (330)
T ss_pred             CCC
Confidence            765

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=96.86  E-value=0.0064  Score=56.21  Aligned_cols=72  Identities=17%  Similarity=0.245  Sum_probs=48.6

Q ss_pred             cccccCCccEEEEEEcCC-CEEEEEEec-------CCCchhHHHHHHHHHHHhcCC--CC-ceeeeeeeEEeCCccEEEE
Q 017594           56 KLGEGGFGPVYKGVLKKG-DEIAVKRLS-------GRSGQGLREMKNEASVIAKVQ--HK-NLVRLLGCCIDRDEKILIY  124 (369)
Q Consensus        56 ~lg~G~~~~v~~~~~~~~-~~valK~~~-------~~~~~~~~~~~~e~~~l~~l~--h~-~i~~~~~~~~~~~~~~lv~  124 (369)
                      .||-|....||++...+| +.++||.-.       ..-+-...+..-|.+.|+...  .| .+++++.+  +.....+||
T Consensus         2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM   79 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM   79 (370)
T ss_pred             cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence            578999999999997654 589999632       112334566667888887763  34 34444433  566778999


Q ss_pred             EecCC
Q 017594          125 EYMPN  129 (369)
Q Consensus       125 e~~~~  129 (369)
                      |++..
T Consensus        80 EdL~~   84 (370)
T TIGR01767        80 EDLSH   84 (370)
T ss_pred             hhCcc
Confidence            98854

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>PRK12396 5-methylribose kinase; Reviewed

Probab=96.85  E-value=0.0036  Score=58.55  Aligned_cols=74  Identities=12%  Similarity=0.194  Sum_probs=51.2

Q ss_pred             CccccccCCccEEEEEEcC-CCEEEEEEec------CCCchhHHHHHHHHHHHhcCC--CCc-eeeeeeeEEeCCccEEE
Q 017594           54 ANKLGEGGFGPVYKGVLKK-GDEIAVKRLS------GRSGQGLREMKNEASVIAKVQ--HKN-LVRLLGCCIDRDEKILI  123 (369)
Q Consensus        54 ~~~lg~G~~~~v~~~~~~~-~~~valK~~~------~~~~~~~~~~~~e~~~l~~l~--h~~-i~~~~~~~~~~~~~~lv  123 (369)
                      .+.||-|.-.-||++.+.+ ++.|+||.-.      .+-.-..++..-|.+.|+...  .|. +++++.+  +.....+|
T Consensus        34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v  111 (409)
T PRK12396         34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV  111 (409)
T ss_pred             eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence            5688999999999999753 5679998632      122345667777888888774  453 4444433  55677888


Q ss_pred             EEecCC
Q 017594          124 YEYMPN  129 (369)
Q Consensus       124 ~e~~~~  129 (369)
                      ||++..
T Consensus       112 MEdL~~  117 (409)
T PRK12396        112 MEDLSD  117 (409)
T ss_pred             HHhCcc
Confidence            888754

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=96.79  E-value=0.003  Score=54.37  Aligned_cols=30  Identities=40%  Similarity=0.560  Sum_probs=21.5

Q ss_pred             CcccCCCCCCCEEE-eCCCceEEeecCCcee
Q 017594          171 RIIHRDLKASNILL-DKDMNPKISDFGMARI  200 (369)
Q Consensus       171 ~i~H~dl~p~NIlv-~~~~~~~L~Dfg~~~~  200 (369)
                      .++|+|+.+.||++ +.++.++|+||..+..
T Consensus       144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~  174 (211)
T PF01633_consen  144 VFCHNDLNPGNILINNKDGEVKLIDFEYAGY  174 (211)
T ss_dssp             EEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred             eEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence            58999999999999 8899999999998653

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>COG3001 Uncharacterized protein conserved in bacteria [Function unknown]

Probab=96.77  E-value=0.069  Score=46.00  Aligned_cols=75  Identities=20%  Similarity=0.306  Sum_probs=51.2

Q ss_pred             ccccccCCccEEEEEEcCCCEEEEEEecCCCchhHHHHHHHHHHHhcCC---CCceeeeeeeEEeCCccEEEEEecCCCC
Q 017594           55 NKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQ---HKNLVRLLGCCIDRDEKILIYEYMPNKS  131 (369)
Q Consensus        55 ~~lg~G~~~~v~~~~~~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~~~~~lv~e~~~~~~  131 (369)
                      +.+..|..-..|...+. ...+.+|.-.   ......+..|+.-|..|.   .-.+.+++.+.....+.|+|++|++-+.
T Consensus        22 ~~v~gG~inea~~v~dg-~~~~FvK~n~---~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~~   97 (286)
T COG3001          22 EEVSGGDINEAWRLRDG-TDPFFVKCNQ---REQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTGP   97 (286)
T ss_pred             cccCCccccceeEeecC-CcceEEEecc---hhhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCCC
Confidence            34445555566655543 6678888643   233456667777777663   4567888888888899999999998766


Q ss_pred             hh
Q 017594          132 LD  133 (369)
Q Consensus       132 L~  133 (369)
                      ++
T Consensus        98 ~d   99 (286)
T COG3001          98 LD   99 (286)
T ss_pred             CC
Confidence            54

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=96.73  E-value=0.015  Score=53.50  Aligned_cols=136  Identities=20%  Similarity=0.231  Sum_probs=77.9

Q ss_pred             CCccEEEEEEcCCCEEEEEEecCCCchhHHHHHHHHHHHhcCCCCc------eeeeeeeE--EeCC--ccEEEEEecCCC
Q 017594           61 GFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKN------LVRLLGCC--IDRD--EKILIYEYMPNK  130 (369)
Q Consensus        61 ~~~~v~~~~~~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~------i~~~~~~~--~~~~--~~~lv~e~~~~~  130 (369)
                      .-..+|.....+|+. ++|+....  .....+..|...+..|.-..      +...-+-.  ....  ..+.+++|++|.
T Consensus        37 ~eN~~f~~~~~~g~~-iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~~l~G~  113 (331)
T COG2334          37 EENSNFRVQTEDGRY-ILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFEYLPGR  113 (331)
T ss_pred             ccCceEEEEecCCCe-EEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEEecCCc
Confidence            567799998887766 88988755  33467778888888884211      11111111  1123  678889999998


Q ss_pred             Chhh-hh------------------cCCC--c---cccCChH-------------HHHHHHHHHHHHHHHHhcCC----C
Q 017594          131 SLDF-FL------------------FDPT--K---RMLLDWV-------------TRVQIIEGIAQGLLYLHQYS----R  169 (369)
Q Consensus       131 ~L~~-~l------------------~~~~--~---~~~~~~~-------------~~~~i~~qi~~al~~LH~~~----~  169 (369)
                      .+.. ..                  ....  +   .....+.             .-.....++...+..+...-    .
T Consensus       114 ~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~~~~lp  193 (331)
T COG2334         114 PLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARLPAHLP  193 (331)
T ss_pred             CcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhchhhCC
Confidence            8762 11                  0000  0   0001111             00112222333333333221    1


Q ss_pred             CC---cccCCCCCCCEEEeCCCc-eEEeecCCce
Q 017594          170 VR---IIHRDLKASNILLDKDMN-PKISDFGMAR  199 (369)
Q Consensus       170 ~~---i~H~dl~p~NIlv~~~~~-~~L~Dfg~~~  199 (369)
                      ..   ++|+|+.|.||+++.+.. .-++||+-+.
T Consensus       194 ~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~  227 (331)
T COG2334         194 ALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG  227 (331)
T ss_pred             cccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence            12   899999999999999885 8999999764

>PF11883 DUF3403: Domain of unknown function (DUF3403); InterPro: IPR021820 This functionally uncharacterised domain of around 50 amino acids is found in the C terminus of eukaryotic S-locus receptor kinase proteins

Probab=96.69  E-value=0.0012  Score=41.75  Aligned_cols=43  Identities=53%  Similarity=0.759  Sum_probs=37.8

Q ss_pred             hccCCCCCCCcccccccccccCCCCCC--ccCCcccccccccccC
Q 017594          327 ATLLPPKQPAFSYVRNTVTSTSSTGKT--EDCSINQVTISLLEAR  369 (369)
Q Consensus       327 ~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~  369 (369)
                      ..++.|++|++-..++.....+++.+.  ..+|.|++|+|.+|+|
T Consensus         4 ~~LP~PKqPgF~~~r~~~e~~sSss~~~~~~~SvNevTiT~l~~R   48 (48)
T PF11883_consen    4 ATLPQPKQPGFFTGRSPSETDSSSSKQRDESCSVNEVTITMLEAR   48 (48)
T ss_pred             ccCCCCCCCCEEeEcCCCCcCCCcccccCCCCCeeeEEEEeEecC
Confidence            468999999999998887777776666  8999999999999998

; GO: 0004674 protein serine/threonine kinase activity

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=96.57  E-value=0.011  Score=50.52  Aligned_cols=116  Identities=20%  Similarity=0.169  Sum_probs=68.7

Q ss_pred             cCCccEEEEEEcCCCEEEEEEecCCCch-hHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEEEEecCCCChhhhhcC
Q 017594           60 GGFGPVYKGVLKKGDEIAVKRLSGRSGQ-GLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFD  138 (369)
Q Consensus        60 G~~~~v~~~~~~~~~~valK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~  138 (369)
                      ++.++.-.++.+=|. ..+|++....-. ....+..++.++.++.  .|+++..-  +...+.++.|.|.....      
T Consensus        73 ~gNsTl~~~kt~iG~-L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i------  141 (308)
T PF07387_consen   73 NGNSTLLIGKTKIGP-LFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKI------  141 (308)
T ss_pred             CCceEEEEeccccch-hhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCccc------
Confidence            444444444433333 344544322211 2244566777777765  46666532  44457789998854211      


Q ss_pred             CCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCC
Q 017594          139 PTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGM  197 (369)
Q Consensus       139 ~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~  197 (369)
                               ... .++..=+++|.-.|+.. ...+|||..|+||+.+..|.+||.|-+.
T Consensus       142 ---------~~~-N~i~agi~~L~~fH~~~-~~~lHGD~np~NiM~D~~G~lKlVDP~~  189 (308)
T PF07387_consen  142 ---------NFS-NFITAGIKDLMDFHSEN-QHCLHGDCNPDNIMCDKFGYLKLVDPVC  189 (308)
T ss_pred             ---------chh-HHHHHhHHHHHHhhccC-CCeecCCCChhheeecCCCCEEecChhh
Confidence                     011 11111146778888542 2599999999999999999999999764

The function of this family is unknown.

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=96.53  E-value=0.028  Score=51.38  Aligned_cols=28  Identities=29%  Similarity=0.395  Sum_probs=24.6

Q ss_pred             CcccCCCCCCCEEEeCCCceEEeecCCce
Q 017594          171 RIIHRDLKASNILLDKDMNPKISDFGMAR  199 (369)
Q Consensus       171 ~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~  199 (369)
                      +++|||+.+.||+++. +.+.|+||+.+.
T Consensus       188 ~liHgD~~~~Nil~~~-~~i~lIDfd~~~  215 (313)
T TIGR02906       188 GFCHQDYAYHNILLKD-NEVYVIDFDYCT  215 (313)
T ss_pred             ceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence            4899999999999988 678999998653

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>PRK11768 serine/threonine protein kinase; Provisional

Probab=96.39  E-value=0.15  Score=47.09  Aligned_cols=97  Identities=10%  Similarity=0.042  Sum_probs=57.7

Q ss_pred             CccccchhhHHHHhcCCccCc----cccccCCccEEEEEEcCCCEEEEEEecCCCchhHHHHHHHHHHHhcCCCCc--ee
Q 017594           35 QFPLFSFSSVSTATNKFSDAN----KLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKN--LV  108 (369)
Q Consensus        35 ~~~~~~~~~~~~~~~~y~i~~----~lg~G~~~~v~~~~~~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~--i~  108 (369)
                      ++...+...+..+...+-+..    ..-.+....||.+...+|..+++|+..... .....+..|...+..|....  ++
T Consensus         7 ~~~~l~p~~~~~a~~~~g~~~~~~~~~l~s~eN~vy~v~~~~~~~~vlKv~r~~~-~~~~~i~~E~~~l~~L~~~gipv~   85 (325)
T PRK11768          7 PFQTLTPDLILDALESLGLRVDGRLLALNSYENRVYQFGDEDGRRVVAKFYRPER-WSDAQILEEHAFALELAEAEIPVV   85 (325)
T ss_pred             CCCCCChHHHHHHHHHcCCCCccceEeeccccceEEEEecCCCCEEEEEEcCccc-CCHHHHHHHHHHHHHHHHCCCCCC
Confidence            445556666666666664421    122455677999988778889999875322 23456677777777663211  22


Q ss_pred             eee---e--eEEeCCccEEEEEecCCCCh
Q 017594          109 RLL---G--CCIDRDEKILIYEYMPNKSL  132 (369)
Q Consensus       109 ~~~---~--~~~~~~~~~lv~e~~~~~~L  132 (369)
                      ...   +  ....++..+.++++++|...
T Consensus        86 ~p~~~~G~~~~~~~g~~~~l~~~~~G~~~  114 (325)
T PRK11768         86 APLAFNGQTLHEHQGFRFALFPRRGGRAP  114 (325)
T ss_pred             CCccCCCCEEEEECCEEEEEEeeeCCCCC
Confidence            211   1  12234557889999887654

>PTZ00384 choline kinase; Provisional

Probab=96.01  E-value=0.058  Score=50.85  Aligned_cols=76  Identities=17%  Similarity=0.291  Sum_probs=45.3

Q ss_pred             cCccccccCCccEEEEEEcCC--CE-----EEEEEecCCCchhHHHHHHHHHHHhcCCCCc-eeeeeeeEEeCCccEEEE
Q 017594           53 DANKLGEGGFGPVYKGVLKKG--DE-----IAVKRLSGRSGQGLREMKNEASVIAKVQHKN-LVRLLGCCIDRDEKILIY  124 (369)
Q Consensus        53 i~~~lg~G~~~~v~~~~~~~~--~~-----valK~~~~~~~~~~~~~~~e~~~l~~l~h~~-i~~~~~~~~~~~~~~lv~  124 (369)
                      .++.|..|-...+|++...++  ..     |+++... ......-.-..|+.+++.+...+ -.++++.+.    .+++.
T Consensus        54 ~i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g-~~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~----~g~l~  128 (383)
T PTZ00384         54 EIKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSS-TYNSLVIDNDLQYNIAKLLGDNNFGPKIIGRFG----DFTIQ  128 (383)
T ss_pred             EEEEeCCcccceEEEEEecCCCCCccccceEEEEecc-CCCceEeccHHHHHHHHHHHhCCCCCeEEEecC----CEEEE
Confidence            344565688899999975432  22     4444322 22221223356888888886444 344555543    36999


Q ss_pred             EecCCCChh
Q 017594          125 EYMPNKSLD  133 (369)
Q Consensus       125 e~~~~~~L~  133 (369)
                      ||++|.++.
T Consensus       129 efIeGr~l~  137 (383)
T PTZ00384        129 EWVEGNTMG  137 (383)
T ss_pred             EEeccccCC
Confidence            999988774

>PRK06148 hypothetical protein; Provisional

Probab=95.94  E-value=0.12  Score=55.15  Aligned_cols=158  Identities=18%  Similarity=0.247  Sum_probs=83.6

Q ss_pred             cchhhH-HHHhcCCccC---ccccccCCccEEEEEEcCCCEEEEEEecCCCchhHHHHHHHHHHHhcC-------CCCce
Q 017594           39 FSFSSV-STATNKFSDA---NKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKV-------QHKNL  107 (369)
Q Consensus        39 ~~~~~~-~~~~~~y~i~---~~lg~G~~~~v~~~~~~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l-------~h~~i  107 (369)
                      .+...+ ..+.+.|-+.   +.|+ |..-.+|++...+|..+++|+......  ......+...+..|       ..|.+
T Consensus        11 ~s~~~~~~~~~~~ygl~~~~~~L~-s~~d~nf~v~~~~g~~yVLKi~~~~~~--~~~~~~q~~~L~hL~~~~~glpvP~~   87 (1013)
T PRK06148         11 FTTKDAEALLAQHFGISATATPLD-GERDLNFRLTTDDGADYILKIVNPSEP--RVESDFQTAALDHLAAVAPDLPVPRL   87 (1013)
T ss_pred             CCHHHHHHHHHHHcCCceEEeecC-CcCCceEEEEeCCCCeEEEEEcCCccc--hhHHHHHHHHHHHHHhhCCCCCcCee
Confidence            333333 3344445543   4453 456888999887788999999875432  23334444555444       23333


Q ss_pred             eeee-----eeEEe-CC--ccEEEEEecCCCChhhhh---------------------cC--CC-ccccCCh--------
Q 017594          108 VRLL-----GCCID-RD--EKILIYEYMPNKSLDFFL---------------------FD--PT-KRMLLDW--------  147 (369)
Q Consensus       108 ~~~~-----~~~~~-~~--~~~lv~e~~~~~~L~~~l---------------------~~--~~-~~~~~~~--------  147 (369)
                      ++..     ..... +.  ..+.+++|++|..+....                     ..  .. ....+.+        
T Consensus        88 i~t~~G~~~~~v~~~~G~~~~vrLl~~l~G~~l~~~~~~t~~~~~~lG~~larlh~al~~F~~p~~~r~~~Wdl~~~~~l  167 (1013)
T PRK06148         88 IPSLSGASLASAQDPDGEPRLLRLLSWLPGTPLAEAAPRTEALLDNLGRALGRLDRALQGFMHPGALRDLDWDLRHAGRA  167 (1013)
T ss_pred             eecCCCCeEEEeecCCCceEEEEEEeccCCCcHHhccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccccccccccchhh
Confidence            3321     11111 11  457789999998775410                     00  00 0000111        


Q ss_pred             ---------HHHHHHHHHHHHHHH-----HHhcCCCCCcccCCCCCCCEEEeCCC--ceE-EeecCCcee
Q 017594          148 ---------VTRVQIIEGIAQGLL-----YLHQYSRVRIIHRDLKASNILLDKDM--NPK-ISDFGMARI  200 (369)
Q Consensus       148 ---------~~~~~i~~qi~~al~-----~LH~~~~~~i~H~dl~p~NIlv~~~~--~~~-L~Dfg~~~~  200 (369)
                               .....++.+++..+.     .+... ...++|+|+.+.||+++.++  ++. |+|||-+..
T Consensus       168 ~~~l~~i~d~~~r~~l~~~~~~~~~~v~p~l~~L-p~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~  236 (1013)
T PRK06148        168 RDRLHFIDDPEDRALVERFLARFERNVAPRLAAL-PAQVIHNDANDYNILVDADDGERISGLIDFGDAVH  236 (1013)
T ss_pred             hhhhhhcCCHHHHHHHHHHHHHHHHHHHHHHhcC-CcceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence                     111222233333222     12111 23499999999999998875  554 999997653

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=95.94  E-value=0.0023  Score=68.23  Aligned_cols=157  Identities=13%  Similarity=0.015  Sum_probs=108.5

Q ss_pred             HHHHHhcCCCCceeeeeeeEEe--CCccEEEEEecCCCChhhhhcCCCc-cccCChHHHHHHHHHH-HHHHHHHhcCC--
Q 017594           95 EASVIAKVQHKNLVRLLGCCID--RDEKILIYEYMPNKSLDFFLFDPTK-RMLLDWVTRVQIIEGI-AQGLLYLHQYS--  168 (369)
Q Consensus        95 e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~i~~qi-~~al~~LH~~~--  168 (369)
                      |...++...|+++.....-...  ....+..++++.+|.+...+..... ..+++...+ ...+++ .....-+|.+.  
T Consensus      1279 e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v-~~~~kvsvl~~~~~ls~tnl 1357 (2724)
T KOG1826|consen 1279 ERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPV-HLRHKVSVLNRNVILSLTNL 1357 (2724)
T ss_pred             hhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchH-HHHHHHHHhccchhhhcccC
Confidence            4444555678877665544432  2346888999999999888765443 333443333 333333 55555544443  


Q ss_pred             CCCcccCCCCCCCEEEeCCCceEEeecCCceecCCCCcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHh
Q 017594          169 RVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS  248 (369)
Q Consensus       169 ~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~t  248 (369)
                      .+..+|.++++.|.++..+..++++++|+.+.-.  ......+...+++.|++|++.+.-.++.++|+|..|+.+|.+..
T Consensus      1358 g~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIkn--p~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs~ 1435 (2724)
T KOG1826|consen 1358 GNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKN--PVLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRSD 1435 (2724)
T ss_pred             CccchhhhhhhhccceecCCcccccccccccccC--chHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHhc
Confidence            3457899999999999999999999999977211  11122333456778899998888889989999999999999999


Q ss_pred             CCCCCC
Q 017594          249 GKKNTG  254 (369)
Q Consensus       249 g~~p~~  254 (369)
                      |..+|-
T Consensus      1436 ~n~~fi 1441 (2724)
T KOG1826|consen 1436 GNAYFI 1441 (2724)
T ss_pred             ccHHHH
Confidence            887653

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=95.62  E-value=0.1  Score=48.15  Aligned_cols=104  Identities=15%  Similarity=0.120  Sum_probs=68.3

Q ss_pred             cEEEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCce
Q 017594          120 KILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMAR  199 (369)
Q Consensus       120 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~  199 (369)
                      .|++|++- |+++.       ........++..++.+.+..+.-+...-  ++-|+|+.-.||+++ +|++.|+||-+++
T Consensus       301 ~yl~~kdh-gt~is-------~ik~~~~~e~lsff~s~~sil~~lekkf--~fehrnlt~~niLId-~GnvtLIDfklsR  369 (488)
T COG5072         301 LYLHFKDH-GTPIS-------IIKADRSEEELSFFWSCISILDILEKKF--PFEHRNLTLDNILID-EGNVTLIDFKLSR  369 (488)
T ss_pred             EEEEEecC-Cceee-------eeecccHHHHHHHHHHHHHHHhhhhhcC--Ccccccccccceeee-cCceEEEEeeeee
Confidence            46667653 44442       1223456788889999998888888776  699999999999999 9999999999987


Q ss_pred             ecCCCCcccccccccccccccCchhhccCCCCcccchHhHHHH
Q 017594          200 ICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVL  242 (369)
Q Consensus       200 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~i  242 (369)
                      .-..+.       .......--|-.+.|. -+..-+||-+--.
T Consensus       370 l~~~q~-------~isy~rldhp~lF~G~-dd~QFeIYrlMr~  404 (488)
T COG5072         370 LSYSQG-------IISYNRLDHPDLFNGV-DDYQFEIYRLMRR  404 (488)
T ss_pred             cccCCc-------eeeccccCchhhhcCc-cceeeeHHHHHHH
Confidence            422111       1112223345544432 2556677765433

>PTZ00296 choline kinase; Provisional

Probab=95.61  E-value=0.11  Score=50.10  Aligned_cols=75  Identities=15%  Similarity=0.139  Sum_probs=46.7

Q ss_pred             cCccccccCCccEEEEEEcC---------CCEEEEEEecCCCchhHHHHHHHHHHHhcCCCCcee-eeeeeEEeCCccEE
Q 017594           53 DANKLGEGGFGPVYKGVLKK---------GDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLV-RLLGCCIDRDEKIL  122 (369)
Q Consensus        53 i~~~lg~G~~~~v~~~~~~~---------~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~-~~~~~~~~~~~~~l  122 (369)
                      -++.|..|-.-.+|++...+         ++.|++++.-.....- -....|..+++.+...++- ++++.+    ..+.
T Consensus       109 ~i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~te~l-IdR~~E~~v~~~ls~~gi~P~l~~~f----~gg~  183 (442)
T PTZ00296        109 RVNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDVDEL-YNPISEFEVYKTMSKYRIAPQLLNTF----SGGR  183 (442)
T ss_pred             EEEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCccce-eCHHHHHHHHHHHHHCCCCCceEEEe----CCCE
Confidence            45667778888899988542         4578888876443222 2345577777777533332 344443    2456


Q ss_pred             EEEecCCCCh
Q 017594          123 IYEYMPNKSL  132 (369)
Q Consensus       123 v~e~~~~~~L  132 (369)
                      +.+|++|.++
T Consensus       184 I~efi~g~~l  193 (442)
T PTZ00296        184 IEEWLYGDPL  193 (442)
T ss_pred             EEEeeCCccC
Confidence            7899988755

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	369
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		1e-50
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		2e-49
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		5e-46
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		5e-46
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		3e-43
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		9e-43
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		9e-43
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		6e-41
3a4o_X	286	Lyn Kinase Domain Length = 286		1e-24
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		4e-24
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		2e-23
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		3e-23
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		3e-23
2pl0_A	289	Lck Bound To Imatinib Length = 289		3e-23
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		3e-23
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		3e-23
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		3e-23
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		3e-23
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		3e-23
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		3e-23
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		3e-23
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		3e-23
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		4e-23
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		1e-22
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		2e-22
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		2e-22
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		2e-22
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		3e-22
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		4e-22
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		4e-22
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		4e-22
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		4e-22
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		6e-22
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		6e-22
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		6e-22
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		6e-22
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		7e-22
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		7e-22
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		7e-22
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		7e-22
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		7e-22
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		8e-22
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		8e-22
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		9e-22
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		1e-21
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		1e-21
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-21
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		1e-21
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		1e-21
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		1e-21
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		1e-21
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		1e-21
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		1e-21
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		2e-21
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-21
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		2e-21
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		2e-21
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		2e-21
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		2e-21
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		2e-21
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		2e-21
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		2e-21
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		2e-21
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		2e-21
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-21
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		2e-21
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		2e-21
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		2e-21
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		2e-21
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		2e-21
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		2e-21
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		2e-21
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		2e-21
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		2e-21
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		2e-21
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		2e-21
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		2e-21
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		3e-21
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		3e-21
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		3e-21
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		3e-21
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		3e-21
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		3e-21
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		3e-21
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		4e-21
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		4e-21
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		4e-21
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		4e-21
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		4e-21
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		8e-21
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		9e-21
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		9e-21
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		1e-20
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		1e-20
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		1e-20
4h58_A	275	Braf In Complex With Compound 3 Length = 275		1e-20
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		1e-20
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		1e-20
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		1e-20
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		1e-20
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		1e-20
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		1e-20
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		1e-20
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		1e-20
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		1e-20
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		1e-20
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		1e-20
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		2e-20
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		2e-20
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		2e-20
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		2e-20
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-20
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		3e-20
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		4e-20
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		4e-20
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		5e-20
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		5e-20
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		6e-20
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		7e-20
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		7e-20
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		8e-20
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		8e-20
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		8e-20
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		8e-20
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		9e-20
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		9e-20
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		9e-20
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		9e-20
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		9e-20
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		9e-20
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		9e-20
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		9e-20
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		1e-19
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		1e-19
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		1e-19
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		1e-19
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		1e-19
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		1e-19
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		1e-19
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		1e-19
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		1e-19
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		1e-19
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		1e-19
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		1e-19
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		1e-19
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		2e-19
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		2e-19
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		2e-19
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		2e-19
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		2e-19
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		2e-19
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		2e-19
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		2e-19
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		2e-19
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		2e-19
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		3e-19
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		3e-19
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		3e-19
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		3e-19
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		3e-19
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		3e-19
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		3e-19
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		3e-19
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		3e-19
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		3e-19
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		3e-19
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		3e-19
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		3e-19
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		3e-19
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		3e-19
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		3e-19
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		3e-19
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		3e-19
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		4e-19
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		4e-19
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		4e-19
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		4e-19
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		4e-19
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		4e-19
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		4e-19
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		4e-19
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		5e-19
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		5e-19
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		5e-19
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		5e-19
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		6e-19
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		6e-19
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		7e-19
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		1e-18
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		1e-18
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		1e-18
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		1e-18
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		1e-18
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		1e-18
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		2e-18
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		2e-18
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-18
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		3e-18
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		3e-18
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		3e-18
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		3e-18
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		3e-18
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		5e-18
1fvr_A	327	Tie2 Kinase Domain Length = 327		6e-18
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		6e-18
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		7e-18
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		7e-18
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		8e-18
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		9e-18
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		9e-18
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		1e-17
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		1e-17
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		1e-17
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		1e-17
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		1e-17
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		1e-17
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		1e-17
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		1e-17
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		1e-17
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		1e-17
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		1e-17
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		1e-17
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		1e-17
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		1e-17
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		1e-17
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		2e-17
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-17
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		2e-17
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		2e-17
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		2e-17
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		2e-17
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		2e-17
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		2e-17
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		2e-17
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		3e-17
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		3e-17
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		4e-17
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		4e-17
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		4e-17
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		5e-17
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		7e-17
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		7e-17
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		7e-17
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		9e-17
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		1e-16
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		1e-16
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		1e-16
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		1e-16
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		1e-16
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		1e-16
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		1e-16
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		1e-16
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		1e-16
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		2e-16
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		2e-16
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		2e-16
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		2e-16
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		2e-16
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		2e-16
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-16
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		2e-16
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		2e-16
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-16
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		2e-16
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-16
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		2e-16
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		2e-16
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		3e-16
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		3e-16
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		3e-16
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		4e-16
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		4e-16
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		4e-16
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		6e-16
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		6e-16
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		7e-16
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		7e-16
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		7e-16
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		8e-16
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		9e-16
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		9e-16
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		1e-15
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		1e-15
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		1e-15
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		1e-15
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		1e-15
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		1e-15
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		1e-15
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		2e-15
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		2e-15
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		2e-15
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		2e-15
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		2e-15
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		2e-15
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-15
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		3e-15
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		3e-15
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		3e-15
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		3e-15
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		3e-15
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		3e-15
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		3e-15
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		3e-15
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		3e-15
3a7f_A	303	Human Mst3 Kinase Length = 303		3e-15
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		3e-15
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		3e-15
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		4e-15
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-15
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		4e-15
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		4e-15
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		4e-15
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		5e-15
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-15
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		5e-15
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		5e-15
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		5e-15
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-15
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		5e-15
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		6e-15
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		6e-15
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		6e-15
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		6e-15
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		6e-15
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		6e-15
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		6e-15
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		6e-15
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		6e-15
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		6e-15
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		7e-15
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		7e-15
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		7e-15
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		7e-15
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		7e-15
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		7e-15
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		7e-15
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		7e-15
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		7e-15
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		7e-15
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		8e-15
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		8e-15
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		8e-15
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		8e-15
3b2t_A	311	Structure Of Phosphotransferase Length = 311		8e-15
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		9e-15
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		9e-15
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		9e-15
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		1e-14
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		1e-14
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		1e-14
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		1e-14
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		1e-14
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		1e-14
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		1e-14
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		1e-14
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		1e-14
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		1e-14
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		1e-14
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		1e-14
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		1e-14
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		2e-14
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		2e-14
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		2e-14
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		2e-14
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		2e-14
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		2e-14
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-14
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		2e-14
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		2e-14
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		3e-14
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-14
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		3e-14
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		3e-14
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		3e-14
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		3e-14
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		3e-14
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		3e-14
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		3e-14
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		3e-14
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		4e-14
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		4e-14
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-14
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		4e-14
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		5e-14
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		5e-14
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		5e-14
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		5e-14
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		5e-14
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		5e-14
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		5e-14
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		5e-14
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		6e-14
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		6e-14
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		6e-14
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		6e-14
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		6e-14
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		6e-14
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		6e-14
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		6e-14
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		6e-14
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		6e-14
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		7e-14
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		7e-14
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		7e-14
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		7e-14
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		8e-14
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		9e-14
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		9e-14
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		1e-13
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		1e-13
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		1e-13
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		1e-13
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		1e-13
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		1e-13
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		1e-13
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		1e-13
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		1e-13
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		1e-13
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		2e-13
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		2e-13
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		2e-13
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		2e-13
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		2e-13
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		2e-13
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		2e-13
4fie_A	423	Full-Length Human Pak4 Length = 423		2e-13
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		2e-13
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		2e-13
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		2e-13
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		2e-13
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		2e-13
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-13
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		2e-13
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		2e-13
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		2e-13
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		2e-13
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		2e-13
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		2e-13
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		2e-13
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		2e-13
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		2e-13
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		2e-13
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		2e-13
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-13
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		2e-13
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		2e-13
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		2e-13
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		2e-13
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		2e-13
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		2e-13
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		2e-13
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		2e-13
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		2e-13
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		2e-13
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		2e-13
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		2e-13
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		2e-13
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		2e-13
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		2e-13
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		3e-13
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		3e-13
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		3e-13
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		3e-13
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		3e-13
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		3e-13
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		3e-13
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		3e-13
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		3e-13
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		3e-13
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		3e-13
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-13
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		3e-13
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		3e-13
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		3e-13
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		3e-13
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		3e-13
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		3e-13
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		4e-13
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		4e-13
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		4e-13
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		4e-13
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-13
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		4e-13
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		4e-13
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		4e-13
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		4e-13
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		4e-13
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-13
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		4e-13
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		4e-13
3kk8_A	284	Camkii Substrate Complex A Length = 284		4e-13
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		4e-13
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		5e-13
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		5e-13
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		5e-13
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		5e-13
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		5e-13
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		6e-13
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		6e-13
3kk9_A	282	Camkii Substrate Complex B Length = 282		6e-13
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		6e-13
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		6e-13
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		6e-13
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		7e-13
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		7e-13
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		8e-13
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		9e-13
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		1e-12
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		1e-12
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		1e-12
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		1e-12
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		1e-12
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		1e-12
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		1e-12
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		1e-12
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		1e-12
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		1e-12
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		1e-12
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		1e-12
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		2e-12
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		2e-12
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		2e-12
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		2e-12
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		2e-12
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		2e-12
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		2e-12
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		2e-12
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		2e-12
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		2e-12
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		3e-12
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		3e-12
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		3e-12
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		3e-12
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		3e-12
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-12
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-12
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-12
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		3e-12
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		4e-12
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		4e-12
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		4e-12
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		4e-12
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		4e-12
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		4e-12
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		4e-12
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		4e-12
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		4e-12
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		4e-12
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		5e-12
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		5e-12
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		5e-12
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		5e-12
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		5e-12
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		5e-12
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		5e-12
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		5e-12
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		5e-12
2oza_B	366	Structure Of P38alpha Complex Length = 366		5e-12
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		6e-12
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		6e-12
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		6e-12
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		6e-12
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		6e-12
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		7e-12
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		7e-12
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		7e-12
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		7e-12
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		7e-12
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		7e-12
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		8e-12
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		8e-12
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		8e-12
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		8e-12
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		8e-12
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		8e-12
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		8e-12
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		8e-12
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		9e-12
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		9e-12
3g51_A	325	Structural Diversity Of The Active Conformation Of		9e-12
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		9e-12
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		9e-12
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		9e-12
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		9e-12
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		1e-11
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		1e-11
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		1e-11
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		1e-11
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		1e-11
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		1e-11
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		1e-11
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		1e-11
3hec_A	348	P38 In Complex With Imatinib Length = 348		1e-11
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		1e-11
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		1e-11
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		1e-11
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		1e-11
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		1e-11
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		1e-11
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		1e-11
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		1e-11
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		1e-11
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		1e-11
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		1e-11
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		1e-11
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		1e-11
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		1e-11
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		1e-11
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		1e-11
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		1e-11
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		1e-11
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		1e-11
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		1e-11
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		1e-11
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		1e-11
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		1e-11
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		1e-11
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		1e-11
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		1e-11
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		1e-11
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		1e-11
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		1e-11
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		2e-11
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		2e-11
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-11
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		2e-11
4exu_A	371	Mapk13, Inactive Form Length = 371		2e-11
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		2e-11
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		2e-11
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		2e-11
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		2e-11
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		2e-11
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		2e-11
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		2e-11
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		2e-11
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		2e-11
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		2e-11
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		2e-11
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		2e-11
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		2e-11
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		2e-11
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		2e-11
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		2e-11
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		2e-11
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		2e-11
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		2e-11
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		2e-11
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		2e-11
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		2e-11
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		2e-11
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		2e-11
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		2e-11
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		2e-11
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		2e-11
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		2e-11
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		2e-11
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		2e-11
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		2e-11
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		2e-11
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		2e-11
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		2e-11
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		2e-11
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		2e-11
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		2e-11
3soa_A	444	Full-Length Human Camkii Length = 444		2e-11
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		3e-11
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		3e-11
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		3e-11
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-11
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		3e-11
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		3e-11
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		3e-11
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		3e-11
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		3e-11
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		3e-11
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		3e-11
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		3e-11
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		3e-11
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		3e-11
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		4e-11
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		4e-11
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		4e-11
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		4e-11
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		4e-11
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		4e-11
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		4e-11
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		4e-11
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		4e-11
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		4e-11
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		5e-11
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		5e-11
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		5e-11
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		5e-11
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		5e-11
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		5e-11
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		5e-11
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		5e-11
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		5e-11
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		6e-11
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		6e-11
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		6e-11
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		6e-11
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		6e-11
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		6e-11
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		6e-11
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		6e-11
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		6e-11
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		7e-11
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		7e-11
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		7e-11
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		8e-11
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		8e-11
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		8e-11
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		8e-11
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		8e-11
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		8e-11
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		8e-11
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		8e-11
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		9e-11
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		9e-11
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		9e-11
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		9e-11
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		1e-10
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		1e-10
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		1e-10
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-10
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		1e-10
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-10
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		1e-10
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		1e-10
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		1e-10
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		2e-10
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		2e-10
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		2e-10
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		2e-10
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		2e-10
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		2e-10
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		2e-10
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-10
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		2e-10
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		2e-10
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-10
4fl3_A	635	Structural And Biophysical Characterization Of The		2e-10
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		2e-10
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		2e-10
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		2e-10
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		2e-10
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		2e-10
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		2e-10
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		2e-10
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		2e-10
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		2e-10
4fl2_A	636	Structural And Biophysical Characterization Of The		2e-10
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		2e-10
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		2e-10
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		2e-10
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		2e-10
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		2e-10
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		2e-10
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		2e-10
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-10
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		2e-10
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		2e-10
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		2e-10
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		2e-10
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		2e-10
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		2e-10
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		2e-10
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		2e-10
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		2e-10
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		2e-10
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		2e-10
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		2e-10
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		2e-10
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		2e-10
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		2e-10
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		3e-10
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		3e-10
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		3e-10
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		3e-10
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		3e-10
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		3e-10
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		3e-10
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		3e-10
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		3e-10
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		3e-10
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		3e-10
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		3e-10
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		3e-10
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		4e-10
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		4e-10
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		4e-10
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		4e-10
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		4e-10
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		4e-10
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		4e-10
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		4e-10
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		4e-10
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		4e-10
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		4e-10
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		4e-10
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		4e-10
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		4e-10
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		5e-10
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		5e-10
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		5e-10
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		5e-10
4ae9_A	343	Structure And Function Of The Human Sperm-specific		5e-10
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		5e-10
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		5e-10
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		6e-10
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		6e-10
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		6e-10
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		6e-10
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		6e-10
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		6e-10
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		6e-10
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		6e-10
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		6e-10
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		6e-10
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		6e-10
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		7e-10
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		7e-10
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		7e-10
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		7e-10
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		7e-10
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		7e-10
4ae6_A	343	Structure And Function Of The Human Sperm-specific		7e-10
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		7e-10
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		8e-10
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		8e-10
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		8e-10
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		8e-10
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		8e-10
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		8e-10
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		8e-10
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		8e-10
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		9e-10
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		9e-10
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		9e-10
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		9e-10
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		1e-09
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		1e-09
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		1e-09
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		1e-09
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		1e-09
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		1e-09
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		1e-09
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-09
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		2e-09
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		2e-09
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		2e-09
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		2e-09
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		2e-09
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		2e-09
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		2e-09
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		2e-09
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		2e-09
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		2e-09
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		2e-09
4fvr_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain M		2e-09
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		2e-09
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		2e-09
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		2e-09
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		2e-09
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		3e-09
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		3e-09
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		3e-09
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		3e-09
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		3e-09
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		3e-09
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		4e-09
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		4e-09
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		4e-09
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		4e-09
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		5e-09
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		5e-09
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		5e-09
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		5e-09
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		5e-09
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		5e-09
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		6e-09
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		6e-09
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		6e-09
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		6e-09
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		6e-09
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		7e-09
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		7e-09
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		7e-09
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		8e-09
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		8e-09
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		8e-09
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		8e-09
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		8e-09
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		8e-09
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		8e-09
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		8e-09
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		8e-09
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		9e-09
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		9e-09
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		1e-08
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		1e-08
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		1e-08
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-08
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		1e-08
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		1e-08
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		1e-08
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		1e-08
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		1e-08
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		1e-08
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		1e-08
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		1e-08
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		2e-08
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		2e-08
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		2e-08
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		2e-08
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		2e-08
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		2e-08
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		2e-08
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		2e-08
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		2e-08
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		2e-08
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		3e-08
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		3e-08
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		3e-08
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		4e-08
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		4e-08
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		5e-08
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		8e-08
3kmw_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		9e-08
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		9e-08
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		1e-07
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		1e-07
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		1e-07
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		1e-07
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		2e-07
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		2e-07
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		2e-07
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		2e-07
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		2e-07
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		2e-07
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		2e-07
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		3e-07
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		3e-07
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		3e-07
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		4e-07
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		4e-07
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		4e-07
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		5e-07
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		6e-07
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		7e-07
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		7e-07
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		1e-06
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		1e-06
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		1e-06
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		2e-06
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		2e-06
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		2e-06
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		2e-06
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		2e-06
3llt_A	360	Crystal Structure Of Pf14_0431, Kinase Domain Lengt		4e-06
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		4e-06
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		4e-06
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		5e-06
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		6e-06
1q8y_A	373	The Structure Of The Yeast Sr Protein Kinase, Sky1p		6e-06
1how_A	373	The X-Ray Crystal Structure Of Sky1p, An Sr Protein		7e-06
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		7e-06
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		7e-06
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		7e-06
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		8e-06
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		8e-06
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		9e-06
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		9e-06
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		1e-05
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-05
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		1e-05
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-05
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		1e-05
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		1e-05
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-05
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		1e-05
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		1e-05
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-05
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		1e-05
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		1e-05
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		1e-05
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		1e-05
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		1e-05
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		1e-05
4f99_A	361	Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti		1e-05
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		1e-05
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		1e-05
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		1e-05
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		1e-05
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		1e-05
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		1e-05
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		1e-05
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		1e-05
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		1e-05

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  196 bits (499), Expect = 1e-50,   Method: Compositional matrix adjust.
 Identities = 114/307 (37%), Positives = 175/307 (57%), Gaps = 7/307 (2%)
Query: 25  AKRSKKKEVDQFPLFSFSSVSTATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGR 84
           A+   +  + Q   FS   +  A++ FS+ N LG GGFG VYKG L  G  +AVKRL   
Sbjct: 14  AEEDPEVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEE 73
Query: 85  SGQGLR-EMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFD-PTKR 142
             QG   + + E  +I+   H+NL+RL G C+   E++L+Y YM N S+   L + P  +
Sbjct: 74  RXQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQ 133
Query: 143 MLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICG 202
             LDW  R +I  G A+GL YLH +   +IIHRD+KA+NILLD++    + DFG+A++  
Sbjct: 134 PPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 193
Query: 203 GNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYR---TD 259
             +     + + GT G+++PEY   G  S K+DVF +GV+LLE+++G++   L R    D
Sbjct: 194 YKDXHVXXA-VRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDD 252
Query: 260 SLNLLGYAWDLWTSNRTLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVV 319
            + LL +   L    +   L+D  L+  Y  ++ + +   +ALLC Q S  +RP M++VV
Sbjct: 253 DVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEE-VEQLIQVALLCTQSSPMERPKMSEVV 311
Query: 320 SMLTNEA 326
            ML  + 
Sbjct: 312 RMLEGDG 318

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  192 bits (489), Expect = 2e-49,   Method: Compositional matrix adjust.
 Identities = 112/307 (36%), Positives = 173/307 (56%), Gaps = 7/307 (2%)
Query: 25  AKRSKKKEVDQFPLFSFSSVSTATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGR 84
           A+   +  + Q   FS   +  A++ F + N LG GGFG VYKG L  G  +AVKRL   
Sbjct: 6   AEEDPEVHLGQLKRFSLRELQVASDNFXNKNILGRGGFGKVYKGRLADGXLVAVKRLKEE 65
Query: 85  SGQGLR-EMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFD-PTKR 142
             QG   + + E  +I+   H+NL+RL G C+   E++L+Y YM N S+   L + P  +
Sbjct: 66  RTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQ 125
Query: 143 MLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICG 202
             LDW  R +I  G A+GL YLH +   +IIHRD+KA+NILLD++    + DFG+A++  
Sbjct: 126 PPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 185
Query: 203 GNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYR---TD 259
             +     + + G  G+++PEY   G  S K+DVF +GV+LLE+++G++   L R    D
Sbjct: 186 YKDXHVXXA-VRGXIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDD 244
Query: 260 SLNLLGYAWDLWTSNRTLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVV 319
            + LL +   L    +   L+D  L+  Y  ++ + +   +ALLC Q S  +RP M++VV
Sbjct: 245 DVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEE-VEQLIQVALLCTQSSPMERPKMSEVV 303
Query: 320 SMLTNEA 326
            ML  + 
Sbjct: 304 RMLEGDG 310

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  181 bits (460), Expect = 5e-46,   Method: Compositional matrix adjust.
 Identities = 112/280 (40%), Positives = 174/280 (62%), Gaps = 16/280 (5%)
Query: 47  ATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKN 106
           ATN F     +G G FG VYKGVL+ G ++A+KR +  S QG+ E + E   ++  +H +
Sbjct: 37  ATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPH 96
Query: 107 LVRLLGCCIDRDEKILIYEYMPNKSLDFFLFD---PTKRMLLDWVTRVQIIEGIAQGLLY 163
           LV L+G C +R+E ILIY+YM N +L   L+    PT  M + W  R++I  G A+GL Y
Sbjct: 97  LVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPT--MSMSWEQRLEICIGAARGLHY 154
Query: 164 LHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNEL-QANTSRIV-GTYGYMS 221
           LH  +   IIHRD+K+ NILLD++  PKI+DFG+++   G EL Q +   +V GT GY+ 
Sbjct: 155 LHTRA---IIHRDVKSINILLDENFVPKITDFGISK--KGTELGQTHLXXVVKGTLGYID 209
Query: 222 PEYALEGIFSIKSDVFSFGVLLLEIVSGKKNT--GLYRTDSLNLLGYAWDLWTSNRTLEL 279
           PEY ++G  + KSDV+SFGV+L E++  +      L R + +NL  +A +   + +  ++
Sbjct: 210 PEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPR-EMVNLAEWAVESHNNGQLEQI 268
Query: 280 IDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVV 319
           +DP L D+   +  L ++ + A+ C+  S++DRP+M DV+
Sbjct: 269 VDPNLADKIRPES-LRKFGDTAVKCLALSSEDRPSMGDVL 307

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  181 bits (459), Expect = 5e-46,   Method: Compositional matrix adjust.
 Identities = 112/280 (40%), Positives = 174/280 (62%), Gaps = 16/280 (5%)
Query: 47  ATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKN 106
           ATN F     +G G FG VYKGVL+ G ++A+KR +  S QG+ E + E   ++  +H +
Sbjct: 37  ATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPH 96
Query: 107 LVRLLGCCIDRDEKILIYEYMPNKSLDFFLFD---PTKRMLLDWVTRVQIIEGIAQGLLY 163
           LV L+G C +R+E ILIY+YM N +L   L+    PT  M + W  R++I  G A+GL Y
Sbjct: 97  LVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPT--MSMSWEQRLEICIGAARGLHY 154
Query: 164 LHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNEL-QANTSRIV-GTYGYMS 221
           LH  +   IIHRD+K+ NILLD++  PKI+DFG+++   G EL Q +   +V GT GY+ 
Sbjct: 155 LHTRA---IIHRDVKSINILLDENFVPKITDFGISK--KGTELDQTHLXXVVKGTLGYID 209
Query: 222 PEYALEGIFSIKSDVFSFGVLLLEIVSGKKNT--GLYRTDSLNLLGYAWDLWTSNRTLEL 279
           PEY ++G  + KSDV+SFGV+L E++  +      L R + +NL  +A +   + +  ++
Sbjct: 210 PEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPR-EMVNLAEWAVESHNNGQLEQI 268
Query: 280 IDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVV 319
           +DP L D+   +  L ++ + A+ C+  S++DRP+M DV+
Sbjct: 269 VDPNLADKIRPES-LRKFGDTAVKCLALSSEDRPSMGDVL 307

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  172 bits (436), Expect = 3e-43,   Method: Compositional matrix adjust.
 Identities = 116/306 (37%), Positives = 158/306 (51%), Gaps = 21/306 (6%)
Query: 35  QFPLFSFSSVSTATNKFSD------ANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQG 88
           +F  FSF  +   TN F +       NK+GEGGFG VYKG +     +AVK+L+      
Sbjct: 11  RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNN-TTVAVKKLAAMVDIT 69
Query: 89  LREMKN----EASVIAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSL--DFFLFDPTKR 142
             E+K     E  V+AK QH+NLV LLG   D D+  L+Y YMPN SL       D T  
Sbjct: 70  TEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPP 129
Query: 143 MLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICG 202
             L W  R +I +G A G+ +LH+      IHRD+K++NILLD+    KISDFG+AR   
Sbjct: 130 --LSWHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASE 184
Query: 203 GNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLN 262
                   SRIVGT  YM+PE AL G  + KSD++SFGV+LLEI++G      +R   L 
Sbjct: 185 KFAQTVMXSRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLL 243
Query: 263 LLGYAWDLWTSNRTLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSML 322
           L              + ID  + D  S+    +   ++A  C+ E  + RP +  V  +L
Sbjct: 244 LDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMY--SVASQCLHEKKNKRPDIKKVQQLL 301
Query: 323 TNEAAT 328
               A+
Sbjct: 302 QEMTAS 307

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  170 bits (431), Expect = 9e-43,   Method: Compositional matrix adjust.
 Identities = 115/306 (37%), Positives = 157/306 (51%), Gaps = 21/306 (6%)
Query: 35  QFPLFSFSSVSTATNKFSD------ANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQG 88
           +F  FSF  +   TN F +       NK+GEGGFG VYKG +     +AVK+L+      
Sbjct: 11  RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNN-TTVAVKKLAAMVDIT 69
Query: 89  LREMKN----EASVIAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSL--DFFLFDPTKR 142
             E+K     E  V+AK QH+NLV LLG   D D+  L+Y YMPN SL       D T  
Sbjct: 70  TEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPP 129
Query: 143 MLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICG 202
             L W  R +I +G A G+ +LH+      IHRD+K++NILLD+    KISDFG+AR   
Sbjct: 130 --LSWHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASE 184
Query: 203 GNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLN 262
                    RIVGT  YM+PE AL G  + KSD++SFGV+LLEI++G      +R   L 
Sbjct: 185 KFAQTVMXXRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLL 243
Query: 263 LLGYAWDLWTSNRTLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSML 322
           L              + ID  + D  S+    +   ++A  C+ E  + RP +  V  +L
Sbjct: 244 LDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMY--SVASQCLHEKKNKRPDIKKVQQLL 301
Query: 323 TNEAAT 328
               A+
Sbjct: 302 QEMTAS 307

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score =  170 bits (431), Expect = 9e-43,   Method: Compositional matrix adjust.
 Identities = 115/306 (37%), Positives = 157/306 (51%), Gaps = 21/306 (6%)
Query: 35  QFPLFSFSSVSTATNKFSD------ANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQG 88
           +F  FSF  +   TN F +       NK+GEGGFG VYKG +     +AVK+L+      
Sbjct: 5   RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNN-TTVAVKKLAAMVDIT 63
Query: 89  LREMKN----EASVIAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSL--DFFLFDPTKR 142
             E+K     E  V+AK QH+NLV LLG   D D+  L+Y YMPN SL       D T  
Sbjct: 64  TEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPP 123
Query: 143 MLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICG 202
             L W  R +I +G A G+ +LH+      IHRD+K++NILLD+    KISDFG+AR   
Sbjct: 124 --LSWHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASE 178
Query: 203 GNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLN 262
                    RIVGT  YM+PE AL G  + KSD++SFGV+LLEI++G      +R   L 
Sbjct: 179 KFAQXVMXXRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLL 237
Query: 263 LLGYAWDLWTSNRTLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSML 322
           L              + ID  + D  S+    +   ++A  C+ E  + RP +  V  +L
Sbjct: 238 LDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMY--SVASQCLHEKKNKRPDIKKVQQLL 295
Query: 323 TNEAAT 328
               A+
Sbjct: 296 QEMTAS 301

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score =  164 bits (416), Expect = 6e-41,   Method: Compositional matrix adjust.
 Identities = 115/306 (37%), Positives = 153/306 (50%), Gaps = 21/306 (6%)
Query: 35  QFPLFSFSSVSTATNKFSD------ANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQG 88
           +F  FSF  +   TN F +       NK GEGGFG VYKG +     +AVK+L+      
Sbjct: 2   RFHSFSFYELKNVTNNFDERPISVGGNKXGEGGFGVVYKGYVNN-TTVAVKKLAAMVDIT 60
Query: 89  LREMKN----EASVIAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSL--DFFLFDPTKR 142
             E+K     E  V AK QH+NLV LLG   D D+  L+Y Y PN SL       D T  
Sbjct: 61  TEELKQQFDQEIKVXAKCQHENLVELLGFSSDGDDLCLVYVYXPNGSLLDRLSCLDGTPP 120
Query: 143 MLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICG 202
             L W  R +I +G A G+ +LH+      IHRD+K++NILLD+    KISDFG+AR   
Sbjct: 121 --LSWHXRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASE 175
Query: 203 GNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLN 262
                   SRIVGT  Y +PE AL G  + KSD++SFGV+LLEI++G      +R   L 
Sbjct: 176 KFAQXVXXSRIVGTTAYXAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLL 234
Query: 263 LLGYAWDLWTSNRTLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSML 322
           L              + ID    D   S  +   Y+ +A  C+ E  + RP +  V  +L
Sbjct: 235 LDIKEEIEDEEKTIEDYIDKKXNDA-DSTSVEAXYS-VASQCLHEKKNKRPDIKKVQQLL 292
Query: 323 TNEAAT 328
               A+
Sbjct: 293 QEXTAS 298

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score =  110 bits (276), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 90/275 (32%), Positives = 136/275 (49%), Gaps = 31/275 (11%)
Query: 55  NKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCC 114
            +LG G FG V+ G      ++AVK L   +   ++    EA+++  +QH  LVRL    
Sbjct: 19  KRLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAV- 76
Query: 115 IDRDEKI-LIYEYMPNKSL-DFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRI 172
           + R+E I +I EYM   SL DF   D   ++LL     +     IA+G+ Y+    R   
Sbjct: 77  VTREEPIYIITEYMAKGSLLDFLKSDEGGKVLLP--KLIDFSAQIAEGMAYIE---RKNY 131
Query: 173 IHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSI 232
           IHRDL+A+N+L+ + +  KI+DFG+AR+   NE  A          + +PE    G F+I
Sbjct: 132 IHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPI-KWTAPEAINFGCFTI 190
Query: 233 KSDVFSFGVLLLEIVSGKK--NTGLYRTDSLNLLGYAWDL-WTSNRTLELIDPILEDEYS 289
           KSDV+SFG+LL EIV+  K    G    D +  L   + +    N   EL D        
Sbjct: 191 KSDVWSFGILLYEIVTYGKIPYPGRTNADVMTALSQGYRMPRVENCPDELYD-------- 242
Query: 290 SKQMLLRYANIALLCVQESADDRPTMNDVVSMLTN 324
                     I  +C +E A++RPT + + S+L +
Sbjct: 243 ----------IMKMCWKEKAEERPTFDYLQSVLDD 267

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score =  108 bits (271), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 86/271 (31%), Positives = 132/271 (48%), Gaps = 29/271 (10%)
Query: 56  KLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCI 115
           KLG G FG V+ G      ++AVK L   +   ++    EA+++  +QH  LVRL     
Sbjct: 19  KLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVT 77
Query: 116 DRDEKILIYEYMPNKSL-DFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 174
             +   +I E+M   SL DF   D   ++LL     +     IA+G+ Y+    R   IH
Sbjct: 78  KEEPIYIITEFMAKGSLLDFLKSDEGGKVLLP--KLIDFSAQIAEGMAYIE---RKNYIH 132
Query: 175 RDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKS 234
           RDL+A+N+L+ + +  KI+DFG+AR+   NE  A          + +PE    G F+IKS
Sbjct: 133 RDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPI-KWTAPEAINFGCFTIKS 191
Query: 235 DVFSFGVLLLEIVSGKK--NTGLYRTDSLNLLGYAWDL-WTSNRTLELIDPILEDEYSSK 291
           +V+SFG+LL EIV+  K    G    D ++ L   + +    N   EL D          
Sbjct: 192 NVWSFGILLYEIVTYGKIPYPGRTNADVMSALSQGYRMPRMENCPDELYD---------- 241
Query: 292 QMLLRYANIALLCVQESADDRPTMNDVVSML 322
                   I  +C +E A++RPT + + S+L
Sbjct: 242 --------IMKMCWKEKAEERPTFDYLQSVL 264

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 75/211 (35%), Positives = 113/211 (53%), Gaps = 31/211 (14%)
Query: 57  LGEGGFGPVYKGVLKKGDEIAVKRLSGRS----GQGLREMKNEASVIAKVQHKNLVRLLG 112
           +G GGFG VY+     GDE+AVK           Q +  ++ EA + A ++H N++ L G
Sbjct: 15  IGIGGFGKVYRA-FWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRG 73
Query: 113 CCIDRDEKILIYEYMPNKSLDFFLFDPTKRM----LLDWVTRVQIIEGIAQGLLYLHQYS 168
            C+      L+ E+     L+  L    KR+    L++W  +      IA+G+ YLH  +
Sbjct: 74  VCLKEPNLCLVMEFARGGPLNRVL--SGKRIPPDILVNWAVQ------IARGMNYLHDEA 125
Query: 169 RVRIIHRDLKASNILL-----DKDMNP---KISDFGMARICGGNELQANTS-RIVGTYGY 219
            V IIHRDLK+SNIL+     + D++    KI+DFG+AR     E    T     G Y +
Sbjct: 126 IVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR-----EWHRTTKMSAAGAYAW 180
Query: 220 MSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 250
           M+PE     +FS  SDV+S+GVLL E+++G+
Sbjct: 181 MAPEVIRASMFSKGSDVWSYGVLLWELLTGE 211

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score =  106 bits (264), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 89/278 (32%), Positives = 139/278 (50%), Gaps = 40/278 (14%)
Query: 56  KLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCI 115
           +LG G FG V+ G      ++AVK L  +          EA+++ ++QH+ LVRL    +
Sbjct: 28  RLGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLY-AVV 85
Query: 116 DRDEKILIYEYMPNKSLDFFLFDP-----TKRMLLDWVTRVQIIEGIAQGLLYLHQYSRV 170
            ++   +I EYM N SL  FL  P     T   LLD   +      IA+G+ ++ + +  
Sbjct: 86  TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQ------IAEGMAFIEERN-- 137
Query: 171 RIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIF 230
             IHRDL+A+NIL+   ++ KI+DFG+AR+   NE  A          + +PE    G F
Sbjct: 138 -YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPI-KWTAPEAINYGTF 195
Query: 231 SIKSDVFSFGVLLLEIVSGKK--NTGLYRTDSLNLLGYAWDLWTSNRTLELIDP--ILED 286
           +IKSDV+SFG+LL EIV+  +    G+   + +  L          R   ++ P    E+
Sbjct: 196 TIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL---------ERGYRMVRPDNCPEE 246
Query: 287 EYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTN 324
            Y     L+R      LC +E  +DRPT + + S+L +
Sbjct: 247 LYQ----LMR------LCWKERPEDRPTFDYLRSVLED 274

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score =  105 bits (263), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 89/278 (32%), Positives = 139/278 (50%), Gaps = 40/278 (14%)
Query: 56  KLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCI 115
           +LG G FG V+ G      ++AVK L  +          EA+++ ++QH+ LVRL    +
Sbjct: 26  RLGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAV-V 83
Query: 116 DRDEKILIYEYMPNKSLDFFLFDP-----TKRMLLDWVTRVQIIEGIAQGLLYLHQYSRV 170
            ++   +I EYM N SL  FL  P     T   LLD   +      IA+G+ ++ + +  
Sbjct: 84  TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQ------IAEGMAFIEERN-- 135
Query: 171 RIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIF 230
             IHRDL+A+NIL+   ++ KI+DFG+AR+   NE  A          + +PE    G F
Sbjct: 136 -YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPI-KWTAPEAINYGTF 193
Query: 231 SIKSDVFSFGVLLLEIVSGKK--NTGLYRTDSLNLLGYAWDLWTSNRTLELIDP--ILED 286
           +IKSDV+SFG+LL EIV+  +    G+   + +  L          R   ++ P    E+
Sbjct: 194 TIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL---------ERGYRMVRPDNCPEE 244
Query: 287 EYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTN 324
            Y     L+R      LC +E  +DRPT + + S+L +
Sbjct: 245 LYQ----LMR------LCWKERPEDRPTFDYLRSVLED 272

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score =  105 bits (263), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 89/278 (32%), Positives = 139/278 (50%), Gaps = 40/278 (14%)
Query: 56  KLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCI 115
           +LG G FG V+ G      ++AVK L  +          EA+++ ++QH+ LVRL    +
Sbjct: 30  RLGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLY-AVV 87
Query: 116 DRDEKILIYEYMPNKSLDFFLFDP-----TKRMLLDWVTRVQIIEGIAQGLLYLHQYSRV 170
            ++   +I EYM N SL  FL  P     T   LLD   +      IA+G+ ++ + +  
Sbjct: 88  TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQ------IAEGMAFIEERN-- 139
Query: 171 RIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIF 230
             IHRDL+A+NIL+   ++ KI+DFG+AR+   NE  A          + +PE    G F
Sbjct: 140 -YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPI-KWTAPEAINYGTF 197
Query: 231 SIKSDVFSFGVLLLEIVSGKK--NTGLYRTDSLNLLGYAWDLWTSNRTLELIDP--ILED 286
           +IKSDV+SFG+LL EIV+  +    G+   + +  L          R   ++ P    E+
Sbjct: 198 TIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL---------ERGYRMVRPDNCPEE 248
Query: 287 EYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTN 324
            Y     L+R      LC +E  +DRPT + + S+L +
Sbjct: 249 LYQ----LMR------LCWKERPEDRPTFDYLRSVLED 276

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score =  105 bits (263), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 89/278 (32%), Positives = 139/278 (50%), Gaps = 40/278 (14%)
Query: 56  KLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCI 115
           +LG G FG V+ G      ++AVK L  +          EA+++ ++QH+ LVRL    +
Sbjct: 22  RLGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAV-V 79
Query: 116 DRDEKILIYEYMPNKSLDFFLFDP-----TKRMLLDWVTRVQIIEGIAQGLLYLHQYSRV 170
            ++   +I EYM N SL  FL  P     T   LLD   +      IA+G+ ++ + +  
Sbjct: 80  TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQ------IAEGMAFIEERN-- 131
Query: 171 RIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIF 230
             IHRDL+A+NIL+   ++ KI+DFG+AR+   NE  A          + +PE    G F
Sbjct: 132 -YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPI-KWTAPEAINYGTF 189
Query: 231 SIKSDVFSFGVLLLEIVSGKK--NTGLYRTDSLNLLGYAWDLWTSNRTLELIDP--ILED 286
           +IKSDV+SFG+LL EIV+  +    G+   + +  L          R   ++ P    E+
Sbjct: 190 TIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL---------ERGYRMVRPDNCPEE 240
Query: 287 EYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTN 324
            Y     L+R      LC +E  +DRPT + + S+L +
Sbjct: 241 LYQ----LMR------LCWKERPEDRPTFDYLRSVLED 268

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score =  105 bits (263), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 89/278 (32%), Positives = 139/278 (50%), Gaps = 40/278 (14%)
Query: 56  KLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCI 115
           +LG G FG V+ G      ++AVK L  +          EA+++ ++QH+ LVRL    +
Sbjct: 26  RLGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAV-V 83
Query: 116 DRDEKILIYEYMPNKSLDFFLFDP-----TKRMLLDWVTRVQIIEGIAQGLLYLHQYSRV 170
            ++   +I EYM N SL  FL  P     T   LLD   +      IA+G+ ++ + +  
Sbjct: 84  TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQ------IAEGMAFIEERN-- 135
Query: 171 RIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIF 230
             IHRDL+A+NIL+   ++ KI+DFG+AR+   NE  A          + +PE    G F
Sbjct: 136 -YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPI-KWTAPEAINYGTF 193
Query: 231 SIKSDVFSFGVLLLEIVSGKK--NTGLYRTDSLNLLGYAWDLWTSNRTLELIDP--ILED 286
           +IKSDV+SFG+LL EIV+  +    G+   + +  L          R   ++ P    E+
Sbjct: 194 TIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL---------ERGYRMVRPDNCPEE 244
Query: 287 EYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTN 324
            Y     L+R      LC +E  +DRPT + + S+L +
Sbjct: 245 LYQ----LMR------LCWKERPEDRPTFDYLRSVLED 272

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score =  105 bits (263), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 89/278 (32%), Positives = 139/278 (50%), Gaps = 40/278 (14%)
Query: 56  KLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCI 115
           +LG G FG V+ G      ++AVK L  +          EA+++ ++QH+ LVRL    +
Sbjct: 20  RLGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAV-V 77
Query: 116 DRDEKILIYEYMPNKSLDFFLFDP-----TKRMLLDWVTRVQIIEGIAQGLLYLHQYSRV 170
            ++   +I EYM N SL  FL  P     T   LLD   +      IA+G+ ++ + +  
Sbjct: 78  TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQ------IAEGMAFIEERN-- 129
Query: 171 RIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIF 230
             IHRDL+A+NIL+   ++ KI+DFG+AR+   NE  A          + +PE    G F
Sbjct: 130 -YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPI-KWTAPEAINYGTF 187
Query: 231 SIKSDVFSFGVLLLEIVSGKK--NTGLYRTDSLNLLGYAWDLWTSNRTLELIDP--ILED 286
           +IKSDV+SFG+LL EIV+  +    G+   + +  L          R   ++ P    E+
Sbjct: 188 TIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL---------ERGYRMVRPDNCPEE 238
Query: 287 EYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTN 324
            Y     L+R      LC +E  +DRPT + + S+L +
Sbjct: 239 LYQ----LMR------LCWKERPEDRPTFDYLRSVLED 266

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score =  105 bits (263), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 89/278 (32%), Positives = 139/278 (50%), Gaps = 40/278 (14%)
Query: 56  KLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCI 115
           +LG G FG V+ G      ++AVK L  +          EA+++ ++QH+ LVRL    +
Sbjct: 29  RLGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAV-V 86
Query: 116 DRDEKILIYEYMPNKSLDFFLFDP-----TKRMLLDWVTRVQIIEGIAQGLLYLHQYSRV 170
            ++   +I EYM N SL  FL  P     T   LLD   +      IA+G+ ++ + +  
Sbjct: 87  TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQ------IAEGMAFIEERN-- 138
Query: 171 RIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIF 230
             IHRDL+A+NIL+   ++ KI+DFG+AR+   NE  A          + +PE    G F
Sbjct: 139 -YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPI-KWTAPEAINYGTF 196
Query: 231 SIKSDVFSFGVLLLEIVSGKK--NTGLYRTDSLNLLGYAWDLWTSNRTLELIDP--ILED 286
           +IKSDV+SFG+LL EIV+  +    G+   + +  L          R   ++ P    E+
Sbjct: 197 TIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL---------ERGYRMVRPDNCPEE 247
Query: 287 EYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTN 324
            Y     L+R      LC +E  +DRPT + + S+L +
Sbjct: 248 LYQ----LMR------LCWKERPEDRPTFDYLRSVLED 275

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score =  105 bits (263), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 89/278 (32%), Positives = 139/278 (50%), Gaps = 40/278 (14%)
Query: 56  KLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCI 115
           +LG G FG V+ G      ++AVK L  +          EA+++ ++QH+ LVRL    +
Sbjct: 25  RLGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAV-V 82
Query: 116 DRDEKILIYEYMPNKSLDFFLFDP-----TKRMLLDWVTRVQIIEGIAQGLLYLHQYSRV 170
            ++   +I EYM N SL  FL  P     T   LLD   +      IA+G+ ++ + +  
Sbjct: 83  TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQ------IAEGMAFIEERN-- 134
Query: 171 RIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIF 230
             IHRDL+A+NIL+   ++ KI+DFG+AR+   NE  A          + +PE    G F
Sbjct: 135 -YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPI-KWTAPEAINYGTF 192
Query: 231 SIKSDVFSFGVLLLEIVSGKK--NTGLYRTDSLNLLGYAWDLWTSNRTLELIDP--ILED 286
           +IKSDV+SFG+LL EIV+  +    G+   + +  L          R   ++ P    E+
Sbjct: 193 TIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL---------ERGYRMVRPDNCPEE 243
Query: 287 EYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTN 324
            Y     L+R      LC +E  +DRPT + + S+L +
Sbjct: 244 LYQ----LMR------LCWKERPEDRPTFDYLRSVLED 271

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score =  105 bits (263), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 89/278 (32%), Positives = 139/278 (50%), Gaps = 40/278 (14%)
Query: 56  KLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCI 115
           +LG G FG V+ G      ++AVK L  +          EA+++ ++QH+ LVRL    +
Sbjct: 20  RLGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAV-V 77
Query: 116 DRDEKILIYEYMPNKSLDFFLFDP-----TKRMLLDWVTRVQIIEGIAQGLLYLHQYSRV 170
            ++   +I EYM N SL  FL  P     T   LLD   +      IA+G+ ++ + +  
Sbjct: 78  TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQ------IAEGMAFIEERN-- 129
Query: 171 RIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIF 230
             IHRDL+A+NIL+   ++ KI+DFG+AR+   NE  A          + +PE    G F
Sbjct: 130 -YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPI-KWTAPEAINYGTF 187
Query: 231 SIKSDVFSFGVLLLEIVSGKK--NTGLYRTDSLNLLGYAWDLWTSNRTLELIDP--ILED 286
           +IKSDV+SFG+LL EIV+  +    G+   + +  L          R   ++ P    E+
Sbjct: 188 TIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL---------ERGYRMVRPDNCPEE 238
Query: 287 EYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTN 324
            Y     L+R      LC +E  +DRPT + + S+L +
Sbjct: 239 LYQ----LMR------LCWKERPEDRPTFDYLRSVLED 266

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score =  105 bits (263), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 89/278 (32%), Positives = 139/278 (50%), Gaps = 40/278 (14%)
Query: 56  KLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCI 115
           +LG G FG V+ G      ++AVK L  +          EA+++ ++QH+ LVRL    +
Sbjct: 21  RLGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAV-V 78
Query: 116 DRDEKILIYEYMPNKSLDFFLFDP-----TKRMLLDWVTRVQIIEGIAQGLLYLHQYSRV 170
            ++   +I EYM N SL  FL  P     T   LLD   +      IA+G+ ++ + +  
Sbjct: 79  TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQ------IAEGMAFIEERN-- 130
Query: 171 RIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIF 230
             IHRDL+A+NIL+   ++ KI+DFG+AR+   NE  A          + +PE    G F
Sbjct: 131 -YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPI-KWTAPEAINYGTF 188
Query: 231 SIKSDVFSFGVLLLEIVSGKK--NTGLYRTDSLNLLGYAWDLWTSNRTLELIDP--ILED 286
           +IKSDV+SFG+LL EIV+  +    G+   + +  L          R   ++ P    E+
Sbjct: 189 TIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL---------ERGYRMVRPDNCPEE 239
Query: 287 EYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTN 324
            Y     L+R      LC +E  +DRPT + + S+L +
Sbjct: 240 LYQ----LMR------LCWKERPEDRPTFDYLRSVLED 267

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score =  105 bits (263), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 89/278 (32%), Positives = 139/278 (50%), Gaps = 40/278 (14%)
Query: 56  KLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCI 115
           +LG G FG V+ G      ++AVK L  +          EA+++ ++QH+ LVRL    +
Sbjct: 20  RLGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAV-V 77
Query: 116 DRDEKILIYEYMPNKSLDFFLFDP-----TKRMLLDWVTRVQIIEGIAQGLLYLHQYSRV 170
            ++   +I EYM N SL  FL  P     T   LLD   +      IA+G+ ++ + +  
Sbjct: 78  TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQ------IAEGMAFIEERN-- 129
Query: 171 RIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIF 230
             IHRDL+A+NIL+   ++ KI+DFG+AR+   NE  A          + +PE    G F
Sbjct: 130 -YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPI-KWTAPEAINYGTF 187
Query: 231 SIKSDVFSFGVLLLEIVSGKK--NTGLYRTDSLNLLGYAWDLWTSNRTLELIDP--ILED 286
           +IKSDV+SFG+LL EIV+  +    G+   + +  L          R   ++ P    E+
Sbjct: 188 TIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL---------ERGYRMVRPDNCPEE 238
Query: 287 EYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTN 324
            Y     L+R      LC +E  +DRPT + + S+L +
Sbjct: 239 LYQ----LMR------LCWKERPEDRPTFDYLRSVLED 266

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score =  105 bits (262), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 89/278 (32%), Positives = 139/278 (50%), Gaps = 40/278 (14%)
Query: 56  KLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCI 115
           +LG G FG V+ G      ++AVK L  +          EA+++ ++QH+ LVRL    +
Sbjct: 15  RLGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAV-V 72
Query: 116 DRDEKILIYEYMPNKSLDFFLFDP-----TKRMLLDWVTRVQIIEGIAQGLLYLHQYSRV 170
            ++   +I EYM N SL  FL  P     T   LLD   +      IA+G+ ++ + +  
Sbjct: 73  TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQ------IAEGMAFIEERN-- 124
Query: 171 RIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIF 230
             IHRDL+A+NIL+   ++ KI+DFG+AR+   NE  A          + +PE    G F
Sbjct: 125 -YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPI-KWTAPEAINYGTF 182
Query: 231 SIKSDVFSFGVLLLEIVSGKK--NTGLYRTDSLNLLGYAWDLWTSNRTLELIDP--ILED 286
           +IKSDV+SFG+LL EIV+  +    G+   + +  L          R   ++ P    E+
Sbjct: 183 TIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL---------ERGYRMVRPDNCPEE 233
Query: 287 EYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTN 324
            Y     L+R      LC +E  +DRPT + + S+L +
Sbjct: 234 LYQ----LMR------LCWKERPEDRPTFDYLRSVLED 261

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 88/278 (31%), Positives = 139/278 (50%), Gaps = 40/278 (14%)
Query: 56  KLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCI 115
           +LG G FG V+ G      ++AVK L  +          EA+++ ++QH+ LVRL    +
Sbjct: 16  RLGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAV-V 73
Query: 116 DRDEKILIYEYMPNKSLDFFLFDP-----TKRMLLDWVTRVQIIEGIAQGLLYLHQYSRV 170
            ++   +I EYM N SL  FL  P     T   LLD   +      IA+G+ ++ + +  
Sbjct: 74  TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQ------IAEGMAFIEERN-- 125
Query: 171 RIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIF 230
             IHR+L+A+NIL+   ++ KI+DFG+AR+   NE  A          + +PE    G F
Sbjct: 126 -YIHRNLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPI-KWTAPEAINYGTF 183
Query: 231 SIKSDVFSFGVLLLEIVSGKK--NTGLYRTDSLNLLGYAWDLWTSNRTLELIDP--ILED 286
           +IKSDV+SFG+LL EIV+  +    G+   + +  L          R   ++ P    E+
Sbjct: 184 TIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL---------ERGYRMVRPDNCPEE 234
Query: 287 EYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTN 324
            Y     L+R      LC +E  +DRPT + + S+L +
Sbjct: 235 LYQ----LMR------LCWKERPEDRPTFDYLRSVLED 262

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 68/194 (35%), Positives = 107/194 (55%), Gaps = 9/194 (4%)
Query: 56  KLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCI 115
           KLG+G FG V+ G       +A+K L   +         EA V+ K++H+ LV+L    +
Sbjct: 191 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAV-V 248
Query: 116 DRDEKILIYEYMPNKSL-DFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 174
             +   ++ EYM   SL DF   +  K + L  +  V +   IA G+ Y+    R+  +H
Sbjct: 249 SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQL--VDMAAQIASGMAYVE---RMNYVH 303
Query: 175 RDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKS 234
           RDL+A+NIL+ +++  K++DFG+AR+   NE  A          + +PE AL G F+IKS
Sbjct: 304 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPI-KWTAPEAALYGRFTIKS 362
Query: 235 DVFSFGVLLLEIVS 248
           DV+SFG+LL E+ +
Sbjct: 363 DVWSFGILLTELTT 376

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 68/194 (35%), Positives = 107/194 (55%), Gaps = 9/194 (4%)
Query: 56  KLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCI 115
           KLG+G FG V+ G       +A+K L   +         EA V+ K++H+ LV+L    +
Sbjct: 191 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAV-V 248
Query: 116 DRDEKILIYEYMPNKSL-DFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 174
             +   ++ EYM   SL DF   +  K + L  +  V +   IA G+ Y+    R+  +H
Sbjct: 249 SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQL--VDMAAQIASGMAYVE---RMNYVH 303
Query: 175 RDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKS 234
           RDL+A+NIL+ +++  K++DFG+AR+   NE  A          + +PE AL G F+IKS
Sbjct: 304 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPI-KWTAPEAALYGRFTIKS 362
Query: 235 DVFSFGVLLLEIVS 248
           DV+SFG+LL E+ +
Sbjct: 363 DVWSFGILLTELTT 376

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 68/194 (35%), Positives = 107/194 (55%), Gaps = 9/194 (4%)
Query: 56  KLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCI 115
           KLG+G FG V+ G       +A+K L   +         EA V+ K++H+ LV+L    +
Sbjct: 274 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLY-AVV 331
Query: 116 DRDEKILIYEYMPNKSL-DFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 174
             +   ++ EYM   SL DF   +  K + L  +  V +   IA G+ Y+    R+  +H
Sbjct: 332 SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQL--VDMAAQIASGMAYVE---RMNYVH 386
Query: 175 RDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKS 234
           RDL+A+NIL+ +++  K++DFG+AR+   NE  A          + +PE AL G F+IKS
Sbjct: 387 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKS 445
Query: 235 DVFSFGVLLLEIVS 248
           DV+SFG+LL E+ +
Sbjct: 446 DVWSFGILLTELTT 459

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score =  102 bits (255), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 68/194 (35%), Positives = 107/194 (55%), Gaps = 9/194 (4%)
Query: 56  KLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCI 115
           KLG+G FG V+ G       +A+K L   +         EA V+ K++H+ LV+L    +
Sbjct: 191 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAV-V 248
Query: 116 DRDEKILIYEYMPNKSL-DFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 174
             +   ++ EYM   SL DF   +  K + L  +  V +   IA G+ Y+    R+  +H
Sbjct: 249 SEEPIYIVGEYMSKGSLLDFLKGETGKYLRLPQL--VDMAAQIASGMAYVE---RMNYVH 303
Query: 175 RDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKS 234
           RDL+A+NIL+ +++  K++DFG+AR+   NE  A          + +PE AL G F+IKS
Sbjct: 304 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKS 362
Query: 235 DVFSFGVLLLEIVS 248
           DV+SFG+LL E+ +
Sbjct: 363 DVWSFGILLTELTT 376

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score =  102 bits (254), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 68/194 (35%), Positives = 107/194 (55%), Gaps = 9/194 (4%)
Query: 56  KLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCI 115
           KLG+G FG V+ G       +A+K L   +         EA V+ K++H+ LV+L    +
Sbjct: 18  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAV-V 75
Query: 116 DRDEKILIYEYMPNKSL-DFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 174
             +   ++ EYM   SL DF   +  K + L  +  V +   IA G+ Y+    R+  +H
Sbjct: 76  SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQL--VDMAAQIASGMAYVE---RMNYVH 130
Query: 175 RDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKS 234
           RDL+A+NIL+ +++  K++DFG+AR+   NE  A          + +PE AL G F+IKS
Sbjct: 131 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPI-KWTAPEAALYGRFTIKS 189
Query: 235 DVFSFGVLLLEIVS 248
           DV+SFG+LL E+ +
Sbjct: 190 DVWSFGILLTELTT 203

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score =  102 bits (254), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 68/194 (35%), Positives = 107/194 (55%), Gaps = 9/194 (4%)
Query: 56  KLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCI 115
           KLG+G FG V+ G       +A+K L   +         EA V+ K++H+ LV+L    +
Sbjct: 15  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAV-V 72
Query: 116 DRDEKILIYEYMPNKSL-DFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 174
             +   ++ EYM   SL DF   +  K + L  +  V +   IA G+ Y+    R+  +H
Sbjct: 73  SEEPIXIVTEYMSKGSLLDFLKGETGKYLRLPQL--VDMAAQIASGMAYVE---RMNYVH 127
Query: 175 RDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKS 234
           RDL+A+NIL+ +++  K++DFG+AR+   NE  A          + +PE AL G F+IKS
Sbjct: 128 RDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKF-PIKWTAPEAALYGRFTIKS 186
Query: 235 DVFSFGVLLLEIVS 248
           DV+SFG+LL E+ +
Sbjct: 187 DVWSFGILLTELTT 200

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score =  102 bits (254), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 69/195 (35%), Positives = 107/195 (54%), Gaps = 7/195 (3%)
Query: 55  NKLGEGGFGPVYKGVLKKGD-EIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGC 113
           +KLG G +G VY GV KK    +AVK L   + + + E   EA+V+ +++H NLV+LLG 
Sbjct: 38  HKLGGGQYGEVYVGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 96
Query: 114 CIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRII 173
           C       ++ EYMP  +L  +L +   R  +  V  + +   I+  + YL    +   I
Sbjct: 97  CTLEPPFYIVTEYMPYGNLLDYLRE-CNREEVTAVVLLYMATQISSAMEYL---EKKNFI 152
Query: 174 HRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIK 233
           HRDL A N L+ ++   K++DFG++R+  G+   A+         + +PE      FSIK
Sbjct: 153 HRDLAARNCLVGENHVVKVADFGLSRLMTGDTYTAHAGAKFPI-KWTAPESLAYNTFSIK 211
Query: 234 SDVFSFGVLLLEIVS 248
           SDV++FGVLL EI +
Sbjct: 212 SDVWAFGVLLWEIAT 226

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score =  102 bits (253), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 68/194 (35%), Positives = 107/194 (55%), Gaps = 9/194 (4%)
Query: 56  KLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCI 115
           KLG+G FG V+ G       +A+K L   +         EA V+ K++H+ LV+L    +
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKIRHEKLVQLYAV-V 82
Query: 116 DRDEKILIYEYMPNKSL-DFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 174
             +   ++ EYM   SL DF   +  K + L  +  V +   IA G+ Y+    R+  +H
Sbjct: 83  SEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQL--VDMAAQIASGMAYVE---RMNYVH 137
Query: 175 RDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKS 234
           RDL+A+NIL+ +++  K++DFG+AR+   NE  A          + +PE AL G F+IKS
Sbjct: 138 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKS 196
Query: 235 DVFSFGVLLLEIVS 248
           DV+SFG+LL E+ +
Sbjct: 197 DVWSFGILLTELTT 210

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score =  101 bits (252), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 68/194 (35%), Positives = 107/194 (55%), Gaps = 9/194 (4%)
Query: 56  KLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCI 115
           KLG+G FG V+ G       +A+K L   +         EA V+ K++H+ LV+L    +
Sbjct: 22  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAV-V 79
Query: 116 DRDEKILIYEYMPNKSL-DFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 174
             +   ++ EYM   SL DF   +  K + L  +  V +   IA G+ Y+    R+  +H
Sbjct: 80  SEEPIYIVTEYMNKGSLLDFLKGETGKYLRLPQL--VDMSAQIASGMAYVE---RMNYVH 134
Query: 175 RDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKS 234
           RDL+A+NIL+ +++  K++DFG+AR+   NE  A          + +PE AL G F+IKS
Sbjct: 135 RDLRAANILVGENLVCKVADFGLARLIEDNEWTARQGAKF-PIKWTAPEAALYGRFTIKS 193
Query: 235 DVFSFGVLLLEIVS 248
           DV+SFG+LL E+ +
Sbjct: 194 DVWSFGILLTELTT 207

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score =  101 bits (252), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 68/194 (35%), Positives = 107/194 (55%), Gaps = 9/194 (4%)
Query: 56  KLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCI 115
           KLG+G FG V+ G       +A+K L   +         EA V+ K++H+ LV+L    +
Sbjct: 14  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAV-V 71
Query: 116 DRDEKILIYEYMPNKSL-DFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 174
             +   ++ EYM   SL DF   +  K + L  +  V +   IA G+ Y+    R+  +H
Sbjct: 72  SEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQL--VDMAAQIASGMAYVE---RMNYVH 126
Query: 175 RDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKS 234
           RDL+A+NIL+ +++  K++DFG+AR+   NE  A          + +PE AL G F+IKS
Sbjct: 127 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPI-KWTAPEAALYGRFTIKS 185
Query: 235 DVFSFGVLLLEIVS 248
           DV+SFG+LL E+ +
Sbjct: 186 DVWSFGILLTELTT 199

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score =  101 bits (252), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 68/194 (35%), Positives = 107/194 (55%), Gaps = 9/194 (4%)
Query: 56  KLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCI 115
           KLG+G FG V+ G       +A+K L   +         EA V+ K++H+ LV+L    +
Sbjct: 16  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAV-V 73
Query: 116 DRDEKILIYEYMPNKSL-DFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 174
             +   ++ EYM   SL DF   +  K + L  +  V +   IA G+ Y+    R+  +H
Sbjct: 74  SEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQL--VDMAAQIASGMAYVE---RMNYVH 128
Query: 175 RDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKS 234
           RDL+A+NIL+ +++  K++DFG+AR+   NE  A          + +PE AL G F+IKS
Sbjct: 129 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPI-KWTAPEAALYGRFTIKS 187
Query: 235 DVFSFGVLLLEIVS 248
           DV+SFG+LL E+ +
Sbjct: 188 DVWSFGILLTELTT 201

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  101 bits (252), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 64/201 (31%), Positives = 107/201 (53%), Gaps = 6/201 (2%)
Query: 56  KLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLR--EMKNEASVIAKVQHKNLVRLLGC 113
           K+G G FG V++     G ++AVK L  +     R  E   E +++ +++H N+V  +G 
Sbjct: 44  KIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGA 102
Query: 114 CIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRII 173
                   ++ EY+   SL   L     R  LD   R+ +   +A+G+ YLH  +   I+
Sbjct: 103 VTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPP-IV 161
Query: 174 HRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIK 233
           HRDLK+ N+L+DK    K+ DFG++R+     L +  +   GT  +M+PE   +   + K
Sbjct: 162 HRDLKSPNLLVDKKYTVKVCDFGLSRLKASXFLXSKXA--AGTPEWMAPEVLRDEPSNEK 219
Query: 234 SDVFSFGVLLLEIVSGKKNTG 254
           SDV+SFGV+L E+ + ++  G
Sbjct: 220 SDVYSFGVILWELATLQQPWG 240

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score =  101 bits (252), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 68/194 (35%), Positives = 107/194 (55%), Gaps = 9/194 (4%)
Query: 56  KLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCI 115
           KLG+G FG V+ G       +A+K L   +         EA V+ K++H+ LV+L    +
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAV-V 82
Query: 116 DRDEKILIYEYMPNKSL-DFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 174
             +   ++ EYM   SL DF   +  K + L  +  V +   IA G+ Y+    R+  +H
Sbjct: 83  SEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQL--VDMAAQIASGMAYVE---RMNYVH 137
Query: 175 RDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKS 234
           RDL+A+NIL+ +++  K++DFG+AR+   NE  A          + +PE AL G F+IKS
Sbjct: 138 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKS 196
Query: 235 DVFSFGVLLLEIVS 248
           DV+SFG+LL E+ +
Sbjct: 197 DVWSFGILLTELTT 210

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score =  101 bits (251), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 81/278 (29%), Positives = 138/278 (49%), Gaps = 38/278 (13%)
Query: 57  LGEGGFGPVYKGVLK----KGDEIAVKRLS-GRSGQGLREMKNEASVIAKVQHKNLVRLL 111
           +G G FG V  G LK    K   +A+K L  G + +  R+   EAS++ +  H N++RL 
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112
Query: 112 GCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVR 171
           G        +++ EYM N SLD FL     +  +  +  V ++ GIA G+ YL   S + 
Sbjct: 113 GVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTV--IQLVGMLRGIASGMKYL---SDMG 167
Query: 172 IIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVG-TYGYMSPEYALEGIF 230
            +HRDL A NIL++ ++  K+SDFG+AR+   +   A T+R       + SPE      F
Sbjct: 168 YVHRDLAARNILINSNLVCKVSDFGLARVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKF 227
Query: 231 SIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELID------PIL 284
           +  SDV+S+G++L E++S  +                W++ ++   ++ +D      P +
Sbjct: 228 TSASDVWSYGIVLWEVMSYGERP-------------YWEM-SNQDVIKAVDEGYRLPPPM 273
Query: 285 EDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSML 322
           +   +  Q++L        C Q+  ++RP    +VS+L
Sbjct: 274 DCPAALYQLMLD-------CWQKDRNNRPKFEQIVSIL 304

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score =  101 bits (251), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 68/194 (35%), Positives = 107/194 (55%), Gaps = 9/194 (4%)
Query: 56  KLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCI 115
           KLG+G FG V+ G       +A+K L   +         EA V+ K++H+ LV+L    +
Sbjct: 22  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAV-V 79
Query: 116 DRDEKILIYEYMPNKSL-DFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 174
             +   ++ EYM   SL DF   +  K + L  +  V +   IA G+ Y+    R+  +H
Sbjct: 80  SEEPIYIVTEYMNKGSLLDFLKGETGKYLRLPQL--VDMSAQIASGMAYVE---RMNYVH 134
Query: 175 RDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKS 234
           RDL+A+NIL+ +++  K++DFG+AR+   NE  A          + +PE AL G F+IKS
Sbjct: 135 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKS 193
Query: 235 DVFSFGVLLLEIVS 248
           DV+SFG+LL E+ +
Sbjct: 194 DVWSFGILLTELTT 207

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score =  101 bits (251), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 91/301 (30%), Positives = 145/301 (48%), Gaps = 39/301 (12%)
Query: 39  FSFSSVSTATNKFS---DAN------KLGEGGFGPVYKGVLKKGDE----IAVKRL-SGR 84
           F+F   + A  +F+   DA+       +G G FG V  G LK   +    +A+K L +G 
Sbjct: 10  FTFEDPNQAVREFAKEIDASCIKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGY 69
Query: 85  SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRML 144
           + +  R+  +EAS++ +  H N++ L G        ++I EYM N SLD FL     R  
Sbjct: 70  TDKQRRDFLSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFT 129
Query: 145 LDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGN 204
           +  +  V ++ GI  G+ YL   S V   HRDL A NIL++ ++  K+SDFGM+R+   +
Sbjct: 130 V--IQLVGMLRGIGSGMKYLSDMSAV---HRDLAARNILVNSNLVCKVSDFGMSRVLEDD 184
Query: 205 ELQANTSRIVG-TYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNL 263
              A T+R       + +PE      F+  SDV+S+G+++ E++S  +            
Sbjct: 185 PEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERP---------- 234
Query: 264 LGYAWDLWTSNRTLELIDPILEDEYSSKQMLLRYA--NIALLCVQESADDRPTMNDVVSM 321
               WD+  SN+  ++I  I E       M    A   + L C Q+   DRP    +V+M
Sbjct: 235 ---YWDM--SNQ--DVIKAIEEGYRLPPPMDCPIALHQLMLDCWQKERSDRPKFGQIVNM 287
Query: 322 L 322
           L
Sbjct: 288 L 288

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score =  101 bits (251), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 68/194 (35%), Positives = 107/194 (55%), Gaps = 9/194 (4%)
Query: 56  KLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCI 115
           KLG+G FG V+ G       +A+K L   +         EA V+ K++H+ LV+L    +
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAV-V 82
Query: 116 DRDEKILIYEYMPNKSL-DFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 174
             +   ++ EYM   SL DF   +  K + L  +  V +   IA G+ Y+    R+  +H
Sbjct: 83  SEEPIYIVIEYMSKGSLLDFLKGEMGKYLRLPQL--VDMAAQIASGMAYVE---RMNYVH 137
Query: 175 RDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKS 234
           RDL+A+NIL+ +++  K++DFG+AR+   NE  A          + +PE AL G F+IKS
Sbjct: 138 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKS 196
Query: 235 DVFSFGVLLLEIVS 248
           DV+SFG+LL E+ +
Sbjct: 197 DVWSFGILLTELTT 210

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score =  101 bits (251), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 68/194 (35%), Positives = 107/194 (55%), Gaps = 9/194 (4%)
Query: 56  KLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCI 115
           KLG+G FG V+ G       +A+K L   +         EA V+ K++H+ LV+L    +
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAV-V 82
Query: 116 DRDEKILIYEYMPNKSL-DFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 174
             +   ++ EYM   SL DF   +  K + L  +  V +   IA G+ Y+    R+  +H
Sbjct: 83  SEEPIYIVCEYMSKGSLLDFLKGEMGKYLRLPQL--VDMAAQIASGMAYVE---RMNYVH 137
Query: 175 RDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKS 234
           RDL+A+NIL+ +++  K++DFG+AR+   NE  A          + +PE AL G F+IKS
Sbjct: 138 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKS 196
Query: 235 DVFSFGVLLLEIVS 248
           DV+SFG+LL E+ +
Sbjct: 197 DVWSFGILLTELTT 210

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score =  101 bits (251), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 68/194 (35%), Positives = 107/194 (55%), Gaps = 9/194 (4%)
Query: 56  KLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCI 115
           KLG+G FG V+ G       +A+K L   +         EA V+ K++H+ LV+L    +
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAV-V 82
Query: 116 DRDEKILIYEYMPNKSL-DFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 174
             +   ++ EYM   SL DF   +  K + L  +  V +   IA G+ Y+    R+  +H
Sbjct: 83  SEEPIYIVIEYMSKGSLLDFLKGEMGKYLRLPQL--VDMAAQIASGMAYVE---RMNYVH 137
Query: 175 RDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKS 234
           RDL+A+NIL+ +++  K++DFG+AR+   NE  A          + +PE AL G F+IKS
Sbjct: 138 RDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKF-PIKWTAPEAALYGRFTIKS 196
Query: 235 DVFSFGVLLLEIVS 248
           DV+SFG+LL E+ +
Sbjct: 197 DVWSFGILLTELTT 210

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  100 bits (250), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 63/201 (31%), Positives = 108/201 (53%), Gaps = 6/201 (2%)
Query: 56  KLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLR--EMKNEASVIAKVQHKNLVRLLGC 113
           K+G G FG V++     G ++AVK L  +     R  E   E +++ +++H N+V  +G 
Sbjct: 44  KIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGA 102
Query: 114 CIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRII 173
                   ++ EY+   SL   L     R  LD   R+ +   +A+G+ YLH  +   I+
Sbjct: 103 VTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN-PPIV 161
Query: 174 HRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIK 233
           HR+LK+ N+L+DK    K+ DFG++R+     L + ++   GT  +M+PE   +   + K
Sbjct: 162 HRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSA--AGTPEWMAPEVLRDEPSNEK 219
Query: 234 SDVFSFGVLLLEIVSGKKNTG 254
           SDV+SFGV+L E+ + ++  G
Sbjct: 220 SDVYSFGVILWELATLQQPWG 240

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score =  100 bits (250), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 67/194 (34%), Positives = 105/194 (54%), Gaps = 9/194 (4%)
Query: 56  KLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCI 115
           KLG+G FG V+ G       +A+K L             EA V+ K++H+ LV+L    +
Sbjct: 192 KLGQGCFGEVWMGTWNGTTRVAIKTLKP-GNMSPEAFLQEAQVMKKLRHEKLVQLYAV-V 249
Query: 116 DRDEKILIYEYMPNKSL-DFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 174
             +   ++ EYM   SL DF   +  K + L  +  V +   IA G+ Y+    R+  +H
Sbjct: 250 SEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQL--VDMAAQIASGMAYVE---RMNYVH 304
Query: 175 RDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKS 234
           RDL+A+NIL+ +++  K++DFG+ R+   NE  A          + +PE AL G F+IKS
Sbjct: 305 RDLRAANILVGENLVCKVADFGLGRLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKS 363
Query: 235 DVFSFGVLLLEIVS 248
           DV+SFG+LL E+ +
Sbjct: 364 DVWSFGILLTELTT 377

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 71/220 (32%), Positives = 120/220 (54%), Gaps = 22/220 (10%)
Query: 57  LGEGGFGPVYKGVLKKGDE-----IAVKRLSGRSGQGLR-EMKNEASVIAKVQHKNLVRL 110
           LG G FG VYKG+     E     +A+K L+  +G     E  +EA ++A + H +LVRL
Sbjct: 23  LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 82
Query: 111 LGCCIDRDEKILIYEYMPNKSLDFFLFDPT----KRMLLDWVTRVQIIEGIAQGLLYLHQ 166
           LG C+    + L+ + MP+  L  ++ +       ++LL+W  +      IA+G++YL +
Sbjct: 83  LGVCLSPTIQ-LVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQ------IAKGMMYLEE 135
Query: 167 YSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAL 226
               R++HRDL A N+L+    + KI+DFG+AR+  G+E + N         +M+ E   
Sbjct: 136 R---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIH 192
Query: 227 EGIFSIKSDVFSFGVLLLEIVS--GKKNTGLYRTDSLNLL 264
              F+ +SDV+S+GV + E+++  GK   G+   +  +LL
Sbjct: 193 YRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLL 232

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 80/278 (28%), Positives = 138/278 (49%), Gaps = 38/278 (13%)
Query: 57  LGEGGFGPVYKGVLK----KGDEIAVKRLS-GRSGQGLREMKNEASVIAKVQHKNLVRLL 111
           +G G FG V  G LK    K   +A+K L  G + +  R+   EAS++ +  H N++RL 
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112
Query: 112 GCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVR 171
           G        +++ EYM N SLD FL     +  +  +  V ++ GIA G+ YL   S + 
Sbjct: 113 GVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTV--IQLVGMLRGIASGMKYL---SDMG 167
Query: 172 IIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVG-TYGYMSPEYALEGIF 230
            +HRDL A NIL++ ++  K+SDFG++R+   +   A T+R       + SPE      F
Sbjct: 168 FVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKF 227
Query: 231 SIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELID------PIL 284
           +  SDV+S+G++L E++S  +                W++ ++   ++ +D      P +
Sbjct: 228 TSASDVWSYGIVLWEVMSYGERP-------------YWEM-SNQDVIKAVDEGYRLPPPM 273
Query: 285 EDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSML 322
           +   +  Q++L        C Q+  ++RP    +VS+L
Sbjct: 274 DCPAALYQLMLD-------CWQKDRNNRPKFEQIVSIL 304

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 71/220 (32%), Positives = 120/220 (54%), Gaps = 22/220 (10%)
Query: 57  LGEGGFGPVYKGVLKKGDE-----IAVKRLSGRSGQGLR-EMKNEASVIAKVQHKNLVRL 110
           LG G FG VYKG+     E     +A+K L+  +G     E  +EA ++A + H +LVRL
Sbjct: 46  LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 105
Query: 111 LGCCIDRDEKILIYEYMPNKSLDFFLFDPT----KRMLLDWVTRVQIIEGIAQGLLYLHQ 166
           LG C+    + L+ + MP+  L  ++ +       ++LL+W  +      IA+G++YL +
Sbjct: 106 LGVCLSPTIQ-LVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQ------IAKGMMYLEE 158
Query: 167 YSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAL 226
               R++HRDL A N+L+    + KI+DFG+AR+  G+E + N         +M+ E   
Sbjct: 159 R---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIH 215
Query: 227 EGIFSIKSDVFSFGVLLLEIVS--GKKNTGLYRTDSLNLL 264
              F+ +SDV+S+GV + E+++  GK   G+   +  +LL
Sbjct: 216 YRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLL 255

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 68/194 (35%), Positives = 106/194 (54%), Gaps = 9/194 (4%)
Query: 56  KLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCI 115
           KLG+G FG V+ G       +A+K L   +         EA V+ K++H+ LV+L    +
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAV-V 82
Query: 116 DRDEKILIYEYMPNKSL-DFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 174
             +   ++ EYM   SL DF   +  K + L  +  V +   IA G+ Y+    R+  +H
Sbjct: 83  SEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQL--VDMAAQIASGMAYVE---RMNYVH 137
Query: 175 RDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKS 234
           RDL A+NIL+ +++  K++DFG+AR+   NE  A          + +PE AL G F+IKS
Sbjct: 138 RDLAAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKS 196
Query: 235 DVFSFGVLLLEIVS 248
           DV+SFG+LL E+ +
Sbjct: 197 DVWSFGILLTELTT 210

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 85/286 (29%), Positives = 133/286 (46%), Gaps = 32/286 (11%)
Query: 56  KLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCI 115
           +LG G FG V+ G      ++A+K L   +         EA ++ K++H  LV+L    +
Sbjct: 16  RLGNGQFGEVWMGTWNGNTKVAIKTLKPGT-MSPESFLEEAQIMKKLKHDKLVQLYAV-V 73
Query: 116 DRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHR 175
             +   ++ EYM   SL  FL D   R L      V +   +A G+ Y+    R+  IHR
Sbjct: 74  SEEPIYIVTEYMNKGSLLDFLKDGEGRAL-KLPNLVDMAAQVAAGMAYIE---RMNYIHR 129
Query: 176 DLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSD 235
           DL+++NIL+   +  KI+DFG+AR+   NE  A          + +PE AL G F+IKSD
Sbjct: 130 DLRSANILVGNGLICKIADFGLARLIEDNEXTARQGAKF-PIKWTAPEAALYGRFTIKSD 188
Query: 236 VFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELID-----PILEDEYSS 290
           V+SFG+LL E+V+     G      +N          +   LE ++     P  +D   S
Sbjct: 189 VWSFGILLTELVT----KGRVPYPGMN----------NREVLEQVERGYRMPCPQDCPIS 234
Query: 291 KQMLLRYANIALLCVQESADDRPTMNDVVSMLTNEAATLLPPKQPA 336
              L+      + C ++  ++RPT   + S L +      P  QP 
Sbjct: 235 LHELM------IHCWKKDPEERPTFEYLQSFLEDYFTATEPQYQPG 274

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 68/195 (34%), Positives = 108/195 (55%), Gaps = 7/195 (3%)
Query: 55  NKLGEGGFGPVYKGVLKKGD-EIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGC 113
           +KLG G +G VY+GV KK    +AVK L   + + + E   EA+V+ +++H NLV+LLG 
Sbjct: 24  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 82
Query: 114 CIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRII 173
           C       +I E+M   +L  +L +   R  ++ V  + +   I+  + YL    +   I
Sbjct: 83  CTREPPFYIIIEFMTYGNLLDYLRE-CNRQEVNAVVLLYMATQISSAMEYL---EKKNFI 138
Query: 174 HRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIK 233
           HRDL A N L+ ++   K++DFG++R+  G+   A+         + +PE      FSIK
Sbjct: 139 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-KWTAPESLAYNKFSIK 197
Query: 234 SDVFSFGVLLLEIVS 248
           SDV++FGVLL EI +
Sbjct: 198 SDVWAFGVLLWEIAT 212

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 68/195 (34%), Positives = 108/195 (55%), Gaps = 7/195 (3%)
Query: 55  NKLGEGGFGPVYKGVLKKGD-EIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGC 113
           +KLG G +G VY+GV KK    +AVK L   + + + E   EA+V+ +++H NLV+LLG 
Sbjct: 24  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 82
Query: 114 CIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRII 173
           C       +I E+M   +L  +L +   R  ++ V  + +   I+  + YL    +   I
Sbjct: 83  CTREPPFYIITEFMTYGNLLDYLRE-CNRQEVNAVVLLYMATQISSAMEYL---EKKNFI 138
Query: 174 HRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIK 233
           HRDL A N L+ ++   K++DFG++R+  G+   A+         + +PE      FSIK
Sbjct: 139 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-KWTAPESLAYNKFSIK 197
Query: 234 SDVFSFGVLLLEIVS 248
           SDV++FGVLL EI +
Sbjct: 198 SDVWAFGVLLWEIAT 212

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 85/277 (30%), Positives = 136/277 (49%), Gaps = 24/277 (8%)
Query: 55  NKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLRE-MKNEASVIAKVQHKNLVRLLGC 113
            ++G G FG V+ G     D++A+K +  R G    E    EA V+ K+ H  LV+L G 
Sbjct: 13  QEIGSGQFGLVHLGYWLNKDKVAIKTI--REGAMSEEDFIEEAEVMMKLSHPKLVQLYGV 70
Query: 114 CIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRII 173
           C+++    L++E+M +  L  +L   T+R L    T + +   + +G+ YL + S   +I
Sbjct: 71  CLEQAPICLVFEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLEEAS---VI 125
Query: 174 HRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIK 233
           HRDL A N L+ ++   K+SDFGM R    ++  ++T        + SPE      +S K
Sbjct: 126 HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPV-KWASPEVFSFSRYSSK 184
Query: 234 SDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYSSKQM 293
           SDV+SFGVL+ E+ S  K     R++S  +     D+ T  R   L  P L   +  +  
Sbjct: 185 SDVWSFGVLMWEVFSEGKIPYENRSNSEVVE----DISTGFR---LYKPRLASTHVYQ-- 235
Query: 294 LLRYANIALLCVQESADDRPTMNDVVSMLTNEAATLL 330
                 I   C +E  +DRP  + ++  L   AA+ L
Sbjct: 236 ------IMNHCWKERPEDRPAFSRLLRQLAAIAASGL 266

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 68/195 (34%), Positives = 108/195 (55%), Gaps = 7/195 (3%)
Query: 55  NKLGEGGFGPVYKGVLKKGD-EIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGC 113
           +KLG G +G VY+GV KK    +AVK L   + + + E   EA+V+ +++H NLV+LLG 
Sbjct: 19  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 77
Query: 114 CIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRII 173
           C       +I E+M   +L  +L +   R  ++ V  + +   I+  + YL    +   I
Sbjct: 78  CTREPPFYIITEFMTYGNLLDYLRE-CNRQEVNAVVLLYMATQISSAMEYL---EKKNFI 133
Query: 174 HRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIK 233
           HRDL A N L+ ++   K++DFG++R+  G+   A+         + +PE      FSIK
Sbjct: 134 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-KWTAPESLAYNKFSIK 192
Query: 234 SDVFSFGVLLLEIVS 248
           SDV++FGVLL EI +
Sbjct: 193 SDVWAFGVLLWEIAT 207

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 80/278 (28%), Positives = 138/278 (49%), Gaps = 38/278 (13%)
Query: 57  LGEGGFGPVYKGVLK----KGDEIAVKRLS-GRSGQGLREMKNEASVIAKVQHKNLVRLL 111
           +G G FG V  G LK    K   +A+K L  G + +  R+   EAS++ +  H N++RL 
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112
Query: 112 GCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVR 171
           G        +++ EYM N SLD FL     +  +  +  V ++ GIA G+ YL   S + 
Sbjct: 113 GVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTV--IQLVGMLRGIASGMKYL---SDMG 167
Query: 172 IIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVG-TYGYMSPEYALEGIF 230
            +HRDL A NIL++ ++  K+SDFG++R+   +   A T+R       + SPE      F
Sbjct: 168 YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKF 227
Query: 231 SIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELID------PIL 284
           +  SDV+S+G++L E++S  +                W++ ++   ++ +D      P +
Sbjct: 228 TSASDVWSYGIVLWEVMSYGERP-------------YWEM-SNQDVIKAVDEGYRLPPPM 273
Query: 285 EDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSML 322
           +   +  Q++L        C Q+  ++RP    +VS+L
Sbjct: 274 DCPAALYQLMLD-------CWQKDRNNRPKFEQIVSIL 304

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 80/278 (28%), Positives = 138/278 (49%), Gaps = 38/278 (13%)
Query: 57  LGEGGFGPVYKGVLK----KGDEIAVKRLS-GRSGQGLREMKNEASVIAKVQHKNLVRLL 111
           +G G FG V  G LK    K   +A+K L  G + +  R+   EAS++ +  H N++RL 
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112
Query: 112 GCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVR 171
           G        +++ EYM N SLD FL     +  +  +  V ++ GIA G+ YL   S + 
Sbjct: 113 GVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTV--IQLVGMLRGIASGMKYL---SDMG 167
Query: 172 IIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVG-TYGYMSPEYALEGIF 230
            +HRDL A NIL++ ++  K+SDFG++R+   +   A T+R       + SPE      F
Sbjct: 168 YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKF 227
Query: 231 SIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELID------PIL 284
           +  SDV+S+G++L E++S  +                W++ ++   ++ +D      P +
Sbjct: 228 TSASDVWSYGIVLWEVMSYGERP-------------YWEM-SNQDVIKAVDEGYRLPPPM 273
Query: 285 EDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSML 322
           +   +  Q++L        C Q+  ++RP    +VS+L
Sbjct: 274 DCPAALYQLMLD-------CWQKDRNNRPKFEQIVSIL 304

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 80/278 (28%), Positives = 138/278 (49%), Gaps = 38/278 (13%)
Query: 57  LGEGGFGPVYKGVLK----KGDEIAVKRLS-GRSGQGLREMKNEASVIAKVQHKNLVRLL 111
           +G G FG V  G LK    K   +A+K L  G + +  R+   EAS++ +  H N++RL 
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112
Query: 112 GCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVR 171
           G        +++ EYM N SLD FL     +  +  +  V ++ GIA G+ YL   S + 
Sbjct: 113 GVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTV--IQLVGMLRGIASGMKYL---SDMG 167
Query: 172 IIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVG-TYGYMSPEYALEGIF 230
            +HRDL A NIL++ ++  K+SDFG++R+   +   A T+R       + SPE      F
Sbjct: 168 YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKF 227
Query: 231 SIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELID------PIL 284
           +  SDV+S+G++L E++S  +                W++ ++   ++ +D      P +
Sbjct: 228 TSASDVWSYGIVLWEVMSYGERP-------------YWEM-SNQDVIKAVDEGYRLPPPM 273
Query: 285 EDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSML 322
           +   +  Q++L        C Q+  ++RP    +VS+L
Sbjct: 274 DCPAALYQLMLD-------CWQKDRNNRPKFEQIVSIL 304

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 87/279 (31%), Positives = 137/279 (49%), Gaps = 40/279 (14%)
Query: 55  NKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCC 114
            +LG G  G V+ G      ++AVK L  +          EA+++ ++QH+ LVRL    
Sbjct: 19  ERLGAGQAGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAV- 76
Query: 115 IDRDEKILIYEYMPNKSLDFFLFDP-----TKRMLLDWVTRVQIIEGIAQGLLYLHQYSR 169
           + ++   +I EYM N SL  FL  P     T   LLD   +      IA+G+ ++ + + 
Sbjct: 77  VTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQ------IAEGMAFIEERN- 129
Query: 170 VRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGI 229
              IHRDL+A+NIL+   ++ KI+DFG+AR+    E  A          + +PE    G 
Sbjct: 130 --YIHRDLRAANILVSDTLSCKIADFGLARLIEDAEXTAREGAKFPI-KWTAPEAINYGT 186
Query: 230 FSIKSDVFSFGVLLLEIVSGKK--NTGLYRTDSLNLLGYAWDLWTSNRTLELIDP--ILE 285
           F+IKSDV+SFG+LL EIV+  +    G+   + +  L          R   ++ P    E
Sbjct: 187 FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL---------ERGYRMVRPDNCPE 237
Query: 286 DEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTN 324
           + Y     L+R      LC +E  +DRPT + + S+L +
Sbjct: 238 ELYQ----LMR------LCWKERPEDRPTFDYLRSVLED 266

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 68/195 (34%), Positives = 108/195 (55%), Gaps = 7/195 (3%)
Query: 55  NKLGEGGFGPVYKGVLKKGD-EIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGC 113
           +KLG G +G VY+GV KK    +AVK L   + + + E   EA+V+ +++H NLV+LLG 
Sbjct: 23  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 81
Query: 114 CIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRII 173
           C       +I E+M   +L  +L +   R  ++ V  + +   I+  + YL    +   I
Sbjct: 82  CTREPPFYIITEFMTYGNLLDYLRE-CNRQEVNAVVLLYMATQISSAMEYL---EKKNFI 137
Query: 174 HRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIK 233
           HRDL A N L+ ++   K++DFG++R+  G+   A+         + +PE      FSIK
Sbjct: 138 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-KWTAPESLAYNKFSIK 196
Query: 234 SDVFSFGVLLLEIVS 248
           SDV++FGVLL EI +
Sbjct: 197 SDVWAFGVLLWEIAT 211

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 82/270 (30%), Positives = 131/270 (48%), Gaps = 28/270 (10%)
Query: 56  KLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCI 115
           KLG G FG V+     K  ++AVK +   S   +     EA+V+  +QH  LV+L    +
Sbjct: 22  KLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKL-HAVV 79
Query: 116 DRDEKILIYEYMPNKSL-DFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 174
            ++   +I E+M   SL DF   D   +  L     +     IA+G+ ++ Q +    IH
Sbjct: 80  TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLP--KLIDFSAQIAEGMAFIEQRN---YIH 134
Query: 175 RDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKS 234
           RDL+A+NIL+   +  KI+DFG+AR+   NE  A          + +PE    G F+IKS
Sbjct: 135 RDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPI-KWTAPEAINFGSFTIKS 193
Query: 235 DVFSFGVLLLEIVSGKK--NTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYSSKQ 292
           DV+SFG+LL+EIV+  +    G+   + +  L          R   +  P    E   ++
Sbjct: 194 DVWSFGILLMEIVTYGRIPYPGMSNPEVIRAL---------ERGYRMPRP----ENCPEE 240
Query: 293 MLLRYANIALLCVQESADDRPTMNDVVSML 322
           +     NI + C +   ++RPT   + S+L
Sbjct: 241 LY----NIMMRCWKNRPEERPTFEYIQSVL 266

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 80/278 (28%), Positives = 138/278 (49%), Gaps = 38/278 (13%)
Query: 57  LGEGGFGPVYKGVLK----KGDEIAVKRLS-GRSGQGLREMKNEASVIAKVQHKNLVRLL 111
           +G G FG V  G LK    K   +A+K L  G + +  R+   EAS++ +  H N++RL 
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112
Query: 112 GCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVR 171
           G        +++ EYM N SLD FL     +  +  +  V ++ GIA G+ YL   S + 
Sbjct: 113 GVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTV--IQLVGMLRGIASGMKYL---SDMG 167
Query: 172 IIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVG-TYGYMSPEYALEGIF 230
            +HRDL A NIL++ ++  K+SDFG++R+   +   A T+R       + SPE      F
Sbjct: 168 YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKF 227
Query: 231 SIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELID------PIL 284
           +  SDV+S+G++L E++S  +                W++ ++   ++ +D      P +
Sbjct: 228 TSASDVWSYGIVLWEVMSYGERP-------------YWEM-SNQDVIKAVDEGYRLPPPM 273
Query: 285 EDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSML 322
           +   +  Q++L        C Q+  ++RP    +VS+L
Sbjct: 274 DCPAALYQLMLD-------CWQKDRNNRPKFEQIVSIL 304

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 85/297 (28%), Positives = 145/297 (48%), Gaps = 39/297 (13%)
Query: 38  LFSFSSVSTATNKFSDANKLGEGGFGPVYKGVLK----KGDEIAVKRLS-GRSGQGLREM 92
           +  F+    ATN  S    +G G FG V  G LK    K   +A+K L  G + +  R+ 
Sbjct: 33  VHEFAKELDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDF 91
Query: 93  KNEASVIAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQ 152
             EAS++ +  H N++RL G        +++ EYM N SLD FL     +  +  +  V 
Sbjct: 92  LGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTV--IQLVG 149
Query: 153 IIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR 212
           ++ GIA G+ YL   S +  +HRDL A NIL++ ++  K+SDFG++R+   +   A T+R
Sbjct: 150 MLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTR 206
Query: 213 IVG-TYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLW 271
                  + SPE      F+  SDV+S+G++L E++S  +                W++ 
Sbjct: 207 GGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP-------------YWEM- 252
Query: 272 TSNRTLELID------PILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSML 322
           ++   ++ +D      P ++   +  Q++L        C Q+  ++RP    +VS+L
Sbjct: 253 SNQDVIKAVDEGYRLPPPMDCPAALYQLMLD-------CWQKDRNNRPKFEQIVSIL 302

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 68/198 (34%), Positives = 108/198 (54%), Gaps = 11/198 (5%)
Query: 57  LGEGGFGPVYKGVLK----KGDEIAVKRLS-GRSGQGLREMKNEASVIAKVQHKNLVRLL 111
           +G G FG V  G LK    K   +A+K L  G + +  R+   EAS++ +  H N++RL 
Sbjct: 24  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 83
Query: 112 GCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVR 171
           G        +++ EYM N SLD FL     +  +  +  V ++ GIA G+ YL   S + 
Sbjct: 84  GVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTV--IQLVGMLRGIASGMKYL---SDMG 138
Query: 172 IIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT-YGYMSPEYALEGIF 230
            +HRDL A NIL++ ++  K+SDFG++R+   +   A T+R       + SPE      F
Sbjct: 139 YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKF 198
Query: 231 SIKSDVFSFGVLLLEIVS 248
           +  SDV+S+G++L E++S
Sbjct: 199 TSASDVWSYGIVLWEVMS 216

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 68/195 (34%), Positives = 108/195 (55%), Gaps = 7/195 (3%)
Query: 55  NKLGEGGFGPVYKGVLKKGD-EIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGC 113
           +KLG G +G VY+GV KK    +AVK L   + + + E   EA+V+ +++H NLV+LLG 
Sbjct: 24  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 82
Query: 114 CIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRII 173
           C       +I E+M   +L  +L +   R  ++ V  + +   I+  + YL    +   I
Sbjct: 83  CTREPPFYIITEFMTYGNLLDYLRE-CNRQEVNAVVLLYMATQISSAMEYL---EKKNFI 138
Query: 174 HRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIK 233
           HRDL A N L+ ++   K++DFG++R+  G+   A+         + +PE      FSIK
Sbjct: 139 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPI-KWTAPESLAYNKFSIK 197
Query: 234 SDVFSFGVLLLEIVS 248
           SDV++FGVLL EI +
Sbjct: 198 SDVWAFGVLLWEIAT 212

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 69/195 (35%), Positives = 107/195 (54%), Gaps = 7/195 (3%)
Query: 55  NKLGEGGFGPVYKGVLKKGD-EIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGC 113
           +KLG G FG VY+GV KK    +AVK L   + + + E   EA+V+ +++H NLV+LLG 
Sbjct: 17  HKLGGGQFGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 75
Query: 114 CIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRII 173
           C       +I E+M   +L  +L +   R  +  V  + +   I+  + YL    +   I
Sbjct: 76  CTREPPFYIITEFMTYGNLLDYLRE-CNRQEVSAVVLLYMATQISSAMEYL---EKKNFI 131
Query: 174 HRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIK 233
           HRDL A N L+ ++   K++DFG++R+  G+   A+         + +PE      FSIK
Sbjct: 132 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPI-KWTAPESLAYNKFSIK 190
Query: 234 SDVFSFGVLLLEIVS 248
           SDV++FGVLL EI +
Sbjct: 191 SDVWAFGVLLWEIAT 205

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 68/195 (34%), Positives = 108/195 (55%), Gaps = 7/195 (3%)
Query: 55  NKLGEGGFGPVYKGVLKKGD-EIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGC 113
           +KLG G +G VY+GV KK    +AVK L   + + + E   EA+V+ +++H NLV+LLG 
Sbjct: 21  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 79
Query: 114 CIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRII 173
           C       +I E+M   +L  +L +   R  ++ V  + +   I+  + YL    +   I
Sbjct: 80  CTREPPFYIITEFMTYGNLLDYLRE-CNRQEVNAVVLLYMATQISSAMEYL---EKKNFI 135
Query: 174 HRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIK 233
           HRDL A N L+ ++   K++DFG++R+  G+   A+         + +PE      FSIK
Sbjct: 136 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-KWTAPESLAYNKFSIK 194
Query: 234 SDVFSFGVLLLEIVS 248
           SDV++FGVLL EI +
Sbjct: 195 SDVWAFGVLLWEIAT 209

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 68/195 (34%), Positives = 108/195 (55%), Gaps = 7/195 (3%)
Query: 55  NKLGEGGFGPVYKGVLKKGD-EIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGC 113
           +KLG G +G VY+GV KK    +AVK L   + + + E   EA+V+ +++H NLV+LLG 
Sbjct: 21  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 79
Query: 114 CIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRII 173
           C       +I E+M   +L  +L +   R  ++ V  + +   I+  + YL    +   I
Sbjct: 80  CTREPPFYIITEFMTYGNLLDYLRE-CNRQEVNAVVLLYMATQISSAMEYL---EKKNFI 135
Query: 174 HRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIK 233
           HRDL A N L+ ++   K++DFG++R+  G+   A+         + +PE      FSIK
Sbjct: 136 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-KWTAPESLAYNKFSIK 194
Query: 234 SDVFSFGVLLLEIVS 248
           SDV++FGVLL EI +
Sbjct: 195 SDVWAFGVLLWEIAT 209

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 99.8 bits (247), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 68/195 (34%), Positives = 108/195 (55%), Gaps = 7/195 (3%)
Query: 55  NKLGEGGFGPVYKGVLKKGD-EIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGC 113
           +KLG G +G VY+GV KK    +AVK L   + + + E   EA+V+ +++H NLV+LLG 
Sbjct: 32  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 90
Query: 114 CIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRII 173
           C       +I E+M   +L  +L +   R  ++ V  + +   I+  + YL    +   I
Sbjct: 91  CTREPPFYIITEFMTYGNLLDYLRE-CNRQEVNAVVLLYMATQISSAMEYL---EKKNFI 146
Query: 174 HRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIK 233
           HRDL A N L+ ++   K++DFG++R+  G+   A+         + +PE      FSIK
Sbjct: 147 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-KWTAPESLAYNKFSIK 205
Query: 234 SDVFSFGVLLLEIVS 248
           SDV++FGVLL EI +
Sbjct: 206 SDVWAFGVLLWEIAT 220

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 99.8 bits (247), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 68/195 (34%), Positives = 108/195 (55%), Gaps = 7/195 (3%)
Query: 55  NKLGEGGFGPVYKGVLKKGD-EIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGC 113
           +KLG G +G VY+GV KK    +AVK L   + + + E   EA+V+ +++H NLV+LLG 
Sbjct: 19  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 77
Query: 114 CIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRII 173
           C       +I E+M   +L  +L +   R  ++ V  + +   I+  + YL    +   I
Sbjct: 78  CTREPPFYIITEFMTYGNLLDYLRE-CNRQEVNAVVLLYMATQISSAMEYL---EKKNFI 133
Query: 174 HRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIK 233
           HRDL A N L+ ++   K++DFG++R+  G+   A+         + +PE      FSIK
Sbjct: 134 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-KWTAPESLAYNKFSIK 192
Query: 234 SDVFSFGVLLLEIVS 248
           SDV++FGVLL EI +
Sbjct: 193 SDVWAFGVLLWEIAT 207

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 99.8 bits (247), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 68/195 (34%), Positives = 108/195 (55%), Gaps = 7/195 (3%)
Query: 55  NKLGEGGFGPVYKGVLKKGD-EIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGC 113
           +KLG G +G VY+GV KK    +AVK L   + + + E   EA+V+ +++H NLV+LLG 
Sbjct: 24  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 82
Query: 114 CIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRII 173
           C       +I E+M   +L  +L +   R  ++ V  + +   I+  + YL    +   I
Sbjct: 83  CTREPPFYIITEFMTYGNLLDYLRE-CNRQEVNAVVLLYMATQISSAMEYL---EKKNFI 138
Query: 174 HRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIK 233
           HRDL A N L+ ++   K++DFG++R+  G+   A+         + +PE      FSIK
Sbjct: 139 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-KWTAPESLAYNKFSIK 197
Query: 234 SDVFSFGVLLLEIVS 248
           SDV++FGVLL EI +
Sbjct: 198 SDVWAFGVLLWEIAT 212

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 99.8 bits (247), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 67/194 (34%), Positives = 106/194 (54%), Gaps = 9/194 (4%)
Query: 56  KLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCI 115
           KLG+G FG V+ G       +A+K L   +         EA V+ K++H+ LV+L    +
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAV-V 82
Query: 116 DRDEKILIYEYMPNKSL-DFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 174
             +   ++ EYM    L DF   +  K + L  +  V +   IA G+ Y+    R+  +H
Sbjct: 83  SEEPIYIVMEYMSKGCLLDFLKGEMGKYLRLPQL--VDMAAQIASGMAYVE---RMNYVH 137
Query: 175 RDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKS 234
           RDL+A+NIL+ +++  K++DFG+AR+   NE  A          + +PE AL G F+IKS
Sbjct: 138 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKS 196
Query: 235 DVFSFGVLLLEIVS 248
           DV+SFG+LL E+ +
Sbjct: 197 DVWSFGILLTELTT 210

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 99.8 bits (247), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 85/274 (31%), Positives = 134/274 (48%), Gaps = 30/274 (10%)
Query: 57  LGEGGFGPVYKGVLKKGDE----IAVKRL-SGRSGQGLREMKNEASVIAKVQHKNLVRLL 111
           +G G FG V  G LK   +    +A+K L +G + +  R+  +EAS++ +  H N++ L 
Sbjct: 22  IGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHLE 81
Query: 112 GCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVR 171
           G        ++I EYM N SLD FL     R  +  +  V ++ GI  G+ YL   S V 
Sbjct: 82  GVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTV--IQLVGMLRGIGSGMKYLSDMSYV- 138
Query: 172 IIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVG-TYGYMSPEYALEGIF 230
             HRDL A NIL++ ++  K+SDFGM+R+   +   A T+R       + +PE      F
Sbjct: 139 --HRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKF 196
Query: 231 SIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYSS 290
           +  SDV+S+G+++ E++S  +                WD+  SN+  ++I  I E     
Sbjct: 197 TSASDVWSYGIVMWEVMSYGERP-------------YWDM--SNQ--DVIKAIEEGYRLP 239
Query: 291 KQMLLRYA--NIALLCVQESADDRPTMNDVVSML 322
             M    A   + L C Q+   DRP    +V+ML
Sbjct: 240 PPMDCPIALHQLMLDCWQKERSDRPKFGQIVNML 273

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 99.8 bits (247), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 85/274 (31%), Positives = 134/274 (48%), Gaps = 30/274 (10%)
Query: 57  LGEGGFGPVYKGVLKKGDE----IAVKRL-SGRSGQGLREMKNEASVIAKVQHKNLVRLL 111
           +G G FG V  G LK   +    +A+K L +G + +  R+  +EAS++ +  H N++ L 
Sbjct: 16  IGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHLE 75
Query: 112 GCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVR 171
           G        ++I EYM N SLD FL     R  +  +  V ++ GI  G+ YL   S V 
Sbjct: 76  GVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTV--IQLVGMLRGIGSGMKYLSDMSYV- 132
Query: 172 IIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVG-TYGYMSPEYALEGIF 230
             HRDL A NIL++ ++  K+SDFGM+R+   +   A T+R       + +PE      F
Sbjct: 133 --HRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKF 190
Query: 231 SIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYSS 290
           +  SDV+S+G+++ E++S  +                WD+  SN+  ++I  I E     
Sbjct: 191 TSASDVWSYGIVMWEVMSYGERP-------------YWDM--SNQ--DVIKAIEEGYRLP 233
Query: 291 KQMLLRYA--NIALLCVQESADDRPTMNDVVSML 322
             M    A   + L C Q+   DRP    +V+ML
Sbjct: 234 PPMDCPIALHQLMLDCWQKERSDRPKFGQIVNML 267

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 99.8 bits (247), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 80/278 (28%), Positives = 137/278 (49%), Gaps = 38/278 (13%)
Query: 57  LGEGGFGPVYKGVLK----KGDEIAVKRLS-GRSGQGLREMKNEASVIAKVQHKNLVRLL 111
           +G G FG V  G LK    K   +A+K L  G + +  R+   EAS++ +  H N++RL 
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112
Query: 112 GCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVR 171
           G        +++ EYM N SLD FL     +  +  +  V ++ GIA G+ YL   S + 
Sbjct: 113 GVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTV--IQLVGMLRGIASGMKYL---SDMG 167
Query: 172 IIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVG-TYGYMSPEYALEGIF 230
            +HRDL A NIL++ ++  K+SDFG+ R+   +   A T+R       + SPE      F
Sbjct: 168 YVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKF 227
Query: 231 SIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELID------PIL 284
           +  SDV+S+G++L E++S  +                W++ ++   ++ +D      P +
Sbjct: 228 TSASDVWSYGIVLWEVMSYGERP-------------YWEM-SNQDVIKAVDEGYRLPPPM 273
Query: 285 EDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSML 322
           +   +  Q++L        C Q+  ++RP    +VS+L
Sbjct: 274 DCPAALYQLMLD-------CWQKDRNNRPKFEQIVSIL 304

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 99.8 bits (247), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 80/278 (28%), Positives = 138/278 (49%), Gaps = 38/278 (13%)
Query: 57  LGEGGFGPVYKGVLK----KGDEIAVKRLS-GRSGQGLREMKNEASVIAKVQHKNLVRLL 111
           +G G FG V  G LK    K   +A+K L  G + +  R+   EAS++ +  H N++RL 
Sbjct: 41  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 100
Query: 112 GCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVR 171
           G        +++ EYM N SLD FL     +  +  +  V ++ GIA G+ YL   S + 
Sbjct: 101 GVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTV--IQLVGMLRGIASGMKYL---SDMG 155
Query: 172 IIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVG-TYGYMSPEYALEGIF 230
            +HRDL A NIL++ ++  K+SDFG++R+   +   A T+R       + SPE      F
Sbjct: 156 YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKF 215
Query: 231 SIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELID------PIL 284
           +  SDV+S+G++L E++S  +                W++ ++   ++ +D      P +
Sbjct: 216 TSASDVWSYGIVLWEVMSYGERP-------------YWEM-SNQDVIKAVDEGYRLPPPM 261
Query: 285 EDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSML 322
           +   +  Q++L        C Q+  ++RP    +VS+L
Sbjct: 262 DCPAALYQLMLD-------CWQKDRNNRPKFEQIVSIL 292

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 99.8 bits (247), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 67/194 (34%), Positives = 106/194 (54%), Gaps = 9/194 (4%)
Query: 56  KLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCI 115
           KLG+G FG V+ G       +A+K L   +         EA V+ K++H+ LV+L    +
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAV-V 82
Query: 116 DRDEKILIYEYMPNKSL-DFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 174
             +   ++ EYM    L DF   +  K + L  +  V +   IA G+ Y+    R+  +H
Sbjct: 83  SEEPIYIVTEYMSKGCLLDFLKGEMGKYLRLPQL--VDMAAQIASGMAYVE---RMNYVH 137
Query: 175 RDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKS 234
           RDL+A+NIL+ +++  K++DFG+AR+   NE  A          + +PE AL G F+IKS
Sbjct: 138 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKS 196
Query: 235 DVFSFGVLLLEIVS 248
           DV+SFG+LL E+ +
Sbjct: 197 DVWSFGILLTELTT 210

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 99.8 bits (247), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 68/195 (34%), Positives = 108/195 (55%), Gaps = 7/195 (3%)
Query: 55  NKLGEGGFGPVYKGVLKKGD-EIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGC 113
           +KLG G +G VY+GV KK    +AVK L   + + + E   EA+V+ +++H NLV+LLG 
Sbjct: 20  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 78
Query: 114 CIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRII 173
           C       +I E+M   +L  +L +   R  ++ V  + +   I+  + YL    +   I
Sbjct: 79  CTREPPFYIIIEFMTYGNLLDYLRE-CNRQEVNAVVLLYMATQISSAMEYL---EKKNFI 134
Query: 174 HRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIK 233
           HRDL A N L+ ++   K++DFG++R+  G+   A+         + +PE      FSIK
Sbjct: 135 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPI-KWTAPESLAYNKFSIK 193
Query: 234 SDVFSFGVLLLEIVS 248
           SDV++FGVLL EI +
Sbjct: 194 SDVWAFGVLLWEIAT 208

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 68/195 (34%), Positives = 107/195 (54%), Gaps = 7/195 (3%)
Query: 55  NKLGEGGFGPVYKGVLKKGD-EIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGC 113
           +KLG G +G VY+GV KK    +AVK L   + + + E   EA+V+ +++H NLV+LLG 
Sbjct: 19  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 77
Query: 114 CIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRII 173
           C       +I E+M   +L  +L +   R  +  V  + +   I+  + YL    +   I
Sbjct: 78  CTREPPFYIITEFMTYGNLLDYLRE-CNRQEVSAVVLLYMATQISSAMEYL---EKKNFI 133
Query: 174 HRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIK 233
           HRDL A N L+ ++   K++DFG++R+  G+   A+         + +PE      FSIK
Sbjct: 134 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-KWTAPESLAYNKFSIK 192
Query: 234 SDVFSFGVLLLEIVS 248
           SDV++FGVLL EI +
Sbjct: 193 SDVWAFGVLLWEIAT 207

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 68/195 (34%), Positives = 107/195 (54%), Gaps = 7/195 (3%)
Query: 55  NKLGEGGFGPVYKGVLKKGD-EIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGC 113
           +KLG G +G VY+GV KK    +AVK L   + + + E   EA+V+ +++H NLV+LLG 
Sbjct: 17  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 75
Query: 114 CIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRII 173
           C       +I E+M   +L  +L +   R  +  V  + +   I+  + YL    +   I
Sbjct: 76  CTREPPFYIITEFMTYGNLLDYLRE-CNRQEVSAVVLLYMATQISSAMEYL---EKKNFI 131
Query: 174 HRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIK 233
           HRDL A N L+ ++   K++DFG++R+  G+   A+         + +PE      FSIK
Sbjct: 132 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTFTAHAGAKFPI-KWTAPESLAYNKFSIK 190
Query: 234 SDVFSFGVLLLEIVS 248
           SDV++FGVLL EI +
Sbjct: 191 SDVWAFGVLLWEIAT 205

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 68/195 (34%), Positives = 107/195 (54%), Gaps = 7/195 (3%)
Query: 55  NKLGEGGFGPVYKGVLKKGD-EIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGC 113
           +KLG G +G VY+GV KK    +AVK L   + + + E   EA+V+ +++H NLV+LLG 
Sbjct: 24  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 82
Query: 114 CIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRII 173
           C       +I E+M   +L  +L +   R  +  V  + +   I+  + YL    +   I
Sbjct: 83  CTREPPFYIITEFMTYGNLLDYLRE-CNRQEVSAVVLLYMATQISSAMEYL---EKKNFI 138
Query: 174 HRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIK 233
           HRDL A N L+ ++   K++DFG++R+  G+   A+         + +PE      FSIK
Sbjct: 139 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-KWTAPESLAYNKFSIK 197
Query: 234 SDVFSFGVLLLEIVS 248
           SDV++FGVLL EI +
Sbjct: 198 SDVWAFGVLLWEIAT 212

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 68/195 (34%), Positives = 107/195 (54%), Gaps = 7/195 (3%)
Query: 55  NKLGEGGFGPVYKGVLKKGD-EIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGC 113
           +KLG G +G VY+GV KK    +AVK L   + + + E   EA+V+ +++H NLV+LLG 
Sbjct: 19  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 77
Query: 114 CIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRII 173
           C       +I E+M   +L  +L +   R  +  V  + +   I+  + YL    +   I
Sbjct: 78  CTREPPFYIIIEFMTYGNLLDYLRE-CNRQEVSAVVLLYMATQISSAMEYL---EKKNFI 133
Query: 174 HRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIK 233
           HRDL A N L+ ++   K++DFG++R+  G+   A+         + +PE      FSIK
Sbjct: 134 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-KWTAPESLAYNKFSIK 192
Query: 234 SDVFSFGVLLLEIVS 248
           SDV++FGVLL EI +
Sbjct: 193 SDVWAFGVLLWEIAT 207

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 82/272 (30%), Positives = 132/272 (48%), Gaps = 28/272 (10%)
Query: 56  KLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCI 115
           KLG G FG V+     K  ++AVK +   S   +     EA+V+  +QH  LV+L    +
Sbjct: 195 KLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKL-HAVV 252
Query: 116 DRDEKILIYEYMPNKSL-DFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 174
            ++   +I E+M   SL DF   D   +  L     +     IA+G+ ++ Q +    IH
Sbjct: 253 TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLP--KLIDFSAQIAEGMAFIEQRN---YIH 307
Query: 175 RDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKS 234
           RDL+A+NIL+   +  KI+DFG+AR+   NE  A          + +PE    G F+IKS
Sbjct: 308 RDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKF-PIKWTAPEAINFGSFTIKS 366
Query: 235 DVFSFGVLLLEIVSGKK--NTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYSSKQ 292
           DV+SFG+LL+EIV+  +    G+   + +  L          R   +  P    E   ++
Sbjct: 367 DVWSFGILLMEIVTYGRIPYPGMSNPEVIRAL---------ERGYRMPRP----ENCPEE 413
Query: 293 MLLRYANIALLCVQESADDRPTMNDVVSMLTN 324
           +     NI + C +   ++RPT   + S+L +
Sbjct: 414 LY----NIMMRCWKNRPEERPTFEYIQSVLDD 441

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 79/271 (29%), Positives = 134/271 (49%), Gaps = 34/271 (12%)
Query: 51  FSDANKLGEGGFGPVYKGV-LKKGDEIAVKRLS---GRSGQGLREMKNEASVIAKVQHKN 106
           FSD  ++G G FG VY    ++  + +A+K++S    +S +  +++  E   + K++H N
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 107 LVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQ 166
            ++  GC +      L+ EY    + D  L +  K+ L + V    +  G  QGL YLH 
Sbjct: 77  TIQYRGCYLREHTAWLVMEYCLGSASD--LLEVHKKPLQE-VEIAAVTHGALQGLAYLHS 133
Query: 167 YSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAL 226
           ++   +IHRD+KA NILL +    K+ DFG A I       A  +  VGT  +M+PE  L
Sbjct: 134 HN---MIHRDVKAGNILLSEPGLVKLGDFGSASI------MAPANXFVGTPYWMAPEVIL 184
Query: 227 ---EGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPI 283
              EG +  K DV+S G+  +E+   ++   L+  ++++ L +       N +     P 
Sbjct: 185 AMDEGQYDGKVDVWSLGITCIEL--AERKPPLFNMNAMSALYHI----AQNES-----PA 233
Query: 284 LEDEYSSKQMLLRYANIALLCVQESADDRPT 314
           L+  + S+     + N    C+Q+   DRPT
Sbjct: 234 LQSGHWSEY----FRNFVDSCLQKIPQDRPT 260

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 99.0 bits (245), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 68/195 (34%), Positives = 107/195 (54%), Gaps = 7/195 (3%)
Query: 55  NKLGEGGFGPVYKGVLKKGD-EIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGC 113
           +KLG G +G VY+GV KK    +AVK L   + + + E   EA+V+ +++H NLV+LLG 
Sbjct: 19  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 77
Query: 114 CIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRII 173
           C       +I E+M   +L  +L +   R  +  V  + +   I+  + YL    +   I
Sbjct: 78  CTREPPFYIIIEFMTYGNLLDYLRE-CNRQEVSAVVLLYMATQISSAMEYL---EKKNFI 133
Query: 174 HRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIK 233
           HRDL A N L+ ++   K++DFG++R+  G+   A+         + +PE      FSIK
Sbjct: 134 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-KWTAPESLAYNKFSIK 192
Query: 234 SDVFSFGVLLLEIVS 248
           SDV++FGVLL EI +
Sbjct: 193 SDVWAFGVLLWEIAT 207

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 99.0 bits (245), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 68/195 (34%), Positives = 107/195 (54%), Gaps = 7/195 (3%)
Query: 55  NKLGEGGFGPVYKGVLKKGD-EIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGC 113
           +KLG G +G VY+GV KK    +AVK L   + + + E   EA+V+ +++H NLV+LLG 
Sbjct: 19  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 77
Query: 114 CIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRII 173
           C       +I E+M   +L  +L +   R  +  V  + +   I+  + YL    +   I
Sbjct: 78  CTREPPFYIITEFMTYGNLLDYLRE-CNRQEVSAVVLLYMATQISSAMEYL---EKKNFI 133
Query: 174 HRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIK 233
           HRDL A N L+ ++   K++DFG++R+  G+   A+         + +PE      FSIK
Sbjct: 134 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-KWTAPESLAYNKFSIK 192
Query: 234 SDVFSFGVLLLEIVS 248
           SDV++FGVLL EI +
Sbjct: 193 SDVWAFGVLLWEIAT 207

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 99.0 bits (245), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 68/195 (34%), Positives = 107/195 (54%), Gaps = 7/195 (3%)
Query: 55  NKLGEGGFGPVYKGVLKKGD-EIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGC 113
           +KLG G +G VY+GV KK    +AVK L   + + + E   EA+V+ +++H NLV+LLG 
Sbjct: 17  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 75
Query: 114 CIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRII 173
           C       +I E+M   +L  +L +   R  +  V  + +   I+  + YL    +   I
Sbjct: 76  CTREPPFYIIIEFMTYGNLLDYLRE-CNRQEVSAVVLLYMATQISSAMEYL---EKKNFI 131
Query: 174 HRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIK 233
           HRDL A N L+ ++   K++DFG++R+  G+   A+         + +PE      FSIK
Sbjct: 132 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPI-KWTAPESLAYNKFSIK 190
Query: 234 SDVFSFGVLLLEIVS 248
           SDV++FGVLL EI +
Sbjct: 191 SDVWAFGVLLWEIAT 205

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 99.0 bits (245), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 68/195 (34%), Positives = 107/195 (54%), Gaps = 7/195 (3%)
Query: 55  NKLGEGGFGPVYKGVLKKGD-EIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGC 113
           +KLG G +G VY+GV KK    +AVK L   + + + E   EA+V+ +++H NLV+LLG 
Sbjct: 20  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 78
Query: 114 CIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRII 173
           C       +I E+M   +L  +L +   R  ++ V  + +   I+  + YL    +   I
Sbjct: 79  CTREPPFYIITEFMTYGNLLDYLRE-CNRQEVNAVVLLYMATQISSAMEYL---EKKNFI 134
Query: 174 HRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIK 233
           HRDL A N L+ ++   K++DFG++R+  G+   A          + +PE      FSIK
Sbjct: 135 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPI-KWTAPESLAYNKFSIK 193
Query: 234 SDVFSFGVLLLEIVS 248
           SDV++FGVLL EI +
Sbjct: 194 SDVWAFGVLLWEIAT 208

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 99.0 bits (245), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 68/195 (34%), Positives = 107/195 (54%), Gaps = 7/195 (3%)
Query: 55  NKLGEGGFGPVYKGVLKKGD-EIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGC 113
           +KLG G +G VY+GV KK    +AVK L   + + + E   EA+V+ +++H NLV+LLG 
Sbjct: 21  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 79
Query: 114 CIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRII 173
           C       +I E+M   +L  +L +   R  ++ V  + +   I+  + YL    +   I
Sbjct: 80  CTREPPFYIITEFMTYGNLLDYLRE-CNRQEVNAVVLLYMATQISSAMEYL---EKKNFI 135
Query: 174 HRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIK 233
           HRDL A N L+ ++   K++DFG++R+  G+   A          + +PE      FSIK
Sbjct: 136 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPI-KWTAPESLAYNKFSIK 194
Query: 234 SDVFSFGVLLLEIVS 248
           SDV++FGVLL EI +
Sbjct: 195 SDVWAFGVLLWEIAT 209

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 99.0 bits (245), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 79/271 (29%), Positives = 134/271 (49%), Gaps = 34/271 (12%)
Query: 51  FSDANKLGEGGFGPVYKGV-LKKGDEIAVKRLS---GRSGQGLREMKNEASVIAKVQHKN 106
           FSD  ++G G FG VY    ++  + +A+K++S    +S +  +++  E   + K++H N
Sbjct: 56  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115
Query: 107 LVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQ 166
            ++  GC +      L+ EY    + D  L +  K+ L + V    +  G  QGL YLH 
Sbjct: 116 TIQYRGCYLREHTAWLVMEYCLGSASD--LLEVHKKPLQE-VEIAAVTHGALQGLAYLHS 172
Query: 167 YSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAL 226
           ++   +IHRD+KA NILL +    K+ DFG A I       A  +  VGT  +M+PE  L
Sbjct: 173 HN---MIHRDVKAGNILLSEPGLVKLGDFGSASI------MAPANXFVGTPYWMAPEVIL 223
Query: 227 ---EGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPI 283
              EG +  K DV+S G+  +E+   ++   L+  ++++ L +       N +     P 
Sbjct: 224 AMDEGQYDGKVDVWSLGITCIEL--AERKPPLFNMNAMSALYHI----AQNES-----PA 272
Query: 284 LEDEYSSKQMLLRYANIALLCVQESADDRPT 314
           L+  + S+     + N    C+Q+   DRPT
Sbjct: 273 LQSGHWSEY----FRNFVDSCLQKIPQDRPT 299

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 97.8 bits (242), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 67/195 (34%), Positives = 107/195 (54%), Gaps = 7/195 (3%)
Query: 55  NKLGEGGFGPVYKGVLKKGD-EIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGC 113
           +KLG G +G VY+GV KK    +AVK L   + + + E   EA+V+ +++H NLV+LLG 
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 284
Query: 114 CIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRII 173
           C       +I E+M   +L  +L +   R  +  V  + +   I+  + YL    +   I
Sbjct: 285 CTREPPFYIITEFMTYGNLLDYLRE-CNRQEVSAVVLLYMATQISSAMEYL---EKKNFI 340
Query: 174 HRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIK 233
           HR+L A N L+ ++   K++DFG++R+  G+   A+         + +PE      FSIK
Sbjct: 341 HRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-KWTAPESLAYNKFSIK 399
Query: 234 SDVFSFGVLLLEIVS 248
           SDV++FGVLL EI +
Sbjct: 400 SDVWAFGVLLWEIAT 414

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 97.8 bits (242), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 67/195 (34%), Positives = 108/195 (55%), Gaps = 7/195 (3%)
Query: 55  NKLGEGGFGPVYKGVLKKGD-EIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGC 113
           +KLG G +G VY+GV KK    +AVK L   + + + E   EA+V+ +++H NLV+LLG 
Sbjct: 265 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 323
Query: 114 CIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRII 173
           C       +I E+M   +L  +L +   R  ++ V  + +   I+  + YL    +   I
Sbjct: 324 CTREPPFYIITEFMTYGNLLDYLRE-CNRQEVNAVVLLYMATQISSAMEYL---EKKNFI 379
Query: 174 HRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIK 233
           HR+L A N L+ ++   K++DFG++R+  G+   A+         + +PE      FSIK
Sbjct: 380 HRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-KWTAPESLAYNKFSIK 438
Query: 234 SDVFSFGVLLLEIVS 248
           SDV++FGVLL EI +
Sbjct: 439 SDVWAFGVLLWEIAT 453

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 64/202 (31%), Positives = 109/202 (53%), Gaps = 13/202 (6%)
Query: 54  ANKLGEGGFGPVYKGVLKKGDEIAVKRL--SGRSGQGLREMKNEASVIAKVQHKNLVRLL 111
             ++G G FG VYKG  K   ++AVK L  +  + Q L+  KNE  V+ K +H N++  +
Sbjct: 15  GQRIGSGSFGTVYKG--KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 72
Query: 112 GCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVR 171
           G    + +  ++ ++    SL   L     +   + +  + I    AQG+ YLH  S   
Sbjct: 73  GYST-KPQLAIVTQWCEGSSLYHHLHIIETK--FEMIKLIDIARQTAQGMDYLHAKS--- 126
Query: 172 IIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAL---EG 228
           IIHRDLK++NI L +D+  KI DFG+A +           ++ G+  +M+PE      + 
Sbjct: 127 IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKN 186
Query: 229 IFSIKSDVFSFGVLLLEIVSGK 250
            +S +SDV++FG++L E+++G+
Sbjct: 187 PYSFQSDVYAFGIVLYELMTGQ 208

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 64/202 (31%), Positives = 109/202 (53%), Gaps = 13/202 (6%)
Query: 54  ANKLGEGGFGPVYKGVLKKGDEIAVKRL--SGRSGQGLREMKNEASVIAKVQHKNLVRLL 111
             ++G G FG VYKG  K   ++AVK L  +  + Q L+  KNE  V+ K +H N++  +
Sbjct: 18  GQRIGSGSFGTVYKG--KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 75
Query: 112 GCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVR 171
           G    + +  ++ ++    SL   L     +   + +  + I    AQG+ YLH  S   
Sbjct: 76  GYST-KPQLAIVTQWCEGSSLYHHLHIIETK--FEMIKLIDIARQTAQGMDYLHAKS--- 129
Query: 172 IIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAL---EG 228
           IIHRDLK++NI L +D+  KI DFG+A +           ++ G+  +M+PE      + 
Sbjct: 130 IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKN 189
Query: 229 IFSIKSDVFSFGVLLLEIVSGK 250
            +S +SDV++FG++L E+++G+
Sbjct: 190 PYSFQSDVYAFGIVLYELMTGQ 211

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 64/202 (31%), Positives = 109/202 (53%), Gaps = 13/202 (6%)
Query: 54  ANKLGEGGFGPVYKGVLKKGDEIAVKRL--SGRSGQGLREMKNEASVIAKVQHKNLVRLL 111
             ++G G FG VYKG  K   ++AVK L  +  + Q L+  KNE  V+ K +H N++  +
Sbjct: 18  GQRIGSGSFGTVYKG--KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 75
Query: 112 GCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVR 171
           G    + +  ++ ++    SL   L     +   + +  + I    AQG+ YLH  S   
Sbjct: 76  GYST-KPQLAIVTQWCEGSSLYHHLHIIETK--FEMIKLIDIARQTAQGMDYLHAKS--- 129
Query: 172 IIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAL---EG 228
           IIHRDLK++NI L +D+  KI DFG+A +           ++ G+  +M+PE      + 
Sbjct: 130 IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKN 189
Query: 229 IFSIKSDVFSFGVLLLEIVSGK 250
            +S +SDV++FG++L E+++G+
Sbjct: 190 PYSFQSDVYAFGIVLYELMTGQ 211

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 64/202 (31%), Positives = 109/202 (53%), Gaps = 13/202 (6%)
Query: 54  ANKLGEGGFGPVYKGVLKKGDEIAVKRL--SGRSGQGLREMKNEASVIAKVQHKNLVRLL 111
             ++G G FG VYKG  K   ++AVK L  +  + Q L+  KNE  V+ K +H N++  +
Sbjct: 13  GQRIGSGSFGTVYKG--KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 70
Query: 112 GCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVR 171
           G    + +  ++ ++    SL   L     +   + +  + I    AQG+ YLH  S   
Sbjct: 71  GYST-KPQLAIVTQWCEGSSLYHHLHIIETK--FEMIKLIDIARQTAQGMDYLHAKS--- 124
Query: 172 IIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAL---EG 228
           IIHRDLK++NI L +D+  KI DFG+A +           ++ G+  +M+PE      + 
Sbjct: 125 IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKN 184
Query: 229 IFSIKSDVFSFGVLLLEIVSGK 250
            +S +SDV++FG++L E+++G+
Sbjct: 185 PYSFQSDVYAFGIVLYELMTGQ 206

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 66/198 (33%), Positives = 105/198 (53%), Gaps = 9/198 (4%)
Query: 55  NKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLRE-MKNEASVIAKVQHKNLVRLLGC 113
            ++G G FG V+ G     D++A+K +  R G    E    EA V+ K+ H  LV+L G 
Sbjct: 13  QEIGSGQFGLVHLGYWLNKDKVAIKTI--REGAMSEEDFIEEAEVMMKLSHPKLVQLYGV 70
Query: 114 CIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRII 173
           C+++    L++E+M +  L  +L   T+R L    T + +   + +G+ YL +     +I
Sbjct: 71  CLEQAPICLVFEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VI 125
Query: 174 HRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIK 233
           HRDL A N L+ ++   K+SDFGM R    ++  ++T        + SPE      +S K
Sbjct: 126 HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPV-KWASPEVFSFSRYSSK 184
Query: 234 SDVFSFGVLLLEIVSGKK 251
           SDV+SFGVL+ E+ S  K
Sbjct: 185 SDVWSFGVLMWEVFSEGK 202

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 66/206 (32%), Positives = 113/206 (54%), Gaps = 21/206 (10%)
Query: 54  ANKLGEGGFGPVYKGVLKKGDEIAVKRL--SGRSGQGLREMKNEASVIAKVQHKNLVRLL 111
             ++G G FG VYKG  K   ++AVK L  +  + Q L+  KNE  V+ K +H N++  +
Sbjct: 33  GQRIGSGSFGTVYKG--KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 90
Query: 112 GCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVR 171
           G    + +  ++ ++    SL   L     +   + +  + I    AQG+ YLH  S   
Sbjct: 91  GYST-KPQLAIVTQWCEGSSLYHHLHIIETK--FEMIKLIDIARQTAQGMDYLHAKS--- 144
Query: 172 IIHRDLKASNILLDKDMNPKISDFGMA----RICGGNELQANTSRIVGTYGYMSPEYAL- 226
           IIHRDLK++NI L +D+  KI DFG+A    R  G ++ +    ++ G+  +M+PE    
Sbjct: 145 IIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFE----QLSGSILWMAPEVIRM 200
Query: 227 --EGIFSIKSDVFSFGVLLLEIVSGK 250
             +  +S +SDV++FG++L E+++G+
Sbjct: 201 QDKNPYSFQSDVYAFGIVLYELMTGQ 226

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 64/202 (31%), Positives = 109/202 (53%), Gaps = 13/202 (6%)
Query: 54  ANKLGEGGFGPVYKGVLKKGDEIAVKRL--SGRSGQGLREMKNEASVIAKVQHKNLVRLL 111
             ++G G FG VYKG  K   ++AVK L  +  + Q L+  KNE  V+ K +H N++  +
Sbjct: 40  GQRIGSGSFGTVYKG--KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 97
Query: 112 GCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVR 171
           G    + +  ++ ++    SL   L     +   + +  + I    AQG+ YLH  S   
Sbjct: 98  GYST-KPQLAIVTQWCEGSSLYHHLHIIETK--FEMIKLIDIARQTAQGMDYLHAKS--- 151
Query: 172 IIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAL---EG 228
           IIHRDLK++NI L +D+  KI DFG+A +           ++ G+  +M+PE      + 
Sbjct: 152 IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKN 211
Query: 229 IFSIKSDVFSFGVLLLEIVSGK 250
            +S +SDV++FG++L E+++G+
Sbjct: 212 PYSFQSDVYAFGIVLYELMTGQ 233

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 66/198 (33%), Positives = 105/198 (53%), Gaps = 9/198 (4%)
Query: 55  NKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLRE-MKNEASVIAKVQHKNLVRLLGC 113
            ++G G FG V+ G     D++A+K +  R G    E    EA V+ K+ H  LV+L G 
Sbjct: 11  QEIGSGQFGLVHLGYWLNKDKVAIKTI--REGAMSEEDFIEEAEVMMKLSHPKLVQLYGV 68
Query: 114 CIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRII 173
           C+++    L++E+M +  L  +L   T+R L    T + +   + +G+ YL +     +I
Sbjct: 69  CLEQAPICLVFEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VI 123
Query: 174 HRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIK 233
           HRDL A N L+ ++   K+SDFGM R    ++  ++T        + SPE      +S K
Sbjct: 124 HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPV-KWASPEVFSFSRYSSK 182
Query: 234 SDVFSFGVLLLEIVSGKK 251
           SDV+SFGVL+ E+ S  K
Sbjct: 183 SDVWSFGVLMWEVFSEGK 200

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 66/206 (32%), Positives = 113/206 (54%), Gaps = 21/206 (10%)
Query: 54  ANKLGEGGFGPVYKGVLKKGDEIAVKRL--SGRSGQGLREMKNEASVIAKVQHKNLVRLL 111
             ++G G FG VYKG  K   ++AVK L  +  + Q L+  KNE  V+ K +H N++  +
Sbjct: 13  GQRIGSGSFGTVYKG--KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 70
Query: 112 GCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVR 171
           G    + +  ++ ++    SL   L     +   + +  + I    AQG+ YLH  S   
Sbjct: 71  GYST-KPQLAIVTQWCEGSSLYHHLHIIETK--FEMIKLIDIARQTAQGMDYLHAKS--- 124
Query: 172 IIHRDLKASNILLDKDMNPKISDFGMA----RICGGNELQANTSRIVGTYGYMSPEYAL- 226
           IIHRDLK++NI L +D+  KI DFG+A    R  G ++ +    ++ G+  +M+PE    
Sbjct: 125 IIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFE----QLSGSILWMAPEVIRM 180
Query: 227 --EGIFSIKSDVFSFGVLLLEIVSGK 250
             +  +S +SDV++FG++L E+++G+
Sbjct: 181 QDKNPYSFQSDVYAFGIVLYELMTGQ 206

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 97.1 bits (240), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 82/297 (27%), Positives = 137/297 (46%), Gaps = 42/297 (14%)
Query: 56  KLGEGGFGPVY----KGVLKKGDE--IAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVR 109
           +LGEG FG V+      +L + D+  +AVK L   S    ++ + EA ++  +QH+++VR
Sbjct: 25  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVR 84
Query: 110 LLGCCIDRDEKILIYEYMPNKSLDFFL--FDPTKRML----------LDWVTRVQIIEGI 157
             G C +    ++++EYM +  L+ FL    P  ++L          L     + +   +
Sbjct: 85  FFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV 144
Query: 158 AQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTY 217
           A G++YL   + +  +HRDL   N L+ + +  KI DFGM+R     +      R +   
Sbjct: 145 AAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 201
Query: 218 GYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTG--LYRTDSLNLLGYAWDLWTSNR 275
            +M PE  L   F+ +SDV+SFGV+L EI +  K     L  T++++ +       T  R
Sbjct: 202 RWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCI-------TQGR 254
Query: 276 TLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNEAATLLPP 332
            LE       + Y+          I   C Q     R ++ DV + L  +A    PP
Sbjct: 255 ELERPRACPPEVYA----------IMRGCWQREPQQRHSIKDVHARL--QALAQAPP 299

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 97.1 bits (240), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 82/257 (31%), Positives = 130/257 (50%), Gaps = 45/257 (17%)
Query: 16  IELPANNKQAKRSKKKEVDQFPLFSFSSVSTATNKFSDANKLGEGGFGPVYKGVL----- 70
           +E+P  N Q K++K KE+      S S+V     +F +  +LGE  FG VYKG L     
Sbjct: 7   MEMPLIN-QHKQAKLKEI------SLSAV-----RFME--ELGEDRFGKVYKGHLFGPAP 52
Query: 71  -KKGDEIAVKRLSGRSGQGLRE-MKNEASVIAKVQHKNLVRLLGCCIDRDEKILIYEYMP 128
            ++   +A+K L  ++   LRE  ++EA + A++QH N+V LLG         +I+ Y  
Sbjct: 53  GEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCS 112
Query: 129 NKSLDFFLF-------------DPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHR 175
           +  L  FL              D T +  L+    V ++  IA G+ YL   S   ++H+
Sbjct: 113 HGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYL---SSHHVVHK 169
Query: 176 DLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT----YGYMSPEYALEGIFS 231
           DL   N+L+   +N KISD G+ R        A+  +++G       +M+PE  + G FS
Sbjct: 170 DLATRNVLVYDKLNVKISDLGLFR----EVYAADYYKLLGNSLLPIRWMAPEAIMYGKFS 225
Query: 232 IKSDVFSFGVLLLEIVS 248
           I SD++S+GV+L E+ S
Sbjct: 226 IDSDIWSYGVVLWEVFS 242

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 97.1 bits (240), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 81/278 (29%), Positives = 138/278 (49%), Gaps = 37/278 (13%)
Query: 57  LGEGGFGPVYKGVLK-----KGDEIAVKRL-SGRSGQGLREMKNEASVIAKVQHKNLVRL 110
           +G G FG VYKG+LK     K   +A+K L +G + +   +   EA ++ +  H N++RL
Sbjct: 52  IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRL 111
Query: 111 LGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRV 170
            G        ++I EYM N +LD FL +  K      +  V ++ GIA G+ YL   + +
Sbjct: 112 EGVISKYKPMMIITEYMENGALDKFLRE--KDGEFSVLQLVGMLRGIAAGMKYL---ANM 166
Query: 171 RIIHRDLKASNILLDKDMNPKISDFGMARICGGN-ELQANTSRIVGTYGYMSPEYALEGI 229
             +HRDL A NIL++ ++  K+SDFG++R+   + E    TS       + +PE      
Sbjct: 167 NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRK 226
Query: 230 FSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELID-----PIL 284
           F+  SDV+SFG+++ E+++  +                W+L +++  ++ I+     P  
Sbjct: 227 FTSASDVWSFGIVMWEVMTYGERP-------------YWEL-SNHEVMKAINDGFRLPTP 272
Query: 285 EDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSML 322
            D  S+   L+      + C Q+    RP   D+VS+L
Sbjct: 273 MDCPSAIYQLM------MQCWQQERARRPKFADIVSIL 304

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 97.1 bits (240), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 82/297 (27%), Positives = 137/297 (46%), Gaps = 42/297 (14%)
Query: 56  KLGEGGFGPVY----KGVLKKGDE--IAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVR 109
           +LGEG FG V+      +L + D+  +AVK L   S    ++ + EA ++  +QH+++VR
Sbjct: 19  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVR 78
Query: 110 LLGCCIDRDEKILIYEYMPNKSLDFFL--FDPTKRML----------LDWVTRVQIIEGI 157
             G C +    ++++EYM +  L+ FL    P  ++L          L     + +   +
Sbjct: 79  FFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV 138
Query: 158 AQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTY 217
           A G++YL   + +  +HRDL   N L+ + +  KI DFGM+R     +      R +   
Sbjct: 139 AAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 195
Query: 218 GYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTG--LYRTDSLNLLGYAWDLWTSNR 275
            +M PE  L   F+ +SDV+SFGV+L EI +  K     L  T++++ +       T  R
Sbjct: 196 RWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCI-------TQGR 248
Query: 276 TLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNEAATLLPP 332
            LE       + Y+          I   C Q     R ++ DV + L  +A    PP
Sbjct: 249 ELERPRACPPEVYA----------IMRGCWQREPQQRHSIKDVHARL--QALAQAPP 293

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 97.1 bits (240), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 66/198 (33%), Positives = 105/198 (53%), Gaps = 9/198 (4%)
Query: 55  NKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLRE-MKNEASVIAKVQHKNLVRLLGC 113
            ++G G FG V+ G     D++A+K +  R G    E    EA V+ K+ H  LV+L G 
Sbjct: 16  QEIGSGQFGLVHLGYWLNKDKVAIKTI--REGAMSEEDFIEEAEVMMKLSHPKLVQLYGV 73
Query: 114 CIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRII 173
           C+++    L++E+M +  L  +L   T+R L    T + +   + +G+ YL +     +I
Sbjct: 74  CLEQAPICLVFEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VI 128
Query: 174 HRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIK 233
           HRDL A N L+ ++   K+SDFGM R    ++  ++T        + SPE      +S K
Sbjct: 129 HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPV-KWASPEVFSFSRYSSK 187
Query: 234 SDVFSFGVLLLEIVSGKK 251
           SDV+SFGVL+ E+ S  K
Sbjct: 188 SDVWSFGVLMWEVFSEGK 205

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 97.1 bits (240), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 64/202 (31%), Positives = 109/202 (53%), Gaps = 13/202 (6%)
Query: 54  ANKLGEGGFGPVYKGVLKKGDEIAVKRL--SGRSGQGLREMKNEASVIAKVQHKNLVRLL 111
             ++G G FG VYKG  K   ++AVK L  +  + Q L+  KNE  V+ K +H N++  +
Sbjct: 41  GQRIGSGSFGTVYKG--KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 98
Query: 112 GCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVR 171
           G    + +  ++ ++    SL   L     +   + +  + I    AQG+ YLH  S   
Sbjct: 99  GYST-KPQLAIVTQWCEGSSLYHHLHIIETK--FEMIKLIDIARQTAQGMDYLHAKS--- 152
Query: 172 IIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAL---EG 228
           IIHRDLK++NI L +D+  KI DFG+A +           ++ G+  +M+PE      + 
Sbjct: 153 IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKN 212
Query: 229 IFSIKSDVFSFGVLLLEIVSGK 250
            +S +SDV++FG++L E+++G+
Sbjct: 213 PYSFQSDVYAFGIVLYELMTGQ 234

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 66/206 (32%), Positives = 113/206 (54%), Gaps = 21/206 (10%)
Query: 54  ANKLGEGGFGPVYKGVLKKGDEIAVKRL--SGRSGQGLREMKNEASVIAKVQHKNLVRLL 111
             ++G G FG VYKG  K   ++AVK L  +  + Q L+  KNE  V+ K +H N++  +
Sbjct: 41  GQRIGSGSFGTVYKG--KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 98
Query: 112 GCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVR 171
           G    + +  ++ ++    SL   L     +   + +  + I    AQG+ YLH  S   
Sbjct: 99  GYST-KPQLAIVTQWCEGSSLYHHLHIIETK--FEMIKLIDIARQTAQGMDYLHAKS--- 152
Query: 172 IIHRDLKASNILLDKDMNPKISDFGMA----RICGGNELQANTSRIVGTYGYMSPEYAL- 226
           IIHRDLK++NI L +D+  KI DFG+A    R  G ++ +    ++ G+  +M+PE    
Sbjct: 153 IIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFE----QLSGSILWMAPEVIRM 208
Query: 227 --EGIFSIKSDVFSFGVLLLEIVSGK 250
             +  +S +SDV++FG++L E+++G+
Sbjct: 209 QDKNPYSFQSDVYAFGIVLYELMTGQ 234

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 79/278 (28%), Positives = 137/278 (49%), Gaps = 38/278 (13%)
Query: 57  LGEGGFGPVYKGVLK----KGDEIAVKRLS-GRSGQGLREMKNEASVIAKVQHKNLVRLL 111
           +G G FG V  G LK    K   +A+K L  G + +  R+   EAS++ +  H N++RL 
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112
Query: 112 GCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVR 171
           G        +++ E M N SLD FL     +  +  +  V ++ GIA G+ YL   S + 
Sbjct: 113 GVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTV--IQLVGMLRGIASGMKYL---SDMG 167
Query: 172 IIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVG-TYGYMSPEYALEGIF 230
            +HRDL A NIL++ ++  K+SDFG++R+   +   A T+R       + SPE      F
Sbjct: 168 YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKF 227
Query: 231 SIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELID------PIL 284
           +  SDV+S+G++L E++S  +                W++ ++   ++ +D      P +
Sbjct: 228 TSASDVWSYGIVLWEVMSYGERP-------------YWEM-SNQDVIKAVDEGYRLPPPM 273
Query: 285 EDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSML 322
           +   +  Q++L        C Q+  ++RP    +VS+L
Sbjct: 274 DCPAALYQLMLD-------CWQKDRNNRPKFEQIVSIL 304

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 82/297 (27%), Positives = 137/297 (46%), Gaps = 42/297 (14%)
Query: 56  KLGEGGFGPVY----KGVLKKGDE--IAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVR 109
           +LGEG FG V+      +L + D+  +AVK L   S    ++ + EA ++  +QH+++VR
Sbjct: 48  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVR 107
Query: 110 LLGCCIDRDEKILIYEYMPNKSLDFFL--FDPTKRML----------LDWVTRVQIIEGI 157
             G C +    ++++EYM +  L+ FL    P  ++L          L     + +   +
Sbjct: 108 FFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV 167
Query: 158 AQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTY 217
           A G++YL   + +  +HRDL   N L+ + +  KI DFGM+R     +      R +   
Sbjct: 168 AAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 224
Query: 218 GYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTG--LYRTDSLNLLGYAWDLWTSNR 275
            +M PE  L   F+ +SDV+SFGV+L EI +  K     L  T++++ +       T  R
Sbjct: 225 RWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCI-------TQGR 277
Query: 276 TLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNEAATLLPP 332
            LE       + Y+          I   C Q     R ++ DV + L  +A    PP
Sbjct: 278 ELERPRACPPEVYA----------IMRGCWQREPQQRHSIKDVHARL--QALAQAPP 322

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 67/198 (33%), Positives = 107/198 (54%), Gaps = 11/198 (5%)
Query: 57  LGEGGFGPVYKGVLK----KGDEIAVKRLS-GRSGQGLREMKNEASVIAKVQHKNLVRLL 111
           +G G FG V  G LK    K   +A+K L  G + +  R+   EAS++ +  H N++RL 
Sbjct: 24  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 83
Query: 112 GCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVR 171
           G        +++ E M N SLD FL     +  +  +  V ++ GIA G+ YL   S + 
Sbjct: 84  GVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTV--IQLVGMLRGIASGMKYL---SDMG 138
Query: 172 IIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT-YGYMSPEYALEGIF 230
            +HRDL A NIL++ ++  K+SDFG++R+   +   A T+R       + SPE      F
Sbjct: 139 YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKF 198
Query: 231 SIKSDVFSFGVLLLEIVS 248
           +  SDV+S+G++L E++S
Sbjct: 199 TSASDVWSYGIVLWEVMS 216

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 67/198 (33%), Positives = 107/198 (54%), Gaps = 11/198 (5%)
Query: 57  LGEGGFGPVYKGVLK----KGDEIAVKRLS-GRSGQGLREMKNEASVIAKVQHKNLVRLL 111
           +G G FG V  G LK    K   +A+K L  G + +  R+   EAS++ +  H N++RL 
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112
Query: 112 GCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVR 171
           G        +++ E M N SLD FL     +  +  +  V ++ GIA G+ YL   S + 
Sbjct: 113 GVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTV--IQLVGMLRGIASGMKYL---SDMG 167
Query: 172 IIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVG-TYGYMSPEYALEGIF 230
            +HRDL A NIL++ ++  K+SDFG++R+   +   A T+R       + SPE      F
Sbjct: 168 AVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKF 227
Query: 231 SIKSDVFSFGVLLLEIVS 248
           +  SDV+S+G++L E++S
Sbjct: 228 TSASDVWSYGIVLWEVMS 245

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 64/202 (31%), Positives = 108/202 (53%), Gaps = 13/202 (6%)
Query: 54  ANKLGEGGFGPVYKGVLKKGDEIAVKRL--SGRSGQGLREMKNEASVIAKVQHKNLVRLL 111
             ++G G FG VYKG  K   ++AVK L  +  + Q L+  KNE  V+ K +H N++  +
Sbjct: 13  GQRIGSGSFGTVYKG--KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 70
Query: 112 GCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVR 171
           G      +  ++ ++    SL   L     +   + +  + I    AQG+ YLH  S   
Sbjct: 71  GYST-APQLAIVTQWCEGSSLYHHLHIIETK--FEMIKLIDIARQTAQGMDYLHAKS--- 124
Query: 172 IIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAL---EG 228
           IIHRDLK++NI L +D+  KI DFG+A +           ++ G+  +M+PE      + 
Sbjct: 125 IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKN 184
Query: 229 IFSIKSDVFSFGVLLLEIVSGK 250
            +S +SDV++FG++L E+++G+
Sbjct: 185 PYSFQSDVYAFGIVLYELMTGQ 206

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 95.5 bits (236), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 82/279 (29%), Positives = 135/279 (48%), Gaps = 38/279 (13%)
Query: 57  LGEGGFGPVYKGVLK----KGDEIAVKRL-SGRSGQGLREMKNEASVIAKVQHKNLVRLL 111
           +G G FG V +G LK    K   +A+K L  G + +  RE  +EAS++ + +H N++RL 
Sbjct: 24  IGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRLE 83
Query: 112 GCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQII---EGIAQGLLYLHQYS 168
           G   +    +++ E+M N +LD FL     R+     T +Q++    GIA G+ YL + S
Sbjct: 84  GVVTNSMPVMILTEFMENGALDSFL-----RLNDGQFTVIQLVGMLRGIASGMRYLAEMS 138
Query: 169 RVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVG---TYGYMSPEYA 225
            V   HRDL A NIL++ ++  K+SDFG++R    N      +  +G      + +PE  
Sbjct: 139 YV---HRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKIPIRWTAPEAI 195
Query: 226 LEGIFSIKSDVFSFGVLLLEIVS--GKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPI 283
               F+  SD +S+G+++ E++S   +    +   D +N +   + L           P 
Sbjct: 196 AFRKFTSASDAWSYGIVMWEVMSFGERPYWDMSNQDVINAIEQDYRL-----------PP 244
Query: 284 LEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSML 322
             D  +S   L+      L C Q+  + RP    VVS L
Sbjct: 245 PPDCPTSLHQLM------LDCWQKDRNARPRFPQVVSAL 277

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 95.5 bits (236), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 64/198 (32%), Positives = 104/198 (52%), Gaps = 7/198 (3%)
Query: 54  ANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGC 113
             ++G G FG V+ G     D++A+K +   S     +   EA V+ K+ H  LV+L G 
Sbjct: 32  VQEIGSGQFGLVHLGYWLNKDKVAIKTIKEGS-MSEDDFIEEAEVMMKLSHPKLVQLYGV 90
Query: 114 CIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRII 173
           C+++    L++E+M +  L  +L   T+R L    T + +   + +G+ YL +     +I
Sbjct: 91  CLEQAPICLVFEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VI 145
Query: 174 HRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIK 233
           HRDL A N L+ ++   K+SDFGM R    ++  ++T        + SPE      +S K
Sbjct: 146 HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPV-KWASPEVFSFSRYSSK 204
Query: 234 SDVFSFGVLLLEIVSGKK 251
           SDV+SFGVL+ E+ S  K
Sbjct: 205 SDVWSFGVLMWEVFSEGK 222

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 95.5 bits (236), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 77/289 (26%), Positives = 132/289 (45%), Gaps = 38/289 (13%)
Query: 56  KLGEGGFGPVYKG----VLKKGDEI--AVKRLSGRSGQGLREMKNEASVIAKVQHKNLVR 109
           +LGEG FG V+      +  + D+I  AVK L   S    ++   EA ++  +QH+++V+
Sbjct: 20  ELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVK 79
Query: 110 LLGCCIDRDEKILIYEYMPNKSLDFFL--FDPTKRML--------LDWVTRVQIIEGIAQ 159
             G C++ D  I+++EYM +  L+ FL    P   ++        L     + I + IA 
Sbjct: 80  FYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAA 139
Query: 160 GLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGY 219
           G++YL   +    +HRDL   N L+ +++  KI DFGM+R     +        +    +
Sbjct: 140 GMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRW 196
Query: 220 MSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLEL 279
           M PE  +   F+ +SDV+S GV+L EI +  K                W   ++N  +E 
Sbjct: 197 MPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQ--------------PWYQLSNNEVIEC 242
Query: 280 IDP--ILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNEA 326
           I    +L+   +  Q +     + L C Q     R  +  + ++L N A
Sbjct: 243 ITQGRVLQRPRTCPQEVY---ELMLGCWQREPHMRKNIKGIHTLLQNLA 288

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 95.1 bits (235), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 66/198 (33%), Positives = 104/198 (52%), Gaps = 9/198 (4%)
Query: 55  NKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLRE-MKNEASVIAKVQHKNLVRLLGC 113
            ++G G FG V+ G     D++A+K +  R G    E    EA V+ K+ H  LV+L G 
Sbjct: 14  QEIGSGQFGLVHLGYWLNKDKVAIKTI--REGAMSEEDFIEEAEVMMKLSHPKLVQLYGV 71
Query: 114 CIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRII 173
           C+++    L+ E+M +  L  +L   T+R L    T + +   + +G+ YL +     +I
Sbjct: 72  CLEQAPICLVTEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VI 126
Query: 174 HRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIK 233
           HRDL A N L+ ++   K+SDFGM R    ++  ++T        + SPE      +S K
Sbjct: 127 HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPV-KWASPEVFSFSRYSSK 185
Query: 234 SDVFSFGVLLLEIVSGKK 251
           SDV+SFGVL+ E+ S  K
Sbjct: 186 SDVWSFGVLMWEVFSEGK 203

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 95.1 bits (235), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 80/276 (28%), Positives = 134/276 (48%), Gaps = 32/276 (11%)
Query: 57  LGEGGFGPVYKGVLK----KGDEIAVKRL-SGRSGQGLREMKNEASVIAKVQHKNLVRLL 111
           +G G FG V +G LK    K   +A+K L  G + +  RE  +EAS++ + +H N++RL 
Sbjct: 22  IGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRLE 81
Query: 112 GCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVR 171
           G   +    +++ E+M N +LD FL     +  +  +  V ++ GIA G+ YL + S V 
Sbjct: 82  GVVTNSMPVMILTEFMENGALDSFLRLNDGQFTV--IQLVGMLRGIASGMRYLAEMSYV- 138
Query: 172 IIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVG---TYGYMSPEYALEG 228
             HRDL A NIL++ ++  K+SDFG++R    N      +  +G      + +PE     
Sbjct: 139 --HRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGGKIPIRWTAPEAIAFR 196
Query: 229 IFSIKSDVFSFGVLLLEIVS--GKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILED 286
            F+  SD +S+G+++ E++S   +    +   D +N +   + L           P   D
Sbjct: 197 KFTSASDAWSYGIVMWEVMSFGERPYWDMSNQDVINAIEQDYRL-----------PPPPD 245
Query: 287 EYSSKQMLLRYANIALLCVQESADDRPTMNDVVSML 322
             +S   L+      L C Q+  + RP    VVS L
Sbjct: 246 CPTSLHQLM------LDCWQKDRNARPRFPQVVSAL 275

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 94.7 bits (234), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 115/210 (54%), Gaps = 20/210 (9%)
Query: 49  NKFSDANKLGEGGFGPVYKGV-LKKGDEI----AVKRL-SGRSGQGLREMKNEASVIAKV 102
            +F     LG G FG VYKG+ + +G+++    A+K L    S +  +E+ +EA V+A V
Sbjct: 12  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 71
Query: 103 QHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPT----KRMLLDWVTRVQIIEGIA 158
            + ++ RLLG C+    + LI + MP   L  ++ +       + LL+W  +      IA
Sbjct: 72  DNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 124
Query: 159 QGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG 218
           +G+ YL      R++HRDL A N+L+    + KI+DFG+A++ G  E + +         
Sbjct: 125 EGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 181
Query: 219 YMSPEYALEGIFSIKSDVFSFGVLLLEIVS 248
           +M+ E  L  I++ +SDV+S+GV + E+++
Sbjct: 182 WMALESILHRIYTHQSDVWSYGVTVWELMT 211

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 94.7 bits (234), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 115/210 (54%), Gaps = 20/210 (9%)
Query: 49  NKFSDANKLGEGGFGPVYKGV-LKKGDEI----AVKRL-SGRSGQGLREMKNEASVIAKV 102
            +F     LG G FG VYKG+ + +G+++    A+K L    S +  +E+ +EA V+A V
Sbjct: 19  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 78
Query: 103 QHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPT----KRMLLDWVTRVQIIEGIA 158
            + ++ RLLG C+    + LI + MP   L  ++ +       + LL+W  +      IA
Sbjct: 79  DNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 131
Query: 159 QGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG 218
           +G+ YL      R++HRDL A N+L+    + KI+DFG+A++ G  E + +         
Sbjct: 132 KGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 188
Query: 219 YMSPEYALEGIFSIKSDVFSFGVLLLEIVS 248
           +M+ E  L  I++ +SDV+S+GV + E+++
Sbjct: 189 WMALESILHRIYTHQSDVWSYGVTVWELMT 218

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 94.7 bits (234), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 66/216 (30%), Positives = 105/216 (48%), Gaps = 22/216 (10%)
Query: 56  KLGEGGFGPVYKGVL------KKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVR 109
           +LGEG FG V+          K    +AVK L   +    ++ + EA ++  +QH+++V+
Sbjct: 22  ELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVK 81
Query: 110 LLGCCIDRDEKILIYEYMPNKSLDFFL--FDPTKRMLLDWVTR-----------VQIIEG 156
             G C D D  I+++EYM +  L+ FL    P   +L+D   R           + I   
Sbjct: 82  FYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQ 141
Query: 157 IAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 216
           IA G++YL   +    +HRDL   N L+  ++  KI DFGM+R     +        +  
Sbjct: 142 IASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLP 198
Query: 217 YGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKN 252
             +M PE  +   F+ +SDV+SFGV+L EI +  K 
Sbjct: 199 IRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQ 234

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 94.7 bits (234), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 115/210 (54%), Gaps = 20/210 (9%)
Query: 49  NKFSDANKLGEGGFGPVYKGV-LKKGDEI----AVKRL-SGRSGQGLREMKNEASVIAKV 102
            +F     LG G FG VYKG+ + +G+++    A+K L    S +  +E+ +EA V+A V
Sbjct: 25  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 84
Query: 103 QHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPT----KRMLLDWVTRVQIIEGIA 158
            + ++ RLLG C+    + LI + MP   L  ++ +       + LL+W  +      IA
Sbjct: 85  DNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 137
Query: 159 QGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG 218
           +G+ YL      R++HRDL A N+L+    + KI+DFG+A++ G  E + +         
Sbjct: 138 KGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 194
Query: 219 YMSPEYALEGIFSIKSDVFSFGVLLLEIVS 248
           +M+ E  L  I++ +SDV+S+GV + E+++
Sbjct: 195 WMALESILHRIYTHQSDVWSYGVTVWELMT 224

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 94.4 bits (233), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 115/210 (54%), Gaps = 20/210 (9%)
Query: 49  NKFSDANKLGEGGFGPVYKGV-LKKGDEI----AVKRL-SGRSGQGLREMKNEASVIAKV 102
            +F     LG G FG VYKG+ + +G+++    A+K L    S +  +E+ +EA V+A V
Sbjct: 16  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 75
Query: 103 QHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPT----KRMLLDWVTRVQIIEGIA 158
            + ++ RLLG C+    + LI + MP   L  ++ +       + LL+W  +      IA
Sbjct: 76  DNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 128
Query: 159 QGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG 218
           +G+ YL      R++HRDL A N+L+    + KI+DFG+A++ G  E + +         
Sbjct: 129 KGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 185
Query: 219 YMSPEYALEGIFSIKSDVFSFGVLLLEIVS 248
           +M+ E  L  I++ +SDV+S+GV + E+++
Sbjct: 186 WMALESILHRIYTHQSDVWSYGVTVWELMT 215

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 94.4 bits (233), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 115/210 (54%), Gaps = 20/210 (9%)
Query: 49  NKFSDANKLGEGGFGPVYKGV-LKKGDEI----AVKRL-SGRSGQGLREMKNEASVIAKV 102
            +F     LG G FG VYKG+ + +G+++    A+K L    S +  +E+ +EA V+A V
Sbjct: 9   TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 68
Query: 103 QHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPT----KRMLLDWVTRVQIIEGIA 158
            + ++ RLLG C+    + LI + MP   L  ++ +       + LL+W  +      IA
Sbjct: 69  DNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 121
Query: 159 QGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG 218
           +G+ YL      R++HRDL A N+L+    + KI+DFG+A++ G  E + +         
Sbjct: 122 KGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 178
Query: 219 YMSPEYALEGIFSIKSDVFSFGVLLLEIVS 248
           +M+ E  L  I++ +SDV+S+GV + E+++
Sbjct: 179 WMALESILHRIYTHQSDVWSYGVTVWELMT 208

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 94.4 bits (233), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 115/210 (54%), Gaps = 20/210 (9%)
Query: 49  NKFSDANKLGEGGFGPVYKGV-LKKGDEI----AVKRL-SGRSGQGLREMKNEASVIAKV 102
            +F     LG G FG VYKG+ + +G+++    A+K L    S +  +E+ +EA V+A V
Sbjct: 16  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 75
Query: 103 QHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPT----KRMLLDWVTRVQIIEGIA 158
            + ++ RLLG C+    + LI + MP   L  ++ +       + LL+W  +      IA
Sbjct: 76  DNPHVCRLLGICLTSTVQ-LIMQLMPFGXLLDYVREHKDNIGSQYLLNWCVQ------IA 128
Query: 159 QGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG 218
           +G+ YL      R++HRDL A N+L+    + KI+DFG+A++ G  E + +         
Sbjct: 129 KGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 185
Query: 219 YMSPEYALEGIFSIKSDVFSFGVLLLEIVS 248
           +M+ E  L  I++ +SDV+S+GV + E+++
Sbjct: 186 WMALESILHRIYTHQSDVWSYGVTVWELMT 215

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 94.4 bits (233), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 115/210 (54%), Gaps = 20/210 (9%)
Query: 49  NKFSDANKLGEGGFGPVYKGV-LKKGDEI----AVKRL-SGRSGQGLREMKNEASVIAKV 102
            +F     LG G FG VYKG+ + +G+++    A+K L    S +  +E+ +EA V+A V
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 103 QHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPT----KRMLLDWVTRVQIIEGIA 158
            + ++ RLLG C+    + LI + MP   L  ++ +       + LL+W  +      IA
Sbjct: 75  DNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 127
Query: 159 QGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG 218
           +G+ YL      R++HRDL A N+L+    + KI+DFG+A++ G  E + +         
Sbjct: 128 KGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 184
Query: 219 YMSPEYALEGIFSIKSDVFSFGVLLLEIVS 248
           +M+ E  L  I++ +SDV+S+GV + E+++
Sbjct: 185 WMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 94.4 bits (233), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 115/210 (54%), Gaps = 20/210 (9%)
Query: 49  NKFSDANKLGEGGFGPVYKGV-LKKGDEI----AVKRL-SGRSGQGLREMKNEASVIAKV 102
            +F     LG G FG VYKG+ + +G+++    A+K L    S +  +E+ +EA V+A V
Sbjct: 17  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 76
Query: 103 QHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPT----KRMLLDWVTRVQIIEGIA 158
            + ++ RLLG C+    + LI + MP   L  ++ +       + LL+W  +      IA
Sbjct: 77  DNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 129
Query: 159 QGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG 218
           +G+ YL      R++HRDL A N+L+    + KI+DFG+A++ G  E + +         
Sbjct: 130 KGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 186
Query: 219 YMSPEYALEGIFSIKSDVFSFGVLLLEIVS 248
           +M+ E  L  I++ +SDV+S+GV + E+++
Sbjct: 187 WMALESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 94.4 bits (233), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 115/210 (54%), Gaps = 20/210 (9%)
Query: 49  NKFSDANKLGEGGFGPVYKGV-LKKGDEI----AVKRL-SGRSGQGLREMKNEASVIAKV 102
            +F     LG G FG VYKG+ + +G+++    A+K L    S +  +E+ +EA V+A V
Sbjct: 18  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 77
Query: 103 QHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPT----KRMLLDWVTRVQIIEGIA 158
            + ++ RLLG C+    + LI + MP   L  ++ +       + LL+W  +      IA
Sbjct: 78  DNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 130
Query: 159 QGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG 218
           +G+ YL      R++HRDL A N+L+    + KI+DFG+A++ G  E + +         
Sbjct: 131 KGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 187
Query: 219 YMSPEYALEGIFSIKSDVFSFGVLLLEIVS 248
           +M+ E  L  I++ +SDV+S+GV + E+++
Sbjct: 188 WMALESILHRIYTHQSDVWSYGVTVWELMT 217

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 94.4 bits (233), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 115/210 (54%), Gaps = 20/210 (9%)
Query: 49  NKFSDANKLGEGGFGPVYKGV-LKKGDEI----AVKRL-SGRSGQGLREMKNEASVIAKV 102
            +F     LG G FG VYKG+ + +G+++    A+K L    S +  +E+ +EA V+A V
Sbjct: 17  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 76
Query: 103 QHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPT----KRMLLDWVTRVQIIEGIA 158
            + ++ RLLG C+    + LI + MP   L  ++ +       + LL+W  +      IA
Sbjct: 77  DNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 129
Query: 159 QGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG 218
           +G+ YL      R++HRDL A N+L+    + KI+DFG+A++ G  E + +         
Sbjct: 130 KGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 186
Query: 219 YMSPEYALEGIFSIKSDVFSFGVLLLEIVS 248
           +M+ E  L  I++ +SDV+S+GV + E+++
Sbjct: 187 WMALESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 94.4 bits (233), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 115/210 (54%), Gaps = 20/210 (9%)
Query: 49  NKFSDANKLGEGGFGPVYKGV-LKKGDEI----AVKRL-SGRSGQGLREMKNEASVIAKV 102
            +F     LG G FG VYKG+ + +G+++    A+K L    S +  +E+ +EA V+A V
Sbjct: 21  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 80
Query: 103 QHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPT----KRMLLDWVTRVQIIEGIA 158
            + ++ RLLG C+    + LI + MP   L  ++ +       + LL+W  +      IA
Sbjct: 81  DNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 133
Query: 159 QGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG 218
           +G+ YL      R++HRDL A N+L+    + KI+DFG+A++ G  E + +         
Sbjct: 134 KGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 190
Query: 219 YMSPEYALEGIFSIKSDVFSFGVLLLEIVS 248
           +M+ E  L  I++ +SDV+S+GV + E+++
Sbjct: 191 WMALESILHRIYTHQSDVWSYGVTVWELMT 220

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 94.4 bits (233), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 79/273 (28%), Positives = 131/273 (47%), Gaps = 38/273 (13%)
Query: 55  NKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCC 114
            KLG G FG V+     K  ++AVK +   S   +     EA+V+  +QH  LV+L    
Sbjct: 188 KKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKL-HAV 245
Query: 115 IDRDEKILIYEYMPNKSL-DFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRII 173
           + ++   +I E+M   SL DF   D   +  L     +     IA+G+ ++ Q +    I
Sbjct: 246 VTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLP--KLIDFSAQIAEGMAFIEQRN---YI 300
Query: 174 HRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIK 233
           HRDL+A+NIL+   +  KI+DFG+AR+     ++           + +PE    G F+IK
Sbjct: 301 HRDLRAANILVSASLVCKIADFGLARVGAKFPIK-----------WTAPEAINFGSFTIK 349
Query: 234 SDVFSFGVLLLEIVSGKK--NTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYSSK 291
           SDV+SFG+LL+EIV+  +    G+   + +  L          R   +  P    E   +
Sbjct: 350 SDVWSFGILLMEIVTYGRIPYPGMSNPEVIRAL---------ERGYRMPRP----ENCPE 396
Query: 292 QMLLRYANIALLCVQESADDRPTMNDVVSMLTN 324
           ++     NI + C +   ++RPT   + S+L +
Sbjct: 397 ELY----NIMMRCWKNRPEERPTFEYIQSVLDD 425

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 94.4 bits (233), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 115/210 (54%), Gaps = 20/210 (9%)
Query: 49  NKFSDANKLGEGGFGPVYKGV-LKKGDEI----AVKRL-SGRSGQGLREMKNEASVIAKV 102
            +F     LG G FG VYKG+ + +G+++    A+K L    S +  +E+ +EA V+A V
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 103 QHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPT----KRMLLDWVTRVQIIEGIA 158
            + ++ RLLG C+    + LI + MP   L  ++ +       + LL+W  +      IA
Sbjct: 75  DNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 127
Query: 159 QGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG 218
           +G+ YL      R++HRDL A N+L+    + KI+DFG+A++ G  E + +         
Sbjct: 128 KGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 184
Query: 219 YMSPEYALEGIFSIKSDVFSFGVLLLEIVS 248
           +M+ E  L  I++ +SDV+S+GV + E+++
Sbjct: 185 WMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 115/210 (54%), Gaps = 20/210 (9%)
Query: 49  NKFSDANKLGEGGFGPVYKGV-LKKGDEI----AVKRL-SGRSGQGLREMKNEASVIAKV 102
            +F     LG G FG VYKG+ + +G+++    A+K L    S +  +E+ +EA V+A V
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 103 QHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPT----KRMLLDWVTRVQIIEGIA 158
            + ++ RLLG C+    + LI + MP   L  ++ +       + LL+W  +      IA
Sbjct: 75  DNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 127
Query: 159 QGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG 218
           +G+ YL      R++HRDL A N+L+    + KI+DFG+A++ G  E + +         
Sbjct: 128 KGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 184
Query: 219 YMSPEYALEGIFSIKSDVFSFGVLLLEIVS 248
           +M+ E  L  I++ +SDV+S+GV + E+++
Sbjct: 185 WMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 115/210 (54%), Gaps = 20/210 (9%)
Query: 49  NKFSDANKLGEGGFGPVYKGV-LKKGDEI----AVKRL-SGRSGQGLREMKNEASVIAKV 102
            +F     LG G FG VYKG+ + +G+++    A+K L    S +  +E+ +EA V+A V
Sbjct: 18  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 77
Query: 103 QHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPT----KRMLLDWVTRVQIIEGIA 158
            + ++ RLLG C+    + LI + MP   L  ++ +       + LL+W  +      IA
Sbjct: 78  DNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 130
Query: 159 QGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG 218
           +G+ YL      R++HRDL A N+L+    + KI+DFG+A++ G  E + +         
Sbjct: 131 KGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 187
Query: 219 YMSPEYALEGIFSIKSDVFSFGVLLLEIVS 248
           +M+ E  L  I++ +SDV+S+GV + E+++
Sbjct: 188 WMALESILHRIYTHQSDVWSYGVTVWELMT 217

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 85/278 (30%), Positives = 128/278 (46%), Gaps = 23/278 (8%)
Query: 57  LGEGGFG--------PVYKGVLKKGDEIAVKRLSGRSGQGLRE-MKNEASVIAKVQHKNL 107
           LGEG FG        P   G    G+ +AVK L    G   R   K E  ++  + H+++
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGT---GEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHI 78
Query: 108 VRLLGCCIDRDEKIL--IYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLH 165
           ++  GCC D+ EK L  + EY+P  SL  +L     R  +     +   + I +G+ YLH
Sbjct: 79  IKYKGCCEDQGEKSLQLVMEYVPLGSLRDYL----PRHSIGLAQLLLFAQQICEGMAYLH 134
Query: 166 QYSRVRIIHRDLKASNILLDKDMNPKISDFGMAR-ICGGNELQANTSRIVGTYGYMSPEY 224
                  IHR+L A N+LLD D   KI DFG+A+ +  G+E             + +PE 
Sbjct: 135 S---QHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPEC 191
Query: 225 ALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPIL 284
             E  F   SDV+SFGV L E+++   ++    T  L L+G A    T  R  EL++   
Sbjct: 192 LKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGE 251
Query: 285 EDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSML 322
                 K     Y ++   C +  A  RPT  +++ +L
Sbjct: 252 RLPRPDKCPCEVY-HLMKNCWETEASFRPTFENLIPIL 288

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 115/210 (54%), Gaps = 20/210 (9%)
Query: 49  NKFSDANKLGEGGFGPVYKGV-LKKGDEI----AVKRL-SGRSGQGLREMKNEASVIAKV 102
            +F     LG G FG VYKG+ + +G+++    A+K L    S +  +E+ +EA V+A V
Sbjct: 40  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 99
Query: 103 QHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPT----KRMLLDWVTRVQIIEGIA 158
            + ++ RLLG C+    + LI + MP   L  ++ +       + LL+W  +      IA
Sbjct: 100 DNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 152
Query: 159 QGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG 218
           +G+ YL      R++HRDL A N+L+    + KI+DFG+A++ G  E + +         
Sbjct: 153 KGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 209
Query: 219 YMSPEYALEGIFSIKSDVFSFGVLLLEIVS 248
           +M+ E  L  I++ +SDV+S+GV + E+++
Sbjct: 210 WMALESILHRIYTHQSDVWSYGVTVWELMT 239

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 115/210 (54%), Gaps = 20/210 (9%)
Query: 49  NKFSDANKLGEGGFGPVYKGV-LKKGDEI----AVKRL-SGRSGQGLREMKNEASVIAKV 102
            +F     LG G FG VYKG+ + +G+++    A+K L    S +  +E+ +EA V+A V
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 103 QHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPT----KRMLLDWVTRVQIIEGIA 158
            + ++ RLLG C+    + LI + MP   L  ++ +       + LL+W  +      IA
Sbjct: 75  DNPHVCRLLGICLTSTVQ-LITQLMPFGXLLDYVREHKDNIGSQYLLNWCVQ------IA 127
Query: 159 QGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG 218
           +G+ YL      R++HRDL A N+L+    + KI+DFG+A++ G  E + +         
Sbjct: 128 KGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 184
Query: 219 YMSPEYALEGIFSIKSDVFSFGVLLLEIVS 248
           +M+ E  L  I++ +SDV+S+GV + E+++
Sbjct: 185 WMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 115/210 (54%), Gaps = 20/210 (9%)
Query: 49  NKFSDANKLGEGGFGPVYKGV-LKKGDEI----AVKRL-SGRSGQGLREMKNEASVIAKV 102
            +F     LG G FG VYKG+ + +G+++    A+K L    S +  +E+ +EA V+A V
Sbjct: 18  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 77
Query: 103 QHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPT----KRMLLDWVTRVQIIEGIA 158
            + ++ RLLG C+    + LI + MP   L  ++ +       + LL+W  +      IA
Sbjct: 78  DNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 130
Query: 159 QGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG 218
           +G+ YL      R++HRDL A N+L+    + KI+DFG+A++ G  E + +         
Sbjct: 131 KGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 187
Query: 219 YMSPEYALEGIFSIKSDVFSFGVLLLEIVS 248
           +M+ E  L  I++ +SDV+S+GV + E+++
Sbjct: 188 WMALESILHRIYTHQSDVWSYGVTVWELMT 217

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 85/278 (30%), Positives = 128/278 (46%), Gaps = 23/278 (8%)
Query: 57  LGEGGFG--------PVYKGVLKKGDEIAVKRLSGRSGQGLRE-MKNEASVIAKVQHKNL 107
           LGEG FG        P   G    G+ +AVK L    G   R   K E  ++  + H+++
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGT---GEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHI 78
Query: 108 VRLLGCCIDRDEKIL--IYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLH 165
           ++  GCC D+ EK L  + EY+P  SL  +L     R  +     +   + I +G+ YLH
Sbjct: 79  IKYKGCCEDQGEKSLQLVMEYVPLGSLRDYL----PRHSIGLAQLLLFAQQICEGMAYLH 134
Query: 166 QYSRVRIIHRDLKASNILLDKDMNPKISDFGMAR-ICGGNELQANTSRIVGTYGYMSPEY 224
                  IHR+L A N+LLD D   KI DFG+A+ +  G+E             + +PE 
Sbjct: 135 A---QHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPEC 191
Query: 225 ALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPIL 284
             E  F   SDV+SFGV L E+++   ++    T  L L+G A    T  R  EL++   
Sbjct: 192 LKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGE 251
Query: 285 EDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSML 322
                 K     Y ++   C +  A  RPT  +++ +L
Sbjct: 252 RLPRPDKCPCEVY-HLMKNCWETEASFRPTFENLIPIL 288

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 115/210 (54%), Gaps = 20/210 (9%)
Query: 49  NKFSDANKLGEGGFGPVYKGV-LKKGDEI----AVKRL-SGRSGQGLREMKNEASVIAKV 102
            +F     LG G FG VYKG+ + +G+++    A+K L    S +  +E+ +EA V+A V
Sbjct: 18  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 77
Query: 103 QHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPT----KRMLLDWVTRVQIIEGIA 158
            + ++ RLLG C+    + LI + MP   L  ++ +       + LL+W  +      IA
Sbjct: 78  DNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 130
Query: 159 QGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG 218
           +G+ YL      R++HRDL A N+L+    + KI+DFG+A++ G  E + +         
Sbjct: 131 KGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 187
Query: 219 YMSPEYALEGIFSIKSDVFSFGVLLLEIVS 248
           +M+ E  L  I++ +SDV+S+GV + E+++
Sbjct: 188 WMALESILHRIYTHQSDVWSYGVTVWELMT 217

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 71/217 (32%), Positives = 108/217 (49%), Gaps = 17/217 (7%)
Query: 46  TATNKFSDANKLGEGGFGPVYKGVLKK--GDE----IAVKRLSGRSGQGLR-EMKNEASV 98
            A  K + + +LG+G FG VY+GV K    DE    +A+K ++  +    R E  NEASV
Sbjct: 7   VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 66
Query: 99  IAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWV-------TRV 151
           + +    ++VRLLG        ++I E M    L  +L      M  + V         +
Sbjct: 67  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMI 126
Query: 152 QIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTS 211
           Q+   IA G+ YL+     + +HRDL A N ++ +D   KI DFGM R     +      
Sbjct: 127 QMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGG 183
Query: 212 RIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 248
           + +    +MSPE   +G+F+  SDV+SFGV+L EI +
Sbjct: 184 KGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 220

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 115/210 (54%), Gaps = 20/210 (9%)
Query: 49  NKFSDANKLGEGGFGPVYKGV-LKKGDEI----AVKRL-SGRSGQGLREMKNEASVIAKV 102
            +F     LG G FG VYKG+ + +G+++    A+K L    S +  +E+ +EA V+A V
Sbjct: 22  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 81
Query: 103 QHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPT----KRMLLDWVTRVQIIEGIA 158
            + ++ RLLG C+    + LI + MP   L  ++ +       + LL+W  +      IA
Sbjct: 82  DNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 134
Query: 159 QGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG 218
           +G+ YL      R++HRDL A N+L+    + KI+DFG+A++ G  E + +         
Sbjct: 135 KGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 191
Query: 219 YMSPEYALEGIFSIKSDVFSFGVLLLEIVS 248
           +M+ E  L  I++ +SDV+S+GV + E+++
Sbjct: 192 WMALESILHRIYTHQSDVWSYGVTVWELMT 221

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 71/217 (32%), Positives = 108/217 (49%), Gaps = 17/217 (7%)
Query: 46  TATNKFSDANKLGEGGFGPVYKGVLKK--GDE----IAVKRLSGRSGQGLR-EMKNEASV 98
            A  K + + +LG+G FG VY+GV K    DE    +A+K ++  +    R E  NEASV
Sbjct: 16  VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 75
Query: 99  IAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWV-------TRV 151
           + +    ++VRLLG        ++I E M    L  +L      M  + V         +
Sbjct: 76  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMI 135
Query: 152 QIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTS 211
           Q+   IA G+ YL+     + +HRDL A N ++ +D   KI DFGM R     +      
Sbjct: 136 QMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGG 192
Query: 212 RIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 248
           + +    +MSPE   +G+F+  SDV+SFGV+L EI +
Sbjct: 193 KGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 229

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 72/229 (31%), Positives = 116/229 (50%), Gaps = 33/229 (14%)
Query: 44  VSTATNKFSDANKLGEGGFGPVYKGVL------KKGDEIAVKRLSGRSGQGLRE-MKNEA 96
           +S +  +F +  +LGE  FG VYKG L      ++   +A+K L  ++   LRE  ++EA
Sbjct: 6   ISLSAVRFME--ELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEA 63
Query: 97  SVIAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLF-------------DPTKRM 143
            + A++QH N+V LLG         +I+ Y  +  L  FL              D T + 
Sbjct: 64  MLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKS 123
Query: 144 LLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGG 203
            L+    V ++  IA G+ YL   S   ++H+DL   N+L+   +N KISD G+ R    
Sbjct: 124 ALEPPDFVHLVAQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFR---- 176
Query: 204 NELQANTSRIVGT----YGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 248
               A+  +++G       +M+PE  + G FSI SD++S+GV+L E+ S
Sbjct: 177 EVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 225

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 93.6 bits (231), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 111/206 (53%), Gaps = 21/206 (10%)
Query: 54  ANKLGEGGFGPVYKGVLKKGDEIAVKRL--SGRSGQGLREMKNEASVIAKVQHKNLVRLL 111
             ++G G FG VYKG  K   ++AVK L  +  + Q L+  KNE  V+ K +H N++  +
Sbjct: 17  GQRIGSGSFGTVYKG--KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 74
Query: 112 GCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVR 171
           G    + +  ++ ++    SL   L     +  +  +  + I    A+G+ YLH  S   
Sbjct: 75  GYST-KPQLAIVTQWCEGSSLYHHLHASETKFEMKKL--IDIARQTARGMDYLHAKS--- 128
Query: 172 IIHRDLKASNILLDKDMNPKISDFGMA----RICGGNELQANTSRIVGTYGYMSPEYAL- 226
           IIHRDLK++NI L +D   KI DFG+A    R  G ++ +    ++ G+  +M+PE    
Sbjct: 129 IIHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFE----QLSGSILWMAPEVIRM 184
Query: 227 --EGIFSIKSDVFSFGVLLLEIVSGK 250
                +S +SDV++FG++L E+++G+
Sbjct: 185 QDSNPYSFQSDVYAFGIVLYELMTGQ 210

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 114/210 (54%), Gaps = 20/210 (9%)
Query: 49  NKFSDANKLGEGGFGPVYKGV-LKKGDEI----AVKRL-SGRSGQGLREMKNEASVIAKV 102
            +F     LG G FG VYKG+ + +G+++    A+K L    S +  +E+ +EA V+A V
Sbjct: 19  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 78
Query: 103 QHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPT----KRMLLDWVTRVQIIEGIA 158
            + ++ RLLG C+    + LI + MP   L  ++ +       + LL+W  +      IA
Sbjct: 79  DNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 131
Query: 159 QGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG 218
           +G+ YL      R++HRDL A N+L+    + KI+DFG A++ G  E + +         
Sbjct: 132 KGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIK 188
Query: 219 YMSPEYALEGIFSIKSDVFSFGVLLLEIVS 248
           +M+ E  L  I++ +SDV+S+GV + E+++
Sbjct: 189 WMALESILHRIYTHQSDVWSYGVTVWELMT 218

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 71/217 (32%), Positives = 108/217 (49%), Gaps = 17/217 (7%)
Query: 46  TATNKFSDANKLGEGGFGPVYKGVLKK--GDE----IAVKRLSGRSGQGLR-EMKNEASV 98
            A  K + + +LG+G FG VY+GV K    DE    +A+K ++  +    R E  NEASV
Sbjct: 22  VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 81
Query: 99  IAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWV-------TRV 151
           + +    ++VRLLG        ++I E M    L  +L      M  + V         +
Sbjct: 82  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMI 141
Query: 152 QIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTS 211
           Q+   IA G+ YL+     + +HRDL A N ++ +D   KI DFGM R     +      
Sbjct: 142 QMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGG 198
Query: 212 RIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 248
           + +    +MSPE   +G+F+  SDV+SFGV+L EI +
Sbjct: 199 KGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 235

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 71/217 (32%), Positives = 108/217 (49%), Gaps = 17/217 (7%)
Query: 46  TATNKFSDANKLGEGGFGPVYKGVLKK--GDE----IAVKRLSGRSGQGLR-EMKNEASV 98
            A  K + + +LG+G FG VY+GV K    DE    +A+K ++  +    R E  NEASV
Sbjct: 15  VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 74
Query: 99  IAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWV-------TRV 151
           + +    ++VRLLG        ++I E M    L  +L      M  + V         +
Sbjct: 75  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMI 134
Query: 152 QIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTS 211
           Q+   IA G+ YL+     + +HRDL A N ++ +D   KI DFGM R     +      
Sbjct: 135 QMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGG 191
Query: 212 RIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 248
           + +    +MSPE   +G+F+  SDV+SFGV+L EI +
Sbjct: 192 KGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 228

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 71/217 (32%), Positives = 108/217 (49%), Gaps = 17/217 (7%)
Query: 46  TATNKFSDANKLGEGGFGPVYKGVLKK--GDE----IAVKRLSGRSGQGLR-EMKNEASV 98
            A  K + + +LG+G FG VY+GV K    DE    +A+K ++  +    R E  NEASV
Sbjct: 12  VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 71
Query: 99  IAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWV-------TRV 151
           + +    ++VRLLG        ++I E M    L  +L      M  + V         +
Sbjct: 72  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMI 131
Query: 152 QIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTS 211
           Q+   IA G+ YL+     + +HRDL A N ++ +D   KI DFGM R     +      
Sbjct: 132 QMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGG 188
Query: 212 RIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 248
           + +    +MSPE   +G+F+  SDV+SFGV+L EI +
Sbjct: 189 KGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 225

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 78/274 (28%), Positives = 136/274 (49%), Gaps = 30/274 (10%)
Query: 57  LGEGGFGPVYKGVLK----KGDEIAVKRLS-GRSGQGLREMKNEASVIAKVQHKNLVRLL 111
           +G G FG V  G LK    +   +A+K L  G + +  R+   EAS++ +  H N++ L 
Sbjct: 30  IGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIHLE 89
Query: 112 GCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVR 171
           G        +++ EYM N SLD FL     +  +  +  V ++ GI+ G+ YL   S + 
Sbjct: 90  GVVTKSKPVMIVTEYMENGSLDTFLKKNDGQFTV--IQLVGMLRGISAGMKYL---SDMG 144
Query: 172 IIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVG-TYGYMSPEYALEGIF 230
            +HRDL A NIL++ ++  K+SDFG++R+   +   A T+R       + +PE      F
Sbjct: 145 YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAFRKF 204
Query: 231 SIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYSS 290
           +  SDV+S+G+++ E+VS  +                W++  +N+  ++I  + E     
Sbjct: 205 TSASDVWSYGIVMWEVVSYGERP-------------YWEM--TNQ--DVIKAVEEGYRLP 247
Query: 291 KQMLLRYA--NIALLCVQESADDRPTMNDVVSML 322
             M    A   + L C Q+  + RP  +++V+ML
Sbjct: 248 SPMDCPAALYQLMLDCWQKERNSRPKFDEIVNML 281

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 114/210 (54%), Gaps = 20/210 (9%)
Query: 49  NKFSDANKLGEGGFGPVYKGV-LKKGDEI----AVKRL-SGRSGQGLREMKNEASVIAKV 102
            +F     LG G FG VYKG+ + +G+++    A+K L    S +  +E+ +EA V+A V
Sbjct: 17  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 76
Query: 103 QHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPT----KRMLLDWVTRVQIIEGIA 158
            + ++ RLLG C+    + LI + MP   L  ++ +       + LL+W  +      IA
Sbjct: 77  DNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 129
Query: 159 QGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG 218
           +G+ YL      R++HRDL A N+L+    + KI+DFG A++ G  E + +         
Sbjct: 130 KGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIK 186
Query: 219 YMSPEYALEGIFSIKSDVFSFGVLLLEIVS 248
           +M+ E  L  I++ +SDV+S+GV + E+++
Sbjct: 187 WMALESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 111/206 (53%), Gaps = 21/206 (10%)
Query: 54  ANKLGEGGFGPVYKGVLKKGDEIAVKRL--SGRSGQGLREMKNEASVIAKVQHKNLVRLL 111
             ++G G FG VYKG  K   ++AVK L  +  + Q L+  KNE  V+ K +H N++  +
Sbjct: 29  GQRIGSGSFGTVYKG--KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 86
Query: 112 GCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVR 171
           G    + +  ++ ++    SL   L     +  +  +  + I    A+G+ YLH  S   
Sbjct: 87  GYST-KPQLAIVTQWCEGSSLYHHLHASETKFEMKKL--IDIARQTARGMDYLHAKS--- 140
Query: 172 IIHRDLKASNILLDKDMNPKISDFGMA----RICGGNELQANTSRIVGTYGYMSPEYAL- 226
           IIHRDLK++NI L +D   KI DFG+A    R  G ++ +    ++ G+  +M+PE    
Sbjct: 141 IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFE----QLSGSILWMAPEVIRM 196
Query: 227 --EGIFSIKSDVFSFGVLLLEIVSGK 250
                +S +SDV++FG++L E+++G+
Sbjct: 197 QDSNPYSFQSDVYAFGIVLYELMTGQ 222

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 71/217 (32%), Positives = 108/217 (49%), Gaps = 17/217 (7%)
Query: 46  TATNKFSDANKLGEGGFGPVYKGVLKK--GDE----IAVKRLSGRSGQGLR-EMKNEASV 98
            A  K + + +LG+G FG VY+GV K    DE    +A+K ++  +    R E  NEASV
Sbjct: 15  VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 74
Query: 99  IAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWV-------TRV 151
           + +    ++VRLLG        ++I E M    L  +L      M  + V         +
Sbjct: 75  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMI 134
Query: 152 QIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTS 211
           Q+   IA G+ YL+     + +HRDL A N ++ +D   KI DFGM R     +      
Sbjct: 135 QMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGG 191
Query: 212 RIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 248
           + +    +MSPE   +G+F+  SDV+SFGV+L EI +
Sbjct: 192 KGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 228

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 92.8 bits (229), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 71/217 (32%), Positives = 108/217 (49%), Gaps = 17/217 (7%)
Query: 46  TATNKFSDANKLGEGGFGPVYKGVLKK--GDE----IAVKRLSGRSGQGLR-EMKNEASV 98
            A  K + + +LG+G FG VY+GV K    DE    +A+K ++  +    R E  NEASV
Sbjct: 13  VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 72
Query: 99  IAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWV-------TRV 151
           + +    ++VRLLG        ++I E M    L  +L      M  + V         +
Sbjct: 73  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMI 132
Query: 152 QIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTS 211
           Q+   IA G+ YL+     + +HRDL A N ++ +D   KI DFGM R     +      
Sbjct: 133 QMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGG 189
Query: 212 RIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 248
           + +    +MSPE   +G+F+  SDV+SFGV+L EI +
Sbjct: 190 KGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 226

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 92.8 bits (229), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 71/217 (32%), Positives = 108/217 (49%), Gaps = 17/217 (7%)
Query: 46  TATNKFSDANKLGEGGFGPVYKGVLKK--GDE----IAVKRLSGRSGQGLR-EMKNEASV 98
            A  K + + +LG+G FG VY+GV K    DE    +A+K ++  +    R E  NEASV
Sbjct: 22  VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 81
Query: 99  IAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWV-------TRV 151
           + +    ++VRLLG        ++I E M    L  +L      M  + V         +
Sbjct: 82  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMI 141
Query: 152 QIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTS 211
           Q+   IA G+ YL+     + +HRDL A N ++ +D   KI DFGM R     +      
Sbjct: 142 QMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGG 198
Query: 212 RIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 248
           + +    +MSPE   +G+F+  SDV+SFGV+L EI +
Sbjct: 199 KGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 235

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 114/210 (54%), Gaps = 20/210 (9%)
Query: 49  NKFSDANKLGEGGFGPVYKGV-LKKGDEI----AVKRL-SGRSGQGLREMKNEASVIAKV 102
            +F     LG G FG VYKG+ + +G+++    A+K L    S +  +E+ +EA V+A V
Sbjct: 17  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 76
Query: 103 QHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPT----KRMLLDWVTRVQIIEGIA 158
            + ++ RLLG C+    + LI + MP   L  ++ +       + LL+W  +      IA
Sbjct: 77  DNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 129
Query: 159 QGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG 218
           +G+ YL      R++HRDL A N+L+    + KI+DFG A++ G  E + +         
Sbjct: 130 KGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIK 186
Query: 219 YMSPEYALEGIFSIKSDVFSFGVLLLEIVS 248
           +M+ E  L  I++ +SDV+S+GV + E+++
Sbjct: 187 WMALESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 68/206 (33%), Positives = 104/206 (50%), Gaps = 21/206 (10%)
Query: 55  NKLGEGGFGPV----YKGVL-KKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVR 109
            +LG+G FG V    Y  +    G+ +AVK+L   + + LR+ + E  ++  +QH N+V+
Sbjct: 47  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 106
Query: 110 LLGCCID--RDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQY 167
             G C    R    LI EY+P  SL  +L    +R  +D +  +Q    I +G+ YL   
Sbjct: 107 YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER--IDHIKLLQYTSQICKGMEYL--- 161
Query: 168 SRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG-----YMSP 222
              R IHRDL   NIL++ +   KI DFG+ ++      Q      V   G     + +P
Sbjct: 162 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLP----QDKEXXKVKEPGESPIFWYAP 217
Query: 223 EYALEGIFSIKSDVFSFGVLLLEIVS 248
           E   E  FS+ SDV+SFGV+L E+ +
Sbjct: 218 ESLTESKFSVASDVWSFGVVLYELFT 243

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 114/210 (54%), Gaps = 20/210 (9%)
Query: 49  NKFSDANKLGEGGFGPVYKGV-LKKGDEI----AVKRL-SGRSGQGLREMKNEASVIAKV 102
            +F     LG G FG VYKG+ + +G+++    A+K L    S +  +E+ +EA V+A V
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 103 QHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPT----KRMLLDWVTRVQIIEGIA 158
            + ++ RLLG C+    + LI + MP   L  ++ +       + LL+W  +      IA
Sbjct: 75  DNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 127
Query: 159 QGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG 218
           +G+ YL      R++HRDL A N+L+    + KI+DFG A++ G  E + +         
Sbjct: 128 KGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIK 184
Query: 219 YMSPEYALEGIFSIKSDVFSFGVLLLEIVS 248
           +M+ E  L  I++ +SDV+S+GV + E+++
Sbjct: 185 WMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 71/217 (32%), Positives = 108/217 (49%), Gaps = 17/217 (7%)
Query: 46  TATNKFSDANKLGEGGFGPVYKGVLKK--GDE----IAVKRLSGRSGQGLR-EMKNEASV 98
            A  K + + +LG+G FG VY+GV K    DE    +A+K ++  +    R E  NEASV
Sbjct: 16  VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 75
Query: 99  IAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWV-------TRV 151
           + +    ++VRLLG        ++I E M    L  +L      M  + V         +
Sbjct: 76  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMI 135
Query: 152 QIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTS 211
           Q+   IA G+ YL+     + +HRDL A N ++ +D   KI DFGM R     +      
Sbjct: 136 QMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGG 192
Query: 212 RIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 248
           + +    +MSPE   +G+F+  SDV+SFGV+L EI +
Sbjct: 193 KGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 229

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 71/217 (32%), Positives = 108/217 (49%), Gaps = 17/217 (7%)
Query: 46  TATNKFSDANKLGEGGFGPVYKGVLKK--GDE----IAVKRLSGRSGQGLR-EMKNEASV 98
            A  K + + +LG+G FG VY+GV K    DE    +A+K ++  +    R E  NEASV
Sbjct: 9   VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 68
Query: 99  IAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWV-------TRV 151
           + +    ++VRLLG        ++I E M    L  +L      M  + V         +
Sbjct: 69  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMI 128
Query: 152 QIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTS 211
           Q+   IA G+ YL+     + +HRDL A N ++ +D   KI DFGM R     +      
Sbjct: 129 QMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGG 185
Query: 212 RIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 248
           + +    +MSPE   +G+F+  SDV+SFGV+L EI +
Sbjct: 186 KGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 222

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 68/205 (33%), Positives = 104/205 (50%), Gaps = 21/205 (10%)
Query: 56  KLGEGGFGPV----YKGVL-KKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRL 110
           +LG+G FG V    Y  +    G+ +AVK+L   + + LR+ + E  ++  +QH N+V+ 
Sbjct: 16  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 75
Query: 111 LGCCID--RDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYS 168
            G C    R    LI EY+P  SL  +L    +R  +D +  +Q    I +G+ YL    
Sbjct: 76  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER--IDHIKLLQYTSQICKGMEYL---G 130
Query: 169 RVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG-----YMSPE 223
             R IHRDL   NIL++ +   KI DFG+ ++      Q      V   G     + +PE
Sbjct: 131 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLP----QDKEXXKVKEPGESPIFWYAPE 186
Query: 224 YALEGIFSIKSDVFSFGVLLLEIVS 248
              E  FS+ SDV+SFGV+L E+ +
Sbjct: 187 SLTESKFSVASDVWSFGVVLYELFT 211

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 71/217 (32%), Positives = 108/217 (49%), Gaps = 17/217 (7%)
Query: 46  TATNKFSDANKLGEGGFGPVYKGVLKK--GDE----IAVKRLSGRSGQGLR-EMKNEASV 98
            A  K + + +LG+G FG VY+GV K    DE    +A+K ++  +    R E  NEASV
Sbjct: 44  VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 103
Query: 99  IAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWV-------TRV 151
           + +    ++VRLLG        ++I E M    L  +L      M  + V         +
Sbjct: 104 MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMI 163
Query: 152 QIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTS 211
           Q+   IA G+ YL+     + +HRDL A N ++ +D   KI DFGM R     +      
Sbjct: 164 QMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGG 220
Query: 212 RIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 248
           + +    +MSPE   +G+F+  SDV+SFGV+L EI +
Sbjct: 221 KGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 257

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 68/205 (33%), Positives = 104/205 (50%), Gaps = 21/205 (10%)
Query: 56  KLGEGGFGPV----YKGVL-KKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRL 110
           +LG+G FG V    Y  +    G+ +AVK+L   + + LR+ + E  ++  +QH N+V+ 
Sbjct: 17  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 76
Query: 111 LGCCID--RDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYS 168
            G C    R    LI EY+P  SL  +L    +R  +D +  +Q    I +G+ YL    
Sbjct: 77  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER--IDHIKLLQYTSQICKGMEYL---G 131
Query: 169 RVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG-----YMSPE 223
             R IHRDL   NIL++ +   KI DFG+ ++      Q      V   G     + +PE
Sbjct: 132 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLP----QDKEXXKVKEPGESPIFWYAPE 187
Query: 224 YALEGIFSIKSDVFSFGVLLLEIVS 248
              E  FS+ SDV+SFGV+L E+ +
Sbjct: 188 SLTESKFSVASDVWSFGVVLYELFT 212

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 114/210 (54%), Gaps = 20/210 (9%)
Query: 49  NKFSDANKLGEGGFGPVYKGV-LKKGDEI----AVKRL-SGRSGQGLREMKNEASVIAKV 102
            +F     LG G FG VYKG+ + +G+++    A+K L    S +  +E+ +EA V+A V
Sbjct: 17  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 76
Query: 103 QHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPT----KRMLLDWVTRVQIIEGIA 158
            + ++ RLLG C+    + LI + MP   L  ++ +       + LL+W  +      IA
Sbjct: 77  DNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 129
Query: 159 QGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG 218
           +G+ YL      R++HRDL A N+L+    + KI+DFG A++ G  E + +         
Sbjct: 130 KGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIK 186
Query: 219 YMSPEYALEGIFSIKSDVFSFGVLLLEIVS 248
           +M+ E  L  I++ +SDV+S+GV + E+++
Sbjct: 187 WMALESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 68/205 (33%), Positives = 104/205 (50%), Gaps = 21/205 (10%)
Query: 56  KLGEGGFGPV----YKGVLKK-GDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRL 110
           +LG+G FG V    Y  +    G+ +AVK+L   + + LR+ + E  ++  +QH N+V+ 
Sbjct: 22  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 81
Query: 111 LGCCID--RDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYS 168
            G C    R    LI EY+P  SL  +L    +R  +D +  +Q    I +G+ YL    
Sbjct: 82  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER--IDHIKLLQYTSQICKGMEYL---G 136
Query: 169 RVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG-----YMSPE 223
             R IHRDL   NIL++ +   KI DFG+ ++      Q      V   G     + +PE
Sbjct: 137 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLP----QDKEXXKVKEPGESPIFWYAPE 192
Query: 224 YALEGIFSIKSDVFSFGVLLLEIVS 248
              E  FS+ SDV+SFGV+L E+ +
Sbjct: 193 SLTESKFSVASDVWSFGVVLYELFT 217

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 68/206 (33%), Positives = 104/206 (50%), Gaps = 21/206 (10%)
Query: 55  NKLGEGGFGPV----YKGVL-KKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVR 109
            +LG+G FG V    Y  +    G+ +AVK+L   + + LR+ + E  ++  +QH N+V+
Sbjct: 20  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 79
Query: 110 LLGCCID--RDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQY 167
             G C    R    LI EY+P  SL  +L    +R  +D +  +Q    I +G+ YL   
Sbjct: 80  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER--IDHIKLLQYTSQICKGMEYL--- 134
Query: 168 SRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG-----YMSP 222
              R IHRDL   NIL++ +   KI DFG+ ++      Q      V   G     + +P
Sbjct: 135 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLP----QDKEXXKVKEPGESPIFWYAP 190
Query: 223 EYALEGIFSIKSDVFSFGVLLLEIVS 248
           E   E  FS+ SDV+SFGV+L E+ +
Sbjct: 191 ESLTESKFSVASDVWSFGVVLYELFT 216

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 68/205 (33%), Positives = 104/205 (50%), Gaps = 21/205 (10%)
Query: 56  KLGEGGFGPV----YKGVLKK-GDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRL 110
           +LG+G FG V    Y  +    G+ +AVK+L   + + LR+ + E  ++  +QH N+V+ 
Sbjct: 20  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 79
Query: 111 LGCCID--RDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYS 168
            G C    R    LI EY+P  SL  +L    +R  +D +  +Q    I +G+ YL    
Sbjct: 80  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQAHAER--IDHIKLLQYTSQICKGMEYL---G 134
Query: 169 RVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG-----YMSPE 223
             R IHRDL   NIL++ +   KI DFG+ ++      Q      V   G     + +PE
Sbjct: 135 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLP----QDKEXXKVKEPGESPIFWYAPE 190
Query: 224 YALEGIFSIKSDVFSFGVLLLEIVS 248
              E  FS+ SDV+SFGV+L E+ +
Sbjct: 191 SLTESKFSVASDVWSFGVVLYELFT 215

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 68/205 (33%), Positives = 104/205 (50%), Gaps = 21/205 (10%)
Query: 56  KLGEGGFGPV----YKGVL-KKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRL 110
           +LG+G FG V    Y  +    G+ +AVK+L   + + LR+ + E  ++  +QH N+V+ 
Sbjct: 17  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 76
Query: 111 LGCCID--RDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYS 168
            G C    R    LI EY+P  SL  +L    +R  +D +  +Q    I +G+ YL    
Sbjct: 77  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER--IDHIKLLQYTSQICKGMEYL---G 131
Query: 169 RVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG-----YMSPE 223
             R IHRDL   NIL++ +   KI DFG+ ++      Q      V   G     + +PE
Sbjct: 132 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLP----QDKEXXKVKEPGESPIFWYAPE 187
Query: 224 YALEGIFSIKSDVFSFGVLLLEIVS 248
              E  FS+ SDV+SFGV+L E+ +
Sbjct: 188 SLTESKFSVASDVWSFGVVLYELFT 212

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 68/205 (33%), Positives = 104/205 (50%), Gaps = 21/205 (10%)
Query: 56  KLGEGGFGPV----YKGVLKK-GDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRL 110
           +LG+G FG V    Y  +    G+ +AVK+L   + + LR+ + E  ++  +QH N+V+ 
Sbjct: 23  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 82
Query: 111 LGCCID--RDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYS 168
            G C    R    LI EY+P  SL  +L    +R  +D +  +Q    I +G+ YL    
Sbjct: 83  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER--IDHIKLLQYTSQICKGMEYL---G 137
Query: 169 RVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG-----YMSPE 223
             R IHRDL   NIL++ +   KI DFG+ ++      Q      V   G     + +PE
Sbjct: 138 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLP----QDKEXXKVKEPGESPIFWYAPE 193
Query: 224 YALEGIFSIKSDVFSFGVLLLEIVS 248
              E  FS+ SDV+SFGV+L E+ +
Sbjct: 194 SLTESKFSVASDVWSFGVVLYELFT 218

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 92.4 bits (228), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 68/206 (33%), Positives = 104/206 (50%), Gaps = 21/206 (10%)
Query: 55  NKLGEGGFGPV----YKGVL-KKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVR 109
            +LG+G FG V    Y  +    G+ +AVK+L   + + LR+ + E  ++  +QH N+V+
Sbjct: 14  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 73
Query: 110 LLGCCID--RDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQY 167
             G C    R    LI EY+P  SL  +L    +R  +D +  +Q    I +G+ YL   
Sbjct: 74  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER--IDHIKLLQYTSQICKGMEYL--- 128
Query: 168 SRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG-----YMSP 222
              R IHRDL   NIL++ +   KI DFG+ ++      Q      V   G     + +P
Sbjct: 129 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLP----QDKEXXKVKEPGESPIFWYAP 184
Query: 223 EYALEGIFSIKSDVFSFGVLLLEIVS 248
           E   E  FS+ SDV+SFGV+L E+ +
Sbjct: 185 ESLTESKFSVASDVWSFGVVLYELFT 210

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 92.4 bits (228), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 68/205 (33%), Positives = 104/205 (50%), Gaps = 21/205 (10%)
Query: 56  KLGEGGFGPV----YKGVLKK-GDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRL 110
           +LG+G FG V    Y  +    G+ +AVK+L   + + LR+ + E  ++  +QH N+V+ 
Sbjct: 20  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 79
Query: 111 LGCCID--RDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYS 168
            G C    R    LI EY+P  SL  +L    +R  +D +  +Q    I +G+ YL    
Sbjct: 80  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER--IDHIKLLQYTSQICKGMEYL---G 134
Query: 169 RVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG-----YMSPE 223
             R IHRDL   NIL++ +   KI DFG+ ++      Q      V   G     + +PE
Sbjct: 135 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLP----QDKEXXKVKEPGESPIFWYAPE 190
Query: 224 YALEGIFSIKSDVFSFGVLLLEIVS 248
              E  FS+ SDV+SFGV+L E+ +
Sbjct: 191 SLTESKFSVASDVWSFGVVLYELFT 215

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 92.4 bits (228), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 114/210 (54%), Gaps = 20/210 (9%)
Query: 49  NKFSDANKLGEGGFGPVYKGV-LKKGDEI----AVKRL-SGRSGQGLREMKNEASVIAKV 102
            +F     LG G FG VYKG+ + +G+++    A+K L    S +  +E+ +EA V+A V
Sbjct: 22  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 81
Query: 103 QHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPT----KRMLLDWVTRVQIIEGIA 158
            + ++ RLLG C+    + LI + MP   L  ++ +       + LL+W  +      IA
Sbjct: 82  DNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 134
Query: 159 QGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG 218
           +G+ YL      R++HRDL A N+L+    + KI+DFG A++ G  E + +         
Sbjct: 135 KGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIK 191
Query: 219 YMSPEYALEGIFSIKSDVFSFGVLLLEIVS 248
           +M+ E  L  I++ +SDV+S+GV + E+++
Sbjct: 192 WMALESILHRIYTHQSDVWSYGVTVWELMT 221

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 92.4 bits (228), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 76/263 (28%), Positives = 132/263 (50%), Gaps = 30/263 (11%)
Query: 72  KGDEIAVKRLSGRSGQ-GLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIYEYMPNK 130
           K +++A+KR++    Q  + E+  E   +++  H N+V      + +DE  L+ + +   
Sbjct: 39  KKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGG 98
Query: 131 S-LDFFLF----DPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLD 185
           S LD           K  +LD  T   I+  + +GL YLH+  +   IHRD+KA NILL 
Sbjct: 99  SVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQ---IHRDVKAGNILLG 155
Query: 186 KDMNPKISDFGM-ARICGGNELQANTSR--IVGTYGYMSPEYALEGI--FSIKSDVFSFG 240
           +D + +I+DFG+ A +  G ++  N  R   VGT  +M+PE  +E +  +  K+D++SFG
Sbjct: 156 EDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPE-VMEQVRGYDFKADIWSFG 214
Query: 241 VLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYSSKQMLLRYA-- 298
           +  +E+ +G      Y    + +L           TL+   P LE     K+ML +Y   
Sbjct: 215 ITAIELATGAAPYHKYPPMKVLML-----------TLQNDPPSLETGVQDKEMLKKYGKS 263
Query: 299 --NIALLCVQESADDRPTMNDVV 319
              +  LC+Q+  + RPT  +++
Sbjct: 264 FRKMISLCLQKDPEKRPTAAELL 286

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 68/205 (33%), Positives = 104/205 (50%), Gaps = 21/205 (10%)
Query: 56  KLGEGGFGPV----YKGVLKK-GDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRL 110
           +LG+G FG V    Y  +    G+ +AVK+L   + + LR+ + E  ++  +QH N+V+ 
Sbjct: 24  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 83
Query: 111 LGCCID--RDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYS 168
            G C    R    LI EY+P  SL  +L    +R  +D +  +Q    I +G+ YL    
Sbjct: 84  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER--IDHIKLLQYTSQICKGMEYL---G 138
Query: 169 RVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG-----YMSPE 223
             R IHRDL   NIL++ +   KI DFG+ ++      Q      V   G     + +PE
Sbjct: 139 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLP----QDKEXXKVKEPGESPIFWYAPE 194
Query: 224 YALEGIFSIKSDVFSFGVLLLEIVS 248
              E  FS+ SDV+SFGV+L E+ +
Sbjct: 195 SLTESKFSVASDVWSFGVVLYELFT 219

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 84/278 (30%), Positives = 126/278 (45%), Gaps = 23/278 (8%)
Query: 57  LGEGGFG--------PVYKGVLKKGDEIAVKRLSGRSGQGLRE-MKNEASVIAKVQHKNL 107
           LGEG FG        P   G    G+ +AVK L    G  LR   + E  ++  + H+++
Sbjct: 17  LGEGHFGKVSLYCYDPTNDGT---GEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHI 73
Query: 108 VRLLGCCIDRDEKI--LIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLH 165
           V+  GCC D+ EK   L+ EY+P  SL  +L     R  +     +   + I +G+ YLH
Sbjct: 74  VKYKGCCEDQGEKSVQLVMEYVPLGSLRDYL----PRHCVGLAQLLLFAQQICEGMAYLH 129
Query: 166 QYSRVRIIHRDLKASNILLDKDMNPKISDFGMAR-ICGGNELQANTSRIVGTYGYMSPEY 224
                  IHR L A N+LLD D   KI DFG+A+ +  G+E             + +PE 
Sbjct: 130 A---QHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPEC 186
Query: 225 ALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPIL 284
             E  F   SDV+SFGV L E+++   +     T    L+G+     T  R  EL++   
Sbjct: 187 LKECKFYYASDVWSFGVTLYELLTYCDSNQSPHTKFTELIGHTQGQMTVLRLTELLERG- 245
Query: 285 EDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSML 322
           E      +      ++   C +  A  RPT  ++V +L
Sbjct: 246 ERLPRPDRCPCEIYHLMKNCWETEASFRPTFQNLVPIL 283

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 84/278 (30%), Positives = 126/278 (45%), Gaps = 23/278 (8%)
Query: 57  LGEGGFG--------PVYKGVLKKGDEIAVKRLSGRSGQGLRE-MKNEASVIAKVQHKNL 107
           LGEG FG        P   G    G+ +AVK L    G  LR   + E  ++  + H+++
Sbjct: 16  LGEGHFGKVSLYCYDPTNDGT---GEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHI 72
Query: 108 VRLLGCCIDRDEKI--LIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLH 165
           V+  GCC D+ EK   L+ EY+P  SL  +L     R  +     +   + I +G+ YLH
Sbjct: 73  VKYKGCCEDQGEKSVQLVMEYVPLGSLRDYL----PRHCVGLAQLLLFAQQICEGMAYLH 128
Query: 166 QYSRVRIIHRDLKASNILLDKDMNPKISDFGMAR-ICGGNELQANTSRIVGTYGYMSPEY 224
                  IHR L A N+LLD D   KI DFG+A+ +  G+E             + +PE 
Sbjct: 129 A---QHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPEC 185
Query: 225 ALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPIL 284
             E  F   SDV+SFGV L E+++   +     T    L+G+     T  R  EL++   
Sbjct: 186 LKECKFYYASDVWSFGVTLYELLTYCDSNQSPHTKFTELIGHTQGQMTVLRLTELLERG- 244
Query: 285 EDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSML 322
           E      +      ++   C +  A  RPT  ++V +L
Sbjct: 245 ERLPRPDRCPCEIYHLMKNCWETEASFRPTFQNLVPIL 282

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 67/205 (32%), Positives = 106/205 (51%), Gaps = 21/205 (10%)
Query: 56  KLGEGGFGPV----YKGVL-KKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRL 110
           +LG+G FG V    Y  +    G+ +AVK+L   + + LR+ + E  ++  +QH N+V+ 
Sbjct: 17  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 76
Query: 111 LGCCID--RDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYS 168
            G C    R    LI EY+P  SL  +L    +R  +D +  +Q    I +G+ YL    
Sbjct: 77  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER--IDHIKLLQYTSQICKGMEYL---G 131
Query: 169 RVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE-----LQANTSRIVGTYGYMSPE 223
             R IHRDL   NIL++ +   KI DFG+ ++   ++      +   S I     + +PE
Sbjct: 132 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIF----WYAPE 187
Query: 224 YALEGIFSIKSDVFSFGVLLLEIVS 248
              E  FS+ SDV+SFGV+L E+ +
Sbjct: 188 SLTESKFSVASDVWSFGVVLYELFT 212

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 77/276 (27%), Positives = 135/276 (48%), Gaps = 32/276 (11%)
Query: 57  LGEGGFGPVYKGVLKKGDE----IAVKRL-SGRSGQGLREMKNEASVIAKVQHKNLVRLL 111
           +G G FG V  G LK   +    +A+K L SG + +  R+  +EAS++ +  H N++ L 
Sbjct: 41  IGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLE 100
Query: 112 GCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVR 171
           G        ++I E+M N SLD FL     +  +  +  V ++ GIA G+ YL   + + 
Sbjct: 101 GVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTV--IQLVGMLRGIAAGMKYL---ADMN 155
Query: 172 IIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVG---TYGYMSPEYALEG 228
            +HRDL A NIL++ ++  K+SDFG++R    +      +  +G      + +PE     
Sbjct: 156 YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYR 215
Query: 229 IFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEY 288
            F+  SDV+S+G+++ E++S  +                WD+  +N+  ++I+ I +D  
Sbjct: 216 KFTSASDVWSYGIVMWEVMSYGERP-------------YWDM--TNQ--DVINAIEQDYR 258
Query: 289 SSKQMLLRYA--NIALLCVQESADDRPTMNDVVSML 322
               M    A   + L C Q+  + RP    +V+ L
Sbjct: 259 LPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTL 294

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 76/263 (28%), Positives = 132/263 (50%), Gaps = 30/263 (11%)
Query: 72  KGDEIAVKRLSGRSGQ-GLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIYEYMPNK 130
           K +++A+KR++    Q  + E+  E   +++  H N+V      + +DE  L+ + +   
Sbjct: 34  KKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGG 93
Query: 131 S-LDFFLF----DPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLD 185
           S LD           K  +LD  T   I+  + +GL YLH+  +   IHRD+KA NILL 
Sbjct: 94  SVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQ---IHRDVKAGNILLG 150
Query: 186 KDMNPKISDFGM-ARICGGNELQANTSR--IVGTYGYMSPEYALEGI--FSIKSDVFSFG 240
           +D + +I+DFG+ A +  G ++  N  R   VGT  +M+PE  +E +  +  K+D++SFG
Sbjct: 151 EDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPE-VMEQVRGYDFKADIWSFG 209
Query: 241 VLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYSSKQMLLRYA-- 298
           +  +E+ +G      Y    + +L           TL+   P LE     K+ML +Y   
Sbjct: 210 ITAIELATGAAPYHKYPPMKVLML-----------TLQNDPPSLETGVQDKEMLKKYGKS 258
Query: 299 --NIALLCVQESADDRPTMNDVV 319
              +  LC+Q+  + RPT  +++
Sbjct: 259 FRKMISLCLQKDPEKRPTAAELL 281

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 92.0 bits (227), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 68/205 (33%), Positives = 104/205 (50%), Gaps = 21/205 (10%)
Query: 56  KLGEGGFGPV----YKGVL-KKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRL 110
           +LG+G FG V    Y  +    G+ +AVK+L   + + LR+ + E  ++  +QH N+V+ 
Sbjct: 35  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 94
Query: 111 LGCCID--RDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYS 168
            G C    R    LI EY+P  SL  +L    +R  +D +  +Q    I +G+ YL    
Sbjct: 95  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER--IDHIKLLQYTSQICKGMEYL---G 149
Query: 169 RVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG-----YMSPE 223
             R IHRDL   NIL++ +   KI DFG+ ++      Q      V   G     + +PE
Sbjct: 150 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLP----QDKEXXKVKEPGESPIFWYAPE 205
Query: 224 YALEGIFSIKSDVFSFGVLLLEIVS 248
              E  FS+ SDV+SFGV+L E+ +
Sbjct: 206 SLTESKFSVASDVWSFGVVLYELFT 230

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 92.0 bits (227), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 68/205 (33%), Positives = 104/205 (50%), Gaps = 21/205 (10%)
Query: 56  KLGEGGFGPV----YKGVL-KKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRL 110
           +LG+G FG V    Y  +    G+ +AVK+L   + + LR+ + E  ++  +QH N+V+ 
Sbjct: 35  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 94
Query: 111 LGCCID--RDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYS 168
            G C    R    LI EY+P  SL  +L    +R  +D +  +Q    I +G+ YL    
Sbjct: 95  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER--IDHIKLLQYTSQICKGMEYL---G 149
Query: 169 RVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG-----YMSPE 223
             R IHRDL   NIL++ +   KI DFG+ ++      Q      V   G     + +PE
Sbjct: 150 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLP----QDKEXXKVKEPGESPIFWYAPE 205
Query: 224 YALEGIFSIKSDVFSFGVLLLEIVS 248
              E  FS+ SDV+SFGV+L E+ +
Sbjct: 206 SLTESKFSVASDVWSFGVVLYELFT 230

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 92.0 bits (227), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 114/210 (54%), Gaps = 20/210 (9%)
Query: 49  NKFSDANKLGEGGFGPVYKGV-LKKGDEI----AVKRL-SGRSGQGLREMKNEASVIAKV 102
            +F     L  G FG VYKG+ + +G+++    A+K L    S +  +E+ +EA V+A V
Sbjct: 22  TEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 81
Query: 103 QHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPT----KRMLLDWVTRVQIIEGIA 158
            + ++ RLLG C+    + LI + MP   L  ++ +       + LL+W  +      IA
Sbjct: 82  DNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 134
Query: 159 QGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG 218
           +G+ YL      R++HRDL A N+L+    + KI+DFG+A++ G  E + +         
Sbjct: 135 KGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 191
Query: 219 YMSPEYALEGIFSIKSDVFSFGVLLLEIVS 248
           +M+ E  L  I++ +SDV+S+GV + E+++
Sbjct: 192 WMALESILHRIYTHQSDVWSYGVTVWELMT 221

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 92.0 bits (227), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 114/210 (54%), Gaps = 20/210 (9%)
Query: 49  NKFSDANKLGEGGFGPVYKGV-LKKGDEI----AVKRL-SGRSGQGLREMKNEASVIAKV 102
            +F     LG G FG VYKG+ + +G+++    A+  L    S +  +E+ +EA V+A V
Sbjct: 49  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKANKEILDEAYVMASV 108
Query: 103 QHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPT----KRMLLDWVTRVQIIEGIA 158
            + ++ RLLG C+    + LI + MP   L  ++ +       + LL+W  +      IA
Sbjct: 109 DNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 161
Query: 159 QGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG 218
           +G+ YL      R++HRDL A N+L+    + KI+DFG+A++ G  E + +         
Sbjct: 162 KGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 218
Query: 219 YMSPEYALEGIFSIKSDVFSFGVLLLEIVS 248
           +M+ E  L  I++ +SDV+S+GV + E+++
Sbjct: 219 WMALESILHRIYTHQSDVWSYGVTVWELMT 248

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 92.0 bits (227), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 110/206 (53%), Gaps = 21/206 (10%)
Query: 54  ANKLGEGGFGPVYKGVLKKGDEIAVKRL--SGRSGQGLREMKNEASVIAKVQHKNLVRLL 111
             ++G G FG VYKG  K   ++AVK L  +  + Q L+  KNE  V+ K +H N++  +
Sbjct: 29  GQRIGSGSFGTVYKG--KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 86
Query: 112 GCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVR 171
           G      +  ++ ++    SL   L     +  +  +  + I    A+G+ YLH  S   
Sbjct: 87  GYSTA-PQLAIVTQWCEGSSLYHHLHASETKFEMKKL--IDIARQTARGMDYLHAKS--- 140
Query: 172 IIHRDLKASNILLDKDMNPKISDFGMA----RICGGNELQANTSRIVGTYGYMSPEYAL- 226
           IIHRDLK++NI L +D   KI DFG+A    R  G ++ +    ++ G+  +M+PE    
Sbjct: 141 IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFE----QLSGSILWMAPEVIRM 196
Query: 227 --EGIFSIKSDVFSFGVLLLEIVSGK 250
                +S +SDV++FG++L E+++G+
Sbjct: 197 QDSNPYSFQSDVYAFGIVLYELMTGQ 222

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 92.0 bits (227), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 114/210 (54%), Gaps = 20/210 (9%)
Query: 49  NKFSDANKLGEGGFGPVYKGV-LKKGDEI----AVKRL-SGRSGQGLREMKNEASVIAKV 102
            +F     L  G FG VYKG+ + +G+++    A+K L    S +  +E+ +EA V+A V
Sbjct: 15  TEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 103 QHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPT----KRMLLDWVTRVQIIEGIA 158
            + ++ RLLG C+    + LI + MP   L  ++ +       + LL+W  +      IA
Sbjct: 75  DNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 127
Query: 159 QGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG 218
           +G+ YL      R++HRDL A N+L+    + KI+DFG+A++ G  E + +         
Sbjct: 128 KGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 184
Query: 219 YMSPEYALEGIFSIKSDVFSFGVLLLEIVS 248
           +M+ E  L  I++ +SDV+S+GV + E+++
Sbjct: 185 WMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 91.7 bits (226), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 114/210 (54%), Gaps = 20/210 (9%)
Query: 49  NKFSDANKLGEGGFGPVYKGV-LKKGDEI----AVKRL-SGRSGQGLREMKNEASVIAKV 102
            +F     L  G FG VYKG+ + +G+++    A+K L    S +  +E+ +EA V+A V
Sbjct: 22  TEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 81
Query: 103 QHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPT----KRMLLDWVTRVQIIEGIA 158
            + ++ RLLG C+    + LI + MP   L  ++ +       + LL+W  +      IA
Sbjct: 82  DNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 134
Query: 159 QGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG 218
           +G+ YL      R++HRDL A N+L+    + KI+DFG+A++ G  E + +         
Sbjct: 135 KGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 191
Query: 219 YMSPEYALEGIFSIKSDVFSFGVLLLEIVS 248
           +M+ E  L  I++ +SDV+S+GV + E+++
Sbjct: 192 WMALESILHRIYTHQSDVWSYGVTVWELMT 221

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 91.7 bits (226), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 71/217 (32%), Positives = 107/217 (49%), Gaps = 17/217 (7%)
Query: 46  TATNKFSDANKLGEGGFGPVYKGVLKK--GDE----IAVKRLSGRSGQGLR-EMKNEASV 98
            A  K + + +LG+G FG VY+GV K    DE    +A+K ++  +    R E  NEASV
Sbjct: 9   VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 68
Query: 99  IAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWV-------TRV 151
           + +    ++VRLLG        ++I E M    L  +L      M  + V         +
Sbjct: 69  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMI 128
Query: 152 QIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTS 211
           Q+   IA G+ YL+     + +HRDL A N  + +D   KI DFGM R     +      
Sbjct: 129 QMAGEIADGMAYLNAN---KFVHRDLAARNCXVAEDFTVKIGDFGMTRDIYETDYYRKGG 185
Query: 212 RIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 248
           + +    +MSPE   +G+F+  SDV+SFGV+L EI +
Sbjct: 186 KGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 222

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 91.3 bits (225), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 67/205 (32%), Positives = 104/205 (50%), Gaps = 21/205 (10%)
Query: 56  KLGEGGFGPV----YKGVL-KKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRL 110
           +LG+G FG V    Y  +    G+ +AVK+L   + + LR+ + E  ++  +QH N+V+ 
Sbjct: 20  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 79
Query: 111 LGCCID--RDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYS 168
            G C    R    LI E++P  SL  +L    +R  +D +  +Q    I +G+ YL    
Sbjct: 80  KGVCYSAGRRNLKLIMEFLPYGSLREYLQKHKER--IDHIKLLQYTSQICKGMEYL---G 134
Query: 169 RVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG-----YMSPE 223
             R IHRDL   NIL++ +   KI DFG+ ++      Q      V   G     + +PE
Sbjct: 135 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLP----QDKEXXKVKEPGESPIFWYAPE 190
Query: 224 YALEGIFSIKSDVFSFGVLLLEIVS 248
              E  FS+ SDV+SFGV+L E+ +
Sbjct: 191 SLTESKFSVASDVWSFGVVLYELFT 215

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 90/316 (28%), Positives = 134/316 (42%), Gaps = 50/316 (15%)
Query: 33  VDQFPLFSFSSVSTATNKFSDANKLGEGGFGPVYKGVL--KKG----DEIAVKRL-SGRS 85
           VD F +                  LGEG FG V K      KG      +AVK L    S
Sbjct: 7   VDAFKILEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENAS 66
Query: 86  GQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTK---- 141
              LR++ +E +V+ +V H ++++L G C      +LI EY    SL  FL +  K    
Sbjct: 67  PSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPG 126
Query: 142 ---------RMLLDWVTRVQIIEG--------IAQGLLYLHQYSRVRIIHRDLKASNILL 184
                       LD      +  G        I+QG+ YL   + ++++HRDL A NIL+
Sbjct: 127 YLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILV 183
Query: 185 DKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLL 244
            +    KISDFG++R     +     S+      +M+ E   + I++ +SDV+SFGVLL 
Sbjct: 184 AEGRKMKISDFGLSRDVYEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLW 243
Query: 245 EIVS--GKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYSSKQMLLRYANIAL 302
           EIV+  G    G+      NLL        +   +E  D   E+ Y           + L
Sbjct: 244 EIVTLGGNPYPGIPPERLFNLL-------KTGHRMERPDNCSEEMY----------RLML 286
Query: 303 LCVQESADDRPTMNDV 318
            C ++  D RP   D+
Sbjct: 287 QCWKQEPDKRPVFADI 302

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 66/205 (32%), Positives = 106/205 (51%), Gaps = 21/205 (10%)
Query: 56  KLGEGGFGPV----YKGVL-KKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRL 110
           +LG+G FG V    Y  +    G+ +AVK+L   + + LR+ + E  ++  +QH N+V+ 
Sbjct: 18  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 77
Query: 111 LGCCID--RDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYS 168
            G C    R    LI EY+P  SL  +L    +R  +D +  +Q    I +G+ YL    
Sbjct: 78  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER--IDHIKLLQYTSQICKGMEYL---G 132
Query: 169 RVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE-----LQANTSRIVGTYGYMSPE 223
             R IHR+L   NIL++ +   KI DFG+ ++   ++      +   S I     + +PE
Sbjct: 133 TKRYIHRNLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIF----WYAPE 188
Query: 224 YALEGIFSIKSDVFSFGVLLLEIVS 248
              E  FS+ SDV+SFGV+L E+ +
Sbjct: 189 SLTESKFSVASDVWSFGVVLYELFT 213

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 90/316 (28%), Positives = 134/316 (42%), Gaps = 50/316 (15%)
Query: 33  VDQFPLFSFSSVSTATNKFSDANKLGEGGFGPVYKGVL--KKG----DEIAVKRL-SGRS 85
           VD F +                  LGEG FG V K      KG      +AVK L    S
Sbjct: 7   VDAFKILEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENAS 66
Query: 86  GQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTK---- 141
              LR++ +E +V+ +V H ++++L G C      +LI EY    SL  FL +  K    
Sbjct: 67  PSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPG 126
Query: 142 ---------RMLLDWVTRVQIIEG--------IAQGLLYLHQYSRVRIIHRDLKASNILL 184
                       LD      +  G        I+QG+ YL   + ++++HRDL A NIL+
Sbjct: 127 YLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILV 183
Query: 185 DKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLL 244
            +    KISDFG++R     +     S+      +M+ E   + I++ +SDV+SFGVLL 
Sbjct: 184 AEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLW 243
Query: 245 EIVS--GKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYSSKQMLLRYANIAL 302
           EIV+  G    G+      NLL        +   +E  D   E+ Y           + L
Sbjct: 244 EIVTLGGNPYPGIPPERLFNLL-------KTGHRMERPDNCSEEMY----------RLML 286
Query: 303 LCVQESADDRPTMNDV 318
            C ++  D RP   D+
Sbjct: 287 QCWKQEPDKRPVFADI 302

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 84/278 (30%), Positives = 126/278 (45%), Gaps = 23/278 (8%)
Query: 57  LGEGGFG--------PVYKGVLKKGDEIAVKRLSGRSGQGLRE-MKNEASVIAKVQHKNL 107
           LGEG FG        P   G    G+ +AVK L   +G   R   K E  ++  + H+++
Sbjct: 39  LGEGHFGKVSLYCYDPTNDGT---GEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHI 95
Query: 108 VRLLGCCIDRDEKIL--IYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLH 165
           ++  GCC D     L  + EY+P  SL  +L     R  +     +   + I +G+ YLH
Sbjct: 96  IKYKGCCEDAGAASLQLVMEYVPLGSLRDYL----PRHSIGLAQLLLFAQQICEGMAYLH 151
Query: 166 QYSRVRIIHRDLKASNILLDKDMNPKISDFGMAR-ICGGNELQANTSRIVGTYGYMSPEY 224
                  IHRDL A N+LLD D   KI DFG+A+ +  G+E             + +PE 
Sbjct: 152 A---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEXYRVREDGDSPVFWYAPEC 208
Query: 225 ALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPIL 284
             E  F   SDV+SFGV L E+++   ++    T  L L+G A    T  R  EL++   
Sbjct: 209 LKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGE 268
Query: 285 EDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSML 322
                 K     Y ++   C +  A  RPT  +++ +L
Sbjct: 269 RLPRPDKCPAEVY-HLMKNCWETEASFRPTFENLIPIL 305

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 91/316 (28%), Positives = 133/316 (42%), Gaps = 50/316 (15%)
Query: 33  VDQFPLFSFSSVSTATNKFSDANKLGEGGFGPVYKGVL--KKG----DEIAVKRL-SGRS 85
           VD F +                  LGEG FG V K      KG      +AVK L    S
Sbjct: 7   VDAFKILEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENAS 66
Query: 86  GQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTK---- 141
              LR++ +E +V+ +V H ++++L G C      +LI EY    SL  FL +  K    
Sbjct: 67  PSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPG 126
Query: 142 ---------RMLLDWVTRVQIIEG--------IAQGLLYLHQYSRVRIIHRDLKASNILL 184
                       LD      +  G        I+QG+ YL + S   ++HRDL A NIL+
Sbjct: 127 YLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMS---LVHRDLAARNILV 183
Query: 185 DKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLL 244
            +    KISDFG++R     +     S+      +M+ E   + I++ +SDV+SFGVLL 
Sbjct: 184 AEGRKMKISDFGLSRDVYEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLW 243
Query: 245 EIVS--GKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYSSKQMLLRYANIAL 302
           EIV+  G    G+      NLL        +   +E  D   E+ Y           + L
Sbjct: 244 EIVTLGGNPYPGIPPERLFNLL-------KTGHRMERPDNCSEEMY----------RLML 286
Query: 303 LCVQESADDRPTMNDV 318
            C ++  D RP   D+
Sbjct: 287 QCWKQEPDKRPVFADI 302

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 64/202 (31%), Positives = 109/202 (53%), Gaps = 19/202 (9%)
Query: 57  LGEGGFGPVYKGVLKKGDE----IAVKRL-SGRSGQGLREMKNEASVIAKVQHKNLVRLL 111
           +G G  G V  G L+   +    +A+K L +G + +  R+  +EAS++ +  H N++RL 
Sbjct: 57  IGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLE 116
Query: 112 GCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVR 171
           G        +++ EYM N SLD FL     +  +  +  V ++ G+  G+ YL   S + 
Sbjct: 117 GVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTI--MQLVGMLRGVGAGMRYL---SDLG 171
Query: 172 IIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG-----YMSPEYAL 226
            +HRDL A N+L+D ++  K+SDFG++R+   +   A T+    T G     + +PE   
Sbjct: 172 YVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAXTT----TGGKIPIRWTAPEAIA 227
Query: 227 EGIFSIKSDVFSFGVLLLEIVS 248
              FS  SDV+SFGV++ E+++
Sbjct: 228 FRTFSSASDVWSFGVVMWEVLA 249

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 64/202 (31%), Positives = 109/202 (53%), Gaps = 19/202 (9%)
Query: 57  LGEGGFGPVYKGVLKKGDE----IAVKRL-SGRSGQGLREMKNEASVIAKVQHKNLVRLL 111
           +G G  G V  G L+   +    +A+K L +G + +  R+  +EAS++ +  H N++RL 
Sbjct: 57  IGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLE 116
Query: 112 GCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVR 171
           G        +++ EYM N SLD FL     +  +  +  V ++ G+  G+ YL   S + 
Sbjct: 117 GVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTI--MQLVGMLRGVGAGMRYL---SDLG 171
Query: 172 IIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG-----YMSPEYAL 226
            +HRDL A N+L+D ++  K+SDFG++R+   +   A T+    T G     + +PE   
Sbjct: 172 YVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTT----TGGKIPIRWTAPEAIA 227
Query: 227 EGIFSIKSDVFSFGVLLLEIVS 248
              FS  SDV+SFGV++ E+++
Sbjct: 228 FRTFSSASDVWSFGVVMWEVLA 249

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 77/248 (31%), Positives = 117/248 (47%), Gaps = 33/248 (13%)
Query: 27  RSKKKEVDQFPLFSFSSVSTATNKFSDANK--------LGEGGFGPVYKGVLKKGD---- 74
           R+     D  P +SF+  +++ +   +  +        LG G FG VY+G +        
Sbjct: 1   RTSTIMTDYNPNYSFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPS 60
Query: 75  --EIAVKRLSGR-SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKS 131
             ++AVK L    S Q   +   EA +I+K+ H+N+VR +G  +    + ++ E M    
Sbjct: 61  PLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVRCIGVSLQSLPRFILLELMAGGD 120
Query: 132 LDFFLFD----PTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILL--- 184
           L  FL +    P++   L  +  + +   IA G  YL +      IHRD+ A N LL   
Sbjct: 121 LKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCP 177
Query: 185 DKDMNPKISDFGMARICGGNELQANTSRIVGT----YGYMSPEYALEGIFSIKSDVFSFG 240
                 KI DFGMAR    +  +A+  R  G       +M PE  +EGIF+ K+D +SFG
Sbjct: 178 GPGRVAKIGDFGMAR----DIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFG 233
Query: 241 VLLLEIVS 248
           VLL EI S
Sbjct: 234 VLLWEIFS 241

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 80/266 (30%), Positives = 123/266 (46%), Gaps = 33/266 (12%)
Query: 9   LKADNVIIELPANNKQAKRSKKKEVDQFPLFSFSSVSTATNKFSDANK--------LGEG 60
           L+A  + ++ P       R+     D  P +SF+  +++ +   +  +        LG G
Sbjct: 9   LQAMQMELQSPEYKLSKLRTSTIMTDYNPNYSFAGKTSSISDLKEVPRKNITLIRGLGHG 68
Query: 61  GFGPVYKGVLKKGD------EIAVKRLSGR-SGQGLREMKNEASVIAKVQHKNLVRLLGC 113
            FG VY+G +          ++AVK L    S Q   +   EA +I+K  H+N+VR +G 
Sbjct: 69  AFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGV 128
Query: 114 CIDRDEKILIYEYMPNKSLDFFLFD----PTKRMLLDWVTRVQIIEGIAQGLLYLHQYSR 169
            +    + ++ E M    L  FL +    P++   L  +  + +   IA G  YL +   
Sbjct: 129 SLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN-- 186
Query: 170 VRIIHRDLKASNILLD---KDMNPKISDFGMARICGGNELQANTSRIVGT----YGYMSP 222
              IHRD+ A N LL         KI DFGMAR    +  +A+  R  G       +M P
Sbjct: 187 -HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRASYYRKGGCAMLPVKWMPP 241
Query: 223 EYALEGIFSIKSDVFSFGVLLLEIVS 248
           E  +EGIF+ K+D +SFGVLL EI S
Sbjct: 242 EAFMEGIFTSKTDTWSFGVLLWEIFS 267

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 61/201 (30%), Positives = 108/201 (53%), Gaps = 10/201 (4%)
Query: 51  FSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVR 109
           F    KLGEG +G VYK + K+ G  +A+K++   S   L+E+  E S++ +    ++V+
Sbjct: 31  FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD--LQEIIKEISIMQQCDSPHVVK 88
Query: 110 LLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSR 169
             G      +  ++ EY    S+   +    K +  D +    I++   +GL YLH    
Sbjct: 89  YYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIA--TILQSTLKGLEYLH---F 143
Query: 170 VRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGI 229
           +R IHRD+KA NILL+ + + K++DFG+A      +  A  + ++GT  +M+PE   E  
Sbjct: 144 MRKIHRDIKAGNILLNTEGHAKLADFGVAGQL--TDXMAKRNXVIGTPFWMAPEVIQEIG 201
Query: 230 FSIKSDVFSFGVLLLEIVSGK 250
           ++  +D++S G+  +E+  GK
Sbjct: 202 YNCVADIWSLGITAIEMAEGK 222

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 110/206 (53%), Gaps = 21/206 (10%)
Query: 54  ANKLGEGGFGPVYKGVLKKGDEIAVK--RLSGRSGQGLREMKNEASVIAKVQHKNLVRLL 111
           + ++G G FG VYKG  K   ++AVK  ++   + +  +  +NE +V+ K +H N++  +
Sbjct: 41  STRIGSGSFGTVYKG--KWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFM 98
Query: 112 GCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVR 171
           G  + +D   ++ ++    SL   L    +         + I    AQG+ YLH  +   
Sbjct: 99  G-YMTKDNLAIVTQWCEGSSLYKHLH--VQETKFQMFQLIDIARQTAQGMDYLHAKN--- 152
Query: 172 IIHRDLKASNILLDKDMNPKISDFGMA----RICGGNELQANTSRIVGTYGYMSPEYAL- 226
           IIHRD+K++NI L + +  KI DFG+A    R  G  +++  T  ++    +M+PE    
Sbjct: 153 IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVL----WMAPEVIRM 208
Query: 227 --EGIFSIKSDVFSFGVLLLEIVSGK 250
                FS +SDV+S+G++L E+++G+
Sbjct: 209 QDNNPFSFQSDVYSYGIVLYELMTGE 234

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 77/248 (31%), Positives = 116/248 (46%), Gaps = 33/248 (13%)
Query: 27  RSKKKEVDQFPLFSFSSVSTATNKFSDANK--------LGEGGFGPVYKGVLKKGD---- 74
           R+     D  P +SF+  +++ +   +  +        LG G FG VY+G +        
Sbjct: 7   RTSTIMTDYNPNYSFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPS 66
Query: 75  --EIAVKRLSGR-SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKS 131
             ++AVK L    S Q   +   EA +I+K  H+N+VR +G  +    + ++ E M    
Sbjct: 67  PLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGD 126
Query: 132 LDFFLFD----PTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILL--- 184
           L  FL +    P++   L  +  + +   IA G  YL +      IHRD+ A N LL   
Sbjct: 127 LKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCP 183
Query: 185 DKDMNPKISDFGMARICGGNELQANTSRIVGT----YGYMSPEYALEGIFSIKSDVFSFG 240
                 KI DFGMAR    +  +A+  R  G       +M PE  +EGIF+ K+D +SFG
Sbjct: 184 GPGRVAKIGDFGMAR----DIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFG 239
Query: 241 VLLLEIVS 248
           VLL EI S
Sbjct: 240 VLLWEIFS 247

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 77/248 (31%), Positives = 116/248 (46%), Gaps = 33/248 (13%)
Query: 27  RSKKKEVDQFPLFSFSSVSTATNKFSDANK--------LGEGGFGPVYKGVLKKGD---- 74
           R+     D  P +SF+  +++ +   +  +        LG G FG VY+G +        
Sbjct: 1   RTSTIMTDYNPNYSFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPS 60
Query: 75  --EIAVKRLSGR-SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKS 131
             ++AVK L    S Q   +   EA +I+K  H+N+VR +G  +    + ++ E M    
Sbjct: 61  PLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGD 120
Query: 132 LDFFLFD----PTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILL--- 184
           L  FL +    P++   L  +  + +   IA G  YL +      IHRD+ A N LL   
Sbjct: 121 LKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCP 177
Query: 185 DKDMNPKISDFGMARICGGNELQANTSRIVGT----YGYMSPEYALEGIFSIKSDVFSFG 240
                 KI DFGMAR    +  +A+  R  G       +M PE  +EGIF+ K+D +SFG
Sbjct: 178 GPGRVAKIGDFGMAR----DIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFG 233
Query: 241 VLLLEIVS 248
           VLL EI S
Sbjct: 234 VLLWEIFS 241

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 76/276 (27%), Positives = 134/276 (48%), Gaps = 32/276 (11%)
Query: 57  LGEGGFGPVYKGVLKKGDE----IAVKRL-SGRSGQGLREMKNEASVIAKVQHKNLVRLL 111
           +G G FG V  G LK   +    +A+K L SG + +  R+  +EAS++ +  H N++ L 
Sbjct: 15  IGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLE 74
Query: 112 GCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVR 171
           G        ++I E+M N SLD FL     +  +  +  V ++ GIA G+ YL   + + 
Sbjct: 75  GVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTV--IQLVGMLRGIAAGMKYL---ADMN 129
Query: 172 IIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVG---TYGYMSPEYALEG 228
            +HR L A NIL++ ++  K+SDFG++R    +      +  +G      + +PE     
Sbjct: 130 YVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYR 189
Query: 229 IFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEY 288
            F+  SDV+S+G+++ E++S  +                WD+  +N+  ++I+ I +D  
Sbjct: 190 KFTSASDVWSYGIVMWEVMSYGERP-------------YWDM--TNQ--DVINAIEQDYR 232
Query: 289 SSKQMLLRYA--NIALLCVQESADDRPTMNDVVSML 322
               M    A   + L C Q+  + RP    +V+ L
Sbjct: 233 LPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTL 268

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 88.6 bits (218), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 86/312 (27%), Positives = 140/312 (44%), Gaps = 58/312 (18%)
Query: 56  KLGEGGFGPVYKGVLK---KGD---EIAVKRLSGRSGQGLR-EMKNEASVIAKVQHKNLV 108
           +LG+G FG VY+G  +   KG+    +AVK ++  +    R E  NEASV+      ++V
Sbjct: 24  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 83
Query: 109 RLLGCCIDRDEKILIYEYMPNKSLDFFLFD-------------PTKRMLLDWVTRVQIIE 155
           RLLG        +++ E M +  L  +L               PT + +      +Q+  
Sbjct: 84  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEM------IQMAA 137
Query: 156 GIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVG 215
            IA G+ YL+     + +HRDL A N ++  D   KI DFGM R     +      + + 
Sbjct: 138 EIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLL 194
Query: 216 TYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS--GKKNTGLYRTDSLNLL---GYAWDL 270
              +M+PE   +G+F+  SD++SFGV+L EI S   +   GL     L  +   GY    
Sbjct: 195 PVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGY---- 250
Query: 271 WTSNRTLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNEAATLL 330
                 L+  D   E          R  ++  +C Q + + RPT  ++V++L ++    L
Sbjct: 251 ------LDQPDNCPE----------RVTDLMRMCWQFNPNMRPTFLEIVNLLKDD----L 290
Query: 331 PPKQPAFSYVRN 342
            P  P  S+  +
Sbjct: 291 HPSFPEVSFFHS 302

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 73/231 (31%), Positives = 114/231 (49%), Gaps = 31/231 (13%)
Query: 36  FPLFSFSSVSTATNKFSDANKLGEGGFGPVYKGVLKKGD---EIAVKRLSGRSGQG-LRE 91
           +P+  ++ +     KF D   +GEG FG V K  +KK     + A+KR+   + +   R+
Sbjct: 19  YPVLDWNDI-----KFQDV--IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRD 71
Query: 92  MKNEASVIAKV-QHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFL-------FDP---- 139
              E  V+ K+  H N++ LLG C  R    L  EY P+ +L  FL        DP    
Sbjct: 72  FAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAI 131
Query: 140 --TKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGM 197
             +    L     +     +A+G+ YL   S+ + IHRDL A NIL+ ++   KI+DFG+
Sbjct: 132 ANSTASTLSSQQLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGL 188
Query: 198 ARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 248
           +R   G E+    +       +M+ E     +++  SDV+S+GVLL EIVS
Sbjct: 189 SR---GQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 236

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 73/231 (31%), Positives = 114/231 (49%), Gaps = 31/231 (13%)
Query: 36  FPLFSFSSVSTATNKFSDANKLGEGGFGPVYKGVLKKGD---EIAVKRLSGRSGQG-LRE 91
           +P+  ++ +     KF D   +GEG FG V K  +KK     + A+KR+   + +   R+
Sbjct: 9   YPVLDWNDI-----KFQDV--IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRD 61
Query: 92  MKNEASVIAKV-QHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFL-------FDP---- 139
              E  V+ K+  H N++ LLG C  R    L  EY P+ +L  FL        DP    
Sbjct: 62  FAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAI 121
Query: 140 --TKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGM 197
             +    L     +     +A+G+ YL   S+ + IHRDL A NIL+ ++   KI+DFG+
Sbjct: 122 ANSTASTLSSQQLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGL 178
Query: 198 ARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 248
           +R   G E+    +       +M+ E     +++  SDV+S+GVLL EIVS
Sbjct: 179 SR---GQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 226

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 88.2 bits (217), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 109/215 (50%), Gaps = 12/215 (5%)
Query: 38  LFSFSSVSTATNKFSDANKLGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKNEA 96
           L S  SV     K++   K+G+G  G VY  + +  G E+A+++++ +       + NE 
Sbjct: 9   LRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEI 68
Query: 97  SVIAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEG 156
            V+ + ++ N+V  L   +  DE  ++ EY+   SL     D      +D      +   
Sbjct: 69  LVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRE 124
Query: 157 IAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGM-ARICGGNELQANTSRIVG 215
             Q L +LH     ++IHRD+K+ NILL  D + K++DFG  A+I      Q+  S +VG
Sbjct: 125 CLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQI---TPEQSKRSEMVG 178
Query: 216 TYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 250
           T  +M+PE      +  K D++S G++ +E++ G+
Sbjct: 179 TPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 88.2 bits (217), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 90/334 (26%), Positives = 146/334 (43%), Gaps = 60/334 (17%)
Query: 36  FP--LFSFSSVSTATNKFSDANKLGEGGFGPVYKGVLK---KGD---EIAVKRLSGRSGQ 87
           FP  +F       +  K +   +LG+G FG VY+G  +   KG+    +AVK ++  +  
Sbjct: 2   FPSSVFVPDEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASL 61
Query: 88  GLR-EMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFD-------- 138
             R E  NEASV+      ++VRLLG        +++ E M +  L  +L          
Sbjct: 62  RERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENN 121
Query: 139 -----PTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKIS 193
                PT + +      +Q+   IA G+ YL+     + +HRDL A N ++  D   KI 
Sbjct: 122 PGRPPPTLQEM------IQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIG 172
Query: 194 DFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS--GKK 251
           DFGM R     +      + +    +M+PE   +G+F+  SD++SFGV+L EI S   + 
Sbjct: 173 DFGMTRDIXETDXXRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQP 232
Query: 252 NTGLYRTDSLNLL---GYAWDLWTSNRTLELIDPILEDEYSSKQMLLRYANIALLCVQES 308
             GL     L  +   GY          L+  D   E          R  ++  +C Q +
Sbjct: 233 YQGLSNEQVLKFVMDGGY----------LDQPDNCPE----------RVTDLMRMCWQFN 272
Query: 309 ADDRPTMNDVVSMLTNEAATLLPPKQPAFSYVRN 342
              RPT  ++V++L ++    L P  P  S+  +
Sbjct: 273 PKMRPTFLEIVNLLKDD----LHPSFPEVSFFHS 302

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 87.8 bits (216), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 86/312 (27%), Positives = 139/312 (44%), Gaps = 58/312 (18%)
Query: 56  KLGEGGFGPVYKGVLK---KGD---EIAVKRLSGRSGQGLR-EMKNEASVIAKVQHKNLV 108
           +LG+G FG VY+G  +   KG+    +AVK ++  +    R E  NEASV+      ++V
Sbjct: 21  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 80
Query: 109 RLLGCCIDRDEKILIYEYMPNKSLDFFLFD-------------PTKRMLLDWVTRVQIIE 155
           RLLG        +++ E M +  L  +L               PT + +      +Q+  
Sbjct: 81  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEM------IQMAA 134
Query: 156 GIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVG 215
            IA G+ YL+     + +HRDL A N ++  D   KI DFGM R     +      + + 
Sbjct: 135 EIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLL 191
Query: 216 TYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS--GKKNTGLYRTDSLNLL---GYAWDL 270
              +M+PE   +G+F+  SD++SFGV+L EI S   +   GL     L  +   GY    
Sbjct: 192 PVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGY---- 247
Query: 271 WTSNRTLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNEAATLL 330
                 L+  D   E          R  ++  +C Q +   RPT  ++V++L ++    L
Sbjct: 248 ------LDQPDNCPE----------RVTDLMRMCWQFNPKMRPTFLEIVNLLKDD----L 287
Query: 331 PPKQPAFSYVRN 342
            P  P  S+  +
Sbjct: 288 HPSFPEVSFFHS 299

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 87.8 bits (216), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 109/215 (50%), Gaps = 12/215 (5%)
Query: 38  LFSFSSVSTATNKFSDANKLGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKNEA 96
           L S  SV     K++   K+G+G  G VY  + +  G E+A+++++ +       + NE 
Sbjct: 10  LRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEI 69
Query: 97  SVIAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEG 156
            V+ + ++ N+V  L   +  DE  ++ EY+   SL     D      +D      +   
Sbjct: 70  LVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRE 125
Query: 157 IAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGM-ARICGGNELQANTSRIVG 215
             Q L +LH     ++IHRD+K+ NILL  D + K++DFG  A+I      Q+  S +VG
Sbjct: 126 CLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE---QSKRSXMVG 179
Query: 216 TYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 250
           T  +M+PE      +  K D++S G++ +E++ G+
Sbjct: 180 TPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 214

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 87.8 bits (216), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 109/215 (50%), Gaps = 12/215 (5%)
Query: 38  LFSFSSVSTATNKFSDANKLGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKNEA 96
           L S  SV     K++   K+G+G  G VY  + +  G E+A+++++ +       + NE 
Sbjct: 9   LRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEI 68
Query: 97  SVIAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEG 156
            V+ + ++ N+V  L   +  DE  ++ EY+   SL     D      +D      +   
Sbjct: 69  LVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRE 124
Query: 157 IAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGM-ARICGGNELQANTSRIVG 215
             Q L +LH     ++IHRD+K+ NILL  D + K++DFG  A+I      Q+  S +VG
Sbjct: 125 CLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQI---TPEQSKRSXMVG 178
Query: 216 TYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 250
           T  +M+PE      +  K D++S G++ +E++ G+
Sbjct: 179 TPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 109/215 (50%), Gaps = 12/215 (5%)
Query: 38  LFSFSSVSTATNKFSDANKLGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKNEA 96
           L S  SV     K++   K+G+G  G VY  + +  G E+A+++++ +       + NE 
Sbjct: 9   LRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEI 68
Query: 97  SVIAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEG 156
            V+ + ++ N+V  L   +  DE  ++ EY+   SL     D      +D      +   
Sbjct: 69  LVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRE 124
Query: 157 IAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGM-ARICGGNELQANTSRIVG 215
             Q L +LH     ++IHRD+K+ NILL  D + K++DFG  A+I      Q+  S +VG
Sbjct: 125 CLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQI---TPEQSKRSTMVG 178
Query: 216 TYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 250
           T  +M+PE      +  K D++S G++ +E++ G+
Sbjct: 179 TPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 76/248 (30%), Positives = 115/248 (46%), Gaps = 33/248 (13%)
Query: 27  RSKKKEVDQFPLFSFSSVSTATNKFSDANK--------LGEGGFGPVYKGVLKKGD---- 74
           R+     D  P + F+  +++ +   +  +        LG G FG VY+G +        
Sbjct: 17  RTSTIMTDYNPNYCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPS 76
Query: 75  --EIAVKRLSGR-SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKS 131
             ++AVK L    S Q   +   EA +I+K  H+N+VR +G  +    + ++ E M    
Sbjct: 77  PLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGD 136
Query: 132 LDFFLFD----PTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILL--- 184
           L  FL +    P++   L  +  + +   IA G  YL +      IHRD+ A N LL   
Sbjct: 137 LKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCP 193
Query: 185 DKDMNPKISDFGMARICGGNELQANTSRIVGT----YGYMSPEYALEGIFSIKSDVFSFG 240
                 KI DFGMAR    +  +A+  R  G       +M PE  +EGIF+ K+D +SFG
Sbjct: 194 GPGRVAKIGDFGMAR----DIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFG 249
Query: 241 VLLLEIVS 248
           VLL EI S
Sbjct: 250 VLLWEIFS 257

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 72/210 (34%), Positives = 103/210 (49%), Gaps = 25/210 (11%)
Query: 57  LGEGGFGPVYKGVLKKGD------EIAVKRLSGR-SGQGLREMKNEASVIAKVQHKNLVR 109
           LG G FG VY+G +          ++AVK L    S Q   +   EA +I+K+ H+N+VR
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVR 112
Query: 110 LLGCCIDRDEKILIYEYMPNKSLDFFLFD----PTKRMLLDWVTRVQIIEGIAQGLLYLH 165
            +G  +    + ++ E M    L  FL +    P++   L  +  + +   IA G  YL 
Sbjct: 113 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 172
Query: 166 QYSRVRIIHRDLKASNILL---DKDMNPKISDFGMARICGGNELQANTSRIVGT----YG 218
           +      IHRD+ A N LL         KI DFGMAR    +  +A+  R  G       
Sbjct: 173 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRASYYRKGGCAMLPVK 225
Query: 219 YMSPEYALEGIFSIKSDVFSFGVLLLEIVS 248
           +M PE  +EGIF+ K+D +SFGVLL EI S
Sbjct: 226 WMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 104/204 (50%), Gaps = 11/204 (5%)
Query: 51  FSDANKLGEGGFGPVYKG-VLKKGDEIAVKRLSGRS---GQGLREMKNEASVIAKVQHKN 106
           F   N LG+G F  VY+   +  G E+A+K +  ++      ++ ++NE  +  +++H +
Sbjct: 13  FKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPS 72
Query: 107 LVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQ 166
           ++ L     D +   L+ E   N  ++ +L +  K    +       +  I  G+LYLH 
Sbjct: 73  ILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEAR--HFMHQIITGMLYLHS 130
Query: 167 YSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAL 226
           +    I+HRDL  SN+LL ++MN KI+DFG+A        +  T  + GT  Y+SPE A 
Sbjct: 131 HG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT--LCGTPNYISPEIAT 185
Query: 227 EGIFSIKSDVFSFGVLLLEIVSGK 250
                ++SDV+S G +   ++ G+
Sbjct: 186 RSAHGLESDVWSLGCMFYTLLIGR 209

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 72/210 (34%), Positives = 102/210 (48%), Gaps = 25/210 (11%)
Query: 57  LGEGGFGPVYKGVLKKGD------EIAVKRLSG-RSGQGLREMKNEASVIAKVQHKNLVR 109
           LG G FG VY+G +          ++AVK L    S Q   +   EA +I+K  H+N+VR
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 110 LLGCCIDRDEKILIYEYMPNKSLDFFLFD----PTKRMLLDWVTRVQIIEGIAQGLLYLH 165
            +G  +    + ++ E M    L  FL +    P++   L  +  + +   IA G  YL 
Sbjct: 98  CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 157
Query: 166 QYSRVRIIHRDLKASNILL---DKDMNPKISDFGMARICGGNELQANTSRIVGT----YG 218
           +      IHRD+ A N LL         KI DFGMAR    +  +A+  R  G       
Sbjct: 158 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRASYYRKGGCAMLPVK 210
Query: 219 YMSPEYALEGIFSIKSDVFSFGVLLLEIVS 248
           +M PE  +EGIF+ K+D +SFGVLL EI S
Sbjct: 211 WMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 76/248 (30%), Positives = 116/248 (46%), Gaps = 33/248 (13%)
Query: 27  RSKKKEVDQFPLFSFSSVSTATNKFSDANK--------LGEGGFGPVYKGVLKKGD---- 74
           R+     D  P +SF+  +++ +   +  +        LG G FG VY+G +        
Sbjct: 1   RTSTIMTDYNPNYSFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPS 60
Query: 75  --EIAVKRLSGR-SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKS 131
             ++AVK L    S Q   +   EA +I+K  H+N+VR +G  +    + ++ E M    
Sbjct: 61  PLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGD 120
Query: 132 LDFFLFD----PTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILL--- 184
           L  FL +    P++   L  +  + +   IA G  YL +      IHRD+ A N LL   
Sbjct: 121 LKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCP 177
Query: 185 DKDMNPKISDFGMARICGGNELQANTSRIVGT----YGYMSPEYALEGIFSIKSDVFSFG 240
                 KI DFGMA+    +  +A+  R  G       +M PE  +EGIF+ K+D +SFG
Sbjct: 178 GPGRVAKIGDFGMAQ----DIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFG 233
Query: 241 VLLLEIVS 248
           VLL EI S
Sbjct: 234 VLLWEIFS 241

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 72/210 (34%), Positives = 102/210 (48%), Gaps = 25/210 (11%)
Query: 57  LGEGGFGPVYKGVLKKGD------EIAVKRLSG-RSGQGLREMKNEASVIAKVQHKNLVR 109
           LG G FG VY+G +          ++AVK L    S Q   +   EA +I+K  H+N+VR
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVYSEQDELDFLMEALIISKFNHQNIVR 112
Query: 110 LLGCCIDRDEKILIYEYMPNKSLDFFLFD----PTKRMLLDWVTRVQIIEGIAQGLLYLH 165
            +G  +    + ++ E M    L  FL +    P++   L  +  + +   IA G  YL 
Sbjct: 113 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 172
Query: 166 QYSRVRIIHRDLKASNILL---DKDMNPKISDFGMARICGGNELQANTSRIVGT----YG 218
           +      IHRD+ A N LL         KI DFGMAR    +  +A+  R  G       
Sbjct: 173 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRASYYRKGGCAMLPVK 225
Query: 219 YMSPEYALEGIFSIKSDVFSFGVLLLEIVS 248
           +M PE  +EGIF+ K+D +SFGVLL EI S
Sbjct: 226 WMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 76/248 (30%), Positives = 114/248 (45%), Gaps = 33/248 (13%)
Query: 27  RSKKKEVDQFPLFSFSSVSTATNKFSDANK--------LGEGGFGPVYKGVLKKGD---- 74
           R+     D  P + F+  +++ +   +  +        LG G FG VY+G +        
Sbjct: 41  RTSTIMTDYNPNYCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPS 100
Query: 75  --EIAVKRLSGR-SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKS 131
             ++AVK L    S Q   +   EA +I+K  H+N+VR +G  +    + ++ E M    
Sbjct: 101 PLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGD 160
Query: 132 LDFFLFD----PTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILL--- 184
           L  FL +    P++   L  +  + +   IA G  YL +      IHRD+ A N LL   
Sbjct: 161 LKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCP 217
Query: 185 DKDMNPKISDFGMARICGGNELQANTSRIVGT----YGYMSPEYALEGIFSIKSDVFSFG 240
                 KI DFGMAR    +  +A   R  G       +M PE  +EGIF+ K+D +SFG
Sbjct: 218 GPGRVAKIGDFGMAR----DIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFG 273
Query: 241 VLLLEIVS 248
           VLL EI S
Sbjct: 274 VLLWEIFS 281

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 78/268 (29%), Positives = 121/268 (45%), Gaps = 26/268 (9%)
Query: 55  NKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCC 114
            +LG G FG V  G  +   ++A+K +   S     E   EA V+  + H+ LV+L G C
Sbjct: 14  KELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVC 72
Query: 115 IDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 174
             +    +I EYM N  L  +L +   R        +++ + + + + YL      + +H
Sbjct: 73  TKQRPIFIITEYMANGCLLNYLREMRHRFQTQ--QLLEMCKDVCEAMEYLES---KQFLH 127
Query: 175 RDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG--YMSPEYALEGIFSI 232
           RDL A N L++     K+SDFG++R    +E    TS +   +   +  PE  +   FS 
Sbjct: 128 RDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY---TSSVGSKFPVRWSPPEVLMYSKFSS 184
Query: 233 KSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYSSKQ 292
           KSD+++FGVL+ EI S  K      T+S      A       + L L  P L  E     
Sbjct: 185 KSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIA-------QGLRLYRPHLASE----- 232
Query: 293 MLLRYANIALLCVQESADDRPTMNDVVS 320
              +   I   C  E AD+RPT   ++S
Sbjct: 233 ---KVYTIMYSCWHEKADERPTFKILLS 257

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 76/248 (30%), Positives = 114/248 (45%), Gaps = 33/248 (13%)
Query: 27  RSKKKEVDQFPLFSFSSVSTATNKFSDANK--------LGEGGFGPVYKGVLKKGD---- 74
           R+     D  P + F+  +++ +   +  +        LG G FG VY+G +        
Sbjct: 18  RTSTIMTDYNPNYCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPS 77
Query: 75  --EIAVKRLSGR-SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKS 131
             ++AVK L    S Q   +   EA +I+K  H+N+VR +G  +    + ++ E M    
Sbjct: 78  PLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGD 137
Query: 132 LDFFLFD----PTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILL--- 184
           L  FL +    P++   L  +  + +   IA G  YL +      IHRD+ A N LL   
Sbjct: 138 LKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCP 194
Query: 185 DKDMNPKISDFGMARICGGNELQANTSRIVGT----YGYMSPEYALEGIFSIKSDVFSFG 240
                 KI DFGMAR    +  +A   R  G       +M PE  +EGIF+ K+D +SFG
Sbjct: 195 GPGRVAKIGDFGMAR----DIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFG 250
Query: 241 VLLLEIVS 248
           VLL EI S
Sbjct: 251 VLLWEIFS 258

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 78/267 (29%), Positives = 122/267 (45%), Gaps = 26/267 (9%)
Query: 56  KLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCI 115
           +LG G FG V  G  +   ++A+K +   S     E   EA V+  + H+ LV+L G C 
Sbjct: 31  ELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCT 89
Query: 116 DRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHR 175
            +    +I EYM N  L  +L +   R     +  +++ + + + + YL      + +HR
Sbjct: 90  KQRPIFIITEYMANGCLLNYLREMRHRFQTQQL--LEMCKDVCEAMEYLES---KQFLHR 144
Query: 176 DLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG--YMSPEYALEGIFSIK 233
           DL A N L++     K+SDFG++R    +E    TS +   +   +  PE  +   FS K
Sbjct: 145 DLAARNCLVNDQGVVKVSDFGLSRYVLDDE---ETSSVGSKFPVRWSPPEVLMYSKFSSK 201
Query: 234 SDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYSSKQM 293
           SD+++FGVL+ EI S  K      T+S      A       + L L  P L  E      
Sbjct: 202 SDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIA-------QGLRLYRPHLASE------ 248
Query: 294 LLRYANIALLCVQESADDRPTMNDVVS 320
             +   I   C  E AD+RPT   ++S
Sbjct: 249 --KVYTIMYSCWHEKADERPTFKILLS 273

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 72/210 (34%), Positives = 102/210 (48%), Gaps = 25/210 (11%)
Query: 57  LGEGGFGPVYKGVLKKGD------EIAVKRLSG-RSGQGLREMKNEASVIAKVQHKNLVR 109
           LG G FG VY+G +          ++AVK L    S Q   +   EA +I+K  H+N+VR
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 110 LLGCCIDRDEKILIYEYMPNKSLDFFLFD----PTKRMLLDWVTRVQIIEGIAQGLLYLH 165
            +G  +    + ++ E M    L  FL +    P++   L  +  + +   IA G  YL 
Sbjct: 98  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 157
Query: 166 QYSRVRIIHRDLKASNILL---DKDMNPKISDFGMARICGGNELQANTSRIVGT----YG 218
           +      IHRD+ A N LL         KI DFGMAR    +  +A+  R  G       
Sbjct: 158 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRASYYRKGGCAMLPVK 210
Query: 219 YMSPEYALEGIFSIKSDVFSFGVLLLEIVS 248
           +M PE  +EGIF+ K+D +SFGVLL EI S
Sbjct: 211 WMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 72/210 (34%), Positives = 102/210 (48%), Gaps = 25/210 (11%)
Query: 57  LGEGGFGPVYKGVLKKGD------EIAVKRLSGR-SGQGLREMKNEASVIAKVQHKNLVR 109
           LG G FG VY+G +          ++AVK L    S Q   +   EA +I+K  H+N+VR
Sbjct: 30  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 89
Query: 110 LLGCCIDRDEKILIYEYMPNKSLDFFLFD----PTKRMLLDWVTRVQIIEGIAQGLLYLH 165
            +G  +    + ++ E M    L  FL +    P++   L  +  + +   IA G  YL 
Sbjct: 90  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 149
Query: 166 QYSRVRIIHRDLKASNILL---DKDMNPKISDFGMARICGGNELQANTSRIVGT----YG 218
           +      IHRD+ A N LL         KI DFGMAR    +  +A+  R  G       
Sbjct: 150 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRASYYRKGGCAMLPVK 202
Query: 219 YMSPEYALEGIFSIKSDVFSFGVLLLEIVS 248
           +M PE  +EGIF+ K+D +SFGVLL EI S
Sbjct: 203 WMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 232

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 72/210 (34%), Positives = 102/210 (48%), Gaps = 25/210 (11%)
Query: 57  LGEGGFGPVYKGVLKKGD------EIAVKRLSGR-SGQGLREMKNEASVIAKVQHKNLVR 109
           LG G FG VY+G +          ++AVK L    S Q   +   EA +I+K  H+N+VR
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 112
Query: 110 LLGCCIDRDEKILIYEYMPNKSLDFFLFD----PTKRMLLDWVTRVQIIEGIAQGLLYLH 165
            +G  +    + ++ E M    L  FL +    P++   L  +  + +   IA G  YL 
Sbjct: 113 CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 172
Query: 166 QYSRVRIIHRDLKASNILL---DKDMNPKISDFGMARICGGNELQANTSRIVGT----YG 218
           +      IHRD+ A N LL         KI DFGMAR    +  +A+  R  G       
Sbjct: 173 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRASYYRKGGCAMLPVK 225
Query: 219 YMSPEYALEGIFSIKSDVFSFGVLLLEIVS 248
           +M PE  +EGIF+ K+D +SFGVLL EI S
Sbjct: 226 WMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 76/266 (28%), Positives = 120/266 (45%), Gaps = 22/266 (8%)
Query: 55  NKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCC 114
            +LG G FG V  G  +   ++A+K +   S     E   EA V+  + H+ LV+L G C
Sbjct: 10  KELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVC 68
Query: 115 IDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 174
             +    +I EYM N  L  +L +   R     +  +++ + + + + YL      + +H
Sbjct: 69  TKQRPIFIITEYMANGCLLNYLREMRHRFQTQQL--LEMCKDVCEAMEYLES---KQFLH 123
Query: 175 RDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKS 234
           RDL A N L++     K+SDFG++R    +E  ++         +  PE  +   FS KS
Sbjct: 124 RDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPV-RWSPPEVLMYSKFSSKS 182
Query: 235 DVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYSSKQML 294
           D+++FGVL+ EI S  K      T+S      A       + L L  P L  E       
Sbjct: 183 DIWAFGVLMWEIYSLGKMPYERFTNSETAEHIA-------QGLRLYRPHLASE------- 228
Query: 295 LRYANIALLCVQESADDRPTMNDVVS 320
            +   I   C  E AD+RPT   ++S
Sbjct: 229 -KVYTIMYSCWHEKADERPTFKILLS 253

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 76/265 (28%), Positives = 119/265 (44%), Gaps = 22/265 (8%)
Query: 56  KLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCI 115
           +LG G FG V  G  +   ++A+K +   S     E   EA V+  + H+ LV+L G C 
Sbjct: 16  ELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCT 74
Query: 116 DRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHR 175
            +    +I EYM N  L  +L +   R        +++ + + + + YL      + +HR
Sbjct: 75  KQRPIFIITEYMANGCLLNYLREMRHRFQTQ--QLLEMCKDVCEAMEYLES---KQFLHR 129
Query: 176 DLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSD 235
           DL A N L++     K+SDFG++R    +E  ++         +  PE  +   FS KSD
Sbjct: 130 DLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPV-RWSPPEVLMYSKFSSKSD 188
Query: 236 VFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYSSKQMLL 295
           +++FGVL+ EI S  K      T+S      A       + L L  P L  E        
Sbjct: 189 IWAFGVLMWEIYSLGKMPYERFTNSETAEHIA-------QGLRLYRPHLASE-------- 233
Query: 296 RYANIALLCVQESADDRPTMNDVVS 320
           +   I   C  E AD+RPT   ++S
Sbjct: 234 KVYTIMYSCWHEKADERPTFKILLS 258

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 90/334 (26%), Positives = 146/334 (43%), Gaps = 60/334 (17%)
Query: 36  FP--LFSFSSVSTATNKFSDANKLGEGGFGPVYKGVLK---KGD---EIAVKRLSGRSGQ 87
           FP  +F       +  K +   +LG+G FG VY+G  +   KG+    +AVK ++  +  
Sbjct: 2   FPSSVFVPDEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASL 61
Query: 88  GLR-EMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFD-------- 138
             R E  NEASV+      ++VRLLG        +++ E M +  L  +L          
Sbjct: 62  RERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENN 121
Query: 139 -----PTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKIS 193
                PT + +      +Q+   IA G+ YL+     + +HRDL A N ++  D   KI 
Sbjct: 122 PGRPPPTLQEM------IQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIG 172
Query: 194 DFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS--GKK 251
           DFGM R     +      + +    +M+PE   +G+F+  SD++SFGV+L EI S   + 
Sbjct: 173 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQP 232
Query: 252 NTGLYRTDSLNLL---GYAWDLWTSNRTLELIDPILEDEYSSKQMLLRYANIALLCVQES 308
             GL     L  +   GY          L+  D   E          R  ++  +C Q +
Sbjct: 233 YQGLSNEQVLKFVMDGGY----------LDQPDNCPE----------RVTDLMRMCWQFN 272
Query: 309 ADDRPTMNDVVSMLTNEAATLLPPKQPAFSYVRN 342
              RPT  ++V++L ++    L P  P  S+  +
Sbjct: 273 PKMRPTFLEIVNLLKDD----LHPSFPEVSFFHS 302

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 78/267 (29%), Positives = 122/267 (45%), Gaps = 26/267 (9%)
Query: 56  KLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCI 115
           +LG G FG V  G  +   ++A+K +   S     E   EA V+  + H+ LV+L G C 
Sbjct: 31  ELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCT 89
Query: 116 DRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHR 175
            +    +I EYM N  L  +L +   R     +  +++ + + + + YL      + +HR
Sbjct: 90  KQRPIFIITEYMANGCLLNYLREMRHRFQTQQL--LEMCKDVCEAMEYLES---KQFLHR 144
Query: 176 DLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG--YMSPEYALEGIFSIK 233
           DL A N L++     K+SDFG++R    +E    TS +   +   +  PE  +   FS K
Sbjct: 145 DLAARNCLVNDQGVVKVSDFGLSRYVLDDEY---TSSVGSKFPVRWSPPEVLMYSKFSSK 201
Query: 234 SDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYSSKQM 293
           SD+++FGVL+ EI S  K      T+S      A       + L L  P L  E      
Sbjct: 202 SDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIA-------QGLRLYRPHLASE------ 248
Query: 294 LLRYANIALLCVQESADDRPTMNDVVS 320
             +   I   C  E AD+RPT   ++S
Sbjct: 249 --KVYTIMYSCWHEKADERPTFKILLS 273

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 76/266 (28%), Positives = 120/266 (45%), Gaps = 22/266 (8%)
Query: 55  NKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCC 114
            +LG G FG V  G  +   ++A+K +   S     E   EA V+  + H+ LV+L G C
Sbjct: 21  KELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVC 79
Query: 115 IDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 174
             +    +I EYM N  L  +L +   R     +  +++ + + + + YL      + +H
Sbjct: 80  TKQRPIFIITEYMANGCLLNYLREMRHRFQTQQL--LEMCKDVCEAMEYLES---KQFLH 134
Query: 175 RDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKS 234
           RDL A N L++     K+SDFG++R    +E  ++         +  PE  +   FS KS
Sbjct: 135 RDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPV-RWSPPEVLMYSKFSSKS 193
Query: 235 DVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYSSKQML 294
           D+++FGVL+ EI S  K      T+S      A       + L L  P L  E       
Sbjct: 194 DIWAFGVLMWEIYSLGKMPYERFTNSETAEHIA-------QGLRLYRPHLASE------- 239
Query: 295 LRYANIALLCVQESADDRPTMNDVVS 320
            +   I   C  E AD+RPT   ++S
Sbjct: 240 -KVYTIMYSCWHEKADERPTFKILLS 264

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 69/213 (32%), Positives = 115/213 (53%), Gaps = 16/213 (7%)
Query: 46  TATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLREMK-NEASVIAKVQ 103
           +++++F    KLG G +  VYKG+ K  G  +A+K +   S +G       E S++ +++
Sbjct: 2   SSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELK 61
Query: 104 HKNLVRLLGCCIDRDEKILIYEYMPN---KSLDFFLFDPTKRML-LDWVTRVQIIEGIAQ 159
           H+N+VRL       ++  L++E+M N   K +D      T R L L+ V   Q    + Q
Sbjct: 62  HENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQW--QLLQ 119
Query: 160 GLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANT-SRIVGTYG 218
           GL + H+    +I+HRDLK  N+L++K    K+ DFG+AR  G   +  NT S  V T  
Sbjct: 120 GLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFG---IPVNTFSSEVVTLW 173
Query: 219 YMSPEYALEG-IFSIKSDVFSFGVLLLEIVSGK 250
           Y +P+  +    +S   D++S G +L E+++GK
Sbjct: 174 YRAPDVLMGSRTYSTSIDIWSCGCILAEMITGK 206

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 72/231 (31%), Positives = 114/231 (49%), Gaps = 31/231 (13%)
Query: 36  FPLFSFSSVSTATNKFSDANKLGEGGFGPVYKGVLKKGD---EIAVKRLSGRSGQG-LRE 91
           +P+  ++ +     KF D   +GEG FG V K  +KK     + A+KR+   + +   R+
Sbjct: 16  YPVLDWNDI-----KFQDV--IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRD 68
Query: 92  MKNEASVIAKV-QHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFL-------FDP---- 139
              E  V+ K+  H N++ LLG C  R    L  EY P+ +L  FL        DP    
Sbjct: 69  FAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAI 128
Query: 140 --TKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGM 197
             +    L     +     +A+G+ YL   S+ + IHR+L A NIL+ ++   KI+DFG+
Sbjct: 129 ANSTASTLSSQQLLHFAADVARGMDYL---SQKQFIHRNLAARNILVGENYVAKIADFGL 185
Query: 198 ARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 248
           +R   G E+    +       +M+ E     +++  SDV+S+GVLL EIVS
Sbjct: 186 SR---GQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 233

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 61/203 (30%), Positives = 108/203 (53%), Gaps = 21/203 (10%)
Query: 57  LGEGGFGPVYKGVLK----KGDEIAVKRLS-GRSGQGLREMKNEASVIAKVQHKNLVRLL 111
           +G G FG V  G LK    +   +A+K L  G + +  R+   EAS++ +  H N+V L 
Sbjct: 51  IGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQRRDFLCEASIMGQFDHPNVVHLE 110
Query: 112 GCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVR 171
           G        +++ E+M N +LD FL     +  +  +  V ++ GIA G+ YL   + + 
Sbjct: 111 GVVTRGKPVMIVIEFMENGALDAFLRKHDGQFTV--IQLVGMLRGIAAGMRYL---ADMG 165
Query: 172 IIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG------YMSPEYA 225
            +HRDL A NIL++ ++  K+SDFG++R+     ++ +   +  T G      + +PE  
Sbjct: 166 YVHRDLAARNILVNSNLVCKVSDFGLSRV-----IEDDPEAVYTTTGGKIPVRWTAPEAI 220
Query: 226 LEGIFSIKSDVFSFGVLLLEIVS 248
               F+  SDV+S+G+++ E++S
Sbjct: 221 QYRKFTSASDVWSYGIVMWEVMS 243

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 76/266 (28%), Positives = 120/266 (45%), Gaps = 22/266 (8%)
Query: 55  NKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCC 114
            +LG G FG V  G  +   ++A+K +   S     E   EA V+  + H+ LV+L G C
Sbjct: 15  KELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVC 73
Query: 115 IDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 174
             +    +I EYM N  L  +L +   R     +  +++ + + + + YL      + +H
Sbjct: 74  TKQRPIFIITEYMANGCLLNYLREMRHRFQTQQL--LEMCKDVCEAMEYLES---KQFLH 128
Query: 175 RDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKS 234
           RDL A N L++     K+SDFG++R    +E  ++         +  PE  +   FS KS
Sbjct: 129 RDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSRGSKFPV-RWSPPEVLMYSKFSSKS 187
Query: 235 DVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYSSKQML 294
           D+++FGVL+ EI S  K      T+S      A       + L L  P L  E       
Sbjct: 188 DIWAFGVLMWEIYSLGKMPYERFTNSETAEHIA-------QGLRLYRPHLASE------- 233
Query: 295 LRYANIALLCVQESADDRPTMNDVVS 320
            +   I   C  E AD+RPT   ++S
Sbjct: 234 -KVYTIMYSCWHEKADERPTFKILLS 258

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 66/202 (32%), Positives = 107/202 (52%), Gaps = 20/202 (9%)
Query: 57  LGEGGFGPVYKGVLKKGDE-----IAVKRL-SGRSGQGLREMKNEASVIAKVQHKNLVRL 110
           LG G FG VYKG+     E     +A+K L    S +  +E+ +EA V+A V    + RL
Sbjct: 25  LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVSRL 84
Query: 111 LGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRM----LLDWVTRVQIIEGIAQGLLYLHQ 166
           LG C+    + L+ + MP   L   + +   R+    LL+W  +      IA+G+ YL  
Sbjct: 85  LGICLTSTVQ-LVTQLMPYGCLLDHVRENRGRLGSQDLLNWCMQ------IAKGMSYLED 137
Query: 167 YSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAL 226
              VR++HRDL A N+L+    + KI+DFG+AR+   +E + +         +M+ E  L
Sbjct: 138 ---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESIL 194
Query: 227 EGIFSIKSDVFSFGVLLLEIVS 248
              F+ +SDV+S+GV + E+++
Sbjct: 195 RRRFTHQSDVWSYGVTVWELMT 216

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 90/334 (26%), Positives = 145/334 (43%), Gaps = 60/334 (17%)
Query: 36  FP--LFSFSSVSTATNKFSDANKLGEGGFGPVYKGVLK---KGD---EIAVKRLSGRSGQ 87
           FP  +F       +  K +   +LG+G FG VY+G  +   KG+    +AVK ++  +  
Sbjct: 2   FPSSVFVPDEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASL 61
Query: 88  GLR-EMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFD-------- 138
             R E  NEASV+      ++VRLLG        +++ E M +  L  +L          
Sbjct: 62  RERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENN 121
Query: 139 -----PTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKIS 193
                PT + +      +Q+   IA G+ YL+     + +HRDL A N ++  D   KI 
Sbjct: 122 PGRPPPTLQEM------IQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIG 172
Query: 194 DFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS--GKK 251
           DFGM R            + +    +M+PE   +G+F+  SD++SFGV+L EI S   + 
Sbjct: 173 DFGMTRDIYETAYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQP 232
Query: 252 NTGLYRTDSLNLL---GYAWDLWTSNRTLELIDPILEDEYSSKQMLLRYANIALLCVQES 308
             GL     L  +   GY          L+  D   E          R  ++  +C Q +
Sbjct: 233 YQGLSNEQVLKFVMDGGY----------LDQPDNCPE----------RVTDLMRMCWQFN 272
Query: 309 ADDRPTMNDVVSMLTNEAATLLPPKQPAFSYVRN 342
              RPT  ++V++L ++    L P  P  S+  +
Sbjct: 273 PKMRPTFLEIVNLLKDD----LHPSFPEVSFFHS 302

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 86/312 (27%), Positives = 139/312 (44%), Gaps = 58/312 (18%)
Query: 56  KLGEGGFGPVYKGVLK---KGD---EIAVKRLSGRSGQGLR-EMKNEASVIAKVQHKNLV 108
           +LG+G FG VY+G  +   KG+    +AVK ++  +    R E  NEASV+      ++V
Sbjct: 23  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 82
Query: 109 RLLGCCIDRDEKILIYEYMPNKSLDFFLFD-------------PTKRMLLDWVTRVQIIE 155
           RLLG        +++ E M +  L  +L               PT + +      +Q+  
Sbjct: 83  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEM------IQMAA 136
Query: 156 GIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVG 215
            IA G+ YL+     + +HRDL A N ++  D   KI DFGM R     +      + + 
Sbjct: 137 EIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLL 193
Query: 216 TYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS--GKKNTGLYRTDSLNLL---GYAWDL 270
              +M+PE   +G+F+  SD++SFGV+L EI S   +   GL     L  +   GY    
Sbjct: 194 PVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGY---- 249
Query: 271 WTSNRTLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNEAATLL 330
                 L+  D   E          R  ++  +C Q +   RPT  ++V++L ++    L
Sbjct: 250 ------LDQPDNCPE----------RVTDLMRMCWQFNPKMRPTFLEIVNLLKDD----L 289
Query: 331 PPKQPAFSYVRN 342
            P  P  S+  +
Sbjct: 290 HPSFPEVSFFHS 301

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 72/275 (26%), Positives = 127/275 (46%), Gaps = 37/275 (13%)
Query: 57  LGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCID 116
           +G G FG V K   +  D +A+K++   S +  +    E   +++V H N+V+L G C++
Sbjct: 17  VGRGAFGVVCKAKWRAKD-VAIKQIESESER--KAFIVELRQLSRVNHPNIVKLYGACLN 73
Query: 117 RDEKILIYEYMPNKSLDFFLF--DP----TKRMLLDWVTRVQIIEGIAQGLLYLHQYSRV 170
                L+ EY    SL   L   +P    T    + W  +       +QG+ YLH     
Sbjct: 74  --PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQC------SQGVAYLHSMQPK 125
Query: 171 RIIHRDLKASNILLDKDMNP-KISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGI 229
            +IHRDLK  N+LL       KI DFG A      ++Q + +   G+  +M+PE      
Sbjct: 126 ALIHRDLKPPNLLLVAGGTVLKICDFGTA-----CDIQTHMTNNKGSAAWMAPEVFEGSN 180
Query: 230 FSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYS 289
           +S K DVFS+G++L E+++ +K        +  ++   W +    R      P++++   
Sbjct: 181 YSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIM---WAVHNGTRP-----PLIKNLPK 232
Query: 290 SKQMLLRYANIALLCVQESADDRPTMNDVVSMLTN 324
             + L+        C  +    RP+M ++V ++T+
Sbjct: 233 PIESLM------TRCWSKDPSQRPSMEEIVKIMTH 261

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 85/312 (27%), Positives = 140/312 (44%), Gaps = 58/312 (18%)
Query: 56  KLGEGGFGPVYKGVLK---KGD---EIAVKRLSGRSGQGLR-EMKNEASVIAKVQHKNLV 108
           +LG+G FG VY+G  +   KG+    +AVK ++  +    R E  NEASV+      ++V
Sbjct: 24  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 83
Query: 109 RLLGCCIDRDEKILIYEYMPNKSLDFFLFD-------------PTKRMLLDWVTRVQIIE 155
           RLLG        +++ E M +  L  +L               PT + +      +Q+  
Sbjct: 84  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEM------IQMAA 137
Query: 156 GIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVG 215
            IA G+ YL+     + +HR+L A N ++  D   KI DFGM R     +      + + 
Sbjct: 138 EIADGMAYLNAK---KFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLL 194
Query: 216 TYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS--GKKNTGLYRTDSLNLL---GYAWDL 270
              +M+PE   +G+F+  SD++SFGV+L EI S   +   GL     L  +   GY    
Sbjct: 195 PVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGY---- 250
Query: 271 WTSNRTLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNEAATLL 330
                 L+  D   E          R  ++  +C Q + + RPT  ++V++L ++    L
Sbjct: 251 ------LDQPDNCPE----------RVTDLMRMCWQFNPNMRPTFLEIVNLLKDD----L 290
Query: 331 PPKQPAFSYVRN 342
            P  P  S+  +
Sbjct: 291 HPSFPEVSFFHS 302

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 85/312 (27%), Positives = 140/312 (44%), Gaps = 58/312 (18%)
Query: 56  KLGEGGFGPVYKGVLK---KGD---EIAVKRLSGRSGQGLR-EMKNEASVIAKVQHKNLV 108
           +LG+G FG VY+G  +   KG+    +AVK ++  +    R E  NEASV+      ++V
Sbjct: 25  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 84
Query: 109 RLLGCCIDRDEKILIYEYMPNKSLDFFLFD-------------PTKRMLLDWVTRVQIIE 155
           RLLG        +++ E M +  L  +L               PT + +      +Q+  
Sbjct: 85  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEM------IQMAA 138
Query: 156 GIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVG 215
            IA G+ YL+     + +HR+L A N ++  D   KI DFGM R     +      + + 
Sbjct: 139 EIADGMAYLNAK---KFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLL 195
Query: 216 TYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS--GKKNTGLYRTDSLNLL---GYAWDL 270
              +M+PE   +G+F+  SD++SFGV+L EI S   +   GL     L  +   GY    
Sbjct: 196 PVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGY---- 251
Query: 271 WTSNRTLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNEAATLL 330
                 L+  D   E          R  ++  +C Q + + RPT  ++V++L ++    L
Sbjct: 252 ------LDQPDNCPE----------RVTDLMRMCWQFNPNMRPTFLEIVNLLKDD----L 291
Query: 331 PPKQPAFSYVRN 342
            P  P  S+  +
Sbjct: 292 HPSFPEVSFFHS 303

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 72/275 (26%), Positives = 127/275 (46%), Gaps = 37/275 (13%)
Query: 57  LGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCID 116
           +G G FG V K   +  D +A+K++   S +  +    E   +++V H N+V+L G C++
Sbjct: 16  VGRGAFGVVCKAKWRAKD-VAIKQIESESER--KAFIVELRQLSRVNHPNIVKLYGACLN 72
Query: 117 RDEKILIYEYMPNKSLDFFLF--DP----TKRMLLDWVTRVQIIEGIAQGLLYLHQYSRV 170
                L+ EY    SL   L   +P    T    + W  +       +QG+ YLH     
Sbjct: 73  --PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQC------SQGVAYLHSMQPK 124
Query: 171 RIIHRDLKASNILLDKDMNP-KISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGI 229
            +IHRDLK  N+LL       KI DFG A      ++Q + +   G+  +M+PE      
Sbjct: 125 ALIHRDLKPPNLLLVAGGTVLKICDFGTA-----CDIQTHMTNNKGSAAWMAPEVFEGSN 179
Query: 230 FSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYS 289
           +S K DVFS+G++L E+++ +K        +  ++   W +    R      P++++   
Sbjct: 180 YSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIM---WAVHNGTRP-----PLIKNLPK 231
Query: 290 SKQMLLRYANIALLCVQESADDRPTMNDVVSMLTN 324
             + L+        C  +    RP+M ++V ++T+
Sbjct: 232 PIESLM------TRCWSKDPSQRPSMEEIVKIMTH 260

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 84.7 bits (208), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 72/294 (24%), Positives = 140/294 (47%), Gaps = 38/294 (12%)
Query: 45  STATNKFSDANKLGEGGFGPVYKGVLKKGDE-IAVKRLSGRSGQG-------LREMKNEA 96
           + A N+     ++G+GGFG V+KG L K    +A+K L     +G        +E + E 
Sbjct: 15  TLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREV 74
Query: 97  SVIAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEG 156
            +++ + H N+V+L G  +  +   ++ E++P   L   L D  K   + W  +++++  
Sbjct: 75  FIMSNLNHPNIVKLYG--LMHNPPRMVMEFVPCGDLYHRLLD--KAHPIKWSVKLRLMLD 130
Query: 157 IAQGLLYLHQYSRVRIIHRDLKASNILL-----DKDMNPKISDFGMARICGGNELQANTS 211
           IA G+ Y+ Q     I+HRDL++ NI L     +  +  K++DFG+++     +   + S
Sbjct: 131 IALGIEYM-QNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ-----QSVHSVS 184
Query: 212 RIVGTYGYMSPEY--ALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWD 269
            ++G + +M+PE   A E  ++ K+D +SF ++L  I++G+     Y    +  +    +
Sbjct: 185 GLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIRE 244
Query: 270 LWTSNRTLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLT 323
                   E + P + ++        R  N+  LC       RP  + +V  L+
Sbjct: 245 --------EGLRPTIPEDCPP-----RLRNVIELCWSGDPKKRPHFSYIVKELS 285

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 84.7 bits (208), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 71/273 (26%), Positives = 131/273 (47%), Gaps = 31/273 (11%)
Query: 51  FSDANKLGEGGFGPVYKGVLKKGDEI-AVKRLS-GRSGQGLREMKNEASVIAKVQHKNLV 108
           F+  +++G+G FG VYKG+     E+ A+K +    +   + +++ E +V+++     + 
Sbjct: 21  FTKLDRIGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 80
Query: 109 RLLGCCIDRDEKILIYEYMPNKS-LDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQY 167
           R  G  +   +  +I EY+   S LD     P +   +       I+  I +GL YLH  
Sbjct: 81  RYFGSYLKSTKLWIIMEYLGGGSALDLLKPGPLEETYI-----ATILREILKGLDYLHS- 134
Query: 168 SRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALE 227
              R IHRD+KA+N+LL +  + K++DFG+A      +++ N    VGT  +M+PE   +
Sbjct: 135 --ERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNX--FVGTPFWMAPEVIKQ 190
Query: 228 GIFSIKSDVFSFGVLLLEIVSGK-KNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILED 286
             +  K+D++S G+  +E+  G+  N+ L+    L L+         N       P LE 
Sbjct: 191 SAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLI-------PKNSP-----PTLEG 238
Query: 287 EYSSKQMLLRYANIALLCVQESADDRPTMNDVV 319
           ++S       +      C+ +    RPT  +++
Sbjct: 239 QHSKP-----FKEFVEACLNKDPRFRPTAKELL 266

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 84.7 bits (208), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 69/215 (32%), Positives = 105/215 (48%), Gaps = 32/215 (14%)
Query: 57  LGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLG---- 112
           +G G +G VYKG L +   +AVK  S  + Q     KN   V   ++H N+ R +     
Sbjct: 21  IGRGRYGAVYKGSLDE-RPVAVKVFSFANRQNFINEKNIYRV-PLMEHDNIARFIVGDER 78
Query: 113 -CCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLH------ 165
                R E +L+ EY PN SL  +L   T     DWV+  ++   + +GL YLH      
Sbjct: 79  VTADGRMEYLLVMEYYPNGSLXKYLSLHTS----DWVSSCRLAHSVTRGLAYLHTELPRG 134
Query: 166 QYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNEL----QANTSRI--VGTYGY 219
            + +  I HRDL + N+L+  D    ISDFG++    GN L    + + + I  VGT  Y
Sbjct: 135 DHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRY 194
Query: 220 MSPEYALEGIFSIKS--------DVFSFGVLLLEI 246
           M+PE  LEG  +++         D+++ G++  EI
Sbjct: 195 MAPE-VLEGAVNLRDXESALKQVDMYALGLIYWEI 228

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 84.3 bits (207), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 77/270 (28%), Positives = 121/270 (44%), Gaps = 30/270 (11%)
Query: 55  NKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCC 114
            +LG G FG V  G  K   ++AVK +   S     E   EA  + K+ H  LV+  G C
Sbjct: 14  KELGSGQFGVVKLGKWKGQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYGVC 72
Query: 115 IDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 174
                  ++ EY+ N  L  +L    K   L+    +++   + +G+ +L  +   + IH
Sbjct: 73  SKEYPIYIVTEYISNGCLLNYLRSHGKG--LEPSQLLEMCYDVCEGMAFLESH---QFIH 127
Query: 175 RDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT---YGYMSPEYALEGIFS 231
           RDL A N L+D+D+  K+SDFGM R    ++  ++    VGT     + +PE      +S
Sbjct: 128 RDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSS----VGTKFPVKWSAPEVFHYFKYS 183
Query: 232 IKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYSS 290
            KSDV++FG+L+ E+ S GK    LY    + L          ++   L  P L  +   
Sbjct: 184 SKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVL--------KVSQGHRLYRPHLASD--- 232
Query: 291 KQMLLRYANIALLCVQESADDRPTMNDVVS 320
                    I   C  E  + RPT   ++S
Sbjct: 233 -----TIYQIMYSCWHELPEKRPTFQQLLS 257

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 107/210 (50%), Gaps = 12/210 (5%)
Query: 43  SVSTATNKFSDANKLGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKNEASVIAK 101
           SV     K++   K+G+G  G VY  + +  G E+A+++++ +       + NE  V+ +
Sbjct: 15  SVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRE 74
Query: 102 VQHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGL 161
            ++ N+V  L   +  DE  ++ EY+   SL     D      +D      +     Q L
Sbjct: 75  NKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECLQAL 130
Query: 162 LYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGM-ARICGGNELQANTSRIVGTYGYM 220
            +LH     ++IHR++K+ NILL  D + K++DFG  A+I      Q+  S +VGT  +M
Sbjct: 131 EFLHSN---QVIHRNIKSDNILLGMDGSVKLTDFGFCAQITPE---QSKRSTMVGTPYWM 184
Query: 221 SPEYALEGIFSIKSDVFSFGVLLLEIVSGK 250
           +PE      +  K D++S G++ +E++ G+
Sbjct: 185 APEVVTRKAYGPKVDIWSLGIMAIEMIEGE 214

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 78/286 (27%), Positives = 132/286 (46%), Gaps = 36/286 (12%)
Query: 57  LGEGGFGPVYKGVLKKGD----EIAVKRLSGRSGQG-LREMKNEASVIAKVQHKNLVRLL 111
           +G G FG VY G L   D      AVK L+  +  G + +   E  ++    H N++ LL
Sbjct: 37  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 96
Query: 112 GCCIDRD-EKILIYEYMPNKSLDFFL----FDPTKRMLLDWVTRVQIIEGIAQGLLYLHQ 166
           G C+  +   +++  YM +  L  F+     +PT + L+ +  +V      A+G+ YL  
Sbjct: 97  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV------AKGMKYL-- 148
Query: 167 YSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQA--NTSRIVGTYGYMSPEY 224
            +  + +HRDL A N +LD+    K++DFG+AR     E  +  N +       +M+ E 
Sbjct: 149 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGAKLPVKWMALES 207
Query: 225 ALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPIL 284
                F+ KSDV+SFGVLL E+++     G      +N       L    R       +L
Sbjct: 208 LQTQKFTTKSDVWSFGVLLWELMT----RGAPPYPDVNTFDITVYLLQGRR-------LL 256
Query: 285 EDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNEAATLL 330
           + EY    +      + L C    A+ RP+ +++VS ++   +T +
Sbjct: 257 QPEYCPDPLY----EVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 298

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 111/209 (53%), Gaps = 19/209 (9%)
Query: 49  NKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRL------SGRSGQGLREMKNEASVIAKV 102
            K+    K+GEG +G VYK    +G  +A+KR+       G     +RE+    S++ ++
Sbjct: 21  EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREI----SLLKEL 76
Query: 103 QHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLL 162
            H N+V L+          L++E+M  K L   L D  K  L D   ++ + + + +G+ 
Sbjct: 77  HHPNIVSLIDVIHSERCLTLVFEFM-EKDLKKVL-DENKTGLQDSQIKIYLYQ-LLRGVA 133
Query: 163 YLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSP 222
           + HQ+   RI+HRDLK  N+L++ D   K++DFG+AR   G  +++ T  +V T  Y +P
Sbjct: 134 HCHQH---RILHRDLKPQNLLINSDGALKLADFGLAR-AFGIPVRSYTHEVV-TLWYRAP 188
Query: 223 EYAL-EGIFSIKSDVFSFGVLLLEIVSGK 250
           +  +    +S   D++S G +  E+++GK
Sbjct: 189 DVLMGSKKYSTSVDIWSIGCIFAEMITGK 217

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 111/209 (53%), Gaps = 19/209 (9%)
Query: 49  NKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRL------SGRSGQGLREMKNEASVIAKV 102
            K+    K+GEG +G VYK    +G  +A+KR+       G     +RE+    S++ ++
Sbjct: 21  EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREI----SLLKEL 76
Query: 103 QHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLL 162
            H N+V L+          L++E+M  K L   L D  K  L D   ++ + + + +G+ 
Sbjct: 77  HHPNIVSLIDVIHSERCLTLVFEFM-EKDLKKVL-DENKTGLQDSQIKIYLYQ-LLRGVA 133
Query: 163 YLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSP 222
           + HQ+   RI+HRDLK  N+L++ D   K++DFG+AR   G  +++ T  +V T  Y +P
Sbjct: 134 HCHQH---RILHRDLKPQNLLINSDGALKLADFGLAR-AFGIPVRSYTHEVV-TLWYRAP 188
Query: 223 EYAL-EGIFSIKSDVFSFGVLLLEIVSGK 250
           +  +    +S   D++S G +  E+++GK
Sbjct: 189 DVLMGSKKYSTSVDIWSIGCIFAEMITGK 217

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 78/286 (27%), Positives = 132/286 (46%), Gaps = 36/286 (12%)
Query: 57  LGEGGFGPVYKGVLKKGD----EIAVKRLSGRSGQG-LREMKNEASVIAKVQHKNLVRLL 111
           +G G FG VY G L   D      AVK L+  +  G + +   E  ++    H N++ LL
Sbjct: 33  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 92
Query: 112 GCCIDRD-EKILIYEYMPNKSLDFFL----FDPTKRMLLDWVTRVQIIEGIAQGLLYLHQ 166
           G C+  +   +++  YM +  L  F+     +PT + L+ +  +V      A+G+ YL  
Sbjct: 93  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV------AKGMKYL-- 144
Query: 167 YSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQA--NTSRIVGTYGYMSPEY 224
            +  + +HRDL A N +LD+    K++DFG+AR     E  +  N +       +M+ E 
Sbjct: 145 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES 203
Query: 225 ALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPIL 284
                F+ KSDV+SFGVLL E+++     G      +N       L    R       +L
Sbjct: 204 LQTQKFTTKSDVWSFGVLLWELMT----RGAPPYPDVNTFDITVYLLQGRR-------LL 252
Query: 285 EDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNEAATLL 330
           + EY    +      + L C    A+ RP+ +++VS ++   +T +
Sbjct: 253 QPEYCPDPLY----EVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 294

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 72/294 (24%), Positives = 139/294 (47%), Gaps = 38/294 (12%)
Query: 45  STATNKFSDANKLGEGGFGPVYKGVLKKGDE-IAVKRLSGRSGQG-------LREMKNEA 96
           + A N+     ++G+GGFG V+KG L K    +A+K L     +G        +E + E 
Sbjct: 15  TLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREV 74
Query: 97  SVIAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEG 156
            +++ + H N+V+L G  +  +   ++ E++P   L   L D  K   + W  +++++  
Sbjct: 75  FIMSNLNHPNIVKLYG--LMHNPPRMVMEFVPCGDLYHRLLD--KAHPIKWSVKLRLMLD 130
Query: 157 IAQGLLYLHQYSRVRIIHRDLKASNILL-----DKDMNPKISDFGMARICGGNELQANTS 211
           IA G+ Y+ Q     I+HRDL++ NI L     +  +  K++DFG ++     +   + S
Sbjct: 131 IALGIEYM-QNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQ-----QSVHSVS 184
Query: 212 RIVGTYGYMSPEY--ALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWD 269
            ++G + +M+PE   A E  ++ K+D +SF ++L  I++G+     Y    +  +    +
Sbjct: 185 GLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIRE 244
Query: 270 LWTSNRTLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLT 323
                   E + P + ++        R  N+  LC       RP  + +V  L+
Sbjct: 245 --------EGLRPTIPEDCPP-----RLRNVIELCWSGDPKKRPHFSYIVKELS 285

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 78/286 (27%), Positives = 132/286 (46%), Gaps = 36/286 (12%)
Query: 57  LGEGGFGPVYKGVLKKGD----EIAVKRLSGRSGQG-LREMKNEASVIAKVQHKNLVRLL 111
           +G G FG VY G L   D      AVK L+  +  G + +   E  ++    H N++ LL
Sbjct: 57  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 116
Query: 112 GCCIDRD-EKILIYEYMPNKSLDFFL----FDPTKRMLLDWVTRVQIIEGIAQGLLYLHQ 166
           G C+  +   +++  YM +  L  F+     +PT + L+ +  +V      A+G+ YL  
Sbjct: 117 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV------AKGMKYL-- 168
Query: 167 YSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQA--NTSRIVGTYGYMSPEY 224
            +  + +HRDL A N +LD+    K++DFG+AR     E  +  N +       +M+ E 
Sbjct: 169 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES 227
Query: 225 ALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPIL 284
                F+ KSDV+SFGVLL E+++     G      +N       L    R       +L
Sbjct: 228 LQTQKFTTKSDVWSFGVLLWELMT----RGAPPYPDVNTFDITVYLLQGRR-------LL 276
Query: 285 EDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNEAATLL 330
           + EY    +      + L C    A+ RP+ +++VS ++   +T +
Sbjct: 277 QPEYCPDPLY----EVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 318

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 78/286 (27%), Positives = 132/286 (46%), Gaps = 36/286 (12%)
Query: 57  LGEGGFGPVYKGVLKKGD----EIAVKRLSGRSGQG-LREMKNEASVIAKVQHKNLVRLL 111
           +G G FG VY G L   D      AVK L+  +  G + +   E  ++    H N++ LL
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 112 GCCIDRD-EKILIYEYMPNKSLDFFL----FDPTKRMLLDWVTRVQIIEGIAQGLLYLHQ 166
           G C+  +   +++  YM +  L  F+     +PT + L+ +  +V      A+G+ YL  
Sbjct: 98  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV------AKGMKYL-- 149
Query: 167 YSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQA--NTSRIVGTYGYMSPEY 224
            +  + +HRDL A N +LD+    K++DFG+AR     E  +  N +       +M+ E 
Sbjct: 150 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES 208
Query: 225 ALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPIL 284
                F+ KSDV+SFGVLL E+++     G      +N       L    R       +L
Sbjct: 209 LQTQKFTTKSDVWSFGVLLWELMT----RGAPPYPDVNTFDITVYLLQGRR-------LL 257
Query: 285 EDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNEAATLL 330
           + EY    +      + L C    A+ RP+ +++VS ++   +T +
Sbjct: 258 QPEYCPDPLY----EVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 299

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 78/286 (27%), Positives = 132/286 (46%), Gaps = 36/286 (12%)
Query: 57  LGEGGFGPVYKGVLKKGD----EIAVKRLSGRSGQG-LREMKNEASVIAKVQHKNLVRLL 111
           +G G FG VY G L   D      AVK L+  +  G + +   E  ++    H N++ LL
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 112 GCCIDRD-EKILIYEYMPNKSLDFFL----FDPTKRMLLDWVTRVQIIEGIAQGLLYLHQ 166
           G C+  +   +++  YM +  L  F+     +PT + L+ +  +V      A+G+ YL  
Sbjct: 98  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV------AKGMKYL-- 149
Query: 167 YSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQA--NTSRIVGTYGYMSPEY 224
            +  + +HRDL A N +LD+    K++DFG+AR     E  +  N +       +M+ E 
Sbjct: 150 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES 208
Query: 225 ALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPIL 284
                F+ KSDV+SFGVLL E+++     G      +N       L    R       +L
Sbjct: 209 LQTQKFTTKSDVWSFGVLLWELMT----RGAPPYPDVNTFDITVYLLQGRR-------LL 257
Query: 285 EDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNEAATLL 330
           + EY    +      + L C    A+ RP+ +++VS ++   +T +
Sbjct: 258 QPEYCPDPLY----EVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 299

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 78/286 (27%), Positives = 132/286 (46%), Gaps = 36/286 (12%)
Query: 57  LGEGGFGPVYKGVLKKGD----EIAVKRLSGRSGQG-LREMKNEASVIAKVQHKNLVRLL 111
           +G G FG VY G L   D      AVK L+  +  G + +   E  ++    H N++ LL
Sbjct: 36  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 95
Query: 112 GCCIDRD-EKILIYEYMPNKSLDFFL----FDPTKRMLLDWVTRVQIIEGIAQGLLYLHQ 166
           G C+  +   +++  YM +  L  F+     +PT + L+ +  +V      A+G+ YL  
Sbjct: 96  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV------AKGMKYL-- 147
Query: 167 YSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQA--NTSRIVGTYGYMSPEY 224
            +  + +HRDL A N +LD+    K++DFG+AR     E  +  N +       +M+ E 
Sbjct: 148 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES 206
Query: 225 ALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPIL 284
                F+ KSDV+SFGVLL E+++     G      +N       L    R       +L
Sbjct: 207 LQTQKFTTKSDVWSFGVLLWELMT----RGAPPYPDVNTFDITVYLLQGRR-------LL 255
Query: 285 EDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNEAATLL 330
           + EY    +      + L C    A+ RP+ +++VS ++   +T +
Sbjct: 256 QPEYCPDPLY----EVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 297

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 78/286 (27%), Positives = 132/286 (46%), Gaps = 36/286 (12%)
Query: 57  LGEGGFGPVYKGVLKKGD----EIAVKRLSGRSGQG-LREMKNEASVIAKVQHKNLVRLL 111
           +G G FG VY G L   D      AVK L+  +  G + +   E  ++    H N++ LL
Sbjct: 37  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 96
Query: 112 GCCIDRD-EKILIYEYMPNKSLDFFL----FDPTKRMLLDWVTRVQIIEGIAQGLLYLHQ 166
           G C+  +   +++  YM +  L  F+     +PT + L+ +  +V      A+G+ YL  
Sbjct: 97  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV------AKGMKYL-- 148
Query: 167 YSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQA--NTSRIVGTYGYMSPEY 224
            +  + +HRDL A N +LD+    K++DFG+AR     E  +  N +       +M+ E 
Sbjct: 149 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES 207
Query: 225 ALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPIL 284
                F+ KSDV+SFGVLL E+++     G      +N       L    R       +L
Sbjct: 208 LQTQKFTTKSDVWSFGVLLWELMT----RGAPPYPDVNTFDITVYLLQGRR-------LL 256
Query: 285 EDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNEAATLL 330
           + EY    +      + L C    A+ RP+ +++VS ++   +T +
Sbjct: 257 QPEYCPDPLY----EVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 298

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 78/286 (27%), Positives = 132/286 (46%), Gaps = 36/286 (12%)
Query: 57  LGEGGFGPVYKGVLKKGD----EIAVKRLSGRSGQG-LREMKNEASVIAKVQHKNLVRLL 111
           +G G FG VY G L   D      AVK L+  +  G + +   E  ++    H N++ LL
Sbjct: 35  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 94
Query: 112 GCCIDRD-EKILIYEYMPNKSLDFFL----FDPTKRMLLDWVTRVQIIEGIAQGLLYLHQ 166
           G C+  +   +++  YM +  L  F+     +PT + L+ +  +V      A+G+ YL  
Sbjct: 95  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV------AKGMKYL-- 146
Query: 167 YSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQA--NTSRIVGTYGYMSPEY 224
            +  + +HRDL A N +LD+    K++DFG+AR     E  +  N +       +M+ E 
Sbjct: 147 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES 205
Query: 225 ALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPIL 284
                F+ KSDV+SFGVLL E+++     G      +N       L    R       +L
Sbjct: 206 LQTQKFTTKSDVWSFGVLLWELMT----RGAPPYPDVNTFDITVYLLQGRR-------LL 254
Query: 285 EDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNEAATLL 330
           + EY    +      + L C    A+ RP+ +++VS ++   +T +
Sbjct: 255 QPEYCPDPLY----EVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 296

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 78/286 (27%), Positives = 132/286 (46%), Gaps = 36/286 (12%)
Query: 57  LGEGGFGPVYKGVLKKGD----EIAVKRLSGRSGQG-LREMKNEASVIAKVQHKNLVRLL 111
           +G G FG VY G L   D      AVK L+  +  G + +   E  ++    H N++ LL
Sbjct: 30  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 89
Query: 112 GCCIDRD-EKILIYEYMPNKSLDFFL----FDPTKRMLLDWVTRVQIIEGIAQGLLYLHQ 166
           G C+  +   +++  YM +  L  F+     +PT + L+ +  +V      A+G+ YL  
Sbjct: 90  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV------AKGMKYL-- 141
Query: 167 YSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQA--NTSRIVGTYGYMSPEY 224
            +  + +HRDL A N +LD+    K++DFG+AR     E  +  N +       +M+ E 
Sbjct: 142 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES 200
Query: 225 ALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPIL 284
                F+ KSDV+SFGVLL E+++     G      +N       L    R       +L
Sbjct: 201 LQTQKFTTKSDVWSFGVLLWELMT----RGAPPYPDVNTFDITVYLLQGRR-------LL 249
Query: 285 EDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNEAATLL 330
           + EY    +      + L C    A+ RP+ +++VS ++   +T +
Sbjct: 250 QPEYCPDPLY----EVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 291

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 78/286 (27%), Positives = 132/286 (46%), Gaps = 36/286 (12%)
Query: 57  LGEGGFGPVYKGVLKKGD----EIAVKRLSGRSGQG-LREMKNEASVIAKVQHKNLVRLL 111
           +G G FG VY G L   D      AVK L+  +  G + +   E  ++    H N++ LL
Sbjct: 56  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 115
Query: 112 GCCIDRD-EKILIYEYMPNKSLDFFL----FDPTKRMLLDWVTRVQIIEGIAQGLLYLHQ 166
           G C+  +   +++  YM +  L  F+     +PT + L+ +  +V      A+G+ YL  
Sbjct: 116 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV------AKGMKYL-- 167
Query: 167 YSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQA--NTSRIVGTYGYMSPEY 224
            +  + +HRDL A N +LD+    K++DFG+AR     E  +  N +       +M+ E 
Sbjct: 168 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES 226
Query: 225 ALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPIL 284
                F+ KSDV+SFGVLL E+++     G      +N       L    R       +L
Sbjct: 227 LQTQKFTTKSDVWSFGVLLWELMT----RGAPPYPDVNTFDITVYLLQGRR-------LL 275
Query: 285 EDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNEAATLL 330
           + EY    +      + L C    A+ RP+ +++VS ++   +T +
Sbjct: 276 QPEYCPDPLY----EVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 317

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/197 (31%), Positives = 96/197 (48%), Gaps = 7/197 (3%)
Query: 54  ANKLGEGGFGPVYKGVLKKGDE-IAVKRLSGRSGQGLR-EMKNEASVIAKVQHKNLVRLL 111
             ++G G FG V+ G L+  +  +AVK         L+ +   EA ++ +  H N+VRL+
Sbjct: 119 GEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLI 178
Query: 112 GCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVR 171
           G C  +    ++ E +  +  DF  F  T+   L   T +Q++   A G+ YL       
Sbjct: 179 GVCTQKQPIYIVMELV--QGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKC--- 233
Query: 172 IIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFS 231
            IHRDL A N L+ +    KISDFGM+R        A+         + +PE    G +S
Sbjct: 234 CIHRDLAARNCLVTEKNVLKISDFGMSREEADGVXAASGGLRQVPVKWTAPEALNYGRYS 293
Query: 232 IKSDVFSFGVLLLEIVS 248
            +SDV+SFG+LL E  S
Sbjct: 294 SESDVWSFGILLWETFS 310

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 77/286 (26%), Positives = 132/286 (46%), Gaps = 36/286 (12%)
Query: 57  LGEGGFGPVYKGVLKKGD----EIAVKRLSGRSGQG-LREMKNEASVIAKVQHKNLVRLL 111
           +G G FG VY G L   D      AVK L+  +  G + +   E  ++    H N++ LL
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 112 GCCIDRD-EKILIYEYMPNKSLDFFL----FDPTKRMLLDWVTRVQIIEGIAQGLLYLHQ 166
           G C+  +   +++  YM +  L  F+     +PT + L+ +  +V      A+G+ +L  
Sbjct: 98  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV------AKGMKFL-- 149
Query: 167 YSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQA--NTSRIVGTYGYMSPEY 224
            +  + +HRDL A N +LD+    K++DFG+AR     E  +  N +       +M+ E 
Sbjct: 150 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES 208
Query: 225 ALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPIL 284
                F+ KSDV+SFGVLL E+++     G      +N       L    R       +L
Sbjct: 209 LQTQKFTTKSDVWSFGVLLWELMT----RGAPPYPDVNTFDITVYLLQGRR-------LL 257
Query: 285 EDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNEAATLL 330
           + EY    +      + L C    A+ RP+ +++VS ++   +T +
Sbjct: 258 QPEYCPDPLY----EVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 299

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/197 (31%), Positives = 96/197 (48%), Gaps = 7/197 (3%)
Query: 54  ANKLGEGGFGPVYKGVLKKGDE-IAVKRLSGRSGQGLR-EMKNEASVIAKVQHKNLVRLL 111
             ++G G FG V+ G L+  +  +AVK         L+ +   EA ++ +  H N+VRL+
Sbjct: 119 GEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLI 178
Query: 112 GCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVR 171
           G C  +    ++ E +  +  DF  F  T+   L   T +Q++   A G+ YL       
Sbjct: 179 GVCTQKQPIYIVMELV--QGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKC--- 233
Query: 172 IIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFS 231
            IHRDL A N L+ +    KISDFGM+R        A+         + +PE    G +S
Sbjct: 234 CIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYS 293
Query: 232 IKSDVFSFGVLLLEIVS 248
            +SDV+SFG+LL E  S
Sbjct: 294 SESDVWSFGILLWETFS 310

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 77/286 (26%), Positives = 132/286 (46%), Gaps = 36/286 (12%)
Query: 57  LGEGGFGPVYKGVLKKGD----EIAVKRLSGRSGQG-LREMKNEASVIAKVQHKNLVRLL 111
           +G G FG VY G L   D      AVK L+  +  G + +   E  ++    H N++ LL
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 112 GCCIDRD-EKILIYEYMPNKSLDFFL----FDPTKRMLLDWVTRVQIIEGIAQGLLYLHQ 166
           G C+  +   +++  YM +  L  F+     +PT + L+ +  +V      A+G+ +L  
Sbjct: 98  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV------AKGMKFL-- 149
Query: 167 YSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQA--NTSRIVGTYGYMSPEY 224
            +  + +HRDL A N +LD+    K++DFG+AR     E  +  N +       +M+ E 
Sbjct: 150 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES 208
Query: 225 ALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPIL 284
                F+ KSDV+SFGVLL E+++     G      +N       L    R       +L
Sbjct: 209 LQTQKFTTKSDVWSFGVLLWELMT----RGAPPYPDVNTFDITVYLLQGRR-------LL 257
Query: 285 EDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNEAATLL 330
           + EY    +      + L C    A+ RP+ +++VS ++   +T +
Sbjct: 258 QPEYCPDPLY----EVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 299

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 77/286 (26%), Positives = 132/286 (46%), Gaps = 36/286 (12%)
Query: 57  LGEGGFGPVYKGVLKKGD----EIAVKRLSGRSGQG-LREMKNEASVIAKVQHKNLVRLL 111
           +G G FG VY G L   D      AVK L+  +  G + +   E  ++    H N++ LL
Sbjct: 36  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 95
Query: 112 GCCIDRD-EKILIYEYMPNKSLDFFL----FDPTKRMLLDWVTRVQIIEGIAQGLLYLHQ 166
           G C+  +   +++  YM +  L  F+     +PT + L+ +  +V      A+G+ +L  
Sbjct: 96  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV------AKGMKFL-- 147
Query: 167 YSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQA--NTSRIVGTYGYMSPEY 224
            +  + +HRDL A N +LD+    K++DFG+AR     E  +  N +       +M+ E 
Sbjct: 148 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES 206
Query: 225 ALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPIL 284
                F+ KSDV+SFGVLL E+++     G      +N       L    R       +L
Sbjct: 207 LQTQKFTTKSDVWSFGVLLWELMT----RGAPPYPDVNTFDITVYLLQGRR-------LL 255
Query: 285 EDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNEAATLL 330
           + EY    +      + L C    A+ RP+ +++VS ++   +T +
Sbjct: 256 QPEYCPDPLY----EVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 297

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 70/237 (29%), Positives = 122/237 (51%), Gaps = 24/237 (10%)
Query: 47  ATNKFSDANKLGEGGFGPVYKGV-LKKGDE-IAVKRL---SGRSGQGLREMKNEASV--I 99
           A  ++    ++GEG +G V+K   LK G   +A+KR+   +G  G  L  ++  A +  +
Sbjct: 9   ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 68
Query: 100 AKVQHKNLVRLLGCCI----DRDEKI-LIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQII 154
              +H N+VRL   C     DR+ K+ L++E++ ++ L  +L D      +   T   ++
Sbjct: 69  ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYL-DKVPEPGVPTETIKDMM 126
Query: 155 EGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIV 214
             + +GL +LH +   R++HRDLK  NIL+      K++DFG+ARI      Q   + +V
Sbjct: 127 FQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARI---YSFQMALTSVV 180
Query: 215 GTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDS-LNLLGYAWDL 270
            T  Y +PE  L+  ++   D++S G +  E+   K    L+R  S ++ LG   D+
Sbjct: 181 VTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKP---LFRGSSDVDQLGKILDV 234

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 77/286 (26%), Positives = 132/286 (46%), Gaps = 36/286 (12%)
Query: 57  LGEGGFGPVYKGVLKKGD----EIAVKRLSGRSGQG-LREMKNEASVIAKVQHKNLVRLL 111
           +G G FG VY G L   D      AVK L+  +  G + +   E  ++    H N++ LL
Sbjct: 97  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 156
Query: 112 GCCIDRD-EKILIYEYMPNKSLDFFL----FDPTKRMLLDWVTRVQIIEGIAQGLLYLHQ 166
           G C+  +   +++  YM +  L  F+     +PT + L+ +  +V      A+G+ +L  
Sbjct: 157 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV------AKGMKFL-- 208
Query: 167 YSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQA--NTSRIVGTYGYMSPEY 224
            +  + +HRDL A N +LD+    K++DFG+AR     E  +  N +       +M+ E 
Sbjct: 209 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES 267
Query: 225 ALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPIL 284
                F+ KSDV+SFGVLL E+++     G      +N       L    R       +L
Sbjct: 268 LQTQKFTTKSDVWSFGVLLWELMT----RGAPPYPDVNTFDITVYLLQGRR-------LL 316
Query: 285 EDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNEAATLL 330
           + EY    +      + L C    A+ RP+ +++VS ++   +T +
Sbjct: 317 QPEYCPDPLY----EVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 358

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 77/286 (26%), Positives = 132/286 (46%), Gaps = 36/286 (12%)
Query: 57  LGEGGFGPVYKGVLKKGD----EIAVKRLSGRSGQG-LREMKNEASVIAKVQHKNLVRLL 111
           +G G FG VY G L   D      AVK L+  +  G + +   E  ++    H N++ LL
Sbjct: 43  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 102
Query: 112 GCCIDRD-EKILIYEYMPNKSLDFFL----FDPTKRMLLDWVTRVQIIEGIAQGLLYLHQ 166
           G C+  +   +++  YM +  L  F+     +PT + L+ +  +V      A+G+ +L  
Sbjct: 103 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV------AKGMKFL-- 154
Query: 167 YSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQA--NTSRIVGTYGYMSPEY 224
            +  + +HRDL A N +LD+    K++DFG+AR     E  +  N +       +M+ E 
Sbjct: 155 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES 213
Query: 225 ALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPIL 284
                F+ KSDV+SFGVLL E+++     G      +N       L    R       +L
Sbjct: 214 LQTQKFTTKSDVWSFGVLLWELMT----RGAPPYPDVNTFDITVYLLQGRR-------LL 262
Query: 285 EDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNEAATLL 330
           + EY    +      + L C    A+ RP+ +++VS ++   +T +
Sbjct: 263 QPEYCPDPLY----EVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 304

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 77/286 (26%), Positives = 132/286 (46%), Gaps = 36/286 (12%)
Query: 57  LGEGGFGPVYKGVLKKGD----EIAVKRLSGRSGQG-LREMKNEASVIAKVQHKNLVRLL 111
           +G G FG VY G L   D      AVK L+  +  G + +   E  ++    H N++ LL
Sbjct: 39  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 98
Query: 112 GCCIDRD-EKILIYEYMPNKSLDFFL----FDPTKRMLLDWVTRVQIIEGIAQGLLYLHQ 166
           G C+  +   +++  YM +  L  F+     +PT + L+ +  +V      A+G+ +L  
Sbjct: 99  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV------AKGMKFL-- 150
Query: 167 YSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQA--NTSRIVGTYGYMSPEY 224
            +  + +HRDL A N +LD+    K++DFG+AR     E  +  N +       +M+ E 
Sbjct: 151 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES 209
Query: 225 ALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPIL 284
                F+ KSDV+SFGVLL E+++     G      +N       L    R       +L
Sbjct: 210 LQTQKFTTKSDVWSFGVLLWELMT----RGAPPYPDVNTFDITVYLLQGRR-------LL 258
Query: 285 EDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNEAATLL 330
           + EY    +      + L C    A+ RP+ +++VS ++   +T +
Sbjct: 259 QPEYCPDPLY----EVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 300

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 63/195 (32%), Positives = 107/195 (54%), Gaps = 17/195 (8%)
Query: 57  LGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCID 116
           +G+G FG V  G  + G+++AVK +  ++    +    EASV+ +++H NLV+LLG  ++
Sbjct: 20  IGKGEFGDVMLGDYR-GNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 76
Query: 117 RDEKI-LIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHR 175
               + ++ EYM   SL  +L     R +L     ++    + + + YL   +    +HR
Sbjct: 77  EKGGLYIVTEYMAKGSLVDYL-RSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHR 132
Query: 176 DLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVG--TYGYMSPEYALEGIFSIK 233
           DL A N+L+ +D   K+SDFG+ +       +A++++  G     + +PE   E  FS K
Sbjct: 133 DLAARNVLVSEDNVAKVSDFGLTK-------EASSTQDTGKLPVKWTAPEALREAAFSTK 185
Query: 234 SDVFSFGVLLLEIVS 248
           SDV+SFG+LL EI S
Sbjct: 186 SDVWSFGILLWEIYS 200

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 77/286 (26%), Positives = 132/286 (46%), Gaps = 36/286 (12%)
Query: 57  LGEGGFGPVYKGVLKKGD----EIAVKRLSGRSGQG-LREMKNEASVIAKVQHKNLVRLL 111
           +G G FG VY G L   D      AVK L+  +  G + +   E  ++    H N++ LL
Sbjct: 39  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 98
Query: 112 GCCIDRD-EKILIYEYMPNKSLDFFL----FDPTKRMLLDWVTRVQIIEGIAQGLLYLHQ 166
           G C+  +   +++  YM +  L  F+     +PT + L+ +  +V      A+G+ +L  
Sbjct: 99  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV------AKGMKFL-- 150
Query: 167 YSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQA--NTSRIVGTYGYMSPEY 224
            +  + +HRDL A N +LD+    K++DFG+AR     E  +  N +       +M+ E 
Sbjct: 151 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGAKLPVKWMALES 209
Query: 225 ALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPIL 284
                F+ KSDV+SFGVLL E+++     G      +N       L    R       +L
Sbjct: 210 LQTQKFTTKSDVWSFGVLLWELMT----RGAPPYPDVNTFDITVYLLQGRR-------LL 258
Query: 285 EDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNEAATLL 330
           + EY    +      + L C    A+ RP+ +++VS ++   +T +
Sbjct: 259 QPEYCPDPLY----EVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 300

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 70/237 (29%), Positives = 122/237 (51%), Gaps = 24/237 (10%)
Query: 47  ATNKFSDANKLGEGGFGPVYKGV-LKKGDE-IAVKRL---SGRSGQGLREMKNEASV--I 99
           A  ++    ++GEG +G V+K   LK G   +A+KR+   +G  G  L  ++  A +  +
Sbjct: 9   ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 68
Query: 100 AKVQHKNLVRLLGCCI----DRDEKI-LIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQII 154
              +H N+VRL   C     DR+ K+ L++E++ ++ L  +L D      +   T   ++
Sbjct: 69  ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYL-DKVPEPGVPTETIKDMM 126
Query: 155 EGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIV 214
             + +GL +LH +   R++HRDLK  NIL+      K++DFG+ARI      Q   + +V
Sbjct: 127 FQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARI---YSFQMALTSVV 180
Query: 215 GTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDS-LNLLGYAWDL 270
            T  Y +PE  L+  ++   D++S G +  E+   K    L+R  S ++ LG   D+
Sbjct: 181 VTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKP---LFRGSSDVDQLGKILDV 234

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 70/237 (29%), Positives = 122/237 (51%), Gaps = 24/237 (10%)
Query: 47  ATNKFSDANKLGEGGFGPVYKGV-LKKGDE-IAVKRL---SGRSGQGLREMKNEASV--I 99
           A  ++    ++GEG +G V+K   LK G   +A+KR+   +G  G  L  ++  A +  +
Sbjct: 9   ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 68
Query: 100 AKVQHKNLVRLLGCCI----DRDEKI-LIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQII 154
              +H N+VRL   C     DR+ K+ L++E++ ++ L  +L D      +   T   ++
Sbjct: 69  ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYL-DKVPEPGVPTETIKDMM 126
Query: 155 EGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIV 214
             + +GL +LH +   R++HRDLK  NIL+      K++DFG+ARI      Q   + +V
Sbjct: 127 FQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARI---YSFQMALTSVV 180
Query: 215 GTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDS-LNLLGYAWDL 270
            T  Y +PE  L+  ++   D++S G +  E+   K    L+R  S ++ LG   D+
Sbjct: 181 VTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKP---LFRGSSDVDQLGKILDV 234

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 69/210 (32%), Positives = 98/210 (46%), Gaps = 24/210 (11%)
Query: 51  FSDANKLGEGGFGPVYKG-VLKKGDEIAVKRLSGRSGQGLREMK-----NEASVIAKVQH 104
           F     LGEG F  V     L    E A+K L  R    ++E K      E  V++++ H
Sbjct: 39  FKFGKILGEGSFSTVVLARELATSREYAIKILEKR--HIIKENKVPYVTRERDVMSRLDH 96
Query: 105 KNLVRLLGCCIDRDEKILIYEYMPNKSLDFFL-----FDPTKRMLLDWVTRVQIIEGIAQ 159
              V+L  C  D ++      Y  N  L  ++     FD T        TR    E I  
Sbjct: 97  PFFVKLYFCFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET-------CTRFYTAE-IVS 148
Query: 160 GLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGY 219
            L YLH      IIHRDLK  NILL++DM+ +I+DFG A++      QA  +  VGT  Y
Sbjct: 149 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 205
Query: 220 MSPEYALEGIFSIKSDVFSFGVLLLEIVSG 249
           +SPE   E      SD+++ G ++ ++V+G
Sbjct: 206 VSPELLTEKSACKSSDLWALGCIIYQLVAG 235

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 71/294 (24%), Positives = 139/294 (47%), Gaps = 38/294 (12%)
Query: 45  STATNKFSDANKLGEGGFGPVYKGVLKKGDE-IAVKRLSGRSGQG-------LREMKNEA 96
           + A N+     ++G+GGFG V+KG L K    +A+K L     +G        +E + E 
Sbjct: 15  TLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREV 74
Query: 97  SVIAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEG 156
            +++ + H N+V+L G  +  +   ++ E++P   L   L D  K   + W  +++++  
Sbjct: 75  FIMSNLNHPNIVKLYG--LMHNPPRMVMEFVPCGDLYHRLLD--KAHPIKWSVKLRLMLD 130
Query: 157 IAQGLLYLHQYSRVRIIHRDLKASNILL-----DKDMNPKISDFGMARICGGNELQANTS 211
           IA G+ Y+ Q     I+HRDL++ NI L     +  +  K++DF +++     +   + S
Sbjct: 131 IALGIEYM-QNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQ-----QSVHSVS 184
Query: 212 RIVGTYGYMSPEY--ALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWD 269
            ++G + +M+PE   A E  ++ K+D +SF ++L  I++G+     Y    +  +    +
Sbjct: 185 GLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIRE 244
Query: 270 LWTSNRTLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLT 323
                   E + P + ++        R  N+  LC       RP  + +V  L+
Sbjct: 245 --------EGLRPTIPEDCPP-----RLRNVIELCWSGDPKKRPHFSYIVKELS 285

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 63/195 (32%), Positives = 107/195 (54%), Gaps = 17/195 (8%)
Query: 57  LGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCID 116
           +G+G FG V  G  + G+++AVK +  ++    +    EASV+ +++H NLV+LLG  ++
Sbjct: 201 IGKGEFGDVMLGDYR-GNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 257
Query: 117 RDEKI-LIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHR 175
               + ++ EYM   SL  +L     R +L     ++    + + + YL   +    +HR
Sbjct: 258 EKGGLYIVTEYMAKGSLVDYL-RSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHR 313
Query: 176 DLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVG--TYGYMSPEYALEGIFSIK 233
           DL A N+L+ +D   K+SDFG+ +       +A++++  G     + +PE   E  FS K
Sbjct: 314 DLAARNVLVSEDNVAKVSDFGLTK-------EASSTQDTGKLPVKWTAPEALREKKFSTK 366
Query: 234 SDVFSFGVLLLEIVS 248
           SDV+SFG+LL EI S
Sbjct: 367 SDVWSFGILLWEIYS 381

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 63/195 (32%), Positives = 107/195 (54%), Gaps = 17/195 (8%)
Query: 57  LGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCID 116
           +G+G FG V  G  + G+++AVK +  ++    +    EASV+ +++H NLV+LLG  ++
Sbjct: 14  IGKGEFGDVMLGDYR-GNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 70
Query: 117 RDEKI-LIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHR 175
               + ++ EYM   SL  +L     R +L     ++    + + + YL   +    +HR
Sbjct: 71  EKGGLYIVTEYMAKGSLVDYL-RSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHR 126
Query: 176 DLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT--YGYMSPEYALEGIFSIK 233
           DL A N+L+ +D   K+SDFG+ +       +A++++  G     + +PE   E  FS K
Sbjct: 127 DLAARNVLVSEDNVAKVSDFGLTK-------EASSTQDTGKLPVKWTAPEALREKKFSTK 179
Query: 234 SDVFSFGVLLLEIVS 248
           SDV+SFG+LL EI S
Sbjct: 180 SDVWSFGILLWEIYS 194

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 63/195 (32%), Positives = 107/195 (54%), Gaps = 17/195 (8%)
Query: 57  LGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCID 116
           +G+G FG V  G  + G+++AVK +  ++    +    EASV+ +++H NLV+LLG  ++
Sbjct: 29  IGKGEFGDVMLGDYR-GNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 85
Query: 117 RDEKI-LIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHR 175
               + ++ EYM   SL  +L     R +L     ++    + + + YL   +    +HR
Sbjct: 86  EKGGLYIVTEYMAKGSLVDYL-RSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHR 141
Query: 176 DLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT--YGYMSPEYALEGIFSIK 233
           DL A N+L+ +D   K+SDFG+ +       +A++++  G     + +PE   E  FS K
Sbjct: 142 DLAARNVLVSEDNVAKVSDFGLTK-------EASSTQDTGKLPVKWTAPEALREKKFSTK 194
Query: 234 SDVFSFGVLLLEIVS 248
           SDV+SFG+LL EI S
Sbjct: 195 SDVWSFGILLWEIYS 209

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 81.3 bits (199), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 107/203 (52%), Gaps = 13/203 (6%)
Query: 51  FSDANKLGEGGFGPVYKGVLKKGDEI-AVKRLS-GRSGQGLREMKNEASVIAKVQHKNLV 108
           F+   K+G+G FG V+KG+  +  ++ A+K +    +   + +++ E +V+++     + 
Sbjct: 9   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 68
Query: 109 RLLGCCIDRDEKILIYEYMPNKS-LDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQY 167
           +  G  +   +  +I EY+   S LD     P     LD      I+  I +GL YLH  
Sbjct: 69  KYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP-----LDETQIATILREILKGLDYLHSE 123
Query: 168 SRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALE 227
            +   IHRD+KA+N+LL +    K++DFG+A      +++ NT   VGT  +M+PE   +
Sbjct: 124 KK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVIKQ 178
Query: 228 GIFSIKSDVFSFGVLLLEIVSGK 250
             +  K+D++S G+  +E+  G+
Sbjct: 179 SAYDSKADIWSLGITAIELARGE 201

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 81.3 bits (199), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 83/298 (27%), Positives = 128/298 (42%), Gaps = 42/298 (14%)
Query: 49  NKFSDANKLGEGGFGPVYKGV---LKKGD---EIAVKRLSGRSGQGLRE-MKNEASVIAK 101
           N       LG G FG V +     L K D   ++AVK L   +    +E + +E  +++ 
Sbjct: 38  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 97
Query: 102 V-QHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFL-------FDPTKRMLLDWVTRVQI 153
           + QH+N+V LLG C      ++I EY     L  FL        D      L+    +  
Sbjct: 98  LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHF 157
Query: 154 IEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMAR--ICGGNELQANTS 211
              +AQG+ +L   +    IHRD+ A N+LL      KI DFG+AR  +   N +    +
Sbjct: 158 SSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNA 214
Query: 212 RIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLW 271
           R+     +M+PE   + +++++SDV+S+G+LL EI             SL L  Y   L 
Sbjct: 215 RL--PVKWMAPESIFDCVYTVQSDVWSYGILLWEIF------------SLGLNPYPGILV 260
Query: 272 TSNRTLELIDPILEDEYSSKQMLLRYANIALL---CVQESADDRPTMNDVVSMLTNEA 326
            S         +++D Y   Q      NI  +   C       RPT   + S L  +A
Sbjct: 261 NSK-----FYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQA 313

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 107/203 (52%), Gaps = 13/203 (6%)
Query: 51  FSDANKLGEGGFGPVYKGVLKKGDEI-AVKRLS-GRSGQGLREMKNEASVIAKVQHKNLV 108
           F+   K+G+G FG V+KG+  +  ++ A+K +    +   + +++ E +V+++     + 
Sbjct: 29  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 88
Query: 109 RLLGCCIDRDEKILIYEYMPNKS-LDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQY 167
           +  G  +   +  +I EY+   S LD     P     LD      I+  I +GL YLH  
Sbjct: 89  KYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP-----LDETQIATILREILKGLDYLHSE 143
Query: 168 SRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALE 227
            +   IHRD+KA+N+LL +    K++DFG+A      +++ NT   VGT  +M+PE   +
Sbjct: 144 KK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVIKQ 198
Query: 228 GIFSIKSDVFSFGVLLLEIVSGK 250
             +  K+D++S G+  +E+  G+
Sbjct: 199 SAYDSKADIWSLGITAIELARGE 221

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 69/242 (28%), Positives = 116/242 (47%), Gaps = 35/242 (14%)
Query: 32  EVDQFPLFSFSSVSTATNKFSDANKLGEGGFGPVY--------KGVLKKGDEIAVKRLSG 83
           E+ + P + F       +K +    LGEG FG V         K   K+   +AVK L  
Sbjct: 23  ELPEDPKWEFPR-----DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKD 77
Query: 84  RSGQ-GLREMKNEASVIAKV-QHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFL----- 136
            + +  L ++ +E  ++  + +HKN++ LLG C       +I EY    +L  +L     
Sbjct: 78  DATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRP 137
Query: 137 ------FD----PTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDK 186
                 +D    P ++M       V     +A+G+ YL   +  + IHRDL A N+L+ +
Sbjct: 138 PGMEYSYDINRVPEEQMTFK--DLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTE 192
Query: 187 DMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEI 246
           +   KI+DFG+AR     +   NT+       +M+PE   + +++ +SDV+SFGVL+ EI
Sbjct: 193 NNVMKIADFGLARDINNIDYYKNTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 252
Query: 247 VS 248
            +
Sbjct: 253 FT 254

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 66/215 (30%), Positives = 107/215 (49%), Gaps = 26/215 (12%)
Query: 57  LGEGGFGPVY--------KGVLKKGDEIAVKRL-SGRSGQGLREMKNEASVIAKV-QHKN 106
           LGEG FG V         K    +  ++AVK L S  + + L ++ +E  ++  + +HKN
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 107 LVRLLGCCIDRDEKILIYEYMPNKSLDFFL-----------FDPTKRMLLDWVTR--VQI 153
           ++ LLG C       +I EY    +L  +L           F+P+        ++  V  
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQLSSKDLVSC 155
Query: 154 IEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRI 213
              +A+G+ YL   +  + IHRDL A N+L+ +D   KI+DFG+AR     +    T+  
Sbjct: 156 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDXXKKTTNG 212
Query: 214 VGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 248
                +M+PE   + I++ +SDV+SFGVLL EI +
Sbjct: 213 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 83/298 (27%), Positives = 128/298 (42%), Gaps = 42/298 (14%)
Query: 49  NKFSDANKLGEGGFGPVYKGV---LKKGD---EIAVKRLSGRSGQGLRE-MKNEASVIAK 101
           N       LG G FG V +     L K D   ++AVK L   +    +E + +E  +++ 
Sbjct: 46  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105
Query: 102 V-QHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFL-------FDPTKRMLLDWVTRVQI 153
           + QH+N+V LLG C      ++I EY     L  FL        D      L+    +  
Sbjct: 106 LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHF 165
Query: 154 IEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMAR--ICGGNELQANTS 211
              +AQG+ +L   +    IHRD+ A N+LL      KI DFG+AR  +   N +    +
Sbjct: 166 SSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNA 222
Query: 212 RIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLW 271
           R+     +M+PE   + +++++SDV+S+G+LL EI             SL L  Y   L 
Sbjct: 223 RL--PVKWMAPESIFDCVYTVQSDVWSYGILLWEIF------------SLGLNPYPGILV 268
Query: 272 TSNRTLELIDPILEDEYSSKQMLLRYANIALL---CVQESADDRPTMNDVVSMLTNEA 326
            S         +++D Y   Q      NI  +   C       RPT   + S L  +A
Sbjct: 269 NSK-----FYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQA 321

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 85/311 (27%), Positives = 134/311 (43%), Gaps = 55/311 (17%)
Query: 49  NKFSDANKLGEGGFGPVYKGV---LKKGD---EIAVKRLSGRSGQGLRE-MKNEASVIAK 101
           N       LG G FG V +     L K D   ++AVK L   +    +E + +E  +++ 
Sbjct: 31  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 90
Query: 102 V-QHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEG---- 156
           + QH+N+V LLG C      ++I EY     L  FL    + ML   +   Q  EG    
Sbjct: 91  LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLAPGQDPEGLDKE 150
Query: 157 ----------------IAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMAR- 199
                           +AQG+ +L   +    IHRD+ A N+LL      KI DFG+AR 
Sbjct: 151 DGRPLELRDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARD 207
Query: 200 -ICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRT 258
            +   N +    +R+     +M+PE   + +++++SDV+S+G+LL EI            
Sbjct: 208 IMNDSNYIVKGNARL--PVKWMAPESIFDCVYTVQSDVWSYGILLWEIF----------- 254
Query: 259 DSLNLLGYAWDLWTSNRTLELIDPILEDEYSSKQMLLRYANIALL---CVQESADDRPTM 315
            SL L  Y   +  +++  +L+    +D Y   Q      NI  +   C       RPT 
Sbjct: 255 -SLGLNPYP-GILVNSKFYKLV----KDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTF 308
Query: 316 NDVVSMLTNEA 326
             + S L  +A
Sbjct: 309 QQICSFLQEQA 319

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 70/222 (31%), Positives = 110/222 (49%), Gaps = 35/222 (15%)
Query: 57  LGEGGFGPVYK----GVLKKGD--EIAVKRLSGRSGQGLRE-MKNEASVIAKV-QHKNLV 108
           LG G FG V      G+ K G   ++AVK L  ++    RE + +E  ++ ++  H+N+V
Sbjct: 53  LGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIV 112
Query: 109 RLLGCCIDRDEKILIYEYMPNKSLDFFL-------------FDPTKRM-------LLDWV 148
            LLG C       LI+EY     L  +L             ++  KR+       +L + 
Sbjct: 113 NLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFE 172
Query: 149 TRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMAR--ICGGNEL 206
             +     +A+G+ +L   S    +HRDL A N+L+      KI DFG+AR  +   N +
Sbjct: 173 DLLCFAYQVAKGMEFLEFKS---CVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYV 229
Query: 207 QANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 248
               +R+     +M+PE   EGI++IKSDV+S+G+LL EI S
Sbjct: 230 VRGNARL--PVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 82/304 (26%), Positives = 134/304 (44%), Gaps = 48/304 (15%)
Query: 49  NKFSDANKLGEGGFGPVYKGV---LKKGD---EIAVKRLSGRSGQGLRE-MKNEASVIAK 101
           N       LG G FG V +     L K D   ++AVK L   +    +E + +E  +++ 
Sbjct: 46  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105
Query: 102 V-QHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFL-----------FDPTKRMLLDWVT 149
           + QH+N+V LLG C      ++I EY     L  FL           ++P+        +
Sbjct: 106 LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKRPPGLEYSYNPSHNPEEQLSS 165
Query: 150 R--VQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMAR--ICGGNE 205
           R  +     +AQG+ +L   +    IHRD+ A N+LL      KI DFG+AR  +   N 
Sbjct: 166 RDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNY 222
Query: 206 LQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLG 265
           +    +R+     +M+PE   + +++++SDV+S+G+LL EI             SL L  
Sbjct: 223 IVKGNARL--PVKWMAPESIFDCVYTVQSDVWSYGILLWEIF------------SLGLNP 268
Query: 266 YAWDLWTSNRTLELIDPILEDEYSSKQMLLRYANIALL---CVQESADDRPTMNDVVSML 322
           Y   +  +++  +L+    +D Y   Q      NI  +   C       RPT   + S L
Sbjct: 269 YP-GILVNSKFYKLV----KDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFL 323
Query: 323 TNEA 326
             +A
Sbjct: 324 QEQA 327

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 65/229 (28%), Positives = 112/229 (48%), Gaps = 33/229 (14%)
Query: 49  NKFSDANKLGEGGFGPVYK----GVL--KKGDEIAVKRLSGRSGQGLR-EMKNEASVIAK 101
           N       +GEG FG V++    G+L  +    +AVK L   +   ++ + + EA+++A+
Sbjct: 47  NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 106
Query: 102 VQHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLL-----DWVTRVQ---- 152
             + N+V+LLG C       L++EYM    L+ FL   +   +      D  TR +    
Sbjct: 107 FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 166
Query: 153 ------------IIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMAR- 199
                       I   +A G+ YL   S  + +HRDL   N L+ ++M  KI+DFG++R 
Sbjct: 167 GPPPLSCAEQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRN 223
Query: 200 ICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 248
           I   +  +A+ +  +    +M PE      ++ +SDV+++GV+L EI S
Sbjct: 224 IYSADYYKADGNDAIPI-RWMPPESIFYNRYTTESDVWAYGVVLWEIFS 271

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 84/302 (27%), Positives = 131/302 (43%), Gaps = 46/302 (15%)
Query: 49  NKFSDANKLGEGGFGPVYKGV---LKKGD---EIAVKRLSGRSGQGLRE-MKNEASVIAK 101
           N       LG G FG V +     L K D   ++AVK L   +    +E + +E  +++ 
Sbjct: 46  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105
Query: 102 V-QHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWV---------TR- 150
           + QH+N+V LLG C      ++I EY     L  FL   ++ +  D           TR 
Sbjct: 106 LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRD 165
Query: 151 -VQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMAR--ICGGNELQ 207
            +     +AQG+ +L   +    IHRD+ A N+LL      KI DFG+AR  +   N + 
Sbjct: 166 LLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIV 222
Query: 208 ANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYA 267
              +R+     +M+PE   + +++++SDV+S+G+LL EI             SL L  Y 
Sbjct: 223 KGNARL--PVKWMAPESIFDCVYTVQSDVWSYGILLWEIF------------SLGLNPYP 268
Query: 268 WDLWTSNRTLELIDPILEDEYSSKQMLLRYANIALL---CVQESADDRPTMNDVVSMLTN 324
             L  S         +++D Y   Q      NI  +   C       RPT   + S L  
Sbjct: 269 GILVNSK-----FYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQE 323
Query: 325 EA 326
           +A
Sbjct: 324 QA 325

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 84/302 (27%), Positives = 131/302 (43%), Gaps = 46/302 (15%)
Query: 49  NKFSDANKLGEGGFGPVYKGV---LKKGD---EIAVKRLSGRSGQGLRE-MKNEASVIAK 101
           N       LG G FG V +     L K D   ++AVK L   +    +E + +E  +++ 
Sbjct: 46  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105
Query: 102 V-QHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWV---------TR- 150
           + QH+N+V LLG C      ++I EY     L  FL   ++ +  D           TR 
Sbjct: 106 LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTLSTRD 165
Query: 151 -VQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMAR--ICGGNELQ 207
            +     +AQG+ +L   +    IHRD+ A N+LL      KI DFG+AR  +   N + 
Sbjct: 166 LLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIV 222
Query: 208 ANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYA 267
              +R+     +M+PE   + +++++SDV+S+G+LL EI             SL L  Y 
Sbjct: 223 KGNARL--PVKWMAPESIFDCVYTVQSDVWSYGILLWEIF------------SLGLNPYP 268
Query: 268 WDLWTSNRTLELIDPILEDEYSSKQMLLRYANIALL---CVQESADDRPTMNDVVSMLTN 324
             L  S         +++D Y   Q      NI  +   C       RPT   + S L  
Sbjct: 269 GILVNSK-----FYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQE 323
Query: 325 EA 326
           +A
Sbjct: 324 QA 325

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 108/203 (53%), Gaps = 13/203 (6%)
Query: 51  FSDANKLGEGGFGPVYKGVLKKGDEI-AVKRLS-GRSGQGLREMKNEASVIAKVQHKNLV 108
           F+   ++G+G FG V+KG+  +  ++ A+K +    +   + +++ E +V+++     + 
Sbjct: 25  FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSSYVT 84
Query: 109 RLLGCCIDRDEKILIYEYMPNKS-LDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQY 167
           +  G  +   +  +I EY+   S LD     P      D      +++ I +GL YLH  
Sbjct: 85  KYYGSYLKGSKLWIIMEYLGGGSALDLLRAGP-----FDEFQIATMLKEILKGLDYLHSE 139
Query: 168 SRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALE 227
            +   IHRD+KA+N+LL +  + K++DFG+A      +++ NT   VGT  +M+PE   +
Sbjct: 140 KK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVIQQ 194
Query: 228 GIFSIKSDVFSFGVLLLEIVSGK 250
             +  K+D++S G+  +E+  G+
Sbjct: 195 SAYDSKADIWSLGITAIELAKGE 217

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 102/208 (49%), Gaps = 24/208 (11%)
Query: 57  LGEGGFGPVYKGVLKKGDEIAV-KRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCI 115
           LG+G FG   K   ++  E+ V K L     +  R    E  V+  ++H N+++ +G  +
Sbjct: 18  LGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGV-L 76
Query: 116 DRDEKI-LIYEYMPNKSLDFFLFDPTKRM--LLDWVTRVQIIEGIAQGLLYLHQYSRVRI 172
            +D+++  I EY+   +L   +    K M     W  RV   + IA G+ YLH    + I
Sbjct: 77  YKDKRLNFITEYIKGGTLRGII----KSMDSQYPWSQRVSFAKDIASGMAYLHS---MNI 129
Query: 173 IHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR------------IVGTYGYM 220
           IHRDL + N L+ ++ N  ++DFG+AR+    + Q    R            +VG   +M
Sbjct: 130 IHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWM 189
Query: 221 SPEYALEGIFSIKSDVFSFGVLLLEIVS 248
           +PE      +  K DVFSFG++L EI+ 
Sbjct: 190 APEMINGRSYDEKVDVFSFGIVLCEIIG 217

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 107/215 (49%), Gaps = 26/215 (12%)
Query: 57  LGEGGFGPVY--------KGVLKKGDEIAVKRL-SGRSGQGLREMKNEASVIAKV-QHKN 106
           LGEG FG V         K    +  ++AVK L S  + + L ++ +E  ++  + +HKN
Sbjct: 21  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 80
Query: 107 LVRLLGCCIDRDEKILIYEYMPNKSLDFFL-----------FDPTKRMLLDWVTR--VQI 153
           ++ LLG C       +I EY    +L  +L           ++P+        ++  V  
Sbjct: 81  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSC 140
Query: 154 IEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRI 213
              +A+G+ YL   +  + IHRDL A N+L+ +D   KI+DFG+AR     +    T+  
Sbjct: 141 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 197
Query: 214 VGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 248
                +M+PE   + I++ +SDV+SFGVLL EI +
Sbjct: 198 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 232

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 64/204 (31%), Positives = 105/204 (51%), Gaps = 20/204 (9%)
Query: 57  LGEGGFGPVYKGVL-----KKGDEIAVKRLSGRSG-QGLREMKNEASVIAKVQHKNLVRL 110
           LGEG FG V            G+++AVK L   SG   + ++K E  ++  + H+N+V+ 
Sbjct: 29  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 88
Query: 111 LGCCI-DRDEKI-LIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYL--HQ 166
            G C  D    I LI E++P+ SL  +L  P  +  ++   +++    I +G+ YL   Q
Sbjct: 89  KGICTEDGGNGIKLIMEFLPSGSLKEYL--PKNKNKINLKQQLKYAVQICKGMDYLGSRQ 146
Query: 167 YSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE--LQANTSRIVGTYGYMSPEY 224
           Y     +HRDL A N+L++ +   KI DFG+ +    ++        R    + Y +PE 
Sbjct: 147 Y-----VHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWY-APEC 200
Query: 225 ALEGIFSIKSDVFSFGVLLLEIVS 248
            ++  F I SDV+SFGV L E+++
Sbjct: 201 LMQSKFYIASDVWSFGVTLHELLT 224

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 69/210 (32%), Positives = 98/210 (46%), Gaps = 24/210 (11%)
Query: 51  FSDANKLGEGGFGPVYKG-VLKKGDEIAVKRLSGRSGQGLREMK-----NEASVIAKVQH 104
           F     LGEG F  V     L    E A+K L  R    ++E K      E  V++++ H
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKR--HIIKENKVPYVTRERDVMSRLDH 91
Query: 105 KNLVRLLGCCIDRDEKILIYEYMPNKSLDFFL-----FDPTKRMLLDWVTRVQIIEGIAQ 159
              V+L     D ++      Y  N  L  ++     FD T        TR    E I  
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGCLLKYIRKIGSFDET-------CTRFYTAE-IVS 143
Query: 160 GLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGY 219
            L YLH      IIHRDLK  NILL++DM+ +I+DFG A++      QA  +  VGT  Y
Sbjct: 144 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQY 200
Query: 220 MSPEYALEGIFSIKSDVFSFGVLLLEIVSG 249
           +SPE   E   S  SD+++ G ++ ++V+G
Sbjct: 201 VSPELLTEKSASKSSDLWALGCIIYQLVAG 230

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 107/208 (51%), Gaps = 21/208 (10%)
Query: 57  LGEGGFGPVYKGVLKKGD----EIAVK--RLSGRSGQGLREMKNEASVIAKVQHKNLVRL 110
           LGEG FG V +G LK+ D    ++AVK  +L   S + + E  +EA+ +    H N++RL
Sbjct: 42  LGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRL 101
Query: 111 LGCCIDRDEK-----ILIYEYMPNKSLDFFLFDP---TKRMLLDWVTRVQIIEGIAQGLL 162
           LG CI+   +     ++I  +M    L  +L      T    +   T ++ +  IA G+ 
Sbjct: 102 LGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGME 161
Query: 163 YLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMAR--ICGGNELQANTSRIVGTYGYM 220
           YL   S    +HRDL A N +L  DM   ++DFG+++    G    Q   +++     ++
Sbjct: 162 YL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKM--PVKWI 216
Query: 221 SPEYALEGIFSIKSDVFSFGVLLLEIVS 248
           + E   + +++ KSDV++FGV + EI +
Sbjct: 217 AIESLADRVYTSKSDVWAFGVTMWEIAT 244

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 107/215 (49%), Gaps = 26/215 (12%)
Query: 57  LGEGGFGPVY--------KGVLKKGDEIAVKRL-SGRSGQGLREMKNEASVIAKV-QHKN 106
           LGEG FG V         K    +  ++AVK L S  + + L ++ +E  ++  + +HKN
Sbjct: 29  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 88
Query: 107 LVRLLGCCIDRDEKILIYEYMPNKSLDFFL-----------FDPTKRMLLDWVTR--VQI 153
           ++ LLG C       +I EY    +L  +L           ++P+        ++  V  
Sbjct: 89  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 148
Query: 154 IEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRI 213
              +A+G+ YL   +  + IHRDL A N+L+ +D   KI+DFG+AR     +    T+  
Sbjct: 149 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 205
Query: 214 VGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 248
                +M+PE   + I++ +SDV+SFGVLL EI +
Sbjct: 206 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 240

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 107/215 (49%), Gaps = 26/215 (12%)
Query: 57  LGEGGFGPVY--------KGVLKKGDEIAVKRL-SGRSGQGLREMKNEASVIAKV-QHKN 106
           LGEG FG V         K    +  ++AVK L S  + + L ++ +E  ++  + +HKN
Sbjct: 25  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 84
Query: 107 LVRLLGCCIDRDEKILIYEYMPNKSLDFFL-----------FDPTKRMLLDWVTR--VQI 153
           ++ LLG C       +I EY    +L  +L           ++P+        ++  V  
Sbjct: 85  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 144
Query: 154 IEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRI 213
              +A+G+ YL   +  + IHRDL A N+L+ +D   KI+DFG+AR     +    T+  
Sbjct: 145 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 201
Query: 214 VGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 248
                +M+PE   + I++ +SDV+SFGVLL EI +
Sbjct: 202 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 236

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 63/199 (31%), Positives = 103/199 (51%), Gaps = 13/199 (6%)
Query: 56  KLGEGGFGPVYKGVL---KKGDEIAVKRL-SGRSGQGLREMKNEASVIAKVQHKNLVRLL 111
           +LG G FG V +GV    KK  ++A+K L  G       EM  EA ++ ++ +  +VRL+
Sbjct: 17  ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 76
Query: 112 GCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVR 171
           G C   +  +L+ E      L  FL    KR  +      +++  ++ G+ YL + +   
Sbjct: 77  GVC-QAEALMLVMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKN--- 130
Query: 172 IIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTY--GYMSPEYALEGI 229
            +HRDL A N+LL      KISDFG+++  G ++    T+R  G +   + +PE      
Sbjct: 131 FVHRDLAARNVLLVNRHYAKISDFGLSKALGADD-SYYTARSAGKWPLKWYAPECINFRK 189
Query: 230 FSIKSDVFSFGVLLLEIVS 248
           FS +SDV+S+GV + E +S
Sbjct: 190 FSSRSDVWSYGVTMWEALS 208

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 107/215 (49%), Gaps = 26/215 (12%)
Query: 57  LGEGGFGPVY--------KGVLKKGDEIAVKRL-SGRSGQGLREMKNEASVIAKV-QHKN 106
           LGEG FG V         K    +  ++AVK L S  + + L ++ +E  ++  + +HKN
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 107 LVRLLGCCIDRDEKILIYEYMPNKSLDFFL-----------FDPTKRMLLDWVTR--VQI 153
           ++ LLG C       +I EY    +L  +L           ++P+        ++  V  
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQLSSKDLVSC 155
Query: 154 IEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRI 213
              +A+G+ YL   +  + IHRDL A N+L+ +D   KI+DFG+AR     +    T+  
Sbjct: 156 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 212
Query: 214 VGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 248
                +M+PE   + I++ +SDV+SFGVLL EI +
Sbjct: 213 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 56/196 (28%), Positives = 98/196 (50%), Gaps = 10/196 (5%)
Query: 56  KLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCC 114
           K+GEG  G V     K  G ++AVK +  R  Q    + NE  ++   QH N+V +    
Sbjct: 52  KIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSY 111
Query: 115 IDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 174
           +  +E  ++ E++   +L     D   ++ L+      + E + Q L YLH      +IH
Sbjct: 112 LVGEELWVLMEFLQGGALT----DIVSQVRLNEEQIATVCEAVLQALAYLHAQG---VIH 164
Query: 175 RDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKS 234
           RD+K+ +ILL  D   K+SDFG       +        +VGT  +M+PE     +++ + 
Sbjct: 165 RDIKSDSILLTLDGRVKLSDFGFCAQISKD--VPKRKXLVGTPYWMAPEVISRSLYATEV 222
Query: 235 DVFSFGVLLLEIVSGK 250
           D++S G++++E+V G+
Sbjct: 223 DIWSLGIMVIEMVDGE 238

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 107/215 (49%), Gaps = 26/215 (12%)
Query: 57  LGEGGFGPVY--------KGVLKKGDEIAVKRL-SGRSGQGLREMKNEASVIAKV-QHKN 106
           LGEG FG V         K    +  ++AVK L S  + + L ++ +E  ++  + +HKN
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 107 LVRLLGCCIDRDEKILIYEYMPNKSLDFFL-----------FDPTKRMLLDWVTR--VQI 153
           ++ LLG C       +I EY    +L  +L           ++P+        ++  V  
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 155
Query: 154 IEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRI 213
              +A+G+ YL   +  + IHRDL A N+L+ +D   KI+DFG+AR     +    T+  
Sbjct: 156 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 212
Query: 214 VGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 248
                +M+PE   + I++ +SDV+SFGVLL EI +
Sbjct: 213 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 64/204 (31%), Positives = 105/204 (51%), Gaps = 20/204 (9%)
Query: 57  LGEGGFGPVYKGVL-----KKGDEIAVKRLSGRSG-QGLREMKNEASVIAKVQHKNLVRL 110
           LGEG FG V            G+++AVK L   SG   + ++K E  ++  + H+N+V+ 
Sbjct: 17  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 76
Query: 111 LGCCI-DRDEKI-LIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYL--HQ 166
            G C  D    I LI E++P+ SL  +L  P  +  ++   +++    I +G+ YL   Q
Sbjct: 77  KGICTEDGGNGIKLIMEFLPSGSLKEYL--PKNKNKINLKQQLKYAVQICKGMDYLGSRQ 134
Query: 167 YSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE--LQANTSRIVGTYGYMSPEY 224
           Y     +HRDL A N+L++ +   KI DFG+ +    ++        R    + Y +PE 
Sbjct: 135 Y-----VHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWY-APEC 188
Query: 225 ALEGIFSIKSDVFSFGVLLLEIVS 248
            ++  F I SDV+SFGV L E+++
Sbjct: 189 LMQSKFYIASDVWSFGVTLHELLT 212

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 108/206 (52%), Gaps = 28/206 (13%)
Query: 57  LGEGGFGPVYKGV-LKKGDEI----AVKRLSGRSG-QGLREMKNEASVIAKVQHKNLVRL 110
           LG G FG V+KGV + +G+ I     +K +  +SG Q  + + +    I  + H ++VRL
Sbjct: 39  LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRL 98
Query: 111 LGCCIDRDEKILIYEYMPNKSLDFFLFDPTKR--------MLLDWVTRVQIIEGIAQGLL 162
           LG C     + L+ +Y+P  SL     D  ++        +LL+W  +      IA+G+ 
Sbjct: 99  LGLCPGSSLQ-LVTQYLPLGSL----LDHVRQHRGALGPQLLLNWGVQ------IAKGMY 147
Query: 163 YLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSP 222
           YL ++    ++HR+L A N+LL      +++DFG+A +   ++ Q   S       +M+ 
Sbjct: 148 YLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMAL 204
Query: 223 EYALEGIFSIKSDVFSFGVLLLEIVS 248
           E    G ++ +SDV+S+GV + E+++
Sbjct: 205 ESIHFGKYTHQSDVWSYGVTVWELMT 230

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 107/215 (49%), Gaps = 26/215 (12%)
Query: 57  LGEGGFGPVY--------KGVLKKGDEIAVKRL-SGRSGQGLREMKNEASVIAKV-QHKN 106
           LGEG FG V         K    +  ++AVK L S  + + L ++ +E  ++  + +HKN
Sbjct: 28  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 87
Query: 107 LVRLLGCCIDRDEKILIYEYMPNKSLDFFL-----------FDPTKRMLLDWVTR--VQI 153
           ++ LLG C       +I EY    +L  +L           ++P+        ++  V  
Sbjct: 88  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 147
Query: 154 IEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRI 213
              +A+G+ YL   +  + IHRDL A N+L+ +D   KI+DFG+AR     +    T+  
Sbjct: 148 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 204
Query: 214 VGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 248
                +M+PE   + I++ +SDV+SFGVLL EI +
Sbjct: 205 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 239

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 107/215 (49%), Gaps = 26/215 (12%)
Query: 57  LGEGGFGPVY--------KGVLKKGDEIAVKRL-SGRSGQGLREMKNEASVIAKV-QHKN 106
           LGEG FG V         K    +  ++AVK L S  + + L ++ +E  ++  + +HKN
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 107 LVRLLGCCIDRDEKILIYEYMPNKSLDFFL-----------FDPTKRMLLDWVTR--VQI 153
           ++ LLG C       +I EY    +L  +L           ++P+        ++  V  
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSC 155
Query: 154 IEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRI 213
              +A+G+ YL   +  + IHRDL A N+L+ +D   KI+DFG+AR     +    T+  
Sbjct: 156 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 212
Query: 214 VGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 248
                +M+PE   + I++ +SDV+SFGVLL EI +
Sbjct: 213 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 106/203 (52%), Gaps = 13/203 (6%)
Query: 51  FSDANKLGEGGFGPVYKGVLKKGDEI-AVKRLS-GRSGQGLREMKNEASVIAKVQHKNLV 108
           F+   K+G+G FG V+KG+  +  ++ A+K +    +   + +++ E +V+++     + 
Sbjct: 24  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83
Query: 109 RLLGCCIDRDEKILIYEYMPNKS-LDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQY 167
           +  G  +   +  +I EY+   S LD     P     LD      I+  I +GL YLH  
Sbjct: 84  KYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP-----LDETQIATILREILKGLDYLHSE 138
Query: 168 SRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALE 227
            +   IHRD+KA+N+LL +    K++DFG+A      +++ N    VGT  +M+PE   +
Sbjct: 139 KK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNX--FVGTPFWMAPEVIKQ 193
Query: 228 GIFSIKSDVFSFGVLLLEIVSGK 250
             +  K+D++S G+  +E+  G+
Sbjct: 194 SAYDSKADIWSLGITAIELARGE 216

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 106/203 (52%), Gaps = 13/203 (6%)
Query: 51  FSDANKLGEGGFGPVYKGVLKKGDEI-AVKRLS-GRSGQGLREMKNEASVIAKVQHKNLV 108
           F+   K+G+G FG V+KG+  +  ++ A+K +    +   + +++ E +V+++     + 
Sbjct: 9   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 68
Query: 109 RLLGCCIDRDEKILIYEYMPNKS-LDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQY 167
           +  G  +   +  +I EY+   S LD     P     LD      I+  I +GL YLH  
Sbjct: 69  KYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP-----LDETQIATILREILKGLDYLHSE 123
Query: 168 SRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALE 227
            +   IHRD+KA+N+LL +    K++DFG+A      +++ N    VGT  +M+PE   +
Sbjct: 124 KK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNX--FVGTPFWMAPEVIKQ 178
Query: 228 GIFSIKSDVFSFGVLLLEIVSGK 250
             +  K+D++S G+  +E+  G+
Sbjct: 179 SAYDSKADIWSLGITAIELARGE 201

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 107/215 (49%), Gaps = 26/215 (12%)
Query: 57  LGEGGFGPVY--------KGVLKKGDEIAVKRL-SGRSGQGLREMKNEASVIAKV-QHKN 106
           LGEG FG V         K    +  ++AVK L S  + + L ++ +E  ++  + +HKN
Sbjct: 77  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136
Query: 107 LVRLLGCCIDRDEKILIYEYMPNKSLDFFL-----------FDPTKRMLLDWVTR--VQI 153
           ++ LLG C       +I EY    +L  +L           ++P+        ++  V  
Sbjct: 137 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 196
Query: 154 IEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRI 213
              +A+G+ YL   +  + IHRDL A N+L+ +D   KI+DFG+AR     +    T+  
Sbjct: 197 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 253
Query: 214 VGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 248
                +M+PE   + I++ +SDV+SFGVLL EI +
Sbjct: 254 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 68/210 (32%), Positives = 104/210 (49%), Gaps = 21/210 (10%)
Query: 57  LGEGGFGPVYK----GVLKKGDE--IAVKRL-SGRSGQGLREMKNEASVIAKV-QHKNLV 108
           LG G FG V +    G+ K      +AVK L  G +    R + +E  ++  +  H N+V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 109 RLLGCCIDRDEKIL-IYEYMPNKSLDFFL------FDPTKRMLLDWVTRVQIIE---GIA 158
            LLG C      ++ I E+    +L  +L      F P K +  D++T   +I     +A
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLIXYSFQVA 154
Query: 159 QGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG 218
           +G+ +L   +  + IHRDL A NILL +    KI DFG+AR    +              
Sbjct: 155 KGMEFL---ASRKXIHRDLAARNILLSEKNVVKIXDFGLARDIYKDPDYVRKGDARLPLK 211
Query: 219 YMSPEYALEGIFSIKSDVFSFGVLLLEIVS 248
           +M+PE   + +++I+SDV+SFGVLL EI S
Sbjct: 212 WMAPETIFDRVYTIQSDVWSFGVLLWEIFS 241

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 68/242 (28%), Positives = 115/242 (47%), Gaps = 35/242 (14%)
Query: 32  EVDQFPLFSFSSVSTATNKFSDANKLGEGGFGPVY--------KGVLKKGDEIAVKRLSG 83
           E+ + P + F       +K +    LGEG FG V         K   K+   +AVK L  
Sbjct: 23  ELPEDPKWEFPR-----DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKD 77
Query: 84  RSGQ-GLREMKNEASVIAKV-QHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFL----- 136
            + +  L ++ +E  ++  + +HKN++ LLG C       +I EY    +L  +L     
Sbjct: 78  DATEKDLSDLVSEMEMMKMIGKHKNIIHLLGACTQDGPLYVIVEYASKGNLREYLRARRP 137
Query: 137 ------FD----PTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDK 186
                 +D    P ++M       V     +A+G+ YL   +  + IHRDL A N+L+ +
Sbjct: 138 PGMEYSYDINRVPEEQMTFK--DLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTE 192
Query: 187 DMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEI 246
           +   KI+DFG+AR     +    T+       +M+PE   + +++ +SDV+SFGVL+ EI
Sbjct: 193 NNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 252
Query: 247 VS 248
            +
Sbjct: 253 FT 254

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 68/242 (28%), Positives = 115/242 (47%), Gaps = 35/242 (14%)
Query: 32  EVDQFPLFSFSSVSTATNKFSDANKLGEGGFGPVY--------KGVLKKGDEIAVKRLSG 83
           E+ + P + F       +K +    LGEG FG V         K   K+   +AVK L  
Sbjct: 23  ELPEDPKWEFPR-----DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKD 77
Query: 84  RSGQ-GLREMKNEASVIAKV-QHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFL----- 136
            + +  L ++ +E  ++  + +HKN++ LLG C       +I EY    +L  +L     
Sbjct: 78  DATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRP 137
Query: 137 ------FD----PTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDK 186
                 +D    P ++M       V     +A+G+ YL   +  + IHRDL A N+L+ +
Sbjct: 138 PGMEXSYDINRVPEEQMTFK--DLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTE 192
Query: 187 DMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEI 246
           +   KI+DFG+AR     +    T+       +M+PE   + +++ +SDV+SFGVL+ EI
Sbjct: 193 NNVMKIADFGLARDINNIDXXKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 252
Query: 247 VS 248
            +
Sbjct: 253 FT 254

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 68/242 (28%), Positives = 115/242 (47%), Gaps = 35/242 (14%)
Query: 32  EVDQFPLFSFSSVSTATNKFSDANKLGEGGFGPVY--------KGVLKKGDEIAVKRLSG 83
           E+ + P + F       +K +    LGEG FG V         K   K+   +AVK L  
Sbjct: 23  ELPEDPKWEFPR-----DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKD 77
Query: 84  RSGQ-GLREMKNEASVIAKV-QHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFL----- 136
            + +  L ++ +E  ++  + +HKN++ LLG C       +I EY    +L  +L     
Sbjct: 78  DATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRP 137
Query: 137 ------FD----PTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDK 186
                 +D    P ++M       V     +A+G+ YL   +  + IHRDL A N+L+ +
Sbjct: 138 PGMEYSYDINRVPEEQMTFK--DLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTE 192
Query: 187 DMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEI 246
           +   KI+DFG+AR     +    T+       +M+PE   + +++ +SDV+SFGVL+ EI
Sbjct: 193 NNVMKIADFGLARDINNIDXXKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 252
Query: 247 VS 248
            +
Sbjct: 253 FT 254

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 108/206 (52%), Gaps = 28/206 (13%)
Query: 57  LGEGGFGPVYKGV-LKKGDEI----AVKRLSGRSG-QGLREMKNEASVIAKVQHKNLVRL 110
           LG G FG V+KGV + +G+ I     +K +  +SG Q  + + +    I  + H ++VRL
Sbjct: 21  LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRL 80
Query: 111 LGCCIDRDEKILIYEYMPNKSLDFFLFDPTKR--------MLLDWVTRVQIIEGIAQGLL 162
           LG C     + L+ +Y+P  SL     D  ++        +LL+W  +      IA+G+ 
Sbjct: 81  LGLCPGSSLQ-LVTQYLPLGSL----LDHVRQHRGALGPQLLLNWGVQ------IAKGMY 129
Query: 163 YLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSP 222
           YL ++    ++HR+L A N+LL      +++DFG+A +   ++ Q   S       +M+ 
Sbjct: 130 YLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMAL 186
Query: 223 EYALEGIFSIKSDVFSFGVLLLEIVS 248
           E    G ++ +SDV+S+GV + E+++
Sbjct: 187 ESIHFGKYTHQSDVWSYGVTVWELMT 212

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 59/198 (29%), Positives = 105/198 (53%), Gaps = 15/198 (7%)
Query: 56  KLGEGGFGPVYKGVLKKGDEIAV-KRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCC 114
           +LG+G FG VYK   K+   +A  K +  +S + L +   E  ++A   H N+V+LL   
Sbjct: 44  ELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 103
Query: 115 IDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQII-EGIAQGLLYLHQYSRVRII 173
              +   ++ E+    ++D  + +  +R L +  +++Q++ +     L YLH     +II
Sbjct: 104 YYENNLWILIEFCAGGAVDAVMLE-LERPLTE--SQIQVVCKQTLDALNYLHDN---KII 157
Query: 174 HRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAL-----EG 228
           HRDLKA NIL   D + K++DFG++       +Q   S  +GT  +M+PE  +     + 
Sbjct: 158 HRDLKAGNILFTLDGDIKLADFGVSAK-NTRXIQRRDS-FIGTPYWMAPEVVMCETSKDR 215
Query: 229 IFSIKSDVFSFGVLLLEI 246
            +  K+DV+S G+ L+E+
Sbjct: 216 PYDYKADVWSLGITLIEM 233

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 68/242 (28%), Positives = 115/242 (47%), Gaps = 35/242 (14%)
Query: 32  EVDQFPLFSFSSVSTATNKFSDANKLGEGGFGPVY--------KGVLKKGDEIAVKRLSG 83
           E+ + P + F       +K +    LGEG FG V         K   K+   +AVK L  
Sbjct: 23  ELPEDPKWEFPR-----DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKD 77
Query: 84  -RSGQGLREMKNEASVIAKV-QHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFL----- 136
             + + L ++ +E  ++  + +HKN++ LLG C       +I EY    +L  +L     
Sbjct: 78  DATEEDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRP 137
Query: 137 ------FD----PTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDK 186
                 +D    P ++M       V     +A+G+ YL   +  + IHRDL A N+L+ +
Sbjct: 138 PGMEYSYDINRVPEEQMTFK--DLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTE 192
Query: 187 DMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEI 246
           +   KI+DFG+AR     +    T+       +M+PE   + +++ +SDV+SFGVL+ EI
Sbjct: 193 NNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 252
Query: 247 VS 248
            +
Sbjct: 253 FT 254

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 106/200 (53%), Gaps = 19/200 (9%)
Query: 56  KLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCC 114
           +LG+G FG VYK   K+ G   A K +  +S + L +   E  ++A   H  +V+LLG  
Sbjct: 18  ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAY 77
Query: 115 IDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQII-EGIAQGLLYLHQYSRVRII 173
               +  ++ E+ P  ++D  + +   R L +   ++Q++   + + L +LH     RII
Sbjct: 78  YHDGKLWIMIEFCPGGAVDAIMLE-LDRGLTE--PQIQVVCRQMLEALNFLHSK---RII 131
Query: 174 HRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR--IVGTYGYMSPEYAL----- 226
           HRDLKA N+L+  + + +++DFG++       L+    R   +GT  +M+PE  +     
Sbjct: 132 HRDLKAGNVLMTLEGDIRLADFGVS----AKNLKTLQKRDSFIGTPYWMAPEVVMCETMK 187
Query: 227 EGIFSIKSDVFSFGVLLLEI 246
           +  +  K+D++S G+ L+E+
Sbjct: 188 DTPYDYKADIWSLGITLIEM 207

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 102/198 (51%), Gaps = 15/198 (7%)
Query: 56  KLGEGGFGPVYKGVLKKGDEIAV-KRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCC 114
           +LG+G FG VYK   K+   +A  K +  +S + L +   E  ++A   H N+V+LL   
Sbjct: 44  ELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 103
Query: 115 IDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQII-EGIAQGLLYLHQYSRVRII 173
              +   ++ E+    ++D  + +  +R L +  +++Q++ +     L YLH     +II
Sbjct: 104 YYENNLWILIEFCAGGAVDAVMLE-LERPLTE--SQIQVVCKQTLDALNYLHDN---KII 157
Query: 174 HRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAL-----EG 228
           HRDLKA NIL   D + K++DFG++               +GT  +M+PE  +     + 
Sbjct: 158 HRDLKAGNILFTLDGDIKLADFGVS--AKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDR 215
Query: 229 IFSIKSDVFSFGVLLLEI 246
            +  K+DV+S G+ L+E+
Sbjct: 216 PYDYKADVWSLGITLIEM 233

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 106/200 (53%), Gaps = 19/200 (9%)
Query: 56  KLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCC 114
           +LG+G FG VYK   K+ G   A K +  +S + L +   E  ++A   H  +V+LLG  
Sbjct: 26  ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAY 85
Query: 115 IDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQII-EGIAQGLLYLHQYSRVRII 173
               +  ++ E+ P  ++D  + +   R L +   ++Q++   + + L +LH     RII
Sbjct: 86  YHDGKLWIMIEFCPGGAVDAIMLE-LDRGLTE--PQIQVVCRQMLEALNFLHSK---RII 139
Query: 174 HRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR--IVGTYGYMSPEYAL----- 226
           HRDLKA N+L+  + + +++DFG++       L+    R   +GT  +M+PE  +     
Sbjct: 140 HRDLKAGNVLMTLEGDIRLADFGVS----AKNLKTLQKRDSFIGTPYWMAPEVVMCETMK 195
Query: 227 EGIFSIKSDVFSFGVLLLEI 246
           +  +  K+D++S G+ L+E+
Sbjct: 196 DTPYDYKADIWSLGITLIEM 215

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 68/242 (28%), Positives = 115/242 (47%), Gaps = 35/242 (14%)
Query: 32  EVDQFPLFSFSSVSTATNKFSDANKLGEGGFGPVY--------KGVLKKGDEIAVKRLSG 83
           E+ + P + F       +K +    LGEG FG V         K   K+   +AVK L  
Sbjct: 23  ELPEDPKWEFPR-----DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKD 77
Query: 84  RSGQ-GLREMKNEASVIAKV-QHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFL----- 136
            + +  L ++ +E  ++  + +HKN++ LLG C       +I EY    +L  +L     
Sbjct: 78  DATEKDLSDLVSEMEMMKMIGKHKNIITLLGACTQDGPLYVIVEYASKGNLREYLRARRP 137
Query: 137 ------FD----PTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDK 186
                 +D    P ++M       V     +A+G+ YL   +  + IHRDL A N+L+ +
Sbjct: 138 PGMEYSYDINRVPEEQMTFK--DLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTE 192
Query: 187 DMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEI 246
           +   KI+DFG+AR     +    T+       +M+PE   + +++ +SDV+SFGVL+ EI
Sbjct: 193 NNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 252
Query: 247 VS 248
            +
Sbjct: 253 FT 254

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 68/210 (32%), Positives = 97/210 (46%), Gaps = 24/210 (11%)
Query: 51  FSDANKLGEGGFGPVYKG-VLKKGDEIAVKRLSGRSGQGLREMK-----NEASVIAKVQH 104
           F     LGEG F  V     L    E A+K L  R    ++E K      E  V++++ H
Sbjct: 9   FKFGKILGEGSFSTVVLARELATSREYAIKILEKR--HIIKENKVPYVTRERDVMSRLDH 66
Query: 105 KNLVRLLGCCIDRDEKILIYEYMPNKSLDFFL-----FDPTKRMLLDWVTRVQIIEGIAQ 159
              V+L     D ++      Y  N  L  ++     FD T        TR    E I  
Sbjct: 67  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET-------CTRFYTAE-IVS 118
Query: 160 GLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGY 219
            L YLH      IIHRDLK  NILL++DM+ +I+DFG A++      QA  +  VGT  Y
Sbjct: 119 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 175
Query: 220 MSPEYALEGIFSIKSDVFSFGVLLLEIVSG 249
           +SPE   E      SD+++ G ++ ++V+G
Sbjct: 176 VSPELLTEKSACKSSDLWALGCIIYQLVAG 205

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 68/210 (32%), Positives = 104/210 (49%), Gaps = 21/210 (10%)
Query: 57  LGEGGFGPVYK----GVLKKGDE--IAVKRL-SGRSGQGLREMKNEASVIAKV-QHKNLV 108
           LG G FG V +    G+ K      +AVK L  G +    R + +E  ++  +  H N+V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 109 RLLGCCIDRDEKIL-IYEYMPNKSLDFFL------FDPTKRMLLDWVTRVQIIE---GIA 158
            LLG C      ++ I E+    +L  +L      F P K +  D++T   +I     +A
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLICYSFQVA 154
Query: 159 QGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG 218
           +G+ +L   +  + IHRDL A NILL +    KI DFG+AR    +              
Sbjct: 155 KGMEFL---ASRKXIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLK 211
Query: 219 YMSPEYALEGIFSIKSDVFSFGVLLLEIVS 248
           +M+PE   + +++I+SDV+SFGVLL EI S
Sbjct: 212 WMAPETIFDRVYTIQSDVWSFGVLLWEIFS 241

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 68/210 (32%), Positives = 97/210 (46%), Gaps = 24/210 (11%)
Query: 51  FSDANKLGEGGFGPVYKG-VLKKGDEIAVKRLSGRSGQGLREMK-----NEASVIAKVQH 104
           F     LGEG F  V     L    E A+K L  R    ++E K      E  V++++ H
Sbjct: 12  FKFGKILGEGSFSTVVLARELATSREYAIKILEKR--HIIKENKVPYVTRERDVMSRLDH 69
Query: 105 KNLVRLLGCCIDRDEKILIYEYMPNKSLDFFL-----FDPTKRMLLDWVTRVQIIEGIAQ 159
              V+L     D ++      Y  N  L  ++     FD T        TR    E I  
Sbjct: 70  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET-------CTRFYTAE-IVS 121
Query: 160 GLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGY 219
            L YLH      IIHRDLK  NILL++DM+ +I+DFG A++      QA  +  VGT  Y
Sbjct: 122 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 178
Query: 220 MSPEYALEGIFSIKSDVFSFGVLLLEIVSG 249
           +SPE   E      SD+++ G ++ ++V+G
Sbjct: 179 VSPELLTEKSACKSSDLWALGCIIYQLVAG 208

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 78.2 bits (191), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 62/199 (31%), Positives = 103/199 (51%), Gaps = 13/199 (6%)
Query: 56  KLGEGGFGPVYKGVL---KKGDEIAVKRL-SGRSGQGLREMKNEASVIAKVQHKNLVRLL 111
           +LG G FG V +GV    KK  ++A+K L  G       EM  EA ++ ++ +  +VRL+
Sbjct: 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 402
Query: 112 GCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVR 171
           G C   +  +L+ E      L  FL    KR  +      +++  ++ G+ YL + +   
Sbjct: 403 GVC-QAEALMLVMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKN--- 456
Query: 172 IIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG--YMSPEYALEGI 229
            +HR+L A N+LL      KISDFG+++  G ++    T+R  G +   + +PE      
Sbjct: 457 FVHRNLAARNVLLVNRHYAKISDFGLSKALGADD-SYYTARSAGKWPLKWYAPECINFRK 515
Query: 230 FSIKSDVFSFGVLLLEIVS 248
           FS +SDV+S+GV + E +S
Sbjct: 516 FSSRSDVWSYGVTMWEALS 534

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 78.2 bits (191), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 68/210 (32%), Positives = 97/210 (46%), Gaps = 24/210 (11%)
Query: 51  FSDANKLGEGGFGPVYKG-VLKKGDEIAVKRLSGRSGQGLREMK-----NEASVIAKVQH 104
           F     LGEG F  V     L    E A+K L  R    ++E K      E  V++++ H
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKR--HIIKENKVPYVTRERDVMSRLDH 91
Query: 105 KNLVRLLGCCIDRDEKILIYEYMPNKSLDFFL-----FDPTKRMLLDWVTRVQIIEGIAQ 159
              V+L     D ++      Y  N  L  ++     FD T        TR    E I  
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET-------CTRFYTAE-IVS 143
Query: 160 GLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGY 219
            L YLH      IIHRDLK  NILL++DM+ +I+DFG A++      QA  +  VGT  Y
Sbjct: 144 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 200
Query: 220 MSPEYALEGIFSIKSDVFSFGVLLLEIVSG 249
           +SPE   E      SD+++ G ++ ++V+G
Sbjct: 201 VSPELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 78.2 bits (191), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 68/210 (32%), Positives = 97/210 (46%), Gaps = 24/210 (11%)
Query: 51  FSDANKLGEGGFGPVYKG-VLKKGDEIAVKRLSGRSGQGLREMK-----NEASVIAKVQH 104
           F     LGEG F  V     L    E A+K L  R    ++E K      E  V++++ H
Sbjct: 11  FKFGKILGEGSFSTVVLARELATSREYAIKILEKR--HIIKENKVPYVTRERDVMSRLDH 68
Query: 105 KNLVRLLGCCIDRDEKILIYEYMPNKSLDFFL-----FDPTKRMLLDWVTRVQIIEGIAQ 159
              V+L     D ++      Y  N  L  ++     FD T        TR    E I  
Sbjct: 69  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET-------CTRFYTAE-IVS 120
Query: 160 GLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGY 219
            L YLH      IIHRDLK  NILL++DM+ +I+DFG A++      QA  +  VGT  Y
Sbjct: 121 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 177
Query: 220 MSPEYALEGIFSIKSDVFSFGVLLLEIVSG 249
           +SPE   E      SD+++ G ++ ++V+G
Sbjct: 178 VSPELLTEKSACKSSDLWALGCIIYQLVAG 207

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 78.2 bits (191), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 68/210 (32%), Positives = 97/210 (46%), Gaps = 24/210 (11%)
Query: 51  FSDANKLGEGGFGPVYKG-VLKKGDEIAVKRLSGRSGQGLREMK-----NEASVIAKVQH 104
           F     LGEG F  V     L    E A+K L  R    ++E K      E  V++++ H
Sbjct: 32  FKFGKILGEGSFSTVVLARELATSREYAIKILEKR--HIIKENKVPYVTRERDVMSRLDH 89
Query: 105 KNLVRLLGCCIDRDEKILIYEYMPNKSLDFFL-----FDPTKRMLLDWVTRVQIIEGIAQ 159
              V+L     D ++      Y  N  L  ++     FD T        TR    E I  
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET-------CTRFYTAE-IVS 141
Query: 160 GLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGY 219
            L YLH      IIHRDLK  NILL++DM+ +I+DFG A++      QA  +  VGT  Y
Sbjct: 142 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 198
Query: 220 MSPEYALEGIFSIKSDVFSFGVLLLEIVSG 249
           +SPE   E      SD+++ G ++ ++V+G
Sbjct: 199 VSPELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 78.2 bits (191), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 68/210 (32%), Positives = 97/210 (46%), Gaps = 24/210 (11%)
Query: 51  FSDANKLGEGGFGPVYKG-VLKKGDEIAVKRLSGRSGQGLREMK-----NEASVIAKVQH 104
           F     LGEG F  V     L    E A+K L  R    ++E K      E  V++++ H
Sbjct: 35  FKFGKILGEGSFSTVVLARELATSREYAIKILEKR--HIIKENKVPYVTRERDVMSRLDH 92
Query: 105 KNLVRLLGCCIDRDEKILIYEYMPNKSLDFFL-----FDPTKRMLLDWVTRVQIIEGIAQ 159
              V+L     D ++      Y  N  L  ++     FD T        TR    E I  
Sbjct: 93  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET-------CTRFYTAE-IVS 144
Query: 160 GLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGY 219
            L YLH      IIHRDLK  NILL++DM+ +I+DFG A++      QA  +  VGT  Y
Sbjct: 145 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQY 201
Query: 220 MSPEYALEGIFSIKSDVFSFGVLLLEIVSG 249
           +SPE   E      SD+++ G ++ ++V+G
Sbjct: 202 VSPELLTEKSACKSSDLWALGCIIYQLVAG 231

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 78.2 bits (191), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 68/242 (28%), Positives = 115/242 (47%), Gaps = 35/242 (14%)
Query: 32  EVDQFPLFSFSSVSTATNKFSDANKLGEGGFGPVY--------KGVLKKGDEIAVKRLSG 83
           E+ + P + F       +K +    LGEG FG V         K   K+   +AVK L  
Sbjct: 69  ELPEDPKWEFPR-----DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKD 123
Query: 84  RSGQ-GLREMKNEASVIAKV-QHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFL----- 136
            + +  L ++ +E  ++  + +HKN++ LLG C       +I EY    +L  +L     
Sbjct: 124 DATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRP 183
Query: 137 ------FD----PTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDK 186
                 +D    P ++M       V     +A+G+ YL   +  + IHRDL A N+L+ +
Sbjct: 184 PGMEYSYDINRVPEEQMTFK--DLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTE 238
Query: 187 DMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEI 246
           +   KI+DFG+AR     +    T+       +M+PE   + +++ +SDV+SFGVL+ EI
Sbjct: 239 NNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 298
Query: 247 VS 248
            +
Sbjct: 299 FT 300

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 78.2 bits (191), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 68/210 (32%), Positives = 97/210 (46%), Gaps = 24/210 (11%)
Query: 51  FSDANKLGEGGFGPVYKG-VLKKGDEIAVKRLSGRSGQGLREMK-----NEASVIAKVQH 104
           F     LGEG F  V     L    E A+K L  R    ++E K      E  V++++ H
Sbjct: 10  FKFGKILGEGSFSTVVLARELATSREYAIKILEKR--HIIKENKVPYVTRERDVMSRLDH 67
Query: 105 KNLVRLLGCCIDRDEKILIYEYMPNKSLDFFL-----FDPTKRMLLDWVTRVQIIEGIAQ 159
              V+L     D ++      Y  N  L  ++     FD T        TR    E I  
Sbjct: 68  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET-------CTRFYTAE-IVS 119
Query: 160 GLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGY 219
            L YLH      IIHRDLK  NILL++DM+ +I+DFG A++      QA  +  VGT  Y
Sbjct: 120 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 176
Query: 220 MSPEYALEGIFSIKSDVFSFGVLLLEIVSG 249
           +SPE   E      SD+++ G ++ ++V+G
Sbjct: 177 VSPELLTEKSACKSSDLWALGCIIYQLVAG 206

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 78.2 bits (191), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 68/210 (32%), Positives = 97/210 (46%), Gaps = 24/210 (11%)
Query: 51  FSDANKLGEGGFGPVYKG-VLKKGDEIAVKRLSGRSGQGLREMK-----NEASVIAKVQH 104
           F     LGEG F  V     L    E A+K L  R    ++E K      E  V++++ H
Sbjct: 31  FKFGKILGEGSFSTVVLARELATSREYAIKILEKR--HIIKENKVPYVTRERDVMSRLDH 88
Query: 105 KNLVRLLGCCIDRDEKILIYEYMPNKSLDFFL-----FDPTKRMLLDWVTRVQIIEGIAQ 159
              V+L     D ++      Y  N  L  ++     FD T        TR    E I  
Sbjct: 89  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET-------CTRFYTAE-IVS 140
Query: 160 GLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGY 219
            L YLH      IIHRDLK  NILL++DM+ +I+DFG A++      QA  +  VGT  Y
Sbjct: 141 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQY 197
Query: 220 MSPEYALEGIFSIKSDVFSFGVLLLEIVSG 249
           +SPE   E      SD+++ G ++ ++V+G
Sbjct: 198 VSPELLTEKSACKSSDLWALGCIIYQLVAG 227

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 102/200 (51%), Gaps = 15/200 (7%)
Query: 56  KLGEGGFGPVYKGVLKKGDEIAV-KRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCC 114
           +LG+G FG VYK   K+   +A  K +  +S + L +   E  ++A   H N+V+LL   
Sbjct: 44  ELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 103
Query: 115 IDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQII-EGIAQGLLYLHQYSRVRII 173
              +   ++ E+    ++D  + +  +R L +  +++Q++ +     L YLH     +II
Sbjct: 104 YYENNLWILIEFCAGGAVDAVMLE-LERPLTE--SQIQVVCKQTLDALNYLHDN---KII 157
Query: 174 HRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAL-----EG 228
           HRDLKA NIL   D + K++DFG++               +GT  +M+PE  +     + 
Sbjct: 158 HRDLKAGNILFTLDGDIKLADFGVS--AKNTRXIQRRDXFIGTPYWMAPEVVMCETSKDR 215
Query: 229 IFSIKSDVFSFGVLLLEIVS 248
            +  K+DV+S G+ L+E+  
Sbjct: 216 PYDYKADVWSLGITLIEMAE 235

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 72/233 (30%), Positives = 119/233 (51%), Gaps = 18/233 (7%)
Query: 47  ATNKFSDANK---LGEGGFGPVYK-GVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKV 102
           A N F   +K   LG G FG V+K      G ++A K +  R  +   E+KNE SV+ ++
Sbjct: 84  AVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQL 143
Query: 103 QHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLL 162
            H NL++L      +++ +L+ EY+    L   + D +    L  +  +  ++ I +G+ 
Sbjct: 144 DHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYN--LTELDTILFMKQICEGIR 201
Query: 163 YLHQYSRVRIIHRDLKASNIL-LDKDMNP-KISDFGMARICGGNE-LQANTSRIVGTYGY 219
           ++HQ   + I+H DLK  NIL +++D    KI DFG+AR     E L+ N     GT  +
Sbjct: 202 HMHQ---MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVN----FGTPEF 254
Query: 220 MSPEYALEGIFSIKSDVFSFGVLLLEIVSG-KKNTGLYRTDSL-NLLGYAWDL 270
           ++PE       S  +D++S GV+   ++SG     G    ++L N+L   WDL
Sbjct: 255 LAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDL 307

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 68/210 (32%), Positives = 97/210 (46%), Gaps = 24/210 (11%)
Query: 51  FSDANKLGEGGFGPVYKG-VLKKGDEIAVKRLSGRSGQGLREMK-----NEASVIAKVQH 104
           F     LGEG F  V     L    E A+K L  R    ++E K      E  V++++ H
Sbjct: 31  FKFGKILGEGSFSTVVLARELATSREYAIKILEKR--HIIKENKVPYVTRERDVMSRLDH 88
Query: 105 KNLVRLLGCCIDRDEKILIYEYMPNKSLDFFL-----FDPTKRMLLDWVTRVQIIEGIAQ 159
              V+L     D ++      Y  N  L  ++     FD T        TR    E I  
Sbjct: 89  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET-------CTRFYTAE-IVS 140
Query: 160 GLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGY 219
            L YLH      IIHRDLK  NILL++DM+ +I+DFG A++      QA  +  VGT  Y
Sbjct: 141 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 197
Query: 220 MSPEYALEGIFSIKSDVFSFGVLLLEIVSG 249
           +SPE   E      SD+++ G ++ ++V+G
Sbjct: 198 VSPELLTEKSACKSSDLWALGCIIYQLVAG 227

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 68/210 (32%), Positives = 97/210 (46%), Gaps = 24/210 (11%)
Query: 51  FSDANKLGEGGFGP-VYKGVLKKGDEIAVKRLSGRSGQGLREMK-----NEASVIAKVQH 104
           F     LGEG F   V    L    E A+K L  R    ++E K      E  V++++ H
Sbjct: 32  FKFGKILGEGSFSTTVLARELATSREYAIKILEKR--HIIKENKVPYVTRERDVMSRLDH 89
Query: 105 KNLVRLLGCCIDRDEKILIYEYMPNKSLDFFL-----FDPTKRMLLDWVTRVQIIEGIAQ 159
              V+L     D ++      Y  N  L  ++     FD T        TR    E I  
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET-------CTRFYTAE-IVS 141
Query: 160 GLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGY 219
            L YLH      IIHRDLK  NILL++DM+ +I+DFG A++      QA  +  VGT  Y
Sbjct: 142 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 198
Query: 220 MSPEYALEGIFSIKSDVFSFGVLLLEIVSG 249
           +SPE   E      SD+++ G ++ ++V+G
Sbjct: 199 VSPELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 68/210 (32%), Positives = 97/210 (46%), Gaps = 24/210 (11%)
Query: 51  FSDANKLGEGGFGPVYKG-VLKKGDEIAVKRLSGRSGQGLREMK-----NEASVIAKVQH 104
           F     LGEG F  V     L    E A+K L  R    ++E K      E  V++++ H
Sbjct: 32  FKFGKILGEGSFSTVVLARELATSREYAIKILEKR--HIIKENKVPYVTRERDVMSRLDH 89
Query: 105 KNLVRLLGCCIDRDEKILIYEYMPNKSLDFFL-----FDPTKRMLLDWVTRVQIIEGIAQ 159
              V+L     D ++      Y  N  L  ++     FD T        TR    E I  
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET-------CTRFYTAE-IVS 141
Query: 160 GLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGY 219
            L YLH      IIHRDLK  NILL++DM+ +I+DFG A++      QA  +  VGT  Y
Sbjct: 142 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 198
Query: 220 MSPEYALEGIFSIKSDVFSFGVLLLEIVSG 249
           +SPE   E      SD+++ G ++ ++V+G
Sbjct: 199 VSPELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 68/210 (32%), Positives = 97/210 (46%), Gaps = 24/210 (11%)
Query: 51  FSDANKLGEGGFGPVYKG-VLKKGDEIAVKRLSGRSGQGLREMK-----NEASVIAKVQH 104
           F     LGEG F  V     L    E A+K L  R    ++E K      E  V++++ H
Sbjct: 16  FKFGKILGEGSFSTVVLARELATSREYAIKILEKR--HIIKENKVPYVTRERDVMSRLDH 73
Query: 105 KNLVRLLGCCIDRDEKILIYEYMPNKSLDFFL-----FDPTKRMLLDWVTRVQIIEGIAQ 159
              V+L     D ++      Y  N  L  ++     FD T        TR    E I  
Sbjct: 74  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET-------CTRFYTAE-IVS 125
Query: 160 GLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGY 219
            L YLH      IIHRDLK  NILL++DM+ +I+DFG A++      QA  +  VGT  Y
Sbjct: 126 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 182
Query: 220 MSPEYALEGIFSIKSDVFSFGVLLLEIVSG 249
           +SPE   E      SD+++ G ++ ++V+G
Sbjct: 183 VSPELLTEKSACKSSDLWALGCIIYQLVAG 212

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 68/210 (32%), Positives = 97/210 (46%), Gaps = 24/210 (11%)
Query: 51  FSDANKLGEGGFGPVYKG-VLKKGDEIAVKRLSGRSGQGLREMK-----NEASVIAKVQH 104
           F     LGEG F  V     L    E A+K L  R    ++E K      E  V++++ H
Sbjct: 32  FKFGKILGEGSFSTVVLARELATSREYAIKILEKR--HIIKENKVPYVTRERDVMSRLDH 89
Query: 105 KNLVRLLGCCIDRDEKILIYEYMPNKSLDFFL-----FDPTKRMLLDWVTRVQIIEGIAQ 159
              V+L     D ++      Y  N  L  ++     FD T        TR    E I  
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET-------CTRFYTAE-IVS 141
Query: 160 GLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGY 219
            L YLH      IIHRDLK  NILL++DM+ +I+DFG A++      QA  +  VGT  Y
Sbjct: 142 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGTAQY 198
Query: 220 MSPEYALEGIFSIKSDVFSFGVLLLEIVSG 249
           +SPE   E      SD+++ G ++ ++V+G
Sbjct: 199 VSPELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 68/210 (32%), Positives = 97/210 (46%), Gaps = 24/210 (11%)
Query: 51  FSDANKLGEGGFGPVYKG-VLKKGDEIAVKRLSGRSGQGLREMK-----NEASVIAKVQH 104
           F     LGEG F  V     L    E A+K L  R    ++E K      E  V++++ H
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKR--HIIKENKVPYVTRERDVMSRLDH 91
Query: 105 KNLVRLLGCCIDRDEKILIYEYMPNKSLDFFL-----FDPTKRMLLDWVTRVQIIEGIAQ 159
              V+L     D ++      Y  N  L  ++     FD T        TR    E I  
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET-------CTRFYTAE-IVS 143
Query: 160 GLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGY 219
            L YLH      IIHRDLK  NILL++DM+ +I+DFG A++      QA  +  VGT  Y
Sbjct: 144 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 200
Query: 220 MSPEYALEGIFSIKSDVFSFGVLLLEIVSG 249
           +SPE   E      SD+++ G ++ ++V+G
Sbjct: 201 VSPELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 68/210 (32%), Positives = 97/210 (46%), Gaps = 24/210 (11%)
Query: 51  FSDANKLGEGGFGPVYKG-VLKKGDEIAVKRLSGRSGQGLREMK-----NEASVIAKVQH 104
           F     LGEG F  V     L    E A+K L  R    ++E K      E  V++++ H
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKR--HIIKENKVPYVTRERDVMSRLDH 91
Query: 105 KNLVRLLGCCIDRDEKILIYEYMPNKSLDFFL-----FDPTKRMLLDWVTRVQIIEGIAQ 159
              V+L     D ++      Y  N  L  ++     FD T        TR    E I  
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET-------CTRFYTAE-IVS 143
Query: 160 GLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGY 219
            L YLH      IIHRDLK  NILL++DM+ +I+DFG A++      QA  +  VGT  Y
Sbjct: 144 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 200
Query: 220 MSPEYALEGIFSIKSDVFSFGVLLLEIVSG 249
           +SPE   E      SD+++ G ++ ++V+G
Sbjct: 201 VSPELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 68/210 (32%), Positives = 97/210 (46%), Gaps = 24/210 (11%)
Query: 51  FSDANKLGEGGFGPVYKG-VLKKGDEIAVKRLSGRSGQGLREMK-----NEASVIAKVQH 104
           F     LGEG F  V     L    E A+K L  R    ++E K      E  V++++ H
Sbjct: 35  FKFGKILGEGSFSTVVLARELATSREYAIKILEKR--HIIKENKVPYVTRERDVMSRLDH 92
Query: 105 KNLVRLLGCCIDRDEKILIYEYMPNKSLDFFL-----FDPTKRMLLDWVTRVQIIEGIAQ 159
              V+L     D ++      Y  N  L  ++     FD T        TR    E I  
Sbjct: 93  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET-------CTRFYTAE-IVS 144
Query: 160 GLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGY 219
            L YLH      IIHRDLK  NILL++DM+ +I+DFG A++      QA  +  VGT  Y
Sbjct: 145 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 201
Query: 220 MSPEYALEGIFSIKSDVFSFGVLLLEIVSG 249
           +SPE   E      SD+++ G ++ ++V+G
Sbjct: 202 VSPELLTEKSACKSSDLWALGCIIYQLVAG 231

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 107/209 (51%), Gaps = 23/209 (11%)
Query: 50  KFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLS-GRSGQGLREMK-NEASVIAKVQHKNL 107
           K+    K+GEG +G VYK     G+  A+K++   +  +G+      E S++ +++H N+
Sbjct: 3   KYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNI 62
Query: 108 VRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRML------LDWVTRVQIIEGIAQGL 161
           V+L      +   +L++E++             K++L      L+ VT    +  +  G+
Sbjct: 63  VKLYDVIHTKKRLVLVFEHLDQD---------LKKLLDVCEGGLESVTAKSFLLQLLNGI 113
Query: 162 LYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMS 221
            Y H     R++HRDLK  N+L++++   KI+DFG+AR   G  ++  T  IV T  Y +
Sbjct: 114 AYCHDR---RVLHRDLKPQNLLINREGELKIADFGLAR-AFGIPVRKYTHEIV-TLWYRA 168
Query: 222 PEYAL-EGIFSIKSDVFSFGVLLLEIVSG 249
           P+  +    +S   D++S G +  E+V+G
Sbjct: 169 PDVLMGSKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 68/210 (32%), Positives = 97/210 (46%), Gaps = 24/210 (11%)
Query: 51  FSDANKLGEGGFGPVYKG-VLKKGDEIAVKRLSGRSGQGLREMK-----NEASVIAKVQH 104
           F     LGEG F  V     L    E A+K L  R    ++E K      E  V++++ H
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKR--HIIKENKVPYVTRERDVMSRLDH 91
Query: 105 KNLVRLLGCCIDRDEKILIYEYMPNKSLDFFL-----FDPTKRMLLDWVTRVQIIEGIAQ 159
              V+L     D ++      Y  N  L  ++     FD T        TR    E I  
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET-------CTRFYTAE-IVS 143
Query: 160 GLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGY 219
            L YLH      IIHRDLK  NILL++DM+ +I+DFG A++      QA  +  VGT  Y
Sbjct: 144 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 200
Query: 220 MSPEYALEGIFSIKSDVFSFGVLLLEIVSG 249
           +SPE   E      SD+++ G ++ ++V+G
Sbjct: 201 VSPELLTEKSAXKSSDLWALGCIIYQLVAG 230

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 77.8 bits (190), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 68/210 (32%), Positives = 97/210 (46%), Gaps = 24/210 (11%)
Query: 51  FSDANKLGEGGFGPVYKG-VLKKGDEIAVKRLSGRSGQGLREMK-----NEASVIAKVQH 104
           F     LGEG F  V     L    E A+K L  R    ++E K      E  V++++ H
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKR--HIIKENKVPYVTRERDVMSRLDH 91
Query: 105 KNLVRLLGCCIDRDEKILIYEYMPNKSLDFFL-----FDPTKRMLLDWVTRVQIIEGIAQ 159
              V+L     D ++      Y  N  L  ++     FD T        TR    E I  
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET-------CTRFYTAE-IVS 143
Query: 160 GLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGY 219
            L YLH      IIHRDLK  NILL++DM+ +I+DFG A++      QA  +  VGT  Y
Sbjct: 144 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 200
Query: 220 MSPEYALEGIFSIKSDVFSFGVLLLEIVSG 249
           +SPE   E      SD+++ G ++ ++V+G
Sbjct: 201 VSPELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 77.8 bits (190), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 113/218 (51%), Gaps = 22/218 (10%)
Query: 51  FSDANKLGEGGFGPVYKGVLK-KGDEIAVKRL------SGRSGQGLREMKNEASVIAKVQ 103
           F    K+GEG +G VYK   K  G+ +A+K++       G     +RE+    S++ ++ 
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREI----SLLKELN 60
Query: 104 HKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLY 163
           H N+V+LL      ++  L++E++ ++ L  F+ D +    +        +  + QGL +
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAF 118
Query: 164 LHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE 223
            H +   R++HRDLK  N+L++ +   K++DFG+AR   G  ++  T  +V T  Y +PE
Sbjct: 119 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYTHEVV-TLWYRAPE 173
Query: 224 YAL-EGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDS 260
             L    +S   D++S G +  E+V+ +    L+  DS
Sbjct: 174 ILLGXKYYSTAVDIWSLGCIFAEMVTRR---ALFPGDS 208

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 77.8 bits (190), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 68/242 (28%), Positives = 115/242 (47%), Gaps = 35/242 (14%)
Query: 32  EVDQFPLFSFSSVSTATNKFSDANKLGEGGFGPVY--------KGVLKKGDEIAVKRLSG 83
           E+ + P + F       +K +    LGEG FG V         K   K+   +AVK L  
Sbjct: 10  ELPEDPKWEFPR-----DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKD 64
Query: 84  RSGQ-GLREMKNEASVIAKV-QHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFL----- 136
            + +  L ++ +E  ++  + +HKN++ LLG C       +I EY    +L  +L     
Sbjct: 65  DATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRP 124
Query: 137 ------FD----PTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDK 186
                 +D    P ++M       V     +A+G+ YL   +  + IHRDL A N+L+ +
Sbjct: 125 PGMEYSYDINRVPEEQMTFK--DLVSCTYQLARGMEYL---ASQKCIHRDLTARNVLVTE 179
Query: 187 DMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEI 246
           +   KI+DFG+AR     +    T+       +M+PE   + +++ +SDV+SFGVL+ EI
Sbjct: 180 NNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 239
Query: 247 VS 248
            +
Sbjct: 240 FT 241

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 68/242 (28%), Positives = 115/242 (47%), Gaps = 35/242 (14%)
Query: 32  EVDQFPLFSFSSVSTATNKFSDANKLGEGGFGPVY--------KGVLKKGDEIAVKRLSG 83
           E+ + P + F       +K +    LGEG FG V         K   K+   +AVK L  
Sbjct: 15  ELPEDPKWEFPR-----DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKD 69
Query: 84  RSGQ-GLREMKNEASVIAKV-QHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFL----- 136
            + +  L ++ +E  ++  + +HKN++ LLG C       +I EY    +L  +L     
Sbjct: 70  DATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRP 129
Query: 137 ------FD----PTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDK 186
                 +D    P ++M       V     +A+G+ YL   +  + IHRDL A N+L+ +
Sbjct: 130 PGMEYSYDINRVPEEQMTFK--DLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTE 184
Query: 187 DMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEI 246
           +   KI+DFG+AR     +    T+       +M+PE   + +++ +SDV+SFGVL+ EI
Sbjct: 185 NNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 244
Query: 247 VS 248
            +
Sbjct: 245 FT 246

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 68/210 (32%), Positives = 97/210 (46%), Gaps = 24/210 (11%)
Query: 51  FSDANKLGEGGFGPVYKG-VLKKGDEIAVKRLSGRSGQGLREMK-----NEASVIAKVQH 104
           F     LGEG F  V     L    E A+K L  R    ++E K      E  V++++ H
Sbjct: 37  FKFGKILGEGSFSTVVLARELATSREYAIKILEKR--HIIKENKVPYVTRERDVMSRLDH 94
Query: 105 KNLVRLLGCCIDRDEKILIYEYMPNKSLDFFL-----FDPTKRMLLDWVTRVQIIEGIAQ 159
              V+L     D ++      Y  N  L  ++     FD T        TR    E I  
Sbjct: 95  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET-------CTRFYTAE-IVS 146
Query: 160 GLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGY 219
            L YLH      IIHRDLK  NILL++DM+ +I+DFG A++      QA  +  VGT  Y
Sbjct: 147 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 203
Query: 220 MSPEYALEGIFSIKSDVFSFGVLLLEIVSG 249
           +SPE   E      SD+++ G ++ ++V+G
Sbjct: 204 VSPELLTEKSACKSSDLWALGCIIYQLVAG 233

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 67/242 (27%), Positives = 115/242 (47%), Gaps = 35/242 (14%)
Query: 32  EVDQFPLFSFSSVSTATNKFSDANKLGEGGFGPVY--------KGVLKKGDEIAVKRLSG 83
           E+ + P + F       +K +    LGEG FG V         K   K+   +AVK L  
Sbjct: 23  ELPEDPKWEFPR-----DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKD 77
Query: 84  RSGQ-GLREMKNEASVIAKV-QHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFL----- 136
            + +  L ++ +E  ++  + +HKN++ LLG C       +I EY    +L  +L     
Sbjct: 78  DATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRP 137
Query: 137 ------FD----PTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDK 186
                 +D    P ++M       V     +A+G+ YL   +  + IHRDL A N+L+ +
Sbjct: 138 PGMEYSYDINRVPEEQMTFK--DLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTE 192
Query: 187 DMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEI 246
           +   +I+DFG+AR     +    T+       +M+PE   + +++ +SDV+SFGVL+ EI
Sbjct: 193 NNVMRIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 252
Query: 247 VS 248
            +
Sbjct: 253 FT 254

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 68/242 (28%), Positives = 115/242 (47%), Gaps = 35/242 (14%)
Query: 32  EVDQFPLFSFSSVSTATNKFSDANKLGEGGFGPVY--------KGVLKKGDEIAVKRLSG 83
           E+ + P + F       +K +    LGEG FG V         K   K+   +AVK L  
Sbjct: 12  ELPEDPKWEFPR-----DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKD 66
Query: 84  RSGQ-GLREMKNEASVIAKV-QHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFL----- 136
            + +  L ++ +E  ++  + +HKN++ LLG C       +I EY    +L  +L     
Sbjct: 67  DATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRP 126
Query: 137 ------FD----PTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDK 186
                 +D    P ++M       V     +A+G+ YL   +  + IHRDL A N+L+ +
Sbjct: 127 PGMEYSYDINRVPEEQMTFK--DLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTE 181
Query: 187 DMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEI 246
           +   KI+DFG+AR     +    T+       +M+PE   + +++ +SDV+SFGVL+ EI
Sbjct: 182 NNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 241
Query: 247 VS 248
            +
Sbjct: 242 FT 243

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 113/218 (51%), Gaps = 22/218 (10%)
Query: 51  FSDANKLGEGGFGPVYKGVLK-KGDEIAVKRL------SGRSGQGLREMKNEASVIAKVQ 103
           F    K+GEG +G VYK   K  G+ +A+K++       G     +RE+    S++ ++ 
Sbjct: 12  FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREI----SLLKELN 67
Query: 104 HKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLY 163
           H N+V+LL      ++  L++E++ ++ L  F+ D +    +        +  + QGL +
Sbjct: 68  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAF 125
Query: 164 LHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE 223
            H +   R++HRDLK  N+L++ +   K++DFG+AR   G  ++  T  +V T  Y +PE
Sbjct: 126 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYTHEVV-TLWYRAPE 180
Query: 224 YAL-EGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDS 260
             L    +S   D++S G +  E+V+ +    L+  DS
Sbjct: 181 ILLGXKYYSTAVDIWSLGCIFAEMVTRR---ALFPGDS 215

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 113/218 (51%), Gaps = 22/218 (10%)
Query: 51  FSDANKLGEGGFGPVYKGVLK-KGDEIAVKRL------SGRSGQGLREMKNEASVIAKVQ 103
           F    K+GEG +G VYK   K  G+ +A+K++       G     +RE+    S++ ++ 
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREI----SLLKELN 60
Query: 104 HKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLY 163
           H N+V+LL      ++  L++E++ ++ L  F+ D +    +        +  + QGL +
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAF 118
Query: 164 LHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE 223
            H +   R++HRDLK  N+L++ +   K++DFG+AR   G  ++  T  +V T  Y +PE
Sbjct: 119 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYTHEVV-TLWYRAPE 173
Query: 224 YALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDS 260
             L    +S   D++S G +  E+V+ +    L+  DS
Sbjct: 174 ILLGCKYYSTAVDIWSLGCIFAEMVTRR---ALFPGDS 208

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 113/218 (51%), Gaps = 22/218 (10%)
Query: 51  FSDANKLGEGGFGPVYKGVLK-KGDEIAVKRL------SGRSGQGLREMKNEASVIAKVQ 103
           F    K+GEG +G VYK   K  G+ +A+K++       G     +RE+    S++ ++ 
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREI----SLLKELN 59
Query: 104 HKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLY 163
           H N+V+LL      ++  L++E++ ++ L  F+ D +    +        +  + QGL +
Sbjct: 60  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAF 117
Query: 164 LHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE 223
            H +   R++HRDLK  N+L++ +   K++DFG+AR   G  ++  T  +V T  Y +PE
Sbjct: 118 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYTHEVV-TLWYRAPE 172
Query: 224 YALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDS 260
             L    +S   D++S G +  E+V+ +    L+  DS
Sbjct: 173 ILLGCKYYSTAVDIWSLGCIFAEMVTRR---ALFPGDS 207

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 107/209 (51%), Gaps = 23/209 (11%)
Query: 50  KFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLS-GRSGQGLREMK-NEASVIAKVQHKNL 107
           K+    K+GEG +G VYK     G+  A+K++   +  +G+      E S++ +++H N+
Sbjct: 3   KYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNI 62
Query: 108 VRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRML------LDWVTRVQIIEGIAQGL 161
           V+L      +   +L++E++             K++L      L+ VT    +  +  G+
Sbjct: 63  VKLYDVIHTKKRLVLVFEHLDQD---------LKKLLDVCEGGLESVTAKSFLLQLLNGI 113
Query: 162 LYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMS 221
            Y H     R++HRDLK  N+L++++   KI+DFG+AR   G  ++  T  +V T  Y +
Sbjct: 114 AYCHDR---RVLHRDLKPQNLLINREGELKIADFGLAR-AFGIPVRKYTHEVV-TLWYRA 168
Query: 222 PEYAL-EGIFSIKSDVFSFGVLLLEIVSG 249
           P+  +    +S   D++S G +  E+V+G
Sbjct: 169 PDVLMGSKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 70/279 (25%), Positives = 127/279 (45%), Gaps = 35/279 (12%)
Query: 51  FSDANKLGEGGFGPVYKG-VLKKGDEIAVKRLSG---RSGQGLREMKNEASVIAKVQHKN 106
           F    K+G G F  VY+   L  G  +A+K++        +   +   E  ++ ++ H N
Sbjct: 34  FRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 93
Query: 107 LVRLLGCCIDRDEKILIYEYMPNKSLDFFL--FDPTKRMLLD---WVTRVQIIEGIAQGL 161
           +++     I+ +E  ++ E      L   +  F   KR++ +   W   VQ+   +    
Sbjct: 94  VIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALE--- 150
Query: 162 LYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMS 221
              H +SR R++HRD+K +N+ +      K+ D G+ R        A++  +VGT  YMS
Sbjct: 151 ---HMHSR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYMS 204
Query: 222 PEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELID 281
           PE   E  ++ KSD++S G LL E+ + +     +  D +N       L++  + +E  D
Sbjct: 205 PERIHENGYNFKSDIWSLGCLLYEMAALQSP---FYGDKMN-------LYSLCKKIEQCD 254
Query: 282 --PILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDV 318
             P+  D YS +   LR   +  +C+    + RP +  V
Sbjct: 255 YPPLPSDHYSEE---LR--QLVNMCINPDPEKRPDVTYV 288

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 107/209 (51%), Gaps = 23/209 (11%)
Query: 50  KFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLS-GRSGQGLREMK-NEASVIAKVQHKNL 107
           K+    K+GEG +G VYK     G+  A+K++   +  +G+      E S++ +++H N+
Sbjct: 3   KYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNI 62
Query: 108 VRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRML------LDWVTRVQIIEGIAQGL 161
           V+L      +   +L++E++             K++L      L+ VT    +  +  G+
Sbjct: 63  VKLYDVIHTKKRLVLVFEHLDQD---------LKKLLDVCEGGLESVTAKSFLLQLLNGI 113
Query: 162 LYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMS 221
            Y H     R++HRDLK  N+L++++   KI+DFG+AR   G  ++  T  +V T  Y +
Sbjct: 114 AYCHDR---RVLHRDLKPQNLLINREGELKIADFGLAR-AFGIPVRKYTHEVV-TLWYRA 168
Query: 222 PEYAL-EGIFSIKSDVFSFGVLLLEIVSG 249
           P+  +    +S   D++S G +  E+V+G
Sbjct: 169 PDVLMGSKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 113/218 (51%), Gaps = 22/218 (10%)
Query: 51  FSDANKLGEGGFGPVYKGVLK-KGDEIAVKRL------SGRSGQGLREMKNEASVIAKVQ 103
           F    K+GEG +G VYK   K  G+ +A+K++       G     +RE+    S++ ++ 
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREI----SLLKELN 59
Query: 104 HKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLY 163
           H N+V+LL      ++  L++E++ ++ L  F+ D +    +        +  + QGL +
Sbjct: 60  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAF 117
Query: 164 LHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE 223
            H +   R++HRDLK  N+L++ +   K++DFG+AR   G  ++  T  +V T  Y +PE
Sbjct: 118 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYTHEVV-TLWYRAPE 172
Query: 224 YALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDS 260
             L    +S   D++S G +  E+V+ +    L+  DS
Sbjct: 173 ILLGCKYYSTAVDIWSLGCIFAEMVTRR---ALFPGDS 207

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 113/218 (51%), Gaps = 22/218 (10%)
Query: 51  FSDANKLGEGGFGPVYKGVLK-KGDEIAVKRL------SGRSGQGLREMKNEASVIAKVQ 103
           F    K+GEG +G VYK   K  G+ +A+K++       G     +RE+    S++ ++ 
Sbjct: 12  FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREI----SLLKELN 67
Query: 104 HKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLY 163
           H N+V+LL      ++  L++E++ ++ L  F+ D +    +        +  + QGL +
Sbjct: 68  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAF 125
Query: 164 LHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE 223
            H +   R++HRDLK  N+L++ +   K++DFG+AR   G  ++  T  +V T  Y +PE
Sbjct: 126 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYTHEVV-TLWYRAPE 180
Query: 224 YALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDS 260
             L    +S   D++S G +  E+V+ +    L+  DS
Sbjct: 181 ILLGCKYYSTAVDIWSLGCIFAEMVTRR---ALFPGDS 215

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 113/218 (51%), Gaps = 22/218 (10%)
Query: 51  FSDANKLGEGGFGPVYKGVLK-KGDEIAVKRL------SGRSGQGLREMKNEASVIAKVQ 103
           F    K+GEG +G VYK   K  G+ +A+K++       G     +RE+    S++ ++ 
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREI----SLLKELN 59
Query: 104 HKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLY 163
           H N+V+LL      ++  L++E++ ++ L  F+ D +    +        +  + QGL +
Sbjct: 60  HPNIVKLLDVIHTENKLYLVFEHV-HQDLKTFM-DASALTGIPLPLIKSYLFQLLQGLAF 117
Query: 164 LHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE 223
            H +   R++HRDLK  N+L++ +   K++DFG+AR   G  ++  T  +V T  Y +PE
Sbjct: 118 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYTHEVV-TLWYRAPE 172
Query: 224 YALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDS 260
             L    +S   D++S G +  E+V+ +    L+  DS
Sbjct: 173 ILLGCKYYSTAVDIWSLGCIFAEMVTRR---ALFPGDS 207

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 113/218 (51%), Gaps = 22/218 (10%)
Query: 51  FSDANKLGEGGFGPVYKGVLK-KGDEIAVKRL------SGRSGQGLREMKNEASVIAKVQ 103
           F    K+GEG +G VYK   K  G+ +A+K++       G     +RE+    S++ ++ 
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREI----SLLKELN 61
Query: 104 HKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLY 163
           H N+V+LL      ++  L++E++ ++ L  F+ D +    +        +  + QGL +
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAF 119
Query: 164 LHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE 223
            H +   R++HRDLK  N+L++ +   K++DFG+AR   G  ++  T  +V T  Y +PE
Sbjct: 120 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYTHEVV-TLWYRAPE 174
Query: 224 YALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDS 260
             L    +S   D++S G +  E+V+ +    L+  DS
Sbjct: 175 ILLGCKYYSTAVDIWSLGCIFAEMVTRR---ALFPGDS 209

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 113/218 (51%), Gaps = 22/218 (10%)
Query: 51  FSDANKLGEGGFGPVYKGVLK-KGDEIAVKRL------SGRSGQGLREMKNEASVIAKVQ 103
           F    K+GEG +G VYK   K  G+ +A+K++       G     +RE+    S++ ++ 
Sbjct: 9   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREI----SLLKELN 64
Query: 104 HKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLY 163
           H N+V+LL      ++  L++E++ ++ L  F+ D +    +        +  + QGL +
Sbjct: 65  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAF 122
Query: 164 LHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE 223
            H +   R++HRDLK  N+L++ +   K++DFG+AR   G  ++  T  +V T  Y +PE
Sbjct: 123 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYTHEVV-TLWYRAPE 177
Query: 224 YALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDS 260
             L    +S   D++S G +  E+V+ +    L+  DS
Sbjct: 178 ILLGCKYYSTAVDIWSLGCIFAEMVTRR---ALFPGDS 212

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 113/218 (51%), Gaps = 22/218 (10%)
Query: 51  FSDANKLGEGGFGPVYKGVLK-KGDEIAVKRL------SGRSGQGLREMKNEASVIAKVQ 103
           F    K+GEG +G VYK   K  G+ +A+K++       G     +RE+    S++ ++ 
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREI----SLLKELN 60
Query: 104 HKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLY 163
           H N+V+LL      ++  L++E++ ++ L  F+ D +    +        +  + QGL +
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAF 118
Query: 164 LHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE 223
            H +   R++HRDLK  N+L++ +   K++DFG+AR   G  ++  T  +V T  Y +PE
Sbjct: 119 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYTHEVV-TLWYRAPE 173
Query: 224 YALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDS 260
             L    +S   D++S G +  E+V+ +    L+  DS
Sbjct: 174 ILLGCKYYSTAVDIWSLGCIFAEMVTRR---ALFPGDS 208

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 109/218 (50%), Gaps = 22/218 (10%)
Query: 51  FSDANKLGEGGFGPVYKGVLK-KGDEIAVKRL------SGRSGQGLREMKNEASVIAKVQ 103
           F    K+GEG +G VYK   K  G+ +A+K++       G     +RE+    S++ ++ 
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREI----SLLKELN 60
Query: 104 HKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLY 163
           H N+V+LL      ++  L++E++     DF        + L  +     +  + QGL +
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQDLKDFMDASALTGIPLPLIK--SYLFQLLQGLAF 118
Query: 164 LHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE 223
            H +   R++HRDLK  N+L++ +   K++DFG+AR   G  ++     +V T  Y +PE
Sbjct: 119 CHSH---RVLHRDLKPENLLINTEGAIKLADFGLAR-AFGVPVRTYXHEVV-TLWYRAPE 173
Query: 224 YALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDS 260
             L    +S   D++S G +  E+V+ +    L+  DS
Sbjct: 174 ILLGCKYYSTAVDIWSLGCIFAEMVTRR---ALFPGDS 208

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 103/213 (48%), Gaps = 24/213 (11%)
Query: 57  LGEGGFGPVYK----GVLKKGD--EIAVKRL-SGRSGQGLREMKNEASVIAKV-QHKNLV 108
           LG G FG V +    G+ K      +AVK L  G +    R + +E  ++  +  H N+V
Sbjct: 36  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 95
Query: 109 RLLGCCIDRDEKILIY----------EYMPNKSLDFFLFDPTKRMLLDWVTRVQIIE--- 155
            LLG C      +++            Y+ +K  +F  +   + +  D++T   +I    
Sbjct: 96  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTPEDLYKDFLTLEHLICYSF 155
Query: 156 GIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVG 215
            +A+G+ +L   +  + IHRDL A NILL +    KI DFG+AR    +           
Sbjct: 156 QVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARL 212
Query: 216 TYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 248
              +M+PE   + +++I+SDV+SFGVLL EI S
Sbjct: 213 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 113/218 (51%), Gaps = 22/218 (10%)
Query: 51  FSDANKLGEGGFGPVYKGVLK-KGDEIAVKRL------SGRSGQGLREMKNEASVIAKVQ 103
           F    K+GEG +G VYK   K  G+ +A+K++       G     +RE+    S++ ++ 
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREI----SLLKELN 60
Query: 104 HKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLY 163
           H N+V+LL      ++  L++E++ ++ L  F+ D +    +        +  + QGL +
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLSF 118
Query: 164 LHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE 223
            H +   R++HRDLK  N+L++ +   K++DFG+AR   G  ++  T  +V T  Y +PE
Sbjct: 119 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYTHEVV-TLWYRAPE 173
Query: 224 YALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDS 260
             L    +S   D++S G +  E+V+ +    L+  DS
Sbjct: 174 ILLGCKYYSTAVDIWSLGCIFAEMVTRR---ALFPGDS 208

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 102/206 (49%), Gaps = 20/206 (9%)
Query: 57  LGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKV-QHKNLVRLLGCCI 115
           +G G +G VYKG   K  ++A  ++   +G    E+K E +++ K   H+N+    G  I
Sbjct: 32  VGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFI 91
Query: 116 DR------DEKILIYEYMPNKSLDFFLFDPTKRMLLD-WVTRVQIIEGIAQGLLYLHQYS 168
            +      D+  L+ E+    S+   + +     L + W+    I   I +GL +LHQ+ 
Sbjct: 92  KKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWI--AYICREILRGLSHLHQH- 148
Query: 169 RVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAL-- 226
             ++IHRD+K  N+LL ++   K+ DFG++        + NT   +GT  +M+PE     
Sbjct: 149 --KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT--FIGTPYWMAPEVIACD 204
Query: 227 ---EGIFSIKSDVFSFGVLLLEIVSG 249
              +  +  KSD++S G+  +E+  G
Sbjct: 205 ENPDATYDFKSDLWSLGITAIEMAEG 230

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 104/213 (48%), Gaps = 25/213 (11%)
Query: 57  LGEGGFGPVYK----GVLKKGDE--IAVKRL-SGRSGQGLREMKNEASVIAKV-QHKNLV 108
           LG G FG V +    G+ K      +AVK L  G +    R + +E  ++  +  H N+V
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 96
Query: 109 RLLGCCIDRDEKILIY----------EYMPNKSLDFFLFDPTKRMLLDWVTRVQIIE--- 155
            LLG C      +++            Y+ +K  +F  + P + +  D++T   +I    
Sbjct: 97  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKP-EDLYKDFLTLEHLIXYSF 155
Query: 156 GIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVG 215
            +A+G+ +L   +  + IHRDL A NILL +    KI DFG+AR    +           
Sbjct: 156 QVAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARL 212
Query: 216 TYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 248
              +M+PE   + +++I+SDV+SFGVLL EI S
Sbjct: 213 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 108/215 (50%), Gaps = 19/215 (8%)
Query: 47  ATNKFSDANKLGEGGFGPVYKGV-LKKGDEIAVKRL---SGRSGQGLREMKNEASV--IA 100
           AT+++    ++G G +G VYK      G  +A+K +   +G  G  +  ++  A +  + 
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 101 KVQHKNLVRLLGCC----IDRDEKI-LIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIE 155
             +H N+VRL+  C     DR+ K+ L++E++ ++ L  +L D      L   T   ++ 
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYL-DKAPPPGLPAETIKDLMR 119
Query: 156 GIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVG 215
              +GL +LH      I+HRDLK  NIL+      K++DFG+ARI      Q   + +V 
Sbjct: 120 QFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARI---YSYQMALAPVVV 173
Query: 216 TYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 250
           T  Y +PE  L+  ++   D++S G +  E+   K
Sbjct: 174 TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 208

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 69/226 (30%), Positives = 111/226 (49%), Gaps = 31/226 (13%)
Query: 38  LFSFSSVSTATNKFSDANKLGEGGFGPVYKGVLKK----GDEIAVKRLSGRSGQGLREMK 93
           +F   S +  ++++     LG+G FG V   +L K    G E AVK +S R    +++  
Sbjct: 15  MFVQHSTAIFSDRYKGQRVLGKGSFGEV---ILCKDKITGQECAVKVISKRQ---VKQKT 68
Query: 94  NEASVIAKVQ------HKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPT-KRMLLD 146
           ++ S++ +VQ      H N+++L     D+    L+ E      L    FD    R    
Sbjct: 69  DKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGEL----FDEIISRKRFS 124
Query: 147 WVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLD---KDMNPKISDFGMARICGG 203
            V   +II  +  G+ Y+H   + +I+HRDLK  N+LL+   KD N +I DFG++     
Sbjct: 125 EVDAARIIRQVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF-- 179
Query: 204 NELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 249
            E        +GT  Y++PE  L G +  K DV+S GV+L  ++SG
Sbjct: 180 -EASKKMKDKIGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 223

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 103/203 (50%), Gaps = 19/203 (9%)
Query: 57  LGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCI 115
           LG+G +G VY G  L     IA+K +  R  +  + +  E ++   ++HKN+V+ LG   
Sbjct: 30  LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 89
Query: 116 DRDEKILIYEYMPNKSLDFFL---FDPTK--RMLLDWVTRVQIIEGIAQGLLYLHQYSRV 170
           +     +  E +P  SL   L   + P K     + + T+ QI+E    GL YLH     
Sbjct: 90  ENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTK-QILE----GLKYLHDN--- 141
Query: 171 RIIHRDLKASNILLDKDMNP-KISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGI 229
           +I+HRD+K  N+L++      KISDFG ++   G  +   T    GT  YM+PE   +G 
Sbjct: 142 QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAG--INPCTETFTGTLQYMAPEIIDKGP 199
Query: 230 --FSIKSDVFSFGVLLLEIVSGK 250
             +   +D++S G  ++E+ +GK
Sbjct: 200 RGYGKAADIWSLGCTIIEMATGK 222

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 69/226 (30%), Positives = 111/226 (49%), Gaps = 31/226 (13%)
Query: 38  LFSFSSVSTATNKFSDANKLGEGGFGPVYKGVLKK----GDEIAVKRLSGRSGQGLREMK 93
           +F   S +  ++++     LG+G FG V   +L K    G E AVK +S R    +++  
Sbjct: 39  MFVQHSTAIFSDRYKGQRVLGKGSFGEV---ILCKDKITGQECAVKVISKRQ---VKQKT 92
Query: 94  NEASVIAKVQ------HKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPT-KRMLLD 146
           ++ S++ +VQ      H N+++L     D+    L+ E      L    FD    R    
Sbjct: 93  DKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGEL----FDEIISRKRFS 148
Query: 147 WVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLD---KDMNPKISDFGMARICGG 203
            V   +II  +  G+ Y+H   + +I+HRDLK  N+LL+   KD N +I DFG++     
Sbjct: 149 EVDAARIIRQVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF-- 203
Query: 204 NELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 249
            E        +GT  Y++PE  L G +  K DV+S GV+L  ++SG
Sbjct: 204 -EASKKMKDKIGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 247

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 67/242 (27%), Positives = 114/242 (47%), Gaps = 35/242 (14%)
Query: 32  EVDQFPLFSFSSVSTATNKFSDANKLGEGGFGPVY--------KGVLKKGDEIAVKRLSG 83
           E+ + P + F       +K +    LGEG FG V         K   K+   +AVK L  
Sbjct: 23  ELPEDPKWEFPR-----DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKD 77
Query: 84  RSGQ-GLREMKNEASVIAKV-QHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFL----- 136
            + +  L ++ +E  ++  + +HKN++ LLG C       +I  Y    +L  +L     
Sbjct: 78  DATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVAYASKGNLREYLRARRP 137
Query: 137 ------FD----PTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDK 186
                 +D    P ++M       V     +A+G+ YL   +  + IHRDL A N+L+ +
Sbjct: 138 PGMEYSYDINRVPEEQMTFK--DLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTE 192
Query: 187 DMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEI 246
           +   KI+DFG+AR     +    T+       +M+PE   + +++ +SDV+SFGVL+ EI
Sbjct: 193 NNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 252
Query: 247 VS 248
            +
Sbjct: 253 FT 254

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 69/226 (30%), Positives = 111/226 (49%), Gaps = 31/226 (13%)
Query: 38  LFSFSSVSTATNKFSDANKLGEGGFGPVYKGVLKK----GDEIAVKRLSGRSGQGLREMK 93
           +F   S +  ++++     LG+G FG V   +L K    G E AVK +S R    +++  
Sbjct: 38  MFVQHSTAIFSDRYKGQRVLGKGSFGEV---ILCKDKITGQECAVKVISKRQ---VKQKT 91
Query: 94  NEASVIAKVQ------HKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPT-KRMLLD 146
           ++ S++ +VQ      H N+++L     D+    L+ E      L    FD    R    
Sbjct: 92  DKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGEL----FDEIISRKRFS 147
Query: 147 WVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLD---KDMNPKISDFGMARICGG 203
            V   +II  +  G+ Y+H   + +I+HRDLK  N+LL+   KD N +I DFG++     
Sbjct: 148 EVDAARIIRQVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF-- 202
Query: 204 NELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 249
            E        +GT  Y++PE  L G +  K DV+S GV+L  ++SG
Sbjct: 203 -EASKKMKDKIGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 246

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 69/226 (30%), Positives = 111/226 (49%), Gaps = 31/226 (13%)
Query: 38  LFSFSSVSTATNKFSDANKLGEGGFGPVYKGVLKK----GDEIAVKRLSGRSGQGLREMK 93
           +F   S +  ++++     LG+G FG V   +L K    G E AVK +S R    +++  
Sbjct: 21  MFVQHSTAIFSDRYKGQRVLGKGSFGEV---ILCKDKITGQECAVKVISKRQ---VKQKT 74
Query: 94  NEASVIAKVQ------HKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPT-KRMLLD 146
           ++ S++ +VQ      H N+++L     D+    L+ E      L    FD    R    
Sbjct: 75  DKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGEL----FDEIISRKRFS 130
Query: 147 WVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLD---KDMNPKISDFGMARICGG 203
            V   +II  +  G+ Y+H   + +I+HRDLK  N+LL+   KD N +I DFG++     
Sbjct: 131 EVDAARIIRQVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLST---H 184
Query: 204 NELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 249
            E        +GT  Y++PE  L G +  K DV+S GV+L  ++SG
Sbjct: 185 FEASKKMKDKIGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 229

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 109/218 (50%), Gaps = 22/218 (10%)
Query: 51  FSDANKLGEGGFGPVYKGVLK-KGDEIAVKRL------SGRSGQGLREMKNEASVIAKVQ 103
           F    K+GEG +G VYK   K  G+ +A+K++       G     +RE+    S++ ++ 
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREI----SLLKELN 63
Query: 104 HKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLY 163
           H N+V+LL      ++  L++E++     DF        + L  +     +  + QGL +
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFLSMDLKDFMDASALTGIPLPLIK--SYLFQLLQGLAF 121
Query: 164 LHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE 223
            H +   R++HRDLK  N+L++ +   K++DFG+AR   G  ++     +V T  Y +PE
Sbjct: 122 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYXHEVV-TLWYRAPE 176
Query: 224 YALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDS 260
             L    +S   D++S G +  E+V+ +    L+  DS
Sbjct: 177 ILLGCKYYSTAVDIWSLGCIFAEMVTRR---ALFPGDS 211

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 109/218 (50%), Gaps = 22/218 (10%)
Query: 51  FSDANKLGEGGFGPVYKGVLK-KGDEIAVKRL------SGRSGQGLREMKNEASVIAKVQ 103
           F    K+GEG +G VYK   K  G+ +A+K++       G     +RE+    S++ ++ 
Sbjct: 7   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREI----SLLKELN 62
Query: 104 HKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLY 163
           H N+V+LL      ++  L++E++     DF        + L  +     +  + QGL +
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFLSMDLKDFMDASALTGIPLPLIK--SYLFQLLQGLAF 120
Query: 164 LHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE 223
            H +   R++HRDLK  N+L++ +   K++DFG+AR   G  ++     +V T  Y +PE
Sbjct: 121 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYXHEVV-TLWYRAPE 175
Query: 224 YALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDS 260
             L    +S   D++S G +  E+V+ +    L+  DS
Sbjct: 176 ILLGCKYYSTAVDIWSLGCIFAEMVTRR---ALFPGDS 210

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 94/321 (29%), Positives = 149/321 (46%), Gaps = 47/321 (14%)
Query: 57  LGEGGFGPVYKGVLK-KGDEIAVKRLSGRSGQG--LREMKNEASVIAKVQHKNLVRLLGC 113
           LG+G FG V K   +    E AVK ++  S +      +  E  ++ K+ H N+++L   
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 114 CIDRDEKILIYEYMPNKSLDFFLFDPT-KRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRI 172
             D     ++ E      L    FD   KR         +II+ +  G+ Y+H+++   I
Sbjct: 90  LEDSSSFYIVGELYTGGEL----FDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN---I 142
Query: 173 IHRDLKASNILL---DKDMNPKISDFGMARICGGNELQANTSRI--VGTYGYMSPEYALE 227
           +HRDLK  NILL   +KD + KI DFG++  C     Q NT     +GT  Y++PE  L 
Sbjct: 143 VHRDLKPENILLESKEKDCDIKIIDFGLS-TC----FQQNTKMKDRIGTAYYIAPE-VLR 196
Query: 228 GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLL------GYAWDL--W--TSNRTL 277
           G +  K DV+S GV+L  ++SG      Y  +  ++L       YA+DL  W   S+   
Sbjct: 197 GTYDEKCDVWSAGVILYILLSG--TPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAK 254
Query: 278 ELIDPILEDEYSSKQMLLRYANIALL---CVQESADDRPTMNDVVSM---LTNEAATLLP 331
           +LI  +L    S     LR      L    +Q+ + + PT++D+ S+   +TN       
Sbjct: 255 DLIRKMLTFHPS-----LRITATQCLEHPWIQKYSSETPTISDLPSLESAMTNIRQFQAE 309
Query: 332 PK--QPAFSYVRNTVTSTSST 350
            K  Q A  Y+ + +T+   T
Sbjct: 310 KKLAQAALLYMASKLTTLDET 330

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 101/213 (47%), Gaps = 21/213 (9%)
Query: 47  ATNKFSDANKLGEGGFGPVYKGVLKKG---------DEIAVKRLSGRSGQGLREMKNEAS 97
           +  K+    K+GEG FG   K +L K           EI + R+S +  +   E + E +
Sbjct: 22  SMEKYVRLQKIGEGSFG---KAILVKSTEDGRQYVIKEINISRMSSKERE---ESRREVA 75
Query: 98  VIAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGI 157
           V+A ++H N+V+      +     ++ +Y     L F   +  K +L       QI++  
Sbjct: 76  VLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDL-FKRINAQKGVLFQ---EDQILDWF 131
Query: 158 AQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTY 217
            Q  L L      +I+HRD+K+ NI L KD   ++ DFG+AR+       A     +GT 
Sbjct: 132 VQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARAC--IGTP 189
Query: 218 GYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 250
            Y+SPE      ++ KSD+++ G +L E+ + K
Sbjct: 190 YYLSPEICENKPYNNKSDIWALGCVLYELCTLK 222

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 101/207 (48%), Gaps = 15/207 (7%)
Query: 50  KFSDANKLGEGGFGPVY---KGVLKKGDEIAVKRL---SGRSGQGLREMKNEASVIAKVQ 103
           ++   +KLG GG   VY     +L    ++A+K +        + L+  + E    +++ 
Sbjct: 12  RYKIVDKLGGGGMSTVYLAEDTILNI--KVAIKAIFIPPREKEETLKRFEREVHNSSQLS 69
Query: 104 HKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLY 163
           H+N+V ++    + D   L+ EY+   +L  ++        L   T +     I  G+ +
Sbjct: 70  HQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYI---ESHGPLSVDTAINFTNQILDGIKH 126
Query: 164 LHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE 223
            H    +RI+HRD+K  NIL+D +   KI DFG+A+      L   T+ ++GT  Y SPE
Sbjct: 127 AHD---MRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSL-TQTNHVLGTVQYFSPE 182
Query: 224 YALEGIFSIKSDVFSFGVLLLEIVSGK 250
            A        +D++S G++L E++ G+
Sbjct: 183 QAKGEATDECTDIYSIGIVLYEMLVGE 209

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 107/215 (49%), Gaps = 19/215 (8%)
Query: 47  ATNKFSDANKLGEGGFGPVYKGV-LKKGDEIAVKRL---SGRSGQGLREMKNEASV--IA 100
           AT+++    ++G G +G VYK      G  +A+K +   +G  G  +  ++  A +  + 
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 101 KVQHKNLVRLLGCC----IDRDEKI-LIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIE 155
             +H N+VRL+  C     DR+ K+ L++E++ ++ L  +L D      L   T   ++ 
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYL-DKAPPPGLPAETIKDLMR 119
Query: 156 GIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVG 215
              +GL +LH      I+HRDLK  NIL+      K++DFG+ARI      Q     +V 
Sbjct: 120 QFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARI---YSYQMALDPVVV 173
Query: 216 TYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 250
           T  Y +PE  L+  ++   D++S G +  E+   K
Sbjct: 174 TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 208

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 103/203 (50%), Gaps = 19/203 (9%)
Query: 57  LGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCI 115
           LG+G +G VY G  L     IA+K +  R  +  + +  E ++   ++HKN+V+ LG   
Sbjct: 16  LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 75
Query: 116 DRDEKILIYEYMPNKSLDFFL---FDPTK--RMLLDWVTRVQIIEGIAQGLLYLHQYSRV 170
           +     +  E +P  SL   L   + P K     + + T+ QI+E    GL YLH     
Sbjct: 76  ENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTK-QILE----GLKYLHDN--- 127
Query: 171 RIIHRDLKASNILLDKDMNP-KISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGI 229
           +I+HRD+K  N+L++      KISDFG ++   G  +   T    GT  YM+PE   +G 
Sbjct: 128 QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAG--INPCTETFTGTLQYMAPEIIDKGP 185
Query: 230 --FSIKSDVFSFGVLLLEIVSGK 250
             +   +D++S G  ++E+ +GK
Sbjct: 186 RGYGKAADIWSLGCTIIEMATGK 208

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 65/200 (32%), Positives = 100/200 (50%), Gaps = 10/200 (5%)
Query: 57  LGEGGFGPVYKGVLKKGDEIAV-KRLS-GRSGQGLREM-KNEASVIAKVQHKNLVRLLGC 113
           +G G +G   K   K   +I V K L  G   +  ++M  +E +++ +++H N+VR    
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 73
Query: 114 CIDRDEKIL--IYEYMPNKSLDFFLFDPTK-RMLLDWVTRVQIIEGIAQGLLYLHQYSR- 169
            IDR    L  + EY     L   +   TK R  LD    ++++  +   L   H+ S  
Sbjct: 74  IIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDG 133
Query: 170 -VRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEG 228
              ++HRDLK +N+ LD   N K+ DFG+ARI   +   A T   VGT  YMSPE     
Sbjct: 134 GHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKT--FVGTPYYMSPEQMNRM 191
Query: 229 IFSIKSDVFSFGVLLLEIVS 248
            ++ KSD++S G LL E+ +
Sbjct: 192 SYNEKSDIWSLGCLLYELCA 211

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 67/242 (27%), Positives = 114/242 (47%), Gaps = 35/242 (14%)
Query: 32  EVDQFPLFSFSSVSTATNKFSDANKLGEGGFGPVY--------KGVLKKGDEIAVKRLSG 83
           E+ + P + F       +K +    LGEG FG V         K   K+   +AVK L  
Sbjct: 23  ELPEDPKWEFPR-----DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKD 77
Query: 84  RSGQ-GLREMKNEASVIAKV-QHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFL----- 136
            + +  L ++ +E  ++  + +HKN++ LLG C       +I  Y    +L  +L     
Sbjct: 78  DATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVGYASKGNLREYLRARRP 137
Query: 137 ------FD----PTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDK 186
                 +D    P ++M       V     +A+G+ YL   +  + IHRDL A N+L+ +
Sbjct: 138 PGMEYSYDINRVPEEQMTFK--DLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTE 192
Query: 187 DMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEI 246
           +   KI+DFG+AR     +    T+       +M+PE   + +++ +SDV+SFGVL+ EI
Sbjct: 193 NNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 252
Query: 247 VS 248
            +
Sbjct: 253 FT 254

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 112/218 (51%), Gaps = 22/218 (10%)
Query: 51  FSDANKLGEGGFGPVYKGVLK-KGDEIAVKRL------SGRSGQGLREMKNEASVIAKVQ 103
           F    K+GEG +G VYK   K  G+ +A+K++       G     +RE+    S++ ++ 
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREI----SLLKELN 63
Query: 104 HKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLY 163
           H N+V+LL      ++  L++E++ ++ L  F+ D +    +        +  + QGL +
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKTFM-DASALTGIPLPLIKSYLFQLLQGLAF 121
Query: 164 LHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE 223
            H +   R++HRDLK  N+L++ +   K++DFG+AR   G  ++     +V T  Y +PE
Sbjct: 122 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYXHEVV-TLWYRAPE 176
Query: 224 YALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDS 260
             L    +S   D++S G +  E+V+ +    L+  DS
Sbjct: 177 ILLGCKYYSTAVDIWSLGCIFAEMVTRR---ALFPGDS 211

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 112/218 (51%), Gaps = 22/218 (10%)
Query: 51  FSDANKLGEGGFGPVYKGVLK-KGDEIAVKRL------SGRSGQGLREMKNEASVIAKVQ 103
           F    K+GEG +G VYK   K  G+ +A+K++       G     +RE+    S++ ++ 
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREI----SLLKELN 60
Query: 104 HKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLY 163
           H N+V+LL      ++  L++E++ ++ L  F+ D +    +        +  + QGL +
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAF 118
Query: 164 LHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE 223
            H +   R++HRDLK  N+L++ +   K++DFG+AR   G  ++     +V T  Y +PE
Sbjct: 119 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYXHEVV-TLWYRAPE 173
Query: 224 YALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDS 260
             L    +S   D++S G +  E+V+ +    L+  DS
Sbjct: 174 ILLGCKYYSTAVDIWSLGCIFAEMVTRR---ALFPGDS 208

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 65/200 (32%), Positives = 100/200 (50%), Gaps = 10/200 (5%)
Query: 57  LGEGGFGPVYKGVLKKGDEIAV-KRLS-GRSGQGLREM-KNEASVIAKVQHKNLVRLLGC 113
           +G G +G   K   K   +I V K L  G   +  ++M  +E +++ +++H N+VR    
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 73
Query: 114 CIDRDEKIL--IYEYMPNKSLDFFLFDPTK-RMLLDWVTRVQIIEGIAQGLLYLHQYSR- 169
            IDR    L  + EY     L   +   TK R  LD    ++++  +   L   H+ S  
Sbjct: 74  IIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDG 133
Query: 170 -VRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEG 228
              ++HRDLK +N+ LD   N K+ DFG+ARI   +E  A     VGT  YMSPE     
Sbjct: 134 GHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDEDFA--KEFVGTPYYMSPEQMNRM 191
Query: 229 IFSIKSDVFSFGVLLLEIVS 248
            ++ KSD++S G LL E+ +
Sbjct: 192 SYNEKSDIWSLGCLLYELCA 211

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 112/218 (51%), Gaps = 22/218 (10%)
Query: 51  FSDANKLGEGGFGPVYKGVLK-KGDEIAVKRL------SGRSGQGLREMKNEASVIAKVQ 103
           F    K+GEG +G VYK   K  G+ +A+ ++       G     +RE+    S++ ++ 
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREI----SLLKELN 60
Query: 104 HKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLY 163
           H N+V+LL      ++  L++E++ ++ L  F+ D +    +        +  + QGL +
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAF 118
Query: 164 LHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE 223
            H +   R++HRDLK  N+L++ +   K++DFG+AR   G  ++  T  +V T  Y +PE
Sbjct: 119 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYTHEVV-TLWYRAPE 173
Query: 224 YALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDS 260
             L    +S   D++S G +  E+V+ +    L+  DS
Sbjct: 174 ILLGCKYYSTAVDIWSLGCIFAEMVTRR---ALFPGDS 208

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 112/218 (51%), Gaps = 22/218 (10%)
Query: 51  FSDANKLGEGGFGPVYKGVLK-KGDEIAVKRL------SGRSGQGLREMKNEASVIAKVQ 103
           F    K+GEG +G VYK   K  G+ +A+ ++       G     +RE+    S++ ++ 
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREI----SLLKELN 59
Query: 104 HKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLY 163
           H N+V+LL      ++  L++E++ ++ L  F+ D +    +        +  + QGL +
Sbjct: 60  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAF 117
Query: 164 LHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE 223
            H +   R++HRDLK  N+L++ +   K++DFG+AR   G  ++  T  +V T  Y +PE
Sbjct: 118 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYTHEVV-TLWYRAPE 172
Query: 224 YALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDS 260
             L    +S   D++S G +  E+V+ +    L+  DS
Sbjct: 173 ILLGCKYYSTAVDIWSLGCIFAEMVTRR---ALFPGDS 207

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 61/197 (30%), Positives = 100/197 (50%), Gaps = 9/197 (4%)
Query: 57  LGEGGFGPVYKGVLKKGDE-IAVKRLSGRSGQGLRE-MKNEASVIAKVQHKNLVRLLGCC 114
           LGEG +G V   V +  +E +AVK +  +      E +K E  + A + H+N+V+  G  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINAMLNHENVVKFYGHR 74
Query: 115 IDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 174
            + + + L  EY     L F   +P   M      R      +  G++YLH    + I H
Sbjct: 75  REGNIQYLFLEYCSGGEL-FDRIEPDIGMPEPDAQR--FFHQLMAGVVYLHG---IGITH 128
Query: 175 RDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKS 234
           RD+K  N+LLD+  N KISDFG+A +   N  +   +++ GT  Y++PE      F  + 
Sbjct: 129 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEP 188
Query: 235 -DVFSFGVLLLEIVSGK 250
            DV+S G++L  +++G+
Sbjct: 189 VDVWSCGIVLTAMLAGE 205

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 112/218 (51%), Gaps = 22/218 (10%)
Query: 51  FSDANKLGEGGFGPVYKGVLK-KGDEIAVKRL------SGRSGQGLREMKNEASVIAKVQ 103
           F    K+GEG +G VYK   K  G+ +A+K++       G     +RE+    S++ ++ 
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREI----SLLKELN 59
Query: 104 HKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLY 163
           H N+V+LL      ++  L++E++ ++ L  F+ D +    +        +  + QGL +
Sbjct: 60  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAF 117
Query: 164 LHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE 223
            H +   R++HRDLK  N+L++ +   K++DFG+AR   G  ++     +V T  Y +PE
Sbjct: 118 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYXHEVV-TLWYRAPE 172
Query: 224 YALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDS 260
             L    +S   D++S G +  E+V+ +    L+  DS
Sbjct: 173 ILLGCKYYSTAVDIWSLGCIFAEMVTRR---ALFPGDS 207

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 112/218 (51%), Gaps = 22/218 (10%)
Query: 51  FSDANKLGEGGFGPVYKGVLK-KGDEIAVKRL------SGRSGQGLREMKNEASVIAKVQ 103
           F    K+GEG +G VYK   K  G+ +A+K++       G     +RE+    S++ ++ 
Sbjct: 7   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREI----SLLKELN 62
Query: 104 HKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLY 163
           H N+V+LL      ++  L++E++ ++ L  F+ D +    +        +  + QGL +
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAF 120
Query: 164 LHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE 223
            H +   R++HRDLK  N+L++ +   K++DFG+AR   G  ++     +V T  Y +PE
Sbjct: 121 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYXHEVV-TLWYRAPE 175
Query: 224 YALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDS 260
             L    +S   D++S G +  E+V+ +    L+  DS
Sbjct: 176 ILLGCKYYSTAVDIWSLGCIFAEMVTRR---ALFPGDS 210

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 112/218 (51%), Gaps = 22/218 (10%)
Query: 51  FSDANKLGEGGFGPVYKGVLK-KGDEIAVKRL------SGRSGQGLREMKNEASVIAKVQ 103
           F    K+GEG +G VYK   K  G+ +A+K++       G     +RE+    S++ ++ 
Sbjct: 7   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREI----SLLKELN 62
Query: 104 HKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLY 163
           H N+V+LL      ++  L++E++ ++ L  F+ D +    +        +  + QGL +
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAF 120
Query: 164 LHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE 223
            H +   R++HRDLK  N+L++ +   K++DFG+AR   G  ++     +V T  Y +PE
Sbjct: 121 CHSH---RVLHRDLKPENLLINTEGAIKLADFGLAR-AFGVPVRTYXHEVV-TLWYRAPE 175
Query: 224 YALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDS 260
             L    +S   D++S G +  E+V+ +    L+  DS
Sbjct: 176 ILLGCKYYSTAVDIWSLGCIFAEMVTRR---ALFPGDS 210

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 112/218 (51%), Gaps = 22/218 (10%)
Query: 51  FSDANKLGEGGFGPVYKGVLK-KGDEIAVKRL------SGRSGQGLREMKNEASVIAKVQ 103
           F    K+GEG +G VYK   K  G+ +A+K++       G     +RE+    S++ ++ 
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREI----SLLKELN 60
Query: 104 HKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLY 163
           H N+V+LL      ++  L++E++ ++ L  F+ D +    +        +  + QGL +
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAF 118
Query: 164 LHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE 223
            H +   R++HRDLK  N+L++ +   K++DFG+AR   G  ++     +V T  Y +PE
Sbjct: 119 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYXHEVV-TLWYRAPE 173
Query: 224 YALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDS 260
             L    +S   D++S G +  E+V+ +    L+  DS
Sbjct: 174 ILLGCKYYSTAVDIWSLGCIFAEMVTRR---ALFPGDS 208

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 107/215 (49%), Gaps = 19/215 (8%)
Query: 47  ATNKFSDANKLGEGGFGPVYKGV-LKKGDEIAVKRL---SGRSGQGLREMKNEASV--IA 100
           AT+++    ++G G +G VYK      G  +A+K +   +G  G  +  ++  A +  + 
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 101 KVQHKNLVRLLGCC----IDRDEKI-LIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIE 155
             +H N+VRL+  C     DR+ K+ L++E++ ++ L  +L D      L   T   ++ 
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYL-DKAPPPGLPAETIKDLMR 119
Query: 156 GIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVG 215
              +GL +LH      I+HRDLK  NIL+      K++DFG+ARI      Q     +V 
Sbjct: 120 QFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARI---YSYQMALFPVVV 173
Query: 216 TYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 250
           T  Y +PE  L+  ++   D++S G +  E+   K
Sbjct: 174 TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 208

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 112/218 (51%), Gaps = 22/218 (10%)
Query: 51  FSDANKLGEGGFGPVYKGVLK-KGDEIAVKRL------SGRSGQGLREMKNEASVIAKVQ 103
           F    K+GEG +G VYK   K  G+ +A+K++       G     +RE+    S++ ++ 
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREI----SLLKELN 59
Query: 104 HKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLY 163
           H N+V+LL      ++  L++E++ ++ L  F+ D +    +        +  + QGL +
Sbjct: 60  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAF 117
Query: 164 LHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE 223
            H +   R++HRDLK  N+L++ +   K++DFG+AR   G  ++     +V T  Y +PE
Sbjct: 118 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYXHEVV-TLWYRAPE 172
Query: 224 YALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDS 260
             L    +S   D++S G +  E+V+ +    L+  DS
Sbjct: 173 ILLGCKYYSTAVDIWSLGCIFAEMVTRR---ALFPGDS 207

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 112/218 (51%), Gaps = 22/218 (10%)
Query: 51  FSDANKLGEGGFGPVYKGVLK-KGDEIAVKRL------SGRSGQGLREMKNEASVIAKVQ 103
           F    K+GEG +G VYK   K  G+ +A+K++       G     +RE+    S++ ++ 
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREI----SLLKELN 61
Query: 104 HKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLY 163
           H N+V+LL      ++  L++E++ ++ L  F+ D +    +        +  + QGL +
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAF 119
Query: 164 LHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE 223
            H +   R++HRDLK  N+L++ +   K++DFG+AR   G  ++     +V T  Y +PE
Sbjct: 120 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYXHEVV-TLWYRAPE 174
Query: 224 YALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDS 260
             L    +S   D++S G +  E+V+ +    L+  DS
Sbjct: 175 ILLGCKYYSTAVDIWSLGCIFAEMVTRR---ALFPGDS 209

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 112/218 (51%), Gaps = 22/218 (10%)
Query: 51  FSDANKLGEGGFGPVYKGVLK-KGDEIAVKRL------SGRSGQGLREMKNEASVIAKVQ 103
           F    K+GEG +G VYK   K  G+ +A+K++       G     +RE+    S++ ++ 
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREI----SLLKELN 63
Query: 104 HKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLY 163
           H N+V+LL      ++  L++E++ ++ L  F+ D +    +        +  + QGL +
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAF 121
Query: 164 LHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE 223
            H +   R++HRDLK  N+L++ +   K++DFG+AR   G  ++     +V T  Y +PE
Sbjct: 122 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYXHEVV-TLWYRAPE 176
Query: 224 YALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDS 260
             L    +S   D++S G +  E+V+ +    L+  DS
Sbjct: 177 ILLGCKYYSTAVDIWSLGCIFAEMVTRR---ALFPGDS 211

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 112/218 (51%), Gaps = 22/218 (10%)
Query: 51  FSDANKLGEGGFGPVYKGVLK-KGDEIAVKRL------SGRSGQGLREMKNEASVIAKVQ 103
           F    K+GEG +G VYK   K  G+ +A+K++       G     +RE+    S++ ++ 
Sbjct: 7   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREI----SLLKELN 62
Query: 104 HKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLY 163
           H N+V+LL      ++  L++E++ ++ L  F+ D +    +        +  + QGL +
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAF 120
Query: 164 LHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE 223
            H +   R++HRDLK  N+L++ +   K++DFG+AR   G  ++     +V T  Y +PE
Sbjct: 121 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYXHEVV-TLWYRAPE 175
Query: 224 YALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDS 260
             L    +S   D++S G +  E+V+ +    L+  DS
Sbjct: 176 ILLGCKYYSTAVDIWSLGCIFAEMVTRR---ALFPGDS 210

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 112/218 (51%), Gaps = 22/218 (10%)
Query: 51  FSDANKLGEGGFGPVYKGVLK-KGDEIAVKRL------SGRSGQGLREMKNEASVIAKVQ 103
           F    K+GEG +G VYK   K  G+ +A+K++       G     +RE+    S++ ++ 
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREI----SLLKELN 60
Query: 104 HKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLY 163
           H N+V+LL      ++  L++E++ ++ L  F+ D +    +        +  + QGL +
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAF 118
Query: 164 LHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE 223
            H +   R++HRDLK  N+L++ +   K++DFG+AR   G  ++     +V T  Y +PE
Sbjct: 119 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYXHEVV-TLWYRAPE 173
Query: 224 YALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDS 260
             L    +S   D++S G +  E+V+ +    L+  DS
Sbjct: 174 ILLGCKYYSTAVDIWSLGCIFAEMVTRR---ALFPGDS 208

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 111/219 (50%), Gaps = 24/219 (10%)
Query: 51  FSDANKLGEGGFGPVYKGVLK-KGDEIAVKRL------SGRSGQGLREMKNEASVIAKVQ 103
           F    K+GEG +G VYK   K  G+ +A+K++       G     +RE+    S++ ++ 
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREI----SLLKELN 63
Query: 104 HKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLF-DPTKRMLLDWVTRVQIIEGIAQGLL 162
           H N+V+LL      ++  L++E++   S+D   F D +    +        +  + QGL 
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFL---SMDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 120
Query: 163 YLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSP 222
           + H +   R++HRDLK  N+L++ +   K++DFG+AR   G  ++     +V T  Y +P
Sbjct: 121 FCHSH---RVLHRDLKPENLLINTEGAIKLADFGLAR-AFGVPVRTYXHEVV-TLWYRAP 175
Query: 223 EYALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDS 260
           E  L    +S   D++S G +  E+V+ +    L+  DS
Sbjct: 176 EILLGCKYYSTAVDIWSLGCIFAEMVTRR---ALFPGDS 211

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 112/218 (51%), Gaps = 22/218 (10%)
Query: 51  FSDANKLGEGGFGPVYKGVLK-KGDEIAVKRL------SGRSGQGLREMKNEASVIAKVQ 103
           F    K+GEG +G VYK   K  G+ +A+K++       G     +RE+    S++ ++ 
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREI----SLLKELN 63
Query: 104 HKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLY 163
           H N+V+LL      ++  L++E++ ++ L  F+ D +    +        +  + QGL +
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAF 121
Query: 164 LHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE 223
            H +   R++HRDLK  N+L++ +   K++DFG+AR   G  ++     +V T  Y +PE
Sbjct: 122 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYXHEVV-TLWYRAPE 176
Query: 224 YALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDS 260
             L    +S   D++S G +  E+V+ +    L+  DS
Sbjct: 177 ILLGCKYYSTAVDIWSLGCIFAEMVTRR---ALFPGDS 211

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 112/218 (51%), Gaps = 22/218 (10%)
Query: 51  FSDANKLGEGGFGPVYKGVLK-KGDEIAVKRL------SGRSGQGLREMKNEASVIAKVQ 103
           F    K+GEG +G VYK   K  G+ +A+K++       G     +RE+    S++ ++ 
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREI----SLLKELN 60
Query: 104 HKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLY 163
           H N+V+LL      ++  L++E++ ++ L  F+ D +    +        +  + QGL +
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAF 118
Query: 164 LHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE 223
            H +   R++HRDLK  N+L++ +   K++DFG+AR   G  ++     +V T  Y +PE
Sbjct: 119 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYXHEVV-TLWYRAPE 173
Query: 224 YALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDS 260
             L    +S   D++S G +  E+V+ +    L+  DS
Sbjct: 174 ILLGCKYYSTAVDIWSLGCIFAEMVTRR---ALFPGDS 208

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 112/218 (51%), Gaps = 22/218 (10%)
Query: 51  FSDANKLGEGGFGPVYKGVLK-KGDEIAVKRL------SGRSGQGLREMKNEASVIAKVQ 103
           F    K+GEG +G VYK   K  G+ +A+K++       G     +RE+    S++ ++ 
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREI----SLLKELN 61
Query: 104 HKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLY 163
           H N+V+LL      ++  L++E++ ++ L  F+ D +    +        +  + QGL +
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAF 119
Query: 164 LHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE 223
            H +   R++HRDLK  N+L++ +   K++DFG+AR   G  ++     +V T  Y +PE
Sbjct: 120 CHSH---RVLHRDLKPENLLINTEGAIKLADFGLAR-AFGVPVRTYXHEVV-TLWYRAPE 174
Query: 224 YALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDS 260
             L    +S   D++S G +  E+V+ +    L+  DS
Sbjct: 175 ILLGCKYYSTAVDIWSLGCIFAEMVTRR---ALFPGDS 209

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 111/219 (50%), Gaps = 24/219 (10%)
Query: 51  FSDANKLGEGGFGPVYKGVLK-KGDEIAVKRL------SGRSGQGLREMKNEASVIAKVQ 103
           F    K+GEG +G VYK   K  G+ +A+K++       G     +RE+    S++ ++ 
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREI----SLLKELN 61
Query: 104 HKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLF-DPTKRMLLDWVTRVQIIEGIAQGLL 162
           H N+V+LL      ++  L++E++   S+D   F D +    +        +  + QGL 
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFL---SMDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 118
Query: 163 YLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSP 222
           + H +   R++HRDLK  N+L++ +   K++DFG+AR   G  ++     +V T  Y +P
Sbjct: 119 FCHSH---RVLHRDLKPENLLINTEGAIKLADFGLAR-AFGVPVRTYXHEVV-TLWYRAP 173
Query: 223 EYALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDS 260
           E  L    +S   D++S G +  E+V+ +    L+  DS
Sbjct: 174 EILLGCKYYSTAVDIWSLGCIFAEMVTRR---ALFPGDS 209

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 112/218 (51%), Gaps = 22/218 (10%)
Query: 51  FSDANKLGEGGFGPVYKGVLK-KGDEIAVKRL------SGRSGQGLREMKNEASVIAKVQ 103
           F    K+GEG +G VYK   K  G+ +A+K++       G     +RE+    S++ ++ 
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREI----SLLKELN 61
Query: 104 HKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLY 163
           H N+V+LL      ++  L++E++ ++ L  F+ D +    +        +  + QGL +
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAF 119
Query: 164 LHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE 223
            H +   R++HRDLK  N+L++ +   K++DFG+AR   G  ++     +V T  Y +PE
Sbjct: 120 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYXHEVV-TLWYRAPE 174
Query: 224 YALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDS 260
             L    +S   D++S G +  E+V+ +    L+  DS
Sbjct: 175 ILLGCKYYSTAVDIWSLGCIFAEMVTRR---ALFPGDS 209

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 112/218 (51%), Gaps = 22/218 (10%)
Query: 51  FSDANKLGEGGFGPVYKGVLK-KGDEIAVKRL------SGRSGQGLREMKNEASVIAKVQ 103
           F    K+GEG +G VYK   K  G+ +A+K++       G     +RE+    S++ ++ 
Sbjct: 9   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREI----SLLKELN 64
Query: 104 HKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLY 163
           H N+V+LL      ++  L++E++ ++ L  F+ D +    +        +  + QGL +
Sbjct: 65  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAF 122
Query: 164 LHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE 223
            H +   R++HRDLK  N+L++ +   K++DFG+AR   G  ++     +V T  Y +PE
Sbjct: 123 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYXHEVV-TLWYRAPE 177
Query: 224 YALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDS 260
             L    +S   D++S G +  E+V+ +    L+  DS
Sbjct: 178 ILLGCKYYSTAVDIWSLGCIFAEMVTRR---ALFPGDS 212

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 71/234 (30%), Positives = 112/234 (47%), Gaps = 29/234 (12%)
Query: 40  SFSSVSTATNKFSDANKLGEGGFGPVYKGVLKKGDE-IAVKRL------SGRSGQGLREM 92
           S +  +T+ +++    KLGEG +G VYK +    +E +A+KR+       G  G  +RE+
Sbjct: 25  SAAPSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREV 84
Query: 93  KNEASVIAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQ 152
               S++ ++QH+N++ L           LI+EY  N    +   +P   M +      Q
Sbjct: 85  ----SLLKELQHRNIIELKSVIHHNHRLHLIFEYAENDLKKYMDKNPDVSMRVIKSFLYQ 140
Query: 153 IIEGIAQGLLYLHQYSRVRIIHRDLKASNILL---DKDMNP--KISDFGMARICGGNELQ 207
           +I G+     + H  SR R +HRDLK  N+LL   D    P  KI DFG+AR   G  ++
Sbjct: 141 LINGVN----FCH--SR-RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR-AFGIPIR 192
Query: 208 ANTSRIVGTYGYMSPEYALEG-IFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDS 260
             T  I+ T  Y  PE  L    +S   D++S   +  E++     T L+  DS
Sbjct: 193 QFTHEII-TLWYRPPEILLGSRHYSTSVDIWSIACIWAEML---MKTPLFPGDS 242

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 73/224 (32%), Positives = 108/224 (48%), Gaps = 35/224 (15%)
Query: 44  VSTATNKFSDANK----LGEGGFGPVYKGVLKK----GDEIAVKRLSGRSGQGLREMKNE 95
           V  +T  FSD  K    LG+G FG V   +L K    G E AVK +S R    +++  ++
Sbjct: 17  VQHSTAIFSDRYKGQRVLGKGSFGEV---ILCKDKITGQECAVKVISKRQ---VKQKTDK 70
Query: 96  ASVIAKVQ------HKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPT-KRMLLDWV 148
            S++ +VQ      H N+ +L     D+    L+ E      L    FD    R     V
Sbjct: 71  ESLLREVQLLKQLDHPNIXKLYEFFEDKGYFYLVGEVYTGGEL----FDEIISRKRFSEV 126
Query: 149 TRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLD---KDMNPKISDFGMARICGGNE 205
              +II  +  G+ Y H   + +I+HRDLK  N+LL+   KD N +I DFG++      E
Sbjct: 127 DAARIIRQVLSGITYXH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF---E 180
Query: 206 LQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 249
                   +GT  Y++PE  L G +  K DV+S GV+L  ++SG
Sbjct: 181 ASKKXKDKIGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 223

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 74.3 bits (181), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 64/221 (28%), Positives = 98/221 (44%), Gaps = 27/221 (12%)
Query: 51  FSDANKLGEGGFGPVYKGVLKKGD-EIAVKRLSGRSGQGLRE-MKNEASVIAKVQHKNLV 108
           F     LG GGFG V++   K  D   A+KR+   + +  RE +  E   +AK++H  +V
Sbjct: 7   FEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIV 66
Query: 109 RLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIE------------G 156
           R     ++++    +    P   L   +    K  L DW+     IE             
Sbjct: 67  RYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQ 126
Query: 157 IAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQ--------- 207
           IA+ + +LH      ++HRDLK SNI    D   K+ DFG+      +E +         
Sbjct: 127 IAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPA 183
Query: 208 -ANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIV 247
            A  +  VGT  YMSPE      +S K D+FS G++L E++
Sbjct: 184 YARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL 224

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 76/309 (24%), Positives = 131/309 (42%), Gaps = 74/309 (23%)
Query: 51  FSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVR 109
           F +   +G GGFG V+K   +  G    ++R+   + +  RE+K     +AK+ H N+V 
Sbjct: 14  FKEIELIGSGGFGQVFKAKHRIDGKTYVIRRVKYNNEKAEREVK----ALAKLDHVNIVH 69
Query: 110 LLGCCIDRDEKILIYEYMP---NKSLDFFLFDPT---------------------KRMLL 145
             GC          ++Y P   + SL+   +DP                      K  L 
Sbjct: 70  YNGCWDG-------FDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLE 122
Query: 146 DWVTR-----------VQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISD 194
            W+ +           +++ E I +G+ Y+H     ++IHRDLK SNI L      KI D
Sbjct: 123 QWIEKRRGEKLDKVLALELFEQITKGVDYIHSK---KLIHRDLKPSNIFLVDTKQVKIGD 179
Query: 195 FGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTG 254
           FG+      +      +R  GT  YMSPE      +  + D+++ G++L E+        
Sbjct: 180 FGLVTSLKND---GKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAEL-------- 228
Query: 255 LYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPT 314
                 L++   A++  TS    +L D I+ D +  K+  L    ++     +  +DRP 
Sbjct: 229 ------LHVCDTAFE--TSKFFTDLRDGIISDIFDKKEKTLLQKLLS-----KKPEDRPN 275
Query: 315 MNDVVSMLT 323
            ++++  LT
Sbjct: 276 TSEILRTLT 284

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 74/290 (25%), Positives = 129/290 (44%), Gaps = 49/290 (16%)
Query: 51  FSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVR 109
           F +   +G GGFG V+K   +  G    +KR+   + +  RE+K     +AK+ H N+V 
Sbjct: 13  FKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVK----ALAKLDHVNIVH 68
Query: 110 LLGCC--IDRDEK--------------ILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQI 153
             GC    D D +               +  E+    +L+ ++ +  +   LD V  +++
Sbjct: 69  YNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWI-EKRRGEKLDKVLALEL 127
Query: 154 IEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRI 213
            E I +G+ Y+H     ++I+RDLK SNI L      KI DFG+      +       R 
Sbjct: 128 FEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKND---GKRXRS 181
Query: 214 VGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTS 273
            GT  YMSPE      +  + D+++ G++L E+              L++   A++  TS
Sbjct: 182 KGTLRYMSPEQISSQDYGKEVDLYALGLILAEL--------------LHVCDTAFE--TS 225
Query: 274 NRTLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLT 323
               +L D I+ D +  K+  L         + +  +DRP  ++++  LT
Sbjct: 226 KFFTDLRDGIISDIFDKKEKTLLQK-----LLSKKPEDRPNTSEILRTLT 270

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 112/218 (51%), Gaps = 22/218 (10%)
Query: 51  FSDANKLGEGGFGPVYKGVLK-KGDEIAVKRL------SGRSGQGLREMKNEASVIAKVQ 103
           F    K+GEG +G VYK   K  G+ +A+K++       G     +RE+    S++ ++ 
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREI----SLLKELN 63
Query: 104 HKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLY 163
           H N+V+LL      ++  L++E++ ++ L  F+ D +    +        +  + QGL +
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEHV-DQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAF 121
Query: 164 LHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE 223
            H +   R++HRDLK  N+L++ +   K++DFG+AR   G  ++     +V T  Y +PE
Sbjct: 122 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYXHEVV-TLWYRAPE 176
Query: 224 YALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDS 260
             L    +S   D++S G +  E+V+ +    L+  DS
Sbjct: 177 ILLGCKYYSTAVDIWSLGCIFAEMVTRR---ALFPGDS 211

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 99/197 (50%), Gaps = 12/197 (6%)
Query: 56  KLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCC 114
           K+GEG  G V    ++  G  +AVK++  R  Q    + NE  ++   QH+N+V +    
Sbjct: 27  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 86
Query: 115 IDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 174
           +  DE  ++ E++   +L   +     RM  + +  V +   + Q L  LH      +IH
Sbjct: 87  LVGDELWVVMEFLEGGALTDIVTH--TRMNEEQIAAVCL--AVLQALSVLHAQG---VIH 139
Query: 175 RDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR-IVGTYGYMSPEYALEGIFSIK 233
           RD+K+ +ILL  D   K+SDFG    C     +    + +VGT  +M+PE      +  +
Sbjct: 140 RDIKSDSILLTHDGRVKLSDFG---FCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPE 196
Query: 234 SDVFSFGVLLLEIVSGK 250
            D++S G++++E+V G+
Sbjct: 197 VDIWSLGIMVIEMVDGE 213

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 64/200 (32%), Positives = 99/200 (49%), Gaps = 10/200 (5%)
Query: 57  LGEGGFGPVYKGVLKKGDEIAV-KRLS-GRSGQGLREM-KNEASVIAKVQHKNLVRLLGC 113
           +G G +G   K   K   +I V K L  G   +  ++M  +E +++ +++H N+VR    
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 73
Query: 114 CIDRDEKIL--IYEYMPNKSLDFFLFDPTK-RMLLDWVTRVQIIEGIAQGLLYLHQYSR- 169
            IDR    L  + EY     L   +   TK R  LD    ++++  +   L   H+ S  
Sbjct: 74  IIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDG 133
Query: 170 -VRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEG 228
              ++HRDLK +N+ LD   N K+ DFG+ARI   N   +     VGT  YMSPE     
Sbjct: 134 GHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL--NHDTSFAKAFVGTPYYMSPEQMNRM 191
Query: 229 IFSIKSDVFSFGVLLLEIVS 248
            ++ KSD++S G LL E+ +
Sbjct: 192 SYNEKSDIWSLGCLLYELCA 211

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 99/197 (50%), Gaps = 12/197 (6%)
Query: 56  KLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCC 114
           K+GEG  G V    ++  G  +AVK++  R  Q    + NE  ++   QH+N+V +    
Sbjct: 36  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 95
Query: 115 IDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 174
           +  DE  ++ E++   +L   +     RM  + +  V +   + Q L  LH      +IH
Sbjct: 96  LVGDELWVVMEFLEGGALTDIVTH--TRMNEEQIAAVCL--AVLQALSVLHAQG---VIH 148
Query: 175 RDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR-IVGTYGYMSPEYALEGIFSIK 233
           RD+K+ +ILL  D   K+SDFG    C     +    + +VGT  +M+PE      +  +
Sbjct: 149 RDIKSDSILLTHDGRVKLSDFG---FCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPE 205
Query: 234 SDVFSFGVLLLEIVSGK 250
            D++S G++++E+V G+
Sbjct: 206 VDIWSLGIMVIEMVDGE 222

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 70/217 (32%), Positives = 111/217 (51%), Gaps = 22/217 (10%)
Query: 45  STATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVK-----RLSG-RSGQGLREMKNEAS 97
           S   + +    +LG G F  V K   K  G E A K     RLS  R G    E++ E +
Sbjct: 1   SMVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVN 60
Query: 98  VIAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGI 157
           ++ +++H N++ L     ++ + +LI E +    L  FL +  + +  D  T  Q ++ I
Sbjct: 61  ILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAE-KESLTEDEAT--QFLKQI 117
Query: 158 AQGLLYLHQYSRVRIIHRDLKASNI-LLDKDM-NPKIS--DFGMA-RICGGNELQANTSR 212
             G+ YLH     RI H DLK  NI LLDK++ NP+I   DFG+A +I  GNE +     
Sbjct: 118 LDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFK----N 170
Query: 213 IVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 249
           I GT  +++PE        +++D++S GV+   ++SG
Sbjct: 171 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 207

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 99/197 (50%), Gaps = 12/197 (6%)
Query: 56  KLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCC 114
           K+GEG  G V    ++  G  +AVK++  R  Q    + NE  ++   QH+N+V +    
Sbjct: 38  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 97
Query: 115 IDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 174
           +  DE  ++ E++   +L   +     RM  + +  V +   + Q L  LH      +IH
Sbjct: 98  LVGDELWVVMEFLEGGALTDIVTH--TRMNEEQIAAVCL--AVLQALSVLHAQG---VIH 150
Query: 175 RDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR-IVGTYGYMSPEYALEGIFSIK 233
           RD+K+ +ILL  D   K+SDFG    C     +    + +VGT  +M+PE      +  +
Sbjct: 151 RDIKSDSILLTHDGRVKLSDFG---FCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPE 207
Query: 234 SDVFSFGVLLLEIVSGK 250
            D++S G++++E+V G+
Sbjct: 208 VDIWSLGIMVIEMVDGE 224

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 74/259 (28%), Positives = 114/259 (44%), Gaps = 24/259 (9%)
Query: 47  ATNKFSDANKLGEGGFGPVYKGVLKKGDEI-AVKRL--SGRSGQGL-REMKNEASVIAKV 102
           A   F     LG+G FG VY    K+   I A+K L  +     G+  +++ E  + + +
Sbjct: 32  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 91
Query: 103 QHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLL 162
           +H N++RL G   D     LI EY P   L     +  K    D       I  +A  L 
Sbjct: 92  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 148
Query: 163 YLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR---IVGTYGY 219
           Y H     R+IHRD+K  N+LL      KI+DFG +       + A +SR   + GT  Y
Sbjct: 149 YCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRTTLCGTLDY 198
Query: 220 MSPEYALEGIFSIKSDVFSFGVLLLEIVSGKK----NTGLYRTDSLNLLGYAWDLWTSNR 275
           + PE     +   K D++S GVL  E + GK     NT       ++ + + +  + +  
Sbjct: 199 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEG 258
Query: 276 TLELIDPILEDEYSSKQML 294
             +LI  +L+   S + ML
Sbjct: 259 ARDLISRLLKHNPSQRPML 277

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 67/213 (31%), Positives = 105/213 (49%), Gaps = 22/213 (10%)
Query: 46  TATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSGQG--LREMKNEASVIAKV 102
           T   +++    LG+G FG V K   +    E AVK ++  S +      +  E  ++ K+
Sbjct: 19  TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKL 78
Query: 103 QHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPT-KRMLLDWVTRVQIIEGIAQGL 161
            H N+++L     D     ++ E      L    FD   KR         +II+ +  G+
Sbjct: 79  DHPNIMKLFEILEDSSSFYIVGELYTGGEL----FDEIIKRKRFSEHDAARIIKQVFSGI 134
Query: 162 LYLHQYSRVRIIHRDLKASNILL---DKDMNPKISDFGMARICGGNELQANTSRI--VGT 216
            Y+H+++   I+HRDLK  NILL   +KD + KI DFG++  C     Q NT     +GT
Sbjct: 135 TYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLS-TC----FQQNTKMKDRIGT 186
Query: 217 YGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 249
             Y++PE  L G +  K DV+S GV+L  ++SG
Sbjct: 187 AYYIAPE-VLRGTYDEKCDVWSAGVILYILLSG 218

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 103/217 (47%), Gaps = 27/217 (12%)
Query: 47  ATNKFSD----ANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGR--SGQGLREMKNEASVI 99
           A+ KFSD      +LG+G F  V + V K  G E A K ++ +  S +  ++++ EA + 
Sbjct: 23  ASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARIC 82
Query: 100 AKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQ 159
            K+QH N+VRL     +     L+++ +    L     D   R           I+ I +
Sbjct: 83  RKLQHPNIVRLHDSIQEESFHYLVFDLVTGGEL---FEDIVAREFYSEADASHCIQQILE 139
Query: 160 GLLYLHQYSRVRIIHRDLKASNILLD---KDMNPKISDFGMARICGGNELQANTSR---- 212
            + Y H      I+HR+LK  N+LL    K    K++DFG+A       ++ N S     
Sbjct: 140 SIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLA-------IEVNDSEAWHG 189
Query: 213 IVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 249
             GT GY+SPE   +  +S   D+++ GV+L  ++ G
Sbjct: 190 FAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 226

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 67/213 (31%), Positives = 105/213 (49%), Gaps = 22/213 (10%)
Query: 46  TATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSGQG--LREMKNEASVIAKV 102
           T   +++    LG+G FG V K   +    E AVK ++  S +      +  E  ++ K+
Sbjct: 19  TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKL 78
Query: 103 QHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPT-KRMLLDWVTRVQIIEGIAQGL 161
            H N+++L     D     ++ E      L    FD   KR         +II+ +  G+
Sbjct: 79  DHPNIMKLFEILEDSSSFYIVGELYTGGEL----FDEIIKRKRFSEHDAARIIKQVFSGI 134
Query: 162 LYLHQYSRVRIIHRDLKASNILL---DKDMNPKISDFGMARICGGNELQANTSRI--VGT 216
            Y+H+++   I+HRDLK  NILL   +KD + KI DFG++  C     Q NT     +GT
Sbjct: 135 TYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLS-TC----FQQNTKMKDRIGT 186
Query: 217 YGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 249
             Y++PE  L G +  K DV+S GV+L  ++SG
Sbjct: 187 AYYIAPE-VLRGTYDEKCDVWSAGVILYILLSG 218

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 74/259 (28%), Positives = 114/259 (44%), Gaps = 24/259 (9%)
Query: 47  ATNKFSDANKLGEGGFGPVYKGVLKKGDEI-AVKRL--SGRSGQGL-REMKNEASVIAKV 102
           A   F     LG+G FG VY    K+   I A+K L  +     G+  +++ E  + + +
Sbjct: 23  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 82
Query: 103 QHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLL 162
           +H N++RL G   D     LI EY P   L     +  K    D       I  +A  L 
Sbjct: 83  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 139
Query: 163 YLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR---IVGTYGY 219
           Y H     R+IHRD+K  N+LL      KI+DFG +       + A +SR   + GT  Y
Sbjct: 140 YCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRTTLCGTLDY 189
Query: 220 MSPEYALEGIFSIKSDVFSFGVLLLEIVSGKK----NTGLYRTDSLNLLGYAWDLWTSNR 275
           + PE     +   K D++S GVL  E + GK     NT       ++ + + +  + +  
Sbjct: 190 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEG 249
Query: 276 TLELIDPILEDEYSSKQML 294
             +LI  +L+   S + ML
Sbjct: 250 ARDLISRLLKHNPSQRPML 268

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 74/259 (28%), Positives = 114/259 (44%), Gaps = 24/259 (9%)
Query: 47  ATNKFSDANKLGEGGFGPVYKGVLKKGDEI-AVKRL--SGRSGQGL-REMKNEASVIAKV 102
           A   F     LG+G FG VY    K+   I A+K L  +     G+  +++ E  + + +
Sbjct: 32  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 91
Query: 103 QHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLL 162
           +H N++RL G   D     LI EY P   L     +  K    D       I  +A  L 
Sbjct: 92  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 148
Query: 163 YLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR---IVGTYGY 219
           Y H     R+IHRD+K  N+LL      KI+DFG +       + A +SR   + GT  Y
Sbjct: 149 YCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRDDLCGTLDY 198
Query: 220 MSPEYALEGIFSIKSDVFSFGVLLLEIVSGKK----NTGLYRTDSLNLLGYAWDLWTSNR 275
           + PE     +   K D++S GVL  E + GK     NT       ++ + + +  + +  
Sbjct: 199 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEG 258
Query: 276 TLELIDPILEDEYSSKQML 294
             +LI  +L+   S + ML
Sbjct: 259 ARDLISRLLKHNPSQRPML 277

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 99/197 (50%), Gaps = 12/197 (6%)
Query: 56  KLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCC 114
           K+GEG  G V    ++  G  +AVK++  R  Q    + NE  ++   QH+N+V +    
Sbjct: 31  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 90
Query: 115 IDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 174
           +  DE  ++ E++   +L   +     RM  + +  V +   + Q L  LH      +IH
Sbjct: 91  LVGDELWVVMEFLEGGALTDIVTH--TRMNEEQIAAVCL--AVLQALSVLHAQG---VIH 143
Query: 175 RDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR-IVGTYGYMSPEYALEGIFSIK 233
           RD+K+ +ILL  D   K+SDFG    C     +    + +VGT  +M+PE      +  +
Sbjct: 144 RDIKSDSILLTHDGRVKLSDFG---FCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPE 200
Query: 234 SDVFSFGVLLLEIVSGK 250
            D++S G++++E+V G+
Sbjct: 201 VDIWSLGIMVIEMVDGE 217

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 68/225 (30%), Positives = 111/225 (49%), Gaps = 15/225 (6%)
Query: 55  NKLGEGGFGPV----YKGVL-KKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVR 109
           ++LG+G FG V    Y  +    G  +AVK+L        R+ + E  ++  +    +V+
Sbjct: 13  SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVK 72
Query: 110 LLGCCID--RDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQY 167
             G      R E  L+ EY+P+  L  FL     R  LD    +     I +G+ YL   
Sbjct: 73  YRGVSYGPGRPELRLVMEYLPSGCLRDFL--QRHRARLDASRLLLYSSQICKGMEYLG-- 128
Query: 168 SRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG--YMSPEYA 225
           SR R +HRDL A NIL++ + + KI+DFG+A++   ++      R  G     + +PE  
Sbjct: 129 SR-RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDK-DXXVVREPGQSPIFWYAPESL 186
Query: 226 LEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDL 270
            + IFS +SDV+SFGV+L E+ +    +     + L ++G   D+
Sbjct: 187 SDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDV 231

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 99/197 (50%), Gaps = 9/197 (4%)
Query: 57  LGEGGFGPVYKGVLKKGDE-IAVKRLSGRSGQGLRE-MKNEASVIAKVQHKNLVRLLGCC 114
           LGEG +G V   V +  +E +AVK +  +      E +K E  +   + H+N+V+  G  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 115 IDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 174
            + + + L  EY     L F   +P   M      R      +  G++YLH    + I H
Sbjct: 75  REGNIQYLFLEYCSGGEL-FDRIEPDIGMPEPDAQR--FFHQLMAGVVYLHG---IGITH 128
Query: 175 RDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKS 234
           RD+K  N+LLD+  N KISDFG+A +   N  +   +++ GT  Y++PE      F  + 
Sbjct: 129 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEP 188
Query: 235 -DVFSFGVLLLEIVSGK 250
            DV+S G++L  +++G+
Sbjct: 189 VDVWSCGIVLTAMLAGE 205

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 99/197 (50%), Gaps = 12/197 (6%)
Query: 56  KLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCC 114
           K+GEG  G V    ++  G  +AVK++  R  Q    + NE  ++   QH+N+V +    
Sbjct: 158 KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 217
Query: 115 IDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 174
           +  DE  ++ E++   +L   +     RM  + +  V +   + Q L  LH      +IH
Sbjct: 218 LVGDELWVVMEFLEGGALTDIVTH--TRMNEEQIAAVCL--AVLQALSVLHAQG---VIH 270
Query: 175 RDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR-IVGTYGYMSPEYALEGIFSIK 233
           RD+K+ +ILL  D   K+SDFG    C     +    + +VGT  +M+PE      +  +
Sbjct: 271 RDIKSDSILLTHDGRVKLSDFG---FCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPE 327
Query: 234 SDVFSFGVLLLEIVSGK 250
            D++S G++++E+V G+
Sbjct: 328 VDIWSLGIMVIEMVDGE 344

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 99/197 (50%), Gaps = 9/197 (4%)
Query: 57  LGEGGFGPVYKGVLKKGDE-IAVKRLSGRSGQGLRE-MKNEASVIAKVQHKNLVRLLGCC 114
           LGEG +G V   V +  +E +AVK +  +      E +K E  +   + H+N+V+  G  
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 115 IDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 174
            + + + L  EY     L F   +P   M      R      +  G++YLH    + I H
Sbjct: 74  REGNIQYLFLEYCSGGEL-FDRIEPDIGMPEPDAQR--FFHQLMAGVVYLHG---IGITH 127
Query: 175 RDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKS 234
           RD+K  N+LLD+  N KISDFG+A +   N  +   +++ GT  Y++PE      F  + 
Sbjct: 128 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEP 187
Query: 235 -DVFSFGVLLLEIVSGK 250
            DV+S G++L  +++G+
Sbjct: 188 VDVWSCGIVLTAMLAGE 204

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 68/214 (31%), Positives = 104/214 (48%), Gaps = 25/214 (11%)
Query: 57  LGEGGFGPVYK----GVLKKGD--EIAVKRL-SGRSGQGLREMKNEASVIAKV-QHKNLV 108
           LG G FG V +    G+ K      +AVK L  G +    R + +E  ++  +  H N+V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 109 RLLGCCIDRDEKIL-IYEYMPNKSLDFFL------FDPTK----RMLLDWVTRVQIIE-- 155
            LLG C      ++ I E+    +L  +L      F P K     +  D++T   +I   
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154
Query: 156 -GIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIV 214
             +A+G+ +L   +  + IHRDL A NILL +    KI DFG+AR    +          
Sbjct: 155 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDAR 211
Query: 215 GTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 248
               +M+PE   + +++I+SDV+SFGVLL EI S
Sbjct: 212 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 99/197 (50%), Gaps = 9/197 (4%)
Query: 57  LGEGGFGPVYKGVLKKGDE-IAVKRLSGRSGQGLRE-MKNEASVIAKVQHKNLVRLLGCC 114
           LGEG +G V   V +  +E +AVK +  +      E +K E  +   + H+N+V+  G  
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 115 IDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 174
            + + + L  EY     L F   +P   M      R      +  G++YLH    + I H
Sbjct: 74  REGNIQYLFLEYCSGGEL-FDRIEPDIGMPEPDAQR--FFHQLMAGVVYLHG---IGITH 127
Query: 175 RDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKS 234
           RD+K  N+LLD+  N KISDFG+A +   N  +   +++ GT  Y++PE      F  + 
Sbjct: 128 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEP 187
Query: 235 -DVFSFGVLLLEIVSGK 250
            DV+S G++L  +++G+
Sbjct: 188 VDVWSCGIVLTAMLAGE 204

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 74/259 (28%), Positives = 114/259 (44%), Gaps = 24/259 (9%)
Query: 47  ATNKFSDANKLGEGGFGPVYKGVLKKGDEI-AVKRL--SGRSGQGL-REMKNEASVIAKV 102
           A   F     LG+G FG VY    K+   I A+K L  +     G+  +++ E  + + +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 103 QHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLL 162
           +H N++RL G   D     LI EY P   L     +  K    D       I  +A  L 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 163 YLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR---IVGTYGY 219
           Y H     R+IHRD+K  N+LL      KI+DFG +       + A +SR   + GT  Y
Sbjct: 123 YCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRTTLCGTLDY 172
Query: 220 MSPEYALEGIFSIKSDVFSFGVLLLEIVSGKK----NTGLYRTDSLNLLGYAWDLWTSNR 275
           + PE     +   K D++S GVL  E + GK     NT       ++ + + +  + +  
Sbjct: 173 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEG 232
Query: 276 TLELIDPILEDEYSSKQML 294
             +LI  +L+   S + ML
Sbjct: 233 ARDLISRLLKHNPSQRPML 251

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 99/197 (50%), Gaps = 9/197 (4%)
Query: 57  LGEGGFGPVYKGVLKKGDE-IAVKRLSGRSGQGLRE-MKNEASVIAKVQHKNLVRLLGCC 114
           LGEG +G V   V +  +E +AVK +  +      E +K E  +   + H+N+V+  G  
Sbjct: 13  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 72
Query: 115 IDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 174
            + + + L  EY     L F   +P   M      R      +  G++YLH    + I H
Sbjct: 73  REGNIQYLFLEYCSGGEL-FDRIEPDIGMPEPDAQR--FFHQLMAGVVYLHG---IGITH 126
Query: 175 RDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKS 234
           RD+K  N+LLD+  N KISDFG+A +   N  +   +++ GT  Y++PE      F  + 
Sbjct: 127 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEP 186
Query: 235 -DVFSFGVLLLEIVSGK 250
            DV+S G++L  +++G+
Sbjct: 187 VDVWSCGIVLTAMLAGE 203

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 68/214 (31%), Positives = 104/214 (48%), Gaps = 25/214 (11%)
Query: 57  LGEGGFGPVYK----GVLKKGD--EIAVKRL-SGRSGQGLREMKNEASVIAKV-QHKNLV 108
           LG G FG V +    G+ K      +AVK L  G +    R + +E  ++  +  H N+V
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 109 RLLGCCIDRDEKIL-IYEYMPNKSLDFFL------FDPTK----RMLLDWVTRVQIIE-- 155
            LLG C      ++ I E+    +L  +L      F P K     +  D++T   +I   
Sbjct: 86  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 156 -GIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIV 214
             +A+G+ +L   +  + IHRDL A NILL +    KI DFG+AR    +          
Sbjct: 146 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDAR 202
Query: 215 GTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 248
               +M+PE   + +++I+SDV+SFGVLL EI S
Sbjct: 203 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 99/197 (50%), Gaps = 9/197 (4%)
Query: 57  LGEGGFGPVYKGVLKKGDE-IAVKRLSGRSGQGLRE-MKNEASVIAKVQHKNLVRLLGCC 114
           LGEG +G V   V +  +E +AVK +  +      E +K E  +   + H+N+V+  G  
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 115 IDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 174
            + + + L  EY     L F   +P   M      R      +  G++YLH    + I H
Sbjct: 74  REGNIQYLFLEYCSGGEL-FDRIEPDIGMPEPDAQR--FFHQLMAGVVYLHG---IGITH 127
Query: 175 RDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKS 234
           RD+K  N+LLD+  N KISDFG+A +   N  +   +++ GT  Y++PE      F  + 
Sbjct: 128 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEP 187
Query: 235 -DVFSFGVLLLEIVSGK 250
            DV+S G++L  +++G+
Sbjct: 188 VDVWSCGIVLTAMLAGE 204

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 68/214 (31%), Positives = 104/214 (48%), Gaps = 25/214 (11%)
Query: 57  LGEGGFGPVYK----GVLKKGD--EIAVKRL-SGRSGQGLREMKNEASVIAKV-QHKNLV 108
           LG G FG V +    G+ K      +AVK L  G +    R + +E  ++  +  H N+V
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 96
Query: 109 RLLGCCIDRDEKIL-IYEYMPNKSLDFFL------FDPTKR----MLLDWVTRVQIIE-- 155
            LLG C      ++ I E+    +L  +L      F P K     +  D++T   +I   
Sbjct: 97  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEAPEDLYKDFLTLEHLICYS 156
Query: 156 -GIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIV 214
             +A+G+ +L   +  + IHRDL A NILL +    KI DFG+AR    +          
Sbjct: 157 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 213
Query: 215 GTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 248
               +M+PE   + +++I+SDV+SFGVLL EI S
Sbjct: 214 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 247

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 70/217 (32%), Positives = 111/217 (51%), Gaps = 22/217 (10%)
Query: 45  STATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVK-----RL-SGRSGQGLREMKNEAS 97
           S   + +    +LG G F  V K   K  G E A K     RL S R G    E++ E +
Sbjct: 22  SMVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLXSSRRGVSREEIEREVN 81
Query: 98  VIAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGI 157
           ++ +++H N++ L     ++ + +LI E +    L  FL +  + +  D  T  Q ++ I
Sbjct: 82  ILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAE-KESLTEDEAT--QFLKQI 138
Query: 158 AQGLLYLHQYSRVRIIHRDLKASNI-LLDKDM-NPKIS--DFGMA-RICGGNELQANTSR 212
             G+ YLH     RI H DLK  NI LLDK++ NP+I   DFG+A +I  GNE +     
Sbjct: 139 LDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFK----N 191
Query: 213 IVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 249
           I GT  +++PE        +++D++S GV+   ++SG
Sbjct: 192 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 228

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 74/259 (28%), Positives = 115/259 (44%), Gaps = 24/259 (9%)
Query: 47  ATNKFSDANKLGEGGFGPVYKGVLKKGDEI-AVKRL--SGRSGQGL-REMKNEASVIAKV 102
           A   F     LG+G FG VY    K+   I A+K L  +     G+  +++ E  + + +
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 103 QHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLL 162
           +H N++RL G   D     LI EY P   +   L   +K    D       I  +A  L 
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSK---FDEQRTATYITELANALS 127
Query: 163 YLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR---IVGTYGY 219
           Y H     R+IHRD+K  N+LL      KI+DFG +       + A +SR   + GT  Y
Sbjct: 128 YCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRTTLCGTLDY 177
Query: 220 MSPEYALEGIFSIKSDVFSFGVLLLEIVSGKK----NTGLYRTDSLNLLGYAWDLWTSNR 275
           + PE     +   K D++S GVL  E + GK     NT       ++ + + +  + +  
Sbjct: 178 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEG 237
Query: 276 TLELIDPILEDEYSSKQML 294
             +LI  +L+   S + ML
Sbjct: 238 ARDLISRLLKHNPSQRPML 256

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 108/220 (49%), Gaps = 28/220 (12%)
Query: 49  NKFSDANKLGEGGFGPVYKGVLKKGD----EIAVKRLSGR--SGQGLREMKNEASVIAKV 102
            +F+    LG+G FG V +  LK+ D    ++AVK L     +   + E   EA+ + + 
Sbjct: 23  QQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEF 82
Query: 103 QHKNLVRLLGCCIDRDEK------ILIYEYMPNKSLDFFLF------DPTKRMLLDWVTR 150
            H ++ +L+G  +    K      ++I  +M +  L  FL       +P     L   T 
Sbjct: 83  DHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFN---LPLQTL 139
Query: 151 VQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMAR--ICGGNELQA 208
           V+ +  IA G+ YL   S    IHRDL A N +L +DM   ++DFG++R    G    Q 
Sbjct: 140 VRFMVDIACGMEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQG 196
Query: 209 NTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 248
             S++     +++ E   + ++++ SDV++FGV + EI++
Sbjct: 197 CASKL--PVKWLALESLADNLYTVHSDVWAFGVTMWEIMT 234

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 75/266 (28%), Positives = 116/266 (43%), Gaps = 24/266 (9%)
Query: 40  SFSSVSTATNKFSDANKLGEGGFGPVYKGVLKKGDEI-AVKRL--SGRSGQGL-REMKNE 95
           +  S   A   F     LG+G FG VY    K+   I A+K L  +     G+  +++ E
Sbjct: 2   AMGSRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRRE 61
Query: 96  ASVIAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIE 155
             + + ++H N++RL G   D     LI EY P   L     +  K    D       I 
Sbjct: 62  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYIT 118
Query: 156 GIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR--- 212
            +A  L Y H     R+IHRD+K  N+LL      KI+DFG +       + A +SR   
Sbjct: 119 ELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRAA 168
Query: 213 IVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKK----NTGLYRTDSLNLLGYAW 268
           + GT  Y+ PE     +   K D++S GVL  E + GK     NT       ++ + + +
Sbjct: 169 LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTF 228
Query: 269 DLWTSNRTLELIDPILEDEYSSKQML 294
             + +    +LI  +L+   S + ML
Sbjct: 229 PDFVTEGARDLISRLLKHNPSQRPML 254

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 99/197 (50%), Gaps = 9/197 (4%)
Query: 57  LGEGGFGPVYKGVLKKGDE-IAVKRLSGRSGQGLRE-MKNEASVIAKVQHKNLVRLLGCC 114
           LGEG +G V   V +  +E +AVK +  +      E +K E  +   + H+N+V+  G  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 115 IDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 174
            + + + L  EY     L F   +P   M      R      +  G++YLH    + I H
Sbjct: 75  REGNIQYLFLEYCSGGEL-FDRIEPDIGMPEPDAQR--FFHQLMAGVVYLHG---IGITH 128
Query: 175 RDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKS 234
           RD+K  N+LLD+  N KISDFG+A +   N  +   +++ GT  Y++PE      F  + 
Sbjct: 129 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEP 188
Query: 235 -DVFSFGVLLLEIVSGK 250
            DV+S G++L  +++G+
Sbjct: 189 VDVWSCGIVLTAMLAGE 205

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 74/259 (28%), Positives = 114/259 (44%), Gaps = 24/259 (9%)
Query: 47  ATNKFSDANKLGEGGFGPVYKGVLKKGDEI-AVKRL--SGRSGQGL-REMKNEASVIAKV 102
           A   F     LG+G FG VY    K+   I A+K L  +     G+  +++ E  + + +
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 103 QHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLL 162
           +H N++RL G   D     LI EY P   L     +  K    D       I  +A  L 
Sbjct: 67  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 123
Query: 163 YLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR---IVGTYGY 219
           Y H     R+IHRD+K  N+LL      KI+DFG +       + A +SR   + GT  Y
Sbjct: 124 YCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRDTLCGTLDY 173
Query: 220 MSPEYALEGIFSIKSDVFSFGVLLLEIVSGKK----NTGLYRTDSLNLLGYAWDLWTSNR 275
           + PE     +   K D++S GVL  E + GK     NT       ++ + + +  + +  
Sbjct: 174 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEG 233
Query: 276 TLELIDPILEDEYSSKQML 294
             +LI  +L+   S + ML
Sbjct: 234 ARDLISRLLKHNPSQRPML 252

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 74/259 (28%), Positives = 114/259 (44%), Gaps = 24/259 (9%)
Query: 47  ATNKFSDANKLGEGGFGPVYKGVLKKGDEI-AVKRL--SGRSGQGL-REMKNEASVIAKV 102
           A   F     LG+G FG VY    K+   I A+K L  +     G+  +++ E  + + +
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 103 QHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLL 162
           +H N++RL G   D     LI EY P   L     +  K    D       I  +A  L 
Sbjct: 67  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 123
Query: 163 YLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR---IVGTYGY 219
           Y H     R+IHRD+K  N+LL      KI+DFG +       + A +SR   + GT  Y
Sbjct: 124 YCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRTDLCGTLDY 173
Query: 220 MSPEYALEGIFSIKSDVFSFGVLLLEIVSGKK----NTGLYRTDSLNLLGYAWDLWTSNR 275
           + PE     +   K D++S GVL  E + GK     NT       ++ + + +  + +  
Sbjct: 174 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEG 233
Query: 276 TLELIDPILEDEYSSKQML 294
             +LI  +L+   S + ML
Sbjct: 234 ARDLISRLLKHNPSQRPML 252

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 99/197 (50%), Gaps = 9/197 (4%)
Query: 57  LGEGGFGPVYKGVLKKGDE-IAVKRLSGRSGQGLRE-MKNEASVIAKVQHKNLVRLLGCC 114
           LGEG +G V   V +  +E +AVK +  +      E +K E  +   + H+N+V+  G  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 115 IDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 174
            + + + L  EY     L F   +P   M      R      +  G++YLH    + I H
Sbjct: 75  REGNIQYLFLEYCSGGEL-FDRIEPDIGMPEPDAQR--FFHQLMAGVVYLHG---IGITH 128
Query: 175 RDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKS 234
           RD+K  N+LLD+  N KISDFG+A +   N  +   +++ GT  Y++PE      F  + 
Sbjct: 129 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEP 188
Query: 235 -DVFSFGVLLLEIVSGK 250
            DV+S G++L  +++G+
Sbjct: 189 VDVWSCGIVLTAMLAGE 205

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 99/197 (50%), Gaps = 9/197 (4%)
Query: 57  LGEGGFGPVYKGVLKKGDE-IAVKRLSGRSGQGLRE-MKNEASVIAKVQHKNLVRLLGCC 114
           LGEG +G V   V +  +E +AVK +  +      E +K E  +   + H+N+V+  G  
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 115 IDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 174
            + + + L  EY     L F   +P   M      R      +  G++YLH    + I H
Sbjct: 74  REGNIQYLFLEYCSGGEL-FDRIEPDIGMPEPDAQR--FFHQLMAGVVYLHG---IGITH 127
Query: 175 RDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKS 234
           RD+K  N+LLD+  N KISDFG+A +   N  +   +++ GT  Y++PE      F  + 
Sbjct: 128 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEP 187
Query: 235 -DVFSFGVLLLEIVSGK 250
            DV+S G++L  +++G+
Sbjct: 188 VDVWSCGIVLTAMLAGE 204

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 68/214 (31%), Positives = 104/214 (48%), Gaps = 25/214 (11%)
Query: 57  LGEGGFGPVYK----GVLKKGD--EIAVKRL-SGRSGQGLREMKNEASVIAKV-QHKNLV 108
           LG G FG V +    G+ K      +AVK L  G +    R + +E  ++  +  H N+V
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 109 RLLGCCIDRDEKIL-IYEYMPNKSLDFFL------FDPTK----RMLLDWVTRVQIIE-- 155
            LLG C      ++ I E+    +L  +L      F P K     +  D++T   +I   
Sbjct: 86  NLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 156 -GIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIV 214
             +A+G+ +L   +  + IHRDL A NILL +    KI DFG+AR    +          
Sbjct: 146 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDAR 202
Query: 215 GTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 248
               +M+PE   + +++I+SDV+SFGVLL EI S
Sbjct: 203 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 99/197 (50%), Gaps = 9/197 (4%)
Query: 57  LGEGGFGPVYKGVLKKGDE-IAVKRLSGRSGQGLRE-MKNEASVIAKVQHKNLVRLLGCC 114
           LGEG +G V   V +  +E +AVK +  +      E +K E  +   + H+N+V+  G  
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGHR 73
Query: 115 IDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 174
            + + + L  EY     L F   +P   M      R      +  G++YLH    + I H
Sbjct: 74  REGNIQYLFLEYCSGGEL-FDRIEPDIGMPEPDAQR--FFHQLMAGVVYLHG---IGITH 127
Query: 175 RDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKS 234
           RD+K  N+LLD+  N KISDFG+A +   N  +   +++ GT  Y++PE      F  + 
Sbjct: 128 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEP 187
Query: 235 -DVFSFGVLLLEIVSGK 250
            DV+S G++L  +++G+
Sbjct: 188 VDVWSCGIVLTAMLAGE 204

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 99/197 (50%), Gaps = 9/197 (4%)
Query: 57  LGEGGFGPVYKGVLKKGDE-IAVKRLSGRSGQGLRE-MKNEASVIAKVQHKNLVRLLGCC 114
           LGEG +G V   V +  +E +AVK +  +      E +K E  +   + H+N+V+  G  
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 115 IDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 174
            + + + L  EY     L F   +P   M      R      +  G++YLH    + I H
Sbjct: 74  REGNIQYLFLEYCSGGEL-FDRIEPDIGMPEPDAQR--FFHQLMAGVVYLHG---IGITH 127
Query: 175 RDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKS 234
           RD+K  N+LLD+  N KISDFG+A +   N  +   +++ GT  Y++PE      F  + 
Sbjct: 128 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEP 187
Query: 235 -DVFSFGVLLLEIVSGK 250
            DV+S G++L  +++G+
Sbjct: 188 VDVWSCGIVLTAMLAGE 204

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 99/197 (50%), Gaps = 9/197 (4%)
Query: 57  LGEGGFGPVYKGVLKKGDE-IAVKRLSGRSGQGLRE-MKNEASVIAKVQHKNLVRLLGCC 114
           LGEG +G V   V +  +E +AVK +  +      E +K E  +   + H+N+V+  G  
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 115 IDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 174
            + + + L  EY     L F   +P   M      R      +  G++YLH    + I H
Sbjct: 74  REGNIQYLFLEYCSGGEL-FDRIEPDIGMPEPDAQR--FFHQLMAGVVYLHG---IGITH 127
Query: 175 RDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKS 234
           RD+K  N+LLD+  N KISDFG+A +   N  +   +++ GT  Y++PE      F  + 
Sbjct: 128 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEP 187
Query: 235 -DVFSFGVLLLEIVSGK 250
            DV+S G++L  +++G+
Sbjct: 188 VDVWSCGIVLTAMLAGE 204

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 74/259 (28%), Positives = 114/259 (44%), Gaps = 24/259 (9%)
Query: 47  ATNKFSDANKLGEGGFGPVYKGVLKKGDEI-AVKRL--SGRSGQGL-REMKNEASVIAKV 102
           A   F     LG+G FG VY    K+   I A+K L  +     G+  +++ E  + + +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 103 QHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLL 162
           +H N++RL G   D     LI EY P   L     +  K    D       I  +A  L 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 163 YLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR---IVGTYGY 219
           Y H     R+IHRD+K  N+LL      KI+DFG +       + A +SR   + GT  Y
Sbjct: 123 YCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRTELCGTLDY 172
Query: 220 MSPEYALEGIFSIKSDVFSFGVLLLEIVSGKK----NTGLYRTDSLNLLGYAWDLWTSNR 275
           + PE     +   K D++S GVL  E + GK     NT       ++ + + +  + +  
Sbjct: 173 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEG 232
Query: 276 TLELIDPILEDEYSSKQML 294
             +LI  +L+   S + ML
Sbjct: 233 ARDLISRLLKHNPSQRPML 251

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 66/211 (31%), Positives = 95/211 (45%), Gaps = 20/211 (9%)
Query: 47  ATNKFSDANKLGEGGFGPVYKGVLKKGDEI-AVKRL--SGRSGQGL-REMKNEASVIAKV 102
           A   F     LG+G FG VY    K+   I A+K L  +     G+  +++ E  + + +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 103 QHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLL 162
           +H N++RL G   D     LI EY P   L     +  K    D       I  +A  L 
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 125
Query: 163 YLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR---IVGTYGY 219
           Y H     R+IHRD+K  N+LL      KI+DFG +       + A +SR   + GT  Y
Sbjct: 126 YCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRTTLCGTLDY 175
Query: 220 MSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 250
           + PE     +   K D++S GVL  E + GK
Sbjct: 176 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 74/259 (28%), Positives = 114/259 (44%), Gaps = 24/259 (9%)
Query: 47  ATNKFSDANKLGEGGFGPVYKGVLKKGDEI-AVKRL--SGRSGQGL-REMKNEASVIAKV 102
           A   F     LG+G FG VY    K+   I A+K L  +     G+  +++ E  + + +
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 103 QHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLL 162
           +H N++RL G   D     LI EY P   L     +  K    D       I  +A  L 
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 127
Query: 163 YLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR---IVGTYGY 219
           Y H     R+IHRD+K  N+LL      KI+DFG +       + A +SR   + GT  Y
Sbjct: 128 YCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRTTLCGTLDY 177
Query: 220 MSPEYALEGIFSIKSDVFSFGVLLLEIVSGKK----NTGLYRTDSLNLLGYAWDLWTSNR 275
           + PE     +   K D++S GVL  E + GK     NT       ++ + + +  + +  
Sbjct: 178 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEG 237
Query: 276 TLELIDPILEDEYSSKQML 294
             +LI  +L+   S + ML
Sbjct: 238 ARDLISRLLKHNPSQRPML 256

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 74/259 (28%), Positives = 114/259 (44%), Gaps = 24/259 (9%)
Query: 47  ATNKFSDANKLGEGGFGPVYKGVLKKGDEI-AVKRL--SGRSGQGL-REMKNEASVIAKV 102
           A   F     LG+G FG VY    K+   I A+K L  +     G+  +++ E  + + +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 103 QHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLL 162
           +H N++RL G   D     LI EY P   L     +  K    D       I  +A  L 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 163 YLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR---IVGTYGY 219
           Y H     R+IHRD+K  N+LL      KI+DFG +       + A +SR   + GT  Y
Sbjct: 123 YCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRTDLCGTLDY 172
Query: 220 MSPEYALEGIFSIKSDVFSFGVLLLEIVSGKK----NTGLYRTDSLNLLGYAWDLWTSNR 275
           + PE     +   K D++S GVL  E + GK     NT       ++ + + +  + +  
Sbjct: 173 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEG 232
Query: 276 TLELIDPILEDEYSSKQML 294
             +LI  +L+   S + ML
Sbjct: 233 ARDLISRLLKHNPSQRPML 251

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 74/259 (28%), Positives = 114/259 (44%), Gaps = 24/259 (9%)
Query: 47  ATNKFSDANKLGEGGFGPVYKGVLKKGDEI-AVKRL--SGRSGQGL-REMKNEASVIAKV 102
           A   F     LG+G FG VY    K+   I A+K L  +     G+  +++ E  + + +
Sbjct: 8   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 67
Query: 103 QHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLL 162
           +H N++RL G   D     LI EY P   L     +  K    D       I  +A  L 
Sbjct: 68  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 124
Query: 163 YLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR---IVGTYGY 219
           Y H     R+IHRD+K  N+LL      KI+DFG +       + A +SR   + GT  Y
Sbjct: 125 YCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRXXLCGTLDY 174
Query: 220 MSPEYALEGIFSIKSDVFSFGVLLLEIVSGKK----NTGLYRTDSLNLLGYAWDLWTSNR 275
           + PE     +   K D++S GVL  E + GK     NT       ++ + + +  + +  
Sbjct: 175 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEG 234
Query: 276 TLELIDPILEDEYSSKQML 294
             +LI  +L+   S + ML
Sbjct: 235 ARDLISRLLKHNPSQRPML 253

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 99/197 (50%), Gaps = 9/197 (4%)
Query: 57  LGEGGFGPVYKGVLKKGDE-IAVKRLSGRSGQGLRE-MKNEASVIAKVQHKNLVRLLGCC 114
           LGEG +G V   V +  +E +AVK +  +      E +K E  +   + H+N+V+  G  
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 115 IDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 174
            + + + L  EY     L F   +P   M      R      +  G++YLH    + I H
Sbjct: 74  REGNIQYLFLEYCSGGEL-FDRIEPDIGMPEPDAQR--FFHQLMAGVVYLHG---IGITH 127
Query: 175 RDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKS 234
           RD+K  N+LLD+  N KISDFG+A +   N  +   +++ GT  Y++PE      F  + 
Sbjct: 128 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEP 187
Query: 235 -DVFSFGVLLLEIVSGK 250
            DV+S G++L  +++G+
Sbjct: 188 VDVWSCGIVLTAMLAGE 204

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 99/197 (50%), Gaps = 9/197 (4%)
Query: 57  LGEGGFGPVYKGVLKKGDE-IAVKRLSGRSGQGLRE-MKNEASVIAKVQHKNLVRLLGCC 114
           LGEG +G V   V +  +E +AVK +  +      E +K E  +   + H+N+V+  G  
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 115 IDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 174
            + + + L  EY     L F   +P   M      R      +  G++YLH    + I H
Sbjct: 74  REGNIQYLFLEYCSGGEL-FDRIEPDIGMPEPDAQR--FFHQLMAGVVYLHG---IGITH 127
Query: 175 RDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKS 234
           RD+K  N+LLD+  N KISDFG+A +   N  +   +++ GT  Y++PE      F  + 
Sbjct: 128 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEP 187
Query: 235 -DVFSFGVLLLEIVSGK 250
            DV+S G++L  +++G+
Sbjct: 188 VDVWSCGIVLTAMLAGE 204

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 68/214 (31%), Positives = 104/214 (48%), Gaps = 25/214 (11%)
Query: 57  LGEGGFGPVYK----GVLKKGD--EIAVKRL-SGRSGQGLREMKNEASVIAKV-QHKNLV 108
           LG G FG V +    G+ K      +AVK L  G +    R + +E  ++  +  H N+V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 109 RLLGCCIDRDEKIL-IYEYMPNKSLDFFL------FDPTK----RMLLDWVTRVQIIE-- 155
            LLG C      ++ I E+    +L  +L      F P K     +  D++T   +I   
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154
Query: 156 -GIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIV 214
             +A+G+ +L   +  + IHRDL A NILL +    KI DFG+AR    +          
Sbjct: 155 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDXVRKGDAR 211
Query: 215 GTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 248
               +M+PE   + +++I+SDV+SFGVLL EI S
Sbjct: 212 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 66/211 (31%), Positives = 95/211 (45%), Gaps = 20/211 (9%)
Query: 47  ATNKFSDANKLGEGGFGPVYKGVLKKGDEI-AVKRL--SGRSGQGL-REMKNEASVIAKV 102
           A   F     LG+G FG VY    K+   I A+K L  +     G+  +++ E  + + +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 103 QHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLL 162
           +H N++RL G   D     LI EY P   L     +  K    D       I  +A  L 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 163 YLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR---IVGTYGY 219
           Y H     R+IHRD+K  N+LL      KI+DFG +       + A +SR   + GT  Y
Sbjct: 123 YCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRTDLCGTLDY 172
Query: 220 MSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 250
           + PE     +   K D++S GVL  E + GK
Sbjct: 173 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 99/197 (50%), Gaps = 9/197 (4%)
Query: 57  LGEGGFGPVYKGVLKKGDE-IAVKRLSGRSGQGLRE-MKNEASVIAKVQHKNLVRLLGCC 114
           LGEG +G V   V +  +E +AVK +  +      E +K E  +   + H+N+V+  G  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 115 IDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 174
            + + + L  EY     L F   +P   M      R      +  G++YLH    + I H
Sbjct: 75  REGNIQYLFLEYCSGGEL-FDRIEPDIGMPEPDAQR--FFHQLMAGVVYLHG---IGITH 128
Query: 175 RDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKS 234
           RD+K  N+LLD+  N KISDFG+A +   N  +   +++ GT  Y++PE      F  + 
Sbjct: 129 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEP 188
Query: 235 -DVFSFGVLLLEIVSGK 250
            DV+S G++L  +++G+
Sbjct: 189 VDVWSCGIVLTAMLAGE 205

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 99/197 (50%), Gaps = 9/197 (4%)
Query: 57  LGEGGFGPVYKGVLKKGDE-IAVKRLSGRSGQGLRE-MKNEASVIAKVQHKNLVRLLGCC 114
           LGEG +G V   V +  +E +AVK +  +      E +K E  +   + H+N+V+  G  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 115 IDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 174
            + + + L  EY     L F   +P   M      R      +  G++YLH    + I H
Sbjct: 75  REGNIQYLFLEYCSGGEL-FDRIEPDIGMPEPDAQR--FFHQLMAGVVYLHG---IGITH 128
Query: 175 RDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKS 234
           RD+K  N+LLD+  N KISDFG+A +   N  +   +++ GT  Y++PE      F  + 
Sbjct: 129 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEP 188
Query: 235 -DVFSFGVLLLEIVSGK 250
            DV+S G++L  +++G+
Sbjct: 189 VDVWSCGIVLTAMLAGE 205

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 99/197 (50%), Gaps = 9/197 (4%)
Query: 57  LGEGGFGPVYKGVLKKGDE-IAVKRLSGRSGQGLRE-MKNEASVIAKVQHKNLVRLLGCC 114
           LGEG +G V   V +  +E +AVK +  +      E +K E  +   + H+N+V+  G  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 115 IDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 174
            + + + L  EY     L F   +P   M      R      +  G++YLH    + I H
Sbjct: 75  REGNIQYLFLEYCSGGEL-FDRIEPDIGMPEPDAQR--FFHQLMAGVVYLHG---IGITH 128
Query: 175 RDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKS 234
           RD+K  N+LLD+  N KISDFG+A +   N  +   +++ GT  Y++PE      F  + 
Sbjct: 129 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEP 188
Query: 235 -DVFSFGVLLLEIVSGK 250
            DV+S G++L  +++G+
Sbjct: 189 VDVWSCGIVLTAMLAGE 205

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 74/259 (28%), Positives = 114/259 (44%), Gaps = 24/259 (9%)
Query: 47  ATNKFSDANKLGEGGFGPVYKGVLKKGDEI-AVKRL--SGRSGQGL-REMKNEASVIAKV 102
           A   F     LG+G FG VY    K+   I A+K L  +     G+  +++ E  + + +
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 103 QHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLL 162
           +H N++RL G   D     LI EY P   L     +  K    D       I  +A  L 
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 127
Query: 163 YLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR---IVGTYGY 219
           Y H     R+IHRD+K  N+LL      KI+DFG +       + A +SR   + GT  Y
Sbjct: 128 YCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRTDLCGTLDY 177
Query: 220 MSPEYALEGIFSIKSDVFSFGVLLLEIVSGKK----NTGLYRTDSLNLLGYAWDLWTSNR 275
           + PE     +   K D++S GVL  E + GK     NT       ++ + + +  + +  
Sbjct: 178 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEG 237
Query: 276 TLELIDPILEDEYSSKQML 294
             +LI  +L+   S + ML
Sbjct: 238 ARDLISRLLKHNPSQRPML 256

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 99/197 (50%), Gaps = 9/197 (4%)
Query: 57  LGEGGFGPVYKGVLKKGDE-IAVKRLSGRSGQGLRE-MKNEASVIAKVQHKNLVRLLGCC 114
           LGEG +G V   V +  +E +AVK +  +      E +K E  +   + H+N+V+  G  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGHR 74
Query: 115 IDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 174
            + + + L  EY     L F   +P   M      R      +  G++YLH    + I H
Sbjct: 75  REGNIQYLFLEYCSGGEL-FDRIEPDIGMPEPDAQR--FFHQLMAGVVYLHG---IGITH 128
Query: 175 RDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKS 234
           RD+K  N+LLD+  N KISDFG+A +   N  +   +++ GT  Y++PE      F  + 
Sbjct: 129 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEP 188
Query: 235 -DVFSFGVLLLEIVSGK 250
            DV+S G++L  +++G+
Sbjct: 189 VDVWSCGIVLTAMLAGE 205

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 99/197 (50%), Gaps = 9/197 (4%)
Query: 57  LGEGGFGPVYKGVLKKGDE-IAVKRLSGRSGQGLRE-MKNEASVIAKVQHKNLVRLLGCC 114
           LGEG +G V   V +  +E +AVK +  +      E +K E  +   + H+N+V+  G  
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 115 IDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 174
            + + + L  EY     L F   +P   M      R      +  G++YLH    + I H
Sbjct: 74  REGNIQYLFLEYCSGGEL-FDRIEPDIGMPEPDAQR--FFHQLMAGVVYLHG---IGITH 127
Query: 175 RDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKS 234
           RD+K  N+LLD+  N KISDFG+A +   N  +   +++ GT  Y++PE      F  + 
Sbjct: 128 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEP 187
Query: 235 -DVFSFGVLLLEIVSGK 250
            DV+S G++L  +++G+
Sbjct: 188 VDVWSCGIVLTAMLAGE 204

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 99/197 (50%), Gaps = 12/197 (6%)
Query: 56  KLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCC 114
           K+GEG  G V    ++  G  +AVK++  R  Q    + NE  ++   QH+N+V +    
Sbjct: 81  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 140
Query: 115 IDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 174
           +  DE  ++ E++   +L   +     RM  + +  V +   + Q L  LH      +IH
Sbjct: 141 LVGDELWVVMEFLEGGALTDIVTH--TRMNEEQIAAVCL--AVLQALSVLHAQG---VIH 193
Query: 175 RDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR-IVGTYGYMSPEYALEGIFSIK 233
           RD+K+ +ILL  D   K+SDFG    C     +    + +VGT  +M+PE      +  +
Sbjct: 194 RDIKSDSILLTHDGRVKLSDFG---FCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPE 250
Query: 234 SDVFSFGVLLLEIVSGK 250
            D++S G++++E+V G+
Sbjct: 251 VDIWSLGIMVIEMVDGE 267

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 66/211 (31%), Positives = 95/211 (45%), Gaps = 20/211 (9%)
Query: 47  ATNKFSDANKLGEGGFGPVYKGVLKKGDEI-AVKRL--SGRSGQGL-REMKNEASVIAKV 102
           A   F     LG+G FG VY    K+   I A+K L  +     G+  +++ E  + + +
Sbjct: 5   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 64
Query: 103 QHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLL 162
           +H N++RL G   D     LI EY P   L     +  K    D       I  +A  L 
Sbjct: 65  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 121
Query: 163 YLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR---IVGTYGY 219
           Y H     R+IHRD+K  N+LL      KI+DFG +       + A +SR   + GT  Y
Sbjct: 122 YCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRTTLCGTLDY 171
Query: 220 MSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 250
           + PE     +   K D++S GVL  E + GK
Sbjct: 172 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 202

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 99/197 (50%), Gaps = 9/197 (4%)
Query: 57  LGEGGFGPVYKGVLKKGDE-IAVKRLSGRSGQGLRE-MKNEASVIAKVQHKNLVRLLGCC 114
           LGEG +G V   V +  +E +AVK +  +      E +K E  +   + H+N+V+  G  
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGHR 73
Query: 115 IDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 174
            + + + L  EY     L F   +P   M      R      +  G++YLH    + I H
Sbjct: 74  REGNIQYLFLEYCSGGEL-FDRIEPDIGMPEPDAQR--FFHQLMAGVVYLHG---IGITH 127
Query: 175 RDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKS 234
           RD+K  N+LLD+  N KISDFG+A +   N  +   +++ GT  Y++PE      F  + 
Sbjct: 128 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEP 187
Query: 235 -DVFSFGVLLLEIVSGK 250
            DV+S G++L  +++G+
Sbjct: 188 VDVWSCGIVLTAMLAGE 204

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 74/259 (28%), Positives = 115/259 (44%), Gaps = 24/259 (9%)
Query: 47  ATNKFSDANKLGEGGFGPVYKGVLKKGDEI-AVKRL--SGRSGQGL-REMKNEASVIAKV 102
           A   F     LG+G FG VY    K+   I A+K L  +     G+  +++ E  + + +
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 103 QHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLL 162
           +H N++RL G   D     LI EY P   +   L   +K    D       I  +A  L 
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSK---FDEQRTATYITELANALS 127
Query: 163 YLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR---IVGTYGY 219
           Y H     R+IHRD+K  N+LL      KI+DFG +       + A +SR   + GT  Y
Sbjct: 128 YCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRXXLXGTLDY 177
Query: 220 MSPEYALEGIFSIKSDVFSFGVLLLEIVSGKK----NTGLYRTDSLNLLGYAWDLWTSNR 275
           + PE     +   K D++S GVL  E + GK     NT       ++ + + +  + +  
Sbjct: 178 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEG 237
Query: 276 TLELIDPILEDEYSSKQML 294
             +LI  +L+   S + ML
Sbjct: 238 ARDLISRLLKHNPSQRPML 256

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 105/201 (52%), Gaps = 19/201 (9%)
Query: 57  LGEGGFGPV-----YKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLL 111
           LGEG FG V     YK   K   +   ++L  +S   +R ++ E S +  ++H ++++L 
Sbjct: 17  LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMR-VEREISYLKLLRHPHIIKLY 75
Query: 112 GCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVR 171
                  + +++ EY   +  D+ +    KRM  D   R    + I   + Y H++   +
Sbjct: 76  DVITTPTDIVMVIEYAGGELFDYIV--EKKRMTEDEGRR--FFQQIICAIEYCHRH---K 128
Query: 172 IIHRDLKASNILLDKDMNPKISDFGMARI-CGGNELQANTSRIVGTYGYMSPEYALEGIF 230
           I+HRDLK  N+LLD ++N KI+DFG++ I   GN L+ +     G+  Y +PE     ++
Sbjct: 129 IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSC----GSPNYAAPEVINGKLY 184
Query: 231 S-IKSDVFSFGVLLLEIVSGK 250
           +  + DV+S G++L  ++ G+
Sbjct: 185 AGPEVDVWSCGIVLYVMLVGR 205

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 66/211 (31%), Positives = 95/211 (45%), Gaps = 20/211 (9%)
Query: 47  ATNKFSDANKLGEGGFGPVYKGVLKKGDEI-AVKRL--SGRSGQGL-REMKNEASVIAKV 102
           A   F     LG+G FG VY    K+   I A+K L  +     G+  +++ E  + + +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 103 QHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLL 162
           +H N++RL G   D     LI EY P   L     +  K    D       I  +A  L 
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 125
Query: 163 YLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR---IVGTYGY 219
           Y H     R+IHRD+K  N+LL      KI+DFG +       + A +SR   + GT  Y
Sbjct: 126 YCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRTTLCGTLDY 175
Query: 220 MSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 250
           + PE     +   K D++S GVL  E + GK
Sbjct: 176 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 69/213 (32%), Positives = 110/213 (51%), Gaps = 22/213 (10%)
Query: 49  NKFSDANKLGEGGFGPVYKGVLK-KGDEIAVK-----RLSG-RSGQGLREMKNEASVIAK 101
           + +    +LG G F  V K   K  G E A K     RLS  R G    E++ E +++ +
Sbjct: 12  DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILRE 71
Query: 102 VQHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGL 161
           ++H N++ L     ++ + +LI E +    L  FL +  + +  D  T  Q ++ I  G+
Sbjct: 72  IRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAE-KESLTEDEAT--QFLKQILDGV 128
Query: 162 LYLHQYSRVRIIHRDLKASNI-LLDKDM-NPKIS--DFGMA-RICGGNELQANTSRIVGT 216
            YLH     RI H DLK  NI LLDK++ NP+I   DFG+A +I  GNE +     I GT
Sbjct: 129 HYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFK----NIFGT 181
Query: 217 YGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 249
             +++PE        +++D++S GV+   ++SG
Sbjct: 182 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 93/339 (27%), Positives = 151/339 (44%), Gaps = 35/339 (10%)
Query: 38  LFSFSSVSTATNKFSDANKLGEGGFGPVY---KGVLKKGDEIAVKRLSGRSGQGLREMKN 94
           +F  S     +  +    KLG G +G V      V      I + R +  S     ++  
Sbjct: 26  MFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLE 85
Query: 95  EASVIAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPT-KRMLLDWVTRVQI 153
           E +V+  + H N+++L     D+    L+ E      L    FD    RM  + V    I
Sbjct: 86  EVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGEL----FDEIIHRMKFNEVDAAVI 141
Query: 154 IEGIAQGLLYLHQYSRVRIIHRDLKASNILL---DKDMNPKISDFGMARICGGNELQANT 210
           I+ +  G+ YLH+++   I+HRDLK  N+LL   +KD   KI DFG++ +    E Q   
Sbjct: 142 IKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVF---ENQKKM 195
Query: 211 SRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLL-----G 265
              +GT  Y++PE  L   +  K DV+S GV+L  +++G    G  +TD   L       
Sbjct: 196 KERLGTAYYIAPE-VLRKKYDEKCDVWSIGVILFILLAGYPPFG-GQTDQEILRKVEKGK 253
Query: 266 YAWDL--W--TSNRTLELIDPILEDEYS---SKQMLLRYANIALLCV-QESADDRPTM-N 316
           Y +D   W   S    +LI  +L+ +     S Q  L +  I  +C  +ES  + P++ N
Sbjct: 254 YTFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEMCSKKESGIELPSLAN 313
Query: 317 DVVSMLTNEAATLLPPKQPAFSYVRNTVTSTSSTGKTED 355
            + +M   + +  L   Q A  Y+ + +TS   T +  D
Sbjct: 314 AIENMRKFQNSQKLA--QAALLYMASKLTSQEETKELTD 350

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 68/214 (31%), Positives = 104/214 (48%), Gaps = 25/214 (11%)
Query: 57  LGEGGFGPVYK----GVLKKGD--EIAVKRL-SGRSGQGLREMKNEASVIAKV-QHKNLV 108
           LG G FG V +    G+ K      +AVK L  G +    R + +E  ++  +  H N+V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 109 RLLGCCIDRDEKIL-IYEYMPNKSLDFFL------FDPTK----RMLLDWVTRVQIIE-- 155
            LLG C      ++ I E+    +L  +L      F P K     +  D++T   +I   
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154
Query: 156 -GIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIV 214
             +A+G+ +L   +  + IHRDL A NILL +    KI DFG+AR    +          
Sbjct: 155 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 211
Query: 215 GTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 248
               +M+PE   + +++I+SDV+SFGVLL EI S
Sbjct: 212 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 58/195 (29%), Positives = 102/195 (52%), Gaps = 21/195 (10%)
Query: 57  LGEGGFGPVYKGV-LKKGDEIAVK-----RLSGRSGQGLREMKNEASVIAKVQHKNLVRL 110
           LGEG FG V        G ++A+K      L+    QG   ++ E S +  ++H ++++L
Sbjct: 22  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQG--RIEREISYLRLLRHPHIIKL 79
Query: 111 LGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRV 170
                 +DE I++ EY  N+  D+ +    +R  +      +  + I   + Y H++   
Sbjct: 80  YDVIKSKDEIIMVIEYAGNELFDYIV----QRDKMSEQEARRFFQQIISAVEYCHRH--- 132
Query: 171 RIIHRDLKASNILLDKDMNPKISDFGMARI-CGGNELQANTSRIVGTYGYMSPEYALEGI 229
           +I+HRDLK  N+LLD+ +N KI+DFG++ I   GN L+ +     G+  Y +PE     +
Sbjct: 133 KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSC----GSPNYAAPEVISGKL 188
Query: 230 FS-IKSDVFSFGVLL 243
           ++  + DV+S GV+L
Sbjct: 189 YAGPEVDVWSCGVIL 203

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 74/259 (28%), Positives = 114/259 (44%), Gaps = 24/259 (9%)
Query: 47  ATNKFSDANKLGEGGFGPVYKGVLKKGDEI-AVKRL--SGRSGQGL-REMKNEASVIAKV 102
           A   F     LG+G FG VY    K+   I A+K L  +     G+  +++ E  + + +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 103 QHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLL 162
           +H N++RL G   D     LI EY P   L     +  K    D       I  +A  L 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 163 YLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR---IVGTYGY 219
           Y H     R+IHRD+K  N+LL      KI+DFG +       + A +SR   + GT  Y
Sbjct: 123 YCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRAALCGTLDY 172
Query: 220 MSPEYALEGIFSIKSDVFSFGVLLLEIVSGKK----NTGLYRTDSLNLLGYAWDLWTSNR 275
           + PE     +   K D++S GVL  E + GK     NT       ++ + + +  + +  
Sbjct: 173 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEG 232
Query: 276 TLELIDPILEDEYSSKQML 294
             +LI  +L+   S + ML
Sbjct: 233 ARDLISRLLKHNPSQRPML 251

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 66/211 (31%), Positives = 95/211 (45%), Gaps = 20/211 (9%)
Query: 47  ATNKFSDANKLGEGGFGPVYKGVLKKGDEI-AVKRL--SGRSGQGL-REMKNEASVIAKV 102
           A   F     LG+G FG VY    K+   I A+K L  +     G+  +++ E  + + +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 103 QHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLL 162
           +H N++RL G   D     LI EY P   L     +  K    D       I  +A  L 
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 125
Query: 163 YLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR---IVGTYGY 219
           Y H     R+IHRD+K  N+LL      KI+DFG +       + A +SR   + GT  Y
Sbjct: 126 YCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRXXLCGTLDY 175
Query: 220 MSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 250
           + PE     +   K D++S GVL  E + GK
Sbjct: 176 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 58/195 (29%), Positives = 102/195 (52%), Gaps = 21/195 (10%)
Query: 57  LGEGGFGPVYKGV-LKKGDEIAVK-----RLSGRSGQGLREMKNEASVIAKVQHKNLVRL 110
           LGEG FG V        G ++A+K      L+    QG   ++ E S +  ++H ++++L
Sbjct: 21  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQG--RIEREISYLRLLRHPHIIKL 78
Query: 111 LGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRV 170
                 +DE I++ EY  N+  D+ +    +R  +      +  + I   + Y H++   
Sbjct: 79  YDVIKSKDEIIMVIEYAGNELFDYIV----QRDKMSEQEARRFFQQIISAVEYCHRH--- 131
Query: 171 RIIHRDLKASNILLDKDMNPKISDFGMARI-CGGNELQANTSRIVGTYGYMSPEYALEGI 229
           +I+HRDLK  N+LLD+ +N KI+DFG++ I   GN L+ +     G+  Y +PE     +
Sbjct: 132 KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSC----GSPNYAAPEVISGKL 187
Query: 230 FS-IKSDVFSFGVLL 243
           ++  + DV+S GV+L
Sbjct: 188 YAGPEVDVWSCGVIL 202

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 67/215 (31%), Positives = 96/215 (44%), Gaps = 20/215 (9%)
Query: 43  SVSTATNKFSDANKLGEGGFGPVYKGVLKKGDEI-AVKRL--SGRSGQGL-REMKNEASV 98
           S   A   F     LG+G FG VY    K+   I A+K L  +     G+  +++ E  +
Sbjct: 5   SRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI 64
Query: 99  IAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIA 158
            + ++H N++RL G   D     LI EY P   L     +  K    D       I  +A
Sbjct: 65  QSHLRHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELA 121
Query: 159 QGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR---IVG 215
             L Y H     R+IHRD+K  N+LL      KI+DFG +       + A +SR   + G
Sbjct: 122 NALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRDDLCG 171
Query: 216 TYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 250
           T  Y+ PE     +   K D++S GVL  E + GK
Sbjct: 172 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 58/195 (29%), Positives = 102/195 (52%), Gaps = 21/195 (10%)
Query: 57  LGEGGFGPVYKGV-LKKGDEIAVK-----RLSGRSGQGLREMKNEASVIAKVQHKNLVRL 110
           LGEG FG V        G ++A+K      L+    QG   ++ E S +  ++H ++++L
Sbjct: 12  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQG--RIEREISYLRLLRHPHIIKL 69
Query: 111 LGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRV 170
                 +DE I++ EY  N+  D+ +    +R  +      +  + I   + Y H++   
Sbjct: 70  YDVIKSKDEIIMVIEYAGNELFDYIV----QRDKMSEQEARRFFQQIISAVEYCHRH--- 122
Query: 171 RIIHRDLKASNILLDKDMNPKISDFGMARI-CGGNELQANTSRIVGTYGYMSPEYALEGI 229
           +I+HRDLK  N+LLD+ +N KI+DFG++ I   GN L+ +     G+  Y +PE     +
Sbjct: 123 KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSC----GSPNYAAPEVISGKL 178
Query: 230 FS-IKSDVFSFGVLL 243
           ++  + DV+S GV+L
Sbjct: 179 YAGPEVDVWSCGVIL 193

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 66/211 (31%), Positives = 95/211 (45%), Gaps = 20/211 (9%)
Query: 47  ATNKFSDANKLGEGGFGPVYKGVLKKGDEI-AVKRL--SGRSGQGL-REMKNEASVIAKV 102
           A   F     LG+G FG VY    K+   I A+K L  +     G+  +++ E  + + +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 103 QHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLL 162
           +H N++RL G   D     LI EY P   L     +  K    D       I  +A  L 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 163 YLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR---IVGTYGY 219
           Y H     R+IHRD+K  N+LL      KI+DFG +       + A +SR   + GT  Y
Sbjct: 123 YCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRTXLCGTLDY 172
Query: 220 MSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 250
           + PE     +   K D++S GVL  E + GK
Sbjct: 173 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 58/195 (29%), Positives = 102/195 (52%), Gaps = 21/195 (10%)
Query: 57  LGEGGFGPVYKGV-LKKGDEIAVK-----RLSGRSGQGLREMKNEASVIAKVQHKNLVRL 110
           LGEG FG V        G ++A+K      L+    QG   ++ E S +  ++H ++++L
Sbjct: 16  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQG--RIEREISYLRLLRHPHIIKL 73
Query: 111 LGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRV 170
                 +DE I++ EY  N+  D+ +    +R  +      +  + I   + Y H++   
Sbjct: 74  YDVIKSKDEIIMVIEYAGNELFDYIV----QRDKMSEQEARRFFQQIISAVEYCHRH--- 126
Query: 171 RIIHRDLKASNILLDKDMNPKISDFGMARI-CGGNELQANTSRIVGTYGYMSPEYALEGI 229
           +I+HRDLK  N+LLD+ +N KI+DFG++ I   GN L+ +     G+  Y +PE     +
Sbjct: 127 KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSC----GSPNYAAPEVISGKL 182
Query: 230 FS-IKSDVFSFGVLL 243
           ++  + DV+S GV+L
Sbjct: 183 YAGPEVDVWSCGVIL 197

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 98/197 (49%), Gaps = 12/197 (6%)
Query: 56  KLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCC 114
           K+GEG  G V     K  G ++AVK++  R  Q    + NE  ++    H N+V +    
Sbjct: 52  KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHDNVVDMYSSY 111
Query: 115 IDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 174
           +  DE  ++ E++   +L   +     RM  + +  V +   + + L YLH      +IH
Sbjct: 112 LVGDELWVVMEFLEGGALTDIVTH--TRMNEEQIATVCL--SVLRALSYLHNQG---VIH 164
Query: 175 RDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR-IVGTYGYMSPEYALEGIFSIK 233
           RD+K+ +ILL  D   K+SDFG    C     +    + +VGT  +M+PE      +  +
Sbjct: 165 RDIKSDSILLTSDGRIKLSDFG---FCAQVSKEVPKRKXLVGTPYWMAPEVISRLPYGTE 221
Query: 234 SDVFSFGVLLLEIVSGK 250
            D++S G++++E++ G+
Sbjct: 222 VDIWSLGIMVIEMIDGE 238

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 68/214 (31%), Positives = 104/214 (48%), Gaps = 25/214 (11%)
Query: 57  LGEGGFGPVYK----GVLKKGD--EIAVKRL-SGRSGQGLREMKNEASVIAKV-QHKNLV 108
           LG G FG V +    G+ K      +AVK L  G +    R + +E  ++  +  H N+V
Sbjct: 72  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 131
Query: 109 RLLGCCIDRDEKIL-IYEYMPNKSLDFFL------FDPTK----RMLLDWVTRVQIIE-- 155
            LLG C      ++ I E+    +L  +L      F P K     +  D++T   +I   
Sbjct: 132 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 191
Query: 156 -GIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIV 214
             +A+G+ +L   +  + IHRDL A NILL +    KI DFG+AR    +          
Sbjct: 192 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 248
Query: 215 GTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 248
               +M+PE   + +++I+SDV+SFGVLL EI S
Sbjct: 249 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 282

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 68/214 (31%), Positives = 104/214 (48%), Gaps = 25/214 (11%)
Query: 57  LGEGGFGPVYK----GVLKKGD--EIAVKRL-SGRSGQGLREMKNEASVIAKV-QHKNLV 108
           LG G FG V +    G+ K      +AVK L  G +    R + +E  ++  +  H N+V
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 109 RLLGCCIDRDEKIL-IYEYMPNKSLDFFL------FDPTK----RMLLDWVTRVQIIE-- 155
            LLG C      ++ I E+    +L  +L      F P K     +  D++T   +I   
Sbjct: 86  NLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 156 -GIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIV 214
             +A+G+ +L   +  + IHRDL A NILL +    KI DFG+AR    +          
Sbjct: 146 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 202
Query: 215 GTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 248
               +M+PE   + +++I+SDV+SFGVLL EI S
Sbjct: 203 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 66/211 (31%), Positives = 95/211 (45%), Gaps = 20/211 (9%)
Query: 47  ATNKFSDANKLGEGGFGPVYKGVLKKGDEI-AVKRL--SGRSGQGL-REMKNEASVIAKV 102
           A   F     LG+G FG VY    K+   I A+K L  +     G+  +++ E  + + +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 103 QHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLL 162
           +H N++RL G   D     LI EY P   L     +  K    D       I  +A  L 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 163 YLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR---IVGTYGY 219
           Y H     R+IHRD+K  N+LL      KI+DFG +       + A +SR   + GT  Y
Sbjct: 123 YCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRXXLCGTLDY 172
Query: 220 MSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 250
           + PE     +   K D++S GVL  E + GK
Sbjct: 173 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 93/208 (44%), Gaps = 14/208 (6%)
Query: 47  ATNKFSDANKLGEGGFGPVYKGVLKKGDEI-AVKRL--SGRSGQGL-REMKNEASVIAKV 102
           A   F     LG+G FG VY    K+   I A+K L  +     G+  +++ E  + + +
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 103 QHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLL 162
           +H N++RL G   D     LI EY P   L     +  K    D       I  +A  L 
Sbjct: 67  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 123
Query: 163 YLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSP 222
           Y H     R+IHRD+K  N+LL      KI+DFG +  C     +  T  + GT  Y+ P
Sbjct: 124 YCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS--CHAPSSRRTT--LSGTLDYLPP 176
Query: 223 EYALEGIFSIKSDVFSFGVLLLEIVSGK 250
           E     +   K D++S GVL  E + GK
Sbjct: 177 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 204

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 94/203 (46%), Gaps = 14/203 (6%)
Query: 51  FSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRS---GQGL-REMKNEASVIAKVQHKN 106
           F     LG+G FG VY    KK   I   ++  +S    +G+  +++ E  + A + H N
Sbjct: 25  FEIGRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQAHLHHPN 84
Query: 107 LVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQ 166
           ++RL     DR    LI EY P   L   L    K    D      I+E +A  L+Y H 
Sbjct: 85  ILRLYNYFYDRRRIYLILEYAPRGELYKEL---QKSCTFDEQRTATIMEELADALMYCHG 141
Query: 167 YSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAL 226
               ++IHRD+K  N+LL      KI+DFG +       L+  T  + GT  Y+ PE   
Sbjct: 142 K---KVIHRDIKPENLLLGLKGELKIADFGWS--VHAPSLRRKT--MCGTLDYLPPEMIE 194
Query: 227 EGIFSIKSDVFSFGVLLLEIVSG 249
             + + K D++  GVL  E++ G
Sbjct: 195 GRMHNEKVDLWCIGVLCYELLVG 217

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 66/211 (31%), Positives = 95/211 (45%), Gaps = 20/211 (9%)
Query: 47  ATNKFSDANKLGEGGFGPVYKGVLKKGDEI-AVKRL--SGRSGQGL-REMKNEASVIAKV 102
           A   F     LG+G FG VY    K+   I A+K L  +     G+  +++ E  + + +
Sbjct: 10  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 69
Query: 103 QHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLL 162
           +H N++RL G   D     LI EY P   L     +  K    D       I  +A  L 
Sbjct: 70  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 126
Query: 163 YLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR---IVGTYGY 219
           Y H     R+IHRD+K  N+LL      KI+DFG +       + A +SR   + GT  Y
Sbjct: 127 YCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRTTLCGTLDY 176
Query: 220 MSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 250
           + PE     +   K D++S GVL  E + GK
Sbjct: 177 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 207

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 51/160 (31%), Positives = 83/160 (51%), Gaps = 13/160 (8%)
Query: 91  EMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSL-----DFFLFDPTKRMLL 145
           + KNE  +I  ++++  +   G   + DE  +IYEYM N S+      FF+ D      +
Sbjct: 89  DFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFI 148
Query: 146 DWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE 205
                  II+ +     Y+H  +   I HRD+K SNIL+DK+   K+SDFG +      +
Sbjct: 149 PIQVIKCIIKSVLNSFSYIH--NEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKK 206
Query: 206 LQANTSRIVGTYGYMSPE-YALEGIFS-IKSDVFSFGVLL 243
           ++   SR  GTY +M PE ++ E  ++  K D++S G+ L
Sbjct: 207 IKG--SR--GTYEFMPPEFFSNESSYNGAKVDIWSLGICL 242

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 68/214 (31%), Positives = 104/214 (48%), Gaps = 25/214 (11%)
Query: 57  LGEGGFGPVYK----GVLKKGD--EIAVKRL-SGRSGQGLREMKNEASVIAKV-QHKNLV 108
           LG G FG V +    G+ K      +AVK L  G +    R + +E  ++  +  H N+V
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 109 RLLGCCIDRDEKIL-IYEYMPNKSLDFFL------FDPTK----RMLLDWVTRVQIIE-- 155
            LLG C      ++ I E+    +L  +L      F P K     +  D++T   +I   
Sbjct: 86  NLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 156 -GIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIV 214
             +A+G+ +L   +  + IHRDL A NILL +    KI DFG+AR    +          
Sbjct: 146 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 202
Query: 215 GTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 248
               +M+PE   + +++I+SDV+SFGVLL EI S
Sbjct: 203 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 66/211 (31%), Positives = 94/211 (44%), Gaps = 20/211 (9%)
Query: 47  ATNKFSDANKLGEGGFGPVYKGVLKKGDEI-AVKRL--SGRSGQGL-REMKNEASVIAKV 102
           A   F     LG+G FG VY    K+   I A+K L  +     G+  +++ E  + + +
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 103 QHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLL 162
           +H N++RL G   D     LI EY P   L     +  K    D       I  +A  L 
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 127
Query: 163 YLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR---IVGTYGY 219
           Y H     R+IHRD+K  N+LL      KI+DFG +       + A +SR   + GT  Y
Sbjct: 128 YCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRTTLCGTLDY 177
Query: 220 MSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 250
           + PE         K D++S GVL  E + GK
Sbjct: 178 LPPEXIEGRXHDEKVDLWSLGVLCYEFLVGK 208

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 64/202 (31%), Positives = 96/202 (47%), Gaps = 19/202 (9%)
Query: 57  LGEGGFGPVYKGVLKKGDEI-AVKRLSGRSGQGLREMKNEASVIAK------VQHKNLVR 109
           LG+G FG V+    KK ++  A+K L  +    L +   E +++ K       +H  L  
Sbjct: 25  LGKGSFGKVFLAEFKKTNQFFAIKAL--KKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 82
Query: 110 LLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSR 169
           +      ++    + EY+    L + +    K    D          I  GL +LH    
Sbjct: 83  MFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK---FDLSRATFYAAEIILGLQFLHSKG- 138
Query: 170 VRIIHRDLKASNILLDKDMNPKISDFGMARICGGNEL-QANTSRIVGTYGYMSPEYALEG 228
             I++RDLK  NILLDKD + KI+DFGM   C  N L  A T+   GT  Y++PE  L  
Sbjct: 139 --IVYRDLKLDNILLDKDGHIKIADFGM---CKENMLGDAKTNXFCGTPDYIAPEILLGQ 193
Query: 229 IFSIKSDVFSFGVLLLEIVSGK 250
            ++   D +SFGVLL E++ G+
Sbjct: 194 KYNHSVDWWSFGVLLYEMLIGQ 215

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 102/216 (47%), Gaps = 27/216 (12%)
Query: 48  TNKFSD----ANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGR--SGQGLREMKNEASVIA 100
           + KFSD      +LG+G F  V + V K  G E A K ++ +  S +  ++++ EA +  
Sbjct: 1   STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICR 60
Query: 101 KVQHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQG 160
           K+QH N+VRL     +     L+++ +    L     D   R           I+ I + 
Sbjct: 61  KLQHPNIVRLHDSIQEESFHYLVFDLVTGGEL---FEDIVAREFYSEADASHCIQQILES 117
Query: 161 LLYLHQYSRVRIIHRDLKASNILLD---KDMNPKISDFGMARICGGNELQANTSR----I 213
           + Y H      I+HR+LK  N+LL    K    K++DFG+A       ++ N S      
Sbjct: 118 IAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLA-------IEVNDSEAWHGF 167
Query: 214 VGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 249
            GT GY+SPE   +  +S   D+++ GV+L  ++ G
Sbjct: 168 AGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 203

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 102/216 (47%), Gaps = 27/216 (12%)
Query: 48  TNKFSD----ANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGR--SGQGLREMKNEASVIA 100
           + KFSD      +LG+G F  V + V K  G E A K ++ +  S +  ++++ EA +  
Sbjct: 1   STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICR 60
Query: 101 KVQHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQG 160
           K+QH N+VRL     +     L+++ +    L     D   R           I+ I + 
Sbjct: 61  KLQHPNIVRLHDSIQEESFHYLVFDLVTGGEL---FEDIVAREFYSEADASHCIQQILES 117
Query: 161 LLYLHQYSRVRIIHRDLKASNILLD---KDMNPKISDFGMARICGGNELQANTSR----I 213
           + Y H      I+HR+LK  N+LL    K    K++DFG+A       ++ N S      
Sbjct: 118 IAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLA-------IEVNDSEAWHGF 167
Query: 214 VGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 249
            GT GY+SPE   +  +S   D+++ GV+L  ++ G
Sbjct: 168 AGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 203

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 64/202 (31%), Positives = 96/202 (47%), Gaps = 19/202 (9%)
Query: 57  LGEGGFGPVYKGVLKKGDEI-AVKRLSGRSGQGLREMKNEASVIAK------VQHKNLVR 109
           LG+G FG V+    KK ++  A+K L  +    L +   E +++ K       +H  L  
Sbjct: 26  LGKGSFGKVFLAEFKKTNQFFAIKAL--KKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 83
Query: 110 LLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSR 169
           +      ++    + EY+    L + +    K    D          I  GL +LH    
Sbjct: 84  MFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK---FDLSRATFYAAEIILGLQFLHSKG- 139
Query: 170 VRIIHRDLKASNILLDKDMNPKISDFGMARICGGNEL-QANTSRIVGTYGYMSPEYALEG 228
             I++RDLK  NILLDKD + KI+DFGM   C  N L  A T+   GT  Y++PE  L  
Sbjct: 140 --IVYRDLKLDNILLDKDGHIKIADFGM---CKENMLGDAKTNEFCGTPDYIAPEILLGQ 194
Query: 229 IFSIKSDVFSFGVLLLEIVSGK 250
            ++   D +SFGVLL E++ G+
Sbjct: 195 KYNHSVDWWSFGVLLYEMLIGQ 216

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 66/233 (28%), Positives = 111/233 (47%), Gaps = 21/233 (9%)
Query: 55  NKLGEGGFGPV----YKGVL-KKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVR 109
           ++LG+G FG V    Y  +    G  +AVK+L        R+ + E  ++  +    +V+
Sbjct: 29  SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVK 88
Query: 110 LLGCCID--RDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQY 167
             G      R    L+ EY+P+  L  FL     R  LD    +     I +G+ YL   
Sbjct: 89  YRGVSYGPGRQSLRLVMEYLPSGCLRDFL--QRHRARLDASRLLLYSSQICKGMEYL--- 143
Query: 168 SRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE-----LQANTSRIVGTYGYMSP 222
              R +HRDL A NIL++ + + KI+DFG+A++   ++      +   S I     + +P
Sbjct: 144 GSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIF----WYAP 199
Query: 223 EYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNR 275
           E   + IFS +SDV+SFGV+L E+ +    +     + L ++G   D+   +R
Sbjct: 200 ESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSR 252

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 66/211 (31%), Positives = 95/211 (45%), Gaps = 20/211 (9%)
Query: 47  ATNKFSDANKLGEGGFGPVYKGVLKKGDEI-AVKRL--SGRSGQGL-REMKNEASVIAKV 102
           A   F     LG+G FG VY    K+   I A+K L  +     G+  +++ E  + + +
Sbjct: 3   ALEDFEIGRPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 62
Query: 103 QHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLL 162
           +H N++RL G   D     LI EY P   L     +  K    D       I  +A  L 
Sbjct: 63  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 119
Query: 163 YLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR---IVGTYGY 219
           Y H     R+IHRD+K  N+LL      KI+DFG +       + A +SR   + GT  Y
Sbjct: 120 YCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRTTLCGTLDY 169
Query: 220 MSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 250
           + PE     +   K D++S GVL  E + GK
Sbjct: 170 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 200

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 66/233 (28%), Positives = 111/233 (47%), Gaps = 21/233 (9%)
Query: 55  NKLGEGGFGPV----YKGVL-KKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVR 109
           ++LG+G FG V    Y  +    G  +AVK+L        R+ + E  ++  +    +V+
Sbjct: 16  SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVK 75
Query: 110 LLGCCID--RDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQY 167
             G      R    L+ EY+P+  L  FL     R  LD    +     I +G+ YL   
Sbjct: 76  YRGVSYGPGRQSLRLVMEYLPSGCLRDFL--QRHRARLDASRLLLYSSQICKGMEYL--- 130
Query: 168 SRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE-----LQANTSRIVGTYGYMSP 222
              R +HRDL A NIL++ + + KI+DFG+A++   ++      +   S I     + +P
Sbjct: 131 GSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIF----WYAP 186
Query: 223 EYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNR 275
           E   + IFS +SDV+SFGV+L E+ +    +     + L ++G   D+   +R
Sbjct: 187 ESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGSERDVPALSR 239

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 107/220 (48%), Gaps = 22/220 (10%)
Query: 45  STATNKFSDANKLGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKNEASV----- 98
           S AT+++    ++G G +G VYK      G  +A+K +   +G G       ++V     
Sbjct: 5   SMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVAL 64
Query: 99  ---IAKVQHKNLVRLLGCC----IDRDEKI-LIYEYMPNKSLDFFLFDPTKRMLLDWVTR 150
              +   +H N+VRL+  C     DR+ K+ L++E++ ++ L  +L D      L   T 
Sbjct: 65  LRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYL-DKAPPPGLPAETI 122
Query: 151 VQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANT 210
             ++    +GL +LH      I+HRDLK  NIL+      K++DFG+ARI      Q   
Sbjct: 123 KDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARI---YSYQMAL 176
Query: 211 SRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 250
           + +V T  Y +PE  L+  ++   D++S G +  E+   K
Sbjct: 177 TPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 64/228 (28%), Positives = 113/228 (49%), Gaps = 25/228 (10%)
Query: 46  TATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQG-LREMKNEASVIAKVQH 104
           T  ++ +    +G+G +G V++G  + G+ +AVK  S R  +   RE +   +V+  ++H
Sbjct: 5   TVAHQITLLECVGKGRYGEVWRGSWQ-GENVAVKIFSSRDEKSWFRETELYNTVM--LRH 61
Query: 105 KNLVRLLGCCI----DRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQG 160
           +N++  +   +       +  LI  Y    SL    +D  +   LD V+ ++I+  IA G
Sbjct: 62  ENILGFIASDMTSRHSSTQLWLITHYHEMGSL----YDYLQLTTLDTVSCLRIVLSIASG 117
Query: 161 LLYLH-----QYSRVRIIHRDLKASNILLDKDMNPKISDFGMARIC--GGNELQANTSRI 213
           L +LH        +  I HRDLK+ NIL+ K+    I+D G+A +     N+L    +  
Sbjct: 118 LAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPR 177
Query: 214 VGTYGYMSPEYALEGI------FSIKSDVFSFGVLLLEIVSGKKNTGL 255
           VGT  YM+PE   E I         + D+++FG++L E+     + G+
Sbjct: 178 VGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGI 225

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 100/207 (48%), Gaps = 26/207 (12%)
Query: 60  GGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGC-----C 114
           G FG V+K  L   + +AVK    +  Q  +  + E   +  ++H+N+++ +G       
Sbjct: 35  GRFGCVWKAQLLN-EYVAVKIFPIQDKQSWQN-EYEVYSLPGMKHENILQFIGAEKRGTS 92
Query: 115 IDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQ-------Y 167
           +D D   LI  +    SL  FL    K  ++ W     I E +A+GL YLH+        
Sbjct: 93  VDVD-LWLITAFHEKGSLSDFL----KANVVSWNELCHIAETMARGLAYLHEDIPGLKDG 147
Query: 168 SRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALE 227
            +  I HRD+K+ N+LL  ++   I+DFG+A      +   +T   VGT  YM+PE  LE
Sbjct: 148 HKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPE-VLE 206
Query: 228 GIFSIKSDVF------SFGVLLLEIVS 248
           G  + + D F      + G++L E+ S
Sbjct: 207 GAINFQRDAFLRIDMYAMGLVLWELAS 233

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 101/215 (46%), Gaps = 27/215 (12%)
Query: 49  NKFSD----ANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGR--SGQGLREMKNEASVIAK 101
            KFSD      +LG+G F  V + V K  G E A K ++ +  S +  ++++ EA +  K
Sbjct: 1   TKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRK 60
Query: 102 VQHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGL 161
           +QH N+VRL     +     L+++ +    L     D   R           I+ I + +
Sbjct: 61  LQHPNIVRLHDSIQEESFHYLVFDLVTGGEL---FEDIVAREFYSEADASHCIQQILESI 117
Query: 162 LYLHQYSRVRIIHRDLKASNILLD---KDMNPKISDFGMARICGGNELQANTSR----IV 214
            Y H      I+HR+LK  N+LL    K    K++DFG+A       ++ N S       
Sbjct: 118 AYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLA-------IEVNDSEAWHGFA 167
Query: 215 GTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 249
           GT GY+SPE   +  +S   D+++ GV+L  ++ G
Sbjct: 168 GTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 202

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 66/218 (30%), Positives = 99/218 (45%), Gaps = 21/218 (9%)
Query: 42  SSVSTATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLREMKNEASVIA 100
           SS     + F     LG+G FG V    +K+ GD  AVK L  +    L++   E ++  
Sbjct: 16  SSNRLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVL--KKDVILQDDDVECTMTE 73
Query: 101 KV------QHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQII 154
           K        H  L +L  C    D    + E++    L F +     R   +   R    
Sbjct: 74  KRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHI--QKSRRFDEARARFYAA 131
Query: 155 EGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMAR--ICGGNELQANTSR 212
           E I   L++LH      II+RDLK  N+LLD + + K++DFGM +  IC G      T+ 
Sbjct: 132 E-IISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNG----VTTAT 183
Query: 213 IVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 250
             GT  Y++PE   E ++    D ++ GVLL E++ G 
Sbjct: 184 FCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGH 221

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 65/228 (28%), Positives = 109/228 (47%), Gaps = 21/228 (9%)
Query: 55  NKLGEGGFGPV----YKGVL-KKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVR 109
           ++LG+G FG V    Y  +    G  +AVK+L        R+ + E  ++  +    +V+
Sbjct: 17  SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVK 76
Query: 110 LLGCCID--RDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQY 167
             G      R    L+ EY+P+  L  FL     R  LD    +     I +G+ YL   
Sbjct: 77  YRGVSYGPGRQSLRLVMEYLPSGCLRDFL--QRHRARLDASRLLLYSSQICKGMEYL--- 131
Query: 168 SRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE-----LQANTSRIVGTYGYMSP 222
              R +HRDL A NIL++ + + KI+DFG+A++   ++      +   S I     + +P
Sbjct: 132 GSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIF----WYAP 187
Query: 223 EYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDL 270
           E   + IFS +SDV+SFGV+L E+ +    +     + L ++G   D+
Sbjct: 188 ESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDV 235

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 109/217 (50%), Gaps = 25/217 (11%)
Query: 57  LGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQG-LREMKNEASVIAKVQHKNLVRLLGCCI 115
           +G+G +G V++G  + G+ +AVK  S R  +   RE +   +V+  ++H+N++  +   +
Sbjct: 16  VGKGRYGEVWRGSWQ-GENVAVKIFSSRDEKSWFRETELYNTVM--LRHENILGFIASDM 72
Query: 116 ----DRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLH-----Q 166
                  +  LI  Y    SL    +D  +   LD V+ ++I+  IA GL +LH      
Sbjct: 73  TSRHSSTQLWLITHYHEMGSL----YDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGT 128
Query: 167 YSRVRIIHRDLKASNILLDKDMNPKISDFGMARIC--GGNELQANTSRIVGTYGYMSPEY 224
             +  I HRDLK+ NIL+ K+    I+D G+A +     N+L    +  VGT  YM+PE 
Sbjct: 129 QGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEV 188
Query: 225 ALEGI------FSIKSDVFSFGVLLLEIVSGKKNTGL 255
             E I         + D+++FG++L E+     + G+
Sbjct: 189 LDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGI 225

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 109/217 (50%), Gaps = 25/217 (11%)
Query: 57  LGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQG-LREMKNEASVIAKVQHKNLVRLLGCCI 115
           +G+G +G V++G  + G+ +AVK  S R  +   RE +   +V+  ++H+N++  +   +
Sbjct: 45  VGKGRYGEVWRGSWQ-GENVAVKIFSSRDEKSWFRETELYNTVM--LRHENILGFIASDM 101
Query: 116 ----DRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLH-----Q 166
                  +  LI  Y    SL    +D  +   LD V+ ++I+  IA GL +LH      
Sbjct: 102 TSRHSSTQLWLITHYHEMGSL----YDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGT 157
Query: 167 YSRVRIIHRDLKASNILLDKDMNPKISDFGMARIC--GGNELQANTSRIVGTYGYMSPEY 224
             +  I HRDLK+ NIL+ K+    I+D G+A +     N+L    +  VGT  YM+PE 
Sbjct: 158 QGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEV 217
Query: 225 ALEGI------FSIKSDVFSFGVLLLEIVSGKKNTGL 255
             E I         + D+++FG++L E+     + G+
Sbjct: 218 LDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGI 254

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 71.2 bits (173), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 73/259 (28%), Positives = 114/259 (44%), Gaps = 24/259 (9%)
Query: 47  ATNKFSDANKLGEGGFGPVYKGVLKKGDEI-AVKRL--SGRSGQGL-REMKNEASVIAKV 102
           A   F     LG+G FG VY    K+   I A+K L  +     G+  +++ E  + + +
Sbjct: 8   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 67
Query: 103 QHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLL 162
           +H N++RL G   D     LI EY P   L     +  K    D       I  +A  L 
Sbjct: 68  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 124
Query: 163 YLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR---IVGTYGY 219
           Y H     R+IHRD+K  N+LL      KI++FG +       + A +SR   + GT  Y
Sbjct: 125 YCHS---KRVIHRDIKPENLLLGSAGELKIANFGWS-------VHAPSSRRTTLCGTLDY 174
Query: 220 MSPEYALEGIFSIKSDVFSFGVLLLEIVSGKK----NTGLYRTDSLNLLGYAWDLWTSNR 275
           + PE     +   K D++S GVL  E + GK     NT       ++ + + +  + +  
Sbjct: 175 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEG 234
Query: 276 TLELIDPILEDEYSSKQML 294
             +LI  +L+   S + ML
Sbjct: 235 ARDLISRLLKHNPSQRPML 253

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 98/197 (49%), Gaps = 9/197 (4%)
Query: 57  LGEGGFGPVYKGVLKKGDE-IAVKRLSGRSGQGLRE-MKNEASVIAKVQHKNLVRLLGCC 114
           LGEG  G V   V +  +E +AVK +  +      E +K E  +   + H+N+V+  G  
Sbjct: 14  LGEGAAGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 115 IDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 174
            + + + L  EY     L F   +P   M      R      +  G++YLH    + I H
Sbjct: 74  REGNIQYLFLEYCSGGEL-FDRIEPDIGMPEPDAQR--FFHQLMAGVVYLHG---IGITH 127
Query: 175 RDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKS 234
           RD+K  N+LLD+  N KISDFG+A +   N  +   +++ GT  Y++PE      F  + 
Sbjct: 128 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEP 187
Query: 235 -DVFSFGVLLLEIVSGK 250
            DV+S G++L  +++G+
Sbjct: 188 VDVWSCGIVLTAMLAGE 204

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 65/211 (30%), Positives = 95/211 (45%), Gaps = 20/211 (9%)
Query: 47  ATNKFSDANKLGEGGFGPVYKGVLKKGDEI-AVKRL--SGRSGQGL-REMKNEASVIAKV 102
           A   F     LG+G FG VY    K+   I A+K L  +     G+  +++ E  + + +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 103 QHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLL 162
           +H N++RL G   D     LI EY P   L     +  K    D       I  +A  L 
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 125
Query: 163 YLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR---IVGTYGY 219
           Y H     R+IHRD+K  N+LL      KI++FG +       + A +SR   + GT  Y
Sbjct: 126 YCHS---KRVIHRDIKPENLLLGSAGELKIANFGWS-------VHAPSSRRTTLCGTLDY 175
Query: 220 MSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 250
           + PE     +   K D++S GVL  E + GK
Sbjct: 176 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 112/220 (50%), Gaps = 34/220 (15%)
Query: 48  TNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRL------SGRSGQGLREMKNEASVIA 100
            +K+    K+G+G FG V+K   +K G ++A+K++       G     LRE+K    ++ 
Sbjct: 17  VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIK----ILQ 72
Query: 101 KVQHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRV--------- 151
            ++H+N+V L+  C  +        Y   K+  + +FD  +  L   ++ V         
Sbjct: 73  LLKHENVVNLIEICRTKAS-----PYNRCKASIYLVFDFCEHDLAGLLSNVLVKFTLSEI 127
Query: 152 -QIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMAR---ICGGNELQ 207
            ++++ +  GL Y+H   R +I+HRD+KA+N+L+ +D   K++DFG+AR   +   ++  
Sbjct: 128 KRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPN 184
Query: 208 ANTSRIVGTYGYMSPEYAL-EGIFSIKSDVFSFGVLLLEI 246
              +R+V T  Y  PE  L E  +    D++  G ++ E+
Sbjct: 185 RYXNRVV-TLWYRPPELLLGERDYGPPIDLWGAGCIMAEM 223

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 111/220 (50%), Gaps = 34/220 (15%)
Query: 48  TNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRL------SGRSGQGLREMKNEASVIA 100
            +K+    K+G+G FG V+K   +K G ++A+K++       G     LRE+K    ++ 
Sbjct: 17  VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIK----ILQ 72
Query: 101 KVQHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRV--------- 151
            ++H+N+V L+  C  +        Y   K   + +FD  +  L   ++ V         
Sbjct: 73  LLKHENVVNLIEICRTKASP-----YNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEI 127
Query: 152 -QIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMAR---ICGGNELQ 207
            ++++ +  GL Y+H   R +I+HRD+KA+N+L+ +D   K++DFG+AR   +   ++  
Sbjct: 128 KRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPN 184
Query: 208 ANTSRIVGTYGYMSPEYAL-EGIFSIKSDVFSFGVLLLEI 246
              +R+V T  Y  PE  L E  +    D++  G ++ E+
Sbjct: 185 RYXNRVV-TLWYRPPELLLGERDYGPPIDLWGAGCIMAEM 223

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 101/206 (49%), Gaps = 14/206 (6%)
Query: 57  LGEGGFGPVYKGVL--KKGDEIAVKRLSGRSGQGL---REMKNEASVIAKVQHKNLVRLL 111
           LGEG FG VY+GV    KG++I V   + +    L    +  +EA ++  + H ++V+L+
Sbjct: 16  LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 75
Query: 112 GCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVR 171
           G  I+ +   +I E  P   L  +L     +  L  +T V     I + + YL     + 
Sbjct: 76  GI-IEEEPTWIIMELYPYGELGHYL--ERNKNSLKVLTLVLYSLQICKAMAYLES---IN 129
Query: 172 IIHRDLKASNILLDKDMNPKISDFGMAR-ICGGNELQANTSRIVGTYGYMSPEYALEGIF 230
            +HRD+   NIL+      K+ DFG++R I   +  +A+ +R+     +MSPE      F
Sbjct: 130 CVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRL--PIKWMSPESINFRRF 187
Query: 231 SIKSDVFSFGVLLLEIVSGKKNTGLY 256
           +  SDV+ F V + EI+S  K    +
Sbjct: 188 TTASDVWMFAVCMWEILSFGKQPFFW 213

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 111/215 (51%), Gaps = 23/215 (10%)
Query: 44  VSTATNKFSDANKLGEGGFGPVYKGVLKKGDEI-AVKRLS---------GRSGQGLREMK 93
           V +   ++   + LGEG F  VYK   K  ++I A+K++          G +   LRE+K
Sbjct: 5   VKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIK 64
Query: 94  NEASVIAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQI 153
               ++ ++ H N++ LL     +    L++++M    L+  + D +  +    +    +
Sbjct: 65  ----LLQELSHPNIIGLLDAFGHKSNISLVFDFM-ETDLEVIIKDNSLVLTPSHIKAYML 119
Query: 154 IEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRI 213
           +    QGL YLHQ+    I+HRDLK +N+LLD++   K++DFG+A+  G    +A   ++
Sbjct: 120 M--TLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN-RAYXHQV 173
Query: 214 VGTYGYMSPEYALEG-IFSIKSDVFSFGVLLLEIV 247
           V T  Y +PE      ++ +  D+++ G +L E++
Sbjct: 174 V-TRWYRAPELLFGARMYGVGVDMWAVGCILAELL 207

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 101/206 (49%), Gaps = 14/206 (6%)
Query: 57  LGEGGFGPVYKGVL--KKGDEIAVKRLSGRSGQGL---REMKNEASVIAKVQHKNLVRLL 111
           LGEG FG VY+GV    KG++I V   + +    L    +  +EA ++  + H ++V+L+
Sbjct: 32  LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 91
Query: 112 GCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVR 171
           G  I+ +   +I E  P   L  +L     +  L  +T V     I + + YL     + 
Sbjct: 92  GI-IEEEPTWIIMELYPYGELGHYL--ERNKNSLKVLTLVLYSLQICKAMAYLES---IN 145
Query: 172 IIHRDLKASNILLDKDMNPKISDFGMAR-ICGGNELQANTSRIVGTYGYMSPEYALEGIF 230
            +HRD+   NIL+      K+ DFG++R I   +  +A+ +R+     +MSPE      F
Sbjct: 146 CVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRL--PIKWMSPESINFRRF 203
Query: 231 SIKSDVFSFGVLLLEIVSGKKNTGLY 256
           +  SDV+ F V + EI+S  K    +
Sbjct: 204 TTASDVWMFAVCMWEILSFGKQPFFW 229

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 98/210 (46%), Gaps = 20/210 (9%)
Query: 51  FSDANKLGEGGFGPVYKGVLKKGDEI----AVKRLSGRSGQGLREMKNEASVIAKVQHKN 106
           F D   LG GGFG V+   +K   ++     + +   +  +G +    E  ++AKV  + 
Sbjct: 187 FLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRF 246
Query: 107 LVRLLGCCIDRDEKILIYEYMPNKSLDFFLFD-----PTKRMLLDWVTRVQIIEGIAQGL 161
           +V L      + +  L+   M    + + +++     P  +         QI+     GL
Sbjct: 247 IVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIV----SGL 302
Query: 162 LYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMA-RICGGNELQANTSRIVGTYGYM 220
            +LHQ +   II+RDLK  N+LLD D N +ISD G+A  +  G   Q  T    GT G+M
Sbjct: 303 EHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKAG---QTKTKGYAGTPGFM 356
Query: 221 SPEYALEGIFSIKSDVFSFGVLLLEIVSGK 250
           +PE  L   +    D F+ GV L E+++ +
Sbjct: 357 APELLLGEEYDFSVDYFALGVTLYEMIAAR 386

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 98/210 (46%), Gaps = 20/210 (9%)
Query: 51  FSDANKLGEGGFGPVYKGVLKKGDEI----AVKRLSGRSGQGLREMKNEASVIAKVQHKN 106
           F D   LG GGFG V+   +K   ++     + +   +  +G +    E  ++AKV  + 
Sbjct: 187 FLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRF 246
Query: 107 LVRLLGCCIDRDEKILIYEYMPNKSLDFFLFD-----PTKRMLLDWVTRVQIIEGIAQGL 161
           +V L      + +  L+   M    + + +++     P  +         QI+     GL
Sbjct: 247 IVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIV----SGL 302
Query: 162 LYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMA-RICGGNELQANTSRIVGTYGYM 220
            +LHQ +   II+RDLK  N+LLD D N +ISD G+A  +  G   Q  T    GT G+M
Sbjct: 303 EHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKAG---QTKTKGYAGTPGFM 356
Query: 221 SPEYALEGIFSIKSDVFSFGVLLLEIVSGK 250
           +PE  L   +    D F+ GV L E+++ +
Sbjct: 357 APELLLGEEYDFSVDYFALGVTLYEMIAAR 386

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 98/210 (46%), Gaps = 20/210 (9%)
Query: 51  FSDANKLGEGGFGPVYKGVLKKGDEI----AVKRLSGRSGQGLREMKNEASVIAKVQHKN 106
           F D   LG GGFG V+   +K   ++     + +   +  +G +    E  ++AKV  + 
Sbjct: 187 FLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRF 246
Query: 107 LVRLLGCCIDRDEKILIYEYMPNKSLDFFLFD-----PTKRMLLDWVTRVQIIEGIAQGL 161
           +V L      + +  L+   M    + + +++     P  +         QI+     GL
Sbjct: 247 IVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIV----SGL 302
Query: 162 LYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMA-RICGGNELQANTSRIVGTYGYM 220
            +LHQ +   II+RDLK  N+LLD D N +ISD G+A  +  G   Q  T    GT G+M
Sbjct: 303 EHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKAG---QTKTKGYAGTPGFM 356
Query: 221 SPEYALEGIFSIKSDVFSFGVLLLEIVSGK 250
           +PE  L   +    D F+ GV L E+++ +
Sbjct: 357 APELLLGEEYDFSVDYFALGVTLYEMIAAR 386

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 101/206 (49%), Gaps = 14/206 (6%)
Query: 57  LGEGGFGPVYKGVL--KKGDEIAVKRLSGRSGQGL---REMKNEASVIAKVQHKNLVRLL 111
           LGEG FG VY+GV    KG++I V   + +    L    +  +EA ++  + H ++V+L+
Sbjct: 20  LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 79
Query: 112 GCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVR 171
           G  I+ +   +I E  P   L  +L     +  L  +T V     I + + YL     + 
Sbjct: 80  GI-IEEEPTWIIMELYPYGELGHYL--ERNKNSLKVLTLVLYSLQICKAMAYLES---IN 133
Query: 172 IIHRDLKASNILLDKDMNPKISDFGMAR-ICGGNELQANTSRIVGTYGYMSPEYALEGIF 230
            +HRD+   NIL+      K+ DFG++R I   +  +A+ +R+     +MSPE      F
Sbjct: 134 CVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRL--PIKWMSPESINFRRF 191
Query: 231 SIKSDVFSFGVLLLEIVSGKKNTGLY 256
           +  SDV+ F V + EI+S  K    +
Sbjct: 192 TTASDVWMFAVCMWEILSFGKQPFFW 217

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 65/211 (30%), Positives = 94/211 (44%), Gaps = 20/211 (9%)
Query: 47  ATNKFSDANKLGEGGFGPVYKGVLKKGDEI-AVKRL--SGRSGQGL-REMKNEASVIAKV 102
           A   F     LG+G FG VY    K    I A+K L  +     G+  +++ E  + + +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 103 QHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLL 162
           +H N++RL G   D     LI EY P   L     +  K    D       I  +A  L 
Sbjct: 66  RHPNILRLYGYFHDSTRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 163 YLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR---IVGTYGY 219
           Y H     ++IHRD+K  N+LL      KI+DFG +       + A +SR   + GT  Y
Sbjct: 123 YCHS---KKVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRAALCGTLDY 172
Query: 220 MSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 250
           + PE     +   K D++S GVL  E + GK
Sbjct: 173 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 98/210 (46%), Gaps = 20/210 (9%)
Query: 51  FSDANKLGEGGFGPVYKGVLKKGDEI----AVKRLSGRSGQGLREMKNEASVIAKVQHKN 106
           F D   LG GGFG V+   +K   ++     + +   +  +G +    E  ++AKV  + 
Sbjct: 187 FLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRF 246
Query: 107 LVRLLGCCIDRDEKILIYEYMPNKSLDFFLFD-----PTKRMLLDWVTRVQIIEGIAQGL 161
           +V L      + +  L+   M    + + +++     P  +         QI+     GL
Sbjct: 247 IVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIV----SGL 302
Query: 162 LYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMA-RICGGNELQANTSRIVGTYGYM 220
            +LHQ +   II+RDLK  N+LLD D N +ISD G+A  +  G   Q  T    GT G+M
Sbjct: 303 EHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKAG---QTKTKGYAGTPGFM 356
Query: 221 SPEYALEGIFSIKSDVFSFGVLLLEIVSGK 250
           +PE  L   +    D F+ GV L E+++ +
Sbjct: 357 APELLLGEEYDFSVDYFALGVTLYEMIAAR 386

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 111/220 (50%), Gaps = 34/220 (15%)
Query: 48  TNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRL------SGRSGQGLREMKNEASVIA 100
            +K+    K+G+G FG V+K   +K G ++A+K++       G     LRE+K    ++ 
Sbjct: 16  VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIK----ILQ 71
Query: 101 KVQHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRV--------- 151
            ++H+N+V L+  C  +        Y   K   + +FD  +  L   ++ V         
Sbjct: 72  LLKHENVVNLIEICRTKAS-----PYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEI 126
Query: 152 -QIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMAR---ICGGNELQ 207
            ++++ +  GL Y+H   R +I+HRD+KA+N+L+ +D   K++DFG+AR   +   ++  
Sbjct: 127 KRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPN 183
Query: 208 ANTSRIVGTYGYMSPEYAL-EGIFSIKSDVFSFGVLLLEI 246
              +R+V T  Y  PE  L E  +    D++  G ++ E+
Sbjct: 184 RYXNRVV-TLWYRPPELLLGERDYGPPIDLWGAGCIMAEM 222

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 94/206 (45%), Gaps = 20/206 (9%)
Query: 51  FSDANKLGEGGFGPVYKGVLKKGDEI-AVKRL--SGRSGQGL-REMKNEASVIAKVQHKN 106
           F     LG+G FG VY    ++   I A+K L  +     G+  +++ E  + + ++H N
Sbjct: 14  FDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPN 73
Query: 107 LVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQ 166
           ++RL G   D     LI EY P   L     +  K    D       I  +A  L Y H 
Sbjct: 74  ILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSRFDEQRTATYITELANALSYCHS 130
Query: 167 YSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR---IVGTYGYMSPE 223
               R+IHRD+K  N+LL  +   KI+DFG +       + A +SR   + GT  Y+ PE
Sbjct: 131 ---KRVIHRDIKPENLLLGSNGELKIADFGWS-------VHAPSSRRTTLCGTLDYLPPE 180
Query: 224 YALEGIFSIKSDVFSFGVLLLEIVSG 249
                +   K D++S GVL  E + G
Sbjct: 181 MIEGRMHDEKVDLWSLGVLCYEFLVG 206

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 94/206 (45%), Gaps = 20/206 (9%)
Query: 51  FSDANKLGEGGFGPVYKGVLKKGDEI-AVKRL--SGRSGQGL-REMKNEASVIAKVQHKN 106
           F     LG+G FG VY    ++   I A+K L  +     G+  +++ E  + + ++H N
Sbjct: 14  FDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPN 73
Query: 107 LVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQ 166
           ++RL G   D     LI EY P   L     +  K    D       I  +A  L Y H 
Sbjct: 74  ILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSRFDEQRTATYITELANALSYCHS 130
Query: 167 YSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR---IVGTYGYMSPE 223
               R+IHRD+K  N+LL  +   KI+DFG +       + A +SR   + GT  Y+ PE
Sbjct: 131 ---KRVIHRDIKPENLLLGSNGELKIADFGWS-------VHAPSSRRDTLCGTLDYLPPE 180
Query: 224 YALEGIFSIKSDVFSFGVLLLEIVSG 249
                +   K D++S GVL  E + G
Sbjct: 181 MIEGRMHDEKVDLWSLGVLCYEFLVG 206

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 111/220 (50%), Gaps = 34/220 (15%)
Query: 48  TNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRL------SGRSGQGLREMKNEASVIA 100
            +K+    K+G+G FG V+K   +K G ++A+K++       G     LRE+K    ++ 
Sbjct: 17  VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIK----ILQ 72
Query: 101 KVQHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRV--------- 151
            ++H+N+V L+  C  +        Y   K   + +FD  +  L   ++ V         
Sbjct: 73  LLKHENVVNLIEICRTKAS-----PYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEI 127
Query: 152 -QIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMAR---ICGGNELQ 207
            ++++ +  GL Y+H   R +I+HRD+KA+N+L+ +D   K++DFG+AR   +   ++  
Sbjct: 128 KRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPN 184
Query: 208 ANTSRIVGTYGYMSPEYAL-EGIFSIKSDVFSFGVLLLEI 246
              +R+V T  Y  PE  L E  +    D++  G ++ E+
Sbjct: 185 RYXNRVV-TLWYRPPELLLGERDYGPPIDLWGAGCIMAEM 223

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 98/215 (45%), Gaps = 37/215 (17%)
Query: 56  KLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSGQGLREMKN-EASVIAKVQHKNLVRL--- 110
           +LG GGFG V + + +  G+++A+K+         RE    E  ++ K+ H N+V     
Sbjct: 22  RLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREV 81
Query: 111 ---LGCCIDRDEKILIYEYMPNKSLDFFL--FD--------PTKRMLLDWVTRVQIIEGI 157
              L      D  +L  EY     L  +L  F+        P + +L D          I
Sbjct: 82  PDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSD----------I 131
Query: 158 AQGLLYLHQYSRVRIIHRDLKASNILLD---KDMNPKISDFGMARICGGNELQANTSRIV 214
           +  L YLH+    RIIHRDLK  NI+L    + +  KI D G A+     EL    +  V
Sbjct: 132 SSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGEL---CTEFV 185
Query: 215 GTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 249
           GT  Y++PE   +  +++  D +SFG L  E ++G
Sbjct: 186 GTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITG 220

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 101/208 (48%), Gaps = 19/208 (9%)
Query: 49  NKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRL------SGRSGQGLREMKNEASVIAKV 102
           + F   ++LG G  G V+K   K    +  ++L           Q +RE++    V+ + 
Sbjct: 68  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQ----VLHEC 123
Query: 103 QHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLL 162
               +V   G      E  +  E+M   SLD  L     R+    + +V I   + +GL 
Sbjct: 124 NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL-KKAGRIPEQILGKVSI--AVIKGLT 180
Query: 163 YLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSP 222
           YL +  + +I+HRD+K SNIL++     K+ DFG++    G  + +  +  VGT  YMSP
Sbjct: 181 YLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRSYMSP 234
Query: 223 EYALEGIFSIKSDVFSFGVLLLEIVSGK 250
           E      +S++SD++S G+ L+E+  G+
Sbjct: 235 ERLQGTHYSVQSDIWSMGLSLVEMAVGR 262

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 67/225 (29%), Positives = 103/225 (45%), Gaps = 30/225 (13%)
Query: 49  NKFSDANKLGEGGFGPVYKGV---LKKGDE---IAVKRLSGRSGQGLRE-MKNEASVIAK 101
           N+ S    LG G FG V +     L K D    +AVK L   +    RE + +E  V++ 
Sbjct: 46  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 105
Query: 102 V-QHKNLVRLLGCCIDRDEKILIYEYMPNKSL--------DFFLFDPTKRMLLDWVTRVQ 152
           +  H N+V LLG C      ++I EY     L        D F+   T   +++      
Sbjct: 106 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 165
Query: 153 IIEG-------IAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICG--G 203
            +E        +A+G+ +L   +    IHRDL A NILL      KI DFG+AR      
Sbjct: 166 DLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARHIKNDS 222
Query: 204 NELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 248
           N +    +R+     +M+PE     +++ +SDV+S+G+ L E+ S
Sbjct: 223 NYVVKGNARL--PVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 265

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 98/215 (45%), Gaps = 37/215 (17%)
Query: 56  KLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSGQGLREMKN-EASVIAKVQHKNLVRL--- 110
           +LG GGFG V + + +  G+++A+K+         RE    E  ++ K+ H N+V     
Sbjct: 21  RLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREV 80
Query: 111 ---LGCCIDRDEKILIYEYMPNKSLDFFL--FD--------PTKRMLLDWVTRVQIIEGI 157
              L      D  +L  EY     L  +L  F+        P + +L D          I
Sbjct: 81  PDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSD----------I 130
Query: 158 AQGLLYLHQYSRVRIIHRDLKASNILLD---KDMNPKISDFGMARICGGNELQANTSRIV 214
           +  L YLH+    RIIHRDLK  NI+L    + +  KI D G A+     EL    +  V
Sbjct: 131 SSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGEL---CTEFV 184
Query: 215 GTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 249
           GT  Y++PE   +  +++  D +SFG L  E ++G
Sbjct: 185 GTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITG 219

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 66/228 (28%), Positives = 106/228 (46%), Gaps = 36/228 (15%)
Query: 49  NKFSDANKLGEGGFGPVYKGV---LKKGDE---IAVKRLSGRSGQGLRE-MKNEASVIAK 101
           N+ S    LG G FG V +     L K D    +AVK L   +    RE + +E  V++ 
Sbjct: 39  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 98
Query: 102 V-QHKNLVRLLGCCIDRDEKILIYEYMPNKSL--------DFFLFDPTKRMLLDWVTRVQ 152
           +  H N+V LLG C      ++I EY     L        D F+   T   +++      
Sbjct: 99  LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 158
Query: 153 IIEG-------IAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE 205
            +E        +A+G+ +L   +    IHRDL A NILL      KI DFG+AR     +
Sbjct: 159 DLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLAR-----D 210
Query: 206 LQANTSRIVG-----TYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 248
           ++ +++ +V         +M+PE     +++ +SDV+S+G+ L E+ S
Sbjct: 211 IKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 258

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 66/240 (27%), Positives = 112/240 (46%), Gaps = 41/240 (17%)
Query: 43  SVSTATNKFSDANKLGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKN---EASV 98
           ++     ++   + +G G +G V     +K G +IAVK+LS R  Q +   K    E  +
Sbjct: 45  TIWEVPERYQTLSPVGSGAYGSVCSSYDVKSGLKIAVKKLS-RPFQSIIHAKRTYRELRL 103
Query: 99  IAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSL----DFFLFDPTKRMLLDWVTRVQ-- 152
           +  ++H+N++ LL              + P  SL    D +L        L+ + + Q  
Sbjct: 104 LKHMKHENVIGLLDV------------FTPATSLEEFNDVYLVTHLMGADLNNIVKCQKL 151
Query: 153 -------IIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE 205
                  +I  I +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR      
Sbjct: 152 TDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----H 203
Query: 206 LQANTSRIVGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLL 264
                +  V T  Y +PE  L  + +++  D++S G ++ E+++G+  T    TD +N L
Sbjct: 204 TDDEMTGYVATRWYRAPEIMLNWMHYNMTVDIWSVGCIMAELLTGR--TLFPGTDHINQL 261

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 66/228 (28%), Positives = 106/228 (46%), Gaps = 36/228 (15%)
Query: 49  NKFSDANKLGEGGFGPVYKGV---LKKGDE---IAVKRLSGRSGQGLRE-MKNEASVIAK 101
           N+ S    LG G FG V +     L K D    +AVK L   +    RE + +E  V++ 
Sbjct: 23  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 102 V-QHKNLVRLLGCCIDRDEKILIYEYMPNKSL--------DFFLFDPTKRMLLDWVTRVQ 152
           +  H N+V LLG C      ++I EY     L        D F+   T   +++      
Sbjct: 83  LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 153 IIEG-------IAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE 205
            +E        +A+G+ +L   +    IHRDL A NILL      KI DFG+AR     +
Sbjct: 143 DLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLAR-----D 194
Query: 206 LQANTSRIVG-----TYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 248
           ++ +++ +V         +M+PE     +++ +SDV+S+G+ L E+ S
Sbjct: 195 IKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 242

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 66/228 (28%), Positives = 106/228 (46%), Gaps = 36/228 (15%)
Query: 49  NKFSDANKLGEGGFGPVYKGV---LKKGDE---IAVKRLSGRSGQGLRE-MKNEASVIAK 101
           N+ S    LG G FG V +     L K D    +AVK L   +    RE + +E  V++ 
Sbjct: 41  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 100
Query: 102 V-QHKNLVRLLGCCIDRDEKILIYEYMPNKSL--------DFFLFDPTKRMLLDWVTRVQ 152
           +  H N+V LLG C      ++I EY     L        D F+   T   +++      
Sbjct: 101 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 160
Query: 153 IIEG-------IAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE 205
            +E        +A+G+ +L   +    IHRDL A NILL      KI DFG+AR     +
Sbjct: 161 DLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLAR-----D 212
Query: 206 LQANTSRIVG-----TYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 248
           ++ +++ +V         +M+PE     +++ +SDV+S+G+ L E+ S
Sbjct: 213 IKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 260

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 102/212 (48%), Gaps = 19/212 (8%)
Query: 49  NKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRL------SGRSGQGLREMKNEASVIAKV 102
           + F   ++LG G  G V+K   K    +  ++L           Q +RE++    V+ + 
Sbjct: 25  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQ----VLHEC 80
Query: 103 QHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLL 162
               +V   G      E  +  E+M   SLD  L     R+    + +V I   + +GL 
Sbjct: 81  NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL-KKAGRIPEQILGKVSI--AVIKGLT 137
Query: 163 YLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSP 222
           YL +  + +I+HRD+K SNIL++     K+ DFG++    G  + +  +  VGT  YMSP
Sbjct: 138 YLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRSYMSP 191
Query: 223 EYALEGIFSIKSDVFSFGVLLLEIVSGKKNTG 254
           E      +S++SD++S G+ L+E+  G+   G
Sbjct: 192 ERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIG 223

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 66/228 (28%), Positives = 106/228 (46%), Gaps = 36/228 (15%)
Query: 49  NKFSDANKLGEGGFGPVYKGV---LKKGDE---IAVKRLSGRSGQGLRE-MKNEASVIAK 101
           N+ S    LG G FG V +     L K D    +AVK L   +    RE + +E  V++ 
Sbjct: 46  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 105
Query: 102 V-QHKNLVRLLGCCIDRDEKILIYEYMPNKSL--------DFFLFDPTKRMLLDWVTRVQ 152
           +  H N+V LLG C      ++I EY     L        D F+   T   +++      
Sbjct: 106 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 165
Query: 153 IIEG-------IAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE 205
            +E        +A+G+ +L   +    IHRDL A NILL      KI DFG+AR     +
Sbjct: 166 DLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLAR-----D 217
Query: 206 LQANTSRIVG-----TYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 248
           ++ +++ +V         +M+PE     +++ +SDV+S+G+ L E+ S
Sbjct: 218 IKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 265

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 106/211 (50%), Gaps = 22/211 (10%)
Query: 51  FSDANKLGEGGFGPVYKGVLKK-GDEIAVKRL------SGRSGQGLREMKNEASVIAKVQ 103
           +    +LG G F  V K   K  G + A K +      S R G    +++ E S++ ++Q
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 104 HKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLY 163
           H N++ L     ++ + ILI E +    L  FL    ++  L      + ++ I  G+ Y
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILNGVYY 129
Query: 164 LHQYSRVRIIHRDLKASNI-LLDKDM-NP--KISDFGMA-RICGGNELQANTSRIVGTYG 218
           LH    ++I H DLK  NI LLD+++  P  KI DFG+A +I  GNE +     I GT  
Sbjct: 130 LHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK----NIFGTPA 182
Query: 219 YMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 249
           +++PE        +++D++S GV+   ++SG
Sbjct: 183 FVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 101/208 (48%), Gaps = 19/208 (9%)
Query: 49  NKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRL------SGRSGQGLREMKNEASVIAKV 102
           + F   ++LG G  G V+K   K    +  ++L           Q +RE++    V+ + 
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQ----VLHEC 61
Query: 103 QHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLL 162
               +V   G      E  +  E+M   SLD  L     R+    + +V I   + +GL 
Sbjct: 62  NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL-KKAGRIPEQILGKVSI--AVIKGLT 118
Query: 163 YLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSP 222
           YL +  + +I+HRD+K SNIL++     K+ DFG++    G  + +  +  VGT  YMSP
Sbjct: 119 YLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRSYMSP 172
Query: 223 EYALEGIFSIKSDVFSFGVLLLEIVSGK 250
           E      +S++SD++S G+ L+E+  G+
Sbjct: 173 ERLQGTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 101/208 (48%), Gaps = 19/208 (9%)
Query: 49  NKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRL------SGRSGQGLREMKNEASVIAKV 102
           + F   ++LG G  G V+K   K    +  ++L           Q +RE++    V+ + 
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQ----VLHEC 61
Query: 103 QHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLL 162
               +V   G      E  +  E+M   SLD  L     R+    + +V I   + +GL 
Sbjct: 62  NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL-KKAGRIPEQILGKVSI--AVIKGLT 118
Query: 163 YLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSP 222
           YL +  + +I+HRD+K SNIL++     K+ DFG++    G  + +  +  VGT  YMSP
Sbjct: 119 YLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRSYMSP 172
Query: 223 EYALEGIFSIKSDVFSFGVLLLEIVSGK 250
           E      +S++SD++S G+ L+E+  G+
Sbjct: 173 ERLQGTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 101/208 (48%), Gaps = 19/208 (9%)
Query: 49  NKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRL------SGRSGQGLREMKNEASVIAKV 102
           + F   ++LG G  G V+K   K    +  ++L           Q +RE++    V+ + 
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQ----VLHEC 61
Query: 103 QHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLL 162
               +V   G      E  +  E+M   SLD  L     R+    + +V I   + +GL 
Sbjct: 62  NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL-KKAGRIPEQILGKVSI--AVIKGLT 118
Query: 163 YLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSP 222
           YL +  + +I+HRD+K SNIL++     K+ DFG++    G  + +  +  VGT  YMSP
Sbjct: 119 YLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRSYMSP 172
Query: 223 EYALEGIFSIKSDVFSFGVLLLEIVSGK 250
           E      +S++SD++S G+ L+E+  G+
Sbjct: 173 ERLQGTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 101/208 (48%), Gaps = 19/208 (9%)
Query: 49  NKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRL------SGRSGQGLREMKNEASVIAKV 102
           + F   ++LG G  G V+K   K    +  ++L           Q +RE++    V+ + 
Sbjct: 33  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQ----VLHEC 88
Query: 103 QHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLL 162
               +V   G      E  +  E+M   SLD  L     R+    + +V I   + +GL 
Sbjct: 89  NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL-KKAGRIPEQILGKVSI--AVIKGLT 145
Query: 163 YLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSP 222
           YL +  + +I+HRD+K SNIL++     K+ DFG++    G  + +  +  VGT  YMSP
Sbjct: 146 YLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRSYMSP 199
Query: 223 EYALEGIFSIKSDVFSFGVLLLEIVSGK 250
           E      +S++SD++S G+ L+E+  G+
Sbjct: 200 ERLQGTHYSVQSDIWSMGLSLVEMAVGR 227

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 67/225 (29%), Positives = 103/225 (45%), Gaps = 39/225 (17%)
Query: 43  SVSTATNKFSDANKLGEGGFGPV---YKGVLKKGDEIAVKRLSGRSGQGLREMKN---EA 96
           S  T   ++ +   +G G  G V   Y  +L++   +A+K+LS R  Q     K    E 
Sbjct: 18  STFTVLKRYQNLKPIGSGAQGIVCAAYDAILERN--VAIKKLS-RPFQNQTHAKRAYREL 74
Query: 97  SVIAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFF--------LFDP----TKRML 144
            ++  V HKN++ LL              + P KSL+ F        L D       +M 
Sbjct: 75  VLMKVVNHKNIIGLLNV------------FTPQKSLEEFQDVYIVMELMDANLSQVIQME 122
Query: 145 LDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGN 204
           LD      ++  +  G+ +LH      IIHRDLK SNI++  D   KI DFG+AR  G +
Sbjct: 123 LDHERMSYLLYQMLVGIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLARTAGTS 179
Query: 205 ELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 249
            +   T  +V  Y Y +PE  L   +    D++S GV++ E++ G
Sbjct: 180 FMM--TPYVVTRY-YRAPEVILGMGYKENVDIWSVGVIMGEMIKG 221

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 101/208 (48%), Gaps = 19/208 (9%)
Query: 49  NKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRL------SGRSGQGLREMKNEASVIAKV 102
           + F   ++LG G  G V+K   K    +  ++L           Q +RE++    V+ + 
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQ----VLHEC 61
Query: 103 QHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLL 162
               +V   G      E  +  E+M   SLD  L     R+    + +V I   + +GL 
Sbjct: 62  NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL-KKAGRIPEQILGKVSI--AVIKGLT 118
Query: 163 YLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSP 222
           YL +  + +I+HRD+K SNIL++     K+ DFG++    G  + +  +  VGT  YMSP
Sbjct: 119 YLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRSYMSP 172
Query: 223 EYALEGIFSIKSDVFSFGVLLLEIVSGK 250
           E      +S++SD++S G+ L+E+  G+
Sbjct: 173 ERLQGTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 101/208 (48%), Gaps = 19/208 (9%)
Query: 49  NKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRL------SGRSGQGLREMKNEASVIAKV 102
           + F   ++LG G  G V+K   K    +  ++L           Q +RE++    V+ + 
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQ----VLHEC 61
Query: 103 QHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLL 162
               +V   G      E  +  E+M   SLD  L     R+    + +V I   + +GL 
Sbjct: 62  NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL-KKAGRIPEQILGKVSI--AVIKGLT 118
Query: 163 YLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSP 222
           YL +  + +I+HRD+K SNIL++     K+ DFG++    G  + +  +  VGT  YMSP
Sbjct: 119 YLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRSYMSP 172
Query: 223 EYALEGIFSIKSDVFSFGVLLLEIVSGK 250
           E      +S++SD++S G+ L+E+  G+
Sbjct: 173 ERLQGTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 105/226 (46%), Gaps = 39/226 (17%)
Query: 43  SVSTATNKFSDANKLGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKN---EASV 98
           ++     ++ + + +G G +G V      K G  +AVK+LS R  Q +   K    E  +
Sbjct: 16  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLS-RPFQSIIHAKRTYRELRL 74
Query: 99  IAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSL----DFFLFDPTKRMLLDWVTRVQ-- 152
           +  ++H+N++ LL              + P +SL    D +L        L+ + + Q  
Sbjct: 75  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 122
Query: 153 -------IIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE 205
                  +I  I +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR      
Sbjct: 123 TDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----H 174
Query: 206 LQANTSRIVGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 250
                +  V T  Y +PE  L  + ++   D++S G ++ E+++G+
Sbjct: 175 TDDEMAGFVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 103/208 (49%), Gaps = 19/208 (9%)
Query: 49  NKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRL------SGRSGQGLREMKNEASVIAKV 102
           + F   ++LG G  G V K   +    I  ++L           Q +RE++    V+ + 
Sbjct: 16  DDFERISELGAGNGGVVTKVQHRPSGLIMARKLIHLEIKPAIRNQIIRELQ----VLHEC 71
Query: 103 QHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLL 162
               +V   G      E  +  E+M   SLD  L +  KR+  + + +V I   + +GL 
Sbjct: 72  NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKE-AKRIPEEILGKVSI--AVLRGLA 128
Query: 163 YLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSP 222
           YL +  + +I+HRD+K SNIL++     K+ DFG++    G  + +  +  VGT  YM+P
Sbjct: 129 YLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRSYMAP 182
Query: 223 EYALEGIFSIKSDVFSFGVLLLEIVSGK 250
           E      +S++SD++S G+ L+E+  G+
Sbjct: 183 ERLQGTHYSVQSDIWSMGLSLVELAVGR 210

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 105/226 (46%), Gaps = 39/226 (17%)
Query: 43  SVSTATNKFSDANKLGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKN---EASV 98
           ++     ++ + + +G G +G V      K G  +AVK+LS R  Q +   K    E  +
Sbjct: 16  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLS-RPFQSIIHAKRTYRELRL 74
Query: 99  IAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSL----DFFLFDPTKRMLLDWVTRVQ-- 152
           +  ++H+N++ LL              + P +SL    D +L        L+ + + Q  
Sbjct: 75  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 122
Query: 153 -------IIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE 205
                  +I  I +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR      
Sbjct: 123 TDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----H 174
Query: 206 LQANTSRIVGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 250
                +  V T  Y +PE  L  + ++   D++S G ++ E+++G+
Sbjct: 175 TDDEMAGFVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 38/102 (37%), Positives = 59/102 (57%), Gaps = 6/102 (5%)
Query: 151 VQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICG--GNELQA 208
           +++I    Q L + HQ     IIHRD+K +NIL+      K+ DFG+AR     GN +  
Sbjct: 119 IEVIADACQALNFSHQNG---IIHRDVKPANILISATNAVKVVDFGIARAIADSGNSVX- 174
Query: 209 NTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 250
            T+ ++GT  Y+SPE A       +SDV+S G +L E+++G+
Sbjct: 175 QTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 216

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 105/226 (46%), Gaps = 39/226 (17%)
Query: 43  SVSTATNKFSDANKLGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKN---EASV 98
           ++     ++ + + +G G +G V      K G  +AVK+LS R  Q +   K    E  +
Sbjct: 12  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLS-RPFQSIIHAKRTYRELRL 70
Query: 99  IAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSL----DFFLFDPTKRMLLDWVTRVQ-- 152
           +  ++H+N++ LL              + P +SL    D +L        L+ + + Q  
Sbjct: 71  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 118
Query: 153 -------IIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE 205
                  +I  I +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR      
Sbjct: 119 TDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----H 170
Query: 206 LQANTSRIVGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 250
                +  V T  Y +PE  L  + ++   D++S G ++ E+++G+
Sbjct: 171 TDDEMAGFVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 67/225 (29%), Positives = 103/225 (45%), Gaps = 39/225 (17%)
Query: 43  SVSTATNKFSDANKLGEGGFGPV---YKGVLKKGDEIAVKRLSGRSGQGLREMKN---EA 96
           S  T   ++ +   +G G  G V   Y  +L++   +A+K+LS R  Q     K    E 
Sbjct: 18  STFTVLKRYQNLKPIGSGAQGIVVAAYDAILERN--VAIKKLS-RPFQNQTHAKRAYREL 74
Query: 97  SVIAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFF--------LFDP----TKRML 144
            ++  V HKN++ LL              + P KSL+ F        L D       +M 
Sbjct: 75  VLMKVVNHKNIIGLLNV------------FTPQKSLEEFQDVYIVMELMDANLSQVIQME 122
Query: 145 LDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGN 204
           LD      ++  +  G+ +LH      IIHRDLK SNI++  D   KI DFG+AR  G +
Sbjct: 123 LDHERMSYLLYQMLVGIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLARTAGTS 179
Query: 205 ELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 249
            +   T  +V  Y Y +PE  L   +    D++S GV++ E++ G
Sbjct: 180 FMM--TPYVVTRY-YRAPEVILGMGYKENVDIWSVGVIMGEMIKG 221

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 105/220 (47%), Gaps = 25/220 (11%)
Query: 46  TATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRL-SGRSGQGLREMKNEASVIAKVQH 104
           T   +     ++G+G +G V+ G  + G+++AVK   +       RE +   +V+  ++H
Sbjct: 34  TIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTEEASWFRETEIYQTVL--MRH 90
Query: 105 KNLVRLLGCCI----DRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQG 160
           +N++  +   I       +  LI +Y  N SL    +D  K   LD  + +++      G
Sbjct: 91  ENILGFIAADIKGTGSWTQLYLITDYHENGSL----YDYLKSTTLDAKSMLKLAYSSVSG 146
Query: 161 LLYLHQ-----YSRVRIIHRDLKASNILLDKDMNPKISDFGMAR--ICGGNELQANTSRI 213
           L +LH        +  I HRDLK+ NIL+ K+    I+D G+A   I   NE+    +  
Sbjct: 147 LCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTR 206
Query: 214 VGTYGYMSPEYALEGI------FSIKSDVFSFGVLLLEIV 247
           VGT  YM PE   E +        I +D++SFG++L E+ 
Sbjct: 207 VGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVA 246

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 96/207 (46%), Gaps = 13/207 (6%)
Query: 49  NKFSDANKLGEGGFGPVYKGVLKKGDEI----AVKRLSGRSGQGLREMKNEASVIAKVQH 104
           N F     LG+GGFG V    ++   ++     +++   +  +G     NE  ++ KV  
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNS 243
Query: 105 KNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYL 164
           + +V L      +D   L+   M    L F ++   +    +    V     I  GL  L
Sbjct: 244 RFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPE-ARAVFYAAEICCGLEDL 302
Query: 165 HQYSRVRIIHRDLKASNILLDKDMNPKISDFGMA-RICGGNELQANTSRIVGTYGYMSPE 223
           H   R RI++RDLK  NILLD   + +ISD G+A  +  G  ++      VGT GYM+PE
Sbjct: 303 H---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGR----VGTVGYMAPE 355
Query: 224 YALEGIFSIKSDVFSFGVLLLEIVSGK 250
                 ++   D ++ G LL E+++G+
Sbjct: 356 VVKNERYTFSPDWWALGCLLYEMIAGQ 382

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 100/208 (48%), Gaps = 19/208 (9%)
Query: 49  NKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRL------SGRSGQGLREMKNEASVIAKV 102
           + F   ++LG G  G V+K   K    +  ++L           Q +RE++    V+ + 
Sbjct: 9   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQ----VLHEC 64
Query: 103 QHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLL 162
               +V   G      E  +  E+M   SLD  L     R+    + +V I   + +GL 
Sbjct: 65  NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL-KKAGRIPEQILGKVSI--AVIKGLT 121
Query: 163 YLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSP 222
           YL +  + +I+HRD+K SNIL++     K+ DFG++    G  +    +  VGT  YMSP
Sbjct: 122 YLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDEMANEFVGTRSYMSP 175
Query: 223 EYALEGIFSIKSDVFSFGVLLLEIVSGK 250
           E      +S++SD++S G+ L+E+  G+
Sbjct: 176 ERLQGTHYSVQSDIWSMGLSLVEMAVGR 203

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 105/226 (46%), Gaps = 39/226 (17%)
Query: 43  SVSTATNKFSDANKLGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKN---EASV 98
           ++     ++ + + +G G +G V      K G  +AVK+LS R  Q +   K    E  +
Sbjct: 16  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLS-RPFQSIIHAKRTYRELRL 74
Query: 99  IAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSL----DFFLFDPTKRMLLDWVTRVQ-- 152
           +  ++H+N++ LL              + P +SL    D +L        L+ + + Q  
Sbjct: 75  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 122
Query: 153 -------IIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE 205
                  +I  I +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR      
Sbjct: 123 TDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----H 174
Query: 206 LQANTSRIVGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 250
                +  V T  Y +PE  L  + ++   D++S G ++ E+++G+
Sbjct: 175 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 106/211 (50%), Gaps = 22/211 (10%)
Query: 51  FSDANKLGEGGFGPVYKGVLKK-GDEIAVKRL------SGRSGQGLREMKNEASVIAKVQ 103
           +    +LG G F  V K   K  G + A K +      S R G    +++ E S++ ++Q
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 104 HKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLY 163
           H N++ L     ++ + ILI E +    L  FL    ++  L      + ++ I  G+ Y
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILNGVYY 129
Query: 164 LHQYSRVRIIHRDLKASNI-LLDKDM-NP--KISDFGMA-RICGGNELQANTSRIVGTYG 218
           LH    ++I H DLK  NI LLD+++  P  KI DFG+A +I  GNE +     I GT  
Sbjct: 130 LHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK----NIFGTPE 182
Query: 219 YMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 249
           +++PE        +++D++S GV+   ++SG
Sbjct: 183 FVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 106/211 (50%), Gaps = 22/211 (10%)
Query: 51  FSDANKLGEGGFGPVYKGVLKK-GDEIAVKRL------SGRSGQGLREMKNEASVIAKVQ 103
           +    +LG G F  V K   K  G + A K +      S R G    +++ E S++ ++Q
Sbjct: 13  YDTGEELGSGKFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 104 HKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLY 163
           H N++ L     ++ + ILI E +    L  FL    ++  L      + ++ I  G+ Y
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILNGVYY 129
Query: 164 LHQYSRVRIIHRDLKASNI-LLDKDM-NP--KISDFGMA-RICGGNELQANTSRIVGTYG 218
           LH    ++I H DLK  NI LLD+++  P  KI DFG+A +I  GNE +     I GT  
Sbjct: 130 LHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK----NIFGTPE 182
Query: 219 YMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 249
           +++PE        +++D++S GV+   ++SG
Sbjct: 183 FVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 106/211 (50%), Gaps = 22/211 (10%)
Query: 51  FSDANKLGEGGFGPVYKGVLKK-GDEIAVKRL------SGRSGQGLREMKNEASVIAKVQ 103
           +    +LG G F  V K   K  G + A K +      S R G    +++ E S++ ++Q
Sbjct: 12  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 71
Query: 104 HKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLY 163
           H N++ L     ++ + ILI E +    L  FL    ++  L      + ++ I  G+ Y
Sbjct: 72  HPNVITLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILNGVYY 128
Query: 164 LHQYSRVRIIHRDLKASNI-LLDKDM-NP--KISDFGMA-RICGGNELQANTSRIVGTYG 218
           LH    ++I H DLK  NI LLD+++  P  KI DFG+A +I  GNE +     I GT  
Sbjct: 129 LHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK----NIFGTPE 181
Query: 219 YMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 249
           +++PE        +++D++S GV+   ++SG
Sbjct: 182 FVAPEIVNYEPLGLEADMWSIGVITYILLSG 212

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 96/207 (46%), Gaps = 13/207 (6%)
Query: 49  NKFSDANKLGEGGFGPVYKGVLKKGDEI----AVKRLSGRSGQGLREMKNEASVIAKVQH 104
           N F     LG+GGFG V    ++   ++     +++   +  +G     NE  ++ KV  
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNS 243
Query: 105 KNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYL 164
           + +V L      +D   L+   M    L F ++   +    +    V     I  GL  L
Sbjct: 244 RFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPE-ARAVFYAAEICCGLEDL 302
Query: 165 HQYSRVRIIHRDLKASNILLDKDMNPKISDFGMA-RICGGNELQANTSRIVGTYGYMSPE 223
           H   R RI++RDLK  NILLD   + +ISD G+A  +  G  ++      VGT GYM+PE
Sbjct: 303 H---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGR----VGTVGYMAPE 355
Query: 224 YALEGIFSIKSDVFSFGVLLLEIVSGK 250
                 ++   D ++ G LL E+++G+
Sbjct: 356 VVKNERYTFSPDWWALGCLLYEMIAGQ 382

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 106/211 (50%), Gaps = 22/211 (10%)
Query: 51  FSDANKLGEGGFGPVYKGVLKK-GDEIAVKRL------SGRSGQGLREMKNEASVIAKVQ 103
           +    +LG G F  V K   K  G + A K +      S R G    +++ E S++ ++Q
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 104 HKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLY 163
           H N++ L     ++ + ILI E +    L  FL    ++  L      + ++ I  G+ Y
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILNGVYY 129
Query: 164 LHQYSRVRIIHRDLKASNI-LLDKDM-NP--KISDFGMA-RICGGNELQANTSRIVGTYG 218
           LH    ++I H DLK  NI LLD+++  P  KI DFG+A +I  GNE +     I GT  
Sbjct: 130 LHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK----NIFGTPE 182
Query: 219 YMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 249
           +++PE        +++D++S GV+   ++SG
Sbjct: 183 FVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 106/211 (50%), Gaps = 22/211 (10%)
Query: 51  FSDANKLGEGGFGPVYKGVLKK-GDEIAVKRL------SGRSGQGLREMKNEASVIAKVQ 103
           +    +LG G F  V K   K  G + A K +      S R G    +++ E S++ ++Q
Sbjct: 12  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 71
Query: 104 HKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLY 163
           H N++ L     ++ + ILI E +    L  FL    ++  L      + ++ I  G+ Y
Sbjct: 72  HPNVITLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILNGVYY 128
Query: 164 LHQYSRVRIIHRDLKASNI-LLDKDM-NP--KISDFGMA-RICGGNELQANTSRIVGTYG 218
           LH    ++I H DLK  NI LLD+++  P  KI DFG+A +I  GNE +     I GT  
Sbjct: 129 LHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK----NIFGTPE 181
Query: 219 YMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 249
           +++PE        +++D++S GV+   ++SG
Sbjct: 182 FVAPEIVNYEPLGLEADMWSIGVITYILLSG 212

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 105/226 (46%), Gaps = 39/226 (17%)
Query: 43  SVSTATNKFSDANKLGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKN---EASV 98
           ++     ++ + + +G G +G V      K G  +AVK+LS R  Q +   K    E  +
Sbjct: 12  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLS-RPFQSIIHAKRTYRELRL 70
Query: 99  IAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSL----DFFLFDPTKRMLLDWVTRVQ-- 152
           +  ++H+N++ LL              + P +SL    D +L        L+ + + Q  
Sbjct: 71  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 118
Query: 153 -------IIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE 205
                  +I  I +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR      
Sbjct: 119 TDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----H 170
Query: 206 LQANTSRIVGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 250
                +  V T  Y +PE  L  + ++   D++S G ++ E+++G+
Sbjct: 171 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 105/226 (46%), Gaps = 39/226 (17%)
Query: 43  SVSTATNKFSDANKLGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKN---EASV 98
           ++     ++ + + +G G +G V      K G  +AVK+LS R  Q +   K    E  +
Sbjct: 22  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLS-RPFQSIIHAKRTYRELRL 80
Query: 99  IAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSL----DFFLFDPTKRMLLDWVTRVQ-- 152
           +  ++H+N++ LL              + P +SL    D +L        L+ + + Q  
Sbjct: 81  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 128
Query: 153 -------IIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE 205
                  +I  I +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR      
Sbjct: 129 TDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----H 180
Query: 206 LQANTSRIVGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 250
                +  V T  Y +PE  L  + ++   D++S G ++ E+++G+
Sbjct: 181 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 40/118 (33%), Positives = 65/118 (55%), Gaps = 9/118 (7%)
Query: 151 VQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICG--GNELQA 208
           +++I    Q L + HQ     IIHRD+K +NI++      K+ DFG+AR     GN +  
Sbjct: 119 IEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSV-T 174
Query: 209 NTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGY 266
            T+ ++GT  Y+SPE A       +SDV+S G +L E+++G+     +  DS + + Y
Sbjct: 175 QTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP---FTGDSPDSVAY 229

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 106/211 (50%), Gaps = 22/211 (10%)
Query: 51  FSDANKLGEGGFGPVYKGVLKK-GDEIAVKRL------SGRSGQGLREMKNEASVIAKVQ 103
           +    +LG G F  V K   K  G + A K +      S R G    +++ E S++ ++Q
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 104 HKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLY 163
           H N++ L     ++ + ILI E +    L  FL    ++  L      + ++ I  G+ Y
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILNGVYY 129
Query: 164 LHQYSRVRIIHRDLKASNI-LLDKDM-NP--KISDFGMA-RICGGNELQANTSRIVGTYG 218
           LH    ++I H DLK  NI LLD+++  P  KI DFG+A +I  GNE +     I GT  
Sbjct: 130 LHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK----NIFGTPE 182
Query: 219 YMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 249
           +++PE        +++D++S GV+   ++SG
Sbjct: 183 FVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 107/215 (49%), Gaps = 17/215 (7%)
Query: 51  FSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLREMKN---EASVIAKVQHKN 106
           F     LG G FG V+    +  G   A+K L       L+++++   E  +++ V H  
Sbjct: 8   FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPF 67
Query: 107 LVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQ 166
           ++R+ G   D  +  +I +Y+    L F L   ++R   + V +    E +   L YLH 
Sbjct: 68  IIRMWGTFQDAQQIFMIMDYIEGGEL-FSLLRKSQR-FPNPVAKFYAAE-VCLALEYLHS 124
Query: 167 YSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAL 226
                II+RDLK  NILLDK+ + KI+DFG A+      +   T  + GT  Y++PE   
Sbjct: 125 KD---IIYRDLKPENILLDKNGHIKITDFGFAKY-----VPDVTYXLCGTPDYIAPEVVS 176
Query: 227 EGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSL 261
              ++   D +SFG+L+ E+++G   T  Y ++++
Sbjct: 177 TKPYNKSIDWWSFGILIYEMLAGY--TPFYDSNTM 209

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 37/102 (36%), Positives = 59/102 (57%), Gaps = 6/102 (5%)
Query: 151 VQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICG--GNELQA 208
           +++I    Q L + HQ     IIHRD+K +NI++      K+ DFG+AR     GN +  
Sbjct: 119 IEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSV-T 174
Query: 209 NTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 250
            T+ ++GT  Y+SPE A       +SDV+S G +L E+++G+
Sbjct: 175 QTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 216

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 106/211 (50%), Gaps = 22/211 (10%)
Query: 51  FSDANKLGEGGFGPVYKGVLKK-GDEIAVKRL------SGRSGQGLREMKNEASVIAKVQ 103
           +    +LG G F  V K   K  G + A K +      S R G    +++ E S++ ++Q
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 104 HKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLY 163
           H N++ L     ++ + ILI E +    L  FL    ++  L      + ++ I  G+ Y
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILNGVYY 129
Query: 164 LHQYSRVRIIHRDLKASNI-LLDKDM-NP--KISDFGMA-RICGGNELQANTSRIVGTYG 218
           LH    ++I H DLK  NI LLD+++  P  KI DFG+A +I  GNE +     I GT  
Sbjct: 130 LHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK----NIFGTPE 182
Query: 219 YMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 249
           +++PE        +++D++S GV+   ++SG
Sbjct: 183 FVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 37/102 (36%), Positives = 59/102 (57%), Gaps = 6/102 (5%)
Query: 151 VQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICG--GNELQA 208
           +++I    Q L + HQ     IIHRD+K +NI++      K+ DFG+AR     GN +  
Sbjct: 119 IEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVT- 174
Query: 209 NTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 250
            T+ ++GT  Y+SPE A       +SDV+S G +L E+++G+
Sbjct: 175 QTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 216

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 37/102 (36%), Positives = 59/102 (57%), Gaps = 6/102 (5%)
Query: 151 VQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICG--GNELQA 208
           +++I    Q L + HQ     IIHRD+K +NI++      K+ DFG+AR     GN +  
Sbjct: 119 IEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVT- 174
Query: 209 NTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 250
            T+ ++GT  Y+SPE A       +SDV+S G +L E+++G+
Sbjct: 175 QTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 216

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 105/226 (46%), Gaps = 39/226 (17%)
Query: 43  SVSTATNKFSDANKLGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKN---EASV 98
           ++     ++ + + +G G +G V      K G  +AVK+LS R  Q +   K    E  +
Sbjct: 35  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLS-RPFQSIIHAKRTYRELRL 93
Query: 99  IAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSL----DFFLFDPTKRMLLDWVTRVQ-- 152
           +  ++H+N++ LL              + P +SL    D +L        L+ + + Q  
Sbjct: 94  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 141
Query: 153 -------IIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE 205
                  +I  I +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR      
Sbjct: 142 TDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----H 193
Query: 206 LQANTSRIVGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 250
                +  V T  Y +PE  L  + ++   D++S G ++ E+++G+
Sbjct: 194 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 239

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 102/212 (48%), Gaps = 26/212 (12%)
Query: 51  FSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRL 110
           +++   +G G FG V++  L + DE+A+K++     Q  R    E  ++  V+H N+V L
Sbjct: 42  YTNCKVIGNGSFGVVFQAKLVESDEVAIKKVL----QDKRFKNRELQIMRIVKHPNVVDL 97
Query: 111 LGCCI---DRDEKI---LIYEYMPN----KSLDFFLFDPTKRMLLDWVTRVQIIEGIAQG 160
                   D+ +++   L+ EY+P      S  +     T  MLL  +   Q++  +A  
Sbjct: 98  KAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLA-- 155
Query: 161 LLYLHQYSRVRIIHRDLKASNILLDKDMNP-KISDFGMARICGGNELQANTSRIVGTYGY 219
             Y+H    + I HRD+K  N+LLD      K+ DFG A+I    E   N S I   Y Y
Sbjct: 156 --YIHS---IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGE--PNVSXICSRY-Y 207
Query: 220 MSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 250
            +PE       ++   D++S G ++ E++ G+
Sbjct: 208 RAPELIFGATNYTTNIDIWSTGCVMAELMQGQ 239

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 106/211 (50%), Gaps = 22/211 (10%)
Query: 51  FSDANKLGEGGFGPVYKGVLKK-GDEIAVKRL------SGRSGQGLREMKNEASVIAKVQ 103
           +    +LG G F  V K   K  G + A K +      S R G    +++ E S++ ++Q
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 104 HKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLY 163
           H N++ L     ++ + ILI E +    L  FL    ++  L      + ++ I  G+ Y
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILNGVYY 129
Query: 164 LHQYSRVRIIHRDLKASNI-LLDKDM-NP--KISDFGMA-RICGGNELQANTSRIVGTYG 218
           LH    ++I H DLK  NI LLD+++  P  KI DFG+A +I  GNE +     I GT  
Sbjct: 130 LHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK----NIFGTPE 182
Query: 219 YMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 249
           +++PE        +++D++S GV+   ++SG
Sbjct: 183 FVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 105/226 (46%), Gaps = 39/226 (17%)
Query: 43  SVSTATNKFSDANKLGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKN---EASV 98
           ++     ++ + + +G G +G V      K G  +AVK+LS R  Q +   K    E  +
Sbjct: 36  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLS-RPFQSIIHAKRTYRELRL 94
Query: 99  IAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSL----DFFLFDPTKRMLLDWVTRVQ-- 152
           +  ++H+N++ LL              + P +SL    D +L        L+ + + Q  
Sbjct: 95  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 142
Query: 153 -------IIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE 205
                  +I  I +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR      
Sbjct: 143 TDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----H 194
Query: 206 LQANTSRIVGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 250
                +  V T  Y +PE  L  + ++   D++S G ++ E+++G+
Sbjct: 195 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 106/211 (50%), Gaps = 22/211 (10%)
Query: 51  FSDANKLGEGGFGPVYKGVLKK-GDEIAVKRL------SGRSGQGLREMKNEASVIAKVQ 103
           +    +LG G F  V K   K  G + A K +      S R G    +++ E S++ ++Q
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 104 HKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLY 163
           H N++ L     ++ + ILI E +    L  FL    ++  L      + ++ I  G+ Y
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILNGVYY 129
Query: 164 LHQYSRVRIIHRDLKASNI-LLDKDM-NP--KISDFGMA-RICGGNELQANTSRIVGTYG 218
           LH    ++I H DLK  NI LLD+++  P  KI DFG+A +I  GNE +     I GT  
Sbjct: 130 LHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK----NIFGTPE 182
Query: 219 YMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 249
           +++PE        +++D++S GV+   ++SG
Sbjct: 183 FVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 105/226 (46%), Gaps = 39/226 (17%)
Query: 43  SVSTATNKFSDANKLGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKN---EASV 98
           ++     ++ + + +G G +G V      K G  +AVK+LS R  Q +   K    E  +
Sbjct: 16  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRL 74
Query: 99  IAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSL----DFFLFDPTKRMLLDWVTRVQ-- 152
           +  ++H+N++ LL              + P +SL    D +L        L+ + + Q  
Sbjct: 75  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 122
Query: 153 -------IIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE 205
                  +I  I +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR      
Sbjct: 123 TDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----H 174
Query: 206 LQANTSRIVGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 250
                +  V T  Y +PE  L  + ++   D++S G ++ E+++G+
Sbjct: 175 TDDEMTGYVATRWYRAPEIMLNAMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 106/211 (50%), Gaps = 22/211 (10%)
Query: 51  FSDANKLGEGGFGPVYKGVLKK-GDEIAVKRL------SGRSGQGLREMKNEASVIAKVQ 103
           +    +LG G F  V K   K  G + A K +      S R G    +++ E S++ ++Q
Sbjct: 13  YDTGEELGSGVFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 104 HKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLY 163
           H N++ L     ++ + ILI E +    L  FL    ++  L      + ++ I  G+ Y
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILNGVYY 129
Query: 164 LHQYSRVRIIHRDLKASNI-LLDKDM-NP--KISDFGMA-RICGGNELQANTSRIVGTYG 218
           LH    ++I H DLK  NI LLD+++  P  KI DFG+A +I  GNE +     I GT  
Sbjct: 130 LHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK----NIFGTPE 182
Query: 219 YMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 249
           +++PE        +++D++S GV+   ++SG
Sbjct: 183 FVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 63/222 (28%), Positives = 101/222 (45%), Gaps = 25/222 (11%)
Query: 41  FSSVSTATNKFSDA----NKLGEGGFGPVYKGVLKKGDE------IAVKRLSGRSGQGLR 90
           F  ++T T +F+D      +LG+G F  V + V K   +      I  K+LS R  Q L 
Sbjct: 20  FQXMATCT-RFTDDYQLFEELGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSARDHQKL- 77
Query: 91  EMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTR 150
             + EA +   ++H N+VRL     +     L+++ +    L     D   R        
Sbjct: 78  --EREARICRLLKHPNIVRLHDSISEEGFHYLVFDLVTGGEL---FEDIVAREYYSEADA 132
Query: 151 VQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLD---KDMNPKISDFGMARICGGNELQ 207
              I  I + + ++HQ+    I+HRDLK  N+LL    K    K++DFG+A    G   Q
Sbjct: 133 SHCIHQILESVNHIHQHD---IVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGE--Q 187
Query: 208 ANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 249
                  GT GY+SPE   +  +    D+++ GV+L  ++ G
Sbjct: 188 QAWFGFAGTPGYLSPEVLRKDPYGKPVDIWACGVILYILLVG 229

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 104/226 (46%), Gaps = 39/226 (17%)
Query: 43  SVSTATNKFSDANKLGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKN---EASV 98
           ++     ++ +   +G G +G V      K G  +AVK+LS R  Q +   K    E  +
Sbjct: 26  TIWEVPERYQNLAPVGSGAYGSVCAAFDTKTGHRVAVKKLS-RPFQSIIHAKRTYRELRL 84
Query: 99  IAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSL----DFFLFDPTKRMLLDWVTRVQ-- 152
           +  ++H+N++ LL              + P +SL    D +L        L+ + + Q  
Sbjct: 85  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 132
Query: 153 -------IIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE 205
                  +I  I +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR      
Sbjct: 133 TDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----H 184
Query: 206 LQANTSRIVGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 250
                +  V T  Y +PE  L  + ++   D++S G ++ E+++G+
Sbjct: 185 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 230

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 106/211 (50%), Gaps = 22/211 (10%)
Query: 51  FSDANKLGEGGFGPVYKGVLKK-GDEIAVKRL------SGRSGQGLREMKNEASVIAKVQ 103
           +    +LG G F  V K   K  G + A K +      S R G    +++ E S++ ++Q
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 104 HKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLY 163
           H N++ L     ++ + ILI E +    L  FL    ++  L      + ++ I  G+ Y
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILNGVYY 129
Query: 164 LHQYSRVRIIHRDLKASNI-LLDKDM-NP--KISDFGMA-RICGGNELQANTSRIVGTYG 218
           LH    ++I H DLK  NI LLD+++  P  KI DFG+A +I  GNE +     I GT  
Sbjct: 130 LHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK----NIFGTPE 182
Query: 219 YMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 249
           +++PE        +++D++S GV+   ++SG
Sbjct: 183 FVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 61/226 (26%), Positives = 106/226 (46%), Gaps = 39/226 (17%)
Query: 43  SVSTATNKFSDANKLGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKN---EASV 98
           ++     ++ + + +G G +G V      K G  +AVK+LS R  Q +   K    E  +
Sbjct: 12  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLS-RPFQSIIHAKRTYRELRL 70
Query: 99  IAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFF--LFDPTKRMLLDWVTRVQ---- 152
           +  ++H+N++ LL              + P +SL+ F  ++  T  M  D    V+    
Sbjct: 71  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCAKL 118
Query: 153 -------IIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE 205
                  +I  I +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR      
Sbjct: 119 TDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----H 170
Query: 206 LQANTSRIVGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 250
                +  V T  Y +PE  L  + ++   D++S G ++ E+++G+
Sbjct: 171 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 98/213 (46%), Gaps = 20/213 (9%)
Query: 46  TATNKFSDANKLGEGGFGPVYKGV-LKKGDEIAVK-----RLSGRSGQGLREMKNEASVI 99
           + T+++     +G+G F  V + V L  G E A K     +LS R  Q L   + EA + 
Sbjct: 1   SMTDEYQLYEDIGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQKL---EREARIC 57
Query: 100 AKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQ 159
             ++H N+VRL     +     L+++ +    L     D   R           I+ I +
Sbjct: 58  RLLKHSNIVRLHDSISEEGFHYLVFDLVTGGEL---FEDIVAREYYSEADASHCIQQILE 114
Query: 160 GLLYLHQYSRVRIIHRDLKASNILLD---KDMNPKISDFGMARICGGNELQANTSRIVGT 216
            +L+ HQ     ++HRDLK  N+LL    K    K++DFG+A    G+  Q       GT
Sbjct: 115 AVLHCHQMG---VVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGD--QQAWFGFAGT 169
Query: 217 YGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 249
            GY+SPE   +  +    D+++ GV+L  ++ G
Sbjct: 170 PGYLSPEVLRKEAYGKPVDIWACGVILYILLVG 202

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 105/226 (46%), Gaps = 39/226 (17%)
Query: 43  SVSTATNKFSDANKLGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKN---EASV 98
           ++     ++ + + +G G +G V      K G  +AVK+LS R  Q +   K    E  +
Sbjct: 23  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRL 81
Query: 99  IAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSL----DFFLFDPTKRMLLDWVTRVQ-- 152
           +  ++H+N++ LL              + P +SL    D +L        L+ + + Q  
Sbjct: 82  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 129
Query: 153 -------IIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE 205
                  +I  I +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR      
Sbjct: 130 TDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTAD-- 184
Query: 206 LQANTSRIVGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 250
                +  V T  Y +PE  L  + ++   D++S G ++ E+++G+
Sbjct: 185 ---EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 99/201 (49%), Gaps = 14/201 (6%)
Query: 54  ANKLGEGGFGPVYKGVLK-KGDEIAVK---RLSGRSGQGLREMKNEASVIAKVQHKNLVR 109
            + LG G FG V  G  +  G ++AVK   R   RS   + +++ E   +   +H ++++
Sbjct: 21  GDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIK 80
Query: 110 LLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSR 169
           L        +  ++ EY+    L  ++    K   LD     ++ + I  G+ Y H++  
Sbjct: 81  LYQVISTPSDIFMVMEYVSGGELFDYI---CKNGRLDEKESRRLFQQILSGVDYCHRHM- 136
Query: 170 VRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGI 229
             ++HRDLK  N+LLD  MN KI+DFG++ +    E    +    G+  Y +PE     +
Sbjct: 137 --VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRXS---CGSPNYAAPEVISGRL 191
Query: 230 FS-IKSDVFSFGVLLLEIVSG 249
           ++  + D++S GV+L  ++ G
Sbjct: 192 YAGPEVDIWSSGVILYALLCG 212

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 100/209 (47%), Gaps = 34/209 (16%)
Query: 57  LGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMK----------------NEASVIA 100
           LG+G FG V+           VK++SG   + L  MK                 E  ++ 
Sbjct: 32  LGQGSFGKVF----------LVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILV 81
Query: 101 KVQHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQG 160
           +V H  +V+L        +  LI +++  +  D F     + M  +   +  + E +A  
Sbjct: 82  EVNHPFIVKLHYAFQTEGKLYLILDFL--RGGDLFTRLSKEVMFTEEDVKFYLAE-LALA 138
Query: 161 LLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYM 220
           L +LH      II+RDLK  NILLD++ + K++DFG+++    +E +A +    GT  YM
Sbjct: 139 LDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCGTVEYM 193
Query: 221 SPEYALEGIFSIKSDVFSFGVLLLEIVSG 249
           +PE       +  +D +SFGVL+ E+++G
Sbjct: 194 APEVVNRRGHTQSADWWSFGVLMFEMLTG 222

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 106/211 (50%), Gaps = 22/211 (10%)
Query: 51  FSDANKLGEGGFGPVYKGVLKK-GDEIAVKRL------SGRSGQGLREMKNEASVIAKVQ 103
           +    +LG G F  V K   K  G + A K +      S R G    +++ E S++ ++Q
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 104 HKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLY 163
           H N++ L     ++ + ILI E +    L  FL    ++  L      + ++ I  G+ Y
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFLKQILNGVYY 129
Query: 164 LHQYSRVRIIHRDLKASNI-LLDKDM-NP--KISDFGMA-RICGGNELQANTSRIVGTYG 218
           LH    ++I H DLK  NI LLD+++  P  KI DFG+A +I  GNE +     I GT  
Sbjct: 130 LHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK----NIFGTPE 182
Query: 219 YMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 249
           +++PE        +++D++S GV+   ++SG
Sbjct: 183 FVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 97/204 (47%), Gaps = 27/204 (13%)
Query: 57  LGEGGFGPV--YKGVLKKGDEIAVKRL--SGRSGQGLREMKNEASVIAKVQHKNLVRLLG 112
           +G+G F  V   + +L  G E+AVK +  +  +   L+++  E  ++  + H N+V+L  
Sbjct: 22  IGKGNFAKVKLARHILT-GKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFE 80
Query: 113 CCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRI 172
                    L+ EY     +  +L    +  + +   R +  + I   + Y HQ     I
Sbjct: 81  VIETEKTLYLVMEYASGGEVFDYLVAHGR--MKEKEARAKFRQ-IVSAVQYCHQKF---I 134
Query: 173 IHRDLKASNILLDKDMNPKISDFGMA-RICGGNELQANTSRIVGTYGYMSPEYALEGIFS 231
           +HRDLKA N+LLD DMN KI+DFG +     GN+L A            +P YA   +F 
Sbjct: 135 VHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDAFCG---------APPYAAPELFQ 185
Query: 232 IKS------DVFSFGVLLLEIVSG 249
            K       DV+S GV+L  +VSG
Sbjct: 186 GKKYDGPEVDVWSLGVILYTLVSG 209

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 105/226 (46%), Gaps = 39/226 (17%)
Query: 43  SVSTATNKFSDANKLGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKN---EASV 98
           ++     ++ + + +G G +G V      K G  +AVK+LS R  Q +   K    E  +
Sbjct: 23  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRL 81
Query: 99  IAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSL----DFFLFDPTKRMLLDWVTRVQ-- 152
           +  ++H+N++ LL              + P +SL    D +L        L+ + + Q  
Sbjct: 82  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 129
Query: 153 -------IIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE 205
                  +I  I +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR      
Sbjct: 130 TDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTAD-- 184
Query: 206 LQANTSRIVGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 250
                +  V T  Y +PE  L  + ++   D++S G ++ E+++G+
Sbjct: 185 ---EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 105/226 (46%), Gaps = 39/226 (17%)
Query: 43  SVSTATNKFSDANKLGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKN---EASV 98
           ++     ++ + + +G G +G V      K G  +AVK+LS R  Q +   K    E  +
Sbjct: 23  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRL 81
Query: 99  IAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSL----DFFLFDPTKRMLLDWVTRVQ-- 152
           +  ++H+N++ LL              + P +SL    D +L        L+ + + Q  
Sbjct: 82  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 129
Query: 153 -------IIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE 205
                  +I  I +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR      
Sbjct: 130 TDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTAD-- 184
Query: 206 LQANTSRIVGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 250
                +  V T  Y +PE  L  + ++   D++S G ++ E+++G+
Sbjct: 185 ---EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 66/225 (29%), Positives = 102/225 (45%), Gaps = 39/225 (17%)
Query: 43  SVSTATNKFSDANKLGEGGFGPV---YKGVLKKGDEIAVKRLSGRSGQGLREMKN---EA 96
           S  T   ++ +   +G G  G V   Y  +L++   +A+K+LS R  Q     K    E 
Sbjct: 18  STFTVLKRYQNLKPIGSGAQGIVCAAYDAILERN--VAIKKLS-RPFQNQTHAKRAYREL 74
Query: 97  SVIAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFF--------LFDP----TKRML 144
            ++  V HKN++ LL              + P KSL+ F        L D       +M 
Sbjct: 75  VLMKCVNHKNIIGLLNV------------FTPQKSLEEFQDVYIVMELMDANLCQVIQME 122
Query: 145 LDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGN 204
           LD      ++  +  G+ +LH      IIHRDLK SNI++  D   KI DFG+AR  G +
Sbjct: 123 LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 179
Query: 205 ELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 249
            +   T  +V  Y Y +PE  L   +    D++S G ++ E++ G
Sbjct: 180 FMM--TPEVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/226 (26%), Positives = 107/226 (47%), Gaps = 39/226 (17%)
Query: 43  SVSTATNKFSDANKLGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKN---EASV 98
           ++     ++ + + +G G +G V      K G  +AVK+LS R  Q +   K    E  +
Sbjct: 36  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLS-RPFQSIIHAKRTYRELRL 94
Query: 99  IAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSL----DFFLFDPTKRMLLDWVTRVQ-- 152
           +  ++H+N++ LL              + P +SL    D +L        L+ + + Q  
Sbjct: 95  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 142
Query: 153 -------IIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE 205
                  +I  I +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR    +E
Sbjct: 143 TDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHT-DDE 198
Query: 206 LQANTSRIVGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 250
           +       V T  Y +PE  L  + ++   D++S G ++ E+++G+
Sbjct: 199 MXGX----VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/200 (30%), Positives = 106/200 (53%), Gaps = 16/200 (8%)
Query: 57  LGEGGFGPVY--KGVLK--KGDEIAVKRLSGRSGQGLRE---MKNEASVIAKVQHKNLVR 109
           LG+G FG V+  + V +   G   A+K L  ++   +R+    K E  ++A V H  +V+
Sbjct: 36  LGQGSFGKVFLVRKVTRPDSGHLYAMKVLK-KATLKVRDRVRTKMERDILADVNHPFVVK 94
Query: 110 LLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSR 169
           L        +  LI +++  +  D F     + M  +   +  + E +A GL +LH    
Sbjct: 95  LHYAFQTEGKLYLILDFL--RGGDLFTRLSKEVMFTEEDVKFYLAE-LALGLDHLHS--- 148
Query: 170 VRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGI 229
           + II+RDLK  NILLD++ + K++DFG+++    +E +A +    GT  YM+PE      
Sbjct: 149 LGIIYRDLKPENILLDEEGHIKLTDFGLSKEAIDHEKKAYS--FCGTVEYMAPEVVNRQG 206
Query: 230 FSIKSDVFSFGVLLLEIVSG 249
            S  +D +S+GVL+ E+++G
Sbjct: 207 HSHSADWWSYGVLMFEMLTG 226

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 105/226 (46%), Gaps = 39/226 (17%)
Query: 43  SVSTATNKFSDANKLGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKN---EASV 98
           ++     ++ + + +G G +G V      K G  +AVK+LS R  Q +   K    E  +
Sbjct: 21  TIWEVPERYQNLSPIGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRL 79
Query: 99  IAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSL----DFFLFDPTKRMLLDWVTRVQ-- 152
           +  ++H+N++ LL              + P +SL    D +L        L+ + + Q  
Sbjct: 80  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 127
Query: 153 -------IIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE 205
                  +I  I +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR      
Sbjct: 128 TDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDXELKILDFGLAR-----H 179
Query: 206 LQANTSRIVGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 250
                +  V T  Y +PE  L  + ++   D++S G ++ E+++G+
Sbjct: 180 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 106/211 (50%), Gaps = 22/211 (10%)
Query: 51  FSDANKLGEGGFGPVYKGVLKK-GDEIAVKRL------SGRSGQGLREMKNEASVIAKVQ 103
           +    +LG G F  V K   K  G + A K +      S R G    +++ E S++ ++Q
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 104 HKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLY 163
           H N++ L     ++ + ILI E +    L  FL    ++  L      + ++ I  G+ Y
Sbjct: 73  HPNVITLHEVYENKTDVILIGELVAGGELFDFL---AEKESLTEEEATEFLKQILNGVYY 129
Query: 164 LHQYSRVRIIHRDLKASNI-LLDKDM-NP--KISDFGMA-RICGGNELQANTSRIVGTYG 218
           LH    ++I H DLK  NI LLD+++  P  KI DFG+A +I  GNE +     I GT  
Sbjct: 130 LHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK----NIFGTPE 182
Query: 219 YMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 249
           +++PE        +++D++S GV+   ++SG
Sbjct: 183 FVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 37/102 (36%), Positives = 59/102 (57%), Gaps = 6/102 (5%)
Query: 151 VQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICG--GNELQA 208
           +++I    Q L + HQ     IIHRD+K +NI++      K+ DFG+AR     GN +  
Sbjct: 136 IEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSV-T 191
Query: 209 NTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 250
            T+ ++GT  Y+SPE A       +SDV+S G +L E+++G+
Sbjct: 192 QTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 233

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 67/226 (29%), Positives = 101/226 (44%), Gaps = 39/226 (17%)
Query: 43  SVSTATNKFSDANKLGEGGFGPV---YKGVLKKGDEIAVKRLSGRSGQGLREMKN---EA 96
           S  T   ++ +   +G G  G V   Y  VL +   +A+K+LS R  Q     K    E 
Sbjct: 18  STFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRN--VAIKKLS-RPFQNQTHAKRAYREL 74
Query: 97  SVIAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFF--------LFDP----TKRML 144
            ++  V HKN++ LL              + P K+L+ F        L D       +M 
Sbjct: 75  VLMKXVNHKNIISLLNV------------FTPQKTLEEFQDVYLVMELMDANLXQVIQME 122
Query: 145 LDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGN 204
           LD      ++  +  G+ +LH      IIHRDLK SNI++  D   KI DFG+AR  G +
Sbjct: 123 LDHERMSYLLYQMLXGIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLARTAGTS 179
Query: 205 ELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 250
            +   T  +V  Y Y +PE  L   +    D++S G ++ E+V  K
Sbjct: 180 FMM--TPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 103/217 (47%), Gaps = 34/217 (15%)
Query: 49  NKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMK--------------- 93
           ++F     LG+G FG V+           VK++SG   + L  MK               
Sbjct: 25  SQFELLKVLGQGSFGKVF----------LVKKISGSDARQLYAMKVLKKATLKVRDRVRT 74
Query: 94  -NEASVIAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQ 152
             E  ++ +V H  +V+L        +  LI +++  +  D F     + M  +   +  
Sbjct: 75  KMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFL--RGGDLFTRLSKEVMFTEEDVKFY 132
Query: 153 IIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR 212
           + E +A  L +LH      II+RDLK  NILLD++ + K++DFG+++    +E +A +  
Sbjct: 133 LAE-LALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS-- 186
Query: 213 IVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 249
             GT  YM+PE       +  +D +SFGVL+ E+++G
Sbjct: 187 FCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTG 223

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 105/226 (46%), Gaps = 39/226 (17%)
Query: 43  SVSTATNKFSDANKLGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKN---EASV 98
           ++     ++ + + +G G +G V      K G  +AVK+LS R  Q +   K    E  +
Sbjct: 12  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRL 70
Query: 99  IAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSL----DFFLFDPTKRMLLDWVTRVQ-- 152
           +  ++H+N++ LL              + P +SL    D +L        L+ + + Q  
Sbjct: 71  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 118
Query: 153 -------IIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE 205
                  +I  I +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR      
Sbjct: 119 TDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----H 170
Query: 206 LQANTSRIVGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 250
                +  V T  Y +PE  L  + ++   D++S G ++ E+++G+
Sbjct: 171 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 105/226 (46%), Gaps = 39/226 (17%)
Query: 43  SVSTATNKFSDANKLGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKN---EASV 98
           ++     ++ + + +G G +G V      K G  +AVK+LS R  Q +   K    E  +
Sbjct: 23  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRL 81
Query: 99  IAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSL----DFFLFDPTKRMLLDWVTRVQ-- 152
           +  ++H+N++ LL              + P +SL    D +L        L+ + + Q  
Sbjct: 82  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 129
Query: 153 -------IIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE 205
                  +I  I +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR      
Sbjct: 130 TDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----H 181
Query: 206 LQANTSRIVGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 250
                +  V T  Y +PE  L  + ++   D++S G ++ E+++G+
Sbjct: 182 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 105/226 (46%), Gaps = 39/226 (17%)
Query: 43  SVSTATNKFSDANKLGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKN---EASV 98
           ++     ++ + + +G G +G V      K G  +AVK+LS R  Q +   K    E  +
Sbjct: 16  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRL 74
Query: 99  IAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSL----DFFLFDPTKRMLLDWVTRVQ-- 152
           +  ++H+N++ LL              + P +SL    D +L        L+ + + Q  
Sbjct: 75  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 122
Query: 153 -------IIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE 205
                  +I  I +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR      
Sbjct: 123 TDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----H 174
Query: 206 LQANTSRIVGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 250
                +  V T  Y +PE  L  + ++   D++S G ++ E+++G+
Sbjct: 175 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 105/226 (46%), Gaps = 39/226 (17%)
Query: 43  SVSTATNKFSDANKLGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKN---EASV 98
           ++     ++ + + +G G +G V      K G  +AVK+LS R  Q +   K    E  +
Sbjct: 21  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRL 79
Query: 99  IAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSL----DFFLFDPTKRMLLDWVTRVQ-- 152
           +  ++H+N++ LL              + P +SL    D +L        L+ + + Q  
Sbjct: 80  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 127
Query: 153 -------IIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE 205
                  +I  I +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR      
Sbjct: 128 TDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----H 179
Query: 206 LQANTSRIVGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 250
                +  V T  Y +PE  L  + ++   D++S G ++ E+++G+
Sbjct: 180 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 105/226 (46%), Gaps = 39/226 (17%)
Query: 43  SVSTATNKFSDANKLGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKN---EASV 98
           ++     ++ + + +G G +G V      K G  +AVK+LS R  Q +   K    E  +
Sbjct: 13  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRL 71
Query: 99  IAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSL----DFFLFDPTKRMLLDWVTRVQ-- 152
           +  ++H+N++ LL              + P +SL    D +L        L+ + + Q  
Sbjct: 72  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 119
Query: 153 -------IIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE 205
                  +I  I +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR      
Sbjct: 120 TDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----H 171
Query: 206 LQANTSRIVGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 250
                +  V T  Y +PE  L  + ++   D++S G ++ E+++G+
Sbjct: 172 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 105/226 (46%), Gaps = 39/226 (17%)
Query: 43  SVSTATNKFSDANKLGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKN---EASV 98
           ++     ++ + + +G G +G V      K G  +AVK+LS R  Q +   K    E  +
Sbjct: 13  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRL 71
Query: 99  IAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSL----DFFLFDPTKRMLLDWVTRVQ-- 152
           +  ++H+N++ LL              + P +SL    D +L        L+ + + Q  
Sbjct: 72  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 119
Query: 153 -------IIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE 205
                  +I  I +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR      
Sbjct: 120 TDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----H 171
Query: 206 LQANTSRIVGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 250
                +  V T  Y +PE  L  + ++   D++S G ++ E+++G+
Sbjct: 172 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 105/226 (46%), Gaps = 39/226 (17%)
Query: 43  SVSTATNKFSDANKLGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKN---EASV 98
           ++     ++ + + +G G +G V      K G  +AVK+LS R  Q +   K    E  +
Sbjct: 15  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRL 73
Query: 99  IAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSL----DFFLFDPTKRMLLDWVTRVQ-- 152
           +  ++H+N++ LL              + P +SL    D +L        L+ + + Q  
Sbjct: 74  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 121
Query: 153 -------IIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE 205
                  +I  I +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR      
Sbjct: 122 TDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----H 173
Query: 206 LQANTSRIVGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 250
                +  V T  Y +PE  L  + ++   D++S G ++ E+++G+
Sbjct: 174 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 219

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 103/217 (47%), Gaps = 34/217 (15%)
Query: 49  NKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMK--------------- 93
           ++F     LG+G FG V+           VK++SG   + L  MK               
Sbjct: 24  SQFELLKVLGQGSFGKVF----------LVKKISGSDARQLYAMKVLKKATLKVRDRVRT 73
Query: 94  -NEASVIAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQ 152
             E  ++ +V H  +V+L        +  LI +++  +  D F     + M  +   +  
Sbjct: 74  KMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFL--RGGDLFTRLSKEVMFTEEDVKFY 131
Query: 153 IIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR 212
           + E +A  L +LH      II+RDLK  NILLD++ + K++DFG+++    +E +A +  
Sbjct: 132 LAE-LALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS-- 185
Query: 213 IVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 249
             GT  YM+PE       +  +D +SFGVL+ E+++G
Sbjct: 186 FCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTG 222

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 105/226 (46%), Gaps = 39/226 (17%)
Query: 43  SVSTATNKFSDANKLGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKN---EASV 98
           ++     ++ + + +G G +G V      K G  +AVK+LS R  Q +   K    E  +
Sbjct: 16  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRL 74
Query: 99  IAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSL----DFFLFDPTKRMLLDWVTRVQ-- 152
           +  ++H+N++ LL              + P +SL    D +L        L+ + + Q  
Sbjct: 75  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 122
Query: 153 -------IIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE 205
                  +I  I +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR      
Sbjct: 123 TDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----H 174
Query: 206 LQANTSRIVGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 250
                +  V T  Y +PE  L  + ++   D++S G ++ E+++G+
Sbjct: 175 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 105/226 (46%), Gaps = 39/226 (17%)
Query: 43  SVSTATNKFSDANKLGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKN---EASV 98
           ++     ++ + + +G G +G V      K G  +AVK+LS R  Q +   K    E  +
Sbjct: 16  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRL 74
Query: 99  IAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSL----DFFLFDPTKRMLLDWVTRVQ-- 152
           +  ++H+N++ LL              + P +SL    D +L        L+ + + Q  
Sbjct: 75  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 122
Query: 153 -------IIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE 205
                  +I  I +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR      
Sbjct: 123 TDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----H 174
Query: 206 LQANTSRIVGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 250
                +  V T  Y +PE  L  + ++   D++S G ++ E+++G+
Sbjct: 175 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 75/272 (27%), Positives = 111/272 (40%), Gaps = 36/272 (13%)
Query: 55  NKLGEGGFGPVYKGVLK----KGDEIAVKRLSG---RSGQGLREMKNEASVIAKVQHKNL 107
            KLG+G FG V +G       K   +AVK L        + + +   E + +  + H+NL
Sbjct: 24  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 83
Query: 108 VRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQY 167
           +RL G  +    K ++ E  P  SL   L       LL  ++R  +   +A+G+ YL   
Sbjct: 84  IRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLESK 140
Query: 168 SRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQA--NTSRIVGTYGYMSPEYA 225
              R IHRDL A N+LL      KI DFG+ R    N+        R V  + + +PE  
Sbjct: 141 ---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKV-PFAWCAPESL 196
Query: 226 LEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLW---TSNRTLELIDP 282
               FS  SD + FGV L E+ +                 Y  + W     ++ L  ID 
Sbjct: 197 KTRTFSHASDTWMFGVTLWEMFT-----------------YGQEPWIGLNGSQILHKIDK 239
Query: 283 ILEDEYSSKQMLLRYANIALLCVQESADDRPT 314
             E     +       N+ + C     +DRPT
Sbjct: 240 EGERLPRPEDCPQDIYNVMVQCWAHKPEDRPT 271

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 105/226 (46%), Gaps = 39/226 (17%)
Query: 43  SVSTATNKFSDANKLGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKN---EASV 98
           ++     ++ + + +G G +G V      K G  +AVK+LS R  Q +   K    E  +
Sbjct: 16  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRL 74
Query: 99  IAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSL----DFFLFDPTKRMLLDWVTRVQ-- 152
           +  ++H+N++ LL              + P +SL    D +L        L+ + + Q  
Sbjct: 75  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 122
Query: 153 -------IIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE 205
                  +I  I +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR      
Sbjct: 123 TDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----H 174
Query: 206 LQANTSRIVGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 250
                +  V T  Y +PE  L  + ++   D++S G ++ E+++G+
Sbjct: 175 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 105/226 (46%), Gaps = 39/226 (17%)
Query: 43  SVSTATNKFSDANKLGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKN---EASV 98
           ++     ++ + + +G G +G V      K G  +AVK+LS R  Q +   K    E  +
Sbjct: 16  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRL 74
Query: 99  IAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSL----DFFLFDPTKRMLLDWVTRVQ-- 152
           +  ++H+N++ LL              + P +SL    D +L        L+ + + Q  
Sbjct: 75  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 122
Query: 153 -------IIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE 205
                  +I  I +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR      
Sbjct: 123 TDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----H 174
Query: 206 LQANTSRIVGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 250
                +  V T  Y +PE  L  + ++   D++S G ++ E+++G+
Sbjct: 175 TDDEMTGXVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 75/272 (27%), Positives = 111/272 (40%), Gaps = 36/272 (13%)
Query: 56  KLGEGGFGPVYKGVLK----KGDEIAVKRLSG---RSGQGLREMKNEASVIAKVQHKNLV 108
           KLG+G FG V +G       K   +AVK L        + + +   E + +  + H+NL+
Sbjct: 19  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 78
Query: 109 RLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYS 168
           RL G  +    K ++ E  P  SL   L       LL  ++R  +   +A+G+ YL    
Sbjct: 79  RLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLESK- 134
Query: 169 RVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQ--ANTSRIVGTYGYMSPEYAL 226
             R IHRDL A N+LL      KI DFG+ R    N+        R V  + + +PE   
Sbjct: 135 --RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV-PFAWCAPESLK 191
Query: 227 EGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLW---TSNRTLELIDPI 283
              FS  SD + FGV L E+ +                 Y  + W     ++ L  ID  
Sbjct: 192 TRTFSHASDTWMFGVTLWEMFT-----------------YGQEPWIGLNGSQILHKIDKE 234
Query: 284 LEDEYSSKQMLLRYANIALLCVQESADDRPTM 315
            E     +       N+ + C     +DRPT 
Sbjct: 235 GERLPRPEDCPQDIYNVMVQCWAHKPEDRPTF 266

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 105/226 (46%), Gaps = 39/226 (17%)
Query: 43  SVSTATNKFSDANKLGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKN---EASV 98
           ++     ++ + + +G G +G V      K G  +AVK+LS R  Q +   K    E  +
Sbjct: 16  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRL 74
Query: 99  IAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSL----DFFLFDPTKRMLLDWVTRVQ-- 152
           +  ++H+N++ LL              + P +SL    D +L        L+ + + Q  
Sbjct: 75  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 122
Query: 153 -------IIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE 205
                  +I  I +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR      
Sbjct: 123 TDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----H 174
Query: 206 LQANTSRIVGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 250
                +  V T  Y +PE  L  + ++   D++S G ++ E+++G+
Sbjct: 175 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 105/226 (46%), Gaps = 39/226 (17%)
Query: 43  SVSTATNKFSDANKLGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKN---EASV 98
           ++     ++ + + +G G +G V      K G  +AVK+LS R  Q +   K    E  +
Sbjct: 21  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRL 79
Query: 99  IAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSL----DFFLFDPTKRMLLDWVTRVQ-- 152
           +  ++H+N++ LL              + P +SL    D +L        L+ + + Q  
Sbjct: 80  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 127
Query: 153 -------IIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE 205
                  +I  I +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR      
Sbjct: 128 TDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDXELKILDFGLAR-----H 179
Query: 206 LQANTSRIVGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 250
                +  V T  Y +PE  L  + ++   D++S G ++ E+++G+
Sbjct: 180 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 105/226 (46%), Gaps = 39/226 (17%)
Query: 43  SVSTATNKFSDANKLGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKN---EASV 98
           ++     ++ + + +G G +G V      K G  +AVK+LS R  Q +   K    E  +
Sbjct: 16  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRL 74
Query: 99  IAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSL----DFFLFDPTKRMLLDWVTRVQ-- 152
           +  ++H+N++ LL              + P +SL    D +L        L+ + + Q  
Sbjct: 75  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 122
Query: 153 -------IIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE 205
                  +I  I +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR      
Sbjct: 123 TDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----H 174
Query: 206 LQANTSRIVGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 250
                +  V T  Y +PE  L  + ++   D++S G ++ E+++G+
Sbjct: 175 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 105/226 (46%), Gaps = 39/226 (17%)
Query: 43  SVSTATNKFSDANKLGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKN---EASV 98
           ++     ++ + + +G G +G V      K G  +AVK+LS R  Q +   K    E  +
Sbjct: 16  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRL 74
Query: 99  IAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSL----DFFLFDPTKRMLLDWVTRVQ-- 152
           +  ++H+N++ LL              + P +SL    D +L        L+ + + Q  
Sbjct: 75  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 122
Query: 153 -------IIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE 205
                  +I  I +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR      
Sbjct: 123 TDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----H 174
Query: 206 LQANTSRIVGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 250
                +  V T  Y +PE  L  + ++   D++S G ++ E+++G+
Sbjct: 175 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 105/226 (46%), Gaps = 39/226 (17%)
Query: 43  SVSTATNKFSDANKLGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKN---EASV 98
           ++     ++ + + +G G +G V      K G  +AVK+LS R  Q +   K    E  +
Sbjct: 21  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRL 79
Query: 99  IAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSL----DFFLFDPTKRMLLDWVTRVQ-- 152
           +  ++H+N++ LL              + P +SL    D +L        L+ + + Q  
Sbjct: 80  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 127
Query: 153 -------IIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE 205
                  +I  I +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR      
Sbjct: 128 TDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----H 179
Query: 206 LQANTSRIVGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 250
                +  V T  Y +PE  L  + ++   D++S G ++ E+++G+
Sbjct: 180 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 105/226 (46%), Gaps = 39/226 (17%)
Query: 43  SVSTATNKFSDANKLGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKN---EASV 98
           ++     ++ + + +G G +G V      K G  +AVK+LS R  Q +   K    E  +
Sbjct: 18  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRL 76
Query: 99  IAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSL----DFFLFDPTKRMLLDWVTRVQ-- 152
           +  ++H+N++ LL              + P +SL    D +L        L+ + + Q  
Sbjct: 77  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 124
Query: 153 -------IIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE 205
                  +I  I +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR      
Sbjct: 125 TDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----H 176
Query: 206 LQANTSRIVGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 250
                +  V T  Y +PE  L  + ++   D++S G ++ E+++G+
Sbjct: 177 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 105/226 (46%), Gaps = 39/226 (17%)
Query: 43  SVSTATNKFSDANKLGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKN---EASV 98
           ++     ++ + + +G G +G V      K G  +AVK+LS R  Q +   K    E  +
Sbjct: 14  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRL 72
Query: 99  IAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSL----DFFLFDPTKRMLLDWVTRVQ-- 152
           +  ++H+N++ LL              + P +SL    D +L        L+ + + Q  
Sbjct: 73  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 120
Query: 153 -------IIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE 205
                  +I  I +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR      
Sbjct: 121 TDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----H 172
Query: 206 LQANTSRIVGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 250
                +  V T  Y +PE  L  + ++   D++S G ++ E+++G+
Sbjct: 173 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 218

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 105/226 (46%), Gaps = 39/226 (17%)
Query: 43  SVSTATNKFSDANKLGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKN---EASV 98
           ++     ++ + + +G G +G V      K G  +AVK+LS R  Q +   K    E  +
Sbjct: 22  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRL 80
Query: 99  IAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSL----DFFLFDPTKRMLLDWVTRVQ-- 152
           +  ++H+N++ LL              + P +SL    D +L        L+ + + Q  
Sbjct: 81  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 128
Query: 153 -------IIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE 205
                  +I  I +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR      
Sbjct: 129 TDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----H 180
Query: 206 LQANTSRIVGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 250
                +  V T  Y +PE  L  + ++   D++S G ++ E+++G+
Sbjct: 181 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 105/226 (46%), Gaps = 39/226 (17%)
Query: 43  SVSTATNKFSDANKLGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKN---EASV 98
           ++     ++ + + +G G +G V      K G  +AVK+LS R  Q +   K    E  +
Sbjct: 18  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRL 76
Query: 99  IAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSL----DFFLFDPTKRMLLDWVTRVQ-- 152
           +  ++H+N++ LL              + P +SL    D +L        L+ + + Q  
Sbjct: 77  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 124
Query: 153 -------IIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE 205
                  +I  I +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR      
Sbjct: 125 TDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----H 176
Query: 206 LQANTSRIVGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 250
                +  V T  Y +PE  L  + ++   D++S G ++ E+++G+
Sbjct: 177 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 96/204 (47%), Gaps = 27/204 (13%)
Query: 57  LGEGGFGPV--YKGVLKKGDEIAVKRL--SGRSGQGLREMKNEASVIAKVQHKNLVRLLG 112
           +G+G F  V   + +L  G E+AVK +  +  +   L+++  E  ++  + H N+V+L  
Sbjct: 22  IGKGNFAKVKLARHILT-GKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFE 80
Query: 113 CCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRI 172
                    L+ EY     +  +L    +  + +   R +  + I   + Y HQ     I
Sbjct: 81  VIETEKTLYLVMEYASGGEVFDYLVAHGR--MKEKEARAKFRQ-IVSAVQYCHQKF---I 134
Query: 173 IHRDLKASNILLDKDMNPKISDFGMA-RICGGNELQANTSRIVGTYGYMSPEYALEGIFS 231
           +HRDLKA N+LLD DMN KI+DFG +     GN+L              SP YA   +F 
Sbjct: 135 VHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCG---------SPPYAAPELFQ 185
Query: 232 IKS------DVFSFGVLLLEIVSG 249
            K       DV+S GV+L  +VSG
Sbjct: 186 GKKYDGPEVDVWSLGVILYTLVSG 209

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 105/226 (46%), Gaps = 39/226 (17%)
Query: 43  SVSTATNKFSDANKLGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKN---EASV 98
           ++     ++ + + +G G +G V      K G  +AVK+LS R  Q +   K    E  +
Sbjct: 18  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRL 76
Query: 99  IAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSL----DFFLFDPTKRMLLDWVTRVQ-- 152
           +  ++H+N++ LL              + P +SL    D +L        L+ + + Q  
Sbjct: 77  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 124
Query: 153 -------IIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE 205
                  +I  I +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR      
Sbjct: 125 TDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----H 176
Query: 206 LQANTSRIVGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 250
                +  V T  Y +PE  L  + ++   D++S G ++ E+++G+
Sbjct: 177 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 92/198 (46%), Gaps = 12/198 (6%)
Query: 57  LGEGGFGPVYKGVLKKGDEIAVKRLSGRS----GQGLREMKNEASVIAKVQHKNLVRLLG 112
           LG+GGF   ++       E+   ++  +S         +M  E S+   + H+++V   G
Sbjct: 29  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 88
Query: 113 CCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRI 172
              D D   ++ E    +SL   L    +R  L        +  I  G  YLH   R R+
Sbjct: 89  FFEDNDFVFVVLELCRRRSL---LELHKRRKALTEPEARYYLRQIVLGCQYLH---RNRV 142
Query: 173 IHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSI 232
           IHRDLK  N+ L++D+  KI DFG+A     +  +  T  + GT  Y++PE   +   S 
Sbjct: 143 IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKT--LCGTPNYIAPEVLSKKGHSF 200
Query: 233 KSDVFSFGVLLLEIVSGK 250
           + DV+S G ++  ++ GK
Sbjct: 201 EVDVWSIGCIMYTLLVGK 218

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 105/226 (46%), Gaps = 39/226 (17%)
Query: 43  SVSTATNKFSDANKLGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKN---EASV 98
           ++     ++ + + +G G +G V      K G  +AVK+LS R  Q +   K    E  +
Sbjct: 22  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRL 80
Query: 99  IAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSL----DFFLFDPTKRMLLDWVTRVQ-- 152
           +  ++H+N++ LL              + P +SL    D +L        L+ + + Q  
Sbjct: 81  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 128
Query: 153 -------IIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE 205
                  +I  I +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR      
Sbjct: 129 TDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----H 180
Query: 206 LQANTSRIVGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 250
                +  V T  Y +PE  L  + ++   D++S G ++ E+++G+
Sbjct: 181 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 105/226 (46%), Gaps = 39/226 (17%)
Query: 43  SVSTATNKFSDANKLGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKN---EASV 98
           ++     ++ + + +G G +G V      K G  +AVK+LS R  Q +   K    E  +
Sbjct: 27  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRL 85
Query: 99  IAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSL----DFFLFDPTKRMLLDWVTRVQ-- 152
           +  ++H+N++ LL              + P +SL    D +L        L+ + + Q  
Sbjct: 86  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 133
Query: 153 -------IIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE 205
                  +I  I +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR      
Sbjct: 134 TDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDXELKILDFGLAR-----H 185
Query: 206 LQANTSRIVGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 250
                +  V T  Y +PE  L  + ++   D++S G ++ E+++G+
Sbjct: 186 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 231

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 75/273 (27%), Positives = 111/273 (40%), Gaps = 36/273 (13%)
Query: 55  NKLGEGGFGPVYKGVLK----KGDEIAVKRLSG---RSGQGLREMKNEASVIAKVQHKNL 107
            KLG+G FG V +G       K   +AVK L        + + +   E + +  + H+NL
Sbjct: 14  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 73
Query: 108 VRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQY 167
           +RL G  +    K ++ E  P  SL   L       LL  ++R  +   +A+G+ YL   
Sbjct: 74  IRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLESK 130
Query: 168 SRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQ--ANTSRIVGTYGYMSPEYA 225
              R IHRDL A N+LL      KI DFG+ R    N+        R V  + + +PE  
Sbjct: 131 ---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV-PFAWCAPESL 186
Query: 226 LEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLW---TSNRTLELIDP 282
               FS  SD + FGV L E+ +                 Y  + W     ++ L  ID 
Sbjct: 187 KTRTFSHASDTWMFGVTLWEMFT-----------------YGQEPWIGLNGSQILHKIDK 229
Query: 283 ILEDEYSSKQMLLRYANIALLCVQESADDRPTM 315
             E     +       N+ + C     +DRPT 
Sbjct: 230 EGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTF 262

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 101/213 (47%), Gaps = 30/213 (14%)
Query: 51  FSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSG--RSGQGLREMKNEASVIAKVQHKNL 107
           +     +G G +G V   + K+ G+++A+K+LS   +S    +    E  ++  +QH+N+
Sbjct: 26  YVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENV 85
Query: 108 VRLLGCCIDRDEKILIYEYMPNKSL----DFFLFDPTKRMLLDWVTRVQIIEGIAQGLLY 163
           + LL              + P  SL    DF+L  P  +  L  +  ++  E   Q L+Y
Sbjct: 86  IGLLDV------------FTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQYLVY 133
Query: 164 -----LHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG 218
                L       ++HRDLK  N+ +++D   KI DFG+AR        A  +  V T  
Sbjct: 134 QMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLAR-----HADAEMTGYVVTRW 188
Query: 219 YMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 250
           Y +PE  L  + ++   D++S G ++ E+++GK
Sbjct: 189 YRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 94/207 (45%), Gaps = 33/207 (15%)
Query: 57  LGEGGFGPV--YKGVLKKGDEIAVKRL--SGRSGQGLREMKNEASVIAKVQHKNLVRLLG 112
           +G+G F  V   + +L  G E+AVK +  +  +   L+++  E  ++  + H N+V+L  
Sbjct: 15  IGKGNFAKVKLARHILT-GKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFE 73
Query: 113 CCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQI---IEGIAQGLLYLHQYSR 169
                    L+ EY     +  +L      +   W+   +       I   + Y HQ   
Sbjct: 74  VIETEKTLYLVMEYASGGEVFDYL------VAHGWMKEKEARAKFRQIVSAVQYCHQKF- 126
Query: 170 VRIIHRDLKASNILLDKDMNPKISDFGMA-RICGGNELQANTSRIVGTYGYMSPEYALEG 228
             I+HRDLKA N+LLD DMN KI+DFG +     GN+L              SP YA   
Sbjct: 127 --IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCG---------SPPYAAPE 175
Query: 229 IFSIKS------DVFSFGVLLLEIVSG 249
           +F  K       DV+S GV+L  +VSG
Sbjct: 176 LFQGKKYDGPEVDVWSLGVILYTLVSG 202

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 66/225 (29%), Positives = 102/225 (45%), Gaps = 39/225 (17%)
Query: 43  SVSTATNKFSDANKLGEGGFGPV---YKGVLKKGDEIAVKRLSGRSGQGLREMKN---EA 96
           S  T   ++ +   +G G  G V   Y  +L++   +A+K+LS R  Q     K    E 
Sbjct: 18  STFTVLKRYQNLKPIGSGAQGIVCAAYDAILERN--VAIKKLS-RPFQNQTHAKRAYREL 74
Query: 97  SVIAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFF--------LFDP----TKRML 144
            ++  V HKN++ LL              + P KSL+ F        L D       +M 
Sbjct: 75  VLMKVVNHKNIIGLLNV------------FTPQKSLEEFQDVYIVMELMDANLSQVIQME 122
Query: 145 LDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGN 204
           LD      ++  +  G+ +LH      IIHRDLK SNI++  D   KI DFG+AR  G +
Sbjct: 123 LDHERMSYLLYQMLVGIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLARTAGTS 179
Query: 205 ELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 249
            +   T  +V  Y Y +PE  L   +    D++S G ++ E++ G
Sbjct: 180 FMM--TPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 96/204 (47%), Gaps = 27/204 (13%)
Query: 57  LGEGGFGPV--YKGVLKKGDEIAVKRL--SGRSGQGLREMKNEASVIAKVQHKNLVRLLG 112
           +G+G F  V   + +L  G E+AVK +  +  +   L+++  E  ++  + H N+V+L  
Sbjct: 22  IGKGNFAKVKLARHILT-GKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFE 80
Query: 113 CCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRI 172
                    L+ EY     +  +L    +  + +   R +  + I   + Y HQ     I
Sbjct: 81  VIETEKTLYLVMEYASGGEVFDYLVAHGR--MKEKEARAKFRQ-IVSAVQYCHQKF---I 134
Query: 173 IHRDLKASNILLDKDMNPKISDFGMA-RICGGNELQANTSRIVGTYGYMSPEYALEGIFS 231
           +HRDLKA N+LLD DMN KI+DFG +     GN+L              SP YA   +F 
Sbjct: 135 VHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCG---------SPPYAAPELFQ 185
Query: 232 IKS------DVFSFGVLLLEIVSG 249
            K       DV+S GV+L  +VSG
Sbjct: 186 GKKYDGPEVDVWSLGVILYTLVSG 209

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 92/203 (45%), Gaps = 16/203 (7%)
Query: 55  NKLGEGGFGPVYKGVLK----KGDEIAVKRLSG---RSGQGLREMKNEASVIAKVQHKNL 107
            KLG+G FG V +G       K   +AVK L        + + +   E + +  + H+NL
Sbjct: 14  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 73
Query: 108 VRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQY 167
           +RL G  +    K ++ E  P  SL   L       LL  ++R  +   +A+G+ YL   
Sbjct: 74  IRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLESK 130
Query: 168 SRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQA--NTSRIVGTYGYMSPEYA 225
              R IHRDL A N+LL      KI DFG+ R    N+        R V  + + +PE  
Sbjct: 131 ---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKV-PFAWCAPESL 186
Query: 226 LEGIFSIKSDVFSFGVLLLEIVS 248
               FS  SD + FGV L E+ +
Sbjct: 187 KTRTFSHASDTWMFGVTLWEMFT 209

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 101/214 (47%), Gaps = 32/214 (14%)
Query: 51  FSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQG---LREMKNEASVIAKVQHKN 106
           +     +G G +G V   + K+ G+++A+K+LS R  Q     +    E  ++  +QH+N
Sbjct: 44  YVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLS-RPFQSEIFAKRAYRELLLLKHMQHEN 102
Query: 107 LVRLLGCCIDRDEKILIYEYMPNKSL----DFFLFDPTKRMLLDWVTRVQIIEGIAQGLL 162
           ++ LL              + P  SL    DF+L  P  +  L  +  ++  E   Q L+
Sbjct: 103 VIGLLDV------------FTPASSLRNFYDFYLVMPFMQTDLQKIMGMEFSEEKIQYLV 150
Query: 163 Y-----LHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTY 217
           Y     L       ++HRDLK  N+ +++D   KI DFG+AR        A  +  V T 
Sbjct: 151 YQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLAR-----HADAEMTGYVVTR 205
Query: 218 GYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 250
            Y +PE  L  + ++   D++S G ++ E+++GK
Sbjct: 206 WYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 239

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 97/206 (47%), Gaps = 21/206 (10%)
Query: 57  LGEGGFGPVYKGVLKK-GDEIAVK-----RLSGRSGQGLREMKNEASVIAKVQHKNLVRL 110
           +G+G F  V + + ++ G + AVK     + +   G    ++K EAS+   ++H ++V L
Sbjct: 32  IGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL 91
Query: 111 LGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQI----IEGIAQGLLYLHQ 166
           L          +++E+M    L    F+  KR    +V    +    +  I + L Y H 
Sbjct: 92  LETYSSDGMLYMVFEFMDGADL---CFEIVKRADAGFVYSEAVASHYMRQILEALRYCHD 148
Query: 167 YSRVRIIHRDLKASNILLDKDMNP---KISDFGMARICGGNELQANTSRIVGTYGYMSPE 223
            +   IIHRD+K  N+LL    N    K+ DFG+A   G + L A     VGT  +M+PE
Sbjct: 149 NN---IIHRDVKPENVLLASKENSAPVKLGDFGVAIQLGESGLVAGGR--VGTPHFMAPE 203
Query: 224 YALEGIFSIKSDVFSFGVLLLEIVSG 249
                 +    DV+  GV+L  ++SG
Sbjct: 204 VVKREPYGKPVDVWGCGVILFILLSG 229

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 105/226 (46%), Gaps = 39/226 (17%)
Query: 43  SVSTATNKFSDANKLGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKN---EASV 98
           ++     ++ + + +G G +G V      K G  +AVK+LS R  Q +   K    E  +
Sbjct: 28  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRL 86
Query: 99  IAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSL----DFFLFDPTKRMLLDWVTRVQ-- 152
           +  ++H+N++ LL              + P +SL    D +L        L+ + + Q  
Sbjct: 87  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 134
Query: 153 -------IIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE 205
                  +I  I +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR      
Sbjct: 135 TDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----H 186
Query: 206 LQANTSRIVGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 250
                +  V T  Y +PE  L  + ++   D++S G ++ E+++G+
Sbjct: 187 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 105/226 (46%), Gaps = 39/226 (17%)
Query: 43  SVSTATNKFSDANKLGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKN---EASV 98
           ++     ++ + + +G G +G V      K G  +AVK+LS R  Q +   K    E  +
Sbjct: 28  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRL 86
Query: 99  IAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSL----DFFLFDPTKRMLLDWVTRVQ-- 152
           +  ++H+N++ LL              + P +SL    D +L        L+ + + Q  
Sbjct: 87  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 134
Query: 153 -------IIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE 205
                  +I  I +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR      
Sbjct: 135 TDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----H 186
Query: 206 LQANTSRIVGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 250
                +  V T  Y +PE  L  + ++   D++S G ++ E+++G+
Sbjct: 187 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 92/198 (46%), Gaps = 12/198 (6%)
Query: 57  LGEGGFGPVYKGVLKKGDEIAVKRLSGRS----GQGLREMKNEASVIAKVQHKNLVRLLG 112
           LG+GGF   ++       E+   ++  +S         +M  E S+   + H+++V   G
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 84
Query: 113 CCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRI 172
              D D   ++ E    +SL   L    +R  L        +  I  G  YLH   R R+
Sbjct: 85  FFEDNDFVFVVLELCRRRSL---LELHKRRKALTEPEARYYLRQIVLGCQYLH---RNRV 138
Query: 173 IHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSI 232
           IHRDLK  N+ L++D+  KI DFG+A     +  +  T  + GT  Y++PE   +   S 
Sbjct: 139 IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKT--LCGTPNYIAPEVLSKKGHSF 196
Query: 233 KSDVFSFGVLLLEIVSGK 250
           + DV+S G ++  ++ GK
Sbjct: 197 EVDVWSIGCIMYTLLVGK 214

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 105/226 (46%), Gaps = 39/226 (17%)
Query: 43  SVSTATNKFSDANKLGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKN---EASV 98
           ++     ++ + + +G G +G V      K G  +AVK+LS R  Q +   K    E  +
Sbjct: 27  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRL 85
Query: 99  IAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSL----DFFLFDPTKRMLLDWVTRVQ-- 152
           +  ++H+N++ LL              + P +SL    D +L        L+ + + Q  
Sbjct: 86  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 133
Query: 153 -------IIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE 205
                  +I  I +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR      
Sbjct: 134 TDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----H 185
Query: 206 LQANTSRIVGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 250
                +  V T  Y +PE  L  + ++   D++S G ++ E+++G+
Sbjct: 186 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 231

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 105/226 (46%), Gaps = 39/226 (17%)
Query: 43  SVSTATNKFSDANKLGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKN---EASV 98
           ++     ++ + + +G G +G V      K G  +AVK+LS R  Q +   K    E  +
Sbjct: 16  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRL 74
Query: 99  IAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSL----DFFLFDPTKRMLLDWVTRVQ-- 152
           +  ++H+N++ LL              + P +SL    D +L        L+ + + Q  
Sbjct: 75  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKXQKL 122
Query: 153 -------IIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE 205
                  +I  I +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR      
Sbjct: 123 TDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDXELKILDFGLAR-----H 174
Query: 206 LQANTSRIVGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 250
                +  V T  Y +PE  L  + ++   D++S G ++ E+++G+
Sbjct: 175 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 66/225 (29%), Positives = 102/225 (45%), Gaps = 39/225 (17%)
Query: 43  SVSTATNKFSDANKLGEGGFGPV---YKGVLKKGDEIAVKRLSGRSGQGLREMKN---EA 96
           S  T   ++ +   +G G  G V   Y  +L++   +A+K+LS R  Q     K    E 
Sbjct: 18  STFTVLKRYQNLKPIGSGAQGIVCAAYDAILERN--VAIKKLS-RPFQNQTHAKRAYREL 74
Query: 97  SVIAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFF--------LFDP----TKRML 144
            ++  V HKN++ LL              + P KSL+ F        L D       +M 
Sbjct: 75  VLMKCVNHKNIIGLLNV------------FTPQKSLEEFQDVYIVMELMDANLSQVIQME 122
Query: 145 LDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGN 204
           LD      ++  +  G+ +LH      IIHRDLK SNI++  D   KI DFG+AR  G +
Sbjct: 123 LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 179
Query: 205 ELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 249
            +   T  +V  Y Y +PE  L   +    D++S G ++ E++ G
Sbjct: 180 FMM--TPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 105/226 (46%), Gaps = 39/226 (17%)
Query: 43  SVSTATNKFSDANKLGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKN---EASV 98
           ++     ++ + + +G G +G V      K G  +AVK+LS R  Q +   K    E  +
Sbjct: 16  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRL 74
Query: 99  IAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSL----DFFLFDPTKRMLLDWVTRVQ-- 152
           +  ++H+N++ LL              + P +SL    D +L        L+ + + Q  
Sbjct: 75  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKXQKL 122
Query: 153 -------IIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE 205
                  +I  I +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR      
Sbjct: 123 TDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----H 174
Query: 206 LQANTSRIVGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 250
                +  V T  Y +PE  L  + ++   D++S G ++ E+++G+
Sbjct: 175 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 75/272 (27%), Positives = 111/272 (40%), Gaps = 36/272 (13%)
Query: 55  NKLGEGGFGPVYKGVLK----KGDEIAVKRLSG---RSGQGLREMKNEASVIAKVQHKNL 107
            KLG+G FG V +G       K   +AVK L        + + +   E + +  + H+NL
Sbjct: 24  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 83
Query: 108 VRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQY 167
           +RL G  +    K ++ E  P  SL   L       LL  ++R  +   +A+G+ YL   
Sbjct: 84  IRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLESK 140
Query: 168 SRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQ--ANTSRIVGTYGYMSPEYA 225
              R IHRDL A N+LL      KI DFG+ R    N+        R V  + + +PE  
Sbjct: 141 ---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV-PFAWCAPESL 196
Query: 226 LEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLW---TSNRTLELIDP 282
               FS  SD + FGV L E+ +                 Y  + W     ++ L  ID 
Sbjct: 197 KTRTFSHASDTWMFGVTLWEMFT-----------------YGQEPWIGLNGSQILHKIDK 239
Query: 283 ILEDEYSSKQMLLRYANIALLCVQESADDRPT 314
             E     +       N+ + C     +DRPT
Sbjct: 240 EGERLPRPEDCPQDIYNVMVQCWAHKPEDRPT 271

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/226 (26%), Positives = 107/226 (47%), Gaps = 39/226 (17%)
Query: 43  SVSTATNKFSDANKLGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKN---EASV 98
           ++     ++ + + +G G +G V      K G  +AVK+LS R  Q +   K    E  +
Sbjct: 39  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRL 97
Query: 99  IAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSL----DFFLFDPTKRMLLDWVTRVQ-- 152
           +  ++H+N++ LL              + P +SL    D +L        L+ + + Q  
Sbjct: 98  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 145
Query: 153 -------IIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE 205
                  +I  I +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR    +E
Sbjct: 146 TDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDE 201
Query: 206 LQANTSRIVGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 250
           +       V T  Y +PE  L  + ++   D++S G ++ E+++G+
Sbjct: 202 MXG----YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 243

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 105/226 (46%), Gaps = 39/226 (17%)
Query: 43  SVSTATNKFSDANKLGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKN---EASV 98
           ++     ++ + + +G G +G V      K G  +AVK+LS R  Q +   K    E  +
Sbjct: 39  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRL 97
Query: 99  IAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSL----DFFLFDPTKRMLLDWVTRVQ-- 152
           +  ++H+N++ LL              + P +SL    D +L        L+ + + Q  
Sbjct: 98  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 145
Query: 153 -------IIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE 205
                  +I  I +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR      
Sbjct: 146 TDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----H 197
Query: 206 LQANTSRIVGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 250
                +  V T  Y +PE  L  + ++   D++S G ++ E+++G+
Sbjct: 198 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 243

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 105/226 (46%), Gaps = 39/226 (17%)
Query: 43  SVSTATNKFSDANKLGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKN---EASV 98
           ++     ++ + + +G G +G V      K G  +AVK+LS R  Q +   K    E  +
Sbjct: 36  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRL 94
Query: 99  IAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSL----DFFLFDPTKRMLLDWVTRVQ-- 152
           +  ++H+N++ LL              + P +SL    D +L        L+ + + Q  
Sbjct: 95  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 142
Query: 153 -------IIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE 205
                  +I  I +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR      
Sbjct: 143 TDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----H 194
Query: 206 LQANTSRIVGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 250
                +  V T  Y +PE  L  + ++   D++S G ++ E+++G+
Sbjct: 195 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 105/226 (46%), Gaps = 39/226 (17%)
Query: 43  SVSTATNKFSDANKLGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKN---EASV 98
           ++     ++ + + +G G +G V      K G  +AVK+LS R  Q +   K    E  +
Sbjct: 35  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRL 93
Query: 99  IAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSL----DFFLFDPTKRMLLDWVTRVQ-- 152
           +  ++H+N++ LL              + P +SL    D +L        L+ + + Q  
Sbjct: 94  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 141
Query: 153 -------IIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE 205
                  +I  I +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR      
Sbjct: 142 TDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----H 193
Query: 206 LQANTSRIVGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 250
                +  V T  Y +PE  L  + ++   D++S G ++ E+++G+
Sbjct: 194 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 239

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 92/198 (46%), Gaps = 12/198 (6%)
Query: 57  LGEGGFGPVYKGVLKKGDEIAVKRLSGRS----GQGLREMKNEASVIAKVQHKNLVRLLG 112
           LG+GGF   ++       E+   ++  +S         +M  E S+   + H+++V   G
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 84
Query: 113 CCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRI 172
              D D   ++ E    +SL   L    +R  L        +  I  G  YLH   R R+
Sbjct: 85  FFEDNDFVFVVLELCRRRSL---LELHKRRKALTEPEARYYLRQIVLGCQYLH---RNRV 138
Query: 173 IHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSI 232
           IHRDLK  N+ L++D+  KI DFG+A     +  +  T  + GT  Y++PE   +   S 
Sbjct: 139 IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKT--LCGTPNYIAPEVLSKKGHSF 196
Query: 233 KSDVFSFGVLLLEIVSGK 250
           + DV+S G ++  ++ GK
Sbjct: 197 EVDVWSIGCIMYTLLVGK 214

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 94/201 (46%), Gaps = 18/201 (8%)
Query: 57  LGEGGFGPVYKGVLKKGDEIAVKRLSGRS----GQGLREMKNEASVIAKVQHKNLVRLLG 112
           LG+GGF   ++       E+   ++  +S         +M  E S+   + H+++V   G
Sbjct: 47  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 106
Query: 113 CCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRI 172
              D D   ++ E    +SL   L    +R  L        +  I  G  YLH   R R+
Sbjct: 107 FFEDNDFVFVVLELCRRRSL---LELHKRRKALTEPEARYYLRQIVLGCQYLH---RNRV 160
Query: 173 IHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR---IVGTYGYMSPEYALEGI 229
           IHRDLK  N+ L++D+  KI DFG+A      +++ +  R   + GT  Y++PE   +  
Sbjct: 161 IHRDLKLGNLFLNEDLEVKIGDFGLA-----TKVEYDGERKKVLCGTPNYIAPEVLSKKG 215
Query: 230 FSIKSDVFSFGVLLLEIVSGK 250
            S + DV+S G ++  ++ GK
Sbjct: 216 HSFEVDVWSIGCIMYTLLVGK 236

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 94/204 (46%), Gaps = 20/204 (9%)
Query: 55  NKLGEGGFGPVYKGV-LKKGDEIAVK-----RLSGRSGQGLREMKNEASVIAKVQHKNLV 108
            +LG+G F  V + V +  G E A K     +LS R  Q   +++ EA +   ++H N+V
Sbjct: 28  EELGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSARDHQ---KLEREARICRLLKHPNIV 84
Query: 109 RLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYS 168
           RL     +     LI++ +    L     D   R           I+ I + +L+ HQ  
Sbjct: 85  RLHDSISEEGHHYLIFDLVTGGEL---FEDIVAREYYSEADASHCIQQILEAVLHCHQMG 141
Query: 169 RVRIIHRDLKASNILLD---KDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYA 225
              ++HRDLK  N+LL    K    K++DFG+A    G   Q       GT GY+SPE  
Sbjct: 142 ---VVHRDLKPENLLLASKLKGAAVKLADFGLAIEVEGE--QQAWFGFAGTPGYLSPEVL 196
Query: 226 LEGIFSIKSDVFSFGVLLLEIVSG 249
            +  +    D+++ GV+L  ++ G
Sbjct: 197 RKDPYGKPVDLWACGVILYILLVG 220

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 66/225 (29%), Positives = 102/225 (45%), Gaps = 39/225 (17%)
Query: 43  SVSTATNKFSDANKLGEGGFGPV---YKGVLKKGDEIAVKRLSGRSGQGLREMKN---EA 96
           S  T   ++ +   +G G  G V   Y  +L++   +A+K+LS R  Q     K    E 
Sbjct: 18  STFTVLKRYQNLKPIGSGAQGIVCAAYDAILERN--VAIKKLS-RPFQNQTHAKRAYREL 74
Query: 97  SVIAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFF--------LFDP----TKRML 144
            ++  V HKN++ LL              + P KSL+ F        L D       +M 
Sbjct: 75  VLMKCVNHKNIIGLLNV------------FTPQKSLEEFQDVYIVMELMDANLCQVIQME 122
Query: 145 LDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGN 204
           LD      ++  +  G+ +LH      IIHRDLK SNI++  D   KI DFG+AR  G +
Sbjct: 123 LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 179
Query: 205 ELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 249
            +   T  +V  Y Y +PE  L   +    D++S G ++ E++ G
Sbjct: 180 FMM--TPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 66/225 (29%), Positives = 102/225 (45%), Gaps = 39/225 (17%)
Query: 43  SVSTATNKFSDANKLGEGGFGPV---YKGVLKKGDEIAVKRLSGRSGQGLREMKN---EA 96
           S  T   ++ +   +G G  G V   Y  +L++   +A+K+LS R  Q     K    E 
Sbjct: 18  STFTVLKRYQNLKPIGSGAQGIVCAAYDAILERN--VAIKKLS-RPFQNQTHAKRAYREL 74
Query: 97  SVIAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFF--------LFDP----TKRML 144
            ++  V HKN++ LL              + P KSL+ F        L D       +M 
Sbjct: 75  VLMKVVNHKNIIGLLNV------------FTPQKSLEEFQDVYIVMELMDANLSQVIQME 122
Query: 145 LDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGN 204
           LD      ++  +  G+ +LH      IIHRDLK SNI++  D   KI DFG+AR  G +
Sbjct: 123 LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLARTAGTS 179
Query: 205 ELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 249
            +   T  +V  Y Y +PE  L   +    D++S G ++ E++ G
Sbjct: 180 FMM--TPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 66/225 (29%), Positives = 102/225 (45%), Gaps = 39/225 (17%)
Query: 43  SVSTATNKFSDANKLGEGGFGPV---YKGVLKKGDEIAVKRLSGRSGQGLREMKN---EA 96
           S  T   ++ +   +G G  G V   Y  +L++   +A+K+LS R  Q     K    E 
Sbjct: 18  STFTVLKRYQNLKPIGSGAQGIVCAAYDAILERN--VAIKKLS-RPFQNQTHAKRAYREL 74
Query: 97  SVIAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFF--------LFDP----TKRML 144
            ++  V HKN++ LL              + P KSL+ F        L D       +M 
Sbjct: 75  VLMKCVNHKNIIGLLNV------------FTPQKSLEEFQDVYIVMELMDANLCQVIQME 122
Query: 145 LDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGN 204
           LD      ++  +  G+ +LH      IIHRDLK SNI++  D   KI DFG+AR  G +
Sbjct: 123 LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 179
Query: 205 ELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 249
            +   T  +V  Y Y +PE  L   +    D++S G ++ E++ G
Sbjct: 180 FMM--TPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 75/273 (27%), Positives = 111/273 (40%), Gaps = 36/273 (13%)
Query: 55  NKLGEGGFGPVYKGVLK----KGDEIAVKRLSG---RSGQGLREMKNEASVIAKVQHKNL 107
            KLG+G FG V +G       K   +AVK L        + + +   E + +  + H+NL
Sbjct: 18  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 77
Query: 108 VRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQY 167
           +RL G  +    K ++ E  P  SL   L       LL  ++R  +   +A+G+ YL   
Sbjct: 78  IRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLESK 134
Query: 168 SRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQ--ANTSRIVGTYGYMSPEYA 225
              R IHRDL A N+LL      KI DFG+ R    N+        R V  + + +PE  
Sbjct: 135 ---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV-PFAWCAPESL 190
Query: 226 LEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLW---TSNRTLELIDP 282
               FS  SD + FGV L E+ +                 Y  + W     ++ L  ID 
Sbjct: 191 KTRTFSHASDTWMFGVTLWEMFT-----------------YGQEPWIGLNGSQILHKIDK 233
Query: 283 ILEDEYSSKQMLLRYANIALLCVQESADDRPTM 315
             E     +       N+ + C     +DRPT 
Sbjct: 234 EGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTF 266

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 100/201 (49%), Gaps = 15/201 (7%)
Query: 55  NKLGEGGFGPVYKGVLKKGDE-IAVK--RLSGRSGQGLREMKNEASVIAKVQHKNLVRLL 111
           +KLGEG +  VYKG  K  D  +A+K  RL    G     ++ E S++  ++H N+V L 
Sbjct: 8   DKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIR-EVSLLKDLKHANIVTLH 66
Query: 112 GCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVR 171
                     L++EY+ +K L  +L D     +++       +  + +GL Y H   R +
Sbjct: 67  DIIHTEKSLTLVFEYL-DKDLKQYLDDCGN--IINMHNVKLFLFQLLRGLAYCH---RQK 120
Query: 172 IIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANT-SRIVGTYGYMSPEYALEGI- 229
           ++HRDLK  N+L+++    K++DFG+AR      +   T    V T  Y  P+  L    
Sbjct: 121 VLHRDLKPQNLLINERGELKLADFGLAR---AKSIPTKTYDNEVVTLWYRPPDILLGSTD 177
Query: 230 FSIKSDVFSFGVLLLEIVSGK 250
           +S + D++  G +  E+ +G+
Sbjct: 178 YSTQIDMWGVGCIFYEMATGR 198

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 67/226 (29%), Positives = 101/226 (44%), Gaps = 39/226 (17%)
Query: 43  SVSTATNKFSDANKLGEGGFGPV---YKGVLKKGDEIAVKRLSGRSGQGLREMKN---EA 96
           S  T   ++ +   +G G  G V   Y  VL +   +A+K+LS R  Q     K    E 
Sbjct: 18  STFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRN--VAIKKLS-RPFQNQTHAKRAYREL 74
Query: 97  SVIAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFF--------LFDP----TKRML 144
            ++  V HKN++ LL              + P K+L+ F        L D       +M 
Sbjct: 75  VLMKCVNHKNIISLLNV------------FTPQKTLEEFQDVYLVMELMDANLXQVIQME 122
Query: 145 LDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGN 204
           LD      ++  +  G+ +LH      IIHRDLK SNI++  D   KI DFG+AR  G +
Sbjct: 123 LDHERMSYLLYQMLXGIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLARTAGTS 179
Query: 205 ELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 250
            +   T  +V  Y Y +PE  L   +    D++S G ++ E+V  K
Sbjct: 180 FMM--TPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 66/225 (29%), Positives = 102/225 (45%), Gaps = 39/225 (17%)
Query: 43  SVSTATNKFSDANKLGEGGFGPV---YKGVLKKGDEIAVKRLSGRSGQGLREMKN---EA 96
           S  T   ++ +   +G G  G V   Y  +L++   +A+K+LS R  Q     K    E 
Sbjct: 18  STFTVLKRYQNLKPIGSGAQGIVCAAYDAILERN--VAIKKLS-RPFQNQTHAKRAYREL 74
Query: 97  SVIAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFF--------LFDP----TKRML 144
            ++  V HKN++ LL              + P KSL+ F        L D       +M 
Sbjct: 75  VLMKCVNHKNIIGLLNV------------FTPQKSLEEFQDVYIVMELMDANLSQVIQME 122
Query: 145 LDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGN 204
           LD      ++  +  G+ +LH      IIHRDLK SNI++  D   KI DFG+AR  G +
Sbjct: 123 LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLARTAGTS 179
Query: 205 ELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 249
            +   T  +V  Y Y +PE  L   +    D++S G ++ E++ G
Sbjct: 180 FMM--TPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 105/226 (46%), Gaps = 39/226 (17%)
Query: 43  SVSTATNKFSDANKLGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKN---EASV 98
           ++     ++ + + +G G +G V      K G  +AVK+LS R  Q +   K    E  +
Sbjct: 22  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRL 80
Query: 99  IAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSL----DFFLFDPTKRMLLDWVTRVQ-- 152
           +  ++H+N++ LL              + P +SL    D +L        L+ + + Q  
Sbjct: 81  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 128
Query: 153 -------IIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE 205
                  +I  I +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR      
Sbjct: 129 TDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDSELKILDFGLAR-----H 180
Query: 206 LQANTSRIVGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 250
                +  V T  Y +PE  L  + ++   D++S G ++ E+++G+
Sbjct: 181 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 105/226 (46%), Gaps = 39/226 (17%)
Query: 43  SVSTATNKFSDANKLGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKN---EASV 98
           ++     ++ + + +G G +G V      K G  +AVK+LS R  Q +   K    E  +
Sbjct: 18  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRL 76
Query: 99  IAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSL----DFFLFDPTKRMLLDWVTRVQ-- 152
           +  ++H+N++ LL              + P +SL    D +L        L+ + + Q  
Sbjct: 77  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 124
Query: 153 -------IIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE 205
                  +I  I +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR      
Sbjct: 125 TDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDSELKILDFGLAR-----H 176
Query: 206 LQANTSRIVGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 250
                +  V T  Y +PE  L  + ++   D++S G ++ E+++G+
Sbjct: 177 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 67/226 (29%), Positives = 101/226 (44%), Gaps = 39/226 (17%)
Query: 43  SVSTATNKFSDANKLGEGGFGPV---YKGVLKKGDEIAVKRLSGRSGQGLREMKN---EA 96
           S  T   ++ +   +G G  G V   Y  VL +   +A+K+LS R  Q     K    E 
Sbjct: 18  STFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRN--VAIKKLS-RPFQNQTHAKRAYREL 74
Query: 97  SVIAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFF--------LFDP----TKRML 144
            ++  V HKN++ LL              + P K+L+ F        L D       +M 
Sbjct: 75  VLMKXVNHKNIISLLNV------------FTPQKTLEEFQDVYLVMELMDANLXQVIQME 122
Query: 145 LDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGN 204
           LD      ++  +  G+ +LH      IIHRDLK SNI++  D   KI DFG+AR  G +
Sbjct: 123 LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLARTAGTS 179
Query: 205 ELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 250
            +   T  +V  Y Y +PE  L   +    D++S G ++ E+V  K
Sbjct: 180 FMM--TPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 66/225 (29%), Positives = 102/225 (45%), Gaps = 39/225 (17%)
Query: 43  SVSTATNKFSDANKLGEGGFGPV---YKGVLKKGDEIAVKRLSGRSGQGLREMKN---EA 96
           S  T   ++ +   +G G  G V   Y  +L++   +A+K+LS R  Q     K    E 
Sbjct: 19  STFTVLKRYQNLKPIGSGAQGIVCAAYDAILERN--VAIKKLS-RPFQNQTHAKRAYREL 75
Query: 97  SVIAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFF--------LFDP----TKRML 144
            ++  V HKN++ LL              + P KSL+ F        L D       +M 
Sbjct: 76  VLMKCVNHKNIIGLLNV------------FTPQKSLEEFQDVYIVMELMDANLCQVIQME 123
Query: 145 LDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGN 204
           LD      ++  +  G+ +LH      IIHRDLK SNI++  D   KI DFG+AR  G +
Sbjct: 124 LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 180
Query: 205 ELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 249
            +   T  +V  Y Y +PE  L   +    D++S G ++ E++ G
Sbjct: 181 FMM--TPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMIKG 222

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 67/226 (29%), Positives = 101/226 (44%), Gaps = 39/226 (17%)
Query: 43  SVSTATNKFSDANKLGEGGFGPV---YKGVLKKGDEIAVKRLSGRSGQGLREMKN---EA 96
           S  T   ++ +   +G G  G V   Y  VL +   +A+K+LS R  Q     K    E 
Sbjct: 18  STFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRN--VAIKKLS-RPFQNQTHAKRAYREL 74
Query: 97  SVIAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFF--------LFDP----TKRML 144
            ++  V HKN++ LL              + P K+L+ F        L D       +M 
Sbjct: 75  VLMKXVNHKNIISLLNV------------FTPQKTLEEFQDVYLVMELMDANLCQVIQME 122
Query: 145 LDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGN 204
           LD      ++  +  G+ +LH      IIHRDLK SNI++  D   KI DFG+AR  G +
Sbjct: 123 LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLARTAGTS 179
Query: 205 ELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 250
            +   T  +V  Y Y +PE  L   +    D++S G ++ E+V  K
Sbjct: 180 FMM--TPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 105/209 (50%), Gaps = 14/209 (6%)
Query: 47  ATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKR-LSGRSGQGLREMK-NEASVIAKVQ 103
           +  K+ +   +GEG +G V K   K  G  +A+K+ L     + ++++   E  ++ +++
Sbjct: 23  SMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLR 82
Query: 104 HKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLY 163
           H+NLV LL  C  +    L++E++ +  LD     P     LD+    + +  I  G+ +
Sbjct: 83  HENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNG---LDYQVVQKYLFQIINGIGF 139
Query: 164 LHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMAR-ICGGNELQANTSRIVGTYGYMSP 222
            H ++   IIHRD+K  NIL+ +    K+ DFG AR +    E+  +    V T  Y +P
Sbjct: 140 CHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDE---VATRWYRAP 193
Query: 223 EYALEGI-FSIKSDVFSFGVLLLEIVSGK 250
           E  +  + +    DV++ G L+ E+  G+
Sbjct: 194 ELLVGDVKYGKAVDVWAIGCLVTEMFMGE 222

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 96/201 (47%), Gaps = 18/201 (8%)
Query: 57  LGEGGFGPVYKGVLKKGDEIAVKRLSGRS----GQGLREMKNEASVIAKVQHKNLVRLLG 112
           LG+GGF   ++       E+   ++  +S         +M  E S+   + H+++V   G
Sbjct: 49  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108
Query: 113 CCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRI 172
              D D   ++ E    +SL        ++ L +   R  + + I  G  YLH   R R+
Sbjct: 109 FFEDNDFVFVVLELCRRRSL--LELHKRRKALTEPEARYYLRQ-IVLGCQYLH---RNRV 162
Query: 173 IHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR---IVGTYGYMSPEYALEGI 229
           IHRDLK  N+ L++D+  KI DFG+A      +++ +  R   + GT  Y++PE   +  
Sbjct: 163 IHRDLKLGNLFLNEDLEVKIGDFGLA-----TKVEYDGERKKVLCGTPNYIAPEVLSKKG 217
Query: 230 FSIKSDVFSFGVLLLEIVSGK 250
            S + DV+S G ++  ++ GK
Sbjct: 218 HSFEVDVWSIGCIMYTLLVGK 238

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 92/203 (45%), Gaps = 16/203 (7%)
Query: 55  NKLGEGGFGPVYKGVLK----KGDEIAVKRLSG---RSGQGLREMKNEASVIAKVQHKNL 107
            KLG+G FG V +G       K   +AVK L        + + +   E + +  + H+NL
Sbjct: 14  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 73
Query: 108 VRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQY 167
           +RL G  +    K ++ E  P  SL   L       LL  ++R  +   +A+G+ YL   
Sbjct: 74  IRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLESK 130
Query: 168 SRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQ--ANTSRIVGTYGYMSPEYA 225
              R IHRDL A N+LL      KI DFG+ R    N+        R V  + + +PE  
Sbjct: 131 ---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV-PFAWCAPESL 186
Query: 226 LEGIFSIKSDVFSFGVLLLEIVS 248
               FS  SD + FGV L E+ +
Sbjct: 187 KTRTFSHASDTWMFGVTLWEMFT 209

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 67/226 (29%), Positives = 101/226 (44%), Gaps = 39/226 (17%)
Query: 43  SVSTATNKFSDANKLGEGGFGPV---YKGVLKKGDEIAVKRLSGRSGQGLREMKN---EA 96
           S  T   ++ +   +G G  G V   Y  VL +   +A+K+LS R  Q     K    E 
Sbjct: 11  STFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRN--VAIKKLS-RPFQNQTHAKRAYREL 67
Query: 97  SVIAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFF--------LFDP----TKRML 144
            ++  V HKN++ LL              + P K+L+ F        L D       +M 
Sbjct: 68  VLMKCVNHKNIISLLNV------------FTPQKTLEEFQDVYLVMELMDANLXQVIQME 115
Query: 145 LDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGN 204
           LD      ++  +  G+ +LH      IIHRDLK SNI++  D   KI DFG+AR  G +
Sbjct: 116 LDHERMSYLLYQMLXGIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLARTAGTS 172
Query: 205 ELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 250
            +   T  +V  Y Y +PE  L   +    D++S G ++ E+V  K
Sbjct: 173 FMM--TPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 66/225 (29%), Positives = 106/225 (47%), Gaps = 33/225 (14%)
Query: 42  SSVSTATNK------FSDANKLGEGGFGPV--YKGVLKKGDEIAVKRL--SGRSGQGLRE 91
           +S+++AT++      +     +G+G F  V   + VL  G E+AVK +  +  +   L++
Sbjct: 2   NSITSATDEQPHIGNYRLQKTIGKGNFAKVKLARHVLT-GREVAVKIIDKTQLNPTSLQK 60
Query: 92  MKNEASVIAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRV 151
           +  E  ++  + H N+V+L           L+ EY     +  +L    +  + +   R 
Sbjct: 61  LFREVRIMKILNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGR--MKEKEARA 118
Query: 152 QIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMA-RICGGNELQANT 210
           +  + I   + Y HQ     I+HRDLKA N+LLD DMN KI+DFG +     GN+L    
Sbjct: 119 KFRQ-IVSAVQYCHQKY---IVHRDLKAENLLLDGDMNIKIADFGFSNEFTVGNKLDTFC 174
Query: 211 SRIVGTYGYMSPEYALEGIFSIKS------DVFSFGVLLLEIVSG 249
                     SP YA   +F  K       DV+S GV+L  +VSG
Sbjct: 175 G---------SPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSG 210

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 94/201 (46%), Gaps = 18/201 (8%)
Query: 57  LGEGGFGPVYKGVLKKGDEIAVKRLSGRS----GQGLREMKNEASVIAKVQHKNLVRLLG 112
           LG+GGF   ++       E+   ++  +S         +M  E S+   + H+++V   G
Sbjct: 23  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82
Query: 113 CCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRI 172
              D D   ++ E    +SL   L    +R  L        +  I  G  YLH   R R+
Sbjct: 83  FFEDNDFVFVVLELCRRRSL---LELHKRRKALTEPEARYYLRQIVLGCQYLH---RNRV 136
Query: 173 IHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR---IVGTYGYMSPEYALEGI 229
           IHRDLK  N+ L++D+  KI DFG+A      +++ +  R   + GT  Y++PE   +  
Sbjct: 137 IHRDLKLGNLFLNEDLEVKIGDFGLA-----TKVEYDGERKKVLCGTPNYIAPEVLSKKG 191
Query: 230 FSIKSDVFSFGVLLLEIVSGK 250
            S + DV+S G ++  ++ GK
Sbjct: 192 HSFEVDVWSIGCIMYTLLVGK 212

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 96/204 (47%), Gaps = 27/204 (13%)
Query: 57  LGEGGFGPV--YKGVLKKGDEIAVKRL--SGRSGQGLREMKNEASVIAKVQHKNLVRLLG 112
           +G+G F  V   + +L  G E+A+K +  +  +   L+++  E  ++  + H N+V+L  
Sbjct: 23  IGKGNFAKVKLARHILT-GREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFE 81
Query: 113 CCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRI 172
                    LI EY     +  +L    +    +  ++ + I    Q   Y HQ    RI
Sbjct: 82  VIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQ---YCHQK---RI 135
Query: 173 IHRDLKASNILLDKDMNPKISDFGMA-RICGGNELQANTSRIVGTYGYMSPEYALEGIFS 231
           +HRDLKA N+LLD DMN KI+DFG +     G +L A            +P YA   +F 
Sbjct: 136 VHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFCG---------APPYAAPELFQ 186
Query: 232 IKS------DVFSFGVLLLEIVSG 249
            K       DV+S GV+L  +VSG
Sbjct: 187 GKKYDGPEVDVWSLGVILYTLVSG 210

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 73/241 (30%), Positives = 106/241 (43%), Gaps = 40/241 (16%)
Query: 28  SKKKEVDQFPLFSFS-SVSTATNKFSDANKLGEGGFGPV---YKGVLKKGDEIAVKRLSG 83
           SK K  +QF     + S  T   ++     +G G  G V   +  VL  G  +AVK+LS 
Sbjct: 2   SKSKVDNQFYSVEVADSTFTVLKRYQQLKPIGSGAQGIVCAAFDTVL--GINVAVKKLS- 58
Query: 84  RSGQGLREMKN---EASVIAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFF----- 135
           R  Q     K    E  ++  V HKN++ LL              + P K+L+ F     
Sbjct: 59  RPFQNQTHAKRAYRELVLLKCVNHKNIISLLNV------------FTPQKTLEEFQDVYL 106
Query: 136 ---LFDP----TKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDM 188
              L D        M LD      ++  +  G+ +LH      IIHRDLK SNI++  D 
Sbjct: 107 VMELMDANLCQVIHMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDC 163
Query: 189 NPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 248
             KI DFG+AR    N +   T  +V  Y Y +PE  L   ++   D++S G ++ E+V 
Sbjct: 164 TLKILDFGLARTACTNFMM--TPYVVTRY-YRAPEVILGMGYAANVDIWSVGCIMGELVK 220
Query: 249 G 249
           G
Sbjct: 221 G 221

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 99/208 (47%), Gaps = 27/208 (12%)
Query: 60  GGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLL-----GCC 114
           G FG V+K  L   D +AVK    +  Q  +  + E      ++H+NL++ +     G  
Sbjct: 26  GRFGCVWKAQLMN-DFVAVKIFPLQDKQSWQS-EREIFSTPGMKHENLLQFIAAEKRGSN 83
Query: 115 IDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQ-------- 166
           ++  E  LI  +    SL  +L    K  ++ W     + E +++GL YLH+        
Sbjct: 84  LEV-ELWLITAFHDKGSLTDYL----KGNIITWNELCHVAETMSRGLSYLHEDVPWCRGE 138
Query: 167 YSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAL 226
             +  I HRD K+ N+LL  D+   ++DFG+A      +   +T   VGT  YM+PE  L
Sbjct: 139 GHKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPGDTHGQVGTRRYMAPE-VL 197
Query: 227 EGIFSIKSDVF------SFGVLLLEIVS 248
           EG  + + D F      + G++L E+VS
Sbjct: 198 EGAINFQRDAFLRIDMYAMGLVLWELVS 225

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 96/211 (45%), Gaps = 20/211 (9%)
Query: 48  TNKFSDANKLGEGGFGPVYKGV-LKKGDEIAV-----KRLSGRSGQGLREMKNEASVIAK 101
           T ++    +LG+G F  V + V +  G E A      K+LS R  Q L   + EA +   
Sbjct: 10  TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKL---EREARICRL 66
Query: 102 VQHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGL 161
           ++H N+VRL     +     LI++ +    L     D   R           I+ I + +
Sbjct: 67  LKHPNIVRLHDSISEEGHHYLIFDLVTGGEL---FEDIVAREYYSEADASHCIQQILEAV 123
Query: 162 LYLHQYSRVRIIHRDLKASNILLD---KDMNPKISDFGMARICGGNELQANTSRIVGTYG 218
           L+ HQ     ++HR+LK  N+LL    K    K++DFG+A    G   Q       GT G
Sbjct: 124 LHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGE--QQAWFGFAGTPG 178
Query: 219 YMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 249
           Y+SPE   +  +    D+++ GV+L  ++ G
Sbjct: 179 YLSPEVLRKDPYGKPVDLWACGVILYILLVG 209

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 95/214 (44%), Gaps = 13/214 (6%)
Query: 42  SSVSTATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRS----GQGLREMKNEAS 97
           +S S     F     +G G +  V    LKK D I   R+  +      + +  ++ E  
Sbjct: 45  ASSSLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKH 104
Query: 98  VIAKV-QHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEG 156
           V  +   H  LV L  C         + EY+    L F +    +R L +   R    E 
Sbjct: 105 VFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHM--QRQRKLPEEHARFYSAE- 161
Query: 157 IAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 216
           I+  L YLH+     II+RDLK  N+LLD + + K++D+GM +   G      TS   GT
Sbjct: 162 ISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSTFCGT 216
Query: 217 YGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 250
             Y++PE      +    D ++ GVL+ E+++G+
Sbjct: 217 PNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR 250

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 73/247 (29%), Positives = 108/247 (43%), Gaps = 40/247 (16%)
Query: 23  KQAKRSKKKEVDQFPLFSFS-SVSTATNKFSDANKLGEGGFGPV---YKGVLKKGDEIAV 78
           K    SK K  +QF       S  T   ++ +   +G G  G V   Y  VL +   +A+
Sbjct: 35  KHYNMSKSKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRN--VAI 92
Query: 79  KRLSGRSGQGLREMKN---EASVIAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFF 135
           K+LS R  Q     K    E  ++  V HKN++ LL              + P K+L+ F
Sbjct: 93  KKLS-RPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV------------FTPQKTLEEF 139
Query: 136 --------LFDP----TKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNIL 183
                   L D       +M LD      ++  +  G+ +LH      IIHRDLK SNI+
Sbjct: 140 QDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIV 196
Query: 184 LDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLL 243
           +  D   KI DFG+AR  G + +   T  +V  Y Y +PE  L   +    D++S G ++
Sbjct: 197 VKSDCTLKILDFGLARTAGTSFMM--TPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIM 253
Query: 244 LEIVSGK 250
            E+V  K
Sbjct: 254 GEMVRHK 260

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 109/211 (51%), Gaps = 20/211 (9%)
Query: 49  NKFSDANKLGEGGFGPVYKGVLKKGDEI-AVKRL------SGRSGQGLREMKNEASVIAK 101
            K+    K+GEG +G V+K   ++  EI A+KR+       G     LRE+     ++ +
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREI----CLLKE 57
Query: 102 VQHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGL 161
           ++HKN+VRL        +  L++E+  ++ L  + FD     L   + +  + + + +GL
Sbjct: 58  LKHKNIVRLHDVLHSDKKLTLVFEFC-DQDLKKY-FDSCNGDLDPEIVKSFLFQ-LLKGL 114
Query: 162 LYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMS 221
            + H  +   ++HRDLK  N+L++++   K++DFG+AR   G  ++  ++ +V T  Y  
Sbjct: 115 GFCHSRN---VLHRDLKPQNLLINRNGELKLADFGLAR-AFGIPVRCYSAEVV-TLWYRP 169
Query: 222 PEYALEG-IFSIKSDVFSFGVLLLEIVSGKK 251
           P+      ++S   D++S G +  E+ +  +
Sbjct: 170 PDVLFGAKLYSTSIDMWSAGCIFAELANAAR 200

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 96/204 (47%), Gaps = 27/204 (13%)
Query: 57  LGEGGFGPV--YKGVLKKGDEIAVKRL--SGRSGQGLREMKNEASVIAKVQHKNLVRLLG 112
           +G+G F  V   + +L  G E+AV+ +  +  +   L+++  E  ++  + H N+V+L  
Sbjct: 22  IGKGNFAKVKLARHILT-GKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFE 80
Query: 113 CCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRI 172
                    L+ EY     +  +L    +  + +   R +  + I   + Y HQ     I
Sbjct: 81  VIETEKTLYLVMEYASGGEVFDYLVAHGR--MKEKEARAKFRQ-IVSAVQYCHQKF---I 134
Query: 173 IHRDLKASNILLDKDMNPKISDFGMA-RICGGNELQANTSRIVGTYGYMSPEYALEGIFS 231
           +HRDLKA N+LLD DMN KI+DFG +     GN+L              SP YA   +F 
Sbjct: 135 VHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCG---------SPPYAAPELFQ 185
Query: 232 IKS------DVFSFGVLLLEIVSG 249
            K       DV+S GV+L  +VSG
Sbjct: 186 GKKYDGPEVDVWSLGVILYTLVSG 209

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 105/226 (46%), Gaps = 39/226 (17%)
Query: 43  SVSTATNKFSDANKLGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKN---EASV 98
           ++     ++ + + +G G +G V      K G  +AVK+LS R  Q +   K    E  +
Sbjct: 16  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRL 74
Query: 99  IAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSL----DFFLFDPTKRMLLDWVTRVQ-- 152
           +  ++H+N++ LL              + P +SL    D +L        L+ + + Q  
Sbjct: 75  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 122
Query: 153 -------IIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE 205
                  +I  I +GL Y+H      IIHRDLK SN+ +++D   KI D+G+AR      
Sbjct: 123 TDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDYGLAR-----H 174
Query: 206 LQANTSRIVGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 250
                +  V T  Y +PE  L  + ++   D++S G ++ E+++G+
Sbjct: 175 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 67/226 (29%), Positives = 101/226 (44%), Gaps = 39/226 (17%)
Query: 43  SVSTATNKFSDANKLGEGGFGPV---YKGVLKKGDEIAVKRLSGRSGQGLREMKN---EA 96
           S  T   ++ +   +G G  G V   Y  VL +   +A+K+LS R  Q     K    E 
Sbjct: 18  STFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRN--VAIKKLS-RPFQNQTHAKRAYREL 74
Query: 97  SVIAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFF--------LFDP----TKRML 144
            ++  V HKN++ LL              + P K+L+ F        L D       +M 
Sbjct: 75  VLMKCVNHKNIISLLNV------------FTPQKTLEEFQDVYLVMELMDANLCQVIQME 122
Query: 145 LDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGN 204
           LD      ++  +  G+ +LH      IIHRDLK SNI++  D   KI DFG+AR  G +
Sbjct: 123 LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 179
Query: 205 ELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 250
            +   T  +V  Y Y +PE  L   +    D++S G ++ E+V  K
Sbjct: 180 FMM--TPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 67/226 (29%), Positives = 101/226 (44%), Gaps = 39/226 (17%)
Query: 43  SVSTATNKFSDANKLGEGGFGPV---YKGVLKKGDEIAVKRLSGRSGQGLREMKN---EA 96
           S  T   ++ +   +G G  G V   Y  VL +   +A+K+LS R  Q     K    E 
Sbjct: 19  STFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRN--VAIKKLS-RPFQNQTHAKRAYREL 75
Query: 97  SVIAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFF--------LFDP----TKRML 144
            ++  V HKN++ LL              + P K+L+ F        L D       +M 
Sbjct: 76  VLMKCVNHKNIISLLNV------------FTPQKTLEEFQDVYLVMELMDANLCQVIQME 123
Query: 145 LDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGN 204
           LD      ++  +  G+ +LH      IIHRDLK SNI++  D   KI DFG+AR  G +
Sbjct: 124 LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 180
Query: 205 ELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 250
            +   T  +V  Y Y +PE  L   +    D++S G ++ E+V  K
Sbjct: 181 FMM--TPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 223

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 67/226 (29%), Positives = 101/226 (44%), Gaps = 39/226 (17%)
Query: 43  SVSTATNKFSDANKLGEGGFGPV---YKGVLKKGDEIAVKRLSGRSGQGLREMKN---EA 96
           S  T   ++ +   +G G  G V   Y  VL +   +A+K+LS R  Q     K    E 
Sbjct: 19  STFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRN--VAIKKLS-RPFQNQTHAKRAYREL 75
Query: 97  SVIAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFF--------LFDP----TKRML 144
            ++  V HKN++ LL              + P K+L+ F        L D       +M 
Sbjct: 76  VLMKCVNHKNIISLLNV------------FTPQKTLEEFQDVYLVMELMDANLCQVIQME 123
Query: 145 LDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGN 204
           LD      ++  +  G+ +LH      IIHRDLK SNI++  D   KI DFG+AR  G +
Sbjct: 124 LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 180
Query: 205 ELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 250
            +   T  +V  Y Y +PE  L   +    D++S G ++ E+V  K
Sbjct: 181 FMM--TPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 223

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 74/249 (29%), Positives = 110/249 (44%), Gaps = 44/249 (17%)
Query: 23  KQAKRSKKKEVDQFPLFSFS---SVSTATNKFSDANKLGEGGFGPV---YKGVLKKGDEI 76
           K    SK K  +QF  +S     S  T   ++ +   +G G  G V   Y  VL +   +
Sbjct: 35  KHYNMSKSKVDNQF--YSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRN--V 90
Query: 77  AVKRLSGRSGQGLREMKN---EASVIAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSLD 133
           A+K+LS R  Q     K    E  ++  V HKN++ LL              + P K+L+
Sbjct: 91  AIKKLS-RPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV------------FTPQKTLE 137
Query: 134 FF--------LFDP----TKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASN 181
            F        L D       +M LD      ++  +  G+ +LH      IIHRDLK SN
Sbjct: 138 EFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSN 194
Query: 182 ILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGV 241
           I++  D   KI DFG+AR  G + +   T  +V  Y Y +PE  L   +    D++S G 
Sbjct: 195 IVVKSDCTLKILDFGLARTAGTSFMM--TPYVVTRY-YRAPEVILGMGYKENVDIWSVGC 251
Query: 242 LLLEIVSGK 250
           ++ E+V  K
Sbjct: 252 IMGEMVRHK 260

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 67/226 (29%), Positives = 101/226 (44%), Gaps = 39/226 (17%)
Query: 43  SVSTATNKFSDANKLGEGGFGPV---YKGVLKKGDEIAVKRLSGRSGQGLREMKN---EA 96
           S  T   ++ +   +G G  G V   Y  VL +   +A+K+LS R  Q     K    E 
Sbjct: 17  STFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRN--VAIKKLS-RPFQNQTHAKRAYREL 73
Query: 97  SVIAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFF--------LFDP----TKRML 144
            ++  V HKN++ LL              + P K+L+ F        L D       +M 
Sbjct: 74  VLMKCVNHKNIISLLNV------------FTPQKTLEEFQDVYLVMELMDANLCQVIQME 121
Query: 145 LDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGN 204
           LD      ++  +  G+ +LH      IIHRDLK SNI++  D   KI DFG+AR  G +
Sbjct: 122 LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 178
Query: 205 ELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 250
            +   T  +V  Y Y +PE  L   +    D++S G ++ E+V  K
Sbjct: 179 FMM--TPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 221

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 95/214 (44%), Gaps = 13/214 (6%)
Query: 42  SSVSTATNKFSDANKLGEGGFGPVYKGVLKKGDEI----AVKRLSGRSGQGLREMKNEAS 97
           +S S     F     +G G +  V    LKK D I     VK+      + +  ++ E  
Sbjct: 13  ASSSLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKH 72
Query: 98  VIAKV-QHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEG 156
           V  +   H  LV L  C         + EY+    L F +    +R L +   R    E 
Sbjct: 73  VFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHM--QRQRKLPEEHARFYSAE- 129
Query: 157 IAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 216
           I+  L YLH+     II+RDLK  N+LLD + + K++D+GM +   G      TS   GT
Sbjct: 130 ISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSXFCGT 184
Query: 217 YGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 250
             Y++PE      +    D ++ GVL+ E+++G+
Sbjct: 185 PNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR 218

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 67/226 (29%), Positives = 101/226 (44%), Gaps = 39/226 (17%)
Query: 43  SVSTATNKFSDANKLGEGGFGPV---YKGVLKKGDEIAVKRLSGRSGQGLREMKN---EA 96
           S  T   ++ +   +G G  G V   Y  VL +   +A+K+LS R  Q     K    E 
Sbjct: 12  STFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRN--VAIKKLS-RPFQNQTHAKRAYREL 68
Query: 97  SVIAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFF--------LFDP----TKRML 144
            ++  V HKN++ LL              + P K+L+ F        L D       +M 
Sbjct: 69  VLMKCVNHKNIISLLNV------------FTPQKTLEEFQDVYLVMELMDANLCQVIQME 116
Query: 145 LDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGN 204
           LD      ++  +  G+ +LH      IIHRDLK SNI++  D   KI DFG+AR  G +
Sbjct: 117 LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 173
Query: 205 ELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 250
            +   T  +V  Y Y +PE  L   +    D++S G ++ E+V  K
Sbjct: 174 FMM--TPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 216

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 67/226 (29%), Positives = 101/226 (44%), Gaps = 39/226 (17%)
Query: 43  SVSTATNKFSDANKLGEGGFGPV---YKGVLKKGDEIAVKRLSGRSGQGLREMKN---EA 96
           S  T   ++ +   +G G  G V   Y  VL +   +A+K+LS R  Q     K    E 
Sbjct: 18  STFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRN--VAIKKLS-RPFQNQTHAKRAYREL 74
Query: 97  SVIAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFF--------LFDP----TKRML 144
            ++  V HKN++ LL              + P K+L+ F        L D       +M 
Sbjct: 75  VLMKCVNHKNIISLLNV------------FTPQKTLEEFQDVYLVMELMDANLCQVIQME 122
Query: 145 LDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGN 204
           LD      ++  +  G+ +LH      IIHRDLK SNI++  D   KI DFG+AR  G +
Sbjct: 123 LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 179
Query: 205 ELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 250
            +   T  +V  Y Y +PE  L   +    D++S G ++ E+V  K
Sbjct: 180 FMM--TPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 67/226 (29%), Positives = 101/226 (44%), Gaps = 39/226 (17%)
Query: 43  SVSTATNKFSDANKLGEGGFGPV---YKGVLKKGDEIAVKRLSGRSGQGLREMKN---EA 96
           S  T   ++ +   +G G  G V   Y  VL +   +A+K+LS R  Q     K    E 
Sbjct: 11  STFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRN--VAIKKLS-RPFQNQTHAKRAYREL 67
Query: 97  SVIAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFF--------LFDP----TKRML 144
            ++  V HKN++ LL              + P K+L+ F        L D       +M 
Sbjct: 68  VLMKCVNHKNIISLLNV------------FTPQKTLEEFQDVYLVMELMDANLCQVIQME 115
Query: 145 LDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGN 204
           LD      ++  +  G+ +LH      IIHRDLK SNI++  D   KI DFG+AR  G +
Sbjct: 116 LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 172
Query: 205 ELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 250
            +   T  +V  Y Y +PE  L   +    D++S G ++ E+V  K
Sbjct: 173 FMM--TPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 67/226 (29%), Positives = 101/226 (44%), Gaps = 39/226 (17%)
Query: 43  SVSTATNKFSDANKLGEGGFGPV---YKGVLKKGDEIAVKRLSGRSGQGLREMKN---EA 96
           S  T   ++ +   +G G  G V   Y  VL +   +A+K+LS R  Q     K    E 
Sbjct: 12  STFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRN--VAIKKLS-RPFQNQTHAKRAYREL 68
Query: 97  SVIAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFF--------LFDP----TKRML 144
            ++  V HKN++ LL              + P K+L+ F        L D       +M 
Sbjct: 69  VLMKCVNHKNIISLLNV------------FTPQKTLEEFQDVYLVMELMDANLCQVIQME 116
Query: 145 LDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGN 204
           LD      ++  +  G+ +LH      IIHRDLK SNI++  D   KI DFG+AR  G +
Sbjct: 117 LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 173
Query: 205 ELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 250
            +   T  +V  Y Y +PE  L   +    D++S G ++ E+V  K
Sbjct: 174 FMM--TPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 216

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 67/226 (29%), Positives = 102/226 (45%), Gaps = 39/226 (17%)
Query: 43  SVSTATNKFSDANKLGEGGFGPV---YKGVLKKGDEIAVKRLSGRSGQGLREMKN---EA 96
           S  T   ++ +   +G G  G V   Y  +L++   +A+K+LS R  Q     K    E 
Sbjct: 12  STFTVLKRYQNLKPIGSGAQGIVCAAYDAILERN--VAIKKLS-RPFQNQTHAKRAYREL 68
Query: 97  SVIAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFF--------LFDP----TKRML 144
            ++  V HKN++ LL              + P KSL+ F        L D       +M 
Sbjct: 69  VLMKCVNHKNIIGLLNV------------FTPQKSLEEFQDVYIVMELMDANLCQVIQME 116
Query: 145 LDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGN 204
           LD      ++  +  G+ +LH      IIHRDLK SNI++  D   KI DFG+AR  G +
Sbjct: 117 LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 173
Query: 205 ELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 250
            +   T  +V  Y Y +PE  L   +    D++S G ++ E+V  K
Sbjct: 174 FMM--TPYVVTRY-YRAPEVILGMGYKENVDLWSVGCIMGEMVCHK 216

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 95/204 (46%), Gaps = 27/204 (13%)
Query: 57  LGEGGFGPV--YKGVLKKGDEIAVKRL--SGRSGQGLREMKNEASVIAKVQHKNLVRLLG 112
           +G+G F  V   + +L  G E+A+K +  +  +   L+++  E  ++  + H N+V+L  
Sbjct: 20  IGKGNFAKVKLARHILT-GREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFE 78
Query: 113 CCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRI 172
                    LI EY     +  +L    +    +  ++ + I    Q   Y HQ    RI
Sbjct: 79  VIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQ---YCHQK---RI 132
Query: 173 IHRDLKASNILLDKDMNPKISDFGMA-RICGGNELQANTSRIVGTYGYMSPEYALEGIFS 231
           +HRDLKA N+LLD DMN KI+DFG +     G +L              SP YA   +F 
Sbjct: 133 VHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDTFCG---------SPPYAAPELFQ 183
Query: 232 IKS------DVFSFGVLLLEIVSG 249
            K       DV+S GV+L  +VSG
Sbjct: 184 GKKYDGPEVDVWSLGVILYTLVSG 207

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 96/204 (47%), Gaps = 27/204 (13%)
Query: 57  LGEGGFGPV--YKGVLKKGDEIAVKRL--SGRSGQGLREMKNEASVIAKVQHKNLVRLLG 112
           +G+G F  V   + +L  G E+AV+ +  +  +   L+++  E  ++  + H N+V+L  
Sbjct: 22  IGKGNFAKVKLARHILT-GKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFE 80
Query: 113 CCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRI 172
                    L+ EY     +  +L    +  + +   R +  + I   + Y HQ     I
Sbjct: 81  VIETEKTLYLVMEYASGGEVFDYLVAHGR--MKEKEARAKFRQ-IVSAVQYCHQKF---I 134
Query: 173 IHRDLKASNILLDKDMNPKISDFGMA-RICGGNELQANTSRIVGTYGYMSPEYALEGIFS 231
           +HRDLKA N+LLD DMN KI+DFG +     GN+L              SP YA   +F 
Sbjct: 135 VHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDEFCG---------SPPYAAPELFQ 185
Query: 232 IKS------DVFSFGVLLLEIVSG 249
            K       DV+S GV+L  +VSG
Sbjct: 186 GKKYDGPEVDVWSLGVILYTLVSG 209

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 100/212 (47%), Gaps = 29/212 (13%)
Query: 56  KLGEGGFGPVYKGVLKKGD-EIAVKRLS------GRSGQGLR-------EMKNEASVIAK 101
           KLG G +G V     K G  E A+K +       GR     +       E+ NE S++  
Sbjct: 43  KLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKS 102
Query: 102 VQHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPT-KRMLLDWVTRVQIIEGIAQG 160
           + H N+++L     D+    L+ E+     L    F+    R   D      I++ I  G
Sbjct: 103 LDHPNIIKLFDVFEDKKYFYLVTEFYEGGEL----FEQIINRHKFDECDAANIMKQILSG 158
Query: 161 LLYLHQYSRVRIIHRDLKASNILLDKD---MNPKISDFGMARICGGNELQANTSRIVGTY 217
           + YLH+++   I+HRD+K  NILL+     +N KI DFG++     +         +GT 
Sbjct: 159 ICYLHKHN---IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKD---YKLRDRLGTA 212
Query: 218 GYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 249
            Y++PE  L+  ++ K DV+S GV++  ++ G
Sbjct: 213 YYIAPE-VLKKKYNEKCDVWSCGVIMYILLCG 243

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 55/168 (32%), Positives = 94/168 (55%), Gaps = 16/168 (9%)
Query: 89  LREMKNEASVIAKVQHKNLVRLLGCCIDRDEKIL--IYEYMPNKSLDFFLFDPTKRMLLD 146
           + ++  E +++ K+ H N+V+L+    D +E  L  ++E +    +   +  PT + L +
Sbjct: 80  IEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPV---MEVPTLKPLSE 136
Query: 147 WVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMA-RICGGNE 205
              R    + + +G+ YLH     +IIHRD+K SN+L+ +D + KI+DFG++    G + 
Sbjct: 137 DQARF-YFQDLIKGIEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDA 192
Query: 206 LQANTSRIVGTYGYMSPEYALE--GIFSIKS-DVFSFGVLLLEIVSGK 250
           L +NT   VGT  +M+PE   E   IFS K+ DV++ GV L   V G+
Sbjct: 193 LLSNT---VGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 67/226 (29%), Positives = 102/226 (45%), Gaps = 39/226 (17%)
Query: 43  SVSTATNKFSDANKLGEGGFGPV---YKGVLKKGDEIAVKRLSGRSGQGLREMKN---EA 96
           S  T   ++ +   +G G  G V   Y  +L++   +A+K+LS R  Q     K    E 
Sbjct: 23  STFTVLKRYQNLKPIGSGAQGIVCAAYDAILERN--VAIKKLS-RPFQNQTHAKRAYREL 79
Query: 97  SVIAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFF--------LFDP----TKRML 144
            ++  V HKN++ LL              + P KSL+ F        L D       +M 
Sbjct: 80  VLMKCVNHKNIIGLLNV------------FTPQKSLEEFQDVYIVMELMDANLCQVIQME 127
Query: 145 LDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGN 204
           LD      ++  +  G+ +LH      IIHRDLK SNI++  D   KI DFG+AR  G +
Sbjct: 128 LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 184
Query: 205 ELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 250
            +   T  +V  Y Y +PE  L   +    D++S G ++ E+V  K
Sbjct: 185 FMM--TPYVVTRY-YRAPEVILGMGYKENVDLWSVGCIMGEMVCHK 227

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 111/227 (48%), Gaps = 34/227 (14%)
Query: 50  KFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRL--SGRSGQGLREMKNEASVIAKVQ-HK 105
           K+    KLG+G +G V+K + ++ G+ +AVK++  + ++    +    E  ++ ++  H+
Sbjct: 10  KYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHE 69
Query: 106 NLVRLLGCC-IDRDEKI-LIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLY 163
           N+V LL     D D  + L+++YM        L    +  +L+ V +  ++  + + + Y
Sbjct: 70  NIVNLLNVLRADNDRDVYLVFDYMETD-----LHAVIRANILEPVHKQYVVYQLIKVIKY 124
Query: 164 LHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMA-------RICGGNELQANT------ 210
           LH      ++HRD+K SNILL+ + + K++DFG++       R+     L  N       
Sbjct: 125 LHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFD 181
Query: 211 ------SRIVGTYGYMSPEYALEGIFSIKS-DVFSFGVLLLEIVSGK 250
                 +  V T  Y +PE  L      K  D++S G +L EI+ GK
Sbjct: 182 DDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 105/226 (46%), Gaps = 39/226 (17%)
Query: 43  SVSTATNKFSDANKLGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKN---EASV 98
           ++     ++ + + +G G +G V      K G  +AVK+LS +  Q +   K    E  +
Sbjct: 28  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-KPFQSIIHAKRTYRELRL 86
Query: 99  IAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSL----DFFLFDPTKRMLLDWVTRVQ-- 152
           +  ++H+N++ LL              + P +SL    D +L        L+ + + Q  
Sbjct: 87  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 134
Query: 153 -------IIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE 205
                  +I  I +GL Y+H      IIHRDLK SN+ +++D   KI DFG+AR      
Sbjct: 135 TDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----H 186
Query: 206 LQANTSRIVGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 250
                +  V T  Y +PE  L  + ++   D++S G ++ E+++G+
Sbjct: 187 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 65/209 (31%), Positives = 97/209 (46%), Gaps = 19/209 (9%)
Query: 53  DANKLGEGGFGPVYKGVLKKGDEI-AVKRLSGRSGQGLREMKN---EASVIAKVQH-KNL 107
           D  ++G G +G V K V K   +I AVKR+  RS    +E K    +  V+ +      +
Sbjct: 26  DLGEIGRGAYGSVNKMVHKPSGQIMAVKRI--RSTVDEKEQKQLLMDLDVVMRSSDCPYI 83
Query: 108 VRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYL--H 165
           V+  G      +  +  E M   S  F  F      +LD V   +I+  I    +    H
Sbjct: 84  VQFYGALFREGDCWICMELM---STSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNH 140
Query: 166 QYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY- 224
               ++IIHRD+K SNILLD+  N K+ DFG   I G        +R  G   YM+PE  
Sbjct: 141 LKENLKIIHRDIKPSNILLDRSGNIKLCDFG---ISGQLVDSIAKTRDAGCRPYMAPERI 197
Query: 225 ---ALEGIFSIKSDVFSFGVLLLEIVSGK 250
              A    + ++SDV+S G+ L E+ +G+
Sbjct: 198 DPSASRQGYDVRSDVWSLGITLYELATGR 226

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 64/232 (27%), Positives = 115/232 (49%), Gaps = 29/232 (12%)
Query: 50  KFSDANKLGEGGFGPV---YKGVLKKGDEIAVKRLSGRSGQG-----LREMKNEASVIAK 101
           ++++ + +GEG +G V   Y  V K    +A+K++S    Q      LRE+K    ++ +
Sbjct: 24  RYTNLSYIGEGAYGMVCSAYDNVNKV--RVAIKKISPFEHQTYCQRTLREIK----ILLR 77
Query: 102 VQHKNLVRL----LGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGI 157
            +H+N++ +        I++ + + I + +     D +    T+ +  D +     +  I
Sbjct: 78  FRHENIIGINDIIRAPTIEQMKDVYIVQDL--METDLYKLLKTQHLSNDHI--CYFLYQI 133
Query: 158 AQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQAN-TSRIVGT 216
            +GL Y+H      ++HRDLK SN+LL+   + KI DFG+AR+   +       +  V T
Sbjct: 134 LRGLKYIHS---ANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVAT 190
Query: 217 YGYMSPEYALEGIFSIKS-DVFSFGVLLLEIVSGKK-NTGLYRTDSLN-LLG 265
             Y +PE  L      KS D++S G +L E++S +    G +  D LN +LG
Sbjct: 191 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILG 242

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 103/208 (49%), Gaps = 25/208 (12%)
Query: 57  LGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQG-LREMKNEASVIAKVQHKNLVRLLGCCI 115
           +G+G +G V++G L  G+ +AVK  S R  Q   RE +   +V+  ++H N++  +   +
Sbjct: 16  VGKGRYGEVWRG-LWHGESVAVKIFSSRDEQSWFRETEIYNTVL--LRHDNILGFIASDM 72
Query: 116 ----DRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLH-----Q 166
                  +  LI  Y  + SL  FL    +R  L+    +++    A GL +LH      
Sbjct: 73  TSRNSSTQLWLITHYHEHGSLYDFL----QRQTLEPHLALRLAVSAACGLAHLHVEIFGT 128
Query: 167 YSRVRIIHRDLKASNILLDKDMNPKISDFGMARIC--GGNELQANTSRIVGTYGYMSPEY 224
             +  I HRD K+ N+L+  ++   I+D G+A +   G + L    +  VGT  YM+PE 
Sbjct: 129 QGKPAIAHRDFKSRNVLVKSNLQCCIADLGLAVMHSQGSDYLDIGNNPRVGTKRYMAPEV 188
Query: 225 ALEGIFS------IKSDVFSFGVLLLEI 246
             E I +        +D+++FG++L EI
Sbjct: 189 LDEQIRTDCFESYKWTDIWAFGLVLWEI 216

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 64/232 (27%), Positives = 115/232 (49%), Gaps = 29/232 (12%)
Query: 50  KFSDANKLGEGGFGPV---YKGVLKKGDEIAVKRLSGRSGQG-----LREMKNEASVIAK 101
           ++++ + +GEG +G V   Y  V K    +A+K++S    Q      LRE+K    ++ +
Sbjct: 24  RYTNLSYIGEGAYGMVCSAYDNVNKV--RVAIKKISPFEHQTYCQRTLREIK----ILLR 77
Query: 102 VQHKNLVRL----LGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGI 157
            +H+N++ +        I++ + + I + +     D +    T+ +  D +     +  I
Sbjct: 78  FRHENIIGINDIIRAPTIEQMKDVYIVQDL--METDLYKLLKTQHLSNDHI--CYFLYQI 133
Query: 158 AQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQAN-TSRIVGT 216
            +GL Y+H      ++HRDLK SN+LL+   + KI DFG+AR+   +       +  V T
Sbjct: 134 LRGLKYIHS---ANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVAT 190
Query: 217 YGYMSPEYALEGIFSIKS-DVFSFGVLLLEIVSGKK-NTGLYRTDSLN-LLG 265
             Y +PE  L      KS D++S G +L E++S +    G +  D LN +LG
Sbjct: 191 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILG 242

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 64/232 (27%), Positives = 115/232 (49%), Gaps = 29/232 (12%)
Query: 50  KFSDANKLGEGGFGPV---YKGVLKKGDEIAVKRLSGRSGQG-----LREMKNEASVIAK 101
           ++++ + +GEG +G V   Y  V K    +A+K++S    Q      LRE+K    ++ +
Sbjct: 24  RYTNLSYIGEGAYGMVCSAYDNVNKV--RVAIKKISPFEHQTYCQRTLREIK----ILLR 77
Query: 102 VQHKNLVRL----LGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGI 157
            +H+N++ +        I++ + + I + +     D +    T+ +  D +     +  I
Sbjct: 78  FRHENIIGINDIIRAPTIEQMKDVYIVQDL--METDLYKLLKTQHLSNDHI--CYFLYQI 133
Query: 158 AQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQAN-TSRIVGT 216
            +GL Y+H      ++HRDLK SN+LL+   + KI DFG+AR+   +       +  V T
Sbjct: 134 LRGLKYIHS---ANVLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYVAT 190
Query: 217 YGYMSPEYALEGIFSIKS-DVFSFGVLLLEIVSGKK-NTGLYRTDSLN-LLG 265
             Y +PE  L      KS D++S G +L E++S +    G +  D LN +LG
Sbjct: 191 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILG 242

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 104/226 (46%), Gaps = 39/226 (17%)
Query: 43  SVSTATNKFSDANKLGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKN---EASV 98
           ++     ++ + + +G G +G V      K G  +AVK+LS R  Q +   K    E  +
Sbjct: 16  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLS-RPFQSIIHAKRTYRELRL 74
Query: 99  IAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSL----DFFLFDPTKRMLLDWVTRVQ-- 152
           +  ++H+N++ LL              + P +SL    D +L        L+ + + Q  
Sbjct: 75  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 122
Query: 153 -------IIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE 205
                  +I  I +GL Y+H      IIHRDLK SN+ +++D   KI DF +AR      
Sbjct: 123 TDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFYLAR-----H 174
Query: 206 LQANTSRIVGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 250
                +  V T  Y +PE  L  + ++   D++S G ++ E+++G+
Sbjct: 175 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 96/201 (47%), Gaps = 18/201 (8%)
Query: 57  LGEGGFGPVYKGVLKKGDEIAVKRLSGRS----GQGLREMKNEASVIAKVQHKNLVRLLG 112
           LG+GGF   Y+       E+   ++  +S         +M  E ++   + + ++V   G
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHG 109
Query: 113 CCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRI 172
              D D   ++ E    +SL        ++ + +   R  + + I QG+ YLH     R+
Sbjct: 110 FFEDDDFVYVVLEICRRRSL--LELHKRRKAVTEPEARYFMRQTI-QGVQYLHNN---RV 163
Query: 173 IHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR---IVGTYGYMSPEYALEGI 229
           IHRDLK  N+ L+ DM+ KI DFG+A      +++ +  R   + GT  Y++PE   +  
Sbjct: 164 IHRDLKLGNLFLNDDMDVKIGDFGLA-----TKIEFDGERKKTLCGTPNYIAPEVLCKKG 218
Query: 230 FSIKSDVFSFGVLLLEIVSGK 250
            S + D++S G +L  ++ GK
Sbjct: 219 HSFEVDIWSLGCILYTLLVGK 239

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 64/232 (27%), Positives = 115/232 (49%), Gaps = 29/232 (12%)
Query: 50  KFSDANKLGEGGFGPV---YKGVLKKGDEIAVKRLSGRSGQG-----LREMKNEASVIAK 101
           ++++ + +GEG +G V   Y  V K    +A+K++S    Q      LRE+K    ++ +
Sbjct: 26  RYTNLSYIGEGAYGMVCSAYDNVNKV--RVAIKKISPFEHQTYCQRTLREIK----ILLR 79
Query: 102 VQHKNLVRL----LGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGI 157
            +H+N++ +        I++ + + I + +     D +    T+ +  D +     +  I
Sbjct: 80  FRHENIIGINDIIRAPTIEQMKDVYIVQDL--METDLYKLLKTQHLSNDHI--CYFLYQI 135
Query: 158 AQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQAN-TSRIVGT 216
            +GL Y+H      ++HRDLK SN+LL+   + KI DFG+AR+   +       +  V T
Sbjct: 136 LRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 192
Query: 217 YGYMSPEYALEGIFSIKS-DVFSFGVLLLEIVSGKK-NTGLYRTDSLN-LLG 265
             Y +PE  L      KS D++S G +L E++S +    G +  D LN +LG
Sbjct: 193 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILG 244

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 96/201 (47%), Gaps = 18/201 (8%)
Query: 57  LGEGGFGPVYKGVLKKGDEIAVKRLSGRS----GQGLREMKNEASVIAKVQHKNLVRLLG 112
           LG+GGF   Y+       E+   ++  +S         +M  E ++   + + ++V   G
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHG 109
Query: 113 CCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRI 172
              D D   ++ E    +SL        ++ + +   R  + + I QG+ YLH     R+
Sbjct: 110 FFEDDDFVYVVLEICRRRSL--LELHKRRKAVTEPEARYFMRQTI-QGVQYLHNN---RV 163
Query: 173 IHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR---IVGTYGYMSPEYALEGI 229
           IHRDLK  N+ L+ DM+ KI DFG+A      +++ +  R   + GT  Y++PE   +  
Sbjct: 164 IHRDLKLGNLFLNDDMDVKIGDFGLA-----TKIEFDGERKKDLCGTPNYIAPEVLCKKG 218
Query: 230 FSIKSDVFSFGVLLLEIVSGK 250
            S + D++S G +L  ++ GK
Sbjct: 219 HSFEVDIWSLGCILYTLLVGK 239

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 100/225 (44%), Gaps = 39/225 (17%)
Query: 43  SVSTATNKFSDANKLGEGGFGPV---YKGVLKKGDEIAVKRLSGRSGQGLREMKN---EA 96
           S  T   ++ +   +G G  G V   Y  +L++   +A+K+LS R  Q     K    E 
Sbjct: 20  STFTVLKRYQNLKPIGSGAQGIVCAAYDAILERN--VAIKKLS-RPFQNQTHAKRAYREL 76
Query: 97  SVIAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFF--------LFDP----TKRML 144
            ++  V HKN++ LL              + P KSL+ F        L D       +M 
Sbjct: 77  VLMKCVNHKNIIGLLNV------------FTPQKSLEEFQDVYIVMELMDANLCQVIQME 124
Query: 145 LDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGN 204
           LD      ++  +  G+ +LH      IIHRDLK SNI++  D   KI DFG+AR  G +
Sbjct: 125 LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 181
Query: 205 ELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 249
            +       V T  Y +PE  L   +    D++S G ++ E++ G
Sbjct: 182 FMMVP---FVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 223

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 64/232 (27%), Positives = 115/232 (49%), Gaps = 29/232 (12%)
Query: 50  KFSDANKLGEGGFGPV---YKGVLKKGDEIAVKRLSGRSGQG-----LREMKNEASVIAK 101
           ++++ + +GEG +G V   Y  V K    +A+K++S    Q      LRE+K    ++ +
Sbjct: 24  RYTNLSYIGEGAYGMVCSAYDNVNKV--RVAIKKISPFEHQTYCQRTLREIK----ILLR 77
Query: 102 VQHKNLVRL----LGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGI 157
            +H+N++ +        I++ + + I + +     D +    T+ +  D +     +  I
Sbjct: 78  FRHENIIGINDIIRAPTIEQMKDVYIVQDL--METDLYKLLKTQHLSNDHI--CYFLYQI 133
Query: 158 AQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQAN-TSRIVGT 216
            +GL Y+H      ++HRDLK SN+LL+   + KI DFG+AR+   +       +  V T
Sbjct: 134 LRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 190
Query: 217 YGYMSPEYALEGIFSIKS-DVFSFGVLLLEIVSGKK-NTGLYRTDSLN-LLG 265
             Y +PE  L      KS D++S G +L E++S +    G +  D LN +LG
Sbjct: 191 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILG 242

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 39/92 (42%), Positives = 53/92 (57%), Gaps = 3/92 (3%)
Query: 157 IAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 216
           +A+G+ +L   S  + IHRDL A NILL ++   KI DFG+AR    N            
Sbjct: 208 VARGMEFL---SSRKCIHRDLAARNILLSENNVVKICDFGLARDIYKNPDYVRKGDTRLP 264
Query: 217 YGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 248
             +M+PE   + I+S KSDV+S+GVLL EI S
Sbjct: 265 LKWMAPESIFDKIYSTKSDVWSYGVLLWEIFS 296

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 96/201 (47%), Gaps = 18/201 (8%)
Query: 57  LGEGGFGPVYKGVLKKGDEIAVKRLSGRS----GQGLREMKNEASVIAKVQHKNLVRLLG 112
           LG+GGF   Y+       E+   ++  +S         +M  E ++   + + ++V   G
Sbjct: 34  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHG 93
Query: 113 CCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRI 172
              D D   ++ E    +SL        ++ + +   R  + + I QG+ YLH     R+
Sbjct: 94  FFEDDDFVYVVLEICRRRSL--LELHKRRKAVTEPEARYFMRQTI-QGVQYLHNN---RV 147
Query: 173 IHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR---IVGTYGYMSPEYALEGI 229
           IHRDLK  N+ L+ DM+ KI DFG+A      +++ +  R   + GT  Y++PE   +  
Sbjct: 148 IHRDLKLGNLFLNDDMDVKIGDFGLA-----TKIEFDGERKKDLCGTPNYIAPEVLCKKG 202
Query: 230 FSIKSDVFSFGVLLLEIVSGK 250
            S + D++S G +L  ++ GK
Sbjct: 203 HSFEVDIWSLGCILYTLLVGK 223

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 96/201 (47%), Gaps = 18/201 (8%)
Query: 57  LGEGGFGPVYKGVLKKGDEIAVKRLSGRS----GQGLREMKNEASVIAKVQHKNLVRLLG 112
           LG+GGF   Y+       E+   ++  +S         +M  E ++   + + ++V   G
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHG 109
Query: 113 CCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRI 172
              D D   ++ E    +SL        ++ + +   R  + + I QG+ YLH     R+
Sbjct: 110 FFEDDDFVYVVLEICRRRSL--LELHKRRKAVTEPEARYFMRQTI-QGVQYLHNN---RV 163
Query: 173 IHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR---IVGTYGYMSPEYALEGI 229
           IHRDLK  N+ L+ DM+ KI DFG+A      +++ +  R   + GT  Y++PE   +  
Sbjct: 164 IHRDLKLGNLFLNDDMDVKIGDFGLA-----TKIEFDGERKKXLCGTPNYIAPEVLCKKG 218
Query: 230 FSIKSDVFSFGVLLLEIVSGK 250
            S + D++S G +L  ++ GK
Sbjct: 219 HSFEVDIWSLGCILYTLLVGK 239

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 66/226 (29%), Positives = 101/226 (44%), Gaps = 39/226 (17%)
Query: 43  SVSTATNKFSDANKLGEGGFGPV---YKGVLKKGDEIAVKRLSGRSGQGLREMKN---EA 96
           S  T   ++ +   +G G  G V   Y  +L++   +A+K+LS R  Q     K    E 
Sbjct: 18  STFTVLKRYQNLKPIGSGAQGIVCAAYDAILERN--VAIKKLS-RPFQNQTHAKRAYREL 74
Query: 97  SVIAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFF--------LFDP----TKRML 144
            ++  V HKN++ LL              + P KSL+ F        L D       +M 
Sbjct: 75  VLMKCVNHKNIIGLLNV------------FTPQKSLEEFQDVYIVMELMDANLCQVIQME 122
Query: 145 LDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGN 204
           LD      ++  +  G+ +LH      IIHRDLK SNI++  D   KI DFG+AR  G +
Sbjct: 123 LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 179
Query: 205 ELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 250
            +      +V  Y Y +PE  L   +    D++S G ++ E+V  K
Sbjct: 180 FMM--EPEVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMVCHK 222

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 101/206 (49%), Gaps = 20/206 (9%)
Query: 56  KLGEGGFGPVYKGVLK-----KGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRL 110
           +LG G FG V KG  +     K   + + +          E+  EA+V+ ++ +  +VR+
Sbjct: 34  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 93
Query: 111 LGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRV 170
           +G C + +  +L+ E      L+ +L     R + D    ++++  ++ G+ YL +    
Sbjct: 94  IGIC-EAESWMLVMEMAELGPLNKYL--QQNRHVKD-KNIIELVHQVSMGMKYLEE---S 146
Query: 171 RIIHRDLKASNILLDKDMNPKISDFGMARICGGNE----LQANTSRIVGTYGYMSPEYAL 226
             +HRDL A N+LL      KISDFG+++    +E     Q +    V  Y   +PE   
Sbjct: 147 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY---APECIN 203
Query: 227 EGIFSIKSDVFSFGVLLLEIVS-GKK 251
              FS KSDV+SFGVL+ E  S G+K
Sbjct: 204 YYKFSSKSDVWSFGVLMWEAFSYGQK 229

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 101/206 (49%), Gaps = 20/206 (9%)
Query: 56  KLGEGGFGPVYKGVLK-----KGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRL 110
           +LG G FG V KG  +     K   + + +          E+  EA+V+ ++ +  +VR+
Sbjct: 34  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 93
Query: 111 LGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRV 170
           +G C + +  +L+ E      L+ +L     R + D    ++++  ++ G+ YL +    
Sbjct: 94  IGIC-EAESWMLVMEMAELGPLNKYL--QQNRHVKD-KNIIELVHQVSMGMKYLEE---S 146
Query: 171 RIIHRDLKASNILLDKDMNPKISDFGMARICGGNE----LQANTSRIVGTYGYMSPEYAL 226
             +HRDL A N+LL      KISDFG+++    +E     Q +    V  Y   +PE   
Sbjct: 147 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY---APECIN 203
Query: 227 EGIFSIKSDVFSFGVLLLEIVS-GKK 251
              FS KSDV+SFGVL+ E  S G+K
Sbjct: 204 YYKFSSKSDVWSFGVLMWEAFSYGQK 229

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 62/228 (27%), Positives = 112/228 (49%), Gaps = 28/228 (12%)
Query: 50  KFSDANKLGEGGFGPV---YKGVLKKGDEIAVKRLSGRSGQG-----LREMKNEASVIAK 101
           ++++ + +GEG +G V   Y  V K    +A+K++S    Q      LRE+K    ++ +
Sbjct: 32  RYTNLSYIGEGAYGMVCSAYDNVNKV--RVAIKKISPFEHQTYCQRTLREIK----ILLR 85
Query: 102 VQHKNLVRL----LGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGI 157
            +H+N++ +        I++ + + I + +     D +    T+ +  D +     +  I
Sbjct: 86  FRHENIIGINDIIRAPTIEQMKDVYIVQDL--METDLYKLLKTQHLSNDHI--CYFLYQI 141
Query: 158 AQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQAN-TSRIVGT 216
            +GL Y+H      ++HRDLK SN+LL+   + KI DFG+AR+   +       +  V T
Sbjct: 142 LRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 198
Query: 217 YGYMSPEYALEGIFSIKS-DVFSFGVLLLEIVSGKK-NTGLYRTDSLN 262
             Y +PE  L      KS D++S G +L E++S +    G +  D LN
Sbjct: 199 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLN 246

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 62/228 (27%), Positives = 112/228 (49%), Gaps = 28/228 (12%)
Query: 50  KFSDANKLGEGGFGPV---YKGVLKKGDEIAVKRLSGRSGQG-----LREMKNEASVIAK 101
           ++++ + +GEG +G V   Y  V K    +A+K++S    Q      LRE+K    ++ +
Sbjct: 24  RYTNLSYIGEGAYGMVCSAYDNVNKV--RVAIKKISPFEHQTYCQRTLREIK----ILLR 77
Query: 102 VQHKNLVRL----LGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGI 157
            +H+N++ +        I++ + + I + +     D +    T+ +  D +     +  I
Sbjct: 78  FRHENIIGINDIIRAPTIEQMKDVYIVQDL--METDLYKLLKTQHLSNDHI--CYFLYQI 133
Query: 158 AQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQAN-TSRIVGT 216
            +GL Y+H      ++HRDLK SN+LL+   + KI DFG+AR+   +       +  V T
Sbjct: 134 LRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 190
Query: 217 YGYMSPEYALEGIFSIKS-DVFSFGVLLLEIVSGKK-NTGLYRTDSLN 262
             Y +PE  L      KS D++S G +L E++S +    G +  D LN
Sbjct: 191 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLN 238

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 91/199 (45%), Gaps = 13/199 (6%)
Query: 57  LGEGGFGPVYKGVLKKGDEI----AVKRLSGRSGQGLREMKNEASVIAKV-QHKNLVRLL 111
           +G G +  V    LKK D I     VK+      + +  ++ E  V  +   H  LV L 
Sbjct: 13  IGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 72
Query: 112 GCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVR 171
            C         + EY+    L F +    +R L +   R    E I+  L YLH+     
Sbjct: 73  SCFQTESRLFFVIEYVNGGDLMFHM--QRQRKLPEEHARFYSAE-ISLALNYLHERG--- 126
Query: 172 IIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFS 231
           II+RDLK  N+LLD + + K++D+GM +   G      TS   GT  Y++PE      + 
Sbjct: 127 IIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSXFCGTPNYIAPEILRGEDYG 184
Query: 232 IKSDVFSFGVLLLEIVSGK 250
              D ++ GVL+ E+++G+
Sbjct: 185 FSVDWWALGVLMFEMMAGR 203

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 67/266 (25%), Positives = 106/266 (39%), Gaps = 72/266 (27%)
Query: 51  FSDANKLGEGGFGPVYKGVLKKGD-EIAVKRLSGRSGQGLRE-MKNEASVIAKVQHKNLV 108
           F     +G GGFG V++   K  D   A+KR+   + +  RE +  E   +AK++H  +V
Sbjct: 8   FEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIV 67
Query: 109 RLLGCCIDRDEKILIYE----YMPNKSLDFFLFDPT---------KRM------------ 143
           R     ++   +    E    ++ ++S D+ L  P+         +RM            
Sbjct: 68  RYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQL 127
Query: 144 --------------------LLDWVTR------------VQIIEGIAQGLLYLHQYSRVR 171
                               L DW+ R            + I   IA+ + +LH      
Sbjct: 128 QPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKG--- 184
Query: 172 IIHRDLKASNILLDKDMNPKISDFGMARICGGNELQ----------ANTSRIVGTYGYMS 221
           ++HRDLK SNI    D   K+ DFG+      +E +          A     VGT  YMS
Sbjct: 185 LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHXGQVGTKLYMS 244
Query: 222 PEYALEGIFSIKSDVFSFGVLLLEIV 247
           PE      +S K D+FS G++L E++
Sbjct: 245 PEQIHGNNYSHKVDIFSLGLILFELL 270

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 68/222 (30%), Positives = 101/222 (45%), Gaps = 33/222 (14%)
Query: 43  SVSTATNKFSDANKLGEGGFGPV---YKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVI 99
           S  T   ++     +G G  G V   +  VL  G  +AVK+LS       R  +N+    
Sbjct: 16  STFTVLKRYQQLKPIGSGAQGIVCAAFDTVL--GINVAVKKLS-------RPFQNQTH-- 64
Query: 100 AKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFF--------LFDP----TKRMLLDW 147
           AK  ++ LV LL C   ++   L+  + P K+L+ F        L D        M LD 
Sbjct: 65  AKRAYRELV-LLKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIHMELDH 123
Query: 148 VTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQ 207
                ++  +  G+ +LH      IIHRDLK SNI++  D   KI DFG+AR    N + 
Sbjct: 124 ERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTASTNFMM 180
Query: 208 ANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 249
             T  +V  Y Y +PE  L   +    D++S G ++ E+V G
Sbjct: 181 --TPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGELVKG 219

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 91/199 (45%), Gaps = 13/199 (6%)
Query: 57  LGEGGFGPVYKGVLKKGDEI----AVKRLSGRSGQGLREMKNEASVIAKV-QHKNLVRLL 111
           +G G +  V    LKK D I     VK+      + +  ++ E  V  +   H  LV L 
Sbjct: 17  IGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 76
Query: 112 GCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVR 171
            C         + EY+    L F +    +R L +   R    E I+  L YLH+     
Sbjct: 77  SCFQTESRLFFVIEYVNGGDLMFHM--QRQRKLPEEHARFYSAE-ISLALNYLHERG--- 130
Query: 172 IIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFS 231
           II+RDLK  N+LLD + + K++D+GM +   G      TS   GT  Y++PE      + 
Sbjct: 131 IIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSXFCGTPNYIAPEILRGEDYG 188
Query: 232 IKSDVFSFGVLLLEIVSGK 250
              D ++ GVL+ E+++G+
Sbjct: 189 FSVDWWALGVLMFEMMAGR 207

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 62/228 (27%), Positives = 112/228 (49%), Gaps = 28/228 (12%)
Query: 50  KFSDANKLGEGGFGPV---YKGVLKKGDEIAVKRLSGRSGQG-----LREMKNEASVIAK 101
           ++++ + +GEG +G V   Y  V K    +A+K++S    Q      LRE+K    ++ +
Sbjct: 44  RYTNLSYIGEGAYGMVCSAYDNVNKV--RVAIKKISPFEHQTYCQRTLREIK----ILLR 97
Query: 102 VQHKNLVRL----LGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGI 157
            +H+N++ +        I++ + + I + +     D +    T+ +  D +     +  I
Sbjct: 98  FRHENIIGINDIIRAPTIEQMKDVYIVQDL--METDLYKLLKTQHLSNDHI--CYFLYQI 153
Query: 158 AQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQAN-TSRIVGT 216
            +GL Y+H      ++HRDLK SN+LL+   + KI DFG+AR+   +       +  V T
Sbjct: 154 LRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 210
Query: 217 YGYMSPEYALEGIFSIKS-DVFSFGVLLLEIVSGKK-NTGLYRTDSLN 262
             Y +PE  L      KS D++S G +L E++S +    G +  D LN
Sbjct: 211 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLN 258

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 61/228 (26%), Positives = 112/228 (49%), Gaps = 28/228 (12%)
Query: 50  KFSDANKLGEGGFGPV---YKGVLKKGDEIAVKRLSGRSGQG-----LREMKNEASVIAK 101
           ++++ + +GEG +G V   Y  V K    +A+K++S    Q      LRE+K    ++ +
Sbjct: 44  RYTNLSYIGEGAYGMVCSAYDNVNKV--RVAIKKISPFEHQTYCQRTLREIK----ILLR 97
Query: 102 VQHKNLVRL----LGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGI 157
            +H+N++ +        I++ + + +  ++     D +    T+ +  D +     +  I
Sbjct: 98  FRHENIIGINDIIRAPTIEQMKDVYLVTHL--MGADLYKLLKTQHLSNDHIC--YFLYQI 153
Query: 158 AQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQAN-TSRIVGT 216
            +GL Y+H      ++HRDLK SN+LL+   + KI DFG+AR+   +       +  V T
Sbjct: 154 LRGLKYIHS---ANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVAT 210
Query: 217 YGYMSPEYALEGIFSIKS-DVFSFGVLLLEIVSGKK-NTGLYRTDSLN 262
             Y +PE  L      KS D++S G +L E++S +    G +  D LN
Sbjct: 211 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLN 258

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 104/226 (46%), Gaps = 39/226 (17%)
Query: 43  SVSTATNKFSDANKLGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKN---EASV 98
           ++     ++ + + +G G +G V      K G  +AVK+LS R  Q +   K    E  +
Sbjct: 16  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRL 74
Query: 99  IAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSL----DFFLFDPTKRMLLDWVTRVQ-- 152
           +  ++H+N++ LL              + P +SL    D +L        L+ + + Q  
Sbjct: 75  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKSQKL 122
Query: 153 -------IIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE 205
                  +I  I +GL Y+H      IIHRDLK SN+ +++D   KI DFG+ R      
Sbjct: 123 TDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDSELKILDFGLCR-----H 174
Query: 206 LQANTSRIVGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 250
                +  V T  Y +PE  L  + ++   D++S G ++ E+++G+
Sbjct: 175 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 101/206 (49%), Gaps = 20/206 (9%)
Query: 56  KLGEGGFGPVYKGVLK-----KGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRL 110
           +LG G FG V KG  +     K   + + +          E+  EA+V+ ++ +  +VR+
Sbjct: 32  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 91
Query: 111 LGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRV 170
           +G C + +  +L+ E      L+ +L     R + D    ++++  ++ G+ YL +    
Sbjct: 92  IGIC-EAESWMLVMEMAELGPLNKYL--QQNRHVKD-KNIIELVHQVSMGMKYLEE---S 144
Query: 171 RIIHRDLKASNILLDKDMNPKISDFGMARICGGNE----LQANTSRIVGTYGYMSPEYAL 226
             +HRDL A N+LL      KISDFG+++    +E     Q +    V  Y   +PE   
Sbjct: 145 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY---APECIN 201
Query: 227 EGIFSIKSDVFSFGVLLLEIVS-GKK 251
              FS KSDV+SFGVL+ E  S G+K
Sbjct: 202 YYKFSSKSDVWSFGVLMWEAFSYGQK 227

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 101/206 (49%), Gaps = 20/206 (9%)
Query: 56  KLGEGGFGPVYKGVLK-----KGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRL 110
           +LG G FG V KG  +     K   + + +          E+  EA+V+ ++ +  +VR+
Sbjct: 14  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 73
Query: 111 LGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRV 170
           +G C + +  +L+ E      L+ +L     R + D    ++++  ++ G+ YL +    
Sbjct: 74  IGIC-EAESWMLVMEMAELGPLNKYL--QQNRHVKD-KNIIELVHQVSMGMKYLEE---S 126
Query: 171 RIIHRDLKASNILLDKDMNPKISDFGMARICGGNE----LQANTSRIVGTYGYMSPEYAL 226
             +HRDL A N+LL      KISDFG+++    +E     Q +    V  Y   +PE   
Sbjct: 127 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY---APECIN 183
Query: 227 EGIFSIKSDVFSFGVLLLEIVS-GKK 251
              FS KSDV+SFGVL+ E  S G+K
Sbjct: 184 YYKFSSKSDVWSFGVLMWEAFSYGQK 209

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 93/206 (45%), Gaps = 20/206 (9%)
Query: 51  FSDANKLGEGGFGPVYKGVLKKGDEI-AVKRL--SGRSGQGL-REMKNEASVIAKVQHKN 106
           F     LG+G FG VY    K+   I A+K L  S    +G+  +++ E  + + ++H N
Sbjct: 17  FDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPN 76
Query: 107 LVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQ 166
           ++R+     DR    L+ E+ P   L   L    K    D       +E +A  L Y H+
Sbjct: 77  ILRMYNYFHDRKRIYLMLEFAPRGELYKEL---QKHGRFDEQRSATFMEELADALHYCHE 133
Query: 167 YSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR---IVGTYGYMSPE 223
               ++IHRD+K  N+L+      KI+DFG +       + A + R   + GT  Y+ PE
Sbjct: 134 R---KVIHRDIKPENLLMGYKGELKIADFGWS-------VHAPSLRRRXMCGTLDYLPPE 183
Query: 224 YALEGIFSIKSDVFSFGVLLLEIVSG 249
                    K D++  GVL  E + G
Sbjct: 184 MIEGKTHDEKVDLWCAGVLCYEFLVG 209

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 68/280 (24%), Positives = 121/280 (43%), Gaps = 37/280 (13%)
Query: 57  LGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCID 116
           +G+G FG VY G       I +  +   +   L+  K E     + +H+N+V  +G C+ 
Sbjct: 41  IGKGRFGQVYHGRWHGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMS 100
Query: 117 RDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRD 176
                +I      ++L   + D   +++LD     QI + I +G+ YLH      I+H+D
Sbjct: 101 PPHLAIITSLCKGRTLYSVVRD--AKIVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKD 155
Query: 177 LKASNILLDKDMNPK--ISDFGMARICGGNELQANTSRIVGTYGY-----------MSPE 223
           LK+ N+  D   N K  I+DFG+  I G  +      ++    G+           +SP+
Sbjct: 156 LKSKNVFYD---NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPD 212
Query: 224 YALEGI-FSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDP 282
              + + FS  SDVF+ G +  E+ +       ++T     +   W + T       + P
Sbjct: 213 TEEDKLPFSKHSDVFALGTIWYELHA---REWPFKTQPAEAI--IWQMGTG------MKP 261
Query: 283 ILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSML 322
            L      K++    ++I L C     ++RPT   ++ ML
Sbjct: 262 NLSQIGMGKEI----SDILLFCWAFEQEERPTFTKLMDML 297

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 100/200 (50%), Gaps = 15/200 (7%)
Query: 56  KLGEGGFGPVYKGVLK-----KGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRL 110
           +LG G FG V KG  +     K   + + +          E+  EA+V+ ++ +  +VR+
Sbjct: 18  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 77
Query: 111 LGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRV 170
           +G C + +  +L+ E      L+ +L     R + D    ++++  ++ G+ YL + +  
Sbjct: 78  IGIC-EAESWMLVMEMAELGPLNKYL--QQNRHVKD-KNIIELVHQVSMGMKYLEESN-- 131
Query: 171 RIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTY--GYMSPEYALEG 228
             +HRDL A N+LL      KISDFG+++    +E     ++  G +   + +PE     
Sbjct: 132 -FVHRDLAARNVLLVTQHYAKISDFGLSKALRADE-NXYKAQTHGKWPVKWYAPECINYY 189
Query: 229 IFSIKSDVFSFGVLLLEIVS 248
            FS KSDV+SFGVL+ E  S
Sbjct: 190 KFSSKSDVWSFGVLMWEAFS 209

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 64.3 bits (155), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 93/206 (45%), Gaps = 20/206 (9%)
Query: 51  FSDANKLGEGGFGPVYKGVLKKGDEI-AVKRL--SGRSGQGL-REMKNEASVIAKVQHKN 106
           F     LG+G FG VY    K+   I A+K L  S    +G+  +++ E  + + ++H N
Sbjct: 16  FDIVRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPN 75
Query: 107 LVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQ 166
           ++R+     DR    L+ E+ P   L   L    K    D       +E +A  L Y H+
Sbjct: 76  ILRMYNYFHDRKRIYLMLEFAPRGELYKEL---QKHGRFDEQRSATFMEELADALHYCHE 132
Query: 167 YSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR---IVGTYGYMSPE 223
               ++IHRD+K  N+L+      KI+DFG +       + A + R   + GT  Y+ PE
Sbjct: 133 R---KVIHRDIKPENLLMGYKGELKIADFGWS-------VHAPSLRRRXMCGTLDYLPPE 182
Query: 224 YALEGIFSIKSDVFSFGVLLLEIVSG 249
                    K D++  GVL  E + G
Sbjct: 183 MIEGKTHDEKVDLWCAGVLCYEFLVG 208

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 64.3 bits (155), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 98/202 (48%), Gaps = 19/202 (9%)
Query: 56  KLGEGGFGPVYKGVLK-----KGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRL 110
           +LG G FG V KG  +     K   + + +          E+  EA+V+ ++ +  +VR+
Sbjct: 12  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 71
Query: 111 LGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRV 170
           +G C + +  +L+ E      L+ +L     R + D    ++++  ++ G+ YL +    
Sbjct: 72  IGIC-EAESWMLVMEMAELGPLNKYL--QQNRHVKD-KNIIELVHQVSMGMKYLEE---S 124
Query: 171 RIIHRDLKASNILLDKDMNPKISDFGMARICGGNE----LQANTSRIVGTYGYMSPEYAL 226
             +HRDL A N+LL      KISDFG+++    +E     Q +    V  Y   +PE   
Sbjct: 125 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY---APECIN 181
Query: 227 EGIFSIKSDVFSFGVLLLEIVS 248
              FS KSDV+SFGVL+ E  S
Sbjct: 182 YYKFSSKSDVWSFGVLMWEAFS 203

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 66/226 (29%), Positives = 101/226 (44%), Gaps = 39/226 (17%)
Query: 43  SVSTATNKFSDANKLGEGGFGPV---YKGVLKKGDEIAVKRLSGRSGQGLREMKN---EA 96
           S  T   ++ +   +G G  G V   Y  +L++   +A+K+LS R  Q     K    E 
Sbjct: 18  STFTVLKRYQNLKPIGSGAQGIVCAAYDAILERN--VAIKKLS-RPFQNQTHAKRAYREL 74
Query: 97  SVIAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFF--------LFDP----TKRML 144
            ++  V HKN++ LL              + P KSL+ F        L D       +M 
Sbjct: 75  VLMKCVNHKNIIGLLNV------------FTPQKSLEEFQDVYIVMELMDANLCQVIQME 122
Query: 145 LDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGN 204
           LD      ++  +  G+ +LH      IIHRDLK SNI++  D   KI DFG+AR  G +
Sbjct: 123 LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 179
Query: 205 ELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 250
            +      +V  Y Y +PE  L   +    D++S G ++ E+V  K
Sbjct: 180 FMM--EPEVVTRY-YRAPEVILGMGYKENVDLWSVGCIMGEMVCHK 222

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 99/202 (49%), Gaps = 19/202 (9%)
Query: 56  KLGEGGFGPVYKGVLK-----KGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRL 110
           +LG G FG V KG  +     K   + + +          E+  EA+V+ ++ +  +VR+
Sbjct: 24  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83
Query: 111 LGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRV 170
           +G C + +  +L+ E      L+ +L     R + D    ++++  ++ G+ YL + +  
Sbjct: 84  IGIC-EAESWMLVMEMAELGPLNKYL--QQNRHVKD-KNIIELVHQVSMGMKYLEESN-- 137
Query: 171 RIIHRDLKASNILLDKDMNPKISDFGMARICGGNE----LQANTSRIVGTYGYMSPEYAL 226
             +HRDL A N+LL      KISDFG+++    +E     Q +    V  Y   +PE   
Sbjct: 138 -FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY---APECIN 193
Query: 227 EGIFSIKSDVFSFGVLLLEIVS 248
              FS KSDV+SFGVL+ E  S
Sbjct: 194 YYKFSSKSDVWSFGVLMWEAFS 215

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 98/202 (48%), Gaps = 19/202 (9%)
Query: 56  KLGEGGFGPVYKGVLK-----KGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRL 110
           +LG G FG V KG  +     K   + + +          E+  EA+V+ ++ +  +VR+
Sbjct: 18  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 77
Query: 111 LGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRV 170
           +G C + +  +L+ E      L+ +L     R + D    ++++  ++ G+ YL +    
Sbjct: 78  IGIC-EAESWMLVMEMAELGPLNKYL--QQNRHVKD-KNIIELVHQVSMGMKYLEE---S 130
Query: 171 RIIHRDLKASNILLDKDMNPKISDFGMARICGGNE----LQANTSRIVGTYGYMSPEYAL 226
             +HRDL A N+LL      KISDFG+++    +E     Q +    V  Y   +PE   
Sbjct: 131 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY---APECIN 187
Query: 227 EGIFSIKSDVFSFGVLLLEIVS 248
              FS KSDV+SFGVL+ E  S
Sbjct: 188 YYKFSSKSDVWSFGVLMWEAFS 209

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/199 (30%), Positives = 94/199 (47%), Gaps = 17/199 (8%)
Query: 57  LGEGGFGPV--YKGVLKKGDEIAVKRL--SGRSGQGLREMKNEASVIAKVQHKNLVRLLG 112
           +G+G F  V   + +L  G E+AVK +  +  +   L+++  E  +   + H N+V+L  
Sbjct: 22  IGKGNFAKVKLARHILT-GKEVAVKIIDKTQLNSSSLQKLFREVRIXKVLNHPNIVKLFE 80
Query: 113 CCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRI 172
                    L+ EY     +  +L    +    +   + + I    Q   Y HQ     I
Sbjct: 81  VIETEKTLYLVXEYASGGEVFDYLVAHGRXKEKEARAKFRQIVSAVQ---YCHQKF---I 134
Query: 173 IHRDLKASNILLDKDMNPKISDFGMA-RICGGNELQANTSRIVGTYGYMSPE-YALEGIF 230
           +HRDLKA N+LLD D N KI+DFG +     GN+L A      G   Y +PE +  +   
Sbjct: 135 VHRDLKAENLLLDADXNIKIADFGFSNEFTFGNKLDA----FCGAPPYAAPELFQGKKYD 190
Query: 231 SIKSDVFSFGVLLLEIVSG 249
             + DV+S GV+L  +VSG
Sbjct: 191 GPEVDVWSLGVILYTLVSG 209

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 104/226 (46%), Gaps = 39/226 (17%)
Query: 43  SVSTATNKFSDANKLGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKN---EASV 98
           ++     ++ + + +G G +G V      K G  +AVK+LS R  Q +   K    E  +
Sbjct: 16  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRL 74
Query: 99  IAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSL----DFFLFDPTKRMLLDWVTRVQ-- 152
           +  ++H+N++ LL              + P +SL    D +L        L+ + + Q  
Sbjct: 75  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 122
Query: 153 -------IIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE 205
                  +I  I +GL Y+H      IIHRDLK SN+ +++D   KI  FG+AR      
Sbjct: 123 TDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILGFGLAR-----H 174
Query: 206 LQANTSRIVGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 250
                +  V T  Y +PE  L  + ++   D++S G ++ E+++G+
Sbjct: 175 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 62/228 (27%), Positives = 111/228 (48%), Gaps = 28/228 (12%)
Query: 50  KFSDANKLGEGGFGPV---YKGVLKKGDEIAVKRLSGRSGQG-----LREMKNEASVIAK 101
           ++++ + +GEG +G V   Y  V K    +A+K++S    Q      LRE+K    ++  
Sbjct: 26  RYTNLSYIGEGAYGMVCSAYDNVNKV--RVAIKKISPFEHQTYCQRTLREIK----ILLA 79
Query: 102 VQHKNLVRL----LGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGI 157
            +H+N++ +        I++ + + I + +     D +    T+ +  D +     +  I
Sbjct: 80  FRHENIIGINDIIRAPTIEQMKDVYIVQDL--METDLYKLLKTQHLSNDHI--CYFLYQI 135
Query: 158 AQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQAN-TSRIVGT 216
            +GL Y+H      ++HRDLK SN+LL+   + KI DFG+AR+   +       +  V T
Sbjct: 136 LRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 192
Query: 217 YGYMSPEYALEGIFSIKS-DVFSFGVLLLEIVSGKK-NTGLYRTDSLN 262
             Y +PE  L      KS D++S G +L E++S +    G +  D LN
Sbjct: 193 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLN 240

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 104/226 (46%), Gaps = 39/226 (17%)
Query: 43  SVSTATNKFSDANKLGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKN---EASV 98
           ++     ++ + + +G G +G V      K G  +AVK+LS R  Q +   K    E  +
Sbjct: 16  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRL 74
Query: 99  IAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSL----DFFLFDPTKRMLLDWVTRVQ-- 152
           +  ++H+N++ LL              + P +SL    D +L        L+ + + Q  
Sbjct: 75  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 122
Query: 153 -------IIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE 205
                  +I  I +GL Y+H      IIHRDLK SN+ +++D   KI D G+AR      
Sbjct: 123 TDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDAGLAR-----H 174
Query: 206 LQANTSRIVGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 250
                +  V T  Y +PE  L  + ++   D++S G ++ E+++G+
Sbjct: 175 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/228 (26%), Positives = 112/228 (49%), Gaps = 28/228 (12%)
Query: 50  KFSDANKLGEGGFGPV---YKGVLKKGDEIAVKRLSGRSGQG-----LREMKNEASVIAK 101
           ++++ + +GEG +G V   Y  + K    +A+K++S    Q      LRE+K    ++ +
Sbjct: 28  RYTNLSYIGEGAYGMVCSAYDNLNKV--RVAIKKISPFEHQTYXQRTLREIK----ILLR 81
Query: 102 VQHKNLVRL----LGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGI 157
            +H+N++ +        I++ + + I + +     D +    T+ +  D +     +  I
Sbjct: 82  FRHENIIGINDIIRAPTIEQMKDVYIVQDL--METDLYKLLKTQHLSNDHI--CYFLYQI 137
Query: 158 AQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQAN-TSRIVGT 216
            +GL Y+H      ++HRDLK SN+LL+   + KI DFG+AR+   +       +  V T
Sbjct: 138 LRGLKYIHS---ANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVAT 194
Query: 217 YGYMSPEYALEGIFSIKS-DVFSFGVLLLEIVSGKK-NTGLYRTDSLN 262
             Y +PE  L      KS D++S G +L E++S +    G +  D LN
Sbjct: 195 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLN 242

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/228 (26%), Positives = 112/228 (49%), Gaps = 28/228 (12%)
Query: 50  KFSDANKLGEGGFGPV---YKGVLKKGDEIAVKRLSGRSGQG-----LREMKNEASVIAK 101
           ++++ + +GEG +G V   Y  + K    +A+K++S    Q      LRE+K    ++ +
Sbjct: 28  RYTNLSYIGEGAYGMVCSAYDNLNKV--RVAIKKISPFEHQTYCQRTLREIK----ILLR 81
Query: 102 VQHKNLVRL----LGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGI 157
            +H+N++ +        I++ + + I + +     D +    T+ +  D +     +  I
Sbjct: 82  FRHENIIGINDIIRAPTIEQMKDVYIVQDL--METDLYKLLKTQHLSNDHI--CYFLYQI 137
Query: 158 AQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQAN-TSRIVGT 216
            +GL Y+H      ++HRDLK SN+LL+   + KI DFG+AR+   +       +  V T
Sbjct: 138 LRGLKYIHS---ANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVAT 194
Query: 217 YGYMSPEYALEGIFSIKS-DVFSFGVLLLEIVSGKK-NTGLYRTDSLN 262
             Y +PE  L      KS D++S G +L E++S +    G +  D LN
Sbjct: 195 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLN 242

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/228 (26%), Positives = 112/228 (49%), Gaps = 28/228 (12%)
Query: 50  KFSDANKLGEGGFGPV---YKGVLKKGDEIAVKRLSGRSGQG-----LREMKNEASVIAK 101
           ++++ + +GEG +G V   Y  + K    +A+K++S    Q      LRE+K    ++ +
Sbjct: 29  RYTNLSYIGEGAYGMVCSAYDNLNKV--RVAIKKISPFEHQTYCQRTLREIK----ILLR 82
Query: 102 VQHKNLVRL----LGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGI 157
            +H+N++ +        I++ + + I + +     D +    T+ +  D +     +  I
Sbjct: 83  FRHENIIGINDIIRAPTIEQMKDVYIVQDL--METDLYKLLKTQHLSNDHI--CYFLYQI 138
Query: 158 AQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQAN-TSRIVGT 216
            +GL Y+H      ++HRDLK SN+LL+   + KI DFG+AR+   +       +  V T
Sbjct: 139 LRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 195
Query: 217 YGYMSPEYALEGIFSIKS-DVFSFGVLLLEIVSGKK-NTGLYRTDSLN 262
             Y +PE  L      KS D++S G +L E++S +    G +  D LN
Sbjct: 196 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLN 243

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/228 (26%), Positives = 112/228 (49%), Gaps = 28/228 (12%)
Query: 50  KFSDANKLGEGGFGPV---YKGVLKKGDEIAVKRLSGRSGQG-----LREMKNEASVIAK 101
           ++++ + +GEG +G V   Y  + K    +A+K++S    Q      LRE+K    ++ +
Sbjct: 30  RYTNLSYIGEGAYGMVCSAYDNLNKV--RVAIKKISPFEHQTYCQRTLREIK----ILLR 83
Query: 102 VQHKNLVRL----LGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGI 157
            +H+N++ +        I++ + + I + +     D +    T+ +  D +     +  I
Sbjct: 84  FRHENIIGINDIIRAPTIEQMKDVYIVQDL--METDLYKLLKTQHLSNDHI--CYFLYQI 139
Query: 158 AQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQAN-TSRIVGT 216
            +GL Y+H      ++HRDLK SN+LL+   + KI DFG+AR+   +       +  V T
Sbjct: 140 LRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 196
Query: 217 YGYMSPEYALEGIFSIKS-DVFSFGVLLLEIVSGKK-NTGLYRTDSLN 262
             Y +PE  L      KS D++S G +L E++S +    G +  D LN
Sbjct: 197 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLN 244

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/228 (26%), Positives = 112/228 (49%), Gaps = 28/228 (12%)
Query: 50  KFSDANKLGEGGFGPV---YKGVLKKGDEIAVKRLSGRSGQG-----LREMKNEASVIAK 101
           ++++ + +GEG +G V   Y  + K    +A+K++S    Q      LRE+K    ++ +
Sbjct: 21  RYTNLSYIGEGAYGMVCSAYDNLNKV--RVAIKKISPFEHQTYCQRTLREIK----ILLR 74
Query: 102 VQHKNLVRL----LGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGI 157
            +H+N++ +        I++ + + I + +     D +    T+ +  D +     +  I
Sbjct: 75  FRHENIIGINDIIRAPTIEQMKDVYIVQDL--METDLYKLLKTQHLSNDHI--CYFLYQI 130
Query: 158 AQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQAN-TSRIVGT 216
            +GL Y+H      ++HRDLK SN+LL+   + KI DFG+AR+   +       +  V T
Sbjct: 131 LRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 187
Query: 217 YGYMSPEYALEGIFSIKS-DVFSFGVLLLEIVSGKK-NTGLYRTDSLN 262
             Y +PE  L      KS D++S G +L E++S +    G +  D LN
Sbjct: 188 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLN 235

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/228 (26%), Positives = 112/228 (49%), Gaps = 28/228 (12%)
Query: 50  KFSDANKLGEGGFGPV---YKGVLKKGDEIAVKRLSGRSGQG-----LREMKNEASVIAK 101
           ++++ + +GEG +G V   Y  + K    +A+K++S    Q      LRE+K    ++ +
Sbjct: 28  RYTNLSYIGEGAYGMVCSAYDNLNKV--RVAIKKISPFEHQTYCQRTLREIK----ILLR 81
Query: 102 VQHKNLVRL----LGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGI 157
            +H+N++ +        I++ + + I + +     D +    T+ +  D +     +  I
Sbjct: 82  FRHENIIGINDIIRAPTIEQMKDVYIVQDL--METDLYKLLKTQHLSNDHI--CYFLYQI 137
Query: 158 AQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQAN-TSRIVGT 216
            +GL Y+H      ++HRDLK SN+LL+   + KI DFG+AR+   +       +  V T
Sbjct: 138 LRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 194
Query: 217 YGYMSPEYALEGIFSIKS-DVFSFGVLLLEIVSGKK-NTGLYRTDSLN 262
             Y +PE  L      KS D++S G +L E++S +    G +  D LN
Sbjct: 195 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLN 242

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/228 (26%), Positives = 112/228 (49%), Gaps = 28/228 (12%)
Query: 50  KFSDANKLGEGGFGPV---YKGVLKKGDEIAVKRLSGRSGQG-----LREMKNEASVIAK 101
           ++++ + +GEG +G V   Y  + K    +A+K++S    Q      LRE+K    ++ +
Sbjct: 22  RYTNLSYIGEGAYGMVCSAYDNLNKV--RVAIKKISPFEHQTYCQRTLREIK----ILLR 75
Query: 102 VQHKNLVRL----LGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGI 157
            +H+N++ +        I++ + + I + +     D +    T+ +  D +     +  I
Sbjct: 76  FRHENIIGINDIIRAPTIEQMKDVYIVQDL--METDLYKLLKTQHLSNDHI--CYFLYQI 131
Query: 158 AQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQAN-TSRIVGT 216
            +GL Y+H      ++HRDLK SN+LL+   + KI DFG+AR+   +       +  V T
Sbjct: 132 LRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 188
Query: 217 YGYMSPEYALEGIFSIKS-DVFSFGVLLLEIVSGKK-NTGLYRTDSLN 262
             Y +PE  L      KS D++S G +L E++S +    G +  D LN
Sbjct: 189 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLN 236

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 94/209 (44%), Gaps = 19/209 (9%)
Query: 51  FSDANKLGEGGFGPVYKGVL-KKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVR 109
           ++D   +G G FG VY+  L   G+ +A+K++     Q  R    E  ++ K+ H N+VR
Sbjct: 56  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----QDKRFKNRELQIMRKLDHCNIVR 111
Query: 110 LLGCCIDRDEKI------LIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLY 163
           L        EK       L+ +Y+P             +  L  +     +  + + L Y
Sbjct: 112 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 171
Query: 164 LHQYSRVRIIHRDLKASNILLDKDMNP-KISDFGMARICGGNELQANTSRIVGTYGYMSP 222
           +H +    I HRD+K  N+LLD D    K+ DFG A+     E   N S I   Y Y +P
Sbjct: 172 IHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSXICSRY-YRAP 225
Query: 223 EYALEGI-FSIKSDVFSFGVLLLEIVSGK 250
           E       ++   DV+S G +L E++ G+
Sbjct: 226 ELIFGATDYTSSIDVWSAGCVLAELLLGQ 254

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/228 (26%), Positives = 112/228 (49%), Gaps = 28/228 (12%)
Query: 50  KFSDANKLGEGGFGPV---YKGVLKKGDEIAVKRLSGRSGQG-----LREMKNEASVIAK 101
           ++++ + +GEG +G V   Y  + K    +A+K++S    Q      LRE+K    ++ +
Sbjct: 22  RYTNLSYIGEGAYGMVCSAYDNLNKV--RVAIKKISPFEHQTYCQRTLREIK----ILLR 75
Query: 102 VQHKNLVRL----LGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGI 157
            +H+N++ +        I++ + + I + +     D +    T+ +  D +     +  I
Sbjct: 76  FRHENIIGINDIIRAPTIEQMKDVYIVQDL--METDLYKLLKTQHLSNDHI--CYFLYQI 131
Query: 158 AQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQAN-TSRIVGT 216
            +GL Y+H      ++HRDLK SN+LL+   + KI DFG+AR+   +       +  V T
Sbjct: 132 LRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 188
Query: 217 YGYMSPEYALEGIFSIKS-DVFSFGVLLLEIVSGKK-NTGLYRTDSLN 262
             Y +PE  L      KS D++S G +L E++S +    G +  D LN
Sbjct: 189 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLN 236

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/228 (27%), Positives = 111/228 (48%), Gaps = 28/228 (12%)
Query: 50  KFSDANKLGEGGFGPV---YKGVLKKGDEIAVKRLSGRSGQG-----LREMKNEASVIAK 101
           ++++ + +GEG +G V   Y  V K    +A+K++S    Q      LRE+K    ++  
Sbjct: 26  RYTNLSYIGEGAYGMVCSAYDNVNKV--RVAIKKISPFEHQTYCQRTLREIK----ILLA 79
Query: 102 VQHKNLVRL----LGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGI 157
            +H+N++ +        I++ + + I + +     D +    T+ +  D +     +  I
Sbjct: 80  FRHENIIGINDIIRAPTIEQMKDVYIVQDL--METDLYKLLKTQHLSNDHI--CYFLYQI 135
Query: 158 AQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQAN-TSRIVGT 216
            +GL Y+H      ++HRDLK SN+LL+   + KI DFG+AR+   +       +  V T
Sbjct: 136 LRGLKYIHS---ANVLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVAT 192
Query: 217 YGYMSPEYALEGIFSIKS-DVFSFGVLLLEIVSGKK-NTGLYRTDSLN 262
             Y +PE  L      KS D++S G +L E++S +    G +  D LN
Sbjct: 193 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLN 240

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 109/210 (51%), Gaps = 20/210 (9%)
Query: 50  KFSDANKLGEGGFGPVYKGVLKKGDEI-AVKRL------SGRSGQGLREMKNEASVIAKV 102
           K+    K+GEG +G V+K   ++  EI A+KR+       G     LRE+     ++ ++
Sbjct: 3   KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREI----CLLKEL 58
Query: 103 QHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLL 162
           +HKN+VRL        +  L++E+  ++ L  + FD     L   + +  + + + +GL 
Sbjct: 59  KHKNIVRLHDVLHSDKKLTLVFEFC-DQDLKKY-FDSCNGDLDPEIVKSFLFQ-LLKGLG 115
Query: 163 YLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSP 222
           + H  +   ++HRDLK  N+L++++   K+++FG+AR   G  ++  ++ +V T  Y  P
Sbjct: 116 FCHSRN---VLHRDLKPQNLLINRNGELKLANFGLAR-AFGIPVRCYSAEVV-TLWYRPP 170
Query: 223 EYALEG-IFSIKSDVFSFGVLLLEIVSGKK 251
           +      ++S   D++S G +  E+ +  +
Sbjct: 171 DVLFGAKLYSTSIDMWSAGCIFAELANAGR 200

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 101/208 (48%), Gaps = 19/208 (9%)
Query: 51  FSDANKLGEGGFGPVYKGV-LKKGDEIAVKRL--SGRSGQGLREMKNEASVIAKVQHKNL 107
           + D   +G G +G V   V  + G ++A+K+L    +S    +    E  ++  ++H+N+
Sbjct: 27  YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENV 86
Query: 108 VRLLGCCIDR---DEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQ-IIEGIAQGLLY 163
           + LL         D+    Y  MP    D       +++  D   R+Q ++  + +GL Y
Sbjct: 87  IGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGED---RIQFLVYQMLKGLRY 143
Query: 164 LHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE 223
           +H      IIHRDLK  N+ +++D   KI DFG+AR     +  +     V T  Y +PE
Sbjct: 144 IHAAG---IIHRDLKPGNLAVNEDCELKILDFGLAR-----QADSEMXGXVVTRWYRAPE 195
Query: 224 YALEGI-FSIKSDVFSFGVLLLEIVSGK 250
             L  + ++   D++S G ++ E+++GK
Sbjct: 196 VILNWMRYTQTVDIWSVGCIMAEMITGK 223

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 104/226 (46%), Gaps = 39/226 (17%)
Query: 43  SVSTATNKFSDANKLGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKN---EASV 98
           ++     ++ + + +G G +G V      K G  +AVK+LS R  Q +   K    E  +
Sbjct: 16  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRL 74
Query: 99  IAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSL----DFFLFDPTKRMLLDWVTRVQ-- 152
           +  ++H+N++ LL              + P +SL    D +L        L+ + + Q  
Sbjct: 75  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 122
Query: 153 -------IIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE 205
                  +I  I +GL Y+H      IIHRDLK SN+ +++D   KI D G+AR      
Sbjct: 123 TDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDRGLAR-----H 174
Query: 206 LQANTSRIVGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 250
                +  V T  Y +PE  L  + ++   D++S G ++ E+++G+
Sbjct: 175 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 103/212 (48%), Gaps = 39/212 (18%)
Query: 56  KLGEGGFGPVYKG--------------VLK-KGDEIAVKRLSGRSGQGLREMKNEASVIA 100
           +LG G FG V KG              +LK + ++ A+K           E+  EA+V+ 
Sbjct: 376 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKD----------ELLAEANVMQ 425
Query: 101 KVQHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQG 160
           ++ +  +VR++G C + +  +L+ E      L+ +L     R + D    ++++  ++ G
Sbjct: 426 QLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYL--QQNRHVKD-KNIIELVHQVSMG 481
Query: 161 LLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE----LQANTSRIVGT 216
           + YL + +    +HRDL A N+LL      KISDFG+++    +E     Q +    V  
Sbjct: 482 MKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKW 538
Query: 217 YGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 248
           Y   +PE      FS KSDV+SFGVL+ E  S
Sbjct: 539 Y---APECINYYKFSSKSDVWSFGVLMWEAFS 567

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 94/209 (44%), Gaps = 19/209 (9%)
Query: 51  FSDANKLGEGGFGPVYKGVL-KKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVR 109
           ++D   +G G FG VY+  L   G+ +A+K++     Q  R    E  ++ K+ H N+VR
Sbjct: 30  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----QDKRFKNRELQIMRKLDHCNIVR 85
Query: 110 LLGCCIDRDEKI------LIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLY 163
           L        EK       L+ +Y+P             +  L  +     +  + + L Y
Sbjct: 86  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 145
Query: 164 LHQYSRVRIIHRDLKASNILLDKDMNP-KISDFGMARICGGNELQANTSRIVGTYGYMSP 222
           +H +    I HRD+K  N+LLD D    K+ DFG A+     E   N S I   Y Y +P
Sbjct: 146 IHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSXICSRY-YRAP 199
Query: 223 EYALEGI-FSIKSDVFSFGVLLLEIVSGK 250
           E       ++   DV+S G +L E++ G+
Sbjct: 200 ELIFGATDYTSSIDVWSAGCVLAELLLGQ 228

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/197 (26%), Positives = 95/197 (48%), Gaps = 14/197 (7%)
Query: 57  LGEGGFGPVYKGVLKKGDE----IAVKRLSGRSGQGLRE-MKNEASVIAKVQHKNLVRLL 111
           +GEG FG V++G+    +     +A+K     +   +RE    EA  + +  H ++V+L+
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 112 GCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVR 171
           G  I  +   +I E      L  FL    ++  LD  + +     ++  L YL      R
Sbjct: 78  GV-ITENPVWIIMELCTLGELRSFL--QVRKFSLDLASLILYAYQLSTALAYLESK---R 131
Query: 172 IIHRDLKASNILLDKDMNPKISDFGMAR-ICGGNELQANTSRIVGTYGYMSPEYALEGIF 230
            +HRD+ A N+L+  +   K+ DFG++R +      +A+  ++     +M+PE      F
Sbjct: 132 FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTXXKASKGKL--PIKWMAPESINFRRF 189
Query: 231 SIKSDVFSFGVLLLEIV 247
           +  SDV+ FGV + EI+
Sbjct: 190 TSASDVWMFGVCMWEIL 206

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 94/209 (44%), Gaps = 19/209 (9%)
Query: 51  FSDANKLGEGGFGPVYKGVL-KKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVR 109
           ++D   +G G FG VY+  L   G+ +A+K++     Q  R    E  ++ K+ H N+VR
Sbjct: 34  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----QDKRFKNRELQIMRKLDHCNIVR 89
Query: 110 LLGCCIDRDEKI------LIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLY 163
           L        EK       L+ +Y+P             +  L  +     +  + + L Y
Sbjct: 90  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 149
Query: 164 LHQYSRVRIIHRDLKASNILLDKDMNP-KISDFGMARICGGNELQANTSRIVGTYGYMSP 222
           +H +    I HRD+K  N+LLD D    K+ DFG A+     E   N S I   Y Y +P
Sbjct: 150 IHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSXICSRY-YRAP 203
Query: 223 EYALEGI-FSIKSDVFSFGVLLLEIVSGK 250
           E       ++   DV+S G +L E++ G+
Sbjct: 204 ELIFGATDYTSSIDVWSAGCVLAELLLGQ 232

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 100/208 (48%), Gaps = 22/208 (10%)
Query: 54  ANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLR------EMKNEASVIAKVQHKN 106
             +LG G F  V K   K  G E A K +  R  +  R      E++ E S++ +V H N
Sbjct: 17  GEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPN 76
Query: 107 LVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQ 166
           ++ L     +R + +LI E +    L  FL    ++  L        I+ I  G+ YLH 
Sbjct: 77  IITLHDVYENRTDVVLILELVSGGELFDFL---AQKESLSEEEATSFIKQILDGVNYLHT 133
Query: 167 YSRVRIIHRDLKASNI-LLDKDM---NPKISDFGMAR-ICGGNELQANTSRIVGTYGYMS 221
               +I H DLK  NI LLDK++   + K+ DFG+A  I  G E +     I GT  +++
Sbjct: 134 K---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFK----NIFGTPEFVA 186
Query: 222 PEYALEGIFSIKSDVFSFGVLLLEIVSG 249
           PE        +++D++S GV+   ++SG
Sbjct: 187 PEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 95/205 (46%), Gaps = 15/205 (7%)
Query: 49  NKFSDANKLGEGGFGPVY-KGVLKKGDEIAVKRLSGRSGQGLREMK---NEASVIAKVQH 104
           ++F     +G G FG V     ++ G+  A+K L  +    L++++   NE  ++  V  
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 105 KNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYL 164
             LV+L     D     ++ EYMP   +    F   +R  +   +        AQ +L  
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYMPGGDM----FSHLRR--IGRFSEPHARFYAAQIVLTF 154
Query: 165 HQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY 224
                + +I+RDLK  N+L+D+    K++DFG A+   G      T  + GT  Y++PE 
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKG-----RTWXLCGTPEYLAPEI 209
Query: 225 ALEGIFSIKSDVFSFGVLLLEIVSG 249
            L   ++   D ++ GVL+ E+ +G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 94/209 (44%), Gaps = 19/209 (9%)
Query: 51  FSDANKLGEGGFGPVYKGVL-KKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVR 109
           ++D   +G G FG VY+  L   G+ +A+K++     Q  R    E  ++ K+ H N+VR
Sbjct: 27  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----QDKRFKNRELQIMRKLDHCNIVR 82
Query: 110 LLGCCIDRDEKI------LIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLY 163
           L        EK       L+ +Y+P             +  L  +     +  + + L Y
Sbjct: 83  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 142
Query: 164 LHQYSRVRIIHRDLKASNILLDKDMNP-KISDFGMARICGGNELQANTSRIVGTYGYMSP 222
           +H +    I HRD+K  N+LLD D    K+ DFG A+     E   N S I   Y Y +P
Sbjct: 143 IHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSYICSRY-YRAP 196
Query: 223 EYALEGI-FSIKSDVFSFGVLLLEIVSGK 250
           E       ++   DV+S G +L E++ G+
Sbjct: 197 ELIFGATDYTSSIDVWSAGCVLAELLLGQ 225

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 94/209 (44%), Gaps = 19/209 (9%)
Query: 51  FSDANKLGEGGFGPVYKGVL-KKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVR 109
           ++D   +G G FG VY+  L   G+ +A+K++     Q  R    E  ++ K+ H N+VR
Sbjct: 50  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----QDKRFKNRELQIMRKLDHCNIVR 105
Query: 110 LLGCCIDRDEKI------LIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLY 163
           L        EK       L+ +Y+P             +  L  +     +  + + L Y
Sbjct: 106 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 165
Query: 164 LHQYSRVRIIHRDLKASNILLDKDMNP-KISDFGMARICGGNELQANTSRIVGTYGYMSP 222
           +H +    I HRD+K  N+LLD D    K+ DFG A+     E   N S I   Y Y +P
Sbjct: 166 IHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSYICSRY-YRAP 219
Query: 223 EYALEGI-FSIKSDVFSFGVLLLEIVSGK 250
           E       ++   DV+S G +L E++ G+
Sbjct: 220 ELIFGATDYTSSIDVWSAGCVLAELLLGQ 248

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 97/205 (47%), Gaps = 16/205 (7%)
Query: 51  FSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLRE-MKNEASVIAKVQHKNLV 108
           F     LG G F  V     K  G   AVK +  ++ +G    ++NE +V+ K++H+N+V
Sbjct: 24  FEFKETLGTGAFSEVVLAEEKATGKLFAVKCIPKKALKGKESSIENEIAVLRKIKHENIV 83
Query: 109 RLLGCCIDRDEKILIYEYMPNKSLDFFLFDP-TKRMLLDWVTRVQIIEGIAQGLLYLHQY 167
            L       +   L+ + +    L    FD   ++          +I  +   + YLH  
Sbjct: 84  ALEDIYESPNHLYLVMQLVSGGEL----FDRIVEKGFYTEKDASTLIRQVLDAVYYLH-- 137
Query: 168 SRVRIIHRDLKASNILL---DKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY 224
            R+ I+HRDLK  N+L    D++    ISDFG++++ G  ++    S   GT GY++PE 
Sbjct: 138 -RMGIVHRDLKPENLLYYSQDEESKIMISDFGLSKMEGKGDV---MSTACGTPGYVAPEV 193
Query: 225 ALEGIFSIKSDVFSFGVLLLEIVSG 249
             +  +S   D +S GV+   ++ G
Sbjct: 194 LAQKPYSKAVDCWSIGVIAYILLCG 218

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 94/209 (44%), Gaps = 19/209 (9%)
Query: 51  FSDANKLGEGGFGPVYKGVL-KKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVR 109
           ++D   +G G FG VY+  L   G+ +A+K++     Q  R    E  ++ K+ H N+VR
Sbjct: 23  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----QDKRFKNRELQIMRKLDHCNIVR 78
Query: 110 LLGCCIDRDEKI------LIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLY 163
           L        EK       L+ +Y+P             +  L  +     +  + + L Y
Sbjct: 79  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 138
Query: 164 LHQYSRVRIIHRDLKASNILLDKDMNP-KISDFGMARICGGNELQANTSRIVGTYGYMSP 222
           +H +    I HRD+K  N+LLD D    K+ DFG A+     E   N S I   Y Y +P
Sbjct: 139 IHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSXICSRY-YRAP 192
Query: 223 EYALEGI-FSIKSDVFSFGVLLLEIVSGK 250
           E       ++   DV+S G +L E++ G+
Sbjct: 193 ELIFGATDYTSSIDVWSAGCVLAELLLGQ 221

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 102/212 (48%), Gaps = 39/212 (18%)
Query: 56  KLGEGGFGPVYKG--------------VLK-KGDEIAVKRLSGRSGQGLREMKNEASVIA 100
           +LG G FG V KG              +LK + ++ A+K           E+  EA+V+ 
Sbjct: 377 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKD----------ELLAEANVMQ 426
Query: 101 KVQHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQG 160
           ++ +  +VR++G C + +  +L+ E      L+ +L     R + D    ++++  ++ G
Sbjct: 427 QLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYL--QQNRHVKD-KNIIELVHQVSMG 482
Query: 161 LLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE----LQANTSRIVGT 216
           + YL +      +HRDL A N+LL      KISDFG+++    +E     Q +    V  
Sbjct: 483 MKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKW 539
Query: 217 YGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 248
           Y   +PE      FS KSDV+SFGVL+ E  S
Sbjct: 540 Y---APECINYYKFSSKSDVWSFGVLMWEAFS 568

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 94/209 (44%), Gaps = 19/209 (9%)
Query: 51  FSDANKLGEGGFGPVYKGVL-KKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVR 109
           ++D   +G G FG VY+  L   G+ +A+K++     Q  R    E  ++ K+ H N+VR
Sbjct: 56  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----QDKRFKNRELQIMRKLDHCNIVR 111
Query: 110 LLGCCIDRDEKI------LIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLY 163
           L        EK       L+ +Y+P             +  L  +     +  + + L Y
Sbjct: 112 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 171
Query: 164 LHQYSRVRIIHRDLKASNILLDKDMNP-KISDFGMARICGGNELQANTSRIVGTYGYMSP 222
           +H +    I HRD+K  N+LLD D    K+ DFG A+     E   N S I   Y Y +P
Sbjct: 172 IHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSYICSRY-YRAP 225
Query: 223 EYALEGI-FSIKSDVFSFGVLLLEIVSGK 250
           E       ++   DV+S G +L E++ G+
Sbjct: 226 ELIFGATDYTSSIDVWSAGCVLAELLLGQ 254

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 94/209 (44%), Gaps = 19/209 (9%)
Query: 51  FSDANKLGEGGFGPVYKGVL-KKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVR 109
           ++D   +G G FG VY+  L   G+ +A+K++     Q  R    E  ++ K+ H N+VR
Sbjct: 41  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----QDKRFKNRELQIMRKLDHCNIVR 96
Query: 110 LLGCCIDRDEKI------LIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLY 163
           L        EK       L+ +Y+P             +  L  +     +  + + L Y
Sbjct: 97  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 156
Query: 164 LHQYSRVRIIHRDLKASNILLDKDMNP-KISDFGMARICGGNELQANTSRIVGTYGYMSP 222
           +H +    I HRD+K  N+LLD D    K+ DFG A+     E   N S I   Y Y +P
Sbjct: 157 IHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSXICSRY-YRAP 210
Query: 223 EYALEGI-FSIKSDVFSFGVLLLEIVSGK 250
           E       ++   DV+S G +L E++ G+
Sbjct: 211 ELIFGATDYTSSIDVWSAGCVLAELLLGQ 239

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 94/209 (44%), Gaps = 19/209 (9%)
Query: 51  FSDANKLGEGGFGPVYKGVL-KKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVR 109
           ++D   +G G FG VY+  L   G+ +A+K++     Q  R    E  ++ K+ H N+VR
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----QDKRFKNRELQIMRKLDHCNIVR 77
Query: 110 LLGCCIDRDEKI------LIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLY 163
           L        EK       L+ +Y+P             +  L  +     +  + + L Y
Sbjct: 78  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137
Query: 164 LHQYSRVRIIHRDLKASNILLDKDMNP-KISDFGMARICGGNELQANTSRIVGTYGYMSP 222
           +H +    I HRD+K  N+LLD D    K+ DFG A+     E   N S I   Y Y +P
Sbjct: 138 IHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSXICSRY-YRAP 191
Query: 223 EYALEGI-FSIKSDVFSFGVLLLEIVSGK 250
           E       ++   DV+S G +L E++ G+
Sbjct: 192 ELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 95/205 (46%), Gaps = 15/205 (7%)
Query: 49  NKFSDANKLGEGGFGPVY-KGVLKKGDEIAVKRLSGRSGQGLREMK---NEASVIAKVQH 104
           ++F     +G G FG V     ++ G+  A+K L  +    L++++   NE  ++  V  
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 105 KNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYL 164
             LV+L     D     ++ EYMP   +    F   +R  +   +        AQ +L  
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYMPGGDM----FSHLRR--IGRFSEPHARFYAAQIVLTF 154
Query: 165 HQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY 224
                + +I+RDLK  N+L+D+    K++DFG A+   G      T  + GT  Y++PE 
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKG-----RTWXLCGTPEYLAPEI 209
Query: 225 ALEGIFSIKSDVFSFGVLLLEIVSG 249
            L   ++   D ++ GVL+ E+ +G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 94/209 (44%), Gaps = 19/209 (9%)
Query: 51  FSDANKLGEGGFGPVYKGVL-KKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVR 109
           ++D   +G G FG VY+  L   G+ +A+K++     Q  R    E  ++ K+ H N+VR
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----QDKRFKNRELQIMRKLDHCNIVR 77
Query: 110 LLGCCIDRDEKI------LIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLY 163
           L        EK       L+ +Y+P             +  L  +     +  + + L Y
Sbjct: 78  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137
Query: 164 LHQYSRVRIIHRDLKASNILLDKDMNP-KISDFGMARICGGNELQANTSRIVGTYGYMSP 222
           +H +    I HRD+K  N+LLD D    K+ DFG A+     E   N S I   Y Y +P
Sbjct: 138 IHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSXICSRY-YRAP 191
Query: 223 EYALEGI-FSIKSDVFSFGVLLLEIVSGK 250
           E       ++   DV+S G +L E++ G+
Sbjct: 192 ELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 94/209 (44%), Gaps = 19/209 (9%)
Query: 51  FSDANKLGEGGFGPVYKGVL-KKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVR 109
           ++D   +G G FG VY+  L   G+ +A+K++     Q  R    E  ++ K+ H N+VR
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----QDKRFKNRELQIMRKLDHCNIVR 77
Query: 110 LLGCCIDRDEKI------LIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLY 163
           L        EK       L+ +Y+P             +  L  +     +  + + L Y
Sbjct: 78  LRYFFYSSGEKKDVVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137
Query: 164 LHQYSRVRIIHRDLKASNILLDKDMNP-KISDFGMARICGGNELQANTSRIVGTYGYMSP 222
           +H +    I HRD+K  N+LLD D    K+ DFG A+     E   N S I   Y Y +P
Sbjct: 138 IHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSXICSRY-YRAP 191
Query: 223 EYALEGI-FSIKSDVFSFGVLLLEIVSGK 250
           E       ++   DV+S G +L E++ G+
Sbjct: 192 ELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 94/209 (44%), Gaps = 19/209 (9%)
Query: 51  FSDANKLGEGGFGPVYKGVL-KKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVR 109
           ++D   +G G FG VY+  L   G+ +A+K++     Q  R    E  ++ K+ H N+VR
Sbjct: 34  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----QDKRFKNRELQIMRKLDHCNIVR 89
Query: 110 LLGCCIDRDEKI------LIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLY 163
           L        EK       L+ +Y+P             +  L  +     +  + + L Y
Sbjct: 90  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 149
Query: 164 LHQYSRVRIIHRDLKASNILLDKDMNP-KISDFGMARICGGNELQANTSRIVGTYGYMSP 222
           +H +    I HRD+K  N+LLD D    K+ DFG A+     E   N S I   Y Y +P
Sbjct: 150 IHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSXICSRY-YRAP 203
Query: 223 EYALEGI-FSIKSDVFSFGVLLLEIVSGK 250
           E       ++   DV+S G +L E++ G+
Sbjct: 204 ELIFGATDYTSSIDVWSAGCVLAELLLGQ 232

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 104/226 (46%), Gaps = 39/226 (17%)
Query: 43  SVSTATNKFSDANKLGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKN---EASV 98
           ++     ++ + + +G G +G V      K G  +AVK+LS R  Q +   K    E  +
Sbjct: 16  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRL 74
Query: 99  IAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSL----DFFLFDPTKRMLLDWVTRVQ-- 152
           +  ++H+N++ LL              + P +SL    D +L        L+ + + Q  
Sbjct: 75  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 122
Query: 153 -------IIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE 205
                  +I  I +GL Y+H      IIHRDLK SN+ +++D   KI D G+AR      
Sbjct: 123 TDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDGGLAR-----H 174
Query: 206 LQANTSRIVGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 250
                +  V T  Y +PE  L  + ++   D++S G ++ E+++G+
Sbjct: 175 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 94/209 (44%), Gaps = 19/209 (9%)
Query: 51  FSDANKLGEGGFGPVYKGVL-KKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVR 109
           ++D   +G G FG VY+  L   G+ +A+K++     QG      E  ++ K+ H N+VR
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----QGKAFKNRELQIMRKLDHCNIVR 77
Query: 110 LLGCCIDRDEKI------LIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLY 163
           L        EK       L+ +Y+P             +  L  +     +  + + L Y
Sbjct: 78  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137
Query: 164 LHQYSRVRIIHRDLKASNILLDKDMNP-KISDFGMARICGGNELQANTSRIVGTYGYMSP 222
           +H +    I HRD+K  N+LLD D    K+ DFG A+     E   N S I   Y Y +P
Sbjct: 138 IHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSYICSRY-YRAP 191
Query: 223 EYALEGI-FSIKSDVFSFGVLLLEIVSGK 250
           E       ++   DV+S G +L E++ G+
Sbjct: 192 ELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 94/209 (44%), Gaps = 19/209 (9%)
Query: 51  FSDANKLGEGGFGPVYKGVL-KKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVR 109
           ++D   +G G FG VY+  L   G+ +A+K++     Q  R    E  ++ K+ H N+VR
Sbjct: 35  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----QDKRFKNRELQIMRKLDHCNIVR 90
Query: 110 LLGCCIDRDEKI------LIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLY 163
           L        EK       L+ +Y+P             +  L  +     +  + + L Y
Sbjct: 91  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 150
Query: 164 LHQYSRVRIIHRDLKASNILLDKDMNP-KISDFGMARICGGNELQANTSRIVGTYGYMSP 222
           +H +    I HRD+K  N+LLD D    K+ DFG A+     E   N S I   Y Y +P
Sbjct: 151 IHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSYICSRY-YRAP 204
Query: 223 EYALEGI-FSIKSDVFSFGVLLLEIVSGK 250
           E       ++   DV+S G +L E++ G+
Sbjct: 205 ELIFGATDYTSSIDVWSAGCVLAELLLGQ 233

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 100/208 (48%), Gaps = 22/208 (10%)
Query: 54  ANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLR------EMKNEASVIAKVQHKN 106
             +LG G F  V K   K  G E A K +  R  +  R      E++ E S++ +V H N
Sbjct: 17  GEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHN 76
Query: 107 LVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQ 166
           ++ L     +R + +LI E +    L  FL    ++  L        I+ I  G+ YLH 
Sbjct: 77  VITLHDVYENRTDVVLILELVSGGELFDFL---AQKESLSEEEATSFIKQILDGVNYLHT 133
Query: 167 YSRVRIIHRDLKASNI-LLDKDM---NPKISDFGMAR-ICGGNELQANTSRIVGTYGYMS 221
               +I H DLK  NI LLDK++   + K+ DFG+A  I  G E +     I GT  +++
Sbjct: 134 K---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFK----NIFGTPEFVA 186
Query: 222 PEYALEGIFSIKSDVFSFGVLLLEIVSG 249
           PE        +++D++S GV+   ++SG
Sbjct: 187 PEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 95/205 (46%), Gaps = 15/205 (7%)
Query: 49  NKFSDANKLGEGGFGPVY-KGVLKKGDEIAVKRLSGRSGQGLREMK---NEASVIAKVQH 104
           ++F     LG G FG V     ++ G+  A+K L  +    L+E++   NE  ++  V  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNF 100
Query: 105 KNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYL 164
             LV+L     D     ++ EY P   +    F   +R  +   +        AQ +L  
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGEM----FSHLRR--IGRFSEPHARFYAAQIVLTF 154
Query: 165 HQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY 224
                + +I+RDLK  N+++D+    K++DFG+A+   G      T  + GT  Y++PE 
Sbjct: 155 EYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGLAKRVKG-----RTWXLCGTPEYLAPEI 209
Query: 225 ALEGIFSIKSDVFSFGVLLLEIVSG 249
            L   ++   D ++ GVL+ E+ +G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 94/209 (44%), Gaps = 19/209 (9%)
Query: 51  FSDANKLGEGGFGPVYKGVL-KKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVR 109
           ++D   +G G FG VY+  L   G+ +A+K++     Q  R    E  ++ K+ H N+VR
Sbjct: 58  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----QDKRFKNRELQIMRKLDHCNIVR 113
Query: 110 LLGCCIDRDEKI------LIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLY 163
           L        EK       L+ +Y+P             +  L  +     +  + + L Y
Sbjct: 114 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 173
Query: 164 LHQYSRVRIIHRDLKASNILLDKDMNP-KISDFGMARICGGNELQANTSRIVGTYGYMSP 222
           +H +    I HRD+K  N+LLD D    K+ DFG A+     E   N S I   Y Y +P
Sbjct: 174 IHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSYICSRY-YRAP 227
Query: 223 EYALEGI-FSIKSDVFSFGVLLLEIVSGK 250
           E       ++   DV+S G +L E++ G+
Sbjct: 228 ELIFGATDYTSSIDVWSAGCVLAELLLGQ 256

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 94/209 (44%), Gaps = 19/209 (9%)
Query: 51  FSDANKLGEGGFGPVYKGVL-KKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVR 109
           ++D   +G G FG VY+  L   G+ +A+K++     QG      E  ++ K+ H N+VR
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----QGKAFKNRELQIMRKLDHCNIVR 77
Query: 110 LLGCCIDRDEKI------LIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLY 163
           L        EK       L+ +Y+P             +  L  +     +  + + L Y
Sbjct: 78  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137
Query: 164 LHQYSRVRIIHRDLKASNILLDKDMNP-KISDFGMARICGGNELQANTSRIVGTYGYMSP 222
           +H +    I HRD+K  N+LLD D    K+ DFG A+     E   N S I   Y Y +P
Sbjct: 138 IHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSYICSRY-YRAP 191
Query: 223 EYALEGI-FSIKSDVFSFGVLLLEIVSGK 250
           E       ++   DV+S G +L E++ G+
Sbjct: 192 ELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 100/205 (48%), Gaps = 12/205 (5%)
Query: 49  NKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKR-LSGRSGQGLREMK-NEASVIAKVQHK 105
            K+    K+GEG +G V+K   +  G  +A+K+ L       ++++   E  ++ +++H 
Sbjct: 3   EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHP 62
Query: 106 NLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLH 165
           NLV LL     +    L++EY  +  L     D  +R + + + +  I     Q + + H
Sbjct: 63  NLVNLLEVFRRKRRLHLVFEYCDHTVLH--ELDRYQRGVPEHLVK-SITWQTLQAVNFCH 119
Query: 166 QYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYA 225
           +++    IHRD+K  NIL+ K    K+ DFG AR+  G     +    V T  Y SPE  
Sbjct: 120 KHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDE--VATRWYRSPELL 174
Query: 226 L-EGIFSIKSDVFSFGVLLLEIVSG 249
           + +  +    DV++ G +  E++SG
Sbjct: 175 VGDTQYGPPVDVWAIGCVFAELLSG 199

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 100/201 (49%), Gaps = 14/201 (6%)
Query: 54  ANKLGEGGFGPVYKGVLK-KGDEIAVK---RLSGRSGQGLREMKNEASVIAKVQHKNLVR 109
            + LG G FG V  G  +  G ++AVK   R   RS   + ++K E   +   +H ++++
Sbjct: 16  GDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIK 75
Query: 110 LLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSR 169
           L        +  ++ EY+    L  ++    K   ++ +   ++ + I   + Y H++  
Sbjct: 76  LYQVISTPTDFFMVMEYVSGGELFDYI---CKHGRVEEMEARRLFQQILSAVDYCHRHM- 131
Query: 170 VRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGI 229
             ++HRDLK  N+LLD  MN KI+DFG++ +    E   ++    G+  Y +PE     +
Sbjct: 132 --VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRDSC---GSPNYAAPEVISGRL 186
Query: 230 FS-IKSDVFSFGVLLLEIVSG 249
           ++  + D++S GV+L  ++ G
Sbjct: 187 YAGPEVDIWSCGVILYALLCG 207

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 100/208 (48%), Gaps = 22/208 (10%)
Query: 54  ANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLR------EMKNEASVIAKVQHKN 106
             +LG G F  V K   K  G E A K +  R  +  R      E++ E S++ +V H N
Sbjct: 17  GEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHN 76
Query: 107 LVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQ 166
           ++ L     +R + +LI E +    L  FL    ++  L        I+ I  G+ YLH 
Sbjct: 77  VITLHDVYENRTDVVLILELVSGGELFDFL---AQKESLSEEEATSFIKQILDGVNYLHT 133
Query: 167 YSRVRIIHRDLKASNI-LLDKDM---NPKISDFGMAR-ICGGNELQANTSRIVGTYGYMS 221
               +I H DLK  NI LLDK++   + K+ DFG+A  I  G E +     I GT  +++
Sbjct: 134 K---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFK----NIFGTPEFVA 186
Query: 222 PEYALEGIFSIKSDVFSFGVLLLEIVSG 249
           PE        +++D++S GV+   ++SG
Sbjct: 187 PEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 100/208 (48%), Gaps = 22/208 (10%)
Query: 54  ANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLR------EMKNEASVIAKVQHKN 106
             +LG G F  V K   K  G E A K +  R  +  R      E++ E S++ +V H N
Sbjct: 17  GEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHN 76
Query: 107 LVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQ 166
           ++ L     +R + +LI E +    L  FL    ++  L        I+ I  G+ YLH 
Sbjct: 77  VITLHDVYENRTDVVLILELVSGGELFDFL---AQKESLSEEEATSFIKQILDGVNYLHT 133
Query: 167 YSRVRIIHRDLKASNI-LLDKDM---NPKISDFGMAR-ICGGNELQANTSRIVGTYGYMS 221
               +I H DLK  NI LLDK++   + K+ DFG+A  I  G E +     I GT  +++
Sbjct: 134 K---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFK----NIFGTPEFVA 186
Query: 222 PEYALEGIFSIKSDVFSFGVLLLEIVSG 249
           PE        +++D++S GV+   ++SG
Sbjct: 187 PEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 94/209 (44%), Gaps = 19/209 (9%)
Query: 51  FSDANKLGEGGFGPVYKGVL-KKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVR 109
           ++D   +G G FG VY+  L   G+ +A+K++     Q  R    E  ++ K+ H N+VR
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----QDKRFKNRELQIMRKLDHCNIVR 77
Query: 110 LLGCCIDRDEKI------LIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLY 163
           L        EK       L+ +Y+P             +  L  +     +  + + L Y
Sbjct: 78  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137
Query: 164 LHQYSRVRIIHRDLKASNILLDKDMNP-KISDFGMARICGGNELQANTSRIVGTYGYMSP 222
           +H +    I HRD+K  N+LLD D    K+ DFG A+     E   N S I   Y Y +P
Sbjct: 138 IHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSYICSRY-YRAP 191
Query: 223 EYALEGI-FSIKSDVFSFGVLLLEIVSGK 250
           E       ++   DV+S G +L E++ G+
Sbjct: 192 ELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 94/209 (44%), Gaps = 19/209 (9%)
Query: 51  FSDANKLGEGGFGPVYKGVL-KKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVR 109
           ++D   +G G FG VY+  L   G+ +A+K++     Q  R    E  ++ K+ H N+VR
Sbjct: 60  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----QDKRFKNRELQIMRKLDHCNIVR 115
Query: 110 LLGCCIDRDEKI------LIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLY 163
           L        EK       L+ +Y+P             +  L  +     +  + + L Y
Sbjct: 116 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 175
Query: 164 LHQYSRVRIIHRDLKASNILLDKDMNP-KISDFGMARICGGNELQANTSRIVGTYGYMSP 222
           +H +    I HRD+K  N+LLD D    K+ DFG A+     E   N S I   Y Y +P
Sbjct: 176 IHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSYICSRY-YRAP 229
Query: 223 EYALEGI-FSIKSDVFSFGVLLLEIVSGK 250
           E       ++   DV+S G +L E++ G+
Sbjct: 230 ELIFGATDYTSSIDVWSAGCVLAELLLGQ 258

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 100/208 (48%), Gaps = 22/208 (10%)
Query: 54  ANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLR------EMKNEASVIAKVQHKN 106
             +LG G F  V K   K  G E A K +  R  +  R      E++ E S++ +V H N
Sbjct: 17  GEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHN 76
Query: 107 LVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQ 166
           ++ L     +R + +LI E +    L  FL    ++  L        I+ I  G+ YLH 
Sbjct: 77  VITLHDVYENRTDVVLILELVSGGELFDFL---AQKESLSEEEATSFIKQILDGVNYLHT 133
Query: 167 YSRVRIIHRDLKASNI-LLDKDM---NPKISDFGMAR-ICGGNELQANTSRIVGTYGYMS 221
               +I H DLK  NI LLDK++   + K+ DFG+A  I  G E +     I GT  +++
Sbjct: 134 K---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFK----NIFGTPEFVA 186
Query: 222 PEYALEGIFSIKSDVFSFGVLLLEIVSG 249
           PE        +++D++S GV+   ++SG
Sbjct: 187 PEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 101/206 (49%), Gaps = 25/206 (12%)
Query: 57  LGEGGFGPVYKGVL----KKGDEIAVKRLSGRSG-QGLREMKNEASVIAKVQHKNLVRLL 111
           +G+G FG VY G      +   + A+K LS  +  Q +     E  ++  + H N++ L+
Sbjct: 29  IGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALI 88
Query: 112 GCCIDRDE-KILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRV 170
           G  +  +    ++  YM +  L  F+  P +   +  +    +   +A+G+ YL   +  
Sbjct: 89  GIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGL--QVARGMEYL---AEQ 143
Query: 171 RIIHRDLKASNILLDKDMNPKISDFGMARICGGNEL----QANTSRIVGTYGYMSPEYAL 226
           + +HRDL A N +LD+    K++DFG+AR     E     Q   +R+   +       AL
Sbjct: 144 KFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWT------AL 197
Query: 227 EGI----FSIKSDVFSFGVLLLEIVS 248
           E +    F+ KSDV+SFGVLL E+++
Sbjct: 198 ESLQTYRFTTKSDVWSFGVLLWELLT 223

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 94/209 (44%), Gaps = 19/209 (9%)
Query: 51  FSDANKLGEGGFGPVYKGVL-KKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVR 109
           ++D   +G G FG VY+  L   G+ +A+K++     Q  R    E  ++ K+ H N+VR
Sbjct: 26  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----QDKRFKNRELQIMRKLDHCNIVR 81
Query: 110 LLGCCIDRDEKI------LIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLY 163
           L        EK       L+ +Y+P             +  L  +     +  + + L Y
Sbjct: 82  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 141
Query: 164 LHQYSRVRIIHRDLKASNILLDKDMNP-KISDFGMARICGGNELQANTSRIVGTYGYMSP 222
           +H +    I HRD+K  N+LLD D    K+ DFG A+     E   N S I   Y Y +P
Sbjct: 142 IHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSXICSRY-YRAP 195
Query: 223 EYALEGI-FSIKSDVFSFGVLLLEIVSGK 250
           E       ++   DV+S G +L E++ G+
Sbjct: 196 ELIFGATDYTSSIDVWSAGCVLAELLLGQ 224

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 94/209 (44%), Gaps = 19/209 (9%)
Query: 51  FSDANKLGEGGFGPVYKGVL-KKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVR 109
           ++D   +G G FG VY+  L   G+ +A+K++     QG      E  ++ K+ H N+VR
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----QGKAFKNRELQIMRKLDHCNIVR 77
Query: 110 LLGCCIDRDEKI------LIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLY 163
           L        EK       L+ +Y+P             +  L  +     +  + + L Y
Sbjct: 78  LRYFFYSSGEKKDEVYLNLVLDYVPATVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137
Query: 164 LHQYSRVRIIHRDLKASNILLDKDMNP-KISDFGMARICGGNELQANTSRIVGTYGYMSP 222
           +H +    I HRD+K  N+LLD D    K+ DFG A+     E   N S I   Y Y +P
Sbjct: 138 IHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSXICSRY-YRAP 191
Query: 223 EYALEGI-FSIKSDVFSFGVLLLEIVSGK 250
           E       ++   DV+S G +L E++ G+
Sbjct: 192 ELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 61/228 (26%), Positives = 111/228 (48%), Gaps = 28/228 (12%)
Query: 50  KFSDANKLGEGGFGPV---YKGVLKKGDEIAVKRLSGRSGQG-----LREMKNEASVIAK 101
           ++++ + +GEG +G V   Y  + K    +A+K++S    Q      LRE+K    ++ +
Sbjct: 28  RYTNLSYIGEGAYGMVCSAYDNLNKV--RVAIKKISPFEHQTYCQRTLREIK----ILLR 81
Query: 102 VQHKNLVRL----LGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGI 157
            +H+N++ +        I++ + + I + +     D +    T+ +  D +     +  I
Sbjct: 82  FRHENIIGINDIIRAPTIEQMKDVYIVQDL--METDLYKLLKTQHLSNDHI--CYFLYQI 137
Query: 158 AQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQAN-TSRIVGT 216
            +GL Y+H      ++HRDLK SN+LL+   + KI DFG+AR+   +          V T
Sbjct: 138 LRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVAT 194
Query: 217 YGYMSPEYALEGIFSIKS-DVFSFGVLLLEIVSGKK-NTGLYRTDSLN 262
             Y +PE  L      KS D++S G +L E++S +    G +  D LN
Sbjct: 195 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLN 242

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 94/209 (44%), Gaps = 19/209 (9%)
Query: 51  FSDANKLGEGGFGPVYKGVL-KKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVR 109
           ++D   +G G FG VY+  L   G+ +A+K++     Q  R    E  ++ K+ H N+VR
Sbjct: 101 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----QDKRFKNRELQIMRKLDHCNIVR 156
Query: 110 LLGCCIDRDEKI------LIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLY 163
           L        EK       L+ +Y+P             +  L  +     +  + + L Y
Sbjct: 157 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 216
Query: 164 LHQYSRVRIIHRDLKASNILLDKDMNP-KISDFGMARICGGNELQANTSRIVGTYGYMSP 222
           +H +    I HRD+K  N+LLD D    K+ DFG A+     E   N S I   Y Y +P
Sbjct: 217 IHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSYICSRY-YRAP 270
Query: 223 EYALEGI-FSIKSDVFSFGVLLLEIVSGK 250
           E       ++   DV+S G +L E++ G+
Sbjct: 271 ELIFGATDYTSSIDVWSAGCVLAELLLGQ 299

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 100/208 (48%), Gaps = 22/208 (10%)
Query: 54  ANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLR------EMKNEASVIAKVQHKN 106
             +LG G F  V K   K  G E A K +  R  +  R      E++ E S++ +V H N
Sbjct: 17  GEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHN 76
Query: 107 LVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQ 166
           ++ L     +R + +LI E +    L  FL    ++  L        I+ I  G+ YLH 
Sbjct: 77  VITLHDVYENRTDVVLILELVSGGELFDFL---AQKESLSEEEATSFIKQILDGVNYLHT 133
Query: 167 YSRVRIIHRDLKASNI-LLDKDM---NPKISDFGMAR-ICGGNELQANTSRIVGTYGYMS 221
               +I H DLK  NI LLDK++   + K+ DFG+A  I  G E +     I GT  +++
Sbjct: 134 K---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFK----NIFGTPEFVA 186
Query: 222 PEYALEGIFSIKSDVFSFGVLLLEIVSG 249
           PE        +++D++S GV+   ++SG
Sbjct: 187 PEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 61/228 (26%), Positives = 111/228 (48%), Gaps = 28/228 (12%)
Query: 50  KFSDANKLGEGGFGPV---YKGVLKKGDEIAVKRLSGRSGQG-----LREMKNEASVIAK 101
           ++++ + +GEG +G V   Y  + K    +A+K++S    Q      LRE+K    ++ +
Sbjct: 29  RYTNLSYIGEGAYGMVCSAYDNLNKV--RVAIKKISPFEHQTYCQRTLREIK----ILLR 82
Query: 102 VQHKNLVRL----LGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGI 157
            +H+N++ +        I++ + + I + +     D +    T+ +  D +     +  I
Sbjct: 83  FRHENIIGINDIIRAPTIEQMKDVYIVQDL--METDLYKLLKTQHLSNDHI--CYFLYQI 138
Query: 158 AQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQAN-TSRIVGT 216
            +GL Y+H      ++HRDLK SN+LL+   + KI DFG+AR+   +          V T
Sbjct: 139 LRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVAT 195
Query: 217 YGYMSPEYALEGIFSIKS-DVFSFGVLLLEIVSGKK-NTGLYRTDSLN 262
             Y +PE  L      KS D++S G +L E++S +    G +  D LN
Sbjct: 196 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLN 243

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 63/200 (31%), Positives = 97/200 (48%), Gaps = 17/200 (8%)
Query: 57  LGEGGFGPVYKGVLKKGDEI--AVKRLSGRSGQGLREMKN---EASVIAK-VQHKNLVRL 110
           +G+G FG V      K +E+  AVK L  ++    +E K+   E +V+ K V+H  LV L
Sbjct: 46  IGKGSFGKVLLA-RHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 104
Query: 111 LGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRV 170
                  D+   + +Y+    L + L    +R  L+   R    E IA  L YLH    +
Sbjct: 105 HFSFQTADKLYFVLDYINGGELFYHL--QRERCFLEPRARFYAAE-IASALGYLHS---L 158
Query: 171 RIIHRDLKASNILLDKDMNPKISDFGMARICGGN-ELQANTSRIVGTYGYMSPEYALEGI 229
            I++RDLK  NILLD   +  ++DFG+   C  N E  + TS   GT  Y++PE   +  
Sbjct: 159 NIVYRDLKPENILLDSQGHIVLTDFGL---CKENIEHNSTTSTFCGTPEYLAPEVLHKQP 215
Query: 230 FSIKSDVFSFGVLLLEIVSG 249
           +    D +  G +L E++ G
Sbjct: 216 YDRTVDWWCLGAVLYEMLYG 235

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 63/242 (26%), Positives = 112/242 (46%), Gaps = 56/242 (23%)
Query: 50  KFSDANKLGEGGFGPV---YKGVLKKGDEIAVKRLSGRSGQG-----LREMKNEASVIAK 101
           ++++ + +GEG +G V   Y  + K    +A+K++S    Q      LRE+K    ++ +
Sbjct: 28  RYTNLSYIGEGAYGMVCSAYDNLNKV--RVAIKKISPFEHQTYCQRTLREIK----ILLR 81
Query: 102 VQHKNLV------------RLLGCCIDRD------EKILIYEYMPNKSLDFFLFDPTKRM 143
            +H+N++            ++    I +D       K+L  +++ N  + +FL+      
Sbjct: 82  FRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKCQHLSNDHICYFLYQ----- 136
Query: 144 LLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGG 203
                        I +GL Y+H      ++HRDLK SN+LL+   + KI DFG+AR+   
Sbjct: 137 -------------ILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADP 180
Query: 204 NELQAN-TSRIVGTYGYMSPEYALEGIFSIKS-DVFSFGVLLLEIVSGKK-NTGLYRTDS 260
           +       +  V T  Y +PE  L      KS D++S G +L E++S +    G +  D 
Sbjct: 181 DHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQ 240
Query: 261 LN 262
           LN
Sbjct: 241 LN 242

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 53/197 (26%), Positives = 95/197 (48%), Gaps = 14/197 (7%)
Query: 57  LGEGGFGPVYKGVLKKGDE----IAVKRLSGRSGQGLRE-MKNEASVIAKVQHKNLVRLL 111
           +GEG FG V++G+    +     +A+K     +   +RE    EA  + +  H ++V+L+
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 112 GCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVR 171
           G  I  +   +I E      L  FL    ++  LD  + +     ++  L YL      R
Sbjct: 458 GV-ITENPVWIIMELCTLGELRSFL--QVRKFSLDLASLILYAYQLSTALAYLESK---R 511
Query: 172 IIHRDLKASNILLDKDMNPKISDFGMAR-ICGGNELQANTSRIVGTYGYMSPEYALEGIF 230
            +HRD+ A N+L+  +   K+ DFG++R +      +A+  ++     +M+PE      F
Sbjct: 512 FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL--PIKWMAPESINFRRF 569
Query: 231 SIKSDVFSFGVLLLEIV 247
           +  SDV+ FGV + EI+
Sbjct: 570 TSASDVWMFGVCMWEIL 586

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 99/201 (49%), Gaps = 14/201 (6%)
Query: 54  ANKLGEGGFGPVYKGVLK-KGDEIAVK---RLSGRSGQGLREMKNEASVIAKVQHKNLVR 109
            + LG G FG V  G  +  G ++AVK   R   RS   + ++K E   +   +H ++++
Sbjct: 16  GDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIK 75
Query: 110 LLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSR 169
           L        +  ++ EY+    L  ++    K   ++ +   ++ + I   + Y H++  
Sbjct: 76  LYQVISTPTDFFMVMEYVSGGELFDYI---CKHGRVEEMEARRLFQQILSAVDYCHRHM- 131
Query: 170 VRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGI 229
             ++HRDLK  N+LLD  MN KI+DFG++ +    E    +    G+  Y +PE     +
Sbjct: 132 --VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC---GSPNYAAPEVISGRL 186
Query: 230 FS-IKSDVFSFGVLLLEIVSG 249
           ++  + D++S GV+L  ++ G
Sbjct: 187 YAGPEVDIWSCGVILYALLCG 207

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 60/228 (26%), Positives = 112/228 (49%), Gaps = 28/228 (12%)
Query: 50  KFSDANKLGEGGFGPV---YKGVLKKGDEIAVKRLSGRSGQG-----LREMKNEASVIAK 101
           ++++ + +GEG +G V   Y  + K    +A++++S    Q      LRE+K    ++ +
Sbjct: 28  RYTNLSYIGEGAYGMVCSAYDNLNKV--RVAIRKISPFEHQTYCQRTLREIK----ILLR 81
Query: 102 VQHKNLVRL----LGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGI 157
            +H+N++ +        I++ + + I + +     D +    T+ +  D +     +  I
Sbjct: 82  FRHENIIGINDIIRAPTIEQMKDVYIVQDL--METDLYKLLKTQHLSNDHI--CYFLYQI 137
Query: 158 AQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQAN-TSRIVGT 216
            +GL Y+H      ++HRDLK SN+LL+   + KI DFG+AR+   +       +  V T
Sbjct: 138 LRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 194
Query: 217 YGYMSPEYALEGIFSIKS-DVFSFGVLLLEIVSGKK-NTGLYRTDSLN 262
             Y +PE  L      KS D++S G +L E++S +    G +  D LN
Sbjct: 195 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLN 242

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 61/197 (30%), Positives = 96/197 (48%), Gaps = 16/197 (8%)
Query: 54  ANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRS-GQGLR-EMKNEASVIAKVQH-KNLVR 109
           + +LG G F  V + + K  G E A K L  R  GQ  R E+ +E +V+   +    ++ 
Sbjct: 34  SKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVIN 93
Query: 110 LLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSR 169
           L     +  E ILI EY     + F L  P    ++     +++I+ I +G+ YLHQ + 
Sbjct: 94  LHEVYENTSEIILILEYAAGGEI-FSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNN- 151
Query: 170 VRIIHRDLKASNILLDKDMNP----KISDFGMARICGGNELQANTSRIVGTYGYMSPEYA 225
             I+H DLK  NILL   + P    KI DFGM+R  G          I+GT  Y++PE  
Sbjct: 152 --IVHLDLKPQNILL-SSIYPLGDIKIVDFGMSRKIGH---ACELREIMGTPEYLAPEIL 205
Query: 226 LEGIFSIKSDVFSFGVL 242
                +  +D+++ G++
Sbjct: 206 NYDPITTATDMWNIGII 222

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 53/197 (26%), Positives = 95/197 (48%), Gaps = 14/197 (7%)
Query: 57  LGEGGFGPVYKGVLKKGDE----IAVKRLSGRSGQGLRE-MKNEASVIAKVQHKNLVRLL 111
           +GEG FG V++G+    +     +A+K     +   +RE    EA  + +  H ++V+L+
Sbjct: 46  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 105
Query: 112 GCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVR 171
           G  I  +   +I E      L  FL    ++  LD  + +     ++  L YL      R
Sbjct: 106 GV-ITENPVWIIMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYLESK---R 159
Query: 172 IIHRDLKASNILLDKDMNPKISDFGMAR-ICGGNELQANTSRIVGTYGYMSPEYALEGIF 230
            +HRD+ A N+L+  +   K+ DFG++R +      +A+  ++     +M+PE      F
Sbjct: 160 FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL--PIKWMAPESINFRRF 217
Query: 231 SIKSDVFSFGVLLLEIV 247
           +  SDV+ FGV + EI+
Sbjct: 218 TSASDVWMFGVCMWEIL 234

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 102/212 (48%), Gaps = 23/212 (10%)
Query: 48  TNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVK-----RLSGRSGQGLREMKNEASVIAK 101
           ++++    KLG G +G V     K  G E A+K      ++  S  G   + +E +V+ +
Sbjct: 20  SDRYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSG--ALLDEVAVLKQ 77
Query: 102 VQHKNLVRLLGCCIDRDEKILIYE-YMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQG 160
           + H N+++L     D+    L+ E Y   +  D  +     R     V    I++ +  G
Sbjct: 78  LDHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIIL----RQKFSEVDAAVIMKQVLSG 133
Query: 161 LLYLHQYSRVRIIHRDLKASNILLD---KDMNPKISDFGMARICGGNELQANTSRIVGTY 217
             YLH+++   I+HRDLK  N+LL+   +D   KI DFG++      E+       +GT 
Sbjct: 134 TTYLHKHN---IVHRDLKPENLLLESKSRDALIKIVDFGLS---AHFEVGGKMKERLGTA 187
Query: 218 GYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 249
            Y++PE  L   +  K DV+S GV+L  ++ G
Sbjct: 188 YYIAPE-VLRKKYDEKCDVWSCGVILYILLCG 218

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 53/197 (26%), Positives = 95/197 (48%), Gaps = 14/197 (7%)
Query: 57  LGEGGFGPVYKGVLKKGDE----IAVKRLSGRSGQGLRE-MKNEASVIAKVQHKNLVRLL 111
           +GEG FG V++G+    +     +A+K     +   +RE    EA  + +  H ++V+L+
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 112 GCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVR 171
           G  I  +   +I E      L  FL    ++  LD  + +     ++  L YL      R
Sbjct: 78  GV-ITENPVWIIMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYLESK---R 131
Query: 172 IIHRDLKASNILLDKDMNPKISDFGMAR-ICGGNELQANTSRIVGTYGYMSPEYALEGIF 230
            +HRD+ A N+L+  +   K+ DFG++R +      +A+  ++     +M+PE      F
Sbjct: 132 FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL--PIKWMAPESINFRRF 189
Query: 231 SIKSDVFSFGVLLLEIV 247
           +  SDV+ FGV + EI+
Sbjct: 190 TSASDVWMFGVCMWEIL 206

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 102/212 (48%), Gaps = 23/212 (10%)
Query: 48  TNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVK-----RLSGRSGQGLREMKNEASVIAK 101
           ++++    KLG G +G V     K  G E A+K      ++  S  G   + +E +V+ +
Sbjct: 3   SDRYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGA--LLDEVAVLKQ 60
Query: 102 VQHKNLVRLLGCCIDRDEKILIYE-YMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQG 160
           + H N+++L     D+    L+ E Y   +  D  +     R     V    I++ +  G
Sbjct: 61  LDHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIIL----RQKFSEVDAAVIMKQVLSG 116
Query: 161 LLYLHQYSRVRIIHRDLKASNILLD---KDMNPKISDFGMARICGGNELQANTSRIVGTY 217
             YLH+++   I+HRDLK  N+LL+   +D   KI DFG++      E+       +GT 
Sbjct: 117 TTYLHKHN---IVHRDLKPENLLLESKSRDALIKIVDFGLS---AHFEVGGKMKERLGTA 170
Query: 218 GYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 249
            Y++PE  L   +  K DV+S GV+L  ++ G
Sbjct: 171 YYIAPE-VLRKKYDEKCDVWSCGVILYILLCG 201

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 53/197 (26%), Positives = 95/197 (48%), Gaps = 14/197 (7%)
Query: 57  LGEGGFGPVYKGVLKKGDE----IAVKRLSGRSGQGLRE-MKNEASVIAKVQHKNLVRLL 111
           +GEG FG V++G+    +     +A+K     +   +RE    EA  + +  H ++V+L+
Sbjct: 15  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 74
Query: 112 GCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVR 171
           G  I  +   +I E      L  FL    ++  LD  + +     ++  L YL      R
Sbjct: 75  GV-ITENPVWIIMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYLESK---R 128
Query: 172 IIHRDLKASNILLDKDMNPKISDFGMAR-ICGGNELQANTSRIVGTYGYMSPEYALEGIF 230
            +HRD+ A N+L+  +   K+ DFG++R +      +A+  ++     +M+PE      F
Sbjct: 129 FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL--PIKWMAPESINFRRF 186
Query: 231 SIKSDVFSFGVLLLEIV 247
           +  SDV+ FGV + EI+
Sbjct: 187 TSASDVWMFGVCMWEIL 203

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 53/197 (26%), Positives = 95/197 (48%), Gaps = 14/197 (7%)
Query: 57  LGEGGFGPVYKGVLKKGDE----IAVKRLSGRSGQGLRE-MKNEASVIAKVQHKNLVRLL 111
           +GEG FG V++G+    +     +A+K     +   +RE    EA  + +  H ++V+L+
Sbjct: 18  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 112 GCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVR 171
           G  I  +   +I E      L  FL    ++  LD  + +     ++  L YL      R
Sbjct: 78  GV-ITENPVWIIMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYLESK---R 131
Query: 172 IIHRDLKASNILLDKDMNPKISDFGMAR-ICGGNELQANTSRIVGTYGYMSPEYALEGIF 230
            +HRD+ A N+L+  +   K+ DFG++R +      +A+  ++     +M+PE      F
Sbjct: 132 FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL--PIKWMAPESINFRRF 189
Query: 231 SIKSDVFSFGVLLLEIV 247
           +  SDV+ FGV + EI+
Sbjct: 190 TSASDVWMFGVCMWEIL 206

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 53/197 (26%), Positives = 95/197 (48%), Gaps = 14/197 (7%)
Query: 57  LGEGGFGPVYKGVLKKGDE----IAVKRLSGRSGQGLRE-MKNEASVIAKVQHKNLVRLL 111
           +GEG FG V++G+    +     +A+K     +   +RE    EA  + +  H ++V+L+
Sbjct: 20  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 79
Query: 112 GCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVR 171
           G  I  +   +I E      L  FL    ++  LD  + +     ++  L YL      R
Sbjct: 80  GV-ITENPVWIIMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYLESK---R 133
Query: 172 IIHRDLKASNILLDKDMNPKISDFGMAR-ICGGNELQANTSRIVGTYGYMSPEYALEGIF 230
            +HRD+ A N+L+  +   K+ DFG++R +      +A+  ++     +M+PE      F
Sbjct: 134 FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL--PIKWMAPESINFRRF 191
Query: 231 SIKSDVFSFGVLLLEIV 247
           +  SDV+ FGV + EI+
Sbjct: 192 TSASDVWMFGVCMWEIL 208

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 101/220 (45%), Gaps = 12/220 (5%)
Query: 50  KFSDANKLGEGGFGPV---YKGVLKKGDEIAVKRLSGRSGQG-LREMKNEASVIAKVQHK 105
           +++    +GEG +G V   Y  V K    +A+K++S    Q   +    E  ++ + +H+
Sbjct: 44  RYTQLQYIGEGAYGMVSSAYDHVRKT--RVAIKKISPFEHQTYCQRTLREIQILLRFRHE 101
Query: 106 NLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLH 165
           N++ +         + +   Y+    ++  L+   K   L        +  I +GL Y+H
Sbjct: 102 NVIGIRDILRASTLEAMRDVYIVQDLMETDLYKLLKSQQLSNDHICYFLYQILRGLKYIH 161
Query: 166 QYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQAN-TSRIVGTYGYMSPEY 224
                 ++HRDLK SN+L++   + KI DFG+ARI           +  V T  Y +PE 
Sbjct: 162 S---ANVLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEXVATRWYRAPEI 218
Query: 225 ALEGIFSIKS-DVFSFGVLLLEIVSGKK-NTGLYRTDSLN 262
            L      KS D++S G +L E++S +    G +  D LN
Sbjct: 219 MLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLN 258

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 53/197 (26%), Positives = 95/197 (48%), Gaps = 14/197 (7%)
Query: 57  LGEGGFGPVYKGVLKKGDE----IAVKRLSGRSGQGLRE-MKNEASVIAKVQHKNLVRLL 111
           +GEG FG V++G+    +     +A+K     +   +RE    EA  + +  H ++V+L+
Sbjct: 23  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 82
Query: 112 GCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVR 171
           G  I  +   +I E      L  FL    ++  LD  + +     ++  L YL      R
Sbjct: 83  GV-ITENPVWIIMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYLESK---R 136
Query: 172 IIHRDLKASNILLDKDMNPKISDFGMAR-ICGGNELQANTSRIVGTYGYMSPEYALEGIF 230
            +HRD+ A N+L+  +   K+ DFG++R +      +A+  ++     +M+PE      F
Sbjct: 137 FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL--PIKWMAPESINFRRF 194
Query: 231 SIKSDVFSFGVLLLEIV 247
           +  SDV+ FGV + EI+
Sbjct: 195 TSASDVWMFGVCMWEIL 211

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 34/95 (35%), Positives = 60/95 (63%), Gaps = 6/95 (6%)
Query: 165 HQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY 224
           H ++R  +++RDLK +NILLD+  + +ISD G+A  C  ++ + + S  VGT+GYM+PE 
Sbjct: 307 HMHNRF-VVYRDLKPANILLDEHGHVRISDLGLA--CDFSKKKPHAS--VGTHGYMAPEV 361
Query: 225 ALEGI-FSIKSDVFSFGVLLLEIVSGKKNTGLYRT 258
             +G+ +   +D FS G +L +++ G      ++T
Sbjct: 362 LQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKT 396

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 34/95 (35%), Positives = 60/95 (63%), Gaps = 6/95 (6%)
Query: 165 HQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY 224
           H ++R  +++RDLK +NILLD+  + +ISD G+A  C  ++ + + S  VGT+GYM+PE 
Sbjct: 307 HMHNRF-VVYRDLKPANILLDEHGHVRISDLGLA--CDFSKKKPHAS--VGTHGYMAPEV 361
Query: 225 ALEGI-FSIKSDVFSFGVLLLEIVSGKKNTGLYRT 258
             +G+ +   +D FS G +L +++ G      ++T
Sbjct: 362 LQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKT 396

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 34/95 (35%), Positives = 60/95 (63%), Gaps = 6/95 (6%)
Query: 165 HQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY 224
           H ++R  +++RDLK +NILLD+  + +ISD G+A  C  ++ + + S  VGT+GYM+PE 
Sbjct: 306 HMHNRF-VVYRDLKPANILLDEHGHVRISDLGLA--CDFSKKKPHAS--VGTHGYMAPEV 360
Query: 225 ALEGI-FSIKSDVFSFGVLLLEIVSGKKNTGLYRT 258
             +G+ +   +D FS G +L +++ G      ++T
Sbjct: 361 LQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKT 395

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 34/95 (35%), Positives = 60/95 (63%), Gaps = 6/95 (6%)
Query: 165 HQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY 224
           H ++R  +++RDLK +NILLD+  + +ISD G+A  C  ++ + + S  VGT+GYM+PE 
Sbjct: 307 HMHNRF-VVYRDLKPANILLDEHGHVRISDLGLA--CDFSKKKPHAS--VGTHGYMAPEV 361
Query: 225 ALEGI-FSIKSDVFSFGVLLLEIVSGKKNTGLYRT 258
             +G+ +   +D FS G +L +++ G      ++T
Sbjct: 362 LQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKT 396

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 53/197 (26%), Positives = 95/197 (48%), Gaps = 14/197 (7%)
Query: 57  LGEGGFGPVYKGVLKKGDE----IAVKRLSGRSGQGLRE-MKNEASVIAKVQHKNLVRLL 111
           +GEG FG V++G+    +     +A+K     +   +RE    EA  + +  H ++V+L+
Sbjct: 21  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 80
Query: 112 GCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVR 171
           G  I  +   +I E      L  FL    ++  LD  + +     ++  L YL      R
Sbjct: 81  GV-ITENPVWIIMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYLESK---R 134
Query: 172 IIHRDLKASNILLDKDMNPKISDFGMAR-ICGGNELQANTSRIVGTYGYMSPEYALEGIF 230
            +HRD+ A N+L+  +   K+ DFG++R +      +A+  ++     +M+PE      F
Sbjct: 135 FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL--PIKWMAPESINFRRF 192
Query: 231 SIKSDVFSFGVLLLEIV 247
           +  SDV+ FGV + EI+
Sbjct: 193 TSASDVWMFGVCMWEIL 209

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 107/220 (48%), Gaps = 26/220 (11%)
Query: 49  NKFSDANKLGEGGFGPVYKGVLKKGDE-IAVKRLSGRSGQGLREMKNEASVIAKVQHKNL 107
           +++ D   LG GG G V+  V    D+ +A+K++     Q ++    E  +I ++ H N+
Sbjct: 11  SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNI 70
Query: 108 VRL--------------LGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQI 153
           V++              +G   + +   ++ EYM     +     P    LL+   R+ +
Sbjct: 71  VKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGP----LLEEHARLFM 126
Query: 154 IEGIAQGLLYLHQYSRVRIIHRDLKASNILLD-KDMNPKISDFGMARICGGN-ELQANTS 211
            + + +GL Y+H      ++HRDLK +N+ ++ +D+  KI DFG+ARI   +   + + S
Sbjct: 127 YQ-LLRGLKYIHS---ANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLS 182
Query: 212 RIVGTYGYMSPEYALEGIFSIKS-DVFSFGVLLLEIVSGK 250
             + T  Y SP   L      K+ D+++ G +  E+++GK
Sbjct: 183 EGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 59/233 (25%), Positives = 111/233 (47%), Gaps = 29/233 (12%)
Query: 34  DQFPLFSFSSVSTATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVK-------RLSGRS 85
           D+ P   +++      K+   + +G G    V + V +  G E AVK       RLS   
Sbjct: 81  DELP--DWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQ 138
Query: 86  GQGLRE-MKNEASVIAKVQ-HKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRM 143
            + +RE  + E  ++ +V  H +++ L+          L+++ M    L  +L   T+++
Sbjct: 139 LEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYL---TEKV 195
Query: 144 LLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMA-RICG 202
            L       I+  + + + +LH  +   I+HRDLK  NILLD +M  ++SDFG +  +  
Sbjct: 196 ALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRLSDFGFSCHLEP 252
Query: 203 GNELQANTSRIVGTYGYMSPEY------ALEGIFSIKSDVFSFGVLLLEIVSG 249
           G +L+     + GT GY++PE            +  + D+++ GV+L  +++G
Sbjct: 253 GEKLR----ELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAG 301

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 95/205 (46%), Gaps = 15/205 (7%)
Query: 49  NKFSDANKLGEGGFGPVY-KGVLKKGDEIAVKRLSGRSGQGLREMK---NEASVIAKVQH 104
           ++F     LG G FG V     ++ G+  A+K L  +    L+E++   NE  ++  V  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNF 100
Query: 105 KNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYL 164
             LV+L     D     ++ EY P   +    F   +R  +   +        AQ +L  
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGEM----FSHLRR--IGRFSEPHARFYAAQIVLTF 154
Query: 165 HQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY 224
                + +I+RDLK  N+++D+    +++DFG+A+   G      T  + GT  Y++PE 
Sbjct: 155 EYLHSLDLIYRDLKPENLMIDQQGYIQVTDFGLAKRVKG-----RTWXLCGTPEYLAPEI 209
Query: 225 ALEGIFSIKSDVFSFGVLLLEIVSG 249
            L   ++   D ++ GVL+ E+ +G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 53/197 (26%), Positives = 94/197 (47%), Gaps = 14/197 (7%)
Query: 57  LGEGGFGPVYKGVLKKGDE----IAVKRLSGRSGQGLRE-MKNEASVIAKVQHKNLVRLL 111
           +GEG FG V++G+    +     +A+K     +   +RE    EA  + +  H ++V+L+
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 112 GCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVR 171
           G  I  +   +I E      L  FL    ++  LD  + +     ++  L YL      R
Sbjct: 78  GV-ITENPVWIIMELCTLGELRSFL--QVRKFSLDLASLILYAYQLSTALAYLESK---R 131
Query: 172 IIHRDLKASNILLDKDMNPKISDFGMAR-ICGGNELQANTSRIVGTYGYMSPEYALEGIF 230
            +HRD+ A N+L+      K+ DFG++R +      +A+  ++     +M+PE      F
Sbjct: 132 FVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKL--PIKWMAPESINFRRF 189
Query: 231 SIKSDVFSFGVLLLEIV 247
           +  SDV+ FGV + EI+
Sbjct: 190 TSASDVWMFGVCMWEIL 206

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 103/221 (46%), Gaps = 26/221 (11%)
Query: 39  FSFSSVSTATNKFSDANKLGEGGFGPVYKGVLKKGDEI--AVKRLSGRSGQGLREMKNEA 96
           F  S+       ++  N +G G +G V K  ++KG  I  A K++     + +   K E 
Sbjct: 16  FQGSTKGDINQYYTLENTIGRGSWGEV-KIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEI 74
Query: 97  SVIAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTR----VQ 152
            ++  + H N++RL     D  +  L+ E      L        +R++   V R     +
Sbjct: 75  EIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGEL-------FERVVHKRVFRESDAAR 127
Query: 153 IIEGIAQGLLYLHQYSRVRIIHRDLKASNILL--DKDMNP-KISDFGM-ARICGGNELQA 208
           I++ +   + Y H   ++ + HRDLK  N L   D   +P K+ DFG+ AR   G  ++ 
Sbjct: 128 IMKDVLSAVAYCH---KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRT 184
Query: 209 NTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 249
                VGT  Y+SP+  LEG++  + D +S GV++  ++ G
Sbjct: 185 K----VGTPYYVSPQ-VLEGLYGPECDEWSAGVMMYVLLCG 220

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 97/207 (46%), Gaps = 19/207 (9%)
Query: 49  NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLREMK---NEASVIAKVQH 104
           ++F     LG G FG V     K+ G+  A+K L  +    L++++   NE  ++  V  
Sbjct: 34  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 93
Query: 105 KNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRM--LLDWVTRVQIIEGIAQGLL 162
             LV+L     D     ++ EY+P   +    F   +R+    +   R    + I     
Sbjct: 94  PFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFXEPHARFYAAQ-IVLTFE 148
Query: 163 YLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSP 222
           YLH    + +I+RDLK  N+L+D+    +++DFG A+   G      T  + GT  Y++P
Sbjct: 149 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAP 200
Query: 223 EYALEGIFSIKSDVFSFGVLLLEIVSG 249
           E  L   ++   D ++ GVL+ E+ +G
Sbjct: 201 EIILSKGYNKAVDWWALGVLIYEMAAG 227

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 97/207 (46%), Gaps = 19/207 (9%)
Query: 49  NKFSDANKLGEGGFGPVY-KGVLKKGDEIAVKRLSGRSGQGLREMK---NEASVIAKVQH 104
           ++F     LG G FG V     ++ G+  A+K L  +    L++++   NE  ++  V  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 105 KNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRM--LLDWVTRVQIIEGIAQGLL 162
             LV+L     D     ++ EY+P   +    F   +R+    +   R    + I     
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFXEPHARFYAAQ-IVLTFE 156
Query: 163 YLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSP 222
           YLH    + +I+RDLK  N+L+D+    +++DFG A+   G      T  + GT  Y++P
Sbjct: 157 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAP 208
Query: 223 EYALEGIFSIKSDVFSFGVLLLEIVSG 249
           E  L   ++   D ++ GVL+ E+ +G
Sbjct: 209 EIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 97/207 (46%), Gaps = 19/207 (9%)
Query: 49  NKFSDANKLGEGGFGPVY-KGVLKKGDEIAVKRLSGRSGQGLREMK---NEASVIAKVQH 104
           ++F     LG G FG V     ++ G+  A+K L  +    L++++   NE  ++  V  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 105 KNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRM--LLDWVTRVQIIEGIAQGLL 162
             LV+L     D     ++ EY+P   +    F   +R+    +   R    + I     
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFXEPHARFYAAQ-IVLTFE 155
Query: 163 YLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSP 222
           YLH    + +I+RDLK  N+L+D+    +++DFG A+   G      T  + GT  Y++P
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAP 207
Query: 223 EYALEGIFSIKSDVFSFGVLLLEIVSG 249
           E  L   ++   D ++ GVL+ E+ +G
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 97/207 (46%), Gaps = 19/207 (9%)
Query: 49  NKFSDANKLGEGGFGPVY-KGVLKKGDEIAVKRLSGRSGQGLREMK---NEASVIAKVQH 104
           ++F     LG G FG V     ++ G+  A+K L  +    L++++   NE  ++  V  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 105 KNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRM--LLDWVTRVQIIEGIAQGLL 162
             LV+L     D     ++ EY+P   +    F   +R+    +   R    + I     
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFXEPHARFYAAQ-IVLTFE 155
Query: 163 YLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSP 222
           YLH    + +I+RDLK  N+L+D+    +++DFG A+   G      T  + GT  Y++P
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAP 207
Query: 223 EYALEGIFSIKSDVFSFGVLLLEIVSG 249
           E  L   ++   D ++ GVL+ E+ +G
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 53/197 (26%), Positives = 94/197 (47%), Gaps = 14/197 (7%)
Query: 57  LGEGGFGPVYKGVLKKGDE----IAVKRLSGRSGQGLRE-MKNEASVIAKVQHKNLVRLL 111
           +GEG FG V++G+    +     +A+K     +   +RE    EA  + +  H ++V+L+
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 112 GCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVR 171
           G  I  +   +I E      L  FL    ++  LD  + +     ++  L YL      R
Sbjct: 458 GV-ITENPVWIIMELCTLGELRSFL--QVRKFSLDLASLILYAYQLSTALAYLESK---R 511
Query: 172 IIHRDLKASNILLDKDMNPKISDFGMAR-ICGGNELQANTSRIVGTYGYMSPEYALEGIF 230
            +HRD+ A N+L+      K+ DFG++R +      +A+  ++     +M+PE      F
Sbjct: 512 FVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKL--PIKWMAPESINFRRF 569
Query: 231 SIKSDVFSFGVLLLEIV 247
           +  SDV+ FGV + EI+
Sbjct: 570 TSASDVWMFGVCMWEIL 586

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 95/205 (46%), Gaps = 15/205 (7%)
Query: 49  NKFSDANKLGEGGFGPVY-KGVLKKGDEIAVKRLSGRSGQGLREMK---NEASVIAKVQH 104
           ++F     LG G FG V     ++ G+  A+K L  +    L++++   NE  ++  V  
Sbjct: 27  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 86
Query: 105 KNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYL 164
             LV+L     D     ++ EY+P   +    F   +R  +   +        AQ +L  
Sbjct: 87  PFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRR--IGRFSEPHARFYAAQIVLTF 140
Query: 165 HQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY 224
                + +I+RDLK  N+L+D+    +++DFG A+   G      T  + GT  Y++PE 
Sbjct: 141 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWTLCGTPEYLAPEI 195
Query: 225 ALEGIFSIKSDVFSFGVLLLEIVSG 249
            L   ++   D ++ GVL+ E+ +G
Sbjct: 196 ILSKGYNKAVDWWALGVLIYEMAAG 220

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 36/92 (39%), Positives = 53/92 (57%), Gaps = 3/92 (3%)
Query: 157 IAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 216
           +A+G+ +L   +  + IHRDL A NILL +    KI DFG+AR    +            
Sbjct: 207 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 263
Query: 217 YGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 248
             +M+PE   + +++I+SDV+SFGVLL EI S
Sbjct: 264 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 295

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 96/207 (46%), Gaps = 19/207 (9%)
Query: 49  NKFSDANKLGEGGFGPVY-KGVLKKGDEIAVKRLSGRSGQGLREMK---NEASVIAKVQH 104
           ++F     LG G FG V     ++ G+  A+K L  +    L++++   NE  ++  V  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 105 KNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRM--LLDWVTRVQIIEGIAQGLL 162
             LV+L     D     ++ EY P   +    F   +R+    +   R    + I     
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGEM----FSHLRRIGRFXEPHARFYAAQ-IVLTFE 155
Query: 163 YLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSP 222
           YLH    + +I+RDLK  N+++D+    K++DFG A+   G      T  + GT  Y++P
Sbjct: 156 YLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKG-----RTWXLCGTPEYLAP 207
Query: 223 EYALEGIFSIKSDVFSFGVLLLEIVSG 249
           E  L   ++   D ++ GVL+ E+ +G
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 36/92 (39%), Positives = 53/92 (57%), Gaps = 3/92 (3%)
Query: 157 IAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 216
           +A+G+ +L   +  + IHRDL A NILL +    KI DFG+AR    +            
Sbjct: 209 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 265
Query: 217 YGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 248
             +M+PE   + +++I+SDV+SFGVLL EI S
Sbjct: 266 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 297

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 95/205 (46%), Gaps = 15/205 (7%)
Query: 49  NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLREMK---NEASVIAKVQH 104
           ++F     LG G FG V     K+ G+  A+K L  +    L++++   NE  ++  V  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 105 KNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYL 164
             LV+L     D     ++ EY+P   +    F   +R  +   +        AQ +L  
Sbjct: 101 PFLVKLEYSFKDNSNLYMVMEYVPGGEM----FSHLRR--IGRFSEPHARFYAAQIVLTF 154
Query: 165 HQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY 224
                + +I+RDLK  N+L+D+    +++DFG A+   G      T  + GT  Y++PE 
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAPEI 209
Query: 225 ALEGIFSIKSDVFSFGVLLLEIVSG 249
            L   ++   D ++ GVL+ E+ +G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 95/205 (46%), Gaps = 15/205 (7%)
Query: 49  NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLREMK---NEASVIAKVQH 104
           ++F     LG G FG V     K+ G+  A+K L  +    L++++   NE  ++  V  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 105 KNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYL 164
             LV+L     D     ++ EY+P   +    F   +R  +   +        AQ +L  
Sbjct: 101 PFLVKLEYSFKDNSNLYMVMEYVPGGEM----FSHLRR--IGRFSEPHARFYAAQIVLTF 154
Query: 165 HQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY 224
                + +I+RDLK  N+L+D+    +++DFG A+   G      T  + GT  Y++PE 
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAPEI 209
Query: 225 ALEGIFSIKSDVFSFGVLLLEIVSG 249
            L   ++   D ++ GVL+ E+ +G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 95/205 (46%), Gaps = 15/205 (7%)
Query: 49  NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLREMK---NEASVIAKVQH 104
           ++F     LG G FG V     K+ G+  A+K L  +    L++++   NE  ++  V  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 105 KNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYL 164
             LV+L     D     ++ EY+P   +    F   +R  +   +        AQ +L  
Sbjct: 101 PFLVKLEYSFKDNSNLYMVMEYVPGGEM----FSHLRR--IGRFSEPHARFYAAQIVLTF 154
Query: 165 HQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY 224
                + +I+RDLK  N+L+D+    +++DFG A+   G      T  + GT  Y++PE 
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAPEI 209
Query: 225 ALEGIFSIKSDVFSFGVLLLEIVSG 249
            L   ++   D ++ GVL+ E+ +G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 98/205 (47%), Gaps = 26/205 (12%)
Query: 55  NKLGEGGFGPVYKGVLKKGDEI--AVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLG 112
           N +G G +G V K  ++KG  I  A K++     + +   K E  ++  + H N++RL  
Sbjct: 15  NTIGRGSWGEV-KIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYE 73
Query: 113 CCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTR----VQIIEGIAQGLLYLHQYS 168
              D  +  L+ E      L        +R++   V R     +I++ +   + Y H   
Sbjct: 74  TFEDNTDIYLVMELCTGGEL-------FERVVHKRVFRESDAARIMKDVLSAVAYCH--- 123
Query: 169 RVRIIHRDLKASNILL--DKDMNP-KISDFGM-ARICGGNELQANTSRIVGTYGYMSPEY 224
           ++ + HRDLK  N L   D   +P K+ DFG+ AR   G  ++      VGT  Y+SP+ 
Sbjct: 124 KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTK----VGTPYYVSPQ- 178
Query: 225 ALEGIFSIKSDVFSFGVLLLEIVSG 249
            LEG++  + D +S GV++  ++ G
Sbjct: 179 VLEGLYGPECDEWSAGVMMYVLLCG 203

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 95/205 (46%), Gaps = 15/205 (7%)
Query: 49  NKFSDANKLGEGGFGPVY-KGVLKKGDEIAVKRLSGRSGQGLREMK---NEASVIAKVQH 104
           ++F     +G G FG V     ++ G+  A+K L  +    L++++   NE  ++  V  
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 105 KNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYL 164
             LV+L     D     ++ EY+P   +    F   +R  +   +        AQ +L  
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRR--IGRFSEPHARFYAAQIVLTF 154
Query: 165 HQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY 224
                + +I+RDLK  N+L+D+    K++DFG A+   G      T  + GT  Y++PE 
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKG-----RTWXLCGTPEYLAPEI 209
Query: 225 ALEGIFSIKSDVFSFGVLLLEIVSG 249
            L   ++   D ++ GVL+ E+ +G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 95/205 (46%), Gaps = 15/205 (7%)
Query: 49  NKFSDANKLGEGGFGPVY-KGVLKKGDEIAVKRLSGRSGQGLREMK---NEASVIAKVQH 104
           ++F     LG G FG V     ++ G+  A+K L  +    L++++   NE  ++  V  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 105 KNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYL 164
             LV+L     D     ++ EY+P   +    F   +R  +   +        AQ +L  
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRR--IGRFSEPHARFYAAQIVLTF 155
Query: 165 HQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY 224
                + +I+RDLK  N+L+D+    +++DFG A+   G      T  + GT  Y++PE 
Sbjct: 156 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAPEI 210
Query: 225 ALEGIFSIKSDVFSFGVLLLEIVSG 249
            L   ++   D ++ GVL+ E+ +G
Sbjct: 211 ILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 95/205 (46%), Gaps = 15/205 (7%)
Query: 49  NKFSDANKLGEGGFGPVY-KGVLKKGDEIAVKRLSGRSGQGLREMK---NEASVIAKVQH 104
           ++F     LG G FG V     ++ G+  A+K L  +    L++++   NE  ++  V  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 105 KNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYL 164
             LV+L     D     ++ EY+P   +    F   +R  +   +        AQ +L  
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRR--IGRFSEPHARFYAAQIVLTF 154
Query: 165 HQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY 224
                + +I+RDLK  N+L+D+    +++DFG A+   G      T  + GT  Y++PE 
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAPEI 209
Query: 225 ALEGIFSIKSDVFSFGVLLLEIVSG 249
            L   ++   D ++ GVL+ E+ +G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 36/92 (39%), Positives = 53/92 (57%), Gaps = 3/92 (3%)
Query: 157 IAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 216
           +A+G+ +L   +  + IHRDL A NILL +    KI DFG+AR    +            
Sbjct: 202 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 258
Query: 217 YGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 248
             +M+PE   + +++I+SDV+SFGVLL EI S
Sbjct: 259 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 290

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 36/92 (39%), Positives = 53/92 (57%), Gaps = 3/92 (3%)
Query: 157 IAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 216
           +A+G+ +L   +  + IHRDL A NILL +    KI DFG+AR    +            
Sbjct: 200 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 256
Query: 217 YGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 248
             +M+PE   + +++I+SDV+SFGVLL EI S
Sbjct: 257 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 288

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 95/205 (46%), Gaps = 15/205 (7%)
Query: 49  NKFSDANKLGEGGFGPVY-KGVLKKGDEIAVKRLSGRSGQGLREMK---NEASVIAKVQH 104
           ++F     LG G FG V     ++ G+  A+K L  +    L++++   NE  ++  V  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 105 KNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYL 164
             LV+L     D     ++ EY+P   +    F   +R  +   +        AQ +L  
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRR--IGRFSEPHARFYAAQIVLTF 154
Query: 165 HQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY 224
                + +I+RDLK  N+L+D+    +++DFG A+   G      T  + GT  Y++PE 
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAPEI 209
Query: 225 ALEGIFSIKSDVFSFGVLLLEIVSG 249
            L   ++   D ++ GVL+ E+ +G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 95/205 (46%), Gaps = 15/205 (7%)
Query: 49  NKFSDANKLGEGGFGPVY-KGVLKKGDEIAVKRLSGRSGQGLREMK---NEASVIAKVQH 104
           ++F     LG G FG V     ++ G+  A+K L  +    L++++   NE  ++  V  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 105 KNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYL 164
             LV+L     D     ++ EY+P   +    F   +R  +   +        AQ +L  
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRR--IGRFSEPHARFYAAQIVLTF 154
Query: 165 HQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY 224
                + +I+RDLK  N+L+D+    +++DFG A+   G      T  + GT  Y++PE 
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAPEI 209
Query: 225 ALEGIFSIKSDVFSFGVLLLEIVSG 249
            L   ++   D ++ GVL+ E+ +G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 95/205 (46%), Gaps = 15/205 (7%)
Query: 49  NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLREMK---NEASVIAKVQH 104
           ++F     LG G FG V     K+ G+  A+K L  +    L++++   NE  ++  V  
Sbjct: 34  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 93
Query: 105 KNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYL 164
             LV+L     D     ++ EY+P   +    F   +R  +   +        AQ +L  
Sbjct: 94  PFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRR--IGRFSEPHARFYAAQIVLTF 147
Query: 165 HQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY 224
                + +I+RDLK  N+L+D+    +++DFG A+   G      T  + GT  Y++PE 
Sbjct: 148 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAPEI 202
Query: 225 ALEGIFSIKSDVFSFGVLLLEIVSG 249
            L   ++   D ++ GVL+ E+ +G
Sbjct: 203 ILSKGYNKAVDWWALGVLIYEMAAG 227

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 95/205 (46%), Gaps = 15/205 (7%)
Query: 49  NKFSDANKLGEGGFGPVY-KGVLKKGDEIAVKRLSGRSGQGLREMK---NEASVIAKVQH 104
           ++F     LG G FG V     ++ G+  A+K L  +    L++++   NE  ++  V  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 105 KNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYL 164
             LV+L     D     ++ EY+P   +    F   +R  +   +        AQ +L  
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRR--IGRFSEPHARFYAAQIVLTF 155
Query: 165 HQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY 224
                + +I+RDLK  N+L+D+    +++DFG A+   G      T  + GT  Y++PE 
Sbjct: 156 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWTLCGTPEYLAPEI 210
Query: 225 ALEGIFSIKSDVFSFGVLLLEIVSG 249
            L   ++   D ++ GVL+ E+ +G
Sbjct: 211 ILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 105/211 (49%), Gaps = 29/211 (13%)
Query: 57  LGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQG-LREMKNEASVIAKVQHKNLVRLLGCCI 115
           +G+G FG V++G  + G+E+AVK  S R  +   RE +   +V+  ++H+N++  +    
Sbjct: 12  IGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTVM--LRHENILGFIAA-D 67
Query: 116 DRD-----EKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQ---- 166
           ++D     +  L+ +Y  + SL    FD   R  +     +++    A GL +LH     
Sbjct: 68  NKDNGTWTQLWLVSDYHEHGSL----FDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVG 123
Query: 167 -YSRVRIIHRDLKASNILLDKDMNPKISDFGMA--RICGGNELQANTSRIVGTYGYMSPE 223
              +  I HRDLK+ NIL+ K+    I+D G+A       + +    +  VGT  YM+PE
Sbjct: 124 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE 183
Query: 224 YALEGIFSIK-------SDVFSFGVLLLEIV 247
             L+   ++K       +D+++ G++  EI 
Sbjct: 184 -VLDDSINMKHFESFKRADIYAMGLVFWEIA 213

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 94/205 (45%), Gaps = 15/205 (7%)
Query: 49  NKFSDANKLGEGGFGPVY-KGVLKKGDEIAVKRLSGRSGQGLREMK---NEASVIAKVQH 104
           ++F     LG G FG V     ++ G+  A+K L  +    L++++   NE  ++  V  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 105 KNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYL 164
             LV+L     D     ++ EY P   +    F   +R  +   +        AQ +L  
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGEM----FSHLRR--IGRFSEPHARFYAAQIVLTF 154
Query: 165 HQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY 224
                + +I+RDLK  N+++D+    K++DFG A+   G      T  + GT  Y++PE 
Sbjct: 155 EYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKG-----RTWXLCGTPEYLAPEI 209
Query: 225 ALEGIFSIKSDVFSFGVLLLEIVSG 249
            L   ++   D ++ GVL+ E+ +G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 105/211 (49%), Gaps = 29/211 (13%)
Query: 57  LGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQG-LREMKNEASVIAKVQHKNLVRLLGCCI 115
           +G+G FG V++G  + G+E+AVK  S R  +   RE +   +V+  ++H+N++  +    
Sbjct: 37  IGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTVM--LRHENILGFIAA-D 92
Query: 116 DRD-----EKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQ---- 166
           ++D     +  L+ +Y  + SL    FD   R  +     +++    A GL +LH     
Sbjct: 93  NKDNGTWTQLWLVSDYHEHGSL----FDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVG 148
Query: 167 -YSRVRIIHRDLKASNILLDKDMNPKISDFGMA--RICGGNELQANTSRIVGTYGYMSPE 223
              +  I HRDLK+ NIL+ K+    I+D G+A       + +    +  VGT  YM+PE
Sbjct: 149 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE 208
Query: 224 YALEGIFSIK-------SDVFSFGVLLLEIV 247
             L+   ++K       +D+++ G++  EI 
Sbjct: 209 -VLDDSINMKHFESFKRADIYAMGLVFWEIA 238

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 95/205 (46%), Gaps = 15/205 (7%)
Query: 49  NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLREMK---NEASVIAKVQH 104
           ++F     LG G FG V     K+ G+  A+K L  +    L++++   NE  ++  V  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 105 KNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYL 164
             LV+L     D     ++ EY+P   +    F   +R  +   +        AQ +L  
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRR--IGRFSEPHARFYAAQIVLTF 155
Query: 165 HQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY 224
                + +I+RDLK  N+L+D+    +++DFG A+   G      T  + GT  Y++PE 
Sbjct: 156 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAPEI 210
Query: 225 ALEGIFSIKSDVFSFGVLLLEIVSG 249
            L   ++   D ++ GVL+ E+ +G
Sbjct: 211 ILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 105/211 (49%), Gaps = 29/211 (13%)
Query: 57  LGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQG-LREMKNEASVIAKVQHKNLVRLLGCCI 115
           +G+G FG V++G  + G+E+AVK  S R  +   RE +   +V+  ++H+N++  +    
Sbjct: 50  IGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTVM--LRHENILGFIAA-D 105
Query: 116 DRD-----EKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQ---- 166
           ++D     +  L+ +Y  + SL    FD   R  +     +++    A GL +LH     
Sbjct: 106 NKDNGTWTQLWLVSDYHEHGSL----FDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVG 161
Query: 167 -YSRVRIIHRDLKASNILLDKDMNPKISDFGMA--RICGGNELQANTSRIVGTYGYMSPE 223
              +  I HRDLK+ NIL+ K+    I+D G+A       + +    +  VGT  YM+PE
Sbjct: 162 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE 221
Query: 224 YALEGIFSIK-------SDVFSFGVLLLEIV 247
             L+   ++K       +D+++ G++  EI 
Sbjct: 222 -VLDDSINMKHFESFKRADIYAMGLVFWEIA 251

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 96/211 (45%), Gaps = 20/211 (9%)
Query: 48  TNKFSDANKLGEGGFGPVYKGV-LKKGDEIAVK-----RLSGRSGQGLREMKNEASVIAK 101
           T+++    +LG+G F  V + + +  G E A K     +LS R  Q L   + EA +   
Sbjct: 3   TDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKL---EREARICRL 59
Query: 102 VQHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGL 161
           ++H N+VRL     +     L+++ +    L     D   R           I+ I + +
Sbjct: 60  LKHPNIVRLHDSISEEGFHYLVFDLVTGGEL---FEDIVAREYYSEADASHCIQQILESV 116
Query: 162 LYLHQYSRVRIIHRDLKASNILL---DKDMNPKISDFGMARICGGNELQANTSRIVGTYG 218
            + H      I+HRDLK  N+LL    K    K++DFG+A    G+  Q       GT G
Sbjct: 117 NHCHLNG---IVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGD--QQAWFGFAGTPG 171
Query: 219 YMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 249
           Y+SPE   +  +    D+++ GV+L  ++ G
Sbjct: 172 YLSPEVLRKDPYGKPVDMWACGVILYILLVG 202

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 95/205 (46%), Gaps = 15/205 (7%)
Query: 49  NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLREMK---NEASVIAKVQH 104
           ++F     LG G FG V     K+ G+  A+K L  +    L++++   NE  ++  V  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 105 KNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYL 164
             LV+L     D     ++ EY+P   +    F   +R  +   +        AQ +L  
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRR--IGRFSEPHARFYAAQIVLTF 155
Query: 165 HQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY 224
                + +I+RDLK  N+L+D+    +++DFG A+   G      T  + GT  Y++PE 
Sbjct: 156 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAPEI 210
Query: 225 ALEGIFSIKSDVFSFGVLLLEIVSG 249
            L   ++   D ++ GVL+ E+ +G
Sbjct: 211 ILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 60/228 (26%), Positives = 106/228 (46%), Gaps = 43/228 (18%)
Query: 43  SVSTATNKFSDANKLGEGGFGPV---YKGVLKKGDEIAVKRLSGRSGQGL---REMKNEA 96
           +V     +      +G G +G V   Y   L++  ++AVK+LS R  Q L   R    E 
Sbjct: 14  TVWEVPQRLQGLRPVGSGAYGSVCSAYDARLRQ--KVAVKKLS-RPFQSLIHARRTYREL 70
Query: 97  SVIAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFF--LFDPTKRMLLDW--VTRVQ 152
            ++  ++H+N++ LL              + P  S++ F  ++  T  M  D   + + Q
Sbjct: 71  RLLKHLKHENVIGLLDV------------FTPATSIEDFSEVYLVTTLMGADLNNIVKCQ 118
Query: 153 ---------IIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGG 203
                    ++  + +GL Y+H      IIHRDLK SN+ +++D   +I DFG+AR    
Sbjct: 119 ALSDEHVQFLVYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLAR---- 171
Query: 204 NELQANTSRIVGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 250
            +     +  V T  Y +PE  L  + ++   D++S G ++ E++ GK
Sbjct: 172 -QADEEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGK 218

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 95/205 (46%), Gaps = 15/205 (7%)
Query: 49  NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLREMK---NEASVIAKVQH 104
           ++F     LG G FG V     K+ G+  A+K L  +    L++++   NE  ++  V  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 105 KNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYL 164
             LV+L     D     ++ EY+P   +    F   +R  +   +        AQ +L  
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRR--IGRFSEPHARFYAAQIVLTF 155
Query: 165 HQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY 224
                + +I+RDLK  N+L+D+    +++DFG A+   G      T  + GT  Y++PE 
Sbjct: 156 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAPEI 210
Query: 225 ALEGIFSIKSDVFSFGVLLLEIVSG 249
            L   ++   D ++ GVL+ E+ +G
Sbjct: 211 ILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 105/211 (49%), Gaps = 29/211 (13%)
Query: 57  LGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQG-LREMKNEASVIAKVQHKNLVRLLGCCI 115
           +G+G FG V++G  + G+E+AVK  S R  +   RE +   +V+  ++H+N++  +    
Sbjct: 11  IGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTVM--LRHENILGFIAA-D 66
Query: 116 DRD-----EKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQ---- 166
           ++D     +  L+ +Y  + SL    FD   R  +     +++    A GL +LH     
Sbjct: 67  NKDNGTWTQLWLVSDYHEHGSL----FDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVG 122
Query: 167 -YSRVRIIHRDLKASNILLDKDMNPKISDFGMA--RICGGNELQANTSRIVGTYGYMSPE 223
              +  I HRDLK+ NIL+ K+    I+D G+A       + +    +  VGT  YM+PE
Sbjct: 123 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE 182
Query: 224 YALEGIFSIK-------SDVFSFGVLLLEIV 247
             L+   ++K       +D+++ G++  EI 
Sbjct: 183 -VLDDSINMKHFESFKRADIYAMGLVFWEIA 212

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 105/211 (49%), Gaps = 29/211 (13%)
Query: 57  LGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQG-LREMKNEASVIAKVQHKNLVRLLGCCI 115
           +G+G FG V++G  + G+E+AVK  S R  +   RE +   +V+  ++H+N++  +    
Sbjct: 14  IGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTVM--LRHENILGFIAA-D 69
Query: 116 DRD-----EKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQ---- 166
           ++D     +  L+ +Y  + SL    FD   R  +     +++    A GL +LH     
Sbjct: 70  NKDNGTWTQLWLVSDYHEHGSL----FDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVG 125
Query: 167 -YSRVRIIHRDLKASNILLDKDMNPKISDFGMA--RICGGNELQANTSRIVGTYGYMSPE 223
              +  I HRDLK+ NIL+ K+    I+D G+A       + +    +  VGT  YM+PE
Sbjct: 126 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE 185
Query: 224 YALEGIFSIK-------SDVFSFGVLLLEIV 247
             L+   ++K       +D+++ G++  EI 
Sbjct: 186 -VLDDSINMKHFESFKRADIYAMGLVFWEIA 215

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 94/205 (45%), Gaps = 15/205 (7%)
Query: 49  NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLREMK---NEASVIAKVQH 104
           ++F     LG G FG V     K+ G+  A+K L  +    L++++   NE  ++  V  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 105 KNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYL 164
             LV+L     D     ++ EY P   +    F   +R  +   +        AQ +L  
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYAPGGEM----FSHLRR--IGRFSEPHARFYAAQIVLTF 155
Query: 165 HQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY 224
                + +I+RDLK  N+++D+    K++DFG A+   G      T  + GT  Y++PE 
Sbjct: 156 EYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKG-----RTWXLCGTPEYLAPEI 210
Query: 225 ALEGIFSIKSDVFSFGVLLLEIVSG 249
            L   ++   D ++ GVL+ E+ +G
Sbjct: 211 ILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 107/212 (50%), Gaps = 32/212 (15%)
Query: 57  LGEGGFGPVYKGVLKK-GD-------EIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLV 108
           LG+G F  ++KGV ++ GD       E+ +K L              AS+++K+ HK+LV
Sbjct: 16  LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75
Query: 109 RLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYS 168
              G C+  DE IL+ E++   SLD +L      + + W  ++++ + +A  + +L + +
Sbjct: 76  LNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILW--KLEVAKQLAAAMHFLEENT 133
Query: 169 RVRIIHRDLKASNILL-----DKDMNP---KISDFGMA-RICGGNELQANTSRIVGTYGY 219
              +IH ++ A NILL      K  NP   K+SD G++  +   + LQ    RI     +
Sbjct: 134 ---LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQ---ERI----PW 183
Query: 220 MSPEYALEGI--FSIKSDVFSFGVLLLEIVSG 249
           + PE  +E     ++ +D +SFG  L EI SG
Sbjct: 184 VPPE-CIENPKNLNLATDKWSFGTTLWEICSG 214

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 95/209 (45%), Gaps = 36/209 (17%)
Query: 57  LGEGGFGPVYKGVLKKGDE------IAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRL 110
           LG G F  V     K+  +      IA K L G+ G     M+NE +V+ K++H N+V L
Sbjct: 26  LGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGS----MENEIAVLHKIKHPNIVAL 81
Query: 111 LGCCIDRDEKILIYEYMPNKSL-------DFFLFDPTKRMLLDWVTRVQIIEGIAQGLLY 163
                      LI + +    L        F+      R++       Q+++ +     Y
Sbjct: 82  DDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIF------QVLDAVK----Y 131
Query: 164 LHQYSRVRIIHRDLKASNIL---LDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYM 220
           LH    + I+HRDLK  N+L   LD+D    ISDFG++++    +  +  S   GT GY+
Sbjct: 132 LHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM---EDPGSVLSTACGTPGYV 185
Query: 221 SPEYALEGIFSIKSDVFSFGVLLLEIVSG 249
           +PE   +  +S   D +S GV+   ++ G
Sbjct: 186 APEVLAQKPYSKAVDCWSIGVIAYILLCG 214

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 105/211 (49%), Gaps = 29/211 (13%)
Query: 57  LGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQG-LREMKNEASVIAKVQHKNLVRLLGCCI 115
           +G+G FG V++G  + G+E+AVK  S R  +   RE +   +V+  ++H+N++  +    
Sbjct: 17  IGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTVM--LRHENILGFIAA-D 72
Query: 116 DRD-----EKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQ---- 166
           ++D     +  L+ +Y  + SL    FD   R  +     +++    A GL +LH     
Sbjct: 73  NKDNGTWTQLWLVSDYHEHGSL----FDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVG 128
Query: 167 -YSRVRIIHRDLKASNILLDKDMNPKISDFGMA--RICGGNELQANTSRIVGTYGYMSPE 223
              +  I HRDLK+ NIL+ K+    I+D G+A       + +    +  VGT  YM+PE
Sbjct: 129 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE 188
Query: 224 YALEGIFSIK-------SDVFSFGVLLLEIV 247
             L+   ++K       +D+++ G++  EI 
Sbjct: 189 -VLDDSINMKHFESFKRADIYAMGLVFWEIA 218

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 97/213 (45%), Gaps = 20/213 (9%)
Query: 46  TATNKFSDANKLGEGGFGPVYKGV-LKKGDEIAVK-----RLSGRSGQGLREMKNEASVI 99
           + T+++    +LG+G F  V + + +  G E A K     +LS R  Q L   + EA + 
Sbjct: 1   SMTDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKL---EREARIC 57
Query: 100 AKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQ 159
             ++H N+VRL     +     L+++ +    L     D   R           I+ I +
Sbjct: 58  RLLKHPNIVRLHDSISEEGFHYLVFDLVTGGEL---FEDIVAREYYSEADASHCIQQILE 114
Query: 160 GLLYLHQYSRVRIIHRDLKASNILL---DKDMNPKISDFGMARICGGNELQANTSRIVGT 216
            + + H      I+HRDLK  N+LL    K    K++DFG+A    G+  Q       GT
Sbjct: 115 SVNHCHLNG---IVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGD--QQAWFGFAGT 169
Query: 217 YGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 249
            GY+SPE   +  +    D+++ GV+L  ++ G
Sbjct: 170 PGYLSPEVLRKDPYGKPVDMWACGVILYILLVG 202

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 96/205 (46%), Gaps = 15/205 (7%)
Query: 49  NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLREMK---NEASVIAKVQH 104
           ++F     LG G FG V     K+ G+  A+K L  +    L++++   NE  ++  V  
Sbjct: 62  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 121
Query: 105 KNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYL 164
             LV+L     D     ++ EY+P   +    F   +R  +   +        AQ +L  
Sbjct: 122 PFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRR--IGRFSEPHARFYAAQIVLTF 175
Query: 165 HQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY 224
                + +I+RDLK  N+L+D+    +++DFG A+      ++  T  + GT  Y++PE 
Sbjct: 176 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAPEI 230
Query: 225 ALEGIFSIKSDVFSFGVLLLEIVSG 249
            L   ++   D ++ GVL+ E+ +G
Sbjct: 231 ILSKGYNKAVDWWALGVLIYEMAAG 255

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 96/212 (45%), Gaps = 20/212 (9%)
Query: 49  NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVK--RLSGRSGQGLREMKNEASVIAKVQHK 105
           N   +  ++G G  G V+K   +K G  IAVK  R SG   +  R + +   V+      
Sbjct: 25  NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCP 84
Query: 106 NLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRV--QIIEGIAQGLLY 163
            +V+  G  I   +  +  E M   +         KRM      R+  ++   I + L Y
Sbjct: 85  YIVQCFGTFITNTDVFIAMELMGTCAEKL-----KKRMQGPIPERILGKMTVAIVKALYY 139
Query: 164 LHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE 223
           L +  +  +IHRD+K SNILLD+    K+ DFG   I G         R  G   YM+PE
Sbjct: 140 LKE--KHGVIHRDVKPSNILLDERGQIKLCDFG---ISGRLVDDKAKDRSAGCAAYMAPE 194
Query: 224 Y-----ALEGIFSIKSDVFSFGVLLLEIVSGK 250
                   +  + I++DV+S G+ L+E+ +G+
Sbjct: 195 RIDPPDPTKPDYDIRADVWSLGISLVELATGQ 226

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/228 (26%), Positives = 106/228 (46%), Gaps = 43/228 (18%)
Query: 43  SVSTATNKFSDANKLGEGGFGPV---YKGVLKKGDEIAVKRLSGRSGQGL---REMKNEA 96
           +V     +      +G G +G V   Y   L++  ++AVK+LS R  Q L   R    E 
Sbjct: 22  TVWEVPQRLQGLRPVGSGAYGSVCSAYDARLRQ--KVAVKKLS-RPFQSLIHARRTYREL 78
Query: 97  SVIAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFF--LFDPTKRMLLDW--VTRVQ 152
            ++  ++H+N++ LL              + P  S++ F  ++  T  M  D   + + Q
Sbjct: 79  RLLKHLKHENVIGLLDV------------FTPATSIEDFSEVYLVTTLMGADLNNIVKCQ 126
Query: 153 ---------IIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGG 203
                    ++  + +GL Y+H      IIHRDLK SN+ +++D   +I DFG+AR    
Sbjct: 127 ALSDEHVQFLVYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDSELRILDFGLAR---- 179
Query: 204 NELQANTSRIVGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 250
            +     +  V T  Y +PE  L  + ++   D++S G ++ E++ GK
Sbjct: 180 -QADEEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGK 226

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/247 (25%), Positives = 111/247 (44%), Gaps = 46/247 (18%)
Query: 51  FSDANKLGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVR 109
           F +   LG+G FG V K          A+K++   + + L  + +E  ++A + H+ +VR
Sbjct: 8   FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIR-HTEEKLSTILSEVMLLASLNHQYVVR 66
Query: 110 LLGCCIDRDEKI-------------LIYEYMPNKSLDFFLFDPTKRMLLD--WVTRVQII 154
                ++R   +             +  EY  N++L   +         D  W    QI+
Sbjct: 67  YYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDEYWRLFRQIL 126
Query: 155 EGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMAR--------------- 199
           E ++    Y+H      IIHRDLK  NI +D+  N KI DFG+A+               
Sbjct: 127 EALS----YIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQN 179
Query: 200 ICGGNELQANTSRIVGTYGYMSPEYALEGI--FSIKSDVFSFGVLLLEIVSGKKNTGLYR 257
           + G ++   N +  +GT  Y++ E  L+G   ++ K D++S G++  E++    +TG+ R
Sbjct: 180 LPGSSD---NLTSAIGTAMYVATE-VLDGTGHYNEKIDMYSLGIIFFEMIY-PFSTGMER 234
Query: 258 TDSLNLL 264
            + L  L
Sbjct: 235 VNILKKL 241

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 94/205 (45%), Gaps = 15/205 (7%)
Query: 49  NKFSDANKLGEGGFGPVY-KGVLKKGDEIAVKRLSGRSGQGLREMK---NEASVIAKVQH 104
           ++F     LG G FG V     ++ G+  A+K L  +    L++++   NE  ++  V  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 105 KNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYL 164
             LV+L     D     ++ EY P   +    F   +R  +   +        AQ +L  
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGEM----FSHLRR--IGRFSEPHARFYAAQIVLTF 154
Query: 165 HQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY 224
                + +I+RDLK  N+++D+    +++DFG A+   G      T  + GT  Y++PE 
Sbjct: 155 EYLHSLDLIYRDLKPENLMIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAPEI 209
Query: 225 ALEGIFSIKSDVFSFGVLLLEIVSG 249
            L   ++   D ++ GVL+ E+ +G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 95/206 (46%), Gaps = 21/206 (10%)
Query: 57  LGEGGFGPVYKGVLKK-GDEIAVK-----RLSGRSGQGLREMKNEASVIAKVQHKNLVRL 110
           +G+G F  V + + ++ G + AVK     + +   G    ++K EAS+   ++H ++V L
Sbjct: 32  IGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL 91
Query: 111 LGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQI----IEGIAQGLLYLHQ 166
           L          +++E+M    L    F+  KR    +V    +    +  I + L Y H 
Sbjct: 92  LETYSSDGMLYMVFEFMDGADL---CFEIVKRADAGFVYSEAVASHYMRQILEALRYCHD 148
Query: 167 YSRVRIIHRDLKASNILLDKDMNP---KISDFGMARICGGNELQANTSRIVGTYGYMSPE 223
            +   IIHRD+K   +LL    N    K+  FG+A   G + L A     VGT  +M+PE
Sbjct: 149 NN---IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGR--VGTPHFMAPE 203
Query: 224 YALEGIFSIKSDVFSFGVLLLEIVSG 249
                 +    DV+  GV+L  ++SG
Sbjct: 204 VVKREPYGKPVDVWGCGVILFILLSG 229

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 35/95 (36%), Positives = 57/95 (60%), Gaps = 7/95 (7%)
Query: 157 IAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR-IVG 215
           I+ GL +LH+     II+RDLK  N++LD + + KI+DFGM   C  + +   T+R   G
Sbjct: 129 ISIGLFFLHKRG---IIYRDLKLDNVMLDSEGHIKIADFGM---CKEHMMDGVTTREFCG 182
Query: 216 TYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 250
           T  Y++PE      +    D +++GVLL E+++G+
Sbjct: 183 TPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQ 217

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 95/207 (45%), Gaps = 19/207 (9%)
Query: 49  NKFSDANKLGEGGFGPVY-KGVLKKGDEIAVKRLSGRSGQGLREMK---NEASVIAKVQH 104
           ++F     LG G FG V     ++ G+  A+K L  +    L++++   NE  ++  V  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 105 KNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRM--LLDWVTRVQIIEGIAQGLL 162
             L +L     D     ++ EY P   +    F   +R+    +   R    + I     
Sbjct: 102 PFLTKLEFSFKDNSNLYMVMEYAPGGEM----FSHLRRIGRFXEPHARFYAAQ-IVLTFE 156
Query: 163 YLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSP 222
           YLH    + +I+RDLK  N+++D+    K++DFG A+   G      T  + GT  Y++P
Sbjct: 157 YLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKG-----RTWXLCGTPEYLAP 208
Query: 223 EYALEGIFSIKSDVFSFGVLLLEIVSG 249
           E  L   ++   D ++ GVL+ E+ +G
Sbjct: 209 EIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/202 (24%), Positives = 91/202 (45%), Gaps = 10/202 (4%)
Query: 50  KFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVR 109
           K+  A  LG G FG V++ V     +  + +     G     +K E S++   +H+N++ 
Sbjct: 6   KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILH 65
Query: 110 LLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSR 169
           L       +E ++I+E++    LD F    T    L+    V  +  + + L +LH ++ 
Sbjct: 66  LHESFESMEELVMIFEFISG--LDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN- 122
Query: 170 VRIIHRDLKASNILLD--KDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALE 227
             I H D++  NI+    +    KI +FG AR     +   N   +     Y +PE    
Sbjct: 123 --IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD---NFRLLFTAPEYYAPEVHQH 177
Query: 228 GIFSIKSDVFSFGVLLLEIVSG 249
            + S  +D++S G L+  ++SG
Sbjct: 178 DVVSTATDMWSLGTLVYVLLSG 199

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 97/204 (47%), Gaps = 22/204 (10%)
Query: 57  LGEGGFGPVYKGVLK-----KGDEIAVKRLSG----RSGQGLREMKNEASVIAKVQHKNL 107
           LG+GG+G V++ V K      G   A+K L      R+ +     K E +++ +V+H  +
Sbjct: 25  LGKGGYGKVFQ-VRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFI 83
Query: 108 VRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQY 167
           V L+       +  LI EY+    L F   +     + D  T    +  I+  L +LHQ 
Sbjct: 84  VDLIYAFQTGGKLYLILEYLSGGEL-FMQLEREGIFMED--TACFYLAEISMALGHLHQK 140
Query: 168 SRVRIIHRDLKASNILLDKDMNPKISDFGMAR--ICGGNELQANTSRIVGTYGYMSPEYA 225
               II+RDLK  NI+L+   + K++DFG+ +  I  G      T    GT  YM+PE  
Sbjct: 141 G---IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGT----VTHXFCGTIEYMAPEIL 193
Query: 226 LEGIFSIKSDVFSFGVLLLEIVSG 249
           +    +   D +S G L+ ++++G
Sbjct: 194 MRSGHNRAVDWWSLGALMYDMLTG 217

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 95/206 (46%), Gaps = 21/206 (10%)
Query: 57  LGEGGFGPVYKGVLKK-GDEIAVK-----RLSGRSGQGLREMKNEASVIAKVQHKNLVRL 110
           +G+G F  V + + ++ G + AVK     + +   G    ++K EAS+   ++H ++V L
Sbjct: 34  IGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL 93
Query: 111 LGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQI----IEGIAQGLLYLHQ 166
           L          +++E+M    L    F+  KR    +V    +    +  I + L Y H 
Sbjct: 94  LETYSSDGMLYMVFEFMDGADL---CFEIVKRADAGFVYSEAVASHYMRQILEALRYCHD 150
Query: 167 YSRVRIIHRDLKASNILLDKDMNP---KISDFGMARICGGNELQANTSRIVGTYGYMSPE 223
            +   IIHRD+K   +LL    N    K+  FG+A   G + L A     VGT  +M+PE
Sbjct: 151 NN---IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGR--VGTPHFMAPE 205
Query: 224 YALEGIFSIKSDVFSFGVLLLEIVSG 249
                 +    DV+  GV+L  ++SG
Sbjct: 206 VVKREPYGKPVDVWGCGVILFILLSG 231

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 97/204 (47%), Gaps = 22/204 (10%)
Query: 57  LGEGGFGPVYKGVLK-----KGDEIAVKRLSG----RSGQGLREMKNEASVIAKVQHKNL 107
           LG+GG+G V++ V K      G   A+K L      R+ +     K E +++ +V+H  +
Sbjct: 25  LGKGGYGKVFQ-VRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFI 83
Query: 108 VRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQY 167
           V L+       +  LI EY+    L F   +     + D  T    +  I+  L +LHQ 
Sbjct: 84  VDLIYAFQTGGKLYLILEYLSGGEL-FMQLEREGIFMED--TACFYLAEISMALGHLHQK 140
Query: 168 SRVRIIHRDLKASNILLDKDMNPKISDFGMAR--ICGGNELQANTSRIVGTYGYMSPEYA 225
               II+RDLK  NI+L+   + K++DFG+ +  I  G      T    GT  YM+PE  
Sbjct: 141 G---IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGT----VTHTFCGTIEYMAPEIL 193
Query: 226 LEGIFSIKSDVFSFGVLLLEIVSG 249
           +    +   D +S G L+ ++++G
Sbjct: 194 MRSGHNRAVDWWSLGALMYDMLTG 217

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 93/205 (45%), Gaps = 15/205 (7%)
Query: 49  NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLREMK---NEASVIAKVQH 104
           ++F     LG G FG V     K+ G+  A+K L  +    L++++   NE  +   V  
Sbjct: 42  DQFERIRTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRIQQAVNF 101
Query: 105 KNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYL 164
             LV+L     D     ++ EY P   +    F   +R  +   +        AQ +L  
Sbjct: 102 PFLVKLEFSFKDNSNLYMVLEYAPGGEM----FSHLRR--IGRFSEPHARFYAAQIVLTF 155
Query: 165 HQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY 224
                + +I+RDLK  N+L+D+    K++DFG A+   G      T  + GT  Y++PE 
Sbjct: 156 EYLHSLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKG-----RTWXLCGTPEYLAPEI 210
Query: 225 ALEGIFSIKSDVFSFGVLLLEIVSG 249
            L   ++   D ++ GVL+ E+ +G
Sbjct: 211 ILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/228 (26%), Positives = 105/228 (46%), Gaps = 43/228 (18%)
Query: 43  SVSTATNKFSDANKLGEGGFGPV---YKGVLKKGDEIAVKRLSGRSGQGL---REMKNEA 96
           +V     +      +G G +G V   Y   L++  ++AVK+LS R  Q L   R    E 
Sbjct: 22  TVWEVPQRLQGLRPVGSGAYGSVCSAYDARLRQ--KVAVKKLS-RPFQSLIHARRTYREL 78
Query: 97  SVIAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFF--LFDPTKRMLLDWVTRVQ-- 152
            ++  ++H+N++ LL              + P  S++ F  ++  T  M  D    V+  
Sbjct: 79  RLLKHLKHENVIGLLDV------------FTPATSIEDFSEVYLVTTLMGADLNNIVKSQ 126
Query: 153 ---------IIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGG 203
                    ++  + +GL Y+H      IIHRDLK SN+ +++D   +I DFG+AR    
Sbjct: 127 ALSDEHVQFLVYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDSELRILDFGLAR---- 179
Query: 204 NELQANTSRIVGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 250
            +     +  V T  Y +PE  L  + ++   D++S G ++ E++ GK
Sbjct: 180 -QADEEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGK 226

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/199 (26%), Positives = 94/199 (47%), Gaps = 15/199 (7%)
Query: 56  KLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCC 114
           +LG G FG V++ V K  G     K ++         +KNE S++ ++ H  L+ L    
Sbjct: 58  ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF 117
Query: 115 IDRDEKILIYEYMPNKSLDFFLFD--PTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRI 172
            D+ E +LI E++        LFD    +   +     +  +    +GL ++H++S   I
Sbjct: 118 EDKYEMVLILEFLSGGE----LFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS---I 170
Query: 173 IHRDLKASNILLD--KDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIF 230
           +H D+K  NI+ +  K  + KI DFG+A     +E+   T+    T  + +PE       
Sbjct: 171 VHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT---ATAEFAAPEIVDREPV 227
Query: 231 SIKSDVFSFGVLLLEIVSG 249
              +D+++ GVL   ++SG
Sbjct: 228 GFYTDMWAIGVLGYVLLSG 246

>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 106/212 (50%), Gaps = 32/212 (15%)
Query: 57  LGEGGFGPVYKGVLKK-GD-------EIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLV 108
           LG+G F  ++KGV ++ GD       E+ +K L              AS+++K+ HK+LV
Sbjct: 16  LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75
Query: 109 RLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYS 168
              G C   DE IL+ E++   SLD +L      + + W  ++++ + +A  + +L + +
Sbjct: 76  LNYGVCFCGDENILVQEFVKFGSLDTYLKKNKNCINILW--KLEVAKQLAWAMHFLEENT 133
Query: 169 RVRIIHRDLKASNILL-----DKDMNP---KISDFGMA-RICGGNELQANTSRIVGTYGY 219
              +IH ++ A NILL      K  NP   K+SD G++  +   + LQ    RI     +
Sbjct: 134 ---LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQ---ERI----PW 183
Query: 220 MSPEYALEGI--FSIKSDVFSFGVLLLEIVSG 249
           + PE  +E     ++ +D +SFG  L EI SG
Sbjct: 184 VPPE-CIENPKNLNLATDKWSFGTTLWEICSG 214

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 93/198 (46%), Gaps = 13/198 (6%)
Query: 56  KLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCC 114
           +LG G FG V++   +  G+  A K +          ++ E   ++ ++H  LV L    
Sbjct: 58  ELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF 117
Query: 115 IDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 174
            D +E ++IYE+M    L   + D   +M  D    V+ +  + +GL ++H+ +    +H
Sbjct: 118 EDDNEMVMIYEFMSGGELFEKVADEHNKMSED--EAVEYMRQVCKGLCHMHENN---YVH 172
Query: 175 RDLKASNILL--DKDMNPKISDFGM-ARICGGNELQANTSRIVGTYGYMSPEYALEGIFS 231
            DLK  NI+    +    K+ DFG+ A +     ++  T    GT  + +PE A      
Sbjct: 173 LDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT----GTAEFAAPEVAEGKPVG 228
Query: 232 IKSDVFSFGVLLLEIVSG 249
             +D++S GVL   ++SG
Sbjct: 229 YYTDMWSVGVLSYILLSG 246

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 93/205 (45%), Gaps = 15/205 (7%)
Query: 49  NKFSDANKLGEGGFGPVY-KGVLKKGDEIAVKRLSGRSGQGLREMK---NEASVIAKVQH 104
           ++F     LG G FG V     ++ G+  A+K L  +    L++++   NE  ++  V  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 105 KNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYL 164
             L +L     D     ++ EY P   +    F   +R  +   +        AQ +L  
Sbjct: 102 PFLTKLEFSFKDNSNLYMVMEYAPGGEM----FSHLRR--IGRFSEPHARFYAAQIVLTF 155
Query: 165 HQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY 224
                + +I+RDLK  N+++D+    K++DFG A+   G      T  + GT  Y++PE 
Sbjct: 156 EYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKG-----RTWXLCGTPEYLAPEI 210
Query: 225 ALEGIFSIKSDVFSFGVLLLEIVSG 249
            L   ++   D ++ GVL+ E+ +G
Sbjct: 211 ILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/201 (26%), Positives = 95/201 (47%), Gaps = 15/201 (7%)
Query: 56  KLGEGGFGPVYKGVLKK-GDEIAVKRLS-GRSGQGLREMKNEASVIAKVQHKNLVRLLGC 113
           KLG G FG V+    +  G E  +K ++  RS   + +++ E  V+  + H N++++   
Sbjct: 29  KLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEV 88
Query: 114 CIDRDEKILIYEYMPNKSLDFFLFDPTKR-MLLDWVTRVQIIEGIAQGLLYLHQYSRVRI 172
             D     ++ E      L   +     R   L      ++++ +   L Y H      +
Sbjct: 89  FEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ---HV 145
Query: 173 IHRDLKASNILLDKDMNP----KISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEG 228
           +H+DLK  NIL  +D +P    KI DFG+A +   +E   N +   GT  YM+PE     
Sbjct: 146 VHKDLKPENILF-QDTSPHSPIKIIDFGLAELFKSDEHSTNAA---GTALYMAPEVFKRD 201
Query: 229 IFSIKSDVFSFGVLLLEIVSG 249
           + + K D++S GV++  +++G
Sbjct: 202 V-TFKCDIWSAGVVMYFLLTG 221

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 93/205 (45%), Gaps = 15/205 (7%)
Query: 49  NKFSDANKLGEGGFGPVY-KGVLKKGDEIAVKRLSGRSGQGLREMK---NEASVIAKVQH 104
           ++F     LG G FG V     ++ G+  A+K L  +    L++++   NE  ++  V  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 105 KNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYL 164
             L +L     D     ++ EY P   +    F   +R  +   +        AQ +L  
Sbjct: 102 PFLTKLEFSFKDNSNLYMVMEYAPGGEM----FSHLRR--IGRFSEPHARFYAAQIVLTF 155
Query: 165 HQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY 224
                + +I+RDLK  N+++D+    K++DFG A+   G      T  + GT  Y++PE 
Sbjct: 156 EYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKG-----RTWXLCGTPEYLAPEI 210
Query: 225 ALEGIFSIKSDVFSFGVLLLEIVSG 249
            L   ++   D ++ GVL+ E+ +G
Sbjct: 211 ILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 95/209 (45%), Gaps = 36/209 (17%)
Query: 57  LGEGGFGPVYKGVLKKGDE------IAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRL 110
           LG G F  V     K+  +      IA + L G+ G     M+NE +V+ K++H N+V L
Sbjct: 26  LGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGS----MENEIAVLHKIKHPNIVAL 81
Query: 111 LGCCIDRDEKILIYEYMPNKSL-------DFFLFDPTKRMLLDWVTRVQIIEGIAQGLLY 163
                      LI + +    L        F+      R++       Q+++ +     Y
Sbjct: 82  DDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIF------QVLDAVK----Y 131
Query: 164 LHQYSRVRIIHRDLKASNIL---LDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYM 220
           LH    + I+HRDLK  N+L   LD+D    ISDFG++++    +  +  S   GT GY+
Sbjct: 132 LHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM---EDPGSVLSTACGTPGYV 185
Query: 221 SPEYALEGIFSIKSDVFSFGVLLLEIVSG 249
           +PE   +  +S   D +S GV+   ++ G
Sbjct: 186 APEVLAQKPYSKAVDCWSIGVIAYILLCG 214

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 50/178 (28%), Positives = 91/178 (51%), Gaps = 19/178 (10%)
Query: 81  LSGRSGQGLREMK-NEASVIAKVQ-HKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFD 138
            S    Q LRE    E  ++ KV  H N+++L           L+++ M    L  +L  
Sbjct: 58  FSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL-- 115
Query: 139 PTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMA 198
            T+++ L      +I+  + + +  LH   ++ I+HRDLK  NILLD DMN K++DFG +
Sbjct: 116 -TEKVTLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFS 171
Query: 199 -RICGGNELQANTSRIVGTYGYMSPEYALEGI------FSIKSDVFSFGVLLLEIVSG 249
            ++  G +L++    + GT  Y++PE     +      +  + D++S GV++  +++G
Sbjct: 172 CQLDPGEKLRS----VCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 225

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 95/209 (45%), Gaps = 36/209 (17%)
Query: 57  LGEGGFGPVYKGVLKKGDE------IAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRL 110
           LG G F  V     K+  +      IA + L G+ G     M+NE +V+ K++H N+V L
Sbjct: 26  LGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGS----MENEIAVLHKIKHPNIVAL 81
Query: 111 LGCCIDRDEKILIYEYMPNKSL-------DFFLFDPTKRMLLDWVTRVQIIEGIAQGLLY 163
                      LI + +    L        F+      R++       Q+++ +     Y
Sbjct: 82  DDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIF------QVLDAVK----Y 131
Query: 164 LHQYSRVRIIHRDLKASNIL---LDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYM 220
           LH    + I+HRDLK  N+L   LD+D    ISDFG++++    +  +  S   GT GY+
Sbjct: 132 LHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM---EDPGSVLSTACGTPGYV 185
Query: 221 SPEYALEGIFSIKSDVFSFGVLLLEIVSG 249
           +PE   +  +S   D +S GV+   ++ G
Sbjct: 186 APEVLAQKPYSKAVDCWSIGVIAYILLCG 214

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 93/198 (46%), Gaps = 13/198 (6%)
Query: 56  KLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCC 114
           +LG G FG V++   +  G+  A K +          ++ E   ++ ++H  LV L    
Sbjct: 164 ELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF 223
Query: 115 IDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 174
            D +E ++IYE+M    L   + D   +M  D    V+ +  + +GL ++H+ +    +H
Sbjct: 224 EDDNEMVMIYEFMSGGELFEKVADEHNKMSED--EAVEYMRQVCKGLCHMHENN---YVH 278
Query: 175 RDLKASNILL--DKDMNPKISDFGM-ARICGGNELQANTSRIVGTYGYMSPEYALEGIFS 231
            DLK  NI+    +    K+ DFG+ A +     ++  T    GT  + +PE A      
Sbjct: 279 LDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT----GTAEFAAPEVAEGKPVG 334
Query: 232 IKSDVFSFGVLLLEIVSG 249
             +D++S GVL   ++SG
Sbjct: 335 YYTDMWSVGVLSYILLSG 352

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 95/209 (45%), Gaps = 36/209 (17%)
Query: 57  LGEGGFGPVYKGVLKKGDE------IAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRL 110
           LG G F  V     K+  +      IA + L G+ G     M+NE +V+ K++H N+V L
Sbjct: 26  LGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGS----MENEIAVLHKIKHPNIVAL 81
Query: 111 LGCCIDRDEKILIYEYMPNKSL-------DFFLFDPTKRMLLDWVTRVQIIEGIAQGLLY 163
                      LI + +    L        F+      R++       Q+++ +     Y
Sbjct: 82  DDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIF------QVLDAVK----Y 131
Query: 164 LHQYSRVRIIHRDLKASNIL---LDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYM 220
           LH    + I+HRDLK  N+L   LD+D    ISDFG++++    +  +  S   GT GY+
Sbjct: 132 LHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM---EDPGSVLSTACGTPGYV 185
Query: 221 SPEYALEGIFSIKSDVFSFGVLLLEIVSG 249
           +PE   +  +S   D +S GV+   ++ G
Sbjct: 186 APEVLAQKPYSKAVDCWSIGVIAYILLCG 214

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 64/230 (27%), Positives = 98/230 (42%), Gaps = 23/230 (10%)
Query: 27  RSKKKEVDQFPLFSFSSV-STATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGR 84
           R +  E  Q P +  S   S     F   ++LG G +G V+K   K+ G   AVKR    
Sbjct: 34  RGEASETLQSPGYDPSRPESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKR---- 89
Query: 85  SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRML 144
           S    R  K+ A  +A+V     V    CC+  ++    +E      L   L  P+ +  
Sbjct: 90  SMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQA---WEEGGILYLQTELCGPSLQQH 146
Query: 145 LD-W---VTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGM--- 197
            + W   +   Q+   +   LL L       ++H D+K +NI L      K+ DFG+   
Sbjct: 147 CEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVE 206
Query: 198 ARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIV 247
               G  E+Q    R      YM+PE  L+G +   +DVFS G+ +LE+ 
Sbjct: 207 LGTAGAGEVQEGDPR------YMAPEL-LQGSYGTAADVFSLGLTILEVA 249

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 50/178 (28%), Positives = 90/178 (50%), Gaps = 19/178 (10%)
Query: 81  LSGRSGQGLREMK-NEASVIAKVQ-HKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFD 138
            S    Q LRE    E  ++ KV  H N+++L           L+++ M    L  +L  
Sbjct: 45  FSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL-- 102
Query: 139 PTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMA 198
            T+++ L      +I+  + + +  LH   ++ I+HRDLK  NILLD DMN K++DFG +
Sbjct: 103 -TEKVTLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFS 158
Query: 199 -RICGGNELQANTSRIVGTYGYMSPEYALEGI------FSIKSDVFSFGVLLLEIVSG 249
            ++  G +L+     + GT  Y++PE     +      +  + D++S GV++  +++G
Sbjct: 159 CQLDPGEKLR----EVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 212

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 68/281 (24%), Positives = 131/281 (46%), Gaps = 46/281 (16%)
Query: 56  KLGEGGFGPVYK-GVLKKGDEIAVKRLSG--RSGQGLREMKNEASVIAKVQHKNLVRLLG 112
           +LG G +G V K   +  G  +AVKR+     S +  R + +    +  V     V   G
Sbjct: 58  ELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYG 117
Query: 113 CCIDRDEKILIYEYMPNKSLDFF---LFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSR 169
                 +  +  E M + SLD F   + D  + +  D + ++ +   I + L +LH  S+
Sbjct: 118 ALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAV--SIVKALEHLH--SK 172
Query: 170 VRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRI-VGTYGYMSPEYALEG 228
           + +IHRD+K SN+L++     K+ DFG++    G  + +    I  G   YM+PE     
Sbjct: 173 LSVIHRDVKPSNVLINALGQVKMCDFGIS----GYLVDSVAKTIDAGCKPYMAPERINPE 228
Query: 229 I----FSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTS-----NRTLEL 279
           +    +S+KSD++S G+ ++E               L +L + +D W +      + +E 
Sbjct: 229 LNQKGYSVKSDIWSLGITMIE---------------LAILRFPYDSWGTPFQQLKQVVEE 273
Query: 280 IDPILE-DEYSSKQMLLRYANIALLCVQESADDRPTMNDVV 319
             P L  D++S++     + +    C+++++ +RPT  +++
Sbjct: 274 PSPQLPADKFSAE-----FVDFTSQCLKKNSKERPTYPELM 309

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 50/178 (28%), Positives = 90/178 (50%), Gaps = 19/178 (10%)
Query: 81  LSGRSGQGLREMK-NEASVIAKVQ-HKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFD 138
            S    Q LRE    E  ++ KV  H N+++L           L+++ M    L  +L  
Sbjct: 58  FSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL-- 115
Query: 139 PTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMA 198
            T+++ L      +I+  + + +  LH   ++ I+HRDLK  NILLD DMN K++DFG +
Sbjct: 116 -TEKVTLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFS 171
Query: 199 -RICGGNELQANTSRIVGTYGYMSPEYALEGI------FSIKSDVFSFGVLLLEIVSG 249
            ++  G +L+     + GT  Y++PE     +      +  + D++S GV++  +++G
Sbjct: 172 CQLDPGEKLR----EVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 225

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 93/209 (44%), Gaps = 17/209 (8%)
Query: 49  NKFSDANKLGEGGFGPVYKGVLKK----GDEIAVKRLSGRSGQGLREMKN---EASVIAK 101
           N+F     LG+G FG V   +L K    G   A+K L         E+ +   E  V+  
Sbjct: 8   NEFEYLKLLGKGTFGKV---ILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQN 64
Query: 102 VQHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGL 161
            +H  L  L       D    + EY     L F L    +R+  +   R    E I   L
Sbjct: 65  SRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHL--SRERVFSEDRARFYGAE-IVSAL 121
Query: 162 LYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMS 221
            YLH  S   +++RDLK  N++LDKD + KI+DFG+ +   G +  A      GT  Y++
Sbjct: 122 DYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKXFCGTPEYLA 177
Query: 222 PEYALEGIFSIKSDVFSFGVLLLEIVSGK 250
           PE   +  +    D +  GV++ E++ G+
Sbjct: 178 PEVLEDNDYGRAVDWWGLGVVMYEMMCGR 206

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 93/209 (44%), Gaps = 17/209 (8%)
Query: 49  NKFSDANKLGEGGFGPVYKGVLKK----GDEIAVKRLSGRSGQGLREMKN---EASVIAK 101
           N+F     LG+G FG V   +L K    G   A+K L         E+ +   E  V+  
Sbjct: 9   NEFEYLKLLGKGTFGKV---ILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQN 65
Query: 102 VQHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGL 161
            +H  L  L       D    + EY     L F L    +R+  +   R    E I   L
Sbjct: 66  SRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHL--SRERVFSEDRARFYGAE-IVSAL 122
Query: 162 LYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMS 221
            YLH  S   +++RDLK  N++LDKD + KI+DFG+ +   G +  A      GT  Y++
Sbjct: 123 DYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKXFCGTPEYLA 178
Query: 222 PEYALEGIFSIKSDVFSFGVLLLEIVSGK 250
           PE   +  +    D +  GV++ E++ G+
Sbjct: 179 PEVLEDNDYGRAVDWWGLGVVMYEMMCGR 207

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 64/247 (25%), Positives = 111/247 (44%), Gaps = 46/247 (18%)
Query: 51  FSDANKLGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVR 109
           F +   LG+G FG V K          A+K++   + + L  + +E  ++A + H+ +VR
Sbjct: 8   FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIR-HTEEKLSTILSEVMLLASLNHQYVVR 66
Query: 110 LLGCCIDRDEKILIYEYMPNKSLDFF---------LFDPTKRMLLD------WVTRVQII 154
                ++R   +     +  KS  F          L+D      L+      W    QI+
Sbjct: 67  YYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQIL 126
Query: 155 EGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMAR--------------- 199
           E ++    Y+H      IIHRDLK  NI +D+  N KI DFG+A+               
Sbjct: 127 EALS----YIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQN 179
Query: 200 ICGGNELQANTSRIVGTYGYMSPEYALEGI--FSIKSDVFSFGVLLLEIVSGKKNTGLYR 257
           + G ++   N +  +GT  Y++ E  L+G   ++ K D++S G++  E++    +TG+ R
Sbjct: 180 LPGSSD---NLTSAIGTAMYVATE-VLDGTGHYNEKIDMYSLGIIFFEMIY-PFSTGMER 234
Query: 258 TDSLNLL 264
            + L  L
Sbjct: 235 VNILKKL 241

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 95/211 (45%), Gaps = 33/211 (15%)
Query: 56  KLGEGGFGPVYKGV-LKKGDEIAVKRLSGR--SGQGLREMKNEASVIAKVQHKNLVRLLG 112
           ++G G F  VYKG+  +   E+A   L  R  +    +  K EA  +  +QH N+VR   
Sbjct: 33  EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEXLKGLQHPNIVRFYD 92
Query: 113 C---------CIDRDEKILIYEYMPNKSLDFFL--FDPTK-RMLLDWVTRVQIIEGIAQG 160
                     CI     +L+ E   + +L  +L  F   K ++L  W  +      I +G
Sbjct: 93  SWESTVKGKKCI-----VLVTELXTSGTLKTYLKRFKVXKIKVLRSWCRQ------ILKG 141
Query: 161 LLYLHQYSRVRIIHRDLKASNILLDKDMNP-KISDFGMARICGGNELQANTSRIVGTYGY 219
           L +LH  +   IIHRDLK  NI +       KI D G+A +   +  +A    ++GT  +
Sbjct: 142 LQFLHTRTPP-IIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKA----VIGTPEF 196
Query: 220 MSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 250
            +PE   E  +    DV++FG   LE  + +
Sbjct: 197 XAPE-XYEEKYDESVDVYAFGXCXLEXATSE 226

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 100/212 (47%), Gaps = 20/212 (9%)
Query: 49  NKFSDANKLGEGGFGPVYKGVLKKGDE---IAVKRLSGRSGQGLREMKN---EASVIAKV 102
           + F     +G+G FG V   +++K D     A+K ++ +      E++N   E  ++  +
Sbjct: 15  DHFEILRAIGKGSFGKV--CIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGL 72
Query: 103 QHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLL 162
           +H  LV L     D ++  ++ + +    L + L    + +     T    I  +   L 
Sbjct: 73  EHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHL---QQNVHFKEETVKLFICELVMALD 129
Query: 163 YLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSP 222
           YL      RIIHRD+K  NILLD+  +  I+DF +A +    E Q  T  + GT  YM+P
Sbjct: 130 YLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAML-PRETQITT--MAGTKPYMAP 183
Query: 223 EY--ALEGI-FSIKSDVFSFGVLLLEIVSGKK 251
           E   + +G  +S   D +S GV   E++ G++
Sbjct: 184 EMFSSRKGAGYSFAVDWWSLGVTAYELLRGRR 215

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 93/209 (44%), Gaps = 17/209 (8%)
Query: 49  NKFSDANKLGEGGFGPVYKGVLKK----GDEIAVKRLSGRSGQGLREMKN---EASVIAK 101
           N+F     LG+G FG V   +L K    G   A+K L         E+ +   E  V+  
Sbjct: 10  NEFEYLKLLGKGTFGKV---ILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQN 66
Query: 102 VQHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGL 161
            +H  L  L       D    + EY     L F L    +R+  +   R    E I   L
Sbjct: 67  SRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHL--SRERVFSEDRARFYGAE-IVSAL 123
Query: 162 LYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMS 221
            YLH  S   +++RDLK  N++LDKD + KI+DFG+ +   G +  A      GT  Y++
Sbjct: 124 DYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKXFCGTPEYLA 179
Query: 222 PEYALEGIFSIKSDVFSFGVLLLEIVSGK 250
           PE   +  +    D +  GV++ E++ G+
Sbjct: 180 PEVLEDNDYGRAVDWWGLGVVMYEMMCGR 208

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 98/214 (45%), Gaps = 19/214 (8%)
Query: 42  SSVSTATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLREMK---NEAS 97
           S  +   ++F     LG G FG V     K+ G+  A+K L  +    L++++   NE  
Sbjct: 29  SQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKR 88
Query: 98  VIAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRM--LLDWVTRVQIIE 155
           ++  V    LV+L     D     ++ EY+    +    F   +R+    +   R    +
Sbjct: 89  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFXEPHARFYAAQ 144
Query: 156 GIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVG 215
            I     YLH    + +I+RDLK  N+L+D+    +++DFG A+   G      T  + G
Sbjct: 145 -IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCG 195
Query: 216 TYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 249
           T  Y++PE  L   ++   D ++ GVL+ E+ +G
Sbjct: 196 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 229

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 93/209 (44%), Gaps = 17/209 (8%)
Query: 49  NKFSDANKLGEGGFGPVYKGVLKK----GDEIAVKRLSGRSGQGLREMKN---EASVIAK 101
           N+F     LG+G FG V   +L K    G   A+K L         E+ +   E  V+  
Sbjct: 151 NEFEYLKLLGKGTFGKV---ILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQN 207
Query: 102 VQHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGL 161
            +H  L  L       D    + EY     L F L    +R+  +   R    E I   L
Sbjct: 208 SRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHL--SRERVFSEDRARFYGAE-IVSAL 264
Query: 162 LYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMS 221
            YLH  S   +++RDLK  N++LDKD + KI+DFG+ +   G +  A      GT  Y++
Sbjct: 265 DYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKTFCGTPEYLA 320
Query: 222 PEYALEGIFSIKSDVFSFGVLLLEIVSGK 250
           PE   +  +    D +  GV++ E++ G+
Sbjct: 321 PEVLEDNDYGRAVDWWGLGVVMYEMMCGR 349

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 93/209 (44%), Gaps = 17/209 (8%)
Query: 49  NKFSDANKLGEGGFGPVYKGVLKK----GDEIAVKRLSGRSGQGLREMKN---EASVIAK 101
           N+F     LG+G FG V   +L K    G   A+K L         E+ +   E  V+  
Sbjct: 148 NEFEYLKLLGKGTFGKV---ILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQN 204
Query: 102 VQHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGL 161
            +H  L  L       D    + EY     L F L    +R+  +   R    E I   L
Sbjct: 205 SRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHL--SRERVFSEDRARFYGAE-IVSAL 261
Query: 162 LYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMS 221
            YLH  S   +++RDLK  N++LDKD + KI+DFG+ +   G +  A      GT  Y++
Sbjct: 262 DYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKTFCGTPEYLA 317
Query: 222 PEYALEGIFSIKSDVFSFGVLLLEIVSGK 250
           PE   +  +    D +  GV++ E++ G+
Sbjct: 318 PEVLEDNDYGRAVDWWGLGVVMYEMMCGR 346

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 98/214 (45%), Gaps = 19/214 (8%)
Query: 42  SSVSTATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLREMK---NEAS 97
           S  +   ++F     LG G FG V     K+ G+  A+K L  +    L++++   NE  
Sbjct: 34  SQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKR 93
Query: 98  VIAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRM--LLDWVTRVQIIE 155
           ++  V    LV+L     D     ++ EY+    +    F   +R+    +   R    +
Sbjct: 94  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFXEPHARFYAAQ 149
Query: 156 GIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVG 215
            I     YLH    + +I+RDLK  N+L+D+    +++DFG A+   G      T  + G
Sbjct: 150 -IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCG 200
Query: 216 TYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 249
           T  Y++PE  L   ++   D ++ GVL+ E+ +G
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 98/214 (45%), Gaps = 19/214 (8%)
Query: 42  SSVSTATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLREMK---NEAS 97
           S  +   ++F     LG G FG V     K+ G+  A+K L  +    L++++   NE  
Sbjct: 34  SQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKR 93
Query: 98  VIAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRM--LLDWVTRVQIIE 155
           ++  V    LV+L     D     ++ EY+    +    F   +R+    +   R    +
Sbjct: 94  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFXEPHARFYAAQ 149
Query: 156 GIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVG 215
            I     YLH    + +I+RDLK  N+L+D+    +++DFG A+   G      T  + G
Sbjct: 150 -IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCG 200
Query: 216 TYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 249
           T  Y++PE  L   ++   D ++ GVL+ E+ +G
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 98/214 (45%), Gaps = 19/214 (8%)
Query: 42  SSVSTATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLREMK---NEAS 97
           S  +   ++F     LG G FG V     K+ G+  A+K L  +    L++++   NE  
Sbjct: 34  SQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKR 93
Query: 98  VIAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRM--LLDWVTRVQIIE 155
           ++  V    LV+L     D     ++ EY+    +    F   +R+    +   R    +
Sbjct: 94  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFXEPHARFYAAQ 149
Query: 156 GIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVG 215
            I     YLH    + +I+RDLK  N+L+D+    +++DFG A+   G      T  + G
Sbjct: 150 -IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCG 200
Query: 216 TYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 249
           T  Y++PE  L   ++   D ++ GVL+ E+ +G
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 98/214 (45%), Gaps = 19/214 (8%)
Query: 42  SSVSTATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLREMK---NEAS 97
           S  +   ++F     LG G FG V     K+ G+  A+K L  +    L++++   NE  
Sbjct: 34  SQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKR 93
Query: 98  VIAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRM--LLDWVTRVQIIE 155
           ++  V    LV+L     D     ++ EY+    +    F   +R+    +   R    +
Sbjct: 94  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFAEPHARFYAAQ 149
Query: 156 GIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVG 215
            I     YLH    + +I+RDLK  N+L+D+    +++DFG A+   G      T  + G
Sbjct: 150 -IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCG 200
Query: 216 TYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 249
           T  Y++PE  L   ++   D ++ GVL+ E+ +G
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 54/212 (25%), Positives = 96/212 (45%), Gaps = 15/212 (7%)
Query: 42  SSVSTATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLREMK---NEAS 97
           S  +   ++F     LG G FG V     K+ G+  A+K L  +    L++++   NE  
Sbjct: 21  SQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKR 80
Query: 98  VIAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGI 157
           ++  V    LV+L     D     ++ EY+    +    F   +R  +   +        
Sbjct: 81  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRR--IGRFSEPHARFYA 134
Query: 158 AQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTY 217
           AQ +L       + +I+RDLK  N+L+D+    +++DFG A+   G      T  + GT 
Sbjct: 135 AQIVLTFEYLHSLDLIYRDLKPENLLIDEQGYIQVTDFGFAKRVKG-----RTWXLCGTP 189
Query: 218 GYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 249
            Y++PE  L   ++   D ++ GVL+ E+ +G
Sbjct: 190 EYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 221

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 54/212 (25%), Positives = 96/212 (45%), Gaps = 15/212 (7%)
Query: 42  SSVSTATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLREMK---NEAS 97
           S  +   ++F     LG G FG V     K+ G+  A+K L  +    L++++   NE  
Sbjct: 34  SQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKR 93
Query: 98  VIAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGI 157
           ++  V    LV+L     D     ++ EY+    +    F   +R  +   +        
Sbjct: 94  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRR--IGRFSEPHARFYA 147
Query: 158 AQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTY 217
           AQ +L       + +I+RDLK  N+L+D+    +++DFG A+   G      T  + GT 
Sbjct: 148 AQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLAGTP 202
Query: 218 GYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 249
            Y++PE  L   ++   D ++ GVL+ E+ +G
Sbjct: 203 EYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 54/212 (25%), Positives = 96/212 (45%), Gaps = 15/212 (7%)
Query: 42  SSVSTATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLREMK---NEAS 97
           S  +   ++F     LG G FG V     K+ G+  A+K L  +    L++++   NE  
Sbjct: 35  SQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKR 94
Query: 98  VIAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGI 157
           ++  V    LV+L     D     ++ EY+    +    F   +R  +   +        
Sbjct: 95  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRR--IGRFSEPHARFYA 148
Query: 158 AQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTY 217
           AQ +L       + +I+RDLK  N+L+D+    +++DFG A+   G      T  + GT 
Sbjct: 149 AQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTP 203
Query: 218 GYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 249
            Y++PE  L   ++   D ++ GVL+ E+ +G
Sbjct: 204 EYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 54/212 (25%), Positives = 96/212 (45%), Gaps = 15/212 (7%)
Query: 42  SSVSTATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLREMK---NEAS 97
           S  +   ++F     LG G FG V     K+ G+  A+K L  +    L++++   NE  
Sbjct: 34  SQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKR 93
Query: 98  VIAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGI 157
           ++  V    LV+L     D     ++ EY+    +    F   +R  +   +        
Sbjct: 94  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRR--IGRFSEPHARFYA 147
Query: 158 AQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTY 217
           AQ +L       + +I+RDLK  N+L+D+    +++DFG A+   G      T  + GT 
Sbjct: 148 AQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTP 202
Query: 218 GYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 249
            Y++PE  L   ++   D ++ GVL+ E+ +G
Sbjct: 203 EYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 99/214 (46%), Gaps = 19/214 (8%)
Query: 42  SSVSTATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLREMK---NEAS 97
           S  +   ++F     LG G FG V     K+ G+  A+K L  +    L++++   NE  
Sbjct: 55  SQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKR 114
Query: 98  VIAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRM--LLDWVTRVQIIE 155
           ++  V    LV+L     D     ++ EY+    +    F   +R+    +   R    +
Sbjct: 115 ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFXEPHARFYAAQ 170
Query: 156 GIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVG 215
            I     YLH    + +I+RDLK  N+L+D+    +++DFG A+      ++  T  + G
Sbjct: 171 -IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCG 221
Query: 216 TYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 249
           T  Y++PE  L   ++   D ++ GVL+ E+ +G
Sbjct: 222 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 255

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 36/95 (37%), Positives = 54/95 (56%), Gaps = 7/95 (7%)
Query: 157 IAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR-IVG 215
           IA GL +L       II+RDLK  N++LD + + KI+DFGM   C  N     T++   G
Sbjct: 451 IAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGM---CKENIWDGVTTKXFCG 504
Query: 216 TYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 250
           T  Y++PE      +    D ++FGVLL E+++G+
Sbjct: 505 TPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 539

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 94/205 (45%), Gaps = 15/205 (7%)
Query: 49  NKFSDANKLGEGGFGPVY-KGVLKKGDEIAVKRLSGRSGQGLREMK---NEASVIAKVQH 104
           ++F     LG G FG V     ++ G+  A+K L  +    L++++   NE  ++  V  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 105 KNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYL 164
             LV+L     D     ++ EY+    +    F   +R  +   +        AQ +L  
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRR--IGRFSEPHARFYAAQIVLTF 154
Query: 165 HQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY 224
                + +I+RDLK  N+L+D+    +++DFG A+   G      T  + GT  Y++PE 
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAPEI 209
Query: 225 ALEGIFSIKSDVFSFGVLLLEIVSG 249
            L   ++   D ++ GVL+ E+ +G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 64/230 (27%), Positives = 107/230 (46%), Gaps = 32/230 (13%)
Query: 43  SVSTATNKFSDANKL-----GEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKNEA 96
           S  + + +F D  +L     GEG    V   + L    E AVK +  + G     +  E 
Sbjct: 2   STDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREV 61
Query: 97  SVIAKVQ-HKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIE 155
            ++ + Q H+N++ L+    + D   L++E M   S+   L    KR   + +    +++
Sbjct: 62  EMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSI---LSHIHKRRHFNELEASVVVQ 118
Query: 156 GIAQGLLYLHQYSRVRIIHRDLKASNILLDK--DMNP-KISDFGMARICGGNELQANTSR 212
            +A  L +LH      I HRDLK  NIL +    ++P KI DFG+     G +L  + S 
Sbjct: 119 DVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFGLG---SGIKLNGDCSP 172
Query: 213 I--------VGTYGYMSPE----YALEG-IFSIKSDVFSFGVLLLEIVSG 249
           I         G+  YM+PE    ++ E  I+  + D++S GV+L  ++SG
Sbjct: 173 ISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSG 222

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 54/212 (25%), Positives = 96/212 (45%), Gaps = 15/212 (7%)
Query: 42  SSVSTATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLREMK---NEAS 97
           S  +   ++F     LG G FG V     K+ G+  A+K L  +    L++++   NE  
Sbjct: 34  SQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKR 93
Query: 98  VIAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGI 157
           ++  V    LV+L     D     ++ EY+    +    F   +R  +   +        
Sbjct: 94  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRR--IGRFSEPHARFYA 147
Query: 158 AQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTY 217
           AQ +L       + +I+RDLK  N+L+D+    +++DFG A+   G      T  + GT 
Sbjct: 148 AQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTP 202
Query: 218 GYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 249
            Y++PE  L   ++   D ++ GVL+ E+ +G
Sbjct: 203 EYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 54/212 (25%), Positives = 96/212 (45%), Gaps = 15/212 (7%)
Query: 42  SSVSTATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLREMK---NEAS 97
           S  +   ++F     LG G FG V     K+ G+  A+K L  +    L++++   NE  
Sbjct: 34  SQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKR 93
Query: 98  VIAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGI 157
           ++  V    LV+L     D     ++ EY+    +    F   +R  +   +        
Sbjct: 94  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRR--IGRFSEPHARFYA 147
Query: 158 AQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTY 217
           AQ +L       + +I+RDLK  N+L+D+    +++DFG A+   G      T  + GT 
Sbjct: 148 AQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTP 202
Query: 218 GYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 249
            Y++PE  L   ++   D ++ GVL+ E+ +G
Sbjct: 203 EYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 54/212 (25%), Positives = 96/212 (45%), Gaps = 15/212 (7%)
Query: 42  SSVSTATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLREMK---NEAS 97
           S  +   ++F     LG G FG V     K+ G+  A+K L  +    L++++   NE  
Sbjct: 34  SQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKR 93
Query: 98  VIAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGI 157
           ++  V    LV+L     D     ++ EY+    +    F   +R  +   +        
Sbjct: 94  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRR--IGRFSEPHARFYA 147
Query: 158 AQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTY 217
           AQ +L       + +I+RDLK  N+L+D+    +++DFG A+   G      T  + GT 
Sbjct: 148 AQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTP 202
Query: 218 GYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 249
            Y++PE  L   ++   D ++ GVL+ E+ +G
Sbjct: 203 EYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 54/212 (25%), Positives = 96/212 (45%), Gaps = 15/212 (7%)
Query: 42  SSVSTATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLREMK---NEAS 97
           S  +   ++F     LG G FG V     K+ G+  A+K L  +    L++++   NE  
Sbjct: 34  SQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKR 93
Query: 98  VIAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGI 157
           ++  V    LV+L     D     ++ EY+    +    F   +R  +   +        
Sbjct: 94  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRR--IGRFSEPHARFYA 147
Query: 158 AQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTY 217
           AQ +L       + +I+RDLK  N+L+D+    +++DFG A+   G      T  + GT 
Sbjct: 148 AQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTP 202
Query: 218 GYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 249
            Y++PE  L   ++   D ++ GVL+ E+ +G
Sbjct: 203 EYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 36/95 (37%), Positives = 54/95 (56%), Gaps = 7/95 (7%)
Query: 157 IAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR-IVG 215
           IA GL +L       II+RDLK  N++LD + + KI+DFGM   C  N     T++   G
Sbjct: 130 IAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGM---CKENIWDGVTTKXFCG 183
Query: 216 TYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 250
           T  Y++PE      +    D ++FGVLL E+++G+
Sbjct: 184 TPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 218

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 89/206 (43%), Gaps = 12/206 (5%)
Query: 49  NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLREMKN---EASVIAKVQH 104
           N F     LG+G FG V     K  G   A+K L         E+ +   E+ V+   +H
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 105 KNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYL 164
             L  L       D    + EY     L F L    +R+  +   R    E I   L YL
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGELFFHL--SRERVFTEERARFYGAE-IVSALEYL 121
Query: 165 HQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY 224
           H      +++RD+K  N++LDKD + KI+DFG+ +   G    A      GT  Y++PE 
Sbjct: 122 HSRD---VVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKXFCGTPEYLAPEV 176
Query: 225 ALEGIFSIKSDVFSFGVLLLEIVSGK 250
             +  +    D +  GV++ E++ G+
Sbjct: 177 LEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/212 (25%), Positives = 96/212 (45%), Gaps = 15/212 (7%)
Query: 42  SSVSTATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLREMK---NEAS 97
           S  +   ++F     LG G FG V     K+ G+  A+K L  +    L++++   NE  
Sbjct: 34  SQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKR 93
Query: 98  VIAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGI 157
           ++  V    LV+L     D     ++ EY+    +    F   +R  +   +        
Sbjct: 94  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRR--IGRFSEPHARFYA 147
Query: 158 AQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTY 217
           AQ +L       + +I+RDLK  N+L+D+    +++DFG A+   G      T  + GT 
Sbjct: 148 AQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLXGTP 202
Query: 218 GYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 249
            Y++PE  L   ++   D ++ GVL+ E+ +G
Sbjct: 203 EYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 97/203 (47%), Gaps = 26/203 (12%)
Query: 57  LGEGGFGPVYKGVLKK---GDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGC 113
           LG G F  V+  ++K+   G   A+K +          ++NE +V+ K++H+N+V L   
Sbjct: 17  LGSGAFSEVF--LVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDI 74
Query: 114 CIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQ----IIEGIAQGLLYLHQYSR 169
                   L+ + +    L    FD   R+L   V   +    +I+ +   + YLH+   
Sbjct: 75  YESTTHYYLVMQLVSGGEL----FD---RILERGVYTEKDASLVIQQVLSAVKYLHENG- 126
Query: 170 VRIIHRDLKASNIL-LDKDMNPKI--SDFGMARICGGNELQANTSRIVGTYGYMSPEYAL 226
             I+HRDLK  N+L L  + N KI  +DFG++++    E     S   GT GY++PE   
Sbjct: 127 --IVHRDLKPENLLYLTPEENSKIMITDFGLSKM----EQNGIMSTACGTPGYVAPEVLA 180
Query: 227 EGIFSIKSDVFSFGVLLLEIVSG 249
           +  +S   D +S GV+   ++ G
Sbjct: 181 QKPYSKAVDCWSIGVITYILLCG 203

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/230 (24%), Positives = 101/230 (43%), Gaps = 45/230 (19%)
Query: 51  FSDANKLGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVR 109
           F +   LG+G FG V K          A+K++   + + L  + +E  ++A + H+ +VR
Sbjct: 8   FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIR-HTEEKLSTILSEVXLLASLNHQYVVR 66
Query: 110 LLGCCIDRDEKI-------------LIYEYMPNKSLDFFLFDPTKRMLLD--WVTRVQII 154
                ++R   +             +  EY  N++L   +         D  W    QI+
Sbjct: 67  YYAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRDEYWRLFRQIL 126
Query: 155 EGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMAR--------------- 199
           E ++    Y+H      IIHR+LK  NI +D+  N KI DFG+A+               
Sbjct: 127 EALS----YIHSQG---IIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQN 179
Query: 200 ICGGNELQANTSRIVGTYGYMSPEYALEGI--FSIKSDVFSFGVLLLEIV 247
           + G ++   N +  +GT  Y++ E  L+G   ++ K D +S G++  E +
Sbjct: 180 LPGSSD---NLTSAIGTAXYVATE-VLDGTGHYNEKIDXYSLGIIFFEXI 225

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 68/224 (30%), Positives = 105/224 (46%), Gaps = 43/224 (19%)
Query: 55  NKLGEGGFGPV--YKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLG 112
            KLGEGGF  V   +G L  G   A+KR+     Q   E + EA +     H N++RL+ 
Sbjct: 35  QKLGEGGFSYVDLVEG-LHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVA 93
Query: 113 CCI-DRDEKILIYEYMPNKSLDFF----LFDPTKRML--LDWVTRVQIIE---GIAQGLL 162
            C+ +R  K   +  +P     FF    L++  +R+    +++T  QI+    GI +GL 
Sbjct: 94  YCLRERGAKHEAWLLLP-----FFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLE 148
Query: 163 YLHQYSRVRIIHRDLKASNILLDKDMNPKISDFG-MARICGGNE-------LQANTSRIV 214
            +H        HRDLK +NILL  +  P + D G M + C   E       LQ   ++  
Sbjct: 149 AIHAKGYA---HRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRC 205
Query: 215 GTYGYMSPEYALEGIFSIKS--------DVFSFGVLLLEIVSGK 250
            T  Y +PE     +FS++S        DV+S G +L  ++ G+
Sbjct: 206 -TISYRAPE-----LFSVQSHCVIDERTDVWSLGCVLYAMMFGE 243

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 89/206 (43%), Gaps = 12/206 (5%)
Query: 49  NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLREMKN---EASVIAKVQH 104
           N F     LG+G FG V     K  G   A+K L         E+ +   E+ V+   +H
Sbjct: 8   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 67
Query: 105 KNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYL 164
             L  L       D    + EY     L F L    +R+  +   R    E I   L YL
Sbjct: 68  PFLTALKYAFQTHDRLCFVMEYANGGELFFHL--SRERVFTEERARFYGAE-IVSALEYL 124
Query: 165 HQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY 224
           H      +++RD+K  N++LDKD + KI+DFG+ +   G    A      GT  Y++PE 
Sbjct: 125 HSRD---VVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYLAPEV 179
Query: 225 ALEGIFSIKSDVFSFGVLLLEIVSGK 250
             +  +    D +  GV++ E++ G+
Sbjct: 180 LEDNDYGRAVDWWGLGVVMYEMMCGR 205

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 89/206 (43%), Gaps = 12/206 (5%)
Query: 49  NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLREMKN---EASVIAKVQH 104
           N F     LG+G FG V     K  G   A+K L         E+ +   E+ V+   +H
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 105 KNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYL 164
             L  L       D    + EY     L F L    +R+  +   R    E I   L YL
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGELFFHL--SRERVFTEERARFYGAE-IVSALEYL 121
Query: 165 HQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY 224
           H      +++RD+K  N++LDKD + KI+DFG+ +   G    A      GT  Y++PE 
Sbjct: 122 HSRD---VVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKXFCGTPEYLAPEV 176
Query: 225 ALEGIFSIKSDVFSFGVLLLEIVSGK 250
             +  +    D +  GV++ E++ G+
Sbjct: 177 LEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 89/206 (43%), Gaps = 12/206 (5%)
Query: 49  NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLREMKN---EASVIAKVQH 104
           N F     LG+G FG V     K  G   A+K L         E+ +   E+ V+   +H
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 105 KNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYL 164
             L  L       D    + EY     L F L    +R+  +   R    E I   L YL
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGELFFHL--SRERVFTEERARFYGAE-IVSALEYL 121
Query: 165 HQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY 224
           H      +++RD+K  N++LDKD + KI+DFG+ +   G    A      GT  Y++PE 
Sbjct: 122 HSRD---VVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKXFCGTPEYLAPEV 176
Query: 225 ALEGIFSIKSDVFSFGVLLLEIVSGK 250
             +  +    D +  GV++ E++ G+
Sbjct: 177 LEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 89/206 (43%), Gaps = 12/206 (5%)
Query: 49  NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLREMKN---EASVIAKVQH 104
           N F     LG+G FG V     K  G   A+K L         E+ +   E+ V+   +H
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 105 KNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYL 164
             L  L       D    + EY     L F L    +R+  +   R    E I   L YL
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGELFFHL--SRERVFTEERARFYGAE-IVSALEYL 121
Query: 165 HQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY 224
           H      +++RD+K  N++LDKD + KI+DFG+ +   G    A      GT  Y++PE 
Sbjct: 122 HSRD---VVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYLAPEV 176
Query: 225 ALEGIFSIKSDVFSFGVLLLEIVSGK 250
             +  +    D +  GV++ E++ G+
Sbjct: 177 LEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 62/231 (26%), Positives = 106/231 (45%), Gaps = 35/231 (15%)
Query: 41  FSSVSTATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVK--RLSGRSGQGLREMKNEASV 98
           F S+S     +S   ++G GG   V++ + +K    A+K   L     Q L   +NE + 
Sbjct: 20  FQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAY 79
Query: 99  IAKVQHKN--LVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEG 156
           + K+Q  +  ++RL    I       IY  M   ++D   +   K+ +  W  R    + 
Sbjct: 80  LNKLQQHSDKIIRLYDYEITDQ---YIYMVMECGNIDLNSWLKKKKSIDPW-ERKSYWKN 135
Query: 157 IAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRI--- 213
           + + +  +HQ+    I+H DLK +N L+   M  K+ DFG+A     N++Q +T+ +   
Sbjct: 136 MLEAVHTIHQHG---IVHSDLKPANFLIVDGM-LKLIDFGIA-----NQMQPDTTSVVKD 186
Query: 214 --VGTYGYMSPEYALEGIFSIKS------------DVFSFGVLLLEIVSGK 250
             VGT  YM PE A++ + S +             DV+S G +L  +  GK
Sbjct: 187 SQVGTVNYMPPE-AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 236

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 89/206 (43%), Gaps = 12/206 (5%)
Query: 49  NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLREMKN---EASVIAKVQH 104
           N F     LG+G FG V     K  G   A+K L         E+ +   E+ V+   +H
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 105 KNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYL 164
             L  L       D    + EY     L F L    +R+  +   R    E I   L YL
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGELFFHL--SRERVFTEERARFYGAE-IVSALEYL 121
Query: 165 HQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY 224
           H      +++RD+K  N++LDKD + KI+DFG+ +   G    A      GT  Y++PE 
Sbjct: 122 HSRD---VVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYLAPEV 176
Query: 225 ALEGIFSIKSDVFSFGVLLLEIVSGK 250
             +  +    D +  GV++ E++ G+
Sbjct: 177 LEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 89/206 (43%), Gaps = 12/206 (5%)
Query: 49  NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLREMKN---EASVIAKVQH 104
           N F     LG+G FG V     K  G   A+K L         E+ +   E+ V+   +H
Sbjct: 10  NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 69
Query: 105 KNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYL 164
             L  L       D    + EY     L F L    +R+  +   R    E I   L YL
Sbjct: 70  PFLTALKYAFQTHDRLCFVMEYANGGELFFHL--SRERVFTEERARFYGAE-IVSALEYL 126
Query: 165 HQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY 224
           H      +++RD+K  N++LDKD + KI+DFG+ +   G    A      GT  Y++PE 
Sbjct: 127 HSRD---VVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKXFCGTPEYLAPEV 181
Query: 225 ALEGIFSIKSDVFSFGVLLLEIVSGK 250
             +  +    D +  GV++ E++ G+
Sbjct: 182 LEDNDYGRAVDWWGLGVVMYEMMCGR 207

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/212 (25%), Positives = 97/212 (45%), Gaps = 15/212 (7%)
Query: 42  SSVSTATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLREMK---NEAS 97
           S  +   ++F     LG G FG V     K+ G+  A+K L  +    L++++   NE  
Sbjct: 55  SQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKR 114
Query: 98  VIAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGI 157
           ++  V    LV+L     D     ++ EY+    +    F   +R  +   +        
Sbjct: 115 ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRR--IGRFSEPHARFYA 168
Query: 158 AQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTY 217
           AQ +L       + +I+RDLK  N+L+D+    +++DFG A+      ++  T  + GT 
Sbjct: 169 AQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGATWTLCGTP 223
Query: 218 GYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 249
            Y++PE  L   ++   D ++ GVL+ E+ +G
Sbjct: 224 EYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 255

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 100/222 (45%), Gaps = 30/222 (13%)
Query: 44  VSTATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSG--RSGQGLREMKNEASVIA 100
           V   ++ F   + LGEG +G V     K  G+ +A+K++    +    LR ++ E  ++ 
Sbjct: 6   VYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLR-EIKILK 64
Query: 101 KVQHKNLVRLLGCCIDR-------DEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQI 153
             +H+N++ +    I R       +E  +I E M     D      T+ +  D +     
Sbjct: 65  HFKHENIITIFN--IQRPDSFENFNEVYIIQELM---QTDLHRVISTQMLSDDHIQYF-- 117
Query: 154 IEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNEL------- 206
              I Q L  +       +IHRDLK SN+L++ + + K+ DFG+ARI   +         
Sbjct: 118 ---IYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTG 174
Query: 207 -QANTSRIVGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEI 246
            Q+  +  V T  Y +PE  L    +S   DV+S G +L E+
Sbjct: 175 QQSGMTEXVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAEL 216

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/225 (25%), Positives = 95/225 (42%), Gaps = 53/225 (23%)
Query: 51  FSDANKLGEGGFGP-VYKGVLKKGDEIAVKRL-------SGRSGQGLREMKNEASVIAKV 102
           F   + LG G  G  VY+G+    D +AVKR+       + R  Q LRE           
Sbjct: 26  FCPKDVLGHGAEGTIVYRGMFDNRD-VAVKRILPECFSFADREVQLLRESD--------- 75
Query: 103 QHKNLVRLLGCCIDRDEKI----------LIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQ 152
           +H N++R    C ++D +            + EY+  K       +P           + 
Sbjct: 76  EHPNVIRYF--CTEKDRQFQYIAIELCAATLQEYVEQKDFAHLGLEP-----------IT 122
Query: 153 IIEGIAQGLLYLHQYSRVRIIHRDLKASNILL-----DKDMNPKISDFGMA-RICGGNEL 206
           +++    GL +LH    + I+HRDLK  NIL+        +   ISDFG+  ++  G   
Sbjct: 123 LLQQTTSGLAHLHS---LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHS 179
Query: 207 QANTSRIVGTYGYMSPEYALEGI---FSIKSDVFSFGVLLLEIVS 248
            +  S + GT G+++PE   E      +   D+FS G +   ++S
Sbjct: 180 FSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVIS 224

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 64/230 (27%), Positives = 105/230 (45%), Gaps = 32/230 (13%)
Query: 43  SVSTATNKFSDANKL-----GEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKNEA 96
           S  +   KF D  KL     GEG +  V   V L+ G E AVK +  ++G     +  E 
Sbjct: 2   STDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREV 61
Query: 97  SVIAKVQ-HKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIE 155
             + + Q +KN++ L+    D     L++E +   S+   L    K+   +     +++ 
Sbjct: 62  ETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSI---LAHIQKQKHFNEREASRVVR 118
Query: 156 GIAQGLLYLHQYSRVRIIHRDLKASNILLD--KDMNP-KISDFGMARICGGNELQANTSR 212
            +A  L +LH      I HRDLK  NIL +  + ++P KI DF +     G +L  + + 
Sbjct: 119 DVAAALDFLHTKG---IAHRDLKPENILCESPEKVSPVKICDFDLG---SGMKLNNSCTP 172
Query: 213 I--------VGTYGYMSPE----YALEGIFSIK-SDVFSFGVLLLEIVSG 249
           I         G+  YM+PE    +  +  F  K  D++S GV+L  ++SG
Sbjct: 173 ITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSG 222

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 100/222 (45%), Gaps = 30/222 (13%)
Query: 44  VSTATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSG--RSGQGLREMKNEASVIA 100
           V   ++ F   + LGEG +G V     K  G+ +A+K++    +    LR ++ E  ++ 
Sbjct: 6   VYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLR-EIKILK 64
Query: 101 KVQHKNLVRLLGCCIDR-------DEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQI 153
             +H+N++ +    I R       +E  +I E M     D      T+ +  D +     
Sbjct: 65  HFKHENIITIFN--IQRPDSFENFNEVYIIQELM---QTDLHRVISTQMLSDDHIQYF-- 117
Query: 154 IEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNEL------- 206
              I Q L  +       +IHRDLK SN+L++ + + K+ DFG+ARI   +         
Sbjct: 118 ---IYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTG 174
Query: 207 -QANTSRIVGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEI 246
            Q+  +  V T  Y +PE  L    +S   DV+S G +L E+
Sbjct: 175 QQSGMTEYVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAEL 216

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 62/230 (26%), Positives = 106/230 (46%), Gaps = 34/230 (14%)
Query: 42  SSVSTATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLREMK---NEAS 97
            S ST+ + +  ++ LG+G    V++G  KK GD  A+K  +  S   LR +     E  
Sbjct: 2   GSQSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF--LRPVDVQMREFE 59
Query: 98  VIAKVQHKNLVRLLGCCIDRD----EKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQI 153
           V+ K+ HKN+V+L    I+ +     K+LI E+ P  SL   L +P+    L     + +
Sbjct: 60  VLKKLNHKNIVKLF--AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIV 117
Query: 154 IEGIAQGLLYLHQYSRVRIIHRDLKASNILL----DKDMNPKISDFGMARICGGNELQAN 209
           +  +  G+ +L +     I+HR++K  NI+     D     K++DFG AR     EL+ +
Sbjct: 118 LRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR-----ELEDD 169
Query: 210 TS--RIVGTYGYMSPEYALEGI--------FSIKSDVFSFGVLLLEIVSG 249
                + GT  Y+ P+     +        +    D++S GV      +G
Sbjct: 170 EQFVXLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATG 219

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/212 (25%), Positives = 96/212 (45%), Gaps = 15/212 (7%)
Query: 42  SSVSTATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLREMK---NEAS 97
           S  +   ++F     LG G FG V     K+ G+  A+K L  +    L++++   NE  
Sbjct: 34  SQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKR 93
Query: 98  VIAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGI 157
           ++  V    LV+L     D     ++ EY+    +    F   +R  +   +        
Sbjct: 94  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRR--IGRFSEPHARFYA 147
Query: 158 AQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTY 217
           AQ +L       + +I+RDLK  N+L+D+    +++DFG A+   G      T  + GT 
Sbjct: 148 AQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTP 202
Query: 218 GYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 249
            Y++PE  L   ++   D ++ GVL+ ++ +G
Sbjct: 203 EYLAPEIILSKGYNKAVDWWALGVLIYQMAAG 234

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 68/295 (23%), Positives = 135/295 (45%), Gaps = 48/295 (16%)
Query: 43  SVSTATNKFSDANKLGEGGFGPVYK-GVLKKGDEIAVKRLSG--RSGQGLREMKNEASVI 99
           S+    +      +LG G +G V K   +  G  +AVKR+     S +  R + +    +
Sbjct: 1   SMEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISM 60
Query: 100 AKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFF---LFDPTKRMLLDWVTRVQIIEG 156
             V     V   G      +  +  E M + SLD F   + D  + +  D + ++ +   
Sbjct: 61  RTVDCPFTVTFYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAV--S 117
Query: 157 IAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIV-- 214
           I + L +LH  S++ +IHRD+K SN+L++     K+ DFG++       L  + ++ +  
Sbjct: 118 IVKALEHLH--SKLSVIHRDVKPSNVLINALGQVKMCDFGIS-----GYLVDDVAKDIDA 170
Query: 215 GTYGYMSPEYALEGI----FSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDL 270
           G   YM+PE     +    +S+KSD++S G+ ++E               L +L + +D 
Sbjct: 171 GCKPYMAPERINPELNQKGYSVKSDIWSLGITMIE---------------LAILRFPYDS 215
Query: 271 WTS-----NRTLELIDPILE-DEYSSKQMLLRYANIALLCVQESADDRPTMNDVV 319
           W +      + +E   P L  D++S++     + +    C+++++ +RPT  +++
Sbjct: 216 WGTPFQQLKQVVEEPSPQLPADKFSAE-----FVDFTSQCLKKNSKERPTYPELM 265

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 104/227 (45%), Gaps = 30/227 (13%)
Query: 43  SVSTATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLREMK---NEASV 98
           S ST+ + +  ++ LG+G    V++G  KK GD  A+K  +  S   LR +     E  V
Sbjct: 3   SQSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF--LRPVDVQMREFEV 60
Query: 99  IAKVQHKNLVRLLGCCIDRD----EKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQII 154
           + K+ HKN+V+L    I+ +     K+LI E+ P  SL   L +P+    L     + ++
Sbjct: 61  LKKLNHKNIVKLF--AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVL 118
Query: 155 EGIAQGLLYLHQYSRVRIIHRDLKASNILL----DKDMNPKISDFGMARICGGNELQANT 210
             +  G+ +L +     I+HR++K  NI+     D     K++DFG AR    +E     
Sbjct: 119 RDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE---QF 172
Query: 211 SRIVGTYGYMSPEYALEGI--------FSIKSDVFSFGVLLLEIVSG 249
             + GT  Y+ P+     +        +    D++S GV      +G
Sbjct: 173 VSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATG 219

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/226 (24%), Positives = 107/226 (47%), Gaps = 23/226 (10%)
Query: 40  SFSSVSTATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSG------RSGQGLREM 92
           SF       +++     +G G +G V     +  G ++A+K++         + + LRE+
Sbjct: 45  SFDVTFDVGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLREL 104
Query: 93  KNEASVIAKVQHKNLVRL---LGCCIDRDEKILIYEYMPNKSLDFF-LFDPTKRMLLDWV 148
           K    ++   +H N++ +   L   +   E   +Y  +     D   +   ++ + L+ V
Sbjct: 105 K----ILKHFKHDNIIAIKDILRPTVPYGEFKSVYVVLDLMESDLHQIIHSSQPLTLEHV 160
Query: 149 TRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMAR-IC-GGNEL 206
                +  + +GL Y+H     ++IHRDLK SN+L++++   KI DFGMAR +C    E 
Sbjct: 161 R--YFLYQLLRGLKYMHS---AQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEH 215
Query: 207 QANTSRIVGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGKK 251
           Q   +  V T  Y +PE  L    ++   D++S G +  E+++ ++
Sbjct: 216 QYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQ 261

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 99/222 (44%), Gaps = 30/222 (13%)
Query: 44  VSTATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSG--RSGQGLREMKNEASVIA 100
           V   ++ F   + LGEG +G V     K  G+ +A+K++    +    LR ++ E  ++ 
Sbjct: 6   VYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLR-EIKILK 64
Query: 101 KVQHKNLVRLLGCCIDR-------DEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQI 153
             +H+N++ +    I R       +E  +I E M     D      T+ +  D +     
Sbjct: 65  HFKHENIITIFN--IQRPDSFENFNEVYIIQELM---QTDLHRVISTQMLSDDHIQYF-- 117
Query: 154 IEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNEL------- 206
              I Q L  +       +IHRDLK SN+L++ + + K+ DFG+ARI   +         
Sbjct: 118 ---IYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTG 174
Query: 207 -QANTSRIVGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEI 246
            Q+     V T  Y +PE  L    +S   DV+S G +L E+
Sbjct: 175 QQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAEL 216

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/226 (24%), Positives = 107/226 (47%), Gaps = 23/226 (10%)
Query: 40  SFSSVSTATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSG------RSGQGLREM 92
           SF       +++     +G G +G V     +  G ++A+K++         + + LRE+
Sbjct: 46  SFDVTFDVGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLREL 105
Query: 93  KNEASVIAKVQHKNLVRL---LGCCIDRDEKILIYEYMPNKSLDFF-LFDPTKRMLLDWV 148
           K    ++   +H N++ +   L   +   E   +Y  +     D   +   ++ + L+ V
Sbjct: 106 K----ILKHFKHDNIIAIKDILRPTVPYGEFKSVYVVLDLMESDLHQIIHSSQPLTLEHV 161
Query: 149 TRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMAR-IC-GGNEL 206
                +  + +GL Y+H     ++IHRDLK SN+L++++   KI DFGMAR +C    E 
Sbjct: 162 R--YFLYQLLRGLKYMHS---AQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEH 216
Query: 207 QANTSRIVGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGKK 251
           Q   +  V T  Y +PE  L    ++   D++S G +  E+++ ++
Sbjct: 217 QYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQ 262

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 52/212 (24%), Positives = 96/212 (45%), Gaps = 15/212 (7%)
Query: 42  SSVSTATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLREMK---NEAS 97
           S  +   ++F     LG G FG V     K+ G+  A+K L  +    L++++   NE  
Sbjct: 34  SQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKR 93
Query: 98  VIAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGI 157
           ++  V    LV+L     D     ++ EY+    +    F   +R  +   +        
Sbjct: 94  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRR--IGRFSEPHARFYA 147
Query: 158 AQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTY 217
           AQ +L       + +I+RDLK  N+++D+    +++DFG A+   G      T  + GT 
Sbjct: 148 AQIVLTFEYLHSLDLIYRDLKPENLIIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTP 202
Query: 218 GYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 249
            Y++PE  +   ++   D ++ GVL+ E+ +G
Sbjct: 203 EYLAPEIIISKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 53/212 (25%), Positives = 95/212 (44%), Gaps = 15/212 (7%)
Query: 42  SSVSTATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLREMK---NEAS 97
           S  +   ++F     LG G FG V     K+ G+  A+K L  +    L++++   NE  
Sbjct: 34  SQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKR 93
Query: 98  VIAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGI 157
           ++  V    LV+L     D     ++ EY+    +    F   +R  +   +        
Sbjct: 94  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRR--IGRFSEPHARFYA 147
Query: 158 AQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTY 217
           AQ +L       + +I+RDLK  N+L+D+    +++DFG A+   G      T  + GT 
Sbjct: 148 AQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTP 202
Query: 218 GYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 249
            Y++P   L   ++   D ++ GVL+ E+ +G
Sbjct: 203 EYLAPAIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 101/215 (46%), Gaps = 28/215 (13%)
Query: 48  TNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGR--------SGQGLREMKNEASV 98
           + K+S  + LG G FG V+  V K K  E+ VK +               L ++  E ++
Sbjct: 23  SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAI 82
Query: 99  IAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLF-DPTKRM---LLDWVTRVQII 154
           +++V+H N++++L    ++    L+ E      LD F F D   R+   L  ++ R Q++
Sbjct: 83  LSRVEHANIIKVLDIFENQGFFQLVMEKH-GSGLDLFAFIDRHPRLDEPLASYIFR-QLV 140
Query: 155 EGIAQGLLYLHQYSRVR-IIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRI 213
             +         Y R++ IIHRD+K  NI++ +D   K+ DFG A      +L       
Sbjct: 141 SAVG--------YLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKL---FYTF 189
Query: 214 VGTYGYMSPEYALEGIF-SIKSDVFSFGVLLLEIV 247
            GT  Y +PE  +   +   + +++S GV L  +V
Sbjct: 190 CGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLV 224

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 63/230 (27%), Positives = 106/230 (46%), Gaps = 32/230 (13%)
Query: 43  SVSTATNKFSDANKL-----GEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKNEA 96
           S  + + +F D  +L     GEG    V   + L    E AVK +  + G     +  E 
Sbjct: 2   STDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREV 61
Query: 97  SVIAKVQ-HKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIE 155
            ++ + Q H+N++ L+    + D   L++E M   S+   L    KR   + +    +++
Sbjct: 62  EMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSI---LSHIHKRRHFNELEASVVVQ 118
Query: 156 GIAQGLLYLHQYSRVRIIHRDLKASNILLDK--DMNP-KISDFGMARICGGNELQANTSR 212
            +A  L +LH      I HRDLK  NIL +    ++P KI DF +     G +L  + S 
Sbjct: 119 DVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLG---SGIKLNGDCSP 172
Query: 213 I--------VGTYGYMSPE----YALEG-IFSIKSDVFSFGVLLLEIVSG 249
           I         G+  YM+PE    ++ E  I+  + D++S GV+L  ++SG
Sbjct: 173 ISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSG 222

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 61/231 (26%), Positives = 104/231 (45%), Gaps = 35/231 (15%)
Query: 41  FSSVSTATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVK--RLSGRSGQGLREMKNEASV 98
           F S+S     +S   ++G GG   V++ + +K    A+K   L     Q L   +NE + 
Sbjct: 20  FQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAY 79
Query: 99  IAKVQHKN--LVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEG 156
           + K+Q  +  ++RL    I       IY  M   ++D   +   K+ +  W  R    + 
Sbjct: 80  LNKLQQHSDKIIRLYDYEITDQ---YIYMVMECGNIDLNSWLKKKKSIDPW-ERKSYWKN 135
Query: 157 IAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRI--- 213
           + + +  +HQ+    I+H DLK +N L+   M  K+ DFG+A     N++Q +   +   
Sbjct: 136 MLEAVHTIHQHG---IVHSDLKPANFLIVDGM-LKLIDFGIA-----NQMQPDXXXVVKD 186
Query: 214 --VGTYGYMSPEYALEGIFSIKS------------DVFSFGVLLLEIVSGK 250
             VGT  YM PE A++ + S +             DV+S G +L  +  GK
Sbjct: 187 SQVGTVNYMPPE-AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 236

>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 54/200 (27%), Positives = 94/200 (47%), Gaps = 17/200 (8%)
Query: 56  KLGEGGFGPVYKGVLKKGDEIAVKRLSGR--SGQGLREMKNEASVIAKVQHKNLVRLLGC 113
           KL E   G ++KG  + G++I VK L  R  S +  R+   E   +    H N++ +LG 
Sbjct: 17  KLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGA 75
Query: 114 C--IDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVR 171
           C         LI  +MP  SL   L + T   ++D    V+    +A+G+ +LH    + 
Sbjct: 76  CQSPPAPHPTLITHWMPYGSLYNVLHEGTN-FVVDQSQAVKFALDMARGMAFLHTLEPL- 133
Query: 172 IIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY---ALEG 228
           I    L + ++++D+DM  +IS   MA +    +    +   +    +++PE      E 
Sbjct: 134 IPRHALNSRSVMIDEDMTARIS---MADV----KFSFQSPGRMYAPAWVAPEALQKKPED 186
Query: 229 IFSIKSDVFSFGVLLLEIVS 248
                +D++SF VLL E+V+
Sbjct: 187 TNRRSADMWSFAVLLWELVT 206

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 98/211 (46%), Gaps = 31/211 (14%)
Query: 51  FSDANKLGEGGFGPVYKGVLKKGDE--IAVKRLSGRSGQGLREMKNEASVIAKVQHKNLV 108
           F   ++LG G    VY+   +KG +   A+K L     + +  ++ E  V+ ++ H N++
Sbjct: 55  FEVESELGRGATSIVYR-CKQKGTQKPYALKVLKKTVDKKI--VRTEIGVLLRLSHPNII 111
Query: 109 RLLGCCIDRDEKILIYEYMPNKSLDFFLFDP-------TKRMLLDWVTRVQIIEGIAQGL 161
           +L        E  L+ E +    L    FD        ++R   D V   QI+E +A   
Sbjct: 112 KLKEIFETPTEISLVLELVTGGEL----FDRIVEKGYYSERDAADAVK--QILEAVA--- 162
Query: 162 LYLHQYSRVRIIHRDLKASNILLD---KDMNPKISDFGMARICGGNELQANTSRIVGTYG 218
            YLH+     I+HRDLK  N+L      D   KI+DFG+++I    E Q     + GT G
Sbjct: 163 -YLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIV---EHQVLMKTVCGTPG 215
Query: 219 YMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 249
           Y +PE      +  + D++S G++   ++ G
Sbjct: 216 YCAPEILRGCAYGPEVDMWSVGIITYILLCG 246

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/212 (25%), Positives = 95/212 (44%), Gaps = 15/212 (7%)
Query: 42  SSVSTATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLREMK---NEAS 97
           S  +   ++F     LG G FG V     K+ G+  A+K L  +    L++++   NE  
Sbjct: 34  SQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKR 93
Query: 98  VIAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGI 157
           ++  V    LV+L     D     ++ EY+    +    F   +R  +   +        
Sbjct: 94  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRR--IGRFSEPHARFYA 147
Query: 158 AQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTY 217
           AQ +L       + +I+RDLK  N+L+D+    +++DFG A+   G      T  + GT 
Sbjct: 148 AQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTP 202
Query: 218 GYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 249
             ++PE  L   ++   D ++ GVL+ E+ +G
Sbjct: 203 EALAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 60/228 (26%), Positives = 104/228 (45%), Gaps = 35/228 (15%)
Query: 44  VSTATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVK--RLSGRSGQGLREMKNEASVIAK 101
           +S     +S   ++G GG   V++ + +K    A+K   L     Q L   +NE + + K
Sbjct: 7   ISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNK 66
Query: 102 VQHKN--LVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQ 159
           +Q  +  ++RL    I       IY  M   ++D   +   K+ +  W  R    + + +
Sbjct: 67  LQQHSDKIIRLYDYEITDQ---YIYMVMECGNIDLNSWLKKKKSIDPW-ERKSYWKNMLE 122
Query: 160 GLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRI-----V 214
            +  +HQ+    I+H DLK +N L+   M  K+ DFG+A     N++Q +T+ +     V
Sbjct: 123 AVHTIHQHG---IVHSDLKPANFLIVDGM-LKLIDFGIA-----NQMQPDTTSVVKDSQV 173
Query: 215 GTYGYMSPEYALEGIFSIKS------------DVFSFGVLLLEIVSGK 250
           GT  YM PE A++ + S +             DV+S G +L  +  GK
Sbjct: 174 GTVNYMPPE-AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 220

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 60/228 (26%), Positives = 104/228 (45%), Gaps = 35/228 (15%)
Query: 44  VSTATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVK--RLSGRSGQGLREMKNEASVIAK 101
           +S     +S   ++G GG   V++ + +K    A+K   L     Q L   +NE + + K
Sbjct: 51  ISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNK 110
Query: 102 VQHKN--LVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQ 159
           +Q  +  ++RL    I       IY  M   ++D   +   K+ +  W  R    + + +
Sbjct: 111 LQQHSDKIIRLYDYEITDQ---YIYMVMECGNIDLNSWLKKKKSIDPW-ERKSYWKNMLE 166
Query: 160 GLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRI-----V 214
            +  +HQ+    I+H DLK +N L+   M  K+ DFG+A     N++Q +T+ +     V
Sbjct: 167 AVHTIHQHG---IVHSDLKPANFLIVDGM-LKLIDFGIA-----NQMQPDTTSVVKDSQV 217
Query: 215 GTYGYMSPEYALEGIFSIKS------------DVFSFGVLLLEIVSGK 250
           GT  YM PE A++ + S +             DV+S G +L  +  GK
Sbjct: 218 GTVNYMPPE-AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 264

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 60/228 (26%), Positives = 104/228 (45%), Gaps = 35/228 (15%)
Query: 44  VSTATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVK--RLSGRSGQGLREMKNEASVIAK 101
           +S     +S   ++G GG   V++ + +K    A+K   L     Q L   +NE + + K
Sbjct: 4   ISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNK 63
Query: 102 VQHKN--LVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQ 159
           +Q  +  ++RL    I       IY  M   ++D   +   K+ +  W  R    + + +
Sbjct: 64  LQQHSDKIIRLYDYEITDQ---YIYMVMECGNIDLNSWLKKKKSIDPW-ERKSYWKNMLE 119
Query: 160 GLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRI-----V 214
            +  +HQ+    I+H DLK +N L+   M  K+ DFG+A     N++Q +T+ +     V
Sbjct: 120 AVHTIHQHG---IVHSDLKPANFLIVDGM-LKLIDFGIA-----NQMQPDTTSVVKDSQV 170
Query: 215 GTYGYMSPEYALEGIFSIKS------------DVFSFGVLLLEIVSGK 250
           GT  YM PE A++ + S +             DV+S G +L  +  GK
Sbjct: 171 GTVNYMPPE-AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 217

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 90/207 (43%), Gaps = 16/207 (7%)
Query: 48  TNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNL 107
           ++++     +G G FG       K+ +E+   +   R  +    +K E      ++H N+
Sbjct: 18  SDRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKIAANVKREIINHRSLRHPNI 77
Query: 108 VRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRV--QIIEGIAQGLLYLH 165
           VR     +      ++ EY     L F       R   D       Q+I G++    Y H
Sbjct: 78  VRFKEVILTPTHLAIVMEYASGGEL-FERICNAGRFSEDEARFFFQQLISGVS----YCH 132
Query: 166 QYSRVRIIHRDLKASNILLDKDMNP--KISDFGMARICGGNELQANTSRIVGTYGYMSPE 223
               +++ HRDLK  N LLD    P  KI DFG ++    + L +     VGT  Y++PE
Sbjct: 133 A---MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVGTPAYIAPE 186
Query: 224 YALEGIFSIK-SDVFSFGVLLLEIVSG 249
             L+  +  K +DV+S GV L  ++ G
Sbjct: 187 VLLKKEYDGKVADVWSCGVTLYVMLVG 213

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 60/228 (26%), Positives = 104/228 (45%), Gaps = 35/228 (15%)
Query: 44  VSTATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVK--RLSGRSGQGLREMKNEASVIAK 101
           +S     +S   ++G GG   V++ + +K    A+K   L     Q L   +NE + + K
Sbjct: 3   ISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNK 62
Query: 102 VQHKN--LVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQ 159
           +Q  +  ++RL    I       IY  M   ++D   +   K+ +  W  R    + + +
Sbjct: 63  LQQHSDKIIRLYDYEITDQ---YIYMVMECGNIDLNSWLKKKKSIDPW-ERKSYWKNMLE 118
Query: 160 GLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRI-----V 214
            +  +HQ+    I+H DLK +N L+   M  K+ DFG+A     N++Q +T+ +     V
Sbjct: 119 AVHTIHQHG---IVHSDLKPANFLIVDGM-LKLIDFGIA-----NQMQPDTTSVVKDSQV 169
Query: 215 GTYGYMSPEYALEGIFSIKS------------DVFSFGVLLLEIVSGK 250
           GT  YM PE A++ + S +             DV+S G +L  +  GK
Sbjct: 170 GTVNYMPPE-AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 216

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 92/200 (46%), Gaps = 18/200 (9%)
Query: 57  LGEGGFGPVYKGVLKKGDE-IAVKRLSGRSGQGLREMKNEASVIAKVQ-HKNLVRLLGCC 114
           LGEG F    K V KK ++  AVK +S R     ++   E + +   + H N+V+L    
Sbjct: 19  LGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQK---EITALKLCEGHPNIVKLHEVF 75
Query: 115 IDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQ-IIEGIAQGLLYLHQYSRVRII 173
            D+    L+ E +    L    F+  K+      T    I+  +   + ++H    V ++
Sbjct: 76  HDQLHTFLVMELLNGGEL----FERIKKKKHFSETEASYIMRKLVSAVSHMHD---VGVV 128
Query: 174 HRDLKASNILL---DKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIF 230
           HRDLK  N+L    + ++  KI DFG AR+   +     T     T  Y +PE   +  +
Sbjct: 129 HRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCF--TLHYAAPELLNQNGY 186
Query: 231 SIKSDVFSFGVLLLEIVSGK 250
               D++S GV+L  ++SG+
Sbjct: 187 DESCDLWSLGVILYTMLSGQ 206

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 60/228 (26%), Positives = 104/228 (45%), Gaps = 35/228 (15%)
Query: 44  VSTATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVK--RLSGRSGQGLREMKNEASVIAK 101
           +S     +S   ++G GG   V++ + +K    A+K   L     Q L   +NE + + K
Sbjct: 51  ISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNK 110
Query: 102 VQHKN--LVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQ 159
           +Q  +  ++RL    I       IY  M   ++D   +   K+ +  W  R    + + +
Sbjct: 111 LQQHSDKIIRLYDYEITDQ---YIYMVMECGNIDLNSWLKKKKSIDPW-ERKSYWKNMLE 166
Query: 160 GLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRI-----V 214
            +  +HQ+    I+H DLK +N L+   M  K+ DFG+A     N++Q +T+ +     V
Sbjct: 167 AVHTIHQHG---IVHSDLKPANFLIVDGM-LKLIDFGIA-----NQMQPDTTSVVKDSQV 217
Query: 215 GTYGYMSPEYALEGIFSIKS------------DVFSFGVLLLEIVSGK 250
           GT  YM PE A++ + S +             DV+S G +L  +  GK
Sbjct: 218 GTVNYMPPE-AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 264

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 65/220 (29%), Positives = 102/220 (46%), Gaps = 33/220 (15%)
Query: 57  LGEGGFGPVYKGVLKKGDEI-AVKRLSG-----RSGQGLREMKNEASVIAKVQHKNLVRL 110
           +G G FG V     K   ++ A+K LS      RS         E  ++A      +V+L
Sbjct: 83  IGRGAFGEVQLVRHKASQKVYAMKLLSKFEMIKRSDSAF--FWEERDIMAFANSPWVVQL 140
Query: 111 LGCCIDRDEKIL--IYEYMPNKSLDFFL--FDPTKRMLLDWVTRVQIIEGIAQGLLYLHQ 166
              C  +D+K L  + EYMP   L   +  +D  ++    W          A+ +L L  
Sbjct: 141 F--CAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEK----WAKFY-----TAEVVLALDA 189
Query: 167 YSRVRIIHRDLKASNILLDKDMNPKISDFGMA-RICGGNELQANTSRIVGTYGYMSPEY- 224
              + +IHRD+K  N+LLDK  + K++DFG   ++     +  +T+  VGT  Y+SPE  
Sbjct: 190 IHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVHCDTA--VGTPDYISPEVL 247
Query: 225 ---ALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSL 261
                +G +  + D +S GV L E++ G  +T  Y  DSL
Sbjct: 248 KSQGGDGYYGRECDWWSVGVFLFEMLVG--DTPFY-ADSL 284

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 90/207 (43%), Gaps = 16/207 (7%)
Query: 48  TNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNL 107
           ++++     +G G FG       K+ +E+   +   R  +    +K E      ++H N+
Sbjct: 17  SDRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREIINHRSLRHPNI 76
Query: 108 VRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRV--QIIEGIAQGLLYLH 165
           VR     +      ++ EY     L F       R   D       Q+I G++    Y H
Sbjct: 77  VRFKEVILTPTHLAIVMEYASGGEL-FERICNAGRFSEDEARFFFQQLISGVS----YCH 131
Query: 166 QYSRVRIIHRDLKASNILLDKDMNP--KISDFGMARICGGNELQANTSRIVGTYGYMSPE 223
               +++ HRDLK  N LLD    P  KI DFG ++    + L +     VGT  Y++PE
Sbjct: 132 A---MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVGTPAYIAPE 185
Query: 224 YALEGIFSIK-SDVFSFGVLLLEIVSG 249
             L+  +  K +DV+S GV L  ++ G
Sbjct: 186 VLLKKEYDGKVADVWSCGVTLYVMLVG 212

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 91/207 (43%), Gaps = 16/207 (7%)
Query: 48  TNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNL 107
           ++++     +G G FG       K+ +E+   +   R  +    +K E      ++H N+
Sbjct: 18  SDRYELVKDIGAGNFGVARLMRDKQANELVAVKYIERGEKIDENVKREIINHRSLRHPNI 77
Query: 108 VRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRV--QIIEGIAQGLLYLH 165
           VR     +      ++ EY     L F       R   D       Q+I G++    Y H
Sbjct: 78  VRFKEVILTPTHLAIVMEYASGGEL-FERICNAGRFSEDEARFFFQQLISGVS----YAH 132
Query: 166 QYSRVRIIHRDLKASNILLDKDMNP--KISDFGMARICGGNELQANTSRIVGTYGYMSPE 223
               +++ HRDLK  N LLD    P  KI+DFG ++    + L +     VGT  Y++PE
Sbjct: 133 A---MQVAHRDLKLENTLLDGSPAPRLKIADFGYSK---ASVLHSQPKSAVGTPAYIAPE 186
Query: 224 YALEGIFSIK-SDVFSFGVLLLEIVSG 249
             L+  +  K +DV+S GV L  ++ G
Sbjct: 187 VLLKKEYDGKVADVWSCGVTLYVMLVG 213

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 64/283 (22%), Positives = 126/283 (44%), Gaps = 52/283 (18%)
Query: 56  KLGEGGFGPVYKG-VLKKGDEIAVKRLSGR-SGQGLREMKNEASVIAKVQHKNLVRLLGC 113
           +LG G +G V K   +  G   AVKR+    + Q  + +  +  +  +            
Sbjct: 41  ELGRGAYGVVEKXRHVPSGQIXAVKRIRATVNSQEQKRLLXDLDISXRTVDCPFTVTFYG 100
Query: 114 CIDRDEKILIYEYMPNKSLDFF---LFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRV 170
            + R+  + I   + + SLD F   + D  + +  D + ++ +   I + L +LH  S++
Sbjct: 101 ALFREGDVWICXELXDTSLDKFYKQVIDKGQTIPEDILGKIAV--SIVKALEHLH--SKL 156
Query: 171 RIIHRDLKASNILLDKDMNPKISDFGMA---------RICGGNELQANTSRIVGTYGYMS 221
            +IHRD+K SN+L++     K  DFG++          I  G +      RI       +
Sbjct: 157 SVIHRDVKPSNVLINALGQVKXCDFGISGYLVDDVAKDIDAGCKPYXAPERI-------N 209
Query: 222 PEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTS-----NRT 276
           PE   +G +S+KSD++S G+  +E               L +L + +D W +      + 
Sbjct: 210 PELNQKG-YSVKSDIWSLGITXIE---------------LAILRFPYDSWGTPFQQLKQV 253
Query: 277 LELIDPILE-DEYSSKQMLLRYANIALLCVQESADDRPTMNDV 318
           +E   P L  D++S++     + +    C+++++ +RPT  ++
Sbjct: 254 VEEPSPQLPADKFSAE-----FVDFTSQCLKKNSKERPTYPEL 291

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 68/276 (24%), Positives = 122/276 (44%), Gaps = 40/276 (14%)
Query: 37  PLFSFSSV--STATNKFSDANKLGEGGFGPVYKGVLKKG-DEIAVKRLS--------GRS 85
           PL S  SV      +++  +  LG G  G V     +K   ++A+K +S         R 
Sbjct: 2   PLGSHMSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSARE 61
Query: 86  GQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPT--KRM 143
                 ++ E  ++ K+ H  ++++     D ++  ++ E M    L    FD     + 
Sbjct: 62  ADPALNVETEIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGEL----FDKVVGNKR 116
Query: 144 LLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILL---DKDMNPKISDFGMARI 200
           L +   ++   + +   + YLH+     IIHRDLK  N+LL   ++D   KI+DFG ++I
Sbjct: 117 LKEATCKLYFYQMLL-AVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKI 172
Query: 201 CGGNELQANTSRIVGTYGYMSPEYALE---GIFSIKSDVFSFGVLLLEIVSGKKNTGLYR 257
            G   L      + GT  Y++PE  +      ++   D +S GV+L   +SG      +R
Sbjct: 173 LGETSLMRT---LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHR 229
Query: 258 T-----DSLNLLGYAW--DLWT--SNRTLELIDPIL 284
           T     D +    Y +  ++W   S + L+L+  +L
Sbjct: 230 TQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLL 265

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 63/254 (24%), Positives = 113/254 (44%), Gaps = 38/254 (14%)
Query: 57  LGEGGFGPVYKGVLKKG-DEIAVKRLS--------GRSGQGLREMKNEASVIAKVQHKNL 107
           LG G  G V     +K   ++A+K +S         R       ++ E  ++ K+ H  +
Sbjct: 18  LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 77
Query: 108 VRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPT--KRMLLDWVTRVQIIEGIAQGLLYLH 165
           +++     D ++  ++ E M    L    FD     + L +   ++   + +   + YLH
Sbjct: 78  IKIKNF-FDAEDYYIVLELMEGGEL----FDKVVGNKRLKEATCKLYFYQMLL-AVQYLH 131
Query: 166 QYSRVRIIHRDLKASNILL---DKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSP 222
           +     IIHRDLK  N+LL   ++D   KI+DFG ++I G   L      + GT  Y++P
Sbjct: 132 ENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRT---LCGTPTYLAP 185
Query: 223 EYALE---GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRT-----DSLNLLGYAW--DLWT 272
           E  +      ++   D +S GV+L   +SG      +RT     D +    Y +  ++W 
Sbjct: 186 EVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWA 245
Query: 273 --SNRTLELIDPIL 284
             S + L+L+  +L
Sbjct: 246 EVSEKALDLVKKLL 259

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 63/254 (24%), Positives = 113/254 (44%), Gaps = 38/254 (14%)
Query: 57  LGEGGFGPVYKGVLKKG-DEIAVKRLS--------GRSGQGLREMKNEASVIAKVQHKNL 107
           LG G  G V     +K   ++A+K +S         R       ++ E  ++ K+ H  +
Sbjct: 17  LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 76
Query: 108 VRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPT--KRMLLDWVTRVQIIEGIAQGLLYLH 165
           +++     D ++  ++ E M    L    FD     + L +   ++   + +   + YLH
Sbjct: 77  IKIKNF-FDAEDYYIVLELMEGGEL----FDKVVGNKRLKEATCKLYFYQMLL-AVQYLH 130
Query: 166 QYSRVRIIHRDLKASNILL---DKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSP 222
           +     IIHRDLK  N+LL   ++D   KI+DFG ++I G   L      + GT  Y++P
Sbjct: 131 ENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRT---LCGTPTYLAP 184
Query: 223 EYALE---GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRT-----DSLNLLGYAW--DLWT 272
           E  +      ++   D +S GV+L   +SG      +RT     D +    Y +  ++W 
Sbjct: 185 EVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWA 244
Query: 273 --SNRTLELIDPIL 284
             S + L+L+  +L
Sbjct: 245 EVSEKALDLVKKLL 258

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 63/254 (24%), Positives = 113/254 (44%), Gaps = 38/254 (14%)
Query: 57  LGEGGFGPVYKGVLKKG-DEIAVKRLS--------GRSGQGLREMKNEASVIAKVQHKNL 107
           LG G  G V     +K   ++A+K +S         R       ++ E  ++ K+ H  +
Sbjct: 18  LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 77
Query: 108 VRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPT--KRMLLDWVTRVQIIEGIAQGLLYLH 165
           +++     D ++  ++ E M    L    FD     + L +   ++   + +   + YLH
Sbjct: 78  IKIKNF-FDAEDYYIVLELMEGGEL----FDKVVGNKRLKEATCKLYFYQMLL-AVQYLH 131
Query: 166 QYSRVRIIHRDLKASNILL---DKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSP 222
           +     IIHRDLK  N+LL   ++D   KI+DFG ++I G   L      + GT  Y++P
Sbjct: 132 ENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRT---LCGTPTYLAP 185
Query: 223 EYALE---GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRT-----DSLNLLGYAW--DLWT 272
           E  +      ++   D +S GV+L   +SG      +RT     D +    Y +  ++W 
Sbjct: 186 EVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWA 245
Query: 273 --SNRTLELIDPIL 284
             S + L+L+  +L
Sbjct: 246 EVSEKALDLVKKLL 259

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 63/254 (24%), Positives = 113/254 (44%), Gaps = 38/254 (14%)
Query: 57  LGEGGFGPVYKGVLKKG-DEIAVKRLS--------GRSGQGLREMKNEASVIAKVQHKNL 107
           LG G  G V     +K   ++A+K +S         R       ++ E  ++ K+ H  +
Sbjct: 18  LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 77
Query: 108 VRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPT--KRMLLDWVTRVQIIEGIAQGLLYLH 165
           +++     D ++  ++ E M    L    FD     + L +   ++   + +   + YLH
Sbjct: 78  IKIKNF-FDAEDYYIVLELMEGGEL----FDKVVGNKRLKEATCKLYFYQMLL-AVQYLH 131
Query: 166 QYSRVRIIHRDLKASNILL---DKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSP 222
           +     IIHRDLK  N+LL   ++D   KI+DFG ++I G   L      + GT  Y++P
Sbjct: 132 ENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRT---LCGTPTYLAP 185
Query: 223 EYALE---GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRT-----DSLNLLGYAW--DLWT 272
           E  +      ++   D +S GV+L   +SG      +RT     D +    Y +  ++W 
Sbjct: 186 EVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWA 245
Query: 273 --SNRTLELIDPIL 284
             S + L+L+  +L
Sbjct: 246 EVSEKALDLVKKLL 259

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 60/242 (24%), Positives = 108/242 (44%), Gaps = 31/242 (12%)
Query: 56  KLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLR-EMKNEASVIAKVQHKNLVRLLGCC 114
           K+G G +G VYK   K G +     L    G G+      E +++ +++H N++ L    
Sbjct: 28  KVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVF 87
Query: 115 IDR-DEKI-LIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLY-----LHQY 167
           +   D K+ L+++Y  +       F    +        VQ+  G+ + LLY     +H  
Sbjct: 88  LSHADRKVWLLFDYAEHDLWHIIKFHRASKAN---KKPVQLPRGMVKSLLYQILDGIHYL 144
Query: 168 SRVRIIHRDLKASNILL----DKDMNPKISDFGMARICGGN-ELQANTSRIVGTYGYMSP 222
               ++HRDLK +NIL+     +    KI+D G AR+     +  A+   +V T+ Y +P
Sbjct: 145 HANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAP 204
Query: 223 EYALEGIFSIKS-DVFSFGVLLLEIVSGK----------KNTGLYRTDSL----NLLGYA 267
           E  L      K+ D+++ G +  E+++ +          K +  Y  D L    N++G+ 
Sbjct: 205 ELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFP 264
Query: 268 WD 269
            D
Sbjct: 265 AD 266

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 55/219 (25%), Positives = 98/219 (44%), Gaps = 29/219 (13%)
Query: 57  LGEGGFGPVYKGVLKKG-DEIAVKRLS--------GRSGQGLREMKNEASVIAKVQHKNL 107
           LG G  G V     +K   ++A++ +S         R       ++ E  ++ K+ H  +
Sbjct: 157 LGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 216
Query: 108 VRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPT--KRMLLDWVTRVQIIEGIAQGLLYLH 165
           +++     D ++  ++ E M    L    FD     + L +   ++   + +   + YLH
Sbjct: 217 IKIKNF-FDAEDYYIVLELMEGGEL----FDKVVGNKRLKEATCKLYFYQMLL-AVQYLH 270
Query: 166 QYSRVRIIHRDLKASNILL---DKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSP 222
           +     IIHRDLK  N+LL   ++D   KI+DFG ++I G   L      + GT  Y++P
Sbjct: 271 ENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRT---LCGTPTYLAP 324
Query: 223 EYALE---GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRT 258
           E  +      ++   D +S GV+L   +SG      +RT
Sbjct: 325 EVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRT 363

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 48/185 (25%), Positives = 85/185 (45%), Gaps = 20/185 (10%)
Query: 82  SGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPT- 140
           S R       ++ E  ++ K+ H  ++++     D ++  ++ E M    L    FD   
Sbjct: 177 SAREADPALNVETEIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGEL----FDKVV 231
Query: 141 -KRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILL---DKDMNPKISDFG 196
             + L +   ++   + +   + YLH+     IIHRDLK  N+LL   ++D   KI+DFG
Sbjct: 232 GNKRLKEATCKLYFYQMLL-AVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFG 287
Query: 197 MARICGGNELQANTSRIVGTYGYMSPEYALE---GIFSIKSDVFSFGVLLLEIVSGKKNT 253
            ++I G   L      + GT  Y++PE  +      ++   D +S GV+L   +SG    
Sbjct: 288 HSKILGETSLMRT---LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPF 344
Query: 254 GLYRT 258
             +RT
Sbjct: 345 SEHRT 349

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 59/228 (25%), Positives = 103/228 (45%), Gaps = 35/228 (15%)
Query: 44  VSTATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVK--RLSGRSGQGLREMKNEASVIAK 101
           +S     +S   ++G GG   V++ + +K    A+K   L     Q L   +NE + + K
Sbjct: 51  ISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNK 110
Query: 102 VQHKN--LVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQ 159
           +Q  +  ++RL    I       IY  M   ++D   +   K+ +  W  R    + + +
Sbjct: 111 LQQHSDKIIRLYDYEITDQ---YIYMVMECGNIDLNSWLKKKKSIDPW-ERKSYWKNMLE 166
Query: 160 GLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRI-----V 214
            +  +HQ+    I+H DLK +N L+   M  K+ DFG+A     N++Q +T+ +     V
Sbjct: 167 AVHTIHQHG---IVHSDLKPANFLIVDGM-LKLIDFGIA-----NQMQPDTTSVVKDSQV 217
Query: 215 GTYGYMSPEYALEGIFSIKS------------DVFSFGVLLLEIVSGK 250
           G   YM PE A++ + S +             DV+S G +L  +  GK
Sbjct: 218 GAVNYMPPE-AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 264

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 93/217 (42%), Gaps = 27/217 (12%)
Query: 57  LGEGGFGPVYKGVLKKGDEI-AVKRLSG-----RSGQGLREMKNEASVIAKVQHKNLVRL 110
           +G G FG V     K   ++ A+K LS      RS         E  ++A      +V+L
Sbjct: 77  IGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAF--FWEERDIMAFANSPWVVQL 134
Query: 111 LGCCIDRDEKILIYEYMPNKSLDFFL--FDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYS 168
                D     ++ EYMP   L   +  +D  ++    W          A+ +L L    
Sbjct: 135 FYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEK----WARFY-----TAEVVLALDAIH 185
Query: 169 RVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY---- 224
            +  IHRD+K  N+LLDK  + K++DFG   +    E        VGT  Y+SPE     
Sbjct: 186 SMGFIHRDVKPDNMLLDKSGHLKLADFGTC-MKMNKEGMVRCDTAVGTPDYISPEVLKSQ 244
Query: 225 ALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSL 261
             +G +  + D +S GV L E++ G  +T  Y  DSL
Sbjct: 245 GGDGYYGRECDWWSVGVFLYEMLVG--DTPFY-ADSL 278

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 93/217 (42%), Gaps = 27/217 (12%)
Query: 57  LGEGGFGPVYKGVLKKGDEI-AVKRLSG-----RSGQGLREMKNEASVIAKVQHKNLVRL 110
           +G G FG V     K   ++ A+K LS      RS         E  ++A      +V+L
Sbjct: 82  IGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAF--FWEERDIMAFANSPWVVQL 139
Query: 111 LGCCIDRDEKILIYEYMPNKSLDFFL--FDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYS 168
                D     ++ EYMP   L   +  +D  ++    W          A+ +L L    
Sbjct: 140 FYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEK----WARFY-----TAEVVLALDAIH 190
Query: 169 RVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY---- 224
            +  IHRD+K  N+LLDK  + K++DFG   +    E        VGT  Y+SPE     
Sbjct: 191 SMGFIHRDVKPDNMLLDKSGHLKLADFGTC-MKMNKEGMVRCDTAVGTPDYISPEVLKSQ 249
Query: 225 ALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSL 261
             +G +  + D +S GV L E++ G  +T  Y  DSL
Sbjct: 250 GGDGYYGRECDWWSVGVFLYEMLVG--DTPFY-ADSL 283

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 93/217 (42%), Gaps = 27/217 (12%)
Query: 57  LGEGGFGPVYKGVLKKGDEI-AVKRLSG-----RSGQGLREMKNEASVIAKVQHKNLVRL 110
           +G G FG V     K   ++ A+K LS      RS         E  ++A      +V+L
Sbjct: 82  IGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAF--FWEERDIMAFANSPWVVQL 139
Query: 111 LGCCIDRDEKILIYEYMPNKSLDFFL--FDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYS 168
                D     ++ EYMP   L   +  +D  ++    W          A+ +L L    
Sbjct: 140 FYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEK----WARFY-----TAEVVLALDAIH 190
Query: 169 RVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY---- 224
            +  IHRD+K  N+LLDK  + K++DFG   +    E        VGT  Y+SPE     
Sbjct: 191 SMGFIHRDVKPDNMLLDKSGHLKLADFGTC-MKMNKEGMVRCDTAVGTPDYISPEVLKSQ 249
Query: 225 ALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSL 261
             +G +  + D +S GV L E++ G  +T  Y  DSL
Sbjct: 250 GGDGYYGRECDWWSVGVFLYEMLVG--DTPFY-ADSL 283

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 89/207 (42%), Gaps = 16/207 (7%)
Query: 48  TNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNL 107
           ++++     +G G FG       K+ +E+   +   R  +    +K E      ++H N+
Sbjct: 18  SDRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREIINHRSLRHPNI 77
Query: 108 VRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRV--QIIEGIAQGLLYLH 165
           VR     +      ++ EY     L F       R   D       Q+I G++    Y H
Sbjct: 78  VRFKEVILTPTHLAIVMEYASGGEL-FERICNAGRFSEDEARFFFQQLISGVS----YCH 132
Query: 166 QYSRVRIIHRDLKASNILLDKDMNP--KISDFGMARICGGNELQANTSRIVGTYGYMSPE 223
               +++ HRDLK  N LLD    P  KI  FG ++    + L +     VGT  Y++PE
Sbjct: 133 A---MQVCHRDLKLENTLLDGSPAPRLKICAFGYSK---SSVLHSQPKSTVGTPAYIAPE 186
Query: 224 YALEGIFSIK-SDVFSFGVLLLEIVSG 249
             L+  +  K +DV+S GV L  ++ G
Sbjct: 187 VLLKKEYDGKVADVWSCGVTLYVMLVG 213

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 35/93 (37%), Positives = 49/93 (52%), Gaps = 9/93 (9%)
Query: 160 GLLYLHQYSRVRIIHRDLKASNILLDKDMNP--KISDFGMARICGGNELQANTSRIVGTY 217
           G+ Y H    ++I HRDLK  N LLD    P  KI DFG ++    + L +     VGT 
Sbjct: 128 GVSYCHS---MQICHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVGTP 181
Query: 218 GYMSPEYALEGIFSIK-SDVFSFGVLLLEIVSG 249
            Y++PE  L   +  K +DV+S GV L  ++ G
Sbjct: 182 AYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVG 214

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 45/151 (29%), Positives = 69/151 (45%), Gaps = 10/151 (6%)
Query: 57  LGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQ-HKNLVRLLGCC 114
           L EGGF  VY+   +  G E A+KRL     +  R +  E   + K+  H N+V+     
Sbjct: 36  LAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAA 95
Query: 115 -IDRDE------KILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQY 167
            I ++E      + L+   +    L  FL     R  L   T ++I     + + ++H+ 
Sbjct: 96  SIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHR- 154
Query: 168 SRVRIIHRDLKASNILLDKDMNPKISDFGMA 198
            +  IIHRDLK  N+LL      K+ DFG A
Sbjct: 155 QKPPIIHRDLKVENLLLSNQGTIKLCDFGSA 185

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 89/207 (42%), Gaps = 16/207 (7%)
Query: 48  TNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNL 107
           ++++     +G G FG       K+ +E+   +   R  +    +K E      ++H N+
Sbjct: 18  SDRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREIINHRSLRHPNI 77
Query: 108 VRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRV--QIIEGIAQGLLYLH 165
           VR     +      ++ EY     L F       R   D       Q+I G++    Y H
Sbjct: 78  VRFKEVILTPTHLAIVMEYASGGEL-FERICNAGRFSEDEARFFFQQLISGVS----YCH 132
Query: 166 QYSRVRIIHRDLKASNILLDKDMNP--KISDFGMARICGGNELQANTSRIVGTYGYMSPE 223
               +++ HRDLK  N LLD    P  KI  FG ++    + L +     VGT  Y++PE
Sbjct: 133 A---MQVCHRDLKLENTLLDGSPAPRLKICAFGYSK---SSVLHSQPKDTVGTPAYIAPE 186
Query: 224 YALEGIFSIK-SDVFSFGVLLLEIVSG 249
             L+  +  K +DV+S GV L  ++ G
Sbjct: 187 VLLKKEYDGKVADVWSCGVTLYVMLVG 213

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 100/227 (44%), Gaps = 25/227 (11%)
Query: 49  NKFSDANKLGEGGFGPVYKGVL------KKGDEIAVKRLSGRSGQGLREMKNEASVIAKV 102
            K+   + LGEG +G V K VL      ++  +I  K+   R   G   +K E  ++ ++
Sbjct: 5   GKYLMGDLLGEGSYGKV-KEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRL 63
Query: 103 QHKNLVRLLGCCIDRDEK--ILIYEYMPNKSLDFFLFDPTKRMLLDWVTR--VQIIEGIA 158
           +HKN+++L+    + +++   ++ EY      +     P KR  +        Q+I+G  
Sbjct: 64  RHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDG-- 121
Query: 159 QGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG 218
             L YLH      I+H+D+K  N+LL      KIS  G+A                G+  
Sbjct: 122 --LEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPA 176
Query: 219 YMSPEYA--LEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNL 263
           +  PE A  L+     K D++S GV L  I      TGLY  +  N+
Sbjct: 177 FQPPEIANGLDTFSGFKVDIWSAGVTLYNI-----TTGLYPFEGDNI 218

>pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 63/258 (24%), Positives = 106/258 (41%), Gaps = 49/258 (18%)
Query: 34  DQFPLFSFSSVSTATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMK 93
           D+   FS+       N F    K+G+G FG V         +    ++     +  R  K
Sbjct: 20  DEIVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAK 79
Query: 94  NEASVIAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTR--- 150
            EA ++ K+Q+ ++       +    K + Y++M        +F+P    L + +TR   
Sbjct: 80  IEADILKKIQNDDINNNNI--VKYHGKFMYYDHMC------LIFEPLGPSLYEIITRNNY 131
Query: 151 ---------VQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARIC 201
                    +  IE I + L YL + S   + H DLK  NILLD     K S   + R+ 
Sbjct: 132 NGFHIEDIKLYCIE-ILKALNYLRKMS---LTHTDLKPENILLDDPYFEK-SLITVRRVT 186
Query: 202 GGNELQANTSR---------------------IVGTYGYMSPEYALEGIFSIKSDVFSFG 240
            G ++Q   ++                     I+ T  Y +PE  L   + + SD++SFG
Sbjct: 187 DGKKIQIYRTKSTGIKLIDFGCATFKSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFG 246
Query: 241 VLLLEIVSGKKNTGLYRT 258
            +L E+ +G   + L+RT
Sbjct: 247 CVLAELYTG---SLLFRT 261

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 60/229 (26%), Positives = 107/229 (46%), Gaps = 32/229 (13%)
Query: 49  NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNL 107
           ++F      G+G FG V  G  K  G  +A+K++        RE++     +A + H N+
Sbjct: 23  DRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQD-LAVLHHPNI 81
Query: 108 VRL------LGCCIDRDEKIL----IYEYMPNK----SLDFFLFDPTKRMLLDWVTRVQI 153
           V+L      LG   +RD + +    + EY+P+       +++        +L  V   Q+
Sbjct: 82  VQLQSYFYTLG---ERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQL 138
Query: 154 IEGIAQGLLYLHQYSRVRIIHRDLKASNILLDK-DMNPKISDFGMARICGGNELQANTSR 212
           I  I  G L+L     V + HRD+K  N+L+++ D   K+ DFG A+    +E   N + 
Sbjct: 139 IRSI--GCLHL---PSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSE--PNVAY 191
Query: 213 IVGTYGYMSPEYAL-EGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDS 260
           I   Y Y +PE       ++   D++S G +  E++ G+    ++R D+
Sbjct: 192 ICSRY-YRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEP---IFRGDN 236

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 52/215 (24%), Positives = 95/215 (44%), Gaps = 23/215 (10%)
Query: 57  LGEGGFGPVYKGVLKKGDEIAVKRL-----SGRSGQGL------REMKNEASVIAKVQHK 105
           +  G +G V  GV  +G  +A+KR+      GR+   L      + +  E  ++    H 
Sbjct: 30  ISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHP 89
Query: 106 NLVRLLGCCIDRDEKILIYEYMPNKSL--DFFLFDPTKRMLLDWVTRVQIIEGIAQGLLY 163
           N++ L    +  +E  +   Y+  + +  D       +R+++        +  I  GL  
Sbjct: 90  NILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILLGLHV 149
Query: 164 LHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE 223
           LH+     ++HRDL   NILL  + +  I DF +AR    +   AN +  V    Y +PE
Sbjct: 150 LHEAG---VVHRDLHPGNILLADNNDITICDFNLAR---EDTADANKTHYVTHRWYRAPE 203
Query: 224 YALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYR 257
             ++   F+   D++S G ++ E+ + K    L+R
Sbjct: 204 LVMQFKGFTKLVDMWSAGCVMAEMFNRK---ALFR 235

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 92/208 (44%), Gaps = 20/208 (9%)
Query: 57  LGEGGFGPVYKGVLKKGDEIAVKRL-----SGRSGQGL------REMKNEASVIAKVQHK 105
           +  G +G V  GV  +G  +A+KR+      GR+   L      + +  E  ++    H 
Sbjct: 30  ISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHP 89
Query: 106 NLVRLLGCCIDRDEKILIYEYMPNKSL--DFFLFDPTKRMLLDWVTRVQIIEGIAQGLLY 163
           N++ L    +  +E  +   Y+  + +  D       +R+++        +  I  GL  
Sbjct: 90  NILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILLGLHV 149
Query: 164 LHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE 223
           LH+     ++HRDL   NILL  + +  I DF +AR    +   AN +  V    Y +PE
Sbjct: 150 LHEAG---VVHRDLHPGNILLADNNDITICDFNLAR---EDTADANKTHYVTHRWYRAPE 203
Query: 224 YALE-GIFSIKSDVFSFGVLLLEIVSGK 250
             ++   F+   D++S G ++ E+ + K
Sbjct: 204 LVMQFKGFTKLVDMWSAGCVMAEMFNRK 231

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 51/215 (23%), Positives = 95/215 (44%), Gaps = 40/215 (18%)
Query: 57  LGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMK--NEASVIAKVQHKNLVRLLGCC 114
           LG G +G V+           V+++SG     L  MK   +A+++ K +     R     
Sbjct: 62  LGTGAYGKVF----------LVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQV 111
Query: 115 ID--RDEKILIYEYMPNKSLDFFLFDPTK-RMLLDWVTRVQIIEGIAQG----------- 160
           ++  R    L+       +L +     TK  ++LD++   ++   ++Q            
Sbjct: 112 LEHIRQSPFLV-------TLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIY 164
Query: 161 ----LLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 216
               +L L    ++ II+RD+K  NILLD + +  ++DFG+++    +E +       GT
Sbjct: 165 VGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETE-RAYDFCGT 223
Query: 217 YGYMSPEYALEGI--FSIKSDVFSFGVLLLEIVSG 249
             YM+P+    G        D +S GVL+ E+++G
Sbjct: 224 IEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTG 258

>pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 34/104 (32%), Positives = 55/104 (52%), Gaps = 13/104 (12%)
Query: 152 QIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNP------KISDFGMARICGGNE 205
           QI + +  GL Y+H+  R  IIH D+K  N+L++   +P      KI+D G A  C  +E
Sbjct: 135 QISKQLLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA--CWYDE 190
Query: 206 LQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 249
              N+   + T  Y SPE  L   +   +D++S   L+ E+++G
Sbjct: 191 HYTNS---IQTREYRSPEVLLGAPWGCGADIWSTACLIFELITG 231

>pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 34/104 (32%), Positives = 55/104 (52%), Gaps = 13/104 (12%)
Query: 152 QIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNP------KISDFGMARICGGNE 205
           QI + +  GL Y+H+  R  IIH D+K  N+L++   +P      KI+D G A  C  +E
Sbjct: 135 QISKQLLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA--CWYDE 190
Query: 206 LQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 249
              N+   + T  Y SPE  L   +   +D++S   L+ E+++G
Sbjct: 191 HYTNS---IQTREYRSPEVLLGAPWGCGADIWSTACLIFELITG 231

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 49/204 (24%), Positives = 94/204 (46%), Gaps = 17/204 (8%)
Query: 57  LGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLRE----MKNEASVIAKVQHKNLVRLLG 112
           +G G FG V    LK  D++   ++  +     R      + E  V+     K +  L  
Sbjct: 82  IGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHY 141
Query: 113 CCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRI 172
              D +   L+ +Y     L   L    +  L + + R  +    A+ ++ +    ++  
Sbjct: 142 AFQDDNNLYLVMDYYVGGDL-LTLLSKFEDRLPEEMARFYL----AEMVIAIDSVHQLHY 196
Query: 173 IHRDLKASNILLDKDMNPKISDFGMA-RICGGNELQANTSRIVGTYGYMSPEY--ALE-- 227
           +HRD+K  NIL+D + + +++DFG   ++     +Q++ +  VGT  Y+SPE   A+E  
Sbjct: 197 VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVA--VGTPDYISPEILQAMEGG 254
Query: 228 -GIFSIKSDVFSFGVLLLEIVSGK 250
            G +  + D +S GV + E++ G+
Sbjct: 255 KGRYGPECDWWSLGVCMYEMLYGE 278

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 97/209 (46%), Gaps = 28/209 (13%)
Query: 57  LGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKN------EASVIAKVQ----HK 105
           LG+GGFG V+ G  L    ++A+K +      G   + +      E +++ KV     H 
Sbjct: 39  LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98
Query: 106 NLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRV---QIIEGIAQGLL 162
            ++RLL     ++  +L+ E  P  + D F +   K  L +  +R    Q++  I     
Sbjct: 99  GVIRLLDWFETQEGFMLVLE-RPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQ---- 153
Query: 163 YLHQYSRVRIIHRDLKASNILLD-KDMNPKISDFGMARICGGNELQANTSRIVGTYGYMS 221
             H +SR  ++HRD+K  NIL+D +    K+ DFG     G        +   GT  Y  
Sbjct: 154 --HCHSR-GVVHRDIKDENILIDLRRGCAKLIDFGS----GALLHDEPYTDFDGTRVYSP 206
Query: 222 PEY-ALEGIFSIKSDVFSFGVLLLEIVSG 249
           PE+ +     ++ + V+S G+LL ++V G
Sbjct: 207 PEWISRHQYHALPATVWSLGILLYDMVCG 235

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 30/99 (30%), Positives = 56/99 (56%), Gaps = 6/99 (6%)
Query: 157 IAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 216
           I + +L +    ++  +HRD+K  N+LLD + + +++DFG   +   ++    +S  VGT
Sbjct: 181 IGEMVLAIDSIHQLHYVHRDIKPDNVLLDVNGHIRLADFGSC-LKMNDDGTVQSSVAVGT 239
Query: 217 YGYMSPEY--ALE---GIFSIKSDVFSFGVLLLEIVSGK 250
             Y+SPE   A+E   G +  + D +S GV + E++ G+
Sbjct: 240 PDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGE 278

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 30/99 (30%), Positives = 56/99 (56%), Gaps = 6/99 (6%)
Query: 157 IAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 216
           I + +L +    ++  +HRD+K  N+LLD + + +++DFG   +   ++    +S  VGT
Sbjct: 197 IGEMVLAIDSIHQLHYVHRDIKPDNVLLDVNGHIRLADFGSC-LKMNDDGTVQSSVAVGT 255
Query: 217 YGYMSPEY--ALE---GIFSIKSDVFSFGVLLLEIVSGK 250
             Y+SPE   A+E   G +  + D +S GV + E++ G+
Sbjct: 256 PDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGE 294

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 55/222 (24%), Positives = 104/222 (46%), Gaps = 38/222 (17%)
Query: 57  LGEGGFGPVYKGVLKKGDE-IAVKRLSGRSGQGLREMKN---EASVIAKVQHKNLVRLLG 112
           +G G +G VY    K  ++ +A+K+++ R  + L + K    E +++ +++   ++RL  
Sbjct: 34  IGRGSYGYVYLAYDKNTEKNVAIKKVN-RMFEDLIDCKRILREITILNRLKSDYIIRLYD 92
Query: 113 CCIDRD----EKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYS 168
             I  D    +++ I   + +  L      P   + L       I+  +  G  ++H+  
Sbjct: 93  LIIPDDLLKFDELYIVLEIADSDLKKLFKTP---IFLTEEHIKTILYNLLLGENFIHESG 149
Query: 169 RVRIIHRDLKASNILLDKDMNPKISDFGMARICGG-------NELQAN------------ 209
              IIHRDLK +N LL++D + K+ DFG+AR           N+L+ N            
Sbjct: 150 ---IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKK 206
Query: 210 --TSRIVGTYGYMSPEYA-LEGIFSIKSDVFSFGVLLLEIVS 248
             TS +V T  Y +PE   L+  ++   D++S G +  E+++
Sbjct: 207 QLTSHVV-TRWYRAPELILLQENYTKSIDIWSTGCIFAELLN 247

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 47.8 bits (112), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 92/208 (44%), Gaps = 28/208 (13%)
Query: 57  LGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKN------EASVIAKVQ--HKNL 107
           LG GGFG VY G+ +     +A+K +         E+ N      E  ++ KV      +
Sbjct: 44  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 103
Query: 108 VRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTR---VQIIEGIAQGLLYL 164
           +RLL      D  +LI E  P    D F F   +  L + + R    Q++E +     + 
Sbjct: 104 IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARSFFWQVLEAVR----HC 158
Query: 165 HQYSRVRIIHRDLKASNILLDKDMNP-KISDFGMARICGGNELQANT-SRIVGTYGYMSP 222
           H      ++HRD+K  NIL+D +    K+ DFG      G  L+    +   GT  Y  P
Sbjct: 159 HNCG---VLHRDIKDENILIDLNRGELKLIDFG-----SGALLKDTVYTDFDGTRVYSPP 210
Query: 223 EYALEGIFSIKS-DVFSFGVLLLEIVSG 249
           E+     +  +S  V+S G+LL ++V G
Sbjct: 211 EWIRYHRYHGRSAAVWSLGILLYDMVCG 238

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 47.8 bits (112), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 36/96 (37%), Positives = 52/96 (54%), Gaps = 9/96 (9%)
Query: 159 QGLLYLHQYSRVRIIHRDLKASNILLDKD-MNPKISDFGMARIC----GGNELQANTSRI 213
           +GL YLH  SR RI+H D+KA N+LL  D  +  + DFG A +C    G  +       I
Sbjct: 196 EGLEYLH--SR-RILHGDVKADNVLLSSDGSHAALCDFGHA-VCLQPDGLGKSLLTGDYI 251
Query: 214 VGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 249
            GT  +M+PE  L      K DV+S   ++L +++G
Sbjct: 252 PGTETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLNG 287

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 92/208 (44%), Gaps = 28/208 (13%)
Query: 57  LGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKN------EASVIAKVQ--HKNL 107
           LG GGFG VY G+ +     +A+K +         E+ N      E  ++ KV      +
Sbjct: 59  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 118
Query: 108 VRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTR---VQIIEGIAQGLLYL 164
           +RLL      D  +LI E  P    D F F   +  L + + R    Q++E +     + 
Sbjct: 119 IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARSFFWQVLEAVR----HC 173
Query: 165 HQYSRVRIIHRDLKASNILLDKDMNP-KISDFGMARICGGNELQANT-SRIVGTYGYMSP 222
           H      ++HRD+K  NIL+D +    K+ DFG      G  L+    +   GT  Y  P
Sbjct: 174 HNCG---VLHRDIKDENILIDLNRGELKLIDFG-----SGALLKDTVYTDFDGTRVYSPP 225
Query: 223 EYALEGIFSIKS-DVFSFGVLLLEIVSG 249
           E+     +  +S  V+S G+LL ++V G
Sbjct: 226 EWIRYHRYHGRSAAVWSLGILLYDMVCG 253

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 92/208 (44%), Gaps = 28/208 (13%)
Query: 57  LGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKN------EASVIAKVQ--HKNL 107
           LG GGFG VY G+ +     +A+K +         E+ N      E  ++ KV      +
Sbjct: 45  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 104
Query: 108 VRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTR---VQIIEGIAQGLLYL 164
           +RLL      D  +LI E  P    D F F   +  L + + R    Q++E +     + 
Sbjct: 105 IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARSFFWQVLEAVR----HC 159
Query: 165 HQYSRVRIIHRDLKASNILLDKDMNP-KISDFGMARICGGNELQANT-SRIVGTYGYMSP 222
           H      ++HRD+K  NIL+D +    K+ DFG      G  L+    +   GT  Y  P
Sbjct: 160 HNCG---VLHRDIKDENILIDLNRGELKLIDFG-----SGALLKDTVYTDFDGTRVYSPP 211
Query: 223 EYALEGIFSIKS-DVFSFGVLLLEIVSG 249
           E+     +  +S  V+S G+LL ++V G
Sbjct: 212 EWIRYHRYHGRSAAVWSLGILLYDMVCG 239

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 92/208 (44%), Gaps = 28/208 (13%)
Query: 57  LGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKN------EASVIAKVQ--HKNL 107
           LG GGFG VY G+ +     +A+K +         E+ N      E  ++ KV      +
Sbjct: 31  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 90
Query: 108 VRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTR---VQIIEGIAQGLLYL 164
           +RLL      D  +LI E  P    D F F   +  L + + R    Q++E +     + 
Sbjct: 91  IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARSFFWQVLEAVR----HC 145
Query: 165 HQYSRVRIIHRDLKASNILLDKDMNP-KISDFGMARICGGNELQANT-SRIVGTYGYMSP 222
           H      ++HRD+K  NIL+D +    K+ DFG      G  L+    +   GT  Y  P
Sbjct: 146 HNCG---VLHRDIKDENILIDLNRGELKLIDFG-----SGALLKDTVYTDFDGTRVYSPP 197
Query: 223 EYALEGIFSIKS-DVFSFGVLLLEIVSG 249
           E+     +  +S  V+S G+LL ++V G
Sbjct: 198 EWIRYHRYHGRSAAVWSLGILLYDMVCG 225

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 92/208 (44%), Gaps = 28/208 (13%)
Query: 57  LGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKN------EASVIAKVQ--HKNL 107
           LG GGFG VY G+ +     +A+K +         E+ N      E  ++ KV      +
Sbjct: 45  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 104
Query: 108 VRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTR---VQIIEGIAQGLLYL 164
           +RLL      D  +LI E  P    D F F   +  L + + R    Q++E +     + 
Sbjct: 105 IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARSFFWQVLEAVR----HC 159
Query: 165 HQYSRVRIIHRDLKASNILLDKDMNP-KISDFGMARICGGNELQANT-SRIVGTYGYMSP 222
           H      ++HRD+K  NIL+D +    K+ DFG      G  L+    +   GT  Y  P
Sbjct: 160 HNCG---VLHRDIKDENILIDLNRGELKLIDFG-----SGALLKDTVYTDFDGTRVYSPP 211
Query: 223 EYALEGIFSIKS-DVFSFGVLLLEIVSG 249
           E+     +  +S  V+S G+LL ++V G
Sbjct: 212 EWIRYHRYHGRSAAVWSLGILLYDMVCG 239

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 92/208 (44%), Gaps = 28/208 (13%)
Query: 57  LGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKN------EASVIAKVQ--HKNL 107
           LG GGFG VY G+ +     +A+K +         E+ N      E  ++ KV      +
Sbjct: 31  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 90
Query: 108 VRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTR---VQIIEGIAQGLLYL 164
           +RLL      D  +LI E  P    D F F   +  L + + R    Q++E +     + 
Sbjct: 91  IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARSFFWQVLEAVR----HC 145
Query: 165 HQYSRVRIIHRDLKASNILLDKDMNP-KISDFGMARICGGNELQANT-SRIVGTYGYMSP 222
           H      ++HRD+K  NIL+D +    K+ DFG      G  L+    +   GT  Y  P
Sbjct: 146 HNCG---VLHRDIKDENILIDLNRGELKLIDFG-----SGALLKDTVYTDFDGTRVYSPP 197
Query: 223 EYALEGIFSIKS-DVFSFGVLLLEIVSG 249
           E+     +  +S  V+S G+LL ++V G
Sbjct: 198 EWIRYHRYHGRSAAVWSLGILLYDMVCG 225

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 92/208 (44%), Gaps = 28/208 (13%)
Query: 57  LGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKN------EASVIAKVQ--HKNL 107
           LG GGFG VY G+ +     +A+K +         E+ N      E  ++ KV      +
Sbjct: 44  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 103
Query: 108 VRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTR---VQIIEGIAQGLLYL 164
           +RLL      D  +LI E  P    D F F   +  L + + R    Q++E +     + 
Sbjct: 104 IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARSFFWQVLEAVR----HC 158
Query: 165 HQYSRVRIIHRDLKASNILLDKDMNP-KISDFGMARICGGNELQANT-SRIVGTYGYMSP 222
           H      ++HRD+K  NIL+D +    K+ DFG      G  L+    +   GT  Y  P
Sbjct: 159 HNCG---VLHRDIKDENILIDLNRGELKLIDFG-----SGALLKDTVYTDFDGTRVYSPP 210
Query: 223 EYALEGIFSIKS-DVFSFGVLLLEIVSG 249
           E+     +  +S  V+S G+LL ++V G
Sbjct: 211 EWIRYHRYHGRSAAVWSLGILLYDMVCG 238

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 92/208 (44%), Gaps = 28/208 (13%)
Query: 57  LGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKN------EASVIAKVQ--HKNL 107
           LG GGFG VY G+ +     +A+K +         E+ N      E  ++ KV      +
Sbjct: 45  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 104
Query: 108 VRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTR---VQIIEGIAQGLLYL 164
           +RLL      D  +LI E  P    D F F   +  L + + R    Q++E +     + 
Sbjct: 105 IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARSFFWQVLEAVR----HC 159
Query: 165 HQYSRVRIIHRDLKASNILLDKDMNP-KISDFGMARICGGNELQANT-SRIVGTYGYMSP 222
           H      ++HRD+K  NIL+D +    K+ DFG      G  L+    +   GT  Y  P
Sbjct: 160 HNCG---VLHRDIKDENILIDLNRGELKLIDFG-----SGALLKDTVYTDFDGTRVYSPP 211
Query: 223 EYALEGIFSIKS-DVFSFGVLLLEIVSG 249
           E+     +  +S  V+S G+LL ++V G
Sbjct: 212 EWIRYHRYHGRSAAVWSLGILLYDMVCG 239

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 90/207 (43%), Gaps = 26/207 (12%)
Query: 57  LGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKN------EASVIAKVQ--HKNL 107
           LG GGFG VY G+ +     +A+K +         E+ N      E  ++ KV      +
Sbjct: 12  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 71
Query: 108 VRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTR---VQIIEGIAQGLLYL 164
           +RLL      D  +LI E  P    D F F   +  L + + R    Q++E +     + 
Sbjct: 72  IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARSFFWQVLEAVR----HC 126
Query: 165 HQYSRVRIIHRDLKASNILLDKDMNP-KISDFGMARICGGNELQANTSRIVGTYGYMSPE 223
           H      ++HRD+K  NIL+D +    K+ DFG     G        +   GT  Y  PE
Sbjct: 127 HNXG---VLHRDIKDENILIDLNRGELKLIDFG----SGALLKDTVYTDFDGTRVYSPPE 179
Query: 224 YALEGIFSIKS-DVFSFGVLLLEIVSG 249
           +     +  +S  V+S G+LL ++V G
Sbjct: 180 WIRYHRYHGRSAAVWSLGILLYDMVCG 206

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 92/208 (44%), Gaps = 28/208 (13%)
Query: 57  LGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKN------EASVIAKVQ--HKNL 107
           LG GGFG VY G+ +     +A+K +         E+ N      E  ++ KV      +
Sbjct: 59  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 118
Query: 108 VRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTR---VQIIEGIAQGLLYL 164
           +RLL      D  +LI E  P    D F F   +  L + + R    Q++E +     + 
Sbjct: 119 IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARSFFWQVLEAVR----HC 173
Query: 165 HQYSRVRIIHRDLKASNILLDKDMNP-KISDFGMARICGGNELQANT-SRIVGTYGYMSP 222
           H      ++HRD+K  NIL+D +    K+ DFG      G  L+    +   GT  Y  P
Sbjct: 174 HNCG---VLHRDIKDENILIDLNRGELKLIDFG-----SGALLKDTVYTDFDGTRVYSPP 225
Query: 223 EYALEGIFSIKS-DVFSFGVLLLEIVSG 249
           E+     +  +S  V+S G+LL ++V G
Sbjct: 226 EWIRYHRYHGRSAAVWSLGILLYDMVCG 253

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 92/208 (44%), Gaps = 28/208 (13%)
Query: 57  LGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKN------EASVIAKVQ--HKNL 107
           LG GGFG VY G+ +     +A+K +         E+ N      E  ++ KV      +
Sbjct: 45  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 104
Query: 108 VRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTR---VQIIEGIAQGLLYL 164
           +RLL      D  +LI E  P    D F F   +  L + + R    Q++E +     + 
Sbjct: 105 IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARSFFWQVLEAVR----HC 159
Query: 165 HQYSRVRIIHRDLKASNILLDKDMNP-KISDFGMARICGGNELQANT-SRIVGTYGYMSP 222
           H      ++HRD+K  NIL+D +    K+ DFG      G  L+    +   GT  Y  P
Sbjct: 160 HNCG---VLHRDIKDENILIDLNRGELKLIDFG-----SGALLKDTVYTDFDGTRVYSPP 211
Query: 223 EYALEGIFSIKS-DVFSFGVLLLEIVSG 249
           E+     +  +S  V+S G+LL ++V G
Sbjct: 212 EWIRYHRYHGRSAAVWSLGILLYDMVCG 239

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 92/208 (44%), Gaps = 28/208 (13%)
Query: 57  LGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKN------EASVIAKVQ--HKNL 107
           LG GGFG VY G+ +     +A+K +         E+ N      E  ++ KV      +
Sbjct: 44  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 103
Query: 108 VRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTR---VQIIEGIAQGLLYL 164
           +RLL      D  +LI E  P    D F F   +  L + + R    Q++E +     + 
Sbjct: 104 IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARSFFWQVLEAVR----HC 158
Query: 165 HQYSRVRIIHRDLKASNILLDKDMNP-KISDFGMARICGGNELQANT-SRIVGTYGYMSP 222
           H      ++HRD+K  NIL+D +    K+ DFG      G  L+    +   GT  Y  P
Sbjct: 159 HNCG---VLHRDIKDENILIDLNRGELKLIDFG-----SGALLKDTVYTDFDGTRVYSPP 210
Query: 223 EYALEGIFSIKS-DVFSFGVLLLEIVSG 249
           E+     +  +S  V+S G+LL ++V G
Sbjct: 211 EWIRYHRYHGRSAAVWSLGILLYDMVCG 238

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 92/208 (44%), Gaps = 28/208 (13%)
Query: 57  LGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKN------EASVIAKVQ--HKNL 107
           LG GGFG VY G+ +     +A+K +         E+ N      E  ++ KV      +
Sbjct: 16  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 75
Query: 108 VRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTR---VQIIEGIAQGLLYL 164
           +RLL      D  +LI E  P    D F F   +  L + + R    Q++E +     + 
Sbjct: 76  IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARSFFWQVLEAVR----HC 130
Query: 165 HQYSRVRIIHRDLKASNILLDKDMNP-KISDFGMARICGGNELQANT-SRIVGTYGYMSP 222
           H      ++HRD+K  NIL+D +    K+ DFG      G  L+    +   GT  Y  P
Sbjct: 131 HNCG---VLHRDIKDENILIDLNRGELKLIDFG-----SGALLKDTVYTDFDGTRVYSPP 182
Query: 223 EYALEGIFSIKS-DVFSFGVLLLEIVSG 249
           E+     +  +S  V+S G+LL ++V G
Sbjct: 183 EWIRYHRYHGRSAAVWSLGILLYDMVCG 210

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 92/208 (44%), Gaps = 28/208 (13%)
Query: 57  LGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKN------EASVIAKVQ--HKNL 107
           LG GGFG VY G+ +     +A+K +         E+ N      E  ++ KV      +
Sbjct: 44  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 103
Query: 108 VRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTR---VQIIEGIAQGLLYL 164
           +RLL      D  +LI E  P    D F F   +  L + + R    Q++E +     + 
Sbjct: 104 IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARSFFWQVLEAVR----HC 158
Query: 165 HQYSRVRIIHRDLKASNILLDKDMNP-KISDFGMARICGGNELQANT-SRIVGTYGYMSP 222
           H      ++HRD+K  NIL+D +    K+ DFG      G  L+    +   GT  Y  P
Sbjct: 159 HNCG---VLHRDIKDENILIDLNRGELKLIDFG-----SGALLKDTVYTDFDGTRVYSPP 210
Query: 223 EYALEGIFSIKS-DVFSFGVLLLEIVSG 249
           E+     +  +S  V+S G+LL ++V G
Sbjct: 211 EWIRYHRYHGRSAAVWSLGILLYDMVCG 238

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 35/120 (29%), Positives = 57/120 (47%), Gaps = 21/120 (17%)
Query: 151 VQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLD-------------KDMNPKISDFGM 197
           + ++  IA G+ +LH    ++IIHRDLK  NIL+              +++   ISDFG+
Sbjct: 136 ISLLRQIASGVAHLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGL 192
Query: 198 ARI--CGGNELQANTSRIVGTYGYMSPEYALEGI---FSIKSDVFSFGVLLLEIVSGKKN 252
            +    G    + N +   GT G+ +PE   E      +   D+FS G +   I+S  K+
Sbjct: 193 CKKLDSGQXXFRXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKH 252

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 57/221 (25%), Positives = 96/221 (43%), Gaps = 46/221 (20%)
Query: 51  FSDA----NKLGEGGFGPVYKGVLKKGD-EIAVKRLSGRSGQGLREMKNEASVIAKV-QH 104
           FSD       +G G +    + V K  + E AVK +     +  R+   E  ++ +  QH
Sbjct: 25  FSDGYVVKETIGVGSYSECKRCVHKATNMEYAVKVID----KSKRDPSEEIEILLRYGQH 80
Query: 105 KNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQ---------IIE 155
            N++ L     D     L+ E M    L            LD + R +         ++ 
Sbjct: 81  PNIITLKDVYDDGKHVYLVTELMRGGEL------------LDKILRQKFFSEREASFVLH 128
Query: 156 GIAQGLLYLHQYSRVRIIHRDLKASNIL-LDKDMNP---KISDFGMARICGGNELQANTS 211
            I + + YLH      ++HRDLK SNIL +D+  NP   +I DFG A+     +L+A   
Sbjct: 129 TIGKTVEYLHSQG---VVHRDLKPSNILYVDESGNPECLRICDFGFAK-----QLRAENG 180
Query: 212 RIVG---TYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 249
            ++    T  +++PE      +    D++S G+LL  +++G
Sbjct: 181 LLMTPCYTANFVAPEVLKRQGYDEGCDIWSLGILLYTMLAG 221

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 35/120 (29%), Positives = 57/120 (47%), Gaps = 21/120 (17%)
Query: 151 VQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLD-------------KDMNPKISDFGM 197
           + ++  IA G+ +LH    ++IIHRDLK  NIL+              +++   ISDFG+
Sbjct: 136 ISLLRQIASGVAHLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGL 192
Query: 198 ARI--CGGNELQANTSRIVGTYGYMSPEYALEGI---FSIKSDVFSFGVLLLEIVSGKKN 252
            +    G    + N +   GT G+ +PE   E      +   D+FS G +   I+S  K+
Sbjct: 193 CKKLDSGQXXFRXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKH 252

>pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 66/286 (23%), Positives = 119/286 (41%), Gaps = 57/286 (19%)
Query: 30  KKEVDQFPLFSFSSVSTATNKFSDANKLGEGGFGPVYKGV--LKKGDE--IAVKRLSGRS 85
           KK++++     + +V   +N F   +K+GEG F  VY     L+ G E  IA+K L   S
Sbjct: 6   KKDIEKL----YEAVPQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS 61
Query: 86  GQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKS----LDFFLFDPTK 141
              +R       +       N++ +  C    D  ++   Y+ ++S    L+   F   +
Sbjct: 62  -HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIAMPYLEHESFLDILNSLSFQEVR 120
Query: 142 RMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNP-KISDFGMAR- 199
             +L+          + + L  +HQ+    I+HRD+K SN L ++ +    + DFG+A+ 
Sbjct: 121 EYMLN----------LFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVDFGLAQG 167
Query: 200 -------------------ICGGNELQANTSR------IVGTYGYMSPEYALEGIFSIKS 234
                               C  N+     SR        GT G+ +PE   +      +
Sbjct: 168 THDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTA 227
Query: 235 -DVFSFGVLLLEIVSGKKNTGLYR-TDSLNLLGYAWDLWTSNRTLE 278
            D++S GV+ L ++SG+     Y+ +D L  L     +  S  T++
Sbjct: 228 IDMWSAGVIFLSLLSGR--YPFYKASDDLTALAQIMTIRGSRETIQ 271

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 37/98 (37%), Positives = 54/98 (55%), Gaps = 13/98 (13%)
Query: 159 QGLLYLHQYSRVRIIHRDLKASNILLDKD-MNPKISDFGMARIC------GGNELQANTS 211
           +GL YLH  SR RI+H D+KA N+LL  D  +  + DFG A +C      G + L  +  
Sbjct: 177 EGLEYLH--SR-RILHGDVKADNVLLSSDGSHAALCDFGHA-VCLQPDGLGKDLLTGDY- 231
Query: 212 RIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 249
            I GT  +M+PE  L      K DV+S   ++L +++G
Sbjct: 232 -IPGTETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLNG 268

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 56/234 (23%), Positives = 101/234 (43%), Gaps = 35/234 (14%)
Query: 57  LGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKN---EASVIAKVQHKNLVRLLGC 113
           +G G +G V +   K    +   +   R  + L + K    E +++ ++ H ++V++L  
Sbjct: 61  IGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDI 120
Query: 114 CIDRD-EKI-LIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVR 171
            I +D EK   +Y  +     DF     T   L +   +  ++  +  G+ Y+H      
Sbjct: 121 VIPKDVEKFDELYVVLEIADSDFKKLFRTPVYLTELHIKT-LLYNLLVGVKYVHSAG--- 176
Query: 172 IIHRDLKASNILLDKDMNPKISDFGMARIC----GGNE---------------------L 206
           I+HRDLK +N L+++D + K+ DFG+AR       GN                      L
Sbjct: 177 ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNL 236
Query: 207 QANTSRIVGTYGYMSPEYA-LEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTD 259
           +   +  V T  Y +PE   L+  ++   DV+S G +  E+++  K    Y  D
Sbjct: 237 KRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHAD 290

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 92/208 (44%), Gaps = 28/208 (13%)
Query: 57  LGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKN------EASVIAKVQ--HKNL 107
           LG GGFG VY G+ +     +A+K +         E+ N      E  ++ KV      +
Sbjct: 32  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 91
Query: 108 VRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTR---VQIIEGIAQGLLYL 164
           +RLL      D  +LI E  P    D F F   +  L + + R    Q++E +     + 
Sbjct: 92  IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARSFFWQVLEAVR----HC 146
Query: 165 HQYSRVRIIHRDLKASNILLDKDMNP-KISDFGMARICGGNELQANT-SRIVGTYGYMSP 222
           H      ++HRD+K  NIL+D +    K+ DFG      G  L+    +   GT  Y  P
Sbjct: 147 HNCG---VLHRDIKDENILIDLNRGELKLIDFG-----SGALLKDTVYTDFDGTRVYSPP 198
Query: 223 EYALEGIFSIKS-DVFSFGVLLLEIVSG 249
           E+     +  +S  V+S G+LL ++V G
Sbjct: 199 EWIRYHRYHGRSAAVWSLGILLYDMVCG 226

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 92/208 (44%), Gaps = 28/208 (13%)
Query: 57  LGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKN------EASVIAKVQ--HKNL 107
           LG GGFG VY G+ +     +A+K +         E+ N      E  ++ KV      +
Sbjct: 17  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 76
Query: 108 VRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTR---VQIIEGIAQGLLYL 164
           +RLL      D  +LI E  P    D F F   +  L + + R    Q++E +     + 
Sbjct: 77  IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARSFFWQVLEAVR----HC 131
Query: 165 HQYSRVRIIHRDLKASNILLDKDMNP-KISDFGMARICGGNELQANT-SRIVGTYGYMSP 222
           H      ++HRD+K  NIL+D +    K+ DFG      G  L+    +   GT  Y  P
Sbjct: 132 HNCG---VLHRDIKDENILIDLNRGELKLIDFG-----SGALLKDTVYTDFDGTRVYSPP 183
Query: 223 EYALEGIFSIKS-DVFSFGVLLLEIVSG 249
           E+     +  +S  V+S G+LL ++V G
Sbjct: 184 EWIRYHRYHGRSAAVWSLGILLYDMVCG 211

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 92/208 (44%), Gaps = 28/208 (13%)
Query: 57  LGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKN------EASVIAKVQ--HKNL 107
           LG GGFG VY G+ +     +A+K +         E+ N      E  ++ KV      +
Sbjct: 17  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 76
Query: 108 VRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTR---VQIIEGIAQGLLYL 164
           +RLL      D  +LI E  P    D F F   +  L + + R    Q++E +     + 
Sbjct: 77  IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARSFFWQVLEAVR----HC 131
Query: 165 HQYSRVRIIHRDLKASNILLDKDMNP-KISDFGMARICGGNELQANT-SRIVGTYGYMSP 222
           H      ++HRD+K  NIL+D +    K+ DFG      G  L+    +   GT  Y  P
Sbjct: 132 HNCG---VLHRDIKDENILIDLNRGELKLIDFG-----SGALLKDTVYTDFDGTRVYSPP 183
Query: 223 EYALEGIFSIKS-DVFSFGVLLLEIVSG 249
           E+     +  +S  V+S G+LL ++V G
Sbjct: 184 EWIRYHRYHGRSAAVWSLGILLYDMVCG 211

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 92/208 (44%), Gaps = 28/208 (13%)
Query: 57  LGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKN------EASVIAKVQ--HKNL 107
           LG GGFG VY G+ +     +A+K +         E+ N      E  ++ KV      +
Sbjct: 32  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 91
Query: 108 VRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTR---VQIIEGIAQGLLYL 164
           +RLL      D  +LI E  P    D F F   +  L + + R    Q++E +     + 
Sbjct: 92  IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARSFFWQVLEAVR----HC 146
Query: 165 HQYSRVRIIHRDLKASNILLDKDMNP-KISDFGMARICGGNELQANT-SRIVGTYGYMSP 222
           H      ++HRD+K  NIL+D +    K+ DFG      G  L+    +   GT  Y  P
Sbjct: 147 HNCG---VLHRDIKDENILIDLNRGELKLIDFG-----SGALLKDTVYTDFDGTRVYSPP 198
Query: 223 EYALEGIFSIKS-DVFSFGVLLLEIVSG 249
           E+     +  +S  V+S G+LL ++V G
Sbjct: 199 EWIRYHRYHGRSAAVWSLGILLYDMVCG 226

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 92/208 (44%), Gaps = 28/208 (13%)
Query: 57  LGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKN------EASVIAKVQ--HKNL 107
           LG GGFG VY G+ +     +A+K +         E+ N      E  ++ KV      +
Sbjct: 32  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 91
Query: 108 VRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTR---VQIIEGIAQGLLYL 164
           +RLL      D  +LI E  P    D F F   +  L + + R    Q++E +     + 
Sbjct: 92  IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARSFFWQVLEAVR----HC 146
Query: 165 HQYSRVRIIHRDLKASNILLDKDMNP-KISDFGMARICGGNELQANT-SRIVGTYGYMSP 222
           H      ++HRD+K  NIL+D +    K+ DFG      G  L+    +   GT  Y  P
Sbjct: 147 HNCG---VLHRDIKDENILIDLNRGELKLIDFG-----SGALLKDTVYTDFDGTRVYSPP 198
Query: 223 EYALEGIFSIKS-DVFSFGVLLLEIVSG 249
           E+     +  +S  V+S G+LL ++V G
Sbjct: 199 EWIRYHRYHGRSAAVWSLGILLYDMVCG 226

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 57/221 (25%), Positives = 96/221 (43%), Gaps = 46/221 (20%)
Query: 51  FSDA----NKLGEGGFGPVYKGVLKKGD-EIAVKRLSGRSGQGLREMKNEASVIAKV-QH 104
           FSD       +G G +    + V K  + E AVK +     +  R+   E  ++ +  QH
Sbjct: 25  FSDGYVVKETIGVGSYSECKRCVHKATNMEYAVKVID----KSKRDPSEEIEILLRYGQH 80
Query: 105 KNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQ---------IIE 155
            N++ L     D     L+ E M    L            LD + R +         ++ 
Sbjct: 81  PNIITLKDVYDDGKHVYLVTELMRGGEL------------LDKILRQKFFSEREASFVLH 128
Query: 156 GIAQGLLYLHQYSRVRIIHRDLKASNIL-LDKDMNP---KISDFGMARICGGNELQANTS 211
            I + + YLH      ++HRDLK SNIL +D+  NP   +I DFG A+     +L+A   
Sbjct: 129 TIGKTVEYLHSQG---VVHRDLKPSNILYVDESGNPECLRICDFGFAK-----QLRAENG 180
Query: 212 RIVG---TYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG 249
            ++    T  +++PE      +    D++S G+LL  +++G
Sbjct: 181 LLMTPCYTANFVAPEVLKRQGYDEGCDIWSLGILLYTMLAG 221

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 92/208 (44%), Gaps = 28/208 (13%)
Query: 57  LGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKN------EASVIAKVQ--HKNL 107
           LG GGFG VY G+ +     +A+K +         E+ N      E  ++ KV      +
Sbjct: 64  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 123
Query: 108 VRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTR---VQIIEGIAQGLLYL 164
           +RLL      D  +LI E  P    D F F   +  L + + R    Q++E +     + 
Sbjct: 124 IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQEELARSFFWQVLEAVR----HC 178
Query: 165 HQYSRVRIIHRDLKASNILLDKDMNP-KISDFGMARICGGNELQANT-SRIVGTYGYMSP 222
           H      ++HRD+K  NIL+D +    K+ DFG      G  L+    +   GT  Y  P
Sbjct: 179 HNCG---VLHRDIKDENILIDLNRGELKLIDFG-----SGALLKDTVYTDFDGTRVYSPP 230
Query: 223 EYALEGIFSIKS-DVFSFGVLLLEIVSG 249
           E+     +  +S  V+S G+LL ++V G
Sbjct: 231 EWIRYHRYHGRSAAVWSLGILLYDMVCG 258
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	369
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	1e-149
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	1e-146
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	1e-128
3soc_A	322	Activin receptor type-2A; structural genomics cons	6e-96
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	7e-83
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	7e-67
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	9e-65
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	3e-64
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	3e-62
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	1e-61
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	2e-61
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	5e-61
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	5e-59
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	7e-57
3q4u_A	301	Activin receptor type-1; structural genomics conso	9e-56
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	2e-54
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	2e-54
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	3e-52
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	1e-51
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	2e-51
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	2e-51
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	5e-50
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	7e-50
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	1e-49
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	9e-49
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	4e-48
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	4e-48
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	4e-48
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	4e-48
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	5e-48
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	8e-48
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	1e-47
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	3e-47
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	4e-47
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	4e-47
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	4e-47
4aoj_A	329	High affinity nerve growth factor receptor; transf	5e-47
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	8e-47
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	8e-47
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	8e-47
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	8e-47
3pls_A	298	Macrophage-stimulating protein receptor; protein k	9e-47
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	9e-47
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	1e-46
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	3e-46
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	5e-46
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	7e-46
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	8e-46
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	9e-46
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	1e-45
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	2e-45
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	2e-45
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	3e-45
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	3e-45
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	5e-45
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	8e-45
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	1e-44
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	2e-44
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	2e-44
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	2e-44
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	4e-44
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	6e-44
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	7e-44
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	9e-44
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	1e-43
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	2e-43
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	4e-43
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	1e-42
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	6e-42
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	1e-41
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	3e-40
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	8e-40
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	5e-39
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	2e-38
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	2e-37
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	3e-37
2a19_B	284	Interferon-induced, double-stranded RNA-activated	3e-37
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	2e-36
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	3e-36
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	8e-36
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	9e-36
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	3e-35
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	3e-35
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	6e-35
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	3e-34
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	2e-33
3fme_A	290	Dual specificity mitogen-activated protein kinase;	3e-33
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	3e-33
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	4e-33
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	4e-33
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	1e-32
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	2e-32
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	3e-32
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	3e-32
3an0_A	340	Dual specificity mitogen-activated protein kinase;	4e-32
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	4e-32
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	1e-31
3aln_A	327	Dual specificity mitogen-activated protein kinase;	2e-31
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	7e-31
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	8e-31
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	1e-30
2dyl_A	318	Dual specificity mitogen-activated protein kinase	1e-30
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	2e-30
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	2e-30
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	4e-30
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	7e-30
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	9e-30
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	1e-29
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	2e-29
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	5e-29
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	7e-29
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	1e-28
3ork_A	311	Serine/threonine protein kinase; structural genomi	2e-28
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	5e-28
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	6e-28
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	8e-28
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	1e-27
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	1e-27
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	2e-27
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	2e-27
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	3e-27
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	4e-27
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	4e-27
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	4e-27
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	4e-27
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	5e-27
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	5e-27
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	9e-27
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	1e-26
3niz_A	311	Rhodanese family protein; structural genomics, str	1e-26
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	2e-26
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	3e-26
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	3e-26
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	4e-26
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	6e-26
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	9e-26
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	9e-26
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	1e-25
3o0g_A	292	Cell division protein kinase 5; kinase activator c	1e-25
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	1e-25
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	1e-25
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	2e-25
3bhy_A	283	Death-associated protein kinase 3; death associate	2e-25
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	2e-25
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	2e-25
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	3e-25
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	3e-25
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	7e-25
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	7e-25
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	9e-25
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	1e-24
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	2e-24
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	2e-24
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	3e-24
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	5e-24
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	5e-24
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	6e-24
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	9e-24
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	1e-23
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	1e-23
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	1e-23
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	3e-23
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	3e-23
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	3e-23
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	4e-23
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	4e-23
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	6e-23
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	6e-23
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	7e-23
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	9e-23
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	1e-22
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	2e-22
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	2e-22
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	2e-22
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	4e-22
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	6e-22
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	6e-22
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	1e-21
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	1e-21
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	5e-21
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	2e-20
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	2e-20
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	6e-20
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	2e-11
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	7e-20
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	2e-19
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	2e-19
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	4e-19
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	4e-19
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	4e-19
3uqc_A	286	Probable conserved transmembrane protein; structur	3e-18
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	5e-18
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	5e-18
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	1e-17
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	1e-17
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	3e-17
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	3e-17
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	4e-17
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	1e-16
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	1e-16
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	2e-16
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	2e-16
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	2e-16
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	5e-16
3rp9_A	458	Mitogen-activated protein kinase; structural genom	6e-16
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	1e-15
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	1e-15
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	4e-15
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	5e-15
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	8e-15
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	1e-14
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	1e-14
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	1e-14
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	2e-14
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	2e-14
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	2e-14
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	5e-14
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	5e-14
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	6e-14
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	6e-14
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	7e-14
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	7e-14
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	7e-13
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	2e-12
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	3e-11
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	9e-10
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	1e-09
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	1e-09
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	1e-09
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	2e-09
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	3e-09
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	5e-09
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	6e-09
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	8e-09
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	4e-07
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	1e-06
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	2e-06
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	5e-06
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	3e-06

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  421 bits (1085), Expect = e-149
 Identities = 115/305 (37%), Positives = 162/305 (53%), Gaps = 19/305 (6%)

Query: 35  QFPLFSFSSVSTATNKFSD------ANKLGEGGFGPVYKGVLKKGDEIAVKRLSGR---- 84
           +F  FSF  +   TN F +       NK+GEGGFG VYKG +     +AVK+L+      
Sbjct: 11  RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVN-NTTVAVKKLAAMVDIT 69

Query: 85  SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRML 144
           + +  ++   E  V+AK QH+NLV LLG   D D+  L+Y YMPN SL   L        
Sbjct: 70  TEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPP 129

Query: 145 LDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGN 204
           L W  R +I +G A G+ +LH+      IHRD+K++NILLD+    KISDFG+AR     
Sbjct: 130 LSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLARASEKF 186

Query: 205 ELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLL 264
                TSRIVGT  YM+PE  L G  + KSD++SFGV+LLEI++G      +R     LL
Sbjct: 187 AQTVMTSRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQ-LLL 244

Query: 265 GYAWDLWTSNRTLE-LIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLT 323
               ++    +T+E  ID  + D   S  +     ++A  C+ E  + RP +  V  +L 
Sbjct: 245 DIKEEIEDEEKTIEDYIDKKMND-ADSTSV-EAMYSVASQCLHEKKNKRPDIKKVQQLLQ 302

Query: 324 NEAAT 328
              A+
Sbjct: 303 EMTAS 307

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  415 bits (1070), Expect = e-146
 Identities = 112/293 (38%), Positives = 170/293 (58%), Gaps = 7/293 (2%)

Query: 39  FSFSSVSTATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGL-REMKNEAS 97
           FS   +  A++ FS+ N LG GGFG VYKG L  G  +AVKRL     QG   + + E  
Sbjct: 20  FSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVE 79

Query: 98  VIAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTK-RMLLDWVTRVQIIEG 156
           +I+   H+NL+RL G C+   E++L+Y YM N S+   L +  + +  LDW  R +I  G
Sbjct: 80  MISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALG 139

Query: 157 IAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 216
            A+GL YLH +   +IIHRD+KA+NILLD++    + DFG+A++    +    T  + GT
Sbjct: 140 SARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTT-AVRGT 198

Query: 217 YGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRT---DSLNLLGYAWDLWTS 273
            G+++PEY   G  S K+DVF +GV+LLE+++G++   L R    D + LL +   L   
Sbjct: 199 IGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE 258

Query: 274 NRTLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNEA 326
            +   L+D  L+  Y  +++  +   +ALLC Q S  +RP M++VV ML  + 
Sbjct: 259 KKLEALVDVDLQGNYKDEEV-EQLIQVALLCTQSSPMERPKMSEVVRMLEGDG 310

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  370 bits (953), Expect = e-128
 Identities = 103/286 (36%), Positives = 169/286 (59%), Gaps = 6/286 (2%)

Query: 39  FSFSSVSTATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASV 98
                +  ATN F     +G G FG VYKGVL+ G ++A+KR +  S QG+ E + E   
Sbjct: 29  VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIET 88

Query: 99  IAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTK-RMLLDWVTRVQIIEGI 157
           ++  +H +LV L+G C +R+E ILIY+YM N +L   L+      M + W  R++I  G 
Sbjct: 89  LSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGA 148

Query: 158 AQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTY 217
           A+GL YLH  +   IIHRD+K+ NILLD++  PKI+DFG+++     +    ++ + GT 
Sbjct: 149 ARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTL 205

Query: 218 GYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYR-TDSLNLLGYAWDLWTSNRT 276
           GY+ PEY ++G  + KSDV+SFGV+L E++  +         + +NL  +A +   + + 
Sbjct: 206 GYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQL 265

Query: 277 LELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSML 322
            +++DP L D+   + +  ++ + A+ C+  S++DRP+M DV+  L
Sbjct: 266 EQIVDPNLADKIRPESL-RKFGDTAVKCLALSSEDRPSMGDVLWKL 310

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  287 bits (737), Expect = 6e-96
 Identities = 68/311 (21%), Positives = 124/311 (39%), Gaps = 34/311 (10%)

Query: 39  FSFSSVSTATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASV 98
               ++   +           G FG V+K  L   + +AVK    +  Q   + + E   
Sbjct: 14  LGTENLYFQSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDKQSW-QNEYEVYS 71

Query: 99  IAKVQHKNLVRLLGCCI----DRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQII 154
           +  ++H+N+++ +G          +  LI  +    SL  FL    K  ++ W     I 
Sbjct: 72  LPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL----KANVVSWNELCHIA 127

Query: 155 EGIAQGLLYLHQ-------YSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQ 207
           E +A+GL YLH+         +  I HRD+K+ N+LL  ++   I+DFG+A      +  
Sbjct: 128 ETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSA 187

Query: 208 ANTSRIVGTYGYMSPEYALEGI-----FSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLN 262
            +T   VGT  YM+PE     I       ++ D+++ G++L E+ S          +   
Sbjct: 188 GDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDE--Y 245

Query: 263 LLGYAWDLWTSNRTLE---------LIDPILEDEYSSKQMLLRYANIALLCVQESADDRP 313
           +L +  ++   + +LE            P+L D +     +         C    A+ R 
Sbjct: 246 MLPFEEEIG-QHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARL 304

Query: 314 TMNDVVSMLTN 324
           +   V   +T 
Sbjct: 305 SAGCVGERITQ 315

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  254 bits (651), Expect = 7e-83
 Identities = 76/334 (22%), Positives = 129/334 (38%), Gaps = 45/334 (13%)

Query: 39  FSFSSVSTATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASV 98
            + S  S   +       +G G +G VYKG L     +AVK  S  + Q      NE ++
Sbjct: 3   AAASEPSLDLDNLKLLELIGRGRYGAVYKGSLD-ERPVAVKVFSFANRQ---NFINEKNI 58

Query: 99  --IAKVQHKNLVRLLGCCI-----DRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRV 151
             +  ++H N+ R +          R E +L+ EY PN SL  +L   T     DWV+  
Sbjct: 59  YRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT----SDWVSSC 114

Query: 152 QIIEGIAQGLLYLHQ------YSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGN- 204
           ++   + +GL YLH       + +  I HRDL + N+L+  D    ISDFG++    GN 
Sbjct: 115 RLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNR 174

Query: 205 -----ELQANTSRIVGTYGYMSPEYALEGIFSI--------KSDVFSFGVLLLEIVSGKK 251
                E        VGT  YM+PE  LEG  ++        + D+++ G++  EI     
Sbjct: 175 LVRPGEEDNAAISEVGTIRYMAPEV-LEGAVNLRDXESALKQVDMYALGLIYWEIFMRCT 233

Query: 252 NTGLYRTDSLNLLGYAWDLWTSNRTLELID--------PILEDEYSSKQMLLR-YANIAL 302
           +     +     + +  ++       ++          P   + +    + +R       
Sbjct: 234 DLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIE 293

Query: 303 LCVQESADDRPTMNDVVSMLTNEAATLLPPKQPA 336
            C  + A+ R T       +          K  +
Sbjct: 294 DCWDQDAEARLTAQXAEERMAELMMIWERNKSVS 327

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  212 bits (543), Expect = 7e-67
 Identities = 73/282 (25%), Positives = 131/282 (46%), Gaps = 21/282 (7%)

Query: 55  NKLGEGGFGPVYKGVLKKGDEIAVKRLSGR--SGQGLREMKNEASVIAKVQHKNLVRLLG 112
            K+G G FG V++     G ++AVK L  +    + + E   E +++ +++H N+V  +G
Sbjct: 43  EKIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMG 101

Query: 113 CCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRI 172
                    ++ EY+   SL   L     R  LD   R+ +   +A+G+ YLH      I
Sbjct: 102 AVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN-RNPPI 160

Query: 173 IHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSI 232
           +HR+LK+ N+L+DK    K+ DFG++R+     L + ++   GT  +M+PE   +   + 
Sbjct: 161 VHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSA--AGTPEWMAPEVLRDEPSNE 218

Query: 233 KSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYSSKQ 292
           KSDV+SFGV+L E+ + ++    +   +LN       +    + LE+   +         
Sbjct: 219 KSDVYSFGVILWELATLQQ---PW--GNLNPAQVVAAVGFKCKRLEIPRNLNPQ------ 267

Query: 293 MLLRYANIALLCVQESADDRPTMNDVVSMLTNEAATLLPPKQ 334
                A I   C       RP+   ++ +L     + +PP  
Sbjct: 268 ----VAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPPPN 305

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  207 bits (528), Expect = 9e-65
 Identities = 69/301 (22%), Positives = 124/301 (41%), Gaps = 25/301 (8%)

Query: 49  NKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLV 108
            +      +G G FG V K   +   ++A+K++   S    +    E   +++V H N+V
Sbjct: 8   KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQI--ESESERKAFIVELRQLSRVNHPNIV 64

Query: 109 RLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYS 168
           +L G C++     L+ EY    SL   L              +      +QG+ YLH   
Sbjct: 65  KLYGACLN--PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQ 122

Query: 169 RVRIIHRDLKASNILLDKDMN-PKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALE 227
              +IHRDLK  N+LL       KI DFG A      ++Q + +   G+  +M+PE    
Sbjct: 123 PKALIHRDLKPPNLLLVAGGTVLKICDFGTAC-----DIQTHMTNNKGSAAWMAPEVFEG 177

Query: 228 GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDE 287
             +S K DVFS+G++L E+++ +K    +           W +    R   LI  + +  
Sbjct: 178 SNYSEKCDVFSWGIILWEVITRRK---PFDEIGGPAFRIMWAVHNGTR-PPLIKNLPKP- 232

Query: 288 YSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNEAATLLPPKQPAFSYVRNTVTST 347
                      ++   C  +    RP+M ++V ++T+         +P     ++++   
Sbjct: 233 ---------IESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPLQYPCQHSLPPG 283

Query: 348 S 348
            
Sbjct: 284 E 284

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  206 bits (525), Expect = 3e-64
 Identities = 68/283 (24%), Positives = 114/283 (40%), Gaps = 36/283 (12%)

Query: 55  NKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGC 113
             LG+G FG   K   ++ G+ + +K L     +  R    E  V+  ++H N+++ +G 
Sbjct: 16  EVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGV 75

Query: 114 CIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRII 173
                    I EY+   +L   +     +    W  RV   + IA G+ YLH  +   II
Sbjct: 76  LYKDKRLNFITEYIKGGTLRGIIKSMDSQ--YPWSQRVSFAKDIASGMAYLHSMN---II 130

Query: 174 HRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR------------IVGTYGYMS 221
           HRDL + N L+ ++ N  ++DFG+AR+    + Q    R            +VG   +M+
Sbjct: 131 HRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMA 190

Query: 222 PEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELID 281
           PE      +  K DVFSFG++L EI+                   A   +   RT++   
Sbjct: 191 PEMINGRSYDEKVDVFSFGIVLCEIIGRVN---------------ADPDYLP-RTMDFGL 234

Query: 282 PILEDE--YSSKQMLLRYANIALLCVQESADDRPTMNDVVSML 322
            +      Y        +  I + C     + RP+   +   L
Sbjct: 235 NVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWL 277

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  199 bits (508), Expect = 3e-62
 Identities = 79/282 (28%), Positives = 127/282 (45%), Gaps = 36/282 (12%)

Query: 55  NKLGEGGFGPVYKGVLKKGDEIAVKRL----SGRSGQGLREMKNEASVIAKVQHKNLVRL 110
             +G GGFG VY+     GDE+AVK           Q +  ++ EA + A ++H N++ L
Sbjct: 13  EIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIAL 71

Query: 111 LGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRV 170
            G C+      L+ E+     L+  L        +     V     IA+G+ YLH  + V
Sbjct: 72  RGVCLKEPNLCLVMEFARGGPLNRVLSGKR----IPPDILVNWAVQIARGMNYLHDEAIV 127

Query: 171 RIIHRDLKASNILLDKDMNP--------KISDFGMARICGGNELQANTSRIVGTYGYMSP 222
            IIHRDLK+SNIL+ + +          KI+DFG+AR       +       G Y +M+P
Sbjct: 128 PIIHRDLKSSNILILQKVENGDLSNKILKITDFGLARE----WHRTTKMSAAGAYAWMAP 183

Query: 223 EYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDP 282
           E     +FS  SDV+S+GVLL E+++G+     +    ++ L  A+ +  +   L +   
Sbjct: 184 EVIRASMFSKGSDVWSYGVLLWELLTGEV---PF--RGIDGLAVAYGVAMNKLALPIPST 238

Query: 283 ILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTN 324
             E           +A +   C       RP+  +++  LT 
Sbjct: 239 CPEP----------FAKLMEDCWNPDPHSRPSFTNILDQLTT 270

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  198 bits (505), Expect = 2e-61
 Identities = 67/291 (23%), Positives = 131/291 (45%), Gaps = 38/291 (13%)

Query: 49  NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQG-------LREMKNEASVIA 100
           N+     ++G+GGFG V+KG L K    +A+K L     +G        +E + E  +++
Sbjct: 19  NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMS 78

Query: 101 KVQHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQG 160
            + H N+V+L G   +     ++ E++P   L   L D      + W  +++++  IA G
Sbjct: 79  NLNHPNIVKLYGLMHN--PPRMVMEFVPCGDLYHRLLDKAHP--IKWSVKLRLMLDIALG 134

Query: 161 LLYLHQYSRVRIIHRDLKASNILLDK-----DMNPKISDFGMARICGGNELQANTSRIVG 215
           + Y+       I+HRDL++ NI L        +  K++DFG+++     +   + S ++G
Sbjct: 135 IEYMQN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ-----QSVHSVSGLLG 188

Query: 216 TYGYMSPE--YALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTS 273
            + +M+PE   A E  ++ K+D +SF ++L  I++G+     +   S   + +   +   
Sbjct: 189 NFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEG---PFDEYSYGKIKFINMIREE 245

Query: 274 NRTLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTN 324
                + +              R  N+  LC       RP  + +V  L+ 
Sbjct: 246 GLRPTIPEDCPP----------RLRNVIELCWSGDPKKRPHFSYIVKELSE 286

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  196 bits (500), Expect = 5e-61
 Identities = 60/276 (21%), Positives = 113/276 (40%), Gaps = 34/276 (12%)

Query: 55  NKLGEGGFGPVYKGVLKKGDEIAVKRLSGR--SGQGLREMKNEASVIAKVQHKNLVRLLG 112
            KL E   G ++KG  + G++I VK L  R  S +  R+   E   +    H N++ +LG
Sbjct: 16  TKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLG 74

Query: 113 CCIDRDEKIL--IYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRV 170
            C          I  +MP  SL   L + T   ++D    V+    +A+G+ +LH    +
Sbjct: 75  ACQSPPAPHPTLITHWMPYGSLYNVLHEGTNF-VVDQSQAVKFALDMARGMAFLHTLEPL 133

Query: 171 RIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEG-- 228
            I    L + ++++D+DM  +IS   +            +   +    +++PE AL+   
Sbjct: 134 -IPRHALNSRSVMIDEDMTARISMADVKFS-------FQSPGRMYAPAWVAPE-ALQKKP 184

Query: 229 --IFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILED 286
                  +D++SF VLL E+V+ +     +    L+ +     +        +   I   
Sbjct: 185 EDTNRRSADMWSFAVLLWELVTREV---PF--ADLSNMEIGMKVALEGLRPTIPPGISP- 238

Query: 287 EYSSKQMLLRYANIALLCVQESADDRPTMNDVVSML 322
                      + +  +C+ E    RP  + +V +L
Sbjct: 239 ---------HVSKLMKICMNEDPAKRPKFDMIVPIL 265

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  191 bits (488), Expect = 5e-59
 Identities = 71/274 (25%), Positives = 126/274 (45%), Gaps = 26/274 (9%)

Query: 55  NKLGEGGFGPVYKGVLKKGDEIAVKRL--SGRSGQGLREMKNEASVIAKVQHKNLVRLLG 112
            ++G G FG VYKG      ++AVK L  +  + Q L+  KNE  V+ K +H N++  +G
Sbjct: 30  QRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 87

Query: 113 CCIDRDEKI-LIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVR 171
                  ++ ++ ++    SL   L     +   +    + I    A+G+ YLH      
Sbjct: 88  YS--TAPQLAIVTQWCEGSSLYHHLHASETK--FEMKKLIDIARQTARGMDYLHA---KS 140

Query: 172 IIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE---YALEG 228
           IIHRDLK++NI L +D   KI DFG+A             ++ G+  +M+PE        
Sbjct: 141 IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSN 200

Query: 229 IFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEY 288
            +S +SDV++FG++L E+++G+     Y     N+      +    R     D       
Sbjct: 201 PYSFQSDVYAFGIVLYELMTGQL---PYS----NINNRDQIIEMVGRGSLSPDLSKVRSN 253

Query: 289 SSKQMLLRYANIALLCVQESADDRPTMNDVVSML 322
             K+M      +   C+++  D+RP+   +++ +
Sbjct: 254 CPKRM----KRLMAECLKKKRDERPSFPRILAEI 283

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  187 bits (476), Expect = 7e-57
 Identities = 64/295 (21%), Positives = 118/295 (40%), Gaps = 37/295 (12%)

Query: 55  NKLGEGGFGPVYKGVLKKGDEIAVKRL--SGRSGQGLREMKNEASVIAKVQHKNLVRLLG 112
             +G+G FG VY G      E+A++ +     +   L+  K E     + +H+N+V  +G
Sbjct: 39  ELIGKGRFGQVYHGRWH--GEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMG 96

Query: 113 CCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRI 172
            C+      +I      ++L   + D      LD     QI + I +G+ YLH      I
Sbjct: 97  ACMSPPHLAIITSLCKGRTLYSVVRDAKIV--LDVNKTRQIAQEIVKGMGYLHA---KGI 151

Query: 173 IHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRI---VGTYGYMSPE------ 223
           +H+DLK+ N+  D +    I+DFG+  I G  +      ++    G   +++PE      
Sbjct: 152 LHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLS 210

Query: 224 ---YALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELI 280
                 +  FS  SDVF+ G +  E+ + +     ++  +       W + T  +     
Sbjct: 211 PDTEEDKLPFSKHSDVFALGTIWYELHAREW---PFK--TQPAEAIIWQMGTGMKP---- 261

Query: 281 DPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNEAATLLPPKQP 335
             + +     +      ++I L C     ++RPT   ++ ML            P
Sbjct: 262 -NLSQIGMGKE-----ISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRRLSHP 310

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  183 bits (467), Expect = 9e-56
 Identities = 70/300 (23%), Positives = 124/300 (41%), Gaps = 44/300 (14%)

Query: 55  NKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASV--IAKVQHKNLVRLLG 112
             +G+G +G V++G  + G+ +AVK  S R     +    E  +     ++H+N++  + 
Sbjct: 14  ECVGKGRYGEVWRGSWQ-GENVAVKIFSSRD---EKSWFRETELYNTVMLRHENILGFIA 69

Query: 113 CCIDRDEKI----LIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLH--- 165
             +          LI  Y    SL  +L    +   LD V+ ++I+  IA GL +LH   
Sbjct: 70  SDMTSRHSSTQLWLITHYHEMGSLYDYL----QLTTLDTVSCLRIVLSIASGLAHLHIEI 125

Query: 166 --QYSRVRIIHRDLKASNILLDKDMNPKISDFGMARI---CGGNELQANTSRIVGTYGYM 220
                +  I HRDLK+ NIL+ K+    I+D G+A +           N  R VGT  YM
Sbjct: 126 FGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPR-VGTKRYM 184

Query: 221 SPE------YALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAW-DLWTS 273
           +PE               + D+++FG++L E+     + G+            + D+  +
Sbjct: 185 APEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKP-----PFYDVVPN 239

Query: 274 NRTLELID---------PILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTN 324
           + + E +          P + + + S   L   A +   C  ++   R T   +   LT 
Sbjct: 240 DPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTK 299

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  181 bits (461), Expect = 2e-54
 Identities = 70/295 (23%), Positives = 125/295 (42%), Gaps = 34/295 (11%)

Query: 55  NKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASV--IAKVQHKNLVRLLG 112
            ++G+G +G V+ G  + G+++AVK               E  +     ++H+N++  + 
Sbjct: 43  KQIGKGRYGEVWMGKWR-GEKVAVKVFFTTE---EASWFRETEIYQTVLMRHENILGFIA 98

Query: 113 CCIDRDEKI----LIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLH--- 165
             I          LI +Y  N SL  +L    K   LD  + +++      GL +LH   
Sbjct: 99  ADIKGTGSWTQLYLITDYHENGSLYDYL----KSTTLDAKSMLKLAYSSVSGLCHLHTEI 154

Query: 166 --QYSRVRIIHRDLKASNILLDKDMNPKISDFGMARIC--GGNELQANTSRIVGTYGYMS 221
                +  I HRDLK+ NIL+ K+    I+D G+A       NE+    +  VGT  YM 
Sbjct: 155 FSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMP 214

Query: 222 PEYALEGI-------FSIKSDVFSFGVLLLEIVSGKKNTGL---YRTDSLNLLGY--AWD 269
           PE  L+           I +D++SFG++L E+     + G+   Y+    +L+    +++
Sbjct: 215 PE-VLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYE 273

Query: 270 LWTSNRTLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTN 324
                  ++ + P   + +SS + L +   +   C   +   R T   V   L  
Sbjct: 274 DMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAK 328

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  176 bits (447), Expect = 3e-52
 Identities = 71/300 (23%), Positives = 125/300 (41%), Gaps = 44/300 (14%)

Query: 55  NKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASV--IAKVQHKNLVRLLG 112
             +G+G FG V++G  + G+E+AVK  S    +  R    EA +     ++H+N++  + 
Sbjct: 48  ESIGKGRFGEVWRGKWR-GEEVAVKIFSS---REERSWFREAEIYQTVMLRHENILGFIA 103

Query: 113 CCIDRDEKI----LIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQ-- 166
                +       L+ +Y  + SL  +L     R  +     +++    A GL +LH   
Sbjct: 104 ADNKDNGTWTQLWLVSDYHEHGSLFDYL----NRYTVTVEGMIKLALSTASGLAHLHMEI 159

Query: 167 ---YSRVRIIHRDLKASNILLDKDMNPKISDFGMARI---CGGNELQANTSRIVGTYGYM 220
                +  I HRDLK+ NIL+ K+    I+D G+A            A   R VGT  YM
Sbjct: 160 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHR-VGTKRYM 218

Query: 221 SPEYALEGI-------FSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTS 273
           +PE  L+            ++D+++ G++  EI       G++    L      +DL  S
Sbjct: 219 APE-VLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPY----YDLVPS 273

Query: 274 NRTLELID---------PILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTN 324
           + ++E +          P + + + S + L   A I   C   +   R T   +   L+ 
Sbjct: 274 DPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ 333

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  175 bits (445), Expect = 1e-51
 Identities = 71/277 (25%), Positives = 112/277 (40%), Gaps = 34/277 (12%)

Query: 56  KLGEGGFGPVYKGVLKKGD-EIAVKRL-SGRSGQGLREMKNEASVIAKVQHKNLVRLLGC 113
           ++G G FG V+ G L+  +  +AVK            +   EA ++ +  H N+VRL+G 
Sbjct: 121 QIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 180

Query: 114 CIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRII 173
           C  +    ++ E +       FL   T+   L   T +Q++   A G+ YL        I
Sbjct: 181 CTQKQPIYIVMELVQGGDFLTFLR--TEGARLRVKTLLQMVGDAAAGMEYLES---KCCI 235

Query: 174 HRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIK 233
           HRDL A N L+ +    KISDFGM+R        A+         + +PE    G +S +
Sbjct: 236 HRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSE 295

Query: 234 SDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLG---YAWDLWTSNRTLELIDPILEDEY-- 288
           SDV+SFG+LL E  S               LG   Y     ++ +T E +    E     
Sbjct: 296 SDVWSFGILLWETFS---------------LGASPYPN--LSNQQTREFV----EKGGRL 334

Query: 289 -SSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTN 324
              +        +   C       RP+ + +   L +
Sbjct: 335 PCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQS 371

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  172 bits (437), Expect = 2e-51
 Identities = 73/295 (24%), Positives = 125/295 (42%), Gaps = 47/295 (15%)

Query: 55  NKLGEGGFGPVYKGVLK-----KGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVR 109
            +LG+G FG V            G+ +AVK+L   + + LR+ + E  ++  +QH N+V+
Sbjct: 16  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 75

Query: 110 LLGCCIDRDEK--ILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQY 167
             G C     +   LI EY+P  SL  +L     +  +D +  +Q    I +G+ YL   
Sbjct: 76  YKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYL--- 130

Query: 168 SRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG------YMS 221
              R IHRDL   NIL++ +   KI DFG+ ++     L  +               + +
Sbjct: 131 GTKRYIHRDLATRNILVENENRVKIGDFGLTKV-----LPQDKEFFKVKEPGESPIFWYA 185

Query: 222 PEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYA-WDLWTSNRTLELI 280
           PE   E  FS+ SDV+SFGV+L E+ +  + +     + + ++G            +EL+
Sbjct: 186 PESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELL 245

Query: 281 D-----------PILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTN 324
                       P  ++ Y           I   C   + + RP+  D+   +  
Sbjct: 246 KNNGRLPRPDGCP--DEIY----------MIMTECWNNNVNQRPSFRDLALRVDQ 288

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  172 bits (439), Expect = 2e-51
 Identities = 73/295 (24%), Positives = 125/295 (42%), Gaps = 47/295 (15%)

Query: 55  NKLGEGGFGPVYKGVL-----KKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVR 109
            +LG+G FG V            G+ +AVK+L   + + LR+ + E  ++  +QH N+V+
Sbjct: 47  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 106

Query: 110 LLGCCIDRDEK--ILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQY 167
             G C     +   LI EY+P  SL  +L     +  +D +  +Q    I +G+ YL   
Sbjct: 107 YKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYL--- 161

Query: 168 SRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG------YMS 221
              R IHRDL   NIL++ +   KI DFG+ ++     L  +               + +
Sbjct: 162 GTKRYIHRDLATRNILVENENRVKIGDFGLTKV-----LPQDKEYYKVKEPGESPIFWYA 216

Query: 222 PEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYA-WDLWTSNRTLELI 280
           PE   E  FS+ SDV+SFGV+L E+ +  + +     + + ++G            +EL+
Sbjct: 217 PESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELL 276

Query: 281 D-----------PILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTN 324
                       P  ++ Y           I   C   + + RP+  D+   +  
Sbjct: 277 KNNGRLPRPDGCP--DEIY----------MIMTECWNNNVNQRPSFRDLALRVDQ 319

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  169 bits (430), Expect = 5e-50
 Identities = 82/294 (27%), Positives = 123/294 (41%), Gaps = 47/294 (15%)

Query: 55  NKLGEGGFGPVYKGVLK-----KGDEIAVKRL-SGRSGQGLREMKNEASVIAKVQHKNLV 108
             LGEG FG V            G+ +AVK L +    Q     K E  ++  + H++++
Sbjct: 37  RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHII 96

Query: 109 RLLGCCIDRDEK--ILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQ 166
           +  GCC D       L+ EY+P  SL  +L     R  +     +   + I +G+ YLH 
Sbjct: 97  KYKGCCEDAGAASLQLVMEYVPLGSLRDYL----PRHSIGLAQLLLFAQQICEGMAYLHA 152

Query: 167 YSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG-----YMS 221
                 IHRDL A N+LLD D   KI DFG+A+              V   G     + +
Sbjct: 153 ---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYR----VREDGDSPVFWYA 205

Query: 222 PEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELID 281
           PE   E  F   SDV+SFGV L E+++   ++    T  L L+G A    T  R  EL++
Sbjct: 206 PECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLE 265

Query: 282 -----------PILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTN 324
                      P   + Y          ++   C +  A  RPT  +++ +L  
Sbjct: 266 RGERLPRPDKCP--AEVY----------HLMKNCWETEASFRPTFENLIPILKT 307

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  168 bits (428), Expect = 7e-50
 Identities = 63/290 (21%), Positives = 121/290 (41%), Gaps = 41/290 (14%)

Query: 55  NKLGEGGFGPVYKGVLK-----KGDEIAVKRL-SGRSGQGLREMKNEASVIAKVQHKNLV 108
             LGEG FG V            G+++AVK L     G  + ++K E  ++  + H+N+V
Sbjct: 27  RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 86

Query: 109 RLLGCCIDRDEK--ILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQ 166
           +  G C +       LI E++P+ SL  +L  P  +  ++   +++    I +G+ YL  
Sbjct: 87  KYKGICTEDGGNGIKLIMEFLPSGSLKEYL--PKNKNKINLKQQLKYAVQICKGMDYL-- 142

Query: 167 YSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG------YM 220
               + +HRDL A N+L++ +   KI DFG+ +      ++ +               + 
Sbjct: 143 -GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKA-----IETDKEYYTVKDDRDSPVFWY 196

Query: 221 SPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDLWTSNRTLEL 279
           +PE  ++  F I SDV+SFGV L E+++    ++         +        T  R +  
Sbjct: 197 APECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQ-MTVTRLVNT 255

Query: 280 ID-------PILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSML 322
           +        P         ++   Y  +   C +    +R +  +++   
Sbjct: 256 LKEGKRLPCP----PNCPDEV---Y-QLMRKCWEFQPSNRTSFQNLIEGF 297

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  168 bits (428), Expect = 1e-49
 Identities = 79/321 (24%), Positives = 134/321 (41%), Gaps = 48/321 (14%)

Query: 55  NKLGEGGFGPVYKGVLK-----KGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVR 109
           ++LG+G FG V            G  +AVK+L        R+ + E  ++  +    +V+
Sbjct: 29  SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVK 88

Query: 110 LLGCCIDRDEK--ILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQY 167
             G       +   L+ EY+P+  L  FL     R  LD    +     I +G+ YL   
Sbjct: 89  YRGVSYGPGRQSLRLVMEYLPSGCLRDFL--QRHRARLDASRLLLYSSQICKGMEYLGS- 145

Query: 168 SRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG------YMS 221
              R +HRDL A NIL++ + + KI+DFG+A++     L  +    V          + +
Sbjct: 146 --RRCVHRDLAARNILVESEAHVKIADFGLAKL-----LPLDKDYYVVREPGQSPIFWYA 198

Query: 222 PEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDLWTSNRTLELI 280
           PE   + IFS +SDV+SFGV+L E+ +   K+      + L ++G   D+   +R LEL+
Sbjct: 199 PESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPS-AEFLRMMGCERDVPALSRLLELL 257

Query: 281 D-----------PILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNEAATL 329
           +           P   + +           +  LC   S  DRP+ + +   L    +  
Sbjct: 258 EEGQRLPAPPACP--AEVH----------ELMKLCWAPSPQDRPSFSALGPQLDMLWSGS 305

Query: 330 LPPKQPAFSYVRNTVTSTSST 350
              +  AF+        + S 
Sbjct: 306 RGCETHAFTAHPEGKHHSLSF 326

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  166 bits (422), Expect = 9e-49
 Identities = 68/213 (31%), Positives = 110/213 (51%), Gaps = 31/213 (14%)

Query: 55  NKLGEGGFGPVYKGVLKKGDE-----IAVKRL-SGRSGQGLREMKNEASVIAKVQHKNLV 108
             LG G FG VYKG+     E     +A+K L    S +  +E+ +EA V+A V + ++ 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80

Query: 109 RLLGCCIDRDEKILIYEYMPNKSLDFFLFDP----TKRMLLDWVTRVQIIEGIAQGLLYL 164
           RLLG C+      LI + MP   L  ++ +       + LL+W         IA+G+ YL
Sbjct: 81  RLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCV------QIAKGMNYL 133

Query: 165 HQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG-----Y 219
                 R++HRDL A N+L+    + KI+DFG+A++ G  E + +        G     +
Sbjct: 134 ---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG-----GKVPIKW 185

Query: 220 MSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKK 251
           M+ E  L  I++ +SDV+S+GV + E+++ G K
Sbjct: 186 MALESILHRIYTHQSDVWSYGVTVWELMTFGSK 218

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  167 bits (426), Expect = 4e-48
 Identities = 62/197 (31%), Positives = 105/197 (53%), Gaps = 17/197 (8%)

Query: 55  NKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCC 114
             +G+G FG V  G  + G+++AVK +  ++    +    EASV+ +++H NLV+LLG  
Sbjct: 199 QTIGKGEFGDVMLGDYR-GNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLLGVI 255

Query: 115 IDRDEKI-LIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRII 173
           ++    + ++ EYM   SL  +L    + +L      ++    + + + YL        +
Sbjct: 256 VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVL-GGDCLLKFSLDVCEAMEYL---EGNNFV 311

Query: 174 HRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGY--MSPEYALEGIFS 231
           HRDL A N+L+ +D   K+SDFG+ +       +A++++  G       +PE   E  FS
Sbjct: 312 HRDLAARNVLVSEDNVAKVSDFGLTK-------EASSTQDTGKLPVKWTAPEALREKKFS 364

Query: 232 IKSDVFSFGVLLLEIVS 248
            KSDV+SFG+LL EI S
Sbjct: 365 TKSDVWSFGILLWEIYS 381

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  164 bits (418), Expect = 4e-48
 Identities = 63/205 (30%), Positives = 107/205 (52%), Gaps = 21/205 (10%)

Query: 55  NKLGEGGFGPVYKGVLKKGDE----IAVKRL-SGRSGQGLREMKNEASVIAKVQHKNLVR 109
             +G G  G V  G L+   +    +A+K L +G + +  R+  +EAS++ +  H N++R
Sbjct: 55  KIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIR 114

Query: 110 LLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSR 169
           L G        +++ EYM N SLD FL     +     +  V ++ G+  G+ YL   S 
Sbjct: 115 LEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQ--FTIMQLVGMLRGVGAGMRYL---SD 169

Query: 170 VRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG------YMSPE 223
           +  +HRDL A N+L+D ++  K+SDFG++R+   +   A T+      G      + +PE
Sbjct: 170 LGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTT-----GGKIPIRWTAPE 224

Query: 224 YALEGIFSIKSDVFSFGVLLLEIVS 248
                 FS  SDV+SFGV++ E+++
Sbjct: 225 AIAFRTFSSASDVWSFGVVMWEVLA 249

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  164 bits (418), Expect = 4e-48
 Identities = 63/205 (30%), Positives = 107/205 (52%), Gaps = 22/205 (10%)

Query: 56  KLGEGGFGPVYKGVLKKGDE-----IAVKRL-SGRSGQGLREMKNEASVIAKVQHKNLVR 109
            +G G FG VYKG+LK         +A+K L +G + +   +   EA ++ +  H N++R
Sbjct: 51  VIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIR 110

Query: 110 LLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSR 169
           L G        ++I EYM N +LD FL +         +  V ++ GIA G+ YL   + 
Sbjct: 111 LEGVISKYKPMMIITEYMENGALDKFLREKDGE--FSVLQLVGMLRGIAAGMKYL---AN 165

Query: 170 VRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG------YMSPE 223
           +  +HRDL A NIL++ ++  K+SDFG++R+   +     T+      G      + +PE
Sbjct: 166 MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTS-----GGKIPIRWTAPE 220

Query: 224 YALEGIFSIKSDVFSFGVLLLEIVS 248
                 F+  SDV+SFG+++ E+++
Sbjct: 221 AISYRKFTSASDVWSFGIVMWEVMT 245

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  162 bits (413), Expect = 4e-48
 Identities = 65/198 (32%), Positives = 104/198 (52%), Gaps = 15/198 (7%)

Query: 55  NKLGEGGFGPVYKGVLKKGDEIAVKRL-SGRSGQGLREMKNEASVIAKVQHKNLVRLLGC 113
            ++G G FG V+ G     D++A+K +  G   +   +   EA V+ K+ H  LV+L G 
Sbjct: 14  QEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE--EDFIEEAEVMMKLSHPKLVQLYGV 71

Query: 114 CIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRII 173
           C+++    L+ E+M +  L  +L   T+R L    T + +   + +G+ YL       +I
Sbjct: 72  CLEQAPICLVTEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYL---EEACVI 126

Query: 174 HRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT---YGYMSPEYALEGIF 230
           HRDL A N L+ ++   K+SDFGM R    ++  ++T    GT     + SPE      +
Sbjct: 127 HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST----GTKFPVKWASPEVFSFSRY 182

Query: 231 SIKSDVFSFGVLLLEIVS 248
           S KSDV+SFGVL+ E+ S
Sbjct: 183 SSKSDVWSFGVLMWEVFS 200

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  162 bits (413), Expect = 5e-48
 Identities = 64/197 (32%), Positives = 104/197 (52%), Gaps = 17/197 (8%)

Query: 55  NKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCC 114
             +G+G FG V  G  + G+++AVK +  ++    +    EASV+ +++H NLV+LLG  
Sbjct: 27  QTIGKGEFGDVMLGDYR-GNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLLGVI 83

Query: 115 IDRDEKILI-YEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRII 173
           ++    + I  EYM   SL  +L     R +L     ++    + + + YL        +
Sbjct: 84  VEEKGGLYIVTEYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYL---EGNNFV 139

Query: 174 HRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGY--MSPEYALEGIFS 231
           HRDL A N+L+ +D   K+SDFG+ +       +A++++  G       +PE   E  FS
Sbjct: 140 HRDLAARNVLVSEDNVAKVSDFGLTK-------EASSTQDTGKLPVKWTAPEALREKKFS 192

Query: 232 IKSDVFSFGVLLLEIVS 248
            KSDV+SFG+LL EI S
Sbjct: 193 TKSDVWSFGILLWEIYS 209

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  162 bits (413), Expect = 8e-48
 Identities = 71/288 (24%), Positives = 119/288 (41%), Gaps = 52/288 (18%)

Query: 55  NKLGEGGFGPVYKGVLKKGDE----IAVKRL-SGRSGQGLREMKNEASVIAKVQHKNLVR 109
             +G G FG VY G L   D      AVK L        + +   E  ++    H N++ 
Sbjct: 31  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 90

Query: 110 LLGCCIDRDEKIL-IYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYS 168
           LLG C+  +   L +  YM +  L  F+ +            +     +A+G+ YL   +
Sbjct: 91  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNE--THNPTVKDLIGFGLQVAKGMKYL---A 145

Query: 169 RVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG------YMSP 222
             + +HRDL A N +LD+    K++DFG+AR    +        +    G      +M+ 
Sbjct: 146 SKKFVHRDLAARNCMLDEKFTVKVADFGLAR----DMYDKEYYSVHNKTGAKLPVKWMAL 201

Query: 223 EYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYA--WDLWTSNRTLELI 280
           E      F+ KSDV+SFGVLL E+++                G     D+  +    ++ 
Sbjct: 202 ESLQTQKFTTKSDVWSFGVLLWELMT---------------RGAPPYPDV--NTF--DIT 242

Query: 281 DPILED------EYSSKQMLLRYANIALLCVQESADDRPTMNDVVSML 322
             +L+       EY    +   Y  + L C    A+ RP+ +++VS +
Sbjct: 243 VYLLQGRRLLQPEYCPDPL---Y-EVMLKCWHPKAEMRPSFSELVSRI 286

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  161 bits (411), Expect = 1e-47
 Identities = 83/305 (27%), Positives = 126/305 (41%), Gaps = 68/305 (22%)

Query: 55  NKLGEGGFGPVYKGVLKKGDE------IAVKRL-SGRSGQGLREMKNEASVIAKVQHKNL 107
            +LGE  FG VYKG L           +A+K L     G    E ++EA + A++QH N+
Sbjct: 15  EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNV 74

Query: 108 VRLLGCCIDRDEKILIYEYMPNKSLDFFL-------------FDPTKRMLLDWVTRVQII 154
           V LLG         +I+ Y  +  L  FL              D T +  L+    V ++
Sbjct: 75  VCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLV 134

Query: 155 EGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIV 214
             IA G+ YL   S   ++H+DL   N+L+   +N KISD G+ R     E+ A     +
Sbjct: 135 AQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFR-----EVYAADYYKL 186

Query: 215 GTYG-----YMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYA-- 267
                    +M+PE  + G FSI SD++S+GV+L E+ S                G    
Sbjct: 187 LGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS---------------YGLQPY 231

Query: 268 WDLWTSNRTLELIDPILEDEYSSKQMLLR--------YANIALLCVQESADDRPTMNDVV 319
                SN+  ++++ I        Q+L          Y  + + C  E    RP   D+ 
Sbjct: 232 CGY--SNQ--DVVEMIRNR-----QVLPCPDDCPAWVY-ALMIECWNEFPSRRPRFKDIH 281

Query: 320 SMLTN 324
           S L  
Sbjct: 282 SRLRA 286

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  161 bits (409), Expect = 3e-47
 Identities = 59/198 (29%), Positives = 97/198 (48%), Gaps = 15/198 (7%)

Query: 55  NKLGEGGFGPVYKGVLKKGDEIAVKRL-SGRSGQGLREMKNEASVIAKVQHKNLVRLLGC 113
            +LG G FG V  G  +   ++A+K +  G   +   E   EA V+  + H+ LV+L G 
Sbjct: 30  KELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE--DEFIEEAKVMMNLSHEKLVQLYGV 87

Query: 114 CIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRII 173
           C  +    +I EYM N  L  +L     R        +++ + + + + YL      + +
Sbjct: 88  CTKQRPIFIITEYMANGCLLNYL--REMRHRFQTQQLLEMCKDVCEAMEYL---ESKQFL 142

Query: 174 HRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT---YGYMSPEYALEGIF 230
           HRDL A N L++     K+SDFG++R    +E  ++     G+     +  PE  +   F
Sbjct: 143 HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSV----GSKFPVRWSPPEVLMYSKF 198

Query: 231 SIKSDVFSFGVLLLEIVS 248
           S KSD+++FGVL+ EI S
Sbjct: 199 SSKSDIWAFGVLMWEIYS 216

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  162 bits (411), Expect = 4e-47
 Identities = 83/332 (25%), Positives = 134/332 (40%), Gaps = 71/332 (21%)

Query: 55  NKLGEGGFGPVYKGVLKKGDE---IAVKRL-SGRSGQGLREMKNEASVIAKV-QHKNLVR 109
           + +GEG FG V K  +KK       A+KR+    S    R+   E  V+ K+  H N++ 
Sbjct: 31  DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 90

Query: 110 LLGCCIDRDEKILIYEYMPNKSLDFFL-------------FDPTKRMLLDWVTRVQIIEG 156
           LLG C  R    L  EY P+ +L  FL                +    L     +     
Sbjct: 91  LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 150

Query: 157 IAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTS----- 211
           +A+G+ YL   S+ + IHRDL A NIL+ ++   KI+DFG++R  G       T      
Sbjct: 151 VARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR--GQEVYVKKTMGRLPV 205

Query: 212 RIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLG---YAW 268
           R      +M+ E     +++  SDV+S+GVLL EIVS               LG   Y  
Sbjct: 206 R------WMAIESLNYSVYTTNSDVWSYGVLLWEIVS---------------LGGTPY-C 243

Query: 269 DLWTSNRTLELIDPILED------EYSSKQMLLRYANIALLCVQESADDRPTMNDVVS-- 320
            +  +    EL + + +            ++   Y ++   C +E   +RP+   ++   
Sbjct: 244 GM--TCA--ELYEKLPQGYRLEKPLNCDDEV---Y-DLMRQCWREKPYERPSFAQILVSL 295

Query: 321 --MLTNEAATLLPPKQPAFSYVRNTVTSTSST 350
             ML      +       F+Y     ++  + 
Sbjct: 296 NRMLEERKTYVNTTLYEKFTYAGIDCSAEEAA 327

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  163 bits (414), Expect = 4e-47
 Identities = 68/202 (33%), Positives = 107/202 (52%), Gaps = 15/202 (7%)

Query: 55  NKLGEGGFGPVYKGVLKKGDE----IAVKRL-SGRSGQGLREMKNEASVIAKVQHKNLVR 109
             +G G FG V  G LK   +    +A+K L  G + +  R+   EAS++ +  H N++R
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110

Query: 110 LLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSR 169
           L G        +++ EYM N SLD FL     +     +  V ++ GIA G+ YL   S 
Sbjct: 111 LEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQ--FTVIQLVGMLRGIASGMKYL---SD 165

Query: 170 VRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT---YGYMSPEYAL 226
           +  +HRDL A NIL++ ++  K+SDFG+ R+   +   A T+R  G      + SPE   
Sbjct: 166 MGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTR--GGKIPIRWTSPEAIA 223

Query: 227 EGIFSIKSDVFSFGVLLLEIVS 248
              F+  SDV+S+G++L E++S
Sbjct: 224 YRKFTSASDVWSYGIVLWEVMS 245

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  161 bits (409), Expect = 4e-47
 Identities = 63/218 (28%), Positives = 103/218 (47%), Gaps = 32/218 (14%)

Query: 55  NKLGEGGFGPVYKGVLKKGDE------IAVKRLSGRSGQGLREMKNEASVIAKVQHKNLV 108
            +LGEG FG V+               +AVK L   +    ++ + EA ++  +QH+++V
Sbjct: 21  RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIV 80

Query: 109 RLLGCCIDRDEKILIYEYMPNKSLDFFL-------------FDPTKRMLLDWVTRVQIIE 155
           +  G C D D  I+++EYM +  L+ FL                  +  L     + I  
Sbjct: 81  KFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 140

Query: 156 GIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVG 215
            IA G++YL   +    +HRDL   N L+  ++  KI DFGM+R     ++ +     VG
Sbjct: 141 QIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSR-----DVYSTDYYRVG 192

Query: 216 TYG-----YMSPEYALEGIFSIKSDVFSFGVLLLEIVS 248
            +      +M PE  +   F+ +SDV+SFGV+L EI +
Sbjct: 193 GHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT 230

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  161 bits (410), Expect = 5e-47
 Identities = 61/217 (28%), Positives = 102/217 (47%), Gaps = 31/217 (14%)

Query: 55  NKLGEGGFGPVYKGVLKKGDE------IAVKRLSGRSGQGLREMKNEASVIAKVQHKNLV 108
            +LGEG FG V+               +AVK L   S    ++ + EA ++  +QH+++V
Sbjct: 47  WELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIV 106

Query: 109 RLLGCCIDRDEKILIYEYMPNKSLDFFL------------FDPTKRMLLDWVTRVQIIEG 156
           R  G C +    ++++EYM +  L+ FL             +      L     + +   
Sbjct: 107 RFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQ 166

Query: 157 IAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT 216
           +A G++YL   + +  +HRDL   N L+ + +  KI DFGM+R     ++ +     VG 
Sbjct: 167 VAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSR-----DIYSTDYYRVGG 218

Query: 217 YG-----YMSPEYALEGIFSIKSDVFSFGVLLLEIVS 248
                  +M PE  L   F+ +SDV+SFGV+L EI +
Sbjct: 219 RTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFT 255

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  159 bits (405), Expect = 8e-47
 Identities = 73/198 (36%), Positives = 107/198 (54%), Gaps = 15/198 (7%)

Query: 55  NKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLRE-MKNEASVIAKVQHKNLVRLLGC 113
            +LG G FG V+ G      ++AVK L  + G    +    EA+++ ++QH+ LVRL   
Sbjct: 19  ERLGAGQFGEVWMGYYNGHTKVAVKSL--KQGSMSPDAFLAEANLMKQLQHQRLVRLYAV 76

Query: 114 CIDRDEKILI-YEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRI 172
                E I I  EYM N SL  FL  P   + L     + +   IA+G+ ++        
Sbjct: 77  VTQ--EPIYIITEYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFI---EERNY 130

Query: 173 IHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGY--MSPEYALEGIF 230
           IHRDL+A+NIL+   ++ KI+DFG+AR+   NE    T+R    +     +PE    G F
Sbjct: 131 IHRDLRAANILVSDTLSCKIADFGLARLIEDNEY---TAREGAKFPIKWTAPEAINYGTF 187

Query: 231 SIKSDVFSFGVLLLEIVS 248
           +IKSDV+SFG+LL EIV+
Sbjct: 188 TIKSDVWSFGILLTEIVT 205

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  164 bits (417), Expect = 8e-47
 Identities = 66/197 (33%), Positives = 100/197 (50%), Gaps = 13/197 (6%)

Query: 55  NKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCC 114
            KLG G FG V+     K  ++AVK +       +     EA+V+  +QH  LV+L    
Sbjct: 194 KKLGAGQFGEVWMATYNKHTKVAVKTMK-PGSMSVEAFLAEANVMKTLQHDKLVKLHAVV 252

Query: 115 IDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 174
             ++   +I E+M   SL  FL    +         +     IA+G+ ++    +   IH
Sbjct: 253 T-KEPIYIITEFMAKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFI---EQRNYIH 307

Query: 175 RDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT---YGYMSPEYALEGIFS 231
           RDL+A+NIL+   +  KI+DFG+AR+   NE  A      G      + +PE    G F+
Sbjct: 308 RDLRAANILVSASLVCKIADFGLARVIEDNEYTARE----GAKFPIKWTAPEAINFGSFT 363

Query: 232 IKSDVFSFGVLLLEIVS 248
           IKSDV+SFG+LL+EIV+
Sbjct: 364 IKSDVWSFGILLMEIVT 380

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  159 bits (405), Expect = 8e-47
 Identities = 59/197 (29%), Positives = 98/197 (49%), Gaps = 15/197 (7%)

Query: 56  KLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLRE-MKNEASVIAKVQHKNLVRLLGCC 114
           +LG G FG V  G  K   ++AVK +  + G    +    EA  + K+ H  LV+  G C
Sbjct: 15  ELGSGQFGVVKLGKWKGQYDVAVKMI--KEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVC 72

Query: 115 IDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 174
                  ++ EY+ N  L  +L   +    L+    +++   + +G+ +L      + IH
Sbjct: 73  SKEYPIYIVTEYISNGCLLNYL--RSHGKGLEPSQLLEMCYDVCEGMAFL---ESHQFIH 127

Query: 175 RDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT---YGYMSPEYALEGIFS 231
           RDL A N L+D+D+  K+SDFGM R    ++  ++     GT     + +PE      +S
Sbjct: 128 RDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSV----GTKFPVKWSAPEVFHYFKYS 183

Query: 232 IKSDVFSFGVLLLEIVS 248
            KSDV++FG+L+ E+ S
Sbjct: 184 SKSDVWAFGILMWEVFS 200

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  160 bits (406), Expect = 8e-47
 Identities = 56/203 (27%), Positives = 94/203 (46%), Gaps = 21/203 (10%)

Query: 56  KLGEGGFGPVYKGVLKKGDE---IAVKRL-SGRSGQGLREMKNEASVIAKVQHKNLVRLL 111
           +LG G FG V +GV +   +   +A+K L  G       EM  EA ++ ++ +  +VRL+
Sbjct: 17  ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 76

Query: 112 GCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVR 171
           G C   +  +L+ E      L  FL    +   +      +++  ++ G+ YL       
Sbjct: 77  GVC-QAEALMLVMEMAGGGPLHKFLVGKREE--IPVSNVAELLHQVSMGMKYL---EEKN 130

Query: 172 IIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG------YMSPEYA 225
            +HRDL A N+LL      KISDFG+++  G ++                   + +PE  
Sbjct: 131 FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARS-----AGKWPLKWYAPECI 185

Query: 226 LEGIFSIKSDVFSFGVLLLEIVS 248
               FS +SDV+S+GV + E +S
Sbjct: 186 NFRKFSSRSDVWSYGVTMWEALS 208

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  160 bits (407), Expect = 9e-47
 Identities = 54/205 (26%), Positives = 91/205 (44%), Gaps = 19/205 (9%)

Query: 55  NKLGEGGFGPVYKGVLKKGDE----IAVKRL-SGRSGQGLREMKNEASVIAKVQHKNLVR 109
             +G+G FG VY G      +     A+K L      Q +     E  ++  + H N++ 
Sbjct: 27  RVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLA 86

Query: 110 LLGCCIDRDEKILI-YEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYS 168
           L+G  +  +    +   YM +  L  F+  P  +        +     +A+G+ YL   +
Sbjct: 87  LIGIMLPPEGLPHVLLPYMCHGDLLQFIRSP--QRNPTVKDLISFGLQVARGMEYL---A 141

Query: 169 RVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG-----YMSPE 223
             + +HRDL A N +LD+    K++DFG+AR     E     S     +      + + E
Sbjct: 142 EQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREY---YSVQQHRHARLPVKWTALE 198

Query: 224 YALEGIFSIKSDVFSFGVLLLEIVS 248
                 F+ KSDV+SFGVLL E+++
Sbjct: 199 SLQTYRFTTKSDVWSFGVLLWELLT 223

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  160 bits (406), Expect = 9e-47
 Identities = 69/199 (34%), Positives = 105/199 (52%), Gaps = 15/199 (7%)

Query: 55  NKLGEGGFGPVYKGVLKKGD-EIAVKRL-SGRSGQGLREMKNEASVIAKVQHKNLVRLLG 112
           +KLG G +G VY+GV KK    +AVK L          E   EA+V+ +++H NLV+LLG
Sbjct: 19  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV--EEFLKEAAVMKEIKHPNLVQLLG 76

Query: 113 CCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRI 172
            C       +I E+M   +L  +L +   R  +  V  + +   I+  + YL    +   
Sbjct: 77  VCTREPPFYIITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYL---EKKNF 132

Query: 173 IHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT---YGYMSPEYALEGI 229
           IHRDL A N L+ ++   K++DFG++R+  G+   A+     G      + +PE      
Sbjct: 133 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA----GAKFPIKWTAPESLAYNK 188

Query: 230 FSIKSDVFSFGVLLLEIVS 248
           FSIKSDV++FGVLL EI +
Sbjct: 189 FSIKSDVWAFGVLLWEIAT 207

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  164 bits (418), Expect = 1e-46
 Identities = 67/195 (34%), Positives = 107/195 (54%), Gaps = 7/195 (3%)

Query: 55  NKLGEGGFGPVYKGVLKKGD-EIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGC 113
           +KLG G +G VY+GV KK    +AVK L   + + + E   EA+V+ +++H NLV+LLG 
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 284

Query: 114 CIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRII 173
           C       +I E+M   +L  +L +   R  +  V  + +   I+  + YL    +   I
Sbjct: 285 CTREPPFYIITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYL---EKKNFI 340

Query: 174 HRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIK 233
           HR+L A N L+ ++   K++DFG++R+  G+   A+         + +PE      FSIK
Sbjct: 341 HRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF-PIKWTAPESLAYNKFSIK 399

Query: 234 SDVFSFGVLLLEIVS 248
           SDV++FGVLL EI +
Sbjct: 400 SDVWAFGVLLWEIAT 414

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  161 bits (408), Expect = 3e-46
 Identities = 71/287 (24%), Positives = 121/287 (42%), Gaps = 50/287 (17%)

Query: 55  NKLGEGGFGPVYKGVLKKGDE----IAVKRL-SGRSGQGLREMKNEASVIAKVQHKNLVR 109
             +G G FG VY G L   D      AVK L        + +   E  ++    H N++ 
Sbjct: 95  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 154

Query: 110 LLGCCIDRDEKIL-IYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYS 168
           LLG C+  +   L +  YM +  L  F+ +            +     +A+G+ +L   +
Sbjct: 155 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNE--THNPTVKDLIGFGLQVAKGMKFL---A 209

Query: 169 RVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG-----YMSPE 223
             + +HRDL A N +LD+    K++DFG+AR     E  +  ++   T       +M+ E
Sbjct: 210 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNK---TGAKLPVKWMALE 266

Query: 224 YALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYA--WDLWTSNRTLELID 281
                 F+ KSDV+SFGVLL E+++                G     D+  +    ++  
Sbjct: 267 SLQTQKFTTKSDVWSFGVLLWELMT---------------RGAPPYPDV--NTF--DITV 307

Query: 282 PILED------EYSSKQMLLRYANIALLCVQESADDRPTMNDVVSML 322
            +L+       EY    +   Y  + L C    A+ RP+ +++VS +
Sbjct: 308 YLLQGRRLLQPEYCPDPL---Y-EVMLKCWHPKAEMRPSFSELVSRI 350

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  159 bits (404), Expect = 5e-46
 Identities = 66/209 (31%), Positives = 108/209 (51%), Gaps = 30/209 (14%)

Query: 55  NKLGEGGFGPVYKGVLKKGDE-----IAVKRL-SGRSGQGLREMKNEASVIAKVQHKNLV 108
             LG G FG VYKG+     E     +A+K L    S +  +E+ +EA V+A V + ++ 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80

Query: 109 RLLGCCIDRDEKILIYEYMPNKSLDFFLFDP----TKRMLLDWVTRVQIIEGIAQGLLYL 164
           RLLG C+      LI + MP   L  ++ +       + LL+W         IA+G+ YL
Sbjct: 81  RLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCV------QIAKGMNYL 133

Query: 165 HQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG-----Y 219
                 R++HRDL A N+L+    + KI+DFG+A++ G  E + +        G     +
Sbjct: 134 ---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG-----GKVPIKW 185

Query: 220 MSPEYALEGIFSIKSDVFSFGVLLLEIVS 248
           M+ E  L  I++ +SDV+S+GV + E+++
Sbjct: 186 MALESILHRIYTHQSDVWSYGVTVWELMT 214

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  158 bits (402), Expect = 7e-46
 Identities = 70/213 (32%), Positives = 97/213 (45%), Gaps = 27/213 (12%)

Query: 55  NKLGEGGFGPVYKGVLKKGD------EIAVKRL-SGRSGQGLREMKNEASVIAKVQHKNL 107
             LG G FG VY+G +          ++AVK L    S Q   +   EA +I+K  H+N+
Sbjct: 36  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 95

Query: 108 VRLLGCCIDRDEKILIYEYMPNKSLDFFL----FDPTKRMLLDWVTRVQIIEGIAQGLLY 163
           VR +G  +    + ++ E M    L  FL      P++   L  +  + +   IA G  Y
Sbjct: 96  VRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 155

Query: 164 LHQYSRVRIIHRDLKASNILLDK---DMNPKISDFGMARICGGNELQANTSRIVGTYGY- 219
           L        IHRD+ A N LL         KI DFGMAR     ++   +    G     
Sbjct: 156 L---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR-----DIYRASYYRKGGCAML 207

Query: 220 ----MSPEYALEGIFSIKSDVFSFGVLLLEIVS 248
               M PE  +EGIF+ K+D +SFGVLL EI S
Sbjct: 208 PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  158 bits (402), Expect = 8e-46
 Identities = 67/213 (31%), Positives = 100/213 (46%), Gaps = 27/213 (12%)

Query: 55  NKLGEGGFGPVYKGVLKKGDE------IAVKRL-SGRSGQGLREMKNEASVIAKVQHKNL 107
            +LG+G FG VY+GV K   +      +A+K +    S +   E  NEASV+ +    ++
Sbjct: 31  RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 90

Query: 108 VRLLGCCIDRDEKILIYEYMPNKSLDFFL-------FDPTKRMLLDWVTRVQIIEGIAQG 160
           VRLLG        ++I E M    L  +L        +            +Q+   IA G
Sbjct: 91  VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADG 150

Query: 161 LLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGY- 219
           + YL   +  + +HRDL A N ++ +D   KI DFGM R     ++        G  G  
Sbjct: 151 MAYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTR-----DIYETDYYRKGGKGLL 202

Query: 220 ----MSPEYALEGIFSIKSDVFSFGVLLLEIVS 248
               MSPE   +G+F+  SDV+SFGV+L EI +
Sbjct: 203 PVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 235

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  158 bits (401), Expect = 9e-46
 Identities = 61/213 (28%), Positives = 104/213 (48%), Gaps = 27/213 (12%)

Query: 55  NKLGEGGFGPVYKGVLKKGDE----IAVKRL--SGRSGQGLREMKNEASVIAKVQHKNLV 108
             LGEG FG V +G LK+ D     +AVK +     S + + E  +EA+ +    H N++
Sbjct: 40  KILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVI 99

Query: 109 RLLGCCIDRD-----EKILIYEYMPNKSLDFFL---FDPTKRMLLDWVTRVQIIEGIAQG 160
           RLLG CI+       + ++I  +M    L  +L      T    +   T ++ +  IA G
Sbjct: 100 RLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALG 159

Query: 161 LLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG-- 218
           + YL   S    +HRDL A N +L  DM   ++DFG+++     ++ +      G     
Sbjct: 160 MEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSK-----KIYSGDYYRQGRIAKM 211

Query: 219 ---YMSPEYALEGIFSIKSDVFSFGVLLLEIVS 248
              +++ E   + +++ KSDV++FGV + EI +
Sbjct: 212 PVKWIAIESLADRVYTSKSDVWAFGVTMWEIAT 244

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  157 bits (398), Expect = 1e-45
 Identities = 60/294 (20%), Positives = 115/294 (39%), Gaps = 61/294 (20%)

Query: 56  KLGEGGFGPVYKGVLKKGD--------EIAVKRLSGRSGQGLREMKNEASVIAKVQHKNL 107
            LG+G F  ++KGV ++          E+ +K L              AS+++K+ HK+L
Sbjct: 15  SLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHL 74

Query: 108 VRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQY 167
           V   G C+  DE IL+ E++   SLD +L     +  ++ + ++++ + +A  + +L   
Sbjct: 75  VLNYGVCVCGDENILVQEFVKFGSLDTYLKK--NKNCINILWKLEVAKQLAAAMHFL--- 129

Query: 168 SRVRIIHRDLKASNILLDKDMNP--------KISDFGMARICGGNELQANTSRIVGTYGY 219
               +IH ++ A NILL ++ +         K+SD G++              ++     
Sbjct: 130 EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISIT------------VLPKDIL 177

Query: 220 ------MSPEYALEG-IFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYA--WDL 270
                 + PE        ++ +D +SFG  L EI S                G      L
Sbjct: 178 QERIPWVPPECIENPKNLNLATDKWSFGTTLWEICS---------------GGDKPLSAL 222

Query: 271 WTSNRTLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTN 324
              ++    +    +            AN+   C+    D RP+   ++  L +
Sbjct: 223 --DSQ--RKLQFYEDRHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNS 272

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  157 bits (400), Expect = 2e-45
 Identities = 58/210 (27%), Positives = 101/210 (48%), Gaps = 32/210 (15%)

Query: 55  NKLGEGGFGPVYKGVLKKGDE-----IAVKRLSGRSG-QGLREMKNEASVIAKVQHKNLV 108
             LG G FG V+KGV     E     + +K +  +SG Q  + + +    I  + H ++V
Sbjct: 19  KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 78

Query: 109 RLLGCCIDRDEKI-LIYEYMPNKSLDFFLFDP----TKRMLLDWVTRVQIIEGIAQGLLY 163
           RLLG C      + L+ +Y+P  SL   +         ++LL+W         IA+G+ Y
Sbjct: 79  RLLGLCPG--SSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGV------QIAKGMYY 130

Query: 164 LHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG----- 218
           L       ++HR+L A N+LL      +++DFG+A +   ++ Q   S            
Sbjct: 131 L---EEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSE-----AKTPIK 182

Query: 219 YMSPEYALEGIFSIKSDVFSFGVLLLEIVS 248
           +M+ E    G ++ +SDV+S+GV + E+++
Sbjct: 183 WMALESIHFGKYTHQSDVWSYGVTVWELMT 212

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  158 bits (402), Expect = 2e-45
 Identities = 70/213 (32%), Positives = 96/213 (45%), Gaps = 27/213 (12%)

Query: 55  NKLGEGGFGPVYKGVLKKGD------EIAVKRL-SGRSGQGLREMKNEASVIAKVQHKNL 107
             LG G FG VY+G +          ++AVK L    S Q   +   EA +I+K  H+N+
Sbjct: 77  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 136

Query: 108 VRLLGCCIDRDEKILIYEYMPNKSLDFFL----FDPTKRMLLDWVTRVQIIEGIAQGLLY 163
           VR +G  +    + ++ E M    L  FL      P++   L  +  + +   IA G  Y
Sbjct: 137 VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 196

Query: 164 LHQYSRVRIIHRDLKASNILLDK---DMNPKISDFGMARICGGNELQANTSRIVGTYGY- 219
           L        IHRD+ A N LL         KI DFGMAR     ++        G     
Sbjct: 197 L---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR-----DIYRAGYYRKGGCAML 248

Query: 220 ----MSPEYALEGIFSIKSDVFSFGVLLLEIVS 248
               M PE  +EGIF+ K+D +SFGVLL EI S
Sbjct: 249 PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 281

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  157 bits (398), Expect = 3e-45
 Identities = 71/323 (21%), Positives = 124/323 (38%), Gaps = 57/323 (17%)

Query: 55  NKLGEGGFGPVYKGVLKKGDE----IAVKRL--SGRSGQGLREMKNEASVIAKVQHKNLV 108
             LG+G FG V +  LK+ D     +AVK L     +   + E   EA+ + +  H ++ 
Sbjct: 29  RMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVA 88

Query: 109 RLLGCCIDRDEKI------LIYEYMPNKSLDFFLFD---PTKRMLLDWVTRVQIIEGIAQ 159
           +L+G  +    K       +I  +M +  L  FL           L   T V+ +  IA 
Sbjct: 89  KLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIAC 148

Query: 160 GLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG- 218
           G+ YL   S    IHRDL A N +L +DM   ++DFG++R     ++ +      G    
Sbjct: 149 GMEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSR-----KIYSGDYYRQGCASK 200

Query: 219 ----YMSPEYALEGIFSIKSDVFSFGVLLLEIVS-------GKKNTGLYRTDSLNLLGYA 267
               +++ E   + ++++ SDV++FGV + EI++       G +N  +Y           
Sbjct: 201 LPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIY----------- 249

Query: 268 WDLWTSNRTLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNEAA 327
            +       L+     +E+ Y          ++   C       RP+   +   L N   
Sbjct: 250 -NYLIGGNRLKQPPECMEEVY----------DLMYQCWSADPKQRPSFTCLRMELENILG 298

Query: 328 TLLPPKQPAFSYVRNTVTSTSST 350
            L            N   +    
Sbjct: 299 HLSVLSTSQDPLYINIERAHHHH 321

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  155 bits (395), Expect = 3e-45
 Identities = 57/208 (27%), Positives = 85/208 (40%), Gaps = 28/208 (13%)

Query: 56  KLGEGGFGPVYKGVLKKGD----EIAVKRL---SGRSGQGLREMKNEASVIAKVQHKNLV 108
           KLG+G FG V +G           +AVK L        + + +   E + +  + H+NL+
Sbjct: 25  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 84

Query: 109 RLLGCCIDRDEKI-LIYEYMPNKSLDFFLFDPTKR----MLLDWVTRVQIIEGIAQGLLY 163
           RL G  +     + ++ E  P  SL   L           L  +         +A+G+ Y
Sbjct: 85  RLYGVVLT--PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV------QVAEGMGY 136

Query: 164 LHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT---YGYM 220
           L      R IHRDL A N+LL      KI DFG+ R    N+              + + 
Sbjct: 137 L---ESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQE--HRKVPFAWC 191

Query: 221 SPEYALEGIFSIKSDVFSFGVLLLEIVS 248
           +PE      FS  SD + FGV L E+ +
Sbjct: 192 APESLKTRTFSHASDTWMFGVTLWEMFT 219

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  155 bits (394), Expect = 5e-45
 Identities = 51/211 (24%), Positives = 88/211 (41%), Gaps = 38/211 (18%)

Query: 56  KLGEGGFGPVYKGVLKKGDE----IAVKRL-SGRSGQGLREMKNEASVIAKVQHKNLVRL 110
            +GEG FG V++G+    +     +A+K   +  S     +   EA  + +  H ++V+L
Sbjct: 22  CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 81

Query: 111 LGCCIDRDEKILI-YEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSR 169
           +G   +    + I  E      L  FL    ++  LD  + +     ++  L YL     
Sbjct: 82  IGVITE--NPVWIIMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYL---ES 134

Query: 170 VRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGY---------- 219
            R +HRD+ A N+L+  +   K+ DFG++R    +              Y          
Sbjct: 135 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST-------------YYKASKGKLPI 181

Query: 220 --MSPEYALEGIFSIKSDVFSFGVLLLEIVS 248
             M+PE      F+  SDV+ FGV + EI+ 
Sbjct: 182 KWMAPESINFRRFTSASDVWMFGVCMWEILM 212

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  154 bits (392), Expect = 8e-45
 Identities = 53/214 (24%), Positives = 85/214 (39%), Gaps = 44/214 (20%)

Query: 56  KLGEGGFGPVYKGVLKKGDE----IAVKRL-SGRSGQGLREMKNEASVIAKVQHKNLVRL 110
            LGEG FG VY+GV          +AVK      +     +  +EA ++  + H ++V+L
Sbjct: 19  ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKL 78

Query: 111 LGCCIDRDEKILIYEYMPNKSLDFFL----FDPTKRMLLDWVTRVQIIEGIAQGLLYLHQ 166
           +G   + +   +I E  P   L  +L           L+ +         I + + YL  
Sbjct: 79  IGII-EEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSL------QICKAMAYL-- 129

Query: 167 YSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGY------- 219
              +  +HRD+   NIL+      K+ DFG++R     +             Y       
Sbjct: 130 -ESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDED-------------YYKASVTR 175

Query: 220 -----MSPEYALEGIFSIKSDVFSFGVLLLEIVS 248
                MSPE      F+  SDV+ F V + EI+S
Sbjct: 176 LPIKWMSPESINFRRFTTASDVWMFAVCMWEILS 209

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  161 bits (408), Expect = 1e-44
 Identities = 57/200 (28%), Positives = 95/200 (47%), Gaps = 15/200 (7%)

Query: 56  KLGEGGFGPVYKGVLKKGDE---IAVKRL-SGRSGQGLREMKNEASVIAKVQHKNLVRLL 111
           +LG G FG V +GV +   +   +A+K L  G       EM  EA ++ ++ +  +VRL+
Sbjct: 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 402

Query: 112 GCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVR 171
           G C   +  +L+ E      L  FL    KR  +      +++  ++ G+ YL       
Sbjct: 403 GVC-QAEALMLVMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYL---EEKN 456

Query: 172 IIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGT---YGYMSPEYALEG 228
            +HR+L A N+LL      KISDFG+++  G ++                + +PE     
Sbjct: 457 FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTAR--SAGKWPLKWYAPECINFR 514

Query: 229 IFSIKSDVFSFGVLLLEIVS 248
            FS +SDV+S+GV + E +S
Sbjct: 515 KFSSRSDVWSYGVTMWEALS 534

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  159 bits (404), Expect = 2e-44
 Identities = 79/278 (28%), Positives = 127/278 (45%), Gaps = 42/278 (15%)

Query: 55  NKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLRE-MKNEASVIAKVQHKNLVRLLGC 113
            KLG+G FG V+ G       +A+K L  + G    E    EA V+ K++H+ LV+L   
Sbjct: 273 VKLGQGCFGEVWMGTWNGTTRVAIKTL--KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 330

Query: 114 CIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRII 173
             +    I + EYM   SL  FL        L     V +   IA G+ Y+    R+  +
Sbjct: 331 VSEEPIYI-VTEYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYV---ERMNYV 385

Query: 174 HRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIK 233
           HRDL+A+NIL+ +++  K++DFG+AR+   NE  A          + +PE AL G F+IK
Sbjct: 386 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIK 444

Query: 234 SDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELID-------PIL-- 284
           SDV+SFG+LL E+             +   + Y      +   L+ ++       P    
Sbjct: 445 SDVWSFGILLTELT------------TKGRVPYPG--MVNREVLDQVERGYRMPCPPECP 490

Query: 285 EDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSML 322
           E  +          ++   C ++  ++RPT   + + L
Sbjct: 491 ESLH----------DLMCQCWRKEPEERPTFEYLQAFL 518

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  154 bits (392), Expect = 2e-44
 Identities = 62/221 (28%), Positives = 100/221 (45%), Gaps = 35/221 (15%)

Query: 55  NKLGEGGFGPVYKGVLKKGDE------IAVKRL-SGRSGQGLREMKNEASVIAKV-QHKN 106
             LG G FG V +      D+      +AVK L  G +    R + +E  ++  +  H N
Sbjct: 33  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 92

Query: 107 LVRLLGCCIDRDEKI-LIYEYMPNKSLDFFL-------------FDPTKRMLLDWVTRVQ 152
           +V LLG C      + +I E+    +L  +L              +   +  L     + 
Sbjct: 93  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 152

Query: 153 IIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR 212
               +A+G+ +L   +  + IHRDL A NILL +    KI DFG+AR     ++  +   
Sbjct: 153 YSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR-----DIYKDPDY 204

Query: 213 IVGTYG-----YMSPEYALEGIFSIKSDVFSFGVLLLEIVS 248
           +          +M+PE   + +++I+SDV+SFGVLL EI S
Sbjct: 205 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  157 bits (400), Expect = 2e-44
 Identities = 70/195 (35%), Positives = 104/195 (53%), Gaps = 9/195 (4%)

Query: 55  NKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLRE-MKNEASVIAKVQHKNLVRLLGC 113
            KLG+G FG V+ G       +A+K L  + G    E    EA V+ K++H+ LV+L   
Sbjct: 190 VKLGQGCFGEVWMGTWNGTTRVAIKTL--KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 247

Query: 114 CIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRII 173
             +    I + EYM   SL  FL        L     V +   IA G+ Y+    R+  +
Sbjct: 248 VSEEPIYI-VTEYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYV---ERMNYV 302

Query: 174 HRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIK 233
           HRDL+A+NIL+ +++  K++DFG+AR+   NE  A          + +PE AL G F+IK
Sbjct: 303 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIK 361

Query: 234 SDVFSFGVLLLEIVS 248
           SDV+SFG+LL E+ +
Sbjct: 362 SDVWSFGILLTELTT 376

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  153 bits (388), Expect = 4e-44
 Identities = 58/204 (28%), Positives = 98/204 (48%), Gaps = 23/204 (11%)

Query: 56  KLGEGGFGPVYKGVLKKGD---EIAVKRL-SGRSGQGLR-EMKNEASVIAKVQHKNLVRL 110
           +LG G FG V KG  +       +AVK L +  +   L+ E+  EA+V+ ++ +  +VR+
Sbjct: 24  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83

Query: 111 LGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRV 170
           +G C + +  +L+ E      L+ +L    +   +     ++++  ++ G+ YL      
Sbjct: 84  IGIC-EAESWMLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQVSMGMKYL---EES 136

Query: 171 RIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG------YMSPEY 224
             +HRDL A N+LL      KISDFG+++    +E                   + +PE 
Sbjct: 137 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQT-----HGKWPVKWYAPEC 191

Query: 225 ALEGIFSIKSDVFSFGVLLLEIVS 248
                FS KSDV+SFGVL+ E  S
Sbjct: 192 INYYKFSSKSDVWSFGVLMWEAFS 215

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  153 bits (388), Expect = 6e-44
 Identities = 67/228 (29%), Positives = 103/228 (45%), Gaps = 43/228 (18%)

Query: 55  NKLGEGGFGPVYKGVLKKGDE------IAVKRL-SGRSGQGLREMKNEASVIAKVQHKNL 107
             LGEG FG V K              +AVK L    S   LR++ +E +V+ +V H ++
Sbjct: 29  KTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHV 88

Query: 108 VRLLGCCIDRDEKILIYEYMPNKSLDFFL---------------------FDPTKRMLLD 146
           ++L G C      +LI EY    SL  FL                      D      L 
Sbjct: 89  IKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALT 148

Query: 147 WVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMAR-ICGGNE 205
               +     I+QG+ YL   + ++++HRDL A NIL+ +    KISDFG++R +   + 
Sbjct: 149 MGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDS 205

Query: 206 LQANTS-----RIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 248
               +      +      +M+ E   + I++ +SDV+SFGVLL EIV+
Sbjct: 206 YVKRSQGRIPVK------WMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  153 bits (389), Expect = 7e-44
 Identities = 61/214 (28%), Positives = 99/214 (46%), Gaps = 24/214 (11%)

Query: 55  NKLGEGGFGPVYKGVLKKGDE------IAVKRL-SGRSGQGLREMKNEASVIAKV-QHKN 106
             LG G FG V +       +      +AVK L S         + +E  +++ + QH+N
Sbjct: 52  KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 111

Query: 107 LVRLLGCCIDRDEKILIYEYMPNKSLDFFL--------FDPTKRMLLDWVTRVQIIE--- 155
           +V LLG C      ++I EY     L  FL         DP   +     +   ++    
Sbjct: 112 IVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSS 171

Query: 156 GIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMAR-ICGGNELQANTSRIV 214
            +AQG+ +L   +    IHRD+ A N+LL      KI DFG+AR I   +      +  +
Sbjct: 172 QVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARL 228

Query: 215 GTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 248
               +M+PE   + +++++SDV+S+G+LL EI S
Sbjct: 229 -PVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  153 bits (389), Expect = 9e-44
 Identities = 59/227 (25%), Positives = 96/227 (42%), Gaps = 41/227 (18%)

Query: 55  NKLGEGGFGPVYKGVLKKGDE------IAVKRL-SGRSGQGLREMKNEASVIAKVQHKNL 107
             +GEG FG V++              +AVK L    S     + + EA+++A+  + N+
Sbjct: 53  RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNI 112

Query: 108 VRLLGCCIDRDEKILIYEYMPNKSLDFFL---------------------FDPTKRMLLD 146
           V+LLG C       L++EYM    L+ FL                             L 
Sbjct: 113 VKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLS 172

Query: 147 WVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNEL 206
              ++ I   +A G+ YL   S  + +HRDL   N L+ ++M  KI+DFG++R      +
Sbjct: 173 CAEQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSR-----NI 224

Query: 207 QANTSRIVGTYGY-----MSPEYALEGIFSIKSDVFSFGVLLLEIVS 248
            +                M PE      ++ +SDV+++GV+L EI S
Sbjct: 225 YSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 271

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  153 bits (388), Expect = 1e-43
 Identities = 61/222 (27%), Positives = 103/222 (46%), Gaps = 36/222 (16%)

Query: 55  NKLGEGGFGPVYKGVLKKGDE--------IAVKRL-SGRSGQGLREMKNEASVIAKV-QH 104
             LGEG FG V        D+        +AVK L    + + L ++ +E  ++  + +H
Sbjct: 41  KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100

Query: 105 KNLVRLLGCCIDRDEKILIYEYMPNKSLDFFL-------------FDPTKRMLLDWVTRV 151
           KN++ LLG C       +I EY    +L  +L              +      + +   V
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160

Query: 152 QIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTS 211
                +A+G+ YL   +  + IHRDL A N+L+ ++   KI+DFG+AR     ++     
Sbjct: 161 SCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR-----DINNIDY 212

Query: 212 RIVGTYG-----YMSPEYALEGIFSIKSDVFSFGVLLLEIVS 248
               T G     +M+PE   + +++ +SDV+SFGVL+ EI +
Sbjct: 213 YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  152 bits (385), Expect = 2e-43
 Identities = 62/218 (28%), Positives = 93/218 (42%), Gaps = 28/218 (12%)

Query: 55  NKLGEGGFGPVYKGV---LKKGDE---IAVKRL-SGRSGQGLREMKNEASVIAKV-QHKN 106
             LG G FG V +     L K D    +AVK L           + +E  V++ +  H N
Sbjct: 29  KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMN 88

Query: 107 LVRLLGCCIDRDEKILIYEYMPNKSLDFFL---------------FDPTKRMLLDWVTRV 151
           +V LLG C      ++I EY     L  FL                     + LD    +
Sbjct: 89  IVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLL 148

Query: 152 QIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMAR-ICGGNELQANT 210
                +A+G+ +L   +    IHRDL A NILL      KI DFG+AR I   +      
Sbjct: 149 SFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKG 205

Query: 211 SRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 248
           +  +    +M+PE     +++ +SDV+S+G+ L E+ S
Sbjct: 206 NARL-PVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 242

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  152 bits (387), Expect = 4e-43
 Identities = 72/305 (23%), Positives = 122/305 (40%), Gaps = 65/305 (21%)

Query: 55  NKLGEGGFGPVYKGVLKKGDE--------IAVKRL-SGRSGQGLREMKNEASVIAKV-QH 104
             LGEG FG V        D+        +AVK L    + + L ++ +E  ++  + +H
Sbjct: 87  KPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 146

Query: 105 KNLVRLLGCCIDRDEKILIYEYMPNKSLDFFL-------------FDPTKRMLLDWVTRV 151
           KN++ LLG C       +I EY    +L  +L              +      + +   V
Sbjct: 147 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 206

Query: 152 QIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTS 211
                +A+G+ YL   +  + IHRDL A N+L+ ++   KI+DFG+AR     ++     
Sbjct: 207 SCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR-----DINNIDY 258

Query: 212 RIVGTYG-----YMSPEYALEGIFSIKSDVFSFGVLLLEIVS-------GKKNTGLYRTD 259
               T G     +M+PE   + +++ +SDV+SFGVL+ EI +       G     L+   
Sbjct: 259 YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF--- 315

Query: 260 SLNLLGYAWDLWTSNRTLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVV 319
                     L      ++   P       + ++   Y  +   C       RPT   +V
Sbjct: 316 ---------KLLKEGHRMDK--P----ANCTNEL---Y-MMMRDCWHAVPSQRPTFKQLV 356

Query: 320 SMLTN 324
             L  
Sbjct: 357 EDLDR 361

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  151 bits (384), Expect = 1e-42
 Identities = 66/222 (29%), Positives = 102/222 (45%), Gaps = 36/222 (16%)

Query: 55  NKLGEGGFGPVYKGVLKKGD--------EIAVKRL-SGRSGQGLREMKNEASVIAKV-QH 104
             LGEG FG V        D        ++AVK L S  + + L ++ +E  ++  + +H
Sbjct: 75  KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 134

Query: 105 KNLVRLLGCCIDRDEKILIYEYMPNKSLDFFL-------------FDPTKRMLLDWVTRV 151
           KN++ LLG C       +I EY    +L  +L                     L     V
Sbjct: 135 KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 194

Query: 152 QIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTS 211
                +A+G+ YL   +  + IHRDL A N+L+ +D   KI+DFG+AR     ++     
Sbjct: 195 SCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR-----DIHHIDY 246

Query: 212 RIVGTYG-----YMSPEYALEGIFSIKSDVFSFGVLLLEIVS 248
               T G     +M+PE   + I++ +SDV+SFGVLL EI +
Sbjct: 247 YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  154 bits (391), Expect = 6e-42
 Identities = 50/198 (25%), Positives = 90/198 (45%), Gaps = 12/198 (6%)

Query: 56  KLGEGGFGPVYKGVLKKGDE----IAVKRL-SGRSGQGLREMKNEASVIAKVQHKNLVRL 110
            +GEG FG V++G+    +     +A+K   +  S     +   EA  + +  H ++V+L
Sbjct: 397 CIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 456

Query: 111 LGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRV 170
           +G     +   +I E      L  FL    ++  LD  + +     ++  L YL      
Sbjct: 457 IGVIT-ENPVWIIMELCTLGELRSFL--QVRKFSLDLASLILYAYQLSTALAYL---ESK 510

Query: 171 RIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIF 230
           R +HRD+ A N+L+  +   K+ DFG++R    +     +   +    +M+PE      F
Sbjct: 511 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL-PIKWMAPESINFRRF 569

Query: 231 SIKSDVFSFGVLLLEIVS 248
           +  SDV+ FGV + EI+ 
Sbjct: 570 TSASDVWMFGVCMWEILM 587

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  148 bits (375), Expect = 1e-41
 Identities = 61/228 (26%), Positives = 94/228 (41%), Gaps = 43/228 (18%)

Query: 55  NKLGEGGFGPVYKGVLKKGDE------IAVKRL-SGRSGQGLREMKNEASVIAKV-QHKN 106
             LG G FG V         +      +AVK L           + +E  ++ ++  H+N
Sbjct: 51  KVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHEN 110

Query: 107 LVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEG---------- 156
           +V LLG C       LI+EY     L  +L    ++   D +                  
Sbjct: 111 IVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLT 170

Query: 157 ----------IAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMAR-ICGGNE 205
                     +A+G+ +L        +HRDL A N+L+      KI DFG+AR I   + 
Sbjct: 171 FEDLLCFAYQVAKGMEFL---EFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSN 227

Query: 206 LQANTS-----RIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS 248
                +     +      +M+PE   EGI++IKSDV+S+G+LL EI S
Sbjct: 228 YVVRGNARLPVK------WMAPESLFEGIYTIKSDVWSYGILLWEIFS 269

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  143 bits (363), Expect = 3e-40
 Identities = 64/281 (22%), Positives = 117/281 (41%), Gaps = 35/281 (12%)

Query: 49  NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVK--RLSGRSGQGLREM-KNEASVIAKVQH 104
             F    K+G G F  VY+      G  +A+K  ++        R     E  ++ ++ H
Sbjct: 32  ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91

Query: 105 KNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKR-------MLLDWVTRVQIIEGI 157
            N+++     I+ +E  ++ E      L   +    K+        +  +   VQ+    
Sbjct: 92  PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYF--VQL---- 145

Query: 158 AQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTY 217
              L ++H     R++HRD+K +N+ +      K+ D G+ R        A++  +VGT 
Sbjct: 146 CSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTP 200

Query: 218 GYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTL 277
            YMSPE   E  ++ KSD++S G LL E+ + +     +  D +NL      +   +   
Sbjct: 201 YYMSPERIHENGYNFKSDIWSLGCLLYEMAALQS---PFYGDKMNLYSLCKKIEQCD--- 254

Query: 278 ELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDV 318
               P+  D YS +   LR   +  +C+    + RP +  V
Sbjct: 255 --YPPLPSDHYSEE---LR--QLVNMCINPDPEKRPDVTYV 288

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  143 bits (362), Expect = 8e-40
 Identities = 71/318 (22%), Positives = 129/318 (40%), Gaps = 51/318 (16%)

Query: 49  NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVK--RLSGRSGQGLREMKNEASVIAKVQHK 105
            K+    K+GEG FG        + G +  +K   +S  S +   E + E +V+A ++H 
Sbjct: 24  EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83

Query: 106 NLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRML-----LDWVTRVQIIEGIAQG 160
           N+V+      +     ++ +Y     L   +      +      LDW   VQI       
Sbjct: 84  NIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWF--VQI----CLA 137

Query: 161 LLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYM 220
           L ++H     +I+HRD+K+ NI L KD   ++ DFG+AR+       A     +GT  Y+
Sbjct: 138 LKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARA--CIGTPYYL 192

Query: 221 SPEYALEGI-FSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLEL 279
           SPE   E   ++ KSD+++ G +L E+ + K     +   S+                 L
Sbjct: 193 SPE-ICENKPYNNKSDIWALGCVLYELCTLKH---AFEAGSM---------------KNL 233

Query: 280 IDPILEDEYS------SKQMLLRYANIALLCVQESADDRPTMNDVVSM--LTNEAATLLP 331
           +  I+   +       S  +     ++     + +  DRP++N ++    +       L 
Sbjct: 234 VLKIISGSFPPVSLHYSYDL----RSLVSQLFKRNPRDRPSVNSILEKGFIAKRIEKFLS 289

Query: 332 PKQPAFSYVRNTVTSTSS 349
           P+  A  +   T +   S
Sbjct: 290 PQLIAEEFCLKTFSKFGS 307

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  140 bits (354), Expect = 5e-39
 Identities = 64/294 (21%), Positives = 116/294 (39%), Gaps = 45/294 (15%)

Query: 49  NKFSDANKLGEGGFGPVYKGVLKKGDEI-AVKRLS-GRSGQGLREMKNEASVIAKVQHKN 106
             F     LG GGFG V++   K  D   A+KR+          ++  E   +AK++H  
Sbjct: 5   TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64

Query: 107 LVRLLGCCIDRDE---------KILIY---EYMPNKSLDFFLFDPTKRMLLDWVTRVQII 154
           +VR     ++++          K+ +Y   +    ++L  ++         +    + I 
Sbjct: 65  IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIF 124

Query: 155 EGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANT---- 210
             IA+ + +LH      ++HRDLK SNI    D   K+ DFG+      +E +       
Sbjct: 125 LQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPM 181

Query: 211 ------SRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLL 264
                 +  VGT  YMSPE      +S K D+FS G++L E+        LY   +    
Sbjct: 182 PAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFEL--------LYPFSTQMER 233

Query: 265 GYAWDLWTSNRTLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDV 318
                   + +      P+   +Y  + ++++        +  S  +RP   ++
Sbjct: 234 VRTLTDVRNLK----FPPLFTQKYPCEYVMVQ------DMLSPSPMERPEAINI 277

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  138 bits (349), Expect = 2e-38
 Identities = 68/306 (22%), Positives = 128/306 (41%), Gaps = 45/306 (14%)

Query: 24  QAKRSKKKEVDQFPLFSFSSVSTATNKFSDANKLGEGGFGPVYKGV-LKKGDEIAVK--R 80
           Q +R+++++  +        +S          ++G G F  VYKG+  +   E+A    +
Sbjct: 1   QEERNQQQDDIEELETKAVGMSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQ 60

Query: 81  LSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEK----ILIYEYMPNKSLDFFL 136
               +    +  K EA ++  +QH N+VR         +     +L+ E M + +L  +L
Sbjct: 61  DRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYL 120

Query: 137 --FDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLD-KDMNPKIS 193
             F   K  +L    R QI+    +GL +LH      IIHRDLK  NI +     + KI 
Sbjct: 121 KRFKVMKIKVLRSWCR-QIL----KGLQFLHT-RTPPIIHRDLKCDNIFITGPTGSVKIG 174

Query: 194 DFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNT 253
           D G+A +   +        ++GT  +M+PE   E  +    DV++FG+ +LE+ + +   
Sbjct: 175 DLGLATLKRAS----FAKAVIGTPEFMAPEMYEEK-YDESVDVYAFGMCMLEMATSE--- 226

Query: 254 GLYRTDSLNLLGYAWDLWTSNRTLELI-----DPILEDEYSSKQMLLRYANIALLCVQES 308
                       Y +    +   +         P   D+ +  ++      I   C++++
Sbjct: 227 ------------YPYSECQNAAQIYRRVTSGVKPASFDKVAIPEV----KEIIEGCIRQN 270

Query: 309 ADDRPT 314
            D+R +
Sbjct: 271 KDERYS 276

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  135 bits (342), Expect = 2e-37
 Identities = 68/286 (23%), Positives = 112/286 (39%), Gaps = 50/286 (17%)

Query: 56  KLGEGGFGPVYKGVLKKGDEI-AVK--RLSGRSGQGLREMKNEASVIAKVQHKNLVRLLG 112
            +G G +G   K   K   +I   K       +    + + +E +++ +++H N+VR   
Sbjct: 13  TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 72

Query: 113 CCIDRDEKIL--IYEYMPNKSLDFFLFDPTKR-------MLLDWVTRVQIIEGIAQGLLY 163
             IDR    L  + EY     L   +   TK         +L  +   Q+       L  
Sbjct: 73  RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVM--TQL----TLALKE 126

Query: 164 LHQ--YSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMS 221
            H+       ++HRDLK +N+ LD   N K+ DFG+ARI   +   A T   VGT  YMS
Sbjct: 127 CHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKT--FVGTPYYMS 184

Query: 222 PEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELID 281
           PE      ++ KSD++S G LL E+ +       +   S                 EL  
Sbjct: 185 PEQMNRMSYNEKSDIWSLGCLLYELCALMP---PFTAFSQK---------------ELAG 226

Query: 282 PILEDEYS------SKQMLLRYANIALLCVQESADDRPTMNDVVSM 321
            I E ++       S ++      I    +      RP++ +++  
Sbjct: 227 KIREGKFRRIPYRYSDEL----NEIITRMLNLKDYHRPSVEEILEN 268

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  135 bits (342), Expect = 3e-37
 Identities = 59/259 (22%), Positives = 96/259 (37%), Gaps = 26/259 (10%)

Query: 5   LDLNLKADNVIIE---LPANNKQAKRSKKKEVDQFPLFSFSSVSTAT-NKFSDANKLGEG 60
             ++L  +N+  +        + + R +  E  Q P +  S   +     F   ++LG G
Sbjct: 9   SGVDLGTENLYFQSMHQLQPRRVSFRGEASETLQSPGYDPSRPESFFQQSFQRLSRLGHG 68

Query: 61  GFGPVYKGVLKKGDEI-AVK--RLSGRSGQGLREMKNEASVIAKV-QHKNLVRLLGCCID 116
            +G V+K   K+   + AVK      R  +       E     KV QH   VRL     +
Sbjct: 69  SYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEE 128

Query: 117 RDEKILIYEYMPNKSLDFFLFDPTKRM----LLDWVTRVQIIEGIAQGLLYLHQYSRVRI 172
                L  E     SL          +    +  ++            L +LH      +
Sbjct: 129 GGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYL--RDT----LLALAHLHSQ---GL 178

Query: 173 IHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSI 232
           +H D+K +NI L      K+ DFG+    G            G   YM+PE  L+G +  
Sbjct: 179 VHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGA-GEV--QEGDPRYMAPE-LLQGSYGT 234

Query: 233 KSDVFSFGVLLLEIVSGKK 251
            +DVFS G+ +LE+    +
Sbjct: 235 AADVFSLGLTILEVACNME 253

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  134 bits (340), Expect = 3e-37
 Identities = 69/292 (23%), Positives = 122/292 (41%), Gaps = 51/292 (17%)

Query: 45  STATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLREMKNEASVIAKVQ 103
                 F +   +G GGFG V+K   +  G    +KR+         + + E   +AK+ 
Sbjct: 7   KRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVK----YNNEKAEREVKALAKLD 62

Query: 104 HKNLVRLLGCCIDRDEKI----------------LIYEYMPNKSLDFFLFDPTKRMLLDW 147
           H N+V   GC    D                   +  E+    +L+ ++ +  +   LD 
Sbjct: 63  HVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWI-EKRRGEKLDK 121

Query: 148 VTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQ 207
           V  +++ E I +G+ Y+H     ++I+RDLK SNI L      KI DFG+      N+ +
Sbjct: 122 VLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSL-KNDGK 177

Query: 208 ANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYA 267
                  GT  YMSPE      +  + D+++ G++L E++                   A
Sbjct: 178 RTR--SKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDT--------------A 221

Query: 268 WDLWTSNRTLELIDPILEDEYSSK-QMLLRYANIALLCVQESADDRPTMNDV 318
           ++  TS    +L D I+ D +  K + LL+        + +  +DRP  +++
Sbjct: 222 FE--TSKFFTDLRDGIISDIFDKKEKTLLQ------KLLSKKPEDRPNTSEI 265

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  133 bits (336), Expect = 2e-36
 Identities = 60/227 (26%), Positives = 99/227 (43%), Gaps = 25/227 (11%)

Query: 40  SFSSVSTATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKR--LSGRSGQGLREMKNEAS 97
            F S+S     +S   ++G GG   V++ + +K    A+K   L     Q L   +NE +
Sbjct: 19  YFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIA 78

Query: 98  VIAKVQHKNL--VRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIE 155
            + K+Q  +   +RL    I      ++ E   N  L+ +L    K+  +D   R    +
Sbjct: 79  YLNKLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWL---KKKKSIDPWERKSYWK 134

Query: 156 GIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVG 215
            + + +  +HQ+    I+H DLK +N L+      K+ DFG+A     +         VG
Sbjct: 135 NMLEAVHTIHQH---GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVG 190

Query: 216 TYGYMSPEYALEGI------------FSIKSDVFSFGVLLLEIVSGK 250
           T  YM PE A++ +             S KSDV+S G +L  +  GK
Sbjct: 191 TVNYMPPE-AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 236

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  132 bits (334), Expect = 3e-36
 Identities = 61/199 (30%), Positives = 99/199 (49%), Gaps = 11/199 (5%)

Query: 57  LGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCI 115
           LG+G +G VY G  L     IA+K +  R  +  + +  E ++   ++HKN+V+ LG   
Sbjct: 30  LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 89

Query: 116 DRDEKILIY-EYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 174
           +    I I+ E +P  SL   L      +  +  T     + I +GL YLH     +I+H
Sbjct: 90  ENG-FIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QIVH 145

Query: 175 RDLKASNILLD-KDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGI--FS 231
           RD+K  N+L++      KISDFG ++   G      T    GT  YM+PE   +G   + 
Sbjct: 146 RDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET--FTGTLQYMAPEIIDKGPRGYG 203

Query: 232 IKSDVFSFGVLLLEIVSGK 250
             +D++S G  ++E+ +GK
Sbjct: 204 KAADIWSLGCTIIEMATGK 222

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  131 bits (332), Expect = 8e-36
 Identities = 63/290 (21%), Positives = 110/290 (37%), Gaps = 47/290 (16%)

Query: 56  KLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCC 114
           KLGEGGF  V        G   A+KR+     Q   E + EA +     H N++RL+  C
Sbjct: 36  KLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYC 95

Query: 115 IDRDEK----ILIYEYMPNKSL-DFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSR 169
           +          L+  +    +L +       K   L     + ++ GI +GL  +H    
Sbjct: 96  LRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHA--- 152

Query: 170 VRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIV-------GTYGYMSP 222
               HRDLK +NILL  +  P + D G       +   +  +  +        T  Y +P
Sbjct: 153 KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAP 212

Query: 223 E-YALEGIFSI--KSDVFSFGVLLLEIVSGKK--NTGLYRTDSLNLL---GYAWDLWT-- 272
           E ++++    I  ++DV+S G +L  ++ G+   +    + DS+ L      +       
Sbjct: 213 ELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLSIPQSPRH 272

Query: 273 SNRTLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSML 322
           S+   +L+            M+                 RP +  ++S L
Sbjct: 273 SSALWQLL----------NSMM-----------TVDPHQRPHIPLLLSQL 301

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  132 bits (334), Expect = 9e-36
 Identities = 63/239 (26%), Positives = 107/239 (44%), Gaps = 22/239 (9%)

Query: 17  ELPANNKQAKRSKKKEVDQFPLFSFSSVSTATNKFSDANKLGEGGFGPVYKGVLKKGDEI 76
           EL  + +Q KR +     +  +          + F   ++LG G  G V+K   K    +
Sbjct: 6   ELELDEQQRKRLEAFLTQKQKVGELKD-----DDFEKISELGAGNGGVVFKVSHKPSGLV 60

Query: 77  -AVKRLSGRSGQG-LREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSLDF 134
            A K +          ++  E  V+ +     +V   G      E  +  E+M   SLD 
Sbjct: 61  MARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQ 120

Query: 135 FLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISD 194
            L     R+    + +  +   + +GL YL    + +I+HRD+K SNIL++     K+ D
Sbjct: 121 VL-KKAGRIPEQILGK--VSIAVIKGLTYLR--EKHKIMHRDVKPSNILVNSRGEIKLCD 175

Query: 195 FGMARICGGNEL---QANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 250
           FG++      +L    AN+   VGT  YMSPE      +S++SD++S G+ L+E+  G+
Sbjct: 176 FGVSG-----QLIDSMANS--FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 227

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  130 bits (330), Expect = 3e-35
 Identities = 56/212 (26%), Positives = 93/212 (43%), Gaps = 25/212 (11%)

Query: 55  NKLGEGGFGPVYKGVLKKGDEIAVKR--LSGRSGQGLREMKNEASVIAKVQHKNL--VRL 110
            ++G GG   V++ + +K    A+K   L     Q L   +NE + + K+Q  +   +RL
Sbjct: 15  KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74

Query: 111 LGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRV 170
               I      ++ E   N  L+ +L    K+  +D   R    + + + +  +HQ+   
Sbjct: 75  YDYEITDQYIYMVMEC-GNIDLNSWL---KKKKSIDPWERKSYWKNMLEAVHTIHQH--- 127

Query: 171 RIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGI- 229
            I+H DLK +N L+      K+ DFG+A     +         VGT  YM PE A++ + 
Sbjct: 128 GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPE-AIKDMS 185

Query: 230 -----------FSIKSDVFSFGVLLLEIVSGK 250
                       S KSDV+S G +L  +  GK
Sbjct: 186 SSRENGKSKSKISPKSDVWSLGCILYYMTYGK 217

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  130 bits (328), Expect = 3e-35
 Identities = 56/231 (24%), Positives = 98/231 (42%), Gaps = 37/231 (16%)

Query: 48  TNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKN 106
            + F +   LG+G FG V K          A+K++     + L  + +E  ++A + H+ 
Sbjct: 5   ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEK-LSTILSEVMLLASLNHQY 63

Query: 107 LVRLLGCCIDRDEKILIYEYMPNKSLDFF---------LFD--PTKRMLLD----WVTRV 151
           +VR     ++R   +     +  KS  F          L+D   ++ +       W    
Sbjct: 64  VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFR 123

Query: 152 QIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARIC---------- 201
           QI+E ++    Y+H      IIHRDLK  NI +D+  N KI DFG+A+            
Sbjct: 124 QILEALS----YIHSQ---GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLD 176

Query: 202 --GGNELQANTSRIVGTYGYMSPE-YALEGIFSIKSDVFSFGVLLLEIVSG 249
                    N +  +GT  Y++ E     G ++ K D++S G++  E++  
Sbjct: 177 SQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP 227

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  131 bits (330), Expect = 6e-35
 Identities = 56/212 (26%), Positives = 93/212 (43%), Gaps = 25/212 (11%)

Query: 55  NKLGEGGFGPVYKGVLKKGDEIAVKR--LSGRSGQGLREMKNEASVIAKVQHKNL--VRL 110
            ++G GG   V++ + +K    A+K   L     Q L   +NE + + K+Q  +   +RL
Sbjct: 62  KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 121

Query: 111 LGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRV 170
               I      ++ E   N  L+ +L    K+  +D   R    + + + +  +HQ+   
Sbjct: 122 YDYEITDQYIYMVMEC-GNIDLNSWL---KKKKSIDPWERKSYWKNMLEAVHTIHQH--- 174

Query: 171 RIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGI- 229
            I+H DLK +N L+  D   K+ DFG+A     +         VG   YM PE A++ + 
Sbjct: 175 GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPE-AIKDMS 232

Query: 230 -----------FSIKSDVFSFGVLLLEIVSGK 250
                       S KSDV+S G +L  +  GK
Sbjct: 233 SSRENGKSKSKISPKSDVWSLGCILYYMTYGK 264

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  127 bits (322), Expect = 3e-34
 Identities = 50/216 (23%), Positives = 86/216 (39%), Gaps = 20/216 (9%)

Query: 42  SSVSTATNKFSDANKLGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKNEASVIA 100
                  +  +   ++G G FG V++    + G + AVK++     +       E    A
Sbjct: 51  YEYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR-----VEELVACA 105

Query: 101 KVQHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFL--FDPTKRMLLDWVTRVQIIEGIA 158
            +    +V L G   +     +  E +   SL   +            +    Q +EG  
Sbjct: 106 GLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLG-QALEG-- 162

Query: 159 QGLLYLHQYSRVRIIHRDLKASNILLDKDMNP-KISDFGMARICGGNELQANTSR---IV 214
             L YLH     RI+H D+KA N+LL  D +   + DFG A     + L  +      I 
Sbjct: 163 --LEYLHT---RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIP 217

Query: 215 GTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 250
           GT  +M+PE  +      K D++S   ++L +++G 
Sbjct: 218 GTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGC 253

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  125 bits (316), Expect = 2e-33
 Identities = 60/245 (24%), Positives = 108/245 (44%), Gaps = 29/245 (11%)

Query: 18  LPANNKQAKRSKKKEVDQFPLFSFSSVSTATN---KFSDANKLGEGGFGPVYKGVLKK-G 73
           +    +           +    +   V    +         K+GEG  G V     K  G
Sbjct: 11  VDLGTENLYFQSGVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSG 70

Query: 74  DEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSLD 133
            ++AVK +  R  Q    + NE  ++   QH N+V +    +  +E  ++ E++   +L 
Sbjct: 71  RQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGAL- 129

Query: 134 FFLFDPTKRMLLDWVTRVQIIEG-IA-------QGLLYLHQYSRVRIIHRDLKASNILLD 185
                       D V++V++ E  IA       Q L YLH      +IHRD+K+ +ILL 
Sbjct: 130 -----------TDIVSQVRLNEEQIATVCEAVLQALAYLHA---QGVIHRDIKSDSILLT 175

Query: 186 KDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLE 245
            D   K+SDFG       +  +  +  +VGT  +M+PE     +++ + D++S G++++E
Sbjct: 176 LDGRVKLSDFGFCAQISKDVPKRKS--LVGTPYWMAPEVISRSLYATEVDIWSLGIMVIE 233

Query: 246 IVSGK 250
           +V G+
Sbjct: 234 MVDGE 238

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  124 bits (313), Expect = 3e-33
 Identities = 56/220 (25%), Positives = 99/220 (45%), Gaps = 22/220 (10%)

Query: 43  SVSTATNKFSDANKLGEGGFGPVYKGVLKKGDEI-AVKRLSGRSG-QGLREMKNEASVIA 100
           S+    +      +LG G +G V K       +I AVKR+      Q  + +  +  +  
Sbjct: 1   SMEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISM 60

Query: 101 K-VQHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFL---FDPTKRMLLDWVTRVQIIEG 156
           + V     V   G      +  +  E M + SLD F     D  + +  D + +  I   
Sbjct: 61  RTVDCPFTVTFYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGK--IAVS 117

Query: 157 IAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICG--GNELQANTSRIV 214
           I + L +LH  S++ +IHRD+K SN+L++     K+ DFG   I G   +++  +     
Sbjct: 118 IVKALEHLH--SKLSVIHRDVKPSNVLINALGQVKMCDFG---ISGYLVDDVAKDID--A 170

Query: 215 GTYGYMSPE----YALEGIFSIKSDVFSFGVLLLEIVSGK 250
           G   YM+PE       +  +S+KSD++S G+ ++E+   +
Sbjct: 171 GCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILR 210

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  124 bits (314), Expect = 3e-33
 Identities = 54/223 (24%), Positives = 96/223 (43%), Gaps = 24/223 (10%)

Query: 45  STATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLRE-MKNEASVIAKV 102
           ST+ + +  ++ LG+G    V++G  KK GD  A+K  +  S     +    E  V+ K+
Sbjct: 5   STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKL 64

Query: 103 QHKNLVRLLGCCIDRDEKILIY---EYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQ 159
            HKN+V+L     +           E+ P  SL   L +P+    L     + ++  +  
Sbjct: 65  NHKNIVKLFAI-EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVG 123

Query: 160 GLLYLHQYSRVRIIHRDLKASNILL----DKDMNPKISDFGMARICGGNELQANTSRIVG 215
           G+ +L +     I+HR++K  NI+     D     K++DFG AR    +E    +  + G
Sbjct: 124 GMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ-FVS--LYG 177

Query: 216 TYGYMSPE--------YALEGIFSIKSDVFSFGVLLLEIVSGK 250
           T  Y+ P+           +  +    D++S GV      +G 
Sbjct: 178 TEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  124 bits (314), Expect = 4e-33
 Identities = 69/339 (20%), Positives = 115/339 (33%), Gaps = 90/339 (26%)

Query: 49  NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLS-GRSGQGLREMKNEASVIAKVQHKN 106
             F     +G GGFG V++   K      A+KR+          ++  E   +AK++H  
Sbjct: 6   TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 65

Query: 107 LVRLLGCCIDRD------------------------EKILIYEYMPNKSLDFFLFDPTKR 142
           +VR     ++                             +    +  + +D F    T  
Sbjct: 66  IVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVG 125

Query: 143 M---------------------LLDWVTR------------VQIIEGIAQGLLYLHQYSR 169
                                 L DW+ R            + I   IA+ + +LH    
Sbjct: 126 QLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSK-- 183

Query: 170 VRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTS----------RIVGTYGY 219
             ++HRDLK SNI    D   K+ DFG+      +E +                VGT  Y
Sbjct: 184 -GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLY 242

Query: 220 MSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLEL 279
           MSPE      +S K D+FS G++L E++     T + R   +  +          R L+ 
Sbjct: 243 MSPEQIHGNNYSHKVDIFSLGLILFELLYSFS-TQMERVRIITDV----------RNLKF 291

Query: 280 IDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDV 318
             P+L  +   ++       +    +  S  +RP   D+
Sbjct: 292 --PLLFTQKYPQE-----HMMVQDMLSPSPTERPEATDI 323

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  124 bits (313), Expect = 4e-33
 Identities = 60/212 (28%), Positives = 106/212 (50%), Gaps = 26/212 (12%)

Query: 48  TNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKN 106
             K++   K+G+G  G VY  +    G E+A+++++ +       + NE  V+ + ++ N
Sbjct: 19  KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78

Query: 107 LVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEG-IA------- 158
           +V  L   +  DE  ++ EY+   SL             D VT   + EG IA       
Sbjct: 79  IVNYLDSYLVGDELWVVMEYLAGGSL------------TDVVTETCMDEGQIAAVCRECL 126

Query: 159 QGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG 218
           Q L +LH     ++IHRD+K+ NILL  D + K++DFG        + + +T  +VGT  
Sbjct: 127 QALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPY 181

Query: 219 YMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 250
           +M+PE      +  K D++S G++ +E++ G+
Sbjct: 182 WMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  124 bits (314), Expect = 1e-32
 Identities = 54/223 (24%), Positives = 96/223 (43%), Gaps = 24/223 (10%)

Query: 45  STATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLRE-MKNEASVIAKV 102
           ST+ + +  ++ LG+G    V++G  KK GD  A+K  +  S     +    E  V+ K+
Sbjct: 5   STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKL 64

Query: 103 QHKNLVRLLGCCIDRDEKILIY---EYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQ 159
            HKN+V+L     +           E+ P  SL   L +P+    L     + ++  +  
Sbjct: 65  NHKNIVKLF-AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVG 123

Query: 160 GLLYLHQYSRVRIIHRDLKASNILL----DKDMNPKISDFGMARICGGNELQANTSRIVG 215
           G+ +L +     I+HR++K  NI+     D     K++DFG AR    +E    +  + G
Sbjct: 124 GMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ-FVS--LYG 177

Query: 216 TYGYMSPE--------YALEGIFSIKSDVFSFGVLLLEIVSGK 250
           T  Y+ P+           +  +    D++S GV      +G 
Sbjct: 178 TEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  123 bits (311), Expect = 2e-32
 Identities = 58/203 (28%), Positives = 95/203 (46%), Gaps = 22/203 (10%)

Query: 57  LGEGGFGPVYKGVLKK-GDEIAVKRLSGRS--GQGLRE-MKNEASVIAKVQHKNLVRLLG 112
           LG+GGF   ++       +  A K +          RE M  E S+   + H+++V   G
Sbjct: 49  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108

Query: 113 CCIDRDEKILIYEYMPNKSLDFFLFDPTKRM--LLDWVTRVQIIEGIAQGLLYLHQYSRV 170
              D D   ++ E    +SL     +  KR   L +   R   +  I  G  YLH+    
Sbjct: 109 FFEDNDFVFVVLELCRRRSL----LELHKRRKALTEPEAR-YYLRQIVLGCQYLHRN--- 160

Query: 171 RIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR---IVGTYGYMSPEYALE 227
           R+IHRDLK  N+ L++D+  KI DFG+A      +++ +  R   + GT  Y++PE   +
Sbjct: 161 RVIHRDLKLGNLFLNEDLEVKIGDFGLA-----TKVEYDGERKKVLCGTPNYIAPEVLSK 215

Query: 228 GIFSIKSDVFSFGVLLLEIVSGK 250
              S + DV+S G ++  ++ GK
Sbjct: 216 KGHSFEVDVWSIGCIMYTLLVGK 238

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  121 bits (306), Expect = 3e-32
 Identities = 57/201 (28%), Positives = 102/201 (50%), Gaps = 17/201 (8%)

Query: 57  LGEGGFGPVYKGV-LKKGDEIAVKRLSGRS--GQGLRE-MKNEASVIAKVQHKNLVRLLG 112
           LG+G F  VY+   +  G E+A+K +  ++    G+ + ++NE  +  +++H +++ L  
Sbjct: 19  LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYN 78

Query: 113 CCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRI 172
              D +   L+ E   N  +         +   +   R   +  I  G+LYLH +    I
Sbjct: 79  YFEDSNYVYLVLEMCHNGEM-NRYLKNRVKPFSENEAR-HFMHQIITGMLYLHSH---GI 133

Query: 173 IHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR---IVGTYGYMSPEYALEGI 229
           +HRDL  SN+LL ++MN KI+DFG+A      +L+    +   + GT  Y+SPE A    
Sbjct: 134 LHRDLTLSNLLLTRNMNIKIADFGLA-----TQLKMPHEKHYTLCGTPNYISPEIATRSA 188

Query: 230 FSIKSDVFSFGVLLLEIVSGK 250
             ++SDV+S G +   ++ G+
Sbjct: 189 HGLESDVWSLGCMFYTLLIGR 209

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  121 bits (307), Expect = 3e-32
 Identities = 58/203 (28%), Positives = 95/203 (46%), Gaps = 22/203 (10%)

Query: 57  LGEGGFGPVYKGVLKK-GDEIAVKRLSGRS--GQGLRE-MKNEASVIAKVQHKNLVRLLG 112
           LG+GGF   ++       +  A K +          RE M  E S+   + H+++V   G
Sbjct: 23  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82

Query: 113 CCIDRDEKILIYEYMPNKSLDFFLFDPTKRM--LLDWVTRVQIIEGIAQGLLYLHQYSRV 170
              D D   ++ E    +SL     +  KR   L +   R   +  I  G  YLH+    
Sbjct: 83  FFEDNDFVFVVLELCRRRSL----LELHKRRKALTEPEAR-YYLRQIVLGCQYLHRN--- 134

Query: 171 RIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR---IVGTYGYMSPEYALE 227
           R+IHRDLK  N+ L++D+  KI DFG+A      +++ +  R   + GT  Y++PE   +
Sbjct: 135 RVIHRDLKLGNLFLNEDLEVKIGDFGLA-----TKVEYDGERKKVLCGTPNYIAPEVLSK 189

Query: 228 GIFSIKSDVFSFGVLLLEIVSGK 250
              S + DV+S G ++  ++ GK
Sbjct: 190 KGHSFEVDVWSIGCIMYTLLVGK 212

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  122 bits (308), Expect = 4e-32
 Identities = 73/324 (22%), Positives = 119/324 (36%), Gaps = 55/324 (16%)

Query: 56  KLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLREMKNEASVIAKVQ-HKNLVRLLGC 113
            L EGGF  VY+      G E A+KRL     +  R +  E   + K+  H N+V+    
Sbjct: 35  VLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSA 94

Query: 114 CIDRDEK-------ILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQ 166
                E+        L+   +    L  FL     R  L   T ++I     + + ++H 
Sbjct: 95  ASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMH- 153

Query: 167 YSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRI----------VGT 216
             +  IIHRDLK  N+LL      K+ DFG A         + +++             T
Sbjct: 154 RQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTT 213

Query: 217 YGYMSPE-YALEGIFSI--KSDVFSFGVLLLEIVSGK---KNTGLYRTDSLNLLGYAWDL 270
             Y +PE   L   F I  K D+++ G +L  +   +   ++    R             
Sbjct: 214 PMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLR------------- 260

Query: 271 WTSNRTLELIDPILEDEYSSKQMLLRYANIALL---CVQESADDRPTMNDVVSMLTNEAA 327
                       I+  +YS      +Y     L    +Q + ++R ++ +VV  L   AA
Sbjct: 261 ------------IVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAA 308

Query: 328 TL-LPPKQPAFSYVRNTVTSTSST 350
              + PK P    +       S+T
Sbjct: 309 ARNVNPKSPITELLEQNGGYGSAT 332

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  120 bits (303), Expect = 1e-31
 Identities = 64/231 (27%), Positives = 115/231 (49%), Gaps = 12/231 (5%)

Query: 21  NNKQAKRSKKKEVDQFPLFSFSSVSTATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVK 79
              Q +   ++++ +  L   S        F    KLGEG +G VYK + K+ G  +A+K
Sbjct: 3   ETVQLRNPPRRQLKK--LDEDSLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIK 60

Query: 80  RLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDP 139
           ++       L+E+  E S++ +    ++V+  G      +  ++ EY    S+   +   
Sbjct: 61  QVP--VESDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLR 118

Query: 140 TKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMAR 199
            K +  D +    I++   +GL YLH     R IHRD+KA NILL+ + + K++DFG+A 
Sbjct: 119 NKTLTEDEIAT--ILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAG 173

Query: 200 ICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 250
                  + NT  ++GT  +M+PE   E  ++  +D++S G+  +E+  GK
Sbjct: 174 QLTDTMAKRNT--VIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGK 222

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  120 bits (303), Expect = 2e-31
 Identities = 59/207 (28%), Positives = 98/207 (47%), Gaps = 21/207 (10%)

Query: 56  KLGEGGFGPVYKGVLKKGDEI-AVKRLSGRSG-QGLREMKNEASVIAK-VQHKNLVRLLG 112
           ++G G +G V K V K   +I AVKR+      +  +++  +  V+ +      +V+  G
Sbjct: 29  EIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYG 88

Query: 113 CCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQ---IIEGIAQGLLYLHQYSR 169
                 +  +  E M + S D F       +L D +       I     + L +L     
Sbjct: 89  ALFREGDCWICMELM-STSFDKFY-KYVYSVLDDVIPEEILGKITLATVKALNHLK--EN 144

Query: 170 VRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR--IVGTYGYMSPE---- 223
           ++IIHRD+K SNILLD+  N K+ DFG   I G  +L  + ++    G   YM+PE    
Sbjct: 145 LKIIHRDIKPSNILLDRSGNIKLCDFG---ISG--QLVDSIAKTRDAGCRPYMAPERIDP 199

Query: 224 YALEGIFSIKSDVFSFGVLLLEIVSGK 250
            A    + ++SDV+S G+ L E+ +G+
Sbjct: 200 SASRQGYDVRSDVWSLGITLYELATGR 226

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  122 bits (308), Expect = 7e-31
 Identities = 60/206 (29%), Positives = 92/206 (44%), Gaps = 17/206 (8%)

Query: 56  KLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLRE-MKNEASVIAKVQHKNLVRLL-- 111
           +LG GGFG V + + +  G+++A+K+         RE    E  ++ K+ H N+V     
Sbjct: 21  RLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREV 80

Query: 112 ----GCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQY 167
                     D  +L  EY     L  +L        L       ++  I+  L YLH+ 
Sbjct: 81  PDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHEN 140

Query: 168 SRVRIIHRDLKASNILLD---KDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY 224
              RIIHRDLK  NI+L    + +  KI D G A+     EL       VGT  Y++PE 
Sbjct: 141 ---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGEL-CTEF--VGTLQYLAPEL 194

Query: 225 ALEGIFSIKSDVFSFGVLLLEIVSGK 250
             +  +++  D +SFG L  E ++G 
Sbjct: 195 LEQKKYTVTVDYWSFGTLAFECITGF 220

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  118 bits (297), Expect = 8e-31
 Identities = 52/209 (24%), Positives = 103/209 (49%), Gaps = 13/209 (6%)

Query: 48  TNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKN 106
              +    +LG+G FG VYK   K+ G   A K +  +S + L +   E  ++A   H  
Sbjct: 18  NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPY 77

Query: 107 LVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQ 166
           +V+LLG      +  ++ E+ P  ++D  + +  + +    +    +   + + L +LH 
Sbjct: 78  IVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQV--VCRQMLEALNFLHS 135

Query: 167 YSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE--- 223
               RIIHRDLKA N+L+  + + +++DFG++        + ++   +GT  +M+PE   
Sbjct: 136 K---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS--FIGTPYWMAPEVVM 190

Query: 224 --YALEGIFSIKSDVFSFGVLLLEIVSGK 250
                +  +  K+D++S G+ L+E+   +
Sbjct: 191 CETMKDTPYDYKADIWSLGITLIEMAQIE 219

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  117 bits (296), Expect = 1e-30
 Identities = 56/202 (27%), Positives = 105/202 (51%), Gaps = 11/202 (5%)

Query: 51  FSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQG-LREMKNEASVIAKVQHKNLV 108
           F+   K+G+G FG V+KG+  +    +A+K +     +  + +++ E +V+++     + 
Sbjct: 24  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83

Query: 109 RLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYS 168
           +  G  +   +  +I EY+   S      D  +   LD      I+  I +GL YLH   
Sbjct: 84  KYYGSYLKDTKLWIIMEYLGGGSAL----DLLEPGPLDETQIATILREILKGLDYLH--- 136

Query: 169 RVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEG 228
             + IHRD+KA+N+LL +    K++DFG+A      +++ NT   VGT  +M+PE   + 
Sbjct: 137 SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVIKQS 194

Query: 229 IFSIKSDVFSFGVLLLEIVSGK 250
            +  K+D++S G+  +E+  G+
Sbjct: 195 AYDSKADIWSLGITAIELARGE 216

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  118 bits (297), Expect = 1e-30
 Identities = 52/212 (24%), Positives = 95/212 (44%), Gaps = 20/212 (9%)

Query: 49  NKFSDANKLGEGGFGPVYKGVLKKGDEI-AVKRL-SGRSGQGLREMKNEASVIAK-VQHK 105
           N   +  ++G G  G V+K   +K   + AVK++    + +  + +  +  V+ K     
Sbjct: 25  NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCP 84

Query: 106 NLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLH 165
            +V+  G  I   +  +  E M     +         +    + +  +   I + L YL 
Sbjct: 85  YIVQCFGTFITNTDVFIAMELM-GTCAEKLKKRMQGPIPERILGK--MTVAIVKALYYLK 141

Query: 166 QYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICG--GNELQANTSRIVGTYGYMSPE 223
              +  +IHRD+K SNILLD+    K+ DFG   I G   ++   + S   G   YM+PE
Sbjct: 142 --EKHGVIHRDVKPSNILLDERGQIKLCDFG---ISGRLVDDKAKDRS--AGCAAYMAPE 194

Query: 224 -----YALEGIFSIKSDVFSFGVLLLEIVSGK 250
                   +  + I++DV+S G+ L+E+ +G+
Sbjct: 195 RIDPPDPTKPDYDIRADVWSLGISLVELATGQ 226

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  118 bits (297), Expect = 2e-30
 Identities = 57/219 (26%), Positives = 92/219 (42%), Gaps = 31/219 (14%)

Query: 56  KLGEGGFGPVY---------------KGVLKKGDEIAVKRLSGRSGQGLRE-MKNEASVI 99
            L +G F  +                K +L+K  +         S +   +  KNE  +I
Sbjct: 38  TLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQII 97

Query: 100 AKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSL-----DFFLFDPTKRMLLDWVTRVQII 154
             ++++  +   G   + DE  +IYEYM N S+      FF+ D      +       II
Sbjct: 98  TDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCII 157

Query: 155 EGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIV 214
           + +     Y+H  +   I HRD+K SNIL+DK+   K+SDFG +      +++   S   
Sbjct: 158 KSVLNSFSYIH--NEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIK--GS--R 211

Query: 215 GTYGYMSPEYALEGIFSI---KSDVFSFGVLLLEIVSGK 250
           GTY +M PE       S    K D++S G+ L  +    
Sbjct: 212 GTYEFMPPE-FFSNESSYNGAKVDIWSLGICLYVMFYNV 249

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  116 bits (294), Expect = 2e-30
 Identities = 55/199 (27%), Positives = 96/199 (48%), Gaps = 11/199 (5%)

Query: 56  KLGEGGFGPVYKGV-LKKGDEIAVKRLS---GRSGQGLREMKNEASVIAKVQHKNLVRLL 111
           KLG GG   VY         ++A+K +        + L+  + E    +++ H+N+V ++
Sbjct: 18  KLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMI 77

Query: 112 GCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVR 171
               + D   L+ EY+   +L  ++        L   T +     I  G+ + H    +R
Sbjct: 78  DVDEEDDCYYLVMEYIEGPTLSEYI---ESHGPLSVDTAINFTNQILDGIKHAH---DMR 131

Query: 172 IIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFS 231
           I+HRD+K  NIL+D +   KI DFG+A+      L   T+ ++GT  Y SPE A      
Sbjct: 132 IVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSL-TQTNHVLGTVQYFSPEQAKGEATD 190

Query: 232 IKSDVFSFGVLLLEIVSGK 250
             +D++S G++L E++ G+
Sbjct: 191 ECTDIYSIGIVLYEMLVGE 209

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  115 bits (291), Expect = 4e-30
 Identities = 51/240 (21%), Positives = 89/240 (37%), Gaps = 46/240 (19%)

Query: 42  SSVSTATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKR--LSGRSGQGLREMKNEASV 98
              S  T +F +  K+G G FG V+K V +  G   A+KR           +    E   
Sbjct: 4   GMKSRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYA 63

Query: 99  IAKV-QHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRM-------LLDWVTR 150
            A + QH ++VR      + D  ++  EY    SL   + +  + M       L D +  
Sbjct: 64  HAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLL-- 121

Query: 151 VQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNP-------------------K 191
           +Q+     +GL Y+H    + ++H D+K SNI + +   P                   K
Sbjct: 122 LQV----GRGLRYIHS---MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFK 174

Query: 192 ISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 250
           I D G            +     G   +++ E   E      K+D+F+  + ++     +
Sbjct: 175 IGDLGHVTRIS------SPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAE 228

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  119 bits (301), Expect = 7e-30
 Identities = 43/204 (21%), Positives = 78/204 (38%), Gaps = 26/204 (12%)

Query: 56  KLGEGGFGPVYKG---VLKKGDEIAVKRLSGRSGQGLREM-KNEASVIAKVQHKNLVRLL 111
            +  GG G +Y      +  G  + +K L        + M   E   +A+V H ++V++ 
Sbjct: 87  CIAHGGLGWIYLALDRNVN-GRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIF 145

Query: 112 --GCCIDRDEKILIY---EYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQ 166
                 DR    + Y   EY+  +SL            L     +  +  I   L YLH 
Sbjct: 146 NFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK-----LPVAEAIAYLLEILPALSYLH- 199

Query: 167 YSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAL 226
              + +++ DLK  NI+L ++   K+ D G                + GT G+ +PE   
Sbjct: 200 --SIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINS------FGYLYGTPGFQAPEIV- 249

Query: 227 EGIFSIKSDVFSFGVLLLEIVSGK 250
               ++ +D+++ G  L  +    
Sbjct: 250 RTGPTVATDIYTVGRTLAALTLDL 273

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  114 bits (288), Expect = 9e-30
 Identities = 59/207 (28%), Positives = 92/207 (44%), Gaps = 16/207 (7%)

Query: 49  NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLS----GRSGQGLREMKNEASVIAKVQ 103
             F     LG+G FG VY    K+    +A+K L      ++G    +++ E  + + ++
Sbjct: 9   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGV-EHQLRREVEIQSHLR 67

Query: 104 HKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLY 163
           H N++RL G   D     LI EY P  ++ +       +   +  T    I  +A  L Y
Sbjct: 68  HPNILRLYGYFHDATRVYLILEYAPLGTV-YRELQKLSK-FDEQRTA-TYITELANALSY 124

Query: 164 LHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE 223
            H     R+IHRD+K  N+LL      KI+DFG +     +        + GT  Y+ PE
Sbjct: 125 CHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT--D--LCGTLDYLPPE 177

Query: 224 YALEGIFSIKSDVFSFGVLLLEIVSGK 250
                +   K D++S GVL  E + GK
Sbjct: 178 MIEGRMHDEKVDLWSLGVLCYEFLVGK 204

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  117 bits (294), Expect = 1e-29
 Identities = 48/211 (22%), Positives = 85/211 (40%), Gaps = 21/211 (9%)

Query: 50  KFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKV-QHKNLV 108
            F   + LG G  G +    +    ++AVKR+             E  ++ +  +H N++
Sbjct: 25  SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPEC---FSFADREVQLLRESDEHPNVI 81

Query: 109 RLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYS 168
           R      DR  + +  E       ++      K      +  + +++    GL +LH   
Sbjct: 82  RYFCTEKDRQFQYIAIELCAATLQEYVE---QKDFAHLGLEPITLLQQTTSGLAHLHSL- 137

Query: 169 RVRIIHRDLKASNILL-----DKDMNPKISDFGMARIC-GGNELQANTSRIVGTYGYMSP 222
              I+HRDLK  NIL+        +   ISDFG+ +    G    +  S + GT G+++P
Sbjct: 138 --NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAP 195

Query: 223 EYALEGIF----SIKSDVFSFGVLLLEIVSG 249
           E  L        +   D+FS G +   ++S 
Sbjct: 196 EM-LSEDCKENPTYTVDIFSAGCVFYYVISE 225

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  115 bits (290), Expect = 2e-29
 Identities = 24/249 (9%), Positives = 54/249 (21%), Gaps = 43/249 (17%)

Query: 37  PLFSFSSVSTATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGR---SGQGLREM 92
                S +S    K      L  G    V+     +  ++ A+K  +     S   L  +
Sbjct: 50  ETTVDSLLSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERL 109

Query: 93  KNEASVIAKVQHKNLVRLLGCC--------------------------IDRDEKILIYEY 126
                  A++  ++                                        +L+   
Sbjct: 110 HEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPA 169

Query: 127 MP---NKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNIL 183
                        F    R     +    +   + +    L       ++H      N+ 
Sbjct: 170 ASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSK---GLVHGHFTPDNLF 226

Query: 184 LDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAL--EGIFSIKSDVFSFGV 241
           +  D    + D       G                Y   E+       F+   + +  G+
Sbjct: 227 IMPDGRLMLGDVSALWKVG-----TRGPASSVPVTYAPREFLNASTATFTHALNAWQLGL 281

Query: 242 LLLEIVSGK 250
            +  +    
Sbjct: 282 SIYRVWCLF 290

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  116 bits (292), Expect = 5e-29
 Identities = 61/246 (24%), Positives = 103/246 (41%), Gaps = 36/246 (14%)

Query: 23  KQAKRSKKKEVDQFPLFSFSSVSTATNKFSDA----NKLGEGGFGPVYKGVLKK-GDEIA 77
             + R                +++     S+      KLG G +G V     K    E A
Sbjct: 7   HSSGRENLYFQGDLQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERA 66

Query: 78  VKRLSGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFF 135
           +K +     S     ++  E +V+  + H N+++L     D+    L+ E      L   
Sbjct: 67  IKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGEL--- 123

Query: 136 LFDPTKRMLLDWVTR--------VQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILL--- 184
            FD    +    + R          II+ +  G+ YLH+++   I+HRDLK  N+LL   
Sbjct: 124 -FD---EI----IHRMKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESK 172

Query: 185 DKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLL 244
           +KD   KI DFG++ +    +        +GT  Y++PE  L   +  K DV+S GV+L 
Sbjct: 173 EKDALIKIVDFGLSAVFENQK---KMKERLGTAYYIAPE-VLRKKYDEKCDVWSIGVILF 228

Query: 245 EIVSGK 250
            +++G 
Sbjct: 229 ILLAGY 234

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  113 bits (285), Expect = 7e-29
 Identities = 69/255 (27%), Positives = 113/255 (44%), Gaps = 25/255 (9%)

Query: 6   DLNLKADNVIIELPANNKQAKRSKKKEVDQFPLFSFSSVSTATNKFSDANKLGEGGFGPV 65
           D ++     +    A +      +   +    +            FSD  ++G G FG V
Sbjct: 11  DYDIPTTENLYFQGAMDPMPAGGRAGSLKDPDVAELFFKDDPEKLFSDLREIGHGSFGAV 70

Query: 66  YKGVLKK-GDEIAVKRLS---GRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKI 121
           Y     +  + +A+K++S    +S +  +++  E   + K++H N ++  GC +      
Sbjct: 71  YFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAW 130

Query: 122 LIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQI---IEGIAQGLLYLHQYSRVRIIHRDLK 178
           L+ EY    + D  L +  K+ L      V+I     G  QGL YLH +    +IHRD+K
Sbjct: 131 LVMEYCLGSASD--LLEVHKKPL----QEVEIAAVTHGALQGLAYLHSH---NMIHRDVK 181

Query: 179 ASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE---YALEGIFSIKSD 235
           A NILL +    K+ DFG A         AN+   VGT  +M+PE      EG +  K D
Sbjct: 182 AGNILLSEPGLVKLGDFGSA----SIMAPANS--FVGTPYWMAPEVILAMDEGQYDGKVD 235

Query: 236 VFSFGVLLLEIVSGK 250
           V+S G+  +E+   K
Sbjct: 236 VWSLGITCIELAERK 250

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  112 bits (282), Expect = 1e-28
 Identities = 51/203 (25%), Positives = 83/203 (40%), Gaps = 19/203 (9%)

Query: 56  KLGEGGFGPVYKGV-LKKGDEIAVKRLSGR--SGQGLRE-MKNEASVIAKVQHKNLVRLL 111
            +G GG G VY+     +   +A+K +S    S    R  M+ EA    ++Q  ++V + 
Sbjct: 41  LVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIH 100

Query: 112 GCCIDRDEK----ILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQY 167
               D  E      +    +    L   L    ++  L     V I+  I   L   H  
Sbjct: 101 ----DFGEIDGQLYVDMRLINGVDLAAML---RRQGPLAPPRAVAIVRQIGSALDAAH-- 151

Query: 168 SRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALE 227
                 HRD+K  NIL+  D    + DFG+A      +L       VGT  YM+PE   E
Sbjct: 152 -AAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQ-LGNTVGTLYYMAPERFSE 209

Query: 228 GIFSIKSDVFSFGVLLLEIVSGK 250
              + ++D+++   +L E ++G 
Sbjct: 210 SHATYRADIYALTCVLYECLTGS 232

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  111 bits (280), Expect = 2e-28
 Identities = 54/204 (26%), Positives = 89/204 (43%), Gaps = 15/204 (7%)

Query: 56  KLGEGGFGPVYKGV-LKKGDEIAVKRLS---GRSGQGLREMKNEASVIAKVQHKNLVRLL 111
            LG GG   V+    L+   ++AVK L     R        + EA   A + H  +V + 
Sbjct: 19  ILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 78

Query: 112 GCCIDRDEKILIY----EYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQY 167
                      +     EY+   +L   +        +     +++I    Q L + H  
Sbjct: 79  DTGEAETPAGPLPYIVMEYVDGVTLRDIV---HTEGPMTPKRAIEVIADACQALNFSH-- 133

Query: 168 SRVRIIHRDLKASNILLDKDMNPKISDFGMAR-ICGGNELQANTSRIVGTYGYMSPEYAL 226
            +  IIHRD+K +NI++      K+ DFG+AR I         T+ ++GT  Y+SPE A 
Sbjct: 134 -QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQAR 192

Query: 227 EGIFSIKSDVFSFGVLLLEIVSGK 250
                 +SDV+S G +L E+++G+
Sbjct: 193 GDSVDARSDVYSLGCVLYEVLTGE 216

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  112 bits (281), Expect = 5e-28
 Identities = 53/237 (22%), Positives = 95/237 (40%), Gaps = 19/237 (8%)

Query: 16  IELPANNKQAKRSKKKEVDQFPLFSFSSVSTATNKFSD----ANKLGEGGFGPVYKGVLK 71
           +    +  +     K   D +  +    V        D      +LG G FG V++ V K
Sbjct: 14  VRGKYDGPKINDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEK 73

Query: 72  K-GDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIYEYMPNK 130
             G     K ++         +KNE S++ ++ H  L+ L     D+ E +LI E++   
Sbjct: 74  ATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGG 133

Query: 131 SLDFFLFD--PTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILL-DKD 187
            L    FD    +   +     +  +    +GL ++H++    I+H D+K  NI+   K 
Sbjct: 134 EL----FDRIAAEDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKK 186

Query: 188 MNP-KISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLL 243
            +  KI DFG+A     +E+         T  + +PE          +D+++ GVL 
Sbjct: 187 ASSVKIIDFGLATKLNPDEIVKV---TTATAEFAAPEIVDREPVGFYTDMWAIGVLG 240

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  111 bits (280), Expect = 6e-28
 Identities = 62/236 (26%), Positives = 103/236 (43%), Gaps = 21/236 (8%)

Query: 19  PANNKQAKRSKKKEVDQFPLFSFSSVSTATNKFSD------ANKLGEGGFGPVYKGVLKK 72
           P  +K+              F    V+      +          LG G FG V+K     
Sbjct: 53  PVKSKRTSALAVDIPAPPAPFDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETA 112

Query: 73  -GDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKS 131
            G ++A K +  R  +   E+KNE SV+ ++ H NL++L      +++ +L+ EY+    
Sbjct: 113 TGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGE 172

Query: 132 LDFFLFD--PTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILL-DKDM 188
           L    FD    +   L  +  +  ++ I +G+ ++HQ     I+H DLK  NIL  ++D 
Sbjct: 173 L----FDRIIDESYNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDA 225

Query: 189 NP-KISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLL 243
              KI DFG+AR     E         GT  +++PE       S  +D++S GV+ 
Sbjct: 226 KQIKIIDFGLARRYKPRE---KLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIA 278

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  113 bits (284), Expect = 8e-28
 Identities = 51/234 (21%), Positives = 93/234 (39%), Gaps = 19/234 (8%)

Query: 19  PANNKQAKRSKKKEVDQFPLFSFSSVSTATNKFSD----ANKLGEGGFGPVYKGVLKK-G 73
                 +        D +  +    V    +   D      +LG G FG V++   +  G
Sbjct: 123 RGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATG 182

Query: 74  DEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSLD 133
           +  A K +          ++ E   ++ ++H  LV L     D +E ++IYE+M      
Sbjct: 183 NNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGE-- 240

Query: 134 FFLFD--PTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILL-DKDMNP 190
             LF+    +   +     V+ +  + +GL ++H+ +    +H DLK  NI+   K  N 
Sbjct: 241 --LFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNE 295

Query: 191 -KISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLL 243
            K+ DFG+       +   +     GT  + +PE A        +D++S GVL 
Sbjct: 296 LKLIDFGLTAHLDPKQ---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLS 346

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  108 bits (273), Expect = 1e-27
 Identities = 51/217 (23%), Positives = 88/217 (40%), Gaps = 27/217 (12%)

Query: 40  SFSSVSTATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLREM-KNEAS 97
           +     T  + F    KLG G FG V+    +  G E  +K ++    Q   E  + E  
Sbjct: 13  NLYFQGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIE 72

Query: 98  VIAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTR------- 150
           V+  + H N++++     D     ++ E      L     +   R++             
Sbjct: 73  VLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGEL----LE---RIVSAQARGKALSEGY 125

Query: 151 -VQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILL---DKDMNPKISDFGMARICGGNEL 206
             ++++ +   L Y H      ++H+DLK  NIL          KI DFG+A +   +E 
Sbjct: 126 VAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEH 182

Query: 207 QANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLL 243
             N     GT  YM+PE   +   + K D++S GV++
Sbjct: 183 STN---AAGTALYMAPE-VFKRDVTFKCDIWSAGVVM 215

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  108 bits (273), Expect = 1e-27
 Identities = 53/199 (26%), Positives = 87/199 (43%), Gaps = 16/199 (8%)

Query: 57  LGEGGFGPVYKGVLKK-GDEIAVKRLS----GRSGQGLREMKNEASVIAKVQHKNLVRLL 111
           LG+G FG VY    K+    +A+K L      + G    +++ E  + + ++H N++R+ 
Sbjct: 22  LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGV-EHQLRREIEIQSHLRHPNILRMY 80

Query: 112 GCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVR 171
               DR    L+ E+ P   L +       R   +  +    +E +A  L Y H+    +
Sbjct: 81  NYFHDRKRIYLMLEFAPRGEL-YKELQKHGR-FDEQRSA-TFMEELADALHYCHER---K 134

Query: 172 IIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFS 231
           +IHRD+K  N+L+      KI+DFG +           T    GT  Y+ PE        
Sbjct: 135 VIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRR--RTM--CGTLDYLPPEMIEGKTHD 190

Query: 232 IKSDVFSFGVLLLEIVSGK 250
            K D++  GVL  E + G 
Sbjct: 191 EKVDLWCAGVLCYEFLVGM 209

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  112 bits (281), Expect = 2e-27
 Identities = 59/258 (22%), Positives = 108/258 (41%), Gaps = 47/258 (18%)

Query: 21  NNKQAKRSKKKEVDQFPLFSFSSVSTATNKFSDA----NKLGEGGFGPVYKGVLKK-GDE 75
           ++  +   +        +     V     K  ++     KLG G +G V     K    E
Sbjct: 4   HHHHSSGRENLYFQGIAINPGMYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSE 63

Query: 76  IAVKRLS-------------GRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKIL 122
            A+K +                  +   E+ NE S++  + H N+++L     D+    L
Sbjct: 64  KAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYL 123

Query: 123 IYEYMPNKSLDFFLFDPTKRMLLDWVTR--------VQIIEGIAQGLLYLHQYSRVRIIH 174
           + E+     L    F+   ++    + R          I++ I  G+ YLH+++   I+H
Sbjct: 124 VTEFYEGGEL----FE---QI----INRHKFDECDAANIMKQILSGICYLHKHN---IVH 169

Query: 175 RDLKASNILL---DKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFS 231
           RD+K  NILL   +  +N KI DFG++     +         +GT  Y++PE  L+  ++
Sbjct: 170 RDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKL---RDRLGTAYYIAPE-VLKKKYN 225

Query: 232 IKSDVFSFGVLLLEIVSG 249
            K DV+S GV++  ++ G
Sbjct: 226 EKCDVWSCGVIMYILLCG 243

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  111 bits (280), Expect = 2e-27
 Identities = 62/210 (29%), Positives = 97/210 (46%), Gaps = 33/210 (15%)

Query: 55  NKLGEGGFGPVYKGVLKK-GDEIAVKRLSGR---SGQGLREMKNEASVIAKVQHKNLVRL 110
             LG+G FG V     K  G E AVK +S R          +  E  ++ ++ H N+++L
Sbjct: 32  RVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKL 91

Query: 111 LGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTR--------VQIIEGIAQGLL 162
                D+    L+ E      L    FD    +    ++R         +II  +  G+ 
Sbjct: 92  YEFFEDKGYFYLVGEVYTGGEL----FD---EI----ISRKRFSEVDAARIIRQVLSGIT 140

Query: 163 YLHQYSRVRIIHRDLKASNILL---DKDMNPKISDFGMARICGGNELQANTSRIVGTYGY 219
           Y+H+     I+HRDLK  N+LL    KD N +I DFG++     ++        +GT  Y
Sbjct: 141 YMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKM---KDKIGTAYY 194

Query: 220 MSPEYALEGIFSIKSDVFSFGVLLLEIVSG 249
           ++PE  L G +  K DV+S GV+L  ++SG
Sbjct: 195 IAPE-VLHGTYDEKCDVWSTGVILYILLSG 223

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  109 bits (275), Expect = 3e-27
 Identities = 47/222 (21%), Positives = 87/222 (39%), Gaps = 18/222 (8%)

Query: 42  SSVSTATNKFSDANKLGEG--GFGPVYKGVLKK-GDEIAVKR--LSGRSGQGLREMKNEA 96
           SS       +     +G+G      V     K  G+ + V+R  L   S + +  ++ E 
Sbjct: 18  SSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGEL 77

Query: 97  SVIAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSL-DFFLFDPTKRMLLDWVTRVQIIE 155
            V     H N+V      I  +E  ++  +M   S  D  L        ++ +    I++
Sbjct: 78  HVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKD--LICTHFMDGMNELAIAYILQ 135

Query: 156 GIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANT----- 210
           G+ + L Y+H       +HR +KAS+IL+  D    +S          +  +        
Sbjct: 136 GVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFP 192

Query: 211 SRIVGTYGYMSPEYALEGI--FSIKSDVFSFGVLLLEIVSGK 250
              V    ++SPE   + +  +  KSD++S G+   E+ +G 
Sbjct: 193 KYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGH 234

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  107 bits (270), Expect = 4e-27
 Identities = 59/202 (29%), Positives = 94/202 (46%), Gaps = 32/202 (15%)

Query: 56  KLGEGGFGPVYKGVLKK-GDEIAVKRLSGR--SGQGLREMKNEASVIAKVQHKNLVRLLG 112
            LG+G FG V K   +    E AVK ++      +    +  E  ++ K+ H N+++L  
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88

Query: 113 CCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTR--------VQIIEGIAQGLLYL 164
              D     ++ E      L    FD    +    + R         +II+ +  G+ Y+
Sbjct: 89  ILEDSSSFYIVGELYTGGEL----FD---EI----IKRKRFSEHDAARIIKQVFSGITYM 137

Query: 165 HQYSRVRIIHRDLKASNILL---DKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMS 221
           H+++   I+HRDLK  NILL   +KD + KI DFG++     N         +GT  Y++
Sbjct: 138 HKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK---MKDRIGTAYYIA 191

Query: 222 PEYALEGIFSIKSDVFSFGVLL 243
           PE  L G +  K DV+S GV+L
Sbjct: 192 PE-VLRGTYDEKCDVWSAGVIL 212

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  110 bits (275), Expect = 4e-27
 Identities = 32/233 (13%), Positives = 69/233 (29%), Gaps = 43/233 (18%)

Query: 57  LGEGGFGPVYKGV-LKKGDEIAVKRLS---GRSGQGLREMKNEASVIAKVQH-------- 104
           LG+       +    + G+   V             +++MK E   +  ++         
Sbjct: 86  LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 145

Query: 105 --------KNLVRLLGCCI-------DRDEKIL-IYEYMPNKSLDFFLF------DPTKR 142
                    +LV+             +RD  +L  +   P    +   F        +  
Sbjct: 146 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 205

Query: 143 MLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICG 202
             L    R+Q+   + + L  LH Y    ++H  L+  +I+LD+     ++ F       
Sbjct: 206 KSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVR-D 261

Query: 203 GNELQANTSRIVGTYGYMSPEYAL-----EGIFSIKSDVFSFGVLLLEIVSGK 250
           G    +   R        +            + +   D ++ G+ +  I    
Sbjct: 262 GASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCAD 314

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  110 bits (278), Expect = 4e-27
 Identities = 61/209 (29%), Positives = 97/209 (46%), Gaps = 32/209 (15%)

Query: 55  NKLGEGGFGPVYKGVLKK-GDEIAVKRLSGR--SGQGLREMKNEASVIAKVQHKNLVRLL 111
             LG+G FG V K   +    E AVK ++      +    +  E  ++ K+ H N+++L 
Sbjct: 28  CMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLF 87

Query: 112 GCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTR--------VQIIEGIAQGLLY 163
               D     ++ E          LFD    +    + R         +II+ +  G+ Y
Sbjct: 88  EILEDSSSFYIVGELYTGGE----LFD---EI----IKRKRFSEHDAARIIKQVFSGITY 136

Query: 164 LHQYSRVRIIHRDLKASNILL---DKDMNPKISDFGMARICGGNELQANTSRIVGTYGYM 220
           +H++    I+HRDLK  NILL   +KD + KI DFG++     N         +GT  Y+
Sbjct: 137 MHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM---KDRIGTAYYI 190

Query: 221 SPEYALEGIFSIKSDVFSFGVLLLEIVSG 249
           +PE  L G +  K DV+S GV+L  ++SG
Sbjct: 191 APE-VLRGTYDEKCDVWSAGVILYILLSG 218

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  107 bits (270), Expect = 4e-27
 Identities = 59/221 (26%), Positives = 105/221 (47%), Gaps = 22/221 (9%)

Query: 45  STATNKFSDANKLGEGGFGPVYKGVLKKGDEI-AVKRLSGRSGQ-GLREMKNEASVIAKV 102
           S   + +     +G G    V         E  A+KR++    Q  + E+  E   +++ 
Sbjct: 11  SINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQC 70

Query: 103 QHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIE--GIA-- 158
            H N+V      + +DE  L+ + +   S+     D  K ++     +  +++   IA  
Sbjct: 71  HHPNIVSYYTSFVVKDELWLVMKLLSGGSV----LDIIKHIVAKGEHKSGVLDESTIATI 126

Query: 159 -----QGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGM-ARICGGNELQANTSR 212
                +GL YLH   +   IHRD+KA NILL +D + +I+DFG+ A +  G ++  N  R
Sbjct: 127 LREVLEGLEYLH---KNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVR 183

Query: 213 --IVGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 250
              VGT  +M+PE   +   +  K+D++SFG+  +E+ +G 
Sbjct: 184 KTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGA 224

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  108 bits (273), Expect = 5e-27
 Identities = 51/202 (25%), Positives = 86/202 (42%), Gaps = 23/202 (11%)

Query: 56  KLGEGGFGPVYKGVLKK-GDEIAVK-----RLSGRSGQGLREMKNEASVIAKVQHKNLVR 109
            +G+G F  V + + ++ G + AVK     + +   G    ++K EAS+   ++H ++V 
Sbjct: 31  VIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVE 90

Query: 110 LLGCCIDRDEKILIYEYMPNKSLDFFLFD--PTKRMLLDWVT-RV--QIIEGIAQGLLYL 164
           LL          +++E+M    L          +       +  V    +  I + L Y 
Sbjct: 91  LLETYSSDGMLYMVFEFMDGADL----CFEIVKRADAGFVYSEAVASHYMRQILEALRYC 146

Query: 165 HQYSRVRIIHRDLKASNILL---DKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMS 221
           H      IIHRD+K   +LL   +     K+  FG+A   G + L A     VGT  +M+
Sbjct: 147 HDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGG--RVGTPHFMA 201

Query: 222 PEYALEGIFSIKSDVFSFGVLL 243
           PE      +    DV+  GV+L
Sbjct: 202 PEVVKREPYGKPVDVWGCGVIL 223

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  108 bits (271), Expect = 5e-27
 Identities = 59/217 (27%), Positives = 101/217 (46%), Gaps = 22/217 (10%)

Query: 48  TNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLREMKNEASVIAKV-QHK 105
              F     +G G +G VYKG   K G   A+K +   +G    E+K E +++ K   H+
Sbjct: 23  AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD-VTGDEEEEIKQEINMLKKYSHHR 81

Query: 106 NLVRLLGCCIDRDEKI------LIYEYMPNKSL-DFFLFDPTKRMLLDWVTRVQIIEGIA 158
           N+    G  I ++         L+ E+    S+ D         +  +W+    I   I 
Sbjct: 82  NIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIA--YICREIL 139

Query: 159 QGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG 218
           +GL +LHQ+   ++IHRD+K  N+LL ++   K+ DFG++        + NT   +GT  
Sbjct: 140 RGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT--FIGTPY 194

Query: 219 YMSPE-----YALEGIFSIKSDVFSFGVLLLEIVSGK 250
           +M+PE        +  +  KSD++S G+  +E+  G 
Sbjct: 195 WMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGA 231

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  106 bits (267), Expect = 9e-27
 Identities = 48/193 (24%), Positives = 83/193 (43%), Gaps = 16/193 (8%)

Query: 56  KLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCC 114
            +G G +G V   V K      A K++     + +   K E  ++  + H N++RL    
Sbjct: 16  TIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETF 75

Query: 115 IDRDEKILIYEYMPNKSLDFFLFDP-TKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRII 173
            D  +  L+ E          LF+    + +       +I++ +   + Y H+     + 
Sbjct: 76  EDNTDIYLVMELCTGGE----LFERVVHKRVFRESDAARIMKDVLSAVAYCHKL---NVA 128

Query: 174 HRDLKASNILL---DKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIF 230
           HRDLK  N L      D   K+ DFG+A      ++       VGT  Y+SP+  LEG++
Sbjct: 129 HRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMM---RTKVGTPYYVSPQ-VLEGLY 184

Query: 231 SIKSDVFSFGVLL 243
             + D +S GV++
Sbjct: 185 GPECDEWSAGVMM 197

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score =  106 bits (268), Expect = 1e-26
 Identities = 60/198 (30%), Positives = 87/198 (43%), Gaps = 10/198 (5%)

Query: 57  LGEGGFGPVYKGVLKKGDEI-AVKRLSGRSGQGLRE---MKNEASVIAKVQHKNLVRLLG 112
           LGEG F  V            A+K L  R      +   +  E  V++++ H   V+L  
Sbjct: 38  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYF 97

Query: 113 CCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRI 172
              D ++      Y  N  L                TR    E I   L YLH      I
Sbjct: 98  TFQDDEKLYFGLSYAKNGEL-LKYIRKIGSFDET-CTRFYTAE-IVSALEYLHGKG---I 151

Query: 173 IHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSI 232
           IHRDLK  NILL++DM+ +I+DFG A++      QA  +  VGT  Y+SPE   E     
Sbjct: 152 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACK 211

Query: 233 KSDVFSFGVLLLEIVSGK 250
            SD+++ G ++ ++V+G 
Sbjct: 212 SSDLWALGCIIYQLVAGL 229

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score =  106 bits (268), Expect = 1e-26
 Identities = 61/211 (28%), Positives = 108/211 (51%), Gaps = 23/211 (10%)

Query: 49  NKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLS------GRSGQGLREMKNEASVIAKV 102
            K+    K+GEG +G VYK    +G  +A+KR+       G     +RE+    S++ ++
Sbjct: 21  EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREI----SLLKEL 76

Query: 103 QHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRV--QIIEGIAQG 160
            H N+V L+          L++E+M  K L   L +    +    +     Q++ G+A  
Sbjct: 77  HHPNIVSLIDVIHSERCLTLVFEFME-KDLKKVLDENKTGLQDSQIKIYLYQLLRGVA-- 133

Query: 161 LLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYM 220
             + HQ+   RI+HRDLK  N+L++ D   K++DFG+AR   G  +++ T  +V T  Y 
Sbjct: 134 --HCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAF-GIPVRSYTHEVV-TLWYR 186

Query: 221 SPEYAL-EGIFSIKSDVFSFGVLLLEIVSGK 250
           +P+  +    +S   D++S G +  E+++GK
Sbjct: 187 APDVLMGSKKYSTSVDIWSIGCIFAEMITGK 217

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  107 bits (268), Expect = 3e-26
 Identities = 34/239 (14%), Positives = 72/239 (30%), Gaps = 54/239 (22%)

Query: 57  LGEGGFGPVYKGVLKK-GDEIAVKRLSGR---SGQGLREMKNEASVIAKVQ--------- 103
           LG+       +   ++ G+   V             +++MK E   +  ++         
Sbjct: 81  LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 140

Query: 104 ----------------HKNLVRLLGCCIDRDEK--ILIYEYMPNKSLDFF--LFD-PTKR 142
                            K ++R+     D        +Y  M +    F   L    +  
Sbjct: 141 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 200

Query: 143 MLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICG 202
             L    R+Q+   + + L  LH Y    ++H  L+  +I+LD+     ++ F      G
Sbjct: 201 KSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG 257

Query: 203 GNELQANTSRIVGTYGYMSPEYAL-----------EGIFSIKSDVFSFGVLLLEIVSGK 250
                        + G+  PE                + +   D ++ G+++  I    
Sbjct: 258 ------ARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCAD 310

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  106 bits (267), Expect = 3e-26
 Identities = 29/216 (13%), Positives = 66/216 (30%), Gaps = 24/216 (11%)

Query: 55  NKLGEGGFGPVYKGV------LKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLV 108
           + LGEG F  VY+         K   +  +K     +             +        +
Sbjct: 71  HLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFM 130

Query: 109 RLLGCCIDRDEKILIYEYMPNKSLDFFL---FDPTKRMLLDWVTRVQIIEGIAQGLLYLH 165
           +     + ++  +L+ E     +L   +    +  ++++   +     +  +   +  +H
Sbjct: 131 KFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMR-MLYMIEQVH 189

Query: 166 QYSRVRIIHRDLKASNILL-----------DKDMNPKISDFGMARICGGNELQANTSRIV 214
                 IIH D+K  N +L           D      + D G +            +   
Sbjct: 190 D---CEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKC 246

Query: 215 GTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 250
            T G+   E      ++ + D F     +  ++ G 
Sbjct: 247 ETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGT 282

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  104 bits (263), Expect = 4e-26
 Identities = 66/217 (30%), Positives = 97/217 (44%), Gaps = 41/217 (18%)

Query: 48  TNKFSDA----NKLGEGGFGPVYKGVLKK-GDEIAVK-----RLSGRSGQGLREMKNEAS 97
           + KFSD      +LG+G F  V + V K  G E A K     +LS R  Q L     EA 
Sbjct: 1   STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLE---REAR 57

Query: 98  VIAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRV------ 151
           +  K+QH N+VRL     +     L+++ +        LF+       D V R       
Sbjct: 58  ICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGE----LFE-------DIVAREFYSEAD 106

Query: 152 --QIIEGIAQGLLYLHQYSRVRIIHRDLKASNILL---DKDMNPKISDFGMARICGGNEL 206
               I+ I + + Y H      I+HR+LK  N+LL    K    K++DFG+A     +E 
Sbjct: 107 ASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA 163

Query: 207 QANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLL 243
                   GT GY+SPE   +  +S   D+++ GV+L
Sbjct: 164 ---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVIL 197

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  106 bits (267), Expect = 6e-26
 Identities = 51/227 (22%), Positives = 81/227 (35%), Gaps = 32/227 (14%)

Query: 49  NKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKV-QHKNL 107
           N       LG G  G V      +G  +AVKR+             E  ++ +   H N+
Sbjct: 15  NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF---CDIALMEIKLLTESDDHPNV 71

Query: 108 VRLLGCCIDRDEKILIYEYMPNKSLDFFL---FDPTKRMLLDWVTRVQIIEGIAQGLLYL 164
           +R            +  E       D             L      + ++  IA G+ +L
Sbjct: 72  IRYYCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHL 131

Query: 165 HQYSRVRIIHRDLKASNILLD-------------KDMNPKISDFGMARICGGNE--LQAN 209
           H    ++IIHRDLK  NIL+              +++   ISDFG+ +     +   + N
Sbjct: 132 HS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTN 188

Query: 210 TSRIVGTYGYMSPEYALEGIFSI-------KSDVFSFGVLLLEIVSG 249
            +   GT G+ +PE   E              D+FS G +   I+S 
Sbjct: 189 LNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSK 235

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  105 bits (264), Expect = 9e-26
 Identities = 58/254 (22%), Positives = 100/254 (39%), Gaps = 47/254 (18%)

Query: 19  PANNKQAKRSKKKEVDQFPLFSFSSVSTATNKFSDA----NKLGEGGFGPVYKGVLKK-G 73
             N+ Q K ++                 A  +F       + +G G    V + V +  G
Sbjct: 60  KLNDAQPKGTENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATG 119

Query: 74  DEIAVK-------RLSGRSGQGLREM-KNEASVIAKV-QHKNLVRLLGCCIDRDEKILIY 124
            E AVK       RLS    + +RE  + E  ++ +V  H +++ L+          L++
Sbjct: 120 HEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVF 179

Query: 125 EYMPNKSLDFFLFDPTKRMLLDWVTRVQ---------IIEGIAQGLLYLHQYSRVRIIHR 175
           + M                L D++T            I+  + + + +LH      I+HR
Sbjct: 180 DLMRKGE------------LFDYLTEKVALSEKETRSIMRSLLEAVSFLHAN---NIVHR 224

Query: 176 DLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE------YALEGI 229
           DLK  NILLD +M  ++SDFG +      E       + GT GY++PE            
Sbjct: 225 DLKPENILLDDNMQIRLSDFGFSCHLEPGEK---LRELCGTPGYLAPEILKCSMDETHPG 281

Query: 230 FSIKSDVFSFGVLL 243
           +  + D+++ GV+L
Sbjct: 282 YGKEVDLWACGVIL 295

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  104 bits (261), Expect = 9e-26
 Identities = 46/201 (22%), Positives = 85/201 (42%), Gaps = 32/201 (15%)

Query: 56  KLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCC 114
            LG G F  V+    +  G   A+K +          ++NE +V+ K++H+N+V L    
Sbjct: 16  VLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIY 75

Query: 115 IDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTR---------VQIIEGIAQGLLYLH 165
                  L+ + +            +   L D +             +I+ +   + YLH
Sbjct: 76  ESTTHYYLVMQLV------------SGGELFDRILERGVYTEKDASLVIQQVLSAVKYLH 123

Query: 166 QYSRVRIIHRDLKASNILL---DKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSP 222
           +     I+HRDLK  N+L    +++    I+DFG++++     +        GT GY++P
Sbjct: 124 EN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMST----ACGTPGYVAP 176

Query: 223 EYALEGIFSIKSDVFSFGVLL 243
           E   +  +S   D +S GV+ 
Sbjct: 177 EVLAQKPYSKAVDCWSIGVIT 197

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score =  103 bits (260), Expect = 1e-25
 Identities = 59/211 (27%), Positives = 105/211 (49%), Gaps = 23/211 (10%)

Query: 49  NKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLS------GRSGQGLREMKNEASVIAKV 102
            K+    K+GEG +G VYK     G+  A+K++       G     +RE+    S++ ++
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREI----SILKEL 57

Query: 103 QHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRV--QIIEGIAQG 160
           +H N+V+L      +   +L++E++  + L   L      +          Q++ GIA  
Sbjct: 58  KHSNIVKLYDVIHTKKRLVLVFEHLD-QDLKKLLDVCEGGLESVTAKSFLLQLLNGIA-- 114

Query: 161 LLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYM 220
             Y H     R++HRDLK  N+L++++   KI+DFG+AR   G  ++  T  IV T  Y 
Sbjct: 115 --YCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAF-GIPVRKYTHEIV-TLWYR 167

Query: 221 SPEYAL-EGIFSIKSDVFSFGVLLLEIVSGK 250
           +P+  +    +S   D++S G +  E+V+G 
Sbjct: 168 APDVLMGSKKYSTTIDIWSVGCIFAEMVNGT 198

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score =  103 bits (260), Expect = 1e-25
 Identities = 51/207 (24%), Positives = 103/207 (49%), Gaps = 24/207 (11%)

Query: 55  NKLGEGGFGPVYKGVLKKGDEI-AVKRLS------GRSGQGLREMKNEASVIAKVQHKNL 107
            K+GEG +G V+K   ++  EI A+KR+       G     LRE+     ++ +++HKN+
Sbjct: 8   EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREI----CLLKELKHKNI 63

Query: 108 VRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRV--QIIEGIAQGLLYLH 165
           VRL        +  L++E+   + L  +       +  + V     Q+++G+     + H
Sbjct: 64  VRLHDVLHSDKKLTLVFEFCD-QDLKKYFDSCNGDLDPEIVKSFLFQLLKGLG----FCH 118

Query: 166 QYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYA 225
                 ++HRDLK  N+L++++   K+++FG+AR   G  ++  ++ +V T  Y  P+  
Sbjct: 119 SR---NVLHRDLKPQNLLINRNGELKLANFGLARAF-GIPVRCYSAEVV-TLWYRPPDVL 173

Query: 226 L-EGIFSIKSDVFSFGVLLLEIVSGKK 251
               ++S   D++S G +  E+ +  +
Sbjct: 174 FGAKLYSTSIDMWSAGCIFAELANAGR 200

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score =  104 bits (261), Expect = 1e-25
 Identities = 64/218 (29%), Positives = 117/218 (53%), Gaps = 26/218 (11%)

Query: 46  TATNKFSDANKLGEGGFGPVYKGVLKKGDEI-AVKRLSGRSGQG-----LREMKNEASVI 99
           +++++F    KLG G +  VYKG+ K      A+K +   S +G     +RE+    S++
Sbjct: 2   SSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREI----SLM 57

Query: 100 AKVQHKNLVRLLGCCIDRDEKILIYEYMPN---KSLDFFLFDPTKRMLLDWVTR---VQI 153
            +++H+N+VRL       ++  L++E+M N   K +D      T R L   + +    Q+
Sbjct: 58  KELKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQL 117

Query: 154 IEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRI 213
           ++G+A    + H+    +I+HRDLK  N+L++K    K+ DFG+AR   G  +   +S +
Sbjct: 118 LQGLA----FCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAF-GIPVNTFSSEV 169

Query: 214 VGTYGYMSPEYAL-EGIFSIKSDVFSFGVLLLEIVSGK 250
           V T  Y +P+  +    +S   D++S G +L E+++GK
Sbjct: 170 V-TLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGK 206

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  103 bits (260), Expect = 1e-25
 Identities = 56/214 (26%), Positives = 86/214 (40%), Gaps = 44/214 (20%)

Query: 56  KLGEGGFGPVYKGVLKK-GDEIAVK--------RLSGRSGQGLREM-KNEASVIAKV-QH 104
            LG G    V + + K    E AVK          S    Q LRE    E  ++ KV  H
Sbjct: 24  ILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGH 83

Query: 105 KNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQ---------IIE 155
            N+++L           L+++ M    L             D++T            I+ 
Sbjct: 84  PNIIQLKDTYETNTFFFLVFDLMKKGEL------------FDYLTEKVTLSEKETRKIMR 131

Query: 156 GIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVG 215
            + + +  LH+     I+HRDLK  NILLD DMN K++DFG +      E       + G
Sbjct: 132 ALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK---LREVCG 185

Query: 216 TYGYMSPE------YALEGIFSIKSDVFSFGVLL 243
           T  Y++PE            +  + D++S GV++
Sbjct: 186 TPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIM 219

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  104 bits (262), Expect = 2e-25
 Identities = 60/233 (25%), Positives = 108/233 (46%), Gaps = 31/233 (13%)

Query: 25  AKRSKKKEVDQFPLFSFSSVSTATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSG 83
           A  +  +++ +   F  ++ +  ++ +    +LG+G F  V + V K  G E A K ++ 
Sbjct: 5   ASMTGGQQMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINT 64

Query: 84  R--SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTK 141
           +  S +  ++++ EA +  K+QH N+VRL     +     L+++ +    L    F+   
Sbjct: 65  KKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGEL----FE--- 117

Query: 142 RMLLDWVTRV--------QIIEGIAQGLLYLHQYSRVRIIHRDLKASNILL---DKDMNP 190
               D V R           I+ I + + Y H      I+HR+LK  N+LL    K    
Sbjct: 118 ----DIVAREFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAV 170

Query: 191 KISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLL 243
           K++DFG+A     +E         GT GY+SPE   +  +S   D+++ GV+L
Sbjct: 171 KLADFGLAIEVNDSEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVIL 220

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  103 bits (258), Expect = 2e-25
 Identities = 55/208 (26%), Positives = 88/208 (42%), Gaps = 38/208 (18%)

Query: 56  KLGEGGFGPVYKGVLKK-GDEIAVK-----RLSGRSGQGLREM-KNEASVIAKVQHKNLV 108
           +LG G F  V K   K  G E A K     RLS       RE  + E +++ +++H N++
Sbjct: 12  ELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNII 71

Query: 109 RLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLD---------WVTRVQIIEGIAQ 159
            L     ++ + +LI E +    L    FD    +               + QI++G+  
Sbjct: 72  TLHDIFENKTDVVLILELVSGGEL----FD---FLAEKESLTEDEATQFLK-QILDGVH- 122

Query: 160 GLLYLHQYSRVRIIHRDLKASNILL----DKDMNPKISDFGMARICGGNELQANTSRIVG 215
              YLH     RI H DLK  NI+L      +   K+ DFG+A              I G
Sbjct: 123 ---YLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGN---EFKNIFG 173

Query: 216 TYGYMSPEYALEGIFSIKSDVFSFGVLL 243
           T  +++PE        +++D++S GV+ 
Sbjct: 174 TPEFVAPEIVNYEPLGLEADMWSIGVIT 201

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  103 bits (259), Expect = 2e-25
 Identities = 57/200 (28%), Positives = 88/200 (44%), Gaps = 22/200 (11%)

Query: 56  KLGEGGFGPVYKGVLKK-GDEIAVK-----RLSGRSGQGLRE-MKNEASVIAKVQHKNLV 108
           +LG G F  V K   K  G E A K     +         RE ++ E S++ +V H N++
Sbjct: 19  ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVI 78

Query: 109 RLLGCCIDRDEKILIYEYMPNKSLDFFLFDP-TKRMLLDWVTRVQIIEGIAQGLLYLHQY 167
            L     +R + +LI E +        LFD   ++  L        I+ I  G+ YLH  
Sbjct: 79  TLHDVYENRTDVVLILELVSGGE----LFDFLAQKESLSEEEATSFIKQILDGVNYLHTK 134

Query: 168 SRVRIIHRDLKASNILL-DKDMNP---KISDFGMARICGGNELQANTSRIVGTYGYMSPE 223
               I H DLK  NI+L DK++     K+ DFG+A              I GT  +++PE
Sbjct: 135 K---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE---FKNIFGTPEFVAPE 188

Query: 224 YALEGIFSIKSDVFSFGVLL 243
                   +++D++S GV+ 
Sbjct: 189 IVNYEPLGLEADMWSIGVIT 208

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  104 bits (261), Expect = 2e-25
 Identities = 55/200 (27%), Positives = 85/200 (42%), Gaps = 22/200 (11%)

Query: 56  KLGEGGFGPVYKGVLKK-GDEIAVK-----RLSGRSGQGLRE-MKNEASVIAKVQHKNLV 108
           +LG G F  V K   K  G E A K     +         RE ++ E S++ +V H N++
Sbjct: 19  ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNII 78

Query: 109 RLLGCCIDRDEKILIYEYMPNKSLDFFLFDP-TKRMLLDWVTRVQIIEGIAQGLLYLHQY 167
            L     +R + +LI E +        LFD   ++  L        I+ I  G+ YLH  
Sbjct: 79  TLHDVYENRTDVVLILELVSGGE----LFDFLAQKESLSEEEATSFIKQILDGVNYLHTK 134

Query: 168 SRVRIIHRDLKASNILL----DKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE 223
               I H DLK  NI+L        + K+ DFG+A              I GT  +++PE
Sbjct: 135 K---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE---FKNIFGTPEFVAPE 188

Query: 224 YALEGIFSIKSDVFSFGVLL 243
                   +++D++S GV+ 
Sbjct: 189 IVNYEPLGLEADMWSIGVIT 208

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  103 bits (259), Expect = 3e-25
 Identities = 52/280 (18%), Positives = 93/280 (33%), Gaps = 58/280 (20%)

Query: 21  NNKQAKRSKKKEVDQFPLFSFSSVSTATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVK 79
           ++     S ++ +     F   S+     K+     +G+G +G V   +  +     A+K
Sbjct: 2   HHHHHHSSGRENLY----FQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIK 57

Query: 80  -----RLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIYEYM------- 127
                ++   + + +  +K E  ++ K+ H N+ RL     D     L+ E         
Sbjct: 58  IMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLD 117

Query: 128 ------------------PNKSLDFFLFDPTKRMLLDWVTRV------------QIIEGI 157
                               +       +           R              I+  I
Sbjct: 118 KLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQI 177

Query: 158 AQGLLYLHQYSRVRIIHRDLKASNILL--DKDMNPKISDFGMARICGGNELQANT--SRI 213
              L YLH      I HRD+K  N L   +K    K+ DFG+++             +  
Sbjct: 178 FSALHYLHNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTK 234

Query: 214 VGTYGYMSPEYALEGI---FSIKSDVFSFGVLLLEIVSGK 250
            GT  +++PE  L      +  K D +S GVLL  ++ G 
Sbjct: 235 AGTPYFVAPE-VLNTTNESYGPKCDAWSAGVLLHLLLMGA 273

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  103 bits (258), Expect = 3e-25
 Identities = 44/193 (22%), Positives = 83/193 (43%), Gaps = 16/193 (8%)

Query: 56  KLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCC 114
            LG G FG V++ V          K +  + G     +K E S++   +H+N++ L    
Sbjct: 12  DLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESF 70

Query: 115 IDRDEKILIYEYMPNKSLDFFLFD--PTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRI 172
              +E ++I+E++    +    F+   T    L+    V  +  + + L +LH ++   I
Sbjct: 71  ESMEELVMIFEFISGLDI----FERINTSAFELNEREIVSYVHQVCEALQFLHSHN---I 123

Query: 173 IHRDLKASNILL--DKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIF 230
            H D++  NI+    +    KI +FG AR     +       +     Y +PE     + 
Sbjct: 124 GHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL---LFTAPEYYAPEVHQHDVV 180

Query: 231 SIKSDVFSFGVLL 243
           S  +D++S G L+
Sbjct: 181 STATDMWSLGTLV 193

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score =  101 bits (255), Expect = 7e-25
 Identities = 60/213 (28%), Positives = 96/213 (45%), Gaps = 34/213 (15%)

Query: 57  LGEGGFGPVYKGV-LKKGDEIAVKRLS----GRSGQGLREMKNEASVIAKVQHKNLVRLL 111
           LGEG +G V + +  +     AVK L      R   G   +K E  ++ +++HKN+++L+
Sbjct: 13  LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72

Query: 112 GCCIDRDEKILIY---EYMPNKSLDFFLFD--PTKRMLLDWVTR---VQIIEGIAQGLLY 163
              +  +EK  +Y   EY      +  + D  P KR            Q+I+G+     Y
Sbjct: 73  DV-LYNEEKQKMYMVMEYCVCGMQE--MLDSVPEKR-FPVCQAHGYFCQLIDGLE----Y 124

Query: 164 LHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARI----CGGNELQANTSRIVGTYGY 219
           LH      I+H+D+K  N+LL      KIS  G+A         +  +  TS+  G+  +
Sbjct: 125 LHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCR--TSQ--GSPAF 177

Query: 220 MSPEYA--LEGIFSIKSDVFSFGVLLLEIVSGK 250
             PE A  L+     K D++S GV L  I +G 
Sbjct: 178 QPPEIANGLDTFSGFKVDIWSAGVTLYNITTGL 210

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  102 bits (256), Expect = 7e-25
 Identities = 55/208 (26%), Positives = 84/208 (40%), Gaps = 38/208 (18%)

Query: 56  KLGEGGFGPVYKGVLKK-GDEIAVK-----RLSGRSGQGLRE-MKNEASVIAKVQHKNLV 108
           +LG G F  V K   K  G + A K     R         RE ++ E S++ ++QH N++
Sbjct: 18  ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77

Query: 109 RLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLD---------WVTRVQIIEGIAQ 159
            L     ++ + ILI E +    L    FD    +               + QI+ G+  
Sbjct: 78  TLHEVYENKTDVILILELVAGGEL----FD---FLAEKESLTEEEATEFLK-QILNGVY- 128

Query: 160 GLLYLHQYSRVRIIHRDLKASNILL----DKDMNPKISDFGMARICGGNELQANTSRIVG 215
              YLH      I H DLK  NI+L          KI DFG+A              I G
Sbjct: 129 ---YLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIFG 179

Query: 216 TYGYMSPEYALEGIFSIKSDVFSFGVLL 243
           T  +++PE        +++D++S GV+ 
Sbjct: 180 TPEFVAPEIVNYEPLGLEADMWSIGVIT 207

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score =  102 bits (256), Expect = 9e-25
 Identities = 58/239 (24%), Positives = 114/239 (47%), Gaps = 39/239 (16%)

Query: 35  QFPLFSFSSVSTATNKFSDANKLGEGGFGPVYKGVLKKGDEI-AVKRL---SGRSG---Q 87
           Q+            +K+    K+G+G FG V+K   +K  +  A+K++   + + G    
Sbjct: 4   QYDSVECPFCDEV-SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPIT 62

Query: 88  GLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKI--------LIYEYMPN--KSLDFFLF 137
            LRE+K    ++  ++H+N+V L+  C  +            L++++  +    L   L 
Sbjct: 63  ALREIK----ILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGL---LS 115

Query: 138 DPTKRMLLDWVTRV--QIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDF 195
           +   +  L  + RV   ++ G+     Y+H+    +I+HRD+KA+N+L+ +D   K++DF
Sbjct: 116 NVLVKFTLSEIKRVMQMLLNGLY----YIHRN---KILHRDMKAANVLITRDGVLKLADF 168

Query: 196 GMARICG---GNELQANTSRIVGTYGYMSPEYAL-EGIFSIKSDVFSFGVLLLEIVSGK 250
           G+AR       ++    T+R+V T  Y  PE  L E  +    D++  G ++ E+ +  
Sbjct: 169 GLARAFSLAKNSQPNRYTNRVV-TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRS 226

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  103 bits (258), Expect = 1e-24
 Identities = 56/255 (21%), Positives = 100/255 (39%), Gaps = 47/255 (18%)

Query: 17  ELPANNKQAKRSKKKEVDQFPLFSFSSVSTATNKFSD----ANKLGEGGFGPVYKGVLKK 72
            L  N++ A    + +V  F   +    S       D    +  LG G  G V     +K
Sbjct: 99  PLNNNSEIALSLSRNKVFVFFDLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLAFERK 158

Query: 73  -GDEIAVK-----RLSGRSGQGLRE---MKNEASVIAKVQHKNLVRLLGCCIDRDEKILI 123
              ++A++     + +  S +       ++ E  ++ K+ H  ++++     D ++  ++
Sbjct: 159 TCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNF-FDAEDYYIV 217

Query: 124 YEYMPNKSLDFFLFDPTKRMLLDWVTRVQ---------IIEGIAQGLLYLHQYSRVRIIH 174
            E M    L             D V   +             +   + YLH+     IIH
Sbjct: 218 LELMEGGEL------------FDKVVGNKRLKEATCKLYFYQMLLAVQYLHEN---GIIH 262

Query: 175 RDLKASNILL---DKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE---YALEG 228
           RDLK  N+LL   ++D   KI+DFG ++I G   L      + GT  Y++PE        
Sbjct: 263 RDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL---MRTLCGTPTYLAPEVLVSVGTA 319

Query: 229 IFSIKSDVFSFGVLL 243
            ++   D +S GV+L
Sbjct: 320 GYNRAVDCWSLGVIL 334

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score =  101 bits (253), Expect = 2e-24
 Identities = 57/211 (27%), Positives = 104/211 (49%), Gaps = 23/211 (10%)

Query: 49  NKFSDANKLGEGGFGPVYKGVLKKGDEI-AVKRLSGRSGQG-----LREMKNEASVIAKV 102
             +   +KLGEG +  VYKG  K  D + A+K +     +G     +RE+    S++  +
Sbjct: 2   ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREV----SLLKDL 57

Query: 103 QHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRV--QIIEGIAQG 160
           +H N+V L           L++EY+ +K L  +L D    + +  V     Q++ G+A  
Sbjct: 58  KHANIVTLHDIIHTEKSLTLVFEYL-DKDLKQYLDDCGNIINMHNVKLFLFQLLRGLA-- 114

Query: 161 LLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYM 220
             Y H+    +++HRDLK  N+L+++    K++DFG+AR       +   + +V T  Y 
Sbjct: 115 --YCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAK-SIPTKTYDNEVV-TLWYR 167

Query: 221 SPEYAL-EGIFSIKSDVFSFGVLLLEIVSGK 250
            P+  L    +S + D++  G +  E+ +G+
Sbjct: 168 PPDILLGSTDYSTQIDMWGVGCIFYEMATGR 198

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score =  101 bits (253), Expect = 2e-24
 Identities = 56/192 (29%), Positives = 100/192 (52%), Gaps = 26/192 (13%)

Query: 44  VSTATNKFSDANKLGEGGFGPVYKGVLKKGDEI-AVK--RLSGRSGQ-------GLREMK 93
           V +   ++   + LGEG F  VYK   K  ++I A+K  +L  RS          LRE+K
Sbjct: 5   VKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIK 64

Query: 94  NEASVIAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTR--V 151
               ++ ++ H N++ LL     +    L++++M    L+  + D +  +    +    +
Sbjct: 65  ----LLQELSHPNIIGLLDAFGHKSNISLVFDFME-TDLEVIIKDNSLVLTPSHIKAYML 119

Query: 152 QIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTS 211
             ++G+     YLHQ+    I+HRDLK +N+LLD++   K++DFG+A+   G+  +A T 
Sbjct: 120 MTLQGLE----YLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSF-GSPNRAYTH 171

Query: 212 RIVGTYGYMSPE 223
           ++V T  Y +PE
Sbjct: 172 QVV-TRWYRAPE 182

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score =  100 bits (252), Expect = 3e-24
 Identities = 56/212 (26%), Positives = 97/212 (45%), Gaps = 24/212 (11%)

Query: 49  NKFSDANKLGEGGFGPVYKGVLKKGDEI-AVKRL------SGRSGQGLREMKNEASVIAK 101
            K+ +   +GEG +G V K   K    I A+K+              +RE+K    ++ +
Sbjct: 25  EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIK----LLKQ 80

Query: 102 VQHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRV--QIIEGIAQ 159
           ++H+NLV LL  C  +    L++E++ + ++   L      +    V +   QII GI  
Sbjct: 81  LRHENLVNLLEVCKKKKRWYLVFEFV-DHTILDDLELFPNGLDYQVVQKYLFQIINGIG- 138

Query: 160 GLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGY 219
              + H +    IIHRD+K  NIL+ +    K+ DFG AR       +     +  T  Y
Sbjct: 139 ---FCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAA-PGEVYDDEVA-TRWY 190

Query: 220 MSPEYAL-EGIFSIKSDVFSFGVLLLEIVSGK 250
            +PE  + +  +    DV++ G L+ E+  G+
Sbjct: 191 RAPELLVGDVKYGKAVDVWAIGCLVTEMFMGE 222

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score =  100 bits (250), Expect = 5e-24
 Identities = 56/201 (27%), Positives = 88/201 (43%), Gaps = 26/201 (12%)

Query: 56  KLGEGGFGPVYKGVLKK-GDEIAVKRLSGR--SGQGLREMKNEASVIAKVQH-KNLVRLL 111
           +LG G F  V + + K  G E A K L  R        E+ +E +V+   +    ++ L 
Sbjct: 36  ELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLH 95

Query: 112 GCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTR------VQIIEGIAQGLLYLH 165
               +  E ILI EY         +F      L +          +++I+ I +G+ YLH
Sbjct: 96  EVYENTSEIILILEYAAGGE----IFS---LCLPELAEMVSENDVIRLIKQILEGVYYLH 148

Query: 166 QYSRVRIIHRDLKASNILL---DKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSP 222
           Q     I+H DLK  NILL       + KI DFGM+R  G          I+GT  Y++P
Sbjct: 149 QN---NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHAC---ELREIMGTPEYLAP 202

Query: 223 EYALEGIFSIKSDVFSFGVLL 243
           E       +  +D+++ G++ 
Sbjct: 203 EILNYDPITTATDMWNIGIIA 223

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  101 bits (254), Expect = 5e-24
 Identities = 51/219 (23%), Positives = 91/219 (41%), Gaps = 36/219 (16%)

Query: 44  VSTATNKFSDA----NKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLREM--KNEA 96
            +    +F++      +LG+G F  V + V    G E A   ++ +          + EA
Sbjct: 2   ATITCTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREA 61

Query: 97  SVIAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTR------ 150
            +   ++H N+VRL     +     LI++ +            T   L + +        
Sbjct: 62  RICRLLKHPNIVRLHDSISEEGHHYLIFDLV------------TGGELFEDIVAREYYSE 109

Query: 151 ---VQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILL---DKDMNPKISDFGMARICGGN 204
                 I+ I + +L+ HQ     ++HR+LK  N+LL    K    K++DFG+A    G 
Sbjct: 110 ADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGE 166

Query: 205 ELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLL 243
           +         GT GY+SPE   +  +    D+++ GV+L
Sbjct: 167 QQAWFG--FAGTPGYLSPEVLRKDPYGKPVDLWACGVIL 203

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score =  102 bits (255), Expect = 6e-24
 Identities = 58/198 (29%), Positives = 92/198 (46%), Gaps = 11/198 (5%)

Query: 57  LGEGGFGPVYKGVLKKGDEI-AVKRLSGR---SGQGLREMKNEASVIAKVQHKNLVRLLG 112
           LG+GGFG V    ++   ++ A K+L  +     +G     NE  ++ KV  + +V L  
Sbjct: 192 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAY 251

Query: 113 CCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRI 172
               +D   L+   M    L F ++   +    +        E I  GL  LH+    RI
Sbjct: 252 AYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAE-ICCGLEDLHRE---RI 307

Query: 173 IHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSI 232
           ++RDLK  NILLD   + +ISD G+A      +        VGT GYM+PE      ++ 
Sbjct: 308 VYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT---IKGRVGTVGYMAPEVVKNERYTF 364

Query: 233 KSDVFSFGVLLLEIVSGK 250
             D ++ G LL E+++G+
Sbjct: 365 SPDWWALGCLLYEMIAGQ 382

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 98.5 bits (246), Expect = 9e-24
 Identities = 59/232 (25%), Positives = 99/232 (42%), Gaps = 53/232 (22%)

Query: 57  LGEGGFGPVYKGV-LKKGDEIAVKRLS----------------------GRSGQGLREM- 92
           +G+G +G V            A+K LS                             R   
Sbjct: 21  IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80

Query: 93  ---KNEASVIAKVQHKNLVRLLGCCIDRDEKILIY---EYMPNKSLDFFLFD-PTKRMLL 145
                E +++ K+ H N+V+L+   +D   +  +Y   E +    +     + PT + L 
Sbjct: 81  EQVYQEIAILKKLDHPNVVKLV-EVLDDPNEDHLYMVFELVNQGPV----MEVPTLKPLS 135

Query: 146 DWVTRV---QIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICG 202
           +   R     +I+GI     YLH     +IIHRD+K SN+L+ +D + KI+DFG++    
Sbjct: 136 EDQARFYFQDLIKGIE----YLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFGVSNEFK 188

Query: 203 GNELQANTSRIVGTYGYMSPEYALEGIFSI----KSDVFSFGVLLLEIVSGK 250
           G++   + +  VGT  +M+PE +L     I      DV++ GV L   V G+
Sbjct: 189 GSDALLSNT--VGTPAFMAPE-SLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score =  101 bits (253), Expect = 1e-23
 Identities = 57/199 (28%), Positives = 94/199 (47%), Gaps = 10/199 (5%)

Query: 57  LGEGGFGPVYKGVLKKGDEI-AVKRLSGR---SGQGLREMKNEASVIAKVQHKNLVRLLG 112
           LG GGFG V+   +K   ++ A K+L+ +     +G +    E  ++AKV  + +V L  
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAY 252

Query: 113 CCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQI-IEGIAQGLLYLHQYSRVR 171
               + +  L+   M    + + +++  +        R       I  GL +LHQ     
Sbjct: 253 AFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR---N 309

Query: 172 IIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFS 231
           II+RDLK  N+LLD D N +ISD G+A      + +       GT G+M+PE  L   + 
Sbjct: 310 IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGY--AGTPGFMAPELLLGEEYD 367

Query: 232 IKSDVFSFGVLLLEIVSGK 250
              D F+ GV L E+++ +
Sbjct: 368 FSVDYFALGVTLYEMIAAR 386

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 99.7 bits (249), Expect = 1e-23
 Identities = 57/224 (25%), Positives = 100/224 (44%), Gaps = 44/224 (19%)

Query: 48  TNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNL 107
              +++   +G G FG V++  L + DE+A+K++        RE++    ++  V+H N+
Sbjct: 39  EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKNRELQ----IMRIVKHPNV 94

Query: 108 VRLLGC----CIDRDEKI--LIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEG----- 156
           V L          +DE    L+ EY+P +++         R    +    Q +       
Sbjct: 95  VDLKAFFYSNGDKKDEVFLNLVLEYVP-ETV--------YRASRHYAKLKQTMPMLLIKL 145

Query: 157 ----IAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNP-KISDFGMARICGGNELQANTS 211
               + + L Y+H    + I HRD+K  N+LLD      K+ DFG A+I      + N S
Sbjct: 146 YMYQLLRSLAYIHS---IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL--IAGEPNVS 200

Query: 212 RIVGTYGYMSPEYALEGIF-----SIKSDVFSFGVLLLEIVSGK 250
            I   Y Y +PE     IF     +   D++S G ++ E++ G+
Sbjct: 201 YICSRY-YRAPEL----IFGATNYTTNIDIWSTGCVMAELMQGQ 239

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 98.5 bits (246), Expect = 1e-23
 Identities = 52/204 (25%), Positives = 88/204 (43%), Gaps = 27/204 (13%)

Query: 56  KLGEGGFGPVYKGVLKK-GDEIAVK-----RLSGRSGQGLRE---MKNEASVIAKVQHKN 106
            LG G  G V     +K   ++A+K     + +  S +       ++ E  ++ K+ H  
Sbjct: 17  TLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 76

Query: 107 LVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDP-TKRMLLDWVTRVQIIEGIAQGLLYLH 165
           ++++     D ++  ++ E M        LFD       L   T       +   + YLH
Sbjct: 77  IIKIKN-FFDAEDYYIVLELMEGGE----LFDKVVGNKRLKEATCKLYFYQMLLAVQYLH 131

Query: 166 QYSRVRIIHRDLKASNILL---DKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSP 222
           +     IIHRDLK  N+LL   ++D   KI+DFG ++I G   L      + GT  Y++P
Sbjct: 132 EN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL---MRTLCGTPTYLAP 185

Query: 223 E---YALEGIFSIKSDVFSFGVLL 243
           E         ++   D +S GV+L
Sbjct: 186 EVLVSVGTAGYNRAVDCWSLGVIL 209

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 97.6 bits (244), Expect = 3e-23
 Identities = 59/232 (25%), Positives = 100/232 (43%), Gaps = 46/232 (19%)

Query: 45  STATNKFSDANKLGEGGFGPVYKGVLKKGDEI-AVKRL------SGRSG---QGLRE--- 91
           S AT+++    ++G G +G VYK          A+K +       G  G     +RE   
Sbjct: 5   SMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVAL 64

Query: 92  MKNEASVIAKVQHKNLVRLL----GCCIDRDEKI-LIYEYMP--------NKSLDFFLFD 138
           ++     +   +H N+VRL+        DR+ K+ L++E++                  +
Sbjct: 65  LRR----LEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAE 120

Query: 139 PTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMA 198
             K ++       Q + G+     +LH      I+HRDLK  NIL+      K++DFG+A
Sbjct: 121 TIKDLMR------QFLRGLD----FLHAN---CIVHRDLKPENILVTSGGTVKLADFGLA 167

Query: 199 RICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 250
           RI       A T  +V T  Y +PE  L+  ++   D++S G +  E+   K
Sbjct: 168 RIYSYQ--MALTPVVV-TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 97.7 bits (244), Expect = 3e-23
 Identities = 61/221 (27%), Positives = 101/221 (45%), Gaps = 30/221 (13%)

Query: 45  STATNKFSDANKLGEGGFGPVYKGVLKKGDEI-AVKRLS------GRSGQGLREMKNEAS 97
           +T+ +++    KLGEG +G VYK +    +E  A+KR+       G  G  +RE+    S
Sbjct: 30  ATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREV----S 85

Query: 98  VIAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRV--QIIE 155
           ++ ++QH+N++ L           LI+EY     L  ++ D    + +  +     Q+I 
Sbjct: 86  LLKELQHRNIIELKSVIHHNHRLHLIFEYA-ENDLKKYM-DKNPDVSMRVIKSFLYQLIN 143

Query: 156 GIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNP-----KISDFGMARICGGNELQANT 210
           G+     + H     R +HRDLK  N+LL           KI DFG+AR   G  ++  T
Sbjct: 144 GVN----FCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF-GIPIRQFT 195

Query: 211 SRIVGTYGYMSPEYAL-EGIFSIKSDVFSFGVLLLEIVSGK 250
             I+ T  Y  PE  L    +S   D++S   +  E++   
Sbjct: 196 HEII-TLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKT 235

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 99.1 bits (247), Expect = 3e-23
 Identities = 53/218 (24%), Positives = 99/218 (45%), Gaps = 35/218 (16%)

Query: 56  KLGEGGFGPVYKGVLKK---GDEIAVKRLS--GRSGQGLREMKNEASVIAKVQHKNLVRL 110
           K+G G +G VYK   K      + A+K++   G S    RE+     ++ +++H N++ L
Sbjct: 28  KVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIA----LLRELKHPNVISL 83

Query: 111 LGCCIDR-DEKI-LIYEYMPN---KSLDFFLFDPTKRMLLDWVTRV------QIIEGIAQ 159
               +   D K+ L+++Y  +     + F       +  +     +      QI++GI  
Sbjct: 84  QKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIH- 142

Query: 160 GLLYLHQYSRVRIIHRDLKASNILLDKDMNP----KISDFGMARICG--GNELQANTSRI 213
              YLH      ++HRDLK +NIL+  +       KI+D G AR+       L      +
Sbjct: 143 ---YLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVV 196

Query: 214 VGTYGYMSPEYAL-EGIFSIKSDVFSFGVLLLEIVSGK 250
           V T+ Y +PE  L    ++   D+++ G +  E+++ +
Sbjct: 197 V-TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 233

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 97.2 bits (243), Expect = 4e-23
 Identities = 54/212 (25%), Positives = 97/212 (45%), Gaps = 24/212 (11%)

Query: 49  NKFSDANKLGEGGFGPVYKGVLKKGDEI-AVKRL------SGRSGQGLREMKNEASVIAK 101
            K+    K+GEG +G V+K   +   +I A+K+              LRE++    ++ +
Sbjct: 3   EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIR----MLKQ 58

Query: 102 VQHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRV--QIIEGIAQ 159
           ++H NLV LL     +    L++EY  + ++   L    + +    V  +  Q ++ +  
Sbjct: 59  LKHPNLVNLLEVFRRKRRLHLVFEYC-DHTVLHELDRYQRGVPEHLVKSITWQTLQAVN- 116

Query: 160 GLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGY 219
              + H++     IHRD+K  NIL+ K    K+ DFG AR+  G         +  T  Y
Sbjct: 117 ---FCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTG-PSDYYDDEVA-TRWY 168

Query: 220 MSPEYAL-EGIFSIKSDVFSFGVLLLEIVSGK 250
            SPE  + +  +    DV++ G +  E++SG 
Sbjct: 169 RSPELLVGDTQYGPPVDVWAIGCVFAELLSGV 200

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 97.3 bits (243), Expect = 4e-23
 Identities = 62/226 (27%), Positives = 106/226 (46%), Gaps = 44/226 (19%)

Query: 49  NKFSDANKLGEGGFGPVYKGV-LKKGDEI-AVKRL---SGRSG---QGLRE---MKNEAS 97
            ++    ++GEG +G V+K   LK G    A+KR+   +G  G     +RE   +++   
Sbjct: 11  QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRH--- 67

Query: 98  VIAKVQHKNLVRLL----GCCIDRDEKI-LIYEYMP--------NKSLDFFLFDPTKRML 144
            +   +H N+VRL         DR+ K+ L++E++                  +  K M+
Sbjct: 68  -LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMM 126

Query: 145 LDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGN 204
                  Q++ G+     +LH +   R++HRDLK  NIL+      K++DFG+ARI    
Sbjct: 127 F------QLLRGLD----FLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ 173

Query: 205 ELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 250
              A TS +V T  Y +PE  L+  ++   D++S G +  E+   K
Sbjct: 174 --MALTSVVV-TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 96.6 bits (241), Expect = 6e-23
 Identities = 52/210 (24%), Positives = 90/210 (42%), Gaps = 30/210 (14%)

Query: 57  LGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKNEASV---IA-------KVQHK 105
           LG+GGFG V+ G  L    ++A+K +      G   + +  +    +A          H 
Sbjct: 39  LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98

Query: 106 NLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTR---VQIIEGIAQGLL 162
            ++RLL     ++  +L+ E  P  + D F +   K  L +  +R    Q++  I     
Sbjct: 99  GVIRLLDWFETQEGFMLVLER-PLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQ---- 153

Query: 163 YLHQYSRVRIIHRDLKASNILLDKDMNP-KISDFGMARICGGNELQANTSRIVGTYGYMS 221
           + H      ++HRD+K  NIL+D      K+ DFG   +              GT  Y  
Sbjct: 154 HCHSR---GVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYT--DF--DGTRVYSP 206

Query: 222 PEYALEGI--FSIKSDVFSFGVLLLEIVSG 249
           PE+ +      ++ + V+S G+LL ++V G
Sbjct: 207 PEW-ISRHQYHALPATVWSLGILLYDMVCG 235

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 96.6 bits (241), Expect = 6e-23
 Identities = 51/210 (24%), Positives = 83/210 (39%), Gaps = 37/210 (17%)

Query: 57  LGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLREMKNEASVIAKVQ-HKNLVRLLGCC 114
           LGEG    V   +      E AVK +  + G     +  E  ++ + Q H+N++ L+   
Sbjct: 21  LGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFF 80

Query: 115 IDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRV--------QIIEGIAQGLLYLHQ 166
            + D   L++E M   S+          +      R          +++ +A  L +LH 
Sbjct: 81  EEEDRFYLVFEKMRGGSI----LS---HI----HKRRHFNELEASVVVQDVASALDFLHN 129

Query: 167 YSRVRIIHRDLKASNILL---DKDMNPKISDFGMARICGGNELQANTSR-----IVGTYG 218
                I HRDLK  NIL    ++    KI DF +      N   +  S        G+  
Sbjct: 130 ---KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAE 186

Query: 219 YMSPE-----YALEGIFSIKSDVFSFGVLL 243
           YM+PE          I+  + D++S GV+L
Sbjct: 187 YMAPEVVEAFSEEASIYDKRCDLWSLGVIL 216

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 96.6 bits (241), Expect = 7e-23
 Identities = 56/213 (26%), Positives = 86/213 (40%), Gaps = 36/213 (16%)

Query: 57  LGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKN------EASVIAKVQHK--NL 107
           LG GGFG VY G+ +     +A+K +         E+ N      E  ++ KV      +
Sbjct: 51  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110

Query: 108 VRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTR---VQIIEGIAQGLLYL 164
           +RLL      D  +LI E  P    D F F   +  L + + R    Q++E +     + 
Sbjct: 111 IRLLDWFERPDSFVLILER-PEPVQDLFDFITERGALQEELARSFFWQVLEAVR----HC 165

Query: 165 HQYSRVRIIHRDLKASNILLDKD-MNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE 223
           H      ++HRD+K  NIL+D +    K+ DFG   +              GT  Y  PE
Sbjct: 166 HNC---GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYT--DF--DGTRVYSPPE 218

Query: 224 YALEGIFSIK------SDVFSFGVLLLEIVSGK 250
                           + V+S G+LL ++V G 
Sbjct: 219 -----WIRYHRYHGRSAAVWSLGILLYDMVCGD 246

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 95.3 bits (238), Expect = 9e-23
 Identities = 61/208 (29%), Positives = 93/208 (44%), Gaps = 33/208 (15%)

Query: 57  LGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLRE-MKNEASVIAKVQHKNLVRLLGCC 114
           LGEG +G V   V     + +AVK +  +      E +K E  +   + H+N+V+  G  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74

Query: 115 IDRDEKILIYEYMPNKSLDFFLFD---PTKRMLLDWVTRV--QIIEGIAQGLLYLHQYSR 169
            + + + L  EY     L    FD   P   M      R   Q++ G+     YLH    
Sbjct: 75  REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVV----YLHGI-- 124

Query: 170 VRIIHRDLKASNILLDKDMNPKISDFGMARI--CGGNELQANTSRIVGTYGYMSPEYALE 227
             I HRD+K  N+LLD+  N KISDFG+A +      E   N     GT  Y++PE    
Sbjct: 125 -GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM--CGTLPYVAPE---- 177

Query: 228 GIFSIK------SDVFSFGVLLLEIVSG 249
            +   +       DV+S G++L  +++G
Sbjct: 178 -LLKRREFHAEPVDVWSCGIVLTAMLAG 204

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 96.6 bits (241), Expect = 1e-22
 Identities = 55/240 (22%), Positives = 95/240 (39%), Gaps = 53/240 (22%)

Query: 40  SFSSVSTATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVK------RLSGRSGQGLREM 92
           +        ++F      G+G FG V  G  K  G  +A+K      R   R    L+ M
Sbjct: 14  ADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRE---LQIM 70

Query: 93  KNEASVIAKVQHKNLVRLLGCCIDRDEK-------ILIYEYMPNKSLDFFLFDPTKRMLL 145
           +     +A + H N+V+L        E+        ++ EY+P  +L         R   
Sbjct: 71  Q----DLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVP-DTL--------HRCCR 117

Query: 146 DWVTRVQIIEG---------IAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNP-KISDF 195
           ++  R               + + +  LH  S   + HRD+K  N+L+++     K+ DF
Sbjct: 118 NYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSV-NVCHRDIKPHNVLVNEADGTLKLCDF 176

Query: 196 GMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKS-----DVFSFGVLLLEIVSGK 250
           G A+    +E   N + I   Y Y +PE     IF  +      D++S G +  E++ G+
Sbjct: 177 GSAKKLSPSE--PNVAYICSRY-YRAPEL----IFGNQHYTTAVDIWSVGCIFAEMMLGE 229

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 96.2 bits (240), Expect = 2e-22
 Identities = 53/249 (21%), Positives = 100/249 (40%), Gaps = 33/249 (13%)

Query: 8   NLKADNVIIELPANNKQAKRSKKKEVDQFPLFSFSSVSTATNKFSDANKLGEGGFGPVYK 67
           +L  +N+  +  ++   +       +        S+    ++ F   ++LG G    VY+
Sbjct: 12  DLGTENLYFQSMSSVTASAAPGTASLVPDYWIDGSNRDALSDFFEVESELGRGATSIVYR 71

Query: 68  GVLKK-GDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIYEY 126
              K      A+K L     +  + ++ E  V+ ++ H N+++L        E  L+ E 
Sbjct: 72  CKQKGTQKPYALKVLKKTVDK--KIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLEL 129

Query: 127 MPNKSLDFFLFDPTKRMLLDWVTR---------VQIIEGIAQGLLYLHQYSRVRIIHRDL 177
           +            T   L D +              ++ I + + YLH+     I+HRDL
Sbjct: 130 V------------TGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHEN---GIVHRDL 174

Query: 178 KASNILL---DKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKS 234
           K  N+L      D   KI+DFG+++I     L      + GT GY +PE      +  + 
Sbjct: 175 KPENLLYATPAPDAPLKIADFGLSKIVEHQVL---MKTVCGTPGYCAPEILRGCAYGPEV 231

Query: 235 DVFSFGVLL 243
           D++S G++ 
Sbjct: 232 DMWSVGIIT 240

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 95.8 bits (239), Expect = 2e-22
 Identities = 63/210 (30%), Positives = 99/210 (47%), Gaps = 37/210 (17%)

Query: 57  LGEGGFGPVYKGV-LKKGDEIAVKRLSGR--SGQGLREMKNEASVIAKVQHKNLVRLLGC 113
           +G+G F  V     +  G E+A+K +     +   L+++  E  ++  + H N+V+L   
Sbjct: 23  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82

Query: 114 CIDRDEKI-LIYEYMPNKSLDFFLFD--PTKRMLLDWVTRV---QIIEGIAQGLLYLHQY 167
            I+ ++ + LI EY     +    FD       + +   R    QI+  +     Y HQ 
Sbjct: 83  -IETEKTLYLIMEYASGGEV----FDYLVAHGRMKEKEARSKFRQIVSAVQ----YCHQK 133

Query: 168 SRVRIIHRDLKASNILLDKDMNPKISDFGMARIC-GGNELQANTSRIVGTYGYMSPEYAL 226
              RI+HRDLKA N+LLD DMN KI+DFG +     G +L  +     G   Y +PE   
Sbjct: 134 ---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKL--DAF--CGAPPYAAPE--- 183

Query: 227 EGIFS------IKSDVFSFGVLLLEIVSGK 250
             +F        + DV+S GV+L  +VSG 
Sbjct: 184 --LFQGKKYDGPEVDVWSLGVILYTLVSGS 211

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 95.1 bits (237), Expect = 2e-22
 Identities = 61/208 (29%), Positives = 93/208 (44%), Gaps = 33/208 (15%)

Query: 57  LGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLRE-MKNEASVIAKVQHKNLVRLLGCC 114
           LGEG +G V   V     + +AVK +  +      E +K E  +   + H+N+V+  G  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74

Query: 115 IDRDEKILIYEYMPNKSLDFFLFD---PTKRMLLDWVTRV--QIIEGIAQGLLYLHQYSR 169
            + + + L  EY     L    FD   P   M      R   Q++ G+     YLH    
Sbjct: 75  REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVV----YLHGI-- 124

Query: 170 VRIIHRDLKASNILLDKDMNPKISDFGMARI--CGGNELQANTSRIVGTYGYMSPEYALE 227
             I HRD+K  N+LLD+  N KISDFG+A +      E   N     GT  Y++PE    
Sbjct: 125 -GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM--CGTLPYVAPE---- 177

Query: 228 GIFSIK------SDVFSFGVLLLEIVSG 249
            +   +       DV+S G++L  +++G
Sbjct: 178 -LLKRREFHAEPVDVWSCGIVLTAMLAG 204

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 95.9 bits (239), Expect = 4e-22
 Identities = 61/225 (27%), Positives = 98/225 (43%), Gaps = 45/225 (20%)

Query: 48  TNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKN 106
              ++D   +G G FG VY+  L   G+ +A+K++        RE++    ++ K+ H N
Sbjct: 53  EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ----IMRKLDHCN 108

Query: 107 LVRLLGCCIDRDEKI------LIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEG---- 156
           +VRL        EK       L+ +Y+P +++         R+   +    Q +      
Sbjct: 109 IVRLRYFFYSSGEKKDEVYLNLVLDYVP-ETV--------YRVARHYSRAKQTLPVIYVK 159

Query: 157 -----IAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNP-KISDFGMARICGGNELQANT 210
                + + L Y+H      I HRD+K  N+LLD D    K+ DFG A+     E   N 
Sbjct: 160 LYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNV 214

Query: 211 SRIVGTYGYMSPEYALEGIFSIKS-----DVFSFGVLLLEIVSGK 250
           S I   Y Y +PE     IF         DV+S G +L E++ G+
Sbjct: 215 SYICSRY-YRAPEL----IFGATDYTSSIDVWSAGCVLAELLLGQ 254

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 94.4 bits (235), Expect = 6e-22
 Identities = 53/212 (25%), Positives = 89/212 (41%), Gaps = 36/212 (16%)

Query: 57  LGEGGFGPVYKGV-LKKGDEIAVK--------RLSGRSGQGLREMKNEASVIAKVQHKNL 107
           LG G FG V+  V  +K  E+ VK                 L ++  E +++++V+H N+
Sbjct: 32  LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91

Query: 108 VRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRV---QIIEGIAQGLLYL 164
           +++L    ++    L+ E   +  LD F F      L + +      Q++  +     YL
Sbjct: 92  IKVLDIFENQGFFQLVMEKHGS-GLDLFAFIDRHPRLDEPLASYIFRQLVSAVG----YL 146

Query: 165 HQYSRVRIIHRDLKASNILLDKDMNPKISDFGM-ARICGGNELQANTSRIVGTYGYMSPE 223
                  IIHRD+K  NI++ +D   K+ DFG  A +  G      T    GT  Y +PE
Sbjct: 147 RLK---DIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLF--YTF--CGTIEYCAPE 199

Query: 224 YALEGIFSIKS------DVFSFGVLLLEIVSG 249
                +           +++S GV L  +V  
Sbjct: 200 -----VLMGNPYRGPELEMWSLGVTLYTLVFE 226

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 94.3 bits (235), Expect = 6e-22
 Identities = 50/203 (24%), Positives = 77/203 (37%), Gaps = 34/203 (16%)

Query: 55  NKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGC 113
             +G G +    + + K    E AVK +         E      ++   QH N++ L   
Sbjct: 28  EDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEE---IEILLRYGQHPNIITLKDV 84

Query: 114 CIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTR---------VQIIEGIAQGLLYL 164
             D     ++ E M    L            LD + R           ++  I + + YL
Sbjct: 85  YDDGKYVYVVTELMKGGEL------------LDKILRQKFFSEREASAVLFTITKTVEYL 132

Query: 165 HQYSRVRIIHRDLKASNILL-DKDMNP---KISDFGMARICGGNELQANTSRIVGTYGYM 220
           H      ++HRDLK SNIL  D+  NP   +I DFG A+          T     T  ++
Sbjct: 133 HA---QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMT--PCYTANFV 187

Query: 221 SPEYALEGIFSIKSDVFSFGVLL 243
           +PE      +    D++S GVLL
Sbjct: 188 APEVLERQGYDAACDIWSLGVLL 210

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 93.5 bits (233), Expect = 1e-21
 Identities = 52/201 (25%), Positives = 84/201 (41%), Gaps = 32/201 (15%)

Query: 56  KLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLREMKNEASVIAKVQ-HKNLVRLLGC 113
            LGEG F    K V KK     AVK +S R        + E + +   + H N+V+L   
Sbjct: 18  PLGEGSFSICRKCVHKKSNQAFAVKIISKRM---EANTQKEITALKLCEGHPNIVKLHEV 74

Query: 114 CIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRV--------QIIEGIAQGLLYLH 165
             D+    L+ E +    L    F+   R+      +          I+  +   + ++H
Sbjct: 75  FHDQLHTFLVMELLNGGEL----FE---RI----KKKKHFSETEASYIMRKLVSAVSHMH 123

Query: 166 QYSRVRIIHRDLKASNILL---DKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSP 222
               V ++HRDLK  N+L    + ++  KI DFG AR+   +     T     T  Y +P
Sbjct: 124 D---VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKT--PCFTLHYAAP 178

Query: 223 EYALEGIFSIKSDVFSFGVLL 243
           E   +  +    D++S GV+L
Sbjct: 179 ELLNQNGYDESCDLWSLGVIL 199

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 95.7 bits (238), Expect = 1e-21
 Identities = 59/202 (29%), Positives = 97/202 (48%), Gaps = 18/202 (8%)

Query: 57  LGEGGFGPVYKGVLKKGDEI-AVKRLSGR---SGQGLREMKNEASVIAKVQHKN---LVR 109
           +G GGFG VY        ++ A+K L  +     QG     NE  +++ V   +   +V 
Sbjct: 197 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 256

Query: 110 LLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSR 169
           +       D+   I + M    L + L      +  +   R    E I  GL ++H    
Sbjct: 257 MSYAFHTPDKLSFILDLMNGGDLHYHLSQ--HGVFSEADMRFYAAE-IILGLEHMHNR-- 311

Query: 170 VRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGI 229
             +++RDLK +NILLD+  + +ISD G+A  C  ++ + + S  VGT+GYM+PE   +G+
Sbjct: 312 -FVVYRDLKPANILLDEHGHVRISDLGLA--CDFSKKKPHAS--VGTHGYMAPEVLQKGV 366

Query: 230 FSIKS-DVFSFGVLLLEIVSGK 250
               S D FS G +L +++ G 
Sbjct: 367 AYDSSADWFSLGCMLFKLLRGH 388

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 91.6 bits (228), Expect = 5e-21
 Identities = 47/203 (23%), Positives = 78/203 (38%), Gaps = 34/203 (16%)

Query: 56  KLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLREMKNEASVIAKVQ-HKNLVRLLGC 113
            LG G  G V +   ++ G + A+K L         + + E     +     ++V +L  
Sbjct: 36  VLGLGVNGKVLECFHRRTGQKCALKLLYDS-----PKARQEVDHHWQASGGPHIVCILDV 90

Query: 114 CIDRDEKI----LIYEYMPNKSLDFFLFDPTKRMLLDWVTR------VQIIEGIAQGLLY 163
             +         +I E M    L    F    R+              +I+  I   + +
Sbjct: 91  YENMHHGKRCLLIIMECMEGGEL----FS---RIQERGDQAFTEREAAEIMRDIGTAIQF 143

Query: 164 LHQYSRVRIIHRDLKASNILL---DKDMNPKISDFGMARICGGNELQANTSRIVGTYGYM 220
           LH      I HRD+K  N+L    +KD   K++DFG A+    N LQ        T  Y+
Sbjct: 144 LHS---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQ----TPCYTPYYV 196

Query: 221 SPEYALEGIFSIKSDVFSFGVLL 243
           +PE      +    D++S GV++
Sbjct: 197 APEVLGPEKYDKSCDMWSLGVIM 219

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 88.8 bits (221), Expect = 2e-20
 Identities = 57/210 (27%), Positives = 94/210 (44%), Gaps = 36/210 (17%)

Query: 57  LGEGGFGPVYKGV-LKKGDEIAVKRLSGRS--GQGLRE-MKNEASVIAKVQHKNLVRLLG 112
           LG G FG V  G     G ++AVK L+ +      +   +K E   +   +H ++++L  
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78

Query: 113 CCIDRDEKI-LIYEYMPNKSLDFFLFD--PTKRMLLDWVTRV---QIIEGIAQGLLYLHQ 166
             I       ++ EY+    L    FD       + +   R    QI+  +     Y H+
Sbjct: 79  V-ISTPTDFFMVMEYVSGGEL----FDYICKHGRVEEMEARRLFQQILSAVD----YCHR 129

Query: 167 YSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAL 226
           +    ++HRDLK  N+LLD  MN KI+DFG++ +    E    TS   G+  Y +PE   
Sbjct: 130 H---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF-LRTS--CGSPNYAAPE--- 180

Query: 227 EGIFS------IKSDVFSFGVLLLEIVSGK 250
             + S       + D++S GV+L  ++ G 
Sbjct: 181 --VISGRLYAGPEVDIWSCGVILYALLCGT 208

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 88.8 bits (220), Expect = 6e-20
 Identities = 43/132 (32%), Positives = 66/132 (50%), Gaps = 11/132 (8%)

Query: 118 DEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDL 177
           +EK L          D +    T   L+ +  +      +A+G+ +L   +  + IHRDL
Sbjct: 169 EEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQ------VAKGMEFL---ASRKCIHRDL 219

Query: 178 KASNILLDKDMNPKISDFGMAR-ICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDV 236
            A NILL +    KI DFG+AR I    +        +    +M+PE   + +++I+SDV
Sbjct: 220 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL-PLKWMAPETIFDRVYTIQSDV 278

Query: 237 FSFGVLLLEIVS 248
           +SFGVLL EI S
Sbjct: 279 WSFGVLLWEIFS 290

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 63.4 bits (154), Expect = 2e-11
 Identities = 34/160 (21%), Positives = 55/160 (34%), Gaps = 19/160 (11%)

Query: 55  NKLGEGGFGPVYKGVLKKGDE------IAVKRL-SGRSGQGLREMKNEASVIAKV-QHKN 106
             LG G FG V +      D+      +AVK L  G +    R + +E  ++  +  H N
Sbjct: 28  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 87

Query: 107 LVRLLGCCIDRDEKI-LIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLH 165
           +V LLG C      + +I E+    +L  +L       +       +  +G         
Sbjct: 88  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGK-------- 139

Query: 166 QYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE 205
               V  I  DLK     +    +   S F   +     E
Sbjct: 140 --DYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVE 177

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 88.5 bits (220), Expect = 7e-20
 Identities = 56/217 (25%), Positives = 98/217 (45%), Gaps = 51/217 (23%)

Query: 57  LGEGGFGPVYKGV-LKKGDEIAVKRLSGR--SGQGLRE-MKNEASVIAKVQHKNLVRLLG 112
           LGEG FG V      K   ++A+K +S +      +   ++ E S +  ++H ++++L  
Sbjct: 17  LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKL-- 74

Query: 113 CCIDRDEKILIYEYMPNKSLDFF--------LFD--PTKRMLLDWVTRV---QIIEGIAQ 159
                      Y+ +   +            LFD    K+ + +   R    QII  I  
Sbjct: 75  -----------YDVITTPTDIVMVIEYAGGELFDYIVEKKRMTEDEGRRFFQQIICAIE- 122

Query: 160 GLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGY 219
              Y H++   +I+HRDLK  N+LLD ++N KI+DFG++ I         TS   G+  Y
Sbjct: 123 ---YCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNF-LKTS--CGSPNY 173

Query: 220 MSPEYALEGIFS------IKSDVFSFGVLLLEIVSGK 250
            +PE     + +       + DV+S G++L  ++ G+
Sbjct: 174 AAPE-----VINGKLYAGPEVDVWSCGIVLYVMLVGR 205

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 87.9 bits (218), Expect = 2e-19
 Identities = 52/247 (21%), Positives = 92/247 (37%), Gaps = 41/247 (16%)

Query: 19  PANNKQAKRSKKKEVDQFPLFSF-SSVSTATNKFSD-----ANKLGEGGFGPVYKGVLKK 72
           PA      +       QFP F   S +    N   D     +  LG G  G V +   K+
Sbjct: 26  PALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKR 85

Query: 73  -GDEIAVKRLSGRSGQGLREMKNEASVIAKVQ-HKNLVRLLGCCIDRDEKI----LIYEY 126
             ++ A+K L         + + E  +  +     ++VR++    +         ++ E 
Sbjct: 86  TQEKFALKMLQDCP-----KARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMEC 140

Query: 127 MPNKSLDFFLFDPTKRMLLDWVTR------VQIIEGIAQGLLYLHQYSRVRIIHRDLKAS 180
           +    L    F    R+              +I++ I + + YLH  +   I HRD+K  
Sbjct: 141 LDGGEL----FS---RIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPE 190

Query: 181 NILL---DKDMNPKISDFGMARIC-GGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDV 236
           N+L      +   K++DFG A+     N L         T  Y++PE      +    D+
Sbjct: 191 NLLYTSKRPNAILKLTDFGFAKETTSHNSLT----TPCYTPYYVAPEVLGPEKYDKSCDM 246

Query: 237 FSFGVLL 243
           +S GV++
Sbjct: 247 WSLGVIM 253

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 87.9 bits (218), Expect = 2e-19
 Identities = 53/204 (25%), Positives = 91/204 (44%), Gaps = 19/204 (9%)

Query: 57  LGEGGFGPVYKGVLKKGDEI-AVKRLSGRSGQGLRE---MKNEASVIAKVQHKNLVRLLG 112
           +G G FG V    LK  D++ A+K L+        E    + E  V+     K +  L  
Sbjct: 82  IGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHY 141

Query: 113 CCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRI 172
              D +   L+ +Y     L   L    +  L + + R  + E +   +  +HQ      
Sbjct: 142 AFQDDNNLYLVMDYYVGGDL-LTLLSKFEDRLPEEMARFYLAE-MVIAIDSVHQLH---Y 196

Query: 173 IHRDLKASNILLDKDMNPKISDFGMA-RICGGNELQANTSRIVGTYGYMSPEYALEGIFS 231
           +HRD+K  NIL+D + + +++DFG   ++     +Q++    VGT  Y+SPE  L+ +  
Sbjct: 197 VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSV--AVGTPDYISPE-ILQAMEG 253

Query: 232 IKS------DVFSFGVLLLEIVSG 249
            K       D +S GV + E++ G
Sbjct: 254 GKGRYGPECDWWSLGVCMYEMLYG 277

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 87.5 bits (217), Expect = 4e-19
 Identities = 61/210 (29%), Positives = 98/210 (46%), Gaps = 36/210 (17%)

Query: 57  LGEGGFGPVYKGV-LKKGDEIAVK---RLSGRSGQGLREMKNEASVIAKVQHKNLVRLLG 112
           LG G FG V  G     G ++AVK   R   RS   + +++ E   +   +H ++++L  
Sbjct: 24  LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83

Query: 113 CCIDRDEKI-LIYEYMPNKSLDFFLFD--PTKRMLLDWVTRV---QIIEGIAQGLLYLHQ 166
             I     I ++ EY+    L    FD       L +  +R    QI+ G+     Y H+
Sbjct: 84  V-ISTPSDIFMVMEYVSGGEL----FDYICKNGRLDEKESRRLFQQILSGVD----YCHR 134

Query: 167 YSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAL 226
           +    ++HRDLK  N+LLD  MN KI+DFG++ +    E    TS   G+  Y +PE   
Sbjct: 135 H---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF-LRTS--CGSPNYAAPE--- 185

Query: 227 EGIFS------IKSDVFSFGVLLLEIVSGK 250
             + S       + D++S GV+L  ++ G 
Sbjct: 186 --VISGRLYAGPEVDIWSSGVILYALLCGT 213

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 86.6 bits (215), Expect = 4e-19
 Identities = 51/197 (25%), Positives = 84/197 (42%), Gaps = 15/197 (7%)

Query: 57  LGEGGFGPVYKGVLKKGDEI-AVKRLSGRSGQGLRE---MKNEASVIAKVQHKNLVRLLG 112
           LG G FG V     K+     A+K L  +    L++     NE  ++  V    LV+L  
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108

Query: 113 CCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRI 172
              D     ++ EY+    +   L         +   R    + I     YLH      +
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLRR--IGRFSEPHARFYAAQ-IVLTFEYLHSLD---L 162

Query: 173 IHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSI 232
           I+RDLK  N+L+D+    +++DFG A+   G      T  + GT   ++PE  L   ++ 
Sbjct: 163 IYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWTLCGTPEALAPEIILSKGYNK 217

Query: 233 KSDVFSFGVLLLEIVSG 249
             D ++ GVL+ E+ +G
Sbjct: 218 AVDWWALGVLIYEMAAG 234

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 86.6 bits (215), Expect = 4e-19
 Identities = 50/207 (24%), Positives = 90/207 (43%), Gaps = 28/207 (13%)

Query: 57  LGEGGFGPVYKGVLKKGDEI-AVKRLS----GRSGQGLREMKNEASVIAKVQHKNLVRLL 111
           +G+G FG V         ++ A+K ++        + +R +  E  ++  ++H  LV L 
Sbjct: 23  IGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNE-VRNVFKELQIMQGLEHPFLVNLW 81

Query: 112 GCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVR 171
               D ++  ++ + +    L  +          +   ++ I E +   L YL      R
Sbjct: 82  YSFQDEEDMFMVVDLLLGGDL-RYHLQQNVHFKEE-TVKLFICE-LVMALDYLQNQ---R 135

Query: 172 IIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFS 231
           IIHRD+K  NILLD+  +  I+DF +A +          + + GT  YM+PE     +FS
Sbjct: 136 IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQ---ITTMAGTKPYMAPE-----MFS 187

Query: 232 IKS--------DVFSFGVLLLEIVSGK 250
            +         D +S GV   E++ G+
Sbjct: 188 SRKGAGYSFAVDWWSLGVTAYELLRGR 214

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 82.9 bits (205), Expect = 3e-18
 Identities = 20/199 (10%), Positives = 57/199 (28%), Gaps = 41/199 (20%)

Query: 56  KLGEGGFGPVYKGV-LKKGDEIAVKRL---SGRSGQGLREMKNEASVIAKVQHKNLVRLL 111
             G       ++ +      ++A+  +          L+E  +    ++++    + R+L
Sbjct: 38  FHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVL 97

Query: 112 GCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVR 171
                R   +++ E++   SL               V  ++ ++ +A      H   R  
Sbjct: 98  DVVHTRAGGLVVAEWIRGGSLQEVADTS-----PSPVGAIRAMQSLAAAADAAH---RAG 149

Query: 172 IIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFS 231
           +       S + +  D +  ++                          M          +
Sbjct: 150 VALSIDHPSRVRVSIDGDVVLAYPA----------------------TMPDA-------N 180

Query: 232 IKSDVFSFGVLLLEIVSGK 250
            + D+   G  L  ++  +
Sbjct: 181 PQDDIRGIGASLYALLVNR 199

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 83.0 bits (206), Expect = 5e-18
 Identities = 59/197 (29%), Positives = 96/197 (48%), Gaps = 15/197 (7%)

Query: 57  LGEGGFGPVYKGVLKKGDEI-AVKRLSGRSGQGLRE---MKNEASVIAKVQHKNLVRLLG 112
           LG G FG V+    +      A+K L       L++     +E  +++ V H  ++R+ G
Sbjct: 14  LGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWG 73

Query: 113 CCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRI 172
              D  +  +I +Y+    L F L   ++R     V +    E +   L YLH      I
Sbjct: 74  TFQDAQQIFMIMDYIEGGEL-FSLLRKSQRFPNP-VAKFYAAE-VCLALEYLHSKD---I 127

Query: 173 IHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSI 232
           I+RDLK  NILLDK+ + KI+DFG A+      +   T  + GT  Y++PE      ++ 
Sbjct: 128 IYRDLKPENILLDKNGHIKITDFGFAK-----YVPDVTYTLCGTPDYIAPEVVSTKPYNK 182

Query: 233 KSDVFSFGVLLLEIVSG 249
             D +SFG+L+ E+++G
Sbjct: 183 SIDWWSFGILIYEMLAG 199

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 84.0 bits (208), Expect = 5e-18
 Identities = 47/205 (22%), Positives = 87/205 (42%), Gaps = 19/205 (9%)

Query: 57  LGEGGFGPVYKGVLKKGDEI-AVKRLSGRSGQGLRE---MKNEASVIAKVQHKNLVRLLG 112
           +G G F  V    +K+  ++ A+K ++        E    + E  V+     + + +L  
Sbjct: 69  IGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHF 128

Query: 113 CCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRI 172
              D +   L+ EY     L   L    +R+  +   R  + E I   +  +H+      
Sbjct: 129 AFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEM-ARFYLAE-IVMAIDSVHRLG---Y 183

Query: 173 IHRDLKASNILLDKDMNPKISDFGMA-RICGGNELQANTSRIVGTYGYMSPE-------Y 224
           +HRD+K  NILLD+  + +++DFG   ++     +++     VGT  Y+SPE        
Sbjct: 184 VHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLV--AVGTPDYLSPEILQAVGGG 241

Query: 225 ALEGIFSIKSDVFSFGVLLLEIVSG 249
              G +  + D ++ GV   E+  G
Sbjct: 242 PGTGSYGPECDWWALGVFAYEMFYG 266

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 83.0 bits (205), Expect = 1e-17
 Identities = 66/255 (25%), Positives = 105/255 (41%), Gaps = 42/255 (16%)

Query: 16  IELPANNKQAKRSKKKEVDQFPLFS-FSSVSTATNKFSDANKLGEGGFGPVYKGVLKK-G 73
           +++    K    SK K  +QF       S  T   ++ +   +G G  G V         
Sbjct: 28  VDVSYIAKHYNMSKSKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLD 87

Query: 74  DEIAVKRLSG---------RSGQGLREMKNEASVIAKVQHKNLVRLL------GCCIDRD 118
             +A+K+LS          R+    RE+     ++  V HKN++ LL          +  
Sbjct: 88  RNVAIKKLSRPFQNQTHAKRA---YRELV----LMKCVNHKNIISLLNVFTPQKTLEEFQ 140

Query: 119 EKILIYEYMP---NKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHR 175
           +  L+ E M     + +   L       LL      Q++     G+ +LH      IIHR
Sbjct: 141 DVYLVMELMDANLCQVIQMELDHERMSYLL-----YQML----CGIKHLHS---AGIIHR 188

Query: 176 DLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSD 235
           DLK SNI++  D   KI DFG+AR  G + +    +  V T  Y +PE  L   +    D
Sbjct: 189 DLKPSNIVVKSDCTLKILDFGLARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVD 245

Query: 236 VFSFGVLLLEIVSGK 250
           ++S G ++ E+V  K
Sbjct: 246 IWSVGCIMGEMVRHK 260

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 82.0 bits (203), Expect = 1e-17
 Identities = 48/226 (21%), Positives = 85/226 (37%), Gaps = 38/226 (16%)

Query: 48  TNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAK------ 101
            + ++    +  G +G V  GV  +G  +A+KR+      G        S + K      
Sbjct: 21  QSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREI 80

Query: 102 -----VQHKNLVRLLGCCI----DRDEKI-LIYEYMPN------KSLDFFLFDPTKRMLL 145
                  H N++ L    +        K+ L+ E M              +     +  +
Sbjct: 81  RLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFM 140

Query: 146 DWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE 205
                  I+     GL  LH+     ++HRDL   NILL  + +  I DF +AR    + 
Sbjct: 141 -----YHIL----LGLHVLHE---AGVVHRDLHPGNILLADNNDITICDFNLAREDTADA 188

Query: 206 LQANTSRIVGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGK 250
              N +  V    Y +PE  ++   F+   D++S G ++ E+ + K
Sbjct: 189 ---NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 81.3 bits (201), Expect = 3e-17
 Identities = 51/207 (24%), Positives = 83/207 (40%), Gaps = 34/207 (16%)

Query: 57  LGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCI 115
           +G G FG           + +AVK +  R       ++ E      ++H N+VR     +
Sbjct: 28  IGSGNFGVARLMRDKLTKELVAVKYIE-RGAAIDENVQREIINHRSLRHPNIVRFKEVIL 86

Query: 116 DRDEKILIYEYMPNKSLDFFLFD---PTKRMLLDWVTRV--QIIEGIAQGLLYLHQYSRV 170
                 +I EY     L    ++      R   D       Q++ G++    Y H    +
Sbjct: 87  TPTHLAIIMEYASGGEL----YERICNAGRFSEDEARFFFQQLLSGVS----YCH---SM 135

Query: 171 RIIHRDLKASNILLDKD--MNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEG 228
           +I HRDLK  N LLD       KI DFG ++    +     ++  VGT  Y++PE     
Sbjct: 136 QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-PKST--VGTPAYIAPE----- 187

Query: 229 IFSIK------SDVFSFGVLLLEIVSG 249
           +   +      +DV+S GV L  ++ G
Sbjct: 188 VLLRQEYDGKIADVWSCGVTLYVMLVG 214

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 81.3 bits (201), Expect = 3e-17
 Identities = 55/202 (27%), Positives = 88/202 (43%), Gaps = 18/202 (8%)

Query: 57  LGEGGFGPVYKGVLKKGDEI-AVKRLSGRSGQGLRE---MKNEASVIAKVQHKNLVRLLG 112
           +G G FG V     K   ++ A+K LS        +      E  ++A      +V+L  
Sbjct: 77  IGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFY 136

Query: 113 CCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRI 172
              D     ++ EYMP   L   L       + +   R    E +   L  +H       
Sbjct: 137 AFQDDRYLYMVMEYMPGGDL-VNLMS--NYDVPEKWARFYTAE-VVLALDAIHSMG---F 189

Query: 173 IHRDLKASNILLDKDMNPKISDFGMA-RICGGNELQANTSRIVGTYGYMSPE----YALE 227
           IHRD+K  N+LLDK  + K++DFG   ++     ++ +T+  VGT  Y+SPE       +
Sbjct: 190 IHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTA--VGTPDYISPEVLKSQGGD 247

Query: 228 GIFSIKSDVFSFGVLLLEIVSG 249
           G +  + D +S GV L E++ G
Sbjct: 248 GYYGRECDWWSVGVFLYEMLVG 269

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 81.3 bits (201), Expect = 4e-17
 Identities = 56/198 (28%), Positives = 84/198 (42%), Gaps = 11/198 (5%)

Query: 57  LGEGGFGPVYKGVLKKGDEI-AVKRLSGRSGQGLRE---MKNEASVIAKVQHKNLVRLLG 112
           LG+G FG V     K      A+K L         E      E  V+   +H  L  L  
Sbjct: 156 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKY 215

Query: 113 CCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRI 172
                D    + EY     L F L    +R+  +   R    E I   L YLH  S   +
Sbjct: 216 SFQTHDRLCFVMEYANGGELFFHL--SRERVFSEDRARFYGAE-IVSALDYLH--SEKNV 270

Query: 173 IHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSI 232
           ++RDLK  N++LDKD + KI+DFG+ +    +     T    GT  Y++PE   +  +  
Sbjct: 271 VYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT--FCGTPEYLAPEVLEDNDYGR 328

Query: 233 KSDVFSFGVLLLEIVSGK 250
             D +  GV++ E++ G+
Sbjct: 329 AVDWWGLGVVMYEMMCGR 346

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 79.4 bits (196), Expect = 1e-16
 Identities = 50/255 (19%), Positives = 100/255 (39%), Gaps = 69/255 (27%)

Query: 46  TATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLREMKNEASVIAKVQH 104
           T++ K+S    LG G FG V +    + G   A+K++        RE+     ++  + H
Sbjct: 4   TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELD----IMKVLDH 59

Query: 105 KNLVRLLGCCIDRDEKI--------------------------------------LIYEY 126
            N+++L+       ++                                       +I EY
Sbjct: 60  VNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEY 119

Query: 127 MPNKSLDFFLFDPTKRMLLDWVTRVQIIEG---------IAQGLLYLHQYSRVRIIHRDL 177
           +P  +L         ++L  ++   + I           + + + ++H    + I HRD+
Sbjct: 120 VP-DTL--------HKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHS---LGICHRDI 167

Query: 178 KASNILLD-KDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGI-FSIKSD 235
           K  N+L++ KD   K+ DFG A+       + + + I   + Y +PE  L    ++   D
Sbjct: 168 KPQNLLVNSKDNTLKLCDFGSAKKL--IPSEPSVAYICSRF-YRAPELMLGATEYTPSID 224

Query: 236 VFSFGVLLLEIVSGK 250
           ++S G +  E++ GK
Sbjct: 225 LWSIGCVFGELILGK 239

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 78.7 bits (195), Expect = 1e-16
 Identities = 56/203 (27%), Positives = 99/203 (48%), Gaps = 18/203 (8%)

Query: 57  LGEGGFGPVY---KGVLKKGDEI-AVKRLS----GRSGQGLREMKNEASVIAKVQHKNLV 108
           LG+GG+G V+   K       +I A+K L      R+ +     K E +++ +V+H  +V
Sbjct: 25  LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIV 84

Query: 109 RLLGCCIDRDEKI-LIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQY 167
            L+        K+ LI EY+    L F   +  + + ++      + E I+  L +LHQ 
Sbjct: 85  DLI-YAFQTGGKLYLILEYLSGGEL-FMQLE-REGIFMEDTACFYLAE-ISMALGHLHQK 140

Query: 168 SRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALE 227
               II+RDLK  NI+L+   + K++DFG+ +    +    +T    GT  YM+PE  + 
Sbjct: 141 G---IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHT--FCGTIEYMAPEILMR 195

Query: 228 GIFSIKSDVFSFGVLLLEIVSGK 250
              +   D +S G L+ ++++G 
Sbjct: 196 SGHNRAVDWWSLGALMYDMLTGA 218

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 78.4 bits (194), Expect = 2e-16
 Identities = 58/201 (28%), Positives = 100/201 (49%), Gaps = 16/201 (7%)

Query: 57  LGEGGFGPVY---KGVLKKGDEI-AVKRLSGRS--GQGLREMKNEASVIAKVQHKNLVRL 110
           LG+G FG V+   K       ++ A+K L   +   +     K E  ++ +V H  +V+L
Sbjct: 32  LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKL 91

Query: 111 LGCCIDRDEKI-LIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSR 169
                  + K+ LI +++    L F           + V +  + E +A  L +LH    
Sbjct: 92  H-YAFQTEGKLYLILDFLRGGDL-FTRLSKEVMFTEEDV-KFYLAE-LALALDHLHSLG- 146

Query: 170 VRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGI 229
             II+RDLK  NILLD++ + K++DFG+++    +E +A +    GT  YM+PE      
Sbjct: 147 --IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCGTVEYMAPEVVNRRG 202

Query: 230 FSIKSDVFSFGVLLLEIVSGK 250
            +  +D +SFGVL+ E+++G 
Sbjct: 203 HTQSADWWSFGVLMFEMLTGT 223

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 79.0 bits (195), Expect = 2e-16
 Identities = 56/222 (25%), Positives = 92/222 (41%), Gaps = 41/222 (18%)

Query: 48  TNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSG---------RSGQGLREMKNEAS 97
             ++ +   +G G  G V           +A+K+LS          R+    RE+     
Sbjct: 24  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRA---YRELV---- 76

Query: 98  VIAKVQHKNLVRLL------GCCIDRDEKILIYEYMP---NKSLDFFLFDPTKRMLLDWV 148
           ++  V HKN++ LL          +  +  ++ E M     + +   L       LL   
Sbjct: 77  LMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLL--- 133

Query: 149 TRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQA 208
              Q++     G+ +LH      IIHRDLK SNI++  D   KI DFG+AR  G + +  
Sbjct: 134 --YQML----CGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMT 184

Query: 209 NTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 250
                V T  Y +PE  L   +    D++S G ++ E++ G 
Sbjct: 185 PY---VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 78.5 bits (194), Expect = 2e-16
 Identities = 52/220 (23%), Positives = 95/220 (43%), Gaps = 41/220 (18%)

Query: 48  TNKFSDANKLGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQG-LREMKNEASVIAK--VQ 103
            + +    KLG G +  V++ + +   +++ VK L     +   RE+K     I +    
Sbjct: 35  QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIK-----ILENLRG 89

Query: 104 HKNLVRLLGCCIDRDEK--ILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGL 161
             N++ L     D   +   L++E++ N   DF     T   L D+  R  + E I + L
Sbjct: 90  GPNIITLADIVKDPVSRTPALVFEHVNN--TDFKQLYQT---LTDYDIRFYMYE-ILKAL 143

Query: 162 LYLHQYSRVRIIHRDLKASNILLD-KDMNPKISDFGMARICGGNELQANTSRIVGTYGYM 220
            Y H  S   I+HRD+K  N+++D +    ++ D+G+A     +  Q    R+   Y + 
Sbjct: 144 DYCH--SM-GIMHRDVKPHNVMIDHEHRKLRLIDWGLAE--FYHPGQEYNVRVASRY-FK 197

Query: 221 SPE---------YALEGIFSIKSDVFSFGVLLLEIVSGKK 251
            PE         Y+L        D++S G +L  ++  K+
Sbjct: 198 GPELLVDYQMYDYSL--------DMWSLGCMLASMIFRKE 229

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 77.3 bits (191), Expect = 5e-16
 Identities = 52/199 (26%), Positives = 84/199 (42%), Gaps = 14/199 (7%)

Query: 57  LGEGGFGPVYKGVLKKGDEI-AVKRLSGRSGQGLRE---MKNEASVIAKVQHKNLVRLLG 112
           LG+G FG V     K      A+K L         E      E+ V+   +H  L  L  
Sbjct: 13  LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK- 71

Query: 113 CCIDRDEKI-LIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVR 171
                 +++  + EY     L FF     +    +   R    E I   L YLH      
Sbjct: 72  YAFQTHDRLCFVMEYANGGEL-FFHLSRERVFTEER-ARFYGAE-IVSALEYLHSRD--- 125

Query: 172 IIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFS 231
           +++RD+K  N++LDKD + KI+DFG+ +    +     T    GT  Y++PE   +  + 
Sbjct: 126 VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT--FCGTPEYLAPEVLEDNDYG 183

Query: 232 IKSDVFSFGVLLLEIVSGK 250
              D +  GV++ E++ G+
Sbjct: 184 RAVDWWGLGVVMYEMMCGR 202

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 77.6 bits (191), Expect = 6e-16
 Identities = 41/237 (17%), Positives = 87/237 (36%), Gaps = 59/237 (24%)

Query: 20  ANNKQAKRSKKKEVDQFPLFSFSSVSTATNKFSDANKLGEGGFGPVYKGV-LKKGDEIAV 78
              ++ +    K     P     S     +++   + +G G +G V +     +   +A+
Sbjct: 26  EGQQRKQHHSSKPTASMPRPH--SDWQIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAI 83

Query: 79  KRLSG---------RSGQGLREMKNEASVIAKVQHKNLVRLLGCCI----DRDEKI-LIY 124
           K++           R    LRE+     ++ ++ H ++V++L   I    ++ +++ ++ 
Sbjct: 84  KKILRVFEDLIDCKRI---LREIA----ILNRLNHDHVVKVLDIVIPKDVEKFDELYVVL 136

Query: 125 EYMP---------NKSLD-----FFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRV 170
           E               L        L+               ++     G+ Y+H     
Sbjct: 137 EIADSDFKKLFRTPVYLTELHIKTLLY--------------NLL----VGVKYVHS---A 175

Query: 171 RIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALE 227
            I+HRDLK +N L+++D + K+ DFG+AR     E   +   I      M+      
Sbjct: 176 GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPH 232

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 77.4 bits (190), Expect = 1e-15
 Identities = 60/202 (29%), Positives = 89/202 (44%), Gaps = 19/202 (9%)

Query: 57  LGEGGFGPVYKGVLKKGDEI-AVKRLSGR---SGQGLREMKNEASVIAKV-QHKNLVRLL 111
           LG+G FG V     K  DE+ AVK L          +     E  V+A   +   L +L 
Sbjct: 349 LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLH 408

Query: 112 GCCIDRDEKI-LIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRV 170
             C    +++  + EY+    L  +      R            E IA GL +L      
Sbjct: 409 -SCFQTMDRLYFVMEYVNGGDL-MYHIQQVGRFKEP-HAVFYAAE-IAIGLFFLQSKG-- 462

Query: 171 RIIHRDLKASNILLDKDMNPKISDFGMAR--ICGGNELQANTSRIVGTYGYMSPEYALEG 228
            II+RDLK  N++LD + + KI+DFGM +  I  G      T    GT  Y++PE     
Sbjct: 463 -IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV----TTKTFCGTPDYIAPEIIAYQ 517

Query: 229 IFSIKSDVFSFGVLLLEIVSGK 250
            +    D ++FGVLL E+++G+
Sbjct: 518 PYGKSVDWWAFGVLLYEMLAGQ 539

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 76.2 bits (188), Expect = 1e-15
 Identities = 54/223 (24%), Positives = 101/223 (45%), Gaps = 44/223 (19%)

Query: 48  TNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSG---------RSGQGLREMKNEAS 97
              +     +G G +G V   + K+ G+++A+K+LS          R+    RE+     
Sbjct: 23  PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRA---YRELL---- 75

Query: 98  VIAKVQHKNLVRLL-----GCCIDRDEKI-LIYEYMP---NKSLDFFLFDPTKRMLLDWV 148
           ++  +QH+N++ LL        +       L+  +M     K +     +   + L+   
Sbjct: 76  LLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQYLV--- 132

Query: 149 TRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQA 208
              Q++    +GL Y+H      ++HRDLK  N+ +++D   KI DFG+AR        A
Sbjct: 133 --YQML----KGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGLARH-----ADA 178

Query: 209 NTSRIVGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGK 250
             +  V T  Y +PE  L    ++   D++S G ++ E+++GK
Sbjct: 179 EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 74.6 bits (184), Expect = 4e-15
 Identities = 54/232 (23%), Positives = 106/232 (45%), Gaps = 57/232 (24%)

Query: 48  TNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSG--------RSGQGLREMKNEASV 98
             ++++ + +GEG +G V           +A+K++S         R+   LRE+K    +
Sbjct: 26  GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRT---LREIK----I 78

Query: 99  IAKVQHKNLVRLLGC----CIDRDEKI-LIYEYMP--------NKSLD-----FFLFDPT 140
           + + +H+N++ +        I++ + + ++ + M          + L      +FL+   
Sbjct: 79  LLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLY--- 135

Query: 141 KRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARI 200
                      QI+    +GL Y+H      ++HRDLK SN+LL+   + KI DFG+AR+
Sbjct: 136 -----------QIL----RGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARV 177

Query: 201 CGGNELQANT-SRIVGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGK 250
              +       +  V T  Y +PE  L    ++   D++S G +L E++S +
Sbjct: 178 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 74.2 bits (183), Expect = 5e-15
 Identities = 65/239 (27%), Positives = 106/239 (44%), Gaps = 28/239 (11%)

Query: 57  LGEGGFGPVYKGVLKKGDEI-AVKRLSGRSGQGLRE---MKNEASVIAKV-QHKNLVRLL 111
           +G G +  V    LKK D I A+K +         +   ++ E  V  +   H  LV L 
Sbjct: 17  IGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 76

Query: 112 GCCIDRDEKI-LIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRV 170
             C   + ++  + EY+    L F +    +R L +   R    E I+  L YLH+    
Sbjct: 77  -SCFQTESRLFFVIEYVNGGDLMFHMQR--QRKLPEEHARFYSAE-ISLALNYLHERG-- 130

Query: 171 RIIHRDLKASNILLDKDMNPKISDFGMAR--ICGGNELQANTSRIVGTYGYMSPEYALEG 228
            II+RDLK  N+LLD + + K++D+GM +  +  G+     TS   GT  Y++PE     
Sbjct: 131 -IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT----TSTFCGTPNYIAPEILRGE 185

Query: 229 IFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDE 287
            +    D ++ GVL+ E+++G+         S   +  + D    N    L   ILE +
Sbjct: 186 DYGFSVDWWALGVLMFEMMAGR---------SPFDIVGSSDNPDQNTEDYLFQVILEKQ 235

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 73.9 bits (182), Expect = 8e-15
 Identities = 64/239 (26%), Positives = 106/239 (44%), Gaps = 28/239 (11%)

Query: 57  LGEGGFGPVYKGVLKKGDEI-AVKRLSGRSGQGLRE---MKNEASVIAKV-QHKNLVRLL 111
           +G G +  V    LKK D I A++ +         +   ++ E  V  +   H  LV L 
Sbjct: 60  IGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 119

Query: 112 GCCIDRDEKI-LIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRV 170
             C   + ++  + EY+    L F +    +R L +   R    E I+  L YLH+    
Sbjct: 120 -SCFQTESRLFFVIEYVNGGDLMFHMQ--RQRKLPEEHARFYSAE-ISLALNYLHERG-- 173

Query: 171 RIIHRDLKASNILLDKDMNPKISDFGMAR--ICGGNELQANTSRIVGTYGYMSPEYALEG 228
            II+RDLK  N+LLD + + K++D+GM +  +  G+     TS   GT  Y++PE     
Sbjct: 174 -IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT----TSTFCGTPNYIAPEILRGE 228

Query: 229 IFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDE 287
            +    D ++ GVL+ E+++G+         S   +  + D    N    L   ILE +
Sbjct: 229 DYGFSVDWWALGVLMFEMMAGR---------SPFDIVGSSDNPDQNTEDYLFQVILEKQ 278

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 73.0 bits (180), Expect = 1e-14
 Identities = 59/202 (29%), Positives = 94/202 (46%), Gaps = 19/202 (9%)

Query: 57  LGEGGFGPVYKGVLKKGDEI-AVKRLSGRSGQGLRE---MKNEASVIAKV-QHKNLVRLL 111
           LG+G FG V    +K+  ++ AVK L         +      E  +++    H  L +L 
Sbjct: 31  LGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLF 90

Query: 112 GCCIDRDEKI-LIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRV 170
            CC    +++  + E++    L  F    ++R       R    E I   L++LH     
Sbjct: 91  -CCFQTPDRLFFVMEFVNGGDL-MFHIQKSRRFDEAR-ARFYAAE-IISALMFLHDKG-- 144

Query: 171 RIIHRDLKASNILLDKDMNPKISDFGMA--RICGGNELQANTSRIVGTYGYMSPEYALEG 228
            II+RDLK  N+LLD + + K++DFGM    IC G      T+   GT  Y++PE   E 
Sbjct: 145 -IIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVT----TATFCGTPDYIAPEILQEM 199

Query: 229 IFSIKSDVFSFGVLLLEIVSGK 250
           ++    D ++ GVLL E++ G 
Sbjct: 200 LYGPAVDWWAMGVLLYEMLCGH 221

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 72.7 bits (179), Expect = 1e-14
 Identities = 51/220 (23%), Positives = 95/220 (43%), Gaps = 24/220 (10%)

Query: 48  TNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQG----LREMKNEASVIAKV 102
            +++ D   LG GG G V+  V       +A+K++     Q     LRE+K    +I ++
Sbjct: 10  GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIK----IIRRL 65

Query: 103 QHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEG------ 156
            H N+V++         ++        +    ++        L  V     +        
Sbjct: 66  DHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARLF 125

Query: 157 ---IAQGLLYLHQYSRVRIIHRDLKASNILLD-KDMNPKISDFGMARICGGNELQANT-S 211
              + +GL Y+H      ++HRDLK +N+ ++ +D+  KI DFG+ARI   +       S
Sbjct: 126 MYQLLRGLKYIHS---ANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLS 182

Query: 212 RIVGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 250
             + T  Y SP   L    ++   D+++ G +  E+++GK
Sbjct: 183 EGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 73.0 bits (180), Expect = 1e-14
 Identities = 60/202 (29%), Positives = 89/202 (44%), Gaps = 19/202 (9%)

Query: 57  LGEGGFGPVYKGVLKKGDEI-AVKRLSGR---SGQGLREMKNEASVIAKV-QHKNLVRLL 111
           LG+G FG V     K  DE+ AVK L          +     E  V+A   +   L +L 
Sbjct: 28  LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLH 87

Query: 112 GCCIDRDEKI-LIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRV 170
             C    +++  + EY+    L  +      R            E IA GL +L      
Sbjct: 88  -SCFQTMDRLYFVMEYVNGGDL-MYHIQQVGRFKEPH-AVFYAAE-IAIGLFFLQSK--- 140

Query: 171 RIIHRDLKASNILLDKDMNPKISDFGMAR--ICGGNELQANTSRIVGTYGYMSPEYALEG 228
            II+RDLK  N++LD + + KI+DFGM +  I  G      T    GT  Y++PE     
Sbjct: 141 GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV----TTKTFCGTPDYIAPEIIAYQ 196

Query: 229 IFSIKSDVFSFGVLLLEIVSGK 250
            +    D ++FGVLL E+++G+
Sbjct: 197 PYGKSVDWWAFGVLLYEMLAGQ 218

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 72.2 bits (176), Expect = 2e-14
 Identities = 38/212 (17%), Positives = 64/212 (30%), Gaps = 47/212 (22%)

Query: 31  KEVDQFPLFSFSSVSTATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRL--------S 82
            E  Q     FS     T K     K+GEG FG V++ +      +A+K +        +
Sbjct: 3   GECSQKGPVPFSHCL-PTEKLQRCEKIGEGVFGEVFQTIADHTP-VAIKIIAIEGPDLVN 60

Query: 83  GRSGQGLREMKNEASV---------IAKVQHKNLVRLLGCCIDRDE--KILIYEYM---- 127
           G   +   E+  E  +             + +  + L      +     +L+  +     
Sbjct: 61  GSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNS 120

Query: 128 ----PNKSLDFF----------------LFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQY 167
                N   DFF                  +  +  L    T   I+  +   L      
Sbjct: 121 TKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEA- 179

Query: 168 SRVRIIHRDLKASNILLDKDMNPKISDFGMAR 199
             +R  HRDL   N+LL K    K+      +
Sbjct: 180 -SLRFEHRDLHWGNVLLKKTSLKKLHYTLNGK 210

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 72.7 bits (179), Expect = 2e-14
 Identities = 56/200 (28%), Positives = 92/200 (46%), Gaps = 15/200 (7%)

Query: 57  LGEGGFGPVYKGVLKKGDEI-AVKRLSGRSGQGLRE---MKNEASVIAK-VQHKNLVRLL 111
           +G+G FG V     K  +   AVK L  ++    +E   + +E +V+ K V+H  LV L 
Sbjct: 46  IGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 105

Query: 112 GCCIDRDEKI-LIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRV 170
                  +K+  + +Y+    L F+     +  L     R    E IA  L YLH  +  
Sbjct: 106 -FSFQTADKLYFVLDYINGGEL-FYHLQRERCFLEPR-ARFYAAE-IASALGYLHSLN-- 159

Query: 171 RIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIF 230
            I++RDLK  NILLD   +  ++DFG+ +    +    +T    GT  Y++PE   +  +
Sbjct: 160 -IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTST--FCGTPEYLAPEVLHKQPY 216

Query: 231 SIKSDVFSFGVLLLEIVSGK 250
               D +  G +L E++ G 
Sbjct: 217 DRTVDWWCLGAVLYEMLYGL 236

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 72.3 bits (178), Expect = 2e-14
 Identities = 56/242 (23%), Positives = 102/242 (42%), Gaps = 70/242 (28%)

Query: 48  TNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSG--------RSGQGLREMKNEASV 98
           ++ F   + LGEG +G V     K  G+ +A+K++          R+   LRE+K    +
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRT---LREIK----I 62

Query: 99  IAKVQHKNLVRLLGC----CIDRDEKI-LIYEYMP--------NKSLD-----FFLFDPT 140
           +   +H+N++ +         +   ++ +I E M          + L      +F++   
Sbjct: 63  LKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIY--- 119

Query: 141 KRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARI 200
                      Q +    + +  LH      +IHRDLK SN+L++ + + K+ DFG+ARI
Sbjct: 120 -----------QTL----RAVKVLHG---SNVIHRDLKPSNLLINSNCDLKVCDFGLARI 161

Query: 201 CGGNELQANTSRIVGTYGYMSPEY-------ALEGIFSIKS-----DVFSFGVLLLEIVS 248
              +E  A+ S   G    M  E+       A E + +        DV+S G +L E+  
Sbjct: 162 I--DESAADNSEPTGQQSGMV-EFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFL 218

Query: 249 GK 250
            +
Sbjct: 219 RR 220

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 71.6 bits (176), Expect = 5e-14
 Identities = 60/254 (23%), Positives = 111/254 (43%), Gaps = 51/254 (20%)

Query: 20  ANNKQAKRSKKKEVDQFPLFSFSSVSTATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAV 78
           A++      ++    +  L    ++     ++ + + +G G +G V      K G  +AV
Sbjct: 2   AHHHHHHSQERPTFYRQELNK--TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAV 59

Query: 79  KRLSG---------RSGQGLREMKNEASVIAKVQHKNLVRLL-----GCCIDRDEKI-LI 123
           K+LS          R+    RE++    ++  ++H+N++ LL        ++    + L+
Sbjct: 60  KKLSRPFQSIIHAKRT---YRELR----LLKHMKHENVIGLLDVFTPARSLEEFNDVYLV 112

Query: 124 YEYMPN------KSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDL 177
              M        K     L D   + L+      QI+    +GL Y+H      IIHRDL
Sbjct: 113 THLMGADLNNIVKCQK--LTDDHVQFLI-----YQIL----RGLKYIHS---ADIIHRDL 158

Query: 178 KASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALE-GIFSIKSDV 236
           K SN+ +++D   KI DFG+AR           +  V T  Y +PE  L    ++   D+
Sbjct: 159 KPSNLAVNEDCELKILDFGLAR-----HTADEMTGYVATRWYRAPEIMLNWMHYNQTVDI 213

Query: 237 FSFGVLLLEIVSGK 250
           +S G ++ E+++G+
Sbjct: 214 WSVGCIMAELLTGR 227

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 71.2 bits (175), Expect = 5e-14
 Identities = 55/233 (23%), Positives = 101/233 (43%), Gaps = 63/233 (27%)

Query: 48  TNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSG---------RSGQGLREMKNEAS 97
              + D   +G G +G V   V  + G ++A+K+L           R+    RE++    
Sbjct: 24  RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRA---YRELR---- 76

Query: 98  VIAKVQHKNLVRLL------GCCIDRDEKILIYEYMP--------NKSLD-----FFLFD 138
           ++  ++H+N++ LL          D  +  L+  +M         ++ L      F ++ 
Sbjct: 77  LLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVY- 135

Query: 139 PTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMA 198
                        Q++    +GL Y+H      IIHRDLK  N+ +++D   KI DFG+A
Sbjct: 136 -------------QML----KGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLA 175

Query: 199 RICGGNELQANTSRIVGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGK 250
           R        +  +  V T  Y +PE  L    ++   D++S G ++ E+++GK
Sbjct: 176 RQ-----ADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 71.1 bits (175), Expect = 6e-14
 Identities = 60/198 (30%), Positives = 92/198 (46%), Gaps = 13/198 (6%)

Query: 57  LGEGGFGPVYKGVLKKGDEI-AVKRLSGRSGQGLREM---KNEASVIAKV-QHKNLVRLL 111
           LG+G FG V+    KK ++  A+K L         ++     E  V++   +H  L  + 
Sbjct: 25  LGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMF 84

Query: 112 GCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVR 171
                ++    + EY+    L  +      +  L         E I  GL +LH      
Sbjct: 85  CTFQTKENLFFVMEYLNGGDL-MYHIQSCHKFDLS-RATFYAAE-IILGLQFLHSKG--- 138

Query: 172 IIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFS 231
           I++RDLK  NILLDKD + KI+DFGM +     + + NT    GT  Y++PE  L   ++
Sbjct: 139 IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT--FCGTPDYIAPEILLGQKYN 196

Query: 232 IKSDVFSFGVLLLEIVSG 249
              D +SFGVLL E++ G
Sbjct: 197 HSVDWWSFGVLLYEMLIG 214

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 71.3 bits (175), Expect = 6e-14
 Identities = 51/218 (23%), Positives = 93/218 (42%), Gaps = 34/218 (15%)

Query: 56  KLGEGGFGPVYKGV-LKKGDEIAVKRLSGRSG-----QGLREMK-----NEASVIAKVQ- 103
           KLG G F  V+    +     +A+K +  R           E+K     N+A    +   
Sbjct: 26  KLGWGHFSTVWLAKDMVNNTHVAMKIV--RGDKVYTEAAEDEIKLLQRVNDADNTKEDSM 83

Query: 104 -HKNLVRLLGCCIDRDEKI----LIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIA 158
              ++++LL     +        +++E +    L        + + L +V +  I + + 
Sbjct: 84  GANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQ--ISKQLL 141

Query: 159 QGLLYLHQYSRVRIIHRDLKASNILLDKDMNP------KISDFGMARICGGNELQANTSR 212
            GL Y+H   R  IIH D+K  N+L++   +P      KI+D G A  C  +E   + + 
Sbjct: 142 LGLDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA--CWYDE---HYTN 194

Query: 213 IVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 250
            + T  Y SPE  L   +   +D++S   L+ E+++G 
Sbjct: 195 SIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGD 232

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 70.8 bits (174), Expect = 7e-14
 Identities = 54/208 (25%), Positives = 92/208 (44%), Gaps = 24/208 (11%)

Query: 57  LGEGGFGPVY---KGVLKKGDEI-AVKRLS----GRSGQGLREMKNEASVIAKVQHKN-L 107
           LG G +G V+   K       ++ A+K L      +  +     + E  V+  ++    L
Sbjct: 62  LGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFL 121

Query: 108 VRLLGCCIDRDEKI-LIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQ 166
           V L       + K+ LI +Y+    L F      +R     V ++ + E I   L +LH+
Sbjct: 122 VTLH-YAFQTETKLHLILDYINGGEL-FTHLSQRERFTEHEV-QIYVGE-IVLALEHLHK 177

Query: 167 YSRVRIIHRDLKASNILLDKDMNPKISDFGMAR--ICGGNELQANTSRIVGTYGYMSPEY 224
                II+RD+K  NILLD + +  ++DFG+++  +    E         GT  YM+P+ 
Sbjct: 178 LG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETER---AYDFCGTIEYMAPDI 231

Query: 225 ALEGIFSIKSDV--FSFGVLLLEIVSGK 250
              G       V  +S GVL+ E+++G 
Sbjct: 232 VRGGDSGHDKAVDWWSLGVLMYELLTGA 259

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 71.3 bits (175), Expect = 7e-14
 Identities = 39/210 (18%), Positives = 75/210 (35%), Gaps = 57/210 (27%)

Query: 48  TNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSG---------RSGQGLREMKNEAS 97
            + +   + +G G +G VY    K     +A+K+++          R    LRE+     
Sbjct: 25  PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRI---LREIT---- 77

Query: 98  VIAKVQHKNLVRLLGCCIDRDEKI-----LIYEYMP---------NKSLD-----FFLFD 138
           ++ +++   ++RL    I  D        ++ E               L        L+ 
Sbjct: 78  ILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKTPIFLTEEHIKTILY- 136

Query: 139 PTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMA 198
                         ++     G  ++H+     IIHRDLK +N LL++D + K+ DFG+A
Sbjct: 137 -------------NLL----LGENFIHE---SGIIHRDLKPANCLLNQDCSVKVCDFGLA 176

Query: 199 RICGGNELQANTSRIVGTYGYMSPEYALEG 228
           R     +     + +            L+ 
Sbjct: 177 RTINSEKDTNIVNDLEENEEPGPHNKNLKK 206

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 67.3 bits (165), Expect = 7e-13
 Identities = 34/158 (21%), Positives = 63/158 (39%), Gaps = 30/158 (18%)

Query: 56  KLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLREMKNEASVIAKV-QHKNLVRLLGC 113
            LG G  G V +   K+  ++ A+K L         + + E  +  +  Q  ++VR++  
Sbjct: 25  VLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDV 79

Query: 114 CIDRDEKI----LIYEYMPNKSLDFFLFDPTKRMLLDWVTR------VQIIEGIAQGLLY 163
             +         ++ E +    L    F    R+              +I++ I + + Y
Sbjct: 80  YENLYAGRKCLLIVMECLDGGEL----FS---RIQDRGDQAFTEREASEIMKSIGEAIQY 132

Query: 164 LHQYSRVRIIHRDLKASNILL---DKDMNPKISDFGMA 198
           LH    + I HRD+K  N+L      +   K++DFG A
Sbjct: 133 LHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFA 167

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 67.0 bits (164), Expect = 2e-12
 Identities = 58/250 (23%), Positives = 102/250 (40%), Gaps = 76/250 (30%)

Query: 48  TNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSG---------RSGQGLREMKNEAS 97
             K+    KLG+G +G V+K + ++ G+ +AVK++           R+    RE+     
Sbjct: 8   LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRT---FREIM---- 60

Query: 98  VIAK--VQHKNLVRLLGCCI-DRDEKI-LIYEYMP--------NKSLD-----FFLFDPT 140
            I      H+N+V LL     D D  + L+++YM            L+     + ++   
Sbjct: 61  -ILTELSGHENIVNLLNVLRADNDRDVYLVFDYMETDLHAVIRANILEPVHKQYVVY--- 116

Query: 141 KRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARI 200
                      Q+I    + + YLH      ++HRD+K SNILL+ + + K++DFG++R 
Sbjct: 117 -----------QLI----KVIKYLHS---GGLLHRDMKPSNILLNAECHVKVADFGLSRS 158

Query: 201 CGGNELQANTSRIVGTYGYMSP--------EY-------ALEGIFSIKS-----DVFSFG 240
                   N   +       +         +Y       A E +          D++S G
Sbjct: 159 FVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLG 218

Query: 241 VLLLEIVSGK 250
            +L EI+ GK
Sbjct: 219 CILGEILCGK 228

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 63.2 bits (154), Expect = 3e-11
 Identities = 48/218 (22%), Positives = 95/218 (43%), Gaps = 30/218 (13%)

Query: 48  TNKFSDANKLGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLRE-MKNEASVIAKVQH- 104
            +++   + +G+G FG V K     + + +A+K +  ++ +      + E  ++  +   
Sbjct: 53  MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKII--KNKKAFLNQAQIEVRLLELMNKH 110

Query: 105 -----KNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKR-----MLLDWVTRVQII 154
                  +V L    + R+   L++E      L + L+D  +      + L+   +    
Sbjct: 111 DTEMKYYIVHLKRHFMFRNHLCLVFE-----MLSYNLYDLLRNTNFRGVSLNLTRK--FA 163

Query: 155 EGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNP--KISDFGMARICGGNELQANTSR 212
           + +   LL+L     + IIH DLK  NILL        KI DFG +  C   +      +
Sbjct: 164 QQMCTALLFLAT-PELSIIHCDLKPENILLCNPKRSAIKIVDFGSS--CQLGQ---RIYQ 217

Query: 213 IVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 250
            + +  Y SPE  L   + +  D++S G +L+E+ +G+
Sbjct: 218 YIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGE 255

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 58.9 bits (142), Expect = 9e-10
 Identities = 33/151 (21%), Positives = 71/151 (47%), Gaps = 17/151 (11%)

Query: 56  KLGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLV-RLLGC 113
           K+G G FG +Y G  ++  +E+A+K  + ++     ++  E+ +   +Q    +  +   
Sbjct: 14  KIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTGIPNVRWF 71

Query: 114 CIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRV--QIIEGIAQGLLYLHQYSRVR 171
            ++ D  +L+ + +   SL+      ++++ L  V  +  Q+I  +     ++H  S   
Sbjct: 72  GVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVE----FVHSKS--- 123

Query: 172 IIHRDLKASNILLDKDMNPK---ISDFGMAR 199
            +HRD+K  N L+          I DFG+A+
Sbjct: 124 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 58.2 bits (141), Expect = 1e-09
 Identities = 38/158 (24%), Positives = 72/158 (45%), Gaps = 17/158 (10%)

Query: 49  NKFSDANKLGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNL 107
           N++    K+G G FG +Y G  +  G+E+A+K    ++     ++  E+ +   +Q    
Sbjct: 9   NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVG 66

Query: 108 V-RLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRV--QIIEGIAQGLLYL 164
           +  +  C  + D  +++ E +   SL+      +++  L  V  +  Q+I  I     Y+
Sbjct: 67  IPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIE----YI 121

Query: 165 HQYSRVRIIHRDLKASNILLDKDMNPK---ISDFGMAR 199
           H  +    IHRD+K  N L+          I DFG+A+
Sbjct: 122 HSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 57.8 bits (140), Expect = 1e-09
 Identities = 32/160 (20%), Positives = 62/160 (38%), Gaps = 19/160 (11%)

Query: 49  NKFSDANKLGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQH-KN 106
             F    K+G G FG +  G  L   + +A+K    +S     ++  E     ++     
Sbjct: 9   PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA--PQLHLEYRFYKQLGSGDG 66

Query: 107 LVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRV--QIIEGIAQGLLYL 164
           + ++           ++ E +   SL+       +   L  V  +  Q+I  +     Y+
Sbjct: 67  IPQVYYFGPCGKYNAMVLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRME----YV 121

Query: 165 HQYSRVRIIHRDLKASNILLDKDMNPK-----ISDFGMAR 199
           H  +   +I+RD+K  N L+ +  N       I DF +A+
Sbjct: 122 HSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 58.2 bits (141), Expect = 1e-09
 Identities = 51/209 (24%), Positives = 90/209 (43%), Gaps = 32/209 (15%)

Query: 57  LGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLRE-MKNEASVIAKVQHK------NLV 108
           +G+G FG V K    K    +A+K +  R+ +        E  ++  ++ +      N++
Sbjct: 105 IGKGSFGQVVKAYDHKVHQHVALKMV--RNEKRFHRQAAEEIRILEHLRKQDKDNTMNVI 162

Query: 109 RLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKR-----MLLDWVTRVQIIEGIAQGLLY 163
            +L     R+   + +E      L   L++  K+       L  V +      I Q L  
Sbjct: 163 HMLENFTFRNHICMTFE-----LLSMNLYELIKKNKFQGFSLPLVRK--FAHSILQCLDA 215

Query: 164 LHQYSRVRIIHRDLKASNILLDKDMNP--KISDFGMARICGGNELQANTSRIVGTYGYMS 221
           LH+    RIIH DLK  NILL +      K+ DFG +  C  ++        + +  Y +
Sbjct: 216 LHKN---RIIHCDLKPENILLKQQGRSGIKVIDFGSS--CYEHQ---RVYTYIQSRFYRA 267

Query: 222 PEYALEGIFSIKSDVFSFGVLLLEIVSGK 250
           PE  L   + +  D++S G +L E+++G 
Sbjct: 268 PEVILGARYGMPIDMWSLGCILAELLTGY 296

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 57.0 bits (138), Expect = 2e-09
 Identities = 39/210 (18%), Positives = 85/210 (40%), Gaps = 26/210 (12%)

Query: 56  KLGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLV-RLLGC 113
           ++GEG FG +++G  L    ++A+K    RS     ++++E      +     +  +   
Sbjct: 17  RIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTGIPNVYYF 74

Query: 114 CIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRV--QIIEGIAQGLLYLHQYSRVR 171
             +    +L+ + +   SL+  L    ++  +  V     Q++  +      +H+ S   
Sbjct: 75  GQEGLHNVLVIDLLG-PSLEDLLDLCGRKFSVKTVAMAAKQMLARVQ----SIHEKS--- 126

Query: 172 IIHRDLKASNILLDKDMNPK-----ISDFGMARI-----CGGNELQANTSRIVGTYGYMS 221
           +++RD+K  N L+ +  +       + DFGM +         +        + GT  YMS
Sbjct: 127 LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMS 186

Query: 222 PEYALEGIF-SIKSDVFSFGVLLLEIVSGK 250
                 G   S + D+ + G + +  + G 
Sbjct: 187 I-NTHLGREQSRRDDLEALGHVFMYFLRGS 215

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 57.1 bits (138), Expect = 3e-09
 Identities = 51/262 (19%), Positives = 102/262 (38%), Gaps = 41/262 (15%)

Query: 20  ANNKQAKRSKKKEVDQFPLFSFSSVSTATNKFSDANKLGEGGFGPVYKGVLKKGDEI--- 76
           A   +   +K+   +QF +    +   A   +     +G+GGFG +Y   +   + +   
Sbjct: 7   AQAGRQSSAKRHLAEQFAVGEIITDMAA-AAWKVGLPIGQGGFGCIYLADMNSSESVGSD 65

Query: 77  ---AVKRLSGRSGQGLREMK-----NEASVIAKVQHKNLVRLLG----------CCIDRD 118
               VK     +G    E+K      +   I K      ++ LG              + 
Sbjct: 66  APCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKS 125

Query: 119 EKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRV--QIIEGIAQGLLYLHQYSRVRIIHRD 176
            + +I +      L        KR     V ++  +I++ +     Y+H++     +H D
Sbjct: 126 YRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILE----YIHEHE---YVHGD 177

Query: 177 LKASNILLDKDMNPKI--SDFGMA-RICGGNELQANTSR----IVGTYGYMSPEYALEGI 229
           +KASN+LL+     ++   D+G+A R C     +A  +       GT  + S + A  G+
Sbjct: 178 IKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSID-AHNGV 236

Query: 230 F-SIKSDVFSFGVLLLEIVSGK 250
             S + D+   G  +++ ++G 
Sbjct: 237 APSRRGDLEILGYCMIQWLTGH 258

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 56.3 bits (136), Expect = 5e-09
 Identities = 33/167 (19%), Positives = 66/167 (39%), Gaps = 32/167 (19%)

Query: 56  KLGEGGFGPVYKGV-LKKGDEIA---VKRLSGRSGQGLREMK-----NEASVIAKVQHKN 106
           K+G GGFG +Y      K ++ A   VK     +G    E+K      +   I K   + 
Sbjct: 44  KIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERK 103

Query: 107 LVRLLG----------CCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRV--QII 154
            +  LG              R  + ++ E +    L   +           V ++  +++
Sbjct: 104 QLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQK-ISGQNGTFKKSTVLQLGIRML 161

Query: 155 EGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKI--SDFGMAR 199
           + +     Y+H+      +H D+KA+N+LL      ++  +D+G++ 
Sbjct: 162 DVLE----YIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSY 201

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 55.9 bits (135), Expect = 6e-09
 Identities = 25/177 (14%), Positives = 66/177 (37%), Gaps = 35/177 (19%)

Query: 49  NKFSDANKLGEGGFGPVYKGV---------LKKGDEIAVKRLSGRSGQGLREMK------ 93
            ++   +       G +Y+             +  + ++K L  + G+   E        
Sbjct: 42  RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLK-LDAKDGRLFNEQNFFQRAA 100

Query: 94  --NEASVIAKVQHKNLV---RLLGCCIDRDE-KILIYEYMPNKSL-DFFLFDPTKRMLLD 146
              + +   K+    L+     +G  + +D+ + L+   +  +SL       P   +   
Sbjct: 101 KPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSER 159

Query: 147 WVTRV--QIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKI--SDFGMAR 199
            V +V  ++++ +     +LH+      +H ++ A NI +D +   ++  + +G A 
Sbjct: 160 SVLQVACRLLDALE----FLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAF 209

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 55.7 bits (134), Expect = 8e-09
 Identities = 59/329 (17%), Positives = 112/329 (34%), Gaps = 112/329 (34%)

Query: 48  TNKFSDANKLGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLREM-KNEASVIAKVQ-- 103
             ++    KLG G F  V+    ++    +A+K +  +S +   E   +E  ++  V+  
Sbjct: 36  NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVV--KSAEHYTETALDEIRLLKSVRNS 93

Query: 104 ------HKNLVRLLGC-----------CIDRDEKILIYEYMPNKSLDFFLFD-PTKRMLL 145
                  + +V+LL             C       +++E +    L  ++     + + L
Sbjct: 94  DPNDPNREMVVQLLDDFKISGVNGTHIC-------MVFEVL-GHHLLKWIIKSNYQGLPL 145

Query: 146 DWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILL--------------------- 184
             V   +II+ + QGL YLH  ++ RIIH D+K  NILL                     
Sbjct: 146 PCVK--KIIQQVLQGLDYLH--TKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSG 201

Query: 185 ----------------------------DKDMNPKISDFGMARICGGNELQANTSRIVGT 216
                                        + +  KI+D G A       +  + +  + T
Sbjct: 202 APPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACW-----VHKHFTEDIQT 256

Query: 217 YGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK------KNTGLYRTDSL-----NLLG 265
             Y S E  +   ++  +D++S   +  E+ +G             R +        LLG
Sbjct: 257 RQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLG 316

Query: 266 -----------YAWDLWTSNRTLELIDPI 283
                      Y+ + +T    L+ I  +
Sbjct: 317 KVPRKLIVAGKYSKEFFTKKGDLKHITKL 345

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 50.0 bits (120), Expect = 4e-07
 Identities = 56/234 (23%), Positives = 94/234 (40%), Gaps = 58/234 (24%)

Query: 56  KLGEGGFGPVYKGV-LKKGDEIAVKRLSGRSGQGLRE-MKNEASVIAKVQH-----KNLV 108
           K+G+G FG V     +      AVK +  R+ +      K EA ++ K+Q+      N+V
Sbjct: 42  KMGDGTFGRVLLCQHIDNKKYYAVKVV--RNIKKYTRSAKIEADILKKIQNDDINNNNIV 99

Query: 109 RLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKR-----MLLDWVTRV--QIIEGIAQGL 161
           +  G  +  D   LI+E      L   L++   R       ++ +     +I++ +    
Sbjct: 100 KYHGKFMYYDHMCLIFE-----PLGPSLYEIITRNNYNGFHIEDIKLYCIEILKALN--- 151

Query: 162 LYLHQYSRVRIIHRDLKASNILLDKDMNP-------------------------KISDFG 196
            YL    ++ + H DLK  NILLD                              K+ DFG
Sbjct: 152 -YLR---KMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFG 207

Query: 197 MARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 250
            A     ++       I+ T  Y +PE  L   + + SD++SFG +L E+ +G 
Sbjct: 208 CA--TFKSD---YHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGS 256

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 48.9 bits (117), Expect = 1e-06
 Identities = 54/230 (23%), Positives = 86/230 (37%), Gaps = 54/230 (23%)

Query: 56  KLGEGGFGPVYKGV--LKKGDEIAVKRLSGRSGQGLRE-MKNEASVIAKVQHK------N 106
            LGEG FG V + +   +   ++A+K +  R+    RE  + E +V+ K++ K       
Sbjct: 26  NLGEGTFGKVVECLDHARGKSQVALKII--RNVGKYREAARLEINVLKKIKEKDKENKFL 83

Query: 107 LVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKR-----MLLDWVTRV--QIIEGIAQ 159
            V +           + +E      L    F+  K        L  V  +  Q+      
Sbjct: 84  CVLMSDWFNFHGHMCIAFE-----LLGKNTFEFLKENNFQPYPLPHVRHMAYQLCH---- 134

Query: 160 GLLYLHQYSRVRIIHRDLKASNILLDKDMNP-------------------KISDFGMARI 200
            L +LH     ++ H DLK  NIL                          +++DFG A  
Sbjct: 135 ALRFLH---ENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSA-- 189

Query: 201 CGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 250
              +E   + + IV T  Y  PE  LE  ++   DV+S G +L E   G 
Sbjct: 190 TFDHE---HHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGF 236

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 48.7 bits (115), Expect = 2e-06
 Identities = 51/325 (15%), Positives = 104/325 (32%), Gaps = 60/325 (18%)

Query: 66  YKGVLKKGDEI-AVKRLSGRSGQGLREMKNEASV---IAKVQHKN----LVRLLGCCIDR 117
              ++   D +    RL           K E  V   + +V   N    +  +       
Sbjct: 51  IDHIIMSKDAVSGTLRLFW-----TLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQP 105

Query: 118 DEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDL 177
                +Y    ++     L++  +      V+R+Q    + Q LL L     V +I   L
Sbjct: 106 SMMTRMYIEQRDR-----LYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNV-LIDGVL 159

Query: 178 ---K---ASNILLDKDMNPKISDFGMARICGGNELQANT--SRIVGTYGYMSPEYA--LE 227
              K   A ++ L   +  K+ DF +  +   N     T    +      + P +    +
Sbjct: 160 GSGKTWVALDVCLSYKVQCKM-DFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSD 218

Query: 228 GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDE 287
              +IK  + S    L  ++  K     Y  + L +L    ++  + +     +      
Sbjct: 219 HSSNIKLRIHSIQAELRRLLKSKP----YE-NCLLVLL---NVQNA-KAWNAFN------ 263

Query: 288 YSSKQMLL--RYANIALLCVQESADDRPTMNDVVSMLT-NEAATLLPPKQPAFSYVRNTV 344
            S K +LL  R+  +    +  +     +++     LT +E  +LL        Y+    
Sbjct: 264 LSCK-ILLTTRFKQVTDF-LSAATTTHISLDHHSMTLTPDEVKSLLL------KYLDCRP 315

Query: 345 TSTSSTGKTEDCSINQVTISLLEAR 369
                    E  + N   +S++   
Sbjct: 316 QDLPR----EVLTTNPRRLSIIAES 336

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 47.5 bits (112), Expect = 5e-06
 Identities = 66/421 (15%), Positives = 128/421 (30%), Gaps = 109/421 (25%)

Query: 4   DLDLN---------LKADNV--IIELPANNKQAKR------SKKKE-VDQF------PLF 39
           + D           L  + +  II          R      SK++E V +F        +
Sbjct: 32  NFDCKDVQDMPKSILSKEEIDHIIMSKDAVSGTLRLFWTLLSKQEEMVQKFVEEVLRINY 91

Query: 40  SF--SSVSTATNKFSDANKLGEGGFGPVYKG--VLKKGDEIAVKRLSG----RSGQGLRE 91
            F  S + T   + S   ++       +Y    V  K +   V RL      R  Q L E
Sbjct: 92  KFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYN---VSRLQPYLKLR--QALLE 146

Query: 92  MKNEA------------SVIA-------KVQHKNLVRL----LGCCIDRDEKILIYEYMP 128
           ++               + +A       KVQ K   ++    L  C +  E +L      
Sbjct: 147 LRPAKNVLIDGVLGSGKTWVALDVCLSYKVQCKMDFKIFWLNLKNC-NSPETVLE----M 201

Query: 129 NKSLDFFLFDPTKRMLLDWVTRVQI-IEGIAQGLLYL---HQYSRVRIIHRDLKASNILL 184
            + L  +  DP      D  + +++ I  I   L  L     Y    ++  +++ +    
Sbjct: 202 LQKL-LYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWN 260

Query: 185 DKDMNPKI----SDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFS--------- 231
             +++ KI        +               +      ++P+     +           
Sbjct: 261 AFNLSCKILLTTRFKQVTDFLSAATTTH--ISLDHHSMTLTPDEVKS-LLLKYLDCRPQD 317

Query: 232 IKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLW---TSNRTLELIDPILE--D 286
           +  +V +     L I++     GL            WD W     ++   +I+  L   +
Sbjct: 318 LPREVLTTNPRRLSIIAESIRDGLAT----------WDNWKHVNCDKLTTIIESSLNVLE 367

Query: 287 EYSSKQMLLRYA------NI--ALLCVQESADDRPTMNDVVSMLTNEAATLLPPKQPAFS 338
               ++M  R +      +I   LL +      +  +  VV+ L   +     PK+   S
Sbjct: 368 PAEYRKMFDRLSVFPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTIS 427

Query: 339 Y 339
            
Sbjct: 428 I 428

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 47.7 bits (114), Expect = 3e-06
 Identities = 55/230 (23%), Positives = 88/230 (38%), Gaps = 54/230 (23%)

Query: 56  KLGEGGFGPVYKGV-LKKGDEI-AVKRLSGRSGQGLRE-MKNEASVIAKVQHK------N 106
            LGEG FG V + +  K G    AVK +  ++     E  ++E  V+  +          
Sbjct: 21  TLGEGAFGKVVECIDHKAGGRHVAVKIV--KNVDRYCEAARSEIQVLEHLNTTDPNSTFR 78

Query: 107 LVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKR-----MLLDWVTRV--QIIEGIAQ 159
            V++L          +++E      L    +D  K        LD + ++  QI + +  
Sbjct: 79  CVQMLEWFEHHGHICIVFE-----LLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVN- 132

Query: 160 GLLYLHQYSRVRIIHRDLKASNILLDKDMNP-------------------KISDFGMARI 200
              +LH     ++ H DLK  NIL  +                       K+ DFG A  
Sbjct: 133 ---FLH---SNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSA-- 184

Query: 201 CGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 250
              +E   + S +V T  Y +PE  L   +S   DV+S G +L+E   G 
Sbjct: 185 TYDDE---HHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGF 231

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	369
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.95
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.92
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.89
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.78
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.69
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.41
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.2
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.04
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	98.94
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.7
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.61
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.6
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.48
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.37
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.31
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.16
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.11
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.06
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	97.9
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.89
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.72
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.7
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.66
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.63
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.47
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.44
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.43
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	97.41
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	97.2
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	97.19
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	97.06
3mes_A	424	Choline kinase; malaria, structural genomics, stru	96.41
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	95.82
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	87.23
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	86.71

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=1.6e-54  Score=397.92  Aligned_cols=250  Identities=23%  Similarity=0.362  Sum_probs=201.0

Q ss_pred             cCCccCccccccCCccEEEEEEc-CCCEEEEEEecCC--CchhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEEEE
Q 017594           49 NKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIYE  125 (369)
Q Consensus        49 ~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  125 (369)
                      ++|++++.||+|+||.||+|+++ +|+.||||++...  .....+.+.+|+.+++.++||||+++++++.+.+.+|+|||
T Consensus        24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE  103 (350)
T 4b9d_A           24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD  103 (350)
T ss_dssp             CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence            68999999999999999999975 4999999999754  23445678899999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCCCC
Q 017594          126 YMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE  205 (369)
Q Consensus       126 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~~~  205 (369)
                      ||+||+|.+++... +...+++..++.++.||+.||.|||++|   |+||||||+|||++.+|.+||+|||+++......
T Consensus       104 y~~gg~L~~~i~~~-~~~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~  179 (350)
T 4b9d_A          104 YCEGGDLFKRINAQ-KGVLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV  179 (350)
T ss_dssp             CCTTCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTEESCCCHHH
T ss_pred             CCCCCcHHHHHHHc-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEcccccceeecCCc
Confidence            99999999998543 2345788899999999999999999999   9999999999999999999999999998654221


Q ss_pred             cccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCccccccCcccc
Q 017594          206 LQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILE  285 (369)
Q Consensus       206 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (369)
                        .......||+.|+|||++.+..|+.++|||||||++|+|++|+.||......     .......... ..    + . 
T Consensus       180 --~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~-----~~~~~i~~~~-~~----~-~-  245 (350)
T 4b9d_A          180 --ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMK-----NLVLKIISGS-FP----P-V-  245 (350)
T ss_dssp             --HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH-----HHHHHHHHTC-CC----C-C-
T ss_pred             --ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH-----HHHHHHHcCC-CC----C-C-
Confidence              1123357999999999999999999999999999999999999999643311     1111111111 10    0 0 


Q ss_pred             ccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 017594          286 DEYSSKQMLLRYANIALLCVQESADDRPTMNDVVS  320 (369)
Q Consensus       286 ~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~  320 (369)
                          +..++.++.+||.+||+.||++|||+.++++
T Consensus       246 ----~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~  276 (350)
T 4b9d_A          246 ----SLHYSYDLRSLVSQLFKRNPRDRPSVNSILE  276 (350)
T ss_dssp             ----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ----CccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                1123677999999999999999999999986

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=2.3e-53  Score=384.64  Aligned_cols=261  Identities=27%  Similarity=0.426  Sum_probs=214.7

Q ss_pred             cCCccCccccccCCccEEEEEEc------CCCEEEEEEecCCCchhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEE
Q 017594           49 NKFSDANKLGEGGFGPVYKGVLK------KGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKIL  122 (369)
Q Consensus        49 ~~y~i~~~lg~G~~~~v~~~~~~------~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l  122 (369)
                      ++|.+.+.||+|+||.||+|++.      ++..||||++........+.+.+|+.++++++||||+++++++.+.+..++
T Consensus        13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l   92 (299)
T 4asz_A           13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM   92 (299)
T ss_dssp             GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence            57889999999999999999864      367899999987766667889999999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhcCCC----------ccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEE
Q 017594          123 IYEYMPNKSLDFFLFDPT----------KRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKI  192 (369)
Q Consensus       123 v~e~~~~~~L~~~l~~~~----------~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L  192 (369)
                      ||||+++|+|.+++....          ....+++..+..++.||+.||+|||+++   ++||||||+|||++.++.+||
T Consensus        93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~~~~Ki  169 (299)
T 4asz_A           93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKI  169 (299)
T ss_dssp             EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEE
T ss_pred             EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCCCcEEE
Confidence            999999999999986432          2346899999999999999999999999   999999999999999999999


Q ss_pred             eecCCceecCCCCcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHh-CCCCCCCCcccccccchhhhhhh
Q 017594          193 SDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDLW  271 (369)
Q Consensus       193 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~  271 (369)
                      +|||+++...............||+.|+|||++.+..|+.++|||||||++|||+| |+.||.......     ......
T Consensus       170 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~-----~~~~i~  244 (299)
T 4asz_A          170 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE-----VIECIT  244 (299)
T ss_dssp             CCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH-----HHHHHH
T ss_pred             CCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH-----HHHHHH
Confidence            99999986654433333344568999999999999999999999999999999998 899997543211     111111


Q ss_pred             hcCccccccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHhhhhc
Q 017594          272 TSNRTLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNEAAT  328 (369)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L~~~~~~  328 (369)
                      . ......          +..++.++.+|+.+||+.||++|||+.+|++.|+++...
T Consensus       245 ~-~~~~~~----------p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~  290 (299)
T 4asz_A          245 Q-GRVLQR----------PRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKA  290 (299)
T ss_dssp             H-TCCCCC----------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             c-CCCCCC----------CccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence            1 111110          112366799999999999999999999999999988764

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=2e-53  Score=390.13  Aligned_cols=250  Identities=23%  Similarity=0.328  Sum_probs=208.1

Q ss_pred             hcCCccCccccccCCccEEEEEEc-CCCEEEEEEecCCCchhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEEEEe
Q 017594           48 TNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIYEY  126 (369)
Q Consensus        48 ~~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  126 (369)
                      ..+|++++.||+|+||.||+|+++ +|+.||||++........+.+.+|+.+|+.++||||++++++|.+++.+|+||||
T Consensus        73 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy  152 (346)
T 4fih_A           73 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF  152 (346)
T ss_dssp             GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             hHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeC
Confidence            367999999999999999999976 4999999999765555556788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCCCCc
Q 017594          127 MPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNEL  206 (369)
Q Consensus       127 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~~~~  206 (369)
                      |++|+|.+++..    ..+++..+..++.||+.||+|||++|   |+||||||+|||++.+|.+||+|||++..+.... 
T Consensus       153 ~~gg~L~~~l~~----~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~-  224 (346)
T 4fih_A          153 LEGGALTDIVTH----TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-  224 (346)
T ss_dssp             CTTEEHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSSS-
T ss_pred             CCCCcHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCceecCCCC-
Confidence            999999998843    34899999999999999999999999   9999999999999999999999999998765432 


Q ss_pred             ccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCccccccCccccc
Q 017594          207 QANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILED  286 (369)
Q Consensus       207 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  286 (369)
                       ......+||+.|+|||++.+..|+.++|||||||++|+|++|.+||.......     ..... ...     ..+.+. 
T Consensus       225 -~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~-----~~~~i-~~~-----~~~~~~-  291 (346)
T 4fih_A          225 -PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK-----AMKMI-RDN-----LPPRLK-  291 (346)
T ss_dssp             -CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-----HHHHH-HHS-----SCCCCS-
T ss_pred             -CcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH-----HHHHH-HcC-----CCCCCC-
Confidence             22334689999999999999999999999999999999999999996432111     01111 000     000110 


Q ss_pred             cccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 017594          287 EYSSKQMLLRYANIALLCVQESADDRPTMNDVVS  320 (369)
Q Consensus       287 ~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~  320 (369)
                        ....++.++.+||.+||+.||++|||+.|+++
T Consensus       292 --~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~  323 (346)
T 4fih_A          292 --NLHKVSPSLKGFLDRLLVRDPAQRATAAELLK  323 (346)
T ss_dssp             --CGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             --ccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence              11123677999999999999999999999987

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=1.4e-52  Score=384.56  Aligned_cols=261  Identities=28%  Similarity=0.396  Sum_probs=208.4

Q ss_pred             cCCccCccccccCCccEEEEEEc------CCCEEEEEEecCCCchhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEE
Q 017594           49 NKFSDANKLGEGGFGPVYKGVLK------KGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKIL  122 (369)
Q Consensus        49 ~~y~i~~~lg~G~~~~v~~~~~~------~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l  122 (369)
                      ++|.+.+.||+|+||.||+|+++      ++..||||++........+.+.+|+.+|++++||||+++++++.+.+..++
T Consensus        41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l  120 (329)
T 4aoj_A           41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM  120 (329)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence            56788899999999999999864      367899999987776677889999999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhcCCCc------------cccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCce
Q 017594          123 IYEYMPNKSLDFFLFDPTK------------RMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNP  190 (369)
Q Consensus       123 v~e~~~~~~L~~~l~~~~~------------~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~  190 (369)
                      ||||+++|+|.+++.....            ..++++..+..++.||+.||+|||+++   ++||||||+|||++.++.+
T Consensus       121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~~~~~~  197 (329)
T 4aoj_A          121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLVV  197 (329)
T ss_dssp             EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEE
T ss_pred             EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEECCCCcE
Confidence            9999999999999865322            245899999999999999999999999   9999999999999999999


Q ss_pred             EEeecCCceecCCCCcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHh-CCCCCCCCcccccccchhhhh
Q 017594          191 KISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWD  269 (369)
Q Consensus       191 ~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~  269 (369)
                      ||+|||+++...............||+.|+|||++.+..++.++|||||||++|||+| |+.||.......     ....
T Consensus       198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~-----~~~~  272 (329)
T 4aoj_A          198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTE-----AIDC  272 (329)
T ss_dssp             EECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHH-----HHHH
T ss_pred             EEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHH-----HHHH
Confidence            9999999987654443334445678999999999999999999999999999999998 899997543211     1111


Q ss_pred             hhhcCccccccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHhhhhc
Q 017594          270 LWTSNRTLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNEAAT  328 (369)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L~~~~~~  328 (369)
                      ...... ..     .     +..+++++.+|+.+||+.||++|||+.+|++.|+.+...
T Consensus       273 i~~g~~-~~-----~-----p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~  320 (329)
T 4aoj_A          273 ITQGRE-LE-----R-----PRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA  320 (329)
T ss_dssp             HHHTCC-CC-----C-----CTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             HHcCCC-CC-----C-----cccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence            111110 00     1     112366799999999999999999999999999998763

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=1.3e-52  Score=383.53  Aligned_cols=261  Identities=21%  Similarity=0.224  Sum_probs=209.2

Q ss_pred             hcCCccCccccccCCccEEEEEEcC-CCEEEEEEecCCCchhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEEEEe
Q 017594           48 TNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIYEY  126 (369)
Q Consensus        48 ~~~y~i~~~lg~G~~~~v~~~~~~~-~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  126 (369)
                      ...|++.++||+|+||.||+|+++. |+.||||++.....     ..+|+.+++.++||||+++++++.+++.+|+||||
T Consensus        57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy  131 (336)
T 4g3f_A           57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMEL  131 (336)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence            3568889999999999999999764 99999999975432     24699999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCC-ceEEeecCCceecCCCC
Q 017594          127 MPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDM-NPKISDFGMARICGGNE  205 (369)
Q Consensus       127 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~-~~~L~Dfg~~~~~~~~~  205 (369)
                      |+|++|.+++..   ...+++..+..++.||+.||+|||+++   |+||||||+|||++.+| .+||+|||++..+....
T Consensus       132 ~~gg~L~~~l~~---~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~  205 (336)
T 4g3f_A          132 LEGGSLGQLIKQ---MGCLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDG  205 (336)
T ss_dssp             CTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTCEEC----
T ss_pred             cCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCC
Confidence            999999999953   345999999999999999999999999   99999999999999987 69999999998765432


Q ss_pred             ccc---ccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCccccccCc
Q 017594          206 LQA---NTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDP  282 (369)
Q Consensus       206 ~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (369)
                      ...   ......||+.|+|||++.+..|+.++|||||||++|+|++|.+||........     .............+  
T Consensus       206 ~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~-----~~~i~~~~~~~~~~--  278 (336)
T 4g3f_A          206 LGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPL-----CLKIASEPPPIREI--  278 (336)
T ss_dssp             --------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCC-----HHHHHHSCCGGGGS--
T ss_pred             cccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHH-----HHHHHcCCCCchhc--
Confidence            211   22335799999999999999999999999999999999999999964432211     11111111100001  


Q ss_pred             cccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHhhhhccCCCC
Q 017594          283 ILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNEAATLLPPK  333 (369)
Q Consensus       283 ~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L~~~~~~~~~~~  333 (369)
                             +..++..+.++|.+||+.||++|||+.||++.|.........-+
T Consensus       279 -------~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~  322 (336)
T 4g3f_A          279 -------PPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLK  322 (336)
T ss_dssp             -------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSC
T ss_pred             -------CccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhcc
Confidence                   11236779999999999999999999999999988877654433

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=1.2e-53  Score=386.02  Aligned_cols=248  Identities=25%  Similarity=0.315  Sum_probs=207.8

Q ss_pred             cCCccCccccccCCccEEEEEEc-CCCEEEEEEecCC---CchhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEEE
Q 017594           49 NKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGR---SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIY  124 (369)
Q Consensus        49 ~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  124 (369)
                      ++|++++.||+|+||.||+|+++ +|+.||+|++...   .....+.+.+|+.+++.++||||++++++|.+++..|+||
T Consensus        32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm  111 (311)
T 4aw0_A           32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL  111 (311)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            56999999999999999999975 4899999998643   2234577899999999999999999999999999999999


Q ss_pred             EecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCCC
Q 017594          125 EYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGN  204 (369)
Q Consensus       125 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~~  204 (369)
                      |||.||+|.+++..   ...+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||++..+...
T Consensus       112 Ey~~gG~L~~~i~~---~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~  185 (311)
T 4aw0_A          112 SYAKNGELLKYIRK---IGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE  185 (311)
T ss_dssp             CCCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             ecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcCCceecCCC
Confidence            99999999999853   345999999999999999999999999   999999999999999999999999999987654


Q ss_pred             CcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCccccccCccc
Q 017594          205 ELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPIL  284 (369)
Q Consensus       205 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (369)
                      .........+||+.|+|||++.+..|+.++|||||||++|+|++|.+||.......     ......... .      .+
T Consensus       186 ~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~-----~~~~i~~~~-~------~~  253 (311)
T 4aw0_A          186 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGL-----IFAKIIKLE-Y------DF  253 (311)
T ss_dssp             TTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-----HHHHHHHTC-C------CC
T ss_pred             CCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-----HHHHHHcCC-C------CC
Confidence            44444455689999999999999999999999999999999999999996432111     111111111 0      01


Q ss_pred             cccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHH
Q 017594          285 EDEYSSKQMLLRYANIALLCVQESADDRPTMNDVV  319 (369)
Q Consensus       285 ~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell  319 (369)
                      .     ..++.++.+||.+||+.||++|||++|++
T Consensus       254 p-----~~~s~~~~dli~~lL~~dp~~R~t~~e~~  283 (311)
T 4aw0_A          254 P-----EKFFPKARDLVEKLLVLDATKRLGCEEME  283 (311)
T ss_dssp             C-----TTCCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred             C-----cccCHHHHHHHHHHccCCHhHCcChHHHc
Confidence            1     11256799999999999999999999874

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=6.8e-52  Score=375.23  Aligned_cols=265  Identities=25%  Similarity=0.407  Sum_probs=205.6

Q ss_pred             HhcCCccCccccccCCccEEEEEEcCCCEEEEEEecCC--CchhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEEE
Q 017594           47 ATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIY  124 (369)
Q Consensus        47 ~~~~y~i~~~lg~G~~~~v~~~~~~~~~~valK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  124 (369)
                      ..+++++.+.||+|+||+||+|++++  .||||++...  .....+.+.+|+.++++++||||+++++++. ++..++||
T Consensus        34 ~~~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~-~~~~~iVm  110 (307)
T 3omv_A           34 EASEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMT-KDNLAIVT  110 (307)
T ss_dssp             CTTSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEE
T ss_pred             cHHHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-CCeEEEEE
Confidence            45788999999999999999998753  6899998643  3345677899999999999999999999875 46789999


Q ss_pred             EecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCCC
Q 017594          125 EYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGN  204 (369)
Q Consensus       125 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~~  204 (369)
                      |||++|+|.+++....  ..+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++.....
T Consensus       111 Ey~~gGsL~~~l~~~~--~~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~  185 (307)
T 3omv_A          111 QWCEGSSLYKHLHVQE--TKFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRW  185 (307)
T ss_dssp             ECCSSCBHHHHHHTSC--CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCCSSCBC----
T ss_pred             EcCCCCCHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeeccCceecccC
Confidence            9999999999986432  34899999999999999999999998   999999999999999999999999999876543


Q ss_pred             CcccccccccccccccCchhhcc---CCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCccccccC
Q 017594          205 ELQANTSRIVGTYGYMSPEYALE---GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELID  281 (369)
Q Consensus       205 ~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (369)
                      ..........||+.|+|||++.+   ..|+.++|||||||++|+|+||+.||.......     ..............+.
T Consensus       186 ~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~-----~~~~~~~~~~~~p~~~  260 (307)
T 3omv_A          186 SGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRD-----QIIFMVGRGYASPDLS  260 (307)
T ss_dssp             --------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH-----HHHHHHHTTCCCCCST
T ss_pred             CcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHH-----HHHHHHhcCCCCCCcc
Confidence            33333445679999999999863   468999999999999999999999996433211     1111111111110000


Q ss_pred             ccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHhhhhccC
Q 017594          282 PILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNEAATLL  330 (369)
Q Consensus       282 ~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L~~~~~~~~  330 (369)
                      . .     +..++.++.+|+.+||+.||++|||+.+|++.|+.+...++
T Consensus       261 ~-~-----~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~lp  303 (307)
T 3omv_A          261 K-L-----YKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLP  303 (307)
T ss_dssp             T-S-----CTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTCC
T ss_pred             c-c-----cccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccCC
Confidence            0 0     11235679999999999999999999999999998876553

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=2e-52  Score=392.62  Aligned_cols=250  Identities=23%  Similarity=0.326  Sum_probs=208.7

Q ss_pred             hcCCccCccccccCCccEEEEEEc-CCCEEEEEEecCCCchhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEEEEe
Q 017594           48 TNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIYEY  126 (369)
Q Consensus        48 ~~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  126 (369)
                      .++|++++.||+|+||.||+|+++ +|+.||||++........+.+.+|+.+|+.++||||++++++|.+.+.+|+||||
T Consensus       150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy  229 (423)
T 4fie_A          150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF  229 (423)
T ss_dssp             GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeC
Confidence            467999999999999999999976 4999999999866655667789999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCCCCc
Q 017594          127 MPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNEL  206 (369)
Q Consensus       127 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~~~~  206 (369)
                      |+||+|.+++..    ..+++..+..++.||+.||+|||++|   |+||||||+|||++.+|.+||+|||++..+.... 
T Consensus       230 ~~gG~L~~~i~~----~~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~-  301 (423)
T 4fie_A          230 LEGGALTDIVTH----TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-  301 (423)
T ss_dssp             CTTEEHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCEECCSSC-
T ss_pred             CCCCcHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccceECCCCC-
Confidence            999999998843    34899999999999999999999999   9999999999999999999999999998765432 


Q ss_pred             ccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCccccccCccccc
Q 017594          207 QANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILED  286 (369)
Q Consensus       207 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  286 (369)
                       ......+||+.|+|||++.+..|+.++|||||||++|+|++|.+||.......     ...... ..     ..+.+. 
T Consensus       302 -~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~-----~~~~i~-~~-----~~~~~~-  368 (423)
T 4fie_A          302 -PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK-----AMKMIR-DN-----LPPRLK-  368 (423)
T ss_dssp             -CCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-----HHHHHH-HS-----CCCCCS-
T ss_pred             -ccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH-----HHHHHH-cC-----CCCCCc-
Confidence             22334679999999999999999999999999999999999999996432111     011110 00     000000 


Q ss_pred             cccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 017594          287 EYSSKQMLLRYANIALLCVQESADDRPTMNDVVS  320 (369)
Q Consensus       287 ~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~  320 (369)
                        ....++.++.+||.+||+.||++|||+.|+++
T Consensus       369 --~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~  400 (423)
T 4fie_A          369 --NLHKVSPSLKGFLDRLLVRDPAQRATAAELLK  400 (423)
T ss_dssp             --CTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             --ccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence              01122667999999999999999999999987

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=4.8e-52  Score=370.43  Aligned_cols=245  Identities=22%  Similarity=0.361  Sum_probs=189.0

Q ss_pred             cCCccCccccccCCccEEEEEEc-CCCEEEEEEecCCC---chhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEEE
Q 017594           49 NKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS---GQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIY  124 (369)
Q Consensus        49 ~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  124 (369)
                      ++|++.+.||+|+||.||+|+++ +|+.||+|++....   ......+.+|+.+++.++||||+++++++.+.+..|+||
T Consensus        13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm   92 (275)
T 3hyh_A           13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI   92 (275)
T ss_dssp             -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence            68999999999999999999965 59999999986442   234567889999999999999999999999999999999


Q ss_pred             EecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCCC
Q 017594          125 EYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGN  204 (369)
Q Consensus       125 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~~  204 (369)
                      ||+ +++|.+++..   +..+++..+..++.||+.||+|||++|   ++||||||+||+++.++.++|+|||++......
T Consensus        93 Ey~-~g~L~~~l~~---~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~  165 (275)
T 3hyh_A           93 EYA-GNELFDYIVQ---RDKMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG  165 (275)
T ss_dssp             ECC-CEEHHHHHHH---SCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSSCC------
T ss_pred             eCC-CCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecCCCeecCCC
Confidence            999 5678777743   345999999999999999999999999   999999999999999999999999999865433


Q ss_pred             CcccccccccccccccCchhhccCCC-CcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCccccccCcc
Q 017594          205 ELQANTSRIVGTYGYMSPEYALEGIF-SIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPI  283 (369)
Q Consensus       205 ~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (369)
                      .   ......||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.......     ..... ..... .     
T Consensus       166 ~---~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~-----~~~~i-~~~~~-~-----  230 (275)
T 3hyh_A          166 N---FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPV-----LFKNI-SNGVY-T-----  230 (275)
T ss_dssp             ------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-----HHHHH-HHTCC-C-----
T ss_pred             C---ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHH-----HHHHH-HcCCC-C-----
Confidence            2   2234579999999999998876 579999999999999999999996432111     11111 11100 0     


Q ss_pred             ccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 017594          284 LEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVS  320 (369)
Q Consensus       284 ~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~  320 (369)
                      +.     ...+.++.+||.+||+.||++|||+.|+++
T Consensus       231 ~p-----~~~s~~~~~li~~~L~~dP~~R~s~~eil~  262 (275)
T 3hyh_A          231 LP-----KFLSPGAAGLIKRMLIVNPLNRISIHEIMQ  262 (275)
T ss_dssp             CC-----TTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             CC-----CCCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence            11     112567899999999999999999999987

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=7.7e-52  Score=376.20  Aligned_cols=258  Identities=29%  Similarity=0.420  Sum_probs=210.0

Q ss_pred             cCCccCccccccCCccEEEEEEc------CCCEEEEEEecCCC-chhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccE
Q 017594           49 NKFSDANKLGEGGFGPVYKGVLK------KGDEIAVKRLSGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKI  121 (369)
Q Consensus        49 ~~y~i~~~lg~G~~~~v~~~~~~------~~~~valK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  121 (369)
                      .++++.+.||+|+||.||+|++.      +++.||||++.... ....+.+.+|+.++.+++||||+++++++...+..+
T Consensus        26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~  105 (308)
T 4gt4_A           26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLS  105 (308)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred             HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEE
Confidence            45678899999999999999863      36789999997543 334577999999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhcCCC-------------ccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCC
Q 017594          122 LIYEYMPNKSLDFFLFDPT-------------KRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDM  188 (369)
Q Consensus       122 lv~e~~~~~~L~~~l~~~~-------------~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~  188 (369)
                      +||||+++|+|.+++....             ....+++..+..++.||+.||+|||+++   ++||||||.|||++.++
T Consensus       106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NILl~~~~  182 (308)
T 4gt4_A          106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKL  182 (308)
T ss_dssp             EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGG
T ss_pred             EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccceEECCCC
Confidence            9999999999999986432             1345889999999999999999999999   99999999999999999


Q ss_pred             ceEEeecCCceecCCCCcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHh-CCCCCCCCcccccccchhh
Q 017594          189 NPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYA  267 (369)
Q Consensus       189 ~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~t-g~~p~~~~~~~~~~~~~~~  267 (369)
                      .+||+|||+++...............||+.|+|||++.+..|+.++|||||||++|||+| |..||.......     ..
T Consensus       183 ~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~-----~~  257 (308)
T 4gt4_A          183 NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD-----VV  257 (308)
T ss_dssp             CEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHH-----HH
T ss_pred             CEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHH-----HH
Confidence            999999999987654433333445678999999999999999999999999999999998 899986543211     11


Q ss_pred             hhhhhcCccccccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHhh
Q 017594          268 WDLWTSNRTLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNE  325 (369)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L~~~  325 (369)
                      .. .........          +..++.++.+|+.+||+.||++|||+.+|++.|+..
T Consensus       258 ~~-i~~~~~~~~----------p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~  304 (308)
T 4gt4_A          258 EM-IRNRQVLPC----------PDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW  304 (308)
T ss_dssp             HH-HHTTCCCCC----------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred             HH-HHcCCCCCC----------cccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence            11 111111111          122367799999999999999999999999999864

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=1.9e-51  Score=369.59  Aligned_cols=249  Identities=26%  Similarity=0.404  Sum_probs=196.9

Q ss_pred             cCC-ccCccccccCCccEEEEEEcC-CCEEEEEEecCC--CchhHHHHHHHHHHHhcCCCCceeeeeeeEEe----CCcc
Q 017594           49 NKF-SDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCID----RDEK  120 (369)
Q Consensus        49 ~~y-~i~~~lg~G~~~~v~~~~~~~-~~~valK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~  120 (369)
                      .+| ++.+.||+|+||.||+|+++. +..||+|++...  .....+.+.+|+.++++++||||+++++++..    ...+
T Consensus        25 gr~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~  104 (290)
T 3fpq_A           25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCI  104 (290)
T ss_dssp             SSEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEE
T ss_pred             CceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEE
Confidence            455 777889999999999999764 889999998643  23445678899999999999999999999875    2457


Q ss_pred             EEEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeC-CCceEEeecCCce
Q 017594          121 ILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDK-DMNPKISDFGMAR  199 (369)
Q Consensus       121 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~-~~~~~L~Dfg~~~  199 (369)
                      |+|||||++|+|.+++..   ...+++..+..++.||+.||+|||+++ ++|+||||||+|||++. +|.+||+|||++.
T Consensus       105 ~lvmEy~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DFGla~  180 (290)
T 3fpq_A          105 VLVTELMTSGTLKTYLKR---FKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLAT  180 (290)
T ss_dssp             EEEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred             EEEEeCCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeCcCCE
Confidence            999999999999999953   345899999999999999999999874 34999999999999974 7899999999997


Q ss_pred             ecCCCCcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCccccc
Q 017594          200 ICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLEL  279 (369)
Q Consensus       200 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (369)
                      .....    ......||+.|+|||++.+ .|+.++|||||||++|+|+||+.||.......     ............. 
T Consensus       181 ~~~~~----~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~-----~~~~~i~~~~~~~-  249 (290)
T 3fpq_A          181 LKRAS----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAA-----QIYRRVTSGVKPA-  249 (290)
T ss_dssp             GCCTT----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH-----HHHHHHTTTCCCG-
T ss_pred             eCCCC----ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHH-----HHHHHHHcCCCCC-
Confidence            54322    2334579999999998865 69999999999999999999999996432111     0111111110000 


Q ss_pred             cCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 017594          280 IDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVS  320 (369)
Q Consensus       280 ~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~  320 (369)
                         ..     +...++++.+||.+||+.||++|||+.++++
T Consensus       250 ---~~-----~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~  282 (290)
T 3fpq_A          250 ---SF-----DKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             ---GG-----GGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ---CC-----CccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence               01     1111456899999999999999999999986

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=1e-50  Score=369.23  Aligned_cols=275  Identities=23%  Similarity=0.294  Sum_probs=205.6

Q ss_pred             hcCCccCccccccCCccEEEEEEcCCCEEEEEEecCCCchhHHHHHHHHHHHhcCCCCceeeeeeeEEeCC----ccEEE
Q 017594           48 TNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDRD----EKILI  123 (369)
Q Consensus        48 ~~~y~i~~~lg~G~~~~v~~~~~~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----~~~lv  123 (369)
                      .++|.+.+.||+|+||.||+|+++ |+.||||++...... ......|+..+..++||||+++++++...+    .+++|
T Consensus         2 ar~i~L~~~iG~G~fG~Vy~~~~~-g~~VAvK~l~~~~~~-~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV   79 (303)
T 3hmm_A            2 ARTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV   79 (303)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEET-TEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred             CcEEEEEEEEeeCCCeEEEEEEEC-CEEEEEEEECccchh-hHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEE
Confidence            467899999999999999999985 889999999654321 222334566667789999999999998654    47999


Q ss_pred             EEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCC-----CCCcccCCCCCCCEEEeCCCceEEeecCCc
Q 017594          124 YEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYS-----RVRIIHRDLKASNILLDKDMNPKISDFGMA  198 (369)
Q Consensus       124 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~-----~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~  198 (369)
                      |||+++|+|.+++..    ..+++..+.+++.|++.||+|||+++     .++|+||||||+|||++.++.+||+|||++
T Consensus        80 ~Ey~~~gsL~~~l~~----~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla  155 (303)
T 3hmm_A           80 SDYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA  155 (303)
T ss_dssp             EECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred             ecCCCCCcHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCC
Confidence            999999999999953    34889999999999999999999871     123999999999999999999999999999


Q ss_pred             eecCCCCccc--ccccccccccccCchhhccC------CCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhh---
Q 017594          199 RICGGNELQA--NTSRIVGTYGYMSPEYALEG------IFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYA---  267 (369)
Q Consensus       199 ~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~------~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~---  267 (369)
                      +.........  ......||+.|+|||++.+.      .++.++|||||||++|||+||.+||+.............   
T Consensus       156 ~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~  235 (303)
T 3hmm_A          156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD  235 (303)
T ss_dssp             EEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSS
T ss_pred             ccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhccccc
Confidence            8765433221  22345799999999998754      467899999999999999999988765432221111100   


Q ss_pred             --hhhhhcCccccccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHhhhhc
Q 017594          268 --WDLWTSNRTLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNEAAT  328 (369)
Q Consensus       268 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L~~~~~~  328 (369)
                        .......-....+++.+.........+..+.+|+.+||+.||++|||+.+|++.|+++...
T Consensus       236 ~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~  298 (303)
T 3hmm_A          236 PSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ  298 (303)
T ss_dssp             CCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             chHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHH
Confidence              0000000011222333333333344567899999999999999999999999999988764

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=1.3e-50  Score=374.45  Aligned_cols=272  Identities=26%  Similarity=0.359  Sum_probs=217.6

Q ss_pred             cchhhHHHHhcCCccCccccccCCccEEEEEEcC------CCEEEEEEecCCC-chhHHHHHHHHHHHhcCCC-Cceeee
Q 017594           39 FSFSSVSTATNKFSDANKLGEGGFGPVYKGVLKK------GDEIAVKRLSGRS-GQGLREMKNEASVIAKVQH-KNLVRL  110 (369)
Q Consensus        39 ~~~~~~~~~~~~y~i~~~lg~G~~~~v~~~~~~~------~~~valK~~~~~~-~~~~~~~~~e~~~l~~l~h-~~i~~~  110 (369)
                      |..+..+...++|++.+.||+|+||.||+|++..      ++.||+|.+.... ....+.+.+|+.+|.++.| |||+++
T Consensus        54 ~~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l  133 (353)
T 4ase_A           54 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL  133 (353)
T ss_dssp             CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             CCCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEE
Confidence            4444556667899999999999999999999653      3579999997543 3345678899999999965 899999


Q ss_pred             eeeEEeC-CccEEEEEecCCCChhhhhcCCCc-------------cccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCC
Q 017594          111 LGCCIDR-DEKILIYEYMPNKSLDFFLFDPTK-------------RMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRD  176 (369)
Q Consensus       111 ~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~-------------~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~d  176 (369)
                      ++++... +.+++|||||++|+|.+++.....             +..+++..+..++.||+.||+|||+++   ++|||
T Consensus       134 ~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---iiHRD  210 (353)
T 4ase_A          134 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRD  210 (353)
T ss_dssp             EEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred             EEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---eecCc
Confidence            9998764 568999999999999999864322             345889999999999999999999999   99999


Q ss_pred             CCCCCEEEeCCCceEEeecCCceecCCCCcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHh-CCCCCCC
Q 017594          177 LKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGL  255 (369)
Q Consensus       177 l~p~NIlv~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~t-g~~p~~~  255 (369)
                      |||+|||++.++.+||+|||+++.+.............||+.|+|||++.+..|+.++|||||||++|||+| |..||..
T Consensus       211 LK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~  290 (353)
T 4ase_A          211 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG  290 (353)
T ss_dssp             CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred             cCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCC
Confidence            999999999999999999999987655443334445678999999999999999999999999999999998 8999975


Q ss_pred             CcccccccchhhhhhhhcCccccccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHhhhhc
Q 017594          256 YRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNEAAT  328 (369)
Q Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L~~~~~~  328 (369)
                      .....     .............     .     +..+++++.+++.+||+.||++|||+.+|++.|+.+...
T Consensus       291 ~~~~~-----~~~~~i~~g~~~~-----~-----p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~  348 (353)
T 4ase_A          291 VKIDE-----EFCRRLKEGTRMR-----A-----PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA  348 (353)
T ss_dssp             CCCSH-----HHHHHHHHTCCCC-----C-----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CCHHH-----HHHHHHHcCCCCC-----C-----CccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHH
Confidence            43221     1111111111111     1     111256799999999999999999999999999988653

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=1.5e-51  Score=372.10  Aligned_cols=247  Identities=22%  Similarity=0.287  Sum_probs=195.4

Q ss_pred             cCCccCccccccCCccEEEEEEc----CCCEEEEEEecCCC--chhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEE
Q 017594           49 NKFSDANKLGEGGFGPVYKGVLK----KGDEIAVKRLSGRS--GQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKIL  122 (369)
Q Consensus        49 ~~y~i~~~lg~G~~~~v~~~~~~----~~~~valK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l  122 (369)
                      ++|++++.||+|+||.||+|+..    +++.||+|++....  ......+..|+.++++++||||+++++++.+++..|+
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i  103 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL  103 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence            67999999999999999999852    37889999986432  1223467789999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecC
Q 017594          123 IYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICG  202 (369)
Q Consensus       123 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~  202 (369)
                      |||||+||+|.+++..   ...+++..+..++.||+.||+|||++|   |+||||||+|||++.+|.++|+|||+++...
T Consensus       104 vmEy~~gg~L~~~l~~---~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~  177 (304)
T 3ubd_A          104 ILDFLRGGDLFTRLSK---EVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESI  177 (304)
T ss_dssp             EECCCTTCEEHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSEEEEC--
T ss_pred             EEEcCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEecccccceecc
Confidence            9999999999999853   345999999999999999999999999   9999999999999999999999999998654


Q ss_pred             CCCcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCccccccCc
Q 017594          203 GNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDP  282 (369)
Q Consensus       203 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (369)
                      ...  .......||+.|+|||++.+..|+.++|||||||++|+|++|..||.......     ......... . .    
T Consensus       178 ~~~--~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~-----~~~~i~~~~-~-~----  244 (304)
T 3ubd_A          178 DHE--KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKE-----TMTMILKAK-L-G----  244 (304)
T ss_dssp             -----CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-----HHHHHHHCC-C-C----
T ss_pred             CCC--ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHH-----HHHHHHcCC-C-C----
Confidence            322  12234579999999999999999999999999999999999999996432111     111111110 0 0    


Q ss_pred             cccccccHHHHHHHHHHHHHHhhcCCCCCCCCH-----HHHHH
Q 017594          283 ILEDEYSSKQMLLRYANIALLCVQESADDRPTM-----NDVVS  320 (369)
Q Consensus       283 ~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~-----~ell~  320 (369)
                       +     +..+++++.+||.+||+.||++|||+     +|+++
T Consensus       245 -~-----p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~  281 (304)
T 3ubd_A          245 -M-----PQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR  281 (304)
T ss_dssp             -C-----CTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred             -C-----CCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence             0     11136679999999999999999985     67774

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=5.9e-50  Score=362.78  Aligned_cols=252  Identities=23%  Similarity=0.332  Sum_probs=189.6

Q ss_pred             hcCCccCccccccCCccEEEEEEc-CCCEEEEEEecCCC-chhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCc------
Q 017594           48 TNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDE------  119 (369)
Q Consensus        48 ~~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~------  119 (369)
                      ..+|++++.||+|+||.||+|+++ +|+.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+.      
T Consensus         4 l~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~   83 (299)
T 4g31_A            4 LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQP   83 (299)
T ss_dssp             HHHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-------
T ss_pred             chhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccc
Confidence            356999999999999999999976 48999999986543 3345678899999999999999999999876543      


Q ss_pred             ------cEEEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEe
Q 017594          120 ------KILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKIS  193 (369)
Q Consensus       120 ------~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~  193 (369)
                            .|+|||||.+++|.+++.........+...++.++.||+.||+|||++|   |+||||||+|||++.++.+||+
T Consensus        84 ~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~~~~~vKl~  160 (299)
T 4g31_A           84 SSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVG  160 (299)
T ss_dssp             ---CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEEC
T ss_pred             cCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEECCCCcEEEc
Confidence                  6899999999999999976555444566678899999999999999999   9999999999999999999999


Q ss_pred             ecCCceecCCCCccc----------ccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCccccccc
Q 017594          194 DFGMARICGGNELQA----------NTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNL  263 (369)
Q Consensus       194 Dfg~~~~~~~~~~~~----------~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~  263 (369)
                      |||++..+.......          ......||+.|+|||++.+..|+.++|||||||++|+|++   ||.....    .
T Consensus       161 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~----~  233 (299)
T 4g31_A          161 DFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQME----R  233 (299)
T ss_dssp             CCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHH----H
T ss_pred             cCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccH----H
Confidence            999998765432211          1123469999999999999999999999999999999996   6542110    0


Q ss_pred             chhhhhhhhcCccccccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 017594          264 LGYAWDLWTSNRTLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVS  320 (369)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~  320 (369)
                      ....... ....        ..  ......++.+.+||.+||+.||++|||+.++++
T Consensus       234 ~~~~~~~-~~~~--------~p--~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  279 (299)
T 4g31_A          234 VRTLTDV-RNLK--------FP--PLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE  279 (299)
T ss_dssp             HHHHHHH-HTTC--------CC--HHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             HHHHHHH-hcCC--------CC--CCCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            0000000 0000        00  111222456788999999999999999999987

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=4.6e-48  Score=359.48  Aligned_cols=205  Identities=24%  Similarity=0.379  Sum_probs=174.0

Q ss_pred             hhHHHHhcCCccCccccccCCccEEEEEEc----CCCEEEEEEecCCCchhHHHHHHHHHHHhcC-CCCceeeeeeeEEe
Q 017594           42 SSVSTATNKFSDANKLGEGGFGPVYKGVLK----KGDEIAVKRLSGRSGQGLREMKNEASVIAKV-QHKNLVRLLGCCID  116 (369)
Q Consensus        42 ~~~~~~~~~y~i~~~lg~G~~~~v~~~~~~----~~~~valK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~  116 (369)
                      ..+..+.++|++.+.||+|+||.||+|+.+    +++.||+|.+.....  ...+.+|+++|+.+ .||||++++++|.+
T Consensus        14 ~~~p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~--~~~~~~E~~~l~~~~~h~nIv~l~~~~~~   91 (361)
T 4f9c_A           14 EAVPQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSH--PIRIAAELQCLTVAGGQDNVMGVKYCFRK   91 (361)
T ss_dssp             HHSGGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSC--HHHHHHHHHHHHHTCSBTTBCCCSEEEEE
T ss_pred             HhcCCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccC--HHHHHHHHHHHHHhcCCCCCceEEEEEEE
Confidence            344567789999999999999999999854    367899999865533  35678899999998 69999999999999


Q ss_pred             CCccEEEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCC-CceEEeec
Q 017594          117 RDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKD-MNPKISDF  195 (369)
Q Consensus       117 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~-~~~~L~Df  195 (369)
                      .++.|+||||+++++|.+++.      .+++..+..++.||+.||+|||++|   |+||||||+|||++.+ +.++|+||
T Consensus        92 ~~~~~lvmE~~~g~~L~~~~~------~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl~DF  162 (361)
T 4f9c_A           92 NDHVVIAMPYLEHESFLDILN------SLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVDF  162 (361)
T ss_dssp             TTEEEEEEECCCCCCHHHHHT------TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCC
T ss_pred             CCEEEEEEeCCCcccHHHHHc------CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEECcC
Confidence            999999999999999999882      2889999999999999999999999   9999999999999877 79999999


Q ss_pred             CCceecCCCCccc--------------------------ccccccccccccCchhhccC-CCCcccchHhHHHHHHHHHh
Q 017594          196 GMARICGGNELQA--------------------------NTSRIVGTYGYMSPEYALEG-IFSIKSDVFSFGVLLLEIVS  248 (369)
Q Consensus       196 g~~~~~~~~~~~~--------------------------~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~t  248 (369)
                      |+++.........                          ......||+.|+|||++.+. .|+.++||||+||++|+|++
T Consensus       163 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~  242 (361)
T 4f9c_A          163 GLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLS  242 (361)
T ss_dssp             TTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHH
T ss_pred             CCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHH
Confidence            9998654322110                          11224699999999998875 48999999999999999999


Q ss_pred             CCCCCCCCc
Q 017594          249 GKKNTGLYR  257 (369)
Q Consensus       249 g~~p~~~~~  257 (369)
                      |+.||....
T Consensus       243 G~~Pf~~~~  251 (361)
T 4f9c_A          243 GRYPFYKAS  251 (361)
T ss_dssp             TCSSSSCCS
T ss_pred             CCCCCCCCC
Confidence            999996544

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=5.2e-48  Score=362.94  Aligned_cols=265  Identities=18%  Similarity=0.256  Sum_probs=199.0

Q ss_pred             HhcCCccCccccccCCccEEEEEEc-CCCEEEEEEecCCC--chhHHHHHHHHHHHhcCCCCceeeeeeeEEe------C
Q 017594           47 ATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS--GQGLREMKNEASVIAKVQHKNLVRLLGCCID------R  117 (369)
Q Consensus        47 ~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------~  117 (369)
                      +.++|++++.||+|+||.||+|+++ +|+.||||++....  ....+.+.+|+.+|+.++||||+++++++..      .
T Consensus        52 i~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~  131 (398)
T 4b99_A           52 VGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEF  131 (398)
T ss_dssp             CCSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTC
T ss_pred             CCCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccC
Confidence            3468999999999999999999975 59999999996442  3345667889999999999999999998764      3


Q ss_pred             CccEEEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCC
Q 017594          118 DEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGM  197 (369)
Q Consensus       118 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~  197 (369)
                      +.+|+||||++ ++|.+++..   ...+++..+..++.||+.||.|||++|   |+||||||+|||++.++.++|+|||+
T Consensus       132 ~~~~ivmE~~~-g~L~~~i~~---~~~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~Ki~DFGl  204 (398)
T 4b99_A          132 KSVYVVLDLME-SDLHQIIHS---SQPLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGM  204 (398)
T ss_dssp             CCEEEEEECCS-EEHHHHHTS---SSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTT
T ss_pred             CEEEEEEeCCC-CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEEEeecce
Confidence            56899999996 568777744   345999999999999999999999999   99999999999999999999999999


Q ss_pred             ceecCCCCc--ccccccccccccccCchhhccC-CCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhh---
Q 017594          198 ARICGGNEL--QANTSRIVGTYGYMSPEYALEG-IFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLW---  271 (369)
Q Consensus       198 ~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~---  271 (369)
                      +..+.....  ........||+.|+|||++.+. .++.++||||+||++|+|++|++||........  ........   
T Consensus       205 a~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~--l~~I~~~~g~p  282 (398)
T 4b99_A          205 ARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQ--LQLIMMVLGTP  282 (398)
T ss_dssp             CBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHH--HHHHHHHHCCC
T ss_pred             eeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHH--HHHHHHhcCCC
Confidence            986643221  1223446899999999998775 569999999999999999999999975431110  00000000   


Q ss_pred             --------hcCccccc---cCccccccc--cHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 017594          272 --------TSNRTLEL---IDPILEDEY--SSKQMLLRYANIALLCVQESADDRPTMNDVVS  320 (369)
Q Consensus       272 --------~~~~~~~~---~~~~~~~~~--~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~  320 (369)
                              ........   +.+......  .....+.++.+||.+||+.||++|||+.|+|+
T Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  344 (398)
T 4b99_A          283 SPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR  344 (398)
T ss_dssp             CGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence                    00000000   000000000  00112567899999999999999999999987

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=3.6e-46  Score=342.81  Aligned_cols=287  Identities=36%  Similarity=0.637  Sum_probs=233.1

Q ss_pred             ccchhhHHHHhcCCccCccccccCCccEEEEEEcCCCEEEEEEecCCCchhHHHHHHHHHHHhcCCCCceeeeeeeEEeC
Q 017594           38 LFSFSSVSTATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDR  117 (369)
Q Consensus        38 ~~~~~~~~~~~~~y~i~~~lg~G~~~~v~~~~~~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~  117 (369)
                      .+++..+....++|++.+.||+|+||.||+|++++|+.||+|++........+.+.+|+.+++.++||||+++++++...
T Consensus        28 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~  107 (321)
T 2qkw_B           28 RVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDER  107 (321)
T ss_dssp             --CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCT
T ss_pred             eecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCC
Confidence            44555566788999999999999999999999888999999998877666678899999999999999999999999999


Q ss_pred             CccEEEEEecCCCChhhhhcCCCc-cccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecC
Q 017594          118 DEKILIYEYMPNKSLDFFLFDPTK-RMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFG  196 (369)
Q Consensus       118 ~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg  196 (369)
                      +..++||||+.+++|.+++..... ...+++..++.++.||+.||.|||+++   ++||||||+||+++.++.++|+|||
T Consensus       108 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg  184 (321)
T 2qkw_B          108 NEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFG  184 (321)
T ss_dssp             TCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCCEEECCCT
T ss_pred             CeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCCEEEeecc
Confidence            999999999999999998865332 335889999999999999999999999   9999999999999999999999999


Q ss_pred             CceecCCCCcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccc-cccchhhhhhhhcCc
Q 017594          197 MARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDS-LNLLGYAWDLWTSNR  275 (369)
Q Consensus       197 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~-~~~~~~~~~~~~~~~  275 (369)
                      ++................|++.|+|||++.+..++.++||||||+++|+|++|+.||....... .....+.........
T Consensus       185 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  264 (321)
T 2qkw_B          185 ISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQ  264 (321)
T ss_dssp             TCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTC
T ss_pred             cccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhcccccc
Confidence            9987554333333344568999999999998999999999999999999999999997544222 111222222223333


Q ss_pred             cccccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHhhhhc
Q 017594          276 TLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNEAAT  328 (369)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L~~~~~~  328 (369)
                      ....+++.+.... ....+..+.+++.+||+.||++|||+.++++.|+.+...
T Consensus       265 ~~~~~~~~~~~~~-~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~  316 (321)
T 2qkw_B          265 LEQIVDPNLADKI-RPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRL  316 (321)
T ss_dssp             CCSSSSSSCTTCS-CHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred             HHHhcChhhcccc-CHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhc
Confidence            3334443333322 334578899999999999999999999999999988764

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=3.6e-46  Score=343.39  Aligned_cols=299  Identities=38%  Similarity=0.647  Sum_probs=235.7

Q ss_pred             HhhhcccccCCCccccchhhHHHHhcCCccCccccccCCccEEEEEEcCCCEEEEEEecCCCc-hhHHHHHHHHHHHhcC
Q 017594           24 QAKRSKKKEVDQFPLFSFSSVSTATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSG-QGLREMKNEASVIAKV  102 (369)
Q Consensus        24 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~i~~~lg~G~~~~v~~~~~~~~~~valK~~~~~~~-~~~~~~~~e~~~l~~l  102 (369)
                      +.+..+.........|++..+....++|++.+.||+|+||.||+|+.++|+.||+|++..... .....+..|+.+++.+
T Consensus         5 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l   84 (326)
T 3uim_A            5 PAEEDPEVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMA   84 (326)
T ss_dssp             ----------CCCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTC
T ss_pred             CcccCcccccCccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhc
Confidence            344555556666778999999999999999999999999999999988899999999875432 2223678999999999


Q ss_pred             CCCceeeeeeeEEeCCccEEEEEecCCCChhhhhcCCC-ccccCChHHHHHHHHHHHHHHHHHhcC---CCCCcccCCCC
Q 017594          103 QHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPT-KRMLLDWVTRVQIIEGIAQGLLYLHQY---SRVRIIHRDLK  178 (369)
Q Consensus       103 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~al~~LH~~---~~~~i~H~dl~  178 (369)
                      +||||+++++++...+..++||||+.+++|.+++.... ....+++..++.++.|++.||.|||+.   +   ++|||||
T Consensus        85 ~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~---ivH~Dlk  161 (326)
T 3uim_A           85 VHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPK---IIHRDVK  161 (326)
T ss_dssp             CCTTBCCCCEEECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSC---EECCCCS
T ss_pred             cCCCccceEEEEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC---eEeCCCc
Confidence            99999999999999999999999999999999987643 344589999999999999999999999   7   9999999


Q ss_pred             CCCEEEeCCCceEEeecCCceecCCCCcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCc-
Q 017594          179 ASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYR-  257 (369)
Q Consensus       179 p~NIlv~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~-  257 (369)
                      |+||+++.++.++|+|||++........ .......|++.|+|||++.+..++.++||||||+++|+|++|..||.... 
T Consensus       162 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~  240 (326)
T 3uim_A          162 AANILLDEEFEAVVGDFGLAKLMDYKDT-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARL  240 (326)
T ss_dssp             GGGEEECTTCCEEECCCSSCEECCSSSS-CEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHH
T ss_pred             hhhEEECCCCCEEeccCccccccCcccc-cccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCccccccc
Confidence            9999999999999999999987653322 22233458999999999998899999999999999999999999996322 


Q ss_pred             --ccccccchhhhhhhhcCccccccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHhhhh
Q 017594          258 --TDSLNLLGYAWDLWTSNRTLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNEAA  327 (369)
Q Consensus       258 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L~~~~~  327 (369)
                        ........+..............+..+..... ...+..+.+++.+||+.||++|||+.++++.|+....
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~  311 (326)
T 3uim_A          241 ANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYK-DEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGL  311 (326)
T ss_dssp             TTTSCSBHHHHHTTTTSSCCSTTSSCTTCTTSCC-HHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSSC
T ss_pred             ccccchhHHHHHHHHhhchhhhhhcChhhccccC-HHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcch
Confidence              12222223333333344444444444444433 3347889999999999999999999999999987544

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=1.5e-46  Score=369.31  Aligned_cols=252  Identities=21%  Similarity=0.295  Sum_probs=208.6

Q ss_pred             hcCCccCccccccCCccEEEEEEc-CCCEEEEEEecCCCchhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEEEEe
Q 017594           48 TNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIYEY  126 (369)
Q Consensus        48 ~~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  126 (369)
                      .++|++++.||+|+||.||+|+++ +|+.||+|++........+.+.+|+.+|+.++||||++++++|.+.+.+|+||||
T Consensus       156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~  235 (573)
T 3uto_A          156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF  235 (573)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence            478999999999999999999976 4999999999877666677889999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCC--CceEEeecCCceecCCC
Q 017594          127 MPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKD--MNPKISDFGMARICGGN  204 (369)
Q Consensus       127 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~--~~~~L~Dfg~~~~~~~~  204 (369)
                      +.||+|.+++...  ...+++..+..++.||+.||.|||+++   |+||||||+|||++.+  +.++|+|||++..+...
T Consensus       236 ~~gg~L~~~i~~~--~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~  310 (573)
T 3uto_A          236 MSGGELFEKVADE--HNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK  310 (573)
T ss_dssp             CCCCBHHHHHTCT--TSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT
T ss_pred             cCCCcHHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeeccceeEccCC
Confidence            9999999888543  234899999999999999999999999   9999999999999854  89999999999887543


Q ss_pred             CcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCccccccCccc
Q 017594          205 ELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPIL  284 (369)
Q Consensus       205 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (369)
                      ..   .....||+.|+|||++.+..|+.++|||||||++|+|++|.+||.......     ......... . ....   
T Consensus       311 ~~---~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~-----~~~~i~~~~-~-~~~~---  377 (573)
T 3uto_A          311 QS---VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE-----TLRNVKSCD-W-NMDD---  377 (573)
T ss_dssp             SE---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH-----HHHHHHTTC-C-CCCS---
T ss_pred             Cc---eeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH-----HHHHHHhCC-C-CCCc---
Confidence            32   233579999999999999999999999999999999999999996433211     011110000 0 0000   


Q ss_pred             cccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 017594          285 EDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVS  320 (369)
Q Consensus       285 ~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~  320 (369)
                         .....++.++.+||.+||+.||++|||+.|+++
T Consensus       378 ---~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~  410 (573)
T 3uto_A          378 ---SAFSGISEDGKDFIRKLLLADPNTRMTIHQALE  410 (573)
T ss_dssp             ---GGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             ---ccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence               001122667899999999999999999999987

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=5.5e-46  Score=364.32  Aligned_cols=249  Identities=24%  Similarity=0.286  Sum_probs=198.5

Q ss_pred             hcCCccCccccccCCccEEEEEEcC-CCEEEEEEecCCC------chhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCcc
Q 017594           48 TNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRS------GQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEK  120 (369)
Q Consensus        48 ~~~y~i~~~lg~G~~~~v~~~~~~~-~~~valK~~~~~~------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~  120 (369)
                      .++|++++.||+|+||.||+|+.+. |+.||+|++....      .........++.+++.++||||++++++|.+.+.+
T Consensus       188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l  267 (689)
T 3v5w_A          188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL  267 (689)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred             hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence            4679999999999999999999764 9999999985321      11122233456777888999999999999999999


Q ss_pred             EEEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCcee
Q 017594          121 ILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARI  200 (369)
Q Consensus       121 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~  200 (369)
                      |+||||+.||+|..++..   ...+++..+..++.||+.||+|||++|   |+||||||+|||++.+|.++|+|||++..
T Consensus       268 ylVmEy~~GGdL~~~l~~---~~~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~DFGlA~~  341 (689)
T 3v5w_A          268 SFILDLMNGGDLHYHLSQ---HGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACD  341 (689)
T ss_dssp             EEEECCCCSCBHHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             EEEEecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEecccceeee
Confidence            999999999999999854   345999999999999999999999999   99999999999999999999999999987


Q ss_pred             cCCCCcccccccccccccccCchhhcc-CCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCccccc
Q 017594          201 CGGNELQANTSRIVGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLEL  279 (369)
Q Consensus       201 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (369)
                      +....    ....+||+.|+|||++.+ ..|+.++|+|||||++|+|++|.+||.........  ..........  .  
T Consensus       342 ~~~~~----~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~--~i~~~i~~~~--~--  411 (689)
T 3v5w_A          342 FSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH--EIDRMTLTMA--V--  411 (689)
T ss_dssp             CSSCC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHH--HHHHHHHHCC--C--
T ss_pred             cCCCC----CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHH--HHHHhhcCCC--C--
Confidence            65432    233589999999999974 57999999999999999999999999643221110  0011111000  0  


Q ss_pred             cCccccccccHHHHHHHHHHHHHHhhcCCCCCCCC-----HHHHHH
Q 017594          280 IDPILEDEYSSKQMLLRYANIALLCVQESADDRPT-----MNDVVS  320 (369)
Q Consensus       280 ~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps-----~~ell~  320 (369)
                         .+     +..++.++.+||.+||+.||++|++     +.+|++
T Consensus       412 ---~~-----p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~  449 (689)
T 3v5w_A          412 ---EL-----PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  449 (689)
T ss_dssp             ---CC-----CTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred             ---CC-----CccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence               00     1122677999999999999999998     688875

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=6.3e-45  Score=332.81  Aligned_cols=266  Identities=24%  Similarity=0.395  Sum_probs=216.4

Q ss_pred             HhcCCccCccccccCCccEEEEEEc-CCCEEEEEEecCCCchhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEEEE
Q 017594           47 ATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIYE  125 (369)
Q Consensus        47 ~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  125 (369)
                      ..++|++.+.||+|+||.||+|.+. +++.||+|++........+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus         8 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   87 (310)
T 3s95_A            8 RPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITE   87 (310)
T ss_dssp             CGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEE
Confidence            3578999999999999999999976 489999999877777777889999999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCCCC
Q 017594          126 YMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE  205 (369)
Q Consensus       126 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~~~  205 (369)
                      |+.+++|.+++...  ...+++..++.++.||+.||+|||+.+   ++||||||+||+++.++.++|+|||++.......
T Consensus        88 ~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  162 (310)
T 3s95_A           88 YIKGGTLRGIIKSM--DSQYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEK  162 (310)
T ss_dssp             CCTTCBHHHHHHHC--CTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTCEECC---
T ss_pred             ecCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeecccceeccccc
Confidence            99999999998653  234889999999999999999999999   9999999999999999999999999998765432


Q ss_pred             cccc------------cccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhc
Q 017594          206 LQAN------------TSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTS  273 (369)
Q Consensus       206 ~~~~------------~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~  273 (369)
                      ....            .....|++.|+|||++.+..++.++||||||+++|+|++|..||................... 
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~-  241 (310)
T 3s95_A          163 TQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLD-  241 (310)
T ss_dssp             -----------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHH-
T ss_pred             ccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhcccc-
Confidence            2111            113468999999999999999999999999999999999999986543222111100000000 


Q ss_pred             CccccccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHhhhhccCC
Q 017594          274 NRTLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNEAATLLP  331 (369)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L~~~~~~~~~  331 (369)
                              ...     +..++..+.+++.+||+.||++|||+.++++.|+.+...+..
T Consensus       242 --------~~~-----~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~~~  286 (310)
T 3s95_A          242 --------RYC-----PPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAG  286 (310)
T ss_dssp             --------HTC-----CTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHH
T ss_pred             --------ccC-----CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhccC
Confidence                    000     111245689999999999999999999999999999876543

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=5e-45  Score=331.60  Aligned_cols=253  Identities=23%  Similarity=0.366  Sum_probs=208.6

Q ss_pred             HHHhcCCccCccccccCCccEEEEEEc-CCCEEEEEEecCCCchhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEE
Q 017594           45 STATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILI  123 (369)
Q Consensus        45 ~~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv  123 (369)
                      ....++|++.+.||+|+||.||+|++. +|+.||+|++........+.+.+|+.+++.++||||+++++++...+..++|
T Consensus        16 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv   95 (297)
T 3fxz_A           16 GDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV   95 (297)
T ss_dssp             SCGGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             CChhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEE
Confidence            345689999999999999999999964 5899999998765555567888999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCC
Q 017594          124 YEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGG  203 (369)
Q Consensus       124 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~  203 (369)
                      |||+.+++|.+++..    ..+++..++.++.||+.||.|||++|   ++||||||+||+++.++.++|+|||++.....
T Consensus        96 ~e~~~~~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  168 (297)
T 3fxz_A           96 MEYLAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITP  168 (297)
T ss_dssp             EECCTTCBHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             EECCCCCCHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCCceecCC
Confidence            999999999998853    24889999999999999999999999   99999999999999999999999999887653


Q ss_pred             CCcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCccccccCcc
Q 017594          204 NELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPI  283 (369)
Q Consensus       204 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (369)
                      ...  ......|++.|+|||++.+..++.++|||||||++|+|++|..||.......     .............     
T Consensus       169 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-----~~~~~~~~~~~~~-----  236 (297)
T 3fxz_A          169 EQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR-----ALYLIATNGTPEL-----  236 (297)
T ss_dssp             TTC--CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-----HHHHHHHHCSCCC-----
T ss_pred             ccc--ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-----HHHHHHhCCCCCC-----
Confidence            322  2334578999999999999999999999999999999999999996433111     0011111110000     


Q ss_pred             ccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 017594          284 LEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVS  320 (369)
Q Consensus       284 ~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~  320 (369)
                          ..+..++..+.++|.+||+.||++|||+.++++
T Consensus       237 ----~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  269 (297)
T 3fxz_A          237 ----QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ  269 (297)
T ss_dssp             ----SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ----CCccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence                001122567899999999999999999999986

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=6.4e-44  Score=325.54  Aligned_cols=285  Identities=39%  Similarity=0.587  Sum_probs=226.2

Q ss_pred             CccccchhhHHHHhcCCccC------ccccccCCccEEEEEEcCCCEEEEEEecCC----CchhHHHHHHHHHHHhcCCC
Q 017594           35 QFPLFSFSSVSTATNKFSDA------NKLGEGGFGPVYKGVLKKGDEIAVKRLSGR----SGQGLREMKNEASVIAKVQH  104 (369)
Q Consensus        35 ~~~~~~~~~~~~~~~~y~i~------~~lg~G~~~~v~~~~~~~~~~valK~~~~~----~~~~~~~~~~e~~~l~~l~h  104 (369)
                      ....|++..+..+.+.|...      +.||+|+||.||+|.. +++.||+|++...    .....+.+.+|+.+++.++|
T Consensus        11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h   89 (307)
T 2nru_A           11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQH   89 (307)
T ss_dssp             CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCC
T ss_pred             CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCC
Confidence            45678888888888887766      9999999999999987 4889999998643    23345778899999999999


Q ss_pred             CceeeeeeeEEeCCccEEEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEE
Q 017594          105 KNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILL  184 (369)
Q Consensus       105 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv  184 (369)
                      |||+++++++...+..+++|||+.+++|.+++........+++..++.++.||+.||.|||+.+   ++|+||+|+||++
T Consensus        90 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nili  166 (307)
T 2nru_A           90 ENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILL  166 (307)
T ss_dssp             TTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEE
T ss_pred             CCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEE
Confidence            9999999999999999999999999999999876555566899999999999999999999999   9999999999999


Q ss_pred             eCCCceEEeecCCceecCCCCcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccc
Q 017594          185 DKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLL  264 (369)
Q Consensus       185 ~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~  264 (369)
                      +.++.++|+|||++................+++.|+|||++.+ .++.++||||||+++|+|++|..||......... .
T Consensus       167 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~-~  244 (307)
T 2nru_A          167 DEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLL-L  244 (307)
T ss_dssp             CTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBT-T
T ss_pred             cCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHH-H
Confidence            9999999999999887654333333344578999999998764 5889999999999999999999999754432211 1


Q ss_pred             hhhhhhhhc-CccccccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHhhhh
Q 017594          265 GYAWDLWTS-NRTLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNEAA  327 (369)
Q Consensus       265 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L~~~~~  327 (369)
                      ......... ......+.+.+..  .....+..+.+++.+||+.||++|||+.++++.|+++.+
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~  306 (307)
T 2nru_A          245 DIKEEIEDEEKTIEDYIDKKMND--ADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA  306 (307)
T ss_dssp             HHHHHHHTTSCCHHHHSCSSCSC--CCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred             HHHHHhhhhhhhhhhhccccccc--cchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence            111111111 1111122222211  123447789999999999999999999999999998865

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=1.6e-44  Score=330.12  Aligned_cols=270  Identities=26%  Similarity=0.433  Sum_probs=207.0

Q ss_pred             HHHhcCCccCccccccCCccEEEEEEcCCCEEEEEEecCCC--chhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEE
Q 017594           45 STATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRS--GQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKIL  122 (369)
Q Consensus        45 ~~~~~~y~i~~~lg~G~~~~v~~~~~~~~~~valK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l  122 (369)
                      .....+|++.+.||+|+||.||+|+++ |..||+|++....  ....+.+.+|+.++++++||||+++++++......++
T Consensus        33 ~i~~~~y~i~~~lG~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l  111 (309)
T 3p86_A           33 DIPWCDLNIKEKIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSI  111 (309)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEE
T ss_pred             cCChhHceeeeEeecCCCeEEEEEEEC-CCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEE
Confidence            344678999999999999999999874 8889999987553  3345678899999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecC
Q 017594          123 IYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICG  202 (369)
Q Consensus       123 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~  202 (369)
                      ||||+.+++|.+++........+++..++.++.||+.||+|||+.+ ++++||||||+||+++.++.++|+|||++....
T Consensus       112 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~  190 (309)
T 3p86_A          112 VTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKA  190 (309)
T ss_dssp             EEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSS-SCCCCTTCCGGGEEECTTCCEEECCCC------
T ss_pred             EEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-CCEECCCCChhhEEEeCCCcEEECCCCCCcccc
Confidence            9999999999999976555556899999999999999999999875 239999999999999999999999999987543


Q ss_pred             CCCcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCccccccCc
Q 017594          203 GNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDP  282 (369)
Q Consensus       203 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (369)
                      ...  .......|++.|+|||++.+..++.++||||||+++|+|++|..||.......     .............    
T Consensus       191 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~-----~~~~~~~~~~~~~----  259 (309)
T 3p86_A          191 STF--LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQ-----VVAAVGFKCKRLE----  259 (309)
T ss_dssp             -------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHH-----HHHHHHHSCCCCC----
T ss_pred             ccc--cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-----HHHHHHhcCCCCC----
Confidence            321  12233568999999999999999999999999999999999999997543211     0011000000000    


Q ss_pred             cccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHhhhhccCCCC
Q 017594          283 ILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNEAATLLPPK  333 (369)
Q Consensus       283 ~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L~~~~~~~~~~~  333 (369)
                       +     +..++..+.++|.+||+.||.+|||+.++++.|+.+.....++.
T Consensus       260 -~-----~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~p~~  304 (309)
T 3p86_A          260 -I-----PRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPPP  304 (309)
T ss_dssp             -C-----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC------
T ss_pred             -C-----CccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCCCCC
Confidence             1     11125669999999999999999999999999999988755443

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=8.7e-45  Score=333.79  Aligned_cols=273  Identities=23%  Similarity=0.309  Sum_probs=212.6

Q ss_pred             HhcCCccCccccccCCccEEEEEEcCCCEEEEEEecCCCchhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCc----cEE
Q 017594           47 ATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDE----KIL  122 (369)
Q Consensus        47 ~~~~y~i~~~lg~G~~~~v~~~~~~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~----~~l  122 (369)
                      ..++|++.+.||+|+||.||+|++. ++.||+|++.... ........|+..++.++||||+++++++.....    .++
T Consensus        22 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~l   99 (322)
T 3soc_A           22 QSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWL   99 (322)
T ss_dssp             TTEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred             chhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEE
Confidence            4589999999999999999999977 7899999996543 233455668888999999999999999987554    699


Q ss_pred             EEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcC----------CCCCcccCCCCCCCEEEeCCCceEE
Q 017594          123 IYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQY----------SRVRIIHRDLKASNILLDKDMNPKI  192 (369)
Q Consensus       123 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~----------~~~~i~H~dl~p~NIlv~~~~~~~L  192 (369)
                      ||||+.+++|.+++..    ..+++..++.++.||+.||.|||+.          +   ++||||||+||+++.++.++|
T Consensus       100 v~e~~~~g~L~~~l~~----~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~---ivH~Dlkp~Nill~~~~~~kL  172 (322)
T 3soc_A          100 ITAFHEKGSLSDFLKA----NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA---ISHRDIKSKNVLLKNNLTACI  172 (322)
T ss_dssp             EEECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE---EECSCCSGGGEEECTTCCEEE
T ss_pred             EEecCCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC---EEeCCCChHhEEECCCCeEEE
Confidence            9999999999999843    3488999999999999999999998          8   999999999999999999999


Q ss_pred             eecCCceecCCCCcccccccccccccccCchhhcc-----CCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchh-
Q 017594          193 SDFGMARICGGNELQANTSRIVGTYGYMSPEYALE-----GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGY-  266 (369)
Q Consensus       193 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~-  266 (369)
                      +|||++................+++.|+|||++.+     ..++.++|||||||++|+|++|..||............. 
T Consensus       173 ~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~  252 (322)
T 3soc_A          173 ADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEE  252 (322)
T ss_dssp             CCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHH
T ss_pred             ccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhh
Confidence            99999987765444333444578999999999876     356778999999999999999999997543222111000 


Q ss_pred             -----hhhhhhcCccccccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHhhhhc
Q 017594          267 -----AWDLWTSNRTLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNEAAT  328 (369)
Q Consensus       267 -----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L~~~~~~  328 (369)
                           ...............+.+.........+..+.++|.+||+.||++|||+.++++.|+.+...
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~  319 (322)
T 3soc_A          253 IGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRL  319 (322)
T ss_dssp             HCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             hccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence                 00000000011112222222222333467799999999999999999999999999998764

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=3.1e-44  Score=330.23  Aligned_cols=255  Identities=24%  Similarity=0.366  Sum_probs=204.6

Q ss_pred             HhcCCccCccccccCCccEEEEEEc-CCCEEEEEEecCCCc-hhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEEE
Q 017594           47 ATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSG-QGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIY  124 (369)
Q Consensus        47 ~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  124 (369)
                      ..++|++.+.||+|+||.||+|++. +++.||+|++..... ...+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus         5 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~   84 (323)
T 3tki_A            5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL   84 (323)
T ss_dssp             TTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEE
Confidence            4579999999999999999999976 589999999864432 23356788999999999999999999999999999999


Q ss_pred             EecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCCC
Q 017594          125 EYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGN  204 (369)
Q Consensus       125 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~~  204 (369)
                      ||+.+++|.+++...   ..+++..++.++.||+.||.|||+.|   ++||||||+||+++.++.++|+|||++..+...
T Consensus        85 e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  158 (323)
T 3tki_A           85 EYCSGGELFDRIEPD---IGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYN  158 (323)
T ss_dssp             ECCTTEEGGGGSBTT---TBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred             EcCCCCcHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeeccceeccC
Confidence            999999999988543   34899999999999999999999999   999999999999999999999999999876533


Q ss_pred             CcccccccccccccccCchhhccCCC-CcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCccccccCcc
Q 017594          205 ELQANTSRIVGTYGYMSPEYALEGIF-SIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPI  283 (369)
Q Consensus       205 ~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (369)
                      ..........|++.|+|||++.+..+ +.++|||||||++|+|++|..||............     +.....  ...+ 
T Consensus       159 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~-----~~~~~~--~~~~-  230 (323)
T 3tki_A          159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSD-----WKEKKT--YLNP-  230 (323)
T ss_dssp             TEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHH-----HHTTCT--TSTT-
T ss_pred             CcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHH-----Hhcccc--cCCc-
Confidence            33333345678999999999987765 78999999999999999999999754432211110     011100  0000 


Q ss_pred             ccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 017594          284 LEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSM  321 (369)
Q Consensus       284 ~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~  321 (369)
                            ...++..+.+||.+||+.||++|||+.++++.
T Consensus       231 ------~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h  262 (323)
T 3tki_A          231 ------WKKIDSAPLALLHKILVENPSARITIPDIKKD  262 (323)
T ss_dssp             ------GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             ------cccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence                  11125668999999999999999999999864

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=1.8e-44  Score=332.25  Aligned_cols=252  Identities=23%  Similarity=0.306  Sum_probs=206.0

Q ss_pred             HHHHhcCCccCccccccCCccEEEEEE-cCCCEEEEEEecCC--CchhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCcc
Q 017594           44 VSTATNKFSDANKLGEGGFGPVYKGVL-KKGDEIAVKRLSGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEK  120 (369)
Q Consensus        44 ~~~~~~~y~i~~~lg~G~~~~v~~~~~-~~~~~valK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~  120 (369)
                      .....++|++.+.||+|+||.||+|++ .+|+.||+|++...  .....+.+.+|+.+++.++||||+++++++...+..
T Consensus        10 ~~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~   89 (328)
T 3fe3_A           10 EQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTL   89 (328)
T ss_dssp             -CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             cCCccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEE
Confidence            334567899999999999999999997 46999999998644  334456788999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCcee
Q 017594          121 ILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARI  200 (369)
Q Consensus       121 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~  200 (369)
                      ++||||+.+++|.+++...   ..+++..++.++.||+.||.|||+++   ++||||||+||+++.++.++|+|||++..
T Consensus        90 ~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~  163 (328)
T 3fe3_A           90 YLIMEYASGGEVFDYLVAH---GRMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNE  163 (328)
T ss_dssp             EEEECCCTTCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTCCGG
T ss_pred             EEEEECCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeeccCcee
Confidence            9999999999999988543   34899999999999999999999999   99999999999999999999999999876


Q ss_pred             cCCCCcccccccccccccccCchhhccCCCC-cccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCccccc
Q 017594          201 CGGNELQANTSRIVGTYGYMSPEYALEGIFS-IKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLEL  279 (369)
Q Consensus       201 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (369)
                      .....   ......|++.|+|||++.+..+. .++|||||||++|+|++|..||.......     ..........    
T Consensus       164 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-----~~~~i~~~~~----  231 (328)
T 3fe3_A          164 FTVGG---KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKE-----LRERVLRGKY----  231 (328)
T ss_dssp             GSSSC---GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-----HHHHHHHCCC----
T ss_pred             cCCCC---ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHH-----HHHHHHhCCC----
Confidence            54332   23345789999999999887764 79999999999999999999996433111     1111111100    


Q ss_pred             cCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 017594          280 IDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSM  321 (369)
Q Consensus       280 ~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~  321 (369)
                         ..     +...+.++.+||.+||+.||.+|||+.++++.
T Consensus       232 ---~~-----p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  265 (328)
T 3fe3_A          232 ---RI-----PFYMSTDCENLLKRFLVLNPIKRGTLEQIMKD  265 (328)
T ss_dssp             ---CC-----CTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred             ---CC-----CCCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence               00     11125678999999999999999999999874

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=1.6e-43  Score=331.48  Aligned_cols=263  Identities=26%  Similarity=0.397  Sum_probs=212.9

Q ss_pred             HhcCCccCccccccCCccEEEEEEc--------CCCEEEEEEecCCC-chhHHHHHHHHHHHhcC-CCCceeeeeeeEEe
Q 017594           47 ATNKFSDANKLGEGGFGPVYKGVLK--------KGDEIAVKRLSGRS-GQGLREMKNEASVIAKV-QHKNLVRLLGCCID  116 (369)
Q Consensus        47 ~~~~y~i~~~lg~G~~~~v~~~~~~--------~~~~valK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~  116 (369)
                      ..++|++.+.||+|+||.||+|++.        ++..||+|++.... ......+.+|+.+++.+ +||||+++++++..
T Consensus        79 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~  158 (370)
T 2psq_A           79 PRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ  158 (370)
T ss_dssp             CGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECS
T ss_pred             cHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEcc
Confidence            4578999999999999999999853        24569999997553 33456788999999999 89999999999999


Q ss_pred             CCccEEEEEecCCCChhhhhcCCCc-------------cccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEE
Q 017594          117 RDEKILIYEYMPNKSLDFFLFDPTK-------------RMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNIL  183 (369)
Q Consensus       117 ~~~~~lv~e~~~~~~L~~~l~~~~~-------------~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIl  183 (369)
                      .+..++||||+.+++|.+++.....             ...+++..++.++.||+.||.|||+++   ++||||||+||+
T Consensus       159 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIl  235 (370)
T 2psq_A          159 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVL  235 (370)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEE
T ss_pred             CCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhhEE
Confidence            9999999999999999999864321             234788899999999999999999999   999999999999


Q ss_pred             EeCCCceEEeecCCceecCCCCcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHh-CCCCCCCCcccccc
Q 017594          184 LDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLN  262 (369)
Q Consensus       184 v~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~t-g~~p~~~~~~~~~~  262 (369)
                      ++.++.++|+|||++................+++.|+|||++.+..++.++|||||||++|+|++ |..||.......  
T Consensus       236 l~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~--  313 (370)
T 2psq_A          236 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE--  313 (370)
T ss_dssp             ECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG--
T ss_pred             ECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHH--
Confidence            99999999999999987655433333334456788999999999999999999999999999999 999986533211  


Q ss_pred             cchhhhhhhhcCccccccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHhhhhc
Q 017594          263 LLGYAWDLWTSNRTLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNEAAT  328 (369)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L~~~~~~  328 (369)
                          ............     .     +..++.++.++|.+||+.||++||++.++++.|+.+...
T Consensus       314 ----~~~~~~~~~~~~-----~-----~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~  365 (370)
T 2psq_A          314 ----LFKLLKEGHRMD-----K-----PANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTL  365 (370)
T ss_dssp             ----HHHHHHTTCCCC-----C-----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ----HHHHHhcCCCCC-----C-----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence                111111111000     0     112256799999999999999999999999999998764

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=1.2e-43  Score=327.29  Aligned_cols=276  Identities=17%  Similarity=0.175  Sum_probs=216.9

Q ss_pred             HhcCCccCccccccCCccEEEEEEc-CCCEEEEEEecCCCchhHHHHHHHHHHHhcC-CCCceeeeeeeEEeCCccEEEE
Q 017594           47 ATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSGQGLREMKNEASVIAKV-QHKNLVRLLGCCIDRDEKILIY  124 (369)
Q Consensus        47 ~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~  124 (369)
                      ..++|++.+.||+|+||.||+|++. +|+.||+|++.....  ...+..|+.+++.+ +||||+++++++...+..++||
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~   84 (330)
T 2izr_A            7 VGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVL   84 (330)
T ss_dssp             ETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEE
T ss_pred             EcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEE
Confidence            4578999999999999999999964 588999999875432  24678899999999 8999999999999999999999


Q ss_pred             EecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCc-----eEEeecCCce
Q 017594          125 EYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMN-----PKISDFGMAR  199 (369)
Q Consensus       125 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~-----~~L~Dfg~~~  199 (369)
                      ||+ +++|.+++...  ...+++..++.++.||+.||+|||+.+   ++||||||+||+++.++.     ++|+|||++.
T Consensus        85 e~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~  158 (330)
T 2izr_A           85 ELL-GPSLEDLFDLC--DRTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK  158 (330)
T ss_dssp             ECC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEECCCTTCE
T ss_pred             EeC-CCCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEEEEcccce
Confidence            999 89999988643  345899999999999999999999999   999999999999998887     9999999998


Q ss_pred             ecCCCCccc-----ccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcC
Q 017594          200 ICGGNELQA-----NTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSN  274 (369)
Q Consensus       200 ~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~  274 (369)
                      .+.......     ......|++.|+|||++.+..++.++|||||||++|+|++|..||...........  .... ...
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~--~~~i-~~~  235 (330)
T 2izr_A          159 EYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKER--YQKI-GDT  235 (330)
T ss_dssp             ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHH--HHHH-HHH
T ss_pred             eeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHH--HHHH-Hhh
Confidence            765433211     12345789999999999999999999999999999999999999975432221100  0000 000


Q ss_pred             ccccccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHhhhhccCCCCCCCcccc
Q 017594          275 RTLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNEAATLLPPKQPAFSYV  340 (369)
Q Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L~~~~~~~~~~~~~~~~~~  340 (369)
                      ... .....+     ...++ ++.+++..||+.||.+||++.+|++.|+.+............+|.
T Consensus       236 ~~~-~~~~~~-----~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw~  294 (330)
T 2izr_A          236 KRA-TPIEVL-----CENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKGYMFDYEYDWI  294 (330)
T ss_dssp             HHH-SCHHHH-----TTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCCSCCCTTT
T ss_pred             hcc-CCHHHH-----hccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHcCCCCCCCccCC
Confidence            000 000000     00113 799999999999999999999999999999887766555555554

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.1e-43  Score=334.16  Aligned_cols=281  Identities=26%  Similarity=0.358  Sum_probs=220.3

Q ss_pred             hhHHHHhcCCccCccccccCCccEEEEEEc--------CCCEEEEEEecCCC-chhHHHHHHHHHHHhcC-CCCceeeee
Q 017594           42 SSVSTATNKFSDANKLGEGGFGPVYKGVLK--------KGDEIAVKRLSGRS-GQGLREMKNEASVIAKV-QHKNLVRLL  111 (369)
Q Consensus        42 ~~~~~~~~~y~i~~~lg~G~~~~v~~~~~~--------~~~~valK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~  111 (369)
                      +......++|++.+.||+|+||.||+|++.        .+..||+|++.... ......+.+|+.+++.+ +||||++++
T Consensus        62 ~~~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~  141 (382)
T 3tt0_A           62 PRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLL  141 (382)
T ss_dssp             TTTBCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             cccccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhhe
Confidence            334556689999999999999999999953        23579999997543 34456788999999999 899999999


Q ss_pred             eeEEeCCccEEEEEecCCCChhhhhcCCCc-------------cccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCC
Q 017594          112 GCCIDRDEKILIYEYMPNKSLDFFLFDPTK-------------RMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLK  178 (369)
Q Consensus       112 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-------------~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~  178 (369)
                      +++...+..++||||+.+++|.+++.....             ...+++..++.++.||+.||.|||+.+   ++|||||
T Consensus       142 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlk  218 (382)
T 3tt0_A          142 GACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLA  218 (382)
T ss_dssp             EEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCC
T ss_pred             eeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCC
Confidence            999999999999999999999999864321             235899999999999999999999999   9999999


Q ss_pred             CCCEEEeCCCceEEeecCCceecCCCCcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHh-CCCCCCCCc
Q 017594          179 ASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYR  257 (369)
Q Consensus       179 p~NIlv~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~t-g~~p~~~~~  257 (369)
                      |+||+++.++.++|+|||++................+++.|+|||++.+..++.++|||||||++|+|++ |..||....
T Consensus       219 p~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~  298 (382)
T 3tt0_A          219 ARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP  298 (382)
T ss_dssp             GGGEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred             cceEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC
Confidence            9999999999999999999987654433333444567788999999999999999999999999999999 999986433


Q ss_pred             ccccccchhhhhhhhcCccccccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHhhhhccCCCCCCCc
Q 017594          258 TDSLNLLGYAWDLWTSNRTLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNEAATLLPPKQPAF  337 (369)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L~~~~~~~~~~~~~~~  337 (369)
                      ...      .............     .     ..++.++.++|.+||+.||++|||+.++++.|+.+.........+.+
T Consensus       299 ~~~------~~~~~~~~~~~~~-----~-----~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~~~~~  362 (382)
T 3tt0_A          299 VEE------LFKLLKEGHRMDK-----P-----SNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQEMGYY  362 (382)
T ss_dssp             HHH------HHHHHHTTCCCCC-----C-----SSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCSCC----
T ss_pred             HHH------HHHHHHcCCCCCC-----C-----ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhcCCCCCC
Confidence            111      1111111111000     0     11256799999999999999999999999999999987766555554


Q ss_pred             cccc
Q 017594          338 SYVR  341 (369)
Q Consensus       338 ~~~~  341 (369)
                      ....
T Consensus       363 ~~~~  366 (382)
T 3tt0_A          363 HHHH  366 (382)
T ss_dssp             ----
T ss_pred             Cccc
Confidence            4333

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=2.1e-43  Score=320.51  Aligned_cols=277  Identities=16%  Similarity=0.208  Sum_probs=219.8

Q ss_pred             HHhcCCccCccccccCCccEEEEEE-cCCCEEEEEEecCCCchhHHHHHHHHHHHhcC-CCCceeeeeeeEEeCCccEEE
Q 017594           46 TATNKFSDANKLGEGGFGPVYKGVL-KKGDEIAVKRLSGRSGQGLREMKNEASVIAKV-QHKNLVRLLGCCIDRDEKILI  123 (369)
Q Consensus        46 ~~~~~y~i~~~lg~G~~~~v~~~~~-~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv  123 (369)
                      ...++|++.+.||+|++|.||+|++ .+|+.||+|++.....  ...+.+|+..++.+ .|++++++++++......++|
T Consensus         7 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv   84 (298)
T 1csn_A            7 VVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLV   84 (298)
T ss_dssp             EETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEE
T ss_pred             ccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc--cHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEE
Confidence            4568899999999999999999996 4588999999864432  24678899999999 799999999999999999999


Q ss_pred             EEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCc-----eEEeecCCc
Q 017594          124 YEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMN-----PKISDFGMA  198 (369)
Q Consensus       124 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~-----~~L~Dfg~~  198 (369)
                      +||+ +++|.+++...  ...+++..++.++.||+.||.|||+++   ++||||||+||+++.++.     ++|+|||++
T Consensus        85 ~e~~-~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~  158 (298)
T 1csn_A           85 IDLL-GPSLEDLLDLC--GRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMV  158 (298)
T ss_dssp             EECC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTC
T ss_pred             EEec-CCCHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEEEEECccc
Confidence            9999 99999998643  234899999999999999999999999   999999999999987776     999999999


Q ss_pred             eecCCCCcc-----cccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCccccccc-chhhhhhhh
Q 017594          199 RICGGNELQ-----ANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNL-LGYAWDLWT  272 (369)
Q Consensus       199 ~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~-~~~~~~~~~  272 (369)
                      .........     .......|++.|+|||++.+..++.++||||||+++|+|++|..||.......... .........
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~  238 (298)
T 1csn_A          159 KFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQ  238 (298)
T ss_dssp             EESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHH
T ss_pred             cccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhcc
Confidence            877543322     12234568999999999999999999999999999999999999997543221110 000000000


Q ss_pred             cCccccccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHhhhhccCCCCCCCcccc
Q 017594          273 SNRTLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNEAATLLPPKQPAFSYV  340 (369)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L~~~~~~~~~~~~~~~~~~  340 (369)
                      .......          ...++.++.+++.+||+.||++||++.+|++.|+++...+......+.+|.
T Consensus       239 ~~~~~~~----------~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw~  296 (298)
T 1csn_A          239 STPLREL----------CAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTEDENFDWN  296 (298)
T ss_dssp             HSCHHHH----------TTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCSCSCCGGG
T ss_pred             CccHHHH----------HhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcCCCCCCccccC
Confidence            0000000          011256799999999999999999999999999999998877766666654

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=5.4e-44  Score=328.44  Aligned_cols=271  Identities=24%  Similarity=0.417  Sum_probs=198.2

Q ss_pred             hhhHHHHhcCCccCccccccCCccEEEEEEcC-CC---EEEEEEecCC--CchhHHHHHHHHHHHhcCCCCceeeeeeeE
Q 017594           41 FSSVSTATNKFSDANKLGEGGFGPVYKGVLKK-GD---EIAVKRLSGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCC  114 (369)
Q Consensus        41 ~~~~~~~~~~y~i~~~lg~G~~~~v~~~~~~~-~~---~valK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~  114 (369)
                      ++.+....++|++.+.||+|+||.||+|++.. +.   .||+|++...  .....+.+.+|+.+++.++||||+++++++
T Consensus        15 ~~~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~   94 (323)
T 3qup_A           15 LEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVS   94 (323)
T ss_dssp             -CTTBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEE
T ss_pred             hhhcccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhcee
Confidence            34445567899999999999999999999654 32   7999998754  344567888999999999999999999999


Q ss_pred             EeCCcc------EEEEEecCCCChhhhhcCCC---ccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEe
Q 017594          115 IDRDEK------ILIYEYMPNKSLDFFLFDPT---KRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLD  185 (369)
Q Consensus       115 ~~~~~~------~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~  185 (369)
                      ......      ++++||+.+++|.+++....   ....+++..++.++.||+.||.|||+.|   ++||||||+||+++
T Consensus        95 ~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli~  171 (323)
T 3qup_A           95 LRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLA  171 (323)
T ss_dssp             ECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEC
T ss_pred             eccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEEc
Confidence            876655      99999999999998885322   1225889999999999999999999999   99999999999999


Q ss_pred             CCCceEEeecCCceecCCCCcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHh-CCCCCCCCcccccccc
Q 017594          186 KDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLL  264 (369)
Q Consensus       186 ~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~t-g~~p~~~~~~~~~~~~  264 (369)
                      .++.++|+|||++................+++.|+|||.+.+..++.++|||||||++|+|++ |..||........   
T Consensus       172 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~---  248 (323)
T 3qup_A          172 EDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEI---  248 (323)
T ss_dssp             TTSCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH---
T ss_pred             CCCCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHH---
Confidence            999999999999987654433333333456778999999999999999999999999999999 8999864432110   


Q ss_pred             hhhhhhhhcCccccccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHhhhhccC
Q 017594          265 GYAWDLWTSNRTLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNEAATLL  330 (369)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L~~~~~~~~  330 (369)
                         ............          +..++..+.++|.+||+.||++|||+.++++.|+++.....
T Consensus       249 ---~~~~~~~~~~~~----------~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~  301 (323)
T 3qup_A          249 ---YNYLIGGNRLKQ----------PPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLS  301 (323)
T ss_dssp             ---HHHHHTTCCCCC----------CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC--
T ss_pred             ---HHHHhcCCCCCC----------CCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhh
Confidence               111111110000          11125679999999999999999999999999999988543

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=1.3e-43  Score=324.37  Aligned_cols=268  Identities=29%  Similarity=0.415  Sum_probs=216.4

Q ss_pred             hhHHHHhcCCccCccccccCCccEEEEEEc------CCCEEEEEEecCCC-chhHHHHHHHHHHHhcCCCCceeeeeeeE
Q 017594           42 SSVSTATNKFSDANKLGEGGFGPVYKGVLK------KGDEIAVKRLSGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCC  114 (369)
Q Consensus        42 ~~~~~~~~~y~i~~~lg~G~~~~v~~~~~~------~~~~valK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~  114 (369)
                      .......++|++.+.||+|+||.||+|.+.      ++..||+|++.... ....+.+.+|+.+++.++||||+++++++
T Consensus        16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~   95 (314)
T 2ivs_A           16 PKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGAC   95 (314)
T ss_dssp             TTTBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred             cccccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEE
Confidence            344455789999999999999999999862      35789999987543 34457788999999999999999999999


Q ss_pred             EeCCccEEEEEecCCCChhhhhcCCCc---------------------cccCChHHHHHHHHHHHHHHHHHhcCCCCCcc
Q 017594          115 IDRDEKILIYEYMPNKSLDFFLFDPTK---------------------RMLLDWVTRVQIIEGIAQGLLYLHQYSRVRII  173 (369)
Q Consensus       115 ~~~~~~~lv~e~~~~~~L~~~l~~~~~---------------------~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~  173 (369)
                      ...+..++||||+.+++|.+++.....                     ...+++..++.++.||+.||.|||+++   ++
T Consensus        96 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iv  172 (314)
T 2ivs_A           96 SQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LV  172 (314)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred             ecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---Cc
Confidence            999999999999999999999865332                     234888999999999999999999999   99


Q ss_pred             cCCCCCCCEEEeCCCceEEeecCCceecCCCCcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHh-CCCC
Q 017594          174 HRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKN  252 (369)
Q Consensus       174 H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~t-g~~p  252 (369)
                      |+||||+||+++.++.++|+|||++................+++.|+|||++.+..++.++||||||+++|+|++ |..|
T Consensus       173 H~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p  252 (314)
T 2ivs_A          173 HRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP  252 (314)
T ss_dssp             CCCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCS
T ss_pred             ccccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCC
Confidence            999999999999999999999999987755443333334456788999999999899999999999999999999 9999


Q ss_pred             CCCCcccccccchhhhhhhhcCccccccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHhhhhc
Q 017594          253 TGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNEAAT  328 (369)
Q Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L~~~~~~  328 (369)
                      |.......      ............     .     +..++..+.++|.+||+.||++||++.++++.|+.+...
T Consensus       253 ~~~~~~~~------~~~~~~~~~~~~-----~-----~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~  312 (314)
T 2ivs_A          253 YPGIPPER------LFNLLKTGHRME-----R-----PDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVK  312 (314)
T ss_dssp             STTCCGGG------HHHHHHTTCCCC-----C-----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             CCCCCHHH------HHHHhhcCCcCC-----C-----CccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhh
Confidence            86433211      111111111100     0     111256799999999999999999999999999988764

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=1.2e-43  Score=317.82  Aligned_cols=259  Identities=27%  Similarity=0.413  Sum_probs=211.6

Q ss_pred             HhcCCccCccccccCCccEEEEEEcCCCEEEEEEecCCCchhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEEEEe
Q 017594           47 ATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIYEY  126 (369)
Q Consensus        47 ~~~~y~i~~~lg~G~~~~v~~~~~~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  126 (369)
                      ..++|++.+.||+|+||.||+|++.+++.||+|++..... ..+.+.+|+.++++++||||+++++++.+....++||||
T Consensus         8 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   86 (269)
T 4hcu_A            8 DPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEF   86 (269)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred             ChhhceeeheecCCCccEEEEEEecCCCeEEEEEeccccc-CHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEe
Confidence            3578999999999999999999998888999999975543 346788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCCCCc
Q 017594          127 MPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNEL  206 (369)
Q Consensus       127 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~~~~  206 (369)
                      +++++|.+++....  ..+++..++.++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||++........
T Consensus        87 ~~~~~L~~~l~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  161 (269)
T 4hcu_A           87 MEHGCLSDYLRTQR--GLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY  161 (269)
T ss_dssp             CTTCBHHHHHHTTT--TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHH
T ss_pred             CCCCcHHHHHHhcC--cccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEecccccccccccccc
Confidence            99999999986433  34889999999999999999999999   99999999999999999999999999876543221


Q ss_pred             ccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHh-CCCCCCCCcccccccchhhhhhhhcCccccccCcccc
Q 017594          207 QANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILE  285 (369)
Q Consensus       207 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (369)
                       .......++..|+|||++.+..++.++||||||+++|+|++ |..||.......     ...... ..     ......
T Consensus       162 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~-----~~~~~~-~~-----~~~~~~  229 (269)
T 4hcu_A          162 -TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE-----VVEDIS-TG-----FRLYKP  229 (269)
T ss_dssp             -HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-----HHHHHH-TT-----CCCCCC
T ss_pred             -ccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHH-----HHHHHh-cC-----ccCCCC
Confidence             12223345778999999998999999999999999999999 999986433211     111110 00     000001


Q ss_pred             ccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHhhhhc
Q 017594          286 DEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNEAAT  328 (369)
Q Consensus       286 ~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L~~~~~~  328 (369)
                           ...+..+.+++.+||+.||++|||+.++++.|+.+...
T Consensus       230 -----~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~~  267 (269)
T 4hcu_A          230 -----RLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES  267 (269)
T ss_dssp             -----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             -----CcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHHc
Confidence                 11156699999999999999999999999999998764

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=4.9e-43  Score=321.61  Aligned_cols=275  Identities=21%  Similarity=0.303  Sum_probs=214.6

Q ss_pred             HHhcCCccCccccccCCccEEEEEEcC-CCEEEEEEecCCC-chhHHHHHHHHHHHhcCCCCceeeeeeeEEeCC--ccE
Q 017594           46 TATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCCIDRD--EKI  121 (369)
Q Consensus        46 ~~~~~y~i~~~lg~G~~~~v~~~~~~~-~~~valK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~  121 (369)
                      ...++|++.+.||+|+||.||+|++.. |+.||+|++.... ....+.+.+|+.+++.++||||+++++++....  ..+
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   85 (319)
T 4euu_A            6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKV   85 (319)
T ss_dssp             CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEE
T ss_pred             CCCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEE
Confidence            456899999999999999999999765 8999999987433 233567789999999999999999999988765  679


Q ss_pred             EEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEE----eCCCceEEeecCC
Q 017594          122 LIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILL----DKDMNPKISDFGM  197 (369)
Q Consensus       122 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv----~~~~~~~L~Dfg~  197 (369)
                      +||||+.+++|.+++........+++..++.++.||+.||.|||+.+   ++||||||+||++    +.++.++|+|||+
T Consensus        86 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~  162 (319)
T 4euu_A           86 LIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGA  162 (319)
T ss_dssp             EEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEEEECCCTT
T ss_pred             EEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceEEEccCCC
Confidence            99999999999999976555555899999999999999999999999   9999999999999    7777899999999


Q ss_pred             ceecCCCCcccccccccccccccCchhhc--------cCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhh
Q 017594          198 ARICGGNELQANTSRIVGTYGYMSPEYAL--------EGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWD  269 (369)
Q Consensus       198 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--------~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~  269 (369)
                      +........   .....+++.|+|||++.        +..++.++|||||||++|+|++|..||.......... .....
T Consensus       163 a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~-~~~~~  238 (319)
T 4euu_A          163 ARELEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNK-EVMYK  238 (319)
T ss_dssp             CEECCTTCC---BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCH-HHHHH
T ss_pred             ceecCCCCc---eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhH-HHHHH
Confidence            987654332   22346899999999886        5678999999999999999999999996543221111 11111


Q ss_pred             hhhcC--cccc-----------ccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHhhhh
Q 017594          270 LWTSN--RTLE-----------LIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNEAA  327 (369)
Q Consensus       270 ~~~~~--~~~~-----------~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L~~~~~  327 (369)
                      .....  ....           ...............+..+.++|.+||+.||++|||+.++++..+...-
T Consensus       239 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~~  309 (319)
T 4euu_A          239 IITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH  309 (319)
T ss_dssp             HHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHTC
T ss_pred             HhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHhh
Confidence            11100  0000           0000011112234557889999999999999999999999999886654

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=6.1e-44  Score=332.81  Aligned_cols=276  Identities=26%  Similarity=0.349  Sum_probs=219.1

Q ss_pred             CccccchhhHHHHhcCCccCccccccCCccEEEEEEc------CCCEEEEEEecCCC-chhHHHHHHHHHHHhcC-CCCc
Q 017594           35 QFPLFSFSSVSTATNKFSDANKLGEGGFGPVYKGVLK------KGDEIAVKRLSGRS-GQGLREMKNEASVIAKV-QHKN  106 (369)
Q Consensus        35 ~~~~~~~~~~~~~~~~y~i~~~lg~G~~~~v~~~~~~------~~~~valK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~  106 (369)
                      ....+.....+...++|++.+.||+|+||.||+|++.      +++.||+|++.... ....+.+.+|+.++..+ +|||
T Consensus         8 ~~~~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpn   87 (359)
T 3vhe_A            8 ERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN   87 (359)
T ss_dssp             GGSCCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTT
T ss_pred             hhCCCCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcc
Confidence            3445666677778899999999999999999999842      35789999997543 33456788999999999 7899


Q ss_pred             eeeeeeeEEeCCc-cEEEEEecCCCChhhhhcCCCc--------------------------------------------
Q 017594          107 LVRLLGCCIDRDE-KILIYEYMPNKSLDFFLFDPTK--------------------------------------------  141 (369)
Q Consensus       107 i~~~~~~~~~~~~-~~lv~e~~~~~~L~~~l~~~~~--------------------------------------------  141 (369)
                      |+++++++...+. .++||||+.+++|.+++.....                                            
T Consensus        88 iv~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  167 (359)
T 3vhe_A           88 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGF  167 (359)
T ss_dssp             BCCEEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC--------------------------------------
T ss_pred             eeeeeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccc
Confidence            9999999887654 8999999999999999865432                                            


Q ss_pred             -------------------cccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecC
Q 017594          142 -------------------RMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICG  202 (369)
Q Consensus       142 -------------------~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~  202 (369)
                                         ...+++..++.++.||+.||+|||+++   ++||||||+||+++.++.++|+|||++....
T Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~  244 (359)
T 3vhe_A          168 VEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIY  244 (359)
T ss_dssp             ----------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTT
T ss_pred             ccccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeec
Confidence                               222888999999999999999999999   9999999999999999999999999998765


Q ss_pred             CCCcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHh-CCCCCCCCcccccccchhhhhhhhcCccccccC
Q 017594          203 GNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDLWTSNRTLELID  281 (369)
Q Consensus       203 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (369)
                      ............+++.|+|||++.+..++.++||||||+++|+|++ |..||........     .............  
T Consensus       245 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~-----~~~~~~~~~~~~~--  317 (359)
T 3vhe_A          245 KDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE-----FCRRLKEGTRMRA--  317 (359)
T ss_dssp             SCTTCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH-----HHHHHHHTCCCCC--
T ss_pred             ccccchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHH-----HHHHHHcCCCCCC--
Confidence            4433333444567889999999999999999999999999999998 9999865432211     1111111111110  


Q ss_pred             ccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHhhhhc
Q 017594          282 PILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNEAAT  328 (369)
Q Consensus       282 ~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L~~~~~~  328 (369)
                         .     ..++.++.+++.+||+.||++|||+.++++.|+.+...
T Consensus       318 ---~-----~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~  356 (359)
T 3vhe_A          318 ---P-----DYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA  356 (359)
T ss_dssp             ---C-----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ---C-----CCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHH
Confidence               0     11256699999999999999999999999999988763

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=1.6e-43  Score=321.25  Aligned_cols=279  Identities=25%  Similarity=0.374  Sum_probs=208.6

Q ss_pred             HHhcCCccCccccccCCccEEEEEE-----cCCCEEEEEEecCCCchhHHHHHHHHHHHhcCCCCceeeeeeeEEeC--C
Q 017594           46 TATNKFSDANKLGEGGFGPVYKGVL-----KKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDR--D  118 (369)
Q Consensus        46 ~~~~~y~i~~~lg~G~~~~v~~~~~-----~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~  118 (369)
                      ...++|++.+.||+|+||.||+|+.     .+++.||+|++........+.+.+|+.+++.++||||+++++++...  .
T Consensus         7 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   86 (295)
T 3ugc_A            7 FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR   86 (295)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHT
T ss_pred             CCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCC
Confidence            3468999999999999999999984     24889999999877766678899999999999999999999998643  5


Q ss_pred             ccEEEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCc
Q 017594          119 EKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMA  198 (369)
Q Consensus       119 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~  198 (369)
                      ..++||||+.+++|.+++....  ..+++..++.++.||+.||.|||+.+   ++||||||+||+++.++.++|+|||++
T Consensus        87 ~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~~  161 (295)
T 3ugc_A           87 NLKLIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLT  161 (295)
T ss_dssp             SCEEEEECCTTCBHHHHHHHCG--GGCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCSC
T ss_pred             ceEEEEEeCCCCCHHHHHHhcc--cccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEccCccc
Confidence            6899999999999999986532  34889999999999999999999999   999999999999999999999999999


Q ss_pred             eecCCCCcc-cccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhh-hhhhhcCcc
Q 017594          199 RICGGNELQ-ANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYA-WDLWTSNRT  276 (369)
Q Consensus       199 ~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~-~~~~~~~~~  276 (369)
                      ......... .......++..|+|||++.+..++.++||||||+++|+|++|..|+.............. .........
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (295)
T 3ugc_A          162 KVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHL  241 (295)
T ss_dssp             C-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHH
T ss_pred             ccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHH
Confidence            876543221 112223466779999999999999999999999999999999998764321100000000 000000000


Q ss_pred             ccccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHhhhhccC
Q 017594          277 LELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNEAATLL  330 (369)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L~~~~~~~~  330 (369)
                      ...+..... ...+..++.++.++|.+||+.||++|||+.++++.|+.+...+.
T Consensus       242 ~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~l~  294 (295)
T 3ugc_A          242 IELLKNNGR-LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMA  294 (295)
T ss_dssp             HHHHHTTCC-CCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC--
T ss_pred             HHHHhccCc-CCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhcc
Confidence            000000000 00011235679999999999999999999999999999887553

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=3e-43  Score=323.99  Aligned_cols=263  Identities=26%  Similarity=0.400  Sum_probs=209.7

Q ss_pred             HHhcCCccCccccccCCccEEEEEEcC----CCEEEEEEecCC-CchhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCcc
Q 017594           46 TATNKFSDANKLGEGGFGPVYKGVLKK----GDEIAVKRLSGR-SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEK  120 (369)
Q Consensus        46 ~~~~~y~i~~~lg~G~~~~v~~~~~~~----~~~valK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~  120 (369)
                      ...++|++.+.||+|+||.||+|++..    +..||+|++... .....+.+.+|+.+++.++||||+++++++.+.+..
T Consensus        46 ~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  125 (325)
T 3kul_A           46 IEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLA  125 (325)
T ss_dssp             CCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCC
T ss_pred             cChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCcc
Confidence            345789999999999999999999752    445999999754 334456788999999999999999999999998999


Q ss_pred             EEEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCcee
Q 017594          121 ILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARI  200 (369)
Q Consensus       121 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~  200 (369)
                      ++||||+.+++|.+++....  ..+++..++.++.||+.||.|||+.+   ++||||||+||+++.++.++|+|||++..
T Consensus       126 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  200 (325)
T 3kul_A          126 MIVTEYMENGSLDTFLRTHD--GQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRV  200 (325)
T ss_dssp             EEEEECCTTCBHHHHHHTTT--TCSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCSSCEE
T ss_pred             EEEeeCCCCCcHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCCcccc
Confidence            99999999999999986432  34899999999999999999999999   99999999999999999999999999987


Q ss_pred             cCCCCccc-ccccccccccccCchhhccCCCCcccchHhHHHHHHHHHh-CCCCCCCCcccccccchhhhhhhhcCcccc
Q 017594          201 CGGNELQA-NTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDLWTSNRTLE  278 (369)
Q Consensus       201 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (369)
                      ........ ......++..|+|||++.+..++.++||||||+++|+|++ |..||.......     ..... ...... 
T Consensus       201 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~-----~~~~~-~~~~~~-  273 (325)
T 3kul_A          201 LEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRD-----VISSV-EEGYRL-  273 (325)
T ss_dssp             CC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH-----HHHHH-HTTCCC-
T ss_pred             cccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHH-----HHHHH-HcCCCC-
Confidence            65432211 1222345678999999998999999999999999999999 999986433211     01111 011000 


Q ss_pred             ccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHhhhhcc
Q 017594          279 LIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNEAATL  329 (369)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L~~~~~~~  329 (369)
                          ..     +..++..+.++|.+||+.||++|||+.+|++.|+.+....
T Consensus       274 ----~~-----~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~  315 (325)
T 3kul_A          274 ----PA-----PMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSP  315 (325)
T ss_dssp             ----CC-----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSC
T ss_pred             ----CC-----CCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCc
Confidence                00     1122567999999999999999999999999999998743

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=7.1e-43  Score=318.90  Aligned_cols=267  Identities=24%  Similarity=0.395  Sum_probs=208.0

Q ss_pred             hcCCccCccccccCCccEEEEEEcCCCEEEEEEecCCCchhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEEEEec
Q 017594           48 TNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIYEYM  127 (369)
Q Consensus        48 ~~~y~i~~~lg~G~~~~v~~~~~~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~  127 (369)
                      .++|++.+.||+|+||.||+|++. ++.||+|.+...  ...+.+..|+..++.++||||+++++++.  +..++||||+
T Consensus         7 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~   81 (307)
T 2eva_A            7 YKEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYA   81 (307)
T ss_dssp             GGGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECC
T ss_pred             HhHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcC
Confidence            478999999999999999999986 788999998644  34577889999999999999999999875  4689999999


Q ss_pred             CCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCc-eEEeecCCceecCCCCc
Q 017594          128 PNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMN-PKISDFGMARICGGNEL  206 (369)
Q Consensus       128 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~-~~L~Dfg~~~~~~~~~~  206 (369)
                      ++++|.+++........++...++.++.|++.||.|||+.+..+++||||||+||+++.++. ++|+|||++......  
T Consensus        82 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~--  159 (307)
T 2eva_A           82 EGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH--  159 (307)
T ss_dssp             TTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC---------
T ss_pred             CCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc--
Confidence            99999999976555556788899999999999999999932123999999999999998887 799999998754322  


Q ss_pred             ccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCccccccCccccc
Q 017594          207 QANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILED  286 (369)
Q Consensus       207 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  286 (369)
                         .....+++.|+|||++.+..++.++||||||+++|+|++|..||........   ...+...... ...     ...
T Consensus       160 ---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~---~~~~~~~~~~-~~~-----~~~  227 (307)
T 2eva_A          160 ---MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAF---RIMWAVHNGT-RPP-----LIK  227 (307)
T ss_dssp             --------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHH---HHHHHHHTTC-CCC-----CBT
T ss_pred             ---cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHH---HHHHHHhcCC-CCC-----ccc
Confidence               2233589999999999998999999999999999999999999864332111   0111111110 000     111


Q ss_pred             cccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHhhhhccCCCCCCCcc
Q 017594          287 EYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNEAATLLPPKQPAFS  338 (369)
Q Consensus       287 ~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L~~~~~~~~~~~~~~~~  338 (369)
                           .++..+.+++.+||+.||++|||+.++++.|+.+.........|...
T Consensus       228 -----~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~~~~~~~  274 (307)
T 2eva_A          228 -----NLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPLQY  274 (307)
T ss_dssp             -----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCCTTSCCCC
T ss_pred             -----ccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhccCCCCcccc
Confidence                 12566899999999999999999999999999999887766555543

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=2.4e-43  Score=328.72  Aligned_cols=253  Identities=24%  Similarity=0.285  Sum_probs=205.7

Q ss_pred             HHhcCCccCccccccCCccEEEEEEcC-CCEEEEEEecCCCch------hHHHHHHHHHHHhcCCCCceeeeeeeEEeCC
Q 017594           46 TATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQ------GLREMKNEASVIAKVQHKNLVRLLGCCIDRD  118 (369)
Q Consensus        46 ~~~~~y~i~~~lg~G~~~~v~~~~~~~-~~~valK~~~~~~~~------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~  118 (369)
                      .+.++|++.+.||+|+||.||+|+.+. |+.||+|++......      ..+.+.+|+.+++.++||||+++++++....
T Consensus         9 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~   88 (361)
T 2yab_A            9 KVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRT   88 (361)
T ss_dssp             CGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred             ChhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCC
Confidence            356789999999999999999999764 899999998754321      3467889999999999999999999999999


Q ss_pred             ccEEEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCC----ceEEee
Q 017594          119 EKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDM----NPKISD  194 (369)
Q Consensus       119 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~----~~~L~D  194 (369)
                      ..++||||+.+++|.+++..   ...+++..++.++.||+.||.|||++|   ++||||||+||+++.++    .++|+|
T Consensus        89 ~~~lv~e~~~gg~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~~vkl~D  162 (361)
T 2yab_A           89 DVVLILELVSGGELFDFLAQ---KESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLID  162 (361)
T ss_dssp             EEEEEEECCCSCBHHHHHTT---CSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECC
T ss_pred             EEEEEEEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCccCEEEEe
Confidence            99999999999999999854   345899999999999999999999999   99999999999998777    799999


Q ss_pred             cCCceecCCCCcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcC
Q 017594          195 FGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSN  274 (369)
Q Consensus       195 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~  274 (369)
                      ||++.......   ......|++.|+|||++.+..++.++|||||||++|+|++|..||.......     ....... .
T Consensus       163 FG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~-----~~~~i~~-~  233 (361)
T 2yab_A          163 FGLAHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE-----TLANITA-V  233 (361)
T ss_dssp             CSSCEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH-----HHHHHHT-T
T ss_pred             cCCceEcCCCC---ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHH-----HHHHHHh-c
Confidence            99998765432   2234568999999999999899999999999999999999999996432111     0000000 0


Q ss_pred             ccccccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 017594          275 RTLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVS  320 (369)
Q Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~  320 (369)
                      ..      .+.. .....++..+.+||.+||..||++|||+.++++
T Consensus       234 ~~------~~~~-~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  272 (361)
T 2yab_A          234 SY------DFDE-EFFSQTSELAKDFIRKLLVKETRKRLTIQEALR  272 (361)
T ss_dssp             CC------CCCH-HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             CC------CCCc-hhccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            00      0000 001122567999999999999999999999985

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=1.1e-43  Score=317.70  Aligned_cols=260  Identities=27%  Similarity=0.382  Sum_probs=212.0

Q ss_pred             HHhcCCccCccccccCCccEEEEEEcCCCEEEEEEecCCCchhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEEEE
Q 017594           46 TATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIYE  125 (369)
Q Consensus        46 ~~~~~y~i~~~lg~G~~~~v~~~~~~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  125 (369)
                      ...++|++.+.||+|+||.||+|+++++..||+|++..... ....+.+|+.+++.++||||+++++++......++|||
T Consensus         5 l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   83 (268)
T 3sxs_A            5 LKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTE   83 (268)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred             echhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEE
Confidence            35688999999999999999999998888899999975543 34678899999999999999999999999899999999


Q ss_pred             ecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCCCC
Q 017594          126 YMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE  205 (369)
Q Consensus       126 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~~~  205 (369)
                      |+++++|.+++...  ...+++..++.++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||++.......
T Consensus        84 ~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~  158 (268)
T 3sxs_A           84 YISNGCLLNYLRSH--GKGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ  158 (268)
T ss_dssp             CCTTCBHHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCEEECCTTC
T ss_pred             ccCCCcHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCccceecchhh
Confidence            99999999988542  334899999999999999999999999   9999999999999999999999999998765433


Q ss_pred             cccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHh-CCCCCCCCcccccccchhhhhhhhcCccccccCccc
Q 017594          206 LQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPIL  284 (369)
Q Consensus       206 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (369)
                      .. ......++..|+|||++.+..++.++||||||+++|+|++ |..||.......     .........   ....   
T Consensus       159 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~-----~~~~~~~~~---~~~~---  226 (268)
T 3sxs_A          159 YV-SSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSE-----VVLKVSQGH---RLYR---  226 (268)
T ss_dssp             EE-ECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHH-----HHHHHHTTC---CCCC---
T ss_pred             hh-cccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHH-----HHHHHHcCC---CCCC---
Confidence            21 1222345678999999998899999999999999999999 999986443211     011110000   0000   


Q ss_pred             cccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHhhhhc
Q 017594          285 EDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNEAAT  328 (369)
Q Consensus       285 ~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L~~~~~~  328 (369)
                           +...+..+.+++.+||+.||++|||+.++++.|+.+...
T Consensus       227 -----~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~  265 (268)
T 3sxs_A          227 -----PHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREK  265 (268)
T ss_dssp             -----CTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred             -----CCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhc
Confidence                 011155689999999999999999999999999988764

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=2e-43  Score=323.16  Aligned_cols=268  Identities=22%  Similarity=0.288  Sum_probs=203.0

Q ss_pred             hHHHHhcCCccCccccccCCccEEEEEEcCCCEEEEEEecCCC--chhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCcc
Q 017594           43 SVSTATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRS--GQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEK  120 (369)
Q Consensus        43 ~~~~~~~~y~i~~~lg~G~~~~v~~~~~~~~~~valK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~  120 (369)
                      ....+.++|++++.||+|+||.||+|++.+|+.||+|++....  ......+.+|+.+++.++||||+++++++......
T Consensus        15 ~~q~l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~   94 (311)
T 3niz_A           15 YFQGLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCL   94 (311)
T ss_dssp             CEECSSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCE
T ss_pred             eecchHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEE
Confidence            4455678999999999999999999999889999999986442  22346778899999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCcee
Q 017594          121 ILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARI  200 (369)
Q Consensus       121 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~  200 (369)
                      ++||||+.+ ++.+.+...  ...+++..++.++.||+.||.|||+.|   ++||||||+||+++.++.++|+|||++..
T Consensus        95 ~lv~e~~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~  168 (311)
T 3niz_A           95 TLVFEFMEK-DLKKVLDEN--KTGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARA  168 (311)
T ss_dssp             EEEEECCSE-EHHHHHHTC--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEEcCCCC-CHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCcCcee
Confidence            999999986 565665432  234889999999999999999999999   99999999999999999999999999987


Q ss_pred             cCCCCcccccccccccccccCchhhcc-CCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCcc--c
Q 017594          201 CGGNELQANTSRIVGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRT--L  277 (369)
Q Consensus       201 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~--~  277 (369)
                      ......  ......+++.|+|||++.+ ..++.++|||||||++|+|++|..||..........  ...........  .
T Consensus       169 ~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~--~i~~~~~~~~~~~~  244 (311)
T 3niz_A          169 FGIPVR--SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLP--KIFSILGTPNPREW  244 (311)
T ss_dssp             TTSCCC-----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHH--HHHHHHCCCCTTTS
T ss_pred             cCCCcc--cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHH--HHHHHHCCCChHHh
Confidence            643221  2233467999999999876 568999999999999999999999997544322110  00000000000  0


Q ss_pred             c----------ccCccccccc---cHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 017594          278 E----------LIDPILEDEY---SSKQMLLRYANIALLCVQESADDRPTMNDVVS  320 (369)
Q Consensus       278 ~----------~~~~~~~~~~---~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~  320 (369)
                      .          ..........   ....++.++.+||.+||+.||++|||+.++++
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  300 (311)
T 3niz_A          245 PQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN  300 (311)
T ss_dssp             GGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             hhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence            0          0000000000   01112467899999999999999999999997

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=3.2e-44  Score=330.65  Aligned_cols=279  Identities=26%  Similarity=0.350  Sum_probs=210.4

Q ss_pred             hcCCccCccccccCCccEEEEEE-----cCCCEEEEEEecCCCchhHHHHHHHHHHHhcCCCCceeeeeeeEE--eCCcc
Q 017594           48 TNKFSDANKLGEGGFGPVYKGVL-----KKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCI--DRDEK  120 (369)
Q Consensus        48 ~~~y~i~~~lg~G~~~~v~~~~~-----~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~  120 (369)
                      .++|++.+.||+|+||.||+|+.     .+++.||+|++........+.+.+|+.+++.++||||+++++++.  .....
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~  101 (327)
T 3lxl_A           22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSL  101 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEE
T ss_pred             hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceE
Confidence            47899999999999999999984     347889999998777666778999999999999999999999887  34568


Q ss_pred             EEEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCcee
Q 017594          121 ILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARI  200 (369)
Q Consensus       121 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~  200 (369)
                      ++||||+++++|.+++...  ...+++..++.++.||+.||.|||+.+   ++|+||||+||+++.++.++|+|||++..
T Consensus       102 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~  176 (327)
T 3lxl_A          102 RLVMEYLPSGCLRDFLQRH--RARLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAKL  176 (327)
T ss_dssp             EEEEECCTTCBHHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCGGGCEE
T ss_pred             EEEEeecCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEccccccee
Confidence            9999999999999998542  234899999999999999999999999   99999999999999999999999999987


Q ss_pred             cCCCCcc-cccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCccccc
Q 017594          201 CGGNELQ-ANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLEL  279 (369)
Q Consensus       201 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (369)
                      ....... .......++..|+|||++.+..++.++||||||+++|+|++|..||..........................
T Consensus       177 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (327)
T 3lxl_A          177 LPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLEL  256 (327)
T ss_dssp             CCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHH
T ss_pred             cccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHH
Confidence            6543322 122334577889999999999999999999999999999999999764321110000000000000000000


Q ss_pred             cCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHhhhhccCCC
Q 017594          280 IDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNEAATLLPP  332 (369)
Q Consensus       280 ~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L~~~~~~~~~~  332 (369)
                      +...... ..+..++..+.++|.+||+.||++|||+.++++.|+.+.......
T Consensus       257 ~~~~~~~-~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~  308 (327)
T 3lxl_A          257 LEEGQRL-PAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRGC  308 (327)
T ss_dssp             HHTTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC-------
T ss_pred             hhcccCC-CCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhcCc
Confidence            0000000 001122567999999999999999999999999999987755433

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=9.1e-43  Score=320.18  Aligned_cols=248  Identities=25%  Similarity=0.359  Sum_probs=204.9

Q ss_pred             CccCccccccCCccEEEEEEc-CCCEEEEEEecCCCchhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEEEEecCC
Q 017594           51 FSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIYEYMPN  129 (369)
Q Consensus        51 y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~  129 (369)
                      |...+.||+|+||.||+|+.+ +|+.||+|++........+.+.+|+.+++.++||||+++++++...+..++||||+.+
T Consensus        47 ~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  126 (321)
T 2c30_A           47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQG  126 (321)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCCCS
T ss_pred             hhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEecCCC
Confidence            778889999999999999976 5999999999866666667889999999999999999999999999999999999999


Q ss_pred             CChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCCCCcccc
Q 017594          130 KSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQAN  209 (369)
Q Consensus       130 ~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~~~~~~~  209 (369)
                      ++|.+++..    ..+++..++.++.||+.||.|||+.+   ++||||||+||+++.++.++|+|||++........  .
T Consensus       127 ~~L~~~l~~----~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~--~  197 (321)
T 2c30_A          127 GALTDIVSQ----VRLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP--K  197 (321)
T ss_dssp             CBHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC--C
T ss_pred             CCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCcEEEeeeeeeeecccCcc--c
Confidence            999998843    34899999999999999999999999   99999999999999999999999999887654321  2


Q ss_pred             cccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCccccccCcccccccc
Q 017594          210 TSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYS  289 (369)
Q Consensus       210 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  289 (369)
                      .....|++.|+|||++.+..++.++||||||+++|+|++|..||.......     ..... ...     ..+.+..   
T Consensus       198 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~-----~~~~~-~~~-----~~~~~~~---  263 (321)
T 2c30_A          198 RKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQ-----AMKRL-RDS-----PPPKLKN---  263 (321)
T ss_dssp             BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-----HHHHH-HHS-----SCCCCTT---
T ss_pred             cccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-----HHHHH-hcC-----CCCCcCc---
Confidence            234578999999999999999999999999999999999999986432111     00011 000     0001100   


Q ss_pred             HHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 017594          290 SKQMLLRYANIALLCVQESADDRPTMNDVVSM  321 (369)
Q Consensus       290 ~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~  321 (369)
                      ....+..+.++|.+||+.||++|||+.++++.
T Consensus       264 ~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h  295 (321)
T 2c30_A          264 SHKVSPVLRDFLERMLVRDPQERATAQELLDH  295 (321)
T ss_dssp             GGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             cccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            11125668999999999999999999999973

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=5.9e-43  Score=317.51  Aligned_cols=265  Identities=23%  Similarity=0.354  Sum_probs=207.8

Q ss_pred             HHhcCCccCccccccCCccEEEEEEc-CCCEEEEEEecCC---CchhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccE
Q 017594           46 TATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGR---SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKI  121 (369)
Q Consensus        46 ~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  121 (369)
                      .+.++|++.+.||+|+||.||+|++. ++..||+|++...   .....+.+.+|+..++.++||||+++++++...+..+
T Consensus         8 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~   87 (294)
T 4eqm_A            8 IINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYY   87 (294)
T ss_dssp             CEETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEE
T ss_pred             HhhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEE
Confidence            35689999999999999999999965 4889999998543   2344567889999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceec
Q 017594          122 LIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARIC  201 (369)
Q Consensus       122 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~  201 (369)
                      +||||+++++|.+++..   ...+++..++.++.||+.||.|||+.|   ++||||||+||+++.++.++|+|||++...
T Consensus        88 lv~e~~~g~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~  161 (294)
T 4eqm_A           88 LVMEYIEGPTLSEYIES---HGPLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKAL  161 (294)
T ss_dssp             EEEECCCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCSSSTTC
T ss_pred             EEEeCCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeCCCcccc
Confidence            99999999999999853   345899999999999999999999999   999999999999999999999999998765


Q ss_pred             CCCCcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCccccccC
Q 017594          202 GGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELID  281 (369)
Q Consensus       202 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (369)
                      ..... .......|++.|+|||++.+..++.++||||||+++|+|++|..||........     ........ .. ...
T Consensus       162 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~-----~~~~~~~~-~~-~~~  233 (294)
T 4eqm_A          162 SETSL-TQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSI-----AIKHIQDS-VP-NVT  233 (294)
T ss_dssp             --------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHH-----HHHHHSSC-CC-CHH
T ss_pred             ccccc-cccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHH-----HHHHhhcc-CC-Ccc
Confidence            43221 122334689999999999999999999999999999999999999964331110     00110000 00 000


Q ss_pred             ccccccccHHHHHHHHHHHHHHhhcCCCCCCC-CHHHHHHHHHhhhhcc
Q 017594          282 PILEDEYSSKQMLLRYANIALLCVQESADDRP-TMNDVVSMLTNEAATL  329 (369)
Q Consensus       282 ~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp-s~~ell~~L~~~~~~~  329 (369)
                      ...     ...++..+.++|.+||+.||++|| +++++.+.|+.+....
T Consensus       234 ~~~-----~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~  277 (294)
T 4eqm_A          234 TDV-----RKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHEN  277 (294)
T ss_dssp             HHS-----CTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSS
T ss_pred             hhc-----ccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhc
Confidence            000     111256799999999999999999 9999999998876643

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=3.5e-43  Score=324.64  Aligned_cols=249  Identities=22%  Similarity=0.287  Sum_probs=203.7

Q ss_pred             hcCCccCccccccCCccEEEEEEc-CCCEEEEEEecCC---CchhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEE
Q 017594           48 TNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGR---SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILI  123 (369)
Q Consensus        48 ~~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv  123 (369)
                      .++|++++.||+|+||.||+|+.+ +|+.||+|++...   .......+..|+.+++.++||||+++++++...+..++|
T Consensus         4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv   83 (337)
T 1o6l_A            4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV   83 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence            468999999999999999999976 4899999998643   123456788899999999999999999999999999999


Q ss_pred             EEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCC
Q 017594          124 YEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGG  203 (369)
Q Consensus       124 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~  203 (369)
                      |||+.+++|..++..   ...+++..++.++.||+.||.|||++|   ++||||||+||+++.+|.++|+|||++.....
T Consensus        84 ~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~  157 (337)
T 1o6l_A           84 MEYANGGELFFHLSR---ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGIS  157 (337)
T ss_dssp             EECCTTCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred             EeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeeccchhhccc
Confidence            999999999888843   345899999999999999999999999   99999999999999999999999999875432


Q ss_pred             CCcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCccccccCcc
Q 017594          204 NELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPI  283 (369)
Q Consensus       204 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (369)
                      ..  .......|++.|+|||++.+..++.++|+|||||++|+|++|..||.......     ....... ... .     
T Consensus       158 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~-----~~~~i~~-~~~-~-----  223 (337)
T 1o6l_A          158 DG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER-----LFELILM-EEI-R-----  223 (337)
T ss_dssp             TT--CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-----HHHHHHH-CCC-C-----
T ss_pred             CC--CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHH-----HHHHHHc-CCC-C-----
Confidence            21  12334578999999999999999999999999999999999999986432111     0111111 100 0     


Q ss_pred             ccccccHHHHHHHHHHHHHHhhcCCCCCCC-----CHHHHHHH
Q 017594          284 LEDEYSSKQMLLRYANIALLCVQESADDRP-----TMNDVVSM  321 (369)
Q Consensus       284 ~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp-----s~~ell~~  321 (369)
                      +     +..++.++.++|.+||+.||++||     ++.++++.
T Consensus       224 ~-----p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h  261 (337)
T 1o6l_A          224 F-----PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH  261 (337)
T ss_dssp             C-----CTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred             C-----CCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence            0     111256799999999999999999     89999864

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=2.9e-43  Score=326.09  Aligned_cols=270  Identities=26%  Similarity=0.388  Sum_probs=214.6

Q ss_pred             hhHHHHhcCCccCccccccCCccEEEEEEcC------CCEEEEEEecCCC-chhHHHHHHHHHHHhcCCCCceeeeeeeE
Q 017594           42 SSVSTATNKFSDANKLGEGGFGPVYKGVLKK------GDEIAVKRLSGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCC  114 (369)
Q Consensus        42 ~~~~~~~~~y~i~~~lg~G~~~~v~~~~~~~------~~~valK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~  114 (369)
                      ..+....++|++.+.||+|+||.||+|++.+      ++.||+|++.... ......+.+|+.+++.++||||+++++++
T Consensus        40 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~  119 (343)
T 1luf_A           40 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVC  119 (343)
T ss_dssp             HHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             ceeEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence            3445567899999999999999999999753      4789999997543 33456788999999999999999999999


Q ss_pred             EeCCccEEEEEecCCCChhhhhcCCCc---------------------cccCChHHHHHHHHHHHHHHHHHhcCCCCCcc
Q 017594          115 IDRDEKILIYEYMPNKSLDFFLFDPTK---------------------RMLLDWVTRVQIIEGIAQGLLYLHQYSRVRII  173 (369)
Q Consensus       115 ~~~~~~~lv~e~~~~~~L~~~l~~~~~---------------------~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~  173 (369)
                      ...+..++||||+.+++|.+++.....                     ...+++..++.++.||+.||.|||+++   ++
T Consensus       120 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---iv  196 (343)
T 1luf_A          120 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FV  196 (343)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CC
T ss_pred             ccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ee
Confidence            999999999999999999999865321                     256899999999999999999999999   99


Q ss_pred             cCCCCCCCEEEeCCCceEEeecCCceecCCCCcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHh-CCCC
Q 017594          174 HRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKN  252 (369)
Q Consensus       174 H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~t-g~~p  252 (369)
                      ||||||+||+++.++.++|+|||++................+++.|+|||++.+..++.++||||||+++|+|++ |..|
T Consensus       197 H~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p  276 (343)
T 1luf_A          197 HRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP  276 (343)
T ss_dssp             CSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred             cCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCc
Confidence            999999999999999999999999876643332223334467889999999998899999999999999999999 9999


Q ss_pred             CCCCcccccccchhhhhhhhcCccccccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHhhhhccC
Q 017594          253 TGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNEAATLL  330 (369)
Q Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L~~~~~~~~  330 (369)
                      |.......     .. ...........          +..++..+.++|.+||+.||++|||+.++++.|+++.....
T Consensus       277 ~~~~~~~~-----~~-~~~~~~~~~~~----------~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~~  338 (343)
T 1luf_A          277 YYGMAHEE-----VI-YYVRDGNILAC----------PENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERAE  338 (343)
T ss_dssp             TTTSCHHH-----HH-HHHHTTCCCCC----------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC---
T ss_pred             CCCCChHH-----HH-HHHhCCCcCCC----------CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhhh
Confidence            86433111     11 11111111110          11125679999999999999999999999999999887543

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=6.5e-43  Score=321.96  Aligned_cols=254  Identities=24%  Similarity=0.320  Sum_probs=201.5

Q ss_pred             HHhcCCccCccccccCCccEEEEEEc-CCCEEEEEEecCCC-chhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCc----
Q 017594           46 TATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDE----  119 (369)
Q Consensus        46 ~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~----  119 (369)
                      ...++|++.+.||+|+||.||+|+++ +|+.||+|++.... ....+.+.+|+.+++.++||||+++++++.+...    
T Consensus         3 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~   82 (332)
T 3qd2_B            3 RYLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQ   82 (332)
T ss_dssp             HHHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHH
T ss_pred             hhhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhh
Confidence            34678999999999999999999976 69999999987443 3345778999999999999999999999865432    


Q ss_pred             -----------------------------------------------------cEEEEEecCCCChhhhhcCCCccccCC
Q 017594          120 -----------------------------------------------------KILIYEYMPNKSLDFFLFDPTKRMLLD  146 (369)
Q Consensus       120 -----------------------------------------------------~~lv~e~~~~~~L~~~l~~~~~~~~~~  146 (369)
                                                                           .++||||+.+++|.+++..........
T Consensus        83 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~  162 (332)
T 3qd2_B           83 EEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDRE  162 (332)
T ss_dssp             HHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSC
T ss_pred             hhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchh
Confidence                                                                 799999999999999998766656667


Q ss_pred             hHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCCCCcc----------ccccccccc
Q 017594          147 WVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQ----------ANTSRIVGT  216 (369)
Q Consensus       147 ~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~~~~~----------~~~~~~~~~  216 (369)
                      +..++.++.||+.||.|||+++   ++||||||+||+++.++.++|+|||++.........          .......|+
T Consensus       163 ~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt  239 (332)
T 3qd2_B          163 HGVCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGT  239 (332)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-C
T ss_pred             hHHHHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCC
Confidence            7778999999999999999999   999999999999999999999999999877543211          112334689


Q ss_pred             ccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCccccccCccccccccHHHHHHH
Q 017594          217 YGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYSSKQMLLR  296 (369)
Q Consensus       217 ~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (369)
                      +.|+|||++.+..++.++|||||||++|+|++|..|+....       ... ..     ....     .........+..
T Consensus       240 ~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~~-------~~~-~~-----~~~~-----~~~~~~~~~~~~  301 (332)
T 3qd2_B          240 KLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERV-------RII-TD-----VRNL-----KFPLLFTQKYPQ  301 (332)
T ss_dssp             GGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHHH-------HHH-HH-----HHTT-----CCCHHHHHHCHH
T ss_pred             cCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHHH-------HHH-HH-----hhcc-----CCCcccccCChh
Confidence            99999999999999999999999999999999876632100       000 00     0000     001112233567


Q ss_pred             HHHHHHHhhcCCCCCCCCHHHHHH
Q 017594          297 YANIALLCVQESADDRPTMNDVVS  320 (369)
Q Consensus       297 l~~li~~~L~~dP~~Rps~~ell~  320 (369)
                      +.++|.+||+.||++|||+.++++
T Consensus       302 ~~~li~~~l~~~p~~Rps~~~~l~  325 (332)
T 3qd2_B          302 EHMMVQDMLSPSPTERPEATDIIE  325 (332)
T ss_dssp             HHHHHHHHHCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHccCCCCcCCCHHHHhh
Confidence            899999999999999999999986

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=1.9e-43  Score=331.78  Aligned_cols=263  Identities=25%  Similarity=0.342  Sum_probs=211.2

Q ss_pred             HHHhcCCccCccccccCCccEEEEEEc-CCCEEEEEEecCCC-chhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEE
Q 017594           45 STATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKIL  122 (369)
Q Consensus        45 ~~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l  122 (369)
                      ....++|++.+.||+|+||.||+|+++ ++..||+|++.... ......+.+|+.+++.++||||+++++++...+..++
T Consensus       110 ~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l  189 (377)
T 3cbl_A          110 VLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYI  189 (377)
T ss_dssp             BCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred             EEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEE
Confidence            344678999999999999999999986 58999999987543 2334467789999999999999999999998899999


Q ss_pred             EEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecC
Q 017594          123 IYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICG  202 (369)
Q Consensus       123 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~  202 (369)
                      ||||+.+++|.+++...  ...+++..++.++.||+.||+|||+++   ++||||||+||+++.++.++|+|||++....
T Consensus       190 v~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~  264 (377)
T 3cbl_A          190 VMELVQGGDFLTFLRTE--GARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSREEA  264 (377)
T ss_dssp             EEECCTTCBHHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECT
T ss_pred             EEEcCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcCCCceecC
Confidence            99999999999988532  334889999999999999999999999   9999999999999999999999999988654


Q ss_pred             CCCcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHh-CCCCCCCCcccccccchhhhhhhhcCccccccC
Q 017594          203 GNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDLWTSNRTLELID  281 (369)
Q Consensus       203 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (369)
                      ............++..|+|||++.+..++.++|||||||++|+|++ |..||.......      ............   
T Consensus       265 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~------~~~~~~~~~~~~---  335 (377)
T 3cbl_A          265 DGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQ------TREFVEKGGRLP---  335 (377)
T ss_dssp             TSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHH------HHHHHHTTCCCC---
T ss_pred             CCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH------HHHHHHcCCCCC---
Confidence            3322222222335678999999998899999999999999999998 999986543211      011111110000   


Q ss_pred             ccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHhhhhc
Q 017594          282 PILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNEAAT  328 (369)
Q Consensus       282 ~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L~~~~~~  328 (369)
                        .     +..++..+.+++.+||+.||++|||+.+|++.|+.+...
T Consensus       336 --~-----~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~  375 (377)
T 3cbl_A          336 --C-----PELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR  375 (377)
T ss_dssp             --C-----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             --C-----CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence              0     111256789999999999999999999999999988764

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=9.4e-43  Score=316.73  Aligned_cols=264  Identities=26%  Similarity=0.350  Sum_probs=202.0

Q ss_pred             HHhcCCccCccccccCCccEEEEEEcCCCEEEEEEecCCCchhHHHHHHHHHHHhc--CCCCceeeeeeeEEeC----Cc
Q 017594           46 TATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAK--VQHKNLVRLLGCCIDR----DE  119 (369)
Q Consensus        46 ~~~~~y~i~~~lg~G~~~~v~~~~~~~~~~valK~~~~~~~~~~~~~~~e~~~l~~--l~h~~i~~~~~~~~~~----~~  119 (369)
                      ...++|++.+.||+|+||.||+|++ +|+.||+|++....   ...+..|.+++..  ++||||+++++++...    ..
T Consensus         5 ~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~   80 (301)
T 3q4u_A            5 TVARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSRD---EKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQ   80 (301)
T ss_dssp             CCGGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGGG---HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEE
T ss_pred             cccCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEecccc---chhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCce
Confidence            3568999999999999999999998 48899999986432   2455556666666  7899999999987543    44


Q ss_pred             cEEEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHh--------cCCCCCcccCCCCCCCEEEeCCCceE
Q 017594          120 KILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLH--------QYSRVRIIHRDLKASNILLDKDMNPK  191 (369)
Q Consensus       120 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH--------~~~~~~i~H~dl~p~NIlv~~~~~~~  191 (369)
                      .++||||+.+++|.+++..    ..+++..++.++.||+.||.|||        +.+   ++||||||+||+++.++.++
T Consensus        81 ~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~Nill~~~~~~k  153 (301)
T 3q4u_A           81 LWLITHYHEMGSLYDYLQL----TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRDLKSKNILVKKNGQCC  153 (301)
T ss_dssp             EEEEECCCTTCBHHHHHTT----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSCCCGGGEEECTTSCEE
T ss_pred             eEEehhhccCCCHHHHHhh----cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCCCChHhEEEcCCCCEE
Confidence            7999999999999999843    34899999999999999999999        888   99999999999999999999


Q ss_pred             EeecCCceecCCCCccc--ccccccccccccCchhhccC------CCCcccchHhHHHHHHHHHhC----------CCCC
Q 017594          192 ISDFGMARICGGNELQA--NTSRIVGTYGYMSPEYALEG------IFSIKSDVFSFGVLLLEIVSG----------KKNT  253 (369)
Q Consensus       192 L~Dfg~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~------~~~~~~DiwslG~il~~l~tg----------~~p~  253 (369)
                      |+|||++..........  ......|++.|+|||++.+.      .++.++|||||||++|+|++|          ..||
T Consensus       154 l~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf  233 (301)
T 3q4u_A          154 IADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPF  233 (301)
T ss_dssp             ECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTT
T ss_pred             EeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccc
Confidence            99999987665432221  12234689999999999876      566799999999999999999          6666


Q ss_pred             CCCcccccccchhhhhhhhcCccccccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHhh
Q 017594          254 GLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNE  325 (369)
Q Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L~~~  325 (369)
                      ............. ......    ....+.+.........+..+.+++.+||+.||++|||+.++++.|+++
T Consensus       234 ~~~~~~~~~~~~~-~~~~~~----~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i  300 (301)
T 3q4u_A          234 YDVVPNDPSFEDM-RKVVCV----DQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI  300 (301)
T ss_dssp             TTTSCSSCCHHHH-HHHHTT----SCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred             cccCCCCcchhhh-hHHHhc----cCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence            4332221111111 111111    111122222222334578899999999999999999999999999875

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=4.7e-43  Score=316.11  Aligned_cols=263  Identities=27%  Similarity=0.386  Sum_probs=210.8

Q ss_pred             hhHHHHhcCCccCccccccCCccEEEEEEcCCCEEEEEEecCCCchhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccE
Q 017594           42 SSVSTATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKI  121 (369)
Q Consensus        42 ~~~~~~~~~y~i~~~lg~G~~~~v~~~~~~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  121 (369)
                      .......++|++.+.||+|+||.||+|.++++..||+|++..... ..+.+.+|+.+++.++||||+++++++...+..+
T Consensus        17 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   95 (283)
T 3gen_A           17 GSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIF   95 (283)
T ss_dssp             CTTBCCGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred             CCccCCHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCC-CHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeE
Confidence            344456789999999999999999999998888999999975543 3467889999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceec
Q 017594          122 LIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARIC  201 (369)
Q Consensus       122 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~  201 (369)
                      +||||+.+++|.+++...  ...+++..++.++.||+.||.|||+++   ++|+||||+||+++.++.++|+|||++...
T Consensus        96 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~  170 (283)
T 3gen_A           96 IITEYMANGCLLNYLREM--RHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYV  170 (283)
T ss_dssp             EEECCCTTCBHHHHHHCG--GGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTGGGGB
T ss_pred             EEEeccCCCcHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEccccccccc
Confidence            999999999999998652  334899999999999999999999999   999999999999999999999999998765


Q ss_pred             CCCCcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHh-CCCCCCCCcccccccchhhhhhhhcCcccccc
Q 017594          202 GGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDLWTSNRTLELI  280 (369)
Q Consensus       202 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (369)
                      ..... .......+++.|+|||++.+..++.++||||||+++|+|++ |..||.......     ...... ..     .
T Consensus       171 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~-----~~~~~~-~~-----~  238 (283)
T 3gen_A          171 LDDEY-TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE-----TAEHIA-QG-----L  238 (283)
T ss_dssp             CCHHH-HSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH-----HHHHHH-TT-----C
T ss_pred             ccccc-ccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhH-----HHHHHh-cc-----c
Confidence            43221 11222345778999999998899999999999999999998 999987543211     001110 00     0


Q ss_pred             CccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHhhhh
Q 017594          281 DPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNEAA  327 (369)
Q Consensus       281 ~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L~~~~~  327 (369)
                      .....     ...+..+.++|.+||+.||++|||+.++++.|+.+..
T Consensus       239 ~~~~~-----~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~  280 (283)
T 3gen_A          239 RLYRP-----HLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMD  280 (283)
T ss_dssp             CCCCC-----TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCCCC-----CcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhh
Confidence            00011     1114568999999999999999999999999998765

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=6.6e-44  Score=326.32  Aligned_cols=265  Identities=22%  Similarity=0.294  Sum_probs=199.8

Q ss_pred             HHHhcCCccCccccccCCccEEEEEEc-CCCEEEEEEecCCC---chhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCcc
Q 017594           45 STATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS---GQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEK  120 (369)
Q Consensus        45 ~~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~  120 (369)
                      ..+.++|++.+.||+|+||.||+|++. +++.||+|++....   ......+.+|+.+++.++||||+++++++......
T Consensus         8 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~   87 (311)
T 3ork_A            8 SHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPA   87 (311)
T ss_dssp             SEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETT
T ss_pred             ceecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCC
Confidence            345689999999999999999999964 58899999997542   23345778899999999999999999998876554


Q ss_pred             ----EEEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecC
Q 017594          121 ----ILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFG  196 (369)
Q Consensus       121 ----~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg  196 (369)
                          ++||||+++++|.+++..   ...+++..++.++.||+.||.|||+++   ++||||||+||+++.++.++|+|||
T Consensus        88 ~~~~~lv~e~~~g~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg  161 (311)
T 3ork_A           88 GPLPYIVMEYVDGVTLRDIVHT---EGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFG  161 (311)
T ss_dssp             EEEEEEEEECCCEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEEECCCS
T ss_pred             CcccEEEEecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEEEeecc
Confidence                999999999999999853   335899999999999999999999999   9999999999999999999999999


Q ss_pred             CceecCCCCcc-cccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCc
Q 017594          197 MARICGGNELQ-ANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNR  275 (369)
Q Consensus       197 ~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  275 (369)
                      ++......... .......|++.|+|||++.+..++.++||||||+++|+|++|..||.......     ..........
T Consensus       162 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~-----~~~~~~~~~~  236 (311)
T 3ork_A          162 IARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS-----VAYQHVREDP  236 (311)
T ss_dssp             CC------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH-----HHHHHHHCCC
T ss_pred             CcccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHH-----HHHHHhcCCC
Confidence            98866433221 12233468999999999999999999999999999999999999996433111     1111111110


Q ss_pred             cccccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHH-HHHHHHhhhhc
Q 017594          276 TLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMND-VVSMLTNEAAT  328 (369)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e-ll~~L~~~~~~  328 (369)
                      ..        .......++.++.++|.+||+.||++||++.+ +.+.|......
T Consensus       237 ~~--------~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~  282 (311)
T 3ork_A          237 IP--------PSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNG  282 (311)
T ss_dssp             CC--------HHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHTT
T ss_pred             CC--------cccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhcC
Confidence            00        00001112567999999999999999996555 55666665543

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.7e-43  Score=324.44  Aligned_cols=268  Identities=26%  Similarity=0.352  Sum_probs=210.5

Q ss_pred             HHHhcCCccCccccccCCccEEEEEEc------CCCEEEEEEecCCC-chhHHHHHHHHHHHhcC-CCCceeeeeeeEEe
Q 017594           45 STATNKFSDANKLGEGGFGPVYKGVLK------KGDEIAVKRLSGRS-GQGLREMKNEASVIAKV-QHKNLVRLLGCCID  116 (369)
Q Consensus        45 ~~~~~~y~i~~~lg~G~~~~v~~~~~~------~~~~valK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~  116 (369)
                      +...++|++.+.||+|+||.||+|++.      ++..||+|++.... ....+.+.+|+.++..+ .||||+++++++..
T Consensus        41 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~  120 (344)
T 1rjb_A           41 EFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTL  120 (344)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             ccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEee
Confidence            445689999999999999999999962      35679999987442 33456788999999999 89999999999999


Q ss_pred             CCccEEEEEecCCCChhhhhcCCCcc--------------------ccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCC
Q 017594          117 RDEKILIYEYMPNKSLDFFLFDPTKR--------------------MLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRD  176 (369)
Q Consensus       117 ~~~~~lv~e~~~~~~L~~~l~~~~~~--------------------~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~d  176 (369)
                      .+..++||||+++++|.+++......                    ..+++..++.++.||+.||.|||+.|   ++|||
T Consensus       121 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~D  197 (344)
T 1rjb_A          121 SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRD  197 (344)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETT
T ss_pred             CCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---cccCC
Confidence            99999999999999999998654321                    34788999999999999999999999   99999


Q ss_pred             CCCCCEEEeCCCceEEeecCCceecCCCCcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHh-CCCCCCC
Q 017594          177 LKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGL  255 (369)
Q Consensus       177 l~p~NIlv~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~t-g~~p~~~  255 (369)
                      |||+||+++.++.++|+|||++................+++.|+|||++.+..++.++||||||+++|+|++ |..||..
T Consensus       198 ikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~  277 (344)
T 1rjb_A          198 LAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPG  277 (344)
T ss_dssp             CSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred             CChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCccc
Confidence            999999999999999999999986654333233334456788999999998999999999999999999998 9999865


Q ss_pred             CcccccccchhhhhhhhcCccccccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHhhhhccC
Q 017594          256 YRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNEAATLL  330 (369)
Q Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L~~~~~~~~  330 (369)
                      ......     ..........     ....     ...+..+.++|.+||+.||.+|||+.++++.|+.+.....
T Consensus       278 ~~~~~~-----~~~~~~~~~~-----~~~~-----~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~  337 (344)
T 1rjb_A          278 IPVDAN-----FYKLIQNGFK-----MDQP-----FYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADAE  337 (344)
T ss_dssp             CCCSHH-----HHHHHHTTCC-----CCCC-----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC----
T ss_pred             CCcHHH-----HHHHHhcCCC-----CCCC-----CCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHHH
Confidence            432211     1111111100     0000     1125679999999999999999999999999999877543

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=9.2e-43  Score=318.55  Aligned_cols=267  Identities=26%  Similarity=0.380  Sum_probs=215.0

Q ss_pred             HHHhcCCccCccccccCCccEEEEEE------cCCCEEEEEEecCCCc-hhHHHHHHHHHHHhcC-CCCceeeeeeeEEe
Q 017594           45 STATNKFSDANKLGEGGFGPVYKGVL------KKGDEIAVKRLSGRSG-QGLREMKNEASVIAKV-QHKNLVRLLGCCID  116 (369)
Q Consensus        45 ~~~~~~y~i~~~lg~G~~~~v~~~~~------~~~~~valK~~~~~~~-~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~  116 (369)
                      ....++|++.+.||+|+||.||+|++      .++..||+|++..... ...+.+.+|+.++..+ +||||+++++++..
T Consensus        19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~   98 (313)
T 1t46_A           19 EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTI   98 (313)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             ccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEec
Confidence            34567899999999999999999985      2367899999975532 3457788999999999 89999999999999


Q ss_pred             CCccEEEEEecCCCChhhhhcCCCc---------------cccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCC
Q 017594          117 RDEKILIYEYMPNKSLDFFLFDPTK---------------RMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASN  181 (369)
Q Consensus       117 ~~~~~lv~e~~~~~~L~~~l~~~~~---------------~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~N  181 (369)
                      .+..++||||+.+++|.+++.....               ...+++..++.++.||+.||.|||+++   ++|+||||+|
T Consensus        99 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~N  175 (313)
T 1t46_A           99 GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARN  175 (313)
T ss_dssp             SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGG
T ss_pred             CCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccce
Confidence            9999999999999999998865332               224899999999999999999999999   9999999999


Q ss_pred             EEEeCCCceEEeecCCceecCCCCcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHh-CCCCCCCCcccc
Q 017594          182 ILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDS  260 (369)
Q Consensus       182 Ilv~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~t-g~~p~~~~~~~~  260 (369)
                      |+++.++.++|+|||++................+++.|+|||++.+..++.++||||||+++|+|++ |..||.......
T Consensus       176 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~  255 (313)
T 1t46_A          176 ILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS  255 (313)
T ss_dssp             EEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH
T ss_pred             EEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchh
Confidence            9999999999999999987655433333334456788999999999999999999999999999998 999986543221


Q ss_pred             cccchhhhhhhhcCccccccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHhhhhcc
Q 017594          261 LNLLGYAWDLWTSNRTLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNEAATL  329 (369)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L~~~~~~~  329 (369)
                      .     ........ .    .....     ...+..+.++|.+||+.||.+|||+.++++.|+++....
T Consensus       256 ~-----~~~~~~~~-~----~~~~~-----~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~  309 (313)
T 1t46_A          256 K-----FYKMIKEG-F----RMLSP-----EHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISES  309 (313)
T ss_dssp             H-----HHHHHHHT-C----CCCCC-----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred             H-----HHHHhccC-C----CCCCc-----ccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHh
Confidence            1     11111110 0    00001     112567999999999999999999999999999987753

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=1.2e-43  Score=325.50  Aligned_cols=278  Identities=28%  Similarity=0.377  Sum_probs=211.2

Q ss_pred             HhcCC-ccCccccccCCccEEEEEEc-----CCCEEEEEEecCCC-chhHHHHHHHHHHHhcCCCCceeeeeeeEEeC--
Q 017594           47 ATNKF-SDANKLGEGGFGPVYKGVLK-----KGDEIAVKRLSGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCCIDR--  117 (369)
Q Consensus        47 ~~~~y-~i~~~lg~G~~~~v~~~~~~-----~~~~valK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--  117 (369)
                      +.++| ++++.||+|+||.||++.+.     +|+.||+|++.... ......+.+|+.+++.++||||+++++++.+.  
T Consensus        28 ~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  107 (318)
T 3lxp_A           28 FHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGA  107 (318)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTT
T ss_pred             ecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCC
Confidence            44566 99999999999999988642     57889999997553 34456788999999999999999999999874  


Q ss_pred             CccEEEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCC
Q 017594          118 DEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGM  197 (369)
Q Consensus       118 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~  197 (369)
                      ...++||||+.+++|.+++..    ..+++..++.++.||+.||.+||+.+   ++|+||||+||+++.++.++|+|||+
T Consensus       108 ~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~  180 (318)
T 3lxp_A          108 ASLQLVMEYVPLGSLRDYLPR----HSIGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGL  180 (318)
T ss_dssp             TEEEEEECCCTTCBHHHHGGG----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGG
T ss_pred             ceEEEEEecccCCcHHHHHhh----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEECCccc
Confidence            567999999999999999843    23889999999999999999999999   99999999999999999999999999


Q ss_pred             ceecCCCCcc-cccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCcc
Q 017594          198 ARICGGNELQ-ANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRT  276 (369)
Q Consensus       198 ~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  276 (369)
                      +......... .......++..|+|||++.+..++.++||||||+++|+|++|..||.......................
T Consensus       181 a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  260 (318)
T 3lxp_A          181 AKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRL  260 (318)
T ss_dssp             CEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHH
T ss_pred             cccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHH
Confidence            9877543322 122334577889999999999999999999999999999999999864321110000000000000000


Q ss_pred             ccccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHhhhhccCCC
Q 017594          277 LELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNEAATLLPP  332 (369)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L~~~~~~~~~~  332 (369)
                      ...+...... ..+..++..+.++|.+||+.||++|||+.++++.|+.+......+
T Consensus       261 ~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~~~  315 (318)
T 3lxp_A          261 TELLERGERL-PRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQGQ  315 (318)
T ss_dssp             HHHHHTTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHC-
T ss_pred             HHHHhcccCC-CCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhccC
Confidence            0100000000 001122567999999999999999999999999999998866543

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=7.5e-43  Score=315.95  Aligned_cols=266  Identities=26%  Similarity=0.431  Sum_probs=199.3

Q ss_pred             hHHHHhcCCccCccccccCCccEEEEEEcCCCEEEEEEecCCC--chhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCcc
Q 017594           43 SVSTATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRS--GQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEK  120 (369)
Q Consensus        43 ~~~~~~~~y~i~~~lg~G~~~~v~~~~~~~~~~valK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~  120 (369)
                      ..+...++|++.+.||+|+||.||+|+++.  .|++|++....  ....+.+.+|+.+++.++||||++++++. .....
T Consensus        18 ~~ei~~~~y~~~~~lG~G~~g~Vy~~~~~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~   94 (289)
T 3og7_A           18 DWEIPDGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQL   94 (289)
T ss_dssp             CCBCCTTSCEEEEEEEECSSEEEEEEESSS--EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSC
T ss_pred             CCccCccceeeeeEecCCCCeEEEEEEEcC--ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCcc
Confidence            345567899999999999999999998653  59999986443  34457788999999999999999999964 56678


Q ss_pred             EEEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCcee
Q 017594          121 ILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARI  200 (369)
Q Consensus       121 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~  200 (369)
                      ++||||+.+++|.+++...  ...+++..++.++.||+.||.|||+.+   ++||||||+||+++.++.++|+|||++..
T Consensus        95 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~  169 (289)
T 3og7_A           95 AIVTQWCEGSSLYHHLHAS--ETKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATE  169 (289)
T ss_dssp             EEEEECCCEEEHHHHHTTC-----CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC----
T ss_pred             EEEEEecCCCcHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEccceeccc
Confidence            9999999999999888543  344889999999999999999999999   99999999999999999999999999876


Q ss_pred             cCCCCcccccccccccccccCchhhc---cCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCccc
Q 017594          201 CGGNELQANTSRIVGTYGYMSPEYAL---EGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTL  277 (369)
Q Consensus       201 ~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  277 (369)
                      ..............+++.|+|||++.   +..++.++||||||+++|+|++|..||.......     ............
T Consensus       170 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-----~~~~~~~~~~~~  244 (289)
T 3og7_A          170 KSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD-----QIIEMVGRGSLS  244 (289)
T ss_dssp             --------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHH-----HHHHHHHHTSCC
T ss_pred             cccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHH-----HHHHHhcccccC
Confidence            54333233334456899999999986   6678899999999999999999999996543211     111111111111


Q ss_pred             cccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHhhhh
Q 017594          278 ELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNEAA  327 (369)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L~~~~~  327 (369)
                      ..+...      ...++..+.++|.+||+.||.+|||+.++++.|+.+..
T Consensus       245 ~~~~~~------~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~  288 (289)
T 3og7_A          245 PDLSKV------RSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR  288 (289)
T ss_dssp             CCTTSS------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred             cchhhc------cccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence            111111      01125679999999999999999999999999998764

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.2e-43  Score=323.15  Aligned_cols=252  Identities=21%  Similarity=0.288  Sum_probs=205.5

Q ss_pred             HhcCCccCccccccCCccEEEEEEcC-CCEEEEEEecCCCchhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEEEE
Q 017594           47 ATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIYE  125 (369)
Q Consensus        47 ~~~~y~i~~~lg~G~~~~v~~~~~~~-~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  125 (369)
                      +.++|++.+.||+|+||.||+|+++. ++.||+|.+.... .....+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus         3 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e   81 (321)
T 1tki_A            3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFE   81 (321)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             hhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEE
Confidence            45799999999999999999999764 7889999987543 345678899999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeC--CCceEEeecCCceecCC
Q 017594          126 YMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDK--DMNPKISDFGMARICGG  203 (369)
Q Consensus       126 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~--~~~~~L~Dfg~~~~~~~  203 (369)
                      |+.+++|.+++...  ...+++..++.++.||+.||.|||++|   ++||||||+||+++.  ++.++|+|||++..+..
T Consensus        82 ~~~g~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~  156 (321)
T 1tki_A           82 FISGLDIFERINTS--AFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP  156 (321)
T ss_dssp             CCCCCBHHHHHTSS--SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCT
T ss_pred             eCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECCCCeECCC
Confidence            99999999988542  235899999999999999999999999   999999999999987  78999999999987654


Q ss_pred             CCcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCccccccCcc
Q 017594          204 NELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPI  283 (369)
Q Consensus       204 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (369)
                      ..   ......+++.|+|||++.+..++.++|||||||++|+|++|..||.......     ...........       
T Consensus       157 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-----~~~~i~~~~~~-------  221 (321)
T 1tki_A          157 GD---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ-----IIENIMNAEYT-------  221 (321)
T ss_dssp             TC---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH-----HHHHHHHTCCC-------
T ss_pred             CC---ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHH-----HHHHHHcCCCC-------
Confidence            32   2233568999999999998889999999999999999999999996433111     01111110000       


Q ss_pred             ccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 017594          284 LEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVS  320 (369)
Q Consensus       284 ~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~  320 (369)
                      . .......++.++.++|.+||+.||.+|||+.++++
T Consensus       222 ~-~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~  257 (321)
T 1tki_A          222 F-DEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ  257 (321)
T ss_dssp             C-CHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             C-ChhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            0 00001123667999999999999999999999997

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.2e-42  Score=320.17  Aligned_cols=253  Identities=24%  Similarity=0.307  Sum_probs=205.4

Q ss_pred             HHhcCCccCccccccCCccEEEEEEc-CCCEEEEEEecCCCc------hhHHHHHHHHHHHhcCCCCceeeeeeeEEeCC
Q 017594           46 TATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSG------QGLREMKNEASVIAKVQHKNLVRLLGCCIDRD  118 (369)
Q Consensus        46 ~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~~~------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~  118 (369)
                      .+.++|++.+.||+|+||.||+|+.+ +|+.||+|++.....      ...+.+.+|+.+++.++||||+++++++....
T Consensus         8 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~   87 (326)
T 2y0a_A            8 NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKT   87 (326)
T ss_dssp             CHHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred             CcccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC
Confidence            35578999999999999999999976 489999999865432      13577889999999999999999999999999


Q ss_pred             ccEEEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCC----ceEEee
Q 017594          119 EKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDM----NPKISD  194 (369)
Q Consensus       119 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~----~~~L~D  194 (369)
                      ..++||||+.+++|.+++..   ...+++..++.++.||+.||.|||+++   ++||||||+||+++.++    .++|+|
T Consensus        88 ~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~D  161 (326)
T 2y0a_A           88 DVILILELVAGGELFDFLAE---KESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIID  161 (326)
T ss_dssp             EEEEEEECCCSCBHHHHHTT---SSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCCEEECC
T ss_pred             EEEEEEEcCCCCCHHHHHHh---cCCcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCCEEEEE
Confidence            99999999999999999854   345899999999999999999999999   99999999999998887    799999


Q ss_pred             cCCceecCCCCcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcC
Q 017594          195 FGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSN  274 (369)
Q Consensus       195 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~  274 (369)
                      ||++.......   ......|++.|+|||++.+..++.++|||||||++|+|++|..||.......     .........
T Consensus       162 fg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-----~~~~~~~~~  233 (326)
T 2y0a_A          162 FGLAHKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE-----TLANVSAVN  233 (326)
T ss_dssp             CTTCEECCTTS---CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH-----HHHHHHHTC
T ss_pred             CCCCeECCCCC---ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH-----HHHHHHhcC
Confidence            99998765332   2233468999999999998999999999999999999999999986432111     000000000


Q ss_pred             ccccccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 017594          275 RTLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVS  320 (369)
Q Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~  320 (369)
                             ..... ......+..+.++|.+||+.||++|||+.++++
T Consensus       234 -------~~~~~-~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  271 (326)
T 2y0a_A          234 -------YEFED-EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ  271 (326)
T ss_dssp             -------CCCCH-HHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             -------CCcCc-cccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence                   00000 001122567899999999999999999999997

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.4e-42  Score=319.01  Aligned_cols=283  Identities=24%  Similarity=0.336  Sum_probs=211.6

Q ss_pred             ccccchhhHHHHhcCCccCccccccCCccEEEEEEcCCCEEEEEEecCCCchhHHHHHHHHHHHhcC--CCCceeeeeee
Q 017594           36 FPLFSFSSVSTATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKV--QHKNLVRLLGC  113 (369)
Q Consensus        36 ~~~~~~~~~~~~~~~y~i~~~lg~G~~~~v~~~~~~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l--~h~~i~~~~~~  113 (369)
                      ...+.........++|++.+.||+|+||.||+|+.+ |+.||+|++....   ......|.+++..+  +||||++++++
T Consensus        24 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~   99 (337)
T 3mdy_A           24 GSGLPLLVQRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTE---EASWFRETEIYQTVLMRHENILGFIAA   99 (337)
T ss_dssp             CSSSCHHHHTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEE
T ss_pred             CCCCCcccccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEeccc---cchhhhHHHHHHHHhhcCCCeeeEEEE
Confidence            335556667778899999999999999999999987 8899999986433   23445556666554  89999999999


Q ss_pred             EEeC----CccEEEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcC--------CCCCcccCCCCCCC
Q 017594          114 CIDR----DEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQY--------SRVRIIHRDLKASN  181 (369)
Q Consensus       114 ~~~~----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~--------~~~~i~H~dl~p~N  181 (369)
                      +...    ...++||||+.+++|.+++..    ..+++..++.++.|++.||.|||+.        +   ++||||||+|
T Consensus       100 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dikp~N  172 (337)
T 3mdy_A          100 DIKGTGSWTQLYLITDYHENGSLYDYLKS----TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPA---IAHRDLKSKN  172 (337)
T ss_dssp             EEESCGGGCEEEEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCC---EECSCCCGGG
T ss_pred             EccCCCCCCceEEEEeccCCCcHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCC---EEecccchHH
Confidence            9877    678999999999999999843    3488999999999999999999988        7   9999999999


Q ss_pred             EEEeCCCceEEeecCCceecCCCCcccc--cccccccccccCchhhccCCCCcc------cchHhHHHHHHHHHhCCCCC
Q 017594          182 ILLDKDMNPKISDFGMARICGGNELQAN--TSRIVGTYGYMSPEYALEGIFSIK------SDVFSFGVLLLEIVSGKKNT  253 (369)
Q Consensus       182 Ilv~~~~~~~L~Dfg~~~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~------~DiwslG~il~~l~tg~~p~  253 (369)
                      |+++.++.++|+|||++..+........  .....|++.|+|||++.+..++..      +|||||||++|+|++|..|+
T Consensus       173 ill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~  252 (337)
T 3mdy_A          173 ILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSG  252 (337)
T ss_dssp             EEECTTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBT
T ss_pred             EEECCCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcc
Confidence            9999999999999999977654332211  123468999999999987766554      99999999999999995444


Q ss_pred             CCCcccccccch-----hhhhhhhcCccccccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHhhhhc
Q 017594          254 GLYRTDSLNLLG-----YAWDLWTSNRTLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNEAAT  328 (369)
Q Consensus       254 ~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L~~~~~~  328 (369)
                      +...........     ................+..........++.++.++|.+||+.||++|||+.++++.|+.+...
T Consensus       253 ~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~  332 (337)
T 3mdy_A          253 GIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSES  332 (337)
T ss_dssp             TBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             cccccccccHhhhcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhh
Confidence            321111100000     000000000111122223333333445688899999999999999999999999999998875


Q ss_pred             c
Q 017594          329 L  329 (369)
Q Consensus       329 ~  329 (369)
                      .
T Consensus       333 ~  333 (337)
T 3mdy_A          333 Q  333 (337)
T ss_dssp             T
T ss_pred             c
Confidence            4

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=1.6e-42  Score=320.30  Aligned_cols=269  Identities=25%  Similarity=0.381  Sum_probs=214.8

Q ss_pred             HHHHhcCCccCccccccCCccEEEEEEc--------CCCEEEEEEecCCC-chhHHHHHHHHHHHhcC-CCCceeeeeee
Q 017594           44 VSTATNKFSDANKLGEGGFGPVYKGVLK--------KGDEIAVKRLSGRS-GQGLREMKNEASVIAKV-QHKNLVRLLGC  113 (369)
Q Consensus        44 ~~~~~~~y~i~~~lg~G~~~~v~~~~~~--------~~~~valK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~  113 (369)
                      .....++|++.+.||+|+||.||+|++.        ++..||+|++.... ......+.+|+.+++.+ +||||++++++
T Consensus        30 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~  109 (334)
T 2pvf_A           30 WEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGA  109 (334)
T ss_dssp             TBCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             ccCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEE
Confidence            3445689999999999999999999963        46789999997543 34456788999999999 89999999999


Q ss_pred             EEeCCccEEEEEecCCCChhhhhcCCCc-------------cccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCC
Q 017594          114 CIDRDEKILIYEYMPNKSLDFFLFDPTK-------------RMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKAS  180 (369)
Q Consensus       114 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~-------------~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~  180 (369)
                      +...+..++||||+.+++|.+++.....             ...+++..++.++.||+.||.|||+.+   ++|+||||+
T Consensus       110 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~  186 (334)
T 2pvf_A          110 CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAAR  186 (334)
T ss_dssp             ECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGG
T ss_pred             EccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCccc
Confidence            9999999999999999999999865432             234788999999999999999999999   999999999


Q ss_pred             CEEEeCCCceEEeecCCceecCCCCcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHh-CCCCCCCCccc
Q 017594          181 NILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTD  259 (369)
Q Consensus       181 NIlv~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~t-g~~p~~~~~~~  259 (369)
                      ||+++.++.++|+|||++................+++.|+|||++.+..++.++||||||+++|+|++ |..||......
T Consensus       187 NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~  266 (334)
T 2pvf_A          187 NVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE  266 (334)
T ss_dssp             GEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHH
T ss_pred             eEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHH
Confidence            99999999999999999987665433333333456788999999998899999999999999999999 99998643311


Q ss_pred             ccccchhhhhhhhcCccccccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHhhhhccCC
Q 017594          260 SLNLLGYAWDLWTSNRTLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNEAATLLP  331 (369)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L~~~~~~~~~  331 (369)
                      .      ............     .     +..++..+.++|.+||+.||.+|||+.++++.|+.+......
T Consensus       267 ~------~~~~~~~~~~~~-----~-----~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~~~  322 (334)
T 2pvf_A          267 E------LFKLLKEGHRMD-----K-----PANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTN  322 (334)
T ss_dssp             H------HHHHHHHTCCCC-----C-----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC-
T ss_pred             H------HHHHHhcCCCCC-----C-----CccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcccc
Confidence            1      011111110000     0     111256699999999999999999999999999999875443

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=9.1e-43  Score=325.30  Aligned_cols=261  Identities=22%  Similarity=0.344  Sum_probs=206.4

Q ss_pred             cchhhHHHHhcCCccCccccccCCccEEEEEEc-CCCEEEEEEecCCC--chhHHHHHHHHHHHhcCCCCceeeeeeeEE
Q 017594           39 FSFSSVSTATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS--GQGLREMKNEASVIAKVQHKNLVRLLGCCI  115 (369)
Q Consensus        39 ~~~~~~~~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~  115 (369)
                      +.......+.++|++.+.||+|+||.||+|.++ +|+.||+|++....  ....+.+.+|+.+++.++||||+++++++.
T Consensus        19 ~~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~   98 (362)
T 2bdw_A           19 FMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQ   98 (362)
T ss_dssp             -----CCHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred             EeecCCCCcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence            344445566789999999999999999999976 48999999997543  344567889999999999999999999999


Q ss_pred             eCCccEEEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCC---ceEE
Q 017594          116 DRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDM---NPKI  192 (369)
Q Consensus       116 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~---~~~L  192 (369)
                      +.+..++||||+.+++|.+.+..   ...+++..++.++.||+.||.|||+++   ++||||||+||+++.++   .++|
T Consensus        99 ~~~~~~lv~e~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl  172 (362)
T 2bdw_A           99 EESFHYLVFDLVTGGELFEDIVA---REFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKL  172 (362)
T ss_dssp             CSSEEEEEECCCCSCBHHHHHTT---CSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEE
T ss_pred             eCCEEEEEEecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEE
Confidence            99999999999999999888854   345899999999999999999999999   99999999999997654   5999


Q ss_pred             eecCCceecCCCCcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhh
Q 017594          193 SDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWT  272 (369)
Q Consensus       193 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~  272 (369)
                      +|||++.......   ......|++.|+|||++.+..++.++|||||||++|+|++|..||.......     ..... .
T Consensus       173 ~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~-----~~~~i-~  243 (362)
T 2bdw_A          173 ADFGLAIEVNDSE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR-----LYAQI-K  243 (362)
T ss_dssp             CCCTTCBCCTTCC---SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-----HHHHH-H
T ss_pred             eecCcceEecCCc---ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH-----HHHHH-H
Confidence            9999998665332   1233578999999999999899999999999999999999999986432111     00011 0


Q ss_pred             cCccccccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 017594          273 SNRTLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSM  321 (369)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~  321 (369)
                      .... ....+      ....++.++.++|.+||+.||++||++.++++.
T Consensus       244 ~~~~-~~~~~------~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  285 (362)
T 2bdw_A          244 AGAY-DYPSP------EWDTVTPEAKSLIDSMLTVNPKKRITADQALKV  285 (362)
T ss_dssp             HTCC-CCCTT------GGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             hCCC-CCCcc------cccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            0000 00000      011225679999999999999999999998854

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=2.4e-42  Score=310.09  Aligned_cols=255  Identities=24%  Similarity=0.355  Sum_probs=206.3

Q ss_pred             HHhcCCccCccccccCCccEEEEEEc-CCCEEEEEEecCCC-chhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEE
Q 017594           46 TATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILI  123 (369)
Q Consensus        46 ~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv  123 (369)
                      ...++|++.+.||+|++|.||+|++. +++.|++|++.... ....+.+.+|+.+++.++||||+++++++...+..++|
T Consensus         4 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   83 (276)
T 2yex_A            4 PFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF   83 (276)
T ss_dssp             HHHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             ceecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEE
Confidence            35688999999999999999999976 58999999986432 23457788999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCC
Q 017594          124 YEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGG  203 (369)
Q Consensus       124 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~  203 (369)
                      +|++.+++|.+++..   ...+++..++.++.||+.||.|||+.|   ++|+||+|+||+++.++.++|+|||.+.....
T Consensus        84 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~  157 (276)
T 2yex_A           84 LEYCSGGELFDRIEP---DIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRY  157 (276)
T ss_dssp             EECCTTEEGGGGSBT---TTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEE
T ss_pred             EEecCCCcHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCccccCC
Confidence            999999999988854   334899999999999999999999999   99999999999999999999999999886643


Q ss_pred             CCcccccccccccccccCchhhccCCC-CcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCccccccCc
Q 017594          204 NELQANTSRIVGTYGYMSPEYALEGIF-SIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDP  282 (369)
Q Consensus       204 ~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (369)
                      ...........+++.|+|||++.+..+ +.++||||||+++|+|++|..||..........     ..+.....  ... 
T Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~-----~~~~~~~~--~~~-  229 (276)
T 2yex_A          158 NNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY-----SDWKEKKT--YLN-  229 (276)
T ss_dssp             TTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHH-----HHHHTTCT--TST-
T ss_pred             CcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHH-----HHhhhccc--ccC-
Confidence            332223344568999999999987665 789999999999999999999997544322111     11111100  000 


Q ss_pred             cccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 017594          283 ILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVS  320 (369)
Q Consensus       283 ~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~  320 (369)
                            ....++..+.++|.+||+.||++|||+.++++
T Consensus       230 ------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  261 (276)
T 2yex_A          230 ------PWKKIDSAPLALLHKILVENPSARITIPDIKK  261 (276)
T ss_dssp             ------TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ------chhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence                  01112566899999999999999999999986

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=8.9e-43  Score=321.07  Aligned_cols=259  Identities=28%  Similarity=0.435  Sum_probs=199.9

Q ss_pred             hcCCccCccccccCCccEEEEEEcC-CCE----EEEEEecCC-CchhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccE
Q 017594           48 TNKFSDANKLGEGGFGPVYKGVLKK-GDE----IAVKRLSGR-SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKI  121 (369)
Q Consensus        48 ~~~y~i~~~lg~G~~~~v~~~~~~~-~~~----valK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  121 (369)
                      .++|++.+.||+|+||.||+|++.. ++.    |++|.+... .......+.+|+.+++.++||||+++++++... ..+
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-~~~   92 (327)
T 3lzb_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ   92 (327)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESS-SEE
T ss_pred             HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecC-Cce
Confidence            5789999999999999999999653 544    577777533 334567888999999999999999999999764 588


Q ss_pred             EEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceec
Q 017594          122 LIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARIC  201 (369)
Q Consensus       122 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~  201 (369)
                      ++++++.+++|.+++....  ..+++..++.++.||+.||.|||+++   ++||||||+||+++.++.++|+|||++...
T Consensus        93 ~v~~~~~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~  167 (327)
T 3lzb_A           93 LITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL  167 (327)
T ss_dssp             EEECCCSSCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTC----
T ss_pred             EEEEecCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccCcceeEc
Confidence            9999999999999886432  34889999999999999999999999   999999999999999999999999999876


Q ss_pred             CCCCcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHh-CCCCCCCCcccccccchhhhhhhhcCcccccc
Q 017594          202 GGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDLWTSNRTLELI  280 (369)
Q Consensus       202 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (369)
                      .............++..|+|||++.+..++.++|||||||++|+|++ |..||........      ...........  
T Consensus       168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~------~~~~~~~~~~~--  239 (327)
T 3lzb_A          168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI------SSILEKGERLP--  239 (327)
T ss_dssp             ------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH------HHHHHTTCCCC--
T ss_pred             cCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHH------HHHHHcCCCCC--
Confidence            54433333334456778999999999999999999999999999999 9999865432211      11111111000  


Q ss_pred             CccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHhhhhc
Q 017594          281 DPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNEAAT  328 (369)
Q Consensus       281 ~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L~~~~~~  328 (369)
                         .     +..++.++.++|.+||+.||.+||++.++++.|+.+...
T Consensus       240 ---~-----~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~  279 (327)
T 3lzb_A          240 ---Q-----PPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARD  279 (327)
T ss_dssp             ---C-----CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTS
T ss_pred             ---C-----CccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence               0     111256699999999999999999999999999998754

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=4.2e-43  Score=323.90  Aligned_cols=247  Identities=21%  Similarity=0.329  Sum_probs=199.5

Q ss_pred             HhcCCccCccccccCCccEEEEEE-cCCCEEEEEEecCCC---chhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEE
Q 017594           47 ATNKFSDANKLGEGGFGPVYKGVL-KKGDEIAVKRLSGRS---GQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKIL  122 (369)
Q Consensus        47 ~~~~y~i~~~lg~G~~~~v~~~~~-~~~~~valK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l  122 (369)
                      ..++|++.+.||+|+||.||+|++ .+|+.||+|++....   ......+.+|+.+++.++||||+++++++...+..++
T Consensus         7 ~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l   86 (336)
T 3h4j_B            7 HIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVM   86 (336)
T ss_dssp             EETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             ccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence            347899999999999999999997 458999999986321   1223578899999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecC
Q 017594          123 IYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICG  202 (369)
Q Consensus       123 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~  202 (369)
                      ||||+ +++|.+++..   ...+++..++.++.||+.||.|||+.|   ++||||||+||+++.++.++|+|||++....
T Consensus        87 v~E~~-~g~l~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~  159 (336)
T 3h4j_B           87 VIEYA-GGELFDYIVE---KKRMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMT  159 (336)
T ss_dssp             EECCC-CEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSSCTBTTT
T ss_pred             EEECC-CCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEeccceecc
Confidence            99999 5677776643   344899999999999999999999999   9999999999999999999999999987654


Q ss_pred             CCCcccccccccccccccCchhhccCCC-CcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCccccccC
Q 017594          203 GNELQANTSRIVGTYGYMSPEYALEGIF-SIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELID  281 (369)
Q Consensus       203 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (369)
                      ...   ......|++.|+|||++.+..+ +.++|||||||++|+|++|..||........               ...+.
T Consensus       160 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~---------------~~~i~  221 (336)
T 3h4j_B          160 DGN---FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNL---------------FKKVN  221 (336)
T ss_dssp             TSB---TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTC---------------BCCCC
T ss_pred             CCc---ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHH---------------HHHHH
Confidence            332   2233468999999999988776 6899999999999999999999864321110               00000


Q ss_pred             ccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 017594          282 PILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVS  320 (369)
Q Consensus       282 ~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~  320 (369)
                      ....  ..+...+..+.++|.+||+.||.+|||+.++++
T Consensus       222 ~~~~--~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~  258 (336)
T 3h4j_B          222 SCVY--VMPDFLSPGAQSLIRRMIVADPMQRITIQEIRR  258 (336)
T ss_dssp             SSCC--CCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTT
T ss_pred             cCCC--CCcccCCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence            0000  001112567899999999999999999999986

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=1.3e-42  Score=314.70  Aligned_cols=263  Identities=20%  Similarity=0.268  Sum_probs=198.8

Q ss_pred             cCCccCccccccCCccEEEEEEc-CCCEEEEEEecCCC--chhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEEEE
Q 017594           49 NKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS--GQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIYE  125 (369)
Q Consensus        49 ~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  125 (369)
                      ++|++.+.||+|+||.||+|+++ +|+.||+|++....  ......+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   81 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence            58999999999999999999976 48899999987443  2334678889999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCCCC
Q 017594          126 YMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE  205 (369)
Q Consensus       126 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~~~  205 (369)
                      |+.++.+..+...   ...+++..++.++.||+.||.|||++|   ++||||||+||+++.++.++|+|||++.......
T Consensus        82 ~~~~~l~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~  155 (292)
T 3o0g_A           82 FCDQDLKKYFDSC---NGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPV  155 (292)
T ss_dssp             CCSEEHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCSCC
T ss_pred             cCCCCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecCCcc
Confidence            9987655554432   234899999999999999999999999   9999999999999999999999999998764322


Q ss_pred             cccccccccccccccCchhhccCC-CCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcC--c----ccc
Q 017594          206 LQANTSRIVGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSN--R----TLE  278 (369)
Q Consensus       206 ~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~--~----~~~  278 (369)
                        .......+++.|+|||++.+.. ++.++|||||||++|+|++|..||.......... ..........  .    ...
T Consensus       156 --~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~-~~i~~~~~~~~~~~~~~~~~  232 (292)
T 3o0g_A          156 --RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQL-KRIFRLLGTPTEEQWPSMTK  232 (292)
T ss_dssp             --SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHH-HHHHHHHCCCCTTTCTTGGG
T ss_pred             --ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHH-HHHHHHhCCCChhhhhhhcc
Confidence              2223346789999999987765 8999999999999999999888854332111100 0000000000  0    000


Q ss_pred             c--------cCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 017594          279 L--------IDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVS  320 (369)
Q Consensus       279 ~--------~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~  320 (369)
                      .        ..............+..+.+||.+||+.||++|||+.++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  282 (292)
T 3o0g_A          233 LPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             STTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             cccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence            0        00000000001123567899999999999999999999986

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=1.7e-42  Score=310.47  Aligned_cols=255  Identities=30%  Similarity=0.454  Sum_probs=196.0

Q ss_pred             HhcCCccCccccccCCccEEEEEEcCCCEEEEEEecCCCc----hhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEE
Q 017594           47 ATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSG----QGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKIL  122 (369)
Q Consensus        47 ~~~~y~i~~~lg~G~~~~v~~~~~~~~~~valK~~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l  122 (369)
                      ..++|++.+.||+|+||.||+|.+. |+.||+|++.....    ...+.+.+|+.+++.++||||+++++++...+..++
T Consensus         5 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   83 (271)
T 3dtc_A            5 DFAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCL   83 (271)
T ss_dssp             CTTSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEE
T ss_pred             chhheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEE
Confidence            3578999999999999999999986 88999999864422    235678899999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeC--------CCceEEee
Q 017594          123 IYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDK--------DMNPKISD  194 (369)
Q Consensus       123 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~--------~~~~~L~D  194 (369)
                      ||||+.+++|.+++.    ...+++..++.++.|++.||.|||+++..+++||||||+||+++.        ++.++|+|
T Consensus        84 v~e~~~~~~L~~~~~----~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~D  159 (271)
T 3dtc_A           84 VMEFARGGPLNRVLS----GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITD  159 (271)
T ss_dssp             EEECCTTEEHHHHHT----SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECC
T ss_pred             EEEcCCCCCHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEcc
Confidence            999999999999884    235899999999999999999999987444789999999999985        77899999


Q ss_pred             cCCceecCCCCcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcC
Q 017594          195 FGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSN  274 (369)
Q Consensus       195 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~  274 (369)
                      ||++.......    .....+++.|+|||.+.+..++.++||||||+++|+|++|..||.......     .........
T Consensus       160 fg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-----~~~~~~~~~  230 (271)
T 3dtc_A          160 FGLAREWHRTT----KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLA-----VAYGVAMNK  230 (271)
T ss_dssp             CCC-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHH-----HHHHHHTSC
T ss_pred             CCccccccccc----ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-----HHHhhhcCC
Confidence            99987654322    223468899999999999999999999999999999999999986433111     011111111


Q ss_pred             ccccccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHhh
Q 017594          275 RTLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNE  325 (369)
Q Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L~~~  325 (369)
                       ....    .     +..++..+.++|.+||+.||.+|||+.++++.|+++
T Consensus       231 -~~~~----~-----~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l  271 (271)
T 3dtc_A          231 -LALP----I-----PSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI  271 (271)
T ss_dssp             -CCCC----C-----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred             -CCCC----C-----CcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence             0000    0     111256699999999999999999999999999864

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=1.1e-42  Score=318.60  Aligned_cols=273  Identities=26%  Similarity=0.358  Sum_probs=216.5

Q ss_pred             ccchhhHHHHhcCCccCccccccCCccEEEEEEc------CCCEEEEEEecCCC-chhHHHHHHHHHHHhcC-CCCceee
Q 017594           38 LFSFSSVSTATNKFSDANKLGEGGFGPVYKGVLK------KGDEIAVKRLSGRS-GQGLREMKNEASVIAKV-QHKNLVR  109 (369)
Q Consensus        38 ~~~~~~~~~~~~~y~i~~~lg~G~~~~v~~~~~~------~~~~valK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~  109 (369)
                      .+.........++|++.+.||+|+||.||+|++.      +++.||+|++.... ......+.+|+.++..+ +||||++
T Consensus        16 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~   95 (316)
T 2xir_A           16 PYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN   95 (316)
T ss_dssp             CCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred             cccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeee
Confidence            3455566667899999999999999999999842      36789999997543 23456788999999999 6899999


Q ss_pred             eeeeEEeCC-ccEEEEEecCCCChhhhhcCCCc-------------cccCChHHHHHHHHHHHHHHHHHhcCCCCCcccC
Q 017594          110 LLGCCIDRD-EKILIYEYMPNKSLDFFLFDPTK-------------RMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHR  175 (369)
Q Consensus       110 ~~~~~~~~~-~~~lv~e~~~~~~L~~~l~~~~~-------------~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~  175 (369)
                      +++++...+ ..++|+||+.+++|.+++.....             +..+++..++.++.||+.||.|||+.+   ++|+
T Consensus        96 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~  172 (316)
T 2xir_A           96 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHR  172 (316)
T ss_dssp             EEEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---CCCS
T ss_pred             EEEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---cccc
Confidence            999987654 48999999999999999865432             223788899999999999999999999   9999


Q ss_pred             CCCCCCEEEeCCCceEEeecCCceecCCCCcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHh-CCCCCC
Q 017594          176 DLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTG  254 (369)
Q Consensus       176 dl~p~NIlv~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~t-g~~p~~  254 (369)
                      ||||+||+++.++.++|+|||++................+++.|+|||++.+..++.++||||||+++|+|++ |..||.
T Consensus       173 dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~  252 (316)
T 2xir_A          173 DLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP  252 (316)
T ss_dssp             CCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred             cCccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCc
Confidence            9999999999999999999999987654433333334567889999999999999999999999999999998 999986


Q ss_pred             CCcccccccchhhhhhhhcCccccccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHhhhhc
Q 017594          255 LYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNEAAT  328 (369)
Q Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L~~~~~~  328 (369)
                      .......     ............     ..     ...+..+.++|.+||+.||.+|||+.++++.|+.+...
T Consensus       253 ~~~~~~~-----~~~~~~~~~~~~-----~~-----~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~  311 (316)
T 2xir_A          253 GVKIDEE-----FCRRLKEGTRMR-----AP-----DYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA  311 (316)
T ss_dssp             TCCCSHH-----HHHHHHHTCCCC-----CC-----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ccchhHH-----HHHHhccCccCC-----CC-----CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhh
Confidence            5432211     111111111000     00     11256699999999999999999999999999988764

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=1.6e-43  Score=322.06  Aligned_cols=274  Identities=23%  Similarity=0.358  Sum_probs=205.9

Q ss_pred             HhcCCccCccccccCCccEEEEEE-----cCCCEEEEEEecCCC-chhHHHHHHHHHHHhcCCCCceeeeeeeEEeC--C
Q 017594           47 ATNKFSDANKLGEGGFGPVYKGVL-----KKGDEIAVKRLSGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCCIDR--D  118 (369)
Q Consensus        47 ~~~~y~i~~~lg~G~~~~v~~~~~-----~~~~~valK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~  118 (369)
                      ..++|++.+.||+|+||.||+|++     .+++.||+|++.... ......+.+|+.+++.++||||+++++++...  .
T Consensus        19 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   98 (302)
T 4e5w_A           19 EKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGN   98 (302)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---C
T ss_pred             hhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCc
Confidence            357799999999999999999983     358899999987442 33457788999999999999999999999876  6


Q ss_pred             ccEEEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCc
Q 017594          119 EKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMA  198 (369)
Q Consensus       119 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~  198 (369)
                      ..++||||+.+++|.+++...  ...+++..++.++.||+.||+|||+.+   ++|+||||+||+++.++.++|+|||++
T Consensus        99 ~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~  173 (302)
T 4e5w_A           99 GIKLIMEFLPSGSLKEYLPKN--KNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLT  173 (302)
T ss_dssp             CEEEEEECCTTCBHHHHHHHH--TTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTC
T ss_pred             eEEEEEEeCCCCcHHHHHHhc--cccCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEECccccc
Confidence            689999999999999998432  234889999999999999999999999   999999999999999999999999999


Q ss_pred             eecCCCCcc-cccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCccc
Q 017594          199 RICGGNELQ-ANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTL  277 (369)
Q Consensus       199 ~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  277 (369)
                      ......... .......++..|+|||++.+..++.++||||||+++|+|++|..|+........................
T Consensus       174 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  253 (302)
T 4e5w_A          174 KAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLV  253 (302)
T ss_dssp             EECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHH
T ss_pred             ccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHH
Confidence            877544322 2233345778899999999999999999999999999999999886422100000000000000000000


Q ss_pred             cccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHhhh
Q 017594          278 ELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNEA  326 (369)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L~~~~  326 (369)
                      ..+...... ..+..++..+.++|.+||+.||++|||+.++++.|+.+.
T Consensus       254 ~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll  301 (302)
T 4e5w_A          254 NTLKEGKRL-PCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL  301 (302)
T ss_dssp             HHHHTTCCC-CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHhccCCC-CCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence            000000000 001122567999999999999999999999999998764

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=1.9e-42  Score=316.76  Aligned_cols=274  Identities=26%  Similarity=0.390  Sum_probs=205.2

Q ss_pred             ccchhhHHHHhcCCccCccccccCCccEEEEEEcC----CCEEEEEEecCC--CchhHHHHHHHHHHHhcCCCCceeeee
Q 017594           38 LFSFSSVSTATNKFSDANKLGEGGFGPVYKGVLKK----GDEIAVKRLSGR--SGQGLREMKNEASVIAKVQHKNLVRLL  111 (369)
Q Consensus        38 ~~~~~~~~~~~~~y~i~~~lg~G~~~~v~~~~~~~----~~~valK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~  111 (369)
                      .-.+..+....++|++.+.||+|+||.||+|....    +..||+|++...  .....+.+.+|+.+++.++||||++++
T Consensus        23 ~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~  102 (313)
T 3brb_A           23 QNKLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLL  102 (313)
T ss_dssp             -CCTTTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCC
T ss_pred             hhhHHhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeee
Confidence            34456666778999999999999999999998542    447999998754  233456788999999999999999999


Q ss_pred             eeEEeCCc-----cEEEEEecCCCChhhhhcCC---CccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEE
Q 017594          112 GCCIDRDE-----KILIYEYMPNKSLDFFLFDP---TKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNIL  183 (369)
Q Consensus       112 ~~~~~~~~-----~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIl  183 (369)
                      +++.....     .++|+||+.+++|.+++...   .....+++..++.++.||+.||.|||+++   ++||||||+||+
T Consensus       103 ~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIl  179 (313)
T 3brb_A          103 GVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCM  179 (313)
T ss_dssp             EEEEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGGEE
T ss_pred             EEEeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEE
Confidence            99986543     49999999999999887432   23355899999999999999999999999   999999999999


Q ss_pred             EeCCCceEEeecCCceecCCCCcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHh-CCCCCCCCcccccc
Q 017594          184 LDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLN  262 (369)
Q Consensus       184 v~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~t-g~~p~~~~~~~~~~  262 (369)
                      ++.++.++|+|||++................+++.|+|||.+.+..++.++||||||+++|+|++ |..||........ 
T Consensus       180 i~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~-  258 (313)
T 3brb_A          180 LRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEM-  258 (313)
T ss_dssp             ECTTSCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH-
T ss_pred             EcCCCcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHH-
Confidence            99999999999999887654332233333456788999999999999999999999999999999 8888864432110 


Q ss_pred             cchhhhhhhhcCccccccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHhhhhccC
Q 017594          263 LLGYAWDLWTSNRTLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNEAATLL  330 (369)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L~~~~~~~~  330 (369)
                          . ..........     ..     ..++..+.++|.+||+.||++|||+.++++.|+.+...++
T Consensus       259 ----~-~~~~~~~~~~-----~~-----~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~lp  311 (313)
T 3brb_A          259 ----Y-DYLLHGHRLK-----QP-----EDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESLP  311 (313)
T ss_dssp             ----H-HHHHTTCCCC-----CB-----TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC-
T ss_pred             ----H-HHHHcCCCCC-----CC-----ccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcC
Confidence                0 1111110000     01     1125679999999999999999999999999999987654

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=9.4e-43  Score=320.65  Aligned_cols=259  Identities=26%  Similarity=0.384  Sum_probs=204.5

Q ss_pred             hcCCccCccccccCCccEEEEEEcC-CCE----EEEEEecCCC-chhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccE
Q 017594           48 TNKFSDANKLGEGGFGPVYKGVLKK-GDE----IAVKRLSGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKI  121 (369)
Q Consensus        48 ~~~y~i~~~lg~G~~~~v~~~~~~~-~~~----valK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  121 (369)
                      .++|++.+.||+|+||.||+|++.. ++.    |++|.+.... ......+.+|+.+++.++||||+++++++. +...+
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~   90 (325)
T 3kex_A           12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQ   90 (325)
T ss_dssp             TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEE
T ss_pred             HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccE
Confidence            4789999999999999999999654 443    7888775332 233356678999999999999999999885 56789


Q ss_pred             EEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceec
Q 017594          122 LIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARIC  201 (369)
Q Consensus       122 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~  201 (369)
                      +|+||+.+++|.+++...  +..+++..++.++.||+.||.|||+.|   ++||||||+||+++.++.++|+|||++...
T Consensus        91 ~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~  165 (325)
T 3kex_A           91 LVTQYLPLGSLLDHVRQH--RGALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLL  165 (325)
T ss_dssp             EEEECCTTCBSHHHHHSS--GGGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSCSGGGGS
T ss_pred             EEEEeCCCCCHHHHHHHc--cccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCCCccccc
Confidence            999999999999988653  345888999999999999999999999   999999999999999999999999999877


Q ss_pred             CCCCcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHh-CCCCCCCCcccccccchhhhhhhhcCcccccc
Q 017594          202 GGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDLWTSNRTLELI  280 (369)
Q Consensus       202 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (369)
                      .............++..|+|||++.+..++.++||||||+++|+|++ |..||.......      ............. 
T Consensus       166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~------~~~~~~~~~~~~~-  238 (325)
T 3kex_A          166 PPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAE------VPDLLEKGERLAQ-  238 (325)
T ss_dssp             CCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTH------HHHHHHTTCBCCC-
T ss_pred             CcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHH------HHHHHHcCCCCCC-
Confidence            55444334444567889999999998999999999999999999999 999987543211      1111111110000 


Q ss_pred             CccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHhhhhc
Q 017594          281 DPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNEAAT  328 (369)
Q Consensus       281 ~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L~~~~~~  328 (369)
                          .     ..++.++.+++.+||+.||++||++.++++.|+.+...
T Consensus       239 ----~-----~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~  277 (325)
T 3kex_A          239 ----P-----QICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARD  277 (325)
T ss_dssp             ----C-----TTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTS
T ss_pred             ----C-----CcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence                0     01144588999999999999999999999999988764

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=3.5e-42  Score=312.11  Aligned_cols=276  Identities=20%  Similarity=0.274  Sum_probs=208.1

Q ss_pred             HHhcCCccCccccccCCccEEEEEE-cCCCEEEEEEecCCCchhHHHHHHHHHHHhcCCCCceeeeeeeE-EeCCccEEE
Q 017594           46 TATNKFSDANKLGEGGFGPVYKGVL-KKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCC-IDRDEKILI  123 (369)
Q Consensus        46 ~~~~~y~i~~~lg~G~~~~v~~~~~-~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~~lv  123 (369)
                      ...++|++.+.||+|+||.||+|++ .+++.||+|++......  ..+..|+.+++.++|++++..+..+ ......++|
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv   83 (296)
T 4hgt_A            6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV   83 (296)
T ss_dssp             -----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C--CCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEE
T ss_pred             ccCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc--hHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEE
Confidence            4568999999999999999999996 45889999987644322  4577899999999987766655554 566778999


Q ss_pred             EEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEE---eCCCceEEeecCCcee
Q 017594          124 YEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILL---DKDMNPKISDFGMARI  200 (369)
Q Consensus       124 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv---~~~~~~~L~Dfg~~~~  200 (369)
                      ||++ +++|.+++...  ...+++..++.++.||+.||.|||+++   ++||||||+||++   +.++.++|+|||++..
T Consensus        84 ~e~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~  157 (296)
T 4hgt_A           84 MELL-GPSLEDLFNFC--SRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK  157 (296)
T ss_dssp             EECC-CCBHHHHHHHT--TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred             EEcc-CCCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEecCcccee
Confidence            9999 89999888532  234899999999999999999999999   9999999999999   7889999999999987


Q ss_pred             cCCCCccc-----ccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccc-hhhhhhhhcC
Q 017594          201 CGGNELQA-----NTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLL-GYAWDLWTSN  274 (369)
Q Consensus       201 ~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~-~~~~~~~~~~  274 (369)
                      ........     ......+++.|+|||++.+..++.++|||||||++|+|++|..||........... ........ .
T Consensus       158 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~-~  236 (296)
T 4hgt_A          158 YRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKM-S  236 (296)
T ss_dssp             CBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHH-H
T ss_pred             ccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccc-c
Confidence            75443211     22345789999999999999999999999999999999999999975432211110 00000000 0


Q ss_pred             ccccccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHhhhhccCCCCCCCccc
Q 017594          275 RTLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNEAATLLPPKQPAFSY  339 (369)
Q Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L~~~~~~~~~~~~~~~~~  339 (369)
                      .....    .     ...++..+.++|.+||+.||++|||+.++++.|+++.........-+.++
T Consensus       237 ~~~~~----~-----~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~~~~~~~~dw  292 (296)
T 4hgt_A          237 TPIEV----L-----CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDW  292 (296)
T ss_dssp             SCHHH----H-----TTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHTCCTTCCCGG
T ss_pred             chhhh----h-----hccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhCCCccCccch
Confidence            00000    0     01125679999999999999999999999999999998877655444443

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=8.3e-43  Score=328.87  Aligned_cols=277  Identities=17%  Similarity=0.228  Sum_probs=206.9

Q ss_pred             HHhcCCccCcccccc--CCccEEEEEEc-CCCEEEEEEecCCC--chhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCcc
Q 017594           46 TATNKFSDANKLGEG--GFGPVYKGVLK-KGDEIAVKRLSGRS--GQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEK  120 (369)
Q Consensus        46 ~~~~~y~i~~~lg~G--~~~~v~~~~~~-~~~~valK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~  120 (369)
                      ...++|++++.||+|  +||.||+|+++ +|+.||+|++....  ......+.+|+.+++.++||||+++++++...+..
T Consensus        22 ~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  101 (389)
T 3gni_B           22 PEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNEL  101 (389)
T ss_dssp             CCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred             CCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEE
Confidence            456899999999999  99999999976 59999999987442  34456788899999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCcee
Q 017594          121 ILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARI  200 (369)
Q Consensus       121 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~  200 (369)
                      ++||||+.+++|.+++.... ...+++..++.++.||+.||.|||+++   ++||||||+||+++.++.++|+|||.+..
T Consensus       102 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~dfg~~~~  177 (389)
T 3gni_B          102 WVVTSFMAYGSAKDLICTHF-MDGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLS  177 (389)
T ss_dssp             EEEEECCTTCBHHHHHHHTC-TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred             EEEEEccCCCCHHHHHhhhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEccccccee
Confidence            99999999999999986532 234899999999999999999999999   99999999999999999999999998765


Q ss_pred             cCCCCc-----ccccccccccccccCchhhcc--CCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhh---
Q 017594          201 CGGNEL-----QANTSRIVGTYGYMSPEYALE--GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDL---  270 (369)
Q Consensus       201 ~~~~~~-----~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~---  270 (369)
                      ......     ........++..|+|||++.+  ..++.++|||||||++|+|++|..||.................   
T Consensus       178 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~  257 (389)
T 3gni_B          178 MISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCL  257 (389)
T ss_dssp             CEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC--------
T ss_pred             eccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCcc
Confidence            432111     111222467888999999987  5789999999999999999999999975432221100000000   


Q ss_pred             h-----hcCc-------------cccccC--------ccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH--H
Q 017594          271 W-----TSNR-------------TLELID--------PILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSM--L  322 (369)
Q Consensus       271 ~-----~~~~-------------~~~~~~--------~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~--L  322 (369)
                      .     ....             ......        ...........++..+.+||.+||+.||++|||+.++++.  +
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f  337 (389)
T 3gni_B          258 LDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFF  337 (389)
T ss_dssp             ------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGG
T ss_pred             ccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHH
Confidence            0     0000             000000        0000001122335679999999999999999999999964  5


Q ss_pred             Hhhh
Q 017594          323 TNEA  326 (369)
Q Consensus       323 ~~~~  326 (369)
                      +.+.
T Consensus       338 ~~~~  341 (389)
T 3gni_B          338 KQIK  341 (389)
T ss_dssp             GGC-
T ss_pred             HHHh
Confidence            4443

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=4.8e-43  Score=325.99  Aligned_cols=255  Identities=22%  Similarity=0.327  Sum_probs=203.2

Q ss_pred             HhcCCccCccccccCCccEEEEEEc-CCCEEEEEEecCC-----CchhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCcc
Q 017594           47 ATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGR-----SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEK  120 (369)
Q Consensus        47 ~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~-----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~  120 (369)
                      +.++|++.+.||+|+||.||+|+++ +|+.||+|++...     .....+.+.+|+.+++.++||||+++++++...+..
T Consensus        22 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  101 (351)
T 3c0i_A           22 FEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGML  101 (351)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred             cccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence            4578999999999999999999975 4899999998532     112357788999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhcCCC-ccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCc---eEEeecC
Q 017594          121 ILIYEYMPNKSLDFFLFDPT-KRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMN---PKISDFG  196 (369)
Q Consensus       121 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~---~~L~Dfg  196 (369)
                      ++||||+.+++|.+.+.... ....+++..++.++.||+.||.|||+++   ++||||||+||+++.++.   ++|+|||
T Consensus       102 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~vkl~Dfg  178 (351)
T 3c0i_A          102 YMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFG  178 (351)
T ss_dssp             EEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCCEEECCCT
T ss_pred             EEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCcEEEecCc
Confidence            99999999999977764321 2335889999999999999999999999   999999999999987655   9999999


Q ss_pred             CceecCCCCcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCcc
Q 017594          197 MARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRT  276 (369)
Q Consensus       197 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  276 (369)
                      ++........  ......|++.|+|||++.+..++.++|||||||++|+|++|..||......      ....... ...
T Consensus       179 ~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~------~~~~i~~-~~~  249 (351)
T 3c0i_A          179 VAIQLGESGL--VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKER------LFEGIIK-GKY  249 (351)
T ss_dssp             TCEECCTTSC--BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHHH------HHHHHHH-TCC
T ss_pred             ceeEecCCCe--eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHHH------HHHHHHc-CCC
Confidence            9987654321  223346899999999999999999999999999999999999998642210      0000000 000


Q ss_pred             ccccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 017594          277 LELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVS  320 (369)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~  320 (369)
                      .  ..+     .....++.++.++|.+||+.||++|||+.++++
T Consensus       250 ~--~~~-----~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~  286 (351)
T 3c0i_A          250 K--MNP-----RQWSHISESAKDLVRRMLMLDPAERITVYEALN  286 (351)
T ss_dssp             C--CCH-----HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             C--CCc-----cccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            0  000     001122567999999999999999999999985

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=2e-42  Score=324.47  Aligned_cols=251  Identities=22%  Similarity=0.333  Sum_probs=202.7

Q ss_pred             HhcCCccCccccccCCccEEEEEEcC-CCEEEEEEecCCC---chhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEE
Q 017594           47 ATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRS---GQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKIL  122 (369)
Q Consensus        47 ~~~~y~i~~~lg~G~~~~v~~~~~~~-~~~valK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l  122 (369)
                      ..++|++++.||+|+||.||+|+.+. ++.||+|++....   ......+.+|+.+++.++||||+++++++...+..++
T Consensus        13 ~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~l   92 (384)
T 4fr4_A           13 NFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFM   92 (384)
T ss_dssp             CGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred             ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence            45789999999999999999999765 8899999986331   2345678899999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecC
Q 017594          123 IYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICG  202 (369)
Q Consensus       123 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~  202 (369)
                      ||||+.+++|..++...   ..+++..++.++.||+.||.|||+.|   ++||||||+||+++.+|.++|+|||++....
T Consensus        93 v~e~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~  166 (384)
T 4fr4_A           93 VVDLLLGGDLRYHLQQN---VHFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLP  166 (384)
T ss_dssp             EECCCTTEEHHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred             EEecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEeccceeeecc
Confidence            99999999999998643   34899999999999999999999999   9999999999999999999999999998764


Q ss_pred             CCCcccccccccccccccCchhhcc---CCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCccccc
Q 017594          203 GNELQANTSRIVGTYGYMSPEYALE---GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLEL  279 (369)
Q Consensus       203 ~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (369)
                      ...   ......|++.|+|||++.+   ..++.++|||||||++|+|++|..||..........  ..... ... ... 
T Consensus       167 ~~~---~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~--~~~~~-~~~-~~~-  238 (384)
T 4fr4_A          167 RET---QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKE--IVHTF-ETT-VVT-  238 (384)
T ss_dssp             TTC---CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHH--HHHHH-HHC-CCC-
T ss_pred             CCC---ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHH--HHHHH-hhc-ccC-
Confidence            332   2334578999999999863   458999999999999999999999996443221110  00000 000 000 


Q ss_pred             cCccccccccHHHHHHHHHHHHHHhhcCCCCCCCC-HHHHHH
Q 017594          280 IDPILEDEYSSKQMLLRYANIALLCVQESADDRPT-MNDVVS  320 (369)
Q Consensus       280 ~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps-~~ell~  320 (369)
                          .     +..++..+.+||.+||+.||.+||+ +.++++
T Consensus       239 ----~-----p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~  271 (384)
T 4fr4_A          239 ----Y-----PSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN  271 (384)
T ss_dssp             ----C-----CTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred             ----C-----CCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence                0     1112567999999999999999998 777764

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=5.6e-42  Score=310.89  Aligned_cols=276  Identities=21%  Similarity=0.278  Sum_probs=214.4

Q ss_pred             HhcCCccCccccccCCccEEEEEE-cCCCEEEEEEecCCCchhHHHHHHHHHHHhcCCCCceeeeeeeE-EeCCccEEEE
Q 017594           47 ATNKFSDANKLGEGGFGPVYKGVL-KKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCC-IDRDEKILIY  124 (369)
Q Consensus        47 ~~~~y~i~~~lg~G~~~~v~~~~~-~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~~lv~  124 (369)
                      ..++|++.+.||+|+||.||+|++ .+|+.||+|++......  ..+..|+.+++.++|++++..+..+ ......++||
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~   84 (296)
T 3uzp_A            7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM   84 (296)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC--CHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred             eccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch--hHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEE
Confidence            468999999999999999999996 45889999998755432  4688899999999988766555554 5567789999


Q ss_pred             EecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEE---eCCCceEEeecCCceec
Q 017594          125 EYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILL---DKDMNPKISDFGMARIC  201 (369)
Q Consensus       125 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv---~~~~~~~L~Dfg~~~~~  201 (369)
                      ||+ +++|.+++...  ...+++..++.++.||+.||.|||+++   ++||||||+||++   +.++.++|+|||++...
T Consensus        85 e~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~  158 (296)
T 3uzp_A           85 ELL-GPSLEDLFNFC--SRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY  158 (296)
T ss_dssp             ECC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred             Eec-CCCHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEeeCCCcccc
Confidence            999 88999988532  234899999999999999999999999   9999999999999   48889999999999876


Q ss_pred             CCCCccc-----ccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCccccccc-chhhhhhhhcCc
Q 017594          202 GGNELQA-----NTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNL-LGYAWDLWTSNR  275 (369)
Q Consensus       202 ~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~-~~~~~~~~~~~~  275 (369)
                      .......     ......+++.|+|||++.+..++.++||||||+++|+|++|+.||.......... ........... 
T Consensus       159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-  237 (296)
T 3uzp_A          159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST-  237 (296)
T ss_dssp             BCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHS-
T ss_pred             cccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCC-
Confidence            5443211     1234568999999999999999999999999999999999999997543221110 00000000000 


Q ss_pred             cccccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHhhhhccCCCCCCCcccc
Q 017594          276 TLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNEAATLLPPKQPAFSYV  340 (369)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L~~~~~~~~~~~~~~~~~~  340 (369)
                      ...    .+     ...++.++.+++.+||+.||++|||+.++++.|+.+..........+.+|.
T Consensus       238 ~~~----~~-----~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~~~~~~~dw~  293 (296)
T 3uzp_A          238 PIE----VL-----CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWN  293 (296)
T ss_dssp             CHH----HH-----TTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTCCSSCCCGGG
T ss_pred             chH----HH-----HhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCCccccccccc
Confidence            000    00     011256799999999999999999999999999999998877766666654

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=2.2e-42  Score=325.04  Aligned_cols=254  Identities=22%  Similarity=0.269  Sum_probs=206.8

Q ss_pred             HhcCCccCccccccCCccEEEEEEc-CCCEEEEEEecCCCchhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEEEE
Q 017594           47 ATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIYE  125 (369)
Q Consensus        47 ~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  125 (369)
                      ..++|++.+.||+|+||.||+|.++ +|+.||+|++..........+.+|+.+++.++||||+++++++.+....++|||
T Consensus        49 ~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E  128 (387)
T 1kob_A           49 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILE  128 (387)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEE
T ss_pred             cccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEE
Confidence            4578999999999999999999976 488999999987665556778899999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeC--CCceEEeecCCceecCC
Q 017594          126 YMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDK--DMNPKISDFGMARICGG  203 (369)
Q Consensus       126 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~--~~~~~L~Dfg~~~~~~~  203 (369)
                      |+.+++|.+++...  ...+++..++.++.||+.||.|||++|   ++||||||+||+++.  ++.++|+|||++.....
T Consensus       129 ~~~gg~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~  203 (387)
T 1kob_A          129 FLSGGELFDRIAAE--DYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNP  203 (387)
T ss_dssp             CCCCCBHHHHTTCT--TCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCT
T ss_pred             cCCCCcHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEecccceecCC
Confidence            99999999888543  234899999999999999999999999   999999999999974  47799999999987654


Q ss_pred             CCcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCccccccCcc
Q 017594          204 NELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPI  283 (369)
Q Consensus       204 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (369)
                      ...   .....+++.|+|||++.+..++.++|||||||++|+|++|..||.......     ......... . .. ...
T Consensus       204 ~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~-----~~~~i~~~~-~-~~-~~~  272 (387)
T 1kob_A          204 DEI---VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE-----TLQNVKRCD-W-EF-DED  272 (387)
T ss_dssp             TSC---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH-----HHHHHHHCC-C-CC-CSS
T ss_pred             Ccc---eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHH-----HHHHHHhCC-C-CC-Ccc
Confidence            322   223468999999999999999999999999999999999999997533111     011110000 0 00 000


Q ss_pred             ccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 017594          284 LEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSM  321 (369)
Q Consensus       284 ~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~  321 (369)
                      .     ...++.++.++|.+||+.||++|||+.++++.
T Consensus       273 ~-----~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h  305 (387)
T 1kob_A          273 A-----FSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH  305 (387)
T ss_dssp             T-----TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             c-----cccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence            0     01125679999999999999999999999973

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=7.1e-43  Score=326.74  Aligned_cols=263  Identities=30%  Similarity=0.404  Sum_probs=209.1

Q ss_pred             HhcCCccCccccccCCccEEEEEEc------CCCEEEEEEecCC-CchhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCc
Q 017594           47 ATNKFSDANKLGEGGFGPVYKGVLK------KGDEIAVKRLSGR-SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDE  119 (369)
Q Consensus        47 ~~~~y~i~~~lg~G~~~~v~~~~~~------~~~~valK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~  119 (369)
                      ..++|++.+.||+|+||.||+|++.      ++..||+|++... .......+..|+.+++.++||||+++++++.....
T Consensus        69 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  148 (367)
T 3l9p_A           69 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP  148 (367)
T ss_dssp             CGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             CHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC
Confidence            4578999999999999999999943      3668999998644 33445568889999999999999999999999999


Q ss_pred             cEEEEEecCCCChhhhhcCCC----ccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCC---ceEE
Q 017594          120 KILIYEYMPNKSLDFFLFDPT----KRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDM---NPKI  192 (369)
Q Consensus       120 ~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~---~~~L  192 (369)
                      .++||||+.+++|.+++....    ....+++..++.++.||+.||.|||++|   ++||||||+||+++.++   .++|
T Consensus       149 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kL  225 (367)
T 3l9p_A          149 RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKI  225 (367)
T ss_dssp             CEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEE
T ss_pred             CEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCceEEE
Confidence            999999999999999886432    1244888999999999999999999999   99999999999998555   4999


Q ss_pred             eecCCceecCCCCcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHh-CCCCCCCCcccccccchhhhhhh
Q 017594          193 SDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDLW  271 (369)
Q Consensus       193 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~  271 (369)
                      +|||++................+++.|+|||++.+..++.++|||||||++|+|++ |..||.......     .. ...
T Consensus       226 ~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~-----~~-~~i  299 (367)
T 3l9p_A          226 GDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE-----VL-EFV  299 (367)
T ss_dssp             CCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH-----HH-HHH
T ss_pred             CCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH-----HH-HHH
Confidence            99999875533222223333467889999999999999999999999999999998 999986443111     01 111


Q ss_pred             hcCccccccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHhhhhc
Q 017594          272 TSNRTLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNEAAT  328 (369)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L~~~~~~  328 (369)
                      .......     .     +..++..+.+++.+||+.||++|||+.+|++.|+.+...
T Consensus       300 ~~~~~~~-----~-----~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~  346 (367)
T 3l9p_A          300 TSGGRMD-----P-----PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD  346 (367)
T ss_dssp             HTTCCCC-----C-----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             HcCCCCC-----C-----CccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhC
Confidence            1110000     0     111256689999999999999999999999999888764

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=1.3e-42  Score=325.51  Aligned_cols=261  Identities=29%  Similarity=0.428  Sum_probs=199.0

Q ss_pred             HhcCCccCccccccCCccEEEEEEc----CCCEEEEEEecCC-CchhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccE
Q 017594           47 ATNKFSDANKLGEGGFGPVYKGVLK----KGDEIAVKRLSGR-SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKI  121 (369)
Q Consensus        47 ~~~~y~i~~~lg~G~~~~v~~~~~~----~~~~valK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  121 (369)
                      ...+|++.+.||+|+||.||+|+.+    ++..||+|++... .....+.+.+|+.++.+++||||+++++++......+
T Consensus        43 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  122 (373)
T 2qol_A           43 DATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVM  122 (373)
T ss_dssp             CGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCE
T ss_pred             CHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceE
Confidence            4568999999999999999999965    4778999999754 3344567889999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceec
Q 017594          122 LIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARIC  201 (369)
Q Consensus       122 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~  201 (369)
                      +||||+++++|.+++...  ...+++..++.++.||+.||.|||+.+   ++||||||+||+++.++.++|+|||++...
T Consensus       123 lv~e~~~~~sL~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  197 (373)
T 2qol_A          123 IVTEYMENGSLDSFLRKH--DAQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVL  197 (373)
T ss_dssp             EEEECCTTCBHHHHHHTT--TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC------
T ss_pred             EEEeCCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCcccccc
Confidence            999999999999998643  234889999999999999999999999   999999999999999999999999998876


Q ss_pred             CCCCccc-ccccccccccccCchhhccCCCCcccchHhHHHHHHHHHh-CCCCCCCCcccccccchhhhhhhhcCccccc
Q 017594          202 GGNELQA-NTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDLWTSNRTLEL  279 (369)
Q Consensus       202 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (369)
                      ....... ......++..|+|||++.+..++.++||||||+++|+|++ |..||.......     .... ......   
T Consensus       198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~-----~~~~-i~~~~~---  268 (373)
T 2qol_A          198 EDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD-----VIKA-VDEGYR---  268 (373)
T ss_dssp             ----------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHH-----HHHH-HHTTEE---
T ss_pred             ccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH-----HHHH-HHcCCC---
Confidence            5332111 1112234678999999999999999999999999999998 999986433111     0000 000000   


Q ss_pred             cCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHhhhhc
Q 017594          280 IDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNEAAT  328 (369)
Q Consensus       280 ~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L~~~~~~  328 (369)
                        ..     .+..++..+.+++.+||+.||++||++.++++.|+.+...
T Consensus       269 --~~-----~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~  310 (373)
T 2qol_A          269 --LP-----PPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN  310 (373)
T ss_dssp             --CC-----CCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             --CC-----CCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhC
Confidence              00     0111256799999999999999999999999999998764

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=4e-43  Score=325.55  Aligned_cols=255  Identities=24%  Similarity=0.313  Sum_probs=196.6

Q ss_pred             HHHhcCCccCccccccCCccEEEEEEcCCCEEEEEEecCCC--chhHHHHHHHHHHHhcCCC--CceeeeeeeEEeCCcc
Q 017594           45 STATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRS--GQGLREMKNEASVIAKVQH--KNLVRLLGCCIDRDEK  120 (369)
Q Consensus        45 ~~~~~~y~i~~~lg~G~~~~v~~~~~~~~~~valK~~~~~~--~~~~~~~~~e~~~l~~l~h--~~i~~~~~~~~~~~~~  120 (369)
                      ....++|++.+.||+|+||.||+|.+.+++.||+|++....  ......+.+|+.++..++|  +||+++++++...+..
T Consensus         5 ~~~~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~   84 (343)
T 3dbq_A            5 SVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYI   84 (343)
T ss_dssp             ESSSCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred             eeecCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEE
Confidence            44578899999999999999999998889999999987443  3345678899999999976  9999999999999999


Q ss_pred             EEEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCcee
Q 017594          121 ILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARI  200 (369)
Q Consensus       121 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~  200 (369)
                      ++||| +.+++|.+++..   ...+++..++.++.||+.||.|||+.+   ++||||||+||+++ ++.++|+|||++..
T Consensus        85 ~lv~e-~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~DFG~a~~  156 (343)
T 3dbq_A           85 YMVME-CGNIDLNSWLKK---KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQ  156 (343)
T ss_dssp             EEEEC-CCSEEHHHHHHH---SCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSSSCC
T ss_pred             EEEEe-CCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEeecccccc
Confidence            99999 567899888854   345889999999999999999999999   99999999999997 67899999999987


Q ss_pred             cCCCCcccccccccccccccCchhhcc-----------CCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhh
Q 017594          201 CGGNELQANTSRIVGTYGYMSPEYALE-----------GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWD  269 (369)
Q Consensus       201 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-----------~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~  269 (369)
                      ..............|++.|+|||++.+           ..++.++|||||||++|+|++|..||........    ....
T Consensus       157 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~----~~~~  232 (343)
T 3dbq_A          157 MQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS----KLHA  232 (343)
T ss_dssp             C------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHH----HHHH
T ss_pred             cCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHH----HHHH
Confidence            654433333344578999999999864           6788999999999999999999999964321110    0011


Q ss_pred             hhhcCccccccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 017594          270 LWTSNRTLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSM  321 (369)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~  321 (369)
                      ....... ..    ....     .+..+.++|.+||+.||.+|||+.++++.
T Consensus       233 ~~~~~~~-~~----~~~~-----~~~~l~~li~~~L~~dp~~Rpt~~e~l~h  274 (343)
T 3dbq_A          233 IIDPNHE-IE----FPDI-----PEKDLQDVLKCCLKRDPKQRISIPELLAH  274 (343)
T ss_dssp             HHCTTSC-CC----CCCC-----SCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             HhcCCcc-cC----Cccc-----CCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence            1100000 00    0000     14568999999999999999999999864

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=5.1e-43  Score=316.73  Aligned_cols=257  Identities=24%  Similarity=0.392  Sum_probs=203.1

Q ss_pred             HhcCCccCccccccCCccEEEEEEcC-C-------CEEEEEEecCCCchhHHHHHHHHHHHhcCCCCceeeeeeeEEeCC
Q 017594           47 ATNKFSDANKLGEGGFGPVYKGVLKK-G-------DEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDRD  118 (369)
Q Consensus        47 ~~~~y~i~~~lg~G~~~~v~~~~~~~-~-------~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~  118 (369)
                      ..++|++.+.||+|+||.||+|+++. +       ..|++|++........+.+.+|+.+++.++||||+++++++...+
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   85 (289)
T 4fvq_A            6 RNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGD   85 (289)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTT
T ss_pred             chhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCC
Confidence            35789999999999999999999654 3       469999997666666788999999999999999999999999999


Q ss_pred             ccEEEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCc--------e
Q 017594          119 EKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMN--------P  190 (369)
Q Consensus       119 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~--------~  190 (369)
                      ..++||||+.+++|.+++...  ...+++..++.++.||+.||.|||+++   ++||||||+||+++.++.        +
T Consensus        86 ~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~  160 (289)
T 4fvq_A           86 ENILVQEFVKFGSLDTYLKKN--KNCINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFI  160 (289)
T ss_dssp             CCEEEEECCTTCBHHHHHHHT--GGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGTBCCEE
T ss_pred             CCEEEEECCCCCCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCccccccccee
Confidence            999999999999999998643  234889999999999999999999999   999999999999998887        9


Q ss_pred             EEeecCCceecCCCCcccccccccccccccCchhhcc-CCCCcccchHhHHHHHHHHHhCCC-CCCCCcccccccchhhh
Q 017594          191 KISDFGMARICGGNELQANTSRIVGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGKK-NTGLYRTDSLNLLGYAW  268 (369)
Q Consensus       191 ~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~tg~~-p~~~~~~~~~~~~~~~~  268 (369)
                      +|+|||++.....      .....++..|+|||++.+ ..++.++||||||+++|+|++|.. ||.......      ..
T Consensus       161 kl~Dfg~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~------~~  228 (289)
T 4fvq_A          161 KLSDPGISITVLP------KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQR------KL  228 (289)
T ss_dssp             EECCCCSCTTTSC------HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH------HH
T ss_pred             eeccCcccccccC------ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHH------HH
Confidence            9999999764422      123357888999999887 678999999999999999999654 443221110      00


Q ss_pred             hhhhcCccccccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHhhhhccCCC
Q 017594          269 DLWTSNRTLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNEAATLLPP  332 (369)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L~~~~~~~~~~  332 (369)
                      ......  . .+...         .+.++.++|.+||+.||++|||+.++++.|+.+......+
T Consensus       229 ~~~~~~--~-~~~~~---------~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~~~~  280 (289)
T 4fvq_A          229 QFYEDR--H-QLPAP---------KAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDLVP  280 (289)
T ss_dssp             HHHHTT--C-CCCCC---------SSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC------
T ss_pred             HHhhcc--C-CCCCC---------CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCCC
Confidence            000000  0 00000         1345889999999999999999999999999888754433

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=4.3e-43  Score=327.96  Aligned_cols=286  Identities=16%  Similarity=0.152  Sum_probs=213.3

Q ss_pred             HHhcCCccCccccccCCccEEEEEEcC------CCEEEEEEecCCCchhH-----------HHHHHHHHHHhcCCCCcee
Q 017594           46 TATNKFSDANKLGEGGFGPVYKGVLKK------GDEIAVKRLSGRSGQGL-----------REMKNEASVIAKVQHKNLV  108 (369)
Q Consensus        46 ~~~~~y~i~~~lg~G~~~~v~~~~~~~------~~~valK~~~~~~~~~~-----------~~~~~e~~~l~~l~h~~i~  108 (369)
                      ...++|++.+.||+|+||.||+|.++.      ++.||+|++........           .....|+..+..++||||+
T Consensus        32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv  111 (364)
T 3op5_A           32 MAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVP  111 (364)
T ss_dssp             TTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSC
T ss_pred             cCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCC
Confidence            345699999999999999999999764      47899999875542111           1122355567778899999


Q ss_pred             eeeeeEEeC----CccEEEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEE
Q 017594          109 RLLGCCIDR----DEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILL  184 (369)
Q Consensus       109 ~~~~~~~~~----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv  184 (369)
                      ++++++...    ...++||||+ +++|.+++...  ...+++..++.++.||+.||.|||+++   ++||||||+||++
T Consensus       112 ~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~--~~~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~Nill  185 (364)
T 3op5_A          112 KYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEAN--AKRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLL  185 (364)
T ss_dssp             CEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHT--TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEE
T ss_pred             eEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHHHEEE
Confidence            999998765    3479999999 99999988643  245899999999999999999999999   9999999999999


Q ss_pred             e--CCCceEEeecCCceecCCCCccc-----ccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCc
Q 017594          185 D--KDMNPKISDFGMARICGGNELQA-----NTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYR  257 (369)
Q Consensus       185 ~--~~~~~~L~Dfg~~~~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~  257 (369)
                      +  .++.++|+|||++..+.......     ......|++.|+|||++.+..++.++|||||||++|+|++|..||....
T Consensus       186 ~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~  265 (364)
T 3op5_A          186 NYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNL  265 (364)
T ss_dssp             ESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGT
T ss_pred             ecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccc
Confidence            9  88999999999998765332111     1123458999999999999999999999999999999999999997432


Q ss_pred             ccccccchhhhhhhhcCccccccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHhhhhccCCCCCCCc
Q 017594          258 TDSLNLLGYAWDLWTSNRTLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNEAATLLPPKQPAF  337 (369)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L~~~~~~~~~~~~~~~  337 (369)
                      .+... ....... ........++..+.    ...++.++.+++..||+.+|++||++.+|++.|+.+............
T Consensus       266 ~~~~~-~~~~~~~-~~~~~~~~~~~~~~----~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~~  339 (364)
T 3op5_A          266 KDPKY-VRDSKIR-YRENIASLMDKCFP----AANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGSKDDGKL  339 (364)
T ss_dssp             TCHHH-HHHHHHH-HHHCHHHHHHHHSC----TTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCCCCCC
T ss_pred             cCHHH-HHHHHHH-hhhhHHHHHHHhcc----cccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCcCCcc
Confidence            21110 0000000 00111111111111    111256799999999999999999999999999999998887777777


Q ss_pred             cccccc
Q 017594          338 SYVRNT  343 (369)
Q Consensus       338 ~~~~~~  343 (369)
                      ++....
T Consensus       340 dw~~~~  345 (364)
T 3op5_A          340 DLSVVE  345 (364)
T ss_dssp             CC----
T ss_pred             ceEecc
Confidence            766444

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=7.4e-43  Score=320.66  Aligned_cols=270  Identities=27%  Similarity=0.406  Sum_probs=214.8

Q ss_pred             cchhhHHHHhcCCccCccccccCCccEEEEEEc------CCCEEEEEEecCCC-chhHHHHHHHHHHHhcCCCCceeeee
Q 017594           39 FSFSSVSTATNKFSDANKLGEGGFGPVYKGVLK------KGDEIAVKRLSGRS-GQGLREMKNEASVIAKVQHKNLVRLL  111 (369)
Q Consensus        39 ~~~~~~~~~~~~y~i~~~lg~G~~~~v~~~~~~------~~~~valK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~  111 (369)
                      +.........++|++.+.||+|+||.||+|++.      ++..||+|.+.... ......+.+|+.+++.++||||++++
T Consensus        15 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~   94 (322)
T 1p4o_A           15 YVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLL   94 (322)
T ss_dssp             CCCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEE
T ss_pred             cChhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeE
Confidence            444555667899999999999999999999854      36789999997543 23345678899999999999999999


Q ss_pred             eeEEeCCccEEEEEecCCCChhhhhcCCCc-------cccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEE
Q 017594          112 GCCIDRDEKILIYEYMPNKSLDFFLFDPTK-------RMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILL  184 (369)
Q Consensus       112 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-------~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv  184 (369)
                      +++...+..++||||+.+++|.+++.....       ...+++..++.++.||+.||.|||++|   ++||||||+||++
T Consensus        95 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NIli  171 (322)
T 1p4o_A           95 GVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMV  171 (322)
T ss_dssp             EEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEE
T ss_pred             EEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccceEEE
Confidence            999999999999999999999998854211       134688999999999999999999999   9999999999999


Q ss_pred             eCCCceEEeecCCceecCCCCcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHh-CCCCCCCCccccccc
Q 017594          185 DKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNL  263 (369)
Q Consensus       185 ~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~t-g~~p~~~~~~~~~~~  263 (369)
                      +.++.++|+|||++................+++.|+|||++.+..++.++||||||+++|+|++ |..||.......   
T Consensus       172 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---  248 (322)
T 1p4o_A          172 AEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ---  248 (322)
T ss_dssp             CTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHH---
T ss_pred             cCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHH---
Confidence            9999999999999876543332222333456788999999998899999999999999999999 888886433111   


Q ss_pred             chhhhhhhhcCccccccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHhhhh
Q 017594          264 LGYAWDLWTSNRTLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNEAA  327 (369)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L~~~~~  327 (369)
                         .............          +..++..+.++|.+||+.||++|||+.++++.|+.+..
T Consensus       249 ---~~~~~~~~~~~~~----------~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~  299 (322)
T 1p4o_A          249 ---VLRFVMEGGLLDK----------PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME  299 (322)
T ss_dssp             ---HHHHHHTTCCCCC----------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred             ---HHHHHHcCCcCCC----------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence               0111111111100          11125669999999999999999999999999988755

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=4e-43  Score=326.34  Aligned_cols=250  Identities=24%  Similarity=0.352  Sum_probs=198.5

Q ss_pred             HHhcCCccCccccccCCccEEEEEEcC-CCEEEEEEecCC---CchhHHHHHHHHHHHhcC-CCCceeeeeeeEEeCCcc
Q 017594           46 TATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGR---SGQGLREMKNEASVIAKV-QHKNLVRLLGCCIDRDEK  120 (369)
Q Consensus        46 ~~~~~y~i~~~lg~G~~~~v~~~~~~~-~~~valK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~  120 (369)
                      ...++|++++.||+|+||.||+|+.+. |+.||+|++...   .......+..|..++..+ +||||+++++++...+..
T Consensus        20 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~   99 (353)
T 3txo_A           20 LGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRL   99 (353)
T ss_dssp             ---CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred             CchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEE
Confidence            345789999999999999999999764 899999998643   223456677899999988 699999999999999999


Q ss_pred             EEEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCcee
Q 017594          121 ILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARI  200 (369)
Q Consensus       121 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~  200 (369)
                      |+||||+.+++|..++..   ...+++..++.++.||+.||+|||++|   ++||||||+||+++.++.++|+|||++..
T Consensus       100 ~lv~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~DFG~a~~  173 (353)
T 3txo_A          100 FFVMEFVNGGDLMFHIQK---SRRFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKE  173 (353)
T ss_dssp             EEEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred             EEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEccccceee
Confidence            999999999999988854   344899999999999999999999999   99999999999999999999999999875


Q ss_pred             cCCCCcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCcccccc
Q 017594          201 CGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELI  280 (369)
Q Consensus       201 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (369)
                      .....  .......|++.|+|||++.+..++.++|+|||||++|+|++|..||.......     ......... .    
T Consensus       174 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~-----~~~~i~~~~-~----  241 (353)
T 3txo_A          174 GICNG--VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDD-----LFEAILNDE-V----  241 (353)
T ss_dssp             SCC-----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-----HHHHHHHCC-C----
T ss_pred             cccCC--ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHH-----HHHHHHcCC-C----
Confidence            33221  22334578999999999998899999999999999999999999996443211     111111110 0    


Q ss_pred             CccccccccHHHHHHHHHHHHHHhhcCCCCCCCCH------HHHHH
Q 017594          281 DPILEDEYSSKQMLLRYANIALLCVQESADDRPTM------NDVVS  320 (369)
Q Consensus       281 ~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~------~ell~  320 (369)
                        ..     +...+.++.++|.+||+.||++||++      .++++
T Consensus       242 --~~-----p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~  280 (353)
T 3txo_A          242 --VY-----PTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR  280 (353)
T ss_dssp             --CC-----CTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred             --CC-----CCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence              00     11125668999999999999999998      77775

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=2.5e-42  Score=330.08  Aligned_cols=257  Identities=21%  Similarity=0.300  Sum_probs=204.7

Q ss_pred             HHHHhcCCccCccccccCCccEEEEEEc-CCCEEEEEEecCCC--chhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCcc
Q 017594           44 VSTATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS--GQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEK  120 (369)
Q Consensus        44 ~~~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~  120 (369)
                      ...+.++|++.+.||+|+||.||+|.+. +|+.+|+|++....  ....+.+.+|+.+++.++||||+++++++.+.+..
T Consensus         6 ~~~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~   85 (444)
T 3soa_A            6 CTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHH   85 (444)
T ss_dssp             -CHHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEE
T ss_pred             cccccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEE
Confidence            3456789999999999999999999965 48899999987553  23456788999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEe---CCCceEEeecCC
Q 017594          121 ILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLD---KDMNPKISDFGM  197 (369)
Q Consensus       121 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~---~~~~~~L~Dfg~  197 (369)
                      ++||||+.+++|.+.+...   ..+++..+..++.||+.||.|||++|   ++||||||+||+++   .++.++|+|||+
T Consensus        86 ~lv~E~~~gg~L~~~i~~~---~~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~DFG~  159 (444)
T 3soa_A           86 YLIFDLVTGGELFEDIVAR---EYYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGL  159 (444)
T ss_dssp             EEEECCCBCCBHHHHHHHC---SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEECCCSS
T ss_pred             EEEEEeCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEccCce
Confidence            9999999999998888543   44899999999999999999999999   99999999999998   467899999999


Q ss_pred             ceecCCCCcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCccc
Q 017594          198 ARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTL  277 (369)
Q Consensus       198 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  277 (369)
                      +........  ......|++.|+|||++.+..++.++|||||||++|+|++|.+||.......     ..... ..... 
T Consensus       160 a~~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~-----~~~~i-~~~~~-  230 (444)
T 3soa_A          160 AIEVEGEQQ--AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHR-----LYQQI-KAGAY-  230 (444)
T ss_dssp             CBCCCTTCC--BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-----HHHHH-HHTCC-
T ss_pred             eEEecCCCc--eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHH-----HHHHH-HhCCC-
Confidence            976653321  2233578999999999999899999999999999999999999986433111     00111 11000 


Q ss_pred             cccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 017594          278 ELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSM  321 (369)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~  321 (369)
                      ....+.      ...++.++.+||.+||+.||++|||+.++++.
T Consensus       231 ~~~~~~------~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~h  268 (444)
T 3soa_A          231 DFPSPE------WDTVTPEAKDLINKMLTINPSKRITAAEALKH  268 (444)
T ss_dssp             CCCTTT------TTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             CCCccc------cccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence            000000      01125679999999999999999999999973

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=1.7e-42  Score=317.70  Aligned_cols=245  Identities=24%  Similarity=0.308  Sum_probs=202.8

Q ss_pred             hcCCccCccccccCCccEEEEEEc-CCCEEEEEEecCCC---chhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEE
Q 017594           48 TNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS---GQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILI  123 (369)
Q Consensus        48 ~~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv  123 (369)
                      .++|++.+.||+|+||.||+|+.+ +|+.||+|++....   ....+.+.+|..+++.++||||+++++++.+.+..++|
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv   84 (318)
T 1fot_A            5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI   84 (318)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence            468999999999999999999976 58999999986431   23356778899999999999999999999999999999


Q ss_pred             EEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCC
Q 017594          124 YEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGG  203 (369)
Q Consensus       124 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~  203 (369)
                      |||+.+++|.+++...   ..+++..++.++.||+.||.|||++|   ++||||||+||+++.+|.++|+|||++.....
T Consensus        85 ~e~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~  158 (318)
T 1fot_A           85 MDYIEGGELFSLLRKS---QRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPD  158 (318)
T ss_dssp             ECCCCSCBHHHHHHHT---SSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred             EeCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecCcceecCC
Confidence            9999999999998543   34899999999999999999999999   99999999999999999999999999986543


Q ss_pred             CCcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCccccccCcc
Q 017594          204 NELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPI  283 (369)
Q Consensus       204 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (369)
                      .     .....|++.|+|||++.+..++.++|+|||||++|+|++|..||.......     ......... . .     
T Consensus       159 ~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-----~~~~i~~~~-~-~-----  221 (318)
T 1fot_A          159 V-----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMK-----TYEKILNAE-L-R-----  221 (318)
T ss_dssp             C-----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH-----HHHHHHHCC-C-C-----
T ss_pred             c-----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH-----HHHHHHhCC-C-C-----
Confidence            2     233578999999999999999999999999999999999999986432111     111111110 0 0     


Q ss_pred             ccccccHHHHHHHHHHHHHHhhcCCCCCCC-----CHHHHHH
Q 017594          284 LEDEYSSKQMLLRYANIALLCVQESADDRP-----TMNDVVS  320 (369)
Q Consensus       284 ~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp-----s~~ell~  320 (369)
                      +.     ..++.++.++|.+||+.||++||     ++.++++
T Consensus       222 ~p-----~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~  258 (318)
T 1fot_A          222 FP-----PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN  258 (318)
T ss_dssp             CC-----TTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred             CC-----CCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence            00     11256799999999999999999     8999985

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=1.7e-42  Score=319.20  Aligned_cols=259  Identities=28%  Similarity=0.440  Sum_probs=201.6

Q ss_pred             hcCCccCccccccCCccEEEEEEcC-CCE----EEEEEecCC-CchhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccE
Q 017594           48 TNKFSDANKLGEGGFGPVYKGVLKK-GDE----IAVKRLSGR-SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKI  121 (369)
Q Consensus        48 ~~~y~i~~~lg~G~~~~v~~~~~~~-~~~----valK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  121 (369)
                      .++|++.+.||+|+||.||+|++.. ++.    |++|.+... .......+.+|+.+++.++||||+++++++... ..+
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~   92 (327)
T 3poz_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ   92 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS-SEE
T ss_pred             HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC-CeE
Confidence            5789999999999999999999643 443    588887533 234457788999999999999999999999764 578


Q ss_pred             EEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceec
Q 017594          122 LIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARIC  201 (369)
Q Consensus       122 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~  201 (369)
                      ++++++.+++|.+++....  ..+++..++.++.||+.||.|||+.+   ++||||||+||+++.++.++|+|||++...
T Consensus        93 ~v~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~  167 (327)
T 3poz_A           93 LITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL  167 (327)
T ss_dssp             EEEECCTTCBHHHHHHHST--TSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTHHHHH
T ss_pred             EEEEecCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccCcceeEc
Confidence            9999999999999886432  34889999999999999999999999   999999999999999999999999999877


Q ss_pred             CCCCcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHh-CCCCCCCCcccccccchhhhhhhhcCcccccc
Q 017594          202 GGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDLWTSNRTLELI  280 (369)
Q Consensus       202 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (369)
                      .............++..|+|||++.+..++.++|||||||++|+|++ |..||........      ...........  
T Consensus       168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~------~~~~~~~~~~~--  239 (327)
T 3poz_A          168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI------SSILEKGERLP--  239 (327)
T ss_dssp             TTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH------HHHHHTTCCCC--
T ss_pred             cCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHH------HHHHHcCCCCC--
Confidence            55443333344456789999999999999999999999999999999 9999864432111      11111110000  


Q ss_pred             CccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHhhhhc
Q 017594          281 DPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNEAAT  328 (369)
Q Consensus       281 ~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L~~~~~~  328 (369)
                         .     +..++.++.+++.+||+.||++||++.++++.|+.+...
T Consensus       240 ---~-----~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~  279 (327)
T 3poz_A          240 ---Q-----PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD  279 (327)
T ss_dssp             ---C-----CTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTS
T ss_pred             ---C-----CccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhh
Confidence               0     111255689999999999999999999999999988763

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=1.7e-42  Score=309.68  Aligned_cols=258  Identities=28%  Similarity=0.409  Sum_probs=210.5

Q ss_pred             hcCCccCccccccCCccEEEEEEcCCCEEEEEEecCCCchhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEEEEec
Q 017594           48 TNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIYEYM  127 (369)
Q Consensus        48 ~~~y~i~~~lg~G~~~~v~~~~~~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~  127 (369)
                      .++|++.+.||+|+||.||+|.+.+++.|++|++..... ..+.+.+|+.+++.++||||+++++++...+..+++||++
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   85 (267)
T 3t9t_A            7 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFM   85 (267)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCC
T ss_pred             hhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCC
Confidence            578999999999999999999998888999999976543 3467889999999999999999999999999999999999


Q ss_pred             CCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCCCCcc
Q 017594          128 PNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQ  207 (369)
Q Consensus       128 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~~~~~  207 (369)
                      ++++|.+++...  ...+++..++.++.|++.||.+||+.+   ++|+||+|+||+++.++.++|+|||++........ 
T Consensus        86 ~~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~-  159 (267)
T 3t9t_A           86 EHGCLSDYLRTQ--RGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-  159 (267)
T ss_dssp             TTCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHH-
T ss_pred             CCCcHHHHHhhC--cccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEcccccccccccccc-
Confidence            999999998543  234789999999999999999999999   99999999999999999999999999876543211 


Q ss_pred             cccccccccccccCchhhccCCCCcccchHhHHHHHHHHHh-CCCCCCCCcccccccchhhhhhhhcCccccccCccccc
Q 017594          208 ANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILED  286 (369)
Q Consensus       208 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  286 (369)
                      .......++..|+|||++.+..++.++||||||+++|+|++ |..||.......     ....... . .    ..... 
T Consensus       160 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~-----~~~~i~~-~-~----~~~~~-  227 (267)
T 3t9t_A          160 TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE-----VVEDIST-G-F----RLYKP-  227 (267)
T ss_dssp             HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-----HHHHHHT-T-C----CCCCC-
T ss_pred             cccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHH-----HHHHHhc-C-C----cCCCC-
Confidence            11223356778999999998899999999999999999999 899986432111     1111111 0 0    00000 


Q ss_pred             cccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHhhhhc
Q 017594          287 EYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNEAAT  328 (369)
Q Consensus       287 ~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L~~~~~~  328 (369)
                          ...+..+.+++.+||+.||++|||+.++++.|+.+..+
T Consensus       228 ----~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~  265 (267)
T 3t9t_A          228 ----RLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES  265 (267)
T ss_dssp             ----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             ----ccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence                11256689999999999999999999999999998763

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=4.3e-43  Score=326.47  Aligned_cols=278  Identities=13%  Similarity=0.136  Sum_probs=214.1

Q ss_pred             hcCCccCccccccCCccEEEEEEcC---------CCEEEEEEecCCCchhHHHHHHHHHHHhcCCCCceee---------
Q 017594           48 TNKFSDANKLGEGGFGPVYKGVLKK---------GDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVR---------  109 (369)
Q Consensus        48 ~~~y~i~~~lg~G~~~~v~~~~~~~---------~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~---------  109 (369)
                      .++|++.+.||+|+||.||+|++..         ++.||+|++...     ..+.+|+.+++.++||||++         
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~  115 (352)
T 2jii_A           41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP  115 (352)
T ss_dssp             SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred             CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence            5899999999999999999999764         788999998754     35778999999999998887         


Q ss_pred             ------eeeeEEe-CCccEEEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCE
Q 017594          110 ------LLGCCID-RDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNI  182 (369)
Q Consensus       110 ------~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NI  182 (369)
                            +++++.. ....++||||+ +++|.+++... ....+++..++.++.||+.||.|||+++   ++||||||+||
T Consensus       116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NI  190 (352)
T 2jii_A          116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVS-PKHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAENI  190 (352)
T ss_dssp             TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHS-GGGCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCGGGE
T ss_pred             ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhC-CcCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHE
Confidence                  5666665 67789999999 99999998643 1355899999999999999999999999   99999999999


Q ss_pred             EEeCCC--ceEEeecCCceecCCCCccc-----ccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCC
Q 017594          183 LLDKDM--NPKISDFGMARICGGNELQA-----NTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGL  255 (369)
Q Consensus       183 lv~~~~--~~~L~Dfg~~~~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~  255 (369)
                      +++.++  .++|+|||++..+.......     ......+++.|+|||++.+..++.++|||||||++|+|++|..||..
T Consensus       191 l~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~  270 (352)
T 2jii_A          191 FVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTN  270 (352)
T ss_dssp             EEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGG
T ss_pred             EEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence            999998  89999999997664322111     11234689999999999998999999999999999999999999975


Q ss_pred             CcccccccchhhhhhhhcCccccccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHhhhhccCCCCCC
Q 017594          256 YRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNEAATLLPPKQP  335 (369)
Q Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L~~~~~~~~~~~~~  335 (369)
                      ...............  ..............    ..++..+.++|.+||+.||++|||+.+|++.|+.+..........
T Consensus       271 ~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~----~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~~~~~  344 (352)
T 2jii_A          271 CLPNTEDIMKQKQKF--VDKPGPFVGPCGHW----IRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLRVSPYD  344 (352)
T ss_dssp             GTTCHHHHHHHHHHH--HHSCCCEECTTSCE----ECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCTTS
T ss_pred             CCcCHHHHHHHHHhc--cCChhhhhhhcccc----CCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcCCCcCc
Confidence            432111111111100  01111111111100    011566999999999999999999999999999999988776666


Q ss_pred             Cccccc
Q 017594          336 AFSYVR  341 (369)
Q Consensus       336 ~~~~~~  341 (369)
                      +.++..
T Consensus       345 ~~dw~~  350 (352)
T 2jii_A          345 PIGLPM  350 (352)
T ss_dssp             CCCCCC
T ss_pred             cccCcC
Confidence            666543

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=4.4e-42  Score=312.23  Aligned_cols=249  Identities=23%  Similarity=0.302  Sum_probs=194.7

Q ss_pred             hcCCccCccccccCCccEEEEEEc-CCCEEEEEEecCCCc--------------------------hhHHHHHHHHHHHh
Q 017594           48 TNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSG--------------------------QGLREMKNEASVIA  100 (369)
Q Consensus        48 ~~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~~~--------------------------~~~~~~~~e~~~l~  100 (369)
                      .++|++.+.||+|+||.||+|++. +|+.||+|++.....                          ...+.+.+|+.+++
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~   91 (298)
T 2zv2_A           12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK   91 (298)
T ss_dssp             ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred             ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence            478999999999999999999975 488899999865421                          12356788999999


Q ss_pred             cCCCCceeeeeeeEEe--CCccEEEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCC
Q 017594          101 KVQHKNLVRLLGCCID--RDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLK  178 (369)
Q Consensus       101 ~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~  178 (369)
                      .++||||+++++++..  ....++||||+++++|.+++.    ...+++..++.++.||+.||.|||+++   ++|+|||
T Consensus        92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlk  164 (298)
T 2zv2_A           92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT----LKPLSEDQARFYFQDLIKGIEYLHYQK---IIHRDIK  164 (298)
T ss_dssp             TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC----SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCC
T ss_pred             hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCC
Confidence            9999999999999986  567899999999999977652    345899999999999999999999999   9999999


Q ss_pred             CCCEEEeCCCceEEeecCCceecCCCCcccccccccccccccCchhhccCC---CCcccchHhHHHHHHHHHhCCCCCCC
Q 017594          179 ASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGI---FSIKSDVFSFGVLLLEIVSGKKNTGL  255 (369)
Q Consensus       179 p~NIlv~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~---~~~~~DiwslG~il~~l~tg~~p~~~  255 (369)
                      |+||+++.++.++|+|||++........  ......+++.|+|||++.+..   ++.++|||||||++|+|++|..||..
T Consensus       165 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~  242 (298)
T 2zv2_A          165 PSNLLVGEDGHIKIADFGVSNEFKGSDA--LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMD  242 (298)
T ss_dssp             GGGEEECTTSCEEECCCTTCEECSSSSC--EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             HHHEEECCCCCEEEecCCCccccccccc--cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCC
Confidence            9999999999999999999987654321  123346899999999987654   47889999999999999999999864


Q ss_pred             CcccccccchhhhhhhhcCccccccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 017594          256 YRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVS  320 (369)
Q Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~  320 (369)
                      .....     .. ........ ...   ..     ..++.++.++|.+||+.||++|||+.++++
T Consensus       243 ~~~~~-----~~-~~~~~~~~-~~~---~~-----~~~~~~l~~li~~~l~~dp~~R~s~~e~l~  292 (298)
T 2zv2_A          243 ERIMC-----LH-SKIKSQAL-EFP---DQ-----PDIAEDLKDLITRMLDKNPESRIVVPEIKL  292 (298)
T ss_dssp             SSHHH-----HH-HHHHHCCC-CCC---SS-----SCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             ccHHH-----HH-HHHhcccC-CCC---Cc-----cccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence            32110     00 00011100 000   00     112566999999999999999999999975

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=4.3e-42  Score=310.78  Aligned_cols=262  Identities=23%  Similarity=0.324  Sum_probs=197.7

Q ss_pred             cCCccCccccccCCccEEEEEEcCCCEEEEEEecCCCc--hhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEEEEe
Q 017594           49 NKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSG--QGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIYEY  126 (369)
Q Consensus        49 ~~y~i~~~lg~G~~~~v~~~~~~~~~~valK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  126 (369)
                      ++|++++.||+|+||.||+|++.+|+.||+|++.....  .....+.+|+.+++.++||||+++++++...+..++|||+
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence            58999999999999999999998899999999865432  2346788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCCCCc
Q 017594          127 MPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNEL  206 (369)
Q Consensus       127 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~~~~  206 (369)
                      +.+ +|.+++....  ..+++..++.++.||+.||.|||++|   ++||||||+||+++.++.++|+|||++........
T Consensus        82 ~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  155 (288)
T 1ob3_A           82 LDQ-DLKKLLDVCE--GGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVR  155 (288)
T ss_dssp             CSE-EHHHHHHTST--TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred             cCC-CHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECccccccCcccc
Confidence            986 7777775432  34889999999999999999999999   99999999999999999999999999876543221


Q ss_pred             ccccccccccccccCchhhcc-CCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcC------cc--c
Q 017594          207 QANTSRIVGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSN------RT--L  277 (369)
Q Consensus       207 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~------~~--~  277 (369)
                        ......+++.|+|||++.+ ..++.++|||||||++|+|++|..||.........  ..........      ..  .
T Consensus       156 --~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~  231 (288)
T 1ob3_A          156 --KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQL--MRIFRILGTPNSKNWPNVTEL  231 (288)
T ss_dssp             --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH--HHHHHHHCCCCTTTSTTGGGS
T ss_pred             --ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH--HHHHHHHCCCChhhchhhhcc
Confidence              1223467999999999875 45899999999999999999999999754321100  0000000000      00  0


Q ss_pred             cccCcccc------ccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 017594          278 ELIDPILE------DEYSSKQMLLRYANIALLCVQESADDRPTMNDVVS  320 (369)
Q Consensus       278 ~~~~~~~~------~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~  320 (369)
                      ...++...      ........+.++.++|.+||+.||++|||+.++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  280 (288)
T 1ob3_A          232 PKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (288)
T ss_dssp             TTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             cccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            00000000      00001112567899999999999999999999986

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=1.5e-42  Score=322.32  Aligned_cols=254  Identities=22%  Similarity=0.299  Sum_probs=191.1

Q ss_pred             HHHHhcCCccCccccccCCccEEEEEEcC-CCEEEEEEecCCCchhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEE
Q 017594           44 VSTATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKIL  122 (369)
Q Consensus        44 ~~~~~~~y~i~~~lg~G~~~~v~~~~~~~-~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l  122 (369)
                      ...+.++|++.+.||+|+||.||+|+++. ++.||+|++....  ..+.+.+|+.+++.++||||+++++++...+..++
T Consensus        48 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  125 (349)
T 2w4o_A           48 RDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISL  125 (349)
T ss_dssp             CSCGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             cccccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEE
Confidence            34567889999999999999999999764 8889999997543  23567889999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeC---CCceEEeecCCce
Q 017594          123 IYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDK---DMNPKISDFGMAR  199 (369)
Q Consensus       123 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~---~~~~~L~Dfg~~~  199 (369)
                      ||||+.+++|.+++...   ..+++..++.++.||+.||.|||+.+   ++||||||+||+++.   ++.++|+|||++.
T Consensus       126 v~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~  199 (349)
T 2w4o_A          126 VLELVTGGELFDRIVEK---GYYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSK  199 (349)
T ss_dssp             EECCCCSCBHHHHHTTC---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECCCC---
T ss_pred             EEEeCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEccCcccc
Confidence            99999999999988543   34899999999999999999999999   999999999999975   8899999999987


Q ss_pred             ecCCCCcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCccccc
Q 017594          200 ICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLEL  279 (369)
Q Consensus       200 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (369)
                      ......   ......|++.|+|||++.+..++.++|||||||++|+|++|..||........     .......... ..
T Consensus       200 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-----~~~~i~~~~~-~~  270 (349)
T 2w4o_A          200 IVEHQV---LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQF-----MFRRILNCEY-YF  270 (349)
T ss_dssp             ----------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHH-----HHHHHHTTCC-CC
T ss_pred             ccCccc---ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHH-----HHHHHHhCCC-cc
Confidence            654322   12334689999999999998999999999999999999999999864332210     0111111100 00


Q ss_pred             cCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 017594          280 IDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVS  320 (369)
Q Consensus       280 ~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~  320 (369)
                      ..+.      ....+.++.+||.+||+.||++|||+.++++
T Consensus       271 ~~~~------~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  305 (349)
T 2w4o_A          271 ISPW------WDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ  305 (349)
T ss_dssp             CTTT------TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             CCch------hhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            0000      0112567999999999999999999999987

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=3.2e-42  Score=310.03  Aligned_cols=267  Identities=30%  Similarity=0.433  Sum_probs=212.3

Q ss_pred             HHHHhcCCccCccccccCCccEEEEEEcCCCEEEEEEecCCCchhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEE
Q 017594           44 VSTATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILI  123 (369)
Q Consensus        44 ~~~~~~~y~i~~~lg~G~~~~v~~~~~~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv  123 (369)
                      .....++|++.+.||+|+||.||+|..+++..||+|.+.... ...+.+.+|+.+++.++||||+++++++. .+..++|
T Consensus         8 ~~v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v   85 (279)
T 1qpc_A            8 WEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYII   85 (279)
T ss_dssp             TBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEE
T ss_pred             cccCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEE
Confidence            344568999999999999999999998888899999987543 34577889999999999999999999876 5578999


Q ss_pred             EEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCC
Q 017594          124 YEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGG  203 (369)
Q Consensus       124 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~  203 (369)
                      |||+.+++|.+++... ....+++..++.++.|++.||.|||++|   ++|+||+|+||+++.++.++|+|||++.....
T Consensus        86 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~  161 (279)
T 1qpc_A           86 TEYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIED  161 (279)
T ss_dssp             EECCTTCBHHHHTTSH-HHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred             EecCCCCCHHHHHhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECCCcccccccC
Confidence            9999999999998542 2235889999999999999999999999   99999999999999999999999999987654


Q ss_pred             CCcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHh-CCCCCCCCcccccccchhhhhhhhcCccccccCc
Q 017594          204 NELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDP  282 (369)
Q Consensus       204 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (369)
                      ... .......++..|+|||++.+..++.++||||||+++|+|++ |..||.......     ..... ...     ...
T Consensus       162 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~-----~~~~~-~~~-----~~~  229 (279)
T 1qpc_A          162 NEY-TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE-----VIQNL-ERG-----YRM  229 (279)
T ss_dssp             SCE-ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-----HHHHH-HTT-----CCC
T ss_pred             ccc-ccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHH-----HHHHH-hcc-----cCC
Confidence            322 12223346778999999998899999999999999999999 899986432111     00111 000     000


Q ss_pred             cccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHhhhhccCCCC
Q 017594          283 ILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNEAATLLPPK  333 (369)
Q Consensus       283 ~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L~~~~~~~~~~~  333 (369)
                      ...     ..++..+.+++.+||+.||++|||+.++++.|+.+........
T Consensus       230 ~~~-----~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~~  275 (279)
T 1qpc_A          230 VRP-----DNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATEGQY  275 (279)
T ss_dssp             CCC-----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC----
T ss_pred             CCc-----ccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhccCCC
Confidence            011     1125679999999999999999999999999999887655443

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=3.9e-42  Score=309.95  Aligned_cols=261  Identities=21%  Similarity=0.311  Sum_probs=198.2

Q ss_pred             HHHhcCCccCccccccCCccEEEEEEcC----CCEEEEEEecCCC-chhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCc
Q 017594           45 STATNKFSDANKLGEGGFGPVYKGVLKK----GDEIAVKRLSGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDE  119 (369)
Q Consensus        45 ~~~~~~y~i~~~lg~G~~~~v~~~~~~~----~~~valK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~  119 (369)
                      +...++|++.+.||+|+||.||+|++..    +..|++|++.... ....+.+.+|+..++.++||||+++++++ .++.
T Consensus        11 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-~~~~   89 (281)
T 1mp8_A           11 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-TENP   89 (281)
T ss_dssp             BCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-CSSS
T ss_pred             EEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEE-ccCc
Confidence            4456899999999999999999999643    4469999987543 33456788999999999999999999997 4567


Q ss_pred             cEEEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCce
Q 017594          120 KILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMAR  199 (369)
Q Consensus       120 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~  199 (369)
                      .++||||+.+++|.+++...  ...+++..++.++.||+.||.|||+.+   ++|+||||+||+++.++.++|+|||++.
T Consensus        90 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~  164 (281)
T 1mp8_A           90 VWIIMELCTLGELRSFLQVR--KYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSR  164 (281)
T ss_dssp             CEEEEECCTTEEHHHHHHHT--TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC-----
T ss_pred             cEEEEecCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECcccccc
Confidence            89999999999999988543  234889999999999999999999999   9999999999999999999999999988


Q ss_pred             ecCCCCcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHh-CCCCCCCCcccccccchhhhhhhhcCcccc
Q 017594          200 ICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDLWTSNRTLE  278 (369)
Q Consensus       200 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (369)
                      ....... .......+++.|+|||++.+..++.++||||||+++|+|++ |..||.......     ...... ......
T Consensus       165 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~-----~~~~i~-~~~~~~  237 (281)
T 1mp8_A          165 YMEDSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND-----VIGRIE-NGERLP  237 (281)
T ss_dssp             ---------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG-----HHHHHH-TTCCCC
T ss_pred             ccCcccc-cccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHH-----HHHHHH-cCCCCC
Confidence            6643321 11223345778999999998899999999999999999996 999986443211     111111 110000


Q ss_pred             ccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHhhhhc
Q 017594          279 LIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNEAAT  328 (369)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L~~~~~~  328 (369)
                           .     +..++..+.++|.+||+.||++|||+.++++.|+.+...
T Consensus       238 -----~-----~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~  277 (281)
T 1mp8_A          238 -----M-----PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE  277 (281)
T ss_dssp             -----C-----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             -----C-----CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence                 1     111256799999999999999999999999999988653

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=2.8e-42  Score=311.76  Aligned_cols=264  Identities=28%  Similarity=0.417  Sum_probs=214.5

Q ss_pred             hHHHHhcCCccCccccccCCccEEEEEEcC-CCEEEEEEecCCCchhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccE
Q 017594           43 SVSTATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKI  121 (369)
Q Consensus        43 ~~~~~~~~y~i~~~lg~G~~~~v~~~~~~~-~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  121 (369)
                      ......++|++.+.||+|+||.||+|.++. +..||+|++.... ...+.+.+|+.+++.++||||+++++++......+
T Consensus         7 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   85 (288)
T 3kfa_A            7 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY   85 (288)
T ss_dssp             TTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEE
T ss_pred             cccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEE
Confidence            344567899999999999999999999765 8889999997543 44577889999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceec
Q 017594          122 LIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARIC  201 (369)
Q Consensus       122 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~  201 (369)
                      +||||+.+++|.+++... ....+++..++.++.||+.||.|||+.+   ++|+||||+||+++.++.++|+|||++...
T Consensus        86 ~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~  161 (288)
T 3kfa_A           86 IITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLM  161 (288)
T ss_dssp             EEEECCTTEEHHHHHHHC-CTTTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECCCCGGGTS
T ss_pred             EEEEcCCCCcHHHHHHhc-ccCCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEccCccceec
Confidence            999999999999998653 2345889999999999999999999999   999999999999999999999999998766


Q ss_pred             CCCCcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHh-CCCCCCCCcccccccchhhhhhhhcCcccccc
Q 017594          202 GGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDLWTSNRTLELI  280 (369)
Q Consensus       202 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (369)
                      ..... .......+++.|+|||++.+..++.++||||||+++|+|++ |..||........      ........     
T Consensus       162 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~------~~~~~~~~-----  229 (288)
T 3kfa_A          162 TGDTY-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV------YELLEKDY-----  229 (288)
T ss_dssp             CSSSS-EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH------HHHHHTTC-----
T ss_pred             cCCcc-ccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH------HHHHhccC-----
Confidence            53321 22233456778999999998999999999999999999999 9999864432110      11111110     


Q ss_pred             CccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHhhhhc
Q 017594          281 DPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNEAAT  328 (369)
Q Consensus       281 ~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L~~~~~~  328 (369)
                      ....     +..++..+.+++.+||+.||++|||+.++++.|+.+...
T Consensus       230 ~~~~-----~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~  272 (288)
T 3kfa_A          230 RMER-----PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE  272 (288)
T ss_dssp             CCCC-----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CCCC-----CCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHh
Confidence            0000     111256799999999999999999999999999887663

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=2.8e-42  Score=324.63  Aligned_cols=256  Identities=22%  Similarity=0.348  Sum_probs=200.7

Q ss_pred             HHhcCCccCccccccCCccEEEEEEcC-CCEEEEEEecCC---CchhHHHHHHHHHHHhcC-CCCceeeeeeeEEeCCcc
Q 017594           46 TATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGR---SGQGLREMKNEASVIAKV-QHKNLVRLLGCCIDRDEK  120 (369)
Q Consensus        46 ~~~~~y~i~~~lg~G~~~~v~~~~~~~-~~~valK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~  120 (369)
                      ...++|++++.||+|+||.||+|+.+. ++.||+|++...   .......+..|..++.++ +||||+++++++...+..
T Consensus        49 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~  128 (396)
T 4dc2_A           49 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRL  128 (396)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred             CChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEE
Confidence            345789999999999999999999765 788999998643   223345577889998877 899999999999999999


Q ss_pred             EEEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCcee
Q 017594          121 ILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARI  200 (369)
Q Consensus       121 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~  200 (369)
                      ++||||+.+++|..++..   ...+++..++.++.||+.||.|||++|   ++||||||+||+++.++.++|+|||++..
T Consensus       129 ~lV~E~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFGla~~  202 (396)
T 4dc2_A          129 FFVIEYVNGGDLMFHMQR---QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKE  202 (396)
T ss_dssp             EEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred             EEEEEcCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEeecceeee
Confidence            999999999999888853   344899999999999999999999999   99999999999999999999999999875


Q ss_pred             cCCCCcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCccccc---ccchhhhhhhhcCccc
Q 017594          201 CGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSL---NLLGYAWDLWTSNRTL  277 (369)
Q Consensus       201 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~---~~~~~~~~~~~~~~~~  277 (369)
                      .....  .......||+.|+|||++.+..++.++|+|||||++|+|++|..||........   ............... 
T Consensus       203 ~~~~~--~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~-  279 (396)
T 4dc2_A          203 GLRPG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI-  279 (396)
T ss_dssp             CCCTT--CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCC-
T ss_pred             cccCC--CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhcccc-
Confidence            32221  223445789999999999999999999999999999999999999964321110   001111111111110 


Q ss_pred             cccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCH------HHHHH
Q 017594          278 ELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTM------NDVVS  320 (369)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~------~ell~  320 (369)
                      .     +     +..++.++.+||.+||+.||++||++      .+|++
T Consensus       280 ~-----~-----p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~  318 (396)
T 4dc2_A          280 R-----I-----PRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG  318 (396)
T ss_dssp             C-----C-----CTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHH
T ss_pred             C-----C-----CCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhc
Confidence            0     0     11125679999999999999999996      56654

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=2.5e-42  Score=310.35  Aligned_cols=253  Identities=20%  Similarity=0.265  Sum_probs=205.0

Q ss_pred             HHHhcCCccCccccccCCccEEEEEEcC-CCEEEEEEecCCCchhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEE
Q 017594           45 STATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILI  123 (369)
Q Consensus        45 ~~~~~~y~i~~~lg~G~~~~v~~~~~~~-~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv  123 (369)
                      ..+.++|++.+.||+|+||.||+|.++. +..+++|++........+.+.+|+.+++.++||||+++++++......++|
T Consensus         5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv   84 (277)
T 3f3z_A            5 GDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLV   84 (277)
T ss_dssp             -CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhhhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEE
Confidence            3467899999999999999999999765 778999998765555668899999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEE---eCCCceEEeecCCcee
Q 017594          124 YEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILL---DKDMNPKISDFGMARI  200 (369)
Q Consensus       124 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv---~~~~~~~L~Dfg~~~~  200 (369)
                      |||+.+++|.+++..   ...+++..++.++.|++.||.|||+.+   ++|+||+|+||++   +.++.++|+|||++..
T Consensus        85 ~e~~~~~~L~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~  158 (277)
T 3f3z_A           85 MELCTGGELFERVVH---KRVFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAAR  158 (277)
T ss_dssp             EECCCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred             EeccCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEeccccee
Confidence            999999999888743   344899999999999999999999999   9999999999999   7889999999999987


Q ss_pred             cCCCCcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCcccccc
Q 017594          201 CGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELI  280 (369)
Q Consensus       201 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (369)
                      .....   ......+++.|+|||++.+. ++.++||||||+++|+|++|..||.......     ....... ... .. 
T Consensus       159 ~~~~~---~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-----~~~~~~~-~~~-~~-  226 (277)
T 3f3z_A          159 FKPGK---MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSE-----VMLKIRE-GTF-TF-  226 (277)
T ss_dssp             CCTTS---CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-----HHHHHHH-CCC-CC-
T ss_pred             ccCcc---chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHH-----HHHHHHh-CCC-CC-
Confidence            65332   22334689999999988654 8999999999999999999999986433111     0011100 000 00 


Q ss_pred             CccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 017594          281 DPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVS  320 (369)
Q Consensus       281 ~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~  320 (369)
                           .......++..+.++|.+||+.||++|||+.++++
T Consensus       227 -----~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~  261 (277)
T 3f3z_A          227 -----PEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALE  261 (277)
T ss_dssp             -----CHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             -----CchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                 00000122567999999999999999999999985

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=6.5e-42  Score=319.47  Aligned_cols=255  Identities=20%  Similarity=0.242  Sum_probs=194.1

Q ss_pred             HHhcCCccCccccccCCccEEEEEEc-CCCEEEEEEecCCCchhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEEE
Q 017594           46 TATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIY  124 (369)
Q Consensus        46 ~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  124 (369)
                      ...++|++++.||+|+||.||+|+.+ +++.||+|++..... ..+.+.+|+..++.++||||+++++++......++||
T Consensus        17 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~   95 (361)
T 3uc3_A           17 HDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIM   95 (361)
T ss_dssp             CCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT-SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc-ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEE
Confidence            45689999999999999999999976 589999999975432 2367889999999999999999999999999999999


Q ss_pred             EecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCc--eEEeecCCceecC
Q 017594          125 EYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMN--PKISDFGMARICG  202 (369)
Q Consensus       125 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~--~~L~Dfg~~~~~~  202 (369)
                      ||+.+++|.+++..   ...+++..++.++.||+.||.|||++|   ++||||||+||+++.++.  ++|+|||++....
T Consensus        96 e~~~~~~L~~~l~~---~~~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~  169 (361)
T 3uc3_A           96 EYASGGELYERICN---AGRFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSV  169 (361)
T ss_dssp             ECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCCCC----
T ss_pred             EeCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecCcccccc
Confidence            99999999988843   334899999999999999999999999   999999999999987765  9999999987432


Q ss_pred             CCCcccccccccccccccCchhhccCCCCcc-cchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCccccccC
Q 017594          203 GNELQANTSRIVGTYGYMSPEYALEGIFSIK-SDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELID  281 (369)
Q Consensus       203 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (369)
                      ..   .......|++.|+|||++.+..++.+ +|||||||++|+|++|..||......... ............      
T Consensus       170 ~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~-~~~~~~~~~~~~------  239 (361)
T 3uc3_A          170 LH---SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDY-RKTIQRILSVKY------  239 (361)
T ss_dssp             --------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCH-HHHHHHHHTTCC------
T ss_pred             cc---CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHH-HHHHHHHhcCCC------
Confidence            22   12233468999999999988877655 89999999999999999999754321111 001111110000      


Q ss_pred             ccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 017594          282 PILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSM  321 (369)
Q Consensus       282 ~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~  321 (369)
                       ....   ...++..+.+||.+||+.||++|||+.++++.
T Consensus       240 -~~~~---~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h  275 (361)
T 3uc3_A          240 -SIPD---DIRISPECCHLISRIFVADPATRISIPEIKTH  275 (361)
T ss_dssp             -CCCT---TSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             -CCCC---cCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence             0000   00125668999999999999999999999964

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=1.5e-42  Score=317.00  Aligned_cols=270  Identities=20%  Similarity=0.315  Sum_probs=203.0

Q ss_pred             HHhcCCccCccccccCCccEEEEEEc-CCCEEEEEEecCC---CchhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccE
Q 017594           46 TATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGR---SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKI  121 (369)
Q Consensus        46 ~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  121 (369)
                      ...++|++.+.||+|+||.||+|... +|+.||+|++...   .......+.+|+.+++.++||||+++++++...+..+
T Consensus        29 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~  108 (310)
T 2wqm_A           29 NTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELN  108 (310)
T ss_dssp             SSGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred             ccccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEE
Confidence            44578999999999999999999964 5899999998753   2344567889999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhcCCC-ccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCcee
Q 017594          122 LIYEYMPNKSLDFFLFDPT-KRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARI  200 (369)
Q Consensus       122 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~  200 (369)
                      +|||++.+++|.+++.... ....+++..++.++.||+.||.|||+.+   ++|+||+|+||+++.++.++|+|||++..
T Consensus       109 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~  185 (310)
T 2wqm_A          109 IVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRF  185 (310)
T ss_dssp             EEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC-----
T ss_pred             EEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEeccceee
Confidence            9999999999998885321 2345889999999999999999999999   99999999999999999999999999876


Q ss_pred             cCCCCcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCcccccc
Q 017594          201 CGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELI  280 (369)
Q Consensus       201 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (369)
                      ......  ......++..|+|||++.+..++.++||||||+++|+|++|..||.........   ..... .........
T Consensus       186 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~---~~~~~-~~~~~~~~~  259 (310)
T 2wqm_A          186 FSSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYS---LCKKI-EQCDYPPLP  259 (310)
T ss_dssp             ---------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHH---HHHHH-HTTCSCCCC
T ss_pred             ecCCCc--cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHH---HHHHh-hcccCCCCc
Confidence            543221  122346789999999999999999999999999999999999998643211100   01111 111110000


Q ss_pred             CccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHhhhhccCCCC
Q 017594          281 DPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNEAATLLPPK  333 (369)
Q Consensus       281 ~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L~~~~~~~~~~~  333 (369)
                               ...++.++.++|.+||+.||++|||+.++++.|+++.+....+.
T Consensus       260 ---------~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~~~  303 (310)
T 2wqm_A          260 ---------SDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTASSL  303 (310)
T ss_dssp             ---------TTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC---
T ss_pred             ---------ccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhhhh
Confidence                     11125679999999999999999999999999999999776543

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.3e-42  Score=309.51  Aligned_cols=266  Identities=25%  Similarity=0.375  Sum_probs=212.7

Q ss_pred             HhcCCccCc-cccccCCccEEEEEEc---CCCEEEEEEecCCC-chhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccE
Q 017594           47 ATNKFSDAN-KLGEGGFGPVYKGVLK---KGDEIAVKRLSGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKI  121 (369)
Q Consensus        47 ~~~~y~i~~-~lg~G~~~~v~~~~~~---~~~~valK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  121 (369)
                      ..++|.+.+ .||+|+||.||+|.+.   ++..||+|++.... ....+.+.+|+.+++.++||||+++++++ ..+..+
T Consensus         7 ~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~   85 (287)
T 1u59_A            7 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALM   85 (287)
T ss_dssp             CGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEE
T ss_pred             cHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcE
Confidence            356777777 9999999999999853   47789999997643 34567788999999999999999999998 566799


Q ss_pred             EEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceec
Q 017594          122 LIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARIC  201 (369)
Q Consensus       122 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~  201 (369)
                      +|||++.+++|.+++...  ...+++..++.++.||+.||.+||+.+   ++|+||+|+||+++.++.++|+|||++...
T Consensus        86 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~  160 (287)
T 1u59_A           86 LVMEMAGGGPLHKFLVGK--REEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKAL  160 (287)
T ss_dssp             EEEECCTTEEHHHHHTTC--TTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred             EEEEeCCCCCHHHHHHhC--CccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECcccceeee
Confidence            999999999999988542  345899999999999999999999999   999999999999999999999999999876


Q ss_pred             CCCCccc-ccccccccccccCchhhccCCCCcccchHhHHHHHHHHHh-CCCCCCCCcccccccchhhhhhhhcCccccc
Q 017594          202 GGNELQA-NTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDLWTSNRTLEL  279 (369)
Q Consensus       202 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (369)
                      ....... ......+++.|+|||++.+..++.++||||||+++|+|++ |..||.......     .. .........  
T Consensus       161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~-----~~-~~i~~~~~~--  232 (287)
T 1u59_A          161 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE-----VM-AFIEQGKRM--  232 (287)
T ss_dssp             TTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH-----HH-HHHHTTCCC--
T ss_pred             ccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH-----HH-HHHhcCCcC--
Confidence            5433211 1223345788999999998889999999999999999998 999986443211     00 111111100  


Q ss_pred             cCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHhhhhccCCCCC
Q 017594          280 IDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNEAATLLPPKQ  334 (369)
Q Consensus       280 ~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L~~~~~~~~~~~~  334 (369)
                         ...     ..++..+.++|.+||+.||++||++.++++.|+.+..+...+..
T Consensus       233 ---~~~-----~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~~~  279 (287)
T 1u59_A          233 ---ECP-----PECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVE  279 (287)
T ss_dssp             ---CCC-----TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTTCS
T ss_pred             ---CCC-----CCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCCccc
Confidence               011     12256799999999999999999999999999999887665443

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=1.1e-42  Score=324.70  Aligned_cols=219  Identities=28%  Similarity=0.324  Sum_probs=186.5

Q ss_pred             cccccCCCccccchhhHHHHhcCCccCccccccCCccEEEEEEc-CCCEEEEEEecCCCchhHHHHHHHHHHHhcCC---
Q 017594           28 SKKKEVDQFPLFSFSSVSTATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSGQGLREMKNEASVIAKVQ---  103 (369)
Q Consensus        28 ~~~~~~~~~~~~~~~~~~~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~---  103 (369)
                      ..+...++...++++....+.++|++.+.||+|+||.||+|++. +++.||+|++... .........|+.+++.+.   
T Consensus        14 ~~~~~~~~~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~   92 (360)
T 3llt_A           14 LYFQGDDEIVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDD   92 (360)
T ss_dssp             ------CGGGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCS
T ss_pred             eeeecCccceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccC
Confidence            44566777889999999999999999999999999999999975 5889999998743 334466778999999986   


Q ss_pred             --CCceeeeeeeEEeCCccEEEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCC
Q 017594          104 --HKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASN  181 (369)
Q Consensus       104 --h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~N  181 (369)
                        ||||+++++++...+..++|||++ +++|.+++.... ...+++..++.++.||+.||.|||+.|   ++||||||+|
T Consensus        93 ~~h~~iv~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~N  167 (360)
T 3llt_A           93 INNNNIVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNN-YNGFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPEN  167 (360)
T ss_dssp             TTGGGBCCEEEEEEETTEEEEEECCC-CCBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGG
T ss_pred             CCCCCeecccceeeECCeeEEEEcCC-CCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCccc
Confidence              999999999999999999999999 889988886432 234889999999999999999999999   9999999999


Q ss_pred             EEEeC-------------------------CCceEEeecCCceecCCCCcccccccccccccccCchhhccCCCCcccch
Q 017594          182 ILLDK-------------------------DMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDV  236 (369)
Q Consensus       182 Ilv~~-------------------------~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di  236 (369)
                      |+++.                         ++.++|+|||++......     .....+++.|+|||++.+..++.++||
T Consensus       168 Ill~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di  242 (360)
T 3llt_A          168 ILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY-----HGSIINTRQYRAPEVILNLGWDVSSDM  242 (360)
T ss_dssp             EEESCTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC-----CCSCCSCGGGCCHHHHTTCCCCTTHHH
T ss_pred             EEEccccccccccchhcccccccccccccCCCCEEEEeccCceecCCC-----CcCccCcccccCcHHHcCCCCCCccch
Confidence            99975                         789999999999764322     233468999999999999999999999


Q ss_pred             HhHHHHHHHHHhCCCCCCCCc
Q 017594          237 FSFGVLLLEIVSGKKNTGLYR  257 (369)
Q Consensus       237 wslG~il~~l~tg~~p~~~~~  257 (369)
                      |||||++|+|++|..||....
T Consensus       243 wslG~il~ell~g~~pf~~~~  263 (360)
T 3llt_A          243 WSFGCVLAELYTGSLLFRTHE  263 (360)
T ss_dssp             HHHHHHHHHHHHSSCSCCCSS
T ss_pred             HHHHHHHHHHHHCCCCCCCCc
Confidence            999999999999999997543

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=1.6e-42  Score=317.72  Aligned_cols=270  Identities=22%  Similarity=0.236  Sum_probs=208.2

Q ss_pred             HHHHhcCCccCccccccCCccEEEEEE-cCCCEEEEEEecCCCchhHHHHHHHHHHHhcCCCCceeeeeeeEEe----CC
Q 017594           44 VSTATNKFSDANKLGEGGFGPVYKGVL-KKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCID----RD  118 (369)
Q Consensus        44 ~~~~~~~y~i~~~lg~G~~~~v~~~~~-~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~  118 (369)
                      +....++|++.+.||+|+||.||+|+. .+|+.||+|++........+.+.+|+.+++.++||||+++++++..    ..
T Consensus        24 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  103 (317)
T 2buj_A           24 VIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKH  103 (317)
T ss_dssp             EEETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEE
T ss_pred             EEECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCc
Confidence            344568999999999999999999997 4589999999876666667888999999999999999999999873    34


Q ss_pred             ccEEEEEecCCCChhhhhcCC-CccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCC
Q 017594          119 EKILIYEYMPNKSLDFFLFDP-TKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGM  197 (369)
Q Consensus       119 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~  197 (369)
                      ..++|+||+.+++|.+++... .....+++..++.++.||+.||.|||+.+   ++|+||+|+||+++.++.++|+|||+
T Consensus       104 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~dfg~  180 (317)
T 2buj_A          104 EAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLGS  180 (317)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCSS
T ss_pred             eeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEEEEecCc
Confidence            679999999999998888542 12355899999999999999999999999   99999999999999999999999998


Q ss_pred             ceecCCCCccc-------ccccccccccccCchhhccCC---CCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhh
Q 017594          198 ARICGGNELQA-------NTSRIVGTYGYMSPEYALEGI---FSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYA  267 (369)
Q Consensus       198 ~~~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~---~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~  267 (369)
                      +..........       ......+++.|+|||++.+..   ++.++||||||+++|+|++|..||..........    
T Consensus       181 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~----  256 (317)
T 2buj_A          181 MNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSV----  256 (317)
T ss_dssp             CEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCH----
T ss_pred             chhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchh----
Confidence            87643211110       011234688999999987544   6889999999999999999999985321111000    


Q ss_pred             hhhhhcCccccccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHhhhhccC
Q 017594          268 WDLWTSNRTLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNEAATLL  330 (369)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L~~~~~~~~  330 (369)
                      ....... .    ...     ....++..+.++|.+||+.||.+|||+.++++.|+.+....+
T Consensus       257 ~~~~~~~-~----~~~-----~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~  309 (317)
T 2buj_A          257 ALAVQNQ-L----SIP-----QSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPAP  309 (317)
T ss_dssp             HHHHHCC-------CC-----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCCCC
T ss_pred             hHHhhcc-C----CCC-----ccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCCCC
Confidence            0000000 0    000     001125679999999999999999999999999998876443

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=8.6e-42  Score=328.55  Aligned_cols=252  Identities=22%  Similarity=0.350  Sum_probs=205.8

Q ss_pred             HhcCCccCccccccCCccEEEEEEc-CCCEEEEEEecCCC---chhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEE
Q 017594           47 ATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS---GQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKIL  122 (369)
Q Consensus        47 ~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l  122 (369)
                      ..++|.+.+.||+|+||.||+|++. +|+.||+|++....   ......+.+|+.+++.++||||+++++++...+..++
T Consensus        14 ~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~l   93 (476)
T 2y94_A           14 KIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFM   93 (476)
T ss_dssp             EETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             eecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence            3578999999999999999999976 59999999986432   1234678899999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecC
Q 017594          123 IYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICG  202 (369)
Q Consensus       123 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~  202 (369)
                      ||||+.+++|.+++..   ...+++..++.++.||+.||.|||++|   ++||||||+||+++.++.++|+|||++....
T Consensus        94 v~E~~~gg~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DFG~a~~~~  167 (476)
T 2y94_A           94 VMEYVSGGELFDYICK---NGRLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMS  167 (476)
T ss_dssp             EEECCSSEEHHHHTTS---SSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred             EEeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEeccchhhcc
Confidence            9999999999999854   344899999999999999999999999   9999999999999999999999999998765


Q ss_pred             CCCcccccccccccccccCchhhccCCC-CcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCccccccC
Q 017594          203 GNELQANTSRIVGTYGYMSPEYALEGIF-SIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELID  281 (369)
Q Consensus       203 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (369)
                      ....   .....|++.|+|||++.+..+ +.++|||||||++|+|++|..||.......     ...... .... .   
T Consensus       168 ~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~-----~~~~i~-~~~~-~---  234 (476)
T 2y94_A          168 DGEF---LRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPT-----LFKKIC-DGIF-Y---  234 (476)
T ss_dssp             TTCC---BCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHH-----HHHHHH-TTCC-C---
T ss_pred             cccc---ccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHH-----HHHHHh-cCCc-C---
Confidence            4321   233478999999999988765 789999999999999999999996432111     111111 1100 0   


Q ss_pred             ccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH--HHHh
Q 017594          282 PILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVS--MLTN  324 (369)
Q Consensus       282 ~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~--~L~~  324 (369)
                        .     +...+.++.+||.+||+.||++|||+.++++  .+..
T Consensus       235 --~-----p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~  272 (476)
T 2y94_A          235 --T-----PQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQ  272 (476)
T ss_dssp             --C-----CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHT
T ss_pred             --C-----CccCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhh
Confidence              0     0112566899999999999999999999997  4544

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=1.5e-42  Score=320.57  Aligned_cols=245  Identities=24%  Similarity=0.334  Sum_probs=201.8

Q ss_pred             HHHhcCCccCccccccCCccEEEEEEc-CCCEEEEEEecCCCc--------hhHHHHHHHHHHHhcCCCCceeeeeeeEE
Q 017594           45 STATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSG--------QGLREMKNEASVIAKVQHKNLVRLLGCCI  115 (369)
Q Consensus        45 ~~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~~~--------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~  115 (369)
                      ....++|++.+.||+|+||.||+|++. +|+.||+|++.....        .....+..|+.+++.++||||+++++++.
T Consensus        20 ~~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~   99 (335)
T 3dls_A           20 GEYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFE   99 (335)
T ss_dssp             THHHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEE
T ss_pred             cccccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence            456789999999999999999999965 488899999875421        12335667999999999999999999999


Q ss_pred             eCCccEEEEEecCCC-ChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEee
Q 017594          116 DRDEKILIYEYMPNK-SLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISD  194 (369)
Q Consensus       116 ~~~~~~lv~e~~~~~-~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~D  194 (369)
                      +.+..++|||++.++ +|..++...   ..+++..++.++.||+.||.|||+.+   ++||||||+||+++.++.++|+|
T Consensus       100 ~~~~~~lv~e~~~~g~~l~~~~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~D  173 (335)
T 3dls_A          100 NQGFFQLVMEKHGSGLDLFAFIDRH---PRLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLID  173 (335)
T ss_dssp             CSSEEEEEEECCTTSCBHHHHHHTC---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECC
T ss_pred             eCCEEEEEEEeCCCCccHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCcEEEee
Confidence            999999999998766 888888543   34899999999999999999999999   99999999999999999999999


Q ss_pred             cCCceecCCCCcccccccccccccccCchhhccCCC-CcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhc
Q 017594          195 FGMARICGGNELQANTSRIVGTYGYMSPEYALEGIF-SIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTS  273 (369)
Q Consensus       195 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~  273 (369)
                      ||++........   .....|++.|+|||++.+..+ +.++|||||||++|+|++|..||.......             
T Consensus       174 fg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-------------  237 (335)
T 3dls_A          174 FGSAAYLERGKL---FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETV-------------  237 (335)
T ss_dssp             CTTCEECCTTCC---BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGGT-------------
T ss_pred             cccceECCCCCc---eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHHH-------------
Confidence            999987654322   223468999999999988776 889999999999999999999986321100             


Q ss_pred             CccccccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 017594          274 NRTLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSM  321 (369)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~  321 (369)
                         ......       +..++.++.++|.+||+.||++|||+.++++.
T Consensus       238 ---~~~~~~-------~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h  275 (335)
T 3dls_A          238 ---EAAIHP-------PYLVSKELMSLVSGLLQPVPERRTTLEKLVTD  275 (335)
T ss_dssp             ---TTCCCC-------SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred             ---hhccCC-------CcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence               000000       00125669999999999999999999999984

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=1.6e-41  Score=314.36  Aligned_cols=280  Identities=23%  Similarity=0.289  Sum_probs=217.5

Q ss_pred             CCccccchhhHHHHhcCCccCccccccCCccEEEEEEcCCCEEEEEEecCCCchhHHHHHHHHHHHhc--CCCCceeeee
Q 017594           34 DQFPLFSFSSVSTATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAK--VQHKNLVRLL  111 (369)
Q Consensus        34 ~~~~~~~~~~~~~~~~~y~i~~~lg~G~~~~v~~~~~~~~~~valK~~~~~~~~~~~~~~~e~~~l~~--l~h~~i~~~~  111 (369)
                      .+....++.....+.++|++.+.||+|+||.||+|++. |+.||+|++....   ...+..|.+++..  ++||||++++
T Consensus        27 ~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~---~~~~~~e~~~~~~~~l~h~ni~~~~  102 (342)
T 1b6c_B           27 GSGSGLPLLVQRTIARTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFI  102 (342)
T ss_dssp             TCCSSSCHHHHHHHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEECGGG---HHHHHHHHHHHHHSCCCCTTBCCEE
T ss_pred             CCCCCCceeecccccccEEEEeeecCCCCcEEEEEEEc-CccEEEEEeCchh---HHHHHHHHHHHHHhhcCCCcEEEEE
Confidence            34446667777888999999999999999999999985 8899999986432   3566778888877  7899999999


Q ss_pred             eeEEeCC----ccEEEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHh--------cCCCCCcccCCCCC
Q 017594          112 GCCIDRD----EKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLH--------QYSRVRIIHRDLKA  179 (369)
Q Consensus       112 ~~~~~~~----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH--------~~~~~~i~H~dl~p  179 (369)
                      +++....    ..++||||+.+++|.+++..    ..+++..++.++.||+.||.|||        +.+   ++|+||||
T Consensus       103 ~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp  175 (342)
T 1b6c_B          103 AADNKDNGTWTQLWLVSDYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKS  175 (342)
T ss_dssp             EEEECCCSSCCCEEEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCSG
T ss_pred             eeecccCCccceeEEEEeecCCCcHHHHHhc----cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---eeeCCCCH
Confidence            9998776    78999999999999999843    34889999999999999999999        777   99999999


Q ss_pred             CCEEEeCCCceEEeecCCceecCCCCccc--ccccccccccccCchhhccC------CCCcccchHhHHHHHHHHHhC--
Q 017594          180 SNILLDKDMNPKISDFGMARICGGNELQA--NTSRIVGTYGYMSPEYALEG------IFSIKSDVFSFGVLLLEIVSG--  249 (369)
Q Consensus       180 ~NIlv~~~~~~~L~Dfg~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~------~~~~~~DiwslG~il~~l~tg--  249 (369)
                      +||+++.++.++|+|||++..........  ......+++.|+|||++.+.      .++.++||||||+++|+|++|  
T Consensus       176 ~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~  255 (342)
T 1b6c_B          176 KNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCS  255 (342)
T ss_dssp             GGEEECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBC
T ss_pred             HHEEECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccC
Confidence            99999999999999999998765433221  22344689999999998765      344789999999999999999  


Q ss_pred             --------CCCCCCCcccccccchhhhhhhhcCccccccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 017594          250 --------KKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSM  321 (369)
Q Consensus       250 --------~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~  321 (369)
                              ..||............. .....    .....+.+.........+..+.+++.+||+.||++|||+.++++.
T Consensus       256 ~~~~~~~~~~p~~~~~~~~~~~~~~-~~~~~----~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~  330 (342)
T 1b6c_B          256 IGGIHEDYQLPYYDLVPSDPSVEEM-RKVVC----EQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT  330 (342)
T ss_dssp             BTTBCCCCCCTTTTTSCSSCCHHHH-HHHHT----TSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred             cCCcccccccCccccCcCcccHHHH-HHHHH----HHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence                    55664332211111111 11111    111222222222333457789999999999999999999999999


Q ss_pred             HHhhhhcc
Q 017594          322 LTNEAATL  329 (369)
Q Consensus       322 L~~~~~~~  329 (369)
                      |+.+....
T Consensus       331 L~~i~~~~  338 (342)
T 1b6c_B          331 LSQLSQQE  338 (342)
T ss_dssp             HHHHHHTT
T ss_pred             HHHHHHHh
Confidence            99987753

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=2.9e-42  Score=315.91  Aligned_cols=261  Identities=21%  Similarity=0.277  Sum_probs=199.0

Q ss_pred             HhcCCccC-ccccccCCccEEEEEEc-CCCEEEEEEecCCCchhHHHHHHHHHHHhcC-CCCceeeeeeeEEeCCccEEE
Q 017594           47 ATNKFSDA-NKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSGQGLREMKNEASVIAKV-QHKNLVRLLGCCIDRDEKILI  123 (369)
Q Consensus        47 ~~~~y~i~-~~lg~G~~~~v~~~~~~-~~~~valK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv  123 (369)
                      +.++|++. +.||+|+||.||+|++. +++.||+|++..........+.+|+.++.++ .||||+++++++...+..++|
T Consensus        10 ~~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv   89 (316)
T 2ac3_A           10 FEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLV   89 (316)
T ss_dssp             TTTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             cceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEE
Confidence            45789985 78999999999999965 5899999999766555667889999999985 799999999999999999999


Q ss_pred             EEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCc---eEEeecCCcee
Q 017594          124 YEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMN---PKISDFGMARI  200 (369)
Q Consensus       124 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~---~~L~Dfg~~~~  200 (369)
                      |||+.+++|.+++..   ...+++..++.++.||+.||+|||+++   ++||||||+||+++.++.   ++|+|||++..
T Consensus        90 ~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~  163 (316)
T 2ac3_A           90 FEKMRGGSILSHIHK---RRHFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSG  163 (316)
T ss_dssp             EECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECCTTCCC-
T ss_pred             EEcCCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEEccCccc
Confidence            999999999998854   345899999999999999999999999   999999999999988776   99999999876


Q ss_pred             cCCCCcc-----cccccccccccccCchhhcc-----CCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccc------
Q 017594          201 CGGNELQ-----ANTSRIVGTYGYMSPEYALE-----GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLL------  264 (369)
Q Consensus       201 ~~~~~~~-----~~~~~~~~~~~y~aPE~~~~-----~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~------  264 (369)
                      .......     .......|++.|+|||++.+     ..++.++|||||||++|+|++|..||...........      
T Consensus       164 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~  243 (316)
T 2ac3_A          164 IKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACP  243 (316)
T ss_dssp             ------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCH
T ss_pred             cccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccch
Confidence            5422111     11123458999999999875     5588999999999999999999999975432211000      


Q ss_pred             ---hhhhhhhhcCccccccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 017594          265 ---GYAWDLWTSNRTLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVS  320 (369)
Q Consensus       265 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~  320 (369)
                         ............ .     +. ......++..+.+||.+||+.||++|||+.++++
T Consensus       244 ~~~~~~~~~i~~~~~-~-----~~-~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  295 (316)
T 2ac3_A          244 ACQNMLFESIQEGKY-E-----FP-DKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ  295 (316)
T ss_dssp             HHHHHHHHHHHHCCC-C-----CC-HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             hHHHHHHHHHhccCc-c-----cC-chhcccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence               000000000000 0     00 0001123567999999999999999999999997

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=7.6e-43  Score=322.15  Aligned_cols=277  Identities=23%  Similarity=0.241  Sum_probs=199.5

Q ss_pred             cchhhHHHHhcCCccCccccccCCccEEEEEEc-CCCEEEEEEecCCCchhHHHHHHHHHHHhcCC-CCceeeeeeeEEe
Q 017594           39 FSFSSVSTATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSGQGLREMKNEASVIAKVQ-HKNLVRLLGCCID  116 (369)
Q Consensus        39 ~~~~~~~~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~  116 (369)
                      +.-..+.....+|++.+.||+|+||.||+|++. +|+.||+|++..........+.+|+..+..+. ||||+++++++..
T Consensus        18 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~   97 (337)
T 3ll6_A           18 FVGQTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASI   97 (337)
T ss_dssp             STTCEEEETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEE
T ss_pred             hhcceeeccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccc
Confidence            334455666789999999999999999999975 58999999987666666778889999999996 9999999999853


Q ss_pred             --------CCccEEEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCC
Q 017594          117 --------RDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDM  188 (369)
Q Consensus       117 --------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~  188 (369)
                              ....++++||+. ++|.+++........+++..++.++.||+.||.|||+.+ ++++|+||||+||+++.++
T Consensus        98 ~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~NIl~~~~~  175 (337)
T 3ll6_A           98 GKEESDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLLSNQG  175 (337)
T ss_dssp             CTTTSTTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGGCEECTTS
T ss_pred             cccccccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCcccEEECCCC
Confidence                    334799999996 577777654333445899999999999999999999874 2399999999999999999


Q ss_pred             ceEEeecCCceecCCCCccc----------ccccccccccccCchhh---ccCCCCcccchHhHHHHHHHHHhCCCCCCC
Q 017594          189 NPKISDFGMARICGGNELQA----------NTSRIVGTYGYMSPEYA---LEGIFSIKSDVFSFGVLLLEIVSGKKNTGL  255 (369)
Q Consensus       189 ~~~L~Dfg~~~~~~~~~~~~----------~~~~~~~~~~y~aPE~~---~~~~~~~~~DiwslG~il~~l~tg~~p~~~  255 (369)
                      .++|+|||++..........          ......+++.|+|||++   .+..++.++||||||+++|+|++|..||..
T Consensus       176 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~  255 (337)
T 3ll6_A          176 TIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFED  255 (337)
T ss_dssp             CEEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC--
T ss_pred             CEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcc
Confidence            99999999998765332211          11134578999999998   566789999999999999999999999864


Q ss_pred             CcccccccchhhhhhhhcCccccccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHhhhhccCCCCCC
Q 017594          256 YRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNEAATLLPPKQP  335 (369)
Q Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L~~~~~~~~~~~~~  335 (369)
                      .......         . ...    ......     ..+..+.++|.+||+.||++|||+.++++.|+.+..........
T Consensus       256 ~~~~~~~---------~-~~~----~~~~~~-----~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~~~~~~~  316 (337)
T 3ll6_A          256 GAKLRIV---------N-GKY----SIPPHD-----TQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNVNPKS  316 (337)
T ss_dssp             --------------------C----CCCTTC-----CSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHTTCCTTS
T ss_pred             hhHHHhh---------c-Ccc----cCCccc-----ccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccCCCCCc
Confidence            3211100         0 000    000000     01344789999999999999999999999999998876544444


Q ss_pred             C
Q 017594          336 A  336 (369)
Q Consensus       336 ~  336 (369)
                      +
T Consensus       317 ~  317 (337)
T 3ll6_A          317 P  317 (337)
T ss_dssp             C
T ss_pred             c
Confidence            3

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=5.1e-42  Score=324.20  Aligned_cols=276  Identities=21%  Similarity=0.305  Sum_probs=214.5

Q ss_pred             HHhcCCccCccccccCCccEEEEEEcC-CCEEEEEEecCCC-chhHHHHHHHHHHHhcCCCCceeeeeeeEEeCC--ccE
Q 017594           46 TATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCCIDRD--EKI  121 (369)
Q Consensus        46 ~~~~~y~i~~~lg~G~~~~v~~~~~~~-~~~valK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~  121 (369)
                      ...++|++.+.||+|+||.||+|++.. |+.||+|++.... ....+.+.+|+.+++.++||||+++++++....  ..+
T Consensus         6 ~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~   85 (396)
T 4eut_A            6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKV   85 (396)
T ss_dssp             CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEE
T ss_pred             CCCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeE
Confidence            456899999999999999999999765 8999999987432 233567788999999999999999999998765  679


Q ss_pred             EEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEE----eCCCceEEeecCC
Q 017594          122 LIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILL----DKDMNPKISDFGM  197 (369)
Q Consensus       122 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv----~~~~~~~L~Dfg~  197 (369)
                      +||||+.+++|.+++........+++..++.++.||+.||.|||+.+   ++||||||+||++    +.++.++|+|||+
T Consensus        86 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~  162 (396)
T 4eut_A           86 LIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGA  162 (396)
T ss_dssp             EEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEEEECCGGG
T ss_pred             EEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeEEEecCCC
Confidence            99999999999999976555455899999999999999999999999   9999999999999    6777899999999


Q ss_pred             ceecCCCCcccccccccccccccCchhhcc--------CCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhh
Q 017594          198 ARICGGNELQANTSRIVGTYGYMSPEYALE--------GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWD  269 (369)
Q Consensus       198 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~  269 (369)
                      +.......   ......|++.|+|||++.+        ..++.++|||||||++|+|++|..||......... ......
T Consensus       163 a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~-~~~~~~  238 (396)
T 4eut_A          163 ARELEDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN-KEVMYK  238 (396)
T ss_dssp             CEECCCGG---GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTC-HHHHHH
T ss_pred             ceEccCCC---ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccch-HHHHHH
Confidence            98765432   2223468999999999864        56788999999999999999999999654322111 111111


Q ss_pred             hhhcCc--ccccc-----------CccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHhhhhc
Q 017594          270 LWTSNR--TLELI-----------DPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNEAAT  328 (369)
Q Consensus       270 ~~~~~~--~~~~~-----------~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L~~~~~~  328 (369)
                      ......  ....+           .............+..+.+++.+||+.||++||++.++++.++.+...
T Consensus       239 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~  310 (396)
T 4eut_A          239 IITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR  310 (396)
T ss_dssp             HHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred             HhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence            111100  00000           000011112345578899999999999999999999999999887663

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=3.3e-42  Score=319.85  Aligned_cols=245  Identities=22%  Similarity=0.283  Sum_probs=203.0

Q ss_pred             hcCCccCccccccCCccEEEEEEc-CCCEEEEEEecCCC---chhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEE
Q 017594           48 TNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS---GQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILI  123 (369)
Q Consensus        48 ~~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv  123 (369)
                      .++|++++.||+|+||.||+|+.+ +|+.||+|++....   ....+.+.+|+.+++.++||||+++++++.+....++|
T Consensus        40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv  119 (350)
T 1rdq_E           40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV  119 (350)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence            478999999999999999999976 48999999986432   23356788899999999999999999999999999999


Q ss_pred             EEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCC
Q 017594          124 YEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGG  203 (369)
Q Consensus       124 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~  203 (369)
                      |||+.+++|.+++..   ...+++..++.++.||+.||.|||++|   ++||||||+||+++.++.++|+|||++.....
T Consensus       120 ~e~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~  193 (350)
T 1rdq_E          120 MEYVAGGEMFSHLRR---IGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG  193 (350)
T ss_dssp             EECCTTCBHHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred             EcCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEcccccceeccC
Confidence            999999999998854   234899999999999999999999999   99999999999999999999999999987643


Q ss_pred             CCcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCccccccCcc
Q 017594          204 NELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPI  283 (369)
Q Consensus       204 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (369)
                      .     .....|++.|+|||++.+..++.++|+|||||++|+|++|..||.......     ....... ... .     
T Consensus       194 ~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~-----~~~~i~~-~~~-~-----  256 (350)
T 1rdq_E          194 R-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ-----IYEKIVS-GKV-R-----  256 (350)
T ss_dssp             C-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-----HHHHHHH-CCC-C-----
T ss_pred             C-----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHH-----HHHHHHc-CCC-C-----
Confidence            2     223468999999999999999999999999999999999999986432111     1111111 100 0     


Q ss_pred             ccccccHHHHHHHHHHHHHHhhcCCCCCCCC-----HHHHHH
Q 017594          284 LEDEYSSKQMLLRYANIALLCVQESADDRPT-----MNDVVS  320 (369)
Q Consensus       284 ~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps-----~~ell~  320 (369)
                      +.     ..++.++.++|.+||+.||++||+     +.+|++
T Consensus       257 ~p-----~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~  293 (350)
T 1rdq_E          257 FP-----SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             CC-----TTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             CC-----CCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence            01     112567999999999999999998     888875

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=4.6e-42  Score=316.32  Aligned_cols=249  Identities=24%  Similarity=0.303  Sum_probs=193.8

Q ss_pred             HhcCCccCccccccCCccEEEEEE----cCCCEEEEEEecCCC----chhHHHHHHHHHHHhcCCCCceeeeeeeEEeCC
Q 017594           47 ATNKFSDANKLGEGGFGPVYKGVL----KKGDEIAVKRLSGRS----GQGLREMKNEASVIAKVQHKNLVRLLGCCIDRD  118 (369)
Q Consensus        47 ~~~~y~i~~~lg~G~~~~v~~~~~----~~~~~valK~~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~  118 (369)
                      ..++|++.+.||+|+||.||+|+.    .+|+.||+|++....    ......+..|+.+++.++||||+++++++...+
T Consensus        15 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~   94 (327)
T 3a62_A           15 RPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGG   94 (327)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSS
T ss_pred             CHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCC
Confidence            357899999999999999999996    468999999987542    233456778999999999999999999999999


Q ss_pred             ccEEEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCc
Q 017594          119 EKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMA  198 (369)
Q Consensus       119 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~  198 (369)
                      ..++||||+.+++|.+++..   ...+++..++.++.||+.||.|||++|   ++||||||+||+++.++.++|+|||++
T Consensus        95 ~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~~  168 (327)
T 3a62_A           95 KLYLILEYLSGGELFMQLER---EGIFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLC  168 (327)
T ss_dssp             CEEEEEECCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEECCCSCC
T ss_pred             EEEEEEeCCCCCcHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEEeCCcc
Confidence            99999999999999988853   344889999999999999999999999   999999999999999999999999998


Q ss_pred             eecCCCCcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCcccc
Q 017594          199 RICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLE  278 (369)
Q Consensus       199 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (369)
                      .......  .......|++.|+|||++.+..++.++||||||+++|+|++|..||.......     .........  . 
T Consensus       169 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-----~~~~i~~~~--~-  238 (327)
T 3a62_A          169 KESIHDG--TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKK-----TIDKILKCK--L-  238 (327)
T ss_dssp             ------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-----HHHHHHHTC--C-
T ss_pred             cccccCC--ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHH-----HHHHHHhCC--C-
Confidence            7543221  12233468999999999998899999999999999999999999996433111     111111100  0 


Q ss_pred             ccCccccccccHHHHHHHHHHHHHHhhcCCCCCCC-----CHHHHHH
Q 017594          279 LIDPILEDEYSSKQMLLRYANIALLCVQESADDRP-----TMNDVVS  320 (369)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp-----s~~ell~  320 (369)
                          .+.     ..++..+.++|.+||+.||++||     ++.++++
T Consensus       239 ----~~p-----~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~  276 (327)
T 3a62_A          239 ----NLP-----PYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA  276 (327)
T ss_dssp             ----CCC-----TTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred             ----CCC-----CCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence                000     11256799999999999999999     7788876

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=4.8e-42  Score=314.83  Aligned_cols=268  Identities=25%  Similarity=0.326  Sum_probs=187.2

Q ss_pred             HhcCCccCccccccCCccEEEEEEc-CCCEEEEEEecCCC-chhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEEE
Q 017594           47 ATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIY  124 (369)
Q Consensus        47 ~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  124 (369)
                      ..++|++++.||+|+||.||+|.++ +|+.||+|++.... ......+.+|+.+++.++||||+++++++..++..++||
T Consensus         3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   82 (317)
T 2pmi_A            3 SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVF   82 (317)
T ss_dssp             ----------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEE
T ss_pred             cccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEE
Confidence            3578999999999999999999965 48999999986543 233467889999999999999999999999999999999


Q ss_pred             EecCCCChhhhhcCC---CccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceec
Q 017594          125 EYMPNKSLDFFLFDP---TKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARIC  201 (369)
Q Consensus       125 e~~~~~~L~~~l~~~---~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~  201 (369)
                      ||+.+ +|.+++...   .....+++..++.++.||+.||.|||+.|   ++||||||+||+++.++.++|+|||++...
T Consensus        83 e~~~~-~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~  158 (317)
T 2pmi_A           83 EFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAF  158 (317)
T ss_dssp             ECCCC-BHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCSSCEET
T ss_pred             EecCC-CHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEECcCccceec
Confidence            99984 787776432   11234889999999999999999999999   999999999999999999999999999876


Q ss_pred             CCCCcccccccccccccccCchhhcc-CCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccch---------hhhhhh
Q 017594          202 GGNELQANTSRIVGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLG---------YAWDLW  271 (369)
Q Consensus       202 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~---------~~~~~~  271 (369)
                      ....  .......+++.|+|||++.+ ..++.++|||||||++|+|++|..||............         ..+...
T Consensus       159 ~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  236 (317)
T 2pmi_A          159 GIPV--NTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSV  236 (317)
T ss_dssp             TSCC--CCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGG
T ss_pred             CCCc--ccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhh
Confidence            4322  12233467999999999876 46899999999999999999999999754321110000         000000


Q ss_pred             h-cCccccccCccccc-------cccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 017594          272 T-SNRTLELIDPILED-------EYSSKQMLLRYANIALLCVQESADDRPTMNDVVS  320 (369)
Q Consensus       272 ~-~~~~~~~~~~~~~~-------~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~  320 (369)
                      . .......+......       .......+.++.+||.+||+.||++|||+.++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~  293 (317)
T 2pmi_A          237 TKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH  293 (317)
T ss_dssp             GGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             hhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence            0 00000000000000       0000112567999999999999999999999986

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=1.9e-41  Score=306.21  Aligned_cols=256  Identities=26%  Similarity=0.487  Sum_probs=201.2

Q ss_pred             HhcCCccCccccccCCccEEEEEEc-CCCEEEEEEecCCCchh-------HHHHHHHHHHHhcCCCCceeeeeeeEEeCC
Q 017594           47 ATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSGQG-------LREMKNEASVIAKVQHKNLVRLLGCCIDRD  118 (369)
Q Consensus        47 ~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~~~~~-------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~  118 (369)
                      ..++|++.+.||+|+||.||+|++. +++.||+|++.......       .+.+.+|+.+++.++||||+++++++.+  
T Consensus        17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--   94 (287)
T 4f0f_A           17 ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHN--   94 (287)
T ss_dssp             CSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETT--
T ss_pred             hhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecC--
Confidence            4578999999999999999999975 58999999986543221       2678899999999999999999999854  


Q ss_pred             ccEEEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCc-----eEEe
Q 017594          119 EKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMN-----PKIS  193 (369)
Q Consensus       119 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~-----~~L~  193 (369)
                      ..++||||+.+++|.+.+...  ...+++..++.++.|++.||.|||+++ ++++|+||||+||+++.++.     ++|+
T Consensus        95 ~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~~~~~~~~~kl~  171 (287)
T 4f0f_A           95 PPRMVMEFVPCGDLYHRLLDK--AHPIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVA  171 (287)
T ss_dssp             TTEEEEECCTTCBHHHHHHCT--TSCCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCCCTTCSCCEEEC
T ss_pred             CCeEEEEecCCCCHHHHHhcc--cCCccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEeccCCCCceeEEeC
Confidence            348999999999998877543  335899999999999999999999875 23999999999999988776     9999


Q ss_pred             ecCCceecCCCCcccccccccccccccCchhhc--cCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhh
Q 017594          194 DFGMARICGGNELQANTSRIVGTYGYMSPEYAL--EGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLW  271 (369)
Q Consensus       194 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~  271 (369)
                      |||++.....     ......+++.|+|||++.  ...++.++|||||||++|+|++|..||...........   ... 
T Consensus       172 Dfg~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~---~~~-  242 (287)
T 4f0f_A          172 DFGLSQQSVH-----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFI---NMI-  242 (287)
T ss_dssp             CCTTCBCCSS-----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHH---HHH-
T ss_pred             CCCccccccc-----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHH---HHH-
Confidence            9999874332     233456899999999983  55678999999999999999999999975442221111   000 


Q ss_pred             hcCccccccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHhh
Q 017594          272 TSNRTLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNE  325 (369)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L~~~  325 (369)
                      .......    ....     .++..+.++|.+||+.||++|||+.++++.|+++
T Consensus       243 ~~~~~~~----~~~~-----~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l  287 (287)
T 4f0f_A          243 REEGLRP----TIPE-----DCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL  287 (287)
T ss_dssp             HHSCCCC----CCCT-----TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred             hccCCCC----CCCc-----ccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence            1111111    1111     1256799999999999999999999999999864

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=7.9e-42  Score=316.80  Aligned_cols=254  Identities=23%  Similarity=0.347  Sum_probs=201.8

Q ss_pred             hcCCccCccccccCCccEEEEEEcC-CCEEEEEEecCC---CchhHHHHHHHHHHHhcC-CCCceeeeeeeEEeCCccEE
Q 017594           48 TNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGR---SGQGLREMKNEASVIAKV-QHKNLVRLLGCCIDRDEKIL  122 (369)
Q Consensus        48 ~~~y~i~~~lg~G~~~~v~~~~~~~-~~~valK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~l  122 (369)
                      .++|++.+.||+|+||.||+|+.+. |+.||+|++...   .......+..|..++..+ +||||+++++++...+..++
T Consensus         8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l   87 (345)
T 3a8x_A            8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF   87 (345)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEE
Confidence            4689999999999999999999764 888999998743   233456678899999988 89999999999999999999


Q ss_pred             EEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecC
Q 017594          123 IYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICG  202 (369)
Q Consensus       123 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~  202 (369)
                      ||||+.+++|..++..   ...+++..++.++.||+.||.|||+++   ++||||||+||+++.++.++|+|||++....
T Consensus        88 v~e~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~  161 (345)
T 3a8x_A           88 VIEYVNGGDLMFHMQR---QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL  161 (345)
T ss_dssp             EECCCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCGGGCBCSC
T ss_pred             EEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEecccccccc
Confidence            9999999999988853   334899999999999999999999999   9999999999999999999999999987543


Q ss_pred             CCCcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCccccc---ccchhhhhhhhcCccccc
Q 017594          203 GNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSL---NLLGYAWDLWTSNRTLEL  279 (369)
Q Consensus       203 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~  279 (369)
                      ...  .......|++.|+|||++.+..++.++|+|||||++|+|++|..||........   ...............   
T Consensus       162 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~---  236 (345)
T 3a8x_A          162 RPG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI---  236 (345)
T ss_dssp             CTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCC---
T ss_pred             CCC--CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCC---
Confidence            221  123345789999999999999999999999999999999999999964321110   000111111111110   


Q ss_pred             cCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCH------HHHHH
Q 017594          280 IDPILEDEYSSKQMLLRYANIALLCVQESADDRPTM------NDVVS  320 (369)
Q Consensus       280 ~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~------~ell~  320 (369)
                         .+.     ..++.++.++|.+||+.||.+||++      .++++
T Consensus       237 ---~~p-----~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~  275 (345)
T 3a8x_A          237 ---RIP-----RSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG  275 (345)
T ss_dssp             ---CCC-----TTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHT
T ss_pred             ---CCC-----CCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhc
Confidence               011     1125679999999999999999996      56664

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=1.5e-41  Score=312.10  Aligned_cols=253  Identities=24%  Similarity=0.284  Sum_probs=205.4

Q ss_pred             HHhcCCccCccccccCCccEEEEEEc-CCCEEEEEEecCCCch------hHHHHHHHHHHHhcCCCCceeeeeeeEEeCC
Q 017594           46 TATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSGQ------GLREMKNEASVIAKVQHKNLVRLLGCCIDRD  118 (369)
Q Consensus        46 ~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~~~~------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~  118 (369)
                      ...++|++.+.||+|+||.||+|+++ +|+.||+|++......      ..+.+.+|+.+++.++||||+++++++....
T Consensus         9 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   88 (321)
T 2a2a_A            9 KVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRT   88 (321)
T ss_dssp             CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred             hhhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCC
Confidence            35678999999999999999999976 4899999998754321      3567889999999999999999999999999


Q ss_pred             ccEEEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCC----ceEEee
Q 017594          119 EKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDM----NPKISD  194 (369)
Q Consensus       119 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~----~~~L~D  194 (369)
                      ..++||||+.+++|.+++...   ..+++..++.++.||+.||.|||+.|   ++|+||+|+||+++.++    .++|+|
T Consensus        89 ~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~~kl~D  162 (321)
T 2a2a_A           89 DVVLILELVSGGELFDFLAQK---ESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLID  162 (321)
T ss_dssp             EEEEEECCCCSCBHHHHHHTC---SCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECC
T ss_pred             EEEEEEEcCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCCEEEcc
Confidence            999999999999999998543   34889999999999999999999999   99999999999999888    799999


Q ss_pred             cCCceecCCCCcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcC
Q 017594          195 FGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSN  274 (369)
Q Consensus       195 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~  274 (369)
                      ||++.......   ......+++.|+|||++.+..++.++||||||+++|+|++|..||.......     .........
T Consensus       163 fg~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-----~~~~i~~~~  234 (321)
T 2a2a_A          163 FGLAHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE-----TLANITSVS  234 (321)
T ss_dssp             CTTCEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH-----HHHHHHTTC
T ss_pred             CccceecCccc---cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHH-----HHHHHHhcc
Confidence            99998765432   2233468999999999999999999999999999999999999986432111     000000000


Q ss_pred             ccccccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 017594          275 RTLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVS  320 (369)
Q Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~  320 (369)
                       .  .....     .....+..+.++|.+||+.||++|||+.++++
T Consensus       235 -~--~~~~~-----~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~  272 (321)
T 2a2a_A          235 -Y--DFDEE-----FFSHTSELAKDFIRKLLVKETRKRLTIQEALR  272 (321)
T ss_dssp             -C--CCCHH-----HHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred             -c--ccChh-----hhcccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence             0  00000     01122567899999999999999999999987

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=1.1e-42  Score=322.13  Aligned_cols=251  Identities=25%  Similarity=0.372  Sum_probs=201.0

Q ss_pred             HHHHhcCCccCccccccCCccEEEEEEcC-CCEEEEEEecCCC---chhHHHHHHHHHHHhcC-CCCceeeeeeeEEeCC
Q 017594           44 VSTATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRS---GQGLREMKNEASVIAKV-QHKNLVRLLGCCIDRD  118 (369)
Q Consensus        44 ~~~~~~~y~i~~~lg~G~~~~v~~~~~~~-~~~valK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~  118 (369)
                      .....++|++.+.||+|+||.||+|+.+. |+.||+|++....   ......+..|..++..+ +||||+++++++.+.+
T Consensus        12 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~   91 (345)
T 1xjd_A           12 IKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKE   91 (345)
T ss_dssp             ----CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSS
T ss_pred             CCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCC
Confidence            34556899999999999999999999764 8899999986431   23345677888888876 8999999999999999


Q ss_pred             ccEEEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCc
Q 017594          119 EKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMA  198 (369)
Q Consensus       119 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~  198 (369)
                      ..|+||||+.+++|..++..   ...+++..++.++.||+.||.|||++|   ++||||||+||+++.+|.++|+|||++
T Consensus        92 ~~~lv~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a  165 (345)
T 1xjd_A           92 NLFFVMEYLNGGDLMYHIQS---CHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMC  165 (345)
T ss_dssp             EEEEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTC
T ss_pred             EEEEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEEeEChhh
Confidence            99999999999999998853   334899999999999999999999999   999999999999999999999999998


Q ss_pred             eecCCCCcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCcccc
Q 017594          199 RICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLE  278 (369)
Q Consensus       199 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (369)
                      .......  .......|++.|+|||++.+..++.++|+|||||++|+|++|..||.......     ....... ..   
T Consensus       166 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~-----~~~~i~~-~~---  234 (345)
T 1xjd_A          166 KENMLGD--AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE-----LFHSIRM-DN---  234 (345)
T ss_dssp             BCCCCTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-----HHHHHHH-CC---
T ss_pred             hhcccCC--CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHH-----HHHHHHh-CC---
Confidence            7543221  12334578999999999999999999999999999999999999996432111     1111111 10   


Q ss_pred             ccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHH-HHH
Q 017594          279 LIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMN-DVV  319 (369)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~-ell  319 (369)
                         ....     ..++.++.++|.+||+.||++||++. +|+
T Consensus       235 ---~~~p-----~~~s~~~~~li~~lL~~dp~~R~~~~~~i~  268 (345)
T 1xjd_A          235 ---PFYP-----RWLEKEAKDLLVKLFVREPEKRLGVRGDIR  268 (345)
T ss_dssp             ---CCCC-----TTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred             ---CCCC-----cccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence               0011     11256799999999999999999997 665

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=7.1e-42  Score=312.29  Aligned_cols=266  Identities=24%  Similarity=0.333  Sum_probs=195.4

Q ss_pred             HHHhcCCccCccccccCCccEEEEEEc-CCCEEEEEEecCCC-----chhHHHHHHHHHHHhcC---CCCceeeeeeeEE
Q 017594           45 STATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS-----GQGLREMKNEASVIAKV---QHKNLVRLLGCCI  115 (369)
Q Consensus        45 ~~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~~-----~~~~~~~~~e~~~l~~l---~h~~i~~~~~~~~  115 (369)
                      ....++|++.+.||+|+||.||+|++. +|+.||+|++....     ........+|+.+++.+   .||||+++++++.
T Consensus         5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~   84 (308)
T 3g33_A            5 SMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCA   84 (308)
T ss_dssp             -----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEE
T ss_pred             cccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeee
Confidence            456789999999999999999999964 58999999986322     11224556677776666   4999999999998


Q ss_pred             eCC-----ccEEEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCce
Q 017594          116 DRD-----EKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNP  190 (369)
Q Consensus       116 ~~~-----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~  190 (369)
                      ...     ..++++|++.+ +|.+++..... ..+++..++.++.||+.||+|||+++   ++||||||+||+++.++.+
T Consensus        85 ~~~~~~~~~~~lv~e~~~~-~L~~~~~~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~  159 (308)
T 3g33_A           85 TSRTDREIKVTLVFEHVDQ-DLRTYLDKAPP-PGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTV  159 (308)
T ss_dssp             ECCSSSEEEEEEEEECCCC-BHHHHHHTCCT-TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEECTTSCE
T ss_pred             ccCCCCceeEEEEehhhhc-CHHHHHhhccC-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCE
Confidence            765     47999999974 88888765332 34899999999999999999999999   9999999999999999999


Q ss_pred             EEeecCCceecCCCCcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhh
Q 017594          191 KISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDL  270 (369)
Q Consensus       191 ~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~  270 (369)
                      +|+|||++.......   ......+++.|+|||++.+..++.++|||||||++|+|++|.+||.........  ......
T Consensus       160 kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~--~~i~~~  234 (308)
T 3g33_A          160 KLADFGLARIYSYQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQL--GKIFDL  234 (308)
T ss_dssp             EECSCSCTTTSTTCC---CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHH--HHHHHH
T ss_pred             EEeeCccccccCCCc---ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHH--HHHHHH
Confidence            999999987654322   223456899999999999999999999999999999999999999654321110  000000


Q ss_pred             hh---cCccc---cccCcccc----cc--ccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 017594          271 WT---SNRTL---ELIDPILE----DE--YSSKQMLLRYANIALLCVQESADDRPTMNDVVS  320 (369)
Q Consensus       271 ~~---~~~~~---~~~~~~~~----~~--~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~  320 (369)
                      ..   .....   ......+.    ..  .....++..+.+||.+||+.||++|||+.++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  296 (308)
T 3g33_A          235 IGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ  296 (308)
T ss_dssp             HCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             hCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence            00   00000   00000000    00  001122567899999999999999999999986

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=2.8e-42  Score=318.39  Aligned_cols=268  Identities=26%  Similarity=0.368  Sum_probs=212.7

Q ss_pred             hHHHHhcCCccCccccccCCccEEEEEEcC-C-----CEEEEEEecCCC-chhHHHHHHHHHHHhcC-CCCceeeeeeeE
Q 017594           43 SVSTATNKFSDANKLGEGGFGPVYKGVLKK-G-----DEIAVKRLSGRS-GQGLREMKNEASVIAKV-QHKNLVRLLGCC  114 (369)
Q Consensus        43 ~~~~~~~~y~i~~~lg~G~~~~v~~~~~~~-~-----~~valK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~  114 (369)
                      ......++|++.+.||+|+||.||+|.+.. +     ..|++|.+.... ....+.+.+|+.+++.+ +||||+++++++
T Consensus        40 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~  119 (333)
T 2i1m_A           40 KWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGAC  119 (333)
T ss_dssp             GGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             cccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence            445567889999999999999999999653 2     479999987543 33456788999999999 899999999999


Q ss_pred             EeCCccEEEEEecCCCChhhhhcCCCc-----------cccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEE
Q 017594          115 IDRDEKILIYEYMPNKSLDFFLFDPTK-----------RMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNIL  183 (369)
Q Consensus       115 ~~~~~~~lv~e~~~~~~L~~~l~~~~~-----------~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIl  183 (369)
                      ...+..++||||+.+++|.+++.....           ...+++..++.++.||+.||.|||+++   ++||||||+||+
T Consensus       120 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl  196 (333)
T 2i1m_A          120 THGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVL  196 (333)
T ss_dssp             CSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGCE
T ss_pred             ecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccceEE
Confidence            999999999999999999988854211           234789999999999999999999999   999999999999


Q ss_pred             EeCCCceEEeecCCceecCCCCcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHh-CCCCCCCCcccccc
Q 017594          184 LDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLN  262 (369)
Q Consensus       184 v~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~t-g~~p~~~~~~~~~~  262 (369)
                      ++.++.++|+|||++................++..|+|||++.+..++.++||||||+++|+|++ |..||........ 
T Consensus       197 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~-  275 (333)
T 2i1m_A          197 LTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSK-  275 (333)
T ss_dssp             EEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHH-
T ss_pred             ECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHH-
Confidence            99999999999999986644332222333456788999999998899999999999999999998 8899864332110 


Q ss_pred             cchhhhhhhhcCccccccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHhhhhc
Q 017594          263 LLGYAWDLWTSNRTLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNEAAT  328 (369)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L~~~~~~  328 (369)
                          ..........     ....     ...+..+.++|.+||+.||.+|||+.++++.|+.+...
T Consensus       276 ----~~~~~~~~~~-----~~~~-----~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~  327 (333)
T 2i1m_A          276 ----FYKLVKDGYQ-----MAQP-----AFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQE  327 (333)
T ss_dssp             ----HHHHHHHTCC-----CCCC-----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ----HHHHHhcCCC-----CCCC-----CCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHh
Confidence                1111111100     0000     11156689999999999999999999999999887653

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=4.2e-42  Score=318.67  Aligned_cols=263  Identities=20%  Similarity=0.227  Sum_probs=202.6

Q ss_pred             hhHHHHhcCCccCccccccCCccEEEEEEc-CCCEEEEEEecCC-----CchhHHHHHHHHHHHhcCCCCceeeeeeeEE
Q 017594           42 SSVSTATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGR-----SGQGLREMKNEASVIAKVQHKNLVRLLGCCI  115 (369)
Q Consensus        42 ~~~~~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~-----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~  115 (369)
                      ..+..+.++|++.+.||+|+||.||+|+++ ++..||+|++...     .....+.+..|+.+++.++||||+++++++.
T Consensus        19 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~   98 (345)
T 3hko_A           19 GSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYE   98 (345)
T ss_dssp             BCHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred             chhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhc
Confidence            345678899999999999999999999975 4888999998533     2344578889999999999999999999999


Q ss_pred             eCCccEEEEEecCCCChhhhhcCCC-------------------------------------ccccCChHHHHHHHHHHH
Q 017594          116 DRDEKILIYEYMPNKSLDFFLFDPT-------------------------------------KRMLLDWVTRVQIIEGIA  158 (369)
Q Consensus       116 ~~~~~~lv~e~~~~~~L~~~l~~~~-------------------------------------~~~~~~~~~~~~i~~qi~  158 (369)
                      +.+..++||||+.+++|.+++....                                     ....+++..++.++.||+
T Consensus        99 ~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~  178 (345)
T 3hko_A           99 DEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIF  178 (345)
T ss_dssp             CSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHH
T ss_pred             cCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHH
Confidence            9999999999999999998884210                                     012245677889999999


Q ss_pred             HHHHHHhcCCCCCcccCCCCCCCEEEeCCC--ceEEeecCCceecCCCCc--ccccccccccccccCchhhcc--CCCCc
Q 017594          159 QGLLYLHQYSRVRIIHRDLKASNILLDKDM--NPKISDFGMARICGGNEL--QANTSRIVGTYGYMSPEYALE--GIFSI  232 (369)
Q Consensus       159 ~al~~LH~~~~~~i~H~dl~p~NIlv~~~~--~~~L~Dfg~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~--~~~~~  232 (369)
                      .||+|||+.+   ++||||||+||+++.++  .++|+|||++..+.....  ........+++.|+|||++.+  ..++.
T Consensus       179 ~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~  255 (345)
T 3hko_A          179 SALHYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGP  255 (345)
T ss_dssp             HHHHHHHHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCT
T ss_pred             HHHHHHHHCC---ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCc
Confidence            9999999999   99999999999998776  899999999986643221  112234568999999999875  67899


Q ss_pred             ccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCccccccCccccccccHHHHHHHHHHHHHHhhcCCCCCC
Q 017594          233 KSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYSSKQMLLRYANIALLCVQESADDR  312 (369)
Q Consensus       233 ~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R  312 (369)
                      ++|||||||++|+|++|..||.......     ............  ..+      ....++..+.++|.+||+.||.+|
T Consensus       256 ~~DiwslG~il~el~~g~~pf~~~~~~~-----~~~~~~~~~~~~--~~~------~~~~~~~~~~~li~~~l~~~p~~R  322 (345)
T 3hko_A          256 KCDAWSAGVLLHLLLMGAVPFPGVNDAD-----TISQVLNKKLCF--ENP------NYNVLSPLARDLLSNLLNRNVDER  322 (345)
T ss_dssp             HHHHHHHHHHHHHHHHSSCSSCCSSHHH-----HHHHHHHCCCCT--TSG------GGGGSCHHHHHHHHHHSCSCTTTS
T ss_pred             HHHHHHHHHHHHHHHHCCCCCCCCChHH-----HHHHHHhccccc--CCc------ccccCCHHHHHHHHHHcCCChhHC
Confidence            9999999999999999999996443211     111111111000  000      011125679999999999999999


Q ss_pred             CCHHHHHH
Q 017594          313 PTMNDVVS  320 (369)
Q Consensus       313 ps~~ell~  320 (369)
                      |++.++++
T Consensus       323 ps~~~~l~  330 (345)
T 3hko_A          323 FDAMRALQ  330 (345)
T ss_dssp             CCHHHHHH
T ss_pred             CCHHHHhc
Confidence            99999987

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=7.6e-42  Score=308.04  Aligned_cols=254  Identities=24%  Similarity=0.391  Sum_probs=206.3

Q ss_pred             HHHhcCCccCccccccCCccEEEEEEc-CCCEEEEEEecCCCchhHHHHHHHHHHHhcCCCCceeeeeeeEEe-------
Q 017594           45 STATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCID-------  116 (369)
Q Consensus        45 ~~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-------  116 (369)
                      .....+|++.+.||+|+||.||+|++. +|+.||+|++....    ..+.+|+.+++.++||||+++++++..       
T Consensus         7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   82 (284)
T 2a19_B            7 KRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPET   82 (284)
T ss_dssp             HHHHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---
T ss_pred             chhccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccc
Confidence            456788999999999999999999976 58999999997554    356789999999999999999998854       


Q ss_pred             ---------CCccEEEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCC
Q 017594          117 ---------RDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKD  187 (369)
Q Consensus       117 ---------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~  187 (369)
                               ....++||||+.+++|.+++... ....+++..++.++.||+.||.|||+.+   ++|+||+|+||+++.+
T Consensus        83 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~  158 (284)
T 2a19_B           83 SSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKR-RGEKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDT  158 (284)
T ss_dssp             ------CCEEEEEEEEECCCCSCBHHHHHHHG-GGSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEET
T ss_pred             ccccccccCcceEEEEEeccCCCCHHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHEEEcCC
Confidence                     34579999999999999998542 2345889999999999999999999999   9999999999999999


Q ss_pred             CceEEeecCCceecCCCCcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhh
Q 017594          188 MNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYA  267 (369)
Q Consensus       188 ~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~  267 (369)
                      +.++|+|||++........   .....+++.|+|||++.+..++.++||||||+++|+|++|..|+....        ..
T Consensus       159 ~~~kl~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~--------~~  227 (284)
T 2a19_B          159 KQVKIGDFGLVTSLKNDGK---RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETS--------KF  227 (284)
T ss_dssp             TEEEECCCTTCEESSCCSC---CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHH--------HH
T ss_pred             CCEEECcchhheecccccc---ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHH--------HH
Confidence            9999999999887654322   223468999999999999899999999999999999999998753110        00


Q ss_pred             hhhhhcCccccccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHhhhhccC
Q 017594          268 WDLWTSNRTLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNEAATLL  330 (369)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L~~~~~~~~  330 (369)
                      .......        .+..     .++..+.++|.+||+.||++|||+.++++.|..+.....
T Consensus       228 ~~~~~~~--------~~~~-----~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~  277 (284)
T 2a19_B          228 FTDLRDG--------IISD-----IFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPE  277 (284)
T ss_dssp             HHHHHTT--------CCCT-----TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC---
T ss_pred             HHHhhcc--------cccc-----cCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCC
Confidence            0000000        1111     125568999999999999999999999999999887544

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=2.6e-41  Score=306.98  Aligned_cols=265  Identities=26%  Similarity=0.365  Sum_probs=206.4

Q ss_pred             HHHhcCCccCccccccCCccEEEEEEcC----CCEEEEEEecCCC-chhHHHHHHHHHHHhcCCCCceeeeeeeEE-eCC
Q 017594           45 STATNKFSDANKLGEGGFGPVYKGVLKK----GDEIAVKRLSGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCCI-DRD  118 (369)
Q Consensus        45 ~~~~~~y~i~~~lg~G~~~~v~~~~~~~----~~~valK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~  118 (369)
                      .....+|++.+.||+|+||.||+|++.+    +..+++|.+.... ....+.+.+|+.++++++||||+++++++. .++
T Consensus        21 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  100 (298)
T 3f66_A           21 GPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEG  100 (298)
T ss_dssp             CGGGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSS
T ss_pred             CccceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCC
Confidence            4456789999999999999999999543    2358999887543 344567889999999999999999999864 456


Q ss_pred             ccEEEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCc
Q 017594          119 EKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMA  198 (369)
Q Consensus       119 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~  198 (369)
                      ..++||||+.+++|.+++...  ...+++..++.++.|++.||.|||+++   ++||||||+||+++.++.++|+|||++
T Consensus       101 ~~~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~a  175 (298)
T 3f66_A          101 SPLVVLPYMKHGDLRNFIRNE--THNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLA  175 (298)
T ss_dssp             CCEEEEECCTTCBHHHHHHCT--TCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSCGGG
T ss_pred             ceEEEEeCCCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEECccccc
Confidence            789999999999999998653  334788999999999999999999999   999999999999999999999999999


Q ss_pred             eecCCCCccc--ccccccccccccCchhhccCCCCcccchHhHHHHHHHHHh-CCCCCCCCcccccccchhhhhhhhcCc
Q 017594          199 RICGGNELQA--NTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDLWTSNR  275 (369)
Q Consensus       199 ~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~  275 (369)
                      ..........  ......+++.|+|||.+.+..++.++||||||+++|+|++ |.+||........     ........ 
T Consensus       176 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~-----~~~~~~~~-  249 (298)
T 3f66_A          176 RDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI-----TVYLLQGR-  249 (298)
T ss_dssp             CCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTH-----HHHHHTTC-
T ss_pred             ccccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHH-----HHHHhcCC-
Confidence            8665432211  1223456778999999999999999999999999999999 5556543322111     00110000 


Q ss_pred             cccccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHhhhhccC
Q 017594          276 TLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNEAATLL  330 (369)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L~~~~~~~~  330 (369)
                       ...    .     +..++..+.+++.+||+.||++|||+.++++.|+.+.....
T Consensus       250 -~~~----~-----~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~  294 (298)
T 3f66_A          250 -RLL----Q-----PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI  294 (298)
T ss_dssp             -CCC----C-----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTSC
T ss_pred             -CCC----C-----CccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhc
Confidence             000    0     11125569999999999999999999999999999988654

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.2e-41  Score=304.80  Aligned_cols=263  Identities=24%  Similarity=0.317  Sum_probs=206.2

Q ss_pred             cCCccCccccccCCccEEEEEEcC-CC---EEEEEEecCCC-chhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCcc-EE
Q 017594           49 NKFSDANKLGEGGFGPVYKGVLKK-GD---EIAVKRLSGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEK-IL  122 (369)
Q Consensus        49 ~~y~i~~~lg~G~~~~v~~~~~~~-~~---~valK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~-~l  122 (369)
                      .+|.+.+.||+|+||.||+|++.+ +.   .|++|.+.... ....+.+.+|+.+++.++||||+++++++...+.. ++
T Consensus        21 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  100 (298)
T 3pls_A           21 VVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHV  100 (298)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred             eEEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEE
Confidence            456778999999999999999543 32   69999987543 34457788999999999999999999999876665 99


Q ss_pred             EEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecC
Q 017594          123 IYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICG  202 (369)
Q Consensus       123 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~  202 (369)
                      ++||+.+++|.+++...  ...+++..++.++.|++.||.|||+.|   ++||||||+||+++.++.++|+|||++....
T Consensus       101 v~e~~~~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~  175 (298)
T 3pls_A          101 LLPYMCHGDLLQFIRSP--QRNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARDIL  175 (298)
T ss_dssp             EECCCTTCBHHHHHHCT--TCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECCTTSSCTTT
T ss_pred             EEecccCCCHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEeCcCCCccccc
Confidence            99999999999998653  344788899999999999999999999   9999999999999999999999999997654


Q ss_pred             CCCc--ccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCC-CCCcccccccchhhhhhhhcCccccc
Q 017594          203 GNEL--QANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNT-GLYRTDSLNLLGYAWDLWTSNRTLEL  279 (369)
Q Consensus       203 ~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~-~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (369)
                      ....  ........++..|+|||.+.+..++.++||||||+++|+|++|..|+ .......     . ........... 
T Consensus       176 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~-----~-~~~~~~~~~~~-  248 (298)
T 3pls_A          176 DREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFD-----L-THFLAQGRRLP-  248 (298)
T ss_dssp             TGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGG-----H-HHHHHTTCCCC-
T ss_pred             CCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHH-----H-HHHhhcCCCCC-
Confidence            3321  11223345788999999999999999999999999999999965554 3221111     0 00000110000 


Q ss_pred             cCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHhhhhccCCC
Q 017594          280 IDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNEAATLLPP  332 (369)
Q Consensus       280 ~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L~~~~~~~~~~  332 (369)
                          .     +..++..+.+++.+||+.||.+|||+.++++.|+++...+...
T Consensus       249 ----~-----~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~~~  292 (298)
T 3pls_A          249 ----Q-----PEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLGD  292 (298)
T ss_dssp             ----C-----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCCSC
T ss_pred             ----C-----CccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHhcc
Confidence                0     1112566999999999999999999999999999998876544

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=3.8e-42  Score=324.29  Aligned_cols=267  Identities=23%  Similarity=0.327  Sum_probs=191.9

Q ss_pred             HHHhcCCccCccccccCCccEEEEEEc-CCCEEEEEEecCC--CchhHHHHHHHHHHHhcCC-CCceeeeeeeEEeCC--
Q 017594           45 STATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGR--SGQGLREMKNEASVIAKVQ-HKNLVRLLGCCIDRD--  118 (369)
Q Consensus        45 ~~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~--  118 (369)
                      ....++|++++.||+|+||.||+|.+. +|+.||+|++...  .......+.+|+.+++.+. ||||+++++++...+  
T Consensus         5 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~   84 (388)
T 3oz6_A            5 RHVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDR   84 (388)
T ss_dssp             HHHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSS
T ss_pred             CcccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCC
Confidence            356789999999999999999999965 4899999998543  3345567788999999997 999999999997544  


Q ss_pred             ccEEEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCc
Q 017594          119 EKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMA  198 (369)
Q Consensus       119 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~  198 (369)
                      ..|+||||+++ +|..++..    ..+++..+..++.||+.||.|||+.|   ++||||||+||+++.++.++|+|||++
T Consensus        85 ~~~lv~e~~~~-~L~~~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a  156 (388)
T 3oz6_A           85 DVYLVFDYMET-DLHAVIRA----NILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLS  156 (388)
T ss_dssp             CEEEEEECCSE-EHHHHHHH----TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             EEEEEecccCc-CHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEecCCccc
Confidence            68999999974 77777743    35889999999999999999999999   999999999999999999999999999


Q ss_pred             eecCCCCc-------------------ccccccccccccccCchhhcc-CCCCcccchHhHHHHHHHHHhCCCCCCCCcc
Q 017594          199 RICGGNEL-------------------QANTSRIVGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRT  258 (369)
Q Consensus       199 ~~~~~~~~-------------------~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~tg~~p~~~~~~  258 (369)
                      ..+.....                   ........|++.|+|||++.+ ..++.++|||||||++|+|++|.+||.....
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~  236 (388)
T 3oz6_A          157 RSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSST  236 (388)
T ss_dssp             EESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred             ccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence            87643110                   111233568999999999876 6789999999999999999999999975432


Q ss_pred             cccccchhhhhhhhcCc-----------c--------------ccccCcccc-------ccccHHHHHHHHHHHHHHhhc
Q 017594          259 DSLNLLGYAWDLWTSNR-----------T--------------LELIDPILE-------DEYSSKQMLLRYANIALLCVQ  306 (369)
Q Consensus       259 ~~~~~~~~~~~~~~~~~-----------~--------------~~~~~~~~~-------~~~~~~~~~~~l~~li~~~L~  306 (369)
                      ....  ...........           .              .......+.       .......++.++.+||.+||+
T Consensus       237 ~~~~--~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~  314 (388)
T 3oz6_A          237 MNQL--ERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQ  314 (388)
T ss_dssp             HHHH--HHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCC
T ss_pred             HHHH--HHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhc
Confidence            1110  00000000000           0              000000000       000000225678999999999


Q ss_pred             CCCCCCCCHHHHHHH
Q 017594          307 ESADDRPTMNDVVSM  321 (369)
Q Consensus       307 ~dP~~Rps~~ell~~  321 (369)
                      .||++|||+.++++.
T Consensus       315 ~dP~~R~t~~e~l~H  329 (388)
T 3oz6_A          315 FNPNKRISANDALKH  329 (388)
T ss_dssp             SSGGGSCCHHHHTTS
T ss_pred             cCcccCCCHHHHhCC
Confidence            999999999999874

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=9.2e-42  Score=311.83  Aligned_cols=266  Identities=23%  Similarity=0.287  Sum_probs=198.8

Q ss_pred             hcCCccCccccccCCccEEEEEEcC-CCEEEEEEecCCCc--hhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEEE
Q 017594           48 TNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSG--QGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIY  124 (369)
Q Consensus        48 ~~~y~i~~~lg~G~~~~v~~~~~~~-~~~valK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  124 (369)
                      .++|++++.||+|+||.||+|++.. |+.||+|++.....  ...+.+.+|+.+++.++||||+++++++...+..++||
T Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   81 (311)
T 4agu_A            2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVF   81 (311)
T ss_dssp             -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEE
Confidence            4789999999999999999999765 89999999865432  23456778999999999999999999999999999999


Q ss_pred             EecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCCC
Q 017594          125 EYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGN  204 (369)
Q Consensus       125 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~~  204 (369)
                      ||+.+++|..++...   ..+++..++.++.|++.||.|||+.|   ++||||||+||+++.++.++|+|||++......
T Consensus        82 e~~~~~~l~~~~~~~---~~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  155 (311)
T 4agu_A           82 EYCDHTVLHELDRYQ---RGVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGP  155 (311)
T ss_dssp             ECCSEEHHHHHHHTS---SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred             EeCCCchHHHHHhhh---cCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCCchhccCc
Confidence            999999998887543   34899999999999999999999999   999999999999999999999999999876533


Q ss_pred             CcccccccccccccccCchhhcc-CCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccc---------hhhhhhhhcC
Q 017594          205 ELQANTSRIVGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLL---------GYAWDLWTSN  274 (369)
Q Consensus       205 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~---------~~~~~~~~~~  274 (369)
                      ..  ......++..|+|||++.+ ..++.++||||||+++|+|++|..||...........         ......+...
T Consensus       156 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (311)
T 4agu_A          156 SD--YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTN  233 (311)
T ss_dssp             ------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTC
T ss_pred             cc--ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccc
Confidence            21  1223467899999999876 6689999999999999999999999975442211000         0000000000


Q ss_pred             cccccc---Cccccc--cccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 017594          275 RTLELI---DPILED--EYSSKQMLLRYANIALLCVQESADDRPTMNDVVSM  321 (369)
Q Consensus       275 ~~~~~~---~~~~~~--~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~  321 (369)
                      ......   .+....  .......+..+.++|.+||+.||++|||+.++++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  285 (311)
T 4agu_A          234 QYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH  285 (311)
T ss_dssp             GGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred             cccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence            000000   000000  00001235678999999999999999999999963

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=9.6e-42  Score=316.51  Aligned_cols=270  Identities=19%  Similarity=0.193  Sum_probs=200.6

Q ss_pred             HHhcCCccCccccccCCccEEEEEEc----CCCEEEEEEecCCCchh-----------HHHHHHHHHHHhcCCCCceeee
Q 017594           46 TATNKFSDANKLGEGGFGPVYKGVLK----KGDEIAVKRLSGRSGQG-----------LREMKNEASVIAKVQHKNLVRL  110 (369)
Q Consensus        46 ~~~~~y~i~~~lg~G~~~~v~~~~~~----~~~~valK~~~~~~~~~-----------~~~~~~e~~~l~~l~h~~i~~~  110 (369)
                      ...++|++.+.||+|+||.||+|++.    ++..+|+|++.......           ...+..|+..++.+.||||+++
T Consensus        34 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~  113 (345)
T 2v62_A           34 MEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLF  113 (345)
T ss_dssp             TTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCE
T ss_pred             ccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCccee
Confidence            34578999999999999999999975    57889999987553221           1234567888999999999999


Q ss_pred             eeeEEe----CCccEEEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeC
Q 017594          111 LGCCID----RDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDK  186 (369)
Q Consensus       111 ~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~  186 (369)
                      ++++..    ....++||||+ +++|.+++...   ..+++..++.++.||+.||.|||+.+   ++||||||+||+++.
T Consensus       114 ~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~  186 (345)
T 2v62_A          114 YGSGLTEFKGRSYRFMVMERL-GIDLQKISGQN---GTFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGY  186 (345)
T ss_dssp             EEEEEEESSSCEEEEEEEECE-EEEHHHHCBGG---GBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEES
T ss_pred             ecccccccCCCcEEEEEEecc-CCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEEEcc
Confidence            999987    67789999999 99999998543   26899999999999999999999999   999999999999998


Q ss_pred             CC--ceEEeecCCceecCCCCcc-----cccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCccc
Q 017594          187 DM--NPKISDFGMARICGGNELQ-----ANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTD  259 (369)
Q Consensus       187 ~~--~~~L~Dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~  259 (369)
                      ++  .++|+|||++..+......     .......++..|+|||++.+..++.++|||||||++|+|++|..||......
T Consensus       187 ~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~  266 (345)
T 2v62_A          187 KNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKD  266 (345)
T ss_dssp             SSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTC
T ss_pred             CCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccc
Confidence            87  9999999999876432211     1113346899999999999999999999999999999999999999532211


Q ss_pred             ccccchhhhhhhhcCccccccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHhhhhc
Q 017594          260 SLNLLGYAWDLWTSNRTLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNEAAT  328 (369)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L~~~~~~  328 (369)
                      ...... .....     ...+...+........++.++.++|.+||+.||++||++.+|++.|+++...
T Consensus       267 ~~~~~~-~~~~~-----~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~  329 (345)
T 2v62_A          267 PVAVQT-AKTNL-----LDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGIP  329 (345)
T ss_dssp             HHHHHH-HHHHH-----HHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCCC
T ss_pred             cHHHHH-HHHhh-----cccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCCc
Confidence            111000 00000     0000000000000002256799999999999999999999999999987653

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=9.1e-42  Score=327.76  Aligned_cols=271  Identities=27%  Similarity=0.414  Sum_probs=212.2

Q ss_pred             hHHHHhcCCccCccccccCCccEEEEEEcCCCEEEEEEecCCCchhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEE
Q 017594           43 SVSTATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKIL  122 (369)
Q Consensus        43 ~~~~~~~~y~i~~~lg~G~~~~v~~~~~~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l  122 (369)
                      ..+...++|++.+.||+|+||.||+|.++++..||+|++.... ...+.+.+|+.++++++||||+++++++.. +..++
T Consensus       178 ~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~i  255 (452)
T 1fmk_A          178 AWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYI  255 (452)
T ss_dssp             CSBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred             ccccChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEE
Confidence            3445567899999999999999999999887889999997543 335678999999999999999999999865 77899


Q ss_pred             EEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecC
Q 017594          123 IYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICG  202 (369)
Q Consensus       123 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~  202 (369)
                      ||||+.+++|.+++... ....+++..++.++.||+.||+|||+++   ++||||||+||+++.++.++|+|||++....
T Consensus       256 v~e~~~~gsL~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~  331 (452)
T 1fmk_A          256 VTEYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIE  331 (452)
T ss_dssp             EECCCTTCBHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC---
T ss_pred             EehhhcCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCCccceecC
Confidence            99999999999998532 2244889999999999999999999999   9999999999999999999999999998664


Q ss_pred             CCCcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHh-CCCCCCCCcccccccchhhhhhhhcCccccccC
Q 017594          203 GNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDLWTSNRTLELID  281 (369)
Q Consensus       203 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (369)
                      .... .......++..|+|||++.+..++.++||||||+++|+|++ |..||.......     ..... ....     .
T Consensus       332 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~-----~~~~i-~~~~-----~  399 (452)
T 1fmk_A          332 DNEY-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE-----VLDQV-ERGY-----R  399 (452)
T ss_dssp             ------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-----HHHHH-HTTC-----C
T ss_pred             CCce-ecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHH-----HHHHH-HcCC-----C
Confidence            3221 11222345778999999998999999999999999999999 899986432111     01111 1110     0


Q ss_pred             ccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHhhhhccCCCCCCC
Q 017594          282 PILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNEAATLLPPKQPA  336 (369)
Q Consensus       282 ~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L~~~~~~~~~~~~~~  336 (369)
                      ...     +..++..+.++|.+||+.||++|||+.+|++.|+.+.....+...|+
T Consensus       400 ~~~-----~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~~~~~~~~  449 (452)
T 1fmk_A          400 MPC-----PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPG  449 (452)
T ss_dssp             CCC-----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCCCCCCS
T ss_pred             CCC-----CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccCCcccccc
Confidence            000     11235679999999999999999999999999999988766655544

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=4.7e-42  Score=315.96  Aligned_cols=255  Identities=20%  Similarity=0.235  Sum_probs=182.2

Q ss_pred             hcCCccC---ccccccCCccEEEEEEc-CCCEEEEEEecCCCchhHHHHHHHHHHHhcCC-CCceeeeeeeEEeCCccEE
Q 017594           48 TNKFSDA---NKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSGQGLREMKNEASVIAKVQ-HKNLVRLLGCCIDRDEKIL  122 (369)
Q Consensus        48 ~~~y~i~---~~lg~G~~~~v~~~~~~-~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~l  122 (369)
                      .++|++.   +.||+|+||.||+|+++ +|+.||+|++...   .......|+.+++.+. ||||+++++++.+....++
T Consensus         7 ~~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~l   83 (325)
T 3kn6_A            7 YQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFL   83 (325)
T ss_dssp             HHHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEE
Confidence            4556664   78999999999999976 4899999998643   2367778999999997 9999999999999999999


Q ss_pred             EEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCC---ceEEeecCCce
Q 017594          123 IYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDM---NPKISDFGMAR  199 (369)
Q Consensus       123 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~---~~~L~Dfg~~~  199 (369)
                      ||||+.+++|.+++...   ..+++..++.++.||+.||.|||+++   ++||||||+||+++.++   .++|+|||++.
T Consensus        84 v~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~  157 (325)
T 3kn6_A           84 VMELLNGGELFERIKKK---KHFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFAR  157 (325)
T ss_dssp             EECCCCSCBHHHHHHHC---SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTTCE
T ss_pred             EEEccCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEeccccce
Confidence            99999999999988543   45899999999999999999999999   99999999999998766   79999999998


Q ss_pred             ecCCCCcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccc-cchhhhhhhhcCcccc
Q 017594          200 ICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLN-LLGYAWDLWTSNRTLE  278 (369)
Q Consensus       200 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~  278 (369)
                      ......  .......+++.|+|||++.+..++.++|||||||++|+|++|..||......... ..............  
T Consensus       158 ~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~--  233 (325)
T 3kn6_A          158 LKPPDN--QPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDF--  233 (325)
T ss_dssp             ECCC------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCC--
T ss_pred             ecCCCC--CcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCC--
Confidence            654322  1223346789999999999999999999999999999999999999754321100 00000011111000  


Q ss_pred             ccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 017594          279 LIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVS  320 (369)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~  320 (369)
                          .. .......++.++.+||.+||+.||++|||+.++++
T Consensus       234 ----~~-~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  270 (325)
T 3kn6_A          234 ----SF-EGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY  270 (325)
T ss_dssp             ----CC-CSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred             ----CC-CcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence                00 00011223677999999999999999999999885

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.1e-41  Score=313.53  Aligned_cols=277  Identities=25%  Similarity=0.379  Sum_probs=210.6

Q ss_pred             HhcCCccCccccccCCccEEEEEE-----cCCCEEEEEEecCCCchhHHHHHHHHHHHhcCCCCceeeeeeeEEeCC--c
Q 017594           47 ATNKFSDANKLGEGGFGPVYKGVL-----KKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDRD--E  119 (369)
Q Consensus        47 ~~~~y~i~~~lg~G~~~~v~~~~~-----~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~  119 (369)
                      ..++|++++.||+|+||.||+|+.     .+|+.||+|++........+.+.+|+.+++.++||||+++++++...+  .
T Consensus        39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  118 (326)
T 2w1i_A           39 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN  118 (326)
T ss_dssp             CGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----C
T ss_pred             CHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCc
Confidence            457799999999999999999983     358899999998776666778999999999999999999999887544  6


Q ss_pred             cEEEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCce
Q 017594          120 KILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMAR  199 (369)
Q Consensus       120 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~  199 (369)
                      .++|+|++.+++|.+++....  ..+++..++.++.||+.||.+||+.+   ++|+||||+||+++.++.++|+|||++.
T Consensus       119 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~Dfg~~~  193 (326)
T 2w1i_A          119 LKLIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTK  193 (326)
T ss_dssp             CEEEECCCTTCBHHHHHHHST--TSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred             eEEEEECCCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEecCcchh
Confidence            899999999999999986432  34889999999999999999999999   9999999999999999999999999998


Q ss_pred             ecCCCCccc-ccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhh-hhhhhcCccc
Q 017594          200 ICGGNELQA-NTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYA-WDLWTSNRTL  277 (369)
Q Consensus       200 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~-~~~~~~~~~~  277 (369)
                      ......... ......++..|+|||++.+..++.++||||||+++|+|++|..||.............. ..........
T Consensus       194 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (326)
T 2w1i_A          194 VLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI  273 (326)
T ss_dssp             ECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHH
T ss_pred             hccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHH
Confidence            765433211 12223466779999999988899999999999999999999988753210000000000 0000000000


Q ss_pred             cccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHhhhhcc
Q 017594          278 ELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNEAATL  329 (369)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L~~~~~~~  329 (369)
                      +.+..... ...+..++.++.++|.+||+.||++|||+.++++.|+++...+
T Consensus       274 ~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~l  324 (326)
T 2w1i_A          274 ELLKNNGR-LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQM  324 (326)
T ss_dssp             HHHHTTCC-CCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             HHhhcCCC-CCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHh
Confidence            00000000 0001122567999999999999999999999999999987654

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=1.4e-41  Score=306.54  Aligned_cols=252  Identities=23%  Similarity=0.340  Sum_probs=203.5

Q ss_pred             HhcCCccCccccccCCccEEEEEEcC-CCEEEEEEecCC--CchhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEE
Q 017594           47 ATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILI  123 (369)
Q Consensus        47 ~~~~y~i~~~lg~G~~~~v~~~~~~~-~~~valK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv  123 (369)
                      +.++|++.+.||+|+||.||+|.++. |+.||+|++...  .....+.+.+|+.+++.++||||+++++++...+..++|
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v   83 (284)
T 3kk8_A            4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV   83 (284)
T ss_dssp             TTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEE
Confidence            56899999999999999999999764 889999998643  233456788999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCc---eEEeecCCcee
Q 017594          124 YEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMN---PKISDFGMARI  200 (369)
Q Consensus       124 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~---~~L~Dfg~~~~  200 (369)
                      |||+.+++|.+.+..   ...+++..++.++.||+.||.|||+.+   ++||||+|+||+++.++.   ++|+|||++..
T Consensus        84 ~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~  157 (284)
T 3kk8_A           84 FDLVTGGELFEDIVA---REFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIE  157 (284)
T ss_dssp             ECCCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred             EecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEeeceeeEE
Confidence            999999999887743   345899999999999999999999999   999999999999987665   99999999977


Q ss_pred             cCCCCcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCcccccc
Q 017594          201 CGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELI  280 (369)
Q Consensus       201 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (369)
                      ......   .....+++.|+|||++.+..++.++||||||+++|+|++|..||.......     ..... ..... ...
T Consensus       158 ~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~-----~~~~~-~~~~~-~~~  227 (284)
T 3kk8_A          158 VNDSEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR-----LYAQI-KAGAY-DYP  227 (284)
T ss_dssp             CCSSCB---CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-----HHHHH-HHTCC-CCC
T ss_pred             cccCcc---ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhH-----HHHHH-Hhccc-cCC
Confidence            653322   233468999999999999999999999999999999999999986433111     00000 00000 000


Q ss_pred             CccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 017594          281 DPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVS  320 (369)
Q Consensus       281 ~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~  320 (369)
                      .+.      ...++..+.++|.+||+.||++|||+.++++
T Consensus       228 ~~~------~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  261 (284)
T 3kk8_A          228 SPE------WDTVTPEAKSLIDSMLTVNPKKRITADQALK  261 (284)
T ss_dssp             TTT------TTTSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             chh------hcccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence            000      0112566899999999999999999999997

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=6e-42  Score=309.42  Aligned_cols=254  Identities=21%  Similarity=0.322  Sum_probs=198.3

Q ss_pred             HHhcCCccCccccccCCccEEEEEEc-CCCEEEEEEecCCC-chhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEE
Q 017594           46 TATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILI  123 (369)
Q Consensus        46 ~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv  123 (369)
                      .+.++|++.+.||+|+||.||+|+.. ++..+|+|++.... ....+.+.+|+.+++.++||||+++++++......++|
T Consensus        19 ~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv   98 (285)
T 3is5_A           19 TIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIV   98 (285)
T ss_dssp             CHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ChhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEE
Confidence            45688999999999999999999975 48899999986543 23457888999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhcCC-CccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEE---eCCCceEEeecCCce
Q 017594          124 YEYMPNKSLDFFLFDP-TKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILL---DKDMNPKISDFGMAR  199 (369)
Q Consensus       124 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv---~~~~~~~L~Dfg~~~  199 (369)
                      |||+.+++|.+.+... .....+++..++.++.||+.||.|||+.+   ++|+||||+||++   +.++.++|+|||++.
T Consensus        99 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~  175 (285)
T 3is5_A           99 METCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAE  175 (285)
T ss_dssp             ECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEECCCCCCC
T ss_pred             EEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEEeeecce
Confidence            9999999998887432 12355899999999999999999999999   9999999999999   456789999999987


Q ss_pred             ecCCCCcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCccccc
Q 017594          200 ICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLEL  279 (369)
Q Consensus       200 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (369)
                      ......   ......+++.|+|||++. ..++.++||||||+++|+|++|..||........     ............ 
T Consensus       176 ~~~~~~---~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~-----~~~~~~~~~~~~-  245 (285)
T 3is5_A          176 LFKSDE---HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEV-----QQKATYKEPNYA-  245 (285)
T ss_dssp             C-------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-----HHHHHHCCCCCC-
T ss_pred             ecCCcc---cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHH-----HhhhccCCcccc-
Confidence            654332   223346899999999875 5688999999999999999999999975431110     000000000000 


Q ss_pred             cCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 017594          280 IDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVS  320 (369)
Q Consensus       280 ~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~  320 (369)
                          ..    ....+..+.++|.+||+.||++|||+.++++
T Consensus       246 ----~~----~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  278 (285)
T 3is5_A          246 ----VE----CRPLTPQAVDLLKQMLTKDPERRPSAAQVLH  278 (285)
T ss_dssp             ----C------CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred             ----cc----cCcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                00    0001566899999999999999999999986

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=5.3e-42  Score=318.63  Aligned_cols=250  Identities=25%  Similarity=0.301  Sum_probs=201.9

Q ss_pred             HhcCCccCccccccCCccEEEEEEcC-CCEEEEEEecCCC---chhHHHHHHHHHHHhcC-CCCceeeeeeeEEeCCccE
Q 017594           47 ATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRS---GQGLREMKNEASVIAKV-QHKNLVRLLGCCIDRDEKI  121 (369)
Q Consensus        47 ~~~~y~i~~~lg~G~~~~v~~~~~~~-~~~valK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~  121 (369)
                      ..++|++++.||+|+||.||+|+.+. |+.||+|++....   ....+.+..|..++..+ .||+|+++++++...+..|
T Consensus        18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~   97 (353)
T 2i0e_A           18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY   97 (353)
T ss_dssp             -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred             chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence            45789999999999999999999775 7889999986431   23456678899999988 7999999999999999999


Q ss_pred             EEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceec
Q 017594          122 LIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARIC  201 (369)
Q Consensus       122 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~  201 (369)
                      +||||+.+++|..++..   ...+++..++.++.||+.||.|||++|   ++||||||+||+++.+|.++|+|||++...
T Consensus        98 lv~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~  171 (353)
T 2i0e_A           98 FVMEYVNGGDLMYHIQQ---VGRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEN  171 (353)
T ss_dssp             EEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred             EEEeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEEeCCccccc
Confidence            99999999999998853   234899999999999999999999999   999999999999999999999999998754


Q ss_pred             CCCCcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCccccccC
Q 017594          202 GGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELID  281 (369)
Q Consensus       202 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (369)
                      ....  .......|++.|+|||++.+..++.++|+|||||++|+|++|..||.......     ....... ... .   
T Consensus       172 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~-----~~~~i~~-~~~-~---  239 (353)
T 2i0e_A          172 IWDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE-----LFQSIME-HNV-A---  239 (353)
T ss_dssp             CCTT--CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-----HHHHHHH-CCC-C---
T ss_pred             ccCC--cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHH-----HHHHHHh-CCC-C---
Confidence            3221  22334578999999999999999999999999999999999999996432111     1111111 100 0   


Q ss_pred             ccccccccHHHHHHHHHHHHHHhhcCCCCCCCC-----HHHHHHH
Q 017594          282 PILEDEYSSKQMLLRYANIALLCVQESADDRPT-----MNDVVSM  321 (369)
Q Consensus       282 ~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps-----~~ell~~  321 (369)
                        +     +..++.++.++|.+||+.||.+||+     +.+|++.
T Consensus       240 --~-----p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h  277 (353)
T 2i0e_A          240 --Y-----PKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH  277 (353)
T ss_dssp             --C-----CTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTS
T ss_pred             --C-----CCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence              0     1112667999999999999999995     5777753

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=1.5e-41  Score=310.40  Aligned_cols=267  Identities=20%  Similarity=0.213  Sum_probs=199.7

Q ss_pred             hHHHHhcCCccCccccccCCccEEEEEEc-CCCEEEEEEecCCC---chhHHHHHHHHHHHhcCCCCceeeeeeeEEeCC
Q 017594           43 SVSTATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS---GQGLREMKNEASVIAKVQHKNLVRLLGCCIDRD  118 (369)
Q Consensus        43 ~~~~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~  118 (369)
                      ......++|++.+.||+|+||.||+|++. +++.||+|++....   ....+.+.+|+.+++.++||||+++++++...+
T Consensus        28 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~  107 (309)
T 2h34_A           28 REGTQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDG  107 (309)
T ss_dssp             ------CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETT
T ss_pred             CCCcEeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCC
Confidence            34455689999999999999999999976 58889999987542   223467889999999999999999999999999


Q ss_pred             ccEEEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCc
Q 017594          119 EKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMA  198 (369)
Q Consensus       119 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~  198 (369)
                      ..++++|++++++|.+++..   ...+++..++.++.||+.||.|||+.+   ++|+||+|+||+++.++.++|+|||++
T Consensus       108 ~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~Dfg~~  181 (309)
T 2h34_A          108 QLYVDMRLINGVDLAAMLRR---QGPLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIA  181 (309)
T ss_dssp             EEEEEEECCCCEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSCCC-
T ss_pred             eEEEEEEecCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEecCccC
Confidence            99999999999999998853   345899999999999999999999999   999999999999999999999999998


Q ss_pred             eecCCCCcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCcccc
Q 017594          199 RICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLE  278 (369)
Q Consensus       199 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (369)
                      ........ .......+++.|+|||++.+..++.++||||||+++|+|++|..||......      ............ 
T Consensus       182 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~------~~~~~~~~~~~~-  253 (309)
T 2h34_A          182 SATTDEKL-TQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS------VMGAHINQAIPR-  253 (309)
T ss_dssp             ----------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH------HHHHHHHSCCCC-
T ss_pred             cccccccc-ccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH------HHHHHhccCCCC-
Confidence            76543221 1222346889999999999889999999999999999999999998743311      000111100000 


Q ss_pred             ccCccccccccHHHHHHHHHHHHHHhhcCCCCCCC-CHHHHHHHHHhhhhccC
Q 017594          279 LIDPILEDEYSSKQMLLRYANIALLCVQESADDRP-TMNDVVSMLTNEAATLL  330 (369)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp-s~~ell~~L~~~~~~~~  330 (369)
                             .......++..+.++|.+||+.||++|| +++++++.|+.......
T Consensus       254 -------~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~~  299 (309)
T 2h34_A          254 -------PSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATAD  299 (309)
T ss_dssp             -------GGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC---
T ss_pred             -------ccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhhc
Confidence                   0000111256689999999999999999 99999999998877544

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=4.9e-42  Score=323.52  Aligned_cols=255  Identities=24%  Similarity=0.324  Sum_probs=197.1

Q ss_pred             HHHhcCCccCccccccCCccEEEEEEcCCCEEEEEEecCC--CchhHHHHHHHHHHHhcCC--CCceeeeeeeEEeCCcc
Q 017594           45 STATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGR--SGQGLREMKNEASVIAKVQ--HKNLVRLLGCCIDRDEK  120 (369)
Q Consensus        45 ~~~~~~y~i~~~lg~G~~~~v~~~~~~~~~~valK~~~~~--~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~  120 (369)
                      .....+|++.+.||+|+||.||+|.+.+++.||+|++...  .......+.+|+.+++.+.  ||||+++++++...+..
T Consensus        52 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~  131 (390)
T 2zmd_A           52 SVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYI  131 (390)
T ss_dssp             EETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred             cccCCceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEE
Confidence            3445679999999999999999999888999999998644  2344577889999999996  59999999999999999


Q ss_pred             EEEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCcee
Q 017594          121 ILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARI  200 (369)
Q Consensus       121 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~  200 (369)
                      ++||| +.+++|.+++...   ..+++..++.++.||+.||.|||+++   ++||||||+||+++ ++.++|+|||++..
T Consensus       132 ~lv~E-~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DFG~a~~  203 (390)
T 2zmd_A          132 YMVME-CGNIDLNSWLKKK---KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQ  203 (390)
T ss_dssp             EEEEE-CCSEEHHHHHHHC---SSCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCCSSSCC
T ss_pred             EEEEe-cCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEecCcccc
Confidence            99999 6678998888543   35888899999999999999999999   99999999999995 58999999999987


Q ss_pred             cCCCCcccccccccccccccCchhhcc-----------CCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhh
Q 017594          201 CGGNELQANTSRIVGTYGYMSPEYALE-----------GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWD  269 (369)
Q Consensus       201 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-----------~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~  269 (369)
                      +.............|++.|+|||++.+           ..++.++|||||||++|+|++|..||.......    .....
T Consensus       204 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~----~~~~~  279 (390)
T 2zmd_A          204 MQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI----SKLHA  279 (390)
T ss_dssp             C---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH----HHHHH
T ss_pred             ccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHH----HHHHH
Confidence            654333223344578999999999865           368899999999999999999999996432110    00111


Q ss_pred             hhhcCccccccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 017594          270 LWTSNRTLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSM  321 (369)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~  321 (369)
                      .........     ....     .+.++.+||.+||+.||.+|||+.++++.
T Consensus       280 ~~~~~~~~~-----~~~~-----~~~~~~~li~~~L~~dP~~Rps~~ell~h  321 (390)
T 2zmd_A          280 IIDPNHEIE-----FPDI-----PEKDLQDVLKCCLKRDPKQRISIPELLAH  321 (390)
T ss_dssp             HHCTTSCCC-----CCCC-----SCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             HhCccccCC-----CCcc-----chHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence            111110000     0011     14568999999999999999999999864

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=7.9e-42  Score=314.75  Aligned_cols=267  Identities=23%  Similarity=0.305  Sum_probs=210.4

Q ss_pred             CccccchhhHHHHhcCCccC-ccccccCCccEEEEEEc-CCCEEEEEEecCCC--chhHHHHHHHHHHHhcCC-CCceee
Q 017594           35 QFPLFSFSSVSTATNKFSDA-NKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS--GQGLREMKNEASVIAKVQ-HKNLVR  109 (369)
Q Consensus        35 ~~~~~~~~~~~~~~~~y~i~-~~lg~G~~~~v~~~~~~-~~~~valK~~~~~~--~~~~~~~~~e~~~l~~l~-h~~i~~  109 (369)
                      .-+...++....+.++|.+. +.||+|+||.||+|+.+ +|+.||+|++....  ......+..|+.++..+. ||||++
T Consensus        14 ~~~n~~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~   93 (327)
T 3lm5_A           14 GTENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVIN   93 (327)
T ss_dssp             --CCCCSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCC
T ss_pred             cchhhHHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEE
Confidence            33567888999999999998 89999999999999976 48999999987432  233567889999999995 699999


Q ss_pred             eeeeEEeCCccEEEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeC---
Q 017594          110 LLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDK---  186 (369)
Q Consensus       110 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~---  186 (369)
                      +++++......++||||+.+++|.+++... ....+++..++.++.||+.||+|||+.|   ++||||||+||+++.   
T Consensus        94 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~~~~  169 (327)
T 3lm5_A           94 LHEVYENTSEIILILEYAAGGEIFSLCLPE-LAEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYP  169 (327)
T ss_dssp             EEEEEECSSEEEEEEECCTTEEGGGGGSSC-C-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESCBTT
T ss_pred             EEEEEEeCCeEEEEEEecCCCcHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEecCCC
Confidence            999999999999999999999999888543 2345899999999999999999999999   999999999999987   


Q ss_pred             CCceEEeecCCceecCCCCcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchh
Q 017594          187 DMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGY  266 (369)
Q Consensus       187 ~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~  266 (369)
                      ++.++|+|||++.......   ......+++.|+|||++.+..++.++||||||+++|+|++|..||........     
T Consensus       170 ~~~~kL~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-----  241 (327)
T 3lm5_A          170 LGDIKIVDFGMSRKIGHAC---ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQET-----  241 (327)
T ss_dssp             BCCEEECCGGGCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-----
T ss_pred             CCcEEEeeCccccccCCcc---ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHH-----
Confidence            7899999999998765332   12334689999999999999999999999999999999999999864432110     


Q ss_pred             hhhhhhcCccccccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 017594          267 AWDLWTSNRTLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSM  321 (369)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~  321 (369)
                      ........  .......      ...++..+.++|.+||+.||++|||+.++++.
T Consensus       242 ~~~i~~~~--~~~~~~~------~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h  288 (327)
T 3lm5_A          242 YLNISQVN--VDYSEET------FSSVSQLATDFIQSLLVKNPEKRPTAEICLSH  288 (327)
T ss_dssp             HHHHHHTC--CCCCTTT------TTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred             HHHHHhcc--cccCchh------hcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence            00000000  0000000      01125668999999999999999999999863

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=1.5e-41  Score=318.20  Aligned_cols=252  Identities=24%  Similarity=0.310  Sum_probs=198.2

Q ss_pred             hcCCcc--CccccccCCccEEEEEEc-CCCEEEEEEecCCCchhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEEE
Q 017594           48 TNKFSD--ANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIY  124 (369)
Q Consensus        48 ~~~y~i--~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  124 (369)
                      ...|.+  .+.||+|+||.||+|+.. +|+.||+|++........+.+.+|+.+++.++||||+++++++...+..++||
T Consensus        86 ~~~~~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~  165 (373)
T 2x4f_A           86 NSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVM  165 (373)
T ss_dssp             GGTEEEEEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             ccceeeecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEE
Confidence            344555  568999999999999975 48999999998776666778999999999999999999999999999999999


Q ss_pred             EecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEE--eCCCceEEeecCCceecC
Q 017594          125 EYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILL--DKDMNPKISDFGMARICG  202 (369)
Q Consensus       125 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv--~~~~~~~L~Dfg~~~~~~  202 (369)
                      ||+++++|.+++...  ...+++..++.++.||+.||.|||+.+   ++||||||+||++  +.++.++|+|||++....
T Consensus       166 E~~~~~~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~  240 (373)
T 2x4f_A          166 EYVDGGELFDRIIDE--SYNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYK  240 (373)
T ss_dssp             ECCTTCEEHHHHHHT--GGGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSCEECC
T ss_pred             eCCCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCceecC
Confidence            999999998877532  234889999999999999999999999   9999999999999  466789999999998765


Q ss_pred             CCCcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCccccccCc
Q 017594          203 GNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDP  282 (369)
Q Consensus       203 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (369)
                      ....   .....|++.|+|||++.+..++.++|||||||++|+|++|..||.......     ......... . .....
T Consensus       241 ~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~-----~~~~i~~~~-~-~~~~~  310 (373)
T 2x4f_A          241 PREK---LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAE-----TLNNILACR-W-DLEDE  310 (373)
T ss_dssp             TTCB---CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHH-----HHHHHHHTC-C-CSCSG
T ss_pred             Cccc---cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHH-----HHHHHHhcc-C-CCChh
Confidence            4322   223468999999999998899999999999999999999999996443211     011111100 0 00000


Q ss_pred             cccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 017594          283 ILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVS  320 (369)
Q Consensus       283 ~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~  320 (369)
                            ....++.++.+||.+||+.||.+|||+.++++
T Consensus       311 ------~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~  342 (373)
T 2x4f_A          311 ------EFQDISEEAKEFISKLLIKEKSWRISASEALK  342 (373)
T ss_dssp             ------GGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             ------hhccCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence                  01112567999999999999999999999997

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=2.4e-41  Score=302.51  Aligned_cols=256  Identities=22%  Similarity=0.352  Sum_probs=205.1

Q ss_pred             HhcCCccCccccccCCccEEEEEEcCCCEEEEEEecCCC--chhHHHHHHHHHHHhcCCCCceeeeeeeEEeC--CccEE
Q 017594           47 ATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRS--GQGLREMKNEASVIAKVQHKNLVRLLGCCIDR--DEKIL  122 (369)
Q Consensus        47 ~~~~y~i~~~lg~G~~~~v~~~~~~~~~~valK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~l  122 (369)
                      ..++|++.+.||+|+||.||+|+++ |..||+|++....  ....+.+.+|+.+++.++||||+++++++...  ...++
T Consensus         8 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l   86 (271)
T 3kmu_A            8 DFKQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTL   86 (271)
T ss_dssp             CGGGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEE
T ss_pred             CHHHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEe
Confidence            4578999999999999999999986 8889999987543  34456788999999999999999999999876  67899


Q ss_pred             EEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecC
Q 017594          123 IYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICG  202 (369)
Q Consensus       123 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~  202 (369)
                      ||||+++++|.+++.... ...+++..++.++.||+.||.|||+.+ ..++|+||||+||+++.++.++|.|||+.....
T Consensus        87 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~  164 (271)
T 3kmu_A           87 ITHWMPYGSLYNVLHEGT-NFVVDQSQAVKFALDMARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTARISMADVKFSFQ  164 (271)
T ss_dssp             EEECCTTCBHHHHHHSCS-SCCCCHHHHHHHHHHHHHHHHHHTTSS-SCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS
T ss_pred             eecccCCCcHHHHHhhcc-cCCCCHHHHHHHHHHHHHHHHHHhcCC-CceecCCCccceEEEcCCcceeEEeccceeeec
Confidence            999999999999996533 235899999999999999999999864 349999999999999999999999988765322


Q ss_pred             CCCcccccccccccccccCchhhccCCCCc---ccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCccccc
Q 017594          203 GNELQANTSRIVGTYGYMSPEYALEGIFSI---KSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLEL  279 (369)
Q Consensus       203 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~---~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (369)
                             .....+++.|+|||++.+..++.   ++||||||+++|+|++|..||.......     ......... .   
T Consensus       165 -------~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-----~~~~~~~~~-~---  228 (271)
T 3kmu_A          165 -------SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNME-----IGMKVALEG-L---  228 (271)
T ss_dssp             -------CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHH-----HHHHHHHSC-C---
T ss_pred             -------ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHH-----HHHHHHhcC-C---
Confidence                   22346789999999998765544   7999999999999999999986433211     011111111 1   


Q ss_pred             cCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHhhhh
Q 017594          280 IDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNEAA  327 (369)
Q Consensus       280 ~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L~~~~~  327 (369)
                       .+....     .++..+.++|.+||+.||++|||+.++++.|+.+..
T Consensus       229 -~~~~~~-----~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~  270 (271)
T 3kmu_A          229 -RPTIPP-----GISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD  270 (271)
T ss_dssp             -CCCCCT-----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred             -CCCCCC-----CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence             111111     125679999999999999999999999999998764

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=4.8e-42  Score=317.88  Aligned_cols=253  Identities=20%  Similarity=0.243  Sum_probs=199.1

Q ss_pred             HHhcCCccCccccccCCccEEEEEEcC-CCEEEEEEecCCCchhHHHHHHHHHHHhcC-CCCceeeeeeeEEeCCccEEE
Q 017594           46 TATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLREMKNEASVIAKV-QHKNLVRLLGCCIDRDEKILI  123 (369)
Q Consensus        46 ~~~~~y~i~~~lg~G~~~~v~~~~~~~-~~~valK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv  123 (369)
                      .+.++|++.+.||+|+||.||+|+++. |+.||+|++.....    ...+|++++.++ +||||+++++++.+....++|
T Consensus        19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv   94 (342)
T 2qr7_A           19 QFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVV   94 (342)
T ss_dssp             CHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEE
T ss_pred             CccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEE
Confidence            456889999999999999999999764 88999999975543    234677788777 799999999999999999999


Q ss_pred             EEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCC----CceEEeecCCce
Q 017594          124 YEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKD----MNPKISDFGMAR  199 (369)
Q Consensus       124 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~----~~~~L~Dfg~~~  199 (369)
                      |||+.+++|.+.+...   ..+++..++.++.||+.||.|||++|   ++||||||+||++..+    +.++|+|||++.
T Consensus        95 ~E~~~gg~L~~~i~~~---~~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~  168 (342)
T 2qr7_A           95 TELMKGGELLDKILRQ---KFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAK  168 (342)
T ss_dssp             ECCCCSCBHHHHHHTC---TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEECCCTTCE
T ss_pred             EeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEEECCCcc
Confidence            9999999999888543   34899999999999999999999999   9999999999998543    359999999998


Q ss_pred             ecCCCCcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCccccc
Q 017594          200 ICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLEL  279 (369)
Q Consensus       200 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (369)
                      .......  ......+++.|+|||++.+..++.++|||||||++|+|++|..||.....+...  ...... ...... .
T Consensus       169 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~--~~~~~i-~~~~~~-~  242 (342)
T 2qr7_A          169 QLRAENG--LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPE--EILARI-GSGKFS-L  242 (342)
T ss_dssp             ECBCTTC--CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHH--HHHHHH-HHCCCC-C
T ss_pred             cCcCCCC--ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHH--HHHHHH-ccCCcc-c
Confidence            7653321  223346899999999998888999999999999999999999999753322111  011111 111100 0


Q ss_pred             cCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 017594          280 IDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVS  320 (369)
Q Consensus       280 ~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~  320 (369)
                           ... ....++.++.+||.+||+.||++||++.++++
T Consensus       243 -----~~~-~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~  277 (342)
T 2qr7_A          243 -----SGG-YWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR  277 (342)
T ss_dssp             -----CST-TTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             -----Ccc-ccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence                 000 01122667999999999999999999999986

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.1e-41  Score=311.58  Aligned_cols=262  Identities=27%  Similarity=0.425  Sum_probs=202.9

Q ss_pred             HHhcCCccCccccccCCccEEEEEEcC-----CCEEEEEEecCCC-chhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCc
Q 017594           46 TATNKFSDANKLGEGGFGPVYKGVLKK-----GDEIAVKRLSGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDE  119 (369)
Q Consensus        46 ~~~~~y~i~~~lg~G~~~~v~~~~~~~-----~~~valK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~  119 (369)
                      ....+|++.+.||+|+||.||+|.++.     +..||+|++.... ......+.+|+.+++.++||||+++++++...+.
T Consensus        41 i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  120 (333)
T 1mqb_A           41 IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKP  120 (333)
T ss_dssp             CCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred             CChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCC
Confidence            345789999999999999999999653     2359999987543 3345568899999999999999999999999899


Q ss_pred             cEEEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCce
Q 017594          120 KILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMAR  199 (369)
Q Consensus       120 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~  199 (369)
                      .++||||+.+++|.+++...  ...+++..++.++.||+.||.|||+.|   ++||||||+||+++.++.++|+|||++.
T Consensus       121 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~  195 (333)
T 1mqb_A          121 MMIITEYMENGALDKFLREK--DGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSR  195 (333)
T ss_dssp             EEEEEECCTTEEHHHHHHHT--TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred             cEEEEeCCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCCCcch
Confidence            99999999999999998543  234889999999999999999999999   9999999999999999999999999988


Q ss_pred             ecCCCCccc-ccccccccccccCchhhccCCCCcccchHhHHHHHHHHHh-CCCCCCCCcccccccchhhhhhhhcCccc
Q 017594          200 ICGGNELQA-NTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDLWTSNRTL  277 (369)
Q Consensus       200 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  277 (369)
                      ......... ......++..|+|||++.+..++.++||||||+++|+|++ |..||.......     .. .........
T Consensus       196 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~-----~~-~~~~~~~~~  269 (333)
T 1mqb_A          196 VLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE-----VM-KAINDGFRL  269 (333)
T ss_dssp             ---------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-----HH-HHHHTTCCC
T ss_pred             hhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHH-----HH-HHHHCCCcC
Confidence            765332111 1222345778999999998999999999999999999998 999986433111     01 111111000


Q ss_pred             cccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHhhhhc
Q 017594          278 ELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNEAAT  328 (369)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L~~~~~~  328 (369)
                           ..     +..++..+.++|.+||+.||++||++.++++.|+.+...
T Consensus       270 -----~~-----~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~  310 (333)
T 1mqb_A          270 -----PT-----PMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA  310 (333)
T ss_dssp             -----CC-----CTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             -----CC-----cccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence                 00     111256699999999999999999999999999988764

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=1e-41  Score=327.61  Aligned_cols=266  Identities=29%  Similarity=0.400  Sum_probs=213.9

Q ss_pred             hhhHHHHhcCCccCccccccCCccEEEEEEcCCCEEEEEEecCCCchhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCcc
Q 017594           41 FSSVSTATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEK  120 (369)
Q Consensus        41 ~~~~~~~~~~y~i~~~lg~G~~~~v~~~~~~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~  120 (369)
                      ........++|++.+.||+|+||.||+|.++++..||+|++.... ...+.+.+|+.+++.++||||+++++++. .+..
T Consensus       180 ~~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~  257 (454)
T 1qcf_A          180 KDAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPI  257 (454)
T ss_dssp             TTCSBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSC
T ss_pred             ccceeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCcc
Confidence            344456678899999999999999999999888899999997544 34678899999999999999999999986 6679


Q ss_pred             EEEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCcee
Q 017594          121 ILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARI  200 (369)
Q Consensus       121 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~  200 (369)
                      ++||||+.+++|.+++.... ...++...++.++.||+.||+|||+++   ++||||||+||+++.++.++|+|||++..
T Consensus       258 ~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~  333 (454)
T 1qcf_A          258 YIITEFMAKGSLLDFLKSDE-GSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARV  333 (454)
T ss_dssp             EEEECCCTTCBHHHHHHSHH-HHTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECSTTGGGG
T ss_pred             EEEEeecCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEeeCCCceE
Confidence            99999999999999986432 234788899999999999999999999   99999999999999999999999999986


Q ss_pred             cCCCCcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHh-CCCCCCCCcccccccchhhhhhhhcCccccc
Q 017594          201 CGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDLWTSNRTLEL  279 (369)
Q Consensus       201 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (369)
                      ...... .......++..|+|||++.+..++.++||||||+++|+|++ |..||.......     ..... .....   
T Consensus       334 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~-----~~~~i-~~~~~---  403 (454)
T 1qcf_A          334 IEDNEY-TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE-----VIRAL-ERGYR---  403 (454)
T ss_dssp             BCCHHH-HTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH-----HHHHH-HHTCC---
T ss_pred             cCCCce-eccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHH-----HHHHH-HcCCC---
Confidence            543211 11222345678999999998999999999999999999999 999986433111     11111 10000   


Q ss_pred             cCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHhhhhcc
Q 017594          280 IDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNEAATL  329 (369)
Q Consensus       280 ~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L~~~~~~~  329 (369)
                        ...     +..++..+.++|.+||+.||++|||+.+|++.|+.+....
T Consensus       404 --~~~-----~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~~  446 (454)
T 1qcf_A          404 --MPR-----PENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTAT  446 (454)
T ss_dssp             --CCC-----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSSS
T ss_pred             --CCC-----CCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhcc
Confidence              000     1122567999999999999999999999999999887643

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=6.8e-42  Score=307.70  Aligned_cols=253  Identities=24%  Similarity=0.393  Sum_probs=185.0

Q ss_pred             HHHHhcCCccCccccccCCccEEEEEEc-CCCEEEEEEecCCC---chhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCc
Q 017594           44 VSTATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS---GQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDE  119 (369)
Q Consensus        44 ~~~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~  119 (369)
                      +....++|++.+.||+|+||.||+|++. +|+.||+|++....   ....+.+.+|+.+++.++||||+++++++.+.+.
T Consensus         6 ~g~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   85 (278)
T 3cok_A            6 IGEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNY   85 (278)
T ss_dssp             HCSSGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSE
T ss_pred             cccccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCe
Confidence            3345578999999999999999999974 58999999986432   1234678899999999999999999999999999


Q ss_pred             cEEEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCce
Q 017594          120 KILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMAR  199 (369)
Q Consensus       120 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~  199 (369)
                      .++|+||+.+++|.+++...  ...+++..++.++.||+.||.|||+.+   ++|+||+|+||+++.++.++|+|||++.
T Consensus        86 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~  160 (278)
T 3cok_A           86 VYLVLEMCHNGEMNRYLKNR--VKPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLAT  160 (278)
T ss_dssp             EEEEEECCTTEEHHHHHHTC--SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECCCTTCE
T ss_pred             EEEEEecCCCCcHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEeeccee
Confidence            99999999999999988643  245899999999999999999999999   9999999999999999999999999988


Q ss_pred             ecCCCCcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCccccc
Q 017594          200 ICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLEL  279 (369)
Q Consensus       200 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (369)
                      .......  ......+++.|+|||++.+..++.++||||||+++|+|++|..||..........     ... ..     
T Consensus       161 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~-----~~~-~~-----  227 (278)
T 3cok_A          161 QLKMPHE--KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLN-----KVV-LA-----  227 (278)
T ss_dssp             ECC------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC----------CC-SS-----
T ss_pred             eccCCCC--cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHH-----HHh-hc-----
Confidence            7643221  1223467899999999998889999999999999999999999987543211000     000 00     


Q ss_pred             cCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 017594          280 IDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVS  320 (369)
Q Consensus       280 ~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~  320 (369)
                       ....     +..++.++.++|.+||+.||++|||+.++++
T Consensus       228 -~~~~-----~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  262 (278)
T 3cok_A          228 -DYEM-----PSFLSIEAKDLIHQLLRRNPADRLSLSSVLD  262 (278)
T ss_dssp             -CCCC-----CTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             -ccCC-----ccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence             0000     1112567899999999999999999999986

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=8.1e-42  Score=312.48  Aligned_cols=252  Identities=23%  Similarity=0.244  Sum_probs=193.4

Q ss_pred             hhhHHHHhcCCccCccccccCCccEEEEEEc-CCCEEEEEEecCCCc--hhHHHHHHHHHHHhcC-CCCceeeeeeeEEe
Q 017594           41 FSSVSTATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSG--QGLREMKNEASVIAKV-QHKNLVRLLGCCID  116 (369)
Q Consensus        41 ~~~~~~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~~~--~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~  116 (369)
                      ........++|++.+.||+|+||+||+|++. +|+.||+|++.....  ........|+..+..+ .|+||+++++++.+
T Consensus        49 ~~~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~  128 (311)
T 3p1a_A           49 SRPESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEE  128 (311)
T ss_dssp             TSSSCHHHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred             CCccchhhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEe
Confidence            3334556688999999999999999999976 599999999864422  2223344455555444 89999999999999


Q ss_pred             CCccEEEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecC
Q 017594          117 RDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFG  196 (369)
Q Consensus       117 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg  196 (369)
                      .+..++|||++ +++|.+++...  ...+++..++.++.||+.||+|||+.+   ++||||||+||+++.++.++|+|||
T Consensus       129 ~~~~~lv~e~~-~~~L~~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DFG  202 (311)
T 3p1a_A          129 GGILYLQTELC-GPSLQQHCEAW--GASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFG  202 (311)
T ss_dssp             TTEEEEEEECC-CCBHHHHHHHH--CSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCCT
T ss_pred             CCEEEEEEecc-CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEccce
Confidence            99999999999 55777776432  335899999999999999999999999   9999999999999999999999999


Q ss_pred             CceecCCCCcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCcc
Q 017594          197 MARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRT  276 (369)
Q Consensus       197 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  276 (369)
                      ++.......   ......|++.|+|||++.+ .++.++|||||||++|+|++|..|+....         .+........
T Consensus       203 ~a~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~---------~~~~~~~~~~  269 (311)
T 3p1a_A          203 LLVELGTAG---AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGE---------GWQQLRQGYL  269 (311)
T ss_dssp             TCEECC---------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHH---------HHHHHTTTCC
T ss_pred             eeeecccCC---CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcc---------HHHHHhccCC
Confidence            987764332   2233468999999998875 78999999999999999999976653211         0111111100


Q ss_pred             ccccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 017594          277 LELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVS  320 (369)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~  320 (369)
                          .+     .....++.++.++|.+||+.||++|||+.++++
T Consensus       270 ----~~-----~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~  304 (311)
T 3p1a_A          270 ----PP-----EFTAGLSSELRSVLVMMLEPDPKLRATAEALLA  304 (311)
T ss_dssp             ----CH-----HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             ----Cc-----ccccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence                00     011122577999999999999999999999986

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=7.1e-42  Score=307.84  Aligned_cols=248  Identities=25%  Similarity=0.340  Sum_probs=199.2

Q ss_pred             HhcCCccCccccccCCccEEEEEEcC-CCEEEEEEecCCC---chhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEE
Q 017594           47 ATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRS---GQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKIL  122 (369)
Q Consensus        47 ~~~~y~i~~~lg~G~~~~v~~~~~~~-~~~valK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l  122 (369)
                      ..++|++.+.||+|++|.||+|+++. +..||+|++....   ......+.+|+.+++.++||||+++++++.+....++
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   86 (279)
T 3fdn_A            7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL   86 (279)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEE
Confidence            34789999999999999999999765 7789999985432   2234668889999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecC
Q 017594          123 IYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICG  202 (369)
Q Consensus       123 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~  202 (369)
                      ||||+.+++|.+++...   ..+++..++.++.||+.||.|||+.|   ++||||+|+||+++.++.++|+|||++....
T Consensus        87 v~e~~~~~~l~~~l~~~---~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~  160 (279)
T 3fdn_A           87 ILEYAPLGTVYRELQKL---SKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP  160 (279)
T ss_dssp             EECCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSCCEESCC-
T ss_pred             EEecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEeccccccCC
Confidence            99999999998888532   34889999999999999999999998   9999999999999999999999999875443


Q ss_pred             CCCcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCccccccCc
Q 017594          203 GNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDP  282 (369)
Q Consensus       203 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (369)
                      ...    .....+++.|+|||.+.+..++.++||||||+++|+|++|..||.......     .........       .
T Consensus       161 ~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-----~~~~~~~~~-------~  224 (279)
T 3fdn_A          161 SSR----RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE-----TYKRISRVE-------F  224 (279)
T ss_dssp             -----------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH-----HHHHHHHTC-------C
T ss_pred             ccc----ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHH-----HHHHHHhCC-------C
Confidence            221    233468999999999999999999999999999999999999986432111     000000000       0


Q ss_pred             cccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 017594          283 ILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSM  321 (369)
Q Consensus       283 ~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~  321 (369)
                      ...     ...+..+.++|.+||+.||.+|||+.++++.
T Consensus       225 ~~~-----~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h  258 (279)
T 3fdn_A          225 TFP-----DFVTEGARDLISRLLKHNPSQRPMLREVLEH  258 (279)
T ss_dssp             CCC-----TTSCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred             CCC-----CcCCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence            001     1125668999999999999999999999974

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=1.6e-41  Score=307.48  Aligned_cols=265  Identities=25%  Similarity=0.358  Sum_probs=208.2

Q ss_pred             hHHHHhcCCccCc-cccccCCccEEEEEEc---CCCEEEEEEecCCC--chhHHHHHHHHHHHhcCCCCceeeeeeeEEe
Q 017594           43 SVSTATNKFSDAN-KLGEGGFGPVYKGVLK---KGDEIAVKRLSGRS--GQGLREMKNEASVIAKVQHKNLVRLLGCCID  116 (369)
Q Consensus        43 ~~~~~~~~y~i~~-~lg~G~~~~v~~~~~~---~~~~valK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~  116 (369)
                      .+....++|++.+ .||+|+||.||+|.+.   .++.|++|++....  ....+.+.+|+.+++.++||||+++++++ .
T Consensus        10 ~~~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~   88 (291)
T 1xbb_A           10 EVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-E   88 (291)
T ss_dssp             -CBCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-E
T ss_pred             eeeecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-C
Confidence            3344567899998 9999999999999643   36789999987543  23356788999999999999999999998 5


Q ss_pred             CCccEEEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecC
Q 017594          117 RDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFG  196 (369)
Q Consensus       117 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg  196 (369)
                      .+..++|+|++.+++|.+++...   ..+++..++.++.||+.||.|||+.+   ++|+||+|+||+++.++.++|+|||
T Consensus        89 ~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg  162 (291)
T 1xbb_A           89 AESWMLVMEMAELGPLNKYLQQN---RHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFG  162 (291)
T ss_dssp             SSSEEEEEECCTTEEHHHHHHHC---TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCT
T ss_pred             CCCcEEEEEeCCCCCHHHHHHhC---cCCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEccCC
Confidence            67889999999999999998543   34889999999999999999999999   9999999999999999999999999


Q ss_pred             CceecCCCCccc-ccccccccccccCchhhccCCCCcccchHhHHHHHHHHHh-CCCCCCCCcccccccchhhhhhhhcC
Q 017594          197 MARICGGNELQA-NTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDLWTSN  274 (369)
Q Consensus       197 ~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~  274 (369)
                      ++.......... ......++..|+|||.+.+..++.++||||||+++|+|++ |..||.......      ........
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~------~~~~~~~~  236 (291)
T 1xbb_A          163 LSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE------VTAMLEKG  236 (291)
T ss_dssp             TCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH------HHHHHHTT
T ss_pred             cceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHH------HHHHHHcC
Confidence            998765433221 1122345678999999998889999999999999999999 999987543211      11111111


Q ss_pred             ccccccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHhhhhccC
Q 017594          275 RTLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNEAATLL  330 (369)
Q Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L~~~~~~~~  330 (369)
                      ....     .     +..++..+.++|.+||+.||.+||++.++++.|+++.....
T Consensus       237 ~~~~-----~-----~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~  282 (291)
T 1xbb_A          237 ERMG-----C-----PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVV  282 (291)
T ss_dssp             CCCC-----C-----CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHH
T ss_pred             CCCC-----C-----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHh
Confidence            1000     1     11225679999999999999999999999999998877543

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=1.7e-41  Score=326.54  Aligned_cols=264  Identities=23%  Similarity=0.244  Sum_probs=195.1

Q ss_pred             HHhcCCccCccccccCCccEEEEEEcC-CCEEEEEEecCC--CchhHHHHHHHHHHHhcCCCCceeeeeeeEEeCC----
Q 017594           46 TATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDRD----  118 (369)
Q Consensus        46 ~~~~~y~i~~~lg~G~~~~v~~~~~~~-~~~valK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----  118 (369)
                      ...++|++++.||+|+||.||+|++.. |+.||+|++...  .......+.+|+.+++.++||||+++++++....    
T Consensus        59 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~  138 (464)
T 3ttj_A           59 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEE  138 (464)
T ss_dssp             EEETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTT
T ss_pred             eecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCcccc
Confidence            346899999999999999999999654 889999999753  3344567889999999999999999999997553    


Q ss_pred             --ccEEEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecC
Q 017594          119 --EKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFG  196 (369)
Q Consensus       119 --~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg  196 (369)
                        ..|+||||++++ +...+..     .+++..++.++.||+.||.|||+.|   ++||||||+||+++.++.++|+|||
T Consensus       139 ~~~~~lv~E~~~~~-l~~~~~~-----~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~kl~DFG  209 (464)
T 3ttj_A          139 FQDVYLVMELMDAN-LCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG  209 (464)
T ss_dssp             CCEEEEEEECCSEE-HHHHHTS-----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCC
T ss_pred             CCeEEEEEeCCCCC-HHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEEEEEEE
Confidence              469999999876 4444421     2788999999999999999999999   9999999999999999999999999


Q ss_pred             CceecCCCCcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccc----------h-
Q 017594          197 MARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLL----------G-  265 (369)
Q Consensus       197 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~----------~-  265 (369)
                      ++.......   ......+++.|+|||++.+..++.++|||||||++|+|++|+.||...........          . 
T Consensus       210 ~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~  286 (464)
T 3ttj_A          210 LARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEF  286 (464)
T ss_dssp             CC-----CC---CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHH
T ss_pred             eeeecCCCc---ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence            998654322   22335789999999999999999999999999999999999999975431110000          0 


Q ss_pred             ------hhhhhhhcC------ccccccCcc-ccc-cccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 017594          266 ------YAWDLWTSN------RTLELIDPI-LED-EYSSKQMLLRYANIALLCVQESADDRPTMNDVVSM  321 (369)
Q Consensus       266 ------~~~~~~~~~------~~~~~~~~~-~~~-~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~  321 (369)
                            .........      ......... ... .......+.++.+||.+||+.||++|||+.|+++.
T Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H  356 (464)
T 3ttj_A          287 MKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH  356 (464)
T ss_dssp             HTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             HHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence                  000000000      000000000 000 01122236779999999999999999999999964

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=4.4e-41  Score=322.81  Aligned_cols=255  Identities=27%  Similarity=0.371  Sum_probs=207.0

Q ss_pred             HHhcCCccCccccccCCccEEEEEEcCCCEEEEEEecCCCchhHHHHHHHHHHHhcCCCCceeeeeeeEEeCC-ccEEEE
Q 017594           46 TATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDRD-EKILIY  124 (369)
Q Consensus        46 ~~~~~y~i~~~lg~G~~~~v~~~~~~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~lv~  124 (369)
                      ...++|++.+.||+|+||.||+|.++ |+.||+|++....  ..+.+.+|+.++++++||||+++++++.... ..++||
T Consensus       190 i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~  266 (450)
T 1k9a_A          190 LNMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT  266 (450)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEE
T ss_pred             cChHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEE
Confidence            45678999999999999999999986 7799999997553  4578899999999999999999999987665 689999


Q ss_pred             EecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCCC
Q 017594          125 EYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGN  204 (369)
Q Consensus       125 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~~  204 (369)
                      ||+.+++|.+++... ....++...++.++.||+.||+|||+++   ++||||||+||+++.++.++|+|||++......
T Consensus       267 e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  342 (450)
T 1k9a_A          267 EYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST  342 (450)
T ss_dssp             ECCTTCBHHHHHHHH-CTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCCTTCEECC--
T ss_pred             EecCCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeCCCccccccc
Confidence            999999999998643 2234688899999999999999999999   999999999999999999999999998754322


Q ss_pred             CcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHh-CCCCCCCCcccccccchhhhhhhhcCccccccCcc
Q 017594          205 ELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPI  283 (369)
Q Consensus       205 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (369)
                           .....++..|+|||++.+..++.++||||||+++|+|++ |..||.......     ..... .....     ..
T Consensus       343 -----~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~-----~~~~i-~~~~~-----~~  406 (450)
T 1k9a_A          343 -----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD-----VVPRV-EKGYK-----MD  406 (450)
T ss_dssp             ---------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTT-----HHHHH-HTTCC-----CC
T ss_pred             -----ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH-----HHHHH-HcCCC-----CC
Confidence                 112246788999999999999999999999999999998 999987543221     11111 11100     00


Q ss_pred             ccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHhhhhc
Q 017594          284 LEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNEAAT  328 (369)
Q Consensus       284 ~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L~~~~~~  328 (369)
                      .     +..++..+.++|.+||+.||++|||+.+|++.|+.+...
T Consensus       407 ~-----p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~  446 (450)
T 1k9a_A          407 A-----PDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTH  446 (450)
T ss_dssp             C-----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             C-----CCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence            0     112256799999999999999999999999999988753

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=2.3e-41  Score=306.86  Aligned_cols=251  Identities=24%  Similarity=0.332  Sum_probs=205.2

Q ss_pred             HHhcCCccCccccccCCccEEEEEEcC-CCEEEEEEecCC---CchhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccE
Q 017594           46 TATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGR---SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKI  121 (369)
Q Consensus        46 ~~~~~y~i~~~lg~G~~~~v~~~~~~~-~~~valK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  121 (369)
                      ...++|++.+.||+|+||.||+|++.. ++.|++|++...   .....+.+..|+.+++.+.||||+++++++...+..+
T Consensus        12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   91 (294)
T 2rku_A           12 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVF   91 (294)
T ss_dssp             TTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred             CcccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEE
Confidence            456889999999999999999999765 888999998643   2334567888999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceec
Q 017594          122 LIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARIC  201 (369)
Q Consensus       122 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~  201 (369)
                      +|+||+.+++|.+++..   ...+++..++.++.||+.||.|||+.|   ++|+||+|+||+++.++.++|+|||++...
T Consensus        92 lv~e~~~~~~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~  165 (294)
T 2rku_A           92 VVLELCRRRSLLELHKR---RKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKV  165 (294)
T ss_dssp             EEEECCTTCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEEecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEeccCceec
Confidence            99999999999888743   345899999999999999999999999   999999999999999999999999999876


Q ss_pred             CCCCcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCccccccC
Q 017594          202 GGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELID  281 (369)
Q Consensus       202 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (369)
                      ....  .......+++.|+|||++.+..++.++||||||+++|+|++|..||.......     ..... .....     
T Consensus       166 ~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-----~~~~~-~~~~~-----  232 (294)
T 2rku_A          166 EYDG--ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE-----TYLRI-KKNEY-----  232 (294)
T ss_dssp             CSTT--CCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH-----HHHHH-HTTCC-----
T ss_pred             ccCc--cccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-----HHHHH-hhccC-----
Confidence            4322  12233568899999999998889999999999999999999999986433111     00000 00000     


Q ss_pred             ccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 017594          282 PILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSM  321 (369)
Q Consensus       282 ~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~  321 (369)
                       .+.     ...+..+.++|.+||+.||++|||+.++++.
T Consensus       233 -~~~-----~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~  266 (294)
T 2rku_A          233 -SIP-----KHINPVAASLIQKMLQTDPTARPTINELLND  266 (294)
T ss_dssp             -CCC-----TTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred             -CCc-----cccCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence             001     1125568999999999999999999999973

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=1e-41  Score=314.83  Aligned_cols=274  Identities=25%  Similarity=0.353  Sum_probs=199.0

Q ss_pred             HHhcCCccCccccccCCccEEEEEEcCCCEEEEEEecCCCchhHHHHHHHHHH--HhcCCCCceeeeeeeEEe-----CC
Q 017594           46 TATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASV--IAKVQHKNLVRLLGCCID-----RD  118 (369)
Q Consensus        46 ~~~~~y~i~~~lg~G~~~~v~~~~~~~~~~valK~~~~~~~~~~~~~~~e~~~--l~~l~h~~i~~~~~~~~~-----~~  118 (369)
                      ...++|++.+.||+|+||.||+|+. +++.||+|++.....   ..+..|.++  +..++||||+++++.+..     ..
T Consensus        10 ~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~---~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~   85 (336)
T 3g2f_A           10 LDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANR---QNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRM   85 (336)
T ss_dssp             CCTTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGGH---HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCE
T ss_pred             cChHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccch---hhHHHHHHHHHHHhccCcchhhheecccccccCCCc
Confidence            3457999999999999999999987 488999999864432   333444444  445799999999976542     22


Q ss_pred             ccEEEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcC---------CCCCcccCCCCCCCEEEeCCCc
Q 017594          119 EKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQY---------SRVRIIHRDLKASNILLDKDMN  189 (369)
Q Consensus       119 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---------~~~~i~H~dl~p~NIlv~~~~~  189 (369)
                      ..++||||+++++|.+++...    ..++..++.++.||+.||.|||+.         +   ++||||||+||+++.++.
T Consensus        86 ~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~---ivH~Dikp~Nill~~~~~  158 (336)
T 3g2f_A           86 EYLLVMEYYPNGSLXKYLSLH----TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA---ISHRDLNSRNVLVKNDGT  158 (336)
T ss_dssp             EEEEEECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC---EECSSCSGGGEEECTTSC
T ss_pred             eEEEEEecCCCCcHHHHHhhc----ccchhHHHHHHHHHHHHHHHHHhhhccccccccc---eeecccccceEEEcCCCc
Confidence            468999999999999998432    257888999999999999999999         8   999999999999999999


Q ss_pred             eEEeecCCceecCCCCcc------cccccccccccccCchhhcc-------CCCCcccchHhHHHHHHHHHhCCCCCCCC
Q 017594          190 PKISDFGMARICGGNELQ------ANTSRIVGTYGYMSPEYALE-------GIFSIKSDVFSFGVLLLEIVSGKKNTGLY  256 (369)
Q Consensus       190 ~~L~Dfg~~~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~-------~~~~~~~DiwslG~il~~l~tg~~p~~~~  256 (369)
                      ++|+|||++..+......      .......|++.|+|||++.+       ..++.++|||||||++|+|++|..||...
T Consensus       159 ~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~  238 (336)
T 3g2f_A          159 CVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPG  238 (336)
T ss_dssp             EEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTT
T ss_pred             EEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCc
Confidence            999999999876543211      11223468999999999876       45678899999999999999997776443


Q ss_pred             cccccccchhhhhhhhcCc--------cccccCcccccc-ccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHhhhh
Q 017594          257 RTDSLNLLGYAWDLWTSNR--------TLELIDPILEDE-YSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNEAA  327 (369)
Q Consensus       257 ~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~-~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L~~~~~  327 (369)
                      ...................        ......+.+... ......+..+.++|.+||+.||++|||+.++++.|+.+..
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~  318 (336)
T 3g2f_A          239 ESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMM  318 (336)
T ss_dssp             SCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             cchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHH
Confidence            3211111000000000000        000011111111 1122346789999999999999999999999999999997


Q ss_pred             ccC
Q 017594          328 TLL  330 (369)
Q Consensus       328 ~~~  330 (369)
                      ...
T Consensus       319 ~~~  321 (336)
T 3g2f_A          319 IWE  321 (336)
T ss_dssp             CCC
T ss_pred             HHH
Confidence            544

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=2.3e-41  Score=312.65  Aligned_cols=250  Identities=24%  Similarity=0.334  Sum_probs=205.1

Q ss_pred             HHhcCCccCccccccCCccEEEEEEcC-CCEEEEEEecCC---CchhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccE
Q 017594           46 TATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGR---SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKI  121 (369)
Q Consensus        46 ~~~~~y~i~~~lg~G~~~~v~~~~~~~-~~~valK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  121 (369)
                      ...++|++.+.||+|+||.||+|++.. ++.|++|++...   .....+.+..|+.+++.++|+||+++++++.+.+..+
T Consensus        38 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  117 (335)
T 2owb_A           38 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVF  117 (335)
T ss_dssp             TTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred             ccCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEE
Confidence            456889999999999999999999765 788999998643   2344567888999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceec
Q 017594          122 LIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARIC  201 (369)
Q Consensus       122 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~  201 (369)
                      +||||+.+++|.+++..   ...+++..++.++.||+.||.|||+++   ++|+||+|+||+++.++.++|+|||++...
T Consensus       118 lv~e~~~~~~L~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~  191 (335)
T 2owb_A          118 VVLELCRRRSLLELHKR---RKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKV  191 (335)
T ss_dssp             EEECCCTTCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEEecCCCCCHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeeccCceec
Confidence            99999999999988743   345899999999999999999999999   999999999999999999999999999876


Q ss_pred             CCCCcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCccccccC
Q 017594          202 GGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELID  281 (369)
Q Consensus       202 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (369)
                      ....  .......++..|+|||++.+..++.++||||||+++|+|++|..||.......     ..... .....     
T Consensus       192 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-----~~~~~-~~~~~-----  258 (335)
T 2owb_A          192 EYDG--ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE-----TYLRI-KKNEY-----  258 (335)
T ss_dssp             CSTT--CCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH-----HHHHH-HHTCC-----
T ss_pred             ccCc--ccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHH-----HHHHH-hcCCC-----
Confidence            4322  12233568999999999998889999999999999999999999986433111     00000 00000     


Q ss_pred             ccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 017594          282 PILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVS  320 (369)
Q Consensus       282 ~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~  320 (369)
                       .+..     .++..+.++|.+||+.||++|||+.++++
T Consensus       259 -~~~~-----~~~~~~~~li~~~l~~dp~~Rps~~ell~  291 (335)
T 2owb_A          259 -SIPK-----HINPVAASLIQKMLQTDPTARPTINELLN  291 (335)
T ss_dssp             -CCCT-----TSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             -CCCc-----cCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence             0011     12456899999999999999999999996

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=4.4e-41  Score=304.83  Aligned_cols=253  Identities=26%  Similarity=0.400  Sum_probs=199.4

Q ss_pred             cCCccCccccccCCccEEEEEEc-CCCEEEEEEecCCCchhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEEEEec
Q 017594           49 NKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIYEYM  127 (369)
Q Consensus        49 ~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~  127 (369)
                      .+|.....||+|+||.||+|++. ++..|++|.+........+.+.+|+.+++.++||||+++++++...+..++|+|++
T Consensus        22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  101 (295)
T 2clq_A           22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQV  101 (295)
T ss_dssp             CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeC
Confidence            34566669999999999999965 48899999998766566678899999999999999999999999999999999999


Q ss_pred             CCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeC-CCceEEeecCCceecCCCCc
Q 017594          128 PNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDK-DMNPKISDFGMARICGGNEL  206 (369)
Q Consensus       128 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~-~~~~~L~Dfg~~~~~~~~~~  206 (369)
                      .+++|.+++........+++..++.++.||+.||.|||+.+   ++|+||+|+||+++. ++.++|+|||++....... 
T Consensus       102 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~-  177 (295)
T 2clq_A          102 PGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN-  177 (295)
T ss_dssp             SEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTTCEESCC---
T ss_pred             CCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeecccccccCCCC-
Confidence            99999999876544455778889999999999999999999   999999999999987 8999999999988764322 


Q ss_pred             ccccccccccccccCchhhccCC--CCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCccccccCccc
Q 017594          207 QANTSRIVGTYGYMSPEYALEGI--FSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPIL  284 (369)
Q Consensus       207 ~~~~~~~~~~~~y~aPE~~~~~~--~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (369)
                       .......++..|+|||++.+..  ++.++||||||+++|+|++|..||.........    ........     ..+.+
T Consensus       178 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~----~~~~~~~~-----~~~~~  247 (295)
T 2clq_A          178 -PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAA----MFKVGMFK-----VHPEI  247 (295)
T ss_dssp             ----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHH----HHHHHHHC-----CCCCC
T ss_pred             -CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHH----HHhhcccc-----ccccc
Confidence             1123346889999999987643  789999999999999999999998633211100    00000000     00111


Q ss_pred             cccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 017594          285 EDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVS  320 (369)
Q Consensus       285 ~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~  320 (369)
                      .     ..++..+.++|.+||+.||++||++.++++
T Consensus       248 ~-----~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  278 (295)
T 2clq_A          248 P-----ESMSAEAKAFILKCFEPDPDKRACANDLLV  278 (295)
T ss_dssp             C-----TTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred             c-----ccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            1     112567899999999999999999999985

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=2.4e-41  Score=311.50  Aligned_cols=264  Identities=30%  Similarity=0.404  Sum_probs=205.5

Q ss_pred             HHhcCCccCccccccCCccEEEEEE------cCCCEEEEEEecCC-CchhHHHHHHHHHHHhcCCCCceeeeeeeEEeCC
Q 017594           46 TATNKFSDANKLGEGGFGPVYKGVL------KKGDEIAVKRLSGR-SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDRD  118 (369)
Q Consensus        46 ~~~~~y~i~~~lg~G~~~~v~~~~~------~~~~~valK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~  118 (369)
                      ...++|++.+.||+|+||.||+|++      .++..||+|++... .......+.+|+.+++.++||||+++++++....
T Consensus        27 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  106 (327)
T 2yfx_A           27 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSL  106 (327)
T ss_dssp             CCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             CChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCC
Confidence            3468999999999999999999983      24778999999644 3344567888999999999999999999999999


Q ss_pred             ccEEEEEecCCCChhhhhcCCCc----cccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeC---CCceE
Q 017594          119 EKILIYEYMPNKSLDFFLFDPTK----RMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDK---DMNPK  191 (369)
Q Consensus       119 ~~~lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~---~~~~~  191 (369)
                      ..++||||+.+++|.+++.....    ...+++..++.++.||+.||.|||+.+   ++||||+|+||+++.   +..++
T Consensus       107 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~~~k  183 (327)
T 2yfx_A          107 PRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAK  183 (327)
T ss_dssp             SCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEE
T ss_pred             CcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcceEE
Confidence            99999999999999999865332    244888899999999999999999999   999999999999984   44699


Q ss_pred             EeecCCceecCCCCcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHh-CCCCCCCCcccccccchhhhhh
Q 017594          192 ISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDL  270 (369)
Q Consensus       192 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~  270 (369)
                      |+|||++................+++.|+|||++.+..++.++||||||+++|+|++ |..||.......      ....
T Consensus       184 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~------~~~~  257 (327)
T 2yfx_A          184 IGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE------VLEF  257 (327)
T ss_dssp             ECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH------HHHH
T ss_pred             ECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHH------HHHH
Confidence            999999876544333233334467889999999998899999999999999999998 889986432111      0111


Q ss_pred             hhcCccccccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHhhhhc
Q 017594          271 WTSNRTLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNEAAT  328 (369)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L~~~~~~  328 (369)
                      ........     ..     ..++..+.++|.+||+.||.+||++.++++.|+.+...
T Consensus       258 ~~~~~~~~-----~~-----~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~  305 (327)
T 2yfx_A          258 VTSGGRMD-----PP-----KNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD  305 (327)
T ss_dssp             HHTTCCCC-----CC-----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             HhcCCCCC-----CC-----CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcC
Confidence            11110000     01     11256689999999999999999999999999887663

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=4.4e-41  Score=302.94  Aligned_cols=260  Identities=25%  Similarity=0.351  Sum_probs=204.1

Q ss_pred             HHHhcCCccCccccccCCccEEEEEEcC----CCEEEEEEecCC-CchhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCc
Q 017594           45 STATNKFSDANKLGEGGFGPVYKGVLKK----GDEIAVKRLSGR-SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDE  119 (369)
Q Consensus        45 ~~~~~~y~i~~~lg~G~~~~v~~~~~~~----~~~valK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~  119 (369)
                      ....++|++.+.||+|+||.||+|++..    +..|++|.+... .....+.+.+|+.+++.++||||+++++++.+ +.
T Consensus         8 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~   86 (281)
T 3cc6_A            8 GIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EP   86 (281)
T ss_dssp             SCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SS
T ss_pred             eecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CC
Confidence            3456889999999999999999999643    235999998755 33445778899999999999999999999754 56


Q ss_pred             cEEEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCce
Q 017594          120 KILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMAR  199 (369)
Q Consensus       120 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~  199 (369)
                      .++|+|++.+++|.+++...  ...+++..++.++.||+.||.|||+++   ++|+||||+||+++.++.++|+|||++.
T Consensus        87 ~~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~  161 (281)
T 3cc6_A           87 TWIIMELYPYGELGHYLERN--KNSLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSR  161 (281)
T ss_dssp             CEEEEECCTTCBHHHHHHHH--TTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCCCGGG
T ss_pred             CEEEEecCCCCCHHHHHHhc--cccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCccCCCc
Confidence            79999999999999988542  234889999999999999999999999   9999999999999999999999999987


Q ss_pred             ecCCCCcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHh-CCCCCCCCcccccccchhhhhhhhcCcccc
Q 017594          200 ICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDLWTSNRTLE  278 (369)
Q Consensus       200 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (369)
                      ....... .......++..|+|||++.+..++.++||||||+++|+|++ |..||........     . ..........
T Consensus       162 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~-----~-~~~~~~~~~~  234 (281)
T 3cc6_A          162 YIEDEDY-YKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDV-----I-GVLEKGDRLP  234 (281)
T ss_dssp             CC----------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGH-----H-HHHHHTCCCC
T ss_pred             ccccccc-cccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHH-----H-HHHhcCCCCC
Confidence            6543221 11223356778999999998899999999999999999998 9999864332211     0 0111110000


Q ss_pred             ccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHhhhh
Q 017594          279 LIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNEAA  327 (369)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L~~~~~  327 (369)
                           .     +..++..+.++|.+||+.||++|||+.++++.|+.+..
T Consensus       235 -----~-----~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~  273 (281)
T 3cc6_A          235 -----K-----PDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQ  273 (281)
T ss_dssp             -----C-----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -----C-----CCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHH
Confidence                 0     01125669999999999999999999999999988765

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=1.9e-41  Score=305.77  Aligned_cols=254  Identities=22%  Similarity=0.288  Sum_probs=205.6

Q ss_pred             HhcCCccCccccccCCccEEEEEEcC-CCEEEEEEecCCC---chhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEE
Q 017594           47 ATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRS---GQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKIL  122 (369)
Q Consensus        47 ~~~~y~i~~~lg~G~~~~v~~~~~~~-~~~valK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l  122 (369)
                      ..++|++.+.||+|++|.||+|++.. +..|++|++....   ......+.+|+.+++.++||||+++++++...+..++
T Consensus        12 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   91 (284)
T 2vgo_A           12 TIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYL   91 (284)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred             hhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEE
Confidence            34789999999999999999999764 7789999986432   1234678899999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecC
Q 017594          123 IYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICG  202 (369)
Q Consensus       123 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~  202 (369)
                      ||||+.+++|.+++...   ..+++..++.++.||+.||.|||+.|   ++|+||+|+||+++.++.++|+|||++....
T Consensus        92 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~  165 (284)
T 2vgo_A           92 MLEFAPRGELYKELQKH---GRFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAP  165 (284)
T ss_dssp             EECCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCTTCEECS
T ss_pred             EEEeCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEecccccccCc
Confidence            99999999998888542   34889999999999999999999999   9999999999999999999999999987654


Q ss_pred             CCCcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCccccccCc
Q 017594          203 GNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDP  282 (369)
Q Consensus       203 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (369)
                      ...    .....+++.|+|||++.+..++.++||||||+++|+|++|..||.......     ....... ...      
T Consensus       166 ~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-----~~~~~~~-~~~------  229 (284)
T 2vgo_A          166 SLR----RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTE-----THRRIVN-VDL------  229 (284)
T ss_dssp             SSC----BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH-----HHHHHHT-TCC------
T ss_pred             ccc----cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhH-----HHHHHhc-ccc------
Confidence            322    233468899999999999999999999999999999999999986433111     0001100 000      


Q ss_pred             cccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH--HHHhhhh
Q 017594          283 ILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVS--MLTNEAA  327 (369)
Q Consensus       283 ~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~--~L~~~~~  327 (369)
                      .+.     ..++..+.++|.+||+.||.+||++.++++  .+.....
T Consensus       230 ~~~-----~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~~~~  271 (284)
T 2vgo_A          230 KFP-----PFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKANSR  271 (284)
T ss_dssp             CCC-----TTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHHHCC
T ss_pred             CCC-----CcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHhhcc
Confidence            011     112566899999999999999999999996  4554433

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=3.3e-41  Score=327.29  Aligned_cols=261  Identities=28%  Similarity=0.420  Sum_probs=211.9

Q ss_pred             HHHhcCCccCccccccCCccEEEEEEcC-CCEEEEEEecCCCchhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEE
Q 017594           45 STATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILI  123 (369)
Q Consensus        45 ~~~~~~y~i~~~lg~G~~~~v~~~~~~~-~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv  123 (369)
                      .....+|++.+.||+|+||.||+|+++. +..||+|++.... ...+.+.+|+.++++++||||+++++++......++|
T Consensus       216 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv  294 (495)
T 1opk_A          216 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII  294 (495)
T ss_dssp             BCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred             ccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEE
Confidence            3456779999999999999999999875 8889999997543 3457889999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCC
Q 017594          124 YEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGG  203 (369)
Q Consensus       124 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~  203 (369)
                      |||+.+++|.+++.... ...+++..++.++.||+.||+|||+++   ++||||||+||+++.++.++|+|||++.....
T Consensus       295 ~E~~~~g~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~  370 (495)
T 1opk_A          295 TEFMTYGNLLDYLRECN-RQEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTG  370 (495)
T ss_dssp             EECCTTCBHHHHHHHSC-TTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEECCTT
T ss_pred             EEccCCCCHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeecccceeccC
Confidence            99999999999986432 345889999999999999999999999   99999999999999999999999999987643


Q ss_pred             CCcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHh-CCCCCCCCcccccccchhhhhhhhcCccccccCc
Q 017594          204 NELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDP  282 (369)
Q Consensus       204 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (369)
                      ... .......++..|+|||++.+..++.++||||||+++|+|++ |..||.......      .........     ..
T Consensus       371 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~------~~~~~~~~~-----~~  438 (495)
T 1opk_A          371 DTY-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ------VYELLEKDY-----RM  438 (495)
T ss_dssp             CCE-ECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG------HHHHHHTTC-----CC
T ss_pred             Cce-eecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHH------HHHHHHcCC-----CC
Confidence            321 12223345678999999998999999999999999999999 899986443211      111111110     00


Q ss_pred             cccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHhhhh
Q 017594          283 ILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNEAA  327 (369)
Q Consensus       283 ~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L~~~~~  327 (369)
                      ..     +..++..+.+||.+||+.||++|||+.+|++.|+.+..
T Consensus       439 ~~-----~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~  478 (495)
T 1opk_A          439 ER-----PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ  478 (495)
T ss_dssp             CC-----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCS
T ss_pred             CC-----CCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHh
Confidence            00     11225679999999999999999999999999988754

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=4.9e-42  Score=329.28  Aligned_cols=249  Identities=22%  Similarity=0.280  Sum_probs=193.7

Q ss_pred             HhcCCccCccccccCCccEEEEEEc-CCCEEEEEEecCC---CchhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEE
Q 017594           47 ATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGR---SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKIL  122 (369)
Q Consensus        47 ~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l  122 (369)
                      ..++|++.+.||+|+||.||+|+.. +|+.||+|++...   .......+..|+.+++.++||||+++++++...+..++
T Consensus       146 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~l  225 (446)
T 4ejn_A          146 TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCF  225 (446)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEE
T ss_pred             ChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEE
Confidence            4578999999999999999999965 4899999998642   22334566789999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhc-CCCCCcccCCCCCCCEEEeCCCceEEeecCCceec
Q 017594          123 IYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQ-YSRVRIIHRDLKASNILLDKDMNPKISDFGMARIC  201 (369)
Q Consensus       123 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~-~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~  201 (369)
                      ||||+.+++|..++..   ...+++..+..++.||+.||+|||+ .|   ++||||||+||+++.++.++|+|||++...
T Consensus       226 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~DFG~a~~~  299 (446)
T 4ejn_A          226 VMEYANGGELFFHLSR---ERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEG  299 (446)
T ss_dssp             EECCCSSCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEECCCCCCCTT
T ss_pred             EEeeCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEccCCCceec
Confidence            9999999999888843   3458999999999999999999998 88   999999999999999999999999998753


Q ss_pred             CCCCcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCccccccC
Q 017594          202 GGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELID  281 (369)
Q Consensus       202 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (369)
                      ....  .......|++.|+|||++.+..++.++|||||||++|+|++|..||.......     ....... ... .   
T Consensus       300 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~-----~~~~i~~-~~~-~---  367 (446)
T 4ejn_A          300 IKDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK-----LFELILM-EEI-R---  367 (446)
T ss_dssp             CC-------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-----HHHHHHH-CCC-C---
T ss_pred             cCCC--cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHH-----HHHHHHh-CCC-C---
Confidence            3221  22334578999999999999999999999999999999999999996433211     0011110 000 0   


Q ss_pred             ccccccccHHHHHHHHHHHHHHhhcCCCCCCC-----CHHHHHH
Q 017594          282 PILEDEYSSKQMLLRYANIALLCVQESADDRP-----TMNDVVS  320 (369)
Q Consensus       282 ~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp-----s~~ell~  320 (369)
                        +     +..++.++.+||.+||+.||.+||     ++.++++
T Consensus       368 --~-----p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~  404 (446)
T 4ejn_A          368 --F-----PRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ  404 (446)
T ss_dssp             --C-----CTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             --C-----CccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence              0     111256799999999999999999     9999986

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=6.2e-41  Score=316.91  Aligned_cols=254  Identities=19%  Similarity=0.233  Sum_probs=191.4

Q ss_pred             HhcCCccC-ccccccCCccEEEEEEc-CCCEEEEEEecCCCchhHHHHHHHHHHHh-cCCCCceeeeeeeEEe----CCc
Q 017594           47 ATNKFSDA-NKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSGQGLREMKNEASVIA-KVQHKNLVRLLGCCID----RDE  119 (369)
Q Consensus        47 ~~~~y~i~-~~lg~G~~~~v~~~~~~-~~~~valK~~~~~~~~~~~~~~~e~~~l~-~l~h~~i~~~~~~~~~----~~~  119 (369)
                      ..++|.+. +.||.|+||.||+|+++ +|+.||+|++...     ..+.+|+.++. ..+||||+++++++..    ...
T Consensus        59 ~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~  133 (400)
T 1nxk_A           59 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKC  133 (400)
T ss_dssp             GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred             ccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcE
Confidence            45667776 78999999999999976 4889999998632     45667888764 4589999999999875    556


Q ss_pred             cEEEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeC---CCceEEeecC
Q 017594          120 KILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDK---DMNPKISDFG  196 (369)
Q Consensus       120 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~---~~~~~L~Dfg  196 (369)
                      .|+||||+.+++|.+++.... ...+++..++.++.||+.||.|||+.+   ++||||||+||+++.   ++.++|+|||
T Consensus       134 ~~lv~E~~~gg~L~~~l~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~kl~DFG  209 (400)
T 1nxk_A          134 LLIVMECLDGGELFSRIQDRG-DQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFG  209 (400)
T ss_dssp             EEEEEECCCSEEHHHHHHCC----CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCEEECCCT
T ss_pred             EEEEEEeCCCCcHHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccEEEEecc
Confidence            899999999999999986532 345899999999999999999999999   999999999999987   7889999999


Q ss_pred             CceecCCCCcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCcc
Q 017594          197 MARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRT  276 (369)
Q Consensus       197 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  276 (369)
                      ++.......   ......+++.|+|||++.+..++.++|||||||++|+|++|..||..........  ...........
T Consensus       210 ~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~--~~~~~i~~~~~  284 (400)
T 1nxk_A          210 FAKETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP--GMKTRIRMGQY  284 (400)
T ss_dssp             TCEECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCC--SHHHHHHHTCC
T ss_pred             cccccCCCC---ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccH--HHHHHHHcCcc
Confidence            998654322   1234568999999999999999999999999999999999999996543211100  00000000000


Q ss_pred             ccccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 017594          277 LELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSM  321 (369)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~  321 (369)
                       ....+      ....++.++.+||.+||+.||++|||+.++++.
T Consensus       285 -~~~~~------~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h  322 (400)
T 1nxk_A          285 -EFPNP------EWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH  322 (400)
T ss_dssp             -CCCTT------TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             -cCCCc------ccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence             00000      001226679999999999999999999999974

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=1.5e-41  Score=313.44  Aligned_cols=265  Identities=24%  Similarity=0.344  Sum_probs=199.0

Q ss_pred             hcCCccCccccccCCccEEEEEEcC-CCEEEEEEecCCCc--hhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEEE
Q 017594           48 TNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSG--QGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIY  124 (369)
Q Consensus        48 ~~~y~i~~~lg~G~~~~v~~~~~~~-~~~valK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  124 (369)
                      .++|++.+.||+|+||.||+|++.. |+.||+|++.....  ...+.+.+|+.+++.++||||+++++++...+..++||
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  103 (331)
T 4aaa_A           24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF  103 (331)
T ss_dssp             GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence            4789999999999999999999765 89999999865432  23455778999999999999999999999999999999


Q ss_pred             EecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCCC
Q 017594          125 EYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGN  204 (369)
Q Consensus       125 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~~  204 (369)
                      ||+.++++..+....   ..+++..++.++.||+.||.|||+.|   ++||||||+||+++.++.++|+|||++......
T Consensus       104 e~~~~~~l~~~~~~~---~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  177 (331)
T 4aaa_A          104 EFVDHTILDDLELFP---NGLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAP  177 (331)
T ss_dssp             ECCSEEHHHHHHHST---TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred             ecCCcchHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCCceeecCC
Confidence            999999998876443   34899999999999999999999999   999999999999999999999999998765432


Q ss_pred             CcccccccccccccccCchhhccC-CCCcccchHhHHHHHHHHHhCCCCCCCCcccccccc---------hhhhhhhhcC
Q 017594          205 ELQANTSRIVGTYGYMSPEYALEG-IFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLL---------GYAWDLWTSN  274 (369)
Q Consensus       205 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~---------~~~~~~~~~~  274 (369)
                      ..  ......++..|+|||++.+. .++.++|||||||++|+|++|..||...........         ......+...
T Consensus       178 ~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (331)
T 4aaa_A          178 GE--VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKN  255 (331)
T ss_dssp             --------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHC
T ss_pred             cc--ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhc
Confidence            21  22334688999999998765 789999999999999999999999975442111000         0000000000


Q ss_pred             cc-ccccCccccccc----cHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 017594          275 RT-LELIDPILEDEY----SSKQMLLRYANIALLCVQESADDRPTMNDVVS  320 (369)
Q Consensus       275 ~~-~~~~~~~~~~~~----~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~  320 (369)
                      .. .....+......    ....++..+.+||.+||+.||++|||+.++++
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~  306 (331)
T 4aaa_A          256 PVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH  306 (331)
T ss_dssp             GGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             cccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence            00 000000000000    01123677999999999999999999999985

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=3.8e-41  Score=314.89  Aligned_cols=259  Identities=13%  Similarity=0.119  Sum_probs=208.0

Q ss_pred             hHHHHhcCCccCccccccCCccEEEEE------EcCCCEEEEEEecCCCchhHHHHHHHHHHHhcCC---CCceeeeeee
Q 017594           43 SVSTATNKFSDANKLGEGGFGPVYKGV------LKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQ---HKNLVRLLGC  113 (369)
Q Consensus        43 ~~~~~~~~y~i~~~lg~G~~~~v~~~~------~~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~---h~~i~~~~~~  113 (369)
                      .+....++|++.+.||+|+||.||+|.      ..+++.||+|++.....   ..+..|+.++..++   |+|+++++++
T Consensus        59 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~e~~~~~~l~~~~~~~iv~~~~~  135 (365)
T 3e7e_A           59 EFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANP---WEFYIGTQLMERLKPSMQHMFMKFYSA  135 (365)
T ss_dssp             EEECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCCH---HHHHHHHHHHHHSCGGGGGGBCCEEEE
T ss_pred             eEEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCCh---hHHHHHHHHHHHhhhhhhhhhhhhhee
Confidence            344556889999999999999999994      44588999999976543   46677777777776   8999999999


Q ss_pred             EEeCCccEEEEEecCCCChhhhhcCC--CccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeC-----
Q 017594          114 CIDRDEKILIYEYMPNKSLDFFLFDP--TKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDK-----  186 (369)
Q Consensus       114 ~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~-----  186 (369)
                      +...+..++||||+++++|.+++...  .....+++..++.++.||+.||+|||+.+   ++||||||+||+++.     
T Consensus       136 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~~~~~  212 (365)
T 3e7e_A          136 HLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQ  212 (365)
T ss_dssp             EECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGGGTCC
T ss_pred             eecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEecccccCc
Confidence            99999999999999999999998531  12345899999999999999999999999   999999999999998     


Q ss_pred             ------CCceEEeecCCceecCCCCcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccc
Q 017594          187 ------DMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDS  260 (369)
Q Consensus       187 ------~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~  260 (369)
                            ++.++|+|||++..+.............|++.|+|||++.+..++.++|||||||++|+|++|+.||.......
T Consensus       213 ~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~  292 (365)
T 3e7e_A          213 DDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE  292 (365)
T ss_dssp             ------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE
T ss_pred             cccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCc
Confidence                  89999999999976543333333445678999999999999999999999999999999999999985322111


Q ss_pred             cccchhhhhhhhcCccccccCccccccccHHHHHHHHHHHHHHhhcCCCCCC-CCHHHHHHHHHhhhhc
Q 017594          261 LNLLGYAWDLWTSNRTLELIDPILEDEYSSKQMLLRYANIALLCVQESADDR-PTMNDVVSMLTNEAAT  328 (369)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R-ps~~ell~~L~~~~~~  328 (369)
                      .                 .+...+....    .+..+.+++..||+.+|.+| |++.++.+.|+.....
T Consensus       293 ~-----------------~~~~~~~~~~----~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~  340 (365)
T 3e7e_A          293 C-----------------KPEGLFRRLP----HLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQ  340 (365)
T ss_dssp             E-----------------EECSCCTTCS----SHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHH
T ss_pred             e-----------------eechhccccC----cHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHH
Confidence            0                 0111111111    15568899999999999999 5788888888887764

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=8.4e-41  Score=322.20  Aligned_cols=266  Identities=19%  Similarity=0.292  Sum_probs=206.7

Q ss_pred             HhcCCccCccccccCCccEEEEEEc-CCCEEEEEEecCCCchhHHHHHHHHHHHhcCCC-CceeeeeeeEEeCCccEEEE
Q 017594           47 ATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSGQGLREMKNEASVIAKVQH-KNLVRLLGCCIDRDEKILIY  124 (369)
Q Consensus        47 ~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~  124 (369)
                      ..++|++.+.||+|+||.||+|++. +++.||||++......  ..+..|+.+++.+.| +++..+..++......++||
T Consensus         5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvm   82 (483)
T 3sv0_A            5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVM   82 (483)
T ss_dssp             ETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS--CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEE
T ss_pred             cCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc--HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEE
Confidence            4589999999999999999999964 5899999988654332  457789999999987 45666666667778889999


Q ss_pred             EecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEE---eCCCceEEeecCCceec
Q 017594          125 EYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILL---DKDMNPKISDFGMARIC  201 (369)
Q Consensus       125 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv---~~~~~~~L~Dfg~~~~~  201 (369)
                      ||+ +++|.+++...  ...+++..++.++.||+.||.|||+++   ++||||||+|||+   +.++.++|+|||++..+
T Consensus        83 e~~-g~sL~~ll~~~--~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~  156 (483)
T 3sv0_A           83 DLL-GPSLEDLFNFC--SRKLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY  156 (483)
T ss_dssp             ECC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred             ECC-CCCHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEeCCcceec
Confidence            999 88999988532  234899999999999999999999999   9999999999999   68899999999999877


Q ss_pred             CCCCccc-----ccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCcc
Q 017594          202 GGNELQA-----NTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRT  276 (369)
Q Consensus       202 ~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  276 (369)
                      .......     ......|+..|+|||++.+..++.++|||||||++|+|++|..||...........   .........
T Consensus       157 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~---~~~i~~~~~  233 (483)
T 3sv0_A          157 RDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQK---YEKISEKKV  233 (483)
T ss_dssp             BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHH---HHHHHHHHH
T ss_pred             cCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHH---HHHHhhccc
Confidence            5433211     12245789999999999999999999999999999999999999975432211100   000000000


Q ss_pred             ccccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHhhhhcc
Q 017594          277 LELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNEAATL  329 (369)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L~~~~~~~  329 (369)
                      ...+...      ...++.++.++|..||+.+|++||++.+|++.|+.+....
T Consensus       234 ~~~~~~l------~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~  280 (483)
T 3sv0_A          234 ATSIEAL------CRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIRE  280 (483)
T ss_dssp             HSCHHHH------HTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred             cccHHHH------hcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHc
Confidence            0000000      0122567999999999999999999999999999886543

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=5.3e-41  Score=302.58  Aligned_cols=259  Identities=22%  Similarity=0.288  Sum_probs=205.2

Q ss_pred             HhcCCccCccccccCCccEEEEEEc-CCCEEEEEEecCCCc------hhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCc
Q 017594           47 ATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSG------QGLREMKNEASVIAKVQHKNLVRLLGCCIDRDE  119 (369)
Q Consensus        47 ~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~~~------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~  119 (369)
                      +.++|++.+.||+|+||.||+|+.. +|+.||+|++.....      ...+.+.+|+.+++.++||||+++++++.....
T Consensus         3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~   82 (283)
T 3bhy_A            3 VEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTD   82 (283)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             hhhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCe
Confidence            4578999999999999999999976 589999999865421      135778899999999999999999999999999


Q ss_pred             cEEEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCC----ceEEeec
Q 017594          120 KILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDM----NPKISDF  195 (369)
Q Consensus       120 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~----~~~L~Df  195 (369)
                      .++|||++.+++|.+++..   ...+++..++.++.||+.||.|||+.+   ++|+||+|+||+++.++    .++|+||
T Consensus        83 ~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~~kl~df  156 (283)
T 3bhy_A           83 VVLILELVSGGELFDFLAE---KESLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDF  156 (283)
T ss_dssp             EEEEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCCEEECCC
T ss_pred             EEEEEeecCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCceEEEec
Confidence            9999999999999998843   345899999999999999999999999   99999999999998877    8999999


Q ss_pred             CCceecCCCCcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCc
Q 017594          196 GMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNR  275 (369)
Q Consensus       196 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  275 (369)
                      |++.......   ......+++.|+|||++.+..++.++||||||+++|+|++|..||.......     ..... ....
T Consensus       157 g~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-----~~~~~-~~~~  227 (283)
T 3bhy_A          157 GIAHKIEAGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQE-----TLTNI-SAVN  227 (283)
T ss_dssp             TTCEECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH-----HHHHH-HTTC
T ss_pred             ccceeccCCC---cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHH-----HHHHh-Hhcc
Confidence            9998764332   1223468899999999998899999999999999999999999986432111     00000 0000


Q ss_pred             cccccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH--HHHhhhh
Q 017594          276 TLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVS--MLTNEAA  327 (369)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~--~L~~~~~  327 (369)
                      .      ... .......+..+.++|.+||+.||++|||+.++++  .++....
T Consensus       228 ~------~~~-~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~  274 (283)
T 3bhy_A          228 Y------DFD-EEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRR  274 (283)
T ss_dssp             C------CCC-HHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHHH
T ss_pred             c------CCc-chhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHHH
Confidence            0      000 0001122567899999999999999999999997  4555544

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=9.4e-41  Score=310.48  Aligned_cols=267  Identities=20%  Similarity=0.306  Sum_probs=198.4

Q ss_pred             hcCCccCccccccCCccEEEEEEc-CCCEEEEEEecCCCc--hhHHHHHHHHHHHhcCCCCceeeeeeeEEeC-------
Q 017594           48 TNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSG--QGLREMKNEASVIAKVQHKNLVRLLGCCIDR-------  117 (369)
Q Consensus        48 ~~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-------  117 (369)
                      .++|++++.||+|+||.||+|++. +|+.||+|++.....  .....+.+|+.+++.++||||+++++++...       
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   95 (351)
T 3mi9_A           16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   95 (351)
T ss_dssp             GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred             ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence            478999999999999999999974 589999999864432  2345677899999999999999999998863       


Q ss_pred             -CccEEEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecC
Q 017594          118 -DEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFG  196 (369)
Q Consensus       118 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg  196 (369)
                       +..++||||+.+ ++...+....  ..+++..++.++.||+.||.|||+.|   ++||||||+||+++.++.++|+|||
T Consensus        96 ~~~~~lv~e~~~~-~l~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg  169 (351)
T 3mi9_A           96 KGSIYLVFDFCEH-DLAGLLSNVL--VKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFG  169 (351)
T ss_dssp             -CEEEEEEECCSE-EHHHHHHCTT--SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCT
T ss_pred             CceEEEEEeccCC-CHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCCEEEccch
Confidence             457999999986 5545553322  34899999999999999999999999   9999999999999999999999999


Q ss_pred             CceecCCCCcc--cccccccccccccCchhhcc-CCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccc---------
Q 017594          197 MARICGGNELQ--ANTSRIVGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLL---------  264 (369)
Q Consensus       197 ~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~---------  264 (369)
                      ++..+......  .......+++.|+|||++.+ ..++.++|||||||++|+|++|..||...........         
T Consensus       170 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~  249 (351)
T 3mi9_A          170 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT  249 (351)
T ss_dssp             TCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred             hcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence            99876532211  22233567999999998875 5689999999999999999999999975432111000         


Q ss_pred             hhhhhhhhcCccccccCccccc------cccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 017594          265 GYAWDLWTSNRTLELIDPILED------EYSSKQMLLRYANIALLCVQESADDRPTMNDVVS  320 (369)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~  320 (369)
                      ...+...........+......      .......+..+.+||.+||+.||++|||+.++++
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  311 (351)
T 3mi9_A          250 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN  311 (351)
T ss_dssp             TTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence            0000000000011111000000      0011111456899999999999999999999997

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=9.1e-42  Score=319.28  Aligned_cols=247  Identities=23%  Similarity=0.279  Sum_probs=191.0

Q ss_pred             HHhcCCccCccccccCCccEEEEEEcC-CCEEEEEEecCCC---chhHHHHHHHHHH-HhcCCCCceeeeeeeEEeCCcc
Q 017594           46 TATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRS---GQGLREMKNEASV-IAKVQHKNLVRLLGCCIDRDEK  120 (369)
Q Consensus        46 ~~~~~y~i~~~lg~G~~~~v~~~~~~~-~~~valK~~~~~~---~~~~~~~~~e~~~-l~~l~h~~i~~~~~~~~~~~~~  120 (369)
                      ...++|++++.||+|+||.||+|+.+. ++.||+|++....   ......+..|..+ ++.++||||+++++++...+..
T Consensus        35 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~  114 (373)
T 2r5t_A           35 AKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKL  114 (373)
T ss_dssp             CCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEE
T ss_pred             CChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEE
Confidence            345789999999999999999999765 8889999986442   1223445556665 4668999999999999999999


Q ss_pred             EEEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCcee
Q 017594          121 ILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARI  200 (369)
Q Consensus       121 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~  200 (369)
                      |+||||+.+++|..++..   ...+++..++.++.||+.||.|||++|   ++||||||+||+++.+|.++|+|||++..
T Consensus       115 ~lv~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DFG~a~~  188 (373)
T 2r5t_A          115 YFVLDYINGGELFYHLQR---ERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKE  188 (373)
T ss_dssp             EEEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCBCGG
T ss_pred             EEEEeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeCccccc
Confidence            999999999999988853   344889999999999999999999999   99999999999999999999999999875


Q ss_pred             cCCCCcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCcccccc
Q 017594          201 CGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELI  280 (369)
Q Consensus       201 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (369)
                      .....  .......|++.|+|||++.+..++.++|+|||||++|+|++|..||.......     ....... ... .  
T Consensus       189 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~-----~~~~i~~-~~~-~--  257 (373)
T 2r5t_A          189 NIEHN--STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE-----MYDNILN-KPL-Q--  257 (373)
T ss_dssp             GBCCC--CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHH-----HHHHHHH-SCC-C--
T ss_pred             cccCC--CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHH-----HHHHHHh-ccc-C--
Confidence            43221  22334578999999999999999999999999999999999999996432111     1111111 100 0  


Q ss_pred             CccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHH
Q 017594          281 DPILEDEYSSKQMLLRYANIALLCVQESADDRPTMND  317 (369)
Q Consensus       281 ~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e  317 (369)
                         +..     .++..+.++|.+||+.||.+||++.+
T Consensus       258 ---~~~-----~~~~~~~~li~~lL~~dp~~R~~~~~  286 (373)
T 2r5t_A          258 ---LKP-----NITNSARHLLEGLLQKDRTKRLGAKD  286 (373)
T ss_dssp             ---CCS-----SSCHHHHHHHHHHTCSSGGGSTTTTT
T ss_pred             ---CCC-----CCCHHHHHHHHHHcccCHHhCCCCCC
Confidence               011     12566899999999999999999853

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=1.6e-41  Score=313.01  Aligned_cols=272  Identities=21%  Similarity=0.262  Sum_probs=192.8

Q ss_pred             chhhHHHHhcCCccCccccccCCccEEEEEEc-CCCEEEEEEecCCCc--hhHHHHHHHHHHHhcCCCCceeeeeeeEEe
Q 017594           40 SFSSVSTATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSG--QGLREMKNEASVIAKVQHKNLVRLLGCCID  116 (369)
Q Consensus        40 ~~~~~~~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~  116 (369)
                      +........++|++.+.||+|+||.||+|++. +|+.||+|++.....  .....+.+|+.+++.++||||+++++++..
T Consensus        25 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~  104 (329)
T 3gbz_A           25 SAAPSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHH  104 (329)
T ss_dssp             -------CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEE
T ss_pred             ccCCcccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEec
Confidence            33445666789999999999999999999965 588999999865432  224556789999999999999999999999


Q ss_pred             CCccEEEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEe-----CCCceE
Q 017594          117 RDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLD-----KDMNPK  191 (369)
Q Consensus       117 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~-----~~~~~~  191 (369)
                      .+..++||||+.+ +|.+++...   ..+++..++.++.||+.||.|||+.+   ++||||||+||+++     .++.++
T Consensus       105 ~~~~~lv~e~~~~-~L~~~~~~~---~~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~k  177 (329)
T 3gbz_A          105 NHRLHLIFEYAEN-DLKKYMDKN---PDVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLK  177 (329)
T ss_dssp             TTEEEEEEECCSE-EHHHHHHHC---TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEE
T ss_pred             CCEEEEEEecCCC-CHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEE
Confidence            9999999999985 888887543   34899999999999999999999999   99999999999995     445599


Q ss_pred             EeecCCceecCCCCcccccccccccccccCchhhccC-CCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchh----
Q 017594          192 ISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEG-IFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGY----  266 (369)
Q Consensus       192 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~----  266 (369)
                      |+|||++.......  .......+++.|+|||++.+. .++.++|||||||++|+|++|..||.............    
T Consensus       178 l~Dfg~a~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~  255 (329)
T 3gbz_A          178 IGDFGLARAFGIPI--RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLG  255 (329)
T ss_dssp             ECCTTHHHHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHC
T ss_pred             ECcCCCccccCCcc--cccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhC
Confidence            99999987664322  122334678999999998864 58999999999999999999999997543211100000    


Q ss_pred             -----hhhhhh-cCccccccCccccc---cccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 017594          267 -----AWDLWT-SNRTLELIDPILED---EYSSKQMLLRYANIALLCVQESADDRPTMNDVVS  320 (369)
Q Consensus       267 -----~~~~~~-~~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~  320 (369)
                           .+.... ..............   .......+.++.+||.+||+.||++|||+.++++
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  318 (329)
T 3gbz_A          256 LPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE  318 (329)
T ss_dssp             CCCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             CCchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence                 000000 00000000000000   0001113567899999999999999999999986

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=2e-41  Score=304.77  Aligned_cols=255  Identities=26%  Similarity=0.360  Sum_probs=200.2

Q ss_pred             HHhcCCccCccccccCCccEEEEEEcCCCEEEEEEecCCCchhHHHHHHHHHHHhcCCCCceeeeeeeEEeC-CccEEEE
Q 017594           46 TATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDR-DEKILIY  124 (369)
Q Consensus        46 ~~~~~y~i~~~lg~G~~~~v~~~~~~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~  124 (369)
                      ...++|++.+.||+|++|.||+|+++ |+.||+|++....  ..+.+.+|+.+++.++||||+++++++... +..++|+
T Consensus        18 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~   94 (278)
T 1byg_A           18 LNMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT   94 (278)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEE
T ss_pred             CChhhceEEeEEecCCCceEEEEEEc-CCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEE
Confidence            34689999999999999999999876 8899999987543  457788999999999999999999987554 4789999


Q ss_pred             EecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCCC
Q 017594          125 EYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGN  204 (369)
Q Consensus       125 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~~  204 (369)
                      ||+.+++|.+++... ....+++..++.++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++......
T Consensus        95 e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~  170 (278)
T 1byg_A           95 EYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST  170 (278)
T ss_dssp             CCCTTEEHHHHHHHH-HHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC-------
T ss_pred             ecCCCCCHHHHHHhc-ccccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeecccccccccc
Confidence            999999999988532 2233788899999999999999999999   999999999999999999999999998754322


Q ss_pred             CcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHh-CCCCCCCCcccccccchhhhhhhhcCccccccCcc
Q 017594          205 ELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPI  283 (369)
Q Consensus       205 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (369)
                           .....++..|+|||++.+..++.++||||||+++|+|++ |..||.......     .. .......     ...
T Consensus       171 -----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~-----~~-~~~~~~~-----~~~  234 (278)
T 1byg_A          171 -----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD-----VV-PRVEKGY-----KMD  234 (278)
T ss_dssp             ----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG-----HH-HHHTTTC-----CCC
T ss_pred             -----ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH-----HH-HHHhcCC-----CCC
Confidence                 122356788999999998899999999999999999998 999986543211     00 1111110     001


Q ss_pred             ccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHhhhhc
Q 017594          284 LEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNEAAT  328 (369)
Q Consensus       284 ~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L~~~~~~  328 (369)
                      ..     ..++..+.++|.+||+.||++|||+.++++.|+.+...
T Consensus       235 ~~-----~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~  274 (278)
T 1byg_A          235 AP-----DGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH  274 (278)
T ss_dssp             CC-----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             Cc-----ccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhh
Confidence            11     11256799999999999999999999999999998764

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=7.9e-42  Score=323.15  Aligned_cols=260  Identities=21%  Similarity=0.245  Sum_probs=205.6

Q ss_pred             hhhHHHHhcCCccCccccccCCccEEEEEEcC-CCEEEEEEecCCC---chhHHHHHHHHHHHhcCCCCceeeeeeeEEe
Q 017594           41 FSSVSTATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRS---GQGLREMKNEASVIAKVQHKNLVRLLGCCID  116 (369)
Q Consensus        41 ~~~~~~~~~~y~i~~~lg~G~~~~v~~~~~~~-~~~valK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~  116 (369)
                      +..+....++|++++.||+|+||.||+|+.+. ++.||+|++....   ......+..|+.++..++||||+++++++.+
T Consensus        61 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~  140 (410)
T 3v8s_A           61 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD  140 (410)
T ss_dssp             HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred             HHhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEE
Confidence            34455567899999999999999999999765 8899999986321   1122457789999999999999999999999


Q ss_pred             CCccEEEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecC
Q 017594          117 RDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFG  196 (369)
Q Consensus       117 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg  196 (369)
                      ....|+||||+.+++|.+++..    ..+++..++.++.||+.||.|||++|   ++||||||+||+++.++.++|+|||
T Consensus       141 ~~~~~lV~E~~~gg~L~~~l~~----~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFG  213 (410)
T 3v8s_A          141 DRYLYMVMEYMPGGDLVNLMSN----YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFG  213 (410)
T ss_dssp             SSEEEEEECCCTTEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCT
T ss_pred             CCEEEEEEeCCCCCcHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCCEEEeccc
Confidence            9999999999999999998843    24889999999999999999999999   9999999999999999999999999


Q ss_pred             CceecCCCCcccccccccccccccCchhhccCC----CCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhh
Q 017594          197 MARICGGNELQANTSRIVGTYGYMSPEYALEGI----FSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWT  272 (369)
Q Consensus       197 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~----~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~  272 (369)
                      ++........ .......|++.|+|||++.+..    ++.++|+|||||++|+|++|..||.......     .......
T Consensus       214 ~a~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~-----~~~~i~~  287 (410)
T 3v8s_A          214 TCMKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG-----TYSKIMN  287 (410)
T ss_dssp             TCEECCTTSE-EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHH-----HHHHHHT
T ss_pred             eeEeeccCCc-ccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhh-----HHHHHHh
Confidence            9987654321 1223457999999999987655    8899999999999999999999996433111     0011110


Q ss_pred             cCccccccCccccccccHHHHHHHHHHHHHHhhcCCCCC--CCCHHHHHHH
Q 017594          273 SNRTLELIDPILEDEYSSKQMLLRYANIALLCVQESADD--RPTMNDVVSM  321 (369)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~--Rps~~ell~~  321 (369)
                      .........        ...++.++.+||.+||+.+|.+  ||++.+|++.
T Consensus       288 ~~~~~~~p~--------~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H  330 (410)
T 3v8s_A          288 HKNSLTFPD--------DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH  330 (410)
T ss_dssp             HHHHCCCCT--------TCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred             ccccccCCC--------cccccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence            000000000        0012567999999999999988  9999999964

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=3.4e-41  Score=327.47  Aligned_cols=264  Identities=24%  Similarity=0.333  Sum_probs=205.0

Q ss_pred             CccccchhhHHHHhcCCccCccccccCCccEEEEEEc-CCCEEEEEEecCCC--chhHHHHHHHHHHHhcCCCCceeeee
Q 017594           35 QFPLFSFSSVSTATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS--GQGLREMKNEASVIAKVQHKNLVRLL  111 (369)
Q Consensus        35 ~~~~~~~~~~~~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~  111 (369)
                      ....+.......+.++|++++.||+|+||.||+|+++ ++..||+|++....  ......+.+|+.+++.++||||++++
T Consensus        23 ~~~~~~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~  102 (494)
T 3lij_A           23 TPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLY  102 (494)
T ss_dssp             CGGGGCCCCBCCHHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEE
T ss_pred             chhheeecCCCchhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEE
Confidence            3334555555667889999999999999999999976 48899999987542  23356788999999999999999999


Q ss_pred             eeEEeCCccEEEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCC---C
Q 017594          112 GCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKD---M  188 (369)
Q Consensus       112 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~---~  188 (369)
                      +++.+....++||||+.+++|.+.+..   ...+++..++.++.||+.||.|||++|   ++||||||+||+++..   +
T Consensus       103 ~~~~~~~~~~lv~e~~~~g~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~  176 (494)
T 3lij_A          103 DFFEDKRNYYLVMECYKGGELFDEIIH---RMKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDA  176 (494)
T ss_dssp             EEEECSSEEEEEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTC
T ss_pred             EEEEeCCEEEEEEecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCC
Confidence            999999999999999999999887743   345899999999999999999999999   9999999999999764   4


Q ss_pred             ceEEeecCCceecCCCCcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhh
Q 017594          189 NPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAW  268 (369)
Q Consensus       189 ~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~  268 (369)
                      .++|+|||++..+....   ......|++.|+|||++. ..++.++|||||||++|+|++|.+||.......     ...
T Consensus       177 ~~kl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-----~~~  247 (494)
T 3lij_A          177 LIKIVDFGLSAVFENQK---KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQE-----ILR  247 (494)
T ss_dssp             CEEECCCTTCEECBTTB---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-----HHH
T ss_pred             cEEEEECCCCeECCCCc---cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH-----HHH
Confidence            59999999998765432   223356899999999876 568999999999999999999999997543211     111


Q ss_pred             hhhhcCccccccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 017594          269 DLWTSNRTLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSM  321 (369)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~  321 (369)
                      ........  ...+      .....+..+.+||.+||+.||.+|||+.++++.
T Consensus       248 ~i~~~~~~--~~~~------~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h  292 (494)
T 3lij_A          248 KVEKGKYT--FDSP------EWKNVSEGAKDLIKQMLQFDSQRRISAQQALEH  292 (494)
T ss_dssp             HHHHTCCC--CCSG------GGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred             HHHhCCCC--CCch------hcccCCHHHHHHHHHHCCCChhhCccHHHHhcC
Confidence            11111000  0000      011125679999999999999999999999953

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=2.7e-41  Score=307.92  Aligned_cols=252  Identities=21%  Similarity=0.314  Sum_probs=201.9

Q ss_pred             HHhcCCccCccccccCCccEEEEEEc-CCCEEEEEEecCCCchhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEEE
Q 017594           46 TATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIY  124 (369)
Q Consensus        46 ~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  124 (369)
                      .+.++|++.+.||+|+||.||+|++. +|+.||+|++..........+.+|+.+++.++||||+++++++......++||
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   85 (304)
T 2jam_A            6 NIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVM   85 (304)
T ss_dssp             CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             chhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEE
Confidence            45689999999999999999999976 58999999998665444567889999999999999999999999999999999


Q ss_pred             EecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEE---eCCCceEEeecCCceec
Q 017594          125 EYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILL---DKDMNPKISDFGMARIC  201 (369)
Q Consensus       125 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv---~~~~~~~L~Dfg~~~~~  201 (369)
                      |++.+++|.+++..   ...+++..++.++.||+.||.|||+.|   ++|+||+|+||++   +.++.++|+|||++...
T Consensus        86 e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~  159 (304)
T 2jam_A           86 QLVSGGELFDRILE---RGVYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKME  159 (304)
T ss_dssp             CCCCSCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCC
T ss_pred             EcCCCccHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccCCcceec
Confidence            99999999888843   335889999999999999999999999   9999999999999   77889999999998754


Q ss_pred             CCCCcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCccccccC
Q 017594          202 GGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELID  281 (369)
Q Consensus       202 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (369)
                      ...    ......+++.|+|||++.+..++.++||||||+++|+|++|..||.......     ..... ..... ....
T Consensus       160 ~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-----~~~~i-~~~~~-~~~~  228 (304)
T 2jam_A          160 QNG----IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESK-----LFEKI-KEGYY-EFES  228 (304)
T ss_dssp             CCB----TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHH-----HHHHH-HHCCC-CCCT
T ss_pred             CCC----ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH-----HHHHH-HcCCC-CCCc
Confidence            322    1223468999999999999999999999999999999999999986432111     00011 00000 0000


Q ss_pred             ccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 017594          282 PILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVS  320 (369)
Q Consensus       282 ~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~  320 (369)
                      + .     ...++..+.++|.+||+.||++|||+.++++
T Consensus       229 ~-~-----~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  261 (304)
T 2jam_A          229 P-F-----WDDISESAKDFICHLLEKDPNERYTCEKALS  261 (304)
T ss_dssp             T-T-----TTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             c-c-----cccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            0 0     1112567999999999999999999999996

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=4.4e-41  Score=309.65  Aligned_cols=261  Identities=28%  Similarity=0.373  Sum_probs=205.4

Q ss_pred             hcCCccCccccccCCccEEEEEEcC-CCE--EEEEEecCC-CchhHHHHHHHHHHHhcC-CCCceeeeeeeEEeCCccEE
Q 017594           48 TNKFSDANKLGEGGFGPVYKGVLKK-GDE--IAVKRLSGR-SGQGLREMKNEASVIAKV-QHKNLVRLLGCCIDRDEKIL  122 (369)
Q Consensus        48 ~~~y~i~~~lg~G~~~~v~~~~~~~-~~~--valK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~l  122 (369)
                      .++|++.+.||+|+||.||+|+++. |..  +++|.+... .......+.+|+.+++.+ +||||+++++++...+..++
T Consensus        24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l  103 (327)
T 1fvr_A           24 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL  103 (327)
T ss_dssp             GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred             HHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEE
Confidence            3789999999999999999999654 554  489988643 233456688899999999 89999999999999999999


Q ss_pred             EEEecCCCChhhhhcCCC-------------ccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCc
Q 017594          123 IYEYMPNKSLDFFLFDPT-------------KRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMN  189 (369)
Q Consensus       123 v~e~~~~~~L~~~l~~~~-------------~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~  189 (369)
                      ||||+++++|.+++....             ....+++..++.++.||+.||.|||+++   ++||||||+||+++.++.
T Consensus       104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~  180 (327)
T 1fvr_A          104 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYV  180 (327)
T ss_dssp             EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGC
T ss_pred             EEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceEEEcCCCe
Confidence            999999999999986543             2346899999999999999999999999   999999999999999999


Q ss_pred             eEEeecCCceecCCCCcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHh-CCCCCCCCcccccccchhhh
Q 017594          190 PKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAW  268 (369)
Q Consensus       190 ~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~t-g~~p~~~~~~~~~~~~~~~~  268 (369)
                      ++|+|||++......   .......++..|+|||++.+..++.++|||||||++|+|++ |..||.......     .. 
T Consensus       181 ~kL~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~-----~~-  251 (327)
T 1fvr_A          181 AKIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE-----LY-  251 (327)
T ss_dssp             EEECCTTCEESSCEE---CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-----HH-
T ss_pred             EEEcccCcCcccccc---ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHH-----HH-
Confidence            999999998643211   11222346788999999998889999999999999999998 999986433111     00 


Q ss_pred             hhhhcCccccccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHhhhhccC
Q 017594          269 DLWTSNRTLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNEAATLL  330 (369)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L~~~~~~~~  330 (369)
                      ......     ......     ..++..+.++|.+||+.||.+|||+.++++.|+.+.....
T Consensus       252 ~~~~~~-----~~~~~~-----~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~  303 (327)
T 1fvr_A          252 EKLPQG-----YRLEKP-----LNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK  303 (327)
T ss_dssp             HHGGGT-----CCCCCC-----TTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSS
T ss_pred             HHhhcC-----CCCCCC-----CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhc
Confidence            110000     000001     1125669999999999999999999999999999888654

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=2.6e-41  Score=315.28  Aligned_cols=265  Identities=25%  Similarity=0.331  Sum_probs=203.8

Q ss_pred             HHhcCCccCccccccCCccEEEEEEc-CCCEEEEEEecCC-CchhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEE
Q 017594           46 TATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGR-SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILI  123 (369)
Q Consensus        46 ~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv  123 (369)
                      ...++|++.+.||+|+||.||+|++. +|..||+|++... .....+.+.+|+.+++.++||||+++++++...+..++|
T Consensus        30 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  109 (360)
T 3eqc_A           30 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC  109 (360)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEE
T ss_pred             cccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEE
Confidence            44678999999999999999999976 5889999998755 334456788999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcC-CCCCcccCCCCCCCEEEeCCCceEEeecCCceecC
Q 017594          124 YEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQY-SRVRIIHRDLKASNILLDKDMNPKISDFGMARICG  202 (369)
Q Consensus       124 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~-~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~  202 (369)
                      |||+++++|.+++..   ...+++..++.++.|++.||.|||+. +   ++|+||||+||+++.++.++|+|||++....
T Consensus       110 ~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  183 (360)
T 3eqc_A          110 MEHMDGGSLDQVLKK---AGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI  183 (360)
T ss_dssp             ECCCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHH
T ss_pred             EECCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCCEEEEECCCCcccc
Confidence            999999999999854   33488999999999999999999986 8   9999999999999999999999999986543


Q ss_pred             CCCcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccch----------hhhh---
Q 017594          203 GNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLG----------YAWD---  269 (369)
Q Consensus       203 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~----------~~~~---  269 (369)
                      ..    ......+++.|+|||++.+..++.++|||||||++|+|++|..||............          ..+.   
T Consensus       184 ~~----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (360)
T 3eqc_A          184 DS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRT  259 (360)
T ss_dssp             HH----C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC----------------
T ss_pred             cc----cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCccc
Confidence            21    123346899999999999999999999999999999999999999754321110000          0000   


Q ss_pred             -----------hhhcCccccccCcccc---ccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 017594          270 -----------LWTSNRTLELIDPILE---DEYSSKQMLLRYANIALLCVQESADDRPTMNDVVS  320 (369)
Q Consensus       270 -----------~~~~~~~~~~~~~~~~---~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~  320 (369)
                                 ........+.++....   .......++.++.+||.+||+.||++|||+.++++
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  324 (360)
T 3eqc_A          260 PGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV  324 (360)
T ss_dssp             --------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             CCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence                       0000000000000000   00011122567999999999999999999999995

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=5.1e-41  Score=320.79  Aligned_cols=201  Identities=23%  Similarity=0.382  Sum_probs=167.0

Q ss_pred             HhcCCccCccccccCCccEEEEEEcC-CCEEEEEEecCC--CchhHHHHHHHHHHHhcCCCCceeeeeeeEEeC-----C
Q 017594           47 ATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDR-----D  118 (369)
Q Consensus        47 ~~~~y~i~~~lg~G~~~~v~~~~~~~-~~~valK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~  118 (369)
                      +.++|++.+.||+|+||.||+|+++. |+.||+|++...  .....+.+.+|+.+++.++||||+++++++...     .
T Consensus        24 i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~  103 (432)
T 3n9x_A           24 VPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFD  103 (432)
T ss_dssp             CCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred             ecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCC
Confidence            35899999999999999999999764 788999999753  334456788999999999999999999999766     5


Q ss_pred             ccEEEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCc
Q 017594          119 EKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMA  198 (369)
Q Consensus       119 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~  198 (369)
                      ..|+|||+++ ++|..++..   ...+++..++.++.||+.||.|||+.|   ++||||||+||+++.++.++|+|||++
T Consensus       104 ~~~lv~e~~~-~~L~~~~~~---~~~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL~DFGla  176 (432)
T 3n9x_A          104 ELYIVLEIAD-SDLKKLFKT---PIFLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLA  176 (432)
T ss_dssp             CEEEEEECCS-EEHHHHHHS---SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             eEEEEEecCC-cCHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEEccCCCc
Confidence            6899999986 488888854   344899999999999999999999999   999999999999999999999999999


Q ss_pred             eecCCCCcc--------------------cccccccccccccCchhh-ccCCCCcccchHhHHHHHHHHHhCCCCCC
Q 017594          199 RICGGNELQ--------------------ANTSRIVGTYGYMSPEYA-LEGIFSIKSDVFSFGVLLLEIVSGKKNTG  254 (369)
Q Consensus       199 ~~~~~~~~~--------------------~~~~~~~~~~~y~aPE~~-~~~~~~~~~DiwslG~il~~l~tg~~p~~  254 (369)
                      .........                    .......+++.|+|||++ .+..++.++|||||||++|+|++|..||.
T Consensus       177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~  253 (432)
T 3n9x_A          177 RTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI  253 (432)
T ss_dssp             EEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred             ccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence            876543211                    112345789999999986 56679999999999999999998766554

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=2.7e-41  Score=307.37  Aligned_cols=254  Identities=22%  Similarity=0.388  Sum_probs=199.2

Q ss_pred             HHhcCCccCccccccCCccEEEEEEcC-CCEEEEEEecCCCchhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEEE
Q 017594           46 TATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIY  124 (369)
Q Consensus        46 ~~~~~y~i~~~lg~G~~~~v~~~~~~~-~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  124 (369)
                      ...++|++.+.||+|+||.||+|++.. |..|++|++........+.+..|+.+++.++||||+++++++...+..++|+
T Consensus        16 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   95 (302)
T 2j7t_A           16 DPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMI   95 (302)
T ss_dssp             CGGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEE
T ss_pred             CCccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEE
Confidence            456899999999999999999999764 8899999998666666788899999999999999999999999999999999


Q ss_pred             EecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCCC
Q 017594          125 EYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGN  204 (369)
Q Consensus       125 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~~  204 (369)
                      ||+.+++|..++...  ...+++..++.++.||+.||.|||+.|   ++|+||+|+||+++.++.++|+|||++......
T Consensus        96 e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  170 (302)
T 2j7t_A           96 EFCPGGAVDAIMLEL--DRGLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT  170 (302)
T ss_dssp             ECCTTEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHHHHHHHH
T ss_pred             EeCCCCcHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCCcccccc
Confidence            999999998887532  234889999999999999999999999   999999999999999999999999986532211


Q ss_pred             CcccccccccccccccCchhh-----ccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCccccc
Q 017594          205 ELQANTSRIVGTYGYMSPEYA-----LEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLEL  279 (369)
Q Consensus       205 ~~~~~~~~~~~~~~y~aPE~~-----~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (369)
                      .  .......+++.|+|||++     .+..++.++||||||+++|+|++|..||.......     ........... ..
T Consensus       171 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-----~~~~~~~~~~~-~~  242 (302)
T 2j7t_A          171 L--QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR-----VLLKIAKSDPP-TL  242 (302)
T ss_dssp             H--HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-----HHHHHHHSCCC-CC
T ss_pred             c--cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHH-----HHHHHhccCCc-cc
Confidence            1  112234678999999988     36678999999999999999999999987543111     01111111100 00


Q ss_pred             cCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 017594          280 IDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVS  320 (369)
Q Consensus       280 ~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~  320 (369)
                              ..+..++..+.++|.+||+.||++|||+.++++
T Consensus       243 --------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  275 (302)
T 2j7t_A          243 --------LTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE  275 (302)
T ss_dssp             --------SSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred             --------CCccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence                    011122567999999999999999999999986

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=7.5e-41  Score=322.15  Aligned_cols=196  Identities=23%  Similarity=0.403  Sum_probs=153.9

Q ss_pred             HhcCCccCccccccCCccEEEEEEc-CCCEEEEEEecCC--CchhHHHHHHHHHHHhcCCCCceeeeeeeEEeC-----C
Q 017594           47 ATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDR-----D  118 (369)
Q Consensus        47 ~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~  118 (369)
                      +.++|++.+.||+|+||.||+|+++ +|+.||+|++...  .....+.+.+|+.+++.++||||+++++++...     .
T Consensus        51 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~  130 (458)
T 3rp9_A           51 IPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFD  130 (458)
T ss_dssp             SCTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred             cCCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCc
Confidence            3478999999999999999999966 5899999998643  334456788999999999999999999998543     4


Q ss_pred             ccEEEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCc
Q 017594          119 EKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMA  198 (369)
Q Consensus       119 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~  198 (369)
                      ..|+|||++. ++|..++..   ...+++..++.++.||+.||.|||+.+   ++||||||+|||++.++.++|+|||++
T Consensus       131 ~~~lv~e~~~-~~L~~~~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl~DFGla  203 (458)
T 3rp9_A          131 ELYVVLEIAD-SDFKKLFRT---PVYLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLA  203 (458)
T ss_dssp             CEEEEECCCS-EEHHHHHHS---SCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             eEEEEEeccc-cchhhhccc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEeecccccc
Confidence            6899999875 577777754   344899999999999999999999999   999999999999999999999999999


Q ss_pred             eecCCCCcc-------------------------cccccccccccccCchhh-ccCCCCcccchHhHHHHHHHHHhC
Q 017594          199 RICGGNELQ-------------------------ANTSRIVGTYGYMSPEYA-LEGIFSIKSDVFSFGVLLLEIVSG  249 (369)
Q Consensus       199 ~~~~~~~~~-------------------------~~~~~~~~~~~y~aPE~~-~~~~~~~~~DiwslG~il~~l~tg  249 (369)
                      .........                         .......||+.|+|||++ .+..++.++|||||||++|+|++|
T Consensus       204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg  280 (458)
T 3rp9_A          204 RTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM  280 (458)
T ss_dssp             BCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred             hhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence            876432111                         112334679999999976 466799999999999999999994

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=9.7e-41  Score=303.99  Aligned_cols=250  Identities=25%  Similarity=0.425  Sum_probs=205.5

Q ss_pred             HhcCCccCccccccCCccEEEEEEc-CCCEEEEEEecCCC-chhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEEE
Q 017594           47 ATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIY  124 (369)
Q Consensus        47 ~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  124 (369)
                      ..++|++.+.||+|+||.||+|++. +++.||+|++.... ....+.+.+|+.+++.+.||||+++++++......++||
T Consensus        20 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   99 (303)
T 3a7i_A           20 PEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIM   99 (303)
T ss_dssp             GGGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hHHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEE
Confidence            4577999999999999999999965 48899999987543 344678899999999999999999999999999999999


Q ss_pred             EecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCCC
Q 017594          125 EYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGN  204 (369)
Q Consensus       125 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~~  204 (369)
                      ||+.+++|.+++..    ..+++..++.++.||+.||.+||+.|   ++|+||+|+||+++.++.++|+|||++......
T Consensus       100 e~~~~~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~  172 (303)
T 3a7i_A          100 EYLGGGSALDLLEP----GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT  172 (303)
T ss_dssp             ECCTTEEHHHHHTT----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECBTT
T ss_pred             EeCCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeecccceecCcc
Confidence            99999999998843    34899999999999999999999999   999999999999999999999999999876543


Q ss_pred             CcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCccccccCccc
Q 017594          205 ELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPIL  284 (369)
Q Consensus       205 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (369)
                      ..  ......+++.|+|||++.+..++.++||||||+++|+|++|..||.......     ..... ....     .+.+
T Consensus       173 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-----~~~~~-~~~~-----~~~~  239 (303)
T 3a7i_A          173 QI--KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMK-----VLFLI-PKNN-----PPTL  239 (303)
T ss_dssp             BC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-----HHHHH-HHSC-----CCCC
T ss_pred             cc--ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHH-----HHHHh-hcCC-----CCCC
Confidence            21  2233468899999999999999999999999999999999999986432111     00000 0000     0111


Q ss_pred             cccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 017594          285 EDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSM  321 (369)
Q Consensus       285 ~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~  321 (369)
                      ...     ++..+.++|.+||+.||++|||+.++++.
T Consensus       240 ~~~-----~~~~l~~li~~~l~~dp~~Rps~~~ll~~  271 (303)
T 3a7i_A          240 EGN-----YSKPLKEFVEACLNKEPSFRPTAKELLKH  271 (303)
T ss_dssp             CSS-----CCHHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred             ccc-----cCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence            111     15568999999999999999999999974

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=4.8e-41  Score=327.22  Aligned_cols=262  Identities=24%  Similarity=0.325  Sum_probs=206.5

Q ss_pred             ccccchhhHHHHhcCCccCccccccCCccEEEEEEcC-CCEEEEEEecCCCc-------------hhHHHHHHHHHHHhc
Q 017594           36 FPLFSFSSVSTATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSG-------------QGLREMKNEASVIAK  101 (369)
Q Consensus        36 ~~~~~~~~~~~~~~~y~i~~~lg~G~~~~v~~~~~~~-~~~valK~~~~~~~-------------~~~~~~~~e~~~l~~  101 (369)
                      ...|.......+.++|++++.||+|+||.||+|+.+. ++.||+|++.....             ...+.+.+|+.+++.
T Consensus        23 ~~~~~~~~~~~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~  102 (504)
T 3q5i_A           23 PGMYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKS  102 (504)
T ss_dssp             GGGGCCEECSCGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHT
T ss_pred             hhheeeccCCCcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHh
Confidence            3445555566788999999999999999999999764 88999999865421             234678899999999


Q ss_pred             CCCCceeeeeeeEEeCCccEEEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCC
Q 017594          102 VQHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASN  181 (369)
Q Consensus       102 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~N  181 (369)
                      ++||||+++++++.+....++||||+.+++|.+.+..   ...+++..++.++.||+.||.|||+.|   ++||||||+|
T Consensus       103 l~hpniv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~N  176 (504)
T 3q5i_A          103 LDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIIN---RHKFDECDAANIMKQILSGICYLHKHN---IVHRDIKPEN  176 (504)
T ss_dssp             CCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGG
T ss_pred             CCCCCCCeEEEEEEcCCEEEEEEecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHH
Confidence            9999999999999999999999999999999888843   345899999999999999999999999   9999999999


Q ss_pred             EEEeCCC---ceEEeecCCceecCCCCcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcc
Q 017594          182 ILLDKDM---NPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRT  258 (369)
Q Consensus       182 Ilv~~~~---~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~  258 (369)
                      |+++.++   .++|+|||++.......   ......|++.|+|||++. ..++.++|||||||++|+|++|..||.....
T Consensus       177 il~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~  252 (504)
T 3q5i_A          177 ILLENKNSLLNIKIVDFGLSSFFSKDY---KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQND  252 (504)
T ss_dssp             EEESSTTCCSSEEECCCTTCEECCTTS---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred             EEEecCCCCccEEEEECCCCEEcCCCC---ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence            9998776   69999999998765432   223346899999999886 4689999999999999999999999974332


Q ss_pred             cccccchhhhhhhhcCccccccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 017594          259 DSLNLLGYAWDLWTSNRTLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVS  320 (369)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~  320 (369)
                      ..     ............        .......++.++.+||.+||+.||.+|||+.++++
T Consensus       253 ~~-----~~~~i~~~~~~~--------~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~  301 (504)
T 3q5i_A          253 QD-----IIKKVEKGKYYF--------DFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALN  301 (504)
T ss_dssp             HH-----HHHHHHHCCCCC--------CHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HH-----HHHHHHcCCCCC--------CccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence            11     111111100000        00001122567999999999999999999999986

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=5.8e-41  Score=309.08  Aligned_cols=257  Identities=17%  Similarity=0.273  Sum_probs=199.0

Q ss_pred             hcCCccCccccccCCccEEEEEEc-CCCEEEEEEecCCCchhHHHHHHHHHHHhcCC-CCceeeeeeeEEe--CCccEEE
Q 017594           48 TNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSGQGLREMKNEASVIAKVQ-HKNLVRLLGCCID--RDEKILI  123 (369)
Q Consensus        48 ~~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~--~~~~~lv  123 (369)
                      .++|++.+.||+|+||.||+|++. +++.||+|++....   .+.+.+|+.+++.++ ||||+++++++..  ....++|
T Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv  111 (330)
T 3nsz_A           35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV  111 (330)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEE
T ss_pred             CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc---hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEE
Confidence            478999999999999999999964 58999999997543   367889999999997 9999999999987  5678999


Q ss_pred             EEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCC-ceEEeecCCceecC
Q 017594          124 YEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDM-NPKISDFGMARICG  202 (369)
Q Consensus       124 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~-~~~L~Dfg~~~~~~  202 (369)
                      |||+.+++|..++.      .+++..++.++.||+.||.|||++|   ++||||||+||+++.++ .++|+|||++....
T Consensus       112 ~e~~~~~~l~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~  182 (330)
T 3nsz_A          112 FEHVNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH  182 (330)
T ss_dssp             EECCCCCCHHHHGG------GCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred             EeccCchhHHHHHH------hCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeCCCceEcC
Confidence            99999999988873      2788899999999999999999999   99999999999999777 89999999998765


Q ss_pred             CCCcccccccccccccccCchhhcc-CCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhh--------hhhhc
Q 017594          203 GNELQANTSRIVGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAW--------DLWTS  273 (369)
Q Consensus       203 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~--------~~~~~  273 (369)
                      ....   .....++..|+|||++.+ ..++.++|||||||++|+|++|..||...............        .....
T Consensus       183 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~  259 (330)
T 3nsz_A          183 PGQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDK  259 (330)
T ss_dssp             TTCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHH
T ss_pred             CCCc---cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHH
Confidence            3322   233467889999999876 67899999999999999999999998543322111000000        00000


Q ss_pred             --------------CccccccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 017594          274 --------------NRTLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVS  320 (369)
Q Consensus       274 --------------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~  320 (369)
                                    ............. .....++.++.+||.+||+.||++|||+.++++
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~  319 (330)
T 3nsz_A          260 YNIELDPRFNDILGRHSRKRWERFVHS-ENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  319 (330)
T ss_dssp             TTCCCCTHHHHHHCCCCCCCGGGGCCT-TTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             hccccccchhhhhhhccccchhhhccc-cccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence                          0000000000000 011113677999999999999999999999997

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=1.9e-41  Score=323.01  Aligned_cols=264  Identities=19%  Similarity=0.218  Sum_probs=207.0

Q ss_pred             chhhHHHHhcCCccCccccccCCccEEEEEEcC-CCEEEEEEecCCC---chhHHHHHHHHHHHhcCCCCceeeeeeeEE
Q 017594           40 SFSSVSTATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRS---GQGLREMKNEASVIAKVQHKNLVRLLGCCI  115 (369)
Q Consensus        40 ~~~~~~~~~~~y~i~~~lg~G~~~~v~~~~~~~-~~~valK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~  115 (369)
                      .++.+....++|++.+.||+|+||.||+|+.+. ++.||+|++....   ......+..|..++..++||||+++++++.
T Consensus        65 ~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~  144 (437)
T 4aw2_A           65 KVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQ  144 (437)
T ss_dssp             HHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred             hhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe
Confidence            345555667899999999999999999999765 7889999986421   112234778999999999999999999999


Q ss_pred             eCCccEEEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeec
Q 017594          116 DRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDF  195 (369)
Q Consensus       116 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Df  195 (369)
                      +.+..++||||+.+++|.+++...  ...+++..++.++.||+.||.|||+++   ++||||||+||+++.++.++|+||
T Consensus       145 ~~~~~~lV~Ey~~gg~L~~~l~~~--~~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~vkL~DF  219 (437)
T 4aw2_A          145 DDNNLYLVMDYYVGGDLLTLLSKF--EDRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADF  219 (437)
T ss_dssp             CSSEEEEEECCCTTCBHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCC
T ss_pred             eCCEEEEEEecCCCCcHHHHHHHc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCCEEEcch
Confidence            999999999999999999999653  234899999999999999999999999   999999999999999999999999


Q ss_pred             CCceecCCCCcccccccccccccccCchhhc-----cCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhh
Q 017594          196 GMARICGGNELQANTSRIVGTYGYMSPEYAL-----EGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDL  270 (369)
Q Consensus       196 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~  270 (369)
                      |++........ .......|++.|+|||++.     ...++.++|||||||++|+|++|..||........     ....
T Consensus       220 Gla~~~~~~~~-~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~-----~~~i  293 (437)
T 4aw2_A          220 GSCLKLMEDGT-VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVET-----YGKI  293 (437)
T ss_dssp             TTCEECCTTSC-EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH-----HHHH
T ss_pred             hhhhhcccCCC-cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHH-----HHhh
Confidence            99976643322 1223357999999999987     56789999999999999999999999964331110     1111


Q ss_pred             hhcCccccccCccccccccHHHHHHHHHHHHHHhhcCCCCC--CCCHHHHHHH
Q 017594          271 WTSNRTLELIDPILEDEYSSKQMLLRYANIALLCVQESADD--RPTMNDVVSM  321 (369)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~--Rps~~ell~~  321 (369)
                      ......... ... .     ...+.++.+||.+||+.+|++  ||+++++++.
T Consensus       294 ~~~~~~~~~-p~~-~-----~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~H  339 (437)
T 4aw2_A          294 MNHKERFQF-PTQ-V-----TDVSENAKDLIRRLICSREHRLGQNGIEDFKKH  339 (437)
T ss_dssp             HTHHHHCCC-CSS-C-----CCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred             hhccccccC-Ccc-c-----ccCCHHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence            100000000 000 0     012567999999999998888  9999999863

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=1.8e-40  Score=302.38  Aligned_cols=253  Identities=20%  Similarity=0.238  Sum_probs=196.5

Q ss_pred             HhcCCccCccccccCCccEEEEEEc-CCCEEEEEEecCCC----chhHHHHHHHHHHHhcCCCCceeeeeeeEE--eCCc
Q 017594           47 ATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS----GQGLREMKNEASVIAKVQHKNLVRLLGCCI--DRDE  119 (369)
Q Consensus        47 ~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~  119 (369)
                      ..++|++.+.||+|+||.||+|.+. +++.|++|++....    ......+.+|+.+++.++||||+++++++.  ....
T Consensus         3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   82 (305)
T 2wtk_C            3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQK   82 (305)
T ss_dssp             --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---C
T ss_pred             cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCe
Confidence            5689999999999999999999975 48899999986432    234567889999999999999999999984  4457


Q ss_pred             cEEEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCce
Q 017594          120 KILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMAR  199 (369)
Q Consensus       120 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~  199 (369)
                      .++||||+.++ +.+++... ....+++..++.++.||+.||.|||+++   ++|+||+|+||+++.++.++|+|||++.
T Consensus        83 ~~lv~e~~~~~-l~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl~dfg~~~  157 (305)
T 2wtk_C           83 MYMVMEYCVCG-MQEMLDSV-PEKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAE  157 (305)
T ss_dssp             EEEEEECCSEE-HHHHHHHS-TTCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred             EEEEehhccCC-HHHHHHhC-cccccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEeecccccc
Confidence            89999999887 55555332 2345889999999999999999999999   9999999999999999999999999998


Q ss_pred             ecCCCCcccccccccccccccCchhhccCC--CCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCccc
Q 017594          200 ICGGNELQANTSRIVGTYGYMSPEYALEGI--FSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTL  277 (369)
Q Consensus       200 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  277 (369)
                      ...............+++.|+|||++.+..  ++.++||||||+++|+|++|..||.......     .. ........ 
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-----~~-~~i~~~~~-  230 (305)
T 2wtk_C          158 ALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYK-----LF-ENIGKGSY-  230 (305)
T ss_dssp             ECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHH-----HH-HHHHHCCC-
T ss_pred             ccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHH-----HH-HHHhcCCC-
Confidence            765433333333456899999999987644  4789999999999999999999987432111     00 11001100 


Q ss_pred             cccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 017594          278 ELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSM  321 (369)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~  321 (369)
                           .+..     .++..+.++|.+||+.||.+|||+.++++.
T Consensus       231 -----~~~~-----~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  264 (305)
T 2wtk_C          231 -----AIPG-----DCGPPLSDLLKGMLEYEPAKRFSIRQIRQH  264 (305)
T ss_dssp             -----CCCS-----SSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred             -----CCCC-----ccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence                 0111     125668999999999999999999999963

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=2.2e-41  Score=309.77  Aligned_cols=264  Identities=23%  Similarity=0.305  Sum_probs=200.8

Q ss_pred             ccccchhhHHHHhcCCccCccccccCCccEEEEEEcCCCEEEEEEecCC--CchhHHHHHHHHHHHhcCC--CCceeeee
Q 017594           36 FPLFSFSSVSTATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGR--SGQGLREMKNEASVIAKVQ--HKNLVRLL  111 (369)
Q Consensus        36 ~~~~~~~~~~~~~~~y~i~~~lg~G~~~~v~~~~~~~~~~valK~~~~~--~~~~~~~~~~e~~~l~~l~--h~~i~~~~  111 (369)
                      ...++++.+....++|++.+.||+|+||.||+|.+.+++.||+|++...  .......+.+|+.++..++  |+||++++
T Consensus        15 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~   94 (313)
T 3cek_A           15 TENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY   94 (313)
T ss_dssp             -----CCEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEE
T ss_pred             CCCCCeeeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEE
Confidence            3477888888999999999999999999999999888999999998644  2345577889999999997  59999999


Q ss_pred             eeEEeCCccEEEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceE
Q 017594          112 GCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPK  191 (369)
Q Consensus       112 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~  191 (369)
                      +++...+..+++|| +.+++|.+++...   ..+++..++.++.||+.||.|||+++   ++||||||+||+++. +.++
T Consensus        95 ~~~~~~~~~~lv~e-~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~-~~~k  166 (313)
T 3cek_A           95 DYEITDQYIYMVME-CGNIDLNSWLKKK---KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD-GMLK  166 (313)
T ss_dssp             EEEECSSEEEEEEC-CCSEEHHHHHHHC---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEET-TEEE
T ss_pred             EEeecCCEEEEEEe-cCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEEC-CeEE
Confidence            99999999999999 5678998888543   35889999999999999999999999   999999999999964 8999


Q ss_pred             EeecCCceecCCCCcccccccccccccccCchhhcc-----------CCCCcccchHhHHHHHHHHHhCCCCCCCCcccc
Q 017594          192 ISDFGMARICGGNELQANTSRIVGTYGYMSPEYALE-----------GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDS  260 (369)
Q Consensus       192 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----------~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~  260 (369)
                      |+|||++................+++.|+|||++.+           ..++.++||||||+++|+|++|..||.......
T Consensus       167 L~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~  246 (313)
T 3cek_A          167 LIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI  246 (313)
T ss_dssp             ECCCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHH
T ss_pred             EeeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHH
Confidence            999999987654333223334568999999999865           468889999999999999999999986432111


Q ss_pred             cccchhhhhhhhcCccccccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 017594          261 LNLLGYAWDLWTSNRTLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSM  321 (369)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~  321 (369)
                      .    ............     .....     .+..+.++|.+||+.||.+||++.++++.
T Consensus       247 ~----~~~~~~~~~~~~-----~~~~~-----~~~~l~~li~~~l~~dp~~Rps~~ell~h  293 (313)
T 3cek_A          247 S----KLHAIIDPNHEI-----EFPDI-----PEKDLQDVLKCCLKRDPKQRISIPELLAH  293 (313)
T ss_dssp             H----HHHHHHCTTSCC-----CCCCC-----SCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             H----HHHHHHhccccc-----CCccc-----chHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence            0    001111100000     00011     14568999999999999999999999963

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=4.5e-41  Score=312.14  Aligned_cols=248  Identities=30%  Similarity=0.454  Sum_probs=198.0

Q ss_pred             HhcCCccCccccccCCccEEEEEEc-CCCEEEEEEecCCC---chhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEE
Q 017594           47 ATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS---GQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKIL  122 (369)
Q Consensus        47 ~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l  122 (369)
                      ..++|++.+.||+|+||.||+|+.. +|+.||+|++....   ....+.+.+|+.+++.++||||+++++++...+..++
T Consensus        52 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l  131 (348)
T 1u5q_A           52 PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWL  131 (348)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             hhhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEE
Confidence            3466999999999999999999964 58899999987543   2334668899999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecC
Q 017594          123 IYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICG  202 (369)
Q Consensus       123 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~  202 (369)
                      ||||+.+ ++.+++..  ....+++..++.++.|++.||.|||+++   ++||||||+||+++.++.++|+|||++....
T Consensus       132 v~e~~~g-~l~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~  205 (348)
T 1u5q_A          132 VMEYCLG-SASDLLEV--HKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMA  205 (348)
T ss_dssp             EEECCSE-EHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSS
T ss_pred             EEecCCC-CHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccCceecC
Confidence            9999975 56555532  2345899999999999999999999999   9999999999999999999999999987653


Q ss_pred             CCCcccccccccccccccCchhhc---cCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCccccc
Q 017594          203 GNELQANTSRIVGTYGYMSPEYAL---EGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLEL  279 (369)
Q Consensus       203 ~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (369)
                      .      .....|++.|+|||++.   +..++.++|||||||++|+|++|..||.......     ..........    
T Consensus       206 ~------~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~-----~~~~~~~~~~----  270 (348)
T 1u5q_A          206 P------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-----ALYHIAQNES----  270 (348)
T ss_dssp             S------BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-----HHHHHHHSCC----
T ss_pred             C------CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH-----HHHHHHhcCC----
Confidence            2      22346899999999984   5678999999999999999999999986433111     1111111110    


Q ss_pred             cCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 017594          280 IDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSM  321 (369)
Q Consensus       280 ~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~  321 (369)
                        +...    ...++..+.++|.+||+.||++|||+.++++.
T Consensus       271 --~~~~----~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h  306 (348)
T 1u5q_A          271 --PALQ----SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH  306 (348)
T ss_dssp             --CCCC----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred             --CCCC----CCCCCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence              0000    01125668999999999999999999999864

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.5e-41  Score=315.18  Aligned_cols=259  Identities=22%  Similarity=0.324  Sum_probs=193.4

Q ss_pred             HhcCCccCccccccCCccEEEEEEc-CCCEEEEEEecCC--CchhHHHHHHHHHHHhcCCCCceeeeeeeEEeCC-----
Q 017594           47 ATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDRD-----  118 (369)
Q Consensus        47 ~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----  118 (369)
                      ..++|++.+.||+|+||.||+|++. +|+.||+|++...  .....+.+.+|+.+++.++||||+++++++....     
T Consensus        23 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~  102 (367)
T 1cm8_A           23 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF  102 (367)
T ss_dssp             CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred             ecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccC
Confidence            4588999999999999999999975 5999999998643  2334567789999999999999999999997653     


Q ss_pred             -ccEEEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCC
Q 017594          119 -EKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGM  197 (369)
Q Consensus       119 -~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~  197 (369)
                       ..++|||++ +++|.+++..    ..+++..++.++.||+.||.|||+.|   ++||||||+||+++.++.++|+|||+
T Consensus       103 ~~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~  174 (367)
T 1cm8_A          103 TDFYLVMPFM-GTDLGKLMKH----EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGL  174 (367)
T ss_dssp             CCCEEEEECC-SEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTT
T ss_pred             ceEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCEEEEeeec
Confidence             459999999 7889888843    34889999999999999999999999   99999999999999999999999999


Q ss_pred             ceecCCCCcccccccccccccccCchhhcc-CCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhh-----
Q 017594          198 ARICGGNELQANTSRIVGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLW-----  271 (369)
Q Consensus       198 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~-----  271 (369)
                      +......     .....++..|+|||++.+ ..++.++|||||||++|+|++|+.||........  ........     
T Consensus       175 a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~--l~~i~~~~g~~~~  247 (367)
T 1cm8_A          175 ARQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQ--LKEIMKVTGTPPA  247 (367)
T ss_dssp             CEECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHHHHCCCCH
T ss_pred             ccccccc-----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHhcCCCCH
Confidence            9875432     233467999999999876 6799999999999999999999999975432110  00000000     


Q ss_pred             ------hcC---ccccccCccccccc--cHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 017594          272 ------TSN---RTLELIDPILEDEY--SSKQMLLRYANIALLCVQESADDRPTMNDVVS  320 (369)
Q Consensus       272 ------~~~---~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~  320 (369)
                            ...   .....+........  .....+..+.+||.+||+.||++|||+.++++
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~  307 (367)
T 1cm8_A          248 EFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA  307 (367)
T ss_dssp             HHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhc
Confidence                  000   00000000000000  00112567999999999999999999999997

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=2.3e-41  Score=303.81  Aligned_cols=252  Identities=21%  Similarity=0.353  Sum_probs=196.3

Q ss_pred             HHHHhcCCccCccccccCCccEEEEEEc-CCCEEEEEEecCCC---chhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCc
Q 017594           44 VSTATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS---GQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDE  119 (369)
Q Consensus        44 ~~~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~  119 (369)
                      .....++|++.+.||+|++|.||+|+++ +|+.|++|++....   ......+.+|+..++.++||||+++++++...+.
T Consensus         6 g~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   85 (276)
T 2h6d_A            6 GRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTD   85 (276)
T ss_dssp             -CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred             CcceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCe
Confidence            3345689999999999999999999976 58999999986432   2234678899999999999999999999999999


Q ss_pred             cEEEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCce
Q 017594          120 KILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMAR  199 (369)
Q Consensus       120 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~  199 (369)
                      .++|+|++.+++|.+++..   ...+++..++.++.||+.||.|||+++   ++|+||+|+||+++.++.++|+|||++.
T Consensus        86 ~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~  159 (276)
T 2h6d_A           86 FFMVMEYVSGGELFDYICK---HGRVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSN  159 (276)
T ss_dssp             EEEEEECCCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCCCGGG
T ss_pred             EEEEEeccCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeeccccc
Confidence            9999999999999998853   234889999999999999999999999   9999999999999999999999999987


Q ss_pred             ecCCCCcccccccccccccccCchhhccCCC-CcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCcccc
Q 017594          200 ICGGNELQANTSRIVGTYGYMSPEYALEGIF-SIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLE  278 (369)
Q Consensus       200 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (369)
                      .......   .....+++.|+|||.+.+..+ +.++||||||+++|+|++|..||.......      ..........  
T Consensus       160 ~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~------~~~~~~~~~~--  228 (276)
T 2h6d_A          160 MMSDGEF---LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPT------LFKKIRGGVF--  228 (276)
T ss_dssp             CCCC----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHHCCC--
T ss_pred             ccCCCcc---eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHH------HHHHhhcCcc--
Confidence            6543321   223467889999999887765 689999999999999999999986432111      0011111000  


Q ss_pred             ccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 017594          279 LIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSM  321 (369)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~  321 (369)
                          ...     ..++..+.++|.+||+.||++|||+.++++.
T Consensus       229 ----~~~-----~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h  262 (276)
T 2h6d_A          229 ----YIP-----EYLNRSVATLLMHMLQVDPLKRATIKDIREH  262 (276)
T ss_dssp             ----CCC-----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred             ----cCc-----hhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence                001     1125568999999999999999999999973

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=9.7e-41  Score=305.45  Aligned_cols=253  Identities=25%  Similarity=0.413  Sum_probs=199.1

Q ss_pred             HHHhcCCccCccccccCCccEEEEEEcC-CCEEEEEEecCCCchhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEE
Q 017594           45 STATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILI  123 (369)
Q Consensus        45 ~~~~~~y~i~~~lg~G~~~~v~~~~~~~-~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv  123 (369)
                      ....++|++.+.||.|+||.||+|+++. |+.||+|.+....  ..+.+.+|+.+++.++||||+++++++...+..++|
T Consensus        25 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv  102 (314)
T 3com_A           25 KQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIV  102 (314)
T ss_dssp             -----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hcchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEE
Confidence            3457889999999999999999999764 8999999997543  346788999999999999999999999999999999


Q ss_pred             EEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCC
Q 017594          124 YEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGG  203 (369)
Q Consensus       124 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~  203 (369)
                      |||+.+++|.+++..  ....+++..++.++.||+.||.|||+.|   ++|+||+|+||+++.++.++|+|||++.....
T Consensus       103 ~e~~~~~~L~~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~  177 (314)
T 3com_A          103 MEYCGAGSVSDIIRL--RNKTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTD  177 (314)
T ss_dssp             EECCTTEEHHHHHHH--HTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECBT
T ss_pred             eecCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeecccchhhhh
Confidence            999999999998852  2345899999999999999999999999   99999999999999999999999999987653


Q ss_pred             CCcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCccccccCcc
Q 017594          204 NELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPI  283 (369)
Q Consensus       204 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (369)
                      ...  ......+++.|+|||++.+..++.++||||||+++|+|++|..||.......     ..........      +.
T Consensus       178 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-----~~~~~~~~~~------~~  244 (314)
T 3com_A          178 TMA--KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMR-----AIFMIPTNPP------PT  244 (314)
T ss_dssp             TBS--CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHH-----HHHHHHHSCC------CC
T ss_pred             hcc--ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHH-----HHHHHhcCCC------cc
Confidence            321  2233468899999999998899999999999999999999999986432110     0000000000      00


Q ss_pred             ccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 017594          284 LEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVS  320 (369)
Q Consensus       284 ~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~  320 (369)
                      ..   .+..++..+.++|.+||+.||++|||+.++++
T Consensus       245 ~~---~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~  278 (314)
T 3com_A          245 FR---KPELWSDNFTDFVKQCLVKSPEQRATATQLLQ  278 (314)
T ss_dssp             CS---SGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             cC---CcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence            00   01112567999999999999999999999986

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=2.6e-41  Score=310.87  Aligned_cols=269  Identities=21%  Similarity=0.330  Sum_probs=194.6

Q ss_pred             cCCccCccccccCCccEEEEEEc-CCCEEEEEEecCCCch-hHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEEEEe
Q 017594           49 NKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSGQ-GLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIYEY  126 (369)
Q Consensus        49 ~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  126 (369)
                      ++|++++.||+|+||.||+|++. +++.||+|++...... ....+.+|+.+++.++||||+++++++...+..++||||
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   81 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence            58999999999999999999976 5889999998644321 111344689999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCCCCc
Q 017594          127 MPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNEL  206 (369)
Q Consensus       127 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~~~~  206 (369)
                      +.+ +|.+++...  ...+++..++.++.||+.||.|||+.|   ++||||||+||+++.++.++|+|||++....... 
T Consensus        82 ~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~-  154 (324)
T 3mtl_A           82 LDK-DLKQYLDDC--GNIINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPT-  154 (324)
T ss_dssp             CSE-EHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEEECC-----
T ss_pred             ccc-CHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCcccccccCCc-
Confidence            985 676666432  335889999999999999999999999   9999999999999999999999999987554222 


Q ss_pred             ccccccccccccccCchhhcc-CCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcC---cccccc--
Q 017594          207 QANTSRIVGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSN---RTLELI--  280 (369)
Q Consensus       207 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~--  280 (369)
                       .......+++.|+|||++.+ ..++.++|||||||++|+|++|..||.........  ..........   ......  
T Consensus       155 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~--~~i~~~~~~~~~~~~~~~~~~  231 (324)
T 3mtl_A          155 -KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQL--HFIFRILGTPTEETWPGILSN  231 (324)
T ss_dssp             ---------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH--HHHHHHHCCCCTTTSTTGGGC
T ss_pred             -cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH--HHHHHHhCCCChHhchhhhcc
Confidence             12233467899999999876 56899999999999999999999999754321110  0000000000   000000  


Q ss_pred             -------Ccccccc---ccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH--HHHhhhh
Q 017594          281 -------DPILEDE---YSSKQMLLRYANIALLCVQESADDRPTMNDVVS--MLTNEAA  327 (369)
Q Consensus       281 -------~~~~~~~---~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~--~L~~~~~  327 (369)
                             .+.....   .....++.++.+||.+||+.||++|||+.++++  .+.....
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~  290 (324)
T 3mtl_A          232 EEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGE  290 (324)
T ss_dssp             HHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCS
T ss_pred             hhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhccc
Confidence                   0000000   001122567899999999999999999999997  4444433

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=9.1e-41  Score=301.31  Aligned_cols=247  Identities=21%  Similarity=0.327  Sum_probs=198.3

Q ss_pred             HHhcCCccCccccccCCccEEEEEEc-CCCEEEEEEecCC--CchhHHHHHHHHHHHhcC-CCCceeeeeeeEEeCCccE
Q 017594           46 TATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGR--SGQGLREMKNEASVIAKV-QHKNLVRLLGCCIDRDEKI  121 (369)
Q Consensus        46 ~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~--~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~  121 (369)
                      ...++|++.+.||+|+||.||+|++. +++.||+|++...  .......+..|+..+..+ +||||+++++++.+.+..+
T Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~   87 (289)
T 1x8b_A            8 RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHML   87 (289)
T ss_dssp             HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEE
T ss_pred             cccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEE
Confidence            35688999999999999999999976 5899999998753  233456777899999999 8999999999999999999


Q ss_pred             EEEEecCCCChhhhhcCCCc-cccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCC-------------
Q 017594          122 LIYEYMPNKSLDFFLFDPTK-RMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKD-------------  187 (369)
Q Consensus       122 lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~-------------  187 (369)
                      +||||+++++|.+++..... ...+++..++.++.||+.||.|||+++   ++|+||||+||+++.+             
T Consensus        88 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~~~~~~~~  164 (289)
T 1x8b_A           88 IQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDED  164 (289)
T ss_dssp             EEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC---------------
T ss_pred             EEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCcccccccccc
Confidence            99999999999999854321 245899999999999999999999999   9999999999999844             


Q ss_pred             ------CceEEeecCCceecCCCCcccccccccccccccCchhhccC-CCCcccchHhHHHHHHHHHhCCCCCCCCcccc
Q 017594          188 ------MNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEG-IFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDS  260 (369)
Q Consensus       188 ------~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~  260 (369)
                            ..++|+|||.+.......      ...+++.|+|||++.+. .++.++|||||||++|+|++|.+++.....  
T Consensus       165 ~~~~~~~~~kl~Dfg~~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~--  236 (289)
T 1x8b_A          165 DWASNKVMFKIGDLGHVTRISSPQ------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ--  236 (289)
T ss_dssp             -----CCCEEECCCTTCEETTCSC------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH--
T ss_pred             cccCCceEEEEcccccccccCCcc------ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhH--
Confidence                  479999999988765322      23588999999998765 567899999999999999999877542210  


Q ss_pred             cccchhhhhhhhcCccccccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 017594          261 LNLLGYAWDLWTSNRTLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVS  320 (369)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~  320 (369)
                             +.........     .+..     .++..+.++|.+||+.||++|||+.++++
T Consensus       237 -------~~~~~~~~~~-----~~~~-----~~~~~~~~li~~~l~~dp~~Rps~~~ll~  279 (289)
T 1x8b_A          237 -------WHEIRQGRLP-----RIPQ-----VLSQEFTELLKVMIHPDPERRPSAMALVK  279 (289)
T ss_dssp             -------HHHHHTTCCC-----CCSS-----CCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             -------HHHHHcCCCC-----CCCc-----ccCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence                   1111111111     1111     12567999999999999999999999986

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.5e-41  Score=312.09  Aligned_cols=268  Identities=22%  Similarity=0.289  Sum_probs=194.6

Q ss_pred             HHHHhcCCccCccccccCCccEEEEEEc-CCCEEEEEEecCCCch-----hHHHHHHHHHHHhcCCCCceeeeeeeEEeC
Q 017594           44 VSTATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSGQ-----GLREMKNEASVIAKVQHKNLVRLLGCCIDR  117 (369)
Q Consensus        44 ~~~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~  117 (369)
                      +....++|++.+.||+|+||.||+|++. +|+.||+|++......     ....+.+|+.+++.++||||+++++++...
T Consensus         5 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   84 (346)
T 1ua2_A            5 VKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHK   84 (346)
T ss_dssp             --------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCT
T ss_pred             hHHHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeC
Confidence            3455689999999999999999999975 4899999998643211     124677899999999999999999999999


Q ss_pred             CccEEEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCC
Q 017594          118 DEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGM  197 (369)
Q Consensus       118 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~  197 (369)
                      +..++||||+.+ +|..++...  ...+++..++.++.||+.||.|||+.+   ++||||||+||+++.++.++|+|||+
T Consensus        85 ~~~~lv~e~~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~  158 (346)
T 1ua2_A           85 SNISLVFDFMET-DLEVIIKDN--SLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGL  158 (346)
T ss_dssp             TCCEEEEECCSE-EHHHHHTTC--CSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGG
T ss_pred             CceEEEEEcCCC-CHHHHHHhc--CcCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEEEeccc
Confidence            999999999986 677776442  335788899999999999999999999   99999999999999999999999999


Q ss_pred             ceecCCCCcccccccccccccccCchhhccC-CCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhc---
Q 017594          198 ARICGGNELQANTSRIVGTYGYMSPEYALEG-IFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTS---  273 (369)
Q Consensus       198 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~---  273 (369)
                      +.......  .......+++.|+|||++.+. .++.++|||||||++|+|++|.+||.........  .........   
T Consensus       159 a~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~--~~i~~~~~~~~~  234 (346)
T 1ua2_A          159 AKSFGSPN--RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQL--TRIFETLGTPTE  234 (346)
T ss_dssp             GSTTTSCC--CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH--HHHHHHHCCCCT
T ss_pred             ceeccCCc--ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHH--HHHHHHcCCCCh
Confidence            87664322  122334689999999998754 5899999999999999999999998654321110  000000000   


Q ss_pred             ---CccccccCcccc---cccc----HHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 017594          274 ---NRTLELIDPILE---DEYS----SKQMLLRYANIALLCVQESADDRPTMNDVVSM  321 (369)
Q Consensus       274 ---~~~~~~~~~~~~---~~~~----~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~  321 (369)
                         .......+....   ....    ....+.++.+||.+||+.||++|||+.++++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  292 (346)
T 1ua2_A          235 EQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM  292 (346)
T ss_dssp             TTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             hhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence               000000000000   0000    01225679999999999999999999999974

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=6e-41  Score=303.32  Aligned_cols=261  Identities=26%  Similarity=0.342  Sum_probs=197.7

Q ss_pred             HhcCCccCccccccCCccEEEEEEcC--CC--EEEEEEecCC---CchhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCc
Q 017594           47 ATNKFSDANKLGEGGFGPVYKGVLKK--GD--EIAVKRLSGR---SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDE  119 (369)
Q Consensus        47 ~~~~y~i~~~lg~G~~~~v~~~~~~~--~~--~valK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~  119 (369)
                      ..++|++.+.||+|+||.||+|++..  +.  .|++|++...   .....+.+.+|+.+++.++||||+++++++... .
T Consensus        16 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~   94 (291)
T 1u46_A           16 GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP-P   94 (291)
T ss_dssp             CGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-S
T ss_pred             chhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccC-C
Confidence            35789999999999999999998532  33  5899988643   234567788999999999999999999998765 4


Q ss_pred             cEEEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCce
Q 017594          120 KILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMAR  199 (369)
Q Consensus       120 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~  199 (369)
                      .++|+|++.+++|.+++...  ...+++..++.++.||+.||.|||+.+   ++|+||+|+||+++.++.++|+|||++.
T Consensus        95 ~~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~  169 (291)
T 1u46_A           95 MKMVTELAPLGSLLDRLRKH--QGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMR  169 (291)
T ss_dssp             CEEEEECCTTCBHHHHHHHH--GGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred             ceeeEecccCCCHHHHHHhc--cCCcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEccccccc
Confidence            89999999999999888542  245889999999999999999999999   9999999999999999999999999998


Q ss_pred             ecCCCCccc-ccccccccccccCchhhccCCCCcccchHhHHHHHHHHHh-CCCCCCCCcccccccchhhhhhhhcCccc
Q 017594          200 ICGGNELQA-NTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDLWTSNRTL  277 (369)
Q Consensus       200 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  277 (369)
                      ......... ......++..|+|||++.+..++.++||||||+++|+|++ |..||.......     ............
T Consensus       170 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~-----~~~~~~~~~~~~  244 (291)
T 1u46_A          170 ALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ-----ILHKIDKEGERL  244 (291)
T ss_dssp             ECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-----HHHHHHTSCCCC
T ss_pred             cccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHH-----HHHHHHccCCCC
Confidence            765433221 1223456778999999998889999999999999999999 999986443111     111111111000


Q ss_pred             cccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHhhhhc
Q 017594          278 ELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNEAAT  328 (369)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L~~~~~~  328 (369)
                      .     .     +..++..+.++|.+||+.||++|||+.++++.|+++...
T Consensus       245 ~-----~-----~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~  285 (291)
T 1u46_A          245 P-----R-----PEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPT  285 (291)
T ss_dssp             C-----C-----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred             C-----C-----CcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCcc
Confidence            0     0     111256799999999999999999999999999987753

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=8.1e-41  Score=318.10  Aligned_cols=254  Identities=22%  Similarity=0.305  Sum_probs=192.3

Q ss_pred             HHHhcCCccCccccccCCccEEEEEEcC-CCEEEEEEecCCC--------chhHHHHHHHHHHHhcCCCCceeeeeeeEE
Q 017594           45 STATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRS--------GQGLREMKNEASVIAKVQHKNLVRLLGCCI  115 (369)
Q Consensus        45 ~~~~~~y~i~~~lg~G~~~~v~~~~~~~-~~~valK~~~~~~--------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~  115 (369)
                      ....++|++.+.||+|+||.||+|.++. ++.||+|++....        ......+.+|+.++++++||||+++++++.
T Consensus       131 ~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~  210 (419)
T 3i6u_A          131 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD  210 (419)
T ss_dssp             HHHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE
T ss_pred             hhhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence            4567899999999999999999999754 8899999986431        112234778999999999999999999975


Q ss_pred             eCCccEEEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCC---ceEE
Q 017594          116 DRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDM---NPKI  192 (369)
Q Consensus       116 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~---~~~L  192 (369)
                       .+..++||||+.+++|.+++..   ...+++..++.++.||+.||.|||+++   ++||||||+||+++.++   .++|
T Consensus       211 -~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kl  283 (419)
T 3i6u_A          211 -AEDYYIVLELMEGGELFDKVVG---NKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKI  283 (419)
T ss_dssp             -SSEEEEEEECCTTCBGGGGTSS---SCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSSSCCEEE
T ss_pred             -cCceEEEEEcCCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCCcceEEE
Confidence             4568999999999999888854   345899999999999999999999999   99999999999997554   5999


Q ss_pred             eecCCceecCCCCcccccccccccccccCchhhcc---CCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhh
Q 017594          193 SDFGMARICGGNELQANTSRIVGTYGYMSPEYALE---GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWD  269 (369)
Q Consensus       193 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~  269 (369)
                      +|||++.......   ......|++.|+|||++.+   ..++.++|||||||++|+|++|..||.........     ..
T Consensus       284 ~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~-----~~  355 (419)
T 3i6u_A          284 TDFGHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL-----KD  355 (419)
T ss_dssp             CCSSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCH-----HH
T ss_pred             eecccceecCCCc---cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHH-----HH
Confidence            9999998654322   2234568999999999853   66889999999999999999999999743321110     00


Q ss_pred             hhhcCccccccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 017594          270 LWTSNRTLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVS  320 (369)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~  320 (369)
                      ....... .....      .....+..+.++|.+||+.||++|||+.++++
T Consensus       356 ~i~~~~~-~~~~~------~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  399 (419)
T 3i6u_A          356 QITSGKY-NFIPE------VWAEVSEKALDLVKKLLVVDPKARFTTEEALR  399 (419)
T ss_dssp             HHHTTCC-CCCHH------HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HHhcCCC-CCCch------hhcccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence            1111100 00000      01112567999999999999999999999987

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.1e-40  Score=312.29  Aligned_cols=262  Identities=27%  Similarity=0.389  Sum_probs=197.2

Q ss_pred             hcCCccCccccccCCccEEEEEEcC--C--CEEEEEEecCC-CchhHHHHHHHHHHHhcCCCCceeeeeeeEEe-CCccE
Q 017594           48 TNKFSDANKLGEGGFGPVYKGVLKK--G--DEIAVKRLSGR-SGQGLREMKNEASVIAKVQHKNLVRLLGCCID-RDEKI  121 (369)
Q Consensus        48 ~~~y~i~~~lg~G~~~~v~~~~~~~--~--~~valK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~  121 (369)
                      ..+|++.+.||+|+||.||+|++.+  +  ..|++|.+... .....+.+.+|+.+++.++||||+++++++.. ++..+
T Consensus        88 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~  167 (373)
T 3c1x_A           88 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL  167 (373)
T ss_dssp             TEEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCE
T ss_pred             hceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeE
Confidence            3457888999999999999999542  2  35899988643 33456778899999999999999999998654 45789


Q ss_pred             EEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceec
Q 017594          122 LIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARIC  201 (369)
Q Consensus       122 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~  201 (369)
                      +||||+.+++|.+++....  ..+++..++.++.||+.||.|||+++   ++||||||+||+++.++.++|+|||++...
T Consensus       168 lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DFG~a~~~  242 (373)
T 3c1x_A          168 VVLPYMKHGDLRNFIRNET--HNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDM  242 (373)
T ss_dssp             EEEECCTTCBHHHHHHCTT--CCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC------
T ss_pred             EEEECCCCCCHHHHHhhcc--cCCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEeeccccccc
Confidence            9999999999999986432  34788899999999999999999999   999999999999999999999999999865


Q ss_pred             CCCCccc--ccccccccccccCchhhccCCCCcccchHhHHHHHHHHHh-CCCCCCCCcccccccchhhhhhhhcCcccc
Q 017594          202 GGNELQA--NTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDLWTSNRTLE  278 (369)
Q Consensus       202 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (369)
                      .......  ......++..|+|||++.+..++.++|||||||++|+|++ |.+||........     ..........  
T Consensus       243 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~-----~~~~~~~~~~--  315 (373)
T 3c1x_A          243 YDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI-----TVYLLQGRRL--  315 (373)
T ss_dssp             ---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCH-----HHHHHTTCCC--
T ss_pred             cccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHH-----HHHHHcCCCC--
Confidence            4332111  1223356778999999999999999999999999999999 6777754332111     1111111100  


Q ss_pred             ccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHhhhhccC
Q 017594          279 LIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNEAATLL  330 (369)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L~~~~~~~~  330 (369)
                          ..     +..++..+.+++.+||+.||++|||+.++++.|+.+...+.
T Consensus       316 ----~~-----p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~  358 (373)
T 3c1x_A          316 ----LQ-----PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI  358 (373)
T ss_dssp             ----CC-----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred             ----CC-----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcc
Confidence                00     11125669999999999999999999999999999988665

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=5.5e-41  Score=325.41  Aligned_cols=254  Identities=24%  Similarity=0.306  Sum_probs=202.2

Q ss_pred             HHHhcCCccCccccccCCccEEEEEEc-CCCEEEEEEecCC--CchhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccE
Q 017594           45 STATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKI  121 (369)
Q Consensus        45 ~~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  121 (369)
                      ..+.++|++.+.||+|+||.||+|+++ +|+.||+|++...  .......+.+|+.+++.++||||+++++++......+
T Consensus        18 g~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~   97 (486)
T 3mwu_A           18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFY   97 (486)
T ss_dssp             CHHHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             CChhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEE
Confidence            356789999999999999999999976 5899999998532  1234577889999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEe---CCCceEEeecCCc
Q 017594          122 LIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLD---KDMNPKISDFGMA  198 (369)
Q Consensus       122 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~---~~~~~~L~Dfg~~  198 (369)
                      +|+||+.+++|.+.+..   ...+++..++.++.||+.||.|||++|   ++||||||+||+++   .++.++|+|||++
T Consensus        98 lv~e~~~~~~L~~~~~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a  171 (486)
T 3mwu_A           98 IVGELYTGGELFDEIIK---RKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLS  171 (486)
T ss_dssp             EEECCCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEECSCSCT
T ss_pred             EEEEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEEECCcC
Confidence            99999999999888743   345899999999999999999999999   99999999999995   4567999999998


Q ss_pred             eecCCCCcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCcccc
Q 017594          199 RICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLE  278 (369)
Q Consensus       199 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (369)
                      ..+....   ......|++.|+|||++.+ .++.++|||||||++|+|++|..||.......     .............
T Consensus       172 ~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-----~~~~i~~~~~~~~  242 (486)
T 3mwu_A          172 TCFQQNT---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYD-----ILKRVETGKYAFD  242 (486)
T ss_dssp             TTBCCC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-----HHHHHHHTCCCSC
T ss_pred             eECCCCC---ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-----HHHHHHhCCCCCC
Confidence            7654332   2233468999999998875 58999999999999999999999986432111     1111111110000


Q ss_pred             ccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 017594          279 LIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSM  321 (369)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~  321 (369)
                              ......++.++.++|.+||+.||++|||+.++++.
T Consensus       243 --------~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h  277 (486)
T 3mwu_A          243 --------LPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH  277 (486)
T ss_dssp             --------SGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred             --------CcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence                    00011226679999999999999999999999974

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=1.9e-41  Score=328.48  Aligned_cols=254  Identities=25%  Similarity=0.327  Sum_probs=205.4

Q ss_pred             HHHHhcCCccCccccccCCccEEEEEEc-CCCEEEEEEecCCC---chhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCc
Q 017594           44 VSTATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS---GQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDE  119 (369)
Q Consensus        44 ~~~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~  119 (369)
                      ...+.++|++.+.||+|+||.||+|+.+ +|+.||+|++....   ......+.+|+.++++++||||+++++++.....
T Consensus        21 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~  100 (484)
T 3nyv_A           21 TAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGY  100 (484)
T ss_dssp             CCCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred             CCcccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence            3456789999999999999999999976 58999999986442   3446788999999999999999999999999999


Q ss_pred             cEEEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEE---eCCCceEEeecC
Q 017594          120 KILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILL---DKDMNPKISDFG  196 (369)
Q Consensus       120 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv---~~~~~~~L~Dfg  196 (369)
                      .++|+||+.+++|.+.+...   ..+++..++.++.||+.||.|||+++   ++||||||+||++   +.++.++|+|||
T Consensus       101 ~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg  174 (484)
T 3nyv_A          101 FYLVGEVYTGGELFDEIISR---KRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFG  174 (484)
T ss_dssp             EEEEECCCCSCBHHHHHHTC---SCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCTT
T ss_pred             EEEEEecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEEEeee
Confidence            99999999999998888543   34899999999999999999999999   9999999999999   567899999999


Q ss_pred             CceecCCCCcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCcc
Q 017594          197 MARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRT  276 (369)
Q Consensus       197 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  276 (369)
                      ++..+....   ......|++.|+|||++.+ .++.++|||||||++|+|++|.+||.......     ...........
T Consensus       175 ~a~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-----~~~~i~~~~~~  245 (484)
T 3nyv_A          175 LSTHFEASK---KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYD-----ILKKVEKGKYT  245 (484)
T ss_dssp             HHHHBCCCC---SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-----HHHHHHHCCCC
T ss_pred             eeEEccccc---ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHH-----HHHHHHcCCCC
Confidence            987664332   2233468999999998865 68999999999999999999999997433111     11111111000


Q ss_pred             ccccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 017594          277 LELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVS  320 (369)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~  320 (369)
                      ..        ......++..+.+||.+||+.||++|||+.++++
T Consensus       246 ~~--------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~  281 (484)
T 3nyv_A          246 FE--------LPQWKKVSESAKDLIRKMLTYVPSMRISARDALD  281 (484)
T ss_dssp             CC--------SGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             CC--------CcccccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence            00        0001122667999999999999999999999996

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=1.2e-41  Score=307.78  Aligned_cols=259  Identities=23%  Similarity=0.321  Sum_probs=188.7

Q ss_pred             HHhcCCccCccccccCCccEEEEEEc-CCCEEEEEEecCCCc--hhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEE
Q 017594           46 TATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSG--QGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKIL  122 (369)
Q Consensus        46 ~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l  122 (369)
                      ...++|++.+.||+|+||.||+|++. +|+.||+|++.....  .....+.++...++.+.||||+++++++...+..++
T Consensus         4 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~l   83 (290)
T 3fme_A            4 VKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWI   83 (290)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEE
T ss_pred             ccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEE
Confidence            45689999999999999999999974 588999999875422  222334455556888899999999999999999999


Q ss_pred             EEEecCCCChhhhhcC-CCccccCChHHHHHHHHHHHHHHHHHhcC-CCCCcccCCCCCCCEEEeCCCceEEeecCCcee
Q 017594          123 IYEYMPNKSLDFFLFD-PTKRMLLDWVTRVQIIEGIAQGLLYLHQY-SRVRIIHRDLKASNILLDKDMNPKISDFGMARI  200 (369)
Q Consensus       123 v~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~i~~qi~~al~~LH~~-~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~  200 (369)
                      ||||+++ +|.+++.. ......+++..++.++.||+.||.|||++ |   ++||||||+||+++.++.++|+|||++..
T Consensus        84 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~  159 (290)
T 3fme_A           84 CMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKMCDFGISGY  159 (290)
T ss_dssp             EEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEEBCCC-----
T ss_pred             EEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecCCccc
Confidence            9999975 66665532 12234589999999999999999999998 8   99999999999999999999999999876


Q ss_pred             cCCCCcccccccccccccccCchhh----ccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCcc
Q 017594          201 CGGNELQANTSRIVGTYGYMSPEYA----LEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRT  276 (369)
Q Consensus       201 ~~~~~~~~~~~~~~~~~~y~aPE~~----~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  276 (369)
                      .....   ......+++.|+|||++    .+..++.++||||||+++|+|++|..||.........    ..........
T Consensus       160 ~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~----~~~~~~~~~~  232 (290)
T 3fme_A          160 LVDDV---AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQ----LKQVVEEPSP  232 (290)
T ss_dssp             -------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHH----HHHHHHSCCC
T ss_pred             ccccc---cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHH----HHHHhccCCC
Confidence            54332   12233688999999996    4567899999999999999999999999643321110    1111111100


Q ss_pred             ccccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH--HHHhh
Q 017594          277 LELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVS--MLTNE  325 (369)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~--~L~~~  325 (369)
                       ..         ....++.++.++|.+||+.||++|||+.++++  .++..
T Consensus       233 -~~---------~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~~  273 (290)
T 3fme_A          233 -QL---------PADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLH  273 (290)
T ss_dssp             -CC---------CTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred             -Cc---------ccccCCHHHHHHHHHHhhcChhhCcCHHHHHhCcccccC
Confidence             00         01112567999999999999999999999997  44443

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=4.2e-41  Score=329.48  Aligned_cols=271  Identities=27%  Similarity=0.420  Sum_probs=215.1

Q ss_pred             hhHHHHhcCCccCccccccCCccEEEEEEcCCCEEEEEEecCCCchhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccE
Q 017594           42 SSVSTATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKI  121 (369)
Q Consensus        42 ~~~~~~~~~y~i~~~lg~G~~~~v~~~~~~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  121 (369)
                      ...+...++|++.+.||+|+||.||+|.++.+..||+|++.... ...+.+.+|+.+++.++|+||+++++++.+ +..+
T Consensus       260 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~  337 (535)
T 2h8h_A          260 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIY  337 (535)
T ss_dssp             TCSBCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred             cceecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccce
Confidence            33445667899999999999999999999888889999997544 335678999999999999999999999865 7789


Q ss_pred             EEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceec
Q 017594          122 LIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARIC  201 (369)
Q Consensus       122 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~  201 (369)
                      +||||+.+++|.+++... ....+++..++.++.||+.||.|||+++   ++||||||+||+++.++.++|+|||++...
T Consensus       338 lv~e~~~~gsL~~~l~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~  413 (535)
T 2h8h_A          338 IVTEYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLI  413 (535)
T ss_dssp             EEECCCTTEEHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCTTSTTTC
T ss_pred             EeeehhcCCcHHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEcccccceec
Confidence            999999999999998532 2244889999999999999999999999   999999999999999999999999998765


Q ss_pred             CCCCcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHh-CCCCCCCCcccccccchhhhhhhhcCcccccc
Q 017594          202 GGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDLWTSNRTLELI  280 (369)
Q Consensus       202 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (369)
                      ..... .......++..|+|||++.+..++.++||||||+++|+|++ |..||.......     ..... ......   
T Consensus       414 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~-----~~~~i-~~~~~~---  483 (535)
T 2h8h_A          414 EDNEY-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE-----VLDQV-ERGYRM---  483 (535)
T ss_dssp             CCHHH-HTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHH-----HHHHH-HTTCCC---
T ss_pred             CCCce-ecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-----HHHHH-HcCCCC---
Confidence            43211 11222345678999999998999999999999999999999 899986432111     01111 111000   


Q ss_pred             CccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHhhhhccCCCCCC
Q 017594          281 DPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNEAATLLPPKQP  335 (369)
Q Consensus       281 ~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L~~~~~~~~~~~~~  335 (369)
                        ..     +..++..+.+||.+||+.||++|||+.+|++.|+.+.....+...+
T Consensus       484 --~~-----~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~~~~~~  531 (535)
T 2h8h_A          484 --PC-----PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQP  531 (535)
T ss_dssp             --CC-----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCCSCSSCC
T ss_pred             --CC-----CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhccCcccCc
Confidence              00     1122567999999999999999999999999999987765544433

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=5e-41  Score=311.76  Aligned_cols=263  Identities=23%  Similarity=0.313  Sum_probs=204.8

Q ss_pred             HHHHhcCCccCccccccCCccEEEEEEcCCCEEEEEEecCCCch-----------------hHHHHHHHHHHHhcCCCCc
Q 017594           44 VSTATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQ-----------------GLREMKNEASVIAKVQHKN  106 (369)
Q Consensus        44 ~~~~~~~y~i~~~lg~G~~~~v~~~~~~~~~~valK~~~~~~~~-----------------~~~~~~~e~~~l~~l~h~~  106 (369)
                      .....++|++.+.||+|+||.||+|++ +|+.||+|++......                 ..+.+.+|+.+++.++|||
T Consensus        26 ~~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~  104 (348)
T 2pml_X           26 KDKYINDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEY  104 (348)
T ss_dssp             SCEEETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTT
T ss_pred             cccccCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCC
Confidence            334568999999999999999999999 7999999998633211                 1178899999999999999


Q ss_pred             eeeeeeeEEeCCccEEEEEecCCCChhhh------hcCCCccccCChHHHHHHHHHHHHHHHHHhc-CCCCCcccCCCCC
Q 017594          107 LVRLLGCCIDRDEKILIYEYMPNKSLDFF------LFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQ-YSRVRIIHRDLKA  179 (369)
Q Consensus       107 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~------l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~-~~~~~i~H~dl~p  179 (369)
                      |+++++++.+.+..++||||+++++|.++      +.. .....+++..++.++.||+.||.|||+ .|   ++|+||+|
T Consensus       105 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~-~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dl~p  180 (348)
T 2pml_X          105 CLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDK-NYTCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICHRDVKP  180 (348)
T ss_dssp             BCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCS-SSCCCCCHHHHHHHHHHHHHHHHHHHHTSC---EECCCCCG
T ss_pred             cceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhh-ccccCCCHHHHHHHHHHHHHHHHHHhccCC---EeecCCCh
Confidence            99999999999999999999999999888      432 124568999999999999999999999 88   99999999


Q ss_pred             CCEEEeCCCceEEeecCCceecCCCCcccccccccccccccCchhhccC-CCCc-ccchHhHHHHHHHHHhCCCCCCCCc
Q 017594          180 SNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEG-IFSI-KSDVFSFGVLLLEIVSGKKNTGLYR  257 (369)
Q Consensus       180 ~NIlv~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~-~~DiwslG~il~~l~tg~~p~~~~~  257 (369)
                      +||+++.++.++|+|||++......    ......++..|+|||++.+. .++. ++||||||+++|+|++|..||....
T Consensus       181 ~Nil~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~  256 (348)
T 2pml_X          181 SNILMDKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKI  256 (348)
T ss_dssp             GGEEECTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             HhEEEcCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            9999999999999999999876433    23345689999999999877 6666 9999999999999999999997543


Q ss_pred             ccccccchhhhhhhhcCccc-c-----ccCcccc--ccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 017594          258 TDSLNLLGYAWDLWTSNRTL-E-----LIDPILE--DEYSSKQMLLRYANIALLCVQESADDRPTMNDVVS  320 (369)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~-~-----~~~~~~~--~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~  320 (369)
                      ....    .. ......... .     ...+...  .......++..+.++|.+||+.||.+|||+.++++
T Consensus       257 ~~~~----~~-~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~  322 (348)
T 2pml_X          257 SLVE----LF-NNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK  322 (348)
T ss_dssp             CSHH----HH-HHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             cHHH----HH-HHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            2110    00 000000000 0     0000000  00011223667999999999999999999999987

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=7.8e-41  Score=307.70  Aligned_cols=264  Identities=23%  Similarity=0.376  Sum_probs=200.2

Q ss_pred             CccccchhhHHHHhcCCccCccccccCCccEEEEEEc-CCCEEEEEEecCCCchhHHHHHHHHHHHhcC-CCCceeeeee
Q 017594           35 QFPLFSFSSVSTATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSGQGLREMKNEASVIAKV-QHKNLVRLLG  112 (369)
Q Consensus        35 ~~~~~~~~~~~~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~  112 (369)
                      ++..+.+..+....++|++.+.||+|+||.||+|++. +|+.||+|++.... .....+..|+.+++.+ +||||+++++
T Consensus        10 ~~~~~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~   88 (326)
T 2x7f_A           10 SLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYG   88 (326)
T ss_dssp             ------CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEE
T ss_pred             cchhccchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeee
Confidence            3445566677778899999999999999999999975 58999999987543 3346788999999999 7999999999


Q ss_pred             eEEe------CCccEEEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeC
Q 017594          113 CCID------RDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDK  186 (369)
Q Consensus       113 ~~~~------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~  186 (369)
                      ++..      ....++||||+.+++|.+++... ....+++..++.++.||+.||.|||+.|   ++|+||+|+||+++.
T Consensus        89 ~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~  164 (326)
T 2x7f_A           89 AFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNT-KGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTE  164 (326)
T ss_dssp             EEEECC--CCCCEEEEEEECCTTEEHHHHHHHS-GGGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECT
T ss_pred             EEeeccCccccceEEEEEEcCCCCcHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEEcC
Confidence            9987      45789999999999999998643 2345889999999999999999999999   999999999999999


Q ss_pred             CCceEEeecCCceecCCCCcccccccccccccccCchhhc-----cCCCCcccchHhHHHHHHHHHhCCCCCCCCccccc
Q 017594          187 DMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAL-----EGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSL  261 (369)
Q Consensus       187 ~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~  261 (369)
                      ++.++|+|||++.......  .......+++.|+|||++.     +..++.++|||||||++|+|++|..||....... 
T Consensus       165 ~~~~kl~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-  241 (326)
T 2x7f_A          165 NAEVKLVDFGVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR-  241 (326)
T ss_dssp             TCCEEECCCTTTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHH-
T ss_pred             CCCEEEeeCcCceecCcCc--cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHH-
Confidence            9999999999987654321  1123346889999999986     5668999999999999999999999986432111 


Q ss_pred             ccchhhhhhhhcCccccccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 017594          262 NLLGYAWDLWTSNRTLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVS  320 (369)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~  320 (369)
                          ......... ....    ..     ..++..+.++|.+||+.||++||++.++++
T Consensus       242 ----~~~~~~~~~-~~~~----~~-----~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  286 (326)
T 2x7f_A          242 ----ALFLIPRNP-APRL----KS-----KKWSKKFQSFIESCLVKNHSQRPATEQLMK  286 (326)
T ss_dssp             ----HHHHHHHSC-CCCC----SC-----SCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             ----HHHHhhcCc-cccC----Cc-----cccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence                011111100 0000    00     112566999999999999999999999987

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=1.4e-40  Score=311.05  Aligned_cols=257  Identities=21%  Similarity=0.320  Sum_probs=204.4

Q ss_pred             hhHHHHhcCCccCccccccCCccEEEEEEc-CCCEEEEEEecCCCc--------hhHHHHHHHHHHHhcC-CCCceeeee
Q 017594           42 SSVSTATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSG--------QGLREMKNEASVIAKV-QHKNLVRLL  111 (369)
Q Consensus        42 ~~~~~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~~~--------~~~~~~~~e~~~l~~l-~h~~i~~~~  111 (369)
                      .....+.++|++.+.||.|++|.||+|+++ +|+.||||++.....        ...+.+..|+.+++.+ .||||++++
T Consensus        87 ~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~  166 (365)
T 2y7j_A           87 AAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLI  166 (365)
T ss_dssp             HHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEE
T ss_pred             hhhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEE
Confidence            334556788999999999999999999986 599999999865431        1245677899999999 799999999


Q ss_pred             eeEEeCCccEEEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceE
Q 017594          112 GCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPK  191 (369)
Q Consensus       112 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~  191 (369)
                      +++......++||||+.+++|.+++..   ...+++..+..++.||+.||.|||+.|   ++|+||+|+||+++.++.++
T Consensus       167 ~~~~~~~~~~lv~e~~~g~~L~~~l~~---~~~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~~~ik  240 (365)
T 2y7j_A          167 DSYESSSFMFLVFDLMRKGELFDYLTE---KVALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIR  240 (365)
T ss_dssp             EEEEBSSEEEEEECCCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEE
T ss_pred             EEEeeCCEEEEEEEeCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEE
Confidence            999999999999999999999998853   345899999999999999999999999   99999999999999999999


Q ss_pred             EeecCCceecCCCCcccccccccccccccCchhhcc------CCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccch
Q 017594          192 ISDFGMARICGGNELQANTSRIVGTYGYMSPEYALE------GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLG  265 (369)
Q Consensus       192 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~  265 (369)
                      |+|||++.......   ......|++.|+|||++.+      ..++.++|||||||++|+|++|..||.......     
T Consensus       241 l~DfG~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~-----  312 (365)
T 2y7j_A          241 LSDFGFSCHLEPGE---KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQIL-----  312 (365)
T ss_dssp             ECCCTTCEECCTTC---CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-----
T ss_pred             EEecCcccccCCCc---ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHH-----
Confidence            99999988765432   2233578999999999863      358899999999999999999999986432110     


Q ss_pred             hhhhhhhcCccccccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 017594          266 YAWDLWTSNRTLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVS  320 (369)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~  320 (369)
                      ..... ...... ...      ......+..+.++|.+||+.||++|||+.++++
T Consensus       313 ~~~~i-~~~~~~-~~~------~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~  359 (365)
T 2y7j_A          313 MLRMI-MEGQYQ-FSS------PEWDDRSSTVKDLISRLLQVDPEARLTAEQALQ  359 (365)
T ss_dssp             HHHHH-HHTCCC-CCH------HHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HHHHH-HhCCCC-CCC------cccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            00000 000000 000      000112566999999999999999999999987

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=1.1e-40  Score=301.61  Aligned_cols=252  Identities=25%  Similarity=0.379  Sum_probs=197.9

Q ss_pred             HHhcCCccCccccccCCccEEEEEEcC-CCEEEEEEecCC--CchhHHHHHHHHHHHhcCCCCceeeeeeeEEe----CC
Q 017594           46 TATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCID----RD  118 (369)
Q Consensus        46 ~~~~~y~i~~~lg~G~~~~v~~~~~~~-~~~valK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~  118 (369)
                      ...+.|++.+.||+|+||.||+|.+.. +..|++|.+...  .....+.+.+|+.+++.++||||+++++++..    ..
T Consensus        23 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~  102 (290)
T 1t4h_A           23 NDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKK  102 (290)
T ss_dssp             TTSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCE
T ss_pred             cCceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCc
Confidence            445679999999999999999999754 888999998643  33445678899999999999999999999875    34


Q ss_pred             ccEEEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEe-CCCceEEeecCC
Q 017594          119 EKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLD-KDMNPKISDFGM  197 (369)
Q Consensus       119 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~-~~~~~~L~Dfg~  197 (369)
                      ..++||||+.+++|.+++..   ...+++..++.++.||+.||.|||+.+ .+++|+||+|+||+++ .++.++|+|||+
T Consensus       103 ~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~kl~Dfg~  178 (290)
T 1t4h_A          103 CIVLVTELMTSGTLKTYLKR---FKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGL  178 (290)
T ss_dssp             EEEEEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTG
T ss_pred             eEEEEEEecCCCCHHHHHHH---ccCCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEEEeeCCC
Confidence            57999999999999999853   345889999999999999999999874 2499999999999997 789999999999


Q ss_pred             ceecCCCCcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCccc
Q 017594          198 ARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTL  277 (369)
Q Consensus       198 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  277 (369)
                      +......    ......+++.|+|||++. ..++.++||||||+++|+|++|..||........     ...........
T Consensus       179 ~~~~~~~----~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~-----~~~~~~~~~~~  248 (290)
T 1t4h_A          179 ATLKRAS----FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ-----IYRRVTSGVKP  248 (290)
T ss_dssp             GGGCCTT----SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH-----HHHHHTTTCCC
T ss_pred             ccccccc----ccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHH-----HHHHHhccCCc
Confidence            8654322    123346899999999876 4589999999999999999999999964332111     00111111000


Q ss_pred             cccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 017594          278 ELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVS  320 (369)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~  320 (369)
                      .    ..     ....+.++.++|.+||+.||.+|||+.++++
T Consensus       249 ~----~~-----~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  282 (290)
T 1t4h_A          249 A----SF-----DKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             G----GG-----GGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             c----cc-----CCCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence            0    00     1111456999999999999999999999986

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=1.6e-41  Score=308.80  Aligned_cols=267  Identities=24%  Similarity=0.373  Sum_probs=186.3

Q ss_pred             HHHHhcCCccCccccccCCccEEEEEEc-CCCEEEEEEecCCC-chhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccE
Q 017594           44 VSTATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKI  121 (369)
Q Consensus        44 ~~~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  121 (369)
                      .....++|++.+.||+|++|.||+|.+. +++.||+|++.... ......+.+|+.+++.++||||+++++++...+..+
T Consensus        10 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   89 (303)
T 2vwi_A           10 WSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELW   89 (303)
T ss_dssp             ---CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEE
T ss_pred             cccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcE
Confidence            4455789999999999999999999954 58899999886442 233466778999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhcC-----CCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecC
Q 017594          122 LIYEYMPNKSLDFFLFD-----PTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFG  196 (369)
Q Consensus       122 lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg  196 (369)
                      +||||+.+++|.+++..     ......+++..++.++.||+.||.|||+.|   ++|+||+|+||+++.++.++|+|||
T Consensus        90 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg  166 (303)
T 2vwi_A           90 LVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFG  166 (303)
T ss_dssp             EEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCH
T ss_pred             EEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCEEEEecc
Confidence            99999999999888753     112345899999999999999999999999   9999999999999999999999999


Q ss_pred             CceecCCCCcc---cccccccccccccCchhhcc-CCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhh
Q 017594          197 MARICGGNELQ---ANTSRIVGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWT  272 (369)
Q Consensus       197 ~~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~  272 (369)
                      ++.........   .......+++.|+|||++.+ ..++.++||||||+++|+|++|..||.........     .....
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-----~~~~~  241 (303)
T 2vwi_A          167 VSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVL-----MLTLQ  241 (303)
T ss_dssp             HHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHH-----HHHHT
T ss_pred             chheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHH-----HHHhc
Confidence            98765432211   11223468899999999875 56899999999999999999999999754322110     00000


Q ss_pred             cCccccccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 017594          273 SNRTLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVS  320 (369)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~  320 (369)
                      .. . ...............++..+.++|.+||+.||.+|||+.++++
T Consensus       242 ~~-~-~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  287 (303)
T 2vwi_A          242 ND-P-PSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR  287 (303)
T ss_dssp             SS-C-CCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             cC-C-CccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence            00 0 0000000000000112456899999999999999999999986

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=1.3e-40  Score=324.95  Aligned_cols=256  Identities=25%  Similarity=0.337  Sum_probs=206.2

Q ss_pred             HHhcCCccCccccccCCccEEEEEEc-CCCEEEEEEecCCC---chhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccE
Q 017594           46 TATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS---GQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKI  121 (369)
Q Consensus        46 ~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  121 (369)
                      ...++|++.+.||+|+||.||+|+.+ +|+.||+|++....   ......+..|+.++..++||||+++++++.+.+..+
T Consensus       181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~  260 (576)
T 2acx_A          181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALC  260 (576)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             ccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEE
Confidence            34577999999999999999999976 59999999986431   223456788999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceec
Q 017594          122 LIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARIC  201 (369)
Q Consensus       122 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~  201 (369)
                      +||||+.+++|..++.... ...+++..++.++.||+.||.|||++|   ++||||||+||+++.+|.++|+|||++...
T Consensus       261 lVmEy~~gg~L~~~l~~~~-~~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~DFGla~~~  336 (576)
T 2acx_A          261 LVLTLMNGGDLKFHIYHMG-QAGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHV  336 (576)
T ss_dssp             EEECCCCSCBHHHHHHSSS-SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred             EEEEcCCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEecccceec
Confidence            9999999999998886533 334899999999999999999999999   999999999999999999999999999876


Q ss_pred             CCCCcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCccccccC
Q 017594          202 GGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELID  281 (369)
Q Consensus       202 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (369)
                      .....   .....|++.|+|||++.+..++.++|+|||||++|+|++|..||.........  ..........      .
T Consensus       337 ~~~~~---~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~--~~i~~~i~~~------~  405 (576)
T 2acx_A          337 PEGQT---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKR--EEVERLVKEV------P  405 (576)
T ss_dssp             CTTCC---EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCH--HHHHHHHHHC------C
T ss_pred             ccCcc---ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhH--HHHHHHhhcc------c
Confidence            54322   22347899999999999989999999999999999999999999754321100  0011110000      0


Q ss_pred             ccccccccHHHHHHHHHHHHHHhhcCCCCCCC-----CHHHHHHH
Q 017594          282 PILEDEYSSKQMLLRYANIALLCVQESADDRP-----TMNDVVSM  321 (369)
Q Consensus       282 ~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp-----s~~ell~~  321 (369)
                      ....     ..++.++.+||.+||+.||++||     ++.++++.
T Consensus       406 ~~~p-----~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H  445 (576)
T 2acx_A          406 EEYS-----ERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEH  445 (576)
T ss_dssp             CCCC-----TTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred             ccCC-----ccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence            0001     11256799999999999999999     78898853

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=4.1e-41  Score=318.49  Aligned_cols=263  Identities=19%  Similarity=0.234  Sum_probs=205.6

Q ss_pred             chhhHHHHhcCCccCccccccCCccEEEEEEc-CCCEEEEEEecCCC---chhHHHHHHHHHHHhcCCCCceeeeeeeEE
Q 017594           40 SFSSVSTATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS---GQGLREMKNEASVIAKVQHKNLVRLLGCCI  115 (369)
Q Consensus        40 ~~~~~~~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~  115 (369)
                      .++......++|++.+.||+|+||.||+|+.+ +|+.||+|++....   ......+..|..++..++||||+++++++.
T Consensus        52 ~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~  131 (412)
T 2vd5_A           52 RLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQ  131 (412)
T ss_dssp             HHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred             hhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEe
Confidence            44555666789999999999999999999975 58999999986421   122345778999999999999999999999


Q ss_pred             eCCccEEEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeec
Q 017594          116 DRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDF  195 (369)
Q Consensus       116 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Df  195 (369)
                      +.+..|+||||+.+++|..++...  ...+++..++.++.||+.||+|||+++   ++||||||+||+++.++.++|+||
T Consensus       132 ~~~~~~lVmE~~~gg~L~~~l~~~--~~~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~vkL~DF  206 (412)
T 2vd5_A          132 DENYLYLVMEYYVGGDLLTLLSKF--GERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLADF  206 (412)
T ss_dssp             CSSEEEEEECCCCSCBHHHHHHHH--SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCC
T ss_pred             eCCEEEEEEcCCCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCCEEEeec
Confidence            999999999999999999998542  235899999999999999999999999   999999999999999999999999


Q ss_pred             CCceecCCCCcccccccccccccccCchhhc-------cCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhh
Q 017594          196 GMARICGGNELQANTSRIVGTYGYMSPEYAL-------EGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAW  268 (369)
Q Consensus       196 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-------~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~  268 (369)
                      |++........ .......|++.|+|||++.       +..++.++|+|||||++|+|++|..||.......     ...
T Consensus       207 Gla~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~-----~~~  280 (412)
T 2vd5_A          207 GSCLKLRADGT-VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAE-----TYG  280 (412)
T ss_dssp             TTCEECCTTSC-EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHH-----HHH
T ss_pred             hhheeccCCCc-cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHH-----HHH
Confidence            99987653322 1122357899999999987       3568999999999999999999999996433111     000


Q ss_pred             hhhhcCccccccCccccccccHHHHHHHHHHHHHHhhcCCCCCC---CCHHHHHHH
Q 017594          269 DLWTSNRTLELIDPILEDEYSSKQMLLRYANIALLCVQESADDR---PTMNDVVSM  321 (369)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R---ps~~ell~~  321 (369)
                      ..........  .+..     ...++.++.+||.+||+ +|.+|   |+++++++.
T Consensus       281 ~i~~~~~~~~--~p~~-----~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H  328 (412)
T 2vd5_A          281 KIVHYKEHLS--LPLV-----DEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTH  328 (412)
T ss_dssp             HHHTHHHHCC--CC---------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred             HHHhcccCcC--CCcc-----ccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence            1100000000  0000     11226679999999999 99998   589999853

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=1.5e-41  Score=318.93  Aligned_cols=248  Identities=15%  Similarity=0.174  Sum_probs=189.7

Q ss_pred             HhcCCccCccccccCCccEEEEEE-cCCCEEEEEEecCC---CchhHHHHHHHHH---HHhcCCCCceeeee-------e
Q 017594           47 ATNKFSDANKLGEGGFGPVYKGVL-KKGDEIAVKRLSGR---SGQGLREMKNEAS---VIAKVQHKNLVRLL-------G  112 (369)
Q Consensus        47 ~~~~y~i~~~lg~G~~~~v~~~~~-~~~~~valK~~~~~---~~~~~~~~~~e~~---~l~~l~h~~i~~~~-------~  112 (369)
                      ..++|++.+.||+|+||.||+|++ .+|+.||+|++...   .....+.+.+|+.   .++.++||||++++       +
T Consensus        71 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~  150 (377)
T 3byv_A           71 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD  150 (377)
T ss_dssp             CCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSE
T ss_pred             CCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhh
Confidence            357899999999999999999996 45999999998632   3345677889994   55555799999988       6


Q ss_pred             eEEeCC-----------------ccEEEEEecCCCChhhhhcCCCc----cccCChHHHHHHHHHHHHHHHHHhcCCCCC
Q 017594          113 CCIDRD-----------------EKILIYEYMPNKSLDFFLFDPTK----RMLLDWVTRVQIIEGIAQGLLYLHQYSRVR  171 (369)
Q Consensus       113 ~~~~~~-----------------~~~lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~i~~qi~~al~~LH~~~~~~  171 (369)
                      ++...+                 ..+++|||+ +++|.+++.....    ...+++..++.++.||+.||+|||+++   
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---  226 (377)
T 3byv_A          151 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---  226 (377)
T ss_dssp             EEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred             hhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC---
Confidence            655443                 278999999 5799888854211    112334788889999999999999999   


Q ss_pred             cccCCCCCCCEEEeCCCceEEeecCCceecCCCCcccccccccccccccCchhhccC-----------CCCcccchHhHH
Q 017594          172 IIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEG-----------IFSIKSDVFSFG  240 (369)
Q Consensus       172 i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----------~~~~~~DiwslG  240 (369)
                      ++||||||+||+++.++.++|+|||++.....     ......| +.|+|||++.+.           .++.++||||||
T Consensus       227 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG  300 (377)
T 3byv_A          227 LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALG  300 (377)
T ss_dssp             EECSCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHH
T ss_pred             eecCCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHH
Confidence            99999999999999999999999999886432     2233456 899999999877           899999999999


Q ss_pred             HHHHHHHhCCCCCCCCcccccccchhhhhhhhcCccccccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 017594          241 VLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVS  320 (369)
Q Consensus       241 ~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~  320 (369)
                      |++|+|++|..||.........               ..+.... .     .++.++.++|.+||+.||++|||+.++++
T Consensus       301 ~il~elltg~~Pf~~~~~~~~~---------------~~~~~~~-~-----~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  359 (377)
T 3byv_A          301 LVIYWIWCADLPITKDAALGGS---------------EWIFRSC-K-----NIPQPVRALLEGFLRYPKEDRLLPLQAME  359 (377)
T ss_dssp             HHHHHHHHSSCCC------CCS---------------GGGGSSC-C-----CCCHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred             HHHHHHHHCCCCCcccccccch---------------hhhhhhc-c-----CCCHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence            9999999999998643311100               0000000 0     11566999999999999999999999995


Q ss_pred             --HHHhh
Q 017594          321 --MLTNE  325 (369)
Q Consensus       321 --~L~~~  325 (369)
                        .++.+
T Consensus       360 hp~f~~~  366 (377)
T 3byv_A          360 TPEYEQL  366 (377)
T ss_dssp             SHHHHHH
T ss_pred             ChHHHHH
Confidence              44443

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=8.4e-41  Score=312.04  Aligned_cols=271  Identities=18%  Similarity=0.233  Sum_probs=197.9

Q ss_pred             cchhhHHHHhcCCccCccccccCCccEEEEEEcCCCEEEEEEecCCCc-----------hhHHHHHHHHHHHhcCCCCce
Q 017594           39 FSFSSVSTATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSG-----------QGLREMKNEASVIAKVQHKNL  107 (369)
Q Consensus        39 ~~~~~~~~~~~~y~i~~~lg~G~~~~v~~~~~~~~~~valK~~~~~~~-----------~~~~~~~~e~~~l~~l~h~~i  107 (369)
                      ..++.+....++|++.+.||+|+||.||+|.+.+|..||+|++.....           ...+.+.+|+.+++.++||||
T Consensus        12 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i   91 (362)
T 3pg1_A           12 DLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNI   91 (362)
T ss_dssp             HHHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTB
T ss_pred             HHHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCc
Confidence            356778889999999999999999999999988899999999853221           123678899999999999999


Q ss_pred             eeeeeeEEeC-----CccEEEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCE
Q 017594          108 VRLLGCCIDR-----DEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNI  182 (369)
Q Consensus       108 ~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NI  182 (369)
                      +++++++...     ...++||||+.+ +|.+.+..  ....+++..++.++.||+.||.|||+.+   ++|+||||+||
T Consensus        92 v~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NI  165 (362)
T 3pg1_A           92 LGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHD--QRIVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNI  165 (362)
T ss_dssp             CCCSEEEEECCTTTCCEEEEEEECCSE-EHHHHHHC--TTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGE
T ss_pred             cceeeeEEeccCCCcceEEEEEccCCC-CHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCc---CEecCCChHHE
Confidence            9999998543     357999999985 66566543  2345899999999999999999999999   99999999999


Q ss_pred             EEeCCCceEEeecCCceecCCCCcccccccccccccccCchhhcc-CCCCcccchHhHHHHHHHHHhCCCCCCCCccccc
Q 017594          183 LLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSL  261 (369)
Q Consensus       183 lv~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~  261 (369)
                      +++.++.++|+|||++.......   ......+++.|+|||++.+ ..++.++|||||||++|+|++|..||........
T Consensus       166 l~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~  242 (362)
T 3pg1_A          166 LLADNNDITICDFNLAREDTADA---NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQ  242 (362)
T ss_dssp             EECTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred             EEcCCCCEEEEecCccccccccc---ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHH
Confidence            99999999999999987543222   2233467889999999876 6789999999999999999999999975431110


Q ss_pred             ccchhhhhhh-----------hcCccc----cccCcccccc--ccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 017594          262 NLLGYAWDLW-----------TSNRTL----ELIDPILEDE--YSSKQMLLRYANIALLCVQESADDRPTMNDVVS  320 (369)
Q Consensus       262 ~~~~~~~~~~-----------~~~~~~----~~~~~~~~~~--~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~  320 (369)
                      .  .......           ......    ..........  ......+..+.+||.+||+.||++|||+.++++
T Consensus       243 ~--~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  316 (362)
T 3pg1_A          243 L--NKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR  316 (362)
T ss_dssp             H--HHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             H--HHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHc
Confidence            0  0000000           000000    0000000000  001112566899999999999999999999996

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=4.1e-40  Score=327.01  Aligned_cols=264  Identities=25%  Similarity=0.382  Sum_probs=204.7

Q ss_pred             cCCccCc-cccccCCccEEEEEEc---CCCEEEEEEecCCC-chhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEE
Q 017594           49 NKFSDAN-KLGEGGFGPVYKGVLK---KGDEIAVKRLSGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILI  123 (369)
Q Consensus        49 ~~y~i~~-~lg~G~~~~v~~~~~~---~~~~valK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv  123 (369)
                      .++.+.+ .||+|+||.||+|.++   ++..||+|++.... ....+.+.+|+.+++.++||||+++++++.. +..++|
T Consensus       335 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv  413 (613)
T 2ozo_A          335 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV  413 (613)
T ss_dssp             TSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEE
T ss_pred             cceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEE
Confidence            3444444 7999999999999864   35679999997543 3356788999999999999999999999875 679999


Q ss_pred             EEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCC
Q 017594          124 YEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGG  203 (369)
Q Consensus       124 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~  203 (369)
                      |||+.+++|.+++...  ...+++..++.++.||+.||+|||+++   ++||||||+||+++.++.++|+|||++.....
T Consensus       414 ~E~~~~g~L~~~l~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~  488 (613)
T 2ozo_A          414 MEMAGGGPLHKFLVGK--REEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALGA  488 (613)
T ss_dssp             EECCTTCBHHHHHTTC--TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTTTTCC-
T ss_pred             EEeCCCCcHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCcccccC
Confidence            9999999999998543  345899999999999999999999999   99999999999999999999999999976543


Q ss_pred             CCccc-ccccccccccccCchhhccCCCCcccchHhHHHHHHHHHh-CCCCCCCCcccccccchhhhhhhhcCccccccC
Q 017594          204 NELQA-NTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDLWTSNRTLELID  281 (369)
Q Consensus       204 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (369)
                      ..... ......++..|+|||++.+..++.++|||||||++|+|++ |..||.......      ............   
T Consensus       489 ~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~------~~~~i~~~~~~~---  559 (613)
T 2ozo_A          489 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE------VMAFIEQGKRME---  559 (613)
T ss_dssp             -------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHH------HHHHHHTTCCCC---
T ss_pred             CCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHH------HHHHHHcCCCCC---
Confidence            22111 1112234678999999999999999999999999999998 999987543211      111111111000   


Q ss_pred             ccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHhhhhccCCCCC
Q 017594          282 PILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNEAATLLPPKQ  334 (369)
Q Consensus       282 ~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L~~~~~~~~~~~~  334 (369)
                        .     +..++.++.++|.+||+.||++||++.+|++.|+.+........+
T Consensus       560 --~-----p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~~~~~~  605 (613)
T 2ozo_A          560 --C-----PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVE  605 (613)
T ss_dssp             --C-----CTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHHSCSCC
T ss_pred             --C-----CCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHhccccC
Confidence              0     112366799999999999999999999999999998776654433

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=4.6e-41  Score=317.26  Aligned_cols=269  Identities=20%  Similarity=0.255  Sum_probs=202.3

Q ss_pred             hhhHHHHhcCCccCccccccCCccEEEEEEc-CCCEEEEEEecCCCchhHHHHHHHHHHHhcCC--------CCceeeee
Q 017594           41 FSSVSTATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSGQGLREMKNEASVIAKVQ--------HKNLVRLL  111 (369)
Q Consensus        41 ~~~~~~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~--------h~~i~~~~  111 (369)
                      ++....+.++|++.+.||+|+||.||+|++. +++.||+|++... ....+.+.+|+.+++.++        |+||++++
T Consensus        29 ~~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~  107 (397)
T 1wak_A           29 VKIGDLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLL  107 (397)
T ss_dssp             SCTTCEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEE
T ss_pred             EehhhhcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeee
Confidence            4444566789999999999999999999965 4888999999744 344567888999999885        78899999


Q ss_pred             eeEE----eCCccEEEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcC-CCCCcccCCCCCCCEEEeC
Q 017594          112 GCCI----DRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQY-SRVRIIHRDLKASNILLDK  186 (369)
Q Consensus       112 ~~~~----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~-~~~~i~H~dl~p~NIlv~~  186 (369)
                      +++.    .....++|||++.++.+..+...  ....+++..++.++.||+.||.|||++ |   ++||||||+||+++.
T Consensus       108 ~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~NIll~~  182 (397)
T 1wak_A          108 DDFKISGVNGTHICMVFEVLGHHLLKWIIKS--NYQGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENILLSV  182 (397)
T ss_dssp             EEEEEEETTEEEEEEEECCCCCBHHHHHHHT--TTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGGEEECC
T ss_pred             cceeecCCCCceEEEEEeccCccHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHeeEec
Confidence            9987    45678999999965555544432  223489999999999999999999998 8   999999999999987


Q ss_pred             CC-------------------------------------------------ceEEeecCCceecCCCCcccccccccccc
Q 017594          187 DM-------------------------------------------------NPKISDFGMARICGGNELQANTSRIVGTY  217 (369)
Q Consensus       187 ~~-------------------------------------------------~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~  217 (369)
                      ++                                                 .++|+|||++......     .....++.
T Consensus       183 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~gt~  257 (397)
T 1wak_A          183 NEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQTR  257 (397)
T ss_dssp             CHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCSCG
T ss_pred             cchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----CccCCCCC
Confidence            75                                                 7999999999865432     23346899


Q ss_pred             cccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCccccccc----chhhhhh------------------hhcCc
Q 017594          218 GYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNL----LGYAWDL------------------WTSNR  275 (369)
Q Consensus       218 ~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~----~~~~~~~------------------~~~~~  275 (369)
                      .|+|||++.+..++.++|||||||++|+|++|..||..........    .......                  +....
T Consensus       258 ~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~  337 (397)
T 1wak_A          258 QYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKG  337 (397)
T ss_dssp             GGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTS
T ss_pred             cccCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCcc
Confidence            9999999999999999999999999999999999997654322110    0000000                  00000


Q ss_pred             cccccCccc---------cccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 017594          276 TLELIDPIL---------EDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVS  320 (369)
Q Consensus       276 ~~~~~~~~~---------~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~  320 (369)
                      ....+....         .....+...+..+.+||.+||+.||++|||+.++++
T Consensus       338 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  391 (397)
T 1wak_A          338 DLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR  391 (397)
T ss_dssp             SBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred             ccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence            000000000         000113345778999999999999999999999986

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=1.9e-40  Score=310.80  Aligned_cols=262  Identities=23%  Similarity=0.267  Sum_probs=191.6

Q ss_pred             HhcCCccCccccccCCccEEEEEEc-CCCEEEEEEecCC--CchhHHHHHHHHHHHhcCCCCceeeeeeeEEeCC-----
Q 017594           47 ATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDRD-----  118 (369)
Q Consensus        47 ~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----  118 (369)
                      ..++|++.+.||+|+||.||+|.+. +|+.||+|++...  .......+.+|+.+++.++||||+++++++....     
T Consensus        23 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~  102 (371)
T 2xrw_A           23 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF  102 (371)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTC
T ss_pred             hhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccc
Confidence            4589999999999999999999965 4888999998753  2344567788999999999999999999997654     


Q ss_pred             -ccEEEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCC
Q 017594          119 -EKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGM  197 (369)
Q Consensus       119 -~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~  197 (369)
                       ..++||||+.+ +|.+.+.     ..+++..+..++.||+.||.|||++|   ++||||||+||+++.++.++|+|||+
T Consensus       103 ~~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~  173 (371)
T 2xrw_A          103 QDVYIVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL  173 (371)
T ss_dssp             CEEEEEEECCSE-EHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCC
T ss_pred             cceEEEEEcCCC-CHHHHHh-----hccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEEEeec
Confidence             67999999976 5666663     23788999999999999999999999   99999999999999999999999999


Q ss_pred             ceecCCCCcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccc----------hh-
Q 017594          198 ARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLL----------GY-  266 (369)
Q Consensus       198 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~----------~~-  266 (369)
                      +.......   ......+++.|+|||++.+..++.++|||||||++|+|++|..||...........          .. 
T Consensus       174 a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  250 (371)
T 2xrw_A          174 ARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFM  250 (371)
T ss_dssp             -------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHH
T ss_pred             cccccccc---ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence            87654321   12234689999999999999999999999999999999999999975432110000          00 


Q ss_pred             ------hhhhhhcC------ccccccCccccc--cccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 017594          267 ------AWDLWTSN------RTLELIDPILED--EYSSKQMLLRYANIALLCVQESADDRPTMNDVVS  320 (369)
Q Consensus       267 ------~~~~~~~~------~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~  320 (369)
                            ........      ............  .......+.++.+||.+||+.||++|||+.++++
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~  318 (371)
T 2xrw_A          251 KKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ  318 (371)
T ss_dssp             TTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             HHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhC
Confidence                  00000000      000000000000  0112334678999999999999999999999996

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=1.8e-40  Score=304.87  Aligned_cols=254  Identities=23%  Similarity=0.315  Sum_probs=196.3

Q ss_pred             HHHhcCCccCccccccCCccEEEEEEcC-CCEEEEEEecCCC--------chhHHHHHHHHHHHhcCCCCceeeeeeeEE
Q 017594           45 STATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRS--------GQGLREMKNEASVIAKVQHKNLVRLLGCCI  115 (369)
Q Consensus        45 ~~~~~~y~i~~~lg~G~~~~v~~~~~~~-~~~valK~~~~~~--------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~  115 (369)
                      ..+.++|++.+.||+|+||.||+|++.. ++.||+|++....        ......+.+|+.+++.++||||+++++++.
T Consensus         6 ~~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~   85 (322)
T 2ycf_A            6 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD   85 (322)
T ss_dssp             HHHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred             hhhhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEc
Confidence            3466899999999999999999999764 7899999986432        122345778999999999999999999986


Q ss_pred             eCCccEEEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCc---eEE
Q 017594          116 DRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMN---PKI  192 (369)
Q Consensus       116 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~---~~L  192 (369)
                      .. ..++||||+.+++|.+++..   ...+++..++.++.||+.||.|||+++   ++|+||||+||+++.++.   ++|
T Consensus        86 ~~-~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl  158 (322)
T 2ycf_A           86 AE-DYYIVLELMEGGELFDKVVG---NKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKI  158 (322)
T ss_dssp             SS-SEEEEEECCTTEETHHHHST---TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSSCCEEE
T ss_pred             CC-ceEEEEecCCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCCCeEEE
Confidence            54 48999999999999888854   345899999999999999999999999   999999999999987665   999


Q ss_pred             eecCCceecCCCCcccccccccccccccCchhhc---cCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhh
Q 017594          193 SDFGMARICGGNELQANTSRIVGTYGYMSPEYAL---EGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWD  269 (369)
Q Consensus       193 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~  269 (369)
                      +|||++.......   ......+++.|+|||++.   ...++.++|||||||++|+|++|..||.........     ..
T Consensus       159 ~Dfg~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-----~~  230 (322)
T 2ycf_A          159 TDFGHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL-----KD  230 (322)
T ss_dssp             CCCTTCEECCCCH---HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCH-----HH
T ss_pred             ccCccceeccccc---ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHH-----HH
Confidence            9999998764322   122346899999999874   567899999999999999999999999754322110     00


Q ss_pred             hhhcCccccccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 017594          270 LWTSNRTLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVS  320 (369)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~  320 (369)
                      ....... ... +.     ....++..+.++|.+||+.||++||++.++++
T Consensus       231 ~~~~~~~-~~~-~~-----~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~  274 (322)
T 2ycf_A          231 QITSGKY-NFI-PE-----VWAEVSEKALDLVKKLLVVDPKARFTTEEALR  274 (322)
T ss_dssp             HHHHTCC-CCC-HH-----HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             HHHhCcc-ccC-ch-----hhhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence            0000000 000 00     01122567999999999999999999999985

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=4.5e-41  Score=308.28  Aligned_cols=274  Identities=24%  Similarity=0.395  Sum_probs=202.7

Q ss_pred             chhhHHHHhcCCccCccccccCCccEEEEEEcCCCEEEEEEecCCC--chhHHHHHHHHHHHhcCCCCceeeeeeeEEeC
Q 017594           40 SFSSVSTATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRS--GQGLREMKNEASVIAKVQHKNLVRLLGCCIDR  117 (369)
Q Consensus        40 ~~~~~~~~~~~y~i~~~lg~G~~~~v~~~~~~~~~~valK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~  117 (369)
                      ..+......++|++.+.||+|+||.||+|+++.  .+++|++....  ....+.+.+|+.+++.++||||+++++++...
T Consensus        24 ~~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~  101 (319)
T 2y4i_B           24 FLQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSP  101 (319)
T ss_dssp             CGGGSSSCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECS
T ss_pred             ccccccCCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecC
Confidence            445555667899999999999999999999763  48999986432  22334567899999999999999999999999


Q ss_pred             CccEEEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCC
Q 017594          118 DEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGM  197 (369)
Q Consensus       118 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~  197 (369)
                      ...++++||+.+++|.+++...  ...+++..++.++.||+.||.|||+.+   ++||||+|+||+++ ++.++|+|||+
T Consensus       102 ~~~~iv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~Dfg~  175 (319)
T 2y4i_B          102 PHLAIITSLCKGRTLYSVVRDA--KIVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITDFGL  175 (319)
T ss_dssp             SCEEEECBCCCSEEHHHHTTSS--CCCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEECCCSC
T ss_pred             CceEEEeecccCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEeecCC
Confidence            9999999999999999998543  335889999999999999999999999   99999999999998 67999999999


Q ss_pred             ceecCCCC---cccccccccccccccCchhhcc---------CCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccch
Q 017594          198 ARICGGNE---LQANTSRIVGTYGYMSPEYALE---------GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLG  265 (369)
Q Consensus       198 ~~~~~~~~---~~~~~~~~~~~~~y~aPE~~~~---------~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~  265 (369)
                      +.......   .........+++.|+|||++.+         ..++.++||||||+++|+|++|..||.......     
T Consensus       176 ~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-----  250 (319)
T 2y4i_B          176 FSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEA-----  250 (319)
T ss_dssp             CC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHH-----
T ss_pred             ccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-----
Confidence            77553211   1112223457889999999864         357889999999999999999999986433211     


Q ss_pred             hhhhhhhcCccccccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHhhhhccCCCCCCC
Q 017594          266 YAWDLWTSNRTLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNEAATLLPPKQPA  336 (369)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L~~~~~~~~~~~~~~  336 (369)
                      ......... .     +....    ..++..+.+++.+||+.||++|||+.++++.|+.+.........|.
T Consensus       251 ~~~~~~~~~-~-----~~~~~----~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~~~~~~~  311 (319)
T 2y4i_B          251 IIWQMGTGM-K-----PNLSQ----IGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRRLSHPG  311 (319)
T ss_dssp             HHHHHHTTC-C-----CCCCC----SSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC-----------
T ss_pred             HHHHhccCC-C-----CCCCc----CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhccCCCCc
Confidence            111111110 0     00000    0114558999999999999999999999999999988765544444

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=3.6e-40  Score=321.01  Aligned_cols=256  Identities=24%  Similarity=0.357  Sum_probs=205.2

Q ss_pred             HhcCCccCccccccCCccEEEEEEc-CCCEEEEEEecCCC---chhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEE
Q 017594           47 ATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS---GQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKIL  122 (369)
Q Consensus        47 ~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l  122 (369)
                      ..++|++.+.||+|+||.||+|+.+ +|+.||+|++....   ......+..|+.+++.++||||+++++++...+..|+
T Consensus       183 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~l  262 (543)
T 3c4z_A          183 GEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCL  262 (543)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             ChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEE
Confidence            3478999999999999999999976 49999999986432   2334677889999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhcCCCc-cccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceec
Q 017594          123 IYEYMPNKSLDFFLFDPTK-RMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARIC  201 (369)
Q Consensus       123 v~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~  201 (369)
                      ||||+++++|..++..... ...+++..++.++.||+.||.|||++|   ++||||||+||+++.+|.++|+|||++...
T Consensus       263 VmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~DFGla~~~  339 (543)
T 3c4z_A          263 VMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVEL  339 (543)
T ss_dssp             EECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred             EEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEeecceeeec
Confidence            9999999999988865332 345899999999999999999999999   999999999999999999999999999876


Q ss_pred             CCCCcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCccccccC
Q 017594          202 GGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELID  281 (369)
Q Consensus       202 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (369)
                      .....  ......|++.|+|||++.+..++.++|+|||||++|+|++|..||........ ............  ..   
T Consensus       340 ~~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~-~~~~~~~i~~~~--~~---  411 (543)
T 3c4z_A          340 KAGQT--KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE-NKELKQRVLEQA--VT---  411 (543)
T ss_dssp             CTTCC--CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCC-HHHHHHHHHHCC--CC---
T ss_pred             cCCCc--ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchh-HHHHHHHHhhcc--cC---
Confidence            54322  12334789999999999999999999999999999999999999975431110 001111111100  00   


Q ss_pred             ccccccccHHHHHHHHHHHHHHhhcCCCCCCCCH-----HHHHH
Q 017594          282 PILEDEYSSKQMLLRYANIALLCVQESADDRPTM-----NDVVS  320 (369)
Q Consensus       282 ~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~-----~ell~  320 (369)
                        .     +..++..+.++|.+||+.||++||++     .+|++
T Consensus       412 --~-----p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~  448 (543)
T 3c4z_A          412 --Y-----PDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRT  448 (543)
T ss_dssp             --C-----CTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred             --C-----CcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence              0     11226679999999999999999964     67764

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=1.3e-40  Score=311.08  Aligned_cols=264  Identities=19%  Similarity=0.256  Sum_probs=198.9

Q ss_pred             HhcCCccCccccccCCccEEEEEEc-CCCEEEEEEecCCC-chhHHHHHHHHHHHhcCCCCceeeeeeeEEeC-----Cc
Q 017594           47 ATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCCIDR-----DE  119 (369)
Q Consensus        47 ~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~  119 (369)
                      ...+|++++.||+|+||.||+|++. ++..||+|++.... ......+.+|+.+++.++||||+++++++...     ..
T Consensus        25 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  104 (364)
T 3qyz_A           25 VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD  104 (364)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred             ccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccce
Confidence            3579999999999999999999976 47889999997543 33446788999999999999999999998654     35


Q ss_pred             cEEEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCce
Q 017594          120 KILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMAR  199 (369)
Q Consensus       120 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~  199 (369)
                      .++|+|++.+ +|..++..    ..+++..++.++.||+.||.|||++|   ++||||||+||+++.++.++|+|||++.
T Consensus       105 ~~iv~e~~~~-~L~~~l~~----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~  176 (364)
T 3qyz_A          105 VYIVQDLMET-DLYKLLKT----QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLAR  176 (364)
T ss_dssp             EEEEEECCSE-EHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             EEEEEcccCc-CHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEEEeCcceE
Confidence            7999999975 78777743    34889999999999999999999999   9999999999999999999999999998


Q ss_pred             ecCCCCccc-ccccccccccccCchhhc-cCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCc--
Q 017594          200 ICGGNELQA-NTSRIVGTYGYMSPEYAL-EGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNR--  275 (369)
Q Consensus       200 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~-~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~--  275 (369)
                      ......... ......|++.|+|||++. +..++.++|||||||++|+|++|..||..........  ..........  
T Consensus       177 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~--~i~~~~~~~~~~  254 (364)
T 3qyz_A          177 VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLN--HILGILGSPSQE  254 (364)
T ss_dssp             ECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHH--HHHHHHCSCCHH
T ss_pred             ecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHH--HHHHHhCCCCHH
Confidence            765332211 123457899999999865 4558999999999999999999999997543221100  0000000000  


Q ss_pred             ---------cccccCcccc-ccc----cHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 017594          276 ---------TLELIDPILE-DEY----SSKQMLLRYANIALLCVQESADDRPTMNDVVS  320 (369)
Q Consensus       276 ---------~~~~~~~~~~-~~~----~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~  320 (369)
                               .......... ...    .....+.++.+||.+||+.||++|||+.++++
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  313 (364)
T 3qyz_A          255 DLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA  313 (364)
T ss_dssp             HHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence                     0000000000 000    00112567899999999999999999999996

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=5.8e-41  Score=316.67  Aligned_cols=267  Identities=19%  Similarity=0.249  Sum_probs=196.7

Q ss_pred             HHHHhcCCccCccccccCCccEEEEEEcCCCEEEEEEecCCCchhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCc----
Q 017594           44 VSTATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDE----  119 (369)
Q Consensus        44 ~~~~~~~y~i~~~lg~G~~~~v~~~~~~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~----  119 (369)
                      ......+|++.+.||+|+||.||+|++..+..+|+|++.....    ...+|+.+++.++||||+++++++.....    
T Consensus        35 ~~~~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~  110 (394)
T 4e7w_A           35 GEQREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDE  110 (394)
T ss_dssp             CCEEEEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSC
T ss_pred             CCcccceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCc
Confidence            3445678999999999999999999987777799998864432    22468999999999999999999865443    


Q ss_pred             --cEEEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEe-CCCceEEeecC
Q 017594          120 --KILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLD-KDMNPKISDFG  196 (369)
Q Consensus       120 --~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~-~~~~~~L~Dfg  196 (369)
                        .++||||+.++.+............+++..++.++.||+.||+|||+.|   ++||||||+||+++ .++.++|+|||
T Consensus       111 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~kL~DFG  187 (394)
T 4e7w_A          111 VFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFG  187 (394)
T ss_dssp             EEEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCT
T ss_pred             eEEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcEEEeeCC
Confidence              7899999987655444322222445889999999999999999999999   99999999999999 79999999999


Q ss_pred             CceecCCCCcccccccccccccccCchhhccC-CCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhh-------
Q 017594          197 MARICGGNELQANTSRIVGTYGYMSPEYALEG-IFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAW-------  268 (369)
Q Consensus       197 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~-------  268 (369)
                      ++........   .....+++.|+|||++.+. .++.++|||||||++|+|++|+.||.......... ....       
T Consensus       188 ~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~-~i~~~~g~p~~  263 (394)
T 4e7w_A          188 SAKILIAGEP---NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLV-EIIKVLGTPSR  263 (394)
T ss_dssp             TCEECCTTCC---CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH-HHHHHHCCCCH
T ss_pred             CcccccCCCC---CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH-HHHHHhCCCCH
Confidence            9987643322   2234678999999998764 58999999999999999999999997543211100 0000       


Q ss_pred             ---hhhhcCccccccCccccc---cccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 017594          269 ---DLWTSNRTLELIDPILED---EYSSKQMLLRYANIALLCVQESADDRPTMNDVVSM  321 (369)
Q Consensus       269 ---~~~~~~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~  321 (369)
                         ...........+......   .......+.++.+||.+||+.||++|||+.++++.
T Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  322 (394)
T 4e7w_A          264 EQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH  322 (394)
T ss_dssp             HHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             HHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence               000000000000000000   00011135679999999999999999999999974

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=8.1e-41  Score=312.60  Aligned_cols=261  Identities=23%  Similarity=0.306  Sum_probs=183.4

Q ss_pred             HHhcCCccCccccccCCccEEEEEEc-CCCEEEEEEecCC--CchhHHHHHHHHHHHhcCCCCceeeeeeeEEeC-----
Q 017594           46 TATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDR-----  117 (369)
Q Consensus        46 ~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----  117 (369)
                      ...++|++++.||+|+||.||+|.+. +|+.||+|++...  .......+.+|+.+++.++||||+++++++...     
T Consensus        26 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~  105 (367)
T 2fst_X           26 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEE  105 (367)
T ss_dssp             EEETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGG
T ss_pred             CCCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCcccc
Confidence            34589999999999999999999965 4889999998653  233456778999999999999999999998654     


Q ss_pred             -CccEEEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecC
Q 017594          118 -DEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFG  196 (369)
Q Consensus       118 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg  196 (369)
                       ...+++++++ +++|..++..    ..+++..++.++.||+.||.|||+.|   ++||||||+||+++.++.++|+|||
T Consensus       106 ~~~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kL~DFG  177 (367)
T 2fst_X          106 FNDVYLVTHLM-GADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFG  177 (367)
T ss_dssp             CCCCEEEEECC-CEECC---------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC--
T ss_pred             CCeEEEEeccc-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCEEEeecc
Confidence             5579999998 6788777743    34899999999999999999999999   9999999999999999999999999


Q ss_pred             CceecCCCCcccccccccccccccCchhhcc-CCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhh---
Q 017594          197 MARICGGNELQANTSRIVGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWT---  272 (369)
Q Consensus       197 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~---  272 (369)
                      ++......     .....++..|+|||++.+ ..++.++|||||||++|+|++|+.||........  .........   
T Consensus       178 ~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~--l~~i~~~~g~p~  250 (367)
T 2fst_X          178 LARHTADE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ--LKLILRLVGTPG  250 (367)
T ss_dssp             ------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHHHHHHHCSCC
T ss_pred             cccccccc-----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHHhCCCC
Confidence            98765422     233468999999999876 6789999999999999999999999975432110  000000000   


Q ss_pred             --------cCccc---cccCcccccccc--HHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 017594          273 --------SNRTL---ELIDPILEDEYS--SKQMLLRYANIALLCVQESADDRPTMNDVVSM  321 (369)
Q Consensus       273 --------~~~~~---~~~~~~~~~~~~--~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~  321 (369)
                              .....   ..+.........  ....+..+.+||.+||+.||++|||+.++++.
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h  312 (367)
T 2fst_X          251 AELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  312 (367)
T ss_dssp             HHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             HHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence                    00000   000000000000  01125678999999999999999999999963

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=3.8e-40  Score=299.23  Aligned_cols=254  Identities=22%  Similarity=0.302  Sum_probs=202.1

Q ss_pred             HHHhcCCccCccccccCCccEEEEEEc-CCCEEEEEEecCCC---------chhHHHHHHHHHHHhcCC-CCceeeeeee
Q 017594           45 STATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS---------GQGLREMKNEASVIAKVQ-HKNLVRLLGC  113 (369)
Q Consensus        45 ~~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~~---------~~~~~~~~~e~~~l~~l~-h~~i~~~~~~  113 (369)
                      ....++|++.+.||+|++|.||+|+++ +|+.||+|++....         ....+.+.+|+.+++++. ||||++++++
T Consensus        13 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~   92 (298)
T 1phk_A           13 HGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDT   92 (298)
T ss_dssp             --CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred             cchhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeee
Confidence            456689999999999999999999976 48899999986543         122456778999999995 9999999999


Q ss_pred             EEeCCccEEEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEe
Q 017594          114 CIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKIS  193 (369)
Q Consensus       114 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~  193 (369)
                      +......++||||+.+++|.+++..   ...+++..++.++.||+.||.|||+.|   ++|+||+|+||+++.++.++|+
T Consensus        93 ~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~  166 (298)
T 1phk_A           93 YETNTFFFLVFDLMKKGELFDYLTE---KVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLT  166 (298)
T ss_dssp             EECSSEEEEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEEC
T ss_pred             eccCCeEEEEEeccCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCCcEEEe
Confidence            9999999999999999999999853   345899999999999999999999999   9999999999999999999999


Q ss_pred             ecCCceecCCCCcccccccccccccccCchhhc------cCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhh
Q 017594          194 DFGMARICGGNELQANTSRIVGTYGYMSPEYAL------EGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYA  267 (369)
Q Consensus       194 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~------~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~  267 (369)
                      |||++.......   ......+++.|+|||++.      ...++.++||||||+++|+|++|..||.......     ..
T Consensus       167 dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-----~~  238 (298)
T 1phk_A          167 DFGFSCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML-----ML  238 (298)
T ss_dssp             CCTTCEECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-----HH
T ss_pred             cccchhhcCCCc---ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHH-----HH
Confidence            999998765332   223346889999999885      4568899999999999999999999986432111     00


Q ss_pred             hhhhhcCccccccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 017594          268 WDLWTSNRTLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVS  320 (369)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~  320 (369)
                       ........ ....+      ....++..+.++|.+||+.||++|||+.++++
T Consensus       239 -~~~~~~~~-~~~~~------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (298)
T 1phk_A          239 -RMIMSGNY-QFGSP------EWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  283 (298)
T ss_dssp             -HHHHHTCC-CCCTT------TGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             -HHHhcCCc-ccCcc------cccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence             00001100 00000      01122567999999999999999999999986

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=8.1e-41  Score=314.63  Aligned_cols=270  Identities=20%  Similarity=0.245  Sum_probs=195.0

Q ss_pred             HHHhcCCccCccccccCCccEEEEEEc-CCCEEEEEEecCCCchhHHHHHHHHHHHhcCCCCceeeeeeeEEeC------
Q 017594           45 STATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDR------  117 (369)
Q Consensus        45 ~~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------  117 (369)
                      +...++|++.+.||+|+||.||+|++. +|+.||+|++.....    ...+|+.+++.++||||+++++++...      
T Consensus         3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~   78 (383)
T 3eb0_A            3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK   78 (383)
T ss_dssp             ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred             ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence            456789999999999999999999964 589999999875432    234699999999999999999998543      


Q ss_pred             --------------------------------CccEEEEEecCCCChhhhhcC-CCccccCChHHHHHHHHHHHHHHHHH
Q 017594          118 --------------------------------DEKILIYEYMPNKSLDFFLFD-PTKRMLLDWVTRVQIIEGIAQGLLYL  164 (369)
Q Consensus       118 --------------------------------~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~i~~qi~~al~~L  164 (369)
                                                      ...++||||+.+ +|.+.+.. ......+++..++.++.||+.||.||
T Consensus        79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L  157 (383)
T 3eb0_A           79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFI  157 (383)
T ss_dssp             -------------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred             ccccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence                                            337899999985 66555532 12234589999999999999999999


Q ss_pred             hcCCCCCcccCCCCCCCEEEe-CCCceEEeecCCceecCCCCcccccccccccccccCchhhccC-CCCcccchHhHHHH
Q 017594          165 HQYSRVRIIHRDLKASNILLD-KDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEG-IFSIKSDVFSFGVL  242 (369)
Q Consensus       165 H~~~~~~i~H~dl~p~NIlv~-~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~i  242 (369)
                      |+.|   ++||||||+||+++ .++.++|+|||++........   .....++..|+|||++.+. .++.++||||+||+
T Consensus       158 H~~g---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~i  231 (383)
T 3eb0_A          158 HSLG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP---SVAYICSRFYRAPELMLGATEYTPSIDLWSIGCV  231 (383)
T ss_dssp             HTTT---EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC---CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHH
T ss_pred             HHCc---CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC---CcCcccCCCccCHHHhcCCCCCCcchhhhhHHHH
Confidence            9999   99999999999998 688999999999987644322   2234678899999998765 48999999999999


Q ss_pred             HHHHHhCCCCCCCCcccccccchhhhh--------hhh-cCccccccCccccc----cccHHHHHHHHHHHHHHhhcCCC
Q 017594          243 LLEIVSGKKNTGLYRTDSLNLLGYAWD--------LWT-SNRTLELIDPILED----EYSSKQMLLRYANIALLCVQESA  309 (369)
Q Consensus       243 l~~l~tg~~p~~~~~~~~~~~~~~~~~--------~~~-~~~~~~~~~~~~~~----~~~~~~~~~~l~~li~~~L~~dP  309 (369)
                      +|+|++|..||.......... .....        ... .........+....    ...+...+.++.+||.+||+.||
T Consensus       232 l~ell~g~~pf~~~~~~~~~~-~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP  310 (383)
T 3eb0_A          232 FGELILGKPLFSGETSIDQLV-RIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEP  310 (383)
T ss_dssp             HHHHHHSSCSSCCSSHHHHHH-HHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSG
T ss_pred             HHHHHhCCCCCCCCChHHHHH-HHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCCh
Confidence            999999999997543211100 00000        000 00000000000000    00111235679999999999999


Q ss_pred             CCCCCHHHHHH--HHHhhh
Q 017594          310 DDRPTMNDVVS--MLTNEA  326 (369)
Q Consensus       310 ~~Rps~~ell~--~L~~~~  326 (369)
                      ++|||+.++++  .+..+.
T Consensus       311 ~~R~t~~e~l~hp~f~~~~  329 (383)
T 3eb0_A          311 DLRINPYEAMAHPFFDHLR  329 (383)
T ss_dssp             GGSCCHHHHHTSGGGHHHH
T ss_pred             hhCCCHHHHhcCHHHHHHH
Confidence            99999999994  344443

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=3.3e-40  Score=310.38  Aligned_cols=243  Identities=22%  Similarity=0.304  Sum_probs=178.5

Q ss_pred             cccccccccceeEeecccchHhhhcccc-cCCCccccchhhHHHHhcCCccCccccccCCccEEEEEEc-CCCEEEEEEe
Q 017594            4 DLDLNLKADNVIIELPANNKQAKRSKKK-EVDQFPLFSFSSVSTATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRL   81 (369)
Q Consensus         4 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~   81 (369)
                      +|-+.+.+.|+-++.-...+..++.... -.+....|.+.......++|++.+.||+|+||.||+|++. +++.||+|++
T Consensus         8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~   87 (382)
T 2vx3_A            8 SSGVDLGTENLYFQSMSSHKKERKVYNDGYDDDNYDYIVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKII   87 (382)
T ss_dssp             ------------------------CBGGGTBCTTSCBCCCTTCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEE
T ss_pred             ccccccCCCceEeccccccccccCcCcCCcCCCCCcEEeecCCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEE
Confidence            4566778888887654443322222111 1223335677888888999999999999999999999976 4788999999


Q ss_pred             cCCCchhHHHHHHHHHHHhcCC-CC-----ceeeeeeeEEeCCccEEEEEecCCCChhhhhcCCCccccCChHHHHHHHH
Q 017594           82 SGRSGQGLREMKNEASVIAKVQ-HK-----NLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIE  155 (369)
Q Consensus        82 ~~~~~~~~~~~~~e~~~l~~l~-h~-----~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~  155 (369)
                      ... ......+..|+.++..+. |+     +++++.+++...+..++|||++.+ +|.+++.... ...+++..+..++.
T Consensus        88 ~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~-~~~~~~~~~~~i~~  164 (382)
T 2vx3_A           88 KNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSY-NLYDLLRNTN-FRGVSLNLTRKFAQ  164 (382)
T ss_dssp             CSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEEEEEEECCCC-BHHHHHHHTT-TSCCCHHHHHHHHH
T ss_pred             ecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCceEEEEecCCC-CHHHHHhhcC-cCCCCHHHHHHHHH
Confidence            743 233466777888888774 44     499999999999999999999965 8888775432 23488999999999


Q ss_pred             HHHHHHHHHhc--CCCCCcccCCCCCCCEEEe--CCCceEEeecCCceecCCCCcccccccccccccccCchhhccCCCC
Q 017594          156 GIAQGLLYLHQ--YSRVRIIHRDLKASNILLD--KDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFS  231 (369)
Q Consensus       156 qi~~al~~LH~--~~~~~i~H~dl~p~NIlv~--~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~  231 (369)
                      ||+.||.|||.  .+   ++||||||+||+++  .++.++|+|||++......     .....+++.|+|||++.+..++
T Consensus       165 qi~~al~~lH~~~~~---ivHrDlkp~NIll~~~~~~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~  236 (382)
T 2vx3_A          165 QMCTALLFLATPELS---IIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQR-----IYQYIQSRFYRSPEVLLGMPYD  236 (382)
T ss_dssp             HHHHHHHHHTSTTTC---EECCCCSGGGEEESSTTSCCEEECCCTTCEETTCC-----CCSSCSCGGGCCHHHHTTCCCC
T ss_pred             HHHHHHHHhccCCCC---EEcCCCCcccEEEecCCCCcEEEEeccCceecccc-----cccccCCccccChHHHcCCCCC
Confidence            99999999995  56   99999999999995  4778999999999876432     2234688999999999999999


Q ss_pred             cccchHhHHHHHHHHHhCCCCCCCCc
Q 017594          232 IKSDVFSFGVLLLEIVSGKKNTGLYR  257 (369)
Q Consensus       232 ~~~DiwslG~il~~l~tg~~p~~~~~  257 (369)
                      .++|||||||++|+|++|..||....
T Consensus       237 ~~~DiwSlG~il~elltg~~pf~~~~  262 (382)
T 2vx3_A          237 LAIDMWSLGCILVEMHTGEPLFSGAN  262 (382)
T ss_dssp             THHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             cHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            99999999999999999999997543

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=7e-41  Score=301.18  Aligned_cols=260  Identities=24%  Similarity=0.322  Sum_probs=202.2

Q ss_pred             HhcCCccCccccccCCccEEEEEEc-CCCEEEEEEecCCC--chhHHHHHHHHHHHhcCCCCceeeeeeeEEe--CCccE
Q 017594           47 ATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS--GQGLREMKNEASVIAKVQHKNLVRLLGCCID--RDEKI  121 (369)
Q Consensus        47 ~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~  121 (369)
                      ..++|++.+.||+|+||.||+|+++ +|+.|++|.+....  ....+.+.+|+.+++.++||||+++++++..  ....+
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   83 (279)
T 2w5a_A            4 RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLY   83 (279)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEE
T ss_pred             chhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEE
Confidence            4578999999999999999999976 58999999987543  3445678899999999999999999998754  56789


Q ss_pred             EEEEecCCCChhhhhcCCC-ccccCChHHHHHHHHHHHHHHHHHhcCC--CCCcccCCCCCCCEEEeCCCceEEeecCCc
Q 017594          122 LIYEYMPNKSLDFFLFDPT-KRMLLDWVTRVQIIEGIAQGLLYLHQYS--RVRIIHRDLKASNILLDKDMNPKISDFGMA  198 (369)
Q Consensus       122 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~al~~LH~~~--~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~  198 (369)
                      +||||+++++|.+++.... ....+++..++.++.||+.||.|||+.+  ..+++|+||+|+||+++.++.++|+|||++
T Consensus        84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~  163 (279)
T 2w5a_A           84 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA  163 (279)
T ss_dssp             EEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHH
T ss_pred             EEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchh
Confidence            9999999999999885422 2344899999999999999999999875  123999999999999999999999999998


Q ss_pred             eecCCCCcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCcccc
Q 017594          199 RICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLE  278 (369)
Q Consensus       199 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (369)
                      ........  ......++..|+|||++.+..++.++||||||+++|+|++|..||.......     .... ........
T Consensus       164 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-----~~~~-i~~~~~~~  235 (279)
T 2w5a_A          164 RILNHDTS--FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE-----LAGK-IREGKFRR  235 (279)
T ss_dssp             HHC---CH--HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-----HHHH-HHHTCCCC
T ss_pred             eeeccccc--cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHH-----HHHH-Hhhccccc
Confidence            76543221  1223467899999999998899999999999999999999999987543111     1111 11111100


Q ss_pred             ccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHh
Q 017594          279 LIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTN  324 (369)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L~~  324 (369)
                           +.     ..++.++.++|.+||+.||++|||+.+|++.+..
T Consensus       236 -----~~-----~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~  271 (279)
T 2w5a_A          236 -----IP-----YRYSDELNEIITRMLNLKDYHRPSVEEILENPLI  271 (279)
T ss_dssp             -----CC-----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred             -----CC-----cccCHHHHHHHHHHcCCCcccCCCHHHHHhChhh
Confidence                 11     1125679999999999999999999999986543

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.8e-40  Score=309.14  Aligned_cols=255  Identities=22%  Similarity=0.291  Sum_probs=200.2

Q ss_pred             hcCCccCccccccCCccEEEEEE----cCCCEEEEEEecCCC----chhHHHHHHHHHHHhcC-CCCceeeeeeeEEeCC
Q 017594           48 TNKFSDANKLGEGGFGPVYKGVL----KKGDEIAVKRLSGRS----GQGLREMKNEASVIAKV-QHKNLVRLLGCCIDRD  118 (369)
Q Consensus        48 ~~~y~i~~~lg~G~~~~v~~~~~----~~~~~valK~~~~~~----~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~  118 (369)
                      .++|++.+.||+|+||.||+|+.    .+|+.||+|++....    ......+..|+.++..+ .||||+++++++....
T Consensus        53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~  132 (355)
T 1vzo_A           53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET  132 (355)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred             ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence            47899999999999999999997    368999999986432    12335566789999999 6999999999999999


Q ss_pred             ccEEEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCc
Q 017594          119 EKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMA  198 (369)
Q Consensus       119 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~  198 (369)
                      ..++||||+.+++|.+++..   ...+++..++.++.||+.||.|||+++   ++||||||+||+++.++.++|+|||++
T Consensus       133 ~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~DfG~a  206 (355)
T 1vzo_A          133 KLHLILDYINGGELFTHLSQ---RERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLS  206 (355)
T ss_dssp             EEEEEECCCCSCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred             eEEEEeecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEEeeCCCC
Confidence            99999999999999999854   335899999999999999999999999   999999999999999999999999998


Q ss_pred             eecCCCCcccccccccccccccCchhhcc--CCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCcc
Q 017594          199 RICGGNELQANTSRIVGTYGYMSPEYALE--GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRT  276 (369)
Q Consensus       199 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  276 (369)
                      ..+..... .......|++.|+|||++.+  ..++.++|||||||++|+|++|..||........ ............  
T Consensus       207 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~-~~~~~~~~~~~~--  282 (355)
T 1vzo_A          207 KEFVADET-ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS-QAEISRRILKSE--  282 (355)
T ss_dssp             EECCGGGG-GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCC-HHHHHHHHHHCC--
T ss_pred             eecccCCC-CcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccch-HHHHHHHHhccC--
Confidence            86543221 12233568999999999885  3478999999999999999999999964432111 011111111100  


Q ss_pred             ccccCccccccccHHHHHHHHHHHHHHhhcCCCCCCC-----CHHHHHHHH
Q 017594          277 LELIDPILEDEYSSKQMLLRYANIALLCVQESADDRP-----TMNDVVSML  322 (369)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp-----s~~ell~~L  322 (369)
                           +..     +..++..+.+||.+||+.||++||     ++.++++..
T Consensus       283 -----~~~-----~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~  323 (355)
T 1vzo_A          283 -----PPY-----PQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL  323 (355)
T ss_dssp             -----CCC-----CTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred             -----CCC-----CcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence                 001     111256689999999999999999     999998754

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=2.3e-40  Score=305.69  Aligned_cols=270  Identities=21%  Similarity=0.264  Sum_probs=204.1

Q ss_pred             chhhHHHHhcCCccCccccccCCccEEEEEE-c-CCCEEEEEEecCCCchhHHHHHHHHHHHhcCCCC------ceeeee
Q 017594           40 SFSSVSTATNKFSDANKLGEGGFGPVYKGVL-K-KGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHK------NLVRLL  111 (369)
Q Consensus        40 ~~~~~~~~~~~y~i~~~lg~G~~~~v~~~~~-~-~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~------~i~~~~  111 (369)
                      .++....+.++|++.+.||+|+||.||+|.+ + +|+.||+|++... ....+.+..|+.+++.++|+      ++++++
T Consensus         5 ~~~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~   83 (339)
T 1z57_A            5 ICQSGDVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQML   83 (339)
T ss_dssp             TCSTTCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEE
T ss_pred             eeecCCCccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeee
Confidence            3445556778999999999999999999997 3 4788999998744 33456778899999888654      499999


Q ss_pred             eeEEeCCccEEEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeC-----
Q 017594          112 GCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDK-----  186 (369)
Q Consensus       112 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~-----  186 (369)
                      +++...+..++|||++ +++|.+++.... ...+++..++.++.||+.||.|||+++   ++||||||+||+++.     
T Consensus        84 ~~~~~~~~~~lv~e~~-~~~l~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~  158 (339)
T 1z57_A           84 EWFEHHGHICIVFELL-GLSTYDFIKENG-FLPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTE  158 (339)
T ss_dssp             EEEEETTEEEEEEECC-CCBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEE
T ss_pred             cccccCCcEEEEEcCC-CCCHHHHHHhcC-CCCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEecccccc
Confidence            9999999999999999 778888875432 235889999999999999999999999   999999999999987     


Q ss_pred             --------------CCceEEeecCCceecCCCCcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCC
Q 017594          187 --------------DMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKN  252 (369)
Q Consensus       187 --------------~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p  252 (369)
                                    ++.++|+|||++......     .....+++.|+|||++.+..++.++|||||||++|+|++|..|
T Consensus       159 ~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p  233 (339)
T 1z57_A          159 AYNPKIKRDERTLINPDIKVVDFGSATYDDEH-----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTV  233 (339)
T ss_dssp             EEC----CEEEEESCCCEEECCCSSCEETTSC-----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred             ccCCccccccccccCCCceEeeCcccccCccc-----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCC
Confidence                          668999999998764322     2334689999999999998999999999999999999999999


Q ss_pred             CCCCcccccccc-h-----hhhhhhhcCcc---------------------ccccCccccccccHHHHHHHHHHHHHHhh
Q 017594          253 TGLYRTDSLNLL-G-----YAWDLWTSNRT---------------------LELIDPILEDEYSSKQMLLRYANIALLCV  305 (369)
Q Consensus       253 ~~~~~~~~~~~~-~-----~~~~~~~~~~~---------------------~~~~~~~~~~~~~~~~~~~~l~~li~~~L  305 (369)
                      |........... .     ...........                     .....+...........+.++.+||.+||
T Consensus       234 f~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L  313 (339)
T 1z57_A          234 FPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKML  313 (339)
T ss_dssp             CCCSCHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHT
T ss_pred             CCCCChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHh
Confidence            975432110000 0     00000000000                     00000000001112233678999999999


Q ss_pred             cCCCCCCCCHHHHHH
Q 017594          306 QESADDRPTMNDVVS  320 (369)
Q Consensus       306 ~~dP~~Rps~~ell~  320 (369)
                      +.||.+|||+.++++
T Consensus       314 ~~dP~~Rpt~~ell~  328 (339)
T 1z57_A          314 EYDPAKRITLREALK  328 (339)
T ss_dssp             CSSTTTSCCHHHHTT
T ss_pred             CcCcccccCHHHHhc
Confidence            999999999999985

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=1.5e-40  Score=304.59  Aligned_cols=264  Identities=22%  Similarity=0.301  Sum_probs=193.3

Q ss_pred             HhcCCccCccccccCCccEEEEEEcC-CCEEEEEEecCCCchhHHHHHHHHHHHhcCCCCceeeeeeeEE----------
Q 017594           47 ATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCI----------  115 (369)
Q Consensus        47 ~~~~y~i~~~lg~G~~~~v~~~~~~~-~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~----------  115 (369)
                      +.++|++.+.||+|++|.||+|++.. |+.||+|++........+.+.+|+.+++.++||||+++++++.          
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   88 (320)
T 2i6l_A            9 LGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDV   88 (320)
T ss_dssp             ETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC--
T ss_pred             cCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccc
Confidence            45899999999999999999999775 8899999998777667788899999999999999999998873          


Q ss_pred             ----eCCccEEEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEe-CCCce
Q 017594          116 ----DRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLD-KDMNP  190 (369)
Q Consensus       116 ----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~-~~~~~  190 (369)
                          .....++||||+. ++|.+++..    ..+++..++.++.||+.||.|||++|   ++||||||+||+++ .++.+
T Consensus        89 ~~~~~~~~~~lv~e~~~-~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~  160 (320)
T 2i6l_A           89 GSLTELNSVYIVQEYME-TDLANVLEQ----GPLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVL  160 (320)
T ss_dssp             --CCSCSEEEEEEECCS-EEHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTTEE
T ss_pred             ccccccCceeEEeeccC-CCHHHHhhc----CCccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCeE
Confidence                3356799999998 588888743    34889999999999999999999999   99999999999997 56789


Q ss_pred             EEeecCCceecCCCCcc-cccccccccccccCchhhcc-CCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhh
Q 017594          191 KISDFGMARICGGNELQ-ANTSRIVGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAW  268 (369)
Q Consensus       191 ~L~Dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~  268 (369)
                      +|+|||++......... .......++..|+|||++.+ ..++.++||||||+++|+|++|..||.........  ....
T Consensus       161 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~--~~~~  238 (320)
T 2i6l_A          161 KIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQM--QLIL  238 (320)
T ss_dssp             EECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH--HHHH
T ss_pred             EEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHH--HHHH
Confidence            99999998865432111 11233456889999998765 67899999999999999999999999754321100  0000


Q ss_pred             hhhhc------CccccccC----cccc-cc----ccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 017594          269 DLWTS------NRTLELID----PILE-DE----YSSKQMLLRYANIALLCVQESADDRPTMNDVVS  320 (369)
Q Consensus       269 ~~~~~------~~~~~~~~----~~~~-~~----~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~  320 (369)
                      .....      ......+.    .... ..    .....++.++.++|.+||+.||++|||+.++++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  305 (320)
T 2i6l_A          239 ESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS  305 (320)
T ss_dssp             HHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             HhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence            00000      00000000    0000 00    000123677999999999999999999999986

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=2.1e-40  Score=308.99  Aligned_cols=272  Identities=17%  Similarity=0.214  Sum_probs=188.0

Q ss_pred             hhHHHHhcCCccCccccccCCccEEEEEEc-CCCEEEEEEecCCCchhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCc-
Q 017594           42 SSVSTATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDE-  119 (369)
Q Consensus        42 ~~~~~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-  119 (369)
                      .......++|++.+.||+|+||.||+|++. +|+.||+|++.... ........++..+..++||||+++++++..... 
T Consensus        16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~   94 (360)
T 3e3p_A           16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGER   94 (360)
T ss_dssp             HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred             hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence            445667789999999999999999999975 48999999886543 223456677888888999999999999876443 


Q ss_pred             ------cEEEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHh--cCCCCCcccCCCCCCCEEEeC-CCce
Q 017594          120 ------KILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLH--QYSRVRIIHRDLKASNILLDK-DMNP  190 (369)
Q Consensus       120 ------~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH--~~~~~~i~H~dl~p~NIlv~~-~~~~  190 (369)
                            .++||||+.++.+..+.........+++..++.++.||+.||.|||  +.|   ++||||||+||+++. ++.+
T Consensus        95 ~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NIll~~~~~~~  171 (360)
T 3e3p_A           95 DRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVLVNEADGTL  171 (360)
T ss_dssp             CTTCEEEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGEEEETTTTEE
T ss_pred             cccceeEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHEEEeCCCCcE
Confidence                  7899999987544333221233445888999999999999999999  888   999999999999997 8999


Q ss_pred             EEeecCCceecCCCCcccccccccccccccCchhhccC-CCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchh---
Q 017594          191 KISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEG-IFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGY---  266 (369)
Q Consensus       191 ~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~---  266 (369)
                      +|+|||++........   .....+++.|+|||++.+. .++.++|||||||++|+|++|..||.............   
T Consensus       172 kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~  248 (360)
T 3e3p_A          172 KLCDFGSAKKLSPSEP---NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVL  248 (360)
T ss_dssp             EECCCTTCBCCCTTSC---CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHH
T ss_pred             EEeeCCCceecCCCCC---cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHc
Confidence            9999999987653322   2234678999999998654 48999999999999999999999997543211100000   


Q ss_pred             ------hhhhhhcCc-cccccCcc-c--ccc--ccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 017594          267 ------AWDLWTSNR-TLELIDPI-L--EDE--YSSKQMLLRYANIALLCVQESADDRPTMNDVVS  320 (369)
Q Consensus       267 ------~~~~~~~~~-~~~~~~~~-~--~~~--~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~  320 (369)
                            .+....... ........ .  ...  ......+.++.+||.+||+.||.+|||+.++++
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  314 (360)
T 3e3p_A          249 GCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALC  314 (360)
T ss_dssp             CCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             CCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhc
Confidence                  000000000 00000000 0  000  000012677999999999999999999999996

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=3.9e-40  Score=330.22  Aligned_cols=249  Identities=25%  Similarity=0.307  Sum_probs=202.4

Q ss_pred             HhcCCccCccccccCCccEEEEEEcC-CCEEEEEEecCC---CchhHHHHHHHHHHHhcC-CCCceeeeeeeEEeCCccE
Q 017594           47 ATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGR---SGQGLREMKNEASVIAKV-QHKNLVRLLGCCIDRDEKI  121 (369)
Q Consensus        47 ~~~~y~i~~~lg~G~~~~v~~~~~~~-~~~valK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~  121 (369)
                      ...+|++++.||+|+||.||+|+.+. ++.||+|++...   .....+.+..|..++..+ +||+|+.+++++...+.+|
T Consensus       339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~  418 (674)
T 3pfq_A          339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY  418 (674)
T ss_dssp             -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred             cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence            45689999999999999999999764 888999998642   223446677899999988 6999999999999999999


Q ss_pred             EEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceec
Q 017594          122 LIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARIC  201 (369)
Q Consensus       122 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~  201 (369)
                      +||||+.+++|..++...   ..+++..++.++.||+.||+|||+++   |+||||||+|||++.++.++|+|||++...
T Consensus       419 lV~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~DFGla~~~  492 (674)
T 3pfq_A          419 FVMEYVNGGDLMYHIQQV---GRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEN  492 (674)
T ss_dssp             EEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEECCCTTCEEC
T ss_pred             EEEeCcCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEeecceeecc
Confidence            999999999999988543   34899999999999999999999999   999999999999999999999999999864


Q ss_pred             CCCCcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCccccccC
Q 017594          202 GGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELID  281 (369)
Q Consensus       202 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (369)
                      ....  .......||+.|+|||++.+..++.++|+||||+++|+|++|..||.......     ...... .... .   
T Consensus       493 ~~~~--~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~-----~~~~i~-~~~~-~---  560 (674)
T 3pfq_A          493 IWDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE-----LFQSIM-EHNV-A---  560 (674)
T ss_dssp             CCTT--CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-----HHHHHH-SSCC-C---
T ss_pred             ccCC--cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHH-----HHHHHH-hCCC-C---
Confidence            3222  22344579999999999999999999999999999999999999997433111     111111 1100 0   


Q ss_pred             ccccccccHHHHHHHHHHHHHHhhcCCCCCCCCH-----HHHHH
Q 017594          282 PILEDEYSSKQMLLRYANIALLCVQESADDRPTM-----NDVVS  320 (369)
Q Consensus       282 ~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~-----~ell~  320 (369)
                        +     +..++.++.+||.+||+.||++||++     .+|++
T Consensus       561 --~-----p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~  597 (674)
T 3pfq_A          561 --Y-----PKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE  597 (674)
T ss_dssp             --C-----CTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred             --C-----CccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence              0     11226779999999999999999997     77764

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=4.5e-40  Score=308.25  Aligned_cols=259  Identities=21%  Similarity=0.308  Sum_probs=194.5

Q ss_pred             HhcCCccCccccccCCccEEEEEEc-CCCEEEEEEecCCC--chhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCcc---
Q 017594           47 ATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS--GQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEK---  120 (369)
Q Consensus        47 ~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~---  120 (369)
                      +.++|++.+.||+|+||.||+|++. +|+.||+|++....  ......+.+|+.+++.++||||+++++++...+..   
T Consensus        40 l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  119 (371)
T 4exu_A           40 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF  119 (371)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTC
T ss_pred             ccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccc
Confidence            4589999999999999999999976 48899999997542  23356788999999999999999999999876655   


Q ss_pred             ---EEEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCC
Q 017594          121 ---ILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGM  197 (369)
Q Consensus       121 ---~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~  197 (369)
                         ++||||+. ++|...+.     ..+++..++.++.||+.||.|||+.|   ++||||||+||+++.++.++|+|||+
T Consensus       120 ~~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg~  190 (371)
T 4exu_A          120 YDFYLVMPFMQ-TDLQKIMG-----MEFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGL  190 (371)
T ss_dssp             CCCEEEEECCC-EEHHHHTT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECSTTC
T ss_pred             eeEEEEEcccc-ccHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEEEEecCc
Confidence               99999997 46766662     22889999999999999999999999   99999999999999999999999999


Q ss_pred             ceecCCCCcccccccccccccccCchhhcc-CCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhc--C
Q 017594          198 ARICGGNELQANTSRIVGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTS--N  274 (369)
Q Consensus       198 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~--~  274 (369)
                      +......     .....+++.|+|||++.+ ..++.++|||||||++|+|++|..||..........  ........  .
T Consensus       191 a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~--~i~~~~~~~~~  263 (371)
T 4exu_A          191 ARHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLT--QILKVTGVPGT  263 (371)
T ss_dssp             C-------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH--HHHHHHCCCCH
T ss_pred             ccccccC-----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHH--HHHHHhCCCcH
Confidence            8755422     233467999999999887 678999999999999999999999997543111000  00000000  0


Q ss_pred             cc------------ccccCccccccc--cHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 017594          275 RT------------LELIDPILEDEY--SSKQMLLRYANIALLCVQESADDRPTMNDVVSM  321 (369)
Q Consensus       275 ~~------------~~~~~~~~~~~~--~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~  321 (369)
                      ..            ...+........  .....+..+.+||.+||+.||++|||+.++++.
T Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  324 (371)
T 4exu_A          264 EFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH  324 (371)
T ss_dssp             HHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             HHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence            00            000000000000  001125679999999999999999999999863

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=3.2e-40  Score=309.25  Aligned_cols=253  Identities=10%  Similarity=0.048  Sum_probs=179.2

Q ss_pred             hcCCccCccccccCCccEEEEEEc-CCCEEEEEEecCCCc---hhHHHHHHHH---HHHhcCCCCceeeee-------ee
Q 017594           48 TNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSG---QGLREMKNEA---SVIAKVQHKNLVRLL-------GC  113 (369)
Q Consensus        48 ~~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~~~---~~~~~~~~e~---~~l~~l~h~~i~~~~-------~~  113 (369)
                      ..+|++.+.||+|+||.||+|++. +|+.||+|++.....   ...+.+.+|+   ..|+. +|||+++++       ++
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~p~d~  139 (371)
T 3q60_A           61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRRRLLLPSDA  139 (371)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------CBCCCCEE
T ss_pred             ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEeeehh
Confidence            456999999999999999999976 588999999986542   3345667774   45555 699977754       44


Q ss_pred             EEeC-----------------CccEEEEEecCCCChhhhhcCCCccccCChHHH------HHHHHHHHHHHHHHhcCCCC
Q 017594          114 CIDR-----------------DEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTR------VQIIEGIAQGLLYLHQYSRV  170 (369)
Q Consensus       114 ~~~~-----------------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~------~~i~~qi~~al~~LH~~~~~  170 (369)
                      +...                 ...++||||+. ++|.+++...  ...+.....      ..++.||+.||+|||+++  
T Consensus       140 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~--~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~--  214 (371)
T 3q60_A          140 VAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTL--DFVYVFRGDEGILALHILTAQLIRLAANLQSKG--  214 (371)
T ss_dssp             EEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHH--HHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred             eecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHh--ccccchhhhhhhhhHHHHHHHHHHHHHHHHHCC--
Confidence            4333                 23799999998 7999888543  223444555      678899999999999999  


Q ss_pred             CcccCCCCCCCEEEeCCCceEEeecCCceecCCCCcccccccccccccccCchhhcc--CCCCcccchHhHHHHHHHHHh
Q 017594          171 RIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALE--GIFSIKSDVFSFGVLLLEIVS  248 (369)
Q Consensus       171 ~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslG~il~~l~t  248 (369)
                       ++||||||+||+++.++.++|+|||++.......     ....+++.|+|||++.+  ..++.++|||||||++|+|++
T Consensus       215 -ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ellt  288 (371)
T 3q60_A          215 -LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRG-----PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWC  288 (371)
T ss_dssp             -EEETTCSGGGEEECTTSCEEECCGGGEEETTCEE-----EGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHH
T ss_pred             -CccCcCCHHHEEECCCCCEEEEecceeeecCCCc-----cCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHh
Confidence             9999999999999999999999999998654221     13356699999999987  679999999999999999999


Q ss_pred             CCCCCCCCcccccccchhhhhhhhcCccccccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 017594          249 GKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVS  320 (369)
Q Consensus       249 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~  320 (369)
                      |..||.............  .............+.      ...++..+.+||.+||+.||++|||+.++++
T Consensus       289 g~~Pf~~~~~~~~~~~~~--~~~~~~~~~~~~~~~------~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  352 (371)
T 3q60_A          289 LFLPFGLVTPGIKGSWKR--PSLRVPGTDSLAFGS------CTPLPDFVKTLIGRFLNFDRRRRLLPLEAME  352 (371)
T ss_dssp             SSCSTTBCCTTCTTCCCB--CCTTSCCCCSCCCTT------SSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred             CCCCCCCcCcccccchhh--hhhhhccccccchhh------ccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            999997553221110000  000000000000000      0122567999999999999999999999984

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=2.3e-40  Score=313.78  Aligned_cols=270  Identities=21%  Similarity=0.303  Sum_probs=182.3

Q ss_pred             HHhcCCcc-CccccccCCccEEEEEEc---CCCEEEEEEecCCCchhHHHHHHHHHHHhcCCCCceeeeeeeEEe--CCc
Q 017594           46 TATNKFSD-ANKLGEGGFGPVYKGVLK---KGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCID--RDE  119 (369)
Q Consensus        46 ~~~~~y~i-~~~lg~G~~~~v~~~~~~---~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~  119 (369)
                      ...+.|++ .++||+|+||.||+|+.+   +++.||+|++.....  ...+.+|+.+++.++||||+++++++..  ...
T Consensus        17 ~~~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~   94 (405)
T 3rgf_A           17 RVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRK   94 (405)
T ss_dssp             CHHHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC--CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTE
T ss_pred             hhhhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC--CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCe
Confidence            34566777 458999999999999965   478899999975432  2567889999999999999999999964  567


Q ss_pred             cEEEEEecCCCChhhhhcCC------CccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEE----eCCCc
Q 017594          120 KILIYEYMPNKSLDFFLFDP------TKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILL----DKDMN  189 (369)
Q Consensus       120 ~~lv~e~~~~~~L~~~l~~~------~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv----~~~~~  189 (369)
                      .++||||+.+ +|.+++...      .....+++..++.++.||+.||.|||+.+   ++||||||+||++    +.++.
T Consensus        95 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~  170 (405)
T 3rgf_A           95 VWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGR  170 (405)
T ss_dssp             EEEEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTTC
T ss_pred             EEEEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCCc
Confidence            8999999976 555555321      12234889999999999999999999999   9999999999999    67789


Q ss_pred             eEEeecCCceecCCCCcc-cccccccccccccCchhhccC-CCCcccchHhHHHHHHHHHhCCCCCCCCccccccc----
Q 017594          190 PKISDFGMARICGGNELQ-ANTSRIVGTYGYMSPEYALEG-IFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNL----  263 (369)
Q Consensus       190 ~~L~Dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~----  263 (369)
                      ++|+|||++..+...... .......|++.|+|||++.+. .++.++|||||||++|+|++|.+||.....+....    
T Consensus       171 ~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~  250 (405)
T 3rgf_A          171 VKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYH  250 (405)
T ss_dssp             EEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCC
T ss_pred             EEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccch
Confidence            999999999876533211 222345789999999998874 58999999999999999999999996543211000    


Q ss_pred             ---chhhhhhhhc--CccccccCc----------ccccc---ccHH--------HHHHHHHHHHHHhhcCCCCCCCCHHH
Q 017594          264 ---LGYAWDLWTS--NRTLELIDP----------ILEDE---YSSK--------QMLLRYANIALLCVQESADDRPTMND  317 (369)
Q Consensus       264 ---~~~~~~~~~~--~~~~~~~~~----------~~~~~---~~~~--------~~~~~l~~li~~~L~~dP~~Rps~~e  317 (369)
                         ..........  ......+..          .....   ....        ..+..+.+||.+||+.||++|||+.+
T Consensus       251 ~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e  330 (405)
T 3rgf_A          251 HDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQ  330 (405)
T ss_dssp             HHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHH
T ss_pred             HHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHH
Confidence               0000000000  000000000          00000   0000        00456889999999999999999999


Q ss_pred             HHHH
Q 017594          318 VVSM  321 (369)
Q Consensus       318 ll~~  321 (369)
                      +++.
T Consensus       331 ~L~h  334 (405)
T 3rgf_A          331 AMQD  334 (405)
T ss_dssp             HHTS
T ss_pred             HhcC
Confidence            9973

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=1.3e-39  Score=294.25  Aligned_cols=254  Identities=24%  Similarity=0.304  Sum_probs=202.1

Q ss_pred             HHHHhcCCccCccccccCCccEEEEEEc-CCCEEEEEEecCCC--chhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCcc
Q 017594           44 VSTATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS--GQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEK  120 (369)
Q Consensus        44 ~~~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~  120 (369)
                      .....++|++.+.||+|++|.||+|++. +++.|++|++....  ......+.+|+.+++.++||||+++++++......
T Consensus        17 ~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   96 (287)
T 2wei_A           17 QGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSF   96 (287)
T ss_dssp             THHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred             HHHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeE
Confidence            4567789999999999999999999976 58999999986432  23457788999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCC---CceEEeecCC
Q 017594          121 ILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKD---MNPKISDFGM  197 (369)
Q Consensus       121 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~---~~~~L~Dfg~  197 (369)
                      ++|+|++.+++|.+.+..   ...+++..++.++.||+.||.+||+.+   ++|+||+|+||+++.+   +.++|+|||+
T Consensus        97 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~  170 (287)
T 2wei_A           97 YIVGELYTGGELFDEIIK---RKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGL  170 (287)
T ss_dssp             EEEECCCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECSTTG
T ss_pred             EEEEEccCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEEeccCc
Confidence            999999999999887743   234899999999999999999999999   9999999999999654   4699999999


Q ss_pred             ceecCCCCcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCccc
Q 017594          198 ARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTL  277 (369)
Q Consensus       198 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  277 (369)
                      +........   .....+++.|+|||++.+ .++.++||||||+++|+|++|..||.......     ............
T Consensus       171 ~~~~~~~~~---~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-----~~~~~~~~~~~~  241 (287)
T 2wei_A          171 STCFQQNTK---MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYD-----ILKRVETGKYAF  241 (287)
T ss_dssp             GGTBCCCSS---CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-----HHHHHHHCCCCC
T ss_pred             ceeecCCCc---cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHH-----HHHHHHcCCCCC
Confidence            876543321   222357889999998865 48999999999999999999999986433111     111111110000


Q ss_pred             cccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 017594          278 ELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVS  320 (369)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~  320 (369)
                      .     .   .....++.++.++|.+||+.||++|||+.++++
T Consensus       242 ~-----~---~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  276 (287)
T 2wei_A          242 D-----L---PQWRTISDDAKDLIRKMLTFHPSLRITATQCLE  276 (287)
T ss_dssp             C-----S---GGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             C-----c---hhhhhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence            0     0   001122567999999999999999999999997

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=5.7e-40  Score=305.04  Aligned_cols=275  Identities=20%  Similarity=0.232  Sum_probs=205.7

Q ss_pred             CCCccccchhhHHHHhcCCccCccccccCCccEEEEEEcC-C-CEEEEEEecCCCchhHHHHHHHHHHHhcCCCCc----
Q 017594           33 VDQFPLFSFSSVSTATNKFSDANKLGEGGFGPVYKGVLKK-G-DEIAVKRLSGRSGQGLREMKNEASVIAKVQHKN----  106 (369)
Q Consensus        33 ~~~~~~~~~~~~~~~~~~y~i~~~lg~G~~~~v~~~~~~~-~-~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~----  106 (369)
                      ++....+.+.....+.++|++.+.||+|+||.||+|++.. + ..||+|++... ....+.+..|+.+++.++|++    
T Consensus         3 ~~~~~~~~~~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~   81 (355)
T 2eu9_A            3 DDKEGHLVCRIGDWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENK   81 (355)
T ss_dssp             BCTTSCBCCCTTCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSC
T ss_pred             cccCCCcccccCceecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCc
Confidence            4455566777777888999999999999999999999754 4 68999998743 334567778999999887654    


Q ss_pred             --eeeeeeeEEeCCccEEEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEE
Q 017594          107 --LVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILL  184 (369)
Q Consensus       107 --i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv  184 (369)
                        ++.+.+++......++|||++.+ ++.+.+... ....+++..++.++.||+.||.|||+++   ++||||||+||++
T Consensus        82 ~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll  156 (355)
T 2eu9_A           82 FLCVLMSDWFNFHGHMCIAFELLGK-NTFEFLKEN-NFQPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILF  156 (355)
T ss_dssp             SCBCCEEEEEEETTEEEEEEECCCC-BHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEE
T ss_pred             eeEEEeeeeeeeCCeEEEEEeccCC-ChHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEE
Confidence              88999999999999999999955 454444332 2234889999999999999999999999   9999999999999


Q ss_pred             -------------------eCCCceEEeecCCceecCCCCcccccccccccccccCchhhccCCCCcccchHhHHHHHHH
Q 017594          185 -------------------DKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLE  245 (369)
Q Consensus       185 -------------------~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~  245 (369)
                                         +.++.++|+|||++......     .....+++.|+|||++.+..++.++|||||||++|+
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~e  231 (355)
T 2eu9_A          157 VNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEH-----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFE  231 (355)
T ss_dssp             SCCCEEEEECCC-CCCEEEESCCCEEECCCTTCEETTSC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHH
T ss_pred             ecccccccccccccccccccCCCcEEEeecCcccccccc-----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHH
Confidence                               67889999999998764322     233468999999999999999999999999999999


Q ss_pred             HHhCCCCCCCCcccccccchhhhhhh--------hcCccc---------------------cccCccccccccHHHHHHH
Q 017594          246 IVSGKKNTGLYRTDSLNLLGYAWDLW--------TSNRTL---------------------ELIDPILEDEYSSKQMLLR  296 (369)
Q Consensus       246 l~tg~~p~~~~~~~~~~~~~~~~~~~--------~~~~~~---------------------~~~~~~~~~~~~~~~~~~~  296 (369)
                      |++|..||.........  .......        ......                     ....+...........+.+
T Consensus       232 l~~g~~pf~~~~~~~~~--~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (355)
T 2eu9_A          232 YYRGFTLFQTHENREHL--VMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQ  309 (355)
T ss_dssp             HHHSSCSCCCSSHHHHH--HHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHH
T ss_pred             HHhCCCCCCCCCHHHHH--HHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHH
Confidence            99999999754321100  0000000        000000                     0000000000111223567


Q ss_pred             HHHHHHHhhcCCCCCCCCHHHHHH
Q 017594          297 YANIALLCVQESADDRPTMNDVVS  320 (369)
Q Consensus       297 l~~li~~~L~~dP~~Rps~~ell~  320 (369)
                      +.+||.+||+.||++|||+.++++
T Consensus       310 l~~li~~~L~~dP~~Rpt~~e~l~  333 (355)
T 2eu9_A          310 LFDLMRRMLEFDPAQRITLAEALL  333 (355)
T ss_dssp             HHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             HHHHHHHHhcCChhhCcCHHHHhc
Confidence            999999999999999999999985

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=1.3e-39  Score=302.80  Aligned_cols=265  Identities=22%  Similarity=0.268  Sum_probs=197.6

Q ss_pred             HHhcCCccCccccccCCccEEEEEEc-CCCEEEEEEecCCC-chhHHHHHHHHHHHhcCCCCceeeeeeeEEeC-----C
Q 017594           46 TATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCCIDR-----D  118 (369)
Q Consensus        46 ~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~  118 (369)
                      .+.++|++.+.||+|+||.||+|++. +|+.||+|++.... ......+.+|+.+++.++||||+++++++...     .
T Consensus         8 ~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   87 (353)
T 2b9h_A            8 NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFN   87 (353)
T ss_dssp             CSCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCC
T ss_pred             ccccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccc
Confidence            35689999999999999999999976 48899999996443 33445677899999999999999999987654     5


Q ss_pred             ccEEEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCc
Q 017594          119 EKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMA  198 (369)
Q Consensus       119 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~  198 (369)
                      ..++|+|++. ++|.+++..    ..+++..++.++.||+.||.|||++|   ++||||||+||+++.++.++|+|||++
T Consensus        88 ~~~lv~e~~~-~~L~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a  159 (353)
T 2b9h_A           88 EVYIIQELMQ-TDLHRVIST----QMLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLA  159 (353)
T ss_dssp             CEEEEECCCS-EEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTC
T ss_pred             eEEEEEeccC-ccHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEEEecccc
Confidence            6899999997 478777743    34889999999999999999999999   999999999999999999999999999


Q ss_pred             eecCCCCccc--------ccccccccccccCchhhcc-CCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhh
Q 017594          199 RICGGNELQA--------NTSRIVGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWD  269 (369)
Q Consensus       199 ~~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~  269 (369)
                      ..........        ......|++.|+|||++.+ ..++.++|||||||++|+|++|..||.........  .....
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~--~~~~~  237 (353)
T 2b9h_A          160 RIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQL--LLIFG  237 (353)
T ss_dssp             EECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH--HHHHH
T ss_pred             cccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHH--HHHHH
Confidence            8765332111        1122467899999998764 67899999999999999999999999754311100  00000


Q ss_pred             hhhcC---ccc---------cc---cCccccc--cccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 017594          270 LWTSN---RTL---------EL---IDPILED--EYSSKQMLLRYANIALLCVQESADDRPTMNDVVS  320 (369)
Q Consensus       270 ~~~~~---~~~---------~~---~~~~~~~--~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~  320 (369)
                      .....   ...         +.   +......  ......++.++.++|.+||+.||++|||+.++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  305 (353)
T 2b9h_A          238 IIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE  305 (353)
T ss_dssp             HHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence            00000   000         00   0000000  0001123567899999999999999999999997

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=3e-40  Score=314.29  Aligned_cols=262  Identities=21%  Similarity=0.284  Sum_probs=191.0

Q ss_pred             HhcCCccCccccccCCccEEEEEEc-CCCEEEEEEecCCCchhHHHHHHHHHHHhcCCCCceeeeeeeEEeC------Cc
Q 017594           47 ATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDR------DE  119 (369)
Q Consensus        47 ~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~~  119 (369)
                      ...+|++.+.||+|+||.||+|++. +|+.||||++.....    ...+|+++++.++||||+++++++...      ..
T Consensus        52 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~  127 (420)
T 1j1b_A           52 QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY  127 (420)
T ss_dssp             EEEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEE
T ss_pred             ccceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccCCCCccee
Confidence            3457999999999999999999976 489999999865432    234699999999999999999988542      12


Q ss_pred             cEEEEEecCCCChhhhhcC-CCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCC-CceEEeecCC
Q 017594          120 KILIYEYMPNKSLDFFLFD-PTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKD-MNPKISDFGM  197 (369)
Q Consensus       120 ~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~-~~~~L~Dfg~  197 (369)
                      .++||||+.++ +...+.. ......+++..++.++.||+.||.|||+++   ++||||||+||+++.+ +.++|+|||+
T Consensus       128 ~~lv~e~~~~~-l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~kl~DFG~  203 (420)
T 1j1b_A          128 LNLVLDYVPET-VYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGS  203 (420)
T ss_dssp             EEEEEECCCEE-HHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred             EEeehhccccc-HHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeEEeccchh
Confidence            57999999864 4444321 122345889999999999999999999999   9999999999999965 5689999999


Q ss_pred             ceecCCCCcccccccccccccccCchhhccC-CCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhh-------h
Q 017594          198 ARICGGNELQANTSRIVGTYGYMSPEYALEG-IFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAW-------D  269 (369)
Q Consensus       198 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~-------~  269 (369)
                      +........   .....+++.|+|||++.+. .++.++|||||||++|+|++|+.||........ ......       .
T Consensus       204 a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~-l~~i~~~lg~p~~~  279 (420)
T 1j1b_A          204 AKQLVRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQ-LVEIIKVLGTPTRE  279 (420)
T ss_dssp             CEECCTTCC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHHHCSCCHH
T ss_pred             hhhcccCCC---ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHhCCCCHH
Confidence            987643322   2234679999999998764 789999999999999999999999975432110 000000       0


Q ss_pred             hhh--cCccccccCcccccc-c---cHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 017594          270 LWT--SNRTLELIDPILEDE-Y---SSKQMLLRYANIALLCVQESADDRPTMNDVVS  320 (369)
Q Consensus       270 ~~~--~~~~~~~~~~~~~~~-~---~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~  320 (369)
                      .+.  .........+.+... .   .....+.++.+||.+||+.||.+||++.++++
T Consensus       280 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~  336 (420)
T 1j1b_A          280 QIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA  336 (420)
T ss_dssp             HHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence            000  000000000000000 0   01122567999999999999999999999985

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=5.1e-40  Score=313.48  Aligned_cols=204  Identities=22%  Similarity=0.289  Sum_probs=172.2

Q ss_pred             hHHHHhcCCccCccccccCCccEEEEEEcC-CCEEEEEEecCCCchhHHHHHHHHHHHhcC------CCCceeeeeeeEE
Q 017594           43 SVSTATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLREMKNEASVIAKV------QHKNLVRLLGCCI  115 (369)
Q Consensus        43 ~~~~~~~~y~i~~~lg~G~~~~v~~~~~~~-~~~valK~~~~~~~~~~~~~~~e~~~l~~l------~h~~i~~~~~~~~  115 (369)
                      .......+|++.+.||+|+||.||+|.+.. ++.||+|++... ......+..|+.+++.+      .|+||+++++++.
T Consensus        91 ~~~~~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~  169 (429)
T 3kvw_A           91 PHDHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFT  169 (429)
T ss_dssp             TTCEETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEE
T ss_pred             CCCcccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecc
Confidence            345567889999999999999999999765 889999999754 23345667788877776      5779999999999


Q ss_pred             eCCccEEEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCc--eEEe
Q 017594          116 DRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMN--PKIS  193 (369)
Q Consensus       116 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~--~~L~  193 (369)
                      .....++|||++. ++|.+++.... ...+++..++.++.||+.||+|||+.+   ++||||||+||+++.++.  ++|+
T Consensus       170 ~~~~~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~vkL~  244 (429)
T 3kvw_A          170 FRNHICMTFELLS-MNLYELIKKNK-FQGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVI  244 (429)
T ss_dssp             ETTEEEEEECCCC-CBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCEEEC
T ss_pred             cCCeEEEEEeccC-CCHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcceEEe
Confidence            9999999999996 57777775432 234889999999999999999999999   999999999999999887  9999


Q ss_pred             ecCCceecCCCCcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCc
Q 017594          194 DFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYR  257 (369)
Q Consensus       194 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~  257 (369)
                      |||++......     .....+++.|+|||++.+..++.++|||||||++|+|++|.+||....
T Consensus       245 DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~  303 (429)
T 3kvw_A          245 DFGSSCYEHQR-----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGED  303 (429)
T ss_dssp             CCTTCEETTCC-----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             ecccceecCCc-----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCC
Confidence            99998764432     223467899999999999999999999999999999999999997543

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=1.2e-39  Score=296.08  Aligned_cols=253  Identities=23%  Similarity=0.346  Sum_probs=190.7

Q ss_pred             HhcCCccCccccccCCccEEEEEEc-CCCEEEEEEecCCCchhHHHHHHHHHHHhcCCCCceeeeeeeEEe---------
Q 017594           47 ATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCID---------  116 (369)
Q Consensus        47 ~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---------  116 (369)
                      ..++|++.+.||+|+||.||+|++. +|+.||+|++... ......+.+|+.+++.++||||+++++++.+         
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   82 (303)
T 1zy4_A            4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT   82 (303)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred             ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence            4678999999999999999999975 5899999998643 3445778899999999999999999998865         


Q ss_pred             ----CCccEEEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEE
Q 017594          117 ----RDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKI  192 (369)
Q Consensus       117 ----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L  192 (369)
                          ....++||||+.+++|.+++...  ...+++..++.++.||+.||+|||+++   ++|+||+|+||+++.++.++|
T Consensus        83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~~~~~kl  157 (303)
T 1zy4_A           83 AVKKKSTLFIQMEYCENGTLYDLIHSE--NLNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKI  157 (303)
T ss_dssp             ---CEEEEEEEEECCCSCBHHHHHHHS--CGGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEE
T ss_pred             ccccCCceEEEEecCCCCCHHHhhhcc--ccccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcCCCCEEE
Confidence                34579999999999999998642  234778899999999999999999999   999999999999999999999


Q ss_pred             eecCCceecCCCCc------------ccccccccccccccCchhhccC-CCCcccchHhHHHHHHHHHhCCCCCCCCccc
Q 017594          193 SDFGMARICGGNEL------------QANTSRIVGTYGYMSPEYALEG-IFSIKSDVFSFGVLLLEIVSGKKNTGLYRTD  259 (369)
Q Consensus       193 ~Dfg~~~~~~~~~~------------~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~tg~~p~~~~~~~  259 (369)
                      +|||++........            ........+++.|+|||++.+. .++.++|||||||++|+|++   ||......
T Consensus       158 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~  234 (303)
T 1zy4_A          158 GDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMER  234 (303)
T ss_dssp             CCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHH
T ss_pred             eeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhH
Confidence            99999876543210            1112234578999999998764 68999999999999999998   44321100


Q ss_pred             ccccchhhhhhhhcCccccccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 017594          260 SLNLLGYAWDLWTSNRTLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVS  320 (369)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~  320 (369)
                      .    ... ......  .....+...     ...+..+.++|.+||+.||.+|||+.++++
T Consensus       235 ~----~~~-~~~~~~--~~~~~~~~~-----~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  283 (303)
T 1zy4_A          235 V----NIL-KKLRSV--SIEFPPDFD-----DNKMKVEKKIIRLLIDHDPNKRPGARTLLN  283 (303)
T ss_dssp             H----HHH-HHHHST--TCCCCTTCC-----TTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             H----HHH-Hhcccc--ccccCcccc-----ccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence            0    000 000000  000111111     112456899999999999999999999997

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=1.2e-39  Score=301.31  Aligned_cols=254  Identities=19%  Similarity=0.230  Sum_probs=174.7

Q ss_pred             HHhcCCccCc-cccccCCccEEEEEEc-CCCEEEEEEecCCCchhHHHHHHHHHHHhcCCCCceeeeeeeEEe----CCc
Q 017594           46 TATNKFSDAN-KLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCID----RDE  119 (369)
Q Consensus        46 ~~~~~y~i~~-~lg~G~~~~v~~~~~~-~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~  119 (369)
                      ...++|++.+ .||+|+||.||+|+++ +|+.||+|++....    .........++.+.||||+++++++..    ...
T Consensus        25 ~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~  100 (336)
T 3fhr_A           25 AVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP----KARQEVDHHWQASGGPHIVCILDVYENMHHGKRC  100 (336)
T ss_dssp             CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH----HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred             cccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH----HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCce
Confidence            4568999965 6999999999999976 58999999986432    222333445667799999999999876    345


Q ss_pred             cEEEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeC---CCceEEeecC
Q 017594          120 KILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDK---DMNPKISDFG  196 (369)
Q Consensus       120 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~---~~~~~L~Dfg  196 (369)
                      .++||||+.+++|.+++.... ...+++..++.++.||+.||.|||+.|   ++||||||+||+++.   ++.++|+|||
T Consensus       101 ~~lv~e~~~gg~L~~~l~~~~-~~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~~kl~Dfg  176 (336)
T 3fhr_A          101 LLIIMECMEGGELFSRIQERG-DQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFG  176 (336)
T ss_dssp             EEEEEECCTTEEHHHHHHTC--CCCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCT
T ss_pred             EEEEEeccCCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCceEEEeccc
Confidence            799999999999999986543 245899999999999999999999999   999999999999976   4559999999


Q ss_pred             CceecCCCCcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCcc
Q 017594          197 MARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRT  276 (369)
Q Consensus       197 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  276 (369)
                      ++.......    .....+++.|+|||++.+..++.++||||||+++|+|++|..||...........  ........ .
T Consensus       177 ~~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~--~~~~~~~~-~  249 (336)
T 3fhr_A          177 FAKETTQNA----LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPG--MKRRIRLG-Q  249 (336)
T ss_dssp             TCEEC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-----------------------
T ss_pred             cceeccccc----cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhh--HHHhhhcc-c
Confidence            998654322    2334678999999999888999999999999999999999999864432211000  00000000 0


Q ss_pred             ccccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 017594          277 LELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVS  320 (369)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~  320 (369)
                      .....+      ....++..+.++|.+||+.||++|||+.++++
T Consensus       250 ~~~~~~------~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  287 (336)
T 3fhr_A          250 YGFPNP------EWSEVSEDAKQLIRLLLKTDPTERLTITQFMN  287 (336)
T ss_dssp             -CCCTT------TSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             cccCch------hhccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            000000      00122567999999999999999999999997

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=1.7e-39  Score=323.46  Aligned_cols=252  Identities=26%  Similarity=0.372  Sum_probs=197.6

Q ss_pred             ccccccCCccEEEEEEc---CCCEEEEEEecCCC--chhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEEEEecCC
Q 017594           55 NKLGEGGFGPVYKGVLK---KGDEIAVKRLSGRS--GQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIYEYMPN  129 (369)
Q Consensus        55 ~~lg~G~~~~v~~~~~~---~~~~valK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~  129 (369)
                      +.||+|+||.||+|.+.   .+..||+|++....  ....+.+.+|+.+++.++||||+++++++. .+..++||||+.+
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-~~~~~lv~E~~~~  453 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAEL  453 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEE-SSSEEEEEECCTT
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCCEEEEEEccCC
Confidence            47999999999999753   36789999987532  233578899999999999999999999986 4568999999999


Q ss_pred             CChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCCCCcc-c
Q 017594          130 KSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQ-A  208 (369)
Q Consensus       130 ~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~~~~~-~  208 (369)
                      ++|.+++..   ...+++..++.++.||+.||+|||+++   ++||||||+||+++.++.++|+|||++..+...... .
T Consensus       454 g~L~~~l~~---~~~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~  527 (635)
T 4fl3_A          454 GPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK  527 (635)
T ss_dssp             EEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC------
T ss_pred             CCHHHHHhh---CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccc
Confidence            999999853   344889999999999999999999999   999999999999999999999999999876533221 1


Q ss_pred             ccccccccccccCchhhccCCCCcccchHhHHHHHHHHHh-CCCCCCCCcccccccchhhhhhhhcCccccccCcccccc
Q 017594          209 NTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDE  287 (369)
Q Consensus       209 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  287 (369)
                      ......++..|+|||++.+..++.++|||||||++|+|++ |..||.......      .............        
T Consensus       528 ~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~------~~~~i~~~~~~~~--------  593 (635)
T 4fl3_A          528 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE------VTAMLEKGERMGC--------  593 (635)
T ss_dssp             -------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH------HHHHHHTTCCCCC--------
T ss_pred             cccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH------HHHHHHcCCCCCC--------
Confidence            1222345678999999999999999999999999999998 999986543211      1111111111000        


Q ss_pred             ccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHhhhhcc
Q 017594          288 YSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNEAATL  329 (369)
Q Consensus       288 ~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L~~~~~~~  329 (369)
                        +..++.++.++|.+||+.||++||++.+|++.|+.+..++
T Consensus       594 --p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~l  633 (635)
T 4fl3_A          594 --PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV  633 (635)
T ss_dssp             --CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred             --CCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence              1122567999999999999999999999999999876543

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=4.1e-40  Score=301.07  Aligned_cols=246  Identities=21%  Similarity=0.355  Sum_probs=189.0

Q ss_pred             hhHHHHhcCCccCccccccCCccEEEEEEc-CCCEEEEEEecCCCch------hHHHHHHHHHHHhcC----CCCceeee
Q 017594           42 SSVSTATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSGQ------GLREMKNEASVIAKV----QHKNLVRL  110 (369)
Q Consensus        42 ~~~~~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~~~~------~~~~~~~e~~~l~~l----~h~~i~~~  110 (369)
                      +......++|++.+.||+|+||.||+|++. +|+.||+|++......      ....+..|+.++.++    +|+||+++
T Consensus        24 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~  103 (312)
T 2iwi_A           24 KDREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRL  103 (312)
T ss_dssp             ---------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCE
T ss_pred             cchhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeE
Confidence            445677899999999999999999999964 5889999999754321      122345688888888    89999999


Q ss_pred             eeeEEeCCccEEEEEe-cCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEe-CCC
Q 017594          111 LGCCIDRDEKILIYEY-MPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLD-KDM  188 (369)
Q Consensus       111 ~~~~~~~~~~~lv~e~-~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~-~~~  188 (369)
                      ++++...+..++|+|+ +.+++|.+++..   ...+++..++.++.||+.||.|||+.+   ++||||+|+||+++ .++
T Consensus       104 ~~~~~~~~~~~~v~e~~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~  177 (312)
T 2iwi_A          104 LDWFETQEGFMLVLERPLPAQDLFDYITE---KGPLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRG  177 (312)
T ss_dssp             EEEC-----CEEEEECCSSEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEETTTT
T ss_pred             EEEEecCCeEEEEEEecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeCCCC
Confidence            9999999999999999 788999998854   335899999999999999999999999   99999999999999 889


Q ss_pred             ceEEeecCCceecCCCCcccccccccccccccCchhhccCCC-CcccchHhHHHHHHHHHhCCCCCCCCcccccccchhh
Q 017594          189 NPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIF-SIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYA  267 (369)
Q Consensus       189 ~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~  267 (369)
                      .++|+|||++.......    .....++..|+|||++.+..+ +.++||||||+++|+|++|..||.....         
T Consensus       178 ~~kl~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~---------  244 (312)
T 2iwi_A          178 CAKLIDFGSGALLHDEP----YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE---------  244 (312)
T ss_dssp             EEEECCCSSCEECCSSC----BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH---------
T ss_pred             eEEEEEcchhhhcccCc----ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH---------
Confidence            99999999988765432    233468899999999877665 4589999999999999999999863210         


Q ss_pred             hhhhhcCccccccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 017594          268 WDLWTSNRTLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVS  320 (369)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~  320 (369)
                        .....  ..     +.     ..++..+.++|.+||+.||++|||+.++++
T Consensus       245 --~~~~~--~~-----~~-----~~~~~~~~~li~~~l~~~p~~Rps~~e~l~  283 (312)
T 2iwi_A          245 --ILEAE--LH-----FP-----AHVSPDCCALIRRCLAPKPSSRPSLEEILL  283 (312)
T ss_dssp             --HHHTC--CC-----CC-----TTSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             --Hhhhc--cC-----Cc-----ccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence              00000  00     00     112566899999999999999999999997

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=3.8e-39  Score=296.36  Aligned_cols=265  Identities=23%  Similarity=0.315  Sum_probs=195.7

Q ss_pred             HHhcCCccCccccccCCccEEEEEEc--CCCEEEEEEecCCC--chhHHHHHHHHHHHhcC---CCCceeeeeeeEE---
Q 017594           46 TATNKFSDANKLGEGGFGPVYKGVLK--KGDEIAVKRLSGRS--GQGLREMKNEASVIAKV---QHKNLVRLLGCCI---  115 (369)
Q Consensus        46 ~~~~~y~i~~~lg~G~~~~v~~~~~~--~~~~valK~~~~~~--~~~~~~~~~e~~~l~~l---~h~~i~~~~~~~~---  115 (369)
                      ...++|++.+.||+|+||.||+|++.  +|+.||+|++....  ......+.+|+.+++.+   .||||+++++++.   
T Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~   87 (326)
T 1blx_A            8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR   87 (326)
T ss_dssp             CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred             CchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecc
Confidence            35689999999999999999999973  57889999886332  11123455666666655   8999999999987   


Q ss_pred             --eCCccEEEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEe
Q 017594          116 --DRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKIS  193 (369)
Q Consensus       116 --~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~  193 (369)
                        .....++|+|++. ++|.+++.... ...+++..++.++.||+.||.|||+.|   ++|+||+|+||+++.++.++|+
T Consensus        88 ~~~~~~~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~~~~kl~  162 (326)
T 1blx_A           88 TDRETKLTLVFEHVD-QDLTTYLDKVP-EPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLA  162 (326)
T ss_dssp             CSSEEEEEEEEECCS-CBHHHHHHHSC-TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEEC
T ss_pred             cCCCceEEEEEecCC-CCHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCCCCEEEe
Confidence              4567899999998 58888875432 234889999999999999999999999   9999999999999999999999


Q ss_pred             ecCCceecCCCCcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhh-
Q 017594          194 DFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWT-  272 (369)
Q Consensus       194 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~-  272 (369)
                      |||++.......   ......++..|+|||++.+..++.++||||||+++|+|++|..||.........  ........ 
T Consensus       163 Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~--~~i~~~~~~  237 (326)
T 1blx_A          163 DFGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQL--GKILDVIGL  237 (326)
T ss_dssp             SCCSCCCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH--HHHHHHHCC
T ss_pred             cCcccccccCCC---CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHH--HHHHHHcCC
Confidence            999987654221   223356789999999999889999999999999999999999999754321100  00000000 


Q ss_pred             --cCcc-------ccccCccccc--cccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 017594          273 --SNRT-------LELIDPILED--EYSSKQMLLRYANIALLCVQESADDRPTMNDVVS  320 (369)
Q Consensus       273 --~~~~-------~~~~~~~~~~--~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~  320 (369)
                        ....       ..........  ......++..+.+||.+||+.||++|||+.++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  296 (326)
T 1blx_A          238 PGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  296 (326)
T ss_dssp             CCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             CCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence              0000       0000000000  0001122567899999999999999999999995

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=2.1e-40  Score=304.32  Aligned_cols=249  Identities=22%  Similarity=0.332  Sum_probs=197.7

Q ss_pred             cchhhHHHHhcCCccCccccccCCccEEEEEEc-CCCEEEEEEecCCCch------hHHHHHHHHHHHhcCC--CCceee
Q 017594           39 FSFSSVSTATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSGQ------GLREMKNEASVIAKVQ--HKNLVR  109 (369)
Q Consensus        39 ~~~~~~~~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~~~~------~~~~~~~e~~~l~~l~--h~~i~~  109 (369)
                      ..........++|++.+.||+|+||.||+|++. +|+.||+|++......      ....+..|+.+++.+.  |+|+++
T Consensus        33 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~  112 (320)
T 3a99_A           33 APGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIR  112 (320)
T ss_dssp             -------CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCC
T ss_pred             CcccccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceE
Confidence            345556677899999999999999999999965 4888999998644211      1234567899999996  599999


Q ss_pred             eeeeEEeCCccEEEEEecCC-CChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEe-CC
Q 017594          110 LLGCCIDRDEKILIYEYMPN-KSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLD-KD  187 (369)
Q Consensus       110 ~~~~~~~~~~~~lv~e~~~~-~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~-~~  187 (369)
                      +++++...+..++++|++.+ ++|.+++..   ...+++..++.++.||+.||.|||+.+   ++||||||+||+++ .+
T Consensus       113 ~~~~~~~~~~~~lv~e~~~~~~~L~~~l~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~  186 (320)
T 3a99_A          113 LLDWFERPDSFVLILERPEPVQDLFDFITE---RGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNR  186 (320)
T ss_dssp             EEEEEECSSEEEEEEECCSSEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTT
T ss_pred             EEEEEecCCcEEEEEEcCCCCccHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeCCC
Confidence            99999999999999999976 889888853   345899999999999999999999999   99999999999999 78


Q ss_pred             CceEEeecCCceecCCCCcccccccccccccccCchhhccCCC-CcccchHhHHHHHHHHHhCCCCCCCCcccccccchh
Q 017594          188 MNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIF-SIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGY  266 (369)
Q Consensus       188 ~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~  266 (369)
                      +.++|+|||++.......    .....+++.|+|||++.+..+ +.++||||||+++|+|++|..||.....        
T Consensus       187 ~~~kL~Dfg~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~--------  254 (320)
T 3a99_A          187 GELKLIDFGSGALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE--------  254 (320)
T ss_dssp             TEEEECCCTTCEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH--------
T ss_pred             CCEEEeeCcccccccccc----ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh--------
Confidence            899999999998765332    223468999999999887665 7889999999999999999999863210        


Q ss_pred             hhhhhhcCccccccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 017594          267 AWDLWTSNRTLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVS  320 (369)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~  320 (369)
                         ......   .    ...     .++.++.++|.+||+.||++|||+.++++
T Consensus       255 ---~~~~~~---~----~~~-----~~~~~~~~li~~~l~~dp~~Rps~~~ll~  293 (320)
T 3a99_A          255 ---IIRGQV---F----FRQ-----RVSSECQHLIRWCLALRPSDRPTFEEIQN  293 (320)
T ss_dssp             ---HHHCCC---C----CSS-----CCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ---hhcccc---c----ccc-----cCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence               000000   0    001     12566899999999999999999999987

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=1.7e-39  Score=302.23  Aligned_cols=255  Identities=21%  Similarity=0.304  Sum_probs=193.1

Q ss_pred             hcCCccCccccccCCccEEEEEEc-CCCEEEEEEecCCC--chhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCc-----
Q 017594           48 TNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS--GQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDE-----  119 (369)
Q Consensus        48 ~~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-----  119 (369)
                      .++|.+.+.||+|+||.||+|+++ +|+.||+|++....  ......+.+|+.+++.++||||+++++++.....     
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  102 (353)
T 3coi_A           23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  102 (353)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence            578999999999999999999975 48899999986542  2335677889999999999999999999987654     


Q ss_pred             -cEEEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCc
Q 017594          120 -KILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMA  198 (369)
Q Consensus       120 -~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~  198 (369)
                       .++|||++. ++|..++.     ..+++..++.++.||+.||.|||++|   ++||||||+||+++.++.++|+|||++
T Consensus       103 ~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~  173 (353)
T 3coi_A          103 DFYLVMPFMQ-TDLQKIMG-----LKFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLA  173 (353)
T ss_dssp             CCEEEEECCS-EEGGGTTT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEEECSTTCT
T ss_pred             eEEEEecccc-CCHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEEEeecccc
Confidence             499999997 47766652     23889999999999999999999999   999999999999999999999999998


Q ss_pred             eecCCCCcccccccccccccccCchhhcc-CCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhh-----
Q 017594          199 RICGGNELQANTSRIVGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWT-----  272 (369)
Q Consensus       199 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~-----  272 (369)
                      ......     .....+++.|+|||++.+ ..++.++|||||||++|+|++|..||........  .........     
T Consensus       174 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~--~~~i~~~~~~~~~~  246 (353)
T 3coi_A          174 RHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQ--LTQILKVTGVPGTE  246 (353)
T ss_dssp             TC-------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHH--HHHHHHHHCBCCHH
T ss_pred             cCCCCC-----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHHhCCCCHH
Confidence            754322     223467899999999876 6789999999999999999999999975431110  000000000     


Q ss_pred             ------c-------CccccccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 017594          273 ------S-------NRTLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVS  320 (369)
Q Consensus       273 ------~-------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~  320 (369)
                            .       ..........+..  .....+..+.++|.+||+.||++|||+.++++
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  305 (353)
T 3coi_A          247 FVQKLNDKAAKSYIQSLPQTPRKDFTQ--LFPRASPQAADLLEKMLELDVDKRLTAAQALT  305 (353)
T ss_dssp             HHTTCSCHHHHHHHHTSCBCSSCCTTT--TCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             HHHHHhhHHHHHHHHhCcCCCCccHHH--hcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence                  0       0000000000000  01122667999999999999999999999986

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=6.2e-39  Score=320.58  Aligned_cols=262  Identities=21%  Similarity=0.311  Sum_probs=205.2

Q ss_pred             hHHHHhcCCccCccccccCCccEEEEEEcC----CCEEEEEEecCCC-chhHHHHHHHHHHHhcCCCCceeeeeeeEEeC
Q 017594           43 SVSTATNKFSDANKLGEGGFGPVYKGVLKK----GDEIAVKRLSGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCCIDR  117 (369)
Q Consensus        43 ~~~~~~~~y~i~~~lg~G~~~~v~~~~~~~----~~~valK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~  117 (369)
                      ......++|++.+.||+|+||.||+|++..    +..|++|.+.... ....+.+.+|+.+++.++||||+++++++. +
T Consensus       384 ~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~  462 (656)
T 2j0j_A          384 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-E  462 (656)
T ss_dssp             GTBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-S
T ss_pred             ccccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-c
Confidence            344556789999999999999999999643    4569999987543 334467889999999999999999999984 5


Q ss_pred             CccEEEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCC
Q 017594          118 DEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGM  197 (369)
Q Consensus       118 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~  197 (369)
                      +..++||||+.+++|.+++...  ...+++..++.++.||+.||.|||+++   ++||||||+||+++.++.++|+|||+
T Consensus       463 ~~~~lv~E~~~~g~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL~DFG~  537 (656)
T 2j0j_A          463 NPVWIIMELCTLGELRSFLQVR--KFSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGL  537 (656)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHT--TTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCC
T ss_pred             CceEEEEEcCCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEEEecCC
Confidence            6789999999999999998542  234889999999999999999999999   99999999999999999999999999


Q ss_pred             ceecCCCCcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHh-CCCCCCCCcccccccchhhhhhhhcCcc
Q 017594          198 ARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDLWTSNRT  276 (369)
Q Consensus       198 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  276 (369)
                      +........ .......+++.|+|||++.+..++.++||||||+++|+|++ |..||.......     ....... ...
T Consensus       538 a~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~-----~~~~i~~-~~~  610 (656)
T 2j0j_A          538 SRYMEDSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND-----VIGRIEN-GER  610 (656)
T ss_dssp             CCSCCC-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-----HHHHHHH-TCC
T ss_pred             CeecCCCcc-eeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHH-----HHHHHHc-CCC
Confidence            986643321 11223346778999999998899999999999999999997 999986433111     1111111 100


Q ss_pred             ccccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHhhhh
Q 017594          277 LELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNEAA  327 (369)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L~~~~~  327 (369)
                      ..     .     +..++..+.++|.+||+.||++|||+.+|++.|+.+..
T Consensus       611 ~~-----~-----~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~  651 (656)
T 2j0j_A          611 LP-----M-----PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE  651 (656)
T ss_dssp             CC-----C-----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CC-----C-----CccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence            00     0     11125679999999999999999999999999998765

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=2.1e-39  Score=298.38  Aligned_cols=256  Identities=25%  Similarity=0.388  Sum_probs=176.6

Q ss_pred             HhcCCccCccccccCCccEEEEEEc-CCCEEEEEEecCCC-chhHHHHHHHHH-HHhcCCCCceeeeeeeEEeCCccEEE
Q 017594           47 ATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS-GQGLREMKNEAS-VIAKVQHKNLVRLLGCCIDRDEKILI  123 (369)
Q Consensus        47 ~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~~-~~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~lv  123 (369)
                      ..++|++.+.||+|+||.||+|.++ +|+.||+|++.... ......+..|+. +++.++||||+++++++...+..++|
T Consensus        20 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv   99 (327)
T 3aln_A           20 TAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWIC   99 (327)
T ss_dssp             CSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEE
T ss_pred             CHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEE
Confidence            3589999999999999999999975 58899999997543 223344455555 67778999999999999999999999


Q ss_pred             EEecCCCChhhhhcC--CCccccCChHHHHHHHHHHHHHHHHHhcC-CCCCcccCCCCCCCEEEeCCCceEEeecCCcee
Q 017594          124 YEYMPNKSLDFFLFD--PTKRMLLDWVTRVQIIEGIAQGLLYLHQY-SRVRIIHRDLKASNILLDKDMNPKISDFGMARI  200 (369)
Q Consensus       124 ~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~i~~qi~~al~~LH~~-~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~  200 (369)
                      |||+.+ +|.+++..  ......+++..++.++.|++.||.|||+. +   ++|+||+|+||+++.++.++|+|||++..
T Consensus       100 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~  175 (327)
T 3aln_A          100 MELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKLCDFGISGQ  175 (327)
T ss_dssp             ECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEECCCSSSCC
T ss_pred             EeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEEccCCCcee
Confidence            999986 66665532  11134588999999999999999999998 8   99999999999999999999999999876


Q ss_pred             cCCCCcccccccccccccccCchhh----ccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCcc
Q 017594          201 CGGNELQANTSRIVGTYGYMSPEYA----LEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRT  276 (369)
Q Consensus       201 ~~~~~~~~~~~~~~~~~~y~aPE~~----~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  276 (369)
                      .....   ......+++.|+|||++    .+..++.++||||||+++|+|++|..||..........          ...
T Consensus       176 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~----------~~~  242 (327)
T 3aln_A          176 LVDSI---AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQL----------TQV  242 (327)
T ss_dssp             ---------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-----------------CCC
T ss_pred             ccccc---ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHH----------HHH
Confidence            54322   12223688999999998    45678999999999999999999999986432111000          000


Q ss_pred             ccccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 017594          277 LELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVS  320 (369)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~  320 (369)
                      .....+.+... ....++..+.++|.+||+.||++|||+.++++
T Consensus       243 ~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  285 (327)
T 3aln_A          243 VKGDPPQLSNS-EEREFSPSFINFVNLCLTKDESKRPKYKELLK  285 (327)
T ss_dssp             CCSCCCCCCCC-SSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             hcCCCCCCCCc-ccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence            00000000000 00112566999999999999999999999985

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=3.3e-39  Score=308.35  Aligned_cols=254  Identities=23%  Similarity=0.288  Sum_probs=187.5

Q ss_pred             hcCCccCccccccCCccEEEEEEcCCCEEEEEEecCCCchhHHHHHHHHHHHhcC-CCCceeeeeeeEEeCCccEEEEEe
Q 017594           48 TNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKV-QHKNLVRLLGCCIDRDEKILIYEY  126 (369)
Q Consensus        48 ~~~y~i~~~lg~G~~~~v~~~~~~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~  126 (369)
                      .+.|.+.+.||+|+||+||.+...+|+.||+|++....   .+.+..|+.+++.+ +||||+++++++...+..++|||+
T Consensus        14 ~~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~---~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~   90 (434)
T 2rio_A           14 KNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF---CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALEL   90 (434)
T ss_dssp             SSCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGG---HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECC
T ss_pred             hheeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHH---HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEec
Confidence            35667788999999999988777779999999986432   35677899999876 899999999999999999999999


Q ss_pred             cCCCChhhhhcCCCccc----cCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCC-------------Cc
Q 017594          127 MPNKSLDFFLFDPTKRM----LLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKD-------------MN  189 (369)
Q Consensus       127 ~~~~~L~~~l~~~~~~~----~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~-------------~~  189 (369)
                      ++ ++|.+++.......    ..++..++.++.||+.||+|||+++   ++||||||+||+++.+             +.
T Consensus        91 ~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~  166 (434)
T 2rio_A           91 CN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLR  166 (434)
T ss_dssp             CS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCCTTCCCSCE
T ss_pred             CC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccccccCCCceE
Confidence            96 59988886533211    1133356789999999999999999   9999999999999754             47


Q ss_pred             eEEeecCCceecCCCCccc--ccccccccccccCchhhcc-------CCCCcccchHhHHHHHHHHHh-CCCCCCCCccc
Q 017594          190 PKISDFGMARICGGNELQA--NTSRIVGTYGYMSPEYALE-------GIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTD  259 (369)
Q Consensus       190 ~~L~Dfg~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~-------~~~~~~~DiwslG~il~~l~t-g~~p~~~~~~~  259 (369)
                      ++|+|||++..........  ......|++.|+|||++.+       ..++.++|||||||++|+|++ |..||+.....
T Consensus       167 ~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~  246 (434)
T 2rio_A          167 ILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSR  246 (434)
T ss_dssp             EEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTH
T ss_pred             EEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhh
Confidence            9999999998775433211  1233568999999999865       568999999999999999999 99998643211


Q ss_pred             ccccchhhhhhhhcCccccccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 017594          260 SLNLLGYAWDLWTSNRTLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVS  320 (369)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~  320 (369)
                      .   .    ............     .......++.++.++|.+||+.||++|||+.++++
T Consensus       247 ~---~----~i~~~~~~~~~~-----~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  295 (434)
T 2rio_A          247 E---S----NIIRGIFSLDEM-----KCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR  295 (434)
T ss_dssp             H---H----HHHHTCCCCCCC-----TTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             H---H----HHhcCCCCcccc-----cccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence            1   0    000000000000     11112344778999999999999999999999985

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=4.6e-39  Score=317.41  Aligned_cols=280  Identities=23%  Similarity=0.261  Sum_probs=201.2

Q ss_pred             hhHHHHhcCCccCccccccCCccEEEEEEc-CCCEEEEEEecCC-CchhHHHHHHHHHHHhcCCCCceeeeeeeEEe---
Q 017594           42 SSVSTATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGR-SGQGLREMKNEASVIAKVQHKNLVRLLGCCID---  116 (369)
Q Consensus        42 ~~~~~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---  116 (369)
                      .......++|++.+.||.|+||.||+|.+. +|+.||+|++... .......+..|+.+++.++||||+++++++..   
T Consensus         7 ~~pg~~~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~   86 (676)
T 3qa8_A            7 SLPTQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQK   86 (676)
T ss_dssp             ----------CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCC
T ss_pred             CCCCCCCCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeeccccc
Confidence            344555689999999999999999999975 4899999998754 33445678889999999999999999998765   


Q ss_pred             ---CCccEEEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCc---e
Q 017594          117 ---RDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMN---P  190 (369)
Q Consensus       117 ---~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~---~  190 (369)
                         .+..++||||+.+++|.+++........+++..++.++.||+.||.|||+.|   ++||||+|+||+++.++.   +
T Consensus        87 ~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~~v  163 (676)
T 3qa8_A           87 LAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIH  163 (676)
T ss_dssp             CCTTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSCEE
T ss_pred             ccCCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCceeE
Confidence               5678999999999999999977555556889999999999999999999999   999999999999997765   8


Q ss_pred             EEeecCCceecCCCCcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCccccccc----chh
Q 017594          191 KISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNL----LGY  266 (369)
Q Consensus       191 ~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~----~~~  266 (369)
                      +|+|||++........   .....+++.|+|||++.+..++.++||||||+++|+|++|..||..........    ...
T Consensus       164 KL~DFG~a~~~~~~~~---~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~  240 (676)
T 3qa8_A          164 KIIDLGYAKELDQGEL---CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKS  240 (676)
T ss_dssp             EECSCCCCCBTTSCCC---CCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC---
T ss_pred             EEcccccccccccccc---cccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhccc
Confidence            9999999987654322   233578999999999999999999999999999999999999996432100000    000


Q ss_pred             hhhhhhcCccccc--cCcc-ccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHH-----HHHHHhhhh
Q 017594          267 AWDLWTSNRTLEL--IDPI-LEDEYSSKQMLLRYANIALLCVQESADDRPTMNDV-----VSMLTNEAA  327 (369)
Q Consensus       267 ~~~~~~~~~~~~~--~~~~-~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~el-----l~~L~~~~~  327 (369)
                      .............  .... .........++..+.++|.+||+.||++|||+.++     .+.+..+..
T Consensus       241 ~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~  309 (676)
T 3qa8_A          241 NEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILS  309 (676)
T ss_dssp             ---CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHC
T ss_pred             chhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHh
Confidence            0000000000000  0000 00111122247789999999999999999999873     345544444

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=3.8e-39  Score=301.82  Aligned_cols=263  Identities=21%  Similarity=0.287  Sum_probs=196.2

Q ss_pred             HhcCCccCccccccCCccEEEEEEc-CCCEEEEEEecCCCchhHHHHHHHHHHHhcCC-----------CCceeeeeeeE
Q 017594           47 ATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSGQGLREMKNEASVIAKVQ-----------HKNLVRLLGCC  114 (369)
Q Consensus        47 ~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~-----------h~~i~~~~~~~  114 (369)
                      ..++|++.+.||+|+||.||+|++. +++.||+|++... ......+.+|+.+++.+.           |+||+++++++
T Consensus        17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~   95 (373)
T 1q8y_A           17 KDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHF   95 (373)
T ss_dssp             TTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEE
T ss_pred             cCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHh
Confidence            3578999999999999999999974 5889999999743 234466788999888886           78999999998


Q ss_pred             EeCC----ccEEEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcC-CCCCcccCCCCCCCEEEeC---
Q 017594          115 IDRD----EKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQY-SRVRIIHRDLKASNILLDK---  186 (369)
Q Consensus       115 ~~~~----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~-~~~~i~H~dl~p~NIlv~~---  186 (369)
                      ....    ..++++|++ +++|.+++.... ...+++..++.++.||+.||.|||++ |   ++||||||+||+++.   
T Consensus        96 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NIll~~~~~  170 (373)
T 1q8y_A           96 NHKGPNGVHVVMVFEVL-GENLLALIKKYE-HRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDS  170 (373)
T ss_dssp             EEEETTEEEEEEEECCC-CEEHHHHHHHTT-TSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEET
T ss_pred             hccCCCCceEEEEEecC-CCCHHHHHHHhh-ccCCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHeEEeccCC
Confidence            8654    689999999 888888875432 23488999999999999999999998 8   999999999999954   


Q ss_pred             ---CCceEEeecCCceecCCCCcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCccccccc
Q 017594          187 ---DMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNL  263 (369)
Q Consensus       187 ---~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~  263 (369)
                         .+.++|+|||++......     .....+++.|+|||++.+..++.++|||||||++|+|++|..||..........
T Consensus       171 ~~~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~  245 (373)
T 1q8y_A          171 PENLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTK  245 (373)
T ss_dssp             TTTEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------C
T ss_pred             CcCcceEEEcccccccccCCC-----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCC
Confidence               347999999999865432     223468999999999999999999999999999999999999997543211100


Q ss_pred             ----chhhh------------------hhhhcCccccccCcc--------cc-ccccHHHHHHHHHHHHHHhhcCCCCCC
Q 017594          264 ----LGYAW------------------DLWTSNRTLELIDPI--------LE-DEYSSKQMLLRYANIALLCVQESADDR  312 (369)
Q Consensus       264 ----~~~~~------------------~~~~~~~~~~~~~~~--------~~-~~~~~~~~~~~l~~li~~~L~~dP~~R  312 (369)
                          .....                  ..+........+...        +. ....+...+.++.+||.+||+.||++|
T Consensus       246 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R  325 (373)
T 1q8y_A          246 DDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKR  325 (373)
T ss_dssp             HHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTC
T ss_pred             hHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCcccc
Confidence                00000                  000000000000000        00 001123457889999999999999999


Q ss_pred             CCHHHHHH
Q 017594          313 PTMNDVVS  320 (369)
Q Consensus       313 ps~~ell~  320 (369)
                      ||+.++++
T Consensus       326 pt~~ell~  333 (373)
T 1q8y_A          326 ADAGGLVN  333 (373)
T ss_dssp             BCHHHHHT
T ss_pred             CCHHHHhh
Confidence            99999997

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=2.7e-38  Score=285.56  Aligned_cols=241  Identities=12%  Similarity=0.073  Sum_probs=187.8

Q ss_pred             hhhHH-HHhcCCccCccccccCCccEEEEEEcC-CCEEEEEEecCCC---chhHHHHHHHHHHHhcCCCCceeeeeeeEE
Q 017594           41 FSSVS-TATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRS---GQGLREMKNEASVIAKVQHKNLVRLLGCCI  115 (369)
Q Consensus        41 ~~~~~-~~~~~y~i~~~lg~G~~~~v~~~~~~~-~~~valK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~  115 (369)
                      +.... .+.++|++.+.||+|+||.||+|++.. |+.||+|++....   ......+.+|+..+..++||||+++++++.
T Consensus        22 ~~~g~~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~  101 (286)
T 3uqc_A           22 LVPGARIANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVH  101 (286)
T ss_dssp             CCTTCEETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred             CCCCCEEecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEE
Confidence            33444 566899999999999999999999765 8899999997553   233467889999999999999999999999


Q ss_pred             eCCccEEEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeec
Q 017594          116 DRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDF  195 (369)
Q Consensus       116 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Df  195 (369)
                      ..+..|+||||+++++|.+++...     .....+..++.||+.||.|||++|   ++||||||+||+++.+|.++|+++
T Consensus       102 ~~~~~~lv~e~~~g~~L~~~l~~~-----~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~  173 (286)
T 3uqc_A          102 TRAGGLVVAEWIRGGSLQEVADTS-----PSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYP  173 (286)
T ss_dssp             ETTEEEEEEECCCEEEHHHHHTTC-----CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSC
T ss_pred             ECCcEEEEEEecCCCCHHHHHhcC-----CChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEec
Confidence            999999999999999999998431     345578889999999999999999   999999999999999999999854


Q ss_pred             CCceecCCCCcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCc
Q 017594          196 GMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNR  275 (369)
Q Consensus       196 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  275 (369)
                      +.                      .+       .++.++|||||||++|+|++|+.||............  ...     
T Consensus       174 ~~----------------------~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~--~~~-----  217 (286)
T 3uqc_A          174 AT----------------------MP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPA--ERD-----  217 (286)
T ss_dssp             CC----------------------CT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEEC--CBC-----
T ss_pred             cc----------------------cC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHH--HHH-----
Confidence            32                      22       3688999999999999999999999754322110000  000     


Q ss_pred             cccccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHhhhhcc
Q 017594          276 TLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNEAATL  329 (369)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L~~~~~~~  329 (369)
                      ......   ........++.++.++|.+||+.||++| |+.++++.|+.+....
T Consensus       218 ~~~~~~---~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~  267 (286)
T 3uqc_A          218 TAGQPI---EPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAVA  267 (286)
T ss_dssp             TTSCBC---CHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC--
T ss_pred             hccCCC---ChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhccC
Confidence            000000   0000011225679999999999999999 9999999999987753

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=9.7e-39  Score=292.48  Aligned_cols=253  Identities=23%  Similarity=0.370  Sum_probs=180.1

Q ss_pred             HHhcCCccCccccccCCccEEEEEEc-CCCEEEEEEecCCCch--hHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEE
Q 017594           46 TATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSGQ--GLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKIL  122 (369)
Q Consensus        46 ~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l  122 (369)
                      ...++|++.+.||+|+||.||+|+++ +|+.||+|++......  ....+.++..+++.++||||+++++++...+..++
T Consensus        22 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~l  101 (318)
T 2dyl_A           22 AEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFI  101 (318)
T ss_dssp             CCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEE
Confidence            34578999999999999999999976 5899999999755322  22334455567888899999999999999999999


Q ss_pred             EEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcC-CCCCcccCCCCCCCEEEeCCCceEEeecCCceec
Q 017594          123 IYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQY-SRVRIIHRDLKASNILLDKDMNPKISDFGMARIC  201 (369)
Q Consensus       123 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~-~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~  201 (369)
                      ||||+ ++.+..+...  ....+++..++.++.||+.||.|||+. +   ++|+||+|+||+++.++.++|+|||++...
T Consensus       102 v~e~~-~~~~~~l~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~  175 (318)
T 2dyl_A          102 AMELM-GTCAEKLKKR--MQGPIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDFGISGRL  175 (318)
T ss_dssp             EECCC-SEEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEEECCCTTC---
T ss_pred             EEecc-CCcHHHHHHH--hccCCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEEEEECCCchhc
Confidence            99999 5555555432  134588999999999999999999995 8   999999999999999999999999998765


Q ss_pred             CCCCcccccccccccccccCchhhc-----cCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCcc
Q 017594          202 GGNELQANTSRIVGTYGYMSPEYAL-----EGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRT  276 (369)
Q Consensus       202 ~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  276 (369)
                      ....   ......+++.|+|||++.     +..++.++||||||+++|+|++|..||........    ......... .
T Consensus       176 ~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~----~~~~~~~~~-~  247 (318)
T 2dyl_A          176 VDDK---AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFE----VLTKVLQEE-P  247 (318)
T ss_dssp             --------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHH----HHHHHHHSC-C
T ss_pred             cCCc---cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHH----HHHHHhccC-C
Confidence            4322   122346889999999984     45688999999999999999999999875332111    111111111 0


Q ss_pred             ccccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 017594          277 LELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVS  320 (369)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~  320 (369)
                           +.+...   ..++.++.++|.+||+.||.+||++.++++
T Consensus       248 -----~~~~~~---~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (318)
T 2dyl_A          248 -----PLLPGH---MGFSGDFQSFVKDCLTKDHRKRPKYNKLLE  283 (318)
T ss_dssp             -----CCCCSS---SCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             -----CCCCcc---CCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence                 000000   012566999999999999999999999986

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=5.4e-39  Score=306.35  Aligned_cols=253  Identities=21%  Similarity=0.316  Sum_probs=187.5

Q ss_pred             HHHhcCCccCccccccCCccEEEEEEcCCCEEEEEEecCCCchhHHHHHHHHHHHhcC-CCCceeeeeeeEEeCCccEEE
Q 017594           45 STATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKV-QHKNLVRLLGCCIDRDEKILI  123 (369)
Q Consensus        45 ~~~~~~y~i~~~lg~G~~~~v~~~~~~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv  123 (369)
                      .....+|.+.+.||+|+||+||.....+|+.||||++.....   ..+.+|+.+++.+ +||||+++++++.+....++|
T Consensus        20 ~i~~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv   96 (432)
T 3p23_A           20 IVGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIA   96 (432)
T ss_dssp             EETTEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE---EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEE
T ss_pred             EEccEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH---HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEE
Confidence            344567999999999999998766666799999999975433   2356799999999 799999999999999999999


Q ss_pred             EEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeC---C--CceEEeecCCc
Q 017594          124 YEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDK---D--MNPKISDFGMA  198 (369)
Q Consensus       124 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~---~--~~~~L~Dfg~~  198 (369)
                      ||++.+ +|.+++.....  ......++.++.||+.||.|||+++   ++||||||+||+++.   +  ..++|+|||++
T Consensus        97 ~E~~~g-~L~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a  170 (432)
T 3p23_A           97 IELCAA-TLQEYVEQKDF--AHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLC  170 (432)
T ss_dssp             EECCSE-EHHHHHHSSSC--CCCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEECCTTEE
T ss_pred             EECCCC-CHHHHHHhcCC--CccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEecccce
Confidence            999974 88888764332  2445567889999999999999999   999999999999953   2  35789999999


Q ss_pred             eecCCCCcc-cccccccccccccCchhhc---cCCCCcccchHhHHHHHHHHHh-CCCCCCCCcccccccchhhhhhhhc
Q 017594          199 RICGGNELQ-ANTSRIVGTYGYMSPEYAL---EGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDLWTS  273 (369)
Q Consensus       199 ~~~~~~~~~-~~~~~~~~~~~y~aPE~~~---~~~~~~~~DiwslG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~  273 (369)
                      ......... .......|++.|+|||++.   ...++.++|||||||++|+|++ |..||+.......       .....
T Consensus       171 ~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~-------~~~~~  243 (432)
T 3p23_A          171 KKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQA-------NILLG  243 (432)
T ss_dssp             ECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHH-------HHHTT
T ss_pred             eeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHH-------HHHhc
Confidence            876533211 2223456899999999987   4567889999999999999999 8999853321110       00000


Q ss_pred             CccccccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 017594          274 NRTLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVS  320 (369)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~  320 (369)
                      ........       .....+..+.+||.+||+.||++|||+.++++
T Consensus       244 ~~~~~~~~-------~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~  283 (432)
T 3p23_A          244 ACSLDCLH-------PEKHEDVIARELIEKMIAMDPQKRPSAKHVLK  283 (432)
T ss_dssp             CCCCTTSC-------TTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             cCCccccC-------ccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence            00000000       11122566889999999999999999999984

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=1.4e-37  Score=313.16  Aligned_cols=244  Identities=19%  Similarity=0.308  Sum_probs=196.1

Q ss_pred             HHHHhcCCccCccccccCCccEEEEEEc--CCCEEEEEEecCCC-chhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCc-
Q 017594           44 VSTATNKFSDANKLGEGGFGPVYKGVLK--KGDEIAVKRLSGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDE-  119 (369)
Q Consensus        44 ~~~~~~~y~i~~~lg~G~~~~v~~~~~~--~~~~valK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-  119 (369)
                      ...+.++|++.+.||+|+||.||+|.+.  +|+.|++|++.... ......+..|+.++..++||||+++++++...+. 
T Consensus        75 g~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~  154 (681)
T 2pzi_A           75 GDIVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRH  154 (681)
T ss_dssp             TCEETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTT
T ss_pred             CCEeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCC
Confidence            3456689999999999999999999975  58899999986443 3445567889999999999999999999987665 


Q ss_pred             ----cEEEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeec
Q 017594          120 ----KILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDF  195 (369)
Q Consensus       120 ----~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Df  195 (369)
                          .|+||||+.+++|.+++..     .+++..++.++.||+.||.|||++|   ++||||||+||+++.+ .++|+||
T Consensus       155 ~~~~~~lv~E~~~g~~L~~~~~~-----~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl~DF  225 (681)
T 2pzi_A          155 GDPVGYIVMEYVGGQSLKRSKGQ-----KLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKLIDL  225 (681)
T ss_dssp             SCEEEEEEEECCCCEECC----C-----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEECCC
T ss_pred             CCceeEEEEEeCCCCcHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEEEec
Confidence                6999999999999877632     4899999999999999999999999   9999999999999885 9999999


Q ss_pred             CCceecCCCCcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCc
Q 017594          196 GMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNR  275 (369)
Q Consensus       196 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  275 (369)
                      |++......      ....|++.|+|||++.+.. +.++|||||||++|+|++|.+||.......               
T Consensus       226 G~a~~~~~~------~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~---------------  283 (681)
T 2pzi_A          226 GAVSRINSF------GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDG---------------  283 (681)
T ss_dssp             TTCEETTCC------SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSS---------------
T ss_pred             ccchhcccC------CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCccccccc---------------
Confidence            999865432      3346899999999987654 889999999999999999988865211100               


Q ss_pred             cccccCccccccccHHHHHHHHHHHHHHhhcCCCCCCC-CHHHHHHHHHhhh
Q 017594          276 TLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRP-TMNDVVSMLTNEA  326 (369)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp-s~~ell~~L~~~~  326 (369)
                          +    .........+..+.++|.+||+.||++|| +++++.+.|....
T Consensus       284 ----~----~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~  327 (681)
T 2pzi_A          284 ----L----PEDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVL  327 (681)
T ss_dssp             ----C----CTTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred             ----c----cccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHH
Confidence                0    01111222356799999999999999999 5666767666554

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=5.8e-37  Score=278.64  Aligned_cols=230  Identities=18%  Similarity=0.232  Sum_probs=178.3

Q ss_pred             HhcCCccC-ccccccCCccEEEEEEc-CCCEEEEEEecCCCchhHHHHHHHHHHH-hcCCCCceeeeeeeEEe----CCc
Q 017594           47 ATNKFSDA-NKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSGQGLREMKNEASVI-AKVQHKNLVRLLGCCID----RDE  119 (369)
Q Consensus        47 ~~~~y~i~-~~lg~G~~~~v~~~~~~-~~~~valK~~~~~~~~~~~~~~~e~~~l-~~l~h~~i~~~~~~~~~----~~~  119 (369)
                      ..++|.+. +.||+|+||.||+|.+. +++.||+|++...     ....+|+.++ +.++||||+++++++..    ...
T Consensus        15 ~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~   89 (299)
T 3m2w_A           15 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKC   89 (299)
T ss_dssp             GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred             cccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCce
Confidence            44667777 78999999999999975 5889999998642     4567788887 56689999999999876    667


Q ss_pred             cEEEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeC---CCceEEeecC
Q 017594          120 KILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDK---DMNPKISDFG  196 (369)
Q Consensus       120 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~---~~~~~L~Dfg  196 (369)
                      .++||||+.+++|.+++.... ...+++..++.++.||+.||.|||+.+   ++|+||||+||+++.   ++.++|+|||
T Consensus        90 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~kl~Dfg  165 (299)
T 3m2w_A           90 LLIVMECLDGGELFSRIQDRG-DQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFG  165 (299)
T ss_dssp             EEEEECCCCSCBHHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCT
T ss_pred             EEEEEeecCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcEEEeccc
Confidence            899999999999999986532 235899999999999999999999999   999999999999988   7889999999


Q ss_pred             CceecCCCCcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCcc
Q 017594          197 MARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRT  276 (369)
Q Consensus       197 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  276 (369)
                      ++....                        +..++.++|||||||++|+|++|..||.........           ...
T Consensus       166 ~a~~~~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~-----------~~~  210 (299)
T 3m2w_A          166 FAKETT------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS-----------PGM  210 (299)
T ss_dssp             TCEECT------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC------------------CCS
T ss_pred             cccccc------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhh-----------HHH
Confidence            876432                        245678999999999999999999998643311100           000


Q ss_pred             ccccCcccc--ccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 017594          277 LELIDPILE--DEYSSKQMLLRYANIALLCVQESADDRPTMNDVVS  320 (369)
Q Consensus       277 ~~~~~~~~~--~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~  320 (369)
                      ...+.....  .......++.++.++|.+||+.||++|||+.++++
T Consensus       211 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~  256 (299)
T 3m2w_A          211 KTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN  256 (299)
T ss_dssp             CCSSCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HHHHhhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence            000000000  00001123677999999999999999999999997

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=6.9e-37  Score=290.48  Aligned_cols=242  Identities=16%  Similarity=0.177  Sum_probs=177.9

Q ss_pred             hcCCccCccccccCCccEEEEEEc-CCCEEEEEEecCCCc---hhHHHHHHHHHHHhcCCC-Cce---------eeeee-
Q 017594           48 TNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSG---QGLREMKNEASVIAKVQH-KNL---------VRLLG-  112 (369)
Q Consensus        48 ~~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~~~---~~~~~~~~e~~~l~~l~h-~~i---------~~~~~-  112 (369)
                      ...|...+.||+|+||.||+|++. +|+.||||++.....   ...+.+.+|+.+++.+.| .+.         +...+ 
T Consensus        77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~  156 (413)
T 3dzo_A           77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  156 (413)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred             ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence            345888999999999999999965 599999999873322   235778899999999976 211         11111 


Q ss_pred             -----------eEEe-----CCccEEEEEecCCCChhhhhcC----CCccccCChHHHHHHHHHHHHHHHHHhcCCCCCc
Q 017594          113 -----------CCID-----RDEKILIYEYMPNKSLDFFLFD----PTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRI  172 (369)
Q Consensus       113 -----------~~~~-----~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i  172 (369)
                                 ++..     ....+++|+.+ +++|.+++..    ......+++..++.++.||+.||+|||+++   +
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i  232 (413)
T 3dzo_A          157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---L  232 (413)
T ss_dssp             EECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred             cccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC---c
Confidence                       1111     12346677754 6788777731    122345778889999999999999999999   9


Q ss_pred             ccCCCCCCCEEEeCCCceEEeecCCceecCCCCcccccccccccccccCchhh----------ccCCCCcccchHhHHHH
Q 017594          173 IHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYA----------LEGIFSIKSDVFSFGVL  242 (369)
Q Consensus       173 ~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~----------~~~~~~~~~DiwslG~i  242 (369)
                      +||||||+||+++.++.++|+|||++......     .....| +.|+|||++          .+..++.++|||||||+
T Consensus       233 iHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvi  306 (413)
T 3dzo_A          233 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLA  306 (413)
T ss_dssp             ECSCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHH
T ss_pred             ccCCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHH
Confidence            99999999999999999999999998765422     233456 999999998          55568889999999999


Q ss_pred             HHHHHhCCCCCCCCcccccccchhhhhhhhcCccccccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 017594          243 LLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVS  320 (369)
Q Consensus       243 l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~  320 (369)
                      +|+|++|+.||........                  ....+....   .++..+.+||.+||+.||++||++.++++
T Consensus       307 l~elltg~~Pf~~~~~~~~------------------~~~~~~~~~---~~~~~~~~li~~~l~~dP~~Rpt~~~~l~  363 (413)
T 3dzo_A          307 IYWIWCADLPNTDDAALGG------------------SEWIFRSCK---NIPQPVRALLEGFLRYPKEDRLLPLQAME  363 (413)
T ss_dssp             HHHHHHSSCCCCTTGGGSC------------------SGGGGSSCC---CCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             HHHHHHCCCCCCCcchhhh------------------HHHHHhhcc---cCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence            9999999999964331110                  001111000   11566999999999999999999877653

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=1.5e-36  Score=280.44  Aligned_cols=242  Identities=17%  Similarity=0.178  Sum_probs=181.6

Q ss_pred             HhcCCccCccccccCCccEEEEEEcCCCEEEEEEecCCC--------chhHHHHHHHHHHHhcCC---------CCceee
Q 017594           47 ATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRS--------GQGLREMKNEASVIAKVQ---------HKNLVR  109 (369)
Q Consensus        47 ~~~~y~i~~~lg~G~~~~v~~~~~~~~~~valK~~~~~~--------~~~~~~~~~e~~~l~~l~---------h~~i~~  109 (369)
                      ..++|++.+.||+|+||.||+|++ +|+.||+|++....        ....+.+.+|+.+++.++         ||||++
T Consensus        18 ~~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~   96 (336)
T 2vuw_A           18 PTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG   96 (336)
T ss_dssp             CHHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred             ccccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence            357899999999999999999998 58999999987542        223467888999988886         555555


Q ss_pred             eee-----------------eEEe-------------CCccEEEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHH
Q 017594          110 LLG-----------------CCID-------------RDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQ  159 (369)
Q Consensus       110 ~~~-----------------~~~~-------------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~  159 (369)
                      +.+                 ++..             ....++||||+.++++.+.+..    ..+++..++.++.||+.
T Consensus        97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~----~~~~~~~~~~i~~qi~~  172 (336)
T 2vuw_A           97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT----KLSSLATAKSILHQLTA  172 (336)
T ss_dssp             EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT----TCCCHHHHHHHHHHHHH
T ss_pred             hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh----cCCCHHHHHHHHHHHHH
Confidence            544                 4433             6789999999999966555522    34789999999999999


Q ss_pred             HHHHHh-cCCCCCcccCCCCCCCEEEeCCC--------------------ceEEeecCCceecCCCCccccccccccccc
Q 017594          160 GLLYLH-QYSRVRIIHRDLKASNILLDKDM--------------------NPKISDFGMARICGGNELQANTSRIVGTYG  218 (369)
Q Consensus       160 al~~LH-~~~~~~i~H~dl~p~NIlv~~~~--------------------~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~  218 (369)
                      ||.||| +.+   ++||||||+|||++.++                    .++|+|||++......       ...|++.
T Consensus       173 aL~~lH~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-------~~~gt~~  242 (336)
T 2vuw_A          173 SLAVAEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-------IVVFCDV  242 (336)
T ss_dssp             HHHHHHHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-------EEECCCC
T ss_pred             HHHHHHHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-------cEEEeec
Confidence            999999 899   99999999999999887                    8999999999866432       3478999


Q ss_pred             ccCchhhccCCCCcccchHhHHHH-HHHHHhCCCCCCCCcccccccchhhhhhhhcCccccc-cCccccccccHHHHHHH
Q 017594          219 YMSPEYALEGIFSIKSDVFSFGVL-LLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLEL-IDPILEDEYSSKQMLLR  296 (369)
Q Consensus       219 y~aPE~~~~~~~~~~~DiwslG~i-l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~  296 (369)
                      |+|||++.+.. +.++||||||++ .+++++|..||...          .|........... .............++.+
T Consensus       243 y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  311 (336)
T 2vuw_A          243 SMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNV----------LWLHYLTDKMLKQMTFKTKCNTPAMKQIKRK  311 (336)
T ss_dssp             TTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHH----------HHHHHHHHHHHHTCCCSSCCCSHHHHHHHHH
T ss_pred             ccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcch----------hhhhHHHHhhhhhhccCcccchhhhhhcCHH
Confidence            99999998766 889999998777 77788898886311          0000000000000 00000111123456889


Q ss_pred             HHHHHHHhhcCCCCCCCCHHHHH
Q 017594          297 YANIALLCVQESADDRPTMNDVV  319 (369)
Q Consensus       297 l~~li~~~L~~dP~~Rps~~ell  319 (369)
                      +.+||.+||+.|     |+.+++
T Consensus       312 ~~dli~~~L~~d-----sa~e~l  329 (336)
T 2vuw_A          312 IQEFHRTMLNFS-----SATDLL  329 (336)
T ss_dssp             HHHHHHHGGGSS-----SHHHHH
T ss_pred             HHHHHHHHhccC-----CHHHHH
Confidence            999999999976     999988

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.95  E-value=3.6e-29  Score=245.78  Aligned_cols=184  Identities=16%  Similarity=0.123  Sum_probs=127.4

Q ss_pred             ccccCCccEEEEE-EcCCCEEEEEEecCCC----------chhHHHHHHHHHHHhcC-CCCceeeeeeeEEeCCccEEEE
Q 017594           57 LGEGGFGPVYKGV-LKKGDEIAVKRLSGRS----------GQGLREMKNEASVIAKV-QHKNLVRLLGCCIDRDEKILIY  124 (369)
Q Consensus        57 lg~G~~~~v~~~~-~~~~~~valK~~~~~~----------~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~  124 (369)
                      .+.|+.|....++ .-.|+.+++|++....          ....+.+.+|+++|+++ .|+||+++++++++++..|+||
T Consensus       242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM  321 (569)
T 4azs_A          242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM  321 (569)
T ss_dssp             -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred             cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence            3455555555544 2238889999986441          12345688999999999 6999999999999999999999


Q ss_pred             EecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCCC
Q 017594          125 EYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGN  204 (369)
Q Consensus       125 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~~  204 (369)
                      ||++|++|.+.+...   .++++.   .|+.||+.||+|+|++|   |+||||||+|||++.+|.+||+|||+++.....
T Consensus       322 Eyv~G~~L~d~i~~~---~~l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~  392 (569)
T 4azs_A          322 EKLPGRLLSDMLAAG---EEIDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGSIVTTPQD  392 (569)
T ss_dssp             ECCCSEEHHHHHHTT---CCCCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTTEESCC--
T ss_pred             ecCCCCcHHHHHHhC---CCCCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeecccCeeCCCC
Confidence            999999999999653   335543   58999999999999999   999999999999999999999999999866433


Q ss_pred             CcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCC
Q 017594          205 ELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKN  252 (369)
Q Consensus       205 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p  252 (369)
                      .  .......||+.|+|||++.+ .+..++|+|++|++++.|.++..+
T Consensus       393 ~--~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~  437 (569)
T 4azs_A          393 C--SWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN  437 (569)
T ss_dssp             ---CCSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred             C--ccccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence            2  22334579999999998875 456789999999998887665443

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.92  E-value=2.7e-25  Score=217.07  Aligned_cols=185  Identities=20%  Similarity=0.201  Sum_probs=143.1

Q ss_pred             ccCccccccCCccEEEEEEcCCCEEEEEEecCCCc--------hhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEE
Q 017594           52 SDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSG--------QGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILI  123 (369)
Q Consensus        52 ~i~~~lg~G~~~~v~~~~~~~~~~valK~~~~~~~--------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv  123 (369)
                      ...+.||+|+||.||+|... +..+++|+......        ...+.+.+|+.++++++||||+++..++...+..++|
T Consensus       339 ~~~~~LG~G~fg~Vy~~~~~-~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV  417 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRDSYL-DFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM  417 (540)
T ss_dssp             ---------CCEEEEEEECS-SCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred             CCCCEEeeCCCEEEEEEEEC-CCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence            45679999999999999544 78889998653321        1134578999999999999999666666678889999


Q ss_pred             EEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCC
Q 017594          124 YEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGG  203 (369)
Q Consensus       124 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~  203 (369)
                      |||+++++|.+++..           ...++.||+.+|.|||+++   ++||||||+||+++.  .++|+|||+++....
T Consensus       418 mE~~~ggsL~~~l~~-----------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DFGla~~~~~  481 (540)
T 3en9_A          418 MSYINGKLAKDVIED-----------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDFGLGKISNL  481 (540)
T ss_dssp             EECCCSEEHHHHSTT-----------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCCTTCEECCC
T ss_pred             EECCCCCCHHHHHHH-----------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEECccCEECCC
Confidence            999999999999843           4579999999999999999   999999999999998  999999999988754


Q ss_pred             CCccc-----ccccccccccccCchhhcc--CCCCcccchHhHHHHHHHHHhCCCCC
Q 017594          204 NELQA-----NTSRIVGTYGYMSPEYALE--GIFSIKSDVFSFGVLLLEIVSGKKNT  253 (369)
Q Consensus       204 ~~~~~-----~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslG~il~~l~tg~~p~  253 (369)
                      .....     ......||+.|+|||++..  ..|+...|+|+.++-..+-..++.+|
T Consensus       482 ~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY  538 (540)
T 3en9_A          482 DEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY  538 (540)
T ss_dssp             HHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred             ccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence            32211     1124578999999999986  56888899999998888877766554

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.89  E-value=4.6e-23  Score=185.13  Aligned_cols=150  Identities=18%  Similarity=0.136  Sum_probs=119.8

Q ss_pred             HHHHhcCCccCccccccCCccEEEEEEcCCCEEEEEEecCCCc------------------hhHHHHHHHHHHHhcCCCC
Q 017594           44 VSTATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSG------------------QGLREMKNEASVIAKVQHK  105 (369)
Q Consensus        44 ~~~~~~~y~i~~~lg~G~~~~v~~~~~~~~~~valK~~~~~~~------------------~~~~~~~~e~~~l~~l~h~  105 (369)
                      .......|.+.+.||.|++|.||+|.+.+|+.||+|++.....                  .....+.+|+.+++.++  
T Consensus        85 ~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--  162 (282)
T 1zar_A           85 LVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--  162 (282)
T ss_dssp             HHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--
T ss_pred             HHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--
Confidence            3344556777899999999999999997799999999864321                  12456789999999999  


Q ss_pred             ceeeeeeeEEeCCccEEEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEe
Q 017594          106 NLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLD  185 (369)
Q Consensus       106 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~  185 (369)
                      | +++.+++. .+..++||||+++++|.+ +..         .....++.|++.||.+||+.|   ++||||||+||+++
T Consensus       163 ~-~~v~~~~~-~~~~~lvmE~~~g~~L~~-l~~---------~~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~NILl~  227 (282)
T 1zar_A          163 G-LAVPKVYA-WEGNAVLMELIDAKELYR-VRV---------ENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVS  227 (282)
T ss_dssp             T-SSSCCEEE-EETTEEEEECCCCEEGGG-CCC---------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEE
T ss_pred             C-CCcCeEEe-ccceEEEEEecCCCcHHH-cch---------hhHHHHHHHHHHHHHHHHHCC---CEeCCCCHHHEEEE
Confidence            4 66666553 366799999999999987 311         234569999999999999999   99999999999999


Q ss_pred             CCCceEEeecCCceecCCCCcccccccccccccccCchhhc
Q 017594          186 KDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAL  226 (369)
Q Consensus       186 ~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  226 (369)
                       ++.++|+|||++..               +..+.|||++.
T Consensus       228 -~~~vkl~DFG~a~~---------------~~~~~a~e~l~  252 (282)
T 1zar_A          228 -EEGIWIIDFPQSVE---------------VGEEGWREILE  252 (282)
T ss_dssp             -TTEEEECCCTTCEE---------------TTSTTHHHHHH
T ss_pred             -CCcEEEEECCCCeE---------------CCCCCHHHHHH
Confidence             99999999999853               33467888775

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.78  E-value=3.9e-19  Score=157.52  Aligned_cols=138  Identities=15%  Similarity=0.149  Sum_probs=106.1

Q ss_pred             cCCccCccccccCCccEEEEEE-cCCCE--EEEEEecCCCch------------------------hHHHHHHHHHHHhc
Q 017594           49 NKFSDANKLGEGGFGPVYKGVL-KKGDE--IAVKRLSGRSGQ------------------------GLREMKNEASVIAK  101 (369)
Q Consensus        49 ~~y~i~~~lg~G~~~~v~~~~~-~~~~~--valK~~~~~~~~------------------------~~~~~~~e~~~l~~  101 (369)
                      .-|.+.+.||+|+||.||+|.+ .+|+.  ||+|++......                        ....+..|+..+..
T Consensus        47 ~~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~  126 (258)
T 1zth_A           47 YITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLER  126 (258)
T ss_dssp             SEEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHH
T ss_pred             CchhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHH
Confidence            3477899999999999999997 67888  999987533111                        11357789999999


Q ss_pred             CCCCce--eeeeeeEEeCCccEEEEEecCC-C----ChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHh-cCCCCCcc
Q 017594          102 VQHKNL--VRLLGCCIDRDEKILIYEYMPN-K----SLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLH-QYSRVRII  173 (369)
Q Consensus       102 l~h~~i--~~~~~~~~~~~~~~lv~e~~~~-~----~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH-~~~~~~i~  173 (369)
                      +.|+++  +.++..    ...++||||+.+ +    +|.++...      .++..+..++.||+.+|.+|| ..|   ++
T Consensus       127 l~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~------~~~~~~~~i~~qi~~~l~~lH~~~g---iv  193 (258)
T 1zth_A          127 AKEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE------LKELDVEGIFNDVVENVKRLYQEAE---LV  193 (258)
T ss_dssp             HHHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG------GGGSCHHHHHHHHHHHHHHHHHTSC---EE
T ss_pred             HHhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc------cChHHHHHHHHHHHHHHHHHHHHCC---EE
Confidence            987754  333332    467999999942 3    55554421      234567889999999999999 998   99


Q ss_pred             cCCCCCCCEEEeCCCceEEeecCCceec
Q 017594          174 HRDLKASNILLDKDMNPKISDFGMARIC  201 (369)
Q Consensus       174 H~dl~p~NIlv~~~~~~~L~Dfg~~~~~  201 (369)
                      ||||||.||+++.  .++|+|||++...
T Consensus       194 HrDlkp~NILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          194 HADLSEYNIMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             CSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred             eCCCCHHHEEEcC--cEEEEECcccccC
Confidence            9999999999988  9999999998754

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.69  E-value=1.9e-17  Score=152.99  Aligned_cols=137  Identities=13%  Similarity=0.121  Sum_probs=99.8

Q ss_pred             CccCccccccCCccEEEEEEcCCCEEEEEEecCCCch--------------hHH--------HHHHHHHHHhcCCCCcee
Q 017594           51 FSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQ--------------GLR--------EMKNEASVIAKVQHKNLV  108 (369)
Q Consensus        51 y~i~~~lg~G~~~~v~~~~~~~~~~valK~~~~~~~~--------------~~~--------~~~~e~~~l~~l~h~~i~  108 (369)
                      |.+.+.||.|++|.||+|...+|+.||||++......              ...        ....|...|.++.+.++.
T Consensus        97 Y~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~  176 (397)
T 4gyi_A           97 YSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFP  176 (397)
T ss_dssp             SEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCS
T ss_pred             EEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCC
Confidence            9999999999999999999988999999987532100              000        123456666666444332


Q ss_pred             eeeeeEEeCCccEEEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCC
Q 017594          109 RLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDM  188 (369)
Q Consensus       109 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~  188 (369)
                      ... .+. ....++||||++|.++..+..         ......++.||+.+|.+||..|   ++||||||.|||++.++
T Consensus       177 vp~-p~~-~~~~~LVME~i~G~~L~~l~~---------~~~~~~l~~qll~~l~~lH~~g---IVHrDLKp~NILl~~dg  242 (397)
T 4gyi_A          177 VPE-PIA-QSRHTIVMSLVDALPMRQVSS---------VPDPASLYADLIALILRLAKHG---LIHGDFNEFNILIREEK  242 (397)
T ss_dssp             CCC-EEE-EETTEEEEECCSCEEGGGCCC---------CSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEEEEE
T ss_pred             CCe-eee-ccCceEEEEecCCccHhhhcc---------cHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeCCC
Confidence            111 111 124589999999988765431         1234568899999999999999   99999999999998776


Q ss_pred             ----------ceEEeecCCceec
Q 017594          189 ----------NPKISDFGMARIC  201 (369)
Q Consensus       189 ----------~~~L~Dfg~~~~~  201 (369)
                                .+.|+||+.+...
T Consensus       243 d~~d~~~~~~~~~iID~~Q~V~~  265 (397)
T 4gyi_A          243 DAEDPSSITLTPIIIXFPQMVSM  265 (397)
T ss_dssp             CSSCTTSEEEEEEECCCTTCEET
T ss_pred             CcccccccccceEEEEeCCcccC
Confidence                      3899999987643

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.41  E-value=1e-12  Score=116.26  Aligned_cols=145  Identities=17%  Similarity=0.117  Sum_probs=112.3

Q ss_pred             HHhcCCccCccccccCCccEEEEEEcCCCEEEEEEecCCCchhHHHHHHHHHHHhcCC-CCceeeeeeeEEeCCccEEEE
Q 017594           46 TATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQ-HKNLVRLLGCCIDRDEKILIY  124 (369)
Q Consensus        46 ~~~~~y~i~~~lg~G~~~~v~~~~~~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~  124 (369)
                      .....|++...++.|+.+.||++... ++.+++|+...........+..|+.+++.+. +..+.++++++......|+||
T Consensus        11 ~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~   89 (263)
T 3tm0_A           11 KLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLM   89 (263)
T ss_dssp             HHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEE
T ss_pred             HHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEE
Confidence            34467999999999999999999855 6899999986422122346788999999884 567888998888888899999


Q ss_pred             EecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCC------------------------------------
Q 017594          125 EYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYS------------------------------------  168 (369)
Q Consensus       125 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~------------------------------------  168 (369)
                      |+++|.++.....        +......++.+++.++..||+..                                    
T Consensus        90 e~i~G~~l~~~~~--------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (263)
T 3tm0_A           90 SEADGVLCSEEYE--------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEED  161 (263)
T ss_dssp             ECCSSEEHHHHCC--------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTT
T ss_pred             EecCCeehhhccC--------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccccc
Confidence            9999999876531        12233467889999999999821                                    


Q ss_pred             --------------------CCCcccCCCCCCCEEEeCCCceEEeecCCce
Q 017594          169 --------------------RVRIIHRDLKASNILLDKDMNPKISDFGMAR  199 (369)
Q Consensus       169 --------------------~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~  199 (369)
                                          ...++|||++|.||+++.++.+.|+||+.+.
T Consensus       162 ~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T 3tm0_A          162 TPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             CSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred             ccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence                                1348999999999999876556799998764

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.20  E-value=4.1e-11  Score=105.46  Aligned_cols=138  Identities=16%  Similarity=0.163  Sum_probs=100.5

Q ss_pred             hcCCccCccccccCCccEEEEEEcCCCEEEEEEecCCCchhHHHHHHHHHHHhcCCCCc--eeeeeeeEEeCCccEEEEE
Q 017594           48 TNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKN--LVRLLGCCIDRDEKILIYE  125 (369)
Q Consensus        48 ~~~y~i~~~lg~G~~~~v~~~~~~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~--i~~~~~~~~~~~~~~lv~e  125 (369)
                      ...|.+....+.|..+.||++...+|..+++|+....   ....+..|+.+++.+.+.+  +.+++.+....+..++|||
T Consensus        19 ~~~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e   95 (264)
T 1nd4_A           19 LFGYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLG   95 (264)
T ss_dssp             TTTCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEE
T ss_pred             cCCCceEecccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEE
Confidence            3455554444566679999998777888999997644   2245678888888885433  5668888777777899999


Q ss_pred             ecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCC-------------------------------------
Q 017594          126 YMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYS-------------------------------------  168 (369)
Q Consensus       126 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~-------------------------------------  168 (369)
                      +++|.++.  ..   .   .+   ...++.+++.++..||+..                                     
T Consensus        96 ~i~G~~l~--~~---~---~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (264)
T 1nd4_A           96 EVPGQDLL--SS---H---LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQG  164 (264)
T ss_dssp             CCSSEETT--TS---C---CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTT
T ss_pred             ecCCcccC--cC---c---CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccC
Confidence            99998874  21   1   11   2356777888888888753                                     


Q ss_pred             ------------------CCCcccCCCCCCCEEEeCCCceEEeecCCce
Q 017594          169 ------------------RVRIIHRDLKASNILLDKDMNPKISDFGMAR  199 (369)
Q Consensus       169 ------------------~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~  199 (369)
                                        ...++|||++|.||+++.++.+.|+||+.+.
T Consensus       165 ~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~  213 (264)
T 1nd4_A          165 LAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG  213 (264)
T ss_dssp             CCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             ccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence                              1129999999999999877666799999864

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.04  E-value=7.9e-10  Score=102.24  Aligned_cols=144  Identities=14%  Similarity=0.233  Sum_probs=105.0

Q ss_pred             CccCccccccCCccEEEEEEcCCCEEEEEEec--CCC-chhHHHHHHHHHHHhcCCC--CceeeeeeeEEeC---CccEE
Q 017594           51 FSDANKLGEGGFGPVYKGVLKKGDEIAVKRLS--GRS-GQGLREMKNEASVIAKVQH--KNLVRLLGCCIDR---DEKIL  122 (369)
Q Consensus        51 y~i~~~lg~G~~~~v~~~~~~~~~~valK~~~--~~~-~~~~~~~~~e~~~l~~l~h--~~i~~~~~~~~~~---~~~~l  122 (369)
                      ...++.|+.|.++.||++... +..+++|+..  ... ......+..|+.+++.+..  ..+++++.++.+.   ...|+
T Consensus        40 ~~~~~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~  118 (359)
T 3dxp_A           40 PLSVEQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFY  118 (359)
T ss_dssp             CCEEEECCC-CCSCEEEEECS-SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEE
T ss_pred             CceEEEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEE
Confidence            345678899999999999876 4678888775  222 1223567789999998863  4577788877665   34799


Q ss_pred             EEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCC----------------------------------
Q 017594          123 IYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYS----------------------------------  168 (369)
Q Consensus       123 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~----------------------------------  168 (369)
                      |||+++|..+.+...     ..++......++.+++.+|..||...                                  
T Consensus       119 vme~v~G~~l~~~~~-----~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (359)
T 3dxp_A          119 IMEFVSGRVLWDQSL-----PGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETES  193 (359)
T ss_dssp             EEECCCCBCCCCTTC-----TTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSC
T ss_pred             EEEecCCeecCCCcc-----ccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcC
Confidence            999999987743221     12567778889999999999999731                                  


Q ss_pred             ---------------------CCCcccCCCCCCCEEEeCCCc--eEEeecCCcee
Q 017594          169 ---------------------RVRIIHRDLKASNILLDKDMN--PKISDFGMARI  200 (369)
Q Consensus       169 ---------------------~~~i~H~dl~p~NIlv~~~~~--~~L~Dfg~~~~  200 (369)
                                           ...++|||+++.||+++.++.  +.|+||+.+..
T Consensus       194 ~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          194 IPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             CHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             ChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                                 135999999999999987753  68999998764

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=98.94  E-value=6.5e-10  Score=100.36  Aligned_cols=186  Identities=18%  Similarity=0.196  Sum_probs=119.2

Q ss_pred             CccccccCCccEEEEEEcCCCEEEEEEecCCCchhHHHHHHHHHHHhcCC-CCc--eeeeeeeEEeCC---ccEEEEEec
Q 017594           54 ANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQ-HKN--LVRLLGCCIDRD---EKILIYEYM  127 (369)
Q Consensus        54 ~~~lg~G~~~~v~~~~~~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~-h~~--i~~~~~~~~~~~---~~~lv~e~~  127 (369)
                      ++.++.|....||.+.    ..+++|+....  .....+..|+..++.+. +..  +.+++.......   ..|+||+++
T Consensus        25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i   98 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI   98 (304)
T ss_dssp             CCEEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred             eEecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence            4568899999999873    56888986422  34567888999998873 332  334444332222   348999999


Q ss_pred             CCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCC---------------------------------------
Q 017594          128 PNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYS---------------------------------------  168 (369)
Q Consensus       128 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---------------------------------------  168 (369)
                      +|.++.....     ..++......++.+++..+..||+..                                       
T Consensus        99 ~G~~l~~~~~-----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  173 (304)
T 3sg8_A           99 KGVPLTPLLL-----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKV  173 (304)
T ss_dssp             CCEECCHHHH-----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHH
T ss_pred             CCeECCcccc-----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHH
Confidence            9988865332     12566677788888888888888621                                       


Q ss_pred             ----------------CCCcccCCCCCCCEEEeC--CCceEEeecCCceecCCCCcccccccccccccccCchhhcc---
Q 017594          169 ----------------RVRIIHRDLKASNILLDK--DMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALE---  227 (369)
Q Consensus       169 ----------------~~~i~H~dl~p~NIlv~~--~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~---  227 (369)
                                      ...++|||++|.||+++.  .+.+.|+||+.+........   .........-..|+....   
T Consensus       174 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~D---l~~~~~~~~~~~~~~~~~~l~  250 (304)
T 3sg8_A          174 DDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDND---FISLMEDDEEYGMEFVSKILN  250 (304)
T ss_dssp             HHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHH---HHTTCCTTTSCCHHHHHHHHH
T ss_pred             HHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHH---HHHHHhhccccCHHHHHHHHH
Confidence                            134799999999999998  45678999998765321110   000000000022222110   


Q ss_pred             --CC---------CCcccchHhHHHHHHHHHhCCCCC
Q 017594          228 --GI---------FSIKSDVFSFGVLLLEIVSGKKNT  253 (369)
Q Consensus       228 --~~---------~~~~~DiwslG~il~~l~tg~~p~  253 (369)
                        +.         .....+.|++|.++|.+.+|..+|
T Consensus       251 ~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          251 HYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             HHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred             HcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence              00         012258999999999999998764

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.60  E-value=4.7e-07  Score=79.87  Aligned_cols=134  Identities=19%  Similarity=0.182  Sum_probs=98.6

Q ss_pred             cccccCCc-cEEEEEEcC-CCEEEEEEecCCCchhHHHHHHHHHHHhcCC-CCceeeeeeeEEeCCccEEEEEecCCCCh
Q 017594           56 KLGEGGFG-PVYKGVLKK-GDEIAVKRLSGRSGQGLREMKNEASVIAKVQ-HKNLVRLLGCCIDRDEKILIYEYMPNKSL  132 (369)
Q Consensus        56 ~lg~G~~~-~v~~~~~~~-~~~valK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L  132 (369)
                      .+..|..+ .||+..... +..+++|+...   .....+..|+..|+.+. +--+.+++.++.+.+..++||++++|.++
T Consensus        31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~---~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~  107 (272)
T 4gkh_A           31 RDNVGQSGATIYRLYGKPNAPELFLKHGKG---SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTA  107 (272)
T ss_dssp             EEECSSSSCEEEEEECCTTCCCEEEEEEET---HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEH
T ss_pred             EccCCCcCCeEEEEEecCCCeEEEEEECCC---CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccc
Confidence            34445555 589887554 66789998653   23467788999998884 33467788888888889999999999888


Q ss_pred             hhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCC--------------------------------------------
Q 017594          133 DFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYS--------------------------------------------  168 (369)
Q Consensus       133 ~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~--------------------------------------------  168 (369)
                      .+....       .......++.+++..|..||...                                            
T Consensus       108 ~~~~~~-------~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  180 (272)
T 4gkh_A          108 FQVLEE-------YPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVW  180 (272)
T ss_dssp             HHHHHH-------CGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHH
T ss_pred             cccccC-------CHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHH
Confidence            665421       12234567778888888888753                                            


Q ss_pred             -----------CCCcccCCCCCCCEEEeCCCceEEeecCCce
Q 017594          169 -----------RVRIIHRDLKASNILLDKDMNPKISDFGMAR  199 (369)
Q Consensus       169 -----------~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~  199 (369)
                                 ...++|||+.+.||+++.++.+-|+||+.+.
T Consensus       181 ~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~  222 (272)
T 4gkh_A          181 KEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG  222 (272)
T ss_dssp             HHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             HHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence                       1147999999999999987777899999765

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.48  E-value=1.2e-06  Score=79.01  Aligned_cols=136  Identities=20%  Similarity=0.183  Sum_probs=93.3

Q ss_pred             CccccccCCccEEEEEEcCCCEEEEEEecCCCchhHHHHHHHHHHHhcCCCC---ceeeeeeeEE-eCCccEEEEEecCC
Q 017594           54 ANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHK---NLVRLLGCCI-DRDEKILIYEYMPN  129 (369)
Q Consensus        54 ~~~lg~G~~~~v~~~~~~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~---~i~~~~~~~~-~~~~~~lv~e~~~~  129 (369)
                      ++.++.|....||..    |..+++|+..  .......+..|+..|+.+.+.   .+.+++.+.. ..+..+++|++++|
T Consensus        24 v~~l~~G~~n~v~~v----g~~~VlR~~~--~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G   97 (306)
T 3tdw_A           24 VESLGEGFRNYAILV----NGDWVFRFPK--SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG   97 (306)
T ss_dssp             EEEEEECSSEEEEEE----TTTEEEEEES--SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred             eeecCCCcceeEEEE----CCEEEEEecC--CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence            456788888899988    5678888853  233456788999999998642   3555565553 34457899999999


Q ss_pred             CChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCC-----------------------------------------
Q 017594          130 KSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYS-----------------------------------------  168 (369)
Q Consensus       130 ~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~-----------------------------------------  168 (369)
                      ..+......     .++......++.++...|..||+..                                         
T Consensus        98 ~~l~~~~~~-----~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l  172 (306)
T 3tdw_A           98 QILGEDGMA-----VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYL  172 (306)
T ss_dssp             EECHHHHHT-----TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHH
T ss_pred             eECchhhhh-----hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHH
Confidence            888653211     1234444555555555555555432                                         


Q ss_pred             ----------------CCCcccCCCCCCCEEEeC---CCce-EEeecCCcee
Q 017594          169 ----------------RVRIIHRDLKASNILLDK---DMNP-KISDFGMARI  200 (369)
Q Consensus       169 ----------------~~~i~H~dl~p~NIlv~~---~~~~-~L~Dfg~~~~  200 (369)
                                      ...++|||++|.||+++.   ++.+ .|+||+.+..
T Consensus       173 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~  224 (306)
T 3tdw_A          173 TLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI  224 (306)
T ss_dssp             HHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred             HHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence                            124699999999999987   4554 8999997653

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.31  E-value=1.7e-06  Score=79.51  Aligned_cols=81  Identities=7%  Similarity=-0.013  Sum_probs=54.0

Q ss_pred             Cccc-cccCCccEEEEEEc-------CCCEEEEEEecCCC---chhHHHHHHHHHHHhcCC-C--CceeeeeeeEEeC--
Q 017594           54 ANKL-GEGGFGPVYKGVLK-------KGDEIAVKRLSGRS---GQGLREMKNEASVIAKVQ-H--KNLVRLLGCCIDR--  117 (369)
Q Consensus        54 ~~~l-g~G~~~~v~~~~~~-------~~~~valK~~~~~~---~~~~~~~~~e~~~l~~l~-h--~~i~~~~~~~~~~--  117 (369)
                      .+.| +.|....+|.+...       ++..+++|+.....   ......+..|+.+++.+. +  ..+.+++.+..+.  
T Consensus        25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~  104 (357)
T 3ats_A           25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV  104 (357)
T ss_dssp             EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred             EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence            4567 78888999998754       25678899865322   001245677888887774 2  3466677666544  


Q ss_pred             -CccEEEEEecCCCChhh
Q 017594          118 -DEKILIYEYMPNKSLDF  134 (369)
Q Consensus       118 -~~~~lv~e~~~~~~L~~  134 (369)
                       ...++|||+++|..+.+
T Consensus       105 ~g~~~~v~e~l~G~~l~~  122 (357)
T 3ats_A          105 LGTPFFLMDYVEGVVPPD  122 (357)
T ss_dssp             TSSCEEEEECCCCBCCCB
T ss_pred             cCCceEEEEecCCCChhh
Confidence             34689999999877653

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=98.16  E-value=1.2e-05  Score=71.62  Aligned_cols=82  Identities=16%  Similarity=0.198  Sum_probs=59.6

Q ss_pred             HhcCCccCccccccCCccEEEEEEcCCCEEEEEEecCCCchhHHHHHHHHHHHhcCCCC---ceeeeeeeEEeCCccEEE
Q 017594           47 ATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHK---NLVRLLGCCIDRDEKILI  123 (369)
Q Consensus        47 ~~~~y~i~~~lg~G~~~~v~~~~~~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~---~i~~~~~~~~~~~~~~lv  123 (369)
                      ...+..-++.+|.|..+.||+++..+|+.|++|+...........+..|+..|+.|...   .+++++..    +..+++
T Consensus        13 ~G~~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~----~~~~lv   88 (288)
T 3f7w_A           13 TGREVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW----DDRTLA   88 (288)
T ss_dssp             HCCCEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE----ETTEEE
T ss_pred             cCCCeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec----cCceEE
Confidence            34566678889999999999999999999999987654444345678899988887421   23444433    245889


Q ss_pred             EEecCCCCh
Q 017594          124 YEYMPNKSL  132 (369)
Q Consensus       124 ~e~~~~~~L  132 (369)
                      ||++.+...
T Consensus        89 ~e~l~~~~~   97 (288)
T 3f7w_A           89 MEWVDERPP   97 (288)
T ss_dssp             EECCCCCCC
T ss_pred             EEeecccCC
Confidence            999887654

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.11  E-value=1.2e-05  Score=74.97  Aligned_cols=76  Identities=12%  Similarity=0.217  Sum_probs=49.4

Q ss_pred             cCccccccCCccEEEEEEc-CCCEEEEEEecCCCc-------hhHHHHHHHHHHHhcCCC--C-ceeeeeeeEEeCCccE
Q 017594           53 DANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSG-------QGLREMKNEASVIAKVQH--K-NLVRLLGCCIDRDEKI  121 (369)
Q Consensus        53 i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~~~-------~~~~~~~~e~~~l~~l~h--~-~i~~~~~~~~~~~~~~  121 (369)
                      ..+.||.|..+.||++... +++.+++|.......       ........|++.++.+..  + .+.+++.+  +....+
T Consensus        34 ~~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~  111 (397)
T 2olc_A           34 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAV  111 (397)
T ss_dssp             EEEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTE
T ss_pred             EEEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccE
Confidence            3567899999999999754 478899997643211       123456778888887732  3 33444433  456679


Q ss_pred             EEEEecCCC
Q 017594          122 LIYEYMPNK  130 (369)
Q Consensus       122 lv~e~~~~~  130 (369)
                      +|||++.+.
T Consensus       112 lvmE~l~g~  120 (397)
T 2olc_A          112 TVMEDLSHL  120 (397)
T ss_dssp             EEECCCTTS
T ss_pred             EEEEeCCCc
Confidence            999999764

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.06  E-value=2e-05  Score=71.68  Aligned_cols=73  Identities=10%  Similarity=0.183  Sum_probs=41.5

Q ss_pred             ccccccCCccEEEEEEcCCCEEEEEEecCCCchhHHHHHHHHHHHhcCC-----CCceeeee-e--eEEeCCccEEEEEe
Q 017594           55 NKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQ-----HKNLVRLL-G--CCIDRDEKILIYEY  126 (369)
Q Consensus        55 ~~lg~G~~~~v~~~~~~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~-----h~~i~~~~-~--~~~~~~~~~lv~e~  126 (369)
                      +.|+.|..+.+|++...+| .+++|+.... .   ..+..|+.+++.|.     .|.++... +  +....+..++++++
T Consensus        38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~-~---~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~  112 (346)
T 2q83_A           38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRP-E---KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW  112 (346)
T ss_dssp             EECC----CEEEEEEETTE-EEEEEEECSC-H---HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred             eeccccccCcEEEEEeCCC-CEEEEecCCC-H---HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence            4455677899999987654 5889988752 1   33444555555442     23333311 0  12345667899999


Q ss_pred             cCCCCh
Q 017594          127 MPNKSL  132 (369)
Q Consensus       127 ~~~~~L  132 (369)
                      ++|..+
T Consensus       113 i~G~~~  118 (346)
T 2q83_A          113 IEGRPF  118 (346)
T ss_dssp             CCCBCC
T ss_pred             ecCccC
Confidence            998654

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=97.90  E-value=0.00011  Score=61.61  Aligned_cols=140  Identities=12%  Similarity=0.031  Sum_probs=89.7

Q ss_pred             CChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCCCCcccc
Q 017594          130 KSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQAN  209 (369)
Q Consensus       130 ~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~~~~~~~  209 (369)
                      .+|.+++..  .+.+++++.+|.++.|.+.+|.-+-....  -...=+.|..|++..+|.|.+.+ +.+.          
T Consensus        33 vSL~eIL~~--~~~PlsEEqaWALc~Qc~~~L~~~~~~~~--~~~~i~~~~~i~l~~dG~V~f~~-~~s~----------   97 (229)
T 2yle_A           33 LSLEEILRL--YNQPINEEQAWAVCYQCCGSLRAAARRRQ--PRHRVRSAAQIRVWRDGAVTLAP-AADD----------   97 (229)
T ss_dssp             EEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHTTC--CCCCCCSGGGEEEETTSCEEECC-C-------------
T ss_pred             ccHHHHHHH--cCCCcCHHHHHHHHHHHHHHHHhhhhccc--CCceecCCcceEEecCCceeccc-cccc----------
Confidence            367777753  45679999999999999999877622110  12333557999999999998864 1110          


Q ss_pred             cccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCccccccCcccccccc
Q 017594          210 TSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYS  289 (369)
Q Consensus       210 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  289 (369)
                          .....+.|||... ...+.+.=|||||+++|.-+--..|-                    ....++          
T Consensus        98 ----~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~e--------------------~eE~eL----------  142 (229)
T 2yle_A           98 ----AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLKE--------------------NEEREL----------  142 (229)
T ss_dssp             -------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCCT--------------------TEEECC----------
T ss_pred             ----ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCCc--------------------ccchhh----------
Confidence                1233466888653 34567889999999999999654331                    111111          


Q ss_pred             HHHHHHHHHHHHHHhhcC-------------------------CCCCCCCHHHHHHHHH
Q 017594          290 SKQMLLRYANIALLCVQE-------------------------SADDRPTMNDVVSMLT  323 (369)
Q Consensus       290 ~~~~~~~l~~li~~~L~~-------------------------dP~~Rps~~ell~~L~  323 (369)
                          ++.|.+||..|..-                         .+..|+++++|++.=+
T Consensus       143 ----S~~LE~LL~~Mt~~~~d~~~~DeG~~~~~eg~~d~~~~~~~~~~~sl~~Vi~~C~  197 (229)
T 2yle_A          143 ----SPPLEQLIDHMANTVEADGSNDEGYEAAEEGLGDEDEKRKISAIRSYRDVMKLCA  197 (229)
T ss_dssp             ----CHHHHHHHHHHTTCCC--------------------CCSCCCCCCSHHHHHHHHH
T ss_pred             ----CHHHHHHHHHHHhcccccccccccccccccccccccccccccCcCCHHHHHHHHH
Confidence                66788888888755                         3468899999886543

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.89  E-value=0.0001  Score=66.21  Aligned_cols=76  Identities=16%  Similarity=0.110  Sum_probs=59.1

Q ss_pred             cCccccccCCccEEEEEEcCCCEEEEEEecCCCchhHHHHHHHHHHHhcCC---CCceeeeeeeEEeCCccEEEEEecCC
Q 017594           53 DANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQ---HKNLVRLLGCCIDRDEKILIYEYMPN  129 (369)
Q Consensus        53 i~~~lg~G~~~~v~~~~~~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~~~~~lv~e~~~~  129 (369)
                      -.+.|+.|....+|+.... +..+++|+....   ....+..|+..|+.|.   ...+++++.+.......++|||++++
T Consensus        40 ~~~~l~gG~~n~~y~v~~~-~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G  115 (312)
T 3jr1_A           40 HKEKLYSGEMNEIWLINDE-VQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNK  115 (312)
T ss_dssp             EEEEECCSSSSEEEEEESS-SCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCC
T ss_pred             eeEEeCCccceeeeEEEEC-CCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccC
Confidence            3467889999999999864 678899987532   3466788888888873   35677888877777789999999998


Q ss_pred             CCh
Q 017594          130 KSL  132 (369)
Q Consensus       130 ~~L  132 (369)
                      ..+
T Consensus       116 ~~~  118 (312)
T 3jr1_A          116 SKN  118 (312)
T ss_dssp             CCC
T ss_pred             CCC
Confidence            865

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.72  E-value=0.00016  Score=66.84  Aligned_cols=142  Identities=18%  Similarity=0.187  Sum_probs=80.9

Q ss_pred             CccccccCCccEEEEEEc--------CCCEEEEEEecCCCchhHHHHHHHHHHHhcCC-CCceeeeeeeEEeCCccEEEE
Q 017594           54 ANKLGEGGFGPVYKGVLK--------KGDEIAVKRLSGRSGQGLREMKNEASVIAKVQ-HKNLVRLLGCCIDRDEKILIY  124 (369)
Q Consensus        54 ~~~lg~G~~~~v~~~~~~--------~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~  124 (369)
                      ++.|..|-...+|++...        +++.+++|+... .........+|+.+++.|. +.-..+++..+.+    .+|+
T Consensus        55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~-~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~  129 (379)
T 3feg_A           55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGA-ILQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLE  129 (379)
T ss_dssp             CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEE
T ss_pred             EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCC-ccchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEE
Confidence            456777888999999864        247899998643 2233456678888888874 2223555555432    3999


Q ss_pred             EecCCCChhhhh-----------------cCC--CccccCC--hHHHHHHHHHHHH-------------------HHH--
Q 017594          125 EYMPNKSLDFFL-----------------FDP--TKRMLLD--WVTRVQIIEGIAQ-------------------GLL--  162 (369)
Q Consensus       125 e~~~~~~L~~~l-----------------~~~--~~~~~~~--~~~~~~i~~qi~~-------------------al~--  162 (369)
                      +|++|.++..--                 ...  .-.....  ...+.++..++..                   .+.  
T Consensus       130 e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L  209 (379)
T 3feg_A          130 QYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNL  209 (379)
T ss_dssp             ECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHH
T ss_pred             EEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHH
Confidence            999987653210                 000  0011111  2233344433321                   122  


Q ss_pred             --HHhcC-CCCCcccCCCCCCCEEEeCC----CceEEeecCCcee
Q 017594          163 --YLHQY-SRVRIIHRDLKASNILLDKD----MNPKISDFGMARI  200 (369)
Q Consensus       163 --~LH~~-~~~~i~H~dl~p~NIlv~~~----~~~~L~Dfg~~~~  200 (369)
                        .|... ....++|+|+.+.||+++.+    +.+.|+||..+..
T Consensus       210 ~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          210 RKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             HHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             HHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence              22222 12359999999999999876    7899999998753

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.70  E-value=0.00016  Score=67.88  Aligned_cols=75  Identities=9%  Similarity=0.079  Sum_probs=43.9

Q ss_pred             CcccCCCCCCCEEEeCCCceEEeecCCceecCCCCccccccccc--ccccccCchhhccC---CCCcccchHhHHHHHHH
Q 017594          171 RIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIV--GTYGYMSPEYALEG---IFSIKSDVFSFGVLLLE  245 (369)
Q Consensus       171 ~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~--~~~~y~aPE~~~~~---~~~~~~DiwslG~il~~  245 (369)
                      .++|||++|.||+++.++ +.++||+.+..-...   .......  -...|++|+.....   .-.....+.+++..++.
T Consensus       233 ~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~---~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (420)
T 2pyw_A          233 ALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMG---FDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWN  308 (420)
T ss_dssp             EEECSCCSGGGEEECSSC-EEECCCTTCEEECHH---HHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHH
T ss_pred             eEEecCCCCCcEEEeCCC-CEEEeCcccccCchH---HHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHH
Confidence            499999999999998876 999999987643210   0000001  01235555543211   11122445577777777


Q ss_pred             HHhC
Q 017594          246 IVSG  249 (369)
Q Consensus       246 l~tg  249 (369)
                      .+++
T Consensus       309 ~y~~  312 (420)
T 2pyw_A          309 LFNK  312 (420)
T ss_dssp             HHHH
T ss_pred             HHHH
Confidence            7765

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.66  E-value=0.00022  Score=64.19  Aligned_cols=158  Identities=14%  Similarity=0.092  Sum_probs=83.4

Q ss_pred             cchhhHHHHhcCCcc-----CccccccCCccEEEEEEcCCCEEEEEEecCCCchhHHHHHHHHHHHhcCCCCc--eeeee
Q 017594           39 FSFSSVSTATNKFSD-----ANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKN--LVRLL  111 (369)
Q Consensus        39 ~~~~~~~~~~~~y~i-----~~~lg~G~~~~v~~~~~~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~--i~~~~  111 (369)
                      .+...+.....+|.+     ++.|+.|....+|.+...+| .+++|+.....  ....+..|+.++..+...+  +.+++
T Consensus         7 ~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~--~~~~l~~e~~~l~~L~~~g~~vP~~~   83 (322)
T 2ppq_A            7 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPL   83 (322)
T ss_dssp             CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred             CCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCCC--CHHHHHHHHHHHHHHHHCCCCCCccc
Confidence            344455555566765     34456688889999987655 67889886521  1234556677666663111  22332


Q ss_pred             ee------EEeCCccEEEEEecCCCChhhh--------------hcC---C-Ccc--ccCC---hHHHH-----------
Q 017594          112 GC------CIDRDEKILIYEYMPNKSLDFF--------------LFD---P-TKR--MLLD---WVTRV-----------  151 (369)
Q Consensus       112 ~~------~~~~~~~~lv~e~~~~~~L~~~--------------l~~---~-~~~--~~~~---~~~~~-----------  151 (369)
                      ..      ....+..++++++++|..+...              ++.   . ...  ....   +...+           
T Consensus        84 ~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~  163 (322)
T 2ppq_A           84 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE  163 (322)
T ss_dssp             CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred             CCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhh
Confidence            11      1234557899999988754210              000   0 000  0000   00000           


Q ss_pred             -HHHHHHHHHHHHHhcC----CCCCcccCCCCCCCEEEeCCCceEEeecCCce
Q 017594          152 -QIIEGIAQGLLYLHQY----SRVRIIHRDLKASNILLDKDMNPKISDFGMAR  199 (369)
Q Consensus       152 -~i~~qi~~al~~LH~~----~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~  199 (369)
                       .+...+...+..++..    ....++|+|+.+.||+++.++.+.|+||+.+.
T Consensus       164 ~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~  216 (322)
T 2ppq_A          164 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  216 (322)
T ss_dssp             TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             hhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence             0001133344444421    12359999999999999987666899998764

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.63  E-value=0.00019  Score=64.12  Aligned_cols=131  Identities=15%  Similarity=0.181  Sum_probs=77.2

Q ss_pred             CccCccccccCCccEEEEEEcCCCEEEEEEecCCCchhHHHHHHHHHHHhcCCCCce-eeeeeeEEeCCccEEEEEec-C
Q 017594           51 FSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNL-VRLLGCCIDRDEKILIYEYM-P  128 (369)
Q Consensus        51 y~i~~~lg~G~~~~v~~~~~~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~lv~e~~-~  128 (369)
                      |.-++.|+.|....+|++     +.+++|+....... ......|+..++.+...++ .+++..  +.+..+++++|+ +
T Consensus        20 ~~~i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~   91 (301)
T 3dxq_A           20 YTGPLERLGGLTNLVFRA-----GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAG   91 (301)
T ss_dssp             CCSCEEEESCSSEEEEEE-----TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTT
T ss_pred             ccceeEcCCcccccccee-----eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCC
Confidence            444788999999999999     56888987643211 1123457777776642222 344433  445568999999 6


Q ss_pred             CCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcC-----------------------------------------
Q 017594          129 NKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQY-----------------------------------------  167 (369)
Q Consensus       129 ~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~-----------------------------------------  167 (369)
                      +.++.......          ...++.+++..|..||..                                         
T Consensus        92 g~~l~~~~~~~----------~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  161 (301)
T 3dxq_A           92 AQTMSPEKFKT----------RPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGG  161 (301)
T ss_dssp             CEECCHHHHHH----------STTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHH
T ss_pred             CccCCHhhHhh----------hHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHH
Confidence            65553210000          000122222222222221                                         


Q ss_pred             ---------CCCCcccCCCCCCCEEEeCCCceEEeecCCcee
Q 017594          168 ---------SRVRIIHRDLKASNILLDKDMNPKISDFGMARI  200 (369)
Q Consensus       168 ---------~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~  200 (369)
                               ....++|+|+.+.||+ ..++.+.++||+.+..
T Consensus       162 l~~~l~~~~~~~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~  202 (301)
T 3dxq_A          162 VRSALAAHPLPLAACHCDPLCENFL-DTGERMWIVDWEYSGM  202 (301)
T ss_dssp             HHHHHHSSCCCCEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             HHHHHHhcCCCceeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence                     1234899999999999 6677889999998764

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.47  E-value=0.0017  Score=58.40  Aligned_cols=95  Identities=8%  Similarity=0.031  Sum_probs=56.8

Q ss_pred             ccccchhhHHHHhcCCcc-----CccccccCCccEEEEEEcCCCEEEEEEecCCCchhHHHHHHHHHHHhcCCCC--cee
Q 017594           36 FPLFSFSSVSTATNKFSD-----ANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHK--NLV  108 (369)
Q Consensus        36 ~~~~~~~~~~~~~~~y~i-----~~~lg~G~~~~v~~~~~~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~--~i~  108 (369)
                      +...+...+.....+|.+     +..++ |....||.+...+|+.+++|+..... .....+..|...+..+...  .++
T Consensus         8 ~~~l~~~~i~~~l~~~g~~~~~~~~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp   85 (328)
T 1zyl_A            8 FQTLHPDTIMDALFEHGIRVDSGLTPLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVA   85 (328)
T ss_dssp             CCCCCHHHHHHHHHHTTCCCCSCCEEEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBC
T ss_pred             CCCCCHHHHHHHHHHcCCCCCceEEeec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeec
Confidence            334444445444455533     23466 88889999887667789999986331 1235666777777776421  233


Q ss_pred             eeeee-----EEeCCccEEEEEecCCCCh
Q 017594          109 RLLGC-----CIDRDEKILIYEYMPNKSL  132 (369)
Q Consensus       109 ~~~~~-----~~~~~~~~lv~e~~~~~~L  132 (369)
                      +++..     ...++..++++++++|..+
T Consensus        86 ~~~~~~g~~~~~~~g~~~~l~~~i~G~~~  114 (328)
T 1zyl_A           86 APVAFNGQTLLNHQGFYFAVFPSVGGRQF  114 (328)
T ss_dssp             CCCCBTTBSCEEETTEEEEEEECCCCEEC
T ss_pred             ceeecCCcEEEEECCEEEEEEEecCCCCC
Confidence            33332     1224456789999988654

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.44  E-value=0.00039  Score=65.49  Aligned_cols=73  Identities=12%  Similarity=0.218  Sum_probs=48.5

Q ss_pred             CccccccCCccEEEEEEcC--------CCEEEEEEecCCCchhHHHHHHHHHHHhcCCCCc-eeeeeeeEEeCCccEEEE
Q 017594           54 ANKLGEGGFGPVYKGVLKK--------GDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKN-LVRLLGCCIDRDEKILIY  124 (369)
Q Consensus        54 ~~~lg~G~~~~v~~~~~~~--------~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~-i~~~~~~~~~~~~~~lv~  124 (369)
                      ++.|+.|....+|++...+        +..+++|+......  ...+..|+.+++.+...+ ..++++.+.  +  .+|+
T Consensus        78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~--~~~li~E~~~l~~L~~~g~~P~l~~~~~--~--g~v~  151 (429)
T 1nw1_A           78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPET--ESHLVAESVIFTLLSERHLGPKLYGIFS--G--GRLE  151 (429)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCC--HHHHHHHHHHHHHHHHTTSSSCEEEEET--T--EEEE
T ss_pred             EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCc--HHHHHHHHHHHHHHHhCCCCCcEEEEeC--C--CEEE
Confidence            4567888889999998653        57899998853221  134557888888874333 345555442  2  4899


Q ss_pred             EecCCCCh
Q 017594          125 EYMPNKSL  132 (369)
Q Consensus       125 e~~~~~~L  132 (369)
                      +|++|.++
T Consensus       152 e~l~G~~l  159 (429)
T 1nw1_A          152 EYIPSRPL  159 (429)
T ss_dssp             CCCCEEEC
T ss_pred             EEeCCccc
Confidence            99987554

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.43  E-value=0.0014  Score=59.31  Aligned_cols=32  Identities=28%  Similarity=0.458  Sum_probs=27.2

Q ss_pred             CCcccCCCCCCCEEEeCC----CceEEeecCCceec
Q 017594          170 VRIIHRDLKASNILLDKD----MNPKISDFGMARIC  201 (369)
Q Consensus       170 ~~i~H~dl~p~NIlv~~~----~~~~L~Dfg~~~~~  201 (369)
                      ..++|||+.+.||+++.+    +.+.|+||+.+..-
T Consensus       183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G  218 (333)
T 3csv_A          183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG  218 (333)
T ss_dssp             CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred             CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence            359999999999999875    67999999987653

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=97.41  E-value=0.00071  Score=64.12  Aligned_cols=74  Identities=12%  Similarity=0.100  Sum_probs=47.1

Q ss_pred             CccccccCCccEEEEEEcC-CCEEEEEEecCCCchhHHHHHHHHHHHhcCCCCce-eeeeeeEEeCCccEEEEEecCCCC
Q 017594           54 ANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNL-VRLLGCCIDRDEKILIYEYMPNKS  131 (369)
Q Consensus        54 ~~~lg~G~~~~v~~~~~~~-~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~lv~e~~~~~~  131 (369)
                      ++.|+.|....+|++...+ +..+++|+....... .-....|+.+++.|...++ .+++..+  .  ...|++|++|.+
T Consensus       113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~-~idR~~E~~vl~~L~~~gl~P~ll~~~--~--~G~v~e~I~G~~  187 (458)
T 2qg7_A          113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDE-IINREREKKISCILYNKNIAKKIYVFF--T--NGRIEEFMDGYA  187 (458)
T ss_dssp             EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCS-CSCHHHHHHHHHHHTTSSSBCCEEEEE--T--TEEEEECCCSEE
T ss_pred             EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhh-hcCHHHHHHHHHHHHhcCCCCCEEEEe--C--CeEEEEeeCCcc
Confidence            4577888899999998765 478889987533211 1122578888888864443 4566555  2  246999998765


Q ss_pred             h
Q 017594          132 L  132 (369)
Q Consensus       132 L  132 (369)
                      +
T Consensus       188 l  188 (458)
T 2qg7_A          188 L  188 (458)
T ss_dssp             C
T ss_pred             C
Confidence            5

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=97.20  E-value=0.0038  Score=56.68  Aligned_cols=31  Identities=23%  Similarity=0.386  Sum_probs=27.2

Q ss_pred             CCcccCCCCCCCEEEeCCCceEEeecCCcee
Q 017594          170 VRIIHRDLKASNILLDKDMNPKISDFGMARI  200 (369)
Q Consensus       170 ~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~  200 (369)
                      ..++|||+.+.||+++.++.+.|+||+.+..
T Consensus       206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~  236 (339)
T 3i1a_A          206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML  236 (339)
T ss_dssp             CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred             ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence            3599999999999999888899999987653

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=97.19  E-value=0.00079  Score=61.93  Aligned_cols=74  Identities=15%  Similarity=0.141  Sum_probs=44.1

Q ss_pred             CccccccCCccEEEEEEcC---------CCEEEEEEecCCCchhHHHHHHHHHHHhcCCCCc-eeeeeeeEEeCCccEEE
Q 017594           54 ANKLGEGGFGPVYKGVLKK---------GDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKN-LVRLLGCCIDRDEKILI  123 (369)
Q Consensus        54 ~~~lg~G~~~~v~~~~~~~---------~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~-i~~~~~~~~~~~~~~lv  123 (369)
                      ++.|+.|....+|++...+         +..+++|+..... ........|...++.+...+ ..+++..+    ..++|
T Consensus        38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~~~~E~~~l~~L~~~g~~P~~~~~~----~~~~v  112 (369)
T 3c5i_A           38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHV-DELYNTISEFEVYKTMSKYKIAPQLLNTF----NGGRI  112 (369)
T ss_dssp             EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTG-GGTSCHHHHHHHHHHHHHTTSSCCEEEEE----TTEEE
T ss_pred             EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCc-cceecHHHHHHHHHHHHhcCCCCceEEec----CCcEE
Confidence            4567788889999998653         2688889875432 21122356777777774323 34555443    24789


Q ss_pred             EEecCCCCh
Q 017594          124 YEYMPNKSL  132 (369)
Q Consensus       124 ~e~~~~~~L  132 (369)
                      ++|++|..+
T Consensus       113 ~e~i~G~~l  121 (369)
T 3c5i_A          113 EEWLYGDPL  121 (369)
T ss_dssp             EECCCSEEC
T ss_pred             EEEecCCcC
Confidence            999988654

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=96.41  E-value=0.007  Score=56.61  Aligned_cols=74  Identities=11%  Similarity=0.082  Sum_probs=47.7

Q ss_pred             CccccccCCccEEEEEEcC--------CCEEEEEEecCCCchhHHHHHHHHHHHhcCC-CCceeeeeeeEEeCCccEEEE
Q 017594           54 ANKLGEGGFGPVYKGVLKK--------GDEIAVKRLSGRSGQGLREMKNEASVIAKVQ-HKNLVRLLGCCIDRDEKILIY  124 (369)
Q Consensus        54 ~~~lg~G~~~~v~~~~~~~--------~~~valK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~  124 (369)
                      ++.+..|-...+|++...+        ++.+++++..... ...-...+|+.+++.+. +.-..++++.+    ..+.|+
T Consensus        75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t-~~~idR~~E~~~l~~L~~~gi~P~l~~~~----~~~~I~  149 (424)
T 3mes_A           75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV-GKFYDSKVELDVFRYLSNINIAPNIIADF----PEGRIE  149 (424)
T ss_dssp             EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEE----TTEEEE
T ss_pred             EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc-chhcCHHHHHHHHHHHHhcCCCCCEEEEc----CCCEEE
Confidence            4567778889999998653        5789999875432 21223356777777774 22234445432    248899


Q ss_pred             EecCCCCh
Q 017594          125 EYMPNKSL  132 (369)
Q Consensus       125 e~~~~~~L  132 (369)
                      +|++|.++
T Consensus       150 efI~G~~l  157 (424)
T 3mes_A          150 EFIDGEPL  157 (424)
T ss_dssp             ECCCSEEC
T ss_pred             EEeCCccC
Confidence            99998764

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=95.82  E-value=0.023  Score=52.71  Aligned_cols=30  Identities=27%  Similarity=0.393  Sum_probs=25.2

Q ss_pred             CcccCCCCCCCEEE------eCCCceEEeecCCcee
Q 017594          171 RIIHRDLKASNILL------DKDMNPKISDFGMARI  200 (369)
Q Consensus       171 ~i~H~dl~p~NIlv------~~~~~~~L~Dfg~~~~  200 (369)
                      .++|+|+.+.||++      +.++.+.++||..+..
T Consensus       245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            36899999999999      4467799999998764

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=87.23  E-value=1.2  Score=37.09  Aligned_cols=115  Identities=8%  Similarity=0.064  Sum_probs=74.1

Q ss_pred             CCCceeeeeeeEEeCCccEEEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHH-HHhcCCCCCcccCCCCCCC
Q 017594          103 QHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLL-YLHQYSRVRIIHRDLKASN  181 (369)
Q Consensus       103 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~-~LH~~~~~~i~H~dl~p~N  181 (369)
                      .||++  -..+-..++.+.+.+..-.+..-...+      ..++....++++.+|+.... +++.     -+|--++|+|
T Consensus        48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i------~~~~~~eKlrll~nl~~L~~~~~~~-----r~tf~l~P~N  114 (219)
T 4ano_A           48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAI------RKTTLLSRIRAAIHLVSKVKHHSAR-----RLIFIVCPEN  114 (219)
T ss_dssp             SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHH------HTSCHHHHHHHHHHHHHHHSSCCSS-----SEECCCCGGG
T ss_pred             cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHH------HhcCHHHHHHHHHHHHHHHHHhhhC-----ceeEEEeCce
Confidence            57777  344445666677766654333222222      22677888999998887766 4432     5788999999


Q ss_pred             EEEeCCCceEEeecCCceecCCCCcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCC
Q 017594          182 ILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTG  254 (369)
Q Consensus       182 Ilv~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~  254 (369)
                      ++++.++.+++.-.|+-.                   .++|...     +...=+-++=|++..++.++..|.
T Consensus       115 L~f~~~~~p~i~hRGi~~-------------------~lpP~e~-----~ee~fl~qyKali~all~~K~~Fe  163 (219)
T 4ano_A          115 LMFNRALEPFFLHVGVKE-------------------SLPPDEW-----DDERLLREVKATVLALTEGEYRFD  163 (219)
T ss_dssp             EEECTTCCEEESCCEETT-------------------TBSSCSC-----CHHHHHHHHHHHHHHHTTCSSCHH
T ss_pred             EEEeCCCcEEEEEcCCcc-------------------cCCCCCC-----CHHHHHHHHHHHHHHHHcCCCCHH
Confidence            999999999998766521                   2233211     111223467788888998887654

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=86.71  E-value=0.95  Score=37.65  Aligned_cols=116  Identities=11%  Similarity=0.047  Sum_probs=75.7

Q ss_pred             CCCceeeeeeeEEeCCccEEEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCE
Q 017594          103 QHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNI  182 (369)
Q Consensus       103 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NI  182 (369)
                      .||+++.. .+-..++.+.+.++.-.  ....+-    .-...+....++++.+|+....+++.     -+|--++|+|+
T Consensus        43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~--~~~~f~----~ik~~~~~eKlr~l~ni~~l~~~~~~-----r~tf~L~P~NL  110 (215)
T 4ann_A           43 HSPYFIDA-ELTELRDSFQIHYDIND--NHTPFD----NIKSFTKNEKLRYLLNIKNLEEVNRT-----RYTFVLAPDEL  110 (215)
T ss_dssp             CCTTBCCE-EEEECSSEEEEEECCCT--TSEEGG----GGGGSCHHHHHHHHHHGGGGGGGGGS-----SEECCCSGGGE
T ss_pred             cCCcccce-EEEEcccEEEEEEEcCc--ccCCHH----HHHhcCHHHHHHHHHHHHHHHHHhcC-----ceEEEEecceE
Confidence            57888766 45555665555555433  222221    11226788899999999888855543     47889999999


Q ss_pred             EEeCCCceEEeecCCceecCCCCcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCC
Q 017594          183 LLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTG  254 (369)
Q Consensus       183 lv~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~  254 (369)
                      +++.++.+++.-.|+-.                   -++|.     .++...=+-.+=|++..+++++..|.
T Consensus       111 ~f~~~~~p~i~~RGik~-------------------~l~P~-----~~~ee~fL~qyKAliiall~~K~~Fe  158 (215)
T 4ann_A          111 FFTRDGLPIAKTRGLQN-------------------VVDPL-----PVSEAEFLTRYKALVICAFNEKQSFD  158 (215)
T ss_dssp             EECTTSCEEESCCEETT-------------------TBSCC-----CCCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred             EEcCCCCEEEEEccCcc-------------------CCCCC-----CCCHHHHHHHHHHHHHHHHcCCCCHH
Confidence            99999999998766421                   12222     11222234467889999999988764

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	369
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	4e-74
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	6e-69
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	9e-69
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	2e-67
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	5e-67
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	4e-66
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	2e-65
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	5e-64
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	3e-63
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	3e-63
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	1e-62
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	4e-62
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	7e-62
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	1e-61
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	2e-61
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	4e-61
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	5e-61
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	3e-60
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	8e-60
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	3e-59
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	3e-59
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	1e-58
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	1e-58
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	4e-58
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	5e-58
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	1e-57
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	4e-57
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	2e-55
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	5e-54
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	1e-53
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	2e-52
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	1e-51
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	2e-49
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	7e-49
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	2e-46
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	7e-46
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	3e-45
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	1e-44
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	2e-44
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	2e-44
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	1e-43
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	1e-43
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	1e-42
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	2e-42
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	3e-42
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	4e-42
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	1e-41
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	1e-41
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	3e-41
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	1e-40
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	2e-40
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	3e-39
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	9e-38
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	1e-37
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	3e-37
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	4e-36
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	1e-34
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	7e-32
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	1e-31
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	6e-31
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	5e-30
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	1e-28
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	7e-25

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  229 bits (584), Expect = 4e-74
 Identities = 70/288 (24%), Positives = 133/288 (46%), Gaps = 22/288 (7%)

Query: 49  NKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLV 108
            + +   ++G G FG VYKG       + +  ++  + Q L+  KNE  V+ K +H N++
Sbjct: 8   GQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 67

Query: 109 RLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYS 168
             +G      +  ++ ++    SL   L     +   + +  + I    AQG+ YLH  S
Sbjct: 68  LFMGYS-TAPQLAIVTQWCEGSSLYHHLHIIETK--FEMIKLIDIARQTAQGMDYLHAKS 124

Query: 169 RVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAL-- 226
              IIHRDLK++NI L +D+  KI DFG+A +           ++ G+  +M+PE     
Sbjct: 125 ---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 181

Query: 227 -EGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILE 285
            +  +S +SDV++FG++L E+++G+         ++N       +         +  +  
Sbjct: 182 DKNPYSFQSDVYAFGIVLYELMTGQLP-----YSNINNRDQIIFMVGRGYLSPDLSKVRS 236

Query: 286 DEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNEAATLLPPK 333
           +    K M      +   C+++  D+RP    +++ +   A +L  PK
Sbjct: 237 N--CPKAM----KRLMAECLKKKRDERPLFPQILASIELLARSL--PK 276

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  216 bits (551), Expect = 6e-69
 Identities = 76/288 (26%), Positives = 128/288 (44%), Gaps = 22/288 (7%)

Query: 49  NKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLV 108
                  KLG+G FG V+ G       +A+K L             EA V+ K++H+ LV
Sbjct: 17  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLV 75

Query: 109 RLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYS 168
           +L       +   ++ EYM   SL  FL   T + L      V +   IA G+ Y+ +  
Sbjct: 76  QLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYL-RLPQLVDMAAQIASGMAYVERM- 132

Query: 169 RVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEG 228
               +HRDL+A+NIL+ +++  K++DFG+AR+   NE  A          + +PE AL G
Sbjct: 133 --NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG-AKFPIKWTAPEAALYG 189

Query: 229 IFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEY 288
            F+IKSDV+SFG+LL E+ +  +                +    +   L+ ++       
Sbjct: 190 RFTIKSDVWSFGILLTELTTKGRVP--------------YPGMVNREVLDQVERGYRMPC 235

Query: 289 SSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNEAATLLPPKQPA 336
             +       ++   C ++  ++RPT   + + L +   +  P  QP 
Sbjct: 236 PPE-CPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPG 282

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  215 bits (548), Expect = 9e-69
 Identities = 79/277 (28%), Positives = 134/277 (48%), Gaps = 28/277 (10%)

Query: 49  NKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLV 108
                  +LG G FG V+ G      ++AVK L  +          EA+++ ++QH+ LV
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLV 71

Query: 109 RLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYS 168
           RL       +   +I EYM N SL  FL  P   + L     + +   IA+G+ ++ + +
Sbjct: 72  RLYAVVTQ-EPIYIITEYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEERN 129

Query: 169 RVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEG 228
               IHRDL+A+NIL+   ++ KI+DFG+AR+   NE  A          + +PE    G
Sbjct: 130 ---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREG-AKFPIKWTAPEAINYG 185

Query: 229 IFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELID---PILE 285
            F+IKSDV+SFG+LL EIV+  +                +   T+   ++ ++    ++ 
Sbjct: 186 TFTIKSDVWSFGILLTEIVTHGRI--------------PYPGMTNPEVIQNLERGYRMVR 231

Query: 286 DEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSML 322
            +   +++      +  LC +E  +DRPT + + S+L
Sbjct: 232 PDNCPEEL----YQLMRLCWKERPEDRPTFDYLRSVL 264

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  211 bits (538), Expect = 2e-67
 Identities = 73/268 (27%), Positives = 123/268 (45%), Gaps = 22/268 (8%)

Query: 55  NKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCC 114
            ++G G FG V+ G     D++A+K +         +   EA V+ K+ H  LV+L G C
Sbjct: 11  QEIGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 69

Query: 115 IDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 174
           +++    L++E+M +  L  +L    +R L    T + +   + +G+ YL +     +IH
Sbjct: 70  LEQAPICLVFEFMEHGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYLEEA---CVIH 124

Query: 175 RDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKS 234
           RDL A N L+ ++   K+SDFGM R    ++   +++       + SPE      +S KS
Sbjct: 125 RDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT-SSTGTKFPVKWASPEVFSFSRYSSKS 183

Query: 235 DVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYSSKQML 294
           DV+SFGVL+ E+ S  K     R++S         +   +    L  P L          
Sbjct: 184 DVWSFGVLMWEVFSEGKIPYENRSNS-------EVVEDISTGFRLYKPRLAST------- 229

Query: 295 LRYANIALLCVQESADDRPTMNDVVSML 322
                I   C +E  +DRP  + ++  L
Sbjct: 230 -HVYQIMNHCWKERPEDRPAFSRLLRQL 256

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  212 bits (539), Expect = 5e-67
 Identities = 64/291 (21%), Positives = 120/291 (41%), Gaps = 28/291 (9%)

Query: 56  KLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCI 115
            +G+G FG V++G  + G+E+AVK  S R  +     + E      ++H+N++  +    
Sbjct: 10  SIGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWF-REAEIYQTVMLRHENILGFIAADN 67

Query: 116 DRDEKI----LIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQ----- 166
             +       L+ +Y  + SL  +L     R  +     +++    A GL +LH      
Sbjct: 68  KDNGTWTQLWLVSDYHEHGSLFDYL----NRYTVTVEGMIKLALSTASGLAHLHMEIVGT 123

Query: 167 YSRVRIIHRDLKASNILLDKDMNPKISDFGMARIC--GGNELQANTSRIVGTYGYMSPEY 224
             +  I HRDLK+ NIL+ K+    I+D G+A       + +    +  VGT  YM+PE 
Sbjct: 124 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEV 183

Query: 225 ALEGI------FSIKSDVFSFGVLLLEIVSGKKNTGLYRTDS-----LNLLGYAWDLWTS 273
             + I         ++D+++ G++  EI       G++         L     + +    
Sbjct: 184 LDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRK 243

Query: 274 NRTLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTN 324
               + + P + + + S + L   A I   C   +   R T   +   L+ 
Sbjct: 244 VVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ 294

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  209 bits (533), Expect = 4e-66
 Identities = 75/301 (24%), Positives = 131/301 (43%), Gaps = 37/301 (12%)

Query: 39  FSFSSVSTATNKFSDA---------NKLGEGGFGPVYKGVLKKGDE----IAVKRL-SGR 84
           F+F   + A  +F+             +G G FG V  G LK   +    +A+K L SG 
Sbjct: 7   FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66

Query: 85  SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRML 144
           + +  R+  +EAS++ +  H N++ L G        ++I E+M N SLD FL     +  
Sbjct: 67  TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQF- 125

Query: 145 LDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGN 204
              +  V ++ GIA G+ YL        +HRDL A NIL++ ++  K+SDFG++R    +
Sbjct: 126 -TVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181

Query: 205 ELQANTSRIVG---TYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSL 261
                 +  +G      + +PE      F+  SDV+S+G+++ E++S  +          
Sbjct: 182 TSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGE---------- 231

Query: 262 NLLGYAWDLWTSNRTLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSM 321
                 +   T+   +  I+                  + L C Q+  + RP    +V+ 
Sbjct: 232 ----RPYWDMTNQDVINAIEQDYRLPPPMD-CPSALHQLMLDCWQKDRNHRPKFGQIVNT 286

Query: 322 L 322
           L
Sbjct: 287 L 287

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  206 bits (524), Expect = 2e-65
 Identities = 72/270 (26%), Positives = 120/270 (44%), Gaps = 22/270 (8%)

Query: 55  NKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCC 114
            +LG G FG V  G  +   ++A+K +         E   EA V+  + H+ LV+L G C
Sbjct: 10  KELGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVC 68

Query: 115 IDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 174
             +    +I EYM N  L  +L +   R        +++ + + + + YL      + +H
Sbjct: 69  TKQRPIFIITEYMANGCLLNYLREMRHR--FQTQQLLEMCKDVCEAMEYLESK---QFLH 123

Query: 175 RDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKS 234
           RDL A N L++     K+SDFG++R    +E  ++         +  PE  +   FS KS
Sbjct: 124 RDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVG-SKFPVRWSPPEVLMYSKFSSKS 182

Query: 235 DVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYSSKQML 294
           D+++FGVL+ EI S  K                ++ +T++ T E I   L          
Sbjct: 183 DIWAFGVLMWEIYSLGK--------------MPYERFTNSETAEHIAQGLRLYRPHL-AS 227

Query: 295 LRYANIALLCVQESADDRPTMNDVVSMLTN 324
            +   I   C  E AD+RPT   ++S + +
Sbjct: 228 EKVYTIMYSCWHEKADERPTFKILLSNILD 257

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  203 bits (518), Expect = 5e-64
 Identities = 76/275 (27%), Positives = 126/275 (45%), Gaps = 22/275 (8%)

Query: 49  NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNL 107
              +  +KLG G +G VY+GV KK    +AVK L       + E   EA+V+ +++H NL
Sbjct: 17  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNL 75

Query: 108 VRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQY 167
           V+LLG C       +I E+M   +L  +L +   R  +  V  + +   I+  + YL + 
Sbjct: 76  VQLLGVCTREPPFYIITEFMTYGNLLDYLRE-CNRQEVSAVVLLYMATQISSAMEYLEKK 134

Query: 168 SRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALE 227
                IHRDL A N L+ ++   K++DFG++R+  G+   A+         + +PE    
Sbjct: 135 ---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAG-AKFPIKWTAPESLAY 190

Query: 228 GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDE 287
             FSIKSDV++FGVLL EI +   +               +     ++  EL++     E
Sbjct: 191 NKFSIKSDVWAFGVLLWEIATYGMSP--------------YPGIDLSQVYELLEKDYRME 236

Query: 288 YSSKQMLLRYANIALLCVQESADDRPTMNDVVSML 322
                   +   +   C Q +  DRP+  ++    
Sbjct: 237 RPEG-CPEKVYELMRACWQWNPSDRPSFAEIHQAF 270

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  201 bits (511), Expect = 3e-63
 Identities = 70/275 (25%), Positives = 117/275 (42%), Gaps = 28/275 (10%)

Query: 49  NKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLV 108
            +      +G+G FG V  G  + G+++AVK +  ++    +    EASV+ +++H NLV
Sbjct: 7   KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLV 63

Query: 109 RLLGCCIDRDEKI-LIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQY 167
           +LLG  ++    + ++ EYM   SL  +L     R +L     ++    + + + YL   
Sbjct: 64  QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRS-RGRSVLGGDCLLKFSLDVCEAMEYLEGN 122

Query: 168 SRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALE 227
                +HRDL A N+L+ +D   K+SDFG+ +     E  +          + +PE   E
Sbjct: 123 ---NFVHRDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEALRE 174

Query: 228 GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDE 287
             FS KSDV+SFG+LL EI S  +    Y    L  +            ++  D      
Sbjct: 175 KKFSTKSDVWSFGILLWEIYSFGRVP--YPRIPLKDV---VPRVEKGYKMDAPDGCPPA- 228

Query: 288 YSSKQMLLRYANIALLCVQESADDRPTMNDVVSML 322
                       +   C    A  RP+   +   L
Sbjct: 229 ---------VYEVMKNCWHLDAAMRPSFLQLREQL 254

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  202 bits (516), Expect = 3e-63
 Identities = 70/301 (23%), Positives = 120/301 (39%), Gaps = 38/301 (12%)

Query: 47  ATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLRE-MKNEASVIAKVQH 104
             + F   ++LG G  G V+K   K  G  +A K +       +R  +  E  V+ +   
Sbjct: 4   KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNS 63

Query: 105 KNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYL 164
             +V   G      E  +  E+M   SLD  L    K   +      ++   + +GL YL
Sbjct: 64  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK---KAGRIPEQILGKVSIAVIKGLTYL 120

Query: 165 HQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY 224
               + +I+HRD+K SNIL++     K+ DFG++     +      +  VGT  YMSPE 
Sbjct: 121 R--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM----ANSFVGTRSYMSPER 174

Query: 225 ALEGIFSIKSDVFSFGVLLLEIVSGK------------------------KNTGLYRTDS 260
                +S++SD++S G+ L+E+  G+                        +     RT  
Sbjct: 175 LQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG 234

Query: 261 LNLLGYAWDLWTSNRTLELIDPILEDEY---SSKQMLLRYANIALLCVQESADDRPTMND 317
             L  Y  D        EL+D I+ +      S    L + +    C+ ++  +R  +  
Sbjct: 235 RPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQ 294

Query: 318 V 318
           +
Sbjct: 295 L 295

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  200 bits (509), Expect = 1e-62
 Identities = 68/304 (22%), Positives = 122/304 (40%), Gaps = 50/304 (16%)

Query: 49  NKFSDANKLGEGGFGPVYKGVLKK------GDEIAVKRLSGRSGQGLR-EMKNEASVIAK 101
           N       +GEG FG V++              +AVK L   +   ++ + + EA+++A+
Sbjct: 13  NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 72

Query: 102 VQHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRML----------------- 144
             + N+V+LLG C       L++EYM    L+ FL   +   +                 
Sbjct: 73  FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 132

Query: 145 ----LDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARI 200
               L    ++ I   +A G+ YL +    + +HRDL   N L+ ++M  KI+DFG++R 
Sbjct: 133 GPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRN 189

Query: 201 CGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDS 260
               +             +M PE      ++ +SDV+++GV+L EI S            
Sbjct: 190 IYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP------- 242

Query: 261 LNLLGYAWDLWTSNRTLELIDPILEDEYSS--KQMLLRYANIALLCVQESADDRPTMNDV 318
                     +      E+I  + +    +  +   L   N+  LC  +   DRP+   +
Sbjct: 243 ----------YYGMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSI 292

Query: 319 VSML 322
             +L
Sbjct: 293 HRIL 296

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  199 bits (507), Expect = 4e-62
 Identities = 69/284 (24%), Positives = 121/284 (42%), Gaps = 28/284 (9%)

Query: 55  NKLGEGGFGPVYKGVLKKGD----EIAVKRLSGRSGQG-LREMKNEASVIAKVQHKNLVR 109
             +G G FG VY G L   D      AVK L+  +  G + +   E  ++    H N++ 
Sbjct: 33  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 92

Query: 110 LLGCCIDRDEKI-LIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYS 168
           LLG C+  +    ++  YM +  L  F+ + T    +  +    +          +   +
Sbjct: 93  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKG-----MKFLA 147

Query: 169 RVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR--IVGTYGYMSPEYAL 226
             + +HRDL A N +LD+    K++DFG+AR     E  +  ++        +M+ E   
Sbjct: 148 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQ 207

Query: 227 EGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILED 286
              F+ KSDV+SFGVLL E+++            +N       L    R       +L+ 
Sbjct: 208 TQKFTTKSDVWSFGVLLWELMTRGAPP----YPDVNTFDITVYLLQGRR-------LLQP 256

Query: 287 EYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNEAATLL 330
           EY    +      + L C    A+ RP+ +++VS ++   +T +
Sbjct: 257 EYCPDPL----YEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 296

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  198 bits (503), Expect = 7e-62
 Identities = 67/287 (23%), Positives = 117/287 (40%), Gaps = 26/287 (9%)

Query: 56  KLGEGGFGPVYKGVLK---KGDEIAVKRLSGRSGQG-LREMKNEASVIAKVQHKNLVRLL 111
           +LG G FG V +GV +   K  ++A+K L   + +    EM  EA ++ ++ +  +VRL+
Sbjct: 16  ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 75

Query: 112 GCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVR 171
           G C      +L+ E      L  FL    KR  +      +++  ++ G+ YL + +   
Sbjct: 76  GVCQAE-ALMLVMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKN--- 129

Query: 172 IIHRDLKASNILLDKDMNPKISDFGMARICGGNELQAN-TSRIVGTYGYMSPEYALEGIF 230
            +HRDL A N+LL      KISDFG+++  G ++      S       + +PE      F
Sbjct: 130 FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKF 189

Query: 231 SIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYSS 290
           S +SDV+S+GV + E +S  +                +        +  I+     E   
Sbjct: 190 SSRSDVWSYGVTMWEALSYGQ--------------KPYKKMKGPEVMAFIEQGKRMECPP 235

Query: 291 KQMLLRYANIALLCVQESADDRPTMNDVVSMLTNEAATLLPPKQPAF 337
           +        +   C     +DRP    V   +     +L    +   
Sbjct: 236 E-CPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVEGHH 281

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  198 bits (504), Expect = 1e-61
 Identities = 77/280 (27%), Positives = 124/280 (44%), Gaps = 34/280 (12%)

Query: 48  TNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQG---LREMKNEASVIAKVQ 103
              FSD  ++G G FG VY     +  + +A+K++S    Q     +++  E   + K++
Sbjct: 14  EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73

Query: 104 HKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLY 163
           H N ++  GC +      L+ EY    + D        +  L  V    +  G  QGL Y
Sbjct: 74  HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEV---HKKPLQEVEIAAVTHGALQGLAY 130

Query: 164 LHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE 223
           LH +    +IHRD+KA NILL +    K+ DFG A I       A  +  VGT  +M+PE
Sbjct: 131 LHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIM------APANSFVGTPYWMAPE 181

Query: 224 YAL---EGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELI 280
             L   EG +  K DV+S G+  +E+   K    L+  ++++ L             +  
Sbjct: 182 VILAMDEGQYDGKVDVWSLGITCIELAERK--PPLFNMNAMSAL---------YHIAQNE 230

Query: 281 DPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVS 320
            P L+  + S+       N    C+Q+   DRPT   ++ 
Sbjct: 231 SPALQSGHWSEYF----RNFVDSCLQKIPQDRPTSEVLLK 266

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  196 bits (499), Expect = 2e-61
 Identities = 73/281 (25%), Positives = 129/281 (45%), Gaps = 27/281 (9%)

Query: 49  NKFSDANKLGEGGFGPVYKGVLKKGDE-----IAVKRLS-GRSGQGLREMKNEASVIAKV 102
           +  +    +G G FG VYKG+LK         +A+K L  G + +   +   EA ++ + 
Sbjct: 7   SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66

Query: 103 QHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLL 162
            H N++RL G        ++I EYM N +LD FL +  K      +  V ++ GIA G+ 
Sbjct: 67  SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLRE--KDGEFSVLQLVGMLRGIAAGMK 124

Query: 163 YLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANT-SRIVGTYGYMS 221
           YL     +  +HRDL A NIL++ ++  K+SDFG++R+   +     T S       + +
Sbjct: 125 YLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTA 181

Query: 222 PEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELID 281
           PE      F+  SDV+SFG+++ E+++  +                +   +++  ++ I+
Sbjct: 182 PEAISYRKFTSASDVWSFGIVMWEVMTYGE--------------RPYWELSNHEVMKAIN 227

Query: 282 PILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSML 322
                             + + C Q+    RP   D+VS+L
Sbjct: 228 DGFRLPT-PMDCPSAIYQLMMQCWQQERARRPKFADIVSIL 267

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  195 bits (497), Expect = 4e-61
 Identities = 63/274 (22%), Positives = 118/274 (43%), Gaps = 31/274 (11%)

Query: 55  NKLGEGGFGPVYKGVLKK-GDEIAVKRLSGR--SGQGLREMKNEASVIAKVQHKNLVRLL 111
            ++G G F  VYKG+  +   E+A   L  R  +    +  K EA ++  +QH N+VR  
Sbjct: 15  IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFY 74

Query: 112 GCCID----RDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQY 167
                    +   +L+ E M + +L  +L    +  ++           I +GL +LH  
Sbjct: 75  DSWESTVKGKKCIVLVTELMTSGTLKTYLK---RFKVMKIKVLRSWCRQILKGLQFLHTR 131

Query: 168 SRVRIIHRDLKASNILL-DKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAL 226
           +   IIHRDLK  NI +     + KI D G+A +   +        ++GT  +M+PE   
Sbjct: 132 TP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS----FAKAVIGTPEFMAPEM-Y 185

Query: 227 EGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILED 286
           E  +    DV++FG+ +LE+ + +                        R    + P   D
Sbjct: 186 EEKYDESVDVYAFGMCMLEMATSE----------YPYSECQNAAQIYRRVTSGVKPASFD 235

Query: 287 EYSSKQMLLRYANIALLCVQESADDRPTMNDVVS 320
           + +  ++      I   C++++ D+R ++ D+++
Sbjct: 236 KVAIPEV----KEIIEGCIRQNKDERYSIKDLLN 265

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  195 bits (497), Expect = 5e-61
 Identities = 64/278 (23%), Positives = 114/278 (41%), Gaps = 28/278 (10%)

Query: 53  DANKLGEGGFGPVYKGVLKK---GDEIAVKRLSGRSGQG--LREMKNEASVIAKVQHKNL 107
           +  +LG G FG V KG  +       +AVK L   +       E+  EA+V+ ++ +  +
Sbjct: 11  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 70

Query: 108 VRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQY 167
           VR++G C + +  +L+ E      L+ +L        +     ++++  ++ G+ YL + 
Sbjct: 71  VRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRH---VKDKNIIELVHQVSMGMKYLEES 126

Query: 168 SRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTS-RIVGTYGYMSPEYAL 226
                +HRDL A N+LL      KISDFG+++    +E              + +PE   
Sbjct: 127 ---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECIN 183

Query: 227 EGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILED 286
              FS KSDV+SFGVL+ E  S  +                +     +    +++     
Sbjct: 184 YYKFSSKSDVWSFGVLMWEAFSYGQ--------------KPYRGMKGSEVTAMLEKGERM 229

Query: 287 EYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTN 324
              +        ++  LC     ++RP    V   L N
Sbjct: 230 GCPAG-CPREMYDLMNLCWTYDVENRPGFAAVELRLRN 266

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  195 bits (495), Expect = 3e-60
 Identities = 70/278 (25%), Positives = 123/278 (44%), Gaps = 27/278 (9%)

Query: 51  FSDANKLGEGGFGPVYKGVLKKGDE-----IAVKRLS-GRSGQGLREMKNEASVIAKVQH 104
           F     LG G FG VYKG+     E     +A+K L    S +  +E+ +EA V+A V +
Sbjct: 11  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70

Query: 105 KNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYL 164
            ++ RLLG C+      LI + MP   L  ++ +    +       +     IA+G+ YL
Sbjct: 71  PHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNI--GSQYLLNWCVQIAKGMNYL 127

Query: 165 HQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY 224
                 R++HRDL A N+L+    + KI+DFG+A++ G  E + +         +M+ E 
Sbjct: 128 EDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 184

Query: 225 ALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPIL 284
            L  I++ +SDV+S+GV + E+++                   +D   ++    +++   
Sbjct: 185 ILHRIYTHQSDVWSYGVTVWELMTFGS--------------KPYDGIPASEISSILEKGE 230

Query: 285 EDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSML 322
                     +    I + C    AD RP   +++   
Sbjct: 231 RLPQ-PPICTIDVYMIMVKCWMIDADSRPKFRELIIEF 267

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  194 bits (493), Expect = 8e-60
 Identities = 73/298 (24%), Positives = 120/298 (40%), Gaps = 45/298 (15%)

Query: 56  KLGEGGFGPVYKGVLKKGDE------IAVKRLSGRSGQGLRE-MKNEASVIAKV-QHKNL 107
            LG G FG V         +      +AVK L  ++    RE + +E  ++ ++  H+N+
Sbjct: 44  VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENI 103

Query: 108 VRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRM--------------------LLDW 147
           V LLG C       LI+EY     L  +L    ++                     +L +
Sbjct: 104 VNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTF 163

Query: 148 VTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQ 207
              +     +A+G+ +L        +HRDL A N+L+      KI DFG+AR    +   
Sbjct: 164 EDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNY 220

Query: 208 ANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYA 267
                      +M+PE   EGI++IKSDV+S+G+LL EI S   N   Y    ++     
Sbjct: 221 VVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVN--PYPGIPVDAN--F 276

Query: 268 WDLWTSNRTLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNE 325
           + L  +   ++      E+ Y           I   C    +  RP+  ++ S L  +
Sbjct: 277 YKLIQNGFKMDQPFYATEEIY----------IIMQSCWAFDSRKRPSFPNLTSFLGCQ 324

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  190 bits (484), Expect = 3e-59
 Identities = 69/275 (25%), Positives = 115/275 (41%), Gaps = 30/275 (10%)

Query: 55  NKLGEGGFGPVYKGVLKK-GDEIAVKRL--SGRSGQGLREMKNEASVIAKVQHKNLVRLL 111
             +G G +G   K   K  G  +  K L     +    + + +E +++ +++H N+VR  
Sbjct: 10  YTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYY 69

Query: 112 GCCIDRDEKIL--IYEYMPNKSLDFFLFDPTK-RMLLDWVTRVQIIEGIAQGLLYLHQYS 168
              IDR    L  + EY     L   +   TK R  LD    ++++  +   L   H+ S
Sbjct: 70  DRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRS 129

Query: 169 RV--RIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAL 226
                ++HRDLK +N+ LD   N K+ DFG+ARI   +   A     VGT  YMSPE   
Sbjct: 130 DGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKA--FVGTPYYMSPEQMN 187

Query: 227 EGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILED 286
              ++ KSD++S G LL E+ +                      +T+    EL   I E 
Sbjct: 188 RMSYNEKSDIWSLGCLLYELCALMP------------------PFTAFSQKELAGKIREG 229

Query: 287 EYSS--KQMLLRYANIALLCVQESADDRPTMNDVV 319
           ++     +       I    +      RP++ +++
Sbjct: 230 KFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEIL 264

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  191 bits (487), Expect = 3e-59
 Identities = 71/300 (23%), Positives = 115/300 (38%), Gaps = 40/300 (13%)

Query: 49  NKFSDANKLGEGGFGPVYKGVLKK------GDEIAVKRLSGRSGQGLRE-MKNEASVIAK 101
           N+ S    LG G FG V +              +AVK L   +    RE + +E  V++ 
Sbjct: 23  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82

Query: 102 V-QHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFD---------------PTKRMLL 145
           +  H N+V LLG C      ++I EY     L  FL                     + L
Sbjct: 83  LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142

Query: 146 DWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE 205
           D    +     +A+G+ +L        IHRDL A NILL      KI DFG+AR    + 
Sbjct: 143 DLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199

Query: 206 LQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLG 265
                        +M+PE     +++ +SDV+S+G+ L E+ S   +        + +  
Sbjct: 200 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSS----PYPGMPVDS 255

Query: 266 YAWDLWTSNRTLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNE 325
             + +            +L  E++  +M     +I   C       RPT   +V ++  +
Sbjct: 256 KFYKMIKEGF------RMLSPEHAPAEM----YDIMKTCWDADPLKRPTFKQIVQLIEKQ 305

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  189 bits (482), Expect = 1e-58
 Identities = 62/274 (22%), Positives = 118/274 (43%), Gaps = 35/274 (12%)

Query: 55  NKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGC 113
            +LG+G FG VYK   K+     A K +  +S + L +   E  ++A   H N+V+LL  
Sbjct: 18  GELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA 77

Query: 114 CIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRII 173
               +   ++ E+    ++D  + +  +   L       + +     L YLH     +II
Sbjct: 78  FYYENNLWILIEFCAGGAVDAVMLELERP--LTESQIQVVCKQTLDALNYLHD---NKII 132

Query: 174 HRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAL-----EG 228
           HRDLKA NIL   D + K++DFG++        + ++   +GT  +M+PE  +     + 
Sbjct: 133 HRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS--FIGTPYWMAPEVVMCETSKDR 190

Query: 229 IFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEY 288
            +  K+DV+S G+ L+E+   +                          + ++  I + E 
Sbjct: 191 PYDYKADVWSLGITLIEMAEIEP------------------PHHELNPMRVLLKIAKSEP 232

Query: 289 SSKQMLLRY----ANIALLCVQESADDRPTMNDV 318
            +     R+     +    C++++ D R T + +
Sbjct: 233 PTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQL 266

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  190 bits (483), Expect = 1e-58
 Identities = 78/306 (25%), Positives = 131/306 (42%), Gaps = 36/306 (11%)

Query: 49  NKFSDANKLGEGGFGPVYKGVLKK------GDEIAVKRLS-GRSGQGLREMKNEASVIAK 101
            K + + +LG+G FG VY+GV K          +A+K ++   S +   E  NEASV+ +
Sbjct: 20  EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79

Query: 102 VQHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRML-------LDWVTRVQII 154
               ++VRLLG        ++I E M    L  +L      M              +Q+ 
Sbjct: 80  FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139

Query: 155 EGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIV 214
             IA G+ YL+     + +HRDL A N ++ +D   KI DFGM R     +      + +
Sbjct: 140 GEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 196

Query: 215 GTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSN 274
               +MSPE   +G+F+  SDV+SFGV+L EI +  +      ++               
Sbjct: 197 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE-----QVLRFVMEG 251

Query: 275 RTLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNEAATLLP-PK 333
             L+  D   +              +  +C Q +   RP+  +++S +  E   + P  +
Sbjct: 252 GLLDKPDNCPDM----------LFELMRMCWQYNPKMRPSFLEIISSIKEE---MEPGFR 298

Query: 334 QPAFSY 339
           + +F Y
Sbjct: 299 EVSFYY 304

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  188 bits (477), Expect = 4e-58
 Identities = 72/277 (25%), Positives = 110/277 (39%), Gaps = 28/277 (10%)

Query: 55  NKLGEGGFGPVYKGVLK----KGDEIAVKRLSGR---SGQGLREMKNEASVIAKVQHKNL 107
            KLG+G FG V +G       K   +AVK L        + + +   E + +  + H+NL
Sbjct: 14  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 73

Query: 108 VRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQY 167
           +RL G  +    K+ + E  P  SL   L       LL  ++R      +A+G+ YL   
Sbjct: 74  IRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSR--YAVQVAEGMGYLESK 130

Query: 168 SRVRIIHRDLKASNILLDKDMNPKISDFGMAR-ICGGNELQANTSRIVGTYGYMSPEYAL 226
              R IHRDL A N+LL      KI DFG+ R +   ++           + + +PE   
Sbjct: 131 ---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLK 187

Query: 227 EGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILED 286
              FS  SD + FGV L E+ +  +                W     ++ L  ID   E 
Sbjct: 188 TRTFSHASDTWMFGVTLWEMFTYGQ--------------EPWIGLNGSQILHKIDKEGER 233

Query: 287 EYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLT 323
               +       N+ + C     +DRPT   +   L 
Sbjct: 234 LPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLL 270

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  188 bits (479), Expect = 5e-58
 Identities = 76/305 (24%), Positives = 121/305 (39%), Gaps = 46/305 (15%)

Query: 36  FPLFSFSSVSTATNKFSDANKLGEGGFGPVYKGVLKKGD---EIAVKRLS-GRSGQGLRE 91
           +P+  +       N     + +GEG FG V K  +KK     + A+KR+    S    R+
Sbjct: 4   YPVLDW-------NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRD 56

Query: 92  MKNEASVIAKV-QHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFL-------------F 137
              E  V+ K+  H N++ LLG C  R    L  EY P+ +L  FL              
Sbjct: 57  FAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAI 116

Query: 138 DPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGM 197
             +    L     +     +A+G+ YL Q    + IHRDL A NIL+ ++   KI+DFG+
Sbjct: 117 ANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGL 173

Query: 198 ARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYR 257
           +R           +       +M+ E     +++  SDV+S+GVLL EIVS         
Sbjct: 174 SRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT----- 225

Query: 258 TDSLNLLGYAWDLWTSNRTLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMND 317
                     +   T     E +      E           ++   C +E   +RP+   
Sbjct: 226 ---------PYCGMTCAELYEKLPQGYRLEKPLN-CDDEVYDLMRQCWREKPYERPSFAQ 275

Query: 318 VVSML 322
           ++  L
Sbjct: 276 ILVSL 280

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  186 bits (474), Expect = 1e-57
 Identities = 63/269 (23%), Positives = 115/269 (42%), Gaps = 23/269 (8%)

Query: 55  NKLGEGGFGPVYKGVLKK-GDEIAVKRLS-GRSGQGLREMKNEASVIAKVQHKNLVRLLG 112
             LGEG +G V   V +   + +AVK +   R+      +K E  +   + H+N+V+  G
Sbjct: 11  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 70

Query: 113 CCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRI 172
              + + + L  EY     L   +      + +      +    +  G++YLH      I
Sbjct: 71  HRREGNIQYLFLEYCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHGI---GI 124

Query: 173 IHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIF-S 231
            HRD+K  N+LLD+  N KISDFG+A +   N  +   +++ GT  Y++PE      F +
Sbjct: 125 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 184

Query: 232 IKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYSSK 291
              DV+S G++L  +++G+        D  +     +  W   +T       ++      
Sbjct: 185 EPVDVWSCGIVLTAMLAGE-----LPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSA--PL 237

Query: 292 QMLLRYANIALLCVQESADDRPTMNDVVS 320
            +L +        + E+   R T+ D+  
Sbjct: 238 ALLHK-------ILVENPSARITIPDIKK 259

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  185 bits (470), Expect = 4e-57
 Identities = 68/271 (25%), Positives = 110/271 (40%), Gaps = 33/271 (12%)

Query: 55  NKLGEGGFGPVYKGVLKKGDEI-AVKRLS---GRSGQGLREMKNEASVIAKVQHKNLVRL 110
             LG+G FG VY    K+   I A+K L            +++ E  + + ++H N++RL
Sbjct: 12  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 71

Query: 111 LGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRV 170
            G   D     LI EY P  ++   L   +K    D       I  +A  L Y H     
Sbjct: 72  YGYFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELANALSYCHSK--- 125

Query: 171 RIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIF 230
           R+IHRD+K  N+LL      KI+DFG +     +      + + GT  Y+ PE     + 
Sbjct: 126 RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RTTLCGTLDYLPPEMIEGRMH 181

Query: 231 SIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYSS 290
             K D++S GVL  E + GK                    + +N   E    I   E++ 
Sbjct: 182 DEKVDLWSLGVLCYEFLVGKP------------------PFEANTYQETYKRISRVEFTF 223

Query: 291 KQMLLRYA-NIALLCVQESADDRPTMNDVVS 320
              +   A ++    ++ +   RP + +V+ 
Sbjct: 224 PDFVTEGARDLISRLLKHNPSQRPMLREVLE 254

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  181 bits (461), Expect = 2e-55
 Identities = 70/280 (25%), Positives = 129/280 (46%), Gaps = 24/280 (8%)

Query: 40  SFSSVSTATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLREMKNEASV 98
           S  SV     K++   K+G+G  G VY  +    G E+A+++++ +       + NE  V
Sbjct: 11  SIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILV 70

Query: 99  IAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIA 158
           + + ++ N+V  L   +  DE  ++ EY+   S    L D      +D      +     
Sbjct: 71  MRENKNPNIVNYLDSYLVGDELWVVMEYLAGGS----LTDVVTETCMDEGQIAAVCRECL 126

Query: 159 QGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG 218
           Q L +LH     ++IHRD+K+ NILL  D + K++DFG          Q+  S +VGT  
Sbjct: 127 QALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE--QSKRSTMVGTPY 181

Query: 219 YMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLE 278
           +M+PE      +  K D++S G++ +E++ G+     Y  ++     Y   L  +N T E
Sbjct: 182 WMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEP---PYLNENPLRALY---LIATNGTPE 235

Query: 279 LIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDV 318
           L +P   ++ S+      + +    C+    + R +  ++
Sbjct: 236 LQNP---EKLSAI-----FRDFLNRCLDMDVEKRGSAKEL 267

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  177 bits (449), Expect = 5e-54
 Identities = 57/274 (20%), Positives = 105/274 (38%), Gaps = 27/274 (9%)

Query: 56  KLGEGGFGPVYKGVLKKGDE----IAVKRLSGRSGQGLRE-MKNEASVIAKVQHKNLVRL 110
            +GEG FG V++G+    +     +A+K     +   +RE    EA  + +  H ++V+L
Sbjct: 14  CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 73

Query: 111 LGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRV 170
           +G   + +   +I E      L  FL        LD  + +     ++  L YL      
Sbjct: 74  IGVITE-NPVWIIMELCTLGELRSFLQVRKYS--LDLASLILYAYQLSTALAYLESK--- 127

Query: 171 RIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIF 230
           R +HRD+ A N+L+  +   K+ DFG++R    +      S+      +M+PE      F
Sbjct: 128 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY-KASKGKLPIKWMAPESINFRRF 186

Query: 231 SIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYSS 290
           +  SDV+ FGV + EI+           ++            +   L +           
Sbjct: 187 TSASDVWMFGVCMWEILMHGVKPFQGVKNN-----DVIGRIENGERLPMPPNCPPT---- 237

Query: 291 KQMLLRYANIALLCVQESADDRPTMNDVVSMLTN 324
                   ++   C       RP   ++ + L+ 
Sbjct: 238 ------LYSLMTKCWAYDPSRRPRFTELKAQLST 265

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  177 bits (449), Expect = 1e-53
 Identities = 69/298 (23%), Positives = 112/298 (37%), Gaps = 39/298 (13%)

Query: 49  NKFSDANKLGEGGFGPVYKGVLKK------GDEIAVKRLSGRSGQG-LREMKNEASVIAK 101
           ++      LG G FG V +              +AVK L   +     R + +E  ++  
Sbjct: 13  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72

Query: 102 -VQHKNLVRLLGCCIDRDEKILI-YEYMPNKSLDFFLF-------------DPTKRMLLD 146
              H N+V LLG C      +++  E+    +L  +L              +   +  L 
Sbjct: 73  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132

Query: 147 WVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNEL 206
               +     +A+G+ +L      + IHRDL A NILL +    KI DFG+AR    +  
Sbjct: 133 LEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189

Query: 207 QANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGY 266
                       +M+PE   + +++I+SDV+SFGVLL EI S   +        + +   
Sbjct: 190 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP----YPGVKIDEE 245

Query: 267 AWDLWTSNRTLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTN 324
                     +   D    + Y             L C       RPT +++V  L N
Sbjct: 246 FCRRLKEGTRMRAPDYTTPEMY----------QTMLDCWHGEPSQRPTFSELVEHLGN 293

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  174 bits (441), Expect = 2e-52
 Identities = 74/297 (24%), Positives = 120/297 (40%), Gaps = 41/297 (13%)

Query: 49  NKFSDANKLGEGGFGPVYKGVLK--------KGDEIAVKRL-SGRSGQGLREMKNEASVI 99
           ++      LGEG FG V              +  ++AVK L S  + + L ++ +E  ++
Sbjct: 13  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72

Query: 100 AKV-QHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRML-------------L 145
             + +HKN++ LLG C       +I EY    +L  +L       L             L
Sbjct: 73  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132

Query: 146 DWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE 205
                V     +A+G+ YL      + IHRDL A N+L+ +D   KI+DFG+AR     +
Sbjct: 133 SSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189

Query: 206 LQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLG 265
               T+       +M+PE   + I++ +SDV+SFGVLL EI +   +   Y    +  L 
Sbjct: 190 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGS--PYPGVPVEEL- 246

Query: 266 YAWDLWTSNRTLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSML 322
             + L      ++       +             +   C       RPT   +V  L
Sbjct: 247 --FKLLKEGHRMDKPSNCTNE----------LYMMMRDCWHAVPSQRPTFKQLVEDL 291

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  171 bits (435), Expect = 1e-51
 Identities = 61/269 (22%), Positives = 103/269 (38%), Gaps = 29/269 (10%)

Query: 55  NKLGEGGFGPVYKGVLKK-GDEIAVKRLSGR---SGQGLREMKNEASVIAKVQHKNLVRL 110
             LGEG F  V          E A+K L  R       +  +  E  V++++ H   V+L
Sbjct: 14  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 73

Query: 111 LGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRV 170
                D ++      Y  N  L  ++                     A+ +  L      
Sbjct: 74  YFTFQDDEKLYFGLSYAKNGELLKYIRKIGS------FDETCTRFYTAEIVSALEYLHGK 127

Query: 171 RIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIF 230
            IIHRDLK  NILL++DM+ +I+DFG A++      QA  +  VGT  Y+SPE   E   
Sbjct: 128 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSA 187

Query: 231 SIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYSS 290
              SD+++ G ++ ++V+G                     + +     +   I++ EY  
Sbjct: 188 CKSSDLWALGCIIYQLVAGLP------------------PFRAGNEYLIFQKIIKLEYDF 229

Query: 291 KQMLLRYA-NIALLCVQESADDRPTMNDV 318
            +     A ++    +   A  R    ++
Sbjct: 230 PEKFFPKARDLVEKLLVLDATKRLGCEEM 258

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  167 bits (425), Expect = 2e-49
 Identities = 51/271 (18%), Positives = 101/271 (37%), Gaps = 34/271 (12%)

Query: 56  KLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCC 114
           +LG G FG V++   +  G+  A K +          ++ E   ++ ++H  LV L    
Sbjct: 33  ELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF 92

Query: 115 IDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 174
            D +E ++IYE+M    L   + D   +  +     V+ +  + +GL ++H       +H
Sbjct: 93  EDDNEMVMIYEFMSGGELFEKVADEHNK--MSEDEAVEYMRQVCKGLCHMH---ENNYVH 147

Query: 175 RDLKASNILLDKDMNP--KISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSI 232
            DLK  NI+     +   K+ DFG+       +   +     GT  + +PE A       
Sbjct: 148 LDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ---SVKVTTGTAEFAAPEVAEGKPVGY 204

Query: 233 KSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYSSKQ 292
            +D++S GVL   ++SG                     +      E +  +   +++   
Sbjct: 205 YTDMWSVGVLSYILLSGLS------------------PFGGENDDETLRNVKSCDWNMDD 246

Query: 293 MLLRY-----ANIALLCVQESADDRPTMNDV 318
                      +     +    + R T++  
Sbjct: 247 SAFSGISEDGKDFIRKLLLADPNTRMTIHQA 277

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  166 bits (421), Expect = 7e-49
 Identities = 54/271 (19%), Positives = 103/271 (38%), Gaps = 34/271 (12%)

Query: 56  KLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCC 114
           +LG G FG V++ V K  G     K ++         +KNE S++ ++ H  L+ L    
Sbjct: 36  ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF 95

Query: 115 IDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 174
            D+ E +LI E++    L   +     +  +     +  +    +GL ++H      I+H
Sbjct: 96  EDKYEMVLILEFLSGGELFDRIAAEDYK--MSEAEVINYMRQACEGLKHMH---EHSIVH 150

Query: 175 RDLKASNILLDKDMNP--KISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSI 232
            D+K  NI+ +       KI DFG+A     +E+         T  + +PE         
Sbjct: 151 LDIKPENIMCETKKASSVKIIDFGLATKLNPDEI---VKVTTATAEFAAPEIVDREPVGF 207

Query: 233 KSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYSSKQ 292
            +D+++ GVL   ++SG                     +     LE +  +   ++   +
Sbjct: 208 YTDMWAIGVLGYVLLSGLS------------------PFAGEDDLETLQNVKRCDWEFDE 249

Query: 293 MLLRYANIALL-----CVQESADDRPTMNDV 318
                 +          +Q+    R T++D 
Sbjct: 250 DAFSSVSPEAKDFIKNLLQKEPRKRLTVHDA 280

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  159 bits (403), Expect = 2e-46
 Identities = 59/289 (20%), Positives = 114/289 (39%), Gaps = 21/289 (7%)

Query: 48  TNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLRE-MKNEASVIAKVQHK 105
             ++++ + +GEG +G V           +A+K++S    Q   +    E  ++ + +H+
Sbjct: 7   GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66

Query: 106 NLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLH 165
           N++ +         + +   Y+    +   L+   K   L        +  I +GL Y+H
Sbjct: 67  NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIH 126

Query: 166 QYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANT-SRIVGTYGYMSPEY 224
                 ++HRDLK SN+LL+   + KI DFG+AR+   +       +  V T  Y +PE 
Sbjct: 127 S---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 183

Query: 225 ALEGIFSIKS-DVFSFGVLLLEIVSGK------KNTGLYRTDSLNLLGYAWDLWTSNRTL 277
            L      KS D++S G +L E++S +                  L   + +       L
Sbjct: 184 MLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 243

Query: 278 ELIDPILEDEYSSKQMLLRYAN------IALL--CVQESADDRPTMNDV 318
           +  + +L   + +K    R         + LL   +  +   R  +   
Sbjct: 244 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQA 292

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  157 bits (398), Expect = 7e-46
 Identities = 53/271 (19%), Positives = 108/271 (39%), Gaps = 35/271 (12%)

Query: 56  KLGEGGFGPVYKGVLKKGDEI-AVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCC 114
            LG G FG V++ V     +    K +    G     +K E S++   +H+N++ L    
Sbjct: 12  DLGRGEFGIVHRCVETSSKKTYMAKFVK-VKGTDQVLVKKEISILNIARHRNILHLHESF 70

Query: 115 IDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIH 174
              +E ++I+E++    +   +   T    L+    V  +  + + L +LH +    I H
Sbjct: 71  ESMEELVMIFEFISGLDIFERIN--TSAFELNEREIVSYVHQVCEALQFLHSH---NIGH 125

Query: 175 RDLKASNILLDKDMNP--KISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSI 232
            D++  NI+     +   KI +FG AR     +   N   +     Y +PE     + S 
Sbjct: 126 FDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD---NFRLLFTAPEYYAPEVHQHDVVST 182

Query: 233 KSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYSSKQ 292
            +D++S G L+  ++SG                     + +    ++I+ I+  EY+  +
Sbjct: 183 ATDMWSLGTLVYVLLSGIN------------------PFLAETNQQIIENIMNAEYTFDE 224

Query: 293 MLLRYANIALL-----CVQESADDRPTMNDV 318
              +  +I  +      + +    R T ++ 
Sbjct: 225 EAFKEISIEAMDFVDRLLVKERKSRMTASEA 255

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  155 bits (393), Expect = 3e-45
 Identities = 54/201 (26%), Positives = 89/201 (44%), Gaps = 15/201 (7%)

Query: 55  NKLGEGGFGPVYKGVLKK-GDEIAVKRLS---GRSGQGLREMKNEASVIAKVQHKNLVRL 110
             LG G FG V+    +  G   A+K L        + +    +E  +++ V H  ++R+
Sbjct: 10  RTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRM 69

Query: 111 LGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRV 170
            G   D  +  +I +Y+    L   L    +                A+  L L      
Sbjct: 70  WGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFY------AAEVCLALEYLHSK 123

Query: 171 RIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIF 230
            II+RDLK  NILLDK+ + KI+DFG A+      +   T  + GT  Y++PE      +
Sbjct: 124 DIIYRDLKPENILLDKNGHIKITDFGFAK-----YVPDVTYTLCGTPDYIAPEVVSTKPY 178

Query: 231 SIKSDVFSFGVLLLEIVSGKK 251
           +   D +SFG+L+ E+++G  
Sbjct: 179 NKSIDWWSFGILIYEMLAGYT 199

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  153 bits (388), Expect = 1e-44
 Identities = 52/285 (18%), Positives = 102/285 (35%), Gaps = 25/285 (8%)

Query: 49  NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNL 107
           N++    K+G G FG +Y G     G+E+A+K    ++     ++  E+ +   +Q    
Sbjct: 7   NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVG 64

Query: 108 VRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQY 167
           +  +  C    +  ++   +   SL+      +++      T + + + +   + Y+H  
Sbjct: 65  IPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRK--FSLKTVLLLADQMISRIEYIH-- 120

Query: 168 SRVRIIHRDLKASNIL---LDKDMNPKISDFGMARICGGNELQAN-----TSRIVGTYGY 219
                IHRD+K  N L     K     I DFG+A+         +        + GT  Y
Sbjct: 121 -SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARY 179

Query: 220 MSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLEL 279
            S    L    S + D+ S G +L+    G       +  +             +  +E+
Sbjct: 180 ASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEV 239

Query: 280 IDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTN 324
           +      E         +A     C     DD+P  + +  +  N
Sbjct: 240 LCKGYPSE---------FATYLNFCRSLRFDDKPDYSYLRQLFRN 275

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  152 bits (385), Expect = 2e-44
 Identities = 64/285 (22%), Positives = 117/285 (41%), Gaps = 29/285 (10%)

Query: 48  TNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLS---GRSGQGLREMKNEASVIAKVQ 103
           ++++     LG GG   V+     +   ++AVK L     R        + EA   A + 
Sbjct: 6   SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65

Query: 104 HKNLVRLLGCCIDRDEKI----LIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQ 159
           H  +V +               ++ EY+   +L   +        +     +++I    Q
Sbjct: 66  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQ 122

Query: 160 GLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMAR-ICGGNELQANTSRIVGTYG 218
            L + HQ     IIHRD+K +NI++      K+ DFG+AR I         T+ ++GT  
Sbjct: 123 ALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 179

Query: 219 YMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLE 278
           Y+SPE A       +SDV+S G +L E+++G+     +  DS         +   +   +
Sbjct: 180 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGEP---PFTGDS------PVSVAYQHVRED 230

Query: 279 LIDPILEDEYSSKQMLLRYANIALLCVQESADDRP-TMNDVVSML 322
            I P    E  S  +      + L  + ++ ++R  T  ++ + L
Sbjct: 231 PIPPSARHEGLSADL----DAVVLKALAKNPENRYQTAAEMRADL 271

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  153 bits (387), Expect = 2e-44
 Identities = 54/278 (19%), Positives = 104/278 (37%), Gaps = 31/278 (11%)

Query: 48  TNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLRE-MKNEASVIAKVQHK 105
            + +   + LG G F  V     K+    +A+K ++ ++ +G    M+NE +V+ K++H 
Sbjct: 8   RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHP 67

Query: 106 NLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLH 165
           N+V L           LI + +    L   +    ++         ++I  +   + YLH
Sbjct: 68  NIVALDDIYESGGHLYLIMQLVSGGELFDRI---VEKGFYTERDASRLIFQVLDAVKYLH 124

Query: 166 QYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYA 225
               V    +        LD+D    ISDFG++++     +    S   GT GY++PE  
Sbjct: 125 DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSV---LSTACGTPGYVAPEVL 181

Query: 226 LEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILE 285
            +  +S   D +S GV+   ++ G                     +      +L + IL+
Sbjct: 182 AQKPYSKAVDCWSIGVIAYILLCGYP------------------PFYDENDAKLFEQILK 223

Query: 286 DEYSSKQMLLRY-----ANIALLCVQESADDRPTMNDV 318
            EY               +     +++  + R T    
Sbjct: 224 AEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQA 261

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  150 bits (380), Expect = 1e-43
 Identities = 62/291 (21%), Positives = 112/291 (38%), Gaps = 49/291 (16%)

Query: 50  KFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRL--------SGRSGQGLRE-MKNEASVI 99
            +     LG G    V + + K    E AVK +        S    Q LRE    E  ++
Sbjct: 4   NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63

Query: 100 AKVQ-HKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIA 158
            KV  H N+++L           L+++ M    L  +L   T+++ L      +I+  + 
Sbjct: 64  RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL---TEKVTLSEKETRKIMRALL 120

Query: 159 QGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYG 218
           + +  LH   ++ I+HRDLK  NILLD DMN K++DFG +      E       + GT  
Sbjct: 121 EVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE---KLREVCGTPS 174

Query: 219 YMSPEYALEGI------FSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWT 272
           Y++PE     +      +  + D++S GV++  +++G                     + 
Sbjct: 175 YLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSP------------------PFW 216

Query: 273 SNRTLELIDPILEDEYSSKQMLLRY-----ANIALLCVQESADDRPTMNDV 318
             + + ++  I+   Y               ++    +      R T  + 
Sbjct: 217 HRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEA 267

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  152 bits (386), Expect = 1e-43
 Identities = 58/210 (27%), Positives = 92/210 (43%), Gaps = 18/210 (8%)

Query: 49  NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLS---GRSGQGLREMKNEASVIAKVQ- 103
           N FS    +G GGFG VY       G   A+K L     +  QG     NE  +++ V  
Sbjct: 4   NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63

Query: 104 --HKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGL 161
                +V +       D+   I + M    L + L    +  +            I  GL
Sbjct: 64  GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLS---QHGVFSEADMRFYAAEIILGL 120

Query: 162 LYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMS 221
            ++H      +++RDLK +NILLD+  + +ISD G+A      +        VGT+GYM+
Sbjct: 121 EHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----PHASVGTHGYMA 173

Query: 222 PEYALEGI-FSIKSDVFSFGVLLLEIVSGK 250
           PE   +G+ +   +D FS G +L +++ G 
Sbjct: 174 PEVLQKGVAYDSSADWFSLGCMLFKLLRGH 203

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  149 bits (376), Expect = 1e-42
 Identities = 67/269 (24%), Positives = 105/269 (39%), Gaps = 32/269 (11%)

Query: 55  NKLGEGGFGPVYKGVLKK-GDEIAVKRLS---GRSGQGLREMKNEASVIAKV-QHKNLVR 109
             LG+G FG V+    KK     A+K L          +     E  V++   +H  L  
Sbjct: 8   KMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 67

Query: 110 LLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSR 169
           +      ++    + EY+    L + +    K    D          I  GL +LH    
Sbjct: 68  MFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK---FDLSRATFYAAEIILGLQFLHSK-- 122

Query: 170 VRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGI 229
             I++RDLK  NILLDKD + KI+DFGM +     + + NT    GT  Y++PE  L   
Sbjct: 123 -GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT--FCGTPDYIAPEILLGQK 179

Query: 230 FSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDEYS 289
           ++   D +SFGVLL E++ G+                    +      EL   I  D   
Sbjct: 180 YNHSVDWWSFGVLLYEMLIGQS------------------PFHGQDEEELFHSIRMDNPF 221

Query: 290 SKQMLLRYA-NIALLCVQESADDRPTMND 317
             + L + A ++ +       + R  +  
Sbjct: 222 YPRWLEKEAKDLLVKLFVREPEKRLGVRG 250

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  147 bits (372), Expect = 2e-42
 Identities = 64/301 (21%), Positives = 112/301 (37%), Gaps = 28/301 (9%)

Query: 55  NKLGEGGFGPVYKGVLKK-GDEIAVKRL-----SGRSGQGLREMKNEASVIAKVQHKNLV 108
           + LGEG F  VYK   K     +A+K++     S       R    E  ++ ++ H N++
Sbjct: 4   DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63

Query: 109 RLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYS 168
            LL     +    L++++M               ++L        +    QGL YLHQ+ 
Sbjct: 64  GLLDAFGHKSNISLVFDFMETDLEVII---KDNSLVLTPSHIKAYMLMTLQGLEYLHQH- 119

Query: 169 RVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALE- 227
              I+HRDLK +N+LLD++   K++DFG+A+  G        +  V T  Y +PE     
Sbjct: 120 --WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP--NRAYTHQVVTRWYRAPELLFGA 175

Query: 228 GIFSIKSDVFSFGVLLLEIVSGK------KNTGLYRTDSLNLLGYAWDLWTSNRTLELID 281
            ++ +  D+++ G +L E++          +          L     + W    +L    
Sbjct: 176 RMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYV 235

Query: 282 PILEDEYSSKQMLLRYANIALL-----CVQESADDRPTMNDVVSM--LTNEAATLLPPKQ 334
                       +   A   LL         +   R T    + M   +N        + 
Sbjct: 236 TFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTPGCQL 295

Query: 335 P 335
           P
Sbjct: 296 P 296

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  148 bits (375), Expect = 3e-42
 Identities = 55/209 (26%), Positives = 93/209 (44%), Gaps = 19/209 (9%)

Query: 51  FSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVR 109
           ++D   +G G FG VY+  L   G+ +A+K++     Q  R    E  ++ K+ H N+VR
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----QDKRFKNRELQIMRKLDHCNIVR 77

Query: 110 LLGCCIDRDEK------ILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLY 163
           L        EK       L+ +Y+P             +  L  +     +  + + L Y
Sbjct: 78  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137

Query: 164 LHQYSRVRIIHRDLKASNILLDKD-MNPKISDFGMARICGGNELQANTSRIVGTYGYMSP 222
           +H +    I HRD+K  N+LLD D    K+ DFG A+     E   +    + +  Y +P
Sbjct: 138 IHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY---ICSRYYRAP 191

Query: 223 EYALEGI-FSIKSDVFSFGVLLLEIVSGK 250
           E       ++   DV+S G +L E++ G+
Sbjct: 192 ELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  147 bits (371), Expect = 4e-42
 Identities = 59/293 (20%), Positives = 114/293 (38%), Gaps = 28/293 (9%)

Query: 47  ATNKFSDANKLGEGGFGPVYKGVLKK--GDEIAVKRLSGRSGQG------LREMKNEASV 98
           A  ++    ++GEG +G V+K    K  G  +A+KR+  ++G+       +RE+      
Sbjct: 5   ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVA-VLRH 63

Query: 99  IAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSLD---FFLFDPTKRMLLDWVTRVQIIE 155
           +   +H N+VRL   C            +  + +D       D      +   T   ++ 
Sbjct: 64  LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMF 123

Query: 156 GIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVG 215
            + +GL +LH +   R++HRDLK  NIL+      K++DFG+ARI          + +V 
Sbjct: 124 QLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM---ALTSVVV 177

Query: 216 TYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK------KNTGLYRTDSLNLLGYAWD 269
           T  Y +PE  L+  ++   D++S G +  E+   K       +          +     +
Sbjct: 178 TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEE 237

Query: 270 LWTSNRTLELIDPILEDEYSSKQMLLRYANIAL----LCVQESADDRPTMNDV 318
            W  +  L       +     ++ +     +       C+  +   R +    
Sbjct: 238 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 290

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  145 bits (367), Expect = 1e-41
 Identities = 54/205 (26%), Positives = 96/205 (46%), Gaps = 11/205 (5%)

Query: 49  NKFSDANKLGEGGFGPVYKGVLKKGDEIAVK--RLSGRSGQGLREMKNEASVIAKVQHKN 106
            K+    K+GEG +G VYK     G+  A+K  RL             E S++ +++H N
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61

Query: 107 LVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQ 166
           +V+L      +   +L++E++                 L+ VT    +  +  G+ Y H 
Sbjct: 62  IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDV---CEGGLESVTAKSFLLQLLNGIAYCHD 118

Query: 167 YSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAL 226
               R++HRDLK  N+L++++   KI+DFG+AR  G    +      + T  Y +P+  +
Sbjct: 119 R---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTH--EIVTLWYRAPDVLM 173

Query: 227 -EGIFSIKSDVFSFGVLLLEIVSGK 250
               +S   D++S G +  E+V+G 
Sbjct: 174 GSKKYSTTIDIWSVGCIFAEMVNGT 198

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  145 bits (366), Expect = 1e-41
 Identities = 42/293 (14%), Positives = 98/293 (33%), Gaps = 39/293 (13%)

Query: 49  NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNL 107
             +    ++GEG FG +++G       ++A+K    RS     ++++E      +     
Sbjct: 5   VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTG 62

Query: 108 VRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQY 167
           +  +          ++   +   SL+  L    ++      T     + +   +  +H+ 
Sbjct: 63  IPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRK--FSVKTVAMAAKQMLARVQSIHEK 120

Query: 168 SRVRIIHRDLKASNILLDKDMNP-----KISDFGMARICGGNELQAN-----TSRIVGTY 217
               +++RD+K  N L+ +  +       + DFGM +       + +        + GT 
Sbjct: 121 ---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTA 177

Query: 218 GYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTL 277
            YMS    L    S + D+ + G + +  + G                  W    +    
Sbjct: 178 RYMSINTHLGREQSRRDDLEALGHVFMYFLRGS---------------LPWQGLKAATNK 222

Query: 278 ELIDPILEDEYSSKQMLLR------YANIALLCVQESADDRPTMNDVVSMLTN 324
           +  + I E + S+    L       +          + D  P  + +  + + 
Sbjct: 223 QKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSK 275

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  144 bits (364), Expect = 3e-41
 Identities = 52/204 (25%), Positives = 93/204 (45%), Gaps = 9/204 (4%)

Query: 50  KFSDANKLGEGGFGPVYKGVLKK-GDEIAVK--RLSGRSGQGLREMKNEASVIAKVQHKN 106
            F    K+GEG +G VYK   K  G+ +A+K  RL   +         E S++ ++ H N
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62

Query: 107 LVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQ 166
           +V+LL      ++  L++E++      F        + L  +        + Q L  L  
Sbjct: 63  IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSY-----LFQLLQGLAF 117

Query: 167 YSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYAL 226
               R++HRDLK  N+L++ +   K++DFG+AR   G  ++  T  +V  +         
Sbjct: 118 CHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEVVTLWYRAPEILLG 176

Query: 227 EGIFSIKSDVFSFGVLLLEIVSGK 250
              +S   D++S G +  E+V+ +
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRR 200

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  142 bits (359), Expect = 1e-40
 Identities = 62/279 (22%), Positives = 107/279 (38%), Gaps = 43/279 (15%)

Query: 56  KLGEGGFGPVYKGVLKK-GDEIAVKRL------SGRSGQGLREMKNEASVIAKVQHKNLV 108
           +LG G F  V K   K  G + A K +      S R G    +++ E S++ ++QH N++
Sbjct: 17  ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 76

Query: 109 RLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYS 168
            L     ++ + ILI E +    L  F     ++  L      + ++ I  G+ YLH   
Sbjct: 77  TLHEVYENKTDVILILELVAGGELFDF---LAEKESLTEEEATEFLKQILNGVYYLHSL- 132

Query: 169 RVRIIHRDLKASNILLDKDMNP----KISDFGMARICGGNELQANTSRIVGTYGYMSPEY 224
             +I H DLK  NI+L     P    KI DFG+A              I GT  +++PE 
Sbjct: 133 --QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIFGTPEFVAPEI 187

Query: 225 ALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPIL 284
                  +++D++S GV+   ++SG                     +  +   E +  + 
Sbjct: 188 VNYEPLGLEADMWSIGVITYILLSGA------------------SPFLGDTKQETLANVS 229

Query: 285 EDEYSSKQMLLRYANIALL-----CVQESADDRPTMNDV 318
              Y  +       +          + +    R T+ D 
Sbjct: 230 AVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDS 268

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  141 bits (357), Expect = 2e-40
 Identities = 59/274 (21%), Positives = 97/274 (35%), Gaps = 43/274 (15%)

Query: 56  KLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLREMKN------EASVIAKVQ--HKN 106
            LG GGFG VY G+       +A+K +         E+ N      E  ++ KV      
Sbjct: 11  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70

Query: 107 LVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQ 166
           ++RLL      D  +LI E        F     T+R  L           + + + + H 
Sbjct: 71  VIRLLDWFERPDSFVLILERPEPVQDLFDFI--TERGALQEELARSFFWQVLEAVRHCHN 128

Query: 167 YSRVRIIHRDLKASNILLDKD-MNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYA 225
                ++HRD+K  NIL+D +    K+ DFG   +          +   GT  Y  PE+ 
Sbjct: 129 C---GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----VYTDFDGTRVYSPPEWI 181

Query: 226 L-EGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPIL 284
                    + V+S G+LL ++V G                     +  +  +       
Sbjct: 182 RYHRYHGRSAAVWSLGILLYDMVCGDI------------------PFEHDEEIIRGQVFF 223

Query: 285 EDEYSSKQMLLRYANIALLCVQESADDRPTMNDV 318
               SS+       ++   C+     DRPT  ++
Sbjct: 224 RQRVSSE-----CQHLIRWCLALRPSDRPTFEEI 252

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  140 bits (352), Expect = 3e-39
 Identities = 59/299 (19%), Positives = 119/299 (39%), Gaps = 35/299 (11%)

Query: 49  NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRL--SGRSGQGLREMKNEASVIAKVQHK 105
           +K+    K+G+G FG V+K   +K G ++A+K++               E  ++  ++H+
Sbjct: 10  SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69

Query: 106 NLVRLLGCCIDRDEKI--------LIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGI 157
           N+V L+  C  +            L++++  +        +   +  L  + RV     +
Sbjct: 70  NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLS-NVLVKFTLSEIKRV-----M 123

Query: 158 AQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARI--CGGNELQANTSRIVG 215
              L  L+   R +I+HRD+KA+N+L+ +D   K++DFG+AR      N      +  V 
Sbjct: 124 QMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVV 183

Query: 216 TYGYMSPEYAL-EGIFSIKSDVFSFGVLLLEIVSGKK------NTGLYRTDSLNLLGYAW 268
           T  Y  PE  L E  +    D++  G ++ E+ +                 S        
Sbjct: 184 TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP 243

Query: 269 DLWTSNRTLELIDPILEDEYSSKQMLLRYAN-------IALL--CVQESADDRPTMNDV 318
           ++W +    EL + +   +   +++  R          + L+   +      R   +D 
Sbjct: 244 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDA 302

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  136 bits (343), Expect = 9e-38
 Identities = 50/206 (24%), Positives = 84/206 (40%), Gaps = 12/206 (5%)

Query: 49  NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLS---GRSGQGLREMKNEASVIAKVQH 104
           N F     LG+G FG V     K  G   A+K L      +   +     E+ V+   +H
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64

Query: 105 KNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYL 164
             L  L       D    + EY     L F L   ++  +             A+ +  L
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGELFFHL---SRERVFTEERARFYG---AEIVSAL 118

Query: 165 HQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEY 224
                  +++RD+K  N++LDKD + KI+DFG+ +    +   A      GT  Y++PE 
Sbjct: 119 EYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD--GATMKTFCGTPEYLAPEV 176

Query: 225 ALEGIFSIKSDVFSFGVLLLEIVSGK 250
             +  +    D +  GV++ E++ G+
Sbjct: 177 LEDNDYGRAVDWWGLGVVMYEMMCGR 202

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  135 bits (339), Expect = 1e-37
 Identities = 44/206 (21%), Positives = 92/206 (44%), Gaps = 10/206 (4%)

Query: 49  NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVK--RLSGRSGQGLREMKNEASVIAKVQHK 105
            K+    K+GEG +G V+K   ++  + +A+K  RL             E  ++ +++HK
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61

Query: 106 NLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLH 165
           N+VRL        +  L++E+       +F            +    +   + Q L  L 
Sbjct: 62  NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCN------GDLDPEIVKSFLFQLLKGLG 115

Query: 166 QYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYA 225
                 ++HRDLK  N+L++++   K+++FG+AR   G  ++  ++ +V  +        
Sbjct: 116 FCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAF-GIPVRCYSAEVVTLWYRPPDVLF 174

Query: 226 LEGIFSIKSDVFSFGVLLLEIVSGKK 251
              ++S   D++S G +  E+ +  +
Sbjct: 175 GAKLYSTSIDMWSAGCIFAELANAGR 200

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  135 bits (340), Expect = 3e-37
 Identities = 49/271 (18%), Positives = 102/271 (37%), Gaps = 30/271 (11%)

Query: 57  LGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLREMKNEASVIAKV-QHKNLVRLLGCC 114
           LG G  G V +   K+  ++ A+K L         + + E  +  +  Q  ++VR++   
Sbjct: 20  LGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVY 74

Query: 115 IDRDEK----ILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRV 170
            +        +++ E +    L   + D   +         +I++ I + + YLH    +
Sbjct: 75  ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAF-TEREASEIMKSIGEAIQYLHS---I 130

Query: 171 RIIHRDLKASNILLDKDMNP---KISDFGMARICGGNELQANTSRIVGTYGYMSPEYALE 227
            I HRD+K  N+L          K++DFG A+    +           T  Y++PE    
Sbjct: 131 NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY---TPYYVAPEVLGP 187

Query: 228 GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDE 287
             +    D++S GV++  ++ G      + ++    +             E  +P   + 
Sbjct: 188 EKYDKSCDMWSLGVIMYILLCGYP---PFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEV 244

Query: 288 YSSKQMLLRYANIALLCVQESADDRPTMNDV 318
               +ML+R        ++     R T+ + 
Sbjct: 245 SEEVKMLIR------NLLKTEPTQRMTITEF 269

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  132 bits (333), Expect = 4e-36
 Identities = 56/227 (24%), Positives = 96/227 (42%), Gaps = 15/227 (6%)

Query: 28  SKKKEVDQFPLFSFSSVSTATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSG 86
           +K KE       + S  +   ++F     LG G FG V     K+ G+  A+K L  +  
Sbjct: 20  AKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKV 79

Query: 87  QGLREMK---NEASVIAKVQHKNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRM 143
             L++++   NE  ++  V    LV+L     D     ++ EY+    +   L    +  
Sbjct: 80  VKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR---RIG 136

Query: 144 LLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGG 203
                        I     YLH      +I+RDLK  N+L+D+    +++DFG A+   G
Sbjct: 137 RFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193

Query: 204 NELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 250
                 T  + GT   ++PE  L   ++   D ++ GVL+ E+ +G 
Sbjct: 194 -----RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGY 235

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  128 bits (322), Expect = 1e-34
 Identities = 52/212 (24%), Positives = 97/212 (45%), Gaps = 23/212 (10%)

Query: 49  NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRL--SGRSGQGLREMKNEASVIAKVQHK 105
             + D   +G G +G V   V  + G ++A+K+L    +S    +    E  ++  ++H+
Sbjct: 18  AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHE 77

Query: 106 NLVRLLGCCIDRD------EKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQ 159
           N++ LL      +      +  L+  +M             K   L       ++  + +
Sbjct: 78  NVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLM-----KHEKLGEDRIQFLVYQMLK 132

Query: 160 GLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGY 219
           GL Y+H      IIHRDLK  N+ +++D   KI DFG+AR     +  +  +  V T  Y
Sbjct: 133 GLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLAR-----QADSEMTGYVVTRWY 184

Query: 220 MSPEYALEGI-FSIKSDVFSFGVLLLEIVSGK 250
            +PE  L  + ++   D++S G ++ E+++GK
Sbjct: 185 RAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 216

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  121 bits (303), Expect = 7e-32
 Identities = 55/211 (26%), Positives = 91/211 (43%), Gaps = 21/211 (9%)

Query: 49  NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLS--GRSGQGLREMKNEASVIAKVQHK 105
            ++ +   +G G  G V           +A+K+LS   ++    +    E  ++  V HK
Sbjct: 17  KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76

Query: 106 NLVRLLGCCI------DRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQ 159
           N++ LL          +  +  L+ E M              +M LD      ++  +  
Sbjct: 77  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI------QMELDHERMSYLLYQMLC 130

Query: 160 GLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGY 219
           G+ +LH      IIHRDLK SNI++  D   KI DFG+AR  G + +    +  V T  Y
Sbjct: 131 GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM---MTPYVVTRYY 184

Query: 220 MSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 250
            +PE  L   +    D++S G ++ E+V  K
Sbjct: 185 RAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  119 bits (299), Expect = 1e-31
 Identities = 49/207 (23%), Positives = 87/207 (42%), Gaps = 18/207 (8%)

Query: 55  NKLGEGGFGPVYKGVLKK----GDEIAVKRLS----GRSGQGLREMKNEASVIAKVQHK- 105
             LG G +G V+          G   A+K L      +  +     + E  V+  ++   
Sbjct: 30  KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 89

Query: 106 NLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLH 165
            LV L        +  LI +Y+    L   L    +       T  ++   + + +L L 
Sbjct: 90  FLVTLHYAFQTETKLHLILDYINGGELFTHLSQRER------FTEHEVQIYVGEIVLALE 143

Query: 166 QYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYA 225
              ++ II+RD+K  NILLD + +  ++DFG+++    +E +       GT  YM+P+  
Sbjct: 144 HLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETE-RAYDFCGTIEYMAPDIV 202

Query: 226 LEGI--FSIKSDVFSFGVLLLEIVSGK 250
             G        D +S GVL+ E+++G 
Sbjct: 203 RGGDSGHDKAVDWWSLGVLMYELLTGA 229

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  118 bits (295), Expect = 6e-31
 Identities = 43/237 (18%), Positives = 97/237 (40%), Gaps = 28/237 (11%)

Query: 20  ANNKQAKRSKKKEVDQFPLFSFSSVSTATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAV 78
            N  + +     E       +        + +    KLG G +  V++ +     +++ V
Sbjct: 13  VNTHRPREYWDYESHVVEWGNQ-------DDYQLVRKLGRGKYSEVFEAINITNNEKVVV 65

Query: 79  KRLSGRSGQGLREMKNEASVIAKVQ-HKNLVRLLGCCIDRDEK--ILIYEYMPNKSLDFF 135
           K L        +++K E  ++  ++   N++ L     D   +   L++E++ N      
Sbjct: 66  KILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQL 122

Query: 136 LFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLD-KDMNPKISD 194
                 + L D+  R   +  I + L Y H    + I+HRD+K  N+++D +    ++ D
Sbjct: 123 Y-----QTLTDYDIR-FYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLID 173

Query: 195 FGMARICGGNELQANTSRIVGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGK 250
           +G+A      +     +  V +  +  PE  ++  ++    D++S G +L  ++  K
Sbjct: 174 WGLAEFYHPGQEY---NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRK 227

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  115 bits (289), Expect = 5e-30
 Identities = 50/207 (24%), Positives = 90/207 (43%), Gaps = 11/207 (5%)

Query: 48  TNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLS--GRSGQGLREMKNEASVIAKVQH 104
             ++ + + +G G +G V      K G  +AVK+LS   +S    +    E  ++  ++H
Sbjct: 17  PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 76

Query: 105 KNLVRLLGCCIDRDEKILI-YEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLY 163
           +N++ LL               Y+    +   L +  K   L       +I  I +GL Y
Sbjct: 77  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 136

Query: 164 LHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPE 223
           +H      IIHRDLK SN+ +++D   KI DFG+AR          T  +   +      
Sbjct: 137 IHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----MTGYVATRWYRAPEI 189

Query: 224 YALEGIFSIKSDVFSFGVLLLEIVSGK 250
                 ++   D++S G ++ E+++G+
Sbjct: 190 MLNWMHYNQTVDIWSVGCIMAELLTGR 216

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  112 bits (279), Expect = 1e-28
 Identities = 44/219 (20%), Positives = 86/219 (39%), Gaps = 22/219 (10%)

Query: 49  NKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNL 107
            ++    KLG G F  V+          +A+K + G         ++E  ++ +V   + 
Sbjct: 13  ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVY-TEAAEDEIKLLQRVNDADN 71

Query: 108 VRLLGCCIDRDEKILIY---------------EYMPNKSLDFFLFDPTKRMLLDWVTRVQ 152
            +      +   K+L +               E +    L        + + L +V   Q
Sbjct: 72  TKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYV--KQ 129

Query: 153 IIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDK-DMNPKISDFGMARICGGNELQANTS 211
           I + +  GL Y+H+  R  IIH D+K  N+L++  D    +    +A +        + +
Sbjct: 130 ISKQLLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYT 187

Query: 212 RIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK 250
             + T  Y SPE  L   +   +D++S   L+ E+++G 
Sbjct: 188 NSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGD 226

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 97.9 bits (243), Expect = 7e-25
 Identities = 36/202 (17%), Positives = 69/202 (34%), Gaps = 27/202 (13%)

Query: 55  NKLGEGGFGPVYKGVLKKGDEIAVK--RLSGRSGQ--------GLREMKNEASVIAKVQH 104
             +GEG    V+    +K  E  VK  ++   S +        G       A   A+ + 
Sbjct: 6   KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65

Query: 105 KNLVRLLGCCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYL 164
           + L +L G  + +      Y +  N  L   +       +       ++++ I + +   
Sbjct: 66  RALQKLQGLAVPKV-----YAWEGNAVLMELIDAKELYRVRVENPD-EVLDMILEEVAKF 119

Query: 165 HQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQANTSR-IVGTYGYMSPE 223
           +      I+H DL   N+L+  +    I DF  +   G    +    R +     Y S  
Sbjct: 120 YHR---GIVHGDLSQYNVLVS-EEGIWIIDFPQSVEVGEEGWREILERDVRNIITYFSRT 175

Query: 224 YALEGIFSIKSDVFSFGVLLLE 245
           Y        + D+ S    +L+
Sbjct: 176 Y------RTEKDINSAIDRILQ 191

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	369
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.88
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.93
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	98.33
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.94
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	97.47
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	97.34
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	97.34

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.4e-53  Score=375.47  Aligned_cols=254  Identities=24%  Similarity=0.342  Sum_probs=205.2

Q ss_pred             HhcCCccCccccccCCccEEEEEEc-CCCEEEEEEecCCC-chhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEEE
Q 017594           47 ATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIY  124 (369)
Q Consensus        47 ~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  124 (369)
                      +.++|++++.||+|+||.||+|+++ +|+.||+|++.... ....+.+.+|+.+++.++||||+++++++.+.+..|+||
T Consensus         3 f~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivm   82 (271)
T d1nvra_           3 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL   82 (271)
T ss_dssp             TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             CCcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEE
Confidence            3468999999999999999999975 58999999987543 233456889999999999999999999999999999999


Q ss_pred             EecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCCC
Q 017594          125 EYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGN  204 (369)
Q Consensus       125 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~~  204 (369)
                      ||+++++|.+++..   ...+++..++.++.||+.||+|||++|   ++||||||+||+++.++.++|+|||++......
T Consensus        83 Ey~~gg~L~~~l~~---~~~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~  156 (271)
T d1nvra_          83 EYCSGGELFDRIEP---DIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYN  156 (271)
T ss_dssp             ECCTTEEGGGGSBT---TTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECEET
T ss_pred             eccCCCcHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhheeeccC
Confidence            99999999999854   345899999999999999999999999   999999999999999999999999999877544


Q ss_pred             CcccccccccccccccCchhhccCCC-CcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCccccccCcc
Q 017594          205 ELQANTSRIVGTYGYMSPEYALEGIF-SIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPI  283 (369)
Q Consensus       205 ~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (369)
                      ..........||+.|+|||++.+..+ +.++|||||||++|+|++|+.||..........     ...........    
T Consensus       157 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~-----~~~~~~~~~~~----  227 (271)
T d1nvra_         157 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY-----SDWKEKKTYLN----  227 (271)
T ss_dssp             TEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHH-----HHHHTTCTTST----
T ss_pred             CccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHH-----HHHhcCCCCCC----
Confidence            43334445679999999999988776 678999999999999999999996543221111     00011100000    


Q ss_pred             ccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 017594          284 LEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVS  320 (369)
Q Consensus       284 ~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~  320 (369)
                           ....++.++.+||.+||+.||++|||+.|+++
T Consensus       228 -----~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~  259 (271)
T d1nvra_         228 -----PWKKIDSAPLALLHKILVENPSARITIPDIKK  259 (271)
T ss_dssp             -----TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             -----ccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence                 01122567899999999999999999999976

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.3e-52  Score=373.58  Aligned_cols=250  Identities=23%  Similarity=0.373  Sum_probs=207.9

Q ss_pred             hcCCccCccccccCCccEEEEEEc-CCCEEEEEEecCCCchhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEEEEe
Q 017594           48 TNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIYEY  126 (369)
Q Consensus        48 ~~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  126 (369)
                      .++|++++.||+|+||.||+|+++ +|+.||+|++........+.+.+|+.+++.++||||+++++++.+.+..|+||||
T Consensus        19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy   98 (293)
T d1yhwa1          19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   98 (293)
T ss_dssp             TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             ccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEe
Confidence            468999999999999999999965 5999999998765555567899999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCCCCc
Q 017594          127 MPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNEL  206 (369)
Q Consensus       127 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~~~~  206 (369)
                      +.+++|.+++..    ..+++..+..++.||+.||+|||++|   ++||||||+||+++.++.++|+|||++..+.... 
T Consensus        99 ~~gg~L~~~~~~----~~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~-  170 (293)
T d1yhwa1          99 LAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ-  170 (293)
T ss_dssp             CTTCBHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTT-
T ss_pred             cCCCcHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhheeecccc-
Confidence            999999988743    34899999999999999999999999   9999999999999999999999999998765332 


Q ss_pred             ccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCccccccCccccc
Q 017594          207 QANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILED  286 (369)
Q Consensus       207 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  286 (369)
                       .......||+.|+|||++.+..++.++|||||||++|+|++|..||.......     .............        
T Consensus       171 -~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~-----~~~~~~~~~~~~~--------  236 (293)
T d1yhwa1         171 -SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR-----ALYLIATNGTPEL--------  236 (293)
T ss_dssp             -CCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-----HHHHHHHHCSCCC--------
T ss_pred             -ccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHH-----HHHHHHhCCCCCC--------
Confidence             22334579999999999999999999999999999999999999996433111     1111111111000        


Q ss_pred             cccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 017594          287 EYSSKQMLLRYANIALLCVQESADDRPTMNDVVS  320 (369)
Q Consensus       287 ~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~  320 (369)
                       ..+..++.++.+||.+||+.||++|||+.|+++
T Consensus       237 -~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  269 (293)
T d1yhwa1         237 -QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ  269 (293)
T ss_dssp             -SSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             -CCcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence             011223677999999999999999999999986

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.9e-51  Score=364.77  Aligned_cols=265  Identities=26%  Similarity=0.426  Sum_probs=205.4

Q ss_pred             HhcCCccCccccccCCccEEEEEEcCCCEEEEEEecCC--CchhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEEE
Q 017594           47 ATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIY  124 (369)
Q Consensus        47 ~~~~y~i~~~lg~G~~~~v~~~~~~~~~~valK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  124 (369)
                      ..++|++.+.||+|+||.||+|+++  ..||||++...  .....+.+.+|+.++++++||||+++++++. +...++||
T Consensus         6 ~~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~~~~~lv~   82 (276)
T d1uwha_           6 PDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLAIVT   82 (276)
T ss_dssp             CTTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEE
T ss_pred             ccccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEe-ccEEEEEE
Confidence            3578999999999999999999865  36999998643  3445678889999999999999999999864 46789999


Q ss_pred             EecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCCC
Q 017594          125 EYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGN  204 (369)
Q Consensus       125 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~~  204 (369)
                      ||+++++|.+++....  ..+++..+..++.||+.||+|||+++   ++||||||+||+++.++.+||+|||++......
T Consensus        83 Ey~~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~  157 (276)
T d1uwha_          83 QWCEGSSLYHHLHIIE--TKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRW  157 (276)
T ss_dssp             ECCCEEEHHHHHHTSC--CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC----
T ss_pred             ecCCCCCHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEccccceeecccc
Confidence            9999999999886432  34899999999999999999999998   999999999999999999999999999876544


Q ss_pred             CcccccccccccccccCchhhcc---CCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCccccccC
Q 017594          205 ELQANTSRIVGTYGYMSPEYALE---GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELID  281 (369)
Q Consensus       205 ~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (369)
                      ..........||+.|+|||++.+   ..++.++|||||||++|+|+||+.||........     .............+.
T Consensus       158 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~-----~~~~~~~~~~~p~~~  232 (276)
T d1uwha_         158 SGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ-----IIFMVGRGYLSPDLS  232 (276)
T ss_dssp             --------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH-----HHHHHHHTSCCCCGG
T ss_pred             CCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHH-----HHHHHhcCCCCCcch
Confidence            33334445678999999999864   4589999999999999999999999974332111     111111111110000


Q ss_pred             ccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHhhhhccC
Q 017594          282 PILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNEAATLL  330 (369)
Q Consensus       282 ~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L~~~~~~~~  330 (369)
                      ..      +..++.++.+|+.+||+.||++|||+.+|++.|+.+...++
T Consensus       233 ~~------~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~~P  275 (276)
T d1uwha_         233 KV------RSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLP  275 (276)
T ss_dssp             GS------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred             hc------cccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHcCC
Confidence            00      11125679999999999999999999999999999887543

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-51  Score=365.73  Aligned_cols=245  Identities=25%  Similarity=0.340  Sum_probs=203.9

Q ss_pred             cCCccCccccccCCccEEEEEEc-CCCEEEEEEecCC---CchhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEEE
Q 017594           49 NKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGR---SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIY  124 (369)
Q Consensus        49 ~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  124 (369)
                      ++|++.+.||+|+||.||+|+++ +|+.||+|++...   .....+.+.+|+.+++.++||||+++++++.+++..++||
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm   85 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL   85 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence            57999999999999999999976 4889999998632   2233567889999999999999999999999999999999


Q ss_pred             EecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCCC
Q 017594          125 EYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGN  204 (369)
Q Consensus       125 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~~  204 (369)
                      ||+++++|.+++..   ...+++..+..++.||+.||+|||++|   ++||||||+||+++.++.++|+|||++......
T Consensus        86 Ey~~~g~L~~~l~~---~~~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~  159 (263)
T d2j4za1          86 EYAPLGTVYRELQK---LSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS  159 (263)
T ss_dssp             ECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC
T ss_pred             eecCCCcHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeecccceeeecCCC
Confidence            99999999998853   345899999999999999999999999   999999999999999999999999999765433


Q ss_pred             CcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCccccccCccc
Q 017594          205 ELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPIL  284 (369)
Q Consensus       205 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (369)
                      .    .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.......     ...... ...      ..+
T Consensus       160 ~----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~-----~~~~i~-~~~------~~~  223 (263)
T d2j4za1         160 R----RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE-----TYKRIS-RVE------FTF  223 (263)
T ss_dssp             C----CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH-----HHHHHH-TTC------CCC
T ss_pred             c----ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHH-----HHHHHH-cCC------CCC
Confidence            2    234578999999999999999999999999999999999999996432111     111111 110      001


Q ss_pred             cccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 017594          285 EDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVS  320 (369)
Q Consensus       285 ~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~  320 (369)
                      .     ..++.++.+||.+||+.||++|||+.|+++
T Consensus       224 p-----~~~s~~~~~li~~~L~~dp~~R~t~~eil~  254 (263)
T d2j4za1         224 P-----DFVTEGARDLISRLLKHNPSQRPMLREVLE  254 (263)
T ss_dssp             C-----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             C-----ccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence            1     112667999999999999999999999986

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.9e-51  Score=366.82  Aligned_cols=251  Identities=24%  Similarity=0.372  Sum_probs=205.7

Q ss_pred             cCCccCccccccCCccEEEEEEc-CCCEEEEEEecCCCchhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEEEEec
Q 017594           49 NKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIYEYM  127 (369)
Q Consensus        49 ~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~  127 (369)
                      +.|++++.||+|+||.||+|+++ +|+.||+|++........+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~   91 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC   91 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence            46899999999999999999975 48899999998766666788899999999999999999999999999999999999


Q ss_pred             CCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCCCCcc
Q 017594          128 PNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQ  207 (369)
Q Consensus       128 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~~~~~  207 (369)
                      .+++|..++...  ...+++..+..++.||+.||.|||++|   ++||||||+||+++.++.++|+|||++.......  
T Consensus        92 ~~g~L~~~~~~~--~~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~--  164 (288)
T d2jfla1          92 AGGAVDAVMLEL--ERPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI--  164 (288)
T ss_dssp             TTEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECHHHH--
T ss_pred             CCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhhccCCCc--
Confidence            999999887432  345899999999999999999999999   9999999999999999999999999987643221  


Q ss_pred             cccccccccccccCchhhc-----cCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCccccccCc
Q 017594          208 ANTSRIVGTYGYMSPEYAL-----EGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDP  282 (369)
Q Consensus       208 ~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (369)
                      .......||+.|+|||++.     +..|+.++|||||||++|+|++|..||.......     ...........      
T Consensus       165 ~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~-----~~~~i~~~~~~------  233 (288)
T d2jfla1         165 QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMR-----VLLKIAKSEPP------  233 (288)
T ss_dssp             HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGG-----HHHHHHHSCCC------
T ss_pred             ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHH-----HHHHHHcCCCC------
Confidence            1223457899999999984     4568999999999999999999999996443211     11111111100      


Q ss_pred             cccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 017594          283 ILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVS  320 (369)
Q Consensus       283 ~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~  320 (369)
                      .+   ..+..++.++.+||.+||+.||++|||+.|+++
T Consensus       234 ~~---~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~  268 (288)
T d2jfla1         234 TL---AQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ  268 (288)
T ss_dssp             CC---SSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             CC---CccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            00   011223677999999999999999999999986

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-50  Score=359.20  Aligned_cols=257  Identities=28%  Similarity=0.417  Sum_probs=200.5

Q ss_pred             hcCCccCccccccCCccEEEEEEcCCCEEEEEEecCCCchhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEEEEec
Q 017594           48 TNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIYEYM  127 (369)
Q Consensus        48 ~~~y~i~~~lg~G~~~~v~~~~~~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~  127 (369)
                      .++|++.+.||+|+||.||+|++++++.||||++.... ...+.+.+|+.++++++||||+++++++...+..++||||+
T Consensus         4 p~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~   82 (263)
T d1sm2a_           4 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM   82 (263)
T ss_dssp             CSCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred             hHHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEec
Confidence            36899999999999999999999888899999997543 34467899999999999999999999999999999999999


Q ss_pred             CCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCCCCcc
Q 017594          128 PNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQ  207 (369)
Q Consensus       128 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~~~~~  207 (369)
                      .+++|.+++...  ...+++..+..++.||+.||.|||+.+   ++||||||+||+++.++.+||+|||+++....... 
T Consensus        83 ~~g~L~~~l~~~--~~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~-  156 (263)
T d1sm2a_          83 EHGCLSDYLRTQ--RGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-  156 (263)
T ss_dssp             TTCBHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC-----------
T ss_pred             CCCcHHHHhhcc--ccCCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchheeccCCCc-
Confidence            999999988643  344788999999999999999999999   99999999999999999999999999987654322 


Q ss_pred             cccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhC-CCCCCCCcccccccchhhhhhhhcCccccccCccccc
Q 017594          208 ANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSG-KKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILED  286 (369)
Q Consensus       208 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  286 (369)
                      .......|+..|+|||++.+..++.++|||||||++|+|+|+ .+||......     ...........      ...  
T Consensus       157 ~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~-----~~~~~i~~~~~------~~~--  223 (263)
T d1sm2a_         157 TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS-----EVVEDISTGFR------LYK--  223 (263)
T ss_dssp             --------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHH-----HHHHHHHHTCC------CCC--
T ss_pred             eeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHH-----HHHHHHHhcCC------CCC--
Confidence            222334688999999999999999999999999999999995 5454422211     01111111100      000  


Q ss_pred             cccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHhhhh
Q 017594          287 EYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNEAA  327 (369)
Q Consensus       287 ~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L~~~~~  327 (369)
                         +..++.++.+++.+||+.||++|||+++|++.|+++..
T Consensus       224 ---p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~e  261 (263)
T d1sm2a_         224 ---PRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE  261 (263)
T ss_dssp             ---CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ---ccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence               11125678999999999999999999999999998865

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-51  Score=368.95  Aligned_cols=249  Identities=25%  Similarity=0.310  Sum_probs=202.1

Q ss_pred             cCCccCccccccCCccEEEEEEc-CCCEEEEEEecCC---CchhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEEE
Q 017594           49 NKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGR---SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIY  124 (369)
Q Consensus        49 ~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  124 (369)
                      ++|++++.||+|+||.||+|+++ +|+.||+|++...   .....+.+.+|++++++++||||+++++++.+++..|+||
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm   87 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL   87 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred             CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence            57999999999999999999975 5899999998632   1234567889999999999999999999999999999999


Q ss_pred             EecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCCC
Q 017594          125 EYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGN  204 (369)
Q Consensus       125 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~~  204 (369)
                      ||+++++|.+++..   ...+++..++.++.||+.||+|||+++   ++||||||+||+++.++.++|+|||++..+...
T Consensus        88 Ey~~gg~L~~~~~~---~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~  161 (288)
T d1uu3a_          88 SYAKNGELLKYIRK---IGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE  161 (288)
T ss_dssp             CCCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred             EccCCCCHHHhhhc---cCCCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEecccccceecccC
Confidence            99999999888743   345899999999999999999999999   999999999999999999999999999877644


Q ss_pred             CcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCccccccCccc
Q 017594          205 ELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPIL  284 (369)
Q Consensus       205 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (369)
                      ..........||+.|+|||++.+..++.++|||||||++|+|++|..||.......     ....... ...      .+
T Consensus       162 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~-----~~~~i~~-~~~------~~  229 (288)
T d1uu3a_         162 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL-----IFQKIIK-LEY------DF  229 (288)
T ss_dssp             --------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-----HHHHHHT-TCC------CC
T ss_pred             CcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHH-----HHHHHHc-CCC------CC
Confidence            43334445679999999999999999999999999999999999999996432111     1111111 100      01


Q ss_pred             cccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 017594          285 EDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVS  320 (369)
Q Consensus       285 ~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~  320 (369)
                      .     ..++.++.+||.+||+.||++|||++|+++
T Consensus       230 p-----~~~s~~~~~li~~~L~~dP~~R~t~~e~~~  260 (288)
T d1uu3a_         230 P-----EKFFPKARDLVEKLLVLDATKRLGCEEMEG  260 (288)
T ss_dssp             C-----TTCCHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred             C-----ccCCHHHHHHHHHHccCCHhHCcCHHHHcC
Confidence            1     112567999999999999999999999754

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.8e-50  Score=362.70  Aligned_cols=263  Identities=28%  Similarity=0.396  Sum_probs=211.8

Q ss_pred             HHHHhcCCccCccccccCCccEEEEEEcC-CCEEEEEEecCCCchhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEE
Q 017594           44 VSTATNKFSDANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKIL  122 (369)
Q Consensus        44 ~~~~~~~y~i~~~lg~G~~~~v~~~~~~~-~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l  122 (369)
                      .+...++|++.+.||+|+||.||+|+++. |+.||+|++.... ...+.+.+|+.++++++||||+++++++.+++..++
T Consensus        12 wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i   90 (287)
T d1opja_          12 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI   90 (287)
T ss_dssp             TBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred             cEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEE
Confidence            34456789999999999999999999764 8889999987543 345788999999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecC
Q 017594          123 IYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICG  202 (369)
Q Consensus       123 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~  202 (369)
                      ||||+.+|+|..++... ....+++..+..++.||+.||+|||+++   ++||||||+|||++.++.+||+|||++....
T Consensus        91 v~E~~~~g~l~~~l~~~-~~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~  166 (287)
T d1opja_          91 ITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMT  166 (287)
T ss_dssp             EEECCTTCBHHHHHHHS-CTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCTTTCC
T ss_pred             EeecccCcchHHHhhhc-cccchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEccccceeecC
Confidence            99999999999888543 2345899999999999999999999999   9999999999999999999999999998665


Q ss_pred             CCCcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCccccccCc
Q 017594          203 GNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDP  282 (369)
Q Consensus       203 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (369)
                      .... .......+++.|+|||++.+..++.++|||||||++|+|++|..|+.......     ...........     .
T Consensus       167 ~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~-----~~~~~i~~~~~-----~  235 (287)
T d1opja_         167 GDTY-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS-----QVYELLEKDYR-----M  235 (287)
T ss_dssp             SSSS-EEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHH-----HHHHHHHTTCC-----C
T ss_pred             CCCc-eeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHH-----HHHHHHhcCCC-----C
Confidence            4322 22233457889999999999999999999999999999999776653222111     11111111110     0


Q ss_pred             cccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHhhhh
Q 017594          283 ILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNEAA  327 (369)
Q Consensus       283 ~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L~~~~~  327 (369)
                      ..     +..++.++.+||.+||+.||++|||+.+|++.|+.+..
T Consensus       236 ~~-----~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~  275 (287)
T d1opja_         236 ER-----PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ  275 (287)
T ss_dssp             CC-----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTS
T ss_pred             CC-----CccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence            01     11125679999999999999999999999999987654

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.3e-51  Score=360.97  Aligned_cols=254  Identities=24%  Similarity=0.346  Sum_probs=193.4

Q ss_pred             cCCccCccccccCCccEEEEEEc-CCCEEEEEEecCCC--chhHHHHHHHHHHHhcCCCCceeeeeeeEEe--CCccEEE
Q 017594           49 NKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS--GQGLREMKNEASVIAKVQHKNLVRLLGCCID--RDEKILI  123 (369)
Q Consensus        49 ~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv  123 (369)
                      ++|++++.||+|+||.||+|+++ +|+.||+|.+....  ....+.+.+|++++++++||||+++++++.+  .+..|+|
T Consensus         4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv   83 (269)
T d2java1           4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV   83 (269)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred             hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence            57999999999999999999975 48999999987543  3345668899999999999999999999865  3568999


Q ss_pred             EEecCCCChhhhhcCCC-ccccCChHHHHHHHHHHHHHHHHHhcCC--CCCcccCCCCCCCEEEeCCCceEEeecCCcee
Q 017594          124 YEYMPNKSLDFFLFDPT-KRMLLDWVTRVQIIEGIAQGLLYLHQYS--RVRIIHRDLKASNILLDKDMNPKISDFGMARI  200 (369)
Q Consensus       124 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~al~~LH~~~--~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~  200 (369)
                      |||+++++|.+++.... .+..+++..++.++.||+.||.|||+.+  ..+++||||||+|||++.++.++|+|||++..
T Consensus        84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~  163 (269)
T d2java1          84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI  163 (269)
T ss_dssp             EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred             EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence            99999999999885422 2456899999999999999999999864  12499999999999999999999999999987


Q ss_pred             cCCCCcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCcccccc
Q 017594          201 CGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELI  280 (369)
Q Consensus       201 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (369)
                      +....  .......||+.|+|||++.+..++.++|||||||++|+|++|..||.......     .... ........  
T Consensus       164 ~~~~~--~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~-----~~~~-i~~~~~~~--  233 (269)
T d2java1         164 LNHDT--SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE-----LAGK-IREGKFRR--  233 (269)
T ss_dssp             C-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH-----HHHH-HHHTCCCC--
T ss_pred             cccCC--CccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHH-----HHHH-HHcCCCCC--
Confidence            65322  12234578999999999999999999999999999999999999996433111     1111 11111111  


Q ss_pred             CccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 017594          281 DPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVS  320 (369)
Q Consensus       281 ~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~  320 (369)
                         +     +..++.++.+||.+||+.||++|||+.||++
T Consensus       234 ---~-----~~~~s~~l~~li~~~L~~dp~~Rps~~ell~  265 (269)
T d2java1         234 ---I-----PYRYSDELNEIITRMLNLKDYHRPSVEEILE  265 (269)
T ss_dssp             ---C-----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ---C-----CcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence               1     1122667999999999999999999999986

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=8.8e-50  Score=367.58  Aligned_cols=253  Identities=22%  Similarity=0.274  Sum_probs=208.0

Q ss_pred             hcCCccCccccccCCccEEEEEEc-CCCEEEEEEecCCCchhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEEEEe
Q 017594           48 TNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIYEY  126 (369)
Q Consensus        48 ~~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  126 (369)
                      .++|++++.||+|+||.||+|+++ +|+.||+|++..........+.+|+.+++.++||||+++++++.+++..|+||||
T Consensus        28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~  107 (352)
T d1koba_          28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF  107 (352)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            468999999999999999999975 5999999999876666667788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEe--CCCceEEeecCCceecCCC
Q 017594          127 MPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLD--KDMNPKISDFGMARICGGN  204 (369)
Q Consensus       127 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~--~~~~~~L~Dfg~~~~~~~~  204 (369)
                      |++++|.+.+...  ...+++..++.++.||+.||.|||++|   ++||||||+|||++  .++.++|+|||++..+...
T Consensus       108 ~~gg~L~~~~~~~--~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~  182 (352)
T d1koba_         108 LSGGELFDRIAAE--DYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD  182 (352)
T ss_dssp             CCCCBHHHHTTCT--TCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred             CCCChHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeecccceecCCC
Confidence            9999998876432  334899999999999999999999999   99999999999997  6789999999999877543


Q ss_pred             CcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCccccccCccc
Q 017594          205 ELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPIL  284 (369)
Q Consensus       205 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (369)
                      ..   .....+++.|+|||++.+..++.++|||||||++|+|++|..||.......     ..........  ..... .
T Consensus       183 ~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~-----~~~~i~~~~~--~~~~~-~  251 (352)
T d1koba_         183 EI---VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE-----TLQNVKRCDW--EFDED-A  251 (352)
T ss_dssp             SC---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH-----HHHHHHHCCC--CCCSS-T
T ss_pred             Cc---eeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH-----HHHHHHhCCC--CCCcc-c
Confidence            22   233578999999999999999999999999999999999999996433111     1111111100  00000 0


Q ss_pred             cccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 017594          285 EDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSM  321 (369)
Q Consensus       285 ~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~  321 (369)
                           ...++.++.+||.+||+.||.+|||+.|+++.
T Consensus       252 -----~~~~s~~~~~li~~~L~~dp~~R~s~~eil~H  283 (352)
T d1koba_         252 -----FSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH  283 (352)
T ss_dssp             -----TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             -----ccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                 11126679999999999999999999999873

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-50  Score=369.48  Aligned_cols=270  Identities=24%  Similarity=0.333  Sum_probs=207.2

Q ss_pred             HhcCCccCccccccCCccEEEEEEc-CCCEEEEEEecCCC-chhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEEE
Q 017594           47 ATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIY  124 (369)
Q Consensus        47 ~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  124 (369)
                      ..++|++++.||+|+||+||+|++. +|+.||+|++.... ......+.+|+.+|+.++||||++++++|.+.+..++||
T Consensus         4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVm   83 (322)
T d1s9ja_           4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM   83 (322)
T ss_dssp             CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            4678999999999999999999975 58899999987542 334567889999999999999999999999999999999


Q ss_pred             EecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhc-CCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCC
Q 017594          125 EYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQ-YSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGG  203 (369)
Q Consensus       125 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~-~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~  203 (369)
                      ||+.+++|.+++..   ...+++..++.++.||+.||.|||+ ++   |+||||||+||+++.++.++|+|||++..+..
T Consensus        84 Ey~~gg~L~~~l~~---~~~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~  157 (322)
T d1s9ja_          84 EHMDGGSLDQVLKK---AGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID  157 (322)
T ss_dssp             ECCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred             EcCCCCcHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHHHeeECCCCCEEEeeCCCccccCC
Confidence            99999999999853   3458999999999999999999997 48   99999999999999999999999999886532


Q ss_pred             CCcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhh----------hhhh-
Q 017594          204 NELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAW----------DLWT-  272 (369)
Q Consensus       204 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~----------~~~~-  272 (369)
                      .    ......||+.|+|||++.+..|+.++||||+||++|+|++|+.||...............          .... 
T Consensus       158 ~----~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (322)
T d1s9ja_         158 S----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTP  233 (322)
T ss_dssp             H----TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC------------------
T ss_pred             C----ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccc
Confidence            2    223457999999999999999999999999999999999999999654321110000000          0000 


Q ss_pred             -------------cCccccccCcccc---ccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH--HHHhhh
Q 017594          273 -------------SNRTLELIDPILE---DEYSSKQMLLRYANIALLCVQESADDRPTMNDVVS--MLTNEA  326 (369)
Q Consensus       273 -------------~~~~~~~~~~~~~---~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~--~L~~~~  326 (369)
                                   .....+.......   ........+.++.+||.+||+.||++|||++|+++  .+++..
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~~  305 (322)
T d1s9ja_         234 GRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSD  305 (322)
T ss_dssp             ------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHHH
T ss_pred             cccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcCC
Confidence                         0000000000000   00001112567999999999999999999999997  465443

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-49  Score=350.53  Aligned_cols=254  Identities=28%  Similarity=0.399  Sum_probs=209.8

Q ss_pred             hcCCccCccccccCCccEEEEEEcCCCEEEEEEecCCCchhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEEEEec
Q 017594           48 TNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIYEYM  127 (369)
Q Consensus        48 ~~~y~i~~~lg~G~~~~v~~~~~~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~  127 (369)
                      .++|++.+.||+|+||.||+|++++++.||||++..... ..+.+.+|+.++.+++||||+++++++.+.+..++||||+
T Consensus         3 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~   81 (258)
T d1k2pa_           3 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM   81 (258)
T ss_dssp             CCCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECC
T ss_pred             hHHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEcc
Confidence            468999999999999999999998888999999976543 3467899999999999999999999999999999999999


Q ss_pred             CCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCCCCcc
Q 017594          128 PNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQ  207 (369)
Q Consensus       128 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~~~~~  207 (369)
                      .+|++..++...  ...+++..+++++.||++||+|||+.|   ++||||||+||+++.++.++|+|||++........ 
T Consensus        82 ~~g~l~~~~~~~--~~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~-  155 (258)
T d1k2pa_          82 ANGCLLNYLREM--RHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY-  155 (258)
T ss_dssp             TTEEHHHHHHSG--GGCCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSC-
T ss_pred             CCCcHHHhhhcc--ccCCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhheeccCCCc-
Confidence            999998887543  345788899999999999999999999   99999999999999999999999999986654322 


Q ss_pred             cccccccccccccCchhhccCCCCcccchHhHHHHHHHHHh-CCCCCCCCcccccccchhhhhhhhcCccccccCccccc
Q 017594          208 ANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILED  286 (369)
Q Consensus       208 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  286 (369)
                      .......++..|+|||++.+..++.++|||||||++|+|+| |+.||.......     ...... ....     ...  
T Consensus       156 ~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~-----~~~~i~-~~~~-----~~~--  222 (258)
T d1k2pa_         156 TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE-----TAEHIA-QGLR-----LYR--  222 (258)
T ss_dssp             CCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH-----HHHHHH-TTCC-----CCC--
T ss_pred             eeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHH-----HHHHHH-hCCC-----CCC--
Confidence            22333568899999999999999999999999999999998 898987544221     111111 1100     000  


Q ss_pred             cccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHh
Q 017594          287 EYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTN  324 (369)
Q Consensus       287 ~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L~~  324 (369)
                         +..++..+.+||.+||+.||++|||+.+|++.|..
T Consensus       223 ---p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d  257 (258)
T d1k2pa_         223 ---PHLASEKVYTIMYSCWHEKADERPTFKILLSNILD  257 (258)
T ss_dssp             ---CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred             ---cccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence               11125679999999999999999999999999864

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=6.4e-50  Score=368.23  Aligned_cols=253  Identities=21%  Similarity=0.297  Sum_probs=208.5

Q ss_pred             hcCCccCccccccCCccEEEEEEc-CCCEEEEEEecCCCchhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEEEEe
Q 017594           48 TNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIYEY  126 (369)
Q Consensus        48 ~~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  126 (369)
                      .++|++++.||+|+||.||+|+++ +|+.||+|++........+.+.+|+.++++++||||+++++++.+++..|+||||
T Consensus        25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~  104 (350)
T d1koaa2          25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF  104 (350)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            468999999999999999999975 5899999999877666677889999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeC--CCceEEeecCCceecCCC
Q 017594          127 MPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDK--DMNPKISDFGMARICGGN  204 (369)
Q Consensus       127 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~--~~~~~L~Dfg~~~~~~~~  204 (369)
                      +++++|.+++...  ...+++..+..++.||+.||.|||++|   ++||||||+||+++.  ++.++|+|||++..+...
T Consensus       105 ~~gg~L~~~l~~~--~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~  179 (350)
T d1koaa2         105 MSGGELFEKVADE--HNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK  179 (350)
T ss_dssp             CCSCBHHHHHTCT--TSCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT
T ss_pred             CCCCCHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeecchheecccc
Confidence            9999999888543  234899999999999999999999999   999999999999964  578999999999876543


Q ss_pred             CcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCccccccCccc
Q 017594          205 ELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPIL  284 (369)
Q Consensus       205 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (369)
                      ..   .....||+.|+|||++.+..++.++|||||||++|+|++|..||.......     ......... . .. ..  
T Consensus       180 ~~---~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~-----~~~~i~~~~-~-~~-~~--  246 (350)
T d1koaa2         180 QS---VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE-----TLRNVKSCD-W-NM-DD--  246 (350)
T ss_dssp             SC---EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-----HHHHHHHTC-C-CS-CC--
T ss_pred             cc---cceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHH-----HHHHHHhCC-C-CC-Cc--
Confidence            32   233578999999999999999999999999999999999999996432111     111111110 0 00 00  


Q ss_pred             cccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 017594          285 EDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSM  321 (369)
Q Consensus       285 ~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~  321 (369)
                         .....++.++.+||.+||+.||++|||+.|+++.
T Consensus       247 ---~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  280 (350)
T d1koaa2         247 ---SAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH  280 (350)
T ss_dssp             ---GGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred             ---ccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence               0011225679999999999999999999999984

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.8e-50  Score=364.49  Aligned_cols=254  Identities=22%  Similarity=0.271  Sum_probs=191.3

Q ss_pred             HHhcCCccCccccccCCccEEEEEEc-CCCEEEEEEecCCCc-hhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEE
Q 017594           46 TATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSG-QGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILI  123 (369)
Q Consensus        46 ~~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv  123 (369)
                      .+.++|++.+.||+|+||.||+|+++ +|+.||+|++..... .....+.+|+.+++.++||||+++++++.+++..|+|
T Consensus         6 di~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv   85 (307)
T d1a06a_           6 DIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLI   85 (307)
T ss_dssp             CGGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             CCccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence            35578999999999999999999976 489999999875432 2235677899999999999999999999999999999


Q ss_pred             EEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEe---CCCceEEeecCCcee
Q 017594          124 YEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLD---KDMNPKISDFGMARI  200 (369)
Q Consensus       124 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~---~~~~~~L~Dfg~~~~  200 (369)
                      |||+++++|.+++...   ..+++..+..++.||+.||+|||+++   ++||||||+||++.   .++.++|+|||++..
T Consensus        86 mE~~~gg~L~~~l~~~---~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~  159 (307)
T d1a06a_          86 MQLVSGGELFDRIVEK---GFYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKM  159 (307)
T ss_dssp             ECCCCSCBHHHHHHTC---SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC-----
T ss_pred             EeccCCCcHHHhhhcc---cCCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEeccceeEE
Confidence            9999999999998543   45999999999999999999999999   99999999999995   478999999999986


Q ss_pred             cCCCCcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCcccccc
Q 017594          201 CGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELI  280 (369)
Q Consensus       201 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (369)
                      .....   ......||+.|+|||++.+..++.++|||||||++|+|++|..||.......     ..........  ...
T Consensus       160 ~~~~~---~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~-----~~~~i~~~~~--~~~  229 (307)
T d1a06a_         160 EDPGS---VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAK-----LFEQILKAEY--EFD  229 (307)
T ss_dssp             ----------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-----HHHHHHTTCC--CCC
T ss_pred             ccCCC---eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHH-----HHHHHhccCC--CCC
Confidence            54332   2233579999999999999999999999999999999999999996432111     1111111110  000


Q ss_pred             CccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 017594          281 DPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSM  321 (369)
Q Consensus       281 ~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~  321 (369)
                      .+      ....+++++.+||.+||+.||++|||+.|+++.
T Consensus       230 ~~------~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h  264 (307)
T d1a06a_         230 SP------YWDDISDSAKDFIRHLMEKDPEKRFTCEQALQH  264 (307)
T ss_dssp             TT------TTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             Cc------cccCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence            00      011226679999999999999999999999873

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-49  Score=354.15  Aligned_cols=257  Identities=31%  Similarity=0.443  Sum_probs=206.4

Q ss_pred             hcCCccCccccccCCccEEEEEEcCCCEEEEEEecCCCchhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEEEEec
Q 017594           48 TNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIYEYM  127 (369)
Q Consensus        48 ~~~y~i~~~lg~G~~~~v~~~~~~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~  127 (369)
                      .++|++.+.||+|+||.||+|+++++..||||++.... ...+.+.+|+.++++++||||+++++++. ++..++||||+
T Consensus        12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~-~~~~~iv~Ey~   89 (272)
T d1qpca_          12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYM   89 (272)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECC
T ss_pred             HHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeec-cCCeEEEEEeC
Confidence            47899999999999999999999888899999997543 34577899999999999999999999875 46789999999


Q ss_pred             CCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCCCCcc
Q 017594          128 PNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQ  207 (369)
Q Consensus       128 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~~~~~  207 (369)
                      .+|+|.+++... ....+++..+..++.||+.||.|||+++   ++||||||+||+++.++.++|+|||+++....... 
T Consensus        90 ~~g~L~~~~~~~-~~~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~-  164 (272)
T d1qpca_          90 ENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY-  164 (272)
T ss_dssp             TTCBHHHHTTSH-HHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE-
T ss_pred             CCCcHHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeeccccceEEccCCcc-
Confidence            999998877442 2345899999999999999999999999   99999999999999999999999999987754332 


Q ss_pred             cccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCccccccCcccccc
Q 017594          208 ANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDE  287 (369)
Q Consensus       208 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  287 (369)
                      .......+++.|+|||++.+..++.++|||||||++|+|+||..|+.......    . ........     ......  
T Consensus       165 ~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~----~-~~~~i~~~-----~~~~~p--  232 (272)
T d1qpca_         165 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP----E-VIQNLERG-----YRMVRP--  232 (272)
T ss_dssp             ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH----H-HHHHHHTT-----CCCCCC--
T ss_pred             ccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHH----H-HHHHHHhc-----CCCCCc--
Confidence            22233467889999999999999999999999999999999665543222111    0 01111111     011111  


Q ss_pred             ccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHhhh
Q 017594          288 YSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNEA  326 (369)
Q Consensus       288 ~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L~~~~  326 (369)
                         ..++.++.+||.+||+.||++|||+++|++.|+..-
T Consensus       233 ---~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~f  268 (272)
T d1qpca_         233 ---DNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF  268 (272)
T ss_dssp             ---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ---ccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhh
Confidence               122567999999999999999999999999998754

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2.5e-49  Score=357.24  Aligned_cols=259  Identities=27%  Similarity=0.409  Sum_probs=198.6

Q ss_pred             hcCCccCccccccCCccEEEEEEcC-CC---EEEEEEecCC-CchhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEE
Q 017594           48 TNKFSDANKLGEGGFGPVYKGVLKK-GD---EIAVKRLSGR-SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKIL  122 (369)
Q Consensus        48 ~~~y~i~~~lg~G~~~~v~~~~~~~-~~---~valK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l  122 (369)
                      .++|++.+.||+|+||+||+|+++. |+   .||+|.+... .....+.+.+|+.+|++++||||+++++++...+..++
T Consensus        25 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~i  104 (299)
T d1jpaa_          25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMI  104 (299)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred             hhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence            3678899999999999999999653 32   5888988654 33445678899999999999999999999999999999


Q ss_pred             EEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecC
Q 017594          123 IYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICG  202 (369)
Q Consensus       123 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~  202 (369)
                      ||||+++++|.+++....  ..+++..+..++.||+.||.|||+++   ++||||||+|||++.++.+||+|||+++...
T Consensus       105 v~Ey~~~g~L~~~~~~~~--~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~  179 (299)
T d1jpaa_         105 ITEFMENGSLDSFLRQND--GQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLE  179 (299)
T ss_dssp             EEECCTTEEHHHHHHTTT--TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred             EEEecCCCcceeeecccc--CCCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEECCCCcEEECCcccceEcc
Confidence            999999999999886432  34899999999999999999999999   9999999999999999999999999998765


Q ss_pred             CCCcccc---cccccccccccCchhhccCCCCcccchHhHHHHHHHHHh-CCCCCCCCcccccccchhhhhhhhcCcccc
Q 017594          203 GNELQAN---TSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDLWTSNRTLE  278 (369)
Q Consensus       203 ~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (369)
                      .......   .....+++.|+|||.+.+..++.++|||||||++|+|+| |..||.......     ...........  
T Consensus       180 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~-----~~~~i~~~~~~--  252 (299)
T d1jpaa_         180 DDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQD-----VINAIEQDYRL--  252 (299)
T ss_dssp             ----------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-----HHHHHHTTCCC--
T ss_pred             CCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHH-----HHHHHHcCCCC--
Confidence            4322211   122357889999999999999999999999999999998 899986443211     11111111000  


Q ss_pred             ccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHhhhh
Q 017594          279 LIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNEAA  327 (369)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L~~~~~  327 (369)
                          .     .+..++..+.+|+.+||+.||++|||+.+|++.|+++..
T Consensus       253 ----~-----~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~  292 (299)
T d1jpaa_         253 ----P-----PPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR  292 (299)
T ss_dssp             ----C-----CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             ----C-----CCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence                0     011236679999999999999999999999999998865

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-49  Score=354.31  Aligned_cols=249  Identities=26%  Similarity=0.404  Sum_probs=195.8

Q ss_pred             cCC-ccCccccccCCccEEEEEEc-CCCEEEEEEecCC--CchhHHHHHHHHHHHhcCCCCceeeeeeeEEe----CCcc
Q 017594           49 NKF-SDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCID----RDEK  120 (369)
Q Consensus        49 ~~y-~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~  120 (369)
                      +|| ++.+.||+|+||.||+|+++ ++..||+|.+...  .....+.+.+|++++++++||||+++++++..    ....
T Consensus         8 gry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~   87 (270)
T d1t4ha_           8 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCI   87 (270)
T ss_dssp             SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEE
T ss_pred             CCEEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEE
Confidence            455 67788999999999999976 4889999998643  33445678899999999999999999999875    3457


Q ss_pred             EEEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEe-CCCceEEeecCCce
Q 017594          121 ILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLD-KDMNPKISDFGMAR  199 (369)
Q Consensus       121 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~-~~~~~~L~Dfg~~~  199 (369)
                      ++||||+++++|.+++..   ...+++..+..++.||+.||+|||+++ .+++||||||+||+++ .++.++|+|||++.
T Consensus        88 ~ivmE~~~~g~L~~~l~~---~~~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~  163 (270)
T d1t4ha_          88 VLVTELMTSGTLKTYLKR---FKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLAT  163 (270)
T ss_dssp             EEEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred             EEEEeCCCCCcHHHHHhc---cccccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCcce
Confidence            999999999999999853   345899999999999999999999874 3499999999999996 47899999999997


Q ss_pred             ecCCCCcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCccccc
Q 017594          200 ICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLEL  279 (369)
Q Consensus       200 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (369)
                      .....    ......||+.|+|||++.+ .++.++|||||||++|+|++|+.||........     ............ 
T Consensus       164 ~~~~~----~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~-----~~~~i~~~~~~~-  232 (270)
T d1t4ha_         164 LKRAS----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ-----IYRRVTSGVKPA-  232 (270)
T ss_dssp             GCCTT----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH-----HHHHHTTTCCCG-
T ss_pred             eccCC----ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHH-----HHHHHHcCCCCc-
Confidence            54322    2234579999999998865 599999999999999999999999964321110     111111110000 


Q ss_pred             cCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 017594          280 IDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVS  320 (369)
Q Consensus       280 ~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~  320 (369)
                         .+     +...++++.+||.+||+.||++|||+.|+++
T Consensus       233 ---~~-----~~~~~~~~~~li~~~l~~dp~~R~s~~ell~  265 (270)
T d1t4ha_         233 ---SF-----DKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  265 (270)
T ss_dssp             ---GG-----GGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ---cc-----CccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence               01     1112456899999999999999999999986

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-49  Score=361.85  Aligned_cols=259  Identities=27%  Similarity=0.382  Sum_probs=206.0

Q ss_pred             HhcCCccCccccccCCccEEEEEEcC-C-----CEEEEEEecCC-CchhHHHHHHHHHHHhcC-CCCceeeeeeeEEeCC
Q 017594           47 ATNKFSDANKLGEGGFGPVYKGVLKK-G-----DEIAVKRLSGR-SGQGLREMKNEASVIAKV-QHKNLVRLLGCCIDRD  118 (369)
Q Consensus        47 ~~~~y~i~~~lg~G~~~~v~~~~~~~-~-----~~valK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~  118 (369)
                      ..++|++.+.||+|+||+||+|++.. +     ..||+|.+... .......+.+|+.++.++ +||||+++++++.+.+
T Consensus        35 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~  114 (325)
T d1rjba_          35 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG  114 (325)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             CHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCC
Confidence            34689999999999999999999653 2     25899988643 333456788899999998 8999999999999999


Q ss_pred             ccEEEEEecCCCChhhhhcCCCc--------------------cccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCC
Q 017594          119 EKILIYEYMPNKSLDFFLFDPTK--------------------RMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLK  178 (369)
Q Consensus       119 ~~~lv~e~~~~~~L~~~l~~~~~--------------------~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~  178 (369)
                      ..++||||+++|+|.+++.....                    ...+++..++.++.||+.||+|||+++   ++|||||
T Consensus       115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHRDlK  191 (325)
T d1rjba_         115 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLA  191 (325)
T ss_dssp             SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCS
T ss_pred             eEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCc
Confidence            99999999999999999865432                    235788999999999999999999999   9999999


Q ss_pred             CCCEEEeCCCceEEeecCCceecCCCCcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHh-CCCCCCCCc
Q 017594          179 ASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYR  257 (369)
Q Consensus       179 p~NIlv~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~t-g~~p~~~~~  257 (369)
                      |+||+++.++.++|+|||+++...............+|+.|+|||++.+..++.++|||||||++|+|+| |..||....
T Consensus       192 p~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~  271 (325)
T d1rjba_         192 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP  271 (325)
T ss_dssp             GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred             hhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCC
Confidence            9999999999999999999987654443333344567999999999999999999999999999999997 899986543


Q ss_pred             ccccccchhhhhhhhcCccccccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHH
Q 017594          258 TDSLNLLGYAWDLWTSNRTLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLT  323 (369)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L~  323 (369)
                      ...     .............     .     +..++.++.+||.+||+.||++|||+++|++.|.
T Consensus       272 ~~~-----~~~~~~~~~~~~~-----~-----p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~  322 (325)
T d1rjba_         272 VDA-----NFYKLIQNGFKMD-----Q-----PFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG  322 (325)
T ss_dssp             CSH-----HHHHHHHTTCCCC-----C-----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             HHH-----HHHHHHhcCCCCC-----C-----CCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence            221     1111111111000     0     1112567999999999999999999999999985

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-49  Score=357.31  Aligned_cols=252  Identities=24%  Similarity=0.312  Sum_probs=205.2

Q ss_pred             HhcCCccCccccccCCccEEEEEEc-CCCEEEEEEecCCC------chhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCc
Q 017594           47 ATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS------GQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDE  119 (369)
Q Consensus        47 ~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~~------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~  119 (369)
                      +.++|++.+.||+|+||.||+|+++ +|+.||+|++....      ....+.+.+|+.++++++||||+++++++.+.+.
T Consensus         8 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~   87 (293)
T d1jksa_           8 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD   87 (293)
T ss_dssp             GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             cccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence            4578999999999999999999975 58999999986432      1235778999999999999999999999999999


Q ss_pred             cEEEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCC----ceEEeec
Q 017594          120 KILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDM----NPKISDF  195 (369)
Q Consensus       120 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~----~~~L~Df  195 (369)
                      .|+||||+++++|.+++..   ...+++..++.++.||+.||+|||+++   ++||||||+||+++.++    .++|+||
T Consensus        88 ~~iv~E~~~gg~L~~~i~~---~~~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~Df  161 (293)
T d1jksa_          88 VILILELVAGGELFDFLAE---KESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDF  161 (293)
T ss_dssp             EEEEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEECCC
T ss_pred             EEEEEEcCCCccccchhcc---ccccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccceEecch
Confidence            9999999999999999854   345999999999999999999999999   99999999999998776    5999999


Q ss_pred             CCceecCCCCcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCc
Q 017594          196 GMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNR  275 (369)
Q Consensus       196 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  275 (369)
                      |++........   .....+++.|+|||++.+..++.++|||||||++|+|++|..||.......     ......... 
T Consensus       162 G~a~~~~~~~~---~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~-----~~~~i~~~~-  232 (293)
T d1jksa_         162 GLAHKIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE-----TLANVSAVN-  232 (293)
T ss_dssp             TTCEECTTSCB---CSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-----HHHHHHTTC-
T ss_pred             hhhhhcCCCcc---ccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHH-----HHHHHHhcC-
Confidence            99987654322   233468999999999999999999999999999999999999996432111     001110000 


Q ss_pred             cccccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 017594          276 TLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVS  320 (369)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~  320 (369)
                      .      ... ......++.++.+||.+||+.||++|||+.++++
T Consensus       233 ~------~~~-~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  270 (293)
T d1jksa_         233 Y------EFE-DEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ  270 (293)
T ss_dssp             C------CCC-HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             C------CCC-chhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            0      000 0011123667999999999999999999999986

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.8e-49  Score=359.32  Aligned_cols=246  Identities=29%  Similarity=0.450  Sum_probs=200.5

Q ss_pred             hcCCccCccccccCCccEEEEEEc-CCCEEEEEEecCCC---chhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEE
Q 017594           48 TNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS---GQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILI  123 (369)
Q Consensus        48 ~~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv  123 (369)
                      .++|++++.||+|+||.||+|++. +|+.||||++....   ....+.+.+|+.++++++||||+++++++.+.+..|+|
T Consensus        14 ~~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv   93 (309)
T d1u5ra_          14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV   93 (309)
T ss_dssp             HHHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEE
Confidence            356999999999999999999965 48889999987543   23445688899999999999999999999999999999


Q ss_pred             EEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCC
Q 017594          124 YEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGG  203 (369)
Q Consensus       124 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~  203 (369)
                      ||||.++++..++..   +..+++..++.++.||+.||.|||++|   ++||||||+|||++.++.++|+|||++.....
T Consensus        94 ~E~~~~g~l~~~~~~---~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~  167 (309)
T d1u5ra_          94 MEYCLGSASDLLEVH---KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP  167 (309)
T ss_dssp             EECCSEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred             EEecCCCchHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeecccccccCC
Confidence            999999998766643   345899999999999999999999999   99999999999999999999999999876432


Q ss_pred             CCcccccccccccccccCchhhcc---CCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCcccccc
Q 017594          204 NELQANTSRIVGTYGYMSPEYALE---GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELI  280 (369)
Q Consensus       204 ~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (369)
                            .....||+.|+|||++.+   ..|+.++|||||||++|+|++|..||......     ........... .   
T Consensus       168 ------~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~-----~~~~~i~~~~~-~---  232 (309)
T d1u5ra_         168 ------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-----SALYHIAQNES-P---  232 (309)
T ss_dssp             ------BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH-----HHHHHHHHSCC-C---
T ss_pred             ------CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHH-----HHHHHHHhCCC-C---
Confidence                  233579999999999863   46899999999999999999999998643211     11111111111 0   


Q ss_pred             CccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 017594          281 DPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVS  320 (369)
Q Consensus       281 ~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~  320 (369)
                        .+.    +..+++++.+||.+||+.||++|||+.++++
T Consensus       233 --~~~----~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  266 (309)
T d1u5ra_         233 --ALQ----SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK  266 (309)
T ss_dssp             --CCS----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             --CCC----CCCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence              000    1112567999999999999999999999986

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.5e-49  Score=358.32  Aligned_cols=247  Identities=22%  Similarity=0.288  Sum_probs=204.4

Q ss_pred             cCCccCccccccCCccEEEEEEc-CCCEEEEEEecCC---CchhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEEE
Q 017594           49 NKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGR---SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIY  124 (369)
Q Consensus        49 ~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  124 (369)
                      ++|++++.||+|+||.||+|+++ +|+.||+|++...   .....+.+.+|+.+|+.++||||+++++++.+.+.+|+||
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~   84 (337)
T d1o6la_           5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM   84 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence            57999999999999999999975 5999999998643   2234577889999999999999999999999999999999


Q ss_pred             EecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCCC
Q 017594          125 EYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGN  204 (369)
Q Consensus       125 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~~  204 (369)
                      ||+.+++|..++..   ...+++..++.++.||+.||+|||++|   ++||||||+||+++.+|.++|+|||++......
T Consensus        85 ey~~gg~L~~~~~~---~~~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~  158 (337)
T d1o6la_          85 EYANGGELFFHLSR---ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISD  158 (337)
T ss_dssp             ECCTTCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred             eccCCCchhhhhhc---ccCCcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeecccccccccC
Confidence            99999999988854   345899999999999999999999999   999999999999999999999999999865432


Q ss_pred             CcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCccccccCccc
Q 017594          205 ELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPIL  284 (369)
Q Consensus       205 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (369)
                      .  .......||+.|+|||++.+..|+.++|+|||||++|+|++|++||.......     ..... ..... .     +
T Consensus       159 ~--~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~-----~~~~i-~~~~~-~-----~  224 (337)
T d1o6la_         159 G--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER-----LFELI-LMEEI-R-----F  224 (337)
T ss_dssp             T--CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-----HHHHH-HHCCC-C-----C
T ss_pred             C--cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHH-----HHHHH-hcCCC-C-----C
Confidence            2  22334579999999999999999999999999999999999999997543211     11111 11110 0     0


Q ss_pred             cccccHHHHHHHHHHHHHHhhcCCCCCCCC-----HHHHHH
Q 017594          285 EDEYSSKQMLLRYANIALLCVQESADDRPT-----MNDVVS  320 (369)
Q Consensus       285 ~~~~~~~~~~~~l~~li~~~L~~dP~~Rps-----~~ell~  320 (369)
                           +..++.++.+||.+||+.||++|++     +.++++
T Consensus       225 -----p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~  260 (337)
T d1o6la_         225 -----PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  260 (337)
T ss_dssp             -----CTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             -----CccCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence                 1112667899999999999999995     888886

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.6e-49  Score=351.52  Aligned_cols=266  Identities=28%  Similarity=0.410  Sum_probs=207.4

Q ss_pred             hcCCccCccccccCCccEEEEEEcCCCEEEEEEecCCCchhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEEEEec
Q 017594           48 TNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIYEYM  127 (369)
Q Consensus        48 ~~~y~i~~~lg~G~~~~v~~~~~~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~  127 (369)
                      .++|++.+.||+|+||.||+|+++++..||||++.... ...+.+.+|+.++++++||||+++++++. ++..++||||+
T Consensus        16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~-~~~~~lv~Ey~   93 (285)
T d1fmka3          16 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYM   93 (285)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEECCC
T ss_pred             HHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEe-cCCeEEEEEec
Confidence            47899999999999999999999888889999997543 34577999999999999999999999984 56789999999


Q ss_pred             CCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCCCCcc
Q 017594          128 PNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQ  207 (369)
Q Consensus       128 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~~~~~  207 (369)
                      .+|++..++... ....+++..+..++.||+.||+|||+++   ++||||||+||+++.++.++|+|||+++....... 
T Consensus        94 ~~g~l~~~~~~~-~~~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~-  168 (285)
T d1fmka3          94 SKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-  168 (285)
T ss_dssp             TTCBHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC--------
T ss_pred             CCCchhhhhhhc-ccccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccchhhhccCCCc-
Confidence            999998887542 2345899999999999999999999999   99999999999999999999999999986643322 


Q ss_pred             cccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCccccccCcccccc
Q 017594          208 ANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDE  287 (369)
Q Consensus       208 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  287 (369)
                      .......+++.|+|||++.+..++.++|||||||++|+|++|..|+........    .. ........     ...   
T Consensus       169 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~----~~-~~i~~~~~-----~~~---  235 (285)
T d1fmka3         169 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE----VL-DQVERGYR-----MPC---  235 (285)
T ss_dssp             -------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH----HH-HHHHTTCC-----CCC---
T ss_pred             eeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHH----HH-HHHHhcCC-----CCC---
Confidence            222335689999999999999999999999999999999997666543321110    01 11111100     001   


Q ss_pred             ccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHhhhhccCCCCCC
Q 017594          288 YSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNEAATLLPPKQP  335 (369)
Q Consensus       288 ~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L~~~~~~~~~~~~~  335 (369)
                        +..++.++.++|.+||+.||++|||+++|++.|+.......+...|
T Consensus       236 --~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~p~~~p  281 (285)
T d1fmka3         236 --PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQP  281 (285)
T ss_dssp             --CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCCCCCC
T ss_pred             --CcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCCCCCCCC
Confidence              1122567999999999999999999999999999877766544444

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-48  Score=349.04  Aligned_cols=260  Identities=26%  Similarity=0.389  Sum_probs=207.4

Q ss_pred             cCCccCcc-ccccCCccEEEEEEc---CCCEEEEEEecCCC-chhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEE
Q 017594           49 NKFSDANK-LGEGGFGPVYKGVLK---KGDEIAVKRLSGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILI  123 (369)
Q Consensus        49 ~~y~i~~~-lg~G~~~~v~~~~~~---~~~~valK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv  123 (369)
                      ++|.+.+. ||+|+||.||+|.++   ++..||||++.... ....+.+.+|+.++++++||||+++++++.. +..++|
T Consensus         8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv   86 (285)
T d1u59a_           8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV   86 (285)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred             cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEE
Confidence            45677774 999999999999854   24579999987543 3456778899999999999999999999864 578999


Q ss_pred             EEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCC
Q 017594          124 YEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGG  203 (369)
Q Consensus       124 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~  203 (369)
                      |||+++++|.+++...  +..+++..+..++.||+.||+|||+++   ++||||||+||+++.++.++|+|||+++....
T Consensus        87 mE~~~~g~L~~~l~~~--~~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~  161 (285)
T d1u59a_          87 MEMAGGGPLHKFLVGK--REEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGA  161 (285)
T ss_dssp             EECCTTEEHHHHHTTC--TTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred             EEeCCCCcHHHHhhcc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccchhhhcccc
Confidence            9999999999987542  345899999999999999999999999   99999999999999999999999999987754


Q ss_pred             CCcc-cccccccccccccCchhhccCCCCcccchHhHHHHHHHHHh-CCCCCCCCcccccccchhhhhhhhcCccccccC
Q 017594          204 NELQ-ANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDLWTSNRTLELID  281 (369)
Q Consensus       204 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (369)
                      .... .......+++.|+|||++.+..++.++|||||||++|+|+| |..||.......     . ...........   
T Consensus       162 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~-----~-~~~i~~~~~~~---  232 (285)
T d1u59a_         162 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE-----V-MAFIEQGKRME---  232 (285)
T ss_dssp             CSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH-----H-HHHHHTTCCCC---
T ss_pred             cccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHH-----H-HHHHHcCCCCC---
Confidence            3322 22233467899999999999999999999999999999998 899997543211     1 11111111111   


Q ss_pred             ccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHhhhhccC
Q 017594          282 PILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNEAATLL  330 (369)
Q Consensus       282 ~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L~~~~~~~~  330 (369)
                        .     +..++.++.+||.+||+.||++|||+.+|++.|+.....+.
T Consensus       233 --~-----p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~~~  274 (285)
T d1u59a_         233 --C-----PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLA  274 (285)
T ss_dssp             --C-----CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred             --C-----CCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHhh
Confidence              1     11236679999999999999999999999999987765443

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-48  Score=355.89  Aligned_cols=252  Identities=20%  Similarity=0.274  Sum_probs=204.8

Q ss_pred             HhcCCccCccccccCCccEEEEEEc-CCCEEEEEEecCCCchhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEEEE
Q 017594           47 ATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIYE  125 (369)
Q Consensus        47 ~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  125 (369)
                      +.++|++++.||+|+||+||+|+++ +|+.||+|++..... ....+.+|+++|+.++||||+++++++.+.+.+|+|||
T Consensus         3 ~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~-~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE   81 (321)
T d1tkia_           3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT-DQVLVKKEISILNIARHRNILHLHESFESMEELVMIFE   81 (321)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH-HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             CccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcc-cHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence            3578999999999999999999976 488899999976543 34567899999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCC--CceEEeecCCceecCC
Q 017594          126 YMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKD--MNPKISDFGMARICGG  203 (369)
Q Consensus       126 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~--~~~~L~Dfg~~~~~~~  203 (369)
                      ||++++|.+++...  ...+++..++.++.||+.||.|||++|   ++||||||+||+++.+  +.++|+|||++.....
T Consensus        82 ~~~gg~L~~~i~~~--~~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~  156 (321)
T d1tkia_          82 FISGLDIFERINTS--AFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP  156 (321)
T ss_dssp             CCCCCBHHHHHTSS--SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCT
T ss_pred             cCCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccchhhcccc
Confidence            99999999988543  235899999999999999999999999   9999999999999854  5799999999987654


Q ss_pred             CCcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCccccccCcc
Q 017594          204 NELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPI  283 (369)
Q Consensus       204 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (369)
                      ...   .....+++.|+|||...+..++.++|||||||++|+|++|..||.......     ...........       
T Consensus       157 ~~~---~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~-----~~~~i~~~~~~-------  221 (321)
T d1tkia_         157 GDN---FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ-----IIENIMNAEYT-------  221 (321)
T ss_dssp             TCE---EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH-----HHHHHHHTCCC-------
T ss_pred             CCc---ccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHH-----HHHHHHhCCCC-------
Confidence            322   233468999999999999999999999999999999999999996433111     11111110000       


Q ss_pred             ccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 017594          284 LEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVS  320 (369)
Q Consensus       284 ~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~  320 (369)
                      +. ......++.++.+||.+||+.||++|||+.|+++
T Consensus       222 ~~-~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~  257 (321)
T d1tkia_         222 FD-EEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ  257 (321)
T ss_dssp             CC-HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             CC-hhhccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            00 0001123667999999999999999999999997

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-48  Score=347.60  Aligned_cols=260  Identities=27%  Similarity=0.405  Sum_probs=199.8

Q ss_pred             hcCCccCccccccCCccEEEEEEcCC-----CEEEEEEecCCC-chhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccE
Q 017594           48 TNKFSDANKLGEGGFGPVYKGVLKKG-----DEIAVKRLSGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKI  121 (369)
Q Consensus        48 ~~~y~i~~~lg~G~~~~v~~~~~~~~-----~~valK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  121 (369)
                      ...|++.+.||+|+||.||+|.++.+     ..||||++.... ......+.+|+.++++++||||+++++++...+..+
T Consensus         6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~   85 (283)
T d1mqba_           6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM   85 (283)
T ss_dssp             TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred             HHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceE
Confidence            46789999999999999999996542     369999986543 334456889999999999999999999999999999


Q ss_pred             EEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceec
Q 017594          122 LIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARIC  201 (369)
Q Consensus       122 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~  201 (369)
                      +|+||+.++++.+++....  ..+++..+..++.||+.||+|||+++   ++||||||+||+++.++.+||+|||+++..
T Consensus        86 ~v~e~~~~~~l~~~~~~~~--~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~  160 (283)
T d1mqba_          86 IITEYMENGALDKFLREKD--GEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVL  160 (283)
T ss_dssp             EEEECCTTEEHHHHHHHTT--TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred             EEEEecccCcchhhhhccc--ccccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccchhhcc
Confidence            9999999999988775432  34889999999999999999999999   999999999999999999999999999876


Q ss_pred             CCCCc-ccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCcccccc
Q 017594          202 GGNEL-QANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELI  280 (369)
Q Consensus       202 ~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (369)
                      ..... ........|++.|+|||++.+..++.++|||||||++|+|++|..|+.......    . .........     
T Consensus       161 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~----~-~~~~i~~~~-----  230 (283)
T d1mqba_         161 EDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH----E-VMKAINDGF-----  230 (283)
T ss_dssp             -------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH----H-HHHHHHTTC-----
T ss_pred             cCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHH----H-HHHHHhccC-----
Confidence            44322 122233467899999999999999999999999999999999766553322111    0 111111110     


Q ss_pred             CccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHhhhh
Q 017594          281 DPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNEAA  327 (369)
Q Consensus       281 ~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L~~~~~  327 (369)
                      .+..     +..++..+.+||.+||+.||++|||+.+|++.|+.+..
T Consensus       231 ~~~~-----~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~  272 (283)
T d1mqba_         231 RLPT-----PMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR  272 (283)
T ss_dssp             CCCC-----CTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             CCCC-----chhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhh
Confidence            0111     11125679999999999999999999999999998776

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-48  Score=346.64  Aligned_cols=248  Identities=27%  Similarity=0.381  Sum_probs=196.9

Q ss_pred             ccccccCCccEEEEEEcC---CCEEEEEEecCC--CchhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEEEEecCC
Q 017594           55 NKLGEGGFGPVYKGVLKK---GDEIAVKRLSGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIYEYMPN  129 (369)
Q Consensus        55 ~~lg~G~~~~v~~~~~~~---~~~valK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~  129 (369)
                      +.||+|+||.||+|.++.   ++.||+|++...  +....+.+.+|+.++++++||||+++++++. .+..++||||+++
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~-~~~~~lvmE~~~~   91 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAEL   91 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEE-SSSEEEEEECCTT
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEec-cCCEEEEEEcCCC
Confidence            469999999999998643   467999998643  2334567889999999999999999999985 4568999999999


Q ss_pred             CChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCCCCcc-c
Q 017594          130 KSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQ-A  208 (369)
Q Consensus       130 ~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~~~~~-~  208 (369)
                      ++|.+++..   ...+++..+..++.||+.||+|||+++   ++||||||+||+++.++.++|+|||+++.+...... .
T Consensus        92 g~L~~~l~~---~~~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~  165 (277)
T d1xbba_          92 GPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK  165 (277)
T ss_dssp             EEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEE
T ss_pred             CcHHHHHhh---ccCCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhhccccccccc
Confidence            999999854   344899999999999999999999999   999999999999999999999999999876543322 2


Q ss_pred             ccccccccccccCchhhccCCCCcccchHhHHHHHHHHHh-CCCCCCCCcccccccchhhhhhhhcCccccccCcccccc
Q 017594          209 NTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILEDE  287 (369)
Q Consensus       209 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  287 (369)
                      ......|++.|+|||++.+..++.++|||||||++|+|++ |..||.......      ............     .   
T Consensus       166 ~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~------~~~~i~~~~~~~-----~---  231 (277)
T d1xbba_         166 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE------VTAMLEKGERMG-----C---  231 (277)
T ss_dssp             C----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH------HHHHHHTTCCCC-----C---
T ss_pred             cccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHH------HHHHHHcCCCCC-----C---
Confidence            2234568899999999999999999999999999999997 899987433111      111111111111     1   


Q ss_pred             ccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHhh
Q 017594          288 YSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNE  325 (369)
Q Consensus       288 ~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L~~~  325 (369)
                        +..++.++.+||.+||+.||++|||+.+|++.|+..
T Consensus       232 --p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~  267 (277)
T d1xbba_         232 --PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY  267 (277)
T ss_dssp             --CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             --CcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCH
Confidence              112256799999999999999999999999988765

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=2.1e-48  Score=353.47  Aligned_cols=245  Identities=24%  Similarity=0.306  Sum_probs=203.4

Q ss_pred             cCCccCccccccCCccEEEEEEc-CCCEEEEEEecCC---CchhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEEE
Q 017594           49 NKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGR---SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIY  124 (369)
Q Consensus        49 ~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  124 (369)
                      ++|++++.||+|+||.||+|+++ +|+.||+|++...   .....+.+.+|+.+++.++||||+++++++.+.+..|+||
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm   83 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM   83 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence            57999999999999999999975 4899999998632   2234567889999999999999999999999999999999


Q ss_pred             EecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCCC
Q 017594          125 EYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGN  204 (369)
Q Consensus       125 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~~  204 (369)
                      ||+.|+++..++..   ...+++..++.++.||+.||+|||++|   ++||||||+||+++.+|.++|+|||++......
T Consensus        84 E~~~gg~l~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~  157 (316)
T d1fota_          84 DYIEGGELFSLLRK---SQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV  157 (316)
T ss_dssp             CCCCSCBHHHHHHH---TSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred             eecCCccccccccc---cccccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCccceEeccc
Confidence            99999999888854   344788899999999999999999999   999999999999999999999999999876533


Q ss_pred             CcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCccccccCccc
Q 017594          205 ELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPIL  284 (369)
Q Consensus       205 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (369)
                           .....||+.|+|||++.+..|+.++|||||||++|+|++|+.||.......     ......... .  .+    
T Consensus       158 -----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~-----~~~~i~~~~-~--~~----  220 (316)
T d1fota_         158 -----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMK-----TYEKILNAE-L--RF----  220 (316)
T ss_dssp             -----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH-----HHHHHHHCC-C--CC----
T ss_pred             -----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHH-----HHHHHHcCC-C--CC----
Confidence                 234579999999999999999999999999999999999999996432111     111111111 0  00    


Q ss_pred             cccccHHHHHHHHHHHHHHhhcCCCCCCC-----CHHHHHHH
Q 017594          285 EDEYSSKQMLLRYANIALLCVQESADDRP-----TMNDVVSM  321 (369)
Q Consensus       285 ~~~~~~~~~~~~l~~li~~~L~~dP~~Rp-----s~~ell~~  321 (369)
                           +...+.++.++|.+||+.||++|+     |++++++.
T Consensus       221 -----p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H  257 (316)
T d1fota_         221 -----PPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH  257 (316)
T ss_dssp             -----CTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred             -----CCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence                 111256799999999999999996     89999863

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=5.7e-48  Score=355.35  Aligned_cols=244  Identities=23%  Similarity=0.284  Sum_probs=203.4

Q ss_pred             cCCccCccccccCCccEEEEEEc-CCCEEEEEEecCC---CchhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEEE
Q 017594           49 NKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGR---SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIY  124 (369)
Q Consensus        49 ~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  124 (369)
                      ++|++++.||+|+||.||+|+++ +|+.||+|++...   .....+.+.+|+.+++.++||||+++++++......++|+
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~  120 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence            58999999999999999999975 5999999998632   1233567889999999999999999999999999999999


Q ss_pred             EecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCCC
Q 017594          125 EYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGN  204 (369)
Q Consensus       125 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~~  204 (369)
                      ||+.+++|..++..   ...+++..++.++.||+.||.|||+++   ++||||||+|||++.+|.++|+|||++......
T Consensus       121 e~~~~g~l~~~l~~---~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~  194 (350)
T d1rdqe_         121 EYVAGGEMFSHLRR---IGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR  194 (350)
T ss_dssp             ECCTTCBHHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred             ccccccchhhhHhh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeeceeeeecccc
Confidence            99999999888843   345899999999999999999999999   999999999999999999999999999876532


Q ss_pred             CcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCccccccCccc
Q 017594          205 ELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPIL  284 (369)
Q Consensus       205 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (369)
                           .....||+.|+|||++.+..++.++|||||||++|+|++|..||.......     ......... . .     .
T Consensus       195 -----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~-----~~~~i~~~~-~-~-----~  257 (350)
T d1rdqe_         195 -----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ-----IYEKIVSGK-V-R-----F  257 (350)
T ss_dssp             -----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-----HHHHHHHCC-C-C-----C
T ss_pred             -----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHH-----HHHHHhcCC-C-C-----C
Confidence                 233578999999999999999999999999999999999999996432111     111111110 0 0     0


Q ss_pred             cccccHHHHHHHHHHHHHHhhcCCCCCCC-----CHHHHHH
Q 017594          285 EDEYSSKQMLLRYANIALLCVQESADDRP-----TMNDVVS  320 (369)
Q Consensus       285 ~~~~~~~~~~~~l~~li~~~L~~dP~~Rp-----s~~ell~  320 (369)
                           +..++.++.+||.+||+.||.+|+     |+++|++
T Consensus       258 -----p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~  293 (350)
T d1rdqe_         258 -----PSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             -----CTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             -----CccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence                 111266799999999999999994     8999986

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=6.3e-48  Score=344.91  Aligned_cols=261  Identities=22%  Similarity=0.297  Sum_probs=201.9

Q ss_pred             HhcCCccCccccccCCccEEEEEEc-CCCEEEEEEecCCC---chhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCc---
Q 017594           47 ATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS---GQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDE---  119 (369)
Q Consensus        47 ~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~---  119 (369)
                      +.++|++.+.||+|+||.||+|++. +|+.||+|++....   ......+.+|+.+++.++||||+++++++.....   
T Consensus         5 l~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~   84 (277)
T d1o6ya_           5 LSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP   84 (277)
T ss_dssp             ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSE
T ss_pred             ccceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCc
Confidence            4578999999999999999999975 58899999997543   3345578899999999999999999999986543   


Q ss_pred             -cEEEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCc
Q 017594          120 -KILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMA  198 (369)
Q Consensus       120 -~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~  198 (369)
                       .|+||||+++++|..++..   ...+++..+..++.||+.||+|||++|   ++||||||+||+++.++..+++|||.+
T Consensus        85 ~~~lvmE~~~g~~L~~~~~~---~~~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~~  158 (277)
T d1o6ya_          85 LPYIVMEYVDGVTLRDIVHT---EGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIA  158 (277)
T ss_dssp             EEEEEEECCCEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTTC
T ss_pred             eEEEEEECCCCCEehhhhcc---cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccceeehhhhh
Confidence             7899999999999888743   345899999999999999999999999   999999999999999999999999988


Q ss_pred             eecCCCCc-ccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCccc
Q 017594          199 RICGGNEL-QANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTL  277 (369)
Q Consensus       199 ~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  277 (369)
                      ........ ........||+.|+|||++.+..++.++|||||||++|+|+||.+||......     .............
T Consensus       159 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~-----~~~~~~~~~~~~~  233 (277)
T d1o6ya_         159 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV-----SVAYQHVREDPIP  233 (277)
T ss_dssp             EECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH-----HHHHHHHHCCCCC
T ss_pred             hhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHH-----HHHHHHHhcCCCC
Confidence            76543221 12233457899999999999999999999999999999999999999643211     1111111111110


Q ss_pred             cccCccccccccHHHHHHHHHHHHHHhhcCCCCCCC-CHHHHHHHHHhhh
Q 017594          278 ELIDPILEDEYSSKQMLLRYANIALLCVQESADDRP-TMNDVVSMLTNEA  326 (369)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp-s~~ell~~L~~~~  326 (369)
                      .        ......++.++.++|.+||+.||++|| |++++++.|.++.
T Consensus       234 ~--------~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~  275 (277)
T d1o6ya_         234 P--------SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH  275 (277)
T ss_dssp             G--------GGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred             C--------chhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence            0        000111266799999999999999999 8999999887653

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=6.8e-48  Score=348.66  Aligned_cols=261  Identities=26%  Similarity=0.405  Sum_probs=208.9

Q ss_pred             HhcCCccCccccccCCccEEEEEEc------CCCEEEEEEecCCCc-hhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCc
Q 017594           47 ATNKFSDANKLGEGGFGPVYKGVLK------KGDEIAVKRLSGRSG-QGLREMKNEASVIAKVQHKNLVRLLGCCIDRDE  119 (369)
Q Consensus        47 ~~~~y~i~~~lg~G~~~~v~~~~~~------~~~~valK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~  119 (369)
                      ..++|++.+.||+|+||.||+|+++      ++..||||++..... .....+.+|+.++++++||||+++++++.....
T Consensus        11 p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~   90 (301)
T d1lufa_          11 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKP   90 (301)
T ss_dssp             CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred             CHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCc
Confidence            3568999999999999999999965      246799999875433 335678999999999999999999999999999


Q ss_pred             cEEEEEecCCCChhhhhcCCC---------------------ccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCC
Q 017594          120 KILIYEYMPNKSLDFFLFDPT---------------------KRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLK  178 (369)
Q Consensus       120 ~~lv~e~~~~~~L~~~l~~~~---------------------~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~  178 (369)
                      .++++|++.+++|.+++....                     ....+++..+..++.||+.||+|||+++   ++|||||
T Consensus        91 ~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---ivHrDlK  167 (301)
T d1lufa_          91 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLA  167 (301)
T ss_dssp             CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCS
T ss_pred             eEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC---eEeeEEc
Confidence            999999999999999885321                     1234788899999999999999999999   9999999


Q ss_pred             CCCEEEeCCCceEEeecCCceecCCCCcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCC-CCCCCCc
Q 017594          179 ASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK-KNTGLYR  257 (369)
Q Consensus       179 p~NIlv~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~-~p~~~~~  257 (369)
                      |+||+++.++.+||+|||++................+++.|+|||.+.+..++.++|||||||++|+|++|. +||....
T Consensus       168 p~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~  247 (301)
T d1lufa_         168 TRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA  247 (301)
T ss_dssp             GGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred             ccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCC
Confidence            999999999999999999998665444333344456788999999999999999999999999999999985 5665432


Q ss_pred             ccccccchhhhhhhhcCccccccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHhhh
Q 017594          258 TDSLNLLGYAWDLWTSNRTLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNEA  326 (369)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L~~~~  326 (369)
                      ...     ..... ........          +..++.++.+||.+||+.+|++|||+.+|++.|++++
T Consensus       248 ~~e-----~~~~v-~~~~~~~~----------p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~  300 (301)
T d1lufa_         248 HEE-----VIYYV-RDGNILAC----------PENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC  300 (301)
T ss_dssp             HHH-----HHHHH-HTTCCCCC----------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             HHH-----HHHHH-HcCCCCCC----------CccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence            111     11111 11111111          1122567999999999999999999999999999875

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-47  Score=341.32  Aligned_cols=257  Identities=22%  Similarity=0.321  Sum_probs=196.4

Q ss_pred             hcCCccCccccccCCccEEEEEEcC----CCEEEEEEecCCC-chhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEE
Q 017594           48 TNKFSDANKLGEGGFGPVYKGVLKK----GDEIAVKRLSGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKIL  122 (369)
Q Consensus        48 ~~~y~i~~~lg~G~~~~v~~~~~~~----~~~valK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l  122 (369)
                      .++|++.+.||+|+||.||+|++..    +..||+|.+.... ....+.+.+|+.++++++||||+++++++. ++..++
T Consensus         6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~i   84 (273)
T d1mp8a_           6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI   84 (273)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred             HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEE
Confidence            4689999999999999999999643    3458899886443 334567889999999999999999999985 567899


Q ss_pred             EEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecC
Q 017594          123 IYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICG  202 (369)
Q Consensus       123 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~  202 (369)
                      ||||+.++++..++...  ...+++..+..++.||+.||.|||+++   ++||||||+||+++.++.++|+|||++....
T Consensus        85 v~E~~~~g~l~~~~~~~--~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~  159 (273)
T d1mp8a_          85 IMELCTLGELRSFLQVR--KYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYME  159 (273)
T ss_dssp             EEECCTTEEHHHHHHHT--TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC--------
T ss_pred             EEEeccCCcHHhhhhcc--CCCCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccchhheecc
Confidence            99999999998876532  335899999999999999999999999   9999999999999999999999999998654


Q ss_pred             CCCcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHh-CCCCCCCCcccccccchhhhhhhhcCccccccC
Q 017594          203 GNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDLWTSNRTLELID  281 (369)
Q Consensus       203 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (369)
                      .... .......+++.|+|||++.+..++.++|||||||++|+|++ |.+||.......     ..... .......   
T Consensus       160 ~~~~-~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~-----~~~~i-~~~~~~~---  229 (273)
T d1mp8a_         160 DSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND-----VIGRI-ENGERLP---  229 (273)
T ss_dssp             ------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG-----HHHHH-HTTCCCC---
T ss_pred             CCcc-eeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHH-----HHHHH-HcCCCCC---
Confidence            3322 22334467899999999999999999999999999999998 888886543211     11111 1111111   


Q ss_pred             ccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHhhhh
Q 017594          282 PILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNEAA  327 (369)
Q Consensus       282 ~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L~~~~~  327 (369)
                        .     +..++.++.+||.+||+.||++|||+.+|++.|+.+..
T Consensus       230 --~-----~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~  268 (273)
T d1mp8a_         230 --M-----PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE  268 (273)
T ss_dssp             --C-----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             --C-----CCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence              1     11226679999999999999999999999999988754

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-47  Score=347.33  Aligned_cols=257  Identities=28%  Similarity=0.441  Sum_probs=201.3

Q ss_pred             cCCccCccccccCCccEEEEEEcC-CC----EEEEEEecCC-CchhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEE
Q 017594           49 NKFSDANKLGEGGFGPVYKGVLKK-GD----EIAVKRLSGR-SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKIL  122 (369)
Q Consensus        49 ~~y~i~~~lg~G~~~~v~~~~~~~-~~----~valK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l  122 (369)
                      .+|++++.||+|+||+||+|++.. |+    +||+|.+... .....+.+.+|+.++++++||||+++++++.+ +..++
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~-~~~~~   87 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT-STVQL   87 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEE
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCeeE
Confidence            569999999999999999999653 44    5889988643 33446788999999999999999999999975 56778


Q ss_pred             EEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecC
Q 017594          123 IYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICG  202 (369)
Q Consensus       123 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~  202 (369)
                      +++++.+++|.+.+...  ...+++..+..++.||+.||+|||+++   ++||||||+||+++.++.++|+|||++....
T Consensus        88 v~e~~~~~~l~~~~~~~--~~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~~~~  162 (317)
T d1xkka_          88 ITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG  162 (317)
T ss_dssp             EEECCTTCBHHHHHHHT--SSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHHHTT
T ss_pred             EEEeccCCccccccccc--ccCCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeeccccceecc
Confidence            88999999998877543  345889999999999999999999999   9999999999999999999999999998776


Q ss_pred             CCCcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHh-CCCCCCCCcccccccchhhhhhhhcCccccccC
Q 017594          203 GNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDLWTSNRTLELID  281 (369)
Q Consensus       203 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (369)
                      ............|++.|+|||++.+..++.++|||||||++|+|+| |.+||.......      ............   
T Consensus       163 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~------~~~~i~~~~~~~---  233 (317)
T d1xkka_         163 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE------ISSILEKGERLP---  233 (317)
T ss_dssp             TTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGG------HHHHHHHTCCCC---
T ss_pred             cccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHH------HHHHHHcCCCCC---
Confidence            5444333444568999999999999999999999999999999998 788886443211      111111111000   


Q ss_pred             ccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHhhhh
Q 017594          282 PILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNEAA  327 (369)
Q Consensus       282 ~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L~~~~~  327 (369)
                        .     +..++.++.+|+.+||+.||++|||+.+|++.|..+..
T Consensus       234 --~-----p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~  272 (317)
T d1xkka_         234 --Q-----PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR  272 (317)
T ss_dssp             --C-----CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             --C-----CcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHh
Confidence              0     11125679999999999999999999999999988764

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=2.1e-47  Score=353.38  Aligned_cols=248  Identities=24%  Similarity=0.297  Sum_probs=197.3

Q ss_pred             cCCccCccccccCCccEEEEEEc-CCCEEEEEEecCCC---chhHHHH---HHHHHHHhcCCCCceeeeeeeEEeCCccE
Q 017594           49 NKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS---GQGLREM---KNEASVIAKVQHKNLVRLLGCCIDRDEKI  121 (369)
Q Consensus        49 ~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~~---~~~~~~~---~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  121 (369)
                      ++|++.+.||+|+||.||+|+++ +|+.||+|++....   ......+   ..++.+++.++||||+++++++...+..|
T Consensus         4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~   83 (364)
T d1omwa3           4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS   83 (364)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred             HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence            57999999999999999999976 49999999985321   1111223   34577788889999999999999999999


Q ss_pred             EEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceec
Q 017594          122 LIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARIC  201 (369)
Q Consensus       122 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~  201 (369)
                      +||||+.+++|..++..   ...+++..++.++.||+.||.|||++|   ++||||||+|||++.+|.++|+|||++..+
T Consensus        84 ivmE~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla~~~  157 (364)
T d1omwa3          84 FILDLMNGGDLHYHLSQ---HGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDF  157 (364)
T ss_dssp             EEECCCCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTCEEC
T ss_pred             EEEEecCCCcHHHHHHh---cccccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEeeeceeeec
Confidence            99999999999999853   345889999999999999999999999   999999999999999999999999999876


Q ss_pred             CCCCcccccccccccccccCchhhcc-CCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCcccccc
Q 017594          202 GGNELQANTSRIVGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELI  280 (369)
Q Consensus       202 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (369)
                      ....    .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||..........  .....  .....   
T Consensus       158 ~~~~----~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~--~~~~~--~~~~~---  226 (364)
T d1omwa3         158 SKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE--IDRMT--LTMAV---  226 (364)
T ss_dssp             SSSC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHH--HHHHS--SSCCC---
T ss_pred             CCCc----ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHH--HHHhc--ccCCC---
Confidence            5432    233479999999999874 568999999999999999999999997543221100  00000  00000   


Q ss_pred             CccccccccHHHHHHHHHHHHHHhhcCCCCCCCC-----HHHHHH
Q 017594          281 DPILEDEYSSKQMLLRYANIALLCVQESADDRPT-----MNDVVS  320 (369)
Q Consensus       281 ~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps-----~~ell~  320 (369)
                        ..     +..++.++.+||.+||+.||++|||     ++++++
T Consensus       227 --~~-----~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~  264 (364)
T d1omwa3         227 --EL-----PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  264 (364)
T ss_dssp             --CC-----CSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred             --CC-----CCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence              00     1112667999999999999999999     788885

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-47  Score=346.12  Aligned_cols=270  Identities=26%  Similarity=0.338  Sum_probs=202.0

Q ss_pred             chhhHHHHhcCCccCccccccCCccEEEEEEcC------CCEEEEEEecCCC-chhHHHHHHHHHHHhcC-CCCceeeee
Q 017594           40 SFSSVSTATNKFSDANKLGEGGFGPVYKGVLKK------GDEIAVKRLSGRS-GQGLREMKNEASVIAKV-QHKNLVRLL  111 (369)
Q Consensus        40 ~~~~~~~~~~~y~i~~~lg~G~~~~v~~~~~~~------~~~valK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~  111 (369)
                      .....+...++|++.+.||+|+||.||+|++..      ++.||+|++.... ....+.+..|...+.++ +|+||+.++
T Consensus         4 ~~~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~   83 (299)
T d1ywna1           4 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL   83 (299)
T ss_dssp             CHHHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             CCccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEee
Confidence            344444556789999999999999999999542      4579999987443 33445667777777776 688999999


Q ss_pred             eeEEeC-CccEEEEEecCCCChhhhhcCCC-------------ccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCC
Q 017594          112 GCCIDR-DEKILIYEYMPNKSLDFFLFDPT-------------KRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDL  177 (369)
Q Consensus       112 ~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~-------------~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl  177 (369)
                      +++... ...++||||+++++|.+++....             ....+++..+..++.||+.||+|||+++   ++||||
T Consensus        84 ~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrDl  160 (299)
T d1ywna1          84 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDL  160 (299)
T ss_dssp             EEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCC
T ss_pred             eeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCCcC
Confidence            887654 46899999999999999985432             1345889999999999999999999999   999999


Q ss_pred             CCCCEEEeCCCceEEeecCCceecCCCCcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCC-CCCCCC
Q 017594          178 KASNILLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK-KNTGLY  256 (369)
Q Consensus       178 ~p~NIlv~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~-~p~~~~  256 (369)
                      ||+||+++.++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|+|++|. +||...
T Consensus       161 Kp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~  240 (299)
T d1ywna1         161 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV  240 (299)
T ss_dssp             CGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred             CccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCC
Confidence            9999999999999999999998765544444445567899999999999999999999999999999999874 577543


Q ss_pred             cccccccchhhhhhhhcCccccccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHhhhh
Q 017594          257 RTDSLNLLGYAWDLWTSNRTLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNEAA  327 (369)
Q Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L~~~~~  327 (369)
                      .....     ............     ..     ..+++++.++|.+||+.||++|||+.+|++.|+++..
T Consensus       241 ~~~~~-----~~~~~~~~~~~~-----~~-----~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq  296 (299)
T d1ywna1         241 KIDEE-----FCRRLKEGTRMR-----AP-----DYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ  296 (299)
T ss_dssp             CCSHH-----HHHHHHHTCCCC-----CC-----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CHHHH-----HHHHHhcCCCCC-----CC-----ccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence            32211     111111111111     11     1125679999999999999999999999999998764

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-47  Score=341.71  Aligned_cols=257  Identities=26%  Similarity=0.346  Sum_probs=196.8

Q ss_pred             hcCCccCccccccCCccEEEEEEcC--CC--EEEEEEecCC---CchhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCcc
Q 017594           48 TNKFSDANKLGEGGFGPVYKGVLKK--GD--EIAVKRLSGR---SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEK  120 (369)
Q Consensus        48 ~~~y~i~~~lg~G~~~~v~~~~~~~--~~--~valK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~  120 (369)
                      .++|++.+.||+|+||.||+|+.+.  ++  .||+|++...   .....+.+.+|+.++++++||||+++++++.+ ...
T Consensus         7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~   85 (273)
T d1u46a_           7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPM   85 (273)
T ss_dssp             GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred             hHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cch
Confidence            4679999999999999999998543  33  6899988643   33445678999999999999999999999965 578


Q ss_pred             EEEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCcee
Q 017594          121 ILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARI  200 (369)
Q Consensus       121 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~  200 (369)
                      ++|+||++++++.+.+..  ....+++..+..++.||+.||.|||+++   ++||||||+||+++.++.++|+|||++..
T Consensus        86 ~lv~e~~~~~~l~~~~~~--~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~~~  160 (273)
T d1u46a_          86 KMVTELAPLGSLLDRLRK--HQGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRA  160 (273)
T ss_dssp             EEEEECCTTCBHHHHHHH--HGGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred             heeeeeecCcchhhhhhc--ccCCCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeeccchhhhh
Confidence            999999999999887754  2345899999999999999999999999   99999999999999999999999999998


Q ss_pred             cCCCCccc-ccccccccccccCchhhccCCCCcccchHhHHHHHHHHHh-CCCCCCCCcccccccchhhhhhhhcCcccc
Q 017594          201 CGGNELQA-NTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDLWTSNRTLE  278 (369)
Q Consensus       201 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (369)
                      ........ ......++..|+|||++.+..++.++||||||+++|+|+| |..||.......     .............
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~-----~~~~i~~~~~~~~  235 (273)
T d1u46a_         161 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ-----ILHKIDKEGERLP  235 (273)
T ss_dssp             CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-----HHHHHHTSCCCCC
T ss_pred             cccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHH-----HHHHHHhCCCCCC
Confidence            75543322 2233457788999999999999999999999999999998 899986433211     1111111111100


Q ss_pred             ccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHhh
Q 017594          279 LIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNE  325 (369)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L~~~  325 (369)
                           .     +..++..+.+||.+||+.||++|||+.+|++.|+++
T Consensus       236 -----~-----~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~  272 (273)
T d1u46a_         236 -----R-----PEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA  272 (273)
T ss_dssp             -----C-----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -----C-----cccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence                 0     112256799999999999999999999999999875

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-47  Score=339.42  Aligned_cols=252  Identities=27%  Similarity=0.377  Sum_probs=198.4

Q ss_pred             hcCCccCccccccCCccEEEEEEcCCCEEEEEEecCCCchhHHHHHHHHHHHhcCCCCceeeeeeeEEeC-CccEEEEEe
Q 017594           48 TNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDR-DEKILIYEY  126 (369)
Q Consensus        48 ~~~y~i~~~lg~G~~~~v~~~~~~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~  126 (369)
                      .++|++.+.||+|+||.||+|+++ |..||+|++....  ..+.+.+|++++++++||||+++++++.+. +..++||||
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~~--~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey   82 (262)
T d1byga_           6 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY   82 (262)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred             HHHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcHH--HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEec
Confidence            467899999999999999999986 7789999996543  347789999999999999999999998654 568999999


Q ss_pred             cCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCCCCc
Q 017594          127 MPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNEL  206 (369)
Q Consensus       127 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~~~~  206 (369)
                      +++++|.+++... ....+++..+..++.||+.||.|||+.+   ++||||||+||+++.++.++|+|||++......  
T Consensus        83 ~~~g~L~~~l~~~-~~~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~--  156 (262)
T d1byga_          83 MAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--  156 (262)
T ss_dssp             CTTEEHHHHHHHH-HHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred             cCCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeecccccceecCCC--
Confidence            9999999998542 2345899999999999999999999998   999999999999999999999999998754322  


Q ss_pred             ccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHh-CCCCCCCCcccccccchhhhhhhhcCccccccCcccc
Q 017594          207 QANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILE  285 (369)
Q Consensus       207 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (369)
                         .....++..|+|||++.+..++.++|||||||++|+|+| |++||.......     ..... ...     ..+.+.
T Consensus       157 ---~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~-----~~~~i-~~~-----~~~~~~  222 (262)
T d1byga_         157 ---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD-----VVPRV-EKG-----YKMDAP  222 (262)
T ss_dssp             --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG-----HHHHH-TTT-----CCCCCC
T ss_pred             ---CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHH-----HHHHH-HcC-----CCCCCC
Confidence               223457889999999999999999999999999999998 677775432211     11111 111     111111


Q ss_pred             ccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHhhhh
Q 017594          286 DEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNEAA  327 (369)
Q Consensus       286 ~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L~~~~~  327 (369)
                      .     .++..+.+||.+||+.||.+|||+.+|++.|+.++.
T Consensus       223 ~-----~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~  259 (262)
T d1byga_         223 D-----GCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT  259 (262)
T ss_dssp             T-----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             c-----cCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHh
Confidence            1     125678999999999999999999999999998764

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=1.4e-47  Score=341.57  Aligned_cols=251  Identities=23%  Similarity=0.308  Sum_probs=203.0

Q ss_pred             hcCCccCccccccCCccEEEEEEc-CCCEEEEEEecCCCch---------hHHHHHHHHHHHhcCC-CCceeeeeeeEEe
Q 017594           48 TNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSGQ---------GLREMKNEASVIAKVQ-HKNLVRLLGCCID  116 (369)
Q Consensus        48 ~~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~~~~---------~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~  116 (369)
                      .++|++.+.||+|+||+||+|++. +|+.||+|++......         ..+.+.+|+.+++++. ||||+++++++.+
T Consensus         2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~   81 (277)
T d1phka_           2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET   81 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred             cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence            578999999999999999999975 5889999998654311         2345778999999997 9999999999999


Q ss_pred             CCccEEEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecC
Q 017594          117 RDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFG  196 (369)
Q Consensus       117 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg  196 (369)
                      .+..|+||||+++++|.+++..   ...+++..+..++.||+.||+|||++|   ++||||||+||+++.++.++|+|||
T Consensus        82 ~~~~~ivmE~~~~g~L~~~l~~---~~~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~DFG  155 (277)
T d1phka_          82 NTFFFLVFDLMKKGELFDYLTE---KVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFG  155 (277)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCT
T ss_pred             CcceEEEEEcCCCchHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCeEEccch
Confidence            9999999999999999999954   345899999999999999999999999   9999999999999999999999999


Q ss_pred             CceecCCCCcccccccccccccccCchhhcc------CCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhh
Q 017594          197 MARICGGNELQANTSRIVGTYGYMSPEYALE------GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDL  270 (369)
Q Consensus       197 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~  270 (369)
                      ++.......   ......|++.|.|||++.+      ..++.++||||+||++|+|++|+.||.......     .....
T Consensus       156 ~a~~~~~~~---~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~-----~~~~i  227 (277)
T d1phka_         156 FSCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML-----MLRMI  227 (277)
T ss_dssp             TCEECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-----HHHHH
T ss_pred             heeEccCCC---ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHH-----HHHHH
Confidence            998775432   2234578999999999853      457889999999999999999999997433111     11111


Q ss_pred             hhcCccccccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 017594          271 WTSNRTLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVS  320 (369)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~  320 (369)
                      .... .. ...+      ....+++++.+||.+||+.||++|||+.|+++
T Consensus       228 ~~~~-~~-~~~~------~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~  269 (277)
T d1phka_         228 MSGN-YQ-FGSP------EWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  269 (277)
T ss_dssp             HHTC-CC-CCTT------TGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             HhCC-CC-CCCc------ccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence            1111 10 0000      11123677999999999999999999999976

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-47  Score=344.83  Aligned_cols=263  Identities=27%  Similarity=0.390  Sum_probs=208.6

Q ss_pred             HHhcCCccCccccccCCccEEEEEEcC--------CCEEEEEEecCCCc-hhHHHHHHHHHHHhcC-CCCceeeeeeeEE
Q 017594           46 TATNKFSDANKLGEGGFGPVYKGVLKK--------GDEIAVKRLSGRSG-QGLREMKNEASVIAKV-QHKNLVRLLGCCI  115 (369)
Q Consensus        46 ~~~~~y~i~~~lg~G~~~~v~~~~~~~--------~~~valK~~~~~~~-~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~  115 (369)
                      ...++|++.+.||+|+||.||+|+...        +..||+|++..... .....+..|...+.++ +||||+++++++.
T Consensus        10 i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~   89 (299)
T d1fgka_          10 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT   89 (299)
T ss_dssp             CCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             ccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccc
Confidence            345789999999999999999999543        23699999875543 3456777888888888 7999999999999


Q ss_pred             eCCccEEEEEecCCCChhhhhcCCCc-------------cccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCE
Q 017594          116 DRDEKILIYEYMPNKSLDFFLFDPTK-------------RMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNI  182 (369)
Q Consensus       116 ~~~~~~lv~e~~~~~~L~~~l~~~~~-------------~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NI  182 (369)
                      ++...++||||+.+|+|.+++.....             ...+++..+..++.||+.||+|||+.+   ++||||||+||
T Consensus        90 ~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~Ni  166 (299)
T d1fgka_          90 QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNV  166 (299)
T ss_dssp             SSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGE
T ss_pred             cCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeecccce
Confidence            99999999999999999999865431             245899999999999999999999999   99999999999


Q ss_pred             EEeCCCceEEeecCCceecCCCCcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHh-CCCCCCCCccccc
Q 017594          183 LLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSL  261 (369)
Q Consensus       183 lv~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~t-g~~p~~~~~~~~~  261 (369)
                      +++.++.++|+|||++................+++.|+|||.+.+..|+.++||||||+++|+|++ |.+||....... 
T Consensus       167 Ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~-  245 (299)
T d1fgka_         167 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE-  245 (299)
T ss_dssp             EECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH-
T ss_pred             eecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHH-
Confidence            999999999999999987765544444455678899999999999999999999999999999998 688876433211 


Q ss_pred             ccchhhhhhhhcCccccccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHhhhh
Q 017594          262 NLLGYAWDLWTSNRTLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNEAA  327 (369)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L~~~~~  327 (369)
                           .............     ..     .++.++.+||.+||+.||++|||+.+|++.|+++.+
T Consensus       246 -----~~~~i~~~~~~~~-----p~-----~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a  296 (299)
T d1fgka_         246 -----LFKLLKEGHRMDK-----PS-----NCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA  296 (299)
T ss_dssp             -----HHHHHHTTCCCCC-----CS-----SCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -----HHHHHHcCCCCCC-----Cc-----cchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhh
Confidence                 1122111111111     11     125679999999999999999999999999998865

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-47  Score=349.69  Aligned_cols=250  Identities=18%  Similarity=0.226  Sum_probs=197.4

Q ss_pred             hcCCccCc-cccccCCccEEEEEEc-CCCEEEEEEecCCCchhHHHHHHHHHHHhc-CCCCceeeeeeeEEe----CCcc
Q 017594           48 TNKFSDAN-KLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSGQGLREMKNEASVIAK-VQHKNLVRLLGCCID----RDEK  120 (369)
Q Consensus        48 ~~~y~i~~-~lg~G~~~~v~~~~~~-~~~~valK~~~~~~~~~~~~~~~e~~~l~~-l~h~~i~~~~~~~~~----~~~~  120 (369)
                      .++|+++. .||+|+||.||+|++. +|+.||||++...     ..+.+|+.++.+ ++||||++++++|.+    ...+
T Consensus        10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~   84 (335)
T d2ozaa1          10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL   84 (335)
T ss_dssp             GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence            46899875 5999999999999974 5899999998643     467789988654 589999999999875    3568


Q ss_pred             EEEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeC---CCceEEeecCC
Q 017594          121 ILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDK---DMNPKISDFGM  197 (369)
Q Consensus       121 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~---~~~~~L~Dfg~  197 (369)
                      |+|||||+||+|.+++.... ...+++..++.++.||+.||+|||++|   ++||||||+||+++.   ++.++|+|||+
T Consensus        85 ~ivmEy~~gg~L~~~i~~~~-~~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~DFG~  160 (335)
T d2ozaa1          85 LIVMECLDGGELFSRIQDRG-DQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGF  160 (335)
T ss_dssp             EEEEECCCSEEHHHHHHSCS-CCCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred             EEEEECCCCCcHHHHHHhcC-CCCcCHHHHHHHHHHHHHHHHHHHHcC---Cccccccccccccccccccccccccccce
Confidence            99999999999999986532 245899999999999999999999999   999999999999975   56799999999


Q ss_pred             ceecCCCCcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCccc
Q 017594          198 ARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTL  277 (369)
Q Consensus       198 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  277 (369)
                      +........   .....|++.|+|||++.+..|+.++|||||||++|+|++|+.||.........           ....
T Consensus       161 a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~-----------~~~~  226 (335)
T d2ozaa1         161 AKETTSHNS---LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS-----------PGMK  226 (335)
T ss_dssp             CEECCCCCC---CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC------------------
T ss_pred             eeeccCCCc---cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHH-----------HHHH
Confidence            987654332   23457999999999999999999999999999999999999999643211100           0000


Q ss_pred             cccC--ccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 017594          278 ELID--PILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVS  320 (369)
Q Consensus       278 ~~~~--~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~  320 (369)
                      ..+.  ...........++.++.+||.+||+.||++|||+.++++
T Consensus       227 ~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  271 (335)
T d2ozaa1         227 TRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN  271 (335)
T ss_dssp             -CCCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HHHhcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence            0000  000001112344678999999999999999999999987

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.8e-47  Score=343.61  Aligned_cols=258  Identities=22%  Similarity=0.242  Sum_probs=193.4

Q ss_pred             cCccccccCCccEEEEEEc-CCCEEEEEEecCCCch-----hHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEEEEe
Q 017594           53 DANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSGQ-----GLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIYEY  126 (369)
Q Consensus        53 i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  126 (369)
                      .++.||+|+||+||+|+++ +|+.||||++......     ..+.+.+|+.++++++||||+++++++..++..++||||
T Consensus         2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~   81 (299)
T d1ua2a_           2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF   81 (299)
T ss_dssp             EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred             cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence            4678999999999999965 4899999998644221     134678899999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCCCCc
Q 017594          127 MPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNEL  206 (369)
Q Consensus       127 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~~~~  206 (369)
                      +.++++..+..   .+..+++..+..++.||+.||+|||++|   ++||||||+||+++.++.++|+|||++........
T Consensus        82 ~~~~~~~~~~~---~~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~  155 (299)
T d1ua2a_          82 METDLEVIIKD---NSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR  155 (299)
T ss_dssp             CSEEHHHHHTT---CCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC
T ss_pred             hcchHHhhhhh---cccCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCccccccCCCcc
Confidence            99988776663   3345888999999999999999999999   99999999999999999999999999976654322


Q ss_pred             ccccccccccccccCchhhcc-CCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhh---cC---ccccc
Q 017594          207 QANTSRIVGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWT---SN---RTLEL  279 (369)
Q Consensus       207 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~---~~---~~~~~  279 (369)
                        ......||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.........  ........   ..   .....
T Consensus       156 --~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l--~~i~~~~~~~~~~~~~~~~~~  231 (299)
T d1ua2a_         156 --AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQL--TRIFETLGTPTEEQWPDMCSL  231 (299)
T ss_dssp             --CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH--HHHHHHHCCCCTTTSSSTTSS
T ss_pred             --cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHH--HHHHHhcCCCChhhccchhcc
Confidence              2233468999999999865 46799999999999999999999999654321100  00000000   00   00000


Q ss_pred             cC----ccccccc---cHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 017594          280 ID----PILEDEY---SSKQMLLRYANIALLCVQESADDRPTMNDVVS  320 (369)
Q Consensus       280 ~~----~~~~~~~---~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~  320 (369)
                      ..    .......   .....+.++.+||.+||+.||++|||+.|+++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~  279 (299)
T d1ua2a_         232 PDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK  279 (299)
T ss_dssp             TTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             chhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence            00    0000000   00112567999999999999999999999987

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-47  Score=349.48  Aligned_cols=247  Identities=25%  Similarity=0.359  Sum_probs=199.4

Q ss_pred             cCCccCccccccCCccEEEEEEc-CCCEEEEEEecCCC---chhHHHHHHHHHHH-hcCCCCceeeeeeeEEeCCccEEE
Q 017594           49 NKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS---GQGLREMKNEASVI-AKVQHKNLVRLLGCCIDRDEKILI  123 (369)
Q Consensus        49 ~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~~---~~~~~~~~~e~~~l-~~l~h~~i~~~~~~~~~~~~~~lv  123 (369)
                      ++|++++.||+|+||+||+|+++ +|+.||+|++....   ....+.+..|...+ +.++||||+++++++.+.+..|+|
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv   81 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV   81 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence            57999999999999999999976 48899999986321   22334555666655 468999999999999999999999


Q ss_pred             EEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCC
Q 017594          124 YEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGG  203 (369)
Q Consensus       124 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~  203 (369)
                      |||+++|+|.+++..   ...+++..+..++.||+.||+|||+++   ++||||||+|||++.++.++|+|||++.....
T Consensus        82 mEy~~~g~L~~~i~~---~~~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~  155 (320)
T d1xjda_          82 MEYLNGGDLMYHIQS---CHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENML  155 (320)
T ss_dssp             EECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred             EeecCCCcHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccccchhhhccc
Confidence            999999999999853   344899999999999999999999999   99999999999999999999999999986543


Q ss_pred             CCcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCccccccCcc
Q 017594          204 NELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPI  283 (369)
Q Consensus       204 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (369)
                      ..  .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.......      ..........      .
T Consensus       156 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~------~~~~i~~~~~------~  221 (320)
T d1xjda_         156 GD--AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE------LFHSIRMDNP------F  221 (320)
T ss_dssp             TT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHHCCC------C
T ss_pred             cc--ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHH------HHHHHHcCCC------C
Confidence            32  22334578999999999999999999999999999999999999996433111      1111111110      0


Q ss_pred             ccccccHHHHHHHHHHHHHHhhcCCCCCCCCHH-HHHH
Q 017594          284 LEDEYSSKQMLLRYANIALLCVQESADDRPTMN-DVVS  320 (369)
Q Consensus       284 ~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~-ell~  320 (369)
                      .     +..++.++.+||.+||+.||++||++. ++++
T Consensus       222 ~-----p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~  254 (320)
T d1xjda_         222 Y-----PRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ  254 (320)
T ss_dssp             C-----CTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred             C-----CccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence            1     111256799999999999999999995 7764

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.1e-47  Score=343.38  Aligned_cols=265  Identities=26%  Similarity=0.376  Sum_probs=211.6

Q ss_pred             HHhcCCccCccccccCCccEEEEEEc------CCCEEEEEEecCCC-chhHHHHHHHHHHHhcC-CCCceeeeeeeEEeC
Q 017594           46 TATNKFSDANKLGEGGFGPVYKGVLK------KGDEIAVKRLSGRS-GQGLREMKNEASVIAKV-QHKNLVRLLGCCIDR  117 (369)
Q Consensus        46 ~~~~~y~i~~~lg~G~~~~v~~~~~~------~~~~valK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~  117 (369)
                      ...++|++.+.||+|+||.||+|++.      ++..||+|++.... ......+.+|+.++..+ +||||+++++++...
T Consensus        20 ~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~   99 (311)
T d1t46a_          20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIG   99 (311)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             CCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeC
Confidence            33478999999999999999999853      35679999997543 34455688899999999 699999999999999


Q ss_pred             CccEEEEEecCCCChhhhhcCCC---------------ccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCE
Q 017594          118 DEKILIYEYMPNKSLDFFLFDPT---------------KRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNI  182 (369)
Q Consensus       118 ~~~~lv~e~~~~~~L~~~l~~~~---------------~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NI  182 (369)
                      ...+++|||+++++|.+++....               ....+++..+..++.||+.||+|||+++   ++||||||+||
T Consensus       100 ~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp~NI  176 (311)
T d1t46a_         100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNI  176 (311)
T ss_dssp             SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGE
T ss_pred             CEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccccccc
Confidence            99999999999999999885432               2335889999999999999999999999   99999999999


Q ss_pred             EEeCCCceEEeecCCceecCCCCcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHh-CCCCCCCCccccc
Q 017594          183 LLDKDMNPKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVS-GKKNTGLYRTDSL  261 (369)
Q Consensus       183 lv~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~t-g~~p~~~~~~~~~  261 (369)
                      +++.++.++++|||.+................+++.|+|||++.+..++.++|||||||++|+|+| |.+||....... 
T Consensus       177 l~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~-  255 (311)
T d1t46a_         177 LLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS-  255 (311)
T ss_dssp             EEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH-
T ss_pred             cccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHH-
Confidence            999999999999999987765444444455678999999999999999999999999999999999 455554332211 


Q ss_pred             ccchhhhhhhhcCccccccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHhhhhc
Q 017594          262 NLLGYAWDLWTSNRTLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNEAAT  328 (369)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L~~~~~~  328 (369)
                          .......... ..    ..     +...+..+.+||.+||+.||++|||+.+|++.|++....
T Consensus       256 ----~~~~~i~~~~-~~----~~-----~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~  308 (311)
T d1t46a_         256 ----KFYKMIKEGF-RM----LS-----PEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE  308 (311)
T ss_dssp             ----HHHHHHHHTC-CC----CC-----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ----HHHHHHhcCC-CC----CC-----cccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhcc
Confidence                1111111111 00    00     111256799999999999999999999999999876553

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-46  Score=339.58  Aligned_cols=266  Identities=21%  Similarity=0.301  Sum_probs=199.5

Q ss_pred             cCCccCccccccCCccEEEEEEc-CCCEEEEEEecCCC--chhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEEEE
Q 017594           49 NKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS--GQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIYE  125 (369)
Q Consensus        49 ~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  125 (369)
                      ++|++++.||+|+||+||+|++. +|+.||+|++....  ......+.+|++++++++||||+++++++.+....|+|||
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e   81 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE   81 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence            58999999999999999999975 58999999986442  2235678899999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCCCC
Q 017594          126 YMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE  205 (369)
Q Consensus       126 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~~~  205 (369)
                      |+.++.+......  ....+++..++.++.||+.||.|||++|   ++||||||+||+++.++.++|+|||.+.......
T Consensus        82 ~~~~~~~~~~~~~--~~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~  156 (298)
T d1gz8a_          82 FLHQDLKKFMDAS--ALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV  156 (298)
T ss_dssp             CCSEEHHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS
T ss_pred             ecCCchhhhhhhh--cccCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCcceeccCCc
Confidence            9987655544433  2344899999999999999999999999   9999999999999999999999999997664332


Q ss_pred             cccccccccccccccCchhhccCC-CCcccchHhHHHHHHHHHhCCCCCCCCcccccccc---------hhhhhhh-hcC
Q 017594          206 LQANTSRIVGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLL---------GYAWDLW-TSN  274 (369)
Q Consensus       206 ~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~---------~~~~~~~-~~~  274 (369)
                        .......|++.|+|||++.... ++.++|+|||||++|+|++|+.||...........         ...+... ...
T Consensus       157 --~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  234 (298)
T d1gz8a_         157 --RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMP  234 (298)
T ss_dssp             --BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGST
T ss_pred             --ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccccccc
Confidence              2233357899999999887665 57899999999999999999999964331110000         0000000 000


Q ss_pred             ccccccCcccccccc--HHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 017594          275 RTLELIDPILEDEYS--SKQMLLRYANIALLCVQESADDRPTMNDVVSM  321 (369)
Q Consensus       275 ~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~  321 (369)
                      ...............  ....+.++.+||.+||+.||++|||+.|+++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H  283 (298)
T d1gz8a_         235 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH  283 (298)
T ss_dssp             TCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             ccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence            000000000000000  11225678999999999999999999999974

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-46  Score=340.81  Aligned_cols=275  Identities=23%  Similarity=0.294  Sum_probs=204.7

Q ss_pred             hcCCccCccccccCCccEEEEEEcCCCEEEEEEecCCCchhHHHHHHHHHHHhcCCCCceeeeeeeEEeCC----ccEEE
Q 017594           48 TNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDRD----EKILI  123 (369)
Q Consensus        48 ~~~y~i~~~lg~G~~~~v~~~~~~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----~~~lv  123 (369)
                      .++|.+.+.||+|+||.||+|+.+ |+.||||++...... ......|+..+.+++||||+++++++...+    ..++|
T Consensus         2 ~~~~~l~~~iG~G~fg~Vy~~~~~-g~~vAvK~~~~~~~~-~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv   79 (303)
T d1vjya_           2 ARTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV   79 (303)
T ss_dssp             GGGEEEEEEEECCSSSEEEEEEET-TEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred             CcEEEEEEEEeeCCCeEEEEEEEC-CEEEEEEEECccchh-HHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEE
Confidence            467889999999999999999975 889999998644321 122233555556789999999999998654    47999


Q ss_pred             EEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCC-----CCCcccCCCCCCCEEEeCCCceEEeecCCc
Q 017594          124 YEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYS-----RVRIIHRDLKASNILLDKDMNPKISDFGMA  198 (369)
Q Consensus       124 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~-----~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~  198 (369)
                      |||+.+++|.+++..    ..+++...+.++.|++.||+|||..+     .++++||||||+||+|+.++.+||+|||++
T Consensus        80 ~Ey~~~g~L~~~l~~----~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~  155 (303)
T d1vjya_          80 SDYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA  155 (303)
T ss_dssp             EECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred             EecccCCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcc
Confidence            999999999999953    34889999999999999999999741     123999999999999999999999999999


Q ss_pred             eecCCCCccc--ccccccccccccCchhhccC------CCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhh---
Q 017594          199 RICGGNELQA--NTSRIVGTYGYMSPEYALEG------IFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYA---  267 (369)
Q Consensus       199 ~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~------~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~---  267 (369)
                      ..........  ......||+.|+|||++.+.      .++.++|||||||++|+|+||..||+.............   
T Consensus       156 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~  235 (303)
T d1vjya_         156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD  235 (303)
T ss_dssp             EEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSS
T ss_pred             ccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhccccc
Confidence            8775433222  23345789999999998754      267889999999999999999988865442221111110   


Q ss_pred             --hhhhhcCccccccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHhhhhc
Q 017594          268 --WDLWTSNRTLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNEAAT  328 (369)
Q Consensus       268 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L~~~~~~  328 (369)
                        ..............+.+............+.+|+.+||+.||++|||+.||++.|+++...
T Consensus       236 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~  298 (303)
T d1vjya_         236 PSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ  298 (303)
T ss_dssp             CCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             chHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHh
Confidence              0000001111222333333333444467799999999999999999999999999988764

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=2.6e-46  Score=336.04  Aligned_cols=263  Identities=22%  Similarity=0.338  Sum_probs=199.7

Q ss_pred             cCCccCccccccCCccEEEEEEcCCCEEEEEEecCCC--chhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEEEEe
Q 017594           49 NKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRS--GQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIYEY  126 (369)
Q Consensus        49 ~~y~i~~~lg~G~~~~v~~~~~~~~~~valK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  126 (369)
                      ++|++++.||+|+||+||+|++++|+.||+|++....  ....+.+.+|+.++++++||||+++++++...+..++++++
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~   81 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence            5899999999999999999999999999999996543  22357888999999999999999999999999999999999


Q ss_pred             cCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCCCCc
Q 017594          127 MPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNEL  206 (369)
Q Consensus       127 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~~~~  206 (369)
                      +.++.+..+...   ...+++..++.++.||+.||+|||+.+   ++||||||+||+++.++.++|+|||.+........
T Consensus        82 ~~~~~~~~~~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~  155 (286)
T d1ob3a_          82 LDQDLKKLLDVC---EGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVR  155 (286)
T ss_dssp             CSEEHHHHHHTS---TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred             ehhhhHHHHHhh---cCCcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEecccccceecccCcc
Confidence            988877777643   345999999999999999999999999   99999999999999999999999999887643321


Q ss_pred             ccccccccccccccCchhhcc-CCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchh---------hhh-hhhcCc
Q 017594          207 QANTSRIVGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGY---------AWD-LWTSNR  275 (369)
Q Consensus       207 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~---------~~~-~~~~~~  275 (369)
                        ......+++.|.|||.+.+ ..++.++|||||||++|+|++|+.||.............         .+. ......
T Consensus       156 --~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  233 (286)
T d1ob3a_         156 --KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPK  233 (286)
T ss_dssp             --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTT
T ss_pred             --ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhh
Confidence              2233467899999999875 457999999999999999999999996432111000000         000 000000


Q ss_pred             c---ccccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 017594          276 T---LELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVS  320 (369)
Q Consensus       276 ~---~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~  320 (369)
                      .   .....+. .........+.++.+||.+||+.||++|||+.|+++
T Consensus       234 ~~~~~~~~~~~-~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~  280 (286)
T d1ob3a_         234 YDPNFTVYEPL-PWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (286)
T ss_dssp             CCTTCCCCCCC-CGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             cccccccccCc-chhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            0   0000000 000011122567899999999999999999999985

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-46  Score=338.80  Aligned_cols=258  Identities=29%  Similarity=0.367  Sum_probs=203.3

Q ss_pred             cCCccCccccccCCccEEEEEEcC-CC--EEEEEEecCC-CchhHHHHHHHHHHHhcC-CCCceeeeeeeEEeCCccEEE
Q 017594           49 NKFSDANKLGEGGFGPVYKGVLKK-GD--EIAVKRLSGR-SGQGLREMKNEASVIAKV-QHKNLVRLLGCCIDRDEKILI  123 (369)
Q Consensus        49 ~~y~i~~~lg~G~~~~v~~~~~~~-~~--~valK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv  123 (369)
                      ++|++.+.||+|+||.||+|++++ |.  .||||.+... .....+.+.+|+.+|.++ +||||+++++++.+.+..++|
T Consensus        10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV   89 (309)
T d1fvra_          10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA   89 (309)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence            789999999999999999999754 44  4778887543 333456789999999999 799999999999999999999


Q ss_pred             EEecCCCChhhhhcCC-------------CccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCce
Q 017594          124 YEYMPNKSLDFFLFDP-------------TKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNP  190 (369)
Q Consensus       124 ~e~~~~~~L~~~l~~~-------------~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~  190 (369)
                      |||+++|+|.+++...             .....+++..+..++.||+.||.|||+++   ++||||||+|||++.++.+
T Consensus        90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~~  166 (309)
T d1fvra_          90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA  166 (309)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred             EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEEEcCCCce
Confidence            9999999999998653             23456899999999999999999999999   9999999999999999999


Q ss_pred             EEeecCCceecCCCCcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCC-CCCCCcccccccchhhhh
Q 017594          191 KISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKK-NTGLYRTDSLNLLGYAWD  269 (369)
Q Consensus       191 ~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~-p~~~~~~~~~~~~~~~~~  269 (369)
                      +|+|||++.......   ......++..|+|||.+.+..++.++|||||||++|+|++|.. ||.......     ....
T Consensus       167 kl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~-----~~~~  238 (309)
T d1fvra_         167 KIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE-----LYEK  238 (309)
T ss_dssp             EECCTTCEESSCEEC---CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-----HHHH
T ss_pred             EEccccccccccccc---cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHH-----HHHH
Confidence            999999987543221   2223468899999999999999999999999999999999764 564322111     1111


Q ss_pred             hhhcCccccccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHhhhhc
Q 017594          270 LWTSNRTLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNEAAT  328 (369)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L~~~~~~  328 (369)
                      .....      .+...     ..++.++.+||.+||+.||++|||+.+|++.|+++...
T Consensus       239 i~~~~------~~~~~-----~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~  286 (309)
T d1fvra_         239 LPQGY------RLEKP-----LNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE  286 (309)
T ss_dssp             GGGTC------CCCCC-----TTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred             HHhcC------CCCCC-----ccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence            11110      11111     11256799999999999999999999999999998764

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-47  Score=342.50  Aligned_cols=241  Identities=23%  Similarity=0.349  Sum_probs=194.7

Q ss_pred             HhcCCccCccccccCCccEEEEEEc-CCCEEEEEEecCCCc------hhHHHHHHHHHHHhcCC--CCceeeeeeeEEeC
Q 017594           47 ATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSG------QGLREMKNEASVIAKVQ--HKNLVRLLGCCIDR  117 (369)
Q Consensus        47 ~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~~~------~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~  117 (369)
                      +.++|++.+.||+|+||.||+|++. +|+.||+|++.....      .....+..|+.++++++  ||||+++++++.+.
T Consensus         2 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~   81 (273)
T d1xwsa_           2 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP   81 (273)
T ss_dssp             CTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS
T ss_pred             CCCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeC
Confidence            4679999999999999999999975 589999999864321      11233567999999986  89999999999999


Q ss_pred             CccEEEEEecCC-CChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCC-CceEEeec
Q 017594          118 DEKILIYEYMPN-KSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKD-MNPKISDF  195 (369)
Q Consensus       118 ~~~~lv~e~~~~-~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~-~~~~L~Df  195 (369)
                      +..++|||++.+ +++.+++..   +..+++..++.++.||+.||+|||+++   ++||||||+||+++.+ +.++|+||
T Consensus        82 ~~~~lv~e~~~~~~~l~~~~~~---~~~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~DF  155 (273)
T d1xwsa_          82 DSFVLILERPEPVQDLFDFITE---RGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDF  155 (273)
T ss_dssp             SEEEEEEECCSSEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCC
T ss_pred             CeEEEEEEeccCcchHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCeEEECcc
Confidence            999999999976 466666633   345899999999999999999999999   9999999999999855 78999999


Q ss_pred             CCceecCCCCcccccccccccccccCchhhccCCC-CcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcC
Q 017594          196 GMARICGGNELQANTSRIVGTYGYMSPEYALEGIF-SIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSN  274 (369)
Q Consensus       196 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~  274 (369)
                      |++.......    .....||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.....           .....
T Consensus       156 G~a~~~~~~~----~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~-----------i~~~~  220 (273)
T d1xwsa_         156 GSGALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE-----------IIRGQ  220 (273)
T ss_dssp             TTCEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-----------HHHCC
T ss_pred             ccceeccccc----ccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchH-----------Hhhcc
Confidence            9998654322    234578999999999887665 6779999999999999999999964210           00100


Q ss_pred             ccccccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 017594          275 RTLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVS  320 (369)
Q Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~  320 (369)
                         ..+.+         .++.++.+||.+||+.||++|||++|+++
T Consensus       221 ---~~~~~---------~~s~~~~~li~~~L~~dp~~R~s~~eil~  254 (273)
T d1xwsa_         221 ---VFFRQ---------RVSSECQHLIRWCLALRPSDRPTFEEIQN  254 (273)
T ss_dssp             ---CCCSS---------CCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ---cCCCC---------CCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence               00111         12567999999999999999999999987

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-45  Score=332.48  Aligned_cols=257  Identities=26%  Similarity=0.374  Sum_probs=202.4

Q ss_pred             CccccccCCccEEEEEEcCC----CEEEEEEecCC-CchhHHHHHHHHHHHhcCCCCceeeeeeeEEeC-CccEEEEEec
Q 017594           54 ANKLGEGGFGPVYKGVLKKG----DEIAVKRLSGR-SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDR-DEKILIYEYM  127 (369)
Q Consensus        54 ~~~lg~G~~~~v~~~~~~~~----~~valK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~~  127 (369)
                      .++||+|+||+||+|++.++    ..||||++... .....+.+.+|++++++++||||+++++++... ...++||||+
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~  111 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM  111 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred             ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence            56899999999999996442    25899998743 445567899999999999999999999998764 5789999999


Q ss_pred             CCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCCCCcc
Q 017594          128 PNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNELQ  207 (369)
Q Consensus       128 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~~~~~  207 (369)
                      ++++|.+++....  ...++..+..++.|++.||.|||+.+   ++||||||+||+++.++.++|+|||++.........
T Consensus       112 ~~g~l~~~~~~~~--~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~  186 (311)
T d1r0pa_         112 KHGDLRNFIRNET--HNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD  186 (311)
T ss_dssp             TTCBHHHHHHCTT--CCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCC
T ss_pred             ecCchhhhhcccc--ccchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccchhhccccccc
Confidence            9999999886533  34667788999999999999999999   999999999999999999999999999876543322


Q ss_pred             c--ccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCccccccCcccc
Q 017594          208 A--NTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTLELIDPILE  285 (369)
Q Consensus       208 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (369)
                      .  ......|++.|+|||.+.+..++.++||||||+++|+|++|..||........    ...........      .. 
T Consensus       187 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~----~~~~i~~g~~~------~~-  255 (311)
T d1r0pa_         187 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD----ITVYLLQGRRL------LQ-  255 (311)
T ss_dssp             CTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC----------CHHHHHTTCCC------CC-
T ss_pred             cceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHH----HHHHHHcCCCC------CC-
Confidence            2  22234678999999999999999999999999999999998888754331111    11111111110      01 


Q ss_pred             ccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHhhhhccC
Q 017594          286 DEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNEAATLL  330 (369)
Q Consensus       286 ~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L~~~~~~~~  330 (369)
                          +..++.++.+||.+||+.||++|||+.||++.|+++..+..
T Consensus       256 ----p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~~  296 (311)
T d1r0pa_         256 ----PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI  296 (311)
T ss_dssp             ----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred             ----cccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhhh
Confidence                11125669999999999999999999999999999987544

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.6e-46  Score=335.75  Aligned_cols=265  Identities=22%  Similarity=0.297  Sum_probs=193.9

Q ss_pred             HhcCCccCccccccCCccEEEEEEc-C-CCEEEEEEecCCC--chhHHHHHHHHHHHhcC---CCCceeeeeeeEEe---
Q 017594           47 ATNKFSDANKLGEGGFGPVYKGVLK-K-GDEIAVKRLSGRS--GQGLREMKNEASVIAKV---QHKNLVRLLGCCID---  116 (369)
Q Consensus        47 ~~~~y~i~~~lg~G~~~~v~~~~~~-~-~~~valK~~~~~~--~~~~~~~~~e~~~l~~l---~h~~i~~~~~~~~~---  116 (369)
                      ..++|++++.||+|+||+||+|++. + ++.||||++....  ......+.+|+.+++.|   +||||+++++++..   
T Consensus         5 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~   84 (305)
T d1blxa_           5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT   84 (305)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred             CcCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccc
Confidence            3589999999999999999999974 4 5668999985321  12223455666666655   79999999999853   


Q ss_pred             --CCccEEEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEee
Q 017594          117 --RDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISD  194 (369)
Q Consensus       117 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~D  194 (369)
                        ....++++|++.++.+......  ....+++..++.++.||+.||+|||+++   ++||||||+|||++.++.++|+|
T Consensus        85 ~~~~~~~~~~e~~~~~~~~~~~~~--~~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~d  159 (305)
T d1blxa_          85 DRETKLTLVFEHVDQDLTTYLDKV--PEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLAD  159 (305)
T ss_dssp             SSEEEEEEEEECCSCBHHHHHHHS--CTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECS
T ss_pred             ccCceEEEEEEeccCCchhhhhhc--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCCCeeecc
Confidence              2457999999998877655433  3344889999999999999999999999   99999999999999999999999


Q ss_pred             cCCceecCCCCcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhh------
Q 017594          195 FGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAW------  268 (369)
Q Consensus       195 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~------  268 (369)
                      ||++......   .......||+.|+|||++.+..|+.++|||||||++|+|++|++||.......... ....      
T Consensus       160 fg~~~~~~~~---~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~-~i~~~~~~~~  235 (305)
T d1blxa_         160 FGLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLG-KILDVIGLPG  235 (305)
T ss_dssp             CCSCCCCCGG---GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH-HHHHHHCCCC
T ss_pred             hhhhhhhccc---ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHH-HHHHhhCCCc
Confidence            9998754322   22344578999999999999999999999999999999999999997543211000 0000      


Q ss_pred             -hhhhcC-c-cccccCccccc--cccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 017594          269 -DLWTSN-R-TLELIDPILED--EYSSKQMLLRYANIALLCVQESADDRPTMNDVVS  320 (369)
Q Consensus       269 -~~~~~~-~-~~~~~~~~~~~--~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~  320 (369)
                       ..+... . ...........  .......++.+.+||.+||+.||++|||+.|+++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~  292 (305)
T d1blxa_         236 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  292 (305)
T ss_dssp             GGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             hhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence             000000 0 00000000000  0001112567899999999999999999999986

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7e-46  Score=336.22  Aligned_cols=264  Identities=28%  Similarity=0.403  Sum_probs=211.3

Q ss_pred             HHHhcCCccCccccccCCccEEEEEEc------CCCEEEEEEecCC-CchhHHHHHHHHHHHhcCCCCceeeeeeeEEeC
Q 017594           45 STATNKFSDANKLGEGGFGPVYKGVLK------KGDEIAVKRLSGR-SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDR  117 (369)
Q Consensus        45 ~~~~~~y~i~~~lg~G~~~~v~~~~~~------~~~~valK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~  117 (369)
                      +...++|++.+.||+|+||.||+|.++      ++..||||++... .......+.+|+.++++++||||+++++++..+
T Consensus        16 ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~   95 (308)
T d1p4oa_          16 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG   95 (308)
T ss_dssp             BCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSS
T ss_pred             eecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecC
Confidence            334589999999999999999999864      2568999999754 333445688999999999999999999999999


Q ss_pred             CccEEEEEecCCCChhhhhcCC-------CccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCce
Q 017594          118 DEKILIYEYMPNKSLDFFLFDP-------TKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNP  190 (369)
Q Consensus       118 ~~~~lv~e~~~~~~L~~~l~~~-------~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~  190 (369)
                      ...++||||+.+|+|.+++...       .....+++..+.+++.|++.||.|||+++   ++||||||+||+++.++.+
T Consensus        96 ~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~~~~~  172 (308)
T d1p4oa_          96 QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTV  172 (308)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCE
T ss_pred             CceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCceeecCCceE
Confidence            9999999999999998887432       12234688889999999999999999998   9999999999999999999


Q ss_pred             EEeecCCceecCCCCcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCC-CCCCCCcccccccchhhhh
Q 017594          191 KISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGK-KNTGLYRTDSLNLLGYAWD  269 (369)
Q Consensus       191 ~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~-~p~~~~~~~~~~~~~~~~~  269 (369)
                      +|+|||++................+++.|+|||.+.+..++.++||||+|+++|+|+||. +||.......     ....
T Consensus       173 Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~-----~~~~  247 (308)
T d1p4oa_         173 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ-----VLRF  247 (308)
T ss_dssp             EECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHH-----HHHH
T ss_pred             EEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHH-----HHHH
Confidence            999999998765544444444556899999999999999999999999999999999985 6665332111     1111


Q ss_pred             hhhcCccccccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHhhhh
Q 017594          270 LWTSNRTLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNEAA  327 (369)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L~~~~~  327 (369)
                      . ........          +..++..+.++|.+||+.+|++|||+.+|++.|++...
T Consensus       248 i-~~~~~~~~----------p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~  294 (308)
T d1p4oa_         248 V-MEGGLLDK----------PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME  294 (308)
T ss_dssp             H-HTTCCCCC----------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred             H-HhCCCCCC----------cccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence            1 11111110          11125679999999999999999999999999987754

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=5.5e-45  Score=329.43  Aligned_cols=275  Identities=20%  Similarity=0.252  Sum_probs=203.7

Q ss_pred             hcCCccCccccccCCccEEEEEEc-CCCEEEEEEecCCCchhHHHHHHHHHHHhcCCCCc-eeeeeeeEEeCCccEEEEE
Q 017594           48 TNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKN-LVRLLGCCIDRDEKILIYE  125 (369)
Q Consensus        48 ~~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~-i~~~~~~~~~~~~~~lv~e  125 (369)
                      +++|++.+.||+|+||.||+|++. +|+.||||++......  ..+..|+++++.++|++ ++.+..++...+..++|||
T Consensus         6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme   83 (299)
T d1ckia_           6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME   83 (299)
T ss_dssp             TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS--CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             CCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC--HHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEE
Confidence            468999999999999999999975 4889999988754332  45778999999998766 5555666677788899999


Q ss_pred             ecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeC---CCceEEeecCCceecC
Q 017594          126 YMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDK---DMNPKISDFGMARICG  202 (369)
Q Consensus       126 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~---~~~~~L~Dfg~~~~~~  202 (369)
                      ++.+ ++...+..  ....+++..+..++.|++.||+|||++|   ++||||||+||+++.   +..++|+|||++..+.
T Consensus        84 ~~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~  157 (299)
T d1ckia_          84 LLGP-SLEDLFNF--CSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR  157 (299)
T ss_dssp             CCCC-BHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCEECB
T ss_pred             EcCC-chhhhhhh--ccCCCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeeccCcceecc
Confidence            9855 44444432  2234899999999999999999999999   999999999999853   4579999999999875


Q ss_pred             CCCcc-----cccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCccc
Q 017594          203 GNELQ-----ANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTL  277 (369)
Q Consensus       203 ~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  277 (369)
                      .....     .......||+.|+|||.+.+..++.++|||||||++|+|++|..||........................
T Consensus       158 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~  237 (299)
T d1ckia_         158 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI  237 (299)
T ss_dssp             CTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCH
T ss_pred             ccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCCh
Confidence            43321     1223457999999999999999999999999999999999999999765432211110000000000000


Q ss_pred             cccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHhhhhccCCCCCCCccc
Q 017594          278 ELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNEAATLLPPKQPAFSY  339 (369)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L~~~~~~~~~~~~~~~~~  339 (369)
                      ..+         ...++.++.+++.+||+.+|++||++.+|.+.|+.+..........++++
T Consensus       238 ~~~---------~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~~~~~~~~~Dw  290 (299)
T d1ckia_         238 EVL---------CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDW  290 (299)
T ss_dssp             HHH---------TTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHHTCCCSCCCHH
T ss_pred             hHh---------ccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHcCCCCCCCcCc
Confidence            000         11125679999999999999999999999999998766554444444444

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=9.4e-45  Score=326.58  Aligned_cols=275  Identities=16%  Similarity=0.210  Sum_probs=212.5

Q ss_pred             HhcCCccCccccccCCccEEEEEEc-CCCEEEEEEecCCCchhHHHHHHHHHHHhcCCC-CceeeeeeeEEeCCccEEEE
Q 017594           47 ATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSGQGLREMKNEASVIAKVQH-KNLVRLLGCCIDRDEKILIY  124 (369)
Q Consensus        47 ~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~  124 (369)
                      ++++|++.+.||+|+||.||+|++. +|+.||+|++.....  ...+.+|++.+..+.| +|++.+++++......++||
T Consensus         3 ig~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vm   80 (293)
T d1csna_           3 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVI   80 (293)
T ss_dssp             ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEE
T ss_pred             CCCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC--cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEE
Confidence            4689999999999999999999976 488999998865432  2457788999999975 89999999999999999999


Q ss_pred             EecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeC-----CCceEEeecCCce
Q 017594          125 EYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDK-----DMNPKISDFGMAR  199 (369)
Q Consensus       125 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~-----~~~~~L~Dfg~~~  199 (369)
                      |++ +++|.+++....  ..++...+..++.|++.||+|||++|   ++||||||+||+++.     ++.++|+|||+++
T Consensus        81 e~~-~~~l~~~~~~~~--~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~  154 (293)
T d1csna_          81 DLL-GPSLEDLLDLCG--RKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK  154 (293)
T ss_dssp             ECC-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred             Eec-CCCHHHHHHhhc--cchhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEEcccceeE
Confidence            998 678877775432  34889999999999999999999999   999999999999964     5789999999998


Q ss_pred             ecCCCCcc-----cccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCccccccc-chhhhhhhhc
Q 017594          200 ICGGNELQ-----ANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNL-LGYAWDLWTS  273 (369)
Q Consensus       200 ~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~-~~~~~~~~~~  273 (369)
                      .+......     .......||+.|+|||++.+..++.++|||||||++|+|++|..||.......... ..........
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~  234 (293)
T d1csna_         155 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQS  234 (293)
T ss_dssp             ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHH
T ss_pred             EcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCC
Confidence            86543211     12234579999999999999999999999999999999999999997544222111 0000000000


Q ss_pred             CccccccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHHHhhhhccCCCCCCCccc
Q 017594          274 NRTLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSMLTNEAATLLPPKQPAFSY  339 (369)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~L~~~~~~~~~~~~~~~~~  339 (369)
                      ....+.          ...++.++.+++..|++.+|++||+++.+.+.|+.+.........-+++|
T Consensus       235 ~~~~~l----------~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~~~~~~~~~Dw  290 (293)
T d1csna_         235 TPLREL----------CAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTEDENFDW  290 (293)
T ss_dssp             SCHHHH----------TTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCSCSCCGG
T ss_pred             CChHHh----------cCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHcCCCCCCCCCC
Confidence            000000          01125679999999999999999999999999998877665544444443

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.8e-45  Score=331.32  Aligned_cols=267  Identities=19%  Similarity=0.302  Sum_probs=195.7

Q ss_pred             hcCCccCccccccCCccEEEEEEc-CCCEEEEEEecCC--CchhHHHHHHHHHHHhcCCCCceeeeeeeEEe--------
Q 017594           48 TNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCID--------  116 (369)
Q Consensus        48 ~~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--------  116 (369)
                      .++|++++.||+|+||+||+|+++ +|+.||||++...  .......+.+|+.+|+.++|||++++++++..        
T Consensus         9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~   88 (318)
T d3blha1           9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   88 (318)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred             cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence            489999999999999999999975 5999999998543  22345678899999999999999999998854        


Q ss_pred             CCccEEEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecC
Q 017594          117 RDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFG  196 (369)
Q Consensus       117 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg  196 (369)
                      ....+++||++.++.+.....   ....+++..++.++.||+.||.|||++|   ++||||||+||+++.++.++|+|||
T Consensus        89 ~~~~~iv~e~~~~~~~~~~~~---~~~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~dfg  162 (318)
T d3blha1          89 KGSIYLVFDFCEHDLAGLLSN---VLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFG  162 (318)
T ss_dssp             --CEEEEEECCCEEHHHHHTC---TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCT
T ss_pred             CceEEEEEeccCCCccchhhh---cccccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCcEEeeecc
Confidence            345799999998887765543   3344889999999999999999999999   9999999999999999999999999


Q ss_pred             CceecCCCCccc--ccccccccccccCchhhccC-CCCcccchHhHHHHHHHHHhCCCCCCCCcccccccch--------
Q 017594          197 MARICGGNELQA--NTSRIVGTYGYMSPEYALEG-IFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLG--------  265 (369)
Q Consensus       197 ~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~--------  265 (369)
                      ++..+.......  ......||+.|+|||++.+. .++.++||||+||++|+|++|+.||............        
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~  242 (318)
T d3blha1         163 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT  242 (318)
T ss_dssp             TCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred             eeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence            998765433221  12234689999999998755 6899999999999999999999999643211100000        


Q ss_pred             -hhhhhhhcCccccccCcc------ccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 017594          266 -YAWDLWTSNRTLELIDPI------LEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVS  320 (369)
Q Consensus       266 -~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~  320 (369)
                       ..+...........+...      ..........+.++.+||.+||+.||++|||++|+++
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~  304 (318)
T d3blha1         243 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN  304 (318)
T ss_dssp             TTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             hhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHc
Confidence             000000000011111111      1111112222457889999999999999999999996

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-45  Score=339.54  Aligned_cols=268  Identities=21%  Similarity=0.244  Sum_probs=196.6

Q ss_pred             cCCccCccccccCCccEEEEEEc-CCCEEEEEEecCCCchhHHHHHHHHHHHhcCCCCceeeeeeeEEeC------CccE
Q 017594           49 NKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNLVRLLGCCIDR------DEKI  121 (369)
Q Consensus        49 ~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~~~~  121 (369)
                      .+|+.+++||+|+||+||+|+++ +|+.||||++.....    ...+|+.+|++++||||++++++|...      .+.+
T Consensus        20 ~~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~   95 (350)
T d1q5ka_          20 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN   95 (350)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEE
T ss_pred             CCcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEE
Confidence            37899999999999999999976 499999999975432    234699999999999999999998543      2468


Q ss_pred             EEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCC-ceEEeecCCcee
Q 017594          122 LIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDM-NPKISDFGMARI  200 (369)
Q Consensus       122 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~-~~~L~Dfg~~~~  200 (369)
                      +||||+.++.+..+.........+++..++.++.||+.||+|||++|   |+||||||+|||++.++ .++|+|||++..
T Consensus        96 lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~a~~  172 (350)
T d1q5ka_          96 LVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ  172 (350)
T ss_dssp             EEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCTTCEE
T ss_pred             EEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeEecccchhh
Confidence            99999987755444432233456899999999999999999999999   99999999999999875 899999999987


Q ss_pred             cCCCCcccccccccccccccCchhhcc-CCCCcccchHhHHHHHHHHHhCCCCCCCCccccccc---------chhhhhh
Q 017594          201 CGGNELQANTSRIVGTYGYMSPEYALE-GIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNL---------LGYAWDL  270 (369)
Q Consensus       201 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~---------~~~~~~~  270 (369)
                      +.....   .....|++.|+|||++.+ ..++.++||||+||++|+|++|..||..........         ....+..
T Consensus       173 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~  249 (350)
T d1q5ka_         173 LVRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE  249 (350)
T ss_dssp             CCTTSC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHH
T ss_pred             ccCCcc---cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhh
Confidence            654332   223478999999998765 568999999999999999999999997544211100         0000000


Q ss_pred             hhcCccccccCccc---cccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH--HHHhhh
Q 017594          271 WTSNRTLELIDPIL---EDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVS--MLTNEA  326 (369)
Q Consensus       271 ~~~~~~~~~~~~~~---~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~--~L~~~~  326 (369)
                      ..............   .........++++.+||.+||+.||++|||+.|+++  .|+.+.
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~  310 (350)
T d1q5ka_         250 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR  310 (350)
T ss_dssp             HCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred             hccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcccc
Confidence            00000000000000   000111123567999999999999999999999996  355443

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-44  Score=332.36  Aligned_cols=264  Identities=22%  Similarity=0.283  Sum_probs=194.4

Q ss_pred             HhcCCccCccccccCCccEEEEEEc-CCCEEEEEEecCC--CchhHHHHHHHHHHHhcCCCCceeeeeeeEEeCC-----
Q 017594           47 ATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGR--SGQGLREMKNEASVIAKVQHKNLVRLLGCCIDRD-----  118 (369)
Q Consensus        47 ~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----  118 (369)
                      +.++|++++.||+|+||+||+|+++ +|+.||+|++...  .....+.+.+|+.+|+.++||||++++++|...+     
T Consensus        16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~   95 (346)
T d1cm8a_          16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF   95 (346)
T ss_dssp             CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred             cCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcccccc
Confidence            4579999999999999999999975 4999999999743  2334567889999999999999999999997654     


Q ss_pred             -ccEEEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCC
Q 017594          119 -EKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGM  197 (369)
Q Consensus       119 -~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~  197 (369)
                       ..|+||||+ +.+|..+..    ...+++..++.++.||+.||+|||++|   ++||||||+||+++.++.++++|||+
T Consensus        96 ~~~~lv~e~~-~~~l~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg~  167 (346)
T d1cm8a_          96 TDFYLVMPFM-GTDLGKLMK----HEKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGL  167 (346)
T ss_dssp             CCCEEEEECC-SEEHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTT
T ss_pred             ceEEEEEecc-cccHHHHHH----hccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhcccccccccccccc
Confidence             469999999 556766653    335899999999999999999999999   99999999999999999999999999


Q ss_pred             ceecCCCCcccccccccccccccCchhhccC-CCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchh------hhhh
Q 017594          198 ARICGGNELQANTSRIVGTYGYMSPEYALEG-IFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGY------AWDL  270 (369)
Q Consensus       198 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~------~~~~  270 (369)
                      +......     .....+++.|+|||++.+. .++.++||||+||++|+|++|..||.............      ....
T Consensus       168 a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  242 (346)
T d1cm8a_         168 ARQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEF  242 (346)
T ss_dssp             CEECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred             eeccCCc-----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHH
Confidence            9876533     2335689999999998764 57899999999999999999999997543111000000      0000


Q ss_pred             hhc----------CccccccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH--HHhh
Q 017594          271 WTS----------NRTLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVSM--LTNE  325 (369)
Q Consensus       271 ~~~----------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~--L~~~  325 (369)
                      ...          ..........+...  ....+.++.+||.+||+.||++|||+.|+++.  |+.+
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~  307 (346)
T d1cm8a_         243 VQRLQSDEAKNYMKGLPELEKKDFASI--LTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL  307 (346)
T ss_dssp             HHTCSCHHHHHHHHHSCCCCCCCGGGT--CTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred             HhhhcchhhhhhhccCCcccccchHHh--ccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcC
Confidence            000          00000000000000  01125668999999999999999999999974  5544

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=3.8e-44  Score=328.09  Aligned_cols=258  Identities=17%  Similarity=0.265  Sum_probs=196.9

Q ss_pred             hcCCccCccccccCCccEEEEEEc-CCCEEEEEEecCCCchhHHHHHHHHHHHhcCC-CCceeeeeeeEEeC--CccEEE
Q 017594           48 TNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSGQGLREMKNEASVIAKVQ-HKNLVRLLGCCIDR--DEKILI  123 (369)
Q Consensus        48 ~~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~--~~~~lv  123 (369)
                      .++|++++.||+|+||+||+|++. +|+.||+|++....   .+.+.+|+.+|+.++ ||||+++++++...  ...++|
T Consensus        34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v  110 (328)
T d3bqca1          34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV  110 (328)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEE
T ss_pred             CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH---HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEE
Confidence            368999999999999999999975 58899999987543   367889999999995 99999999999744  568999


Q ss_pred             EEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCC-ceEEeecCCceecC
Q 017594          124 YEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDM-NPKISDFGMARICG  202 (369)
Q Consensus       124 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~-~~~L~Dfg~~~~~~  202 (369)
                      |||+.+++|..+.      ..+++..++.++.||+.||.|||++|   |+||||||+|||++.++ .++|+|||++....
T Consensus       111 ~e~~~~~~L~~~~------~~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~  181 (328)
T d3bqca1         111 FEHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH  181 (328)
T ss_dssp             EECCCSCBGGGTT------TSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEECC
T ss_pred             EeecCCCcHHHHh------cCCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeecccccceecc
Confidence            9999999987654      23899999999999999999999999   99999999999998765 58999999998765


Q ss_pred             CCCcccccccccccccccCchhhccC-CCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhh--------hhhhh-
Q 017594          203 GNELQANTSRIVGTYGYMSPEYALEG-IFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYA--------WDLWT-  272 (369)
Q Consensus       203 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~--------~~~~~-  272 (369)
                      ....   .....+|+.|+|||.+.+. .++.++||||+||++|+|++|+.||..............        ..... 
T Consensus       182 ~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~  258 (328)
T d3bqca1         182 PGQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDK  258 (328)
T ss_dssp             TTCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHH
T ss_pred             CCCc---ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhh
Confidence            4322   2334689999999998765 479999999999999999999999975543211100000        00000 


Q ss_pred             --cCc---ccccc-------CccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 017594          273 --SNR---TLELI-------DPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVS  320 (369)
Q Consensus       273 --~~~---~~~~~-------~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~  320 (369)
                        ...   .....       .............+.++.+||.+||+.||++|||++|+++
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~  318 (328)
T d3bqca1         259 YNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  318 (328)
T ss_dssp             TTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             cccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence              000   00000       0000011112223567899999999999999999999986

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-44  Score=324.13  Aligned_cols=264  Identities=20%  Similarity=0.247  Sum_probs=201.9

Q ss_pred             cCCccCccccccCCccEEEEEEc-CCCEEEEEEecCCC--chhHHHHHHHHHHHhcCCCCceeeeeeeEEeCCccEEEEE
Q 017594           49 NKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS--GQGLREMKNEASVIAKVQHKNLVRLLGCCIDRDEKILIYE  125 (369)
Q Consensus        49 ~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  125 (369)
                      +||++++.||+|+||+||+|++. +|+.||+|++....  ......+.+|+.+++.++||||+++++++.+....+++++
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~   81 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence            58999999999999999999975 58899999986442  3446788899999999999999999999999999999999


Q ss_pred             ecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCceecCCCC
Q 017594          126 YMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARICGGNE  205 (369)
Q Consensus       126 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~~~~~~  205 (369)
                      ++.++++..++...   ..+++..++.++.|++.||+|||+++   ++||||||+||+++.++.++|+|||.+.......
T Consensus        82 ~~~~~~l~~~~~~~---~~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~  155 (292)
T d1unla_          82 FCDQDLKKYFDSCN---GDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPV  155 (292)
T ss_dssp             CCSEEHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSCC
T ss_pred             eccccccccccccc---cccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecchhhcccCCC
Confidence            99999988877543   34789999999999999999999999   9999999999999999999999999998765433


Q ss_pred             cccccccccccccccCchhhccCC-CCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhh-------------
Q 017594          206 LQANTSRIVGTYGYMSPEYALEGI-FSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLW-------------  271 (369)
Q Consensus       206 ~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~-------------  271 (369)
                      .  ......++..|.|||++.+.. ++.++|||||||++|+|++|+.||..................             
T Consensus       156 ~--~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (292)
T d1unla_         156 R--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKL  233 (292)
T ss_dssp             S--CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGS
T ss_pred             c--cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhc
Confidence            2  222335678899999887655 689999999999999999999997543321111000000000             


Q ss_pred             hcCccccccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 017594          272 TSNRTLELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPTMNDVVS  320 (369)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~  320 (369)
                      ......................+..+.+||.+||+.||.+|||++|+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~  282 (292)
T d1unla_         234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             TTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             ccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            0000000000000000111122567899999999999999999999986

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-44  Score=330.57  Aligned_cols=268  Identities=18%  Similarity=0.218  Sum_probs=195.8

Q ss_pred             HhcCCccCccccccCCccEEEEEEc-CCCEEEEEEecCCC-chhHHHHHHHHHHHhcCCCCceeeeeeeEEeCC----cc
Q 017594           47 ATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS-GQGLREMKNEASVIAKVQHKNLVRLLGCCIDRD----EK  120 (369)
Q Consensus        47 ~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----~~  120 (369)
                      +..+|++++.||+|+||+||+|+++ +|+.||||++.... ....+.+.+|+.+|+.++|||++++++++....    ..
T Consensus         6 i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~   85 (345)
T d1pmea_           6 VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD   85 (345)
T ss_dssp             CCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred             cCCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccce
Confidence            3478999999999999999999965 59999999997543 334567889999999999999999999987543    23


Q ss_pred             EEEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCcee
Q 017594          121 ILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMARI  200 (369)
Q Consensus       121 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~~  200 (369)
                      +++++++.+++|.+++..    ..+++..++.++.||+.||+|||++|   ++||||||+||+++.++.++|+|||++..
T Consensus        86 ~~l~~~~~~g~L~~~l~~----~~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~~  158 (345)
T d1pmea_          86 VYLVTHLMGADLYKLLKT----QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARV  158 (345)
T ss_dssp             EEEEEECCCEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEEEeecCCchhhhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEcccCceee
Confidence            555666779999998843    24899999999999999999999999   99999999999999999999999999987


Q ss_pred             cCCCCcc-cccccccccccccCchhhc-cCCCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchh-h-----hhhhh
Q 017594          201 CGGNELQ-ANTSRIVGTYGYMSPEYAL-EGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGY-A-----WDLWT  272 (369)
Q Consensus       201 ~~~~~~~-~~~~~~~~~~~y~aPE~~~-~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~-~-----~~~~~  272 (369)
                      ....... .......|++.|+|||++. +..++.++||||+||++|+|++|..||............. .     .....
T Consensus       159 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  238 (345)
T d1pmea_         159 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLN  238 (345)
T ss_dssp             CCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHH
T ss_pred             ccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhh
Confidence            6443222 2234456899999999985 5567899999999999999999999996543111000000 0     00000


Q ss_pred             cC------ccccccCccccccc--cHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 017594          273 SN------RTLELIDPILEDEY--SSKQMLLRYANIALLCVQESADDRPTMNDVVSM  321 (369)
Q Consensus       273 ~~------~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~  321 (369)
                      ..      ..............  .....+.++.+||.+||+.||.+|||+.++++.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h  295 (345)
T d1pmea_         239 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH  295 (345)
T ss_dssp             TCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             hhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            00      00000000000000  001124568999999999999999999999974

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.9e-44  Score=329.21  Aligned_cols=263  Identities=23%  Similarity=0.245  Sum_probs=192.4

Q ss_pred             HhcCCccCccccccCCccEEEEEEc-CCCEEEEEEecCCC--chhHHHHHHHHHHHhcCCCCceeeeeeeEEeC------
Q 017594           47 ATNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS--GQGLREMKNEASVIAKVQHKNLVRLLGCCIDR------  117 (369)
Q Consensus        47 ~~~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------  117 (369)
                      +.++|++++.||+|+||+||+|++. +|+.||||++....  ......+.+|+.++++++||||++++++|...      
T Consensus        15 i~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~   94 (355)
T d2b1pa1          15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF   94 (355)
T ss_dssp             EETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred             ecCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccC
Confidence            3478999999999999999999976 49999999997542  34455688999999999999999999999643      


Q ss_pred             CccEEEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCC
Q 017594          118 DEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGM  197 (369)
Q Consensus       118 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~  197 (369)
                      ...|+||||+.++++..+.      ..+++..++.++.||+.||.|||++|   ++||||||+||+++.++.++++|||+
T Consensus        95 ~~~~iv~Ey~~~~l~~~~~------~~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~~  165 (355)
T d2b1pa1          95 QDVYLVMELMDANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL  165 (355)
T ss_dssp             CEEEEEEECCSEEHHHHHT------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC
T ss_pred             ceeEEEEeccchHHHHhhh------cCCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceeeechhh
Confidence            5679999999877665443      23789999999999999999999999   99999999999999999999999999


Q ss_pred             ceecCCCCcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCccccccc--------------
Q 017594          198 ARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNL--------------  263 (369)
Q Consensus       198 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~--------------  263 (369)
                      +.......   ......+|+.|+|||++.+..++.++||||+||++++|++|+.||..........              
T Consensus       166 ~~~~~~~~---~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~  242 (355)
T d2b1pa1         166 ARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM  242 (355)
T ss_dssp             ------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred             hhcccccc---ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHH
Confidence            87654332   2334468999999999999999999999999999999999999996443111000              


Q ss_pred             ---chhhhhhhhcCc------cccccCccc-cc-cccHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 017594          264 ---LGYAWDLWTSNR------TLELIDPIL-ED-EYSSKQMLLRYANIALLCVQESADDRPTMNDVVSM  321 (369)
Q Consensus       264 ---~~~~~~~~~~~~------~~~~~~~~~-~~-~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~~  321 (369)
                         ............      ......... .. .......+.++.+||.+||+.||++||||+|+|+.
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H  311 (355)
T d2b1pa1         243 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH  311 (355)
T ss_dssp             TTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             HHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence               000000000000      000000011 11 11234457889999999999999999999999964

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-43  Score=325.17  Aligned_cols=265  Identities=22%  Similarity=0.280  Sum_probs=194.7

Q ss_pred             hcCCccCccccccCCccEEEEEEc-CCCEEEEEEecCCC--chhHHHHHHHHHHHhcCCCCceeeeeeeEEeC-----Cc
Q 017594           48 TNKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRS--GQGLREMKNEASVIAKVQHKNLVRLLGCCIDR-----DE  119 (369)
Q Consensus        48 ~~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~  119 (369)
                      .+||++++.||+|+||+||+|++. +|+.||||++....  ....+.+.+|+.+|+.++|||++++++++...     ..
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~   96 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN   96 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred             CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence            579999999999999999999965 59999999997543  33456788999999999999999999998643     33


Q ss_pred             cEEEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCce
Q 017594          120 KILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMAR  199 (369)
Q Consensus       120 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~  199 (369)
                      .+++++++.+++|.+++..    ..+++..++.++.||+.||+|||++|   ++||||||+||+++.++.++++|||++.
T Consensus        97 ~~~i~~~~~gg~L~~~~~~----~~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~a~  169 (348)
T d2gfsa1          97 DVYLVTHLMGADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR  169 (348)
T ss_dssp             CCEEEEECCSEEHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC----
T ss_pred             eEEEEEeecCCchhhhccc----ccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCccccccccccccccccchhc
Confidence            4667778889999998843    24899999999999999999999999   9999999999999999999999999987


Q ss_pred             ecCCCCcccccccccccccccCchhhccC-CCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchh------hhhhhh
Q 017594          200 ICGGNELQANTSRIVGTYGYMSPEYALEG-IFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGY------AWDLWT  272 (369)
Q Consensus       200 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~------~~~~~~  272 (369)
                      ....     ......|+..|+|||+..+. .++.++|||||||++|+|++|..||.............      ......
T Consensus       170 ~~~~-----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~  244 (348)
T d2gfsa1         170 HTDD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK  244 (348)
T ss_dssp             CCTG-----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHT
T ss_pred             ccCc-----ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhh
Confidence            5432     22334688999999987765 46899999999999999999999996543111000000      000000


Q ss_pred             ---cC---ccccccCccccccc--cHHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH--HHHh
Q 017594          273 ---SN---RTLELIDPILEDEY--SSKQMLLRYANIALLCVQESADDRPTMNDVVS--MLTN  324 (369)
Q Consensus       273 ---~~---~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~--~L~~  324 (369)
                         ..   ..............  .....+.++.+||.+||+.||++|||+.|+++  .|++
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~  306 (348)
T d2gfsa1         245 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ  306 (348)
T ss_dssp             TCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTT
T ss_pred             hccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCC
Confidence               00   00000000000000  00112567899999999999999999999997  4444

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-43  Score=321.81  Aligned_cols=252  Identities=22%  Similarity=0.289  Sum_probs=199.0

Q ss_pred             cCCccCccccccCCccEEEEEEc----CCCEEEEEEecCC----CchhHHHHHHHHHHHhcCCC-CceeeeeeeEEeCCc
Q 017594           49 NKFSDANKLGEGGFGPVYKGVLK----KGDEIAVKRLSGR----SGQGLREMKNEASVIAKVQH-KNLVRLLGCCIDRDE  119 (369)
Q Consensus        49 ~~y~i~~~lg~G~~~~v~~~~~~----~~~~valK~~~~~----~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~  119 (369)
                      ++|++++.||+|+||+||+|+..    +|+.||+|++...    +....+.+.+|++++++++| |||+++++++.+...
T Consensus        24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~  103 (322)
T d1vzoa_          24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK  103 (322)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred             hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence            67999999999999999999852    3789999998643    22334567789999999976 899999999999999


Q ss_pred             cEEEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEEeecCCce
Q 017594          120 KILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKISDFGMAR  199 (369)
Q Consensus       120 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~  199 (369)
                      .++++||+.+++|.+++..   ...+++..++.++.||+.||.|||+++   ++||||||+||+++.++.++|+|||++.
T Consensus       104 ~~~v~e~~~~~~L~~~i~~---~~~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG~a~  177 (322)
T d1vzoa_         104 LHLILDYINGGELFTHLSQ---RERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSK  177 (322)
T ss_dssp             EEEEECCCCSCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred             eeeeeecccccHHHHHHHh---cccccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEEeeccchh
Confidence            9999999999999988854   334788999999999999999999999   9999999999999999999999999998


Q ss_pred             ecCCCCcccccccccccccccCchhhccC--CCCcccchHhHHHHHHHHHhCCCCCCCCcccccccchhhhhhhhcCccc
Q 017594          200 ICGGNELQANTSRIVGTYGYMSPEYALEG--IFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNLLGYAWDLWTSNRTL  277 (369)
Q Consensus       200 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  277 (369)
                      .+...... ......+++.|+|||.+.+.  .++.++|||||||++|+|++|..||.......... .......... . 
T Consensus       178 ~~~~~~~~-~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~-~i~~~~~~~~-~-  253 (322)
T d1vzoa_         178 EFVADETE-RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQA-EISRRILKSE-P-  253 (322)
T ss_dssp             ECCGGGGG-GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHH-HHHHHHHHCC-C-
T ss_pred             hhcccccc-cccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHH-HHHHhcccCC-C-
Confidence            76533222 22345789999999998754  46889999999999999999999997544222111 0111110000 0 


Q ss_pred             cccCccccccccHHHHHHHHHHHHHHhhcCCCCCCCC-----HHHHHH
Q 017594          278 ELIDPILEDEYSSKQMLLRYANIALLCVQESADDRPT-----MNDVVS  320 (369)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps-----~~ell~  320 (369)
                           ..     +..++.++.+||.+||++||.+|||     ++|+++
T Consensus       254 -----~~-----~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~  291 (322)
T d1vzoa_         254 -----PY-----PQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE  291 (322)
T ss_dssp             -----CC-----CTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred             -----CC-----cccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence                 00     1123677999999999999999994     889986

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=5.9e-39  Score=297.42  Aligned_cols=264  Identities=20%  Similarity=0.230  Sum_probs=188.3

Q ss_pred             cCCccCccccccCCccEEEEEEc-CCCEEEEEEecCCCchhHHHHHHHHHHHhcCC-----------CCceeeeeeeEEe
Q 017594           49 NKFSDANKLGEGGFGPVYKGVLK-KGDEIAVKRLSGRSGQGLREMKNEASVIAKVQ-----------HKNLVRLLGCCID  116 (369)
Q Consensus        49 ~~y~i~~~lg~G~~~~v~~~~~~-~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~-----------h~~i~~~~~~~~~  116 (369)
                      +||++++.||+|+||+||+|++. +|+.||||++.... ...+.+.+|+.+++.+.           |+||+++++++..
T Consensus        13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~   91 (362)
T d1q8ya_          13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH   91 (362)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred             CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence            57999999999999999999975 58999999997543 33466778888888775           5789999988765


Q ss_pred             C--CccEEEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhc-CCCCCcccCCCCCCCEEEeCCCc----
Q 017594          117 R--DEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQ-YSRVRIIHRDLKASNILLDKDMN----  189 (369)
Q Consensus       117 ~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~-~~~~~i~H~dl~p~NIlv~~~~~----  189 (369)
                      .  ...++++.++.................+++..++.++.||+.||.|||+ .|   |+||||||+||+++.++.    
T Consensus        92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll~~~~~~~~~  168 (362)
T d1q8ya_          92 KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPENL  168 (362)
T ss_dssp             EETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTTTE
T ss_pred             ccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcC---cccccCChhHeeeeccCccccc
Confidence            3  4456666666555433333223344558889999999999999999997 77   999999999999986653    


Q ss_pred             --eEEeecCCceecCCCCcccccccccccccccCchhhccCCCCcccchHhHHHHHHHHHhCCCCCCCCccccccc-chh
Q 017594          190 --PKISDFGMARICGGNELQANTSRIVGTYGYMSPEYALEGIFSIKSDVFSFGVLLLEIVSGKKNTGLYRTDSLNL-LGY  266 (369)
Q Consensus       190 --~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~-~~~  266 (369)
                        ++++|||.+.....     ......+++.|+|||++.+..++.++|+||+||++++|++|+.||.......... ...
T Consensus       169 ~~~kl~dfg~s~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~  243 (362)
T d1q8ya_         169 IQIKIADLGNACWYDE-----HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDH  243 (362)
T ss_dssp             EEEEECCCTTCEETTB-----CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHH
T ss_pred             ceeeEeeccccccccc-----ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHH
Confidence              89999999875432     2234568999999999999999999999999999999999999997543211100 000


Q ss_pred             hh---------------------hhhhcCccccccCcccc---------ccccHHHHHHHHHHHHHHhhcCCCCCCCCHH
Q 017594          267 AW---------------------DLWTSNRTLELIDPILE---------DEYSSKQMLLRYANIALLCVQESADDRPTMN  316 (369)
Q Consensus       267 ~~---------------------~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~  316 (369)
                      ..                     ..+........+.....         ........+.++.+||.+||+.||++|||++
T Consensus       244 ~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~  323 (362)
T d1q8ya_         244 IAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAG  323 (362)
T ss_dssp             HHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHH
T ss_pred             HHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHH
Confidence            00                     00000000001000000         0011234578899999999999999999999


Q ss_pred             HHHHH
Q 017594          317 DVVSM  321 (369)
Q Consensus       317 ell~~  321 (369)
                      |+|+.
T Consensus       324 e~L~H  328 (362)
T d1q8ya_         324 GLVNH  328 (362)
T ss_dssp             HHHTC
T ss_pred             HHhcC
Confidence            99873

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.88  E-value=3.5e-23  Score=173.15  Aligned_cols=165  Identities=18%  Similarity=0.185  Sum_probs=120.4

Q ss_pred             CccCccccccCCccEEEEEEcCCCEEEEEEecCCCc------------------hhHHHHHHHHHHHhcCCCCceeeeee
Q 017594           51 FSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSG------------------QGLREMKNEASVIAKVQHKNLVRLLG  112 (369)
Q Consensus        51 y~i~~~lg~G~~~~v~~~~~~~~~~valK~~~~~~~------------------~~~~~~~~e~~~l~~l~h~~i~~~~~  112 (369)
                      +.+.++||+|+||.||+|++.+|+.||+|++.....                  ........|...+.++.|.+++..++
T Consensus         2 ~~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~   81 (191)
T d1zara2           2 DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA   81 (191)
T ss_dssp             SEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred             chhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence            356789999999999999988899999998753210                  01123345788899999999888775


Q ss_pred             eEEeCCccEEEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCCCCCcccCCCCCCCEEEeCCCceEE
Q 017594          113 CCIDRDEKILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYSRVRIIHRDLKASNILLDKDMNPKI  192 (369)
Q Consensus       113 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~~~~i~H~dl~p~NIlv~~~~~~~L  192 (369)
                      +.    ..+++||++++..+..          ++......++.|++.++.+||++|   ++||||||+||+++.+ .++|
T Consensus        82 ~~----~~~lvme~~~~~~~~~----------l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~-~~~l  143 (191)
T d1zara2          82 WE----GNAVLMELIDAKELYR----------VRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEE-GIWI  143 (191)
T ss_dssp             EE----TTEEEEECCCCEEGGG----------CCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETT-EEEE
T ss_pred             ec----CCEEEEEeeccccccc----------hhhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCC-CEEE
Confidence            53    3589999998765432          344456789999999999999999   9999999999999865 5899


Q ss_pred             eecCCceecCCCCcccccccccccccccCch-----hhccCCCCcccchHhHHHHH
Q 017594          193 SDFGMARICGGNELQANTSRIVGTYGYMSPE-----YALEGIFSIKSDVFSFGVLL  243 (369)
Q Consensus       193 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE-----~~~~~~~~~~~DiwslG~il  243 (369)
                      +|||.+.........          .|+...     .+....|+.++|+||+.--+
T Consensus       144 iDFG~a~~~~~~~~~----------~~l~rd~~~~~~~f~r~y~~~~d~~s~~~~~  189 (191)
T d1zara2         144 IDFPQSVEVGEEGWR----------EILERDVRNIITYFSRTYRTEKDINSAIDRI  189 (191)
T ss_dssp             CCCTTCEETTSTTHH----------HHHHHHHHHHHHHHHHHHCCCCCHHHHHHHH
T ss_pred             EECCCcccCCCCCcH----------HHHHHHHHHHHHHHcCCCCCcccHHHHHHHH
Confidence            999998765422211          111110     01245678899999986443

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.93  E-value=3.3e-09  Score=91.27  Aligned_cols=149  Identities=16%  Similarity=0.120  Sum_probs=107.7

Q ss_pred             hhHHHHhcCCccCccccccCCccEEEEEEcCCCEEEEEEecCCCchhHHHHHHHHHHHhcCC-CCceeeeeeeEEeCCcc
Q 017594           42 SSVSTATNKFSDANKLGEGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQ-HKNLVRLLGCCIDRDEK  120 (369)
Q Consensus        42 ~~~~~~~~~y~i~~~lg~G~~~~v~~~~~~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~  120 (369)
                      +.+......|++.+..+.++.+.||++.. +++.+++|+...........+..|...+..+. +--+.+++.+...++..
T Consensus         7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~   85 (263)
T d1j7la_           7 PELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWS   85 (263)
T ss_dssp             HHHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEE
T ss_pred             HHHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCce
Confidence            45666677888888776666678998864 46678889886554444456777888887774 33466777777778888


Q ss_pred             EEEEEecCCCChhhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCC--------------------------------
Q 017594          121 ILIYEYMPNKSLDFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYS--------------------------------  168 (369)
Q Consensus       121 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~--------------------------------  168 (369)
                      ++||++++|.++......        ......++.+++..+..||+..                                
T Consensus        86 ~lv~~~l~G~~~~~~~~~--------~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (263)
T d1j7la_          86 NLLMSEADGVLCSEEYED--------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCEN  157 (263)
T ss_dssp             EEEEECCSSEEHHHHTTT--------CSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGG
T ss_pred             EEEEEecccccccccccc--------cccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhc
Confidence            999999999888655421        1223345667777888888643                                


Q ss_pred             ------------------------CCCcccCCCCCCCEEEeCCCceEEeecCCce
Q 017594          169 ------------------------RVRIIHRDLKASNILLDKDMNPKISDFGMAR  199 (369)
Q Consensus       169 ------------------------~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~  199 (369)
                                              ...++|||+.|.||+++.++.+.|+||+.+.
T Consensus       158 ~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T d1j7la_         158 WEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             GSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             ccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence                                    0147999999999999977666799998764

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=98.33  E-value=2.8e-06  Score=71.93  Aligned_cols=130  Identities=16%  Similarity=0.155  Sum_probs=89.4

Q ss_pred             cccccCC-ccEEEEEEcCCCEEEEEEecCCCchhHHHHHHHHHHHhcCCC--CceeeeeeeEEeCCccEEEEEecCCCCh
Q 017594           56 KLGEGGF-GPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQH--KNLVRLLGCCIDRDEKILIYEYMPNKSL  132 (369)
Q Consensus        56 ~lg~G~~-~~v~~~~~~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h--~~i~~~~~~~~~~~~~~lv~e~~~~~~L  132 (369)
                      .+..|.. +.||++...++..+++|.......   ..+..|+..++.+..  -.+.+++.+..+.+..++||++++|.++
T Consensus        17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~---~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~   93 (255)
T d1nd4a_          17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL---NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL   93 (255)
T ss_dssp             ECSCTTSSCEEEEEECTTSCCEEEEEECSCTT---SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred             EcCCcccCCeEEEEEeCCCCEEEEEeCCccCH---hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence            3344443 678999988888899998765443   346677777776632  3366677777777888999999988766


Q ss_pred             hhhhcCCCccccCChHHHHHHHHHHHHHHHHHhcCC--------------------------------------------
Q 017594          133 DFFLFDPTKRMLLDWVTRVQIIEGIAQGLLYLHQYS--------------------------------------------  168 (369)
Q Consensus       133 ~~~l~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~--------------------------------------------  168 (369)
                      ....        ...   ...+.++...|..||...                                            
T Consensus        94 ~~~~--------~~~---~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (255)
T d1nd4a_          94 LSSH--------LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELF  162 (255)
T ss_dssp             TTSC--------CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHH
T ss_pred             cccc--------ccH---HHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHH
Confidence            3321        111   123445666666666532                                            


Q ss_pred             -----------CCCcccCCCCCCCEEEeCCCceEEeecCCce
Q 017594          169 -----------RVRIIHRDLKASNILLDKDMNPKISDFGMAR  199 (369)
Q Consensus       169 -----------~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~  199 (369)
                                 ...++|||+.|.||+++.+..+.|+||+.+.
T Consensus       163 ~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~  204 (255)
T d1nd4a_         163 ARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG  204 (255)
T ss_dssp             HHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             HHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence                       1147999999999999987667899998764

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.94  E-value=2.3e-05  Score=70.75  Aligned_cols=77  Identities=13%  Similarity=0.232  Sum_probs=49.5

Q ss_pred             CccccccCCccEEEEEEcC-CCEEEEEEecCC-------CchhHHHHHHHHHHHhcCC-C-C-ceeeeeeeEEeCCccEE
Q 017594           54 ANKLGEGGFGPVYKGVLKK-GDEIAVKRLSGR-------SGQGLREMKNEASVIAKVQ-H-K-NLVRLLGCCIDRDEKIL  122 (369)
Q Consensus        54 ~~~lg~G~~~~v~~~~~~~-~~~valK~~~~~-------~~~~~~~~~~e~~~l~~l~-h-~-~i~~~~~~~~~~~~~~l  122 (369)
                      .+.||.|....||++...+ ++.+++|.-...       ......+...|++.|+.+. + | .+++++.+  +....++
T Consensus        31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l  108 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  108 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence            4578999999999998654 678999964321       1123345566888887663 2 3 34455433  5667899


Q ss_pred             EEEecCCCCh
Q 017594          123 IYEYMPNKSL  132 (369)
Q Consensus       123 v~e~~~~~~L  132 (369)
                      |||++.+..+
T Consensus       109 vmE~L~~~~~  118 (392)
T d2pula1         109 VMEDLSHLKI  118 (392)
T ss_dssp             EECCCTTSEE
T ss_pred             EEeccCCccc
Confidence            9999976543

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=97.47  E-value=0.00021  Score=62.03  Aligned_cols=158  Identities=11%  Similarity=-0.038  Sum_probs=81.7

Q ss_pred             cchhhHHHHhcCCccCcccc-----ccCCccEEEEEEcCCCEEEEEEecCCCchhHHHHHHHHHHHhcCCC-----Ccee
Q 017594           39 FSFSSVSTATNKFSDANKLG-----EGGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQH-----KNLV  108 (369)
Q Consensus        39 ~~~~~~~~~~~~y~i~~~lg-----~G~~~~v~~~~~~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h-----~~i~  108 (369)
                      .+...+..+..+|.+.+...     .|---+.|.++..+| .+++|++....  ....+..++..+..|..     |..+
T Consensus         3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g-~yVLri~~~~~--~~~~l~~~~~~l~~L~~~g~pvp~pi   79 (316)
T d2ppqa1           3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPL   79 (316)
T ss_dssp             CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred             CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCC-cEEEEEcCCCC--CHHHHHHHHHHHHhhhhccccccccc
Confidence            35567778888898755443     566678899987765 47899886432  12445556666666632     2221


Q ss_pred             eee---eeEEeCCccEEEEEecCCCChhhhh------------------cC--CCc------------------cccCCh
Q 017594          109 RLL---GCCIDRDEKILIYEYMPNKSLDFFL------------------FD--PTK------------------RMLLDW  147 (369)
Q Consensus       109 ~~~---~~~~~~~~~~lv~e~~~~~~L~~~l------------------~~--~~~------------------~~~~~~  147 (369)
                      ...   .+.........++.++.+.......                  ..  ...                  ......
T Consensus        80 ~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (316)
T d2ppqa1          80 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE  159 (316)
T ss_dssp             CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred             eecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcc
Confidence            110   0112234455666665554321100                  00  000                  000011


Q ss_pred             HHHHHHHHHHHHHHHHHhcCC-CCCcccCCCCCCCEEEeCCCceEEeecCCce
Q 017594          148 VTRVQIIEGIAQGLLYLHQYS-RVRIIHRDLKASNILLDKDMNPKISDFGMAR  199 (369)
Q Consensus       148 ~~~~~i~~qi~~al~~LH~~~-~~~i~H~dl~p~NIlv~~~~~~~L~Dfg~~~  199 (369)
                      ......+..+...+...+..+ ..+++|+|+.++||+++.+...-++||+.+.
T Consensus       160 ~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         160 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             hhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence            111122222222223222211 2369999999999999988777999999865

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=97.34  E-value=0.0003  Score=63.25  Aligned_cols=73  Identities=12%  Similarity=0.191  Sum_probs=49.5

Q ss_pred             CccccccCCccEEEEEEcC--------CCEEEEEEecCCCchhHHHHHHHHHHHhcCC-CCceeeeeeeEEeCCccEEEE
Q 017594           54 ANKLGEGGFGPVYKGVLKK--------GDEIAVKRLSGRSGQGLREMKNEASVIAKVQ-HKNLVRLLGCCIDRDEKILIY  124 (369)
Q Consensus        54 ~~~lg~G~~~~v~~~~~~~--------~~~valK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~  124 (369)
                      ++.|+.|-.-.+|++...+        .+.|++++....  .......+|..+++.+. +.-..+++.++.    -++|+
T Consensus        47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~--~~~idr~~E~~i~~~ls~~gl~Pkll~~~~----~g~I~  120 (395)
T d1nw1a_          47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFS----GGRLE  120 (395)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEET----TEEEE
T ss_pred             EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc--chhhHHHHHHHHHHHHHhCCCCCeEEEEcC----CceEE
Confidence            4578889999999998653        356777776532  23345667888888874 333456666653    37889


Q ss_pred             EecCCCCh
Q 017594          125 EYMPNKSL  132 (369)
Q Consensus       125 e~~~~~~L  132 (369)
                      +|++|..+
T Consensus       121 efi~g~~l  128 (395)
T d1nw1a_         121 EYIPSRPL  128 (395)
T ss_dssp             CCCCEEEC
T ss_pred             EEeccccC
Confidence            99987654

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=97.34  E-value=0.00088  Score=58.34  Aligned_cols=72  Identities=7%  Similarity=0.007  Sum_probs=46.8

Q ss_pred             cCCccEEEEEEcCCCEEEEEEecCCCchhHHHHHHHHHHHhcCCCCce--eeee-----eeEEeCCccEEEEEecCCCCh
Q 017594           60 GGFGPVYKGVLKKGDEIAVKRLSGRSGQGLREMKNEASVIAKVQHKNL--VRLL-----GCCIDRDEKILIYEYMPNKSL  132 (369)
Q Consensus        60 G~~~~v~~~~~~~~~~valK~~~~~~~~~~~~~~~e~~~l~~l~h~~i--~~~~-----~~~~~~~~~~lv~e~~~~~~L  132 (369)
                      +....||++...+|..|++|+.... ....+++..|...+..|....+  +...     ..+..+...+.+++++.|..+
T Consensus        33 s~EN~vy~v~~~dg~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~  111 (325)
T d1zyla1          33 SYENRVYQFQDEDRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQF  111 (325)
T ss_dssp             CSSSEEEEECCTTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEEC
T ss_pred             cccceeEEEEcCCCCEEEEEEeCCC-CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCC
Confidence            4456899999988999999998643 2344677788888777742211  1111     222345567888998876543